Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" A4GALT "A14GALT, Gb3S, P(k), P1" ENSG00000128274 "Alpha 1,4-galactosyltransferase (P blood group)" Q9NPC4 22 42692112-42721298 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 21.5;ASC TERT1: 17.6;TIME: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "NK-cell: 1.4;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 13 "dendritic cells: 3.4;NK-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001141 Uncertain Mitochondria Mitochondria "HPA001141: AB_1078139" "unprognostic (2.59e-2)" "prognostic favourable (2.48e-4)" "unprognostic (2.24e-2)" "unprognostic (4.54e-3)" "unprognostic (7.41e-2)" "unprognostic (1.53e-1)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-1)" "unprognostic (1.28e-1)" "unprognostic (4.82e-3)" "unprognostic (4.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (8.72e-2)" "unprognostic (3.46e-2)" "unprognostic (2.74e-1)" 22.7 5.9 3.5 8.2 3.7 3.8 15.3 1.4 3.8 21.2 12.0 2.3 32.6 4.8 13.0 16.9 15.0 11.7 11.0 26.8 2.3 1.3 30.0 4.4 14.0 6.4 2.9 3.0 11.8 3.4 1.4 7.7 12.6 2.9 15.4 2.1 9.9 15.4 39.8 12.5 8.7 7.0 18.6 5.3 11.4 11.3 6.7 2.4 1.3 10.7 13.0 10.1 16.1 25.6 0.1 3.4 0.0 0.0 1.4 0.0 0.0 0.6 7.3 0.0 0.0 21.5 17.6 11.0 2.9 3.1 0.6 1.1 2.3 1.2 7.1 5.1 5.1 0.7 7.0 3.4 0.1 0.0 1.4 0.1 11.5 0.2 6.5 0.0 0.5 10.3 1.0 3.0 0.5 2.5 0.0 0.0 2.7 10.0 0.0 0.0 0.9 1.8 0.0 1.6 0.7 14.5 12.5 0.1 0.0 8.9 0.2 0.0 5.7 0.8 15.4 0.0 1.4 13.1 3.8 1.5 6.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.4 0.0 0.0 3.5 3.7 1.4 3.8 2.3 1.3 2.9 3.0 2.9 2.4 AACS "ACSF1, FLJ12389, SUR-5" ENSG00000081760 "Acetoacetyl-CoA synthetase" Q86V21 12 125065379-125143333 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058815 Approved Approved Vesicles Vesicles "HPA058815: " "unprognostic (1.28e-1)" "unprognostic (9.78e-2)" "unprognostic (1.86e-1)" "unprognostic (1.06e-1)" "unprognostic (1.98e-3)" "unprognostic (9.46e-3)" "unprognostic (6.60e-6)" "unprognostic (3.03e-2)" "unprognostic (3.32e-2)" "unprognostic (2.45e-2)" "unprognostic (2.38e-2)" "unprognostic (3.04e-1)" "unprognostic (2.69e-2)" "unprognostic (1.69e-1)" "unprognostic (3.73e-2)" "unprognostic (7.71e-2)" "unprognostic (6.80e-2)" 21.1 6.5 9.0 10.5 13.0 2.5 33.7 6.6 22.0 11.7 9.3 5.3 7.4 12.9 5.2 7.7 22.3 6.6 12.9 5.8 8.1 5.6 6.8 3.3 4.9 4.9 5.1 13.1 4.9 9.7 5.8 6.7 4.8 10.0 6.7 8.6 5.1 33.7 12.9 3.7 26.9 8.7 4.5 4.2 4.3 12.7 9.7 3.6 6.8 7.6 12.2 8.7 5.0 9.9 3.0 11.8 6.9 2.3 5.8 5.7 3.8 14.5 14.5 6.3 8.6 23.4 15.3 10.6 11.8 11.3 14.0 12.6 18.7 9.7 9.0 12.2 14.2 15.9 11.8 12.7 7.6 9.7 10.8 7.2 9.7 14.2 19.5 5.1 7.3 16.9 10.4 11.9 12.1 10.2 5.0 5.6 8.9 26.6 5.9 6.8 8.0 17.2 1.1 16.1 12.4 14.3 22.2 17.0 4.9 12.5 19.8 9.1 14.8 11.3 9.7 6.8 10.8 7.6 9.0 12.7 7.2 9.8 8.5 8.4 7.4 6.9 2.3 6.7 4.2 0.7 5.4 3.0 3.9 3.2 2.8 1.7 5.7 3.8 0.3 5.8 0.8 11.8 2.4 3.8 9.0 13.0 6.6 22.0 8.1 5.6 5.1 13.1 10.0 3.6 AASDH "ACSF4, LYS2, NRPS998" ENSG00000157426 "Aminoadipate-semialdehyde dehydrogenase" Q4L235 4 56338287-56387508 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036472, HPA036473" Approved "HPA036472: , HPA036473: AB_10673656" "unprognostic (1.95e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (5.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (8.75e-2)" "unprognostic (1.29e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-3)" "unprognostic (1.59e-1)" "unprognostic (1.73e-1)" "unprognostic (4.52e-2)" "unprognostic (1.85e-3)" 9.4 13.5 12.0 7.4 15.4 6.8 14.5 28.9 15.6 10.7 8.0 10.2 12.5 7.5 11.7 14.6 10.3 12.3 7.5 7.9 12.8 7.5 11.5 10.7 8.0 9.8 12.9 13.3 15.3 8.1 16.8 28.9 8.4 14.5 11.4 10.1 11.0 11.3 9.9 9.4 12.4 8.6 9.9 12.4 9.4 8.9 8.2 16.0 12.0 12.4 6.9 11.0 11.1 11.0 5.2 3.9 2.5 4.2 4.4 7.7 2.4 5.0 3.4 8.9 6.8 13.6 15.8 5.5 6.3 7.6 6.6 5.7 3.8 10.4 10.9 6.0 6.9 3.2 6.4 6.4 7.4 4.4 6.4 5.1 5.9 4.9 12.1 9.3 3.8 9.0 10.7 7.0 10.5 10.0 11.7 5.6 7.5 4.9 10.9 7.8 5.0 5.0 8.2 4.4 5.0 9.4 4.3 6.0 5.8 7.2 11.6 7.2 9.1 6.0 6.8 4.4 6.0 4.6 4.5 4.5 3.5 7.1 7.0 8.5 4.7 0.0 3.6 2.5 5.1 4.2 6.9 4.3 5.2 4.4 3.9 5.2 7.7 5.6 0.7 4.4 2.7 3.3 4.9 2.4 12.0 15.4 28.9 15.6 12.8 7.5 12.9 13.3 14.5 16.0 AATK "AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77" ENSG00000181409 "Apoptosis associated tyrosine kinase" Q6ZMQ8 17 81117295-81166077 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;intestine: 28.7" "Group enriched" "Detected in some" 6 "CACO-2: 29.6;SH-SY5Y: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 21 "granulocytes: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009073 Enhanced Uncertain Mitochondria Mitochondria "HPA009073: AB_1078076" "unprognostic (3.47e-3)" "unprognostic (3.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.95e-4)" "unprognostic (1.96e-1)" "unprognostic (1.94e-1)" "unprognostic (7.29e-2)" "unprognostic (9.85e-2)" "unprognostic (6.09e-2)" "unprognostic (4.27e-2)" "unprognostic (2.88e-3)" "unprognostic (2.48e-1)" "unprognostic (4.28e-6)" "unprognostic (1.58e-3)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (4.57e-2)" 2.8 4.7 14.3 3.2 16.6 3.7 0.9 19.0 29.0 1.2 3.3 16.5 0.0 28.7 1.0 1.1 1.7 1.2 2.7 2.3 23.6 13.9 1.2 1.2 9.7 1.5 20.1 13.6 1.0 17.9 3.6 6.4 2.6 11.0 2.4 1.1 4.1 5.6 3.6 1.1 1.9 20.3 1.3 35.3 5.9 4.5 1.3 9.8 0.0 1.3 0.0 1.0 1.3 1.1 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 1.6 1.1 1.4 1.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 3.1 0.0 0.1 0.5 0.1 1.3 2.4 0.2 0.0 0.0 2.8 10.2 0.2 0.0 1.4 0.3 0.8 1.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 14.3 16.6 19.0 22.3 23.6 13.9 20.1 13.6 11.0 9.8 ABCA12 "DKFZP434G232, ICR2B, LI2" ENSG00000144452 "ATP binding cassette subfamily A member 12" Q86UK0 2 214931542-215138428 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 23.1;tongue: 29.3" "Cell line enhanced" "Detected in some" "hTCEpi: 28.0;SK-BR-3: 13.1;T-47d: 6.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebral cortex: 1.6;hippocampal formation: 1.8" HPA078239 Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoli, Cytosol" "HPA078239: " "unprognostic (6.12e-2)" "unprognostic (4.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.49e-1)" "unprognostic (2.13e-1)" "unprognostic (2.09e-4)" "unprognostic (6.52e-3)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (2.50e-2)" "unprognostic (7.69e-2)" "unprognostic (5.92e-2)" "unprognostic (2.64e-2)" "unprognostic (2.36e-1)" "unprognostic (5.08e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 6.9 0.1 0.1 6.2 0.3 0.0 1.4 0.0 0.0 4.4 8.4 0.1 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 6.1 4.9 0.0 0.1 0.4 0.0 0.3 0.0 0.1 23.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.1 0.0 29.3 6.1 0.1 3.7 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.0 0.0 2.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 2.0 0.0 13.1 0.0 6.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.0 0.0 ABCA2 ABC2 ENSG00000107331 "ATP binding cassette subfamily A member 2" Q9BZC7 9 137007227-137028922 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 84.3" "Cell line enhanced" "Detected in many" "T-47d: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "dendritic cells: 2.7;NK-cells: 1.2;T-cells: 2.2" "Low region specificity" "Detected in all" HPA042886 Approved "HPA042886: " "unprognostic (1.01e-2)" "unprognostic (9.21e-3)" "unprognostic (9.59e-2)" "unprognostic (6.15e-2)" "unprognostic (1.02e-1)" "unprognostic (8.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.13e-2)" "unprognostic (5.61e-3)" "unprognostic (1.76e-1)" "unprognostic (2.93e-2)" "unprognostic (2.74e-2)" "unprognostic (6.78e-3)" "unprognostic (3.14e-3)" "unprognostic (1.37e-1)" "unprognostic (2.80e-1)" "unprognostic (1.36e-1)" 7.8 6.1 20.0 3.9 42.4 5.7 2.6 16.7 54.2 4.0 4.5 84.3 0.9 3.2 2.8 4.7 3.5 6.3 5.7 7.1 32.2 17.6 4.8 3.8 4.1 4.1 57.5 21.9 2.5 8.6 8.1 7.8 3.3 31.1 5.2 2.5 3.8 8.0 5.1 5.7 6.3 4.1 2.7 70.5 8.3 6.1 3.0 47.7 0.2 9.5 0.1 2.2 3.3 1.8 0.4 2.7 0.4 0.3 1.2 2.2 1.1 4.3 4.8 2.4 9.5 6.0 6.4 4.1 4.8 1.9 2.2 0.8 1.4 5.3 0.2 13.8 5.2 7.4 1.5 3.6 0.4 3.2 3.0 0.4 13.7 1.7 2.9 6.8 7.6 2.7 3.3 1.5 0.4 1.2 1.1 0.8 2.7 13.0 0.0 14.7 1.2 4.8 6.7 2.4 6.4 1.5 1.0 9.1 10.5 5.2 10.2 3.7 34.6 8.9 6.2 6.0 3.3 8.5 2.0 0.1 0.1 0.0 10.1 1.3 3.0 0.0 0.3 0.0 2.2 0.2 1.3 0.4 0.2 0.7 0.3 0.2 0.0 0.9 0.4 1.2 0.0 2.7 1.0 1.1 20.0 42.4 16.7 30.7 32.2 17.6 57.5 21.9 31.1 47.7 ABCA3 "ABC-C, ABC3, EST111653, LBM180" ENSG00000167972 "ATP binding cassette subfamily A member 3" Q99758 16 2275881-2340746 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;lung: 75.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 20.8;T-47d: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007884 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007884: AB_1078077" "unprognostic (2.64e-1)" "unprognostic (2.19e-2)" "unprognostic (6.09e-3)" "unprognostic (2.61e-3)" "unprognostic (2.20e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-2)" "unprognostic (1.86e-1)" "unprognostic (6.58e-3)" "unprognostic (3.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (3.32e-2)" "unprognostic (7.85e-2)" "unprognostic (2.91e-1)" "unprognostic (1.30e-1)" 6.3 6.2 12.9 3.4 15.3 1.6 7.0 21.9 30.8 3.0 3.8 13.1 1.8 2.7 3.2 4.2 3.6 4.9 3.3 5.6 14.6 13.8 3.9 1.5 75.8 3.9 11.4 13.1 3.2 9.6 14.8 6.0 4.7 18.3 5.3 2.1 4.9 8.5 5.0 5.0 4.2 2.5 5.0 11.3 3.7 3.0 7.2 6.1 5.6 16.2 0.5 6.4 3.0 1.3 0.2 0.5 0.0 0.6 2.0 1.5 0.4 0.3 9.5 1.8 14.8 0.4 0.0 0.1 2.6 0.6 1.0 1.1 1.3 1.5 0.1 3.8 1.1 0.2 8.5 0.1 0.3 14.9 5.7 0.9 1.1 0.2 1.3 0.1 1.6 0.1 0.2 0.1 0.5 14.4 10.2 0.0 0.0 12.7 0.0 1.0 2.0 4.6 2.3 0.3 1.6 8.5 0.3 20.8 14.9 1.8 10.5 0.2 34.2 0.9 4.1 0.1 0.5 4.0 4.2 2.8 1.2 0.0 2.1 5.1 0.1 0.0 0.1 0.0 1.5 0.1 0.8 0.2 0.6 1.4 0.5 0.1 0.6 1.5 0.0 2.0 0.6 0.0 0.3 0.4 12.9 15.3 21.9 30.8 14.6 13.8 11.4 13.1 18.3 6.1 ABCA5 EST90625 ENSG00000154265 "ATP binding cassette subfamily A member 5" Q8WWZ7 17 69244311-69327244 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 52.8" "Cell line enhanced" "Detected in many" "SiHa: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022032, HPA062904" Approved Approved Nucleoplasm Nucleoplasm "HPA022032: AB_1844427, HPA062904: " "unprognostic (1.24e-2)" "unprognostic (1.49e-2)" "unprognostic (1.62e-3)" "unprognostic (7.17e-2)" "unprognostic (8.05e-4)" "unprognostic (3.05e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "prognostic favourable (9.97e-5)" "unprognostic (3.60e-2)" "unprognostic (1.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.65e-1)" "unprognostic (2.55e-1)" "unprognostic (8.52e-2)" 10.5 8.6 6.7 3.8 9.8 6.0 12.7 35.6 12.4 8.8 9.6 4.3 13.5 9.7 6.0 7.7 8.6 6.6 4.6 5.2 5.3 6.2 7.9 21.7 4.9 3.3 4.1 7.9 6.9 20.3 13.0 35.9 5.3 13.6 7.4 10.6 15.5 8.2 11.4 52.8 24.0 15.5 3.4 7.6 4.3 8.9 9.0 3.9 1.7 7.9 10.3 5.9 5.5 8.1 4.2 3.9 4.5 0.7 3.0 4.2 1.2 4.2 2.0 1.6 2.4 7.7 5.6 0.5 4.4 4.8 4.6 6.9 0.6 1.6 0.0 2.4 3.8 6.3 1.0 3.7 5.2 0.1 2.9 0.0 4.7 2.9 10.3 0.0 2.7 5.5 4.5 1.9 5.3 10.0 0.0 1.7 0.4 3.6 2.6 0.0 1.6 2.9 0.3 0.1 0.4 0.9 7.0 8.8 1.4 15.8 7.3 4.5 7.5 2.7 7.3 5.3 1.5 4.8 0.9 9.0 0.2 0.3 2.1 0.0 4.7 0.7 0.7 4.5 3.1 0.2 4.2 2.4 4.0 3.4 0.5 4.2 2.1 3.4 1.9 3.0 0.1 3.9 2.4 1.2 6.7 9.8 35.6 12.4 5.3 6.2 4.1 7.9 13.6 3.9 ABCA8 KIAA0822 ENSG00000141338 "ATP binding cassette subfamily A member 8" O94911 17 68867292-68955392 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 16.2;ASC TERT1: 36.1;HSkMC: 27.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044914 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044914: AB_10964859" "unprognostic (2.58e-2)" "unprognostic (2.76e-2)" "unprognostic (1.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.04e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (5.22e-2)" "unprognostic (6.68e-2)" "unprognostic (8.76e-2)" "unprognostic (1.42e-3)" "unprognostic (3.52e-3)" "unprognostic (1.88e-1)" "unprognostic (3.29e-1)" "unprognostic (6.14e-3)" 29.1 25.2 10.0 3.4 27.2 0.5 15.1 3.2 15.4 7.3 12.8 29.9 3.9 5.4 10.2 13.0 12.4 17.6 14.3 30.0 12.5 5.5 8.1 26.6 15.2 1.3 37.8 9.2 44.7 5.1 4.5 14.8 7.6 22.2 10.3 14.3 16.4 9.8 7.9 8.9 4.9 9.9 7.1 28.2 9.9 11.5 15.8 42.7 0.0 13.0 14.2 2.8 13.6 20.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 16.2 36.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 6.0 0.0 0.0 27.3 0.0 0.4 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.0 27.2 3.2 15.4 12.5 5.5 37.8 9.2 22.2 42.7 ABCA9 EST640918 ENSG00000154258 "ATP binding cassette subfamily A member 9" Q8IUA7 17 68974488-69061064 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 42.5" "Group enriched" "Detected in some" 6 "ASC diff: 14.2;ASC TERT1: 30.4;HSkMC: 10.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052113, HPA054823" Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA052113: , HPA054823: " "unprognostic (3.88e-2)" "unprognostic (9.86e-2)" "unprognostic (2.21e-1)" "unprognostic (9.75e-2)" "unprognostic (4.46e-1)" "unprognostic (5.64e-3)" "unprognostic (4.51e-4)" "unprognostic (1.83e-2)" "unprognostic (1.94e-3)" "unprognostic (7.86e-2)" "unprognostic (3.26e-3)" "unprognostic (3.51e-1)" "unprognostic (7.77e-6)" "unprognostic (5.32e-4)" "unprognostic (7.22e-2)" "unprognostic (1.84e-2)" "unprognostic (4.96e-3)" 42.5 4.2 1.2 5.5 2.8 1.7 14.1 2.7 2.6 13.4 17.4 2.6 6.8 1.7 15.5 11.8 25.5 8.8 7.2 15.0 2.1 1.9 2.5 7.6 5.6 2.1 7.8 2.0 25.2 2.3 1.7 2.8 1.1 4.4 13.9 3.8 4.1 5.7 4.7 12.4 5.4 3.7 11.9 3.8 1.6 4.8 10.9 2.1 1.0 7.6 9.9 2.5 20.4 18.7 1.8 0.9 2.9 0.8 1.2 1.3 0.0 0.2 0.4 0.5 0.6 14.2 30.4 0.5 0.3 0.3 0.0 0.2 0.3 0.4 0.4 0.1 0.5 0.4 0.2 0.5 0.2 0.2 0.4 0.5 1.2 0.4 1.5 0.6 0.9 10.8 0.4 2.2 0.2 3.0 0.5 1.0 0.2 0.2 0.2 1.4 0.3 0.3 1.4 0.1 0.2 0.1 1.3 0.5 0.4 0.4 0.3 0.2 0.3 0.5 1.3 0.9 0.4 1.6 0.3 1.0 0.3 0.3 0.3 0.3 1.4 1.7 0.8 1.4 1.3 0.6 1.3 1.1 0.8 0.5 0.9 1.8 1.3 1.3 2.9 1.2 0.5 0.7 0.4 0.0 1.2 2.8 2.7 2.6 2.1 1.9 7.8 2.0 4.4 2.1 ABCB8 "EST328128, M-ABC1, MABC1" ENSG00000197150 "ATP binding cassette subfamily B member 8" Q9NUT2 7 151028422-151047782 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045187 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA045187: AB_10964281" "unprognostic (5.29e-2)" "unprognostic (9.17e-3)" "unprognostic (8.28e-2)" "unprognostic (8.32e-2)" "unprognostic (8.63e-3)" "prognostic favourable (5.91e-4)" "unprognostic (4.76e-2)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "prognostic favourable (3.34e-4)" "unprognostic (2.26e-1)" "prognostic favourable (5.88e-4)" "unprognostic (7.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.64e-2)" "unprognostic (1.23e-1)" 12.6 22.8 14.4 13.8 22.0 12.2 8.5 24.9 24.8 16.3 12.3 22.2 10.4 19.3 16.5 14.9 17.6 12.9 11.5 13.0 14.5 12.8 14.5 33.5 11.7 13.3 19.1 17.9 13.3 12.6 15.4 20.1 23.6 15.9 12.3 9.5 12.5 11.1 12.8 11.2 13.7 14.7 12.7 13.3 11.5 13.1 13.6 19.5 14.0 18.4 11.7 10.6 9.6 10.4 4.4 10.4 10.3 6.7 4.0 7.5 3.6 12.4 19.6 5.0 15.9 8.0 4.7 10.1 6.6 6.8 10.5 11.1 7.8 20.8 6.5 8.8 6.9 13.2 7.3 13.6 4.7 8.1 8.0 5.2 7.8 9.3 5.2 4.0 12.9 8.0 10.3 12.4 5.2 10.4 27.1 9.0 7.8 27.8 15.1 7.5 3.4 22.3 7.2 3.2 23.2 7.0 5.3 4.9 9.8 7.0 20.0 6.3 7.9 5.2 6.4 9.8 2.6 7.0 9.8 9.1 4.5 4.7 13.8 9.6 9.9 10.3 4.5 3.4 7.5 6.7 5.2 4.4 5.3 6.1 6.3 3.5 4.9 6.9 1.1 4.0 4.7 10.4 5.6 3.6 14.4 22.0 24.9 24.8 14.5 12.8 19.1 17.9 15.9 19.5 ABCB9 EST122234 ENSG00000150967 "ATP binding cassette subfamily B member 9" Q9NP78 12 122920951-122981649 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 6.2" "Group enriched" "Detected in many" 5 "B-cells: 6.2;granulocytes: 4.1;T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033052, HPA035113, HPA035114" Approved Supported Vesicles Vesicles "CAB033052: AB_2273463, HPA035113: , HPA035114: AB_10601329" "unprognostic (1.47e-2)" "unprognostic (6.46e-4)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "prognostic unfavourable (5.65e-4)" "unprognostic (1.46e-1)" "unprognostic (2.67e-2)" "unprognostic (2.35e-1)" "unprognostic (4.08e-2)" "unprognostic (6.07e-2)" "unprognostic (2.28e-1)" "unprognostic (1.24e-1)" "unprognostic (1.37e-2)" "unprognostic (6.97e-2)" "unprognostic (1.70e-1)" "unprognostic (3.58e-3)" "unprognostic (2.71e-2)" 3.6 4.2 9.5 3.0 13.1 5.3 3.8 19.7 17.0 2.9 4.0 5.8 2.3 5.0 4.2 9.7 4.7 4.7 4.6 4.6 9.0 11.5 3.3 2.7 3.4 3.1 10.8 10.9 4.7 4.3 6.6 9.9 3.5 9.8 3.5 4.1 3.0 7.7 5.6 3.4 6.0 6.1 3.9 7.5 4.0 4.0 21.3 6.4 2.5 3.6 2.0 3.7 2.9 2.7 6.2 0.4 4.1 0.7 0.5 1.9 1.8 3.7 6.9 3.8 3.7 1.6 3.2 1.8 2.4 3.5 4.2 2.7 2.9 4.2 4.2 2.8 2.4 3.5 2.8 5.8 1.6 0.8 5.6 18.0 5.6 4.6 1.9 0.8 7.3 4.5 2.3 6.1 1.9 4.6 3.6 3.1 2.3 8.2 1.3 1.7 1.2 6.8 5.0 1.1 3.9 2.0 2.4 4.1 1.3 1.2 8.8 8.5 10.1 1.2 2.0 3.0 10.3 9.3 6.8 10.0 5.6 1.1 5.3 2.0 16.3 4.1 0.7 0.7 0.8 0.4 1.9 6.2 0.8 0.7 0.4 1.2 1.5 1.4 1.7 0.5 0.3 0.3 0.5 1.8 9.5 13.1 19.7 17.0 9.0 11.5 10.8 10.9 9.8 6.4 ABCC5 "EST277145, MOAT-C, MRP5, SMRP" ENSG00000114770 "ATP binding cassette subfamily C member 5" O15440 3 183919934-184018015 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044067, HPA052295" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA044067: , HPA052295: " "unprognostic (9.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.83e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-2)" "unprognostic (2.07e-1)" "prognostic unfavourable (6.78e-8)" "unprognostic (4.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.02e-1)" "unprognostic (5.91e-3)" "prognostic unfavourable (3.40e-4)" "unprognostic (1.10e-1)" "unprognostic (9.05e-3)" "unprognostic (1.64e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-2)" 7.9 11.2 24.7 9.6 26.2 12.0 6.7 42.8 28.6 7.7 11.4 12.0 13.4 6.8 14.1 7.0 17.1 6.1 11.6 16.0 19.1 13.7 12.8 3.6 9.4 7.3 20.5 18.5 11.8 4.9 22.4 20.5 10.8 21.7 10.6 14.4 31.1 7.4 9.3 41.0 14.5 8.5 10.5 12.9 16.3 48.5 9.4 20.9 9.3 5.5 7.3 7.4 18.1 12.7 4.2 3.5 15.8 4.5 5.0 7.0 4.5 7.3 4.0 9.3 11.1 9.3 10.6 14.4 5.9 4.7 5.3 5.8 6.3 5.6 7.9 14.0 5.6 29.5 11.4 6.5 7.0 8.6 11.1 16.7 10.1 5.7 3.8 5.1 13.1 16.9 6.6 5.7 3.8 6.2 15.5 11.0 9.1 19.3 13.9 5.8 9.6 7.8 9.7 3.1 4.7 19.4 47.5 17.0 10.1 6.1 33.6 10.0 20.2 1.6 7.1 6.2 6.1 7.9 8.1 4.2 8.2 7.3 4.6 10.2 6.3 10.7 4.5 7.7 7.0 2.1 4.5 3.2 4.0 3.1 3.5 4.2 4.6 6.3 15.8 5.0 3.5 1.3 5.0 4.5 24.7 26.2 42.8 28.6 19.1 13.7 20.5 18.5 21.7 20.9 ABCC6 "ARA, EST349056, MLP1, MRP6, PXE, URG7" ENSG00000091262 "ATP binding cassette subfamily C member 6" O95255 16 16148928-16223522 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 27.4" "Cell line enriched" "Detected in some" 8 "Hep G2: 37.7" "Cancer enhanced" "Detected in many" "liver cancer: 16.7" "Cell type enriched" "Detected in some" 5 "classical monocyte: 7.3" "Lineage enriched" "Detected in many" 5 "monocytes: 7.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038105 Supported "Plasma membrane" "Plasma membrane" "HPA038105: " "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (5.98e-2)" "unprognostic (3.15e-2)" "unprognostic (1.59e-1)" "unprognostic (3.09e-1)" "prognostic favourable (3.82e-4)" "unprognostic (6.54e-3)" "unprognostic (3.64e-1)" "unprognostic (9.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-3)" "unprognostic (3.42e-1)" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.41e-1)" 2.3 1.4 0.2 0.0 0.2 0.0 1.1 0.0 0.0 0.1 1.5 7.0 0.0 0.0 0.0 0.3 1.2 0.8 0.1 0.1 9.0 27.4 2.8 0.0 0.2 0.1 6.7 0.5 0.1 0.0 0.7 1.2 6.7 0.2 1.7 0.0 3.7 0.0 0.2 0.1 2.2 0.0 2.2 0.0 0.0 0.0 0.2 0.9 1.3 7.3 0.6 0.1 1.2 0.0 0.9 0.4 0.0 0.0 0.5 1.1 0.0 0.2 0.5 0.9 3.7 1.4 0.0 0.5 0.0 0.0 0.4 0.0 0.3 0.0 0.4 1.1 0.1 37.7 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.6 0.0 0.4 0.1 4.8 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 7.3 0.3 0.0 1.0 0.0 0.0 0.1 0.0 0.9 0.2 0.1 0.1 1.3 0.6 0.1 0.1 0.0 1.2 ABCC8 "ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2" ENSG00000006071 "ATP binding cassette subfamily C member 8" Q09428 11 17392498-17476879 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;pancreas: 25.5;pituitary gland: 26.6" "Group enriched" "Detected in some" 5 "A549: 4.6;AN3-CA: 3.7;SCLC-21H: 6.5" "Cancer enriched" "Detected in some" 9 "pancreatic cancer: 16.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011451, HPA042318" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" Nucleoli "Golgi apparatus, Cytosol" "CAB011451: , HPA042318: " "unprognostic (4.30e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (4.73e-2)" "unprognostic (9.48e-3)" "unprognostic (2.23e-1)" "unprognostic (4.46e-3)" "unprognostic (2.53e-3)" "unprognostic (6.04e-2)" "unprognostic (2.34e-2)" "unprognostic (8.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.22e-2)" "unprognostic (1.96e-2)" "unprognostic (6.88e-5)" "unprognostic (2.72e-2)" "unprognostic (1.85e-1)" 1.3 6.7 4.4 0.8 6.1 0.9 4.0 28.0 12.3 3.0 1.3 2.6 7.7 1.9 3.1 3.7 0.8 1.2 0.9 2.9 5.1 4.8 1.0 0.8 2.9 0.8 3.6 7.2 0.9 25.5 1.0 26.6 1.6 8.5 2.8 1.3 0.7 0.9 8.5 2.3 1.1 1.5 1.3 4.0 0.9 3.5 1.1 2.3 0.0 6.2 0.0 0.8 0.7 0.8 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.0 4.6 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.9 0.0 0.1 0.1 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 4.4 6.1 28.0 12.3 5.1 4.8 3.6 7.2 8.5 2.3 ABCG8 GBD4 ENSG00000143921 "ATP binding cassette subfamily G member 8" Q9H221 2 43831942-43882987 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "intestine: 62.4;liver: 64.4" "Cell line enriched" "Detected in single" 47 "Hep G2: 14.4" "Cancer enriched" "Detected in some" 30 "liver cancer: 21.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA019556 Uncertain Approved Vesicles Vesicles "HPA019556: AB_1844444" "unprognostic (1.99e-1)" "unprognostic (4.49e-1)" "unprognostic (3.22e-1)" "unprognostic (1.37e-1)" "unprognostic (3.09e-2)" "unprognostic (2.43e-1)" "unprognostic (1.99e-3)" "unprognostic (1.27e-1)" "unprognostic (6.28e-1)" "unprognostic (6.14e-3)" "unprognostic (4.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.68e-1)" "unprognostic (7.86e-3)" "unprognostic (5.03e-1)" "unprognostic (1.50e-1)" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.4 0.1 21.2 0.0 0.0 24.0 0.1 0.1 0.1 0.1 1.7 0.1 0.2 0.3 0.2 64.4 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 62.4 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.6 2.1 0.3 0.5 0.8 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 14.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 2.1 0.3 0.4 0.7 0.3 0.5 0.5 0.6 0.5 0.1 0.7 0.8 0.7 1.7 0.5 0.3 0.6 0.3 0.2 0.2 0.3 0.1 0.4 0.2 0.3 0.2 0.0 0.0 0.0 ABHD12 "ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106" ENSG00000100997 "Abhydrolase domain containing 12" Q8N2K0 20 25294743-25390983 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Cataract, Deafness, Disease mutation, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 71.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026866 Uncertain "HPA026866: AB_1844446" "prognostic unfavourable (3.81e-5)" "prognostic favourable (1.30e-5)" "unprognostic (1.32e-1)" "unprognostic (8.74e-2)" "unprognostic (3.67e-2)" "unprognostic (6.56e-2)" "prognostic unfavourable (7.18e-4)" "unprognostic (8.51e-2)" "unprognostic (7.91e-3)" "unprognostic (2.08e-1)" "unprognostic (4.08e-2)" "unprognostic (8.46e-2)" "unprognostic (1.36e-3)" "unprognostic (2.45e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-1)" "unprognostic (8.11e-3)" 11.3 13.4 27.4 10.0 32.1 9.8 10.4 22.3 39.8 11.1 15.6 30.8 14.1 20.7 9.1 58.9 20.4 11.3 14.0 12.2 41.5 25.9 18.9 13.1 14.0 10.3 31.5 21.0 13.8 65.6 16.0 14.4 25.6 26.9 15.6 15.2 11.5 13.8 17.4 4.0 16.2 21.1 9.9 43.3 7.8 22.1 7.6 19.0 10.2 36.8 7.9 16.0 15.7 10.9 3.9 14.6 12.6 14.2 11.1 11.5 6.0 14.8 34.1 8.8 11.0 18.1 10.8 21.7 21.4 17.9 16.8 19.4 19.9 22.8 4.7 12.1 16.8 24.2 11.1 12.7 14.4 4.8 8.9 7.5 9.3 27.6 14.4 7.2 16.1 13.4 8.3 20.7 9.8 7.7 5.5 71.3 15.9 30.7 11.0 7.7 6.7 21.6 8.4 22.6 44.5 11.3 30.9 11.3 9.4 18.0 44.5 31.7 15.1 12.4 9.6 21.3 14.4 12.9 12.3 8.4 7.7 7.5 14.8 8.6 13.7 9.8 14.2 12.6 8.0 12.2 6.4 3.1 8.8 11.5 14.6 3.9 7.5 7.4 1.8 11.1 13.1 13.1 7.9 6.0 27.4 32.1 22.3 39.8 41.5 25.9 31.5 21.0 26.9 19.0 ABHD13 "bA153I24.2, BEM46L1, C13orf6, FLJ14906" ENSG00000139826 "Abhydrolase domain containing 13" Q7L211 13 108218379-108234255 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032143, HPA032144" Approved Approved Cytosol Cytosol "HPA032143: AB_2674178, HPA032144: AB_10602304" "unprognostic (2.69e-1)" "unprognostic (2.81e-1)" "unprognostic (1.36e-2)" "unprognostic (2.91e-2)" "unprognostic (8.36e-2)" "unprognostic (1.48e-2)" "unprognostic (1.99e-1)" "unprognostic (2.63e-1)" "unprognostic (8.75e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-1)" "unprognostic (6.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.73e-2)" "unprognostic (1.61e-1)" "unprognostic (1.14e-1)" "unprognostic (5.62e-2)" 13.6 12.5 13.8 14.3 14.2 26.7 14.9 17.0 15.5 13.6 17.0 6.8 14.5 13.8 16.3 21.0 15.2 13.5 13.8 12.9 11.7 10.4 12.5 20.1 15.4 14.8 10.1 10.4 13.2 12.4 9.6 14.1 16.5 11.1 13.0 15.0 10.5 14.7 18.1 12.9 12.7 16.7 13.7 10.1 20.0 13.9 8.9 8.2 26.4 15.4 11.3 14.5 13.3 18.6 8.5 8.9 19.2 10.4 11.8 11.8 10.1 9.0 3.8 10.1 5.6 7.9 9.4 4.9 8.9 9.0 7.9 9.4 5.7 8.6 7.6 9.4 6.9 8.3 7.5 10.4 12.6 10.2 6.6 9.3 5.4 5.7 7.9 19.2 11.5 9.7 9.9 6.2 8.0 9.3 5.0 4.3 8.1 3.7 9.3 8.1 4.7 4.5 8.0 7.2 4.4 11.1 8.1 7.7 9.6 4.7 7.9 9.6 7.4 17.9 9.6 5.6 5.8 6.6 6.0 8.5 6.7 8.4 13.3 12.1 10.2 8.7 10.4 19.2 8.0 9.5 11.8 8.5 10.9 9.5 8.9 8.1 10.5 8.7 11.3 11.8 8.4 6.7 10.2 10.1 13.8 14.2 17.0 15.5 11.7 10.4 10.1 10.4 11.1 8.2 ABHD14A "DKFZP564O243, DORZ1" ENSG00000248487 "Abhydrolase domain containing 14A" Q9BUJ0 3 51971426-51981199 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038153, HPA056913" Approved Enhanced Vesicles 260000 Vesicles "HPA038153: , HPA056913: " "unprognostic (4.15e-3)" "unprognostic (6.73e-2)" "unprognostic (1.98e-1)" "unprognostic (3.34e-2)" "unprognostic (2.71e-1)" "unprognostic (1.08e-2)" "unprognostic (8.92e-2)" "prognostic favourable (4.72e-4)" "unprognostic (3.96e-1)" "unprognostic (2.46e-2)" "unprognostic (5.52e-3)" "unprognostic (1.51e-2)" "unprognostic (1.97e-2)" "unprognostic (9.74e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-1)" "unprognostic (1.30e-2)" 11.8 28.0 23.3 6.0 25.8 9.0 9.2 39.6 45.0 18.3 7.3 12.2 8.5 8.0 6.9 23.2 5.4 19.6 9.3 16.4 22.3 27.8 26.2 13.0 9.7 8.9 16.6 23.4 14.8 20.6 15.6 21.3 7.0 18.7 11.6 5.6 26.1 17.7 12.5 23.8 3.9 6.6 8.8 14.5 7.7 11.0 6.2 7.0 6.6 24.1 8.4 8.8 9.2 7.4 15.4 13.9 4.5 6.0 12.0 30.9 15.3 2.8 5.4 3.4 10.4 34.7 17.5 1.9 3.7 6.2 4.5 6.1 6.1 11.3 3.1 2.6 9.2 2.4 3.8 4.1 1.4 10.2 4.2 9.2 15.9 20.2 9.7 12.6 12.4 16.5 2.9 3.8 1.9 5.8 3.7 10.7 7.0 3.2 5.8 12.9 1.9 12.8 4.2 1.8 29.8 8.6 4.4 7.1 11.1 9.4 2.0 5.5 2.9 13.9 3.4 4.1 4.5 9.9 4.3 15.7 14.6 2.6 7.7 20.2 5.9 2.1 6.0 4.5 30.2 3.5 30.9 15.4 26.7 26.8 10.4 12.4 24.6 26.2 0.6 12.0 2.2 13.9 25.7 15.3 23.3 25.8 39.6 45.0 22.3 27.8 16.6 23.4 18.7 7.0 ABHD16A "BAT5, D6S82E, NG26" ENSG00000204427 "Abhydrolase domain containing 16A" O95870 6 31686949-31703444 "Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.6;BJ hTERT+ SV40 Large T+: 2.0;Daudi: 2.1;HEL: 1.3;RPMI-8226: 1.4;SH-SY5Y: 2.6;U-138 MG: 1.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 1.2;neutrophil: 4.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058606 Approved 1400000 "HPA058606: " "unprognostic (1.44e-1)" "unprognostic (1.10e-1)" "unprognostic (7.26e-2)" "prognostic unfavourable (2.63e-4)" "unprognostic (3.14e-1)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" "unprognostic (8.75e-2)" "unprognostic (1.07e-1)" "unprognostic (6.17e-3)" "unprognostic (1.97e-3)" "unprognostic (6.02e-2)" "unprognostic (1.30e-2)" "unprognostic (9.35e-2)" "unprognostic (1.81e-1)" "unprognostic (5.11e-3)" "unprognostic (1.60e-3)" 6.0 9.0 7.7 10.5 8.9 11.8 9.6 15.1 11.2 10.2 8.5 6.7 6.0 5.5 8.4 5.5 18.8 13.0 21.8 11.6 7.0 8.6 7.0 11.8 10.2 7.8 12.6 5.4 6.1 12.1 5.5 16.2 8.8 11.0 9.5 5.5 5.9 6.2 9.1 12.2 9.1 10.0 6.5 12.5 7.2 7.5 15.4 10.9 9.2 18.2 5.0 6.7 7.8 5.2 0.2 0.4 4.3 0.3 0.1 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.0 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.5 2.6 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.2 1.2 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 4.3 0.1 0.1 0.0 0.0 1.2 7.7 8.9 15.1 11.2 7.0 8.6 12.6 5.4 11.0 10.9 ABHD2 LABH2 ENSG00000140526 "Abhydrolase domain containing 2" P08910 15 89087459-89202360 "Enzymes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HEL: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 29.0;neutrophil: 22.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005999 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA005999: AB_1078080" "unprognostic (6.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (3.00e-2)" "unprognostic (2.16e-1)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (3.34e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-3)" "unprognostic (1.80e-1)" "prognostic favourable (2.18e-7)" "unprognostic (4.17e-1)" "unprognostic (3.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" 13.2 24.8 14.8 9.5 19.3 15.6 11.7 25.2 23.4 10.7 16.1 12.0 6.5 23.4 18.2 34.7 9.0 12.1 32.2 24.5 12.2 11.3 11.8 76.4 22.2 11.2 11.1 14.8 13.1 28.3 11.2 18.1 5.6 19.8 22.9 9.6 22.6 11.8 10.0 19.3 7.5 18.5 11.4 8.3 14.2 35.8 42.9 7.6 7.7 8.6 8.1 12.1 13.5 10.4 1.1 3.0 29.0 7.0 4.7 3.5 2.5 8.0 15.5 3.8 4.1 7.5 10.2 2.1 5.4 16.2 5.2 4.9 3.9 14.0 2.3 6.3 6.7 10.7 8.4 6.6 7.3 12.0 3.8 83.5 3.6 2.9 3.9 5.7 19.7 5.2 4.7 18.5 11.9 6.3 7.4 7.2 14.2 3.3 3.5 1.4 1.7 4.6 5.1 8.0 17.4 6.9 12.6 6.6 9.9 10.3 4.9 8.6 5.4 4.5 9.6 18.3 6.2 6.6 13.6 5.9 11.7 2.7 14.9 5.3 14.2 3.1 5.6 29.0 1.6 4.8 0.9 1.1 1.5 1.5 3.0 1.1 1.4 1.5 22.7 4.7 7.0 2.4 3.5 2.5 14.8 19.3 25.2 23.4 12.2 11.3 11.1 14.8 19.8 7.6 ABHD3 LABH3 ENSG00000158201 "Abhydrolase domain containing 3" Q8WU67 18 21650897-21704805 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 54.1;RPMI-8226: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010729 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Vesicles" "Plasma membrane" "HPA010729: AB_1844449" "unprognostic (1.46e-1)" "unprognostic (4.61e-2)" "unprognostic (2.37e-2)" "unprognostic (3.52e-1)" "unprognostic (8.46e-2)" "unprognostic (3.14e-3)" "unprognostic (3.54e-3)" "unprognostic (1.52e-1)" "prognostic unfavourable (8.52e-4)" "unprognostic (6.21e-2)" "unprognostic (1.98e-1)" "unprognostic (6.37e-2)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (3.98e-2)" "unprognostic (4.58e-2)" 9.2 5.4 12.0 14.2 10.7 8.6 20.7 19.5 11.1 6.4 34.2 4.8 5.1 23.8 6.0 5.4 12.7 7.8 13.5 7.1 8.8 8.5 8.7 21.7 12.8 21.3 11.5 5.0 9.4 8.8 10.7 11.8 10.8 16.6 6.9 37.1 14.7 10.3 4.1 10.1 3.8 45.3 5.5 12.3 17.9 19.0 4.4 10.8 20.9 12.9 6.7 13.7 9.2 25.5 7.1 6.1 33.0 23.3 7.1 17.6 9.1 7.4 5.4 5.3 3.4 3.4 2.2 0.0 4.9 2.0 3.5 4.8 5.6 7.7 21.4 9.0 1.6 24.8 8.6 4.0 4.9 13.4 6.0 2.3 9.1 9.6 5.2 10.1 7.8 2.0 4.8 5.2 2.4 2.3 5.9 12.8 3.1 3.0 9.7 11.3 2.6 12.8 54.1 4.0 60.2 9.7 7.2 4.5 2.0 11.2 10.0 2.8 3.1 17.9 1.8 3.4 4.9 6.0 7.5 14.4 9.3 22.1 4.4 13.3 7.8 29.1 10.2 11.4 11.1 17.9 8.5 7.1 10.0 10.6 6.1 5.1 8.2 10.3 33.0 7.1 23.3 4.2 17.6 9.1 12.0 10.7 19.5 11.1 8.8 8.5 11.5 5.0 16.6 10.8 ABHD6 ENSG00000163686 "Abhydrolase domain containing 6" Q9BV23 3 58237506-58295693 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017283, HPA073225" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA017283: AB_1844452, HPA073225: " "unprognostic (4.20e-2)" "unprognostic (7.92e-2)" "prognostic favourable (1.13e-4)" "unprognostic (2.35e-2)" "unprognostic (1.16e-2)" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (1.15e-2)" "unprognostic (9.54e-2)" "unprognostic (1.11e-3)" "unprognostic (1.34e-2)" "unprognostic (1.94e-1)" "prognostic favourable (1.11e-11)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (2.72e-1)" "unprognostic (6.31e-2)" 8.3 10.0 11.6 4.6 14.0 1.0 5.8 17.7 22.5 3.7 8.1 30.0 10.3 26.3 4.7 10.8 4.8 6.9 4.4 4.1 19.0 9.2 24.3 43.4 6.3 5.2 18.6 12.2 4.1 2.4 4.8 15.2 4.8 19.0 4.4 8.1 10.5 3.0 12.9 3.1 17.2 33.5 6.8 24.0 22.8 9.0 3.1 14.3 2.0 6.6 2.1 5.4 4.6 4.1 3.9 7.0 2.1 9.3 0.7 2.6 1.1 2.1 8.0 1.2 5.3 15.1 2.7 14.0 5.6 5.1 5.9 8.1 4.2 2.9 4.0 0.5 3.1 6.3 5.4 2.5 5.3 6.9 2.7 3.4 5.4 5.8 5.1 1.0 18.4 2.6 11.6 5.4 2.7 3.3 4.1 9.4 4.8 1.6 7.0 0.4 3.9 17.7 2.6 2.4 9.1 9.1 2.9 7.0 2.8 6.2 3.4 11.6 2.3 2.8 3.5 4.3 4.7 10.6 6.6 2.8 8.0 0.2 11.0 10.3 5.8 0.0 2.8 2.1 2.1 9.3 2.0 3.9 1.2 2.6 4.6 3.0 1.2 1.5 0.0 0.7 6.2 7.0 1.4 1.1 11.6 14.0 17.7 22.5 19.0 9.2 18.6 12.2 19.0 14.3 AC004754.1 ENSG00000269881 16 249547-269943 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "intestine: 15.3" "Cell line enhanced" "Detected in some" "ASC diff: 2.5;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA011651: , HPA071871: " "unprognostic (1.22e-1)" "unprognostic (2.09e-2)" "unprognostic (2.26e-1)" "unprognostic (1.75e-2)" "unprognostic (5.40e-2)" "unprognostic (2.56e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (3.37e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-3)" "unprognostic (4.66e-2)" "unprognostic (7.84e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-2)" 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.3 0.6 0.6 0.2 15.3 0.3 0.3 0.1 0.2 0.0 0.9 0.4 1.4 0.3 0.1 0.0 0.0 0.7 0.1 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.3 1.0 0.1 7.4 0.2 0.7 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.4 1.8 2.5 2.4 0.5 0.0 1.2 0.0 0.1 0.3 0.1 0.0 5.1 1.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 2.5 0.0 0.0 1.0 0.0 0.2 1.0 0.7 0.0 0.3 0.0 2.2 0.0 0.2 1.2 0.0 1.3 0.0 0.0 0.9 0.0 0.3 1.0 0.0 0.0 0.4 1.0 0.6 0.0 0.4 0.0 1.0 0.0 0.1 0.2 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.8 0.0 0.5 1.5 0.4 0.0 0.4 0.0 0.0 0.0 0.0 AC006538.2 ENSG00000267001 19 2717769-2740048 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 16.1;THP-1: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA058526 Uncertain "HPA058526: " 5.2 2.1 3.0 3.0 5.5 2.5 3.9 3.2 8.9 3.6 5.9 3.8 1.7 6.1 2.3 2.5 2.2 4.3 2.5 3.0 2.9 2.5 2.2 7.3 5.0 3.0 3.4 3.4 2.7 3.0 3.8 2.3 2.6 4.1 2.8 2.5 2.6 7.8 7.1 9.7 3.1 3.0 8.2 5.3 3.2 2.5 16.9 1.9 3.5 2.8 1.2 2.0 4.2 2.3 0.3 1.2 1.1 0.8 0.0 0.8 0.9 2.8 9.4 1.7 0.0 8.2 8.5 0.0 1.6 3.7 4.4 8.2 9.1 0.5 1.7 2.6 4.4 0.0 0.0 1.9 0.0 0.0 0.0 4.9 6.8 12.5 16.1 0.0 0.0 4.4 4.7 8.6 0.3 1.7 4.1 3.6 1.3 8.0 0.4 0.0 0.7 0.0 0.8 0.5 2.5 0.0 4.4 0.2 1.6 4.7 1.4 5.0 2.5 14.6 0.0 1.3 0.3 4.9 2.4 1.8 6.5 2.3 0.8 4.6 0.6 1.1 0.8 0.3 0.0 0.5 0.8 0.0 0.3 0.2 0.9 0.3 0.0 0.1 0.0 0.0 0.0 1.2 0.5 0.9 3.0 5.5 3.2 8.9 2.9 2.5 3.4 3.4 4.1 1.9 AC009163.4 ENSG00000261717 16 75412684-75464706 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "U-698: 20.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA041316 Uncertain "HPA041316: AB_10794371" "unprognostic (1.57e-1)" 5.6 3.0 4.4 2.1 5.7 2.8 5.0 3.3 3.4 2.9 7.1 6.0 3.1 2.1 2.7 2.1 2.4 2.3 2.6 2.3 4.6 4.9 3.3 4.2 2.5 2.5 7.7 2.3 3.5 2.5 6.1 3.2 6.0 5.4 2.5 2.1 3.8 2.1 2.1 15.7 2.1 6.6 2.1 8.3 4.5 3.2 6.3 5.9 2.8 4.3 0.4 2.9 2.8 2.6 9.3 10.2 15.9 10.4 3.5 6.6 4.7 1.1 0.0 1.0 0.0 0.0 0.0 1.0 4.0 0.8 0.0 0.0 1.0 0.9 0.4 4.4 0.0 0.0 0.0 1.2 0.0 1.3 0.4 0.3 0.3 0.0 0.0 2.7 0.6 0.3 0.4 0.0 0.3 0.0 0.5 0.0 0.0 1.5 0.7 0.0 0.1 0.0 4.6 0.7 2.0 0.0 0.6 0.8 0.3 0.4 0.0 0.0 0.7 0.4 0.6 0.0 1.1 0.2 0.0 1.4 3.7 20.4 0.6 0.0 0.2 4.2 7.0 15.9 3.8 10.4 6.6 7.7 3.6 4.5 10.2 9.3 4.9 3.5 7.2 3.5 4.0 6.4 5.1 4.7 4.4 5.7 3.3 3.4 4.6 4.9 7.7 2.3 5.4 5.9 AC018755.2 ENSG00000268500 19 51612091-51646889 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "blood: 50.4;bone marrow: 20.8" "Group enriched" "Detected in some" 11 "HMC-1: 40.3;U-937: 16.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 50.4" "Group enriched" "Detected in many" 5 "granulocytes: 50.4;monocytes: 17.5" HPA009085 Approved "HPA009085: AB_1079965" 1.0 0.4 0.4 5.9 0.1 20.8 0.3 0.0 0.4 0.7 0.3 0.4 0.2 0.0 0.6 1.4 0.6 0.6 0.1 0.1 0.3 0.9 1.9 2.0 0.2 0.1 0.3 0.0 0.2 0.1 0.3 0.0 0.3 0.0 0.3 0.3 0.1 0.2 0.7 3.0 0.3 0.0 0.2 0.1 1.5 0.3 0.8 6.2 50.4 17.5 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 16.3 0.0 2.6 8.9 0.2 0.0 9.1 0.0 0.6 0.0 0.0 6.2 0.8 0.0 0.0 50.4 0.2 17.5 1.3 0.0 3.7 AC068580.4 ENSG00000250644 11 1734821-1763954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 84.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 68.0;SH-SY5Y: 15.5;U-87 MG: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA003001 Uncertain "HPA003001: AB_1078404" "unprognostic (5.71e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-6)" "unprognostic (1.77e-2)" "unprognostic (5.21e-2)" "unprognostic (6.20e-2)" "unprognostic (4.05e-3)" "unprognostic (1.45e-2)" "unprognostic (3.04e-1)" "unprognostic (1.14e-1)" "unprognostic (2.45e-2)" "unprognostic (1.96e-1)" "unprognostic (3.17e-3)" "unprognostic (8.30e-4)" "unprognostic (7.35e-2)" "unprognostic (5.79e-5)" "unprognostic (7.47e-2)" 33.3 84.9 5.0 5.4 5.1 15.6 13.8 12.2 25.7 7.5 8.3 7.6 7.9 5.1 7.0 9.9 6.9 5.3 17.6 18.3 5.6 8.8 32.5 35.5 22.2 17.0 9.7 4.3 7.8 12.5 3.7 4.0 11.1 8.0 6.1 4.4 50.8 20.6 22.6 14.3 10.5 19.1 3.8 7.6 16.7 7.4 7.0 5.2 3.3 6.8 8.9 7.7 13.7 8.3 0.5 3.8 7.6 6.9 8.1 2.0 4.7 0.3 2.6 0.1 0.5 0.9 0.5 0.6 0.8 1.0 0.2 0.3 0.6 68.0 0.1 1.0 3.2 4.8 0.0 0.0 0.0 0.2 1.0 0.4 0.4 0.2 1.1 0.6 1.5 2.5 0.7 0.3 0.3 0.1 0.0 1.0 5.5 6.6 0.0 0.7 0.3 0.2 0.1 1.0 0.4 2.7 3.0 0.2 15.5 0.2 5.1 9.6 12.0 0.3 1.6 3.4 0.5 0.8 1.1 3.0 6.7 0.1 18.7 0.5 2.9 1.5 6.9 2.1 1.9 3.2 1.4 0.5 1.0 1.1 2.1 0.2 1.5 2.0 7.6 8.1 4.3 3.8 1.1 4.7 5.0 5.1 12.2 10.5 5.6 8.8 9.7 4.3 8.0 5.2 AC068775.1 ENSG00000255641 12 10412312-10436001 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 43.7;brain: 11.4;lymphoid tissue: 9.2" "Cell line enriched" "Detected in some" 6 "HeLa: 13.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "NK-cell: 43.7" "Lineage enriched" "Detected in many" 6 "NK-cells: 43.7" HPA062570 Uncertain "HPA062570: " "unprognostic (6.09e-2)" 0.3 0.5 7.0 0.8 4.5 3.0 0.6 1.0 11.4 0.3 1.4 2.0 0.0 0.8 1.0 0.8 0.3 0.3 0.4 0.6 6.8 4.9 0.2 1.1 1.5 1.3 5.7 2.4 0.4 0.3 0.1 0.0 0.5 3.4 0.3 1.0 0.0 1.0 0.1 0.1 0.2 1.6 0.4 3.9 9.2 1.0 0.5 1.5 2.0 0.1 0.0 1.0 1.0 0.0 0.0 0.0 0.3 0.0 43.7 7.6 2.6 0.0 0.8 0.1 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.9 13.6 0.4 0.1 0.0 0.0 2.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 7.6 0.3 43.7 0.0 0.0 0.0 2.6 7.0 4.5 1.0 3.3 6.8 4.9 5.7 2.4 3.4 1.5 AC092718.3 ENSG00000260643 16 81053587-81096296 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 13.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA041368 Approved Approved Vesicles Vesicles "HPA041368: AB_10804001" "unprognostic (3.87e-2)" "unprognostic (1.79e-1)" "unprognostic (1.95e-1)" "unprognostic (2.12e-2)" "unprognostic (8.06e-2)" "unprognostic (1.08e-1)" "unprognostic (3.95e-2)" "unprognostic (8.11e-2)" "unprognostic (2.85e-1)" "unprognostic (2.42e-1)" "unprognostic (3.94e-2)" "unprognostic (3.19e-1)" "unprognostic (2.69e-2)" "unprognostic (2.11e-1)" "unprognostic (1.95e-1)" "unprognostic (9.56e-3)" "unprognostic (3.03e-1)" 5.1 2.7 4.4 1.6 6.3 1.0 2.6 2.6 10.3 1.8 1.3 5.9 5.5 0.8 3.4 7.6 1.3 7.0 1.9 3.4 5.0 6.1 6.0 1.8 1.6 6.8 6.2 2.9 3.6 5.0 2.2 4.0 7.6 2.9 1.3 3.7 3.3 2.6 8.4 1.8 1.1 2.3 5.3 1.4 2.0 5.8 7.2 2.0 15.0 1.6 0.9 1.5 0.0 4.5 5.1 1.5 1.3 3.9 3.6 2.1 4.2 3.4 5.2 3.7 12.0 4.4 5.6 2.2 1.0 2.0 0.3 0.4 5.0 0.8 4.6 1.0 3.6 3.2 1.3 2.9 1.5 5.6 0.9 1.6 3.1 4.3 3.1 2.8 5.3 6.4 3.0 2.8 2.0 3.8 0.4 2.7 4.7 4.2 13.8 2.6 1.8 12.3 1.1 2.1 7.7 1.7 4.2 4.1 2.6 1.1 4.1 1.2 4.9 2.4 0.9 1.9 2.5 1.8 3.0 3.3 5.6 2.6 2.3 2.2 1.5 1.1 1.0 3.6 0.8 3.5 4.5 2.3 1.3 2.9 3.5 3.3 2.4 0.9 3.9 1.3 5.1 0.6 2.1 AC093525.2 ENSG00000260272 16 2496032-2520218 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.5;brain: 5.4" "Cell line enhanced" "Detected in some" "HEK 293: 3.9;RPMI-8226: 3.2;SCLC-21H: 3.4;SH-SY5Y: 4.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" HPA044712 Uncertain "HPA044712: AB_10795619" "unprognostic (4.12e-1)" "unprognostic (9.64e-2)" "unprognostic (4.36e-3)" "unprognostic (1.13e-1)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (3.34e-2)" "unprognostic (2.34e-1)" "unprognostic (1.37e-1)" "unprognostic (9.77e-3)" "unprognostic (9.13e-2)" "unprognostic (9.83e-2)" "unprognostic (5.98e-3)" 0.4 0.1 1.1 0.1 1.0 4.5 0.4 5.4 1.8 0.1 0.4 0.1 0.2 0.1 0.3 0.5 0.7 0.1 1.0 0.9 3.2 0.2 1.0 0.7 0.6 0.1 0.3 0.1 1.5 0.1 0.2 0.2 0.6 0.4 1.1 0.4 0.1 0.5 0.1 0.4 0.2 0.6 0.4 0.2 0.6 0.0 0.1 1.7 0.5 0.8 0.7 0.4 0.0 0.5 0.0 0.7 1.8 0.0 0.0 0.0 0.8 1.2 0.0 0.6 0.0 0.8 0.1 0.0 1.7 0.0 0.9 0.0 0.0 0.3 3.9 0.5 0.5 0.4 1.1 1.3 0.0 0.0 0.4 0.5 0.0 0.9 0.1 0.5 0.0 2.2 0.2 1.1 0.2 1.2 0.4 0.0 3.2 0.6 0.2 3.4 4.3 0.0 0.8 0.9 0.3 0.0 0.0 0.0 0.9 0.0 0.0 1.7 0.6 1.9 0.7 0.3 0.3 0.0 0.8 0.5 0.4 0.7 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.7 0.3 1.7 0.0 0.0 AC119396.1 ENSG00000263264 I3L1I5 19 7348943-7383385 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 61.5" "Cell line enhanced" "Detected in some" "Daudi: 28.2;HL-60: 12.1;HMC-1: 7.7;MOLT-4: 11.7;REH: 10.8;THP-1: 11.7;U-698: 18.3;U-937: 9.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA049151 Uncertain "HPA049151: " "unprognostic (7.21e-3)" "unprognostic (2.33e-1)" "unprognostic (1.07e-1)" "unprognostic (2.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.23e-5)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (2.06e-2)" "unprognostic (1.35e-1)" "unprognostic (2.16e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-2)" "unprognostic (9.22e-2)" "unprognostic (3.55e-2)" 0.5 2.8 0.2 26.7 0.2 13.3 0.4 0.2 0.2 0.7 6.1 0.1 0.0 0.4 6.1 0.3 1.7 0.8 1.9 0.3 0.2 0.2 0.7 0.4 2.0 28.7 0.3 0.5 0.3 0.3 0.0 0.3 0.4 0.1 0.4 0.4 0.4 7.8 0.5 0.3 0.2 9.3 4.0 0.2 21.0 2.9 0.4 0.1 61.5 0.7 0.6 25.9 1.9 0.4 12.1 1.8 15.1 3.9 0.8 4.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 12.1 7.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 1.7 0.0 0.0 10.8 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 18.3 0.0 9.6 0.0 1.2 2.4 15.1 2.7 3.0 2.0 7.3 3.8 2.7 1.3 12.1 4.7 3.1 9.9 0.8 3.9 1.8 3.4 1.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.5 0.1 0.1 AC126755.2 ENSG00000233024 "Nuclear pore complex-interacting protein family member A5 isoform 2 " 16 18358086-18379331 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.5" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.7" "Group enriched" "Detected in many" 6 "B-cells: 4.7;T-cells: 1.8" HPA053611 Approved Uncertain Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (9.10e-2)" "unprognostic (6.00e-3)" "unprognostic (1.66e-1)" "unprognostic (5.77e-2)" "unprognostic (8.31e-2)" "unprognostic (6.34e-2)" "unprognostic (6.34e-2)" "unprognostic (6.76e-2)" "unprognostic (1.30e-3)" "unprognostic (5.87e-2)" "unprognostic (5.79e-3)" "unprognostic (1.60e-2)" "unprognostic (1.25e-5)" "unprognostic (1.96e-1)" "unprognostic (1.90e-2)" "unprognostic (5.38e-2)" "unprognostic (6.45e-3)" 4.1 5.4 5.2 3.3 5.5 3.3 6.0 46.5 10.1 5.4 6.9 3.4 9.5 10.0 4.7 6.3 4.4 3.3 6.4 6.4 3.5 4.6 5.4 4.2 3.3 11.5 6.6 14.3 27.8 2.8 5.4 6.3 3.7 7.0 17.5 9.8 4.5 7.6 2.8 4.9 4.0 4.6 6.5 3.6 4.6 3.8 4.7 0.5 0.5 0.5 0.3 1.8 0.5 7.0 4.6 25.7 21.0 22.1 20.7 6.0 27.0 9.8 13.3 19.8 4.6 4.2 9.7 10.5 23.7 12.7 8.0 7.3 16.3 8.3 7.6 25.9 22.5 22.4 22.4 12.3 59.6 21.2 33.0 16.6 22.4 6.5 6.0 19.5 13.3 10.7 20.1 26.9 10.9 5.8 29.0 6.4 9.7 13.1 13.3 7.3 11.5 16.9 10.7 14.5 9.8 14.7 12.3 18.0 7.9 15.0 8.2 14.7 11.5 14.9 8.0 17.2 9.2 0.0 0.5 0.5 1.8 0.1 0.6 4.7 1.2 0.9 0.2 1.1 1.0 0.4 0.0 0.3 0.3 0.5 0.4 0.5 AC134669.1 ENSG00000265118 17 31305213-31318831 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "blood: 57.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 5.4;HMC-1: 5.2;Karpas-707: 4.8;MOLT-4: 9.3;RPMI-8226: 7.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 57.6" "Low lineage specificity" "Detected in all" HPA045033 Uncertain "HPA045033: " "unprognostic (5.33e-2)" "unprognostic (3.44e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (5.88e-2)" "unprognostic (2.94e-2)" "unprognostic (2.40e-2)" "unprognostic (4.63e-2)" "unprognostic (3.23e-1)" "unprognostic (5.45e-5)" "unprognostic (1.89e-3)" "unprognostic (1.81e-1)" "unprognostic (4.53e-2)" 2.4 0.3 1.4 6.6 2.1 3.0 0.5 0.5 4.5 0.3 1.1 0.5 0.2 1.2 0.5 1.1 0.8 0.7 2.0 0.4 2.6 1.5 0.6 0.7 4.9 4.0 6.8 1.8 0.6 0.3 0.1 0.4 2.0 2.1 0.7 1.2 0.5 2.2 0.6 0.6 0.4 2.6 1.1 4.4 4.5 2.4 0.8 4.3 2.2 0.7 0.2 5.9 1.7 0.5 9.3 14.7 57.6 24.1 4.7 12.3 20.3 0.1 0.0 0.0 0.0 0.0 5.4 0.1 0.4 1.0 0.6 1.2 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 3.4 1.7 5.2 1.2 0.0 0.0 2.2 0.0 0.0 4.8 1.8 0.0 9.3 0.8 0.0 0.0 2.9 0.6 7.5 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.1 1.8 2.1 0.9 0.2 1.1 1.2 4.6 0.0 3.5 0.3 1.6 1.1 1.7 24.1 2.0 8.6 11.0 7.9 9.3 10.0 8.9 14.7 5.6 10.1 9.1 57.6 4.7 10.9 4.8 12.3 20.3 1.4 2.1 0.5 4.5 2.6 1.5 6.8 1.8 2.1 4.3 AC138969.1 ENSG00000183889 "Nuclear pore complex-interacting protein family member A5 isoform 2 " 16 16317444-16350590 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 63.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.3;T-cells: 2.7" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (2.91e-1)" "unprognostic (3.88e-1)" "unprognostic (1.09e-1)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (8.96e-2)" "unprognostic (2.31e-2)" "unprognostic (3.69e-3)" "unprognostic (1.27e-1)" "unprognostic (1.32e-1)" "unprognostic (5.45e-7)" "unprognostic (1.22e-2)" "unprognostic (5.04e-6)" "unprognostic (6.04e-2)" "unprognostic (9.80e-2)" "unprognostic (1.79e-1)" "unprognostic (2.22e-3)" 5.2 6.4 9.8 2.9 7.1 6.5 5.5 35.6 12.6 4.6 9.3 2.7 11.3 17.9 7.0 10.9 9.9 5.5 11.0 9.0 4.6 4.5 6.3 5.3 5.9 16.4 5.6 12.2 17.9 3.3 7.4 11.0 5.4 8.5 10.1 19.0 5.0 12.5 4.4 6.2 5.0 7.4 6.6 7.3 4.4 4.9 4.3 0.8 0.4 0.7 0.2 2.7 0.7 7.8 5.6 15.4 14.5 22.1 20.9 10.8 15.9 7.9 8.5 11.3 3.9 4.7 6.4 15.3 17.5 13.8 9.7 6.6 12.8 2.5 9.2 14.8 38.4 25.4 22.7 9.3 63.0 19.4 42.3 13.3 22.3 5.4 5.4 21.5 12.4 13.2 15.0 34.7 7.1 3.8 18.3 6.3 6.4 13.4 26.1 9.7 10.1 7.8 11.8 25.5 12.5 28.6 3.7 13.3 7.9 8.2 6.0 9.9 17.8 12.1 7.5 10.1 6.8 0.0 0.7 0.4 2.7 0.1 0.8 4.3 2.0 2.3 0.1 1.1 1.5 0.6 0.0 0.2 0.6 0.8 1.1 0.7 ACBD4 FLJ13322 ENSG00000181513 "Acyl-CoA binding domain containing 4" Q8NC06 17 45132600-45144181 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051772 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA051772: " "unprognostic (1.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.59e-2)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (1.60e-2)" "prognostic favourable (4.76e-4)" "unprognostic (2.27e-2)" "unprognostic (9.06e-2)" "unprognostic (4.86e-2)" "prognostic favourable (4.64e-4)" "unprognostic (8.24e-2)" "unprognostic (2.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-1)" "prognostic favourable (6.53e-4)" 7.5 9.5 8.1 8.5 15.3 3.5 6.7 10.8 10.9 8.6 19.6 4.9 14.4 25.9 9.2 6.8 8.3 10.1 10.7 6.2 8.1 6.8 12.3 43.1 6.3 8.0 6.1 11.1 10.4 14.2 13.6 8.5 5.4 6.3 11.1 5.4 9.9 12.3 13.6 5.4 7.5 29.0 10.3 4.8 8.3 7.3 2.5 6.3 3.9 11.3 4.4 7.3 8.5 7.2 8.8 3.5 5.6 4.3 6.3 7.7 5.4 5.9 11.7 1.5 3.3 2.7 5.2 4.1 2.2 4.8 3.7 7.3 4.5 8.4 6.4 5.8 3.2 5.7 2.0 3.8 1.5 9.1 4.6 3.1 7.5 8.9 6.1 1.2 8.7 5.1 3.6 1.3 1.9 3.6 2.0 10.2 1.8 4.0 4.4 1.6 0.2 3.2 3.7 0.3 14.0 9.2 3.8 2.5 1.1 1.6 2.4 6.4 15.7 2.3 1.3 0.9 2.9 1.4 1.4 16.1 4.4 1.9 5.4 1.6 1.6 5.5 3.8 5.6 5.3 4.3 5.7 6.8 6.2 5.9 3.5 8.8 6.7 7.7 1.0 6.3 2.8 2.2 7.1 5.4 8.1 15.3 10.8 10.9 8.1 6.8 6.1 11.1 6.3 6.3 ACBD5 "DKFZp434A2417, KIAA1996" ENSG00000107897 "Acyl-CoA binding domain containing 5" Q5T8D3 10 27195214-27242130 "Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011861, HPA012145" Enhanced Enhanced Peroxisomes Peroxisomes "HPA011861: AB_1844493, HPA012145: AB_1844494" "prognostic unfavourable (3.33e-4)" "unprognostic (4.93e-1)" "unprognostic (3.68e-1)" "unprognostic (1.34e-1)" "unprognostic (6.21e-2)" "unprognostic (5.98e-3)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (2.69e-1)" "unprognostic (3.66e-1)" "unprognostic (1.11e-1)" "unprognostic (4.46e-2)" "prognostic favourable (4.68e-5)" "unprognostic (7.91e-3)" "unprognostic (1.71e-1)" "unprognostic (3.63e-2)" "unprognostic (3.37e-3)" 9.2 15.7 25.7 7.1 21.5 7.7 7.4 13.7 21.3 8.4 15.5 17.7 9.1 23.0 5.6 6.1 7.2 7.4 9.0 23.0 23.0 21.1 22.8 44.7 8.5 7.6 27.4 14.0 6.3 6.5 18.9 6.0 7.8 21.3 9.2 12.6 12.9 7.2 10.2 15.8 9.3 24.6 5.3 31.0 8.4 12.2 10.8 20.9 5.7 16.6 7.6 7.6 9.7 5.8 7.0 12.9 11.5 14.0 9.0 16.6 7.4 12.2 37.5 8.1 9.0 9.8 9.0 10.2 15.4 6.2 14.1 17.1 9.3 19.4 5.5 13.6 10.9 10.0 12.0 8.1 12.1 12.5 11.8 7.6 11.2 7.1 11.4 4.9 10.3 8.7 9.0 11.8 6.8 10.3 6.3 8.4 18.3 9.3 10.1 4.1 6.4 4.8 8.7 21.3 9.5 22.7 11.0 11.5 22.8 17.4 19.1 9.0 9.3 5.6 14.5 13.8 7.6 21.5 12.4 9.8 13.4 9.9 13.9 12.1 5.9 9.4 13.1 10.5 16.6 12.9 16.4 7.0 8.3 13.0 12.9 7.0 5.7 12.0 11.5 9.0 14.0 9.3 7.3 7.4 25.7 21.5 13.7 19.2 23.0 21.1 27.4 14.0 21.3 20.9 ACE "ACE1, CD143, DCP1" ENSG00000159640 "Angiotensin I converting enzyme" P12821 17 63477061-63498380 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 205.6" "Group enriched" "Detected in some" 4 "ASC TERT1: 35.9;HUVEC TERT2: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Group enriched" "Detected in many" 23 "B-cells: 3.7;monocytes: 2.0;T-cells: 1.9" "CAB002426, CAB002921, HPA029298, HPA069790" Enhanced Approved Vesicles "Secreted to blood" 121920000 92000000 Vesicles "CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: " "unprognostic (4.72e-2)" "unprognostic (4.16e-1)" "unprognostic (1.93e-3)" "unprognostic (6.06e-2)" "unprognostic (2.78e-1)" "unprognostic (1.35e-2)" "unprognostic (4.37e-1)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (1.25e-2)" "unprognostic (3.13e-2)" "unprognostic (2.38e-1)" "unprognostic (7.66e-2)" "unprognostic (9.07e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (2.76e-2)" 6.8 2.0 0.5 2.4 4.2 0.0 2.9 0.5 1.1 5.3 83.2 0.7 37.7 46.4 4.5 5.1 1.7 1.5 4.4 4.7 0.6 0.7 2.6 1.4 16.3 2.2 0.4 0.7 1.4 3.0 3.6 3.6 3.6 0.8 3.4 1.4 1.7 2.5 20.1 3.6 1.3 205.6 2.4 0.6 1.4 1.9 32.6 1.3 0.5 6.9 3.1 2.2 1.7 1.6 3.7 0.1 0.0 2.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 1.5 35.9 0.4 1.3 2.6 0.0 0.0 0.5 3.1 0.7 1.0 6.1 0.0 1.7 0.0 0.0 0.0 0.7 3.4 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.0 0.0 18.3 3.0 0.0 0.0 0.6 0.0 0.7 0.2 0.3 0.1 0.2 0.5 0.0 0.0 4.5 3.2 0.0 0.0 0.0 1.6 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.6 0.9 3.7 1.9 1.4 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.5 4.2 0.5 1.1 0.6 0.7 0.4 0.7 0.8 1.3 ACE2 ENSG00000130234 "Angiotensin I converting enzyme 2" Q9BYF1 X 15561033-15602148 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" "Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 122.0" "Cell line enhanced" "Detected in some" "BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.4;NB-4: 2.2;RPMI-8226: 2.0;RT4: 2.4;SH-SY5Y: 2.8" "Cancer enhanced" "Detected in many" "renal cancer: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA000288, CAB026174" Enhanced "Secreted to blood" 85000 "CAB026174: , HPA000288: AB_1078160" "unprognostic (1.40e-1)" "unprognostic (7.26e-2)" "unprognostic (2.76e-2)" "unprognostic (5.71e-2)" "unprognostic (2.51e-1)" "unprognostic (5.26e-2)" "prognostic favourable (4.21e-4)" "unprognostic (2.34e-2)" "unprognostic (6.74e-3)" "unprognostic (2.54e-3)" "unprognostic (1.00e-1)" "unprognostic (1.74e-1)" "prognostic favourable (2.12e-5)" "unprognostic (1.94e-1)" "unprognostic (9.62e-2)" "unprognostic (2.11e-1)" "unprognostic (7.10e-2)" 4.5 0.4 0.2 0.8 0.2 0.0 2.3 0.2 0.2 0.4 49.1 0.2 2.3 46.0 0.4 2.7 1.2 0.6 16.4 10.5 0.2 0.1 23.2 1.2 0.8 0.6 0.2 0.2 1.3 1.6 0.0 0.2 1.0 0.2 0.5 1.3 0.2 1.1 1.2 0.7 0.2 122.0 0.3 0.2 0.2 0.5 17.9 0.2 0.2 4.5 0.5 0.2 0.4 0.9 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.0 0.4 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 4.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.2 0.0 0.0 2.0 0.4 2.4 0.6 2.8 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 ACHE YT ENSG00000087085 "Acetylcholinesterase (Cartwright blood group)" P22303 7 100889994-100896974 "Blood group antigen proteins, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter degradation" "Blood group antigen, Hydrolase, Serine esterase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 43.8;skeletal muscle: 98.2" "Cell line enhanced" "Detected in some" "BEWO: 8.0;CACO-2: 12.6;K-562: 14.8;Karpas-707: 24.7;U-2 OS: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027098 Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" 650000 "Golgi apparatus" Vesicles "HPA027098: " "unprognostic (2.23e-1)" "unprognostic (9.44e-2)" "unprognostic (2.71e-2)" "unprognostic (5.80e-3)" "prognostic unfavourable (5.27e-4)" "unprognostic (2.49e-1)" "unprognostic (2.54e-1)" "unprognostic (1.36e-2)" "unprognostic (2.48e-2)" "unprognostic (8.92e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "prognostic unfavourable (3.88e-5)" "unprognostic (2.95e-1)" "unprognostic (2.59e-2)" "unprognostic (9.28e-2)" "unprognostic (8.38e-2)" 1.4 4.8 5.8 3.5 16.1 10.3 1.4 22.8 11.8 1.4 4.2 2.7 1.4 5.7 1.9 2.6 2.8 1.8 3.1 4.5 5.5 43.8 1.4 1.8 1.8 5.9 22.2 4.8 1.7 1.6 7.0 3.2 2.0 37.9 3.3 3.4 4.6 6.5 3.3 98.2 1.4 7.9 1.9 8.7 2.3 2.1 1.9 2.6 3.5 1.6 15.9 3.2 2.1 1.2 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.3 0.2 0.5 0.0 8.0 0.3 0.0 0.1 0.2 12.6 0.3 0.0 0.4 0.0 0.4 2.1 0.1 0.0 4.3 0.5 0.2 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 14.8 24.7 0.1 3.5 0.0 0.1 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 1.0 0.0 0.0 0.0 0.1 0.7 5.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 16.1 22.8 11.8 5.5 43.8 22.2 4.8 37.9 2.6 ACPP "ACP-3, ACP3, PAP" ENSG00000014257 "Acid phosphatase, prostate" P15309 3 132317367-132368298 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "prostate: 345.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.2;NB-4: 7.7;RPMI-8226: 32.3;U-698: 9.4;U-87 MG: 9.0" "Cancer enriched" "Detected in many" 275 "prostate cancer: 1227.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 43.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB000071, HPA004335, HPA063916" Enhanced "Secreted to blood" 9200 "CAB000071: , HPA004335: AB_1079684, HPA063916: " "unprognostic (6.67e-2)" "unprognostic (4.70e-2)" "unprognostic (1.76e-1)" "unprognostic (7.77e-2)" "unprognostic (1.74e-1)" "unprognostic (2.58e-2)" "unprognostic (2.46e-1)" "unprognostic (7.41e-2)" "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (2.14e-1)" "unprognostic (5.95e-2)" "unprognostic (9.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.18e-1)" "unprognostic (3.91e-2)" "unprognostic (1.71e-1)" 0.4 0.6 0.4 0.7 1.6 1.4 0.8 0.3 0.7 3.9 0.4 0.2 0.0 0.4 0.3 2.5 14.7 0.6 0.2 0.9 0.3 0.3 6.2 0.3 2.0 2.7 0.6 0.8 0.4 0.8 0.5 0.3 5.3 0.7 345.2 0.7 0.8 9.1 0.2 0.3 2.5 0.4 0.4 2.2 1.0 0.5 1.0 0.6 0.2 1.3 6.6 6.8 0.5 1.5 0.2 11.2 43.1 9.7 0.9 0.0 2.9 0.2 0.0 0.0 0.0 0.1 0.6 7.0 0.1 10.2 0.0 0.0 0.2 0.2 5.7 0.4 0.0 2.9 0.0 0.0 0.0 0.0 0.3 1.1 0.2 0.1 0.1 4.1 0.1 0.6 0.8 0.0 0.0 0.0 0.1 1.6 0.1 0.1 0.0 7.7 0.4 1.2 0.0 0.0 32.3 3.1 3.8 0.0 2.5 0.0 1.2 0.3 0.2 3.7 0.0 0.0 0.1 1.5 0.0 0.4 0.2 9.4 9.0 7.3 0.1 0.0 9.7 43.1 0.0 8.6 0.0 0.2 0.0 0.0 11.2 0.0 0.0 0.0 8.5 0.9 7.7 0.8 0.0 2.9 0.4 1.6 0.3 0.7 0.3 0.3 0.6 0.8 0.7 0.6 ACSBG2 "BGR, DKFZp434K1635, PRTD-NY3" ENSG00000130377 "Acyl-CoA synthetase bubblegum family member 2" Q5FVE4 19 6135247-6193094 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis" "Developmental protein, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 71.3" "Cell line enhanced" "Detected in some" "BEWO: 1.5;HEL: 3.4;Karpas-707: 2.6;MCF7: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043421, HPA051013" Enhanced Uncertain Cytosol Cytosol "HPA043421: AB_10794182, HPA051013: " "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-1)" "unprognostic (3.27e-2)" "unprognostic (4.33e-2)" "unprognostic (1.92e-4)" "unprognostic (1.96e-2)" "unprognostic (4.17e-2)" "unprognostic (2.07e-1)" "unprognostic (2.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.13e-2)" "unprognostic (3.91e-3)" "unprognostic (2.20e-1)" "unprognostic (9.23e-2)" "unprognostic (8.78e-2)" "unprognostic (4.70e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.4 0.0 0.1 0.0 0.6 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.4 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 ACSF2 "ACSMW, FLJ20920" ENSG00000167107 "Acyl-CoA synthetase family member 2" Q96CM8 17 50426158-50474845 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 60.0" "Cell line enhanced" "Detected in many" "RT4: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024693 Enhanced Approved Nucleoplasm,Microtubules,Cytosol "Nucleoplasm, Cytosol" Microtubules "HPA024693: " "unprognostic (1.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (1.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.48e-2)" "unprognostic (1.14e-2)" "unprognostic (6.49e-2)" "unprognostic (7.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "prognostic unfavourable (2.17e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (2.45e-2)" "prognostic favourable (2.41e-4)" 13.2 37.6 4.8 7.7 4.4 1.1 16.3 2.0 4.0 8.4 19.1 4.0 30.3 9.2 3.5 15.4 6.7 4.3 7.2 12.9 5.6 2.0 60.0 15.0 9.0 3.7 3.7 2.8 9.4 3.4 2.6 1.7 14.1 3.9 12.4 7.4 7.6 10.1 33.3 28.4 9.7 22.4 4.5 3.5 4.5 8.0 4.5 3.6 3.5 30.6 6.6 5.9 13.0 7.6 7.8 13.8 11.9 6.2 1.2 4.3 2.1 9.6 3.1 2.6 6.2 27.4 5.0 15.3 2.3 3.4 5.0 9.8 12.2 18.4 6.0 5.1 2.8 5.8 1.8 11.3 6.0 7.5 4.4 10.3 1.5 21.7 4.6 1.3 9.6 22.1 17.4 6.4 0.8 6.8 1.2 3.4 5.4 11.6 3.1 4.1 0.4 4.6 7.8 1.9 15.1 1.6 37.5 8.5 4.6 4.5 6.8 4.7 6.0 8.8 5.1 9.1 2.8 1.3 0.7 6.1 1.2 3.1 3.8 6.5 0.5 0.0 2.5 11.9 1.8 6.2 1.6 7.8 1.3 1.8 13.8 1.9 0.6 0.8 0.4 1.2 5.4 5.2 4.3 2.1 4.8 4.4 2.0 4.0 5.6 2.0 3.7 2.8 3.9 3.6 ACSL3 "ACS3, FACL3, PRO2194" ENSG00000123983 "Acyl-CoA synthetase long chain family member 3" O95573 2 222860934-222944639 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 206.1" "Cell line enhanced" "Detected in all" "SK-MEL-30: 92.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011315, HPA071021" Approved Approved "Nucleoli,Lipid droplets" Nucleoli "Lipid droplets" "HPA011315: AB_1848344, HPA071021: " "unprognostic (1.87e-1)" "unprognostic (5.64e-2)" "unprognostic (2.36e-1)" "unprognostic (9.35e-3)" "unprognostic (7.53e-2)" "unprognostic (2.07e-2)" "prognostic unfavourable (2.75e-4)" "prognostic unfavourable (8.78e-4)" "unprognostic (3.90e-2)" "unprognostic (2.50e-1)" "unprognostic (2.64e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-1)" "unprognostic (2.72e-1)" "unprognostic (2.65e-1)" "unprognostic (1.60e-1)" 14.7 17.0 22.8 9.9 26.0 16.3 51.5 19.4 45.9 15.3 16.5 16.1 11.6 12.7 10.9 18.4 28.3 9.0 11.8 22.7 20.9 22.8 17.9 22.3 15.6 10.5 19.6 21.2 11.7 10.3 206.1 8.8 19.1 24.4 44.4 16.7 14.4 34.2 15.5 19.1 11.4 12.7 12.2 22.2 9.7 28.3 13.7 14.2 13.5 17.3 11.2 8.7 14.6 15.4 15.0 22.5 21.8 16.8 16.6 20.1 16.5 9.9 17.6 27.0 29.3 11.8 29.3 7.5 12.7 33.0 15.2 32.2 15.8 25.7 4.8 7.4 12.1 29.4 5.8 28.3 19.8 8.6 11.1 11.2 14.3 17.7 26.0 7.4 5.5 15.1 40.1 25.2 44.0 16.6 21.2 18.3 21.5 21.2 14.4 8.7 13.7 9.2 7.9 22.9 8.1 21.9 40.9 14.2 10.6 7.5 20.3 92.7 10.2 18.1 11.4 10.2 16.3 8.8 9.3 6.5 3.1 16.5 11.0 6.9 30.9 16.6 14.6 21.8 20.1 16.8 19.3 11.6 12.8 14.6 15.7 15.0 18.7 16.7 21.8 16.6 15.9 22.5 9.5 16.5 22.8 26.0 19.4 45.9 20.9 22.8 19.6 21.2 24.4 14.2 ACSL4 "ACS4, FACL4, LACS4, MRX63, MRX68" ENSG00000068366 "Acyl-CoA synthetase long chain family member 4" O60488 X 109624244-109733403 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000286, HPA005552" Supported Approved "Golgi apparatus,Mitochondria" 100000 "Golgi apparatus" Mitochondria "HPA000286: , HPA005552: AB_1078774" "unprognostic (9.13e-2)" "unprognostic (3.38e-1)" "unprognostic (1.39e-1)" "unprognostic (2.61e-1)" "unprognostic (2.55e-1)" "unprognostic (2.94e-2)" "unprognostic (5.32e-2)" "unprognostic (4.14e-3)" "unprognostic (1.92e-1)" "unprognostic (9.45e-2)" "unprognostic (1.92e-2)" "unprognostic (1.21e-1)" "unprognostic (1.64e-2)" "unprognostic (1.81e-1)" "unprognostic (4.78e-1)" "unprognostic (3.29e-2)" "prognostic favourable (5.73e-4)" 29.5 31.1 16.3 25.5 18.0 9.2 30.0 13.9 22.8 34.7 10.5 8.8 4.6 10.0 13.7 11.7 11.2 10.7 20.1 20.3 27.6 20.3 31.2 9.6 27.8 29.6 15.2 19.0 13.1 8.8 16.7 12.9 33.9 21.1 9.7 9.7 8.0 10.7 11.0 42.5 9.1 9.0 15.8 24.6 17.0 12.9 17.7 9.7 9.5 12.8 8.5 11.9 19.5 21.0 2.2 6.5 20.3 10.9 2.2 4.0 3.8 13.7 4.4 5.5 5.9 20.7 13.0 4.3 20.1 22.3 19.7 20.5 4.3 9.6 9.8 7.8 14.5 3.9 4.7 19.4 31.0 3.4 4.9 38.7 6.3 45.8 9.5 9.2 80.3 11.2 7.6 22.5 16.4 14.7 1.1 12.1 22.5 0.9 8.0 12.1 6.9 8.0 5.8 10.1 8.1 28.2 4.4 3.6 2.8 24.0 0.0 12.4 0.3 9.8 27.2 18.0 5.1 28.4 18.4 6.0 6.9 9.2 31.7 20.6 11.4 15.5 7.0 20.3 2.8 9.8 2.0 2.2 2.5 2.2 6.5 2.2 2.0 2.4 19.8 2.2 10.9 2.6 4.0 3.8 16.3 18.0 13.9 22.6 27.6 20.3 15.2 19.0 21.1 9.7 ACSL6 "ACS2, FACL6, KIAA0837, LACS2, LACS5" ENSG00000164398 "Acyl-CoA synthetase long chain family member 6" Q9UKU0 5 131949973-132012243 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.0;ductus deferens: 30.1;seminal vesicle: 35.8;testis: 23.0" "Group enriched" "Detected in some" 5 "SCLC-21H: 14.6;U-937: 8.5" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA040470 Enhanced "HPA040470: AB_10794033" "unprognostic (1.99e-2)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (5.89e-2)" "unprognostic (6.97e-2)" "unprognostic (1.92e-2)" "unprognostic (8.38e-3)" "unprognostic (5.84e-2)" "unprognostic (8.69e-2)" "unprognostic (7.57e-2)" "unprognostic (9.28e-4)" "unprognostic (8.69e-2)" "unprognostic (3.22e-2)" "unprognostic (6.24e-3)" "unprognostic (1.79e-1)" "unprognostic (6.44e-3)" "unprognostic (1.70e-1)" 0.6 4.8 16.5 1.5 15.7 21.3 0.7 22.8 34.0 0.5 0.7 5.3 30.1 5.4 0.5 1.0 0.9 0.7 0.9 2.0 12.4 9.7 2.3 2.6 0.8 2.5 9.6 12.1 0.5 1.9 13.0 2.7 1.1 12.1 0.8 0.8 3.3 0.8 35.8 3.6 0.6 3.3 0.5 4.2 1.2 1.2 23.0 4.7 0.0 0.9 0.0 1.5 0.7 0.3 0.1 0.0 0.6 0.1 1.2 4.2 1.1 0.0 0.0 0.2 0.1 0.5 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.1 1.6 0.2 0.0 0.0 0.9 0.1 0.0 2.2 0.0 0.2 2.1 0.0 0.1 0.0 0.1 0.0 1.0 0.2 0.0 0.0 0.0 1.4 0.9 0.1 0.1 0.0 0.0 0.0 0.0 14.6 0.7 0.2 0.2 1.1 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.5 0.0 0.3 8.5 0.5 0.6 0.1 0.1 1.5 0.0 3.5 0.1 2.1 4.2 0.0 0.1 3.9 1.8 0.2 1.2 0.0 0.0 0.1 1.1 16.5 15.7 22.8 18.8 12.4 9.7 9.6 12.1 12.1 4.7 ACSM1 "BUCS1, MACS1" ENSG00000166743 "Acyl-CoA synthetase medium chain family member 1" Q08AH1 16 20623237-20698890 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "breast: 83.4" "Cell line enriched" "Detected in some" 5 "NTERA-2: 18.4" "Group enriched" "Detected in many" 8 "liver cancer: 14.7;prostate cancer: 36.7" "Cell type enhanced" "Detected in some" "eosinophil: 3.5;memory B-cell: 3.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA046291 Uncertain "HPA046291: AB_10960704" "unprognostic (1.08e-2)" "unprognostic (3.07e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (5.49e-4)" "unprognostic (1.66e-1)" "unprognostic (3.50e-2)" "unprognostic (9.46e-2)" "unprognostic (3.10e-1)" "unprognostic (8.44e-3)" "unprognostic (2.10e-1)" "unprognostic (2.64e-1)" "unprognostic (8.24e-2)" "unprognostic (3.79e-2)" "unprognostic (3.01e-1)" "unprognostic (9.58e-2)" "unprognostic (2.33e-3)" 0.0 0.1 0.0 0.0 0.0 1.1 83.4 0.1 0.1 1.7 0.4 0.2 2.3 0.2 0.1 2.4 0.2 0.1 0.0 0.0 1.2 3.8 0.2 0.1 0.0 2.8 1.4 0.5 0.0 0.0 3.4 0.2 1.2 0.2 0.1 2.2 0.4 0.3 0.0 0.2 2.1 4.5 0.2 0.1 1.1 1.5 3.4 0.0 3.5 0.9 1.3 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.9 0.1 0.0 0.3 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.1 18.4 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.6 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 3.5 0.1 0.2 0.1 3.4 0.6 0.0 0.0 2.9 0.5 0.2 0.0 1.3 0.0 0.0 0.0 0.1 ACSM2A "A-923A4.1, ACSM2, MGC150530" ENSG00000183747 "Acyl-CoA synthetase medium chain family member 2A" Q08AH3 16 20451461-20487667 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 90 "kidney: 63.5;liver: 82.6" "Cell line enriched" "Detected in some" 5 "Hep G2: 6.4" "Group enriched" "Detected in some" 479 "liver cancer: 22.7;renal cancer: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057699 Supported "HPA057699: " "unprognostic (1.17e-4)" "prognostic favourable (1.41e-5)" "unprognostic (5.25e-1)" "unprognostic (2.42e-1)" "unprognostic (9.28e-3)" "unprognostic (1.52e-1)" "unprognostic (5.10e-1)" "unprognostic (2.09e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.0 63.5 82.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.1 0.5 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 ACSM2B "ACSM2, HXMA, HYST1046" ENSG00000066813 "Acyl-CoA synthetase medium chain family member 2B" Q68CK6 16 20536226-20576427 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 69 "kidney: 76.1;liver: 93.4" "Cell line enhanced" "Detected in many" "AF22: 5.4;Hep G2: 9.8" "Group enriched" "Detected in some" 450 "liver cancer: 30.9;renal cancer: 17.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA057699 Supported "HPA057699: " "unprognostic (1.34e-2)" "prognostic favourable (3.31e-4)" "unprognostic (7.13e-2)" "unprognostic (2.29e-1)" "unprognostic (6.67e-2)" "unprognostic (1.24e-1)" "unprognostic (1.15e-1)" "unprognostic (2.22e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 76.1 93.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.9 1.0 0.5 0.2 1.2 0.0 1.0 0.0 5.4 1.5 0.0 0.0 1.3 0.9 0.2 0.0 0.0 1.2 0.9 0.1 2.7 0.0 0.7 0.0 0.0 0.0 1.0 0.7 0.2 1.2 9.8 0.0 1.3 1.3 0.0 0.0 0.0 0.4 0.6 0.8 1.2 0.0 0.7 0.6 1.3 1.2 0.0 0.1 1.1 0.2 0.4 0.2 1.9 1.0 2.6 0.0 1.0 2.0 0.4 0.0 0.0 0.9 0.0 0.7 0.8 0.5 0.7 0.7 3.5 1.9 0.5 0.5 0.2 0.6 0.0 0.6 0.1 0.8 0.2 0.1 0.6 0.7 1.2 1.0 0.2 0.1 0.9 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 ACSS1 "ACAS2L, AceCS2L, dJ568C11.3, MGC33843" ENSG00000154930 "Acyl-CoA synthetase short chain family member 1" Q9NUB1 20 25006230-25058980 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.4" "Cell line enhanced" "Detected in many" "Hep G2: 20.5;MOLT-4: 19.8;RPMI-8226: 30.5;U-937: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041014, HPA043228" Enhanced "HPA041014: , HPA043228: " "unprognostic (6.87e-2)" "prognostic favourable (9.37e-4)" "unprognostic (5.32e-2)" "unprognostic (1.54e-1)" "unprognostic (2.78e-1)" "unprognostic (3.03e-2)" "unprognostic (3.20e-3)" "prognostic favourable (8.33e-5)" "unprognostic (2.44e-1)" "unprognostic (2.17e-2)" "unprognostic (2.43e-1)" "unprognostic (7.72e-2)" "unprognostic (4.58e-3)" "unprognostic (5.85e-2)" "unprognostic (2.68e-1)" "unprognostic (3.69e-1)" "unprognostic (1.60e-1)" 6.1 4.8 22.8 8.6 26.6 16.3 9.1 17.1 19.6 9.0 14.0 21.8 9.7 28.1 8.5 12.3 7.5 10.8 12.4 32.4 26.3 9.2 19.5 5.5 10.8 13.4 15.1 20.4 12.3 28.8 9.3 5.7 66.4 21.3 14.8 12.5 9.9 21.8 10.2 19.5 9.3 25.9 8.0 11.1 16.1 26.9 21.6 22.9 11.9 14.9 4.8 12.2 8.7 7.1 7.2 4.4 8.7 6.3 12.6 5.5 2.7 0.0 4.9 1.4 0.0 4.7 1.8 0.1 0.5 2.1 2.1 1.4 4.9 0.7 8.5 0.8 2.0 2.5 7.2 1.1 0.4 0.0 0.7 14.7 0.1 20.5 4.8 3.5 0.2 3.0 3.7 0.2 0.0 4.6 0.7 16.5 0.2 0.5 19.8 5.9 0.1 7.9 15.5 0.5 30.5 3.1 3.9 3.5 0.1 0.9 1.9 13.7 9.5 7.8 0.7 0.0 0.0 0.0 0.2 11.5 0.7 0.0 0.2 21.2 5.5 6.3 3.7 8.7 5.5 6.3 4.5 5.2 3.7 4.8 4.4 7.2 3.2 4.9 0.8 12.6 4.1 2.8 3.2 2.7 22.8 26.6 17.1 19.6 26.3 9.2 15.1 20.4 21.3 22.9 ACSS2 "ACAS2, AceCS, ACS, ACSA, dJ1161H23.1" ENSG00000131069 "Acyl-CoA synthetase short chain family member 2" Q9NR19 20 34872146-34927962 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.4" "Cell line enhanced" "Detected in many" "RPMI-8226: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 5 "dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004141 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA004141: AB_1078094" "unprognostic (1.97e-2)" "unprognostic (1.33e-1)" "unprognostic (1.70e-1)" "unprognostic (2.25e-2)" "unprognostic (1.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.42e-1)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (3.92e-2)" "unprognostic (1.66e-1)" "unprognostic (1.42e-2)" "prognostic favourable (2.04e-4)" "unprognostic (2.72e-1)" "unprognostic (2.32e-1)" "unprognostic (3.08e-1)" "unprognostic (2.54e-1)" 30.3 12.6 2.8 9.2 7.0 1.9 12.4 5.6 7.0 6.8 21.0 10.6 8.3 21.4 6.6 7.0 8.1 4.5 7.7 24.8 2.9 2.5 11.2 15.7 11.7 3.2 6.8 3.2 5.1 3.2 4.7 2.5 4.6 5.5 3.4 10.4 3.5 9.8 6.8 63.4 6.8 24.1 3.0 6.1 2.7 13.4 3.1 7.1 1.1 3.9 7.3 3.0 6.5 6.1 0.7 12.6 17.0 11.6 0.3 3.0 4.7 11.6 1.6 1.1 1.6 8.3 8.8 12.2 7.0 5.4 1.9 3.4 4.2 6.5 0.0 7.9 3.0 8.9 2.9 17.6 1.4 0.0 2.8 16.3 0.8 2.0 6.1 1.5 9.0 6.0 3.8 2.9 2.7 3.0 10.3 1.2 2.7 1.3 0.5 7.1 0.8 19.9 4.3 7.6 25.7 6.7 1.2 1.0 5.3 8.5 6.3 6.8 3.1 3.6 11.5 2.3 3.2 4.2 2.3 11.1 8.1 3.8 6.6 2.6 1.9 17.0 11.6 3.0 0.6 7.2 0.5 0.4 1.6 0.7 12.6 0.7 3.0 1.5 6.5 0.3 3.4 2.1 1.1 4.7 2.8 7.0 5.6 7.0 2.9 2.5 6.8 3.2 5.5 7.1 ACSS3 FLJ21963 ENSG00000111058 "Acyl-CoA synthetase short chain family member 3" Q9H6R3 12 80936414-81261205 "Enzymes, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 9.3;ASC TERT1: 10.6;Hep G2: 26.2;RH-30: 12.2;SK-BR-3: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "basophil: 8.3;neutrophil: 6.0" "Lineage enriched" "Detected in single" 71 "granulocytes: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039353, HPA047956, HPA061517" Approved Approved Mitochondria Mitochondria "HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: " "unprognostic (8.59e-2)" "unprognostic (9.29e-4)" "unprognostic (1.47e-1)" "unprognostic (9.37e-3)" "unprognostic (2.46e-2)" "unprognostic (2.21e-1)" "unprognostic (9.25e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (7.18e-3)" "unprognostic (1.68e-1)" "unprognostic (7.79e-2)" "prognostic favourable (0.00e+0)" "unprognostic (6.16e-4)" "unprognostic (1.63e-1)" "unprognostic (2.00e-1)" "unprognostic (2.00e-4)" 19.6 18.3 7.4 1.9 8.3 1.0 8.1 2.7 7.7 13.2 2.6 5.5 10.8 1.2 18.2 14.4 2.0 8.3 8.1 10.9 6.4 3.9 24.4 37.1 8.8 1.7 7.4 6.5 16.7 2.6 21.3 11.0 4.1 6.5 7.1 1.6 10.3 20.4 11.4 9.8 2.1 1.9 6.6 5.5 2.8 1.9 4.0 4.1 0.0 9.2 2.9 1.6 3.5 6.3 0.0 0.0 8.3 0.0 0.0 0.1 0.0 0.0 0.1 2.1 0.0 9.3 10.6 0.0 1.5 6.9 1.1 1.2 0.3 0.0 0.1 0.0 3.1 0.1 0.0 0.0 0.6 0.0 1.6 0.0 0.1 26.2 3.2 0.3 0.0 7.1 0.0 0.3 0.0 0.2 0.0 0.0 4.9 0.6 0.0 0.1 3.2 0.0 0.0 12.2 1.6 0.0 0.0 2.1 0.0 0.0 11.5 0.0 5.1 0.3 0.0 1.9 1.8 0.2 0.7 0.1 0.1 0.0 2.3 0.0 2.1 8.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 7.4 8.3 2.7 7.7 6.4 3.9 7.4 6.5 6.5 4.1 ACVR1 "ACVR1A, ACVRLK2, ALK2, SKR1" ENSG00000115170 "Activin A receptor type 1" Q04771 2 157736444-157875862 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007505, HPA046514" Approved Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA007505: AB_1844752, HPA046514: " "unprognostic (6.99e-2)" "unprognostic (3.32e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.73e-1)" "unprognostic (6.09e-2)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (3.99e-1)" "unprognostic (3.20e-1)" "unprognostic (2.65e-2)" "unprognostic (4.29e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-2)" "prognostic unfavourable (5.17e-4)" 18.9 9.2 18.0 10.0 12.7 1.6 38.7 15.3 12.2 25.2 14.4 7.4 8.4 8.9 24.8 26.8 11.0 16.6 20.5 18.8 18.7 8.6 21.7 18.9 22.5 15.1 10.4 7.9 18.5 12.3 11.3 17.0 14.2 12.3 16.8 10.5 14.3 18.1 13.6 15.6 12.8 11.5 29.2 12.3 9.2 11.8 8.8 10.9 7.5 34.0 14.6 6.9 16.1 32.5 1.4 2.4 3.8 2.6 1.9 10.0 1.6 2.1 4.2 4.9 6.4 25.0 26.1 6.9 15.1 25.2 12.1 13.0 3.3 4.7 0.0 7.0 16.4 5.9 3.5 8.2 13.1 14.5 3.0 8.6 2.5 4.8 19.8 0.6 10.2 32.6 15.6 24.9 31.8 13.2 3.1 2.4 15.3 3.7 0.1 0.2 7.4 7.7 1.4 6.6 1.8 15.8 7.9 4.4 5.4 5.8 3.3 20.7 1.7 2.3 19.0 18.5 6.1 9.1 5.7 1.6 1.2 0.1 19.0 0.5 19.9 3.8 2.6 0.2 1.1 1.7 1.2 1.4 7.8 2.5 1.8 0.8 3.1 1.5 0.8 1.9 2.3 2.4 10.0 1.6 18.0 12.7 15.3 12.2 18.7 8.6 10.4 7.9 12.3 10.9 ACVR1B "ActRIB, ACVRLK4, ALK4, SKR2" ENSG00000135503 "Activin A receptor type 1B" P36896 12 51951667-51997078 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026126, HPA063761" Approved Approved Cytosol Cytosol "CAB026126: , HPA063761: " "unprognostic (8.66e-2)" "unprognostic (5.72e-2)" "unprognostic (1.16e-1)" "unprognostic (3.23e-3)" "unprognostic (2.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.21e-3)" "unprognostic (1.00e-1)" "unprognostic (7.68e-2)" "unprognostic (5.29e-2)" "unprognostic (2.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.52e-2)" "unprognostic (9.02e-2)" "unprognostic (6.60e-2)" "unprognostic (8.96e-2)" "unprognostic (4.79e-2)" 11.1 7.4 12.0 6.4 14.6 7.9 14.3 14.2 24.4 8.6 16.7 5.1 28.0 19.2 6.7 13.1 14.4 10.9 11.1 7.6 11.2 10.5 24.6 21.0 10.3 7.1 8.1 14.7 7.1 35.1 24.9 10.9 7.5 7.3 10.0 17.1 8.7 21.7 34.3 11.7 30.6 19.8 8.2 5.8 6.7 17.2 10.6 4.8 3.9 9.9 5.8 8.4 10.1 12.1 0.5 1.3 6.8 4.0 0.1 1.6 0.6 6.2 13.8 10.7 5.9 12.3 9.7 6.1 7.1 8.1 7.6 5.8 27.8 9.7 2.7 10.0 7.7 11.1 10.2 8.6 7.9 4.0 12.0 6.8 3.5 8.6 14.1 10.9 25.5 18.9 11.2 8.6 10.9 10.7 7.2 8.6 6.7 12.8 10.4 9.5 10.4 4.8 5.6 8.3 3.5 21.5 9.6 13.7 11.4 7.7 11.0 5.0 12.1 7.1 6.7 5.2 8.0 5.9 3.4 5.2 3.7 3.8 5.6 5.3 6.7 4.5 2.2 6.8 0.7 3.3 1.0 0.1 0.6 0.7 1.3 0.5 1.6 0.9 1.9 0.1 4.0 0.7 1.0 0.6 12.0 14.6 14.2 24.4 11.2 10.5 8.1 14.7 7.3 4.8 ACVR1C "ACVRLK7, ALK7" ENSG00000123612 "Activin A receptor type 1C" Q8NER5 2 157526767-157629005 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 36.2;breast: 15.3" "Group enriched" "Detected in some" 4 "ASC diff: 15.1;HDLM-2: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.8" "Lineage enriched" "Detected in single" 4 "T-cells: 2.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 29.2;cerebral cortex: 8.1;hippocampal formation: 21.6" "HPA007982, HPA011933" Approved "Intracellular and membrane" "HPA007982: AB_1078134, HPA011933: AB_1844754" "unprognostic (1.03e-1)" "unprognostic (4.55e-2)" "unprognostic (9.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (7.64e-2)" "unprognostic (1.00e-1)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (7.12e-3)" "unprognostic (3.62e-1)" "unprognostic (9.31e-6)" "unprognostic (7.28e-2)" "unprognostic (1.95e-1)" "unprognostic (9.74e-2)" "unprognostic (1.30e-1)" 36.2 3.7 3.9 2.7 10.3 0.7 15.3 1.6 4.4 0.9 9.4 2.7 0.0 5.5 0.7 1.0 0.8 0.8 1.8 1.0 9.2 3.1 1.1 3.3 0.8 1.2 3.7 3.1 5.1 2.4 0.5 12.0 0.7 3.5 0.9 4.4 0.0 1.5 1.0 1.3 0.7 4.4 0.8 2.8 0.8 3.4 1.1 4.0 0.0 0.9 0.5 1.0 0.6 2.9 0.6 0.0 0.0 0.0 0.0 2.8 0.4 2.0 0.0 0.0 0.1 15.1 0.4 0.3 0.4 0.4 0.1 0.5 2.2 0.2 0.0 0.2 1.2 0.0 0.1 0.0 0.3 6.6 1.0 0.0 0.0 0.5 0.0 0.0 1.1 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.4 0.2 0.0 0.0 1.3 0.7 0.0 0.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.3 0.0 0.8 0.2 0.0 0.2 0.8 2.4 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.5 0.0 1.0 0.6 1.8 1.2 0.0 0.5 2.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 3.9 10.3 1.6 4.4 9.2 3.1 3.7 3.1 3.5 4.0 ACVR2A "ACTRII, ACVR2" ENSG00000121989 "Activin A receptor type 2A" P27037 2 147844517-147930826 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 20.5;RH-30: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046997 Approved Approved Cytosol Cytosol "HPA046997: AB_10970077" "unprognostic (4.55e-2)" "unprognostic (2.26e-2)" "unprognostic (2.09e-1)" "unprognostic (7.34e-3)" "unprognostic (2.75e-1)" "unprognostic (1.17e-1)" "unprognostic (4.41e-3)" "unprognostic (8.73e-3)" "unprognostic (1.30e-2)" "unprognostic (3.61e-1)" "unprognostic (1.34e-2)" "unprognostic (1.52e-1)" "prognostic favourable (1.62e-4)" "unprognostic (1.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.95e-1)" "unprognostic (3.99e-2)" 12.0 6.0 13.6 8.2 9.9 3.8 10.7 14.5 14.2 10.2 14.1 4.7 9.7 10.4 9.3 9.9 13.6 7.6 17.7 5.6 10.0 9.0 9.0 10.3 7.5 4.7 5.9 10.6 7.6 9.8 8.6 15.9 10.6 7.3 12.2 9.1 7.6 12.2 12.0 19.6 29.5 17.8 13.8 5.4 6.5 9.3 11.0 6.4 1.5 9.5 6.9 6.8 13.5 11.8 0.7 3.0 0.5 3.6 7.7 4.6 1.4 1.3 1.5 9.8 3.6 5.8 3.7 4.0 3.0 3.6 5.2 9.1 4.2 5.9 0.0 2.7 4.8 4.6 8.9 4.4 6.7 1.0 5.4 0.6 2.7 7.3 20.5 0.6 0.7 6.2 5.6 3.3 6.7 3.9 1.4 2.5 3.5 3.4 0.3 0.5 11.0 2.6 0.1 17.1 0.9 4.2 8.3 9.7 5.5 2.5 3.1 3.7 1.9 1.0 3.0 4.8 5.7 4.5 2.1 0.7 0.2 1.8 3.0 0.3 3.8 0.4 3.0 0.5 1.2 3.6 0.5 0.3 4.6 2.1 2.3 0.7 3.0 0.7 0.1 7.7 3.1 3.0 0.4 1.4 13.6 9.9 14.5 14.2 10.0 9.0 5.9 10.6 7.3 6.4 ACVR2B ActR-IIB ENSG00000114739 "Activin A receptor type 2B" Q13705 3 38453851-38493142 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 16.6;NTERA-2: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007398, CAB025115, HPA040384" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "CAB025115: , HPA007398: , HPA040384: " "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.32e-2)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (1.64e-1)" "unprognostic (1.98e-1)" "unprognostic (1.83e-1)" "unprognostic (4.75e-1)" 2.8 7.4 5.5 4.6 7.9 1.1 5.5 13.2 7.5 5.2 3.4 7.2 4.5 2.8 4.7 5.1 2.5 5.6 3.3 3.9 5.9 5.4 5.3 5.4 6.9 2.2 5.9 5.4 8.3 6.1 11.3 5.1 16.0 6.5 3.9 3.6 5.0 4.6 4.2 15.9 2.4 2.8 4.6 4.7 3.1 4.0 9.1 9.1 12.8 4.8 1.7 2.2 4.2 10.3 0.3 0.3 0.5 0.2 0.5 1.6 0.3 0.8 1.4 16.6 1.4 0.6 0.4 8.9 0.3 0.5 0.3 0.7 2.4 1.1 0.1 1.3 0.4 1.0 6.3 1.0 0.9 2.4 4.1 4.2 2.6 3.5 0.8 3.0 1.6 0.7 0.9 0.5 1.8 1.1 7.0 1.4 0.3 1.3 5.1 1.9 20.5 0.7 1.7 5.5 1.0 1.1 2.0 3.9 6.8 0.5 2.5 2.2 1.4 4.0 0.9 0.6 2.7 0.4 1.4 4.0 5.4 0.9 0.6 2.5 1.1 0.5 0.1 0.1 0.4 0.2 0.6 0.2 1.0 0.5 0.0 0.3 1.6 1.5 0.3 0.5 0.2 0.3 0.7 0.3 5.5 7.9 13.2 7.0 5.9 5.4 5.9 5.4 6.5 9.1 ACVRL1 "ACVRLK1, ALK1, HHT, HHT2, ORW2" ENSG00000139567 "Activin A receptor like type 1" P37023 12 51906908-51923361 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 55.0" "Cell line enhanced" "Detected in some" "ASC diff: 18.1;ASC TERT1: 12.4;EFO-21: 16.0;HUVEC TERT2: 58.5;TIME: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 3.6;myeloid DC: 5.0" "Group enriched" "Detected in many" 12 "dendritic cells: 5.0;monocytes: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007041 Approved "Intracellular and membrane" "HPA007041: AB_1078097" "unprognostic (2.50e-1)" "unprognostic (4.83e-1)" "unprognostic (3.79e-2)" "unprognostic (3.61e-2)" "unprognostic (4.98e-1)" "unprognostic (4.06e-3)" "unprognostic (2.79e-1)" "unprognostic (1.35e-1)" "unprognostic (5.80e-2)" "unprognostic (5.10e-2)" "unprognostic (4.60e-2)" "unprognostic (4.64e-2)" "unprognostic (1.12e-3)" "unprognostic (1.39e-1)" "unprognostic (7.98e-3)" "unprognostic (2.79e-1)" "unprognostic (1.10e-1)" 25.5 5.1 3.2 9.3 4.3 0.2 15.6 1.6 3.6 15.1 20.1 3.7 13.1 4.9 12.7 11.0 12.1 13.9 11.0 15.4 3.7 3.2 13.6 3.4 55.0 19.1 4.9 3.6 5.9 6.1 21.6 2.7 44.1 5.3 12.3 14.7 12.3 6.9 10.6 14.2 8.0 11.1 8.2 3.7 14.8 8.1 3.5 3.6 1.7 12.9 6.8 5.4 9.3 11.2 0.1 5.0 0.3 3.6 0.0 0.1 0.7 0.0 0.2 0.1 0.0 18.1 12.4 0.0 0.8 1.6 0.0 0.0 0.1 0.1 0.0 16.0 6.8 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 2.7 0.0 0.4 5.0 0.0 0.1 0.0 58.5 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 45.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 3.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.7 3.2 4.3 1.6 3.6 3.7 3.2 4.9 3.6 5.3 3.6 ADAM10 "CD156c, HsT18717, kuz, MADM" ENSG00000137845 "ADAM metallopeptidase domain 10" O14672 15 58588807-58749978 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001709, HPA050670" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" 8200000 "Plasma membrane" "Nucleoplasm, Vesicles" "CAB001709: , HPA050670: " "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (5.04e-2)" "unprognostic (3.09e-1)" "unprognostic (2.70e-3)" "unprognostic (7.48e-2)" "prognostic unfavourable (8.46e-5)" "unprognostic (3.99e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (6.69e-2)" "unprognostic (2.57e-2)" "unprognostic (2.57e-3)" "unprognostic (9.14e-2)" "unprognostic (2.09e-2)" "unprognostic (1.60e-2)" 25.9 11.1 15.5 17.1 17.7 15.6 20.0 25.2 17.6 18.6 20.1 15.7 12.7 13.9 19.9 11.8 17.1 13.8 18.0 18.8 17.6 13.7 20.8 14.8 25.0 26.1 23.1 12.4 13.9 13.1 10.9 11.6 36.1 14.5 23.6 16.7 14.6 12.4 19.1 8.9 15.4 15.6 12.8 30.4 40.4 18.4 8.5 18.9 38.5 27.3 9.2 14.9 30.0 19.1 6.2 12.7 26.9 23.7 9.8 12.2 12.8 11.8 26.9 7.3 8.0 9.4 13.6 18.5 10.2 30.4 7.5 10.5 12.4 15.7 5.5 31.6 9.1 24.3 4.4 10.8 10.0 8.2 5.6 9.4 9.8 11.5 10.5 6.6 27.2 11.9 8.0 5.2 7.7 14.6 5.9 15.0 13.2 4.4 21.9 7.6 10.0 3.8 9.1 24.0 14.1 17.5 32.1 8.0 5.2 11.1 12.9 17.6 7.7 13.3 10.3 9.9 11.0 76.0 9.8 8.4 18.1 6.0 13.8 12.9 17.3 12.9 18.8 10.4 8.1 21.5 12.2 5.3 8.0 7.1 12.7 6.2 8.4 7.0 26.9 9.8 23.7 5.8 10.3 12.8 15.5 17.7 25.2 16.9 17.6 13.7 23.1 12.4 14.5 18.9 ADAM11 MDC ENSG00000073670 "ADAM metallopeptidase domain 11" O75078 17 44759031-44781846 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 42.3;heart muscle: 11.2" "Cell line enriched" "Detected in some" 4 "HEK 293: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074550 Enhanced "HPA074550: " "unprognostic (1.79e-1)" "unprognostic (7.78e-2)" "unprognostic (1.73e-3)" "unprognostic (2.59e-3)" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (6.37e-2)" "unprognostic (5.41e-2)" "unprognostic (5.46e-3)" "unprognostic (7.16e-2)" "unprognostic (9.99e-16)" "unprognostic (1.39e-1)" "unprognostic (2.51e-1)" "unprognostic (3.11e-1)" "unprognostic (3.00e-1)" 1.2 0.5 8.5 0.6 7.5 1.0 0.6 42.3 23.1 0.9 0.8 0.7 0.0 0.8 4.0 1.1 1.1 1.2 1.5 11.2 11.4 4.2 0.7 0.6 0.7 0.7 2.7 9.8 0.9 0.6 0.7 0.6 0.7 5.5 1.6 0.6 0.2 0.5 2.2 0.8 2.5 0.7 2.6 1.5 0.7 0.7 2.3 1.1 0.0 0.6 0.0 0.6 0.7 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.6 4.8 0.2 0.0 0.3 0.1 0.0 1.3 0.4 0.7 0.2 0.1 0.3 0.0 0.0 3.6 0.0 0.4 1.4 20.5 0.2 0.4 0.3 0.1 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.1 4.1 0.0 2.4 0.8 1.3 2.8 0.0 0.3 0.0 0.1 3.7 1.9 0.0 0.1 1.0 1.4 0.7 0.0 0.6 1.7 1.8 0.4 0.7 0.2 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 8.5 7.5 42.3 21.0 11.4 4.2 2.7 9.8 5.5 1.1 ADAM12 "MCMPMltna, MLTN" ENSG00000148848 "ADAM metallopeptidase domain 12" O43184 10 126012381-126388455 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 50 "placenta: 487.4" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 46.4;hTEC/SVTERT24-B: 29.2;U-2197: 28.8;U-251 MG: 25.7;U-87 MG: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 9.8" "Lineage enriched" "Detected in single" 98 "T-cells: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA030866, HPA030867, HPA030868" Enhanced Supported "Plasma membrane" "Secreted in female reproductive system" "Plasma membrane" "HPA030866: , HPA030867: AB_10602428, HPA030868: " "unprognostic (3.35e-1)" "unprognostic (1.05e-3)" "unprognostic (3.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.34e-2)" "unprognostic (2.16e-1)" "unprognostic (2.91e-6)" "unprognostic (2.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.53e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.39e-14)" "unprognostic (3.11e-3)" "unprognostic (9.06e-3)" "unprognostic (4.70e-3)" "unprognostic (3.47e-3)" 6.0 0.0 0.6 2.1 2.8 0.0 5.9 0.6 0.6 8.0 0.5 0.5 0.4 0.0 2.6 0.5 0.5 0.1 4.6 0.7 0.6 0.7 1.0 0.4 1.1 1.0 0.8 0.5 8.2 0.6 0.0 1.1 487.4 0.8 0.7 0.1 0.9 1.1 0.4 0.5 0.3 0.4 1.5 0.7 0.5 0.1 0.7 0.6 0.5 0.4 0.5 1.2 4.5 0.8 0.0 0.0 0.0 0.0 0.0 9.8 0.1 4.9 0.7 2.0 0.0 5.9 12.2 0.0 12.9 1.0 4.4 11.1 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.4 4.8 0.5 0.1 0.0 7.9 0.0 0.9 0.0 10.3 14.9 0.0 29.2 0.9 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.8 0.0 1.5 1.3 0.1 13.3 0.1 8.8 1.5 0.0 0.2 0.0 0.0 0.0 15.9 5.3 28.8 25.7 0.0 0.1 0.0 22.1 0.0 9.8 0.0 0.0 0.0 0.5 0.0 9.8 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.6 2.8 0.6 0.6 0.6 0.7 0.8 0.5 0.8 0.6 ADAM15 MDC15 ENSG00000143537 "ADAM metallopeptidase domain 15" Q13444 1 155050566-155062775 "Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion, Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 63.6;RPMI-8226: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 17.2;intermediate monocyte: 12.0;myeloid DC: 28.7" "Group enriched" "Detected in many" 5 "dendritic cells: 28.7;monocytes: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011633, HPA072878" Uncertain Uncertain Vesicles 13000 Vesicles "HPA011633: AB_1844574, HPA072878: " "unprognostic (6.35e-3)" "unprognostic (1.51e-1)" "unprognostic (1.60e-1)" "unprognostic (7.60e-2)" "prognostic unfavourable (5.83e-5)" "unprognostic (2.09e-1)" "prognostic unfavourable (3.49e-4)" "unprognostic (2.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-2)" "unprognostic (2.70e-1)" "prognostic unfavourable (5.64e-9)" "unprognostic (3.35e-2)" "unprognostic (6.20e-2)" "unprognostic (2.04e-2)" "unprognostic (7.40e-2)" 32.7 8.3 7.3 13.3 8.9 19.3 47.9 7.8 13.9 19.9 21.2 22.2 11.9 10.7 20.4 16.2 36.0 19.3 30.3 42.3 8.0 7.7 12.4 12.8 29.2 23.3 10.8 8.3 15.7 17.5 18.9 6.9 25.5 13.9 17.8 15.9 15.4 20.4 12.1 13.6 45.8 20.3 25.6 13.6 16.0 19.6 8.3 7.4 2.7 14.6 41.5 19.7 13.4 26.5 1.1 28.7 0.7 17.2 0.7 4.5 8.1 20.7 6.6 1.3 29.6 10.9 9.1 12.8 9.2 11.7 11.7 8.0 4.8 11.9 5.8 41.3 12.0 26.0 6.6 28.2 3.1 2.6 8.6 1.4 13.1 4.7 19.1 11.7 1.5 9.7 29.9 11.8 17.0 52.9 2.1 24.2 8.7 11.3 0.1 8.6 4.1 63.6 1.8 4.0 67.0 8.5 5.4 4.0 8.7 20.1 25.3 7.9 37.4 7.3 39.0 11.5 4.9 11.4 10.1 2.7 2.1 2.5 8.4 8.9 12.5 0.0 17.2 0.3 4.5 12.0 3.1 1.0 2.3 2.6 28.7 1.1 1.0 1.2 0.7 0.7 2.8 2.3 3.8 8.1 7.3 8.9 7.8 13.9 8.0 7.7 10.8 8.3 13.9 7.4 ADAM17 "CD156B, cSVP, TACE" ENSG00000151694 "ADAM metallopeptidase domain 17" P78536 2 9488486-9555792 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010738, CAB025906, HPA051575" Approved Supported Cytosol "Intracellular and membrane" 27000 Cytosol "CAB025906: , HPA010738: AB_1078100, HPA051575: " "unprognostic (2.28e-1)" "unprognostic (1.29e-3)" "unprognostic (1.28e-1)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "unprognostic (5.15e-2)" "unprognostic (2.12e-3)" "unprognostic (1.55e-1)" "unprognostic (4.09e-2)" "unprognostic (3.69e-1)" "unprognostic (3.53e-3)" "unprognostic (3.13e-1)" "unprognostic (3.82e-3)" "unprognostic (8.63e-2)" "unprognostic (2.61e-1)" "unprognostic (4.48e-2)" "prognostic unfavourable (4.23e-5)" 18.6 11.0 13.6 15.4 13.8 21.9 14.7 20.4 15.5 14.0 11.7 13.8 8.3 8.7 14.2 15.8 18.7 10.7 17.4 13.4 11.2 12.4 12.4 7.8 24.7 15.0 11.6 11.7 18.1 9.6 10.9 11.9 29.0 11.2 8.2 9.4 10.6 12.5 9.8 12.3 16.7 11.1 13.9 14.3 21.4 8.9 17.4 12.3 14.7 12.5 13.9 20.3 12.3 14.4 7.0 7.7 16.0 10.2 6.0 7.9 6.0 7.7 12.7 13.4 13.9 26.5 19.8 24.2 8.1 13.8 9.4 13.9 11.2 18.7 22.1 11.8 10.2 14.2 9.9 17.2 12.9 8.8 9.9 11.3 9.6 9.9 37.5 11.0 12.7 22.1 17.4 15.0 29.1 23.5 15.3 8.5 10.0 7.3 8.3 11.1 11.1 5.2 9.6 13.2 10.5 12.5 12.9 7.9 19.8 9.1 11.1 19.3 5.7 14.2 18.8 16.7 8.7 11.7 15.4 11.1 10.0 19.2 13.8 7.1 19.8 16.0 9.8 7.6 6.1 10.2 7.9 7.0 5.0 5.1 7.7 5.1 4.5 4.6 11.8 6.0 9.5 4.3 5.7 6.0 13.6 13.8 20.4 13.1 11.2 12.4 11.6 11.7 11.2 12.3 ADAM19 MLTNB ENSG00000135074 "ADAM metallopeptidase domain 19" Q9H013 5 157395534-157575775 "Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 49.4;smooth muscle: 46.1" "Cell line enhanced" "Detected in many" "HDLM-2: 31.1;U-251 MG: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 32.3;eosinophil: 37.5;memory B-cell: 14.1;naive B-cell: 15.8;neutrophil: 20.1;plasmacytoid DC: 18.5" "Group enriched" "Detected in many" 5 "B-cells: 15.8;dendritic cells: 18.5;granulocytes: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055537 Approved Vesicles Vesicles "HPA055537: " "unprognostic (4.71e-1)" "unprognostic (1.01e-1)" "unprognostic (1.77e-1)" "unprognostic (4.64e-2)" "unprognostic (1.81e-3)" "unprognostic (2.63e-1)" "unprognostic (2.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (2.80e-1)" "unprognostic (1.42e-1)" "unprognostic (1.56e-1)" "prognostic unfavourable (3.90e-12)" "unprognostic (1.44e-1)" "unprognostic (4.38e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-2)" 3.7 2.5 1.3 49.4 1.5 4.8 2.8 6.9 2.4 4.4 15.1 1.1 3.6 3.9 8.6 5.9 4.6 5.9 14.7 18.9 1.6 1.7 1.6 4.3 9.1 19.2 1.6 1.0 3.0 0.5 0.0 1.4 33.0 3.4 5.9 4.9 5.0 6.8 4.6 3.9 0.8 14.0 46.1 2.8 16.8 7.7 1.3 0.5 5.6 3.1 3.3 29.4 17.0 3.9 15.8 18.5 37.5 3.9 0.1 4.4 2.2 10.9 1.7 3.4 0.0 0.2 0.2 21.9 13.1 4.7 8.2 6.1 5.7 9.0 5.7 0.7 6.7 9.3 0.5 0.8 7.5 31.1 0.3 0.0 0.9 0.7 2.0 0.0 0.0 1.5 0.0 6.4 1.3 9.2 1.6 0.8 17.4 0.0 0.0 0.0 3.6 5.7 0.1 19.6 4.8 0.8 0.1 1.5 1.0 0.0 4.7 0.6 0.0 0.1 14.1 8.9 9.6 2.0 59.2 3.5 0.1 20.5 2.0 0.0 3.9 32.3 3.9 37.5 0.4 0.3 1.0 14.1 4.4 1.0 1.1 15.8 0.1 0.1 20.1 0.1 0.0 18.5 4.4 2.2 1.3 1.5 6.9 2.3 1.6 1.7 1.6 1.0 3.4 0.5 ADAM2 "CT15, FTNB, PH-30b, PH30" ENSG00000104755 "ADAM metallopeptidase domain 2" Q99965 8 39743735-39838289 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 416 "testis: 50.6" "Cell line enriched" "Detected in single" 21 "U-266/70: 2.0" "Cancer enhanced" "Detected in single" "prostate cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB022390, HPA024621, HPA026581" Enhanced "CAB022390: , HPA024621: AB_1844576, HPA026581: AB_1844577" "unprognostic (4.74e-2)" "unprognostic (1.67e-3)" "unprognostic (3.82e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAM21 ADAM31 ENSG00000139985 "ADAM metallopeptidase domain 21" Q9UKJ8 14 70452157-70459899 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 19.7" "Cell line enhanced" "Detected in some" "U-138 MG: 4.5;U-251 MG: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA059016 Uncertain "HPA059016: " "unprognostic (7.85e-2)" "unprognostic (7.67e-3)" "unprognostic (4.20e-2)" "unprognostic (1.35e-2)" "unprognostic (5.12e-1)" "unprognostic (1.48e-1)" "unprognostic (5.98e-2)" "unprognostic (2.16e-1)" "unprognostic (3.30e-1)" "unprognostic (2.41e-1)" "unprognostic (1.16e-1)" "unprognostic (2.72e-1)" "unprognostic (6.78e-2)" "unprognostic (1.82e-2)" "unprognostic (1.52e-1)" "unprognostic (2.08e-1)" "unprognostic (2.72e-1)" 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 19.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 1.6 0.3 0.9 0.2 0.3 0.8 1.6 1.6 0.5 0.9 0.6 0.1 0.4 0.1 1.0 0.0 0.6 0.7 0.1 0.5 1.6 1.0 0.6 0.8 0.6 0.1 0.4 0.3 0.0 0.3 1.0 0.1 0.4 0.9 0.3 0.1 0.8 2.1 0.0 2.0 0.2 0.1 0.2 1.2 1.2 0.0 0.3 0.0 0.7 0.7 0.0 0.7 1.7 0.5 1.7 0.5 4.5 0.2 0.3 4.3 0.3 2.3 0.0 2.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.2 0.2 0.0 0.8 0.8 1.6 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.1 0.3 0.4 0.1 0.3 0.2 0.1 0.1 0.1 ADAM22 MDC2 ENSG00000008277 "ADAM metallopeptidase domain 22" Q9P0K1 7 87934143-88202889 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.9" "Cell line enhanced" "Detected in many" "Karpas-707: 35.5;SH-SY5Y: 33.8;U-266/84: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050325, CAB079064" Supported Approved "Cell Junctions" "Intracellular and membrane" 78000 "Cell Junctions" "CAB079064: , HPA050325: " "unprognostic (1.20e-2)" "unprognostic (8.61e-2)" "unprognostic (3.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.89e-2)" "unprognostic (3.09e-1)" "unprognostic (7.84e-3)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-1)" "unprognostic (3.71e-3)" "unprognostic (1.69e-1)" "unprognostic (3.47e-2)" "unprognostic (4.13e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-4)" "unprognostic (4.70e-2)" 2.9 11.7 10.9 1.5 15.7 1.5 2.1 46.9 36.4 8.6 2.3 6.2 1.6 1.3 6.3 11.2 1.6 3.7 3.7 3.0 14.0 10.6 5.5 0.8 2.0 2.9 8.8 14.4 5.6 1.8 4.5 3.7 0.9 17.0 14.5 2.3 2.9 1.5 7.1 3.3 1.8 1.9 5.0 8.2 2.9 1.4 2.7 5.7 2.8 4.5 0.0 1.9 2.1 2.9 0.4 1.2 1.9 0.0 0.5 1.6 0.1 1.0 0.3 2.1 2.5 0.6 0.1 1.5 0.0 0.2 0.1 0.2 2.1 3.5 3.1 0.8 0.0 0.0 3.0 0.0 0.0 8.5 3.9 2.3 2.2 0.6 0.0 2.8 0.0 0.3 0.0 0.0 0.1 0.2 0.1 35.5 0.1 2.8 3.6 0.5 5.0 1.1 2.1 8.2 4.5 0.0 1.7 11.3 33.8 1.7 0.0 0.3 1.5 0.3 0.0 2.1 1.5 0.4 1.5 8.2 13.6 2.5 1.8 6.0 3.1 1.9 0.0 0.0 1.0 0.0 0.1 0.4 0.3 1.0 0.0 0.3 1.6 1.2 0.2 0.5 0.0 1.2 0.0 0.1 10.9 15.7 46.9 21.8 14.0 10.6 8.8 14.4 17.0 5.7 ADAM23 MDC3 ENSG00000114948 "ADAM metallopeptidase domain 23" O75077 2 206443539-206621130 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 30.5;heart muscle: 19.3;parathyroid gland: 67.6" "Cell line enhanced" "Detected in many" "RH-30: 21.8;RPMI-8226: 56.8;U-266/70: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 5.7" "Lineage enriched" "Detected in single" 14 "T-cells: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033276 Approved "Intracellular and membrane" 24000 "CAB033276: AB_2305247" "unprognostic (7.33e-2)" "unprognostic (7.80e-2)" "unprognostic (4.60e-1)" "unprognostic (5.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.59e-2)" "unprognostic (4.27e-2)" "unprognostic (1.53e-1)" "unprognostic (1.09e-1)" "unprognostic (6.84e-2)" "unprognostic (1.09e-2)" "unprognostic (2.64e-2)" "unprognostic (9.75e-6)" "unprognostic (3.32e-3)" "unprognostic (1.25e-2)" "unprognostic (2.16e-3)" "unprognostic (1.03e-3)" 2.0 4.7 8.5 2.5 30.5 2.3 1.7 14.2 27.4 3.4 2.4 3.4 0.3 2.0 2.5 3.8 3.8 1.2 4.0 19.3 8.7 11.4 1.5 1.4 2.0 2.3 9.8 13.5 2.4 5.7 67.6 4.8 1.0 22.4 1.8 2.6 2.4 1.5 2.8 8.1 1.6 2.4 4.2 3.9 1.4 2.0 6.5 4.0 0.8 1.3 1.6 2.7 3.2 2.4 0.4 0.0 0.0 0.0 0.0 5.7 0.4 0.0 0.3 7.6 0.0 4.1 6.0 0.3 0.8 0.9 1.1 0.2 8.9 0.1 1.0 0.0 1.2 11.4 4.9 0.2 0.1 4.3 4.2 0.0 0.6 0.1 4.0 0.0 0.5 2.2 0.0 0.0 0.0 13.2 0.0 0.0 2.7 0.1 0.1 0.0 14.9 1.5 0.0 21.8 56.8 0.0 5.5 5.9 2.4 0.0 0.0 4.2 0.0 0.0 11.4 3.8 3.5 2.0 1.7 15.5 0.0 0.0 7.2 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.5 30.5 14.2 25.6 8.7 11.4 9.8 13.5 22.4 4.0 ADAM28 "ADAM23, eMDCII, MDC-Lm, MDC-Ls" ENSG00000042980 "ADAM metallopeptidase domain 28" Q9UKQ2 8 24294040-24359018 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.1" "Cell line enriched" "Detected in some" 8 "CAPAN-2: 24.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 24.9;naive B-cell: 32.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074034 Enhanced Approved "Plasma membrane,Mitochondria" "Secreted to blood" "Plasma membrane" Mitochondria "HPA074034: " "unprognostic (4.23e-2)" "unprognostic (1.01e-2)" "unprognostic (2.06e-2)" "prognostic favourable (3.17e-4)" "unprognostic (2.89e-1)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.71e-1)" "unprognostic (1.35e-2)" "unprognostic (3.77e-3)" "unprognostic (7.77e-2)" "unprognostic (3.97e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.62e-1)" 2.0 1.7 7.7 17.4 8.8 3.5 2.1 0.9 5.8 6.7 5.8 12.7 2.0 3.7 3.1 133.1 2.7 5.1 16.7 1.1 8.9 5.0 3.1 1.1 3.1 10.1 12.4 3.7 1.8 2.7 1.0 22.5 1.9 10.8 3.3 5.0 1.9 12.6 5.1 0.7 1.8 17.9 1.7 26.0 15.5 38.7 0.9 12.1 0.8 1.8 0.4 19.9 7.4 1.6 32.2 7.5 12.5 0.9 0.9 0.0 0.9 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 1.0 24.7 0.2 0.7 0.0 0.1 0.0 0.8 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.2 0.6 0.1 0.1 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.1 0.1 1.1 2.1 0.1 1.9 0.9 0.2 12.5 0.9 6.4 0.0 0.2 0.0 24.9 0.0 0.0 7.5 32.2 0.0 0.0 1.6 0.9 0.0 0.4 0.0 0.9 7.7 8.8 0.9 5.8 8.9 5.0 12.4 3.7 10.8 12.1 ADAM30 svph4 ENSG00000134249 "ADAM metallopeptidase domain 30" Q9UKF2 1 119893533-119896495 "Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 301 "testis: 30.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA026080 Uncertain "HPA026080: AB_1844581" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAM32 ENSG00000197140 "ADAM metallopeptidase domain 32" Q8TC27 8 39106990-39284911 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 47.0" "Cell line enhanced" "Detected in some" "MCF7: 2.7;U-2 OS: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA044156, HPA062151" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA044156: AB_10796798, HPA062151: " "unprognostic (2.13e-1)" "unprognostic (6.92e-2)" "unprognostic (4.63e-3)" "unprognostic (8.99e-2)" "unprognostic (1.48e-1)" "unprognostic (1.52e-2)" "unprognostic (5.66e-3)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-1)" "unprognostic (3.38e-2)" "unprognostic (1.13e-7)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (8.34e-3)" "unprognostic (7.82e-2)" 0.6 0.6 0.3 0.2 0.4 0.4 0.6 0.3 0.5 0.6 0.3 0.2 0.2 0.0 0.3 0.8 0.2 0.3 0.5 0.4 0.3 0.7 0.2 0.2 0.2 0.2 0.3 0.6 0.5 1.2 0.1 0.2 0.2 0.4 0.3 0.4 0.4 0.2 0.7 0.2 0.8 0.3 0.2 0.2 0.5 0.1 47.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.9 0.2 1.5 0.4 2.6 0.9 0.0 0.7 0.3 0.1 0.4 2.0 0.2 0.2 1.3 0.4 1.2 0.4 0.1 2.6 0.0 0.5 2.3 0.2 0.5 0.0 1.5 0.1 0.3 0.0 2.2 0.3 0.3 0.2 0.8 2.7 0.2 0.1 0.0 0.1 0.2 0.5 1.3 2.7 0.4 0.6 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.9 0.4 0.2 0.3 0.0 1.1 0.0 0.0 2.6 3.7 0.1 1.4 0.0 0.4 0.1 0.9 0.1 0.7 1.5 0.4 0.2 0.7 0.4 0.3 0.9 0.6 0.9 0.1 0.8 0.7 0.8 1.0 2.6 0.4 0.2 0.2 0.0 0.3 0.4 0.3 0.5 0.3 0.7 0.3 0.6 0.4 0.2 ADAM33 "C20orf153, dJ964F7.1, DKFZp434K0521" ENSG00000149451 "ADAM metallopeptidase domain 33" Q9BZ11 20 3667965-3682246 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 55.7;smooth muscle: 58.0" "Cell line enhanced" "Detected in some" "ASC diff: 30.7;ASC TERT1: 39.7;BJ: 13.5;BJ hTERT+: 23.2;fHDF/TERT166: 13.8;U-2197: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in all" "HPA067152, HPA071758" Approved Uncertain "Nuclear speckles,Plasma membrane" "Plasma membrane" "Nuclear speckles" "HPA067152: , HPA071758: " "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (2.24e-2)" "unprognostic (3.35e-3)" "unprognostic (4.39e-3)" "unprognostic (7.43e-4)" "unprognostic (7.14e-3)" "unprognostic (1.67e-1)" "unprognostic (1.78e-3)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.56e-1)" "unprognostic (2.75e-11)" "unprognostic (1.05e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-5)" "unprognostic (3.10e-3)" 10.0 1.5 4.6 9.2 2.6 0.0 20.2 2.8 2.7 55.7 29.5 2.2 20.9 4.7 44.3 12.3 17.0 16.9 17.5 5.3 5.0 0.9 0.9 0.5 3.6 2.2 4.9 3.0 11.8 1.6 0.0 1.6 5.4 7.0 22.8 5.5 3.7 4.2 27.1 3.5 4.8 9.1 58.0 3.3 1.9 9.9 5.4 3.5 0.1 4.0 10.1 2.0 24.9 36.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 39.7 0.1 13.5 23.2 4.0 7.9 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 6.8 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.6 2.6 2.8 2.7 5.0 0.9 4.9 3.0 7.0 3.5 ADAM7 "EAPI, GP-83" ENSG00000069206 "ADAM metallopeptidase domain 7" Q9H2U9 8 24440930-24526970 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "epididymis: 309.9" "Group enriched" "Detected in some" 31 "BEWO: 4.3;NB-4: 10.8;RPMI-8226: 2.8;SH-SY5Y: 3.3" "Group enriched" "Detected in some" 16 "prostate cancer: 1.0;renal cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA008879 Enhanced "Intracellular and membrane" "HPA008879: AB_10601789" "unprognostic (1.03e-3)" "unprognostic (3.96e-4)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 21.7 0.0 0.1 309.9 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 1.3 0.1 0.3 0.1 0.0 0.1 0.1 0.1 6.8 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 ADAM8 "CD156, CD156a, MS2" ENSG00000151651 "ADAM metallopeptidase domain 8" P78325 10 133262403-133276868 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 56.8;bone marrow: 37.1;lymphoid tissue: 28.3" "Cell line enhanced" "Detected in some" "A-431: 22.3;BEWO: 32.2;CAPAN-2: 27.3;HaCaT: 26.8;HDLM-2: 17.2;U-87 MG: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 20.7;eosinophil: 56.8;neutrophil: 32.9" "Lineage enriched" "Detected in all" 7 "granulocytes: 56.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA064637 Approved "Intracellular and membrane" "HPA064637: " "unprognostic (8.24e-2)" "unprognostic (6.07e-3)" "unprognostic (1.27e-3)" "unprognostic (5.18e-2)" "unprognostic (8.26e-2)" "unprognostic (6.47e-2)" "unprognostic (5.59e-2)" "unprognostic (2.22e-1)" "unprognostic (2.57e-1)" "unprognostic (1.94e-3)" "unprognostic (3.37e-2)" "unprognostic (5.47e-2)" "prognostic unfavourable (3.99e-10)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.28e-1)" "unprognostic (9.32e-2)" 4.8 1.0 0.7 18.0 1.6 37.1 3.1 1.7 1.2 3.8 4.8 0.9 0.2 3.5 1.8 1.6 2.8 3.6 10.1 4.1 0.8 1.1 2.8 4.3 13.0 25.0 1.0 0.2 1.7 2.4 0.1 2.0 7.5 1.6 2.9 0.9 2.9 5.5 0.7 1.5 1.9 6.0 1.6 1.5 28.3 6.9 2.3 0.5 6.6 2.0 1.8 19.7 12.0 2.8 2.5 8.6 56.8 5.4 5.5 5.5 4.6 22.3 0.6 0.2 0.3 0.1 0.0 32.2 0.2 0.5 0.1 0.1 1.7 27.3 0.4 0.6 0.0 26.8 0.0 4.6 0.0 17.2 0.3 0.3 0.1 0.0 0.2 1.3 6.3 0.1 0.4 0.2 0.4 0.0 1.2 0.9 0.0 1.8 0.0 7.6 0.1 0.6 0.1 0.2 2.4 0.3 0.5 0.0 0.3 0.1 0.1 0.4 0.4 0.7 0.6 0.0 0.6 0.2 0.3 1.3 0.8 0.2 13.7 0.7 0.1 20.7 5.4 56.8 5.5 2.1 4.0 2.5 3.7 5.2 8.6 1.5 1.4 2.0 32.9 5.5 2.0 0.1 3.8 4.6 0.7 1.6 1.7 1.2 0.8 1.1 1.0 0.2 1.6 0.5 ADAM9 "CORD9, KIAA0021, MCMP, MDC9, Mltng" ENSG00000168615 "ADAM metallopeptidase domain 9" Q13443 8 38996869-39105144 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Cone-rod dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 11.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004000 Approved "Endoplasmic reticulum,Vesicles" "Secreted - unknown location" 640000 Vesicles "Endoplasmic reticulum" "HPA004000: AB_1844584" "prognostic unfavourable (1.14e-4)" "prognostic unfavourable (2.25e-4)" "unprognostic (1.32e-3)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (7.21e-6)" "unprognostic (5.77e-2)" "unprognostic (1.55e-1)" "unprognostic (1.48e-2)" "prognostic unfavourable (2.52e-5)" "unprognostic (5.83e-2)" "prognostic unfavourable (3.99e-4)" "unprognostic (2.80e-1)" "unprognostic (5.76e-2)" "unprognostic (2.27e-1)" "unprognostic (1.23e-2)" 36.7 25.0 14.7 21.7 13.6 10.4 17.1 20.9 14.4 21.8 24.4 13.2 21.8 19.4 24.9 19.8 24.1 15.5 31.7 28.5 12.5 10.1 29.4 11.6 39.2 20.3 19.2 12.9 17.6 11.1 37.5 10.4 30.1 15.8 23.8 23.8 15.4 44.5 21.4 18.3 12.8 25.4 32.8 22.0 25.7 33.2 13.7 12.7 2.4 24.0 14.9 11.7 34.8 19.2 0.6 8.1 3.4 11.4 3.1 0.8 2.8 41.1 29.8 11.8 7.2 19.1 61.6 15.3 55.9 61.1 31.4 29.4 14.1 29.9 2.1 21.1 38.4 17.6 5.0 39.5 60.9 2.0 5.1 2.2 20.7 12.2 38.7 1.6 4.8 47.4 23.5 30.9 35.2 42.7 4.3 14.0 65.3 4.0 1.6 1.0 1.7 9.6 1.4 21.3 7.1 51.0 11.8 1.6 2.4 14.9 17.9 13.6 14.5 3.0 73.4 24.0 23.1 45.3 25.6 4.5 6.9 2.3 39.8 2.7 16.3 1.4 11.4 2.2 0.6 6.1 0.3 0.1 0.3 0.8 8.1 0.6 0.1 0.6 3.4 3.1 2.6 2.7 0.4 2.8 14.7 13.6 20.9 14.4 12.5 10.1 19.2 12.9 15.8 12.7 ADAMTS1 "C3-C5, KIAA1346, METH1" ENSG00000154734 "ADAM metallopeptidase with thrombospondin type 1 motif 1" Q9UHI8 21 26835747-26845409 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 112.8" "Cell line enhanced" "Detected in many" "ASC diff: 60.9;BJ: 71.0;hTEC/SVTERT24-B: 49.0;hTERT-HME1: 44.6;RPTEC TERT1: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 8.0;NK-cell: 9.0" "Group enriched" "Detected in many" 85 "NK-cells: 9.0;T-cells: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB016394, HPA031498" Uncertain Approved "Plasma membrane" "Secreted to extracellular matrix" 1900000 "Plasma membrane" "CAB016394: AB_626637, HPA031498: " "unprognostic (6.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (1.18e-2)" "prognostic unfavourable (5.13e-4)" "unprognostic (1.03e-1)" "unprognostic (3.28e-1)" "unprognostic (2.37e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.55e-2)" "unprognostic (9.70e-3)" "unprognostic (8.27e-3)" "unprognostic (1.12e-1)" "unprognostic (6.76e-2)" "unprognostic (1.57e-1)" 70.6 13.4 8.2 18.7 14.0 0.7 29.0 6.3 9.2 22.0 18.2 9.5 4.8 3.3 27.7 25.8 30.0 45.8 62.3 40.9 7.6 4.8 15.4 22.8 25.0 10.9 12.7 3.7 112.8 9.3 6.3 7.6 56.8 13.2 23.3 16.5 7.8 5.8 8.1 25.7 6.1 16.2 46.4 10.2 7.2 16.8 12.8 11.4 0.0 14.3 18.1 2.7 32.7 45.3 0.0 0.0 0.0 0.0 9.0 8.0 1.4 0.0 0.0 1.1 0.0 60.9 15.1 3.7 71.0 24.8 12.3 8.1 0.0 0.0 0.0 4.9 22.5 1.3 0.8 3.6 21.7 0.0 22.6 0.0 7.4 0.0 11.7 2.8 0.0 16.9 0.0 49.0 44.6 5.0 1.2 0.0 36.4 0.0 0.3 0.0 4.0 2.8 0.0 28.1 0.2 41.6 4.0 0.0 5.5 3.3 0.0 0.3 0.1 0.7 5.1 17.5 0.9 27.2 10.5 0.1 0.0 0.0 14.4 0.0 5.3 0.0 0.0 0.0 8.0 0.0 0.8 0.0 0.3 0.6 0.0 0.0 0.0 1.5 0.0 9.0 0.0 0.0 0.0 1.4 8.2 14.0 6.3 9.2 7.6 4.8 12.7 3.7 13.2 11.4 ADAMTS4 "ADAMTS-2, ADMP-1, KIAA0688" ENSG00000158859 "ADAM metallopeptidase with thrombospondin type 1 motif 4" O75173 1 161184308-161199056 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 58.0" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 10.7;HUVEC TERT2: 12.9;SH-SY5Y: 7.2;TIME: 10.8;U-251 MG: 9.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in many" 8 "dendritic cells: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025876, HPA051296, HPA068374" Uncertain Supported "Nuclear speckles" "Secreted to extracellular matrix" "Nuclear speckles" "CAB025876: , HPA051296: , HPA068374: " "unprognostic (2.70e-2)" "unprognostic (8.10e-3)" "unprognostic (3.00e-3)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.19e-1)" "unprognostic (1.07e-1)" "prognostic unfavourable (5.00e-4)" "unprognostic (1.20e-2)" "unprognostic (9.59e-3)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "prognostic unfavourable (7.27e-7)" "unprognostic (1.10e-2)" "unprognostic (1.04e-1)" "unprognostic (1.44e-3)" "unprognostic (3.13e-2)" 58.0 9.7 2.6 18.1 20.7 1.8 14.6 1.5 10.7 7.8 6.3 33.4 0.0 1.9 5.8 2.0 7.7 14.2 16.4 19.5 3.4 2.3 3.1 11.0 15.7 2.7 28.6 3.5 35.7 10.6 4.7 4.9 4.4 20.5 5.8 3.4 0.0 1.7 1.7 7.7 1.7 3.0 12.0 15.5 1.9 8.1 1.7 15.7 0.0 7.5 1.2 1.4 8.7 4.0 0.5 8.0 1.0 0.2 0.4 0.6 0.2 0.0 0.0 0.2 0.1 6.0 3.8 0.5 4.8 0.2 0.4 2.8 0.1 0.1 0.2 4.1 1.5 0.1 0.0 0.0 1.7 0.1 0.3 0.1 0.4 1.2 0.6 0.0 0.1 4.2 0.0 10.7 0.1 12.9 0.1 0.3 0.3 0.1 0.0 0.2 4.8 0.0 0.1 4.7 0.1 0.0 0.1 0.1 7.2 0.0 0.1 0.1 0.2 0.5 10.8 6.8 0.1 0.3 9.6 0.2 0.1 0.1 2.1 0.1 0.1 0.7 0.2 0.2 0.6 0.1 0.3 0.3 0.3 0.3 0.1 0.5 0.4 0.4 1.0 0.4 0.1 8.0 0.3 0.2 2.6 20.7 1.5 10.0 3.4 2.3 28.6 3.5 20.5 15.7 ADCK2 MGC20727 ENSG00000133597 "AarF domain containing kinase 2" Q7Z695 7 140673153-140696261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036036 Approved Uncertain Centrosome,Cytosol "Centrosome, Cytosol" "HPA036036: AB_10672078" "unprognostic (2.76e-1)" "unprognostic (1.79e-1)" "unprognostic (5.72e-2)" "unprognostic (5.30e-2)" "unprognostic (4.03e-3)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" "unprognostic (7.48e-2)" "unprognostic (2.61e-1)" "unprognostic (7.10e-3)" "unprognostic (6.81e-3)" "unprognostic (9.36e-3)" "prognostic favourable (9.75e-5)" "unprognostic (1.89e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (2.13e-1)" 12.3 10.6 15.3 11.3 16.6 8.8 13.4 15.4 27.0 12.3 15.1 26.3 13.2 8.8 10.3 11.4 18.0 20.0 10.3 10.2 16.6 18.2 12.3 12.5 12.8 15.6 19.5 13.1 14.5 22.8 21.4 12.7 19.9 18.2 14.4 13.2 10.7 16.8 14.0 12.5 25.8 13.0 10.9 24.0 13.6 13.0 7.6 13.3 20.6 25.1 9.9 16.2 13.4 18.9 8.2 12.0 3.2 5.0 5.1 7.3 2.2 15.9 11.5 2.7 12.7 10.0 11.4 16.4 8.3 10.1 8.7 5.8 10.5 11.3 21.4 12.6 5.8 13.2 13.8 9.4 2.6 15.8 14.2 4.5 4.5 5.1 13.9 3.0 11.3 9.5 28.9 4.9 6.9 7.4 7.9 10.5 3.1 19.9 22.4 7.4 4.0 12.5 17.7 0.1 10.4 4.7 16.0 10.8 7.5 11.4 16.6 11.4 14.7 6.1 7.8 10.9 3.8 18.0 16.0 7.3 11.2 15.8 16.0 12.1 12.9 0.0 3.7 3.2 5.4 5.0 4.9 8.2 4.8 5.3 5.7 4.2 7.3 4.7 0.1 5.1 3.0 12.0 6.0 2.2 15.3 16.6 15.4 27.0 16.6 18.2 19.5 13.1 18.2 13.3 ADCK5 FLJ35454 ENSG00000173137 "AarF domain containing kinase 5" Q3MIX3 8 144373101-144393242 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025692, HPA028679" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA025692: AB_10599486, HPA028679: AB_10600226" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (8.96e-2)" "unprognostic (1.68e-2)" "unprognostic (1.00e-1)" "unprognostic (2.31e-3)" "unprognostic (6.45e-2)" "unprognostic (2.70e-1)" "unprognostic (4.25e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (1.33e-3)" "unprognostic (1.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-1)" "unprognostic (2.90e-2)" 4.1 10.0 4.8 8.9 4.5 4.5 4.3 11.5 9.1 4.6 18.3 2.8 7.6 19.1 5.8 4.2 7.2 4.2 6.3 3.8 3.9 4.1 4.8 6.9 3.7 5.0 3.4 8.4 5.5 5.6 4.7 4.1 3.7 4.5 4.7 4.0 4.6 7.4 4.7 5.6 8.3 17.0 2.7 2.4 6.7 5.6 7.7 3.8 6.8 4.1 4.9 6.1 5.1 5.0 4.7 6.3 2.5 5.4 1.8 4.1 2.8 3.8 4.8 1.0 3.3 0.9 0.8 5.7 3.3 1.8 2.6 0.9 5.2 4.2 1.7 2.3 0.7 5.1 0.2 3.5 0.2 4.3 1.6 4.4 3.6 5.8 2.6 1.0 3.4 1.3 2.1 0.9 0.8 1.8 2.9 3.0 1.5 10.1 3.2 4.4 0.6 3.6 4.2 1.6 3.0 1.7 3.6 0.7 1.8 4.8 3.9 2.7 3.3 3.0 1.2 1.4 5.1 3.5 2.2 1.4 0.4 1.5 3.2 3.8 2.0 1.8 4.2 2.5 2.3 5.4 3.0 1.8 2.8 1.8 6.3 4.7 2.9 1.5 0.7 1.8 5.0 4.0 4.1 2.8 4.8 4.5 11.5 9.1 3.9 4.1 3.4 8.4 4.5 3.8 ADCY3 AC3 ENSG00000138031 "Adenylate cyclase 3" O60266 2 24819169-24919839 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis, Olfaction, Sensory transduction" "Calmodulin-binding, Lyase" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010223 Approved "CAB010223: AB_630839" "unprognostic (3.05e-1)" "unprognostic (1.10e-1)" "unprognostic (4.91e-2)" "unprognostic (1.39e-3)" "unprognostic (5.01e-2)" "unprognostic (7.66e-2)" "unprognostic (1.28e-1)" "unprognostic (6.06e-2)" "unprognostic (8.43e-2)" "unprognostic (6.89e-2)" "unprognostic (8.22e-3)" "unprognostic (2.52e-1)" "prognostic unfavourable (1.32e-9)" "unprognostic (3.74e-2)" "unprognostic (5.56e-2)" "unprognostic (1.11e-1)" "unprognostic (8.55e-3)" 35.8 8.2 14.4 11.7 26.0 13.2 41.2 15.0 21.7 22.5 15.1 16.5 6.5 7.6 23.3 15.6 17.4 21.4 18.2 18.2 13.7 13.1 9.5 4.6 15.3 13.7 29.6 14.1 29.5 7.7 15.4 16.2 58.6 16.3 15.1 11.7 11.3 8.7 24.9 7.9 14.8 12.3 25.1 12.4 11.7 9.8 11.3 18.2 4.3 14.4 13.9 12.8 13.5 24.2 7.2 11.0 3.2 1.8 1.1 3.1 1.2 28.0 19.3 6.3 10.6 32.0 25.5 12.2 14.1 20.7 12.3 11.3 15.6 9.7 9.8 3.2 20.6 20.6 15.4 19.2 8.6 22.3 20.5 16.0 21.2 2.0 24.3 9.1 10.1 21.3 16.3 12.3 18.7 11.3 8.0 17.2 7.2 20.1 8.8 2.1 6.8 8.4 15.6 32.9 20.3 5.3 16.8 10.2 7.5 17.6 21.0 12.1 5.4 7.6 10.8 21.6 15.5 12.5 21.2 17.9 41.6 38.3 7.0 14.4 13.4 3.2 1.8 0.0 0.6 1.8 0.3 6.4 1.4 0.5 11.0 7.2 0.7 0.6 0.0 1.1 0.4 10.1 3.1 1.2 14.4 26.0 15.0 21.7 13.7 13.1 29.6 14.1 16.3 18.2 ADCY7 "AC7, KIAA0037" ENSG00000121281 "Adenylate cyclase 7" P51828 16 50246137-50318135 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 22.9;HMC-1: 63.9;RPMI-8226: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041218, HPA048241" Uncertain Approved Cytosol Cytosol "HPA041218: , HPA048241: " "unprognostic (1.98e-1)" "prognostic unfavourable (5.31e-4)" "unprognostic (1.24e-1)" "unprognostic (1.78e-1)" "unprognostic (3.77e-1)" "unprognostic (2.80e-1)" "unprognostic (3.90e-2)" "unprognostic (7.75e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.18e-1)" "unprognostic (5.59e-3)" "unprognostic (7.34e-2)" "unprognostic (2.15e-3)" "unprognostic (2.18e-1)" "unprognostic (9.52e-4)" 6.3 4.3 7.0 17.4 9.7 14.9 3.9 1.2 5.2 3.7 5.0 9.8 0.8 2.8 3.7 4.8 13.2 5.3 6.9 7.3 5.3 4.2 3.3 3.6 16.4 16.5 8.8 4.4 17.1 3.7 1.0 3.4 9.7 8.6 3.5 5.9 6.2 6.5 1.6 1.8 7.9 10.4 5.0 12.3 26.9 4.9 2.1 9.2 21.8 3.7 3.1 26.0 6.6 6.1 3.6 12.5 6.5 16.7 8.4 7.0 5.0 3.9 5.4 0.2 0.7 0.5 7.0 0.5 2.8 1.3 2.1 2.0 5.1 8.2 1.6 7.4 11.1 14.3 5.6 2.4 2.7 15.1 2.0 22.9 4.1 1.4 6.4 4.3 63.9 3.7 2.3 1.6 2.5 0.6 8.3 3.2 3.0 2.3 1.6 10.2 0.9 7.7 1.6 2.1 31.7 1.5 0.3 0.9 2.6 1.5 0.6 1.3 0.1 12.8 5.0 0.3 7.5 0.8 0.7 0.3 0.1 3.5 2.4 9.3 1.0 6.5 7.8 2.9 7.0 11.7 5.1 3.2 2.8 5.0 12.5 3.6 2.6 3.7 4.4 8.4 16.7 6.5 3.9 5.0 7.0 9.7 1.2 5.2 5.3 4.2 8.8 4.4 8.6 9.2 ADGRG1 "GPR56, TM7LN4, TM7XN1" ENSG00000205336 "Adhesion G protein-coupled receptor G1" Q9Y653 16 57610652-57665580 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein, G-protein coupled receptor, Heparin-binding, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 41.6;RPTEC TERT1: 39.1;SK-BR-3: 53.9;SK-MEL-30: 55.6;TIME: 44.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 48.1" "Lineage enriched" "Detected in many" 6 "T-cells: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046065 Uncertain "Secreted to blood" 22000 "HPA046065: " "unprognostic (4.91e-3)" "unprognostic (1.70e-1)" "unprognostic (2.69e-2)" "unprognostic (1.47e-2)" "unprognostic (2.26e-3)" "prognostic unfavourable (2.53e-4)" "unprognostic (4.87e-2)" "unprognostic (8.35e-2)" "unprognostic (1.82e-2)" "unprognostic (6.77e-2)" "unprognostic (1.52e-1)" "unprognostic (1.36e-2)" "prognostic favourable (5.52e-7)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (3.33e-1)" "unprognostic (1.98e-1)" 18.9 5.6 39.3 5.1 32.3 6.5 19.7 9.1 70.9 15.2 14.2 28.2 14.6 10.3 10.0 34.5 16.8 20.3 26.7 8.7 33.4 15.9 82.1 1.9 15.4 2.2 24.2 22.8 3.1 25.2 13.5 6.7 38.1 27.2 13.0 13.4 6.3 34.3 24.7 5.7 32.6 7.7 7.8 32.0 4.9 18.1 22.1 28.9 12.1 81.4 8.7 7.2 17.8 14.2 0.1 0.1 1.0 0.2 8.7 48.1 8.4 7.7 8.5 2.5 0.1 0.0 0.0 24.9 1.4 0.8 2.5 0.5 6.4 41.6 0.0 20.8 1.3 28.5 0.0 19.3 1.0 0.3 0.0 0.8 10.4 7.3 0.0 0.0 0.4 0.5 27.9 4.5 1.9 20.6 0.0 0.3 0.5 9.6 20.5 0.1 0.3 8.3 0.7 0.2 5.7 39.1 24.6 7.2 0.2 0.4 53.9 55.6 23.9 0.1 44.6 4.7 7.7 0.3 17.3 0.0 0.3 0.1 38.6 0.1 11.3 0.6 0.2 0.0 48.1 0.1 0.5 0.1 3.3 18.3 0.0 0.0 1.7 14.1 1.0 8.7 0.1 0.1 0.0 8.4 39.3 32.3 9.1 35.0 33.4 15.9 24.2 22.8 27.2 28.9 ADIG "MGC39724, RP5-1100H13.2, SMAF1" ENSG00000182035 Adipogenin Q0VDE8 20 38581195-38588463 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 31.4" "Cell line enhanced" "Detected in some" "BEWO: 1.4;Hep G2: 1.2;NB-4: 1.3" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041124 Uncertain "HPA041124: AB_10795534" "unprognostic (2.97e-2)" "unprognostic (7.69e-3)" "unprognostic (2.27e-1)" "unprognostic (4.52e-3)" "unprognostic (1.34e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 7.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.1 0.0 31.4 0.1 0.1 3.2 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 ADORA2A "ADORA2, RDC8" ENSG00000128271 "Adenosine A2a receptor" P29274 22 24417879-24442360 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 22.8;bone marrow: 28.1;brain: 43.9;lymphoid tissue: 59.0" "Cell line enhanced" "Detected in many" "Daudi: 15.0;Karpas-707: 20.7;RPMI-8226: 14.6;SK-BR-3: 29.7;U-266/70: 20.8;U-266/84: 27.1;U-698: 21.2" "Not detected" "Not detected" "Region enriched" "Detected in all" 8 "basal ganglia: 43.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in some" 10 "basal ganglia: 357.5" "Region enriched" "Detected in single" 95 "basal ganglia: 166.0" "CAB001943, HPA065566, HPA075997" Enhanced Supported "CAB001943: , HPA065566: , HPA075997: " "unprognostic (7.30e-2)" "unprognostic (2.42e-2)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (7.44e-2)" "unprognostic (1.88e-3)" "unprognostic (9.85e-2)" "unprognostic (3.63e-1)" "unprognostic (2.88e-2)" "unprognostic (4.57e-3)" "unprognostic (2.15e-3)" "unprognostic (1.87e-3)" "unprognostic (6.81e-4)" "unprognostic (1.50e-1)" "unprognostic (9.78e-3)" "unprognostic (1.30e-1)" "unprognostic (7.10e-3)" 1.0 2.4 1.9 10.4 43.9 28.1 1.5 3.4 3.8 0.8 2.0 1.7 0.3 5.4 1.4 1.4 1.0 0.9 2.4 3.5 2.4 1.8 3.5 4.3 5.1 14.8 2.6 1.6 1.2 0.8 0.0 2.1 1.4 2.3 1.6 0.8 3.3 2.7 1.5 1.2 0.9 2.6 0.7 1.3 7.5 2.8 2.0 5.7 59.0 1.3 0.9 8.6 3.8 1.3 17.7 1.1 13.7 9.0 2.2 22.8 11.2 0.2 0.3 0.4 0.1 0.2 0.1 0.4 0.2 9.3 0.5 0.9 1.7 0.1 15.0 1.0 0.2 0.3 0.9 0.0 0.0 1.8 2.6 0.2 0.0 2.1 0.1 0.3 7.5 0.1 0.0 2.8 0.0 3.3 0.1 20.7 0.0 0.2 5.2 1.6 0.6 0.0 0.1 0.7 14.6 0.0 0.1 1.5 8.7 0.4 29.7 0.1 0.3 1.4 0.2 0.9 1.4 0.2 0.1 20.8 27.1 21.2 4.7 5.1 0.1 3.0 0.8 4.8 8.6 2.6 20.1 9.6 16.1 16.9 1.1 17.7 22.8 18.3 13.7 2.2 9.0 1.1 21.4 11.2 1.9 43.9 3.4 3.8 2.4 1.8 2.6 1.6 2.3 5.7 ADPRM "C17orf48, MDS006" ENSG00000170222 "ADP-ribose/CDP-alcohol diphosphatase, manganese dependent" Q3LIE5 17 10697594-10711233 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023265, HPA023820" Approved "HPA023265: AB_1845590, HPA023820: AB_1845591" "unprognostic (7.58e-3)" "prognostic favourable (1.69e-4)" "unprognostic (1.42e-1)" "prognostic favourable (2.38e-5)" "unprognostic (2.49e-1)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (1.35e-1)" "unprognostic (1.43e-2)" "unprognostic (1.43e-1)" "unprognostic (6.26e-3)" "unprognostic (2.97e-1)" "unprognostic (6.53e-3)" "unprognostic (2.65e-2)" "unprognostic (1.83e-1)" "unprognostic (4.77e-2)" "unprognostic (5.97e-2)" 11.1 8.2 6.4 9.3 13.1 12.9 13.0 9.8 12.2 10.3 8.1 10.1 16.1 6.6 11.3 9.1 7.8 9.0 7.9 6.4 9.6 6.1 7.8 15.2 6.9 23.2 8.1 5.6 14.2 12.4 4.2 11.9 4.9 9.3 16.7 7.5 8.3 8.8 13.4 14.8 9.2 9.9 6.5 7.3 10.5 12.2 9.5 8.2 18.8 14.6 10.4 11.1 8.8 9.0 10.5 4.2 6.1 3.5 4.0 18.7 5.9 4.1 2.2 4.5 5.3 10.4 13.4 2.2 7.8 8.7 5.7 8.6 1.3 1.9 8.0 4.2 8.2 3.4 1.9 5.6 6.8 5.1 5.3 5.8 3.6 4.4 18.6 3.0 5.4 15.4 10.3 6.0 9.0 10.0 3.9 1.5 8.2 1.1 3.8 5.3 3.7 2.1 3.4 5.2 2.4 10.0 3.0 1.0 6.3 4.1 1.6 9.7 3.8 5.9 10.2 4.0 2.4 4.4 5.2 2.0 1.4 2.3 7.8 4.4 6.7 3.4 3.5 6.1 3.2 3.0 5.4 8.2 8.8 5.8 4.2 10.5 18.7 12.0 2.5 4.0 3.1 2.4 7.7 5.9 6.4 13.1 9.8 12.2 9.6 6.1 8.1 5.6 9.3 8.2 AGER "RAGE, SCARJ1" ENSG00000204305 "Advanced glycosylation end-product specific receptor" Q15109 6 32180968-32184324 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lung: 178.6" "Cell line enhanced" "Detected in some" "HEK 293: 5.3;MCF7: 4.5;RPTEC TERT1: 5.5;U-266/70: 6.6" "Cancer enhanced" "Detected in all" "lung cancer: 27.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB011682, HPA064436, HPA069474" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane,Cell Junctions" "Secreted in other tissues" 140000 "Plasma membrane, Cell Junctions" "Nucleoli fibrillar center" "CAB011682: AB_2258049, HPA064436: , HPA069474: " "unprognostic (9.37e-2)" "unprognostic (3.70e-1)" "unprognostic (2.37e-2)" "unprognostic (1.14e-1)" "unprognostic (4.55e-2)" "unprognostic (1.59e-3)" "unprognostic (4.36e-2)" "unprognostic (1.00e-1)" "unprognostic (4.38e-2)" "unprognostic (1.27e-1)" "prognostic favourable (3.41e-4)" "unprognostic (1.24e-1)" "prognostic unfavourable (9.01e-7)" "unprognostic (3.57e-1)" "unprognostic (3.70e-2)" "unprognostic (4.44e-2)" "prognostic favourable (2.74e-6)" 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.9 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.6 0.4 0.4 0.2 0.2 0.2 0.0 0.5 0.2 178.6 0.2 0.2 0.2 0.5 0.3 0.1 0.7 0.4 0.4 0.5 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.0 0.2 0.2 0.2 0.2 22.6 0.2 0.2 0.2 0.3 0.7 0.7 1.0 0.3 0.1 0.5 0.1 0.2 0.2 0.0 0.6 0.3 2.1 2.9 0.1 0.3 0.1 0.2 0.1 0.5 0.2 2.3 0.5 2.3 0.2 1.2 0.4 0.4 5.3 1.4 0.1 0.0 0.0 0.6 2.4 0.3 0.3 0.1 0.2 0.4 0.0 0.8 0.3 4.5 0.3 1.7 0.0 0.0 0.1 0.3 0.3 5.5 0.1 0.1 0.5 0.1 0.0 2.0 1.3 0.1 0.3 0.0 1.6 1.6 0.2 6.6 3.4 2.4 2.3 0.5 0.6 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.3 0.2 0.0 0.7 0.4 0.3 1.0 0.1 0.2 0.7 0.0 0.1 0.2 0.2 0.9 0.2 0.2 0.0 0.2 0.2 0.4 0.2 AGL ENSG00000162688 "Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase" P35573 1 99850084-99924023 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycogen biosynthesis" "Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 23.1;skeletal muscle: 85.6;tongue: 34.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028498, HPA054340" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" 16000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA028498: AB_10600975, HPA054340: " "unprognostic (2.90e-1)" "unprognostic (5.34e-2)" "unprognostic (3.99e-3)" "unprognostic (2.18e-2)" "unprognostic (6.46e-3)" "unprognostic (5.13e-2)" "unprognostic (1.12e-1)" "unprognostic (1.92e-2)" "unprognostic (9.37e-3)" "unprognostic (1.11e-1)" "unprognostic (8.10e-3)" "unprognostic (7.61e-2)" "prognostic favourable (1.73e-10)" "unprognostic (6.38e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" "unprognostic (7.13e-2)" 5.0 4.5 2.5 4.7 3.6 2.0 4.2 5.4 6.1 3.4 4.5 2.1 5.4 3.3 4.8 4.2 9.1 4.1 2.6 8.2 2.2 2.3 5.8 23.1 4.2 5.3 2.4 4.2 3.8 3.6 8.7 4.7 4.8 2.9 5.5 4.2 3.9 5.1 8.7 85.6 3.7 4.0 5.4 2.8 4.8 4.4 2.9 1.2 7.1 4.3 34.4 3.4 6.7 3.6 3.0 2.3 3.5 1.6 6.1 4.3 2.1 11.8 3.5 4.2 6.9 7.0 6.6 14.2 3.8 5.6 3.3 5.9 13.3 4.0 15.6 7.3 6.4 6.7 24.6 7.4 6.3 8.3 7.8 9.1 12.2 7.4 4.6 8.0 5.5 8.1 4.8 4.6 3.9 5.2 14.9 1.1 3.4 3.7 9.4 2.5 6.7 4.6 0.0 1.4 0.8 10.1 16.1 10.5 7.3 10.9 10.5 5.8 7.5 5.4 5.3 4.0 5.8 5.4 3.7 4.5 3.5 18.1 7.1 2.1 2.1 0.1 1.3 3.5 4.3 1.6 4.1 3.0 3.2 2.9 2.3 2.9 3.2 3.2 1.5 6.1 0.9 2.1 3.3 2.1 2.5 3.6 5.4 6.1 2.2 2.3 2.4 4.2 2.9 1.2 AGPAT4 "dJ473J16.2, LPAAT-delta" ENSG00000026652 "1-acylglycerol-3-phosphate O-acyltransferase 4" Q9NRZ5 6 161129979-161274061 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.0" "Cell line enhanced" "Detected in many" "AF22: 19.8;HEL: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053287, HPA060525" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoli, Vesicles" "HPA053287: , HPA060525: " "unprognostic (5.69e-2)" "prognostic unfavourable (1.45e-4)" "unprognostic (1.73e-1)" "unprognostic (3.43e-2)" "unprognostic (4.14e-2)" "unprognostic (6.67e-3)" "unprognostic (1.94e-4)" "unprognostic (1.05e-1)" "unprognostic (3.42e-2)" "unprognostic (2.77e-2)" "unprognostic (1.76e-3)" "unprognostic (1.67e-1)" "prognostic unfavourable (4.08e-4)" "unprognostic (1.82e-2)" "unprognostic (8.87e-2)" "unprognostic (3.63e-4)" "unprognostic (5.51e-2)" 5.6 4.2 10.5 3.5 19.1 8.0 4.5 9.6 26.6 5.3 4.2 35.6 1.0 2.6 10.7 4.5 5.2 7.2 8.0 2.9 14.2 11.8 5.2 2.0 6.1 2.0 25.8 12.4 10.0 2.3 1.3 9.8 14.6 27.4 3.7 4.4 0.7 2.7 4.9 2.1 1.9 2.5 8.5 49.0 5.2 3.0 4.2 19.8 0.6 4.8 2.0 2.2 4.0 3.8 1.1 1.9 0.6 3.5 5.8 7.0 2.1 0.3 0.8 19.8 3.9 3.7 7.6 0.8 0.7 0.2 1.5 2.5 1.1 3.5 0.5 1.4 3.1 0.3 3.6 3.0 1.4 2.2 6.2 14.8 3.5 0.0 2.9 0.1 2.1 9.1 1.5 4.0 2.1 4.6 7.3 6.8 1.8 0.0 1.0 1.6 4.7 7.6 0.0 0.9 0.4 4.3 0.3 11.5 4.4 3.0 1.6 0.8 0.8 1.0 5.1 2.1 2.6 1.4 3.3 0.5 0.7 0.0 7.8 0.8 1.3 0.0 3.5 0.0 7.0 2.8 2.3 0.4 3.3 4.1 1.9 1.1 1.7 2.7 0.6 5.8 2.5 1.5 2.9 2.1 10.5 19.1 9.6 15.8 14.2 11.8 25.8 12.4 27.4 19.8 AGRN AGRIN ENSG00000188157 Agrin O00468 1 1020123-1056118 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Differentiation "Developmental protein" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 45.6;EFO-21: 53.1;HaCaT: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040090 Approved Supported "Plasma membrane,Cytosol" "Secreted to extracellular matrix" 15000000 "Plasma membrane, Cytosol" "HPA040090: AB_10805603" "unprognostic (8.04e-2)" "unprognostic (8.25e-3)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "prognostic unfavourable (4.62e-4)" "unprognostic (2.82e-3)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (9.49e-3)" "unprognostic (1.06e-1)" "unprognostic (8.46e-2)" "unprognostic (8.49e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-1)" "unprognostic (1.31e-2)" 10.2 2.8 13.0 5.3 12.4 2.9 8.3 2.3 24.0 11.3 8.5 20.5 8.9 9.8 8.2 14.5 8.8 11.4 37.2 8.1 10.9 8.3 36.0 9.3 18.1 2.3 9.3 7.0 7.6 25.2 5.7 5.0 11.0 12.7 8.7 2.5 13.6 26.5 10.8 4.7 18.6 11.2 3.9 7.7 7.2 14.1 7.5 8.1 6.4 27.0 9.5 7.6 13.7 6.2 0.0 0.1 0.0 0.5 0.0 1.1 0.1 26.5 16.5 3.2 10.7 0.5 0.7 28.8 13.4 4.3 9.0 5.5 13.9 45.6 0.5 53.1 2.0 46.2 1.1 16.5 1.0 1.0 6.3 0.0 21.6 14.5 3.9 0.3 5.4 2.4 7.2 2.8 6.2 1.5 5.5 0.1 0.7 21.8 0.2 3.8 6.9 12.0 4.2 6.3 4.0 15.8 11.8 0.8 6.4 27.3 29.6 26.0 26.0 2.0 23.5 11.1 39.3 1.5 10.8 0.3 0.2 0.9 7.0 2.4 2.9 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 13.0 12.4 2.3 22.0 10.9 8.3 9.3 7.0 12.7 8.1 AIFM1 "AIF, CMTX4, NAMSD, PDCD8" ENSG00000156709 "Apoptosis inducing factor mitochondria associated 1" O95831 X 130129362-130165887 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "DNA-binding, Oxidoreductase" "Charcot-Marie-Tooth disease, Deafness, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 66.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003764, HPA030611" Enhanced 160000 "CAB003764: AB_289587, HPA030611: " "unprognostic (3.00e-3)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (2.10e-2)" "unprognostic (3.15e-3)" "unprognostic (1.46e-1)" "unprognostic (1.14e-2)" "unprognostic (1.43e-1)" "unprognostic (3.11e-2)" "unprognostic (2.54e-3)" "unprognostic (2.81e-3)" "prognostic favourable (4.42e-10)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (5.04e-2)" "unprognostic (2.11e-2)" 9.9 28.9 7.1 11.3 8.6 5.3 7.1 7.5 8.9 10.4 14.2 8.4 10.0 19.6 9.9 11.7 8.6 13.0 11.4 34.2 7.2 7.0 66.8 50.5 5.8 9.8 8.2 7.1 7.3 14.6 16.8 7.7 6.1 8.8 6.9 14.2 12.3 13.1 9.4 35.7 5.8 23.2 8.9 6.4 8.7 14.9 14.9 7.2 19.5 7.9 16.1 9.7 8.4 6.0 10.8 22.0 9.8 18.3 15.8 12.8 8.0 16.7 31.0 12.7 31.8 14.5 10.4 16.8 10.6 9.2 16.4 13.3 22.0 12.4 36.2 37.1 9.7 16.2 39.2 13.8 17.5 13.8 23.9 22.9 23.4 29.9 18.5 20.1 24.2 12.8 13.6 17.4 14.9 13.8 19.7 16.8 11.5 40.4 20.4 31.6 9.1 24.1 18.5 14.3 41.9 37.1 17.0 16.4 9.6 12.4 28.8 27.7 14.8 18.2 10.0 7.8 7.5 21.3 20.2 9.0 14.5 16.9 10.1 33.7 11.7 2.9 14.8 9.8 9.1 18.3 9.6 10.8 9.7 11.2 22.0 8.1 9.6 9.7 2.1 15.8 15.5 10.6 12.8 8.0 7.1 8.6 7.5 8.9 7.2 7.0 8.2 7.1 8.8 7.2 AKAP1 "AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17" ENSG00000121057 "A-kinase anchoring protein 1" Q92667 17 57085092-57121349 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 80.1;testis: 75.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008620, HPA008691, CAB019286" Supported Supported Mitochondria Mitochondria "CAB019286: , HPA008620: , HPA008691: AB_1078119" "unprognostic (5.52e-2)" "unprognostic (1.83e-1)" "unprognostic (6.96e-3)" "unprognostic (1.78e-1)" "unprognostic (1.79e-2)" "unprognostic (6.38e-2)" "unprognostic (7.19e-2)" "unprognostic (1.48e-2)" "unprognostic (8.14e-2)" "unprognostic (2.36e-2)" "unprognostic (3.22e-1)" "unprognostic (3.00e-1)" "prognostic favourable (7.86e-9)" "unprognostic (6.82e-2)" "unprognostic (2.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.38e-1)" 16.4 6.1 13.5 9.2 16.3 2.8 14.7 13.4 12.5 10.3 28.1 8.7 9.3 22.6 10.2 14.3 18.1 12.5 19.2 35.0 10.0 6.6 11.9 26.4 8.3 4.4 13.6 9.9 9.0 16.4 18.8 7.1 3.3 7.9 15.5 20.6 9.3 13.6 13.9 80.1 10.2 25.2 23.5 8.4 4.9 22.2 75.4 10.1 4.7 14.9 19.7 7.4 20.5 9.8 3.3 6.5 2.8 3.3 6.0 7.4 2.1 16.5 20.7 28.8 9.4 7.5 4.9 17.3 6.9 6.7 9.1 6.5 22.1 14.9 26.6 19.7 5.3 26.3 16.1 15.2 9.2 14.5 23.4 22.6 18.3 42.0 7.0 21.2 8.7 4.3 15.1 10.1 14.2 9.2 15.0 10.3 5.2 14.1 26.7 8.1 10.5 22.3 20.6 12.2 21.7 6.1 19.6 22.1 14.5 5.5 16.1 9.0 11.0 21.9 6.8 8.0 9.0 10.3 15.6 10.2 12.7 20.0 5.1 16.6 7.1 2.8 1.7 0.6 4.7 3.3 4.1 3.3 3.8 3.8 4.0 2.4 7.4 4.0 0.2 6.0 0.9 6.5 2.8 2.1 13.5 16.3 13.4 12.5 10.0 6.6 13.6 9.9 7.9 10.1 AKAP6 "ADAP6, AKAP100, KIAA0311, mAKAP, PRKA6" ENSG00000151320 "A-kinase anchoring protein 6" Q13023 14 32329273-32837681 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 47.0;heart muscle: 46.6;skeletal muscle: 37.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "naive B-cell: 7.8" "Lineage enriched" "Detected in many" 6 "B-cells: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001983, HPA048741" Enhanced "CAB001983: , HPA048741: " "unprognostic (1.99e-1)" "unprognostic (9.92e-2)" "unprognostic (1.88e-1)" "unprognostic (1.37e-1)" "unprognostic (2.52e-1)" "unprognostic (4.33e-2)" "unprognostic (1.41e-4)" "unprognostic (1.81e-3)" "unprognostic (1.93e-2)" "unprognostic (4.49e-3)" "unprognostic (1.24e-3)" "unprognostic (3.54e-1)" "unprognostic (3.33e-16)" "unprognostic (8.57e-2)" "unprognostic (1.27e-1)" "unprognostic (5.14e-3)" "unprognostic (1.79e-3)" 2.1 5.9 17.9 2.9 28.0 1.2 4.5 32.5 34.3 2.3 4.1 28.3 0.0 2.3 4.2 5.9 5.6 3.2 4.0 46.6 16.8 13.7 3.4 2.6 2.8 1.3 27.5 22.2 3.0 1.5 5.3 3.1 4.5 47.0 2.5 2.7 2.3 2.6 1.8 37.0 1.8 2.8 7.3 16.5 1.4 2.1 5.5 29.8 0.0 5.0 6.6 1.4 3.2 1.4 7.8 0.8 1.2 0.3 0.3 1.2 0.5 0.6 0.9 1.2 1.1 0.2 2.0 0.3 1.4 4.1 0.2 0.5 1.3 1.1 1.5 1.1 17.3 0.9 1.3 1.5 0.6 1.4 1.1 1.4 1.8 1.2 0.6 0.1 0.4 2.0 1.5 0.0 0.5 0.1 0.3 4.6 1.2 0.8 0.8 0.3 0.2 1.2 0.8 5.5 0.6 0.5 1.4 5.9 4.7 1.2 0.8 3.7 3.3 0.1 0.3 0.2 0.9 0.9 0.5 2.9 2.5 0.6 1.8 0.1 6.1 0.5 0.3 0.1 0.1 0.2 0.2 0.5 0.1 0.4 0.4 7.8 0.8 1.2 1.2 0.3 0.2 0.8 0.1 0.5 17.9 28.0 32.5 34.3 16.8 13.7 27.5 22.2 47.0 29.8 AKAP9 "AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO" ENSG00000127914 "A-kinase anchoring protein 9" Q99996 7 91940867-92110673 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008548, CAB012909, HPA026109" Supported Enhanced "Golgi apparatus,Vesicles,Centrosome" "Golgi apparatus" "Vesicles, Centrosome" "CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688" "unprognostic (9.57e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (5.97e-3)" "unprognostic (1.20e-1)" "unprognostic (1.47e-1)" "unprognostic (4.75e-2)" "unprognostic (1.31e-2)" "unprognostic (1.28e-1)" "unprognostic (6.59e-2)" "unprognostic (7.59e-2)" "unprognostic (6.32e-2)" "prognostic favourable (2.10e-6)" "unprognostic (8.89e-2)" "unprognostic (1.73e-1)" "unprognostic (7.77e-2)" "unprognostic (3.96e-2)" 13.7 15.9 18.0 22.6 17.1 14.9 15.6 35.8 17.5 14.4 24.5 4.7 17.2 25.5 13.0 17.1 15.3 12.4 15.0 14.8 13.3 7.0 19.5 25.1 19.9 13.2 12.4 12.3 22.3 21.3 22.1 40.5 12.9 14.0 11.9 25.3 11.1 20.1 25.9 29.6 16.1 29.1 12.0 11.1 10.4 15.0 6.9 14.4 10.3 14.9 15.7 8.6 14.0 14.2 34.4 39.5 31.9 16.6 10.6 20.3 3.4 11.2 7.0 10.4 6.6 14.9 11.0 7.4 8.4 5.7 4.3 5.5 11.9 9.8 10.2 12.2 7.4 10.4 10.0 5.5 8.1 9.2 8.5 11.2 12.2 7.8 6.1 18.5 11.9 6.9 8.8 8.9 10.2 9.3 16.6 16.7 7.3 16.3 12.6 7.3 8.0 8.7 7.7 17.4 8.2 5.9 12.4 17.0 11.9 17.8 20.0 8.6 5.2 9.0 17.1 8.7 11.2 15.2 11.4 12.0 13.2 13.7 7.7 9.4 9.8 31.9 16.6 21.4 18.4 9.3 15.4 31.4 18.7 16.7 7.2 34.4 20.3 19.3 23.2 10.6 16.3 39.5 14.9 3.4 18.0 17.1 35.8 17.5 13.3 7.0 12.4 12.3 14.0 14.4 AL121900.2 ENSG00000284776 20 18567453-18744216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBF TERT88: 22.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA040981 Uncertain Uncertain Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA040981: AB_10673268" 4.0 5.7 4.0 4.4 5.8 5.8 6.0 4.5 14.1 3.6 6.2 2.0 6.0 5.2 7.4 5.9 4.5 5.4 5.4 7.8 4.4 15.4 6.3 4.7 6.9 4.5 5.4 7.7 16.1 8.3 5.3 4.4 7.6 4.6 6.4 3.1 8.8 8.2 12.2 1.1 5.5 5.9 4.3 5.8 0.9 6.8 5.4 3.6 5.1 9.9 6.8 5.7 6.4 4.9 6.9 2.9 4.8 3.9 5.9 1.7 3.7 1.7 7.7 3.8 2.6 8.9 0.5 2.3 6.4 6.1 0.7 0.9 5.5 0.5 1.8 7.6 3.4 4.8 14.8 22.4 0.9 0.3 5.0 2.0 2.0 3.0 9.8 5.8 0.0 14.1 4.5 7.3 7.8 0.9 7.8 5.2 2.8 1.7 0.8 2.1 0.0 0.3 4.0 5.3 4.8 4.6 7.7 2.0 0.2 6.3 3.1 4.9 6.4 0.0 8.3 0.4 7.0 5.2 1.7 8.3 1.5 5.0 1.6 5.5 2.9 3.2 2.7 4.8 4.8 5.9 4.9 5.4 3.6 6.9 2.9 1.7 3.4 1.9 3.9 2.8 1.2 4.5 1.7 ALCAM "CD166, MEMD" ENSG00000170017 "Activated leukocyte cell adhesion molecule" Q13740 3 105366909-105576900 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Cell adhesion, Immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 122.5" "Cell line enhanced" "Detected in many" "hTERT-HME1: 64.6;U-138 MG: 77.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 20.7" "Lineage enriched" "Detected in many" 6 "dendritic cells: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002148, HPA010926" Enhanced "Intracellular and membrane" 1800000000 "CAB002148: AB_442053, HPA010926: AB_1078449" "unprognostic (6.82e-2)" "unprognostic (2.66e-1)" "unprognostic (2.13e-1)" "unprognostic (2.19e-1)" "unprognostic (9.48e-3)" "unprognostic (2.08e-2)" "unprognostic (1.63e-3)" "unprognostic (3.89e-2)" "unprognostic (1.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "prognostic favourable (3.15e-4)" "unprognostic (3.15e-1)" "unprognostic (4.47e-2)" "unprognostic (9.57e-2)" "unprognostic (7.76e-2)" 16.6 14.1 23.6 5.2 31.1 4.2 34.2 4.2 25.3 12.9 8.2 25.0 13.9 7.2 7.0 15.4 4.0 20.6 9.9 4.7 23.2 24.3 9.6 19.4 29.6 4.2 45.1 19.7 24.6 15.3 122.5 11.9 5.3 31.5 14.0 6.6 3.0 17.9 17.5 0.9 5.9 7.3 10.8 35.3 3.0 14.2 2.3 43.8 2.2 25.6 2.7 6.2 9.9 5.5 3.5 20.7 3.7 3.2 0.4 1.6 2.0 38.4 14.8 10.7 5.4 16.2 7.1 0.1 31.5 18.4 20.3 28.6 0.1 8.0 2.7 13.1 44.3 29.8 1.7 25.0 60.2 2.5 2.6 0.3 11.4 0.7 18.2 15.6 0.1 12.6 18.7 26.0 64.6 22.3 0.0 4.6 26.6 2.6 2.2 5.7 2.2 16.8 1.4 0.9 0.1 30.8 4.3 7.7 21.5 3.2 3.1 2.0 6.0 10.3 46.2 77.9 26.6 3.4 37.2 0.0 0.0 0.2 17.7 3.3 33.2 0.0 3.2 2.4 0.4 1.5 1.4 3.5 1.1 0.7 20.7 2.2 0.2 0.2 3.7 0.4 0.8 7.4 1.6 2.0 23.6 31.1 4.2 24.6 23.2 24.3 45.1 19.7 31.5 43.8 ALDH16A1 MGC10204 ENSG00000161618 "Aldehyde dehydrogenase 16 family member A1" Q8IZ83 19 49453169-49471048 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059488 Approved Approved Mitochondria 910000 Mitochondria "HPA059488: " "unprognostic (2.39e-1)" "unprognostic (3.95e-3)" "unprognostic (7.10e-2)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (2.95e-3)" "unprognostic (5.58e-2)" "unprognostic (1.45e-1)" "unprognostic (3.92e-2)" "unprognostic (4.90e-1)" "unprognostic (1.19e-3)" "unprognostic (4.28e-2)" "unprognostic (1.91e-3)" "unprognostic (2.94e-2)" "unprognostic (4.19e-1)" "unprognostic (1.27e-1)" "unprognostic (5.23e-3)" 13.3 11.0 6.9 16.9 9.6 13.3 10.5 6.0 8.2 12.3 14.2 6.6 7.4 21.0 12.5 7.7 11.4 9.9 15.3 6.2 4.8 3.0 10.5 22.0 8.7 14.2 12.1 3.1 8.9 15.1 6.5 6.0 10.8 8.5 7.8 4.0 6.2 8.0 9.6 6.5 15.2 19.9 5.6 5.2 21.8 12.4 4.5 9.6 16.8 9.4 10.6 14.6 9.6 9.9 13.2 12.0 12.0 19.8 5.8 7.4 4.5 11.4 15.6 3.7 8.8 1.7 1.2 12.3 7.4 2.3 5.8 6.0 8.0 4.4 17.3 11.8 1.0 7.9 1.5 4.2 0.7 10.8 9.0 13.4 5.6 11.4 2.5 8.2 30.1 2.1 2.5 2.8 2.2 3.7 9.3 18.0 1.4 11.6 5.8 23.3 8.1 0.0 9.8 5.3 12.9 2.7 13.6 6.7 7.6 6.6 7.4 6.1 6.8 9.4 8.3 8.5 5.6 3.8 8.1 15.0 17.3 5.0 2.1 11.6 5.9 7.6 7.1 12.0 6.8 17.7 7.4 12.5 6.8 7.4 11.3 13.2 6.3 6.4 1.3 5.8 19.8 12.0 5.4 4.5 6.9 9.6 6.0 8.2 4.8 3.0 12.1 3.1 8.5 9.6 ALDH3A2 "ALDH10, FALDH, SLS" ENSG00000072210 "Aldehyde dehydrogenase 3 family member A2" P51648 17 19648136-19677598 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014769, CAB020692" Approved "CAB020692: , HPA014769: AB_1844728" "unprognostic (1.42e-1)" "unprognostic (7.62e-2)" "unprognostic (7.77e-2)" "unprognostic (2.49e-2)" "unprognostic (4.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-2)" "unprognostic (2.23e-1)" "unprognostic (3.93e-3)" "unprognostic (2.40e-1)" "unprognostic (2.63e-1)" "prognostic favourable (3.85e-8)" "unprognostic (4.12e-2)" "unprognostic (1.55e-1)" "unprognostic (1.42e-2)" "unprognostic (1.26e-1)" 22.3 66.4 8.5 9.0 24.6 2.8 10.0 8.8 12.8 13.7 15.9 17.5 7.5 15.6 13.5 19.2 39.6 10.7 26.4 12.5 9.5 6.5 52.5 88.6 17.7 4.3 11.1 10.3 13.5 24.4 10.1 14.9 3.1 14.4 20.7 11.1 16.2 26.0 10.0 18.5 57.1 26.6 10.5 10.2 8.0 18.3 9.8 15.4 4.5 27.3 27.9 22.5 9.8 17.0 3.9 14.3 11.6 14.2 8.6 6.4 5.7 6.7 42.3 4.2 10.6 20.2 17.1 2.9 2.0 5.2 4.0 4.6 13.2 11.0 2.1 4.9 8.4 15.1 16.6 20.3 2.9 9.4 7.2 1.0 22.3 32.3 3.8 5.0 0.5 9.4 28.9 3.8 2.3 8.0 0.2 0.1 10.1 9.1 0.1 6.2 10.1 23.2 4.9 12.1 6.4 4.7 21.4 8.2 5.8 18.5 7.1 5.9 12.4 4.6 9.5 2.6 4.7 6.8 6.3 2.9 7.2 3.0 12.6 0.0 8.4 0.0 14.2 11.6 4.2 12.6 6.4 3.9 4.3 3.7 14.3 3.0 4.9 3.4 0.7 8.6 13.7 0.2 5.8 5.7 8.5 24.6 8.8 12.8 9.5 6.5 11.1 10.3 14.4 15.4 ALDH6A1 MMSDH ENSG00000119711 "Aldehyde dehydrogenase 6 family member A1" Q02252 14 74056850-74084493 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 140.0;liver: 134.5" "Cell line enhanced" "Detected in all" "T-47d: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 25.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029072, HPA029073, HPA029074, HPA029075" Enhanced Enhanced Mitochondria 9100 Mitochondria "HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005" "unprognostic (1.45e-1)" "unprognostic (5.38e-2)" "unprognostic (6.89e-2)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (7.93e-2)" "unprognostic (1.11e-3)" "prognostic favourable (4.22e-4)" "unprognostic (1.58e-1)" "unprognostic (9.10e-2)" "unprognostic (3.11e-2)" "unprognostic (2.13e-1)" "prognostic favourable (2.00e-15)" "unprognostic (4.59e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-3)" "unprognostic (1.12e-1)" 14.1 6.9 31.3 2.8 30.9 2.3 6.7 11.6 26.4 8.0 11.0 20.1 4.6 11.0 5.5 5.5 5.0 6.2 4.8 15.6 21.1 14.2 140.0 134.5 4.7 3.0 19.4 18.5 12.3 11.8 16.4 3.2 4.0 14.8 11.0 7.2 7.1 7.8 7.8 10.5 3.4 9.3 5.6 13.1 3.1 9.6 7.4 18.7 2.0 12.1 4.0 3.1 6.3 3.3 4.5 5.6 25.5 3.8 5.5 6.7 2.8 4.6 4.0 5.7 12.1 20.8 10.2 9.2 3.2 6.1 3.5 6.0 9.0 5.2 5.4 7.2 6.9 2.7 12.9 3.6 7.7 4.8 1.8 2.5 4.2 9.9 23.7 1.3 1.2 15.0 6.5 4.5 11.4 6.1 4.0 7.5 2.4 17.7 3.7 2.0 4.5 2.7 7.6 5.9 7.1 5.6 3.5 2.3 3.6 10.7 11.6 2.8 29.6 4.8 1.9 4.0 4.9 6.2 1.2 5.1 9.1 5.5 5.2 1.6 3.8 13.3 3.8 25.5 4.5 2.9 6.7 4.5 5.1 5.3 5.6 3.6 6.5 4.6 1.5 5.5 2.4 3.2 3.6 2.8 31.3 30.9 11.6 26.4 21.1 14.2 19.4 18.5 14.8 18.7 ALDOA ENSG00000285043 "Aldolase, fructose-bisphosphate A" P04075 16 30053090-30070420 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Glycolysis Lyase "Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA004177 Uncertain Supported Cytosol 1200000000 Cytosol "HPA004177: AB_1078128" 1.8 0.9 2.7 1.1 5.0 2.1 7.2 0.7 7.7 4.9 1.5 2.0 2.4 0.0 2.5 3.9 0.9 3.6 1.6 5.3 2.3 1.3 0.0 2.3 2.0 0.8 4.4 2.2 0.8 0.8 3.0 1.4 4.0 2.4 0.5 2.8 1.6 7.5 10.6 0.6 0.1 1.9 0.4 1.7 1.3 11.6 0.8 1.2 4.7 0.2 2.7 1.2 1.0 7.0 6.6 0.9 6.2 4.2 8.5 12.5 3.7 8.8 1.9 6.2 1.5 5.2 1.5 4.0 6.9 5.4 21.6 3.6 5.0 24.5 5.9 6.8 6.3 14.0 10.9 3.8 4.3 7.9 6.0 8.2 5.9 11.5 10.5 2.3 5.1 0.5 10.7 12.2 7.7 1.2 7.1 13.4 3.9 4.9 8.0 2.1 5.5 7.6 4.0 22.4 15.1 0.7 6.1 5.0 1.0 1.6 1.5 5.1 4.0 1.7 8.0 2.4 3.7 5.3 7.3 5.5 8.0 7.6 11.4 3.5 0.1 6.2 0.1 5.3 2.6 7.4 7.0 7.0 5.7 6.6 6.2 8.5 6.6 0.9 4.2 2.3 5.6 5.4 12.5 ALG1 "CDG1K, HMAT1, HMT-1, Mat-1" ENSG00000033011 "ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase" Q9BT22 16 5033960-5087379 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA060392 Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: " "unprognostic (1.66e-2)" "unprognostic (5.18e-1)" "prognostic favourable (5.79e-4)" "unprognostic (1.55e-2)" "unprognostic (2.10e-2)" "unprognostic (3.22e-2)" "unprognostic (2.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (5.27e-2)" "unprognostic (1.02e-2)" "prognostic unfavourable (6.93e-4)" "unprognostic (2.58e-3)" "unprognostic (3.86e-2)" 11.0 22.2 8.7 10.8 12.8 6.6 12.8 9.3 18.8 13.7 16.4 14.9 10.1 14.7 12.1 17.0 11.7 12.4 14.3 8.1 8.8 10.4 18.9 31.6 9.9 12.7 10.5 6.5 10.1 27.9 21.5 13.6 10.7 14.6 10.8 17.2 15.5 20.6 12.0 7.3 9.1 12.8 12.1 9.4 16.2 16.5 19.4 11.4 16.0 15.0 8.7 14.5 12.1 8.7 20.7 24.3 7.8 23.3 20.9 26.5 31.7 6.4 17.6 4.4 8.3 17.0 10.1 8.2 14.5 20.4 19.0 19.0 14.5 23.9 13.7 12.5 18.5 17.4 12.1 14.3 12.9 11.2 13.8 7.7 14.6 29.9 13.9 13.4 13.5 12.3 10.9 14.9 9.4 11.3 9.6 18.0 14.1 17.5 8.6 16.5 16.8 10.1 16.0 6.1 38.2 11.8 7.0 7.5 7.6 15.5 24.3 8.3 15.8 11.0 10.8 8.8 8.2 45.0 12.1 13.1 15.8 9.3 7.3 14.4 12.5 3.3 23.3 7.8 26.5 21.6 23.1 19.8 22.9 25.4 24.3 20.7 21.0 23.7 1.5 20.9 21.2 21.2 21.6 31.7 8.7 12.8 9.3 18.8 8.8 10.4 10.5 6.5 14.6 11.4 ALG14 MGC19780 ENSG00000172339 "ALG14, UDP-N-acetylglucosaminyltransferase subunit" Q96F25 1 94974407-95072945 "Disease related genes, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031829 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA031829: " "unprognostic (7.79e-2)" "unprognostic (3.59e-2)" "unprognostic (1.51e-3)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "unprognostic (6.56e-2)" "unprognostic (4.00e-1)" "unprognostic (2.17e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (7.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (9.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.99e-2)" "unprognostic (1.93e-1)" 5.8 13.2 6.8 4.1 8.5 4.6 6.8 5.6 8.0 5.5 7.5 8.5 7.0 8.5 5.4 11.3 5.7 4.8 6.1 6.3 7.0 7.2 8.9 15.1 5.3 7.5 8.2 4.7 5.3 12.6 5.8 6.6 6.3 8.4 5.1 8.7 6.9 14.5 9.8 7.2 5.0 9.2 4.4 9.4 5.8 6.0 10.0 4.2 3.7 8.5 6.2 5.3 4.8 4.2 4.9 5.8 3.1 3.9 2.8 3.8 1.9 5.1 3.3 2.8 2.5 2.2 3.7 2.5 3.7 4.0 3.9 3.3 3.8 1.8 2.7 3.9 4.6 3.6 3.2 3.6 4.7 5.7 5.4 1.5 3.6 5.8 3.5 3.6 1.0 4.1 3.6 2.9 2.9 3.3 2.8 3.5 3.7 2.5 3.8 2.3 1.7 4.7 2.4 5.6 2.9 4.3 3.0 2.5 3.2 2.1 7.1 6.2 3.1 3.1 2.5 2.5 2.7 4.4 7.8 2.2 2.1 2.4 1.8 1.8 2.0 3.1 3.2 1.1 2.5 3.9 2.4 4.9 3.1 3.1 4.5 4.4 2.9 3.0 2.7 2.8 1.9 5.8 3.8 1.9 6.8 8.5 5.6 8.0 7.0 7.2 8.2 4.7 8.4 4.2 ALG2 "CDG1I, CDGIi, FLJ14511, hALPG2, NET38" ENSG00000119523 "ALG2, alpha-1,3/1,6-mannosyltransferase" Q9H553 9 99216426-99221956 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041512, HPA041601" Approved Enhanced "Actin filaments,Cytosol" "Actin filaments, Cytosol" "HPA041512: AB_10794380, HPA041601: AB_10794302" "unprognostic (8.86e-3)" "unprognostic (4.39e-1)" "unprognostic (2.37e-1)" "prognostic favourable (8.44e-5)" "unprognostic (9.21e-3)" "prognostic unfavourable (1.56e-4)" "unprognostic (1.06e-2)" "unprognostic (5.94e-2)" "unprognostic (3.31e-1)" "unprognostic (3.66e-1)" "unprognostic (2.99e-2)" "unprognostic (1.08e-1)" "prognostic favourable (2.28e-7)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-2)" "unprognostic (4.81e-1)" 12.5 28.0 9.2 9.4 9.7 10.5 16.4 13.1 12.5 18.8 12.9 11.6 31.1 11.0 15.2 39.2 12.3 15.8 13.9 12.1 8.3 9.5 24.8 45.5 16.0 12.8 10.8 6.5 18.4 43.4 14.7 22.4 22.5 12.0 16.7 14.9 14.7 24.1 32.6 13.3 8.7 15.5 12.6 11.3 15.9 15.0 12.6 9.7 14.8 26.0 9.9 15.8 12.9 11.8 16.8 41.0 18.2 18.5 17.5 26.4 17.8 8.1 11.0 8.1 11.6 30.1 19.6 16.7 16.7 26.6 17.1 14.9 13.1 11.8 8.8 7.8 19.2 32.3 13.7 17.9 17.2 13.3 6.3 5.2 8.7 19.4 36.2 9.2 9.9 21.4 23.4 14.5 26.4 19.1 9.1 19.9 15.8 17.1 4.6 10.9 10.5 15.5 5.4 16.5 13.7 22.9 10.4 8.7 7.1 12.3 22.7 21.5 9.2 7.8 13.6 11.7 11.6 14.9 10.4 18.7 10.1 3.8 22.0 7.3 5.7 18.2 18.5 11.2 18.6 14.6 26.4 16.8 17.7 18.4 23.0 13.3 15.4 15.0 5.0 17.5 12.9 41.0 18.8 17.8 9.2 9.7 13.1 12.5 8.3 9.5 10.8 6.5 12.0 9.7 ALG5 bA421P11.2 ENSG00000120697 "ALG5, dolichyl-phosphate beta-glucosyltransferase" Q9Y673 13 36949775-37000261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007989 Approved Approved Cytosol Cytosol "HPA007989: AB_1078132" "unprognostic (1.87e-1)" "unprognostic (1.73e-2)" "unprognostic (6.07e-2)" "unprognostic (1.05e-3)" "unprognostic (3.01e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (1.57e-2)" "unprognostic (5.82e-2)" "unprognostic (5.21e-2)" "unprognostic (7.46e-2)" "unprognostic (3.51e-2)" "unprognostic (3.30e-1)" "prognostic favourable (1.40e-5)" "unprognostic (7.44e-2)" "unprognostic (1.66e-1)" "unprognostic (7.14e-3)" "unprognostic (1.86e-1)" 14.7 18.2 11.8 14.0 14.2 11.3 19.9 10.9 13.7 16.7 16.5 10.3 34.2 13.0 13.5 34.8 11.7 12.4 12.9 13.1 10.0 10.5 18.1 36.7 19.1 28.0 16.1 12.8 11.8 60.4 11.8 11.6 17.0 12.1 12.9 20.8 7.3 30.2 37.0 9.0 11.0 12.6 10.9 15.1 12.9 17.6 7.2 14.2 15.4 25.5 12.1 12.4 12.4 11.1 19.1 45.5 17.7 24.8 22.1 25.2 26.9 10.6 14.3 13.3 13.6 36.6 24.5 9.8 29.6 31.5 25.1 20.5 28.1 37.2 15.3 12.3 17.9 26.4 16.3 22.6 23.4 16.4 32.1 35.3 12.0 17.6 35.8 29.9 18.5 25.7 33.3 20.0 26.8 19.1 16.1 19.2 22.6 19.1 20.1 23.9 13.6 11.7 24.6 16.4 37.6 26.6 20.2 10.6 20.6 12.5 23.2 17.1 14.0 29.7 14.5 14.1 8.0 15.4 18.8 16.4 12.6 20.1 21.7 19.0 23.2 17.7 24.1 10.0 24.4 24.8 24.6 19.1 23.0 24.4 23.6 17.0 21.2 23.2 2.7 22.1 20.2 45.5 25.2 26.9 11.8 14.2 10.9 13.7 10.0 10.5 16.1 12.8 12.1 14.2 ALG8 MGC2840 ENSG00000159063 "ALG8, alpha-1,3-glucosyltransferase" Q9BVK2 11 78100936-78139660 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051898 Approved Approved Nucleoplasm Nucleoplasm "HPA051898: " "unprognostic (1.37e-1)" "unprognostic (9.24e-2)" "unprognostic (4.60e-2)" "unprognostic (2.69e-2)" "unprognostic (2.65e-1)" "unprognostic (6.49e-2)" "unprognostic (5.38e-3)" "unprognostic (5.91e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (5.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.34e-1)" "unprognostic (3.78e-2)" "unprognostic (6.37e-2)" 20.2 24.5 18.0 11.2 22.3 9.7 23.7 13.8 17.9 16.5 15.0 20.7 23.9 10.3 14.5 30.9 13.3 18.4 12.3 13.0 15.9 16.0 24.9 40.8 12.8 15.7 16.0 11.6 22.9 23.4 24.2 23.6 21.7 17.1 15.5 19.0 17.6 23.2 19.5 8.2 13.3 13.3 14.8 17.6 13.8 13.1 38.9 16.5 18.2 29.7 13.1 17.4 13.2 11.2 21.9 19.4 3.0 20.3 18.2 19.0 14.9 9.3 25.9 24.9 21.2 21.5 15.2 13.4 13.8 20.7 23.7 23.0 49.0 34.4 22.0 25.6 16.5 27.1 28.9 19.9 38.3 15.8 17.4 26.5 22.8 22.0 14.0 25.3 17.6 12.1 12.8 27.6 13.8 17.2 32.8 22.7 31.6 13.7 21.1 28.5 27.6 13.6 22.5 11.4 52.3 23.8 14.5 7.3 18.3 19.9 32.3 10.0 36.0 20.0 10.5 16.1 18.7 36.2 11.9 16.3 31.6 32.5 8.9 24.8 27.8 0.3 17.5 3.0 15.7 19.5 17.5 21.9 16.0 16.1 19.4 16.6 19.0 17.2 1.1 18.2 20.3 18.7 13.0 14.9 18.0 22.3 13.8 17.9 15.9 16.0 16.0 11.6 17.1 16.5 ALK CD246 ENSG00000171094 "ALK receptor tyrosine kinase" Q9UM73 2 29192774-29921566 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.1;pituitary gland: 17.9" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 26.4" "Group enriched" "Detected in some" 5 "glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010694 Approved Supported "Plasma membrane" "Plasma membrane" "HPA010694: AB_1078133" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.56e-7)" "unprognostic (7.17e-2)" "unprognostic (1.71e-1)" "unprognostic (9.07e-3)" "unprognostic (6.29e-3)" "unprognostic (1.18e-1)" "unprognostic (1.01e-1)" "unprognostic (2.67e-4)" "unprognostic (3.70e-2)" "unprognostic (2.06e-2)" "unprognostic (7.15e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (3.61e-2)" 1.8 3.1 3.6 1.2 4.4 0.3 1.1 0.5 8.1 0.7 2.1 2.0 0.0 0.7 0.5 0.5 0.6 0.5 1.2 0.4 3.4 4.9 0.4 0.5 1.1 0.5 2.7 4.2 0.6 0.4 0.4 17.9 0.5 5.5 0.5 1.2 2.4 0.9 0.8 0.3 0.9 1.5 0.9 2.1 0.5 0.8 4.9 0.9 0.0 1.6 0.0 0.3 0.6 1.2 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 3.5 0.0 0.0 0.1 0.3 26.4 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 4.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 4.4 0.5 5.9 3.4 4.9 2.7 4.2 5.5 0.9 ALPK1 "FLJ22670, KIAA1527, Lak" ENSG00000073331 "Alpha kinase 1" Q96QP1 4 112285509-112442620 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027435, HPA027443" Approved Approved Centrosome Centrosome "HPA027435: AB_10599614, HPA027443: AB_10599421" "unprognostic (6.24e-2)" "unprognostic (1.92e-1)" "unprognostic (9.30e-2)" "unprognostic (1.69e-2)" "unprognostic (7.40e-2)" "unprognostic (5.45e-2)" "unprognostic (2.55e-2)" "unprognostic (7.47e-2)" "unprognostic (2.34e-1)" "unprognostic (1.38e-1)" "unprognostic (7.14e-2)" "unprognostic (2.78e-1)" "prognostic unfavourable (5.82e-7)" "unprognostic (1.60e-1)" "unprognostic (4.17e-2)" "unprognostic (2.81e-1)" "prognostic favourable (1.17e-4)" 15.1 10.6 5.3 8.3 7.7 17.3 9.3 1.3 5.9 10.8 9.5 5.8 3.0 4.5 9.8 9.2 8.8 9.2 7.5 6.1 6.1 2.3 10.8 13.4 13.2 11.4 9.7 1.0 17.4 9.7 11.0 14.0 11.5 6.6 14.0 7.8 9.6 10.4 6.8 5.0 11.8 12.1 11.3 16.6 16.2 7.4 4.2 8.5 13.7 12.4 4.7 13.7 13.6 11.6 0.9 3.2 16.3 4.3 0.4 0.8 1.2 1.6 5.0 1.5 0.3 6.5 10.4 2.0 1.9 3.4 2.6 3.2 0.5 7.6 5.0 3.3 3.2 1.1 1.7 3.0 3.8 6.4 1.7 3.6 2.0 0.4 10.5 2.2 2.2 12.9 8.5 3.7 7.8 1.0 0.9 8.8 4.9 3.0 1.2 2.0 0.4 1.2 0.6 1.1 1.6 3.8 1.8 0.5 0.8 1.8 6.5 2.8 2.9 4.0 1.9 2.3 2.1 3.7 1.2 2.2 0.7 4.3 5.7 4.5 2.1 1.3 3.2 1.4 0.2 4.3 0.6 0.8 0.6 0.1 3.2 0.9 0.8 0.6 16.3 0.4 1.9 0.5 0.0 1.2 5.3 7.7 1.3 5.9 6.1 2.3 9.7 1.0 6.6 8.5 ALPL "HOPS, TNSALP" ENSG00000162551 "Alkaline phosphatase, liver/bone/kidney" P05186 1 21509372-21578412 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Biomineralization Hydrolase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 73.3;liver: 52.7;lung: 45.1" "Cell line enhanced" "Detected in some" "HSkMC: 52.2;hTEC/SVTERT24-B: 40.8;LHCN-M2: 29.7;SCLC-21H: 26.0" "Cancer enhanced" "Detected in all" "testis cancer: 199.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 91 "neutrophil: 73.3" "Lineage enriched" "Detected in single" 127 "granulocytes: 73.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007105, HPA008765, CAB020829" Enhanced Approved Cytosol "Intracellular and membrane" 7300000 Cytosol "CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138" "unprognostic (3.89e-2)" "unprognostic (1.27e-1)" "unprognostic (5.57e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (7.57e-4)" "unprognostic (3.05e-3)" "unprognostic (6.50e-3)" "unprognostic (1.01e-1)" "prognostic unfavourable (7.08e-4)" "unprognostic (1.17e-2)" "unprognostic (2.48e-3)" "unprognostic (1.74e-1)" "unprognostic (7.28e-2)" "unprognostic (1.73e-2)" "unprognostic (2.27e-1)" "unprognostic (9.70e-3)" "unprognostic (2.58e-1)" 15.9 22.7 4.5 17.6 6.0 2.6 10.6 2.2 7.8 2.2 2.1 4.1 0.7 1.9 3.7 1.1 2.0 5.7 2.8 10.9 5.7 4.2 29.7 52.7 45.1 28.1 5.3 4.8 1.2 4.3 2.4 4.1 2.2 7.7 2.6 1.3 18.3 3.1 6.6 0.9 1.8 2.7 2.5 3.8 19.6 1.8 2.9 2.7 0.5 3.7 1.7 3.9 7.1 8.4 0.5 0.0 73.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 1.9 3.3 0.1 0.7 0.2 0.4 0.2 0.0 0.6 2.2 0.0 0.0 8.9 0.0 0.1 0.0 0.6 0.0 1.1 1.0 0.5 0.0 0.2 52.2 0.0 40.8 0.1 0.0 0.0 0.0 29.7 0.0 0.0 0.0 11.9 0.0 0.0 1.1 0.0 0.0 0.0 26.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 73.3 0.0 0.0 0.0 0.0 0.0 4.5 6.0 2.2 7.8 5.7 4.2 5.3 4.8 7.7 2.7 AMHR2 "MISR2, MISRII" ENSG00000135409 "Anti-Mullerian hormone receptor type 2" Q16671 12 53423855-53431534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.1;ovary: 38.2;testis: 15.2" "Group enriched" "Detected in some" 18 "HEL: 27.6;K-562: 15.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "hippocampal formation: 14.3" "HPA060228, HPA069636" Approved "Nucleoplasm,Vesicles,Centriolar satellite,Cytosol" Vesicles "Nucleoplasm, Centriolar satellite, Cytosol" "HPA060228: , HPA069636: " "unprognostic (5.79e-2)" "unprognostic (3.65e-1)" "unprognostic (3.98e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-3)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.32e-1)" "unprognostic (2.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.97e-1)" 0.3 27.1 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.6 0.4 0.2 0.4 0.8 0.2 0.0 0.2 1.1 0.3 0.2 0.2 0.2 38.2 8.8 0.1 0.2 0.2 0.3 0.4 0.0 0.2 0.2 0.2 2.5 0.0 0.4 0.5 0.2 3.7 0.3 15.2 0.2 0.2 0.2 0.5 0.3 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 27.6 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 AMIGO1 "AMIGO, KIAA1163" ENSG00000181754 "Adhesion molecule with Ig like domain 1" Q86WK6 1 109504175-109509738 "Predicted membrane proteins, Transporters" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.9" "Cell line enhanced" "Detected in many" "SK-BR-3: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5" "Group enriched" "Detected in many" 21 "NK-cells: 1.9;T-cells: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046152 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA046152: " "unprognostic (1.35e-1)" "unprognostic (3.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-2)" "prognostic unfavourable (1.21e-4)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.16e-3)" "unprognostic (3.11e-1)" "unprognostic (9.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" 5.3 14.8 11.8 3.7 19.1 1.0 4.7 23.4 33.9 4.8 6.6 4.8 4.0 3.2 5.7 16.4 4.1 4.9 4.3 11.0 12.2 14.3 7.6 3.5 6.4 5.2 9.9 15.0 12.8 9.2 21.1 8.1 3.0 15.6 9.2 3.7 10.3 9.6 11.1 22.4 3.3 4.1 6.5 6.0 4.6 5.0 4.1 5.3 1.7 9.1 1.9 4.6 4.5 3.8 0.1 0.0 0.0 0.1 1.9 5.4 0.9 2.5 1.2 2.7 9.3 3.5 1.5 3.3 4.3 2.2 5.0 2.4 0.5 0.1 0.2 1.2 2.7 1.4 7.2 0.3 4.2 1.0 0.6 0.0 1.7 0.8 2.9 2.1 5.3 0.7 3.2 1.7 0.0 1.2 2.0 0.0 0.1 4.3 0.4 4.3 1.6 2.9 0.7 0.0 0.3 5.8 1.2 9.4 3.1 1.0 12.3 3.5 3.6 3.0 1.1 0.1 5.8 3.4 1.8 0.2 0.0 0.0 1.8 0.0 2.7 0.0 0.0 0.0 1.5 0.1 1.6 0.1 2.2 2.5 0.0 0.0 5.4 3.9 0.0 1.9 0.0 0.0 1.5 0.9 11.8 19.1 23.4 33.9 12.2 14.3 9.9 15.0 15.6 5.3 AMIGO2 "ALI1, DEGA" ENSG00000139211 "Adhesion molecule with Ig like domain 2" Q86SJ2 12 47075707-47079951 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.9;fHDF/TERT166: 42.2;LHCN-M2: 42.2;RT4: 57.8;U-2 OS: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054004, HPA059601" Uncertain Approved "Golgi apparatus,Plasma membrane,Cytosol" 160000 "Golgi apparatus, Plasma membrane" Cytosol "HPA054004: AB_2682339, HPA059601: " "unprognostic (2.63e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" "unprognostic (3.91e-2)" "unprognostic (3.86e-1)" "unprognostic (1.07e-2)" "unprognostic (3.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-1)" "unprognostic (3.30e-1)" "prognostic unfavourable (1.80e-4)" "unprognostic (2.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-2)" "unprognostic (2.95e-1)" "unprognostic (7.47e-2)" "unprognostic (2.29e-3)" 5.6 11.9 5.4 4.0 8.8 1.4 14.5 1.6 6.5 18.3 20.3 3.5 1.9 1.6 19.7 12.4 3.1 21.2 12.4 3.4 2.7 7.5 4.3 2.9 11.9 6.7 2.9 5.1 43.4 2.3 2.0 9.5 7.6 16.2 12.8 5.6 6.7 3.1 7.1 1.5 2.3 7.1 21.0 3.0 9.8 3.5 13.1 3.6 1.6 2.5 4.1 4.5 16.6 15.1 2.8 7.4 0.1 0.2 6.6 14.2 4.3 9.7 24.1 1.5 0.0 0.6 0.0 3.9 3.3 9.1 1.1 0.9 0.0 43.9 0.0 11.0 42.2 14.6 0.0 27.0 1.3 1.9 0.1 0.0 2.4 0.0 0.9 0.2 0.4 0.2 4.8 28.9 14.3 3.5 1.8 0.0 42.2 0.4 0.7 0.0 1.0 6.1 0.0 10.9 0.0 12.5 57.8 4.4 0.0 17.4 2.1 0.1 2.6 0.2 0.9 0.6 35.0 0.4 26.9 0.4 0.0 0.0 2.3 0.7 0.6 0.0 0.1 0.0 4.0 0.2 5.4 2.8 6.2 6.2 0.6 1.3 14.2 11.1 0.1 6.6 0.0 7.4 3.6 4.3 5.4 8.8 1.6 6.5 2.7 7.5 2.9 5.1 16.2 3.6 AMN amnionless ENSG00000166126 "Amnion associated transmembrane protein" Q9BXJ7 14 102922656-102933596 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 97.6" "Cell line enhanced" "Detected in some" "CACO-2: 11.0;Hep G2: 10.8;U-698: 5.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA000817 Approved "HPA000817: AB_1078146" "unprognostic (2.02e-2)" "unprognostic (1.67e-1)" "unprognostic (3.94e-3)" "unprognostic (7.39e-3)" "unprognostic (9.32e-2)" "unprognostic (1.88e-3)" "unprognostic (8.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (2.97e-2)" "unprognostic (7.57e-2)" "unprognostic (2.43e-2)" "prognostic favourable (9.62e-5)" "unprognostic (8.02e-2)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (1.66e-1)" 0.4 0.0 0.1 3.3 0.1 0.0 0.7 0.1 0.1 0.6 44.3 0.1 0.2 19.3 0.2 3.1 2.6 0.6 10.4 0.2 0.1 0.0 17.2 17.8 1.8 0.5 0.1 0.0 0.1 0.2 0.0 0.4 0.2 0.1 0.4 2.1 0.2 0.7 0.0 0.0 0.9 97.6 0.1 0.0 0.6 3.9 0.3 0.1 0.7 0.7 0.1 1.1 0.5 1.0 0.3 1.8 0.0 0.0 0.0 0.7 0.1 0.6 0.1 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 11.0 0.3 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.5 0.2 0.0 0.8 10.8 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 1.6 0.2 0.0 0.2 0.1 0.2 0.0 0.0 1.0 0.7 0.1 0.1 0.1 0.0 1.4 0.0 0.0 0.0 0.2 0.0 1.0 0.6 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.3 0.7 0.6 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 ANKH "ANK, CCAL2, CMDJ, CPPDD, HANK, SLC62A1" ENSG00000154122 "ANKH inorganic pyrophosphate transport regulator" Q9HCJ1 5 14704800-14871785 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Phosphate transport, Transport" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068104 Approved Cytosol Cytosol "HPA068104: " "unprognostic (1.15e-1)" "unprognostic (3.35e-1)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "prognostic unfavourable (5.62e-4)" "unprognostic (6.58e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.83e-2)" "unprognostic (2.11e-1)" "unprognostic (2.38e-2)" "unprognostic (2.99e-1)" "unprognostic (1.54e-3)" "unprognostic (1.76e-3)" "unprognostic (1.71e-1)" "unprognostic (8.66e-2)" "unprognostic (6.46e-2)" 8.5 9.7 15.2 8.0 17.0 5.9 9.2 29.1 25.9 4.4 10.9 19.5 3.4 14.4 6.5 4.7 6.8 7.2 8.4 27.0 15.9 14.9 7.4 18.1 6.3 9.6 19.7 17.1 14.9 13.1 19.6 19.2 7.3 15.4 29.5 10.3 16.1 11.7 8.6 31.0 17.4 14.9 7.6 22.6 6.3 6.5 2.0 15.3 9.3 9.5 12.7 11.8 6.4 6.3 2.5 0.6 0.7 1.4 0.6 7.0 0.7 3.8 2.9 3.7 0.6 7.8 18.4 1.7 3.7 7.4 1.4 1.5 2.3 4.8 8.9 8.7 5.0 2.5 2.5 4.0 1.6 3.5 6.1 0.2 27.0 6.1 2.6 2.1 0.7 5.7 7.1 4.4 5.1 3.0 1.8 19.3 4.7 5.1 3.6 7.0 1.4 3.2 5.1 1.8 8.0 0.0 1.2 9.0 2.5 17.9 2.9 3.9 0.1 0.8 2.9 3.8 3.9 6.3 6.6 5.1 4.7 7.0 13.2 8.0 15.7 0.7 0.4 0.1 2.4 0.7 4.0 2.5 5.0 3.9 0.6 2.1 5.7 2.6 0.5 0.6 1.4 0.6 7.0 0.7 15.2 17.0 29.1 25.9 15.9 14.9 19.7 17.1 15.4 15.3 ANKLE1 "ANKRD41, FLJ39369, LEMD6" ENSG00000160117 "Ankyrin repeat and LEM domain containing 1" Q8NAG6 19 17281645-17287646 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9" "Cell line enhanced" "Detected in many" "Daudi: 30.2;HL-60: 13.3;NB-4: 17.0;U-937: 23.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.3" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.3" "Group enriched" "Detected in many" 4 "B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3" "Low region specificity" "Detected in many" "HPA026789, HPA073498" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA026789: AB_10611675, HPA073498: " "unprognostic (5.66e-2)" "unprognostic (2.21e-1)" "unprognostic (6.90e-2)" "prognostic unfavourable (4.86e-5)" "unprognostic (2.73e-1)" "unprognostic (1.72e-3)" "unprognostic (2.19e-2)" "unprognostic (2.09e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (7.89e-4)" "unprognostic (5.86e-2)" "unprognostic (0.00e+0)" "unprognostic (2.03e-1)" "unprognostic (1.61e-1)" "unprognostic (2.00e-3)" "unprognostic (4.30e-2)" 0.6 0.5 1.0 12.9 3.1 22.6 0.6 8.3 1.4 0.7 0.7 0.6 0.2 0.3 0.9 1.3 0.5 0.8 0.5 0.2 1.0 1.2 0.5 0.5 1.3 3.7 1.6 0.7 1.7 0.2 0.6 0.9 1.1 1.4 1.0 0.5 0.4 0.7 0.6 0.9 1.4 1.2 0.9 1.2 5.7 0.3 1.0 0.5 8.9 0.6 0.2 5.3 1.0 0.7 3.0 2.2 0.7 4.3 0.0 0.4 0.8 0.1 0.3 1.5 0.7 0.0 0.3 1.4 0.5 0.1 0.3 0.2 6.9 0.4 30.2 0.3 0.1 0.6 11.7 0.1 0.2 9.1 1.5 12.3 4.8 0.0 0.1 13.3 5.1 0.1 0.4 1.2 0.0 0.2 1.6 3.6 0.1 0.2 9.1 17.0 3.7 1.0 7.3 0.0 3.1 0.1 0.1 0.4 2.7 2.9 0.2 0.2 0.0 8.7 0.5 0.1 0.5 0.5 0.3 0.3 0.3 10.7 0.1 23.7 0.6 0.0 1.8 0.7 0.0 4.3 0.0 3.0 0.0 0.4 2.2 1.7 0.1 0.0 0.0 0.0 3.1 1.1 0.0 0.8 1.0 3.1 8.3 1.4 1.0 1.2 1.6 0.7 1.4 0.5 ANKLE2 "KIAA0692, Lem4, LEMD7" ENSG00000176915 "Ankyrin repeat and LEM domain containing 2" Q86XL3 12 132725503-132761888 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003602, HPA074838" Uncertain Supported "Endoplasmic reticulum,Plasma membrane" "Endoplasmic reticulum, Plasma membrane" "HPA003602: AB_1858349, HPA074838: " "unprognostic (4.43e-2)" "unprognostic (6.92e-2)" "unprognostic (7.97e-2)" "unprognostic (9.84e-3)" "unprognostic (1.97e-2)" "unprognostic (5.81e-2)" "prognostic unfavourable (3.97e-6)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (4.76e-2)" "unprognostic (6.10e-2)" "prognostic unfavourable (1.90e-8)" "unprognostic (1.42e-1)" "unprognostic (1.42e-1)" "unprognostic (6.92e-3)" "unprognostic (2.09e-1)" 20.1 26.4 14.9 21.3 17.6 27.2 21.8 23.3 20.4 15.6 15.4 19.6 15.1 14.6 18.9 16.8 23.7 18.6 17.0 16.5 12.4 10.7 16.3 16.3 21.6 24.1 16.0 11.3 20.7 18.1 17.2 22.3 18.3 15.2 17.2 13.9 16.7 19.1 15.7 19.9 27.3 22.8 18.5 13.4 27.4 16.8 43.7 14.1 31.4 17.4 15.8 27.9 16.4 28.6 4.8 3.3 7.7 2.2 4.7 5.5 1.4 20.8 19.5 20.5 12.6 11.9 18.8 25.7 25.5 19.1 25.6 19.7 22.2 14.3 16.4 13.4 22.4 25.2 17.8 23.2 24.6 7.0 22.1 20.8 32.7 10.4 13.3 22.4 14.7 17.4 23.8 24.3 18.1 18.2 18.7 6.5 26.1 15.0 20.8 37.0 17.3 18.8 24.0 13.4 6.9 18.4 27.3 25.1 15.5 32.9 13.9 11.2 24.4 16.3 26.0 30.9 22.3 16.4 28.4 12.1 11.9 20.1 23.9 14.9 17.3 1.4 2.2 7.7 3.6 2.1 4.8 4.8 5.3 5.5 3.3 4.3 5.0 4.1 1.3 4.7 2.2 3.2 4.7 1.4 14.9 17.6 23.3 20.4 12.4 10.7 16.0 11.3 15.2 14.1 ANKRD29 FLJ25053 ENSG00000154065 "Ankyrin repeat domain 29" Q8N6D5 18 23598926-23662885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 12.6;BJ hTERT+: 12.0;hTCEpi: 11.9;PC-3: 11.4;U-2197: 14.9;U-87 MG: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 1.1;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 14 "dendritic cells: 1.6;T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041272, HPA049419" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA041272: AB_2677387, HPA049419: AB_2680757" "unprognostic (4.52e-3)" "unprognostic (8.37e-2)" "unprognostic (7.04e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-3)" "prognostic favourable (1.92e-5)" "unprognostic (3.29e-2)" "prognostic favourable (5.98e-5)" "unprognostic (1.11e-1)" "unprognostic (1.93e-2)" "unprognostic (3.83e-2)" "unprognostic (3.54e-1)" "prognostic favourable (7.20e-5)" "unprognostic (1.10e-2)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" "unprognostic (1.64e-5)" 11.8 6.1 8.9 6.6 6.6 0.2 9.9 1.9 15.1 8.4 3.0 3.7 3.0 1.2 13.1 6.4 6.5 9.6 4.4 4.9 9.8 5.3 2.5 1.6 25.2 14.6 8.7 6.2 12.4 0.8 18.4 6.0 0.3 17.9 7.0 1.8 4.3 5.1 7.5 3.2 3.2 4.5 9.8 3.2 2.0 11.7 2.9 3.1 1.6 2.3 5.5 11.1 4.8 9.1 0.0 1.6 0.0 0.0 0.0 1.1 0.0 1.6 4.8 0.0 0.0 1.2 12.6 0.1 4.7 12.0 1.9 2.4 2.1 0.4 0.0 0.7 2.2 2.4 0.0 6.2 0.4 0.1 4.3 0.0 3.1 0.1 0.2 0.0 0.3 3.3 11.9 1.9 3.2 1.2 0.0 0.2 3.2 0.5 0.0 0.0 0.8 11.4 0.0 0.3 1.1 3.0 1.7 0.7 5.9 1.2 0.2 0.1 1.4 0.0 2.8 0.3 1.7 14.9 4.2 0.0 0.0 0.0 15.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 8.9 6.6 1.9 15.1 9.8 5.3 8.7 6.2 17.9 3.1 ANKRD46 ENSG00000186106 "Ankyrin repeat domain 46" Q86W74 8 100509752-100559784 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013758 Approved Approved Cytosol Cytosol "HPA013758: AB_10962626" "unprognostic (3.71e-3)" "unprognostic (9.01e-2)" "unprognostic (2.03e-1)" "unprognostic (2.22e-2)" "unprognostic (9.82e-2)" "unprognostic (1.16e-1)" "unprognostic (2.63e-1)" "unprognostic (8.84e-2)" "unprognostic (4.79e-2)" "unprognostic (3.56e-1)" "unprognostic (2.98e-2)" "unprognostic (1.51e-1)" "unprognostic (8.08e-3)" "unprognostic (5.29e-2)" "unprognostic (1.82e-1)" "unprognostic (1.81e-2)" "unprognostic (6.29e-3)" 13.0 29.7 25.8 6.0 23.4 1.6 11.1 25.2 34.2 12.2 6.9 13.9 7.6 7.6 9.7 12.8 9.6 8.9 5.9 14.5 24.0 25.9 23.8 29.5 8.0 6.8 21.7 25.2 17.6 13.6 10.7 10.8 15.2 24.5 10.6 7.1 7.7 11.7 10.7 40.3 8.3 8.1 9.5 20.6 7.9 8.4 6.1 14.6 9.4 14.7 6.1 7.9 8.2 7.6 11.3 7.9 10.4 6.0 12.7 15.8 8.7 5.5 7.0 10.5 5.9 8.1 4.8 11.7 7.3 3.3 5.6 4.8 10.1 3.4 17.5 13.7 2.5 4.3 10.6 5.4 6.0 6.2 9.3 21.8 3.5 7.9 4.8 5.1 2.8 3.4 10.0 3.6 6.0 6.9 11.5 5.7 5.3 6.3 23.7 9.5 7.7 5.2 18.5 3.5 11.6 8.2 6.0 11.6 11.8 3.1 5.8 4.6 8.5 8.9 5.1 2.6 2.9 3.8 2.8 13.5 12.7 14.5 2.8 16.7 4.1 10.4 6.0 6.1 12.5 3.2 15.2 11.3 12.0 10.9 7.9 9.5 15.8 13.5 1.5 12.7 5.1 7.4 11.2 8.7 25.8 23.4 25.2 34.2 24.0 25.9 21.7 25.2 24.5 14.6 ANO1 "DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A" ENSG00000131620 "Anoctamin 1" Q5XXA6 11 70078302-70189528 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Developmental protein, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6" "Group enriched" "Detected in some" 5 "A-431: 33.8;CAPAN-2: 52.0;HaCaT: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA032148, HPA057356" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA032148: , HPA057356: " "unprognostic (2.73e-1)" "unprognostic (7.91e-2)" "unprognostic (3.66e-2)" "prognostic favourable (4.58e-6)" "unprognostic (1.90e-1)" "prognostic unfavourable (7.28e-5)" "unprognostic (1.16e-3)" "prognostic unfavourable (2.40e-4)" "unprognostic (2.13e-2)" "unprognostic (3.51e-1)" "prognostic unfavourable (1.70e-4)" "unprognostic (1.21e-1)" "prognostic unfavourable (4.09e-6)" "unprognostic (1.56e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.81e-1)" 6.9 0.4 1.1 2.1 1.1 0.0 17.2 1.6 1.4 9.7 5.3 1.1 142.4 0.2 14.2 38.5 3.6 11.7 10.6 6.9 1.1 0.2 2.6 24.4 4.4 1.5 1.0 1.0 3.9 4.5 0.5 2.0 6.2 1.5 7.2 1.7 1.7 122.9 93.6 3.4 19.1 1.8 5.7 1.0 1.1 9.5 7.6 0.9 1.1 8.9 8.1 3.8 4.5 5.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 33.8 1.3 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 52.0 0.0 0.6 0.0 63.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 4.9 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 10.8 0.2 4.1 0.1 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 1.6 1.4 1.1 0.2 1.0 1.0 1.5 0.9 ANPEP "CD13, gp150, LAP1, p150, PEPN" ENSG00000166825 "Alanyl aminopeptidase, membrane" P15144 15 89784889-89815401 "CD markers, Enzymes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 195.3;kidney: 78.7;pancreas: 93.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 77.0;BJ: 76.7;BJ hTERT+: 109.7;HMC-1: 69.8;HSkMC: 67.4;HUVEC TERT2: 85.8;TIME: 85.8;U-2197: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 5 "neutrophil: 59.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 59.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB002417, HPA004625" Enhanced Supported "Plasma membrane" 1500000000 "Plasma membrane" "CAB002417: AB_563491, HPA004625: " "unprognostic (6.31e-2)" "unprognostic (7.94e-3)" "unprognostic (6.91e-2)" "unprognostic (2.16e-1)" "unprognostic (2.50e-1)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (7.73e-2)" "unprognostic (5.28e-3)" "unprognostic (3.96e-1)" "unprognostic (4.04e-3)" "unprognostic (3.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.61e-3)" "unprognostic (1.99e-2)" 21.3 1.1 0.6 2.9 0.8 9.5 17.0 1.0 1.3 8.2 21.2 0.8 0.5 195.3 1.4 8.4 3.6 1.4 27.7 3.7 0.4 0.3 78.7 37.7 9.7 9.3 0.9 0.9 1.8 93.9 0.0 0.7 14.7 1.3 8.6 4.7 4.0 6.6 1.8 1.6 4.9 155.8 4.3 1.2 7.2 0.8 4.7 0.2 5.6 1.5 4.2 3.8 4.7 3.0 0.0 6.9 59.4 12.8 0.0 0.0 5.5 0.0 4.9 0.0 0.0 60.1 77.0 0.5 76.7 109.7 9.4 8.3 0.5 0.0 0.0 0.9 65.8 0.0 0.5 0.0 3.7 0.0 0.0 14.5 0.4 11.4 35.4 1.0 69.8 67.4 0.1 29.7 0.0 85.8 0.4 0.1 3.6 0.0 0.0 34.1 0.2 5.2 0.0 0.0 0.8 42.9 0.0 0.1 0.7 0.0 0.1 0.0 0.0 6.7 85.8 41.4 0.0 93.5 0.0 0.0 0.0 0.0 0.1 0.0 2.2 5.7 12.8 10.4 0.0 7.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 59.4 0.0 12.0 0.1 0.0 5.5 0.6 0.8 1.0 1.3 0.4 0.3 0.9 0.9 1.3 0.2 ANTXR1 "ATR, FLJ10601, FLJ21776, TEM8" ENSG00000169604 "Anthrax toxin receptor 1" Q9H6X2 2 69013178-69249327 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor Hypotrichosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 72.6;RH-30: 39.4;TIME: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054785 Uncertain Vesicles "Intracellular and membrane" 4100000 Vesicles "HPA054785: " "unprognostic (1.44e-1)" "prognostic unfavourable (5.76e-4)" "unprognostic (8.49e-2)" "unprognostic (4.77e-2)" "unprognostic (3.61e-1)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (4.15e-3)" "unprognostic (9.05e-3)" "unprognostic (1.15e-1)" "unprognostic (3.48e-3)" "unprognostic (2.26e-3)" "unprognostic (9.84e-2)" "prognostic unfavourable (1.22e-5)" "unprognostic (2.09e-2)" 27.5 25.8 10.0 10.1 14.9 0.1 21.1 11.0 9.6 33.4 14.2 23.6 8.5 4.9 35.7 13.5 14.0 20.7 51.5 18.8 17.0 10.1 6.1 3.1 20.1 4.4 19.4 6.5 45.5 3.1 30.5 10.4 32.3 23.6 21.7 8.8 37.2 13.8 23.0 12.4 17.9 8.9 30.4 21.4 11.7 7.4 6.6 16.7 2.6 17.5 10.4 6.7 29.1 24.5 0.0 0.1 0.1 0.0 0.2 0.4 0.0 6.8 8.6 7.6 4.8 35.4 17.3 0.1 11.2 23.0 12.0 9.6 0.0 0.6 0.0 6.6 29.7 6.5 5.3 6.7 11.3 0.0 4.3 1.8 19.2 2.2 15.7 1.5 1.0 28.1 2.7 11.8 7.4 3.3 1.1 0.0 72.6 3.1 4.2 0.1 7.2 5.6 0.0 39.4 0.1 2.9 6.0 4.3 19.4 21.9 0.1 7.7 2.2 0.4 49.3 15.2 12.8 15.3 11.9 0.0 0.0 0.0 7.9 1.3 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 10.0 14.9 11.0 9.0 17.0 10.1 19.4 6.5 23.6 16.7 AP001781.2 ENSG00000258529 11 111786286-111879425 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 5.9;HeLa: 4.6;U-698: 4.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA038575 Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA038575: AB_10672718" 2.2 0.2 1.7 2.8 2.2 2.9 2.5 0.4 2.7 0.4 3.6 1.9 1.0 2.9 2.0 2.1 0.9 0.9 2.0 0.9 3.0 1.2 0.7 2.6 4.1 1.3 1.1 1.5 1.2 1.7 0.4 0.4 2.2 1.2 2.5 1.5 2.8 0.2 1.2 4.1 0.6 1.3 2.2 3.6 2.1 5.6 1.5 5.7 1.3 0.7 3.7 0.2 0.0 1.6 2.0 1.3 1.6 1.7 3.6 2.9 0.3 0.1 1.3 1.3 0.0 1.7 0.4 1.8 0.1 0.3 0.0 5.9 0.0 0.2 0.8 0.0 2.3 0.0 0.0 1.3 0.5 0.0 3.4 4.6 0.4 0.0 0.0 0.8 2.4 2.2 1.7 3.3 0.0 0.3 2.1 0.0 0.0 1.3 2.6 0.5 0.0 0.0 0.0 1.7 1.0 1.9 0.0 0.0 1.6 0.0 0.0 1.1 1.3 0.2 2.4 0.7 1.2 0.0 1.7 1.3 4.4 0.7 3.1 0.4 1.0 1.0 1.3 3.3 1.6 2.2 1.4 2.6 2.1 1.6 1.6 3.6 1.5 0.1 1.7 1.3 2.0 0.9 2.9 AP5S1 "C20orf29, FLJ11168" ENSG00000125843 "Adaptor related protein complex 5 sigma 1 subunit" Q9NUS5 20 3820524-3828837 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034200, HPA043533, HPA048244" Uncertain Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB034200: AB_1564201, HPA043533: , HPA048244: " "unprognostic (1.07e-2)" "unprognostic (1.43e-1)" "unprognostic (8.52e-2)" "unprognostic (2.74e-2)" "unprognostic (1.34e-1)" "unprognostic (2.05e-2)" "unprognostic (5.49e-2)" "unprognostic (7.76e-2)" "unprognostic (1.33e-1)" "unprognostic (8.91e-2)" "unprognostic (5.15e-3)" "unprognostic (8.17e-2)" "prognostic favourable (5.53e-5)" "unprognostic (2.92e-1)" "unprognostic (1.62e-1)" "unprognostic (6.09e-3)" "unprognostic (5.08e-2)" 9.4 14.9 10.1 8.6 13.4 10.7 6.8 7.9 15.3 6.7 10.6 12.0 13.9 10.4 7.1 11.8 8.5 8.2 10.6 13.2 10.2 9.3 12.4 18.9 7.9 19.3 8.9 10.7 8.1 16.9 12.1 9.4 13.0 7.1 8.2 7.5 13.4 13.8 7.0 27.2 7.3 9.9 6.7 8.2 10.2 9.9 19.9 6.3 11.2 13.2 11.2 8.3 7.0 5.8 7.8 10.8 4.7 12.9 6.5 11.9 6.6 10.9 20.9 2.9 2.0 4.1 5.2 3.6 6.7 5.4 6.6 5.3 17.7 11.8 6.3 7.2 7.0 9.8 2.5 10.8 2.3 3.4 7.0 10.5 6.1 15.2 6.9 7.2 6.4 8.9 6.1 8.2 6.5 7.7 7.4 12.5 8.7 18.0 16.7 6.4 2.6 17.1 7.1 4.9 6.5 7.4 8.9 9.1 3.6 6.6 20.3 11.0 10.0 3.7 10.5 13.9 6.7 7.1 12.5 6.7 7.4 3.5 4.8 6.5 11.9 1.7 8.3 4.7 11.9 12.9 9.2 6.1 10.1 9.9 10.8 7.8 9.4 8.7 2.1 6.5 7.0 8.7 10.3 6.6 10.1 13.4 7.9 15.3 10.2 9.3 8.9 10.7 7.1 6.3 APCDD1L FLJ90166 ENSG00000198768 "APC down-regulated 1 like" Q8NCL9 20 58459101-58515131 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "salivary gland: 39.2;smooth muscle: 10.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 42.4;hTEC/SVTERT24-B: 15.0;HUVEC TERT2: 15.2;TIME: 29.8;U-87 MG: 18.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA067015 Uncertain Uncertain Mitochondria Mitochondria "HPA067015: " "unprognostic (2.61e-1)" "unprognostic (8.26e-3)" "unprognostic (4.63e-3)" "unprognostic (1.35e-5)" "unprognostic (4.09e-3)" "unprognostic (9.73e-3)" "unprognostic (1.31e-3)" "unprognostic (1.06e-4)" "unprognostic (7.63e-4)" "unprognostic (2.14e-2)" "unprognostic (7.62e-3)" "unprognostic (2.16e-1)" "unprognostic (6.55e-13)" "unprognostic (5.01e-3)" "unprognostic (3.21e-1)" "unprognostic (2.24e-2)" "unprognostic (1.81e-3)" 0.5 0.6 0.2 0.6 0.2 0.0 5.2 0.6 0.1 3.3 1.2 0.1 0.0 0.1 2.4 0.2 0.8 0.0 2.1 5.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.0 0.1 3.6 0.7 3.2 39.2 1.7 0.6 0.9 0.8 10.9 0.3 0.0 0.6 0.1 0.0 0.0 0.1 1.0 0.6 6.1 5.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 9.0 0.0 0.9 0.6 0.0 2.7 0.0 0.0 42.4 0.4 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 1.2 0.0 15.0 0.2 15.2 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.8 6.4 0.4 0.0 8.3 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 APLP1 APLP ENSG00000105290 "Amyloid beta precursor like protein 1" P51693 19 35867899-35879791 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Endocytosis" Heparin-binding Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 147.5" "Cell line enhanced" "Detected in many" "AF22: 24.8;AN3-CA: 46.0;EFO-21: 24.4;HMC-1: 23.8;SCLC-21H: 26.8;SH-SY5Y: 27.2" "Cancer enhanced" "Detected in many" "glioma: 63.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028970, HPA028971" Enhanced 3900000 "HPA028970: AB_2672847, HPA028971: AB_10601334" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (9.36e-3)" "prognostic unfavourable (3.87e-4)" "unprognostic (7.32e-3)" "unprognostic (1.26e-2)" "unprognostic (1.04e-3)" "unprognostic (2.24e-2)" "unprognostic (4.98e-2)" "unprognostic (6.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.57e-11)" "unprognostic (1.38e-3)" "unprognostic (7.12e-2)" "unprognostic (5.43e-2)" "prognostic unfavourable (2.65e-5)" 2.6 15.6 37.0 2.9 47.9 1.6 1.6 13.1 147.5 2.4 2.6 91.6 0.0 2.0 2.3 2.1 2.2 2.3 4.3 6.0 53.2 37.4 2.4 1.5 2.4 2.1 54.6 24.6 1.9 32.1 5.6 17.6 1.9 38.4 2.3 2.6 3.3 2.4 2.4 1.5 2.0 2.4 2.9 118.2 1.7 9.6 5.7 36.9 0.0 2.2 0.0 2.2 2.1 0.1 1.5 0.4 2.2 0.7 3.0 0.6 0.2 1.4 10.4 24.8 46.0 2.4 1.0 3.2 2.1 1.1 2.4 0.3 2.4 1.4 0.2 24.4 5.3 0.7 7.7 0.5 1.6 17.3 0.9 0.1 3.1 1.4 0.7 0.0 23.8 1.1 0.6 1.0 0.0 0.8 0.9 0.4 7.0 2.3 0.0 0.0 1.2 6.1 2.4 0.1 0.3 0.4 0.3 26.8 27.2 8.0 1.1 0.3 6.0 1.3 0.6 16.7 9.6 9.4 1.3 1.1 0.4 0.1 11.0 0.3 8.4 2.2 0.7 0.4 0.4 0.5 0.3 0.7 0.4 0.6 0.2 1.5 0.5 0.6 2.1 3.0 0.7 0.4 0.2 0.2 37.0 47.9 13.1 54.6 53.2 37.4 54.6 24.6 38.4 36.9 APLP2 "APPH, APPL2" ENSG00000084234 "Amyloid beta precursor like protein 2" Q06481 11 130069837-130144811 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 52.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039319 Approved Approved Vesicles 480000 Vesicles "HPA039319: AB_10673141" "unprognostic (2.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.06e-1)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.10e-2)" "prognostic unfavourable (3.37e-4)" "unprognostic (3.86e-2)" "unprognostic (2.33e-1)" "unprognostic (2.70e-2)" "unprognostic (3.12e-3)" "unprognostic (7.44e-2)" "prognostic favourable (1.33e-9)" "unprognostic (3.20e-3)" "unprognostic (4.95e-2)" "prognostic favourable (2.90e-4)" "unprognostic (4.42e-2)" 72.4 32.9 41.4 29.8 48.5 35.2 43.9 106.0 61.4 39.8 44.9 29.0 31.8 56.6 48.7 42.4 36.2 37.9 51.1 55.6 35.6 49.7 79.2 73.8 82.2 27.3 39.7 43.0 42.0 28.4 76.9 22.3 67.6 48.2 63.4 39.0 105.5 35.4 65.9 17.3 27.3 52.1 46.0 40.9 24.3 33.2 18.2 26.0 12.5 128.7 21.0 17.0 51.0 46.7 12.3 26.0 36.5 52.5 3.6 4.7 25.8 17.8 15.0 27.1 24.3 113.6 74.9 33.9 51.0 62.2 25.5 21.7 111.7 130.7 8.9 133.9 124.2 46.2 20.8 48.5 14.5 13.9 17.3 15.3 11.0 42.8 17.5 46.1 31.2 50.2 31.8 22.4 42.9 78.3 14.6 19.1 42.0 17.7 2.3 20.7 15.8 25.3 5.9 6.3 8.6 68.0 49.9 9.5 20.8 61.5 32.6 7.9 49.8 42.7 134.8 27.5 18.8 42.8 24.6 3.0 4.2 20.9 31.0 42.3 19.5 8.7 52.5 14.3 4.5 28.8 3.4 3.4 3.3 4.2 26.0 12.3 2.5 3.3 36.5 3.6 20.8 2.4 4.7 25.8 41.4 48.5 106.0 61.4 35.6 49.7 39.7 43.0 48.2 26.0 APMAP "BSCv, C20orf3" ENSG00000101474 "Adipocyte plasma membrane associated protein" Q9HDC9 20 24962925-24992979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.8;liver: 100.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 93.8;NK-cells: 43.2;T-cells: 53.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012863, HPA064700" Uncertain Approved "Plasma membrane" 80000000 "Plasma membrane" "HPA012863: AB_1845683, HPA064700: " "unprognostic (4.07e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (8.16e-2)" "unprognostic (6.79e-2)" "unprognostic (2.14e-2)" "unprognostic (1.10e-2)" "unprognostic (4.09e-2)" "unprognostic (3.10e-2)" "unprognostic (1.19e-2)" "unprognostic (6.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.99e-3)" "unprognostic (8.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.51e-2)" 43.5 13.0 14.8 12.4 16.1 44.5 23.1 47.3 22.7 11.7 12.3 15.7 17.9 8.9 14.8 31.8 7.5 13.0 13.4 10.2 18.2 20.9 12.9 100.5 14.4 15.9 15.4 17.2 12.3 12.2 18.9 20.2 28.3 17.0 12.5 12.4 11.6 10.6 18.7 9.8 14.0 9.3 13.8 13.7 16.9 10.2 19.9 15.4 10.6 57.9 5.7 9.2 13.0 10.6 5.2 13.9 93.8 13.9 43.2 53.4 40.1 23.0 40.0 20.6 30.8 40.0 21.9 20.9 30.1 33.0 29.1 30.2 23.6 40.9 9.5 35.2 36.2 42.5 18.8 35.0 34.2 12.7 14.7 10.5 14.4 47.9 31.5 20.6 25.4 29.6 49.6 34.1 24.5 41.4 12.4 43.0 28.2 34.6 14.1 23.2 12.9 36.4 11.8 68.3 19.9 31.0 21.1 33.7 13.0 31.0 53.7 33.3 19.0 17.3 36.2 35.0 31.4 29.6 44.8 24.5 27.1 10.6 18.4 31.3 33.2 7.4 13.9 26.1 53.4 13.4 33.0 5.1 15.1 38.8 13.9 5.2 11.9 30.9 93.8 43.2 9.0 6.8 9.9 40.1 14.8 16.1 47.3 22.7 18.2 20.9 15.4 17.2 17.0 15.4 APOC4-APOC2 ENSG00000224916 "APOC4-APOC2 readthrough (NMD candidate)" 19 44942238-44949565 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 267 "liver: 178.9" "Cell line enriched" "Detected in some" 5 "THP-1: 11.3" "Cancer enriched" "Detected in some" 17 "liver cancer: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055877 Supported "HPA055877: " "unprognostic (1.45e-1)" "unprognostic (4.00e-2)" "unprognostic (1.86e-1)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (1.42e-1)" "unprognostic (1.49e-2)" "unprognostic (2.07e-2)" "unprognostic (1.52e-1)" "unprognostic (4.73e-2)" "unprognostic (1.25e-1)" "unprognostic (1.85e-1)" "unprognostic (2.01e-4)" "unprognostic (2.28e-1)" "unprognostic (2.88e-1)" "unprognostic (5.95e-2)" "unprognostic (1.68e-2)" 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.2 0.1 178.9 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 1.5 2.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.7 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.3 0.2 0.6 0.1 0.1 0.1 APOL1 APOL ENSG00000100342 "Apolipoprotein L1" O14791 22 36253010-36267530 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 62.5;HDLM-2: 40.3;HHSteC: 30.8;RPTEC TERT1: 23.9;RT4: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA018885, CAB056156" Supported "Secreted to blood" 1637000000 19000000000 "CAB056156: , HPA018885: AB_1844953" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "unprognostic (8.98e-3)" "unprognostic (1.67e-1)" "unprognostic (8.28e-2)" "unprognostic (1.41e-2)" "prognostic unfavourable (5.35e-4)" "unprognostic (4.41e-2)" "unprognostic (1.58e-1)" "unprognostic (4.07e-3)" "unprognostic (5.15e-2)" "prognostic unfavourable (7.43e-6)" "unprognostic (1.93e-1)" "unprognostic (3.15e-2)" "unprognostic (5.05e-3)" "prognostic favourable (2.01e-5)" 22.4 7.1 2.5 16.5 3.2 0.7 11.8 1.7 2.6 16.6 13.0 1.8 11.6 9.1 19.9 15.6 15.9 11.5 25.8 11.5 3.5 2.4 22.8 66.4 23.8 9.9 3.6 2.0 21.6 7.8 1.3 6.5 39.3 4.7 26.4 7.8 13.0 9.5 24.1 6.5 3.1 22.9 17.9 4.6 23.1 17.5 6.1 2.4 9.6 21.9 10.0 9.7 25.9 46.3 2.0 3.3 12.7 7.1 17.2 10.9 4.9 5.1 1.1 0.0 0.1 12.0 11.6 3.5 0.5 2.2 3.4 9.7 0.1 8.4 1.7 62.5 5.8 1.2 0.0 4.8 0.9 40.3 0.0 1.4 0.8 9.8 30.8 0.6 5.1 2.0 0.4 9.8 0.2 6.7 6.0 21.4 0.6 0.0 1.9 0.4 0.1 0.0 3.3 0.5 0.7 23.9 37.0 0.5 0.0 2.5 1.4 0.5 0.1 1.8 6.1 7.3 3.2 0.7 0.3 1.6 0.9 0.3 4.1 2.9 1.1 9.8 4.6 3.9 10.9 5.2 8.7 2.0 6.7 9.0 3.3 1.2 4.0 5.4 12.7 17.2 7.1 0.4 4.1 4.9 2.5 3.2 1.7 2.6 3.5 2.4 3.6 2.0 4.7 2.4 APOL4 APOLIV ENSG00000100336 "Apolipoprotein L4" Q9BPW4 22 36189124-36204840 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 8.1;HDLM-2: 45.5;HSkMC: 7.4;K-562: 9.7;SCLC-21H: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 4.3;intermediate monocyte: 2.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;monocytes: 4.3" "HPA049797, HPA055435" Uncertain Supported Vesicles "Secreted to blood" Vesicles "HPA049797: , HPA055435: " "unprognostic (2.73e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.51e-1)" "unprognostic (5.31e-1)" "unprognostic (3.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.55e-1)" "unprognostic (1.91e-1)" "prognostic favourable (3.45e-4)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "prognostic unfavourable (2.00e-5)" "unprognostic (4.26e-2)" "unprognostic (3.69e-1)" "unprognostic (4.18e-2)" "prognostic favourable (2.40e-6)" 2.3 0.8 1.1 2.7 1.3 0.0 2.3 0.9 1.0 2.4 1.2 0.7 0.7 2.2 2.0 0.7 2.4 3.1 3.2 2.8 0.8 1.0 10.3 1.1 7.3 1.7 1.0 0.7 4.2 0.9 0.0 1.9 3.0 1.2 9.0 1.5 1.8 2.9 1.6 1.0 1.6 5.4 2.1 2.3 1.1 2.3 0.7 1.2 7.1 1.1 0.7 2.3 7.4 1.4 0.4 3.8 0.6 4.3 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.9 8.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 45.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.3 9.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 20.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 4.3 0.0 0.0 2.3 0.0 0.4 0.0 0.0 3.8 0.3 0.0 0.0 0.2 0.8 0.2 0.0 0.0 1.2 1.1 1.3 0.9 1.0 0.8 1.0 1.0 0.7 1.2 1.2 APOO "FAM121B, MGC4825, Mic23, MIC26, My025" ENSG00000184831 "Apolipoprotein O" Q9BUR5 X 23833353-23907934 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003187 Supported Approved Mitochondria,Cytosol "Secreted to blood" Mitochondria Cytosol "HPA003187: AB_1079375" "unprognostic (2.53e-2)" "prognostic favourable (3.77e-4)" "unprognostic (4.86e-2)" "unprognostic (6.38e-3)" "unprognostic (3.45e-1)" "unprognostic (2.42e-1)" "unprognostic (6.18e-2)" "unprognostic (2.95e-1)" "unprognostic (6.45e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.22e-1)" "prognostic favourable (2.56e-6)" "unprognostic (2.53e-2)" "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (5.88e-3)" 5.6 13.1 25.5 5.4 21.2 4.4 9.0 18.5 30.9 9.1 10.9 8.5 5.5 9.2 7.2 13.5 7.2 13.6 6.1 38.4 26.0 23.8 29.5 12.2 5.5 6.6 24.9 17.5 7.1 9.0 20.1 15.8 7.1 21.5 9.3 12.5 11.7 14.6 10.4 26.0 4.3 7.6 7.8 18.1 5.4 10.3 10.5 6.8 7.7 13.3 10.4 7.2 6.3 5.8 9.8 14.2 8.5 13.3 7.8 15.0 6.6 14.6 13.4 22.6 15.7 3.8 8.6 3.6 7.4 9.1 15.7 16.5 7.9 7.0 12.7 9.3 6.7 12.1 28.3 14.6 17.5 13.4 20.2 6.4 13.3 12.5 9.0 16.2 7.2 9.6 8.8 17.3 12.9 10.9 9.1 14.4 14.5 13.8 16.2 17.4 20.5 21.7 12.6 11.2 30.5 30.7 7.6 15.3 11.1 16.0 15.3 15.7 26.4 7.2 2.7 10.2 6.1 36.2 11.2 11.2 19.7 11.5 16.4 8.0 14.8 8.5 4.2 1.5 11.5 13.3 15.0 9.8 12.7 11.3 12.0 8.3 10.3 10.1 2.5 7.8 12.6 14.2 11.5 6.6 25.5 21.2 18.5 30.9 26.0 23.8 24.9 17.5 21.5 6.8 APP AD1 ENSG00000142192 "Amyloid beta precursor protein" P05067 21 25880550-26171128 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Alzheimer disease, Amyloidosis, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 24.0" "Lineage enriched" "Detected in many" 6 "dendritic cells: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000157, HPA001462" Enhanced Approved "Golgi apparatus,Vesicles" 15000000 "Golgi apparatus" Vesicles "CAB000157: AB_323833, HPA001462: AB_1078185" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (3.69e-3)" "unprognostic (2.54e-1)" "unprognostic (8.22e-2)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "unprognostic (4.28e-2)" "unprognostic (5.35e-2)" "prognostic favourable (2.79e-6)" "unprognostic (3.77e-2)" "unprognostic (2.46e-1)" "unprognostic (5.23e-2)" "unprognostic (2.08e-3)" 44.8 92.5 89.9 26.3 109.3 21.2 79.9 64.5 139.1 51.7 63.4 86.9 72.0 39.7 52.2 57.2 33.0 57.6 63.4 69.1 104.6 97.7 102.2 54.5 50.2 12.9 97.4 95.8 58.9 57.1 36.4 34.1 79.7 83.2 49.2 59.6 48.9 47.2 66.6 17.2 38.2 34.9 69.3 109.0 26.3 37.9 32.2 67.5 13.9 85.0 21.5 16.7 52.5 58.4 1.5 24.0 0.9 3.9 0.3 1.5 1.8 31.5 40.8 44.8 37.3 61.1 75.8 48.4 64.1 85.6 32.5 38.3 23.4 77.6 0.0 74.7 50.1 21.6 27.3 75.3 27.5 1.2 22.0 0.0 24.6 16.4 59.6 29.9 1.6 68.3 83.3 38.1 70.0 145.5 0.0 3.3 51.0 35.4 0.5 0.3 35.2 36.5 19.6 43.2 26.3 110.1 22.2 22.8 33.3 68.8 45.3 32.2 40.1 32.6 155.5 72.4 30.7 26.3 30.3 19.9 0.2 0.3 58.9 0.1 69.5 0.4 3.9 0.0 0.1 1.2 0.2 0.5 1.4 0.5 3.4 1.5 1.5 0.4 0.9 0.3 0.9 24.0 0.3 1.8 89.9 109.3 64.5 124.6 104.6 97.7 97.4 95.8 83.2 67.5 AQP6 AQP2L ENSG00000086159 "Aquaporin 6" Q13520 12 49967194-49977139 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "kidney: 40.1" "Cell line enhanced" "Detected in some" "A549: 2.5;SH-SY5Y: 2.6" "Cancer enriched" "Detected in many" 9 "renal cancer: 9.1" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 7 "cerebellum: 23.5" "Low region specificity" "Detected in all" HPA015278 Enhanced "HPA015278: AB_10600982" "unprognostic (1.23e-1)" "unprognostic (1.32e-2)" "unprognostic (9.53e-2)" "unprognostic (2.02e-2)" "unprognostic (6.46e-2)" "unprognostic (4.60e-3)" "unprognostic (3.45e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (1.71e-1)" "unprognostic (2.00e-1)" "unprognostic (1.74e-1)" "unprognostic (6.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.03e-2)" "unprognostic (1.77e-1)" 0.1 0.2 0.6 0.1 1.1 0.0 0.1 0.3 1.6 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.7 0.5 40.1 0.2 0.1 0.1 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.1 1.0 0.3 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.8 0.5 1.2 0.2 0.2 0.4 0.2 0.4 2.5 0.1 0.3 0.1 0.0 0.0 0.5 0.3 0.0 0.0 1.4 1.6 0.0 1.1 0.0 0.3 0.4 0.0 0.1 0.2 1.7 0.0 0.1 0.9 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.7 0.0 1.2 0.0 0.7 0.5 1.3 1.2 0.2 0.7 1.2 0.0 0.6 2.6 0.8 0.0 0.8 0.0 0.1 0.0 0.7 1.1 0.0 0.7 0.2 0.2 0.0 0.3 0.3 0.5 1.2 0.2 0.1 0.4 0.1 0.1 0.3 0.1 0.2 0.5 0.8 0.2 0.3 1.1 0.2 0.2 0.2 0.3 0.2 0.6 1.1 0.3 0.3 0.7 0.5 1.2 0.1 0.3 0.1 AQR "fSAP164, IBP160, KIAA0560" ENSG00000021776 "Aquarius intron-binding spliceosomal factor" O60306 15 34851782-34969839 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040624, HPA055647" Enhanced Nucleoplasm Nucleoplasm "HPA040624: , HPA055647: " "unprognostic (1.73e-1)" "unprognostic (3.71e-2)" "unprognostic (2.97e-1)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-2)" "unprognostic (2.65e-1)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "prognostic favourable (4.83e-4)" "unprognostic (2.97e-1)" "unprognostic (2.47e-1)" "unprognostic (3.84e-1)" "unprognostic (3.13e-2)" 15.5 15.8 8.0 14.0 12.4 9.7 16.1 11.2 14.3 16.6 11.2 11.8 8.7 9.2 18.5 11.8 18.3 12.3 8.7 9.9 8.4 7.5 14.4 11.2 10.7 12.6 8.7 6.9 15.5 13.6 16.8 13.2 15.3 13.2 12.0 11.8 12.4 15.1 11.3 8.7 14.2 13.0 14.3 8.3 16.8 12.9 15.8 9.2 27.9 14.8 8.5 16.5 15.7 14.9 5.9 5.5 7.1 5.1 4.5 6.5 2.9 5.0 13.0 8.7 9.1 11.8 11.0 4.5 6.2 7.9 8.2 7.4 5.9 3.1 4.1 4.0 10.4 8.0 14.5 8.8 9.2 5.8 5.9 13.2 11.5 5.4 6.7 10.7 6.2 8.5 5.9 6.5 6.9 7.0 9.3 4.1 8.1 3.4 6.1 7.1 8.6 5.4 8.4 14.9 4.1 8.3 8.9 9.5 7.4 10.1 9.6 2.2 6.8 8.3 9.1 6.2 3.4 4.2 5.4 5.0 6.1 8.3 7.7 9.3 6.2 7.1 4.7 2.7 6.5 5.1 5.7 4.0 5.7 6.2 3.8 5.9 5.8 6.4 2.3 4.5 3.0 5.5 4.6 2.9 8.0 12.4 11.2 13.4 8.4 7.5 8.7 6.9 13.2 9.2 AREG "AREGB, SDGF" ENSG00000109321 Amphiregulin P15514 4 74445134-74455009 "Cancer-related genes, Predicted membrane proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 83.5" "Cell line enhanced" "Detected in some" "CACO-2: 41.8;HBEC3-KT: 72.5;hTCEpi: 73.7;hTERT-HME1: 157.7;MCF7: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "basophil: 8.2;eosinophil: 11.6;NK-cell: 3.3" "Group enriched" "Detected in many" 9 "granulocytes: 11.6;NK-cells: 3.3" "Region enriched" "Detected in single" 4 "olfactory region: 1.5" "Low region specificity" "Detected in all" "HPA008720, CAB023519" Approved Approved Mitochondria Mitochondria "CAB023519: AB_2060673, HPA008720: AB_1844978" "unprognostic (1.44e-2)" "unprognostic (1.84e-3)" "unprognostic (3.36e-2)" "unprognostic (2.26e-1)" "unprognostic (3.54e-3)" "prognostic unfavourable (2.61e-5)" "unprognostic (1.02e-2)" "prognostic unfavourable (1.05e-5)" "unprognostic (2.90e-1)" "unprognostic (8.06e-2)" "prognostic unfavourable (8.32e-5)" "unprognostic (2.56e-2)" "unprognostic (2.49e-3)" "unprognostic (2.40e-2)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (6.83e-3)" 19.5 1.1 0.4 9.2 2.1 28.9 20.3 0.3 0.4 5.7 6.7 0.2 0.2 0.7 1.7 1.6 22.3 6.0 34.8 13.6 0.5 0.4 2.5 1.7 14.4 13.3 0.4 0.0 5.8 1.0 0.0 7.8 83.5 1.3 1.9 5.0 1.4 3.9 0.9 9.9 3.4 10.0 1.5 1.0 11.3 5.3 4.6 0.0 1.6 1.2 13.4 13.6 8.7 4.6 0.4 0.8 11.6 0.0 3.3 0.4 0.1 1.7 11.9 0.0 0.0 0.1 0.1 0.0 0.3 0.5 0.0 0.3 41.8 6.7 0.0 0.9 0.0 1.9 0.0 72.5 0.7 0.0 0.0 0.0 0.3 1.9 22.5 0.2 0.0 0.6 73.7 4.3 157.7 0.0 0.1 0.0 1.6 45.5 0.0 0.0 0.0 4.8 0.0 0.0 0.0 4.1 0.3 0.0 0.0 2.4 0.1 0.0 1.3 0.0 0.1 0.0 1.7 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.2 0.0 11.6 0.0 0.0 0.0 0.3 0.4 0.0 0.8 0.4 0.2 0.0 0.1 3.3 0.0 0.1 0.0 0.1 0.4 2.1 0.3 0.4 0.5 0.4 0.4 0.0 1.3 0.0 AREL1 "FIEL1, KIAA0317" ENSG00000119682 "Apoptosis resistant E3 ubiquitin protein ligase 1" O15033 14 74653437-74713115 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051306 Uncertain "HPA051306: " "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "unprognostic (1.76e-1)" "unprognostic (1.92e-3)" "unprognostic (1.29e-1)" "unprognostic (2.49e-2)" "unprognostic (1.58e-3)" "unprognostic (9.32e-2)" "unprognostic (1.09e-1)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (2.12e-1)" "prognostic favourable (4.67e-6)" "unprognostic (6.73e-2)" "unprognostic (3.14e-1)" "unprognostic (1.52e-1)" "unprognostic (7.18e-2)" 8.5 13.7 11.8 12.2 22.2 17.6 8.8 14.4 25.7 9.3 11.9 16.5 9.8 13.8 12.8 11.4 14.5 12.6 8.4 12.3 11.3 9.7 17.5 9.8 12.1 12.0 8.6 8.4 11.9 15.7 19.4 9.5 11.9 13.3 10.0 15.0 18.3 14.9 9.8 17.9 10.7 16.0 10.1 11.1 12.3 12.0 20.0 7.2 17.1 18.6 11.2 14.9 11.2 10.8 3.2 7.0 9.7 7.6 4.6 7.3 4.5 12.1 15.3 15.2 15.4 13.3 9.6 13.1 13.0 15.3 16.6 16.0 12.8 14.8 10.4 7.0 18.5 15.8 17.5 14.1 21.8 18.6 8.6 16.0 10.2 8.0 8.7 11.3 15.9 12.3 10.3 12.0 13.0 15.6 12.3 11.7 21.3 15.2 11.9 4.9 10.2 15.9 12.7 17.6 6.5 12.7 27.9 16.6 21.8 11.9 15.9 8.4 13.8 12.0 21.8 16.2 19.1 9.6 15.9 14.1 20.7 21.4 19.2 8.6 12.2 2.1 4.8 9.7 7.3 7.6 5.4 3.2 4.2 6.0 7.0 2.1 4.6 3.8 9.7 4.6 4.1 2.3 3.8 4.5 11.8 22.2 14.4 25.7 11.3 9.7 8.6 8.4 13.3 7.2 ARHGAP1 "CDC42GAP, p50rhoGAP, RhoGAP" ENSG00000175220 "Rho GTPase activating protein 1" Q07960 11 46677080-46700615 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004689, HPA008285" Approved Approved Supported Vesicles 16000000 Vesicles "HPA004689: AB_1078194, HPA008285: AB_1078195" "unprognostic (1.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.05e-3)" "unprognostic (5.19e-2)" "unprognostic (2.48e-2)" "unprognostic (9.07e-2)" "prognostic unfavourable (2.14e-4)" "unprognostic (1.34e-3)" "unprognostic (1.24e-1)" "unprognostic (7.96e-2)" "unprognostic (1.35e-2)" "unprognostic (4.94e-1)" "unprognostic (4.79e-2)" "unprognostic (4.13e-2)" "unprognostic (3.49e-2)" "unprognostic (2.55e-1)" "unprognostic (9.24e-2)" 39.9 23.0 17.5 21.3 24.0 17.5 25.8 9.5 30.1 35.6 23.9 42.9 13.1 15.2 43.0 23.9 36.8 31.0 40.2 63.3 23.0 14.8 19.8 19.4 17.9 22.0 17.5 17.7 32.6 17.0 18.6 16.7 32.0 17.1 36.3 20.0 33.8 21.6 39.3 15.1 26.9 19.5 58.5 18.1 29.0 21.4 21.4 24.1 21.0 20.0 16.2 27.2 59.5 27.1 7.9 17.1 18.8 33.4 11.6 14.3 10.3 7.0 17.7 8.9 12.6 44.6 32.9 10.6 15.6 16.0 14.5 13.3 10.6 9.4 10.3 8.6 32.0 17.7 7.0 23.9 10.9 7.1 7.7 11.3 9.1 12.5 14.7 9.6 17.0 43.4 15.0 11.1 13.9 12.4 7.3 9.7 17.6 25.6 6.4 9.5 23.0 9.3 7.7 12.8 15.2 13.7 26.7 3.2 10.2 14.4 22.4 6.0 28.2 11.0 15.4 26.8 8.4 31.6 15.7 10.3 11.3 7.7 25.1 16.2 12.5 12.0 16.3 15.6 14.3 28.2 10.2 7.7 11.3 12.1 16.1 7.9 9.9 11.2 18.8 11.6 33.4 17.1 13.4 10.3 17.5 24.0 9.5 30.1 23.0 14.8 17.5 17.7 17.1 24.1 ARHGAP26 "GRAF, KIAA0621, OPHN1L, OPHN1L1" ENSG00000145819 "Rho GTPase activating protein 26" Q9UNA1 5 142770377-143229011 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "neutrophil: 19.6;NK-cell: 5.8" "Group enriched" "Detected in many" 4 "granulocytes: 19.6;NK-cells: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035106, HPA035107" Enhanced Approved Cytosol Cytosol "HPA035106: , HPA035107: AB_10669855" "prognostic favourable (2.05e-4)" "prognostic favourable (1.36e-4)" "prognostic favourable (6.95e-4)" "prognostic favourable (5.93e-6)" "unprognostic (1.19e-1)" "unprognostic (1.93e-2)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.22e-1)" "unprognostic (9.43e-3)" "unprognostic (7.19e-3)" "unprognostic (8.65e-2)" "unprognostic (3.21e-3)" "unprognostic (5.67e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-2)" "prognostic favourable (2.88e-6)" 13.3 5.7 18.4 18.6 22.7 33.9 13.0 29.2 23.9 15.9 14.2 7.5 9.9 13.2 9.4 10.9 7.6 18.5 16.4 17.0 12.8 10.5 8.0 7.7 20.0 8.8 12.9 15.4 4.8 5.5 4.8 15.1 22.4 11.9 8.5 14.8 8.8 14.6 11.2 14.0 8.5 12.6 11.1 12.6 18.9 17.0 16.1 12.2 10.3 10.0 5.4 13.6 9.4 10.6 0.3 2.0 19.6 2.8 5.8 3.0 1.0 6.8 13.7 3.8 3.5 5.7 6.3 5.9 0.8 1.1 3.3 5.8 18.8 15.5 0.9 6.8 2.2 3.3 1.9 6.4 4.1 14.1 2.2 0.0 1.7 11.9 3.6 10.1 1.3 2.3 11.4 6.1 14.1 4.9 0.2 39.0 1.0 1.0 5.7 4.2 1.8 3.5 2.2 5.7 16.3 9.7 10.5 1.5 2.4 1.7 1.9 3.2 1.0 3.1 9.4 1.8 2.6 0.2 3.6 1.7 5.5 0.2 4.7 9.5 2.5 2.9 2.8 1.6 3.0 1.7 1.3 0.2 0.6 1.8 2.0 0.3 0.2 0.8 19.6 5.8 1.0 0.5 0.2 1.0 18.4 22.7 29.2 23.9 12.8 10.5 12.9 15.4 11.9 12.2 ARHGAP42 "AD031, FLJ32810, GRAF3, TMEM133" ENSG00000165895 "Rho GTPase activating protein 42" "A6NI28, Q9H2Q1" 11 100687653-100993941 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 38.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 22.8;RH-30: 15.8;RT4: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039924, HPA060528" Uncertain Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA039924: AB_10674428, HPA060528: " "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.21e-3)" "unprognostic (2.74e-1)" "unprognostic (1.50e-2)" "unprognostic (4.17e-2)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.30e-2)" "unprognostic (2.36e-1)" "prognostic unfavourable (9.29e-4)" "unprognostic (1.32e-1)" "unprognostic (1.75e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" 11.1 4.9 6.8 8.9 5.8 0.9 10.4 3.0 7.0 9.8 8.3 4.1 2.3 9.9 11.4 7.7 4.3 5.6 9.5 6.5 8.8 3.8 11.9 12.7 13.7 5.1 6.3 5.3 4.8 2.6 9.1 6.0 38.0 5.9 4.8 8.4 25.5 5.1 3.8 9.0 7.2 12.1 5.8 8.7 8.2 11.7 4.1 6.7 12.7 10.9 7.4 3.8 5.5 7.9 1.5 2.5 0.0 0.0 0.7 0.4 0.3 0.5 3.5 4.6 0.1 2.5 3.4 3.1 0.5 0.9 1.1 2.1 4.4 22.8 0.7 6.4 1.7 7.7 2.3 1.7 1.1 0.0 1.9 11.0 8.9 1.4 4.5 0.1 0.0 3.3 2.1 4.2 0.7 1.7 0.4 0.0 3.4 0.6 1.2 0.0 5.5 5.6 3.4 15.8 0.4 5.3 14.8 2.5 1.6 7.6 0.2 6.0 0.8 1.4 3.0 3.0 3.7 3.5 1.7 3.3 0.0 4.4 3.5 2.7 12.9 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.3 6.8 5.8 3.0 7.0 8.8 3.8 6.3 5.3 5.9 6.7 ARL10 ARL10A ENSG00000175414 "ADP ribosylation factor like GTPase 10" Q8N8L6 5 176365468-176401865 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047044 Approved "HPA047044: AB_2679915" "unprognostic (2.50e-2)" "unprognostic (4.77e-2)" "unprognostic (6.90e-2)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" "unprognostic (2.63e-1)" "unprognostic (3.00e-3)" "unprognostic (1.37e-1)" "unprognostic (6.31e-2)" "unprognostic (6.00e-3)" "unprognostic (2.78e-1)" "unprognostic (9.29e-2)" "unprognostic (5.92e-3)" "unprognostic (7.96e-2)" "unprognostic (2.69e-1)" "unprognostic (1.68e-2)" "unprognostic (4.33e-2)" 5.0 3.4 11.1 4.4 11.7 7.0 5.5 11.0 15.6 7.6 7.6 10.1 3.3 2.6 8.0 5.9 8.5 4.6 7.0 6.4 8.7 7.7 3.6 1.9 3.5 5.5 9.2 10.9 11.8 3.9 5.7 9.0 5.9 6.7 5.9 2.9 4.3 3.3 6.2 9.8 25.7 4.8 8.2 10.8 5.1 3.8 3.3 7.9 4.3 4.0 3.1 4.5 6.1 7.6 2.5 0.9 1.4 0.4 1.2 2.0 0.3 0.4 0.1 11.9 5.6 6.4 7.9 0.6 3.1 1.5 4.8 5.1 0.3 0.4 1.1 0.6 6.1 7.8 0.1 0.9 7.2 0.1 4.8 1.0 9.6 1.2 3.9 0.2 1.5 4.6 0.5 6.2 0.0 7.9 0.4 1.2 6.3 7.2 1.3 0.3 2.2 1.3 3.4 2.9 0.0 3.0 4.1 11.0 11.4 2.8 1.7 2.3 0.4 0.9 5.9 4.5 3.7 3.3 0.6 0.4 0.8 0.4 3.7 0.2 1.5 0.7 0.3 0.4 1.4 0.3 1.3 2.5 1.1 2.0 0.3 2.3 0.8 1.5 1.4 1.2 0.4 0.9 1.3 0.3 11.1 11.7 11.0 15.6 8.7 7.7 9.2 10.9 6.7 7.9 ARL6IP5 "DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b" ENSG00000144746 "ADP ribosylation factor like GTPase 6 interacting protein 5" O75915 3 69084944-69106066 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015540, CAB019321" Supported Approved "Endoplasmic reticulum" 19000000 "Endoplasmic reticulum" "CAB019321: , HPA015540: AB_1852061" "unprognostic (8.01e-2)" "unprognostic (1.71e-1)" "unprognostic (8.09e-2)" "unprognostic (1.51e-3)" "unprognostic (2.65e-1)" "unprognostic (3.51e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (3.06e-1)" "unprognostic (3.72e-3)" "unprognostic (1.31e-2)" "unprognostic (7.23e-2)" "unprognostic (2.05e-3)" "unprognostic (3.60e-1)" "unprognostic (4.44e-2)" "unprognostic (3.42e-2)" "unprognostic (1.31e-2)" 53.2 53.2 44.0 37.4 48.5 21.3 51.5 32.9 62.1 48.1 31.9 41.5 16.8 21.1 33.8 40.0 38.5 34.5 37.3 76.0 42.9 51.0 43.3 28.4 44.9 43.7 53.1 30.7 28.9 23.3 18.3 36.3 50.6 81.7 49.2 31.8 32.1 54.9 35.6 69.3 18.5 30.3 37.0 51.6 40.7 27.9 21.4 46.1 32.5 39.9 32.7 45.2 46.9 30.2 57.3 40.4 91.5 57.5 41.4 74.8 114.8 15.1 10.5 12.9 9.5 67.7 63.4 16.4 15.7 35.5 12.2 14.3 5.3 37.0 3.0 5.3 26.9 12.0 10.6 18.0 10.5 59.2 10.0 10.4 17.9 8.0 17.4 8.9 51.6 45.6 32.6 11.2 14.3 37.2 4.5 28.4 29.6 8.7 9.6 11.6 3.3 9.9 8.5 11.9 27.7 60.1 25.5 3.2 8.6 15.5 16.9 20.4 11.2 14.2 36.3 8.1 6.5 20.5 16.9 25.5 35.7 5.5 26.9 22.2 13.1 81.4 57.5 91.5 52.3 51.4 40.1 57.3 73.9 66.5 40.4 43.9 63.1 66.2 24.0 41.4 43.0 25.6 74.8 114.8 44.0 48.5 32.9 62.1 42.9 51.0 53.1 30.7 81.7 46.1 ARMC10 "MGC3195, SVH" ENSG00000170632 "Armadillo repeat containing 10" Q8N2F6 7 103074881-103099764 "Predicted intracellular proteins, Predicted membrane proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011036, HPA011057" Enhanced Enhanced Mitochondria Mitochondria "HPA011036: AB_1080139, HPA011057: AB_1080137" "unprognostic (7.03e-3)" "unprognostic (2.44e-1)" "unprognostic (8.18e-2)" "unprognostic (3.53e-1)" "prognostic unfavourable (8.90e-6)" "unprognostic (3.85e-3)" "prognostic unfavourable (3.58e-4)" "unprognostic (5.57e-2)" "unprognostic (3.49e-2)" "unprognostic (7.90e-2)" "prognostic unfavourable (2.49e-6)" "unprognostic (1.02e-1)" "unprognostic (5.78e-2)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" "unprognostic (1.14e-2)" "unprognostic (5.67e-2)" 21.6 21.7 28.0 12.6 25.0 9.1 24.5 11.4 28.0 24.4 18.6 24.7 20.8 14.0 20.4 24.2 22.2 23.2 20.0 16.7 26.2 26.2 27.4 30.2 15.0 15.7 26.3 24.2 26.5 28.7 26.0 12.0 15.4 19.7 22.2 18.8 17.6 15.7 23.4 15.8 21.6 12.8 20.3 25.5 14.4 19.8 14.1 19.6 21.5 30.7 15.6 15.7 22.3 20.5 5.1 6.8 6.6 5.4 3.9 4.7 2.2 12.5 10.7 6.4 12.3 13.3 12.7 6.4 8.8 9.6 6.4 7.8 5.8 14.9 22.6 19.1 7.7 11.3 8.9 9.8 9.1 8.4 10.2 8.0 4.6 2.7 13.4 21.8 9.6 8.2 17.4 8.0 13.2 14.5 19.4 14.0 11.3 23.2 16.0 16.9 14.2 11.6 9.7 6.6 29.3 16.1 8.8 7.2 9.8 12.0 18.2 13.3 7.3 10.9 9.6 9.9 9.5 23.2 13.2 21.5 33.7 18.2 11.2 20.4 12.4 0.0 4.4 6.6 2.6 5.4 4.5 4.0 4.1 4.4 6.8 5.1 4.6 4.7 0.9 3.9 2.8 5.3 4.2 2.2 28.0 25.0 11.4 28.0 26.2 26.2 26.3 24.2 19.7 19.6 ARMCX1 "ALEX1, GASP7" ENSG00000126947 "Armadillo repeat containing, X-linked 1" Q9P291 X 101550531-101554700 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 26.4;ASC TERT1: 23.8;BJ hTERT+ SV40 Large T+ RasG12V: 27.3;LHCN-M2: 24.0;RH-30: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 9.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005685, CAB020695" Supported Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "CAB020695: , HPA005685: AB_10600781" "unprognostic (2.31e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (2.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.25e-2)" "unprognostic (2.39e-1)" "unprognostic (2.18e-3)" "unprognostic (2.13e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "prognostic favourable (7.32e-5)" "unprognostic (1.02e-1)" "unprognostic (2.85e-2)" "unprognostic (2.20e-3)" "unprognostic (8.77e-2)" "unprognostic (2.12e-2)" "unprognostic (1.09e-2)" 17.5 29.8 13.6 7.4 16.5 2.7 18.9 13.4 21.5 24.4 18.7 9.6 15.9 6.2 27.3 19.0 12.3 16.3 14.8 26.6 13.3 18.4 12.1 3.8 11.6 4.4 13.7 14.6 42.6 10.2 20.1 18.0 12.5 16.4 25.8 7.0 13.0 12.0 21.1 22.7 8.1 7.6 26.3 9.1 11.4 10.0 8.1 10.5 3.5 14.0 11.6 3.3 26.8 29.7 0.2 9.9 0.5 4.3 2.1 3.7 2.1 0.7 0.2 5.5 0.0 26.4 23.8 0.0 8.6 16.9 10.8 27.3 0.0 0.1 0.0 7.4 13.2 0.7 0.0 1.2 6.1 0.0 0.0 4.9 1.6 0.0 14.0 0.0 0.0 19.9 1.6 8.2 0.0 6.5 0.1 0.1 24.0 0.3 0.0 0.0 7.9 0.0 0.0 30.3 0.0 7.4 0.0 5.4 4.5 0.0 0.1 14.8 0.8 3.6 8.6 6.6 3.5 19.1 0.1 0.0 0.1 0.0 6.4 0.0 4.1 0.0 4.3 0.5 0.0 3.9 0.7 0.0 0.6 0.3 9.9 0.2 1.5 3.7 0.1 2.1 1.1 5.1 0.9 2.1 13.6 16.5 13.4 19.9 13.3 18.4 13.7 14.6 16.4 10.5 ARMCX2 "ALEX2, GASP9, KIAA0512" ENSG00000184867 "Armadillo repeat containing, X-linked 2" Q7L311 X 101655281-101659891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 92.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 48.4;NTERA-2: 34.8;RH-30: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005761 Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA005761: AB_10600782" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (4.25e-2)" "unprognostic (1.48e-1)" "unprognostic (9.59e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (3.41e-2)" "prognostic favourable (3.45e-5)" "unprognostic (9.06e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (2.69e-4)" "unprognostic (1.12e-1)" "unprognostic (6.73e-2)" "unprognostic (1.25e-1)" 7.7 21.5 12.5 6.7 19.9 1.0 14.2 17.6 17.5 17.1 11.4 8.2 38.8 3.7 18.4 92.7 6.2 16.7 12.5 18.8 13.2 17.1 13.3 2.6 8.3 4.9 11.8 13.3 28.8 9.8 34.1 38.9 15.4 12.4 17.6 5.3 9.7 23.6 41.8 3.8 3.2 6.2 19.3 9.0 10.9 8.3 6.3 10.7 1.4 35.1 3.6 4.3 13.9 18.9 7.6 1.6 0.0 1.4 4.3 4.4 1.9 0.0 0.0 15.0 0.1 13.4 12.2 0.1 16.4 20.6 0.4 0.4 0.0 6.3 0.0 0.0 21.5 0.4 0.0 0.3 0.1 0.0 0.5 0.0 17.6 0.0 14.1 0.1 0.0 19.2 5.2 12.8 0.1 17.4 0.0 0.1 48.4 0.0 0.0 0.2 34.8 0.1 4.1 26.7 0.0 0.8 0.0 6.0 11.1 0.0 0.0 0.4 7.6 0.0 3.8 18.5 19.7 11.5 0.1 0.0 0.0 0.0 16.9 0.0 0.3 0.0 0.7 0.0 1.6 1.4 0.7 5.1 1.5 1.5 1.1 7.6 4.2 4.4 0.0 4.3 0.9 1.6 0.9 1.9 12.5 19.9 17.6 17.5 13.2 17.1 11.8 13.3 12.4 10.7 ARMCX3 "ALEX3, GASP6" ENSG00000102401 "Armadillo repeat containing, X-linked 3" Q9UH62 X 101622797-101627843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000325, HPA000967, HPA001530" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: " "unprognostic (1.67e-1)" "unprognostic (2.14e-1)" "unprognostic (5.23e-2)" "unprognostic (8.69e-3)" "unprognostic (1.73e-2)" "unprognostic (1.47e-2)" "unprognostic (9.72e-3)" "unprognostic (2.19e-2)" "unprognostic (4.77e-2)" "unprognostic (6.80e-2)" "unprognostic (3.38e-3)" "unprognostic (2.12e-2)" "prognostic favourable (1.55e-5)" "unprognostic (3.29e-2)" "unprognostic (3.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.55e-2)" 21.0 39.2 26.6 14.8 32.9 8.5 20.5 20.5 36.9 30.6 18.8 21.0 37.1 13.3 26.9 67.8 12.7 17.1 22.0 31.7 28.0 26.6 24.0 17.8 19.1 12.7 27.8 29.6 26.7 38.2 62.0 37.9 28.5 35.4 29.1 14.8 13.6 34.8 31.6 25.5 7.9 13.8 24.6 25.7 24.1 19.0 9.2 22.8 8.2 31.9 17.1 13.7 21.4 21.3 11.6 18.8 25.2 11.8 10.2 14.8 9.4 8.7 6.0 16.2 9.0 37.5 41.8 3.6 19.3 18.7 8.5 24.7 7.1 8.2 3.4 11.1 22.5 1.7 12.2 7.1 10.4 6.7 7.7 6.2 20.2 10.1 29.7 6.0 14.9 23.1 9.5 10.2 11.0 16.1 4.8 30.0 23.1 3.9 5.0 0.2 8.3 1.3 6.4 21.2 3.0 11.9 3.6 7.6 6.4 9.3 0.6 20.0 7.1 6.2 22.5 11.3 7.4 25.5 3.7 24.3 6.5 0.0 17.2 4.9 9.5 25.2 11.2 9.5 10.9 11.3 14.8 11.6 10.8 9.5 11.3 7.9 12.2 8.5 4.1 10.2 11.8 18.8 6.6 9.4 26.6 32.9 20.5 36.9 28.0 26.6 27.8 29.6 35.4 22.8 ARMCX6 "FLJ20811, GASP10" ENSG00000198960 "Armadillo repeat containing, X-linked 6" Q7L4S7 X 101615118-101618001 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043030, HPA048125" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" Cytosol "Nucleoplasm, Nuclear membrane" "HPA043030: , HPA048125: " "unprognostic (1.20e-1)" "unprognostic (2.80e-1)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.80e-2)" "unprognostic (1.73e-3)" "unprognostic (1.92e-3)" "unprognostic (4.13e-2)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (3.31e-1)" "unprognostic (3.74e-1)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (7.82e-3)" "unprognostic (2.38e-2)" 15.1 17.2 11.7 12.1 12.1 7.6 12.7 10.9 12.1 18.7 12.0 15.4 22.6 6.7 17.3 25.9 17.3 14.1 12.4 15.6 11.3 12.6 14.1 12.2 11.2 12.1 13.1 10.3 21.3 27.2 23.4 21.0 16.3 13.1 17.7 9.0 11.8 39.2 23.5 6.5 11.3 10.4 17.1 16.7 22.6 10.6 9.0 11.4 17.9 17.3 9.7 19.3 18.8 13.7 12.8 14.1 10.0 7.0 8.1 8.7 6.4 6.6 7.8 12.3 7.0 25.2 15.0 2.4 13.9 13.6 12.5 24.5 4.7 6.4 7.1 14.3 13.0 6.9 11.9 5.6 9.8 6.1 7.3 6.6 10.9 6.2 11.6 6.4 8.4 9.3 5.8 7.7 4.0 12.7 5.4 9.1 18.7 16.3 9.4 0.0 8.8 1.6 9.7 16.5 2.6 9.0 0.9 6.8 6.4 8.2 0.0 10.4 5.7 3.1 9.8 15.3 6.9 21.2 3.2 11.3 6.0 0.0 4.5 1.7 5.0 10.0 3.8 6.3 6.5 7.0 8.7 12.8 7.0 7.3 8.1 9.1 8.4 7.8 0.5 8.1 5.0 14.1 3.9 6.4 11.7 12.1 10.9 12.1 11.3 12.6 13.1 10.3 13.1 11.4 ARSD ENSG00000006756 "Arylsulfatase D" P51689 X 2903970-2929351 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.7;EFO-21: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA004694, HPA063835" Approved Approved "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "HPA004694: AB_1078221, HPA063835: " "unprognostic (3.92e-1)" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "prognostic favourable (5.21e-4)" "unprognostic (5.90e-3)" "unprognostic (6.32e-3)" "unprognostic (1.73e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (4.09e-3)" "unprognostic (7.18e-2)" "unprognostic (3.93e-1)" "prognostic favourable (1.97e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (4.99e-2)" "unprognostic (2.11e-3)" 8.1 5.6 3.7 10.1 3.5 2.3 14.2 3.2 5.0 14.7 15.4 5.8 27.4 11.9 8.9 19.2 9.3 16.6 16.8 8.7 5.7 3.6 34.1 23.8 13.1 11.3 3.1 3.3 13.0 48.1 8.5 3.9 16.2 8.7 11.5 8.5 7.8 15.8 30.9 1.6 5.9 22.3 12.0 4.5 5.7 19.5 5.2 3.3 1.8 12.9 5.6 7.1 12.4 6.9 2.1 6.3 5.7 8.5 3.0 2.6 3.2 4.5 8.1 2.2 10.5 9.5 5.5 0.1 2.6 4.8 1.2 0.8 0.5 15.7 0.0 16.9 5.3 0.0 0.4 1.3 1.1 0.1 0.0 0.0 0.0 2.6 5.2 0.0 6.3 8.6 4.3 2.3 2.5 7.8 0.0 0.0 5.2 11.0 0.0 1.1 1.8 3.4 1.9 0.0 0.1 8.4 0.1 0.0 5.9 3.6 4.3 2.7 11.6 8.7 7.1 0.0 0.3 0.8 1.2 0.1 0.0 0.0 7.7 5.5 5.9 2.1 8.5 5.7 2.6 7.1 1.0 2.1 1.3 2.0 6.3 1.4 0.3 1.5 1.5 3.0 2.7 4.4 0.4 3.2 3.7 3.5 3.2 5.0 5.7 3.6 3.1 3.3 8.7 3.3 ART1 "ART2, CD296" ENSG00000129744 "ADP-ribosyltransferase 1" P52961 11 3645128-3664416 "CD markers, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 20 "skeletal muscle: 50.9;tongue: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051148 Uncertain "HPA051148: " "unprognostic (3.73e-1)" "unprognostic (4.58e-2)" "unprognostic (3.12e-2)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (1.19e-1)" "unprognostic (1.06e-1)" "unprognostic (1.73e-1)" 1.5 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.2 0.1 50.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 13.7 0.5 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.2 0.4 0.0 ART3 ENSG00000156219 "ADP-ribosyltransferase 3" Q13508 4 76011184-76112802 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "brain: 29.1;heart muscle: 55.1;skeletal muscle: 85.2;testis: 42.6;tongue: 27.2" "Group enriched" "Detected in some" 8 "NB-4: 6.1;NTERA-2: 16.5;SK-MEL-30: 7.3" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Region enhanced" "Detected in many" "cerebellum: 29.1" "Cell type enriched" "Detected in single" 5 "gdT-cell: 1.9" "Lineage enriched" "Detected in single" 18 "T-cells: 1.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 5 "cerebellum: 1.2" HPA011268 Enhanced "Intracellular and membrane" 45000000 "HPA011268: AB_1845059" "unprognostic (2.45e-1)" "unprognostic (2.84e-2)" "unprognostic (3.12e-2)" "unprognostic (2.77e-3)" "unprognostic (4.53e-2)" "unprognostic (1.34e-1)" "unprognostic (3.34e-1)" "unprognostic (9.85e-4)" "unprognostic (2.35e-1)" "unprognostic (5.10e-2)" "unprognostic (1.64e-2)" "unprognostic (2.95e-1)" "unprognostic (1.73e-2)" "unprognostic (2.53e-1)" "unprognostic (1.48e-1)" "unprognostic (2.58e-2)" "unprognostic (6.61e-3)" 3.5 0.6 4.9 0.9 1.9 0.4 0.7 29.1 9.0 1.0 1.3 6.0 0.0 0.6 0.5 1.1 2.5 0.5 0.5 55.1 3.0 0.9 0.5 0.5 0.6 0.5 3.9 2.0 0.5 3.8 0.4 1.1 0.5 2.7 1.0 1.4 0.4 1.3 1.0 85.2 0.5 0.8 0.6 3.0 1.5 0.9 42.6 7.2 0.0 0.5 27.2 0.5 0.6 0.7 0.0 0.0 0.1 0.0 0.0 1.9 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.1 16.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.9 1.9 29.1 9.0 3.0 0.9 3.9 2.0 2.7 7.2 ART4 "CD297, DO, DOK1" ENSG00000111339 "ADP-ribosyltransferase 4 (Dombrock blood group)" Q93070 12 14825569-14843533 "Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8" "Cell line enhanced" "Detected in some" "AN3-CA: 5.1;HEL: 10.0;Hep G2: 6.0;HUVEC TERT2: 22.9" "Cancer enhanced" "Detected in some" "liver cancer: 3.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in single" "olfactory region: 2.2" "Low region specificity" "Detected in many" HPA075664 Approved "Rods & Rings" "Secreted to blood" 11000000 "Rods & Rings" "HPA075664: " "unprognostic (2.50e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-1)" "unprognostic (1.18e-2)" "unprognostic (1.55e-1)" "unprognostic (1.37e-2)" "unprognostic (1.92e-1)" "unprognostic (1.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-1)" "unprognostic (1.37e-1)" "unprognostic (1.90e-2)" "unprognostic (2.62e-3)" "unprognostic (4.33e-3)" "unprognostic (1.25e-3)" "unprognostic (1.05e-1)" "unprognostic (1.71e-1)" 2.7 2.0 0.2 1.7 0.2 2.4 2.1 0.2 0.2 1.4 1.3 0.1 1.9 0.0 1.1 3.7 3.1 1.9 6.1 10.1 0.2 0.2 6.6 33.7 2.1 17.0 0.2 0.0 1.3 1.9 0.0 0.4 17.8 0.3 0.8 0.2 0.0 0.7 0.4 1.9 0.5 0.8 1.5 0.2 17.8 0.5 1.4 0.0 0.1 4.6 1.3 1.3 1.3 1.2 0.6 0.6 1.4 0.4 0.6 1.3 0.3 0.0 0.0 0.2 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 6.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.4 0.5 0.3 0.4 0.5 0.3 0.3 0.2 0.6 0.5 1.3 1.4 0.6 0.2 0.6 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.3 0.0 ASB5 ENSG00000164122 "Ankyrin repeat and SOCS box containing 5" Q8WWX0 4 176213673-176277571 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 133.4" "Cell line enriched" "Detected in some" 16 "LHCN-M2: 161.1" "Cancer enhanced" "Detected in some" "prostate cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028870 Approved "Plasma membrane" "Plasma membrane" "HPA028870: AB_10611679" "unprognostic (1.76e-1)" "prognostic unfavourable (5.67e-4)" "unprognostic (1.90e-1)" "unprognostic (7.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" "unprognostic (6.80e-3)" 2.3 0.0 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.3 3.5 0.0 0.0 0.1 0.2 6.3 7.9 0.0 0.4 1.3 0.2 0.2 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.6 1.3 0.0 8.0 0.1 133.4 0.0 0.5 23.5 1.0 0.0 2.0 2.2 0.0 0.0 2.3 31.4 2.2 15.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.9 0.0 3.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 161.1 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.0 0.0 ASGR2 CLEC4H2 ENSG00000161944 "Asialoglycoprotein receptor 2" P07307 17 7101322-7115700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 154.1" "Cell line enriched" "Detected in some" 8 "Hep G2: 105.4" "Cancer enriched" "Detected in many" 66 "liver cancer: 214.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 36.9;myeloid DC: 21.7" "Group enriched" "Detected in many" 52 "dendritic cells: 21.7;monocytes: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014899, HPA015998" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" 4700000 "Endoplasmic reticulum, Plasma membrane" "HPA014899: AB_1845085, HPA015998: AB_1845084" "unprognostic (6.76e-2)" "unprognostic (7.45e-7)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (4.99e-2)" "unprognostic (1.16e-3)" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (9.74e-2)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (9.35e-4)" "unprognostic (1.54e-3)" "unprognostic (6.95e-2)" "unprognostic (1.86e-1)" "unprognostic (7.31e-2)" 0.2 0.0 0.3 1.4 0.1 1.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.1 3.4 0.2 0.2 0.0 0.2 154.1 0.5 4.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.9 0.1 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 21.7 0.5 36.9 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 36.9 0.2 0.0 3.8 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 9.5 0.3 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 ASIC1 "ACCN2, BNaC2, hBNaC2" ENSG00000110881 "Acid sensing ion channel subunit 1" P78348 12 50057548-50083611 "FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 43.7" "Cell line enhanced" "Detected in many" "HEK 293: 16.8;SH-SY5Y: 19.4" "Cancer enhanced" "Detected in many" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058870 Supported "Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" "HPA058870: " "unprognostic (5.32e-3)" "unprognostic (1.70e-1)" "unprognostic (4.00e-2)" "unprognostic (3.56e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-3)" "unprognostic (2.92e-3)" "unprognostic (3.00e-2)" "unprognostic (1.72e-1)" "unprognostic (9.37e-2)" "unprognostic (2.34e-2)" "unprognostic (2.86e-3)" "unprognostic (6.97e-7)" "unprognostic (7.19e-2)" "unprognostic (3.73e-1)" "unprognostic (2.78e-3)" "unprognostic (8.27e-5)" 2.5 1.7 13.9 1.8 20.3 0.8 2.9 20.1 43.7 5.3 3.1 12.8 0.3 2.3 2.5 1.2 3.4 3.6 4.0 2.2 12.3 14.3 1.6 0.9 1.3 1.3 12.9 8.5 1.4 1.4 5.2 0.5 1.5 10.2 4.5 2.5 1.8 5.6 3.4 1.3 1.5 2.5 3.6 5.4 1.1 4.3 1.4 11.0 0.4 1.1 0.0 1.0 2.6 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 2.1 4.7 6.2 14.0 1.9 2.9 3.5 1.5 4.1 2.7 2.7 3.3 1.7 1.3 3.2 0.9 2.2 6.1 5.2 1.6 1.3 16.8 4.2 6.6 2.0 2.7 6.3 15.8 7.4 2.5 0.4 0.6 0.5 2.8 0.1 2.2 2.6 6.0 12.3 2.6 8.3 6.1 5.9 2.8 1.3 0.2 9.2 19.4 3.5 1.2 2.1 7.7 4.1 0.4 2.7 9.1 1.8 0.8 0.0 0.0 0.0 3.5 5.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 13.9 20.3 20.1 18.3 12.3 14.3 12.9 8.5 10.2 11.0 ASIC3 "ACCN3, DRASIC, TNaC1" ENSG00000213199 "Acid sensing ion channel subunit 3" Q9UHC3 7 151048292-151052756 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Cell line enhanced" "Detected in many" "U-266/70: 16.9;U-266/84: 8.9" "Cancer enhanced" "Detected in many" "testis cancer: 7.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049155, HPA054805" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA049155: , HPA054805: " "unprognostic (8.71e-3)" "unprognostic (1.09e-1)" "unprognostic (1.92e-4)" "unprognostic (2.73e-1)" "unprognostic (7.06e-2)" "unprognostic (2.02e-2)" "unprognostic (2.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.42e-1)" "unprognostic (4.45e-2)" "unprognostic (8.64e-3)" "unprognostic (1.67e-2)" "unprognostic (1.33e-12)" "unprognostic (1.49e-2)" "unprognostic (7.38e-2)" "unprognostic (1.65e-2)" "unprognostic (5.31e-3)" 2.6 2.4 6.8 0.9 27.1 1.5 1.3 20.1 15.4 3.6 2.3 0.9 0.5 2.9 4.9 3.5 0.6 2.4 1.9 2.4 6.5 5.3 1.5 1.3 2.7 1.9 4.2 9.9 3.0 1.4 1.4 7.1 1.8 6.2 1.9 1.8 0.7 1.7 1.4 9.0 3.5 2.7 2.4 6.0 2.1 2.8 10.2 2.2 0.5 1.1 0.5 1.9 0.9 1.2 0.0 0.0 0.0 0.8 0.0 0.7 0.0 1.3 3.5 1.6 2.4 3.3 0.0 7.2 0.4 0.0 0.3 0.4 0.7 1.6 0.8 0.4 0.2 2.2 0.9 0.0 0.7 7.7 4.1 1.6 2.6 0.0 0.0 0.1 3.8 0.5 0.5 0.2 0.0 0.1 3.8 6.3 0.5 5.9 0.3 0.4 1.7 2.8 2.9 1.6 0.5 0.3 1.3 2.1 8.4 0.6 0.4 4.1 1.7 0.4 0.1 1.5 2.2 4.0 1.0 16.9 8.9 0.1 2.0 5.6 1.4 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.8 27.1 20.1 15.4 6.5 5.3 4.2 9.9 6.2 2.2 ASPH "BAH, CASQ2BP1, HAAH, JCTN" ENSG00000198363 "Aspartate beta-hydroxylase" Q12797 8 61500556-61714640 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Dioxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 102.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055161, HPA059303" Uncertain Enhanced "Endoplasmic reticulum" 900000 "Endoplasmic reticulum" "HPA055161: , HPA059303: " "unprognostic (8.07e-2)" "prognostic unfavourable (8.07e-5)" "unprognostic (1.73e-2)" "unprognostic (4.48e-2)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.82e-2)" "prognostic unfavourable (3.61e-4)" "unprognostic (6.39e-2)" "unprognostic (3.64e-1)" "prognostic unfavourable (1.75e-4)" "unprognostic (9.50e-2)" "prognostic unfavourable (1.57e-5)" "unprognostic (8.96e-2)" "unprognostic (1.65e-1)" "prognostic unfavourable (4.24e-4)" "unprognostic (2.74e-2)" 104.6 60.4 27.3 15.0 29.5 4.8 84.3 35.2 31.3 22.3 23.8 10.6 18.3 14.0 16.8 17.8 22.4 16.5 19.1 33.9 26.1 22.4 19.0 23.0 22.5 10.9 21.1 22.2 20.5 13.8 12.5 15.7 14.7 20.5 17.3 26.8 23.6 28.8 23.4 103.1 12.0 13.9 26.1 16.7 12.8 30.5 6.4 19.6 2.9 31.7 36.0 13.7 30.0 25.4 3.3 21.0 15.9 5.2 4.9 3.4 2.3 50.0 72.7 10.2 6.2 45.8 43.5 3.5 89.8 83.5 38.5 40.4 12.4 66.7 3.8 6.2 52.6 18.7 6.3 31.3 65.8 1.4 6.4 8.9 44.2 34.0 29.4 1.3 1.4 35.7 7.1 21.4 27.3 16.2 2.4 3.6 33.8 10.6 0.3 1.8 5.8 42.9 2.4 11.0 0.8 23.5 41.5 10.6 3.7 27.9 13.2 11.1 5.4 2.4 50.8 39.0 20.0 35.6 31.6 2.3 2.9 0.1 102.6 0.8 26.0 1.1 5.2 0.1 1.6 1.9 3.1 3.3 2.3 1.6 6.1 3.3 3.4 1.6 15.9 4.9 1.0 21.0 2.3 2.3 27.3 29.5 35.2 31.3 26.1 22.4 21.1 22.2 20.5 19.6 ASPHD1 ENSG00000174939 "Aspartate beta-hydroxylase domain containing 1" Q5U4P2 16 29900375-29919864 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.0;HeLa: 20.6;Hep G2: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045175 Uncertain "HPA045175: AB_10959899" "unprognostic (1.58e-1)" "unprognostic (5.50e-2)" "unprognostic (4.74e-3)" "unprognostic (2.20e-3)" "unprognostic (1.34e-3)" "unprognostic (6.96e-2)" "unprognostic (5.75e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-2)" "unprognostic (8.37e-2)" "prognostic favourable (7.38e-4)" "unprognostic (5.55e-2)" "unprognostic (6.17e-2)" "unprognostic (1.97e-2)" "unprognostic (1.90e-1)" "unprognostic (2.97e-1)" "unprognostic (9.03e-2)" 1.8 5.5 32.0 2.0 38.6 1.5 2.2 22.0 52.3 2.2 2.4 16.2 0.0 5.1 2.4 1.5 1.4 2.6 12.8 1.5 32.5 17.1 2.3 1.6 2.0 1.6 29.8 19.4 1.8 11.6 2.3 10.6 1.6 17.1 2.5 2.3 0.3 7.0 2.1 1.6 1.4 3.4 2.7 24.6 1.5 15.8 4.3 13.4 0.0 1.4 0.0 1.7 1.8 0.0 0.5 0.0 0.0 0.0 0.8 0.3 0.0 1.2 6.2 0.0 4.6 0.0 0.6 0.3 6.8 1.4 4.5 3.1 15.0 20.0 2.5 16.6 3.1 0.7 0.6 1.1 0.9 0.2 0.9 1.4 20.6 28.2 9.3 0.1 15.7 5.4 1.2 6.8 0.3 0.2 0.0 4.3 1.1 12.0 0.2 0.1 9.3 5.4 0.3 0.0 0.9 4.0 0.1 16.2 8.4 0.0 9.9 1.6 3.2 4.3 0.5 2.4 5.2 0.0 1.8 0.3 0.1 0.1 9.9 15.9 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 32.0 38.6 22.0 26.3 32.5 17.1 29.8 19.4 17.1 13.4 ASPHD2 FLJ39838 ENSG00000128203 "Aspartate beta-hydroxylase domain containing 2" Q6ICH7 22 26429273-26445015 "Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell line enhanced" "Detected in many" "Karpas-707: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000820 Uncertain "HPA000820: AB_1078231" "unprognostic (1.12e-1)" "unprognostic (1.64e-1)" "unprognostic (1.07e-2)" "unprognostic (2.71e-1)" "unprognostic (1.94e-1)" "unprognostic (9.07e-2)" "unprognostic (2.02e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-2)" "unprognostic (8.98e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-1)" "prognostic unfavourable (4.06e-5)" "unprognostic (6.55e-2)" "unprognostic (9.26e-2)" "unprognostic (1.09e-2)" "unprognostic (1.11e-2)" 0.9 1.1 7.6 3.8 23.9 2.1 1.1 17.6 13.1 1.8 3.3 1.2 0.3 2.0 2.1 10.5 2.0 0.7 2.7 0.5 5.8 5.0 3.6 0.6 1.5 6.4 3.3 4.4 1.0 1.1 0.4 5.6 2.0 3.9 1.4 3.5 1.1 1.3 1.3 0.6 8.5 2.2 1.4 1.7 4.1 13.0 2.7 4.2 2.4 3.4 0.6 5.3 3.5 1.0 1.7 4.0 0.9 7.7 0.0 1.5 0.7 1.3 0.7 3.5 5.6 0.5 0.3 1.9 1.7 3.9 3.7 5.4 0.0 0.3 1.1 0.4 1.7 1.6 3.9 6.0 2.0 7.9 5.2 0.3 0.0 0.2 3.6 1.9 0.9 0.6 2.9 1.9 2.6 3.9 1.4 18.8 1.1 0.4 1.5 0.8 3.4 0.8 10.1 2.0 3.0 5.2 0.5 9.5 4.1 1.8 0.2 1.9 0.2 2.9 3.6 2.4 11.8 0.5 3.6 5.4 1.3 2.3 3.6 7.1 1.5 0.0 2.1 0.9 0.7 5.4 1.5 1.6 1.2 1.2 3.5 1.7 0.8 0.7 0.6 0.0 7.7 4.0 0.7 0.7 7.6 23.9 17.6 11.4 5.8 5.0 3.3 4.4 3.9 4.2 ASPRV1 "FLJ25084, SASPase, Taps" ENSG00000244617 "Aspartic peptidase retroviral like 1" Q53RT3 2 69960089-69962265 "Plasma proteins, Predicted membrane proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 75.3" "Cell line enhanced" "Detected in many" "REH: 8.8" "Group enriched" "Detected in many" 8 "head and neck cancer: 23.1;melanoma: 35.1" "Cell type enriched" "Detected in some" 6 "neutrophil: 11.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034809, HPA034810" Enhanced 83000 "HPA034809: AB_2674343, HPA034810: AB_10601456" "unprognostic (4.75e-4)" "unprognostic (1.90e-3)" "unprognostic (2.34e-2)" "unprognostic (3.34e-2)" "unprognostic (2.65e-1)" "unprognostic (1.17e-2)" "unprognostic (1.93e-3)" "unprognostic (1.51e-1)" "unprognostic (1.36e-1)" "unprognostic (2.51e-1)" "unprognostic (4.19e-3)" "unprognostic (1.27e-1)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (1.74e-1)" "unprognostic (4.84e-2)" "unprognostic (2.43e-2)" 0.2 0.2 0.5 0.1 0.6 0.0 5.5 0.8 0.4 0.3 0.0 0.3 0.3 0.6 0.0 0.4 0.1 0.1 0.6 0.7 0.2 0.0 0.1 0.1 0.7 0.9 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.2 1.0 75.3 0.2 0.2 1.0 0.4 0.1 0.4 0.0 0.1 0.0 0.6 0.1 1.2 11.2 0.1 0.3 0.9 0.5 0.1 0.7 1.8 3.5 2.3 0.8 0.5 0.4 0.7 0.4 0.3 1.2 0.1 1.3 0.3 0.3 0.5 1.6 0.2 0.4 2.4 4.6 2.7 0.4 1.2 0.9 2.3 2.0 1.1 0.7 0.4 0.7 0.4 1.0 3.6 0.4 0.5 1.9 5.2 1.8 0.4 8.8 1.0 0.5 0.1 0.1 2.0 0.5 0.2 1.4 1.4 0.1 1.0 0.2 0.1 1.8 0.1 0.3 3.9 2.3 2.7 0.2 1.6 2.0 0.0 0.1 1.9 0.7 0.1 0.7 0.0 0.3 0.6 0.1 0.1 0.2 0.6 11.2 0.3 0.1 1.2 0.9 0.5 ASTN2 KIAA0634 ENSG00000148219 "Astrotactin 2" O75129 9 116425225-117415070 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 24.5" "Cancer enhanced" "Detected in all" "prostate cancer: 15.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027035 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA027035: AB_1845122" "unprognostic (3.25e-2)" "unprognostic (2.70e-2)" "unprognostic (7.41e-3)" "unprognostic (5.42e-3)" "unprognostic (1.89e-1)" "unprognostic (2.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.80e-1)" "unprognostic (3.40e-2)" "unprognostic (2.93e-1)" "prognostic favourable (6.66e-16)" "unprognostic (3.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" 4.1 11.9 13.0 3.3 14.9 4.4 5.3 17.2 25.5 5.6 4.6 20.0 5.5 4.6 3.8 5.3 3.2 9.6 3.4 18.6 13.5 16.3 5.5 5.2 3.0 3.0 15.4 19.4 4.0 7.4 5.6 10.7 2.6 16.1 29.2 4.2 6.7 6.1 13.6 7.7 3.5 5.2 3.6 11.3 3.1 4.1 16.7 16.9 1.9 2.4 0.9 2.4 3.6 3.0 2.3 1.3 2.5 0.7 7.8 10.3 1.3 2.5 7.7 3.1 4.7 5.1 4.7 10.2 3.8 1.5 1.7 1.8 5.3 3.0 5.7 4.4 2.5 0.9 7.5 0.4 2.0 3.1 1.9 2.1 3.6 10.9 2.0 1.4 4.1 6.4 0.7 5.1 0.4 1.2 2.6 4.3 5.1 2.6 2.6 1.1 8.9 4.6 3.3 18.1 1.7 5.3 8.2 4.2 24.5 4.5 1.5 3.2 10.2 0.9 2.3 3.9 6.4 3.8 3.2 6.2 3.5 5.4 7.0 1.4 16.7 2.5 0.6 0.6 3.9 0.4 4.8 2.0 4.2 3.2 0.3 2.3 4.0 3.3 2.4 7.8 0.7 1.3 10.3 1.3 13.0 14.9 17.2 23.2 13.5 16.3 15.4 19.4 16.1 16.9 ASZ1 "ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3" ENSG00000154438 "Ankyrin repeat, SAM and basic leucine zipper domain containing 1" Q8WWH4 7 117363222-117428123 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 15.7" "Group enriched" "Detected in some" 24 "Daudi: 3.9;U-266/70: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA020558 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA020558: AB_1845123" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATAD1 FLJ14600 ENSG00000138138 "ATPase family, AAA domain containing 1" Q8NBU5 10 87751512-87841343 "Enzymes, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037569 Uncertain Approved Nucleoli,Mitochondria Nucleoli Mitochondria "HPA037569: AB_10672496" "unprognostic (9.92e-2)" "unprognostic (2.90e-1)" "unprognostic (4.05e-2)" "unprognostic (2.68e-1)" "unprognostic (3.24e-2)" "unprognostic (6.60e-3)" "unprognostic (3.38e-1)" "unprognostic (1.40e-1)" "unprognostic (2.35e-1)" "unprognostic (8.45e-2)" "unprognostic (1.35e-3)" "unprognostic (1.67e-2)" "prognostic favourable (3.98e-6)" "unprognostic (2.35e-1)" "unprognostic (3.29e-1)" "unprognostic (3.45e-2)" "unprognostic (4.22e-2)" 16.2 21.3 20.4 15.1 26.2 8.0 19.4 22.4 29.8 19.2 15.9 14.4 16.0 13.5 19.6 17.0 17.3 14.8 13.3 39.9 20.4 22.2 20.6 22.1 14.1 14.2 20.4 17.1 19.1 12.6 25.6 24.9 30.2 31.2 24.3 18.4 19.8 15.8 20.4 32.1 14.4 14.1 18.4 18.2 12.5 14.0 19.8 14.7 18.0 20.1 18.5 15.7 18.9 15.2 9.0 7.3 6.7 7.6 9.8 13.5 7.4 9.8 9.3 11.9 11.3 14.4 12.7 9.0 10.0 16.6 10.3 11.6 8.4 28.6 9.5 7.7 8.3 16.4 9.9 8.5 12.1 8.5 13.4 7.8 13.0 10.3 17.1 21.2 5.4 12.6 23.8 10.9 27.1 6.8 7.6 12.4 11.4 6.0 13.6 14.4 8.8 6.5 9.3 7.6 10.4 15.8 7.6 7.6 16.6 8.8 6.3 20.1 16.5 10.0 8.4 9.4 8.4 6.3 13.0 16.7 15.3 12.2 10.4 14.8 7.2 6.7 3.8 5.7 9.2 5.9 13.5 9.0 10.3 11.4 7.3 7.6 11.8 11.6 2.2 9.8 7.6 5.5 9.3 7.4 20.4 26.2 22.4 29.8 20.4 22.2 20.4 17.1 31.2 14.7 ATF6 ATF6A ENSG00000118217 "Activating transcription factor 6" P18850 1 161766294-161964070 "Disease related genes, Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005935 Approved 26000000 "HPA005935: " "unprognostic (1.31e-1)" "unprognostic (5.15e-3)" "unprognostic (3.18e-2)" "unprognostic (8.43e-3)" "unprognostic (1.59e-1)" "unprognostic (5.58e-3)" "unprognostic (1.24e-1)" "unprognostic (5.32e-2)" "unprognostic (3.37e-2)" "unprognostic (3.24e-1)" "unprognostic (6.09e-3)" "unprognostic (3.38e-1)" "unprognostic (7.55e-2)" "unprognostic (2.03e-1)" "unprognostic (2.43e-1)" "unprognostic (1.56e-2)" "unprognostic (7.57e-3)" 21.6 14.9 10.6 13.8 12.7 8.6 16.0 14.6 14.5 14.2 14.5 14.7 18.9 9.9 16.0 22.9 14.0 12.5 11.9 13.5 10.5 11.0 20.1 43.1 18.5 19.6 16.3 9.1 17.5 37.4 30.7 18.3 28.9 12.4 14.4 15.2 18.1 17.5 15.7 14.4 18.1 13.2 15.9 16.0 20.5 15.0 13.4 14.2 18.5 18.5 12.1 17.2 17.0 13.1 4.9 7.1 19.6 10.2 4.2 5.6 5.2 10.4 6.5 7.6 8.4 11.7 10.7 10.3 12.3 17.5 11.8 11.8 4.7 13.5 7.1 16.2 18.6 12.4 7.1 10.4 12.8 9.4 5.3 8.8 8.9 4.7 22.9 15.2 14.7 11.0 16.8 11.9 29.6 25.8 14.8 9.1 10.6 5.5 6.2 5.2 6.3 7.9 5.5 10.5 15.3 11.5 6.5 4.3 7.6 12.7 9.1 18.1 9.0 15.5 26.4 10.6 7.5 4.4 13.8 13.0 12.5 10.3 15.4 2.5 11.5 5.3 9.5 6.2 5.3 10.1 5.1 4.4 5.1 4.3 7.1 4.9 5.6 5.4 19.6 4.2 10.2 2.6 4.5 5.2 10.6 12.7 14.6 13.2 10.5 11.0 16.3 9.1 12.4 14.2 ATF6B "CREBL1, G13" ENSG00000213676 "Activating transcription factor 6 beta" Q99941 6 32115264-32128253 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046871 Uncertain Approved Nucleoplasm,Nucleoli 31000000 Nucleoplasm Nucleoli "HPA046871: AB_10963542" "unprognostic (2.93e-3)" "unprognostic (1.56e-1)" "unprognostic (5.50e-2)" "unprognostic (1.82e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (9.80e-3)" "unprognostic (1.55e-1)" "unprognostic (3.15e-1)" "unprognostic (3.68e-2)" "unprognostic (9.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.04e-3)" "unprognostic (1.75e-2)" "unprognostic (1.76e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-2)" 11.7 19.4 23.1 13.7 29.4 24.9 14.3 20.2 19.1 17.8 20.2 15.4 9.8 11.2 19.2 32.7 20.0 27.7 15.4 11.0 19.4 11.4 13.5 14.0 15.6 17.0 20.6 16.5 22.6 18.4 38.1 16.1 21.1 16.9 16.8 18.8 14.1 16.2 14.0 7.1 17.8 15.9 9.4 12.8 22.8 20.2 19.5 17.0 21.7 21.2 11.8 21.0 18.0 16.4 4.4 5.7 6.6 4.1 5.6 4.9 4.4 0.8 2.9 8.1 3.0 6.1 6.9 3.0 3.3 3.2 7.3 9.2 9.5 15.9 14.5 11.7 29.4 4.7 11.0 22.1 5.4 2.9 12.1 1.1 15.3 10.1 20.1 1.1 17.6 11.5 9.8 1.3 20.4 19.9 19.1 19.3 18.7 7.5 10.1 7.1 2.4 0.5 0.7 3.5 6.4 6.6 1.4 0.5 0.8 14.3 7.8 19.4 24.4 1.8 8.6 4.0 4.5 6.5 9.9 19.3 8.3 6.8 9.3 6.7 9.9 6.6 2.2 1.9 4.9 4.1 4.7 4.4 2.8 2.3 5.7 3.4 1.8 3.5 2.5 5.6 3.7 3.8 4.5 4.4 23.1 29.4 20.2 19.1 19.4 11.4 20.6 16.5 16.9 17.0 ATF7 ATFA ENSG00000170653 "Activating transcription factor 7" P17544 12 53507856-53626410 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003384 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA003384: AB_1078234" "unprognostic (2.20e-2)" "unprognostic (3.10e-2)" "unprognostic (2.48e-2)" "unprognostic (7.96e-2)" "unprognostic (2.54e-1)" "unprognostic (4.73e-2)" "unprognostic (1.54e-2)" "unprognostic (9.16e-3)" "unprognostic (3.59e-3)" "unprognostic (8.03e-2)" "unprognostic (1.76e-3)" "unprognostic (2.59e-1)" "unprognostic (3.28e-3)" "prognostic unfavourable (2.10e-4)" "unprognostic (2.51e-1)" "unprognostic (3.37e-1)" "unprognostic (1.17e-1)" 22.6 12.2 18.3 14.6 25.3 11.4 21.5 56.1 22.9 17.8 17.7 31.6 12.1 10.5 21.5 13.0 19.7 14.6 15.6 18.8 20.1 9.5 15.1 12.3 18.0 10.3 28.2 12.9 23.5 15.6 15.3 17.3 15.4 22.2 17.1 18.6 15.6 21.9 13.4 23.1 20.9 12.2 24.5 22.3 11.4 16.1 12.4 27.5 11.4 15.2 10.8 13.1 18.1 18.4 11.5 11.4 14.2 19.5 15.5 11.5 9.3 10.2 19.8 10.5 11.6 20.3 26.0 7.0 12.3 12.8 13.7 9.1 14.2 16.0 16.0 16.4 15.1 12.8 8.2 13.7 12.6 15.5 10.4 13.8 22.8 15.2 13.6 17.7 10.4 20.2 17.9 17.0 19.4 26.8 15.7 14.9 20.4 18.9 10.6 12.4 10.5 10.7 14.1 12.7 15.4 20.6 13.2 8.9 9.5 18.8 13.9 19.5 18.6 11.0 19.7 16.4 11.6 13.0 11.1 7.3 8.7 10.3 13.4 16.8 14.9 12.9 14.8 14.2 8.6 19.5 8.7 10.8 11.5 8.4 11.4 11.5 8.5 9.9 9.3 15.5 14.3 7.8 10.8 9.3 18.3 25.3 56.1 22.9 20.1 9.5 28.2 12.9 22.2 27.5 ATG9A "APG9L1, FLJ22169" ENSG00000198925 "Autophagy related 9A" Q7Z3C6 2 219219380-219229717 "Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA059551 Uncertain Supported Vesicles Vesicles "HPA059551: " "unprognostic (1.53e-2)" "unprognostic (4.03e-1)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (4.80e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (2.18e-5)" "unprognostic (8.99e-3)" "unprognostic (2.07e-1)" "unprognostic (3.55e-3)" "unprognostic (4.67e-2)" "unprognostic (4.21e-1)" "unprognostic (2.23e-2)" "unprognostic (4.84e-2)" "unprognostic (3.15e-1)" "unprognostic (5.61e-2)" "unprognostic (1.95e-2)" 13.9 14.3 15.2 9.0 26.1 23.3 13.2 26.7 37.9 12.2 15.0 23.8 10.0 17.1 14.9 9.4 17.6 10.4 13.3 23.4 14.2 13.2 12.6 21.0 13.6 10.2 18.5 14.0 12.9 16.7 27.0 10.8 20.3 20.6 12.8 14.3 12.5 14.0 14.9 61.3 17.5 19.8 18.0 14.3 13.0 13.0 47.0 16.3 7.8 13.1 16.6 12.6 14.7 12.3 5.0 6.6 8.8 16.8 8.4 7.6 8.5 9.5 12.6 9.9 22.7 20.4 21.4 12.7 17.9 21.1 25.1 22.9 19.1 13.4 2.4 14.4 29.3 21.3 16.0 20.6 19.2 7.7 24.4 19.2 32.5 21.8 20.2 5.1 14.7 21.4 34.2 26.1 24.5 25.7 26.1 9.8 17.3 12.5 4.1 10.7 6.9 10.1 5.6 13.1 9.7 14.7 14.1 15.2 8.8 18.1 16.8 15.8 6.2 12.4 17.4 25.0 11.6 10.1 16.1 5.3 5.0 3.9 20.3 12.0 13.5 4.8 9.4 4.3 6.2 14.4 6.6 5.0 4.9 7.6 6.6 3.4 4.7 5.5 8.8 8.4 16.8 2.9 5.6 8.5 15.2 26.1 26.7 37.9 14.2 13.2 18.5 14.0 20.6 16.3 ATM "ATA, ATC, ATD, ATDC, TEL1, TELO1" ENSG00000149311 "ATM serine/threonine kinase" Q13315 11 108222484-108369102 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000102, HPA067142" Supported Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB000102: , HPA067142: " "unprognostic (9.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.04e-1)" "unprognostic (2.36e-1)" "unprognostic (5.70e-2)" "unprognostic (2.86e-2)" "unprognostic (6.32e-3)" "unprognostic (1.05e-1)" "unprognostic (8.19e-2)" "unprognostic (1.63e-1)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (2.17e-3)" "unprognostic (3.10e-1)" "unprognostic (7.87e-2)" "unprognostic (1.21e-1)" "unprognostic (2.81e-1)" 8.3 10.9 12.7 26.5 19.3 16.8 9.4 17.7 14.4 10.9 8.5 10.9 8.8 6.0 11.2 11.4 6.9 9.5 9.2 9.6 12.4 8.5 7.7 9.5 10.1 33.4 19.6 6.7 20.5 20.7 15.7 29.2 8.8 14.5 9.1 7.9 7.2 15.1 9.8 6.2 8.4 16.5 10.6 23.4 22.6 8.9 6.1 17.9 19.5 10.7 5.1 26.9 10.7 10.7 13.7 6.1 13.5 12.5 7.6 18.5 4.4 2.6 3.8 7.5 4.0 9.8 14.3 1.9 6.0 6.7 3.5 5.8 4.7 6.3 9.4 8.9 4.8 4.0 5.7 5.0 5.4 7.5 3.3 8.5 4.7 4.7 5.1 10.2 9.2 9.2 3.1 5.2 10.2 7.2 8.2 6.4 6.8 1.9 7.0 9.4 6.1 3.8 5.5 5.2 14.8 3.9 5.4 5.1 6.3 6.9 3.2 10.3 4.9 5.8 11.3 8.6 4.8 4.9 5.6 4.3 4.5 47.4 5.7 11.3 9.6 13.5 5.7 3.8 14.9 5.3 10.4 11.1 10.5 11.3 2.7 13.7 18.5 17.9 10.8 7.6 12.5 6.1 5.3 4.4 12.7 19.3 17.7 14.4 12.4 8.5 19.6 6.7 14.5 17.9 ATP10A "ATP10C, ATPVA, ATPVC, KIAA0566" ENSG00000206190 "ATPase phospholipid transporting 10A (putative)" O60312 15 25677273-25865172 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 12.8;fHDF/TERT166: 18.7;HMC-1: 12.5;RPTEC TERT1: 10.0;SK-MEL-30: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 12 "dendritic cells: 3.0;NK-cells: 4.7;T-cells: 4.0" "Low region specificity" "Detected in all" "HPA041496, HPA042509" Uncertain "HPA041496: , HPA042509: " "unprognostic (3.70e-1)" "unprognostic (2.83e-2)" "unprognostic (2.30e-4)" "unprognostic (1.18e-1)" "unprognostic (9.46e-2)" "unprognostic (2.91e-2)" "unprognostic (2.67e-1)" "unprognostic (4.95e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (6.60e-5)" "unprognostic (1.30e-1)" "unprognostic (1.38e-2)" "unprognostic (4.89e-2)" "unprognostic (9.42e-2)" 7.4 14.1 5.3 5.4 9.8 4.7 5.7 3.4 11.0 5.3 3.3 6.2 1.4 1.5 1.9 2.1 3.7 3.1 7.1 2.9 8.0 5.8 6.0 1.0 12.2 14.8 9.3 9.0 1.6 1.9 1.9 2.5 3.6 11.3 3.6 2.3 4.0 14.4 1.5 0.7 3.3 3.6 5.3 6.4 3.5 4.0 6.0 6.2 1.5 3.0 1.6 3.3 4.2 3.3 0.0 3.0 0.0 0.3 4.7 4.0 1.7 0.0 3.3 0.6 0.0 2.7 2.5 0.0 12.8 6.2 3.9 6.9 0.0 0.0 0.0 0.7 18.7 0.0 6.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.6 0.0 0.5 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.9 0.7 2.3 2.3 0.8 10.0 0.0 0.0 0.0 0.0 0.0 16.9 5.1 0.5 0.0 5.2 0.2 7.5 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.3 0.0 1.9 0.2 1.9 0.0 2.2 2.1 0.4 0.0 4.0 3.7 0.0 4.7 0.1 3.0 0.7 1.7 5.3 9.8 3.4 11.0 8.0 5.8 9.3 9.0 11.3 6.2 ATP11B "ATPIF, ATPIR, KIAA0956" ENSG00000058063 "ATPase phospholipid transporting 11B (putative)" Q9Y2G3 3 182793500-182921635 "Enzymes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036237, HPA036238" Uncertain Approved "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA036237: AB_10673123, HPA036238: AB_10670792" "unprognostic (4.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "prognostic unfavourable (3.44e-4)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (6.73e-2)" "unprognostic (2.03e-3)" "unprognostic (7.28e-2)" "unprognostic (1.18e-1)" "prognostic unfavourable (1.09e-4)" "unprognostic (2.02e-1)" "unprognostic (1.71e-1)" "unprognostic (1.62e-1)" "unprognostic (3.22e-1)" "unprognostic (8.66e-2)" "unprognostic (1.35e-1)" 16.8 7.9 7.7 19.7 9.8 35.4 17.0 18.4 9.4 20.5 21.6 8.9 14.3 13.6 15.0 11.7 37.3 11.8 12.7 21.1 6.9 5.9 13.7 14.3 19.4 20.3 10.3 5.7 15.2 14.6 21.0 26.0 8.0 8.3 16.8 16.9 9.8 19.7 13.8 13.1 21.8 22.8 16.5 11.3 23.4 27.6 22.8 8.9 49.0 10.8 20.4 21.9 22.7 25.5 3.6 4.2 7.5 1.8 3.0 3.4 1.3 22.2 3.2 7.0 9.8 15.0 16.4 6.5 10.3 14.2 8.0 9.4 7.9 11.6 10.3 17.7 14.8 13.5 8.4 10.6 14.0 22.9 6.7 24.9 4.3 1.7 8.8 19.6 16.0 11.1 12.0 9.0 13.1 12.6 8.8 32.3 12.9 7.5 16.3 6.3 5.0 6.3 6.8 20.6 12.4 9.7 18.8 4.2 7.6 28.7 3.7 12.5 4.0 14.6 12.3 12.2 13.3 10.5 17.9 44.1 39.4 19.4 8.4 8.4 7.1 7.5 1.7 7.2 3.1 1.8 3.0 3.6 2.7 3.1 1.9 2.4 2.3 3.4 6.8 3.0 1.7 4.2 2.0 1.3 7.7 9.8 18.4 9.4 6.9 5.9 10.3 5.7 8.3 8.9 ATP13A2 "CLN12, HSA9947, PARK9" ENSG00000159363 "ATPase 13A2" Q9NQ11 1 16985958-17011928 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 17.9" "Lineage enriched" "Detected in many" 6 "dendritic cells: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037038, CAB037111, HPA050910, HPA054717" Enhanced "CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: , HPA054717: " "unprognostic (3.81e-2)" "unprognostic (1.84e-2)" "unprognostic (5.61e-2)" "unprognostic (2.17e-2)" "unprognostic (1.66e-2)" "unprognostic (2.03e-1)" "prognostic unfavourable (3.33e-7)" "unprognostic (1.04e-1)" "unprognostic (9.71e-3)" "unprognostic (4.51e-1)" "unprognostic (9.85e-3)" "unprognostic (1.85e-1)" "unprognostic (5.75e-2)" "unprognostic (3.25e-2)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (6.84e-3)" 9.6 12.3 21.9 16.3 25.8 8.7 6.7 25.5 45.3 6.0 12.5 12.0 4.7 10.4 5.3 6.1 8.9 7.1 7.6 4.5 23.8 34.6 6.5 2.5 9.6 13.2 28.4 20.3 5.3 30.1 7.8 22.2 10.5 52.2 7.2 8.3 9.6 15.6 7.2 7.5 10.0 11.1 7.3 10.9 16.1 10.7 6.2 9.9 5.2 8.6 2.9 8.1 9.2 5.2 2.1 17.9 0.4 2.9 2.2 2.5 1.1 10.2 10.8 5.9 23.0 5.5 4.8 15.7 5.9 5.7 6.5 6.9 19.0 11.9 4.6 25.5 9.9 16.2 11.8 21.7 2.3 6.2 22.7 15.9 10.2 9.8 7.2 5.8 7.5 3.8 12.1 18.4 13.5 12.8 10.2 8.8 26.7 8.4 6.7 3.2 8.7 7.4 7.4 22.4 18.1 7.4 15.7 15.9 10.3 26.9 35.0 22.7 11.7 7.0 12.8 7.3 13.7 12.2 11.9 1.8 2.1 4.8 13.7 31.6 11.6 0.0 1.3 0.3 2.4 2.9 2.5 1.2 1.9 2.0 0.4 2.1 1.0 1.4 0.4 2.2 2.7 17.9 1.5 1.1 21.9 25.8 25.5 45.3 23.8 34.6 28.4 20.3 52.2 9.9 ATP13A3 AFURS1 ENSG00000133657 "ATPase 13A3" Q9H7F0 3 194402672-194498364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029471 Approved Approved "Nucleoli,Plasma membrane,Cytosol" Nucleoli "Plasma membrane, Cytosol" "HPA029471: AB_10600784" "unprognostic (5.07e-2)" "unprognostic (3.53e-2)" "unprognostic (2.94e-1)" "unprognostic (5.31e-2)" "unprognostic (3.20e-2)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (9.87e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "prognostic unfavourable (1.60e-4)" "unprognostic (2.70e-2)" "prognostic unfavourable (1.63e-4)" "unprognostic (1.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.34e-2)" "unprognostic (3.77e-1)" 27.1 14.4 9.0 20.8 12.7 17.5 22.8 15.3 13.8 12.1 13.4 10.8 17.2 11.4 16.2 13.2 12.4 11.3 17.1 37.8 9.6 8.1 29.7 56.9 22.1 11.6 10.1 8.3 13.2 11.4 37.6 10.6 28.9 10.6 11.8 12.6 12.9 16.7 15.9 11.8 7.7 15.0 12.1 9.0 17.1 16.3 8.8 8.4 18.9 37.1 12.0 12.7 17.8 16.1 1.9 2.4 2.3 2.3 2.2 4.7 1.0 49.9 5.7 10.2 9.7 11.6 18.1 24.8 17.2 18.7 18.7 34.0 31.3 12.2 19.7 51.1 24.7 17.0 9.7 17.1 43.5 65.7 8.5 10.9 7.6 6.7 20.1 35.4 28.6 8.3 7.7 38.8 25.3 9.7 12.5 39.9 22.7 8.5 14.2 7.1 9.7 9.9 13.0 21.9 11.8 15.8 16.0 15.6 8.3 18.2 19.0 12.8 36.3 24.8 12.6 22.8 19.0 45.3 32.0 26.4 47.5 35.1 45.4 21.0 15.8 1.8 1.7 2.3 1.8 2.3 2.2 1.9 1.7 2.8 2.4 1.1 2.5 2.5 0.3 2.2 0.9 1.6 4.7 1.0 9.0 12.7 15.3 13.8 9.6 8.1 10.1 8.3 10.6 8.4 ATP13A5 FLJ16025 ENSG00000187527 "ATPase 13A5" Q4VNC0 3 193274790-193378843 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 15.2;breast: 17.5;salivary gland: 28.9" "Cell line enhanced" "Detected in some" "PC-3: 1.7;SK-BR-3: 5.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Region enriched" "Detected in many" 10 "pons and medulla: 15.2" "Cell type enriched" "Detected in single" 9 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA031771, HPA031774" Uncertain "HPA031771: , HPA031774: " "unprognostic (7.98e-2)" "unprognostic (3.01e-4)" "unprognostic (2.06e-3)" "unprognostic (2.72e-3)" "unprognostic (3.93e-1)" "unprognostic (1.67e-4)" "unprognostic (3.03e-1)" "unprognostic (2.31e-1)" "unprognostic (2.14e-2)" "unprognostic (1.73e-1)" "unprognostic (7.15e-2)" "unprognostic (1.10e-1)" "unprognostic (8.10e-2)" 0.1 0.0 1.4 0.1 1.5 0.1 17.5 0.3 0.9 0.1 0.1 2.8 0.1 0.0 0.3 0.9 0.9 0.0 0.1 0.1 1.0 0.7 0.1 0.1 0.4 0.1 0.9 0.1 0.2 0.1 0.1 0.2 0.1 15.2 0.3 0.0 0.4 28.9 0.1 1.3 5.1 0.1 0.1 0.3 0.1 1.4 0.3 0.1 0.4 1.4 1.3 0.7 0.1 0.1 0.4 0.4 4.1 0.3 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.7 1.0 1.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.2 0.7 1.7 0.3 1.0 0.0 0.0 0.4 0.6 0.0 0.0 5.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.9 0.3 0.9 0.0 0.3 0.4 0.3 0.4 0.3 0.3 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.2 0.2 4.1 0.3 0.0 0.4 0.1 0.1 1.4 1.5 0.3 0.9 1.0 0.7 0.9 0.1 15.2 0.1 ATP1A1 ENSG00000163399 "ATPase Na+/K+ transporting subunit alpha 1" P05023 1 116372668-116410261 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 195.4;parathyroid gland: 194.4" "Cell line enhanced" "Detected in all" "SK-MEL-30: 248.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018702, CAB069993" Enhanced 380000 "CAB018702: AB_626713, CAB069993: AB_2060979" "unprognostic (6.18e-2)" "unprognostic (2.18e-1)" "unprognostic (6.91e-2)" "unprognostic (1.42e-2)" "unprognostic (6.80e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.42e-4)" "unprognostic (1.80e-1)" "unprognostic (1.21e-2)" "unprognostic (6.32e-2)" "unprognostic (1.61e-2)" "unprognostic (1.65e-1)" "prognostic favourable (8.98e-8)" "unprognostic (4.75e-2)" "unprognostic (1.17e-1)" "unprognostic (3.11e-2)" "prognostic unfavourable (4.01e-4)" 17.4 25.6 22.4 16.2 40.3 10.5 26.9 74.2 67.4 17.8 121.9 14.2 56.1 92.3 13.1 38.3 34.9 17.7 65.8 41.1 26.1 18.7 162.7 34.6 35.1 9.6 19.2 27.6 17.4 78.6 194.4 25.0 19.2 34.1 22.1 65.7 24.1 84.4 53.7 19.0 40.5 195.4 17.7 20.7 13.7 25.0 17.0 13.9 9.1 101.2 13.7 16.2 14.2 23.1 10.3 22.0 6.4 29.7 10.4 30.2 17.2 32.9 12.2 12.7 6.3 25.5 24.7 65.2 19.8 39.4 24.4 34.7 48.7 23.7 26.1 28.0 23.4 43.1 25.0 41.7 35.5 9.6 27.7 15.2 23.0 41.1 19.5 38.1 21.4 27.5 69.9 28.4 37.5 29.9 25.0 25.3 21.6 65.6 15.4 13.8 29.8 24.5 14.9 29.6 23.1 88.1 34.0 12.5 11.0 30.7 58.4 248.8 15.3 22.1 26.3 13.9 19.5 35.9 40.0 12.2 9.5 20.1 42.7 22.0 81.6 6.4 13.3 6.1 23.2 20.9 24.8 10.3 26.4 24.9 22.0 5.3 30.2 22.0 1.6 10.4 29.7 11.1 20.3 17.2 22.4 40.3 74.2 67.4 26.1 18.7 19.2 27.6 34.1 13.9 ATP1B1 ATP1B ENSG00000143153 "ATPase Na+/K+ transporting subunit beta 1" P05026 1 169105697-169132722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 239.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 82.1;SH-SY5Y: 68.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 10.5;gdT-cell: 2.9;intermediate monocyte: 3.0;memory CD4 T-cell: 3.4;myeloid DC: 8.4;NK-cell: 5.6;T-reg: 9.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012911 Enhanced 4100000 "HPA012911: AB_1845173" "unprognostic (4.20e-2)" "unprognostic (3.08e-1)" "unprognostic (1.13e-1)" "unprognostic (1.85e-2)" "unprognostic (1.95e-1)" "unprognostic (5.34e-2)" "unprognostic (2.22e-1)" "unprognostic (1.69e-1)" "unprognostic (3.24e-1)" "unprognostic (6.80e-2)" "unprognostic (1.66e-1)" "unprognostic (1.35e-1)" "prognostic favourable (7.08e-7)" "unprognostic (1.11e-1)" "unprognostic (5.48e-2)" "unprognostic (1.97e-3)" "unprognostic (9.39e-2)" 3.9 26.3 48.7 8.6 45.1 1.3 14.9 39.4 92.1 8.7 43.8 34.5 11.3 61.3 19.8 11.2 28.7 9.4 50.1 36.0 86.3 68.2 239.7 30.6 16.9 1.9 82.3 52.6 11.5 33.0 130.6 16.7 8.3 111.5 9.8 34.8 15.5 55.7 15.4 55.1 11.2 51.2 17.8 64.0 9.6 69.5 8.4 25.9 0.9 60.1 23.7 13.9 12.3 9.0 1.4 8.4 10.5 3.0 5.6 9.1 1.4 14.7 36.0 11.6 9.0 2.8 0.5 4.1 7.2 6.0 7.6 8.0 43.9 29.8 0.0 27.5 5.7 17.4 6.4 13.9 7.9 0.1 2.8 0.9 27.2 20.3 4.4 0.6 1.3 1.5 3.4 5.6 7.3 6.9 0.2 0.2 8.8 5.6 1.2 2.3 4.7 7.7 0.2 14.1 2.6 82.1 18.4 9.3 68.1 43.0 43.4 1.9 8.9 1.4 14.6 5.9 15.7 9.9 26.0 0.9 1.1 0.3 7.0 2.1 7.9 10.5 1.0 0.1 2.9 3.0 1.5 1.4 3.4 1.1 8.4 0.2 1.0 1.1 0.3 5.6 0.9 0.4 9.1 1.4 48.7 45.1 39.4 92.1 86.3 68.2 82.3 52.6 111.5 25.9 ATP1B2 AMOG ENSG00000129244 "ATPase Na+/K+ transporting subunit beta 2" P14415 17 7646627-7657768 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 148.8" "Cell line enhanced" "Detected in some" "AF22: 13.9;HAP1: 4.2;K-562: 6.3" "Cancer enriched" "Detected in many" 17 "glioma: 200.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010698 Enhanced 17000 "HPA010698: AB_1845174" "unprognostic (9.39e-2)" "unprognostic (1.86e-2)" "unprognostic (3.89e-3)" "unprognostic (4.96e-3)" "unprognostic (3.90e-3)" "unprognostic (9.33e-2)" "unprognostic (4.86e-1)" "unprognostic (5.93e-2)" "unprognostic (5.43e-2)" "unprognostic (1.29e-2)" "prognostic favourable (1.05e-4)" "unprognostic (1.10e-1)" "prognostic unfavourable (4.17e-4)" "unprognostic (4.60e-3)" "unprognostic (1.43e-1)" "unprognostic (2.24e-1)" "unprognostic (3.79e-2)" 4.1 6.5 54.7 2.5 61.6 8.1 2.5 62.9 148.8 9.4 3.4 25.1 0.0 2.7 8.0 15.1 3.4 10.9 4.4 5.0 46.1 33.4 6.9 3.4 3.9 2.9 42.4 41.9 23.3 3.3 3.8 10.8 5.0 68.9 4.6 3.8 28.4 3.3 7.6 4.6 2.7 3.0 5.8 58.7 4.8 2.4 4.3 25.7 0.0 4.4 0.0 2.6 3.3 2.0 1.3 0.7 1.5 1.0 1.3 2.0 0.5 0.0 0.0 13.9 0.6 0.4 0.3 0.1 0.2 0.0 0.5 0.4 0.5 0.0 0.4 0.3 0.1 0.4 4.2 0.3 0.2 0.1 1.7 0.3 0.1 0.1 0.2 0.1 1.3 0.8 0.0 0.5 0.0 0.0 6.3 0.8 0.0 0.4 0.3 0.4 2.9 0.3 0.2 0.1 0.2 0.1 0.1 0.2 2.7 0.0 0.1 0.1 0.2 0.3 0.0 0.2 1.1 0.1 0.2 0.6 0.2 0.1 1.3 0.3 0.3 0.9 1.0 0.5 2.0 0.3 1.8 1.3 0.7 1.4 0.3 0.8 1.1 1.0 1.5 1.3 0.2 0.7 0.2 0.5 54.7 61.6 62.9 50.8 46.1 33.4 42.4 41.9 68.9 25.7 ATP1B3 "CD298, FLJ29027" ENSG00000069849 "ATPase Na+/K+ transporting subunit beta 3" P54709 3 141876124-141926514 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020697, HPA048963" Enhanced Supported "Plasma membrane" 100000 "Plasma membrane" "CAB020697: , HPA048963: " "unprognostic (2.31e-1)" "unprognostic (1.11e-3)" "unprognostic (2.75e-1)" "prognostic favourable (5.19e-5)" "unprognostic (2.60e-2)" "unprognostic (3.31e-2)" "prognostic unfavourable (6.32e-6)" "unprognostic (8.11e-3)" "unprognostic (6.99e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (1.29e-5)" "unprognostic (5.14e-2)" "unprognostic (2.04e-1)" "unprognostic (7.19e-3)" "unprognostic (6.15e-2)" 50.5 79.9 12.7 26.3 23.3 17.5 105.9 25.7 35.1 17.7 48.2 9.1 16.8 37.3 17.9 14.6 36.9 20.0 47.8 44.0 16.0 18.9 24.9 7.7 44.9 43.4 21.3 12.8 34.7 11.5 6.3 33.8 32.6 43.3 20.5 58.1 23.9 18.4 24.8 7.4 85.4 57.3 24.3 28.4 16.5 13.5 21.1 13.6 14.5 15.6 41.4 18.4 21.9 31.5 10.4 26.8 13.6 60.9 7.8 20.0 22.5 46.3 28.8 27.1 25.4 72.9 21.2 62.2 54.4 49.5 39.6 44.9 44.8 23.3 37.9 49.2 41.3 101.8 26.9 26.0 45.1 20.6 34.1 33.0 32.5 29.0 28.8 27.2 26.0 22.5 62.1 31.0 30.0 42.2 22.7 33.6 40.5 21.1 27.6 45.5 37.7 13.8 37.9 20.3 38.5 33.2 35.8 22.4 15.2 71.0 33.1 73.0 25.2 33.1 29.3 34.8 13.4 52.0 31.6 25.1 32.2 61.0 45.4 29.6 28.6 13.6 27.1 8.9 19.2 44.5 14.1 10.4 15.6 20.0 26.8 7.5 9.2 16.7 1.9 7.8 60.9 16.4 16.9 22.5 12.7 23.3 25.7 35.1 16.0 18.9 21.3 12.8 43.3 13.6 ATP2B1 PMCA1 ENSG00000070961 "ATPase plasma membrane Ca2+ transporting 1" P20020 12 89588049-89709300 "Enzymes, Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.8" "Cell line enhanced" "Detected in many" "hTERT-HME1: 58.4;LHCN-M2: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005605, HPA011166, HPA012945" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483" "unprognostic (6.78e-2)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (8.23e-2)" "unprognostic (1.72e-1)" "unprognostic (6.44e-2)" "prognostic unfavourable (7.74e-4)" "unprognostic (2.77e-2)" "unprognostic (2.46e-2)" "unprognostic (7.82e-2)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (4.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" 8.7 5.1 23.4 12.5 53.8 40.5 8.8 30.9 44.1 9.0 14.0 4.1 4.0 17.8 8.2 5.8 6.5 8.4 11.3 5.2 29.0 11.8 7.4 10.0 9.2 11.8 7.8 31.5 7.6 7.4 13.7 8.7 11.7 9.2 6.4 14.8 2.9 5.6 6.9 10.9 11.3 12.8 8.7 6.1 12.7 12.4 9.8 16.4 5.7 6.3 6.0 12.3 9.9 7.4 27.1 16.2 41.5 25.6 8.4 16.3 6.2 4.1 21.1 8.3 4.0 12.1 19.3 3.8 12.8 41.9 12.4 19.8 8.4 3.9 8.2 0.9 17.7 3.7 7.3 3.5 34.7 2.8 8.5 2.9 7.4 7.4 39.5 12.2 4.9 15.9 6.7 38.6 58.4 3.1 4.8 3.0 90.7 6.6 3.8 5.2 6.5 10.1 5.4 26.8 3.4 11.8 19.3 7.9 4.3 14.8 4.2 3.5 6.1 1.4 2.2 33.7 5.5 12.3 13.9 2.3 3.5 8.8 15.3 3.5 7.4 2.7 13.0 6.7 7.1 13.6 9.0 27.1 12.4 9.0 16.2 27.0 4.6 5.7 41.5 8.4 25.6 2.9 16.3 6.2 23.4 53.8 30.9 44.1 29.0 11.8 7.8 31.5 9.2 16.4 ATP2B4 "ATP2B2, MXRA1, PMCA4" ENSG00000058668 "ATPase plasma membrane Ca2+ transporting 4" P23634 1 203626561-203744081 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 42.6;BJ hTERT+: 60.6;fHDF/TERT166: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016118, HPA040431" Enhanced Supported "Plasma membrane" 21000 "Plasma membrane" "CAB016118: AB_2061729, HPA040431: " "unprognostic (7.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.60e-2)" "unprognostic (8.17e-2)" "unprognostic (2.53e-2)" "unprognostic (9.23e-3)" "unprognostic (8.68e-2)" "unprognostic (3.81e-2)" "unprognostic (9.74e-2)" "unprognostic (1.70e-1)" "unprognostic (1.64e-2)" "unprognostic (1.12e-1)" "prognostic unfavourable (1.21e-4)" "unprognostic (3.52e-3)" "unprognostic (2.61e-2)" "unprognostic (1.30e-1)" "unprognostic (2.56e-3)" 23.0 14.0 24.8 10.8 14.2 5.9 11.6 9.4 23.6 32.6 44.2 7.5 12.9 5.3 69.6 13.1 20.4 27.0 13.9 24.0 13.1 8.7 5.0 14.2 16.1 5.3 6.4 19.2 21.9 6.4 8.0 4.8 16.2 9.3 17.0 13.4 11.6 7.5 31.5 5.4 22.0 13.2 74.2 5.7 4.8 16.4 13.1 7.5 9.0 8.3 8.4 7.7 32.8 14.2 1.0 4.2 4.5 2.2 4.2 10.4 2.6 9.3 1.7 3.4 3.2 26.5 39.5 18.3 42.6 60.6 7.3 6.2 0.8 4.8 2.1 6.2 45.9 9.2 5.0 5.9 7.6 27.0 1.8 6.3 8.5 0.5 9.5 9.0 11.2 28.7 5.8 23.2 3.6 13.8 2.7 4.3 5.3 0.5 9.1 3.0 2.1 5.3 4.7 2.6 3.4 2.4 0.8 1.0 1.5 15.0 2.2 6.8 2.0 4.4 12.1 17.6 2.6 29.5 10.2 2.9 4.2 1.2 17.6 6.5 5.2 3.0 2.2 0.0 10.4 1.5 7.9 1.0 6.6 8.3 2.4 0.3 1.6 4.2 4.5 4.2 2.2 4.2 6.3 2.6 24.8 14.2 9.4 23.6 13.1 8.7 6.4 19.2 9.3 7.5 ATP2C1 "ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1" ENSG00000017260 "ATPase secretory pathway Ca2+ transporting 1" P98194 3 130850595-131016712 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010207, HPA035116, HPA069684" Supported Supported "Golgi apparatus" 28000 "Golgi apparatus" "CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: " "unprognostic (1.52e-1)" "unprognostic (1.37e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.32e-2)" "prognostic unfavourable (5.06e-6)" "unprognostic (7.66e-2)" "unprognostic (6.52e-2)" "unprognostic (2.45e-1)" "prognostic unfavourable (1.52e-4)" "unprognostic (8.44e-2)" "prognostic favourable (1.55e-4)" "unprognostic (2.19e-1)" "unprognostic (1.95e-1)" "unprognostic (3.73e-2)" "unprognostic (3.06e-1)" 18.6 22.9 29.6 14.5 29.4 20.4 36.8 24.5 34.6 22.2 21.6 23.0 14.3 14.4 19.3 18.0 16.9 23.4 16.8 19.2 31.6 32.3 28.0 17.1 30.7 16.0 31.8 25.4 18.5 14.6 47.6 31.0 19.6 26.7 54.0 22.4 18.1 20.3 16.6 16.1 21.3 16.0 19.2 44.6 11.1 18.7 16.0 25.6 20.5 21.7 15.5 15.4 19.3 29.6 4.7 7.6 21.6 7.0 8.7 7.2 4.9 36.2 14.2 14.3 13.8 40.0 32.5 15.4 39.6 52.8 19.9 25.2 23.1 29.9 13.1 27.5 37.4 43.2 26.8 21.8 29.2 28.4 9.6 35.0 15.1 10.7 25.6 13.9 42.7 25.4 22.0 20.9 23.8 21.1 10.0 23.9 24.5 16.1 13.6 11.1 16.2 15.5 9.9 14.3 20.7 36.7 24.4 22.1 13.2 34.0 10.6 19.9 15.8 11.5 28.7 21.2 11.9 27.3 18.2 15.5 18.8 19.5 21.9 10.5 17.7 21.6 7.0 12.1 6.3 6.0 5.9 4.7 6.2 5.6 7.6 2.9 4.3 4.3 3.5 8.7 7.0 6.6 7.2 4.9 29.6 29.4 24.5 34.6 31.6 32.3 31.8 25.4 26.7 25.6 ATP4B ATP6B ENSG00000186009 "ATPase H+/K+ transporting beta subunit" P51164 13 113648804-113658186 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "stomach 1: 156.3" "Cell line enhanced" "Detected in some" "REH: 3.8;RPMI-8226: 1.6;SCLC-21H: 2.6" "Cancer enriched" "Detected in some" 12 "stomach cancer: 8.9" "Region enriched" "Detected in single" 9 "cerebral cortex: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045400, HPA052649" Enhanced "HPA045400: AB_2679314, HPA052649: AB_2681900" "unprognostic (9.92e-2)" "unprognostic (2.19e-1)" "unprognostic (2.66e-1)" "unprognostic (4.86e-1)" "unprognostic (6.43e-3)" "unprognostic (7.81e-3)" "unprognostic (1.95e-1)" "unprognostic (3.22e-1)" "unprognostic (6.50e-2)" "unprognostic (6.65e-4)" "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (3.78e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 1.0 0.1 0.1 2.0 0.1 0.0 0.1 0.1 1.5 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 6.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 156.3 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.8 0.0 1.6 0.0 0.0 2.6 0.9 0.2 0.7 0.0 0.1 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.1 0.1 ATP5MD "bA792D24.4, DAPIT, MGC14697, USMG5" ENSG00000173915 "ATP synthase membrane subunit DAPIT" Q96IX5 10 103389041-103396466 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044798 Supported Mitochondria Mitochondria "HPA044798: " "unprognostic (4.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.59e-1)" "unprognostic (7.93e-2)" "unprognostic (1.65e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (5.67e-2)" "unprognostic (1.57e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (7.46e-2)" "unprognostic (1.03e-2)" 48.0 46.2 91.7 26.2 67.0 26.6 56.1 33.5 71.7 38.4 77.9 21.2 29.2 43.8 22.1 72.3 56.3 28.8 31.0 131.5 67.8 57.4 79.3 92.5 24.6 27.7 65.2 44.4 19.7 58.1 21.1 38.2 25.9 46.0 30.0 75.8 23.4 52.7 43.3 146.9 22.4 57.3 39.1 41.4 26.1 40.9 20.2 30.7 22.9 31.3 125.5 39.8 41.2 28.9 71.3 109.1 101.2 85.2 50.7 76.6 66.4 60.2 64.1 60.6 72.3 67.8 85.2 39.7 58.0 73.2 59.3 66.4 103.1 67.3 34.7 33.7 65.6 61.8 56.7 59.1 81.9 45.5 101.9 36.0 82.5 115.2 65.9 73.4 55.9 68.7 92.8 53.3 84.3 76.4 47.1 57.9 99.1 93.5 59.5 126.4 45.0 108.5 38.7 37.0 54.0 141.0 98.3 23.0 53.2 30.6 47.0 83.4 41.8 68.2 43.2 29.4 45.1 44.5 75.9 61.1 99.8 57.8 62.1 75.3 22.2 101.2 65.9 88.7 55.9 85.2 63.3 71.3 76.6 65.7 73.3 51.5 65.9 65.6 55.8 50.7 80.6 109.1 71.7 66.4 91.7 67.0 33.5 71.7 67.8 57.4 65.2 44.4 46.0 30.7 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466331 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported Mitochondria 1400000 Mitochondria "HPA067267: , HPA070412: " "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavourable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 42.4 49.0 68.0 36.6 52.0 46.4 42.8 37.3 58.8 30.7 62.7 19.0 39.9 62.9 21.2 41.2 57.4 24.8 36.6 94.5 53.9 49.8 59.6 93.5 30.0 35.5 54.6 43.6 20.7 63.6 16.3 36.7 33.4 36.3 35.0 47.3 30.9 57.1 45.2 178.8 27.8 61.5 24.6 33.0 35.6 43.4 58.3 25.5 52.9 37.9 98.0 37.6 27.8 30.2 68.3 129.7 117.2 104.1 58.3 84.0 140.0 87.2 77.0 65.0 104.9 51.2 52.0 41.1 58.0 45.1 62.3 67.5 81.8 80.6 81.8 61.1 35.9 53.8 71.8 66.3 66.6 58.9 92.2 55.4 123.2 105.4 38.7 94.4 63.5 59.3 64.1 54.1 57.4 59.2 112.3 90.3 65.2 205.0 141.2 163.9 92.4 90.8 63.3 54.2 139.9 131.2 97.0 62.5 68.9 75.9 187.7 54.8 47.3 122.6 50.2 54.9 87.7 90.6 84.5 51.7 118.8 170.7 63.4 92.4 84.1 90.0 104.0 117.2 54.2 104.1 51.7 68.3 63.5 61.0 129.7 56.9 55.8 59.5 49.7 58.3 79.2 102.7 84.0 140.0 68.0 52.0 37.3 58.8 53.9 49.8 54.6 43.6 36.3 25.5 ATP5MG "ATP5JG, ATP5L" ENSG00000167283 "ATP synthase membrane subunit g" O75964 11 118401154-118431496 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA044629 Approved Supported Mitochondria 590000 Mitochondria "HPA044629: " "unprognostic (1.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (1.61e-1)" "unprognostic (3.27e-2)" "unprognostic (3.90e-2)" "unprognostic (8.19e-2)" "unprognostic (5.13e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (7.41e-2)" "prognostic favourable (4.09e-5)" "unprognostic (6.26e-2)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (3.05e-2)" 32.3 42.4 45.3 31.8 46.7 36.0 39.6 38.1 40.4 25.6 39.0 21.1 30.3 33.8 33.9 40.4 27.9 26.5 30.1 85.8 37.5 38.4 55.6 42.6 29.1 41.9 39.2 23.6 31.3 70.1 25.8 31.1 23.6 28.3 26.3 41.5 39.0 71.9 29.5 68.4 20.9 39.5 47.3 27.8 30.7 29.5 17.9 15.7 53.2 33.7 60.2 43.7 30.0 23.6 42.7 54.6 30.8 48.0 32.5 53.5 98.1 21.5 11.2 29.5 28.5 25.5 28.6 23.6 22.1 25.2 20.3 21.6 28.2 35.0 42.8 46.2 24.0 27.6 29.6 30.9 22.6 34.1 19.5 67.6 10.5 17.0 26.2 38.4 32.4 30.4 29.3 25.0 23.9 27.3 30.9 35.9 28.3 38.7 53.6 48.0 18.7 31.2 36.9 24.7 47.0 52.8 18.6 23.4 17.7 33.3 54.1 16.3 39.3 35.9 26.8 16.8 18.8 14.3 25.2 16.4 22.4 43.5 12.5 44.8 20.9 28.8 48.0 30.8 27.1 33.3 39.3 42.7 42.9 35.5 49.9 34.6 53.5 40.2 24.0 32.5 31.5 54.6 45.8 98.1 45.3 46.7 38.1 40.4 37.5 38.4 39.2 23.6 28.3 15.7 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA058978: , HPA060520: " "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favourable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 23.1 34.5 69.4 19.3 64.3 40.2 34.9 31.0 91.7 21.0 43.0 16.0 26.8 44.1 16.5 39.1 27.3 21.3 20.5 87.5 57.5 44.7 43.0 45.2 15.7 28.6 54.0 41.4 22.1 38.2 17.2 29.2 20.5 30.4 22.1 45.6 20.1 28.9 30.3 117.3 17.3 33.6 24.6 28.5 19.5 25.8 17.5 24.4 18.9 23.6 58.9 30.9 18.4 17.2 51.8 63.1 91.6 91.0 32.8 54.6 98.1 38.3 44.4 38.5 36.6 46.1 47.9 38.0 30.1 34.2 37.8 33.1 38.3 27.3 40.3 31.8 30.8 32.8 49.5 36.3 51.2 33.3 50.0 44.9 37.6 58.9 30.4 54.3 31.3 50.2 49.4 25.6 27.4 42.4 27.3 43.3 41.5 114.1 52.4 77.5 30.0 84.9 33.7 33.6 36.6 57.6 54.7 33.3 39.8 25.2 47.3 56.7 58.6 64.6 22.8 14.9 23.3 40.1 24.6 33.2 56.4 56.4 34.9 31.0 25.0 54.8 91.0 55.0 37.5 68.0 41.7 51.8 47.8 42.3 63.1 43.6 54.6 48.4 91.6 32.8 65.0 61.2 46.5 98.1 69.4 64.3 31.0 91.7 57.5 44.7 54.0 41.4 30.4 24.4 ATP5PB ATP5F1 ENSG00000116459 "ATP synthase peripheral stalk-membrane subunit b" P24539 1 111448864-111462773 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046067, HPA057347" Enhanced Supported Mitochondria "Intracellular and membrane" 640000 Mitochondria "HPA046067: AB_10960850, HPA057347: AB_2683416" "unprognostic (4.18e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-3)" "unprognostic (1.73e-2)" "unprognostic (3.56e-2)" "unprognostic (8.18e-2)" "unprognostic (8.52e-3)" "unprognostic (8.82e-2)" "unprognostic (3.67e-2)" "unprognostic (7.18e-3)" "unprognostic (3.29e-1)" "unprognostic (2.92e-1)" "prognostic favourable (3.26e-9)" "prognostic favourable (8.07e-4)" "unprognostic (1.60e-1)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" 11.6 16.0 16.8 11.4 22.6 8.0 10.4 30.7 28.8 10.7 30.0 10.4 11.3 16.1 14.4 10.7 21.1 13.7 9.7 57.1 16.4 15.4 30.5 26.2 10.2 14.2 16.1 15.5 12.6 15.3 18.0 13.3 16.3 22.8 13.4 17.8 9.8 20.4 12.4 83.6 9.7 25.4 13.7 13.9 13.7 13.1 11.4 10.1 18.7 18.6 34.0 15.4 15.5 11.5 8.3 10.8 4.3 10.0 5.9 11.9 22.9 15.3 3.5 13.1 10.1 8.4 7.6 8.4 17.0 18.8 17.7 14.8 6.2 7.8 21.0 15.9 11.2 16.0 19.0 21.0 15.9 16.6 7.4 21.0 4.9 4.2 6.2 26.4 21.2 6.6 9.0 19.5 18.3 14.1 18.4 9.3 10.1 7.1 45.0 6.2 9.9 24.1 11.6 40.7 8.2 14.0 5.2 9.6 3.0 13.3 19.0 14.0 15.2 9.5 13.6 8.3 14.8 16.2 16.8 12.8 12.1 49.9 20.2 20.1 15.5 1.9 10.0 4.3 9.7 6.4 8.6 7.5 10.8 9.2 10.8 8.3 11.9 7.3 2.9 5.9 5.0 5.9 9.0 22.9 16.8 22.6 30.7 28.8 16.4 15.4 16.1 15.5 22.8 10.1 ATP6AP1 "16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3" ENSG00000071553 "ATPase H+ transporting accessory protein 1" Q15904 X 154428632-154436516 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015218 Uncertain Approved "Plasma membrane,Microtubules,Cytosol" 160000 "Plasma membrane, Microtubules, Cytosol" "CAB015218: " "prognostic unfavourable (2.40e-4)" "unprognostic (1.95e-2)" "unprognostic (2.06e-3)" "unprognostic (2.20e-1)" "prognostic unfavourable (8.94e-4)" "unprognostic (1.84e-3)" "unprognostic (4.99e-3)" "unprognostic (2.57e-1)" "unprognostic (1.10e-2)" "unprognostic (1.84e-1)" "prognostic favourable (7.83e-4)" "unprognostic (1.07e-1)" "prognostic favourable (5.26e-8)" "unprognostic (2.45e-1)" "unprognostic (4.66e-2)" "unprognostic (3.39e-1)" "unprognostic (1.62e-1)" 29.8 37.8 36.6 20.0 50.3 27.5 22.1 59.2 82.7 28.4 26.5 39.4 27.4 24.0 20.6 43.2 29.1 29.6 23.0 35.1 40.8 47.5 42.4 26.9 37.9 21.8 36.5 40.5 24.4 42.6 67.1 41.5 66.1 60.1 41.6 24.7 29.8 35.9 29.4 18.4 30.2 24.2 22.9 39.4 36.4 27.6 21.2 24.2 22.1 39.7 20.9 21.4 27.3 21.1 20.1 68.4 64.0 56.6 23.7 28.9 33.8 22.4 21.4 18.3 31.1 29.7 16.4 34.4 16.6 23.6 25.9 37.8 20.2 28.1 13.3 70.4 35.6 24.1 26.9 15.4 14.3 12.1 27.8 7.6 27.5 20.0 37.4 12.3 56.5 21.8 26.4 24.3 14.0 35.9 9.1 37.6 16.9 32.9 8.9 18.6 6.8 21.9 13.8 12.2 34.5 27.4 18.8 18.3 19.0 14.5 59.3 31.1 26.1 30.4 27.7 18.9 17.1 32.2 27.0 54.3 58.3 15.7 22.6 26.7 19.0 37.4 53.9 64.0 28.6 56.6 28.9 17.5 23.7 24.7 68.4 20.1 21.4 23.5 60.0 23.7 43.4 39.0 26.9 33.8 36.6 50.3 59.2 82.7 40.8 47.5 36.5 40.5 60.1 24.2 ATP6AP1L ENSG00000205464 "ATPase H+ transporting accessory protein 1 like" Q52LC2 5 82279462-82386977 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "MOLT-4: 15.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 8 "dendritic cells: 1.3;NK-cells: 1.5;T-cells: 1.2" HPA053771 Approved Approved Nucleoli,Cytosol Cytosol Nucleoli "HPA053771: " "unprognostic (1.64e-1)" "unprognostic (8.15e-2)" "unprognostic (5.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-1)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (5.09e-1)" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (1.94e-1)" "unprognostic (2.22e-3)" "unprognostic (2.92e-1)" "unprognostic (1.46e-1)" "unprognostic (2.14e-2)" "unprognostic (2.43e-2)" 1.6 1.0 2.6 0.2 2.4 0.6 0.7 2.5 2.1 1.8 1.2 0.1 1.5 0.1 1.4 2.4 1.7 2.0 2.7 1.8 0.8 1.4 1.5 0.7 2.5 4.4 2.4 0.1 2.0 0.7 1.4 0.6 2.6 2.5 3.3 5.1 0.2 0.6 2.7 0.8 1.8 3.8 1.5 0.4 0.9 0.5 0.1 1.3 0.0 0.1 1.5 1.2 0.0 0.1 0.0 0.1 1.0 0.6 0.3 0.0 0.1 0.3 0.4 0.9 0.1 0.0 0.0 0.0 0.8 0.0 0.3 2.8 0.0 1.2 0.6 0.5 0.2 0.3 2.2 0.2 0.0 2.0 1.1 0.0 2.6 0.5 0.7 1.2 0.0 0.2 15.3 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 1.2 0.1 0.7 1.2 0.0 1.5 0.0 1.3 0.0 0.0 ATP6AP2 "APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR" ENSG00000182220 "ATPase H+ transporting accessory protein 2" O75787 X 40579372-40606848 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 176.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003156 Approved "HPA003156: AB_1078245" "unprognostic (1.45e-1)" "unprognostic (3.80e-3)" "unprognostic (1.30e-1)" "unprognostic (7.19e-2)" "unprognostic (8.58e-3)" "unprognostic (1.29e-1)" "unprognostic (1.63e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-1)" "unprognostic (4.15e-2)" "unprognostic (1.45e-1)" "unprognostic (1.09e-1)" "prognostic favourable (2.01e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-1)" "unprognostic (1.62e-2)" "unprognostic (2.86e-2)" 25.0 23.8 33.8 17.4 39.3 30.6 31.7 31.5 76.0 35.0 24.0 22.1 13.0 10.0 30.8 25.5 21.4 22.7 23.9 19.3 35.5 36.7 48.7 30.0 30.2 37.9 32.1 34.7 22.3 16.3 176.7 16.1 30.2 37.8 26.4 25.0 21.0 16.8 31.8 8.7 24.0 16.8 35.7 27.8 22.6 15.8 11.9 17.2 16.2 56.1 12.6 19.1 25.7 20.0 16.1 53.2 60.8 78.0 20.0 29.6 85.8 14.7 19.3 14.1 19.0 93.6 59.6 8.8 33.2 51.5 24.5 28.7 11.1 24.2 8.5 16.5 48.4 15.2 21.7 25.8 33.5 16.6 17.1 10.6 18.8 10.7 34.4 18.8 19.8 51.6 34.6 30.1 24.2 32.6 10.7 23.0 37.0 18.5 8.1 16.4 13.0 21.8 7.7 24.8 28.5 31.6 16.5 10.2 9.5 32.3 20.1 20.2 26.1 17.3 32.0 30.9 16.9 36.8 11.1 7.1 12.3 8.4 25.5 15.9 24.0 34.4 78.0 60.8 25.9 55.1 27.0 16.1 26.4 26.6 53.2 15.7 29.6 27.0 39.5 20.0 54.1 19.3 24.7 85.8 33.8 39.3 31.5 76.0 35.5 36.7 32.1 34.7 37.8 17.2 ATP6V0A1 "a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1" ENSG00000033627 "ATPase H+ transporting V0 subunit a1" Q93050 17 42458844-42522611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2;parathyroid gland: 65.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022144 Enhanced Approved "Nuclear speckles,Golgi apparatus,Vesicles,Cytosol" 21000 "Golgi apparatus, Vesicles" "Nuclear speckles, Cytosol" "HPA022144: AB_1845189" "unprognostic (3.93e-2)" "unprognostic (2.02e-1)" "unprognostic (4.35e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-2)" "unprognostic (8.69e-2)" "unprognostic (1.84e-2)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.85e-1)" "prognostic favourable (2.05e-4)" "unprognostic (3.25e-1)" "prognostic favourable (1.28e-4)" "unprognostic (3.07e-1)" "unprognostic (3.68e-2)" "unprognostic (2.62e-2)" "prognostic unfavourable (6.90e-4)" 9.4 15.6 19.3 9.3 46.1 9.9 9.1 55.8 66.2 8.0 11.6 25.8 5.1 17.9 11.4 11.1 9.6 9.7 12.2 9.9 23.8 32.8 20.3 11.3 12.7 6.6 23.6 24.8 11.4 9.3 65.6 23.6 11.2 43.3 9.9 11.3 19.7 8.2 10.7 28.9 14.7 12.4 11.7 23.7 11.1 8.8 9.8 13.1 5.2 16.3 6.7 7.8 6.7 6.9 6.3 9.1 14.2 10.5 0.1 2.8 4.2 6.5 13.5 8.3 14.8 14.0 12.1 4.8 4.6 8.6 9.9 13.0 8.6 14.7 1.2 8.5 9.5 14.2 12.7 7.8 11.5 10.1 13.4 10.5 10.2 6.8 8.6 4.5 19.2 9.0 11.3 15.8 6.8 7.0 38.1 41.4 14.7 5.6 1.8 4.0 5.3 0.1 0.1 8.6 18.2 11.4 5.2 22.9 12.2 7.2 6.6 13.7 15.9 6.8 4.1 8.4 0.3 12.3 5.5 16.9 22.9 2.5 11.3 0.1 9.8 12.1 10.5 8.0 0.8 3.4 1.2 3.5 0.6 0.1 9.1 6.3 1.0 0.8 14.2 0.1 2.4 4.7 2.8 4.2 19.3 46.1 55.8 65.9 23.8 32.8 23.6 24.8 43.3 13.1 ATP6V0A2 "a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1" ENSG00000185344 "ATPase H+ transporting V0 subunit a2" Q9Y487 12 123712318-123761755 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 13.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044279 Approved Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA044279: AB_10961274" "unprognostic (2.60e-1)" "unprognostic (8.79e-3)" "unprognostic (3.60e-2)" "unprognostic (1.50e-1)" "unprognostic (2.70e-1)" "unprognostic (2.29e-2)" "unprognostic (2.06e-4)" "unprognostic (1.40e-1)" "unprognostic (3.77e-2)" "unprognostic (1.75e-1)" "unprognostic (8.85e-3)" "unprognostic (1.63e-1)" "unprognostic (1.26e-1)" "unprognostic (7.48e-2)" "unprognostic (1.12e-1)" "unprognostic (3.47e-1)" "unprognostic (1.58e-1)" 13.5 9.4 7.2 13.0 9.9 15.5 11.5 16.2 9.8 8.9 13.1 13.0 9.0 16.0 13.4 8.8 9.1 10.4 10.4 13.6 8.0 7.9 8.9 13.7 13.1 16.6 12.8 6.9 9.7 18.1 8.1 10.4 10.2 9.1 9.8 12.0 9.8 24.5 10.0 13.0 20.5 15.8 12.3 9.4 13.1 15.9 15.9 10.8 24.0 10.3 8.6 17.5 11.0 10.3 2.3 3.4 13.1 1.5 2.1 2.7 0.9 3.2 8.3 8.6 11.6 5.1 4.9 5.3 3.9 4.6 5.1 5.6 6.1 2.6 12.5 2.8 5.3 7.0 11.2 4.1 3.8 8.5 6.3 18.0 6.6 3.5 8.1 11.4 37.1 4.4 3.6 6.0 6.5 4.4 10.9 2.3 5.6 9.0 10.8 14.1 9.0 5.5 10.4 7.5 4.0 4.9 8.1 5.2 8.8 6.6 4.6 5.8 4.8 8.4 6.4 6.5 2.5 7.9 6.5 7.5 8.2 11.7 5.4 6.9 5.5 6.4 0.9 13.1 2.1 0.9 1.5 1.3 2.1 1.8 1.1 2.3 1.9 2.7 2.4 2.1 1.5 3.4 1.4 0.9 7.2 9.9 16.2 9.8 8.0 7.9 12.8 6.9 9.1 10.8 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2" "Cell line enhanced" "Detected in some" "HMC-1: 18.6;NB-4: 7.1;THP-1: 12.0;U-937: 37.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 6.9;NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040254 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 2.3 1.2 1.6 1.5 2.1 28.1 1.0 0.6 0.9 26.0 1.5 1.7 1.6 0.4 18.2 3.5 0.6 9.5 3.1 0.8 2.5 0.9 1.0 1.2 3.2 0.7 2.7 0.1 3.9 0.4 0.2 1.1 2.9 2.1 0.7 1.2 0.8 0.9 0.6 0.4 0.5 1.1 2.7 3.1 2.3 0.6 0.9 4.6 0.8 0.5 0.8 2.1 1.3 1.5 0.0 2.2 6.9 1.7 10.6 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.1 0.0 3.0 0.6 0.0 0.0 5.2 18.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 12.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 37.6 0.0 6.9 1.7 2.4 0.5 0.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.8 10.6 0.3 0.0 0.0 0.8 1.6 2.1 0.6 0.9 2.5 0.9 2.7 0.1 2.1 4.6 ATP9B ATPIIB ENSG00000166377 "ATPase phospholipid transporting 9B (putative)" O43861 18 79069285-79378287 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029364 Approved "HPA029364: AB_10602595" "unprognostic (2.84e-3)" "unprognostic (1.66e-1)" "unprognostic (1.88e-1)" "unprognostic (6.51e-3)" "unprognostic (7.32e-2)" "unprognostic (7.66e-4)" "unprognostic (2.45e-2)" "unprognostic (7.43e-2)" "unprognostic (2.55e-2)" "unprognostic (8.21e-2)" "unprognostic (1.61e-1)" "unprognostic (2.93e-1)" "unprognostic (1.92e-3)" "unprognostic (1.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.05e-2)" "unprognostic (1.09e-2)" 14.5 11.0 11.7 16.8 11.6 30.1 11.7 16.8 15.2 14.3 10.7 17.5 15.2 7.1 21.8 17.6 11.3 11.9 14.5 10.7 11.4 8.2 13.1 16.7 13.9 13.2 10.8 9.7 18.2 14.3 25.8 15.5 10.9 11.3 12.8 11.4 12.3 14.2 17.3 18.8 13.3 9.1 14.8 17.1 9.7 11.5 22.1 12.4 19.3 14.6 9.6 16.4 14.6 13.3 9.8 8.4 14.2 16.3 8.6 12.2 6.9 15.4 8.1 11.3 12.5 5.9 9.9 8.8 8.3 5.6 5.0 4.2 8.7 11.0 8.6 13.9 6.0 7.0 9.3 4.6 8.1 13.2 3.9 10.1 9.3 6.1 7.8 18.4 10.9 7.9 5.9 8.1 5.0 6.9 9.7 21.8 7.0 13.5 12.0 7.2 16.1 10.1 11.5 9.4 11.5 7.1 13.4 8.4 8.8 9.3 9.8 5.7 11.5 11.0 12.1 10.5 17.1 4.7 5.5 10.9 17.8 19.4 6.1 12.2 10.8 14.2 12.0 9.1 8.4 10.1 9.8 9.0 9.6 8.1 8.4 9.8 12.2 9.5 13.0 8.6 16.3 8.0 7.4 6.9 11.7 11.6 16.8 15.2 11.4 8.2 10.8 9.7 11.3 12.4 ATR "FRP1, MEC1, SCKL, SCKL1" ENSG00000175054 "ATR serine/threonine kinase" Q13535 3 142449235-142578826 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054320 Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA054320: " "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" "unprognostic (2.90e-1)" "unprognostic (4.23e-2)" "unprognostic (2.25e-2)" "unprognostic (6.42e-2)" "prognostic unfavourable (8.39e-5)" "unprognostic (3.44e-1)" "unprognostic (1.67e-1)" "unprognostic (3.02e-1)" "prognostic unfavourable (1.23e-5)" "unprognostic (1.94e-1)" "unprognostic (5.61e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-1)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" 10.5 24.3 7.7 11.4 15.9 10.1 14.8 11.3 14.6 10.1 8.5 10.0 10.4 6.0 14.7 16.8 9.4 12.1 9.3 8.8 9.8 7.1 9.6 12.0 10.3 16.0 10.0 8.1 12.3 13.6 18.0 22.5 8.8 12.5 11.0 11.2 9.5 12.5 10.8 7.7 11.2 10.9 9.8 8.8 14.2 9.0 15.3 9.7 19.0 13.8 7.7 15.1 10.9 10.6 5.8 2.8 2.2 4.0 6.7 6.0 0.8 22.5 11.1 7.4 8.4 10.6 11.6 8.8 12.4 7.0 9.3 9.6 5.2 7.2 18.4 12.9 8.8 14.6 10.9 11.5 14.1 5.9 7.2 10.1 8.4 5.0 4.7 16.9 5.7 9.1 6.4 8.8 10.5 9.6 7.0 8.3 9.5 9.9 12.7 7.0 7.1 7.9 10.6 10.8 13.3 9.4 10.5 5.3 5.3 22.9 8.3 8.1 12.1 6.9 12.4 9.5 4.8 12.3 13.3 10.8 6.4 17.1 12.3 6.6 7.5 0.7 2.7 2.2 4.4 4.0 6.0 3.1 3.2 4.2 2.8 5.8 4.1 4.0 1.7 6.7 2.5 2.5 2.4 0.8 7.7 15.9 11.3 14.6 9.8 7.1 10.0 8.1 12.5 9.7 ATRAID "APR3, C2orf28, HSPC013, p18" ENSG00000138085 "All-trans retinoic acid induced differentiation factor" Q6UW56 2 27212027-27217178 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051353 Uncertain "HPA051353: " "unprognostic (4.58e-2)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (1.34e-1)" "unprognostic (3.85e-2)" "unprognostic (4.41e-2)" "unprognostic (1.59e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (1.25e-2)" "unprognostic (5.73e-2)" "unprognostic (5.35e-3)" "unprognostic (2.36e-2)" "unprognostic (4.86e-2)" "unprognostic (1.77e-1)" "unprognostic (3.76e-1)" "unprognostic (1.92e-1)" 33.2 41.3 18.0 24.8 19.7 19.7 51.7 11.8 20.8 38.3 34.2 26.0 47.0 18.6 36.9 119.7 35.4 43.0 37.0 77.9 17.4 17.1 41.5 34.8 41.6 42.9 24.7 13.8 46.5 70.7 34.2 33.0 60.0 23.7 41.0 30.5 41.0 37.5 48.1 39.9 27.9 33.6 41.0 22.4 28.1 32.9 54.1 21.2 22.5 52.7 32.4 29.3 33.5 30.1 63.9 70.8 48.0 59.8 42.4 62.8 92.9 24.9 30.3 17.1 31.0 95.9 57.0 26.3 15.6 50.7 21.2 19.6 24.2 40.0 12.1 26.9 44.5 22.8 15.7 28.3 17.4 19.2 15.2 14.4 18.6 35.9 43.0 12.6 19.6 44.8 62.0 17.9 40.4 27.2 14.6 43.0 32.0 33.4 15.1 34.6 25.7 24.8 13.7 44.5 59.5 35.7 14.5 18.7 26.7 18.0 24.2 24.2 20.6 21.0 16.7 32.3 18.4 11.6 15.6 60.2 47.7 31.6 34.2 25.6 30.9 37.5 59.8 48.0 51.2 52.3 52.2 63.9 58.9 57.9 61.0 60.3 62.7 57.5 13.4 42.4 54.1 70.8 62.8 92.9 18.0 19.7 11.8 20.8 17.4 17.1 24.7 13.8 23.7 21.2 ATRN "DPPT-L, MGCA" ENSG00000088812 Attractin O75882 20 3471040-3651122 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008853 Approved Approved Cytosol "Secreted to blood" 39000000000 Cytosol "HPA008853: AB_1078248" "unprognostic (6.42e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (2.52e-1)" "unprognostic (5.27e-2)" "unprognostic (1.65e-1)" "unprognostic (3.99e-2)" "unprognostic (4.28e-1)" "unprognostic (3.40e-2)" "unprognostic (4.61e-2)" "unprognostic (1.59e-1)" "prognostic favourable (2.19e-6)" "unprognostic (3.71e-2)" "unprognostic (9.49e-2)" "unprognostic (2.77e-1)" "unprognostic (3.91e-2)" 12.1 22.8 14.9 7.4 20.7 5.7 13.0 18.4 29.3 13.5 22.8 18.3 7.4 39.9 12.2 12.2 9.3 9.2 12.4 14.8 13.6 14.7 18.4 45.2 10.6 7.1 12.8 18.9 11.5 17.7 40.3 13.4 16.5 16.1 10.1 9.5 12.2 14.0 10.7 11.7 13.6 31.1 11.3 15.2 9.7 17.1 16.2 12.3 5.4 24.1 7.5 7.1 12.0 9.8 3.6 5.7 5.7 6.5 3.0 4.8 1.9 17.7 16.7 9.9 8.3 17.7 28.9 12.8 11.9 16.9 12.5 10.6 7.2 12.2 0.0 8.0 16.6 24.9 6.7 25.9 16.8 1.9 5.7 5.5 4.6 15.4 10.6 11.7 3.8 15.4 21.0 13.2 12.8 16.2 8.7 8.7 12.1 5.1 4.7 4.5 6.7 10.1 4.0 23.2 13.3 11.4 12.6 5.9 9.2 11.9 22.2 16.2 11.8 11.2 19.9 13.4 7.9 14.0 11.7 6.1 8.6 0.0 8.2 7.9 13.3 5.7 6.5 3.6 4.8 5.6 2.3 2.8 2.7 3.0 5.7 3.6 4.4 3.7 0.0 3.0 5.7 5.3 3.4 1.9 14.9 20.7 18.4 29.3 13.6 14.7 12.8 18.9 16.1 12.3 ATRNL1 "ALP, FLJ45344, KIAA0534" ENSG00000107518 "Attractin like 1" Q5VV63 10 115093365-115948992 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell line enhanced" "Detected in many" "AN3-CA: 20.4;LHCN-M2: 9.3;RH-30: 13.7;SH-SY5Y: 9.8;U-266/70: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038070 Uncertain Approved Nucleoplasm,Mitochondria 33000000 "Nucleoplasm, Mitochondria" "HPA038070: AB_10697237" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "unprognostic (5.88e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.88e-2)" "unprognostic (5.17e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" "unprognostic (2.50e-2)" "unprognostic (1.04e-3)" "unprognostic (3.10e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (2.08e-3)" 0.9 11.7 8.6 0.7 15.9 0.3 2.1 2.2 26.0 0.9 2.3 2.1 1.1 0.8 12.0 1.1 1.5 1.0 0.8 2.9 9.3 5.8 4.8 2.9 0.6 1.0 4.0 15.7 17.5 2.3 0.3 11.1 3.3 8.4 6.9 0.9 2.0 1.8 8.3 3.8 0.6 1.0 13.4 2.0 0.8 0.9 13.0 2.5 0.0 2.0 0.0 0.9 1.1 1.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.2 20.4 0.0 0.0 0.0 0.1 0.4 3.0 4.4 0.1 0.1 0.0 1.4 0.5 0.0 1.1 0.0 3.5 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 6.9 9.3 0.2 8.0 0.0 6.6 0.1 5.9 13.7 8.8 3.1 0.0 3.4 9.8 0.0 0.0 0.2 1.2 0.0 0.0 0.0 2.5 0.0 2.9 11.3 0.0 3.3 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 15.9 2.2 26.0 9.3 5.8 4.0 15.7 8.4 2.5 ATXN3 "ATX3, JOS, MJD, SCA3" ENSG00000066427 "Ataxin 3" P54252 14 92044496-92106625 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB021976, HPA024123, HPA069338" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB021976: , HPA024123: AB_1845133, HPA069338: " "unprognostic (1.06e-2)" "unprognostic (2.93e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-2)" "unprognostic (5.76e-2)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (9.85e-3)" "unprognostic (1.69e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-2)" "unprognostic (3.06e-2)" "unprognostic (2.03e-2)" "unprognostic (8.94e-3)" "unprognostic (4.22e-1)" "unprognostic (1.64e-1)" "unprognostic (1.11e-1)" 17.8 10.3 10.2 9.1 11.6 14.3 12.8 18.7 12.1 16.0 11.8 12.2 11.9 6.4 17.9 12.4 17.7 9.5 11.2 10.4 9.0 9.9 9.9 16.0 12.3 11.6 16.3 9.5 14.0 10.3 11.9 17.2 11.7 13.8 15.8 11.7 8.6 11.4 10.2 6.1 21.0 8.7 20.6 16.5 12.6 9.0 14.8 14.3 16.2 11.5 12.0 15.6 15.4 13.6 9.8 14.5 11.4 18.8 7.0 8.5 5.3 5.6 11.1 10.0 9.3 14.6 14.3 19.6 6.4 10.4 8.2 11.4 8.0 15.7 11.5 12.8 10.5 9.8 7.7 14.0 18.1 13.1 2.3 4.9 5.4 11.7 12.1 8.6 8.8 11.6 12.5 14.3 15.0 12.6 6.5 8.6 12.4 21.9 9.0 7.8 7.1 9.2 7.2 18.5 6.5 10.5 12.8 3.4 6.0 15.5 6.6 8.8 12.3 6.0 6.7 8.1 11.9 5.2 3.4 7.5 12.5 10.6 6.0 8.5 4.7 11.4 13.4 9.4 5.9 14.5 7.0 7.1 6.9 6.5 14.5 9.8 7.6 8.5 11.3 7.0 18.8 8.4 6.8 5.3 10.2 11.6 18.7 12.1 9.0 9.9 16.3 9.5 13.8 14.3 AVL9 KIAA0241 ENSG00000105778 "AVL9 cell migration associated" Q8NBF6 7 32495426-32588721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050957 Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA050957: " "unprognostic (2.33e-2)" "unprognostic (8.75e-3)" "unprognostic (3.45e-2)" "unprognostic (1.94e-1)" "unprognostic (8.07e-2)" "unprognostic (5.72e-3)" "unprognostic (5.14e-3)" "unprognostic (4.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (4.21e-2)" "unprognostic (9.03e-2)" "unprognostic (1.68e-2)" "unprognostic (3.68e-2)" "unprognostic (9.22e-2)" "unprognostic (4.40e-2)" "unprognostic (1.05e-1)" 12.0 15.8 17.4 16.7 22.9 12.2 15.6 24.1 25.7 14.2 22.5 12.9 14.0 18.8 13.1 18.6 12.4 12.9 11.6 8.8 16.6 20.0 15.6 11.9 12.0 14.1 14.5 15.1 13.8 15.9 12.7 15.9 16.3 17.3 14.4 26.2 15.4 15.2 12.8 12.6 11.6 19.9 12.2 11.5 14.3 17.4 10.0 10.3 21.3 19.3 6.6 15.8 12.9 11.0 12.5 9.9 27.4 10.7 5.1 10.9 9.4 9.7 8.6 9.0 12.2 5.5 7.9 6.3 8.8 11.7 8.7 11.8 6.7 13.2 12.4 0.2 7.7 8.1 8.6 8.7 14.8 5.3 5.3 9.2 6.0 7.3 20.2 15.7 12.2 8.5 8.6 11.1 12.8 12.8 22.5 11.4 27.3 10.0 6.3 13.2 10.1 7.6 6.1 10.0 9.3 9.2 16.6 19.5 12.5 7.4 18.4 7.9 13.1 14.4 9.7 9.1 10.8 7.1 7.6 26.4 22.9 19.8 18.0 14.9 19.8 12.8 10.7 15.5 10.6 8.4 9.1 9.9 8.8 9.9 8.2 12.5 10.9 9.5 27.4 5.1 7.9 9.9 8.0 9.4 17.4 22.9 24.1 25.7 16.6 20.0 14.5 15.1 17.3 10.3 AWAT1 DGAT2L3 ENSG00000204195 "Acyl-CoA wax alcohol acyltransferase 1" Q58HT5 X 70234655-70240627 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "breast: 3.8;skin 1: 6.1" "Cell line enhanced" "Detected in single" "HEK 293: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA063412 Enhanced "HPA063412: " "unprognostic (1.12e-1)" "unprognostic (1.78e-1)" "unprognostic (1.96e-2)" "unprognostic (4.90e-2)" "unprognostic (2.08e-1)" "unprognostic (6.78e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AXL "ARK, JTK11, Tyro7, UFO" ENSG00000167601 "AXL receptor tyrosine kinase" P30530 19 41219203-41261766 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Differentiation, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Oncogene, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 66.1;U-251 MG: 70.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 8.8;plasmacytoid DC: 18.3" "Group enriched" "Detected in many" 14 "dendritic cells: 18.3;NK-cells: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032501, HPA037422, HPA037423, HPA075217" Uncertain Supported "Vesicles,Plasma membrane,Actin filaments" 61000000 "Plasma membrane" "Vesicles, Actin filaments" "CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: , HPA075217: " "unprognostic (2.20e-1)" "unprognostic (2.02e-1)" "unprognostic (6.79e-3)" "unprognostic (1.01e-1)" "unprognostic (1.40e-1)" "unprognostic (8.49e-3)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (3.15e-2)" "unprognostic (2.82e-2)" "unprognostic (9.57e-3)" "unprognostic (1.98e-1)" "prognostic unfavourable (2.53e-7)" "unprognostic (1.16e-3)" "unprognostic (1.52e-2)" "unprognostic (5.56e-2)" "unprognostic (4.83e-3)" 38.0 15.4 10.6 11.7 12.7 1.3 27.1 6.3 12.1 26.2 26.8 13.4 8.1 9.1 28.0 19.4 21.8 17.4 17.8 18.5 11.5 6.1 7.8 13.0 20.0 7.6 10.6 9.3 20.9 5.1 9.6 5.6 26.6 10.1 19.5 10.2 16.8 7.8 20.4 14.1 13.8 12.8 29.4 10.7 27.3 16.2 22.4 10.4 3.4 12.0 8.4 5.8 35.6 18.3 0.1 18.3 0.9 0.2 8.8 0.3 0.2 52.5 21.2 1.3 0.1 4.8 4.8 0.0 41.8 37.6 61.4 38.1 1.1 24.7 0.0 17.0 66.1 4.4 0.0 28.1 52.9 0.0 0.0 0.0 14.0 0.8 17.4 0.0 0.0 3.6 0.5 36.2 56.2 22.7 2.0 0.0 38.0 0.0 0.0 0.0 0.5 10.2 0.0 22.4 0.0 27.4 0.0 0.0 0.0 10.8 0.0 0.2 0.1 0.9 46.6 43.5 29.7 41.5 70.8 0.0 0.1 0.1 29.0 0.0 32.3 0.9 0.2 0.1 0.1 0.2 0.2 0.1 0.3 0.1 4.2 0.1 0.2 0.2 0.3 8.8 0.1 18.3 0.2 0.2 10.6 12.7 6.3 12.1 11.5 6.1 10.6 9.3 10.1 10.4 B3GALT2 beta3Gal-T2 ENSG00000162630 "Beta-1,3-galactosyltransferase 2" O43825 1 193179045-193186654 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;gallbladder: 19.0;heart muscle: 25.1" "Group enriched" "Detected in some" 4 "AF22: 16.0;ASC TERT1: 7.3;LHCN-M2: 10.9;WM-115: 19.0" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 11.9" "Lineage enriched" "Detected in single" 57 "T-cells: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078659 Approved "Plasma membrane,Microtubules" "Plasma membrane, Microtubules" "HPA078659: " "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (1.58e-3)" "unprognostic (2.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" "unprognostic (6.14e-4)" "unprognostic (4.41e-2)" "unprognostic (8.10e-3)" "unprognostic (2.72e-1)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-3)" 0.7 2.0 11.3 1.3 8.9 0.7 0.9 1.4 32.9 0.8 1.7 1.2 0.9 1.6 0.6 1.8 1.2 0.7 19.0 25.1 10.1 7.9 1.7 0.8 2.6 0.7 5.7 19.1 13.8 0.8 0.4 0.9 0.9 5.0 6.5 2.0 0.3 0.5 7.1 0.6 0.7 4.1 0.8 6.5 1.4 2.1 1.4 4.7 0.0 1.8 0.0 1.6 2.0 0.7 0.0 0.2 0.1 0.0 0.0 11.9 0.3 0.0 0.0 16.0 0.0 0.4 7.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.4 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.2 0.0 11.9 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.3 0.3 11.3 8.9 1.4 32.9 10.1 7.9 5.7 19.1 5.0 4.7 B3GAT2 GlcAT-S ENSG00000112309 "Beta-1,3-glucuronyltransferase 2" Q9NPZ5 6 70856679-70957038 "Enzymes, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 27.2" "Cell line enriched" "Detected in some" 20 "SCLC-21H: 22.2" "Group enriched" "Detected in some" 20 "glioma: 4.7;testis cancer: 1.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012059 Uncertain "HPA012059: AB_2061050" "unprognostic (7.10e-3)" "unprognostic (7.81e-2)" "unprognostic (1.63e-1)" "unprognostic (1.10e-3)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.96e-2)" "unprognostic (4.88e-2)" "unprognostic (4.22e-2)" "unprognostic (9.16e-4)" "unprognostic (8.09e-2)" "unprognostic (7.43e-3)" "unprognostic (6.88e-7)" "unprognostic (2.72e-2)" "unprognostic (3.35e-2)" "unprognostic (2.53e-2)" "unprognostic (3.45e-3)" 1.8 1.5 9.5 1.9 7.8 1.6 1.1 3.2 27.2 0.8 1.1 26.2 0.0 2.3 1.4 1.1 1.4 1.1 1.4 1.5 19.2 11.5 1.0 1.3 1.2 2.0 9.7 13.6 1.1 2.2 0.8 0.5 1.2 21.0 1.3 0.9 0.4 1.5 0.9 1.5 1.9 2.4 1.1 17.3 2.0 1.5 2.9 16.3 0.0 1.5 0.0 0.9 1.3 0.9 1.2 1.0 2.0 1.2 1.1 2.2 0.2 0.3 0.0 0.6 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.2 1.1 0.1 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.5 0.7 0.1 0.1 0.2 0.2 0.0 0.2 22.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 1.3 1.2 1.2 1.0 1.0 0.9 1.0 1.5 2.1 0.4 1.2 1.7 1.8 2.0 1.1 1.1 1.0 2.2 0.2 9.5 7.8 3.2 11.2 19.2 11.5 9.7 13.6 21.0 16.3 B3GNT2 "B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT" ENSG00000170340 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2" Q9NY97 2 62196113-62224731 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005997 Approved Approved Vesicles 43000000 Vesicles "HPA005997: AB_1845234" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (2.64e-2)" "unprognostic (1.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.51e-1)" "unprognostic (1.55e-2)" "unprognostic (2.13e-2)" "unprognostic (3.76e-1)" "prognostic unfavourable (1.62e-4)" "unprognostic (3.63e-1)" "unprognostic (1.11e-2)" "unprognostic (9.55e-2)" "unprognostic (3.05e-2)" "unprognostic (3.18e-1)" "unprognostic (1.25e-1)" 18.9 14.3 8.6 10.8 23.0 41.6 17.5 3.1 14.1 18.4 17.9 7.4 5.6 17.9 19.8 8.0 24.5 8.7 18.1 20.9 7.6 11.5 24.4 14.2 23.9 13.9 9.7 7.1 9.0 43.2 5.4 25.9 22.8 9.5 7.5 16.3 14.4 17.2 6.0 5.2 13.0 21.7 16.3 7.6 14.6 12.0 7.0 10.6 27.0 15.6 8.5 18.5 11.8 14.7 8.4 6.8 28.3 5.6 20.3 19.3 8.2 7.6 5.3 8.1 3.5 8.9 4.0 23.3 7.5 8.3 6.0 8.0 10.9 12.4 8.3 6.9 6.9 7.4 5.1 6.3 10.4 17.3 4.1 20.5 2.5 6.4 6.7 12.2 9.2 4.9 11.9 11.5 4.1 8.9 11.1 5.2 7.2 5.8 23.2 18.3 7.7 2.2 42.6 5.6 4.5 11.4 7.5 7.8 5.8 5.3 11.5 8.6 3.3 14.4 10.1 7.3 6.4 12.2 7.4 14.8 5.2 35.9 5.7 21.2 7.0 7.2 4.5 28.3 11.0 4.4 15.6 7.6 8.2 19.3 5.5 8.4 9.9 14.4 11.3 20.3 5.6 6.8 13.2 8.2 8.6 23.0 3.1 14.1 7.6 11.5 9.7 7.1 9.5 10.6 B4GALNT2 "Cad, GALGT2, Sda" ENSG00000167080 "Beta-1,4-N-acetyl-galactosaminyltransferase 2" Q8NHY0 17 49132460-49176840 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.6;lymphoid tissue: 30.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA015721 Approved "HPA015721: AB_1845245" "unprognostic (4.39e-4)" "unprognostic (3.18e-1)" "unprognostic (8.26e-3)" "unprognostic (2.03e-4)" "unprognostic (1.72e-2)" "unprognostic (2.62e-2)" "unprognostic (3.67e-2)" "unprognostic (7.67e-2)" "unprognostic (4.06e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-1)" "prognostic favourable (1.29e-5)" "unprognostic (3.53e-1)" "unprognostic (1.31e-1)" "unprognostic (7.81e-3)" "unprognostic (2.15e-1)" 0.3 0.8 0.4 30.9 0.5 2.2 0.4 0.3 0.5 0.3 19.6 0.3 0.3 0.7 0.3 0.3 0.5 0.4 4.0 0.3 0.3 0.3 8.3 0.3 1.1 0.8 0.3 0.3 0.3 0.5 0.0 0.4 0.7 0.6 0.3 7.9 0.4 1.7 0.3 0.3 1.8 11.9 1.3 1.1 0.8 5.3 0.7 0.3 0.3 10.3 0.3 0.8 0.3 1.4 2.0 1.2 2.3 0.6 0.6 1.6 0.2 1.5 2.9 2.9 5.1 0.1 0.1 1.5 2.2 1.6 0.1 0.2 6.0 2.4 3.5 3.5 0.1 1.6 1.1 0.1 0.4 3.0 3.2 3.8 7.2 3.5 0.1 1.9 6.1 0.3 2.1 0.6 0.3 0.0 2.1 5.8 0.1 1.8 2.5 2.6 3.6 1.5 4.2 1.3 1.1 8.2 2.4 2.7 2.6 1.0 1.3 1.1 3.1 2.5 1.1 3.7 2.3 2.3 1.1 4.4 1.4 3.7 1.3 2.6 1.5 2.3 0.6 0.9 1.1 0.5 0.6 1.3 1.2 0.8 0.5 2.0 1.6 1.5 1.2 0.6 0.3 1.2 0.6 0.2 0.4 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.6 0.3 B4GALT1 "beta4Gal-T1, GGTB2" ENSG00000086062 "Beta-1,4-galactosyltransferase 1" P15291 9 33104082-33167356 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 55.7;SiHa: 105.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 56.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA010806, HPA010807" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" 98000000 "Golgi apparatus" "HPA010806: AB_1078255, HPA010807: AB_1078254" "unprognostic (7.57e-2)" "unprognostic (1.24e-2)" "unprognostic (2.09e-1)" "prognostic favourable (6.85e-7)" "unprognostic (1.83e-2)" "unprognostic (9.94e-2)" "unprognostic (3.08e-2)" "prognostic unfavourable (1.25e-4)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-3)" "unprognostic (2.78e-1)" "unprognostic (7.93e-3)" "unprognostic (4.98e-2)" "unprognostic (3.91e-2)" "unprognostic (7.07e-2)" "unprognostic (3.46e-2)" 32.0 19.5 4.5 22.5 4.5 22.1 35.1 5.9 3.5 25.4 20.4 6.4 29.1 6.5 19.5 34.1 24.7 26.3 24.2 33.1 3.2 2.5 31.7 91.2 34.9 44.9 5.8 2.2 56.8 20.1 30.2 11.9 79.0 5.9 22.6 11.1 32.1 39.1 42.7 15.0 17.6 18.9 17.7 6.4 38.5 19.9 37.6 3.6 23.1 39.3 16.9 41.0 26.4 21.6 24.8 56.4 24.9 9.1 18.2 16.5 5.4 15.9 11.8 2.2 3.0 11.2 19.8 39.9 16.6 20.9 10.0 10.0 7.2 18.6 6.1 10.6 24.2 8.6 2.2 20.6 10.1 55.7 2.2 3.5 49.2 5.5 22.1 2.8 5.9 22.1 36.9 11.4 14.0 10.6 3.9 7.6 9.5 13.9 2.5 5.7 1.3 3.6 3.4 2.0 4.0 30.1 13.9 1.6 2.1 105.0 20.5 4.1 25.9 5.2 9.8 7.2 8.5 23.1 6.4 1.2 2.8 3.8 22.3 3.9 2.6 6.2 9.1 5.0 13.0 7.8 16.5 24.8 8.7 11.4 6.1 20.7 5.3 6.7 24.9 18.2 6.0 56.4 5.7 5.4 4.5 4.5 5.9 3.5 3.2 2.5 5.8 2.2 5.9 3.6 B4GALT2 beta4Gal-T2 ENSG00000117411 "Beta-1,4-galactosyltransferase 2" O60909 1 43978943-43991170 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007620, HPA047739" Supported Supported "Golgi apparatus,Vesicles" 12000 "Golgi apparatus, Vesicles" "HPA007620: , HPA047739: " "unprognostic (1.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (7.59e-2)" "unprognostic (1.19e-1)" "unprognostic (2.35e-1)" "prognostic unfavourable (2.96e-5)" "unprognostic (1.12e-2)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" "unprognostic (4.23e-3)" "unprognostic (7.58e-2)" "prognostic unfavourable (3.62e-5)" "unprognostic (6.54e-2)" "unprognostic (1.52e-1)" "unprognostic (7.66e-2)" "unprognostic (3.12e-3)" 18.6 8.6 34.5 10.1 22.4 4.6 15.6 8.1 35.7 18.4 16.1 16.1 10.7 9.4 13.3 8.5 20.2 11.4 11.9 23.3 25.3 18.9 8.4 24.2 7.7 4.4 18.9 15.6 15.3 39.5 9.9 10.6 9.9 12.7 13.5 10.4 8.7 21.4 21.5 41.0 19.5 9.4 21.3 16.1 5.2 11.2 11.4 11.3 1.9 9.0 12.1 10.1 16.5 11.7 1.7 0.4 0.1 0.6 0.2 2.6 0.7 19.8 14.5 15.2 25.8 20.6 18.5 15.2 22.6 18.6 18.0 16.5 9.5 17.6 13.1 11.5 36.0 13.8 13.5 23.1 8.4 13.2 25.7 8.7 10.1 21.8 16.7 8.3 0.3 16.1 27.0 12.9 26.4 20.8 16.4 8.5 14.0 14.3 4.3 8.3 21.1 18.2 15.6 20.4 20.5 12.7 9.3 27.6 22.9 9.9 31.2 15.1 13.6 9.9 16.3 31.3 40.2 21.6 25.1 3.0 5.9 5.6 14.0 6.3 20.9 0.0 0.2 0.0 2.6 0.6 2.4 1.7 1.2 2.2 0.4 0.5 0.0 2.0 0.1 0.2 0.1 0.2 1.1 0.7 34.5 22.4 8.1 35.7 25.3 18.9 18.9 15.6 12.7 11.3 BACE1 BACE ENSG00000186318 "Beta-secretase 1" P56817 11 117285207-117316259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 53.0;pancreas: 161.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016358 Approved Supported "Plasma membrane" "Plasma membrane" "CAB016358: AB_626716" "unprognostic (7.96e-3)" "unprognostic (8.05e-2)" "unprognostic (3.55e-2)" "unprognostic (3.05e-3)" "unprognostic (8.94e-2)" "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (8.09e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.35e-2)" "unprognostic (1.16e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (6.76e-4)" 6.5 7.1 12.1 3.8 18.8 2.2 5.5 9.6 22.4 9.8 4.6 42.5 2.7 3.4 9.3 5.6 7.6 8.6 9.1 5.9 16.9 12.4 6.8 12.1 7.3 2.8 28.8 15.0 11.4 161.1 12.8 4.2 6.3 26.4 6.5 4.7 6.9 5.3 9.9 6.2 7.2 3.6 11.7 53.0 5.7 4.9 4.1 21.4 0.0 6.3 2.3 2.8 6.7 5.5 4.0 2.2 0.7 3.2 2.2 6.7 1.1 3.9 4.6 9.6 14.7 32.0 34.5 0.4 21.2 18.5 10.3 8.4 3.6 6.2 0.7 5.2 38.3 6.9 10.3 6.1 8.5 2.3 5.5 2.3 7.9 4.3 15.8 0.8 0.5 29.9 9.5 13.2 12.8 8.9 0.8 0.4 18.9 14.2 0.6 1.9 6.2 10.4 1.8 4.3 0.8 4.4 2.2 12.5 14.0 7.9 1.0 2.3 10.2 2.7 12.1 18.6 2.0 19.4 6.8 0.3 0.3 0.4 8.7 1.2 13.0 0.6 2.0 0.7 2.0 3.2 5.2 4.0 6.7 5.3 2.2 1.8 3.1 2.7 0.0 2.2 1.3 1.3 6.3 1.1 12.1 18.8 9.6 21.7 16.9 12.4 28.8 15.0 26.4 21.4 BACE2 "AEPLC, ALP56, CEAP1, DRAP" ENSG00000182240 "Beta-site APP-cleaving enzyme 2" Q9Y5Z0 21 41167801-41282518 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 16.9;SK-BR-3: 28.6;SK-MEL-30: 22.2;WM-115: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 4.8;eosinophil: 8.4" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.4" "Low region specificity" "Detected in all" HPA035416 Approved "Intracellular and membrane" "HPA035416: " "unprognostic (1.71e-2)" "prognostic unfavourable (1.11e-4)" "unprognostic (5.23e-2)" "unprognostic (8.12e-3)" "prognostic unfavourable (5.86e-4)" "unprognostic (1.52e-2)" "unprognostic (2.58e-2)" "unprognostic (2.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.49e-1)" "unprognostic (3.46e-2)" "unprognostic (8.50e-2)" "unprognostic (1.22e-1)" "unprognostic (4.04e-1)" "unprognostic (2.10e-1)" "unprognostic (2.76e-2)" "unprognostic (5.83e-2)" 16.1 2.5 1.4 5.9 1.6 0.9 13.8 0.9 2.0 9.0 11.0 3.4 5.6 5.1 10.3 10.7 13.0 6.8 38.9 7.2 1.7 1.6 11.4 4.4 4.9 21.6 2.7 0.5 8.4 29.0 3.3 2.2 17.2 4.4 22.7 7.4 8.7 28.3 4.4 10.6 5.5 5.4 7.8 5.9 7.0 31.6 5.1 1.4 1.3 9.9 7.6 14.3 11.8 33.6 1.0 0.0 8.4 0.0 0.3 0.0 0.0 16.9 1.6 5.7 0.0 1.5 1.6 0.0 4.2 0.0 2.9 2.5 0.0 6.5 0.0 8.0 5.3 5.3 0.0 10.0 1.0 0.0 8.4 3.3 1.9 0.0 0.7 0.0 8.0 4.1 1.9 0.3 2.1 8.4 0.0 0.0 4.0 3.1 1.9 0.0 4.4 8.7 0.6 0.0 6.3 5.2 1.1 0.2 0.0 0.3 28.6 22.2 8.0 0.0 8.3 4.7 3.4 3.8 6.0 0.0 0.0 0.0 9.8 0.0 20.3 4.8 0.0 8.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 1.6 0.9 2.0 1.7 1.6 2.7 0.5 4.4 1.4 BAK1 "BAK, BCL2L7, CDN1" ENSG00000030110 "BCL2 antagonist/killer 1" Q16611 6 33572547-33580293 "Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005029 Enhanced "CAB005029: AB_562051" "unprognostic (3.52e-1)" "unprognostic (2.58e-1)" "unprognostic (1.26e-1)" "prognostic unfavourable (1.71e-4)" "unprognostic (5.67e-2)" "unprognostic (6.58e-3)" "prognostic unfavourable (4.52e-4)" "prognostic unfavourable (5.64e-4)" "unprognostic (2.36e-1)" "unprognostic (1.73e-1)" "unprognostic (2.80e-3)" "unprognostic (2.09e-1)" "prognostic unfavourable (1.64e-5)" "unprognostic (6.07e-2)" "unprognostic (3.36e-2)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" 8.9 19.8 6.5 14.5 9.3 15.6 5.2 6.7 10.4 7.0 21.2 8.7 6.2 30.9 7.6 7.1 22.1 6.1 14.0 13.8 6.0 5.0 12.7 8.2 9.6 13.0 6.0 7.2 7.1 9.6 6.2 8.7 9.8 7.7 7.9 16.9 8.1 13.1 6.4 10.9 12.6 29.1 8.9 6.2 21.8 14.0 6.0 7.0 15.4 6.8 9.6 18.2 12.2 7.9 12.1 18.8 35.6 27.9 9.2 24.4 20.3 14.5 8.1 8.6 12.9 5.8 5.8 11.0 7.5 6.1 21.8 17.1 16.5 11.4 12.7 13.2 11.1 15.2 16.3 30.8 9.7 14.5 17.4 8.0 7.6 13.3 15.1 17.1 13.1 9.5 24.6 18.2 21.5 11.8 7.2 11.5 8.0 21.3 14.8 11.4 9.5 20.0 14.3 8.3 23.2 18.4 12.0 10.6 7.9 9.7 31.2 14.4 10.2 29.1 11.1 11.6 12.3 7.5 9.7 30.6 37.7 10.7 3.9 20.6 12.7 23.8 19.8 35.6 16.3 27.9 18.6 12.1 15.3 16.3 18.8 8.4 8.6 11.2 13.7 9.2 23.4 6.5 24.4 20.3 6.5 9.3 6.7 10.4 6.0 5.0 6.0 7.2 7.7 7.0 BAMBI NMA ENSG00000095739 "BMP and activin membrane bound inhibitor" Q13145 10 28677342-28682939 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 46.8;seminal vesicle: 52.4" "Cell line enhanced" "Detected in many" "CACO-2: 42.8;SK-MEL-30: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA010819, HPA010866" Approved Approved "Nucleoli fibrillar center,Vesicles,Lipid droplets" Vesicles "Nucleoli fibrillar center, Lipid droplets" "HPA010819: , HPA010866: AB_10601686" "unprognostic (7.02e-3)" "unprognostic (4.52e-2)" "unprognostic (1.28e-2)" "unprognostic (3.17e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (9.42e-6)" "unprognostic (1.09e-1)" "unprognostic (6.45e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-3)" "unprognostic (9.29e-2)" "prognostic favourable (5.25e-4)" "unprognostic (1.01e-1)" "unprognostic (3.24e-1)" "unprognostic (2.38e-2)" "unprognostic (2.10e-2)" 2.0 24.7 6.7 1.8 6.9 3.0 13.6 2.2 6.3 3.9 2.3 12.9 15.5 1.1 10.1 2.0 1.1 2.8 3.0 22.8 6.7 6.4 11.2 12.9 5.7 3.1 12.0 2.9 46.8 3.9 7.4 4.5 20.9 10.5 6.5 2.8 30.4 3.8 52.4 1.2 2.7 1.1 12.7 10.8 9.0 2.3 4.8 7.9 0.1 0.6 2.1 1.3 13.8 11.6 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.2 10.8 1.1 0.6 1.3 0.0 6.5 2.6 0.9 4.2 2.7 42.8 4.5 0.1 1.6 1.9 3.2 2.6 0.4 1.9 2.6 6.0 10.1 1.6 16.2 1.5 0.6 13.4 1.0 0.6 2.8 0.4 0.6 5.7 4.9 0.8 17.8 0.0 0.7 19.6 2.7 0.1 2.0 0.9 3.4 10.4 1.8 1.4 3.5 20.8 51.1 6.1 0.7 0.0 2.8 2.1 4.5 1.3 0.1 3.7 0.0 0.2 2.3 17.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.7 6.9 2.2 4.8 6.7 6.4 12.0 2.9 10.5 7.9 BCAM "CD239, LU" ENSG00000187244 "Basal cell adhesion molecule (Lutheran blood group)" P50895 19 44809059-44821421 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Blood group antigen, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 101.8" "Cell line enhanced" "Detected in many" "BEWO: 30.8;HaCaT: 62.8;SK-BR-3: 58.9;T-47d: 33.4;U-2 OS: 28.9" "Cancer enhanced" "Detected in all" "ovarian cancer: 493.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005654 Uncertain Approved "Nucleoli fibrillar center" 16000000 "Nucleoli fibrillar center" "HPA005654: " "unprognostic (5.63e-2)" "unprognostic (2.98e-2)" "prognostic unfavourable (2.31e-4)" "prognostic unfavourable (1.24e-5)" "unprognostic (1.60e-2)" "unprognostic (1.23e-3)" "unprognostic (2.01e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (6.17e-2)" "unprognostic (2.61e-3)" "unprognostic (1.41e-1)" "prognostic favourable (5.94e-6)" "unprognostic (1.83e-2)" "unprognostic (5.74e-2)" "unprognostic (2.14e-2)" "unprognostic (9.97e-3)" 28.9 7.2 4.9 8.1 5.4 1.4 33.1 3.4 8.7 33.5 8.5 4.4 17.8 5.7 24.8 26.5 15.6 46.3 23.2 23.8 4.5 4.2 101.8 13.2 41.6 5.8 4.4 6.5 30.4 17.8 5.8 9.8 28.7 7.0 42.7 2.4 21.4 17.8 27.3 16.7 12.7 7.4 12.5 3.8 14.2 9.6 13.6 2.6 5.7 93.0 23.7 8.5 14.2 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.1 9.2 0.2 25.6 0.1 0.1 30.8 2.8 1.3 2.3 1.5 13.8 17.6 0.0 14.2 0.3 62.8 2.2 15.7 0.7 0.0 1.6 0.0 1.9 19.1 5.2 0.0 3.4 2.5 6.1 0.8 0.9 1.4 1.4 0.1 0.3 3.6 0.0 0.2 2.9 3.2 0.1 3.0 0.7 19.2 4.5 0.0 0.1 11.4 58.9 0.6 33.4 1.0 3.7 0.6 28.9 0.7 1.3 0.1 0.2 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.9 5.4 3.4 8.7 4.5 4.2 4.4 6.5 7.0 2.6 BCL2L1 "Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52" ENSG00000171552 "BCL2 like 1" Q07817 20 31664452-31723989 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Apoptosis, Endocytosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035734, CAB072801" Approved Approved Mitochondria Mitochondria "CAB072801: , HPA035734: " "unprognostic (2.29e-1)" "unprognostic (5.40e-3)" "unprognostic (1.78e-2)" "prognostic unfavourable (9.10e-4)" "unprognostic (1.37e-1)" "unprognostic (1.09e-1)" "unprognostic (5.04e-2)" "unprognostic (7.82e-3)" "prognostic favourable (9.57e-4)" "unprognostic (1.67e-1)" "prognostic unfavourable (5.87e-4)" "unprognostic (1.06e-1)" "prognostic favourable (8.89e-5)" "unprognostic (9.67e-2)" "unprognostic (3.03e-2)" "unprognostic (2.02e-2)" "unprognostic (3.32e-2)" 30.8 21.4 25.1 16.4 34.3 57.0 40.7 27.7 40.7 28.2 22.6 37.0 13.0 31.3 18.7 12.2 36.9 31.5 35.9 26.9 27.0 23.7 42.6 39.3 40.6 17.8 43.4 24.3 11.5 28.5 17.5 22.8 29.0 33.4 24.8 21.4 31.5 33.8 21.5 21.9 26.1 30.4 19.2 28.8 26.6 28.0 30.2 38.4 56.4 25.8 15.4 20.7 24.5 22.4 3.9 7.8 17.0 8.9 12.5 27.2 16.5 62.7 37.4 6.9 6.6 37.3 27.0 22.1 15.0 24.6 15.7 15.1 88.2 30.5 10.3 38.4 21.7 21.2 9.2 42.5 11.1 10.8 2.4 47.0 8.0 43.9 27.9 4.7 27.9 19.3 17.7 19.9 43.3 22.5 29.1 7.9 53.2 17.9 13.8 4.5 9.5 33.4 8.7 20.8 32.6 64.5 17.5 18.0 8.4 18.4 18.2 8.6 36.2 5.4 31.1 19.9 23.0 7.9 27.0 5.2 29.1 8.5 29.3 20.7 12.5 17.0 8.1 15.4 27.2 8.2 21.0 3.9 12.4 18.1 7.8 3.7 5.7 13.0 9.8 12.5 8.9 4.7 13.8 16.5 25.1 34.3 27.7 40.7 27.0 23.7 43.4 24.3 33.4 38.4 BCL2L10 "BCL-B, Boo, Diva" ENSG00000137875 "BCL2 like 10" Q9HD36 15 52109263-52112775 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 15.3" "Cell line enriched" "Detected in some" 8 "NB-4: 26.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 6.0" "Group enriched" "Detected in some" 6 "basophil: 4.1;memory B-cell: 1.6;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 28 "B-cells: 1.6;dendritic cells: 2.6;granulocytes: 4.1" HPA042222 Approved "HPA042222: AB_10794271" "unprognostic (5.33e-4)" "unprognostic (1.26e-1)" "unprognostic (1.58e-1)" "unprognostic (3.22e-4)" "unprognostic (1.19e-2)" "unprognostic (1.20e-1)" "unprognostic (5.07e-2)" "unprognostic (4.80e-3)" "unprognostic (8.86e-2)" "unprognostic (3.47e-2)" "unprognostic (9.52e-2)" "unprognostic (3.83e-1)" "unprognostic (2.18e-9)" "unprognostic (9.59e-2)" "unprognostic (1.86e-1)" "unprognostic (1.92e-1)" "unprognostic (3.20e-2)" 1.0 3.5 1.0 2.4 6.0 0.3 2.1 1.4 1.6 2.8 3.6 0.1 0.0 3.9 1.1 1.2 6.1 1.3 3.4 0.1 0.5 1.7 6.5 15.3 0.1 1.2 0.3 1.1 0.9 4.2 0.8 3.7 0.2 0.3 2.5 1.7 0.3 1.8 0.4 0.3 10.0 8.1 0.5 0.3 1.6 1.8 0.9 0.5 0.5 0.8 4.3 1.0 2.3 3.9 1.6 2.6 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.1 3.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 1.0 6.0 1.4 1.6 0.5 1.7 0.3 1.1 0.3 0.5 BCL2L13 "BCL-RAMBO, MIL1" ENSG00000099968 "BCL2 like 13" Q9BXK5 22 17628855-17730855 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002052, HPA030994, HPA050377" Uncertain Enhanced Mitochondria Mitochondria "CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: " "unprognostic (1.59e-1)" "unprognostic (8.17e-2)" "unprognostic (2.18e-3)" "unprognostic (1.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.69e-2)" "unprognostic (3.38e-1)" "unprognostic (4.97e-2)" "unprognostic (5.04e-2)" "unprognostic (9.46e-2)" "unprognostic (1.45e-2)" "unprognostic (8.21e-2)" "prognostic favourable (1.96e-8)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (4.27e-1)" "unprognostic (2.81e-1)" 15.3 17.4 13.3 7.6 14.2 10.9 17.3 13.0 17.4 9.2 11.9 14.8 8.8 8.3 10.5 10.7 14.5 11.7 10.0 18.9 12.7 12.2 18.9 20.9 10.6 9.3 14.4 13.4 10.4 22.0 25.8 12.3 14.1 12.2 11.1 14.1 15.2 12.4 9.5 61.2 15.5 12.4 11.7 13.0 8.3 11.2 22.9 11.5 12.1 13.5 14.5 12.3 14.6 10.2 6.5 11.3 4.7 17.3 10.4 8.3 9.5 14.0 6.3 10.1 9.6 16.8 16.2 13.4 10.1 17.7 15.0 17.1 7.1 9.4 12.2 7.3 14.4 19.3 11.6 15.5 15.7 11.7 8.8 11.5 5.7 3.7 21.0 16.0 10.0 13.1 18.2 12.8 34.7 13.1 28.5 11.5 16.3 9.5 8.1 5.1 8.0 7.9 8.6 15.6 4.5 15.6 9.7 14.3 9.0 13.3 13.5 24.1 9.2 15.8 13.0 8.9 4.6 12.7 9.6 9.9 8.9 10.5 13.3 12.3 15.2 3.8 17.3 4.7 4.6 15.6 5.7 6.5 6.2 5.7 11.3 5.4 5.5 4.5 4.4 10.4 11.0 5.7 8.3 9.5 13.3 14.2 13.0 17.4 12.7 12.2 14.4 13.4 12.2 11.5 BCS1L "BCS, BJS, h-BCS, Hs.6719" ENSG00000074582 "BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone" Q9Y276 2 218658764-218663443 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chaperone "Deafness, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037700, HPA037701" Supported "HPA037700: AB_10794619, HPA037701: AB_10805235" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (6.28e-2)" "unprognostic (4.99e-2)" "unprognostic (6.44e-2)" "unprognostic (4.31e-1)" "unprognostic (4.25e-2)" "unprognostic (2.45e-1)" "unprognostic (8.38e-2)" "unprognostic (1.83e-2)" "unprognostic (1.21e-2)" "unprognostic (6.02e-2)" "unprognostic (3.47e-3)" "unprognostic (1.59e-1)" "unprognostic (3.15e-2)" "unprognostic (8.38e-2)" "prognostic favourable (3.31e-4)" 13.4 19.5 16.4 12.6 19.8 10.5 16.2 15.6 23.4 14.1 15.8 18.3 15.8 15.2 22.0 15.1 18.1 19.7 15.2 26.8 14.3 13.5 18.8 29.1 10.7 13.2 19.5 18.5 21.2 26.6 18.9 18.4 11.4 21.9 17.2 16.6 14.8 17.2 18.3 23.4 18.1 13.0 16.7 14.2 15.9 15.5 7.3 18.9 7.2 16.2 15.8 13.2 14.5 14.9 10.9 19.7 11.5 9.8 5.2 10.2 7.9 6.7 14.0 8.0 11.1 18.3 12.3 12.0 11.6 6.4 18.8 13.8 37.1 11.4 10.2 17.0 11.6 18.8 25.9 29.9 10.7 14.8 28.2 16.3 18.0 30.4 21.0 14.1 10.0 15.6 23.0 25.5 33.5 18.8 22.9 14.7 16.7 22.9 10.5 19.0 9.9 17.9 15.2 10.0 15.9 15.7 12.9 17.2 7.5 8.2 19.9 14.6 10.3 14.1 10.9 14.2 11.7 9.1 15.8 11.5 8.9 16.9 8.9 21.7 13.2 11.5 9.8 7.9 8.7 5.8 10.0 10.9 7.0 8.2 19.7 10.1 8.5 10.2 1.2 5.2 0.8 11.1 9.9 7.9 16.4 19.8 15.6 23.4 14.3 13.5 19.5 18.5 21.9 18.9 BDNF ENSG00000176697 "Brain derived neurotrophic factor" P23560 11 27654893-27722058 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5;smooth muscle: 10.5" "Cell line enhanced" "Detected in many" "BJ: 22.4;BJ hTERT+ SV40 Large T+: 17.2;BJ hTERT+ SV40 Large T+ RasG12V: 13.1;HBF TERT88: 16.5;U-138 MG: 24.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009564, HPA031440, HPA056104" Enhanced Supported "Nuclear speckles,Mitochondria" "Secreted to blood" 19244000 "Nuclear speckles, Mitochondria" "CAB009564: AB_2064213, HPA031440: , HPA056104: " "unprognostic (1.25e-2)" "unprognostic (2.84e-1)" "unprognostic (4.35e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-2)" "unprognostic (6.82e-2)" "unprognostic (2.39e-2)" "unprognostic (2.21e-1)" "unprognostic (3.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.22e-2)" "unprognostic (3.88e-2)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (2.84e-3)" 0.9 1.3 5.0 0.6 4.5 0.5 0.6 9.4 14.5 1.6 0.8 0.6 0.7 0.8 0.7 8.2 1.4 0.5 2.1 5.8 8.5 5.7 0.9 0.5 4.1 0.4 2.5 4.7 1.2 1.0 0.2 2.3 3.7 12.7 4.9 0.4 3.0 0.9 4.2 1.3 2.1 0.5 10.5 1.0 0.6 0.9 1.3 0.0 0.0 2.3 0.0 0.4 3.2 1.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 1.6 6.6 0.2 0.0 2.3 1.9 0.0 22.4 4.3 17.2 13.1 0.0 2.6 0.0 2.1 8.1 1.0 0.1 0.2 16.5 0.1 0.1 0.0 2.2 0.0 10.0 0.1 0.1 5.8 2.2 3.8 2.2 0.7 0.0 0.0 2.7 0.0 0.0 0.0 2.1 1.8 0.0 1.3 0.0 2.5 0.0 0.1 0.6 4.3 0.0 0.0 0.1 0.0 7.4 24.1 4.0 9.3 5.0 0.3 0.0 0.0 9.3 0.6 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.1 0.7 0.4 0.0 0.1 0.0 0.4 1.0 0.1 5.0 4.5 9.4 9.4 8.5 5.7 2.5 4.7 12.7 0.0 BEAN1 SCA31 ENSG00000166546 "Brain expressed associated with NEDD4 1" Q3B7T3 16 66427297-66493529 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell line enhanced" "Detected in some" "AN3-CA: 9.5;BEWO: 4.8;RPTEC TERT1: 8.4;U-87 MG: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053851 Uncertain Uncertain Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA053851: " "unprognostic (1.92e-1)" "unprognostic (5.79e-4)" "unprognostic (3.83e-2)" "unprognostic (3.38e-3)" "unprognostic (1.01e-1)" "unprognostic (4.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.13e-1)" "unprognostic (4.89e-1)" "unprognostic (1.59e-1)" "unprognostic (2.13e-3)" "unprognostic (4.18e-2)" "unprognostic (3.38e-2)" "unprognostic (1.63e-1)" "unprognostic (3.10e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-2)" 1.2 1.2 2.9 1.1 2.5 2.9 1.2 6.9 9.6 1.2 0.7 0.1 0.0 0.6 1.2 1.9 1.8 1.9 1.4 3.0 4.6 4.1 0.9 1.1 1.4 0.9 2.3 3.2 1.4 1.9 0.1 0.4 4.5 11.6 1.0 0.9 5.0 1.9 0.4 3.6 3.2 0.8 0.8 1.7 1.2 1.2 3.1 0.2 0.0 1.9 3.1 0.9 1.0 1.0 0.3 2.4 5.2 0.5 0.4 0.2 0.1 0.8 0.9 1.0 9.5 0.3 0.1 4.8 0.3 0.0 0.1 0.1 0.0 1.0 0.1 0.5 0.3 0.2 0.1 0.1 0.3 0.0 0.6 0.0 0.2 0.7 0.7 0.1 0.0 0.7 1.9 0.6 0.3 0.0 0.1 0.3 0.2 0.5 0.0 0.4 0.3 0.5 0.1 0.2 0.5 8.4 0.6 0.1 0.2 0.2 0.2 1.4 0.2 0.1 0.3 0.4 2.6 0.1 0.4 0.5 0.1 0.1 5.5 0.2 1.3 0.4 0.5 1.9 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 0.1 5.2 0.4 0.2 2.4 0.1 0.1 2.9 2.5 6.9 9.6 4.6 4.1 2.3 3.2 11.6 0.2 BEST3 "MGC13168, MGC40411, VMD2L3" ENSG00000127325 "Bestrophin 3" Q8N1M1 12 69643360-69699476 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 125.0" "Group enriched" "Detected in some" 16 "REH: 18.3;RPMI-8226: 19.6;U-698: 32.7" "Cancer enriched" "Detected in single" 9 "glioma: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054582 Approved "HPA054582: " "unprognostic (1.53e-1)" "unprognostic (7.00e-2)" "unprognostic (9.83e-2)" "unprognostic (1.67e-2)" "unprognostic (5.15e-3)" "unprognostic (2.26e-3)" "unprognostic (7.30e-7)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (5.36e-2)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (4.82e-2)" "unprognostic (4.47e-2)" "unprognostic (3.03e-1)" 1.6 0.5 1.7 0.1 1.9 2.4 0.6 6.3 9.3 0.2 0.2 0.9 0.0 0.2 0.2 2.4 1.7 0.1 0.2 0.4 1.8 0.7 0.4 0.3 0.1 0.2 1.8 0.6 0.2 1.0 0.1 0.7 0.3 1.2 1.7 0.2 0.1 1.9 0.1 125.0 0.9 0.1 0.1 1.9 0.1 0.1 2.5 1.0 0.5 0.2 21.9 0.7 0.1 0.0 1.2 0.9 1.7 0.5 0.6 1.0 0.7 0.1 0.2 0.7 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.4 0.1 0.2 1.3 0.3 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.5 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.1 0.2 0.2 0.0 0.8 0.1 0.0 0.0 0.7 0.3 18.3 0.6 19.6 0.9 0.1 0.4 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.5 0.1 0.7 0.1 0.2 32.7 1.4 0.0 0.1 0.3 0.5 0.3 0.5 0.4 0.8 1.2 1.0 0.7 0.3 0.8 1.0 1.0 1.7 0.6 0.4 0.9 0.4 0.7 1.7 1.9 6.3 1.5 1.8 0.7 1.8 0.6 1.2 1.0 BET1L "GOLIM3, GS15" ENSG00000177951 "Bet1 golgi vesicular membrane trafficking protein like" Q9NYM9 11 167784-207428 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039819 Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA039819: AB_10673020" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "unprognostic (2.14e-3)" "unprognostic (2.56e-3)" "prognostic unfavourable (9.80e-4)" "unprognostic (1.18e-1)" "prognostic unfavourable (2.20e-4)" "unprognostic (1.82e-1)" "unprognostic (1.52e-1)" "unprognostic (3.08e-2)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (9.10e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (8.49e-2)" 18.6 20.3 11.4 23.4 15.2 9.2 19.2 14.4 19.8 22.3 18.0 21.0 34.1 17.0 23.4 28.6 16.2 21.7 25.3 18.7 11.6 12.6 21.4 30.3 20.4 20.4 14.9 13.7 33.8 62.2 29.3 31.4 17.3 15.8 27.3 18.0 24.4 35.1 28.0 11.6 18.6 22.4 26.1 13.4 22.3 21.8 27.4 10.5 18.4 27.0 15.6 22.4 25.8 21.0 18.1 12.3 34.3 15.1 15.1 22.5 15.9 18.4 15.4 9.2 11.3 28.5 25.2 13.3 19.7 26.0 21.2 21.8 19.1 17.9 16.3 9.6 35.7 17.2 10.6 18.0 16.3 12.6 11.4 15.1 8.1 19.3 26.4 17.1 29.5 28.3 24.3 12.5 33.7 14.3 21.9 17.1 13.5 10.0 12.5 10.9 14.0 17.5 13.0 13.6 11.0 17.4 8.3 10.0 12.2 17.6 28.5 19.2 14.6 13.5 15.8 16.5 7.7 6.7 9.7 30.3 13.8 14.4 22.3 14.4 15.0 27.0 10.4 34.3 16.7 15.1 20.0 18.1 19.3 17.0 10.5 15.1 22.5 17.3 24.5 15.1 13.2 12.3 14.6 15.9 11.4 15.2 14.4 19.8 11.6 12.6 14.9 13.7 15.8 10.5 BIK NBK ENSG00000100290 "BCL2 interacting killer" Q13323 22 43110748-43129712 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.8;lymphoid tissue: 26.4" "Cell line enhanced" "Detected in many" "A-431: 28.8;CAPAN-2: 14.7;Daudi: 14.4;U-698: 55.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "eosinophil: 28.8;memory B-cell: 7.8;plasmacytoid DC: 24.0" "Group enriched" "Detected in many" 5 "B-cells: 7.8;dendritic cells: 24.0;granulocytes: 28.8" HPA051360 Approved "HPA051360: " "unprognostic (1.18e-3)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (4.09e-1)" "unprognostic (2.06e-3)" "unprognostic (1.64e-1)" "unprognostic (3.86e-3)" "unprognostic (3.27e-1)" "unprognostic (2.71e-2)" "unprognostic (4.36e-3)" "unprognostic (2.36e-1)" "prognostic favourable (7.45e-5)" "unprognostic (1.38e-2)" "unprognostic (2.56e-1)" "unprognostic (4.08e-2)" "unprognostic (3.04e-1)" 0.2 2.2 0.1 23.0 0.9 3.5 4.7 0.1 0.7 3.1 7.7 0.3 8.6 3.5 0.7 2.0 10.5 3.0 19.1 0.6 0.5 0.2 4.2 0.7 2.8 11.1 0.4 0.1 1.8 3.1 0.6 1.1 0.6 0.5 11.9 5.3 0.9 20.9 4.8 0.1 3.1 6.7 0.6 0.6 3.6 13.2 3.0 0.1 4.3 1.8 5.2 26.4 2.7 5.0 7.8 24.0 28.8 1.2 0.3 4.2 2.6 28.8 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.4 14.7 14.4 1.4 0.0 6.4 1.6 0.6 0.0 0.2 2.2 0.0 0.1 1.5 0.2 6.8 1.4 0.0 3.0 0.0 0.0 0.0 0.1 0.6 0.0 7.3 5.3 9.3 2.2 2.4 0.0 0.0 6.6 0.3 0.8 0.5 0.0 1.0 2.7 2.0 0.5 9.4 0.2 0.0 0.8 0.0 0.3 3.5 5.4 55.8 0.0 0.7 0.0 0.7 1.2 28.8 1.2 0.3 1.9 7.8 4.2 1.8 4.3 3.4 2.8 1.5 4.8 0.3 0.3 24.0 2.8 2.6 0.1 0.9 0.1 0.7 0.5 0.2 0.4 0.1 0.5 0.1 BMPR1A "ACVRLK3, ALK3, CD292" ENSG00000107779 "Bone morphogenetic protein receptor type 1A" P36894 10 86756601-86932838 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB019398 Approved Approved Cytosol Cytosol "CAB019398: " "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (3.34e-1)" "unprognostic (9.61e-2)" "unprognostic (1.05e-3)" "unprognostic (9.34e-2)" "prognostic unfavourable (8.93e-4)" "unprognostic (3.64e-1)" "unprognostic (2.38e-2)" "unprognostic (1.53e-1)" "unprognostic (9.24e-2)" "unprognostic (9.42e-2)" "unprognostic (4.32e-2)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "unprognostic (1.01e-2)" "unprognostic (1.07e-1)" 8.9 7.0 9.4 7.9 12.4 0.9 10.7 14.1 9.2 19.4 20.6 10.9 7.7 6.2 16.3 12.3 8.4 10.9 10.8 11.0 7.7 6.1 8.2 4.6 7.4 2.9 7.3 7.6 16.1 10.6 10.0 14.0 7.4 8.5 12.8 9.3 10.9 12.6 14.2 8.4 11.3 9.8 16.5 12.2 3.4 12.1 7.8 9.2 0.3 19.4 7.8 5.7 16.0 11.4 1.8 1.1 3.6 0.8 0.9 1.4 0.3 7.5 3.8 14.7 12.5 7.7 5.0 2.6 7.6 8.0 4.5 5.2 6.5 6.7 2.3 3.5 9.7 8.1 6.5 8.3 6.6 2.5 3.7 2.9 3.6 10.7 4.1 4.0 20.4 4.4 3.5 6.0 4.4 0.0 4.5 1.6 5.2 3.2 2.6 3.2 8.0 1.8 0.0 5.8 0.0 9.2 7.2 1.5 4.8 8.5 4.3 5.1 7.3 2.0 3.8 3.2 5.2 6.6 7.0 0.4 7.0 2.9 2.8 2.7 2.6 2.0 0.8 0.6 1.4 0.5 0.9 1.8 1.4 1.2 0.3 1.5 1.0 1.1 3.6 0.9 0.6 1.1 0.7 0.3 9.4 12.4 14.1 9.2 7.7 6.1 7.3 7.6 8.5 9.2 BMPR2 "BMPR-II, BMPR3, BRK-3, PPH1, T-ALK" ENSG00000204217 "Bone morphogenetic protein receptor type 2" Q13873 2 202376936-202567751 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017385, HPA049014" Approved Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA017385: AB_1845397, HPA049014: " "unprognostic (2.17e-1)" "unprognostic (9.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.55e-1)" "unprognostic (4.30e-2)" "unprognostic (1.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.13e-2)" "unprognostic (1.97e-1)" "unprognostic (1.29e-2)" "unprognostic (1.21e-3)" "unprognostic (9.20e-2)" "unprognostic (1.18e-1)" "unprognostic (3.40e-1)" 18.1 15.0 12.1 9.8 14.2 1.1 10.2 9.5 17.1 15.7 11.7 8.2 6.5 5.5 12.9 10.2 10.6 10.3 13.2 14.6 10.8 13.5 10.7 11.5 24.9 4.4 10.4 14.5 12.0 7.0 15.5 6.1 21.7 10.8 11.0 7.7 11.4 7.1 9.1 10.6 7.2 8.1 15.3 7.5 8.9 7.2 12.9 3.8 3.9 11.6 5.2 5.4 11.1 8.9 1.6 2.6 0.9 2.7 1.1 3.6 0.9 5.7 5.4 5.5 8.7 13.9 13.4 10.7 11.9 12.0 10.4 10.4 4.7 8.7 2.0 13.9 24.0 10.8 7.2 9.2 16.3 5.9 4.9 6.0 5.7 7.3 9.6 1.7 4.7 9.8 8.7 7.6 10.2 30.0 3.9 9.9 12.8 10.7 1.4 1.5 3.0 4.9 3.9 10.9 3.0 8.9 12.2 5.6 5.6 12.6 7.6 14.0 5.8 4.0 33.0 21.2 11.3 7.2 7.2 1.4 1.7 0.6 5.1 3.8 6.1 0.5 2.0 0.9 3.4 1.8 2.5 1.5 1.3 2.2 2.3 1.6 2.7 1.4 0.6 1.1 2.7 2.6 3.6 0.9 12.1 14.2 9.5 17.1 10.8 13.5 10.4 14.5 10.8 3.8 BMT2 "C7orf60, DKFZp762M126, FLJ31818" ENSG00000164603 "Base methyltransferase of 25S rRNA 2 homolog" Q1RMZ1 7 112819147-112939916 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044405, HPA050733" Uncertain Approved Cytosol Cytosol "HPA044405: AB_10959783, HPA050733: " "unprognostic (5.26e-2)" "unprognostic (3.95e-2)" "unprognostic (2.86e-1)" "unprognostic (2.39e-1)" "unprognostic (2.48e-1)" "unprognostic (1.11e-1)" "unprognostic (7.61e-5)" "unprognostic (1.50e-3)" "unprognostic (1.61e-2)" "unprognostic (9.82e-3)" "unprognostic (1.68e-1)" "unprognostic (2.30e-1)" "unprognostic (1.04e-1)" "unprognostic (6.94e-2)" "unprognostic (1.13e-1)" "unprognostic (8.22e-2)" "unprognostic (9.10e-2)" 9.4 7.8 15.5 8.6 14.5 8.1 11.0 27.6 17.1 11.8 11.2 5.2 11.0 5.0 13.9 8.3 13.7 8.7 9.5 22.9 13.0 12.2 10.3 4.5 8.1 9.8 9.0 7.5 11.4 7.9 11.5 18.0 12.0 10.9 11.1 8.3 6.3 9.3 15.9 7.9 9.3 6.9 13.7 11.0 11.9 6.4 14.2 9.7 13.7 10.0 5.1 10.3 14.6 11.0 3.9 5.7 12.7 5.9 5.4 7.3 2.6 4.2 3.6 9.2 8.2 12.4 14.4 2.8 4.5 20.4 8.2 11.9 2.2 3.4 1.4 5.8 8.2 2.0 4.9 6.7 13.4 4.5 5.0 7.4 2.6 2.7 5.6 2.8 7.3 10.8 5.3 6.4 5.6 6.5 2.3 2.8 9.7 3.2 6.7 8.1 2.0 3.8 3.4 12.1 4.4 6.2 5.7 3.7 9.4 8.5 3.5 4.8 1.7 2.6 4.5 10.4 2.6 6.7 3.4 3.6 3.4 2.7 11.3 4.2 6.0 8.0 5.5 9.1 4.9 5.7 6.0 3.9 4.9 5.7 5.7 3.9 6.8 5.7 12.7 5.4 5.9 3.3 7.3 2.6 15.5 14.5 27.6 17.1 13.0 12.2 9.0 7.5 10.9 9.7 BNIP1 "Nip1, SEC20" ENSG00000113734 "BCL2 interacting protein 1" Q12981 5 173144442-173164387 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, ER-Golgi transport, Host-virus interaction, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008009, HPA008149" Supported Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA008009: AB_1078291, HPA008149: " "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (5.89e-2)" "unprognostic (3.08e-1)" "unprognostic (2.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.71e-2)" "unprognostic (1.50e-1)" "unprognostic (7.38e-2)" "unprognostic (2.70e-2)" "unprognostic (1.84e-2)" "unprognostic (2.28e-1)" "unprognostic (4.40e-3)" "unprognostic (2.10e-1)" "unprognostic (2.13e-1)" "unprognostic (5.61e-2)" "unprognostic (3.07e-2)" 12.0 14.5 13.3 9.5 14.5 34.0 13.7 10.1 16.9 10.5 11.1 13.4 9.0 10.2 10.2 15.0 11.4 10.8 9.4 13.0 12.2 14.9 14.5 14.1 10.1 10.9 13.7 12.0 11.3 22.5 13.6 14.7 13.1 17.5 10.6 13.4 10.8 12.4 9.6 20.9 9.0 9.8 10.8 11.8 11.8 11.5 28.1 9.3 14.4 13.1 9.3 12.4 9.9 10.1 9.9 12.7 3.4 9.3 9.6 14.6 8.5 10.7 9.6 11.6 14.3 7.1 16.7 12.9 9.1 14.4 19.6 19.7 16.6 14.9 11.6 10.9 13.6 8.6 14.9 25.9 20.0 18.9 12.0 10.4 6.4 8.7 18.9 16.6 13.1 9.4 13.2 18.0 22.8 14.8 10.0 14.1 15.9 25.1 18.3 14.7 5.1 11.5 12.1 9.3 14.2 11.2 6.6 14.7 9.1 8.1 10.3 19.6 17.4 13.3 11.8 16.9 12.6 14.5 18.4 10.8 12.6 17.8 15.6 17.1 10.9 0.0 8.5 3.4 14.6 9.3 12.4 9.0 12.8 10.5 10.3 9.9 11.0 10.8 0.3 9.6 7.2 12.7 11.1 8.5 13.3 14.5 10.1 16.9 12.2 14.9 13.7 12.0 17.5 9.3 BNIP2 "BNIP-2, Nip2" ENSG00000140299 "BCL2 interacting protein 2" Q12982 15 59659146-59689534 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026843 Approved "HPA026843: AB_1845403" "unprognostic (3.41e-2)" "unprognostic (2.26e-1)" "unprognostic (4.51e-2)" "prognostic favourable (8.42e-4)" "unprognostic (6.70e-2)" "unprognostic (4.81e-2)" "unprognostic (2.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.44e-2)" "unprognostic (1.26e-1)" "unprognostic (4.72e-2)" "unprognostic (6.73e-2)" "prognostic unfavourable (2.19e-5)" "unprognostic (4.68e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" 28.5 14.8 11.7 20.1 14.7 58.8 31.5 11.2 9.4 22.7 17.9 11.5 17.8 8.3 22.8 17.3 21.6 18.5 16.6 30.2 11.2 9.0 14.0 23.5 26.2 41.7 13.6 10.0 21.7 13.1 11.5 12.4 21.7 11.7 20.1 12.3 17.1 17.8 21.6 28.6 17.5 16.9 38.1 13.4 31.3 14.9 13.3 13.8 28.0 16.8 21.7 23.8 28.4 31.7 16.6 21.3 40.9 23.2 17.0 18.9 19.4 13.7 12.3 16.0 13.2 25.8 21.3 14.4 21.6 29.3 19.1 22.0 9.9 6.3 24.3 14.5 29.6 25.4 17.2 24.3 26.1 16.9 10.8 28.0 18.5 10.4 28.5 36.7 32.9 24.7 25.4 17.2 30.7 31.6 16.2 25.0 30.8 7.6 17.7 14.9 14.9 9.0 18.9 21.0 29.5 20.0 29.9 13.4 18.5 14.4 19.0 35.1 15.7 38.3 24.7 21.3 26.1 13.5 20.4 19.2 38.9 32.0 16.8 34.1 21.1 22.1 22.9 34.5 15.8 23.2 18.9 16.6 16.8 16.8 21.3 15.2 17.6 17.3 40.9 17.0 18.7 17.2 17.8 19.4 11.7 14.7 11.2 9.4 11.2 9.0 13.6 10.0 11.7 13.8 BNIP3 Nip3 ENSG00000176171 "BCL2 interacting protein 3" Q12983 10 131966455-131982013 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 122.7" "Cell line enhanced" "Detected in many" "A-431: 73.3;HBF TERT88: 51.0;U-87 MG: 69.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003015, CAB011676" Supported Uncertain Cytosol Cytosol "CAB011676: , HPA003015: AB_1078290" "unprognostic (1.01e-3)" "unprognostic (1.42e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.58e-2)" "unprognostic (1.62e-3)" "unprognostic (6.57e-3)" "unprognostic (1.12e-1)" "unprognostic (2.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "prognostic unfavourable (4.55e-4)" "unprognostic (2.37e-3)" "unprognostic (1.04e-1)" "unprognostic (3.29e-2)" "unprognostic (2.98e-1)" 19.3 12.0 18.3 4.0 18.6 3.0 8.7 13.5 28.3 7.7 4.6 13.0 5.1 4.0 6.0 11.4 8.1 6.0 7.9 43.3 16.9 14.6 27.6 53.4 6.7 4.6 16.5 14.2 19.3 122.7 6.0 7.3 13.0 22.6 18.2 2.9 5.2 19.2 6.6 48.0 9.0 4.5 6.0 13.3 4.9 6.4 6.0 11.1 3.3 10.8 6.2 4.0 9.2 7.3 6.1 3.0 5.1 3.5 2.2 23.4 8.9 73.3 5.9 4.2 11.9 11.4 12.1 21.9 17.9 16.6 13.5 38.7 1.2 1.6 0.1 29.1 10.3 4.5 9.0 25.4 51.0 3.9 6.8 2.6 3.8 17.0 15.3 3.3 2.1 8.4 6.4 13.1 13.3 9.4 6.7 0.2 22.0 5.8 1.7 18.7 3.6 17.8 4.1 2.1 6.2 14.8 1.2 5.6 13.2 3.6 7.6 10.1 4.6 4.7 10.7 19.2 6.4 7.2 14.1 12.6 10.7 10.2 69.4 0.1 3.2 2.2 3.5 5.1 9.8 2.3 10.4 5.7 13.9 10.3 3.0 6.1 23.4 15.4 0.9 2.2 3.1 2.3 13.2 8.9 18.3 18.6 13.5 28.3 16.9 14.6 16.5 14.2 22.6 11.1 BNIP3L "BNIP3a, Nix" ENSG00000104765 "BCL2 interacting protein 3 like" O60238 8 26382898-26505636 "Cancer-related genes, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015652, CAB025371" Enhanced Supported "Nuclear speckles,Mitochondria" Mitochondria "Nuclear speckles" "CAB025371: , HPA015652: AB_1845406" "unprognostic (1.02e-1)" "unprognostic (2.90e-1)" "unprognostic (2.00e-1)" "unprognostic (8.36e-2)" "unprognostic (6.24e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (2.02e-1)" "unprognostic (2.06e-2)" "unprognostic (2.97e-2)" "prognostic unfavourable (5.92e-5)" "unprognostic (8.72e-3)" "unprognostic (5.16e-2)" "prognostic unfavourable (3.95e-4)" "unprognostic (7.59e-3)" 61.7 27.8 32.7 18.2 39.1 79.4 40.1 26.1 39.0 35.0 19.9 32.3 30.7 11.5 27.3 34.0 26.7 26.4 28.0 36.0 36.0 27.4 39.9 22.9 31.3 20.7 43.1 31.9 63.4 10.4 26.8 16.0 51.2 41.0 23.7 14.9 20.9 22.1 39.2 21.0 38.1 14.5 26.5 47.9 19.5 16.7 33.0 43.9 17.8 21.5 12.4 25.2 48.3 30.8 14.2 30.4 68.7 53.9 7.8 17.6 36.3 18.1 6.9 16.6 11.2 46.3 29.2 14.0 18.4 54.1 17.3 38.3 3.1 8.8 5.6 17.4 34.6 9.3 8.2 23.6 57.6 3.6 4.5 23.2 7.2 5.4 25.8 2.0 40.3 35.0 18.6 19.6 11.8 22.1 10.4 13.6 36.2 7.9 14.3 7.6 5.3 7.6 7.7 21.1 11.0 17.9 11.8 17.7 15.8 8.9 1.8 13.9 9.1 4.4 28.9 32.5 14.1 20.3 4.1 20.0 9.0 7.5 49.4 4.2 7.3 49.9 53.9 32.1 7.6 27.8 6.7 12.4 11.4 8.3 30.4 14.2 17.6 12.8 68.7 7.8 17.4 6.9 15.0 36.3 32.7 39.1 26.1 39.0 36.0 27.4 43.1 31.9 41.0 43.9 BNIPL "BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753" ENSG00000163141 "BCL2 interacting protein like" Q7Z465 1 151036570-151047600 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.5;skin 1: 68.6" "Cell line enriched" "Detected in some" 10 "T-47d: 32.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basal ganglia: 1.4;cerebellum: 2.7" "Low region specificity" "Detected in many" HPA019946 Uncertain Cytosol Cytosol "HPA019946: AB_1845408" "unprognostic (2.62e-1)" "unprognostic (7.59e-3)" "unprognostic (3.63e-3)" "prognostic unfavourable (6.50e-4)" "unprognostic (6.58e-2)" "unprognostic (2.82e-2)" "unprognostic (3.32e-3)" "unprognostic (3.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.88e-4)" "unprognostic (1.91e-1)" "unprognostic (8.43e-11)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" "prognostic favourable (4.32e-4)" "unprognostic (6.81e-2)" 0.1 0.1 0.2 0.1 0.2 0.3 6.4 0.2 0.2 9.7 0.1 0.1 9.4 0.1 0.6 0.6 42.5 1.0 0.1 0.2 0.2 0.0 0.5 0.2 6.5 0.2 0.1 0.1 0.2 0.1 0.0 0.1 3.2 0.1 3.4 0.1 0.3 7.1 21.0 0.7 68.6 0.2 0.8 0.1 0.1 0.6 1.0 0.1 0.2 2.7 25.8 23.2 5.0 18.2 1.8 0.8 3.2 0.6 0.5 1.7 0.4 0.3 0.2 0.5 0.6 0.3 0.3 0.6 0.3 0.0 0.2 0.1 1.1 0.4 0.6 0.5 0.0 1.2 0.7 0.2 0.4 0.8 0.8 0.9 0.5 0.2 0.1 0.5 0.6 0.0 2.3 0.1 0.2 0.0 0.5 0.5 0.2 1.4 0.5 0.9 0.5 0.4 0.3 0.2 0.3 0.5 0.3 1.1 0.5 0.4 0.7 0.2 32.4 0.2 0.7 0.6 0.4 0.2 0.1 1.4 1.1 3.1 0.0 0.2 0.6 2.7 0.6 0.7 1.7 0.6 1.4 0.5 1.0 1.2 0.3 1.8 1.0 0.6 3.2 0.5 0.6 0.8 0.6 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.1 BOC CDON2 ENSG00000144857 "BOC cell adhesion associated, oncogene regulated" Q9BWV1 3 113211003-113287459 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 30.7;ASC diff: 45.3;BJ hTERT+: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 8 "B-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025806, HPA060778, HPA061787" Uncertain Enhanced "Nucleoplasm,Plasma membrane" "Intracellular and membrane" 4500000 "Nucleoplasm, Plasma membrane" "CAB025806: , HPA060778: , HPA061787: " "unprognostic (6.89e-3)" "unprognostic (1.34e-2)" "unprognostic (2.62e-3)" "unprognostic (1.03e-2)" "unprognostic (5.03e-3)" "prognostic favourable (4.89e-4)" "unprognostic (8.66e-5)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (4.78e-3)" "unprognostic (3.42e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-3)" "unprognostic (4.94e-3)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "prognostic unfavourable (1.18e-5)" 19.4 4.8 5.3 10.4 8.1 0.4 21.6 4.2 6.0 26.6 23.8 5.4 10.6 3.9 25.8 25.3 19.6 33.2 14.5 20.3 13.3 2.9 4.7 1.0 3.6 3.6 5.5 2.2 26.1 12.0 1.9 12.5 1.9 26.2 21.2 3.9 45.6 17.9 17.4 4.6 25.7 9.6 35.2 36.7 3.5 11.8 9.2 7.6 1.2 13.4 12.9 4.9 28.4 25.0 1.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 2.9 10.7 30.7 45.3 2.4 0.3 4.9 16.2 1.2 1.0 0.0 0.0 0.0 3.0 8.3 0.0 2.1 1.0 0.4 0.0 1.3 0.0 1.0 0.0 0.2 0.1 0.1 7.8 0.7 0.6 0.1 0.0 0.0 0.0 0.2 0.8 0.1 0.5 2.7 2.6 0.0 4.8 0.0 0.2 0.0 3.2 4.6 0.0 0.2 0.1 1.3 0.1 0.0 1.7 2.9 0.0 1.6 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 5.3 8.1 4.2 6.0 13.3 2.9 5.5 2.2 26.2 7.6 BRICD5 "C16orf79, MGC21830" ENSG00000182685 "BRICHOS domain containing 5" Q6PL45 16 2209253-2211950 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 29.7;testis: 42.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 29.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA063522 Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA063522: " "prognostic favourable (9.74e-4)" "unprognostic (7.12e-3)" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (1.93e-3)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (4.34e-3)" "unprognostic (7.56e-2)" "prognostic favourable (7.01e-4)" "unprognostic (9.84e-3)" "unprognostic (2.65e-2)" "unprognostic (9.79e-2)" "unprognostic (2.88e-1)" "unprognostic (3.57e-1)" "prognostic favourable (8.06e-5)" 2.0 4.0 3.2 3.7 4.9 3.0 2.0 29.7 5.3 2.0 2.0 2.0 2.0 5.4 2.8 2.0 2.0 1.6 2.0 2.9 3.5 4.4 2.9 2.0 2.1 4.6 3.1 2.8 2.0 3.0 2.2 3.6 2.9 2.5 2.4 0.5 9.9 3.7 4.0 9.1 2.7 5.2 2.0 3.3 6.3 2.7 42.8 2.0 2.4 6.1 2.0 2.0 2.0 2.0 0.8 0.6 2.3 0.8 0.8 1.7 0.4 2.7 5.5 7.6 4.3 1.2 1.3 13.9 2.7 0.5 1.5 2.3 7.0 6.9 1.5 1.8 0.5 7.4 1.0 1.0 1.1 5.1 3.3 1.7 13.2 1.8 0.7 0.7 4.3 1.5 2.0 2.2 0.5 0.9 1.8 3.9 0.6 7.4 4.7 10.7 7.4 3.1 14.6 5.7 4.9 1.7 2.2 5.3 4.8 2.7 3.3 2.6 3.4 3.9 2.2 7.3 5.9 6.3 2.3 11.9 5.1 3.9 1.3 4.4 3.5 0.4 0.7 2.2 0.6 0.8 0.3 0.3 0.3 0.1 0.6 0.8 1.7 0.4 2.3 0.8 0.2 0.4 0.4 0.4 3.2 4.9 29.7 5.3 3.5 4.4 3.1 2.8 2.5 2.0 BRSK1 KIAA1811 ENSG00000160469 "BR serine/threonine kinase 1" Q8TDC3 19 55282072-55312533 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 65.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 25.9;SH-SY5Y: 23.2;WM-115: 21.1" "Cancer enhanced" "Detected in all" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021212, HPA061719" Enhanced Supported Nucleoplasm Nucleoplasm "HPA021212: AB_1845455, HPA061719: " "unprognostic (1.42e-3)" "unprognostic (2.92e-2)" "unprognostic (1.20e-1)" "unprognostic (6.69e-3)" "unprognostic (2.71e-1)" "unprognostic (4.21e-2)" "unprognostic (3.06e-6)" "unprognostic (4.24e-1)" "unprognostic (2.06e-2)" "unprognostic (3.04e-1)" "prognostic favourable (1.02e-4)" "unprognostic (3.00e-1)" "prognostic unfavourable (7.98e-6)" "unprognostic (1.16e-1)" "unprognostic (6.61e-3)" "unprognostic (1.34e-1)" "unprognostic (2.09e-1)" 1.4 9.8 28.6 3.2 23.6 1.0 1.6 26.7 65.0 1.8 2.2 7.9 0.1 3.3 5.4 3.7 3.0 2.3 3.9 6.5 33.4 20.0 1.4 0.8 1.7 2.4 20.4 14.8 2.4 2.6 12.4 11.0 1.5 13.3 3.8 1.9 2.8 2.5 4.6 1.0 1.1 2.6 4.9 9.2 1.5 1.9 4.4 7.2 0.0 3.0 0.0 1.6 3.2 0.7 0.0 0.3 0.0 0.9 0.1 0.8 0.2 0.3 1.2 15.3 8.0 0.0 0.6 0.1 2.4 3.4 3.3 4.8 5.9 2.7 3.1 1.7 2.7 0.1 3.2 0.1 3.1 14.4 12.6 2.0 1.6 0.6 3.3 0.6 5.9 2.1 0.3 3.3 0.0 0.1 2.8 18.8 2.9 0.8 3.6 0.7 11.1 1.0 8.3 3.8 0.5 0.2 0.0 25.9 23.2 0.0 0.4 5.6 1.3 1.7 0.0 6.3 6.7 3.5 4.6 15.6 11.4 7.0 6.5 1.4 21.1 0.0 0.9 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.2 28.6 23.6 26.7 40.2 33.4 20.0 20.4 14.8 13.3 7.2 BRSK2 "C11orf7, PEN11B, STK29" ENSG00000174672 "BR serine/threonine kinase 2" Q8IWQ3 11 1389899-1462689 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Exocytosis, Mitosis, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 34.9;pancreas: 78.8" "Cell line enhanced" "Detected in some" "AF22: 8.9;AN3-CA: 9.7;CACO-2: 7.7;HAP1: 7.2;NTERA-2: 15.0;SCLC-21H: 35.0" "Cancer enhanced" "Detected in many" "glioma: 3.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 13 "NK-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073690 Approved "Golgi apparatus" "Golgi apparatus" "HPA073690: " "unprognostic (5.47e-2)" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.05e-2)" "unprognostic (3.63e-1)" "unprognostic (6.42e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.17e-7)" "unprognostic (3.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.49e-3)" "unprognostic (1.86e-1)" 1.5 3.5 13.6 1.5 12.8 1.3 1.3 30.8 34.9 1.3 1.5 10.0 0.0 1.7 1.4 1.3 1.3 1.4 1.9 1.5 15.6 10.6 1.4 1.3 1.4 1.3 8.3 17.2 1.4 78.8 1.6 4.6 1.8 9.5 1.6 1.4 2.2 1.6 1.4 1.5 1.5 1.9 1.4 6.5 1.3 1.9 5.5 9.2 0.0 1.9 0.0 1.3 1.3 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 3.9 8.9 9.7 0.1 0.3 0.0 0.1 0.1 0.7 0.3 7.7 0.5 0.0 1.3 0.1 0.0 7.2 0.0 0.6 0.9 3.8 0.0 0.0 0.1 0.4 0.0 0.3 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.9 0.0 0.0 15.0 1.2 0.0 0.0 0.0 0.1 0.1 35.0 5.2 1.7 0.1 2.4 0.2 0.4 0.2 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 13.6 12.8 30.8 23.3 15.6 10.6 8.3 17.2 9.5 9.2 BSCL2 "GNG3LG, SPG17" ENSG00000168000 "BSCL2, seipin lipid droplet biogenesis associated" Q96G97 11 62690275-62709845 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 35.3;Karpas-707: 60.5;RPMI-8226: 41.7;SCLC-21H: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042394 Approved "HPA042394: AB_10794047" "unprognostic (7.78e-2)" "unprognostic (8.74e-2)" "unprognostic (1.24e-1)" "unprognostic (8.17e-2)" "unprognostic (3.08e-2)" "unprognostic (2.01e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (9.30e-2)" "unprognostic (4.44e-2)" "unprognostic (5.13e-3)" "unprognostic (2.41e-1)" "prognostic favourable (7.55e-5)" "unprognostic (3.56e-1)" "unprognostic (1.69e-1)" "unprognostic (1.70e-1)" "unprognostic (1.96e-1)" 6.6 41.6 38.5 3.8 66.3 5.4 13.6 41.0 65.7 20.3 10.6 11.8 13.9 5.4 10.2 77.4 7.6 31.8 11.3 4.7 39.0 81.3 19.0 10.4 11.5 6.6 34.8 27.2 14.1 36.8 35.9 61.0 6.2 32.8 14.2 7.3 12.0 31.1 17.0 6.8 8.8 4.4 7.5 13.2 5.0 10.5 59.5 10.1 9.4 17.2 4.8 5.8 8.9 7.3 19.5 30.8 19.8 33.7 22.1 18.9 25.0 4.0 14.8 10.5 20.2 35.3 12.2 1.8 1.7 9.1 3.4 3.6 2.3 6.3 2.8 3.6 6.5 14.6 1.2 5.2 1.8 7.0 1.1 2.5 8.5 1.8 7.1 2.2 3.3 8.0 4.2 6.8 2.7 2.6 1.8 60.5 5.3 10.5 2.6 4.9 31.5 2.9 5.0 1.0 41.7 16.1 0.6 43.7 6.8 6.5 3.5 5.8 9.9 3.2 1.6 4.2 0.9 5.8 0.9 7.6 16.4 3.7 20.9 0.7 3.5 15.4 33.7 19.8 15.8 24.2 17.3 18.2 16.3 16.3 24.8 19.5 17.1 18.1 8.3 22.1 21.7 30.8 18.9 25.0 38.5 66.3 41.0 63.2 39.0 81.3 34.8 27.2 32.8 10.1 BSG "CD147, EMMPRIN, OK" ENSG00000172270 "Basigin (Ok blood group)" P35613 19 571277-583493 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002427, HPA036048, HPA074870" Enhanced Approved Vesicles 3400000 Vesicles "CAB002427: AB_563501, HPA036048: , HPA074870: " "unprognostic (1.88e-1)" "unprognostic (4.85e-2)" "unprognostic (9.53e-3)" "prognostic favourable (2.59e-4)" "unprognostic (3.34e-1)" "unprognostic (1.38e-2)" "prognostic unfavourable (5.48e-6)" "unprognostic (1.54e-3)" "unprognostic (1.55e-1)" "unprognostic (9.46e-2)" "unprognostic (4.48e-3)" "unprognostic (2.61e-2)" "prognostic favourable (1.95e-6)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (7.30e-2)" "unprognostic (3.22e-1)" 53.0 74.8 60.0 33.3 73.0 86.3 42.3 36.2 103.0 41.7 93.4 57.8 37.3 50.1 56.0 62.2 35.1 48.8 52.0 205.8 58.5 45.9 78.5 39.1 36.1 22.6 57.6 44.0 51.3 64.2 28.2 48.2 96.2 57.9 49.5 39.6 109.4 44.0 48.4 97.4 38.1 45.5 52.9 34.9 28.3 63.9 76.8 30.4 31.8 61.9 45.9 31.2 48.5 31.5 22.0 43.8 89.4 58.7 30.9 44.5 65.5 63.7 86.1 41.1 92.3 122.3 52.6 87.4 53.1 66.4 64.1 55.8 68.6 69.1 22.9 61.7 48.0 104.1 41.6 64.5 22.2 48.0 89.2 15.7 72.8 92.8 77.3 37.9 74.0 54.7 65.5 36.8 41.1 45.9 73.9 108.2 37.6 114.5 27.6 72.7 96.4 44.1 55.5 33.6 75.4 75.7 47.9 63.7 58.0 110.2 44.5 78.8 46.7 117.3 50.5 61.5 39.1 101.9 80.1 69.8 70.2 21.7 116.7 52.6 76.1 32.0 58.7 62.0 44.5 45.2 39.5 22.0 30.2 42.6 39.9 18.3 23.1 29.1 89.4 30.9 48.3 43.8 35.1 65.5 60.0 73.0 36.2 103.0 58.5 45.9 57.6 44.0 57.9 30.4 BSND "BART, DFNB73" ENSG00000162399 "Barttin CLCNK type accessory beta subunit" Q8WZ55 1 54998193-55011784 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Bartter syndrome, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 3.9;kidney: 12.3;salivary gland: 4.2" "Cell line enriched" "Detected in single" 20 "RPMI-8226: 12.9" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.5" "Group enriched" "Detected in some" 5 "basophil: 1.3;neutrophil: 3.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053836, HPA060617" Enhanced "HPA053836: AB_2682277, HPA060617: AB_2732651" "unprognostic (3.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.27e-2)" "unprognostic (6.97e-3)" "unprognostic (3.35e-1)" "unprognostic (8.97e-3)" "unprognostic (2.51e-1)" "unprognostic (1.78e-1)" "unprognostic (4.93e-2)" "unprognostic (6.92e-2)" "unprognostic (2.66e-2)" "unprognostic (1.68e-2)" "unprognostic (1.57e-1)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 3.9 0.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 12.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.3 0.2 0.5 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.2 3.9 0.1 0.4 0.2 0.1 0.1 BST2 "CD317, tetherin" ENSG00000130303 "Bone marrow stromal cell antigen 2" Q10589 19 17402939-17405648 "CD markers, Plasma proteins, Predicted membrane proteins" "Antiviral defense, B-cell activation, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 101.0" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA017060 Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Plasma membrane, Cytosol" "HPA017060: AB_1845467" "prognostic favourable (6.69e-4)" "unprognostic (1.75e-1)" "unprognostic (8.42e-3)" "unprognostic (8.93e-3)" "unprognostic (4.87e-2)" "unprognostic (2.25e-1)" "unprognostic (2.26e-1)" "unprognostic (1.07e-1)" "unprognostic (3.25e-1)" "unprognostic (6.46e-2)" "unprognostic (6.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (3.56e-9)" "unprognostic (1.05e-1)" "prognostic unfavourable (4.22e-4)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" 29.6 72.2 8.4 31.1 9.8 13.6 27.9 2.5 7.6 14.4 12.0 5.6 24.8 6.9 13.4 36.7 8.6 26.8 30.1 13.9 7.9 4.9 24.7 30.8 44.9 16.6 10.0 5.2 101.0 6.9 0.3 8.6 31.5 8.8 15.6 4.8 8.4 11.4 17.5 6.0 3.2 14.0 11.3 9.0 32.9 12.3 8.5 9.4 10.3 10.3 5.9 12.3 14.0 42.4 26.2 74.1 35.8 66.4 57.9 32.6 54.5 39.2 0.0 0.1 18.1 0.0 0.1 6.2 0.1 3.0 58.0 78.1 18.4 35.4 30.4 42.9 24.2 0.1 26.4 2.9 1.8 33.5 0.2 0.4 63.6 17.9 33.2 14.3 38.6 0.1 0.0 19.1 0.0 14.7 17.3 75.8 0.0 10.7 6.8 25.1 19.9 50.8 12.8 0.1 63.5 13.8 0.1 0.0 0.1 40.1 1.5 48.2 30.4 20.3 0.1 0.2 1.4 0.0 0.4 39.1 51.0 20.1 0.1 56.7 0.2 35.8 61.6 21.0 32.6 66.4 30.8 21.0 27.5 30.2 50.7 26.2 22.5 25.6 20.3 57.9 59.3 74.1 24.8 54.5 8.4 9.8 2.5 7.6 7.9 4.9 10.0 5.2 8.8 9.4 BTLA "BTLA1, CD272" ENSG00000186265 "B and T lymphocyte associated" Q7Z6A9 3 112463968-112499561 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 37.2;lymphoid tissue: 30.9" "Group enriched" "Detected in some" 4 "ASC diff: 2.4;Daudi: 1.9;U-698: 6.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 22.6;naive B-cell: 37.2" "Lineage enriched" "Detected in many" 4 "B-cells: 37.2" "Not detected" "Not detected" "HPA047211, HPA062029" Enhanced "HPA047211: , HPA062029: " "unprognostic (1.13e-3)" "unprognostic (2.13e-3)" "unprognostic (5.79e-4)" "unprognostic (1.01e-4)" "unprognostic (7.08e-2)" "unprognostic (7.74e-6)" "unprognostic (6.20e-3)" "unprognostic (7.59e-3)" "unprognostic (5.98e-2)" "unprognostic (1.53e-5)" "unprognostic (2.33e-2)" "unprognostic (1.23e-1)" "unprognostic (1.57e-5)" "unprognostic (2.57e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-1)" "unprognostic (1.42e-2)" 0.6 0.3 0.3 20.3 0.4 1.2 1.1 0.4 0.3 0.5 1.2 0.1 0.0 0.9 0.4 0.1 2.3 0.5 1.0 0.4 0.3 0.3 1.0 0.5 1.2 30.9 0.3 0.0 0.4 0.3 0.0 0.4 0.3 0.1 0.5 0.9 0.2 5.7 0.4 0.3 0.5 6.0 0.2 0.4 18.6 1.7 0.6 0.0 14.6 0.9 1.1 19.4 2.8 0.5 37.2 8.6 0.1 0.0 0.1 5.1 2.4 0.0 0.0 0.0 0.3 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.9 0.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.1 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 3.1 22.6 5.1 2.4 1.5 37.2 4.8 4.7 0.1 0.1 0.0 8.6 1.1 2.4 0.3 0.4 0.4 0.3 0.3 0.3 0.3 0.0 0.1 0.0 BTN1A1 "BT, BTN, BTN1" ENSG00000124557 "Butyrophilin subfamily 1 member A1" Q13410 6 26501221-26510422 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "breast: 27.4" "Cell line enriched" "Detected in some" 5 "CACO-2: 9.8" "Cancer enhanced" "Detected in single" "breast cancer: 0.6" "Cell type enhanced" "Detected in some" "memory B-cell: 5.6;naive B-cell: 2.6" "Lineage enriched" "Detected in many" 4 "B-cells: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011126, CAB037340" Supported "Secreted in female reproductive system" "CAB037340: , HPA011126: AB_1845491" "unprognostic (4.07e-2)" "unprognostic (1.40e-1)" "unprognostic (1.90e-2)" "unprognostic (1.67e-1)" "unprognostic (2.32e-1)" "unprognostic (1.77e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" "unprognostic (3.24e-3)" "unprognostic (2.85e-1)" "unprognostic (1.88e-1)" "unprognostic (5.35e-10)" "unprognostic (4.62e-2)" "unprognostic (1.38e-1)" "unprognostic (4.14e-2)" "unprognostic (5.31e-4)" 0.0 0.0 0.0 0.2 0.0 0.0 27.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 1.0 1.6 0.0 1.3 0.0 0.6 0.1 0.0 5.6 0.0 0.7 1.2 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 5.6 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 BTN2A1 "BT2.1, BTF1, BTN2.1" ENSG00000112763 "Butyrophilin subfamily 2 member A1" Q7KYR7 6 26457904-26476621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA019208 Approved Approved "Plasma membrane" "Plasma membrane" "HPA019208: AB_1845492" "unprognostic (1.86e-1)" "unprognostic (3.48e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "unprognostic (2.29e-1)" "unprognostic (6.17e-2)" "unprognostic (5.74e-3)" "unprognostic (1.22e-2)" "unprognostic (1.03e-1)" "unprognostic (3.26e-2)" "unprognostic (6.90e-3)" "unprognostic (5.14e-2)" "prognostic unfavourable (5.90e-5)" "unprognostic (1.97e-1)" "unprognostic (4.89e-2)" "unprognostic (7.92e-2)" "prognostic favourable (4.52e-5)" 15.3 16.7 10.8 16.3 13.7 18.5 17.2 42.2 16.2 14.8 15.8 13.2 17.4 12.2 18.8 15.0 11.5 14.9 12.7 15.6 11.2 14.6 13.1 8.5 17.2 16.3 14.4 10.2 15.8 8.9 7.7 16.9 23.2 16.1 16.5 14.6 12.0 11.1 19.3 12.1 9.5 13.9 21.1 15.6 23.5 12.4 13.0 15.0 11.3 10.8 7.3 14.4 21.4 13.4 4.8 4.7 28.8 4.8 4.8 8.1 3.4 7.5 6.9 13.7 8.4 6.2 5.0 0.6 16.7 14.1 20.5 18.8 6.1 5.1 6.2 23.0 11.8 3.4 10.8 4.3 19.6 9.0 10.6 3.7 7.4 7.5 9.6 5.3 10.0 6.9 4.1 22.8 7.4 7.4 6.0 9.9 17.5 3.2 9.4 8.9 4.7 5.7 7.8 13.5 6.5 7.6 3.8 14.3 7.8 5.3 6.8 11.9 2.2 4.7 9.7 15.4 8.2 13.3 18.7 8.0 18.6 5.2 6.1 10.6 24.3 16.7 4.8 15.5 6.5 2.7 5.9 4.8 5.4 7.1 4.3 3.9 5.0 6.4 28.8 4.8 4.1 4.7 8.1 3.4 10.8 13.7 42.2 16.2 11.2 14.6 14.4 10.2 16.1 15.0 BTN2A2 "BT2.2, BTF2, BTN2.2" ENSG00000124508 "Butyrophilin subfamily 2 member A2" Q8WVV5 6 26383096-26394874 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 34.1;U-266/70: 27.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 29.0" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA051504 Uncertain Approved Mitochondria Mitochondria "HPA051504: " "prognostic favourable (1.01e-4)" "unprognostic (4.93e-3)" "unprognostic (1.37e-2)" "unprognostic (6.78e-2)" "unprognostic (9.26e-2)" "unprognostic (2.01e-2)" "unprognostic (1.78e-1)" "unprognostic (8.04e-3)" "unprognostic (1.01e-1)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (1.93e-1)" "unprognostic (1.73e-2)" "unprognostic (3.45e-1)" "unprognostic (6.54e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" 7.0 12.4 3.2 22.6 5.2 2.7 7.5 29.0 5.2 8.5 5.7 5.1 4.8 5.2 10.2 10.6 7.4 6.7 7.9 9.5 4.1 3.7 7.5 6.1 15.6 21.8 4.4 3.3 10.3 5.8 12.9 5.5 2.8 9.7 8.8 8.0 11.5 9.3 7.9 2.7 8.0 9.9 8.2 5.3 18.0 7.2 5.1 4.2 13.0 7.0 6.2 26.0 8.5 7.6 20.2 14.9 7.8 9.1 5.1 6.3 4.7 4.7 3.0 6.2 6.6 2.1 3.3 0.4 5.2 13.8 8.2 14.3 1.9 1.9 4.3 5.7 9.4 4.4 4.9 4.0 11.0 13.4 8.3 6.7 5.7 3.7 4.4 1.5 2.4 7.0 1.2 15.8 5.4 7.5 5.4 34.1 3.7 2.0 5.3 1.9 2.3 3.1 12.6 8.8 13.3 5.9 2.7 5.9 8.3 3.4 1.3 14.2 6.3 2.9 8.9 3.0 3.5 2.6 8.0 27.8 17.0 7.6 3.0 6.1 7.5 1.2 8.7 1.5 4.2 9.1 3.9 16.2 3.3 3.7 14.9 20.2 2.8 3.4 7.8 5.1 3.6 6.2 6.3 4.7 3.2 5.2 29.0 5.2 4.1 3.7 4.4 3.3 9.7 4.2 BTN3A1 "BT3.1, BTF5, BTN3.1, CD277" ENSG00000026950 "Butyrophilin subfamily 3 member A1" O00481 6 26402237-26415216 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA012565 Approved Uncertain Vesicles Vesicles "HPA012565: AB_1845494" "unprognostic (2.82e-2)" "unprognostic (6.43e-2)" "unprognostic (1.45e-3)" "unprognostic (4.72e-3)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (3.10e-2)" "unprognostic (9.31e-2)" "unprognostic (9.81e-2)" "unprognostic (8.60e-3)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "prognostic unfavourable (4.15e-5)" "unprognostic (2.45e-1)" "unprognostic (5.02e-2)" "unprognostic (3.26e-2)" "prognostic favourable (4.81e-4)" 11.3 14.3 6.7 33.5 5.4 10.3 10.2 10.7 5.9 18.5 14.9 10.0 10.1 11.5 22.3 14.1 13.1 9.6 16.5 9.0 5.3 6.1 9.7 11.4 29.9 24.1 7.1 5.4 15.5 9.4 5.6 11.2 8.5 7.8 17.9 12.1 12.3 16.7 10.0 4.8 9.7 20.6 10.2 9.0 45.2 12.5 4.9 6.7 16.5 8.5 9.8 32.9 11.6 12.9 9.8 4.4 17.4 5.9 18.4 23.4 12.1 3.7 3.2 4.7 4.8 13.6 14.5 0.5 3.0 12.0 6.9 20.3 0.1 8.1 9.7 10.6 5.5 2.5 1.5 4.8 4.0 9.5 3.3 5.1 3.9 2.2 6.1 4.7 4.7 7.8 2.7 6.0 2.8 9.7 1.2 12.7 2.8 0.3 8.5 2.9 0.5 1.0 11.8 2.1 22.0 4.2 4.7 2.5 5.0 1.7 3.6 6.8 3.3 1.9 2.4 5.3 1.3 1.5 2.9 21.7 22.1 3.5 8.1 10.6 4.1 17.4 5.3 13.5 23.4 5.7 20.9 9.8 14.6 21.7 4.4 5.3 12.7 16.8 11.9 18.4 5.9 2.1 16.9 12.1 6.7 5.4 10.7 5.9 5.3 6.1 7.1 5.4 7.8 6.7 BTN3A2 BTN3.2 ENSG00000186470 "Butyrophilin subfamily 3 member A2" P78410 6 26365159-26378320 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 34.9;U-266/70: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" CAB019392 Uncertain "CAB019392: " "unprognostic (3.77e-2)" "unprognostic (1.17e-2)" "unprognostic (3.73e-2)" "unprognostic (2.86e-2)" "unprognostic (3.66e-2)" "unprognostic (1.60e-1)" "unprognostic (1.40e-1)" "unprognostic (3.89e-1)" "unprognostic (4.04e-2)" "unprognostic (1.30e-3)" "unprognostic (1.12e-1)" "unprognostic (8.45e-2)" "prognostic unfavourable (4.24e-4)" "unprognostic (5.13e-2)" "unprognostic (4.45e-2)" "unprognostic (4.42e-2)" "unprognostic (1.48e-3)" 12.3 19.7 8.5 23.7 8.3 3.6 10.2 3.7 6.4 14.7 15.3 6.7 10.9 12.3 19.7 17.0 9.8 9.9 16.5 7.8 5.3 6.4 10.8 9.9 21.3 17.0 11.4 4.1 14.0 11.7 3.0 14.8 7.8 8.0 11.2 14.0 8.6 12.1 14.2 4.9 10.1 19.2 9.9 12.8 47.0 13.7 4.5 9.0 19.4 10.3 9.5 27.3 14.3 13.4 19.4 6.2 19.6 13.7 30.5 41.5 20.7 4.1 1.8 2.6 2.7 15.2 17.7 0.9 3.9 18.6 7.4 21.0 1.0 14.0 11.4 14.3 5.5 3.7 3.6 7.1 6.7 6.7 4.9 11.8 7.7 6.9 8.3 7.1 10.9 10.8 2.9 7.0 3.1 14.2 3.1 16.0 5.3 0.5 5.9 11.7 0.1 1.4 9.1 4.6 34.9 6.8 2.1 1.7 4.8 2.8 2.8 9.7 2.9 5.8 8.7 8.3 1.7 2.9 4.2 34.8 28.8 6.2 13.4 12.6 7.3 19.6 8.0 17.6 41.5 11.2 31.1 19.4 26.8 36.5 6.2 15.3 27.2 33.3 12.6 30.5 13.7 4.4 32.9 20.7 8.5 8.3 3.7 6.4 5.3 6.4 11.4 4.1 8.0 9.0 BTN3A3 "BTF3, BTN3.3" ENSG00000111801 "Butyrophilin subfamily 3 member A3" O00478 6 26440472-26453415 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 31.1;BJ hTERT+ SV40 Large T+ RasG12V: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA007904, HPA011871" Enhanced "HPA007904: AB_1078307, HPA011871: AB_1845496" "unprognostic (1.18e-2)" "unprognostic (6.54e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-2)" "unprognostic (2.30e-2)" "unprognostic (8.60e-2)" "unprognostic (5.13e-3)" "unprognostic (8.08e-2)" "unprognostic (7.88e-2)" "prognostic favourable (1.80e-4)" "unprognostic (4.45e-2)" "unprognostic (1.13e-1)" "prognostic unfavourable (2.42e-5)" "unprognostic (3.49e-2)" "unprognostic (2.14e-2)" "unprognostic (5.26e-2)" "unprognostic (4.54e-3)" 13.3 19.1 6.6 22.5 8.1 2.6 10.6 5.5 8.6 11.8 8.5 5.9 8.8 9.8 19.1 14.9 7.0 12.1 11.8 7.7 5.2 6.8 8.7 11.8 19.5 15.3 5.8 8.4 12.0 3.9 3.1 24.0 5.5 6.6 12.0 8.5 9.8 8.9 7.9 2.9 6.6 15.7 10.2 7.3 29.4 8.9 3.5 6.0 11.7 10.6 8.4 20.1 12.8 10.1 9.0 5.3 16.3 10.0 19.2 25.3 13.0 1.8 0.8 0.8 0.8 16.3 31.1 0.2 2.5 13.9 5.8 21.1 0.0 5.8 11.5 11.7 4.1 1.3 1.2 4.4 2.8 9.6 2.0 5.3 5.1 0.6 11.9 2.8 1.0 16.4 1.8 5.0 1.8 11.4 0.2 1.7 3.2 0.0 7.5 2.3 0.0 1.3 7.5 1.6 11.0 4.6 1.5 1.0 1.9 1.5 1.5 2.7 0.4 1.5 7.0 2.8 0.6 3.1 1.7 2.0 0.4 1.1 7.5 5.4 2.9 16.3 6.6 5.5 25.2 9.9 20.4 9.0 17.5 25.3 5.3 6.2 17.1 22.9 5.1 19.2 10.0 2.8 19.6 13.0 6.6 8.1 5.5 8.6 5.2 6.8 5.8 8.4 6.6 6.0 BTNL8 "BTN9.2, FLJ21458" ENSG00000113303 "Butyrophilin like 8" Q6UX41 5 180899077-180950906 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "blood: 57.9;intestine: 111.7" "Cell line enriched" "Detected in some" 23 "CACO-2: 28.6" "Group enriched" "Detected in some" 12 "colorectal cancer: 2.6;liver cancer: 1.5;pancreatic cancer: 2.8;stomach cancer: 3.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 13 "neutrophil: 57.9" "Lineage enriched" "Detected in single" 213 "granulocytes: 57.9" HPA039738 Enhanced "HPA039738: " "unprognostic (4.31e-1)" "unprognostic (6.85e-6)" "unprognostic (6.99e-2)" "unprognostic (1.48e-1)" "unprognostic (6.33e-2)" "unprognostic (1.91e-1)" "unprognostic (6.27e-3)" "unprognostic (6.07e-2)" "unprognostic (3.08e-3)" "unprognostic (3.28e-1)" "unprognostic (1.67e-1)" "unprognostic (9.02e-2)" "unprognostic (4.96e-3)" "unprognostic (2.93e-1)" "unprognostic (1.42e-1)" "unprognostic (4.43e-1)" "unprognostic (1.17e-2)" 1.1 0.2 0.1 2.2 0.4 2.3 0.5 0.3 0.7 0.2 37.6 0.1 0.1 43.8 0.2 0.2 0.2 0.6 9.3 0.3 0.3 0.1 0.4 0.3 1.9 2.0 0.3 0.2 0.2 0.5 0.0 0.2 0.2 0.5 0.1 9.7 0.4 0.1 0.1 0.3 0.1 111.7 0.1 0.5 2.2 2.5 3.5 0.3 0.3 0.9 0.2 0.1 0.1 0.7 0.0 0.0 57.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.2 0.0 0.2 0.3 0.0 0.0 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.9 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.3 0.7 0.3 0.1 0.3 0.2 0.5 0.3 BTNL9 "BTN8, FLJ32535" ENSG00000165810 "Butyrophilin like 9" Q6UXG8 5 181040225-181061523 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.2;breast: 76.8" "Cell line enriched" "Detected in some" 6 "U-698: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.8" "Group enriched" "Detected in many" 6 "B-cells: 3.8;granulocytes: 1.3" "Not detected" "Not detected" HPA043429 Approved "Nuclear membrane,Vesicles" "Nuclear membrane" Vesicles "HPA043429: AB_10961264" "unprognostic (2.69e-1)" "unprognostic (1.44e-2)" "unprognostic (5.76e-2)" "prognostic unfavourable (7.51e-4)" "unprognostic (2.07e-1)" "unprognostic (1.43e-1)" "prognostic favourable (1.55e-9)" "unprognostic (2.15e-2)" "unprognostic (8.51e-2)" "unprognostic (1.78e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.71e-2)" "unprognostic (3.43e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-2)" 128.2 2.5 1.5 5.3 1.7 0.3 76.8 1.0 1.8 3.2 11.3 0.8 3.5 0.7 3.9 3.7 2.9 6.0 3.7 11.0 3.4 1.3 3.4 3.0 25.4 2.7 2.5 1.2 1.0 2.0 3.0 1.6 4.3 1.5 3.4 1.5 3.8 3.0 3.5 34.4 2.0 1.9 3.2 2.1 12.7 2.0 3.0 0.9 1.1 6.1 4.0 5.5 3.1 18.3 3.8 0.4 1.3 0.3 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.6 0.0 0.2 1.1 0.0 0.2 0.5 0.0 0.0 0.2 2.8 1.1 0.2 0.1 0.0 0.5 3.3 0.0 0.1 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.1 0.1 0.1 1.8 0.0 0.2 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 4.3 0.1 0.0 0.2 0.1 28.0 0.1 0.0 0.0 1.0 0.3 0.5 0.2 0.1 0.1 3.8 0.2 0.2 0.1 1.9 0.2 0.2 1.3 0.3 0.1 0.4 0.0 0.1 1.5 1.7 1.0 1.8 3.4 1.3 2.5 1.2 1.5 0.9 C10orf128 Em:AC084727.5 ENSG00000204161 "Chromosome 10 open reading frame 128" Q5T292 10 49154725-49188585 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 61.0" "Cell line enhanced" "Detected in some" "HDLM-2: 59.8;HEL: 14.4;K-562: 27.9;U-87 MG: 30.1;U-937: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "eosinophil: 61.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 61.0" "Low region specificity" "Detected in many" HPA058166 Approved "HPA058166: " "unprognostic (1.33e-1)" "unprognostic (5.67e-4)" "unprognostic (1.34e-2)" "unprognostic (1.21e-1)" "unprognostic (4.50e-2)" "unprognostic (4.13e-2)" "unprognostic (5.86e-3)" "unprognostic (9.13e-3)" "unprognostic (2.61e-1)" "unprognostic (1.25e-1)" "unprognostic (5.11e-2)" "unprognostic (2.11e-1)" "prognostic unfavourable (2.86e-5)" "unprognostic (2.45e-2)" "unprognostic (2.22e-2)" "unprognostic (8.69e-3)" "unprognostic (1.24e-1)" 21.6 2.6 5.9 12.9 15.0 2.8 19.4 1.7 9.2 13.1 9.9 19.2 4.6 7.0 11.0 10.0 8.6 9.4 14.7 14.2 9.2 6.7 4.1 7.3 21.1 18.7 27.6 6.5 3.7 3.3 10.1 3.0 8.6 15.0 6.8 11.8 9.6 7.6 6.6 6.7 5.6 17.4 16.8 33.7 23.3 6.7 4.7 20.6 1.5 8.0 9.7 18.0 15.3 13.7 9.1 4.6 61.0 0.9 0.0 9.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 59.8 0.0 14.4 0.0 0.0 0.0 0.1 6.4 0.0 0.0 0.0 0.0 0.4 27.9 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 30.1 25.9 0.0 6.0 0.9 61.0 5.5 0.3 9.1 9.1 3.5 5.4 4.6 2.8 0.2 1.6 4.5 0.0 0.1 0.1 2.7 2.3 5.9 15.0 1.7 9.2 9.2 6.7 27.6 6.5 15.0 20.6 C11orf24 DM4E3 ENSG00000171067 "Chromosome 11 open reading frame 24" Q96F05 11 68261335-68272001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 65.7" "Cell line enhanced" "Detected in all" "SK-MEL-30: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA012748 Uncertain Uncertain Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA012748: AB_1845526" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "prognostic unfavourable (7.38e-4)" "unprognostic (2.31e-2)" "unprognostic (7.91e-2)" "prognostic unfavourable (6.05e-4)" "unprognostic (1.56e-1)" "unprognostic (2.68e-2)" "unprognostic (4.99e-2)" "unprognostic (1.55e-1)" "prognostic unfavourable (1.60e-9)" "unprognostic (2.18e-2)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (8.67e-3)" 12.9 9.3 6.6 12.9 10.6 2.7 14.7 6.7 13.7 14.1 32.6 23.3 8.4 35.2 21.8 12.3 8.6 12.2 19.2 19.1 9.1 6.5 10.0 44.3 12.6 14.4 10.3 8.1 14.1 17.5 5.8 8.1 12.6 14.5 12.2 11.8 14.7 22.1 12.6 6.9 8.9 65.7 21.5 13.8 11.3 13.5 7.8 10.3 3.4 9.2 11.4 18.8 14.6 10.5 23.7 16.4 9.3 11.0 5.5 9.2 6.9 12.3 12.8 7.6 14.8 18.4 18.7 8.8 29.9 19.4 15.1 15.6 27.0 7.6 5.6 9.3 37.0 14.0 11.2 13.4 9.7 6.1 6.6 5.9 13.0 18.0 14.9 5.0 20.0 15.4 10.0 22.8 9.4 6.0 10.4 9.2 12.7 15.4 1.2 7.3 12.7 15.6 2.3 13.0 28.9 6.8 5.9 5.0 9.3 9.7 7.8 62.4 7.3 4.2 6.6 23.7 14.7 29.9 13.1 11.4 11.2 5.2 19.0 3.9 22.8 9.3 7.2 7.5 9.2 11.0 6.2 17.3 5.3 5.7 12.0 23.7 5.0 5.3 1.1 5.5 8.1 16.4 4.8 6.9 6.6 10.6 6.7 13.7 9.1 6.5 10.3 8.1 14.5 10.3 C11orf87 "LOC399947, LOH11CR1A, NEURIM1" ENSG00000185742 "Chromosome 11 open reading frame 87" Q6NUJ2 11 109422120-109429114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 32.3" "Group enriched" "Detected in some" 4 "BJ hTERT+ SV40 Large T+: 3.9;fHDF/TERT166: 15.4;SCLC-21H: 4.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034656 Approved "HPA034656: AB_10600788" "unprognostic (5.42e-2)" "unprognostic (2.09e-1)" "unprognostic (2.28e-1)" "unprognostic (8.55e-2)" "unprognostic (3.87e-2)" "unprognostic (1.85e-1)" "unprognostic (1.63e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-1)" "unprognostic (2.44e-2)" "unprognostic (2.45e-1)" "unprognostic (5.28e-5)" "unprognostic (8.38e-2)" "unprognostic (9.65e-2)" "unprognostic (2.72e-6)" 0.7 1.0 5.8 0.7 18.1 0.7 0.8 2.7 32.3 2.3 0.8 1.5 0.0 0.8 2.2 1.2 0.8 1.1 0.7 0.7 8.3 3.8 0.8 0.7 0.7 0.7 2.5 12.0 0.7 0.7 0.7 0.3 0.8 11.1 0.9 0.7 0.0 0.8 0.8 0.7 0.8 0.7 0.8 1.2 2.2 0.8 0.8 0.1 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.5 0.0 0.1 0.2 3.9 1.9 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 18.1 2.7 27.7 8.3 3.8 2.5 12.0 11.1 0.1 C12orf76 FLJ40142 ENSG00000174456 "Chromosome 12 open reading frame 76" Q8N812 12 110027028-110073686 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 47.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA039713, HPA042013" Uncertain Approved "Plasma membrane,Actin filaments" "Actin filaments" "Plasma membrane" "HPA039713: AB_2676640, HPA042013: " "unprognostic (9.20e-2)" "unprognostic (3.31e-2)" "unprognostic (2.35e-3)" "unprognostic (9.54e-2)" "unprognostic (3.50e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "prognostic favourable (6.44e-5)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (1.75e-1)" "prognostic unfavourable (5.74e-5)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" 5.7 8.8 34.6 8.4 26.1 11.6 9.4 19.7 47.6 6.6 6.1 32.6 2.5 7.6 8.1 14.0 5.9 12.0 6.7 5.3 36.1 33.5 8.5 7.9 9.7 11.4 36.2 21.2 11.9 8.4 5.1 7.5 9.4 26.1 7.5 6.4 5.9 7.7 7.9 8.3 14.6 7.4 5.3 38.7 11.1 9.2 9.8 27.4 4.8 11.1 1.8 7.9 6.3 5.0 14.0 12.8 31.3 9.4 14.3 16.3 11.1 6.4 9.5 11.6 10.4 8.3 17.1 12.7 5.7 3.2 5.5 4.1 7.8 6.3 7.9 6.8 2.5 12.8 4.7 4.7 4.1 11.7 10.1 7.9 14.5 15.7 7.8 12.8 15.4 13.7 15.6 4.8 8.8 8.5 11.7 20.7 5.6 6.9 6.5 21.1 9.0 8.7 12.4 7.1 12.8 9.9 6.2 23.2 12.6 7.1 5.3 12.7 11.5 6.7 10.9 8.4 6.1 6.3 3.3 9.5 10.9 6.5 9.3 7.4 4.8 31.3 9.4 11.2 8.3 6.2 9.2 14.0 13.1 9.3 8.8 11.8 16.3 10.6 12.8 14.3 6.1 12.8 12.6 11.1 34.6 26.1 19.7 35.1 36.1 33.5 36.2 21.2 26.1 27.4 C14orf37 UT2 ENSG00000139971 "Chromosome 14 open reading frame 37" Q86TY3 14 57999735-58298139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Cell line enhanced" "Detected in many" "AF22: 11.0;AN3-CA: 6.9;fHDF/TERT166: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001580, HPA001789" Enhanced Approved "Plasma membrane" 270000 "Plasma membrane" "HPA001580: , HPA001789: AB_1078328" "unprognostic (2.56e-2)" "unprognostic (2.04e-2)" "unprognostic (1.20e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.97e-3)" "unprognostic (1.94e-1)" "unprognostic (7.84e-3)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (2.42e-1)" "unprognostic (1.01e-1)" "unprognostic (3.87e-8)" "unprognostic (5.22e-6)" "unprognostic (4.93e-2)" "unprognostic (8.74e-4)" "unprognostic (3.01e-4)" 2.8 5.3 11.4 1.5 11.7 1.8 2.4 10.1 14.0 4.1 2.3 3.9 1.1 1.6 6.7 4.0 1.9 4.7 3.9 6.3 8.6 4.6 16.5 2.2 1.8 1.1 5.1 7.8 9.3 2.4 9.2 5.8 1.4 21.5 4.0 2.7 3.9 2.0 3.3 1.2 2.5 1.8 5.0 3.3 1.3 3.0 5.1 5.0 0.0 3.4 0.3 0.9 2.6 3.0 0.3 0.6 0.5 0.3 0.1 0.0 0.0 0.0 0.0 11.0 6.9 5.4 2.3 0.0 2.1 1.7 0.4 0.3 0.5 0.1 0.0 0.7 12.0 0.1 3.4 0.0 0.4 0.1 1.1 0.0 0.0 0.5 0.2 0.0 5.5 2.3 0.2 0.2 0.2 0.5 0.1 0.3 1.4 0.3 0.0 0.0 5.1 2.3 1.6 0.3 2.7 4.4 0.5 1.3 0.1 0.1 0.0 0.3 0.3 0.2 0.1 1.6 4.1 0.6 2.9 0.3 0.3 0.0 3.4 0.3 1.2 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 11.4 11.7 10.1 14.0 8.6 4.6 5.1 7.8 21.5 5.0 C16orf54 FLJ35681 ENSG00000185905 "Chromosome 16 open reading frame 54" Q6UWD8 16 29742463-29746006 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 95.2;lymphoid tissue: 41.8" "Cell line enhanced" "Detected in some" "HEL: 13.3;HL-60: 13.4;HMC-1: 8.8;MOLT-4: 11.0;NB-4: 9.1;THP-1: 15.9;U-937: 7.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA060546 Uncertain "HPA060546: " "unprognostic (2.09e-3)" "unprognostic (1.58e-3)" "unprognostic (1.30e-2)" "unprognostic (1.92e-4)" "unprognostic (2.08e-1)" "unprognostic (1.54e-2)" "unprognostic (1.36e-3)" "unprognostic (2.90e-2)" "unprognostic (2.44e-3)" "unprognostic (1.06e-2)" "unprognostic (1.34e-1)" "unprognostic (2.32e-1)" "unprognostic (9.73e-3)" "unprognostic (2.78e-1)" "unprognostic (3.18e-2)" "unprognostic (1.91e-1)" "unprognostic (2.36e-1)" 2.7 0.9 0.8 19.9 0.8 23.2 1.2 0.6 0.7 2.8 3.8 1.3 0.2 1.7 1.3 1.4 2.4 2.1 4.7 2.2 0.8 1.0 1.9 1.3 7.1 41.8 1.1 0.5 0.8 1.0 0.0 0.8 1.6 0.8 1.8 2.2 1.4 6.8 0.2 1.0 0.9 9.3 0.8 1.2 25.4 3.3 0.7 0.8 35.6 1.3 2.3 27.8 3.1 1.8 26.5 14.7 95.2 20.0 36.1 40.7 26.2 3.9 0.0 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 2.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.3 0.2 0.0 0.0 13.4 8.8 0.3 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.1 11.0 9.1 0.8 0.0 6.3 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 15.9 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.6 0.2 7.4 0.1 42.6 18.4 61.9 40.7 16.8 38.5 26.5 40.5 35.6 13.0 21.8 33.7 34.7 95.2 36.1 20.0 14.7 21.2 26.2 0.8 0.8 0.6 0.7 0.8 1.0 1.1 0.5 0.8 0.8 C17orf80 "FLJ20721, HLC-8, MIG3, SPEP1" ENSG00000141219 "Chromosome 17 open reading frame 80" Q9BSJ5 17 73232233-73248947 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012896 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA012896: AB_1850766" "unprognostic (9.22e-2)" "unprognostic (1.62e-1)" "prognostic favourable (1.43e-4)" "unprognostic (5.55e-3)" "unprognostic (8.58e-2)" "unprognostic (2.66e-1)" "prognostic unfavourable (9.02e-6)" "unprognostic (1.08e-1)" "unprognostic (1.00e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.52e-1)" "unprognostic (2.36e-3)" "unprognostic (1.37e-1)" 8.0 10.5 12.8 8.5 13.2 2.4 10.6 27.8 15.4 11.3 11.7 8.4 5.3 9.1 13.1 9.0 10.8 11.2 7.8 13.5 13.8 10.0 11.5 8.6 10.2 11.0 11.8 12.7 16.0 10.1 17.2 24.9 10.9 11.8 11.6 9.0 9.4 9.0 11.2 22.2 7.5 10.4 12.4 14.4 9.9 9.7 32.5 11.3 16.1 14.6 8.3 10.3 10.3 13.3 6.5 7.1 14.6 5.0 5.2 8.7 3.9 9.8 10.4 14.5 8.8 10.7 9.2 14.1 13.0 11.3 18.5 17.6 9.9 8.2 18.8 9.3 6.6 9.9 20.1 7.5 21.7 6.8 13.7 17.3 11.0 11.5 9.3 18.1 10.2 7.1 9.4 12.3 10.2 15.8 18.6 11.3 12.3 5.6 21.0 8.6 11.5 11.3 12.7 39.9 9.6 9.6 7.5 17.8 16.0 6.9 12.7 15.1 13.9 11.5 8.6 19.4 17.9 6.2 12.3 12.8 15.2 18.1 7.8 8.3 12.3 14.6 4.0 5.7 8.5 5.0 8.7 6.5 6.3 7.5 4.6 5.8 6.0 8.6 1.9 5.2 4.7 7.1 8.6 3.9 12.8 13.2 27.8 15.4 13.8 10.0 11.8 12.7 11.8 11.3 C18orf32 FLJ23458 ENSG00000177576 "Chromosome 18 open reading frame 32" Q8TCD1 18 49477250-49487252 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040921 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA040921: AB_10795423" "unprognostic (5.83e-2)" "unprognostic (5.48e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-2)" "unprognostic (4.19e-2)" "unprognostic (1.44e-1)" "unprognostic (1.72e-1)" "unprognostic (2.80e-2)" "unprognostic (6.36e-2)" "unprognostic (4.36e-3)" "unprognostic (2.58e-3)" "unprognostic (2.76e-2)" "prognostic favourable (8.89e-9)" "unprognostic (1.02e-1)" "unprognostic (7.42e-2)" "unprognostic (1.28e-2)" "unprognostic (4.36e-2)" 17.1 16.5 67.0 7.1 59.0 19.1 25.5 27.4 48.4 22.2 24.2 29.5 16.1 10.7 12.7 35.0 13.6 17.2 19.4 25.1 57.5 49.8 42.2 38.6 19.6 14.8 67.8 28.3 16.5 20.1 23.8 20.5 15.7 47.0 21.3 22.4 17.0 21.6 18.9 10.8 10.2 14.2 14.9 78.5 13.6 23.4 15.5 25.2 8.3 28.8 8.0 12.7 19.4 9.6 16.1 21.4 57.2 22.1 9.8 15.4 21.0 7.6 8.8 16.7 10.4 15.2 13.5 19.2 11.6 12.8 11.3 9.6 1.6 3.5 6.9 29.3 9.8 8.9 3.8 13.1 9.7 22.1 7.8 6.2 5.9 10.6 24.2 12.2 13.3 11.7 29.1 7.6 11.3 15.1 7.1 13.3 23.4 4.8 7.7 6.3 4.6 8.8 7.3 5.8 13.9 30.1 15.0 19.2 33.1 7.6 6.0 15.7 8.6 4.5 16.1 11.7 9.9 3.3 12.5 40.6 24.1 7.5 9.2 8.2 10.9 36.3 17.1 43.2 13.9 19.3 15.4 16.1 13.7 14.3 14.1 12.8 11.7 15.4 57.2 9.8 22.1 21.4 14.6 21.0 67.0 59.0 27.4 48.4 57.5 49.8 67.8 28.3 47.0 25.2 C19orf18 MGC41906 ENSG00000177025 "Chromosome 19 open reading frame 18" Q8NEA5 19 57958437-57974534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 22.6" "Cell line enhanced" "Detected in many" "AN3-CA: 4.5;HEK 293: 6.5;RT4: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA014527 Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA014527: AB_1845612" "unprognostic (5.38e-2)" "unprognostic (6.36e-3)" "unprognostic (3.70e-2)" "prognostic favourable (5.07e-4)" "unprognostic (4.85e-2)" "unprognostic (9.50e-2)" "unprognostic (2.75e-1)" "unprognostic (5.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.64e-1)" "unprognostic (4.08e-5)" "unprognostic (1.11e-2)" "unprognostic (8.75e-5)" "unprognostic (1.53e-1)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (1.05e-3)" 1.1 1.7 1.4 1.1 1.8 0.4 3.6 1.1 1.1 1.1 1.3 1.1 1.1 0.8 1.4 5.6 1.1 1.8 1.4 4.2 1.9 1.8 1.1 1.1 1.1 1.1 2.1 1.1 1.3 1.1 1.0 3.6 1.1 3.1 2.7 0.8 1.1 1.2 1.6 4.2 1.2 1.1 1.1 2.3 1.1 0.8 22.6 1.1 1.1 1.3 1.1 1.1 1.1 1.1 2.8 1.6 0.7 0.9 0.8 1.2 0.4 0.2 0.0 1.8 4.5 1.1 1.5 1.4 2.2 0.5 0.6 1.4 0.0 0.4 0.4 1.0 0.6 0.1 0.1 0.0 1.5 0.0 6.5 0.4 0.0 1.5 1.6 0.0 1.1 1.8 2.6 0.1 0.4 0.3 0.2 0.0 3.2 0.0 0.9 0.0 0.1 0.4 1.3 0.0 1.2 1.1 4.3 1.9 0.4 0.9 0.0 0.6 1.5 1.4 0.9 0.3 0.4 0.5 0.5 0.9 3.8 0.1 0.0 0.0 0.5 0.0 0.6 0.7 0.1 0.2 0.0 2.8 1.0 0.6 1.6 1.3 0.6 1.2 0.5 0.8 0.9 1.0 0.0 0.4 1.4 1.8 1.1 1.1 1.9 1.8 2.1 1.1 3.1 1.1 C19orf24 FLJ20640 ENSG00000228300 "Chromosome 19 open reading frame 24" Q9BVV8 19 1275438-1279249 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043279, HPA047026" Uncertain Approved "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA043279: AB_10794656, HPA047026: AB_2679906" "unprognostic (1.10e-1)" "unprognostic (3.39e-1)" "unprognostic (1.12e-1)" "unprognostic (1.65e-3)" "unprognostic (7.05e-2)" "unprognostic (4.90e-1)" "unprognostic (4.23e-3)" "unprognostic (3.12e-2)" "unprognostic (1.18e-1)" "unprognostic (3.59e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (2.54e-3)" "unprognostic (2.16e-1)" "unprognostic (1.10e-1)" "unprognostic (2.25e-2)" 20.2 25.3 13.4 20.9 14.9 17.1 65.7 11.3 15.8 11.7 15.6 9.1 17.5 21.8 13.8 22.0 18.7 13.0 26.5 14.3 13.3 10.9 22.6 48.6 17.0 55.0 13.4 7.0 16.6 41.6 5.9 16.9 18.4 9.7 17.6 6.0 11.1 29.6 22.5 6.9 16.6 19.6 10.5 10.9 22.8 16.6 16.8 10.0 23.1 25.7 19.0 15.8 15.5 21.9 40.9 44.8 9.5 27.5 19.0 33.8 21.3 25.6 24.5 2.3 20.2 3.9 9.3 9.4 12.5 6.7 13.3 11.7 28.0 14.4 7.4 17.5 4.4 13.7 4.1 13.2 1.5 27.0 21.1 8.0 21.9 16.2 16.6 16.9 17.8 11.1 17.1 10.1 4.4 9.7 15.2 42.9 5.3 25.7 20.3 25.1 11.9 24.8 15.1 4.7 46.1 7.4 13.7 16.6 10.8 7.9 19.4 28.9 14.1 28.6 6.1 24.5 7.8 29.8 29.6 28.2 36.6 9.2 26.5 21.2 21.9 9.5 26.8 9.2 31.2 27.5 30.9 40.9 33.8 32.9 26.7 36.0 31.9 32.3 4.7 19.0 23.1 44.8 31.9 21.3 13.4 14.9 11.3 15.8 13.3 10.9 13.4 7.0 9.7 10.0 C19orf38 HIDE1 ENSG00000214212 "Chromosome 19 open reading frame 38" A8MVS5 19 10836575-10869790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 58.7;bone marrow: 54.4" "Cell line enriched" "Detected in some" 4 "U-937: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 19 "classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7" "Group enriched" "Detected in many" 19 "dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012150, HPA055027" Uncertain "Golgi apparatus,Plasma membrane,Cytosol" Cytosol "Golgi apparatus, Plasma membrane" "HPA012150: AB_10603448, HPA055027: " "unprognostic (6.65e-3)" "prognostic favourable (2.43e-4)" "unprognostic (6.44e-4)" "unprognostic (6.98e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-3)" "unprognostic (3.56e-1)" "unprognostic (8.27e-2)" "unprognostic (5.60e-2)" "unprognostic (6.02e-2)" "unprognostic (9.74e-2)" "unprognostic (3.43e-2)" "prognostic unfavourable (1.75e-7)" "unprognostic (2.31e-1)" "unprognostic (4.00e-2)" "unprognostic (1.03e-2)" "unprognostic (2.11e-2)" 2.7 1.2 2.1 6.9 4.0 54.4 1.8 0.7 3.1 2.0 1.3 4.8 0.0 1.3 0.9 4.0 0.9 2.6 2.1 5.6 2.4 2.1 1.4 2.3 12.8 19.6 4.2 0.6 1.6 1.3 0.3 1.0 1.9 3.8 1.6 1.0 1.5 1.0 0.8 2.3 0.6 1.7 2.3 6.3 22.3 1.2 15.0 3.7 4.1 0.7 0.5 2.0 2.8 3.5 2.1 26.2 37.3 58.7 1.2 0.8 20.7 1.5 0.0 0.1 0.3 1.4 0.8 0.1 0.2 0.0 0.2 0.6 0.1 0.2 3.7 0.3 0.0 0.1 0.2 0.2 0.2 1.7 0.4 0.2 0.0 0.0 1.1 2.4 0.4 4.0 0.4 0.7 0.2 0.1 0.2 7.9 0.1 1.3 0.1 5.7 0.3 0.2 2.8 0.0 1.9 0.0 0.1 0.2 0.1 0.7 0.0 0.5 0.1 5.5 0.0 0.0 0.0 0.7 0.0 4.8 2.2 1.1 0.0 32.0 0.0 1.2 44.3 26.1 0.1 48.7 0.2 2.1 0.1 0.1 26.2 1.2 0.8 0.2 37.3 1.2 58.7 0.5 0.3 20.7 2.1 4.0 0.7 3.1 2.4 2.1 4.2 0.6 3.8 3.7 C1GALT1C1 "C1GALT2, COSMC" ENSG00000171155 "C1GALT1 specific chaperone 1" Q96EU7 X 120625793-120630150 "Disease related genes, Predicted membrane proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 83.5" "Cell line enhanced" "Detected in many" "ASC diff: 72.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015632 Approved Approved Cytosol Cytosol "HPA015632: AB_1845625" "prognostic unfavourable (5.66e-4)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-1)" "unprognostic (3.07e-2)" "unprognostic (5.26e-3)" "unprognostic (4.34e-2)" "unprognostic (2.50e-1)" "unprognostic (2.18e-2)" "unprognostic (8.10e-2)" "unprognostic (3.85e-2)" "unprognostic (3.07e-1)" "unprognostic (3.98e-2)" "unprognostic (4.48e-2)" "unprognostic (1.55e-1)" "unprognostic (6.05e-3)" "unprognostic (3.78e-2)" 16.5 28.0 8.4 11.1 9.2 3.0 21.1 9.0 9.9 19.2 16.7 10.8 16.5 12.7 13.0 23.1 15.0 15.1 11.6 17.7 9.0 10.9 25.9 35.2 12.4 12.9 11.0 7.5 13.2 18.8 18.7 83.5 13.3 11.5 14.1 19.4 10.9 19.4 15.5 7.4 5.8 20.6 12.4 12.0 16.5 14.6 9.6 10.6 16.3 19.8 12.3 12.4 13.9 12.3 17.2 23.0 31.3 22.3 15.1 23.8 16.2 8.5 8.3 4.6 7.9 72.7 13.9 7.3 15.6 22.1 8.3 15.7 5.4 27.5 5.5 7.8 31.4 12.0 9.0 7.6 13.2 9.4 10.9 3.5 7.7 7.9 11.3 6.2 5.6 12.0 6.8 10.3 3.4 26.0 2.2 6.5 9.7 11.6 2.1 5.9 5.1 8.3 0.9 3.6 15.2 16.7 5.7 5.1 4.8 14.8 10.2 7.7 8.8 6.1 23.8 3.8 4.7 15.2 14.6 2.8 4.2 4.4 13.9 12.3 8.3 13.3 17.7 27.0 17.6 22.3 19.4 17.2 22.9 19.0 20.1 10.6 23.8 18.9 31.3 15.1 17.5 23.0 21.0 16.2 8.4 9.2 9.0 9.9 9.0 10.9 11.0 7.5 11.5 10.6 C1orf159 FLJ20584 ENSG00000131591 "Chromosome 1 open reading frame 159" Q96HA4 1 1081818-1116361 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA010019 Approved "HPA010019: AB_1078885" "unprognostic (2.79e-1)" "unprognostic (9.46e-2)" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-1)" "unprognostic (2.60e-3)" "prognostic unfavourable (9.58e-6)" "unprognostic (1.34e-1)" "unprognostic (3.09e-1)" "unprognostic (2.04e-2)" "unprognostic (9.29e-2)" "unprognostic (3.26e-3)" "prognostic unfavourable (1.77e-6)" "unprognostic (4.10e-2)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "prognostic favourable (1.62e-4)" 3.7 6.6 8.3 4.9 9.0 5.6 3.1 7.6 10.0 5.5 6.0 11.3 5.4 6.1 6.0 6.9 6.6 4.0 5.9 3.8 8.8 5.8 5.0 5.0 5.6 4.2 6.6 4.9 5.8 5.3 2.2 4.4 5.6 5.0 6.6 1.8 5.8 10.2 6.5 3.6 23.7 5.5 7.5 5.2 7.0 9.0 17.5 5.6 5.2 4.0 5.2 6.4 5.4 4.4 5.0 4.3 9.9 4.9 4.7 5.7 3.9 11.8 9.6 4.5 7.8 1.4 1.4 10.1 6.7 1.6 6.1 4.1 5.1 12.5 3.4 8.3 2.1 9.8 1.9 6.3 1.7 6.4 13.9 2.3 16.4 5.3 2.9 3.9 5.6 3.1 2.9 3.2 1.2 2.9 13.7 2.7 2.2 9.1 7.3 10.1 4.1 15.4 9.1 5.2 6.1 3.5 4.3 9.3 12.4 5.2 9.4 5.3 6.6 5.1 4.9 6.6 7.0 9.7 6.9 4.5 6.0 5.9 5.7 10.8 5.3 9.9 4.9 2.6 5.3 4.4 5.4 5.0 4.9 5.7 3.2 4.7 5.3 5.0 1.1 4.7 3.1 4.3 1.7 3.9 8.3 9.0 7.6 10.0 8.8 5.8 6.6 4.9 5.0 5.6 C1orf162 MGC24133 ENSG00000143110 "Chromosome 1 open reading frame 162" Q8NEQ5 1 111473792-111478512 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 119.1;lymphoid tissue: 86.6" "Group enriched" "Detected in some" 7 "HDLM-2: 44.4;HL-60: 21.6;NB-4: 12.0;THP-1: 17.1;U-937: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA026988 Approved "HPA026988: AB_10600887" "unprognostic (8.79e-2)" "unprognostic (5.18e-3)" "unprognostic (1.14e-2)" "unprognostic (2.11e-1)" "unprognostic (5.20e-2)" "unprognostic (5.96e-2)" "unprognostic (1.61e-1)" "unprognostic (5.66e-2)" "unprognostic (1.11e-1)" "unprognostic (4.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.80e-1)" "prognostic unfavourable (3.14e-6)" "unprognostic (1.29e-2)" "unprognostic (3.15e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-1)" 39.8 9.3 9.2 25.1 17.9 37.5 20.1 4.6 9.3 5.2 6.3 4.9 0.8 2.7 5.4 7.4 4.9 10.2 11.7 14.8 13.4 4.7 17.3 14.8 40.1 86.6 17.5 1.9 5.8 4.5 1.3 9.7 5.6 15.3 5.0 6.9 5.0 5.9 2.5 7.2 3.6 8.3 13.5 31.0 78.1 5.8 6.1 13.9 10.6 6.2 1.1 20.0 7.2 6.7 24.7 83.3 98.7 119.1 40.1 27.8 74.8 0.1 0.0 0.1 0.3 0.1 0.2 0.2 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.2 44.4 0.1 0.1 0.1 0.0 0.2 21.6 3.6 0.0 0.8 0.3 0.3 0.6 0.1 0.1 0.1 0.1 0.1 12.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.1 17.1 0.0 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.1 35.9 0.4 68.4 82.5 98.7 14.2 119.1 4.1 17.5 17.7 8.2 83.3 24.7 27.8 16.8 11.4 40.1 86.3 24.9 5.0 74.8 9.2 17.9 4.6 9.3 13.4 4.7 17.5 1.9 15.3 13.9 C1orf210 "MGC52423, TEMP" ENSG00000253313 "Chromosome 1 open reading frame 210" Q8IVY1 1 43281883-43285617 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.0" "Cell line enhanced" "Detected in some" "A-431: 7.9;BEWO: 8.8;CACO-2: 8.2;CAPAN-2: 26.6;SK-BR-3: 9.3;T-47d: 10.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "basophil: 5.4" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013788 Uncertain Uncertain Nucleoli Nucleoli "HPA013788: AB_1845637" "unprognostic (1.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.54e-2)" "unprognostic (2.74e-1)" "unprognostic (2.01e-2)" "prognostic favourable (0.00e+0)" "unprognostic (7.57e-3)" "unprognostic (3.94e-1)" "unprognostic (1.00e-1)" "unprognostic (1.61e-2)" 0.3 0.1 0.3 6.5 0.3 0.0 7.4 0.3 0.3 3.9 28.6 0.4 7.4 20.6 1.0 10.9 11.2 2.6 20.7 0.3 0.3 0.1 25.2 3.3 13.5 0.3 0.3 0.3 1.0 29.8 3.0 9.6 6.1 0.4 4.4 14.4 0.4 25.8 7.2 0.3 10.6 64.0 0.5 0.3 0.3 14.6 1.1 0.3 1.0 32.1 7.8 7.7 3.4 5.2 0.1 0.3 5.4 0.3 0.4 0.2 0.0 7.9 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.0 0.0 0.0 8.2 26.6 0.0 0.2 0.0 6.0 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 5.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.7 5.1 3.2 0.2 0.0 9.3 0.0 10.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.3 0.4 0.3 0.2 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.4 0.3 C1orf43 "DKFZp586G1722, NICE-3" ENSG00000143612 "Chromosome 1 open reading frame 43" Q9BWL3 1 154206706-154220637 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010725 Approved "HPA010725: AB_1078341" "unprognostic (3.90e-2)" "unprognostic (1.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.12e-1)" "unprognostic (6.87e-2)" "unprognostic (6.15e-3)" "prognostic unfavourable (6.57e-4)" "unprognostic (1.72e-1)" "unprognostic (2.78e-1)" "unprognostic (2.64e-2)" "unprognostic (3.51e-2)" "unprognostic (1.10e-1)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (2.89e-1)" "unprognostic (1.75e-2)" "unprognostic (1.23e-1)" 36.4 36.5 45.5 20.4 47.7 20.7 43.4 36.0 43.5 29.0 33.7 36.2 28.0 34.9 23.1 36.7 30.9 30.9 31.8 53.5 39.9 35.2 55.5 80.2 30.5 27.6 48.4 29.4 23.4 68.9 28.8 24.2 25.1 31.1 29.8 37.2 25.2 31.0 29.0 124.2 27.0 36.6 27.4 46.1 27.0 30.1 19.5 33.8 22.0 38.4 49.0 28.4 32.7 29.0 29.2 59.0 39.0 56.1 21.2 41.6 56.4 28.9 30.9 26.0 30.7 39.0 39.3 16.1 29.1 50.6 34.0 31.8 21.2 41.2 38.3 44.4 26.2 29.7 35.7 26.4 24.5 30.1 39.4 29.5 34.4 27.4 60.7 37.0 35.1 31.9 62.8 36.1 75.4 39.2 30.9 36.5 44.1 46.3 27.8 33.9 50.1 47.4 25.5 23.9 69.2 42.4 30.6 42.4 55.8 26.3 70.2 98.5 69.3 82.1 26.7 26.6 22.4 31.8 36.6 67.3 65.4 36.5 44.5 37.3 70.6 39.0 56.1 35.7 25.4 50.4 30.5 29.2 29.6 27.7 59.0 25.6 31.3 26.1 32.2 21.2 45.3 43.6 41.6 56.4 45.5 47.7 36.0 43.5 39.9 35.2 48.4 29.4 31.1 33.8 C20orf24 "PNAS-11, RIP5" ENSG00000101084 "Chromosome 20 open reading frame 24" Q9BUV8 20 36605734-36612557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA057387 Uncertain Approved Cytosol Cytosol "HPA057387: " "unprognostic (2.14e-1)" "unprognostic (4.75e-3)" "unprognostic (6.83e-2)" "unprognostic (1.78e-3)" "unprognostic (3.88e-1)" "unprognostic (2.24e-2)" "prognostic unfavourable (4.56e-6)" "unprognostic (4.47e-3)" "unprognostic (3.89e-1)" "unprognostic (2.90e-1)" "unprognostic (2.37e-2)" "unprognostic (8.60e-2)" "prognostic unfavourable (2.46e-4)" "unprognostic (2.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "unprognostic (9.98e-2)" 17.0 19.7 15.1 18.5 16.3 25.1 29.1 11.9 21.1 15.8 31.1 10.9 15.2 21.9 11.8 18.1 55.5 10.8 25.1 24.2 14.3 14.0 35.6 71.1 21.4 24.4 15.0 11.7 9.5 27.6 15.4 8.5 19.3 12.6 13.3 26.5 9.8 21.5 17.9 70.0 13.6 26.1 14.6 12.7 26.2 20.0 19.0 11.3 20.4 21.6 42.3 28.3 14.3 20.4 10.0 15.8 41.3 24.2 6.1 11.9 7.7 35.7 26.9 8.9 11.8 21.3 12.3 23.9 22.4 12.3 21.4 19.5 73.6 45.1 15.6 55.6 19.2 26.6 19.1 35.0 20.5 11.7 19.8 37.0 38.2 80.5 25.0 38.9 18.2 15.3 37.1 31.0 17.6 19.6 25.2 36.6 20.2 24.2 22.7 50.2 16.3 57.5 18.2 22.9 38.9 18.5 26.7 16.5 12.5 32.3 83.9 28.1 17.7 32.0 22.1 32.1 22.1 33.1 33.9 23.4 37.8 26.2 34.6 45.4 17.0 7.2 24.2 29.9 6.2 12.4 6.2 10.0 7.4 9.6 15.8 8.1 9.0 6.7 41.3 6.1 14.7 10.8 11.9 7.7 15.1 16.3 11.9 21.1 14.3 14.0 15.0 11.7 12.6 11.3 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.1" "Cell line enhanced" "Detected in all" "HMC-1: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011044 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" "Nucleoplasm, Nucleoli" "Nuclear membrane, Cytosol" "HPA011044: " "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favourable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavourable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 5.2 7.0 15.9 7.3 33.1 14.7 4.8 18.2 31.2 5.8 10.3 7.5 8.3 18.7 4.1 6.1 9.4 10.9 6.3 7.9 15.8 13.6 6.3 7.3 8.3 8.5 9.1 12.6 3.9 7.5 7.8 14.2 4.8 11.7 4.8 8.8 5.6 8.7 7.0 8.3 12.5 19.4 6.1 7.3 9.2 5.5 2.6 9.1 7.0 5.5 6.7 6.6 6.6 5.3 0.4 1.1 5.7 4.2 1.7 1.6 1.1 3.3 2.5 3.5 7.1 4.5 1.9 2.2 5.1 4.5 5.1 4.3 4.0 3.5 5.1 13.4 3.5 7.6 4.3 2.2 2.0 8.0 3.6 20.0 3.2 2.9 6.0 5.7 29.2 2.2 4.5 9.5 3.5 3.2 8.3 9.1 4.7 8.9 6.4 13.8 1.3 6.8 4.1 3.1 5.8 5.0 2.1 10.7 6.1 2.1 11.5 3.2 20.2 7.7 3.8 4.7 1.6 5.6 8.9 4.0 2.4 2.0 2.9 9.9 5.2 1.1 3.0 5.7 0.6 3.2 1.0 0.4 1.4 1.4 1.1 0.1 1.6 0.8 1.0 1.7 4.2 0.7 1.6 1.1 15.9 33.1 18.2 31.2 15.8 13.6 9.1 12.6 11.7 9.1 C2orf16 DKFZp434G118 ENSG00000221843 "Chromosome 2 open reading frame 16" Q68DN1 2 27537386-27582721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 22.3" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.2;SiHa: 4.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "HPA052136, HPA056962" Uncertain Uncertain "Nuclear bodies" "Nuclear bodies" "HPA052136: , HPA056962: " "unprognostic (4.32e-2)" "unprognostic (1.08e-2)" "unprognostic (8.36e-2)" "unprognostic (3.40e-3)" "unprognostic (6.36e-2)" "unprognostic (6.17e-2)" "unprognostic (6.15e-2)" "unprognostic (3.07e-1)" "unprognostic (9.35e-2)" "unprognostic (3.79e-3)" "unprognostic (4.59e-1)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (8.00e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-2)" "unprognostic (8.53e-3)" 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.2 1.0 0.5 0.1 0.4 0.5 0.2 0.2 0.2 0.9 0.2 0.2 0.2 0.2 0.4 0.4 0.0 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.6 22.3 0.2 0.2 0.7 0.2 0.2 0.4 0.2 0.0 0.3 0.3 1.0 0.0 0.6 0.1 1.5 1.6 2.3 1.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 2.1 0.8 2.0 0.0 0.5 0.0 0.0 0.0 1.4 0.4 3.0 1.2 1.5 0.0 1.7 1.3 0.0 0.0 0.2 0.0 0.2 1.2 2.1 0.1 0.3 0.0 0.8 0.4 0.0 1.2 1.3 0.5 0.0 1.5 6.2 1.1 4.4 1.1 0.6 1.0 1.1 2.7 1.4 2.0 0.9 1.0 0.4 0.0 1.9 0.5 0.3 2.0 0.0 1.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.3 0.0 0.8 0.2 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 C2orf74 LOC339804 ENSG00000237651 "Chromosome 2 open reading frame 74" A8MZ97 2 61145068-61164829 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026826 Approved Approved Centrosome Centrosome "HPA026826: AB_10671091" "unprognostic (1.20e-1)" "unprognostic (2.44e-1)" "unprognostic (2.03e-2)" "unprognostic (4.54e-2)" "unprognostic (8.10e-2)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (1.28e-3)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (1.54e-1)" "unprognostic (2.69e-2)" "unprognostic (6.65e-2)" "unprognostic (3.52e-1)" "unprognostic (6.22e-2)" 15.8 19.4 32.2 10.7 38.5 2.4 19.1 12.6 33.7 15.4 11.5 13.6 10.0 3.6 12.7 30.2 9.6 13.6 8.6 25.3 25.8 26.1 26.0 22.7 11.4 12.3 26.9 18.4 17.1 8.9 12.5 26.0 11.2 26.0 13.0 6.0 5.8 8.7 12.5 15.0 5.4 5.7 12.7 22.3 13.5 9.9 27.4 22.5 5.7 20.5 12.5 10.1 9.9 10.0 20.1 10.8 17.0 10.4 18.4 20.6 6.8 5.7 10.0 10.4 0.0 22.3 22.8 9.4 15.1 17.4 14.5 12.0 0.0 9.8 7.2 21.1 12.3 7.8 0.0 12.4 24.9 9.1 6.2 0.0 9.5 11.5 9.0 8.6 8.1 23.4 20.4 10.8 22.1 8.0 0.0 5.5 22.1 10.5 0.0 16.5 9.9 6.3 13.0 12.9 12.1 19.8 4.5 21.6 8.3 1.9 1.9 12.6 7.9 8.7 4.2 12.3 5.3 7.3 18.3 23.1 10.5 27.3 16.2 6.2 10.8 9.9 4.9 17.0 11.4 10.4 14.5 20.1 12.5 11.6 10.8 13.0 20.6 16.3 1.1 18.4 10.1 8.9 16.1 6.8 32.2 38.5 12.6 33.7 25.8 26.1 26.9 18.4 26.0 22.5 C2orf83 DKFZp547H025 ENSG00000042304 "Chromosome 2 open reading frame 83" Q53S99 2 227610090-227648606 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "placenta: 16.3" "Cell line enriched" "Detected in single" 14 "U-2197: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA030319 Approved "HPA030319: AB_10602112" "unprognostic (1.12e-2)" "unprognostic (1.03e-1)" 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf18 G20 ENSG00000088543 "Chromosome 3 open reading frame 18" Q9UK00 3 50558025-50571027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;NK-cells: 2.1;T-cells: 7.7" "Group enriched" "Detected in many" 4 "cerebellum: 31.6;olfactory region: 33.8" "Low region specificity" "Detected in all" HPA012105 Approved Approved Cytosol Cytosol "HPA012105: AB_1845717" "unprognostic (9.29e-3)" "unprognostic (1.46e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (8.19e-2)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (1.05e-2)" "unprognostic (1.64e-1)" "unprognostic (1.76e-1)" "unprognostic (2.10e-3)" "unprognostic (1.29e-2)" "prognostic favourable (2.80e-9)" "unprognostic (7.65e-2)" "unprognostic (4.49e-1)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" 5.1 6.7 10.0 3.4 12.3 1.2 6.2 34.5 20.1 6.0 6.1 8.0 2.2 2.2 8.0 5.1 5.0 8.4 6.0 25.3 8.1 9.7 6.0 3.0 4.1 3.9 11.4 9.3 14.0 6.1 19.2 7.4 2.6 10.3 8.5 3.2 11.9 7.3 11.0 32.4 2.8 2.9 10.4 6.9 4.1 5.2 9.8 6.1 1.8 6.9 7.2 4.0 6.8 4.9 2.9 0.9 0.8 0.5 2.1 7.7 3.0 1.1 1.6 1.9 0.4 6.4 5.8 0.6 6.8 10.6 6.2 4.5 0.1 1.7 1.3 1.6 9.2 0.1 0.0 2.6 3.3 29.2 0.2 2.8 3.8 0.5 3.2 0.0 3.7 5.7 0.3 6.0 0.3 1.2 0.6 1.3 3.6 0.2 0.2 0.8 2.4 7.6 0.6 0.2 1.6 0.3 0.2 2.1 10.1 1.8 0.4 0.1 2.0 0.8 0.3 6.2 4.9 11.3 0.8 1.8 1.4 0.2 8.9 3.1 0.1 0.0 0.5 0.8 6.3 0.2 7.7 2.9 5.5 6.0 0.5 1.8 6.4 7.7 0.0 2.1 0.1 0.9 2.5 3.0 10.0 12.3 34.5 20.1 8.1 9.7 11.4 9.3 10.3 6.1 C3orf52 "FLJ23186, TTMP" ENSG00000114529 "Chromosome 3 open reading frame 52" Q5BVD1 3 112086335-112131004 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 41.2" "Cell line enhanced" "Detected in many" "CACO-2: 14.6;U-698: 20.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.7" "Low lineage specificity" "Detected in single" "HPA008119, HPA011968" Uncertain "HPA008119: AB_1848824, HPA011968: AB_1848826" "unprognostic (8.86e-2)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.45e-2)" "unprognostic (3.87e-3)" "unprognostic (3.49e-4)" "unprognostic (2.54e-1)" "unprognostic (1.39e-2)" "unprognostic (2.30e-1)" "prognostic unfavourable (3.85e-4)" "unprognostic (2.71e-2)" "unprognostic (3.76e-6)" "unprognostic (3.14e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-2)" "unprognostic (9.59e-2)" 1.1 1.0 0.3 5.3 0.7 0.4 1.9 0.3 0.4 1.0 9.1 0.0 6.9 2.8 1.7 1.5 2.7 1.0 12.4 3.0 0.4 0.4 7.1 0.5 6.3 0.8 0.3 0.0 0.6 41.2 0.0 8.7 6.1 0.5 5.4 9.0 0.6 3.9 9.6 1.5 22.3 12.7 4.2 0.3 0.8 10.6 1.0 0.0 20.8 10.7 4.3 3.6 6.1 6.1 0.8 0.8 0.0 0.0 0.0 2.7 1.0 8.5 1.4 2.4 0.0 0.3 0.0 3.1 6.7 2.9 3.9 4.5 14.6 4.6 0.2 1.2 2.0 6.1 2.7 1.7 7.5 0.0 2.3 5.9 2.0 0.7 1.8 0.0 0.0 0.5 3.5 3.5 6.0 0.9 1.5 1.5 2.9 0.6 0.2 0.0 5.1 1.8 0.2 7.8 0.0 7.0 7.6 0.3 0.6 2.6 2.6 2.5 4.0 0.0 2.2 1.4 2.3 0.0 0.0 5.4 0.0 20.4 1.2 0.0 1.3 0.0 0.0 0.0 1.3 0.0 0.4 0.8 2.7 1.3 0.5 0.3 1.5 0.6 0.0 0.0 0.0 0.8 0.0 1.0 0.3 0.7 0.3 0.4 0.4 0.4 0.3 0.0 0.5 0.0 C3orf80 ENSG00000180044 "Chromosome 3 open reading frame 80" F5H4A9 3 160225496-160228213 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.0;intestine: 8.6" "Cell line enriched" "Detected in some" 5 "HMC-1: 55.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047439 Uncertain "HPA047439: AB_10965171" "unprognostic (5.34e-2)" "unprognostic (2.31e-1)" "unprognostic (6.35e-2)" "unprognostic (6.62e-3)" "unprognostic (1.92e-3)" "unprognostic (6.70e-3)" "unprognostic (4.28e-3)" "unprognostic (1.69e-1)" "unprognostic (4.64e-3)" "unprognostic (1.51e-1)" "unprognostic (9.20e-2)" "unprognostic (2.65e-1)" "unprognostic (6.09e-10)" "unprognostic (1.32e-2)" "unprognostic (1.78e-2)" "unprognostic (4.11e-3)" "unprognostic (5.00e-2)" 1.3 0.4 5.2 1.6 9.3 1.4 0.7 5.4 25.0 0.5 8.6 0.1 0.0 1.8 1.2 0.5 5.7 0.3 1.4 0.6 4.3 2.0 0.6 0.8 2.0 0.3 1.7 9.3 0.3 0.4 1.4 0.7 0.3 1.2 1.8 3.3 0.0 0.6 0.8 0.2 0.2 1.3 1.8 0.5 2.7 2.5 1.3 0.0 0.0 0.5 0.0 0.4 2.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 1.1 0.7 4.6 1.3 0.0 0.0 0.9 55.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.0 0.1 11.4 0.0 0.0 0.2 0.0 1.4 0.1 0.0 0.0 0.4 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.2 9.3 5.4 25.0 4.3 2.0 1.7 9.3 1.2 0.0 C4orf3 HCVFTP1 ENSG00000164096 "Chromosome 4 open reading frame 3" Q8WVX3 4 119296419-119304445 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA026907 Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA026907: AB_10600760" "unprognostic (2.97e-1)" "unprognostic (4.68e-2)" "unprognostic (3.32e-1)" "unprognostic (6.85e-3)" "unprognostic (9.30e-2)" "unprognostic (7.15e-3)" "unprognostic (2.04e-1)" "unprognostic (8.85e-2)" "unprognostic (4.90e-2)" "unprognostic (7.11e-2)" "unprognostic (9.94e-3)" "unprognostic (1.84e-1)" "prognostic favourable (3.46e-4)" "unprognostic (8.32e-2)" "unprognostic (2.65e-1)" "unprognostic (3.90e-1)" "unprognostic (1.59e-1)" 51.6 41.9 46.2 39.1 47.2 19.0 31.7 18.2 41.1 46.1 33.5 41.1 25.6 41.3 39.4 49.0 101.3 33.8 37.0 43.4 46.5 45.4 55.8 63.4 33.6 32.2 61.2 31.6 45.1 32.7 19.6 34.7 36.6 47.3 38.7 20.3 33.4 42.6 34.1 70.5 37.7 45.0 41.5 68.7 38.0 26.9 19.4 35.8 30.3 44.2 42.3 39.3 50.0 59.8 60.4 66.8 112.7 53.3 38.0 48.6 65.5 68.5 7.9 23.1 19.1 32.4 24.7 18.9 30.3 8.3 8.9 16.6 8.4 22.8 47.2 23.5 28.9 13.4 10.3 25.1 14.0 31.6 10.1 19.5 18.3 29.7 9.7 32.0 21.4 25.8 21.0 12.8 5.5 14.9 17.4 19.7 32.7 19.7 20.7 29.9 11.7 8.1 14.9 30.9 11.9 16.9 15.6 14.5 23.6 23.0 30.5 15.7 16.3 16.7 29.2 33.0 19.6 19.9 12.3 33.3 34.1 21.9 62.0 13.3 18.7 69.3 50.7 60.4 40.1 53.3 38.7 60.4 47.8 45.0 42.7 46.4 48.4 46.9 112.7 38.0 49.0 66.8 48.6 65.5 46.2 47.2 18.2 41.1 46.5 45.4 61.2 31.6 47.3 35.8 C5orf15 "HTGN29, KCT2" ENSG00000113583 "Chromosome 5 open reading frame 15" Q8NC54 5 133955502-133968787 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011951, HPA039165" Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA011951: , HPA039165: AB_10795580" "unprognostic (2.25e-1)" "unprognostic (3.01e-1)" "unprognostic (2.07e-1)" "unprognostic (4.91e-2)" "unprognostic (1.81e-1)" "unprognostic (2.26e-3)" "unprognostic (1.01e-2)" "unprognostic (7.72e-2)" "unprognostic (2.62e-2)" "unprognostic (7.54e-2)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (9.07e-3)" "unprognostic (5.18e-2)" "unprognostic (1.34e-1)" "unprognostic (1.66e-1)" "unprognostic (2.14e-2)" 25.2 36.1 17.4 28.0 24.0 9.2 39.1 18.4 28.9 24.3 19.4 25.7 23.6 27.7 22.3 27.8 20.2 28.3 24.9 53.2 19.4 20.1 56.1 45.2 34.3 36.8 18.9 15.6 32.6 26.6 28.3 25.2 36.0 31.3 23.9 19.5 21.8 24.6 29.6 20.0 21.2 32.0 17.7 41.8 26.8 27.6 26.8 20.2 21.9 31.2 16.4 20.4 27.5 20.4 16.8 24.0 11.0 22.5 13.5 15.6 17.4 17.4 13.0 18.1 20.9 27.0 30.9 22.3 18.3 24.2 27.8 46.7 12.6 52.2 12.3 33.3 21.8 13.1 14.7 26.3 32.9 14.0 22.5 4.6 9.5 15.9 25.5 7.5 20.8 26.9 16.3 21.7 11.6 11.7 9.7 14.8 22.2 11.0 8.7 14.4 10.1 7.8 8.5 18.7 18.3 45.1 13.4 16.5 12.3 18.1 6.3 28.8 19.4 23.0 10.7 25.1 23.3 10.1 17.9 11.2 10.7 7.5 29.7 18.2 36.9 11.0 21.2 10.6 10.5 22.5 9.8 16.0 11.9 11.4 24.0 16.8 15.6 12.4 10.8 13.5 20.5 17.5 11.4 17.4 17.4 24.0 18.4 28.9 19.4 20.1 18.9 15.6 31.3 20.2 C5orf60 ENSG00000204661 "Chromosome 5 open reading frame 60" A6NFR6 5 179641544-179645046 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 3.7;testis: 12.1" "Cell line enhanced" "Detected in some" "HeLa: 2.2;Karpas-707: 2.5;RT4: 1.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA065431 Enhanced "HPA065431: " "unprognostic (3.47e-3)" "unprognostic (1.00e-1)" "unprognostic (3.23e-1)" "unprognostic (2.62e-1)" "unprognostic (5.66e-5)" "unprognostic (1.18e-1)" "unprognostic (2.65e-2)" "unprognostic (1.71e-1)" "unprognostic (3.50e-3)" "unprognostic (7.11e-2)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" "unprognostic (9.47e-2)" "unprognostic (2.16e-1)" "unprognostic (8.76e-2)" "unprognostic (1.72e-2)" 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.0 0.0 1.8 1.1 3.7 1.1 2.4 1.2 0.2 0.3 0.0 0.0 0.0 0.9 0.0 0.2 0.3 0.1 0.0 0.2 0.0 0.1 0.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 2.2 0.5 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.3 2.5 1.2 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.2 0.0 1.5 0.4 0.9 0.0 1.0 0.1 0.2 0.0 0.0 0.8 0.3 0.3 0.0 0.9 0.6 0.0 0.0 0.2 0.5 3.2 1.1 1.2 0.8 0.5 0.3 1.1 0.6 0.6 0.4 1.8 0.9 1.2 3.7 2.4 0.5 1.1 0.6 0.2 C6orf136 Em:AB023049.8 ENSG00000204564 "Chromosome 6 open reading frame 136" Q5SQH8 6 30647039-30653210 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046804 Uncertain "HPA046804: " "unprognostic (1.94e-2)" "unprognostic (1.71e-3)" "unprognostic (1.26e-1)" "unprognostic (8.01e-3)" "unprognostic (1.65e-2)" "unprognostic (2.76e-2)" "unprognostic (1.61e-1)" "unprognostic (1.79e-1)" "unprognostic (2.13e-1)" "unprognostic (2.62e-2)" "unprognostic (4.72e-3)" "unprognostic (3.43e-1)" "prognostic favourable (9.16e-8)" "unprognostic (2.33e-2)" "unprognostic (4.54e-2)" "unprognostic (6.03e-2)" "prognostic favourable (7.51e-4)" 7.4 13.4 13.5 7.1 19.0 7.5 6.9 22.6 30.0 8.1 22.5 11.9 8.4 24.2 6.2 16.4 9.6 8.4 6.8 16.9 13.5 15.1 14.4 11.7 9.2 8.1 15.8 18.1 5.2 13.3 20.4 12.3 7.0 24.9 7.3 21.3 8.4 8.9 12.1 21.3 14.3 21.5 7.7 11.7 8.2 9.1 7.6 9.5 3.6 10.7 13.0 6.8 10.0 5.8 3.5 2.5 2.2 1.2 1.1 3.9 1.2 3.7 6.1 3.3 2.9 5.1 6.2 5.8 1.4 1.7 3.8 5.3 4.0 2.6 3.2 2.3 1.1 5.0 0.5 0.2 4.1 2.8 4.6 1.7 4.2 2.4 1.3 5.2 5.4 2.8 5.7 2.8 3.4 1.5 4.2 2.4 0.8 6.2 2.3 5.8 3.6 3.4 4.5 3.0 6.4 8.2 5.4 7.9 1.5 1.9 6.5 4.3 3.2 1.2 0.7 1.1 5.5 2.2 4.7 6.3 7.3 2.2 2.0 4.6 2.5 0.1 1.2 0.2 2.0 1.0 2.6 3.5 2.4 1.4 1.2 2.3 3.9 2.3 2.2 1.1 1.1 2.5 1.7 1.2 13.5 19.0 22.6 30.0 13.5 15.1 15.8 18.1 24.9 9.5 C6orf89 "BRAP, FLJ25357" ENSG00000198663 "Chromosome 6 open reading frame 89" Q6UWU4 6 36871870-36928964 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012548 Uncertain "HPA012548: AB_1845748" "unprognostic (2.26e-1)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (3.01e-1)" "unprognostic (1.19e-1)" "unprognostic (2.52e-1)" "unprognostic (2.94e-2)" "unprognostic (1.20e-1)" "unprognostic (1.69e-2)" "unprognostic (1.69e-2)" "unprognostic (2.26e-2)" "unprognostic (1.44e-1)" "prognostic favourable (5.77e-5)" "unprognostic (3.75e-3)" "unprognostic (3.85e-1)" "unprognostic (9.94e-3)" "unprognostic (8.42e-3)" 28.0 38.1 26.5 20.9 31.9 24.8 31.2 20.2 34.9 38.2 27.9 33.1 38.6 21.3 34.7 40.0 28.3 30.9 27.2 44.0 33.2 26.4 31.4 42.9 25.9 25.3 30.2 28.8 36.8 47.4 47.7 32.4 29.5 31.6 29.8 29.4 27.1 29.6 60.4 38.3 22.7 25.1 35.2 38.0 20.5 28.3 36.3 25.3 16.1 45.5 21.0 23.3 31.3 28.4 8.6 11.7 21.9 16.5 8.5 15.5 10.2 9.0 5.6 7.8 11.2 28.7 19.7 4.6 17.9 22.8 12.8 14.1 5.7 9.7 8.1 14.1 37.0 9.9 9.5 11.3 18.6 14.5 8.2 11.7 6.1 6.5 14.3 9.4 12.2 16.9 14.2 15.6 15.0 11.0 22.3 22.7 19.7 9.0 10.3 3.5 2.9 6.3 5.1 7.8 14.7 8.5 8.1 13.8 9.9 12.0 5.9 12.5 14.0 12.9 12.8 18.4 10.6 14.5 14.0 12.2 15.0 86.2 8.2 13.6 19.1 19.6 13.0 16.0 15.4 12.7 15.5 8.6 12.8 14.2 11.7 7.8 9.0 9.5 21.9 8.5 16.5 7.3 12.9 10.2 26.5 31.9 20.2 34.9 33.2 26.4 30.2 28.8 31.6 25.3 C9orf84 FLJ32779 ENSG00000165181 "Chromosome 9 open reading frame 84" Q5VXU9 9 111686173-111795008 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 33.0" "Cell line enriched" "Detected in some" 5 "U-2 OS: 21.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 15 "granulocytes: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA032108 Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA032108: AB_10669884" "unprognostic (2.63e-1)" "unprognostic (1.83e-4)" "unprognostic (9.12e-2)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (9.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.22e-2)" "unprognostic (1.65e-1)" "unprognostic (8.14e-2)" "unprognostic (2.30e-1)" "unprognostic (8.33e-5)" "unprognostic (6.93e-2)" "unprognostic (2.84e-1)" "unprognostic (3.77e-1)" "unprognostic (7.31e-2)" 0.1 2.9 0.1 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.0 0.3 0.6 0.2 0.0 0.1 0.1 0.1 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 1.1 33.0 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.2 0.2 4.1 0.0 0.1 0.2 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 4.7 1.1 0.4 0.0 0.2 0.0 0.0 21.9 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 4.1 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CA12 HsT18816 ENSG00000074410 "Carbonic anhydrase 12" O43570 15 63321378-63382161 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 103.5" "Cell line enhanced" "Detected in many" "A549: 38.2;ASC TERT1: 40.3;RT4: 40.5;SK-BR-3: 32.5;T-47d: 52.3;U-138 MG: 55.8;U-87 MG: 67.0" "Cancer enhanced" "Detected in all" "renal cancer: 109.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008773, CAB025181, CAB062549, CAB068179, HPA073203" Enhanced Approved Nucleoplasm,Vesicles 29000 Nucleoplasm Vesicles "CAB025181: , CAB062549: , CAB068179: , HPA008773: AB_1078394, HPA073203: " "unprognostic (2.01e-1)" "unprognostic (8.38e-3)" "unprognostic (3.47e-1)" "unprognostic (3.25e-3)" "unprognostic (2.73e-2)" "unprognostic (2.47e-2)" "unprognostic (7.48e-2)" "unprognostic (3.43e-3)" "unprognostic (2.29e-1)" "unprognostic (4.67e-2)" "prognostic unfavourable (3.80e-6)" "unprognostic (2.59e-1)" "unprognostic (1.51e-1)" "unprognostic (2.38e-1)" "unprognostic (6.56e-2)" "unprognostic (7.26e-2)" "unprognostic (1.21e-1)" 3.7 0.3 4.7 15.0 27.4 0.3 14.5 3.7 2.3 15.7 32.0 2.6 5.0 0.4 9.8 12.3 42.8 8.5 2.6 1.6 4.9 1.4 103.5 0.3 1.2 0.3 1.8 0.2 2.1 43.8 0.3 3.9 5.9 16.9 3.8 30.3 8.5 8.2 17.9 0.5 44.1 2.4 18.1 0.1 0.4 2.2 1.3 6.7 0.0 1.7 18.4 25.9 10.6 14.5 0.3 0.2 0.6 0.7 0.3 0.2 0.0 0.0 38.2 0.6 0.0 5.1 40.3 2.0 2.7 2.5 0.4 0.7 0.2 0.0 0.0 9.4 2.2 0.2 0.0 1.8 1.1 0.0 1.3 0.0 2.6 0.0 0.1 0.0 0.0 15.2 2.1 11.6 3.7 0.4 0.0 0.0 0.5 22.0 0.0 0.0 0.6 6.0 0.0 0.0 0.0 0.0 40.5 0.3 0.0 0.1 32.5 0.0 52.3 0.0 0.0 55.8 3.0 1.8 0.0 0.0 0.0 0.0 67.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.7 0.2 0.1 0.0 4.7 27.4 3.7 1.3 4.9 1.4 1.8 0.2 16.9 6.7 CA14 ENSG00000118298 "Carbonic anhydrase 14" Q9ULX7 1 150257159-150265078 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1" "Group enriched" "Detected in some" 18 "AF22: 28.0;AN3-CA: 16.6;NTERA-2: 21.8;SK-MEL-30: 55.8" "Group enriched" "Detected in many" 7 "glioma: 4.9;melanoma: 23.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008482 Approved Approved "Plasma membrane" "Plasma membrane" "HPA008482: AB_1078395" "unprognostic (3.06e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (3.25e-2)" "prognostic favourable (8.47e-4)" "unprognostic (7.28e-2)" "unprognostic (4.48e-2)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (2.47e-1)" "unprognostic (5.46e-2)" "unprognostic (1.73e-1)" "unprognostic (5.89e-3)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (1.22e-1)" "unprognostic (5.80e-2)" 0.1 0.3 4.6 0.2 5.2 0.9 0.3 1.4 6.8 0.1 1.7 10.8 0.1 0.3 0.1 0.5 1.6 1.3 0.7 4.4 6.4 4.1 0.3 6.3 0.2 0.2 11.3 3.2 1.4 0.3 0.8 0.1 0.3 4.4 3.2 0.7 29.4 0.6 16.5 24.1 3.7 0.6 0.5 20.9 0.3 0.8 0.5 2.7 0.1 0.9 0.1 0.1 0.2 0.1 2.8 2.2 2.1 2.0 0.2 1.6 0.2 0.2 0.0 28.0 16.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 21.8 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.1 55.8 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 1.2 0.1 0.1 0.1 0.0 0.0 0.9 1.3 1.6 2.0 0.6 2.0 1.0 1.2 0.2 2.8 1.2 1.3 2.1 0.2 0.5 2.2 0.0 0.2 4.6 5.2 1.4 4.7 6.4 4.1 11.3 3.2 4.4 2.7 CA4 "CAIV, Car4, RP17" ENSG00000167434 "Carbonic anhydrase 4" P22748 17 60149936-60170899 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 81.7" "Cell line enhanced" "Detected in some" "HEK 293: 1.4;HUVEC TERT2: 1.7;NTERA-2: 3.9;RPMI-8226: 1.5;RPTEC TERT1: 2.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "cerebellum: 50.1" "Cell type enriched" "Detected in some" 7 "neutrophil: 37.0" "Lineage enriched" "Detected in single" 370 "granulocytes: 37.0" "Region enriched" "Detected in all" 5 "cerebellum: 336.9" "Low region specificity" "Detected in many" "HPA011089, HPA017258" Enhanced Supported Vesicles 190000 Vesicles "HPA011089: AB_1845996, HPA017258: AB_1845997" "unprognostic (2.07e-2)" "unprognostic (7.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.78e-3)" "unprognostic (8.42e-2)" "unprognostic (1.19e-1)" "unprognostic (3.19e-2)" "unprognostic (5.84e-2)" "unprognostic (7.76e-2)" "unprognostic (9.74e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-2)" "unprognostic (2.68e-3)" "unprognostic (8.59e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-1)" "unprognostic (4.57e-2)" 32.2 0.9 3.4 9.8 4.4 5.7 46.4 50.1 11.8 2.3 81.7 2.0 31.5 1.4 2.3 17.4 0.9 1.7 12.2 8.8 4.7 2.6 12.0 0.3 33.3 2.4 3.5 5.2 1.9 9.5 3.3 5.1 3.2 3.0 2.4 54.9 20.3 4.8 24.0 10.0 1.0 3.2 1.1 2.1 4.9 2.5 1.2 0.3 0.2 23.1 5.0 0.2 1.7 7.9 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.5 0.9 0.0 0.3 0.0 0.0 0.4 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.3 3.9 0.0 0.0 0.2 1.5 2.2 0.0 0.8 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 50.1 11.8 4.7 2.6 3.5 5.2 3.0 0.3 CA9 "CAIX, MN" ENSG00000107159 "Carbonic anhydrase 9" Q16790 9 35673856-35681159 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8" "Cell line enhanced" "Detected in some" "A-431: 39.6;HDLM-2: 20.7;U-87 MG: 83.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 7.3" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 4 "cerebellum: 13.8" "Low region specificity" "Detected in all" "CAB005100, CAB017107, HPA055207" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane" Cytosol "CAB005100: AB_2066539, CAB017107: , HPA055207: " "unprognostic (8.01e-3)" "unprognostic (1.34e-2)" "unprognostic (2.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.59e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (1.71e-5)" "unprognostic (1.47e-2)" "unprognostic (3.90e-2)" "unprognostic (1.29e-1)" "unprognostic (6.24e-3)" "unprognostic (1.13e-1)" "prognostic unfavourable (2.22e-7)" "unprognostic (7.29e-2)" "prognostic favourable (9.50e-4)" "unprognostic (2.97e-3)" "unprognostic (8.67e-2)" 1.0 0.1 0.0 0.1 0.3 0.0 0.0 7.3 0.7 0.5 7.2 0.1 0.2 6.7 0.1 1.5 0.3 0.1 70.4 0.7 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.7 47.4 0.0 0.2 0.7 0.4 0.2 0.0 0.1 0.0 0.0 0.0 2.6 8.0 0.0 0.4 0.0 70.8 1.4 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 1.1 0.0 0.0 0.4 0.1 0.0 39.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.3 20.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.0 1.0 0.0 0.0 0.0 83.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.3 7.3 0.7 0.0 0.0 0.0 0.0 0.4 0.0 CABLES2 "C20orf150, dJ908M14.2, ik3-2" ENSG00000149679 "Cdk5 and Abl enzyme substrate 2" Q9BTV7 20 62388632-62407285 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052138 Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" "Nuclear bodies" "Nucleoplasm, Cell Junctions" "HPA052138: " "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (2.25e-1)" "prognostic unfavourable (5.26e-5)" "unprognostic (1.45e-2)" "unprognostic (1.51e-1)" "unprognostic (2.71e-2)" "unprognostic (5.07e-2)" "unprognostic (5.37e-3)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.09e-2)" "prognostic unfavourable (1.24e-6)" "unprognostic (1.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.67e-1)" "unprognostic (2.94e-2)" 2.3 3.3 5.9 5.6 5.6 8.3 2.8 15.1 10.2 3.4 4.4 3.6 1.3 3.6 3.7 3.6 3.7 4.7 3.0 10.5 4.3 5.5 2.6 3.6 2.9 5.7 4.9 5.3 4.3 3.7 4.1 5.8 4.3 7.2 4.1 4.1 3.1 3.6 4.2 5.4 5.2 4.9 4.3 3.5 4.1 3.8 34.9 5.4 5.1 5.7 2.6 5.2 4.1 3.2 1.4 1.1 1.0 1.1 1.5 4.1 0.5 9.5 7.2 12.5 12.7 1.9 2.7 1.7 5.4 5.4 15.2 7.1 25.9 5.5 9.6 4.7 3.5 6.1 7.6 3.6 6.0 4.3 4.2 11.2 3.7 6.2 3.4 4.5 5.8 1.7 4.1 4.3 1.6 3.5 2.8 8.4 3.4 11.7 11.8 3.6 4.1 8.3 16.5 10.5 4.2 2.2 6.3 6.8 10.3 8.0 10.6 2.1 7.2 6.9 3.6 14.1 4.3 18.5 5.6 8.1 6.6 11.4 12.6 5.2 7.3 0.0 0.9 0.2 2.7 1.1 1.5 1.4 1.9 2.1 1.1 1.1 1.0 1.2 1.0 1.5 1.1 0.9 4.1 0.5 5.9 5.6 15.1 10.2 4.3 5.5 4.9 5.3 7.2 5.4 CABP7 MGC57793 ENSG00000100314 "Calcium binding protein 7" Q86V35 22 29720084-29731839 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 30.3;pancreas: 9.6" "Group enriched" "Detected in some" 12 "HEL: 12.5;SCLC-21H: 12.3;SH-SY5Y: 3.9;U-2 OS: 4.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 3.9" "Region enhanced" "Detected in all" "hippocampal formation: 30.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 83.4;hippocampal formation: 224.8;midbrain: 72.1;pons and medulla: 115.1" "Region enriched" "Detected in many" 4 "hippocampal formation: 65.6" HPA016439 Uncertain "HPA016439: AB_2669357" "unprognostic (1.88e-1)" "unprognostic (4.75e-2)" "unprognostic (1.18e-1)" "unprognostic (5.37e-2)" "unprognostic (4.55e-1)" "unprognostic (2.29e-4)" "unprognostic (2.05e-3)" "unprognostic (7.96e-2)" "unprognostic (8.69e-3)" "unprognostic (3.32e-2)" "unprognostic (2.61e-1)" "unprognostic (1.22e-1)" "unprognostic (7.44e-7)" "unprognostic (1.25e-4)" "unprognostic (3.60e-2)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" 0.4 6.0 2.7 0.5 2.6 0.8 0.3 7.2 6.5 0.3 0.5 1.2 0.0 1.5 0.3 1.8 0.7 0.4 0.5 0.3 30.3 2.0 0.3 0.3 0.4 0.5 3.9 1.2 0.4 9.6 0.3 0.1 0.3 16.9 0.4 0.5 2.4 0.8 0.4 0.6 1.0 3.8 0.4 4.1 0.5 0.4 1.2 2.8 0.0 0.7 0.0 0.3 0.4 0.0 0.6 0.6 1.8 1.6 0.5 1.4 0.6 0.1 0.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 12.5 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.3 0.0 0.0 12.3 3.9 0.1 0.2 0.1 0.5 0.0 0.1 0.2 4.1 0.1 0.2 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.8 1.8 0.8 1.3 0.5 0.6 1.1 0.5 0.6 0.4 1.0 1.4 1.3 0.5 1.6 0.6 0.5 0.6 2.7 2.6 7.2 3.0 30.3 2.0 3.9 1.2 16.9 2.8 CACFD1 "C9orf7, D9S2135, flower" ENSG00000160325 "Calcium channel flower domain containing 1" Q9UGQ2 9 133459965-133470848 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015280 Approved Nucleoplasm Nucleoplasm "HPA015280: AB_1845833" "unprognostic (3.15e-2)" "unprognostic (4.25e-1)" "unprognostic (1.96e-3)" "unprognostic (4.48e-1)" "unprognostic (2.77e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-2)" "unprognostic (5.49e-2)" "unprognostic (3.97e-1)" "unprognostic (3.17e-1)" "unprognostic (1.67e-3)" "unprognostic (3.91e-2)" "prognostic favourable (2.83e-8)" "unprognostic (5.10e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (3.99e-3)" 2.8 7.0 7.2 7.4 6.9 3.5 11.4 8.5 9.4 5.7 14.0 9.4 5.9 18.9 6.7 16.9 8.4 7.3 15.8 9.1 6.5 5.5 19.1 33.7 9.8 8.6 12.3 6.7 7.7 16.6 10.6 12.6 5.3 8.4 8.3 8.3 6.9 9.9 10.3 5.2 3.3 17.9 6.3 8.7 5.0 22.1 13.7 8.6 4.4 13.7 3.7 3.8 8.7 12.6 4.2 1.3 7.6 1.4 2.7 1.0 1.1 0.8 3.6 8.0 5.0 1.7 0.8 5.0 2.5 3.3 2.3 0.7 8.0 6.6 0.9 8.0 3.3 1.6 2.5 2.0 0.1 1.4 2.9 0.6 5.2 5.5 4.2 0.0 0.9 1.8 5.4 1.7 1.3 3.0 1.4 2.6 2.5 9.3 1.0 1.3 4.8 3.1 2.1 2.1 7.0 4.7 3.5 10.0 11.3 3.2 13.6 2.0 15.7 1.8 1.3 5.4 5.2 1.4 0.3 4.5 5.5 2.9 2.1 0.6 1.9 3.7 1.4 7.6 0.8 1.1 0.6 3.5 0.7 1.0 1.3 4.2 0.4 0.7 0.2 2.7 0.9 0.5 0.5 1.1 7.2 6.9 8.5 9.4 6.5 5.5 12.3 6.7 8.4 8.6 CACHD1 "KIAA1573, VWCD1" ENSG00000158966 "Cache domain containing 1" 1 64470792-64693058 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 21.6;NTERA-2: 29.6;U-2197: 15.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 11 "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017202 Uncertain Uncertain Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA017202: AB_1852423" "unprognostic (2.92e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-2)" "unprognostic (1.02e-1)" "unprognostic (3.75e-1)" "unprognostic (1.01e-1)" "unprognostic (4.82e-2)" "unprognostic (4.32e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (8.16e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-3)" "unprognostic (2.67e-2)" "unprognostic (3.89e-1)" "unprognostic (3.65e-1)" "unprognostic (2.13e-1)" 5.4 7.6 6.5 0.5 8.4 0.0 4.7 1.2 4.3 7.3 0.8 0.2 6.1 5.2 1.6 8.5 2.1 1.2 3.5 4.2 3.3 0.4 4.7 0.4 2.3 14.2 3.7 5.5 4.5 5.5 4.0 1.0 4.4 4.3 0.8 3.0 0.9 5.3 0.6 1.7 3.3 0.5 2.4 0.2 2.1 4.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.9 21.6 3.2 8.6 3.0 0.0 3.0 4.0 5.1 4.9 12.5 0.1 0.0 8.9 4.9 1.6 12.0 2.5 5.2 2.3 6.5 4.5 1.3 0.0 0.0 1.9 0.0 2.6 1.8 0.6 3.3 2.8 0.0 0.0 0.0 0.3 0.3 0.0 29.6 2.2 2.3 2.2 0.0 0.0 0.6 0.5 11.3 6.6 0.0 2.6 0.8 0.3 1.9 0.5 3.8 15.2 2.7 0.0 0.0 0.0 0.4 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNA1B "CACNL1A5, CACNN, Cav2.2" ENSG00000148408 "Calcium voltage-gated channel subunit alpha1 B" Q00975 9 137877789-138124624 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 6.2;brain: 18.9;fallopian tube: 6.6;pituitary gland: 4.8;testis: 8.1" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 20.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044347 Uncertain "HPA044347: AB_10960837" "unprognostic (1.34e-3)" "unprognostic (2.70e-2)" "unprognostic (8.08e-2)" "unprognostic (2.51e-7)" "unprognostic (8.10e-2)" "unprognostic (1.51e-2)" "unprognostic (1.33e-1)" "unprognostic (3.10e-1)" "unprognostic (2.50e-1)" "unprognostic (2.36e-2)" "unprognostic (9.73e-4)" "unprognostic (5.98e-2)" "unprognostic (6.63e-6)" "unprognostic (4.25e-2)" "unprognostic (4.72e-1)" "unprognostic (7.77e-3)" "unprognostic (8.69e-2)" 0.5 6.2 5.7 0.7 8.7 0.5 0.5 18.7 18.9 1.2 0.8 0.2 0.0 0.6 0.6 1.7 0.4 6.6 1.4 1.0 4.5 7.3 0.4 1.2 0.5 0.5 2.9 9.1 0.5 1.2 0.4 4.8 0.4 3.6 1.6 0.8 0.4 0.4 1.3 0.4 0.9 0.7 0.8 4.5 0.6 0.6 8.1 1.4 0.0 0.9 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 20.7 3.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 8.7 18.7 10.9 4.5 7.3 2.9 9.1 3.6 1.4 CACNA2D1 "CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3" ENSG00000153956 "Calcium voltage-gated channel auxiliary subunit alpha2delta 1" P54289 7 81946444-82443798 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 59.0" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.1;HUVEC TERT2: 24.7;SH-SY5Y: 28.7;TIME: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008213, HPA008621" Enhanced "Intracellular and membrane" 310000000 "HPA008213: AB_1845862, HPA008621: AB_1845863" "unprognostic (5.07e-3)" "unprognostic (2.21e-1)" "unprognostic (4.27e-3)" "unprognostic (2.92e-2)" "unprognostic (2.27e-1)" "unprognostic (1.39e-1)" "unprognostic (1.70e-1)" "unprognostic (3.22e-1)" "unprognostic (3.76e-1)" "unprognostic (2.05e-1)" "unprognostic (6.24e-3)" "unprognostic (2.23e-2)" "prognostic unfavourable (1.16e-4)" "unprognostic (4.28e-3)" "unprognostic (2.13e-1)" "unprognostic (9.18e-2)" "unprognostic (1.03e-4)" 9.9 13.4 15.7 4.2 18.1 0.7 4.3 8.8 20.8 5.7 11.3 7.3 1.0 5.0 7.1 2.9 5.4 4.1 6.3 25.8 12.7 14.9 8.0 1.8 3.6 2.2 6.3 15.6 7.8 2.0 1.9 8.3 4.2 8.6 12.8 5.3 1.9 3.3 6.6 59.0 4.7 3.5 13.0 5.6 4.3 5.5 3.7 8.0 0.0 16.9 14.6 3.3 6.8 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 4.8 0.0 8.5 10.8 0.0 10.5 6.8 5.2 5.1 0.0 1.5 0.0 0.0 9.1 0.0 5.0 0.0 6.9 0.0 6.8 0.3 6.8 0.0 5.6 2.3 0.0 6.3 0.0 18.1 0.0 24.7 0.0 0.1 11.6 0.0 0.0 0.0 5.7 2.2 1.0 0.9 0.0 0.4 0.4 9.7 28.7 2.0 0.0 0.0 0.0 0.0 17.7 9.3 7.0 9.2 0.0 0.0 0.0 0.0 7.8 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 18.1 8.8 20.8 12.7 14.9 6.3 15.6 8.6 8.0 CACNA2D4 ENSG00000151062 "Calcium voltage-gated channel auxiliary subunit alpha2delta 4" Q7Z3S7 12 1791957-1918836 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 47.0" "Cell line enhanced" "Detected in some" "Hep G2: 5.3;HL-60: 3.1;HMC-1: 16.6;NB-4: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 9 "dendritic cells: 4.5;monocytes: 6.6;T-cells: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA031952 Uncertain "HPA031952: AB_10600798" "unprognostic (5.04e-2)" "unprognostic (2.82e-2)" "unprognostic (5.32e-1)" "unprognostic (7.50e-2)" "unprognostic (1.15e-1)" "unprognostic (8.18e-4)" "unprognostic (1.10e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-1)" "unprognostic (3.30e-3)" "unprognostic (1.24e-2)" "unprognostic (1.41e-1)" "unprognostic (1.62e-5)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (2.04e-1)" "unprognostic (2.13e-1)" 1.8 0.7 0.6 2.2 0.9 2.2 0.8 0.1 1.1 1.4 0.8 0.6 0.2 2.3 1.1 0.5 0.8 0.3 1.6 1.6 0.8 0.5 1.5 0.3 1.4 2.2 1.2 0.2 0.4 1.5 0.1 3.9 2.1 1.0 0.7 0.3 47.0 0.7 0.5 0.2 0.2 1.4 1.5 1.3 2.2 0.6 1.7 0.7 1.2 0.5 0.9 1.4 2.3 0.5 0.0 4.5 0.2 6.6 0.6 6.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 5.3 0.3 3.1 16.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.5 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 6.6 0.0 3.5 2.4 6.7 0.0 1.6 2.5 4.5 0.0 0.9 0.5 0.2 0.6 0.7 0.2 0.9 2.3 0.6 0.9 0.1 1.1 0.8 0.5 1.2 0.2 1.0 0.7 CACNB4 EJM4 ENSG00000182389 "Calcium voltage-gated channel auxiliary subunit beta 4" O00305 2 151832768-152099475 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.7" "Cell line enriched" "Detected in some" 4 "HMC-1: 20.7" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in all" 4 "basal ganglia: 28.0;cerebellum: 35.7;cerebral cortex: 21.7;olfactory region: 10.9;pons and medulla: 9.8" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.0" HPA015601 Approved "HPA015601: AB_1845873" "unprognostic (2.92e-1)" "unprognostic (1.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (1.49e-2)" "unprognostic (3.70e-1)" "unprognostic (9.42e-4)" "unprognostic (1.23e-1)" "unprognostic (1.98e-1)" "unprognostic (1.05e-3)" "unprognostic (2.02e-1)" "unprognostic (1.55e-2)" "unprognostic (7.26e-3)" "unprognostic (3.93e-2)" "unprognostic (9.55e-3)" "unprognostic (2.45e-1)" 1.6 1.7 5.2 1.3 28.0 1.7 3.2 35.7 28.0 1.4 1.2 2.6 0.0 1.2 1.4 1.7 3.1 1.1 2.1 1.1 4.5 4.4 2.8 0.9 3.9 1.1 4.3 10.9 1.3 1.2 1.0 3.8 2.1 9.8 3.9 1.4 0.9 2.1 3.9 0.8 11.7 1.1 4.2 3.0 1.2 1.6 4.1 3.4 0.0 3.1 0.0 2.2 3.5 0.8 0.4 1.3 7.0 0.6 0.2 0.1 0.1 0.0 0.0 0.7 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.9 0.0 0.1 0.3 3.2 0.0 0.1 4.0 0.0 0.2 20.7 0.2 0.1 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.3 0.5 0.6 1.8 0.2 0.6 1.2 0.6 1.4 0.7 0.0 0.0 0.0 3.3 0.8 0.0 1.9 2.1 0.6 0.4 0.4 0.0 0.0 0.5 4.8 0.1 1.2 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.4 0.1 0.1 7.0 0.2 0.0 1.3 0.0 0.1 5.2 28.0 35.7 21.7 4.5 4.4 4.3 10.9 9.8 3.4 CADM1 "BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1" ENSG00000182985 "Cell adhesion molecule 1" Q9BY67 11 115169218-115504957 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Differentiation, Host-virus interaction, Immunity, Spermatogenesis" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 69.0;WM-115: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 10.6;myeloid DC: 10.2" "Group enriched" "Detected in many" 6 "dendritic cells: 10.2;T-cells: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037266 Enhanced Supported "Cell Junctions" 200000000 "Cell Junctions" "CAB037266: AB_532287" "unprognostic (1.50e-1)" "unprognostic (2.15e-1)" "unprognostic (1.92e-2)" "prognostic favourable (1.32e-4)" "unprognostic (4.11e-3)" "unprognostic (1.50e-1)" "unprognostic (2.75e-3)" "unprognostic (1.13e-2)" "unprognostic (1.77e-1)" "unprognostic (2.67e-1)" "unprognostic (6.61e-3)" "unprognostic (9.22e-2)" "unprognostic (2.92e-3)" "unprognostic (1.77e-2)" "unprognostic (1.54e-1)" "unprognostic (3.67e-2)" "unprognostic (5.40e-2)" 3.5 15.2 31.3 3.0 33.7 0.5 8.3 53.7 24.8 11.5 7.1 16.9 22.9 4.0 9.1 53.1 6.5 11.4 6.2 12.2 21.5 26.5 15.2 31.3 34.3 6.3 14.2 19.0 6.6 8.0 47.6 24.0 18.1 27.8 7.9 4.4 32.9 17.8 15.1 3.9 5.5 4.4 4.5 11.5 3.9 6.6 23.3 17.1 1.0 34.5 1.3 6.9 6.6 3.6 1.8 10.2 0.1 0.0 0.5 10.6 1.8 0.0 5.4 6.1 0.0 0.0 0.0 0.0 5.7 9.7 0.7 0.0 69.0 6.2 0.0 18.4 8.6 1.1 1.1 6.4 0.4 0.2 9.5 0.0 2.0 26.3 0.0 0.0 13.6 0.0 9.3 0.0 15.4 0.2 0.0 0.6 1.0 4.6 4.5 0.1 5.7 0.0 0.0 0.1 14.0 10.8 0.2 12.1 26.0 0.0 6.1 4.9 22.0 0.3 0.0 0.5 11.2 5.6 3.0 15.6 22.4 4.4 8.8 0.0 44.5 0.1 0.0 0.0 10.6 0.0 4.7 1.8 3.9 2.8 10.2 0.3 0.1 2.7 0.0 0.5 0.0 0.0 6.3 1.8 31.3 33.7 53.7 24.8 21.5 26.5 14.2 19.0 27.8 17.1 CADM2 "IGSF4D, Necl-3, NECL3, SynCAM2" ENSG00000175161 "Cell adhesion molecule 2" Q8N3J6 3 84958981-86074429 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 52.7" "Cell line enhanced" "Detected in some" "AF22: 6.3;AN3-CA: 17.9;U-266/70: 3.1" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 5.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010024 Enhanced 350000 "HPA010024: AB_2068039" "unprognostic (2.23e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (1.90e-4)" "unprognostic (8.64e-2)" "unprognostic (2.27e-1)" "unprognostic (4.76e-3)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (1.90e-1)" "unprognostic (8.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.07e-5)" "unprognostic (9.82e-3)" "unprognostic (1.26e-2)" "unprognostic (4.17e-3)" "unprognostic (1.16e-2)" 5.8 6.3 33.5 2.1 22.7 1.7 3.6 44.8 52.7 2.3 3.0 7.0 0.0 2.0 2.0 2.2 2.7 4.6 2.6 4.2 28.6 11.7 1.9 2.5 2.2 1.8 16.3 31.0 2.3 2.4 3.0 5.5 1.9 24.2 3.4 2.7 8.8 2.3 6.2 4.9 2.0 2.6 2.1 14.0 2.0 3.2 2.2 20.5 0.0 2.1 0.0 1.8 2.0 1.1 1.0 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 6.3 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 22.7 44.8 49.5 28.6 11.7 16.3 31.0 24.2 20.5 CADM3 "BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1" ENSG00000162706 "Cell adhesion molecule 3" Q8N126 1 159171609-159203313 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.5;placenta: 43.1" "Cell line enhanced" "Detected in some" "HHSteC: 19.3;HSkMC: 64.8;hTERT-HME1: 34.7;WM-115: 17.2" "Cancer enhanced" "Detected in many" "glioma: 27.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002981, CAB025746" Enhanced Approved Cytosol "Intracellular and membrane" 790000 Cytosol "CAB025746: , HPA002981: AB_1078916" "unprognostic (1.74e-2)" "unprognostic (8.26e-2)" "unprognostic (1.34e-2)" "unprognostic (1.33e-2)" "unprognostic (9.32e-2)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (6.12e-3)" "prognostic unfavourable (1.03e-5)" "unprognostic (5.52e-2)" "unprognostic (2.59e-1)" "unprognostic (3.64e-1)" "prognostic unfavourable (5.75e-4)" 8.9 5.4 23.3 8.5 41.0 0.9 6.1 88.4 96.5 18.0 8.8 6.9 0.7 3.2 2.2 1.6 7.2 3.2 4.1 4.3 23.2 27.4 1.1 1.1 2.9 7.8 18.5 22.4 1.2 2.0 1.0 7.4 43.1 30.4 1.7 8.9 4.5 2.6 3.6 2.0 7.7 6.4 4.1 9.6 7.6 2.8 2.4 4.6 0.0 4.8 0.7 5.9 10.2 7.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.3 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 19.3 0.0 0.0 64.8 0.0 0.0 34.7 1.5 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 41.0 88.4 55.6 23.2 27.4 18.5 22.4 30.4 4.6 CADM4 "IGSF4C, Necl-4, SynCAM4, TSLL2" ENSG00000105767 "Cell adhesion molecule 4" Q8NFZ8 19 43622368-43639839 "Predicted membrane proteins" "Cell adhesion" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.9" "Cell line enriched" "Detected in many" 5 "WM-115: 109.8" "Cancer enhanced" "Detected in all" "glioma: 108.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012612 Enhanced Approved "Nucleoplasm,Nuclear membrane" 5900000 "Nuclear membrane" Nucleoplasm "HPA012612: AB_1851530" "unprognostic (8.80e-3)" "unprognostic (2.57e-2)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (2.87e-1)" "unprognostic (9.29e-3)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (5.03e-1)" "unprognostic (3.19e-3)" "unprognostic (3.81e-1)" "prognostic favourable (2.28e-6)" "unprognostic (1.39e-1)" "unprognostic (3.35e-2)" "unprognostic (2.59e-1)" "unprognostic (3.93e-2)" 3.0 12.6 29.7 3.4 31.0 0.9 6.6 22.2 68.9 4.6 5.3 32.8 2.5 3.0 10.4 6.7 10.8 3.0 3.7 5.5 31.2 26.5 13.2 3.4 3.1 1.8 37.2 20.4 5.2 10.9 26.1 7.5 1.1 29.1 13.7 2.8 4.9 13.3 10.8 5.0 10.8 3.0 6.8 47.8 1.9 4.0 1.9 26.4 0.0 3.3 1.7 3.4 2.9 2.9 0.1 4.7 0.6 0.3 0.0 0.0 0.0 8.5 2.5 13.4 17.5 0.0 0.2 0.7 0.4 0.7 1.2 1.8 3.7 1.5 0.0 3.2 0.1 2.0 2.9 1.7 1.5 0.1 2.3 0.0 0.5 5.4 1.6 0.0 1.3 0.5 3.9 6.4 0.2 0.8 0.8 0.1 0.1 1.2 1.2 0.1 1.4 0.8 6.9 0.1 0.8 1.7 1.8 1.5 8.6 0.9 2.7 3.4 2.0 0.4 0.3 0.1 20.7 0.1 0.8 1.2 0.8 0.0 0.9 0.1 109.8 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 4.7 0.0 0.0 29.7 31.0 22.2 34.0 31.2 26.5 37.2 20.4 29.1 26.4 CALN1 CABP8 ENSG00000183166 "Calneuron 1" Q9BXU9 7 71779491-72447151 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.0;brain: 48.5;lymphoid tissue: 20.0" "Cell line enriched" "Detected in some" 6 "Karpas-707: 30.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036278, HPA036708" Approved Uncertain "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA036278: AB_10673125, HPA036708: " "unprognostic (6.38e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (1.32e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-2)" "unprognostic (3.67e-4)" "unprognostic (3.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.57e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (7.72e-4)" "unprognostic (2.99e-1)" 0.8 16.0 10.8 0.8 17.7 1.5 1.0 48.5 39.1 2.3 0.9 5.1 0.0 0.9 1.4 0.8 0.8 1.0 1.3 0.8 9.5 4.4 0.8 1.0 0.9 0.8 6.8 7.3 1.0 1.9 0.8 0.3 0.8 18.6 1.0 0.9 0.0 0.8 2.4 0.9 4.2 0.8 0.9 8.4 0.8 0.8 11.3 3.3 20.0 0.9 0.0 0.8 0.9 1.9 0.3 1.3 0.6 0.4 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 30.7 0.0 0.0 0.0 0.0 4.1 0.0 4.7 0.0 0.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 4.9 4.7 0.0 0.2 0.0 0.0 0.6 0.4 0.3 0.2 0.1 0.1 0.2 0.2 0.2 1.3 0.3 0.2 0.2 0.5 0.3 0.1 0.4 0.1 0.1 10.8 17.7 48.5 11.6 9.5 4.4 6.8 7.3 18.6 3.3 CALY "CALCYON, DRD1IP, NSG3" ENSG00000130643 "Calcyon neuron specific vesicular protein" Q9NYX4 10 133324072-133336935 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "adrenal gland: 26.5;brain: 98.9;pituitary gland: 47.7" "Cell line enhanced" "Detected in some" "SH-SY5Y: 2.7;U-266/70: 2.6" "Group enriched" "Detected in some" 14 "glioma: 1.7;pancreatic cancer: 7.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.3;naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042283 Enhanced "HPA042283: AB_10794417" "unprognostic (1.43e-2)" "unprognostic (7.84e-2)" "unprognostic (3.77e-3)" "unprognostic (1.41e-2)" "unprognostic (7.32e-2)" "unprognostic (9.81e-3)" "unprognostic (2.56e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "prognostic favourable (3.54e-4)" "unprognostic (1.23e-2)" "unprognostic (4.19e-10)" "unprognostic (8.04e-3)" "unprognostic (1.29e-1)" "unprognostic (3.60e-1)" "unprognostic (1.63e-1)" 1.8 26.5 27.1 2.7 57.4 1.8 1.8 12.7 67.1 1.7 2.6 3.6 0.0 5.0 1.7 1.9 1.8 2.0 1.8 1.7 31.8 98.9 1.7 1.7 1.9 2.0 25.1 39.8 1.7 6.3 1.7 47.7 1.7 33.9 1.8 2.4 0.7 2.1 2.0 1.7 1.9 3.8 2.1 14.3 1.9 4.1 4.3 4.8 0.0 1.9 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.1 0.8 0.3 0.0 0.0 0.0 0.3 0.6 0.6 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.8 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.3 0.0 0.1 2.6 0.0 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 27.1 57.4 12.7 45.9 31.8 98.9 25.1 39.8 33.9 4.8 CAMK1 CaMKI ENSG00000134072 "Calcium/calmodulin dependent protein kinase I" Q14012 3 9757342-9769992 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Differentiation, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 60.5;blood: 59.4" "Cell line enriched" "Detected in many" 4 "HMC-1: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "eosinophil: 59.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 59.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031904, HPA051409" Approved Approved Cytosol 550000 Cytosol "CAB031904: AB_630964, HPA051409: " "unprognostic (4.43e-2)" "unprognostic (3.05e-1)" "unprognostic (1.68e-1)" "unprognostic (1.29e-1)" "unprognostic (1.11e-1)" "unprognostic (3.06e-2)" "prognostic unfavourable (7.52e-4)" "unprognostic (5.53e-2)" "unprognostic (3.32e-1)" "unprognostic (9.74e-2)" "unprognostic (1.37e-3)" "unprognostic (2.17e-1)" "unprognostic (1.14e-3)" "unprognostic (7.76e-2)" "unprognostic (1.72e-1)" "unprognostic (3.67e-2)" "unprognostic (3.01e-1)" 27.1 60.5 28.0 11.7 26.0 3.5 34.1 12.4 31.2 9.5 10.7 4.4 5.8 6.8 12.6 10.5 7.1 12.6 8.9 10.2 21.4 14.0 13.1 20.7 9.2 10.4 10.3 19.9 21.5 4.5 7.4 7.9 5.1 10.1 18.6 8.1 6.8 5.1 15.1 4.7 3.3 8.3 18.4 7.2 7.1 8.1 13.4 5.6 0.6 7.0 3.7 10.4 9.5 10.3 0.0 3.2 59.4 9.2 0.7 0.4 0.9 0.1 3.6 2.9 0.0 15.1 5.6 7.3 8.6 4.8 9.9 9.4 5.3 0.6 0.2 2.0 5.8 0.6 0.0 1.1 6.2 0.1 21.1 11.6 6.9 7.4 8.4 1.0 92.0 5.9 0.9 13.9 1.5 8.3 1.5 0.2 3.7 2.2 0.0 8.5 2.0 5.7 0.0 0.1 0.2 5.9 0.6 0.9 3.7 1.5 0.1 0.8 0.9 14.9 4.3 4.5 5.6 6.4 10.8 0.0 0.0 0.2 9.6 3.3 0.6 3.3 4.8 59.4 0.0 9.2 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.2 0.7 9.2 0.1 0.4 0.9 28.0 26.0 12.4 31.2 21.4 14.0 10.3 19.9 10.1 5.6 CAMK1D CKLiK ENSG00000183049 "Calcium/calmodulin dependent protein kinase ID" Q8IU85 10 12349482-12835545 "Enzymes, Plasma proteins, Predicted membrane proteins" "Inflammatory response, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 46.7;U-266/70: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 31.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007266 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007266: AB_1078389" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-3)" "unprognostic (4.23e-1)" "unprognostic (2.32e-2)" "unprognostic (6.90e-3)" "prognostic favourable (1.67e-4)" "unprognostic (1.06e-1)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (7.40e-2)" "unprognostic (1.35e-2)" "unprognostic (6.55e-2)" "unprognostic (1.65e-1)" "unprognostic (4.66e-2)" "unprognostic (2.56e-3)" 5.1 5.3 20.9 10.5 22.1 6.6 4.0 23.4 33.5 8.3 11.5 4.6 10.0 3.8 3.3 3.3 8.7 4.3 6.8 13.8 18.6 7.2 2.2 11.5 7.6 9.3 5.8 17.8 2.6 17.0 1.3 2.5 3.2 5.0 4.9 12.9 11.9 4.5 15.4 1.7 18.5 5.5 5.6 4.9 10.5 3.4 6.2 6.8 20.8 13.6 2.9 12.5 8.1 7.0 7.1 4.2 31.8 3.7 1.4 2.3 1.3 0.1 2.5 2.9 0.1 1.8 0.6 0.2 0.4 0.9 0.6 0.9 3.5 2.0 1.4 0.3 0.2 1.3 3.5 0.5 0.5 46.7 1.8 5.6 8.3 0.2 0.5 0.1 5.1 0.1 2.3 1.2 0.1 0.3 0.1 0.2 0.7 2.9 10.9 2.2 1.9 1.1 8.3 1.6 2.6 0.1 2.7 4.5 2.0 5.5 2.0 0.0 1.5 1.3 0.1 2.4 3.6 7.7 1.6 21.5 6.7 4.7 3.6 3.6 0.0 8.3 2.2 31.8 1.8 3.1 1.9 5.6 1.6 2.3 4.2 7.1 1.9 1.3 13.9 1.4 3.7 1.4 0.5 1.3 20.9 22.1 23.4 33.5 18.6 7.2 5.8 17.8 5.0 6.8 CAMK2A "CAMKA, CaMKIINalpha, KIAA0968" ENSG00000070808 "Calcium/calmodulin dependent protein kinase II alpha" Q9UQM7 5 150219491-150290291 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "brain: 105.7;skeletal muscle: 50.1" "Cell line enhanced" "Detected in some" "HaCaT: 2.6;SCLC-21H: 9.5;U-87 MG: 8.0" "Cancer enriched" "Detected in single" 13 "glioma: 6.0" "Group enriched" "Detected in all" 6 "amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1" "Low region specificity" "Detected in all" "CAB004330, HPA051783, HPA051785, HPA053973" Supported Approved "Plasma membrane,Cell Junctions,Cytosol" 21000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB004330: AB_626788, HPA051783: , HPA051785: , HPA053973: " "unprognostic (7.20e-3)" "unprognostic (6.47e-3)" "unprognostic (6.16e-3)" "unprognostic (4.85e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-3)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (3.07e-1)" "unprognostic (1.05e-1)" "unprognostic (4.49e-2)" "unprognostic (1.41e-2)" "unprognostic (2.00e-8)" "unprognostic (2.71e-4)" "unprognostic (1.68e-1)" "unprognostic (1.70e-2)" "unprognostic (1.36e-3)" 1.3 1.7 60.7 1.3 50.6 1.3 1.1 1.4 105.7 1.8 1.3 3.7 0.0 1.2 2.1 1.4 1.9 1.7 1.3 3.7 74.6 10.5 1.6 1.2 1.5 1.2 5.1 39.8 1.3 1.1 1.1 0.4 1.3 2.4 1.6 1.3 0.0 1.2 1.4 50.1 1.6 1.3 2.5 1.7 1.2 1.3 1.2 2.3 0.0 1.2 0.0 1.1 1.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.6 0.0 0.5 1.3 0.8 0.7 0.0 0.1 0.0 0.2 0.6 2.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.5 0.2 1.7 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 9.5 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 8.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 60.7 50.6 1.4 99.6 74.6 10.5 5.1 39.8 2.4 2.3 CAMK2B "CAM2, CAMK2, CAMKB" ENSG00000058404 "Calcium/calmodulin dependent protein kinase II beta" Q13554 7 44217150-44334577 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 41.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006849, HPA026307, HPA051783, HPA051785, HPA053973" Enhanced Supported Supported "Plasma membrane,Cell Junctions,Cytosol" 680000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB006849: , HPA026307: AB_1845941, HPA051783: , HPA051785: , HPA053973: " "unprognostic (1.88e-3)" "unprognostic (4.49e-2)" "unprognostic (3.55e-3)" "unprognostic (1.36e-2)" "unprognostic (5.25e-2)" "unprognostic (2.90e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-1)" "unprognostic (1.17e-2)" "unprognostic (1.60e-2)" "unprognostic (5.23e-7)" "unprognostic (7.04e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (3.95e-2)" 1.4 8.1 20.6 1.4 46.7 1.2 2.0 60.1 81.9 1.2 1.4 4.0 0.7 1.7 1.3 18.8 2.0 1.8 1.2 39.2 36.5 18.0 1.7 3.5 1.2 1.8 10.3 21.3 1.1 3.3 5.6 9.9 1.1 13.4 3.0 1.4 2.7 1.8 2.2 70.7 1.8 1.6 1.2 4.1 1.3 2.4 2.3 4.8 0.0 7.7 2.4 2.0 1.1 0.0 1.3 1.0 3.2 1.2 3.2 1.2 0.8 0.0 0.3 0.2 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.8 0.2 0.1 0.2 0.7 0.0 1.0 2.4 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 5.2 0.0 0.2 0.1 2.3 0.1 0.9 0.1 0.0 0.0 41.0 2.2 0.2 0.0 0.0 1.9 0.1 0.2 0.2 0.3 0.2 0.0 0.5 0.4 0.1 0.1 0.0 0.2 3.2 0.7 1.0 0.8 0.9 1.2 1.1 1.0 0.5 0.5 1.3 1.2 1.1 2.0 3.2 1.2 1.0 0.9 0.8 20.6 46.7 60.1 42.4 36.5 18.0 10.3 21.3 13.4 4.8 CAMK2D CAMKD ENSG00000145349 "Calcium/calmodulin dependent protein kinase II delta" Q13557 4 113451032-113761927 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026281, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" 140000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA026281: AB_1845944, HPA051783: , HPA051785: , HPA053973: " "unprognostic (2.14e-2)" "unprognostic (3.17e-1)" "unprognostic (2.13e-1)" "unprognostic (7.49e-2)" "unprognostic (2.19e-1)" "unprognostic (5.09e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "unprognostic (7.81e-2)" "unprognostic (7.91e-3)" "unprognostic (2.62e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-2)" "unprognostic (1.87e-1)" "unprognostic (1.90e-2)" 22.8 12.9 47.7 18.3 13.0 2.8 23.5 50.2 30.6 11.0 18.2 7.4 28.6 13.6 11.6 9.4 15.6 9.6 14.8 77.1 17.9 21.4 9.6 17.6 14.7 17.5 14.0 23.8 12.9 7.4 33.7 7.0 9.3 12.5 16.3 19.0 9.9 9.4 48.3 48.5 10.8 19.2 26.2 16.0 8.4 17.6 9.4 8.5 11.2 11.6 9.8 14.5 21.5 22.6 18.5 11.2 0.6 8.8 6.4 9.7 5.2 1.0 14.3 15.8 5.3 34.6 66.2 5.6 33.5 22.4 13.2 11.4 9.6 4.0 20.5 4.9 23.3 0.5 9.8 5.2 13.5 7.8 2.5 0.0 5.2 11.0 17.5 0.0 0.0 42.3 7.2 10.2 25.3 11.7 0.8 9.2 24.8 3.8 2.0 0.8 2.2 5.3 4.0 18.5 0.1 13.5 9.7 4.3 4.3 4.5 6.8 4.5 0.1 5.5 7.0 34.9 8.2 14.8 6.6 7.1 3.6 17.6 18.0 1.2 16.4 0.0 8.8 0.0 5.1 5.1 9.7 8.0 5.0 5.6 11.2 18.5 5.8 4.9 0.6 6.4 1.7 0.0 9.3 5.2 47.7 13.0 50.2 25.6 17.9 21.4 14.0 23.8 12.5 8.5 CAMK2G CAMKG ENSG00000148660 "Calcium/calmodulin dependent protein kinase II gamma" Q13555 10 73812501-73874591 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.0" "Cell line enhanced" "Detected in all" "PC-3: 45.4;SK-BR-3: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "granulocytes: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040656, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" 170000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA040656: , HPA051783: , HPA051785: , HPA053973: " "unprognostic (8.63e-3)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (3.46e-3)" "unprognostic (4.27e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-2)" "unprognostic (2.36e-1)" "unprognostic (2.48e-1)" "unprognostic (6.25e-2)" "unprognostic (2.92e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (2.48e-1)" "unprognostic (8.28e-2)" "unprognostic (9.64e-2)" "unprognostic (4.62e-2)" 9.1 8.8 27.4 9.4 20.7 17.4 6.8 22.2 53.8 9.0 37.3 13.3 9.7 19.7 20.1 9.1 20.6 13.2 10.6 6.7 22.8 24.4 11.6 5.9 10.7 8.9 26.8 31.2 6.4 5.7 8.0 6.0 15.8 38.6 18.5 15.5 8.5 12.4 29.8 73.0 9.1 18.1 29.6 29.8 11.0 14.2 3.8 13.4 4.4 6.4 7.6 8.7 26.5 10.8 4.2 7.1 39.8 5.6 9.8 9.2 5.0 10.9 7.9 7.1 13.6 5.2 8.6 8.4 7.5 12.9 10.4 8.5 12.2 11.8 8.1 7.9 9.7 17.0 5.6 6.4 8.3 7.3 6.7 5.5 6.1 5.5 2.6 7.5 9.3 4.5 5.8 10.3 7.2 8.8 6.0 12.1 5.7 7.6 12.5 11.2 5.2 45.4 11.4 7.5 4.3 5.4 15.9 3.7 8.6 4.3 57.2 3.7 10.7 4.7 10.8 7.7 12.4 4.2 10.1 3.7 4.4 7.5 8.3 21.5 2.7 8.5 5.6 39.8 7.5 2.3 9.2 4.2 8.4 8.0 7.1 3.9 8.1 7.9 36.4 9.8 4.0 2.4 8.1 5.0 27.4 20.7 22.2 53.8 22.8 24.4 26.8 31.2 38.6 13.4 CAMK4 CaMK-GR ENSG00000152495 "Calcium/calmodulin dependent protein kinase IV" Q16566 5 111223653-111494886 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Inflammatory response" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.9;lymphoid tissue: 71.7" "Cell line enhanced" "Detected in many" "HDLM-2: 41.2;MOLT-4: 12.6;SH-SY5Y: 16.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 14.1;memory CD4 T-cell: 10.3;memory CD8 T-cell: 7.8;naive CD4 T-cell: 19.8;naive CD8 T-cell: 10.9;T-reg: 11.3" "Lineage enriched" "Detected in single" 26 "T-cells: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004347, HPA011753, HPA017206" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949" "unprognostic (2.99e-5)" "unprognostic (7.19e-2)" "unprognostic (3.43e-3)" "unprognostic (5.11e-2)" "unprognostic (4.75e-3)" "unprognostic (3.48e-2)" "unprognostic (7.66e-4)" "unprognostic (7.22e-3)" "unprognostic (2.49e-1)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.23e-5)" "unprognostic (2.42e-2)" "unprognostic (3.01e-2)" "unprognostic (1.66e-1)" "unprognostic (9.99e-3)" 1.1 6.5 9.5 6.4 34.2 4.6 1.0 48.9 16.5 1.8 2.3 1.0 0.0 2.4 1.3 0.8 1.4 0.9 2.7 0.9 5.9 3.2 1.4 2.5 1.9 12.0 2.3 6.8 1.4 0.9 0.3 1.3 0.6 3.4 5.8 2.5 0.1 1.7 2.6 0.8 0.9 3.8 1.5 2.0 4.2 2.6 13.8 6.6 71.7 1.0 0.0 8.1 2.8 1.1 0.7 0.0 0.4 0.0 0.6 19.8 3.4 0.0 0.0 1.4 1.0 0.3 1.1 0.0 0.3 3.2 3.8 3.7 0.0 0.0 0.0 2.0 0.1 0.1 3.1 0.3 2.8 41.2 2.6 0.6 1.3 0.0 0.1 0.2 0.1 0.1 0.0 8.0 0.8 0.6 0.0 1.5 0.2 0.0 12.6 0.0 1.9 0.1 1.9 2.4 0.1 1.4 0.0 9.1 16.1 0.5 0.0 2.7 0.0 0.2 0.0 7.8 4.6 0.0 6.9 1.3 0.1 0.0 3.8 0.0 3.0 0.0 0.0 0.0 2.8 0.0 14.1 0.7 10.3 7.8 0.0 0.2 19.8 10.9 0.4 0.6 0.0 0.0 11.3 3.4 9.5 34.2 48.9 15.1 5.9 3.2 2.3 6.8 3.4 6.6 CAMKK2 "CAMKK, CAMKKB, KIAA0787, MGC15254" ENSG00000110931 "Calcium/calmodulin dependent protein kinase kinase 2" Q96RR4 12 121237691-121298308 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 125.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 125.5" "Group enriched" "Detected in many" 5 "classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5" "Group enriched" "Detected in all" 5 "dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017389, HPA063713" Approved Supported Supported Cytosol Cytosol "HPA017389: AB_1845956, HPA063713: " "unprognostic (5.08e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-1)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (1.12e-1)" "unprognostic (2.62e-3)" "unprognostic (2.80e-2)" "unprognostic (1.93e-1)" "unprognostic (7.76e-2)" "unprognostic (5.01e-2)" "unprognostic (1.70e-1)" "unprognostic (1.75e-1)" "unprognostic (4.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" 11.7 6.5 19.7 7.8 30.2 13.8 8.8 125.5 45.5 9.0 9.5 7.1 2.6 12.8 8.6 5.3 8.3 11.8 6.3 6.9 11.2 5.1 7.1 8.9 9.6 6.9 6.2 17.3 10.5 5.8 6.4 4.1 7.5 9.1 12.2 9.7 6.2 7.5 13.2 5.1 9.1 13.2 10.3 6.2 14.1 7.6 3.6 5.8 5.2 6.1 4.5 7.2 7.2 7.4 2.2 7.2 26.1 19.4 3.6 2.2 6.3 12.3 9.3 6.9 13.4 20.8 19.4 10.6 10.2 10.9 8.4 7.7 9.7 5.3 19.1 8.6 20.7 10.2 8.5 11.0 6.6 13.1 16.7 9.5 6.2 9.5 14.1 21.6 9.1 12.5 16.4 7.9 18.0 19.6 11.0 10.4 8.1 12.0 23.9 17.8 5.0 10.5 15.6 8.0 16.9 8.1 13.8 26.6 10.6 13.4 7.2 8.5 17.9 26.4 14.3 6.9 5.6 5.8 5.6 39.7 23.6 14.5 12.9 15.1 6.8 0.7 14.2 26.1 2.1 19.4 2.2 2.2 1.7 1.9 7.2 1.2 1.5 1.7 17.2 3.6 16.5 1.6 1.3 6.3 19.7 30.2 125.5 45.5 11.2 5.1 6.2 17.3 9.1 5.8 CANT1 "SCAN-1, SHAPY" ENSG00000171302 "Calcium activated nucleotidase 1" Q8WVQ1 17 78991717-79009867 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019627, HPA019639, HPA022818" Enhanced 2300000 "HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971" "unprognostic (1.98e-2)" "unprognostic (2.49e-2)" "unprognostic (1.50e-2)" "unprognostic (5.36e-2)" "unprognostic (2.13e-2)" "unprognostic (2.21e-2)" "prognostic unfavourable (1.41e-4)" "prognostic unfavourable (2.90e-4)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-1)" "prognostic unfavourable (6.21e-4)" "unprognostic (7.04e-2)" "unprognostic (5.06e-2)" "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" 13.8 15.3 9.6 13.1 10.2 8.1 13.0 12.2 10.8 17.7 43.8 12.3 25.4 25.5 12.0 14.3 27.5 10.0 19.5 10.8 9.0 6.9 10.3 17.7 11.1 11.5 12.5 7.7 10.4 14.7 13.1 11.8 33.0 12.0 36.7 41.5 7.9 30.3 41.4 9.0 8.9 27.2 8.0 12.4 18.1 25.8 19.0 10.3 14.1 12.4 8.9 14.4 10.3 13.7 4.1 3.8 17.5 4.4 3.1 6.2 4.4 26.4 29.0 8.1 11.7 7.7 9.2 10.4 16.3 14.3 17.6 14.9 13.7 25.0 6.4 9.6 11.4 13.4 6.9 12.9 17.6 10.6 12.6 8.3 8.8 11.4 6.6 7.9 13.1 9.5 8.3 16.2 8.8 30.3 10.4 10.9 11.7 14.3 12.0 4.7 5.5 30.9 6.7 13.3 7.2 7.7 13.3 11.7 11.7 8.7 57.8 12.3 71.4 9.5 15.1 26.3 23.8 11.8 20.4 12.9 10.7 6.2 16.8 6.1 16.4 6.1 3.8 8.1 6.2 4.4 6.1 4.1 4.6 5.2 3.8 2.9 4.5 4.4 17.5 3.1 2.9 2.7 3.8 4.4 9.6 10.2 12.2 10.8 9.0 6.9 12.5 7.7 12.0 10.3 CANX "CNX, IP90, P90" ENSG00000127022 Calnexin P27824 5 179678628-179730925 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 107.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004738, HPA009433, HPA009696" Enhanced Enhanced "Endoplasmic reticulum" 82000000 "Endoplasmic reticulum" "CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379" "unprognostic (6.56e-2)" "unprognostic (9.34e-3)" "prognostic favourable (1.38e-4)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" "unprognostic (1.41e-2)" "unprognostic (4.66e-3)" "unprognostic (8.57e-2)" "unprognostic (4.34e-2)" "unprognostic (1.25e-2)" "unprognostic (2.17e-3)" "unprognostic (4.48e-2)" "unprognostic (2.28e-1)" "unprognostic (1.87e-1)" "unprognostic (7.12e-2)" "prognostic unfavourable (3.17e-4)" "unprognostic (2.15e-1)" 49.3 35.4 40.0 35.8 40.9 57.6 37.8 27.3 49.1 93.0 33.6 37.1 48.3 44.0 42.7 115.4 31.6 31.7 30.0 51.3 36.9 50.9 61.6 120.8 34.7 30.1 47.5 27.9 41.0 78.2 13.7 33.0 70.5 44.9 33.5 55.1 32.2 121.5 48.5 28.5 23.4 68.5 60.5 48.8 38.2 31.7 34.3 30.0 31.0 113.4 25.9 29.9 41.4 47.6 10.1 26.3 25.9 28.9 18.7 22.6 30.0 8.2 23.4 19.9 12.1 42.8 31.8 10.1 42.8 47.0 49.4 42.0 20.3 19.2 62.9 60.1 34.3 5.7 31.2 23.3 56.5 16.1 9.5 10.1 58.4 13.2 58.3 19.3 9.6 6.2 42.9 26.5 77.2 20.4 7.9 24.5 5.4 7.7 9.7 0.3 4.0 1.4 10.1 14.4 6.8 36.4 24.5 10.0 2.4 12.0 5.2 107.2 40.5 8.5 38.0 11.3 18.9 12.8 33.2 7.4 25.8 15.9 17.1 12.6 11.0 25.9 28.9 8.8 17.7 21.2 22.6 10.1 13.9 16.3 26.3 7.7 9.5 10.6 6.1 18.7 18.0 25.3 10.1 30.0 40.0 40.9 27.3 33.3 36.9 50.9 47.5 27.9 44.9 30.0 CARD19 "bA370F5.1, BinCARD, C9orf89, MGC11115" ENSG00000165233 "Caspase recruitment domain family member 19" Q96LW7 9 93096218-93113283 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010921, HPA010990, HPA038297" Approved Supported Mitochondria Mitochondria "HPA010921: AB_10670295, HPA010990: , HPA038297: " "unprognostic (7.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "prognostic unfavourable (7.47e-5)" "unprognostic (2.22e-1)" "prognostic unfavourable (1.32e-5)" "unprognostic (1.21e-1)" "unprognostic (1.36e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (9.13e-2)" "unprognostic (6.82e-2)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" 15.1 17.8 9.9 8.1 10.6 6.8 19.6 19.8 15.0 13.5 18.1 13.9 6.4 13.7 13.8 14.2 12.9 12.3 13.0 14.5 9.7 7.5 18.1 12.2 12.0 7.8 14.8 10.7 9.6 9.1 6.1 8.1 7.6 13.7 10.2 7.6 9.9 12.1 10.7 15.5 14.6 12.2 12.5 12.5 12.5 15.7 19.9 10.3 5.3 10.0 13.4 7.1 15.5 12.6 5.6 17.3 23.0 21.7 9.2 11.5 12.3 11.9 11.7 1.4 3.5 1.9 3.7 4.9 9.9 4.9 7.0 3.1 2.8 4.0 2.6 7.0 3.5 20.8 1.2 8.0 0.6 49.1 4.6 4.5 2.5 6.5 7.9 4.0 4.3 9.2 2.5 5.0 2.0 8.1 2.0 4.8 4.7 23.6 4.3 10.9 1.4 26.6 2.9 7.8 10.4 8.5 4.5 3.6 6.6 5.3 2.6 10.8 5.9 4.3 8.0 3.5 7.1 6.6 3.0 3.9 3.5 0.5 14.6 4.1 12.2 14.1 21.7 12.8 6.1 16.0 6.2 5.6 6.0 6.5 17.3 3.3 5.5 5.5 23.0 9.2 9.1 6.2 11.5 12.3 9.9 10.6 19.8 15.0 9.7 7.5 14.8 10.7 13.7 10.3 CASK "CAGH39, FGS4, LIN2, TNRC8" ENSG00000147044 "Calcium/calmodulin dependent serine protein kinase" O14936 X 41514934-41923645 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.3" "Lineage enriched" "Detected in many" 11 "granulocytes: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001949, HPA023857" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB001949: , HPA023857: AB_1846035" "unprognostic (6.30e-2)" "unprognostic (3.78e-2)" "unprognostic (1.48e-1)" "unprognostic (2.48e-3)" "unprognostic (1.56e-1)" "unprognostic (1.29e-1)" "unprognostic (1.42e-3)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (5.85e-3)" "prognostic unfavourable (6.11e-5)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.72e-2)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "unprognostic (2.85e-2)" 9.1 15.9 13.9 18.8 12.7 9.8 13.2 14.2 15.7 11.1 22.1 20.0 7.1 27.1 12.2 13.7 17.2 9.9 16.0 7.0 12.1 12.8 14.6 10.8 10.3 13.6 16.3 8.5 13.9 14.2 11.1 9.8 13.4 11.9 10.7 23.8 10.4 15.9 7.7 5.8 12.8 32.9 12.1 10.1 9.6 16.2 2.9 14.3 30.9 9.3 8.1 14.0 11.8 13.1 0.6 0.3 26.3 0.8 2.4 2.3 0.3 10.8 13.9 13.3 7.9 9.0 7.4 4.3 9.5 7.9 5.6 5.1 29.9 17.7 0.1 4.9 11.8 21.8 14.7 9.7 9.4 9.6 8.2 0.0 12.5 10.6 9.3 1.7 1.4 8.4 26.7 10.6 13.6 4.5 0.8 8.5 12.1 12.7 3.1 0.7 12.2 9.1 5.1 32.8 5.2 12.6 23.7 12.2 6.5 17.9 7.1 5.4 7.7 0.3 5.3 10.5 10.6 8.9 5.2 3.3 2.0 3.6 10.3 1.2 6.7 26.3 0.8 4.8 0.5 0.7 0.5 0.4 0.6 0.8 0.2 0.6 0.7 0.7 1.1 2.4 0.4 0.3 2.3 0.3 13.9 12.7 14.2 14.2 12.1 12.8 16.3 8.5 11.9 14.3 CATSPERD "MGC39581, TMEM146" ENSG00000174898 "Cation channel sperm associated auxiliary subunit delta" Q86XM0 19 5720677-5778734 "Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 32.8" "Cell line enriched" "Detected in single" 60 "HEL: 12.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA024056 Enhanced "HPA024056: AB_1858093" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (3.77e-3)" "unprognostic (9.91e-2)" "unprognostic (3.74e-2)" "unprognostic (6.85e-2)" "unprognostic (2.63e-3)" "unprognostic (2.19e-2)" "unprognostic (5.18e-2)" "unprognostic (2.50e-1)" "unprognostic (5.95e-8)" "unprognostic (2.54e-2)" "unprognostic (9.92e-2)" "unprognostic (2.83e-1)" "unprognostic (3.74e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 32.8 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.5 0.6 0.0 0.1 0.1 0.1 0.1 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Cell line enhanced" "Detected in some" "BEWO: 4.1;HMC-1: 5.2;MCF7: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.4 0.2 1.8 0.8 0.0 4.1 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.2 0.0 0.8 0.0 0.5 0.1 0.0 1.3 0.0 4.2 0.0 0.0 0.0 0.8 0.1 0.0 0.8 1.9 0.1 0.4 0.5 0.4 0.9 0.2 0.4 0.0 0.3 0.0 1.0 0.6 0.0 0.7 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 CAV1 CAV ENSG00000105974 "Caveolin 1" Q03135 7 116524785-116561184 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 142.2;BJ hTERT+: 149.8;HBEC3-KT: 145.9;LHCN-M2: 152.1;U-138 MG: 121.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 10.6;memory B-cell: 6.0" "Group enriched" "Detected in many" 37 "B-cells: 6.0;granulocytes: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003791, HPA049326" Enhanced Supported "Golgi apparatus" "Golgi apparatus" "CAB003791: AB_562068, HPA049326: " "unprognostic (5.98e-2)" "unprognostic (1.35e-3)" "unprognostic (3.35e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-3)" "unprognostic (2.35e-3)" "unprognostic (8.07e-2)" "prognostic unfavourable (7.17e-5)" "unprognostic (1.31e-1)" "unprognostic (2.25e-1)" "unprognostic (1.79e-3)" "unprognostic (7.92e-2)" "prognostic unfavourable (1.29e-4)" "unprognostic (1.65e-3)" "unprognostic (2.72e-1)" "unprognostic (7.40e-2)" "unprognostic (6.14e-3)" 143.9 2.3 2.4 27.5 5.9 0.0 70.5 1.0 3.8 73.8 57.4 2.6 32.3 4.3 84.6 40.9 51.1 31.4 42.0 60.2 2.7 2.3 5.7 4.2 132.7 8.6 7.9 4.5 26.6 3.8 2.0 1.9 92.0 4.2 42.3 13.7 13.6 12.8 26.5 33.3 21.7 18.6 104.0 5.5 28.6 30.1 21.5 5.2 2.8 92.1 34.7 6.6 85.9 33.7 6.0 0.1 10.6 0.0 0.0 0.2 1.1 27.4 22.4 0.6 0.2 92.9 142.2 1.3 65.5 149.8 36.2 38.2 0.1 40.9 0.0 23.2 77.0 51.8 0.1 145.9 55.1 1.8 1.2 0.0 8.9 0.0 12.8 0.0 0.1 48.5 31.0 52.8 35.0 109.0 0.0 1.5 152.1 2.8 0.0 0.0 2.1 10.8 0.3 1.5 15.6 20.5 0.1 0.0 0.0 20.1 1.3 3.2 0.1 0.2 83.7 121.4 13.9 46.3 18.0 6.1 0.9 0.1 48.9 0.0 43.8 10.6 0.0 0.0 0.0 0.0 0.0 6.0 0.2 0.1 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 2.4 5.9 1.0 3.8 2.7 2.3 7.9 4.5 4.2 5.2 CAV2 CAV ENSG00000105971 "Caveolin 2" P51636 7 116287380-116508541 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 48.1;HBEC3-KT: 55.0;LHCN-M2: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 82 "basophil: 31.8" "Lineage enriched" "Detected in single" 318 "granulocytes: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013488, HPA044810" Enhanced Approved Vesicles Vesicles "CAB013488: AB_2533493, HPA044810: " "unprognostic (4.76e-2)" "unprognostic (3.91e-3)" "unprognostic (4.56e-2)" "unprognostic (2.91e-1)" "unprognostic (5.09e-3)" "prognostic unfavourable (5.80e-5)" "unprognostic (3.66e-2)" "unprognostic (2.27e-2)" "unprognostic (3.81e-1)" "unprognostic (3.34e-1)" "prognostic unfavourable (1.21e-4)" "unprognostic (6.32e-2)" "unprognostic (3.44e-3)" "unprognostic (7.84e-3)" "unprognostic (2.88e-1)" "unprognostic (2.42e-1)" "unprognostic (6.34e-3)" 61.9 4.5 3.0 9.5 6.6 0.2 39.9 1.0 3.7 26.3 15.7 3.1 10.3 3.3 23.4 19.6 25.2 10.8 31.3 54.6 4.4 3.1 9.5 17.4 59.4 6.0 7.5 3.8 17.7 16.0 1.4 2.8 35.2 4.6 20.6 5.0 12.1 10.7 10.5 15.3 13.3 8.3 34.0 8.6 25.3 8.9 12.1 5.3 1.7 61.2 23.2 4.9 29.5 15.4 0.0 0.0 31.8 0.0 0.0 0.0 0.2 38.7 10.5 0.4 0.0 18.0 19.3 0.8 27.1 32.3 9.0 8.1 2.0 48.1 0.0 32.5 27.8 37.7 0.5 55.0 13.0 0.0 2.6 0.3 8.1 0.0 11.0 0.0 0.1 11.3 31.8 12.1 25.1 28.9 1.9 1.5 59.3 2.0 0.0 0.0 0.5 6.8 0.4 13.2 0.5 33.1 1.1 0.0 0.0 20.7 0.7 5.0 0.0 0.2 41.3 0.0 5.7 18.0 8.8 1.7 0.0 0.1 3.6 0.0 19.4 31.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 3.0 6.6 1.0 3.7 4.4 3.1 7.5 3.8 4.6 5.3 CAV3 "LGMD1C, LQT9, VIP-21, VIP21" ENSG00000182533 "Caveolin 3" P56539 3 8733800-8841808 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 65.8;tongue: 44.6" "Cell line enriched" "Detected in some" 4 "RH-30: 45.1" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB017518, CAB018557, HPA054488" Enhanced Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: " "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "unprognostic (3.05e-3)" "unprognostic (8.38e-3)" "unprognostic (9.79e-2)" "unprognostic (1.36e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 6.3 2.3 0.0 0.3 10.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.7 1.3 0.1 65.8 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 44.6 1.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 CBARP "BARP, C19orf26, DOS, MGC40084" ENSG00000099625 "CACN beta subunit associated regulatory protein" Q8N350 19 1228287-1238027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;pituitary gland: 13.1" "Cell line enhanced" "Detected in many" "SH-SY5Y: 8.6" "Cancer enhanced" "Detected in many" "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA012777 Approved Nucleoplasm Nucleoplasm "HPA012777: AB_2067005" "unprognostic (1.31e-1)" "unprognostic (4.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" "unprognostic (3.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (2.17e-1)" "unprognostic (4.58e-2)" "unprognostic (2.86e-3)" "unprognostic (3.03e-1)" "unprognostic (5.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (7.42e-5)" 2.3 8.1 7.2 1.5 12.1 1.0 1.2 3.6 17.9 1.2 1.3 5.2 0.0 1.3 1.8 1.1 1.5 1.1 1.8 1.5 8.5 5.6 1.8 1.5 1.4 1.1 3.3 4.7 2.9 2.1 1.6 13.1 1.4 10.6 1.4 1.0 1.2 1.2 1.5 1.3 4.5 1.1 1.2 6.5 1.2 1.9 3.0 2.2 0.0 1.3 0.0 1.2 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.0 5.2 0.2 0.6 1.5 4.4 1.3 0.9 0.9 2.3 0.2 0.0 4.9 0.9 2.3 0.8 0.9 0.2 0.9 1.1 0.1 1.7 1.4 2.2 0.1 1.8 1.2 0.5 1.1 0.3 0.6 2.7 0.1 0.6 3.9 0.0 1.3 3.6 2.1 4.3 0.8 0.3 0.2 0.5 3.2 8.6 0.0 0.1 4.5 0.6 0.9 1.7 1.8 5.5 5.1 1.6 0.5 0.5 0.0 1.4 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 12.1 3.6 17.9 8.5 5.6 3.3 4.7 10.6 2.2 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: " "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 42.1 23.4 11.1 15.4 10.3 5.4 50.3 17.2 12.9 17.5 35.2 8.5 18.1 15.0 24.9 28.6 22.4 18.2 31.5 31.3 10.2 11.0 13.0 15.0 14.0 14.1 9.7 7.9 15.3 80.2 7.6 10.5 10.8 8.4 22.8 13.7 11.5 14.6 24.5 29.3 9.6 16.0 44.8 9.7 13.5 24.2 9.2 8.8 19.3 14.0 8.8 10.9 38.9 24.1 20.7 32.5 7.6 11.0 16.4 46.9 18.3 7.9 7.2 6.0 7.5 30.3 19.5 3.5 13.5 12.2 8.7 8.1 3.3 2.4 5.2 6.0 17.7 2.7 4.4 6.5 6.4 15.3 7.1 2.4 11.0 8.1 7.2 3.8 9.5 11.5 7.8 9.2 7.2 6.0 3.2 10.1 10.8 5.1 4.2 5.6 4.4 22.3 6.1 1.4 4.1 28.7 4.3 3.9 6.6 7.0 9.8 6.6 5.1 4.7 7.5 13.9 7.7 10.0 12.3 4.5 6.7 10.4 25.7 6.1 12.1 7.6 10.6 5.1 36.1 11.0 46.9 20.7 31.7 31.4 11.8 20.1 15.5 21.3 2.1 16.4 6.4 32.5 35.2 18.3 11.1 10.3 17.2 12.9 10.2 11.0 9.7 7.9 8.4 8.8 CCDC136 "DKFZP434G156, KIAA1793, NAG6" ENSG00000128596 "Coiled-coil domain containing 136" Q96JN2 7 128790757-128822132 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 34.7;testis: 109.6" "Cell line enhanced" "Detected in many" "U-87 MG: 18.4;U-937: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010647, HPA071015" Enhanced Uncertain Nucleoli Nucleoli "HPA010647: AB_2259798, HPA071015: " "unprognostic (2.07e-2)" "unprognostic (2.32e-2)" "unprognostic (1.29e-4)" "unprognostic (4.65e-2)" "unprognostic (4.52e-1)" "unprognostic (2.16e-1)" "unprognostic (1.66e-2)" "unprognostic (2.53e-1)" "unprognostic (5.43e-4)" "unprognostic (2.58e-2)" "unprognostic (8.44e-3)" "unprognostic (4.35e-1)" "unprognostic (1.18e-4)" "unprognostic (5.27e-3)" "unprognostic (4.85e-2)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" 2.1 4.0 11.2 2.6 11.7 1.8 2.4 34.7 28.7 2.9 6.5 8.3 2.6 2.4 3.9 2.9 2.5 2.8 2.8 4.9 12.5 20.0 1.5 1.5 1.9 3.0 15.3 16.6 2.8 1.8 1.8 3.8 2.2 11.2 9.9 3.5 13.9 2.0 11.0 3.5 1.6 2.6 17.3 9.7 1.9 2.4 109.6 7.4 0.7 1.7 0.0 2.4 6.4 2.0 0.1 0.6 1.3 0.3 2.7 1.6 0.3 0.7 0.8 7.2 4.8 3.9 3.3 1.2 2.7 3.6 2.8 2.6 1.0 0.6 3.6 0.3 3.7 1.5 4.5 0.5 2.6 10.1 4.6 6.2 1.7 0.0 1.3 0.7 13.5 3.7 0.5 3.0 0.2 1.6 2.2 3.8 1.0 1.3 4.5 1.9 9.9 2.9 11.3 1.2 1.7 0.2 1.2 4.2 12.5 1.6 1.9 2.8 0.1 1.7 1.4 4.5 2.6 2.1 2.1 2.2 0.9 3.7 18.4 27.1 1.1 0.0 0.3 1.3 1.4 0.0 1.6 0.0 1.5 1.1 0.6 0.1 0.0 1.0 0.1 2.7 0.1 0.1 0.0 0.3 11.2 11.7 34.7 28.7 12.5 20.0 15.3 16.6 11.2 7.4 CCDC141 "CAMDI, FLJ39502" ENSG00000163492 "Coiled-coil domain containing 141" 2 178829757-179050086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 47.5;lung: 17.6" "Cell line enhanced" "Detected in some" "CACO-2: 6.2;Daudi: 4.1;HEL: 9.3;RH-30: 5.0;U-266/70: 6.0;U-698: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 12.9" "Group enriched" "Detected in many" 9 "B-cells: 7.6;T-cells: 12.9" HPA012718 Approved Nucleoplasm Nucleoplasm "HPA012718: AB_2072055" "unprognostic (1.58e-1)" "unprognostic (1.85e-2)" "unprognostic (3.10e-2)" "unprognostic (2.37e-1)" "unprognostic (8.62e-3)" "unprognostic (4.25e-2)" "unprognostic (2.98e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.33e-2)" "unprognostic (8.03e-3)" "unprognostic (7.71e-8)" "unprognostic (2.50e-2)" "unprognostic (1.52e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-1)" 1.6 0.6 0.5 7.5 0.6 0.9 4.9 0.5 0.5 0.7 1.2 0.1 0.5 0.2 0.8 2.2 2.5 0.6 6.3 47.5 0.6 0.6 0.5 0.5 17.6 4.4 0.6 0.0 0.8 3.8 0.2 0.5 0.8 1.1 1.0 0.3 1.8 0.6 0.3 9.3 0.5 0.7 1.7 0.7 1.8 0.6 1.6 0.0 11.0 0.7 2.1 7.4 1.4 1.2 7.6 0.0 0.4 0.0 1.1 12.9 0.4 0.2 0.0 0.1 0.3 0.0 0.1 1.9 0.0 0.1 0.0 0.2 6.2 0.5 4.1 0.1 0.0 0.2 0.1 0.0 0.0 3.4 0.2 9.3 0.3 0.0 0.0 1.6 0.5 0.4 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.1 0.1 0.3 3.3 0.7 0.2 5.0 1.5 0.0 0.1 0.2 0.2 0.1 0.3 0.1 0.3 0.4 0.1 0.3 0.2 0.3 0.0 6.0 0.1 8.3 0.3 0.5 0.6 0.3 0.0 0.2 0.3 0.0 0.2 6.6 2.1 1.4 0.0 7.6 6.4 4.8 0.4 1.1 0.0 0.0 12.9 0.4 0.5 0.6 0.5 0.5 0.6 0.6 0.6 0.0 1.1 0.0 CCDC144A "FLJ43983, KIAA0565" ENSG00000170160 "Coiled-coil domain containing 144A" A2RUR9 17 16689537-16777881 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 44.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.9;TIME: 9.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA022996, HPA047220, HPA047851" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA022996: AB_1846136, HPA047220: , HPA047851: " "unprognostic (8.54e-2)" "unprognostic (4.49e-3)" "unprognostic (1.07e-1)" "unprognostic (8.34e-2)" "unprognostic (1.10e-1)" "unprognostic (2.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.69e-2)" "unprognostic (6.95e-2)" "unprognostic (2.60e-2)" "unprognostic (2.73e-1)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (9.49e-2)" "unprognostic (3.32e-1)" "unprognostic (1.41e-1)" "unprognostic (1.74e-1)" 3.7 1.9 2.5 2.7 3.5 5.5 2.7 12.0 3.6 2.1 3.1 2.8 0.4 0.9 5.4 3.9 1.3 2.6 1.7 2.5 4.7 0.8 1.0 1.5 2.8 2.3 4.3 1.8 7.3 5.4 0.2 16.7 3.7 10.3 3.0 1.4 1.7 2.2 1.5 2.4 3.7 2.0 2.5 4.2 2.4 2.2 44.4 2.8 2.4 1.8 0.4 1.5 2.8 4.9 1.0 0.8 0.8 1.3 1.0 3.8 0.0 0.5 3.8 0.9 2.4 3.4 10.9 0.4 0.2 0.0 0.2 0.2 4.8 0.1 0.5 3.3 6.7 5.9 4.9 0.3 0.3 3.4 0.3 0.5 0.5 0.3 0.2 0.7 3.1 2.0 0.1 2.3 0.2 0.1 0.5 0.3 2.2 0.2 0.1 1.2 0.8 0.4 1.5 0.2 0.1 0.1 4.6 1.2 1.3 0.7 0.2 1.4 4.0 0.2 9.3 0.8 0.5 5.2 1.5 6.6 6.8 0.2 0.4 6.8 1.8 0.7 0.6 0.3 2.2 0.5 1.4 1.0 2.1 1.4 0.4 0.5 3.8 1.9 0.8 1.0 1.3 0.8 2.1 0.0 2.5 3.5 12.0 3.6 4.7 0.8 4.3 1.8 10.3 2.8 CCDC155 "FLJ32658, KASH5" ENSG00000161609 "Coiled-coil domain containing 155" Q8N6L0 19 49388218-49417994 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 51.2" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.0;U-266/70: 8.4;U-698: 2.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Region enriched" "Detected in single" 39 "cerebellum: 7.7" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA019937, HPA019940" Enhanced "HPA019937: AB_1848877, HPA019940: AB_1848879" "unprognostic (1.31e-1)" "unprognostic (4.23e-2)" "unprognostic (2.28e-2)" "unprognostic (1.09e-2)" "unprognostic (3.99e-1)" "unprognostic (1.79e-1)" "unprognostic (6.41e-2)" "unprognostic (5.31e-2)" "unprognostic (8.96e-2)" "unprognostic (1.84e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-1)" "unprognostic (7.11e-9)" "unprognostic (6.50e-2)" "unprognostic (4.18e-1)" "unprognostic (3.08e-3)" "unprognostic (1.20e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 1.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.2 0.0 1.6 0.1 0.9 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 8.4 1.3 2.1 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 CCDC167 "C6orf129, dJ153P14.2" ENSG00000198937 "Coiled-coil domain containing 167" Q9P0B6 6 37482920-37499922 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.0" "Cell line enriched" "Detected in many" 9 "U-698: 170.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045215 Uncertain Approved Cytosol Cytosol "HPA045215: AB_10962866" "unprognostic (1.82e-1)" "prognostic favourable (7.59e-4)" "unprognostic (6.99e-2)" "unprognostic (3.66e-1)" "unprognostic (2.86e-1)" "unprognostic (2.07e-1)" "prognostic unfavourable (2.94e-4)" "unprognostic (2.73e-1)" "unprognostic (7.67e-2)" "unprognostic (3.41e-3)" "unprognostic (2.71e-1)" "unprognostic (2.79e-1)" "prognostic unfavourable (1.71e-7)" "unprognostic (1.57e-1)" "unprognostic (4.06e-1)" "unprognostic (2.44e-1)" "unprognostic (1.95e-1)" 6.4 10.3 16.1 11.6 18.9 12.7 10.2 11.3 15.5 12.6 10.5 12.8 11.4 6.3 8.7 25.2 13.6 11.5 6.2 17.3 13.8 12.1 10.2 29.5 7.0 23.0 18.1 9.1 4.6 14.9 6.9 8.4 9.6 15.8 12.2 13.0 5.0 16.2 7.7 10.5 6.5 8.2 16.7 22.8 15.1 7.5 18.8 16.9 32.1 11.5 11.2 35.5 8.7 8.7 24.8 9.9 23.6 6.0 8.6 70.0 26.4 3.0 7.1 16.3 11.2 4.4 7.8 5.9 3.7 2.9 5.7 6.4 7.4 4.6 16.7 8.3 6.2 2.4 10.4 8.5 5.8 13.9 19.3 7.9 3.1 18.7 4.7 7.7 3.1 3.6 17.6 6.1 5.6 17.6 4.9 14.5 9.7 10.1 14.4 6.4 0.9 4.5 9.0 5.7 12.3 7.7 6.0 11.0 13.0 5.5 5.4 8.5 5.9 8.1 4.4 3.8 7.4 2.1 3.7 10.7 10.4 170.9 3.7 16.6 10.6 4.8 6.0 23.6 26.1 5.9 31.1 24.8 43.5 32.8 9.9 17.0 20.1 19.4 1.8 8.6 4.9 6.3 70.0 26.4 16.1 18.9 11.3 15.5 13.8 12.1 18.1 9.1 15.8 16.9 CCDC168 "C13orf40, FLJ40176" ENSG00000175820 "Coiled-coil domain containing 168" Q8NDH2 13 102729369-102759070 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 23.7" "Cell line enhanced" "Detected in some" "HL-60: 1.5;MOLT-4: 1.3;NB-4: 1.0;THP-1: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048184, HPA058793" Uncertain "HPA048184: , HPA058793: " "unprognostic (2.06e-1)" "unprognostic (7.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-4)" "unprognostic (2.09e-2)" "unprognostic (3.68e-2)" "unprognostic (2.74e-1)" "unprognostic (5.05e-2)" "unprognostic (3.61e-1)" "unprognostic (2.89e-3)" "unprognostic (1.73e-1)" "unprognostic (1.44e-5)" "unprognostic (2.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.85e-1)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.7 0.1 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.7 0.1 0.0 0.0 1.5 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.3 1.0 0.0 0.3 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC188 ENSG00000234409 "Coiled-coil domain containing 188" H7C350 22 20148427-20151065 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 6.1;testis: 23.1" "Cell line enhanced" "Detected in some" "AF22: 5.7;SCLC-21H: 7.8;SH-SY5Y: 10.2;U-2 OS: 4.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 47 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 47 "dendritic cells: 4.7" "Low region specificity" "Detected in single" HPA049901 Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA049901: " "unprognostic (9.83e-2)" "unprognostic (3.09e-2)" "unprognostic (9.79e-2)" "unprognostic (6.42e-3)" "unprognostic (2.45e-1)" "unprognostic (3.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.02e-1)" "unprognostic (8.43e-2)" "unprognostic (4.08e-3)" "unprognostic (1.67e-5)" "unprognostic (1.16e-1)" "unprognostic (5.37e-5)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (3.44e-1)" "unprognostic (1.40e-2)" 1.1 0.9 0.4 0.5 0.6 0.5 0.5 1.4 1.2 0.4 0.4 0.4 0.4 1.0 0.6 0.4 0.4 0.4 0.4 0.4 0.4 1.9 0.4 0.4 0.6 0.7 0.5 0.4 0.4 0.4 0.0 6.1 0.8 0.4 0.4 0.0 0.4 0.4 0.4 0.7 1.5 0.5 0.4 0.4 1.8 0.8 23.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 5.7 0.3 0.0 0.7 0.0 1.6 0.8 1.3 0.9 0.1 0.1 0.0 0.2 0.8 0.3 0.0 0.0 0.1 0.2 0.0 1.4 0.2 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.5 0.1 0.2 3.7 1.2 0.5 0.0 0.3 0.0 0.0 1.1 0.2 0.0 0.0 0.1 7.8 10.2 0.5 0.0 0.6 0.0 0.1 4.1 2.4 4.4 3.0 0.2 0.6 0.1 0.2 3.8 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.4 0.6 1.4 0.6 0.4 1.9 0.5 0.4 0.4 0.4 CCDC47 GK001 ENSG00000108588 "Coiled-coil domain containing 47" Q96A33 17 63745250-63776351 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029674, HPA072573, HPA075958" Approved Enhanced "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: " "unprognostic (6.33e-2)" "unprognostic (3.26e-2)" "prognostic favourable (2.17e-4)" "unprognostic (1.38e-1)" "unprognostic (3.54e-1)" "unprognostic (1.47e-2)" "unprognostic (1.53e-2)" "unprognostic (9.08e-2)" "unprognostic (1.57e-1)" "unprognostic (3.68e-1)" "unprognostic (2.73e-1)" "unprognostic (1.26e-1)" "unprognostic (8.35e-2)" "unprognostic (1.88e-1)" "unprognostic (6.43e-2)" "unprognostic (7.46e-2)" "unprognostic (1.16e-1)" 26.2 42.1 26.7 18.7 43.3 11.4 26.7 32.4 31.3 24.4 38.2 23.0 29.2 39.9 20.6 26.3 28.9 21.2 22.8 42.4 26.5 24.0 40.0 71.8 27.4 13.9 29.4 24.8 27.0 30.5 49.3 28.5 49.9 26.4 29.3 38.4 17.7 30.0 29.7 71.9 23.5 44.0 20.7 31.5 26.8 35.9 15.1 34.7 13.3 29.4 24.3 18.1 29.8 24.5 19.9 41.9 37.4 30.8 20.8 25.7 24.2 38.7 36.9 22.9 20.1 32.4 21.6 44.8 39.8 25.8 27.2 32.2 32.5 35.4 30.6 21.3 27.7 31.9 27.7 24.3 48.2 10.7 28.2 44.0 30.4 31.7 31.1 35.1 23.2 22.6 34.3 37.4 32.3 22.6 49.0 26.8 22.1 31.3 26.9 12.9 20.0 37.6 25.0 44.7 42.1 32.6 44.3 21.1 28.7 26.6 68.2 31.8 45.0 19.1 28.8 50.9 32.6 36.9 45.5 26.9 31.9 31.6 29.7 22.4 41.0 22.2 30.7 37.4 22.1 30.8 25.7 19.9 21.9 20.3 41.9 16.0 22.9 20.2 24.5 20.8 30.4 27.9 23.4 24.2 26.7 43.3 32.4 31.3 26.5 24.0 29.4 24.8 26.4 34.7 CCDC51 FLJ12436 ENSG00000164051 "Coiled-coil domain containing 51" Q96ER9 3 48432164-48440456 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010980, HPA011408" Supported Supported Nucleoplasm,Centrosome,Mitochondria "Nucleoplasm, Mitochondria" Centrosome "HPA010980: AB_1846155, HPA011408: AB_2072212" "unprognostic (1.24e-2)" "unprognostic (5.23e-2)" "unprognostic (5.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-1)" "unprognostic (2.75e-3)" "unprognostic (4.71e-3)" "unprognostic (1.26e-2)" "unprognostic (3.04e-1)" "unprognostic (3.26e-2)" "unprognostic (7.70e-2)" "unprognostic (1.47e-3)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" 9.9 14.9 10.1 7.1 12.7 4.5 9.6 10.4 15.9 8.9 12.8 7.5 12.4 11.6 8.2 11.4 15.9 9.7 8.4 12.3 9.2 8.2 15.2 17.8 7.1 9.0 9.9 15.4 8.7 8.5 9.4 7.4 8.5 10.6 7.7 15.1 9.9 11.0 11.2 16.3 10.9 8.8 11.6 8.8 14.7 7.9 10.7 8.9 10.4 11.3 16.1 12.0 8.8 9.7 19.2 18.2 4.8 10.4 10.6 14.8 9.7 9.6 11.8 7.1 8.3 10.5 11.1 19.5 6.4 5.9 12.9 10.6 18.6 16.2 21.0 9.2 5.1 14.1 17.4 21.0 7.9 9.8 11.4 17.9 18.7 13.9 16.2 8.7 8.2 8.4 47.7 16.0 17.5 7.3 9.9 6.1 12.2 9.2 10.1 11.3 15.5 19.1 7.0 8.3 16.2 17.5 12.1 5.9 12.3 10.6 11.6 17.2 12.5 13.5 5.5 7.5 10.2 18.6 12.3 9.9 14.5 10.9 10.0 18.9 7.0 2.0 10.4 4.8 12.0 10.2 12.1 19.2 11.2 14.8 18.2 15.4 11.7 13.4 4.5 10.6 6.1 15.2 13.4 9.7 10.1 12.7 10.4 15.9 9.2 8.2 9.9 15.4 10.6 8.9 CCDC90B "MDS011, MDS025" ENSG00000137500 "Coiled-coil domain containing 90B" Q9GZT6 11 83259097-83286407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011130, HPA011931" Supported Enhanced Mitochondria Mitochondria "HPA011130: AB_1846170, HPA011931: AB_2072332" "unprognostic (5.85e-2)" "unprognostic (1.33e-1)" "unprognostic (7.34e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-1)" "unprognostic (7.48e-2)" "unprognostic (2.99e-1)" "unprognostic (3.57e-3)" "unprognostic (5.76e-3)" "unprognostic (3.53e-2)" "unprognostic (6.01e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-2)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.62e-1)" "unprognostic (2.41e-1)" 15.8 32.0 25.0 11.1 23.3 11.6 18.0 14.3 17.9 15.4 14.5 14.6 17.2 12.1 12.6 29.3 14.3 13.5 15.2 18.2 22.3 25.6 16.4 31.3 11.0 15.0 29.9 14.9 19.4 16.6 15.2 29.5 18.3 24.5 16.3 14.9 8.4 14.5 14.8 12.2 11.6 18.2 14.9 43.9 17.1 13.6 42.2 28.3 15.5 21.6 12.3 13.5 14.8 13.0 18.5 12.7 32.6 19.0 22.5 21.1 12.4 7.3 10.9 18.6 6.0 25.3 19.1 11.4 15.0 12.9 9.5 10.2 12.7 25.5 17.9 19.7 22.2 9.4 8.2 19.2 12.7 12.5 6.5 11.0 7.4 10.6 21.3 11.1 9.6 21.3 26.0 12.2 35.1 21.5 16.3 15.3 34.4 13.0 11.2 14.3 15.4 13.6 13.0 16.7 15.4 19.6 10.9 9.1 21.0 10.5 8.5 9.8 22.0 10.4 20.6 18.6 11.7 34.8 10.1 14.9 19.5 18.2 7.5 9.0 18.3 30.8 8.9 32.6 12.3 19.0 15.6 18.5 17.9 17.0 12.7 16.9 15.5 15.5 4.5 22.5 19.0 9.3 21.1 12.4 25.0 23.3 14.3 17.9 22.3 25.6 29.9 14.9 24.5 28.3 CCPG1 "CPR8, KIAA1254" ENSG00000260916 "Cell cycle progression 1" Q9ULG6 15 55340032-55408510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 49.7;Karpas-707: 72.4;U-266/84: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 52.9;neutrophil: 59.9" "Group enriched" "Detected in all" 7 "granulocytes: 59.9;monocytes: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009432, HPA026861" Approved Approved "Endoplasmic reticulum,Golgi apparatus" "Golgi apparatus" "Endoplasmic reticulum" "HPA009432: , HPA026861: AB_1846192" "unprognostic (3.14e-2)" "unprognostic (2.94e-2)" "unprognostic (3.03e-1)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (1.40e-2)" "unprognostic (8.34e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-2)" "unprognostic (2.61e-2)" "prognostic unfavourable (5.07e-4)" "prognostic unfavourable (5.02e-5)" "unprognostic (1.15e-1)" "unprognostic (1.71e-2)" "unprognostic (1.72e-2)" 22.4 20.3 21.1 11.2 34.8 29.5 20.2 27.6 27.7 32.1 16.0 9.9 28.2 11.9 16.0 19.4 12.7 11.7 26.6 29.7 21.2 26.1 27.5 56.2 23.3 19.8 21.8 18.5 17.4 41.6 37.7 56.3 13.4 21.7 21.0 16.5 13.5 33.1 27.4 44.2 7.8 16.9 16.7 23.2 19.5 22.2 13.8 19.7 5.2 41.9 12.9 11.3 20.0 16.7 3.7 5.5 59.9 15.4 4.9 5.6 5.6 2.8 10.4 2.3 5.2 38.3 13.0 3.3 6.2 11.9 3.7 5.7 3.0 5.0 4.3 21.5 20.6 3.9 2.0 5.3 3.1 11.4 3.1 5.8 13.2 2.7 49.7 8.0 18.1 10.9 12.8 7.8 7.6 13.6 9.7 72.4 11.7 3.9 0.0 4.0 1.4 2.7 1.3 3.7 17.2 7.8 2.1 3.0 4.6 7.4 4.1 31.6 6.6 17.7 13.7 11.0 2.4 8.3 4.2 14.0 51.1 2.7 20.7 16.1 8.7 34.6 11.5 52.9 5.6 10.1 4.8 3.7 3.6 4.3 5.5 2.8 3.1 4.3 59.9 4.9 15.4 0.9 4.4 5.6 21.1 34.8 27.6 27.7 21.2 26.1 21.8 18.5 21.7 19.7 CCR10 GPR2 ENSG00000184451 "C-C motif chemokine receptor 10" P46092 17 42678889-42683917 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.1" "Cell line enhanced" "Detected in some" "Karpas-707: 8.6;RPMI-8226: 6.2;U-266/70: 17.7;U-266/84: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 31.1" "Group enriched" "Detected in many" 9 "dendritic cells: 10.9;T-cells: 31.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011684, HPA048007, HPA069188" Uncertain Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB011684: AB_731502, HPA048007: , HPA069188: " "unprognostic (3.25e-2)" "unprognostic (2.71e-2)" "unprognostic (5.70e-2)" "unprognostic (2.41e-2)" "unprognostic (5.25e-2)" "unprognostic (2.23e-3)" "unprognostic (5.18e-4)" "unprognostic (1.15e-1)" "unprognostic (9.55e-2)" "unprognostic (1.56e-1)" "unprognostic (1.21e-3)" "unprognostic (1.01e-2)" "unprognostic (2.32e-11)" "unprognostic (2.84e-2)" "unprognostic (1.53e-1)" "unprognostic (1.88e-2)" "unprognostic (1.87e-1)" 10.0 5.4 5.7 4.8 5.3 0.7 3.0 7.3 7.3 3.9 9.7 0.9 1.5 5.1 5.8 1.4 1.5 4.5 1.5 2.5 3.5 5.0 1.6 0.5 2.2 12.5 1.9 5.0 5.2 2.6 0.4 14.0 2.3 4.1 2.1 1.0 1.1 4.0 2.0 9.1 1.1 8.7 1.8 4.4 4.3 5.0 2.2 1.2 0.5 1.5 0.3 3.6 1.0 2.0 2.3 10.9 0.1 0.3 0.0 31.1 0.7 0.5 0.8 1.1 4.9 0.3 0.8 1.1 2.4 0.5 0.2 0.4 0.7 0.3 0.1 0.3 0.3 0.9 0.0 0.1 0.1 2.3 1.2 0.0 3.1 0.4 0.7 0.0 0.3 0.8 0.0 0.4 0.0 0.1 2.6 8.6 0.0 0.3 0.1 2.3 0.6 1.2 0.6 0.2 6.2 1.1 0.0 0.8 1.1 0.7 0.0 0.2 0.8 0.9 2.4 2.9 0.6 0.9 0.3 17.7 8.0 2.5 1.4 0.7 0.9 0.0 0.3 0.1 0.2 0.0 0.1 2.3 5.2 2.6 0.2 2.1 0.6 0.8 0.0 0.0 0.1 10.9 31.1 0.7 5.7 5.3 7.3 7.3 3.5 5.0 1.9 5.0 4.1 1.2 CCR3 "CC-CKR-3, CD193, CKR3, CMKBR3" ENSG00000183625 "C-C motif chemokine receptor 3" P51677 3 46163604-46266706 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "blood: 175.9" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 24.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 22 "basophil: 175.9;eosinophil: 152.0" "Lineage enriched" "Detected in many" 92 "granulocytes: 175.9" "Not detected" "Not detected" "Not detected" "Not detected" CAB003795 Uncertain "CAB003795: AB_562259" "unprognostic (1.56e-2)" "unprognostic (6.65e-3)" "unprognostic (1.01e-1)" "unprognostic (3.98e-2)" "unprognostic (1.41e-1)" "unprognostic (3.25e-3)" "unprognostic (3.11e-7)" "unprognostic (4.36e-2)" "unprognostic (3.35e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (3.94e-2)" "unprognostic (3.17e-6)" "unprognostic (1.35e-2)" "unprognostic (1.72e-2)" "unprognostic (2.41e-1)" "unprognostic (9.81e-2)" 0.6 0.2 0.3 2.9 1.1 0.4 0.3 0.2 0.8 0.3 1.3 0.2 0.2 2.9 0.8 0.2 0.4 0.5 1.3 0.3 0.2 0.2 0.5 1.2 5.8 0.6 0.3 0.2 0.2 0.3 0.0 0.3 7.0 0.7 1.0 1.4 0.9 2.4 0.2 3.2 3.6 5.1 1.6 0.5 2.7 2.2 0.4 0.2 0.6 1.8 2.8 0.6 4.0 0.3 0.0 0.2 175.9 0.0 0.0 1.9 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 2.2 0.0 0.7 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.1 0.3 0.1 0.0 0.2 0.0 24.9 0.0 2.0 0.1 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.1 2.7 2.1 0.0 0.0 0.5 0.0 175.9 0.0 152.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.2 1.9 0.3 0.3 1.1 0.2 0.8 0.2 0.2 0.3 0.2 0.7 0.2 CD101 "IGSF2, V7" ENSG00000134256 "CD101 molecule" Q93033 1 117001750-117036476 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;lung: 17.5" "Cell line enriched" "Detected in some" 9 "HMC-1: 24.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 33.7" "Group enriched" "Detected in many" 17 "dendritic cells: 12.2;granulocytes: 33.7;monocytes: 17.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA049527, HPA057763" Approved Uncertain Mitochondria 42000 Mitochondria "HPA049527: , HPA057763: " "unprognostic (1.25e-1)" "unprognostic (7.95e-3)" "unprognostic (5.40e-3)" "unprognostic (4.10e-3)" "unprognostic (2.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.03e-2)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (7.29e-3)" "unprognostic (3.15e-1)" "unprognostic (4.54e-2)" "unprognostic (7.15e-6)" "unprognostic (7.00e-2)" "unprognostic (8.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.28e-2)" 0.9 1.7 0.8 11.3 1.1 5.7 0.8 0.2 1.1 1.3 5.0 0.6 1.2 4.6 1.7 0.4 1.8 1.5 1.4 2.6 1.1 0.5 1.3 0.8 17.5 4.0 1.3 0.2 1.0 2.3 0.0 0.8 0.5 1.1 1.6 3.2 0.7 2.1 1.3 0.5 1.8 10.9 1.6 2.0 7.8 1.8 0.9 1.2 6.4 0.9 2.4 7.4 2.4 1.8 0.1 12.2 33.7 17.4 0.0 1.2 2.5 0.4 0.0 0.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.2 1.8 0.1 0.0 0.0 1.0 0.1 0.8 0.0 0.0 0.1 24.7 0.3 1.2 0.0 0.1 0.2 0.1 0.6 0.1 1.5 0.0 2.8 0.8 0.0 0.0 0.5 0.0 0.6 0.6 0.4 0.6 0.4 0.5 0.3 0.9 0.6 0.5 0.1 0.4 0.5 0.2 0.2 0.1 0.0 0.7 1.9 1.5 0.0 7.6 33.7 0.1 10.0 0.7 0.1 0.2 1.2 12.2 0.0 0.3 1.2 0.3 0.0 17.4 0.0 1.1 2.5 0.8 1.1 0.2 1.1 1.1 0.5 1.3 0.2 1.1 1.2 CD109 "CPAMD7, DKFZp762L1111, FLJ38569" ENSG00000156535 "CD109 molecule" Q6YHK3 6 73695785-73828316 "CD markers, Plasma proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "parathyroid gland: 203.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 61.6;BJ hTERT+: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA008992, HPA015723" Enhanced Supported "Plasma membrane" 120000000 "Plasma membrane" "HPA008992: , HPA015723: " "unprognostic (2.28e-1)" "unprognostic (1.03e-1)" "unprognostic (7.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.17e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-3)" "unprognostic (1.23e-3)" "unprognostic (7.49e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-3)" "unprognostic (8.81e-2)" "prognostic unfavourable (2.65e-4)" "prognostic unfavourable (7.96e-5)" "unprognostic (9.50e-2)" "unprognostic (2.02e-1)" "prognostic unfavourable (4.68e-4)" 27.4 1.5 1.6 1.9 2.2 1.9 6.5 0.4 1.9 15.0 7.1 3.4 2.0 1.5 22.5 8.5 22.4 3.4 2.4 8.2 1.8 1.4 3.5 1.4 14.5 1.4 1.7 1.4 2.8 1.2 203.4 0.6 5.0 3.0 7.1 2.1 0.6 4.2 2.2 4.1 12.4 2.4 12.6 4.5 1.7 1.5 3.3 2.8 6.3 1.7 16.8 4.7 8.7 8.0 0.3 2.6 1.4 0.4 0.6 0.4 0.3 9.2 8.3 0.5 0.0 12.7 61.6 0.0 8.4 37.8 2.8 6.1 0.0 5.4 0.0 5.2 17.3 26.1 0.9 16.9 3.7 2.5 1.4 3.3 6.8 1.4 2.7 0.0 0.0 16.9 13.4 5.2 21.1 20.0 0.0 0.0 12.6 0.2 0.2 0.0 0.6 5.4 0.7 2.4 11.4 1.2 1.0 0.0 0.0 19.1 0.1 8.3 0.2 1.5 18.5 26.4 3.7 4.7 7.2 0.1 5.2 0.0 10.6 0.0 23.4 0.6 0.4 0.3 0.2 0.2 0.1 0.2 0.3 0.2 2.6 0.3 0.4 0.2 1.4 0.6 0.2 1.4 0.1 0.3 1.6 2.2 0.4 1.9 1.8 1.4 1.7 1.4 3.0 2.8 CD151 "PETA-3, RAPH, SFA-1, TSPAN24" ENSG00000177697 "CD151 molecule (Raph blood group)" P48509 11 832843-839831 "Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Blood group antigen" "Deafness, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002428, HPA011906" Supported 680000 "CAB002428: AB_564129, HPA011906: AB_1846245" "unprognostic (1.50e-1)" "unprognostic (1.12e-2)" "unprognostic (5.47e-2)" "unprognostic (5.45e-3)" "unprognostic (4.10e-3)" "unprognostic (2.45e-2)" "prognostic unfavourable (5.58e-4)" "prognostic unfavourable (9.46e-4)" "unprognostic (5.47e-2)" "unprognostic (2.41e-1)" "unprognostic (1.02e-3)" "unprognostic (3.31e-1)" "unprognostic (4.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.24e-1)" "prognostic favourable (6.92e-4)" "unprognostic (7.83e-2)" 63.1 28.1 7.4 19.1 8.1 3.4 133.2 7.9 11.3 39.8 36.0 9.5 37.8 23.2 55.7 45.3 43.1 29.3 63.0 85.2 7.3 7.9 52.8 47.2 45.8 16.3 7.5 10.3 29.8 82.7 27.8 14.1 58.6 10.7 52.0 16.5 31.2 62.9 41.1 19.2 17.1 46.0 62.4 6.7 15.8 31.7 20.8 5.5 2.4 43.2 27.1 16.1 35.9 34.9 2.1 8.1 14.9 14.3 5.2 4.8 6.5 39.5 54.8 7.9 23.7 113.5 47.2 12.4 62.0 42.3 31.3 26.5 28.5 56.5 0.0 24.8 92.6 36.1 7.0 54.7 7.9 14.8 26.9 10.9 16.9 21.7 43.2 8.8 15.2 45.6 36.6 18.3 32.3 36.9 13.3 5.1 46.7 22.2 0.2 10.4 5.2 65.8 2.0 16.4 8.5 69.6 11.5 10.9 12.2 57.4 32.0 10.8 12.9 10.7 63.1 42.6 21.1 13.7 34.3 6.9 7.1 0.4 42.0 9.2 23.5 14.9 12.0 9.6 4.2 12.6 4.8 2.1 3.5 3.6 8.1 1.5 1.5 2.2 5.7 5.2 14.3 1.3 2.1 6.5 7.4 8.1 7.9 11.3 7.3 7.9 7.5 10.3 10.7 5.5 CD163 "M130, MM130, SCARI1" ENSG00000177575 "CD163 molecule" Q86VB7 12 7470813-7503893 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Acute phase, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 113.6" "Cell line enhanced" "Detected in some" "ASC diff: 2.1;CACO-2: 1.9;HSkMC: 5.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 28.2;myeloid DC: 25.3" "Group enriched" "Detected in many" 40 "dendritic cells: 25.3;monocytes: 28.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB002432, HPA046404, HPA051974" Enhanced Approved "Plasma membrane" "Secreted to blood" 903333333 1600000000 "Plasma membrane" "CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (5.02e-3)" "unprognostic (2.72e-1)" "unprognostic (6.17e-3)" "unprognostic (2.09e-1)" "unprognostic (1.02e-1)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "prognostic unfavourable (7.27e-4)" "unprognostic (1.04e-1)" "unprognostic (6.50e-2)" "unprognostic (1.84e-2)" "unprognostic (8.77e-2)" "unprognostic (4.95e-2)" "unprognostic (1.61e-1)" "unprognostic (1.20e-2)" 66.7 23.8 2.1 44.6 7.2 4.1 23.2 2.8 4.9 11.3 25.3 1.6 1.4 3.5 7.2 16.8 11.3 20.1 13.2 15.7 2.8 1.8 43.9 38.9 81.0 99.8 6.9 0.5 10.3 6.7 3.1 11.7 31.9 9.9 6.8 6.5 9.8 8.6 2.2 15.2 4.0 12.5 37.2 5.7 113.6 10.2 19.6 4.3 3.4 15.5 2.9 3.5 20.1 8.3 0.0 25.3 0.6 28.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.1 1.1 0.4 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.6 0.3 5.9 0.0 0.4 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.6 0.0 0.1 1.0 0.1 0.0 0.0 0.3 0.6 0.1 0.2 0.0 0.0 0.3 0.0 1.1 0.3 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.5 28.2 0.1 0.0 2.5 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 6.3 2.1 7.2 2.8 2.4 2.8 1.8 6.9 0.5 9.9 4.3 CD163L1 "CD163B, M160, SCARI2, WC1" ENSG00000177675 "CD163 molecule like 1" Q9NR16 12 7346685-7479897 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.4;lymphoid tissue: 31.2" "Cell line enhanced" "Detected in many" "HDLM-2: 8.2;HUVEC TERT2: 8.8;TIME: 8.3;U-87 MG: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA015663 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" 170000 "Centrosome, Cytosol" Nucleoplasm "HPA015663: AB_2072575" "unprognostic (1.25e-3)" "unprognostic (1.77e-1)" "unprognostic (1.42e-2)" "unprognostic (7.46e-3)" "unprognostic (2.29e-2)" "unprognostic (7.79e-2)" "unprognostic (9.39e-2)" "unprognostic (4.44e-3)" "unprognostic (1.07e-1)" "unprognostic (8.35e-2)" "unprognostic (1.08e-1)" "unprognostic (3.08e-1)" "unprognostic (1.26e-6)" "unprognostic (8.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.69e-1)" 5.0 1.7 1.2 19.1 1.2 0.0 2.5 0.8 1.6 1.4 9.2 0.3 1.0 5.5 1.2 8.5 1.8 1.3 2.6 3.2 1.2 1.0 1.7 1.5 2.8 14.6 1.1 0.7 1.0 1.0 0.1 1.4 6.8 3.3 1.4 15.1 2.7 2.5 1.4 1.1 1.4 18.4 1.8 1.0 31.2 2.6 4.6 0.2 9.5 1.7 6.4 12.9 4.3 1.2 0.2 0.7 0.7 0.8 0.0 0.0 0.2 0.2 0.4 0.2 0.0 1.0 0.3 0.0 0.8 1.8 0.2 0.8 0.0 1.4 0.0 0.3 0.8 0.0 0.0 1.1 1.4 8.2 0.0 0.0 0.4 1.2 0.0 0.5 0.0 0.3 0.0 0.2 3.3 8.8 0.1 4.7 5.2 0.0 0.0 6.5 0.2 0.0 1.5 1.5 1.8 0.0 0.0 1.2 5.5 4.3 6.8 0.0 0.0 5.4 8.3 3.0 2.7 0.3 0.0 0.1 0.1 0.0 19.4 0.4 5.7 0.0 0.8 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.2 0.8 1.6 1.2 1.0 1.1 0.7 3.3 0.2 CD164 "DFNA66, MGC-24, MUC-24" ENSG00000135535 "CD164 molecule" Q04900 6 109366514-109382812 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Myogenesis" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010636 Uncertain "Intracellular and membrane" "HPA010636: AB_1078447" "unprognostic (1.23e-2)" "unprognostic (1.61e-2)" "unprognostic (3.89e-2)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-2)" "unprognostic (1.97e-3)" "unprognostic (1.80e-1)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (8.88e-2)" "unprognostic (1.38e-1)" "unprognostic (7.11e-2)" "unprognostic (1.29e-1)" "unprognostic (1.84e-1)" "unprognostic (3.01e-1)" "unprognostic (1.51e-1)" 85.0 37.6 17.1 37.2 28.5 38.0 72.9 11.2 19.2 34.2 55.2 31.1 57.4 50.5 35.6 44.4 29.6 31.7 58.1 32.0 18.6 22.6 67.4 66.1 52.5 60.9 45.2 16.7 38.0 49.2 30.4 55.0 106.6 28.2 33.4 57.4 44.1 75.1 49.6 38.5 30.6 100.2 41.5 42.8 43.2 55.8 38.1 30.2 50.7 73.3 25.0 34.7 40.3 37.2 32.6 54.2 66.1 48.9 61.1 46.7 83.2 20.2 11.3 6.0 38.1 87.1 84.2 36.9 38.1 48.1 34.3 49.4 22.7 30.9 16.4 36.9 41.2 20.0 22.6 24.4 53.0 33.5 22.6 27.8 12.1 27.3 51.7 32.8 66.4 65.9 48.4 33.9 31.0 31.7 26.5 43.7 47.3 21.2 30.9 40.9 9.0 18.5 20.4 17.8 20.6 50.5 27.3 6.4 13.0 23.2 31.1 55.5 27.2 43.5 32.0 22.4 16.4 32.1 30.1 16.6 23.3 18.9 40.3 38.5 23.0 66.1 47.6 39.9 44.7 48.9 46.4 32.6 36.5 40.9 47.1 28.8 38.3 40.7 32.7 61.1 45.5 54.2 46.7 83.2 17.1 28.5 11.2 19.2 18.6 22.6 45.2 16.7 28.2 30.2 CD164L2 ENSG00000174950 "CD164 molecule like 2" Q6UWJ8 1 27379176-27383380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.5;HaCaT: 3.5;HBEC3-KT: 3.9;hTCEpi: 5.3;SK-BR-3: 4.8;T-47d: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062915 Enhanced Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA062915: " "unprognostic (8.97e-3)" "unprognostic (2.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "prognostic favourable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (4.47e-2)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (4.07e-2)" "unprognostic (5.91e-6)" "unprognostic (1.33e-2)" "unprognostic (6.42e-2)" "unprognostic (1.34e-2)" "unprognostic (2.71e-2)" 0.1 0.1 0.2 0.1 0.5 0.0 2.3 0.1 0.4 3.2 0.4 0.7 1.2 0.0 0.4 12.6 13.4 26.8 0.1 0.1 0.4 0.4 0.4 0.3 7.4 0.1 0.1 0.6 3.3 0.3 0.4 5.8 0.1 1.1 2.4 0.2 1.0 12.9 0.3 0.1 8.1 0.1 0.1 0.1 0.1 0.2 1.0 0.4 0.1 0.9 5.9 6.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 3.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.3 0.0 0.6 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.7 0.1 0.0 0.0 0.1 1.0 0.0 0.9 0.0 0.0 4.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.4 0.4 0.4 0.1 0.6 1.1 0.4 CD180 "LY64, Ly78, RP105" ENSG00000134061 "CD180 molecule" Q99467 5 67179613-67196799 "CD markers, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.2;lymphoid tissue: 38.7" "Group enriched" "Detected in some" 10 "Daudi: 22.8;Karpas-707: 21.4;U-266/70: 17.4;U-266/84: 24.2;U-698: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 28.7;naive B-cell: 29.2" "Group enriched" "Detected in many" 23 "B-cells: 29.2;dendritic cells: 8.5;monocytes: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003740 Enhanced "HPA003740: AB_1078450" "unprognostic (9.33e-2)" "unprognostic (4.58e-2)" "unprognostic (2.81e-3)" "unprognostic (5.85e-3)" "unprognostic (2.25e-2)" "unprognostic (4.04e-3)" "unprognostic (1.09e-1)" "unprognostic (4.95e-2)" "unprognostic (5.83e-2)" "unprognostic (3.71e-1)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.09e-1)" "unprognostic (1.16e-1)" "unprognostic (3.70e-2)" "unprognostic (1.21e-1)" "unprognostic (2.18e-2)" 9.6 1.6 1.4 24.3 3.2 1.9 5.7 0.6 1.3 1.0 2.1 1.6 0.0 1.8 0.9 1.0 1.7 1.3 1.5 4.6 1.2 1.1 2.5 2.7 3.0 30.4 4.1 0.6 1.5 1.0 0.2 1.1 2.9 2.2 1.5 2.5 0.4 3.1 0.4 0.6 0.7 8.4 1.6 3.5 38.7 1.9 0.8 2.8 1.9 1.2 0.2 31.3 4.1 0.8 29.2 8.5 0.3 11.6 0.7 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.1 17.4 24.2 6.4 0.0 1.4 0.0 0.0 4.1 0.3 0.0 7.4 0.0 28.7 0.0 0.0 8.0 29.2 0.0 0.0 0.3 0.7 11.6 8.5 0.0 2.8 1.4 3.2 0.6 1.3 1.2 1.1 4.1 0.6 2.2 2.8 CD1A CD1 ENSG00000158477 "CD1a molecule" P06126 1 158254137-158258269 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 105.1" "Cell line enriched" "Detected in single" 106 "MOLT-4: 35.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "classical monocyte: 5.9;intermediate monocyte: 3.7;memory B-cell: 6.8;myeloid DC: 10.2;naive B-cell: 5.4" "Group enriched" "Detected in many" 35 "B-cells: 6.8;dendritic cells: 10.2;monocytes: 5.9" "CAB000009, HPA010734" Enhanced "CAB000009: AB_2073290, HPA010734: AB_1078452" "unprognostic (7.21e-5)" "prognostic favourable (6.37e-4)" "unprognostic (1.37e-5)" "unprognostic (2.55e-2)" "unprognostic (2.83e-1)" "unprognostic (1.16e-2)" "unprognostic (9.93e-4)" "unprognostic (1.49e-2)" "unprognostic (3.12e-1)" "unprognostic (3.86e-2)" "unprognostic (6.99e-2)" "unprognostic (5.12e-2)" "unprognostic (5.49e-5)" "unprognostic (5.58e-2)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (8.81e-2)" 0.1 0.0 0.1 0.9 0.1 0.0 1.0 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.2 0.1 8.0 0.0 0.6 0.1 0.1 0.0 0.2 0.1 1.8 1.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.2 0.1 0.9 0.1 0.1 20.9 0.3 0.1 0.1 1.4 0.3 0.2 0.1 105.1 0.1 1.0 2.7 0.4 1.1 6.8 10.2 0.0 5.9 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.9 0.0 0.0 3.7 0.2 6.8 0.0 0.0 10.2 5.4 0.1 0.0 0.0 0.0 0.2 0.2 0.0 1.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CD1B CD1 ENSG00000158485 "CD1b molecule" P29016 1 158327951-158331531 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 188.8" "Cell line enriched" "Detected in single" 1104 "MOLT-4: 110.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "myeloid DC: 16.3" "Lineage enriched" "Detected in many" 6 "dendritic cells: 16.3" HPA021824 Approved "HPA021824: AB_1846262" "unprognostic (7.72e-3)" "unprognostic (1.55e-4)" "unprognostic (1.66e-5)" "unprognostic (1.04e-2)" "unprognostic (1.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.89e-4)" "unprognostic (2.27e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (9.53e-2)" "unprognostic (3.23e-1)" "unprognostic (3.52e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-1)" "unprognostic (3.53e-2)" 0.8 0.1 0.2 1.9 0.2 0.0 0.6 0.2 0.2 0.8 0.6 0.3 0.2 0.0 0.3 0.2 0.9 0.7 1.3 0.2 0.2 0.0 0.6 0.3 1.7 4.0 0.2 0.2 0.3 0.3 0.0 0.2 0.2 0.2 0.2 5.6 0.2 0.6 0.2 0.2 6.2 0.8 0.3 0.2 1.9 0.9 0.2 0.2 188.8 0.4 0.4 2.4 0.5 0.8 0.0 16.3 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 CD1D ENSG00000158473 "CD1d molecule" P15813 1 158179947-158184896 "Cancer-related genes, CD markers, Predicted membrane proteins" "Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.5;lymphoid tissue: 17.8" "Cell line enhanced" "Detected in some" "HBEC3-KT: 9.1;HHSteC: 14.1;MOLT-4: 18.6;THP-1: 11.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 49.5;intermediate monocyte: 22.4;myeloid DC: 49.5" "Group enriched" "Detected in many" 8 "dendritic cells: 49.5;monocytes: 49.5" "Low region specificity" "Detected in all" "CAB016107, HPA072662" Enhanced Supported "Endoplasmic reticulum" 720000 "Endoplasmic reticulum" "CAB016107: AB_626960, HPA072662: " "unprognostic (8.67e-2)" "unprognostic (6.99e-2)" "unprognostic (2.48e-1)" "unprognostic (1.48e-2)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (3.85e-1)" "unprognostic (9.67e-3)" "unprognostic (2.37e-1)" "unprognostic (3.52e-1)" "unprognostic (2.23e-2)" "unprognostic (4.46e-2)" "prognostic unfavourable (2.12e-5)" "unprognostic (9.31e-3)" "unprognostic (2.35e-1)" "unprognostic (2.32e-2)" "unprognostic (3.38e-1)" 1.5 1.2 0.0 8.6 0.0 2.6 1.2 0.0 0.0 0.8 2.5 9.5 1.5 0.0 0.4 1.4 2.0 1.4 0.0 0.1 1.6 10.5 2.3 5.5 0.2 0.3 0.7 0.0 0.6 0.0 1.4 3.7 0.7 0.3 0.6 0.0 12.2 2.2 0.4 17.8 1.4 1.4 1.8 3.4 1.6 0.5 6.3 49.5 2.5 49.5 0.1 0.1 23.5 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.2 0.0 4.8 0.0 9.1 0.0 0.0 0.1 0.2 0.0 0.0 14.1 0.1 0.0 5.3 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 18.6 1.8 0.8 0.0 0.0 0.0 0.0 0.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 2.9 0.0 0.0 0.5 0.0 0.5 0.0 5.2 0.7 0.0 49.5 0.1 0.0 22.4 0.1 6.3 0.0 0.0 49.5 4.7 0.0 0.0 2.5 0.1 3.6 0.5 0.0 23.5 CD1E ENSG00000158488 "CD1e molecule" P15812 1 158353696-158357553 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 308.0" "Cell line enriched" "Detected in single" 1338 "MOLT-4: 167.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 13 "myeloid DC: 29.7" "Lineage enriched" "Detected in many" 13 "dendritic cells: 29.7" "Low region specificity" "Detected in all" HPA057769 Uncertain "Intracellular and membrane" "HPA057769: " "unprognostic (7.94e-3)" "unprognostic (1.85e-5)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.33e-1)" "unprognostic (1.54e-3)" "unprognostic (1.24e-1)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (8.55e-2)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (8.50e-2)" "unprognostic (2.45e-1)" 1.0 0.2 0.7 2.8 0.7 0.0 1.1 0.7 0.7 1.5 1.0 0.7 0.7 1.2 0.9 0.7 7.0 1.9 3.9 0.7 0.7 0.2 2.0 0.7 2.4 4.7 0.7 0.7 0.7 0.8 0.0 0.7 0.7 0.7 1.8 4.8 0.8 1.9 0.8 0.8 11.5 2.1 0.8 0.7 3.8 3.1 0.9 0.7 308.0 1.0 1.3 8.1 2.4 2.7 0.0 29.7 0.0 2.2 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 167.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.1 0.1 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.7 0.7 0.7 0.7 0.2 0.7 0.7 0.7 0.7 CD2 SRBC ENSG00000116824 "CD2 molecule" P06729 1 116754385-116769228 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 101.7;lymphoid tissue: 164.4" "Group enriched" "Detected in some" 25 "HDLM-2: 61.1;MOLT-4: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "gdT-cell: 44.4;MAIT T-cell: 42.5;memory CD4 T-cell: 65.3;memory CD8 T-cell: 74.2;naive CD4 T-cell: 34.2;naive CD8 T-cell: 52.4;NK-cell: 101.7;T-reg: 62.3" "Group enriched" "Detected in many" 9 "NK-cells: 101.7;T-cells: 74.2" "Region enhanced" "Detected in single" "basal ganglia: 0.3" "Low region specificity" "Detected in many" "CAB002430, HPA003883" Enhanced "CAB002430: AB_442057, HPA003883: AB_1846263" "prognostic favourable (4.36e-4)" "prognostic favourable (1.47e-4)" "unprognostic (3.34e-3)" "prognostic favourable (1.69e-5)" "unprognostic (1.52e-1)" "prognostic favourable (7.46e-5)" "unprognostic (9.32e-3)" "unprognostic (1.61e-2)" "prognostic favourable (3.97e-5)" "prognostic favourable (7.72e-4)" "unprognostic (4.18e-2)" "unprognostic (3.31e-1)" "prognostic unfavourable (4.82e-6)" "unprognostic (6.16e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-2)" "unprognostic (7.63e-3)" 3.0 1.1 0.6 14.5 0.5 2.4 1.7 0.5 0.6 2.9 6.0 0.6 0.6 4.8 1.7 2.1 3.8 3.1 4.8 1.4 0.6 0.6 3.3 2.5 8.1 33.0 1.2 0.6 1.9 1.6 0.0 1.0 1.0 1.0 2.9 4.7 2.3 4.1 1.3 1.0 1.2 18.8 0.9 1.8 28.8 6.5 1.1 0.8 164.4 3.5 3.4 30.8 7.7 2.7 0.3 9.3 1.4 0.5 101.7 74.2 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.1 0.0 0.1 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.5 0.1 44.4 0.3 42.5 0.3 65.3 74.2 9.3 0.2 34.2 52.4 1.4 101.7 0.2 2.0 62.3 45.9 0.6 0.5 0.5 0.6 0.6 0.6 1.2 0.6 1.0 0.8 CD200 "MOX1, MOX2, MRC, OX-2" ENSG00000091972 "CD200 molecule" P41217 3 112332347-112362812 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 63.5" "Cell line enhanced" "Detected in some" "AF22: 31.2;HHSteC: 11.5;NTERA-2: 19.5;REH: 16.7;SK-MEL-30: 11.5;WM-115: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "memory B-cell: 9.9;naive B-cell: 36.4" "Lineage enriched" "Detected in many" 25 "B-cells: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031149 Approved "HPA031149: AB_10600694" "unprognostic (1.84e-1)" "unprognostic (5.08e-2)" "unprognostic (1.79e-1)" "unprognostic (2.03e-3)" "unprognostic (4.97e-1)" "unprognostic (1.21e-2)" "unprognostic (9.29e-2)" "unprognostic (2.25e-2)" "unprognostic (3.06e-1)" "unprognostic (3.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "unprognostic (1.06e-2)" "unprognostic (2.80e-1)" "unprognostic (4.49e-2)" "unprognostic (1.22e-2)" 12.8 9.5 18.1 10.9 34.3 1.8 7.1 20.9 38.3 16.0 4.5 11.0 1.5 2.6 21.4 5.7 7.0 20.3 10.1 5.8 17.3 42.4 4.9 1.0 7.2 17.7 12.7 19.3 9.3 3.8 10.9 27.9 63.5 19.6 9.7 6.5 7.5 5.4 13.0 1.4 2.8 4.3 13.9 8.4 4.4 3.4 2.3 6.7 12.7 12.4 1.6 17.6 13.9 3.9 36.4 1.1 1.2 0.1 0.6 1.4 1.3 0.0 0.0 31.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 3.3 0.1 0.1 0.1 0.3 0.0 0.1 0.2 11.5 0.0 0.0 0.2 0.1 0.6 0.0 4.4 0.0 0.3 0.0 0.0 0.4 0.1 19.5 0.0 16.7 0.0 0.2 0.2 0.0 8.2 9.6 0.0 0.1 11.5 0.0 0.1 0.0 0.1 1.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 34.0 1.2 0.1 0.1 0.1 0.0 1.4 9.9 0.8 0.2 0.5 36.4 0.9 0.5 0.7 0.6 0.1 1.1 0.4 1.3 18.1 34.3 20.9 38.3 17.3 42.4 12.7 19.3 19.6 6.7 CD200R1 "CD200R, HCRTR2, MOX2R, OX2R" ENSG00000163606 "CD200 receptor 1" Q8TD46 3 112921209-112975122 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 46.7;lymphoid tissue: 21.2" "Cell line enriched" "Detected in some" 8 "HEL: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 46.7;eosinophil: 12.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 46.7" HPA068512 Supported "Plasma membrane" "Intracellular and membrane" 1500000 "Plasma membrane" "HPA068512: " "unprognostic (1.49e-2)" "unprognostic (1.06e-2)" "unprognostic (2.55e-1)" "unprognostic (1.97e-2)" "unprognostic (1.53e-1)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-3)" "unprognostic (8.30e-2)" "unprognostic (1.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.77e-1)" "unprognostic (7.84e-3)" "unprognostic (1.25e-1)" "unprognostic (5.12e-3)" 3.6 1.6 1.0 9.5 1.4 1.8 3.8 0.8 1.4 5.0 3.5 0.3 1.5 2.0 3.9 5.4 7.5 1.3 2.7 5.8 1.0 1.2 1.4 3.4 4.3 9.0 1.0 0.0 1.0 1.1 0.5 1.0 7.8 0.4 4.2 3.5 2.4 2.5 1.6 0.9 3.4 3.3 1.7 0.9 21.2 1.7 2.5 0.5 15.8 2.0 3.9 17.0 3.8 2.0 2.3 5.8 46.7 0.8 0.6 3.7 1.3 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.8 0.2 0.0 0.0 0.0 0.0 0.0 3.1 0.2 25.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 1.1 0.0 46.7 0.8 12.7 1.0 0.4 1.8 2.3 3.7 2.1 5.8 1.2 3.6 1.7 0.2 0.6 0.1 0.1 1.0 1.3 1.0 1.4 0.8 1.4 1.0 1.2 1.0 0.0 0.4 0.5 CD207 "CLEC4K, Langerin" ENSG00000116031 "CD207 molecule" Q9UJ71 2 70830214-70835822 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.5;skin 1: 42.3" "Cell line enriched" "Detected in some" 4 "AN3-CA: 13.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "myeloid DC: 4.0" "Lineage enriched" "Detected in single" 18 "dendritic cells: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002222, HPA011216" Enhanced Approved Cytosol Cytosol "CAB002222: AB_563850, HPA011216: AB_1078453" "unprognostic (1.45e-2)" "unprognostic (8.28e-3)" "unprognostic (9.34e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "unprognostic (2.23e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-3)" "unprognostic (1.05e-1)" "unprognostic (4.86e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-1)" "unprognostic (7.92e-4)" "unprognostic (2.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" 0.5 0.1 0.1 1.8 0.1 0.0 1.4 0.1 0.1 2.4 1.7 0.1 0.1 1.6 1.1 0.4 9.7 0.3 2.9 0.3 0.1 0.1 0.2 0.9 3.7 0.2 0.1 0.1 0.2 0.2 0.0 1.1 0.1 0.1 1.0 1.1 0.4 1.2 0.2 0.1 42.3 2.6 0.1 0.1 1.5 0.4 0.4 0.1 3.3 0.2 11.3 16.5 0.3 1.9 0.0 4.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 13.7 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.1 1.9 0.0 0.0 0.0 2.4 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 CD209 "CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1" ENSG00000090659 "CD209 molecule" Q9NNX6 19 7739994-7747564 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Endocytosis, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.9" "Cell line enriched" "Detected in single" 14 "THP-1: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 3.7;intermediate monocyte: 3.5;myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "CAB032436, CAB033831" Supported "Intracellular and membrane" 970000 "CAB032436: AB_639039, CAB033831: AB_1121347" "unprognostic (2.76e-1)" "unprognostic (1.15e-2)" "unprognostic (5.36e-3)" "unprognostic (1.25e-1)" "unprognostic (4.43e-2)" "unprognostic (1.40e-1)" "unprognostic (5.45e-2)" "unprognostic (3.83e-2)" "unprognostic (2.10e-2)" "unprognostic (1.24e-1)" "unprognostic (9.65e-2)" "unprognostic (1.39e-1)" "prognostic unfavourable (1.15e-5)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (6.17e-2)" "unprognostic (1.09e-1)" 20.3 4.5 0.5 4.1 1.8 0.0 6.8 4.5 0.9 2.0 5.6 0.7 0.3 7.2 1.1 7.3 2.4 3.3 4.4 7.8 0.4 0.7 2.2 5.0 3.7 47.9 1.1 0.5 1.8 3.8 0.4 1.0 12.1 1.8 3.6 7.4 3.2 3.0 0.7 3.5 1.6 10.1 5.2 0.9 1.4 2.6 2.1 0.3 2.3 2.1 2.1 1.3 6.8 1.6 0.3 3.4 0.9 3.7 0.3 0.2 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.2 0.6 0.0 0.1 0.0 0.2 8.6 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 3.7 0.2 0.2 3.5 0.1 0.2 0.1 0.1 3.4 0.3 0.1 0.2 0.9 0.3 0.1 0.3 0.1 1.0 0.5 1.8 4.5 0.9 0.4 0.7 1.1 0.5 1.8 0.3 CD22 "SIGLEC-2, SIGLEC2" ENSG00000012124 "CD22 molecule" P20273 19 35319261-35347355 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 39.3;lymphoid tissue: 77.8;ovary: 35.4" "Cell line enhanced" "Detected in some" "Daudi: 68.2;REH: 20.2;U-698: 54.2;WM-115: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 25 "memory B-cell: 29.8;naive B-cell: 39.3" "Lineage enriched" "Detected in many" 28 "B-cells: 39.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB002418, HPA024353" Enhanced "CAB002418: AB_563529, HPA024353: AB_10600695" "unprognostic (2.80e-3)" "unprognostic (3.99e-2)" "unprognostic (6.79e-3)" "unprognostic (9.17e-2)" "unprognostic (3.07e-1)" "unprognostic (6.45e-3)" "unprognostic (3.79e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (2.47e-1)" "unprognostic (1.75e-3)" "unprognostic (1.98e-2)" "unprognostic (1.48e-2)" "unprognostic (9.05e-2)" "unprognostic (3.04e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" 2.1 1.0 5.5 57.9 6.8 3.1 0.5 0.7 3.2 1.4 1.0 0.9 0.5 0.4 1.4 0.9 4.4 7.9 2.9 0.8 9.9 4.2 1.4 0.6 5.5 52.6 9.8 0.5 35.4 0.5 0.0 0.7 1.0 0.9 2.8 1.5 1.1 5.9 1.1 0.5 0.0 11.6 2.0 13.5 64.1 1.4 1.2 0.6 5.0 1.1 2.3 77.8 4.3 0.9 39.3 1.3 0.3 0.3 0.0 0.0 1.4 0.2 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 1.2 68.2 1.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.1 20.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 54.2 0.5 0.2 12.4 0.0 0.0 0.0 0.0 0.3 0.0 29.8 0.0 0.0 1.3 39.3 0.0 0.0 0.3 0.0 0.2 1.1 0.0 1.4 5.5 6.8 0.7 3.2 9.9 4.2 9.8 0.5 0.9 0.6 CD226 "DNAM-1, DNAM1, PTA1, TLiSA1" ENSG00000150637 "CD226 molecule" Q15762 18 69831158-69961803 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.9;parathyroid gland: 82.5" "Group enriched" "Detected in some" 6 "HEL: 44.3;HMC-1: 19.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 19.4;MAIT T-cell: 7.3;memory CD4 T-cell: 16.1;memory CD8 T-cell: 11.8;naive CD4 T-cell: 9.0;naive CD8 T-cell: 9.7;NK-cell: 14.0;T-reg: 5.5" "Group enriched" "Detected in many" 11 "NK-cells: 14.0;T-cells: 19.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015715, HPA050348" Supported Uncertain Midbody 27000000 Midbody "HPA015715: AB_1846278, HPA050348: " "unprognostic (1.42e-4)" "unprognostic (1.30e-3)" "unprognostic (9.01e-3)" "unprognostic (3.49e-5)" "unprognostic (4.15e-1)" "unprognostic (9.52e-4)" "unprognostic (3.68e-3)" "unprognostic (2.93e-2)" "unprognostic (3.43e-1)" "unprognostic (3.31e-3)" "unprognostic (8.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (2.27e-1)" "unprognostic (3.58e-2)" 1.2 0.6 1.0 7.5 2.0 1.7 0.8 0.7 0.9 1.5 2.9 0.3 0.1 1.1 1.0 1.4 0.8 0.8 1.4 0.9 1.9 1.3 1.3 3.1 5.2 14.0 1.7 0.0 1.0 0.6 82.5 2.4 0.6 1.3 0.9 1.2 2.4 5.4 0.6 1.1 0.4 6.0 1.3 4.2 31.9 1.4 1.8 0.5 6.4 1.8 2.6 10.1 2.0 1.6 0.4 1.5 0.9 0.6 14.0 19.4 6.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 2.3 0.0 44.3 0.1 0.0 0.0 0.3 19.7 0.0 0.5 0.1 0.3 0.0 0.1 4.5 0.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.1 5.4 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.5 19.4 0.4 7.3 0.4 16.1 11.8 1.5 0.1 9.0 9.7 0.9 14.0 0.6 0.1 5.5 6.6 1.0 2.0 0.7 0.9 1.9 1.3 1.7 0.0 1.3 0.5 CD247 "CD3H, CD3Q, CD3Z" ENSG00000198821 "CD247 molecule" P20963 1 167430640-167518610 "CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 62.8;lymphoid tissue: 129.5" "Group enriched" "Detected in some" 28 "HDLM-2: 47.8;MOLT-4: 50.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 26 "gdT-cell: 62.8;MAIT T-cell: 35.4;memory CD4 T-cell: 32.4;memory CD8 T-cell: 36.7;naive CD4 T-cell: 41.3;naive CD8 T-cell: 33.5;NK-cell: 33.4;T-reg: 39.0" "Group enriched" "Detected in many" 31 "NK-cells: 33.4;T-cells: 62.8" "Region enhanced" "Detected in single" "thalamus: 0.7" "Low region specificity" "Detected in all" "CAB004651, HPA008750" Enhanced "CAB004651: AB_425347, HPA008750: AB_1857863" "prognostic favourable (9.12e-4)" "unprognostic (3.21e-3)" "unprognostic (7.09e-3)" "prognostic favourable (8.63e-6)" "unprognostic (1.99e-2)" "prognostic favourable (3.98e-4)" "unprognostic (1.79e-2)" "unprognostic (1.11e-2)" "unprognostic (5.46e-3)" "unprognostic (9.73e-3)" "unprognostic (1.33e-2)" "unprognostic (2.50e-1)" "prognostic unfavourable (9.94e-6)" "unprognostic (1.60e-1)" "unprognostic (5.33e-2)" "unprognostic (4.02e-2)" "unprognostic (5.94e-3)" 2.3 0.5 0.9 13.5 2.1 17.8 1.3 1.2 1.1 1.4 4.4 0.7 0.7 2.9 1.5 1.6 1.4 1.2 2.9 1.0 0.8 1.4 1.9 3.2 7.3 24.3 1.0 0.5 1.0 0.5 0.0 0.6 1.3 0.7 2.0 1.8 1.7 3.3 0.4 1.4 0.6 9.8 0.8 0.9 28.6 2.7 0.9 0.5 129.5 1.8 0.9 18.1 3.5 1.4 1.5 0.4 1.4 0.2 33.4 62.8 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 47.8 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.1 0.0 62.8 0.2 35.4 1.5 32.4 36.7 0.2 0.5 41.3 33.5 1.4 33.4 0.1 0.4 39.0 31.4 0.9 2.1 1.2 1.1 0.8 1.4 1.0 0.5 0.7 0.5 CD248 "CD164L1, TEM1" ENSG00000174807 "CD248 molecule" Q9HCU0 11 66314487-66317044 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.0" "Cell line enhanced" "Detected in some" "ASC diff: 66.6;ASC TERT1: 65.7;BJ hTERT+: 43.3;fHDF/TERT166: 58.0;HSkMC: 70.0;U-2197: 104.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "naive CD8 T-cell: 17.8" "Lineage enriched" "Detected in single" 122 "T-cells: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051856 Enhanced Approved "Nucleoplasm,Plasma membrane" 27000000 "Plasma membrane" Nucleoplasm "HPA051856: " "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.95e-2)" "unprognostic (2.77e-2)" "unprognostic (1.14e-2)" "unprognostic (2.61e-1)" "unprognostic (7.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-2)" "unprognostic (6.31e-2)" "unprognostic (4.77e-2)" "prognostic unfavourable (2.69e-7)" "unprognostic (1.90e-2)" "unprognostic (2.92e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-2)" 59.2 3.5 0.8 14.4 2.5 0.0 55.2 0.6 2.2 21.2 7.6 1.9 6.3 2.7 14.1 22.9 14.8 17.7 12.3 18.2 1.2 0.5 5.3 1.7 9.3 16.2 1.3 1.6 15.6 4.9 1.4 2.3 71.0 2.1 10.6 2.7 11.5 4.6 8.0 6.7 13.3 7.5 27.6 1.2 1.9 7.5 8.0 0.7 4.1 9.4 6.6 4.5 19.5 17.6 0.1 0.0 0.0 0.0 0.0 17.8 1.9 0.0 0.0 0.6 0.0 66.6 65.7 0.0 28.8 43.3 2.1 2.0 0.0 0.0 0.0 0.7 58.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 13.2 0.0 0.0 70.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.1 1.2 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 104.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.3 0.0 0.1 2.8 17.8 0.0 0.0 0.0 0.0 0.0 1.9 0.8 2.5 0.6 2.2 1.2 0.5 1.3 1.6 2.1 0.7 CD27 "S152, TNFRSF7, Tp55" ENSG00000139193 "CD27 molecule" P26842 12 6444867-6451718 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 82.3;lymphoid tissue: 60.4" "Group enriched" "Detected in some" 141 "Daudi: 63.7;U-698: 35.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 82.3" "Group enriched" "Detected in many" 7 "B-cells: 41.8;T-cells: 82.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002420, HPA038936" Enhanced 28000 "CAB002420: AB_563539, HPA038936: " "unprognostic (2.75e-3)" "prognostic favourable (3.77e-5)" "unprognostic (8.87e-3)" "prognostic favourable (2.90e-4)" "unprognostic (2.35e-1)" "prognostic favourable (6.65e-7)" "unprognostic (3.56e-2)" "unprognostic (9.37e-2)" "prognostic favourable (5.50e-4)" "unprognostic (1.31e-3)" "unprognostic (4.32e-2)" "unprognostic (2.74e-1)" "prognostic unfavourable (1.19e-6)" "unprognostic (2.80e-1)" "unprognostic (3.15e-1)" "unprognostic (1.28e-1)" "unprognostic (7.35e-2)" 1.1 0.6 0.4 40.8 0.5 2.0 1.2 0.4 0.4 1.7 10.0 0.2 0.5 5.3 0.8 0.6 4.9 1.6 3.7 0.9 0.4 0.4 1.7 1.0 2.9 49.5 0.4 0.1 1.0 0.5 0.0 0.6 0.4 0.2 1.3 2.9 1.2 10.7 1.4 0.4 0.6 19.4 0.2 0.6 45.7 3.7 0.5 0.1 33.5 3.1 2.3 60.4 9.1 1.2 41.8 0.3 0.8 0.1 8.3 82.3 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 35.3 0.0 0.0 0.0 0.8 0.1 0.1 16.7 0.1 28.7 41.8 40.1 37.5 0.1 10.5 55.6 39.1 0.8 8.3 0.1 0.3 82.3 22.1 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.1 0.2 0.1 CD274 "B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1" ENSG00000120217 "CD274 molecule" Q9NZQ7 9 5450503-5470566 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 23.9;placenta: 56.0" "Cell line enhanced" "Detected in many" "HDLM-2: 33.4;HHSteC: 22.3;U-251 MG: 37.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.4" "Group enriched" "Detected in many" 6 "granulocytes: 8.4;T-cells: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB076385 Enhanced "CAB076385: AB_2687655" "prognostic favourable (8.89e-4)" "unprognostic (4.54e-2)" "prognostic favourable (1.64e-5)" "unprognostic (1.27e-2)" "unprognostic (2.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.61e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (5.67e-4)" "unprognostic (7.39e-3)" "unprognostic (1.69e-2)" "unprognostic (1.24e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-2)" "unprognostic (2.67e-1)" "unprognostic (9.02e-2)" 3.4 2.1 1.7 10.8 3.2 1.4 2.2 2.5 3.3 2.0 2.3 2.5 2.8 2.6 1.7 2.4 3.0 1.9 4.3 9.5 1.4 3.7 3.0 3.6 23.9 6.4 2.3 0.7 1.7 2.7 3.8 7.4 56.0 3.2 2.9 2.2 3.3 1.7 1.6 4.3 1.3 2.7 2.3 2.4 12.8 1.9 1.2 1.0 11.6 3.7 2.1 5.8 3.1 1.9 0.9 0.0 8.4 0.1 0.4 2.4 0.7 5.8 0.1 0.0 0.2 0.0 0.0 0.0 11.7 9.9 3.0 4.1 0.0 1.9 0.0 0.2 0.3 0.2 0.0 5.0 9.7 33.4 0.0 3.3 0.1 0.0 22.3 0.0 0.0 0.2 0.0 6.1 9.1 5.7 0.0 1.1 9.0 0.0 0.1 0.0 0.0 0.1 0.0 1.6 0.3 0.6 0.1 0.0 0.1 0.1 0.9 0.7 0.0 0.1 10.7 6.3 2.0 0.1 37.0 0.2 0.1 0.1 2.1 0.1 0.0 8.4 0.1 0.3 1.2 0.1 2.1 0.9 2.4 1.8 0.0 0.2 1.3 0.7 5.7 0.4 0.0 0.0 1.1 0.7 1.7 3.2 2.5 3.3 1.4 3.7 2.3 0.7 3.2 1.0 CD276 "B7-H3, B7H3, B7RP-2" ENSG00000103855 "CD276 molecule" Q5ZPR3 15 73683966-73714518 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009285, HPA017139, CAB017826" Enhanced Approved Vesicles 8900000 Vesicles "CAB017826: , HPA009285: AB_1078258, HPA017139: AB_1845246" "unprognostic (1.05e-1)" "unprognostic (4.74e-3)" "unprognostic (4.57e-3)" "unprognostic (9.62e-2)" "unprognostic (1.26e-2)" "unprognostic (5.50e-3)" "prognostic unfavourable (9.81e-4)" "unprognostic (2.57e-3)" "unprognostic (1.89e-1)" "unprognostic (3.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.29e-2)" "prognostic unfavourable (6.31e-5)" "unprognostic (1.17e-1)" "unprognostic (9.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.34e-3)" 32.3 16.6 5.8 9.2 3.9 0.6 17.1 3.6 5.3 19.4 8.3 5.1 4.2 8.8 17.2 17.9 6.3 8.1 14.3 12.3 5.6 3.6 7.2 22.9 9.3 6.7 4.6 3.8 16.8 14.3 3.5 5.3 27.7 7.9 16.5 4.2 20.5 12.8 7.8 7.1 12.6 7.0 13.8 4.4 7.4 8.4 9.9 3.9 1.2 7.8 8.3 4.7 12.4 13.6 0.4 0.5 4.0 0.6 0.8 0.2 0.0 9.7 12.1 8.3 18.1 15.2 9.2 25.3 11.4 9.4 7.5 6.8 21.2 20.4 0.1 18.6 10.8 41.6 8.8 10.1 1.2 7.4 20.1 0.7 12.6 10.2 4.6 0.1 12.1 7.3 4.9 6.8 4.4 9.8 3.1 0.2 1.7 15.0 0.1 0.5 20.1 8.8 0.1 12.2 1.6 6.5 13.5 5.7 13.8 10.5 5.2 20.5 8.7 5.3 11.4 16.6 14.9 54.4 11.5 0.2 0.2 0.2 27.5 0.8 11.4 0.9 0.3 0.5 0.1 0.6 0.2 0.2 0.1 0.2 0.2 0.4 0.2 0.1 4.0 0.8 0.3 0.5 0.1 0.0 5.8 3.9 3.6 5.2 5.6 3.6 4.6 3.8 7.9 3.9 CD28 ENSG00000178562 "CD28 molecule" P10747 2 203706475-203738912 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.7;lymphoid tissue: 48.6" "Group enriched" "Detected in some" 14 "Karpas-707: 72.1;RPMI-8226: 33.0;U-266/70: 59.3;U-266/84: 53.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 32.7" "Lineage enriched" "Detected in many" 6 "T-cells: 32.7" "Region enhanced" "Detected in single" "olfactory region: 1.3" "Low region specificity" "Detected in all" HPA070003 Enhanced "HPA070003: " "unprognostic (5.54e-2)" "unprognostic (2.16e-4)" "unprognostic (1.90e-3)" "unprognostic (2.49e-3)" "unprognostic (3.44e-2)" "unprognostic (6.07e-5)" "unprognostic (9.09e-2)" "unprognostic (4.66e-2)" "unprognostic (3.40e-1)" "unprognostic (1.15e-1)" "unprognostic (2.65e-1)" "unprognostic (1.68e-1)" "unprognostic (5.78e-5)" "unprognostic (4.77e-2)" "unprognostic (2.93e-2)" "unprognostic (7.79e-2)" "unprognostic (8.96e-2)" 5.1 0.6 0.4 14.2 0.5 1.9 3.3 0.3 0.4 1.1 1.6 0.4 0.2 0.6 1.1 2.3 1.5 2.1 3.0 4.5 0.4 0.5 1.7 1.5 3.8 23.3 0.5 0.2 1.4 0.6 0.0 0.6 11.0 0.2 1.2 1.3 1.2 3.1 0.8 0.7 1.0 7.2 0.9 0.8 9.0 1.6 0.9 0.0 48.6 1.5 0.8 29.9 4.5 1.4 0.1 0.0 5.1 0.2 0.0 32.7 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 72.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.3 53.0 0.5 0.0 0.0 0.0 0.5 0.2 0.3 3.0 0.1 18.2 0.1 19.4 9.5 0.0 0.1 17.0 6.5 5.1 0.0 0.1 0.0 32.7 4.7 0.4 0.5 0.3 0.4 0.4 0.5 0.5 0.2 0.2 0.0 CD300A "CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60" ENSG00000167851 "CD300a molecule" Q9UGN4 17 74466416-74484796 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 81.1;brain: 28.7;lymphoid tissue: 57.8" "Group enriched" "Detected in some" 5 "HMC-1: 41.3;NB-4: 16.8;RPMI-8226: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA011645 Approved "Intracellular and membrane" 2800000 "HPA011645: AB_1846988" "unprognostic (1.99e-1)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.01e-1)" "unprognostic (1.04e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.17e-2)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (1.91e-5)" "unprognostic (5.97e-2)" "unprognostic (5.45e-3)" "unprognostic (1.36e-1)" "unprognostic (5.72e-2)" 8.6 4.5 9.8 16.0 17.7 11.9 4.4 2.2 11.5 2.0 4.8 3.7 0.0 6.0 1.9 1.3 2.1 2.1 7.7 3.4 7.3 4.2 3.0 7.5 10.6 19.0 20.1 0.3 1.5 2.1 0.3 3.0 6.9 12.6 2.8 4.7 2.3 3.0 1.3 1.1 2.3 7.4 6.0 28.7 57.8 2.4 1.5 17.4 4.1 1.9 0.5 6.0 5.4 2.1 2.2 19.4 81.1 45.7 52.1 29.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 1.9 41.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.5 16.8 0.0 0.0 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.0 81.1 20.4 57.3 29.5 45.7 6.2 2.2 6.1 8.7 19.4 0.6 2.3 7.1 71.6 52.1 44.2 18.1 0.3 19.2 9.8 17.7 2.2 11.5 7.3 4.2 20.1 0.3 12.6 17.4 CD300C "CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR" ENSG00000167850 "CD300c molecule" Q08708 17 74541108-74546143 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 46.8" "Cell line enhanced" "Detected in some" "HEL: 5.2;HMC-1: 25.6;THP-1: 4.8;U-937: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4" "Group enriched" "Detected in many" 5 "dendritic cells: 32.5;monocytes: 46.8" "HPA014523, HPA060349" Approved Uncertain "Golgi apparatus,Vesicles,Mitochondria" "Golgi apparatus" "Vesicles, Mitochondria" "HPA014523: AB_1846293, HPA060349: " "unprognostic (1.55e-2)" "unprognostic (2.60e-1)" "unprognostic (9.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.21e-1)" "unprognostic (3.47e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.68e-2)" "unprognostic (7.51e-2)" "unprognostic (6.51e-2)" "unprognostic (1.50e-2)" "unprognostic (1.37e-3)" "unprognostic (6.27e-2)" "prognostic unfavourable (8.53e-5)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" 9.8 2.8 3.6 9.0 4.6 10.9 1.8 0.4 2.9 1.2 1.7 2.9 0.0 1.5 1.4 1.9 1.0 1.9 2.8 3.4 2.0 1.7 1.9 2.1 11.2 12.3 5.3 1.3 1.1 1.3 0.5 1.2 3.8 3.9 1.9 1.8 1.8 1.8 0.7 1.1 0.9 2.3 4.1 7.1 14.2 1.6 0.9 2.7 0.1 1.6 0.1 1.4 3.5 1.1 0.4 32.5 8.4 46.8 8.6 0.1 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 2.4 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 12.1 0.0 8.4 28.6 1.4 0.1 46.8 0.1 0.4 0.0 0.0 32.5 0.3 0.0 0.0 1.0 8.6 46.4 2.1 0.0 10.7 3.6 4.6 0.4 2.9 2.0 1.7 5.3 1.3 3.9 2.7 CD300E "CD300LE, CLM2, IREM2" ENSG00000186407 "CD300e molecule" Q496F6 17 74609887-74623738 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.5;bone marrow: 22.5;lymphoid tissue: 21.0" "Cell line enhanced" "Detected in some" "HeLa: 1.7;SCLC-21H: 1.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "classical monocyte: 22.7;intermediate monocyte: 36.5;non-classical monocyte: 36.3" "Lineage enriched" "Detected in many" 6 "monocytes: 36.5" "Low region specificity" "Detected in single" HPA015570 Uncertain "HPA015570: AB_1846294" "unprognostic (1.70e-1)" "unprognostic (6.82e-2)" "unprognostic (1.76e-1)" "unprognostic (2.63e-2)" "unprognostic (1.42e-2)" "unprognostic (2.12e-1)" "unprognostic (1.68e-2)" "unprognostic (7.80e-3)" "unprognostic (4.51e-1)" "unprognostic (1.53e-1)" "unprognostic (2.69e-2)" "unprognostic (5.15e-2)" "unprognostic (4.19e-7)" "unprognostic (1.90e-2)" "unprognostic (2.00e-4)" "unprognostic (7.38e-3)" "unprognostic (1.19e-1)" 8.5 0.7 0.5 21.0 0.6 22.5 0.7 1.2 1.0 0.5 1.2 0.3 0.0 0.0 0.7 3.0 0.9 1.5 1.9 2.0 0.5 0.5 2.5 1.1 14.3 9.4 0.5 0.2 1.0 0.8 0.0 0.5 1.7 0.7 0.6 0.2 1.1 0.6 1.6 1.6 0.6 0.7 5.3 0.9 14.3 0.8 0.7 0.3 0.2 1.2 0.8 0.8 1.8 0.6 0.0 5.9 0.5 36.5 0.0 0.0 11.6 0.2 0.0 1.1 0.1 0.0 0.1 0.2 0.2 0.2 0.0 0.1 1.1 0.0 0.5 0.2 0.3 0.2 0.0 0.1 0.0 0.1 0.1 0.0 1.7 0.8 0.0 0.9 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.9 0.2 0.8 0.5 0.4 0.2 0.0 0.2 0.1 0.6 1.5 0.5 0.3 0.0 0.1 0.6 0.0 0.0 0.5 0.7 0.7 0.2 0.9 0.0 0.1 0.0 0.6 0.5 0.0 22.7 0.1 0.0 36.5 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.5 0.0 36.3 0.1 0.0 11.6 0.5 0.6 1.2 1.0 0.5 0.5 0.5 0.2 0.7 0.3 CD300LD "CD300D, CMRF35A4" ENSG00000204345 "CD300 molecule like family member d" Q6UXZ3 17 74579365-74592283 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.5;bone marrow: 3.2" "Cell line enhanced" "Detected in some" "HMC-1: 4.4;RPMI-8226: 2.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "neutrophil: 8.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.5" HPA027756 Uncertain "HPA027756: AB_10601097" "unprognostic (8.03e-2)" "unprognostic (3.30e-1)" 0.3 0.2 0.1 2.2 0.1 3.2 0.2 0.2 0.3 0.4 0.2 0.0 0.2 0.0 0.2 0.4 0.3 0.3 0.1 0.1 0.1 0.2 0.9 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.1 0.0 0.1 1.6 0.9 0.1 0.1 1.4 0.2 1.7 0.1 0.6 0.4 0.1 0.5 0.7 8.5 0.7 0.8 1.3 0.2 0.4 0.3 0.5 1.0 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.4 0.5 0.3 0.5 0.5 0.3 0.5 0.0 0.5 0.2 0.2 1.5 0.7 0.0 1.1 4.4 0.6 0.4 0.3 0.5 0.0 0.5 1.7 0.2 1.4 0.2 0.6 0.5 0.6 0.4 0.6 2.7 0.5 0.8 0.5 0.5 0.7 0.4 0.0 0.6 0.1 0.5 0.6 0.5 1.1 0.0 0.8 0.3 0.6 0.2 0.3 0.3 0.8 0.4 0.4 0.4 0.7 0.2 0.3 0.3 0.2 0.7 0.5 0.5 0.4 8.5 0.8 0.4 0.5 1.3 0.2 CD300LF "CD300f, CLM1, IGSF13, IREM1, NKIR" ENSG00000186074 "CD300 molecule like family member f" Q8TDQ1 17 74694311-74712978 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 47.8;bone marrow: 18.2;lung: 24.1;lymphoid tissue: 29.1" "Group enriched" "Detected in some" 6 "THP-1: 15.6;U-937: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 47.8" "Group enriched" "Detected in many" 46 "dendritic cells: 13.5;granulocytes: 47.8;monocytes: 38.1" HPA013712 Supported "HPA013712: " "unprognostic (6.51e-2)" "unprognostic (1.49e-3)" "unprognostic (3.81e-2)" "unprognostic (4.00e-2)" "unprognostic (8.51e-2)" "unprognostic (6.74e-2)" "unprognostic (1.79e-1)" "unprognostic (3.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.77e-1)" "unprognostic (9.81e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-1)" "unprognostic (9.60e-2)" "unprognostic (4.14e-2)" "unprognostic (7.75e-2)" "unprognostic (4.79e-2)" 3.3 1.0 1.2 9.8 3.1 18.2 0.9 1.5 1.3 0.8 2.3 3.1 0.0 2.7 0.7 0.7 0.9 1.1 1.9 2.4 1.3 1.2 1.1 1.5 24.1 15.6 3.8 0.5 0.9 0.9 0.0 1.0 2.1 2.6 1.4 2.6 0.8 1.9 0.3 0.5 0.5 3.4 2.3 5.8 29.1 1.0 0.7 2.4 1.1 0.8 0.0 4.2 2.8 0.8 0.0 13.5 47.8 38.1 0.7 0.1 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 30.2 0.0 8.4 20.2 47.8 0.0 34.4 0.1 0.0 0.0 0.0 13.5 0.0 0.0 0.0 15.9 0.7 38.1 1.4 0.0 8.2 1.2 3.1 1.5 1.3 1.3 1.2 3.8 0.5 2.6 2.4 CD320 "8D6, 8D6A" ENSG00000167775 "CD320 molecule" Q9NPF0 19 8302127-8308356 "CD markers, Disease related genes, Predicted membrane proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 74.9;RPMI-8226: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014500, HPA073489" Approved Approved Cytosol 400000 Cytosol "HPA014500: AB_1846295, HPA073489: " "unprognostic (9.97e-2)" "unprognostic (2.62e-1)" "unprognostic (3.51e-1)" "unprognostic (2.54e-3)" "unprognostic (2.17e-1)" "unprognostic (2.39e-2)" "prognostic unfavourable (4.02e-4)" "unprognostic (4.19e-2)" "unprognostic (7.13e-2)" "unprognostic (1.31e-1)" "unprognostic (9.35e-3)" "unprognostic (1.25e-1)" "unprognostic (2.03e-1)" "unprognostic (1.07e-1)" "unprognostic (8.92e-2)" "unprognostic (3.14e-1)" "unprognostic (9.90e-2)" 23.1 20.1 13.1 13.4 14.9 6.3 39.0 12.6 19.1 12.0 23.2 9.7 10.5 16.6 15.8 58.1 11.4 14.9 28.9 20.7 13.2 18.7 15.2 16.3 15.1 18.0 18.0 8.5 14.0 27.6 7.6 11.9 38.0 19.9 19.7 14.2 18.6 16.5 12.8 14.0 6.4 17.4 11.9 11.9 32.8 21.3 23.7 9.3 14.3 22.4 9.3 8.6 12.1 19.6 10.3 25.0 0.8 0.6 18.0 51.3 15.0 12.7 13.0 2.9 37.3 9.4 4.9 6.8 6.6 9.0 13.4 10.3 13.9 7.7 11.5 21.0 4.9 8.2 0.0 10.6 2.6 16.1 39.9 5.5 11.2 19.8 6.3 10.5 13.9 4.7 2.5 7.8 6.5 13.1 16.8 39.6 5.2 12.0 11.1 74.9 20.4 54.5 13.7 3.9 68.0 10.0 0.3 27.0 11.7 13.8 5.9 16.8 0.4 4.7 7.3 15.4 11.4 23.0 21.0 37.7 23.6 12.5 11.0 38.6 16.7 0.0 0.6 0.0 51.3 0.6 29.2 10.3 34.0 27.4 1.1 9.9 23.1 26.0 0.8 18.0 0.4 25.0 21.7 15.0 13.1 14.9 12.6 19.1 13.2 18.7 18.0 8.5 19.9 9.3 CD33 "FLJ00391, p67, SIGLEC-3, SIGLEC3" ENSG00000105383 "CD33 molecule" P20138 19 51225064-51243860 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.3;lymphoid tissue: 45.4" "Cell line enhanced" "Detected in some" "HEL: 27.9;HL-60: 37.1;HMC-1: 27.8;NB-4: 17.7;RPMI-8226: 20.0;THP-1: 21.8;U-937: 27.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6" "Group enriched" "Detected in many" 9 "dendritic cells: 49.3;monocytes: 37.6" "CAB011442, HPA035832, HPA064807" Approved Supported "Nucleoplasm,Plasma membrane" 1400000 "Nucleoplasm, Plasma membrane" "CAB011442: , HPA035832: , HPA064807: " "unprognostic (1.18e-2)" "unprognostic (1.45e-2)" "unprognostic (2.80e-2)" "unprognostic (7.14e-2)" "unprognostic (3.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.59e-1)" "unprognostic (5.90e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (2.53e-1)" "unprognostic (6.28e-2)" "unprognostic (6.88e-4)" "unprognostic (7.79e-2)" "unprognostic (3.35e-2)" "unprognostic (6.49e-2)" "unprognostic (1.67e-1)" 10.2 4.3 3.6 8.4 6.0 23.0 6.5 0.8 3.5 2.6 2.7 4.4 0.3 2.5 2.3 5.2 1.7 3.9 5.3 7.5 3.1 2.5 4.1 6.4 11.6 45.4 6.4 1.8 1.9 1.9 0.5 1.7 5.4 5.2 2.6 3.4 2.6 2.9 2.1 1.2 2.5 4.0 5.6 9.9 31.6 2.8 1.5 5.8 2.5 1.7 0.2 2.7 4.7 2.3 0.1 49.3 4.6 37.6 3.3 0.2 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 27.9 0.1 0.0 0.0 37.1 27.8 0.0 0.0 0.0 0.0 0.0 5.1 7.0 0.0 0.0 0.0 17.7 0.0 8.5 0.0 1.4 20.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.8 0.2 4.8 0.4 0.6 0.0 0.1 2.4 0.0 3.2 27.4 0.1 3.3 37.6 2.3 0.0 27.3 0.1 0.0 0.0 0.1 49.3 0.1 0.0 0.0 4.6 3.3 12.6 1.4 0.2 14.7 3.6 6.0 0.8 3.5 3.1 2.5 6.4 1.8 5.2 5.8 CD34 ENSG00000174059 "CD34 molecule" P28906 1 207880972-207911402 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 31.8;MOLT-4: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000018, HPA036722, HPA036723" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" 69000000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB000018: AB_2063006, HPA036722: , HPA036723: " "unprognostic (3.82e-1)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.09e-1)" "unprognostic (1.24e-1)" "prognostic favourable (5.93e-5)" "unprognostic (1.25e-2)" "unprognostic (7.74e-2)" "unprognostic (7.65e-2)" "unprognostic (3.53e-1)" "unprognostic (1.37e-3)" "unprognostic (6.95e-2)" "prognostic unfavourable (8.47e-4)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (1.60e-1)" "unprognostic (1.01e-2)" 61.9 8.8 4.6 12.8 7.6 1.9 37.5 3.1 6.7 38.3 15.9 5.2 20.5 5.0 41.4 40.3 33.8 22.3 20.6 51.2 5.4 4.9 18.8 2.2 25.0 11.9 8.1 6.7 20.7 8.6 7.8 3.6 78.9 6.3 21.0 7.4 12.8 12.4 20.5 39.7 21.2 12.1 42.3 4.7 9.2 11.3 23.1 4.7 3.5 25.8 35.9 11.0 33.6 33.1 0.6 1.7 1.6 0.3 0.6 0.5 1.5 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 1.1 0.3 0.9 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 31.8 0.0 0.0 0.8 0.0 31.4 0.1 0.2 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 1.1 0.0 4.8 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.6 0.2 0.3 0.5 0.2 0.5 0.3 0.3 0.2 0.2 0.6 0.3 0.3 1.1 0.6 0.3 1.7 0.2 1.5 4.6 7.6 3.1 6.7 5.4 4.9 8.1 6.7 6.3 4.7 CD36 "FAT, GP3B, GP4, GPIV, SCARB3" ENSG00000135218 "CD36 molecule" P16671 7 80369575-80679277 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Transport" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 464.3;breast: 156.1" "Group enriched" "Detected in some" 5 "ASC diff: 80.8;HEL: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9" "Group enriched" "Detected in many" 45 "dendritic cells: 56.9;monocytes: 104.4" "Low region specificity" "Detected in many" "HPA002018, CAB025866, HPA071026" Enhanced Enhanced "Golgi apparatus" 92000000 "Golgi apparatus" "CAB025866: , HPA002018: AB_1078464, HPA071026: " "unprognostic (7.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.06e-3)" "unprognostic (6.52e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.63e-1)" "unprognostic (9.35e-2)" "unprognostic (2.64e-2)" "unprognostic (1.97e-1)" "unprognostic (1.23e-3)" "unprognostic (1.18e-1)" "unprognostic (1.84e-3)" "prognostic unfavourable (4.47e-4)" "unprognostic (7.05e-3)" "unprognostic (4.87e-2)" "unprognostic (2.73e-3)" 464.3 3.6 1.2 8.9 1.3 10.9 156.1 0.5 0.5 1.8 31.8 0.6 3.3 9.8 1.8 7.5 7.5 3.3 7.2 76.8 1.8 1.9 2.2 13.3 11.5 4.8 0.6 0.3 2.5 3.9 3.1 0.8 37.9 2.9 9.2 3.5 0.8 4.6 2.3 23.6 5.4 23.4 4.7 0.8 42.8 5.0 6.0 0.5 2.7 13.6 15.3 1.4 9.4 19.2 0.3 56.9 1.8 104.4 0.7 0.2 60.2 0.0 0.0 0.2 0.1 80.8 0.8 0.1 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.0 0.1 0.0 0.1 0.1 38.4 0.1 6.1 0.0 0.0 0.0 7.8 3.1 0.0 0.0 0.2 1.3 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.1 0.0 2.7 4.4 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.1 0.0 13.2 10.2 0.9 104.4 0.3 0.2 30.4 0.2 0.3 0.0 0.0 56.9 0.0 0.1 0.0 1.8 0.7 7.5 14.3 0.1 60.2 1.2 1.3 0.5 0.5 1.8 1.9 0.6 0.3 2.9 0.5 CD37 TSPAN26 ENSG00000104894 "CD37 molecule" P11049 19 49335171-49343335 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 163.4;lymphoid tissue: 109.6" "Cell line enhanced" "Detected in some" "Daudi: 65.7;HMC-1: 65.1;RPMI-8226: 23.4;THP-1: 23.4;U-937: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002492, HPA032120, HPA032121" Enhanced "CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163" "unprognostic (4.30e-3)" "unprognostic (2.39e-3)" "unprognostic (8.85e-2)" "prognostic favourable (4.51e-4)" "unprognostic (5.46e-2)" "unprognostic (4.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.23e-2)" "unprognostic (5.34e-2)" "unprognostic (2.23e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-1)" "unprognostic (2.45e-3)" "unprognostic (7.12e-2)" "unprognostic (3.35e-2)" "unprognostic (7.22e-2)" "unprognostic (7.71e-2)" 7.3 3.1 3.4 62.9 4.8 48.7 3.7 1.0 3.1 1.9 4.2 8.5 0.0 3.2 2.0 2.2 5.9 2.9 5.2 10.4 3.8 3.8 4.3 2.7 25.3 109.6 6.9 1.7 2.5 1.6 0.5 1.9 5.4 4.7 3.5 1.7 2.7 10.7 1.4 1.1 2.0 39.3 1.7 14.5 88.1 5.1 2.9 5.0 47.9 3.4 1.7 86.8 10.2 2.4 163.4 53.7 84.4 62.8 27.9 43.5 58.8 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.7 0.0 0.0 0.1 0.0 0.0 0.0 10.4 0.0 11.5 0.0 0.1 0.0 1.9 65.1 0.0 0.0 0.0 0.0 0.0 0.6 3.6 0.0 0.0 0.1 1.2 0.0 0.0 0.6 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 14.5 0.0 17.4 0.0 42.8 58.2 71.7 34.3 53.4 34.7 137.2 41.8 36.4 41.1 163.4 43.5 36.3 84.4 27.9 62.8 53.7 40.9 58.8 3.4 4.8 1.0 3.1 3.8 3.8 6.9 1.7 4.7 5.0 CD3D T3D ENSG00000167286 "CD3d molecule" P04234 11 118338954-118342744 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 108.7;lymphoid tissue: 181.4" "Cell line enriched" "Detected in some" 5 "MOLT-4: 152.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 53 "gdT-cell: 105.6;MAIT T-cell: 68.6;memory CD4 T-cell: 88.1;memory CD8 T-cell: 97.6;naive CD4 T-cell: 78.8;naive CD8 T-cell: 98.6;T-reg: 108.7" "Lineage enriched" "Detected in many" 63 "T-cells: 108.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" CAB013055 Enhanced "CAB013055: " "prognostic favourable (3.00e-4)" "prognostic favourable (8.46e-5)" "unprognostic (1.05e-2)" "prognostic favourable (1.73e-7)" "unprognostic (6.00e-2)" "prognostic favourable (1.70e-4)" "unprognostic (3.82e-1)" "unprognostic (2.40e-2)" "unprognostic (2.24e-3)" "unprognostic (1.01e-2)" "unprognostic (5.69e-2)" "unprognostic (2.55e-1)" "prognostic unfavourable (3.07e-5)" "unprognostic (9.00e-2)" "unprognostic (2.02e-1)" "unprognostic (3.66e-2)" "prognostic favourable (6.16e-4)" 2.6 0.8 0.5 17.4 0.7 4.8 1.7 0.5 0.7 1.3 4.1 0.7 0.8 4.1 1.2 1.6 3.2 1.9 2.9 1.0 0.7 0.4 2.6 1.9 6.1 40.8 0.9 0.5 1.0 1.2 0.0 0.7 0.8 0.7 2.2 4.3 1.1 9.0 0.8 0.7 1.3 19.3 1.0 1.5 28.6 4.4 0.8 0.5 181.4 2.7 2.8 32.6 5.7 2.4 0.5 0.3 1.7 0.3 0.2 108.7 64.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 152.7 28.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.2 105.6 0.2 68.6 0.5 88.1 97.6 0.3 0.2 78.8 98.6 1.7 0.2 0.3 0.3 108.7 64.9 0.5 0.7 0.5 0.7 0.7 0.4 0.9 0.5 0.7 0.5 CD3E ENSG00000198851 "CD3e molecule" P07766 11 118304545-118316175 "CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 294.2" "Cell line enriched" "Detected in some" 77 "MOLT-4: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 36 "gdT-cell: 59.5;MAIT T-cell: 50.2;memory CD4 T-cell: 50.7;memory CD8 T-cell: 55.7;naive CD4 T-cell: 61.3;naive CD8 T-cell: 62.0;NK-cell: 21.8;T-reg: 46.8" "Group enriched" "Detected in many" 29 "NK-cells: 21.8;T-cells: 62.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000010, HPA040957, HPA043955, CAB072863, CAB072864" Enhanced "CAB000010: AB_2631163, CAB072863: , CAB072864: , HPA040957: AB_2677222, HPA043955: AB_2678747" "prognostic favourable (1.72e-4)" "prognostic favourable (1.62e-4)" "unprognostic (1.51e-2)" "prognostic favourable (2.30e-6)" "unprognostic (4.31e-2)" "prognostic favourable (1.32e-4)" "unprognostic (3.60e-3)" "unprognostic (3.85e-2)" "prognostic favourable (1.18e-4)" "unprognostic (6.11e-3)" "unprognostic (1.59e-1)" "unprognostic (3.59e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (5.46e-2)" "unprognostic (9.28e-2)" "unprognostic (3.13e-2)" "unprognostic (1.12e-2)" 3.9 1.0 0.5 16.7 0.7 6.8 1.9 0.5 0.7 2.1 4.7 0.9 0.7 4.4 2.0 1.4 3.3 3.0 4.0 1.4 0.5 0.5 3.3 2.6 7.3 40.9 1.3 0.6 1.5 1.3 0.0 0.9 1.2 0.9 2.6 3.9 1.9 6.4 1.1 0.8 1.3 21.1 1.1 1.9 34.5 4.6 1.2 0.5 294.2 3.4 2.1 37.8 6.3 3.0 0.2 0.9 1.4 0.2 21.8 62.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 118.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.5 0.0 0.1 0.0 1.3 0.2 0.2 59.5 0.1 50.2 0.1 50.7 55.7 0.1 0.2 61.3 62.0 1.4 21.8 0.2 0.9 46.8 32.9 0.5 0.7 0.5 0.7 0.5 0.5 1.3 0.6 0.9 0.5 CD3G ENSG00000160654 "CD3g molecule" P09693 11 118344344-118355161 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 187.6" "Cell line enriched" "Detected in single" 78 "MOLT-4: 64.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 30 "gdT-cell: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2" "Lineage enriched" "Detected in many" 37 "T-cells: 46.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017520, HPA038494" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB017520: AB_831094, HPA038494: " "prognostic favourable (6.33e-4)" "prognostic favourable (2.61e-4)" "unprognostic (4.58e-3)" "unprognostic (3.12e-5)" "unprognostic (6.30e-2)" "prognostic favourable (3.00e-4)" "unprognostic (1.98e-2)" "unprognostic (1.54e-2)" "unprognostic (8.25e-3)" "unprognostic (1.08e-3)" "unprognostic (1.54e-2)" "unprognostic (2.19e-1)" "prognostic unfavourable (9.33e-5)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (4.13e-2)" "unprognostic (2.10e-3)" 1.1 0.6 0.4 7.1 0.4 0.5 0.8 0.3 0.3 0.7 2.3 0.4 0.4 2.0 0.9 0.6 1.5 1.1 1.9 0.6 0.4 0.4 1.2 0.9 2.4 17.2 0.5 0.2 0.7 0.7 0.0 0.5 0.4 0.3 1.0 1.6 0.9 2.9 0.3 5.9 0.6 8.1 0.2 0.8 11.5 2.4 0.5 0.2 187.6 1.4 1.7 19.2 2.5 1.1 0.1 0.2 1.2 0.2 0.2 46.7 14.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.2 64.9 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.6 0.2 0.2 43.5 0.1 25.6 0.1 36.1 37.1 0.1 0.1 37.6 46.7 1.2 0.2 0.1 0.2 34.2 14.1 0.4 0.4 0.3 0.3 0.4 0.4 0.5 0.2 0.3 0.2 CD4 ENSG00000010610 "CD4 molecule" P01730 12 6786858-6820808 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 111.5;parathyroid gland: 78.4" "Group enriched" "Detected in some" 6 "HEL: 33.5;HL-60: 13.5;NB-4: 19.3;THP-1: 38.1;U-937: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 17 "classical monocyte: 42.2;intermediate monocyte: 42.5;memory CD4 T-cell: 29.1;myeloid DC: 29.3;naive CD4 T-cell: 24.8;non-classical monocyte: 33.3;plasmacytoid DC: 46.7;T-reg: 26.4" "Group enriched" "Detected in many" 20 "dendritic cells: 46.7;monocytes: 42.5;T-cells: 29.1" "Region enriched" "Detected in single" 15 "basal ganglia: 41.4" "Low region specificity" "Detected in many" "CAB000011, HPA004252, HPA004472, CAB068180" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB000011: AB_442062, CAB068180: , HPA004252: AB_1078466, HPA004472: AB_1078465" "unprognostic (1.39e-2)" "unprognostic (1.12e-2)" "unprognostic (2.75e-2)" "prognostic favourable (2.16e-4)" "unprognostic (7.76e-2)" "unprognostic (4.82e-3)" "unprognostic (3.70e-2)" "unprognostic (2.74e-2)" "unprognostic (7.04e-2)" "unprognostic (2.40e-1)" "unprognostic (1.13e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (7.45e-4)" "unprognostic (1.06e-1)" "unprognostic (4.65e-3)" "unprognostic (9.08e-3)" "unprognostic (2.95e-1)" 13.8 5.4 6.1 16.0 5.8 4.4 5.6 1.2 4.3 4.5 5.1 8.6 1.8 3.6 3.5 8.3 3.0 5.5 7.3 5.4 4.9 4.4 6.1 32.2 24.0 30.8 6.3 3.1 3.0 3.1 78.4 3.4 10.9 6.2 4.1 6.5 5.7 5.4 3.9 1.9 3.5 9.5 5.2 10.2 49.1 3.9 2.8 5.7 111.5 3.9 4.1 18.6 8.6 3.2 0.1 46.7 1.9 42.5 0.3 29.1 33.6 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 33.5 0.0 0.2 3.7 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 19.3 0.3 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.1 42.2 0.3 0.3 42.5 1.1 0.0 29.1 0.1 29.3 0.1 24.8 0.1 1.9 0.3 33.3 46.7 26.4 33.6 6.1 5.8 1.2 4.3 4.9 4.4 6.3 3.1 6.2 5.7 CD40 "Bp50, p50, TNFRSF5" ENSG00000101017 "CD40 molecule" P25942 20 46118272-46129863 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Immunity Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.7;EFO-21: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 36.1;naive B-cell: 41.3" "Group enriched" "Detected in many" 6 "B-cells: 41.3;monocytes: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB002495, HPA031567, HPA031568, CAB072868" Enhanced "Secreted to blood" 16000 "CAB002495: AB_563562, CAB072868: , HPA031567: AB_2673936, HPA031568: AB_2673937" "unprognostic (6.41e-2)" "unprognostic (1.55e-2)" "unprognostic (7.08e-3)" "unprognostic (6.21e-2)" "unprognostic (4.23e-3)" "unprognostic (1.25e-1)" "unprognostic (7.64e-3)" "unprognostic (1.34e-1)" "unprognostic (4.15e-2)" "unprognostic (7.16e-2)" "unprognostic (2.48e-2)" "unprognostic (7.04e-2)" "prognostic unfavourable (4.48e-4)" "unprognostic (1.22e-1)" "unprognostic (4.95e-2)" "unprognostic (1.60e-2)" "unprognostic (2.28e-2)" 13.0 4.6 3.6 38.6 4.7 1.1 11.6 9.7 4.4 11.3 9.2 3.6 7.8 6.5 9.6 8.6 9.9 9.7 8.6 9.5 4.5 2.6 10.0 10.0 18.8 34.7 3.3 3.2 14.8 14.0 12.1 5.9 6.5 5.4 14.7 5.2 13.7 13.0 11.6 7.5 9.0 11.8 10.0 4.6 30.1 8.4 4.4 4.4 11.5 16.5 6.7 46.0 12.5 13.8 41.3 4.1 1.0 10.8 0.6 1.4 4.8 9.0 1.4 0.0 4.5 1.7 0.9 1.8 1.6 0.5 1.3 1.3 0.0 26.7 14.5 46.9 0.3 1.1 0.8 5.7 1.4 9.7 0.0 3.4 0.0 2.5 13.4 0.0 4.6 6.0 2.2 5.5 0.0 10.1 1.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.3 0.3 1.5 11.8 0.1 0.0 0.0 7.9 4.5 0.0 0.9 4.8 0.0 0.0 15.0 0.0 0.0 0.0 0.0 9.9 3.4 1.7 0.0 1.0 7.7 0.1 1.3 10.8 0.9 36.1 0.7 0.5 4.1 41.3 1.4 1.0 0.7 0.6 7.5 2.1 1.0 4.8 3.6 4.7 9.7 4.4 4.5 2.6 3.3 3.2 5.4 4.4 CD40LG "CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP" ENSG00000102245 "CD40 ligand" P29965 X 136648193-136660390 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Cytokine "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 29.2;intestine: 8.7;lymphoid tissue: 33.7" "Cell line enriched" "Detected in single" 72 "MOLT-4: 22.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 9.4;MAIT T-cell: 22.9;memory CD4 T-cell: 29.2;naive CD4 T-cell: 28.1" "Lineage enriched" "Detected in single" 58 "T-cells: 29.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045827 Enhanced "Secreted to blood" 433000 "HPA045827: AB_10959606" "unprognostic (1.94e-5)" "unprognostic (1.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.27e-3)" "unprognostic (4.71e-2)" "unprognostic (3.56e-5)" "unprognostic (3.66e-2)" "unprognostic (5.48e-3)" "unprognostic (2.77e-1)" "unprognostic (2.14e-4)" "unprognostic (1.87e-1)" "unprognostic (1.55e-1)" "unprognostic (6.70e-4)" "unprognostic (2.15e-1)" "unprognostic (5.19e-2)" "unprognostic (2.36e-3)" "unprognostic (2.92e-2)" 2.0 0.5 0.3 22.4 0.3 1.4 1.2 0.3 0.3 2.0 3.3 0.1 0.0 1.7 1.5 1.3 1.6 1.6 2.6 1.1 0.4 0.4 1.6 1.1 4.0 14.6 0.4 0.0 0.7 0.6 0.0 0.4 0.2 0.3 1.0 3.1 1.0 4.9 1.3 0.4 1.1 8.7 0.5 0.6 9.9 1.7 0.6 0.1 33.7 1.4 2.0 26.1 3.0 1.4 0.0 0.0 0.5 0.0 0.2 29.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 9.4 0.0 22.9 0.0 29.2 4.1 0.0 0.0 28.1 0.2 0.5 0.2 0.0 0.0 3.3 4.7 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.0 0.3 0.1 CD44 "CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1" ENSG00000026508 "CD44 molecule (Indian blood group)" P16070 11 35138870-35232402 "Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Blood group antigen, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000112, CAB000316, HPA005785" Enhanced Enhanced "Golgi apparatus,Plasma membrane" "Secreted - unknown location" 2400000000 "Plasma membrane" "Golgi apparatus" "CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467" "unprognostic (5.33e-2)" "unprognostic (1.85e-1)" "unprognostic (4.97e-2)" "unprognostic (9.90e-3)" "unprognostic (3.50e-3)" "unprognostic (1.46e-2)" "unprognostic (1.56e-2)" "unprognostic (8.12e-2)" "unprognostic (1.57e-1)" "unprognostic (4.18e-2)" "unprognostic (1.51e-3)" "unprognostic (4.63e-2)" "prognostic unfavourable (1.78e-8)" "unprognostic (6.41e-2)" "unprognostic (4.14e-2)" "unprognostic (3.93e-2)" "unprognostic (7.98e-2)" 45.5 9.0 10.5 42.5 21.7 53.0 35.6 4.7 13.4 43.2 19.5 26.3 8.3 10.6 80.5 20.3 66.5 18.6 48.0 11.7 14.9 9.3 12.4 9.1 43.4 48.4 31.5 6.1 12.8 83.9 0.8 3.8 19.4 40.7 30.1 24.5 30.2 148.2 22.4 15.9 107.7 18.9 44.5 100.5 30.9 19.9 7.2 20.3 17.9 20.6 53.9 53.7 55.0 54.2 22.7 41.0 19.1 65.2 54.6 53.1 59.9 41.5 37.6 0.3 0.1 22.7 62.8 0.1 81.5 63.8 45.4 25.3 2.5 13.1 0.0 10.9 115.5 71.7 0.8 88.6 62.4 8.9 0.4 1.5 18.5 0.0 22.4 21.1 97.8 28.3 70.0 61.1 49.6 15.9 0.3 13.6 43.5 0.2 1.9 13.9 0.8 11.1 0.1 7.7 0.6 66.5 12.0 0.1 0.1 15.4 0.4 36.9 2.2 1.2 45.6 56.6 10.2 69.4 83.7 23.6 25.4 0.2 85.9 11.9 82.2 19.1 65.2 6.0 26.2 45.7 37.0 22.7 39.8 34.9 41.0 16.2 34.5 28.7 16.4 54.6 59.3 14.2 53.1 59.9 10.5 21.7 4.7 13.4 14.9 9.3 31.5 6.1 40.7 20.3 CD46 "MCP, MGC26544, MIC10, TLX, TRA2.10" ENSG00000117335 "CD46 molecule" P15529 1 207752057-207795513 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 41.7;eosinophil: 63.7;neutrophil: 69.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 69.8" "CAB010401, HPA016903" Enhanced Uncertain "Plasma membrane" 1000000 "Plasma membrane" "CAB010401: AB_2291289, HPA016903: AB_1846309" "unprognostic (1.42e-2)" "prognostic unfavourable (8.54e-5)" "unprognostic (3.94e-2)" "unprognostic (2.14e-2)" "unprognostic (3.28e-2)" "unprognostic (6.30e-2)" "unprognostic (1.91e-2)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "unprognostic (2.74e-1)" "unprognostic (8.79e-2)" "unprognostic (2.50e-1)" "unprognostic (6.78e-3)" "prognostic favourable (2.38e-4)" "unprognostic (1.76e-1)" "unprognostic (8.23e-2)" "unprognostic (1.49e-2)" 38.0 78.0 13.0 22.9 20.5 18.5 57.0 12.9 17.8 27.5 35.4 25.3 64.3 32.9 39.7 32.6 43.2 30.4 25.2 20.6 16.1 15.5 50.8 57.8 43.6 25.0 21.4 13.2 27.6 47.9 86.6 32.7 119.6 29.1 47.0 28.5 26.7 68.4 60.5 18.8 18.4 39.8 25.0 21.8 26.9 33.9 16.5 20.7 20.3 25.3 21.8 30.3 37.2 27.0 7.7 8.1 69.8 14.1 7.5 13.5 14.9 26.2 14.8 13.9 6.4 44.0 43.5 21.2 19.7 28.7 13.0 17.7 14.6 69.9 4.0 20.1 19.6 35.6 10.4 27.0 19.9 20.2 14.8 8.7 16.3 26.1 28.0 19.0 30.4 37.4 40.3 19.6 15.5 36.4 18.3 17.5 20.0 12.3 9.0 16.7 15.9 14.8 6.1 22.1 24.7 53.3 52.0 14.1 9.6 24.9 56.1 32.3 44.1 16.3 31.2 14.0 12.5 29.4 22.4 23.6 28.5 12.1 20.5 12.5 13.1 41.7 13.5 63.7 9.2 14.0 12.5 7.7 11.7 10.1 8.1 6.0 13.5 11.2 69.8 7.5 14.1 4.2 10.1 14.9 13.0 20.5 12.9 17.8 16.1 15.5 21.4 13.2 29.1 20.7 CD48 "BCM1, BLAST, hCD48, mCD48, SLAMF2" ENSG00000117091 "CD48 molecule" P09326 1 160678746-160711851 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.3;lymphoid tissue: 86.3" "Cell line enhanced" "Detected in some" "Daudi: 38.0;HMC-1: 42.5;U-266/70: 90.0;U-266/84: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB002497, HPA055146" Enhanced Supported "Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" 2600000 "Plasma membrane" "Nucleoli fibrillar center, Cytosol" "CAB002497: AB_563586, HPA055146: " "prognostic favourable (3.91e-4)" "unprognostic (1.72e-3)" "prognostic favourable (4.17e-4)" "unprognostic (1.58e-3)" "unprognostic (2.36e-1)" "unprognostic (1.71e-3)" "unprognostic (2.09e-2)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-1)" "prognostic unfavourable (3.36e-4)" "unprognostic (3.21e-1)" "unprognostic (4.69e-2)" "unprognostic (9.38e-2)" "unprognostic (8.51e-2)" 5.5 1.4 1.0 44.6 0.9 23.1 2.8 0.6 0.7 3.2 5.0 0.5 1.1 3.2 1.9 2.5 7.3 2.1 4.8 1.8 1.0 1.0 3.6 3.1 15.4 86.3 1.6 0.3 2.3 1.5 0.0 1.3 2.2 0.8 2.8 5.7 2.4 13.9 1.5 1.3 1.2 21.2 1.7 3.8 66.6 5.0 1.3 0.2 50.8 2.9 3.6 58.0 8.6 2.6 34.6 53.6 35.8 74.1 24.9 57.9 81.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 4.5 42.5 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 13.2 6.5 0.0 0.0 0.8 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.0 60.1 15.4 0.0 11.4 0.0 28.2 52.2 35.8 42.4 74.1 57.9 34.6 48.3 48.8 53.6 27.9 49.7 52.5 13.4 24.9 73.5 9.4 36.4 81.3 1.0 0.9 0.6 0.7 1.0 1.0 1.6 0.3 0.8 0.2 CD5 "LEU1, T1" ENSG00000110448 "CD5 molecule" P06127 11 61102395-61127852 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.3;lymphoid tissue: 96.2" "Cell line enriched" "Detected in single" 99 "MOLT-4: 38.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 20 "gdT-cell: 12.9;MAIT T-cell: 9.3;memory CD4 T-cell: 31.2;memory CD8 T-cell: 20.6;naive CD4 T-cell: 25.9;naive CD8 T-cell: 19.5;T-reg: 36.3" "Lineage enriched" "Detected in many" 32 "T-cells: 36.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB015392, CAB020308, HPA043416, HPA060839" Enhanced "CAB015392: AB_2075324, CAB020308: , HPA043416: , HPA060839: " "prognostic favourable (4.05e-4)" "prognostic favourable (9.16e-5)" "unprognostic (2.33e-1)" "prognostic favourable (9.00e-5)" "unprognostic (1.02e-2)" "prognostic favourable (7.41e-6)" "unprognostic (2.45e-3)" "unprognostic (1.37e-2)" "prognostic favourable (3.93e-4)" "unprognostic (1.25e-2)" "unprognostic (5.00e-2)" "unprognostic (2.14e-1)" "prognostic unfavourable (8.94e-5)" "unprognostic (4.78e-2)" "unprognostic (1.02e-2)" "unprognostic (2.38e-1)" "unprognostic (1.06e-1)" 2.1 0.6 0.5 19.4 0.4 6.5 1.3 0.3 0.6 1.6 2.5 0.3 0.3 1.7 1.1 1.7 1.9 1.4 3.9 0.8 0.6 1.3 1.9 1.1 7.1 28.8 0.4 0.1 1.1 0.9 0.0 0.8 0.4 0.3 1.4 1.5 1.6 15.5 1.3 0.6 1.3 10.2 0.4 0.7 13.8 4.8 1.3 0.1 96.2 1.7 2.4 42.2 5.4 1.5 1.1 1.1 0.4 0.7 0.1 36.3 14.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 12.9 0.1 9.3 0.4 31.2 20.6 0.9 1.1 25.9 19.5 0.4 0.1 0.7 1.1 36.3 14.6 0.5 0.4 0.3 0.6 0.6 1.3 0.4 0.1 0.3 0.1 CD55 "CR, CROM, DAF, TC" ENSG00000196352 "CD55 molecule (Cromer blood group)" P08174 1 207321376-207386804 "Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 77.5;HMC-1: 103.6;PC-3: 61.7;U-2197: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 101.4" "Low lineage specificity" "Detected in all" "HPA002190, CAB010454, HPA024386" Enhanced "Secreted to blood" 32300000 310000000 "CAB010454: AB_2075970, HPA002190: AB_1078472, HPA024386: AB_1846319" "unprognostic (4.08e-2)" "unprognostic (3.22e-1)" "unprognostic (3.41e-1)" "unprognostic (1.63e-1)" "unprognostic (9.05e-2)" "unprognostic (1.08e-2)" "unprognostic (1.05e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-2)" "unprognostic (1.55e-2)" "unprognostic (1.86e-1)" "prognostic unfavourable (9.36e-4)" "unprognostic (3.41e-2)" "unprognostic (2.04e-1)" "unprognostic (9.70e-2)" "unprognostic (2.33e-2)" 21.8 63.2 5.8 27.2 20.2 31.9 17.9 4.6 10.5 34.0 14.8 13.8 7.8 12.8 16.3 11.9 36.1 10.4 18.0 32.0 7.5 10.1 9.6 16.7 114.6 41.1 16.7 4.7 31.3 9.1 8.1 12.8 107.0 11.9 9.7 12.4 8.2 82.3 12.8 108.8 37.5 26.0 23.5 11.4 30.4 17.7 10.2 18.8 4.2 13.2 31.4 19.1 39.3 19.1 18.6 18.3 101.4 31.6 19.0 16.9 20.3 4.7 6.5 0.0 2.1 8.3 8.9 33.9 9.0 15.8 5.2 5.6 20.4 6.8 9.2 7.5 5.3 2.7 10.4 2.0 4.8 4.2 3.8 11.9 77.5 3.3 27.0 7.2 103.6 4.2 24.4 6.4 28.1 26.8 12.8 4.4 2.9 5.1 0.7 5.0 6.6 61.7 1.0 6.4 7.2 8.6 4.5 2.6 0.0 48.7 9.9 7.8 8.4 6.1 11.7 2.6 5.0 62.8 3.4 3.7 4.3 6.2 7.1 2.9 11.9 39.3 26.9 35.9 5.5 26.3 8.2 16.9 7.4 5.8 18.3 18.6 16.9 16.4 101.4 19.0 31.6 9.8 5.0 20.3 5.8 20.2 4.6 10.5 7.5 10.1 16.7 4.7 11.9 18.8 CD59 "16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20" ENSG00000085063 "CD59 molecule (CD59 blood group)" P13987 11 33703010-33736491 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 285.5" "Cell line enhanced" "Detected in many" "TIME: 213.3;U-2197: 176.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB001448, HPA026494" Supported Uncertain "Golgi apparatus,Vesicles" "Intracellular and membrane" 98000000 "Golgi apparatus, Vesicles" "CAB001448: AB_563604, HPA026494: AB_1846321" "unprognostic (2.07e-2)" "prognostic unfavourable (3.81e-5)" "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (2.11e-2)" "prognostic unfavourable (3.10e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (4.47e-2)" "unprognostic (2.98e-1)" "prognostic unfavourable (2.92e-5)" "unprognostic (1.66e-2)" "prognostic favourable (1.39e-10)" "prognostic unfavourable (9.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (3.09e-1)" 96.7 41.0 36.7 26.3 44.3 23.8 76.0 25.9 32.7 44.8 36.9 24.0 57.9 16.5 45.4 132.8 68.4 53.2 67.6 90.5 35.6 38.4 100.0 61.0 86.4 39.8 39.7 25.8 39.3 52.3 60.6 48.0 285.5 68.7 47.4 37.7 51.4 114.8 62.6 70.6 43.4 25.0 52.4 32.9 26.2 54.7 28.1 23.1 16.1 85.9 57.7 40.0 51.2 63.4 13.5 20.5 42.8 4.8 17.7 60.4 11.1 16.5 15.5 4.6 13.5 107.8 84.5 2.7 94.2 105.1 23.6 27.7 7.2 49.8 1.2 16.8 101.4 18.7 8.5 93.9 33.2 26.3 12.9 1.7 54.9 10.8 29.4 9.9 5.7 39.2 23.8 20.0 96.4 144.0 11.6 38.3 148.6 15.1 4.6 4.1 2.5 80.9 1.7 14.4 13.3 71.3 28.3 3.2 4.3 32.8 15.2 17.3 11.6 1.0 213.3 54.3 13.0 176.7 32.6 17.0 33.2 1.6 46.7 0.0 94.3 30.5 4.8 42.8 11.3 1.6 14.4 13.5 24.0 12.7 20.5 10.6 15.7 9.3 28.4 17.7 0.9 10.5 60.4 11.1 36.7 44.3 25.9 32.7 35.6 38.4 39.7 25.8 68.7 23.1 CD6 Tp120 ENSG00000013725 "CD6 molecule" P30203 11 60971680-61020377 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.0;lymphoid tissue: 58.1" "Cell line enriched" "Detected in some" 18 "MOLT-4: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 34 "gdT-cell: 12.4;MAIT T-cell: 11.1;memory CD4 T-cell: 23.0;memory CD8 T-cell: 21.4;naive CD4 T-cell: 15.5;naive CD8 T-cell: 11.1;T-reg: 10.1" "Lineage enriched" "Detected in single" 52 "T-cells: 23.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002489, CAB016252" Enhanced "Secreted to blood" 5270000 110000 "CAB002489: AB_563605, CAB016252: AB_631163" "prognostic favourable (1.95e-4)" "prognostic favourable (1.57e-5)" "unprognostic (4.47e-2)" "prognostic favourable (2.41e-4)" "unprognostic (2.06e-2)" "prognostic favourable (5.10e-6)" "unprognostic (8.45e-3)" "unprognostic (8.21e-3)" "unprognostic (2.87e-3)" "unprognostic (5.32e-3)" "unprognostic (2.07e-1)" "unprognostic (5.35e-1)" "prognostic unfavourable (1.82e-4)" "unprognostic (1.77e-1)" "unprognostic (4.95e-2)" "unprognostic (6.19e-2)" "unprognostic (5.96e-2)" 1.5 0.5 0.8 26.4 0.4 5.5 0.9 0.5 1.4 1.3 3.3 0.6 0.8 2.2 1.4 1.5 1.9 1.3 5.0 1.3 0.7 1.8 1.6 1.1 6.9 25.6 1.7 0.5 0.7 0.8 0.0 0.6 0.6 0.4 1.2 1.6 1.2 7.0 0.3 0.3 0.9 13.0 0.7 0.9 18.4 3.4 0.9 0.1 58.1 1.6 1.9 42.0 3.7 1.3 0.4 0.1 0.3 0.0 0.0 23.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.6 0.0 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.4 0.0 11.1 0.4 23.0 21.4 0.1 0.4 15.5 11.1 0.3 0.0 0.0 0.0 10.1 5.1 0.8 0.4 0.5 1.4 0.7 1.8 1.7 0.5 0.4 0.1 CD63 "ME491, MLA1, TSPAN30" ENSG00000135404 "CD63 molecule" P08962 12 55725323-55729707 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 272.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010088, CAB026356" Supported Supported Vesicles "Intracellular and membrane" Vesicles "CAB026356: AB_629864, HPA010088: AB_1846323" "unprognostic (8.76e-3)" "unprognostic (8.81e-2)" "unprognostic (1.27e-1)" "unprognostic (1.28e-3)" "unprognostic (9.48e-2)" "unprognostic (3.66e-3)" "prognostic unfavourable (1.37e-4)" "unprognostic (1.11e-1)" "unprognostic (6.50e-2)" "unprognostic (1.08e-1)" "unprognostic (1.66e-2)" "unprognostic (3.10e-1)" "unprognostic (2.70e-2)" "unprognostic (4.82e-2)" "unprognostic (5.21e-2)" "unprognostic (1.85e-3)" "unprognostic (9.02e-2)" 115.3 88.2 42.5 44.9 37.2 67.4 106.3 13.7 33.1 80.6 84.7 34.4 71.5 39.9 99.7 177.9 70.9 60.4 102.7 154.4 36.9 39.0 106.6 92.5 109.6 113.8 49.8 27.2 93.8 187.1 33.3 49.3 176.9 50.8 82.9 81.8 102.1 105.0 83.7 92.7 38.5 72.4 88.2 43.6 107.7 74.8 52.1 30.5 17.6 108.1 50.7 47.4 96.3 82.2 9.6 40.3 147.4 50.8 58.4 29.8 56.6 21.9 38.3 21.0 20.4 272.1 170.6 27.7 89.3 163.9 52.9 57.7 42.7 44.3 6.3 28.5 133.0 20.4 15.2 37.0 68.1 17.8 14.3 34.5 29.9 23.5 108.3 15.3 82.2 125.6 36.8 58.8 53.9 58.3 19.4 44.2 168.3 35.1 3.1 20.8 19.1 44.5 6.9 46.1 15.8 89.5 74.8 8.2 21.0 24.5 18.5 160.6 26.1 51.2 43.3 34.2 25.0 47.2 29.9 18.1 11.2 4.4 98.1 9.9 62.5 89.6 50.8 147.4 29.8 38.5 21.8 9.6 11.9 23.7 40.3 6.5 5.3 18.1 55.7 58.4 26.1 27.0 10.0 56.6 42.5 37.2 13.7 33.1 36.9 39.0 49.8 27.2 50.8 30.5 CD68 "DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1" ENSG00000129226 "CD68 molecule" P34810 17 7579467-7582113 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 179.1;lymphoid tissue: 139.1" "Cell line enhanced" "Detected in many" "ASC diff: 73.3;U-87 MG: 115.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 155.1;intermediate monocyte: 179.1;non-classical monocyte: 170.1" "Group enriched" "Detected in many" 11 "dendritic cells: 68.4;monocytes: 179.1" "Low region specificity" "Detected in all" "CAB000051, CAB000066, HPA048982, CAB072861, CAB072862" Enhanced Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: , CAB072862: , HPA048982: " "unprognostic (2.16e-2)" "unprognostic (1.47e-2)" "unprognostic (6.46e-2)" "unprognostic (1.49e-3)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (4.75e-4)" "unprognostic (2.83e-2)" "unprognostic (1.31e-1)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (2.59e-1)" "prognostic unfavourable (1.14e-5)" "unprognostic (1.58e-1)" "unprognostic (8.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.65e-2)" 118.4 28.5 12.5 46.8 21.6 46.8 40.9 2.9 11.2 27.1 38.1 15.5 2.1 57.0 9.6 24.1 26.9 17.3 33.7 39.0 10.1 6.9 20.9 43.1 84.4 102.5 21.1 4.4 15.8 7.5 2.1 8.5 34.7 15.7 12.1 18.5 12.8 22.2 4.4 16.1 9.4 58.3 15.6 26.0 139.1 17.6 9.4 16.3 13.3 8.8 12.3 21.1 31.4 19.1 3.7 68.4 11.0 179.1 0.9 0.5 125.6 35.1 7.1 0.4 0.5 73.3 28.0 0.3 11.2 30.7 14.9 17.4 1.5 10.6 0.4 12.8 32.6 1.5 0.1 7.1 10.1 0.3 1.3 5.6 1.7 8.5 6.2 2.7 31.7 8.8 1.4 31.2 23.0 3.9 2.2 3.6 14.4 0.2 0.2 2.4 0.4 5.2 0.4 0.6 20.7 3.0 1.5 0.2 0.4 9.3 4.7 10.9 0.2 21.6 12.2 19.0 1.1 19.0 14.6 0.2 0.2 0.2 115.5 6.9 9.6 10.1 155.1 0.9 0.4 179.1 0.5 3.7 0.2 0.3 40.9 2.0 0.3 0.2 11.0 0.9 170.1 68.4 0.3 125.6 12.5 21.6 2.9 11.2 10.1 6.9 21.1 4.4 15.7 16.3 CD69 CLEC2C ENSG00000110848 "CD69 molecule" Q07108 12 9752486-9760901 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.1;lymphoid tissue: 56.4" "Cell line enhanced" "Detected in some" "HL-60: 12.4;K-562: 24.0;MOLT-4: 8.6;U-266/70: 9.8;U-698: 11.1;U-937: 41.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "NK-cells: 14.8;T-cells: 18.3" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002503, HPA050525" Enhanced "CAB002503: AB_563625, HPA050525: " "prognostic favourable (3.31e-5)" "unprognostic (1.84e-2)" "unprognostic (1.80e-2)" "unprognostic (1.73e-2)" "unprognostic (1.66e-1)" "unprognostic (7.10e-3)" "unprognostic (4.76e-3)" "unprognostic (9.53e-3)" "unprognostic (9.73e-3)" "unprognostic (1.64e-2)" "unprognostic (1.96e-2)" "unprognostic (1.75e-1)" "prognostic unfavourable (7.87e-5)" "unprognostic (2.88e-2)" "unprognostic (3.32e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" 10.1 2.2 1.3 19.9 1.4 52.1 7.0 0.5 0.9 9.0 9.6 4.6 0.8 2.8 5.1 5.1 10.6 6.4 13.6 3.1 2.0 2.2 4.7 6.2 27.0 31.6 4.5 0.6 3.4 1.4 0.9 3.4 1.9 3.5 7.4 8.0 3.3 6.0 2.0 1.5 3.3 14.3 5.0 8.3 43.3 4.3 4.5 1.6 56.4 5.5 6.1 26.7 27.4 5.9 3.9 0.0 3.1 0.1 14.8 18.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.6 12.4 0.5 0.0 0.0 0.0 0.0 0.2 24.0 0.0 0.0 0.0 8.6 2.5 0.0 0.0 0.0 0.0 0.0 0.3 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 1.1 11.1 0.0 41.1 0.0 0.7 0.1 3.1 13.7 0.0 18.3 3.3 8.7 9.9 0.0 3.9 12.6 9.2 0.2 14.8 0.0 0.0 4.3 3.8 1.3 1.4 0.5 0.9 2.0 2.2 4.5 0.6 3.5 1.6 CD7 "GP40, LEU-9, Tp40, TP41" ENSG00000173762 "CD7 molecule" P09564 17 82314868-82317602 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 54.1;lymphoid tissue: 127.6" "Group enriched" "Detected in some" 6 "Hep G2: 21.1;MOLT-4: 48.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 54.1" "Group enriched" "Detected in many" 21 "NK-cells: 54.1;T-cells: 19.0" "CAB002594, HPA039079" Enhanced "CAB002594: , HPA039079: " "unprognostic (3.14e-3)" "prognostic favourable (5.51e-4)" "unprognostic (1.89e-2)" "prognostic favourable (2.03e-5)" "unprognostic (7.69e-3)" "unprognostic (1.09e-3)" "unprognostic (3.28e-2)" "unprognostic (1.34e-1)" "prognostic favourable (2.69e-4)" "unprognostic (3.16e-2)" "unprognostic (1.03e-1)" "unprognostic (2.24e-1)" "prognostic unfavourable (7.75e-11)" "unprognostic (4.69e-2)" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (1.55e-3)" 4.7 0.7 0.5 23.4 0.4 14.5 1.7 0.4 0.3 1.9 8.0 0.3 0.5 7.7 1.8 1.9 3.4 2.4 3.5 1.4 0.5 0.6 2.8 4.1 9.5 50.2 0.9 0.0 1.6 1.0 0.0 1.0 4.0 0.4 2.7 1.0 1.8 6.0 1.1 0.5 1.0 17.5 0.5 1.6 33.0 4.6 0.9 0.1 127.6 2.2 1.0 33.3 4.6 2.2 0.1 1.7 0.6 0.1 54.1 19.0 7.1 0.0 0.0 0.0 0.0 0.0 0.1 5.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 21.1 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.1 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 17.6 0.0 15.1 0.1 7.9 12.8 0.0 0.0 19.0 18.9 0.6 54.1 0.1 1.7 6.8 7.1 0.5 0.4 0.4 0.3 0.5 0.6 0.9 0.0 0.4 0.1 CD70 "CD27L, CD27LG, TNFSF7" ENSG00000125726 "CD70 molecule" P32970 19 6583183-6604103 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Cytokine "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.3;lymphoid tissue: 12.7" "Cell line enhanced" "Detected in many" "SiHa: 36.0;THP-1: 29.6;U-251 MG: 43.8;U-266/70: 78.0;U-266/84: 56.4" "Cancer enhanced" "Detected in many" "renal cancer: 24.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 13.9;T-reg: 23.3" "Group enriched" "Detected in many" 38 "B-cells: 13.9;T-cells: 23.3" HPA046582 Uncertain Nucleoplasm Nucleoplasm "HPA046582: " "unprognostic (8.71e-2)" "unprognostic (9.91e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-4)" "unprognostic (1.73e-2)" "unprognostic (1.51e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (6.29e-4)" "unprognostic (1.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavourable (3.22e-4)" "unprognostic (2.57e-2)" "unprognostic (1.40e-1)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" 5.3 0.2 0.2 9.3 0.2 1.4 2.2 0.9 0.9 1.4 4.1 0.2 0.1 1.0 0.4 1.8 4.0 0.7 0.8 0.4 0.2 0.2 1.7 0.4 1.9 6.1 0.4 0.1 0.3 0.4 0.0 0.3 0.3 0.2 0.9 3.1 0.2 3.1 1.2 1.2 3.3 5.2 0.7 0.5 11.8 1.7 1.9 0.1 3.2 0.8 1.8 12.7 3.1 1.1 13.9 0.1 0.2 0.0 0.4 23.3 0.9 0.2 7.4 0.0 14.5 0.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 13.9 0.8 0.0 10.1 8.9 0.7 0.0 0.0 0.3 0.0 11.0 0.0 0.0 0.0 0.4 0.1 0.0 8.5 6.1 0.0 0.2 0.4 0.2 0.0 0.2 17.5 0.1 13.4 3.7 0.0 3.0 4.7 0.0 0.0 0.0 36.0 0.0 0.1 0.1 29.6 0.2 0.1 6.5 0.0 43.8 78.0 56.4 25.1 8.0 4.4 2.8 0.2 0.0 0.0 1.9 0.0 4.8 13.9 3.2 5.0 0.0 4.0 0.4 1.3 0.1 0.4 0.0 0.1 23.3 0.9 0.2 0.2 0.9 0.9 0.2 0.2 0.4 0.1 0.2 0.1 CD72 "CD72b, LYB2" ENSG00000137101 "CD72 molecule" P21854 9 35609533-35646810 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "blood: 75.5;lymphoid tissue: 59.7" "Cell line enhanced" "Detected in some" "Daudi: 12.4;Karpas-707: 8.0;REH: 5.2;U-698: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 16 "memory B-cell: 34.3;naive B-cell: 75.5" "Lineage enriched" "Detected in many" 22 "B-cells: 75.5" "Region enriched" "Detected in single" 7 "basal ganglia: 3.6" "Low region specificity" "Detected in all" "CAB002505, HPA044658" Enhanced Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "CAB002505: AB_563629, HPA044658: " "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.21e-2)" "unprognostic (8.82e-2)" "unprognostic (1.87e-2)" "unprognostic (7.81e-2)" "unprognostic (7.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.29e-2)" "unprognostic (2.02e-2)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "prognostic unfavourable (2.49e-8)" "unprognostic (1.42e-1)" "unprognostic (2.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.59e-2)" 1.9 1.2 0.8 16.6 1.1 2.6 1.3 0.6 0.6 0.7 0.9 0.2 0.5 0.3 0.8 2.1 0.8 0.7 1.6 0.6 0.8 0.7 1.5 2.3 2.2 26.8 0.8 0.1 0.5 1.4 0.5 1.6 1.5 1.1 0.9 0.3 1.1 3.4 0.1 0.5 0.8 5.2 0.6 1.8 59.7 0.8 0.8 0.2 1.5 1.4 0.3 22.2 4.9 0.6 75.5 3.4 0.2 0.6 1.7 0.7 2.5 0.1 0.0 0.4 0.2 0.7 3.8 0.1 0.2 0.1 0.3 0.5 0.0 0.1 12.4 0.0 0.2 0.0 0.0 0.1 0.4 1.2 0.3 0.4 0.0 0.0 0.4 0.2 2.8 1.1 0.0 0.2 0.3 0.0 0.0 8.0 0.7 0.0 0.2 1.6 0.1 0.1 5.2 0.0 3.8 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.1 0.1 0.0 0.1 0.2 27.7 0.5 0.4 0.0 0.0 0.3 0.0 0.5 0.6 0.7 34.3 0.2 0.3 3.4 75.5 0.1 0.4 0.2 1.7 0.0 1.8 0.3 2.5 0.8 1.1 0.6 0.6 0.8 0.7 0.8 0.1 1.1 0.2 CD74 DHLAG ENSG00000019582 "CD74 molecule" P04233 5 150401637-150412929 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 504.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 115.7;Daudi: 178.0;HDLM-2: 255.6;REH: 154.1;RPMI-8226: 104.9;U-266/70: 85.9;U-698: 98.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 191.6;intermediate monocyte: 303.5;memory B-cell: 467.7;myeloid DC: 437.9;naive B-cell: 504.7;non-classical monocyte: 140.0;plasmacytoid DC: 303.2" "Group enriched" "Detected in all" 5 "B-cells: 504.7;dendritic cells: 437.9;monocytes: 303.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002506, HPA010592" Enhanced Supported "Golgi apparatus" 90000 "Golgi apparatus" "CAB002506: AB_563630, HPA010592: AB_1078482" "prognostic favourable (1.06e-4)" "unprognostic (1.48e-2)" "unprognostic (4.80e-3)" "prognostic favourable (6.53e-6)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (2.05e-1)" "unprognostic (3.69e-3)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (2.20e-2)" "unprognostic (2.64e-1)" "unprognostic (5.44e-3)" "unprognostic (1.73e-1)" "unprognostic (4.95e-2)" "unprognostic (2.05e-1)" "unprognostic (4.24e-2)" 137.8 95.7 53.2 177.0 81.4 40.7 104.2 8.4 43.5 89.6 68.2 79.0 30.0 98.3 60.0 73.9 43.6 68.1 81.3 104.1 46.9 43.5 168.3 60.1 222.5 310.1 78.3 23.1 53.4 34.1 15.1 51.0 27.9 79.8 72.6 63.6 72.9 123.0 55.4 40.5 56.6 182.8 55.1 123.1 372.1 77.3 23.7 68.1 201.1 83.4 45.6 288.2 91.7 47.0 504.7 437.9 76.1 303.5 42.2 41.2 238.1 1.9 0.0 0.0 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.0 23.1 115.7 178.0 7.2 0.0 0.5 0.0 0.0 0.0 255.6 0.0 5.8 0.1 14.1 0.3 0.4 0.3 1.4 0.0 0.0 0.0 0.0 0.4 70.9 0.0 0.0 0.2 0.8 0.3 0.0 154.1 0.2 104.9 0.5 7.5 0.2 0.5 0.3 0.2 5.1 4.7 21.3 0.2 0.6 0.5 0.5 0.2 85.9 9.2 98.6 41.3 8.0 37.7 6.3 191.6 76.1 16.8 303.5 18.7 467.7 14.8 24.8 437.9 504.7 7.8 13.5 16.8 42.2 140.0 303.2 41.2 238.1 53.2 81.4 8.4 43.5 46.9 43.5 78.3 23.1 79.8 68.1 CD79A "IGA, MB-1" ENSG00000105369 "CD79a molecule" P11912 19 41877120-41881372 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 125.3;intestine: 43.5;lymphoid tissue: 119.2" "Group enriched" "Detected in some" 24 "Daudi: 155.5;REH: 48.3;U-698: 135.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "memory B-cell: 106.4;naive B-cell: 125.3" "Lineage enriched" "Detected in many" 41 "B-cells: 125.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB000019 Enhanced "CAB000019: AB_2244527" "prognostic favourable (8.45e-5)" "unprognostic (1.63e-3)" "unprognostic (4.13e-3)" "unprognostic (1.31e-3)" "unprognostic (2.02e-1)" "prognostic favourable (1.18e-5)" "unprognostic (1.23e-2)" "unprognostic (8.11e-3)" "unprognostic (9.41e-3)" "unprognostic (1.12e-2)" "unprognostic (2.53e-1)" "unprognostic (2.32e-1)" "prognostic unfavourable (2.15e-5)" "unprognostic (6.08e-2)" "unprognostic (3.39e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-1)" 1.3 0.6 0.5 103.8 0.5 5.4 1.3 0.5 0.5 1.8 6.3 0.1 0.1 4.9 0.6 0.2 4.4 1.0 2.3 0.8 0.5 0.5 2.3 0.9 4.3 114.9 0.5 0.1 0.6 0.6 0.0 0.5 0.5 0.1 1.0 3.4 1.8 13.6 1.2 0.5 0.5 43.5 0.2 0.5 108.1 9.7 0.8 0.1 32.0 2.4 1.9 119.2 6.8 1.0 125.3 3.0 0.7 0.3 0.2 2.3 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 155.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.9 0.0 0.0 48.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.7 0.1 135.4 0.0 4.6 0.0 0.7 0.1 0.5 0.1 0.1 0.0 106.4 0.3 0.1 0.2 125.3 0.4 2.3 0.4 0.2 0.3 3.0 0.8 4.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.1 0.1 CD79B "B29, IGB" ENSG00000007312 "CD79b molecule" P40259 17 63928740-63932354 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 138.8;lymphoid tissue: 56.6" "Cell line enhanced" "Detected in some" "Daudi: 114.9;REH: 37.8;U-698: 157.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 100.6;naive B-cell: 138.8" "Lineage enriched" "Detected in many" 6 "B-cells: 138.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009178, CAB009751" Enhanced "CAB009751: AB_2275844, HPA009178: AB_1078483" "unprognostic (3.90e-3)" "unprognostic (1.61e-3)" "unprognostic (5.21e-2)" "unprognostic (3.45e-3)" "unprognostic (4.22e-3)" "prognostic favourable (2.35e-4)" "unprognostic (1.82e-1)" "unprognostic (9.25e-3)" "unprognostic (3.89e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (2.87e-2)" "unprognostic (2.50e-3)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (2.75e-1)" 1.7 0.7 0.4 50.6 0.4 11.1 1.2 0.3 0.4 0.6 1.7 0.3 0.3 0.7 0.6 0.5 2.6 0.6 1.4 3.4 0.4 0.2 2.3 1.7 1.3 56.6 0.4 0.3 0.6 1.6 0.0 9.0 0.5 0.3 1.0 1.3 0.8 8.9 0.9 1.2 0.9 22.4 0.5 0.4 56.0 1.8 0.6 0.3 3.7 1.4 1.7 46.6 4.5 0.9 138.8 4.2 0.5 25.0 3.4 9.2 9.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.3 0.0 0.0 0.0 2.4 0.0 0.0 37.8 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.0 0.4 0.0 0.0 5.8 5.6 157.4 0.0 0.2 0.0 0.5 1.1 0.0 4.2 16.5 4.8 100.6 5.4 2.8 4.2 138.8 3.7 2.2 0.5 3.4 25.0 0.6 9.2 9.0 0.4 0.4 0.3 0.4 0.4 0.2 0.4 0.3 0.3 0.3 CD80 "B7-1, B7.1, CD28LG, CD28LG1" ENSG00000121594 "CD80 molecule" P33681 3 119524293-119559602 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 17.5" "Cell line enhanced" "Detected in some" "Daudi: 8.0;HDLM-2: 28.3;Karpas-707: 11.8;U-266/70: 5.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 4.3;non-classical monocyte: 1.1;T-reg: 3.3" "Group enriched" "Detected in many" 24 "B-cells: 4.3;monocytes: 1.1;T-cells: 3.3" "Low region specificity" "Detected in all" "CAB025368, HPA050092" Enhanced "Intracellular and membrane" "CAB025368: , HPA050092: " "unprognostic (2.36e-1)" "unprognostic (1.55e-2)" "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (3.14e-1)" "unprognostic (1.18e-1)" "unprognostic (1.86e-2)" "unprognostic (4.14e-3)" "unprognostic (1.02e-2)" "unprognostic (4.96e-3)" "unprognostic (1.16e-2)" "unprognostic (1.15e-1)" "unprognostic (9.03e-8)" "unprognostic (3.20e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (1.94e-2)" 0.7 0.6 0.4 11.7 0.3 1.5 1.2 0.3 0.3 0.6 0.7 0.3 0.7 1.3 0.4 0.6 0.7 0.3 1.0 0.5 0.9 0.3 0.7 2.0 6.2 7.4 0.4 0.0 0.3 0.9 0.0 1.1 0.7 0.6 0.6 1.7 0.8 3.9 0.2 0.5 0.4 2.4 0.2 0.8 17.5 0.6 0.4 0.0 5.6 1.6 0.8 17.2 1.8 0.4 4.3 0.1 0.0 1.1 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.1 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 4.3 0.5 0.3 0.1 0.6 0.0 0.0 0.0 0.0 1.1 0.0 3.3 0.2 0.4 0.3 0.3 0.3 0.9 0.3 0.4 0.0 0.6 0.0 CD81 "TAPA-1, TAPA1, TSPAN28" ENSG00000110651 "CD81 molecule" P60033 11 2376177-2397419 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 231.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 41.4;naive B-cell: 37.6" "Lineage enriched" "Detected in all" 4 "B-cells: 41.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002507, HPA007234" Supported Supported "Plasma membrane" 1900000 "Plasma membrane" "CAB002507: AB_563639, HPA007234: AB_1846333" "unprognostic (2.96e-1)" "unprognostic (3.40e-1)" "prognostic unfavourable (7.56e-4)" "unprognostic (1.84e-2)" "prognostic unfavourable (8.21e-5)" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "prognostic favourable (3.86e-4)" "unprognostic (3.07e-3)" "unprognostic (2.08e-1)" "unprognostic (3.55e-2)" "unprognostic (1.67e-1)" "unprognostic (2.06e-1)" "unprognostic (2.06e-1)" 102.5 43.7 52.8 40.1 57.0 9.6 79.3 31.7 63.2 124.7 88.9 75.8 261.4 21.1 143.5 141.5 56.8 123.1 86.8 101.2 46.6 52.8 65.5 123.9 107.4 82.4 70.4 51.3 77.9 62.4 41.4 42.9 61.2 63.0 89.3 34.0 46.6 59.7 263.3 22.6 59.6 39.7 138.9 59.3 64.5 52.1 57.6 53.3 25.3 66.3 38.5 37.9 93.5 80.2 41.4 2.1 5.7 1.8 3.5 9.9 2.7 24.5 25.5 20.5 31.3 231.4 131.6 17.2 46.5 103.0 37.6 38.0 23.9 0.1 21.0 16.8 130.3 32.3 12.6 33.1 15.5 9.9 38.9 3.2 9.7 0.0 76.6 13.6 27.6 95.6 47.3 15.3 23.3 35.9 14.3 36.9 52.5 18.8 11.5 17.4 24.6 20.7 23.7 10.3 13.4 40.4 16.6 22.1 24.5 14.8 39.0 28.0 12.9 24.9 47.8 19.2 14.2 35.9 15.9 27.3 6.2 38.3 27.9 8.1 32.8 0.2 0.9 5.7 6.0 1.4 9.9 41.4 4.3 9.4 0.6 37.6 2.6 5.0 0.3 3.5 1.8 2.1 3.0 2.7 52.8 57.0 31.7 63.2 46.6 52.8 70.4 51.3 63.0 53.3 CD82 "IA4, KAI1, R2, ST6, TSPAN27" ENSG00000085117 "CD82 molecule" P27701 11 44564427-44620363 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 77.3;LHCN-M2: 45.7;U-87 MG: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 80.5" "Group enriched" "Detected in all" 6 "B-cells: 51.1;granulocytes: 80.5;T-cells: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002508, HPA028900, HPA061418" Supported Approved Vesicles Vesicles "CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: " "unprognostic (5.31e-2)" "unprognostic (4.62e-1)" "unprognostic (2.38e-2)" "unprognostic (1.33e-1)" "unprognostic (2.79e-1)" "unprognostic (1.37e-2)" "unprognostic (1.78e-1)" "unprognostic (7.29e-2)" "unprognostic (3.48e-1)" "unprognostic (2.97e-1)" "unprognostic (2.58e-2)" "unprognostic (1.58e-1)" "unprognostic (3.48e-3)" "unprognostic (1.86e-3)" "unprognostic (2.33e-2)" "unprognostic (2.88e-2)" "unprognostic (6.30e-2)" 14.7 4.9 16.3 21.6 23.1 43.6 13.8 6.3 13.6 17.5 20.7 23.0 53.0 25.9 4.8 13.5 58.3 19.8 21.7 12.7 16.9 13.3 10.2 18.8 38.8 22.8 17.9 9.2 9.0 11.6 2.8 3.9 20.7 14.0 14.3 6.8 18.6 29.8 55.2 10.5 34.6 36.0 8.9 10.2 21.9 22.5 4.5 12.6 23.9 8.3 23.5 33.5 16.3 28.1 51.1 6.7 80.5 9.1 7.2 25.6 9.5 5.0 0.7 6.6 1.3 4.5 17.2 0.2 2.9 23.6 5.1 13.0 0.3 3.4 5.2 3.5 1.4 19.2 0.9 15.0 11.8 23.2 0.4 32.5 1.5 0.1 3.3 8.9 77.3 23.7 17.6 21.4 11.4 9.0 0.2 1.6 45.7 3.6 8.6 16.7 0.2 0.3 0.2 27.6 7.3 3.0 4.9 0.2 0.3 1.8 27.6 3.8 26.3 8.8 5.0 16.2 2.1 0.3 27.5 0.6 0.0 0.1 54.7 4.9 8.6 48.4 9.1 16.0 4.9 4.8 8.5 51.1 24.9 11.6 2.2 30.9 8.6 3.8 80.5 7.2 3.4 6.7 25.6 9.5 16.3 23.1 6.3 13.6 16.9 13.3 17.9 9.2 14.0 12.6 CD83 "BL11, HB15" ENSG00000112149 "CD83 molecule" Q01151 6 14117256-14136918 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 70.0;lymphoid tissue: 64.5" "Cell line enhanced" "Detected in many" "Daudi: 28.6;HDLM-2: 25.7;U-698: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002509, HPA041454" Enhanced "CAB002509: AB_563641, HPA041454: " "unprognostic (2.22e-3)" "unprognostic (1.92e-2)" "unprognostic (1.22e-1)" "unprognostic (6.39e-2)" "unprognostic (5.83e-2)" "unprognostic (3.02e-2)" "unprognostic (1.00e-2)" "unprognostic (9.05e-3)" "unprognostic (9.05e-2)" "unprognostic (3.91e-2)" "unprognostic (7.37e-2)" "unprognostic (6.68e-2)" "prognostic favourable (3.49e-4)" "unprognostic (2.30e-1)" "unprognostic (7.07e-2)" "unprognostic (1.40e-2)" "unprognostic (2.46e-2)" 14.0 8.3 6.1 64.5 5.7 70.0 7.5 14.2 11.8 17.0 2.0 24.7 3.4 1.8 3.7 8.3 3.6 1.8 9.9 2.6 7.3 12.7 9.7 6.0 29.0 19.5 7.8 2.2 9.7 1.6 2.2 4.1 3.4 10.8 5.2 3.8 3.5 16.4 7.8 1.8 2.6 6.9 2.7 11.1 16.5 2.2 4.0 2.8 33.8 2.3 6.2 57.5 16.4 9.8 19.1 5.2 1.3 15.4 2.6 3.6 2.3 6.5 0.3 4.9 6.8 7.2 1.6 0.1 1.8 6.7 3.2 5.6 0.5 4.3 28.6 5.5 0.5 0.7 1.8 2.0 10.6 25.7 2.7 3.9 8.5 0.7 0.2 5.7 6.3 1.9 0.9 3.0 1.0 0.1 0.8 0.0 0.3 2.4 4.5 10.8 2.0 1.3 4.4 10.7 4.0 2.3 6.5 1.0 1.9 0.4 0.2 4.9 1.1 4.6 0.1 4.9 3.1 0.7 4.4 0.3 0.0 44.0 1.0 7.8 7.4 0.0 1.7 1.1 2.7 10.7 2.9 11.5 2.5 2.2 5.2 19.1 1.8 2.1 1.3 2.6 15.4 1.8 3.6 2.3 6.1 5.7 14.2 11.8 7.3 12.7 7.8 2.2 10.8 2.8 CD84 "hCD84, mCD84, SLAMF5" ENSG00000066294 "CD84 molecule" Q9UIB8 1 160541095-160579516 "CD markers, Predicted membrane proteins" "Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.0" "Cell line enhanced" "Detected in some" "Daudi: 12.4;HEL: 23.7;HL-60: 6.7;HMC-1: 27.1;MOLT-4: 6.6;U-698: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063316, HPA068020, HPA070502" Enhanced Enhanced "Vesicles,Plasma membrane" 36000000 "Plasma membrane" Vesicles "HPA063316: , HPA068020: , HPA070502: " "unprognostic (4.38e-2)" "unprognostic (6.16e-3)" "unprognostic (1.00e-2)" "unprognostic (8.16e-2)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (3.84e-1)" "unprognostic (2.54e-2)" "unprognostic (8.60e-2)" "unprognostic (1.80e-1)" "unprognostic (8.26e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" 15.9 4.8 3.8 18.5 4.5 6.7 3.7 1.3 3.4 3.3 3.2 7.9 7.7 2.5 2.5 4.3 2.7 3.1 6.4 5.0 3.8 3.0 3.1 5.1 9.2 26.0 6.0 2.2 1.8 4.3 0.9 1.9 7.1 5.3 3.7 4.7 2.4 4.3 9.8 1.6 2.7 9.6 4.1 11.1 25.6 3.5 2.8 5.9 13.8 2.9 2.3 16.3 5.8 2.7 5.1 5.4 21.0 7.3 1.0 8.2 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 6.7 27.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 6.6 5.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 1.5 0.0 21.0 7.3 11.0 6.9 6.3 5.2 5.1 5.9 8.2 5.4 4.7 3.5 6.3 1.0 1.0 2.4 3.2 7.9 6.1 3.8 4.5 1.3 3.4 3.8 3.0 6.0 2.2 5.3 5.9 CD86 "B7-2, B7.2, CD28LG2" ENSG00000114013 "CD86 molecule" P42081 3 122055366-122121139 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.0;brain: 26.1" "Cell line enriched" "Detected in some" 7 "HDLM-2: 78.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 25.6;intermediate monocyte: 26.4;memory B-cell: 13.6;myeloid DC: 25.9;naive B-cell: 8.0;non-classical monocyte: 27.0" "Group enriched" "Detected in many" 17 "B-cells: 13.6;dendritic cells: 25.9;monocytes: 27.0" "Low region specificity" "Detected in all" CAB004319 Approved 220000 "CAB004319: AB_627200" "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (3.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-1)" "unprognostic (1.15e-1)" "unprognostic (8.56e-2)" "unprognostic (7.72e-3)" "unprognostic (1.21e-1)" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "prognostic unfavourable (9.83e-5)" "unprognostic (9.72e-2)" "unprognostic (1.70e-2)" "unprognostic (9.78e-2)" "unprognostic (8.67e-2)" 10.5 4.7 7.1 23.6 9.5 6.0 3.6 1.5 6.3 2.9 4.3 9.8 0.6 2.5 2.6 5.2 2.8 3.3 10.4 3.5 7.3 6.0 4.0 7.8 13.0 17.8 11.7 3.0 2.5 2.3 2.1 2.6 10.3 8.1 3.1 5.6 3.0 3.6 1.8 1.3 2.4 6.9 5.1 26.1 22.5 3.4 2.4 10.3 7.7 2.3 2.1 15.0 9.2 2.2 13.6 25.9 0.3 27.0 1.2 0.4 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 78.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 4.2 0.1 9.4 0.0 0.2 0.0 0.0 25.6 0.2 0.0 26.4 0.0 13.6 0.1 0.1 25.9 8.0 0.0 0.0 0.3 1.2 27.0 2.6 0.4 9.3 7.1 9.5 1.5 6.3 7.3 6.0 11.7 3.0 8.1 10.3 CD8A CD8 ENSG00000153563 "CD8a molecule" P01732 2 86784610-86808396 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "blood: 82.2;lymphoid tissue: 262.3" "Cell line enriched" "Detected in some" 4 "MOLT-4: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "MAIT T-cell: 36.7;memory CD8 T-cell: 82.2;naive CD8 T-cell: 77.8" "Lineage enriched" "Detected in many" 20 "T-cells: 82.2" "Low region specificity" "Detected in all" "CAB000012, HPA037756, CAB075722" Enhanced Supported "Plasma membrane" "Intracellular and membrane" 500000 "Plasma membrane" "CAB000012: AB_2075537, CAB075722: , HPA037756: " "unprognostic (1.29e-3)" "prognostic favourable (4.54e-4)" "unprognostic (9.26e-3)" "prognostic favourable (6.15e-6)" "unprognostic (7.28e-2)" "unprognostic (2.79e-3)" "unprognostic (1.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (1.91e-5)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (6.74e-2)" "unprognostic (1.56e-2)" 2.4 1.4 1.4 7.4 2.8 6.8 1.5 1.4 1.2 2.1 5.3 0.8 0.8 4.2 1.5 2.1 2.0 2.1 4.5 1.6 1.2 1.6 1.3 2.1 6.0 23.8 1.0 0.5 1.7 1.2 0.0 0.9 0.6 0.7 2.3 1.9 1.8 3.0 1.1 0.8 0.7 12.2 0.7 1.7 46.4 5.4 1.0 0.5 262.3 2.2 1.6 8.1 3.8 1.9 0.0 0.1 0.6 0.1 4.0 82.2 17.4 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.8 17.4 1.1 0.6 0.3 0.1 0.9 3.9 0.0 0.4 0.9 2.4 0.2 0.1 0.0 0.4 0.5 0.0 0.0 0.6 0.1 0.0 0.1 0.3 0.9 0.0 0.0 0.1 0.1 0.1 0.0 4.8 0.0 36.7 0.0 0.3 82.2 0.0 0.0 0.3 77.8 0.6 4.0 0.1 0.1 0.1 17.4 1.4 2.8 1.4 1.2 1.2 1.6 1.0 0.5 0.7 0.5 CD8B CD8B1 ENSG00000172116 "CD8b molecule" P10966 2 86815339-86861924 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 132.1;lymphoid tissue: 61.5" "Cell line enriched" "Detected in some" 55 "RPMI-8226: 154.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory CD8 T-cell: 73.5;naive CD8 T-cell: 132.1" "Lineage enriched" "Detected in many" 40 "T-cells: 132.1" "CAB004353, HPA029164" Enhanced Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "CAB004353: AB_627211, HPA029164: " "unprognostic (1.83e-3)" "unprognostic (1.98e-3)" "unprognostic (2.22e-2)" "prognostic favourable (7.88e-7)" "unprognostic (6.23e-2)" "unprognostic (7.05e-3)" "unprognostic (1.11e-2)" "unprognostic (2.59e-2)" "unprognostic (5.50e-3)" "unprognostic (5.91e-2)" "unprognostic (9.25e-2)" "unprognostic (4.60e-1)" "prognostic unfavourable (7.11e-6)" "unprognostic (7.84e-2)" "unprognostic (3.00e-1)" "unprognostic (1.86e-2)" "unprognostic (4.33e-2)" 1.2 0.7 1.0 5.3 1.0 3.9 1.0 1.3 1.3 21.2 1.1 1.0 1.0 2.5 1.2 1.0 1.0 1.1 1.8 1.0 1.0 1.8 1.0 1.0 2.7 14.4 1.7 1.0 1.3 1.0 6.4 7.4 1.0 2.2 1.3 1.3 1.0 1.0 1.0 1.0 0.9 11.4 1.0 1.5 12.7 2.3 1.0 1.0 61.5 1.5 1.0 8.1 1.8 1.3 0.1 0.1 3.2 0.1 0.1 132.1 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 154.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 3.2 0.1 0.0 2.0 0.1 10.0 0.0 0.2 73.5 0.0 0.1 0.5 132.1 0.7 0.1 0.1 0.1 0.2 36.3 1.0 1.0 1.3 1.3 1.0 1.8 1.7 1.0 2.2 1.0 CD93 "C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4" ENSG00000125810 "CD93 molecule" Q9NPY3 20 23079349-23086340 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 57.0;TIME: 72.2;U-937: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 14.4;neutrophil: 17.4" "Group enriched" "Detected in many" 40 "dendritic cells: 5.5;granulocytes: 17.4;monocytes: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009300, HPA012368" Enhanced Approved "Vesicles,Plasma membrane" 440000000 "Vesicles, Plasma membrane" "HPA009300: AB_1846342, HPA012368: AB_1846341" "unprognostic (2.05e-1)" "unprognostic (2.85e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (2.31e-1)" "unprognostic (2.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.77e-1)" "unprognostic (4.51e-1)" "unprognostic (3.74e-2)" "unprognostic (2.61e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (2.74e-4)" "unprognostic (8.81e-3)" "unprognostic (6.13e-2)" "unprognostic (4.49e-2)" "unprognostic (3.11e-2)" 50.5 6.1 2.4 15.0 3.4 4.7 31.4 1.0 3.0 13.6 8.1 1.7 3.9 3.2 14.3 12.5 10.0 13.6 14.2 33.3 2.4 2.2 10.8 10.9 34.8 25.3 4.1 1.2 11.6 5.9 5.1 4.3 48.9 5.3 9.7 4.3 4.9 5.9 3.9 16.2 6.8 7.7 15.4 4.3 17.5 7.5 6.9 3.3 6.9 12.3 9.3 4.5 15.6 12.2 0.0 5.5 17.4 14.4 0.0 0.3 4.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 72.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.6 0.0 0.0 14.4 0.2 0.2 10.3 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 17.4 0.0 4.2 0.7 0.3 4.7 2.4 3.4 1.0 3.0 2.4 2.2 4.1 1.2 5.3 3.3 CD96 TACTILE ENSG00000153283 "CD96 molecule" P40200 3 111292719-111665750 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 32.0;lymphoid tissue: 82.4" "Cell line enhanced" "Detected in some" "HEL: 6.7;MOLT-4: 29.2;RT4: 27.1;U-937: 24.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "NK-cells: 20.0;T-cells: 32.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066754 Enhanced 37000 "HPA066754: " "unprognostic (1.06e-3)" "unprognostic (3.95e-3)" "unprognostic (4.16e-3)" "unprognostic (1.91e-5)" "unprognostic (4.72e-3)" "prognostic favourable (5.52e-4)" "unprognostic (2.12e-2)" "unprognostic (3.48e-2)" "unprognostic (6.06e-2)" "unprognostic (4.84e-3)" "unprognostic (2.44e-2)" "unprognostic (2.77e-1)" "prognostic unfavourable (2.02e-6)" "unprognostic (3.12e-1)" "unprognostic (4.42e-2)" "unprognostic (3.90e-2)" "prognostic favourable (5.23e-5)" 5.7 0.9 0.4 18.6 0.5 8.6 3.1 0.6 0.4 2.2 7.1 0.6 0.5 3.6 1.7 1.8 3.4 2.1 3.5 1.3 0.4 0.5 2.3 2.7 9.7 21.9 1.5 0.2 1.4 0.8 0.0 1.1 1.1 1.0 2.6 3.7 2.5 4.0 1.6 0.6 1.3 13.4 1.4 2.0 14.2 3.5 1.0 0.4 82.4 4.8 2.3 23.9 9.9 3.2 5.5 0.1 3.8 0.2 20.0 32.0 11.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 6.7 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.0 29.2 0.1 0.3 0.0 0.0 0.9 0.2 0.2 27.1 0.0 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.1 0.5 0.1 0.0 2.6 0.8 0.0 0.1 24.2 5.2 0.5 0.1 3.8 20.2 0.0 32.0 2.8 18.6 23.5 0.1 5.5 19.4 23.6 0.8 20.0 0.2 0.1 11.8 11.2 0.4 0.5 0.6 0.4 0.4 0.5 1.5 0.2 1.0 0.4 CD99 MIC2 ENSG00000002586 "CD99 molecule (Xg blood group)" P14209 X 2691133-2741309 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 359.1;breast: 433.0;heart muscle: 347.0" "Cell line enhanced" "Detected in many" "ASC diff: 124.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000020, HPA035304" Supported Approved "Golgi apparatus" 34000000 "Golgi apparatus" "CAB000020: AB_2076419, HPA035304: AB_10672861" "unprognostic (3.71e-3)" "unprognostic (2.90e-1)" "unprognostic (5.97e-3)" "unprognostic (7.01e-3)" "unprognostic (2.14e-2)" "unprognostic (6.98e-3)" "unprognostic (3.89e-3)" "unprognostic (1.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "prognostic unfavourable (5.87e-7)" "unprognostic (2.11e-2)" "unprognostic (2.18e-1)" "unprognostic (5.37e-2)" "unprognostic (3.61e-2)" 45.7 14.1 85.8 14.4 100.5 11.1 433.0 45.7 60.9 243.9 31.8 4.5 4.5 19.9 258.4 18.3 26.1 22.2 35.2 347.0 103.4 14.7 66.4 24.6 24.5 16.6 161.0 56.6 187.4 28.9 3.3 67.0 138.7 185.5 30.5 20.6 4.5 18.1 37.7 18.9 28.0 23.8 31.1 359.1 18.5 21.7 23.3 101.3 4.5 15.2 4.5 16.1 24.7 208.8 32.7 62.6 4.3 47.1 32.1 107.1 103.6 23.8 27.4 30.6 41.4 124.2 94.2 18.4 64.0 100.3 40.2 58.6 39.5 16.8 1.6 12.5 88.7 9.3 12.2 16.1 33.4 32.4 30.8 4.6 19.1 34.3 39.4 7.3 36.5 58.5 19.9 22.0 15.5 73.3 5.7 0.0 37.9 18.7 63.6 24.9 10.0 29.9 10.8 25.6 45.2 23.2 16.4 0.1 13.5 15.4 13.8 38.4 12.2 22.8 67.6 49.6 8.4 47.3 21.5 0.1 0.0 10.4 33.2 18.3 30.9 1.8 47.1 1.5 107.1 11.6 60.4 32.7 72.6 94.6 44.6 20.2 26.8 57.1 4.3 32.1 2.6 62.6 74.3 103.6 85.8 100.5 45.7 60.9 103.4 14.7 161.0 56.6 185.5 101.3 CD99L2 "CD99B, MIC2L1" ENSG00000102181 "CD99 molecule like 2" Q8TCZ2 X 150766337-150898816 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038782, HPA038783, HPA061400" Enhanced Supported "Plasma membrane" 790000 "Plasma membrane" "HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: " "unprognostic (2.10e-2)" "unprognostic (2.62e-3)" "unprognostic (3.12e-3)" "unprognostic (6.03e-3)" "unprognostic (1.22e-1)" "unprognostic (2.66e-1)" "unprognostic (5.56e-2)" "prognostic favourable (4.96e-4)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "prognostic favourable (2.74e-5)" "unprognostic (5.50e-2)" "unprognostic (5.13e-2)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (9.23e-2)" "prognostic unfavourable (8.74e-4)" 27.1 16.5 23.3 9.2 30.1 4.5 17.8 27.5 56.7 19.2 12.6 21.0 5.5 6.7 17.6 16.5 9.7 17.6 12.4 32.1 26.3 32.0 14.0 17.0 14.9 9.6 30.5 26.6 26.0 8.4 9.7 8.7 21.5 43.1 13.9 7.4 11.9 8.3 22.0 72.2 6.7 8.0 20.8 31.9 12.5 8.0 7.6 13.3 3.0 7.3 6.9 7.0 10.7 7.7 7.2 10.7 9.4 15.1 8.8 8.9 8.4 2.2 22.6 8.6 10.7 45.6 28.5 2.5 18.6 21.9 9.4 13.6 1.6 2.9 8.2 45.3 32.4 3.7 11.7 12.6 7.8 19.1 9.1 3.5 5.4 2.2 12.3 5.9 6.8 26.9 4.2 6.9 13.3 11.1 2.4 21.6 11.8 4.8 5.2 8.6 3.6 12.3 5.2 7.0 11.2 9.2 1.5 11.4 5.8 7.3 6.3 8.3 1.8 10.2 13.0 14.0 4.3 18.1 13.4 18.4 30.4 8.0 17.6 11.9 10.5 9.4 11.2 7.6 8.8 9.9 7.8 6.4 8.2 8.9 10.7 7.2 8.3 8.5 2.8 8.8 15.1 7.8 5.9 8.4 23.3 30.1 27.5 55.2 26.3 32.0 30.5 26.6 43.1 13.3 CDC14B "Cdc14B1, Cdc14B2, CDC14B3, hCDC14B" ENSG00000081377 "Cell division cycle 14B" O60729 9 96490241-96619830 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 15.1;ASC TERT1: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.9" "Lineage enhanced" "Detected in many" "granulocytes: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013312, HPA064747" Approved Supported Nucleoplasm Nucleoplasm "HPA013312: AB_1846354, HPA064747: " "unprognostic (5.69e-2)" "unprognostic (9.09e-2)" "unprognostic (3.50e-2)" "unprognostic (8.08e-3)" "unprognostic (4.24e-1)" "unprognostic (1.19e-2)" "unprognostic (1.11e-2)" "unprognostic (4.49e-2)" "unprognostic (1.63e-2)" "unprognostic (2.27e-2)" "unprognostic (2.35e-1)" "unprognostic (2.75e-1)" "prognostic favourable (2.97e-10)" "unprognostic (2.01e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (2.82e-4)" "unprognostic (7.40e-2)" 7.3 6.2 6.8 3.0 7.5 4.4 15.7 2.4 6.6 5.3 5.0 14.8 7.1 4.5 4.0 3.7 3.5 7.1 5.9 8.2 6.0 4.6 9.1 16.0 4.9 1.8 9.5 4.0 5.8 7.3 17.1 5.2 3.4 7.1 5.7 5.4 8.3 3.8 7.2 2.2 3.3 7.7 4.2 9.3 2.2 9.3 16.9 8.2 0.2 13.6 2.2 2.1 10.4 10.3 1.6 0.0 9.9 0.0 0.1 2.9 0.8 5.1 2.9 3.1 3.2 15.1 22.7 8.5 3.8 5.0 2.5 4.1 9.9 8.3 0.0 3.7 8.0 5.8 4.4 3.0 3.0 1.3 4.1 0.8 1.0 7.7 2.4 0.0 0.1 9.3 1.5 2.7 2.5 0.5 3.0 0.6 3.5 2.5 0.0 0.8 5.8 2.5 0.0 1.9 0.1 4.0 8.0 0.9 4.9 2.6 0.8 1.5 0.7 1.7 1.5 2.5 3.0 6.5 2.7 0.1 0.0 0.0 2.7 0.0 6.0 9.9 0.0 3.1 2.9 0.0 1.6 1.6 1.3 2.3 0.0 0.8 2.3 1.4 0.0 0.1 0.0 0.0 1.6 0.8 6.8 7.5 2.4 6.6 6.0 4.6 9.5 4.0 7.1 8.2 CDCP1 "CD318, SIMA135" ENSG00000163814 "CUB domain containing protein 1" Q9H5V8 3 45082278-45146422 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.3;HBEC3-KT: 26.6;hTEC/SVTERT24-B: 66.0;hTERT-HME1: 44.8;PC-3: 20.6;RPTEC TERT1: 20.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 5 "pons and medulla: 5.5" "Group enriched" "Detected in some" 5 "myeloid DC: 4.0;neutrophil: 1.8;NK-cell: 7.1" "Group enriched" "Detected in many" 5 "dendritic cells: 4.0;granulocytes: 1.8;NK-cells: 7.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010978, HPA010979, CAB025637" Enhanced "Intracellular and membrane" "CAB025637: , HPA010978: AB_1846403, HPA010979: AB_1846401" "unprognostic (9.31e-2)" "unprognostic (4.50e-2)" "unprognostic (1.67e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (2.94e-2)" "prognostic unfavourable (1.41e-5)" "unprognostic (2.15e-1)" "unprognostic (1.00e-1)" "prognostic unfavourable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (9.98e-3)" "unprognostic (3.59e-2)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" "unprognostic (1.34e-1)" 2.3 0.7 0.5 5.6 1.0 0.2 4.4 0.3 0.7 6.9 17.4 1.1 10.1 11.4 3.2 11.1 28.6 2.4 9.8 0.8 1.0 0.5 4.4 0.8 7.1 1.4 0.6 0.3 1.6 13.9 0.0 2.3 4.0 5.5 5.2 11.3 0.5 11.4 13.0 0.6 15.2 29.8 1.8 1.3 0.8 10.8 1.3 0.5 1.0 21.8 19.2 19.1 7.3 11.7 0.2 4.0 1.8 0.9 7.1 0.3 0.3 12.0 3.6 0.0 0.0 0.0 0.6 2.9 2.2 0.3 1.1 1.0 5.1 23.3 0.0 2.7 0.7 9.7 0.0 26.6 2.2 0.0 0.0 0.0 4.1 0.0 2.0 0.0 0.9 0.9 14.0 66.0 44.8 0.2 7.0 0.0 3.4 0.0 0.0 0.2 1.7 20.6 0.0 0.0 2.0 20.4 9.8 0.8 0.0 4.5 1.2 0.0 5.6 0.1 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.4 0.9 0.1 0.1 0.1 0.0 0.1 0.3 0.1 4.0 0.2 0.2 0.1 1.8 7.1 0.0 0.1 0.0 0.3 0.5 1.0 0.3 0.7 1.0 0.5 0.6 0.3 5.5 0.5 CDCP2 ENSG00000157211 "CUB domain containing protein 2" Q5VXM1 1 54132968-54153770 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.2" "Cell line enhanced" "Detected in single" "CACO-2: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.4" HPA031143 Uncertain "Secreted - unknown location" "HPA031143: AB_10611819" "unprognostic (1.08e-1)" "unprognostic (5.16e-2)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-2)" "unprognostic (4.73e-2)" "unprognostic (5.29e-2)" "unprognostic (2.86e-2)" "unprognostic (2.57e-1)" "unprognostic (1.33e-1)" "unprognostic (1.67e-2)" "unprognostic (7.67e-6)" "unprognostic (2.37e-1)" "unprognostic (1.48e-1)" "unprognostic (5.12e-1)" "unprognostic (2.21e-2)" 0.5 0.3 0.1 0.1 0.5 0.3 0.9 0.1 0.6 1.1 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.6 0.3 0.2 0.0 2.2 0.2 0.1 0.6 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.7 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDH1 "CD324, UVO, uvomorulin" ENSG00000039068 "Cadherin 1" P12830 16 68737225-68835548 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 125.5" "Cell line enhanced" "Detected in some" "BEWO: 105.6;CACO-2: 35.5;CAPAN-2: 49.6;HaCaT: 47.9;hTCEpi: 33.8;MCF7: 29.3;RT4: 36.5;T-47d: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "myeloid DC: 2.8;plasmacytoid DC: 8.5" "Lineage enriched" "Detected in single" 18 "dendritic cells: 8.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857" Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" 22000000 "Plasma membrane, Cell Junctions" "Golgi apparatus" "CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: , CAB072856: , CAB072857: , HPA004812: AB_1078369" "unprognostic (3.95e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-3)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (5.04e-3)" "unprognostic (1.63e-1)" "unprognostic (5.47e-2)" "unprognostic (2.85e-1)" "unprognostic (1.19e-2)" "unprognostic (3.61e-1)" "prognostic favourable (2.06e-4)" "unprognostic (1.21e-1)" "unprognostic (2.62e-1)" "unprognostic (2.51e-1)" "unprognostic (5.92e-2)" 1.1 0.7 1.3 14.8 1.5 0.5 15.3 0.8 1.1 14.4 63.8 1.8 42.4 25.5 4.7 18.6 48.5 9.7 48.9 0.8 1.5 1.0 24.2 64.9 24.4 0.5 1.8 0.9 5.6 71.5 62.2 13.2 55.2 2.8 28.9 25.9 11.8 66.6 43.7 0.8 30.5 125.5 1.5 1.1 3.5 21.6 2.1 1.8 11.7 83.0 26.2 32.6 16.8 21.7 0.0 8.5 0.0 0.0 0.3 0.4 0.1 21.3 2.2 0.0 0.0 0.0 0.0 105.6 0.0 0.0 0.0 0.0 35.5 49.6 0.0 0.4 0.0 47.9 0.0 23.8 0.0 4.1 0.6 0.0 0.1 7.6 0.0 0.0 0.2 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.1 0.8 0.1 0.0 0.0 0.3 8.7 36.5 1.3 0.1 0.2 0.0 9.0 31.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.8 0.0 0.0 0.0 0.0 0.3 0.0 8.5 0.1 0.1 1.3 1.5 0.8 1.1 1.5 1.0 1.8 0.9 2.8 1.8 CDH10 ENSG00000040731 "Cadherin 10" Q9Y6N8 5 24487100-24644978 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 45.4" "Cell line enhanced" "Detected in some" "AF22: 11.5;AN3-CA: 1.8;HAP1: 7.3;U-138 MG: 2.5" "Group enriched" "Detected in some" 7 "glioma: 5.3;prostate cancer: 1.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010651 Approved "HPA010651: AB_1078370" "unprognostic (4.31e-3)" "unprognostic (2.77e-1)" "unprognostic (1.88e-1)" "unprognostic (3.66e-2)" "unprognostic (4.48e-1)" "unprognostic (6.11e-3)" "unprognostic (6.27e-2)" "unprognostic (1.59e-7)" "unprognostic (1.65e-2)" "unprognostic (1.41e-1)" "unprognostic (8.74e-3)" 0.9 2.1 9.4 0.8 9.6 0.8 1.0 45.4 34.0 0.9 1.1 1.5 0.0 0.9 0.9 0.8 0.9 0.9 1.2 0.9 9.4 5.2 1.0 0.8 1.1 0.8 3.6 13.4 0.8 0.9 0.8 2.1 0.8 6.0 8.6 1.3 0.0 0.8 1.4 0.8 0.8 1.1 0.9 7.0 0.8 1.0 1.4 3.7 0.0 0.8 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 2.5 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 9.6 45.4 21.3 9.4 5.2 3.6 13.4 6.0 3.7 CDH11 "CAD11, OB" ENSG00000140937 "Cadherin 11" P55287 16 64943753-65126112 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 71.0" "Cell line enhanced" "Detected in many" "BJ: 47.1;fHDF/TERT166: 64.3;HSkMC: 44.3;PC-3: 55.3;U-2197: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013072 Enhanced 70000 "CAB013072: AB_2533068" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (6.93e-2)" "unprognostic (6.00e-2)" "unprognostic (1.02e-1)" "unprognostic (6.96e-2)" "unprognostic (1.28e-1)" "unprognostic (2.09e-1)" "unprognostic (2.30e-2)" "unprognostic (3.74e-2)" "unprognostic (6.75e-2)" "prognostic unfavourable (2.48e-9)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (1.26e-1)" "unprognostic (5.07e-3)" 8.1 3.6 5.5 9.2 12.1 0.3 6.1 5.5 8.8 24.1 4.3 7.5 2.4 2.7 25.9 5.9 3.0 6.8 22.4 4.6 7.3 5.1 4.8 1.0 20.8 5.9 7.8 8.5 71.0 1.7 1.2 6.0 44.2 8.3 8.0 4.9 22.2 7.3 9.7 2.5 5.7 3.4 20.5 10.6 35.1 5.1 4.0 5.4 0.1 4.8 1.9 4.9 18.4 11.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.2 0.0 7.3 15.9 0.0 47.1 27.3 12.1 6.9 0.8 0.0 0.0 0.0 64.3 0.0 0.0 0.3 8.7 0.0 0.4 0.0 0.2 0.0 6.0 0.0 2.8 44.3 0.0 14.8 3.0 3.4 0.0 0.0 6.4 0.0 0.0 0.0 3.7 55.3 0.1 7.3 0.0 0.0 0.0 0.1 7.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 3.4 37.8 13.3 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 12.1 5.5 8.8 7.3 5.1 7.8 8.5 8.3 5.4 CDH12 "Br-cadherin, CDHB" ENSG00000154162 "Cadherin 12" P55289 5 21750673-22853622 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6" "Cell line enhanced" "Detected in some" "HeLa: 1.5;PC-3: 5.1;SCLC-21H: 7.4;U-2 OS: 3.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029325 Uncertain Uncertain Vesicles Vesicles "HPA029325: " "unprognostic (2.38e-1)" "unprognostic (3.21e-1)" "unprognostic (4.95e-2)" "unprognostic (8.61e-2)" "unprognostic (3.31e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.26e-2)" "unprognostic (1.34e-1)" "unprognostic (3.51e-2)" "unprognostic (3.25e-4)" "unprognostic (7.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.19e-2)" 0.5 5.2 5.8 0.3 17.7 0.4 1.7 2.0 13.8 9.3 0.5 0.0 0.0 0.5 1.3 1.0 0.4 6.7 0.3 0.5 6.3 3.4 0.7 0.5 0.8 0.3 1.4 4.8 0.5 0.5 0.6 8.6 0.7 4.2 0.5 0.6 1.4 3.1 0.9 0.5 2.5 0.4 0.9 2.5 0.3 0.4 2.9 0.5 0.0 0.4 0.0 0.5 1.5 0.2 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.0 1.0 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.1 0.2 0.0 0.1 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.0 5.8 17.7 2.0 13.8 6.3 3.4 1.4 4.8 4.2 0.5 CDH15 "CDH14, CDH3" ENSG00000129910 "Cadherin 15" P55291 16 89171767-89195492 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 44.2;skeletal muscle: 60.3" "Cell line enriched" "Detected in some" 5 "RH-30: 56.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 24 "cerebellum: 44.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "cerebellum: 17.6" "Region enriched" "Detected in many" 6 "cerebellum: 17.9" "HPA009139, HPA070961" Enhanced Supported Enhanced "Golgi apparatus,Plasma membrane" 390000 "Golgi apparatus, Plasma membrane" "HPA009139: AB_1078372, HPA070961: " "unprognostic (1.26e-1)" "unprognostic (7.70e-3)" "unprognostic (6.64e-3)" "unprognostic (2.81e-1)" "unprognostic (7.79e-3)" "unprognostic (2.70e-3)" "unprognostic (2.84e-3)" "unprognostic (4.37e-2)" "unprognostic (2.30e-3)" "unprognostic (7.66e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.14e-7)" "unprognostic (3.09e-2)" "unprognostic (3.13e-1)" "unprognostic (5.50e-2)" "unprognostic (2.64e-2)" 0.8 0.2 0.0 0.1 0.0 0.1 0.1 44.2 0.2 0.7 0.1 0.0 0.0 0.2 0.1 2.8 0.6 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.2 0.1 0.0 0.0 0.1 0.9 0.1 0.0 0.8 1.8 0.5 0.1 0.0 0.3 0.2 60.3 0.1 0.1 0.1 0.3 0.6 0.1 0.3 0.0 0.0 0.1 6.5 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 12.0 0.0 0.0 0.0 0.0 0.1 0.0 56.6 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 44.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 CDH16 ENSG00000166589 "Cadherin 16" O75309 16 66908122-66918984 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 139.7" "Cell line enriched" "Detected in single" 96 "RPTEC TERT1: 69.3" "Cancer enriched" "Detected in many" 15 "renal cancer: 96.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB013526, HPA036260" Enhanced "CAB013526: , HPA036260: " "unprognostic (1.07e-1)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (9.81e-2)" "unprognostic (4.24e-3)" "unprognostic (5.81e-2)" "unprognostic (5.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-2)" "prognostic favourable (1.02e-7)" "unprognostic (2.19e-1)" "unprognostic (1.99e-1)" "unprognostic (7.36e-3)" "unprognostic (2.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.0 0.3 0.0 3.5 0.1 3.4 0.2 0.0 0.0 0.0 139.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.3 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDH17 "cadherin, HPT-1" ENSG00000079112 "Cadherin 17" Q12864 8 94127171-94217303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 184.4" "Group enriched" "Detected in some" 7 "CACO-2: 33.3;U-266/70: 55.3" "Group enriched" "Detected in many" 6 "colorectal cancer: 156.4;stomach cancer: 54.9" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023614, HPA023616, CAB025143, HPA026556" Enhanced Enhanced "Nucleoplasm,Cell Junctions" 3400000 "Cell Junctions" Nucleoplasm "CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897" "unprognostic (2.08e-1)" "unprognostic (5.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (3.02e-1)" "unprognostic (3.06e-2)" "unprognostic (5.60e-2)" "unprognostic (3.38e-3)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.47e-2)" "unprognostic (3.74e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (7.33e-2)" "unprognostic (1.46e-2)" 0.3 0.2 0.2 17.6 0.3 0.3 0.3 0.2 0.2 0.3 88.9 0.2 0.2 54.5 0.4 0.3 0.4 0.4 7.0 0.6 0.2 0.3 0.3 0.3 0.3 0.5 0.2 0.2 0.3 0.4 0.0 0.3 0.2 0.2 0.4 44.0 0.2 0.3 0.2 0.3 0.2 184.4 1.4 0.2 0.6 0.3 0.3 0.2 0.3 0.2 0.2 0.5 0.4 0.3 1.5 0.8 12.1 1.0 1.4 0.6 0.1 0.1 6.1 0.3 0.4 0.0 0.1 0.5 0.1 0.1 0.0 0.1 33.3 1.5 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.5 0.1 0.6 0.2 0.1 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.4 0.2 0.5 0.2 0.2 0.4 0.1 1.0 0.1 0.1 0.6 0.4 0.2 0.2 0.2 0.3 0.3 0.2 0.3 0.3 0.5 0.2 55.3 0.1 0.1 0.1 0.2 0.3 2.5 1.0 1.2 0.5 0.8 0.3 0.6 0.5 0.4 0.8 1.5 0.5 0.6 12.1 1.4 0.5 0.7 0.5 0.1 0.2 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 CDH18 "CDH14, EY-CADHERIN" ENSG00000145526 "Cadherin 18" Q13634 5 19472951-20575873 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 105.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;BEWO: 3.7;EFO-21: 6.3;U-2 OS: 9.9;U-2197: 8.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 7 "cerebellum: 105.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014416 Uncertain "Intracellular and membrane" "HPA014416: " "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (5.26e-7)" "unprognostic (6.36e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (8.78e-2)" "unprognostic (3.30e-2)" "unprognostic (1.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.76e-2)" 0.7 9.3 6.9 0.7 7.1 0.7 0.6 105.4 23.2 1.0 0.6 0.0 0.0 0.7 0.6 0.6 0.7 0.7 0.7 0.6 4.6 8.1 0.9 0.6 0.7 0.8 1.8 8.3 0.7 1.2 2.1 11.3 0.6 7.1 0.8 0.7 2.2 0.6 0.8 0.9 0.8 0.7 0.6 2.2 0.7 0.6 3.7 1.3 0.0 0.6 0.0 0.6 0.6 0.3 0.7 0.3 1.2 0.5 0.6 0.4 0.5 1.6 0.0 0.3 0.0 1.0 4.1 3.7 0.2 2.3 0.1 0.7 0.0 0.0 0.0 6.3 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.1 2.5 0.0 0.2 0.7 0.4 0.2 0.0 0.2 0.3 0.2 0.0 0.1 1.2 0.0 0.0 0.8 0.2 0.1 0.1 0.0 0.1 0.0 0.0 1.9 9.9 8.7 0.0 2.4 0.0 0.0 2.8 0.0 0.0 1.1 0.5 0.3 0.4 0.1 0.2 0.3 0.2 0.2 0.2 0.7 0.4 0.4 1.2 0.6 0.4 0.3 0.2 0.5 6.9 7.1 105.4 14.1 4.6 8.1 1.8 8.3 7.1 1.3 CDH19 CDH7 ENSG00000071991 "Cadherin 19" Q9H159 18 66501083-66604138 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.1" "Group enriched" "Detected in some" 12 "SK-MEL-30: 19.7;WM-115: 35.1" "Cancer enriched" "Detected in some" 21 "melanoma: 16.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA056332 Uncertain 160000 "HPA056332: " "unprognostic (1.63e-2)" "unprognostic (2.63e-2)" "unprognostic (4.26e-2)" "unprognostic (4.10e-2)" "unprognostic (2.51e-2)" "unprognostic (3.14e-2)" "unprognostic (1.93e-1)" "unprognostic (3.79e-1)" "unprognostic (1.02e-1)" "unprognostic (4.39e-2)" "unprognostic (9.33e-2)" "unprognostic (2.25e-2)" "unprognostic (4.58e-3)" "unprognostic (8.16e-3)" "unprognostic (8.21e-2)" "unprognostic (1.56e-5)" 4.5 7.5 4.1 5.4 17.4 0.5 2.3 0.9 10.2 6.4 17.9 5.7 4.6 3.8 1.6 3.2 11.7 2.4 4.7 37.1 5.2 2.3 1.1 7.0 2.1 0.5 22.0 5.5 2.0 2.2 0.6 1.1 5.2 13.1 4.7 5.2 6.9 4.5 7.6 6.0 2.6 5.9 7.2 12.5 4.0 5.8 1.9 20.0 0.0 1.7 2.7 0.4 5.7 12.6 0.2 0.0 1.3 0.1 0.2 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 19.7 0.8 0.0 0.0 0.0 0.2 0.1 0.0 2.2 0.1 0.0 0.1 0.0 35.1 0.0 0.1 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.1 4.1 17.4 0.9 10.2 5.2 2.3 22.0 5.5 13.1 20.0 CDH2 "CD325, CDHN, NCAD" ENSG00000170558 "Cadherin 2" P19022 18 27950966-28177446 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.6;parathyroid gland: 35.4" "Cell line enhanced" "Detected in many" "AF22: 56.4;BJ: 40.7;fHDF/TERT166: 84.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 4.4;neutrophil: 4.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000141, CAB018580, HPA058574, CAB078686" Enhanced Supported "Plasma membrane,Cell Junctions" 160000000 "Plasma membrane, Cell Junctions" "CAB000141: , CAB018580: AB_626778, CAB078686: , HPA058574: " "unprognostic (9.42e-2)" "unprognostic (2.69e-3)" "unprognostic (9.07e-3)" "unprognostic (5.45e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" "unprognostic (3.97e-2)" "unprognostic (2.53e-3)" "unprognostic (6.70e-3)" "unprognostic (1.00e-2)" "unprognostic (7.53e-2)" "unprognostic (3.51e-2)" "unprognostic (3.02e-2)" "unprognostic (1.93e-3)" "unprognostic (6.69e-2)" "unprognostic (1.33e-1)" "unprognostic (2.59e-3)" 0.6 29.6 9.8 1.5 9.4 0.5 0.5 5.7 16.1 3.2 2.0 8.0 0.2 0.8 3.1 1.9 0.6 4.7 1.7 77.6 9.9 9.6 9.2 23.3 0.7 1.1 6.0 9.1 3.4 0.7 35.4 5.4 0.5 5.9 1.4 0.8 6.8 0.5 4.6 0.4 0.5 0.9 3.2 6.7 5.9 2.5 19.6 7.4 0.9 2.8 0.0 1.0 1.0 1.3 0.0 0.0 4.4 0.0 0.7 0.9 0.0 0.0 4.5 56.4 0.0 8.9 1.8 0.0 40.7 12.4 16.6 15.2 0.0 0.0 0.0 21.9 84.2 6.0 9.2 0.0 23.6 0.1 5.9 0.0 15.2 14.0 8.5 0.0 0.0 0.8 0.1 38.1 6.7 14.5 0.0 0.0 12.9 0.0 10.2 0.0 7.5 4.9 0.0 6.7 7.7 0.0 1.8 14.7 25.5 0.0 0.0 4.5 0.0 0.0 2.2 36.0 11.5 0.5 29.4 0.0 0.0 0.0 6.9 0.0 27.7 4.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.7 0.0 0.0 0.0 0.0 9.8 9.4 5.7 10.1 9.9 9.6 6.0 9.1 5.9 7.4 CDH20 "Cdh7, CDH7L3" ENSG00000101542 "Cadherin 20" Q9HBT6 18 61333582-61555773 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 8.8;brain: 32.8" "Cell line enhanced" "Detected in some" "AF22: 3.1;ASC diff: 9.9;HHSteC: 4.6;SH-SY5Y: 6.7" "Cancer enriched" "Detected in single" 15 "glioma: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "basophil: 4.5" "Lineage enriched" "Detected in single" 39 "granulocytes: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015490 Uncertain "HPA015490: AB_1845900" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (1.42e-2)" "unprognostic (3.68e-3)" "unprognostic (2.11e-1)" "unprognostic (5.15e-2)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" "unprognostic (1.52e-1)" "unprognostic (3.69e-2)" "unprognostic (1.82e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-1)" "unprognostic (3.82e-2)" "unprognostic (1.27e-1)" "unprognostic (3.01e-2)" "unprognostic (1.93e-1)" 8.8 1.2 13.4 1.1 13.7 1.0 1.2 6.9 32.8 1.5 1.1 16.8 0.0 1.0 1.1 2.3 2.5 1.3 1.1 1.1 16.0 7.3 1.2 1.0 1.0 1.1 20.4 9.8 1.0 1.3 1.0 1.1 1.1 12.6 1.5 1.0 0.5 1.0 1.1 3.4 2.0 1.0 1.1 12.8 1.2 1.1 1.4 18.9 0.0 1.2 0.5 1.0 1.1 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.4 0.0 0.0 3.1 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 13.4 13.7 6.9 14.0 16.0 7.3 20.4 9.8 12.6 18.9 CDH22 "C20orf25, dJ998H6.1" ENSG00000149654 "Cadherin 22" Q9UJ99 20 46173733-46308498 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.8" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 8.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 55.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012164, HPA012715" Uncertain Supported "HPA012164: AB_1845902, HPA012715: " "unprognostic (2.41e-4)" "unprognostic (1.72e-2)" "unprognostic (3.10e-1)" "unprognostic (4.32e-3)" "unprognostic (3.39e-2)" "unprognostic (4.73e-1)" "unprognostic (4.32e-1)" "unprognostic (2.54e-2)" "unprognostic (5.54e-2)" "unprognostic (4.50e-4)" "unprognostic (2.62e-1)" "unprognostic (3.09e-1)" "unprognostic (7.26e-3)" "unprognostic (5.93e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (9.83e-2)" 0.7 4.2 10.2 0.5 5.7 0.5 0.8 55.8 15.5 0.7 0.6 1.0 0.0 0.6 0.7 0.7 1.2 4.0 0.5 1.0 3.5 3.7 0.7 0.5 0.6 0.5 1.2 8.7 0.9 4.2 0.5 1.1 0.5 3.0 1.5 0.7 1.8 1.0 1.8 1.2 10.4 0.9 0.5 1.9 0.5 0.9 1.4 1.3 0.0 0.7 0.0 0.5 0.5 0.6 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 10.2 5.7 55.8 14.8 3.5 3.7 1.2 8.7 3.0 1.3 CDH23 "CDHR23, DFNB12, USH1D" ENSG00000107736 "Cadherin related 23" Q9H251 10 71396934-71815947 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Hearing, Sensory transduction, Vision" "Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 28.9" "Group enriched" "Detected in some" 4 "RT4: 16.1;SCLC-21H: 6.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 14.4;non-classical monocyte: 19.9" "Lineage enhanced" "Detected in many" "monocytes: 19.9" HPA017232 Approved 14000 "HPA017232: AB_1845903" "unprognostic (6.76e-2)" "unprognostic (2.86e-3)" "unprognostic (3.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.07e-1)" "unprognostic (5.52e-2)" "unprognostic (7.93e-2)" "unprognostic (2.88e-1)" "unprognostic (6.44e-3)" "unprognostic (4.67e-2)" "unprognostic (2.05e-1)" "unprognostic (9.23e-3)" "unprognostic (2.14e-3)" "unprognostic (2.33e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "prognostic favourable (3.40e-4)" 11.9 3.6 4.9 2.7 6.1 2.6 4.2 12.8 4.7 3.7 1.7 6.5 1.6 1.6 8.4 4.7 2.1 5.7 3.1 3.0 3.4 4.1 0.7 10.3 6.1 2.2 5.6 2.6 25.1 12.1 22.6 0.9 0.9 27.4 5.9 1.8 28.9 1.6 1.3 3.4 2.1 2.0 3.1 3.5 5.1 1.5 6.8 6.2 5.0 1.5 2.0 2.0 4.8 4.0 0.0 5.7 3.2 19.9 0.0 0.4 1.4 0.0 0.9 1.0 1.6 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.4 0.1 0.2 0.1 0.0 0.6 1.7 0.0 0.0 0.1 1.7 1.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 1.9 0.0 1.4 0.0 0.1 0.0 16.1 6.7 1.4 0.9 0.2 0.2 0.2 2.7 0.0 0.0 1.4 0.0 0.0 0.8 0.1 0.2 1.9 1.2 0.0 0.0 3.3 2.9 0.1 14.4 0.3 0.0 0.1 0.0 2.7 0.0 0.1 0.4 3.2 0.0 19.9 5.7 0.0 1.4 4.9 6.1 12.8 4.7 3.4 4.1 5.6 2.6 27.4 6.2 CDH24 CDH11L ENSG00000139880 "Cadherin 24" Q86UP0 14 23047062-23057538 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065233 Approved "Nucleoplasm,Cell Junctions,Centriolar satellite,Cytosol" "Nucleoplasm, Centriolar satellite" "Cell Junctions, Cytosol" "HPA065233: " "unprognostic (2.30e-1)" "unprognostic (3.06e-2)" "unprognostic (4.15e-3)" "unprognostic (6.21e-2)" "unprognostic (1.27e-1)" "unprognostic (9.18e-2)" "unprognostic (6.68e-3)" "unprognostic (2.71e-2)" "unprognostic (5.97e-3)" "unprognostic (3.55e-1)" "unprognostic (4.18e-2)" "unprognostic (5.97e-2)" "prognostic unfavourable (1.15e-4)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.37e-2)" "unprognostic (8.85e-2)" 5.8 4.7 8.0 4.3 9.3 2.9 5.0 13.0 12.6 6.2 4.5 4.0 6.1 3.0 13.4 3.2 5.8 5.8 10.1 3.8 10.5 5.1 4.6 1.1 4.7 3.4 4.4 4.8 3.8 3.5 8.3 3.1 5.7 5.3 4.6 4.5 7.9 4.7 4.5 1.8 7.2 5.0 10.2 4.0 5.2 4.1 3.4 6.6 7.8 6.8 3.8 4.1 7.3 6.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 2.5 2.5 10.6 12.0 2.6 1.3 5.9 4.8 3.1 4.0 5.2 3.2 3.5 0.2 3.9 5.2 14.6 4.5 4.0 3.3 3.9 3.8 0.5 6.5 1.0 2.9 7.3 0.2 10.2 1.3 4.4 2.9 6.6 1.5 6.3 3.5 7.2 0.5 4.9 2.6 5.9 12.7 3.5 4.7 1.1 2.1 30.8 8.2 11.2 6.0 0.6 5.3 1.0 6.1 4.0 15.5 1.6 3.5 2.0 0.6 0.1 4.2 2.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.0 9.3 13.0 12.6 10.5 5.1 4.4 4.8 5.3 6.6 CDH26 VR20 ENSG00000124215 "Cadherin 26" Q8IXH8 20 59958427-60034011 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.1;prostate: 15.3" "Cell line enriched" "Detected in some" 6 "RT4: 33.9" "Group enriched" "Detected in some" 6 "cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;eosinophil: 1.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA015722, HPA047578" Uncertain Supported "Plasma membrane,Microtubules" "Plasma membrane" Microtubules "HPA015722: AB_2077659, HPA047578: " "unprognostic (2.42e-1)" "prognostic favourable (7.62e-4)" "unprognostic (4.71e-4)" "unprognostic (8.17e-2)" "unprognostic (9.40e-2)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "prognostic favourable (3.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (3.26e-4)" "unprognostic (8.24e-3)" "unprognostic (9.96e-7)" "unprognostic (1.85e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" 0.8 0.5 0.8 0.7 1.2 1.3 0.8 2.0 1.1 3.8 0.7 0.7 0.7 0.5 1.3 0.7 3.8 2.5 0.7 0.7 1.2 1.0 0.7 0.7 2.9 0.7 1.3 0.7 2.0 0.7 0.7 1.9 0.7 1.4 15.3 0.4 1.4 2.8 0.7 1.0 0.4 0.7 0.7 1.6 0.7 1.9 0.7 0.7 4.2 0.7 0.7 16.1 6.2 1.3 0.0 0.9 1.6 1.4 0.0 0.2 0.4 0.0 0.5 0.1 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.0 0.6 0.6 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.1 0.0 5.2 0.0 0.1 0.0 0.2 0.2 0.1 1.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.4 0.4 0.1 0.0 0.0 0.6 0.0 33.9 0.7 0.1 0.3 0.2 0.1 0.1 0.4 0.1 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.0 1.4 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 1.2 2.0 1.1 1.2 1.0 1.3 0.7 1.4 0.7 CDH3 "CDHP, PCAD" ENSG00000062038 "Cadherin 3" P22223 16 68636189-68722616 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.0;retina: 40.5" "Cell line enhanced" "Detected in some" "A-431: 24.4;HaCaT: 67.7;HBEC3-KT: 32.6;hTCEpi: 26.1;hTERT-HME1: 19.9;RPTEC TERT1: 29.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 10 "pons and medulla: 16.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA001767, CAB002487" Enhanced Supported "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "CAB002487: AB_563446, HPA001767: AB_1078376" "unprognostic (1.55e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-1)" "unprognostic (4.38e-3)" "unprognostic (6.73e-2)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "prognostic unfavourable (8.53e-4)" "unprognostic (1.22e-1)" "unprognostic (3.45e-2)" "prognostic unfavourable (8.43e-4)" "unprognostic (4.30e-2)" "unprognostic (2.41e-5)" "unprognostic (2.11e-1)" "unprognostic (1.09e-1)" "unprognostic (1.33e-3)" "unprognostic (8.56e-2)" 2.2 0.1 1.0 2.5 1.2 0.0 8.7 1.5 1.1 10.5 1.0 2.2 3.0 0.3 9.4 10.3 23.5 8.9 1.4 0.4 1.1 0.8 8.3 0.2 3.6 2.1 0.6 0.4 32.6 0.4 0.5 3.6 6.4 16.0 11.7 0.5 40.5 9.3 4.4 0.1 21.2 0.4 4.1 1.5 10.0 0.7 2.2 0.1 44.0 2.0 26.1 20.1 2.5 6.7 0.9 0.6 1.4 0.5 0.6 0.8 0.2 24.4 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 14.6 9.1 0.0 0.1 0.0 67.7 0.6 32.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 26.1 0.0 19.9 0.0 0.0 0.0 0.0 12.7 0.0 0.0 1.2 2.0 0.0 0.0 0.0 29.3 11.0 0.1 0.0 0.2 0.0 11.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.5 0.2 0.4 0.2 0.3 0.6 0.5 0.4 0.1 0.9 0.6 0.8 1.4 0.6 0.2 0.6 0.2 0.2 1.0 1.2 1.5 1.1 1.1 0.8 0.6 0.4 16.0 0.1 CDH4 ENSG00000179242 "Cadherin 4" P55283 20 61252426-61940617 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;lymphoid tissue: 10.2;skeletal muscle: 9.8" "Cell line enhanced" "Detected in some" "AF22: 7.9;hTERT-HME1: 10.4;U-2 OS: 14.2;U-251 MG: 24.7" "Group enriched" "Detected in many" 6 "glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015613 Supported "Plasma membrane" "Plasma membrane" "HPA015613: AB_1845905" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "unprognostic (3.39e-4)" "unprognostic (2.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.64e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" "unprognostic (6.72e-2)" "unprognostic (6.08e-3)" "unprognostic (1.75e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (6.78e-2)" 1.0 1.2 17.4 0.7 15.8 0.9 0.9 1.3 13.6 0.9 0.7 4.0 0.0 0.8 0.9 0.7 1.4 2.6 0.9 1.0 10.2 6.9 0.8 0.9 1.0 0.9 2.8 11.8 6.2 2.0 0.7 0.5 0.9 3.3 0.8 0.7 0.6 1.5 3.6 9.8 2.7 0.8 0.7 1.6 10.2 0.8 1.9 3.1 0.0 1.7 0.0 0.7 0.8 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.9 7.9 0.0 0.1 0.5 0.1 2.2 0.0 4.0 0.4 0.2 0.0 0.0 0.2 2.6 2.9 0.0 4.3 1.6 0.2 0.0 0.0 0.1 0.1 5.5 0.0 0.1 0.8 1.0 0.8 10.4 0.8 0.0 0.0 1.6 0.3 0.1 0.0 0.9 0.0 0.0 0.0 1.1 2.5 0.0 0.7 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 14.2 0.1 24.7 4.6 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.0 17.4 15.8 1.3 13.6 10.2 6.9 2.8 11.8 3.3 3.1 CDH5 "7B4, CD144" ENSG00000179776 "Cadherin 5" P33151 16 66366622-66404786 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 96.6" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 111.2;TIME: 95.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB028366, HPA075875" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" 1000000000 "Plasma membrane" "Nucleoplasm, Nuclear membrane" "CAB028366: AB_2276033, HPA075875: " "unprognostic (1.05e-1)" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (4.89e-2)" "unprognostic (4.96e-2)" "unprognostic (5.50e-3)" "unprognostic (9.38e-2)" "unprognostic (5.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.33e-2)" "unprognostic (2.32e-1)" "prognostic unfavourable (5.14e-4)" "unprognostic (9.49e-3)" "unprognostic (3.01e-2)" "unprognostic (2.22e-1)" "unprognostic (3.15e-2)" 48.7 5.6 4.0 6.2 5.8 0.6 28.1 2.6 4.8 11.1 6.6 3.4 5.5 3.7 18.7 11.2 8.4 7.2 12.6 21.7 4.5 4.3 7.8 12.7 43.7 9.7 6.5 2.8 7.7 3.6 5.0 3.5 96.6 7.6 9.0 4.8 8.5 5.2 4.4 19.0 7.0 6.8 12.1 5.4 10.8 5.7 6.7 3.3 1.2 16.6 15.7 4.5 11.7 11.3 0.0 0.6 0.4 0.8 0.1 0.1 1.1 0.0 0.0 0.6 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 111.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 95.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 1.1 4.0 5.8 2.6 4.8 4.5 4.3 6.5 2.8 7.6 3.3 CDH6 ENSG00000113361 "Cadherin 6" P55285 5 31193750-31329146 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 73.8" "Cell line enriched" "Detected in some" 8 "EFO-21: 104.0" "Group enriched" "Detected in many" 5 "ovarian cancer: 15.0;renal cancer: 28.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA007047, HPA007403, HPA007456, CAB025274" Enhanced Supported "Cell Junctions" 1200000 "Cell Junctions" "CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373" "unprognostic (3.87e-2)" "unprognostic (4.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.92e-3)" "unprognostic (1.58e-2)" "unprognostic (7.61e-3)" "unprognostic (9.04e-2)" "unprognostic (2.68e-1)" "unprognostic (2.74e-2)" "unprognostic (5.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (8.29e-3)" "unprognostic (1.22e-3)" "unprognostic (2.67e-1)" "unprognostic (6.22e-2)" "unprognostic (2.09e-2)" 6.7 1.9 3.4 2.2 7.5 0.6 3.9 1.1 8.4 7.0 2.1 2.4 1.0 2.1 4.5 8.4 3.8 10.0 13.4 3.0 3.3 4.3 73.8 1.4 6.5 1.1 5.0 4.8 3.5 1.3 2.5 2.1 5.3 5.6 2.4 1.7 20.4 1.4 2.9 1.9 1.8 2.0 4.0 6.3 1.4 1.8 0.9 5.5 0.0 3.5 3.3 1.3 4.4 3.4 0.6 0.5 1.7 0.5 0.7 0.4 0.3 0.0 0.4 13.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 104.0 0.0 0.0 10.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 2.3 0.0 3.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.3 1.5 0.4 0.4 0.4 0.3 0.3 0.4 0.3 0.3 0.2 0.6 0.3 0.4 1.7 0.7 0.5 0.5 0.3 0.3 3.4 7.5 1.1 6.7 3.3 4.3 5.0 4.8 5.6 5.5 CDH7 ENSG00000081138 "Cadherin 7" Q9ULB5 18 65750252-65890341 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 16.7" "Cell line enhanced" "Detected in some" "AF22: 16.9;HEK 293: 3.2;Karpas-707: 6.2;RH-30: 8.1;U-87 MG: 3.8" "Cancer enhanced" "Detected in single" "prostate cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061419 Approved "HPA061419: " "unprognostic (2.81e-3)" "unprognostic (6.95e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (3.45e-2)" "unprognostic (2.41e-1)" "unprognostic (3.95e-3)" "unprognostic (2.88e-1)" "unprognostic (4.28e-4)" "unprognostic (2.70e-2)" "unprognostic (1.49e-1)" "unprognostic (1.72e-1)" 0.4 0.6 2.6 0.3 4.3 0.6 0.4 15.3 7.5 0.3 0.3 0.0 0.0 0.4 0.3 0.6 0.3 0.3 0.4 0.4 0.5 2.5 0.3 0.6 0.4 0.3 1.5 2.1 1.6 0.3 0.3 1.2 0.3 16.7 3.6 0.5 1.3 0.4 1.9 1.0 0.5 0.3 0.2 1.3 0.4 0.3 1.8 0.1 0.7 0.5 0.0 0.4 0.3 0.2 0.8 0.5 1.9 0.4 0.6 0.4 0.1 0.0 0.2 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.1 0.7 0.3 0.1 8.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.8 1.3 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 3.8 0.0 0.0 1.2 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.8 0.4 0.4 1.9 0.6 0.3 0.5 0.2 0.1 2.6 4.3 15.3 5.2 0.5 2.5 1.5 2.1 16.7 0.1 CDH8 ENSG00000150394 "Cadherin 8" P55286 16 61647242-62037035 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 29.6;seminal vesicle: 9.5" "Group enriched" "Detected in some" 4 "AF22: 6.8;fHDF/TERT166: 6.0;HaCaT: 13.6;LHCN-M2: 16.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014908, HPA076441" Approved Approved "Plasma membrane" "Plasma membrane" "HPA014908: AB_1845908, HPA076441: " "unprognostic (1.91e-1)" "unprognostic (2.41e-1)" "unprognostic (4.02e-2)" "unprognostic (7.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.71e-2)" "unprognostic (3.66e-2)" "unprognostic (5.41e-2)" "unprognostic (2.85e-1)" "unprognostic (6.59e-2)" "unprognostic (2.91e-4)" "unprognostic (6.02e-2)" "unprognostic (4.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.06e-1)" 0.9 0.9 13.0 0.7 20.4 0.7 1.2 0.5 29.6 1.4 0.8 5.5 0.0 1.2 0.9 1.1 1.0 0.7 1.1 1.1 10.4 7.7 0.8 0.7 0.9 0.7 9.3 12.2 3.7 0.7 0.8 0.9 1.3 12.8 1.4 0.9 0.0 1.4 9.5 1.4 0.9 1.0 1.4 7.7 0.8 0.8 1.2 5.6 0.0 1.0 0.0 0.8 1.7 0.3 0.0 0.0 1.0 0.2 0.1 0.1 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.0 13.6 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.3 0.0 16.4 0.0 0.0 0.0 1.2 1.2 0.0 0.0 1.0 0.0 1.8 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 13.0 20.4 0.5 17.8 10.4 7.7 9.3 12.2 12.8 5.6 CDH9 ENSG00000113100 "Cadherin 9" Q9ULB4 5 26880600-27121150 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 46.8" "Cell line enhanced" "Detected in some" "K-562: 9.2;NTERA-2: 13.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6" "Cell type enhanced" "Detected in some" "neutrophil: 8.3" "Group enriched" "Detected in many" 5 "B-cells: 4.1;granulocytes: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007167 Approved "HPA007167: AB_1078489" "unprognostic (1.49e-1)" "unprognostic (2.27e-4)" 0.7 0.5 46.8 1.0 24.6 2.8 0.7 0.5 23.7 0.5 0.8 0.0 0.0 0.6 0.9 1.2 0.7 0.5 0.7 0.5 15.9 3.5 10.5 0.5 0.6 1.6 1.2 15.6 0.6 1.1 1.0 0.5 0.8 1.5 1.0 1.2 0.0 0.5 0.1 0.5 1.9 1.5 0.8 0.6 0.8 0.9 3.7 2.6 0.0 1.9 0.0 1.7 0.5 0.5 4.1 0.9 8.3 1.1 0.1 0.8 1.1 2.4 0.9 0.5 0.8 0.4 0.0 1.6 0.0 0.9 0.3 0.6 0.0 0.9 1.3 0.3 0.3 0.3 0.1 0.5 0.0 0.1 0.2 0.5 0.7 2.5 0.0 0.0 1.5 0.6 0.7 0.0 0.0 0.2 9.2 2.3 0.0 1.5 0.8 0.5 13.6 0.5 0.3 0.3 0.4 0.5 0.5 3.1 0.3 0.0 0.4 0.4 0.5 0.9 1.7 0.1 0.8 0.8 0.3 2.7 1.0 4.3 1.0 1.0 0.8 1.3 0.2 0.4 0.2 0.7 0.6 4.1 0.4 0.2 0.1 2.5 0.3 0.5 8.3 0.1 1.1 0.9 0.8 1.1 46.8 24.6 0.5 23.7 15.9 3.5 1.2 15.6 1.5 2.6 CDHR1 "CORD15, KIAA1775, PCDH21, RP65" ENSG00000148600 "Cadherin related family member 1" Q96JP9 10 84194635-84219621 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cone-rod dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 31.2;intestine: 22.6;retina: 42.5;skin 1: 86.8" "Cell line enhanced" "Detected in some" "HAP1: 10.3;HEK 293: 5.3;HEL: 6.2;K-562: 4.4;NTERA-2: 4.5;RPTEC TERT1: 16.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 13.8" "Region enhanced" "Detected in many" "basal ganglia: 31.2" "Cell type enriched" "Detected in single" 11 "NK-cell: 10.5" "Lineage enriched" "Detected in single" 11 "NK-cells: 10.5" "Region enriched" "Detected in some" 21 "olfactory region: 408.8" "Low region specificity" "Detected in all" HPA036819 Enhanced "Intracellular and membrane" "HPA036819: AB_10671750" "unprognostic (8.91e-4)" "unprognostic (5.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.71e-2)" "unprognostic (2.63e-2)" "unprognostic (3.03e-2)" "unprognostic (6.40e-2)" "unprognostic (7.77e-2)" "unprognostic (1.41e-1)" "unprognostic (2.67e-1)" "unprognostic (6.69e-4)" "unprognostic (1.90e-1)" "unprognostic (5.51e-3)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" "unprognostic (4.56e-3)" "unprognostic (5.07e-2)" 0.3 1.2 1.9 0.7 31.2 0.5 2.3 0.9 7.7 2.8 12.3 2.2 0.0 0.3 0.6 2.2 4.8 0.6 0.5 0.9 3.4 2.1 0.5 0.5 0.4 0.7 1.5 3.1 0.8 0.4 0.3 1.5 0.4 9.3 0.9 22.6 42.5 1.0 2.2 0.7 86.8 5.3 0.9 1.2 3.0 0.4 0.4 3.0 2.4 0.4 3.3 0.9 0.4 1.5 0.0 0.0 0.0 0.0 10.5 0.9 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 10.3 2.0 0.0 0.0 5.3 6.2 0.0 0.0 0.2 0.0 0.2 0.0 2.2 0.0 0.7 0.0 4.4 0.0 0.0 0.0 0.0 1.5 4.5 0.0 0.0 0.0 1.3 16.8 0.0 3.5 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.1 1.9 31.2 0.9 7.7 3.4 2.1 1.5 3.1 9.3 3.0 CDHR2 "FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC" ENSG00000074276 "Cadherin related family member 2" Q9BYE9 5 176542511-176595974 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 179.8" "Cell line enriched" "Detected in some" 14 "Hep G2: 21.7" "Group enriched" "Detected in many" 14 "colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "hypothalamus: 2.5" "Low region specificity" "Detected in many" "HPA012569, HPA017053" Enhanced 3600000 "HPA012569: AB_1845298, HPA017053: AB_1845297" "unprognostic (1.34e-2)" "unprognostic (8.90e-4)" "unprognostic (3.82e-2)" "unprognostic (8.51e-2)" "unprognostic (5.10e-4)" "unprognostic (4.24e-3)" "unprognostic (6.66e-2)" "unprognostic (2.06e-3)" "unprognostic (1.54e-1)" "unprognostic (1.99e-1)" "unprognostic (7.66e-3)" "unprognostic (1.75e-1)" "prognostic favourable (9.29e-4)" "unprognostic (6.58e-2)" "unprognostic (3.55e-1)" "unprognostic (2.30e-2)" "unprognostic (1.42e-1)" 0.1 0.0 0.1 2.5 0.3 0.0 0.1 0.1 0.3 0.1 80.0 0.1 0.1 67.2 0.1 0.8 0.1 0.2 7.1 0.1 0.1 0.4 3.0 26.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 2.9 0.5 0.1 0.1 0.1 0.1 179.8 0.1 0.1 0.1 2.8 1.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.3 0.0 0.1 0.1 0.0 0.2 0.3 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.5 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.3 1.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.1 0.3 0.1 0.4 0.1 0.1 0.1 0.1 CDHR3 "CDH28, FLJ23834, FLJ44366" ENSG00000128536 "Cadherin related family member 3" Q6ZTQ4 7 105876796-106033773 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 51.9;lung: 28.9;ovary: 22.3" "Cell line enhanced" "Detected in some" "AF22: 7.7;Daudi: 9.9;WM-115: 6.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 15.9" "Group enriched" "Detected in some" 5 "memory B-cell: 2.9;naive B-cell: 6.9;neutrophil: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 6.9;granulocytes: 1.8" "Low region specificity" "Detected in many" HPA011218 Approved Approved "Nucleoli fibrillar center" "Nucleoli fibrillar center" "HPA011218: AB_1078886" "unprognostic (4.38e-4)" "unprognostic (9.18e-2)" "unprognostic (8.16e-3)" "unprognostic (8.08e-3)" "unprognostic (5.23e-2)" "unprognostic (1.55e-1)" "unprognostic (3.43e-2)" "unprognostic (1.18e-3)" "unprognostic (2.99e-2)" "unprognostic (1.92e-1)" "unprognostic (2.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.18e-1)" "unprognostic (2.77e-2)" "unprognostic (3.70e-3)" "unprognostic (3.51e-3)" 0.4 0.6 2.2 0.6 3.3 0.5 2.5 4.4 1.4 2.4 7.6 4.9 1.1 1.1 2.4 14.9 5.9 51.9 0.2 3.3 3.1 2.1 0.7 0.6 28.9 0.4 1.1 0.3 22.3 0.3 0.1 1.4 0.1 15.9 0.3 0.9 0.1 0.3 0.6 0.5 0.4 12.0 1.7 0.6 0.2 4.6 2.2 1.2 0.1 1.4 0.4 0.7 0.3 0.1 6.9 0.2 1.8 0.2 0.3 0.7 0.1 0.1 0.4 7.7 1.4 2.7 2.6 0.2 0.7 0.6 0.3 0.2 0.0 0.1 9.9 0.0 0.5 0.1 1.8 0.0 0.3 0.8 1.2 0.0 0.2 0.7 0.0 0.1 0.4 0.9 0.3 0.5 0.0 0.0 0.1 0.3 0.3 0.0 0.2 0.1 1.7 0.6 0.0 0.0 0.4 0.1 0.1 0.6 2.8 0.0 0.7 0.5 0.0 0.0 0.4 1.4 0.5 1.5 0.0 0.0 0.0 3.2 0.2 0.3 6.7 0.1 0.1 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 6.9 0.3 0.1 1.8 0.3 0.2 0.2 0.7 0.1 2.2 3.3 4.4 1.4 3.1 2.1 1.1 0.3 15.9 1.2 CDHR4 "CDH29, VLLR9392" ENSG00000187492 "Cadherin related family member 4" A6H8M9 3 49790732-49799835 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 37.8;fallopian tube: 42.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.6;HeLa: 4.4" "Cancer enriched" "Detected in some" 6 "endometrial cancer: 6.8" "Region enhanced" "Detected in some" "pons and medulla: 5.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 17.7" "Low region specificity" "Detected in many" HPA076277 Enhanced "Intracellular and membrane" "HPA076277: " "unprognostic (1.50e-4)" "unprognostic (4.87e-2)" "unprognostic (6.00e-2)" "unprognostic (2.00e-3)" "unprognostic (2.37e-2)" "unprognostic (2.45e-3)" "unprognostic (6.35e-7)" "unprognostic (1.17e-1)" "unprognostic (1.13e-2)" "unprognostic (1.12e-1)" "unprognostic (9.61e-2)" "unprognostic (2.35e-1)" "unprognostic (9.07e-11)" "unprognostic (2.65e-1)" "unprognostic (3.70e-2)" "unprognostic (1.13e-2)" "unprognostic (2.37e-1)" 0.2 0.1 0.4 0.1 1.6 0.3 0.1 0.0 0.0 4.9 0.2 1.9 0.0 0.1 1.3 37.8 0.1 42.7 0.1 0.1 0.7 0.9 0.1 0.1 11.4 0.1 0.0 0.0 8.0 0.0 0.0 0.8 0.6 5.7 0.1 0.1 0.0 0.1 0.2 0.1 0.9 0.1 0.3 0.2 0.0 0.1 3.9 0.0 0.0 0.0 0.5 0.2 0.2 0.1 1.1 1.5 3.0 4.1 1.3 0.4 5.8 0.5 1.7 0.5 0.3 0.5 4.6 0.3 0.4 0.1 0.9 1.0 0.0 2.6 0.0 0.2 1.1 0.5 0.1 0.0 0.3 0.3 0.3 0.8 4.4 1.0 0.0 0.3 0.5 0.7 1.5 0.8 0.3 0.0 0.2 0.7 0.0 0.0 0.0 0.8 0.3 0.2 0.8 0.2 0.0 0.0 0.3 0.1 0.1 1.5 1.1 0.0 0.2 0.1 0.0 0.6 0.2 0.7 0.1 0.6 2.3 0.1 2.1 1.2 0.0 3.0 4.1 0.4 0.4 1.6 0.3 0.4 0.3 0.3 1.5 1.1 0.3 0.4 2.5 1.3 0.2 0.5 0.2 5.8 0.4 1.6 0.0 0.0 0.7 0.9 0.0 0.0 5.7 0.0 CDHR5 "FLJ20219, MU-PCDH, MUCDHL, MUPCDH" ENSG00000099834 "Cadherin related family member 5" Q9HBB8 11 616565-626078 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 296.7" "Cell line enhanced" "Detected in some" "BEWO: 2.4;CACO-2: 6.6;RPMI-8226: 3.7" "Group enriched" "Detected in many" 17 "colorectal cancer: 33.2;liver cancer: 61.6;pancreatic cancer: 12.7;renal cancer: 35.4;stomach cancer: 26.7" "Region enriched" "Detected in single" 7 "pons and medulla: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA009081, HPA009173, CAB025004" Enhanced "Intracellular and membrane" 170000000 "CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429" "unprognostic (7.65e-2)" "unprognostic (1.42e-1)" "unprognostic (9.85e-2)" "unprognostic (1.21e-1)" "unprognostic (1.05e-1)" "unprognostic (5.56e-3)" "unprognostic (4.89e-2)" "unprognostic (3.85e-2)" "unprognostic (5.75e-2)" "unprognostic (6.36e-2)" "unprognostic (7.95e-2)" "unprognostic (5.07e-2)" "unprognostic (5.01e-2)" "unprognostic (3.90e-1)" "unprognostic (8.85e-2)" "unprognostic (2.29e-1)" "unprognostic (2.14e-2)" 0.1 0.3 0.1 8.1 0.1 0.0 0.1 0.1 0.1 0.1 118.7 0.4 0.0 34.3 0.1 0.8 0.1 0.2 12.1 0.1 0.2 0.1 10.9 43.8 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.2 0.0 1.6 0.1 21.3 5.1 0.1 0.0 0.1 0.1 296.7 0.8 0.1 0.1 1.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 6.6 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 1.5 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.7 0.8 0.0 0.1 0.1 3.7 0.0 0.3 0.0 1.6 0.0 0.2 0.0 0.0 0.2 0.6 0.1 0.1 0.3 1.1 0.0 0.3 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 1.6 0.0 CDIP1 "C16orf5, CDIP, LITAFL" ENSG00000089486 "Cell death inducing p53 target 1" Q9H305 16 4510675-4538828 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049352 Approved Supported Nucleoplasm,Centrosome Centrosome Nucleoplasm "HPA049352: " "unprognostic (6.38e-3)" "unprognostic (3.70e-3)" "unprognostic (2.95e-2)" "unprognostic (2.50e-3)" "unprognostic (2.74e-2)" "unprognostic (2.56e-2)" "unprognostic (3.48e-1)" "unprognostic (8.26e-2)" "unprognostic (3.68e-2)" "unprognostic (1.03e-2)" "prognostic favourable (2.14e-5)" "unprognostic (9.05e-2)" "prognostic favourable (1.14e-6)" "unprognostic (1.43e-2)" "unprognostic (3.51e-2)" "unprognostic (9.88e-2)" "unprognostic (4.65e-2)" 17.7 14.2 36.8 6.9 41.6 5.1 8.2 36.4 54.6 13.6 9.5 16.3 2.7 30.0 13.4 4.4 8.0 10.9 9.5 25.0 33.8 37.1 23.7 13.2 9.6 8.2 34.2 38.9 18.7 22.9 10.4 19.3 8.5 26.3 13.2 4.1 7.8 10.8 14.7 34.0 9.1 24.2 8.7 20.7 12.0 9.2 10.1 15.7 13.0 10.6 6.7 6.9 7.8 6.3 8.7 9.2 19.3 19.2 14.3 15.9 7.2 3.8 1.6 5.4 1.6 0.4 0.0 0.1 5.9 0.9 5.8 5.0 9.3 1.5 0.2 6.0 4.8 0.1 4.9 20.8 1.0 13.1 9.3 17.6 6.2 24.1 3.9 8.5 11.0 5.7 10.8 5.2 0.8 4.6 0.3 4.8 6.5 0.4 6.6 11.1 12.0 4.6 25.0 4.8 48.1 1.2 0.1 16.3 7.0 11.8 0.5 7.3 2.1 4.7 0.2 3.0 8.9 2.0 0.2 12.9 11.9 17.8 0.1 8.6 2.0 3.2 7.9 19.3 15.9 12.5 8.6 8.7 5.7 8.9 7.6 8.3 11.4 9.7 6.2 14.3 19.2 9.2 9.1 7.2 36.8 41.6 36.4 50.3 33.8 37.1 34.2 38.9 26.3 15.7 CDKAL1 FLJ20342 ENSG00000145996 "CDK5 regulatory subunit associated protein 1 like 1" Q5VV42 6 20534457-21232404 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "tRNA processing" Transferase "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "SCLC-21H: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057474 Uncertain Vesicles Vesicles "HPA057474: " "unprognostic (9.64e-2)" "unprognostic (7.23e-3)" "unprognostic (8.40e-2)" "prognostic unfavourable (1.03e-4)" "unprognostic (1.05e-1)" "unprognostic (1.51e-2)" "unprognostic (3.47e-2)" "unprognostic (4.25e-3)" "unprognostic (6.72e-3)" "unprognostic (1.61e-3)" "unprognostic (1.42e-1)" "unprognostic (3.73e-2)" "unprognostic (5.79e-3)" "unprognostic (3.11e-2)" "unprognostic (1.75e-2)" "unprognostic (1.83e-2)" "unprognostic (2.60e-2)" 18.5 9.8 10.9 18.0 12.2 14.7 13.9 24.1 10.6 16.6 11.4 14.6 9.6 8.1 19.4 12.1 12.1 13.5 11.4 10.8 9.0 7.8 10.8 9.7 11.9 13.4 12.4 7.7 16.6 14.1 12.0 29.9 12.6 11.2 10.8 12.0 14.3 15.7 11.0 22.2 15.0 11.4 13.7 13.4 13.9 11.7 11.4 13.8 22.9 17.1 13.6 19.4 13.2 12.6 8.1 5.4 3.3 11.2 12.0 9.7 3.6 2.9 1.8 4.2 5.4 2.4 3.2 4.4 3.0 2.8 4.5 6.0 3.3 2.6 6.9 7.7 2.6 2.9 5.6 3.1 6.1 12.4 3.1 5.9 3.1 4.4 3.1 5.8 4.1 2.9 3.3 4.3 4.0 4.1 7.6 2.8 3.3 2.4 7.3 6.9 2.9 2.0 4.3 5.6 6.5 5.8 3.3 66.0 3.9 3.4 5.5 4.4 4.0 2.9 4.0 5.3 3.7 2.1 5.6 4.5 11.9 6.1 1.9 3.3 8.9 1.5 3.6 3.3 7.8 5.9 6.5 8.1 7.7 7.7 4.9 7.8 9.7 8.6 1.9 12.0 11.2 5.4 8.2 3.6 10.9 12.2 24.1 10.6 9.0 7.8 12.4 7.7 11.2 13.8 CDON "CDO, CDON1, ORCAM" ENSG00000064309 "Cell adhesion associated, oncogene regulated" Q4KMG0 11 125955796-126063335 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 23.1;ASC diff: 29.3;RH-30: 40.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 26.8" "Cell type enhanced" "Detected in some" "basophil: 2.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB012422, HPA017377" Uncertain 9400000 "CAB012422: AB_2260246, HPA017377: AB_1846453" "prognostic favourable (1.35e-4)" "unprognostic (1.03e-1)" "unprognostic (2.86e-2)" "unprognostic (1.25e-4)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (2.49e-3)" "unprognostic (5.77e-3)" "unprognostic (2.78e-1)" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (3.09e-1)" "prognostic unfavourable (1.78e-7)" "unprognostic (5.39e-2)" "unprognostic (1.51e-1)" "unprognostic (5.83e-3)" "unprognostic (1.86e-4)" 10.4 0.9 1.2 7.9 2.9 0.1 5.3 26.8 4.2 14.6 10.5 2.3 1.5 1.4 16.4 6.3 5.0 14.1 12.6 4.1 1.0 1.5 1.1 1.2 3.7 1.3 0.9 1.9 28.5 1.3 4.1 4.1 3.2 3.6 4.8 2.1 7.2 1.7 4.1 1.2 12.8 3.8 20.6 1.0 0.8 5.6 4.1 1.0 3.0 27.1 2.8 1.8 6.6 6.7 0.5 0.4 2.8 0.3 0.4 0.7 0.1 1.4 1.7 23.1 2.6 29.3 12.4 0.6 0.5 2.8 0.9 0.3 0.7 9.0 1.2 6.5 0.5 0.3 5.4 1.0 0.8 4.2 4.3 0.4 4.6 2.8 7.0 0.4 1.5 4.0 1.5 0.7 0.2 0.2 0.1 1.5 3.0 0.6 2.8 0.8 2.8 3.6 0.8 40.0 0.9 1.7 0.5 2.2 10.2 2.8 0.4 3.5 1.9 1.1 0.2 3.0 2.3 5.6 3.5 2.2 3.6 0.3 1.7 1.6 2.9 2.8 0.3 0.3 0.3 0.1 0.2 0.2 0.4 0.4 0.0 0.5 0.7 0.5 1.8 0.4 0.3 0.4 0.3 0.1 1.2 2.9 26.8 4.2 1.0 1.5 0.9 1.9 3.6 1.0 CEACAM1 "BGP, BGP1, CD66a" ENSG00000079385 "Carcinoembryonic antigen related cell adhesion molecule 1" P13688 19 42507304-42561234 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 58.7;liver: 46.1;lymphoid tissue: 46.5" "Group enriched" "Detected in some" 4 "CAPAN-2: 12.5;Hep G2: 35.4;RT4: 23.3;SK-MEL-30: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "eosinophil: 20.6;neutrophil: 12.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 20.6" "CAB002146, HPA011041" Enhanced "Intracellular and membrane" 180000000 "CAB002146: AB_563614, HPA011041: AB_1078481" "unprognostic (7.13e-3)" "unprognostic (2.15e-1)" "unprognostic (2.67e-2)" "prognostic favourable (6.32e-7)" "unprognostic (3.04e-1)" "unprognostic (1.80e-3)" "unprognostic (1.21e-1)" "unprognostic (4.45e-2)" "unprognostic (4.43e-1)" "unprognostic (5.46e-3)" "unprognostic (4.87e-2)" "unprognostic (4.03e-1)" "unprognostic (1.92e-2)" "unprognostic (1.88e-1)" "unprognostic (1.06e-1)" "unprognostic (7.55e-2)" "unprognostic (5.52e-3)" 5.3 5.0 0.4 30.2 0.7 15.8 5.3 0.5 0.5 7.7 58.7 0.9 2.5 11.8 3.5 1.5 35.6 1.7 4.3 3.8 0.5 0.5 24.0 46.1 5.4 8.6 1.8 0.0 2.5 1.0 0.0 3.7 16.8 1.0 8.8 35.6 1.7 20.7 5.4 0.9 1.7 54.9 3.0 1.5 5.5 3.6 1.3 0.7 1.2 2.3 18.5 46.5 7.8 12.7 1.9 0.1 20.6 1.8 0.0 1.5 0.3 0.1 2.3 0.1 0.1 0.0 0.0 6.0 0.0 0.1 0.4 0.2 0.9 12.5 0.7 5.0 0.0 0.3 0.0 3.4 0.1 0.0 0.2 0.1 0.1 35.4 0.7 0.0 5.1 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.4 0.1 0.0 0.1 0.7 0.7 0.0 0.5 0.2 23.3 0.1 0.0 0.0 0.0 26.2 0.1 0.0 0.8 0.1 0.2 0.1 0.1 0.7 0.0 1.3 0.0 0.1 0.1 0.4 0.0 20.6 0.0 0.9 0.2 1.9 0.5 0.2 0.1 0.3 0.4 0.1 12.7 0.0 1.8 0.0 1.5 0.3 0.4 0.7 0.5 0.5 0.5 0.5 1.8 0.0 1.0 0.7 CEACAM19 CEAL1 ENSG00000186567 "Carcinoembryonic antigen related cell adhesion molecule 19" Q7Z692 19 44662278-44684359 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 13.8;TIME: 17.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014462, HPA052865" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoli, Mitochondria" Nucleoplasm "HPA014462: , HPA052865: " "unprognostic (2.91e-1)" "unprognostic (5.29e-3)" "unprognostic (6.96e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-2)" "unprognostic (8.43e-2)" "unprognostic (5.22e-2)" "unprognostic (1.15e-2)" "unprognostic (9.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.77e-1)" "unprognostic (3.26e-9)" "unprognostic (8.01e-3)" "unprognostic (9.62e-2)" "unprognostic (1.31e-1)" "unprognostic (2.70e-1)" 1.6 2.9 1.1 0.8 1.9 1.0 2.4 4.3 1.7 3.1 2.4 2.7 2.7 1.4 2.4 4.3 2.1 4.1 1.2 1.8 3.3 4.3 3.8 0.6 0.6 4.0 4.7 1.2 3.9 1.8 4.1 3.3 2.9 3.0 12.5 10.8 2.9 3.0 0.9 1.8 2.0 3.0 3.4 1.7 1.0 4.4 1.7 0.5 1.7 1.0 1.0 0.7 0.6 4.3 8.8 1.3 0.9 3.1 3.6 3.3 2.4 3.6 0.8 1.6 0.3 1.0 0.1 0.8 3.3 5.3 2.2 0.9 0.7 1.2 5.0 0.1 4.7 1.4 3.2 0.2 0.8 1.1 8.8 2.2 5.4 2.1 0.3 0.2 1.2 1.0 0.0 0.5 0.8 1.0 0.0 1.6 0.2 13.8 1.0 1.7 0.4 0.9 0.9 0.8 1.2 0.3 17.8 0.3 6.1 1.3 0.7 0.1 0.3 0.0 0.4 1.7 1.4 1.7 1.0 0.6 0.6 0.4 0.3 0.5 0.3 0.6 0.2 1.7 0.4 0.7 1.6 1.0 0.5 0.5 0.3 0.6 CEACAM21 "FLJ13540, R29124_1" ENSG00000007129 "Carcinoembryonic antigen related cell adhesion molecule 21" Q3KPI0 19 41549518-41586844 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 19.1;bone marrow: 21.1;lymphoid tissue: 22.7" "Cell line enhanced" "Detected in some" "HMC-1: 9.5;Karpas-707: 7.6;U-266/70: 8.4;U-937: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA043411 Uncertain "HPA043411: AB_10794886" "unprognostic (2.55e-1)" "unprognostic (1.61e-3)" "unprognostic (5.73e-2)" "prognostic favourable (1.89e-5)" "unprognostic (2.57e-1)" "unprognostic (8.02e-4)" "unprognostic (3.04e-1)" "unprognostic (2.05e-3)" "unprognostic (1.51e-2)" "unprognostic (2.63e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (3.37e-6)" "unprognostic (2.09e-1)" "unprognostic (3.67e-1)" "unprognostic (1.12e-3)" "unprognostic (1.37e-1)" 1.8 1.2 1.6 18.5 1.7 21.1 1.3 1.0 1.4 3.5 3.8 2.4 0.0 1.2 3.9 1.4 1.5 1.4 1.1 2.1 2.0 7.2 1.4 1.8 7.2 19.2 8.4 0.5 1.1 0.7 0.3 1.0 2.4 1.9 1.2 1.2 2.0 4.3 6.2 0.5 0.6 5.0 0.9 3.3 22.7 1.4 1.5 1.6 11.1 1.2 0.7 22.4 2.9 0.8 6.9 7.0 13.0 4.6 10.3 19.1 10.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 8.4 1.5 1.6 0.0 6.4 0.0 0.0 2.6 10.8 19.1 4.6 12.8 6.7 16.5 13.1 2.8 6.9 14.2 13.8 13.0 10.3 2.8 7.0 14.6 10.1 1.6 1.7 1.0 1.4 2.0 7.2 8.4 0.5 1.9 1.6 CEACAM3 "CD66d, CGM1" ENSG00000170956 "Carcinoembryonic antigen related cell adhesion molecule 3" P40198 19 41796437-41811553 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 60.0;bone marrow: 35.4" "Cell line enhanced" "Detected in single" "PC-3: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 7 "neutrophil: 60.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 60.0" HPA011041 Approved "HPA011041: AB_1078481" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-2)" "unprognostic (2.95e-2)" "unprognostic (2.19e-1)" "unprognostic (8.09e-3)" "unprognostic (1.44e-1)" "unprognostic (2.85e-1)" "unprognostic (1.49e-1)" "unprognostic (3.19e-2)" "unprognostic (1.62e-1)" "unprognostic (8.07e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-1)" "unprognostic (4.68e-2)" "unprognostic (8.44e-2)" "unprognostic (2.83e-1)" 0.9 0.3 0.3 3.6 0.8 35.4 0.7 0.2 0.8 0.6 1.0 0.0 0.0 0.2 0.4 0.2 1.2 0.7 0.4 5.1 0.4 0.3 0.4 1.1 14.0 11.5 1.8 0.1 0.7 1.0 0.2 0.3 4.6 0.5 0.3 0.3 1.4 0.8 0.2 1.5 0.2 0.6 0.4 0.3 10.7 0.4 0.9 0.2 1.6 0.5 0.3 2.7 0.8 0.6 0.0 0.8 60.0 8.9 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 60.0 0.0 8.9 0.0 0.0 0.6 0.3 0.8 0.2 0.8 0.4 0.3 1.8 0.1 0.5 0.2 CEACAM6 "CD66c, NCA" ENSG00000086548 "Carcinoembryonic antigen related cell adhesion molecule 6" P40199 19 41750977-41772208 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 81.4;gallbladder: 75.7;lung: 129.1" "Cell line enriched" "Detected in some" 8 "A549: 57.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.6" "Group enriched" "Detected in many" 6 "granulocytes: 2.6;monocytes: 1.3" "CAB008370, HPA011041" Enhanced 79000000 "CAB008370: AB_592067, HPA011041: AB_1078481" "unprognostic (1.00e-2)" "unprognostic (2.05e-1)" "unprognostic (2.62e-2)" "unprognostic (8.22e-2)" "unprognostic (1.39e-1)" "unprognostic (9.06e-3)" "unprognostic (2.32e-2)" "unprognostic (1.37e-1)" "unprognostic (2.49e-1)" "unprognostic (5.22e-2)" "unprognostic (3.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.42e-4)" "unprognostic (4.08e-1)" "unprognostic (8.71e-3)" "unprognostic (2.85e-1)" "unprognostic (7.68e-2)" 0.3 0.3 0.3 7.4 0.3 29.7 0.3 0.3 0.3 16.8 35.3 0.2 0.1 5.8 0.9 0.2 81.4 1.1 75.7 2.3 0.3 0.3 0.3 0.8 129.1 0.1 0.3 0.1 0.3 1.7 0.0 0.3 32.1 0.2 0.9 43.1 0.2 50.1 0.1 0.3 2.1 12.8 0.9 0.3 0.8 2.6 0.3 0.1 1.0 0.3 25.3 58.1 2.3 21.0 0.1 0.3 2.6 1.3 0.1 0.3 5.2 0.0 57.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 1.6 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.3 0.2 0.6 0.0 0.0 1.5 0.0 0.2 0.6 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.6 0.1 0.5 0.3 0.0 5.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 CEACAM7 "CEA, CGM2" ENSG00000007306 "Carcinoembryonic antigen related cell adhesion molecule 7" Q14002 19 41673307-41706976 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 100.5;lymphoid tissue: 60.9" "Cell line enhanced" "Detected in some" "HaCaT: 2.8;U-2 OS: 1.4;U-266/84: 2.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 66.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA069621 Supported "Intracellular and membrane" "HPA069621: " "unprognostic (5.24e-2)" "unprognostic (2.72e-1)" "unprognostic (1.64e-2)" "unprognostic (6.03e-2)" "unprognostic (2.07e-2)" "unprognostic (4.30e-2)" "unprognostic (3.61e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (1.86e-1)" "unprognostic (3.14e-1)" 0.1 0.1 0.1 60.9 0.1 0.0 0.1 0.1 0.1 9.2 90.0 0.1 0.1 0.0 0.6 0.1 21.1 0.3 5.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.0 0.0 0.1 0.3 0.1 0.3 100.5 0.2 1.5 0.1 0.1 0.5 0.2 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 12.1 19.4 6.1 13.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.1 2.3 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 CEBPZOS CEBPZ-AS1 ENSG00000218739 "CEBPZ opposite strand" A8MTT3 2 37196488-37216193 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053866 Uncertain Approved Nucleoplasm Nucleoplasm "HPA053866: " "unprognostic (2.13e-1)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" "unprognostic (8.05e-3)" "prognostic unfavourable (1.72e-6)" "unprognostic (2.34e-2)" "unprognostic (2.40e-2)" "unprognostic (5.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.79e-1)" "prognostic unfavourable (3.46e-7)" "unprognostic (3.69e-2)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-2)" 16.5 31.3 29.5 16.2 25.4 17.9 18.5 21.0 30.2 16.9 19.8 16.3 19.1 19.0 25.9 33.0 19.3 19.5 14.4 24.5 43.8 23.8 21.5 18.2 13.8 16.5 23.6 31.3 22.8 14.9 18.6 30.2 22.1 25.4 22.3 18.9 16.1 23.9 16.7 38.4 19.0 22.0 17.1 19.4 13.8 15.3 20.3 12.7 12.9 23.7 19.8 15.1 19.4 14.0 20.9 29.4 15.3 15.3 13.1 25.2 13.7 25.9 8.7 18.6 15.1 19.9 21.6 18.1 19.3 17.4 12.5 9.2 8.1 11.8 9.0 10.4 19.1 15.3 10.1 14.6 15.4 24.3 21.1 24.2 10.1 12.7 17.2 30.1 13.6 22.9 20.2 16.8 18.9 20.0 18.2 13.6 20.3 5.2 7.5 29.6 27.5 13.4 22.6 25.7 20.6 22.0 7.1 20.0 19.7 14.7 24.6 18.8 11.0 18.3 17.5 13.6 16.7 19.8 16.6 24.3 0.2 19.6 25.2 18.2 19.2 15.3 14.1 12.1 17.7 15.3 20.4 20.9 20.1 18.5 13.5 18.0 25.2 22.4 5.7 13.1 11.5 29.4 13.7 13.7 29.5 25.4 21.0 30.2 43.8 23.8 23.6 31.3 25.4 12.7 CEND1 "BM88, FLJ90066" ENSG00000184524 "Cell cycle exit and neuronal differentiation 1" Q8N111 11 787104-790123 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 85.2" "Cell line enhanced" "Detected in some" "Karpas-707: 16.7;SCLC-21H: 30.0;SH-SY5Y: 11.2;U-266/70: 11.7;U-87 MG: 15.6" "Cancer enriched" "Detected in many" 13 "glioma: 24.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042527 Enhanced Approved Mitochondria Mitochondria "HPA042527: AB_2678038" "unprognostic (4.62e-3)" "unprognostic (1.34e-4)" "unprognostic (9.66e-3)" "unprognostic (1.27e-2)" "prognostic unfavourable (4.38e-5)" "unprognostic (2.20e-3)" "unprognostic (4.11e-2)" "unprognostic (6.72e-2)" "unprognostic (2.60e-2)" "unprognostic (2.26e-1)" "unprognostic (2.00e-3)" "unprognostic (4.24e-3)" "unprognostic (1.94e-3)" "unprognostic (4.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" 1.9 8.2 28.5 2.9 34.7 1.8 1.8 46.5 85.2 1.8 2.3 8.3 1.3 2.5 1.9 2.0 2.2 1.8 1.9 2.1 34.2 25.3 2.1 1.8 1.8 2.1 32.0 30.7 1.8 1.9 1.9 5.1 1.8 42.4 3.2 1.9 2.1 1.8 3.6 1.8 1.9 2.7 2.3 10.2 1.8 1.9 1.9 5.9 0.0 1.8 0.0 2.0 2.1 0.1 3.6 0.2 0.0 0.7 0.0 1.9 0.3 0.0 0.4 0.4 0.7 0.1 0.1 0.1 0.7 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.1 0.0 2.9 0.3 0.0 0.4 0.0 0.1 0.0 16.7 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 30.0 11.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 11.7 3.2 0.7 15.6 0.1 0.2 0.0 0.0 0.0 0.9 0.7 0.3 3.6 1.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.3 28.5 34.7 46.5 65.2 34.2 25.3 32.0 30.7 42.4 5.9 CEP170 "FAM68A, KAB, KIAA0470" ENSG00000143702 "Centrosomal protein 170" Q5SW79 1 243124428-243255348 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.7" "Cell line enhanced" "Detected in many" "WM-115: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042151, HPA045597, HPA045787" Uncertain Enhanced "Mitotic spindle,Centrosome,Cytosol" Centrosome "Mitotic spindle, Cytosol" "HPA042151: , HPA045597: , HPA045787: " "unprognostic (2.97e-1)" "unprognostic (2.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (7.60e-2)" "unprognostic (6.83e-5)" "unprognostic (8.05e-2)" "unprognostic (9.88e-3)" "unprognostic (7.09e-2)" "unprognostic (3.52e-2)" "unprognostic (6.65e-2)" "prognostic unfavourable (1.30e-9)" "unprognostic (2.21e-2)" "unprognostic (2.17e-1)" "unprognostic (6.49e-3)" "unprognostic (9.62e-3)" 9.5 6.1 13.7 10.8 13.2 36.5 6.8 27.7 23.2 7.4 5.4 11.4 3.1 3.1 9.1 5.2 5.5 6.4 11.1 8.6 12.8 11.2 3.8 6.7 8.4 7.3 19.3 13.7 13.3 2.8 2.8 10.8 9.8 20.2 5.0 4.2 3.3 4.2 5.5 9.3 4.2 4.7 7.4 25.8 7.8 4.2 53.7 18.0 11.6 14.4 3.3 8.9 8.6 6.6 9.4 8.4 12.3 10.1 2.8 4.7 2.1 6.0 5.1 13.1 11.1 8.2 15.9 2.8 16.1 9.5 12.1 11.4 3.1 5.9 4.5 9.8 13.6 3.0 11.3 6.9 17.2 10.0 6.5 4.6 4.8 2.2 7.1 8.2 8.8 10.0 1.9 38.5 16.9 28.1 11.3 4.7 15.3 1.3 5.0 4.3 16.5 14.5 9.0 9.4 1.5 2.5 1.0 19.0 25.7 8.2 0.7 7.7 2.8 11.1 31.1 22.6 6.7 12.1 18.4 4.6 5.9 9.0 12.0 7.5 51.8 3.5 8.3 7.6 1.9 10.0 2.7 3.6 3.8 1.6 8.4 9.4 4.7 2.7 12.3 2.8 10.1 5.5 2.9 2.1 13.7 13.2 27.7 15.8 12.8 11.2 19.3 13.7 20.2 18.0 CEP95 "CCDC45, DKFZp667E1824" ENSG00000258890 "Centrosomal protein 95" Q96GE4 17 64506588-64542461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023654, HPA052426, HPA052428, HPA061371" Approved Approved "Nucleoplasm,Vesicles,Mitotic spindle,Centrosome" Nucleoplasm "Vesicles, Mitotic spindle, Centrosome" "HPA023654: AB_2072077, HPA052426: , HPA052428: , HPA061371: " "unprognostic (1.28e-2)" "unprognostic (9.12e-2)" "unprognostic (3.66e-3)" "unprognostic (4.09e-2)" "unprognostic (3.30e-2)" "prognostic favourable (5.78e-4)" "prognostic unfavourable (2.52e-5)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (3.57e-3)" "prognostic unfavourable (5.76e-5)" "unprognostic (3.48e-1)" "unprognostic (1.84e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" 13.0 8.6 10.9 17.1 13.1 37.9 15.5 27.9 15.6 16.7 14.2 16.2 11.6 11.9 26.5 16.6 10.7 17.1 12.3 10.6 11.5 7.8 14.1 11.7 13.0 20.7 13.6 7.9 27.3 15.5 11.8 20.4 8.5 13.0 15.2 13.5 15.6 13.8 19.8 14.6 21.7 14.2 15.0 17.4 13.2 13.3 16.9 13.9 26.4 21.0 8.6 14.7 14.3 14.0 5.9 3.7 2.2 3.6 2.1 10.8 2.4 10.0 6.4 13.1 11.3 3.5 9.0 13.1 5.1 5.2 6.4 9.7 7.7 5.8 16.1 3.4 7.2 12.8 11.2 9.9 13.2 4.2 8.6 14.3 12.4 14.8 11.6 15.5 7.7 10.2 10.4 7.1 15.9 5.4 16.4 11.8 7.0 11.8 19.6 9.9 8.1 8.0 14.1 23.7 11.9 7.4 16.1 8.3 15.0 7.0 10.3 13.3 11.4 10.4 8.0 14.6 11.4 6.7 6.9 12.0 9.6 17.1 6.3 11.9 8.9 2.2 3.6 2.2 4.5 2.9 10.8 4.5 5.2 4.5 3.4 5.9 8.0 5.4 1.4 2.1 3.4 3.7 4.2 2.4 10.9 13.1 27.9 15.6 11.5 7.8 13.6 7.9 13.0 13.9 CERS2 "FLJ10243, LASS2, SP260" ENSG00000143418 "Ceramide synthase 2" Q96G23 1 150960583-150975004 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 142.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027262 Approved Supported "Nuclear membrane,Endoplasmic reticulum" 24000 "Nuclear membrane, Endoplasmic reticulum" "HPA027262: AB_1852717" "unprognostic (1.01e-1)" "unprognostic (2.70e-3)" "unprognostic (3.72e-2)" "unprognostic (1.29e-2)" "unprognostic (8.23e-2)" "unprognostic (2.03e-2)" "unprognostic (7.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.34e-1)" "unprognostic (4.05e-2)" "unprognostic (8.17e-3)" "unprognostic (1.11e-1)" "unprognostic (2.63e-2)" "unprognostic (1.56e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" 19.4 65.5 17.0 10.5 36.1 13.9 22.6 9.6 21.3 19.8 21.1 59.3 22.1 19.6 16.9 19.0 12.5 21.1 21.6 14.4 23.0 16.1 60.9 142.3 28.6 14.0 50.1 14.5 21.8 29.7 28.7 17.6 24.0 25.5 18.5 18.8 16.5 12.3 19.2 7.1 9.1 33.3 21.2 63.7 13.2 23.4 10.2 38.7 10.2 35.5 8.8 14.0 17.5 25.6 12.3 23.5 56.6 27.0 19.3 33.6 26.2 25.7 28.2 23.8 51.0 71.1 43.7 17.8 26.4 38.8 50.3 34.6 29.5 45.7 22.7 44.1 41.4 29.4 33.0 28.1 41.4 30.8 26.9 31.3 19.8 35.8 51.5 35.5 38.8 39.7 36.3 44.4 55.4 31.3 33.5 52.0 62.8 38.8 23.2 20.5 36.5 50.5 26.5 16.2 36.2 54.5 21.9 22.0 34.3 29.1 51.7 30.1 61.6 53.9 24.3 36.5 16.4 32.9 46.4 33.7 37.8 142.5 41.0 15.2 36.9 56.6 27.0 44.0 28.0 14.6 33.6 12.3 25.7 28.4 23.4 11.4 22.9 22.2 29.2 19.3 10.2 23.5 28.8 26.2 17.0 36.1 9.6 21.3 23.0 16.1 50.1 14.5 25.5 38.7 CERS4 "FLJ12089, LASS4, Trh1" ENSG00000090661 "Ceramide synthase 4" Q9HA82 19 8206736-8262421 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 21.2;NB-4: 38.2;U-937: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033734, HPA054729" Uncertain Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB033734: AB_2132977, HPA054729: " "unprognostic (5.96e-2)" "prognostic favourable (2.71e-4)" "unprognostic (2.46e-2)" "unprognostic (2.82e-2)" "unprognostic (1.30e-1)" "prognostic favourable (7.83e-4)" "unprognostic (1.74e-1)" "prognostic favourable (3.45e-5)" "unprognostic (1.48e-2)" "unprognostic (3.32e-1)" "prognostic favourable (8.05e-4)" "unprognostic (1.77e-1)" "prognostic favourable (9.63e-5)" "unprognostic (6.08e-3)" "unprognostic (2.69e-2)" "unprognostic (2.91e-2)" "unprognostic (8.08e-3)" 6.2 6.7 17.5 10.5 22.9 2.5 21.6 14.5 19.3 13.2 6.8 24.3 7.8 4.6 9.9 41.8 26.4 11.9 7.7 9.7 16.1 10.8 16.5 32.4 12.9 12.2 26.9 13.3 13.8 56.7 11.6 10.1 2.2 16.8 22.4 3.2 26.2 34.8 12.8 2.1 20.9 6.1 8.5 20.3 8.6 9.9 8.4 29.0 6.4 38.1 9.5 15.9 9.3 13.2 13.3 2.7 16.9 4.4 13.5 5.2 3.5 0.1 0.9 0.9 10.0 0.3 0.0 0.7 1.3 3.3 1.5 0.7 7.5 0.8 15.6 11.1 0.0 5.3 6.5 0.1 0.7 13.7 5.1 3.0 0.1 21.2 12.9 0.0 8.5 5.0 8.4 3.5 7.6 0.1 2.2 0.5 0.0 0.3 1.2 38.2 10.2 3.7 18.8 0.2 1.2 2.5 0.0 3.8 5.1 1.6 0.3 5.4 7.4 3.5 0.0 1.1 3.2 7.5 0.0 9.8 7.8 11.9 0.0 23.9 1.1 5.9 4.4 16.9 5.2 2.3 3.9 13.3 3.0 3.1 2.7 12.1 2.8 2.6 14.0 13.5 1.5 2.6 3.5 3.5 17.5 22.9 14.5 19.3 16.1 10.8 26.9 13.3 16.8 29.0 CERS5 "FLJ25304, LASS5, MGC45411, Trh4" ENSG00000139624 "Ceramide synthase 5" Q8N5B7 12 50129306-50167533 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026589 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA026589: AB_1852727" "unprognostic (1.59e-2)" "unprognostic (9.83e-2)" "unprognostic (5.17e-2)" "unprognostic (3.64e-2)" "unprognostic (3.02e-1)" "unprognostic (2.49e-3)" "prognostic unfavourable (4.63e-5)" "unprognostic (5.56e-2)" "unprognostic (1.65e-2)" "unprognostic (9.26e-2)" "unprognostic (1.88e-3)" "unprognostic (5.67e-2)" "prognostic unfavourable (9.33e-11)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "prognostic favourable (5.76e-5)" "unprognostic (3.26e-1)" 18.0 13.2 18.3 13.3 21.6 10.9 18.0 38.3 19.6 21.1 15.0 17.5 8.9 6.3 22.6 20.9 14.1 17.7 14.9 9.9 16.7 11.6 16.0 7.8 14.7 15.1 13.9 19.1 22.5 13.8 23.9 22.4 19.7 14.3 15.6 11.5 14.9 14.6 16.2 5.0 21.5 12.2 21.8 10.3 15.7 13.3 11.6 14.4 12.7 15.5 7.0 14.9 18.4 18.3 21.0 26.1 33.5 35.1 29.0 26.3 22.3 9.3 10.4 23.0 6.5 12.9 10.8 19.5 20.6 17.8 19.8 18.8 24.5 14.7 14.1 17.2 29.1 8.7 10.1 7.9 19.6 22.1 10.3 11.8 8.8 14.8 25.6 11.9 16.0 18.6 12.0 16.3 15.2 18.0 8.8 13.1 24.8 16.2 10.4 32.5 14.8 10.1 13.6 15.1 10.0 25.6 12.0 7.0 11.4 17.4 8.2 27.5 11.2 13.8 17.1 17.0 11.4 12.8 8.9 12.8 12.1 11.3 13.5 8.3 7.8 24.8 19.0 28.1 26.0 25.5 22.9 17.9 22.9 22.4 18.2 21.0 17.9 24.3 33.5 29.0 35.1 26.1 26.3 22.3 18.3 21.6 38.3 19.6 16.7 11.6 13.9 19.1 14.3 14.4 CES2 "CE-2, CES2A1, iCE" ENSG00000172831 "Carboxylesterase 2" O00748 16 66934444-66945096 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "esophagus: 46.7;intestine: 146.9;liver: 78.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA018897 Enhanced Approved "Golgi apparatus,Cytosol" 7500000 "Golgi apparatus, Cytosol" "HPA018897: AB_1846558" "unprognostic (8.15e-3)" "unprognostic (1.82e-2)" "unprognostic (1.32e-1)" "unprognostic (2.67e-3)" "unprognostic (2.74e-2)" "unprognostic (1.38e-1)" "unprognostic (5.80e-2)" "unprognostic (1.31e-1)" "unprognostic (6.93e-2)" "unprognostic (7.99e-2)" "unprognostic (1.73e-3)" "unprognostic (2.66e-2)" "prognostic favourable (1.50e-5)" "unprognostic (8.01e-2)" "unprognostic (1.53e-1)" "unprognostic (4.14e-2)" "unprognostic (1.38e-1)" 5.8 15.3 8.5 8.8 11.7 2.4 5.1 13.0 15.9 9.5 42.3 12.1 11.2 146.9 7.0 11.9 46.7 6.1 14.5 15.2 7.4 6.6 22.5 78.6 6.7 4.6 8.2 10.7 8.4 12.0 10.0 6.8 7.3 10.3 9.7 42.6 13.0 12.7 7.9 11.6 8.9 117.3 10.4 5.6 7.8 10.9 8.5 8.2 9.0 11.7 14.1 12.1 7.6 11.6 6.9 8.9 5.0 10.6 7.9 10.7 5.2 6.8 9.0 9.5 12.7 9.4 8.8 7.2 7.8 12.6 9.2 11.7 9.7 11.4 8.0 7.8 10.2 17.8 6.9 19.7 7.2 7.1 9.6 7.9 5.1 18.2 13.3 10.3 13.8 12.7 37.3 13.0 21.9 6.8 11.0 5.9 15.5 4.3 9.1 8.6 5.1 9.1 10.8 9.6 9.4 26.1 12.0 6.2 8.1 25.5 6.4 6.6 11.1 12.8 8.4 12.1 6.5 7.5 5.9 11.9 14.2 9.5 18.7 8.1 9.1 4.7 10.4 4.7 10.1 7.8 9.2 6.1 7.7 10.7 8.9 6.9 9.5 8.6 5.0 7.9 10.6 7.7 6.8 5.2 8.5 11.7 13.0 15.9 7.4 6.6 8.2 10.7 10.3 8.2 CFAP46 "bA288G11.4, bA288G11.5, bB137A17.2, bB137A17.3, C10orf123, C10orf124, C10orf92, C10orf93, DKFZp434A1721, FLJ25954, TTC40" ENSG00000171811 "Cilia and flagella associated protein 46" Q8IYW2 10 132808392-132942823 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.8;testis: 35.5" "Cell line enhanced" "Detected in some" "AN3-CA: 2.0;CAPAN-2: 2.5;HAP1: 3.3;RPTEC TERT1: 3.0;SH-SY5Y: 3.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "non-classical monocyte: 2.7" "Lineage enhanced" "Detected in single" "monocytes: 2.7" "Low region specificity" "Detected in all" "HPA037786, HPA038034, HPA038867, HPA038868" Uncertain "HPA037786: AB_10672392, HPA038034: , HPA038867: , HPA038868: " "unprognostic (2.83e-2)" "unprognostic (4.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-2)" "unprognostic (1.08e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (1.83e-1)" "unprognostic (4.11e-1)" "unprognostic (5.40e-2)" "unprognostic (6.41e-3)" "unprognostic (1.39e-1)" "unprognostic (1.64e-4)" "unprognostic (1.21e-2)" "unprognostic (8.08e-2)" "unprognostic (4.56e-3)" "unprognostic (2.08e-2)" 0.4 0.7 3.4 0.4 6.7 0.4 0.6 0.7 4.6 1.1 0.4 6.8 2.7 0.6 0.6 9.9 0.7 8.7 0.6 0.8 5.3 3.9 2.4 0.6 2.1 0.4 2.7 3.8 2.3 0.9 1.5 4.2 0.4 9.0 0.5 0.4 1.5 0.6 1.0 32.8 0.5 0.6 0.4 0.9 0.5 3.1 35.5 2.0 0.0 3.5 0.0 0.4 0.4 0.2 0.0 0.0 0.0 2.7 0.7 0.0 0.0 0.0 0.1 0.6 2.0 0.0 0.0 0.0 0.9 0.0 0.6 0.1 0.0 2.5 0.0 0.2 0.1 0.8 3.3 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 1.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.7 0.0 0.0 0.0 3.4 6.7 0.7 4.6 5.3 3.9 2.7 3.8 9.0 2.0 CFAP47 "CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1" ENSG00000165164 "Cilia and flagella associated protein 47" Q6ZTR5 X 35919734-36385319 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.4;fallopian tube: 12.8;pituitary gland: 24.5" "Group enriched" "Detected in some" 7 "Karpas-707: 4.1;U-266/70: 7.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044633, HPA054859" Uncertain "HPA044633: AB_10960684, HPA054859: " "unprognostic (1.88e-1)" "unprognostic (4.38e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (1.09e-1)" "unprognostic (3.13e-2)" "unprognostic (2.15e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (5.61e-2)" "unprognostic (1.50e-5)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "unprognostic (1.48e-2)" "unprognostic (5.19e-3)" 0.3 0.3 2.0 0.2 5.9 0.2 0.3 0.3 1.2 0.9 0.3 6.2 1.2 0.2 0.7 7.0 0.3 12.8 0.2 0.3 3.7 1.3 0.4 0.5 3.7 0.2 1.2 1.5 5.3 0.3 2.3 24.5 0.3 12.4 0.3 0.2 2.0 0.3 0.3 0.3 0.3 0.3 0.2 1.1 0.3 0.3 2.1 2.7 0.0 1.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.9 0.3 1.2 3.7 1.3 1.2 1.5 12.4 2.7 CFAP57 "FLJ32000, WDR65" ENSG00000243710 "Cilia and flagella associated protein 57" Q96MR6 1 43172149-43254358 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 25.6;testis: 29.2" "Cell line enhanced" "Detected in many" "HaCaT: 6.8;HDLM-2: 4.4" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 12.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002736, HPA028623" Enhanced Approved Cytosol Cytosol "HPA002736: AB_2272982, HPA028623: AB_10603234" "unprognostic (1.15e-2)" "unprognostic (2.29e-3)" "unprognostic (2.16e-1)" "prognostic favourable (6.02e-4)" "unprognostic (2.50e-2)" "unprognostic (3.71e-1)" "unprognostic (2.42e-2)" "unprognostic (1.02e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-1)" "unprognostic (2.05e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-2)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-2)" "unprognostic (7.78e-2)" 0.4 0.4 1.6 0.3 6.7 0.2 0.6 0.1 1.8 1.6 0.3 4.2 0.0 0.3 1.0 9.1 0.4 25.6 0.5 0.4 3.6 2.7 1.5 2.7 4.7 0.2 0.3 1.4 7.1 0.9 0.4 5.9 0.5 12.7 0.7 0.3 0.3 0.5 0.5 0.4 0.9 0.3 0.3 0.4 0.2 0.4 29.2 0.4 0.0 1.9 0.0 0.3 0.5 0.2 3.2 2.4 0.7 4.8 1.2 1.5 1.4 2.9 1.0 0.7 0.6 0.2 0.1 0.9 1.1 1.8 1.4 1.4 0.8 1.2 0.3 1.3 2.4 6.8 0.4 0.9 2.6 4.4 0.2 0.3 0.6 0.6 0.5 0.0 0.3 0.2 1.1 1.1 0.4 2.0 0.2 0.1 0.2 0.1 0.3 0.3 1.4 0.1 0.4 1.0 0.2 2.9 0.5 1.1 0.5 1.3 0.2 1.1 1.6 0.5 3.8 0.2 1.4 0.7 0.8 0.4 0.6 0.3 0.3 0.8 0.8 0.5 1.1 0.7 1.4 2.0 1.4 2.2 1.4 1.2 2.4 3.2 1.3 1.3 0.0 1.2 4.8 1.9 1.5 1.4 1.6 6.7 0.1 1.8 3.6 2.7 0.3 1.4 12.7 0.4 CFAP61 "C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156" ENSG00000089101 "Cilia and flagella associated protein 61" Q8NHU2 20 20052514-20360702 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.1;heart muscle: 14.8;pituitary gland: 15.0;skeletal muscle: 23.9;testis: 25.5" "Cell line enhanced" "Detected in some" "Daudi: 4.2;HMC-1: 4.1;SCLC-21H: 9.5;SK-MEL-30: 3.7;U-87 MG: 7.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.3;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009079 Approved "HPA009079: AB_1078344" "unprognostic (5.93e-2)" "unprognostic (1.27e-1)" "unprognostic (6.73e-2)" "unprognostic (1.38e-3)" "unprognostic (6.20e-3)" "unprognostic (3.67e-3)" "unprognostic (8.58e-4)" "unprognostic (8.24e-2)" "unprognostic (8.29e-2)" "unprognostic (3.11e-1)" "unprognostic (1.86e-2)" "unprognostic (1.56e-1)" "unprognostic (2.76e-4)" "unprognostic (2.77e-1)" "unprognostic (9.27e-2)" "unprognostic (3.10e-3)" "unprognostic (3.06e-1)" 0.2 1.2 1.0 0.2 9.5 0.1 0.5 0.6 2.6 0.9 0.2 5.3 0.8 0.1 1.1 4.5 0.2 15.1 0.3 14.8 4.0 1.9 1.1 0.2 3.5 0.2 0.9 2.0 3.3 0.5 1.0 15.0 0.2 11.4 0.5 0.2 0.1 0.3 0.4 23.9 0.5 0.3 0.3 0.7 0.2 0.3 25.5 1.1 0.0 1.1 0.0 0.2 0.2 0.2 0.0 1.5 0.0 0.0 0.6 2.3 0.0 0.4 1.3 0.2 0.5 0.0 0.0 0.5 0.1 0.4 0.0 0.4 0.0 0.7 4.2 0.1 0.0 0.1 0.2 0.0 0.1 1.1 1.5 0.0 0.4 0.0 0.0 0.0 4.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.3 0.3 0.0 0.3 2.1 0.7 0.0 9.5 0.2 0.2 0.4 3.7 0.7 0.0 0.7 0.0 0.4 0.6 0.3 1.4 0.4 0.0 7.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.5 0.0 0.0 1.0 9.5 0.6 2.6 4.0 1.9 0.9 2.0 11.4 1.1 CGRRF1 "CGR19, RNF197" ENSG00000100532 "Cell growth regulator with ring finger domain 1" Q99675 14 54509812-54539309 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002930 Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA002930: AB_1078507" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (5.61e-2)" "unprognostic (4.38e-1)" "unprognostic (1.01e-1)" "unprognostic (3.21e-1)" "prognostic unfavourable (6.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.58e-2)" "unprognostic (2.63e-1)" "unprognostic (7.29e-2)" "unprognostic (2.64e-3)" "prognostic favourable (2.57e-8)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (1.48e-1)" "unprognostic (1.74e-1)" 13.3 12.8 18.3 5.7 19.2 10.2 17.3 21.9 18.9 12.7 11.4 16.2 12.7 8.0 14.3 20.1 8.4 12.6 8.3 12.7 15.2 15.4 20.8 10.3 9.9 10.9 16.6 14.6 11.4 19.5 11.2 16.5 10.0 20.1 14.7 9.9 9.8 9.7 16.3 20.7 5.0 9.6 12.4 18.2 8.8 10.2 24.9 16.7 3.0 18.0 6.3 7.2 12.6 9.2 11.9 6.4 31.3 10.7 12.4 13.7 11.7 8.3 7.5 7.8 7.1 13.6 8.5 6.0 8.2 7.4 11.9 11.7 6.9 9.4 4.6 10.3 6.7 7.4 8.3 6.9 14.1 9.6 7.1 6.4 1.9 8.7 16.9 3.7 3.7 8.4 13.4 8.9 14.6 8.3 2.6 5.7 10.8 14.8 3.8 5.7 5.2 11.9 8.5 9.5 2.7 9.2 11.0 5.7 4.7 6.5 3.5 12.3 9.2 3.3 7.1 14.7 12.5 6.2 6.8 4.2 4.9 6.6 9.1 4.5 9.7 31.3 7.9 13.4 12.3 9.0 12.3 11.1 13.4 13.5 6.4 11.9 13.7 12.6 8.0 12.4 10.7 5.6 13.5 11.7 18.3 19.2 21.9 18.9 15.2 15.4 16.6 14.6 20.1 16.7 CHEK2 "bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53" ENSG00000183765 "Checkpoint kinase 2" O96017 22 28687743-28742422 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001878, CAB002030" Enhanced Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "CAB002030: AB_563660, HPA001878: AB_1078514" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (5.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.42e-1)" "unprognostic (3.83e-2)" "unprognostic (1.49e-3)" "unprognostic (5.08e-3)" "unprognostic (3.33e-3)" "unprognostic (9.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.13e-1)" "prognostic unfavourable (7.80e-9)" "unprognostic (2.38e-2)" "unprognostic (1.78e-1)" "unprognostic (7.27e-2)" "unprognostic (6.79e-3)" 5.6 8.3 2.5 13.0 7.0 13.7 5.6 0.7 5.6 6.6 9.8 2.5 4.8 6.8 4.8 10.9 10.0 4.3 6.0 6.0 4.1 2.3 5.3 6.5 7.9 10.1 6.7 1.6 12.9 6.7 1.2 4.2 10.1 5.1 8.3 10.6 8.7 7.0 5.8 2.2 6.3 8.5 5.4 5.0 9.8 5.8 9.7 3.6 13.1 7.5 4.8 13.7 6.2 6.7 11.8 8.7 6.5 8.4 2.9 4.4 3.7 14.7 4.7 13.5 16.7 3.8 19.2 8.7 7.3 8.6 9.7 14.2 12.0 10.1 17.4 6.2 5.1 14.2 20.5 13.4 11.3 12.4 15.7 22.9 9.0 19.8 3.8 14.5 16.8 8.1 6.2 12.4 11.0 10.7 13.8 15.2 9.0 20.7 11.6 23.3 19.0 12.0 25.3 9.2 20.3 6.0 6.1 7.9 4.5 8.1 14.5 8.0 9.9 13.4 3.7 7.8 9.3 6.8 3.8 9.2 16.2 34.0 7.4 15.2 9.9 6.5 3.7 1.2 1.1 8.4 2.3 11.8 2.2 2.1 8.7 8.4 4.4 2.8 0.3 2.9 4.1 7.0 2.8 3.7 2.5 7.0 0.7 5.6 4.1 2.3 6.7 1.6 5.1 3.6 CHIC1 BRX ENSG00000204116 "Cysteine rich hydrophobic domain 1" Q5VXU3 X 73563200-73687102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA052062" Uncertain Approved "Nuclear speckles,Vesicles,Cytosol" "Nuclear speckles, Vesicles" Cytosol "HPA026782: AB_1846654, HPA052062: " "unprognostic (9.85e-3)" "unprognostic (3.91e-2)" "unprognostic (3.10e-2)" "unprognostic (9.95e-2)" "unprognostic (6.22e-2)" "unprognostic (1.91e-1)" "unprognostic (1.57e-1)" "unprognostic (1.36e-2)" "unprognostic (2.43e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-3)" "unprognostic (2.65e-1)" "prognostic favourable (2.75e-4)" "unprognostic (1.37e-2)" "unprognostic (2.19e-1)" "unprognostic (3.51e-1)" "unprognostic (2.76e-2)" 5.6 13.9 11.0 7.1 16.3 1.5 7.5 14.7 17.6 14.6 8.2 8.5 7.7 4.7 11.1 7.9 5.1 8.7 9.2 10.3 11.7 13.2 12.4 3.4 5.6 7.2 11.2 13.8 11.8 4.1 13.3 18.2 4.4 16.8 9.9 8.6 6.8 5.1 13.0 4.6 6.0 5.9 10.7 15.4 7.7 4.9 3.3 12.5 3.7 12.8 2.6 6.8 7.4 10.1 1.1 0.2 1.0 0.3 1.2 3.0 0.6 4.0 4.1 2.1 2.7 6.0 8.2 0.0 4.5 6.1 3.7 4.5 2.7 5.1 1.9 6.3 4.0 1.2 3.0 2.2 8.3 4.6 3.7 2.7 3.4 0.0 3.9 0.0 5.5 5.6 2.7 7.0 3.8 5.3 0.7 18.3 7.2 0.6 1.6 0.0 6.6 4.1 1.6 5.3 1.2 4.7 2.0 1.2 1.7 5.1 2.4 5.4 2.0 1.1 6.1 4.3 4.2 8.5 2.7 5.2 12.9 0.0 6.3 3.0 3.3 1.0 0.1 0.0 1.9 0.1 3.0 1.1 1.5 1.9 0.0 1.1 1.5 2.0 0.0 1.2 0.3 0.2 1.2 0.6 11.0 16.3 14.7 17.6 11.7 13.2 11.2 13.8 16.8 12.5 CHIC2 BTL ENSG00000109220 "Cysteine rich hydrophobic domain 2" Q9UKJ5 4 54009789-54064690 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA026784, HPA076603" Uncertain Enhanced "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA026782: AB_1846654, HPA026784: , HPA076603: " "unprognostic (4.56e-2)" "unprognostic (2.24e-3)" "unprognostic (3.47e-3)" "unprognostic (9.58e-2)" "unprognostic (1.49e-1)" "unprognostic (2.25e-2)" "unprognostic (7.87e-2)" "unprognostic (1.22e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (2.94e-2)" "unprognostic (5.63e-2)" "prognostic unfavourable (1.56e-4)" "unprognostic (2.89e-1)" "unprognostic (1.77e-1)" "unprognostic (4.56e-2)" "unprognostic (9.40e-2)" 17.0 17.5 9.5 14.6 9.7 23.7 17.1 17.9 12.0 12.8 14.2 7.1 11.9 13.0 16.8 14.9 25.3 11.0 22.1 14.3 7.3 7.9 12.3 20.2 17.7 13.5 6.6 10.0 13.2 9.9 5.5 16.7 18.5 9.9 12.3 9.6 15.9 15.3 9.9 10.9 24.7 20.6 10.8 8.1 18.5 12.9 50.1 8.3 32.3 11.8 11.6 20.5 12.9 16.3 8.4 10.9 63.8 15.9 13.6 15.6 13.6 11.5 2.1 6.4 5.6 10.7 8.2 6.3 16.0 17.0 9.6 9.7 8.3 10.4 9.8 14.4 10.3 3.5 8.6 11.7 10.4 5.4 4.4 5.3 2.0 6.2 32.1 8.7 11.1 11.1 9.6 14.5 22.2 14.0 5.7 7.4 19.1 3.1 10.2 14.0 4.2 7.9 6.6 3.5 3.8 11.0 3.9 9.3 8.8 3.8 5.6 11.7 3.0 13.0 23.9 12.3 9.6 17.6 10.3 8.8 4.2 8.0 9.1 8.7 8.9 56.0 15.9 32.2 12.6 12.4 12.1 8.4 12.8 14.2 10.9 8.2 11.8 12.7 63.8 13.6 12.5 9.1 15.6 13.6 9.5 9.7 17.9 12.0 7.3 7.9 6.6 10.0 9.9 8.3 CHL1 "CALL, FLJ44930, L1CAM2, MGC132578" ENSG00000134121 "Cell adhesion molecule L1 like" O00533 3 196596-409417 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.9" "Group enriched" "Detected in some" 5 "SK-MEL-30: 44.1;WM-115: 14.0" "Cancer enhanced" "Detected in many" "glioma: 15.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 56 "memory B-cell: 4.5;naive B-cell: 6.7" "Lineage enriched" "Detected in single" 67 "B-cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003345, CAB026120" Enhanced "Intracellular and membrane" 6900000000 "CAB026120: , HPA003345: AB_1078516" "unprognostic (5.54e-2)" "unprognostic (2.08e-1)" "unprognostic (7.45e-2)" "unprognostic (7.14e-3)" "unprognostic (1.16e-3)" "unprognostic (1.12e-1)" "unprognostic (3.10e-2)" "unprognostic (2.22e-1)" "unprognostic (5.14e-1)" "unprognostic (1.06e-1)" "unprognostic (7.81e-2)" "unprognostic (3.51e-1)" "prognostic favourable (1.21e-6)" "unprognostic (1.11e-1)" "unprognostic (6.07e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" 12.8 4.7 17.8 7.9 32.1 1.1 8.4 7.3 62.9 2.9 10.8 5.0 0.9 4.6 3.9 2.4 8.8 2.8 5.1 10.0 21.2 19.0 17.2 1.5 5.3 5.8 11.1 28.7 16.5 2.4 2.0 3.7 0.8 17.8 3.1 8.1 2.3 7.1 6.9 0.9 12.1 6.1 5.5 9.9 3.3 3.9 2.2 7.5 0.0 1.7 0.0 3.3 2.4 5.3 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 32.1 7.3 36.1 21.2 19.0 11.1 28.7 17.8 7.5 CHODL "C21orf68, FLJ12627, MT75, PRED12" ENSG00000154645 Chondrolectin Q9H9P2 21 17901263-18267373 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 59.6" "Cell line enhanced" "Detected in some" "U-266/70: 4.0;U-266/84: 9.8;U-87 MG: 11.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 8 "T-cells: 4.9" "Group enriched" "Detected in many" 4 "basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4" "Region enriched" "Detected in all" 6 "olfactory region: 208.8" HPA017282 Enhanced "HPA017282: AB_1846687" "unprognostic (3.91e-1)" "unprognostic (3.18e-2)" "unprognostic (2.37e-2)" "prognostic unfavourable (1.18e-6)" "unprognostic (6.74e-2)" "unprognostic (6.82e-2)" "unprognostic (1.06e-3)" "unprognostic (6.79e-2)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.87e-1)" "unprognostic (4.83e-2)" "unprognostic (1.02e-1)" 2.3 1.9 0.8 2.1 6.8 0.0 1.1 0.5 0.8 0.3 2.3 0.5 4.0 1.5 0.7 1.1 1.4 0.5 0.8 3.4 1.3 8.2 4.7 0.0 0.3 0.3 1.4 0.8 0.5 0.0 0.5 2.1 1.7 8.6 8.2 3.4 1.4 0.6 1.8 1.3 2.1 0.9 0.4 2.2 12.3 0.7 59.6 1.1 0.1 0.9 4.3 1.1 1.1 1.1 0.4 0.6 0.0 0.1 0.4 4.9 0.3 0.0 0.0 0.9 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 2.4 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.6 0.1 2.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.3 0.0 1.0 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.0 9.8 0.3 11.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 4.9 0.4 0.3 0.8 0.1 0.2 0.0 1.1 0.0 0.4 0.1 0.6 1.0 0.3 0.8 6.8 0.5 0.8 1.3 8.2 1.4 0.8 8.6 1.1 CHRM3 ENSG00000133019 "Cholinergic receptor muscarinic 3" P20309 1 239386565-239915452 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 39.8" "Cell line enhanced" "Detected in some" "RPMI-8226: 9.9;SH-SY5Y: 31.8;U-266/70: 13.2;U-266/84: 9.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 8.7" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Group enriched" "Detected in many" 18 "monocytes: 1.2;T-cells: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024106, HPA048036" Approved Supported "Plasma membrane" "Plasma membrane" "HPA024106: AB_1854211, HPA048036: " "unprognostic (1.63e-1)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (4.11e-3)" "unprognostic (3.48e-3)" "unprognostic (5.81e-2)" "unprognostic (2.30e-3)" "unprognostic (5.18e-2)" "unprognostic (1.71e-1)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" "unprognostic (6.44e-2)" "unprognostic (5.34e-4)" "unprognostic (3.04e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (4.88e-2)" 0.8 0.0 2.1 1.4 1.8 0.0 0.8 0.8 8.7 0.8 5.9 0.8 0.8 0.8 1.4 0.8 6.6 0.3 0.8 0.8 2.5 1.8 0.8 0.8 1.5 0.8 0.8 1.1 4.3 8.7 0.2 0.8 0.8 0.8 3.8 2.2 39.8 13.7 2.5 0.8 0.7 1.2 3.3 0.8 1.0 4.8 1.7 0.8 1.3 1.3 0.8 1.6 7.1 0.8 0.0 0.0 0.0 1.2 0.0 2.3 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 3.4 0.3 2.3 1.6 0.0 2.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 5.5 0.5 0.8 0.0 0.0 2.8 5.0 0.0 0.7 9.9 0.4 0.5 0.0 31.8 0.0 0.1 0.1 1.1 0.0 0.0 1.3 0.5 0.1 0.3 13.2 9.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 1.2 0.7 0.0 0.5 0.4 0.0 0.0 2.3 0.7 0.0 0.0 0.7 0.0 0.5 0.2 2.1 1.8 0.8 8.7 2.5 1.8 0.8 1.1 0.8 0.8 CHRNA1 CHRNA ENSG00000138435 "Cholinergic receptor nicotinic alpha 1 subunit" P02708 2 174747592-174787935 "Disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 96.7" "Group enriched" "Detected in some" 18 "LHCN-M2: 87.3;RH-30: 71.4" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Region enhanced" "Detected in single" "hippocampal formation: 2.0" "Cell type enriched" "Detected in single" 27 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 27 "dendritic cells: 2.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA071554 Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA071554: " "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.22e-3)" "unprognostic (2.28e-2)" "unprognostic (2.96e-1)" "unprognostic (8.55e-3)" "unprognostic (5.34e-2)" "unprognostic (5.29e-3)" "unprognostic (9.59e-2)" "unprognostic (9.64e-2)" "unprognostic (9.66e-2)" "unprognostic (6.37e-2)" "unprognostic (4.18e-4)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-2)" 4.5 0.0 0.5 0.5 0.1 0.0 0.6 0.0 0.4 0.7 1.7 0.0 0.1 0.2 0.0 4.6 1.2 0.0 0.0 0.3 2.0 0.1 0.0 0.2 0.7 0.9 0.1 0.0 0.0 0.0 0.0 12.1 0.2 0.0 2.4 1.0 0.0 1.5 0.0 96.7 0.0 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.5 0.0 4.5 1.3 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.2 0.0 0.0 87.3 0.0 0.0 0.0 0.0 0.0 0.0 71.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.1 0.0 0.4 2.0 0.1 0.1 0.0 0.0 0.0 CHRNA7 ENSG00000175344 "Cholinergic receptor nicotinic alpha 7 subunit" P36544 15 31923438-32173018 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 27.2" "Cell line enhanced" "Detected in some" "AN3-CA: 6.2;RT4: 12.0;SH-SY5Y: 6.7;SK-BR-3: 13.2;U-2 OS: 10.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029422, CAB033624" Enhanced "CAB033624: AB_784835, HPA029422: AB_10600863" "unprognostic (3.43e-2)" "unprognostic (8.44e-2)" "unprognostic (2.02e-1)" "unprognostic (4.61e-4)" "unprognostic (6.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.14e-2)" "unprognostic (5.08e-2)" "unprognostic (1.63e-1)" "unprognostic (4.31e-2)" "unprognostic (3.22e-1)" "unprognostic (1.05e-1)" "unprognostic (2.40e-2)" "unprognostic (4.36e-3)" "unprognostic (5.44e-2)" "unprognostic (7.41e-3)" "unprognostic (2.43e-1)" 0.8 12.9 4.4 1.5 3.4 2.3 2.0 0.9 8.4 1.1 12.2 1.0 1.1 7.9 1.4 0.8 0.8 0.7 4.6 1.2 2.5 5.6 0.9 0.4 1.2 2.0 3.8 2.7 2.9 4.9 1.8 2.0 0.4 11.8 2.2 4.0 11.7 2.1 1.2 0.8 0.7 27.2 0.9 3.1 5.2 11.2 5.1 0.6 0.1 4.3 0.9 1.4 3.1 2.0 0.3 1.2 3.1 1.1 1.8 0.7 0.4 0.0 1.4 2.3 6.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 1.8 0.4 0.0 1.8 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 1.1 0.0 0.0 3.7 0.2 0.2 12.0 0.5 6.7 0.2 13.2 0.0 0.0 0.0 0.7 0.0 10.9 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.5 1.1 3.1 0.7 0.4 0.2 0.3 0.4 0.1 1.2 0.2 0.2 0.3 0.7 1.8 0.6 0.7 0.5 0.4 4.4 3.4 0.9 8.4 2.5 5.6 3.8 2.7 11.8 0.6 CHRNB1 CHRNB ENSG00000170175 "Cholinergic receptor nicotinic beta 1 subunit" P11230 17 7445061-7457707 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.6;tongue: 33.9" "Cell line enhanced" "Detected in many" "LHCN-M2: 18.1;RH-30: 37.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005822, CAB011200" Approved "CAB011200: AB_262151, HPA005822: AB_1079484" "unprognostic (2.89e-2)" "unprognostic (3.43e-1)" "unprognostic (1.08e-1)" "unprognostic (2.67e-2)" "unprognostic (4.19e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-2)" "unprognostic (3.56e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-1)" "unprognostic (9.13e-2)" "unprognostic (6.91e-2)" "unprognostic (2.49e-1)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" 4.5 11.5 5.7 1.9 5.1 6.1 3.7 2.3 4.4 3.4 2.0 4.5 3.7 2.3 2.4 5.5 3.6 2.9 1.6 5.0 4.8 3.9 3.9 5.5 2.4 2.6 6.0 3.5 2.9 18.2 8.3 2.5 5.8 4.0 2.6 2.1 4.5 4.5 2.6 81.6 4.0 2.2 2.6 5.1 3.1 2.0 1.2 4.4 4.5 6.0 33.9 3.2 2.4 2.5 7.8 8.2 15.2 11.1 12.3 11.7 7.1 0.8 1.1 2.0 2.4 3.2 2.2 4.5 0.6 2.0 3.0 2.5 0.7 1.1 3.2 2.2 1.2 7.1 0.7 13.0 1.1 3.9 2.5 1.8 1.2 4.1 1.4 1.1 4.6 4.8 3.6 1.8 5.8 2.0 2.3 1.8 18.1 0.5 3.4 2.1 1.4 0.6 2.2 37.6 8.0 8.1 0.7 0.3 5.9 1.2 2.2 2.4 2.1 1.5 1.9 1.3 3.5 0.9 2.5 4.3 4.7 0.9 1.1 2.5 1.1 10.6 6.6 15.2 9.9 7.2 7.7 7.8 11.0 10.0 8.2 7.6 9.0 11.7 2.2 12.3 11.1 6.3 8.9 7.1 5.7 5.1 2.3 4.1 4.8 3.9 6.0 3.5 4.0 4.4 CHRNB4 ENSG00000117971 "Cholinergic receptor nicotinic beta 4 subunit" P30926 15 78624119-78727754 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 6.6;lymphoid tissue: 18.5;retina: 10.6;testis: 10.7" "Group enriched" "Detected in some" 16 "SCLC-21H: 20.2;SH-SY5Y: 26.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "olfactory region: 6.5;pons and medulla: 1.4;thalamus: 4.6" "Not detected" "Not detected" HPA059484 Approved "Endoplasmic reticulum,Cell Junctions" "Endoplasmic reticulum" "Cell Junctions" "HPA059484: " "unprognostic (4.74e-2)" "unprognostic (4.54e-1)" "unprognostic (1.26e-2)" "unprognostic (8.77e-5)" "unprognostic (8.15e-2)" "unprognostic (6.43e-3)" "unprognostic (1.10e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (1.49e-1)" "unprognostic (1.45e-4)" "unprognostic (7.00e-3)" "unprognostic (2.58e-1)" "unprognostic (8.50e-2)" "unprognostic (7.76e-2)" 0.2 6.6 2.7 3.9 0.8 0.7 0.2 0.5 0.4 0.6 2.3 0.2 0.0 0.2 0.8 0.7 1.4 0.1 0.1 0.8 1.0 0.3 0.5 0.1 0.1 2.9 0.2 0.0 0.3 0.2 0.0 1.6 0.0 1.3 0.2 1.1 10.6 2.2 2.4 0.6 0.3 1.0 0.9 1.0 1.0 0.8 10.7 0.1 18.5 0.4 0.3 1.1 0.5 0.5 1.5 0.4 1.4 0.8 1.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 20.2 26.2 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.3 0.5 0.2 0.6 0.9 0.5 0.6 0.2 1.5 0.8 0.8 1.4 1.0 0.4 0.4 0.3 0.0 2.7 0.8 0.5 0.4 1.0 0.3 0.2 0.0 1.3 0.1 CHST10 HNK-1ST ENSG00000115526 "Carbohydrate sulfotransferase 10" O43529 2 100391860-100417656 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "B-cells: 2.3;dendritic cells: 3.1;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012884, HPA051545" Approved Approved Cytosol "Intracellular and membrane" 290000 Cytosol "HPA012884: AB_1846710, HPA051545: " "unprognostic (5.40e-3)" "unprognostic (3.62e-2)" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (3.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.89e-2)" "unprognostic (1.44e-1)" "unprognostic (1.78e-1)" "unprognostic (4.54e-2)" "prognostic favourable (4.05e-4)" "unprognostic (8.02e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-2)" "unprognostic (3.73e-2)" "unprognostic (3.06e-2)" "unprognostic (3.27e-1)" 4.1 6.7 14.6 3.9 18.7 2.6 5.0 12.6 28.2 6.2 4.1 12.1 2.4 2.2 11.4 13.5 4.1 9.7 5.3 10.1 12.4 9.5 4.4 1.2 7.8 4.0 9.8 12.2 12.9 5.3 8.8 8.6 7.8 9.3 8.1 2.4 7.3 5.5 5.4 5.1 1.6 2.5 11.7 8.9 3.7 3.4 5.8 7.6 3.1 9.8 1.6 5.1 5.8 4.9 2.3 3.1 0.0 0.0 0.1 3.5 1.0 0.1 7.8 15.5 7.9 4.7 6.7 7.8 8.9 6.4 12.3 7.9 0.1 4.6 10.8 7.8 5.4 0.0 10.9 1.2 7.9 15.2 11.5 5.5 4.3 12.0 5.7 11.1 14.5 4.9 1.5 5.8 1.1 9.6 15.9 0.0 5.2 2.5 9.8 8.8 22.9 9.6 7.1 9.5 0.1 3.4 3.4 16.8 13.7 0.6 0.0 12.4 4.2 15.4 8.7 8.6 13.6 6.4 8.3 0.0 0.0 11.1 10.5 9.9 10.0 0.0 0.0 0.0 3.5 0.0 1.3 2.3 0.6 2.9 0.6 1.8 0.8 2.3 0.0 0.1 0.0 3.1 0.0 1.0 14.6 18.7 12.6 24.8 12.4 9.5 9.8 12.2 9.3 7.6 CHST12 "C4S-2, C4ST2" ENSG00000136213 "Carbohydrate sulfotransferase 12" Q9NRB3 7 2403560-2448483 "Enzymes, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 25.6;NB-4: 26.5;U-266/70: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041680 Approved Approved "Golgi apparatus" 430000 "Golgi apparatus" "HPA041680: AB_10959789" "unprognostic (4.12e-2)" "unprognostic (3.56e-1)" "unprognostic (3.04e-3)" "unprognostic (1.59e-1)" "unprognostic (2.05e-3)" "unprognostic (7.15e-2)" "unprognostic (2.01e-3)" "unprognostic (1.34e-1)" "unprognostic (3.20e-2)" "unprognostic (4.88e-2)" "prognostic favourable (1.32e-5)" "unprognostic (9.61e-2)" "unprognostic (1.66e-3)" "unprognostic (4.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" 24.2 12.0 9.4 12.1 10.5 14.5 11.2 17.8 16.5 11.9 10.1 13.2 9.0 13.5 14.4 10.6 5.9 11.7 10.9 12.0 8.8 7.7 9.3 6.8 13.6 10.3 10.4 9.2 9.6 17.5 4.9 14.4 9.6 12.7 11.8 4.2 12.3 14.1 11.6 11.9 11.5 10.1 8.1 9.5 25.0 12.4 10.2 8.6 9.0 11.2 4.4 11.8 10.6 10.3 5.7 21.0 16.4 3.5 37.4 30.2 6.7 3.8 4.0 2.4 4.4 3.7 2.7 12.5 7.0 3.3 3.1 4.2 4.4 1.5 3.4 13.4 3.1 3.2 1.5 1.9 0.8 4.5 8.3 2.3 3.4 4.9 1.7 7.8 25.6 3.6 1.1 2.7 0.3 3.2 6.1 12.4 1.4 3.6 8.2 26.5 8.4 7.2 3.1 3.2 17.9 1.5 2.1 3.0 12.2 3.4 2.6 1.7 3.2 10.0 5.3 4.5 11.8 8.8 6.2 37.9 14.6 1.5 3.6 4.0 7.8 15.5 3.5 16.4 30.2 2.8 18.9 5.2 10.7 24.5 6.6 5.7 4.5 13.5 1.0 37.4 1.2 21.0 10.2 6.7 9.4 10.5 17.8 16.5 8.8 7.7 10.4 9.2 12.7 8.6 CHST14 "D4ST-1, D4ST1, HD4ST" ENSG00000169105 "Carbohydrate sulfotransferase 14" Q8NCH0 15 40470998-40474571 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057697, HPA071601" Enhanced Approved Vesicles Vesicles "HPA057697: , HPA071601: " "unprognostic (5.46e-2)" "unprognostic (9.23e-2)" "unprognostic (4.03e-2)" "unprognostic (2.63e-3)" "unprognostic (1.44e-1)" "unprognostic (1.86e-1)" "unprognostic (2.96e-2)" "unprognostic (6.94e-2)" "unprognostic (1.70e-1)" "unprognostic (9.95e-2)" "unprognostic (2.84e-1)" "unprognostic (3.17e-2)" "unprognostic (5.85e-3)" "unprognostic (2.01e-3)" "unprognostic (1.94e-1)" "unprognostic (6.34e-2)" "unprognostic (2.25e-2)" 10.3 7.9 7.1 7.5 6.9 2.3 22.7 6.5 7.4 14.9 7.9 6.0 13.8 3.6 17.5 11.1 6.5 12.3 14.1 12.6 5.5 2.9 8.1 9.6 15.9 20.9 8.1 4.5 18.8 11.6 10.2 11.4 22.4 7.1 10.7 3.8 9.8 12.7 17.2 5.5 6.8 7.1 13.3 5.9 10.5 7.3 9.2 6.3 7.5 12.4 8.3 6.1 12.1 18.2 2.1 3.4 8.0 1.9 5.5 4.0 1.1 11.0 7.3 11.7 31.6 18.4 14.3 18.3 10.9 20.8 19.4 18.4 8.8 5.6 1.8 16.7 18.5 19.1 10.4 6.1 9.1 13.2 6.1 5.7 7.8 8.4 10.0 2.4 14.8 17.4 5.1 6.8 5.2 17.0 5.5 6.6 14.4 8.4 4.0 12.7 7.5 8.5 11.1 14.9 3.2 13.0 5.7 8.5 13.0 9.6 10.8 3.6 15.7 10.2 13.8 32.9 12.2 10.3 10.8 13.4 9.2 5.1 14.8 8.4 23.6 8.0 1.9 3.6 4.0 1.9 1.1 0.5 2.0 3.4 3.4 2.1 1.8 1.4 0.3 5.5 0.9 1.2 1.3 1.1 7.1 6.9 6.5 7.4 5.5 2.9 8.1 4.5 7.1 6.3 CHST15 "BRAG, GALNAC4S-6ST, KIAA0598" ENSG00000182022 "Carbohydrate sulfotransferase 15" Q7LFX5 10 124007666-124093607 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 27.1;REH: 35.6;U-266/70: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.4" "Group enriched" "Detected in many" 10 "granulocytes: 29.4;monocytes: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017584 Approved Approved Centrosome,Cytosol 560000 Cytosol Centrosome "HPA017584: AB_1849437" "unprognostic (1.19e-1)" "unprognostic (2.29e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-2)" "unprognostic (4.12e-2)" "unprognostic (1.18e-2)" "unprognostic (1.90e-1)" "unprognostic (3.02e-2)" "unprognostic (2.40e-2)" "unprognostic (7.62e-3)" "unprognostic (7.90e-2)" "unprognostic (8.16e-2)" "prognostic unfavourable (2.22e-7)" "unprognostic (6.47e-3)" "unprognostic (7.80e-2)" "unprognostic (4.63e-3)" "unprognostic (5.26e-3)" 16.4 10.0 8.7 17.0 20.6 5.7 10.7 3.4 17.9 9.8 15.4 6.6 4.0 8.8 8.6 10.8 11.3 13.1 11.7 6.4 11.3 5.3 9.0 11.9 13.9 35.4 6.5 9.6 35.0 12.6 2.9 7.7 5.9 9.2 8.5 8.3 14.4 8.2 13.4 11.0 8.3 12.5 9.5 9.0 31.5 11.4 4.8 8.7 2.8 19.3 6.1 12.6 12.5 12.0 2.1 2.0 29.4 15.4 0.0 0.1 3.2 12.6 8.5 3.2 0.7 3.1 1.7 0.0 2.6 3.5 1.4 2.0 0.2 6.9 0.0 8.3 10.5 14.4 0.6 8.3 1.2 0.0 2.4 0.0 3.9 6.3 1.0 0.0 16.3 1.0 9.6 3.9 3.3 2.8 0.0 27.1 6.9 7.0 0.0 0.0 2.8 0.0 35.6 4.3 8.4 7.0 1.2 0.3 0.7 6.8 3.9 0.0 2.8 0.0 3.3 0.3 0.1 10.0 0.4 24.6 5.9 6.8 0.1 0.0 0.0 0.0 8.8 6.2 0.0 14.0 0.0 2.0 0.0 0.0 1.8 2.1 0.1 0.0 29.4 0.0 15.4 2.0 0.1 3.2 8.7 20.6 3.4 17.9 11.3 5.3 6.5 9.6 9.2 8.7 CHST2 C6ST ENSG00000175040 "Carbohydrate sulfotransferase 2" Q9Y4C5 3 143119331-143124014 "Predicted membrane proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9" "Cell line enhanced" "Detected in many" "ASC diff: 20.0;ASC TERT1: 20.6;HEL: 15.9;HHSteC: 41.3;HMC-1: 19.0;HSkMC: 21.7;U-266/70: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.4" "Group enriched" "Detected in many" 4 "monocytes: 11.4;NK-cells: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013620 Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA013620: " "unprognostic (1.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.64e-3)" "unprognostic (2.75e-1)" "unprognostic (8.97e-3)" "unprognostic (2.83e-1)" "unprognostic (2.70e-2)" "unprognostic (2.06e-1)" "unprognostic (2.76e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-3)" "unprognostic (9.15e-2)" "unprognostic (1.31e-2)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.58e-3)" "unprognostic (1.34e-1)" 6.5 2.6 8.2 11.6 16.6 20.0 4.1 9.8 15.1 4.6 3.1 6.5 2.6 3.6 6.4 2.7 2.0 1.6 3.1 2.6 7.3 10.4 4.8 1.6 5.1 10.2 10.6 5.8 3.6 2.0 1.5 5.5 15.3 14.0 7.6 2.3 5.9 4.0 15.9 2.7 3.0 4.9 6.0 32.9 17.0 5.4 2.3 4.8 24.7 5.4 0.1 8.1 7.4 5.4 1.4 1.8 0.8 11.4 4.8 0.8 0.9 0.0 0.1 1.0 0.9 20.0 20.6 0.0 1.1 3.2 0.8 0.7 0.0 0.0 0.2 0.7 0.7 0.0 0.7 2.7 0.4 0.2 0.5 15.9 0.0 0.0 41.3 0.4 19.0 21.7 3.3 1.0 3.4 1.2 1.8 1.0 5.2 0.0 2.9 4.0 5.6 2.7 0.1 0.3 0.0 0.5 0.7 1.3 0.0 0.2 0.0 1.8 0.0 0.6 4.1 2.4 1.4 3.2 4.6 18.2 0.2 1.1 4.7 3.0 12.6 0.7 0.6 0.8 0.4 4.5 0.0 1.4 0.1 0.2 1.8 1.0 0.8 0.6 0.3 4.8 11.4 0.1 0.5 0.9 8.2 16.6 9.8 15.1 7.3 10.4 10.6 5.8 14.0 4.8 CHST3 "C6ST, C6ST1" ENSG00000122863 "Carbohydrate sulfotransferase 3" Q7LGC8 10 71964365-72013564 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-251 MG: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047523, HPA055704" Enhanced Approved "Golgi apparatus,Cytosol" 510000 "Golgi apparatus, Cytosol" "HPA047523: , HPA055704: " "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.13e-3)" "unprognostic (1.16e-3)" "unprognostic (2.44e-1)" "unprognostic (4.67e-2)" "unprognostic (4.79e-2)" "unprognostic (7.53e-2)" "unprognostic (7.99e-2)" "unprognostic (3.71e-2)" "unprognostic (2.83e-3)" "unprognostic (5.99e-2)" "unprognostic (1.40e-2)" "unprognostic (2.65e-2)" "unprognostic (7.77e-2)" "unprognostic (2.56e-2)" "unprognostic (2.54e-3)" 22.2 11.6 9.2 7.0 19.4 0.7 12.0 2.9 11.6 10.4 9.0 19.4 4.8 1.7 13.7 7.4 8.4 13.6 6.2 11.9 11.3 5.1 8.6 1.8 6.3 2.2 30.1 5.5 25.0 6.1 1.9 4.0 10.0 15.6 10.7 3.3 5.7 6.3 19.5 13.6 7.1 4.0 21.0 16.2 2.9 11.6 19.4 25.2 0.5 7.3 4.8 2.2 7.5 18.5 0.2 0.3 0.8 0.1 0.1 0.2 0.0 6.7 7.3 3.8 9.3 17.3 6.8 0.1 14.4 13.9 8.9 5.9 6.4 13.7 0.0 10.0 17.0 8.9 3.3 9.9 7.1 0.2 2.5 0.0 12.8 6.1 8.8 0.0 0.0 9.4 11.5 8.8 12.1 2.6 2.0 0.0 9.4 0.2 0.0 0.0 1.6 2.4 0.0 4.5 0.0 12.5 7.0 0.2 3.7 10.9 0.2 10.6 0.8 1.4 5.4 11.0 12.7 18.2 28.8 0.0 0.0 0.0 8.0 0.0 7.7 0.3 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.8 0.1 0.0 0.3 0.1 0.0 9.2 19.4 2.9 11.6 11.3 5.1 30.1 5.5 15.6 25.2 CHST5 "FLJ22167, I-GLCNAC-6-ST" ENSG00000135702 "Carbohydrate sulfotransferase 5" Q9GZS9 16 75528535-75535247 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 32.9" "Cell line enhanced" "Detected in many" "PC-3: 4.6" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.4;stomach cancer: 1.5" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA043804 Enhanced "Intracellular and membrane" "HPA043804: AB_10960563" "unprognostic (6.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.99e-3)" "unprognostic (1.03e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-2)" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (2.09e-2)" "unprognostic (9.03e-3)" "unprognostic (4.27e-2)" "unprognostic (2.05e-3)" "unprognostic (3.56e-1)" "unprognostic (2.52e-2)" "unprognostic (1.46e-1)" "unprognostic (1.42e-2)" 0.4 0.0 0.7 0.4 1.7 0.0 0.4 2.4 1.1 0.4 17.5 0.4 0.4 32.9 0.4 0.4 0.4 1.1 0.4 0.4 0.8 0.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.5 0.4 0.4 0.4 21.6 0.4 0.4 0.4 2.1 0.0 28.5 0.4 0.4 0.4 1.7 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.3 1.1 3.0 1.3 1.1 1.1 0.4 0.4 1.0 1.4 1.6 0.4 0.9 0.7 0.0 0.3 0.6 0.5 0.6 1.9 1.2 0.6 0.3 1.1 0.1 0.7 0.0 0.4 1.4 0.2 0.5 1.8 0.3 0.7 0.8 1.1 0.1 0.0 0.4 0.2 0.4 1.3 0.0 2.7 0.7 3.7 0.9 4.6 0.5 0.4 2.6 1.6 0.4 2.1 3.6 1.9 1.4 0.2 1.0 0.3 0.3 1.5 1.0 2.6 0.3 0.7 1.8 0.2 1.0 0.3 0.9 3.0 1.0 1.0 0.9 1.0 0.8 1.0 0.8 0.7 0.5 1.3 1.1 1.1 2.6 1.1 1.3 1.1 0.7 0.4 0.7 1.7 2.4 1.1 0.8 0.8 0.4 0.4 0.4 0.4 CHST9 "GALNAC-4-ST2, GALNAC4ST-2" ENSG00000154080 "Carbohydrate sulfotransferase 9" Q7L1S5 18 26906481-27185317 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 23.4" "Cell line enhanced" "Detected in some" "CACO-2: 6.3;Hep G2: 9.3;RPTEC TERT1: 29.3;SCLC-21H: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA011393 Uncertain "Intracellular and membrane" "HPA011393: AB_1846733" "unprognostic (9.24e-3)" "unprognostic (1.13e-2)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (4.53e-3)" "unprognostic (9.98e-3)" "unprognostic (9.21e-3)" "unprognostic (7.92e-2)" "unprognostic (1.61e-1)" "unprognostic (2.04e-2)" "unprognostic (3.54e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (3.93e-3)" 0.3 0.4 1.7 0.3 2.4 0.2 3.7 1.0 2.6 4.0 2.1 4.5 0.7 0.4 0.3 0.9 2.2 13.6 4.5 3.4 3.7 2.7 2.4 12.1 8.6 0.1 2.6 0.8 1.2 11.9 0.1 4.3 0.1 4.9 4.8 0.4 5.3 23.4 2.7 0.4 0.4 0.7 0.3 5.3 7.1 1.0 8.5 4.2 0.0 0.3 3.9 7.0 2.6 10.5 0.5 0.1 0.8 0.1 0.3 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 29.3 0.0 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.5 0.2 0.3 0.5 0.3 0.0 0.1 0.1 0.0 1.7 2.4 1.0 2.6 3.7 2.7 2.6 0.8 4.9 4.2 CIP2A KIAA1524 ENSG00000163507 "Cell proliferation regulating inhibitor of protein phosphatase 2A" Q8TCG1 3 108549869-108589644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039570 Approved Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA039570: AB_10796329" "unprognostic (2.02e-1)" "unprognostic (1.54e-2)" "unprognostic (2.31e-3)" "prognostic unfavourable (6.24e-5)" "unprognostic (3.10e-2)" "unprognostic (1.07e-2)" "unprognostic (1.91e-7)" "unprognostic (2.80e-3)" "unprognostic (2.53e-3)" "unprognostic (1.24e-1)" "prognostic unfavourable (9.18e-4)" "unprognostic (6.85e-2)" "prognostic unfavourable (1.42e-4)" "unprognostic (9.11e-3)" "unprognostic (3.73e-1)" "unprognostic (2.11e-1)" "unprognostic (1.25e-1)" 2.1 2.3 2.5 8.5 6.3 10.4 3.6 6.3 6.2 3.2 3.1 2.6 0.8 2.0 3.2 1.8 4.0 1.8 2.0 2.7 2.9 2.1 2.2 1.6 2.2 10.2 2.0 3.2 3.8 1.8 1.8 3.0 3.3 2.4 3.0 4.4 2.2 2.3 1.4 2.0 1.9 2.7 2.5 2.4 5.5 2.0 8.5 1.5 21.5 1.9 1.5 8.0 4.0 2.7 1.9 0.3 0.7 1.1 0.0 1.6 0.6 18.6 5.6 15.7 10.0 0.7 1.5 6.4 14.2 6.7 16.8 19.8 6.7 8.4 12.6 4.9 5.1 9.5 5.3 5.0 30.7 4.0 5.2 15.1 7.6 5.0 0.2 9.7 10.8 0.6 1.0 13.1 5.4 7.5 9.3 20.4 16.5 3.8 11.6 8.6 16.1 9.6 13.3 14.6 6.9 5.1 5.2 7.6 10.0 10.4 4.1 5.8 7.0 6.9 5.5 17.3 19.6 5.2 17.0 4.7 5.2 20.9 7.6 10.5 17.6 0.6 0.3 0.7 0.0 0.5 1.3 1.2 0.7 0.3 0.0 1.9 0.7 1.6 0.0 0.0 1.1 0.3 0.8 0.6 2.5 6.3 6.3 6.2 2.9 2.1 2.0 3.2 2.4 1.5 CISD1 "C10orf70, MDS029, mitoNEET, ZCD1" ENSG00000122873 "CDGSH iron sulfur domain 1" Q9NZ45 10 58269058-58289586 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 63.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074383 Supported Mitochondria Mitochondria "HPA074383: " "prognostic unfavourable (1.11e-4)" "unprognostic (8.60e-3)" "unprognostic (1.07e-1)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (3.22e-2)" "prognostic unfavourable (4.15e-4)" "unprognostic (1.87e-2)" "unprognostic (2.35e-1)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "unprognostic (7.23e-2)" "unprognostic (1.34e-3)" "unprognostic (4.19e-2)" "unprognostic (7.20e-2)" "unprognostic (8.07e-2)" "prognostic unfavourable (6.69e-4)" 4.7 8.9 14.0 5.4 21.6 1.4 5.4 14.8 24.9 6.2 10.3 3.7 3.6 17.8 5.2 3.9 9.5 5.7 6.4 32.1 16.2 17.6 20.8 13.2 4.1 4.9 14.7 19.5 6.4 4.8 63.1 10.5 5.0 16.6 6.9 7.7 5.8 8.0 6.7 43.9 7.2 16.7 8.9 9.0 4.2 6.4 3.0 6.0 3.5 8.7 20.4 5.1 8.3 4.4 7.6 9.5 3.0 5.8 6.1 8.3 5.1 11.9 6.1 4.9 8.9 6.6 7.4 2.9 10.2 11.7 10.2 14.1 14.4 11.3 21.4 8.6 10.5 7.9 13.2 9.1 9.2 9.6 17.9 5.6 10.2 11.5 7.5 9.9 4.4 9.2 7.5 9.7 14.9 11.9 12.4 10.0 7.1 4.0 8.4 10.7 5.2 19.2 6.5 18.1 11.2 13.7 4.2 15.5 5.5 7.8 20.9 7.2 13.9 5.3 11.7 4.4 7.9 12.6 12.0 10.2 16.7 16.1 11.8 9.9 4.2 0.0 5.8 0.3 5.7 4.2 6.7 7.6 6.6 6.6 9.5 6.0 7.7 7.5 3.0 6.1 2.6 6.2 8.3 5.1 14.0 21.6 14.8 24.9 16.2 17.6 14.7 19.5 16.6 6.0 CISD2 "ERIS, Miner1, NAF-1, WFS2, ZCD2" ENSG00000145354 "CDGSH iron sulfur domain 2" Q8N5K1 4 102868974-102892807 "Disease related genes, Predicted membrane proteins" Autophagy "Deafness, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015914 Approved Supported "Endoplasmic reticulum" 80000 "Endoplasmic reticulum" "HPA015914: AB_1846794" "unprognostic (1.65e-1)" "unprognostic (1.45e-1)" "unprognostic (6.54e-3)" "unprognostic (8.02e-2)" "unprognostic (2.78e-2)" "unprognostic (3.56e-2)" "unprognostic (1.17e-3)" "unprognostic (3.48e-3)" "unprognostic (9.12e-3)" "unprognostic (2.04e-1)" "unprognostic (2.54e-1)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" "unprognostic (4.66e-2)" "unprognostic (1.70e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" 8.1 13.8 14.8 13.5 11.3 13.7 11.2 14.5 16.1 13.5 8.3 9.3 9.3 5.0 9.4 14.4 8.5 8.2 11.5 10.6 14.5 17.7 19.8 40.5 8.0 12.8 17.9 8.2 8.2 29.7 13.3 10.7 9.5 15.6 7.8 10.7 9.4 16.3 10.5 4.9 7.7 12.5 8.0 16.7 13.0 7.0 7.6 8.4 11.2 21.2 5.6 8.9 6.8 9.3 5.1 6.9 11.0 5.7 7.9 6.6 4.2 10.5 3.5 3.8 4.7 9.5 10.4 2.4 8.3 3.0 3.5 5.4 4.1 17.8 7.7 7.3 7.7 5.2 18.1 6.5 16.3 6.8 2.8 6.6 2.4 4.2 6.9 11.8 10.6 3.9 10.0 14.9 11.7 6.3 14.3 13.8 9.5 2.8 10.2 3.4 7.4 2.7 4.2 3.9 13.9 8.6 3.3 8.8 5.3 4.9 8.4 7.7 5.5 2.5 2.8 10.5 11.7 14.1 4.9 10.7 14.4 15.6 7.5 3.6 8.0 7.2 5.6 11.0 5.4 5.1 5.8 5.1 5.5 5.6 5.3 4.0 3.8 4.9 4.1 7.9 5.7 6.9 6.6 4.2 14.8 11.3 14.5 16.1 14.5 17.7 17.9 8.2 15.6 8.4 CKAP4 "CLIMP-63, ERGIC-63, P63" ENSG00000136026 "Cytoskeleton associated protein 4" Q07065 12 106237877-106304279 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 73.6;BJ hTERT+: 92.9;fHDF/TERT166: 110.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 34.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000278, HPA000792, HPA001225" Enhanced Uncertain "Nuclear speckles,Cytosol,Cytoplasmic bodies" 11000 "Nuclear speckles, Cytosol" "Cytoplasmic bodies" "HPA000278: AB_1078527, HPA000792: AB_1078526, HPA001225: AB_2666241" "unprognostic (5.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (7.13e-2)" "unprognostic (2.44e-2)" "unprognostic (4.65e-2)" "prognostic unfavourable (6.61e-5)" "prognostic unfavourable (5.61e-4)" "unprognostic (5.02e-2)" "unprognostic (9.66e-3)" "unprognostic (1.95e-1)" "unprognostic (6.23e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (7.20e-3)" "unprognostic (6.97e-2)" "unprognostic (1.29e-2)" "unprognostic (3.66e-2)" 13.0 23.8 7.1 15.3 4.9 39.5 27.2 6.9 8.4 42.3 19.2 6.5 24.8 8.1 23.7 35.2 47.3 17.2 26.6 32.9 5.7 8.0 18.3 42.1 22.2 28.5 6.3 5.4 28.6 55.2 12.7 12.0 30.6 6.8 23.9 20.5 13.2 34.4 28.0 11.1 20.8 10.7 20.4 5.8 16.7 23.0 10.3 4.2 4.0 18.6 30.0 27.8 25.8 21.4 4.2 2.3 34.6 7.5 0.1 1.0 2.4 11.2 14.2 17.2 18.7 33.6 30.0 10.0 73.6 92.9 36.0 41.5 6.0 2.6 0.7 13.4 110.9 20.5 12.6 11.1 25.9 0.3 7.3 0.0 8.2 11.8 25.1 0.1 0.2 28.7 15.3 30.5 22.1 42.1 0.0 1.4 34.1 3.8 0.5 0.4 10.0 17.3 5.2 12.4 0.9 10.9 10.2 5.7 6.3 13.1 8.9 7.0 10.0 5.1 35.9 28.4 15.7 11.7 20.8 3.9 0.0 8.0 20.5 1.4 24.8 34.6 7.5 8.7 0.5 2.7 0.7 4.2 0.7 0.4 2.3 1.6 1.0 0.9 12.7 0.1 4.1 0.0 0.2 2.4 7.1 4.9 6.9 8.4 5.7 8.0 6.3 5.4 6.8 4.2 CKLF-CMTM1 ENSG00000254788 "CKLF-CMTM1 readthrough" 16 66552587-66579135 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 16.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA017136 Approved "HPA017136: AB_1846992" "unprognostic (9.28e-3)" "unprognostic (1.62e-1)" "unprognostic (2.10e-1)" "unprognostic (1.66e-2)" "unprognostic (2.19e-2)" "unprognostic (9.65e-2)" "unprognostic (5.90e-3)" "unprognostic (3.16e-2)" "unprognostic (1.73e-1)" "unprognostic (9.69e-2)" "unprognostic (2.41e-4)" "unprognostic (2.46e-2)" "unprognostic (2.98e-2)" "unprognostic (7.51e-2)" "unprognostic (4.45e-2)" "unprognostic (2.12e-1)" "unprognostic (1.44e-1)" 5.7 4.4 9.5 11.4 8.5 3.7 6.8 10.9 10.4 5.0 6.8 3.5 2.7 3.9 8.2 5.4 4.2 6.7 8.6 4.7 8.0 9.1 5.2 4.6 11.1 16.4 8.6 3.5 9.2 6.3 2.5 4.2 5.9 5.2 5.0 3.5 3.5 4.4 4.2 2.0 3.7 10.1 4.8 7.0 14.7 5.5 16.9 6.8 16.0 4.9 3.8 6.5 3.7 4.4 0.7 3.4 12.5 3.9 1.8 3.6 2.6 4.3 5.5 2.2 5.3 2.6 5.1 0.8 5.0 2.7 4.5 6.8 2.0 4.6 1.6 2.8 0.5 3.3 2.7 0.3 2.9 4.8 1.5 0.4 1.9 0.2 1.9 3.6 2.9 0.2 0.3 2.6 0.5 2.6 1.8 4.8 3.4 1.3 8.2 4.6 1.4 2.3 16.0 7.8 5.4 4.0 1.2 3.4 4.7 8.8 0.6 1.5 2.1 2.0 1.6 6.2 11.1 4.4 1.9 2.9 5.8 6.4 4.0 3.7 9.9 8.5 3.9 10.8 3.0 1.5 3.1 0.4 1.2 1.8 3.4 0.7 0.5 1.4 12.5 1.8 1.8 1.4 3.6 2.6 9.5 8.5 10.9 9.9 8.0 9.1 8.6 3.5 5.2 6.8 CLCA2 CLCRG2 ENSG00000137975 "Chloride channel accessory 2" Q9UQC9 1 86424086-86456558 "Predicted membrane proteins" "Cell adhesion, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1" "Cell line enriched" "Detected in some" 5 "hTCEpi: 67.0" "Group enriched" "Detected in many" 6 "cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047192 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" 66000 "Plasma membrane, Cell Junctions" Nucleoplasm "HPA047192: " "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.96e-3)" "unprognostic (6.99e-2)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (9.99e-3)" "unprognostic (1.97e-8)" "unprognostic (3.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 2.0 0.1 0.1 27.7 0.2 0.1 0.4 0.1 1.1 0.7 105.2 0.1 0.2 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 1.4 0.3 0.1 5.1 0.1 0.1 36.4 0.3 0.1 0.2 0.1 0.0 0.2 0.1 0.7 0.1 42.1 33.9 6.1 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 12.3 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 10.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 67.0 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CLCA4 CaCC2 ENSG00000016602 "Chloride channel accessory 4" Q14CN2 1 86547078-86580754 "Predicted membrane proteins" Transport "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 182.1;intestine: 64.2" "Cell line enriched" "Detected in single" 964 "RT4: 96.4" "Cancer enhanced" "Detected in many" "cervical cancer: 21.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA017045, HPA064770" Uncertain Approved "Nucleoplasm,Plasma membrane,Aggresome" "Intracellular and membrane" 210000 "Plasma membrane" "Nucleoplasm, Aggresome" "HPA017045: AB_2291679, HPA064770: " "unprognostic (1.38e-4)" "unprognostic (1.52e-1)" "prognostic favourable (7.47e-4)" "unprognostic (2.73e-2)" "unprognostic (7.03e-2)" "prognostic favourable (8.63e-4)" "unprognostic (7.59e-2)" "unprognostic (3.35e-1)" "unprognostic (1.26e-1)" "unprognostic (6.01e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-2)" "unprognostic (2.29e-1)" "unprognostic (5.69e-2)" "unprognostic (3.43e-2)" 0.2 0.1 2.2 8.8 3.0 0.1 0.6 0.0 2.0 12.3 64.2 2.0 0.0 0.1 0.3 0.1 182.1 0.1 0.1 0.1 2.2 0.6 0.1 0.1 0.1 0.1 3.2 1.6 0.1 0.0 0.1 0.0 0.1 3.0 1.8 38.4 0.0 5.9 0.1 0.1 4.5 6.1 0.8 2.4 0.1 0.1 0.1 5.0 0.0 0.1 8.6 21.5 9.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.0 0.0 2.0 2.2 0.6 3.2 1.6 3.0 5.0 CLCC1 MCLC ENSG00000121940 "Chloride channel CLIC like 1" Q96S66 1 108929508-108963457 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009087, HPA013210" Enhanced Enhanced "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA009087: AB_1078532, HPA013210: AB_1846895" "unprognostic (2.95e-1)" "unprognostic (1.09e-1)" "prognostic favourable (1.33e-5)" "unprognostic (4.32e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-1)" "unprognostic (2.40e-2)" "unprognostic (1.45e-1)" "unprognostic (5.30e-2)" "unprognostic (9.23e-2)" "unprognostic (1.14e-1)" "unprognostic (1.36e-1)" "unprognostic (7.50e-2)" "unprognostic (1.74e-1)" "unprognostic (2.04e-1)" "unprognostic (4.68e-3)" "unprognostic (9.65e-2)" 17.4 19.5 17.5 13.2 24.8 7.1 19.1 22.8 26.1 19.0 16.4 28.4 22.9 15.6 22.1 31.2 12.2 16.9 15.8 20.2 19.5 15.2 12.2 23.5 15.1 10.9 24.4 16.3 23.3 28.5 26.6 24.4 20.0 20.5 23.1 15.3 17.7 21.8 24.1 29.3 16.1 14.8 19.3 21.5 13.7 17.9 8.3 24.3 5.1 21.7 10.4 12.9 17.1 16.0 7.7 9.5 9.0 15.4 7.1 9.4 5.5 23.6 10.3 13.4 23.1 18.7 16.9 17.3 19.7 16.2 14.0 15.1 11.1 9.9 5.6 21.2 15.6 9.1 12.0 7.5 17.9 17.9 10.8 14.0 12.9 10.2 15.0 13.8 15.5 12.4 11.2 16.1 13.3 12.8 16.9 23.1 10.2 9.4 1.2 5.4 10.1 9.3 12.8 6.8 13.4 11.7 14.1 8.0 12.3 23.1 24.9 17.8 7.8 9.4 13.8 18.7 15.0 17.8 19.3 16.8 13.7 8.7 22.8 11.2 40.2 4.1 9.2 9.0 9.1 11.1 9.4 7.7 7.7 7.2 8.0 5.9 8.7 7.9 1.6 7.1 15.4 9.5 9.2 5.5 17.5 24.8 22.8 26.1 19.5 15.2 24.4 16.3 20.5 24.3 CLCN3 "ClC-3, CLC3" ENSG00000109572 "Chloride voltage-gated channel 3" P51790 4 169612633-169723673 "Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044723 Approved Supported Vesicles Vesicles "HPA044723: AB_10959733" "unprognostic (1.92e-1)" "unprognostic (3.92e-2)" "unprognostic (1.95e-3)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (2.25e-1)" "unprognostic (3.32e-1)" "unprognostic (1.79e-1)" "unprognostic (5.40e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.10e-4)" "unprognostic (2.49e-2)" "unprognostic (2.49e-1)" "unprognostic (1.45e-1)" "unprognostic (6.38e-3)" 11.6 21.1 27.6 10.9 29.9 5.9 18.4 24.9 37.7 15.0 26.7 32.4 15.5 17.1 11.1 17.7 26.6 15.6 22.0 19.6 29.3 29.7 22.2 14.7 11.9 9.0 32.7 22.7 14.0 23.4 29.4 38.7 14.5 36.1 19.5 30.8 20.6 48.5 13.5 14.6 18.0 16.5 10.4 46.1 9.0 23.2 18.4 25.4 10.8 21.7 18.4 13.5 20.5 16.7 8.6 11.9 6.2 8.1 6.9 11.5 7.9 11.8 12.2 18.3 23.3 37.4 31.5 9.0 15.9 19.9 10.7 13.1 8.6 26.8 14.6 9.9 13.2 10.1 22.8 9.8 18.0 12.9 8.9 12.2 19.9 9.9 25.5 14.6 20.5 21.9 22.6 19.0 18.9 19.3 30.2 33.5 18.9 4.2 20.0 3.4 7.5 8.3 9.0 8.1 11.4 22.4 24.4 19.9 19.6 14.1 15.5 24.8 10.5 6.9 16.3 8.6 9.7 13.8 12.3 14.9 22.4 13.0 25.9 5.6 22.7 6.2 6.5 4.7 9.0 8.1 11.5 8.6 6.7 8.2 9.5 7.4 10.4 9.2 5.3 6.9 6.5 11.9 8.1 7.9 27.6 29.9 24.9 36.8 29.3 29.7 32.7 22.7 36.1 25.4 CLCN4 "ClC-4, CLC4" ENSG00000073464 "Chloride voltage-gated channel 4" P51793 X 10156945-10237660 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6" "Cell line enhanced" "Detected in many" "HEL: 16.7;SCLC-21H: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4" "Group enriched" "Detected in many" 9 "B-cells: 6.8;granulocytes: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031313, HPA063637" Enhanced Approved Vesicles Vesicles "HPA031313: AB_10601358, HPA063637: " "unprognostic (1.01e-1)" "unprognostic (1.20e-2)" "unprognostic (5.07e-2)" "prognostic unfavourable (2.13e-5)" "unprognostic (2.96e-1)" "unprognostic (3.75e-1)" "unprognostic (1.04e-2)" "unprognostic (3.66e-1)" "unprognostic (1.75e-1)" "unprognostic (5.99e-2)" "prognostic favourable (9.55e-4)" "unprognostic (9.70e-2)" "unprognostic (9.78e-3)" "unprognostic (1.68e-1)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" 3.1 3.4 9.7 2.0 21.3 2.1 1.6 18.6 29.1 2.0 1.4 15.7 0.0 1.2 1.3 22.8 2.3 3.0 2.8 11.4 13.0 10.5 3.4 3.5 3.4 2.9 23.5 10.4 2.2 2.4 8.9 3.9 1.7 18.2 2.1 1.1 6.0 2.3 1.7 34.6 1.2 1.2 1.4 15.2 3.2 2.1 2.2 17.9 0.0 6.8 2.0 2.2 2.3 0.8 6.8 0.6 4.4 0.5 0.0 0.0 0.6 4.9 3.1 2.3 0.0 1.1 2.0 0.1 0.1 0.0 0.0 0.0 6.0 3.4 3.7 9.0 1.0 1.1 1.4 3.4 0.1 0.0 3.5 16.7 1.7 2.5 5.5 0.0 0.0 10.0 2.7 4.3 1.1 6.4 1.2 0.0 2.3 0.5 0.0 0.1 2.9 10.8 0.0 3.8 0.0 1.5 0.5 17.3 6.5 7.1 0.7 0.0 1.8 2.1 6.3 2.7 4.6 11.8 0.4 0.4 8.3 1.3 8.6 0.0 3.4 2.3 0.5 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.6 6.8 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.6 9.7 21.3 18.6 26.7 13.0 10.5 23.5 10.4 18.2 17.9 CLCN6 "CLC-6, KIAA0046" ENSG00000011021 "Chloride voltage-gated channel 6" P51797 1 11806096-11843144 "Plasma proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032097 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA032097: AB_10670827" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" "unprognostic (2.46e-1)" "unprognostic (8.83e-2)" "unprognostic (2.08e-1)" "unprognostic (3.84e-3)" "unprognostic (1.51e-3)" "unprognostic (6.49e-2)" "unprognostic (7.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.71e-3)" "unprognostic (3.44e-1)" "unprognostic (2.13e-2)" "unprognostic (6.91e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (3.65e-2)" 11.2 14.6 18.9 11.5 18.7 12.2 8.6 18.0 27.9 9.2 8.7 22.4 8.6 9.6 12.8 14.2 6.3 10.7 8.1 15.7 15.0 20.6 10.0 9.1 10.6 11.1 16.4 17.8 21.4 6.6 8.4 14.8 9.6 32.4 11.3 7.8 13.1 6.7 8.7 11.2 10.0 9.1 10.8 15.9 10.6 8.5 16.1 14.5 4.3 10.7 5.0 9.5 7.7 8.2 10.1 3.2 4.2 4.6 2.0 3.2 1.1 5.7 5.3 12.1 10.1 13.0 13.5 3.8 4.8 9.2 6.6 10.4 8.2 13.9 8.1 4.0 4.4 8.5 7.9 8.9 5.9 3.6 4.3 8.4 10.6 10.8 16.8 4.7 7.9 9.2 5.3 12.5 7.0 5.9 10.7 11.8 6.7 3.1 4.9 12.8 8.1 4.2 6.1 6.6 7.4 8.8 4.7 5.3 8.4 3.2 5.1 11.1 4.5 8.5 7.2 6.2 7.0 10.6 3.3 7.1 4.3 21.0 7.7 9.5 4.5 4.2 4.6 1.5 2.6 3.7 1.5 8.0 2.1 3.2 2.7 10.1 2.3 2.1 3.9 2.0 4.6 3.2 1.4 1.1 18.9 18.7 18.0 27.9 15.0 20.6 16.4 17.8 32.4 14.5 CLCN7 "CLC-7, CLC7, OPTA2, PPP1R63" ENSG00000103249 "Chloride voltage-gated channel 7" P51798 16 1444934-1475580 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043019, HPA043586" Supported Supported Nucleoplasm Nucleoplasm "HPA043019: AB_10964727, HPA043586: AB_10965322" "unprognostic (2.69e-1)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (5.61e-2)" "unprognostic (1.90e-2)" "prognostic favourable (5.23e-4)" "unprognostic (1.59e-2)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-2)" "unprognostic (1.41e-2)" "unprognostic (3.98e-1)" "unprognostic (3.49e-3)" "unprognostic (5.81e-2)" "prognostic unfavourable (3.21e-4)" "unprognostic (2.80e-1)" "unprognostic (2.54e-1)" 19.5 34.7 23.2 18.7 23.0 35.0 19.4 22.9 26.8 16.7 15.5 29.3 15.4 18.3 18.8 16.8 12.5 15.8 17.0 15.0 21.9 17.5 19.5 22.7 17.7 19.6 30.3 18.5 14.2 24.1 30.9 19.5 15.5 22.2 14.6 9.4 34.4 17.5 17.5 22.5 21.7 18.9 17.3 18.0 24.8 18.1 17.6 29.5 16.4 21.8 10.9 14.9 17.2 10.2 2.5 2.3 2.0 6.4 0.5 1.6 1.5 5.1 14.3 8.0 12.7 18.3 9.3 12.7 6.9 16.0 15.2 19.0 11.1 19.1 5.8 14.3 9.4 10.8 7.3 8.9 4.6 9.3 11.4 4.2 13.3 11.0 32.0 10.7 17.1 18.5 12.4 13.7 11.8 9.7 16.8 11.4 7.7 10.2 7.5 18.3 8.0 8.1 35.1 5.4 16.2 7.5 7.3 9.1 9.3 11.1 14.1 44.7 12.4 28.6 9.5 13.4 6.1 14.7 6.5 17.3 11.2 6.1 11.2 20.3 8.3 0.0 3.0 2.0 1.6 5.4 0.7 2.2 0.9 0.7 2.3 2.5 0.4 0.6 0.6 0.5 6.4 2.3 0.3 1.5 23.2 23.0 22.9 26.8 21.9 17.5 30.3 18.5 22.2 29.5 CLDN16 "HOMG3, PCLN1" ENSG00000113946 "Claudin 16" Q9Y5I7 3 190322541-190412143 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "kidney: 55.9" "Group enriched" "Detected in some" 131 "EFO-21: 99.0;RPTEC TERT1: 34.8" "Group enriched" "Detected in many" 15 "ovarian cancer: 39.8;thyroid cancer: 29.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA056020 Enhanced "HPA056020: " "unprognostic (5.01e-2)" "unprognostic (7.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavourable (1.99e-5)" "unprognostic (6.06e-4)" "unprognostic (1.30e-1)" "unprognostic (2.07e-1)" "unprognostic (2.39e-2)" "unprognostic (3.31e-1)" "unprognostic (4.20e-1)" "unprognostic (2.76e-3)" "unprognostic (3.70e-1)" "unprognostic (1.96e-1)" "unprognostic (5.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.2 0.8 0.4 0.2 0.3 0.0 0.2 0.2 0.5 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.6 0.2 0.2 0.3 0.4 55.9 1.2 0.2 0.7 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.6 0.5 0.2 1.8 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.4 3.4 0.2 0.4 0.3 0.2 0.5 0.4 1.4 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 1.4 0.1 0.2 0.2 0.2 0.1 0.4 0.2 0.1 0.0 0.5 0.3 0.2 1.2 0.3 0.2 0.4 0.1 0.0 0.4 0.3 0.2 0.5 0.3 0.4 0.3 0.2 0.2 0.2 CLDN7 "CEPTRL2, CPETRL2, Hs.84359" ENSG00000181885 "Claudin 7" O95471 17 7259903-7263983 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 166.7" "Cell line enhanced" "Detected in some" "BEWO: 26.6;CACO-2: 27.7;CAPAN-2: 53.9;HaCaT: 113.3;MCF7: 39.4;SK-BR-3: 47.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013063, HPA014703, HPA073662" Enhanced Approved "Vesicles,Cell Junctions" Vesicles "Cell Junctions" "CAB013063: , HPA014703: AB_1846873, HPA073662: " "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (4.12e-2)" "unprognostic (2.90e-1)" "unprognostic (1.05e-1)" "unprognostic (8.67e-2)" "unprognostic (3.41e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-3)" "unprognostic (8.34e-2)" "unprognostic (4.89e-3)" "unprognostic (1.62e-2)" "prognostic favourable (8.96e-11)" "prognostic favourable (4.09e-4)" "unprognostic (1.87e-1)" "prognostic favourable (1.85e-4)" "unprognostic (1.62e-1)" 1.6 2.0 0.4 28.0 0.4 0.0 9.5 0.4 0.4 9.9 71.4 0.4 47.6 47.2 2.4 49.3 73.4 13.4 47.2 0.7 0.4 0.3 30.0 12.1 32.3 0.8 0.4 0.4 3.4 70.9 12.3 7.3 25.0 0.4 9.8 42.5 0.7 40.9 42.2 0.9 2.9 166.7 1.8 0.5 1.4 1.2 1.8 0.4 1.5 40.5 28.3 45.6 12.2 19.3 3.8 1.6 0.0 3.0 2.2 6.7 2.3 3.2 0.3 0.0 0.0 0.0 0.2 26.6 0.0 0.0 0.0 0.0 27.7 53.9 0.0 1.0 0.1 113.3 0.0 3.4 0.0 0.0 0.6 0.0 0.7 0.0 2.1 0.0 0.2 0.5 5.4 0.0 0.2 2.5 0.3 0.1 0.0 39.4 0.0 0.3 0.1 1.0 0.0 0.0 0.7 0.0 0.0 6.5 0.1 0.3 47.2 0.0 17.2 0.4 5.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 2.2 3.0 4.8 0.5 1.5 3.3 1.6 3.8 3.7 6.7 0.0 2.2 0.1 0.2 0.9 2.3 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavourable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 23.0 14.1 27.8 21.7 12.5 14.3 19.6 20.1 27.8 14.8 18.4 9.0 19.3 13.7 24.4 17.6 10.8 35.2 21.2 7.5 18.8 5.2 13.3 22.2 16.9 18.7 25.3 58.5 15.7 16.8 21.8 9.3 27.8 28.2 9.4 12.4 11.2 20.0 15.6 8.4 30.9 11.5 18.7 8.2 8.3 22.9 19.7 6.6 28.2 6.6 14.3 20.1 26.2 24.2 17.8 18.5 36.8 15.7 14.5 43.8 16.3 33.4 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 CLEC10A "CD301, CLECSF13, CLECSF14, HML, HML2" ENSG00000132514 "C-type lectin domain containing 10A" Q8IUN9 17 7074537-7080307 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Endocytosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.1;lymphoid tissue: 49.3" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.6;NB-4: 4.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 12 "myeloid DC: 81.1" "Lineage enriched" "Detected in many" 12 "dendritic cells: 81.1" HPA021937 Approved "HPA021937: AB_1846905" "unprognostic (3.96e-3)" "unprognostic (1.71e-3)" "unprognostic (2.95e-2)" "unprognostic (2.04e-3)" "unprognostic (4.54e-2)" "prognostic favourable (1.26e-5)" "unprognostic (1.07e-1)" "prognostic favourable (9.24e-4)" "unprognostic (2.70e-2)" "unprognostic (1.41e-1)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.12e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (4.22e-4)" "unprognostic (3.23e-1)" "unprognostic (3.65e-1)" 12.7 4.0 0.4 14.3 0.5 0.6 6.6 0.4 0.6 4.9 9.7 0.8 1.7 7.9 6.4 31.3 6.9 6.1 12.2 17.5 0.4 0.4 4.4 6.2 22.0 49.3 0.6 0.6 4.1 3.3 0.4 2.0 1.3 2.0 7.2 9.7 3.8 5.0 5.9 6.1 5.1 14.3 9.6 0.9 10.2 4.4 3.7 0.5 5.4 4.7 9.9 10.4 9.8 4.6 0.0 81.1 0.3 6.6 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.3 0.0 0.0 0.0 4.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.3 0.6 0.0 0.0 0.1 0.0 0.1 0.0 5.5 0.0 0.0 6.6 0.0 0.0 0.0 0.0 81.1 0.0 0.0 0.0 0.3 0.3 0.0 1.6 0.0 3.3 0.4 0.5 0.4 0.6 0.4 0.4 0.6 0.6 2.0 0.5 CLEC12A "CD371, CLL-1, DCAL-2, MICL" ENSG00000172322 "C-type lectin domain family 12 member A" Q5QGZ9 12 9951316-9995694 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 46.5;bone marrow: 35.4;lung: 36.2;lymphoid tissue: 22.4" "Group enriched" "Detected in some" 6 "HL-60: 11.8;U-937: 36.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "eosinophil: 46.5" "Group enriched" "Detected in many" 38 "dendritic cells: 17.1;granulocytes: 46.5;monocytes: 32.8" HPA048515 Enhanced "HPA048515: " "unprognostic (4.74e-2)" "unprognostic (6.06e-3)" "unprognostic (7.76e-2)" "unprognostic (6.88e-2)" "unprognostic (2.00e-2)" "unprognostic (6.66e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (3.29e-1)" "unprognostic (1.44e-2)" "unprognostic (1.70e-1)" "unprognostic (2.74e-2)" "unprognostic (1.10e-3)" "unprognostic (9.67e-3)" "unprognostic (7.43e-2)" "unprognostic (3.78e-2)" "prognostic favourable (9.33e-4)" 4.2 1.2 0.3 6.4 1.2 35.4 1.2 0.6 1.1 0.9 1.5 0.3 0.1 0.2 1.9 3.7 0.9 1.3 2.8 3.5 0.3 0.3 1.9 3.4 36.2 9.6 0.5 0.8 1.0 1.4 0.0 0.6 3.4 1.2 1.3 1.3 1.4 1.5 0.1 0.7 1.1 1.9 3.5 1.5 22.4 1.3 0.9 0.3 2.8 0.7 0.1 1.2 2.1 1.0 0.0 17.1 46.5 32.8 0.8 0.1 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 11.8 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 36.9 0.0 4.1 32.8 46.5 0.0 26.4 0.1 0.0 0.0 0.0 17.1 0.0 0.0 0.1 10.2 0.8 28.4 1.5 0.0 12.5 0.3 1.2 0.6 1.1 0.3 0.3 0.5 0.8 1.2 0.3 CLEC14A C14orf27 ENSG00000176435 "C-type lectin domain containing 14A" Q86T13 14 38254103-38256369 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 63.2" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 17.0;HUVEC TERT2: 92.2;TIME: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "myeloid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039468, HPA048119" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" 3600000 "Endoplasmic reticulum, Golgi apparatus" "HPA039468: AB_2676524, HPA048119: " "unprognostic (4.02e-1)" "unprognostic (4.26e-2)" "unprognostic (4.20e-3)" "unprognostic (9.44e-2)" "unprognostic (1.35e-1)" "prognostic favourable (4.13e-6)" "unprognostic (2.55e-3)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (6.90e-2)" "unprognostic (5.41e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-2)" "unprognostic (1.75e-2)" "unprognostic (1.55e-1)" "unprognostic (4.97e-2)" "unprognostic (5.28e-2)" 32.2 3.9 3.2 6.8 4.3 0.0 47.8 2.3 3.9 14.5 9.3 3.4 5.9 5.9 18.4 13.3 9.3 9.9 13.6 23.7 3.8 3.4 6.8 11.4 63.2 7.9 4.9 2.2 7.6 3.3 5.0 2.8 15.0 4.4 11.8 4.4 10.8 5.5 6.5 36.5 6.5 7.4 12.1 3.9 9.0 5.9 6.8 2.2 1.4 14.0 21.1 3.8 9.4 14.8 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 92.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 4.3 2.3 3.9 3.8 3.4 4.9 2.2 4.4 2.2 CLEC2A "INPE5792, KACL, PILAR, UNQ5792" ENSG00000188393 "C-type lectin domain family 2 member A" Q6UVW9 12 9898673-9932381 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 37.0" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 13.2;U-937: 32.9" "Cancer enhanced" "Detected in some" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048530, HPA072407" Approved Uncertain "Plasma membrane" "Plasma membrane" "HPA048530: , HPA072407: " "unprognostic (3.10e-1)" "unprognostic (5.29e-2)" "unprognostic (2.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.3 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 CLEC2D "CLAX, LLT1, OCIL" ENSG00000069493 "C-type lectin domain family 2 member D" Q9UHP7 12 9664969-9699555 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 45.6;lymphoid tissue: 47.5" "Group enriched" "Detected in some" 4 "Daudi: 27.2;HDLM-2: 21.2;Karpas-707: 12.9;U-698: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "gdT-cell: 37.8;MAIT T-cell: 23.0;memory B-cell: 15.9;memory CD4 T-cell: 37.3;memory CD8 T-cell: 41.3;naive B-cell: 24.6;naive CD4 T-cell: 39.4;naive CD8 T-cell: 45.6;T-reg: 31.5" "Group enriched" "Detected in many" 11 "B-cells: 24.6;T-cells: 45.6" "HPA017649, HPA047584" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA017649: AB_1846912, HPA047584: " "unprognostic (1.09e-3)" "prognostic favourable (1.37e-4)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (1.29e-1)" "unprognostic (2.77e-4)" "unprognostic (4.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (6.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (5.85e-11)" "unprognostic (1.17e-1)" "unprognostic (2.70e-1)" "unprognostic (3.44e-1)" "prognostic favourable (1.68e-7)" 3.8 1.0 1.1 47.5 1.1 7.8 3.7 0.8 1.0 2.9 6.0 0.6 1.4 1.7 3.0 7.0 3.6 3.2 3.0 3.3 1.2 1.1 2.6 1.3 10.4 28.3 1.7 1.2 4.0 1.5 0.2 1.3 1.7 1.1 4.5 2.1 2.5 9.8 3.2 1.2 2.4 11.2 3.2 2.5 21.3 2.7 5.7 1.0 44.7 2.8 2.7 29.4 8.2 2.5 24.6 0.4 1.1 0.4 3.1 45.6 19.2 0.4 1.0 1.5 0.1 0.2 0.6 1.6 0.7 1.0 0.3 0.9 0.7 0.9 27.2 0.1 0.7 0.3 0.5 0.0 0.5 21.2 0.4 0.8 0.6 1.2 2.4 0.6 0.7 0.9 0.7 0.2 0.9 0.0 0.2 12.9 0.6 1.8 0.3 2.4 1.3 0.2 5.9 0.6 0.8 1.4 1.5 0.2 0.5 0.3 1.1 1.1 0.2 0.7 0.2 0.5 0.7 0.4 0.4 1.8 0.4 41.8 1.2 1.2 0.8 1.1 0.4 0.2 37.8 0.2 23.0 15.9 37.3 41.3 0.4 24.6 39.4 45.6 1.1 3.1 0.2 0.3 31.5 19.2 1.1 1.1 0.8 1.0 1.2 1.1 1.7 1.2 1.1 1.0 CLEC2L FLJ32986 ENSG00000236279 "C-type lectin domain family 2 member L" P0C7M8 7 139523856-139544984 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.8;parathyroid gland: 15.5" "Group enriched" "Detected in some" 5 "U-266/70: 4.3;U-266/84: 15.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045050 Enhanced "HPA045050: AB_10965839" "unprognostic (1.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.20e-4)" "unprognostic (1.24e-2)" "unprognostic (1.33e-2)" "unprognostic (6.17e-2)" "unprognostic (2.29e-6)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (6.73e-2)" "unprognostic (2.68e-1)" "unprognostic (8.31e-2)" "unprognostic (7.94e-4)" "unprognostic (3.57e-3)" "unprognostic (4.03e-2)" "unprognostic (8.42e-3)" "unprognostic (3.02e-2)" 1.1 0.9 9.8 1.0 9.4 1.1 0.8 14.0 24.1 2.3 0.9 1.4 0.0 0.9 2.5 0.5 1.6 0.8 1.9 0.5 13.8 9.2 0.7 0.6 0.7 0.8 15.1 7.2 0.7 0.7 15.5 0.1 0.7 26.8 0.6 0.9 2.2 0.7 0.6 5.5 0.7 1.2 2.2 3.8 0.7 0.6 1.3 0.5 1.8 0.8 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 9.8 9.4 14.0 24.1 13.8 9.2 15.1 7.2 26.8 0.5 CLEC4A "CD367, CLECSF6, DCIR, DDB27" ENSG00000111729 "C-type lectin domain family 4 member A" Q9UMR7 12 8123632-8138607 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.6;lung: 30.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 29.2;classical monocyte: 54.6;intermediate monocyte: 31.2;myeloid DC: 53.2;neutrophil: 48.8;non-classical monocyte: 19.6" "Group enriched" "Detected in many" 12 "dendritic cells: 53.2;granulocytes: 48.8;monocytes: 54.6" HPA007842 Uncertain "HPA007842: AB_1078534" "unprognostic (9.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.41e-2)" "unprognostic (3.13e-2)" "unprognostic (2.69e-1)" "unprognostic (9.34e-2)" "unprognostic (5.49e-2)" "unprognostic (8.22e-2)" "unprognostic (1.62e-1)" "unprognostic (7.84e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.42e-3)" "unprognostic (1.42e-1)" "unprognostic (1.35e-2)" "unprognostic (3.05e-1)" "unprognostic (9.79e-2)" 8.3 2.0 2.7 20.1 4.0 14.6 3.3 2.2 2.6 3.7 3.1 3.5 0.6 3.6 2.7 5.2 2.1 2.9 5.6 3.4 2.5 2.5 5.4 4.1 30.0 25.1 2.8 2.4 5.5 2.5 0.5 3.3 6.0 3.2 4.1 4.6 4.0 2.6 2.2 2.2 3.8 4.7 3.3 8.1 16.3 2.0 2.8 3.7 5.7 2.8 3.2 7.4 6.0 3.1 4.5 53.2 48.8 54.6 0.5 0.2 23.7 0.3 0.0 0.7 1.8 3.4 8.4 1.1 2.2 1.0 1.8 2.5 3.0 1.5 1.3 0.3 1.2 0.4 1.9 0.4 1.1 2.2 2.3 1.4 1.5 0.8 4.2 4.2 5.7 4.2 1.9 0.7 2.4 0.4 0.8 1.2 2.4 1.0 1.2 3.2 1.3 0.8 0.8 1.5 2.1 1.2 2.0 0.3 0.7 0.5 1.6 0.0 0.2 0.3 0.5 3.2 1.9 1.2 1.4 1.5 0.2 1.7 0.4 1.6 0.1 29.2 54.6 0.1 0.1 31.2 0.1 2.0 0.1 0.2 53.2 4.5 0.1 0.1 48.8 0.5 19.6 7.3 0.1 23.7 2.7 4.0 2.2 2.6 2.5 2.5 2.8 2.4 3.2 3.7 CLEC4C "BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL" ENSG00000198178 "C-type lectin domain family 4 member C" Q8WTT0 12 7729415-7751605 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "blood: 80.0" "Cell line enriched" "Detected in some" 4 "HDLM-2: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 16 "plasmacytoid DC: 80.0" "Lineage enriched" "Detected in many" 16 "dendritic cells: 80.0" HPA029432 Approved "HPA029432: AB_10601259" "unprognostic (3.55e-3)" "unprognostic (3.01e-2)" "unprognostic (1.03e-1)" "unprognostic (3.70e-2)" "unprognostic (7.37e-5)" "unprognostic (2.36e-2)" "unprognostic (2.06e-1)" "unprognostic (2.55e-2)" "unprognostic (6.98e-2)" "unprognostic (1.39e-1)" "unprognostic (1.88e-3)" "unprognostic (2.82e-2)" "unprognostic (3.18e-3)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" 0.3 0.2 0.2 1.6 0.2 1.8 2.0 0.2 0.6 0.2 0.2 0.1 0.1 0.0 0.2 0.1 0.3 0.5 1.2 0.3 0.2 0.2 0.5 0.3 1.5 7.0 0.2 0.1 0.4 0.2 0.0 0.2 0.1 0.1 0.2 0.0 0.4 0.3 2.0 0.2 0.3 0.3 0.1 0.2 4.6 0.3 9.9 0.1 6.7 0.3 0.1 7.1 1.9 0.3 0.5 80.0 4.9 0.1 0.5 0.0 0.5 0.2 0.0 0.3 0.3 0.5 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.6 0.3 0.0 0.0 0.3 0.0 0.0 0.2 6.5 0.1 0.3 0.7 0.2 0.0 0.6 1.3 0.4 0.3 0.0 0.0 0.1 0.2 1.0 0.0 0.1 0.1 0.8 1.4 0.2 0.1 0.0 0.1 0.1 0.4 0.2 0.2 0.1 0.1 0.0 0.9 0.1 0.4 0.4 0.2 0.1 0.1 0.6 0.2 1.4 0.1 0.3 0.3 0.9 0.1 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.5 0.0 0.0 2.6 0.5 0.0 80.0 0.0 0.5 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.1 0.1 0.1 CLEC4E "CLECSF9, mincle" ENSG00000166523 "C-type lectin domain family 4 member E" Q9ULY5 12 8533305-8540963 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.7;bone marrow: 37.7;lymphoid tissue: 41.2" "Group enriched" "Detected in some" 4 "NB-4: 5.7;RPTEC TERT1: 16.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "classical monocyte: 22.8;neutrophil: 81.7" "Group enriched" "Detected in many" 17 "granulocytes: 81.7;monocytes: 22.8" "Not detected" "Not detected" HPA004935 Uncertain Uncertain Cytosol Cytosol "HPA004935: " "unprognostic (3.05e-2)" "unprognostic (2.01e-2)" "unprognostic (8.91e-2)" "unprognostic (3.76e-1)" "unprognostic (1.76e-1)" "unprognostic (9.71e-3)" "unprognostic (1.77e-1)" "unprognostic (1.24e-1)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.62e-1)" "unprognostic (1.51e-1)" "unprognostic (8.44e-2)" "unprognostic (2.29e-1)" 8.4 3.0 1.1 20.9 2.4 37.7 17.5 1.2 2.2 3.4 1.4 0.0 1.1 0.1 1.2 1.6 1.7 4.2 6.7 5.9 1.3 1.2 6.2 3.5 25.6 41.2 2.8 0.6 1.0 3.3 0.0 1.7 1.7 9.0 1.6 0.5 1.1 1.2 0.6 2.7 0.7 1.9 3.2 5.3 34.2 1.8 3.3 0.8 0.7 12.8 0.9 1.1 2.2 2.2 0.0 2.9 81.7 22.8 0.0 0.0 4.5 0.1 0.6 0.4 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.1 1.9 0.1 2.6 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.3 0.3 0.0 0.7 0.1 0.0 1.7 0.1 0.7 0.2 0.1 0.0 0.1 0.0 5.7 0.5 0.1 0.1 0.2 0.1 16.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.5 1.2 0.6 0.1 1.1 0.1 0.2 0.1 0.1 1.6 0.4 0.1 0.0 22.8 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 81.7 0.0 0.1 0.1 0.0 4.5 1.1 2.4 1.2 2.2 1.3 1.2 2.8 0.6 9.0 0.8 CLEC4G "LSECtin, UNQ431" ENSG00000182566 "C-type lectin domain family 4 member G" Q6UXB4 19 7728957-7733906 "Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 63.1;lymphoid tissue: 53.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.3;hTEC/SVTERT24-B: 1.0;RPMI-8226: 1.2;RT4: 1.2;TIME: 2.6;U-937: 2.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 11.8" "Cell type enhanced" "Detected in some" "classical monocyte: 13.9;myeloid DC: 11.9" "Group enriched" "Detected in many" 19 "B-cells: 4.1;dendritic cells: 11.9;monocytes: 13.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB003789, HPA014044" Enhanced "CAB003789: , HPA014044: AB_1846916" "unprognostic (7.20e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (3.64e-1)" "unprognostic (4.47e-2)" "unprognostic (1.35e-1)" "unprognostic (7.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.23e-1)" "unprognostic (3.29e-2)" "unprognostic (7.45e-2)" "unprognostic (3.04e-1)" "unprognostic (2.13e-8)" "unprognostic (5.21e-2)" "unprognostic (1.27e-1)" "unprognostic (1.77e-1)" "unprognostic (6.65e-2)" 11.2 0.1 0.9 1.5 1.2 0.9 2.6 11.8 1.6 0.2 1.5 0.2 0.2 0.4 0.2 1.3 5.2 2.7 1.0 7.3 2.6 1.0 0.3 63.1 0.5 53.5 0.8 0.2 0.5 0.8 0.0 0.2 0.8 0.2 0.8 0.7 0.3 4.9 0.5 0.2 0.4 0.7 0.7 0.2 1.3 0.3 0.7 0.2 0.3 0.5 0.6 0.2 2.0 0.6 4.1 11.9 0.5 13.9 0.4 0.1 2.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 1.2 0.1 0.0 0.2 0.0 0.0 0.6 0.7 2.6 0.0 0.1 0.7 0.0 0.1 0.0 0.2 0.0 2.2 0.1 0.0 13.9 0.0 0.0 3.3 0.0 0.3 0.0 0.0 11.9 4.1 0.1 0.0 0.5 0.4 0.4 0.6 0.0 2.8 0.9 1.2 11.8 1.6 2.6 1.0 0.8 0.2 0.2 0.2 CLEC4M "CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN" ENSG00000104938 "C-type lectin domain family 4 member M" Q9H2X3 19 7763149-7769605 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Endocytosis, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "liver: 38.5;lymphoid tissue: 30.1" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 2.5;K-562: 3.4;Karpas-707: 1.3;RPMI-8226: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 18 "B-cells: 1.7" "CAB033689, CAB033691, HPA042661" Supported "Intracellular and membrane" 890000 "CAB033689: AB_831088, CAB033691: AB_2081354, HPA042661: " "unprognostic (1.56e-1)" "unprognostic (3.03e-1)" "unprognostic (1.00e-1)" "unprognostic (1.71e-2)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (6.58e-2)" "unprognostic (1.27e-1)" "unprognostic (4.58e-3)" "unprognostic (4.60e-2)" "unprognostic (5.15e-2)" "unprognostic (1.43e-1)" 0.9 0.9 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.3 0.1 1.2 0.6 0.1 0.1 0.1 0.0 0.1 38.5 2.5 30.1 0.1 0.1 2.7 0.1 0.0 0.1 4.8 0.2 0.1 0.0 0.1 0.8 0.1 0.1 0.0 0.5 0.1 0.1 0.2 0.0 1.4 0.1 0.1 0.2 0.1 0.2 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 3.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 CLEC5A "CLECSF5, MDL-1" ENSG00000258227 "C-type lectin domain containing 5A" Q9NY25 7 141927357-141947007 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 35.8" "Group enriched" "Detected in some" 23 "HL-60: 14.8;U-937: 57.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "classical monocyte: 11.5" "Lineage enriched" "Detected in many" 8 "monocytes: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA054137 Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA054137: " "unprognostic (6.89e-2)" "unprognostic (1.07e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" "unprognostic (1.69e-2)" "unprognostic (4.56e-2)" "unprognostic (1.33e-5)" "unprognostic (4.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavourable (2.21e-4)" "unprognostic (6.58e-3)" "unprognostic (1.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.23e-2)" "unprognostic (1.64e-1)" 1.4 3.2 1.8 7.3 2.4 35.8 0.8 0.8 2.5 1.7 0.4 1.9 0.6 0.4 0.8 0.5 1.4 1.2 2.0 3.8 7.6 3.1 2.9 2.1 13.9 0.3 2.4 0.5 2.7 2.6 1.4 1.1 2.7 8.2 0.9 0.5 0.8 2.7 0.8 0.3 2.7 0.3 1.5 4.8 2.1 0.4 0.9 4.8 1.1 1.4 4.9 1.4 1.9 1.1 0.0 0.5 1.4 11.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.3 0.0 0.0 11.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 1.9 1.8 2.4 0.8 2.5 7.6 3.1 2.4 0.5 8.2 4.8 CLECL1 DCAL1 ENSG00000184293 "C-type lectin like 1" Q8IZS7 12 9715860-9733299 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 9 "blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6" "Group enriched" "Detected in some" 5 "HEL: 15.7;Karpas-707: 21.7;U-698: 55.5;U-937: 30.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 42.4" "Lineage enriched" "Detected in many" 5 "B-cells: 42.4" HPA063928 Supported "Plasma membrane,Centriolar satellite" "Plasma membrane, Centriolar satellite" "HPA063928: " "unprognostic (2.18e-2)" "unprognostic (2.35e-3)" "unprognostic (2.20e-3)" "unprognostic (1.90e-3)" "unprognostic (3.66e-1)" "unprognostic (1.90e-3)" "unprognostic (2.83e-1)" "unprognostic (7.55e-4)" "unprognostic (5.10e-2)" "unprognostic (2.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-5)" "unprognostic (3.31e-1)" "unprognostic (2.45e-1)" "unprognostic (6.10e-2)" "unprognostic (7.39e-2)" 2.7 1.0 0.8 9.8 1.1 0.9 1.1 0.3 0.9 0.6 1.7 1.3 0.1 1.6 0.7 1.3 2.6 0.9 1.5 2.7 1.0 0.9 1.6 1.4 1.9 15.5 1.3 0.7 0.5 1.7 0.0 0.9 0.5 0.9 0.8 2.8 0.8 1.5 0.1 0.5 0.5 11.5 0.9 2.5 20.5 2.6 0.6 0.3 2.2 0.9 0.5 20.6 2.8 2.4 42.4 8.6 0.7 4.6 0.0 3.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 55.5 0.0 30.5 0.0 0.7 2.6 0.1 1.7 4.6 0.0 42.4 1.4 3.5 6.1 14.5 0.0 0.5 0.1 0.0 4.6 8.6 0.1 2.1 0.8 1.1 0.3 0.9 1.0 0.9 1.3 0.7 0.9 0.3 CLGN ENSG00000153132 Calmegin O14967 4 140388455-140427968 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 40.3;pituitary gland: 23.6;testis: 52.6" "Cell line enhanced" "Detected in many" "MOLT-4: 18.4;U-251 MG: 29.2" "Cancer enhanced" "Detected in many" "prostate cancer: 19.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020709, HPA048761, HPA058627" Enhanced Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB020709: , HPA048761: , HPA058627: " "unprognostic (6.74e-2)" "unprognostic (8.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.56e-1)" "unprognostic (3.73e-3)" "unprognostic (6.14e-2)" "unprognostic (4.80e-2)" "unprognostic (3.11e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-2)" "unprognostic (2.45e-3)" "unprognostic (3.00e-3)" "unprognostic (1.29e-1)" "unprognostic (2.59e-1)" "unprognostic (1.01e-1)" 0.4 3.6 2.1 0.7 3.7 1.2 1.6 5.9 3.5 0.8 1.4 0.5 0.0 0.4 1.0 1.6 0.9 7.0 0.4 40.3 0.9 3.4 0.4 3.7 0.5 0.5 1.4 1.6 1.8 1.6 0.2 23.6 0.3 8.6 11.9 0.8 2.4 0.6 0.6 0.4 0.3 0.8 0.9 0.8 0.3 1.6 52.6 0.3 3.1 1.5 0.0 0.8 0.6 0.4 0.5 1.0 3.4 1.1 0.0 0.0 0.1 0.0 4.0 4.3 2.7 1.7 8.9 1.0 0.0 3.8 4.1 7.6 0.1 0.3 0.0 11.6 0.4 0.1 2.9 0.0 6.7 0.2 3.5 1.1 4.1 3.0 17.6 14.8 0.2 1.0 16.3 0.4 0.4 0.1 0.7 0.0 0.0 0.2 18.4 0.2 4.8 11.5 12.3 0.0 0.1 0.0 0.1 6.9 12.4 2.6 1.6 0.7 0.8 2.2 0.0 11.1 2.0 4.0 29.2 5.9 12.7 8.0 17.9 0.6 1.2 3.4 1.1 1.5 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 3.7 5.9 3.5 0.9 3.4 1.4 1.6 8.6 0.3 CLK1 ENSG00000013441 "CDC like kinase 1" P49759 2 200853009-200864744 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033141, HPA062405" Approved Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "CAB033141: AB_1121713, HPA062405: " "unprognostic (9.79e-2)" "unprognostic (2.05e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (9.19e-2)" "unprognostic (4.50e-3)" "unprognostic (1.52e-1)" "unprognostic (2.77e-3)" "unprognostic (1.78e-2)" "unprognostic (2.09e-2)" "unprognostic (1.09e-2)" "unprognostic (5.63e-3)" "unprognostic (2.03e-3)" "unprognostic (9.66e-2)" "unprognostic (2.30e-1)" "unprognostic (1.18e-1)" "prognostic favourable (2.28e-4)" 26.3 55.1 27.8 30.5 43.4 97.6 40.2 40.1 40.7 42.2 23.0 19.9 39.1 12.9 29.1 34.5 26.3 19.1 35.8 26.7 31.0 21.9 21.8 35.3 28.2 30.1 56.0 23.1 48.1 20.9 36.6 41.5 40.0 34.4 34.3 16.5 13.7 25.6 37.1 27.3 32.1 14.9 36.8 55.2 32.4 15.1 12.4 52.6 25.0 30.4 20.2 25.6 51.2 71.8 13.2 9.8 26.2 6.2 6.5 14.4 7.4 8.1 6.1 10.3 3.1 11.7 12.9 8.1 8.8 12.6 9.0 12.0 11.4 5.3 2.8 6.0 5.5 8.8 13.0 4.1 18.5 12.4 11.4 8.3 15.5 14.1 7.0 8.7 14.2 5.9 18.6 11.3 19.9 5.2 10.0 36.8 12.8 5.5 10.2 26.4 6.5 14.0 10.4 12.2 14.6 6.2 5.3 10.4 8.2 7.7 2.9 12.8 2.4 6.0 8.0 10.1 6.9 9.7 9.7 21.7 9.0 6.5 6.5 7.1 6.8 26.2 6.2 13.3 13.6 4.4 13.1 13.2 12.8 12.1 4.1 10.1 14.4 11.4 12.7 6.5 4.2 9.8 13.0 7.4 27.8 43.4 40.1 40.7 31.0 21.9 56.0 23.1 34.4 52.6 CLK4 ENSG00000113240 "CDC like kinase 4" Q9HAZ1 5 178602664-178630615 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043746 Approved Approved "Actin filaments" "Actin filaments" "HPA043746: " "unprognostic (9.46e-2)" "unprognostic (2.24e-2)" "unprognostic (1.48e-1)" "unprognostic (3.44e-2)" "unprognostic (1.59e-1)" "unprognostic (7.16e-3)" "unprognostic (2.67e-1)" "unprognostic (2.04e-2)" "unprognostic (4.37e-2)" "unprognostic (5.92e-2)" "unprognostic (2.90e-3)" "unprognostic (9.62e-3)" "unprognostic (1.13e-2)" "unprognostic (1.26e-1)" "unprognostic (3.38e-1)" "unprognostic (1.20e-1)" "unprognostic (1.14e-3)" 12.2 16.4 17.0 17.4 18.4 11.4 17.3 53.8 24.1 17.9 12.2 11.9 18.3 12.4 17.0 16.4 10.5 11.0 13.1 11.4 15.9 9.5 11.8 16.0 10.9 20.3 21.2 12.7 17.4 16.2 15.4 20.2 13.9 16.3 16.7 8.9 10.8 14.4 17.0 20.6 19.5 11.3 11.3 25.8 17.0 11.0 15.7 22.0 15.0 15.8 9.7 12.7 11.4 18.0 13.2 7.8 16.1 6.1 7.7 13.8 5.2 6.8 6.3 5.9 8.5 17.6 14.8 9.7 6.7 7.6 4.0 7.4 6.7 5.5 3.9 5.4 2.8 9.1 7.5 5.4 6.6 14.1 5.9 1.5 11.9 8.2 6.6 3.1 5.0 6.7 7.9 6.4 8.7 2.7 3.5 11.7 5.1 2.8 4.0 11.4 3.0 3.9 4.0 5.2 5.7 4.0 2.1 6.6 4.4 7.5 4.1 6.9 4.3 6.6 5.6 8.2 3.0 4.2 7.1 7.7 2.9 3.0 5.9 7.6 4.2 6.5 6.1 12.0 10.0 4.1 13.2 13.2 10.3 8.9 5.9 10.4 13.8 10.6 16.1 7.7 4.4 7.8 9.5 5.2 17.0 18.4 53.8 24.1 15.9 9.5 21.2 12.7 16.3 22.0 CLMN "FLJ12383, KIAA0500, KIAA1188" ENSG00000165959 Calmin Q96JQ2 14 95181940-95319906 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.1" "Cell line enhanced" "Detected in many" "SK-BR-3: 13.9;T-47d: 11.6;WM-115: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012634 Enhanced Approved "Nuclear bodies,Cytosol" "Nuclear bodies" Cytosol "HPA012634: AB_1846973" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (4.20e-2)" "unprognostic (6.07e-2)" "unprognostic (8.88e-2)" "unprognostic (4.31e-1)" "unprognostic (4.18e-2)" "unprognostic (7.24e-2)" "unprognostic (8.31e-2)" "unprognostic (2.64e-1)" "unprognostic (1.29e-3)" "unprognostic (3.09e-2)" "prognostic favourable (2.68e-7)" "unprognostic (8.27e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (9.91e-3)" 14.1 2.3 11.0 5.9 36.3 2.0 13.0 3.1 20.1 7.8 15.3 31.6 5.6 4.6 5.6 11.0 4.3 8.2 8.3 3.7 13.0 5.6 18.9 18.8 5.2 2.3 38.1 8.0 3.5 18.1 4.7 3.4 9.2 17.2 8.0 17.6 7.1 9.4 7.9 4.6 3.5 6.9 4.5 14.5 3.6 10.0 33.4 34.0 0.0 6.6 1.8 2.9 7.3 7.1 3.8 3.0 7.2 8.4 0.0 0.1 2.1 5.2 7.1 1.1 0.2 4.4 2.0 0.4 0.1 0.0 0.3 0.2 0.6 9.0 0.0 0.8 0.0 4.7 0.5 3.2 0.0 3.6 1.3 0.1 0.2 4.2 0.4 0.0 0.1 2.1 3.2 1.4 5.1 3.6 0.0 1.0 2.6 4.6 0.2 0.4 0.4 1.7 4.0 3.8 2.3 3.4 8.7 1.4 1.4 1.8 13.9 7.1 11.6 0.3 1.0 0.1 3.2 0.0 0.2 1.4 0.1 4.9 2.5 2.1 13.2 6.0 8.4 0.7 0.0 3.0 0.0 3.8 0.0 0.0 1.8 2.2 0.0 0.1 7.2 0.0 1.8 3.0 0.0 2.1 11.0 36.3 3.1 20.1 13.0 5.6 38.1 8.0 17.2 34.0 CLN3 "BTN1, BTS, JNCL" ENSG00000188603 "CLN3, battenin" Q13286 16 28474111-28495575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 52.7;SK-BR-3: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA063280 Uncertain "HPA063280: " "unprognostic (2.38e-3)" "unprognostic (2.41e-2)" "unprognostic (7.06e-2)" "unprognostic (8.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (2.36e-2)" "unprognostic (1.69e-2)" "unprognostic (6.38e-3)" "unprognostic (8.16e-2)" "unprognostic (6.27e-2)" "unprognostic (5.26e-1)" "unprognostic (9.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.05e-2)" 14.0 23.8 10.6 15.7 11.8 9.0 15.8 14.5 10.3 12.5 27.1 14.6 61.5 14.8 11.7 23.0 15.2 10.6 10.1 9.2 10.8 7.1 18.2 22.3 20.6 15.3 14.4 8.0 14.6 18.4 22.2 6.7 26.0 11.4 13.3 20.4 11.9 22.6 45.3 9.3 16.9 17.4 9.6 13.1 15.8 18.6 7.5 16.5 8.9 19.1 9.4 10.0 15.4 14.8 11.6 28.2 39.6 25.0 15.3 24.1 17.6 6.2 10.7 4.4 10.6 11.9 5.9 52.7 3.9 12.1 8.9 10.8 5.2 15.5 4.6 13.2 7.1 6.6 7.6 7.3 3.8 11.3 10.2 4.4 7.3 15.7 18.4 6.6 19.2 8.0 17.5 6.9 4.4 9.8 7.8 14.1 8.9 14.9 5.9 10.9 6.8 6.9 10.2 4.3 14.4 8.6 14.1 6.0 6.2 1.9 51.8 5.0 16.7 9.1 5.3 5.2 3.0 7.3 6.5 16.0 17.9 4.4 8.5 13.7 3.7 18.1 25.0 39.6 24.1 19.5 18.0 9.6 19.4 23.3 27.2 11.6 16.1 18.2 9.4 15.3 14.3 28.2 19.7 17.6 10.6 11.8 14.5 10.3 10.8 7.1 14.4 8.0 11.4 16.5 CLN5 ENSG00000102805 "CLN5, intracellular trafficking protein" O75503 13 76990660-77019143 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA041788 Approved "Intracellular and membrane" 430000 "HPA041788: AB_10962726" "unprognostic (1.19e-2)" "unprognostic (1.75e-1)" "unprognostic (1.06e-1)" "unprognostic (2.02e-1)" "unprognostic (9.82e-2)" "unprognostic (2.07e-3)" "unprognostic (3.41e-1)" "unprognostic (7.80e-2)" "unprognostic (2.29e-1)" "unprognostic (2.90e-1)" "unprognostic (6.98e-2)" "unprognostic (2.65e-1)" "prognostic favourable (1.52e-9)" "unprognostic (2.35e-1)" "unprognostic (7.04e-2)" "unprognostic (5.64e-2)" "unprognostic (8.15e-2)" 15.7 17.0 10.4 11.0 11.1 8.5 18.2 9.9 9.5 15.7 11.1 12.9 12.7 7.5 13.3 26.0 12.0 15.7 16.4 14.3 10.2 10.0 34.8 21.7 12.7 13.8 16.1 6.8 21.1 15.0 17.5 20.9 22.2 14.2 14.1 10.1 16.7 13.6 15.4 11.4 10.0 13.5 14.0 13.9 12.0 12.9 10.9 13.4 13.5 45.2 7.0 10.8 13.2 11.8 8.1 6.3 24.0 14.4 0.6 13.9 8.0 11.6 5.6 8.2 6.9 36.2 23.7 10.5 11.0 20.0 8.7 15.0 6.3 11.1 5.1 8.7 15.4 12.9 5.5 12.0 9.6 9.5 11.9 6.4 7.1 5.8 16.3 8.9 9.9 21.1 13.6 4.4 8.9 15.2 4.4 9.0 20.3 3.8 5.7 6.1 5.3 5.3 4.5 7.4 4.4 20.4 6.9 3.7 5.6 7.0 8.5 12.9 9.1 12.8 14.8 6.7 5.5 7.6 6.7 12.0 14.0 5.7 17.4 6.8 14.8 24.0 8.9 20.9 2.1 12.4 1.8 8.0 10.3 3.6 6.0 8.1 13.3 8.0 6.6 0.6 14.4 6.3 13.9 8.0 10.4 11.1 9.9 9.5 10.2 10.0 16.1 6.8 14.2 13.4 CLPTM1 ENSG00000104853 "CLPTM1, transmembrane protein" O96005 19 44954585-44993341 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068702, HPA068767" Approved Approved "Nuclear membrane,Centriolar satellite" "Nuclear membrane, Centriolar satellite" "HPA068702: , HPA068767: " "unprognostic (1.40e-1)" "unprognostic (1.32e-1)" "unprognostic (4.07e-1)" "unprognostic (2.19e-1)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.94e-1)" "unprognostic (5.93e-2)" "unprognostic (6.60e-3)" "unprognostic (2.67e-2)" "unprognostic (1.46e-3)" "unprognostic (2.62e-1)" "unprognostic (1.02e-2)" "unprognostic (3.30e-1)" "unprognostic (2.56e-1)" "unprognostic (7.46e-2)" "unprognostic (1.59e-1)" 29.7 53.4 39.4 20.3 56.2 14.7 20.2 26.7 66.4 25.8 26.6 36.8 17.3 31.5 20.3 24.0 23.7 25.6 22.1 32.2 35.7 35.7 40.6 62.5 23.1 19.1 36.0 33.7 26.9 36.2 53.8 21.1 34.3 37.7 27.1 21.3 30.2 38.0 29.6 37.6 32.9 27.6 23.7 27.2 22.6 25.1 26.7 30.7 13.9 27.3 16.1 26.3 19.5 18.6 18.4 24.1 25.5 28.8 12.5 24.4 11.8 26.4 59.8 13.9 27.5 46.4 18.7 14.8 26.2 28.9 30.9 33.3 25.9 26.8 26.3 29.3 34.6 31.3 24.7 23.7 21.0 19.3 34.2 20.4 22.6 21.7 32.8 16.2 23.9 29.3 25.2 29.5 19.1 21.5 21.1 36.9 27.3 23.8 17.0 9.5 12.5 19.9 17.7 15.1 25.5 28.7 37.1 16.4 18.1 32.4 48.2 14.2 26.3 13.0 19.9 34.8 21.7 18.2 32.4 25.9 56.6 20.5 28.8 16.1 31.8 10.4 16.7 25.5 17.0 23.6 14.3 17.5 18.3 24.4 15.4 18.4 14.5 12.2 15.7 12.5 28.8 24.1 15.1 11.8 39.4 56.2 26.7 66.4 35.7 35.7 36.0 33.7 37.7 30.7 CLSTN1 "CDHR12, CSTN1, KIAA0911" ENSG00000171603 "Calsyntenin 1" O94985 1 9729026-9824526 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012412 Enhanced 70000000 "HPA012412: AB_1846981" "unprognostic (4.63e-2)" "unprognostic (2.89e-1)" "unprognostic (9.76e-2)" "unprognostic (1.43e-1)" "unprognostic (9.79e-2)" "unprognostic (1.63e-1)" "unprognostic (2.44e-3)" "unprognostic (3.07e-2)" "unprognostic (2.54e-1)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (1.25e-1)" "prognostic favourable (4.10e-7)" "unprognostic (1.12e-1)" "unprognostic (2.65e-1)" "unprognostic (4.05e-2)" "unprognostic (4.72e-2)" 13.6 20.1 38.2 15.0 51.2 5.2 15.4 90.5 102.0 24.2 28.6 25.1 11.7 16.7 35.9 14.2 21.0 35.1 25.6 16.3 32.1 31.2 23.3 4.7 16.0 16.4 25.8 53.8 33.6 31.1 27.8 21.0 22.8 32.3 33.6 26.1 29.8 30.0 24.9 10.3 45.6 18.6 28.8 22.0 14.4 15.1 8.1 21.6 15.3 20.9 12.9 16.1 18.0 23.6 2.5 2.7 8.5 1.7 0.9 6.3 2.5 27.2 16.2 23.4 21.8 25.0 16.6 7.7 17.4 19.5 22.3 20.4 11.4 65.8 21.5 45.6 34.3 39.0 13.7 61.5 17.9 24.4 16.7 6.4 20.4 12.0 34.7 12.0 10.4 16.9 42.4 28.8 19.6 31.1 2.9 16.8 10.9 12.7 13.3 6.2 9.8 13.0 20.1 8.6 10.3 27.6 7.9 25.0 15.8 25.1 48.4 19.4 9.8 20.6 46.3 26.4 21.0 17.6 28.8 17.1 15.8 31.1 22.6 19.3 29.8 8.5 1.4 4.3 6.3 1.7 3.3 2.3 4.0 4.7 2.7 2.5 2.9 2.6 0.8 0.9 1.7 1.7 3.6 2.5 38.2 51.2 90.5 99.9 32.1 31.2 25.8 53.8 32.3 21.6 CLSTN2 "CDHR13, CS2, CSTN2, FLJ39113" ENSG00000158258 "Calsyntenin 2" Q9H4D0 3 139935185-140577397 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;ovary: 59.4" "Cell line enhanced" "Detected in some" "AF22: 5.7;SCLC-21H: 16.1;THP-1: 10.1" "Cancer enriched" "Detected in many" 7 "breast cancer: 15.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031342, HPA061800" Approved Uncertain "Vesicles,Cytokinetic bridge" 9100 Vesicles "Cytokinetic bridge" "HPA031342: AB_10602800, HPA061800: " "unprognostic (7.58e-2)" "unprognostic (2.64e-2)" "unprognostic (8.02e-2)" "unprognostic (1.51e-3)" "unprognostic (5.52e-3)" "unprognostic (8.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (5.58e-1)" "unprognostic (6.25e-2)" "unprognostic (2.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-2)" "unprognostic (3.16e-2)" "unprognostic (7.63e-5)" "unprognostic (7.22e-5)" 14.2 5.0 4.9 1.0 9.8 0.8 8.5 1.5 19.7 4.1 1.8 2.4 0.3 1.2 5.2 1.8 1.6 3.6 2.6 5.9 15.4 4.0 4.5 1.5 1.7 2.8 4.1 14.3 59.4 2.0 1.5 1.3 1.5 23.7 5.4 1.4 3.0 1.6 1.8 1.9 2.1 1.5 6.6 1.4 0.8 1.4 1.9 0.5 0.0 2.9 0.5 1.0 1.9 4.7 0.3 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.1 5.7 0.0 2.5 0.6 0.1 0.7 0.0 0.0 0.0 3.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 2.3 0.0 0.0 0.0 2.4 10.1 0.0 1.2 0.5 1.6 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 4.9 9.8 1.5 19.7 15.4 4.0 4.1 14.3 23.7 0.5 CLTRN "NX17, TMEM27" ENSG00000147003 "Collectrin, amino acid transport regulator" Q9HBJ8 X 15627318-15665031 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "kidney: 204.4" "Cell line enhanced" "Detected in many" "HaCaT: 10.7;hTERT-HME1: 6.1;RPTEC TERT1: 9.8" "Cancer enriched" "Detected in many" 35 "renal cancer: 106.2" "Region enriched" "Detected in single" 9 "pons and medulla: 5.0" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA048543 Enhanced Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" "HPA048543: " "unprognostic (1.27e-1)" "unprognostic (4.77e-2)" "unprognostic (2.45e-2)" "unprognostic (2.66e-2)" "unprognostic (5.20e-2)" "unprognostic (5.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-2)" "prognostic favourable (5.65e-4)" "unprognostic (1.05e-2)" "unprognostic (3.03e-1)" "prognostic favourable (6.78e-9)" "unprognostic (1.77e-1)" "unprognostic (2.60e-2)" "unprognostic (2.58e-1)" "unprognostic (1.33e-2)" 0.1 0.2 0.3 0.1 0.4 0.0 0.3 0.1 0.2 0.2 0.2 0.5 0.1 0.1 0.2 1.6 0.2 0.4 0.6 0.2 0.5 0.4 204.4 11.5 0.6 0.1 0.3 0.1 0.8 1.2 4.0 0.2 0.7 5.0 0.3 0.0 11.3 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 2.4 0.3 0.1 0.2 0.7 0.1 0.1 0.4 0.2 0.9 0.6 0.0 0.5 0.0 3.0 0.4 3.0 2.2 1.5 0.6 0.8 1.2 1.0 0.1 0.0 0.1 0.1 0.2 0.5 0.3 2.1 0.1 10.7 0.9 2.5 0.0 0.4 1.4 0.3 0.0 1.0 1.6 0.0 0.0 0.2 2.4 0.4 6.1 0.0 0.7 0.6 0.3 3.5 0.2 0.4 3.6 3.1 0.3 0.5 1.3 9.8 0.2 1.4 1.3 0.8 0.2 2.0 1.0 0.3 0.1 0.2 0.5 0.4 0.0 0.6 0.3 0.4 0.9 0.1 0.1 0.0 0.5 0.0 0.6 0.2 1.3 0.4 0.8 0.5 0.6 0.9 3.0 0.9 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.4 0.1 0.2 0.5 0.4 0.3 0.1 5.0 0.1 CLYBL CLB ENSG00000125246 "Citrate lyase beta like" Q8N0X4 13 99606669-99897134 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 57.7" "Cell line enhanced" "Detected in many" "SCLC-21H: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039959, HPA040691" Enhanced Approved Cytosol Cytosol "HPA039959: AB_10793857, HPA040691: AB_10794746" "unprognostic (1.25e-2)" "unprognostic (1.94e-1)" "unprognostic (2.30e-3)" "unprognostic (7.57e-3)" "unprognostic (3.69e-1)" "unprognostic (2.90e-2)" "unprognostic (1.57e-3)" "unprognostic (2.91e-1)" "unprognostic (2.10e-1)" "unprognostic (2.34e-1)" "unprognostic (2.49e-2)" "unprognostic (2.85e-1)" "prognostic favourable (6.66e-16)" "unprognostic (3.74e-2)" "unprognostic (5.41e-2)" "unprognostic (4.78e-2)" "unprognostic (7.82e-2)" 4.2 11.6 6.2 10.4 9.4 2.6 6.0 6.7 6.4 4.6 11.2 3.8 4.8 13.6 5.2 7.6 6.4 4.7 8.3 12.3 5.1 6.3 35.0 57.7 4.7 9.6 7.9 8.6 3.5 15.0 6.1 5.7 2.2 12.5 4.2 12.3 8.9 8.7 5.5 22.2 5.7 12.5 8.6 4.5 5.5 4.8 10.7 4.3 4.6 7.0 13.3 8.2 4.9 4.4 11.0 7.5 1.2 6.7 9.2 16.7 5.5 0.2 1.3 9.8 4.4 4.6 4.3 2.1 0.4 0.9 0.8 1.5 0.2 7.2 1.7 2.8 0.5 2.2 0.8 1.6 1.1 8.6 1.4 10.9 2.6 6.7 3.2 5.8 0.8 2.3 4.9 0.1 3.8 1.2 1.5 5.7 0.9 2.4 2.6 8.1 6.3 2.0 3.4 0.4 4.0 9.7 0.6 31.7 4.8 1.9 2.2 1.9 4.7 7.6 0.1 0.4 1.1 0.8 1.5 13.3 2.6 0.3 6.8 8.6 1.3 1.2 3.3 0.3 7.5 6.7 9.0 10.9 13.3 10.6 6.7 11.0 10.3 12.1 0.5 9.2 3.2 7.5 16.7 5.5 6.2 9.4 6.7 6.4 5.1 6.3 7.9 8.6 12.5 4.3 CMTM1 "CKLFH, CKLFH1a, CKLFSF1" ENSG00000089505 "CKLF like MARVEL transmembrane domain containing 1" Q8IZ96 16 66566393-66579137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 80.7" "Cell line enhanced" "Detected in many" "REH: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.7" "HPA013801, HPA017136" Uncertain Approved Nucleoplasm Nucleoplasm "HPA013801: AB_1846990, HPA017136: AB_1846992" "unprognostic (2.37e-2)" "unprognostic (7.48e-2)" "unprognostic (3.10e-1)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.32e-2)" "unprognostic (2.97e-3)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (1.56e-4)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (3.49e-1)" 0.9 0.8 0.8 1.9 1.2 0.0 0.5 2.2 1.3 0.7 0.9 0.5 0.5 1.7 1.3 1.1 0.6 0.8 1.5 0.7 0.8 1.1 0.8 0.5 0.9 1.2 0.8 0.6 1.7 0.5 0.3 1.1 0.9 0.7 0.7 0.2 0.5 0.6 0.5 0.6 0.6 1.2 0.5 0.9 2.8 0.9 80.7 0.7 0.8 0.7 0.5 0.6 0.9 0.6 0.3 1.9 8.7 2.1 1.3 1.9 1.1 4.2 6.7 1.2 5.6 2.4 2.3 1.2 5.6 2.6 4.5 4.6 1.3 2.8 1.9 2.9 1.6 3.3 1.9 0.3 2.4 7.3 1.3 0.7 2.9 1.4 1.1 3.9 4.9 1.9 0.5 4.0 0.5 2.3 3.4 2.7 1.9 1.6 7.3 3.7 1.0 2.4 16.6 14.3 4.6 4.0 1.9 3.2 4.2 7.7 0.6 2.0 2.0 2.8 5.6 7.9 12.6 4.7 2.4 2.7 6.6 7.2 3.8 5.3 9.3 8.7 2.1 7.1 1.9 0.6 1.6 0.2 0.6 0.9 1.9 0.3 0.5 0.6 8.4 1.3 1.2 0.5 0.6 1.1 0.8 1.2 2.2 1.0 0.8 1.1 0.8 0.6 0.7 0.7 CMTM3 "BNAS2, CKLFSF3, FLJ31762" ENSG00000140931 "CKLF like MARVEL transmembrane domain containing 3" Q96MX0 16 66603874-66613892 "Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 46.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA013870, HPA072695" Approved Approved Nucleoplasm Nucleoplasm "HPA013870: AB_1847003, HPA072695: " "unprognostic (1.59e-1)" "unprognostic (2.83e-2)" "unprognostic (7.63e-2)" "unprognostic (1.49e-1)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (1.80e-3)" "unprognostic (6.65e-3)" "unprognostic (7.75e-2)" "unprognostic (1.60e-2)" "unprognostic (1.22e-2)" "unprognostic (7.38e-2)" "prognostic unfavourable (4.42e-6)" "prognostic unfavourable (1.85e-4)" "unprognostic (7.56e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" 24.3 8.5 5.4 11.5 6.1 8.0 29.5 1.2 4.6 19.1 7.8 10.0 7.7 3.2 18.0 19.1 10.0 12.2 16.3 15.9 5.9 4.9 8.9 6.1 21.7 34.1 6.7 2.6 25.4 6.5 22.9 5.6 30.8 8.4 16.4 6.0 15.5 9.3 8.7 7.9 11.5 9.1 14.0 8.4 19.0 6.2 61.7 6.9 35.6 8.6 10.4 14.6 13.6 21.1 1.4 19.9 7.0 11.3 6.5 12.0 4.4 1.9 9.9 28.0 19.5 21.0 13.2 17.3 5.0 23.3 10.3 10.3 5.4 6.2 0.0 14.1 14.3 2.2 18.8 16.9 8.4 9.6 6.7 6.2 1.3 15.3 28.3 18.4 22.8 26.2 1.3 10.9 2.3 23.4 9.4 0.2 12.8 2.4 14.9 30.8 13.4 9.3 46.5 19.6 0.9 4.9 0.2 2.9 10.0 2.5 0.1 16.3 0.2 17.1 15.5 14.8 17.6 3.5 6.0 1.3 0.2 6.2 9.2 14.3 15.7 6.1 11.3 7.0 7.8 10.9 10.9 1.4 8.8 8.9 9.7 0.8 6.8 8.2 6.6 6.5 6.5 19.9 12.0 4.4 5.4 6.1 1.2 4.6 5.9 4.9 6.7 2.6 8.4 6.9 CMTM5 "CKLFSF5, FLJ37521" ENSG00000166091 "CKLF like MARVEL transmembrane domain containing 5" Q96DZ9 14 23376808-23379772 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 19.4;brain: 67.3" "Cell line enriched" "Detected in some" 6 "HEL: 41.7" "Group enriched" "Detected in some" 37 "glioma: 8.4;melanoma: 3.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 7.6;neutrophil: 2.8" "Lineage enriched" "Detected in single" 11 "granulocytes: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052338 Enhanced Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA052338: AB_2681793" "unprognostic (2.73e-3)" "unprognostic (1.51e-1)" "unprognostic (5.24e-1)" "unprognostic (2.43e-3)" "unprognostic (2.63e-1)" "unprognostic (6.40e-2)" "unprognostic (8.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.27e-2)" "unprognostic (8.40e-2)" "unprognostic (6.24e-4)" "unprognostic (3.03e-3)" "unprognostic (1.97e-3)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" 1.7 1.8 14.1 1.3 19.4 6.6 1.3 4.8 55.4 2.6 1.9 47.0 0.0 1.3 1.6 1.6 2.1 1.7 2.5 5.8 19.6 12.1 1.1 1.0 1.7 1.1 26.9 10.3 1.7 1.1 0.9 0.1 1.5 18.4 1.9 1.6 0.6 3.1 4.2 1.4 1.5 2.0 1.7 67.3 1.9 1.1 1.1 12.7 0.0 1.0 0.0 1.0 1.3 0.7 0.1 0.7 7.6 0.4 0.0 0.3 19.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 7.6 0.4 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.7 0.3 19.4 14.1 19.4 4.8 24.8 19.6 12.1 26.9 10.3 18.4 12.7 CMTM7 "CKLFSF7, FLJ30992" ENSG00000153551 "CKLF like MARVEL transmembrane domain containing 7" Q96FZ5 3 32391671-32483067 "Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077409 Approved "Plasma membrane" "Plasma membrane" "HPA077409: " "unprognostic (2.27e-3)" "unprognostic (3.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.15e-1)" "unprognostic (5.42e-2)" "unprognostic (3.16e-2)" "prognostic unfavourable (3.21e-4)" "unprognostic (3.03e-2)" "unprognostic (3.92e-2)" "unprognostic (2.60e-1)" "unprognostic (6.55e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (1.00e-6)" "unprognostic (5.86e-2)" "unprognostic (2.51e-1)" "unprognostic (3.79e-1)" "unprognostic (3.12e-2)" 14.5 6.5 3.3 18.9 5.7 23.8 43.1 4.5 2.2 10.0 6.2 4.3 11.0 3.1 7.7 12.3 4.8 24.5 14.6 8.3 2.8 2.8 14.8 5.9 25.1 47.5 5.9 1.0 9.3 27.6 0.9 2.8 11.4 4.7 12.8 5.9 6.1 8.7 17.6 4.0 6.4 10.9 7.0 10.3 32.4 8.2 5.8 4.6 45.9 24.5 3.3 23.1 16.5 12.4 10.0 24.8 24.4 47.0 4.9 36.2 22.1 0.1 4.7 10.1 12.3 9.5 9.4 28.9 4.6 5.5 8.3 7.7 5.2 41.1 0.0 14.2 5.5 5.2 12.5 21.2 7.3 0.0 9.9 5.4 0.0 12.0 38.8 1.4 8.8 9.9 2.8 8.5 13.5 18.5 4.5 12.3 6.1 0.1 0.0 12.7 12.2 21.6 26.4 3.8 25.1 11.6 9.1 0.5 10.5 0.6 0.7 23.5 6.4 14.3 10.7 7.8 7.9 8.6 15.9 3.5 1.3 0.0 2.8 17.2 16.4 5.5 47.0 24.4 5.3 44.1 3.2 10.0 17.9 10.9 24.8 7.0 19.5 13.5 18.0 4.9 37.2 10.5 36.2 22.1 3.3 5.7 4.5 2.2 2.8 2.8 5.9 1.0 4.7 4.6 CNEP1R1 "C16orf69, FLJ38101, NEP1-R1, TMEM188" ENSG00000205423 "CTD nuclear envelope phosphatase 1 regulatory subunit 1" Q8N9A8 16 50024410-50037088 "Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042815, HPA077906" Uncertain Supported Cytosol Cytosol "HPA042815: AB_10794765, HPA077906: " "unprognostic (4.11e-2)" "unprognostic (2.45e-1)" "unprognostic (2.79e-2)" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.43e-3)" "unprognostic (1.80e-1)" "unprognostic (3.42e-2)" "unprognostic (8.53e-2)" "unprognostic (3.86e-2)" "unprognostic (1.21e-2)" "unprognostic (3.37e-3)" "unprognostic (5.09e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" 15.4 12.7 14.5 16.3 15.0 25.1 17.0 19.1 17.2 10.6 11.3 12.2 4.0 10.9 13.0 17.1 17.2 10.9 13.5 14.3 12.8 12.6 12.5 12.9 14.1 19.7 17.7 11.9 12.9 13.6 11.7 17.3 18.5 14.0 10.6 16.7 14.9 12.2 10.7 10.5 13.9 12.9 13.9 12.9 21.4 11.9 22.4 14.1 12.4 8.4 10.3 18.6 12.8 12.6 5.5 9.6 28.7 18.7 6.3 9.6 7.2 7.5 7.3 8.6 9.1 17.3 16.6 12.8 15.4 11.8 14.9 9.0 7.6 10.9 8.7 11.6 12.6 12.1 7.0 7.6 19.0 6.2 8.3 4.0 4.4 11.9 11.7 5.4 12.7 12.4 12.8 9.7 7.7 10.2 5.0 5.0 18.9 2.2 10.4 13.8 6.4 9.8 13.2 11.4 8.7 10.0 5.1 6.8 8.0 14.4 5.9 5.5 5.2 6.7 13.2 14.5 11.6 13.6 5.4 8.2 7.4 10.2 8.1 5.6 11.8 7.4 12.2 8.6 9.6 15.7 8.9 5.5 7.6 7.0 9.6 4.9 7.6 8.9 28.7 6.3 18.7 3.8 7.4 7.2 14.5 15.0 19.1 17.2 12.8 12.6 17.7 11.9 14.0 14.1 CNMD "BRICD3, CHM-I, CHM1, LECT1, MYETS1" ENSG00000136110 Chondromodulin O75829 13 52703264-52739812 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.1;salivary gland: 15.1;thyroid gland: 8.0" "Cell line enriched" "Detected in single" 137 "NTERA-2: 32.4" "Group enriched" "Detected in many" 5 "glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010510 Uncertain "Secreted to extracellular matrix" "HPA010510: AB_10602021" "unprognostic (7.52e-3)" "unprognostic (1.34e-1)" "unprognostic (7.36e-2)" "unprognostic (1.45e-2)" "unprognostic (1.15e-1)" "unprognostic (3.22e-1)" "unprognostic (2.84e-2)" "unprognostic (2.63e-2)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-1)" 0.3 0.3 3.1 0.3 11.1 0.3 0.4 0.9 2.5 0.3 0.5 4.3 0.0 0.3 0.3 0.3 0.6 0.4 0.3 0.4 3.0 2.6 0.3 0.3 3.9 0.3 3.7 0.9 0.4 1.1 0.3 2.5 0.5 3.1 1.6 0.5 6.1 15.1 0.4 0.5 0.5 0.4 0.3 4.4 1.0 0.4 4.2 4.1 0.0 8.0 0.0 0.6 0.3 0.0 0.0 0.6 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 3.1 11.1 0.9 2.3 3.0 2.6 3.7 0.9 3.1 4.1 CNOT1 "AD-005, CDC39, KIAA1007, NOT1, NOT1H" ENSG00000125107 "CCR4-NOT transcription complex subunit 1" A5YKK6 16 58519951-58629886 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046577, HPA049664" Approved Supported Cytosol 210000 Cytosol "HPA046577: , HPA049664: " "unprognostic (1.30e-2)" "unprognostic (6.86e-2)" "unprognostic (9.25e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-2)" "unprognostic (7.11e-2)" "unprognostic (3.58e-2)" "unprognostic (2.19e-1)" "unprognostic (6.43e-2)" "unprognostic (6.99e-2)" "unprognostic (1.83e-2)" "unprognostic (6.63e-2)" "unprognostic (1.33e-3)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (5.53e-2)" "unprognostic (1.52e-1)" 20.4 26.5 14.9 31.5 16.5 18.2 18.8 24.2 16.8 21.3 26.6 16.7 26.6 24.3 22.2 19.1 45.6 19.0 15.4 15.5 14.2 9.0 18.8 20.9 19.6 24.1 19.0 12.3 22.6 21.8 39.6 25.4 23.2 16.1 15.9 26.6 17.3 28.3 27.2 32.6 27.4 31.4 20.0 13.6 25.8 22.7 53.9 18.1 45.1 20.2 22.6 32.6 26.9 26.0 15.4 14.6 18.8 20.9 14.6 19.2 10.6 25.9 30.6 23.3 18.7 11.3 14.5 26.8 20.6 18.0 23.7 17.6 34.6 15.7 39.6 9.9 15.7 25.6 37.4 21.0 32.1 14.7 20.4 30.8 25.2 39.5 15.4 47.4 34.5 13.9 14.4 27.5 32.4 18.4 36.0 11.6 16.0 10.6 36.6 12.4 24.1 26.6 46.7 40.3 25.1 13.4 36.6 19.3 12.5 69.9 23.7 11.7 14.2 24.8 20.6 17.4 17.3 13.1 18.0 26.5 26.7 80.4 18.4 20.2 16.1 18.3 11.6 13.0 14.6 15.9 19.2 15.4 14.1 14.6 14.6 14.2 12.6 13.5 18.8 14.6 20.9 7.4 14.8 10.6 14.9 16.5 24.2 16.8 14.2 9.0 19.0 12.3 16.1 18.1 CNPPD1 "C2orf24, CGI-57" ENSG00000115649 "Cyclin Pas1/PHO80 domain containing 1" Q9BV87 2 219171897-219178106 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049303 Uncertain "HPA049303: " "unprognostic (9.24e-2)" "unprognostic (4.12e-2)" "unprognostic (1.09e-1)" "unprognostic (9.43e-2)" "unprognostic (3.68e-2)" "unprognostic (5.74e-3)" "prognostic unfavourable (2.04e-4)" "unprognostic (1.77e-1)" "unprognostic (4.15e-3)" "unprognostic (5.54e-3)" "unprognostic (8.53e-2)" "unprognostic (2.35e-1)" "prognostic favourable (1.62e-10)" "unprognostic (1.48e-2)" "unprognostic (1.51e-1)" "unprognostic (2.62e-2)" "unprognostic (2.54e-2)" 25.9 41.2 17.2 21.2 21.5 34.6 25.7 21.5 22.5 17.9 30.8 36.1 16.8 30.3 21.2 22.7 40.2 17.0 26.4 24.1 15.4 13.3 61.3 27.3 24.9 27.3 26.1 20.4 22.7 29.1 30.7 11.5 26.2 20.4 22.1 23.1 28.0 24.6 26.7 39.2 29.5 32.6 25.5 24.6 32.9 23.0 22.6 23.4 21.5 32.1 20.6 32.2 28.7 21.4 37.3 38.7 31.1 45.6 21.1 28.3 26.5 15.6 11.8 11.9 21.9 24.6 12.4 17.1 20.3 12.0 17.0 13.6 25.4 19.6 9.0 12.0 19.8 22.1 15.7 16.4 9.9 22.9 9.2 36.5 12.3 25.1 30.2 21.4 25.4 13.2 21.2 16.7 15.0 14.1 29.0 33.8 9.8 28.6 23.3 16.3 7.6 15.2 34.9 8.8 30.4 26.1 22.1 15.5 18.6 11.7 29.4 21.5 23.4 24.6 13.3 13.9 13.0 27.1 19.2 26.9 10.5 19.2 18.8 25.7 8.9 28.3 25.1 24.5 22.7 37.3 19.7 34.0 22.2 22.7 38.7 37.3 15.6 17.3 31.1 21.1 45.6 21.4 28.3 26.5 17.2 21.5 21.5 22.5 15.4 13.3 26.1 20.4 20.4 23.4 CNST "C1orf71, FLJ32001, PPP1R64" ENSG00000162852 "Consortin, connexin sorting protein" Q6PJW8 1 246566444-246668584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007225, HPA007226" Approved Supported Vesicles 4600000 Vesicles "HPA007225: AB_1848869, HPA007226: " "unprognostic (1.55e-2)" "unprognostic (9.75e-2)" "unprognostic (3.33e-2)" "unprognostic (9.76e-2)" "unprognostic (2.78e-1)" "unprognostic (4.28e-2)" "unprognostic (3.72e-2)" "unprognostic (7.28e-3)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.52e-2)" "unprognostic (3.47e-2)" "unprognostic (2.73e-3)" "unprognostic (6.17e-2)" "unprognostic (2.63e-1)" "unprognostic (8.77e-3)" "unprognostic (2.26e-1)" 15.5 21.7 10.2 13.7 22.3 21.8 12.8 25.1 22.4 10.6 14.6 8.1 10.2 11.0 14.7 9.4 18.6 10.0 9.7 11.1 9.5 17.6 9.9 25.1 12.4 16.4 11.2 14.1 12.1 11.0 15.2 17.4 11.9 13.7 9.7 13.4 11.6 9.4 9.6 35.5 11.6 15.5 18.4 7.6 12.3 9.6 17.2 9.3 24.6 15.4 10.2 18.6 14.9 11.0 21.1 6.6 21.6 11.1 7.8 19.3 9.0 4.2 5.6 4.1 3.6 6.8 8.0 8.4 13.8 13.7 14.0 10.7 5.4 5.6 12.4 6.2 13.7 4.4 6.4 4.7 19.2 6.9 2.2 14.6 5.1 4.0 9.9 7.2 28.2 7.5 4.5 13.6 14.5 4.3 18.5 5.5 7.9 3.1 7.9 3.3 13.5 4.9 7.8 7.4 10.1 5.3 12.4 9.5 11.4 5.9 3.5 17.1 6.4 6.4 6.1 17.5 4.2 7.2 9.4 16.8 21.3 12.6 4.3 10.8 16.9 21.6 4.7 12.9 8.8 5.0 9.6 19.4 15.0 8.1 4.6 21.1 19.3 10.3 6.2 7.8 11.1 6.6 18.1 9.0 10.2 22.3 25.1 22.4 9.5 17.6 11.2 14.1 13.7 9.3 CNTD1 "CNTD, FLJ40137" ENSG00000176563 "Cyclin N-terminal domain containing 1" Q8N815 17 42798792-42811587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 31.0" "Cell line enhanced" "Detected in some" "A-431: 6.1;ASC diff: 4.2;SiHa: 3.3;T-47d: 2.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA023324 Uncertain "Nucleoplasm,Plasma membrane,Focal adhesion sites" Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA023324: AB_1848931" "unprognostic (5.92e-2)" "unprognostic (1.99e-3)" "unprognostic (3.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.25e-1)" "unprognostic (6.29e-3)" "unprognostic (6.61e-2)" "unprognostic (1.09e-2)" "unprognostic (7.82e-2)" "unprognostic (6.18e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (5.89e-7)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.81e-4)" 0.2 0.1 0.7 0.0 1.4 0.0 1.6 0.2 1.7 0.2 0.6 0.4 0.0 0.0 0.1 0.9 0.1 0.5 0.0 0.1 1.5 0.3 1.2 0.1 0.3 0.0 0.5 0.8 0.3 0.8 0.0 0.1 0.0 0.9 1.1 1.5 0.1 0.5 0.0 0.2 0.1 0.2 0.7 0.8 0.1 2.3 31.0 1.6 0.0 0.1 0.0 0.0 0.2 0.1 0.9 0.1 2.7 0.3 0.1 0.3 0.3 6.1 0.7 0.4 1.3 4.2 1.5 0.0 0.0 0.3 0.4 1.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.6 1.3 0.0 0.0 0.2 0.5 0.0 0.0 0.2 0.0 0.3 0.7 0.0 0.0 0.0 3.3 0.3 0.8 2.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.4 0.0 0.3 0.0 0.3 0.2 0.3 0.4 0.1 0.0 0.1 0.9 0.0 0.0 2.7 0.1 0.1 0.0 0.0 0.3 0.7 1.4 0.2 1.7 1.5 0.3 0.5 0.8 0.9 1.6 CNTFR ENSG00000122756 "Ciliary neurotrophic factor receptor" P26992 9 34551432-34590140 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 44.7;skeletal muscle: 33.6" "Group enriched" "Detected in some" 6 "AF22: 46.8;SH-SY5Y: 22.4" "Cancer enhanced" "Detected in many" "glioma: 22.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025310 Approved 36000000 "CAB025310: " "unprognostic (1.39e-1)" "unprognostic (9.40e-2)" "unprognostic (1.93e-2)" "unprognostic (1.90e-2)" "unprognostic (2.59e-1)" "unprognostic (1.22e-1)" "unprognostic (2.18e-1)" "unprognostic (2.94e-2)" "unprognostic (1.28e-1)" "unprognostic (9.70e-2)" "unprognostic (4.45e-3)" "unprognostic (1.72e-2)" "unprognostic (6.32e-2)" "unprognostic (4.99e-3)" "unprognostic (7.37e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" 44.7 9.4 17.0 2.2 27.9 0.7 17.3 30.6 28.7 11.1 5.8 8.2 1.1 3.4 2.6 2.9 3.9 5.6 5.7 10.1 18.6 11.7 1.9 6.5 2.2 1.5 15.5 9.8 4.5 2.4 0.8 2.5 4.8 12.0 5.3 2.5 7.5 9.0 7.6 33.6 4.4 6.0 1.8 6.3 16.1 3.0 4.9 10.9 0.2 3.2 3.8 1.0 1.4 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 6.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 22.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 27.9 30.6 22.0 18.6 11.7 15.5 9.8 12.0 10.9 CNTN6 NB-3 ENSG00000134115 "Contactin 6" Q9UQ52 3 1092576-1404217 "Predicted membrane proteins" "Cell adhesion, Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 41.4;thyroid gland: 18.9" "Group enriched" "Detected in some" 59 "AF22: 5.4;SH-SY5Y: 6.3" "Group enriched" "Detected in some" 15 "renal cancer: 2.7;thyroid cancer: 3.2" "Region enriched" "Detected in many" 5 "cerebellum: 41.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016645 Uncertain 2100000 "HPA016645: AB_1847149" "unprognostic (1.09e-1)" "unprognostic (3.70e-1)" "unprognostic (2.27e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-1)" "unprognostic (1.05e-4)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (3.80e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.26e-3)" "unprognostic (5.45e-2)" "unprognostic (5.23e-2)" "unprognostic (1.15e-1)" "unprognostic (4.46e-2)" 0.2 4.7 1.6 0.2 2.2 0.2 0.4 41.4 6.3 0.3 0.3 0.1 0.0 0.2 0.3 0.8 0.3 0.4 0.2 0.4 1.5 3.0 0.5 0.2 5.6 0.2 2.4 2.6 0.2 0.3 0.2 0.5 3.4 7.8 0.2 0.3 0.4 0.3 0.3 0.2 0.2 0.2 0.3 1.7 0.2 0.2 0.4 0.3 0.0 18.9 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.2 41.4 6.3 1.5 3.0 2.4 2.6 7.8 0.3 CNTNAP1 "Caspr, CNTNAP, NRXN4, p190" ENSG00000108797 "Contactin associated protein 1" P78357 17 42682613-42699814 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.7;smooth muscle: 26.7" "Cell line enhanced" "Detected in many" "TIME: 29.6;U-138 MG: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011772 Approved Approved Nucleoplasm Nucleoplasm "HPA011772: AB_1079541" "unprognostic (4.04e-2)" "unprognostic (3.69e-1)" "unprognostic (2.37e-3)" "unprognostic (1.89e-1)" "unprognostic (5.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" "unprognostic (2.59e-1)" "unprognostic (9.76e-3)" "unprognostic (1.99e-2)" "unprognostic (1.67e-1)" "prognostic unfavourable (4.16e-14)" "unprognostic (9.52e-3)" "unprognostic (2.27e-2)" "unprognostic (3.11e-2)" "unprognostic (7.37e-3)" 6.1 2.5 35.5 5.9 18.8 1.1 1.7 31.7 48.7 4.7 8.5 2.9 1.4 2.3 12.1 7.1 2.9 7.0 7.1 4.0 29.2 14.8 1.7 0.9 3.9 2.8 10.5 23.9 8.7 6.5 1.7 7.2 5.0 18.4 4.2 4.7 2.1 2.0 7.6 3.5 2.5 2.7 26.7 11.5 3.2 3.9 2.3 13.3 0.0 1.7 0.2 2.9 5.8 3.3 0.0 0.7 0.1 0.0 0.1 1.4 0.0 1.7 2.6 5.7 1.9 8.9 18.2 0.3 10.8 18.8 8.0 7.2 0.3 0.4 0.0 0.6 11.8 2.1 2.8 0.8 6.3 4.2 0.9 0.0 10.6 2.6 4.4 0.0 0.1 17.7 0.0 7.6 1.5 10.0 0.5 3.3 3.0 0.3 0.0 1.5 2.0 2.5 0.3 0.7 1.0 2.1 0.0 1.1 3.4 3.2 0.0 2.0 2.0 0.9 29.6 34.3 5.8 7.9 2.9 4.0 2.4 0.1 9.5 0.7 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 1.4 0.0 35.5 18.8 31.7 48.7 29.2 14.8 10.5 23.9 18.4 13.3 CNTNAP2 "Caspr2, KIAA0868, NRXN4" ENSG00000174469 "Contactin associated protein like 2" Q9UHC6 7 146116002-148420998 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Autism, Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Group enriched" "Detected in some" 4 "AF22: 7.3;CACO-2: 6.1;NTERA-2: 10.9;SCLC-21H: 19.7" "Cancer enhanced" "Detected in many" "prostate cancer: 10.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 31 "memory B-cell: 1.8;naive B-cell: 6.1" "Lineage enriched" "Detected in single" 48 "B-cells: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002739 Enhanced "HPA002739: AB_1078545" "unprognostic (2.49e-2)" "unprognostic (1.49e-2)" "unprognostic (4.05e-1)" "unprognostic (3.08e-3)" "unprognostic (1.77e-1)" "unprognostic (2.29e-1)" "unprognostic (2.51e-2)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-1)" "unprognostic (3.67e-2)" "unprognostic (2.68e-1)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.00e-3)" 0.9 2.0 14.0 1.2 16.6 0.9 2.2 4.4 25.8 0.7 2.3 1.2 0.0 0.7 0.9 0.7 1.4 2.2 0.8 1.0 9.6 6.4 1.0 3.5 0.8 1.6 7.5 16.2 1.7 1.1 0.7 2.7 1.9 17.0 8.7 1.6 2.5 0.9 1.0 0.7 0.8 2.0 0.8 18.1 1.7 1.2 1.4 0.5 2.4 1.5 0.0 1.3 0.8 0.5 6.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 7.3 1.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 6.1 0.1 0.0 0.0 0.2 1.8 1.6 0.5 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 2.0 0.0 0.0 19.7 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 14.0 16.6 4.4 25.8 9.6 6.4 7.5 16.2 17.0 0.5 CNTNAP3 "CASPR3, CNTNAP3A, FLJ14195, KIAA1714" ENSG00000106714 "Contactin associated protein like 3" Q9BZ76 9 39072767-39288315 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.6;esophagus: 9.5" "Cell line enhanced" "Detected in some" "A549: 12.4;AF22: 15.1;TIME: 9.5;WM-115: 25.2" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 22 "neutrophil: 10.6" "Lineage enriched" "Detected in single" 107 "granulocytes: 10.6" HPA047731 Uncertain "Intracellular and membrane" "HPA047731: " "unprognostic (9.06e-3)" "unprognostic (3.07e-2)" "unprognostic (5.74e-2)" "unprognostic (7.89e-2)" "unprognostic (7.03e-2)" "unprognostic (2.33e-3)" "unprognostic (4.58e-2)" "unprognostic (1.34e-2)" "unprognostic (1.51e-1)" "unprognostic (2.94e-2)" "unprognostic (1.11e-1)" "unprognostic (3.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.15e-2)" "unprognostic (1.20e-1)" "unprognostic (1.95e-3)" "unprognostic (1.93e-3)" 2.9 0.1 1.2 0.3 4.8 1.0 2.6 0.4 2.5 0.8 2.4 0.6 0.2 0.2 9.5 1.6 1.1 4.1 1.2 1.3 1.1 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.3 1.7 1.6 1.4 2.8 1.7 0.0 8.3 1.0 2.5 1.1 2.4 0.1 1.9 1.3 0.3 0.5 1.9 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.7 12.4 15.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 3.1 1.2 2.9 0.0 0.0 1.1 0.0 3.3 0.3 0.1 0.1 0.0 0.4 2.8 0.0 1.1 5.9 0.0 0.0 0.2 0.0 0.0 0.0 2.6 3.8 0.0 0.4 3.4 0.3 0.5 1.4 0.5 4.4 0.0 2.4 0.0 2.1 9.5 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 CNTNAP3B ENSG00000154529 "Contactin associated protein like 3B" Q96NU0 9 41890314-42129510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 18.1;AF22: 25.9;WM-115: 17.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "neutrophil: 7.5" "Lineage enriched" "Detected in single" 76 "granulocytes: 7.5" HPA047731 Uncertain "HPA047731: " "unprognostic (2.68e-2)" "unprognostic (9.63e-3)" "unprognostic (2.20e-2)" "unprognostic (2.87e-1)" "unprognostic (1.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.20e-3)" "unprognostic (5.70e-2)" "unprognostic (2.27e-1)" "unprognostic (7.20e-2)" "unprognostic (3.74e-3)" "unprognostic (1.64e-1)" "unprognostic (7.74e-2)" "unprognostic (5.78e-3)" "unprognostic (7.93e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-4)" 4.1 0.6 1.1 0.3 2.2 0.0 4.7 0.5 2.2 1.5 1.1 0.4 1.3 0.0 7.3 1.9 1.3 2.5 1.3 1.4 4.9 1.0 2.1 0.0 0.9 0.4 0.3 0.0 1.2 2.4 1.0 1.7 1.9 1.1 0.7 6.5 0.6 1.9 0.9 1.6 0.5 1.1 0.8 0.1 2.0 1.4 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 18.1 25.9 0.0 0.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.1 2.2 1.5 1.4 0.0 0.0 0.9 0.0 3.2 1.6 0.5 0.9 0.0 2.0 2.1 0.2 0.3 4.2 0.4 0.1 0.0 0.1 0.0 0.0 2.5 5.5 0.0 0.4 7.0 0.8 0.5 1.9 0.2 0.7 0.0 3.5 0.0 2.5 4.5 0.1 1.7 0.1 0.5 0.0 0.0 0.0 0.0 0.8 17.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 CNTNAP4 "CASPR4, KIAA1763" ENSG00000152910 "Contactin associated protein like 4" Q9C0A0 16 76277278-76559238 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "brain: 36.9" "Group enriched" "Detected in some" 6 "Daudi: 13.7;HSkMC: 5.5;Karpas-707: 4.7;RPMI-8226: 8.7" "Cancer enriched" "Detected in single" 5 "glioma: 1.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031859 Enhanced 73000 "HPA031859: AB_10601360" "unprognostic (7.88e-2)" "unprognostic (7.19e-2)" "unprognostic (6.58e-2)" "unprognostic (2.46e-1)" "unprognostic (1.55e-2)" "unprognostic (1.50e-3)" "unprognostic (9.42e-3)" "unprognostic (1.91e-2)" "unprognostic (5.26e-4)" "unprognostic (1.83e-2)" "unprognostic (2.00e-2)" "unprognostic (4.56e-1)" "unprognostic (1.09e-1)" 0.9 2.4 10.2 0.9 19.1 0.9 0.9 13.2 36.9 1.3 0.9 27.6 0.0 1.2 0.9 0.9 0.9 0.9 0.9 0.9 9.9 2.2 1.0 0.9 0.9 1.0 23.1 15.1 1.0 0.9 0.9 0.8 0.9 25.0 1.3 0.9 0.0 0.9 1.4 0.9 0.9 1.1 1.0 30.9 0.9 0.9 2.2 21.4 0.0 0.9 0.0 1.0 0.9 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.3 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.2 19.1 13.2 14.4 9.9 2.2 23.1 15.1 25.0 21.4 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein like 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.4" "Cell line enhanced" "Detected in some" "AF22: 3.2;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.2" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: , HPA069356: " "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.7 2.8 12.9 0.7 7.9 1.0 0.7 3.3 22.4 0.6 0.8 1.5 0.0 1.0 0.7 0.7 0.7 0.6 4.2 0.7 14.0 4.0 1.2 0.7 0.7 0.7 2.2 8.4 0.6 1.1 0.7 0.8 0.7 15.2 0.8 0.8 0.4 0.6 1.0 0.7 0.8 0.9 0.8 1.9 0.7 0.7 0.9 2.8 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.1 0.0 1.3 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 7.9 3.3 22.4 14.0 4.0 2.2 8.4 15.2 2.8 COA1 "C7orf44, FLJ10803, MITRAC15" ENSG00000106603 "Cytochrome c oxidase assembly factor 1 homolog" Q9GZY4 7 43608456-43729717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA011944 Approved Supported Mitochondria Mitochondria "HPA011944: AB_1848671" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" "unprognostic (2.22e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (2.85e-3)" "prognostic unfavourable (7.84e-5)" "unprognostic (2.21e-1)" "unprognostic (4.42e-2)" "unprognostic (2.22e-2)" "unprognostic (5.22e-2)" "unprognostic (6.74e-2)" "unprognostic (1.52e-1)" "unprognostic (3.52e-1)" "unprognostic (1.02e-2)" "unprognostic (2.56e-2)" "unprognostic (5.39e-2)" 13.8 16.2 22.4 14.4 21.7 17.6 14.5 13.8 24.0 11.8 10.9 14.4 17.4 11.4 14.8 14.3 15.1 9.6 10.9 47.8 19.7 18.5 23.4 14.4 11.9 24.2 23.0 13.2 11.1 23.9 9.4 22.1 11.3 17.4 10.9 14.7 17.9 17.5 17.7 55.5 7.0 12.6 9.7 19.9 16.2 14.5 11.8 14.3 16.2 15.8 22.4 28.3 14.8 8.8 21.0 17.9 24.2 17.2 18.6 21.0 14.4 10.6 28.7 23.8 23.5 7.0 7.9 15.9 15.0 25.7 20.3 21.2 21.9 24.5 20.3 25.3 9.1 15.6 27.5 23.0 25.8 18.2 25.2 25.2 17.0 20.1 11.6 19.6 11.2 6.5 14.8 14.8 22.0 18.5 42.7 17.7 16.6 14.6 28.8 49.3 14.9 20.8 17.5 21.8 37.5 24.9 12.0 14.7 26.3 15.0 27.9 9.6 20.9 13.2 13.7 10.1 22.1 9.9 21.1 42.6 34.4 36.4 28.8 25.3 26.9 1.3 15.3 16.0 12.9 17.2 9.5 19.7 12.0 13.2 17.9 21.0 16.9 21.0 24.2 18.6 14.6 16.0 11.5 14.4 22.4 21.7 13.8 24.0 19.7 18.5 23.0 13.2 17.4 14.3 COA3 "CCDC56, COX25, HSPC009, MITRAC12" ENSG00000183978 "Cytochrome c oxidase assembly factor 3" Q9Y2R0 17 42795147-42798704 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031966 Approved Supported Mitochondria Mitochondria "HPA031966: AB_10602115" "unprognostic (1.20e-1)" "prognostic favourable (3.40e-4)" "unprognostic (5.65e-2)" "prognostic favourable (8.93e-4)" "unprognostic (7.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.78e-2)" "unprognostic (1.16e-2)" "unprognostic (1.48e-1)" "unprognostic (2.25e-2)" "unprognostic (8.44e-3)" "unprognostic (1.52e-1)" "prognostic favourable (6.62e-4)" "unprognostic (1.64e-1)" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" "unprognostic (3.01e-2)" 13.4 17.8 34.5 11.1 26.7 4.6 20.6 19.5 31.8 18.7 33.7 18.0 18.2 35.9 14.0 62.6 30.2 26.2 20.0 26.3 29.3 26.0 57.2 44.1 13.7 14.1 31.2 22.2 17.0 97.0 16.2 15.0 17.8 26.1 22.0 31.6 14.9 30.3 25.1 28.7 12.6 33.5 14.5 21.6 12.2 27.1 9.5 17.1 13.1 22.8 28.6 19.8 14.1 18.1 56.1 49.2 46.0 59.1 46.2 50.5 59.7 16.0 54.5 25.1 13.7 23.2 19.8 15.5 12.6 19.3 30.3 27.5 21.5 20.4 0.9 35.9 15.4 15.7 19.3 30.9 28.7 15.7 50.7 10.8 25.7 67.9 16.5 14.6 13.2 20.0 23.3 28.5 16.4 24.0 17.3 14.0 26.8 26.4 4.8 32.1 11.4 19.7 19.2 36.7 27.6 30.7 22.2 18.7 15.7 12.9 13.7 21.9 42.7 19.2 14.6 33.2 17.3 14.0 16.7 16.5 17.8 8.6 24.9 14.6 22.4 46.0 59.1 36.8 39.8 54.9 41.6 56.1 41.4 40.2 49.2 51.2 38.4 38.2 6.3 46.2 45.5 32.9 50.5 59.7 34.5 26.7 19.5 31.8 29.3 26.0 31.2 22.2 26.1 17.1 COL13A1 ENSG00000197467 "Collagen type XIII alpha 1 chain" Q5TAT6 10 69801867-69964275 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Osteogenesis" "Developmental protein, Heparin-binding" "Congenital myasthenic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.6;epididymis: 22.3" "Cell line enhanced" "Detected in many" "BJ: 19.7;BJ hTERT+: 18.3;HUVEC TERT2: 31.9;PC-3: 29.3;TIME: 45.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 18 "cerebellum: 54.6" "Group enriched" "Detected in some" 18 "gdT-cell: 1.9;NK-cell: 1.9" "Group enriched" "Detected in many" 18 "NK-cells: 1.9;T-cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050392 Approved "HPA050392: " "unprognostic (2.79e-2)" "unprognostic (2.82e-3)" "unprognostic (1.38e-1)" "unprognostic (3.86e-1)" "unprognostic (4.67e-4)" "unprognostic (3.13e-1)" "unprognostic (1.69e-1)" "unprognostic (7.43e-2)" "unprognostic (6.16e-3)" "unprognostic (1.22e-1)" "unprognostic (2.60e-1)" "unprognostic (2.53e-2)" "unprognostic (1.36e-5)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.52e-2)" "unprognostic (3.93e-2)" 0.7 1.2 0.5 3.3 1.0 0.0 1.3 54.6 1.3 3.5 3.1 0.6 4.3 1.8 1.4 22.3 1.3 2.0 2.7 2.7 0.6 0.5 1.3 0.5 8.2 0.7 0.9 0.7 1.1 1.2 0.9 2.7 0.9 3.0 10.7 2.3 3.8 1.0 6.2 2.7 3.1 2.9 2.0 1.7 5.0 3.9 0.9 0.7 0.3 1.0 1.1 0.6 2.2 1.2 0.0 0.0 0.1 0.0 1.9 1.9 0.4 0.4 0.1 7.0 0.0 0.0 1.3 0.0 19.7 18.3 3.3 1.6 0.0 0.4 0.0 3.3 8.8 0.7 0.0 0.0 5.6 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 2.8 0.0 8.4 2.6 31.9 0.0 0.0 3.1 0.0 0.0 0.0 1.3 29.3 0.0 0.0 3.5 0.1 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 45.5 0.1 5.4 1.8 15.0 4.4 0.0 0.0 11.7 0.0 16.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.4 0.5 1.0 54.6 1.3 0.6 0.5 0.9 0.7 3.0 0.7 COL17A1 "BP180, BPAG2" ENSG00000065618 "Collagen type XVII alpha 1 chain" Q9UMD9 10 104031286-104086002 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 85.8;skin 1: 123.2;tongue: 64.0" "Cell line enhanced" "Detected in some" "HaCaT: 55.3;HBEC3-KT: 88.6;hTCEpi: 115.1;hTERT-HME1: 98.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 227.4" "Region enriched" "Detected in single" 4 "basal ganglia: 1.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 3.7" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.7" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Not detected" "Not detected" "HPA043673, HPA052963" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to extracellular matrix" "Plasma membrane" "Golgi apparatus" "HPA043673: AB_10960893, HPA052963: " "prognostic favourable (1.38e-4)" "unprognostic (1.33e-1)" "unprognostic (4.01e-1)" "unprognostic (1.01e-1)" "unprognostic (9.65e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (6.82e-3)" "unprognostic (1.63e-1)" "unprognostic (7.85e-3)" "prognostic unfavourable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.75e-2)" "unprognostic (8.35e-2)" 0.2 0.0 0.2 4.4 1.2 7.5 8.1 0.2 0.2 15.2 9.3 0.2 0.9 2.0 0.6 2.6 31.5 0.1 1.2 0.2 0.2 0.1 0.4 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.6 85.8 0.2 5.0 5.4 0.2 15.5 7.3 0.5 123.2 23.2 0.8 0.2 0.3 3.9 4.0 0.2 18.1 2.0 64.0 24.7 3.0 17.3 0.0 0.0 3.7 0.2 0.0 0.0 0.8 3.1 0.0 0.1 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.7 0.0 55.3 0.0 88.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.1 0.0 98.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 5.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.0 0.8 0.2 1.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 COL25A1 ENSG00000188517 "Collagen type XXV alpha 1 chain" Q9BXS0 4 108808725-109302752 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Heparin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.4;retina: 22.1;testis: 23.6" "Cell line enriched" "Detected in some" 8 "HeLa: 30.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029107 Approved "Endoplasmic reticulum,Vesicles,Cytosol" "Vesicles, Cytosol" "Endoplasmic reticulum" "HPA029107: AB_10600802" "unprognostic (1.77e-1)" "unprognostic (2.12e-1)" "unprognostic (1.18e-1)" "unprognostic (8.87e-5)" "unprognostic (2.43e-2)" "unprognostic (3.20e-1)" "unprognostic (7.62e-3)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (3.53e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-1)" "unprognostic (5.30e-3)" "unprognostic (2.82e-3)" "unprognostic (9.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" 9.0 0.8 6.7 0.2 4.4 0.0 5.1 0.8 3.4 1.6 0.9 0.4 0.9 4.0 2.1 3.5 0.8 1.4 3.1 2.0 4.7 2.1 2.9 3.2 0.9 0.1 0.8 0.0 1.6 0.9 3.9 17.4 0.4 2.5 0.9 0.4 22.1 6.7 1.4 1.4 1.1 3.1 1.5 0.9 1.0 0.9 23.6 1.5 0.0 3.7 0.1 0.0 1.6 3.4 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.9 0.0 0.1 0.0 2.3 4.1 30.8 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.8 0.2 3.9 0.0 0.5 0.0 1.1 0.1 0.0 2.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.4 0.8 3.4 4.7 2.1 0.8 0.0 2.5 1.5 COLEC12 "CL-P1, SCARA4, SRCL" ENSG00000158270 "Collectin subfamily member 12" Q5KU26 18 316740-500722 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 40.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.3;BJ: 8.4;HSkMC: 14.3;U-2197: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047917, HPA071056" Enhanced Approved "Golgi apparatus,Vesicles,Cell Junctions" 550000 "Golgi apparatus, Vesicles" "Cell Junctions" "HPA047917: , HPA071056: " "unprognostic (8.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (3.60e-2)" "unprognostic (6.94e-2)" "unprognostic (1.09e-2)" "unprognostic (1.14e-4)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "unprognostic (4.86e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (2.61e-1)" "unprognostic (2.24e-3)" "unprognostic (1.52e-2)" "prognostic unfavourable (8.10e-4)" "unprognostic (3.01e-3)" 14.2 3.7 6.9 4.6 9.7 1.2 9.4 3.5 6.4 40.8 8.0 7.7 5.1 3.4 13.1 9.9 7.5 6.6 8.1 13.5 7.0 6.3 2.7 1.4 18.7 13.9 8.1 5.8 6.8 2.4 1.5 1.5 32.0 10.5 9.6 5.0 23.5 4.8 3.5 6.3 4.4 5.0 14.3 5.2 1.2 5.0 5.0 4.7 0.7 7.6 3.8 4.9 15.0 7.3 0.9 0.9 3.3 0.8 0.7 0.5 0.3 0.0 0.0 1.5 0.0 1.6 17.3 0.6 8.4 2.9 1.2 2.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.0 4.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.3 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.8 0.4 0.5 0.3 0.3 0.5 0.5 0.4 0.2 0.9 0.4 0.4 3.3 0.7 0.5 0.9 0.3 0.3 6.9 9.7 3.5 6.4 7.0 6.3 8.1 5.8 10.5 4.7 COMT ENSG00000093010 Catechol-O-methyltransferase P21964 22 19941607-19969975 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" "Methyltransferase, Transferase" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 139.3" "Cell line enhanced" "Detected in many" "MCF7: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001169, CAB011233" Enhanced Supported "Endoplasmic reticulum,Vesicles" 560000 Vesicles "Endoplasmic reticulum" "CAB011233: , HPA001169: AB_1078402" "unprognostic (5.20e-2)" "unprognostic (2.73e-2)" "unprognostic (3.08e-2)" "prognostic favourable (3.68e-4)" "unprognostic (2.99e-2)" "unprognostic (2.32e-3)" "unprognostic (5.54e-3)" "unprognostic (9.14e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (2.14e-3)" "prognostic favourable (5.67e-4)" "prognostic unfavourable (9.76e-4)" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (3.97e-1)" "unprognostic (1.07e-2)" 18.6 49.0 29.4 14.3 28.8 24.3 27.8 19.6 32.9 22.4 23.4 42.4 36.1 21.0 19.8 33.8 58.1 19.4 36.8 28.1 28.9 22.3 31.1 139.3 30.9 17.0 29.0 18.4 36.3 27.2 14.1 12.7 59.0 23.3 25.7 8.9 24.9 67.3 30.9 21.5 27.7 28.6 15.5 41.0 17.8 24.8 18.2 23.7 11.5 19.2 44.0 32.0 36.3 28.0 11.2 55.1 10.9 60.0 12.9 15.6 28.0 19.0 19.6 2.2 19.4 22.1 19.7 0.8 21.6 27.3 18.5 21.3 16.6 22.2 7.7 9.6 30.9 26.1 3.7 23.2 4.9 16.6 24.7 13.7 10.5 38.7 41.3 22.8 5.5 25.0 28.7 16.1 16.0 17.4 55.4 16.4 15.0 118.0 8.9 41.0 4.8 6.6 13.5 19.4 10.6 19.6 60.5 9.5 8.3 7.2 61.3 17.8 13.2 64.3 20.8 33.2 12.7 10.9 16.2 6.0 2.5 6.3 35.8 30.9 22.8 10.2 60.0 10.9 15.6 39.9 12.8 11.2 10.8 12.6 47.7 10.7 9.6 10.6 2.4 12.9 26.6 55.1 13.3 28.0 29.4 28.8 19.6 32.9 28.9 22.3 29.0 18.4 23.3 23.7 COQ7 "CAT5, CLK-1" ENSG00000167186 "Coenzyme Q7, hydroxylase" Q99807 16 19067599-19080095 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubiquinone biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 45.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067252, HPA071922" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA067252: , HPA071922: " "unprognostic (1.37e-1)" "unprognostic (6.89e-3)" "unprognostic (1.59e-2)" "unprognostic (6.08e-2)" "unprognostic (2.44e-2)" "unprognostic (9.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-2)" "unprognostic (1.15e-1)" "unprognostic (7.27e-3)" "unprognostic (2.15e-1)" "unprognostic (8.32e-2)" "prognostic favourable (8.23e-12)" "unprognostic (2.19e-1)" "unprognostic (2.76e-1)" "unprognostic (3.14e-2)" "unprognostic (5.27e-2)" 9.1 14.2 13.5 7.8 12.9 4.0 12.6 11.3 18.5 11.2 12.8 12.8 15.2 11.4 14.7 17.4 11.9 15.0 13.9 21.1 12.1 13.0 13.5 11.4 14.6 11.1 12.2 12.0 19.4 12.2 23.7 15.1 9.4 12.9 17.1 12.5 16.5 11.3 14.7 37.3 7.5 12.1 11.1 12.4 8.7 11.8 34.7 10.7 9.4 15.3 24.7 7.6 12.1 10.0 5.1 5.3 45.2 4.0 4.1 4.4 1.8 12.4 13.4 11.6 6.8 6.6 7.0 9.8 7.3 6.0 10.0 10.4 8.5 10.4 9.5 35.6 5.6 13.2 16.2 9.1 7.2 8.0 16.3 5.0 12.3 26.0 8.1 12.0 11.2 5.8 8.1 9.3 6.8 8.1 13.8 8.9 7.0 22.4 12.5 9.7 8.8 7.2 15.3 12.9 12.1 8.7 8.4 16.9 9.7 6.8 15.1 8.5 13.8 16.4 8.8 10.7 6.2 7.7 10.5 8.3 13.4 10.4 11.4 7.0 6.8 10.8 4.0 5.8 3.5 3.5 3.3 5.1 3.2 3.1 4.3 5.0 4.4 3.9 45.2 4.1 3.9 5.3 2.0 1.8 13.5 12.9 11.3 18.5 12.1 13.0 12.2 12.0 12.9 10.7 CORIN "ATC2, CRN, Lrp4, PRSC, TMPRSS10" ENSG00000145244 "Corin, serine peptidase" Q9Y5Q5 4 47593998-47838106 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 11.6;heart muscle: 39.5" "Cell line enriched" "Detected in some" 4 "ASC TERT1: 31.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "pons and medulla: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 2.7" "Low region specificity" "Detected in single" HPA070941 Approved "Nuclear bodies,Plasma membrane,Actin filaments" "Intracellular and membrane" "Plasma membrane" "Nuclear bodies, Actin filaments" "HPA070941: " "unprognostic (1.05e-1)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-1)" "unprognostic (3.58e-4)" "unprognostic (3.19e-1)" "unprognostic (3.67e-2)" "unprognostic (8.22e-2)" "unprognostic (9.78e-2)" "unprognostic (6.53e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (5.18e-2)" "unprognostic (7.22e-2)" "unprognostic (1.33e-2)" 0.3 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.1 3.1 0.1 0.1 2.6 0.0 3.4 11.6 0.7 1.2 4.5 39.5 0.0 0.2 2.0 0.0 1.3 0.0 0.2 0.0 0.6 0.1 0.0 1.5 0.6 1.6 1.7 0.0 0.4 0.3 4.6 0.2 5.3 0.4 0.5 0.0 3.5 0.3 3.7 0.0 0.2 0.1 1.7 0.4 0.8 3.2 0.2 0.0 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 7.3 31.8 0.0 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.2 0.0 1.6 0.0 COX11 COX11P ENSG00000166260 "COX11, cytochrome c oxidase copper chaperone" Q9Y6N1 17 54951902-54968785 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044020 Approved "HPA044020: " "unprognostic (1.42e-1)" "unprognostic (6.59e-2)" "prognostic favourable (4.30e-4)" "unprognostic (3.13e-1)" "unprognostic (5.37e-2)" "unprognostic (1.63e-2)" "unprognostic (4.69e-2)" "unprognostic (2.85e-2)" "unprognostic (4.11e-2)" "unprognostic (8.12e-3)" "unprognostic (8.18e-2)" "unprognostic (3.65e-2)" "unprognostic (2.02e-3)" "unprognostic (2.69e-2)" "unprognostic (9.25e-2)" "unprognostic (6.29e-2)" "unprognostic (7.85e-2)" 15.0 15.0 20.2 12.2 28.7 9.0 12.1 20.3 28.1 12.6 17.1 16.1 13.5 45.7 15.2 11.1 12.5 13.5 12.1 21.6 17.7 19.4 28.2 23.0 12.0 13.5 17.8 19.1 16.2 16.1 10.3 18.3 8.7 22.4 15.5 12.3 16.6 16.9 13.0 58.1 10.8 26.0 14.9 15.9 11.3 17.1 10.8 14.9 13.8 18.8 9.4 10.9 18.2 11.4 13.1 12.4 6.9 8.6 8.6 18.6 8.7 16.6 38.3 5.3 13.0 10.3 9.3 12.4 11.5 6.8 9.2 8.1 32.2 4.9 28.3 29.8 6.2 6.4 5.7 6.5 12.5 51.1 26.8 22.6 18.4 38.7 7.3 23.9 8.1 9.8 5.7 9.8 4.1 8.1 13.9 15.3 9.1 20.0 24.6 11.0 6.0 34.5 16.0 25.8 16.4 16.9 12.8 9.2 17.4 13.9 6.0 12.4 18.5 6.6 10.0 17.8 10.0 16.7 20.8 20.3 29.0 24.5 17.5 11.9 11.8 6.9 6.8 6.7 13.6 8.6 17.5 13.1 17.1 14.9 12.4 10.5 17.3 17.2 0.7 8.6 4.8 9.9 18.6 8.7 20.2 28.7 20.3 28.1 17.7 19.4 17.8 19.1 22.4 14.9 COX14 "C12orf62, MGC14288" ENSG00000178449 "COX14, cytochrome c oxidase assembly factor" Q96I36 12 50111979-50120457 "Disease related genes, Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044618, HPA062014" Approved Supported Mitochondria Mitochondria "HPA044618: AB_10960419, HPA062014: " "unprognostic (5.71e-2)" "unprognostic (1.86e-2)" "unprognostic (1.43e-1)" "unprognostic (4.04e-1)" "unprognostic (1.87e-2)" "unprognostic (3.66e-2)" "unprognostic (2.20e-2)" "unprognostic (4.20e-3)" "prognostic unfavourable (7.90e-4)" "unprognostic (7.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.09e-3)" "unprognostic (3.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.84e-2)" "unprognostic (3.07e-3)" 33.1 30.2 25.9 16.7 33.7 17.5 27.8 46.4 28.9 18.5 24.0 16.7 29.7 28.1 13.9 34.0 17.6 17.1 22.1 60.1 23.4 24.9 39.5 40.4 18.2 18.6 29.6 28.7 16.6 19.6 19.5 26.1 15.0 27.8 18.5 22.0 25.1 26.4 30.5 75.4 13.1 27.1 20.5 24.8 19.0 20.9 8.4 26.6 8.7 25.4 38.5 16.7 19.3 21.8 56.8 65.7 56.4 52.2 38.7 58.6 52.5 16.4 31.6 7.0 15.9 31.1 19.1 14.0 12.7 16.4 18.7 16.2 30.1 21.3 15.5 36.6 15.4 16.0 11.8 17.9 16.2 17.0 44.5 30.4 28.0 24.3 13.0 23.7 27.1 24.0 24.8 14.0 16.3 17.1 14.7 30.2 19.0 36.0 19.2 33.7 11.5 42.5 15.8 12.3 35.5 27.1 27.3 18.7 11.1 19.4 35.1 36.9 23.4 20.1 14.9 11.6 12.7 18.9 11.1 22.1 31.6 18.8 17.0 20.6 6.3 56.4 52.2 46.0 43.2 48.9 45.4 56.8 54.5 47.6 49.5 47.1 52.0 50.9 18.8 38.7 44.3 65.7 58.6 52.5 25.9 33.7 46.4 28.9 23.4 24.9 29.6 28.7 27.8 26.6 COX4I1 "COX4, COX4-1" ENSG00000131143 "Cytochrome c oxidase subunit 4I1" P13073 16 85798633-85807044 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002485, CAB004080" Supported Supported Mitochondria 970000 Mitochondria "CAB004080: AB_2085427, HPA002485: AB_1078559" "unprognostic (4.73e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-1)" "unprognostic (6.18e-3)" "unprognostic (2.47e-1)" "unprognostic (4.52e-2)" "unprognostic (2.65e-1)" "unprognostic (1.46e-1)" "unprognostic (5.97e-2)" "unprognostic (7.82e-3)" "unprognostic (3.32e-2)" "unprognostic (2.29e-1)" "prognostic favourable (2.56e-8)" "unprognostic (4.23e-2)" "unprognostic (4.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.38e-2)" 41.6 38.6 101.1 54.0 100.2 66.5 60.6 51.6 86.9 38.1 87.1 38.9 43.9 77.6 33.9 69.3 54.7 50.4 59.8 218.6 82.3 73.0 59.7 69.5 29.6 49.1 100.1 65.9 45.4 71.2 55.7 36.3 36.8 57.0 37.6 98.4 40.6 65.9 53.1 172.3 48.0 76.5 51.2 58.4 40.1 56.5 21.8 38.7 46.6 49.1 112.6 70.2 47.1 52.4 123.0 144.1 74.8 130.8 74.7 121.9 222.6 44.1 72.0 48.9 65.3 90.7 85.1 84.5 40.3 82.5 76.4 38.2 121.7 66.9 72.4 49.6 64.2 88.9 69.6 81.0 68.0 24.6 71.9 40.4 60.9 118.2 81.8 36.6 30.1 98.6 125.8 62.5 85.4 79.7 67.9 29.7 64.7 159.1 73.4 113.6 65.7 84.8 83.3 30.8 63.3 113.3 87.6 58.2 47.3 85.4 54.3 65.3 79.6 102.4 56.0 38.3 44.4 35.2 43.1 60.0 57.0 166.4 58.5 72.7 43.0 50.9 130.8 74.8 72.5 112.8 88.4 123.0 96.3 85.0 144.1 116.1 121.9 100.0 50.7 74.7 98.6 107.7 102.7 222.6 101.1 100.2 51.6 86.9 82.3 73.0 100.1 65.9 57.0 38.7 COX6A1 COX6A ENSG00000111775 "Cytochrome c oxidase subunit 6A1" P12074 12 120438090-120440742 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062394 Approved Supported Mitochondria Mitochondria "HPA062394: " "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (5.10e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-1)" "unprognostic (8.78e-2)" "unprognostic (3.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (3.22e-2)" "unprognostic (2.82e-1)" "prognostic favourable (6.50e-7)" "unprognostic (2.53e-1)" "unprognostic (1.31e-1)" "unprognostic (5.48e-2)" "unprognostic (2.63e-2)" 49.2 48.0 171.0 32.1 103.0 52.6 43.8 44.4 107.5 37.3 96.8 38.5 32.4 102.8 28.0 47.0 59.3 41.8 37.6 41.5 121.5 92.0 85.8 102.6 32.4 39.6 140.0 57.9 27.7 62.7 43.8 38.3 44.4 86.9 43.1 74.3 31.3 63.8 44.2 10.6 37.7 85.7 38.1 67.2 32.1 60.8 28.1 61.2 33.7 48.2 36.0 40.1 42.1 35.0 74.5 102.2 60.5 69.8 47.8 87.4 83.0 46.7 100.0 57.0 59.5 43.9 37.4 69.8 29.8 39.8 52.9 45.2 120.9 47.7 98.5 89.1 42.0 78.2 55.5 65.3 34.4 59.0 119.6 52.8 57.2 88.6 40.6 57.9 38.0 45.0 80.7 48.3 57.3 44.5 51.8 30.8 43.9 130.8 83.4 146.6 51.9 146.8 57.1 38.2 92.2 83.5 112.7 75.2 65.4 54.6 53.6 70.0 96.1 66.1 33.5 33.0 40.8 34.0 41.4 47.9 65.8 76.2 51.8 56.8 43.9 38.5 65.5 58.3 54.4 69.5 58.5 74.5 64.3 59.5 95.1 59.2 59.1 59.3 60.5 47.8 69.8 102.2 87.4 83.0 171.0 103.0 44.4 107.5 121.5 92.0 140.0 57.9 86.9 61.2 COX6C ENSG00000164919 "Cytochrome c oxidase subunit 6C" P09669 8 99873200-99894062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 232.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014295, CAB016244" Enhanced Enhanced Mitochondria 53000 Mitochondria "CAB016244: AB_2085703, HPA014295: " "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-2)" "unprognostic (1.58e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-2)" "unprognostic (1.29e-1)" "unprognostic (3.51e-1)" "unprognostic (3.70e-1)" "unprognostic (8.86e-2)" "unprognostic (3.47e-3)" "unprognostic (1.10e-1)" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" 20.5 43.1 66.1 21.6 56.2 44.4 23.3 28.5 63.8 18.7 46.0 14.3 29.4 113.7 38.8 64.1 31.6 27.4 23.5 113.0 54.8 46.9 38.7 66.8 18.2 23.2 58.8 36.7 32.7 26.5 12.1 24.0 30.7 38.8 23.3 38.1 20.6 32.4 30.1 232.1 31.2 55.8 38.7 40.4 23.7 35.1 29.6 23.5 17.9 19.5 80.6 17.8 31.0 21.3 45.9 62.3 55.7 50.6 37.2 73.5 48.0 16.7 6.7 7.9 32.2 18.0 13.1 13.2 5.5 5.2 3.8 4.3 6.8 35.9 40.7 41.6 8.5 22.3 4.5 45.6 6.3 7.3 11.4 84.4 8.1 19.8 11.7 38.9 26.1 12.1 60.7 3.1 7.0 5.6 5.9 73.1 6.3 16.0 40.4 35.8 15.1 15.6 46.9 2.6 39.8 57.2 89.2 24.5 14.9 3.8 83.6 40.8 58.9 24.9 4.8 28.6 37.2 30.2 7.8 18.2 14.6 24.1 40.2 15.8 25.3 55.7 29.3 22.1 40.1 42.3 41.8 45.9 61.0 42.5 43.8 41.7 73.5 65.7 3.5 37.2 50.6 62.3 56.9 48.0 66.1 56.2 28.5 63.8 54.8 46.9 58.8 36.7 38.8 23.5 COX7A2L "COX7AR, COX7RP, EB1, SIG81" ENSG00000115944 "Cytochrome c oxidase subunit 7A2 like" O14548 2 42333546-42425088 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059124, CAB073545" Enhanced Nucleoli,Mitochondria Mitochondria Nucleoli "CAB073545: , HPA059124: " "unprognostic (3.90e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (5.45e-2)" "unprognostic (4.60e-2)" "unprognostic (1.27e-2)" "prognostic unfavourable (4.13e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-1)" "unprognostic (1.66e-2)" "unprognostic (2.43e-1)" "unprognostic (7.07e-3)" "unprognostic (1.54e-2)" "unprognostic (2.76e-1)" "unprognostic (5.53e-2)" "unprognostic (6.19e-2)" "unprognostic (1.02e-1)" 25.1 73.3 47.3 24.4 63.3 47.7 45.4 35.2 58.2 33.4 33.8 21.0 28.8 31.7 30.2 37.9 20.9 31.2 27.1 49.8 40.4 45.3 50.9 48.9 24.0 28.1 42.6 35.6 49.8 49.3 24.9 42.7 24.0 34.9 29.5 36.2 32.3 37.0 30.3 24.4 21.5 32.1 28.4 33.1 23.1 29.4 24.8 20.5 28.0 35.8 35.8 30.9 24.5 31.1 45.1 59.7 57.2 48.7 40.5 53.7 100.9 37.5 24.1 26.8 29.0 46.0 65.6 32.0 31.2 45.6 28.5 36.4 26.4 27.2 33.3 31.3 35.7 16.9 31.9 33.0 41.8 51.2 24.5 22.5 17.3 46.8 54.2 33.8 25.1 64.3 66.6 27.9 67.4 40.1 32.8 57.2 44.1 30.6 40.3 56.3 26.2 25.1 22.0 46.5 28.3 40.8 30.5 31.8 36.4 13.1 32.9 89.4 23.6 39.5 30.2 25.9 33.9 31.3 30.4 47.0 52.5 25.0 36.6 36.8 21.9 57.2 48.7 27.2 39.0 42.0 50.0 45.1 47.9 45.3 53.1 37.6 53.7 46.1 21.6 40.5 46.3 59.7 52.8 100.9 47.3 63.3 35.2 58.2 40.4 45.3 42.6 35.6 34.9 20.5 COX7B ENSG00000131174 "Cytochrome c oxidase subunit 7B" P24311 X 77899438-77907373 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 81.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058041 Uncertain "HPA058041: " "unprognostic (1.24e-2)" "unprognostic (1.76e-3)" "unprognostic (8.37e-2)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (2.11e-2)" "unprognostic (1.06e-1)" "unprognostic (2.26e-1)" "unprognostic (8.10e-2)" "prognostic favourable (6.80e-6)" "unprognostic (8.58e-2)" "unprognostic (4.62e-1)" "unprognostic (6.38e-2)" "prognostic favourable (2.43e-4)" 9.4 11.5 23.7 9.2 26.8 18.0 18.2 15.4 32.3 13.1 22.5 4.1 19.8 18.0 8.1 16.4 17.1 10.4 10.7 81.4 21.9 20.6 34.6 28.8 9.7 9.9 24.0 22.9 7.2 15.1 11.1 11.7 8.6 21.3 9.6 22.9 6.9 14.5 18.1 69.4 9.2 19.7 15.9 19.0 8.1 14.5 3.0 12.9 4.8 12.2 62.7 10.8 11.3 9.7 16.5 23.0 19.4 25.9 17.2 22.2 19.1 8.1 20.7 11.8 12.1 13.4 11.4 8.1 6.7 10.3 13.2 15.4 24.1 13.8 12.6 10.2 10.9 13.3 31.9 18.4 15.6 5.7 31.3 13.7 29.3 22.9 11.2 21.4 8.6 14.5 15.7 15.8 14.0 14.0 15.8 22.8 14.1 24.0 12.8 20.6 12.1 56.4 11.6 17.6 34.7 35.8 26.3 11.5 7.5 17.4 22.5 10.6 8.7 11.6 9.2 5.9 8.8 13.0 5.9 5.1 13.1 15.8 13.9 28.5 7.7 19.4 20.8 14.0 15.6 25.9 21.1 16.5 20.1 19.0 23.0 13.4 20.7 22.2 15.5 17.2 24.5 17.1 18.4 19.1 23.7 26.8 15.4 32.3 21.9 20.6 24.0 22.9 21.3 12.9 COX7C ENSG00000127184 "Cytochrome c oxidase subunit 7C" P15954 5 86617904-86620962 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 298.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046647 Approved "HPA046647: " "unprognostic (1.45e-1)" "unprognostic (1.74e-2)" "unprognostic (9.10e-2)" "unprognostic (2.86e-1)" "unprognostic (2.85e-1)" "unprognostic (8.08e-2)" "unprognostic (1.04e-1)" "unprognostic (3.70e-1)" "unprognostic (4.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.21e-1)" "prognostic favourable (1.23e-5)" "unprognostic (4.56e-2)" "unprognostic (2.06e-1)" "unprognostic (1.46e-1)" "unprognostic (4.46e-2)" 43.3 60.4 76.4 35.7 68.1 36.8 49.6 41.1 65.0 35.0 74.8 22.7 44.0 76.0 50.7 55.5 53.7 32.6 44.4 150.2 61.8 57.6 91.6 83.1 36.0 66.1 72.0 44.2 51.9 88.8 39.3 47.3 26.5 51.5 42.7 53.9 36.2 127.6 46.1 298.4 28.0 73.3 71.5 39.7 35.5 54.2 31.2 32.1 39.7 56.3 84.9 40.1 53.9 58.0 92.8 91.6 54.1 73.4 51.2 96.5 113.9 54.3 62.8 56.4 105.2 52.7 53.1 63.3 42.3 33.9 28.1 39.7 72.9 99.1 74.0 46.2 31.2 59.2 49.9 80.3 46.1 54.9 76.6 59.2 97.1 75.2 44.2 70.3 70.6 62.1 69.3 35.7 49.1 44.8 35.8 87.2 41.0 108.5 72.9 88.7 60.0 181.9 70.9 65.8 136.2 83.8 104.2 70.5 51.5 40.6 95.7 89.1 97.2 96.0 44.3 26.2 47.9 44.7 80.7 84.5 97.7 85.5 67.0 82.3 49.3 38.0 72.1 54.1 58.1 73.4 72.5 92.8 91.1 71.8 91.6 79.4 96.5 84.2 7.3 51.2 68.2 85.2 80.2 113.9 76.4 68.1 41.1 65.0 61.8 57.6 72.0 44.2 51.5 32.1 COX8A "COX, COX8, COX8-2, COX8L, VIII, VIII-L" ENSG00000176340 "Cytochrome c oxidase subunit 8A" P10176 11 63974607-63976543 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 275.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA055942 Supported "HPA055942: " "unprognostic (6.93e-2)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "unprognostic (7.70e-3)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (3.46e-1)" "unprognostic (6.49e-3)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic favourable (2.51e-6)" "unprognostic (2.70e-2)" "unprognostic (5.41e-2)" "unprognostic (1.13e-1)" "unprognostic (8.44e-2)" 41.4 42.8 54.0 32.8 53.4 50.4 47.4 40.9 60.3 30.2 76.6 18.2 35.5 69.0 23.3 31.2 63.3 35.9 43.9 154.9 41.5 41.0 78.8 61.1 38.1 50.8 54.5 34.0 24.7 43.0 38.7 37.6 32.2 35.7 37.9 51.6 35.9 54.4 50.2 275.5 31.2 66.7 29.9 37.0 31.0 50.8 18.7 24.3 44.6 42.4 121.7 34.8 38.8 29.8 52.7 114.8 87.8 108.6 51.0 75.7 80.3 59.6 79.6 51.4 51.0 22.0 27.0 37.2 31.6 35.5 62.8 48.9 53.2 49.0 28.4 70.0 43.9 59.6 39.6 54.5 21.6 41.8 68.7 41.4 64.6 62.3 35.4 41.7 53.9 34.7 41.4 50.3 40.6 38.9 48.1 62.1 39.5 155.2 59.0 142.0 46.7 139.9 46.3 41.3 119.6 50.8 50.4 46.6 66.0 37.6 54.7 77.5 80.4 45.3 23.9 36.6 49.6 78.3 36.8 78.0 61.1 43.8 47.5 41.2 43.8 78.3 101.8 87.8 57.5 108.6 42.4 52.7 63.2 56.4 114.8 46.4 49.0 53.4 71.3 51.0 97.9 113.0 75.7 80.3 54.0 53.4 40.9 60.3 41.5 41.0 54.5 34.0 35.7 24.3 COX8C COX8-3 ENSG00000187581 "Cytochrome c oxidase subunit 8C" Q7Z4L0 14 93347191-93348356 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 72 "testis: 72.8" "Cell line enriched" "Detected in some" 9 "U-937: 17.6" "Group enriched" "Detected in some" 8 "ovarian cancer: 2.9;testis cancer: 6.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA003127 Approved "HPA003127: AB_1078560" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (3.76e-3)" "unprognostic (2.11e-1)" "unprognostic (2.77e-2)" "unprognostic (7.71e-2)" "unprognostic (3.83e-1)" "unprognostic (1.99e-2)" "unprognostic (8.28e-2)" "unprognostic (6.33e-2)" "unprognostic (2.64e-2)" "unprognostic (9.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 72.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPD GP180 ENSG00000108582 "Carboxypeptidase D" O75976 17 30378905-30469989 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HSkMC: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052796, HPA055465" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear speckles" 930000 "Nucleoplasm, Nuclear speckles" "Nuclear membrane" "HPA052796: , HPA055465: " "unprognostic (1.05e-1)" "unprognostic (1.31e-1)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (6.13e-2)" "unprognostic (1.65e-1)" "unprognostic (7.97e-3)" "unprognostic (4.45e-2)" "unprognostic (2.07e-2)" "unprognostic (2.96e-1)" "unprognostic (1.62e-1)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.25e-2)" "unprognostic (3.36e-1)" "unprognostic (1.08e-1)" 16.4 8.0 9.8 12.3 12.4 18.1 17.9 9.1 13.3 28.6 16.2 18.5 10.1 12.9 12.6 10.1 10.0 15.2 33.6 10.5 12.8 10.4 13.4 26.8 20.0 14.2 22.1 11.4 7.8 14.7 21.2 14.9 22.3 13.9 11.4 13.3 7.5 59.7 7.9 10.0 7.8 22.0 15.1 25.9 7.9 24.6 25.0 13.5 5.8 37.2 7.7 10.0 11.5 11.6 0.4 3.4 19.3 5.5 2.1 3.8 2.5 12.1 18.5 16.1 16.5 16.8 32.0 5.8 16.8 24.6 11.7 14.4 21.7 7.9 1.5 21.4 19.2 8.7 10.4 21.2 19.7 5.7 14.9 3.4 11.4 13.4 20.4 22.6 9.1 57.0 9.5 14.9 14.5 23.6 6.7 18.0 9.3 2.3 7.2 6.2 4.5 4.2 7.0 18.7 4.7 21.8 13.9 4.0 10.2 20.0 17.3 8.7 16.4 15.7 28.1 11.7 7.7 18.1 16.0 7.2 15.1 5.1 14.9 14.8 9.8 2.8 5.5 6.4 3.4 2.8 3.8 0.2 1.7 2.8 3.4 0.4 1.4 1.7 19.3 2.1 2.3 0.4 1.1 2.5 9.8 12.4 9.1 13.3 12.8 10.4 22.1 11.4 13.9 13.5 CPM ENSG00000135678 "Carboxypeptidase M" P14384 12 68842197-68971570 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 56.1" "Cell line enhanced" "Detected in many" "ASC diff: 28.8;ASC TERT1: 20.5;HSkMC: 37.0;SiHa: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 15.5;myeloid DC: 11.9" "Group enriched" "Detected in many" 5 "dendritic cells: 11.9;monocytes: 15.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002657, HPA077243" Enhanced Uncertain Vesicles 5000000 Vesicles "HPA002657: AB_1078398, HPA077243: " "unprognostic (1.74e-1)" "unprognostic (3.11e-1)" "unprognostic (2.88e-3)" "prognostic favourable (1.00e-4)" "unprognostic (4.58e-2)" "unprognostic (8.61e-2)" "unprognostic (1.57e-2)" "unprognostic (2.01e-1)" "unprognostic (8.42e-2)" "unprognostic (1.40e-1)" "unprognostic (1.35e-1)" "unprognostic (1.42e-1)" "unprognostic (1.47e-3)" "unprognostic (8.58e-2)" "unprognostic (6.85e-2)" "unprognostic (2.59e-2)" "unprognostic (1.06e-1)" 56.1 6.6 3.8 5.4 7.0 1.1 37.2 1.2 4.9 6.5 12.9 13.2 0.9 1.6 10.7 6.1 4.1 6.4 6.5 2.9 5.3 3.0 22.1 11.6 24.1 13.0 10.9 4.3 7.5 7.8 3.2 1.0 27.9 5.5 6.2 10.8 2.7 3.2 1.7 8.2 13.0 3.7 2.5 6.7 11.4 5.9 5.8 9.3 1.1 5.1 3.5 4.5 4.4 4.4 2.8 11.9 1.3 15.5 0.3 1.3 4.7 0.0 1.5 0.0 0.0 28.8 20.5 0.3 3.8 0.4 0.6 0.9 1.2 1.6 0.2 3.8 0.5 0.0 0.5 1.0 1.6 0.0 1.0 0.0 6.2 0.1 0.1 0.4 0.7 37.0 0.2 0.4 0.8 0.0 0.0 0.0 2.9 0.6 0.0 0.2 0.6 2.0 1.1 0.2 0.0 2.9 2.2 0.1 0.0 27.1 4.2 3.2 0.4 10.1 0.1 0.5 3.1 0.2 0.0 0.1 0.1 4.9 1.7 5.1 2.3 0.3 15.5 0.1 0.1 10.2 0.0 1.4 1.2 0.0 11.9 2.8 0.7 0.1 1.3 0.3 4.7 0.8 1.3 4.7 3.8 7.0 1.2 4.9 5.3 3.0 10.9 4.3 5.5 9.3 CPOX "CPO, CPX, HCP" ENSG00000080819 "Coproporphyrinogen oxidase" P36551 3 98521132-98593723 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.9" "Cell line enhanced" "Detected in all" "HEL: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015736, HPA054448" Enhanced Mitochondria 140000 Mitochondria "HPA015736: AB_1847194, HPA054448: " "unprognostic (2.14e-1)" "unprognostic (1.04e-1)" "unprognostic (4.07e-2)" "unprognostic (6.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.86e-2)" "prognostic unfavourable (1.04e-5)" "unprognostic (1.62e-1)" "unprognostic (2.67e-2)" "unprognostic (2.15e-2)" "unprognostic (2.57e-1)" 6.6 8.9 12.6 9.0 29.9 30.2 6.6 10.1 21.1 7.5 8.2 29.6 5.7 17.7 8.8 6.4 14.1 6.4 7.2 6.9 17.5 11.7 5.6 29.3 6.3 9.1 42.9 16.2 9.5 6.9 9.9 5.5 14.8 23.7 7.4 10.3 3.4 7.2 7.2 8.5 10.8 12.3 7.7 32.8 9.1 7.7 3.9 36.0 7.7 6.2 7.0 9.8 8.5 10.4 1.7 1.7 0.0 2.1 2.1 3.0 0.7 16.3 7.9 7.0 12.4 13.2 9.8 20.3 10.5 7.6 10.9 12.4 13.1 5.1 1.7 11.9 5.5 11.9 8.7 11.4 18.6 5.2 7.6 56.9 4.5 16.9 6.7 12.0 13.5 7.7 9.6 10.3 4.3 10.3 10.9 7.4 10.2 5.0 12.1 10.3 8.3 14.5 8.6 16.0 7.5 9.2 6.8 4.6 4.6 11.1 3.8 31.6 5.9 7.7 8.6 16.2 15.9 9.2 7.7 11.3 8.9 9.1 16.1 13.2 11.8 0.0 2.1 0.0 1.4 1.0 2.5 1.7 2.4 2.9 1.7 1.5 0.8 3.0 0.0 2.1 0.7 1.1 1.1 0.7 12.6 29.9 10.1 21.1 17.5 11.7 42.9 16.2 23.7 36.0 CPT1A "CPT1, CPT1-L, L-CPT1" ENSG00000110090 "Carnitine palmitoyltransferase 1A" P50416 11 68754620-68844410 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008835 Supported Supported Mitochondria 790000 Mitochondria "HPA008835: AB_1078563" "prognostic unfavourable (3.84e-4)" "unprognostic (1.38e-3)" "unprognostic (3.04e-3)" "unprognostic (2.46e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (2.17e-1)" "unprognostic (4.99e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-2)" "unprognostic (2.92e-2)" "unprognostic (2.34e-1)" "prognostic favourable (2.67e-7)" "unprognostic (9.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-3)" 18.0 18.3 9.9 9.9 12.1 15.8 24.4 7.0 10.3 12.8 31.9 8.2 14.1 33.7 17.0 7.2 11.2 12.8 14.7 14.6 12.0 6.6 30.6 62.0 13.1 10.1 10.5 8.6 17.0 24.4 16.9 13.8 8.7 10.8 15.6 22.0 19.7 12.9 11.4 6.9 10.3 33.4 16.9 8.7 18.9 16.8 10.4 9.0 17.9 13.2 7.5 7.6 11.3 30.2 2.5 11.9 10.6 8.6 5.7 8.8 2.5 8.3 14.8 2.1 14.5 9.5 8.6 0.6 6.7 5.5 5.3 1.1 0.5 28.3 0.0 24.8 17.6 27.5 18.8 4.0 1.6 13.4 1.8 20.5 16.2 6.8 14.2 11.9 24.9 8.9 1.9 10.6 6.4 18.8 2.1 16.9 4.8 24.0 9.7 21.1 0.2 15.8 27.1 0.3 36.5 12.5 20.9 0.3 9.5 18.5 35.7 5.9 31.9 11.6 18.8 11.6 0.2 23.2 9.6 13.2 16.8 8.5 12.2 8.8 12.6 9.2 7.8 10.6 8.8 8.6 5.1 2.3 5.5 5.3 5.0 2.5 3.4 7.0 3.8 5.7 7.2 11.9 2.9 2.5 9.9 12.1 7.0 10.3 12.0 6.6 10.5 8.6 10.8 9.0 CPT1C "CPT1P, CPTIC, FLJ23809" ENSG00000169169 "Carnitine palmitoyltransferase 1C" Q8TCG5 19 49690898-49713731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.0" "Cell line enhanced" "Detected in many" "AF22: 18.4;AN3-CA: 15.5;SH-SY5Y: 33.2;U-87 MG: 13.9" "Cancer enhanced" "Detected in many" "glioma: 9.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014529, HPA063621" Approved Approved Centrosome Centrosome "HPA014529: AB_1847206, HPA063621: " "unprognostic (1.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.73e-1)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "prognostic favourable (1.84e-4)" "unprognostic (4.36e-1)" "unprognostic (1.92e-10)" "unprognostic (9.44e-4)" "unprognostic (3.35e-2)" "unprognostic (3.91e-1)" "unprognostic (4.72e-3)" 3.4 9.3 11.2 3.1 18.9 0.8 1.1 16.3 34.0 4.1 1.9 8.9 0.2 2.7 6.4 5.3 1.8 4.1 7.6 2.8 11.9 12.8 1.6 1.6 2.5 2.6 8.0 13.4 3.8 1.2 0.7 15.6 1.9 11.4 2.8 1.7 7.4 1.5 4.8 1.7 1.5 2.4 7.8 6.6 4.2 1.4 4.1 6.3 0.0 1.7 0.2 1.7 4.4 1.9 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 18.4 15.5 6.7 5.2 0.0 5.8 11.7 7.5 10.6 0.3 0.0 0.3 0.0 5.8 1.3 0.0 0.0 4.0 0.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 6.1 0.0 6.1 0.0 10.4 0.0 0.0 0.4 0.3 0.1 0.0 0.8 3.8 0.0 0.0 0.0 0.4 0.0 12.9 33.2 0.0 0.0 0.0 0.0 0.0 8.4 0.3 0.1 3.5 2.9 0.1 1.3 0.1 13.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 11.2 18.9 16.3 23.4 11.9 12.8 8.0 13.4 11.4 6.3 CR1 "CD35, KN" ENSG00000203710 "Complement C3b/C4b receptor 1 (Knops blood group)" P17927 1 207496147-207641765 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.2;lymphoid tissue: 42.3" "Group enriched" "Detected in some" 9 "HL-60: 8.8;HMC-1: 20.6;NB-4: 8.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "basophil: 23.2;eosinophil: 9.4;neutrophil: 9.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.2" "CAB002491, CAB016271, HPA042455, HPA043579, HPA049348" Enhanced 27000000 "CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: , HPA043579: , HPA049348: " "unprognostic (1.74e-1)" "unprognostic (3.16e-2)" "unprognostic (2.75e-2)" "unprognostic (6.12e-2)" "unprognostic (1.58e-2)" "unprognostic (7.14e-2)" "unprognostic (2.84e-1)" "unprognostic (3.86e-2)" "unprognostic (2.02e-1)" "unprognostic (2.80e-1)" "unprognostic (1.32e-1)" "unprognostic (1.84e-1)" "unprognostic (2.29e-3)" "unprognostic (4.38e-2)" "unprognostic (3.32e-2)" "unprognostic (6.45e-2)" "unprognostic (3.50e-3)" 9.0 1.1 0.6 17.0 0.6 5.8 1.5 0.4 0.5 0.6 1.7 0.2 0.0 0.5 0.7 5.6 1.4 2.2 1.1 8.0 0.6 0.5 2.3 3.8 4.0 42.3 0.6 0.0 1.7 1.2 0.0 0.6 5.5 1.0 1.7 0.7 0.5 1.9 0.0 0.8 0.5 5.1 3.6 0.7 42.0 1.1 0.9 0.1 1.3 0.7 0.0 11.1 3.2 1.3 2.8 0.2 23.2 2.3 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 8.8 20.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.2 2.3 9.4 0.0 1.4 0.4 2.8 0.6 0.3 0.2 1.4 0.1 0.1 9.1 0.0 1.2 0.0 0.0 0.6 0.6 0.6 0.4 0.5 0.6 0.5 0.6 0.0 1.0 0.1 CR2 "C3DR, CD21" ENSG00000117322 "Complement C3d receptor 2" P20023 1 207454230-207489895 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 97.2" "Cell line enhanced" "Detected in some" "Daudi: 21.1;MOLT-4: 11.5;RPMI-8226: 4.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory B-cell: 13.3;naive B-cell: 16.2" "Lineage enriched" "Detected in many" 9 "B-cells: 16.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB002659, HPA052942, HPA060715" Enhanced 150000000 "CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349" "prognostic favourable (6.90e-4)" "unprognostic (1.22e-1)" "unprognostic (9.95e-2)" "unprognostic (3.64e-2)" "unprognostic (2.65e-1)" "unprognostic (1.27e-3)" "unprognostic (1.18e-1)" "unprognostic (6.62e-3)" "unprognostic (1.91e-2)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (7.95e-2)" "unprognostic (2.14e-1)" "unprognostic (1.12e-1)" "unprognostic (2.19e-1)" "unprognostic (2.09e-2)" "unprognostic (3.35e-2)" 0.5 0.3 0.4 97.2 0.3 0.0 0.4 0.3 0.3 0.3 1.2 0.0 0.0 0.0 0.3 0.0 2.8 0.3 0.3 0.3 0.4 0.4 1.4 0.4 2.0 72.8 0.4 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.5 0.9 0.0 6.0 0.0 0.4 0.3 11.5 0.0 0.4 63.4 1.4 0.5 0.0 6.5 0.7 0.3 56.3 0.6 0.3 16.2 0.0 0.2 0.0 0.0 1.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 11.5 0.0 1.9 0.2 0.0 0.2 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 13.3 0.7 0.5 0.0 16.2 1.8 1.6 0.2 0.0 0.0 0.0 0.0 1.1 0.4 0.3 0.3 0.3 0.4 0.4 0.4 0.0 0.0 0.0 CRB1 "LCA8, RP12" ENSG00000134376 "Crumbs 1, cell polarity complex component" P82279 1 197268204-197478455 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Cell line enriched" "Detected in some" 8 "HeLa: 17.1" "Cancer enriched" "Detected in single" 12 "glioma: 2.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "basophil: 9.4" "Lineage enriched" "Detected in single" 22 "granulocytes: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA061250, HPA063127" Approved Uncertain Vesicles "Intracellular and membrane" Vesicles "HPA061250: , HPA063127: " "unprognostic (1.96e-1)" "unprognostic (5.38e-3)" "unprognostic (2.92e-3)" "unprognostic (1.50e-2)" "unprognostic (5.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.38e-1)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (1.48e-3)" "unprognostic (2.59e-1)" "unprognostic (2.01e-3)" "unprognostic (1.78e-3)" "unprognostic (1.56e-1)" "unprognostic (3.36e-2)" "unprognostic (2.96e-1)" 1.1 1.1 11.9 0.9 11.0 1.8 1.2 31.4 20.4 0.9 0.9 10.4 0.0 0.9 0.8 1.2 1.1 2.0 1.0 1.2 11.4 6.2 1.1 0.9 1.0 1.0 4.0 8.9 2.6 1.7 0.7 1.9 0.9 14.1 1.0 0.9 9.0 0.8 0.9 2.4 0.9 0.9 0.8 8.7 0.9 1.5 7.3 9.6 0.0 1.3 0.0 0.8 0.9 0.1 0.1 0.0 9.4 0.0 0.1 0.4 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 17.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.3 0.1 0.0 0.0 0.0 0.0 11.9 11.0 31.4 10.5 11.4 6.2 4.0 8.9 14.1 9.6 CRB2 "FLJ16786, FLJ38464" ENSG00000148204 "Crumbs 2, cell polarity complex component" Q5IJ48 9 123356170-123380324 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Gastrulation "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Cell line enriched" "Detected in some" 7 "AF22: 26.8" "Group enriched" "Detected in some" 7 "glioma: 9.4;ovarian cancer: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA043674 Approved Supported "Intracellular and membrane" 240000 "HPA043674: AB_10962974" "unprognostic (1.38e-2)" "unprognostic (2.39e-2)" "unprognostic (1.26e-1)" "unprognostic (2.83e-4)" "unprognostic (2.85e-2)" "unprognostic (1.14e-2)" "unprognostic (2.31e-1)" "unprognostic (3.69e-4)" "unprognostic (1.20e-1)" "unprognostic (7.28e-3)" "unprognostic (4.66e-3)" "unprognostic (3.09e-1)" "unprognostic (5.56e-5)" "unprognostic (1.31e-1)" "unprognostic (1.55e-1)" "unprognostic (4.38e-2)" "unprognostic (3.38e-1)" 1.3 0.6 6.8 1.9 8.7 1.3 1.0 3.0 16.2 0.5 2.4 21.5 0.0 0.9 2.4 0.9 0.7 3.4 0.5 0.6 9.7 3.7 5.7 0.5 0.6 2.4 7.3 17.4 0.9 0.5 0.5 1.3 0.7 7.4 0.6 1.7 5.1 0.6 0.6 0.5 1.0 1.0 1.3 9.5 1.8 1.1 1.1 7.7 0.0 0.6 0.0 2.3 0.7 0.2 0.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 26.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.0 0.0 3.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.8 8.7 3.0 8.2 9.7 3.7 7.3 17.4 7.4 7.7 CRB3 MGC17303 ENSG00000130545 "Crumbs 3, cell polarity complex component" Q9BUF7 19 6463777-6467221 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 26.2;BEWO: 16.8;CACO-2: 17.6;HaCaT: 17.2;hTCEpi: 13.3;SK-BR-3: 14.0;T-47d: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.3" "Group enriched" "Detected in many" 17 "B-cells: 3.8;T-cells: 11.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA013835 Enhanced Supported "Cell Junctions" "Cell Junctions" "HPA013835: AB_1847214" "unprognostic (3.25e-1)" "unprognostic (4.41e-2)" "unprognostic (9.69e-2)" "prognostic favourable (4.54e-4)" "unprognostic (1.24e-1)" "unprognostic (1.95e-2)" "unprognostic (2.81e-1)" "unprognostic (1.03e-2)" "unprognostic (1.86e-1)" "unprognostic (2.57e-2)" "unprognostic (4.98e-2)" "unprognostic (1.11e-1)" "prognostic favourable (0.00e+0)" "unprognostic (8.42e-3)" "unprognostic (1.96e-1)" "unprognostic (1.12e-2)" "prognostic favourable (8.06e-5)" 0.4 0.1 0.4 5.9 0.5 0.0 2.6 0.4 0.4 4.1 24.4 0.6 20.7 19.8 2.2 12.6 24.2 4.3 14.8 0.4 0.5 0.1 24.8 28.5 11.7 1.4 0.4 0.5 1.4 37.2 7.0 7.7 6.5 1.8 5.0 5.5 4.1 19.3 16.9 0.4 18.3 33.6 0.9 0.4 0.6 16.1 1.6 0.4 0.8 19.4 7.7 10.6 5.2 7.0 3.8 0.0 0.4 0.0 0.0 11.3 2.7 26.2 3.2 0.0 0.1 0.0 0.0 16.8 0.0 0.0 0.0 0.0 17.6 11.1 0.1 10.6 0.0 17.2 0.2 5.8 0.0 0.0 0.2 0.0 0.1 9.7 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.2 0.0 6.9 0.0 0.2 0.6 0.0 0.0 0.0 0.3 7.8 11.1 0.0 0.0 0.1 14.0 0.0 12.2 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 1.7 3.8 5.6 2.6 0.0 1.3 11.3 4.5 0.4 0.0 0.0 0.0 3.6 2.7 0.4 0.5 0.4 0.4 0.5 0.1 0.4 0.5 1.8 0.4 CREB3 "Luman, LZIP, sLZIP" ENSG00000107175 "CAMP responsive element binding protein 3" O43889 9 35732335-35737004 "Predicted membrane proteins, Transcription factors" "Chemotaxis, Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030978 Supported Cytosol Cytosol "HPA030978: " "unprognostic (1.73e-3)" "unprognostic (9.72e-2)" "unprognostic (9.32e-2)" "unprognostic (5.62e-3)" "unprognostic (3.61e-1)" "unprognostic (3.86e-2)" "prognostic unfavourable (5.57e-4)" "unprognostic (4.29e-2)" "unprognostic (4.63e-2)" "prognostic favourable (5.40e-4)" "unprognostic (1.13e-1)" "unprognostic (1.65e-1)" "prognostic favourable (3.77e-5)" "unprognostic (1.48e-1)" "unprognostic (1.61e-1)" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" 15.7 25.1 23.7 12.0 27.6 5.6 19.4 18.5 30.2 25.4 20.3 17.6 28.2 12.8 20.9 22.5 15.0 23.9 25.2 16.3 19.4 21.3 21.3 42.3 15.9 15.3 23.1 17.1 20.2 26.3 22.1 23.1 19.5 17.3 32.9 16.7 17.4 31.7 37.6 12.6 9.9 14.6 26.0 19.6 13.0 20.5 23.0 14.0 9.1 24.4 9.4 14.9 22.0 17.6 17.7 19.4 14.8 16.9 15.9 21.8 15.7 12.2 11.4 12.1 9.0 25.4 16.6 7.9 22.4 35.8 23.9 24.8 12.7 6.0 4.4 9.9 32.7 4.7 7.7 18.5 15.8 16.4 6.4 3.4 10.1 5.8 32.4 5.6 6.8 14.5 15.2 23.2 22.7 14.6 4.9 7.4 24.5 6.0 5.8 2.0 7.5 15.0 6.4 5.3 5.6 19.3 5.9 5.6 7.8 8.9 7.9 5.3 12.1 2.4 15.6 15.8 8.9 11.5 13.7 4.3 5.2 5.3 16.6 2.0 17.2 14.8 16.9 6.3 19.2 16.0 20.7 17.7 16.8 21.8 17.9 12.3 13.7 13.4 7.7 15.9 12.8 19.4 18.5 15.7 23.7 27.6 18.5 30.2 19.4 21.3 23.1 17.1 17.3 14.0 CREB3L1 OASIS ENSG00000157613 "CAMP responsive element binding protein 3 like 1" Q96BA8 11 46277661-46321422 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 60.7" "Cell line enhanced" "Detected in many" "BJ: 30.0;BJ hTERT+: 29.5;BJ hTERT+ SV40 Large T+: 27.6;fHDF/TERT166: 71.4;HHSteC: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA024069, CAB026151" Enhanced "CAB026151: , HPA024069: AB_1854750" "unprognostic (2.46e-2)" "unprognostic (2.80e-1)" "unprognostic (1.34e-1)" "prognostic favourable (3.92e-4)" "unprognostic (1.66e-3)" "unprognostic (2.93e-1)" "unprognostic (5.41e-2)" "unprognostic (2.75e-2)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (1.54e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (2.97e-4)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" "prognostic unfavourable (8.59e-4)" "unprognostic (1.12e-2)" 2.5 3.6 3.7 3.1 2.3 0.0 3.0 1.6 2.9 17.2 13.1 0.9 9.5 8.6 9.7 9.2 2.2 1.7 37.6 4.8 3.3 3.5 1.4 1.5 10.4 0.5 3.4 1.7 9.7 60.7 0.0 3.3 8.2 0.6 17.6 14.1 1.8 28.3 14.3 1.6 2.3 12.9 12.8 1.8 2.2 22.1 3.8 0.2 0.4 1.8 2.2 13.0 15.1 3.4 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.3 5.9 19.1 18.3 0.1 30.0 29.5 27.6 19.2 3.0 0.0 0.0 0.1 71.4 0.0 0.3 0.0 15.4 0.0 0.3 0.4 0.1 0.0 26.6 0.0 0.4 17.5 0.0 15.6 0.5 0.2 2.4 0.0 23.1 0.0 0.0 0.0 3.8 3.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 1.0 0.0 14.5 4.3 11.1 18.2 0.0 0.0 0.0 17.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 3.7 2.3 1.6 2.9 3.3 3.5 3.4 1.7 0.6 0.2 CREB3L2 "BBF2H7, TCAG_1951439" ENSG00000182158 "CAMP responsive element binding protein 3 like 2" Q70SY1 7 137874979-138002067 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015068, HPA015534" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" "Nucleoplasm, Endoplasmic reticulum" "HPA015068: AB_1847224, HPA015534: " "unprognostic (8.50e-2)" "unprognostic (3.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-3)" "unprognostic (9.88e-2)" "unprognostic (9.09e-2)" "unprognostic (5.17e-2)" "unprognostic (4.50e-1)" "unprognostic (4.77e-1)" "unprognostic (8.93e-2)" "unprognostic (9.48e-2)" "unprognostic (9.65e-2)" "unprognostic (2.42e-1)" "unprognostic (3.08e-3)" "unprognostic (7.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.32e-2)" 14.9 19.8 4.7 17.1 9.8 10.8 15.7 1.9 6.0 25.4 16.7 11.4 18.7 11.6 28.2 25.5 12.8 16.2 16.2 20.4 5.6 4.3 17.0 11.7 14.6 15.2 11.8 3.7 25.9 16.0 38.4 28.8 81.6 9.8 15.9 9.5 24.9 26.5 23.3 5.0 6.9 17.5 17.7 6.2 12.1 14.1 9.8 9.1 7.0 35.8 10.9 18.1 21.3 15.7 4.6 12.4 7.4 5.6 6.5 11.8 3.2 4.0 6.2 11.8 0.2 20.2 20.1 8.9 20.0 32.5 14.1 14.2 8.5 3.6 0.8 5.4 21.7 2.1 6.9 14.7 27.6 5.8 3.4 25.3 8.5 20.2 13.4 7.6 36.3 8.3 9.4 17.7 20.8 18.5 13.0 11.8 16.4 7.2 2.4 9.4 4.2 4.4 5.3 6.4 6.7 11.0 4.1 3.0 7.1 6.5 16.9 8.9 2.4 5.7 19.7 18.9 2.9 22.7 7.3 14.0 4.8 5.3 22.7 21.5 41.9 7.4 5.6 5.9 8.2 2.9 10.6 4.0 6.0 8.6 5.8 4.6 2.2 3.8 2.1 6.5 1.5 12.4 11.8 3.2 4.7 9.8 1.9 6.0 5.6 4.3 11.8 3.7 9.8 9.1 CREB3L3 CREB-H ENSG00000060566 "CAMP responsive element binding protein 3 like 3" Q68CJ9 19 4153601-4173054 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 95 "intestine: 117.4;liver: 179.5" "Cell line enhanced" "Detected in some" "HDLM-2: 30.8;Hep G2: 9.7;HMC-1: 5.6;U-266/70: 6.7" "Cancer enriched" "Detected in many" 18 "liver cancer: 91.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 1.0;T-reg: 1.5" "Group enriched" "Detected in many" 13 "granulocytes: 1.0;T-cells: 1.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040671, HPA056228" Enhanced "HPA040671: AB_2677072, HPA056228: " "unprognostic (1.86e-2)" "unprognostic (2.13e-1)" "unprognostic (2.81e-1)" "unprognostic (1.66e-2)" "unprognostic (8.41e-4)" "unprognostic (1.79e-4)" "unprognostic (1.88e-1)" "unprognostic (5.28e-4)" "unprognostic (3.01e-1)" "unprognostic (3.61e-2)" "unprognostic (1.55e-2)" "unprognostic (1.49e-1)" "prognostic unfavourable (3.53e-6)" "unprognostic (3.18e-3)" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (3.35e-2)" 0.1 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 38.6 0.0 0.0 61.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.5 179.5 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.4 0.0 0.1 0.1 0.3 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 9.7 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 2.5 0.3 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 6.7 2.8 0.0 0.0 2.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.2 0.1 0.0 CREB3L4 "AIbZIP, ATCE1, CREB3, CREB4, hJAL" ENSG00000143578 "CAMP responsive element binding protein 3 like 4" Q8TEY5 1 153967534-153974363 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 49.9" "Group enriched" "Detected in many" 4 "MCF7: 24.8;SK-BR-3: 54.8;T-47d: 44.0" "Group enriched" "Detected in all" 5 "breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038122 Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" "Nucleoplasm, Nuclear membrane" Mitochondria "HPA038122: AB_10669516" "unprognostic (1.35e-1)" "unprognostic (4.71e-2)" "unprognostic (8.13e-3)" "prognostic favourable (7.21e-4)" "unprognostic (2.04e-1)" "unprognostic (1.40e-2)" "unprognostic (5.51e-3)" "unprognostic (5.02e-2)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-1)" "unprognostic (7.12e-3)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-2)" "unprognostic (9.34e-3)" 4.3 5.0 3.2 5.4 4.0 2.9 22.6 5.7 3.5 14.6 5.1 4.3 18.3 5.0 8.5 12.1 5.1 8.8 7.9 3.2 2.5 1.4 4.5 8.4 4.7 5.5 3.2 3.0 9.3 7.9 3.7 3.4 6.6 4.0 49.9 6.9 4.7 24.7 11.4 6.1 5.9 5.3 3.4 3.3 4.5 13.2 4.3 3.0 12.9 12.5 6.6 8.3 4.5 15.1 6.6 7.3 2.6 3.5 10.9 6.0 3.1 2.2 3.3 3.1 3.4 2.2 3.2 7.8 1.9 2.2 2.6 2.3 1.5 9.6 4.2 10.1 0.8 3.7 4.6 3.0 1.4 3.4 1.8 3.1 3.5 2.7 1.8 1.4 2.7 3.5 2.9 2.5 5.7 2.3 2.4 5.3 1.2 24.8 2.7 1.1 2.1 4.0 6.1 3.2 7.8 2.8 1.6 5.8 6.3 2.0 54.8 5.2 44.0 4.5 1.4 0.8 2.4 1.6 1.5 9.9 5.1 3.1 1.7 2.5 2.5 2.2 3.5 2.6 4.5 1.5 6.0 6.3 2.6 3.3 6.4 6.6 2.5 4.8 0.1 10.9 2.1 7.3 2.1 3.1 3.2 4.0 5.7 3.5 2.5 1.4 3.2 3.0 4.0 3.0 CRELD1 AVSD2 ENSG00000163703 "Cysteine rich with EGF like domains 1" Q96HD1 3 9933822-9945413 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026964 Uncertain Approved Nucleoli,Cytosol "Intracellular and membrane" 16000000 Cytosol Nucleoli "HPA026964: AB_10602210" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (2.69e-3)" "unprognostic (1.23e-1)" "prognostic unfavourable (8.07e-4)" "unprognostic (3.03e-1)" "unprognostic (3.59e-1)" "unprognostic (2.85e-2)" "unprognostic (1.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.92e-2)" "unprognostic (4.59e-2)" "unprognostic (1.14e-2)" "unprognostic (6.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.89e-1)" "unprognostic (3.78e-2)" 21.8 22.9 31.6 15.3 32.4 7.3 27.3 52.2 45.1 9.9 22.4 12.0 17.1 12.5 15.1 17.8 13.1 20.1 15.8 50.2 25.6 24.9 16.6 23.5 15.8 11.0 17.2 30.7 19.7 15.2 21.9 32.4 15.1 27.2 25.4 11.4 10.0 19.4 32.2 24.4 11.6 13.1 19.5 19.4 11.9 14.8 11.1 22.3 5.9 45.7 7.4 8.2 17.8 15.6 10.5 13.7 11.5 12.5 13.4 14.3 10.4 2.8 5.3 8.7 4.5 14.7 9.6 48.1 10.6 3.2 2.6 5.0 5.1 8.7 3.5 23.4 7.4 1.9 4.2 7.7 1.8 6.9 3.9 3.2 6.9 12.0 29.4 1.1 12.3 9.8 14.2 6.6 6.0 12.1 3.8 4.2 2.5 6.9 2.0 8.6 2.3 3.6 2.1 1.3 8.3 11.3 5.0 3.5 11.2 4.9 4.6 9.5 11.7 6.9 8.4 5.1 8.2 6.7 2.5 4.8 6.2 6.5 11.4 3.6 5.4 11.5 11.4 9.4 14.2 11.6 14.3 8.9 10.5 13.7 8.2 10.5 14.2 12.7 1.8 13.4 12.5 13.7 8.0 10.4 31.6 32.4 52.2 45.1 25.6 24.9 17.2 30.7 27.2 22.3 CRHR1 "CRF-R, CRF1, CRHR" ENSG00000120088 "Corticotropin releasing hormone receptor 1" P34998 17 45784280-45835828 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 23.2;pituitary gland: 16.5" "Group enriched" "Detected in some" 4 "RT4: 7.9;SH-SY5Y: 4.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" CAB025251 Enhanced "Intracellular and membrane" "CAB025251: " "unprognostic (4.59e-2)" "unprognostic (1.43e-2)" "unprognostic (2.59e-7)" "unprognostic (1.76e-1)" "unprognostic (2.71e-1)" "unprognostic (3.94e-2)" "unprognostic (2.48e-1)" "unprognostic (4.55e-4)" "unprognostic (1.65e-2)" "unprognostic (2.21e-1)" "unprognostic (3.33e-4)" "unprognostic (2.07e-5)" "unprognostic (3.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" 0.8 0.6 14.7 0.5 5.1 0.5 1.5 23.2 11.5 1.4 0.6 1.1 0.0 0.8 2.7 1.1 0.5 1.6 0.7 0.5 3.2 2.2 0.6 0.5 0.6 0.5 1.8 5.2 0.6 0.5 0.6 16.5 0.6 2.9 1.3 0.6 1.9 1.2 2.5 0.6 1.4 1.0 1.2 1.0 0.5 0.5 1.0 2.8 0.0 0.9 0.0 0.5 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.6 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 5.1 23.2 11.5 3.2 2.2 1.8 5.2 2.9 2.8 CRIM1 S52 ENSG00000150938 "Cysteine rich transmembrane BMP regulator 1" Q9NZV1 2 36355926-36551135 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 116.2" "Cell line enhanced" "Detected in many" "BJ: 67.0;fHDF/TERT166: 66.1;TIME: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000556 Enhanced "Intracellular and membrane" 120000 "HPA000556: AB_1078567" "unprognostic (2.15e-1)" "unprognostic (5.41e-2)" "unprognostic (6.39e-2)" "unprognostic (3.17e-3)" "unprognostic (3.88e-2)" "unprognostic (3.44e-2)" "unprognostic (1.88e-1)" "unprognostic (6.25e-2)" "unprognostic (2.32e-1)" "unprognostic (4.11e-3)" "unprognostic (8.19e-2)" "unprognostic (1.26e-1)" "prognostic favourable (9.51e-4)" "unprognostic (1.98e-2)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (6.67e-2)" 42.4 6.0 9.1 8.7 11.0 1.1 44.6 6.1 9.0 13.8 13.1 6.4 10.2 5.7 14.9 9.8 12.4 14.2 17.3 32.2 8.6 8.7 28.6 6.2 24.7 13.2 7.6 10.2 15.5 9.2 18.0 4.3 116.2 12.0 14.9 9.4 24.7 13.1 13.8 25.9 13.7 9.0 23.1 10.8 17.5 10.2 8.1 6.2 3.0 18.1 7.9 4.5 16.9 22.3 0.8 5.5 3.4 1.4 1.1 1.6 0.2 14.0 10.7 2.2 2.5 10.4 11.8 18.3 67.0 35.5 37.6 19.8 13.5 4.9 0.0 43.7 66.1 6.1 1.6 10.8 30.8 0.1 1.2 0.4 14.4 7.8 33.5 0.3 0.1 16.5 8.1 15.0 27.1 52.6 0.6 0.1 39.5 1.2 0.0 0.1 1.7 3.2 0.7 2.8 2.1 23.7 5.8 0.2 0.0 11.7 3.8 0.4 10.5 0.2 93.2 47.6 17.1 5.9 32.4 3.7 0.0 0.1 14.0 0.0 14.5 3.4 0.4 1.2 1.6 0.2 1.2 0.6 0.7 0.9 0.3 0.8 0.2 1.0 0.5 1.1 1.4 5.5 0.5 0.2 9.1 11.0 6.1 9.0 8.6 8.7 7.6 10.2 12.0 6.2 CRYAB "CRYA2, HSPB5" ENSG00000109846 "Crystallin alpha B" P02511 11 111908565-111923722 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Eye lens protein" "Cancer-related genes, Cardiomyopathy, Cataract, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 743.1;skeletal muscle: 581.1" "Group enriched" "Detected in some" 5 "ASC diff: 230.1;fHDF/TERT166: 75.0" "Group enriched" "Detected in all" 6 "glioma: 426.4;renal cancer: 575.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002053, CAB040560, HPA057100" Enhanced Enhanced "Plasma membrane,Cytosol" 12000 "Plasma membrane, Cytosol" "CAB002053: AB_442024, CAB040560: , HPA057100: " "unprognostic (1.06e-2)" "unprognostic (2.26e-1)" "prognostic unfavourable (4.90e-5)" "unprognostic (2.46e-2)" "unprognostic (3.02e-2)" "unprognostic (8.41e-3)" "unprognostic (9.29e-3)" "unprognostic (7.35e-2)" "unprognostic (8.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.68e-2)" "unprognostic (7.02e-2)" "unprognostic (3.68e-2)" "unprognostic (7.92e-2)" "unprognostic (8.83e-2)" "unprognostic (1.18e-1)" "prognostic unfavourable (1.70e-5)" 107.4 11.5 47.8 16.7 82.3 2.1 69.5 24.8 153.7 22.4 23.6 132.9 7.2 5.5 14.8 25.9 41.9 13.5 14.0 743.1 65.9 44.0 151.8 3.8 8.4 3.9 139.2 29.7 8.8 6.6 3.3 8.6 16.1 80.7 30.3 12.9 23.3 30.6 75.1 581.1 18.1 6.2 45.2 168.0 5.5 11.6 3.9 101.8 0.0 40.7 94.1 9.2 16.2 53.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.3 230.1 10.1 1.6 6.4 0.2 0.1 0.2 0.1 0.0 0.0 3.8 75.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 1.2 0.6 1.9 0.0 0.0 8.1 1.0 0.0 0.5 0.0 0.5 0.2 18.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.8 3.4 0.5 0.0 0.1 29.8 10.7 0.8 0.3 0.1 0.0 0.0 0.6 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.8 82.3 24.8 48.5 65.9 44.0 139.2 29.7 80.7 101.8 CS ENSG00000062485 "Citrate synthase" O75390 12 56271699-56300392 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tricarboxylic acid cycle" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 125.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754" Enhanced Enhanced Mitochondria 4400000 Mitochondria "CAB075750: , CAB075751: , CAB075752: , CAB075753: , CAB075754: , HPA038460: AB_2676023, HPA038461: AB_2676024" "unprognostic (7.67e-3)" "unprognostic (3.80e-1)" "unprognostic (2.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.70e-2)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (3.34e-2)" "unprognostic (2.43e-1)" "unprognostic (5.58e-2)" "unprognostic (2.56e-1)" "unprognostic (1.97e-2)" "prognostic favourable (1.17e-4)" "unprognostic (1.20e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-2)" "unprognostic (2.02e-1)" 37.1 35.5 11.9 16.3 20.4 19.3 55.6 28.5 43.8 17.2 27.4 14.1 11.3 25.3 19.9 10.8 31.7 16.5 14.0 79.2 11.2 14.5 26.7 12.3 17.3 30.8 12.3 14.2 16.9 20.7 28.1 14.3 11.9 24.8 16.2 32.7 19.8 23.1 17.5 125.9 22.8 27.0 21.2 15.0 18.4 21.4 7.9 11.1 20.7 17.9 48.2 26.1 22.9 19.1 19.5 37.1 59.6 27.8 15.9 19.7 18.2 35.4 38.4 31.3 40.7 41.7 38.8 20.4 29.6 29.1 52.1 36.5 54.1 34.9 69.4 29.1 37.3 38.5 86.6 44.5 49.9 24.1 44.0 47.7 27.9 39.0 23.4 58.3 34.3 42.7 42.6 40.9 49.6 58.6 49.3 41.7 45.5 28.5 48.2 18.0 24.9 55.5 47.0 36.8 52.4 32.3 36.1 41.2 27.0 38.3 45.6 30.0 63.5 34.0 38.8 26.3 36.9 37.1 31.2 27.5 41.9 45.2 24.3 42.9 24.7 14.5 22.0 59.6 15.2 27.8 19.7 19.5 18.3 14.3 37.1 16.7 19.4 15.4 9.8 15.9 27.0 20.5 19.3 18.2 11.9 20.4 28.5 43.8 11.2 14.5 12.3 14.2 24.8 11.1 CSF1 "M-CSF, MCSF, MGC31930" ENSG00000184371 "Colony stimulating factor 1" P09603 1 109910242-109930992 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 46.6;ASC TERT1: 29.3;BJ hTERT+: 30.7;HHSteC: 70.9;HSkMC: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 7.0;eosinophil: 16.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076624 Supported "Nuclear bodies,Plasma membrane" "Secreted to blood" 423300 17000000 "Plasma membrane" "Nuclear bodies" "HPA076624: " "unprognostic (2.35e-3)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-1)" "unprognostic (3.60e-1)" "unprognostic (1.64e-2)" "prognostic unfavourable (4.25e-5)" "unprognostic (1.04e-1)" "unprognostic (1.75e-2)" "unprognostic (2.18e-1)" "unprognostic (1.72e-1)" "unprognostic (5.10e-2)" "prognostic unfavourable (1.00e-11)" "unprognostic (2.03e-1)" "unprognostic (1.88e-2)" "unprognostic (4.01e-1)" "unprognostic (3.16e-2)" 38.1 21.4 11.5 14.6 16.7 10.1 36.5 4.3 14.6 13.8 12.8 28.2 3.6 8.5 12.0 10.1 11.3 15.7 20.6 16.0 11.4 5.8 10.7 10.3 23.5 16.9 24.3 5.4 16.9 11.3 6.7 5.2 26.0 19.2 16.3 11.0 12.2 12.4 11.6 12.7 10.4 12.7 16.0 21.9 25.8 11.9 7.5 20.3 2.9 12.4 7.8 11.0 20.6 29.2 0.0 0.0 16.5 0.0 0.0 1.0 0.1 1.5 5.7 2.9 1.1 46.6 29.3 1.0 6.7 30.7 5.3 4.9 0.2 0.8 0.0 8.4 16.4 1.2 1.2 2.2 2.0 18.6 0.9 2.0 3.3 1.9 70.9 0.0 2.6 45.3 0.6 11.7 7.1 1.0 0.4 1.1 6.3 0.1 0.0 0.3 1.0 0.5 0.2 1.5 0.1 2.2 1.5 0.1 0.3 1.9 0.5 2.3 0.4 0.2 3.5 5.6 1.9 24.5 3.7 0.5 0.2 0.0 14.1 0.0 20.7 7.0 0.0 16.5 0.2 0.0 0.5 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.1 11.5 16.7 4.3 14.6 11.4 5.8 24.3 5.4 19.2 20.3 CSF1R "C-FMS, CD115, CSFR, FMS" ENSG00000182578 "Colony stimulating factor 1 receptor" P07333 5 150053291-150113372 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.5;lymphoid tissue: 82.6" "Group enriched" "Detected in some" 5 "BEWO: 50.6;SK-BR-3: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 60.7;non-classical monocyte: 82.5" "Lineage enriched" "Detected in many" 4 "monocytes: 82.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008970, HPA012323" Uncertain Supported "Vesicles,Plasma membrane" "Intracellular and membrane" 1500000000 "Vesicles, Plasma membrane" "CAB008970: , HPA012323: AB_1848977" "unprognostic (3.82e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-3)" "unprognostic (9.83e-2)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (9.37e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavourable (1.08e-4)" "unprognostic (3.67e-2)" "prognostic unfavourable (4.92e-4)" "unprognostic (1.72e-2)" "unprognostic (4.61e-2)" 20.9 12.4 18.2 28.1 18.9 1.8 7.7 2.8 13.5 9.3 8.3 25.4 1.1 9.2 5.9 13.1 8.4 7.9 16.1 8.7 16.4 13.7 7.8 15.1 13.7 25.4 21.3 6.0 5.3 5.2 5.9 6.4 52.1 17.1 8.5 8.4 16.8 8.0 8.7 3.0 5.8 14.5 16.2 25.8 82.6 9.0 4.9 23.0 3.1 4.2 2.9 8.2 16.4 4.7 0.0 19.1 2.9 82.5 0.0 0.1 13.9 1.7 0.0 0.0 0.0 0.8 0.2 50.6 0.1 0.0 0.0 0.0 1.5 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.1 0.0 19.3 0.0 0.0 7.2 0.0 0.3 0.0 0.0 1.3 0.0 0.1 0.0 2.6 0.9 0.0 0.4 18.1 0.5 0.1 60.7 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 2.9 0.0 82.5 1.4 0.0 13.9 18.2 18.9 2.8 13.4 16.4 13.7 21.3 6.0 17.1 23.0 CSF2RA "alphaGMR, CD116, CSF2R" ENSG00000198223 "Colony stimulating factor 2 receptor alpha subunit" P15509 X 1268800-1310381 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 60.2;placenta: 79.5" "Group enriched" "Detected in some" 7 "BEWO: 59.0;HMC-1: 17.7;SK-MEL-30: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 30.0;eosinophil: 36.0;intermediate monocyte: 17.7;myeloid DC: 31.9;neutrophil: 60.2;plasmacytoid DC: 30.5" "Group enriched" "Detected in many" 28 "dendritic cells: 31.9;granulocytes: 60.2;monocytes: 30.0" CAB016148 Uncertain "Secreted to blood" 9400000 "CAB016148: AB_626868" "unprognostic (4.19e-2)" "prognostic favourable (2.38e-5)" "unprognostic (5.47e-2)" "unprognostic (4.33e-2)" "unprognostic (4.88e-2)" "prognostic favourable (2.81e-4)" "unprognostic (8.24e-2)" "unprognostic (2.17e-1)" "unprognostic (5.55e-2)" "unprognostic (8.48e-2)" "unprognostic (8.89e-2)" "unprognostic (3.80e-1)" "unprognostic (2.89e-2)" "unprognostic (8.91e-3)" "prognostic unfavourable (5.53e-4)" "unprognostic (3.60e-1)" "unprognostic (9.44e-2)" 8.7 2.3 11.8 11.1 11.1 8.9 17.7 3.4 9.6 3.1 2.2 0.6 0.6 2.2 4.4 0.6 2.1 2.2 5.7 3.7 15.0 4.7 2.4 1.7 11.2 8.3 18.8 6.5 3.5 1.0 0.2 2.1 79.5 13.2 1.5 3.3 0.6 3.1 1.0 0.6 1.8 3.3 2.9 25.5 12.6 1.7 0.6 16.3 0.6 2.5 0.6 10.4 4.2 1.5 0.3 31.9 60.2 30.0 1.4 0.2 10.1 0.1 3.4 0.2 0.0 0.0 0.0 59.0 0.0 0.1 0.1 0.0 1.2 0.3 0.0 3.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.4 0.0 0.0 1.3 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 5.4 0.5 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 41.3 2.7 4.9 0.0 0.0 1.7 0.3 0.0 0.1 0.1 0.1 0.0 5.3 0.0 2.4 30.0 36.0 0.0 17.7 0.2 0.3 0.0 0.0 31.9 0.1 0.0 0.0 60.2 1.4 8.4 30.5 0.1 10.1 11.8 11.1 3.4 9.6 15.0 4.7 18.8 6.5 13.2 16.3 CSF2RB "betaGMR, CD131, IL3RB, IL5RB" ENSG00000100368 "Colony stimulating factor 2 receptor beta common subunit" P32927 22 36913628-36940449 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.1;placenta: 73.6" "Group enriched" "Detected in some" 6 "HEL: 26.3;HMC-1: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 53.1;neutrophil: 20.1" "Lineage enriched" "Detected in many" 14 "granulocytes: 53.1" "Low region specificity" "Detected in all" HPA078677 Approved "Golgi apparatus" "Golgi apparatus" "HPA078677: " "unprognostic (1.67e-2)" "unprognostic (9.44e-3)" "unprognostic (1.03e-2)" "unprognostic (6.66e-3)" "unprognostic (1.51e-1)" "prognostic favourable (7.47e-5)" "unprognostic (1.86e-1)" "unprognostic (1.94e-2)" "unprognostic (4.38e-1)" "unprognostic (9.57e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-1)" "unprognostic (1.82e-3)" "unprognostic (5.76e-2)" "unprognostic (3.65e-2)" "unprognostic (1.95e-1)" "unprognostic (8.52e-2)" 8.5 1.8 1.5 28.9 1.5 21.7 6.0 0.6 1.0 3.0 5.9 2.0 0.4 4.5 2.2 2.8 4.0 3.6 5.5 4.2 1.4 1.4 2.4 3.5 12.6 34.1 2.9 0.2 2.5 1.9 0.3 1.2 73.6 2.4 3.5 3.8 2.8 9.7 1.0 2.6 3.8 10.2 3.0 2.9 25.2 3.9 2.1 1.9 8.2 3.4 4.8 30.5 8.2 4.3 0.4 3.8 53.1 2.1 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 26.3 0.0 0.0 0.0 0.4 82.6 0.0 0.0 0.0 0.0 4.6 0.0 3.2 0.0 0.0 0.0 2.7 0.0 0.0 2.6 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.4 0.2 1.6 0.0 3.8 0.0 53.1 1.9 5.8 0.0 2.1 0.0 0.4 0.0 0.0 1.2 0.3 0.0 0.0 20.1 0.0 1.7 3.8 0.6 1.8 1.5 1.5 0.6 1.0 1.4 1.4 2.9 0.2 2.4 1.9 CSF3R "CD114, GCSFR" ENSG00000119535 "Colony stimulating factor 3 receptor" Q99062 1 36466043-36483278 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 167.3;bone marrow: 88.9;lymphoid tissue: 71.4;placenta: 152.7" "Group enriched" "Detected in some" 18 "BEWO: 34.1;NB-4: 9.2;THP-1: 22.4;U-937: 21.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 167.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 167.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017116, HPA048086" Enhanced "Intracellular and membrane" "CAB017116: , HPA048086: " "unprognostic (5.57e-3)" "unprognostic (8.05e-2)" "unprognostic (7.23e-2)" "unprognostic (3.87e-2)" "unprognostic (2.88e-1)" "unprognostic (2.92e-2)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (1.83e-1)" "unprognostic (5.65e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-1)" "prognostic unfavourable (5.72e-4)" "unprognostic (6.33e-2)" "prognostic unfavourable (3.79e-4)" "unprognostic (2.03e-1)" "unprognostic (2.31e-2)" 8.5 1.5 2.9 39.5 3.2 88.9 2.4 0.7 2.9 1.1 1.1 4.2 0.4 0.6 0.7 1.1 1.2 6.9 4.3 5.6 2.6 2.0 1.7 4.5 26.9 27.5 7.2 1.1 1.1 1.3 0.3 1.1 152.7 3.8 1.3 0.5 2.1 1.6 0.5 0.6 0.3 1.6 3.1 7.1 71.4 2.2 1.4 3.3 1.1 1.0 0.4 0.9 4.6 3.9 0.0 8.2 167.3 22.1 0.2 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.6 0.0 0.0 22.1 0.6 0.0 4.8 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 167.3 0.2 1.8 0.2 0.0 10.3 2.9 3.2 0.7 2.9 2.6 2.0 7.2 1.1 3.8 3.3 CSMD1 "KIAA1890, PPP1R24" ENSG00000183117 "CUB and Sushi multiple domains 1" 8 2935353-4994972 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 29.5;testis: 9.0" "Cell line enhanced" "Detected in some" "K-562: 8.8;U-2 OS: 4.3;U-266/70: 4.2;U-266/84: 3.9;U-698: 3.6" "Cancer enhanced" "Detected in some" "testis cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074707 Approved Vesicles Vesicles "HPA074707: " "unprognostic (6.32e-2)" "unprognostic (4.23e-2)" "unprognostic (2.37e-1)" "unprognostic (1.67e-3)" "unprognostic (5.72e-2)" "unprognostic (4.26e-2)" "unprognostic (1.02e-2)" "unprognostic (4.66e-2)" "unprognostic (7.69e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-1)" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (2.74e-2)" "unprognostic (5.09e-2)" "unprognostic (1.26e-2)" "unprognostic (1.11e-1)" 1.0 1.1 20.4 0.8 21.1 0.8 1.4 6.3 29.5 2.5 0.8 1.7 0.0 1.0 1.2 0.9 0.8 3.2 0.8 0.7 12.9 4.5 2.7 0.7 1.4 0.9 3.9 18.2 0.9 0.9 0.7 0.7 2.8 3.4 1.1 0.8 0.0 0.7 1.5 1.1 1.0 1.0 1.7 2.4 2.8 0.8 9.0 2.4 0.0 1.1 0.0 0.9 1.1 0.5 0.0 0.9 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.5 0.0 0.0 0.0 0.1 0.0 0.3 1.7 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.3 0.0 0.0 4.2 3.9 3.6 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 20.4 21.1 6.3 29.5 12.9 4.5 3.9 18.2 3.4 2.4 CSMD2 KIAA1884 ENSG00000121904 "CUB and Sushi multiple domains 2" Q7Z408 1 33513999-34165842 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8" "Cell line enhanced" "Detected in some" "BJ: 4.8;fHDF/TERT166: 5.8;HEL: 8.8;NTERA-2: 7.1;PC-3: 7.3;U-87 MG: 20.9" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008622 Uncertain "HPA008622: AB_1078579" "unprognostic (1.33e-2)" "unprognostic (2.98e-1)" "unprognostic (6.47e-2)" "unprognostic (2.14e-1)" "unprognostic (7.03e-2)" "unprognostic (2.77e-1)" "unprognostic (1.31e-3)" "unprognostic (5.90e-2)" "unprognostic (7.44e-2)" "unprognostic (5.36e-2)" "unprognostic (2.32e-2)" "unprognostic (2.97e-1)" "unprognostic (1.25e-5)" "unprognostic (1.03e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.38e-2)" 2.1 2.3 9.0 2.0 10.6 0.7 0.9 5.9 15.8 1.2 1.1 6.2 1.6 1.7 1.4 1.3 1.1 0.9 6.6 1.5 10.4 7.5 1.0 0.9 1.0 1.9 4.7 9.3 0.9 1.9 0.8 0.8 0.9 10.4 1.4 1.4 2.7 0.9 1.8 0.8 1.6 1.4 2.5 7.4 1.5 1.2 3.4 5.2 0.0 1.3 0.0 2.9 2.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 7.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 2.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 10.6 5.9 15.8 10.4 7.5 4.7 9.3 10.4 5.2 CSMD3 ENSG00000164796 "CUB and Sushi multiple domains 3" Q7Z407 8 112222928-113437099 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 26.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 2.3;hTCEpi: 2.3;hTERT-HME1: 1.6;LHCN-M2: 3.3;RH-30: 2.1;SCLC-21H: 1.4;U-2 OS: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029007 Uncertain "HPA029007: AB_10601802" "unprognostic (2.26e-1)" "unprognostic (2.16e-2)" "unprognostic (2.83e-2)" "unprognostic (5.97e-2)" "unprognostic (3.44e-2)" "unprognostic (1.26e-2)" "unprognostic (3.54e-4)" "unprognostic (2.48e-1)" "unprognostic (2.54e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-2)" "unprognostic (5.03e-10)" "unprognostic (1.95e-1)" "unprognostic (4.14e-3)" "unprognostic (1.91e-2)" "unprognostic (1.74e-3)" 1.0 1.0 26.6 1.0 21.9 1.0 1.0 6.0 18.3 1.6 1.1 2.2 0.0 1.1 1.1 1.1 1.0 2.3 1.0 1.0 14.2 6.7 1.1 1.0 1.1 1.0 3.0 15.8 1.0 1.0 1.0 5.7 1.0 10.9 2.1 1.2 0.0 1.0 2.1 1.0 1.0 1.2 1.1 3.6 2.4 1.3 5.0 7.0 0.0 1.0 0.0 1.0 1.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 2.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.3 0.0 1.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 21.9 6.0 18.3 14.2 6.7 3.0 15.8 10.9 7.0 CSNK1G1 CK1gamma1 ENSG00000169118 "Casein kinase 1 gamma 1" Q9HCP0 15 64165517-64356259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018209 Supported Cytosol Cytosol "HPA018209: AB_1847278" "unprognostic (9.10e-2)" "unprognostic (8.09e-2)" "unprognostic (1.20e-1)" "unprognostic (2.65e-2)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (1.61e-2)" "unprognostic (2.02e-1)" "unprognostic (8.63e-2)" "unprognostic (3.75e-2)" "unprognostic (7.51e-2)" "unprognostic (8.16e-3)" "unprognostic (1.31e-1)" "unprognostic (2.59e-2)" "unprognostic (2.41e-1)" 7.2 7.8 10.2 11.9 15.1 11.6 8.7 12.2 10.6 8.7 7.4 7.6 11.6 7.0 11.1 9.9 15.7 10.8 7.8 5.6 8.9 7.6 8.6 6.0 8.4 9.6 6.6 4.7 8.5 8.8 10.4 16.1 7.2 7.2 6.8 7.9 10.1 8.2 14.5 6.5 10.4 6.8 11.1 5.3 8.2 6.8 41.3 7.3 11.8 11.5 5.6 11.2 8.3 10.6 4.1 4.1 8.8 5.1 5.3 8.0 2.4 5.1 10.7 7.8 10.1 6.7 9.1 7.1 6.3 6.5 10.7 9.7 8.5 10.0 8.0 3.4 9.9 11.7 20.3 12.7 12.6 15.2 5.2 7.4 8.6 5.7 7.7 13.8 8.9 8.1 16.9 10.9 15.7 11.7 9.0 8.4 9.6 7.0 7.0 4.3 7.2 5.6 11.8 9.7 6.4 8.6 20.4 12.5 7.6 8.3 5.0 7.3 8.7 5.4 12.6 9.8 11.7 7.7 7.7 9.7 18.6 6.8 9.1 10.2 6.0 0.9 3.6 5.6 5.7 5.1 8.0 3.6 5.1 4.1 2.7 4.1 5.1 4.7 8.8 5.3 4.3 4.1 3.9 2.4 10.2 15.1 12.2 10.6 8.9 7.6 6.6 4.7 7.2 7.3 CSPG4 "HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2" ENSG00000173546 "Chondroitin sulfate proteoglycan 4" Q6UVK1 15 75674322-75712848 "Predicted membrane proteins" "Angiogenesis, Differentiation, Tissue remodeling" "Developmental protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 19.7;SK-MEL-30: 44.8;U-138 MG: 28.9;WM-115: 42.5" "Cancer enhanced" "Detected in all" "melanoma: 74.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 1.9" "Lineage enriched" "Detected in single" 11 "NK-cells: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001933, HPA002951, CAB016189, HPA042785, HPA050008" Approved Enhanced "Nucleoplasm,Plasma membrane" 28000000 "Plasma membrane" Nucleoplasm "CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: " "unprognostic (5.21e-2)" "unprognostic (2.17e-3)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.56e-2)" "unprognostic (3.58e-1)" "unprognostic (1.09e-2)" "unprognostic (2.11e-2)" "unprognostic (1.07e-1)" "unprognostic (5.00e-2)" "unprognostic (1.63e-1)" "unprognostic (3.14e-1)" "prognostic unfavourable (7.60e-6)" "unprognostic (1.23e-2)" "unprognostic (2.04e-2)" "unprognostic (3.21e-2)" "prognostic unfavourable (4.93e-5)" 36.1 3.1 8.3 10.0 7.9 1.0 19.5 1.6 7.8 15.3 29.2 7.2 6.9 4.6 21.3 14.9 19.9 9.4 18.2 9.2 6.5 5.2 3.5 1.5 10.9 1.4 6.6 5.2 7.0 3.8 3.0 1.6 20.9 6.6 11.4 3.9 10.0 3.4 16.7 25.7 8.0 9.1 37.9 5.4 3.8 14.0 2.5 6.3 0.0 4.7 6.0 1.3 30.3 10.9 0.0 0.1 0.0 0.0 1.9 0.0 0.0 3.5 0.0 0.3 2.2 0.5 3.1 0.0 19.7 8.8 13.8 9.0 0.0 13.7 0.0 0.4 13.7 0.1 0.0 0.1 4.3 0.1 0.0 0.0 5.7 0.0 3.2 0.0 0.0 1.5 0.0 4.2 0.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 44.8 0.3 0.3 0.0 28.9 5.7 1.1 0.2 0.0 0.0 0.0 6.3 0.1 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 8.3 7.9 1.6 5.9 6.5 5.2 6.6 5.2 6.6 6.3 CSPG5 NGC ENSG00000114646 "Chondroitin sulfate proteoglycan 5" O95196 3 47562239-47580792 "Predicted membrane proteins" "Differentiation, Growth regulation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 81.1" "Cell line enhanced" "Detected in many" "AF22: 26.2;HEK 293: 7.2" "Cancer enriched" "Detected in many" 19 "glioma: 48.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049529, HPA067818, HPA071779" Enhanced Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA049529: , HPA067818: , HPA071779: " "unprognostic (2.68e-1)" "unprognostic (2.11e-1)" "unprognostic (8.87e-2)" "unprognostic (3.12e-2)" "unprognostic (2.88e-1)" "unprognostic (7.66e-2)" "unprognostic (5.05e-4)" "unprognostic (1.40e-1)" "unprognostic (3.82e-1)" "prognostic favourable (2.14e-4)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (3.41e-4)" "unprognostic (8.08e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" 1.8 1.8 30.6 1.3 25.8 1.1 1.6 7.2 81.1 1.3 1.4 6.7 0.0 1.1 1.3 1.2 1.3 1.4 1.2 1.3 20.2 17.1 1.2 1.2 1.7 1.3 12.9 12.6 1.1 1.4 1.1 0.2 1.8 5.6 1.5 1.3 8.0 1.1 1.1 1.5 1.6 1.3 1.4 6.2 1.1 1.2 2.2 4.1 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 26.2 4.6 0.5 0.0 0.7 0.5 0.1 1.0 0.3 0.2 1.6 0.1 2.0 0.0 0.4 2.2 0.2 0.2 0.0 7.2 0.4 1.1 0.0 0.0 0.3 1.2 0.0 0.9 0.1 0.0 0.0 5.1 0.2 0.1 1.2 0.2 0.3 2.5 2.7 0.4 0.2 0.5 1.1 0.9 2.8 1.3 1.6 3.3 0.1 1.2 2.4 0.2 0.0 5.4 0.0 1.5 0.6 0.6 0.0 0.4 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 25.8 7.2 22.4 20.2 17.1 12.9 12.6 5.6 4.1 CTAGE1 "CT21.1, CT21.2, CTAGE, cTAGE-1, cTAGE-2" ENSG00000212710 "Cutaneous T cell lymphoma-associated antigen 1" "Q96RT6, Q9HC47" 18 22413601-22417915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 12.9" "Cell line enhanced" "Detected in some" "HBF TERT88: 2.2;U-2 OS: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922, CAB016204" Uncertain "CAB016204: AB_673617, HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.41e-1)" "unprognostic (5.65e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.52e-1)" "unprognostic (1.70e-2)" "unprognostic (3.15e-1)" "unprognostic (1.63e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE15 CTAGE15P ENSG00000271079 "CTAGE family member 15" A4D2H0 7 143571801-143574387 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (2.82e-1)" "unprognostic (8.64e-2)" "unprognostic (3.23e-1)" "unprognostic (3.32e-1)" "unprognostic (2.44e-1)" "unprognostic (2.23e-1)" "unprognostic (4.52e-2)" "unprognostic (9.94e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-2)" "unprognostic (3.72e-1)" "unprognostic (2.47e-1)" "unprognostic (2.33e-1)" "unprognostic (2.91e-2)" "unprognostic (2.39e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.6 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE4 "cTAGE-4, FLJ43692" ENSG00000225932 "CTAGE family member 4" Q8IX94 7 144183466-144186053 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 9.1" "Cell line enhanced" "Detected in some" "A-431: 13.5;hTCEpi: 12.0;RPTEC TERT1: 10.7;T-47d: 7.6;WM-115: 7.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.3;T-reg: 2.0" "Lineage enriched" "Detected in single" 5 "T-cells: 2.0" "HPA000387, HPA000922" Uncertain "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.76e-1)" "unprognostic (3.24e-3)" "unprognostic (2.89e-1)" "unprognostic (5.17e-2)" "unprognostic (2.80e-1)" "unprognostic (3.65e-3)" "unprognostic (1.15e-1)" "unprognostic (1.26e-2)" "unprognostic (4.69e-2)" "unprognostic (1.91e-2)" "unprognostic (9.50e-3)" "unprognostic (1.07e-1)" "unprognostic (2.30e-1)" "unprognostic (8.36e-2)" "unprognostic (2.68e-1)" 1.3 0.9 0.2 0.0 0.7 0.0 3.8 0.1 0.2 0.7 1.2 3.7 1.4 2.5 1.3 1.1 1.9 1.4 0.2 0.4 1.3 1.6 2.0 0.0 0.7 1.9 4.1 0.0 2.1 0.8 1.3 3.5 2.0 0.3 0.3 9.1 1.0 0.0 0.4 1.3 2.4 4.9 7.5 0.0 0.8 1.3 0.4 0.0 0.0 0.0 0.0 2.0 0.0 13.5 0.1 0.0 0.0 0.0 0.0 5.7 0.4 0.2 0.0 0.2 1.3 4.3 0.0 0.0 0.5 0.4 0.0 2.4 0.1 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.3 12.0 0.4 3.7 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 3.5 0.0 0.0 4.9 5.0 0.4 7.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 CTAGE5 "cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, MEA6, MGEA, MGEA11, MGEA6" ENSG00000150527 "CTAGE family member 5, ER export factor" "O15320, Q96PC5" 14 39230231-39388513 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 43.9;Hep G2: 36.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA000387, HPA000922, HPA054066, HPA055459" Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: , HPA055459: " "unprognostic (2.62e-1)" "unprognostic (7.17e-3)" "unprognostic (2.33e-1)" "unprognostic (5.27e-4)" "unprognostic (3.21e-4)" "unprognostic (2.63e-1)" "unprognostic (2.48e-1)" "unprognostic (7.18e-2)" "unprognostic (1.12e-1)" "unprognostic (1.21e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "prognostic favourable (2.81e-4)" "unprognostic (6.93e-2)" "unprognostic (8.08e-2)" "unprognostic (2.91e-1)" "unprognostic (3.97e-2)" 9.3 16.9 7.3 11.4 7.3 7.3 7.9 5.1 7.9 12.1 22.8 5.8 13.5 28.5 8.5 17.9 18.5 8.4 15.1 7.5 6.4 5.9 34.7 52.2 10.6 9.0 7.8 6.5 8.6 20.6 22.9 20.6 6.0 21.1 8.9 12.6 6.0 22.3 17.0 17.4 6.4 52.4 6.9 9.7 9.7 16.0 8.7 8.6 10.1 17.0 15.9 7.0 8.3 10.9 8.7 12.5 24.5 13.5 9.8 11.6 8.4 7.8 8.7 3.7 6.5 7.5 8.5 5.1 4.6 4.8 3.3 3.4 6.7 43.9 9.4 14.4 5.2 12.0 4.4 5.2 3.9 7.3 3.7 5.9 4.2 36.3 17.6 7.9 11.0 5.2 29.8 3.3 24.9 5.4 5.5 24.2 4.9 7.5 5.0 6.4 4.2 7.3 5.2 6.5 11.7 15.3 8.5 3.1 1.8 10.8 11.5 7.0 11.0 8.5 8.4 5.1 3.3 3.7 3.0 13.8 11.9 9.3 2.9 5.0 4.2 22.5 11.8 17.6 11.6 12.3 10.5 8.5 8.9 10.8 12.5 8.7 11.0 10.2 24.5 9.8 13.5 8.7 8.1 8.4 7.3 7.3 5.1 7.9 6.4 5.9 7.8 6.5 21.1 8.6 CTAGE6 "CTAGE6P, MGC41943" ENSG00000271321 "CTAGE family member 6" Q86UF2 7 143755089-143757696 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 40 "testis: 15.0" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;HeLa: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.51e-2)" "unprognostic (8.90e-12)" "unprognostic (1.73e-2)" "unprognostic (2.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE8 ENSG00000244693 "CTAGE family member 8" P0CG41 7 144266701-144269288 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 7.7" "Cell line enhanced" "Detected in some" "A-431: 8.9;CAPAN-2: 3.2;HaCaT: 3.1;HBEC3-KT: 3.0;RT4: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (4.80e-2)" "unprognostic (2.54e-1)" "unprognostic (1.93e-1)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (9.90e-2)" "unprognostic (1.11e-1)" "unprognostic (8.92e-3)" "unprognostic (1.56e-1)" "unprognostic (7.79e-2)" "unprognostic (1.33e-2)" "unprognostic (8.73e-2)" "unprognostic (6.23e-3)" "unprognostic (2.46e-1)" "unprognostic (2.84e-2)" 0.3 0.0 0.0 0.4 0.0 0.2 1.5 0.0 0.0 0.6 1.4 1.8 0.6 0.3 3.9 0.5 0.8 0.0 0.0 0.0 3.3 2.3 1.2 0.2 0.0 0.9 2.5 6.2 1.1 0.4 2.1 1.0 2.4 0.5 0.0 6.9 2.4 0.1 0.0 0.5 2.0 7.7 6.0 0.4 0.6 1.4 0.5 0.6 0.1 0.0 0.1 0.3 0.2 8.9 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.1 0.2 2.6 3.2 0.0 0.0 0.0 3.1 0.0 3.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.0 4.2 0.0 0.0 1.2 2.0 1.6 1.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.2 0.1 0.0 0.1 0.0 0.6 0.2 0.2 CTAGE9 ENSG00000236761 "CTAGE family member 9" A4FU28 6 131708684-131711017 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 29 "testis: 11.6" "Cell line enhanced" "Detected in single" "A-431: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (3.92e-2)" "unprognostic (6.84e-2)" "unprognostic (3.48e-2)" "unprognostic (1.92e-1)" "unprognostic (9.89e-3)" "unprognostic (2.36e-1)" "unprognostic (5.55e-2)" "unprognostic (2.34e-1)" "unprognostic (2.52e-2)" "unprognostic (5.74e-4)" "unprognostic (3.15e-2)" "unprognostic (9.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 11.6 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.2 0.2 1.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.2 CTCFL "BORIS, CT27, dJ579F20.2" ENSG00000124092 "CCCTC-binding factor like" Q8NI51 20 57495966-57525652 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.4" "Group enriched" "Detected in some" 33 "HMC-1: 32.5;K-562: 44.5" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA001472 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA001472: AB_1078583" "unprognostic (2.50e-1)" "unprognostic (4.01e-2)" "unprognostic (7.70e-2)" "unprognostic (1.85e-5)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-2)" "unprognostic (5.26e-3)" "unprognostic (3.60e-1)" "unprognostic (2.20e-1)" "unprognostic (9.00e-2)" "unprognostic (4.16e-2)" "unprognostic (4.75e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.84e-2)" 0.2 0.1 0.1 0.1 0.4 1.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.3 0.1 0.1 0.1 0.4 0.0 0.5 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.1 35.4 0.1 0.1 0.4 0.1 0.1 0.1 0.1 2.1 1.0 4.3 0.8 0.8 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 32.5 0.0 0.0 0.0 0.0 0.0 44.5 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 1.1 0.1 0.1 0.1 1.8 0.7 1.2 0.6 0.7 0.5 1.3 0.4 0.5 0.3 2.1 0.7 0.8 4.3 0.8 0.8 1.0 0.5 0.2 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 CTDNEP1 "DULLARD, HSA011916, NET56" ENSG00000175826 "CTD nuclear envelope phosphatase 1" O95476 17 7243591-7252491 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 140.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037439, HPA066466" Uncertain Approved "Lipid droplets" "Lipid droplets" "HPA037439: AB_10601264, HPA066466: " "unprognostic (7.11e-2)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "prognostic favourable (6.45e-4)" "unprognostic (3.12e-1)" "unprognostic (2.13e-1)" "unprognostic (4.61e-2)" "unprognostic (1.50e-2)" "unprognostic (2.98e-1)" "unprognostic (9.90e-2)" "prognostic favourable (1.81e-4)" "unprognostic (3.37e-1)" "unprognostic (2.77e-3)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (9.97e-2)" "unprognostic (2.02e-2)" 27.1 23.1 21.4 22.4 21.0 24.2 38.8 21.8 26.6 25.3 24.8 26.6 16.7 20.8 31.2 22.8 26.6 27.3 18.8 29.0 21.5 12.9 23.8 20.6 26.5 39.4 24.7 17.1 31.1 27.9 30.7 26.1 30.4 20.5 25.2 27.9 20.4 23.0 23.8 140.1 35.5 30.9 26.7 25.6 38.3 24.3 26.6 24.3 43.8 26.0 31.5 34.1 22.4 26.7 13.0 17.3 18.3 11.8 7.2 11.2 3.8 38.1 57.2 32.2 34.5 50.4 62.1 24.4 28.6 48.0 46.2 39.8 27.3 26.7 35.4 30.5 51.1 32.0 42.2 44.1 51.6 52.5 35.8 24.7 38.4 46.9 46.8 28.1 46.8 50.0 53.7 52.8 56.4 49.1 22.0 26.3 43.3 24.1 31.3 30.1 22.4 24.3 38.1 28.7 28.2 36.7 20.1 12.4 35.5 22.8 22.9 30.5 21.5 23.2 27.9 33.7 29.0 26.9 53.7 22.7 19.8 18.2 43.4 38.8 34.8 6.3 11.8 18.3 10.5 11.7 8.5 13.0 10.1 11.0 8.4 12.4 7.8 11.2 15.6 7.2 7.7 17.3 9.6 3.8 21.4 21.0 21.8 26.6 21.5 12.9 24.7 17.1 20.5 24.3 CTNS "CTNS-LSB, PQLC4" ENSG00000040531 "Cystinosin, lysosomal cystine transporter" O60931 17 3636468-3661542 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046947 Supported "Vesicles,Intermediate filaments" "Vesicles, Intermediate filaments" "HPA046947: " "unprognostic (1.64e-1)" "unprognostic (1.70e-1)" "unprognostic (1.21e-1)" "unprognostic (8.25e-2)" "unprognostic (8.39e-2)" "prognostic favourable (7.33e-4)" "unprognostic (1.28e-2)" "unprognostic (8.02e-2)" "unprognostic (1.94e-1)" "unprognostic (6.62e-3)" "prognostic favourable (6.39e-5)" "unprognostic (8.40e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-1)" "unprognostic (5.64e-2)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 9.6 19.0 8.5 8.2 11.9 8.3 12.1 5.0 9.9 18.8 8.2 16.1 34.8 10.8 10.3 7.2 7.3 8.3 10.6 9.3 7.7 5.9 23.9 16.4 11.4 9.1 12.1 5.6 12.6 32.7 11.3 14.5 13.2 8.5 10.2 6.4 11.4 10.5 46.2 22.6 18.0 9.2 7.9 10.2 12.2 12.9 27.0 13.0 11.7 9.0 6.5 9.0 10.1 9.1 3.5 19.6 13.7 5.6 2.5 3.3 3.7 6.1 13.8 8.1 6.9 13.2 6.7 5.1 6.0 10.1 6.9 8.7 7.7 6.1 3.7 6.4 4.0 15.8 7.1 4.1 5.3 46.0 12.5 4.2 10.4 6.2 17.8 2.8 28.8 8.3 5.2 7.3 5.9 7.6 4.3 5.8 6.5 5.6 2.8 2.7 3.6 6.1 6.2 3.3 8.7 6.2 6.3 1.6 5.9 7.0 9.4 7.0 6.6 2.8 8.9 6.8 4.3 15.4 4.9 4.7 6.0 1.7 10.5 3.0 4.6 13.7 5.6 12.1 1.9 3.7 2.7 3.5 2.3 3.3 5.4 3.1 2.9 3.1 2.0 2.5 3.8 19.6 2.6 3.7 8.5 11.9 5.0 9.9 7.7 5.9 12.1 5.6 8.5 13.0 CTSK "CTSO, CTSO2, PKND, PYCD" ENSG00000143387 "Cathepsin K" P43235 1 150796208-150808323 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 104.1" "Group enriched" "Detected in some" 8 "ASC diff: 200.2;ASC TERT1: 73.3;BJ hTERT+: 161.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 6.7" "Lineage enriched" "Detected in many" 6 "monocytes: 6.7" "Low region specificity" "Detected in all" HPA050346 Supported Vesicles "Intracellular and membrane" Vesicles "HPA050346: " "unprognostic (1.48e-1)" "unprognostic (9.29e-2)" "unprognostic (1.21e-1)" "unprognostic (7.61e-3)" "unprognostic (5.08e-2)" "unprognostic (6.57e-2)" "unprognostic (1.02e-1)" "unprognostic (6.60e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.49e-1)" "unprognostic (3.54e-2)" "prognostic unfavourable (7.12e-5)" "unprognostic (6.07e-3)" "unprognostic (2.98e-2)" "unprognostic (5.93e-3)" "unprognostic (6.41e-2)" 104.1 2.4 1.2 6.5 1.6 1.3 79.3 2.4 2.3 70.6 23.6 2.2 10.1 2.7 72.5 25.9 26.5 12.5 53.4 14.7 1.1 1.1 3.4 1.8 8.7 10.4 1.1 1.7 25.4 2.9 0.3 3.0 30.6 2.6 24.2 11.5 56.0 10.9 6.8 19.9 44.0 11.0 26.9 2.0 5.6 8.6 24.1 0.9 1.1 7.1 13.2 10.7 38.0 48.2 0.1 1.0 1.0 6.7 0.5 1.2 1.8 0.1 0.1 0.3 0.3 200.2 73.3 0.2 5.7 161.8 0.4 0.8 0.0 0.1 0.1 0.2 11.1 0.2 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.0 1.0 0.1 0.4 14.6 0.5 4.5 0.1 0.6 0.0 0.5 0.4 0.3 0.0 0.7 1.1 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.6 0.3 0.0 3.0 0.2 0.2 0.4 0.2 0.1 0.2 0.2 0.6 0.5 1.1 17.0 0.0 0.9 0.0 6.7 1.0 0.7 3.4 0.2 0.0 0.6 0.2 0.4 0.1 0.3 0.5 0.6 0.5 2.0 1.0 1.2 1.8 1.2 1.6 2.4 2.3 1.1 1.1 1.1 1.7 2.6 0.9 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924485-7926166 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 91.1" "Cell line enhanced" "Detected in many" "AN3-CA: 33.2;HEK 293: 23.1;NTERA-2: 25.2;REH: 19.1;SCLC-21H: 19.6;SH-SY5Y: 32.9" "Cancer enhanced" "Detected in all" "ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 2.1 4.8 47.7 2.5 91.1 1.6 2.1 0.0 74.2 5.2 6.1 5.0 3.6 2.6 17.5 5.1 2.4 16.4 1.8 1.6 49.4 16.8 3.1 1.5 3.0 1.6 15.7 20.1 2.7 2.1 2.3 6.5 2.0 4.0 5.5 2.1 0.0 2.1 16.5 1.6 2.8 2.1 7.1 1.5 2.0 2.2 6.1 8.3 0.0 1.8 0.0 1.6 2.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 2.7 7.1 33.2 0.0 0.1 1.6 2.9 0.8 1.4 0.8 0.8 1.7 0.0 5.6 0.7 12.1 1.6 0.3 0.0 1.0 23.1 0.2 1.9 0.5 0.3 0.5 0.6 0.0 0.9 0.5 0.3 1.8 7.0 0.1 0.1 13.4 6.1 4.5 25.2 11.7 19.1 0.0 2.1 5.1 0.5 19.6 32.9 1.7 0.9 3.0 7.3 0.2 2.8 0.7 11.7 1.3 1.6 0.2 0.3 1.5 2.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 91.1 0.0 63.8 49.4 16.8 15.7 20.1 4.0 8.3 CTXN2 ENSG00000233932 "Cortexin 2" P0C2S0 15 48178122-48203756 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "brain: 11.3;pituitary gland: 5.7;testis: 4.9" "Cell line enhanced" "Detected in single" "SCLC-21H: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053168 Uncertain "HPA053168: " "unprognostic (1.90e-1)" "unprognostic (3.85e-3)" "unprognostic (7.43e-2)" "unprognostic (2.18e-4)" "unprognostic (6.81e-3)" "unprognostic (1.72e-1)" "unprognostic (2.80e-1)" "unprognostic (4.61e-2)" 0.5 1.2 6.4 0.7 6.7 0.5 0.6 8.4 9.0 0.5 0.8 0.0 0.0 0.7 0.5 0.6 0.6 1.3 0.7 0.5 4.0 11.3 0.9 0.5 0.6 0.6 7.3 2.9 0.5 1.4 0.6 5.7 0.5 8.8 0.6 0.9 0.0 0.5 0.6 0.6 0.5 1.1 0.6 1.9 0.5 0.6 4.9 1.2 0.0 0.6 0.0 0.6 0.5 0.0 0.0 0.1 0.3 1.5 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 3.6 0.9 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 0.1 0.0 0.0 6.4 6.7 8.4 9.0 4.0 11.3 7.3 2.9 8.8 1.2 CUX1 "CASP, CDP, CDP/Cut, CDP/Cux, CDP1, Clox, CUT, CUTL1, CUX, Cux/CDP, GOLIM6" ENSG00000257923 "Cut like homeobox 1" "Q13948, P39880" 7 101815904-102283958 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Transport" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 21.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003277, HPA003317" Approved Supported "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA003277: AB_10601804, HPA003317: " "unprognostic (5.86e-2)" "unprognostic (5.39e-3)" "unprognostic (9.62e-3)" "unprognostic (1.73e-1)" "prognostic unfavourable (7.51e-4)" "unprognostic (5.85e-2)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (2.89e-3)" "unprognostic (2.20e-1)" "unprognostic (2.50e-1)" "prognostic favourable (5.72e-7)" "unprognostic (1.12e-1)" "unprognostic (8.85e-2)" "unprognostic (1.97e-2)" "unprognostic (2.97e-1)" 19.3 12.7 22.9 19.2 24.4 19.5 12.3 48.6 29.9 31.6 26.4 23.1 17.3 22.2 52.1 17.4 23.9 24.5 23.2 53.8 18.8 18.3 27.4 16.0 22.0 11.8 20.4 11.7 33.0 41.4 34.4 30.2 24.4 16.9 22.8 17.2 26.8 26.3 16.9 31.0 15.9 25.3 27.5 31.6 15.0 23.4 8.3 17.1 44.0 33.5 23.2 24.1 31.8 21.9 2.0 12.1 4.7 21.0 3.0 2.2 4.5 14.3 15.4 10.9 13.4 8.8 18.3 6.8 14.4 15.3 6.1 4.0 9.1 9.2 18.5 23.2 14.2 11.8 6.9 11.6 3.7 8.9 7.7 6.5 11.4 7.6 23.5 8.4 3.6 12.7 23.7 4.7 10.7 7.9 15.1 15.8 5.7 29.5 27.3 10.3 4.4 16.1 18.1 9.0 22.0 10.1 16.4 10.0 29.8 12.6 31.6 12.3 6.2 10.1 11.7 25.9 17.5 19.5 8.2 10.3 4.9 40.1 23.9 7.8 18.0 2.1 8.6 1.5 2.1 8.8 2.2 2.0 1.6 2.2 7.0 1.7 1.6 2.2 4.7 3.0 21.0 12.1 1.5 4.5 22.9 24.4 48.6 29.9 18.8 18.3 20.4 11.7 16.9 17.1 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832149-122850793 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 200 "pancreas: 650.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 7.1;LHCN-M2: 7.9" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 6 "B-cells: 1.1;T-cells: 3.2" "Low region specificity" "Detected in single" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: " "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 650.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.2 0.0 3.2 0.2 1.6 1.6 1.7 0.0 0.4 0.8 1.0 2.5 0.7 0.3 1.7 1.8 3.6 0.9 0.7 1.0 1.7 0.0 1.5 2.6 2.2 2.2 3.5 4.6 0.8 0.3 0.0 3.7 1.1 0.3 1.5 7.1 1.7 1.3 1.5 7.9 0.4 1.9 2.7 1.7 1.3 0.0 4.0 0.6 1.3 1.3 1.8 0.7 0.8 0.4 1.1 1.3 1.9 3.5 0.0 2.4 0.9 0.0 1.9 1.4 3.1 1.2 5.8 0.0 0.0 0.1 0.3 0.8 0.1 1.3 0.6 0.9 1.1 0.1 1.1 1.4 0.7 0.0 0.0 0.2 0.2 3.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CX3CL1 "ABCD-3, C3Xkine, CXC3, CXC3C, fractalkine, neurotactin, NTN, SCYD1" ENSG00000006210 "C-X3-C motif chemokine ligand 1" P78423 16 57372458-57385048 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Chemotaxis" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "EFO-21: 13.4;HDLM-2: 36.5;Hep G2: 27.2;RPTEC TERT1: 16.2;SK-BR-3: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026192, HPA040361" Approved Supported "Plasma membrane" "Secreted to blood" 1867500 "Plasma membrane" "CAB026192: , HPA040361: AB_10796453" "unprognostic (6.89e-3)" "prognostic favourable (9.46e-4)" "unprognostic (1.52e-2)" "unprognostic (3.20e-2)" "unprognostic (1.73e-1)" "unprognostic (1.82e-1)" "unprognostic (7.12e-2)" "unprognostic (2.08e-3)" "unprognostic (4.49e-2)" "unprognostic (3.70e-1)" "unprognostic (2.59e-2)" "unprognostic (2.06e-2)" "prognostic favourable (8.52e-7)" "unprognostic (5.19e-2)" "unprognostic (2.72e-1)" "unprognostic (1.11e-2)" "unprognostic (9.33e-2)" 24.3 3.6 13.4 4.7 26.6 0.7 42.5 3.8 45.1 12.4 5.9 6.9 8.7 4.2 12.1 7.0 10.7 11.7 14.9 12.0 16.4 13.8 14.5 11.2 35.3 6.0 9.2 18.0 5.2 9.6 3.8 4.5 3.4 11.7 22.3 4.5 12.2 39.9 34.4 9.2 9.9 5.0 21.7 6.6 1.5 5.0 3.8 3.9 0.8 12.0 5.7 4.9 19.7 6.7 1.0 0.8 2.1 0.7 0.8 0.6 0.2 0.0 0.3 3.5 3.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 13.4 0.0 0.1 0.0 0.0 0.0 36.5 0.2 0.0 0.0 27.2 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.5 0.0 16.2 0.0 0.1 3.1 0.0 9.5 0.8 0.0 0.1 0.0 0.1 2.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.7 0.5 0.6 0.4 0.3 0.6 0.4 0.3 0.2 1.0 0.4 0.6 2.1 0.8 0.4 0.8 0.2 0.2 13.4 26.6 3.8 37.3 16.4 13.8 9.2 18.0 11.7 3.9 CXADR CAR ENSG00000154639 "CXADR, Ig-like cell adhesion molecule" P78310 21 17512382-17593579 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.4" "Cell line enhanced" "Detected in many" "CACO-2: 31.7;Hep G2: 20.5;NTERA-2: 36.7;RT4: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA003342, CAB005103, HPA030411, HPA030412" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Intracellular and membrane" 11000 "Plasma membrane, Cell Junctions" "CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992" "unprognostic (3.75e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favourable (3.50e-4)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (1.94e-1)" "unprognostic (2.15e-1)" "unprognostic (3.48e-3)" "unprognostic (1.04e-1)" "unprognostic (9.35e-2)" "unprognostic (3.89e-3)" "unprognostic (2.20e-1)" "unprognostic (8.27e-2)" "unprognostic (5.71e-3)" 4.0 3.1 6.4 3.2 9.4 1.3 5.8 2.0 15.4 6.3 27.1 12.5 9.0 24.9 3.3 9.3 15.0 6.5 17.2 10.8 7.9 5.5 5.1 28.6 9.9 4.2 9.2 5.6 1.1 12.0 5.2 11.1 0.3 11.6 9.2 15.4 3.7 16.3 15.8 0.6 30.0 41.4 2.1 13.0 1.4 17.6 8.5 6.9 0.9 13.1 4.9 3.8 14.7 10.0 0.8 0.4 2.6 0.5 0.9 2.7 0.9 5.5 3.1 15.2 0.0 0.0 0.0 9.2 0.0 0.0 0.2 0.9 31.7 4.9 2.0 6.8 0.0 9.6 7.6 2.0 0.3 3.1 6.5 0.0 9.1 20.5 0.9 0.6 0.0 0.0 8.3 0.4 0.1 3.0 0.1 0.1 0.0 0.3 1.2 0.0 36.7 0.0 0.0 5.1 3.9 12.7 35.4 6.1 4.1 3.6 4.1 2.1 8.4 0.1 0.1 0.0 9.1 0.1 2.2 1.5 2.5 0.1 1.2 0.0 0.2 2.6 0.5 0.4 0.5 0.2 1.0 0.3 2.6 0.6 0.1 0.8 2.7 0.8 1.4 0.9 0.2 0.4 0.5 0.9 6.4 9.4 2.0 15.4 7.9 5.5 9.2 5.6 11.6 6.9 CXCL16 "CXCLG16, SR-PSOX, SRPSOX" ENSG00000161921 "C-X-C motif chemokine ligand 16" Q9H2A7 17 4733526-4739922 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 34.3;CACO-2: 23.6;CAPAN-2: 18.7;HaCaT: 38.5;T-47d: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 18.3;intermediate monocyte: 29.3;myeloid DC: 10.7;neutrophil: 25.9;non-classical monocyte: 37.7" "Group enriched" "Detected in many" 7 "dendritic cells: 10.7;granulocytes: 25.9;monocytes: 37.7" "HPA053253, HPA066315" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" 1103333 4000000 "Golgi apparatus" Vesicles "HPA053253: , HPA066315: " "unprognostic (4.64e-3)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (3.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (4.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.78e-2)" "unprognostic (4.74e-2)" "unprognostic (2.37e-2)" "unprognostic (2.48e-2)" "unprognostic (2.60e-1)" 32.5 9.5 8.2 18.7 9.7 16.3 9.7 2.0 6.6 8.0 17.2 15.8 3.4 19.1 4.8 10.5 13.1 9.5 23.0 5.2 9.9 6.9 12.5 34.8 41.9 28.8 13.3 5.1 10.6 11.0 34.6 8.6 9.7 10.0 9.8 8.3 12.7 26.6 5.9 3.3 11.3 29.5 5.2 16.5 34.1 18.7 51.9 10.0 4.5 8.1 8.5 10.1 9.7 7.4 3.4 10.7 25.9 37.7 0.0 0.3 6.9 34.3 4.7 0.0 11.1 0.1 0.9 4.4 0.4 3.3 3.3 4.5 23.6 18.7 0.0 4.2 0.2 38.5 5.5 4.0 1.1 3.5 6.3 0.0 0.5 10.4 2.3 0.0 5.1 0.2 6.6 1.7 0.2 0.9 0.0 0.2 0.2 7.2 0.1 0.6 0.0 2.9 0.4 0.0 5.1 7.0 5.7 0.0 0.3 7.0 2.8 1.8 18.5 0.4 0.1 0.5 2.5 0.8 2.0 1.2 1.5 0.0 0.1 0.1 0.8 0.0 18.3 4.0 0.1 29.3 0.1 2.9 0.3 0.2 10.7 3.4 0.1 0.3 25.9 0.0 37.7 4.6 0.0 6.9 8.2 9.7 2.0 6.6 9.9 6.9 13.3 5.1 10.0 10.0 CYB561 "CYB561A1, FRRS2" ENSG00000008283 "Cytochrome b561" P49447 17 63432304-63446378 "Predicted membrane proteins, Transporters" "Electron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 86.9" "Cell line enhanced" "Detected in many" "SH-SY5Y: 89.0;SK-BR-3: 42.6;T-47d: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014753 Approved "HPA014753: AB_1847364" "prognostic unfavourable (8.89e-5)" "unprognostic (2.90e-1)" "unprognostic (4.01e-1)" "prognostic favourable (2.95e-5)" "unprognostic (1.81e-3)" "unprognostic (3.82e-1)" "unprognostic (1.37e-2)" "unprognostic (8.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.91e-2)" "unprognostic (8.97e-2)" "unprognostic (6.38e-2)" "unprognostic (8.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.89e-1)" 4.7 46.3 7.0 5.6 12.4 1.0 16.6 2.4 12.3 16.6 11.8 3.7 43.7 12.4 5.2 20.9 16.8 19.8 13.2 9.9 7.1 14.5 10.1 12.0 14.6 9.1 4.7 7.8 8.8 86.9 21.8 26.3 12.2 9.9 22.8 7.3 6.2 26.0 32.0 2.7 11.9 13.7 3.4 3.7 2.8 16.9 4.7 1.8 1.2 17.1 8.3 8.3 5.3 8.6 0.4 1.2 3.4 4.4 12.6 16.2 3.1 19.2 6.5 0.5 4.1 2.4 11.1 8.8 1.8 2.4 2.5 1.0 5.9 19.5 0.0 4.5 15.0 16.8 4.1 1.6 1.0 4.9 1.6 2.4 4.1 0.3 4.5 0.2 0.8 1.8 17.1 2.3 0.3 4.8 7.6 3.6 0.8 27.5 0.0 0.9 4.1 9.7 0.0 0.0 6.0 8.1 9.9 15.1 89.0 5.0 42.6 1.9 34.4 1.2 0.7 5.4 5.9 12.5 0.6 0.0 0.1 0.0 4.7 1.0 2.8 0.1 1.1 0.1 12.6 3.4 16.2 0.4 9.6 8.5 1.2 0.4 0.8 2.8 3.4 12.6 4.4 0.0 0.0 3.1 7.0 12.4 2.4 12.3 7.1 14.5 4.7 7.8 9.9 1.8 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348745-61362299 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.7;blood: 98.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8" "Group enriched" "Detected in all" 10 "B-cells: 50.1;dendritic cells: 98.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol "Nucleoli, Vesicles" "Nucleoplasm, Cytosol" "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 10.0 113.7 4.0 22.5 6.4 7.1 7.5 4.7 6.9 6.6 10.9 10.9 14.4 6.1 10.9 9.9 8.8 11.0 11.0 5.7 5.1 4.1 9.7 30.6 12.4 21.7 8.3 3.5 14.5 17.9 9.0 6.6 21.0 6.8 9.2 9.6 10.7 10.9 8.1 10.2 24.8 15.8 7.6 5.6 24.0 8.5 8.0 7.0 16.8 10.0 8.4 33.3 10.7 7.3 50.1 98.8 3.8 7.4 3.3 3.8 8.7 18.0 30.5 4.9 14.1 23.2 15.4 4.1 9.1 13.9 11.0 11.0 8.3 20.2 35.2 16.4 16.0 25.3 4.6 25.4 6.7 23.5 10.4 6.0 20.6 5.6 10.9 8.3 15.8 21.6 35.9 23.9 11.0 16.3 19.8 21.1 18.5 19.4 15.7 3.6 9.1 17.5 19.0 4.7 26.3 12.7 17.9 6.0 10.0 18.6 26.9 21.0 21.8 9.7 10.9 13.0 6.7 12.6 13.1 13.2 17.4 19.7 17.8 14.6 16.3 1.6 7.4 3.8 3.8 6.0 3.4 40.5 2.7 3.4 7.4 50.1 2.8 3.0 2.5 3.3 6.4 98.8 2.6 8.7 4.0 6.4 4.7 6.9 5.1 4.1 8.3 3.5 6.8 7.0 CYB561D1 "FLJ39035, FLJ44753" ENSG00000174151 "Cytochrome b561 family member D1" Q8N8Q1 1 109494052-109502932 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027028 Uncertain "HPA027028: AB_1847365" "unprognostic (2.15e-2)" "unprognostic (3.49e-1)" "unprognostic (1.04e-2)" "unprognostic (1.98e-1)" "unprognostic (2.27e-1)" "prognostic favourable (4.68e-4)" "unprognostic (4.53e-4)" "unprognostic (1.32e-1)" "unprognostic (3.45e-1)" "unprognostic (5.29e-2)" "prognostic favourable (5.16e-6)" "unprognostic (4.30e-1)" "prognostic favourable (2.22e-4)" "unprognostic (1.20e-3)" "unprognostic (2.75e-1)" "unprognostic (4.95e-3)" "unprognostic (5.82e-2)" 6.1 10.5 8.7 10.7 12.0 9.1 7.0 21.7 13.4 4.2 8.4 7.9 13.4 7.1 6.9 14.8 9.3 7.0 6.7 4.6 9.6 5.6 8.2 4.2 7.4 12.8 9.7 10.2 9.4 19.4 11.1 11.2 7.0 8.8 6.8 7.7 4.6 10.8 8.4 7.8 22.5 12.2 6.8 7.8 12.1 9.0 3.9 11.1 10.6 10.3 6.6 12.8 7.0 12.2 4.5 3.0 10.8 4.5 8.7 8.3 3.5 8.2 4.8 3.6 4.2 12.3 9.1 9.1 7.2 5.6 8.2 5.9 4.8 3.7 7.4 7.7 9.2 9.5 4.7 5.9 5.4 6.1 4.3 5.0 6.7 3.7 5.8 10.1 15.6 9.7 14.7 8.1 4.3 5.9 3.1 3.4 5.3 10.4 3.6 5.4 1.7 7.5 6.0 14.5 2.9 7.6 14.0 5.3 4.6 8.1 8.0 7.5 5.5 5.5 7.6 8.2 9.7 11.1 5.8 4.0 2.8 3.7 8.3 8.4 9.0 3.8 3.8 5.6 6.3 4.2 5.5 3.5 6.6 5.6 2.7 4.5 8.3 5.8 10.8 8.7 4.5 3.0 4.7 3.5 8.7 12.0 21.7 13.4 9.6 5.6 9.7 10.2 8.8 11.1 CYB5A CYB5 ENSG00000166347 "Cytochrome b5 type A" P00167 18 74250847-74292016 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 266.8" "Cell line enhanced" "Detected in many" "ASC diff: 151.3;RT4: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006333, HPA047548, HPA058547" Enhanced Enhanced Vesicles,Cytosol 780000 "Vesicles, Cytosol" "CAB006333: , HPA047548: , HPA058547: " "unprognostic (1.88e-1)" "unprognostic (1.28e-1)" "prognostic favourable (5.23e-4)" "unprognostic (1.08e-2)" "unprognostic (1.41e-1)" "unprognostic (9.14e-2)" "prognostic favourable (4.15e-4)" "unprognostic (7.79e-3)" "unprognostic (1.11e-1)" "unprognostic (3.33e-2)" "unprognostic (2.68e-2)" "unprognostic (1.65e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (4.64e-2)" "unprognostic (8.54e-2)" 25.0 13.2 4.3 11.0 5.8 1.5 39.4 6.9 5.9 7.5 68.2 4.3 38.5 37.7 4.9 16.0 8.3 7.0 34.8 14.5 4.1 3.7 76.2 266.8 67.0 9.2 6.5 3.4 25.1 75.3 10.1 6.5 7.2 5.2 13.5 9.0 6.2 7.6 54.9 4.3 11.4 70.7 21.2 11.5 10.3 18.0 12.2 5.5 4.6 4.6 7.9 4.3 21.6 18.8 34.9 16.9 2.1 12.9 10.2 38.0 13.5 9.8 16.8 8.8 0.0 151.3 26.9 11.7 6.8 14.7 14.5 21.8 19.8 10.7 12.0 4.8 12.4 22.0 0.0 9.3 11.6 22.4 11.7 4.4 9.2 52.5 23.5 8.4 5.8 45.0 7.4 8.2 4.2 7.9 7.1 4.5 12.1 17.7 4.7 10.0 3.9 10.9 11.7 2.8 0.2 14.4 66.0 25.1 10.4 6.6 18.0 8.0 35.6 8.0 7.4 0.0 11.4 3.5 8.6 3.2 13.0 3.7 8.9 2.3 8.4 1.1 9.6 2.1 16.7 10.8 38.0 28.5 18.7 19.6 16.9 34.9 18.4 23.1 1.1 10.2 12.9 14.8 14.4 13.5 4.3 5.8 6.9 5.9 4.1 3.7 6.5 3.4 5.2 5.5 CYB5B CYB5-M ENSG00000103018 "Cytochrome b5 type B" O43169 16 69424525-69466266 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 130.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007893 Approved Approved "Endoplasmic reticulum,Centriolar satellite,Cytosol" 1600000 "Endoplasmic reticulum" "Centriolar satellite, Cytosol" "HPA007893: AB_1847369" "unprognostic (1.13e-1)" "unprognostic (4.47e-2)" "unprognostic (9.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.72e-1)" "prognostic unfavourable (2.51e-4)" "unprognostic (2.87e-3)" "unprognostic (4.35e-3)" "unprognostic (3.87e-1)" "unprognostic (1.44e-2)" "unprognostic (1.52e-2)" "unprognostic (3.10e-1)" "prognostic favourable (6.38e-5)" "unprognostic (9.69e-3)" "unprognostic (4.66e-2)" "unprognostic (3.78e-2)" "unprognostic (1.30e-2)" 21.3 130.7 29.6 15.4 33.1 5.9 17.1 12.0 37.9 16.6 29.0 22.8 12.6 21.9 20.5 24.6 21.4 19.2 14.7 18.0 23.1 22.0 26.9 26.5 18.3 20.1 21.6 24.4 19.9 12.8 26.3 16.2 24.6 34.3 17.1 38.2 20.2 14.8 16.7 19.9 16.0 31.2 19.9 20.8 20.7 15.4 14.0 16.0 26.0 19.9 17.6 23.5 24.3 16.0 24.8 44.2 35.8 28.3 32.3 46.0 32.4 29.0 92.5 38.1 23.5 17.6 23.6 16.3 26.0 36.3 43.7 41.3 64.5 35.7 26.5 26.3 25.2 34.6 36.3 37.7 49.7 14.1 13.8 12.8 16.7 75.1 26.0 26.2 28.4 20.2 19.1 51.8 24.8 41.2 20.6 12.8 26.7 37.8 43.0 32.0 28.2 12.7 40.8 21.1 29.1 58.3 33.3 22.3 11.4 69.4 13.3 22.0 25.8 21.1 18.5 25.2 20.8 16.7 22.9 15.6 34.4 81.3 26.0 21.9 29.1 35.8 20.3 24.3 39.3 28.3 32.2 24.8 29.6 30.8 24.8 22.6 24.6 29.2 6.1 32.3 20.1 44.2 46.0 32.4 29.6 33.1 12.0 37.9 23.1 22.0 21.6 24.4 34.3 16.0 CYB5R2 ENSG00000166394 "Cytochrome b5 reductase 2" Q6BCY4 11 7665100-7677222 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 58.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 41.6;BJ hTERT+ SV40 Large T+: 22.3;BJ hTERT+ SV40 Large T+ RasG12V: 20.2;HBF TERT88: 17.8;NTERA-2: 23.4;WM-115: 32.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 5.9;memory B-cell: 12.2" "Group enriched" "Detected in many" 9 "B-cells: 12.2;granulocytes: 5.9" "Low region specificity" "Detected in many" "HPA038962, HPA061707" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038962: AB_10675954, HPA061707: " "unprognostic (1.47e-1)" "unprognostic (2.56e-2)" "unprognostic (8.90e-3)" "unprognostic (4.41e-2)" "unprognostic (4.13e-3)" "unprognostic (1.60e-2)" "unprognostic (4.02e-2)" "unprognostic (2.48e-1)" "unprognostic (3.41e-2)" "unprognostic (1.30e-2)" "unprognostic (2.64e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.40e-1)" "unprognostic (8.16e-2)" "unprognostic (1.70e-1)" "unprognostic (7.01e-2)" 3.3 1.9 9.3 2.8 12.1 1.9 7.7 3.1 12.3 6.6 2.3 26.1 4.2 1.3 10.0 13.1 8.0 5.2 3.4 2.0 11.2 5.3 2.4 2.5 4.6 3.8 22.3 7.3 14.9 2.2 23.1 0.6 6.7 11.6 7.8 2.7 12.2 12.8 11.6 0.8 23.4 1.7 6.8 12.4 2.0 2.2 58.8 14.5 0.2 2.6 6.7 4.9 5.9 7.1 12.2 0.0 5.9 1.0 0.0 0.2 0.7 2.2 1.1 0.5 0.0 0.1 0.6 7.7 14.5 41.6 22.3 20.2 0.2 3.1 0.0 3.5 7.4 0.2 0.0 0.1 17.8 0.0 0.0 0.0 1.2 0.3 12.1 0.1 2.2 6.1 0.4 0.0 1.2 1.8 2.2 0.0 0.1 0.0 0.0 0.0 23.4 1.1 11.0 0.0 0.0 0.0 1.5 0.0 0.2 0.1 9.3 0.6 1.6 3.0 0.0 2.1 0.0 0.1 1.1 0.0 0.0 3.4 0.1 0.0 32.0 0.0 1.0 5.9 0.0 0.5 0.0 12.2 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.7 9.3 12.1 3.1 12.3 11.2 5.3 22.3 7.3 11.6 14.5 CYB5R3 DIA1 ENSG00000100243 "Cytochrome b5 reductase 3" P00387 22 42617840-42649568 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 115.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001566 Approved Supported "Endoplasmic reticulum" 67000000 "Endoplasmic reticulum" "HPA001566: AB_1078601" "unprognostic (4.73e-2)" "unprognostic (2.93e-1)" "unprognostic (1.79e-1)" "unprognostic (1.89e-1)" "unprognostic (3.05e-1)" "unprognostic (1.04e-2)" "prognostic unfavourable (2.13e-5)" "unprognostic (2.45e-1)" "unprognostic (8.22e-3)" "unprognostic (3.01e-1)" "unprognostic (2.72e-2)" "unprognostic (6.76e-2)" "unprognostic (3.33e-3)" "unprognostic (1.31e-1)" "unprognostic (1.64e-1)" "unprognostic (1.92e-1)" "unprognostic (5.24e-2)" 79.7 57.1 33.2 22.8 32.6 19.3 86.8 19.5 33.1 52.4 31.9 37.6 51.8 25.9 51.9 35.0 39.1 39.3 38.6 86.4 31.3 24.1 43.3 78.2 43.5 30.3 31.8 25.4 58.8 21.9 15.1 27.2 32.1 33.9 40.6 21.3 37.9 29.3 96.4 34.4 43.1 32.5 55.5 36.3 20.2 33.7 44.0 25.9 14.1 30.1 28.4 23.2 43.4 53.5 28.6 37.6 70.3 39.7 14.2 22.3 19.7 16.2 10.4 17.2 10.5 115.5 91.8 10.1 47.8 44.4 35.7 31.9 13.6 12.8 7.7 21.4 88.4 15.0 11.4 23.7 18.4 8.3 25.6 10.9 18.0 26.2 29.4 15.2 20.4 55.3 18.8 25.7 17.1 29.5 9.4 40.0 48.5 17.9 14.9 14.0 6.8 19.2 11.0 20.9 17.0 27.5 11.9 7.6 9.9 15.8 15.3 17.4 12.2 14.7 45.2 38.8 24.2 26.1 18.0 10.6 11.5 9.4 45.2 8.9 31.9 26.3 25.7 70.3 19.7 32.4 19.9 28.6 19.1 21.6 37.6 26.4 13.6 14.3 13.4 14.2 39.7 34.3 22.3 19.7 33.2 32.6 19.5 33.1 31.3 24.1 31.8 25.4 33.9 25.9 CYP19A1 "ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM" ENSG00000137869 "Cytochrome P450 family 19 subfamily A member 1" P11511 15 51208057-51338610 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 49 "placenta: 440.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 44.8;HDLM-2: 7.8;HSkMC: 15.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 8 "basal ganglia: 5.9" "Cell type enriched" "Detected in single" 17 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000355, HPA051194" Enhanced Approved Mitochondria Mitochondria "CAB000355: , HPA051194: " "unprognostic (9.41e-2)" "unprognostic (7.44e-2)" "unprognostic (9.52e-5)" "unprognostic (6.81e-2)" "unprognostic (2.72e-1)" "unprognostic (4.25e-4)" "unprognostic (5.18e-5)" "unprognostic (1.54e-3)" "unprognostic (2.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.97e-1)" "unprognostic (5.37e-2)" "unprognostic (1.54e-5)" "unprognostic (2.52e-3)" "unprognostic (2.11e-1)" "unprognostic (1.40e-2)" "unprognostic (1.11e-1)" 9.0 4.6 0.2 0.2 5.9 0.1 2.1 0.2 0.3 0.9 0.3 0.3 0.2 0.4 0.2 0.3 0.3 0.2 0.3 1.3 0.2 0.7 0.3 0.2 0.6 0.2 0.2 0.2 4.4 0.6 0.1 0.2 440.1 0.2 0.5 0.1 0.2 0.9 1.4 0.8 2.3 0.2 0.7 0.5 0.5 0.1 3.0 0.2 0.3 3.0 0.2 0.2 1.2 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 44.8 2.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 7.8 0.0 0.3 0.1 3.7 0.2 0.0 0.0 15.0 0.0 0.1 1.8 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.4 0.6 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 5.9 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.2 CYP1A1 "CP11, CYP1, P1-450, P450-C, P450DX" ENSG00000140465 "Cytochrome P450 family 1 subfamily A member 1" P04798 15 74719542-74725610 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Lyase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "liver: 38.3;lung: 144.1;urinary bladder: 40.0" "Cell line enhanced" "Detected in some" "CACO-2: 24.0;hTCEpi: 13.1;HUVEC TERT2: 12.6;SK-BR-3: 9.8" "Group enriched" "Detected in some" 24 "liver cancer: 18.6;urothelial cancer: 54.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB018654 Uncertain "CAB018654: AB_2088699" "unprognostic (1.71e-2)" "unprognostic (7.86e-2)" "unprognostic (2.57e-2)" "unprognostic (2.89e-1)" "unprognostic (5.45e-3)" "unprognostic (6.34e-2)" "unprognostic (3.08e-1)" "unprognostic (6.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (4.21e-2)" "unprognostic (6.70e-2)" "unprognostic (2.20e-1)" "unprognostic (4.77e-1)" "unprognostic (1.28e-1)" 9.3 0.4 0.1 0.4 0.2 0.2 7.7 0.2 0.5 2.3 0.7 0.4 3.9 0.5 3.8 4.4 1.2 0.2 11.3 3.0 0.1 0.0 0.7 38.3 144.1 0.2 0.1 0.1 0.5 0.5 0.2 0.1 3.5 0.3 0.2 0.2 0.8 2.1 0.5 1.5 8.1 10.7 5.9 0.2 0.2 0.4 0.3 0.1 0.1 0.8 0.8 8.0 40.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.4 0.1 0.0 0.3 0.0 7.8 0.0 0.1 0.4 0.2 24.0 1.0 0.2 6.5 0.0 7.5 0.5 4.8 0.2 0.0 0.7 0.3 1.7 3.5 0.1 0.2 7.7 0.0 13.1 0.2 1.0 12.6 1.4 0.2 0.0 0.5 0.0 0.2 0.1 1.9 0.7 0.0 0.3 0.0 1.6 0.4 0.2 1.1 9.8 2.5 0.3 0.1 0.6 1.1 0.3 3.5 0.0 0.5 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.2 0.3 0.1 0.0 0.1 0.1 0.3 0.1 CYP1B1 "CP1B, GLC3A" ENSG00000138061 "Cytochrome P450 family 1 subfamily B member 1" Q16678 2 38066973-38109902 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Disease mutation, Glaucoma, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.0;lung: 39.2" "Cell line enhanced" "Detected in many" "ASC diff: 24.2;ASC TERT1: 25.9;HSkMC: 103.9;SiHa: 48.4;U-87 MG: 26.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "classical monocyte: 45.0" "Lineage enriched" "Detected in many" 22 "monocytes: 45.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB011705, HPA026863" Approved Uncertain Mitochondria Mitochondria "CAB011705: AB_731810, HPA026863: AB_10600900" "unprognostic (7.25e-3)" "unprognostic (2.28e-1)" "unprognostic (1.24e-3)" "unprognostic (2.27e-1)" "unprognostic (2.04e-2)" "unprognostic (1.68e-1)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (9.69e-2)" "unprognostic (4.20e-1)" "unprognostic (1.84e-1)" "prognostic unfavourable (4.39e-6)" "unprognostic (1.87e-3)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "prognostic unfavourable (2.76e-4)" 9.1 3.1 0.5 9.4 1.2 0.0 11.4 1.0 1.2 11.4 2.1 0.7 4.5 0.0 12.8 5.9 3.5 15.0 6.9 17.5 1.2 8.8 3.5 39.2 26.3 3.1 1.0 6.1 3.6 0.0 1.3 0.8 3.3 10.7 0.0 19.3 0.0 13.0 4.8 0.5 1.4 10.6 5.1 15.7 0.3 3.9 0.5 5.1 2.5 1.1 4.2 6.9 2.1 0.0 0.4 2.0 45.0 0.0 0.0 16.2 1.2 13.0 0.4 0.0 24.2 25.9 0.0 0.1 0.8 0.2 2.3 0.0 5.4 0.0 3.5 3.2 10.6 0.0 0.7 0.4 0.9 0.7 0.0 3.9 0.0 6.6 0.0 0.0 103.9 10.1 5.6 0.2 0.0 0.1 0.0 0.1 5.1 0.0 3.9 1.4 2.5 0.0 0.0 0.0 2.4 0.1 0.1 0.4 48.4 7.0 0.0 9.0 1.9 0.0 0.1 0.0 19.8 0.0 0.0 0.0 0.0 26.4 0.0 2.1 0.4 45.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.0 5.5 0.2 0.0 16.2 CYP20A1 CYP-M ENSG00000119004 "Cytochrome P450 family 20 subfamily A member 1" Q6UW02 2 203238940-203305611 "Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055872, HPA058461" Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments" "Plasma membrane, Cell Junctions, Actin filaments" Nucleoplasm "HPA055872: , HPA058461: " "unprognostic (4.72e-2)" "unprognostic (2.06e-2)" "unprognostic (1.20e-2)" "unprognostic (2.14e-2)" "unprognostic (1.42e-1)" "unprognostic (3.06e-2)" "unprognostic (5.21e-2)" "unprognostic (2.58e-2)" "unprognostic (4.21e-2)" "unprognostic (2.62e-2)" "unprognostic (4.53e-2)" "unprognostic (4.42e-2)" "unprognostic (7.64e-3)" "unprognostic (9.39e-2)" "unprognostic (2.18e-1)" "unprognostic (1.23e-2)" "unprognostic (1.95e-3)" 11.1 14.9 5.0 9.1 6.4 2.8 7.6 6.8 6.1 9.3 8.6 8.6 9.2 6.0 10.8 7.1 8.0 8.0 9.1 7.0 4.5 4.8 13.5 12.5 8.4 7.8 8.1 2.1 13.4 17.3 9.1 13.6 9.4 6.5 9.0 7.8 10.9 9.8 8.8 5.3 6.3 10.5 9.0 6.5 10.1 8.8 10.8 8.1 13.8 16.9 4.3 9.1 7.7 9.7 13.0 13.6 6.8 11.3 8.8 15.5 9.1 5.2 4.8 2.5 4.8 14.4 3.0 5.1 8.8 4.5 3.7 3.9 13.9 7.5 3.8 7.2 5.5 5.7 3.2 4.0 5.2 5.0 3.7 8.1 3.1 6.4 11.2 8.8 5.1 6.8 3.1 6.0 6.3 7.4 12.5 12.9 6.8 7.0 7.4 4.7 9.5 10.7 5.0 5.6 7.3 4.4 10.3 3.7 5.0 0.3 4.6 7.2 2.8 4.8 8.4 12.2 4.7 6.0 5.5 8.8 9.5 4.6 7.5 3.5 5.6 5.2 10.4 6.8 14.4 11.3 15.5 11.1 14.9 12.7 7.8 13.0 12.5 9.2 2.2 8.8 10.5 13.6 13.4 9.1 5.0 6.4 6.8 6.1 4.5 4.8 8.1 2.1 6.5 8.1 CYP2S1 ENSG00000167600 "Cytochrome P450 family 2 subfamily S member 1" Q96SQ9 19 41193049-41207539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.1;gallbladder: 29.1;intestine: 62.7;stomach 1: 45.9" "Cell line enhanced" "Detected in many" "A549: 37.2;CACO-2: 19.2;HaCaT: 19.9;NTERA-2: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 9.5;myeloid DC: 33.1" "Group enriched" "Detected in many" 121 "dendritic cells: 33.1;monocytes: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049227, HPA069248" Approved Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA049227: , HPA069248: " "unprognostic (1.49e-2)" "unprognostic (7.45e-2)" "unprognostic (2.45e-2)" "unprognostic (6.03e-2)" "unprognostic (3.93e-2)" "unprognostic (7.46e-2)" "unprognostic (1.27e-2)" "unprognostic (4.85e-2)" "unprognostic (2.18e-1)" "unprognostic (1.54e-2)" "unprognostic (6.25e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.60e-6)" "unprognostic (1.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.02e-1)" "unprognostic (7.66e-2)" 1.2 0.8 0.8 2.3 1.0 0.5 0.6 0.1 1.0 1.7 18.3 1.2 0.5 37.6 0.3 0.9 10.1 2.4 29.1 1.0 1.4 1.6 0.9 2.1 3.8 3.3 5.6 0.4 0.8 0.6 0.0 0.9 1.6 4.5 0.9 7.2 1.1 3.8 0.3 0.1 2.0 62.7 0.6 1.1 4.0 45.9 0.5 1.2 2.6 0.4 15.8 21.0 3.2 2.7 0.0 33.1 0.0 9.5 0.0 0.1 3.9 1.4 37.2 0.0 0.0 0.0 0.0 1.8 0.2 0.3 0.4 0.1 19.2 5.4 0.1 4.4 0.2 19.9 6.5 10.1 0.1 0.0 0.1 5.0 2.0 6.9 7.9 0.0 0.1 0.3 0.5 0.5 0.3 0.3 2.2 0.1 0.0 0.7 0.1 0.1 28.2 4.8 0.1 0.0 0.3 0.6 7.9 0.0 0.2 3.7 0.0 0.0 4.9 1.9 4.2 0.0 1.6 0.7 0.0 0.2 0.0 0.0 0.2 0.8 0.0 0.0 9.5 0.0 0.0 2.3 0.1 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 3.9 0.8 1.0 0.1 1.0 1.4 1.6 5.6 0.4 4.5 1.2 CYP2U1 SPG49 ENSG00000155016 "Cytochrome P450 family 2 subfamily U member 1" Q7Z449 4 107931369-107953457 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 122.7" "Cell line enhanced" "Detected in many" "ASC diff: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041622, HPA046754, HPA064827" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA041622: , HPA046754: , HPA064827: " "unprognostic (3.54e-1)" "unprognostic (2.45e-1)" "unprognostic (3.08e-1)" "unprognostic (2.84e-1)" "unprognostic (5.16e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (1.20e-3)" "unprognostic (3.19e-1)" "unprognostic (8.97e-3)" "unprognostic (5.41e-3)" "unprognostic (3.02e-1)" "prognostic favourable (2.75e-5)" "prognostic unfavourable (6.97e-4)" "unprognostic (1.19e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.6 7.9 7.7 4.4 9.1 0.4 7.3 11.3 9.2 7.8 7.3 7.0 4.1 4.0 9.5 4.6 6.3 9.8 6.6 8.8 7.1 7.9 6.4 6.8 6.6 6.7 8.3 5.2 12.0 2.6 10.3 8.1 2.7 7.8 12.4 4.7 8.6 4.5 11.0 4.3 3.1 6.0 12.3 7.0 8.5 4.6 3.9 7.4 122.7 4.7 3.5 5.4 7.3 5.3 2.6 2.7 0.7 5.9 1.6 1.7 0.4 2.5 1.2 3.4 6.3 18.8 9.0 0.5 10.8 16.3 6.6 10.5 0.0 1.7 6.9 0.8 6.4 0.1 5.3 4.0 10.4 1.9 1.6 1.4 2.4 0.3 7.5 2.0 0.0 10.1 3.4 3.1 2.1 2.5 0.1 3.3 5.5 1.8 7.4 0.0 3.5 3.0 4.2 4.1 0.0 2.1 4.3 6.7 5.0 2.7 4.7 11.5 2.3 1.0 6.8 4.3 0.5 6.1 4.3 14.0 13.2 2.2 3.5 0.0 4.8 0.0 0.3 0.7 1.2 1.1 0.9 2.0 0.9 1.0 2.2 2.6 1.7 1.3 0.0 1.6 5.9 2.7 0.0 0.4 7.7 9.1 11.3 6.9 7.1 7.9 8.3 5.2 7.8 7.4 CYP3A43 ENSG00000021461 "Cytochrome P450 family 3 subfamily A member 43" Q9HB55 7 99828013-99866102 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 32.5" "Low cell line specificity" "Detected in some" "Cancer enriched" "Detected in single" 18 "liver cancer: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA066463, HPA072245" Enhanced Uncertain Cytosol Cytosol "HPA066463: , HPA072245: " "unprognostic (1.20e-3)" "unprognostic (4.74e-2)" "unprognostic (3.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.52e-1)" "prognostic favourable (3.41e-4)" "unprognostic (1.68e-2)" "unprognostic (1.44e-1)" "unprognostic (2.38e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.23e-2)" "unprognostic (6.46e-2)" "unprognostic (5.90e-2)" "unprognostic (3.10e-1)" "unprognostic (6.37e-4)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.9 0.1 0.0 0.1 0.1 0.1 0.0 0.2 32.5 0.1 0.1 0.1 0.1 0.1 8.0 0.0 2.2 0.1 0.1 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.5 1.6 0.6 0.3 0.6 0.2 0.1 0.0 0.9 0.3 1.1 0.2 0.2 0.0 0.1 0.2 0.2 1.2 0.7 1.5 0.2 0.3 1.3 0.2 0.0 0.7 0.2 0.5 0.9 1.4 1.3 0.3 0.9 1.3 0.0 0.7 0.0 0.0 0.5 1.0 1.0 0.0 0.0 0.0 0.6 0.4 0.0 0.9 0.0 0.2 0.7 1.6 0.5 0.4 0.6 1.7 0.0 0.5 0.0 1.6 0.5 0.2 1.1 0.7 1.1 1.2 0.1 0.8 0.4 0.2 1.5 0.6 0.4 0.6 0.2 0.3 0.3 0.3 0.2 0.1 0.6 0.5 0.5 1.6 0.3 0.2 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CYP3A5 "CP35, P450PCN3, PCN3" ENSG00000106258 "Cytochrome P450 family 3 subfamily A member 5" P20815 7 99648194-99680026 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 72.9;liver: 73.4;stomach 1: 21.3" "Cell line enhanced" "Detected in some" "A549: 3.1;CACO-2: 12.1;CAPAN-2: 8.1;Hep G2: 8.4" "Cancer enhanced" "Detected in many" "liver cancer: 38.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA072245 Uncertain Cytosol Cytosol "HPA072245: " "unprognostic (2.13e-1)" "unprognostic (4.36e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "unprognostic (2.73e-1)" "prognostic favourable (3.72e-5)" "unprognostic (1.37e-3)" "unprognostic (1.21e-2)" "unprognostic (7.29e-3)" "unprognostic (3.85e-1)" "unprognostic (4.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" "unprognostic (2.39e-4)" "unprognostic (6.58e-3)" 1.0 3.3 0.4 2.0 0.5 0.0 1.3 0.6 0.6 1.9 32.6 0.6 1.0 30.3 0.7 0.5 5.2 0.5 8.2 0.4 0.4 0.0 6.8 73.4 2.4 0.8 0.4 0.4 0.6 12.1 0.0 1.8 0.6 0.8 4.9 5.1 0.4 0.6 1.3 0.4 4.3 72.9 0.6 0.5 0.4 21.3 0.7 0.4 0.5 0.4 2.2 4.0 3.0 2.7 0.0 0.2 0.1 0.6 0.0 0.7 0.2 0.0 3.1 0.0 0.0 0.5 0.8 0.1 0.0 0.0 0.0 0.0 12.1 8.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.4 0.1 0.1 0.2 0.0 2.6 0.0 0.1 0.0 2.6 0.2 0.0 0.1 0.0 0.5 0.2 0.0 0.1 0.0 0.8 0.7 0.6 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.5 0.6 0.6 0.4 0.0 0.4 0.4 0.8 0.4 CYP3A7 "CP37, P450-HFLA" ENSG00000160870 "Cytochrome P450 family 3 subfamily A member 7" P24462 7 99684957-99735196 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 82.6" "Group enriched" "Detected in some" 5 "BEWO: 1.8;BJ hTERT+: 3.2;Hep G2: 6.2;HHSteC: 3.6;RT4: 1.9" "Cancer enriched" "Detected in some" 43 "liver cancer: 38.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA072245 Uncertain Cytosol Cytosol "HPA072245: " "unprognostic (8.10e-3)" "unprognostic (1.45e-1)" "unprognostic (3.12e-1)" "unprognostic (5.47e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.34e-2)" "unprognostic (8.28e-2)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-11)" "unprognostic (2.02e-2)" "unprognostic (5.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.34e-3)" 0.1 0.4 0.1 0.1 0.0 0.0 2.6 0.1 0.1 0.0 0.7 0.0 0.0 0.1 0.3 0.1 0.2 0.0 3.9 0.0 0.1 0.0 2.8 82.6 0.6 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.8 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.2 3.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 CYP3A7-CYP3A51P ENSG00000282301 "CYP3A7-CYP3A51P readthrough" P24462 7 99685226-99735093 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 73.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;U-87 MG: 2.6" "Cell type enhanced" "Detected in single" "eosinophil: 1.1" "Low lineage specificity" "Detected in single" HPA072245 Uncertain Cytosol Cytosol "HPA072245: " 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.1 73.9 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.5 0.0 0.3 0.5 1.6 0.5 0.2 4.2 0.0 0.6 0.2 0.0 0.0 0.0 1.3 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.9 1.3 1.9 0.0 0.0 0.4 0.3 0.4 0.4 0.0 0.3 0.0 0.4 1.0 0.1 0.2 1.1 0.5 0.2 0.2 0.1 0.4 1.4 0.0 0.0 0.3 0.2 0.0 0.5 0.6 0.0 0.1 0.4 0.3 0.5 0.5 0.6 0.9 0.7 0.1 2.6 0.7 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 CYP4B1 ENSG00000142973 "Cytochrome P450 family 4 subfamily B member 1" P13584 1 46757838-46819413 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 92.0" "Cell line enriched" "Detected in some" 8 "RT4: 79.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 56.9" "Region enhanced" "Detected in single" "midbrain: 1.7" "Cell type enriched" "Detected in single" 11 "memory CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA004331 Approved Supported Vesicles Vesicles "HPA004331: AB_1078616" "unprognostic (2.29e-2)" "prognostic favourable (5.99e-4)" "unprognostic (7.01e-2)" "unprognostic (1.11e-1)" "unprognostic (2.28e-1)" "unprognostic (8.31e-2)" "unprognostic (1.16e-2)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "unprognostic (2.59e-1)" "unprognostic (6.12e-2)" "unprognostic (5.46e-2)" "unprognostic (7.33e-2)" "unprognostic (1.80e-1)" "unprognostic (1.15e-1)" "unprognostic (1.22e-3)" "unprognostic (6.69e-3)" 41.6 2.2 0.0 0.6 0.1 0.3 45.5 0.1 0.3 9.5 6.7 0.1 7.2 0.7 2.1 2.8 17.9 18.5 0.8 13.5 0.0 0.0 1.4 0.2 92.0 1.5 1.7 0.1 3.3 0.9 0.5 4.8 0.9 0.8 15.4 0.5 2.8 5.0 6.9 14.4 10.4 3.4 6.8 3.5 0.5 3.0 1.7 0.1 0.7 12.7 4.5 5.7 36.5 18.9 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 1.7 0.1 0.8 0.1 CYP4F12 ENSG00000186204 "Cytochrome P450 family 4 subfamily F member 12" 19 15672757-15697174 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 53.0;liver: 24.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.5;HaCaT: 22.0;Hep G2: 6.1;Karpas-707: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 39 "basophil: 5.3;eosinophil: 13.2" "Lineage enriched" "Detected in single" 76 "granulocytes: 13.2" HPA058960 Approved "HPA058960: " "unprognostic (4.30e-4)" "prognostic favourable (1.21e-4)" "unprognostic (1.86e-1)" "unprognostic (1.48e-2)" "unprognostic (1.37e-2)" "unprognostic (5.32e-3)" "unprognostic (1.84e-3)" "unprognostic (9.13e-2)" "unprognostic (9.11e-2)" "unprognostic (2.50e-1)" "unprognostic (4.32e-2)" "unprognostic (1.47e-1)" "unprognostic (1.66e-3)" "unprognostic (6.20e-2)" "unprognostic (5.45e-2)" "unprognostic (3.17e-1)" "prognostic favourable (2.33e-4)" 1.9 0.7 1.6 6.1 0.9 0.6 3.5 0.0 1.9 3.9 24.6 5.6 1.4 24.6 1.4 1.8 11.5 2.1 10.8 1.7 1.9 0.3 1.1 24.2 0.9 0.3 3.0 3.5 1.9 0.2 0.1 0.3 0.4 2.7 4.4 5.1 1.4 3.0 1.5 0.4 12.9 53.0 5.1 0.8 0.7 8.0 0.4 4.8 0.2 0.6 8.9 6.3 10.1 6.5 0.0 0.0 13.2 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.4 0.0 0.0 22.0 0.0 0.0 0.0 1.2 0.0 0.0 0.9 6.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 13.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.9 0.0 1.9 1.9 0.3 3.0 3.5 2.7 4.8 CYP4F2 ENSG00000186115 "Cytochrome P450 family 4 subfamily F member 2" P78329 19 15878023-15898120 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 69.1;liver: 102.9" "Cell line enriched" "Detected in some" 4 "Hep G2: 8.8" "Cancer enriched" "Detected in some" 9 "liver cancer: 29.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "basophil: 8.5" "Lineage enriched" "Detected in single" 86 "granulocytes: 8.5" "HPA014048, HPA017265, HPA058960" Supported "Intracellular and membrane" "HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: " "unprognostic (7.46e-3)" "unprognostic (3.58e-1)" "unprognostic (3.01e-1)" "unprognostic (9.39e-2)" "unprognostic (1.74e-1)" "unprognostic (2.87e-2)" "unprognostic (4.55e-3)" "unprognostic (6.52e-2)" "unprognostic (2.05e-1)" "unprognostic (4.64e-2)" "unprognostic (9.82e-2)" "unprognostic (2.92e-1)" "unprognostic (8.69e-4)" "unprognostic (3.24e-1)" "unprognostic (1.89e-1)" "unprognostic (7.79e-3)" 0.1 0.1 0.2 0.5 0.1 0.0 0.2 0.1 0.2 0.2 10.1 0.2 0.1 24.5 0.1 8.8 0.2 0.1 1.8 0.1 0.2 0.1 11.9 102.9 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.2 1.9 0.0 0.1 0.1 0.2 0.1 0.5 69.1 0.1 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.7 0.1 0.3 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.2 8.8 0.0 0.9 0.5 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 1.5 0.1 0.1 0.3 0.6 0.8 0.1 0.4 0.4 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.1 CYP4F8 ENSG00000186526 "Cytochrome P450 family 4 subfamily F member 8" P98187 19 15615218-15630638 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 155 "ductus deferens: 265.6;seminal vesicle: 360.6" "Group enriched" "Detected in some" 9 "RT4: 1.6;SK-BR-3: 4.5" "Group enriched" "Detected in some" 31 "breast cancer: 2.5;prostate cancer: 3.3;urothelial cancer: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA058960 Approved "HPA058960: " "unprognostic (1.70e-2)" "unprognostic (5.46e-3)" "unprognostic (3.21e-2)" "unprognostic (3.97e-6)" "unprognostic (3.51e-3)" "unprognostic (2.72e-1)" "unprognostic (1.15e-1)" "unprognostic (8.25e-2)" "unprognostic (1.15e-2)" "unprognostic (1.02e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 265.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 360.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP4V2 CYP4AH1 ENSG00000145476 "Cytochrome P450 family 4 subfamily V member 2" Q6ZWL3 4 186191520-186213456 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sensory transduction, Vision" "Monooxygenase, Oxidoreductase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.7" "Cell line enhanced" "Detected in many" "Karpas-707: 12.9;SK-MEL-30: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029122 Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA029122: AB_10601806" "unprognostic (1.65e-1)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "prognostic favourable (5.86e-4)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "prognostic favourable (1.85e-4)" "unprognostic (6.66e-2)" "unprognostic (5.84e-2)" "unprognostic (2.05e-1)" "unprognostic (6.49e-2)" "unprognostic (9.89e-2)" "prognostic favourable (1.49e-7)" "unprognostic (3.25e-2)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" 6.6 16.6 7.8 5.0 12.4 1.6 5.5 8.9 7.5 6.7 8.0 8.9 4.9 11.4 5.7 4.2 5.2 6.2 13.7 7.4 7.7 4.6 21.6 64.7 7.3 4.1 7.7 9.0 6.3 12.1 30.8 16.1 3.0 6.7 5.6 8.2 19.1 6.2 9.1 3.3 2.8 14.7 6.4 7.0 7.5 5.2 3.2 7.4 4.4 11.9 2.1 3.8 8.0 5.1 2.3 2.5 0.0 6.2 1.3 4.0 1.5 2.6 1.8 0.6 0.0 11.1 4.6 0.1 3.7 7.9 1.4 1.9 0.0 10.7 1.0 0.5 2.4 1.3 1.3 1.1 0.4 6.4 1.3 4.0 0.4 0.5 3.3 2.2 2.0 4.1 0.5 1.4 0.6 0.1 1.6 12.9 4.6 2.2 2.4 0.6 1.4 0.0 2.1 0.5 1.1 4.5 5.1 2.8 4.0 0.9 0.0 19.0 1.9 3.5 4.2 2.9 0.7 3.3 1.6 0.0 0.0 0.5 8.8 8.2 3.5 0.0 1.2 0.0 4.0 4.1 2.5 1.0 2.5 3.4 1.5 2.3 2.7 2.3 0.0 1.3 6.2 2.5 2.1 1.5 7.8 12.4 8.9 7.5 7.7 4.6 7.7 9.0 6.7 7.4 CYP4X1 MGC40051 ENSG00000186377 "Cytochrome P450 family 4 subfamily X member 1" Q8N118 1 47023568-47050751 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 38.1" "Cell line enhanced" "Detected in some" "ASC diff: 3.6;CACO-2: 6.1;HEK 293: 2.5;NTERA-2: 2.8;SCLC-21H: 3.7;T-47d: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA017661 Approved "HPA017661: AB_2669633" "unprognostic (1.19e-1)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (1.78e-2)" "unprognostic (9.88e-2)" "unprognostic (1.56e-3)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (2.35e-2)" "unprognostic (1.46e-1)" "unprognostic (2.76e-2)" "unprognostic (3.03e-2)" "unprognostic (1.79e-3)" "unprognostic (3.65e-2)" "unprognostic (8.56e-2)" "unprognostic (5.03e-2)" 7.9 3.6 9.0 1.1 14.9 0.5 16.0 7.1 16.9 38.1 2.0 1.6 2.5 2.1 3.6 3.2 12.0 9.7 2.0 6.7 4.8 10.6 6.3 10.0 8.9 2.0 3.3 13.5 1.7 2.0 2.0 4.1 1.5 7.8 8.0 2.3 17.6 23.7 3.4 4.5 5.0 1.8 2.4 2.0 1.0 14.3 4.2 0.9 0.0 4.0 6.9 8.8 3.9 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.6 0.2 0.1 0.0 0.1 0.0 0.0 6.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 0.6 0.2 3.7 0.0 0.0 0.3 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 14.9 7.1 16.9 4.8 10.6 3.3 13.5 7.8 0.9 CYP51A1 "CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1" ENSG00000001630 "Cytochrome P450 family 51 subfamily A member 1" Q16850 7 92112151-92142952 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041325, HPA043508" Enhanced Enhanced "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA041325: AB_2677411, HPA043508: AB_2678520" "unprognostic (6.68e-2)" "prognostic unfavourable (6.12e-4)" "unprognostic (3.48e-2)" "unprognostic (1.18e-2)" "unprognostic (7.82e-2)" "unprognostic (3.60e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.84e-2)" "unprognostic (1.36e-1)" "unprognostic (9.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.59e-9)" "unprognostic (1.82e-1)" "unprognostic (2.73e-1)" "unprognostic (5.13e-2)" "unprognostic (1.09e-3)" 10.3 27.0 16.7 8.1 22.1 10.5 15.5 13.3 32.0 11.8 21.1 32.9 6.3 33.1 9.1 15.3 23.4 7.1 10.3 9.9 18.6 20.8 18.6 80.9 22.2 5.0 17.2 13.7 21.0 20.2 32.4 11.9 8.8 47.1 18.2 16.9 17.1 11.0 7.7 4.3 12.8 28.8 8.3 43.7 7.3 18.1 35.7 19.5 2.3 14.1 18.7 10.0 9.0 13.2 14.2 14.1 3.5 13.9 6.7 10.7 7.1 24.6 12.1 30.5 19.5 21.5 35.2 4.3 8.4 25.4 10.9 29.8 29.0 45.1 21.5 13.3 14.4 21.6 26.6 53.0 12.7 9.0 18.8 6.2 12.9 21.8 29.3 12.6 9.3 25.5 24.1 42.5 44.8 11.1 23.2 49.6 12.8 25.2 2.7 11.7 22.8 12.1 8.7 6.3 48.5 49.4 41.8 21.5 14.4 17.8 35.4 26.0 12.8 15.2 13.2 15.0 16.7 21.6 10.9 16.9 15.0 19.6 11.5 16.8 19.1 1.8 9.7 3.5 10.7 13.9 7.1 14.2 7.6 8.4 14.1 10.7 7.2 9.2 1.5 6.7 8.3 12.4 5.8 7.1 16.7 22.1 13.3 32.0 18.6 20.8 17.2 13.7 47.1 19.5 CYYR1 C21orf95 ENSG00000166265 "Cysteine and tyrosine rich 1" Q96J86 21 26466209-26573284 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "breast: 59.8" "Cell line enhanced" "Detected in some" "AF22: 8.8;NTERA-2: 24.7;PC-3: 6.8;RH-30: 10.4;SCLC-21H: 21.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 38 "plasmacytoid DC: 21.1" "Lineage enriched" "Detected in single" 73 "dendritic cells: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034921, HPA067685" Uncertain Approved Nucleoplasm Nucleoplasm "CAB034921: AB_2089315, HPA067685: " "unprognostic (5.64e-2)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (2.63e-2)" "unprognostic (2.88e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.46e-1)" "unprognostic (2.44e-3)" "unprognostic (9.29e-3)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" 30.9 28.9 3.8 7.7 4.4 4.0 59.8 2.1 4.3 19.0 8.4 2.7 13.4 3.5 15.1 14.7 13.1 8.6 10.8 29.1 4.7 3.9 10.6 7.1 23.8 13.4 5.6 2.5 9.8 4.5 5.1 3.5 21.7 3.9 11.7 4.0 11.6 5.4 10.5 14.5 4.8 6.8 14.6 5.0 34.1 5.9 9.2 2.5 3.6 11.2 9.1 2.7 11.2 23.9 0.0 21.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.1 0.0 0.2 3.4 0.0 0.0 1.6 0.0 0.0 0.0 24.7 6.8 0.0 10.4 0.0 1.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 21.1 0.0 0.0 3.8 4.4 2.1 4.3 4.7 3.9 5.6 2.5 3.9 2.5 DAG1 "156DAG, A3a, AGRNR, DAG" ENSG00000173402 "Dystroglycan 1" Q14118 3 49468703-49535618 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001960, CAB016353" Enhanced Supported Vesicles "Intracellular and membrane" 70000000 Vesicles "CAB001960: , CAB016353: AB_627292" "unprognostic (1.58e-1)" "unprognostic (5.14e-1)" "unprognostic (6.71e-3)" "unprognostic (3.32e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" "unprognostic (1.67e-1)" "unprognostic (3.27e-2)" "unprognostic (8.18e-2)" "unprognostic (3.91e-2)" "unprognostic (5.70e-3)" "unprognostic (1.10e-1)" "prognostic favourable (2.59e-4)" "unprognostic (9.22e-2)" "unprognostic (1.99e-2)" "unprognostic (7.43e-2)" "unprognostic (1.57e-2)" 19.2 17.4 16.5 10.1 21.1 2.8 16.2 17.3 27.1 17.3 23.9 24.1 13.1 14.1 23.4 14.3 19.1 19.6 19.7 40.9 19.9 10.3 22.7 31.7 18.9 6.3 16.7 15.7 22.6 35.0 32.7 15.8 45.6 18.1 18.6 18.9 22.2 19.9 24.3 57.3 18.7 17.5 27.9 14.0 7.3 22.2 29.4 16.3 6.0 15.3 24.0 14.3 20.4 15.0 3.2 3.6 1.8 6.1 1.9 3.7 3.3 19.5 19.5 13.6 33.6 18.2 8.9 62.0 13.8 20.5 23.7 15.3 16.0 20.8 2.7 14.0 22.5 36.7 11.8 17.9 14.7 2.6 3.9 1.8 19.6 18.2 8.1 2.4 3.9 7.8 16.2 22.5 7.5 21.2 2.8 2.1 6.4 15.7 2.0 1.6 14.5 6.5 1.2 13.2 4.6 18.6 27.5 4.8 9.9 16.6 45.8 22.4 38.6 4.8 11.0 9.0 14.3 16.7 19.7 2.4 4.9 1.7 10.9 2.6 54.2 1.8 2.8 1.1 3.3 3.5 3.7 3.2 2.8 2.5 1.8 2.6 3.0 2.4 0.6 1.9 6.1 3.6 1.9 3.3 16.5 21.1 17.3 27.1 19.9 10.3 16.7 15.7 18.1 16.3 DAPK1 "DAPK, ROCO3" ENSG00000196730 "Death associated protein kinase 1" P53355 9 87497228-87708633 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Apoptosis, Translation regulation" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 94.7" "Cell line enhanced" "Detected in many" "HMC-1: 38.7;HUVEC TERT2: 21.9;RPTEC TERT1: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 5.3;eosinophil: 6.9;intermediate monocyte: 11.9;myeloid DC: 4.0;non-classical monocyte: 11.7;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 55 "dendritic cells: 5.3;granulocytes: 6.9;monocytes: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB037302, HPA040472, HPA048436" Approved Approved Centrosome Centrosome "CAB037302: AB_1078622, HPA040472: , HPA048436: " "unprognostic (2.55e-1)" "unprognostic (1.47e-1)" "prognostic unfavourable (2.48e-5)" "unprognostic (2.77e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (1.75e-1)" "unprognostic (1.88e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-2)" "unprognostic (2.77e-3)" "unprognostic (8.31e-3)" "unprognostic (8.76e-2)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (1.09e-3)" 14.6 4.9 10.4 8.8 25.5 3.8 4.1 2.9 17.6 8.1 16.6 6.5 8.1 7.8 8.7 16.1 4.5 12.2 21.6 4.1 12.4 8.1 14.7 21.3 28.6 8.5 4.6 10.4 32.7 21.2 4.8 16.6 94.7 6.6 5.1 7.5 5.9 9.3 7.3 1.5 3.7 11.0 8.1 4.8 16.4 15.0 6.3 7.3 34.5 7.2 1.5 5.2 13.2 10.5 0.1 5.3 6.9 11.9 0.1 0.1 2.1 0.0 18.2 8.8 6.1 0.2 0.1 14.0 1.2 1.7 7.2 8.1 2.6 0.1 0.1 1.8 0.3 17.0 5.4 0.4 3.1 0.1 4.4 8.8 2.5 8.9 7.8 0.0 38.7 0.5 2.9 1.3 0.5 21.9 6.6 3.7 6.0 0.5 2.6 0.0 9.9 0.0 0.7 7.8 0.0 20.0 18.2 4.0 4.5 0.0 1.8 7.7 0.0 5.8 0.1 0.0 0.1 0.0 0.0 14.6 3.0 0.0 0.1 2.4 1.2 1.3 5.3 6.9 0.0 11.9 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.1 1.6 0.1 11.7 5.3 0.0 2.1 10.4 25.5 2.9 17.6 12.4 8.1 4.6 10.4 6.6 7.3 DAPK2 "DRP-1, MGC119312" ENSG00000035664 "Death associated protein kinase 2" Q9UIK4 15 63907036-64072033 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;skeletal muscle: 46.1" "Cell line enhanced" "Detected in many" "ASC diff: 10.0;HaCaT: 8.3;HMC-1: 17.0;MCF7: 8.6" "Cancer enriched" "Detected in many" 15 "thyroid cancer: 30.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "basophil: 19.1;eosinophil: 51.8;neutrophil: 16.4" "Lineage enriched" "Detected in many" 23 "granulocytes: 51.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071581 Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA071581: " "unprognostic (3.20e-2)" "unprognostic (4.07e-2)" "unprognostic (4.23e-2)" "unprognostic (1.95e-3)" "unprognostic (2.88e-2)" "unprognostic (1.30e-2)" "unprognostic (2.32e-1)" "prognostic favourable (5.63e-4)" "unprognostic (1.04e-1)" "unprognostic (3.18e-1)" "unprognostic (9.21e-2)" "unprognostic (8.51e-2)" "unprognostic (4.77e-7)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (3.20e-3)" "unprognostic (9.07e-2)" 8.2 1.6 2.6 6.8 5.0 10.3 5.2 1.4 3.9 3.6 16.6 12.0 8.3 14.2 1.7 1.5 2.1 1.2 1.7 17.6 3.6 2.0 2.2 1.4 14.0 2.5 6.8 3.0 0.7 1.7 1.1 1.1 0.3 4.7 3.1 4.7 1.9 4.8 4.8 46.1 4.6 25.8 1.2 3.4 4.7 6.9 2.0 6.5 1.1 22.3 8.7 3.3 2.1 9.6 0.3 2.2 51.8 0.0 0.7 0.6 0.3 2.8 2.0 5.6 1.4 10.0 0.4 0.1 1.9 6.0 1.0 1.1 0.8 1.4 0.2 0.6 6.0 8.3 3.5 0.1 0.6 0.2 0.1 1.1 3.9 0.1 0.1 0.1 17.0 1.0 7.2 0.3 0.2 0.6 0.4 0.1 0.7 8.6 0.0 0.3 0.6 2.0 2.6 0.0 0.3 0.0 2.8 0.4 0.3 0.4 1.1 0.0 4.8 0.4 0.4 0.8 1.0 1.3 1.6 0.6 0.2 0.0 0.0 2.7 0.2 19.1 0.0 51.8 0.6 0.0 0.2 0.3 0.1 0.5 0.0 0.1 0.0 0.4 16.4 0.7 0.0 2.2 0.0 0.3 2.6 5.0 1.4 3.9 3.6 2.0 6.8 3.0 4.7 6.5 DAPK3 "ZIP, ZIPK" ENSG00000167657 "Death associated protein kinase 3" O43293 19 3958453-3971123 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation, Translation regulation" "Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028569, HPA064809" Approved Approved Nucleoplasm Nucleoplasm "HPA028569: AB_10794319, HPA064809: " "unprognostic (5.72e-2)" "unprognostic (3.28e-2)" "unprognostic (3.34e-3)" "prognostic favourable (2.01e-5)" "unprognostic (1.83e-1)" "unprognostic (2.37e-1)" "unprognostic (7.72e-3)" "unprognostic (2.16e-1)" "unprognostic (2.46e-2)" "unprognostic (4.95e-2)" "unprognostic (1.84e-3)" "unprognostic (7.64e-2)" "prognostic unfavourable (6.49e-4)" "unprognostic (9.92e-2)" "unprognostic (1.41e-1)" "unprognostic (5.48e-2)" "unprognostic (2.14e-1)" 18.8 10.2 12.6 16.6 16.4 10.0 17.2 14.5 29.5 22.5 30.1 13.6 11.5 18.5 33.1 11.5 20.2 18.5 21.9 49.2 12.4 11.0 10.9 11.0 24.5 11.6 11.9 16.8 18.8 21.7 11.1 14.6 26.0 19.7 21.3 6.9 18.2 15.3 25.8 45.2 17.8 17.0 38.8 10.6 14.7 23.3 15.7 12.7 11.8 11.4 11.6 12.9 26.7 17.8 15.0 14.7 23.9 15.6 17.3 19.5 11.0 25.5 20.3 12.7 16.0 9.5 10.8 19.6 35.3 28.5 28.9 19.1 37.4 7.7 14.2 17.3 30.9 20.4 12.4 20.0 10.5 20.7 20.6 5.7 24.9 21.4 30.3 13.7 21.5 24.5 25.0 26.1 15.1 23.9 18.0 24.7 17.5 16.6 13.5 10.3 19.7 16.3 17.0 18.8 13.2 17.4 20.1 20.1 14.0 23.7 28.7 20.2 20.6 10.8 44.6 37.1 16.8 33.2 44.0 27.6 22.6 16.4 29.6 14.4 19.8 22.1 14.2 23.9 19.5 15.6 14.0 13.5 14.8 17.9 12.6 15.0 11.3 10.8 23.9 17.3 10.6 14.7 17.6 11.0 12.6 16.4 14.5 29.5 12.4 11.0 11.9 16.8 19.7 12.7 DCAF17 "C2orf37, FLJ13096" ENSG00000115827 "DDB1 and CUL4 associated factor 17" Q5H9S7 2 171434217-171485052 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Hypotrichosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053339, HPA055040" Uncertain Supported Nucleoplasm Nucleoplasm "HPA053339: , HPA055040: " "unprognostic (1.60e-2)" "unprognostic (1.21e-1)" "unprognostic (4.05e-1)" "unprognostic (1.03e-2)" "unprognostic (1.60e-1)" "unprognostic (5.98e-2)" "unprognostic (5.60e-2)" "unprognostic (2.67e-2)" "unprognostic (2.30e-3)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (1.12e-2)" "unprognostic (1.41e-1)" "unprognostic (4.27e-1)" "prognostic unfavourable (7.10e-4)" "unprognostic (2.79e-2)" 7.9 9.8 12.3 9.7 19.0 5.7 12.2 14.5 12.1 11.2 10.4 14.5 8.7 8.4 16.2 12.5 9.2 9.2 9.0 7.1 13.6 9.4 11.2 8.3 7.3 12.6 19.2 8.0 14.1 13.1 13.8 10.9 10.0 10.9 10.2 9.2 9.4 9.0 10.2 7.4 13.5 9.5 14.6 17.2 11.5 8.1 10.5 17.3 15.4 19.6 5.0 11.0 10.7 11.1 3.9 2.0 2.3 2.9 2.0 7.1 3.0 6.7 5.6 7.3 8.6 9.3 10.0 11.3 6.0 6.1 6.0 5.7 6.6 4.5 19.6 4.4 7.3 6.7 7.4 7.3 8.4 9.0 5.0 9.0 4.5 11.9 9.5 12.7 6.5 7.8 9.7 7.7 17.2 6.5 14.0 6.8 8.3 4.1 13.9 11.8 10.9 3.5 10.6 9.7 10.6 5.2 6.1 6.5 9.4 5.6 4.8 5.9 3.7 6.7 7.8 7.0 6.3 3.9 5.1 10.3 14.0 16.5 7.4 6.6 7.2 2.3 2.6 1.0 5.0 2.9 7.1 2.8 4.0 3.5 2.0 3.9 4.4 5.4 0.1 2.0 2.5 1.5 3.5 3.0 12.3 19.0 14.5 12.1 13.6 9.4 19.2 8.0 10.9 17.3 DCAKD FLJ22955 ENSG00000172992 "Dephospho-CoA kinase domain containing" Q8WVC6 17 45023340-45061109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060997 Approved Nucleoplasm Nucleoplasm "HPA060997: " "unprognostic (1.32e-2)" "unprognostic (4.79e-3)" "unprognostic (9.71e-2)" "prognostic favourable (7.16e-6)" "unprognostic (1.13e-1)" "unprognostic (8.24e-3)" "unprognostic (7.57e-2)" "unprognostic (6.05e-3)" "unprognostic (4.10e-2)" "unprognostic (1.12e-1)" "unprognostic (2.97e-3)" "unprognostic (4.00e-2)" "unprognostic (6.55e-2)" "unprognostic (5.10e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" "unprognostic (1.82e-2)" 14.6 26.9 25.1 10.3 28.1 6.5 14.9 20.3 32.6 18.8 11.8 31.2 17.8 10.0 18.7 23.7 19.6 28.2 13.6 29.0 28.0 30.0 13.6 15.9 9.9 11.3 28.7 22.9 26.5 16.5 21.1 25.0 11.8 28.6 21.3 10.5 23.7 38.1 22.5 12.7 21.5 10.2 15.6 24.6 11.2 9.8 11.6 23.6 21.8 27.0 8.7 14.8 17.9 15.6 5.7 13.2 2.2 6.5 4.7 9.4 3.9 7.6 14.6 14.1 21.6 12.1 12.9 7.8 6.8 4.6 8.7 8.8 3.5 8.2 13.8 14.9 6.6 9.8 9.8 6.6 7.5 43.1 18.8 14.1 7.0 17.4 14.7 6.0 8.2 15.9 15.6 9.7 2.9 7.4 13.1 9.6 10.2 17.1 18.5 6.7 7.6 12.6 11.2 11.6 11.2 7.9 10.1 17.6 22.5 4.6 3.7 8.1 11.0 8.7 11.1 11.3 7.7 16.2 7.1 12.1 5.7 6.2 19.9 6.1 13.3 1.0 4.5 2.2 7.5 6.5 9.4 5.7 7.6 6.6 7.0 5.1 7.0 7.3 0.8 4.7 4.6 13.2 6.9 3.9 25.1 28.1 20.3 28.1 28.0 30.0 28.7 22.9 28.6 23.6 DCBLD1 "dJ94G16.1, MGC46341" ENSG00000164465 "Discoidin, CUB and LCCL domain containing 1" Q8N8Z6 6 117453817-117569858 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" HPA059667 Approved Approved Cytosol 11000000 Cytosol "HPA059667: " "unprognostic (1.00e-1)" "prognostic unfavourable (6.44e-5)" "unprognostic (1.08e-1)" "unprognostic (3.23e-3)" "unprognostic (2.47e-1)" "unprognostic (2.29e-3)" "unprognostic (1.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.74e-2)" "unprognostic (8.99e-2)" "unprognostic (5.69e-3)" "unprognostic (6.33e-2)" "prognostic unfavourable (8.57e-8)" "unprognostic (6.99e-2)" "unprognostic (4.72e-2)" "unprognostic (7.44e-2)" "unprognostic (1.36e-1)" 15.5 5.2 6.6 7.9 5.6 0.7 12.2 5.1 8.9 12.9 10.6 4.2 10.4 9.0 7.9 6.2 7.9 3.9 12.8 8.2 4.8 3.7 6.1 13.2 15.6 6.3 4.7 3.2 3.2 13.1 12.2 12.6 12.1 7.0 7.6 8.7 4.5 7.1 9.6 17.8 4.3 12.7 7.1 10.2 5.8 10.5 7.6 3.2 1.2 8.8 7.0 5.1 10.5 12.2 0.0 1.2 0.0 0.7 1.0 3.5 1.2 3.1 7.3 2.6 2.9 4.6 5.8 7.4 18.2 24.0 15.5 11.7 15.3 6.9 0.0 9.1 7.8 7.3 5.0 8.1 16.4 1.4 3.8 2.7 7.6 24.9 20.0 3.9 2.3 6.6 19.0 14.0 13.3 21.5 5.8 2.8 20.2 2.5 0.0 2.6 1.9 3.0 0.0 0.5 1.8 3.4 3.8 7.9 0.1 13.4 1.5 2.1 1.9 5.2 15.9 0.0 18.8 5.2 7.9 7.8 2.1 2.1 7.8 3.9 6.8 0.0 0.5 0.0 1.7 0.7 0.3 0.0 2.4 3.5 0.6 0.0 3.0 3.5 0.0 1.0 0.3 1.2 2.2 1.2 6.6 5.6 5.1 8.9 4.8 3.7 4.7 3.2 7.0 3.2 DCBLD2 "CLCP1, ESDN" ENSG00000057019 "Discoidin, CUB and LCCL domain containing 2" Q96PD2 3 98795941-98901689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 61.3;LHCN-M2: 102.3;RPTEC TERT1: 64.1;U-87 MG: 78.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016909 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" 1800000 "Plasma membrane, Cytosol" "Golgi apparatus" "HPA016909: AB_1847510" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" "unprognostic (2.64e-1)" "unprognostic (5.97e-3)" "unprognostic (9.29e-3)" "unprognostic (8.31e-3)" "unprognostic (1.06e-3)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (1.52e-4)" "unprognostic (2.43e-1)" "prognostic unfavourable (3.32e-5)" "prognostic unfavourable (2.87e-4)" "unprognostic (7.76e-2)" "unprognostic (3.93e-2)" "unprognostic (1.59e-3)" 13.1 14.6 4.5 6.4 7.2 1.1 19.3 9.7 9.6 12.0 13.1 5.1 8.1 2.7 16.8 9.2 8.8 13.9 11.7 24.2 4.5 6.2 11.3 9.2 13.1 3.2 6.7 3.5 19.0 6.4 17.6 12.7 9.9 6.5 11.2 6.8 19.3 11.1 14.7 6.6 7.7 5.2 16.7 7.1 2.1 8.6 33.8 7.3 8.1 18.7 6.3 3.6 15.1 6.8 0.6 1.2 1.7 0.5 0.1 1.1 0.2 7.0 51.5 6.9 5.4 9.2 22.0 3.0 15.9 7.6 10.8 12.4 4.3 22.5 0.0 50.1 27.3 6.5 3.1 25.9 25.1 0.1 1.1 2.4 1.6 6.5 5.6 1.1 1.1 8.7 4.0 31.2 61.3 7.1 0.5 0.6 102.3 1.8 0.9 0.7 4.8 17.8 1.0 13.0 0.6 64.1 1.8 1.8 3.2 4.3 0.9 18.6 3.4 0.9 11.7 28.0 22.5 7.1 55.7 0.8 1.2 0.9 78.2 0.4 12.2 1.2 0.5 1.7 0.0 0.1 0.0 0.6 0.1 0.1 0.5 0.2 1.1 0.1 0.9 0.1 0.3 1.2 0.0 0.2 4.5 7.2 9.7 9.6 4.5 6.2 6.7 3.5 6.5 7.3 DCC "IGDCC1, NTN1R1" ENSG00000187323 "DCC netrin 1 receptor" P43146 18 52340172-53535903 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 22.0;testis: 16.5" "Group enriched" "Detected in some" 4 "AF22: 15.1;U-266/70: 46.8;U-266/84: 22.0" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055376, HPA069552" Enhanced Supported "Golgi apparatus" 25000 "Golgi apparatus" "HPA055376: , HPA069552: " "unprognostic (1.96e-3)" "unprognostic (1.69e-2)" "unprognostic (3.13e-1)" "unprognostic (3.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.35e-3)" "unprognostic (2.59e-1)" "unprognostic (5.59e-2)" "unprognostic (2.00e-1)" "unprognostic (2.58e-1)" "unprognostic (8.22e-4)" "unprognostic (4.14e-2)" "unprognostic (1.27e-4)" "unprognostic (7.21e-2)" "unprognostic (1.84e-2)" "unprognostic (1.42e-1)" "unprognostic (2.69e-3)" 0.5 1.9 6.3 0.8 22.0 0.4 0.6 0.7 10.1 0.8 0.9 1.3 0.0 0.5 0.4 1.0 0.7 0.7 0.5 0.5 18.4 2.0 0.9 0.5 3.8 0.4 1.5 9.9 0.7 1.2 0.6 1.1 0.4 5.3 1.3 0.8 0.0 0.8 3.5 0.4 0.8 0.7 0.5 2.4 0.8 0.8 16.5 6.5 0.7 0.5 0.0 1.1 0.8 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 46.8 22.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 22.0 0.7 10.1 18.4 2.0 1.5 9.9 5.3 6.5 DCHS1 "CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16" ENSG00000166341 "Dachsous cadherin-related 1" Q96JQ0 11 6621323-6655854 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 18.8;HUVEC TERT2: 26.1;REH: 12.6;SH-SY5Y: 18.2;TIME: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017970, HPA050246" Approved Approved "Plasma membrane" 75000 "Plasma membrane" "HPA017970: , HPA050246: " "unprognostic (2.42e-1)" "unprognostic (1.13e-1)" "unprognostic (8.93e-2)" "unprognostic (3.52e-2)" "unprognostic (1.83e-1)" "unprognostic (1.38e-3)" "unprognostic (2.52e-2)" "unprognostic (4.55e-3)" "unprognostic (2.63e-2)" "unprognostic (2.93e-2)" "unprognostic (5.96e-2)" "unprognostic (6.87e-2)" "prognostic unfavourable (9.32e-4)" "unprognostic (5.62e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-2)" "unprognostic (1.24e-3)" 9.0 2.0 4.1 7.7 4.7 0.5 6.8 5.2 4.4 26.1 12.9 4.4 9.0 3.8 23.9 4.7 5.0 10.4 9.1 8.0 4.0 4.5 3.4 5.6 7.7 3.9 2.5 3.4 13.7 3.3 1.6 2.7 9.7 3.3 12.0 3.4 9.7 3.3 12.0 3.5 3.4 6.0 16.0 1.6 10.2 6.8 2.6 2.5 5.8 3.3 2.6 2.6 10.9 11.9 0.0 1.4 0.1 0.0 0.0 0.9 0.4 0.0 0.0 18.8 0.1 0.0 0.0 0.1 0.6 4.8 3.0 3.4 0.1 0.0 0.1 2.9 5.4 0.0 1.5 0.0 2.1 0.0 0.5 0.3 0.0 0.0 0.2 0.1 0.0 0.6 0.1 1.4 0.0 26.1 0.1 0.0 1.1 0.0 0.6 0.3 2.8 0.0 12.6 0.0 0.0 0.0 0.0 1.4 18.2 0.0 0.1 0.1 0.0 0.7 11.1 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.8 0.9 0.1 0.0 0.0 1.4 0.0 0.4 4.1 4.7 5.2 4.4 4.0 4.5 2.5 3.4 3.3 2.5 DCHS2 "CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ" ENSG00000197410 "Dachsous cadherin-related 2" 4 154231742-154495570 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "endometrium 1: 8.6" "Cell line enriched" "Detected in some" 6 "U-2 OS: 7.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA064159 Uncertain Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA064159: " "unprognostic (1.38e-2)" "unprognostic (1.51e-1)" "unprognostic (5.74e-3)" "unprognostic (5.93e-2)" "unprognostic (7.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.27e-4)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (1.61e-1)" "unprognostic (2.53e-3)" "unprognostic (1.62e-1)" "unprognostic (1.06e-3)" "unprognostic (3.13e-1)" "unprognostic (2.62e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-3)" 0.9 1.6 3.4 1.3 7.0 1.1 1.0 0.6 4.8 2.6 4.0 1.9 1.1 1.3 8.6 1.5 1.0 2.0 1.6 0.8 3.5 2.6 0.9 0.7 1.1 0.8 3.0 2.3 1.9 0.6 1.1 1.7 0.8 4.6 1.6 1.5 2.7 0.8 3.6 1.0 2.1 1.0 3.0 7.0 0.8 4.9 2.6 2.9 0.0 1.0 0.0 0.9 2.3 1.2 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.4 7.0 0.6 4.8 3.5 2.6 3.0 2.3 4.6 2.9 DCLK1 "DCAMKL1, DCDC3A, DCLK, KIAA0369" ENSG00000133083 "Doublecortin like kinase 1" O15075 13 35768652-36131306 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 76.5" "Cell line enhanced" "Detected in some" "ASC diff: 17.3;ASC TERT1: 16.4;fHDF/TERT166: 13.3;HAP1: 10.3;HSkMC: 15.1;NTERA-2: 21.4" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012405, HPA015040, HPA015655" Enhanced Approved Nucleoplasm,Cytosol 11000 Nucleoplasm Cytosol "CAB012405: , HPA015040: , HPA015655: " "unprognostic (2.29e-1)" "unprognostic (2.56e-1)" "unprognostic (7.45e-2)" "unprognostic (1.30e-2)" "unprognostic (1.99e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-1)" "unprognostic (7.72e-2)" "unprognostic (2.85e-1)" "prognostic unfavourable (4.42e-4)" "unprognostic (1.93e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-4)" 13.9 3.3 14.3 4.2 25.0 1.1 8.6 8.6 76.5 12.2 3.5 8.6 0.5 2.0 6.4 5.8 5.8 3.3 7.1 5.8 21.9 21.9 1.9 1.2 3.0 4.3 11.9 22.5 6.4 2.1 1.5 7.4 1.1 13.9 4.7 4.4 0.5 2.5 4.7 1.9 4.7 2.7 17.0 10.4 4.6 2.5 2.2 8.5 0.0 2.1 1.4 2.9 5.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.0 17.3 16.4 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 13.3 0.0 10.3 0.2 0.0 0.0 0.6 0.0 0.4 0.0 0.6 0.0 0.0 15.1 7.5 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 21.4 0.2 0.0 1.2 0.0 0.6 0.0 4.3 2.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.5 4.4 0.7 0.1 0.0 0.0 1.4 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 25.0 8.6 45.8 21.9 21.9 11.9 22.5 13.9 8.5 DCLK3 "DCAMKL3, DCDC3C, KIAA1765" ENSG00000163673 "Doublecortin like kinase 3" Q9C098 3 36712422-36764349 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;testis: 8.0" "Cell line enhanced" "Detected in some" "NTERA-2: 3.3;SCLC-21H: 3.2;SH-SY5Y: 2.6;U-2 OS: 1.8;U-2197: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Region enhanced" "Detected in many" "basal ganglia: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040685 Approved "HPA040685: " "unprognostic (9.09e-3)" "unprognostic (1.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.66e-2)" "unprognostic (2.41e-1)" "unprognostic (1.80e-1)" "unprognostic (1.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.96e-2)" "unprognostic (1.86e-2)" "unprognostic (2.05e-1)" "unprognostic (7.07e-2)" "unprognostic (6.11e-5)" "unprognostic (7.94e-3)" "unprognostic (5.80e-2)" "unprognostic (3.25e-3)" "unprognostic (1.36e-2)" 1.1 0.4 2.6 1.4 10.0 0.3 0.1 0.1 2.3 0.5 0.2 0.3 0.0 0.5 0.3 0.1 0.1 0.2 0.6 0.9 1.4 0.9 0.0 0.1 0.3 0.2 0.6 0.0 0.0 0.2 0.4 1.8 1.1 0.4 0.3 0.3 1.3 1.7 0.2 2.7 0.4 0.4 0.9 0.7 0.1 0.0 8.0 3.2 0.0 0.9 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 3.2 2.6 0.1 0.3 0.0 0.0 0.4 0.3 0.0 1.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 10.0 0.1 2.3 1.4 0.9 0.6 0.0 0.4 3.2 DCP1B FLJ31638 ENSG00000151065 "Decapping mRNA 1B" Q8IZD4 12 1946054-2004535 "Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in all" 5 "T-cells: 19.1" "Low region specificity" "Detected in all" HPA039709 Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA039709: AB_10672901" "unprognostic (9.60e-2)" "unprognostic (7.19e-3)" "unprognostic (4.37e-3)" "unprognostic (2.13e-1)" "unprognostic (7.00e-2)" "unprognostic (1.08e-1)" "unprognostic (8.94e-2)" "unprognostic (3.26e-1)" "unprognostic (3.13e-1)" "unprognostic (1.53e-2)" "unprognostic (5.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" "unprognostic (3.98e-2)" "unprognostic (1.46e-1)" "unprognostic (1.84e-2)" "unprognostic (7.42e-2)" 7.3 14.3 8.6 7.1 9.9 2.4 7.4 10.7 8.4 11.0 17.9 6.7 5.6 4.8 18.1 9.8 6.1 11.5 9.2 3.2 10.3 4.9 6.5 7.2 6.4 7.0 7.6 8.2 12.9 8.5 8.5 19.8 6.0 6.1 11.7 8.4 7.5 7.2 11.6 8.7 6.2 7.7 29.1 8.5 7.5 9.9 15.8 7.5 10.0 8.0 1.7 7.1 14.4 8.2 3.8 3.9 2.6 3.4 4.0 19.1 3.8 0.1 3.4 6.2 4.8 7.9 10.0 10.4 4.2 8.3 5.3 6.6 0.2 5.3 8.2 1.5 6.1 0.0 4.2 4.4 4.6 13.9 4.6 3.5 2.6 4.9 10.6 4.8 4.0 7.6 7.3 4.8 4.1 8.6 2.1 3.4 6.4 4.2 6.7 4.1 13.6 1.5 3.9 2.9 1.5 6.2 0.0 0.9 4.5 3.6 3.0 3.0 3.0 4.5 5.0 2.5 9.3 5.8 4.2 2.9 2.1 5.6 6.1 3.2 6.4 2.6 2.1 0.2 7.9 3.1 9.7 3.8 8.0 7.6 3.9 3.8 6.3 8.0 0.4 4.0 3.4 2.0 19.1 3.8 8.6 9.9 10.7 8.4 10.3 4.9 7.6 8.2 6.1 7.5 DCT TYRP2 ENSG00000080166 "Dopachrome tautomerase" P40126 13 94436808-94479682 "Enzymes, Predicted membrane proteins" "Melanin biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 58 "retina: 151.5;skin 1: 54.2" "Cell line enriched" "Detected in single" 259 "SK-MEL-30: 75.0" "Cancer enriched" "Detected in some" 215 "melanoma: 155.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010742, HPA010743, HPA010800, CAB017634" Enhanced Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520" "unprognostic (5.99e-2)" "unprognostic (1.67e-2)" "unprognostic (1.54e-2)" "unprognostic (3.17e-2)" "unprognostic (2.45e-2)" "unprognostic (3.35e-2)" "unprognostic (2.15e-2)" "unprognostic (2.81e-2)" "unprognostic (6.07e-2)" "unprognostic (1.81e-1)" "unprognostic (3.64e-3)" "unprognostic (1.06e-2)" "unprognostic (6.18e-5)" "unprognostic (6.97e-2)" "unprognostic (9.87e-2)" "unprognostic (1.22e-3)" "unprognostic (2.42e-1)" 0.2 0.2 0.5 0.1 1.5 0.1 1.7 0.2 0.6 0.2 0.1 0.3 0.1 0.0 0.2 0.5 0.1 0.8 0.1 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 1.4 0.1 0.3 0.2 0.0 151.5 1.4 0.2 0.2 54.2 0.2 0.1 0.8 0.1 0.0 0.3 0.4 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.5 0.2 0.6 0.4 0.5 0.3 0.1 0.3 0.4 DDO ENSG00000203797 "D-aspartate oxidase" Q99489 6 110391771-110415562 "Enzymes, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 14.5;U-937: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.9;myeloid DC: 7.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037525, HPA037526" Enhanced Enhanced Cytosol Cytosol "HPA037525: AB_2675523, HPA037526: AB_10672352" "unprognostic (1.37e-1)" "unprognostic (1.54e-1)" "unprognostic (6.51e-2)" "unprognostic (1.30e-2)" "unprognostic (2.00e-1)" "unprognostic (3.28e-2)" "unprognostic (3.71e-2)" "unprognostic (1.01e-2)" "unprognostic (2.05e-1)" "unprognostic (2.91e-1)" "unprognostic (6.97e-2)" "unprognostic (1.43e-1)" "prognostic favourable (8.69e-5)" "unprognostic (3.51e-4)" "unprognostic (3.36e-3)" "unprognostic (1.27e-3)" "unprognostic (9.06e-2)" 3.7 11.0 5.2 1.1 12.1 1.6 3.3 1.9 5.5 2.7 3.6 10.8 4.9 8.6 2.7 5.4 1.2 6.1 3.9 21.0 6.9 3.4 12.3 12.8 3.9 1.3 8.0 6.1 1.2 5.5 18.6 1.9 2.1 8.0 2.9 3.9 2.3 4.9 3.2 11.3 0.8 7.9 5.6 7.7 2.6 1.9 0.4 8.2 0.0 3.3 5.7 0.5 3.6 1.6 0.0 7.3 0.1 4.9 1.7 0.0 1.5 0.2 0.0 0.0 0.1 0.0 0.2 1.0 0.2 5.1 1.2 0.9 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 2.3 4.6 0.0 4.7 0.0 4.0 1.6 0.0 0.0 0.1 0.0 2.6 0.1 0.0 0.0 1.8 4.2 0.0 0.0 0.2 0.0 0.1 0.1 2.9 14.5 0.0 4.6 0.1 0.1 0.0 0.4 0.6 0.7 1.0 0.9 1.0 0.1 0.0 2.4 0.1 0.3 0.0 1.9 16.1 0.0 0.1 4.6 0.0 0.0 4.9 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 1.7 1.6 0.0 0.0 1.5 5.2 12.1 1.9 5.5 6.9 3.4 8.0 6.1 8.0 8.2 DDOST "GATD6, KIAA0115, OST, OST48, WBP1" ENSG00000244038 "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit" P39656 1 20651767-20661544 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009746, HPA046841, HPA052867" Supported Supported "Endoplasmic reticulum" 3300000 "Endoplasmic reticulum" "CAB009746: AB_2092075, HPA046841: , HPA052867: " "unprognostic (8.57e-3)" "unprognostic (1.35e-2)" "unprognostic (1.57e-2)" "prognostic favourable (5.99e-4)" "unprognostic (1.62e-1)" "prognostic unfavourable (4.88e-4)" "prognostic unfavourable (2.64e-5)" "unprognostic (1.33e-1)" "unprognostic (5.51e-3)" "unprognostic (2.70e-2)" "unprognostic (3.59e-2)" "unprognostic (3.72e-1)" "prognostic unfavourable (9.05e-7)" "unprognostic (1.07e-1)" "unprognostic (2.98e-1)" "unprognostic (1.69e-2)" "unprognostic (1.07e-1)" 25.7 42.7 17.0 28.7 21.6 37.1 42.5 13.9 26.7 32.8 35.3 16.4 52.0 27.3 37.1 54.7 33.2 32.7 40.0 53.2 13.9 15.7 36.0 59.8 37.2 84.7 16.5 18.3 42.4 146.9 25.4 37.2 71.6 16.1 24.9 39.1 29.5 51.3 58.3 25.5 25.1 35.6 32.2 12.8 49.8 36.5 35.1 15.0 32.5 51.5 28.7 34.5 26.7 30.0 45.6 80.1 50.1 57.1 49.7 58.9 80.7 46.3 29.8 26.0 77.0 51.7 54.1 54.3 39.1 78.7 63.7 65.8 39.6 97.2 38.5 65.2 63.3 40.2 35.8 47.9 47.2 30.5 36.8 33.3 19.4 52.0 77.1 51.7 86.2 55.4 53.4 53.3 64.4 72.7 16.1 64.3 38.2 35.4 24.5 42.8 26.7 31.6 21.6 34.9 68.4 52.0 20.5 18.9 32.9 42.2 43.0 58.1 34.4 80.2 37.3 36.7 38.7 63.4 36.0 76.3 82.0 25.9 60.5 69.2 49.3 44.7 55.7 50.1 55.7 57.1 58.9 45.6 48.2 51.3 80.1 39.6 44.1 46.6 14.2 49.7 48.5 65.4 49.2 80.7 17.0 21.6 13.9 26.7 13.9 15.7 16.5 18.3 16.1 15.0 DDR1 "CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6" ENSG00000204580 "Discoidin domain receptor tyrosine kinase 1" Q08345 6 30876421-30900156 "CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lactation, Pregnancy" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 31.2;HBEC3-KT: 24.0;RT4: 31.9;T-47d: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010162, CAB025656, HPA057194" Approved Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" 2100000 "Nucleoplasm, Cell Junctions" "CAB010162: AB_2092090, CAB025656: , HPA057194: " "unprognostic (2.11e-2)" "unprognostic (9.31e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (7.75e-3)" "unprognostic (6.43e-2)" "unprognostic (1.92e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.50e-1)" "unprognostic (4.41e-2)" "prognostic favourable (3.31e-10)" "unprognostic (1.42e-1)" "unprognostic (2.53e-1)" "unprognostic (5.49e-3)" "unprognostic (4.09e-2)" 6.7 11.3 23.5 7.9 36.2 2.2 12.5 6.8 42.2 9.7 25.2 57.4 17.6 16.8 7.7 10.5 30.5 31.7 18.9 8.7 27.8 20.8 19.8 3.5 13.2 3.1 55.7 19.8 11.3 20.9 28.2 14.6 13.3 34.7 17.7 14.9 4.0 28.3 20.5 9.1 41.3 32.1 3.1 43.2 5.1 52.2 5.1 37.0 8.7 20.9 10.5 7.6 16.3 16.6 1.8 0.4 0.0 0.2 0.0 1.8 0.9 19.3 6.4 9.1 1.9 0.6 0.8 5.6 0.5 0.1 0.2 0.0 8.6 10.3 0.1 10.8 1.7 31.2 1.9 24.0 0.1 10.7 3.4 0.0 5.8 2.2 1.8 0.0 0.4 1.2 12.4 0.1 0.2 0.7 5.6 0.2 1.3 12.2 0.6 0.0 1.5 1.3 1.3 6.8 0.7 4.6 31.9 1.6 0.8 1.8 14.4 7.0 35.8 0.2 1.4 4.5 4.2 0.4 4.5 0.2 0.0 0.8 2.9 0.0 3.9 0.0 0.2 0.0 1.1 0.0 0.8 0.4 0.2 0.7 0.4 1.8 1.2 1.8 0.0 0.0 0.0 0.4 0.0 0.9 23.5 36.2 6.8 25.0 27.8 20.8 55.7 19.8 34.7 37.0 DDR2 "NTRKR3, TKT, TYRO10" ENSG00000162733 "Discoidin domain receptor tyrosine kinase 2" Q16832 1 162631373-162787400 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Osteogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 60.6;ASC TERT1: 59.9;BJ hTERT+: 44.3;fHDF/TERT166: 31.7;HSkMC: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;MAIT T-cell: 1.3" "Lineage enriched" "Detected in single" 5 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070112 Supported "Plasma membrane,Actin filaments" 850000 "Plasma membrane, Actin filaments" "HPA070112: " "unprognostic (4.12e-2)" "unprognostic (2.73e-1)" "unprognostic (6.97e-3)" "unprognostic (4.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.16e-2)" "unprognostic (1.81e-1)" "unprognostic (1.19e-1)" "unprognostic (6.62e-2)" "unprognostic (2.24e-2)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "prognostic unfavourable (1.73e-7)" "unprognostic (1.56e-3)" "unprognostic (8.26e-3)" "unprognostic (7.57e-2)" "unprognostic (4.10e-3)" 42.1 43.5 4.7 10.9 6.9 0.2 15.6 7.9 7.1 30.3 30.4 9.0 18.6 3.3 24.2 17.7 25.0 13.4 16.6 15.4 7.9 4.7 4.0 3.3 8.9 5.1 12.9 3.4 26.4 2.2 2.1 4.0 6.6 12.7 21.8 9.1 30.7 6.4 19.3 5.2 6.1 10.1 34.3 19.7 3.4 14.1 8.3 7.5 0.0 8.6 12.8 4.1 29.0 18.3 0.1 0.2 0.0 0.0 0.2 1.3 0.0 0.1 0.0 0.0 16.0 60.6 59.9 0.2 23.6 44.3 10.3 14.9 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.1 14.1 12.7 0.1 0.0 0.0 0.0 26.3 0.0 0.0 42.5 0.1 18.2 0.4 11.8 0.1 5.0 9.4 0.0 0.0 0.0 0.1 0.1 0.0 6.7 0.1 0.0 0.0 0.0 9.7 0.0 0.0 0.8 0.0 0.0 0.6 16.5 3.6 8.3 3.2 0.7 1.3 0.0 14.9 0.0 16.7 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 4.7 6.9 7.9 7.1 7.9 4.7 12.9 3.4 12.7 7.5 DDX3X "DBX, DDX14, DDX3, HLP2" ENSG00000215301 "DEAD-box helicase 3, X-linked" O00571 X 41333284-41364472 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059585" Supported Supported Approved Nucleoplasm,Cytosol 110000 Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: " "unprognostic (2.42e-2)" "unprognostic (1.11e-1)" "unprognostic (8.01e-3)" "unprognostic (1.66e-1)" "unprognostic (8.12e-2)" "unprognostic (6.43e-2)" "unprognostic (1.17e-3)" "unprognostic (1.88e-1)" "unprognostic (9.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.25e-2)" "unprognostic (2.05e-1)" "unprognostic (1.51e-1)" "unprognostic (2.95e-1)" "unprognostic (4.77e-1)" "unprognostic (9.44e-2)" "unprognostic (2.93e-2)" 80.9 49.3 26.1 40.0 34.5 49.3 46.5 31.1 36.2 52.4 43.3 35.1 21.3 29.5 56.4 25.9 53.5 56.3 42.6 47.6 30.8 24.5 55.6 77.9 45.3 40.4 41.4 29.0 60.1 30.9 68.7 60.2 79.9 37.9 30.0 29.2 30.8 37.4 26.5 63.4 42.2 54.0 57.2 53.9 46.1 43.0 27.0 39.0 49.2 45.6 44.0 42.6 55.8 50.2 13.1 20.5 32.0 21.6 17.3 21.5 17.9 45.4 50.5 47.2 25.9 55.6 47.2 28.8 33.1 46.6 34.0 27.4 51.9 30.6 0.5 23.7 37.1 30.7 57.7 46.6 56.7 26.9 45.0 28.9 50.3 31.2 28.9 54.1 52.0 34.1 33.1 57.3 55.4 53.3 53.0 28.6 31.6 34.4 34.1 16.9 45.4 20.4 40.0 50.3 37.0 32.0 61.2 32.3 48.9 75.0 38.5 39.7 34.6 36.8 48.1 35.1 37.6 37.5 39.3 33.4 39.6 44.9 35.4 32.8 33.2 22.5 20.2 17.5 14.8 21.1 21.5 13.1 14.5 16.3 20.5 9.0 16.3 15.1 32.0 17.3 21.6 6.9 14.3 17.9 26.1 34.5 31.1 36.2 30.8 24.5 41.4 29.0 37.9 39.0 DENND1A "FAM31A, FLJ21129, KIAA1608" ENSG00000119522 "DENN domain containing 1A" Q8TEH3 9 123379654-123930152 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020481 Supported Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA020481: AB_2092106" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "unprognostic (2.00e-1)" "unprognostic (4.25e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.19e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (2.48e-3)" "unprognostic (5.63e-2)" "prognostic favourable (4.11e-5)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (9.66e-2)" "unprognostic (4.31e-2)" 11.4 12.2 17.4 13.9 19.8 32.5 10.0 18.6 21.2 10.9 14.8 12.8 10.3 15.8 13.3 9.0 11.3 13.0 10.5 10.3 15.9 12.8 16.4 14.5 9.4 11.6 11.8 14.9 12.0 8.9 20.1 19.0 23.9 13.9 11.0 14.1 14.5 8.5 11.8 11.0 9.3 17.2 14.4 10.1 20.2 9.9 12.1 13.2 10.6 15.5 5.6 9.5 10.6 17.4 1.5 8.4 11.2 15.2 0.5 1.3 3.2 14.7 8.7 7.9 14.9 5.4 8.5 36.6 14.4 21.7 12.3 10.6 11.9 6.6 11.9 3.0 11.6 8.4 6.7 10.4 12.0 5.0 5.1 5.6 21.2 8.7 7.2 6.7 3.8 7.8 9.4 10.1 17.4 10.9 15.3 9.1 9.9 8.4 8.0 9.7 15.7 13.3 12.4 7.7 10.1 6.1 5.2 16.8 13.6 11.6 7.7 8.9 10.5 17.0 5.0 13.3 5.1 15.4 7.5 14.0 10.8 8.2 11.1 13.4 8.7 11.2 15.2 2.8 1.3 10.1 0.7 1.1 0.9 0.6 8.4 1.5 0.6 0.7 9.3 0.5 8.2 1.3 0.4 3.2 17.4 19.8 18.6 21.2 15.9 12.8 11.8 14.9 13.9 13.2 DENND1B "C1orf218, FAM31B, FLJ20054, MGC27044" ENSG00000213047 "DENN domain containing 1B" Q6P3S1 1 197504748-197775696 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042586 Uncertain Supported "Nuclear speckles,Cytosol" Cytosol "Nuclear speckles" "HPA042586: " "unprognostic (8.79e-2)" "unprognostic (1.58e-1)" "unprognostic (4.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.39e-1)" "unprognostic (7.13e-3)" "unprognostic (2.69e-1)" "unprognostic (9.54e-2)" "unprognostic (7.79e-3)" "unprognostic (3.99e-2)" "unprognostic (3.13e-2)" "unprognostic (5.36e-2)" "unprognostic (6.11e-2)" "unprognostic (5.61e-3)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-2)" 5.9 3.9 6.2 12.7 8.3 6.4 8.7 3.9 5.6 5.7 13.0 1.4 8.8 7.5 3.6 6.4 9.0 3.1 5.4 7.3 4.9 4.9 7.9 6.6 7.3 7.8 4.0 2.7 5.6 8.7 9.9 15.9 3.6 3.7 7.5 7.8 6.4 9.9 15.8 6.5 3.8 21.6 4.1 3.5 7.7 6.1 4.4 2.6 17.9 8.2 6.5 11.7 6.9 6.8 2.3 2.0 5.0 0.6 5.8 3.6 0.7 5.9 1.5 1.7 2.9 0.8 4.4 2.7 4.6 3.2 2.8 1.7 1.6 3.8 10.9 2.4 7.0 3.1 2.7 3.3 2.5 8.2 2.9 3.9 3.0 0.7 2.4 12.8 4.9 1.5 4.5 1.1 3.2 1.2 3.0 16.9 2.8 1.1 6.8 6.6 0.6 1.5 4.2 1.5 8.5 7.0 5.6 2.9 4.6 7.1 4.8 1.2 2.0 11.2 3.4 0.3 2.8 0.1 2.7 8.6 0.0 5.5 3.0 5.2 5.3 5.0 0.3 2.3 2.1 0.6 1.1 2.3 1.4 3.3 1.5 0.7 0.8 1.5 1.0 5.8 0.6 2.0 3.6 0.7 6.2 8.3 3.9 5.6 4.9 4.9 4.0 2.7 3.7 2.6 DENND3 KIAA0870 ENSG00000105339 "DENN domain containing 3" A2RUS2 8 141117278-141195808 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.9" "Cell line enhanced" "Detected in many" "HDLM-2: 26.8;HeLa: 33.1;U-937: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 18.0;neutrophil: 22.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 22.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024491, HPA041668" Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA024491: , HPA041668: " "unprognostic (2.27e-1)" "unprognostic (9.62e-2)" "unprognostic (9.47e-3)" "unprognostic (1.66e-1)" "unprognostic (6.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (7.07e-3)" "unprognostic (2.71e-2)" "unprognostic (2.25e-2)" "unprognostic (7.74e-2)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (4.51e-2)" "unprognostic (5.42e-2)" 21.8 6.2 12.2 21.7 15.2 75.9 17.6 1.7 12.3 10.4 17.0 11.5 2.3 5.5 10.3 6.1 6.8 8.3 12.0 8.8 12.1 8.5 12.2 3.9 30.1 27.8 15.9 7.7 8.9 4.7 4.5 5.8 13.0 13.7 9.0 7.4 7.1 10.2 8.3 12.9 8.3 12.7 7.8 21.9 24.7 9.1 4.6 11.8 3.4 11.4 3.5 20.6 9.5 9.8 2.4 2.2 22.2 5.4 1.4 0.4 1.6 6.8 6.2 0.4 1.3 1.9 2.8 1.0 3.9 11.5 1.6 1.3 1.9 6.4 1.8 10.2 7.3 3.5 1.7 4.2 1.1 26.8 1.6 7.1 33.1 0.6 1.7 7.0 1.1 0.2 2.1 1.8 2.3 9.0 0.0 17.3 1.2 2.1 1.0 9.8 0.4 8.1 1.2 0.3 6.7 6.4 2.3 2.0 1.2 0.7 0.5 0.4 2.8 11.3 7.1 0.3 3.1 4.5 0.1 3.5 15.4 0.5 1.1 24.3 0.4 9.3 2.9 18.0 0.4 4.5 0.4 2.4 0.3 0.1 2.2 2.3 0.0 0.1 22.2 1.4 5.4 0.0 0.1 1.6 12.2 15.2 1.7 12.3 12.1 8.5 15.9 7.7 13.7 11.8 DENND5A "FLJ22354, FLJ33829, FLJ43455, KIAA1091, RAB6IP1" ENSG00000184014 "DENN domain containing 5A" Q6IQ26 11 9138825-9265390 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052923, HPA055009" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA052923: , HPA055009: " "unprognostic (5.28e-3)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" "unprognostic (1.28e-2)" "unprognostic (4.03e-1)" "unprognostic (3.48e-1)" "prognostic unfavourable (5.05e-6)" "unprognostic (1.84e-1)" "unprognostic (2.96e-1)" "unprognostic (1.02e-1)" "unprognostic (5.15e-2)" "unprognostic (3.10e-1)" "prognostic unfavourable (1.14e-6)" "unprognostic (9.86e-3)" "unprognostic (1.03e-1)" "unprognostic (4.32e-1)" "unprognostic (1.40e-2)" 26.7 13.0 36.6 18.6 37.2 22.9 15.8 23.7 43.8 20.0 16.8 56.8 9.3 4.4 23.2 16.7 13.8 18.1 19.8 35.2 36.3 31.6 13.1 11.4 22.8 13.4 44.4 20.4 18.2 17.5 18.1 9.2 22.1 35.3 14.5 10.2 13.6 9.0 26.6 12.1 7.3 8.0 32.8 51.0 21.9 10.5 10.4 34.9 7.3 11.5 5.9 12.4 17.9 20.3 1.8 5.1 14.7 9.9 1.7 5.5 2.0 6.4 8.8 24.2 21.6 35.2 32.3 24.1 21.1 31.1 29.2 34.4 8.2 4.9 0.0 9.1 38.8 5.4 21.5 7.1 35.9 22.3 11.7 2.3 13.5 11.9 20.0 11.1 4.8 25.1 4.8 17.4 25.0 26.1 10.6 0.2 30.5 4.9 6.2 7.6 6.8 9.4 10.6 14.4 0.1 13.9 5.0 5.5 11.3 19.8 9.5 10.6 5.1 7.2 18.5 23.0 13.7 27.6 15.5 0.5 0.1 5.5 22.4 5.7 17.3 5.3 5.2 6.1 0.3 7.8 0.8 1.8 1.9 1.6 5.1 0.5 5.5 2.6 14.7 1.7 9.9 1.6 0.0 2.0 36.6 37.2 23.7 33.9 36.3 31.6 44.4 20.4 35.3 34.9 DEXI MYLE ENSG00000182108 "Dexi homolog" O95424 16 10928891-10942460 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041511 Approved Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA041511: AB_10796675" "unprognostic (4.14e-1)" "unprognostic (8.52e-2)" "unprognostic (1.29e-1)" "unprognostic (9.70e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (1.19e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "unprognostic (1.47e-2)" "prognostic favourable (4.23e-4)" "unprognostic (5.21e-2)" "unprognostic (1.33e-3)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.75e-2)" "unprognostic (1.83e-2)" 15.0 25.2 15.7 8.0 20.8 4.1 10.7 14.0 27.5 12.2 13.9 9.8 12.7 11.1 11.7 18.5 12.9 14.5 11.6 32.2 13.1 13.6 13.3 26.3 9.5 9.9 18.8 12.3 15.9 18.0 22.1 12.9 13.3 21.3 13.6 6.6 13.7 15.4 16.6 81.6 10.3 11.1 12.1 9.4 12.7 10.6 8.9 11.9 13.7 18.4 10.6 8.1 10.9 10.5 4.0 2.4 8.2 0.7 3.9 7.0 1.2 9.3 13.7 7.4 13.0 30.2 16.6 6.8 14.5 15.1 9.5 9.1 6.4 9.9 11.2 21.9 16.4 12.2 8.7 15.6 8.2 26.2 19.5 5.5 9.0 27.1 17.3 9.5 10.5 16.9 18.0 9.3 10.8 13.7 12.6 11.2 10.5 16.5 11.8 10.3 10.3 14.3 11.0 9.8 17.1 11.8 7.0 15.3 13.5 13.8 15.3 11.5 12.1 16.5 14.9 9.6 10.4 22.7 9.4 14.9 11.4 3.2 8.4 20.4 10.8 1.7 0.6 8.2 6.0 0.7 5.6 0.6 5.2 7.0 0.4 4.0 6.4 6.0 0.7 3.9 0.3 2.4 3.9 1.2 15.7 20.8 14.0 27.5 13.1 13.6 18.8 12.3 21.3 11.9 DGCR2 "DGS-C, IDD, KIAA0163, LAN, SEZ-12" ENSG00000070413 "DiGeorge syndrome critical region gene 2" P98153 22 19036282-19122454 "Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000873 Uncertain "HPA000873: AB_1847632" "unprognostic (1.68e-1)" "unprognostic (4.27e-2)" "unprognostic (4.03e-2)" "unprognostic (1.33e-2)" "unprognostic (6.28e-2)" "unprognostic (8.51e-2)" "unprognostic (1.05e-1)" "unprognostic (6.86e-2)" "unprognostic (2.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.25e-1)" "unprognostic (2.06e-2)" "prognostic favourable (8.72e-7)" "unprognostic (3.63e-2)" "unprognostic (2.29e-1)" "unprognostic (6.27e-2)" "unprognostic (6.28e-3)" 20.3 21.0 28.6 19.0 30.0 7.2 29.5 30.0 40.0 22.1 26.2 23.3 19.0 26.3 21.7 21.0 27.6 26.0 24.2 24.3 28.7 30.7 19.6 17.8 24.7 29.8 24.3 29.7 30.5 44.5 27.5 21.6 16.9 23.2 25.9 16.9 16.6 31.7 26.3 17.2 46.4 26.3 16.7 19.2 18.5 24.4 19.5 21.6 19.3 28.3 25.0 16.9 20.4 19.2 4.8 5.8 19.8 7.6 4.2 8.0 7.5 16.7 10.5 13.2 23.4 24.3 9.8 12.9 11.2 14.1 11.1 11.0 17.9 19.1 8.9 15.8 12.3 31.7 9.8 10.8 4.7 7.5 17.8 5.9 6.6 14.3 14.7 11.1 13.6 13.9 25.2 8.6 10.1 12.2 44.2 7.8 5.6 17.5 5.8 12.0 11.0 7.7 10.3 14.0 3.4 19.0 18.5 18.1 13.4 20.7 14.5 12.6 13.5 10.1 10.7 20.5 10.6 10.6 9.0 8.7 3.2 5.8 9.7 6.5 15.5 7.3 7.6 12.8 5.5 4.5 4.8 3.9 5.8 5.5 5.8 4.8 7.2 5.5 19.8 4.2 3.2 3.5 8.0 7.5 28.6 30.0 30.0 40.0 28.7 30.7 24.3 29.7 23.2 21.6 DGKE "DAGK6, DGK" ENSG00000153933 "Diacylglycerol kinase epsilon" P52429 17 56834099-56869567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 42.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017167 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA017167: AB_1847638" "unprognostic (1.19e-2)" "unprognostic (2.11e-2)" "unprognostic (2.69e-1)" "prognostic favourable (3.92e-5)" "unprognostic (4.20e-2)" "unprognostic (4.87e-2)" "unprognostic (3.37e-1)" "unprognostic (4.27e-2)" "unprognostic (1.19e-3)" "unprognostic (4.75e-2)" "unprognostic (6.07e-3)" "unprognostic (2.68e-1)" "unprognostic (2.55e-2)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-1)" "unprognostic (3.69e-3)" 7.8 4.9 7.8 8.3 17.7 5.5 5.2 21.3 18.6 9.5 7.4 4.4 5.6 5.4 13.3 8.9 5.0 8.2 9.4 4.9 7.4 9.2 4.2 4.9 8.1 9.3 5.6 10.0 7.3 6.5 9.5 14.5 5.5 9.9 8.9 7.0 17.4 4.3 7.3 2.4 3.4 7.1 9.3 6.8 12.7 6.4 12.5 5.4 14.5 8.3 2.5 8.6 6.5 15.3 2.4 2.4 1.2 0.8 1.9 4.5 0.8 1.6 1.6 1.5 0.1 0.2 0.5 0.7 2.8 2.3 1.9 2.3 3.7 2.0 2.4 3.5 1.5 2.0 3.6 1.5 4.0 7.8 4.6 3.1 3.9 2.4 1.7 6.0 4.5 0.9 2.0 2.0 4.1 2.6 2.5 42.7 2.4 2.4 14.2 3.4 1.1 4.8 4.4 6.2 5.8 1.9 3.7 2.3 1.6 2.3 1.2 0.1 2.6 2.9 2.4 0.5 2.7 0.8 0.4 5.6 11.5 1.6 1.7 3.5 0.1 0.3 0.5 0.0 2.7 0.4 2.0 2.4 1.9 2.3 0.6 0.9 1.9 2.5 1.2 1.9 0.8 2.4 4.5 0.8 7.8 17.7 21.3 18.6 7.4 9.2 5.6 10.0 9.9 5.4 DHCR7 SLOS ENSG00000172893 "7-dehydrocholesterol reductase" Q9UBM7 11 71428193-71452868 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044280 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum" Cytosol "HPA044280: AB_10794893" "unprognostic (1.76e-1)" "unprognostic (1.50e-3)" "unprognostic (1.32e-2)" "unprognostic (7.16e-3)" "unprognostic (2.69e-1)" "unprognostic (2.18e-3)" "unprognostic (8.57e-3)" "unprognostic (3.02e-2)" "unprognostic (4.91e-2)" "unprognostic (1.13e-1)" "unprognostic (1.08e-2)" "unprognostic (5.45e-2)" "prognostic favourable (6.93e-7)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (8.15e-2)" "prognostic unfavourable (5.67e-4)" 8.0 40.1 12.1 5.6 14.5 19.0 16.8 5.3 22.8 5.5 9.3 27.9 8.8 20.8 4.0 27.3 14.6 5.2 5.8 10.7 13.7 13.2 7.1 64.8 12.0 2.7 20.6 12.3 21.5 7.3 14.0 7.0 3.7 23.4 10.0 6.6 16.6 10.0 3.9 5.4 22.9 15.8 4.5 20.5 5.9 8.5 17.7 15.5 2.8 5.4 12.1 7.7 4.3 7.4 6.3 6.2 3.5 1.9 4.6 12.1 5.7 21.6 19.6 19.2 21.2 9.0 14.0 6.0 8.9 23.8 7.6 20.8 73.0 71.1 15.1 14.3 8.5 41.6 22.8 48.3 8.1 5.7 17.1 5.7 16.6 31.2 23.1 10.8 2.8 16.2 21.4 28.6 19.7 11.2 27.0 32.3 7.6 58.1 8.9 12.2 27.5 11.7 8.1 27.0 65.0 28.6 32.7 26.1 9.7 8.5 28.2 20.3 27.3 5.9 10.6 2.1 11.6 0.6 10.7 10.7 12.9 16.1 6.1 19.2 8.6 3.5 1.9 1.7 9.7 1.2 11.8 6.3 8.2 9.0 2.5 5.4 10.5 12.1 1.0 4.6 1.2 6.2 5.1 5.7 12.1 14.5 5.3 22.8 13.7 13.2 20.6 12.3 23.4 15.5 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 72.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 5.9 4.2 4.7 8.8 5.1 2.9 5.0 2.7 5.0 5.9 4.4 6.1 1.4 3.4 6.6 2.3 5.1 5.2 2.3 11.5 4.3 3.0 6.6 72.4 3.4 5.5 4.8 2.7 6.2 9.9 7.1 4.0 2.6 5.2 3.9 4.8 5.9 6.0 4.4 11.7 4.0 3.0 7.5 4.0 3.5 3.4 4.3 5.4 4.0 3.6 7.1 5.1 3.5 3.3 11.2 13.4 3.9 8.1 9.3 12.9 6.8 7.3 15.4 4.5 7.4 2.4 3.2 8.5 6.3 2.5 9.6 7.4 12.1 6.8 16.6 8.6 3.4 7.8 8.8 6.8 11.3 3.7 8.3 9.1 7.5 11.8 6.8 12.6 6.7 3.1 7.0 11.6 12.2 6.9 13.9 3.0 5.8 19.6 11.9 12.1 10.1 6.0 15.1 5.9 17.5 5.8 4.9 5.3 6.3 8.5 9.1 4.1 8.1 6.4 3.0 8.8 5.5 8.3 9.2 5.8 10.8 28.1 4.6 13.8 8.0 3.9 8.1 0.9 9.3 7.7 12.7 11.2 8.9 9.0 13.3 10.6 12.4 12.9 2.1 9.3 5.6 13.4 7.1 6.8 4.7 5.1 2.7 5.0 4.3 3.0 4.8 2.7 5.2 5.4 DHRS3 "RDH17, retSDR1, Rsdr1, SDR1, SDR16C1" ENSG00000162496 "Dehydrogenase/reductase 3" O75911 1 12567910-12617731 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 29.0;CAPAN-2: 59.3;SK-BR-3: 31.8;WM-115: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8" "Group enriched" "Detected in many" 9 "dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010844 Supported Approved Nucleoli,Mitochondria "Nucleoli, Mitochondria" "HPA010844: AB_1847653" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.74e-3)" "unprognostic (1.87e-1)" "unprognostic (3.68e-2)" "unprognostic (2.25e-3)" "unprognostic (5.06e-2)" "unprognostic (3.40e-2)" "unprognostic (5.18e-2)" "unprognostic (1.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.80e-1)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "prognostic favourable (2.65e-4)" "unprognostic (5.48e-2)" 22.7 4.4 6.3 6.2 8.6 2.5 30.6 4.0 7.9 16.7 16.3 3.4 9.2 13.6 7.6 15.5 19.0 12.2 11.2 16.1 6.8 8.6 12.3 45.6 11.6 8.3 9.0 4.5 11.8 20.3 0.5 8.9 11.5 9.8 16.3 5.6 20.3 11.8 14.3 10.2 5.6 18.9 11.1 9.8 4.2 12.3 5.2 4.2 3.1 40.5 5.4 5.2 21.0 9.4 0.2 8.6 2.1 0.3 13.8 33.5 15.6 5.1 29.0 0.0 12.8 16.8 1.4 3.3 1.7 0.0 0.0 0.1 3.4 59.3 0.0 1.4 17.0 23.4 6.2 3.2 0.0 0.0 10.4 4.5 3.0 16.1 2.5 0.0 0.0 8.5 3.9 0.1 0.1 5.4 6.8 0.0 0.1 0.9 1.2 0.2 1.9 11.7 0.1 0.0 5.9 0.0 9.9 0.3 0.5 9.8 31.8 1.8 3.1 1.2 3.9 0.1 0.6 8.9 0.1 0.9 0.0 0.0 6.7 0.4 55.1 2.1 0.2 0.0 33.5 0.1 24.2 0.2 18.3 15.7 8.6 0.2 31.6 19.7 1.7 13.8 0.3 1.0 0.5 15.6 6.3 8.6 4.0 7.9 6.8 8.6 9.0 4.5 9.8 4.2 DHRS7B "CGI-93, DKFZp566O084, MGC8916, SDR32C1" ENSG00000109016 "Dehydrogenase/reductase 7B" Q6IAN0 17 21123364-21193265 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012132, HPA016873" Uncertain Approved "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "HPA012132: AB_1847658, HPA016873: AB_1847657" "unprognostic (1.90e-1)" "unprognostic (3.16e-2)" "unprognostic (2.71e-1)" "prognostic favourable (1.98e-8)" "unprognostic (9.83e-2)" "unprognostic (1.18e-1)" "unprognostic (3.46e-1)" "unprognostic (1.45e-1)" "unprognostic (5.02e-3)" "unprognostic (2.76e-1)" "unprognostic (1.70e-1)" "unprognostic (2.81e-1)" "prognostic favourable (3.95e-5)" "unprognostic (1.20e-2)" "unprognostic (6.26e-2)" "unprognostic (9.20e-2)" "unprognostic (3.97e-1)" 15.9 17.8 14.0 10.3 14.5 2.5 16.2 11.1 15.2 17.6 14.2 11.9 16.7 14.4 13.5 25.3 12.8 15.4 16.3 17.9 11.8 13.2 23.1 18.4 13.9 14.0 14.5 14.8 11.8 18.9 31.2 11.4 14.2 12.9 14.8 15.2 16.5 17.5 10.5 23.7 15.7 18.3 12.7 11.1 11.5 14.7 30.5 9.1 8.0 19.7 15.8 10.9 10.7 12.8 4.2 11.7 15.0 20.4 4.1 5.7 7.5 10.0 11.9 4.4 9.5 11.6 8.0 7.6 9.6 5.4 7.0 12.9 15.0 10.6 4.2 14.7 8.2 14.3 6.4 15.7 10.0 8.1 20.6 5.8 8.8 12.8 6.4 3.2 4.3 6.2 10.5 9.0 13.7 6.8 3.5 5.3 8.2 20.7 3.5 12.7 6.0 5.1 5.9 11.5 7.4 23.4 12.2 2.4 5.1 11.9 10.6 10.3 7.1 6.7 3.4 5.9 4.1 17.6 10.8 2.9 4.5 7.9 9.2 12.0 8.7 9.7 18.9 15.0 3.8 17.9 3.4 4.2 3.8 2.5 11.7 3.6 4.1 3.6 13.5 4.1 20.4 5.0 5.7 7.5 14.0 14.5 11.1 15.2 11.8 13.2 14.5 14.8 12.9 9.1 DHRS9 "3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4" ENSG00000073737 "Dehydrogenase/reductase 9" Q9BPW9 2 169064789-169096167 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.0;blood: 53.1;heart muscle: 32.2;intestine: 30.9" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 8.8;NB-4: 14.4;THP-1: 42.2;TIME: 18.8;U-2197: 13.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 16.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 53.1;eosinophil: 23.9;neutrophil: 19.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 53.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA036491, HPA036667" Approved "Intracellular and membrane" "HPA036491: AB_10673498, HPA036667: AB_10670237" "unprognostic (1.15e-1)" "unprognostic (3.82e-3)" "unprognostic (1.15e-1)" "unprognostic (1.85e-1)" "unprognostic (4.80e-2)" "unprognostic (2.35e-1)" "unprognostic (3.24e-2)" "unprognostic (1.40e-1)" "unprognostic (3.18e-1)" "unprognostic (3.62e-4)" "prognostic unfavourable (2.73e-4)" "unprognostic (2.72e-1)" "unprognostic (3.23e-1)" "unprognostic (1.85e-2)" "unprognostic (1.34e-2)" "unprognostic (1.12e-1)" "unprognostic (1.41e-1)" 40.0 0.1 1.3 14.9 1.0 3.3 2.2 0.3 1.9 4.0 30.9 1.1 0.8 0.6 1.3 0.9 12.8 0.6 2.3 32.2 1.2 0.8 0.4 1.0 9.6 8.0 2.5 1.1 1.2 1.4 0.0 0.3 4.9 1.1 3.5 20.9 0.6 2.9 0.3 1.0 1.5 2.7 3.5 2.4 4.0 4.6 12.3 0.6 0.9 0.5 23.2 12.0 3.7 4.6 1.7 5.4 53.1 6.1 0.0 0.1 1.3 0.0 0.3 0.0 0.0 1.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.4 0.1 0.2 0.5 2.6 8.8 0.4 0.0 0.0 0.0 0.0 14.4 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 42.2 18.8 0.0 0.1 13.9 0.1 0.0 0.0 0.0 0.3 7.5 0.0 53.1 5.4 23.9 0.0 6.1 0.1 1.7 0.0 0.0 5.4 1.0 0.0 0.0 19.5 0.0 1.2 0.4 0.0 1.3 1.3 1.0 0.3 0.7 1.2 0.8 2.5 1.1 1.1 0.6 DHX36 "DDX36, KIAA1488, MLEL1" ENSG00000174953 "DEAH-box helicase 36" Q9H2U1 3 154272546-154324497 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035399 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA035399: AB_10670115" "unprognostic (8.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.86e-1)" "unprognostic (3.50e-3)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (8.80e-3)" "unprognostic (1.03e-1)" "unprognostic (7.51e-2)" "unprognostic (1.26e-1)" "unprognostic (3.94e-2)" "unprognostic (3.90e-2)" "unprognostic (2.72e-1)" "unprognostic (5.09e-2)" "unprognostic (5.27e-1)" "unprognostic (4.96e-2)" "unprognostic (1.37e-1)" 16.3 14.0 11.5 14.1 27.5 12.6 15.7 19.0 21.3 17.9 14.7 10.3 12.4 10.7 20.4 10.6 14.5 14.3 13.7 23.9 13.4 12.7 16.7 17.1 14.6 17.0 12.2 15.0 20.0 13.7 34.0 36.2 16.4 20.1 15.7 12.2 9.3 15.5 20.5 53.4 14.7 14.3 15.1 13.7 18.9 13.4 28.3 11.3 24.3 20.4 13.4 17.1 20.7 15.6 6.3 5.9 3.1 5.7 4.8 6.9 1.1 26.7 18.3 24.9 14.3 11.7 16.5 12.4 17.5 17.6 20.0 23.9 18.6 21.5 26.0 28.4 15.3 17.3 23.4 14.8 31.5 24.9 15.5 18.8 15.7 10.5 19.9 26.1 16.5 18.6 12.6 21.4 26.3 17.1 17.7 15.0 18.4 13.0 21.6 5.7 33.0 17.6 22.5 20.9 37.4 14.3 19.0 23.3 24.8 18.2 19.4 25.4 19.9 13.3 19.3 21.0 13.2 19.6 34.9 28.1 18.1 37.5 17.0 13.7 22.2 1.9 2.7 3.1 6.9 2.8 4.4 4.7 6.1 4.7 2.3 6.3 5.8 6.0 1.1 4.8 5.7 5.9 5.4 1.1 11.5 27.5 19.0 21.3 13.4 12.7 12.2 15.0 20.1 11.3 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000184047 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207663-122226568 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA001825, CAB003857, CAB016688" Supported Enhanced Mitochondria 21000 Mitochondria "CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247" "unprognostic (3.67e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-1)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (2.38e-3)" "unprognostic (1.40e-3)" "unprognostic (5.06e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (4.05e-2)" "prognostic unfavourable (5.35e-4)" "unprognostic (6.68e-2)" "unprognostic (2.36e-1)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" 17.2 29.7 21.9 15.5 24.0 26.7 24.8 21.9 30.1 20.4 25.9 29.0 14.3 20.6 22.2 36.6 23.5 21.8 19.2 20.3 21.2 26.8 31.7 37.2 15.8 20.9 28.3 23.6 22.4 32.6 22.9 30.6 28.5 27.0 21.1 24.2 22.4 22.2 20.2 25.8 18.2 21.3 21.8 29.2 18.5 19.8 62.7 21.8 23.2 26.9 23.0 22.8 20.5 17.9 32.8 35.0 27.5 29.1 29.9 32.1 26.8 19.0 37.8 26.7 18.1 19.2 18.8 20.5 19.8 19.5 23.3 21.0 32.6 10.0 23.3 18.7 17.9 19.0 29.0 23.7 27.7 20.1 22.7 25.5 15.6 29.9 27.4 27.4 10.6 26.0 16.9 27.5 41.3 26.9 29.2 9.9 22.6 28.4 22.4 40.3 21.5 35.5 20.4 26.6 25.6 26.3 29.7 25.3 25.8 26.5 10.6 21.5 35.8 19.3 18.3 18.0 22.2 20.4 17.8 21.6 36.1 33.4 23.0 21.1 23.6 23.6 28.9 27.5 30.4 29.1 29.1 32.8 28.4 28.4 35.0 26.0 27.9 28.2 12.7 29.9 26.5 26.8 32.1 26.8 21.9 24.0 21.9 30.1 21.2 26.8 28.3 23.6 27.0 21.8 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000284934 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207662-122227534 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.7;intestine: 5.3;lymphoid tissue: 3.8" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 20.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA001825 Uncertain Approved Mitochondria 21000 Mitochondria "HPA001825: AB_1857247" 0.1 8.7 0.0 3.8 0.0 0.0 0.0 0.0 0.5 0.2 5.3 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.9 2.4 0.0 1.2 0.6 1.1 0.6 0.6 2.3 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.5 0.4 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.3 0.1 0.2 0.0 0.1 0.7 0.0 0.4 1.8 20.8 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.7 0.5 0.3 1.4 0.6 1.0 0.3 1.0 2.3 0.6 1.2 0.3 1.3 1.1 0.6 0.2 0.4 2.2 0.5 DIO2 "SelY, TXDI2" ENSG00000211448 "Iodothyronine deiodinase 2" Q92813 14 80197527-80387757 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 67.7;thyroid gland: 128.7" "Cell line enhanced" "Detected in some" "BJ: 26.1;fHDF/TERT166: 14.3;HeLa: 29.9;HHSteC: 14.9;SiHa: 54.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 34.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029544, HPA048002" Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA029544: AB_10600804, HPA048002: " "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "prognostic favourable (1.67e-4)" "prognostic favourable (4.62e-6)" "unprognostic (2.76e-1)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (2.07e-1)" "unprognostic (8.78e-2)" "unprognostic (3.68e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-3)" "unprognostic (5.08e-2)" "unprognostic (3.43e-1)" "unprognostic (8.40e-2)" "unprognostic (7.15e-2)" 1.3 1.8 13.0 0.9 12.3 0.7 6.1 1.0 19.7 67.7 1.2 1.6 1.9 1.2 15.6 1.1 36.1 0.9 2.5 4.7 14.2 2.7 2.4 0.7 1.2 1.0 4.1 7.6 0.7 1.3 0.9 35.9 5.9 13.2 5.0 1.3 13.1 17.7 12.4 3.0 3.3 1.2 2.4 1.2 0.9 2.5 2.5 1.4 0.0 128.7 15.8 12.0 2.6 13.7 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.4 0.0 26.1 5.5 2.3 0.3 0.0 0.1 0.0 0.1 14.3 0.5 0.9 0.0 1.9 0.0 0.0 0.0 29.9 0.0 14.9 0.0 0.0 1.6 0.0 0.5 0.0 0.5 0.0 0.2 0.1 0.6 0.0 0.0 0.5 0.1 0.2 1.2 0.0 0.0 0.2 0.0 0.0 54.7 11.4 0.1 0.0 0.0 0.3 0.1 2.4 5.5 6.6 0.8 0.0 0.0 2.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 13.0 12.3 1.0 19.7 14.2 2.7 4.1 7.6 13.2 1.4 DIP2A "C21orf106, Dip2, KIAA0184" ENSG00000160305 "Disco interacting protein 2 homolog A" Q14689 21 46458899-46569852 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052516 Uncertain Approved Nucleoplasm Nucleoplasm "HPA052516: " "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (6.52e-2)" "unprognostic (3.88e-2)" "unprognostic (7.30e-2)" "prognostic favourable (9.35e-5)" "unprognostic (1.37e-1)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (1.09e-1)" "unprognostic (3.86e-2)" "unprognostic (1.70e-2)" "unprognostic (6.05e-3)" "unprognostic (1.05e-1)" "unprognostic (8.08e-2)" "unprognostic (2.46e-1)" "unprognostic (1.78e-3)" 10.8 12.6 9.8 18.1 15.0 16.7 13.1 17.1 14.6 10.5 10.3 20.6 8.6 12.5 11.8 7.6 14.3 11.7 9.0 15.4 11.0 7.5 7.5 5.9 10.5 12.5 14.1 10.7 12.1 13.0 10.8 12.6 10.9 14.7 13.7 7.8 15.1 14.1 9.1 18.3 12.9 13.6 9.5 11.4 15.8 13.8 16.9 13.3 16.0 10.2 7.4 11.3 14.9 11.4 4.0 10.4 11.5 6.5 9.3 15.7 4.0 12.3 8.1 15.8 7.4 7.5 7.0 9.8 8.7 6.8 8.6 7.1 14.2 9.6 5.3 8.2 9.0 6.5 6.9 11.5 5.0 20.2 10.0 17.8 13.3 8.7 5.0 6.5 9.3 6.1 7.9 9.0 9.7 12.5 11.4 12.1 7.1 11.2 9.8 9.8 8.6 8.6 10.1 6.5 10.5 5.2 11.2 8.5 5.4 13.2 8.7 7.6 9.3 6.4 16.9 7.1 5.1 9.9 6.5 12.5 6.3 4.9 7.6 10.8 11.8 8.1 5.4 11.5 15.7 6.3 9.9 3.2 6.9 10.4 2.9 4.0 5.0 9.7 10.4 9.3 6.5 10.4 5.6 4.0 9.8 15.0 17.1 14.6 11.0 7.5 14.1 10.7 14.7 13.3 DLK1 "Delta1, FA1, pG2, Pref-1, ZOG" ENSG00000185559 "Delta like non-canonical Notch ligand 1" P80370 14 100725705-100738224 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 157.6;pituitary gland: 143.1;placenta: 244.9" "Group enriched" "Detected in some" 6 "AF22: 22.5;Hep G2: 75.2;SH-SY5Y: 89.6" "Cancer enhanced" "Detected in many" "liver cancer: 28.1" "Group enriched" "Detected in some" 5 "hypothalamus: 2.6;pons and medulla: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 65.4" "Region enhanced" "Detected in many" "midbrain: 159.6" "CAB005872, HPA062262" Enhanced Approved "Golgi apparatus" 160000 "Golgi apparatus" "CAB005872: AB_731965, HPA062262: " "unprognostic (2.16e-2)" "prognostic unfavourable (2.31e-4)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (4.89e-3)" "unprognostic (5.75e-2)" "unprognostic (1.87e-2)" "unprognostic (1.12e-1)" "unprognostic (5.24e-1)" "unprognostic (3.11e-2)" "unprognostic (6.57e-2)" 0.3 157.6 0.2 0.7 0.8 0.0 0.9 0.0 0.1 0.5 0.0 1.8 0.2 0.2 0.2 4.4 0.3 0.3 0.8 2.7 0.1 2.6 0.1 0.1 0.1 0.1 0.8 0.0 34.9 4.6 0.0 143.1 244.9 6.0 0.2 0.0 0.2 8.2 0.0 2.0 0.1 0.2 0.2 0.3 0.2 0.2 14.2 0.0 0.5 0.0 10.0 1.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 75.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 6.3 89.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.8 0.0 0.0 0.1 2.6 0.8 0.0 6.0 0.0 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 19.3" "Cell line enhanced" "Detected in many" "HaCaT: 16.2;HBEC3-KT: 8.8;hTCEpi: 26.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA061223: , HPA068672: , HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 1.0 1.1 4.5 1.4 7.9 1.7 4.3 12.2 8.2 2.2 0.7 0.9 6.4 1.1 1.4 3.8 10.5 1.1 0.9 1.8 4.1 4.6 0.7 0.7 1.1 1.7 1.5 4.8 1.7 1.5 0.4 0.5 1.3 0.9 10.4 0.5 0.3 12.4 13.0 0.7 19.3 1.0 0.6 1.5 1.5 1.1 1.1 1.2 1.3 0.8 4.7 3.9 2.2 5.3 0.8 1.8 1.0 0.5 2.5 3.2 0.3 5.1 1.8 0.5 7.7 0.0 0.4 1.7 1.9 2.1 2.1 1.0 1.8 0.2 0.9 1.2 0.3 16.2 5.4 8.8 0.4 1.0 2.0 0.4 0.9 2.7 0.5 0.3 1.1 0.9 26.6 0.6 5.0 0.0 0.4 0.7 0.8 1.9 0.4 0.4 0.7 1.9 1.0 0.9 0.5 0.3 1.8 5.7 0.5 0.6 0.2 0.3 0.5 1.6 0.5 0.8 2.5 0.6 3.7 1.2 0.3 1.7 0.1 0.7 0.5 0.9 0.4 0.4 0.7 0.3 3.2 0.6 2.2 2.2 0.1 0.8 0.9 0.4 1.0 2.5 0.5 1.8 0.3 0.3 4.5 7.9 12.2 8.2 4.1 4.6 1.5 4.8 0.9 1.2 DLL1 ENSG00000198719 "Delta like canonical Notch ligand 1" O00548 6 170282206-170306565 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.9" "Cell line enhanced" "Detected in some" "HaCaT: 6.8;HBEC3-KT: 10.5;NB-4: 17.4;THP-1: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 7.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078298 Uncertain Nucleoplasm 210000 Nucleoplasm "HPA078298: " "unprognostic (1.03e-1)" "unprognostic (9.22e-2)" "unprognostic (2.17e-3)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (6.35e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-1)" "unprognostic (9.22e-2)" "unprognostic (1.14e-2)" "unprognostic (1.39e-2)" "unprognostic (2.64e-2)" "unprognostic (5.23e-3)" "unprognostic (3.50e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.66e-1)" 8.9 5.7 4.1 5.5 9.0 3.2 8.6 2.5 13.8 7.4 10.3 18.5 2.6 8.1 6.0 3.0 11.1 5.7 11.4 7.2 5.2 4.0 5.8 13.5 6.8 5.6 5.5 5.2 2.5 13.8 2.2 3.1 5.0 10.0 14.5 5.2 14.3 8.9 7.1 3.8 14.3 13.1 3.9 4.6 36.9 5.9 1.6 7.3 0.9 6.1 5.3 6.3 4.5 11.0 0.0 0.0 0.1 0.9 7.3 0.5 0.2 0.9 0.1 4.2 2.6 0.3 0.2 2.2 0.2 0.6 0.3 0.5 1.0 0.1 0.0 0.2 0.1 6.8 2.6 10.5 0.0 0.2 0.9 0.0 0.0 0.0 0.2 0.0 3.0 0.1 2.0 0.0 1.1 1.1 0.0 0.0 0.4 2.9 0.0 17.4 0.6 0.0 0.8 4.2 0.1 0.0 1.3 1.8 0.1 0.2 0.0 0.0 0.7 14.3 0.4 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.8 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.3 0.1 7.3 0.9 0.0 0.0 0.2 4.1 9.0 2.5 11.2 5.2 4.0 5.5 5.2 10.0 7.3 DLL3 SCDO1 ENSG00000090932 "Delta like canonical Notch ligand 3" Q9NYJ7 19 39498895-39508481 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 38.5" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 41.1" "Group enriched" "Detected in many" 11 "glioma: 29.2;melanoma: 15.5;testis cancer: 8.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4;naive CD8 T-cell: 3.3" "Group enriched" "Detected in many" 13 "B-cells: 5.4;T-cells: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA056533 Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA056533: " "unprognostic (2.52e-1)" "unprognostic (3.81e-1)" "unprognostic (3.13e-2)" "prognostic unfavourable (2.94e-4)" "unprognostic (9.85e-2)" "unprognostic (1.41e-2)" "unprognostic (1.65e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.82e-4)" "unprognostic (4.94e-2)" "unprognostic (5.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.97e-1)" 0.6 0.6 8.9 0.7 10.1 0.6 0.6 1.4 38.5 0.5 0.6 10.3 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.6 6.5 6.8 0.5 0.6 0.6 0.7 4.5 1.9 0.6 0.5 0.6 3.2 0.5 4.3 0.6 0.5 0.0 0.6 0.5 0.5 0.6 0.6 0.5 3.6 0.6 0.6 1.2 2.3 0.0 0.7 0.0 0.6 0.6 0.0 5.4 0.3 0.0 0.0 0.0 3.3 0.4 0.0 1.9 0.4 1.0 0.0 0.0 0.3 0.5 0.0 0.3 0.1 0.3 0.4 0.0 1.9 0.0 0.0 1.2 0.5 0.1 0.5 3.0 0.1 0.0 0.1 0.1 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.4 3.1 0.3 0.1 0.1 0.1 0.1 7.3 7.4 1.4 0.0 41.1 0.0 0.1 0.0 0.0 1.3 0.1 0.5 0.7 0.0 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.9 0.0 0.4 5.4 0.2 1.3 0.3 1.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.4 8.9 10.1 1.4 4.8 6.5 6.8 4.5 1.9 4.3 2.3 DLL4 ENSG00000128917 "Delta like canonical Notch ligand 4" Q9NR61 15 40929340-40939072 "Disease related genes, Predicted membrane proteins" "Angiogenesis, Differentiation, Neurogenesis, Notch signaling pathway, Sensory transduction, Vision" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 10 "BJ hTERT+: 33.8;HUVEC TERT2: 8.9;SCLC-21H: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023392 Uncertain "HPA023392: AB_1847740" "unprognostic (1.92e-2)" "prognostic unfavourable (3.97e-4)" "unprognostic (7.52e-2)" "unprognostic (4.71e-2)" "unprognostic (2.72e-1)" "unprognostic (4.16e-2)" "unprognostic (3.56e-2)" "unprognostic (1.60e-2)" "unprognostic (2.49e-1)" "unprognostic (2.73e-1)" "unprognostic (3.51e-2)" "unprognostic (6.10e-2)" "unprognostic (2.56e-3)" "unprognostic (9.92e-2)" "unprognostic (2.93e-1)" "unprognostic (1.51e-2)" "unprognostic (5.51e-3)" 34.1 3.4 5.9 4.2 8.0 0.9 16.8 5.8 12.6 9.5 8.4 2.7 2.3 5.9 12.0 3.3 5.9 5.6 5.6 15.3 9.4 3.7 6.5 6.0 27.0 6.6 7.7 0.1 8.1 3.9 4.8 5.2 27.4 11.2 8.8 4.7 11.9 3.2 4.4 12.5 4.5 5.3 6.6 5.8 5.9 4.0 3.9 7.8 4.7 13.0 6.1 3.4 9.4 10.8 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 33.8 0.1 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.2 0.6 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.2 0.8 0.0 0.1 18.2 0.0 0.1 0.4 0.0 0.0 1.9 0.5 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.9 8.0 5.8 12.6 9.4 3.7 7.7 0.1 11.2 7.8 DMPK "DM, DM1, DM1PK, DMK, MDPK, MT-PK" ENSG00000104936 "DM1 protein kinase" Q09013 19 45769717-45782552 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.6" "Cell line enhanced" "Detected in many" "RH-30: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007164, HPA008905" Enhanced Approved Vesicles,Cytosol Cytosol Vesicles "HPA007164: AB_1078687, HPA008905: AB_1078685" "unprognostic (7.44e-2)" "unprognostic (2.66e-1)" "unprognostic (1.76e-3)" "unprognostic (2.61e-3)" "unprognostic (1.29e-1)" "unprognostic (5.46e-2)" "unprognostic (8.67e-2)" "unprognostic (1.50e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-1)" "prognostic favourable (9.39e-5)" "unprognostic (1.93e-1)" "unprognostic (1.60e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (4.24e-3)" 9.0 18.7 5.1 9.7 6.3 1.7 4.9 8.8 6.2 16.5 23.4 4.4 15.6 8.7 21.2 15.0 31.2 13.7 20.3 56.7 5.0 5.3 4.9 2.2 6.5 4.1 4.8 6.5 8.4 33.3 3.1 10.7 6.8 5.6 16.3 3.8 22.0 6.1 19.7 79.6 5.1 11.3 65.1 4.2 5.3 12.0 5.9 4.0 1.1 6.1 36.6 5.0 44.9 8.2 1.5 0.0 0.0 0.8 0.3 2.2 0.0 7.2 10.1 12.0 7.4 8.1 11.3 7.2 16.2 12.0 6.5 6.3 1.2 3.9 2.3 2.4 18.5 10.6 3.4 1.6 2.4 11.3 10.6 0.9 12.6 1.7 7.9 0.1 4.1 16.5 5.7 5.6 2.7 3.0 7.1 5.8 9.4 8.0 1.1 2.7 7.1 2.2 3.7 44.2 3.7 3.5 8.3 6.5 10.3 8.8 18.5 5.2 15.2 3.5 9.1 7.6 7.5 7.2 11.8 11.2 9.6 2.3 6.9 1.0 10.6 0.0 0.0 0.0 2.2 0.8 0.5 0.3 0.7 0.2 0.0 1.5 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 5.1 6.3 8.8 6.2 5.0 5.3 4.8 6.5 5.6 4.0 DMRT2 ENSG00000173253 "Doublesex and mab-3 related transcription factor 2" Q9Y5R5 9 1049858-1057552 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 27.3;lymphoid tissue: 18.4;parathyroid gland: 52.9" "Cell line enhanced" "Detected in some" "HaCaT: 3.8;RH-30: 5.2;RPMI-8226: 19.3;SK-MEL-30: 5.3;THP-1: 3.7;WM-115: 3.7" "Cancer enhanced" "Detected in many" "renal cancer: 9.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 1.8" "Group enriched" "Detected in some" 9 "cerebral cortex: 2.3;hippocampal formation: 0.9" HPA029297 Uncertain "HPA029297: AB_10600905" "unprognostic (5.67e-2)" "unprognostic (2.20e-3)" "unprognostic (3.24e-2)" "unprognostic (8.88e-2)" "unprognostic (1.32e-1)" "unprognostic (7.10e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (1.74e-1)" "unprognostic (1.43e-3)" "unprognostic (8.93e-2)" "unprognostic (8.62e-2)" "unprognostic (4.93e-2)" "unprognostic (1.27e-3)" 3.8 0.5 1.9 0.5 6.5 0.4 4.5 0.5 4.5 0.5 1.6 11.0 2.6 0.4 0.5 1.3 0.6 0.6 0.4 0.5 3.2 1.3 27.3 0.4 2.4 0.6 7.0 2.5 0.4 0.4 52.9 0.7 0.6 3.6 0.6 1.1 0.0 1.4 1.5 9.0 0.6 0.4 0.5 3.0 0.4 0.4 0.9 6.2 18.4 0.4 6.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 5.2 19.3 0.0 0.8 3.0 0.0 0.0 0.0 5.3 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 3.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 6.5 0.5 4.5 3.2 1.3 7.0 2.5 3.6 6.2 DMXL2 "DFNA71, KIAA0856, RC3" ENSG00000104093 "Dmx like 2" Q8TDJ6 15 51447711-51622833 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Deafness, Diabetes mellitus, Disease mutation, Hypogonadotropic hypogonadism, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 5.4;intermediate monocyte: 5.1;myeloid DC: 1.6;neutrophil: 5.9;non-classical monocyte: 4.6;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 11 "dendritic cells: 1.6;granulocytes: 5.9;monocytes: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039375 Approved "HPA039375: AB_10673610" "unprognostic (5.66e-2)" "unprognostic (9.67e-2)" "unprognostic (1.40e-2)" "unprognostic (2.21e-1)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (1.05e-2)" "unprognostic (8.38e-2)" "unprognostic (3.39e-1)" "unprognostic (2.32e-1)" "unprognostic (3.67e-3)" "unprognostic (1.24e-1)" "prognostic unfavourable (7.50e-4)" "unprognostic (1.09e-1)" "unprognostic (1.67e-1)" "unprognostic (8.60e-3)" "unprognostic (2.70e-2)" 7.8 7.1 9.8 14.7 25.1 24.9 5.0 18.6 25.9 6.5 8.7 7.0 3.7 13.6 6.8 23.2 3.0 7.4 6.7 5.1 13.9 10.9 8.6 7.2 11.2 6.6 7.5 15.9 7.0 7.8 13.8 18.4 10.1 26.6 4.3 10.6 9.4 7.0 4.3 1.9 2.7 11.4 7.3 5.7 10.8 7.5 12.7 5.0 6.2 6.6 2.8 4.2 8.1 4.4 0.1 1.6 5.9 5.4 0.0 0.4 0.7 5.9 7.4 8.5 5.3 4.3 6.0 2.3 4.5 4.8 4.2 5.9 1.1 3.0 0.0 2.4 2.6 3.4 5.3 3.3 5.8 6.4 2.7 2.5 7.6 2.4 4.8 13.1 4.2 3.4 3.1 6.3 2.4 2.9 5.3 0.6 5.2 8.2 5.3 19.2 7.5 2.9 5.2 6.9 10.8 3.0 11.5 11.2 5.4 5.2 3.2 6.4 4.6 17.7 3.6 5.7 4.0 8.3 5.9 11.9 17.8 0.1 6.4 33.3 5.3 0.0 5.4 0.5 0.1 5.1 0.0 0.1 0.1 0.0 1.6 0.0 0.1 0.4 5.9 0.0 4.6 1.5 0.0 0.7 9.8 25.1 18.6 25.9 13.9 10.9 7.5 15.9 26.6 5.0 DNAH2 "DNHD3, FLJ46675, KIAA1503" ENSG00000183914 "Dynein axonemal heavy chain 2" Q9P225 17 7717354-7833744 "Predicted intracellular proteins, Predicted membrane proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 14.3;parathyroid gland: 20.0;testis: 21.0" "Cell line enhanced" "Detected in some" "A-431: 4.8;CACO-2: 7.5;CAPAN-2: 4.7;SCLC-21H: 4.5;SiHa: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067103 Enhanced Approved Microtubules Microtubules "HPA067103: " "unprognostic (2.03e-2)" "unprognostic (1.79e-2)" "unprognostic (2.23e-2)" "unprognostic (1.25e-1)" "unprognostic (3.92e-2)" "unprognostic (2.51e-1)" "unprognostic (1.35e-1)" "unprognostic (7.50e-3)" "unprognostic (1.29e-2)" "unprognostic (8.28e-2)" "unprognostic (2.51e-3)" "unprognostic (1.74e-1)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (8.74e-3)" "unprognostic (4.60e-2)" 0.2 0.1 1.5 0.2 4.8 0.5 0.5 1.8 0.9 1.3 0.2 7.9 1.1 0.2 0.7 5.7 0.2 14.3 0.4 0.2 2.1 1.9 0.2 0.3 5.5 0.2 0.2 0.6 3.0 0.5 20.0 1.2 1.8 7.0 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 21.0 0.7 0.2 0.3 0.2 0.2 0.2 0.2 1.2 0.6 3.2 0.7 0.6 0.7 0.1 4.8 0.2 0.2 0.3 0.1 0.0 0.8 0.2 0.1 0.0 0.1 7.5 4.7 0.2 2.3 0.1 0.4 0.0 1.1 0.1 0.1 0.2 0.1 0.5 0.1 1.2 0.3 0.2 0.4 0.0 0.7 0.1 0.0 0.2 0.3 0.0 0.9 0.1 0.4 0.4 1.6 0.2 0.5 0.1 0.0 1.4 4.5 0.3 4.5 0.1 2.3 0.4 0.3 0.2 0.4 0.8 0.1 0.0 0.4 0.1 0.2 0.1 0.1 0.8 0.7 0.7 0.4 0.7 0.3 0.5 0.5 0.4 0.6 0.2 1.2 0.5 0.7 3.2 0.6 0.3 0.6 0.3 0.1 1.5 4.8 1.8 0.9 2.1 1.9 0.2 0.6 7.0 0.7 DNAJB12 "DJ10, FLJ20027" ENSG00000148719 "DnaJ heat shock protein family (Hsp40) member B12" Q9NXW2 10 72332830-72355230 "Predicted membrane proteins, Transporters" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010642, HPA072702" Approved Supported "Nuclear membrane,Endoplasmic reticulum" "Endoplasmic reticulum" "Nuclear membrane" "HPA010642: AB_1078692, HPA072702: " "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (4.79e-4)" "unprognostic (6.01e-3)" "unprognostic (2.68e-1)" "prognostic unfavourable (8.17e-4)" "unprognostic (5.73e-2)" "unprognostic (5.60e-2)" "unprognostic (8.85e-3)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (4.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.87e-1)" 24.9 31.7 18.6 20.1 20.6 27.2 32.6 24.0 28.3 24.1 21.8 29.9 26.4 25.0 26.8 31.0 23.8 21.1 28.7 25.3 18.0 17.3 25.6 34.3 26.8 27.5 19.9 19.4 25.4 33.1 38.4 26.2 36.0 20.2 24.5 17.5 27.5 32.4 44.8 40.3 28.6 27.4 22.8 22.3 26.9 24.3 29.2 18.2 20.8 25.5 25.8 23.5 21.1 21.2 7.6 15.5 23.3 19.8 8.3 8.7 9.9 15.5 16.1 10.2 17.0 13.4 13.6 12.9 15.6 27.1 21.5 20.1 18.9 27.1 11.5 12.6 18.8 26.1 9.4 14.0 11.4 12.5 12.8 6.1 9.6 12.2 29.5 12.4 23.5 17.5 29.1 19.0 24.1 14.9 9.6 17.3 17.8 15.0 10.6 10.6 4.7 4.7 9.8 7.7 7.9 15.8 9.1 7.0 10.1 8.5 31.6 15.2 12.1 14.3 16.7 10.8 14.8 12.0 19.5 14.7 10.9 6.7 17.8 13.7 7.3 9.1 18.1 11.0 8.7 19.8 7.8 7.6 8.6 6.5 15.5 7.3 7.2 7.1 23.3 8.3 16.8 10.5 8.7 9.9 18.6 20.6 24.0 28.3 18.0 17.3 19.9 19.4 20.2 18.2 DNAJB14 FLJ14281 ENSG00000164031 "DnaJ heat shock protein family (Hsp40) member B14" Q8TBM8 4 99896248-99946726 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036016 Approved "HPA036016: AB_10670594" "unprognostic (1.90e-2)" "unprognostic (1.68e-1)" "unprognostic (9.04e-3)" "unprognostic (5.33e-2)" "unprognostic (2.10e-1)" "unprognostic (1.71e-1)" "unprognostic (2.35e-2)" "unprognostic (4.34e-2)" "unprognostic (2.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.41e-1)" "unprognostic (2.75e-2)" "prognostic favourable (2.12e-6)" "unprognostic (1.42e-1)" "unprognostic (1.07e-1)" "unprognostic (5.02e-2)" "unprognostic (1.01e-2)" 14.2 13.5 21.9 9.9 25.5 17.0 13.4 21.3 28.5 13.1 14.9 7.7 10.6 10.2 14.2 12.7 11.2 11.0 11.6 9.5 18.0 18.4 15.6 12.2 13.5 15.4 15.8 24.0 14.2 9.7 18.6 22.7 18.2 30.5 14.0 11.2 8.3 11.0 12.4 6.0 11.3 13.3 13.0 16.7 15.0 13.0 4.7 15.2 11.5 19.6 5.5 11.8 13.1 12.0 15.9 14.8 25.8 22.4 15.0 19.5 13.0 7.9 21.2 7.1 8.0 13.2 14.0 7.1 20.2 11.9 6.4 5.9 14.3 19.0 7.5 11.5 8.5 6.7 5.3 8.9 10.4 19.5 6.2 12.5 12.9 11.6 11.6 10.6 19.3 11.5 10.4 7.0 7.0 12.5 10.9 10.9 14.6 16.6 12.6 6.3 4.0 9.6 11.9 8.2 6.7 11.7 16.3 4.1 9.3 10.9 15.9 10.5 9.0 5.0 18.1 11.4 9.9 8.0 6.7 13.7 29.4 9.8 9.4 4.5 13.6 25.8 14.8 16.7 19.5 16.3 17.6 15.9 15.8 17.7 12.8 15.7 18.5 16.6 22.4 15.0 22.4 14.8 18.6 13.0 21.9 25.5 21.3 28.5 18.0 18.4 15.8 24.0 30.5 15.2 DNAJC1 "DNAJL1, ERdj1, MTJ1" ENSG00000136770 "DnaJ heat shock protein family (Hsp40) member C1" Q96KC8 10 21756537-22003769 "Predicted membrane proteins, Transcription factors" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013432 Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA013432: AB_1847797" "unprognostic (7.00e-2)" "unprognostic (9.81e-2)" "unprognostic (3.61e-1)" "unprognostic (5.12e-2)" "unprognostic (5.51e-2)" "unprognostic (1.90e-2)" "prognostic unfavourable (1.96e-5)" "unprognostic (3.81e-2)" "unprognostic (1.21e-1)" "unprognostic (3.46e-2)" "unprognostic (1.09e-1)" "unprognostic (9.36e-2)" "prognostic favourable (2.33e-4)" "unprognostic (4.44e-3)" "unprognostic (4.88e-2)" "unprognostic (1.45e-2)" "unprognostic (2.22e-2)" 14.8 16.0 8.6 13.5 13.4 11.1 14.6 8.3 11.2 14.5 17.8 9.6 16.2 19.9 15.5 14.0 14.1 10.9 16.4 14.2 10.2 7.2 22.1 41.3 20.5 9.5 13.5 6.8 13.4 33.7 27.1 34.3 16.6 13.8 29.2 13.6 12.6 28.5 14.3 10.6 11.6 18.5 22.8 15.0 13.7 19.9 7.7 13.9 12.2 21.8 11.6 11.5 25.9 28.8 6.5 21.5 5.4 15.2 17.9 21.1 7.7 12.5 8.2 18.4 6.8 17.3 12.3 8.0 17.1 7.4 7.1 11.3 11.2 11.1 5.5 7.6 10.4 12.1 4.1 8.6 4.0 29.0 13.9 13.2 6.7 6.6 42.1 0.9 5.7 12.5 15.9 8.4 9.8 9.4 13.8 31.9 8.0 12.8 3.1 4.2 2.4 6.8 4.5 6.4 20.3 9.9 3.0 3.9 5.9 12.6 21.2 12.3 6.7 14.2 14.3 7.0 15.3 11.7 9.7 10.2 3.2 3.8 10.5 42.1 4.1 5.4 9.2 3.6 20.9 8.7 21.1 4.9 12.0 16.6 8.3 6.5 7.8 9.9 5.2 17.9 15.2 21.5 8.4 7.7 8.6 13.4 8.3 11.2 10.2 7.2 13.5 6.8 13.8 13.9 DNAJC10 "ERdj5, PDIA19" ENSG00000077232 "DnaJ heat shock protein family (Hsp40) member C10" Q8IXB1 2 182716041-182794464 "Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 74.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031111 Approved "HPA031111: AB_10601211" "unprognostic (3.29e-2)" "unprognostic (5.20e-3)" "unprognostic (3.10e-3)" "prognostic favourable (6.42e-5)" "unprognostic (1.89e-1)" "unprognostic (1.18e-1)" "unprognostic (4.34e-3)" "unprognostic (1.82e-2)" "unprognostic (1.54e-2)" "unprognostic (4.34e-2)" "unprognostic (2.29e-1)" "unprognostic (9.76e-2)" "prognostic unfavourable (2.19e-7)" "unprognostic (2.91e-1)" "unprognostic (8.96e-2)" "prognostic unfavourable (7.27e-4)" "unprognostic (2.87e-2)" 10.4 8.6 10.2 21.2 12.1 2.8 14.8 11.2 14.5 17.2 10.9 7.4 28.9 8.3 18.5 74.8 8.1 18.8 17.0 17.7 10.8 12.8 14.5 14.0 12.2 17.3 10.7 8.9 14.4 21.9 16.1 17.7 11.5 10.5 12.4 11.8 9.0 19.7 31.5 7.6 6.6 11.7 11.8 11.4 16.3 15.1 14.5 7.7 13.5 17.8 8.2 15.0 10.9 10.3 22.0 13.1 2.1 12.2 6.6 7.3 6.9 10.4 8.1 13.9 7.1 22.8 30.2 14.3 23.0 29.9 14.6 16.3 14.7 19.9 31.8 22.5 21.4 11.5 12.0 18.2 26.5 15.4 10.8 11.1 12.1 11.9 19.6 25.0 21.6 15.8 20.2 17.9 29.8 32.3 10.7 16.5 15.3 4.5 8.8 6.9 22.4 20.0 9.9 14.0 38.1 24.1 12.0 12.4 11.8 14.5 13.6 13.8 6.5 8.4 29.7 25.6 18.6 14.4 16.7 11.5 23.8 17.8 35.5 16.7 22.0 2.1 12.2 0.9 5.8 10.8 7.3 22.0 6.3 6.3 13.1 20.2 6.1 6.3 1.2 6.6 7.7 7.7 5.9 6.9 10.2 12.1 11.2 14.5 10.8 12.8 10.7 8.9 10.5 7.7 DNAJC11 FLJ10737 ENSG00000007923 "DnaJ heat shock protein family (Hsp40) member C11" Q9NVH1 1 6634168-6701924 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028705 Uncertain Approved Cytosol Cytosol "HPA028705: AB_10603662" "unprognostic (3.74e-2)" "unprognostic (3.19e-2)" "unprognostic (4.06e-2)" "unprognostic (6.05e-3)" "unprognostic (9.55e-2)" "unprognostic (6.65e-2)" "unprognostic (4.38e-3)" "unprognostic (6.10e-2)" "unprognostic (6.34e-2)" "unprognostic (2.89e-1)" "unprognostic (1.45e-1)" "unprognostic (1.34e-1)" "prognostic favourable (2.63e-5)" "unprognostic (6.30e-2)" "unprognostic (1.76e-1)" "unprognostic (9.77e-2)" "unprognostic (1.04e-1)" 13.8 24.0 20.5 16.1 25.2 10.2 12.7 19.1 31.3 13.0 23.4 17.3 10.5 22.4 14.6 11.2 19.5 12.7 11.9 26.9 15.7 13.0 33.5 25.8 11.2 14.4 13.9 19.6 16.5 15.3 21.4 13.4 15.5 25.0 12.6 27.4 15.4 13.8 12.4 44.2 16.6 19.5 15.1 14.6 19.6 16.2 12.4 14.2 12.6 12.3 17.2 18.4 14.0 12.6 8.1 12.2 7.2 13.4 10.0 10.1 8.6 16.4 16.1 19.0 17.2 16.7 11.7 17.6 16.5 14.2 32.9 23.3 19.3 23.8 26.4 16.1 18.9 22.3 32.6 26.6 29.1 14.9 22.4 26.9 30.6 19.4 16.2 32.3 14.8 16.9 7.4 29.6 19.5 15.4 33.9 11.8 16.5 13.3 20.1 16.6 19.3 27.8 22.3 16.5 19.2 21.0 14.4 25.4 18.0 18.8 38.7 20.6 15.2 16.8 15.1 19.5 10.4 16.1 19.2 13.7 14.9 35.1 19.0 35.2 9.6 7.2 9.6 3.4 9.4 12.5 9.4 8.1 6.9 10.1 12.2 8.1 7.4 5.9 0.3 10.0 13.4 5.3 7.2 8.6 20.5 25.2 19.1 31.3 15.7 13.0 13.9 19.6 25.0 14.2 DNAJC16 KIAA0962 ENSG00000116138 "DnaJ heat shock protein family (Hsp40) member C16" Q9Y2G8 1 15526813-15592379 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043643 Approved Approved Vesicles Vesicles "HPA043643: AB_10796794" "unprognostic (1.77e-1)" "unprognostic (4.95e-2)" "prognostic favourable (6.77e-4)" "unprognostic (4.52e-2)" "unprognostic (5.51e-2)" "unprognostic (2.05e-2)" "unprognostic (1.91e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (4.28e-2)" "unprognostic (2.35e-2)" "unprognostic (3.74e-2)" "prognostic favourable (7.24e-4)" "unprognostic (3.67e-2)" "unprognostic (3.74e-1)" "unprognostic (5.38e-2)" "unprognostic (4.70e-2)" 9.6 11.5 9.8 9.5 18.7 3.9 12.3 13.2 24.3 10.2 10.9 18.4 14.2 12.0 12.9 14.7 11.5 13.0 11.2 9.1 11.0 10.8 22.1 20.0 8.9 10.5 11.1 10.8 13.1 13.4 20.1 20.3 13.9 17.2 10.8 11.2 12.0 12.1 10.8 19.2 10.2 11.2 11.9 10.7 11.3 9.9 11.1 11.0 11.4 13.9 8.9 12.5 10.3 9.4 6.9 4.1 3.8 4.1 3.2 8.0 3.6 7.4 7.1 5.9 10.8 16.2 13.1 5.5 8.9 9.1 9.0 9.7 6.1 11.0 6.5 6.0 8.9 9.3 7.2 7.9 12.7 7.6 3.4 6.6 8.2 10.6 16.1 10.2 7.7 9.5 9.4 14.5 8.1 10.0 14.0 5.9 10.2 3.0 5.2 5.2 5.7 5.0 6.1 7.6 7.2 11.1 5.2 6.6 6.3 9.2 8.8 7.6 5.6 4.1 13.5 15.9 5.7 14.6 4.8 8.1 11.4 5.8 9.9 5.9 7.5 3.8 4.1 3.0 5.6 4.0 8.0 6.8 5.8 5.0 4.1 6.9 7.4 6.3 2.3 3.2 2.9 3.7 5.3 3.6 9.8 18.7 13.2 24.3 11.0 10.8 11.1 10.8 17.2 11.0 DNAJC18 MGC29463 ENSG00000170464 "DnaJ heat shock protein family (Hsp40) member C18" Q9H819 5 139408588-139444491 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 51.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036538, HPA060154" Approved Supported "Cell Junctions" "Cell Junctions" "HPA036538: AB_10670802, HPA060154: " "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.19e-3)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (2.73e-3)" "unprognostic (8.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "prognostic favourable (5.89e-4)" "unprognostic (8.09e-2)" "unprognostic (1.69e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (6.96e-2)" "unprognostic (1.97e-2)" 4.1 4.0 8.2 2.9 15.7 1.9 4.3 10.7 19.5 4.7 3.3 12.4 0.7 1.8 7.6 4.9 3.9 4.9 4.2 6.3 8.7 8.7 4.5 1.2 4.5 3.3 8.8 11.7 10.7 2.3 6.5 7.1 4.1 16.2 4.9 3.0 3.4 2.1 5.9 8.4 2.2 2.4 6.8 9.0 2.9 2.4 51.4 7.5 1.2 5.1 1.7 2.6 3.4 3.3 3.5 2.0 2.1 2.0 6.0 6.7 1.4 1.7 1.8 11.6 10.7 6.5 6.9 1.3 3.5 7.7 6.2 11.3 4.1 1.4 7.7 9.6 5.4 3.0 6.5 10.5 6.5 17.5 8.6 5.2 4.0 1.9 5.1 0.6 2.6 9.2 1.3 10.3 6.3 8.4 2.3 7.5 9.1 1.0 2.3 2.4 8.0 2.6 6.3 12.7 1.2 3.7 1.9 10.8 11.3 3.6 1.4 7.9 1.6 3.9 10.8 8.3 0.0 2.5 7.4 8.9 11.7 4.1 4.4 3.9 3.5 1.9 2.0 2.1 2.2 1.3 3.2 3.5 3.2 4.1 1.5 3.5 3.2 2.0 0.6 6.0 0.7 2.0 6.7 1.4 8.2 15.7 10.7 19.5 8.7 8.7 8.8 11.7 16.2 7.5 DNAJC30 WBSCR18 ENSG00000176410 "DnaJ heat shock protein family (Hsp40) member C30" Q96LL9 7 73680969-73683453 "Predicted membrane proteins" "ATP synthesis" Chaperone "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017318 Uncertain Supported "HPA017318: AB_1858788" "unprognostic (1.86e-2)" "unprognostic (1.85e-1)" "unprognostic (2.16e-1)" "unprognostic (2.66e-1)" "prognostic unfavourable (1.12e-4)" "unprognostic (5.37e-2)" "unprognostic (1.50e-1)" "unprognostic (2.66e-2)" "unprognostic (4.53e-1)" "unprognostic (3.93e-2)" "unprognostic (2.85e-3)" "unprognostic (4.60e-2)" "prognostic favourable (4.91e-8)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (2.51e-1)" "unprognostic (1.20e-2)" 13.3 20.6 14.7 8.3 15.8 6.4 8.9 8.5 23.4 10.2 8.9 11.1 11.7 9.2 10.2 15.3 7.4 12.0 14.8 18.6 13.4 14.2 14.7 22.1 8.2 9.5 11.8 14.1 14.9 12.2 11.1 14.5 10.3 15.0 12.6 8.2 10.6 14.3 12.3 12.9 7.2 9.2 7.5 7.9 10.0 10.3 24.4 7.3 12.7 16.5 9.7 8.1 9.4 6.0 12.5 7.5 4.6 7.3 6.7 11.9 5.7 6.1 6.1 4.5 9.0 7.1 5.0 4.8 9.7 7.2 7.5 7.4 5.8 6.4 5.4 2.5 7.6 8.7 4.0 5.4 4.3 6.3 8.2 3.2 5.7 6.1 7.4 5.3 4.5 5.6 4.5 6.9 5.9 6.5 6.4 5.0 7.4 12.3 8.5 10.7 3.8 10.5 5.8 3.5 13.2 9.7 7.2 12.2 6.5 9.8 17.4 7.0 15.8 3.5 6.3 8.0 5.8 8.3 6.9 5.3 3.6 5.2 6.4 3.7 9.8 4.6 7.3 4.6 8.1 6.7 10.0 9.0 9.8 9.7 7.3 12.5 11.9 9.9 1.0 6.7 5.1 7.5 6.7 5.7 14.7 15.8 8.5 23.4 13.4 14.2 11.8 14.1 15.0 7.3 DNAJC4 "HSPF2, MCG18" ENSG00000110011 "DnaJ heat shock protein family (Hsp40) member C4" Q9NNZ3 11 64230278-64234286 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011947 Uncertain "HPA011947: AB_1847803" "unprognostic (8.99e-3)" "unprognostic (2.28e-2)" "prognostic unfavourable (3.12e-4)" "unprognostic (2.95e-2)" "unprognostic (1.15e-1)" "unprognostic (5.20e-2)" "unprognostic (8.99e-2)" "unprognostic (1.56e-2)" "unprognostic (7.69e-2)" "unprognostic (5.44e-3)" "unprognostic (1.73e-3)" "unprognostic (1.07e-1)" "prognostic favourable (6.21e-4)" "unprognostic (2.47e-1)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (2.69e-1)" 16.7 26.5 16.5 15.6 17.3 22.5 15.8 14.5 26.6 22.9 24.7 15.3 24.4 23.3 22.1 25.6 28.6 15.2 26.5 26.5 15.0 13.3 25.2 26.4 16.5 22.5 16.4 9.6 29.3 55.1 22.5 19.5 14.7 19.0 28.7 14.1 19.7 50.0 22.8 31.0 19.1 28.2 13.7 15.0 28.1 18.9 72.5 8.6 26.4 33.2 18.0 28.7 22.9 20.3 18.8 46.6 14.8 20.6 14.5 12.2 12.0 4.5 4.3 10.2 15.1 12.5 22.1 7.2 6.7 11.4 4.2 5.8 4.3 6.6 5.4 22.2 11.9 3.6 5.1 6.0 2.4 11.5 6.0 6.8 4.4 11.6 15.2 5.0 16.2 22.8 16.4 6.6 7.7 9.8 4.5 29.0 2.6 11.1 2.0 12.1 2.9 8.4 14.1 2.7 36.4 17.2 3.0 8.9 14.5 6.7 7.6 24.9 18.5 9.1 9.0 4.8 4.9 7.4 3.7 28.6 11.5 6.7 4.3 6.4 13.9 14.8 20.6 14.6 8.3 18.2 10.5 17.5 8.4 9.7 28.7 18.8 12.2 9.4 11.4 14.5 14.4 46.6 7.8 12.0 16.5 17.3 14.5 26.6 15.0 13.3 16.4 9.6 19.0 8.6 DNAJC5 "CLN4, DNAJC5A, FLJ00118, FLJ13070" ENSG00000101152 "DnaJ heat shock protein family (Hsp40) member C5" Q9H3Z4 20 63895182-63936031 "Disease related genes, Predicted membrane proteins" Chaperone "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012737, HPA013154" Approved Uncertain "Golgi apparatus" "Golgi apparatus" "HPA012737: AB_1847293, HPA013154: AB_1847292" "unprognostic (9.96e-3)" "unprognostic (2.75e-1)" "unprognostic (3.91e-1)" "unprognostic (3.61e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-2)" "prognostic unfavourable (8.82e-6)" "unprognostic (3.04e-2)" "unprognostic (2.73e-1)" "unprognostic (2.65e-2)" "unprognostic (1.78e-3)" "unprognostic (1.51e-1)" "prognostic favourable (7.70e-6)" "unprognostic (2.24e-2)" "unprognostic (3.54e-2)" "unprognostic (4.28e-3)" "unprognostic (1.08e-2)" 13.0 14.2 30.5 12.1 36.6 16.4 8.5 38.0 48.6 7.3 12.3 11.2 9.6 14.2 7.2 7.8 29.9 10.8 8.7 22.6 28.1 31.6 9.3 9.6 12.3 14.5 23.8 26.7 5.9 23.7 20.7 15.1 10.7 23.4 11.2 8.9 12.8 14.9 14.3 10.2 16.5 14.7 9.9 12.8 11.7 11.4 8.2 9.2 8.1 14.7 8.4 10.1 11.8 8.2 3.2 9.0 7.5 7.6 2.6 6.7 4.5 11.7 11.1 9.4 9.0 9.5 7.5 6.8 13.0 12.4 22.9 11.0 25.8 14.0 4.7 14.4 12.8 16.6 7.5 24.6 8.7 3.5 6.0 8.9 8.3 14.3 8.8 8.7 20.3 8.6 18.9 10.6 5.7 11.4 8.7 4.1 10.5 8.5 9.3 14.8 3.4 13.4 9.3 5.3 4.8 8.4 11.4 10.3 6.6 14.1 23.8 8.0 11.2 35.4 20.1 20.5 6.6 9.6 9.9 4.9 2.4 6.4 20.5 11.8 12.1 2.2 7.5 4.8 6.7 7.6 4.4 3.2 4.4 6.1 5.2 2.9 5.2 5.6 7.5 2.6 5.7 9.0 5.9 4.5 30.5 36.6 38.0 43.5 28.1 31.6 23.8 26.7 23.4 9.2 DNAJC5G "CSP-gamma, FLJ40417" ENSG00000163793 "DnaJ heat shock protein family (Hsp40) member C5 gamma" Q8N7S2 2 27275421-27281499 "Predicted membrane proteins" Chaperone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "epididymis: 35.8;testis: 58.0" "Cell line enhanced" "Detected in some" "A-431: 2.9;HAP1: 3.9;HMC-1: 1.7;SH-SY5Y: 2.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 2.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA041445 Approved "HPA041445: AB_2677485" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (2.61e-2)" "unprognostic (2.26e-1)" "unprognostic (3.99e-1)" "unprognostic (2.77e-1)" "unprognostic (1.56e-2)" "unprognostic (1.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.06e-1)" "unprognostic (1.75e-4)" "unprognostic (2.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" "unprognostic (7.67e-2)" "unprognostic (1.97e-2)" 0.1 0.7 0.5 0.1 0.1 0.0 0.1 0.1 2.1 0.4 0.1 0.1 0.1 0.0 0.3 35.8 0.1 0.2 0.1 1.3 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 58.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.9 2.4 0.9 0.4 0.7 0.8 2.9 1.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.1 0.3 0.0 1.5 0.1 0.9 1.7 0.0 0.0 0.0 0.7 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.0 1.6 1.6 0.4 0.0 0.4 0.3 2.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 1.6 0.9 0.6 0.3 0.5 0.2 0.2 0.3 0.3 0.1 0.5 0.7 0.3 2.4 0.4 0.6 0.9 0.2 0.8 0.5 0.1 0.1 2.1 0.4 0.0 0.1 0.1 0.1 0.1 DNER "bet, UNQ26" ENSG00000187957 "Delta/notch like EGF repeat containing" Q8NFT8 2 229357629-229714558 "Cancer-related genes, Predicted membrane proteins" "Notch signaling pathway" "Activator, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 45.6;brain: 85.2;salivary gland: 46.1" "Group enriched" "Detected in some" 5 "hTERT-HME1: 39.4;U-138 MG: 66.4;U-87 MG: 39.3" "Cancer enriched" "Detected in many" 32 "glioma: 73.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017320 Enhanced 2700000 "HPA017320: AB_1847808" "unprognostic (4.39e-2)" "unprognostic (1.83e-1)" "unprognostic (3.25e-1)" "unprognostic (1.00e-3)" "unprognostic (8.73e-2)" "unprognostic (6.23e-2)" "prognostic unfavourable (1.05e-4)" "unprognostic (4.23e-3)" "unprognostic (2.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.60e-1)" "unprognostic (8.60e-2)" "prognostic unfavourable (3.42e-4)" "unprognostic (2.59e-2)" "unprognostic (7.32e-2)" "unprognostic (5.63e-2)" "unprognostic (5.13e-3)" 1.7 45.6 25.4 2.2 26.8 1.3 3.1 19.5 85.2 2.2 2.3 38.4 0.0 1.6 2.1 5.7 1.5 4.1 1.5 6.8 23.9 36.8 9.7 1.3 2.0 1.5 39.8 15.2 1.6 1.9 1.7 9.6 1.5 30.0 2.8 2.2 2.5 46.1 1.6 1.3 2.5 1.9 2.2 26.4 1.3 8.3 2.0 30.4 0.0 1.4 0.0 2.1 1.4 0.2 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.1 0.1 0.0 0.0 0.3 2.2 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.7 2.4 1.7 39.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 3.6 0.0 0.4 0.0 3.7 0.0 7.9 0.6 0.2 0.0 0.2 0.0 0.0 0.0 66.4 0.0 2.2 9.9 0.0 0.0 0.0 39.3 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 25.4 26.8 19.5 26.6 23.9 36.8 39.8 15.2 30.0 30.4 DNPEP "ASPEP, DAP" ENSG00000123992 "Aspartyl aminopeptidase" Q9ULA0 2 219373527-219400022 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036398, HPA044860" Enhanced Supported Cytosol 6200000 Cytosol "HPA036398: AB_10970915, HPA044860: AB_10961275" "unprognostic (3.71e-1)" "unprognostic (6.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.75e-1)" "unprognostic (2.54e-3)" "unprognostic (3.34e-2)" "unprognostic (2.44e-1)" "unprognostic (3.49e-2)" "unprognostic (1.61e-1)" "unprognostic (6.13e-2)" "unprognostic (1.67e-1)" "unprognostic (5.63e-3)" "unprognostic (3.49e-1)" "unprognostic (2.50e-1)" "unprognostic (1.85e-3)" 20.1 12.3 8.8 15.5 10.4 7.2 20.0 7.2 9.3 16.5 30.4 8.6 13.8 27.9 15.1 13.3 16.9 15.3 16.6 22.9 10.4 6.8 21.2 33.5 15.5 11.7 10.5 7.2 19.4 19.0 9.7 11.0 28.5 9.4 21.0 15.8 15.9 18.7 14.7 36.6 14.6 50.3 12.9 6.8 17.5 15.2 33.7 9.3 11.3 15.0 20.0 17.4 20.7 13.1 11.6 16.1 5.8 15.0 15.7 15.7 10.9 16.0 8.8 5.4 16.1 14.4 11.9 43.0 8.0 16.2 20.9 22.1 24.3 21.2 9.8 17.3 16.6 15.8 6.5 18.3 7.6 19.2 4.6 15.9 9.0 26.4 38.2 13.1 11.4 19.3 19.5 21.5 18.0 14.3 17.9 15.8 10.7 34.9 20.0 14.6 8.9 5.5 26.0 12.4 12.9 11.6 25.0 6.8 9.2 9.3 30.8 11.3 9.0 14.5 7.9 20.1 16.6 10.5 11.5 17.7 10.3 7.0 28.6 12.6 8.5 5.8 13.2 5.4 13.6 15.0 15.4 10.2 11.0 15.0 16.1 11.6 12.0 15.7 1.0 15.7 12.2 5.8 12.6 10.9 8.8 10.4 7.2 9.3 10.4 6.8 10.5 7.2 9.4 9.3 DOK7 "C4orf25, Dok-7, FLJ33718, FLJ39137" ENSG00000175920 "Docking protein 7" Q18PE1 4 3463311-3501473 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 19.1;skeletal muscle: 17.0" "Cell line enriched" "Detected in some" 4 "MCF7: 27.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.0" "Group enriched" "Detected in some" 8 "cerebellum: 8.7;pons and medulla: 2.5" "Group enriched" "Detected in some" 14 "memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2" "Group enriched" "Detected in many" 15 "B-cells: 6.3;NK-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059449, HPA062780" Approved Enhanced Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA059449: , HPA062780: " "prognostic favourable (8.45e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-2)" "prognostic favourable (2.19e-4)" "unprognostic (5.96e-2)" "unprognostic (6.80e-3)" "unprognostic (1.05e-2)" "unprognostic (9.54e-2)" "unprognostic (1.12e-2)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-4)" "unprognostic (4.61e-3)" "unprognostic (5.09e-1)" "unprognostic (3.16e-2)" "prognostic favourable (1.28e-4)" 1.2 0.5 0.1 0.2 0.2 0.2 0.5 8.7 0.7 1.5 0.3 1.4 0.1 0.1 1.3 4.7 1.1 5.0 3.7 19.1 0.4 0.6 1.4 0.4 1.7 0.7 0.1 0.1 1.3 4.3 0.0 9.7 0.1 2.5 0.7 0.1 2.4 2.0 6.4 17.0 0.3 0.1 0.7 0.1 0.6 2.2 5.3 0.4 0.1 0.6 1.8 0.6 0.6 0.1 6.3 0.0 0.0 0.0 3.2 0.3 0.2 2.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.9 0.0 1.0 0.0 3.4 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.3 27.1 0.0 1.1 0.2 0.1 0.0 5.3 0.2 1.8 2.3 0.4 0.1 2.2 0.0 0.0 6.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.3 0.0 3.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.2 0.1 0.2 8.7 0.7 0.4 0.6 0.1 0.1 2.5 0.4 DONSON "B17, C21orf60, C2TA, DKFZP434M035" ENSG00000159147 "Downstream neighbor of SON" Q9NYP3 21 33559542-33588708 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039558, HPA049033" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cell Junctions" Cytosol "HPA039558: , HPA049033: " "unprognostic (9.90e-3)" "unprognostic (1.01e-3)" "unprognostic (6.58e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.93e-2)" "prognostic unfavourable (8.22e-4)" "unprognostic (4.00e-2)" "unprognostic (5.93e-3)" "prognostic favourable (2.17e-4)" "unprognostic (1.25e-1)" "unprognostic (4.10e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.77e-2)" "unprognostic (1.66e-1)" "unprognostic (2.07e-1)" "unprognostic (8.83e-2)" 6.4 3.5 4.1 9.2 8.0 9.4 10.2 7.8 5.6 6.8 7.1 3.3 3.5 6.1 6.7 5.8 8.3 6.3 5.9 7.5 5.5 4.4 5.6 16.2 5.2 11.1 4.7 4.0 13.5 5.7 11.7 6.9 12.2 8.1 5.7 7.4 4.4 4.8 4.3 5.9 9.1 9.3 5.4 5.2 8.2 5.8 24.0 3.0 26.4 5.0 8.1 10.7 4.5 9.7 0.7 0.5 0.1 0.9 0.4 1.4 0.3 27.0 6.3 13.3 11.6 4.2 7.7 10.4 21.6 9.3 16.6 18.8 17.8 7.4 14.7 5.6 10.7 8.1 17.9 7.7 18.2 14.7 15.5 27.6 13.9 16.1 3.0 14.6 6.7 5.5 2.5 18.7 4.6 10.6 26.3 25.7 14.2 5.5 13.3 5.2 13.8 7.8 12.0 27.6 15.7 7.4 7.3 14.5 6.0 32.4 10.4 9.5 13.6 7.4 6.1 15.8 11.0 11.5 15.2 23.3 22.9 24.2 8.8 19.5 17.8 0.0 0.3 0.1 1.4 0.9 0.7 0.2 1.4 0.6 0.2 0.7 0.8 0.1 0.0 0.4 0.0 0.5 0.6 0.3 4.1 8.0 7.8 5.6 5.5 4.4 4.7 4.0 8.1 3.0 DOPEY1 "dJ202D23.2, KIAA1117" ENSG00000083097 "Dopey family member 1" Q5JWR5 6 83067666-83171350 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027902, HPA027904" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA027902: AB_10600003, HPA027904: AB_10600877" "unprognostic (7.18e-2)" "unprognostic (3.91e-1)" "unprognostic (6.11e-2)" "unprognostic (6.05e-3)" "unprognostic (8.21e-3)" "unprognostic (1.36e-2)" "unprognostic (3.32e-1)" "unprognostic (1.02e-2)" "unprognostic (2.84e-1)" "unprognostic (2.47e-1)" "prognostic favourable (7.36e-4)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" 9.7 8.7 15.7 11.3 19.5 5.5 13.3 25.2 21.2 11.9 9.5 10.1 10.1 9.5 13.9 9.5 9.5 12.0 8.9 10.6 15.2 7.0 8.9 7.5 9.1 8.3 10.9 12.9 17.7 12.1 20.3 21.7 7.3 17.3 12.4 11.0 9.0 13.8 14.9 12.7 16.6 11.7 9.5 13.1 9.5 9.5 14.9 12.8 10.7 16.9 8.5 8.9 12.2 10.7 2.3 2.8 1.4 1.4 1.2 4.1 1.3 3.7 2.7 9.0 8.1 8.2 8.6 4.3 6.3 5.3 4.3 6.3 5.7 0.9 7.2 4.5 6.8 5.0 9.1 6.9 5.5 6.3 10.2 6.0 3.7 2.1 4.4 8.8 6.3 6.8 9.7 6.0 15.8 6.4 12.5 5.4 4.7 3.5 2.6 4.0 1.8 5.5 7.2 6.8 2.6 5.8 10.4 16.2 3.0 4.7 3.0 1.2 4.8 5.0 10.6 5.5 2.0 5.5 4.9 6.7 4.7 4.2 2.9 4.1 4.3 0.1 1.3 1.4 1.9 1.4 1.6 2.3 1.6 4.1 2.8 1.9 3.0 1.4 0.2 1.2 1.2 1.2 1.5 1.3 15.7 19.5 25.2 21.2 15.2 7.0 10.9 12.9 17.3 12.8 DPCR1 "bCX105N19.6, C6orf37, PBLT" ENSG00000168631 "Diffuse panbronchiolitis critical region 1" Q3MIW9 6 30934523-30954221 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "gallbladder: 53.4;stomach 1: 70.9" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;HMC-1: 1.0;NTERA-2: 2.3;RPTEC TERT1: 1.8" "Group enriched" "Detected in some" 9 "pancreatic cancer: 56.8;stomach cancer: 55.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014036 Enhanced "HPA014036: AB_1847841" "unprognostic (2.81e-1)" "unprognostic (4.49e-2)" "unprognostic (9.13e-4)" "unprognostic (6.74e-2)" "unprognostic (4.29e-2)" "unprognostic (8.06e-2)" "unprognostic (3.08e-1)" "unprognostic (1.03e-1)" "unprognostic (3.32e-3)" "unprognostic (2.79e-1)" "prognostic unfavourable (6.58e-4)" "unprognostic (1.13e-1)" "unprognostic (5.97e-2)" "unprognostic (4.76e-2)" "unprognostic (9.80e-2)" "unprognostic (3.20e-2)" "unprognostic (3.58e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 1.9 0.0 0.0 0.0 0.0 4.8 0.0 53.4 0.0 0.0 0.0 0.0 2.5 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 DPEP2 ENSG00000167261 "Dipeptidase 2" Q9H4A9 16 67987394-68000586 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 105.1" "Cell line enhanced" "Detected in some" "HEL: 4.3;HMC-1: 19.5;NB-4: 4.2;U-937: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 43.5;eosinophil: 105.1;neutrophil: 47.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 105.1" "Low region specificity" "Detected in many" HPA035644 Approved 260000000 "HPA035644: AB_10670164" "unprognostic (8.81e-2)" "unprognostic (7.84e-5)" "unprognostic (1.35e-1)" "unprognostic (1.42e-2)" "unprognostic (1.92e-1)" "unprognostic (6.66e-3)" "unprognostic (1.03e-1)" "unprognostic (5.47e-2)" "unprognostic (3.69e-2)" "unprognostic (1.68e-1)" "unprognostic (6.01e-2)" "unprognostic (1.46e-1)" "unprognostic (3.91e-2)" "unprognostic (5.75e-2)" "prognostic unfavourable (8.47e-4)" "unprognostic (7.78e-3)" "unprognostic (3.91e-2)" 7.8 0.9 1.3 7.1 2.4 13.0 3.5 0.7 2.5 1.5 2.6 2.4 1.1 1.7 4.1 4.1 1.8 2.0 6.8 2.4 1.6 1.3 2.0 2.0 11.4 10.4 2.1 2.0 0.7 0.9 0.1 0.9 19.4 2.7 2.4 2.4 5.1 2.8 0.4 1.6 1.2 10.1 2.3 3.3 26.4 1.6 2.5 1.6 3.5 2.5 3.8 11.1 6.3 1.5 5.0 4.3 105.1 15.3 5.6 4.9 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.3 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 4.3 0.0 0.1 0.0 0.1 19.5 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 4.2 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.0 1.1 0.5 0.3 0.0 6.5 0.0 43.5 10.7 105.1 2.3 13.0 2.7 4.1 4.0 1.9 4.3 5.0 4.9 2.5 47.3 5.6 15.3 0.6 4.0 5.7 1.3 2.4 0.7 2.5 1.6 1.3 2.1 2.0 2.7 1.6 DPM3 "MGC125904, MGC125905, MGC34275" ENSG00000179085 "Dolichyl-phosphate mannosyltransferase subunit 3" Q9P2X0 1 155139891-155140595 "Disease related genes, Predicted membrane proteins" "Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014667 Approved 160000 "HPA014667: AB_1847848" "unprognostic (6.47e-2)" "unprognostic (1.49e-2)" "unprognostic (1.18e-1)" "prognostic favourable (7.09e-5)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.67e-2)" "unprognostic (6.83e-3)" "unprognostic (4.71e-1)" "prognostic favourable (8.97e-5)" "unprognostic (1.42e-3)" "unprognostic (8.83e-2)" "unprognostic (1.75e-1)" "unprognostic (1.50e-2)" "unprognostic (1.71e-1)" "unprognostic (1.28e-1)" "prognostic favourable (8.64e-4)" 21.6 32.2 18.8 14.6 21.3 21.8 28.4 13.0 20.7 25.9 36.1 14.6 43.4 31.0 23.4 42.9 19.6 25.1 31.7 26.1 17.4 18.0 23.9 42.5 19.2 17.9 18.1 15.3 19.9 62.6 9.2 32.7 12.4 14.3 22.3 9.9 23.7 42.1 44.8 29.6 13.4 23.4 23.3 15.1 20.0 24.2 21.5 12.2 13.1 47.0 22.2 11.9 17.3 18.1 43.3 49.6 40.4 45.2 36.4 42.1 37.6 22.4 25.2 7.9 18.5 14.5 13.5 8.4 7.4 9.4 10.1 10.6 7.9 26.6 7.2 22.9 6.0 16.2 3.0 8.6 1.2 10.3 51.9 8.0 37.3 26.9 13.7 7.2 10.7 13.3 16.0 7.2 3.1 11.6 9.0 39.1 7.5 54.5 15.8 16.5 19.5 19.6 13.7 8.9 43.4 12.0 15.6 13.8 28.5 16.9 20.2 26.8 13.9 34.9 9.2 6.3 15.1 8.8 10.8 33.2 16.7 21.7 16.4 15.6 4.6 20.3 45.2 40.4 38.8 27.8 42.1 43.3 41.4 37.9 43.7 41.8 39.7 37.9 25.0 36.4 27.6 49.6 32.6 37.6 18.8 21.3 13.0 20.7 17.4 18.0 18.1 15.3 14.3 12.2 DPP10 "DPL2, DPPY, DPRP3" ENSG00000175497 "Dipeptidyl peptidase like 10" Q8N608 2 114442299-115845752 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 15.6;brain: 30.3;pancreas: 23.4" "Cell line enhanced" "Detected in some" "AF22: 5.0;HAP1: 7.5;HMC-1: 5.3;NTERA-2: 4.5;RT4: 8.0;SCLC-21H: 11.9;SH-SY5Y: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048767 Uncertain "HPA048767: " "unprognostic (1.19e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" "unprognostic (1.77e-2)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (6.59e-2)" "unprognostic (2.92e-1)" "unprognostic (5.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-2)" "unprognostic (8.33e-2)" "unprognostic (7.61e-2)" "unprognostic (4.22e-2)" 0.7 15.6 13.4 1.1 15.9 0.9 0.9 1.9 30.3 1.3 3.6 7.9 0.0 2.4 1.4 0.8 0.8 0.9 1.9 0.8 17.5 9.9 1.1 0.9 1.0 0.7 7.1 21.3 0.9 23.4 0.7 1.5 1.8 10.8 0.8 4.6 0.0 1.0 0.8 0.7 0.9 2.4 1.9 12.7 0.7 1.5 2.1 10.3 0.0 1.6 0.0 0.8 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 8.0 11.9 4.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.9 1.9 30.3 17.5 9.9 7.1 21.3 10.8 10.3 DPP6 "DPL1, DPPX" ENSG00000130226 "Dipeptidyl peptidase like 6" P42658 7 153887097-154894285 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.7;endometrium 1: 24.5;thyroid gland: 24.1" "Cell line enriched" "Detected in some" 9 "NTERA-2: 11.0" "Cancer enriched" "Detected in some" 11 "glioma: 12.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050509 Enhanced Supported "HPA050509: " "unprognostic (1.29e-1)" "unprognostic (3.55e-2)" "unprognostic (5.68e-2)" "unprognostic (5.86e-2)" "unprognostic (1.53e-2)" "unprognostic (2.28e-1)" "unprognostic (2.73e-1)" "unprognostic (5.83e-4)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (7.45e-3)" "unprognostic (4.04e-3)" "unprognostic (2.94e-3)" "unprognostic (1.85e-4)" "unprognostic (1.05e-1)" "unprognostic (4.61e-3)" "unprognostic (6.11e-2)" 1.6 7.2 15.4 1.4 32.5 1.3 1.5 26.6 45.7 2.3 6.8 8.7 0.0 1.6 24.5 3.1 1.5 4.6 1.3 1.4 26.6 15.2 3.6 1.2 2.2 1.3 14.0 22.7 1.3 4.0 1.2 4.9 1.3 18.8 1.5 2.4 0.4 1.3 8.1 4.6 3.7 2.0 15.8 7.2 4.2 3.5 7.9 10.0 0.0 24.1 0.0 1.2 1.3 0.4 0.6 0.6 1.9 0.9 0.9 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 11.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.9 0.4 0.7 0.4 0.6 0.7 0.6 0.6 0.4 0.4 0.6 0.7 0.7 1.6 0.9 0.9 0.6 0.5 0.3 15.4 32.5 26.6 32.4 26.6 15.2 14.0 22.7 18.8 10.0 DPY19L3 ENSG00000178904 "Dpy-19 like C-mannosyltransferase 3" Q6ZPD9 19 32405543-32485895 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008325 Approved Approved Microtubules Microtubules "HPA008325: AB_1847853" "unprognostic (9.58e-3)" "unprognostic (3.89e-1)" "unprognostic (2.24e-1)" "unprognostic (3.60e-1)" "unprognostic (5.21e-2)" "prognostic favourable (5.55e-4)" "unprognostic (2.00e-2)" "unprognostic (3.76e-2)" "unprognostic (1.28e-3)" "unprognostic (3.27e-1)" "prognostic favourable (1.70e-4)" "unprognostic (3.26e-1)" "unprognostic (1.02e-2)" "unprognostic (6.34e-2)" "unprognostic (1.87e-1)" "unprognostic (1.75e-1)" "unprognostic (9.72e-3)" 8.4 10.9 20.7 8.1 23.0 11.5 10.1 11.2 18.5 12.8 6.2 15.2 9.9 4.2 10.7 9.3 6.1 8.9 9.7 6.4 17.9 14.1 8.6 7.4 7.6 7.1 15.3 11.0 19.3 11.3 15.0 13.3 11.7 14.5 16.1 6.7 9.8 10.2 8.7 3.6 4.9 5.9 7.6 15.7 10.8 9.8 12.3 10.2 6.8 15.3 4.5 6.9 8.3 7.5 2.9 2.2 9.0 2.7 1.3 2.2 0.8 3.0 5.8 21.8 9.6 22.4 11.5 10.9 9.3 6.6 3.9 6.9 6.7 3.4 11.8 5.9 6.6 1.6 8.8 4.1 7.3 6.0 5.7 15.7 5.8 6.1 14.7 8.1 9.1 12.0 2.2 4.7 4.5 9.1 11.3 3.8 10.0 5.0 2.1 4.1 9.1 2.3 5.7 8.7 3.5 7.3 7.4 4.8 13.1 4.5 4.4 4.9 3.3 9.5 9.9 7.9 5.6 4.7 9.7 5.8 11.8 8.0 11.1 9.8 12.7 6.0 2.5 7.4 1.8 1.9 1.0 2.0 1.7 1.7 2.2 2.9 1.4 1.6 9.0 1.3 2.7 1.6 2.2 0.8 20.7 23.0 11.2 15.0 17.9 14.1 15.3 11.0 14.5 10.2 DPY19L4 ENSG00000156162 "Dpy-19 like 4" Q7Z388 8 94719703-94793836 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024780 Approved "HPA024780: AB_10600869" "unprognostic (1.45e-1)" "unprognostic (2.89e-3)" "unprognostic (3.41e-2)" "prognostic unfavourable (3.73e-4)" "unprognostic (2.28e-1)" "unprognostic (5.54e-2)" "unprognostic (4.94e-2)" "unprognostic (7.17e-2)" "unprognostic (3.18e-2)" "unprognostic (1.04e-1)" "unprognostic (4.72e-2)" "unprognostic (9.38e-2)" "unprognostic (2.25e-1)" "unprognostic (1.48e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-2)" "unprognostic (1.55e-1)" 13.2 18.3 14.5 10.8 16.3 5.7 17.3 9.0 13.6 18.5 10.4 21.6 16.8 8.3 20.0 13.6 11.6 14.4 16.3 18.3 14.9 12.7 18.5 19.1 11.3 12.9 21.5 13.8 21.7 11.5 29.3 16.9 15.3 14.8 16.5 11.4 16.5 13.2 16.8 11.0 11.6 10.3 15.8 21.6 12.9 15.2 12.2 16.0 11.2 20.1 7.4 9.7 13.6 14.4 2.7 3.4 1.5 1.6 3.7 4.6 2.2 14.7 9.6 16.5 10.4 16.8 21.8 9.1 13.3 12.6 12.6 12.5 4.4 21.8 3.3 16.5 12.8 15.7 10.0 10.5 21.0 7.4 8.0 15.4 9.2 7.4 19.6 6.6 3.3 14.4 8.9 10.7 10.3 15.2 10.7 5.7 14.6 9.2 12.5 12.4 6.4 10.8 9.0 11.3 6.6 12.1 11.6 8.1 18.3 10.6 2.3 10.2 14.3 8.3 14.9 13.2 8.1 14.6 11.0 6.3 7.8 8.8 9.9 11.5 18.5 1.5 1.6 0.1 2.9 1.5 4.1 2.7 3.0 4.6 2.7 1.0 3.2 4.2 1.2 3.7 1.6 3.4 1.2 2.2 14.5 16.3 9.0 13.6 14.9 12.7 21.5 13.8 14.8 16.0 DSC1 CDHF1 ENSG00000134765 "Desmocollin 1" Q08554 18 31129236-31162856 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 78.4" "Cell line enhanced" "Detected in some" "BEWO: 1.3;CACO-2: 1.0;HaCaT: 1.0;HEL: 1.5;hTCEpi: 1.0;MCF7: 1.0" "Group enriched" "Detected in some" 17 "head and neck cancer: 7.3;melanoma: 4.1" "Region enriched" "Detected in single" 13 "cerebral cortex: 7.0" "Group enriched" "Detected in some" 8 "naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.2" "Lineage enriched" "Detected in single" 8 "T-cells: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075379 Enhanced 18000000 "HPA075379: " "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (2.12e-1)" "unprognostic (1.10e-1)" "unprognostic (6.95e-2)" "unprognostic (2.48e-2)" "unprognostic (3.71e-2)" "unprognostic (8.19e-3)" "unprognostic (1.56e-1)" "unprognostic (1.89e-1)" "unprognostic (1.27e-1)" "unprognostic (1.78e-1)" "unprognostic (5.65e-6)" "unprognostic (5.08e-2)" "unprognostic (2.91e-1)" "unprognostic (6.99e-2)" "unprognostic (4.74e-5)" 0.2 0.1 0.1 0.3 0.5 0.0 3.5 0.1 7.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 2.8 0.1 0.0 9.1 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.4 0.1 1.3 0.0 0.1 0.0 1.3 1.2 0.0 0.2 78.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 1.1 0.1 16.6 1.5 0.1 0.2 0.0 0.0 0.7 0.0 0.0 5.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.0 0.3 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 5.7 5.2 0.7 0.0 0.0 0.0 0.0 0.9 0.1 0.5 0.1 7.0 0.1 0.1 0.1 0.1 0.0 0.0 DSC2 "CDHF2, DSC3" ENSG00000134755 "Desmocollin 2" Q02487 18 31058840-31102415 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 127.5;lymphoid tissue: 68.2;tongue: 163.9" "Cell line enhanced" "Detected in many" "BEWO: 15.8;CAPAN-2: 20.5;HaCaT: 29.6;hTCEpi: 32.0;SK-BR-3: 18.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 48.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "eosinophil: 20.4;neutrophil: 5.7" "Lineage enriched" "Detected in many" 14 "granulocytes: 20.4" "Not detected" "Not detected" "HPA011911, HPA012615" Enhanced 14000000 "HPA011911: AB_1847618, HPA012615: AB_1847619" "unprognostic (3.28e-2)" "unprognostic (3.20e-1)" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (1.90e-1)" "unprognostic (3.04e-2)" "unprognostic (1.30e-2)" "prognostic unfavourable (5.80e-4)" "unprognostic (7.66e-2)" "unprognostic (4.07e-2)" "unprognostic (1.22e-3)" "unprognostic (2.10e-1)" "unprognostic (1.43e-3)" "unprognostic (1.60e-1)" "unprognostic (1.75e-1)" "unprognostic (2.49e-1)" "prognostic unfavourable (3.01e-4)" 3.3 1.1 1.1 9.8 1.1 0.0 6.3 0.7 0.9 38.1 23.6 0.6 0.2 12.1 3.0 2.4 127.5 1.5 1.1 9.5 1.0 0.9 4.7 4.3 3.3 6.3 1.1 0.6 1.0 3.8 11.8 0.7 20.0 1.1 4.5 13.3 1.3 22.4 0.0 0.7 4.4 33.5 0.8 1.7 6.1 12.6 0.9 0.7 4.8 2.5 163.9 68.2 1.0 39.6 0.0 0.0 20.4 1.5 0.0 0.0 0.3 7.3 0.7 1.2 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 3.8 20.5 0.0 0.3 0.0 29.6 4.9 2.1 0.0 0.0 2.9 11.0 3.6 6.6 0.1 0.0 0.2 0.1 32.0 0.0 3.1 0.0 5.3 0.0 0.0 5.9 0.0 0.4 4.8 7.3 5.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 18.8 0.0 5.0 7.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 20.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.3 1.1 1.1 0.7 0.9 1.0 0.9 1.1 0.6 1.1 0.7 DSC3 "CDHF3, DSC, DSC1, DSC2, DSC4" ENSG00000134762 "Desmocollin 3" Q14574 18 30990008-31042815 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" Hypotrichosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4" "Cell line enhanced" "Detected in some" "HaCaT: 69.4;HBEC3-KT: 16.0;hTCEpi: 41.1;hTERT-HME1: 30.2" "Cancer enhanced" "Detected in many" "cervical cancer: 78.6;head and neck cancer: 107.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basal ganglia: 1.3;hippocampal formation: 3.6" "Not detected" "Not detected" "CAB037328, HPA049265, HPA073937" Enhanced Enhanced "Plasma membrane,Cell Junctions" 2700000 "Plasma membrane, Cell Junctions" "CAB037328: , HPA049265: , HPA073937: " "unprognostic (4.44e-3)" "unprognostic (6.28e-2)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (2.38e-1)" "unprognostic (1.32e-2)" "unprognostic (6.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-2)" "unprognostic (3.92e-3)" "unprognostic (3.13e-1)" "unprognostic (4.13e-4)" "unprognostic (1.22e-2)" "unprognostic (7.85e-2)" "unprognostic (3.47e-1)" "prognostic unfavourable (1.04e-5)" 1.5 0.0 0.0 0.6 0.0 0.0 10.4 0.0 0.0 11.9 1.0 0.0 0.4 0.1 2.1 1.4 73.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 2.4 0.1 16.0 0.1 4.5 0.0 0.0 7.2 0.3 0.2 99.1 0.2 0.1 0.0 0.0 0.0 0.5 0.0 2.2 0.0 92.4 28.4 1.0 14.4 0.7 0.2 1.0 0.5 0.4 0.4 0.1 4.4 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 69.4 0.0 16.0 0.0 0.0 3.8 0.2 1.3 0.1 2.6 0.0 0.0 2.7 41.1 0.0 30.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 5.7 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.3 0.2 0.2 0.4 0.3 0.2 0.0 0.7 0.3 0.4 1.0 0.4 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 DSCAM "CHD2-42, CHD2-52" ENSG00000171587 "DS cell adhesion molecule" O60469 21 40010999-40847139 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.2;pituitary gland: 9.1" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.4;MCF7: 12.0;NTERA-2: 3.3;SCLC-21H: 5.0;T-47d: 3.3" "Cancer enriched" "Detected in single" 14 "glioma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019324 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA019324: " "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (7.59e-2)" "unprognostic (1.99e-2)" "unprognostic (9.98e-2)" "unprognostic (5.49e-4)" "unprognostic (1.78e-1)" "unprognostic (9.58e-2)" "unprognostic (7.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.85e-3)" "unprognostic (2.12e-2)" "unprognostic (2.00e-3)" "unprognostic (2.17e-2)" "unprognostic (2.29e-1)" "unprognostic (8.75e-2)" "unprognostic (5.46e-3)" 0.9 1.1 12.7 0.9 10.3 0.9 1.2 3.0 22.2 0.9 1.0 8.2 0.0 1.0 0.9 2.8 0.9 1.1 1.0 0.9 10.1 8.6 0.9 1.4 1.0 0.9 6.8 10.1 0.9 1.2 0.9 9.1 2.9 9.5 1.0 1.0 0.7 0.9 1.0 0.9 0.9 1.0 0.9 3.7 2.9 0.9 2.0 6.9 0.0 0.9 0.0 0.9 1.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.5 0.0 0.0 0.0 0.0 12.0 0.0 0.0 3.3 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.7 10.3 3.0 14.7 10.1 8.6 6.8 10.1 9.5 6.9 DSCAML1 KIAA1132 ENSG00000177103 "DS cell adhesion molecule like 1" Q8TD84 11 117427773-117817525 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Group enriched" "Detected in some" 4 "EFO-21: 9.0;RPTEC TERT1: 6.6;T-47d: 12.2" "Group enriched" "Detected in some" 5 "glioma: 1.9;ovarian cancer: 0.9;pancreatic cancer: 0.6;renal cancer: 2.5;thyroid cancer: 0.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "memory B-cell: 1.7;naive B-cell: 2.0;T-reg: 2.4" "Group enriched" "Detected in many" 22 "B-cells: 2.0;T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035230 Uncertain "HPA035230: " "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" "unprognostic (1.07e-2)" "unprognostic (6.27e-5)" "unprognostic (8.48e-2)" "unprognostic (1.56e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (7.96e-2)" "unprognostic (2.89e-2)" "unprognostic (2.39e-3)" "unprognostic (8.37e-2)" "prognostic favourable (8.37e-4)" "unprognostic (1.64e-1)" "unprognostic (1.86e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-2)" 1.5 1.7 10.4 1.3 14.5 1.1 1.3 3.4 19.5 1.7 2.2 26.0 0.0 1.8 4.2 2.2 1.3 4.3 3.5 2.1 12.0 5.8 5.6 1.2 2.0 1.4 14.9 11.1 9.9 2.6 1.0 5.0 1.0 12.1 1.7 2.3 10.8 3.6 1.5 2.1 1.0 1.9 2.9 12.2 3.3 1.9 4.2 17.4 0.0 1.5 0.0 1.7 1.7 0.9 2.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 9.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 6.6 0.0 1.1 0.2 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 10.4 14.5 3.4 14.4 12.0 5.8 14.9 11.1 12.1 17.4 DSG1 "CDHF4, DSG" ENSG00000134760 "Desmoglein 1" Q02413 18 31318089-31357029 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 124.8;tongue: 117.4" "Cell line enriched" "Detected in single" 18 "hTCEpi: 14.2" "Group enriched" "Detected in many" 10 "head and neck cancer: 57.0;melanoma: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009394, HPA022128" Enhanced 140000000 "CAB009394: AB_2293011, HPA022128: AB_1847620" "unprognostic (2.55e-2)" "unprognostic (8.87e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (5.22e-1)" "unprognostic (1.81e-2)" "unprognostic (1.57e-2)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (1.04e-2)" "unprognostic (2.19e-1)" "unprognostic (6.15e-2)" "unprognostic (4.24e-3)" "unprognostic (2.87e-1)" "unprognostic (1.44e-1)" "prognostic unfavourable (2.99e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 30.9 0.0 0.0 0.0 0.0 1.3 0.0 18.5 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 4.2 0.0 0.3 124.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.0 0.0 117.4 2.3 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DSG2 CDHF5 ENSG00000046604 "Desmoglein 2" Q14126 18 31498043-31549008 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 37.2;HaCaT: 58.0;HBEC3-KT: 43.0;hTERT-HME1: 46.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 7 "pons and medulla: 6.9" "Cell type enriched" "Detected in single" 10 "basophil: 9.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA004896, CAB025122" Enhanced Supported "Cell Junctions" 94000000 "Cell Junctions" "CAB025122: , HPA004896: AB_1078643" "unprognostic (1.56e-3)" "prognostic unfavourable (8.22e-4)" "prognostic favourable (7.81e-4)" "unprognostic (8.77e-3)" "unprognostic (3.53e-4)" "prognostic unfavourable (5.63e-4)" "unprognostic (2.86e-3)" "prognostic unfavourable (2.43e-4)" "unprognostic (5.21e-2)" "unprognostic (1.49e-1)" "prognostic unfavourable (4.94e-5)" "unprognostic (3.40e-1)" "prognostic favourable (3.14e-10)" "unprognostic (1.76e-1)" "unprognostic (1.51e-1)" "unprognostic (3.72e-1)" "unprognostic (8.57e-3)" 17.3 1.1 0.6 11.6 0.7 0.0 21.1 0.7 0.7 3.9 50.2 1.3 4.0 18.1 3.8 5.6 6.3 4.9 14.2 15.7 0.7 0.6 22.4 10.8 7.0 2.4 0.6 0.9 8.8 15.5 39.9 2.7 39.8 6.9 10.4 23.8 4.5 27.3 1.5 2.2 5.3 70.7 3.1 0.5 0.6 17.3 2.3 0.5 13.6 20.8 3.2 5.8 18.5 7.7 0.1 0.9 9.5 0.0 0.0 0.3 0.0 24.8 9.6 0.8 0.0 0.1 1.6 31.3 0.0 0.0 0.0 0.0 6.7 37.2 0.0 14.1 0.0 58.0 11.8 43.0 0.0 0.0 7.3 0.0 11.1 7.5 4.5 3.1 0.0 2.2 29.9 0.9 46.9 0.0 9.8 0.0 0.0 6.5 6.6 0.4 12.0 5.0 11.0 0.0 15.9 14.4 12.4 5.2 0.0 18.9 13.4 0.0 9.6 2.7 0.0 0.0 5.6 0.0 6.1 1.2 0.0 0.0 4.4 0.0 5.4 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.6 0.7 0.7 0.7 0.7 0.6 0.6 0.9 6.9 0.5 DSG3 CDHF6 ENSG00000134757 "Desmoglein 3" P32926 18 31447795-31478702 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 156.7;lymphoid tissue: 50.7;tongue: 158.9" "Group enriched" "Detected in some" 7 "HaCaT: 41.1;hTCEpi: 101.8" "Group enriched" "Detected in many" 5 "cervical cancer: 104.0;head and neck cancer: 183.9;lung cancer: 36.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 26 "basophil: 9.0" "Lineage enriched" "Detected in single" 42 "granulocytes: 9.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA046864, HPA056863, CAB069880" Enhanced "CAB069880: AB_2093604, HPA046864: AB_2679846, HPA056863: AB_2683260" "unprognostic (5.76e-3)" "unprognostic (6.99e-2)" "unprognostic (7.67e-2)" "unprognostic (7.79e-2)" "unprognostic (1.00e-2)" "unprognostic (4.08e-3)" "unprognostic (1.63e-1)" "unprognostic (3.21e-2)" "prognostic unfavourable (1.43e-5)" "unprognostic (8.26e-2)" "unprognostic (8.35e-7)" "unprognostic (8.85e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "prognostic unfavourable (9.90e-4)" 0.0 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.1 35.9 1.1 0.0 0.0 1.6 2.3 0.0 156.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.1 0.0 10.6 0.0 0.0 10.2 1.8 0.1 0.0 0.0 0.0 0.1 0.0 3.2 0.0 158.9 50.7 0.4 24.8 0.2 0.1 9.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.8 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DSG4 "CDHF13, LAH" ENSG00000175065 "Desmoglein 4" Q86SJ6 18 31376777-31414912 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 7.3;testis: 2.6" "Cell line enriched" "Detected in single" 170 "HaCaT: 30.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.2" HPA059456 Enhanced 300000 "HPA059456: " "unprognostic (9.86e-2)" "unprognostic (8.61e-2)" "unprognostic (2.17e-2)" "unprognostic (2.61e-1)" "unprognostic (5.55e-2)" "unprognostic (5.61e-2)" "unprognostic (2.11e-2)" "unprognostic (6.00e-2)" "unprognostic (1.06e-1)" "unprognostic (2.58e-1)" "unprognostic (2.14e-1)" "unprognostic (1.79e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.0 0.0 7.3 0.7 0.0 0.0 0.0 1.0 2.6 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DTNA "D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3" ENSG00000134769 "Dystrobrevin alpha" Q9Y4J8 18 34493290-34891844 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2" "Cell line enhanced" "Detected in many" "MCF7: 17.5;NTERA-2: 19.5;SCLC-21H: 27.5;U-87 MG: 28.1" "Cancer enriched" "Detected in many" 9 "glioma: 28.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;T-cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015196, HPA071177" Enhanced Approved "Nucleoplasm,Cell Junctions,Intermediate filaments" "Nucleoplasm, Cell Junctions, Intermediate filaments" "CAB015196: AB_2261797, HPA071177: " "unprognostic (1.57e-1)" "unprognostic (4.57e-2)" "unprognostic (3.13e-3)" "unprognostic (7.82e-6)" "unprognostic (5.03e-1)" "unprognostic (2.43e-3)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (1.23e-1)" "unprognostic (6.27e-2)" "unprognostic (1.35e-4)" "unprognostic (6.89e-2)" "prognostic favourable (2.64e-7)" "unprognostic (6.08e-3)" "unprognostic (3.93e-2)" "unprognostic (1.12e-1)" "unprognostic (7.27e-5)" 9.3 5.3 51.5 4.0 47.6 1.6 7.3 37.7 69.1 4.5 5.4 38.7 0.9 3.4 4.3 13.9 13.9 7.6 7.1 82.8 42.3 46.5 2.7 2.5 4.8 2.3 44.7 21.0 5.4 12.3 1.4 6.1 3.6 51.0 14.6 5.6 3.4 5.7 15.9 90.2 1.8 3.9 15.2 106.3 3.9 3.6 4.7 39.5 0.0 9.3 6.5 2.4 12.8 1.7 1.4 7.0 0.4 1.3 1.0 6.7 1.7 0.2 0.1 7.5 0.0 4.8 13.4 1.2 2.0 7.3 0.3 0.9 1.7 0.0 0.0 4.4 0.8 0.6 0.9 3.9 0.7 0.0 5.2 0.0 0.4 3.5 3.9 0.1 0.1 10.2 0.8 6.3 2.2 3.2 1.1 0.9 2.1 17.5 0.1 0.0 19.5 4.0 0.0 3.7 11.9 0.3 0.1 27.5 3.2 0.0 0.7 2.0 10.7 2.6 0.1 8.7 4.7 0.1 2.7 0.6 0.9 0.4 28.1 0.0 3.7 0.4 1.3 0.0 1.4 0.0 1.9 1.4 2.7 1.9 7.0 1.1 2.8 2.0 0.1 1.0 0.0 0.2 6.7 1.7 51.5 47.6 37.7 35.7 42.3 46.5 44.7 21.0 51.0 39.5 DYM "DMC, FLJ20071, SMC" ENSG00000141627 Dymeclin Q7RTS9 18 49041474-49461347 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043551, HPA049187" Approved Supported "Golgi apparatus" "Golgi apparatus" "HPA043551: , HPA049187: " "unprognostic (1.88e-2)" "unprognostic (1.23e-1)" "unprognostic (3.12e-3)" "unprognostic (1.33e-2)" "unprognostic (1.95e-1)" "unprognostic (1.59e-1)" "unprognostic (1.85e-3)" "unprognostic (1.77e-1)" "unprognostic (1.72e-1)" "unprognostic (8.30e-3)" "unprognostic (2.53e-2)" "unprognostic (2.58e-2)" "prognostic favourable (2.76e-5)" "unprognostic (3.89e-1)" "unprognostic (1.69e-1)" "unprognostic (4.26e-3)" "prognostic unfavourable (5.26e-5)" 17.7 19.5 13.6 19.4 15.2 17.0 29.4 23.9 17.9 20.3 17.5 15.1 21.4 12.9 19.5 18.8 20.9 15.8 15.7 18.9 13.3 15.0 17.4 16.5 16.9 21.6 16.8 12.0 24.9 63.2 20.1 19.4 12.9 18.7 19.7 14.2 20.3 26.8 26.9 42.0 16.7 12.0 29.7 17.3 14.4 16.9 33.1 14.1 32.5 26.5 13.5 17.9 23.8 25.9 13.5 21.5 23.0 19.3 21.0 21.3 14.9 12.0 7.3 11.6 17.8 22.1 25.0 9.2 12.0 15.8 14.4 14.1 5.4 7.7 37.4 10.7 22.2 15.4 18.0 15.7 17.7 14.0 9.3 8.7 6.9 15.8 22.1 30.1 15.8 19.4 18.7 16.8 43.4 22.1 9.1 22.8 11.5 12.8 20.3 12.9 3.7 5.7 10.6 14.8 17.6 13.2 13.7 21.6 13.8 8.1 9.8 11.1 13.8 10.9 12.0 13.6 6.5 5.8 6.9 25.8 18.5 21.0 7.3 19.0 15.1 11.9 19.3 23.0 15.8 17.3 21.3 13.5 15.4 14.7 21.5 11.2 15.6 12.2 8.8 21.0 14.1 6.1 15.4 14.9 13.6 15.2 23.9 17.9 13.3 15.0 16.8 12.0 18.7 14.1 DYNAP "C18orf26, FLJ39106" ENSG00000178690 "Dynactin associated protein" Q8N1N2 18 54587757-54599493 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 23.9;tongue: 50.3" "Cell line enriched" "Detected in some" 5 "Karpas-707: 16.5" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA011148 Uncertain "HPA011148: AB_1845609" "unprognostic (9.88e-2)" "unprognostic (2.51e-2)" "unprognostic (1.75e-3)" "unprognostic (1.45e-1)" "unprognostic (8.09e-3)" 0.2 0.2 0.1 0.1 0.1 1.1 0.1 0.1 0.2 0.8 0.1 0.1 0.1 0.1 0.5 1.4 23.9 0.2 0.2 0.3 0.1 0.1 0.3 0.2 0.1 0.4 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.1 2.1 0.1 0.2 0.5 0.2 0.3 0.1 1.4 0.2 0.4 0.1 0.2 0.1 50.3 6.7 0.1 0.3 1.8 1.0 3.1 2.9 0.7 1.0 0.0 1.0 0.3 1.7 0.8 0.9 2.0 1.7 0.4 0.7 1.3 1.3 0.9 0.6 0.9 0.6 0.9 0.6 1.2 0.0 0.7 0.3 0.3 0.3 1.1 0.6 0.7 0.8 0.8 0.8 0.2 1.3 0.4 0.3 1.3 16.5 0.2 0.3 0.6 0.5 2.6 0.5 0.6 2.0 0.8 0.5 0.9 0.7 1.0 0.3 0.3 2.9 0.5 1.1 2.8 0.6 3.2 0.6 0.5 0.6 0.4 1.3 0.9 0.4 0.4 1.2 1.3 2.1 1.0 1.1 0.7 1.0 0.6 0.4 0.4 1.8 0.7 0.7 3.1 0.7 2.9 1.0 0.3 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 DYRK2 ENSG00000127334 "Dual specificity tyrosine phosphorylation regulated kinase 2" Q92630 12 67648338-67665406 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027230, HPA056902" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA027230: AB_1847925, HPA056902: " "unprognostic (5.86e-3)" "unprognostic (4.18e-1)" "unprognostic (4.08e-3)" "unprognostic (2.56e-3)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (7.83e-2)" "unprognostic (2.83e-2)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (2.12e-2)" "unprognostic (2.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "unprognostic (1.35e-1)" 12.2 5.3 4.5 20.1 4.8 8.6 8.1 4.4 6.6 10.1 21.3 4.1 8.3 13.7 14.6 9.6 9.6 9.1 16.9 26.1 4.7 3.2 6.3 4.6 10.1 17.9 4.0 3.3 7.6 8.5 3.6 4.4 13.0 5.0 7.1 15.3 6.6 7.2 6.6 23.7 9.4 26.0 11.2 5.3 10.3 14.0 4.4 3.9 34.3 7.6 12.5 17.2 11.1 12.2 2.7 1.9 5.9 1.3 6.9 6.8 1.6 13.5 7.7 11.5 8.3 5.8 7.9 9.2 13.8 9.0 6.8 3.9 10.1 7.5 25.4 17.1 20.0 15.9 9.2 5.4 7.3 10.9 12.0 4.1 5.1 3.8 2.2 9.2 8.9 6.5 7.8 18.2 14.6 3.8 5.0 13.3 8.6 7.8 7.9 4.5 10.0 12.4 21.1 11.4 11.2 7.9 17.1 15.2 18.0 5.8 7.8 8.0 5.3 7.8 5.6 10.8 10.2 7.4 10.9 6.3 1.0 14.1 10.4 6.3 11.1 3.2 0.5 5.9 5.2 1.3 4.0 2.7 3.9 6.8 1.9 2.7 3.3 6.1 0.7 6.9 1.3 0.8 3.1 1.6 4.5 4.8 4.4 6.6 4.7 3.2 4.0 3.3 5.0 3.9 DYSF "FER1L1, LGMD2B" ENSG00000135636 Dysferlin O75923 2 71453722-71686768 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 39.9;skeletal muscle: 53.3" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 32.4;LHCN-M2: 29.4;RH-30: 31.1;TIME: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 19.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002510, HPA017071, HPA021945" Enhanced Supported "Plasma membrane,Centriolar satellite" "Plasma membrane, Centriolar satellite" "CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928" "unprognostic (1.04e-1)" "unprognostic (7.66e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (1.14e-1)" "unprognostic (2.70e-1)" "unprognostic (3.21e-1)" "unprognostic (2.93e-1)" "unprognostic (6.43e-2)" "unprognostic (4.88e-3)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (1.36e-1)" "unprognostic (5.97e-3)" 6.6 2.1 1.1 7.2 1.3 18.6 7.9 1.2 2.0 1.9 6.4 0.0 3.9 1.6 4.2 4.9 5.1 3.6 3.3 20.8 1.2 2.0 4.7 13.4 9.1 17.8 2.1 0.7 4.1 1.4 2.0 2.1 39.9 7.0 4.8 1.9 3.3 1.9 3.6 53.3 1.7 3.3 12.1 1.4 26.5 3.2 1.5 0.3 0.8 4.9 8.3 1.0 8.7 11.9 0.0 0.0 19.9 2.6 0.3 0.3 0.7 0.4 0.0 1.3 1.1 0.0 0.0 2.4 0.0 0.3 0.8 0.6 0.1 0.3 0.0 4.8 0.0 0.9 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.9 4.2 32.4 3.1 0.0 29.4 0.0 0.0 2.1 3.2 0.3 0.0 31.1 0.0 1.0 0.0 0.0 0.0 1.5 0.2 0.0 0.1 0.3 21.2 0.1 1.5 0.1 0.4 0.0 0.0 0.0 0.0 5.1 0.0 0.0 2.6 0.0 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 19.9 0.3 0.1 0.0 0.0 0.7 1.1 1.3 1.2 2.0 1.2 2.0 2.1 0.7 7.0 0.3 DZIP3 "hRUL138, PPP1R66" ENSG00000198919 "DAZ interacting zinc finger protein 3" Q86Y13 3 108589682-108694846 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 57.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035066, HPA049232" Approved Approved Vesicles Vesicles "HPA035066: AB_10601549, HPA049232: " "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (7.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (2.37e-2)" "unprognostic (3.33e-1)" "unprognostic (5.16e-2)" "unprognostic (2.74e-1)" "unprognostic (3.76e-2)" "unprognostic (2.59e-3)" "unprognostic (5.38e-2)" "prognostic favourable (3.65e-4)" "unprognostic (6.06e-2)" "unprognostic (2.78e-2)" "unprognostic (5.51e-3)" "unprognostic (3.81e-2)" 4.6 9.3 14.1 4.5 25.7 3.1 5.0 14.5 23.7 5.2 4.4 5.8 2.1 2.8 7.4 9.7 3.8 17.4 5.4 10.8 13.2 18.5 10.5 3.9 6.0 8.4 10.3 16.0 10.3 4.9 10.3 57.4 4.5 20.3 9.2 4.5 4.0 3.3 7.0 10.1 3.4 3.6 7.9 9.2 7.0 6.0 29.9 8.0 10.4 12.0 2.8 7.0 5.0 3.5 6.8 1.8 5.2 1.6 11.7 6.5 1.8 6.6 6.0 17.2 10.3 7.6 8.0 5.9 4.2 8.3 7.0 9.5 8.4 4.5 12.0 9.0 4.4 2.5 9.8 3.6 14.8 4.4 4.2 5.5 2.3 5.8 4.6 2.1 3.1 8.3 1.9 6.5 8.1 4.3 5.2 5.9 13.2 6.0 5.3 2.3 10.5 4.3 6.9 14.2 1.1 5.8 3.2 11.7 11.2 7.0 0.7 7.5 10.3 1.9 5.0 6.3 9.6 1.2 3.6 6.8 3.9 23.3 4.8 1.7 7.6 5.2 0.7 1.4 5.0 1.0 6.0 6.8 5.1 6.1 0.6 6.0 4.5 6.0 0.1 11.7 1.6 1.8 6.5 1.8 14.1 25.7 14.5 23.7 13.2 18.5 10.3 16.0 20.3 8.0 E2F5 ENSG00000133740 "E2F transcription factor 5" Q15329 8 85177225-85217158 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 27.0;Daudi: 53.1;U-698: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 13.3;naive B-cell: 7.6" "Lineage enriched" "Detected in many" 9 "B-cells: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055723, HPA065441" Enhanced Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA055723: , HPA065441: " "unprognostic (8.73e-2)" "unprognostic (3.45e-1)" "unprognostic (3.15e-2)" "unprognostic (1.02e-3)" "unprognostic (6.73e-3)" "unprognostic (1.62e-1)" "unprognostic (3.36e-5)" "unprognostic (1.23e-1)" "unprognostic (9.53e-2)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.87e-2)" "prognostic unfavourable (1.89e-6)" "unprognostic (2.88e-2)" "unprognostic (3.25e-2)" "unprognostic (3.64e-1)" "unprognostic (2.95e-3)" 3.0 9.0 6.4 22.2 8.1 1.5 5.9 2.6 5.3 5.0 5.9 4.0 3.4 4.6 5.4 7.4 4.7 7.2 6.6 3.2 5.6 5.6 9.0 4.5 5.1 22.4 4.6 2.7 8.3 14.6 12.7 10.6 4.3 3.8 5.1 7.2 3.4 5.7 5.9 1.1 1.7 7.3 3.8 4.5 9.9 5.1 10.5 3.2 13.6 10.2 3.0 26.0 6.0 7.6 13.3 1.4 0.0 0.0 1.1 0.6 0.6 4.8 5.2 27.0 10.0 0.5 0.7 8.7 0.9 2.1 0.8 2.3 3.1 5.7 53.1 3.8 1.1 1.0 15.7 1.3 1.0 5.5 7.2 5.3 2.9 7.3 4.3 1.6 0.0 1.0 2.1 1.0 3.8 0.8 11.2 0.4 1.4 3.1 5.4 3.5 8.7 4.6 4.3 1.1 5.7 8.7 3.4 3.3 10.4 0.6 1.8 8.0 11.3 1.7 0.0 1.3 1.0 1.5 3.5 10.0 6.7 25.4 1.5 1.3 2.6 0.0 0.0 0.0 0.1 0.0 0.0 13.3 0.0 0.0 0.1 7.6 0.2 0.4 0.0 1.1 0.0 1.4 0.6 0.6 6.4 8.1 2.6 4.5 5.6 5.6 4.6 2.7 3.8 3.2 ECE1 ECE ENSG00000117298 "Endothelin converting enzyme 1" P42892 1 21217247-21345504 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 114.4" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 101.6;TIME: 90.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 21.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001490, HPA013616" Enhanced 2100000 "HPA001490: AB_1078718, HPA013616: AB_1847963" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-2)" "unprognostic (1.49e-2)" "unprognostic (1.46e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (6.20e-2)" "unprognostic (1.92e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (7.70e-2)" "unprognostic (3.55e-2)" "unprognostic (9.10e-2)" "unprognostic (1.97e-2)" "unprognostic (1.97e-2)" 44.0 49.9 10.3 18.7 14.5 17.3 33.7 3.6 15.6 29.5 27.5 19.2 11.2 12.4 24.0 10.5 15.6 19.1 23.0 30.9 12.4 8.0 14.9 41.8 30.1 14.4 13.9 13.4 34.2 42.1 114.4 21.6 27.0 14.6 27.9 14.6 26.5 14.7 11.4 15.2 14.8 23.2 24.1 13.2 23.5 18.9 19.1 14.7 9.5 23.2 10.7 19.1 34.2 37.0 4.6 2.0 21.5 7.5 1.0 6.1 4.2 13.6 9.2 11.8 5.9 17.1 18.2 6.8 20.3 35.5 11.1 10.2 6.6 42.0 4.9 51.2 20.5 5.8 4.8 9.7 9.7 12.4 4.0 7.1 14.2 5.3 22.8 1.0 1.8 9.5 11.4 17.1 8.5 101.6 1.4 2.6 9.4 2.8 2.0 1.6 3.6 7.2 2.5 6.8 7.1 17.3 2.5 4.0 9.8 20.2 11.9 8.8 8.5 2.9 90.1 25.0 12.2 11.0 11.7 4.1 6.9 5.7 52.0 2.4 30.2 0.1 5.8 2.2 2.2 7.5 3.3 4.6 4.6 3.5 0.5 3.1 3.1 1.9 21.5 1.0 5.2 2.0 6.1 4.2 10.3 14.5 3.6 15.6 12.4 8.0 13.9 13.4 14.6 14.7 ECE2 "KIAA0604, MGC2408" ENSG00000145194 "Endothelin converting enzyme 2" O60344 3 184276011-184293031 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "adrenal gland: 14.4;brain: 25.1;pancreas: 29.0;pituitary gland: 7.6" "Cell line enriched" "Detected in some" 8 "REH: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA043346 Uncertain "HPA043346: AB_10794181" "unprognostic (2.70e-2)" "unprognostic (1.44e-2)" "unprognostic (1.91e-2)" "prognostic unfavourable (8.41e-5)" "unprognostic (1.37e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (5.80e-4)" "unprognostic (1.47e-2)" "unprognostic (3.69e-1)" "unprognostic (2.65e-3)" "unprognostic (1.70e-2)" "unprognostic (5.95e-2)" "unprognostic (1.63e-9)" "unprognostic (3.66e-2)" "unprognostic (6.16e-2)" "unprognostic (2.19e-1)" "unprognostic (1.25e-2)" 0.7 14.4 9.1 0.9 17.1 0.7 0.7 17.6 10.5 0.7 1.1 2.2 0.0 0.8 0.7 1.6 0.8 0.9 0.7 1.5 4.6 25.1 0.7 0.7 0.7 0.7 10.3 3.0 0.7 29.0 0.7 7.6 0.7 7.5 1.6 0.9 1.4 1.1 1.1 0.7 0.7 0.8 0.9 2.9 0.7 1.0 0.8 3.3 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 17.1 17.6 5.2 4.6 25.1 10.3 3.0 7.5 3.3 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487828 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;ovary: 57.1" "Group enriched" "Detected in some" 6 "AN3-CA: 29.4;HeLa: 15.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Region enriched" "Detected in many" 5 "hypothalamus: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 0.9 2.6 0.5 0.9 4.0 0.2 0.4 0.7 1.2 0.3 0.4 0.5 0.1 0.3 0.6 4.9 0.3 1.7 1.0 1.1 0.1 28.6 1.0 0.7 0.2 1.2 0.3 0.1 57.1 0.6 0.3 8.9 0.4 5.5 0.3 0.2 11.5 0.3 1.2 1.8 0.3 0.3 1.1 4.5 2.0 0.3 0.8 1.6 0.1 0.5 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.0 0.7 1.2 0.1 28.6 0.3 0.1 5.5 1.6 ECSCR "ARIA, ECSM2" ENSG00000249751 "Endothelial cell surface expressed chemotaxis and apoptosis regulator" Q19T08 5 139448556-139462743 "Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 121 "EFO-21: 48.5;HUVEC TERT2: 122.6;TIME: 90.6" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.7" "Lineage enhanced" "Detected in single" "T-cells: 2.7" HPA063337 Supported "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA063337: " "unprognostic (5.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.69e-2)" "unprognostic (2.15e-3)" "unprognostic (3.95e-2)" "unprognostic (1.12e-1)" "unprognostic (2.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.78e-2)" "unprognostic (1.91e-1)" "unprognostic (1.83e-3)" "unprognostic (2.41e-3)" "unprognostic (1.36e-1)" "unprognostic (9.90e-2)" "unprognostic (2.91e-1)" 14.8 1.9 0.8 5.7 1.6 0.0 17.5 0.4 0.7 13.7 6.1 1.0 5.1 1.9 14.3 14.4 11.0 7.9 8.6 26.9 0.8 5.6 4.3 23.4 26.9 1.4 0.7 7.9 1.0 1.3 0.4 19.6 2.9 9.3 4.3 6.8 3.6 5.5 13.4 2.9 3.4 14.3 4.3 12.1 1.1 6.8 1.1 0.1 11.5 14.5 4.6 13.2 13.1 0.6 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 122.6 0.0 0.0 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 90.6 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.6 1.1 1.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.6 0.0 EDA "ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED" ENSG00000158813 "Ectodysplasin A" Q92838 X 69616067-70039469 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 5.6;Hep G2: 18.2;Karpas-707: 5.1;RPMI-8226: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.0" "Group enriched" "Detected in many" 6 "monocytes: 3.0;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037972, HPA037973" Supported "Vesicles,Lipid droplets" "Intracellular and membrane" Vesicles "Lipid droplets" "HPA037972: , HPA037973: " "unprognostic (3.76e-2)" "unprognostic (8.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.59e-3)" "unprognostic (7.85e-2)" "unprognostic (1.25e-4)" "unprognostic (4.33e-4)" "unprognostic (5.03e-2)" "unprognostic (1.53e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-2)" "unprognostic (2.01e-1)" "prognostic favourable (1.04e-9)" "unprognostic (8.63e-4)" "unprognostic (7.64e-2)" "unprognostic (9.85e-2)" "unprognostic (2.79e-1)" 6.8 11.7 2.2 3.1 3.0 0.3 3.9 0.9 2.4 10.3 3.4 3.9 7.4 0.9 6.3 5.7 5.0 4.4 7.0 13.3 2.6 2.1 6.9 3.1 4.3 5.8 4.3 2.0 7.9 6.3 18.4 1.9 2.7 2.9 8.3 1.7 5.0 5.4 10.4 3.3 5.4 1.6 5.4 4.6 2.0 4.7 2.7 2.3 0.8 8.9 5.0 1.2 4.4 8.1 0.0 0.0 0.0 3.0 0.6 4.0 0.3 0.0 0.6 0.3 2.9 0.6 0.1 0.2 0.0 0.1 0.0 0.0 1.4 0.1 0.3 5.6 0.2 0.4 4.0 1.5 0.0 0.0 4.6 0.0 0.1 18.2 1.1 0.0 1.2 2.4 1.4 0.0 1.0 0.5 0.0 5.1 0.0 1.2 0.0 0.0 3.0 0.4 0.0 1.3 6.1 0.1 0.0 1.6 0.0 0.1 0.4 0.1 0.3 0.1 0.5 1.9 2.4 2.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 3.0 4.0 0.0 1.8 0.9 0.0 0.0 1.1 0.2 0.0 0.6 2.0 0.0 0.0 0.3 2.2 3.0 0.9 2.4 2.6 2.1 4.3 2.0 2.9 2.3 EDA2R "EDA-A2R, EDAA2R, TNFRSF27, XEDAR" ENSG00000131080 "Ectodysplasin A2 receptor" Q9HAV5 X 66595637-66639298 "Predicted membrane proteins" Differentiation "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 14.2;BJ hTERT+: 13.6;HSkMC: 19.3;LHCN-M2: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;naive B-cell: 1.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA054522 Approved "Cell Junctions" "Cell Junctions" "HPA054522: " "unprognostic (1.31e-3)" "unprognostic (3.17e-3)" "unprognostic (2.19e-1)" "unprognostic (8.49e-3)" "unprognostic (4.15e-3)" "unprognostic (3.63e-3)" "unprognostic (2.48e-2)" "unprognostic (3.37e-2)" "unprognostic (2.82e-1)" "unprognostic (7.17e-2)" "unprognostic (6.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.01e-1)" "unprognostic (2.12e-2)" "unprognostic (8.23e-2)" "unprognostic (4.92e-2)" "unprognostic (3.08e-1)" 4.7 9.4 2.3 1.9 3.2 0.0 5.6 1.2 3.0 9.7 3.7 5.7 4.6 0.4 13.5 6.3 3.6 6.5 4.8 2.8 2.9 1.2 3.0 1.2 3.7 0.6 5.7 1.1 12.9 4.9 7.4 16.0 4.8 4.5 14.5 7.6 5.5 6.1 8.3 11.0 2.5 1.8 7.5 8.2 2.0 1.6 2.7 4.0 1.5 8.2 1.9 1.2 6.3 7.4 1.1 0.3 0.0 0.5 0.0 1.1 0.0 0.0 9.1 8.4 0.0 12.2 14.2 0.1 12.5 13.6 1.2 1.9 0.0 0.0 4.5 0.0 8.1 0.0 0.0 4.8 4.1 0.0 4.3 0.0 0.2 5.9 2.1 0.0 0.0 19.3 11.3 9.4 8.6 0.3 0.4 4.7 17.8 1.0 0.2 0.0 3.1 0.0 0.0 1.1 0.0 0.9 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.1 9.5 0.0 6.8 0.0 0.1 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.3 1.1 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 2.3 3.2 1.2 2.6 2.9 1.2 5.7 1.1 4.5 4.0 EDAR "DL, ED1R, ED3, ED5, EDA1R, EDA3, Edar" ENSG00000135960 "Ectodysplasin A receptor" Q9UNE0 2 108894471-108989372 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein, Receptor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.2;esophagus: 9.2;lymphoid tissue: 11.3" "Group enriched" "Detected in some" 6 "CAPAN-2: 6.5;HaCaT: 14.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "naive CD4 T-cell: 10.2;naive CD8 T-cell: 4.8" "Lineage enriched" "Detected in single" 102 "T-cells: 10.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042292 Approved "HPA042292: AB_10794648" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (2.22e-2)" "unprognostic (1.24e-2)" "unprognostic (4.68e-2)" "unprognostic (1.21e-2)" "unprognostic (2.30e-1)" "unprognostic (2.53e-2)" "unprognostic (3.70e-1)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (8.83e-7)" "unprognostic (9.21e-2)" "unprognostic (5.61e-2)" "unprognostic (2.29e-1)" "unprognostic (5.03e-3)" 0.3 0.2 0.3 1.9 0.4 0.5 1.8 0.4 0.3 2.8 2.9 0.1 0.0 2.2 1.1 2.6 9.2 0.4 6.8 0.5 0.3 0.4 1.9 1.9 2.4 6.6 0.3 0.0 0.3 0.5 0.0 0.2 0.2 0.3 1.6 4.5 0.1 3.2 0.1 0.3 3.5 2.5 1.3 1.2 0.5 1.8 0.6 0.2 3.2 0.3 1.7 11.3 4.6 3.5 0.0 0.0 0.0 0.0 0.0 10.2 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 6.5 0.0 0.5 0.0 14.0 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 10.2 4.8 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.4 0.4 0.3 0.3 0.4 0.3 0.0 0.3 0.2 EEF1AKMT4-ECE2 ENSG00000284917 "EEF1AKMT4-ECE2 readthrough" O60344 3 184249695-184293031 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 22.6" "Cell line enriched" "Detected in single" 10 "REH: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043346, HPA062215" Uncertain Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043346: AB_10794181, HPA062215: " 1.2 6.6 0.0 2.1 0.1 0.3 0.3 0.0 1.5 0.6 2.9 0.0 1.5 0.9 0.3 0.3 2.8 0.5 0.6 2.1 0.0 2.8 22.6 1.3 1.5 0.0 0.0 0.9 6.0 1.5 2.0 6.1 0.2 1.4 0.6 0.2 4.0 1.6 3.8 0.3 2.9 0.4 0.0 2.4 0.3 9.7 0.0 3.3 4.9 3.1 2.5 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF1E1 "AIMP3, P18" ENSG00000124802 "Eukaryotic translation elongation factor 1 epsilon 1" O43324 6 8073360-8102578 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA027901, HPA057866" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA027901: AB_10611960, HPA057866: " "unprognostic (9.39e-3)" "prognostic favourable (3.16e-4)" "unprognostic (2.23e-1)" "unprognostic (2.36e-2)" "unprognostic (1.42e-2)" "unprognostic (8.21e-2)" "prognostic unfavourable (1.55e-7)" "unprognostic (1.79e-1)" "unprognostic (5.67e-2)" "prognostic favourable (3.24e-4)" "unprognostic (1.13e-1)" "unprognostic (1.76e-2)" "unprognostic (1.52e-2)" "unprognostic (1.37e-1)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" 10.5 21.8 20.1 14.2 26.9 34.0 18.5 20.0 24.6 10.8 12.2 13.5 12.3 8.2 13.6 19.2 15.9 10.3 9.5 12.5 19.4 27.0 34.9 19.2 9.9 19.7 26.9 16.2 10.8 26.6 19.8 28.6 11.7 41.2 12.5 15.2 9.6 13.5 13.4 14.4 8.4 8.4 13.3 21.3 11.8 14.8 36.3 19.4 9.9 13.9 15.8 20.3 11.6 9.3 20.9 29.6 6.8 15.0 14.0 21.3 13.5 27.7 14.7 23.7 16.3 7.8 13.1 14.4 23.4 14.8 21.1 21.8 24.0 11.6 30.5 51.6 15.2 11.6 26.7 26.9 35.6 17.0 34.8 24.6 19.4 41.6 14.5 48.6 18.1 10.9 25.4 25.1 26.1 29.8 58.7 8.5 20.2 11.6 20.8 39.5 21.3 23.6 25.6 13.9 47.8 34.5 21.5 35.2 10.9 9.9 22.5 27.8 17.9 16.7 15.3 17.7 17.5 16.0 33.9 13.3 60.2 43.3 9.9 20.6 28.0 6.2 11.0 6.8 13.5 15.0 19.1 20.9 18.1 17.8 29.6 20.5 20.3 20.6 1.1 14.0 11.2 13.0 21.3 13.5 20.1 26.9 20.0 24.6 19.4 27.0 26.9 16.2 41.2 19.4 EFCAB14 KIAA0494 ENSG00000159658 "EF-hand calcium binding domain 14" O75071 1 46675159-46719064 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011224, HPA011938" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" 58000 Cytosol "Nucleoli, Golgi apparatus" "HPA011224: AB_1852314, HPA011938: AB_1852317" "unprognostic (2.44e-1)" "unprognostic (5.90e-2)" "unprognostic (7.53e-2)" "unprognostic (2.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.39e-2)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (3.00e-1)" "unprognostic (1.13e-3)" "unprognostic (1.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.94e-1)" "unprognostic (2.46e-1)" 29.4 17.4 29.4 14.3 29.5 6.7 22.5 16.2 24.8 25.3 26.0 40.6 15.6 17.2 23.7 27.3 30.0 22.0 19.7 20.2 27.2 20.5 27.8 24.9 24.0 16.4 31.0 15.2 25.2 16.0 107.1 17.2 25.2 27.3 24.4 24.0 23.0 19.9 24.9 24.7 20.4 26.9 22.5 36.1 24.0 36.4 21.9 30.6 28.7 30.1 13.2 20.2 25.7 20.0 16.6 16.0 30.3 21.1 17.1 28.5 18.3 14.3 8.2 7.0 11.1 33.5 21.1 16.1 15.5 23.0 17.2 17.8 9.8 9.7 11.5 16.3 21.1 17.4 12.0 17.2 23.5 21.9 7.7 14.4 9.1 4.0 11.5 18.6 28.4 18.6 28.7 13.7 11.4 21.0 8.9 16.5 17.8 5.6 12.2 8.4 10.0 9.3 9.3 19.6 10.1 18.2 29.1 3.6 5.0 19.2 27.2 14.6 12.2 16.2 19.3 14.8 7.2 17.1 15.7 16.9 23.5 9.3 18.9 16.0 10.9 15.6 18.6 30.3 23.6 21.1 28.5 16.6 20.6 20.2 16.0 16.2 18.0 19.5 12.5 17.1 18.3 12.9 17.8 18.3 29.4 29.5 16.2 24.8 27.2 20.5 31.0 15.2 27.3 30.6 EFNA3 "Ehk1-L, EPLG3, LERK3" ENSG00000143590 "Ephrin A3" P52797 1 155078872-155087538 "Predicted membrane proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.3;skin 1: 41.3" "Cell line enhanced" "Detected in many" "AN3-CA: 11.7;HAP1: 12.8;SCLC-21H: 19.0;SK-BR-3: 12.4;T-47d: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010494 Uncertain "CAB010494: AB_2097783" "unprognostic (3.75e-2)" "unprognostic (1.53e-2)" "unprognostic (1.56e-2)" "unprognostic (1.51e-2)" "unprognostic (3.88e-2)" "unprognostic (9.92e-2)" "prognostic unfavourable (2.46e-4)" "unprognostic (2.86e-2)" "unprognostic (3.56e-1)" "unprognostic (1.57e-1)" "unprognostic (5.14e-2)" "unprognostic (1.71e-1)" "prognostic unfavourable (9.66e-10)" "unprognostic (2.83e-3)" "unprognostic (6.38e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-3)" 1.0 1.3 5.9 1.1 15.5 0.7 5.8 1.7 17.3 4.7 3.9 0.8 0.0 1.5 1.3 4.4 13.3 1.3 1.1 0.8 6.4 5.6 0.7 1.1 1.0 1.0 2.2 8.6 1.5 1.3 1.6 5.6 1.2 12.2 1.8 4.1 0.4 4.0 1.0 1.1 41.3 1.5 1.2 1.3 1.1 1.3 2.2 1.7 0.0 0.9 8.9 3.8 1.1 9.0 3.1 3.4 2.0 1.8 6.5 3.5 1.1 4.1 1.0 1.8 11.7 2.0 1.0 1.4 0.2 0.3 0.5 0.7 0.7 1.8 3.2 1.9 0.4 7.0 12.8 2.6 0.4 1.9 2.8 0.4 0.4 0.9 0.2 0.5 2.4 0.6 3.1 0.2 0.7 1.0 2.0 2.0 0.4 5.4 0.6 1.7 1.2 3.3 4.1 1.0 10.5 1.4 0.1 19.0 5.8 0.7 12.4 0.3 17.7 0.6 0.3 1.3 3.7 0.5 0.3 4.0 1.7 0.8 2.2 1.6 0.1 0.0 1.4 2.0 2.1 1.8 2.1 2.6 1.7 1.1 3.4 3.1 2.5 1.2 0.1 6.5 0.8 2.6 3.5 1.1 5.9 15.5 1.7 17.3 6.4 5.6 2.2 8.6 12.2 1.7 EFNA4 "EPLG4, LERK4" ENSG00000243364 "Ephrin A4" P52798 1 155063731-155069553 "Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" CAB021350 Uncertain "Secreted to blood" "CAB021350: " "unprognostic (4.65e-2)" "unprognostic (8.07e-2)" "unprognostic (3.43e-2)" "unprognostic (7.04e-2)" "unprognostic (7.91e-2)" "unprognostic (4.81e-1)" "prognostic unfavourable (1.00e-5)" "unprognostic (1.37e-2)" "unprognostic (3.89e-2)" "unprognostic (6.17e-2)" "unprognostic (2.87e-2)" "unprognostic (7.97e-3)" "prognostic unfavourable (3.14e-4)" "prognostic favourable (3.60e-5)" "unprognostic (3.35e-2)" "unprognostic (1.97e-1)" "unprognostic (6.29e-2)" 5.5 10.8 3.5 6.1 1.9 0.9 16.8 2.0 2.1 12.0 18.9 1.9 13.2 9.7 9.4 12.3 20.0 4.9 9.6 6.5 3.0 1.3 8.4 12.8 5.3 10.8 2.4 2.5 16.1 6.3 4.2 2.7 9.7 2.6 11.5 11.5 7.5 20.1 9.5 2.2 25.3 27.0 4.0 1.9 7.0 5.0 5.1 2.2 6.4 12.0 13.5 16.3 6.6 11.5 17.1 18.2 7.8 9.2 2.6 9.5 4.7 6.2 4.7 11.7 17.3 6.9 4.5 9.7 2.8 5.5 5.6 5.2 7.0 10.5 8.1 16.3 2.9 14.9 7.0 4.3 2.3 3.7 2.1 0.7 4.3 9.7 2.5 1.8 12.8 2.7 13.3 2.8 3.3 11.2 3.3 5.5 3.1 13.9 4.1 4.5 21.5 10.0 14.3 4.6 7.8 8.7 5.4 2.8 12.8 5.6 21.3 2.5 13.9 5.7 5.8 3.3 9.9 6.7 4.2 5.6 5.8 7.9 3.1 4.3 3.3 0.0 7.4 5.0 5.9 6.6 6.1 17.1 6.5 6.7 6.0 14.1 9.5 6.3 7.8 2.6 9.2 18.2 6.2 4.7 3.5 1.9 2.0 2.1 3.0 1.3 2.4 2.5 2.6 2.2 EFNA5 "AF1, EPLG7, LERK7" ENSG00000184349 "Ephrin A5" P52803 5 107376889-107670895 "Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 19.3;RPTEC TERT1: 29.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5;memory CD8 T-cell: 3.0" "Group enriched" "Detected in many" 7 "NK-cells: 2.5;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013282, HPA054047" Approved Approved Vesicles,Cytosol "Vesicles, Cytosol" "CAB013282: AB_2533353, HPA054047: " "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.15e-3)" "unprognostic (3.98e-3)" "unprognostic (2.74e-2)" "unprognostic (8.91e-4)" "unprognostic (9.46e-3)" "unprognostic (4.92e-1)" "unprognostic (2.28e-3)" "unprognostic (1.26e-3)" "unprognostic (1.47e-1)" "prognostic unfavourable (1.92e-7)" "prognostic unfavourable (3.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (1.27e-1)" 5.3 1.9 1.9 2.3 6.0 0.0 7.3 10.1 22.2 15.0 4.2 0.9 2.5 1.2 1.6 2.8 9.1 3.9 3.6 8.3 2.5 5.3 5.3 0.6 7.0 3.2 2.1 8.9 5.5 0.7 6.9 18.5 3.1 4.8 6.2 3.6 3.3 11.2 6.8 1.1 13.3 2.3 2.8 3.5 6.3 3.1 1.8 1.1 0.1 2.5 6.0 3.3 4.0 8.1 0.0 0.0 0.4 0.1 2.5 3.5 0.4 6.2 11.1 19.3 0.0 9.3 8.1 1.8 0.2 3.3 2.4 6.0 0.1 7.0 0.0 10.6 1.2 6.5 10.7 9.2 2.3 0.0 6.5 0.0 6.1 0.0 1.8 0.3 0.0 8.6 8.8 0.0 7.8 7.6 0.0 0.0 4.6 6.0 0.0 0.0 2.3 0.9 0.0 8.7 0.2 29.4 8.1 2.9 7.7 3.0 4.5 1.9 1.9 1.2 0.1 14.6 2.6 8.9 3.5 0.5 0.0 4.0 6.4 0.4 15.7 0.2 0.0 0.1 3.5 0.0 0.0 0.0 0.8 3.0 0.0 0.0 0.3 1.4 0.4 2.5 0.1 0.0 0.1 0.4 1.9 6.0 10.1 22.2 2.5 5.3 2.1 8.9 4.8 1.1 EFNB1 "CFNS, Elk-L, EPLG2, LERK2" ENSG00000090776 "Ephrin B1" P98172 X 68828997-68842147 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 35.4;hTCEpi: 27.6;PC-3: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 7.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB031489, HPA067188" Uncertain Supported "Plasma membrane" 790000 "Plasma membrane" "CAB031489: AB_631414, HPA067188: " "unprognostic (2.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.77e-2)" "prognostic unfavourable (3.32e-5)" "unprognostic (1.04e-1)" "unprognostic (2.48e-2)" "unprognostic (8.05e-3)" "unprognostic (2.15e-1)" "prognostic unfavourable (8.68e-4)" "unprognostic (3.94e-2)" "prognostic unfavourable (4.29e-4)" "unprognostic (1.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.76e-2)" "unprognostic (8.03e-2)" "unprognostic (1.72e-3)" "unprognostic (1.86e-2)" 36.5 13.2 5.0 11.5 4.5 1.3 26.5 2.3 4.7 19.5 21.1 4.7 13.1 14.0 15.2 14.9 17.4 15.2 33.7 16.0 3.6 2.7 25.5 15.3 23.0 5.2 4.7 3.5 21.6 4.5 15.0 6.4 34.3 3.9 15.9 10.1 14.9 7.0 13.2 9.1 26.4 24.0 12.3 2.6 15.3 13.3 7.4 4.2 4.8 11.9 22.0 11.2 16.7 14.8 0.5 7.1 0.6 3.4 1.3 1.0 1.0 3.7 1.9 15.6 5.7 8.3 5.1 8.2 3.2 3.5 1.4 1.0 1.7 6.9 0.9 21.2 1.2 19.8 14.7 35.4 0.8 1.5 3.7 0.9 0.8 3.0 7.6 0.7 8.0 9.5 27.6 3.5 16.0 10.8 1.0 0.0 1.2 3.0 1.5 0.7 10.8 26.2 6.6 1.6 5.9 5.9 13.1 5.8 2.8 2.4 0.7 0.9 0.6 1.3 18.1 2.7 3.3 7.2 1.2 0.0 0.8 0.9 1.3 4.0 1.7 0.0 1.3 0.6 1.0 3.4 0.6 0.5 0.9 0.9 7.1 0.4 0.8 0.4 0.3 1.3 2.1 1.0 0.4 1.0 5.0 4.5 2.3 4.7 3.6 2.7 4.7 3.5 3.9 4.2 EFNB2 "EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228" ENSG00000125266 "Ephrin B2" P52799 13 106489731-106535662 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 49.4;SH-SY5Y: 24.8;U-87 MG: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Lineage enhanced" "Detected in single" "NK-cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008999, CAB009368" Supported Supported Nucleoplasm,Cytosol 760000 Nucleoplasm Cytosol "CAB009368: AB_2095700, HPA008999: AB_1078721" "unprognostic (1.70e-1)" "unprognostic (1.95e-3)" "unprognostic (1.72e-1)" "unprognostic (5.22e-3)" "unprognostic (4.52e-3)" "prognostic unfavourable (3.11e-6)" "unprognostic (2.32e-2)" "prognostic unfavourable (8.43e-4)" "unprognostic (2.09e-1)" "unprognostic (1.11e-1)" "prognostic unfavourable (8.70e-5)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" "unprognostic (1.30e-1)" "unprognostic (3.07e-1)" "unprognostic (4.62e-2)" "unprognostic (2.27e-3)" 15.7 4.9 11.2 8.2 11.0 0.8 21.8 8.3 14.0 13.2 23.1 5.8 13.1 13.9 10.8 5.2 11.4 13.6 11.2 11.8 10.4 6.5 9.3 11.8 50.1 7.8 6.2 11.5 8.4 3.7 5.7 6.1 27.7 5.2 11.8 18.4 15.2 12.7 20.6 6.6 14.3 20.6 10.5 5.0 9.3 21.3 7.2 5.9 7.3 11.2 8.8 5.9 7.7 12.4 0.2 0.0 0.4 0.0 1.5 0.0 0.0 11.8 1.1 49.4 0.0 0.1 0.4 0.2 5.4 3.4 5.3 3.1 11.9 18.1 0.0 5.2 1.6 14.1 1.8 6.9 5.8 0.0 10.6 0.0 4.1 0.0 1.0 3.9 0.3 2.3 12.4 0.2 10.6 6.7 0.0 0.0 5.8 2.0 0.1 0.0 2.6 2.4 9.9 2.0 0.0 7.6 1.5 3.5 24.8 2.0 1.0 0.0 0.6 0.1 5.2 10.6 0.0 0.3 12.1 0.1 0.0 0.0 22.2 0.2 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 11.2 11.0 8.3 14.0 10.4 6.5 6.2 11.5 5.2 5.9 EFNB3 "EPLG8, LERK-8" ENSG00000108947 "Ephrin B3" Q15768 17 7705202-7711378 "Cancer-related genes, Predicted membrane proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.6" "Cell line enhanced" "Detected in many" "AF22: 30.7;AN3-CA: 18.2;SH-SY5Y: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001623 Approved "HPA001623: AB_1848026" "unprognostic (5.17e-2)" "unprognostic (7.15e-2)" "unprognostic (6.08e-2)" "prognostic unfavourable (5.52e-4)" "unprognostic (3.27e-1)" "unprognostic (1.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.61e-1)" "unprognostic (2.64e-2)" "unprognostic (1.14e-1)" "prognostic favourable (8.21e-4)" "unprognostic (3.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.00e-1)" "unprognostic (8.56e-2)" "unprognostic (2.20e-2)" 1.7 2.8 10.6 1.1 26.5 0.4 4.3 1.1 34.6 4.8 1.0 4.0 0.0 0.8 12.3 1.0 2.2 6.7 1.8 1.1 10.9 19.0 1.4 2.3 1.5 0.7 3.0 11.8 3.2 1.8 1.1 3.0 1.8 4.3 2.7 1.1 1.4 1.7 1.0 0.8 6.9 1.0 4.7 1.3 0.5 1.3 2.1 2.1 0.0 1.2 0.1 1.4 2.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 30.7 18.2 0.6 0.4 0.2 0.3 4.0 2.7 1.8 1.1 1.9 0.0 0.6 1.1 0.2 7.8 3.8 1.6 0.0 3.8 0.1 0.0 0.0 0.9 0.0 0.0 1.8 0.8 0.8 0.6 0.2 0.0 0.0 0.5 2.9 0.0 0.0 2.7 0.6 0.1 0.1 0.0 4.2 0.4 1.9 16.1 0.0 0.0 0.6 1.6 0.0 0.0 1.8 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.6 26.5 1.1 26.3 10.9 19.0 3.0 11.8 4.3 2.1 EGFR "ERBB, ERBB1" ENSG00000146648 "Epidermal growth factor receptor" P00533 7 55019021-55211628 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Host-virus interaction" "Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 102.3" "Cell line enriched" "Detected in many" 12 "A-431: 337.7" "Cancer enhanced" "Detected in all" "glioma: 136.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000035, HPA001200, HPA018530, CAB068186, CAB073534" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Secreted to blood" 93000000 "Plasma membrane, Cell Junctions" "CAB000035: , CAB068186: , CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044" "unprognostic (2.62e-2)" "unprognostic (9.56e-3)" "unprognostic (1.59e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (6.11e-2)" "unprognostic (4.88e-2)" "unprognostic (2.85e-2)" "unprognostic (3.30e-3)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" "unprognostic (1.93e-3)" "unprognostic (6.98e-3)" "unprognostic (1.72e-1)" "unprognostic (6.62e-2)" "prognostic unfavourable (2.04e-5)" 16.2 8.4 4.9 7.5 6.8 0.1 39.8 5.1 8.5 13.8 7.8 3.3 10.7 3.6 8.2 11.7 15.6 8.8 8.5 4.8 6.8 2.7 7.6 23.5 14.2 2.3 4.1 3.9 10.4 10.1 1.8 2.1 102.3 5.6 10.9 6.7 9.2 15.4 12.9 10.7 32.5 6.3 15.5 3.5 3.3 7.8 5.5 5.9 3.2 12.8 15.5 8.0 10.2 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 337.7 4.3 1.1 1.5 6.9 4.3 1.1 3.3 4.5 2.0 1.6 0.8 3.7 0.2 0.8 2.8 13.5 0.0 14.9 2.5 0.1 0.2 0.0 1.8 0.2 1.8 0.0 0.0 2.1 13.7 5.2 27.9 0.2 0.0 0.0 4.4 0.2 0.0 0.0 0.3 2.2 0.0 0.6 0.0 2.5 3.6 0.0 1.3 2.8 3.4 0.6 0.3 0.7 1.0 1.9 0.5 14.6 3.1 0.0 0.3 0.1 2.5 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 6.8 5.1 6.6 6.8 2.7 4.1 3.9 5.6 5.9 EI24 "EPG4, PIG8, TP53I8" ENSG00000149547 "EI24, autophagy associated transmembrane protein" O14681 11 125569216-125584687 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 164.6" "Cell line enhanced" "Detected in all" "HEL: 117.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047165, HPA051029" Approved Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" "Endoplasmic reticulum, Cytosol" "Golgi apparatus" "HPA047165: AB_2679965, HPA051029: AB_2681317" "unprognostic (2.04e-3)" "unprognostic (2.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.43e-2)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.02e-2)" "unprognostic (6.38e-2)" "unprognostic (6.74e-2)" "unprognostic (1.17e-2)" "prognostic unfavourable (9.28e-4)" "unprognostic (3.50e-2)" "unprognostic (1.35e-1)" "unprognostic (4.58e-2)" "unprognostic (8.35e-2)" "unprognostic (2.07e-1)" "unprognostic (3.01e-1)" 13.4 10.2 13.3 8.9 16.2 4.6 16.7 11.2 22.1 12.7 17.0 14.4 13.8 11.3 13.6 12.9 22.7 12.1 15.8 16.4 10.6 10.7 14.6 55.5 12.1 11.2 12.0 11.1 13.1 34.2 164.6 9.2 11.9 11.0 13.7 18.9 13.2 20.9 14.3 26.5 17.2 16.1 15.9 9.2 10.5 17.7 10.4 10.5 9.9 12.0 14.2 13.0 16.2 12.9 8.5 15.5 5.4 7.3 6.5 10.0 4.9 24.5 18.7 21.4 25.8 35.2 26.8 26.8 25.2 19.1 17.4 15.7 28.4 49.6 24.7 42.9 23.7 28.4 32.5 53.0 22.6 6.5 20.6 117.8 13.4 26.6 26.2 26.5 12.8 25.0 48.6 26.1 38.6 36.7 53.4 10.1 24.4 17.3 12.1 13.6 28.2 20.5 17.8 25.3 21.0 29.0 44.0 20.0 19.2 29.5 35.2 9.5 71.9 26.5 30.5 22.4 15.2 15.6 20.3 6.3 12.7 32.2 9.8 40.8 29.8 4.1 7.3 5.4 8.2 7.0 8.1 8.5 6.5 10.0 11.6 7.3 9.4 7.6 0.9 6.5 5.1 15.5 9.0 4.9 13.3 16.2 11.2 22.1 10.6 10.7 12.0 11.1 11.0 10.5 EIF3L "EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025" ENSG00000100129 "Eukaryotic translation initiation factor 3 subunit L" Q9Y262 22 37848868-37889407 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003028 Approved Approved Nucleoplasm,Nucleoli 22000000 Nucleoli Nucleoplasm "HPA003028: AB_1078726" "unprognostic (2.07e-2)" "unprognostic (3.02e-2)" "unprognostic (5.06e-3)" "unprognostic (3.20e-1)" "unprognostic (3.79e-3)" "unprognostic (9.86e-2)" "unprognostic (1.35e-1)" "unprognostic (9.65e-2)" "unprognostic (2.66e-1)" "unprognostic (5.81e-3)" "unprognostic (2.35e-1)" "unprognostic (9.74e-2)" "prognostic favourable (6.11e-4)" "unprognostic (1.48e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (2.03e-3)" 30.9 18.4 17.4 17.5 19.8 26.4 55.1 34.4 19.3 40.7 29.1 16.1 16.7 20.8 36.1 18.9 33.4 24.2 14.0 15.5 15.0 15.6 23.7 36.1 18.4 31.3 14.0 13.4 63.4 78.8 20.2 26.8 27.9 17.7 38.7 23.8 21.5 39.6 31.0 40.3 30.6 25.2 35.8 15.6 24.7 22.7 19.6 11.4 44.0 54.8 32.3 31.0 38.6 22.0 33.6 58.1 9.8 35.9 25.0 42.5 55.2 16.8 9.6 27.1 19.6 26.2 58.7 19.5 16.2 39.0 26.1 35.8 15.9 12.5 58.1 4.5 18.9 10.8 29.8 22.4 30.8 7.6 49.7 20.5 14.0 7.5 16.4 54.3 17.6 31.6 25.6 19.3 29.2 32.4 17.0 15.9 30.2 6.6 14.4 25.2 15.4 25.3 16.6 37.2 17.0 19.9 10.2 19.7 30.6 16.0 18.8 21.8 14.3 21.9 15.6 16.3 19.8 9.9 12.9 9.5 15.5 23.7 15.3 24.1 13.3 9.8 35.9 9.6 20.7 35.4 34.6 33.6 30.0 25.0 58.1 27.5 42.5 31.8 4.8 25.0 29.1 28.4 29.1 55.2 17.4 19.8 34.4 19.3 15.0 15.6 14.0 13.4 17.7 11.4 ELFN1 PPP1R28 ENSG00000225968 "Extracellular leucine rich repeat and fibronectin type III domain containing 1" P0C7U0 7 1688119-1747954 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 13.3" "Cell line enhanced" "Detected in some" "REH: 19.1;U-138 MG: 12.0;U-2 OS: 17.6;U-2197: 20.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066382 Approved "Nucleoplasm,Cell Junctions" 11000 "Nucleoplasm, Cell Junctions" "HPA066382: " "unprognostic (8.45e-2)" "unprognostic (3.39e-3)" "unprognostic (6.54e-4)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "prognostic favourable (9.68e-4)" "unprognostic (4.60e-3)" "unprognostic (1.63e-3)" "unprognostic (6.60e-2)" "unprognostic (4.14e-3)" "unprognostic (1.11e-2)" "unprognostic (2.31e-2)" "unprognostic (7.47e-3)" "unprognostic (8.63e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-1)" 1.8 0.8 2.2 0.6 1.4 0.0 0.6 0.0 4.2 3.2 0.3 0.2 2.2 0.3 0.3 0.8 0.8 3.3 1.8 2.2 2.8 13.3 0.3 0.1 2.7 0.0 0.2 0.2 0.2 0.7 0.6 0.0 0.5 0.2 1.2 0.6 0.3 0.5 1.7 1.7 0.2 0.7 0.2 0.0 0.5 0.9 0.5 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 2.9 6.2 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.1 0.3 0.0 3.0 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.5 0.0 2.8 1.2 0.7 19.1 0.0 1.9 0.0 0.0 2.8 1.3 0.1 0.1 0.0 0.0 0.2 0.0 12.0 17.6 20.5 0.0 0.0 0.2 5.1 0.0 0.0 1.5 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.5 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.0 ELFN2 "dJ63G5.3, KIAA1904, LRRC62, PPP1R29" ENSG00000166897 "Extracellular leucine rich repeat and fibronectin type III domain containing 2" Q5R3F8 22 37367960-37427470 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.0" "Cell line enhanced" "Detected in some" "A-431: 8.7;CAPAN-2: 8.4;PC-3: 7.9;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000781 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000781: AB_1079280" "unprognostic (2.74e-1)" "unprognostic (6.81e-2)" "unprognostic (2.80e-2)" "unprognostic (1.31e-5)" "unprognostic (3.28e-1)" "unprognostic (2.51e-2)" "unprognostic (7.76e-2)" "unprognostic (4.25e-2)" "unprognostic (6.05e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (4.51e-1)" "prognostic unfavourable (7.21e-4)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" 1.0 2.1 26.8 0.9 10.9 0.9 0.9 0.7 30.0 0.9 0.9 1.9 0.0 0.9 0.9 0.9 0.9 1.0 1.9 0.8 16.2 8.7 1.2 0.8 2.0 1.0 6.7 15.0 0.8 1.1 0.8 0.1 0.8 5.8 2.2 0.9 0.9 0.9 0.9 0.9 1.5 0.9 0.8 3.8 0.9 1.1 4.2 3.9 0.1 0.8 0.0 0.9 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 3.7 0.0 0.0 0.0 0.7 0.0 3.9 2.1 0.9 0.0 1.4 8.4 0.2 5.2 2.8 6.1 0.4 0.8 0.1 0.2 0.0 0.0 3.9 0.0 0.2 0.0 0.1 0.7 0.1 0.3 1.2 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.2 7.9 0.1 0.0 8.4 16.4 0.0 0.7 0.0 3.6 4.6 0.0 0.0 0.1 0.4 0.0 18.6 0.1 2.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 10.9 0.7 16.8 16.2 8.7 6.7 15.0 5.8 3.9 ELMOD1 DKFZp547C176 ENSG00000110675 "ELMO domain containing 1" Q8N336 11 107591091-107666779 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 51.1;pituitary gland: 20.8;skin 1: 34.7" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 11.6;RH-30: 26.5" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038435, HPA066479" Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038435: AB_10795575, HPA066479: " "unprognostic (2.74e-1)" "unprognostic (1.72e-4)" "unprognostic (2.58e-2)" "unprognostic (9.13e-2)" "unprognostic (3.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-1)" "unprognostic (6.59e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (6.29e-2)" "unprognostic (9.44e-2)" "unprognostic (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (3.15e-1)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" 1.5 4.2 10.7 1.5 41.1 1.3 4.1 12.8 51.1 1.5 1.4 1.7 0.0 1.4 1.6 1.3 1.2 3.6 1.2 4.8 13.8 14.3 4.7 1.3 1.6 1.3 8.7 15.2 1.2 1.2 1.2 20.8 1.2 14.8 2.1 1.3 1.4 1.3 1.2 2.8 34.7 1.3 1.4 6.6 1.2 1.2 2.9 3.9 0.0 1.3 0.0 1.2 1.1 0.1 0.9 0.7 2.4 0.9 1.8 0.5 0.2 0.0 0.0 4.4 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.2 0.4 2.1 0.3 0.4 0.0 1.8 0.1 0.0 0.0 1.2 0.1 0.0 0.4 0.1 0.0 0.0 11.6 0.0 0.1 0.8 0.0 0.0 0.1 0.5 1.7 0.0 26.5 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.6 0.1 0.0 0.0 3.5 0.0 2.0 1.6 0.9 0.6 0.4 0.6 0.4 0.5 0.5 0.2 0.2 0.9 0.4 0.5 2.4 1.8 0.6 0.7 0.4 0.2 10.7 41.1 12.8 26.9 13.8 14.3 8.7 15.2 14.8 3.9 ELP6 "C3orf75, FLJ20211, TMEM103" ENSG00000163832 "Elongator acetyltransferase complex subunit 6" Q0PNE2 3 47495640-47513761 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046358, HPA064545" Uncertain Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA046358: AB_10961011, HPA064545: " "unprognostic (2.00e-3)" "unprognostic (2.27e-1)" "unprognostic (7.41e-3)" "unprognostic (2.41e-2)" "unprognostic (2.67e-1)" "unprognostic (8.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (1.24e-2)" "unprognostic (2.07e-2)" "unprognostic (5.38e-2)" "prognostic favourable (3.42e-6)" "unprognostic (1.54e-1)" "unprognostic (9.05e-2)" "unprognostic (2.30e-1)" "unprognostic (6.29e-2)" 10.8 25.9 15.6 16.3 18.5 8.8 15.3 23.2 24.6 12.8 13.3 22.7 19.0 13.3 17.5 22.1 14.2 16.0 13.3 17.0 16.3 15.7 16.4 18.7 11.6 17.5 16.7 21.8 20.8 18.8 16.6 18.8 12.9 19.9 18.1 13.0 18.5 14.8 17.5 23.6 14.7 11.7 16.4 18.6 14.9 13.9 24.9 13.6 23.7 17.8 13.7 17.8 15.5 11.9 20.4 19.5 10.4 12.0 18.4 21.3 14.2 16.7 15.9 21.3 21.5 17.1 15.8 12.1 20.3 14.1 26.0 23.6 15.5 17.8 31.6 12.7 17.5 10.4 20.6 29.6 15.9 17.6 16.0 28.6 24.6 17.2 18.8 21.6 17.8 17.1 16.0 29.6 18.9 22.3 29.9 9.9 25.8 18.5 25.8 24.5 25.5 27.3 12.9 10.3 19.3 18.2 14.9 19.0 18.5 17.3 14.0 10.5 19.1 17.5 14.5 26.6 19.0 13.8 25.3 20.9 27.4 29.0 13.8 26.4 27.1 10.4 12.0 8.4 19.5 11.0 15.1 18.7 18.3 19.5 15.0 20.4 17.3 17.4 1.7 18.4 7.6 19.5 21.3 14.2 15.6 18.5 23.2 24.6 16.3 15.7 16.7 21.8 19.9 13.6 EMC1 KIAA0090 ENSG00000127463 "ER membrane protein complex subunit 1" Q8N766 1 19215664-19251552 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048904 Approved 5600 "HPA048904: " "unprognostic (9.46e-3)" "unprognostic (1.91e-3)" "unprognostic (1.75e-2)" "unprognostic (4.11e-3)" "unprognostic (2.05e-1)" "unprognostic (5.31e-3)" "prognostic unfavourable (8.56e-6)" "unprognostic (5.98e-2)" "unprognostic (1.69e-1)" "unprognostic (1.08e-1)" "unprognostic (4.96e-2)" "unprognostic (2.50e-1)" "unprognostic (3.02e-2)" "unprognostic (1.61e-1)" "unprognostic (1.54e-1)" "unprognostic (6.19e-2)" "prognostic unfavourable (1.43e-4)" 18.9 15.2 13.5 12.8 28.3 9.3 14.4 19.7 37.5 15.7 14.6 21.8 9.7 10.0 19.6 16.1 16.1 14.6 13.5 18.2 12.6 15.5 13.5 20.5 14.6 10.1 13.6 15.7 19.0 13.1 24.4 20.0 31.4 22.8 16.1 16.9 14.8 18.7 13.8 27.0 13.5 12.0 22.0 12.4 12.2 13.5 15.2 12.7 12.1 16.6 10.5 13.9 13.4 14.4 5.7 10.9 3.2 10.8 18.3 8.3 7.2 13.6 12.3 14.0 36.3 22.6 17.7 27.3 22.2 20.9 30.8 30.6 12.9 31.7 12.2 29.4 34.0 15.5 19.4 24.8 36.0 10.3 10.1 14.7 16.8 15.2 16.5 18.7 17.7 18.7 16.2 36.4 30.3 25.9 18.0 18.5 23.7 7.8 7.6 9.2 8.4 11.6 11.4 17.3 21.3 12.5 6.3 17.3 11.9 24.3 12.8 18.4 14.0 11.8 22.8 27.9 18.3 21.2 25.2 10.3 21.7 15.9 26.5 24.7 37.2 3.2 10.8 2.6 7.5 8.1 8.3 5.6 7.4 8.3 10.9 5.7 7.5 7.5 0.4 18.3 10.0 5.2 5.1 7.2 13.5 28.3 19.7 37.5 12.6 15.5 13.6 15.7 22.8 12.7 EMC10 "C19orf63, HSM1, HSS1, INM02" ENSG00000161671 "ER membrane protein complex subunit 10" Q5UCC4 19 50476400-50490870 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 147.8" "Cell line enhanced" "Detected in many" "HEK 293: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053905 Uncertain "Secreted to blood" "HPA053905: " "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (9.86e-3)" "unprognostic (1.65e-1)" "unprognostic (6.94e-2)" "unprognostic (8.38e-3)" "unprognostic (3.23e-2)" "unprognostic (9.87e-2)" "unprognostic (2.77e-1)" "unprognostic (2.99e-1)" "prognostic favourable (4.39e-4)" "unprognostic (5.01e-2)" "prognostic favourable (6.64e-6)" "unprognostic (2.81e-1)" "unprognostic (3.49e-2)" "unprognostic (1.28e-1)" "unprognostic (2.44e-1)" 17.8 24.4 21.9 12.4 21.2 17.2 11.1 10.8 32.1 14.5 22.4 41.1 23.1 23.4 17.4 24.9 14.4 22.7 24.9 21.9 21.8 19.2 33.8 43.2 15.3 19.8 23.0 20.0 22.4 25.6 32.5 48.2 21.1 22.2 20.5 8.7 29.8 29.4 19.0 147.8 13.9 28.7 8.5 31.4 14.6 33.1 24.3 19.1 15.4 34.0 13.7 16.4 12.6 11.7 12.2 10.8 11.2 10.5 4.7 10.3 6.8 16.9 21.0 0.8 8.2 2.4 3.0 0.2 16.6 3.0 1.4 1.6 0.2 11.7 5.6 0.2 2.9 14.3 1.0 2.7 0.5 21.6 51.3 1.1 9.3 0.0 4.0 4.9 33.0 3.6 3.0 1.5 1.1 3.6 10.8 12.0 3.0 11.9 7.7 0.1 0.0 36.6 13.3 2.6 18.0 6.6 15.5 13.1 29.1 24.4 7.9 8.6 8.2 8.9 6.8 1.0 22.6 6.2 8.9 13.3 33.2 4.7 6.7 3.4 8.2 7.8 10.5 11.2 8.1 8.0 6.9 9.4 8.6 8.6 7.7 12.2 10.3 10.0 4.5 4.7 5.9 10.8 6.8 6.8 21.9 21.2 10.8 32.1 21.8 19.2 23.0 20.0 22.2 19.1 EMC3 TMEM111 ENSG00000125037 "ER membrane protein complex subunit 3" Q9P0I2 3 9962537-10011116 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042372 Approved Approved Microtubules,Cytosol Cytosol Microtubules "HPA042372: AB_10795609" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.59e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-3)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-1)" "prognostic favourable (2.81e-6)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.71e-2)" "unprognostic (5.58e-2)" 41.8 31.5 19.8 17.2 27.1 35.4 24.7 17.2 28.0 17.6 25.0 18.6 23.5 23.2 19.4 19.6 31.3 18.8 17.7 28.3 18.6 21.5 33.0 47.2 22.3 12.7 23.6 20.6 16.3 27.2 25.5 15.9 19.6 27.9 20.8 23.2 16.3 26.0 21.9 54.7 25.4 24.8 20.2 21.9 17.1 23.1 52.6 19.2 15.0 37.7 22.4 20.3 27.3 25.4 25.0 35.1 41.6 46.1 28.1 40.2 51.4 13.4 28.6 10.7 6.4 68.6 27.0 36.0 27.7 24.0 17.3 18.8 19.5 21.5 10.7 20.2 31.4 18.9 18.2 16.4 17.9 29.1 18.3 17.5 21.7 12.7 29.6 19.7 19.8 31.6 29.6 30.3 17.5 21.5 22.3 31.5 25.6 33.1 10.4 9.8 11.9 19.6 13.5 15.1 31.9 21.1 24.4 7.6 15.4 19.7 29.7 17.7 25.1 16.2 24.6 17.4 14.6 18.8 28.0 16.9 44.0 21.7 36.7 14.5 21.8 38.4 46.1 41.3 27.4 36.2 28.3 24.9 27.2 31.2 35.1 25.0 19.9 26.8 41.6 28.1 34.7 31.5 40.2 51.4 19.8 27.1 17.2 27.9 18.6 21.5 23.6 20.6 27.9 19.2 EMC4 "FLJ90746, MGC24415, PIG17, TMEM85" ENSG00000128463 "ER membrane protein complex subunit 4" Q5J8M3 15 34224999-34230156 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026868, HPA053440" Approved Supported "Focal adhesion sites" "Focal adhesion sites" "HPA026868: , HPA053440: " "unprognostic (8.99e-2)" "unprognostic (1.59e-1)" "unprognostic (7.68e-2)" "unprognostic (3.29e-2)" "unprognostic (9.23e-2)" "unprognostic (1.29e-3)" "unprognostic (3.25e-1)" "unprognostic (3.61e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-3)" "unprognostic (1.33e-1)" "unprognostic (2.20e-2)" "unprognostic (2.52e-1)" "unprognostic (5.42e-2)" "unprognostic (4.20e-2)" "unprognostic (2.96e-1)" "unprognostic (1.97e-2)" 36.3 34.3 43.5 23.4 48.3 25.4 35.2 34.9 54.3 33.5 32.2 31.0 25.7 27.5 33.5 54.3 36.2 35.4 28.4 38.5 39.4 40.6 39.1 47.5 27.1 24.5 41.7 42.8 35.3 45.2 29.1 29.5 41.5 48.6 32.5 30.1 32.8 38.9 34.7 95.1 29.6 27.9 30.1 36.7 27.2 31.2 26.4 32.0 26.9 34.6 41.2 29.0 28.9 32.6 71.6 53.3 65.7 59.4 60.3 65.9 78.0 31.5 66.4 27.9 36.2 36.5 33.2 25.7 36.3 41.6 44.8 39.0 43.2 28.2 12.5 48.0 41.8 60.9 28.4 35.6 32.2 38.2 27.5 23.7 61.2 39.6 44.1 35.9 23.8 33.3 33.9 32.6 36.7 37.0 29.5 50.0 39.0 36.0 28.5 38.5 31.3 43.5 26.4 25.5 35.5 42.7 49.7 36.9 45.0 27.0 39.6 19.2 26.5 42.7 28.1 41.2 28.2 35.4 36.9 44.3 62.7 32.0 50.1 42.8 34.7 65.7 52.3 54.5 53.0 54.0 57.9 71.6 59.5 63.4 52.2 54.6 60.8 59.8 29.1 60.3 59.4 53.3 65.9 78.0 43.5 48.3 34.9 54.3 39.4 40.6 41.7 42.8 48.6 32.0 EMC7 "C11orf3, C15orf24" ENSG00000134153 "ER membrane protein complex subunit 7" Q9NPA0 15 34084017-34101948 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010029, HPA047572" Approved Approved Nucleoplasm Nucleoplasm "HPA010029: AB_1078335, HPA047572: " "unprognostic (2.16e-1)" "unprognostic (8.16e-3)" "unprognostic (5.28e-2)" "prognostic favourable (4.68e-5)" "unprognostic (7.75e-2)" "prognostic unfavourable (9.25e-5)" "unprognostic (1.35e-1)" "unprognostic (3.68e-2)" "unprognostic (1.18e-1)" "unprognostic (5.65e-3)" "unprognostic (4.67e-2)" "unprognostic (3.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.31e-1)" "unprognostic (2.58e-1)" "unprognostic (2.49e-2)" "unprognostic (2.47e-3)" 31.2 45.1 36.8 22.4 41.6 31.8 29.7 22.5 36.8 25.1 30.1 30.9 38.2 25.1 27.1 53.1 25.0 23.0 24.5 36.5 34.0 45.3 52.5 62.3 26.5 24.4 44.0 38.7 24.1 46.7 35.5 33.5 57.6 35.2 31.8 32.3 29.8 29.6 46.0 44.8 28.2 28.1 29.0 42.2 28.5 28.5 39.3 30.8 18.8 35.3 26.7 21.8 26.3 26.2 37.8 68.8 66.6 54.7 32.6 53.7 49.1 14.1 39.1 14.2 18.1 55.7 31.9 15.0 40.7 42.5 38.2 39.6 35.6 17.1 8.4 42.3 39.7 27.6 20.6 20.5 28.6 20.6 20.5 20.8 58.5 30.3 51.0 20.9 29.7 35.2 39.1 27.2 39.6 24.0 20.3 56.3 36.7 16.4 11.5 23.8 12.7 26.0 14.6 16.5 29.1 40.1 25.2 23.3 17.2 24.2 32.8 20.1 23.8 33.8 20.0 40.9 15.9 27.0 30.3 38.1 46.0 18.8 41.3 32.0 33.1 66.6 47.3 49.0 42.7 51.0 41.6 37.8 42.9 43.4 43.1 28.9 31.6 39.0 41.3 32.6 54.7 68.8 53.7 49.1 36.8 41.6 22.5 36.8 34.0 45.3 44.0 38.7 35.2 30.8 EMCN MUC14 ENSG00000164035 Endomucin Q9ULC0 4 100395341-100880126 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005928 Approved "Intracellular and membrane" "HPA005928: AB_1078735" "unprognostic (8.01e-2)" "unprognostic (2.13e-4)" "unprognostic (1.36e-1)" "unprognostic (2.42e-1)" "unprognostic (2.96e-3)" "unprognostic (2.00e-2)" "prognostic favourable (1.03e-4)" "unprognostic (3.65e-1)" "unprognostic (5.94e-2)" "unprognostic (9.02e-2)" "unprognostic (2.39e-2)" "unprognostic (3.10e-2)" "prognostic favourable (2.25e-4)" "unprognostic (4.75e-3)" "unprognostic (2.36e-1)" "unprognostic (3.23e-1)" "unprognostic (9.75e-2)" 26.3 10.8 3.1 6.2 7.5 0.1 24.0 3.8 6.8 26.4 9.7 1.4 13.1 3.5 28.2 19.7 16.3 10.4 16.4 31.5 4.2 3.9 45.5 4.6 25.1 5.3 5.4 3.5 12.9 3.3 8.3 10.5 0.4 6.7 17.1 4.3 19.8 5.8 16.5 16.8 6.1 5.5 20.4 9.1 1.9 5.5 7.3 3.5 1.0 28.1 20.9 2.5 23.5 21.7 0.2 0.1 1.6 0.4 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.1 25.9 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.6 0.2 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.7 1.2 0.4 0.1 0.0 0.0 3.1 7.5 3.8 6.8 4.2 3.9 5.4 3.5 6.7 3.5 EMD "LEMD5, STA" ENSG00000102119 Emerin P50402 X 154379197-154381523 "Disease related genes, Predicted membrane proteins" Actin-binding "Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000609, CAB001545, CAB002029, CAB058694, CAB062552" Supported Enhanced "Nuclear membrane,Endoplasmic reticulum" 520000 "Nuclear membrane, Endoplasmic reticulum" "CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: , CAB062552: , HPA000609: AB_1078736" "unprognostic (2.92e-1)" "unprognostic (6.59e-3)" "unprognostic (4.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.16e-1)" "unprognostic (9.12e-3)" "unprognostic (3.58e-2)" "unprognostic (6.06e-3)" "unprognostic (7.74e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-2)" "unprognostic (1.49e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (7.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.99e-1)" 25.0 17.5 14.0 17.6 16.0 21.0 26.5 15.8 21.8 24.8 21.3 13.7 22.3 14.0 32.3 25.7 22.9 27.2 28.7 29.5 13.1 14.1 18.2 21.2 22.0 37.4 13.3 16.5 35.9 29.4 20.5 22.8 15.4 11.9 25.5 11.4 20.7 24.5 29.1 62.0 18.1 13.7 40.4 13.1 17.6 20.1 16.1 9.7 16.6 28.1 24.4 18.3 31.7 20.6 23.2 30.5 24.5 19.7 14.7 26.9 15.8 31.2 11.8 8.2 9.0 7.4 14.9 14.7 15.4 16.5 19.7 20.7 10.5 6.1 24.9 23.5 15.8 17.4 15.6 19.1 8.4 14.6 34.1 11.7 17.4 6.2 20.2 11.2 12.9 13.0 15.2 17.6 21.9 13.7 9.6 10.8 13.4 13.3 19.6 20.6 13.7 37.0 16.3 12.2 23.7 10.6 6.0 10.4 12.9 8.0 13.4 18.8 9.3 8.4 12.3 9.8 18.7 22.1 22.1 35.1 26.0 44.9 11.9 19.0 10.6 16.6 16.9 24.5 26.9 19.7 25.0 22.5 25.7 25.7 13.5 23.2 23.1 22.4 18.1 14.7 14.0 30.5 23.9 15.8 14.0 16.0 15.8 21.8 13.1 14.1 13.3 16.5 11.9 9.7 EMP1 "CL-20, TMP" ENSG00000134531 "Epithelial membrane protein 1" P54849 12 13196716-13219939 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 240.9;lymphoid tissue: 129.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 129.3;fHDF/TERT166: 89.9;HaCaT: 80.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 28.6" "Cell type enriched" "Detected in some" 7 "myeloid DC: 7.0" "Lineage enriched" "Detected in single" 14 "dendritic cells: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051931, HPA056250" Approved Nucleoplasm Nucleoplasm "HPA051931: , HPA056250: " "unprognostic (1.40e-2)" "unprognostic (7.30e-2)" "unprognostic (8.01e-2)" "unprognostic (1.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (8.41e-3)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" "prognostic unfavourable (2.26e-8)" "prognostic unfavourable (7.46e-4)" "unprognostic (2.98e-1)" "unprognostic (4.84e-2)" "unprognostic (3.05e-2)" "unprognostic (3.45e-2)" "unprognostic (3.25e-1)" "prognostic unfavourable (9.69e-8)" 63.3 5.0 2.7 8.0 10.4 2.1 20.8 0.8 3.9 51.3 11.6 5.5 4.0 4.6 14.0 10.4 240.9 9.9 25.2 16.1 7.3 2.8 8.9 4.4 18.1 5.9 5.3 0.9 5.7 10.2 2.9 2.8 10.6 28.6 6.3 6.9 17.8 45.4 2.8 12.0 16.8 10.7 17.6 9.7 8.5 6.0 5.2 3.0 0.6 22.5 99.1 129.3 14.1 80.6 0.0 7.0 0.0 0.5 0.1 0.1 0.0 38.1 2.0 0.9 0.2 61.8 129.3 0.1 28.3 51.9 14.6 18.7 0.2 64.6 0.2 20.2 89.9 80.4 1.1 3.7 19.8 0.7 0.0 0.1 6.7 0.0 14.9 0.2 0.2 40.5 5.4 46.4 13.6 33.3 0.2 0.6 34.3 0.1 0.0 0.8 0.7 6.5 0.1 3.9 0.3 42.6 0.4 0.0 0.0 12.6 1.8 21.0 0.3 0.2 36.5 32.8 11.5 30.8 15.2 0.1 0.4 0.2 47.8 0.2 38.5 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.1 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 2.7 10.4 0.8 3.9 7.3 2.8 5.3 0.9 28.6 3.0 EMP3 YMP ENSG00000142227 "Epithelial membrane protein 3" P54852 19 48321509-48330553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 165.9" "Cell line enhanced" "Detected in many" "NB-4: 114.2" "Cancer enhanced" "Detected in all" "melanoma: 195.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062030 Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA062030: " "unprognostic (5.06e-3)" "unprognostic (4.41e-1)" "unprognostic (1.83e-1)" "unprognostic (9.28e-3)" "unprognostic (1.33e-2)" "unprognostic (4.83e-3)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (9.31e-2)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (1.79e-1)" "prognostic unfavourable (2.31e-7)" "prognostic unfavourable (3.13e-4)" "unprognostic (1.16e-1)" "unprognostic (2.41e-1)" "unprognostic (2.90e-3)" 27.6 23.4 10.4 26.5 12.6 66.2 28.7 7.2 8.4 50.6 40.3 9.2 14.6 8.4 45.9 22.6 26.9 26.1 21.1 37.9 10.8 6.9 15.6 7.0 36.1 48.0 15.2 6.7 41.4 6.4 2.2 6.1 29.9 12.7 30.7 15.4 24.7 11.3 23.1 13.2 16.3 20.8 46.7 19.1 27.8 19.2 18.2 8.2 16.2 11.6 13.4 25.6 36.8 30.6 44.9 54.8 165.9 91.0 59.7 119.1 124.8 5.5 62.3 3.4 10.0 55.3 86.4 0.1 38.4 70.0 50.9 45.1 6.0 20.1 0.7 8.7 85.3 1.0 3.7 4.2 31.3 18.3 1.6 26.6 16.4 3.6 46.4 13.1 27.8 46.8 0.8 52.2 36.0 21.8 17.5 45.7 77.8 0.9 1.9 114.2 4.7 15.8 1.6 12.0 27.0 43.6 0.0 0.1 0.2 17.4 0.1 9.9 0.2 20.1 35.8 46.0 20.0 36.4 30.1 24.1 29.9 1.7 27.2 17.3 31.2 165.9 77.2 105.6 109.2 91.0 90.4 44.9 114.8 106.6 54.8 35.4 65.7 78.2 85.7 59.7 86.6 40.8 119.1 124.8 10.4 12.6 7.2 8.4 10.8 6.9 15.2 6.7 12.7 8.2 ENG "CD105, END, HHT1, ORW, ORW1" ENSG00000106991 Endoglin P17813 9 127815012-127854756 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 66.9;TIME: 136.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.2;intermediate monocyte: 17.7;myeloid DC: 6.4;NK-cell: 4.6;non-classical monocyte: 13.0" "Group enriched" "Detected in many" 4 "dendritic cells: 6.4;monocytes: 17.7;NK-cells: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000096, HPA011862, HPA067440, CAB072873" Enhanced Supported "Nuclear bodies,Plasma membrane" 260000000 "Plasma membrane" "Nuclear bodies" "CAB000096: AB_563482, CAB072873: , HPA011862: AB_1846217, HPA067440: " "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-2)" "unprognostic (2.96e-2)" "unprognostic (1.77e-1)" "prognostic favourable (6.61e-4)" "prognostic favourable (5.62e-6)" "unprognostic (2.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.87e-2)" "unprognostic (2.20e-2)" "unprognostic (8.98e-2)" "prognostic unfavourable (4.26e-4)" "unprognostic (3.33e-3)" "unprognostic (7.35e-2)" "unprognostic (2.84e-1)" "unprognostic (1.27e-1)" 40.3 19.3 6.4 26.6 10.5 5.5 52.7 3.9 8.6 26.3 14.0 7.6 18.5 11.2 27.0 25.2 17.2 23.2 28.3 105.4 8.0 5.0 40.8 26.8 66.7 44.1 10.6 7.0 66.4 9.6 8.6 12.5 60.2 10.1 23.1 6.4 35.5 9.9 51.7 24.1 10.1 14.5 23.1 8.7 52.4 11.6 37.2 7.7 6.7 35.4 19.3 11.0 20.3 44.8 1.1 6.4 0.3 17.7 4.6 2.3 4.6 0.1 0.1 0.9 0.0 16.8 11.5 29.6 19.5 14.0 10.4 6.1 0.0 0.1 0.1 9.5 35.8 0.3 0.0 3.1 3.4 0.0 0.0 5.5 11.0 0.6 13.1 2.6 0.0 19.7 0.7 13.5 4.9 66.9 0.0 0.1 12.1 0.1 0.0 0.2 0.2 0.5 8.7 1.7 0.1 0.0 0.0 0.1 0.2 10.3 9.0 2.6 1.8 3.9 136.5 34.1 1.8 22.2 0.0 0.7 0.1 0.1 9.2 6.8 11.2 0.0 12.2 0.3 1.3 17.7 0.4 0.4 2.1 2.3 6.4 1.1 1.3 2.0 0.3 4.6 13.0 2.4 0.8 4.6 6.4 10.5 3.9 8.6 8.0 5.0 10.6 7.0 10.1 7.7 ENPEP "CD249, gp160" ENSG00000138792 "Glutamyl aminopeptidase" Q07075 4 110365733-110565285 "CD markers, Enzymes, Plasma proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 165.1;kidney: 63.8" "Cell line enhanced" "Detected in some" "BEWO: 4.5;HEK 293: 12.1;MOLT-4: 2.9" "Cancer enriched" "Detected in many" 8 "renal cancer: 41.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005128 Enhanced 37000000 "HPA005128: AB_1844795" "unprognostic (2.73e-3)" "unprognostic (2.84e-3)" "unprognostic (5.16e-3)" "unprognostic (3.48e-1)" "unprognostic (2.90e-1)" "unprognostic (8.74e-2)" "unprognostic (3.34e-2)" "unprognostic (1.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.22e-1)" "unprognostic (1.93e-1)" "unprognostic (9.47e-2)" "unprognostic (4.49e-3)" "unprognostic (3.43e-3)" "unprognostic (1.52e-2)" "unprognostic (8.46e-2)" "unprognostic (2.49e-3)" 5.8 1.0 0.4 0.4 0.6 0.0 2.8 0.3 1.0 1.1 54.4 0.4 0.7 11.1 5.3 2.4 0.8 1.4 1.1 2.3 0.5 0.3 63.8 14.5 2.7 0.5 0.4 0.3 1.0 1.0 33.3 0.8 4.4 0.5 1.4 0.0 0.8 0.6 0.5 2.3 0.4 165.1 3.1 0.5 4.7 0.7 0.4 0.4 1.4 2.4 2.0 0.4 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.1 0.0 0.1 0.3 4.5 0.6 0.0 0.2 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 2.9 0.5 0.5 0.0 0.2 0.0 0.5 0.0 0.5 0.1 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 2.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.3 1.0 0.5 0.3 0.4 0.3 0.5 0.4 ENPP1 "M6S1, NPPS, PC-1, PCA1, PDNP1" ENSG00000197594 "Ectonucleotide pyrophosphatase/phosphodiesterase 1" P22413 6 131808016-131895155 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins" Biomineralization Hydrolase "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 22.6;LHCN-M2: 13.5;U-138 MG: 18.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "NK-cell: 4.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB032904, HPA062066" Enhanced "Secreted - unknown location" 2500000 "CAB032904: AB_2099635, HPA062066: " "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.60e-3)" "unprognostic (2.40e-1)" "unprognostic (1.11e-1)" "unprognostic (2.00e-1)" "unprognostic (1.60e-2)" "unprognostic (7.22e-3)" "unprognostic (8.96e-2)" "unprognostic (1.95e-1)" "unprognostic (3.00e-1)" "unprognostic (2.61e-2)" "unprognostic (1.41e-1)" "unprognostic (1.96e-1)" "unprognostic (1.84e-1)" "unprognostic (3.28e-3)" 17.2 2.1 0.5 1.9 0.5 0.0 30.5 0.6 0.4 8.5 2.8 1.6 8.3 1.1 25.7 7.1 1.5 6.4 2.6 1.9 0.5 0.7 10.9 19.4 2.0 0.7 1.1 0.0 7.3 17.5 22.2 27.0 28.9 0.8 3.3 1.2 13.4 5.4 6.5 2.1 1.7 2.6 6.8 2.0 1.2 1.7 4.6 0.3 2.0 13.2 6.9 1.4 3.2 7.7 0.6 2.2 1.4 0.3 4.6 1.7 0.1 0.0 0.8 0.8 0.0 22.6 3.5 0.0 5.8 6.0 2.3 6.3 2.5 0.7 0.0 0.5 3.7 0.0 0.8 0.1 9.7 0.2 1.1 0.0 0.7 7.5 0.7 0.0 2.7 5.8 0.2 6.2 0.2 2.7 0.0 1.2 13.5 1.6 0.0 0.0 5.1 0.8 0.0 6.6 0.1 0.1 0.3 2.2 0.0 0.1 0.8 2.6 2.5 0.0 1.8 18.1 0.6 1.2 5.7 2.2 0.0 0.0 8.3 0.0 2.2 1.4 0.2 0.3 0.3 0.2 1.7 0.3 0.3 0.3 2.2 0.6 0.3 0.3 1.0 4.6 0.3 0.3 0.2 0.1 0.5 0.5 0.6 0.4 0.5 0.7 1.1 0.0 0.8 0.3 ENPP2 "ATX, PD-IALPHA, PDNP2" ENSG00000136960 "Ectonucleotide pyrophosphatase/phosphodiesterase 2" Q13822 8 119557086-119673453 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 103.7;placenta: 79.0" "Cell line enhanced" "Detected in some" "AF22: 24.7;ASC diff: 33.8;ASC TERT1: 72.2;BJ hTERT+: 41.5;fHDF/TERT166: 26.8;HSkMC: 33.1" "Cancer enhanced" "Detected in all" "renal cancer: 46.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023700, HPA053652" Approved Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Intracellular and membrane" 1100000000 "Nucleoplasm, Golgi apparatus" "Actin filaments" "HPA023700: AB_1848170, HPA053652: " "unprognostic (1.17e-2)" "unprognostic (6.29e-2)" "unprognostic (3.63e-2)" "unprognostic (3.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-1)" "unprognostic (9.70e-3)" "unprognostic (7.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "prognostic favourable (2.07e-5)" "unprognostic (5.54e-2)" "unprognostic (3.14e-1)" "unprognostic (2.37e-1)" "unprognostic (5.18e-2)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" 29.9 15.4 24.0 18.2 42.0 0.7 26.2 4.4 33.3 19.6 8.1 103.7 1.7 20.8 44.8 6.4 2.9 18.7 12.7 3.6 39.8 21.5 24.9 8.9 13.5 31.0 71.5 20.9 5.3 5.2 0.9 4.1 79.0 59.7 8.5 10.6 67.6 3.4 9.2 3.0 5.4 12.1 28.9 102.4 17.3 8.3 9.7 63.9 3.6 3.7 0.8 26.1 13.4 5.7 0.2 3.8 26.8 0.1 0.2 1.8 0.3 0.0 0.0 24.7 0.0 33.8 72.2 0.0 22.7 41.5 9.8 9.4 0.0 0.0 0.0 0.3 26.8 0.0 0.5 0.0 6.9 1.8 0.7 0.0 0.0 0.6 15.1 0.0 0.1 33.1 0.2 20.0 1.0 0.1 0.0 4.0 0.5 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.4 23.9 0.1 0.2 0.0 0.0 16.8 0.1 0.5 26.8 0.1 5.2 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 1.8 0.6 0.3 0.2 0.0 3.8 0.0 0.3 24.0 42.0 4.4 33.3 39.8 21.5 71.5 20.9 59.7 63.9 ENPP4 "AP3Aase, KIAA0879, NPP4" ENSG00000001561 "Ectonucleotide pyrophosphatase/phosphodiesterase 4" Q9Y6X5 6 46129993-46146699 "Enzymes, Predicted membrane proteins" "Blood coagulation, Hemostasis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 12.0;SCLC-21H: 12.3;U-266/70: 14.9;U-266/84: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016594 Approved "HPA016594: AB_1848171" "unprognostic (9.87e-2)" "unprognostic (1.74e-1)" "unprognostic (2.75e-2)" "unprognostic (2.01e-1)" "unprognostic (2.92e-1)" "unprognostic (1.90e-1)" "unprognostic (8.13e-2)" "unprognostic (5.51e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-1)" "unprognostic (8.51e-2)" "unprognostic (4.36e-1)" "prognostic favourable (6.95e-7)" "unprognostic (1.82e-2)" "unprognostic (1.83e-1)" "unprognostic (2.62e-2)" "unprognostic (2.56e-1)" 12.7 12.5 14.8 6.2 21.9 30.2 14.3 10.1 20.6 9.8 10.5 19.3 31.9 9.5 3.8 10.9 4.8 9.9 7.3 12.9 19.8 15.7 16.8 9.0 17.9 6.9 30.8 15.6 3.4 10.4 22.2 14.1 3.2 23.9 15.0 11.6 7.1 17.5 30.8 20.9 3.6 8.7 8.6 43.2 11.5 12.3 7.1 22.2 4.8 11.3 7.3 5.6 8.0 5.9 3.1 1.8 0.9 2.7 4.6 11.0 3.1 0.0 0.7 0.5 1.0 0.0 0.0 0.0 1.1 1.1 2.7 0.2 1.2 9.0 10.0 8.7 1.4 0.1 2.7 0.4 0.5 12.0 7.5 5.5 0.0 0.0 0.4 6.8 10.2 1.4 0.0 0.0 0.0 0.9 0.0 0.0 1.0 1.1 5.0 0.6 1.8 0.3 3.8 1.8 3.7 5.7 1.1 12.3 0.0 0.0 1.9 0.0 5.1 2.8 0.0 0.0 4.7 0.2 7.4 14.9 17.0 3.4 7.1 0.0 0.9 0.0 0.4 0.9 11.0 1.3 6.4 3.1 4.1 7.9 1.7 1.5 4.0 7.0 0.3 4.6 2.7 1.8 1.4 3.1 14.8 21.9 10.1 20.6 19.8 15.7 30.8 15.6 23.9 22.2 ENPP5 ENSG00000112796 "Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)" Q9UJA9 6 46159187-46170971 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "epididymis: 116.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.8;HSkMC: 7.9;T-47d: 9.3;U-266/70: 5.8;U-266/84: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 13.4" "Lineage enriched" "Detected in many" 6 "T-cells: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016902 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" 300000 Cytosol Nucleoplasm "HPA016902: AB_1848172" "unprognostic (1.12e-1)" "unprognostic (5.19e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-1)" "unprognostic (7.61e-2)" "unprognostic (1.63e-1)" "unprognostic (5.01e-2)" "prognostic favourable (4.57e-4)" "unprognostic (1.96e-1)" "unprognostic (9.89e-2)" "prognostic favourable (4.04e-4)" "unprognostic (7.00e-2)" "prognostic favourable (4.44e-13)" "unprognostic (4.40e-2)" "unprognostic (2.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.60e-1)" 1.5 4.8 6.5 1.3 10.3 0.8 7.1 9.2 16.1 6.9 2.0 3.3 28.7 1.5 1.6 116.5 1.6 7.9 3.9 3.9 6.6 9.4 12.1 1.0 4.7 1.2 14.2 10.5 5.4 6.2 21.8 23.3 1.5 14.4 14.6 2.3 11.8 6.9 27.5 6.9 1.3 1.6 5.1 5.5 3.2 3.5 16.2 3.5 1.0 24.3 0.9 1.4 5.7 1.7 0.4 0.0 1.0 0.1 2.2 13.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.6 0.1 0.3 11.8 1.9 3.9 0.3 0.0 0.6 1.6 0.1 0.0 2.6 0.8 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.5 2.5 0.0 0.0 0.3 0.2 4.9 0.6 5.1 0.2 0.0 4.9 0.0 9.3 0.0 0.0 0.0 1.4 0.0 0.1 5.8 8.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 13.4 0.1 7.2 0.4 2.7 8.6 0.0 0.4 0.8 8.2 1.0 2.2 0.0 0.0 0.0 2.6 6.5 10.3 9.2 16.1 6.6 9.4 14.2 10.5 14.4 3.5 ENTPD1 "ATPDase, CD39, NTPDase-1, SPG64" ENSG00000138185 "Ectonucleoside triphosphate diphosphohydrolase 1" P49961 10 95711779-95869695 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Hydrolase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 59.4" "Group enriched" "Detected in some" 7 "HDLM-2: 56.0;Karpas-707: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 37.4" "Low lineage specificity" "Detected in many" "CAB002494, HPA014067" Enhanced Uncertain Microtubules Microtubules "CAB002494: AB_563557, HPA014067: AB_1848178" "unprognostic (1.14e-1)" "unprognostic (1.01e-2)" "unprognostic (3.11e-1)" "unprognostic (5.67e-2)" "unprognostic (9.68e-3)" "unprognostic (3.45e-3)" "unprognostic (6.31e-2)" "unprognostic (5.26e-3)" "unprognostic (2.73e-1)" "unprognostic (1.28e-2)" "unprognostic (6.40e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (5.33e-5)" "unprognostic (9.79e-2)" "unprognostic (2.30e-1)" "prognostic favourable (7.89e-4)" "unprognostic (5.09e-2)" 10.4 7.5 7.4 16.2 8.4 15.6 8.8 7.6 6.9 18.9 12.7 13.1 8.7 5.8 59.4 12.8 13.2 15.6 22.2 6.8 7.4 7.4 6.2 3.9 14.8 14.5 8.5 4.9 10.3 2.8 3.0 4.3 24.0 9.9 14.7 9.1 10.8 6.7 12.7 3.3 5.5 12.2 37.2 17.9 25.3 7.5 5.4 7.2 3.5 13.4 12.5 21.1 25.2 12.4 6.0 11.8 37.4 15.2 0.5 5.1 4.6 0.1 0.3 0.9 0.8 0.0 0.0 0.5 0.5 0.4 0.0 0.0 0.5 0.1 1.0 0.6 0.0 0.2 0.0 0.0 0.0 56.0 0.7 0.6 0.4 0.7 0.0 1.5 0.2 0.0 0.0 0.2 0.0 7.4 0.6 46.0 0.0 0.6 0.4 1.5 0.6 0.2 2.3 0.3 0.7 0.5 0.2 0.7 1.0 0.3 1.1 0.7 0.5 1.6 0.8 0.4 0.2 0.6 0.6 6.6 0.9 0.0 0.6 3.1 0.2 0.1 15.2 37.4 0.1 10.7 0.3 6.0 0.6 0.3 11.8 4.6 0.1 0.1 26.7 0.5 2.4 0.7 5.1 4.6 7.4 8.4 7.6 6.9 7.4 7.4 8.5 4.9 9.9 7.2 ENTPD2 "CD39L1, NTPDase-2" ENSG00000054179 "Ectonucleoside triphosphate diphosphohydrolase 2" Q9Y5L3 9 137048098-137054045 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6" "Cell line enhanced" "Detected in some" "Hep G2: 16.6;hTCEpi: 9.2;MCF7: 11.5;SK-BR-3: 15.5;T-47d: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 2.6" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017676 Approved "HPA017676: AB_1848179" "unprognostic (1.64e-1)" "unprognostic (3.35e-2)" "unprognostic (1.76e-1)" "unprognostic (3.33e-2)" "unprognostic (2.15e-3)" "unprognostic (1.07e-1)" "prognostic unfavourable (2.48e-5)" "unprognostic (2.71e-2)" "unprognostic (4.97e-2)" "unprognostic (3.23e-1)" "unprognostic (2.99e-1)" "unprognostic (1.89e-1)" "prognostic favourable (3.51e-6)" "prognostic favourable (1.38e-4)" "unprognostic (2.51e-1)" "unprognostic (8.43e-2)" "unprognostic (1.12e-3)" 1.7 1.6 18.8 1.5 10.1 0.6 7.0 4.0 10.4 9.8 9.1 21.9 1.7 17.6 2.8 4.4 3.3 9.4 10.7 2.7 22.6 9.6 4.5 1.0 1.0 0.5 6.1 12.8 0.8 2.6 1.2 3.1 3.9 11.9 11.2 5.8 2.5 6.2 2.9 3.0 9.3 11.1 1.9 7.5 0.5 9.5 6.8 11.7 0.0 0.7 2.6 1.0 0.9 3.5 0.0 0.0 2.6 0.1 0.0 0.0 0.0 4.4 1.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.8 1.3 0.0 1.0 0.0 3.6 0.3 2.6 0.0 0.0 0.1 0.0 0.5 16.6 0.0 0.0 0.2 0.0 9.2 0.0 2.4 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 2.5 0.0 0.8 1.7 2.0 0.4 2.5 0.1 0.2 15.5 0.0 16.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.8 10.1 4.0 9.8 22.6 9.6 6.1 12.8 11.9 11.7 ENTPD4 "KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase" ENSG00000197217 "Ectonucleoside triphosphate diphosphohydrolase 4" Q9Y227 8 23385783-23457695 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA017655 Supported Supported Vesicles 28000 Vesicles "HPA017655: AB_1848181" "unprognostic (2.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (5.06e-2)" "unprognostic (7.86e-3)" "unprognostic (2.00e-2)" "unprognostic (2.99e-3)" "unprognostic (2.07e-2)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.39e-1)" "unprognostic (1.11e-1)" "unprognostic (6.62e-2)" "unprognostic (3.72e-2)" 16.3 11.5 15.0 21.9 19.8 25.7 15.3 20.3 27.4 15.2 18.5 14.7 15.7 17.0 18.8 17.9 13.3 12.7 14.4 21.0 14.5 12.8 13.0 14.4 19.9 26.0 16.2 12.2 14.7 26.5 30.4 25.2 19.3 20.6 17.6 20.2 18.0 19.5 13.7 14.9 12.2 26.1 16.1 14.5 26.9 19.1 18.7 15.8 17.0 15.8 9.3 30.7 16.7 16.7 9.7 8.0 15.9 9.5 4.4 10.7 6.8 9.9 13.7 17.2 11.9 15.1 19.2 17.6 15.9 15.2 10.8 16.9 19.6 13.2 16.8 11.5 16.0 12.1 7.8 14.4 20.8 4.0 5.4 8.9 8.5 6.8 12.3 4.7 17.7 11.7 17.5 14.4 15.4 15.4 6.1 15.5 18.2 4.5 6.8 5.7 10.0 5.0 6.8 17.2 5.1 13.8 11.8 13.7 13.1 6.0 8.7 11.7 6.4 6.7 19.1 19.7 19.4 22.0 11.7 12.4 5.2 22.0 26.3 5.6 19.7 14.9 6.0 13.7 8.5 9.5 10.0 9.7 8.3 9.1 8.0 6.7 10.7 8.3 15.9 4.4 6.9 7.3 6.5 6.8 15.0 19.8 20.3 27.4 14.5 12.8 16.2 12.2 20.6 15.8 ENTPD6 "CD39L2, dJ738P15.3, IL6ST2, NTPDase-6" ENSG00000197586 "Ectonucleoside triphosphate diphosphohydrolase 6 (putative)" O75354 20 25195693-25226729 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 75.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015491, HPA069555" Approved Supported "Golgi apparatus" "Secreted to blood" 18000 "Golgi apparatus" "HPA015491: , HPA069555: " "unprognostic (3.24e-1)" "unprognostic (1.27e-2)" "unprognostic (5.91e-2)" "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (4.44e-1)" "unprognostic (2.10e-3)" "unprognostic (7.41e-3)" "unprognostic (2.74e-3)" "unprognostic (1.17e-1)" "unprognostic (2.14e-1)" "unprognostic (1.03e-1)" "unprognostic (8.14e-3)" "unprognostic (1.78e-2)" "unprognostic (2.74e-1)" "unprognostic (4.86e-2)" "unprognostic (4.48e-2)" 12.7 19.7 21.8 11.3 46.5 6.7 12.8 33.1 49.1 9.8 31.3 12.1 12.8 31.6 9.4 10.1 9.0 12.5 18.3 27.5 24.9 25.0 13.4 12.9 11.0 7.4 15.1 29.2 16.1 25.6 11.7 20.5 13.2 15.4 25.5 24.5 9.0 36.8 9.7 15.1 6.8 32.2 9.9 8.2 8.3 24.7 16.1 10.5 9.4 10.4 6.1 8.3 10.2 7.1 7.2 17.1 3.0 16.0 8.8 17.9 12.9 20.4 32.4 8.9 17.0 11.2 14.1 19.1 16.8 12.2 14.6 13.5 17.3 15.8 12.4 25.4 16.2 26.8 10.8 25.6 9.7 7.6 9.7 10.1 4.9 39.1 16.8 13.4 15.5 13.2 14.3 18.4 14.0 11.7 13.1 21.7 10.8 19.6 12.5 8.3 5.6 25.4 7.1 27.8 28.4 18.3 12.8 14.2 7.4 4.6 28.5 75.7 20.8 11.3 12.7 17.1 17.8 14.0 19.8 13.6 11.0 5.4 12.2 8.9 32.0 0.0 16.0 3.0 12.7 10.7 17.9 6.1 11.4 10.4 17.1 7.2 12.2 10.6 0.7 8.8 4.8 12.0 10.6 12.9 21.8 46.5 33.1 49.1 24.9 25.0 15.1 29.2 15.4 10.5 ENTPD8 "NTPDase-8, UNQ2492" ENSG00000188833 "Ectonucleoside triphosphate diphosphohydrolase 8" Q5MY95 9 137434364-137441816 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 48.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.0;RPMI-8226: 8.7;T-47d: 4.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021509 Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA021509: AB_1848185" "unprognostic (3.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "unprognostic (1.40e-1)" "unprognostic (6.46e-3)" "unprognostic (8.70e-2)" "unprognostic (3.87e-2)" "unprognostic (8.48e-2)" "unprognostic (1.69e-1)" "unprognostic (2.34e-2)" "unprognostic (1.08e-5)" "prognostic favourable (7.17e-4)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-1)" 0.4 0.0 0.4 2.6 0.4 0.0 0.4 0.4 0.4 0.4 19.2 0.4 0.4 18.5 0.4 0.4 0.4 0.3 2.2 0.4 0.5 0.0 2.1 9.8 0.8 0.4 0.4 0.4 0.4 1.8 0.0 4.2 0.5 0.4 0.4 7.5 0.8 4.1 0.4 0.4 0.0 48.1 0.4 0.4 0.4 6.1 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.0 9.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 1.5 0.2 0.0 0.6 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.6 0.0 0.2 0.1 0.4 0.0 0.0 8.7 1.4 0.0 0.3 0.9 0.2 0.0 0.1 4.7 0.2 0.1 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.5 0.0 0.4 0.4 0.4 0.4 EOGT "AER61, C3orf64, FLJ33770" ENSG00000163378 "EGF domain specific O-linked N-acetylglucosamine transferase" Q5NDL2 3 68975214-69013961 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019460 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" "Nucleoplasm, Nuclear membrane" Cytosol "HPA019460: AB_1844628" "unprognostic (2.62e-1)" "unprognostic (3.72e-1)" "unprognostic (1.07e-1)" "unprognostic (1.95e-2)" "unprognostic (8.96e-2)" "unprognostic (6.30e-2)" "unprognostic (2.18e-3)" "unprognostic (6.66e-2)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" "unprognostic (1.68e-1)" "unprognostic (3.57e-1)" "prognostic unfavourable (8.97e-5)" "unprognostic (7.41e-2)" "unprognostic (4.67e-1)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" 14.9 5.8 3.4 10.1 4.4 3.0 11.9 2.5 4.8 16.8 12.1 4.4 10.2 4.8 23.3 10.4 15.1 11.4 18.1 18.2 3.9 3.6 6.6 5.5 15.8 9.6 4.2 5.0 12.7 7.8 3.9 5.5 15.2 5.1 18.9 5.8 8.7 14.0 24.0 28.0 6.1 7.7 29.4 4.9 10.2 10.1 7.4 2.4 8.3 5.4 14.2 7.3 27.0 9.8 1.7 3.4 5.5 2.2 3.3 9.2 1.8 8.1 2.7 5.4 6.5 7.6 14.9 3.9 11.0 13.5 7.0 9.3 3.7 4.6 0.4 1.7 11.9 2.7 3.7 14.3 8.8 26.3 2.6 8.4 6.2 5.2 8.4 4.7 3.5 12.4 12.2 9.0 11.5 38.4 2.3 5.0 23.4 2.1 0.7 1.5 6.2 1.3 0.3 5.6 3.5 6.0 18.7 0.5 3.0 12.6 1.0 10.0 2.8 6.5 20.3 19.7 6.0 2.2 10.6 2.5 8.3 4.0 7.8 7.3 11.0 5.5 2.2 0.0 3.0 1.9 3.5 1.7 4.8 6.4 3.4 1.2 4.1 4.1 0.3 3.3 0.7 0.6 9.2 1.8 3.4 4.4 2.5 4.8 3.9 3.6 4.2 5.0 5.1 2.4 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.7" "Cell line enhanced" "Detected in many" "HEL: 39.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 10 "cerebellum: 375.3" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" 3400000 "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: , HPA028096: , HPA028412: , HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavourable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favourable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavourable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 9.2 9.6 3.3 19.4 10.2 28.0 9.6 59.7 11.6 8.2 12.4 2.0 9.8 9.3 10.5 5.7 10.8 5.5 7.9 7.5 3.3 4.8 10.0 13.2 11.0 25.4 3.9 3.0 12.3 10.4 9.1 9.0 8.7 10.3 8.3 12.5 14.6 10.1 10.8 15.0 8.9 14.6 9.2 5.8 13.5 14.0 7.9 6.9 42.2 8.1 8.8 19.8 11.3 12.4 9.9 3.0 30.1 2.1 5.7 15.9 7.7 7.3 1.7 18.3 8.6 1.5 0.2 6.1 1.8 2.8 2.3 2.9 4.9 8.8 13.6 4.9 2.5 3.3 22.8 1.7 2.5 24.5 7.0 39.0 5.5 7.9 2.8 13.2 26.0 0.5 5.4 2.2 3.9 4.0 36.7 10.8 0.0 2.5 21.4 8.6 19.2 2.8 32.9 8.0 19.5 2.2 9.3 24.7 18.3 5.7 5.4 12.4 4.1 5.1 0.3 0.1 3.8 3.6 3.8 16.3 21.1 24.3 3.5 13.6 2.0 17.2 2.1 12.6 8.5 0.7 9.6 9.9 12.4 9.3 2.4 9.3 14.8 8.9 30.1 5.7 0.8 3.0 15.9 7.7 3.3 10.2 59.7 11.6 3.3 4.8 3.9 3.0 10.3 6.9 EPB41L3 "4.1B, DAL1, KIAA0987" ENSG00000082397 "Erythrocyte membrane protein band 4.1 like 3" Q9Y2J2 18 5392381-5630700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.8" "Cell line enhanced" "Detected in many" "ASC diff: 17.6;ASC TERT1: 20.5;HUVEC TERT2: 18.5;SCLC-21H: 20.7;TIME: 50.8;U-2 OS: 18.5;U-2197: 18.0;U-251 MG: 21.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.7;non-classical monocyte: 11.6" "Lineage enriched" "Detected in many" 4 "monocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028605 Enhanced Enhanced "Plasma membrane,Cell Junctions" 140000 "Plasma membrane, Cell Junctions" "HPA028605: AB_10611963" "unprognostic (3.58e-3)" "unprognostic (1.17e-2)" "unprognostic (3.61e-1)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "unprognostic (1.44e-2)" "unprognostic (2.60e-1)" "unprognostic (9.73e-2)" "unprognostic (3.40e-1)" "unprognostic (3.63e-3)" "unprognostic (1.07e-3)" "unprognostic (5.81e-2)" "unprognostic (5.96e-2)" "unprognostic (5.65e-3)" "unprognostic (8.99e-2)" "unprognostic (2.72e-2)" "unprognostic (6.59e-3)" 17.1 19.4 12.0 16.4 32.1 2.5 8.9 35.9 36.3 5.1 10.6 36.2 1.4 29.8 5.8 7.1 6.8 8.8 6.0 6.0 11.3 16.6 21.0 3.1 8.8 8.8 46.4 15.9 7.8 4.4 14.7 9.0 12.7 46.8 4.0 8.4 3.8 3.6 5.0 4.6 3.5 27.9 8.3 27.2 10.5 3.2 35.9 36.6 0.9 4.0 1.5 2.6 5.6 5.8 0.0 2.5 0.7 11.6 0.0 0.6 0.7 0.0 0.3 1.2 0.0 17.6 20.5 13.8 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.2 0.0 12.0 0.0 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 1.4 10.7 0.0 3.8 0.0 18.5 0.1 0.1 0.0 0.0 0.1 0.2 2.5 3.9 0.0 0.0 0.0 0.1 1.4 20.7 0.1 0.0 0.1 8.2 0.2 1.4 50.8 0.1 18.5 18.0 21.8 0.0 0.0 0.0 0.0 1.6 2.1 0.0 4.5 0.0 0.0 7.7 0.0 0.0 0.0 0.0 2.5 0.0 0.6 0.0 0.7 0.0 11.6 0.0 0.0 0.7 12.0 32.1 35.9 27.7 11.3 16.6 46.4 15.9 46.8 36.6 EPCAM "17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1" ENSG00000119888 "Epithelial cell adhesion molecule" P16422 2 47345158-47387601 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 303.2" "Cell line enhanced" "Detected in many" "A-431: 58.3;CACO-2: 75.6;CAPAN-2: 106.4;RPTEC TERT1: 45.4;SCLC-21H: 41.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB003809, HPA026761, CAB030012, CAB055098, HPA067463" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: " "unprognostic (6.79e-2)" "unprognostic (2.28e-1)" "unprognostic (1.59e-2)" "unprognostic (1.16e-2)" "unprognostic (1.61e-1)" "unprognostic (3.49e-2)" "unprognostic (2.01e-1)" "unprognostic (3.61e-2)" "unprognostic (3.40e-1)" "prognostic favourable (3.30e-4)" "unprognostic (5.27e-2)" "unprognostic (3.28e-2)" "prognostic favourable (1.04e-6)" "unprognostic (6.38e-3)" "unprognostic (1.28e-1)" "unprognostic (6.45e-3)" "unprognostic (6.08e-2)" 0.4 2.1 1.8 49.8 3.0 0.2 8.9 0.6 1.0 10.8 155.8 0.7 31.5 66.8 4.4 35.2 2.8 10.2 41.6 0.4 1.7 2.7 60.2 1.2 22.6 0.4 1.2 0.4 3.8 54.1 19.8 38.7 2.2 0.9 9.0 70.5 0.7 47.2 25.0 0.5 2.0 303.2 1.7 1.4 0.5 15.3 5.5 0.9 1.7 83.6 4.2 4.1 4.1 2.1 0.2 1.9 0.4 0.2 0.0 0.0 0.6 58.3 0.6 0.0 0.1 0.0 0.0 37.0 0.0 0.0 0.0 0.0 75.6 106.4 0.0 16.4 0.1 27.5 0.5 6.9 0.2 0.0 6.7 0.0 0.3 29.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 17.4 0.0 0.0 29.8 0.0 2.8 19.1 3.8 0.0 0.0 14.8 45.4 25.8 41.1 0.3 0.4 21.7 0.0 18.3 0.1 0.0 0.0 0.7 0.2 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.6 1.8 3.0 0.6 1.0 1.7 2.7 1.2 0.4 0.9 0.9 EPGN "ALGV3072, EPG, epigen, PRO9904" ENSG00000182585 "Epithelial mitogen" Q6UW88 4 74308473-74315307 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.3;esophagus: 39.6;tongue: 25.7" "Group enriched" "Detected in some" 6 "hTCEpi: 61.2;U-2197: 27.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014420 Approved Nucleoplasm,Vesicles,Cytosol "Secreted in other tissues" "Nucleoplasm, Cytosol" Vesicles "HPA014420: AB_10601551" "unprognostic (7.51e-2)" "unprognostic (8.08e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-4)" "unprognostic (2.20e-1)" "unprognostic (2.01e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (4.06e-4)" "unprognostic (3.84e-1)" "unprognostic (7.89e-2)" "prognostic unfavourable (2.40e-4)" 1.1 0.0 0.0 1.3 0.0 0.1 1.0 0.0 0.0 7.9 0.3 0.0 1.0 0.0 0.0 14.3 39.6 1.2 0.3 0.6 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.7 0.0 0.3 0.0 0.0 2.5 2.8 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 25.7 5.4 0.6 6.5 0.4 0.1 0.0 0.6 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 1.1 0.0 1.0 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.1 0.0 61.2 1.0 4.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.2 1.1 0.0 0.1 0.0 0.0 0.1 0.0 27.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EPHA10 "FLJ16103, FLJ33655" ENSG00000183317 "EPH receptor A10" Q5JZY3 1 37713880-37765133 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.6;intestine: 12.6;testis: 24.8" "Cell line enhanced" "Detected in some" "BEWO: 5.1;HDLM-2: 19.2;SCLC-21H: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA027497 Uncertain "Intracellular and membrane" "HPA027497: AB_10601158" "unprognostic (9.27e-2)" "unprognostic (1.21e-1)" "unprognostic (2.94e-2)" "unprognostic (1.24e-6)" "unprognostic (1.06e-1)" "unprognostic (1.11e-2)" "unprognostic (5.39e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.40e-1)" "unprognostic (7.06e-3)" "unprognostic (1.50e-1)" "unprognostic (8.81e-5)" "unprognostic (2.55e-2)" "unprognostic (2.97e-2)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 0.4 1.1 5.8 1.7 15.6 0.7 1.9 1.3 10.5 0.6 12.6 3.6 0.2 5.8 0.5 6.8 0.8 1.8 2.1 0.4 4.6 7.4 0.5 0.4 0.5 0.6 3.5 5.0 0.4 5.1 1.1 10.8 0.4 6.4 1.4 10.3 1.6 2.4 0.7 0.4 0.6 7.3 1.0 2.3 0.5 5.3 24.8 2.1 0.0 1.0 0.0 0.5 0.6 0.3 0.4 0.3 1.5 0.3 0.8 0.7 0.1 1.5 1.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.6 2.8 0.0 0.4 0.0 0.1 0.1 0.0 0.0 19.2 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.0 0.0 0.2 0.7 0.6 0.0 0.0 0.4 0.3 1.7 8.9 0.4 1.1 0.0 0.0 2.8 0.1 0.0 0.0 1.0 0.1 0.0 1.7 1.2 0.0 0.0 0.0 0.0 1.4 0.2 0.1 0.7 0.1 0.4 0.4 0.3 0.3 0.1 0.4 0.6 0.7 1.5 0.8 0.3 0.3 0.2 0.1 5.8 15.6 1.3 10.5 4.6 7.4 3.5 5.0 6.4 2.1 EPHA2 ECK ENSG00000142627 "EPH receptor A2" P29317 1 16124337-16156087 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 51.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 41.9;EFO-21: 40.4;PC-3: 48.0;U-251 MG: 49.2;WM-115: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 115 "plasmacytoid DC: 11.4" "Lineage enriched" "Detected in single" 115 "dendritic cells: 11.4" "Low region specificity" "Detected in all" CAB010464 Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "Nuclear speckles, Golgi apparatus" "CAB010464: AB_631436" "unprognostic (9.41e-2)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.67e-2)" "unprognostic (6.22e-2)" "unprognostic (9.12e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-3)" "unprognostic (2.52e-2)" "unprognostic (7.05e-3)" "unprognostic (1.52e-3)" "unprognostic (2.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (4.77e-3)" "unprognostic (4.40e-2)" 6.7 3.4 1.3 3.1 2.6 0.0 5.2 0.5 2.1 12.1 4.9 1.6 1.9 4.3 7.8 3.8 51.2 4.6 16.7 6.4 1.1 0.8 5.7 8.2 6.6 4.7 2.7 1.3 4.5 10.2 2.2 2.8 8.9 3.4 5.8 2.6 5.4 31.0 2.8 3.4 12.7 13.1 2.7 3.0 2.8 6.8 2.4 1.2 1.2 5.7 21.8 25.5 15.2 18.5 0.0 11.4 0.0 0.0 0.0 0.0 0.0 15.4 31.3 8.7 4.2 0.6 0.7 5.1 9.3 13.3 17.0 10.8 13.0 41.9 0.0 40.4 5.3 6.3 2.0 21.6 5.9 0.0 1.4 0.0 9.1 8.3 11.1 0.0 0.0 1.0 8.1 9.2 20.5 18.1 0.0 0.0 10.7 4.9 0.0 0.0 4.2 48.0 0.0 7.9 0.0 18.0 8.0 0.0 1.3 18.2 4.4 1.2 0.6 0.1 22.3 6.1 16.3 0.4 49.2 0.0 0.1 0.1 4.7 0.0 53.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 1.3 2.6 0.5 2.1 1.1 0.8 2.7 1.3 3.4 1.2 EPHA6 FLJ35246 ENSG00000080224 "EPH receptor A6" Q9UF33 3 96814581-97752460 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.9;ovary: 13.2;testis: 15.5" "Group enriched" "Detected in some" 6 "HEK 293: 8.0;U-266/70: 24.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA007397, HPA058047" Uncertain Enhanced Nucleoplasm Nucleoplasm "HPA007397: AB_2667821, HPA058047: " "unprognostic (9.87e-2)" "unprognostic (1.67e-2)" "unprognostic (3.42e-4)" "unprognostic (7.21e-5)" "unprognostic (8.51e-2)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (3.14e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (1.71e-4)" "unprognostic (1.93e-3)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (7.14e-3)" 0.8 0.5 8.7 0.5 9.8 0.3 0.8 27.9 9.9 2.2 5.8 1.1 0.3 0.6 2.2 1.0 2.1 4.2 2.1 1.1 15.4 1.3 1.3 0.5 0.5 0.4 1.1 6.8 13.2 1.4 0.7 0.6 0.5 5.7 2.5 1.8 0.2 0.6 1.7 0.4 0.5 1.1 3.2 0.8 0.4 1.7 15.5 2.8 0.0 4.3 0.0 0.5 2.1 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.0 0.0 2.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.1 0.0 0.8 24.3 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 9.8 27.9 9.9 15.4 1.3 1.1 6.8 5.7 2.8 EPHA7 Hek11 ENSG00000135333 "EPH receptor A7" Q15375 6 93240020-93419547 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "parathyroid gland: 110.4" "Group enriched" "Detected in some" 4 "AF22: 8.7;HEK 293: 25.0;RH-30: 23.8;THP-1: 20.3" "Cancer enhanced" "Detected in many" "renal cancer: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010496 Approved "Intracellular and membrane" 340000 "CAB010496: AB_2099673" "unprognostic (3.34e-1)" "unprognostic (7.82e-2)" "unprognostic (1.41e-1)" "unprognostic (9.32e-2)" "unprognostic (1.19e-1)" "unprognostic (3.56e-2)" "unprognostic (1.62e-2)" "unprognostic (4.07e-1)" "unprognostic (4.16e-2)" "unprognostic (3.19e-2)" "unprognostic (5.69e-2)" "unprognostic (1.69e-1)" "unprognostic (1.74e-2)" "unprognostic (1.35e-1)" "unprognostic (1.56e-2)" "unprognostic (4.82e-2)" 1.3 1.3 6.0 1.7 24.6 1.2 2.2 21.6 8.6 2.4 24.6 0.0 0.1 2.5 2.0 7.5 14.7 1.7 3.1 4.2 13.8 2.9 6.9 1.3 1.5 1.3 2.4 5.8 3.0 1.3 110.4 5.6 1.6 6.7 17.9 3.6 0.4 8.2 1.9 1.3 1.4 6.5 20.2 4.8 4.7 14.9 2.1 4.4 0.0 1.3 0.0 1.3 9.7 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 25.0 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.0 3.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.5 0.6 4.4 23.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 24.6 21.6 8.6 13.8 2.9 2.4 5.8 6.7 4.4 EPHB1 "EPHT2, Hek6" ENSG00000154928 "EPH receptor B1" P54762 3 134597801-135260467 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 74.7" "Group enriched" "Detected in some" 4 "HDLM-2: 33.9;HMC-1: 20.1;RPTEC TERT1: 9.2" "Cancer enriched" "Detected in many" 6 "glioma: 7.0" "Region enhanced" "Detected in all" "cerebellum: 74.7" "Group enriched" "Detected in some" 33 "neutrophil: 15.9;plasmacytoid DC: 15.4" "Group enriched" "Detected in many" 33 "dendritic cells: 15.4;granulocytes: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067740 Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA067740: " "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.52e-1)" "unprognostic (1.41e-6)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (8.15e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-2)" "unprognostic (1.78e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-4)" 2.0 1.5 9.0 1.8 16.6 1.5 5.5 74.7 23.6 3.6 3.4 3.4 3.1 2.8 4.1 2.0 3.8 2.8 3.3 1.1 9.4 5.3 2.3 2.9 1.0 3.3 2.8 7.0 1.7 1.1 0.6 3.8 0.9 7.1 3.3 1.4 1.9 3.9 5.1 7.4 6.0 1.7 1.7 6.0 3.4 1.3 16.7 6.0 0.0 11.6 2.9 3.3 4.5 2.6 0.0 15.4 15.9 0.0 0.0 0.4 0.1 0.0 0.0 4.7 0.0 0.1 0.0 0.1 3.5 0.0 0.2 0.0 0.0 0.0 0.6 1.0 1.8 0.0 3.1 0.0 0.6 33.9 0.4 2.5 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.5 0.1 0.1 0.1 1.3 0.0 0.0 0.5 0.1 9.2 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.6 2.0 0.3 4.2 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 15.4 0.0 0.1 9.0 16.6 74.7 19.0 9.4 5.3 2.8 7.0 7.1 6.0 EPHB3 "ETK2, Hek2, Tyro6" ENSG00000182580 "EPH receptor B3" P54753 3 184561784-184582409 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Angiogenesis, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 49.3" "Cell line enhanced" "Detected in many" "BEWO: 17.2;HaCaT: 23.6;SK-BR-3: 18.3;T-47d: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 1.1;myeloid DC: 3.1" "Group enriched" "Detected in many" 5 "dendritic cells: 3.1;monocytes: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007698, HPA008184, CAB034350" Enhanced 20000 "CAB034350: AB_2262377, HPA007698: AB_1848205, HPA008184: AB_1848206" "unprognostic (2.94e-2)" "unprognostic (5.88e-2)" "unprognostic (2.17e-2)" "unprognostic (7.80e-2)" "unprognostic (1.52e-1)" "unprognostic (9.19e-2)" "unprognostic (8.35e-2)" "unprognostic (1.94e-1)" "unprognostic (5.51e-2)" "unprognostic (1.76e-1)" "unprognostic (7.42e-2)" "unprognostic (3.31e-1)" "prognostic unfavourable (7.88e-5)" "unprognostic (8.83e-3)" "unprognostic (3.03e-2)" "unprognostic (9.59e-3)" "unprognostic (2.10e-3)" 1.4 0.9 4.5 5.0 2.6 0.5 9.0 9.7 5.7 22.7 8.8 2.3 1.7 5.7 10.0 1.9 19.9 3.0 9.7 1.6 4.7 1.8 1.7 1.0 4.7 1.0 3.3 3.7 9.0 49.3 1.1 1.7 6.3 7.2 7.7 9.7 3.8 27.7 3.5 0.7 32.3 5.6 3.5 1.3 1.2 16.0 1.1 4.0 0.2 1.0 15.7 8.4 4.0 13.6 0.0 3.1 0.3 1.1 0.0 0.4 0.4 3.8 1.3 8.9 0.9 2.7 0.2 17.2 0.6 1.1 1.3 0.7 1.2 0.1 0.0 1.7 3.6 23.6 3.2 1.2 0.3 0.1 0.7 0.0 0.2 0.0 0.2 0.0 0.2 0.7 7.7 1.1 0.1 0.0 0.0 0.0 0.6 10.1 0.0 3.8 0.9 1.5 0.9 5.4 0.0 0.0 3.4 1.1 1.3 0.7 18.3 0.8 12.1 0.1 0.0 2.2 3.2 1.1 1.4 0.0 0.0 0.1 0.2 0.0 8.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.4 4.5 2.6 9.7 5.7 4.7 1.8 3.3 3.7 7.2 4.0 EPHB4 "HTK, Tyro11" ENSG00000196411 "EPH receptor B4" P54760 7 100802565-100827521 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 3.6;neutrophil: 7.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013537 Uncertain 1000000 "CAB013537: " "prognostic unfavourable (8.56e-4)" "unprognostic (1.05e-2)" "prognostic unfavourable (4.33e-4)" "unprognostic (1.33e-1)" "unprognostic (5.23e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.73e-1)" "unprognostic (1.84e-1)" "unprognostic (8.16e-3)" "unprognostic (1.43e-1)" "unprognostic (9.51e-3)" "unprognostic (6.63e-2)" "unprognostic (3.13e-1)" "unprognostic (2.07e-2)" "prognostic unfavourable (8.84e-4)" 14.0 20.7 1.8 4.2 2.9 2.2 17.1 1.9 3.0 29.1 9.5 2.9 14.6 4.1 28.8 10.3 11.0 13.1 35.0 19.0 3.4 1.1 16.8 29.8 16.5 12.0 2.2 0.9 24.6 11.6 5.6 3.1 35.5 3.2 13.7 5.4 11.6 10.8 14.7 5.1 14.2 7.0 12.4 2.2 50.5 8.6 12.2 2.1 2.3 10.2 13.1 7.0 7.7 21.5 0.0 1.6 7.4 3.6 0.0 0.0 1.2 12.5 11.1 11.1 32.2 7.1 4.6 32.9 4.9 10.7 7.7 10.1 9.1 9.6 1.6 22.4 5.0 13.1 4.8 12.9 4.1 2.0 8.9 0.4 6.4 14.1 4.1 0.2 0.3 5.4 19.5 4.9 11.4 28.7 23.6 0.6 6.2 21.8 0.2 4.9 19.0 16.7 17.0 5.5 2.9 9.8 6.6 0.0 9.6 7.5 3.5 7.3 8.9 2.2 24.1 9.6 15.3 17.7 7.2 0.1 0.2 0.5 1.4 4.1 17.4 0.0 3.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 7.4 0.0 0.2 0.3 0.0 1.2 1.8 2.9 1.9 3.0 3.4 1.1 2.2 0.9 3.2 2.1 EPHB6 HEP ENSG00000106123 "EPH receptor B6" 7 142855061-142871094 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1" "Group enriched" "Detected in some" 6 "MOLT-4: 17.8;RT4: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035784 Approved "Nuclear speckles" "Intracellular and membrane" "Nuclear speckles" "HPA035784: " "unprognostic (1.90e-2)" "prognostic favourable (1.80e-4)" "unprognostic (7.08e-3)" "unprognostic (2.95e-2)" "prognostic unfavourable (4.10e-4)" "unprognostic (2.53e-3)" "unprognostic (3.15e-2)" "unprognostic (4.39e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.06e-3)" "unprognostic (3.18e-1)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (4.93e-2)" "unprognostic (3.16e-1)" "prognostic favourable (4.68e-5)" 3.3 1.7 7.4 3.0 30.1 3.3 2.6 3.1 29.3 9.0 1.5 0.8 3.4 0.9 3.0 4.5 7.5 6.4 2.8 1.4 5.4 4.2 1.7 1.3 2.4 3.6 3.3 14.4 3.9 7.8 0.8 1.1 2.9 1.7 6.8 0.9 1.5 4.7 8.1 1.8 32.1 1.6 2.0 1.4 2.6 3.3 3.8 3.6 26.7 6.6 2.5 3.3 5.1 6.5 4.1 0.9 1.0 1.3 0.0 3.1 1.4 0.1 0.0 0.0 0.4 1.9 1.0 0.0 0.2 0.4 0.1 0.0 0.5 1.3 0.0 0.0 0.1 4.4 0.2 0.0 0.0 1.0 0.1 0.3 0.0 0.2 0.6 4.2 0.1 0.3 0.0 1.1 0.0 0.2 0.6 0.0 0.0 0.0 17.8 3.2 3.0 1.3 0.4 0.0 0.0 0.0 33.8 0.0 0.0 1.2 0.8 0.0 2.8 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 1.3 0.5 0.1 1.0 0.6 4.1 2.5 1.4 0.9 1.0 3.1 1.5 1.0 0.0 0.4 0.1 1.9 1.4 7.4 30.1 3.1 29.3 5.4 4.2 3.3 14.4 1.7 3.6 EPOR ENSG00000187266 "Erythropoietin receptor" P19235 19 11377205-11384342 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted membrane proteins" Receptor "Cancer-related genes, Congenital erythrocytosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA077654 Supported "Nuclear speckles,Plasma membrane" "Intracellular and membrane" "Plasma membrane" "Nuclear speckles" "HPA077654: " "unprognostic (9.13e-2)" "unprognostic (7.14e-2)" "unprognostic (1.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (1.11e-1)" "unprognostic (3.70e-1)" "unprognostic (1.50e-2)" "unprognostic (5.60e-2)" "unprognostic (9.00e-2)" "prognostic favourable (3.17e-5)" "unprognostic (6.37e-3)" "unprognostic (1.59e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-1)" "unprognostic (7.48e-2)" "unprognostic (1.01e-3)" 5.5 8.6 2.1 1.1 2.9 14.7 2.6 1.3 1.7 3.9 3.3 2.8 13.3 1.0 3.6 11.6 2.4 3.2 1.8 11.2 1.9 1.4 12.1 8.4 8.5 6.9 1.9 1.6 1.9 9.2 28.1 5.2 12.7 2.3 3.1 1.4 3.3 8.7 18.3 2.0 1.1 1.7 1.5 4.0 8.0 3.7 2.2 1.0 1.6 21.5 1.0 1.5 1.9 2.1 2.6 2.5 12.2 7.7 0.9 4.8 2.9 3.4 1.1 3.5 4.1 5.3 3.4 2.1 2.2 6.8 3.5 4.5 1.2 1.3 2.4 3.9 3.9 0.9 2.7 1.3 4.1 1.9 1.6 13.0 1.1 2.0 3.8 2.7 5.4 2.5 0.5 4.7 3.3 8.2 11.4 11.6 3.9 3.1 2.5 3.2 1.9 9.3 6.7 5.9 5.2 3.3 1.8 1.4 10.9 1.4 2.0 6.0 3.5 4.7 3.4 1.9 2.6 6.5 1.9 5.9 4.3 2.6 10.3 2.6 2.0 8.1 4.2 3.3 2.1 5.1 4.5 2.6 4.2 3.1 2.5 1.6 4.8 2.8 12.2 0.9 7.7 0.1 3.7 2.9 2.1 2.9 1.3 1.7 1.9 1.4 1.9 1.6 2.3 1.0 EQTN "AFAF, C9orf11, equatorin, SPACA8" ENSG00000120160 Equatorin Q9NQ60 9 27284659-27297139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 39.9" "Cell line enhanced" "Detected in some" "AF22: 1.0;BEWO: 2.2;HaCaT: 1.2;HAP1: 1.3;HSkMC: 1.8;K-562: 1.3;RT4: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015089, HPA015504" Enhanced "Intracellular and membrane" "HPA015089: AB_1845795, HPA015504: AB_2067598" "unprognostic (7.83e-2)" "unprognostic (1.55e-1)" "unprognostic (5.64e-2)" "unprognostic (8.12e-3)" "unprognostic (1.34e-3)" "unprognostic (4.41e-2)" "unprognostic (3.21e-1)" "unprognostic (1.06e-1)" "unprognostic (4.32e-1)" "unprognostic (1.89e-1)" "unprognostic (5.67e-2)" "unprognostic (1.14e-1)" "unprognostic (4.59e-2)" "unprognostic (8.46e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.1 0.1 39.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 1.3 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 1.1 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.2 0.2 ERBB2 "CD340, HER-2, HER2, NEU, NGL" ENSG00000141736 "Erb-b2 receptor tyrosine kinase 2" P04626 17 39687914-39730426 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in many" 27 "SK-BR-3: 263.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 8.8" "Lineage enriched" "Detected in many" 4 "T-cells: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555" Enhanced Supported "Plasma membrane,Cytosol" 430000 "Plasma membrane" Cytosol "CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: , HPA001060: , HPA001338: , HPA001383: AB_1078500" "unprognostic (1.97e-1)" "unprognostic (6.60e-3)" "unprognostic (6.21e-2)" "prognostic unfavourable (8.99e-8)" "unprognostic (2.96e-2)" "unprognostic (1.40e-2)" "unprognostic (1.97e-2)" "unprognostic (9.04e-2)" "unprognostic (1.79e-2)" "unprognostic (1.20e-3)" "prognostic unfavourable (9.17e-4)" "unprognostic (3.92e-1)" "prognostic favourable (2.41e-14)" "unprognostic (9.29e-2)" "unprognostic (1.40e-1)" "unprognostic (3.75e-2)" "unprognostic (1.96e-1)" 5.8 2.4 5.2 10.4 7.0 0.1 20.1 4.2 7.0 19.1 46.5 9.1 55.2 21.6 14.9 18.7 40.9 22.7 26.6 24.8 6.3 3.1 37.5 21.5 17.6 3.7 5.1 5.6 19.3 16.2 27.7 8.1 60.8 7.5 23.6 16.6 15.9 28.7 58.1 8.9 35.3 47.2 10.9 4.5 4.0 17.1 6.5 3.7 2.8 35.7 20.8 22.9 19.7 20.3 1.3 0.3 2.1 0.4 0.9 8.8 2.2 3.1 3.8 4.2 2.7 5.1 3.6 5.7 2.2 3.7 4.9 4.2 2.8 8.6 0.2 4.6 5.1 9.8 0.2 5.1 2.3 0.4 3.2 0.1 3.0 4.5 3.0 0.0 0.0 3.5 4.8 3.0 1.8 2.0 0.4 0.1 3.6 4.8 0.5 0.2 7.6 0.9 0.3 1.7 0.4 5.0 9.8 0.8 0.2 4.2 263.9 1.3 7.4 0.1 0.2 2.5 3.3 3.2 1.4 0.4 0.2 0.2 0.2 0.0 8.2 1.6 0.4 0.8 8.8 0.3 0.7 0.9 0.5 2.5 0.3 1.3 1.0 2.5 2.1 0.9 0.2 0.2 0.4 2.2 5.2 7.0 4.2 7.0 6.3 3.1 5.1 5.6 7.5 3.7 ERBB3 "HER3, LCCS2" ENSG00000065361 "Erb-b2 receptor tyrosine kinase 3" P21860 12 56076799-56103505 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 31.1;MCF7: 20.3;RT4: 24.3;SK-BR-3: 28.6;SK-MEL-30: 38.1;T-47d: 31.7;WM-115: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.3" "Low region specificity" "Detected in many" "CAB025331, HPA045396" Uncertain Approved "Plasma membrane,Actin filaments" "Secreted - unknown location" 420000 "Actin filaments" "Plasma membrane" "CAB025331: , HPA045396: " "unprognostic (2.97e-1)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" "unprognostic (8.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.07e-3)" "unprognostic (2.31e-3)" "unprognostic (2.66e-2)" "unprognostic (9.89e-2)" "unprognostic (4.30e-2)" "unprognostic (4.76e-3)" "unprognostic (5.77e-2)" "unprognostic (1.06e-2)" "unprognostic (4.56e-2)" "unprognostic (1.57e-1)" "unprognostic (6.72e-3)" "unprognostic (2.07e-2)" 1.1 1.4 11.6 12.6 16.5 0.6 26.8 2.0 16.7 6.8 40.5 40.3 12.0 37.7 2.8 7.5 29.4 5.7 22.9 3.4 18.6 9.0 16.5 33.9 13.4 0.5 23.5 9.3 0.9 21.5 11.4 1.0 15.4 14.9 16.8 29.7 5.5 36.8 22.3 1.1 30.7 41.3 3.2 27.4 0.5 32.9 1.2 23.8 0.0 4.5 7.4 8.5 11.8 14.4 0.9 0.7 5.3 0.6 1.2 1.2 0.2 10.1 0.6 0.8 0.3 0.0 0.0 16.5 0.8 1.9 1.1 1.1 5.5 18.3 0.0 0.2 0.2 8.6 1.2 1.9 0.6 0.2 0.8 0.0 0.3 31.1 0.0 0.0 0.1 0.4 2.5 0.2 0.0 0.0 0.7 0.3 0.1 20.3 0.1 0.3 2.8 0.4 0.1 1.9 0.5 2.1 24.3 0.9 0.3 0.7 28.6 38.1 31.7 0.1 0.0 0.1 1.1 0.6 0.1 0.3 0.1 0.1 0.1 0.0 40.5 5.3 0.4 0.8 0.9 0.4 0.4 0.4 0.7 0.3 0.3 0.9 0.6 1.2 3.3 1.2 0.6 0.7 0.8 0.2 11.6 16.5 2.0 16.7 18.6 9.0 23.5 9.3 14.9 23.8 ERBB4 "ALS19, HER4" ENSG00000178568 "Erb-b2 receptor tyrosine kinase 4" Q15303 2 211375717-212538841 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Lactation, Transcription, Transcription regulation" "Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.5" "Cell line enhanced" "Detected in some" "AF22: 9.4;EFO-21: 7.0;HEK 293: 5.2;RPTEC TERT1: 7.7;SCLC-21H: 4.3;T-47d: 6.9" "Cancer enhanced" "Detected in many" "breast cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000276, HPA012016, CAB025522" Enhanced 140000 "CAB000276: , CAB025522: , HPA012016: AB_1846541" "unprognostic (1.48e-1)" "unprognostic (3.28e-1)" "unprognostic (4.31e-3)" "unprognostic (1.76e-3)" "unprognostic (3.59e-1)" "unprognostic (2.75e-1)" "unprognostic (2.88e-1)" "unprognostic (9.56e-2)" "unprognostic (2.07e-1)" "unprognostic (4.67e-3)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (7.14e-3)" "unprognostic (1.49e-3)" "unprognostic (1.41e-1)" "unprognostic (1.14e-1)" "unprognostic (4.11e-2)" 1.6 1.9 15.1 1.2 15.0 1.0 13.4 18.6 14.1 7.8 1.1 7.6 8.8 1.1 1.5 1.2 1.3 24.5 1.2 7.0 14.3 6.5 11.9 1.1 2.9 1.2 7.8 10.7 1.3 2.4 10.8 5.1 1.3 8.8 1.7 1.1 2.0 9.7 18.1 3.8 1.8 1.2 1.1 7.3 1.2 1.5 7.6 12.0 0.0 4.5 1.1 1.2 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.4 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 7.0 1.0 0.4 0.2 0.0 0.0 0.1 5.2 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 7.7 0.4 4.3 0.2 0.0 0.1 0.1 6.9 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 15.0 18.6 14.1 14.3 6.5 7.8 10.7 8.8 12.0 EREG ER ENSG00000124882 Epiregulin O14944 4 74365143-74388751 "Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.1;tongue: 44.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 58.9;hTEC/SVTERT24-B: 18.5;U-2197: 40.1;U-87 MG: 68.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054373 Approved Vesicles "Secreted to blood" Vesicles "HPA054373: " "unprognostic (1.26e-2)" "prognostic unfavourable (1.67e-7)" "unprognostic (4.56e-3)" "unprognostic (3.94e-2)" "unprognostic (2.24e-3)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "prognostic unfavourable (1.45e-5)" "unprognostic (1.07e-1)" "unprognostic (7.34e-2)" "prognostic unfavourable (6.57e-5)" "unprognostic (2.94e-1)" "unprognostic (1.70e-6)" "unprognostic (2.42e-2)" "unprognostic (1.13e-2)" "unprognostic (6.59e-3)" "unprognostic (3.16e-3)" 2.2 0.0 0.1 4.6 0.3 52.1 1.2 0.0 0.1 5.0 1.2 0.1 0.0 0.0 0.1 0.5 15.3 1.2 7.3 0.8 0.0 0.0 0.4 0.2 6.7 1.1 0.0 0.2 0.5 0.1 0.0 0.0 2.0 0.3 0.2 1.6 0.1 1.6 0.0 0.5 10.7 1.0 1.3 0.1 1.9 0.3 0.3 0.0 0.2 0.0 44.0 7.2 4.1 4.6 0.6 1.3 2.6 1.2 0.4 0.3 0.3 0.3 8.9 0.0 0.0 0.8 1.5 0.0 2.0 58.9 0.5 0.3 6.9 16.7 0.0 9.8 0.0 0.5 0.0 12.8 0.6 0.0 0.0 0.2 0.3 0.2 0.2 0.0 0.0 0.9 4.5 18.5 9.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.3 0.1 40.1 0.0 0.0 0.0 0.0 68.9 0.0 0.0 1.9 1.2 2.6 0.3 1.0 0.2 0.2 0.2 0.2 1.3 0.6 0.3 0.2 1.0 0.4 0.2 0.4 0.2 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 ERGIC1 "ERGIC-32, ERGIC32, KIAA1181, NET24" ENSG00000113719 "Endoplasmic reticulum-golgi intermediate compartment 1" Q969X5 5 172834275-172952685 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018666, HPA018900" Enhanced Enhanced Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA018666: AB_1848241, HPA018900: AB_1848242" "unprognostic (8.86e-2)" "unprognostic (3.50e-2)" "unprognostic (3.44e-2)" "unprognostic (5.71e-2)" "unprognostic (7.96e-2)" "unprognostic (2.46e-2)" "unprognostic (9.53e-3)" "unprognostic (7.02e-3)" "unprognostic (2.06e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "unprognostic (1.74e-2)" "unprognostic (1.67e-1)" "unprognostic (3.86e-2)" "unprognostic (9.28e-2)" "unprognostic (3.22e-2)" 30.2 56.5 14.2 20.6 13.8 12.0 44.6 25.5 18.1 42.9 30.5 12.3 35.6 24.6 26.4 24.9 22.6 23.7 30.3 20.7 14.2 11.4 36.4 120.8 28.6 29.3 14.5 11.4 22.5 55.5 15.6 18.9 25.5 13.5 48.1 32.9 19.2 51.5 29.3 27.1 16.7 32.6 22.0 10.8 30.8 36.5 15.8 13.2 29.1 41.5 20.9 25.8 21.3 45.8 6.6 4.2 20.8 9.2 8.5 3.8 3.0 20.3 19.5 16.8 37.3 64.3 48.1 9.3 41.6 31.5 18.8 17.6 27.7 21.0 19.7 29.8 70.2 7.5 12.3 55.2 22.1 15.6 12.1 12.1 28.7 14.8 47.1 5.6 3.9 40.8 23.1 27.7 26.0 30.1 7.2 27.6 31.1 25.5 16.1 9.7 10.0 18.1 55.6 11.2 60.4 43.9 11.9 9.5 17.1 14.5 41.5 20.8 17.2 6.4 22.9 30.7 12.6 29.4 16.9 44.0 49.0 8.2 42.7 13.5 13.4 2.1 4.9 12.1 2.3 7.1 3.8 6.6 1.2 1.5 4.2 4.9 1.0 1.6 20.8 8.5 9.2 2.1 0.7 3.0 14.2 13.8 25.5 18.1 14.2 11.4 14.5 11.4 13.5 13.2 ERGIC2 "Erv41, PTX1" ENSG00000087502 "ERGIC and golgi 2" Q96RQ1 12 29337352-29381189 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049695 Approved Supported "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoli "HPA049695: " "unprognostic (1.62e-2)" "unprognostic (3.50e-2)" "unprognostic (5.53e-2)" "unprognostic (3.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.19e-3)" "prognostic unfavourable (8.06e-6)" "unprognostic (3.70e-2)" "unprognostic (2.32e-2)" "prognostic favourable (8.18e-4)" "prognostic unfavourable (7.02e-6)" "unprognostic (2.67e-1)" "prognostic unfavourable (3.76e-6)" "unprognostic (6.02e-2)" "unprognostic (2.08e-1)" "unprognostic (3.19e-2)" "unprognostic (2.64e-1)" 26.6 21.0 24.4 21.9 32.8 5.5 29.9 28.1 36.1 25.4 22.7 14.6 25.8 21.2 23.1 33.1 32.5 16.6 21.2 33.7 25.3 22.6 27.7 36.2 18.6 18.9 29.8 24.2 24.9 32.6 27.3 40.1 40.9 31.2 29.5 21.4 12.1 28.8 23.8 29.2 15.6 24.3 31.4 31.0 25.6 21.1 32.8 30.7 25.7 28.6 21.6 25.8 33.4 20.6 27.0 39.0 59.2 30.1 22.1 40.8 27.5 24.6 22.7 18.6 12.5 26.9 31.7 45.4 40.2 33.9 25.2 27.3 29.9 41.7 13.6 40.1 31.9 25.9 17.7 26.6 40.4 29.1 19.1 22.1 32.5 17.3 15.8 30.7 18.7 22.4 21.4 31.8 32.2 19.5 18.0 38.7 33.6 13.3 15.3 33.3 26.2 64.2 14.2 51.3 27.6 21.4 36.2 7.1 11.6 20.5 23.3 23.8 45.0 25.2 21.6 34.4 29.3 45.4 43.3 28.5 36.0 27.2 28.7 23.0 27.8 24.2 17.0 22.1 29.7 25.3 35.8 27.0 38.1 34.8 17.8 22.3 38.4 32.3 59.2 22.1 30.1 39.0 40.8 27.5 24.4 32.8 28.1 36.1 25.3 22.6 29.8 24.2 31.2 30.7 ERGIC3 "C20orf47, CGI-54, Erv46, NY-BR-84, PRO0989, SDBCAG84" ENSG00000125991 "ERGIC and golgi 3" Q9Y282 20 35542021-35557634 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015242, HPA015968" Approved Supported Nucleoplasm Nucleoplasm "HPA015242: AB_1848238, HPA015968: AB_1848239" "unprognostic (4.36e-2)" "unprognostic (3.43e-2)" "unprognostic (1.18e-1)" "unprognostic (1.16e-1)" "unprognostic (1.93e-1)" "unprognostic (1.93e-2)" "prognostic unfavourable (2.20e-7)" "unprognostic (2.61e-1)" "unprognostic (2.90e-2)" "unprognostic (9.59e-2)" "unprognostic (8.59e-2)" "unprognostic (2.37e-1)" "prognostic unfavourable (9.81e-5)" "unprognostic (9.53e-2)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" "unprognostic (8.64e-2)" 35.5 43.7 23.7 29.5 25.7 29.9 38.3 18.9 35.2 45.3 45.2 28.6 52.7 26.5 42.1 104.8 43.2 72.4 52.2 31.1 22.1 23.8 45.6 60.6 33.2 33.3 20.7 19.3 54.2 86.8 36.0 22.8 59.0 21.4 43.9 42.1 33.6 86.1 46.1 31.7 36.5 42.1 32.1 21.6 28.4 37.1 55.8 13.7 37.8 74.4 40.8 46.2 35.0 34.2 43.9 62.0 27.6 50.5 36.9 46.2 54.4 22.8 44.1 22.6 38.9 80.2 60.8 29.7 31.6 70.2 53.7 53.5 104.6 48.4 17.0 30.9 68.1 34.3 19.0 51.7 39.7 8.4 35.4 35.9 32.9 63.8 41.4 31.2 26.9 67.0 81.8 33.3 42.7 35.0 24.8 55.3 42.9 52.6 24.6 48.6 12.8 43.0 18.8 52.4 48.6 45.4 40.6 22.1 31.7 48.1 39.6 37.5 38.5 53.4 28.0 61.0 24.0 24.4 27.6 22.9 13.8 13.8 64.4 17.2 32.3 22.2 50.5 27.6 33.9 47.8 40.8 43.9 40.3 37.2 62.0 38.5 40.1 40.5 16.8 36.9 40.3 61.5 46.2 54.4 23.7 25.7 18.9 35.2 22.1 23.8 20.7 19.3 21.4 13.7 ERMAP "BTN5, RD, SC" ENSG00000164010 "Erythroblast membrane associated protein (Scianna blood group)" Q96PL5 1 42817088-42844993 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA042573, HPA054672" Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA042573: AB_10794282, HPA054672: " "unprognostic (9.46e-2)" "unprognostic (4.47e-2)" "unprognostic (2.56e-3)" "unprognostic (1.15e-1)" "unprognostic (6.09e-2)" "unprognostic (2.11e-3)" "unprognostic (2.82e-1)" "unprognostic (7.48e-2)" "unprognostic (2.71e-3)" "unprognostic (6.46e-2)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "unprognostic (8.28e-2)" "unprognostic (4.81e-2)" "unprognostic (1.48e-1)" "unprognostic (9.48e-2)" 10.0 14.1 9.3 6.7 10.4 25.7 8.4 2.5 9.3 9.3 7.9 12.4 12.2 6.4 9.4 16.7 8.3 10.2 7.4 4.7 9.3 6.3 7.8 13.1 9.8 4.4 10.4 8.3 6.2 11.7 9.8 12.3 12.0 10.8 9.4 8.3 11.8 10.2 8.0 4.0 9.2 9.4 6.5 14.6 8.6 7.8 4.2 11.9 4.8 13.1 3.2 8.1 9.7 8.0 2.4 8.1 3.0 7.1 3.5 5.0 2.9 3.4 4.6 1.5 4.6 5.2 15.3 1.3 6.9 11.6 6.1 6.2 1.8 6.3 3.1 2.5 7.2 4.4 1.6 2.1 5.6 5.1 5.6 24.7 3.4 1.5 6.5 3.5 12.7 9.3 7.9 2.8 6.7 4.0 16.7 3.1 5.6 2.3 1.7 1.2 3.5 2.5 1.7 2.1 2.9 5.3 5.3 3.2 2.4 5.9 2.2 2.6 4.3 13.1 6.3 4.7 2.8 3.9 3.2 1.4 2.7 1.3 3.8 3.8 2.9 0.5 6.8 3.0 2.1 7.1 1.2 2.4 2.3 2.2 8.1 1.3 2.0 2.3 2.1 3.5 4.5 2.3 5.0 2.9 9.3 10.4 2.5 9.3 9.3 6.3 10.4 8.3 10.8 11.9 ERVMER34-1 envMER34 ENSG00000226887 "Endogenous retrovirus group MER34 member 1, envelope" Q9H9K5 4 52722618-52751640 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "parathyroid gland: 32.0;placenta: 26.9" "Cell line enhanced" "Detected in some" "CACO-2: 27.6;hTCEpi: 19.9;RPTEC TERT1: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA011423, HPA024053" Approved Approved Nucleoplasm,Cytosol "Secreted to blood" 5000000 Nucleoplasm Cytosol "HPA011423: , HPA024053: " "unprognostic (5.34e-2)" "unprognostic (1.29e-1)" "unprognostic (1.91e-3)" "unprognostic (5.86e-2)" "unprognostic (4.08e-4)" "prognostic unfavourable (3.55e-4)" "unprognostic (5.88e-4)" "unprognostic (5.28e-2)" "unprognostic (2.99e-2)" "unprognostic (2.39e-3)" "unprognostic (2.62e-3)" "unprognostic (4.23e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-2)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" "unprognostic (1.82e-1)" 0.3 1.3 1.2 0.4 0.7 0.2 2.8 0.5 3.0 1.3 0.5 0.0 1.4 0.5 0.9 1.3 3.7 0.7 0.4 6.2 0.8 1.0 4.4 0.3 1.8 1.9 0.6 0.2 3.9 1.7 32.0 0.2 26.9 0.8 0.7 0.7 0.8 1.3 3.0 0.2 1.0 0.5 0.4 1.5 1.9 1.1 1.7 0.3 0.0 2.5 3.7 1.2 1.0 1.8 0.6 0.4 1.2 0.1 0.4 0.3 0.0 4.4 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 27.6 5.9 0.0 0.6 0.1 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 1.3 19.9 0.0 2.9 0.0 1.5 0.0 0.1 0.3 0.0 0.0 1.8 0.8 0.0 0.0 0.0 14.7 0.4 1.2 0.2 1.8 0.8 0.0 2.4 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.1 0.5 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.3 0.2 1.1 0.4 0.1 0.4 0.2 0.0 1.2 0.7 0.5 3.0 0.8 1.0 0.6 0.2 0.8 0.3 ESAM W117m ENSG00000149564 "Endothelial cell adhesion molecule" Q96AP7 11 124752583-124762290 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 93.0" "Group enriched" "Detected in some" 13 "HEL: 52.2;HUVEC TERT2: 67.9;TIME: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.7;neutrophil: 5.5" "Group enriched" "Detected in many" 9 "B-cells: 6.7;granulocytes: 5.5;T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051043, HPA056293" Uncertain Approved Microtubules 64000000 Microtubules "HPA051043: , HPA056293: " "unprognostic (1.52e-1)" "unprognostic (2.03e-1)" "unprognostic (1.05e-2)" "unprognostic (3.56e-1)" "unprognostic (1.41e-2)" "unprognostic (4.49e-3)" "unprognostic (2.61e-1)" "unprognostic (1.10e-1)" "unprognostic (9.05e-2)" "unprognostic (2.99e-2)" "unprognostic (3.08e-1)" "unprognostic (3.60e-1)" "unprognostic (1.54e-1)" "unprognostic (1.24e-2)" "unprognostic (5.10e-2)" "unprognostic (2.29e-1)" "unprognostic (5.06e-2)" 37.1 6.0 6.6 5.3 9.6 1.3 44.6 3.8 8.2 11.8 6.1 5.4 3.7 4.3 14.5 9.5 10.7 10.3 11.5 20.1 7.5 6.6 15.5 10.2 38.4 6.9 9.1 3.9 8.4 6.4 5.4 5.5 93.0 9.0 10.9 5.0 12.4 5.1 9.8 14.6 5.9 6.4 17.2 7.2 8.2 7.6 5.4 5.9 0.9 44.9 10.9 5.0 11.4 25.4 6.7 0.3 5.5 0.5 0.0 1.8 19.4 0.2 0.4 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 3.4 0.2 0.7 0.0 0.0 0.9 0.0 0.0 0.4 0.3 52.2 0.0 1.8 0.1 0.1 0.9 0.0 0.0 0.0 0.0 67.9 0.0 1.5 0.1 0.4 0.0 0.0 0.1 0.5 0.0 0.2 0.2 0.0 0.5 0.0 0.2 0.0 3.9 0.0 0.8 0.2 34.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.1 0.5 0.0 0.1 0.2 0.0 1.4 1.3 0.1 0.3 6.7 1.8 0.6 5.5 0.0 0.0 0.3 0.4 19.4 6.6 9.6 3.8 8.2 7.5 6.6 9.1 3.9 9.0 5.9 ESPL1 "ESP1, KIAA0165, SEPA" ENSG00000135476 "Extra spindle pole bodies like 1, separase" Q14674 12 53268299-53293643 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Chromosome partition" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 17.9;lymphoid tissue: 30.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 1.8" "Lineage enriched" "Detected in single" 5 "T-cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB012185, HPA073188" Approved Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB012185: AB_304056, HPA073188: " "unprognostic (1.57e-1)" "unprognostic (3.56e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (5.32e-5)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "prognostic unfavourable (2.01e-5)" "prognostic unfavourable (7.14e-4)" "unprognostic (1.59e-2)" "unprognostic (2.48e-1)" "unprognostic (4.17e-3)" "unprognostic (1.18e-2)" "unprognostic (7.42e-13)" "prognostic favourable (7.10e-4)" "unprognostic (2.39e-1)" "unprognostic (7.41e-2)" "unprognostic (1.42e-1)" 0.7 0.4 0.2 7.1 0.4 7.2 0.3 0.2 0.5 3.9 2.3 0.4 0.8 4.2 0.6 0.7 17.9 0.2 0.5 1.0 1.1 0.1 1.0 0.9 0.7 4.1 0.2 0.2 0.3 0.2 0.0 0.2 3.0 0.6 0.4 1.5 0.6 2.6 0.2 0.2 2.7 4.4 0.5 0.2 3.0 0.8 10.9 0.3 30.3 0.3 2.5 7.8 0.7 6.2 0.0 0.0 0.4 0.1 0.0 1.8 0.0 12.4 12.7 13.7 11.2 0.3 1.2 8.4 8.2 4.2 14.1 9.0 6.9 11.0 22.5 4.6 3.3 10.4 15.8 4.8 7.4 7.0 16.0 15.1 11.5 5.3 0.0 9.4 12.5 0.4 0.3 8.2 4.0 7.2 20.2 20.4 4.2 13.0 14.8 8.1 11.0 6.9 13.9 14.6 9.3 2.0 5.2 9.8 7.6 6.9 10.2 5.3 16.8 6.3 3.3 7.1 13.8 6.0 11.2 15.1 14.0 15.2 4.1 8.9 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.8 0.0 0.2 0.4 0.2 0.5 1.1 0.1 0.2 0.2 0.6 0.3 ESYT2 "CHR2SYT, FAM62B, KIAA1228" ENSG00000117868 "Extended synaptotagmin 2" A0FGR8 7 158730995-158830253 "Plasma proteins, Predicted membrane proteins, Transporters" "Endocytosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002132 Approved Uncertain Cytosol 130000 Cytosol "HPA002132: AB_1078807" "unprognostic (2.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (5.72e-2)" "unprognostic (5.43e-2)" "unprognostic (9.01e-2)" "unprognostic (9.94e-2)" "unprognostic (1.72e-1)" "unprognostic (8.71e-3)" "prognostic unfavourable (5.73e-4)" "unprognostic (2.13e-1)" "unprognostic (7.54e-2)" "unprognostic (6.70e-2)" "unprognostic (4.58e-2)" "unprognostic (3.70e-3)" "prognostic unfavourable (2.81e-5)" 33.3 25.6 15.3 16.2 23.5 19.6 27.3 21.7 26.3 26.7 27.9 17.8 21.6 15.8 31.2 31.0 32.5 28.3 31.1 28.4 16.1 17.5 20.6 16.7 26.1 18.0 15.6 16.7 41.6 23.2 29.7 22.0 35.2 20.6 21.1 22.6 23.4 26.7 31.4 34.5 24.5 22.5 37.8 14.9 13.2 19.4 13.3 12.1 29.0 30.5 24.3 23.2 30.5 27.6 1.4 3.6 2.0 2.3 6.6 8.5 2.9 29.0 17.4 5.6 5.9 18.8 21.9 18.6 13.7 14.1 10.9 12.4 9.7 38.2 8.9 15.9 24.6 14.5 8.0 14.4 10.6 9.2 8.2 7.4 13.9 10.3 19.2 26.4 16.9 15.8 18.0 12.4 16.6 13.0 15.8 30.2 17.9 24.4 27.3 19.1 8.9 16.8 23.3 10.8 10.9 18.7 12.4 16.4 9.0 43.7 35.3 19.9 12.9 28.9 20.0 12.1 6.4 53.6 17.4 20.6 5.3 8.7 30.1 27.4 35.7 2.0 1.9 1.5 8.5 2.3 4.7 1.4 7.1 6.0 3.6 1.0 6.7 7.9 1.2 6.6 1.5 2.4 5.8 2.9 15.3 23.5 21.7 26.3 16.1 17.5 15.6 16.7 20.6 12.1 ESYT3 "CHR3SYT, FAM62C" ENSG00000158220 "Extended synaptotagmin 3" A0FGR9 3 138434586-138481686 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;skin 1: 13.7" "Cell line enhanced" "Detected in some" "HAP1: 3.0;NTERA-2: 7.5;SCLC-21H: 8.1;SiHa: 3.3;SK-MEL-30: 4.0" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Region enriched" "Detected in all" 5 "cerebellum: 28.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 8.5" "Low region specificity" "Detected in all" HPA039200 Approved "HPA039200: AB_10805356" "unprognostic (4.48e-2)" "unprognostic (3.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.38e-4)" "unprognostic (2.23e-1)" "unprognostic (8.22e-2)" "unprognostic (3.55e-3)" "prognostic favourable (8.30e-4)" "unprognostic (3.38e-1)" "unprognostic (5.57e-2)" "unprognostic (6.19e-3)" "unprognostic (4.88e-3)" "unprognostic (3.16e-5)" "unprognostic (3.46e-1)" "unprognostic (1.12e-1)" "unprognostic (2.13e-1)" "unprognostic (6.43e-2)" 0.6 0.8 5.7 0.6 5.8 0.5 2.6 28.5 5.9 1.3 4.9 0.6 0.2 0.7 5.3 0.8 0.9 1.0 2.8 1.1 5.3 3.0 1.8 0.5 12.4 0.5 1.9 4.0 0.9 2.0 3.5 3.0 1.5 4.2 1.0 1.1 0.7 0.8 0.7 0.8 13.7 0.7 4.8 1.2 0.5 2.7 1.4 1.2 0.0 11.5 1.8 1.6 2.5 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.2 0.4 0.0 2.0 1.8 0.6 3.0 0.2 0.0 0.5 0.1 0.2 1.0 1.1 0.3 0.1 0.3 0.1 1.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.7 7.5 0.5 0.0 0.1 0.0 0.8 0.2 8.1 0.0 3.3 0.4 4.0 0.9 0.3 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.7 5.8 28.5 5.9 5.3 3.0 1.9 4.0 4.2 1.2 ETFDH ETFQO ENSG00000171503 "Electron transfer flavoprotein dehydrogenase" Q16134 4 158672125-158709623 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 72.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041978 Enhanced "HPA041978: AB_10795605" "unprognostic (7.19e-2)" "unprognostic (2.28e-1)" "unprognostic (2.90e-2)" "unprognostic (5.92e-3)" "unprognostic (1.91e-1)" "unprognostic (8.45e-2)" "unprognostic (1.23e-3)" "unprognostic (7.17e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (1.71e-2)" "unprognostic (5.76e-2)" "prognostic favourable (5.76e-10)" "unprognostic (2.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.85e-3)" "unprognostic (1.74e-1)" 11.3 20.1 7.0 3.9 8.6 2.8 12.9 10.3 8.2 5.1 12.5 6.5 6.1 23.0 5.7 6.4 10.9 4.3 5.2 47.8 7.2 5.0 17.3 72.8 4.3 2.9 8.0 5.3 5.0 8.9 11.4 8.8 9.0 8.5 5.2 10.5 7.4 7.2 5.6 33.7 7.7 20.4 8.5 4.8 4.8 9.2 4.1 8.4 4.9 6.0 17.5 5.4 5.8 6.1 5.8 11.0 24.5 13.5 6.2 9.2 5.4 5.6 3.5 5.9 10.7 25.6 15.3 2.8 10.0 10.0 7.4 7.2 1.9 12.5 13.8 2.1 12.1 6.6 11.4 9.9 10.4 21.9 8.3 12.7 8.1 3.3 11.2 10.9 12.1 14.1 12.5 8.0 6.8 14.4 7.0 26.1 11.8 5.8 10.5 5.5 2.3 8.6 8.5 2.0 9.7 11.1 4.9 9.0 3.5 10.0 19.9 9.4 13.5 8.4 6.4 6.0 3.1 8.8 5.1 14.7 18.3 9.4 12.4 9.2 6.4 2.5 13.5 24.5 6.7 13.3 8.1 5.8 6.3 6.8 11.0 5.4 7.8 6.6 4.6 6.2 11.7 8.4 9.2 5.4 7.0 8.6 10.3 8.2 7.2 5.0 8.0 5.3 8.5 8.4 ETNK1 "EKI, EKI1" ENSG00000139163 "Ethanolamine kinase 1" Q9HBU6 12 22625075-22690665 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010712, HPA029407" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA010712: , HPA029407: " "unprognostic (2.06e-1)" "unprognostic (7.48e-2)" "unprognostic (1.23e-3)" "unprognostic (2.19e-1)" "unprognostic (8.79e-3)" "unprognostic (1.31e-2)" "prognostic unfavourable (5.85e-4)" "unprognostic (3.98e-3)" "unprognostic (8.30e-2)" "unprognostic (7.97e-3)" "unprognostic (2.01e-1)" "unprognostic (1.64e-2)" "unprognostic (4.53e-3)" "unprognostic (2.77e-1)" "unprognostic (2.91e-1)" "unprognostic (3.01e-1)" "prognostic favourable (1.75e-4)" 15.7 17.7 15.2 41.1 19.4 13.7 16.9 19.7 22.2 12.9 33.2 16.4 14.6 27.2 16.6 24.1 14.7 13.1 27.3 10.4 15.6 23.9 22.0 30.2 19.6 18.5 17.2 15.8 17.2 14.9 15.8 30.6 13.4 18.9 13.8 19.5 15.9 16.7 14.7 8.2 17.8 24.5 10.0 17.1 18.3 53.7 22.3 17.5 33.4 17.6 8.2 16.5 14.2 18.6 16.2 10.7 28.1 17.6 14.0 15.7 13.4 6.7 14.0 15.5 14.3 11.2 11.4 11.6 8.0 6.0 8.3 8.5 10.8 17.0 20.0 7.2 5.2 5.1 13.6 3.8 14.9 16.6 11.0 16.5 6.1 9.2 10.7 15.8 15.2 7.4 3.7 11.1 9.5 10.2 19.8 8.5 10.9 4.6 17.2 32.2 30.0 9.1 15.6 13.8 16.1 13.7 9.1 5.0 8.8 8.7 7.5 12.5 11.8 15.3 8.8 6.6 10.6 8.9 12.0 6.2 7.7 21.5 8.4 10.3 11.0 28.1 11.7 12.1 12.9 17.5 12.7 16.2 14.1 11.9 10.7 13.0 15.7 15.5 11.5 14.0 17.6 9.7 15.3 13.4 15.2 19.4 19.7 22.2 15.6 23.9 17.2 15.8 18.9 17.5 EVA1A "FAM176A, FLJ13391, TMEM166" ENSG00000115363 "Eva-1 homolog A, regulator of programmed cell death" Q9H8M9 2 75469302-75569722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 69.4;pancreas: 32.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.1;U-138 MG: 36.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008055 Approved Supported "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA008055: AB_1080308" "unprognostic (2.72e-1)" "unprognostic (2.61e-2)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.60e-2)" "unprognostic (5.02e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "prognostic favourable (5.67e-4)" "unprognostic (7.33e-2)" "unprognostic (1.22e-1)" "prognostic favourable (5.80e-4)" "unprognostic (8.19e-2)" "unprognostic (4.37e-2)" "unprognostic (2.43e-2)" "unprognostic (9.07e-2)" 0.6 0.3 0.3 0.7 0.5 0.0 1.2 0.3 0.2 3.7 0.6 0.1 11.4 0.5 1.6 5.1 0.5 1.3 0.4 0.6 0.3 0.3 23.6 69.4 15.2 0.1 0.8 0.0 0.8 32.3 0.8 0.8 26.6 0.5 0.6 0.2 5.7 14.3 13.5 0.9 1.5 1.1 0.7 0.4 5.9 0.4 2.2 0.3 3.3 1.2 0.8 0.8 0.3 0.6 0.8 0.0 0.0 0.0 0.0 1.1 0.7 0.3 4.6 0.5 0.1 1.0 7.1 0.5 21.7 14.6 19.3 9.9 0.1 0.4 0.0 2.0 27.1 3.0 0.5 4.6 12.2 0.0 0.3 0.0 0.8 14.3 0.7 0.0 0.0 5.0 2.7 23.8 11.0 12.0 0.0 0.0 14.8 0.0 0.0 0.0 1.0 7.5 2.4 0.0 0.0 10.7 0.1 0.3 0.5 2.0 0.1 16.5 0.0 0.1 9.8 36.4 15.3 0.6 22.6 0.2 0.0 0.0 20.6 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.5 0.3 0.2 0.3 0.3 0.8 0.0 0.5 0.3 EVA1C "B18, B19, C21orf63, C21orf64, FAM176C, PRED34" ENSG00000166979 "Eva-1 homolog C" P58658 21 32412006-32515397 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 13.1;CAPAN-2: 13.2;HBEC3-KT: 9.4;hTCEpi: 10.5;HUVEC TERT2: 10.2;SK-MEL-30: 11.4;U-87 MG: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "granulocytes: 1.8;NK-cells: 3.8;T-cells: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015720, HPA029944, CAB034174" Enhanced "CAB034174: AB_1564317, HPA015720: AB_1845705, HPA029944: AB_10601092" "unprognostic (7.55e-3)" "unprognostic (8.91e-3)" "unprognostic (5.51e-2)" "unprognostic (2.55e-1)" "unprognostic (3.16e-2)" "prognostic favourable (5.06e-4)" "unprognostic (1.40e-3)" "unprognostic (4.24e-3)" "unprognostic (3.39e-1)" "unprognostic (2.65e-2)" "unprognostic (1.65e-1)" "unprognostic (3.84e-2)" "unprognostic (3.29e-2)" "unprognostic (1.08e-1)" "unprognostic (2.73e-1)" "unprognostic (5.95e-3)" "unprognostic (4.25e-3)" 17.1 3.9 5.0 4.5 11.9 1.7 28.1 5.0 7.9 11.9 9.3 12.2 19.5 2.6 18.8 12.8 13.1 23.9 14.3 12.6 4.8 4.2 5.1 2.6 14.3 8.0 9.4 4.1 12.0 5.9 7.5 6.7 8.3 9.8 16.4 3.5 7.4 11.8 25.8 5.8 14.2 5.3 17.2 7.2 5.3 8.2 10.5 8.5 0.5 9.1 10.5 10.7 14.2 14.9 0.0 0.1 1.8 0.5 3.8 5.2 1.8 0.0 13.1 0.1 0.5 2.9 1.9 0.3 2.8 0.5 0.9 0.2 0.0 13.2 0.1 0.2 0.1 0.0 0.5 9.4 0.2 1.4 0.0 0.0 6.2 0.4 3.5 0.0 0.0 0.9 10.5 1.9 7.3 10.2 0.0 0.0 0.5 0.0 0.0 0.0 0.5 2.9 0.0 0.3 0.0 0.3 0.2 3.9 0.6 8.3 0.7 11.4 0.4 0.0 9.2 1.2 0.3 1.6 0.6 0.2 0.0 0.1 11.3 0.1 2.9 1.8 0.0 0.0 4.6 0.2 5.2 0.0 4.9 4.5 0.1 0.0 1.0 2.5 0.0 3.8 0.5 0.0 0.6 1.8 5.0 11.9 5.0 7.9 4.8 4.2 9.4 4.1 9.8 8.5 EVC DWF-1 ENSG00000072840 "EvC ciliary complex subunit 1" P57679 4 5711197-5814305 "Disease related genes, Predicted membrane proteins" "Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 21.1;BJ hTERT+: 26.9;hTERT-HME1: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008703, HPA016046" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA008703: AB_1078765, HPA016046: AB_1848299" "unprognostic (1.69e-1)" "unprognostic (5.39e-2)" "unprognostic (1.15e-1)" "unprognostic (6.58e-2)" "unprognostic (6.61e-2)" "unprognostic (9.37e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-2)" "unprognostic (9.63e-2)" "unprognostic (2.82e-1)" "prognostic favourable (5.60e-9)" "unprognostic (3.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "prognostic unfavourable (9.47e-5)" 5.0 2.9 2.5 4.6 2.7 0.0 4.1 1.9 2.3 13.2 4.3 1.8 8.4 0.6 17.2 10.1 6.0 8.1 16.0 3.8 2.2 2.2 26.5 3.7 6.4 1.0 2.3 1.4 20.2 9.2 14.9 2.3 1.8 2.9 10.2 1.6 12.0 9.1 5.7 2.4 4.2 2.8 15.8 2.4 2.1 3.6 5.3 1.0 1.0 6.9 3.9 3.8 7.5 9.0 0.1 0.3 1.2 0.1 0.1 0.5 0.0 3.1 4.0 2.2 5.8 14.6 21.1 0.8 7.0 26.9 8.1 10.6 0.0 0.0 0.0 2.2 11.1 3.7 2.3 5.8 6.7 5.1 1.6 0.0 2.3 1.0 10.8 0.0 0.6 10.4 8.5 10.8 26.8 5.6 0.0 0.0 18.8 0.0 0.0 0.0 2.4 3.7 4.7 6.2 0.0 2.8 0.5 1.2 3.8 0.0 0.0 2.8 1.4 0.2 9.8 7.0 1.3 4.9 6.1 4.3 3.5 0.3 20.0 0.0 6.5 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.3 0.5 0.0 2.5 2.7 1.9 2.3 2.2 2.2 2.3 1.4 2.9 1.0 EVC2 LBN ENSG00000173040 "EvC ciliary complex subunit 2" Q86UK5 4 5542772-5709548 "Disease related genes, Predicted membrane proteins" "Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 12.2;hTERT-HME1: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040910, HPA048122" Uncertain Approved Mitochondria Mitochondria "HPA040910: , HPA048122: " "unprognostic (6.56e-2)" "unprognostic (6.74e-2)" "unprognostic (5.10e-2)" "unprognostic (2.25e-1)" "unprognostic (8.23e-3)" "unprognostic (2.80e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (1.71e-1)" "unprognostic (1.28e-1)" "unprognostic (8.57e-2)" "unprognostic (9.37e-2)" "prognostic favourable (1.58e-4)" "unprognostic (2.51e-2)" "unprognostic (3.14e-1)" "unprognostic (5.61e-2)" "unprognostic (6.29e-5)" 6.9 1.2 1.2 7.6 1.6 0.3 15.7 1.6 1.0 13.2 5.2 1.1 3.4 1.3 14.1 8.5 5.1 6.3 8.2 4.7 1.9 0.7 8.0 1.4 4.1 3.7 1.6 0.5 14.4 5.0 8.1 2.5 2.6 1.3 8.6 1.3 7.7 5.0 4.2 2.8 5.6 2.9 14.2 1.7 3.6 3.5 4.5 0.6 1.1 12.4 3.7 7.9 7.2 24.6 0.8 0.0 0.0 0.1 0.0 1.2 0.0 0.0 2.4 0.0 6.0 7.9 8.8 0.0 3.6 8.7 3.3 5.5 0.0 0.0 4.5 0.0 2.9 2.5 0.0 1.5 3.1 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 5.5 4.2 4.2 9.8 3.5 0.0 0.2 4.7 0.0 0.0 0.0 3.5 0.0 7.5 7.5 0.0 0.3 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.5 5.9 0.0 0.0 2.2 0.0 3.8 4.0 1.1 2.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.8 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.2 1.6 1.6 1.0 1.9 0.7 1.6 0.5 1.3 0.6 EVI2A "EVDA, EVI2" ENSG00000126860 "Ecotropic viral integration site 2A" P22794 17 31317560-31321884 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.7;brain: 74.0" "Cell line enhanced" "Detected in many" "HHSteC: 19.8;Karpas-707: 32.7;RPMI-8226: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045033, HPA057051" Uncertain Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA045033: , HPA057051: " "unprognostic (7.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" "unprognostic (8.49e-2)" "unprognostic (4.89e-2)" "unprognostic (1.88e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (7.55e-4)" "unprognostic (1.90e-1)" "unprognostic (3.54e-2)" "unprognostic (3.15e-2)" "prognostic unfavourable (2.63e-6)" "unprognostic (7.64e-2)" "unprognostic (4.95e-2)" "unprognostic (5.87e-2)" "unprognostic (2.90e-2)" 6.4 4.7 26.8 25.8 36.0 15.1 4.7 3.8 30.0 5.2 6.2 16.5 0.0 6.3 2.2 1.6 3.5 2.1 10.6 2.6 42.5 21.8 2.2 5.3 12.5 27.4 64.7 13.9 1.6 1.6 1.0 1.6 11.6 33.7 2.4 8.2 0.0 3.0 2.0 1.2 1.5 6.8 4.1 74.0 20.4 6.9 1.2 59.7 32.1 2.0 0.6 22.6 14.2 2.2 8.6 17.9 51.7 26.5 8.9 19.2 23.9 0.0 0.0 0.0 0.0 1.6 10.4 0.0 1.3 2.2 1.7 6.0 0.0 0.4 8.8 0.0 1.7 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 19.8 10.2 11.1 12.8 0.0 2.4 6.8 0.6 0.3 32.7 12.9 0.1 7.3 11.2 0.0 0.0 7.6 1.3 50.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 11.1 4.2 7.2 0.2 0.3 4.7 14.8 0.0 9.9 5.8 7.4 5.9 1.3 26.5 1.0 11.3 12.7 13.7 8.6 16.1 13.1 17.9 4.2 19.2 16.8 51.7 8.9 9.6 5.9 17.1 23.9 26.8 36.0 3.8 24.0 42.5 21.8 64.7 13.9 33.7 59.7 EVI2B "CD361, D17S376, EVDB" ENSG00000185862 "Ecotropic viral integration site 2B" P34910 17 31303766-31314112 "CD markers, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 133.6;lymphoid tissue: 72.8" "Cell line enhanced" "Detected in many" "Daudi: 23.7;HL-60: 26.7;HMC-1: 37.7;Karpas-707: 26.7;NB-4: 21.1;RPMI-8226: 39.0;THP-1: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 133.6" "Group enriched" "Detected in all" 4 "granulocytes: 133.6;monocytes: 34.3" "Low region specificity" "Detected in all" HPA007436 Enhanced "HPA007436: AB_1848307" "unprognostic (1.07e-2)" "unprognostic (1.20e-2)" "unprognostic (5.97e-2)" "unprognostic (4.09e-3)" "unprognostic (2.99e-2)" "unprognostic (1.41e-2)" "unprognostic (3.06e-1)" "unprognostic (3.36e-2)" "unprognostic (1.93e-2)" "unprognostic (1.48e-1)" "unprognostic (1.78e-2)" "unprognostic (2.34e-1)" "prognostic unfavourable (2.05e-4)" "unprognostic (1.56e-2)" "unprognostic (3.32e-2)" "unprognostic (8.64e-2)" "unprognostic (2.73e-2)" 15.0 3.6 4.4 37.7 5.8 44.0 4.2 1.7 4.4 3.7 10.7 6.5 0.3 6.0 2.8 4.8 7.1 4.7 8.1 6.7 6.4 4.4 7.8 7.1 38.5 37.5 10.2 2.6 3.8 2.7 0.4 2.1 4.8 7.8 5.3 8.1 2.5 6.6 1.5 2.3 2.4 23.3 4.2 22.0 72.8 8.0 3.7 6.7 26.1 4.0 3.0 43.0 13.0 7.6 18.6 14.6 133.6 34.3 4.1 16.4 19.8 0.1 0.1 0.0 0.0 1.9 2.5 0.0 0.2 1.6 1.9 3.7 0.0 0.9 23.7 0.0 1.5 0.1 0.0 0.3 2.2 0.0 0.0 0.5 0.0 0.0 19.5 26.7 37.7 4.5 0.0 1.1 1.5 1.9 0.3 26.7 5.6 0.0 7.8 21.1 0.0 0.0 13.6 0.1 39.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 33.7 2.0 0.5 0.0 0.2 1.9 5.1 0.2 5.1 2.4 9.2 0.6 78.9 30.5 74.5 8.2 23.2 7.9 18.6 12.6 10.6 14.6 14.3 9.7 9.1 133.6 4.1 34.3 8.4 16.4 19.8 4.4 5.8 1.7 4.4 6.4 4.4 10.2 2.6 7.8 6.7 EXD2 "C14orf114, EXDL2, FLJ10738" ENSG00000081177 "Exonuclease 3'-5' domain containing 2" Q9NVH0 14 69191511-69244020 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002906, HPA005848" Uncertain Approved "Intermediate filaments,Mitochondria" Mitochondria "Intermediate filaments" "HPA002906: AB_1078767, HPA005848: AB_1078768" "unprognostic (3.36e-2)" "unprognostic (1.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (2.85e-1)" "prognostic unfavourable (8.47e-4)" "unprognostic (9.91e-2)" "unprognostic (8.03e-2)" "unprognostic (2.46e-1)" "unprognostic (4.64e-2)" "unprognostic (8.97e-2)" "prognostic favourable (2.08e-9)" "unprognostic (1.16e-1)" "unprognostic (3.06e-2)" "unprognostic (8.75e-2)" "unprognostic (2.14e-2)" 8.1 7.7 14.3 5.0 19.0 2.3 10.6 20.4 20.1 15.8 8.8 21.7 10.2 7.2 14.4 13.6 10.7 14.5 8.6 8.9 13.8 12.0 11.5 6.0 9.0 4.0 13.7 13.3 12.4 24.9 21.9 13.2 8.0 13.9 11.4 10.0 9.6 17.0 12.1 10.3 7.0 6.8 11.0 20.7 5.8 8.7 20.0 12.6 5.0 12.4 5.2 5.9 10.5 7.9 4.1 7.4 10.9 3.4 3.6 6.0 3.1 18.8 8.9 6.9 10.1 4.2 5.1 8.7 9.4 8.0 8.8 11.7 7.5 13.3 0.0 7.0 9.8 10.7 7.6 9.5 10.0 4.7 9.1 5.5 3.3 4.4 16.6 4.0 5.3 10.3 15.8 9.0 5.9 12.4 3.4 7.3 8.3 9.5 2.3 6.1 7.4 8.9 0.0 6.6 6.6 13.0 7.0 13.4 12.0 7.0 14.8 6.9 19.7 3.5 9.8 8.2 5.8 6.6 4.8 5.6 7.4 0.0 0.0 4.4 6.1 10.9 3.4 2.9 3.3 1.9 6.0 4.1 3.5 3.3 7.4 2.4 4.2 6.0 0.4 3.6 1.7 5.8 2.4 3.1 14.3 19.0 20.4 20.1 13.8 12.0 13.7 13.3 13.9 12.6 EXT1 "LGCR, LGS, ttv" ENSG00000182197 "Exostosin glycosyltransferase 1" Q16394 8 117794490-118111853 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease mutation, Hereditary multiple exostoses, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 55.1;fHDF/TERT166: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044394 Uncertain 9600000 "HPA044394: AB_10963838" "unprognostic (1.29e-2)" "prognostic unfavourable (7.04e-4)" "unprognostic (2.73e-2)" "unprognostic (2.02e-3)" "unprognostic (2.19e-1)" "unprognostic (7.55e-2)" "unprognostic (1.99e-1)" "prognostic unfavourable (1.20e-5)" "unprognostic (1.70e-1)" "unprognostic (3.01e-2)" "unprognostic (1.31e-2)" "unprognostic (6.58e-2)" "unprognostic (1.27e-2)" "unprognostic (9.84e-2)" "unprognostic (9.49e-2)" "prognostic unfavourable (4.64e-4)" "unprognostic (1.85e-1)" 13.8 11.9 5.8 20.5 4.6 2.1 16.5 7.3 7.4 13.3 17.1 4.1 8.7 23.2 11.5 12.5 11.2 8.8 19.3 14.4 4.6 3.1 8.8 66.4 19.9 8.3 3.0 6.8 10.4 17.9 7.1 6.4 15.6 4.8 9.8 16.0 13.2 9.8 13.3 4.2 12.3 32.0 16.8 4.3 20.1 11.5 5.0 2.7 8.7 12.0 10.3 7.2 11.0 18.5 0.8 1.7 1.2 4.5 0.7 2.4 1.0 17.2 5.0 7.5 2.9 13.6 11.0 3.4 32.3 55.1 23.8 21.9 5.1 1.7 0.3 14.5 55.7 10.9 3.3 18.9 33.5 6.5 5.6 0.6 4.7 4.1 6.4 0.0 1.2 6.9 5.1 28.9 26.6 14.6 0.4 4.8 11.0 1.4 0.8 0.0 2.4 6.4 0.0 2.8 0.5 9.4 6.3 2.3 2.2 4.9 2.3 4.8 3.2 0.2 19.4 20.1 18.4 18.4 9.5 2.7 2.7 1.6 18.6 0.0 5.3 0.3 4.4 0.2 0.2 4.5 1.3 0.8 0.5 0.6 1.0 0.1 0.5 0.9 1.2 0.7 2.2 1.7 2.4 1.0 5.8 4.6 7.3 7.4 4.6 3.1 3.0 6.8 4.8 2.7 EXT2 SOTV ENSG00000151348 "Exostosin glycosyltransferase 2" Q93063 11 44095549-44245429 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease mutation, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078409 Supported "Golgi apparatus" 20000000 "Golgi apparatus" "HPA078409: " "unprognostic (5.87e-2)" "unprognostic (3.05e-3)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.42e-1)" "prognostic unfavourable (2.50e-4)" "unprognostic (1.77e-3)" "unprognostic (2.22e-2)" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (1.74e-3)" "unprognostic (3.70e-2)" "prognostic unfavourable (5.36e-6)" "unprognostic (7.07e-3)" "unprognostic (2.97e-1)" "unprognostic (3.85e-1)" "unprognostic (1.36e-2)" 24.5 19.5 11.6 17.2 18.5 6.6 25.8 14.5 23.0 26.8 25.0 15.5 17.5 17.6 37.1 25.5 16.7 26.0 23.4 22.7 11.7 13.0 19.2 36.3 22.3 16.8 11.8 12.3 29.3 21.8 25.7 17.3 58.0 16.2 23.7 20.6 22.9 24.7 22.8 16.9 20.2 34.0 35.0 12.2 18.7 19.3 20.0 11.4 16.2 24.7 16.7 13.0 20.2 23.2 6.7 14.9 13.0 12.0 17.8 17.6 9.8 12.9 17.9 9.7 30.2 44.8 33.0 13.4 40.2 50.3 23.8 32.4 12.7 8.9 8.9 18.3 47.0 20.6 10.4 28.5 28.8 17.9 14.3 8.2 9.4 9.7 17.7 8.2 17.8 25.6 18.9 14.4 22.5 33.8 11.0 16.2 17.3 9.9 5.7 5.0 10.4 12.8 7.2 27.8 4.5 13.7 12.3 7.0 7.8 25.4 10.4 6.7 17.3 8.8 30.5 32.2 21.1 31.5 25.7 7.3 9.5 6.5 21.2 6.4 34.3 9.3 11.9 13.0 15.6 12.0 17.6 6.4 12.5 14.4 14.9 6.7 11.9 11.7 2.6 17.8 8.5 5.1 9.6 9.8 11.6 18.5 14.5 23.0 11.7 13.0 11.8 12.3 16.2 11.4 EXTL3 "botv, REGR" ENSG00000012232 "Exostosin like glycosyltransferase 3" O43909 8 28600469-28755599 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025387 Approved "CAB025387: " "unprognostic (1.35e-1)" "unprognostic (1.31e-1)" "unprognostic (5.53e-2)" "unprognostic (1.19e-3)" "unprognostic (9.83e-2)" "unprognostic (2.41e-1)" "prognostic unfavourable (1.14e-5)" "unprognostic (4.25e-2)" "unprognostic (9.29e-3)" "unprognostic (1.05e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-3)" "prognostic favourable (2.47e-5)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (8.91e-2)" "unprognostic (1.39e-2)" 12.1 19.0 15.4 7.9 19.5 4.0 11.6 14.8 26.9 11.3 10.5 16.2 8.8 6.3 15.0 7.9 14.0 13.7 9.6 34.6 15.4 13.4 8.5 6.7 10.1 5.9 11.6 18.1 12.2 13.0 26.1 13.8 15.7 12.9 10.2 6.5 15.2 8.8 14.8 20.7 13.5 6.8 19.8 11.7 9.3 9.6 14.3 10.8 5.4 9.2 8.7 5.9 12.2 9.5 0.8 2.4 10.0 2.3 1.0 3.6 1.5 19.0 14.4 32.2 16.5 8.8 9.1 7.1 14.4 14.6 9.2 7.7 12.2 6.9 5.1 20.9 17.5 12.9 14.8 23.7 9.9 3.7 8.2 7.3 7.2 6.2 5.1 3.5 20.8 10.2 16.1 7.0 6.4 19.6 6.7 6.7 7.2 3.6 6.4 2.3 21.8 5.9 7.7 13.8 3.0 15.7 12.4 6.9 12.0 6.1 3.8 8.3 3.7 4.4 14.9 12.0 28.4 11.1 12.2 3.6 7.2 5.8 10.1 4.4 10.7 4.0 2.0 3.3 3.6 2.3 2.1 0.6 1.3 1.9 2.4 0.8 1.1 0.9 10.0 1.0 2.3 2.3 0.8 1.5 15.4 19.5 14.8 26.9 15.4 13.4 11.6 18.1 12.9 10.8 F11R "CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1" ENSG00000158769 "F11 receptor" Q9Y624 1 160995211-161021348 "CD markers, Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 37.7;HaCaT: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 44.5;neutrophil: 32.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 44.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004671, HPA043616, HPA061700" Enhanced Supported "Cell Junctions,Microtubules" 41000000 Microtubules "Cell Junctions" "CAB004671: AB_425964, HPA043616: , HPA061700: " "unprognostic (1.60e-2)" "unprognostic (5.78e-3)" "unprognostic (1.78e-3)" "unprognostic (2.24e-1)" "unprognostic (4.99e-2)" "unprognostic (4.89e-2)" "unprognostic (2.28e-1)" "unprognostic (2.55e-1)" "unprognostic (6.35e-2)" "unprognostic (1.98e-3)" "unprognostic (1.87e-2)" "unprognostic (1.24e-1)" "unprognostic (1.78e-1)" "unprognostic (2.50e-1)" "unprognostic (1.59e-1)" "unprognostic (9.72e-3)" "unprognostic (5.01e-2)" 20.7 13.3 3.0 9.6 3.6 6.4 11.8 2.0 3.5 14.5 36.3 3.9 21.4 20.5 8.6 11.2 41.5 12.3 30.5 10.0 3.4 3.2 35.9 69.8 55.0 10.4 3.6 1.8 10.9 37.9 18.5 16.3 61.8 5.3 17.8 19.5 5.7 59.3 23.7 9.0 22.0 59.8 4.9 4.0 27.0 18.8 11.0 3.3 8.1 52.2 25.8 29.9 16.8 19.7 1.3 7.0 44.5 8.9 2.2 3.8 6.6 28.5 3.7 1.1 0.3 0.8 0.0 23.3 0.1 0.0 1.0 1.0 26.4 37.7 2.1 19.4 0.0 49.4 5.8 24.5 1.5 1.6 4.3 6.0 1.5 12.0 1.1 5.6 17.8 0.3 31.0 0.1 8.2 23.2 8.1 0.6 0.1 12.3 1.7 3.2 19.7 5.3 2.6 0.0 9.2 16.6 21.7 8.2 2.1 6.9 29.7 6.1 32.3 10.0 13.9 0.1 0.7 0.1 0.2 6.9 13.6 0.7 4.4 5.5 1.8 7.6 8.9 44.5 3.8 4.5 2.0 1.3 3.5 2.3 7.0 0.9 3.4 2.7 32.2 2.2 3.4 5.3 1.5 6.6 3.0 3.6 2.0 3.5 3.4 3.2 3.6 1.8 5.3 3.3 F3 "CD142, TF" ENSG00000117525 "Coagulation factor III, tissue factor" P13726 1 94529225-94541800 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 115.2;HaCaT: 54.6;HBEC3-KT: 141.7;U-2197: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009438, HPA049292, HPA069132" Uncertain Approved Vesicles "Secreted to blood" 7733431000 Vesicles "CAB009438: AB_668005, HPA049292: , HPA069132: " "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (8.04e-2)" "unprognostic (1.64e-1)" "unprognostic (2.69e-2)" "unprognostic (1.23e-3)" "unprognostic (4.93e-2)" "unprognostic (8.00e-2)" "unprognostic (5.88e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavourable (2.02e-8)" "unprognostic (4.84e-2)" "unprognostic (4.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.08e-1)" 45.5 9.8 27.0 14.1 42.9 2.1 55.1 3.4 27.9 14.8 18.7 20.9 18.7 18.3 30.5 23.7 21.3 25.4 30.9 18.8 26.9 14.5 6.6 2.8 31.4 5.8 14.1 20.3 41.6 35.0 6.1 28.8 65.4 39.2 29.7 22.2 49.9 29.2 33.0 2.4 17.7 19.2 5.9 46.3 2.9 18.2 16.4 16.0 0.0 21.8 17.3 11.9 24.7 22.3 0.5 0.9 2.8 0.8 0.7 0.4 0.2 115.2 0.2 0.2 0.0 12.6 6.2 6.5 16.4 9.8 17.8 19.4 2.0 24.7 0.0 8.4 20.3 54.6 1.4 141.7 29.3 0.1 0.1 0.0 3.5 0.3 4.2 0.0 0.0 10.7 3.2 8.4 41.1 0.1 0.1 0.1 12.4 0.2 0.1 2.4 1.1 0.2 0.1 1.1 0.0 2.2 0.3 0.1 0.3 13.1 5.4 0.4 0.1 1.5 0.0 10.8 0.3 53.8 4.9 0.1 0.1 0.0 8.2 0.6 0.4 1.7 0.8 0.1 0.3 0.3 0.4 0.2 0.3 0.2 0.2 0.5 0.3 0.3 2.8 0.7 0.2 0.9 0.2 0.2 27.0 42.9 3.4 27.1 26.9 14.5 14.1 20.3 39.2 16.0 FAAH FAAH-1 ENSG00000117480 "Fatty acid amide hydrolase" O00519 1 46394265-46413848 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 22.0;RT4: 23.7;SK-BR-3: 12.3" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 19.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007425 Approved Approved Cytosol Cytosol "HPA007425: AB_1078820" "unprognostic (6.12e-2)" "unprognostic (2.04e-1)" "unprognostic (2.51e-2)" "prognostic favourable (1.51e-4)" "unprognostic (1.72e-1)" "unprognostic (4.97e-2)" "unprognostic (2.00e-1)" "unprognostic (6.64e-3)" "unprognostic (2.91e-2)" "unprognostic (2.33e-1)" "unprognostic (4.39e-3)" "unprognostic (9.86e-2)" "prognostic favourable (4.25e-5)" "prognostic favourable (3.63e-5)" "unprognostic (2.66e-1)" "unprognostic (9.97e-2)" "unprognostic (5.00e-3)" 6.1 7.7 11.2 2.5 22.0 7.9 7.9 20.4 21.9 6.9 15.0 40.7 10.1 18.0 3.1 8.2 4.9 10.6 4.6 2.9 14.7 11.7 12.0 18.3 6.7 2.1 19.1 19.3 2.7 18.2 15.1 10.6 3.5 17.6 33.3 12.8 7.4 12.8 8.6 7.1 10.1 17.8 2.3 23.6 2.0 14.3 30.9 18.8 5.6 24.9 3.5 3.5 5.7 4.2 0.1 6.0 19.1 4.7 0.3 0.4 0.9 2.7 0.7 0.4 0.5 0.7 0.5 22.0 0.6 0.3 0.3 0.5 4.0 6.6 0.1 2.3 0.4 9.3 0.4 1.3 0.1 1.2 3.1 0.0 0.1 1.9 0.4 0.8 1.6 0.4 6.3 0.2 0.8 0.0 0.1 0.5 0.0 5.9 0.4 1.2 1.8 0.2 0.5 0.2 0.1 5.2 23.7 2.8 2.1 3.2 12.3 0.1 8.5 8.2 0.0 0.0 0.3 0.6 0.4 1.2 0.5 0.3 0.1 7.5 0.2 0.0 4.7 19.1 0.3 1.2 0.1 0.0 0.3 0.1 5.7 0.1 0.4 0.4 0.2 0.3 0.6 6.0 0.1 0.9 11.2 22.0 20.4 21.9 14.7 11.7 19.1 19.3 17.6 18.8 FADS1 "D5D, FADS6, FADSD5, LLCDL1, TU12" ENSG00000149485 "Fatty acid desaturase 1" O60427 11 61799625-61829318 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 97.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042705 Approved "HPA042705: AB_10795709" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.29e-1)" "unprognostic (1.99e-1)" "unprognostic (8.17e-3)" "unprognostic (1.40e-1)" "unprognostic (1.99e-2)" "unprognostic (3.23e-3)" "unprognostic (7.88e-2)" "unprognostic (1.94e-2)" "unprognostic (4.10e-2)" "unprognostic (2.00e-1)" "prognostic unfavourable (1.95e-9)" "unprognostic (2.29e-2)" "unprognostic (3.59e-2)" "prognostic unfavourable (2.79e-4)" "prognostic unfavourable (1.33e-4)" 15.1 51.6 26.7 14.4 21.8 6.6 7.6 12.5 41.4 9.6 4.8 46.1 12.9 4.6 14.8 5.6 4.6 8.5 11.1 16.6 23.2 21.8 6.5 38.3 14.9 11.5 16.2 25.4 23.2 7.8 34.4 11.3 15.3 27.1 15.2 4.3 23.0 4.9 13.5 8.9 7.7 3.8 15.4 18.6 6.1 5.7 9.0 21.8 3.3 4.5 1.9 6.9 8.7 7.8 4.2 14.9 3.8 21.1 3.6 6.6 7.3 11.6 30.6 29.2 7.3 57.6 97.6 8.5 7.4 36.0 12.8 21.4 9.3 26.0 0.4 8.1 10.9 15.3 23.4 20.6 9.5 2.1 3.3 18.4 35.2 16.8 31.0 4.0 1.9 43.8 6.8 28.5 13.9 11.4 10.1 21.7 12.6 3.2 13.7 4.0 16.9 11.3 15.1 28.9 40.6 14.7 5.2 14.9 16.4 18.6 0.3 16.2 6.9 17.7 10.7 13.3 13.5 13.3 8.9 20.8 18.8 9.4 7.8 18.9 10.8 3.8 18.0 3.2 6.6 21.1 1.4 1.3 2.3 2.7 14.9 4.2 1.3 3.2 1.4 3.6 8.9 12.5 1.4 7.3 26.7 21.8 12.5 25.5 23.2 21.8 16.2 25.4 27.1 21.8 FADS2 "D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13" ENSG00000134824 "Fatty acid desaturase 2" O95864 11 61792980-61867354 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 204.5;seminal vesicle: 98.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 148.0;HBEC3-KT: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006741 Approved "HPA006741: AB_1078796" "unprognostic (2.37e-2)" "unprognostic (1.02e-1)" "unprognostic (8.34e-2)" "unprognostic (4.33e-3)" "unprognostic (4.63e-2)" "unprognostic (2.42e-2)" "unprognostic (4.51e-2)" "unprognostic (4.35e-3)" "unprognostic (2.01e-1)" "unprognostic (4.21e-2)" "unprognostic (8.95e-3)" "unprognostic (7.80e-2)" "prognostic unfavourable (1.00e-7)" "unprognostic (6.19e-2)" "unprognostic (1.34e-1)" "unprognostic (1.41e-2)" "prognostic unfavourable (3.42e-4)" 7.1 85.9 34.3 10.0 31.7 7.5 20.2 10.1 48.5 23.7 4.9 28.6 204.5 9.3 19.9 10.3 3.2 8.9 6.6 8.2 24.4 29.9 3.8 38.0 9.7 6.7 28.1 20.1 8.6 3.1 41.5 11.8 12.8 26.4 32.0 4.3 16.7 5.0 98.8 3.0 26.1 3.6 39.3 17.9 3.3 3.6 10.4 24.0 8.4 2.5 3.2 9.2 10.6 6.5 3.5 13.3 6.9 9.0 6.3 9.4 3.8 1.3 52.1 77.4 42.7 70.5 148.0 20.2 8.7 78.7 12.8 35.1 3.3 17.5 0.3 1.2 19.2 1.5 50.6 88.5 5.5 0.6 1.0 29.6 10.4 7.6 55.6 1.8 1.7 55.6 2.7 46.6 4.2 37.8 1.6 24.0 5.9 1.3 16.6 9.8 33.7 13.7 22.5 1.3 72.8 50.9 0.4 23.0 28.0 5.7 0.1 2.2 2.1 21.8 15.3 1.4 13.9 0.9 1.2 11.2 9.8 3.9 1.4 9.8 15.7 4.5 5.7 6.9 9.4 9.0 2.2 1.6 3.5 5.0 10.5 3.5 2.0 4.4 3.1 6.3 7.5 13.3 3.0 3.8 34.3 31.7 10.1 25.2 24.4 29.9 28.1 20.1 26.4 24.0 FAF2 "ETEA, KIAA0887, UBXD8, UBXN3B" ENSG00000113194 "Fas associated factor family member 2" Q96CS3 5 176447628-176510074 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065968, HPA071246, HPA073828" Approved Enhanced "Endoplasmic reticulum,Lipid droplets" "Lipid droplets" "Endoplasmic reticulum" "HPA065968: , HPA071246: , HPA073828: " "unprognostic (6.25e-3)" "unprognostic (9.61e-2)" "unprognostic (3.52e-3)" "unprognostic (1.02e-3)" "unprognostic (4.74e-2)" "unprognostic (4.47e-2)" "prognostic unfavourable (1.79e-4)" "prognostic unfavourable (1.38e-4)" "unprognostic (6.02e-2)" "unprognostic (2.68e-1)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (2.74e-3)" "unprognostic (9.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.56e-3)" "unprognostic (1.48e-1)" 21.1 27.7 17.5 16.5 28.5 21.7 20.8 25.4 28.3 21.5 19.2 24.4 17.4 17.2 22.3 21.5 23.0 21.0 18.0 15.1 16.8 18.9 20.5 34.2 17.8 17.2 16.4 15.9 29.3 25.9 32.4 31.5 32.0 25.5 22.3 23.1 24.6 20.1 18.6 15.3 25.5 22.6 22.2 14.5 21.0 18.8 31.9 14.2 30.0 23.1 15.2 24.3 20.7 17.5 7.2 10.9 10.0 14.9 12.4 13.1 7.5 13.9 15.9 15.8 17.5 22.4 17.9 21.6 18.3 21.0 20.9 22.7 20.6 25.3 12.2 20.7 19.3 21.6 22.6 46.4 29.0 48.6 12.4 8.0 16.2 10.0 22.9 17.3 10.5 23.5 20.5 25.5 21.3 17.3 11.4 16.7 19.9 23.2 15.1 9.2 12.7 13.5 15.0 13.7 13.6 17.7 18.5 14.0 15.0 22.3 19.4 20.2 22.8 13.8 19.3 28.8 15.6 15.8 24.4 14.4 15.3 16.0 18.2 12.4 25.1 10.0 9.2 6.1 10.0 7.6 12.2 7.2 8.2 10.5 10.9 7.0 10.7 9.5 7.8 12.4 14.9 7.5 13.1 7.5 17.5 28.5 25.4 28.3 16.8 18.9 16.4 15.9 25.5 14.2 FAM105A "FLJ11127, NET20" ENSG00000145569 "Family with sequence similarity 105 member A" Q9NUU6 5 14581775-14615007 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35.4" "Cell line enhanced" "Detected in many" "HeLa: 13.8;HMC-1: 43.3;THP-1: 12.0;U-937: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046638 Uncertain Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA046638: " "unprognostic (1.47e-1)" "unprognostic (6.64e-3)" "unprognostic (1.92e-2)" "unprognostic (1.15e-3)" "unprognostic (6.26e-2)" "unprognostic (1.13e-3)" "unprognostic (2.33e-2)" "unprognostic (2.27e-2)" "unprognostic (6.44e-2)" "unprognostic (2.42e-1)" "prognostic favourable (1.02e-4)" "unprognostic (2.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.38e-2)" "prognostic unfavourable (7.62e-4)" "unprognostic (3.14e-1)" "unprognostic (8.79e-3)" 5.1 3.5 4.0 7.9 4.9 35.4 5.2 3.1 5.1 6.3 15.4 9.0 4.5 8.3 3.0 5.6 2.9 3.1 4.1 3.0 3.9 4.3 5.2 1.9 28.8 16.7 6.1 3.8 4.0 13.3 1.9 8.7 6.7 7.9 12.6 17.3 10.3 3.1 13.5 1.3 2.6 13.7 3.3 10.8 13.2 5.4 4.4 4.1 3.5 27.2 3.0 6.2 7.1 5.8 0.1 26.7 6.9 26.2 14.1 9.6 16.2 0.0 0.6 1.2 0.0 0.2 0.0 5.2 1.5 1.4 0.4 0.7 1.9 1.3 0.0 0.8 0.7 0.1 2.6 1.2 0.6 0.8 3.6 3.4 13.8 0.3 1.3 0.0 43.3 0.1 0.3 0.2 0.0 0.0 0.0 5.4 0.1 1.0 0.0 1.2 1.9 9.2 0.3 0.5 1.5 0.0 10.4 4.5 5.0 0.7 0.4 0.0 0.4 12.0 0.0 0.6 3.4 0.2 1.1 0.0 0.0 0.0 0.7 20.5 0.2 0.0 26.2 0.1 4.5 12.4 6.0 0.1 5.7 6.1 26.7 0.1 7.8 7.5 6.9 14.1 9.4 19.7 9.6 16.2 4.0 4.9 3.1 5.1 3.9 4.3 6.1 3.8 7.9 4.1 FAM162A "C3orf28, E2IG5" ENSG00000114023 "Family with sequence similarity 162 member A" Q96A26 3 122384176-122412334 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035856, HPA058113" Approved Enhanced Mitochondria,Cytosol 29000 "Mitochondria, Cytosol" "HPA035856: AB_10611965, HPA058113: AB_2683609" "unprognostic (1.17e-2)" "unprognostic (1.42e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" "unprognostic (3.99e-1)" "unprognostic (7.84e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (5.91e-3)" "unprognostic (8.74e-2)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (4.10e-2)" "prognostic favourable (3.93e-4)" 13.6 32.8 24.9 18.6 49.9 14.1 18.7 10.7 44.8 21.8 57.8 11.5 19.6 22.7 17.0 25.5 58.7 13.8 25.4 54.2 40.2 21.7 35.9 78.1 12.2 16.5 23.6 27.7 30.2 71.5 24.6 16.1 7.3 31.0 27.3 61.3 16.2 17.7 23.1 56.6 29.2 21.2 27.2 24.4 10.9 25.7 16.9 18.8 8.6 17.9 48.6 16.7 34.6 36.0 26.8 29.4 25.3 24.4 16.4 33.1 12.9 30.4 6.5 9.7 18.1 17.9 16.6 5.0 12.5 11.2 11.9 30.5 16.3 14.0 33.2 21.8 4.3 21.4 17.6 30.4 31.9 17.1 13.2 26.9 11.3 29.1 11.8 26.2 9.6 19.2 16.0 11.3 24.0 15.8 18.1 13.3 17.0 11.9 26.7 31.9 14.3 34.7 16.1 13.9 43.2 34.5 74.4 14.6 11.7 9.3 22.2 25.5 13.9 13.0 11.1 11.8 8.5 6.9 12.9 26.5 9.0 33.7 35.1 25.7 5.4 2.6 9.3 25.3 21.7 23.0 32.1 26.8 29.8 27.1 29.4 23.9 32.6 33.1 3.0 16.4 24.4 24.6 27.1 12.9 24.9 49.9 10.7 44.8 40.2 21.7 23.6 27.7 31.0 18.8 FAM162B "bA86F4.2, C6orf189" ENSG00000183807 "Family with sequence similarity 162 member B" Q5T6X4 6 116752197-116765723 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 51.6" "Cell line enhanced" "Detected in some" "BJ: 6.8;BJ hTERT+: 18.6;BJ hTERT+ SV40 Large T+ RasG12V: 18.0;HHSteC: 5.2;HSkMC: 6.3" "Cancer enriched" "Detected in many" 18 "testis cancer: 32.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "olfactory region: 6.9" "HPA036112, HPA060342" Enhanced "HPA036112: AB_10696649, HPA060342: AB_2684258" "unprognostic (1.81e-1)" "unprognostic (5.65e-3)" "unprognostic (1.54e-1)" "unprognostic (3.38e-1)" "unprognostic (5.45e-2)" "unprognostic (1.86e-5)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-2)" "unprognostic (2.44e-2)" "unprognostic (7.32e-2)" "unprognostic (6.27e-3)" "prognostic unfavourable (2.48e-4)" "unprognostic (1.22e-2)" "unprognostic (1.72e-1)" "unprognostic (2.73e-3)" "unprognostic (4.34e-2)" 11.4 12.5 2.2 1.0 4.0 0.5 11.2 0.5 8.6 13.0 3.8 1.1 4.8 1.1 7.8 7.0 6.5 6.7 4.9 7.7 2.0 1.8 4.3 1.0 14.6 2.4 2.7 5.8 7.7 1.5 2.5 6.1 51.6 1.9 9.7 2.2 6.0 6.5 11.8 7.3 2.5 1.9 3.7 1.3 0.5 3.0 2.9 0.5 0.0 8.7 5.2 1.4 5.7 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 6.8 18.6 3.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 6.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.0 0.5 8.6 2.0 1.8 2.7 5.8 1.9 0.5 FAM163B C9orf166 ENSG00000196990 "Family with sequence similarity 163 member B" P0C2L3 9 133578415-133586197 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 41.7" "Cell line enriched" "Detected in some" 21 "SH-SY5Y: 39.0" "Cancer enriched" "Detected in some" 6 "glioma: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067336 Supported Approved "Nuclear bodies,Plasma membrane,Cytosol" "Nuclear bodies, Plasma membrane, Cytosol" "HPA067336: " "unprognostic (2.94e-2)" "unprognostic (6.87e-3)" "unprognostic (2.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.23e-2)" "unprognostic (9.05e-2)" "unprognostic (1.02e-2)" "unprognostic (3.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (5.75e-4)" "unprognostic (1.07e-1)" "unprognostic (9.54e-2)" "unprognostic (1.65e-1)" "unprognostic (4.73e-4)" 0.1 8.2 10.0 0.0 2.7 0.0 0.0 3.2 41.7 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.4 1.2 6.1 3.9 0.1 2.7 0.0 1.3 3.3 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.5 0.1 0.0 0.0 0.0 1.8 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM171A1 "C10orf38, FLJ12884" ENSG00000148468 "Family with sequence similarity 171 member A1" Q5VUB5 10 15211643-15371062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.9" "Cell line enhanced" "Detected in many" "TIME: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.6;MAIT T-cell: 6.8;memory CD4 T-cell: 3.8;memory CD8 T-cell: 3.3;naive CD4 T-cell: 7.4;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 23 "T-cells: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051345 Approved Approved "Nucleoplasm,Plasma membrane" 96000 "Plasma membrane" Nucleoplasm "HPA051345: " "unprognostic (3.60e-2)" "unprognostic (7.15e-2)" "unprognostic (2.21e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (4.11e-2)" "unprognostic (9.84e-2)" "unprognostic (9.19e-2)" "unprognostic (2.28e-1)" "unprognostic (3.97e-2)" "unprognostic (3.09e-2)" "unprognostic (1.87e-1)" "prognostic favourable (2.71e-5)" "unprognostic (3.08e-1)" "unprognostic (1.86e-1)" "prognostic unfavourable (4.90e-6)" "unprognostic (3.28e-2)" 6.9 3.7 22.1 5.5 37.9 0.2 4.6 11.1 31.8 8.8 16.1 25.3 6.5 13.7 9.7 4.8 4.7 11.8 9.3 7.0 24.1 17.5 17.8 6.2 5.3 3.7 25.1 14.3 10.9 13.8 8.9 1.9 2.9 21.5 8.4 12.9 2.5 10.0 9.4 5.1 2.4 8.9 9.0 43.9 8.5 10.3 2.4 21.9 0.6 4.3 1.1 4.6 6.0 6.2 0.0 0.0 0.0 0.0 0.3 7.4 1.3 0.0 6.2 12.9 4.9 5.2 9.9 0.1 7.8 1.5 3.9 3.4 1.1 7.3 0.0 9.4 20.2 0.6 9.1 0.1 4.5 2.5 14.4 18.1 2.0 17.9 5.7 0.0 14.7 7.8 1.9 10.7 1.5 19.7 7.1 0.0 12.5 0.5 3.1 0.0 12.3 3.5 12.2 6.8 1.9 4.9 0.0 8.9 11.4 4.3 0.1 0.0 0.0 0.2 42.0 5.4 22.9 19.6 8.2 2.6 0.7 0.0 12.0 0.0 4.1 0.0 0.0 0.0 2.6 0.0 6.8 0.0 3.8 3.3 0.0 0.0 7.4 3.7 0.0 0.3 0.0 0.0 0.7 1.3 22.1 37.9 11.1 23.1 24.1 17.5 25.1 14.3 21.5 21.9 FAM171A2 MGC34829 ENSG00000161682 "Family with sequence similarity 171 member A2" A8MVW0 17 44353215-44363875 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5" "Cell line enhanced" "Detected in many" "HEK 293: 10.4;REH: 18.1;SCLC-21H: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019770 Uncertain "HPA019770: AB_1848383" "unprognostic (1.28e-2)" "unprognostic (2.07e-2)" "unprognostic (4.14e-3)" "unprognostic (8.47e-2)" "unprognostic (9.98e-2)" "unprognostic (1.92e-1)" "unprognostic (1.62e-4)" "unprognostic (5.76e-2)" "unprognostic (1.98e-2)" "unprognostic (1.01e-1)" "unprognostic (7.01e-3)" "unprognostic (3.00e-1)" "unprognostic (2.43e-3)" "unprognostic (1.06e-1)" "unprognostic (1.38e-1)" "unprognostic (2.36e-2)" "unprognostic (4.76e-2)" 3.1 3.3 10.3 1.2 12.8 1.0 1.0 13.9 26.5 6.4 1.2 1.7 1.1 1.1 4.1 7.9 2.1 5.4 2.6 1.3 8.6 8.8 1.7 1.0 1.4 1.3 3.7 13.2 5.5 1.1 2.3 7.3 1.8 4.6 2.2 0.9 3.1 1.5 3.2 1.1 2.0 1.2 1.6 1.7 1.4 1.2 1.3 2.2 0.0 2.6 0.0 1.2 1.5 1.9 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 1.8 5.5 7.6 0.9 1.1 3.8 2.0 0.3 1.7 2.2 0.2 0.1 2.4 4.8 0.5 0.1 1.9 0.5 0.2 2.0 10.4 0.7 0.1 1.0 0.6 0.1 0.4 1.3 0.2 0.6 0.0 2.6 1.6 0.0 0.6 6.2 5.6 0.9 8.1 3.9 18.1 3.6 1.4 0.3 0.4 13.0 9.7 0.7 0.1 0.8 2.1 1.3 1.7 2.5 4.9 4.2 0.7 0.8 0.2 0.9 0.2 0.9 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.8 13.9 26.5 8.6 8.8 3.7 13.2 4.6 2.2 FAM171B "FLJ34104, KIAA1946" ENSG00000144369 "Family with sequence similarity 171 member B" Q6P995 2 186693971-186765965 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.0" "Cell line enhanced" "Detected in many" "Karpas-707: 24.9;U-138 MG: 17.3" "Cancer enriched" "Detected in many" 5 "glioma: 15.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010639, HPA013434" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA010639: AB_1852447, HPA013434: AB_2262499" "unprognostic (2.52e-1)" "unprognostic (7.75e-3)" "unprognostic (1.27e-1)" "unprognostic (1.04e-2)" "unprognostic (4.03e-2)" "unprognostic (9.43e-2)" "unprognostic (6.78e-3)" "unprognostic (2.68e-1)" "unprognostic (1.88e-2)" "unprognostic (1.52e-1)" "unprognostic (4.24e-3)" "unprognostic (1.47e-1)" "prognostic unfavourable (9.51e-7)" "unprognostic (4.63e-3)" "unprognostic (1.52e-1)" "unprognostic (2.24e-3)" "prognostic unfavourable (5.03e-4)" 3.1 13.1 32.0 2.0 32.6 1.1 3.7 12.7 62.0 6.7 2.1 5.8 0.1 1.6 7.1 2.6 2.4 3.2 4.9 1.9 25.5 13.1 1.8 1.1 2.0 1.6 9.1 23.0 9.7 1.6 11.4 13.4 3.5 9.7 3.2 2.5 1.4 17.8 2.8 1.3 3.8 1.9 4.5 8.4 2.0 2.4 1.6 10.4 0.0 2.7 0.0 1.7 2.9 1.8 0.3 1.3 1.1 1.7 2.4 1.1 0.5 2.3 2.7 4.1 12.8 12.3 9.3 0.1 2.5 4.5 3.1 4.5 7.5 12.3 0.0 0.9 7.2 0.3 5.6 2.4 4.5 0.0 3.2 2.8 1.3 0.0 1.0 0.8 1.0 11.8 1.0 2.4 1.9 6.8 0.0 24.9 5.9 1.6 1.6 0.0 5.4 2.8 0.0 8.0 0.5 4.9 8.8 12.9 7.0 1.3 0.8 3.4 1.0 0.6 4.0 17.3 2.3 0.3 1.6 6.6 6.4 0.0 5.3 0.0 2.4 1.1 0.7 0.3 0.8 1.7 0.7 0.3 1.0 0.9 0.6 0.2 0.6 1.1 0.4 2.4 1.6 1.3 0.1 0.5 32.0 32.6 12.7 30.4 25.5 13.1 9.1 23.0 9.7 10.4 FAM173A "C16orf24, MGC2494" ENSG00000103254 "Family with sequence similarity 173 member A" Q9BQD7 16 720581-722601 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046262 Approved Approved Cytosol Cytosol "HPA046262: AB_10963070" "unprognostic (3.94e-2)" "unprognostic (8.78e-2)" "unprognostic (1.55e-1)" "unprognostic (2.61e-1)" "unprognostic (6.54e-2)" "prognostic favourable (8.88e-4)" "unprognostic (2.11e-1)" "unprognostic (4.49e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (4.02e-2)" "unprognostic (5.70e-2)" "prognostic favourable (4.24e-5)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (9.28e-2)" "unprognostic (3.60e-3)" 16.0 10.4 15.6 10.3 9.1 7.3 9.6 8.9 21.5 4.8 15.5 8.2 9.3 19.1 6.5 8.3 6.1 5.2 10.6 11.1 13.6 11.5 18.6 15.8 7.5 7.5 11.3 12.2 4.3 10.2 8.5 13.4 5.8 9.2 8.4 3.5 6.5 15.1 8.6 37.3 6.2 14.5 5.6 9.5 15.0 19.3 21.8 7.9 8.6 7.8 11.1 7.1 5.9 8.9 9.0 6.0 5.3 6.8 6.3 18.0 4.2 6.3 4.2 0.8 2.3 0.1 0.3 10.1 5.5 1.4 1.3 1.5 4.2 5.3 8.1 9.9 0.6 9.9 0.8 2.7 0.3 18.0 11.2 3.4 4.4 4.4 1.9 5.7 4.7 0.7 2.0 0.6 1.6 0.5 7.2 3.7 1.1 10.3 0.9 13.7 3.2 13.8 3.4 2.0 15.3 3.5 2.3 3.6 9.5 2.9 4.7 9.1 5.2 5.1 4.6 1.2 9.9 3.5 3.8 32.9 14.7 8.8 2.5 4.2 3.1 0.0 6.8 5.3 7.3 3.9 16.5 9.0 5.8 12.9 4.4 9.0 5.9 18.0 0.8 6.3 4.8 6.0 12.5 4.2 15.6 9.1 8.9 21.5 13.6 11.5 11.3 12.2 9.2 7.9 FAM173B JS-2 ENSG00000150756 "Family with sequence similarity 173 member B" Q6P4H8 5 10226330-10249897 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074513 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA074513: " "prognostic unfavourable (1.32e-6)" "unprognostic (8.87e-3)" "unprognostic (1.23e-3)" "unprognostic (1.20e-1)" "unprognostic (9.24e-2)" "unprognostic (1.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-2)" "unprognostic (6.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-1)" "unprognostic (9.06e-2)" "unprognostic (5.61e-2)" "unprognostic (1.03e-1)" 10.1 14.6 17.7 10.4 16.2 3.3 9.0 20.1 18.6 7.9 9.7 12.2 8.8 7.7 9.3 12.6 7.9 9.2 9.9 8.8 14.9 18.1 12.1 13.1 7.5 8.9 18.8 9.9 8.6 6.8 19.2 22.8 5.3 18.6 12.2 12.4 10.3 8.8 12.3 7.3 7.4 7.1 10.1 13.2 5.6 7.8 6.5 18.9 8.4 12.7 6.2 8.7 11.6 13.9 5.7 8.9 11.6 9.7 5.1 8.6 4.5 7.3 8.0 7.9 7.5 8.7 6.6 2.7 11.3 5.7 6.0 4.7 8.4 12.1 9.4 20.3 8.0 5.5 12.1 10.3 9.8 15.6 7.4 7.8 27.3 6.3 5.9 12.0 9.4 6.1 11.4 9.9 3.4 11.6 10.9 9.6 17.0 6.8 5.9 10.7 4.8 9.7 8.2 5.5 8.3 15.4 9.6 6.3 6.3 39.7 14.0 6.3 14.3 12.6 6.4 12.9 7.6 7.8 8.2 6.5 7.2 10.5 8.1 13.8 5.2 5.0 9.3 11.6 7.0 9.7 8.4 5.7 6.7 8.5 8.9 4.2 6.8 8.6 3.4 5.1 7.7 3.1 7.8 4.5 17.7 16.2 20.1 18.6 14.9 18.1 18.8 9.9 18.6 18.9 FAM174A "NS5ATP6, TMEM157, UNQ1912" ENSG00000174132 "Family with sequence similarity 174 member A" Q8TBP5 5 100535305-100586741 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 8 "neutrophil: 28.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019539 Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA019539: AB_2293743" "unprognostic (2.34e-1)" "unprognostic (2.90e-1)" "unprognostic (1.29e-1)" "unprognostic (9.02e-3)" "prognostic unfavourable (2.57e-6)" "unprognostic (5.55e-3)" "unprognostic (3.06e-1)" "unprognostic (2.60e-1)" "unprognostic (3.60e-2)" "unprognostic (1.30e-2)" "unprognostic (1.73e-2)" "unprognostic (7.69e-2)" "prognostic favourable (5.48e-4)" "unprognostic (1.74e-1)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.45e-1)" 15.6 24.6 18.8 8.3 21.0 3.0 15.3 14.2 26.8 11.1 12.0 16.5 14.0 11.8 11.3 15.2 18.0 35.9 9.5 17.3 22.0 25.0 18.3 15.2 17.6 5.5 19.3 18.2 9.1 26.8 23.6 21.9 15.6 24.1 19.5 9.1 16.6 16.5 13.7 38.8 20.4 10.7 9.6 19.4 10.1 15.5 37.3 12.2 4.4 14.3 17.0 9.6 9.9 11.7 1.5 2.2 28.0 2.7 2.5 2.7 1.6 4.9 5.3 2.1 6.8 5.3 4.2 7.6 11.5 6.4 4.7 6.4 1.0 6.5 0.9 23.4 4.9 4.3 1.8 7.4 3.4 6.0 5.4 0.6 9.1 3.0 7.2 2.5 6.3 5.5 17.7 3.6 2.7 7.0 1.8 6.9 7.8 10.0 0.7 5.4 1.1 14.3 1.7 8.2 8.6 8.2 6.0 4.3 11.6 8.0 7.2 6.3 7.0 5.6 8.0 6.0 3.7 9.5 9.0 21.7 28.4 1.1 7.4 3.4 5.2 3.6 2.5 3.4 1.8 2.7 2.7 1.4 1.8 2.2 2.2 1.5 1.6 2.1 28.0 2.5 2.7 2.2 2.2 1.6 18.8 21.0 14.2 26.8 22.0 25.0 19.3 18.2 24.1 12.2 FAM174B "LOC400451, MGC102891" ENSG00000185442 "Family with sequence similarity 174 member B" Q3ZCQ3 15 92617443-92809884 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 57.6" "Cell line enhanced" "Detected in many" "CACO-2: 21.0;MCF7: 25.3;RPMI-8226: 29.7;RT4: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Group enriched" "Detected in many" 7 "dendritic cells: 4.5;granulocytes: 3.7;T-cells: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015306 Approved Approved "Intermediate filaments" "Intermediate filaments" "HPA015306: " "unprognostic (3.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "prognostic favourable (9.03e-5)" "unprognostic (4.68e-2)" "unprognostic (1.63e-1)" "unprognostic (8.35e-2)" "unprognostic (8.23e-3)" "unprognostic (7.67e-3)" "unprognostic (5.05e-3)" "unprognostic (6.60e-2)" "unprognostic (1.33e-1)" "unprognostic (4.67e-2)" "unprognostic (2.01e-1)" "unprognostic (6.64e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-2)" 6.1 3.5 5.9 3.3 6.3 0.7 17.9 3.9 8.6 10.9 6.2 2.9 21.5 3.6 5.1 4.9 5.2 14.6 6.4 4.2 7.4 8.3 3.3 4.0 16.3 5.5 6.5 6.2 10.2 57.6 2.5 15.9 4.6 6.7 19.4 9.2 7.7 47.7 10.8 16.3 4.9 5.0 4.6 4.9 3.2 17.3 9.7 3.6 4.2 28.9 3.9 4.8 24.4 15.3 0.4 4.5 3.7 0.9 0.7 10.9 0.7 0.0 3.5 2.3 0.7 0.0 0.0 0.2 1.3 6.2 0.0 0.0 21.0 2.4 0.3 6.0 0.1 0.1 3.9 0.1 0.0 0.1 1.8 0.2 0.3 0.2 0.4 0.3 0.9 0.3 0.1 0.0 0.0 3.0 0.3 15.6 3.5 25.3 0.7 0.0 11.3 0.0 2.4 6.5 29.7 1.5 62.7 1.4 1.1 1.8 12.1 3.8 9.7 2.1 0.0 0.0 0.4 0.1 2.9 0.4 4.6 0.7 0.0 0.2 1.5 1.1 0.8 0.9 0.2 0.9 0.4 0.4 2.5 0.0 0.6 0.3 2.8 3.3 3.7 0.7 0.0 4.5 10.9 0.7 5.9 6.3 3.9 8.6 7.4 8.3 6.5 6.2 6.7 3.6 FAM187A ENSG00000214447 "Family with sequence similarity 187 member A" A6NFU0 17 44899712-44905390 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.2;testis: 37.0" "Cell line enhanced" "Detected in many" "A549: 8.7;RPTEC TERT1: 12.3;U-87 MG: 13.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.9" "Low lineage specificity" "Detected in many" "HPA022794, HPA043131" Approved Approved Cytosol Cytosol "HPA022794: AB_1848384, HPA043131: AB_10796686" 0.7 1.3 5.8 0.6 8.9 0.7 1.4 1.0 5.0 2.5 0.9 3.1 1.7 0.3 1.9 2.7 0.5 21.2 3.0 0.6 5.4 6.7 3.7 0.5 2.0 0.7 5.3 4.1 3.7 1.6 2.2 2.2 0.3 4.5 1.1 1.0 1.7 1.3 1.9 0.4 0.6 0.6 1.1 4.2 0.4 0.6 37.0 1.1 0.3 4.5 0.2 0.6 0.9 0.3 0.8 1.8 1.9 2.9 0.2 0.8 2.0 1.7 8.7 2.2 1.7 2.7 3.0 1.4 0.5 4.2 2.4 3.0 2.6 4.6 0.2 1.4 1.6 5.2 0.5 2.2 1.1 5.2 2.1 0.7 3.6 0.7 1.1 1.0 0.7 0.4 3.0 4.7 1.0 1.1 1.6 0.1 0.9 1.1 0.1 1.3 0.7 1.2 0.8 0.2 0.4 12.3 0.8 5.8 1.3 0.5 0.1 0.7 6.2 1.0 0.6 1.0 2.2 1.2 1.0 0.1 0.2 0.4 13.9 0.8 1.1 0.0 2.9 1.9 0.2 0.8 0.0 0.0 0.0 0.8 1.8 0.8 0.0 0.1 0.0 0.2 0.3 0.0 0.6 2.0 5.8 8.9 1.0 5.0 5.4 6.7 5.3 4.1 4.5 1.1 FAM189A2 "C9orf61, X123" ENSG00000135063 "Family with sequence similarity 189 member A2" Q15884 9 69324567-69392558 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 40.1;thyroid gland: 38.0" "Cell line enhanced" "Detected in some" "BEWO: 5.3;NTERA-2: 8.3;RPTEC TERT1: 3.1;RT4: 3.6;SK-MEL-30: 8.0" "Cancer enhanced" "Detected in many" "thyroid cancer: 22.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029411, HPA057207" Approved "HPA029411: AB_10602338, HPA057207: " "unprognostic (2.04e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "prognostic favourable (1.16e-6)" "unprognostic (2.24e-1)" "unprognostic (3.93e-2)" "unprognostic (3.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.09e-1)" "unprognostic (2.71e-3)" "unprognostic (7.84e-2)" "unprognostic (1.07e-2)" "prognostic favourable (1.75e-5)" "unprognostic (3.42e-1)" "unprognostic (2.41e-1)" "unprognostic (4.82e-2)" "unprognostic (1.14e-1)" 3.2 3.1 9.2 1.5 11.6 0.8 13.2 4.5 12.2 25.6 3.9 11.4 8.3 1.8 5.6 2.5 5.3 6.0 2.9 11.5 10.3 4.1 2.0 0.8 21.4 1.3 7.2 4.9 15.0 5.2 8.5 4.7 2.2 20.0 8.9 1.9 6.7 6.4 5.0 40.1 6.7 2.3 6.0 17.1 1.1 9.0 1.5 9.3 3.7 38.0 6.0 1.6 4.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.1 1.1 0.0 0.0 0.9 2.7 0.1 2.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 8.3 0.0 0.0 0.2 0.0 3.1 3.6 0.0 0.1 0.0 0.0 8.0 0.2 0.0 1.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 11.6 4.5 12.2 10.3 4.1 7.2 4.9 20.0 9.3 FAM198B "C4orf18, DKFZp434L142, ENED, FLJ38155" ENSG00000164125 "Family with sequence similarity 198 member B" Q6UWH4 4 158124474-158173318 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 83.8" "Cell line enhanced" "Detected in many" "ASC diff: 21.1;ASC TERT1: 39.8;HSkMC: 45.6;HUVEC TERT2: 50.9;WM-115: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 23.8;intermediate monocyte: 14.8;myeloid DC: 7.6;non-classical monocyte: 6.8" "Group enriched" "Detected in many" 37 "dendritic cells: 7.6;monocytes: 23.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007227 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA007227: AB_1847689" "unprognostic (4.87e-2)" "unprognostic (7.79e-2)" "unprognostic (6.60e-3)" "unprognostic (9.42e-3)" "unprognostic (2.37e-2)" "unprognostic (7.47e-2)" "unprognostic (2.13e-2)" "unprognostic (7.49e-2)" "unprognostic (9.20e-3)" "unprognostic (1.71e-1)" "unprognostic (1.60e-1)" "unprognostic (1.89e-1)" "unprognostic (3.25e-3)" "unprognostic (3.74e-3)" "unprognostic (3.85e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-2)" 24.1 83.8 13.9 12.9 12.6 0.9 15.9 22.9 16.0 16.7 8.9 12.1 6.2 4.5 27.5 13.2 6.0 10.6 12.6 25.8 24.2 9.0 4.2 2.9 6.9 7.1 18.6 20.2 50.1 4.8 4.4 2.7 9.5 12.4 8.3 8.1 4.2 7.9 10.8 3.8 3.5 6.3 23.9 25.9 15.7 7.5 7.0 17.5 0.0 8.2 3.1 2.3 14.2 7.3 0.0 7.6 0.4 23.8 0.0 0.0 7.3 3.2 2.6 1.6 0.3 21.1 39.8 3.0 0.8 0.6 0.1 1.0 3.4 1.2 0.0 0.1 1.3 0.0 18.6 4.9 0.5 0.0 0.0 0.2 0.0 9.5 14.1 0.1 0.0 45.6 1.2 6.5 0.7 50.9 3.3 0.0 9.4 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.1 0.1 0.0 0.0 7.4 2.1 1.4 0.0 2.4 4.3 4.7 2.5 1.6 0.0 0.0 11.6 0.6 0.0 19.6 0.0 23.8 0.0 0.0 14.8 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.4 0.0 6.8 0.3 0.0 7.3 13.9 12.6 22.9 16.0 24.2 9.0 18.6 20.2 12.4 17.5 FAM205A C9orf144B ENSG00000205108 "Family with sequence similarity 205 member A" Q6ZU69 9 34723055-34729467 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 243 "testis: 24.3" "Cell line enhanced" "Detected in single" "THP-1: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA071267 Enhanced "HPA071267: " "unprognostic (2.25e-1)" "unprognostic (3.66e-3)" "unprognostic (6.29e-3)" "unprognostic (1.90e-1)" "unprognostic (2.73e-3)" "unprognostic (7.82e-2)" "unprognostic (9.61e-2)" "unprognostic (6.41e-2)" "unprognostic (4.78e-1)" "unprognostic (7.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM209B "C20orf107, dJ1153D9.4" ENSG00000213714 "Family with sequence similarity 209 member B" Q5JX69 20 56533246-56536520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 40.8" "Cell line enhanced" "Detected in many" "U-266/70: 4.9" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 3.4" "Low lineage specificity" "Detected in many" HPA042144 Enhanced "HPA042144: AB_10794414" "unprognostic (2.93e-1)" "unprognostic (6.90e-2)" "unprognostic (9.49e-3)" "unprognostic (4.96e-3)" "unprognostic (1.72e-1)" "unprognostic (3.77e-1)" "unprognostic (1.72e-1)" "unprognostic (7.77e-2)" "unprognostic (3.63e-2)" "unprognostic (1.43e-1)" "unprognostic (4.59e-4)" "unprognostic (3.47e-1)" "unprognostic (2.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.55e-1)" "unprognostic (7.13e-2)" "unprognostic (1.48e-4)" 0.2 0.0 0.0 0.2 0.1 4.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.3 0.3 0.2 0.0 0.0 0.9 0.1 40.8 0.0 0.3 0.0 0.0 1.0 0.8 3.4 1.1 0.0 2.1 0.4 0.0 2.7 0.7 0.0 0.0 0.3 0.4 1.0 1.8 2.3 0.9 1.7 0.1 0.3 1.8 1.1 1.4 1.2 0.7 2.1 0.4 1.1 1.1 0.0 1.1 0.0 2.2 4.1 1.3 2.0 0.2 1.4 0.0 0.2 1.9 0.0 2.6 0.8 2.0 0.5 1.4 0.7 0.8 0.2 1.4 0.9 1.7 0.4 0.9 3.3 0.6 1.4 0.6 0.0 0.3 0.6 1.7 0.1 4.9 4.4 0.9 0.3 0.9 0.3 0.0 1.1 3.4 2.1 0.4 0.3 0.0 0.1 1.3 0.8 1.0 0.7 0.0 1.8 0.0 0.7 0.0 0.0 0.4 FAM210A "C18orf19, HsT2329, MGC24180" ENSG00000177150 "Family with sequence similarity 210 member A" Q96ND0 18 13663347-13726663 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014324, HPA051564" Uncertain Approved "Nucleoplasm,Golgi apparatus,Mitochondria" "Nucleoplasm, Golgi apparatus, Mitochondria" "HPA014324: AB_2668972, HPA051564: AB_2681536" "unprognostic (1.32e-1)" "unprognostic (6.98e-2)" "unprognostic (5.78e-2)" "unprognostic (9.18e-3)" "unprognostic (4.13e-2)" "prognostic unfavourable (8.14e-4)" "unprognostic (2.23e-3)" "unprognostic (1.11e-2)" "unprognostic (2.26e-1)" "unprognostic (5.53e-3)" "unprognostic (6.79e-3)" "unprognostic (2.98e-2)" "unprognostic (3.27e-3)" "unprognostic (7.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" "unprognostic (4.82e-2)" 10.5 8.1 7.5 8.9 7.1 4.0 9.4 8.3 8.8 5.8 9.9 7.2 5.8 11.5 6.6 4.4 13.5 5.7 5.4 27.5 6.4 7.8 12.0 17.6 5.6 7.4 7.4 6.4 8.7 5.6 7.8 7.5 9.3 8.2 7.1 8.5 6.5 7.0 7.6 27.9 5.6 10.9 8.2 9.1 6.4 6.1 10.2 7.3 5.9 8.4 16.3 8.9 14.7 7.9 9.2 8.6 4.3 10.7 7.6 9.7 5.0 12.4 7.1 5.0 4.7 5.9 6.2 7.3 8.6 8.1 9.8 11.4 9.5 6.1 13.0 10.9 6.1 6.0 9.5 10.8 16.0 8.8 4.4 9.0 5.2 7.0 7.0 15.4 8.5 5.3 8.5 9.4 33.2 6.2 12.2 7.1 11.2 8.6 9.5 9.9 5.6 7.1 7.7 11.9 15.0 8.1 7.9 3.2 5.6 7.6 11.2 20.6 5.9 7.3 6.8 25.0 24.6 15.5 10.6 8.0 10.0 14.9 13.3 8.0 10.0 3.4 7.0 4.3 8.9 10.7 9.7 8.1 7.6 7.7 8.6 9.2 9.6 9.0 1.2 7.6 5.3 5.6 7.2 5.0 7.5 7.1 8.3 8.8 6.4 7.8 7.4 6.4 8.2 7.3 FAM213A "Adrx, C10orf58, MGC4248, PAMM" ENSG00000122378 "Family with sequence similarity 213 member A" Q9BRX8 10 80407829-80437115 "Predicted intracellular proteins, Predicted membrane proteins" Antioxidant "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 120.6" "Cell line enhanced" "Detected in many" "ASC diff: 138.2;HaCaT: 38.8;HUVEC TERT2: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "plasmacytoid DC: 48.5" "Lineage enriched" "Detected in all" 10 "dendritic cells: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009025, HPA024565" Approved "Intracellular and membrane" "HPA009025: AB_1078312, HPA024565: AB_1845519" "unprognostic (1.73e-2)" "unprognostic (2.96e-2)" "unprognostic (6.96e-3)" "unprognostic (2.15e-2)" "unprognostic (3.02e-2)" "unprognostic (4.31e-2)" "unprognostic (3.14e-1)" "unprognostic (6.68e-2)" "unprognostic (2.58e-1)" "unprognostic (7.01e-2)" "unprognostic (3.54e-2)" "unprognostic (2.83e-3)" "unprognostic (3.32e-3)" "unprognostic (3.55e-1)" "unprognostic (6.78e-2)" "unprognostic (1.80e-1)" "prognostic favourable (6.11e-4)" 120.6 9.3 42.3 6.5 47.7 1.7 64.1 9.8 44.0 33.0 21.1 17.8 11.2 28.0 18.4 75.3 22.5 11.3 10.8 22.5 36.2 33.7 38.2 65.6 7.4 7.6 36.6 26.2 11.4 22.3 34.6 23.3 15.5 26.5 25.0 15.1 31.7 17.4 16.6 15.4 27.1 25.4 7.9 29.6 4.4 7.3 17.1 16.3 5.0 19.2 24.3 11.4 19.1 13.0 4.6 48.5 3.3 1.0 1.9 4.4 1.5 3.5 8.7 14.9 0.0 138.2 0.0 1.0 0.5 3.0 0.2 0.0 8.3 10.7 2.2 11.7 0.0 38.8 1.3 1.5 0.0 0.1 2.4 4.5 3.3 12.1 13.4 0.0 1.3 10.3 2.9 0.9 0.0 61.5 3.6 0.0 0.0 12.2 5.6 0.6 7.2 0.0 16.0 6.9 0.1 31.6 14.7 15.4 11.0 1.5 21.0 22.7 9.4 6.3 16.6 0.1 0.1 0.0 0.0 1.3 2.9 0.0 9.5 0.0 1.0 0.2 1.0 3.3 2.1 0.2 1.7 4.6 1.1 1.7 1.0 3.5 4.4 4.4 0.7 1.9 0.0 48.5 0.0 1.5 42.3 47.7 9.8 44.0 36.2 33.7 36.6 26.2 26.5 16.3 FAM220A "ACPIN1, C7orf70, MGC12966, SIPAR" ENSG00000178397 "Family with sequence similarity 220 member A" Q7Z4H9 7 6329409-6348981 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.7;testis: 40.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA055050 Approved Vesicles Vesicles "HPA055050: " "unprognostic (3.49e-2)" "unprognostic (3.53e-1)" "unprognostic (2.69e-2)" "unprognostic (9.79e-2)" "unprognostic (3.26e-2)" "unprognostic (4.02e-2)" "prognostic unfavourable (5.17e-6)" "unprognostic (2.78e-1)" "unprognostic (1.43e-2)" "unprognostic (2.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (8.84e-3)" "unprognostic (1.14e-2)" "prognostic unfavourable (3.47e-4)" "unprognostic (3.71e-2)" 5.8 6.9 10.5 5.1 9.3 2.3 7.7 14.0 16.6 7.5 6.1 6.8 3.8 4.3 8.1 6.1 8.9 6.2 5.9 12.6 10.3 9.7 6.5 5.1 4.9 6.8 8.3 11.6 8.7 10.5 15.3 7.2 6.0 7.9 6.6 4.4 5.6 7.2 6.9 56.7 7.7 4.6 7.3 7.9 5.8 5.3 40.9 5.4 9.7 9.1 11.8 7.7 7.5 6.3 11.1 9.6 9.5 5.5 16.2 10.2 3.8 15.8 10.0 7.4 17.2 17.1 14.5 8.1 8.1 10.2 9.9 11.6 6.6 8.9 13.2 9.4 9.6 11.7 11.1 6.9 12.9 9.2 7.1 4.4 8.0 7.4 18.5 7.9 6.7 8.1 23.3 7.4 17.9 9.2 8.5 12.7 8.5 12.4 4.9 14.6 17.2 13.1 12.7 11.1 11.1 9.0 5.8 7.5 13.1 11.4 14.1 17.0 13.6 20.9 6.9 7.8 18.0 15.2 10.4 13.7 21.2 14.4 9.1 14.4 24.0 6.7 5.5 9.5 5.5 4.5 5.7 11.1 6.6 8.5 9.6 10.6 10.2 8.4 2.4 16.2 4.7 7.7 8.3 3.8 10.5 9.3 14.0 16.6 10.3 9.7 8.3 11.6 7.9 5.4 FAM234A "C16orf9, DKFZP761D0211, FLJ32603, ITFG3" ENSG00000167930 "Family with sequence similarity 234 member A" Q9H0X4 16 234546-268971 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria 3700000 Mitochondria Nucleoplasm "HPA011651: , HPA071871: " "unprognostic (1.00e-1)" "unprognostic (1.85e-2)" "unprognostic (3.49e-1)" "unprognostic (4.80e-2)" "unprognostic (5.51e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-2)" "unprognostic (2.55e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.16e-1)" "unprognostic (3.28e-2)" "unprognostic (2.23e-1)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (3.68e-1)" 20.2 19.1 11.3 11.7 24.3 6.4 16.5 12.2 16.2 11.6 20.3 56.0 13.7 36.3 17.4 12.6 26.4 14.0 16.0 31.1 8.3 7.3 18.3 15.6 11.4 10.5 39.8 9.0 13.4 29.6 24.3 19.2 15.4 37.8 16.8 12.4 15.5 14.1 15.4 51.4 14.9 26.8 29.0 42.0 9.7 18.8 13.0 27.2 7.2 16.6 16.2 6.3 19.0 11.7 10.3 17.8 12.5 17.4 14.2 11.5 12.5 8.9 18.6 23.3 53.8 36.1 21.6 12.3 21.8 27.7 13.3 17.1 18.8 25.9 8.1 35.6 27.4 18.2 7.3 13.1 11.1 11.2 13.0 11.4 11.6 15.1 22.1 6.0 6.8 22.3 20.4 18.8 15.4 21.4 12.6 2.1 14.4 37.0 6.9 6.8 29.3 9.4 20.7 16.3 40.5 23.0 8.7 29.4 23.8 35.3 20.7 18.5 26.5 10.5 21.3 28.1 8.3 15.0 6.6 4.9 2.0 10.7 19.8 9.7 38.2 11.3 17.4 12.5 10.8 16.9 5.6 8.0 9.6 10.2 17.8 10.3 11.1 11.5 7.6 14.2 16.5 6.3 9.3 12.5 11.3 24.3 12.2 16.2 8.3 7.3 39.8 9.0 37.8 27.2 FAM241A "C4orf32, FLJ39370" ENSG00000174749 "Family with sequence similarity 241 member A" Q8N8J7 4 112145397-112195256 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 49.5" "Cell line enhanced" "Detected in many" "Daudi: 25.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062443, HPA069294" Approved Enhanced "Golgi apparatus" "Golgi apparatus" "HPA062443: , HPA069294: " "unprognostic (3.07e-1)" "unprognostic (1.11e-2)" "unprognostic (2.42e-2)" "unprognostic (5.58e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (1.61e-2)" "unprognostic (3.16e-1)" "unprognostic (1.21e-1)" "unprognostic (5.05e-2)" "unprognostic (4.81e-2)" "unprognostic (5.25e-2)" "unprognostic (9.20e-3)" "prognostic unfavourable (8.87e-4)" "unprognostic (4.08e-1)" "unprognostic (7.16e-2)" "unprognostic (1.39e-2)" 43.2 4.8 3.3 11.9 3.0 7.0 49.5 3.6 3.1 6.9 9.5 4.6 10.7 3.1 8.9 6.0 7.6 5.2 6.2 18.5 4.3 3.0 6.4 6.9 10.2 7.2 5.6 1.8 5.2 3.8 7.1 6.3 12.6 3.4 9.7 3.2 2.8 22.3 17.2 11.6 7.2 4.7 9.0 4.3 9.7 8.3 7.7 3.6 6.3 8.5 7.3 6.0 9.3 24.7 2.7 2.8 5.7 1.7 1.7 1.7 0.7 3.9 1.6 1.6 1.3 8.4 4.8 2.5 3.4 0.8 0.6 1.1 1.1 5.0 25.9 3.2 1.8 1.9 2.5 3.5 1.2 12.2 4.2 2.8 3.8 2.1 5.0 6.4 1.7 5.2 5.7 0.9 6.0 17.9 5.2 12.6 2.0 4.1 2.3 4.6 2.0 3.7 5.3 2.7 5.3 2.7 3.8 3.0 2.4 3.1 5.8 1.6 4.1 2.7 11.3 2.0 6.2 1.3 1.2 5.2 6.8 12.0 4.8 3.2 2.6 5.7 1.7 1.6 1.5 1.3 1.3 1.5 1.6 1.1 0.9 2.7 1.5 1.7 4.2 1.7 1.6 2.8 1.7 0.7 3.3 3.0 3.6 2.4 4.3 3.0 5.6 1.8 3.4 3.6 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630251-69633599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5" "Cell line enhanced" "Detected in many" "EFO-21: 20.5;PC-3: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.2" "Lineage enriched" "Detected in single" 25 "T-cells: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavourable (8.64e-4)" "prognostic unfavourable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favourable (9.72e-4)" 1.4 3.3 13.1 2.0 13.5 1.1 5.3 34.5 23.9 1.3 3.0 3.2 0.6 3.0 2.7 13.0 4.0 4.8 2.1 6.9 15.0 17.8 4.7 2.3 4.1 2.7 10.8 14.4 2.0 7.9 5.6 5.3 1.3 8.3 7.8 2.6 5.1 5.6 5.6 1.6 2.4 2.2 4.5 4.6 0.8 4.2 11.4 2.4 0.7 6.0 0.1 2.4 2.6 1.6 0.3 0.0 0.5 0.0 0.2 14.2 2.8 13.3 14.6 1.8 15.0 0.0 0.0 6.5 1.3 0.3 2.4 2.6 10.5 11.1 0.0 20.5 0.3 5.5 7.8 4.5 3.4 13.3 10.7 0.0 3.2 4.0 4.0 0.0 4.8 0.0 4.4 0.1 2.3 0.0 4.9 0.0 0.2 17.9 0.1 0.0 9.0 26.9 0.0 0.0 0.1 5.1 7.6 7.6 10.4 5.5 14.0 8.5 9.6 2.4 0.6 0.4 9.3 0.0 3.9 2.4 6.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 8.9 0.1 8.5 5.6 0.0 0.3 14.2 4.9 0.5 0.2 0.0 0.0 5.3 2.8 13.1 13.5 34.5 23.9 15.0 17.8 10.8 14.4 8.3 2.4 FAM35A "bA163M19.1, FAM35A1, MGC5560" ENSG00000122376 "Family with sequence similarity 35 member A" Q86V20 10 87094161-87191468 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036582 Uncertain Approved "Nucleoplasm,Actin filaments" Nucleoplasm "Actin filaments" "HPA036582: AB_10670233" "unprognostic (1.08e-1)" "unprognostic (2.72e-1)" "prognostic favourable (6.06e-4)" "unprognostic (1.77e-1)" "prognostic favourable (3.09e-4)" "unprognostic (5.34e-2)" "unprognostic (2.68e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (8.20e-2)" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (1.29e-3)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" "unprognostic (6.44e-3)" "unprognostic (3.61e-2)" 17.3 16.9 5.4 14.4 7.2 5.4 15.4 6.4 4.9 12.6 20.2 4.7 9.1 15.0 10.8 10.6 12.6 9.3 7.4 11.5 6.0 6.1 31.2 35.3 12.5 16.4 9.0 3.5 12.7 10.2 3.6 19.4 7.4 6.8 14.0 11.6 7.4 11.4 14.0 9.3 9.1 33.1 14.8 6.9 15.6 8.7 7.1 7.9 12.0 30.7 12.6 9.4 12.3 13.6 9.0 10.7 4.9 11.1 11.2 13.7 8.5 15.9 12.9 7.4 17.0 8.3 8.1 10.8 10.8 15.2 14.5 16.0 14.8 12.3 11.7 6.0 14.6 10.7 18.2 8.2 15.0 16.6 12.0 16.2 12.3 13.9 12.9 25.2 14.2 7.4 15.2 13.2 22.9 9.6 20.5 21.2 13.4 9.1 20.5 18.0 8.5 9.0 12.7 14.7 12.9 13.3 13.4 3.7 15.3 8.3 9.8 14.3 21.7 14.2 9.4 8.3 7.5 12.3 21.4 11.9 26.0 28.4 14.0 31.6 4.4 4.9 7.0 2.3 6.8 11.1 13.7 9.0 10.3 10.0 10.7 7.2 10.5 10.5 0.1 11.2 8.4 3.7 9.7 8.5 5.4 7.2 6.4 4.9 6.0 6.1 9.0 3.5 6.8 7.9 FAM3A "2-19, DXS560S, XAP-7" ENSG00000071889 "Family with sequence similarity 3 member A" P98173 X 154506159-154516242 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025016, HPA035268, HPA056991" Uncertain Approved Nucleoplasm,Nucleoli "Secreted - unknown location" Nucleoli Nucleoplasm "CAB025016: , HPA035268: , HPA056991: " "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (3.19e-2)" "unprognostic (4.73e-2)" "unprognostic (5.19e-2)" "unprognostic (2.54e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (6.27e-2)" "unprognostic (3.42e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (2.74e-1)" "unprognostic (1.41e-1)" "unprognostic (4.04e-1)" "unprognostic (9.71e-2)" 18.9 18.9 18.9 14.7 20.9 13.7 17.3 13.4 25.7 22.3 21.2 31.1 16.3 37.0 18.2 16.2 19.3 19.1 25.3 31.4 21.3 18.7 19.8 28.5 16.1 16.7 23.0 16.4 29.1 35.5 18.2 22.1 21.0 18.5 20.6 9.9 17.3 29.4 34.7 33.4 15.3 33.7 14.4 25.4 18.4 23.6 10.7 16.8 13.5 28.8 16.1 12.2 16.9 16.9 8.0 13.3 21.2 11.5 8.5 13.3 8.9 16.3 15.8 4.0 13.3 12.0 6.1 11.2 8.4 5.8 5.8 6.9 7.2 10.0 10.7 42.8 14.0 12.0 6.2 7.4 1.4 8.7 8.4 4.2 13.8 5.1 18.9 2.8 6.7 7.5 6.7 12.0 8.4 4.0 7.9 7.9 6.6 17.1 5.1 12.1 1.7 19.9 6.4 4.0 29.3 6.3 6.8 7.9 6.0 3.8 9.4 13.8 7.1 4.3 4.5 7.8 4.7 21.1 11.3 30.3 16.6 13.0 14.4 7.3 7.9 21.2 9.9 12.5 13.3 11.5 12.9 6.2 8.2 9.3 9.9 8.0 10.2 11.9 5.0 8.5 9.5 13.3 8.5 8.9 18.9 20.9 13.4 25.7 21.3 18.7 23.0 16.4 18.5 16.8 FAM3B "2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44" ENSG00000183844 "Family with sequence similarity 3 member B" P58499 21 41304212-41357431 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.8;pancreas: 120.3;salivary gland: 67.9" "Cell line enhanced" "Detected in some" "CACO-2: 9.3;CAPAN-2: 5.9;Hep G2: 15.2;RPMI-8226: 42.1" "Cancer enhanced" "Detected in many" "prostate cancer: 40.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 3.0;neutrophil: 6.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015885, HPA029777" Approved Approved Vesicles "Secreted to blood" 2075500 57000 Vesicles "HPA015885: AB_1848396, HPA029777: " "unprognostic (2.88e-1)" "unprognostic (3.31e-3)" "unprognostic (5.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (6.32e-3)" "unprognostic (1.41e-1)" "unprognostic (8.79e-3)" "unprognostic (9.38e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "unprognostic (3.78e-1)" "unprognostic (5.60e-3)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (1.78e-1)" "unprognostic (1.55e-3)" 0.6 0.2 0.2 4.5 0.4 0.0 4.3 0.2 0.3 1.8 38.5 0.4 29.9 38.2 0.2 8.8 17.4 4.5 6.9 0.4 0.2 0.2 5.2 0.6 2.0 0.7 0.3 0.2 0.7 120.3 0.0 1.9 7.9 0.4 10.0 0.0 0.2 67.9 36.0 0.2 0.9 83.8 2.0 0.3 0.5 30.8 2.0 0.2 2.3 3.9 7.4 17.6 17.5 4.7 0.2 1.3 6.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.3 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 42.1 0.0 2.8 0.2 0.2 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 6.9 0.0 0.6 1.3 0.0 0.0 0.2 0.4 0.2 0.3 0.2 0.2 0.3 0.2 0.4 0.2 FAM3D "EF7, OIT1" ENSG00000198643 "Family with sequence similarity 3 member D" Q96BQ1 3 58633946-58666848 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.2;intestine: 69.2;salivary gland: 146.0;seminal vesicle: 88.6" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 3.4;RT4: 2.8;T-47d: 2.3;U-266/70: 1.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 151.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 6.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA013844 Approved "Secreted to digestive system" 8200 "HPA013844: " "prognostic favourable (7.51e-4)" "unprognostic (1.07e-1)" "unprognostic (2.08e-2)" "unprognostic (9.67e-2)" "unprognostic (5.51e-2)" "prognostic favourable (1.89e-4)" "unprognostic (7.97e-2)" "unprognostic (6.54e-2)" "unprognostic (7.43e-2)" "unprognostic (5.48e-2)" "unprognostic (2.23e-2)" "unprognostic (1.42e-1)" "unprognostic (8.68e-2)" "unprognostic (1.64e-1)" "unprognostic (2.00e-1)" "unprognostic (6.97e-4)" "unprognostic (2.34e-2)" 0.3 0.2 0.3 8.5 0.3 0.0 2.2 0.2 0.2 4.4 48.2 0.3 26.1 11.2 0.5 0.3 61.2 0.3 20.0 0.2 0.2 0.2 0.5 0.2 1.5 0.2 0.3 0.2 0.2 0.8 0.0 0.3 0.5 0.3 3.3 69.2 0.3 146.0 88.6 0.4 0.8 26.1 0.8 0.2 0.3 9.5 0.3 0.2 0.3 0.6 15.2 47.1 2.2 13.1 0.0 0.7 6.7 1.6 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 3.4 0.3 0.0 0.0 1.3 0.3 1.4 0.7 0.0 0.3 0.5 1.0 0.1 2.8 0.2 1.3 0.0 0.0 0.0 2.3 0.0 0.5 0.1 0.7 0.9 0.6 1.8 1.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 6.7 0.0 0.5 0.0 0.0 0.9 0.3 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 FAM69A FLJ23493 ENSG00000154511 "Family with sequence similarity 69 member A" Q5T7M9 1 92832737-92961522 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015718, HPA017281" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA015718: AB_1848405, HPA017281: AB_1848406" "prognostic favourable (8.96e-4)" "unprognostic (1.00e-1)" "unprognostic (6.17e-2)" "unprognostic (1.50e-3)" "unprognostic (1.43e-1)" "unprognostic (3.77e-3)" "unprognostic (3.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.10e-1)" "unprognostic (2.19e-1)" "unprognostic (5.04e-2)" "prognostic unfavourable (1.45e-7)" "unprognostic (1.26e-2)" "unprognostic (5.99e-2)" "unprognostic (2.57e-1)" "unprognostic (1.66e-2)" 13.3 3.4 20.7 10.4 22.5 7.0 7.8 19.4 22.2 7.3 13.2 15.9 4.2 8.8 15.7 3.8 9.3 8.3 11.1 5.3 22.6 18.0 6.1 24.7 4.5 10.1 25.0 12.2 6.0 3.5 20.5 4.1 12.8 17.7 9.5 12.4 5.4 5.5 11.3 7.5 5.6 8.2 19.4 24.7 7.6 8.8 6.4 24.4 9.6 6.2 3.6 8.8 12.2 6.0 22.5 7.1 0.2 0.9 11.8 14.2 6.7 4.2 4.7 1.9 4.7 7.4 13.9 2.4 13.4 27.7 7.6 15.5 2.7 0.9 14.5 2.4 24.7 5.5 0.3 10.1 12.7 5.8 4.8 0.5 3.7 6.8 2.6 1.3 0.9 8.2 8.1 16.7 3.8 0.1 5.1 15.5 9.6 1.6 4.8 1.2 3.5 1.9 4.3 14.3 4.5 1.1 4.5 4.9 3.8 3.7 3.7 4.9 1.8 0.4 0.5 9.0 6.9 17.5 4.7 23.4 22.3 17.0 4.3 0.9 0.8 0.0 0.9 0.0 10.5 0.4 8.1 22.5 12.1 8.2 4.3 13.6 14.2 12.1 0.2 11.8 0.2 7.1 10.7 6.7 20.7 22.5 19.4 22.0 22.6 18.0 25.0 12.2 17.7 24.4 FAM69B "C9orf136, MGC20262" ENSG00000165716 "Family with sequence similarity 69 member B" Q5VUD6 9 136712570-136724050 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 28.1;HEK 293: 25.1;HUVEC TERT2: 31.2;REH: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "naive B-cell: 7.3;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 34 "B-cells: 7.3;dendritic cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046812, HPA054443" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA046812: , HPA054443: " "unprognostic (2.78e-2)" "unprognostic (8.07e-2)" "prognostic unfavourable (1.77e-5)" "unprognostic (3.82e-1)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (6.80e-2)" "unprognostic (2.10e-2)" "prognostic favourable (9.48e-5)" "unprognostic (2.77e-1)" "unprognostic (6.67e-3)" "unprognostic (4.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.84e-1)" "unprognostic (2.78e-1)" 8.0 3.8 12.3 3.6 14.2 8.2 5.6 19.8 21.4 6.1 4.6 4.9 2.3 4.7 9.6 5.0 4.7 11.0 5.9 18.8 12.3 14.6 6.6 5.5 11.0 4.5 12.4 15.9 5.4 11.9 7.9 11.4 24.5 14.2 6.5 1.3 17.5 11.2 4.5 9.9 13.0 4.4 4.1 5.3 7.9 3.5 7.5 3.2 1.6 7.6 4.1 2.1 3.2 3.1 7.3 1.9 0.0 0.1 0.0 0.0 0.7 0.5 3.3 9.4 9.2 0.0 0.0 8.4 0.3 0.0 0.3 0.4 9.5 1.5 0.8 28.1 0.0 2.9 4.8 0.1 0.0 1.3 25.1 5.3 0.4 0.3 0.1 0.8 2.8 0.1 0.0 0.1 0.0 31.2 6.2 0.9 0.0 4.1 3.6 8.4 14.5 2.1 20.0 0.2 9.4 0.5 1.0 16.0 17.3 0.4 1.8 7.0 5.2 4.9 16.0 0.8 7.0 1.3 0.5 5.5 0.5 2.4 0.6 0.8 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.7 12.3 14.2 19.8 21.4 12.3 14.6 12.4 15.9 14.2 3.2 FAM76B MGC33371 ENSG00000077458 "Family with sequence similarity 76 member B" Q5HYJ3 11 95768942-95790409 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036608 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA036608: " "unprognostic (8.17e-2)" "unprognostic (2.26e-1)" "unprognostic (8.21e-2)" "unprognostic (2.39e-2)" "unprognostic (3.12e-2)" "unprognostic (1.43e-2)" "unprognostic (2.30e-1)" "unprognostic (2.64e-2)" "unprognostic (1.01e-2)" "unprognostic (1.65e-2)" "unprognostic (1.22e-1)" "unprognostic (3.90e-3)" "prognostic unfavourable (7.17e-5)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.43e-1)" "prognostic favourable (2.72e-4)" 10.1 6.2 5.3 12.1 9.3 35.7 9.3 12.3 9.7 8.5 10.8 6.2 6.1 9.5 8.2 7.5 7.8 7.3 10.1 4.9 6.1 4.4 5.2 13.6 8.2 16.8 10.5 5.6 8.3 6.7 6.3 9.5 8.2 7.1 9.0 5.7 6.3 9.1 8.2 5.6 8.7 9.0 9.8 8.9 8.8 6.6 28.2 10.1 12.0 8.4 4.1 17.8 8.6 7.9 3.0 7.3 8.7 3.0 4.5 7.6 2.8 4.4 3.4 12.9 7.0 2.1 2.2 10.8 7.6 3.7 5.7 6.5 12.7 8.7 16.8 9.7 3.7 8.5 7.5 2.6 6.0 9.0 5.5 19.7 6.2 6.6 5.5 13.8 11.3 2.8 4.3 6.5 5.8 5.3 11.6 9.4 3.1 3.3 15.5 16.2 7.2 3.1 16.8 9.6 9.8 4.2 5.0 5.4 15.5 9.4 5.3 5.7 7.0 6.0 5.4 7.8 8.4 9.2 6.9 5.1 10.8 25.9 1.8 13.5 11.0 0.1 2.9 5.2 5.4 3.0 4.4 3.0 4.9 5.4 2.0 2.6 4.5 6.7 8.7 4.5 2.8 7.3 7.6 2.8 5.3 9.3 12.3 9.7 6.1 4.4 10.5 5.6 7.1 10.1 FAM98B FLJ38426 ENSG00000171262 "Family with sequence similarity 98 member B" Q52LJ0 15 38454127-38487710 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008320, HPA008502" Enhanced Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA008320: AB_1848419, HPA008502: AB_1848420" "unprognostic (1.05e-2)" "unprognostic (3.13e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-2)" "unprognostic (1.54e-2)" "unprognostic (3.09e-2)" "unprognostic (9.25e-3)" "unprognostic (1.74e-1)" "unprognostic (4.69e-2)" "unprognostic (2.18e-1)" "unprognostic (3.15e-1)" "unprognostic (3.15e-2)" "unprognostic (1.51e-2)" "unprognostic (2.26e-1)" "unprognostic (4.36e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" 15.6 15.6 20.4 16.9 21.0 10.8 17.0 27.3 24.4 13.7 19.3 12.7 8.7 12.5 17.9 12.9 14.9 14.5 11.0 15.8 20.1 19.6 17.7 10.1 10.6 16.3 18.6 20.3 15.6 10.6 27.5 18.3 20.1 17.7 16.5 15.7 9.3 11.2 14.2 16.2 11.5 12.8 17.4 21.0 13.8 12.0 13.0 14.0 27.4 15.7 12.3 16.8 14.8 13.4 3.5 2.5 3.7 1.1 3.8 6.6 0.7 13.5 7.2 35.8 18.3 6.6 12.2 17.5 17.4 12.8 17.2 17.4 16.0 6.6 9.4 19.3 14.4 14.4 21.5 17.8 24.3 9.6 11.7 27.6 16.7 12.3 9.6 26.1 16.0 11.2 11.2 15.4 17.9 17.7 19.8 11.8 16.4 6.1 22.0 14.0 19.2 10.1 23.5 19.3 7.8 14.9 17.9 22.1 22.7 19.2 12.3 8.4 15.1 16.2 14.7 19.7 24.0 13.0 19.5 22.0 19.7 34.1 10.7 17.3 20.4 3.7 0.9 2.5 5.3 0.8 4.6 2.8 5.4 4.4 1.1 3.5 6.6 5.1 0.8 3.8 1.1 2.5 3.3 0.7 20.4 21.0 27.3 24.4 20.1 19.6 18.6 20.3 17.7 14.0 FANCA "FA-H, FAA, FACA, FAH, FANCH" ENSG00000187741 "Fanconi anemia complementation group A" O15360 16 89737549-89816657 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.6;testis: 28.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063236 Supported Nucleoplasm Nucleoplasm "HPA063236: " "unprognostic (5.99e-2)" "unprognostic (5.68e-2)" "unprognostic (2.36e-1)" "unprognostic (5.12e-2)" "unprognostic (1.87e-1)" "unprognostic (7.11e-2)" "unprognostic (1.45e-4)" "unprognostic (9.21e-2)" "unprognostic (1.58e-2)" "unprognostic (2.05e-1)" "unprognostic (4.82e-3)" "unprognostic (8.48e-4)" "unprognostic (7.82e-10)" "unprognostic (3.67e-2)" "unprognostic (2.05e-1)" "unprognostic (2.94e-1)" "unprognostic (1.62e-1)" 2.1 2.0 2.2 16.5 3.7 17.1 1.7 5.7 6.6 1.7 5.1 1.1 0.6 5.0 1.7 3.1 6.6 1.9 1.6 1.7 1.8 1.4 2.1 5.8 3.3 11.1 1.3 2.7 1.6 1.8 2.3 1.9 11.2 2.4 1.7 6.3 1.5 2.2 0.5 0.7 5.0 5.4 2.0 1.6 6.9 3.5 28.8 0.8 20.6 1.7 4.6 17.6 2.9 2.5 7.4 6.5 9.9 9.2 7.5 9.5 4.2 9.2 14.2 17.0 14.9 1.1 2.2 13.0 11.5 6.3 19.5 8.2 12.4 15.4 22.7 5.4 3.9 14.2 11.4 8.6 20.6 5.3 19.2 6.7 18.2 25.4 0.7 6.8 7.4 0.7 0.9 15.8 5.0 6.1 16.1 7.0 10.1 21.4 13.6 29.5 11.0 8.9 24.8 13.7 4.1 4.8 8.7 15.3 8.3 17.2 5.1 2.2 9.3 12.3 4.5 15.7 16.5 8.7 12.0 6.3 7.3 22.6 7.4 15.3 14.8 2.6 7.9 9.9 4.7 8.8 3.3 7.4 2.8 4.1 6.5 5.5 0.7 3.0 9.8 7.5 9.2 0.4 9.5 4.2 2.2 3.7 5.7 6.6 1.8 1.4 1.3 2.7 2.4 0.8 FAR2 "FLJ10462, MLSTD1, SDR10E2" ENSG00000064763 "Fatty acyl-CoA reductase 2" Q96K12 12 29149103-29340980 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 25.8;HUVEC TERT2: 30.2;NB-4: 25.9;SK-BR-3: 31.9;TIME: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015884 Approved Approved "Nucleoli,Golgi apparatus" "Golgi apparatus" Nucleoli "HPA015884: AB_1853998" "unprognostic (6.32e-2)" "unprognostic (2.40e-2)" "unprognostic (1.50e-3)" "unprognostic (3.33e-3)" "unprognostic (2.41e-1)" "unprognostic (4.13e-3)" "unprognostic (4.30e-2)" "unprognostic (1.18e-1)" "unprognostic (3.11e-2)" "unprognostic (6.37e-2)" "unprognostic (5.70e-3)" "unprognostic (1.92e-1)" "prognostic unfavourable (4.93e-4)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.33e-1)" "unprognostic (5.22e-3)" 9.4 7.2 9.8 6.9 17.4 12.0 7.6 5.1 18.2 4.6 25.7 3.2 6.1 13.3 6.2 29.4 6.0 3.7 4.2 5.4 12.8 10.9 4.0 3.1 8.6 6.7 9.4 10.4 2.1 2.6 1.0 2.9 19.2 6.6 2.8 22.3 4.1 4.8 1.7 4.5 8.7 14.0 6.0 5.1 12.3 3.7 8.4 5.9 7.2 3.5 4.5 2.3 6.6 4.3 0.9 4.0 23.7 11.5 1.8 7.6 4.4 0.9 1.7 1.7 0.4 2.5 9.9 0.7 7.5 8.8 2.1 2.0 2.9 10.1 1.3 2.0 1.0 0.5 4.6 0.0 0.5 0.6 11.5 25.8 4.1 0.9 5.3 10.3 8.6 2.8 0.0 3.2 4.0 30.2 2.2 1.0 0.3 0.3 6.6 25.9 7.0 19.7 5.5 2.9 1.1 9.3 2.6 3.0 2.7 1.7 31.9 12.7 1.5 9.7 24.5 5.6 1.7 2.0 3.3 1.6 1.6 0.6 8.9 13.6 4.8 1.3 11.5 23.7 2.7 6.9 1.8 0.9 4.5 3.2 4.0 0.7 1.5 1.7 20.7 1.8 3.7 1.5 7.6 4.4 9.8 17.4 5.1 18.2 12.8 10.9 9.4 10.4 6.6 5.9 FAS "APO-1, APT1, CD95, FAS1, TNFRSF6" ENSG00000026103 "Fas cell surface death receptor" P25445 10 88990582-89015785 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Apoptosis "Calmodulin-binding, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 40.1" "Group enriched" "Detected in all" 5 "granulocytes: 40.1;T-cells: 30.9" "Low region specificity" "Detected in all" HPA027444 Uncertain Supported "Nuclear bodies,Plasma membrane,Cytosol" "Secreted to blood" 450000 "Plasma membrane" "Nuclear bodies, Cytosol" "HPA027444: AB_10601378" "unprognostic (6.84e-2)" "unprognostic (2.88e-3)" "unprognostic (8.38e-3)" "unprognostic (1.94e-1)" "unprognostic (2.35e-2)" "unprognostic (9.56e-2)" "unprognostic (7.00e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (7.70e-2)" "unprognostic (1.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.52e-3)" "unprognostic (2.10e-1)" "unprognostic (2.32e-2)" "unprognostic (4.95e-3)" "unprognostic (1.65e-1)" 13.5 26.3 6.1 17.3 7.7 12.4 10.6 2.1 7.2 15.6 14.2 6.1 7.0 5.9 15.7 16.6 14.1 14.2 14.5 8.9 8.2 2.7 11.7 21.9 28.6 15.6 6.0 3.9 24.7 4.1 4.5 4.6 9.0 7.5 22.3 21.3 4.4 7.1 8.5 4.3 9.6 16.3 12.5 10.2 15.3 5.0 7.3 5.1 12.5 10.0 15.8 14.4 14.8 21.4 3.0 4.0 40.1 6.8 1.2 30.9 3.9 8.5 3.3 1.7 5.5 14.2 21.0 0.0 18.9 19.1 0.7 3.7 0.0 9.3 1.7 7.3 17.7 1.3 0.3 15.8 1.3 27.5 2.7 0.1 1.8 5.6 13.6 0.9 0.4 26.0 14.2 11.8 25.5 1.6 0.0 43.8 19.2 0.7 2.7 1.4 0.2 0.9 0.1 0.1 1.7 26.5 2.7 0.1 0.1 2.7 0.0 0.3 6.0 0.3 4.1 6.0 3.4 5.6 4.3 17.2 1.7 0.1 5.0 3.4 1.8 11.3 3.2 9.4 3.3 3.9 4.8 3.0 10.4 7.2 4.0 0.7 1.2 3.4 40.1 1.2 6.8 0.0 30.9 3.9 6.1 7.7 2.1 7.2 8.2 2.7 6.0 3.9 7.5 5.1 FASLG "APT1LG1, CD178, FasL, TNFSF6" ENSG00000117560 "Fas ligand" P48023 1 172659018-172666874 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Apoptosis, Transcription, Transcription regulation" "Cytokine, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.6;lymphoid tissue: 13.4" "Cell line enhanced" "Detected in some" "ASC diff: 1.0;LHCN-M2: 2.4;NB-4: 1.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "gdT-cell: 25.6" "Group enriched" "Detected in many" 12 "NK-cells: 16.0;T-cells: 25.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054959 Approved "Secreted to blood" 34930061667 "HPA054959: " "unprognostic (1.09e-3)" "unprognostic (1.41e-2)" "unprognostic (8.69e-2)" "unprognostic (1.54e-7)" "unprognostic (3.29e-1)" "unprognostic (2.23e-3)" "unprognostic (5.44e-2)" "unprognostic (1.84e-2)" "unprognostic (4.67e-2)" "unprognostic (4.76e-2)" "unprognostic (8.88e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (1.59e-6)" "unprognostic (3.49e-2)" "unprognostic (1.22e-1)" "unprognostic (1.15e-2)" "unprognostic (3.82e-3)" 0.9 1.1 0.5 1.9 0.7 3.6 1.8 0.5 0.8 0.7 2.6 0.6 0.0 3.0 3.9 1.2 1.0 0.8 1.6 1.2 0.5 0.5 1.2 2.2 6.8 7.7 1.4 0.0 1.5 0.6 0.0 0.7 2.4 0.6 4.7 1.2 2.8 1.9 0.3 0.4 0.5 3.8 1.9 1.7 13.4 2.1 0.4 0.0 1.2 1.1 0.0 10.1 1.4 0.9 0.0 0.0 1.6 0.0 16.0 25.6 5.5 0.0 0.0 0.3 0.1 1.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.5 0.5 0.1 0.0 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.4 0.7 0.0 0.2 0.6 2.4 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.1 1.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.7 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 25.6 0.0 15.8 0.0 5.4 13.7 0.0 0.0 1.1 11.7 0.8 16.0 0.0 0.0 0.1 5.5 0.5 0.7 0.5 0.8 0.5 0.5 1.4 0.0 0.6 0.0 FAT1 "CDHF7, CDHR8, FAT" ENSG00000083857 "FAT atypical cadherin 1" Q14517 4 186587783-186726722 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.4" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 63.5;LHCN-M2: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001869, HPA023882" Enhanced "Intracellular and membrane" 120000 "HPA001869: AB_1078818, HPA023882: AB_1848429" "unprognostic (1.98e-1)" "unprognostic (4.91e-2)" "unprognostic (2.50e-2)" "unprognostic (1.86e-1)" "unprognostic (1.53e-2)" "unprognostic (5.82e-3)" "unprognostic (2.31e-1)" "prognostic unfavourable (4.22e-4)" "unprognostic (6.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.15e-3)" "unprognostic (6.80e-2)" "unprognostic (3.57e-2)" "unprognostic (8.03e-3)" "unprognostic (9.41e-2)" "unprognostic (6.25e-3)" "unprognostic (4.27e-2)" 15.5 1.3 7.9 12.3 9.8 0.4 15.4 11.9 8.4 15.9 40.4 11.8 8.1 17.9 20.6 14.0 9.7 9.6 28.2 21.1 10.0 6.0 29.1 13.3 10.9 1.4 11.4 6.2 9.7 13.8 7.5 10.5 14.6 24.7 15.9 22.9 5.0 13.9 18.2 3.0 13.1 76.4 18.3 12.8 1.7 11.5 7.0 11.2 1.3 10.5 10.2 6.7 17.5 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 18.6 18.4 0.0 18.5 22.3 4.5 24.8 41.0 12.1 7.7 11.0 11.0 0.0 6.0 63.5 9.0 7.2 30.6 16.5 0.0 2.9 0.0 6.6 11.1 9.2 8.0 6.6 8.0 11.1 22.5 14.7 0.2 0.1 0.0 46.6 5.9 14.3 0.0 4.1 3.1 0.0 5.1 0.3 18.2 17.5 1.9 7.4 4.3 7.3 2.9 0.0 2.9 5.3 34.6 13.4 0.4 15.4 0.1 0.0 0.1 7.9 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 9.8 11.9 8.4 10.0 6.0 11.4 6.2 24.7 11.2 FAT2 "CDHF8, CDHR9, HFAT2, MEGF1" ENSG00000086570 "FAT atypical cadherin 2" Q9NYQ8 5 151504093-151568944 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 61.0;skin 1: 35.1" "Group enriched" "Detected in some" 9 "BEWO: 16.9;EFO-21: 10.1;HaCaT: 24.4;HBEC3-KT: 11.1;hTCEpi: 33.9" "Group enriched" "Detected in many" 6 "cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6" "Region enriched" "Detected in some" 34 "cerebellum: 61.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "cerebellum: 35.9" "Region enriched" "Detected in single" 67 "cerebellum: 442.8" CAB033680 Enhanced "CAB033680: AB_2100956" "unprognostic (8.06e-3)" "unprognostic (6.01e-2)" "unprognostic (3.47e-1)" "unprognostic (4.80e-3)" "unprognostic (1.33e-1)" "unprognostic (4.43e-1)" "unprognostic (9.78e-3)" "unprognostic (2.28e-1)" "unprognostic (8.25e-2)" "unprognostic (2.65e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-7)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (6.77e-2)" "unprognostic (3.64e-3)" 0.4 0.0 0.4 0.4 1.7 0.0 2.2 61.0 0.4 2.4 0.4 0.4 0.4 0.0 0.4 1.0 11.8 0.5 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 1.3 0.4 0.0 0.4 0.4 0.9 0.9 0.0 0.4 3.8 3.2 0.4 35.1 0.4 0.4 0.4 0.4 0.0 2.7 0.4 0.4 0.4 0.4 1.9 1.0 4.9 0.2 0.6 0.1 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 16.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 24.4 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 1.7 61.0 0.4 0.4 0.0 0.4 0.4 0.9 0.4 FAT3 "CDHF15, CDHR10, KIAA1989" ENSG00000165323 "FAT atypical cadherin 3" Q8TDW7 11 92352096-92896470 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.5;seminal vesicle: 6.0" "Cell line enhanced" "Detected in some" "AF22: 8.0;fHDF/TERT166: 2.4;NTERA-2: 2.7;U-2 OS: 2.3;U-251 MG: 4.6" "Cancer enriched" "Detected in single" 6 "glioma: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026878 Uncertain "HPA026878: AB_1848430" "unprognostic (5.00e-2)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (4.76e-6)" "unprognostic (1.27e-1)" "unprognostic (1.79e-1)" "unprognostic (1.56e-1)" "unprognostic (9.32e-2)" "unprognostic (1.08e-1)" "unprognostic (3.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (5.79e-2)" "unprognostic (3.66e-4)" "unprognostic (8.83e-2)" "unprognostic (7.72e-2)" "unprognostic (2.25e-1)" 0.5 0.1 2.6 0.1 10.5 0.1 0.3 1.4 7.3 0.4 0.2 0.1 0.4 1.0 0.1 0.4 0.2 0.2 1.8 2.2 0.4 0.1 1.4 0.0 2.2 0.8 0.0 0.0 1.8 0.2 3.2 0.2 0.1 6.0 0.2 0.1 0.1 0.2 0.2 0.2 1.2 0.8 0.0 0.4 1.3 0.3 0.2 0.2 0.7 0.0 0.2 0.3 0.0 0.0 0.3 8.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.4 0.0 0.0 0.0 1.6 2.4 1.3 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.2 0.3 0.0 FAT4 "CDHF14, CDHR11, FAT-J" ENSG00000196159 "FAT atypical cadherin 4" Q6V0I7 4 125316399-125492932 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 12.1;ASC TERT1: 9.0;fHDF/TERT166: 8.8;HSkMC: 10.4;HUVEC TERT2: 10.9;TIME: 17.1" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 12 "NK-cells: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052819 Approved Approved Cytosol 7900000 Cytosol "HPA052819: " "unprognostic (1.18e-1)" "unprognostic (1.77e-1)" "unprognostic (7.99e-2)" "unprognostic (1.09e-1)" "unprognostic (2.31e-1)" "unprognostic (2.81e-4)" "unprognostic (6.17e-3)" "unprognostic (1.28e-1)" "unprognostic (1.77e-2)" "unprognostic (2.78e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-1)" "prognostic favourable (1.89e-4)" "unprognostic (2.38e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-2)" "unprognostic (2.49e-3)" 3.8 0.5 0.9 0.8 0.7 0.0 3.2 0.0 0.5 4.4 7.1 0.3 2.7 0.6 1.9 2.1 4.1 5.0 1.0 0.4 2.6 2.0 5.3 0.1 0.9 5.3 0.5 6.7 0.4 2.5 3.6 1.9 1.0 2.3 1.1 1.4 2.4 3.3 0.6 2.1 2.4 0.1 3.9 0.2 3.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 5.9 0.6 12.1 9.0 0.0 2.0 2.3 0.9 1.0 0.0 0.3 0.0 2.4 8.8 0.0 2.2 2.5 0.6 0.0 1.0 1.3 2.5 0.0 3.9 0.8 0.0 10.4 1.3 0.5 5.5 10.9 0.0 1.6 5.0 0.1 0.4 0.0 0.4 0.2 0.7 1.2 0.0 0.1 0.0 0.1 1.2 0.3 0.0 0.0 0.0 0.0 17.1 6.0 1.7 2.1 0.9 0.2 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 FATE1 "CT43, FATE" ENSG00000147378 "Fetal and adult testis expressed 1" Q969F0 X 151716035-151723194 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 155 "testis: 100.9" "Cell line enhanced" "Detected in some" "BEWO: 2.1;U-2197: 1.6;U-266/70: 1.4;U-87 MG: 1.3" "Group enriched" "Detected in some" 9 "renal cancer: 1.2;testis cancer: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA034604 Enhanced "HPA034604: AB_10602318" "unprognostic (1.82e-2)" "unprognostic (7.13e-2)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.40e-5)" "unprognostic (2.10e-1)" "unprognostic (3.70e-3)" "unprognostic (2.58e-1)" "unprognostic (1.16e-1)" "unprognostic (5.07e-3)" "unprognostic (1.55e-1)" "unprognostic (3.50e-2)" "prognostic unfavourable (2.88e-4)" "unprognostic (4.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.68e-1)" "unprognostic (5.34e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 100.9 0.0 0.6 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 FBXO18 "FBH1, Fbx18, FLJ14590" ENSG00000134452 "F-box protein, helicase, 18" Q8NFZ0 10 5890203-5937594 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002844 Supported "HPA002844: AB_1078829" "unprognostic (3.14e-2)" "unprognostic (1.55e-1)" "unprognostic (6.35e-3)" "unprognostic (4.42e-2)" "unprognostic (3.37e-2)" "unprognostic (8.98e-3)" "prognostic unfavourable (7.73e-7)" "unprognostic (1.89e-1)" "unprognostic (2.42e-1)" "unprognostic (3.37e-2)" "unprognostic (1.56e-2)" "unprognostic (2.23e-1)" "unprognostic (6.91e-3)" "unprognostic (3.69e-1)" "unprognostic (4.35e-2)" "unprognostic (1.24e-1)" "unprognostic (9.54e-2)" 21.3 30.6 21.0 22.4 28.2 18.8 32.7 23.0 21.8 23.5 21.9 18.1 26.3 21.7 30.6 21.2 23.8 28.7 22.8 35.1 21.0 13.4 20.4 23.2 22.5 24.2 19.4 18.0 27.5 26.2 23.3 24.5 23.6 22.5 23.9 22.1 23.1 21.0 24.8 23.6 26.2 23.4 27.5 13.5 29.7 22.4 27.1 20.1 36.8 22.8 14.9 23.3 23.8 33.8 6.1 6.1 4.8 3.2 7.2 9.2 2.5 14.4 15.8 14.9 16.3 34.4 22.8 13.4 16.8 11.6 16.7 18.8 18.7 13.3 13.6 11.1 24.4 21.7 20.1 17.9 15.2 14.7 14.8 13.0 12.5 15.9 23.7 6.4 12.7 28.5 17.4 21.1 9.4 28.2 22.9 14.4 17.6 22.0 15.5 9.5 6.8 9.0 17.2 7.1 22.6 16.3 11.8 8.5 12.8 17.2 15.7 23.3 16.0 13.1 17.6 10.7 12.0 28.2 12.9 14.8 11.6 7.6 14.4 9.5 7.4 0.0 3.2 4.8 3.2 2.5 2.1 4.9 3.3 4.1 3.0 6.1 4.0 2.9 2.1 7.2 1.9 6.1 9.2 2.5 21.0 28.2 23.0 21.8 21.0 13.4 19.4 18.0 22.5 20.1 FBXO31 "FBX14, Fbx31, FBXO14, MGC15419" ENSG00000103264 "F-box protein 31" Q5XUX0 16 87326987-87392142 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA030150 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA030150: AB_10670559" "unprognostic (4.85e-1)" "unprognostic (5.76e-3)" "unprognostic (1.67e-1)" "unprognostic (1.53e-2)" "unprognostic (4.04e-1)" "unprognostic (2.25e-1)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.65e-2)" "prognostic favourable (9.16e-5)" "unprognostic (3.00e-2)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.57e-3)" "unprognostic (2.26e-3)" 25.7 11.5 10.5 6.1 12.1 5.4 22.3 39.7 18.7 10.4 14.1 5.9 9.3 9.0 13.3 7.4 10.8 11.1 6.7 17.2 8.3 8.2 5.3 11.3 5.6 6.3 6.9 10.4 13.9 13.5 8.8 16.6 5.4 8.5 9.4 6.4 7.9 10.3 12.0 50.4 8.9 11.4 14.8 4.6 5.3 8.3 9.1 5.6 4.5 6.0 7.0 5.4 12.2 22.6 2.4 0.9 1.4 0.7 0.2 3.7 1.4 4.8 9.3 3.1 8.4 16.1 9.7 9.1 8.5 8.6 8.5 4.5 8.4 4.1 11.4 9.4 9.0 7.5 6.0 7.1 5.7 5.2 11.0 3.8 5.7 23.6 9.0 3.7 3.2 11.5 6.0 11.0 10.5 5.2 10.9 4.5 4.5 7.0 8.6 5.0 6.0 8.3 11.1 3.7 4.8 3.8 3.5 14.5 7.1 19.0 3.9 5.8 6.1 3.2 7.1 8.2 6.2 7.8 6.7 10.4 8.0 14.1 6.5 6.8 5.0 1.4 0.6 0.2 1.0 0.6 1.8 2.4 1.7 2.4 0.4 1.6 1.8 1.9 0.9 0.2 0.7 0.9 3.7 1.4 10.5 12.1 39.7 18.7 8.3 8.2 6.9 10.4 8.5 5.6 FBXW12 "Fbw12, FBXO35" ENSG00000164049 "F-box and WD repeat domain containing 12" Q6X9E4 3 48372219-48401259 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "pancreas: 12.4" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HEK 293: 1.7;SH-SY5Y: 1.0;THP-1: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037491, HPA037492" Uncertain "HPA037491: , HPA037492: " "unprognostic (5.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-2)" "unprognostic (8.56e-2)" "unprognostic (2.17e-1)" "unprognostic (9.48e-2)" "unprognostic (2.95e-1)" "unprognostic (1.21e-3)" "unprognostic (6.96e-3)" "unprognostic (2.36e-1)" "unprognostic (6.29e-3)" "unprognostic (1.43e-1)" "unprognostic (1.29e-1)" "unprognostic (8.81e-3)" 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 12.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.9 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.2 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.8 1.0 0.0 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.3 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FCAMR "CD351, FCA/MR, FKSG87" ENSG00000162897 "Fc fragment of IgA and IgM receptor" Q8WWV6 1 206957965-206970625 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 23.9;liver: 7.6;lymphoid tissue: 23.0" "Cell line enhanced" "Detected in some" "CACO-2: 1.9;HMC-1: 1.0" "Cancer enhanced" "Detected in some" "renal cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056505 Enhanced 3600000 "HPA056505: " "unprognostic (2.94e-1)" "unprognostic (1.06e-1)" "unprognostic (8.53e-2)" "unprognostic (2.92e-1)" "unprognostic (7.44e-2)" "unprognostic (4.55e-3)" "unprognostic (2.69e-3)" "unprognostic (1.08e-4)" "unprognostic (3.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.82e-1)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (1.29e-1)" "unprognostic (3.88e-2)" "unprognostic (2.08e-1)" "unprognostic (1.26e-1)" 0.1 0.1 0.1 23.0 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.6 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 23.9 7.6 0.1 8.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 2.4 0.1 0.1 0.1 1.0 0.1 0.5 0.6 0.1 0.2 0.1 0.2 0.2 0.1 9.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.9 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 FCAR CD89 ENSG00000186431 "Fc fragment of IgA receptor" P24071 19 54874248-54890472 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "IgA-binding protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;lung: 19.5;lymphoid tissue: 15.9" "Cell line enhanced" "Detected in single" "THP-1: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 2.6;neutrophil: 6.1" "Group enriched" "Detected in many" 44 "granulocytes: 6.1;monocytes: 2.6" "Low region specificity" "Detected in many" HPA014050 Approved Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA014050: AB_1846338" "unprognostic (1.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.30e-1)" "unprognostic (4.71e-3)" "unprognostic (3.46e-1)" "unprognostic (2.02e-1)" "unprognostic (7.99e-2)" "unprognostic (1.54e-2)" "unprognostic (1.59e-2)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (7.05e-2)" "unprognostic (4.19e-6)" "unprognostic (9.23e-2)" "unprognostic (8.10e-3)" "unprognostic (8.04e-3)" "unprognostic (9.81e-2)" 4.0 0.6 0.4 1.5 4.4 28.1 0.8 0.1 1.0 0.6 0.6 0.7 0.0 0.6 0.6 0.6 0.6 3.8 0.6 8.2 2.0 0.4 0.6 1.8 19.5 15.9 1.2 0.0 2.2 0.6 0.6 0.3 1.5 4.3 0.6 0.6 0.9 0.6 0.6 0.6 0.6 0.6 0.7 2.7 14.9 0.9 2.1 0.0 1.0 0.6 0.3 0.6 4.4 4.8 0.0 0.0 6.1 2.6 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.7 0.4 4.4 0.1 1.0 2.0 0.4 1.2 0.0 4.3 0.0 FCER1A FCE1A ENSG00000179639 "Fc fragment of IgE receptor Ia" P12319 1 159289714-159308224 "FDA approved drug targets, Predicted membrane proteins" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "blood: 494.6" "Cell line enriched" "Detected in some" 94 "HEL: 97.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "basophil: 494.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 494.6" "Low region specificity" "Detected in all" "CAB022102, HPA036051, CAB055526" Approved "CAB022102: , CAB055526: , HPA036051: " "unprognostic (1.78e-2)" "unprognostic (2.26e-2)" "unprognostic (7.32e-2)" "unprognostic (7.51e-2)" "unprognostic (1.32e-2)" "unprognostic (1.44e-3)" "unprognostic (7.19e-2)" "unprognostic (1.97e-3)" "unprognostic (2.44e-1)" "unprognostic (7.20e-2)" "unprognostic (8.54e-2)" "unprognostic (2.74e-1)" "prognostic favourable (1.20e-4)" "unprognostic (1.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.70e-1)" "unprognostic (3.39e-2)" 5.8 1.4 1.6 3.6 0.8 6.0 9.2 0.9 1.3 8.0 3.4 1.1 3.4 3.2 10.6 5.6 12.1 2.0 25.4 4.1 4.3 1.3 3.6 2.4 27.8 0.6 1.0 5.3 1.5 2.6 0.5 1.9 0.5 2.7 9.4 5.4 6.5 5.9 4.7 1.2 17.9 4.1 6.0 2.8 3.5 2.3 1.5 6.8 2.4 2.5 19.7 16.2 3.8 4.9 0.0 75.4 494.6 0.3 0.4 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.8 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 494.6 0.3 0.9 0.0 0.1 0.1 0.0 0.1 0.0 75.4 0.0 0.0 0.1 0.4 0.4 0.2 10.4 0.0 3.0 1.6 0.8 0.9 1.3 4.3 1.3 1.0 5.3 2.7 6.8 FCER1G ENSG00000158869 "Fc fragment of IgE receptor Ig" P30273 1 161215234-161220699 "FDA approved drug targets, Predicted membrane proteins" "Immunity, Innate immunity" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 262.7;lymphoid tissue: 176.3" "Cell line enhanced" "Detected in some" "HEL: 17.1;HMC-1: 70.0;THP-1: 61.6;U-266/84: 18.9;U-937: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 262.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022108, HPA026872" Supported 9800000 "CAB022108: , HPA026872: AB_1848473" "unprognostic (3.71e-2)" "unprognostic (2.52e-2)" "unprognostic (2.40e-2)" "unprognostic (8.73e-3)" "unprognostic (1.46e-1)" "unprognostic (4.28e-2)" "unprognostic (3.10e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-1)" "unprognostic (9.63e-2)" "unprognostic (2.28e-2)" "unprognostic (5.67e-2)" "prognostic unfavourable (1.83e-6)" "unprognostic (1.99e-1)" "unprognostic (6.28e-2)" "unprognostic (2.04e-2)" "unprognostic (7.87e-2)" 62.6 20.5 12.1 49.5 22.4 71.5 17.6 2.4 10.8 10.6 14.6 14.1 1.3 8.0 7.2 15.9 6.9 20.5 18.8 21.2 15.3 11.2 18.9 35.9 71.2 124.8 23.4 4.5 11.4 7.4 2.9 7.9 38.1 17.0 9.7 21.3 9.7 12.8 7.4 11.9 5.7 13.6 28.5 33.3 176.3 10.9 11.6 16.0 6.5 11.5 6.7 14.7 22.4 10.5 0.9 135.4 73.5 262.7 66.6 2.0 132.1 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.1 0.2 0.5 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 17.1 0.1 3.3 0.0 3.5 70.0 1.4 0.7 0.5 0.0 0.1 0.0 1.6 0.5 0.1 0.3 8.3 0.3 0.0 0.0 1.5 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.6 0.0 61.6 0.1 0.4 0.1 0.2 0.2 0.7 18.9 0.2 0.4 19.3 0.1 64.3 129.8 12.1 0.5 210.3 0.6 0.9 0.4 0.4 97.1 0.3 0.7 2.0 73.5 66.6 262.7 135.4 0.8 132.1 12.1 22.4 2.4 10.8 15.3 11.2 23.4 4.5 17.0 16.0 FCER2 "CD23, CD23A, CLEC4J, FCE2" ENSG00000104921 "Fc fragment of IgE receptor II" P06734 19 7688758-7702146 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "IgE-binding protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 87.2;lymphoid tissue: 38.4" "Cell line enriched" "Detected in some" 14 "HDLM-2: 97.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "memory B-cell: 28.2;naive B-cell: 87.2" "Lineage enriched" "Detected in many" 34 "B-cells: 87.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002624, HPA008928" Enhanced "Secreted to blood" 59000 "CAB002624: , HPA008928: AB_1846285" "unprognostic (3.20e-4)" "unprognostic (1.87e-3)" "unprognostic (1.95e-2)" "unprognostic (2.44e-2)" "unprognostic (4.77e-2)" "unprognostic (1.77e-3)" "unprognostic (1.64e-1)" "unprognostic (1.89e-3)" "unprognostic (2.71e-1)" "unprognostic (1.88e-1)" "unprognostic (2.04e-2)" "unprognostic (8.55e-2)" "unprognostic (2.46e-4)" "unprognostic (2.99e-1)" "unprognostic (1.80e-1)" "unprognostic (4.89e-2)" "unprognostic (5.17e-2)" 2.4 0.3 0.5 17.1 0.5 2.3 1.2 0.3 1.1 0.3 1.0 0.1 0.4 1.3 0.3 2.3 1.0 0.4 0.5 0.8 0.3 0.3 0.6 0.6 0.8 21.1 0.3 0.0 0.4 0.3 0.0 0.3 0.3 0.1 0.3 0.8 0.0 7.5 0.7 0.4 0.6 7.7 0.4 0.3 38.4 0.8 0.5 0.0 6.3 0.7 0.0 33.8 2.0 0.5 87.2 0.7 0.2 2.5 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 97.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.5 0.0 0.0 2.5 0.0 28.2 0.0 0.0 0.7 87.2 0.0 0.0 0.2 0.0 0.7 0.1 0.0 3.0 0.5 0.5 0.3 0.3 0.3 0.3 0.3 0.0 0.1 0.0 FCGR2A "CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2" ENSG00000143226 "Fc fragment of IgG receptor IIa" P12318 1 161505430-161524013 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Immunity "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 182.8" "Cell line enhanced" "Detected in some" "HEL: 14.0;HMC-1: 28.2;K-562: 8.3;NB-4: 7.9;THP-1: 30.0;U-937: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 182.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 182.8" "HPA010718, HPA010776, HPA014730" Enhanced Supported "Golgi apparatus,Plasma membrane" 55000000 "Plasma membrane" "Golgi apparatus" "HPA010718: AB_1078463, HPA010776: , HPA014730: " "unprognostic (2.57e-2)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (4.12e-2)" "unprognostic (5.89e-2)" "unprognostic (6.17e-2)" "unprognostic (1.24e-2)" "unprognostic (1.17e-1)" "unprognostic (7.63e-2)" "unprognostic (1.17e-3)" "unprognostic (2.43e-2)" "unprognostic (2.91e-1)" "prognostic unfavourable (6.49e-7)" "unprognostic (8.85e-3)" "unprognostic (6.47e-3)" "unprognostic (1.54e-1)" "unprognostic (3.42e-2)" 36.8 12.6 13.2 44.6 19.2 18.6 8.2 2.2 10.1 9.1 7.1 10.0 0.0 3.8 4.7 6.6 5.5 11.6 17.0 11.3 17.0 8.9 11.5 7.1 44.1 50.0 25.9 1.7 8.0 5.8 2.8 6.1 47.5 19.6 7.0 9.9 10.8 8.3 4.8 7.3 3.0 7.3 17.6 30.9 43.4 5.9 4.8 19.2 3.2 6.3 2.5 4.4 19.3 4.5 0.2 7.0 182.8 27.2 0.0 0.0 10.6 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.2 0.0 0.3 4.0 28.2 0.3 0.0 0.0 0.0 0.0 8.3 0.2 0.0 0.0 0.2 7.9 0.0 0.6 0.1 0.6 3.8 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 30.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 12.9 3.5 0.1 27.2 31.6 0.0 20.7 0.0 0.2 0.0 0.0 7.0 0.1 0.0 0.0 182.8 0.0 16.7 0.2 0.0 10.6 13.2 19.2 2.2 10.1 17.0 8.9 25.9 1.7 19.6 19.2 FCGR2B "CD32, CD32B, FCG2, FCGR2" ENSG00000072694 "Fc fragment of IgG receptor IIb" P31994 1 161663147-161678654 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Host-virus interaction" "IgG-binding protein, Receptor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 53.3;placenta: 83.2" "Cell line enhanced" "Detected in some" "Daudi: 18.2;HMC-1: 23.0;NB-4: 5.1;RPMI-8226: 8.2" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 53.3;memory B-cell: 42.2" "Group enriched" "Detected in many" 18 "B-cells: 42.2;dendritic cells: 14.5;granulocytes: 53.3" "CAB007796, HPA014730" Enhanced "CAB007796: AB_562288, HPA014730: " "unprognostic (1.58e-1)" "unprognostic (5.14e-2)" "unprognostic (3.32e-3)" "unprognostic (3.12e-2)" "unprognostic (6.79e-3)" "unprognostic (4.05e-3)" "unprognostic (1.27e-1)" "unprognostic (4.65e-3)" "unprognostic (1.91e-1)" "unprognostic (4.72e-2)" "unprognostic (2.89e-2)" "unprognostic (3.49e-1)" "prognostic unfavourable (8.82e-4)" "unprognostic (3.51e-2)" "unprognostic (6.36e-2)" "unprognostic (4.31e-1)" "unprognostic (3.37e-1)" 11.3 2.4 0.0 2.0 0.2 0.0 4.1 0.0 0.0 1.9 3.4 0.2 0.9 0.2 2.1 2.1 2.3 3.7 0.0 0.2 2.0 9.5 5.6 2.5 0.5 0.8 0.6 0.0 0.3 83.2 0.3 2.0 3.3 0.2 0.5 2.0 4.6 3.1 4.7 6.7 1.5 0.1 1.7 5.6 3.3 1.2 42.2 14.5 53.3 1.9 0.1 0.3 2.4 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 5.1 0.1 0.0 0.0 0.0 8.2 0.0 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 2.2 0.0 53.3 1.8 5.4 0.3 1.9 0.1 42.2 0.1 0.2 14.5 34.3 0.0 0.3 11.2 0.1 1.7 0.0 0.0 2.4 FCGR3A "CD16, CD16a, FCG3, FCGR3" ENSG00000203747 "Fc fragment of IgG receptor IIIa" P08637 1 161541759-161550737 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 223.6;lymphoid tissue: 60.8" "Cell line enhanced" "Detected in some" "HaCaT: 1.7;SH-SY5Y: 1.3;U-2197: 1.1;U-266/70: 1.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 109.4;non-classical monocyte: 223.6" "Group enriched" "Detected in many" 4 "granulocytes: 73.0;monocytes: 223.6" "CAB032435, HPA055431" Supported "Secreted to blood" 2500000000 "CAB032435: AB_626925, HPA055431: " "unprognostic (5.27e-2)" "unprognostic (9.95e-2)" "unprognostic (2.37e-2)" "unprognostic (1.66e-1)" "unprognostic (1.39e-1)" "unprognostic (1.82e-1)" "unprognostic (2.24e-2)" "unprognostic (6.06e-2)" "unprognostic (2.41e-1)" "unprognostic (1.64e-1)" "unprognostic (1.98e-2)" "unprognostic (7.52e-2)" "prognostic unfavourable (3.22e-6)" "unprognostic (1.14e-1)" "unprognostic (4.66e-2)" "unprognostic (1.03e-2)" "unprognostic (7.51e-2)" 11.9 9.7 7.5 20.5 12.4 4.4 4.1 1.6 7.0 1.9 2.1 5.5 0.8 0.8 1.1 2.4 1.0 2.4 5.1 6.4 6.3 7.3 2.6 22.5 43.2 8.0 12.7 1.9 1.4 2.9 1.8 3.9 14.6 6.8 2.6 2.3 2.2 2.7 1.3 1.3 0.3 1.2 14.3 25.7 60.8 1.3 1.2 8.0 1.4 1.8 1.3 1.3 6.3 2.3 0.1 11.7 73.0 223.6 7.9 33.9 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.5 0.5 0.0 0.8 0.5 0.4 0.0 0.0 0.5 1.3 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.3 1.6 0.5 33.9 109.4 0.3 0.1 0.3 13.2 11.7 0.0 0.2 12.2 73.0 7.9 223.6 0.2 0.1 35.8 7.5 12.4 1.6 7.0 6.3 7.3 12.7 1.9 6.8 8.0 FCGRT "alpha-chain, FCRN" ENSG00000104870 "Fc fragment of IgG receptor and transporter" P55899 19 49506816-49526333 "Predicted intracellular proteins, Predicted membrane proteins" "IgG-binding protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 164.3" "Cell line enhanced" "Detected in many" "ASC diff: 41.7;Hep G2: 35.6;THP-1: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 164.3" "Group enriched" "Detected in all" 16 "dendritic cells: 70.7;granulocytes: 164.3;monocytes: 100.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012122, HPA015130" Enhanced 17000000 "HPA012122: AB_1848474, HPA015130: AB_1848475" "unprognostic (2.19e-3)" "unprognostic (2.05e-2)" "unprognostic (1.89e-1)" "unprognostic (1.69e-2)" "unprognostic (2.39e-1)" "unprognostic (1.26e-1)" "unprognostic (8.58e-2)" "unprognostic (3.87e-3)" "unprognostic (2.81e-1)" "unprognostic (3.49e-2)" "unprognostic (2.00e-3)" "unprognostic (3.64e-1)" "unprognostic (3.67e-3)" "unprognostic (3.40e-1)" "unprognostic (1.40e-1)" "unprognostic (1.29e-2)" "unprognostic (2.18e-3)" 55.6 25.4 10.9 30.0 10.7 20.9 68.7 5.3 9.6 41.7 104.2 14.3 15.3 54.7 30.8 41.7 19.8 28.7 49.3 42.9 12.0 5.8 32.4 87.4 41.7 51.6 15.8 8.7 41.0 32.2 16.1 17.3 32.0 13.2 28.0 30.3 27.5 20.9 19.4 19.9 22.1 125.2 23.8 14.2 66.3 24.1 24.6 10.2 14.1 28.5 15.3 13.1 20.1 27.9 4.4 70.7 164.3 100.2 2.0 7.0 72.1 0.0 8.7 1.5 31.2 41.7 21.1 1.3 6.7 18.5 5.3 5.9 12.2 5.5 0.0 13.8 10.9 2.1 0.3 0.2 3.3 0.0 11.7 17.2 0.1 35.6 24.8 0.2 3.1 25.1 0.5 4.1 0.0 20.8 2.9 2.9 14.0 0.2 0.1 3.4 0.4 5.6 0.6 8.0 0.9 24.0 2.3 0.6 5.9 1.4 0.0 0.9 6.6 46.8 6.7 13.5 2.5 0.2 0.3 0.6 3.3 2.4 2.0 15.7 1.9 29.3 100.2 63.3 1.9 65.6 2.3 4.1 3.1 3.0 70.7 4.4 7.0 3.9 164.3 2.0 42.3 40.1 1.9 72.1 10.9 10.7 5.3 9.6 12.0 5.8 15.8 8.7 13.2 10.2 FCMR "FAIM3, TOSO" ENSG00000162894 "Fc fragment of IgM receptor" O60667 1 206904386-206923247 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9" "Group enriched" "Detected in some" 5 "RPMI-8226: 51.7;U-266/70: 26.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 99.6;T-cells: 60.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA003910 Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Secreted to blood" 2400000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA003910: AB_1078798" "prognostic favourable (4.23e-4)" "unprognostic (1.16e-3)" "unprognostic (7.48e-2)" "unprognostic (3.06e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-3)" "unprognostic (1.15e-1)" "unprognostic (4.85e-3)" "unprognostic (1.03e-1)" "unprognostic (3.97e-1)" "unprognostic (3.23e-2)" "unprognostic (2.01e-1)" "unprognostic (8.15e-3)" "unprognostic (8.06e-2)" "unprognostic (2.12e-2)" "unprognostic (3.74e-2)" "unprognostic (5.05e-3)" 15.5 0.6 0.5 42.9 0.5 2.9 1.5 0.4 0.4 0.8 2.5 0.4 0.3 1.2 1.2 0.8 3.4 1.3 2.6 1.0 0.5 0.5 2.4 1.5 3.9 77.2 0.5 0.0 1.3 0.7 0.0 0.9 0.8 0.2 1.4 2.3 1.3 10.1 0.3 1.9 0.6 30.1 0.4 0.6 78.8 2.8 0.5 0.0 51.8 1.8 1.2 84.9 8.5 1.2 99.6 1.4 5.3 0.4 18.4 60.0 28.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.1 0.0 0.0 3.3 0.0 0.1 0.1 0.0 0.4 0.2 0.0 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 7.2 0.0 0.1 1.0 0.1 0.0 0.0 1.6 0.2 51.7 0.0 0.1 0.0 0.0 1.0 0.2 4.8 0.1 0.0 0.2 0.0 0.2 0.0 0.0 26.1 1.9 7.2 0.3 0.0 0.2 0.5 0.2 0.2 20.3 0.4 26.4 80.3 28.1 26.2 0.2 99.6 49.5 33.3 5.3 18.4 0.3 1.4 60.0 28.2 0.5 0.5 0.4 0.4 0.5 0.5 0.5 0.0 0.2 0.0 FCN1 FCNM ENSG00000085265 "Ficolin 1" O00602 9 134905890-134917963 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 318.5;bone marrow: 135.4" "Group enriched" "Detected in some" 7 "NB-4: 15.3;U-937: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "classical monocyte: 318.5;intermediate monocyte: 218.1" "Lineage enhanced" "Detected in many" "monocytes: 318.5" "HPA000685, HPA001295, CAB016760" Enhanced "Secreted to blood" 1064333333 63000000 "CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842" "unprognostic (1.57e-2)" "unprognostic (2.23e-1)" "unprognostic (1.14e-3)" "unprognostic (1.34e-1)" "unprognostic (9.91e-2)" "unprognostic (1.62e-3)" "unprognostic (3.66e-3)" "unprognostic (2.21e-1)" "unprognostic (1.14e-1)" "unprognostic (5.59e-2)" "unprognostic (2.49e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (3.98e-4)" "unprognostic (1.73e-2)" "unprognostic (5.58e-2)" "unprognostic (3.27e-2)" "unprognostic (2.28e-1)" 6.6 0.9 0.6 35.2 0.7 135.4 2.2 0.4 1.0 1.8 2.0 0.4 0.0 0.1 1.6 7.8 1.0 3.6 2.9 7.6 0.5 0.6 2.3 4.6 24.9 23.5 2.3 0.1 3.5 1.6 0.0 0.7 9.2 0.9 1.6 1.0 3.0 1.7 0.3 2.7 0.7 1.3 8.1 1.2 47.3 2.2 1.0 0.5 6.8 1.6 1.1 3.6 8.5 1.6 0.8 93.9 53.7 318.5 0.4 0.6 273.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 15.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 1.0 0.0 0.1 0.0 0.2 0.0 22.8 0.0 1.2 318.5 3.0 0.5 218.1 0.6 0.8 0.2 0.3 93.9 0.2 0.3 0.3 53.7 0.4 99.0 2.5 0.3 273.0 0.6 0.7 0.4 1.0 0.5 0.6 2.3 0.1 0.9 0.5 FCRL1 "CD307a, FCRH1, IFGP1, IRTA5" ENSG00000163534 "Fc receptor like 1" Q96LA6 1 157794403-157820105 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 31.6;lymphoid tissue: 55.1" "Group enriched" "Detected in some" 33 "Daudi: 5.6;U-698: 18.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 51 "memory B-cell: 16.8;naive B-cell: 31.6" "Lineage enriched" "Detected in single" 66 "B-cells: 31.6" "Low region specificity" "Detected in all" HPA013323 Enhanced 120000 "HPA013323: AB_1848480" "unprognostic (6.52e-4)" "unprognostic (3.49e-3)" "unprognostic (8.68e-3)" "unprognostic (8.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.01e-5)" "unprognostic (1.47e-2)" "unprognostic (5.48e-3)" "unprognostic (1.40e-2)" "unprognostic (4.30e-2)" "unprognostic (1.81e-1)" "unprognostic (2.85e-2)" "unprognostic (1.44e-3)" "unprognostic (1.96e-1)" "unprognostic (1.65e-2)" "unprognostic (4.80e-2)" "unprognostic (6.74e-2)" 0.5 0.2 0.2 55.1 0.2 6.2 0.3 0.2 0.2 0.2 0.7 0.0 0.0 0.0 0.2 0.1 2.4 0.3 0.2 0.3 0.2 0.2 0.7 0.5 1.9 19.2 0.2 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.5 0.3 0.3 5.4 0.7 0.2 0.2 10.1 0.0 0.2 25.3 0.4 0.2 0.0 1.1 0.7 0.4 49.0 4.5 0.8 31.6 0.0 0.4 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 16.8 0.0 0.0 0.0 31.6 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 FCRL3 "CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e" ENSG00000160856 "Fc receptor like 3" Q96P31 1 157674321-157700857 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.3;lymphoid tissue: 32.2" "Cell line enriched" "Detected in some" 7 "Daudi: 14.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive B-cell: 20.3" "Group enriched" "Detected in many" 56 "B-cells: 20.3;NK-cells: 10.7;T-cells: 10.8" "Low region specificity" "Detected in all" HPA048022 Enhanced "HPA048022: " "unprognostic (6.73e-3)" "unprognostic (5.06e-4)" "unprognostic (1.13e-2)" "unprognostic (2.08e-4)" "unprognostic (3.86e-1)" "unprognostic (1.74e-5)" "unprognostic (1.09e-2)" "unprognostic (4.29e-3)" "unprognostic (3.69e-3)" "unprognostic (2.46e-4)" "unprognostic (1.13e-1)" "unprognostic (2.55e-2)" "unprognostic (2.01e-4)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (2.21e-1)" "unprognostic (6.69e-2)" 0.4 0.2 0.2 29.4 0.2 0.4 0.3 0.2 0.2 0.3 0.6 0.0 0.0 0.0 0.5 0.2 1.5 0.3 0.6 0.3 0.2 0.2 0.5 0.6 0.9 26.4 0.4 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.5 0.6 0.2 5.6 0.0 0.4 0.2 8.7 0.1 0.2 22.4 0.6 0.2 0.0 5.2 0.6 0.6 32.2 1.2 0.3 20.3 0.0 0.2 0.0 10.7 10.8 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 1.0 16.1 1.4 7.2 0.0 20.3 0.1 4.7 0.2 10.7 0.0 0.0 5.6 3.5 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.0 0.0 FCRL4 "CD307d, FCRH4, IGFP2, IRTA1" ENSG00000163518 "Fc receptor like 4" Q96PJ5 1 157573749-157598080 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 5.4;lymphoid tissue: 15.6" "Cell line enriched" "Detected in single" 102 "U-266/70: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 12 "B-cells: 1.1" "Low region specificity" "Detected in many" HPA054030 Approved "HPA054030: " "unprognostic (6.06e-2)" "unprognostic (3.41e-3)" "unprognostic (2.57e-1)" "unprognostic (5.08e-2)" "unprognostic (4.69e-4)" "unprognostic (2.06e-2)" "unprognostic (6.38e-2)" "unprognostic (1.99e-1)" "unprognostic (2.14e-1)" "unprognostic (3.37e-1)" "unprognostic (6.77e-2)" 0.1 0.1 0.1 15.6 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 5.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 2.5 0.0 0.1 0.1 5.4 0.0 0.1 2.2 0.3 0.1 0.0 1.1 0.1 1.9 14.9 0.4 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 FCRLA "FCRL, FCRLa, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595" ENSG00000132185 "Fc receptor like A" Q7L513 1 161706972-161714352 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 66.3;lymphoid tissue: 51.8" "Group enriched" "Detected in some" 6 "Daudi: 91.8;SK-MEL-30: 37.8;U-698: 50.9" "Cancer enriched" "Detected in many" 21 "melanoma: 38.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "memory B-cell: 66.3;naive B-cell: 61.9" "Lineage enriched" "Detected in many" 9 "B-cells: 66.3" "Not detected" "Not detected" "Not detected" "Not detected" CAB016545 Enhanced "Intracellular and membrane" "CAB016545: AB_2247037" "unprognostic (5.46e-4)" "unprognostic (7.19e-2)" "unprognostic (3.69e-3)" "unprognostic (4.75e-4)" "unprognostic (4.69e-2)" "unprognostic (1.48e-4)" "unprognostic (1.45e-2)" "unprognostic (4.15e-3)" "unprognostic (8.66e-2)" "unprognostic (3.58e-4)" "unprognostic (2.19e-2)" "unprognostic (2.89e-1)" "unprognostic (6.84e-5)" "unprognostic (3.21e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-1)" "unprognostic (2.08e-2)" 0.4 0.2 0.6 31.7 0.7 1.3 0.3 0.2 0.3 0.2 0.9 0.2 0.0 0.2 0.2 0.0 2.4 0.2 0.2 0.6 0.5 0.3 0.6 0.4 0.4 26.3 0.4 0.0 0.2 0.2 0.0 0.2 0.1 0.2 0.5 0.9 0.6 4.8 0.0 0.4 0.6 13.9 0.0 0.7 42.4 1.3 0.2 0.1 2.0 0.5 0.3 51.8 1.9 0.4 66.3 6.9 0.0 0.0 0.0 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.4 0.0 0.1 0.0 0.0 91.8 0.0 1.3 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.5 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.6 10.6 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 50.9 0.5 0.0 9.1 0.0 0.0 0.0 0.1 0.0 0.0 66.3 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 6.9 0.0 2.7 0.6 0.7 0.2 0.3 0.5 0.3 0.4 0.0 0.2 0.1 FDFT1 ENSG00000079459 "Farnesyl-diphosphate farnesyltransferase 1" P37268 8 11795573-11839309 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 78.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008874 Approved Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA008874: AB_1078844" "unprognostic (2.33e-1)" "unprognostic (2.60e-1)" "prognostic favourable (4.92e-5)" "unprognostic (1.29e-2)" "unprognostic (1.46e-2)" "unprognostic (1.71e-1)" "unprognostic (8.10e-2)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" "unprognostic (2.45e-1)" "unprognostic (2.31e-3)" "unprognostic (2.57e-1)" "prognostic favourable (6.59e-9)" "unprognostic (2.28e-1)" "unprognostic (4.06e-2)" "unprognostic (3.86e-1)" "unprognostic (2.06e-1)" 20.8 44.3 26.3 22.7 27.7 30.6 57.5 19.5 43.6 27.6 41.7 45.9 20.0 44.6 26.9 29.1 59.4 27.5 19.9 27.1 29.8 32.1 24.9 45.9 30.7 23.4 36.2 34.4 22.9 18.0 17.1 18.2 22.1 47.4 38.8 32.9 32.4 46.5 20.6 71.2 38.4 30.2 18.0 56.5 18.4 35.4 41.3 40.5 25.9 24.7 32.2 25.4 25.8 34.2 44.0 30.5 42.2 19.6 22.6 31.0 29.0 21.6 10.5 47.1 18.8 10.2 17.5 14.3 8.5 14.5 9.0 18.7 14.7 26.8 30.1 4.2 8.5 18.0 23.3 71.0 7.3 5.0 24.9 14.1 8.0 35.0 21.7 7.3 9.9 15.7 18.0 20.1 10.0 11.3 20.3 39.7 8.8 14.1 25.7 17.4 41.2 6.2 15.8 10.9 61.8 41.8 78.8 15.1 9.4 7.4 12.6 21.3 20.7 21.3 14.1 4.2 10.5 1.9 5.3 8.2 20.7 32.8 7.4 24.8 12.4 42.2 19.6 22.6 21.6 17.2 20.8 44.0 22.7 21.2 30.5 35.3 21.5 20.3 18.6 22.6 11.7 22.7 31.0 29.0 26.3 27.7 19.5 43.6 29.8 32.1 36.2 34.4 47.4 40.5 FER1L6 C8ORFK23 ENSG00000214814 "Fer-1 like family member 6" Q2WGJ9 8 123851987-124120061 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "stomach 1: 29.3" "Cell line enhanced" "Detected in some" "AF22: 2.7;ASC TERT1: 4.9;BJ hTERT+: 3.2;PC-3: 4.4;U-87 MG: 4.3" "Group enriched" "Detected in some" 6 "pancreatic cancer: 4.2;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054117 Enhanced "HPA054117: " "unprognostic (1.90e-1)" "unprognostic (3.08e-3)" "unprognostic (2.06e-3)" "unprognostic (3.91e-2)" "unprognostic (2.09e-1)" "unprognostic (9.49e-3)" "unprognostic (1.36e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (3.32e-2)" "unprognostic (3.23e-6)" "unprognostic (7.09e-2)" "unprognostic (8.43e-2)" "unprognostic (2.79e-3)" "unprognostic (6.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.1 1.7 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.4 0.0 3.8 0.0 0.0 0.0 29.3 3.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.2 4.9 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.9 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.3 4.4 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.1 0.0 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGFR1 "BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM" ENSG00000077782 "Fibroblast growth factor receptor 1" P11362 8 38411138-38468834 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Transcription, Transcription regulation" "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 109.2;BJ hTERT+: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033614, HPA056402" Approved 120000000 "CAB033614: AB_783377, HPA056402: " "unprognostic (9.53e-2)" "unprognostic (7.33e-2)" "unprognostic (2.44e-1)" "unprognostic (1.35e-2)" "unprognostic (4.23e-3)" "unprognostic (7.02e-2)" "unprognostic (6.59e-2)" "unprognostic (2.77e-1)" "unprognostic (1.81e-1)" "unprognostic (3.99e-2)" "unprognostic (7.97e-3)" "unprognostic (4.59e-2)" "unprognostic (7.69e-2)" "unprognostic (6.87e-3)" "unprognostic (5.60e-2)" "unprognostic (4.59e-3)" "unprognostic (1.05e-3)" 41.1 8.6 12.5 14.5 12.2 7.2 39.5 45.0 10.5 36.0 31.5 10.1 11.6 5.5 29.3 20.6 22.9 29.4 32.4 31.7 12.8 10.1 11.8 5.4 18.6 9.7 11.4 14.3 42.0 51.2 11.5 22.3 28.4 20.0 28.2 10.8 35.8 14.0 31.6 12.0 12.9 14.4 52.4 15.6 4.5 16.4 16.4 8.5 11.3 12.6 13.0 9.8 39.6 41.2 1.6 0.7 1.8 1.1 0.8 5.7 0.7 2.4 9.3 40.3 109.2 25.1 17.9 26.6 24.8 49.8 17.3 18.0 6.0 1.4 0.3 6.9 23.8 0.0 19.1 1.2 20.0 6.5 4.2 0.0 1.5 5.9 14.1 5.8 0.1 16.2 0.1 14.0 2.8 16.6 2.2 0.1 8.1 2.8 17.0 1.9 28.4 3.9 15.7 4.2 0.0 8.4 0.0 1.6 3.6 4.4 0.2 1.0 2.2 1.1 10.4 11.3 6.2 31.2 5.9 0.4 0.7 0.0 13.4 0.3 5.9 1.4 1.1 0.4 5.7 0.3 3.9 0.7 2.7 3.7 0.1 1.6 1.5 4.1 1.8 0.8 0.5 0.7 2.2 0.7 12.5 12.2 45.0 10.5 12.8 10.1 11.4 14.3 20.0 8.5 FGFR2 "BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25" ENSG00000066468 "Fibroblast growth factor receptor 2" P21802 10 121478334-121598458 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.8" "Cell line enhanced" "Detected in some" "AN3-CA: 57.8;BEWO: 19.4;CACO-2: 15.1;HaCaT: 17.4;HAP1: 18.7;NTERA-2: 18.5;T-47d: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 10.8;eosinophil: 4.6" "Lineage enriched" "Detected in single" 35 "granulocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010886, HPA035305" Uncertain Supported "Nucleoplasm,Vesicles,Cell Junctions" "Secreted - unknown location" 500000 "Cell Junctions" "Nucleoplasm, Vesicles" "CAB010886: AB_259379, HPA035305: AB_10672862" "unprognostic (5.53e-2)" "prognostic favourable (8.79e-4)" "unprognostic (1.08e-1)" "unprognostic (5.23e-2)" "unprognostic (1.73e-1)" "prognostic favourable (9.32e-4)" "unprognostic (1.53e-1)" "unprognostic (4.96e-3)" "unprognostic (1.74e-1)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "unprognostic (2.54e-1)" "unprognostic (6.93e-2)" "unprognostic (2.25e-1)" 2.1 8.8 16.4 3.0 30.3 0.0 9.9 15.8 21.3 6.8 14.1 55.7 5.6 4.2 22.0 6.6 10.2 12.5 12.5 1.4 20.6 11.1 11.4 16.1 13.1 1.0 41.2 13.3 7.4 12.8 25.5 2.5 6.2 30.2 11.7 8.7 16.4 23.8 24.3 0.4 45.4 4.7 18.3 74.8 0.5 9.3 2.9 32.1 0.8 23.4 1.6 3.4 6.9 8.5 0.1 0.1 10.8 0.1 0.1 0.3 0.0 2.2 0.1 9.0 57.8 0.0 0.0 19.4 0.1 0.0 0.0 0.0 15.1 0.3 0.0 4.1 0.9 17.4 18.7 4.0 0.0 0.0 4.0 0.0 0.0 0.3 0.4 0.0 3.8 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 18.5 0.0 0.0 0.0 2.2 5.6 4.9 0.1 0.1 0.1 10.6 0.0 15.5 0.0 0.0 0.1 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 10.8 0.1 4.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 16.4 30.3 15.8 21.3 20.6 11.1 41.2 13.3 30.2 32.1 FGFR3 "ACH, CD333, CEK2, JTK4" ENSG00000068078 "Fibroblast growth factor receptor 3" P22607 4 1793293-1808872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Apoptosis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skin 1: 131.7" "Cell line enhanced" "Detected in many" "CACO-2: 19.1;HaCaT: 14.9;Hep G2: 32.1;NTERA-2: 15.6;RT4: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004231, HPA067204" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" 670000 "Endoplasmic reticulum" "CAB004231: AB_627596, HPA067204: " "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.49e-1)" "prognostic unfavourable (3.77e-4)" "unprognostic (5.90e-2)" "unprognostic (1.24e-3)" "unprognostic (7.22e-2)" "unprognostic (2.54e-1)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.38e-1)" "unprognostic (2.88e-2)" "unprognostic (1.30e-1)" "unprognostic (9.11e-3)" "unprognostic (1.98e-1)" "unprognostic (4.74e-2)" "unprognostic (1.97e-1)" 1.5 1.5 24.7 1.7 30.3 1.6 4.2 10.2 22.0 4.1 4.9 15.8 3.4 9.9 1.8 2.7 26.9 2.0 5.0 2.0 21.6 11.7 9.6 7.4 4.5 1.3 17.6 21.5 1.1 23.0 1.2 3.0 5.6 15.1 3.7 3.8 1.7 3.8 9.0 1.7 131.7 7.4 1.3 9.0 2.1 4.9 8.1 10.6 0.1 1.3 8.5 7.3 8.5 10.1 0.1 0.6 0.1 0.1 0.2 0.3 0.0 0.0 1.5 9.0 2.6 0.0 0.1 9.2 1.0 0.1 0.4 0.2 19.1 0.4 0.0 7.6 0.3 14.9 2.6 0.1 0.1 0.1 9.6 5.9 1.5 32.1 0.0 0.0 0.1 0.0 5.0 0.1 0.0 0.0 6.4 0.0 0.0 9.5 0.3 0.2 15.6 0.0 0.5 0.5 0.1 1.3 19.1 2.6 0.7 0.8 1.6 0.0 8.9 1.1 0.4 0.0 0.9 0.2 0.6 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.6 0.1 0.0 24.7 30.3 10.2 22.0 21.6 11.7 17.6 21.5 15.1 10.6 FGFR4 "CD334, JTK2" ENSG00000160867 "Fibroblast growth factor receptor 4" P22455 5 177086886-177098144 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 33.6;kidney: 37.7;liver: 45.3" "Group enriched" "Detected in many" 4 "CACO-2: 42.0;Hep G2: 42.0;RH-30: 67.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005196, HPA027273, HPA027369, HPA028251" Approved "Intracellular and membrane" 4300000 "CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221" "unprognostic (1.96e-1)" "unprognostic (2.10e-2)" "unprognostic (1.12e-1)" "unprognostic (9.06e-3)" "unprognostic (2.87e-1)" "unprognostic (1.95e-2)" "unprognostic (7.85e-3)" "unprognostic (9.19e-2)" "unprognostic (4.25e-1)" "unprognostic (4.46e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (1.78e-1)" "unprognostic (1.71e-3)" "unprognostic (2.41e-1)" "unprognostic (5.75e-2)" "unprognostic (4.68e-2)" 0.5 5.7 0.7 14.3 0.6 0.1 1.6 2.6 0.5 2.8 10.4 0.9 0.7 13.5 0.9 4.8 1.6 1.7 33.6 0.7 0.8 0.3 37.7 45.3 25.3 2.5 0.7 1.0 13.6 26.0 0.0 0.7 1.3 0.8 4.0 3.7 2.0 1.6 0.3 4.3 0.5 17.3 1.6 0.8 11.2 5.4 2.9 0.4 0.3 0.8 2.3 0.7 1.9 3.6 1.1 0.9 3.0 1.1 0.4 0.4 0.0 0.7 11.8 0.2 2.9 0.0 0.0 5.8 0.0 0.0 0.0 0.0 42.0 1.6 1.2 5.5 0.0 0.6 2.3 0.4 0.0 0.7 2.8 0.1 0.6 42.0 1.3 0.1 1.0 0.2 0.0 2.1 0.0 0.0 3.9 0.1 0.9 9.6 0.0 0.8 7.1 1.0 1.9 67.6 7.1 5.7 0.1 0.4 0.7 0.4 3.0 1.4 2.9 0.6 0.2 0.0 5.7 0.0 0.1 0.4 0.4 0.7 0.0 0.2 0.5 1.5 1.1 0.4 0.4 0.3 0.3 1.1 0.4 0.0 0.1 0.6 0.4 0.4 3.0 0.4 0.3 0.9 0.2 0.0 0.7 0.6 2.6 0.5 0.8 0.3 0.7 1.0 0.8 0.4 FGFRL1 ENSG00000127418 "Fibroblast growth factor receptor like 1" Q8N441 4 1009936-1026897 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 51.1" "Cell line enhanced" "Detected in many" "U-251 MG: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.5;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;monocytes: 3.6;T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026019, HPA068828" Approved Supported Vesicles Vesicles "CAB026019: , HPA068828: " "unprognostic (1.30e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "unprognostic (2.80e-2)" "unprognostic (1.23e-2)" "unprognostic (1.48e-1)" "unprognostic (2.62e-2)" "unprognostic (9.79e-2)" "unprognostic (4.87e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-3)" "unprognostic (1.49e-1)" "unprognostic (7.80e-2)" "unprognostic (1.06e-2)" "unprognostic (1.96e-2)" 21.8 22.9 16.0 6.1 20.5 5.8 21.5 13.8 20.6 8.1 6.6 9.1 5.3 6.6 6.6 5.0 4.7 19.7 9.8 12.2 16.6 3.6 11.5 25.1 6.4 4.0 8.8 8.4 14.0 51.1 12.6 9.0 3.1 17.0 7.6 4.8 12.7 29.3 3.1 9.6 3.7 6.0 4.1 14.0 5.3 15.0 3.2 11.1 1.0 33.8 3.9 3.6 6.2 11.5 0.4 0.3 1.2 3.6 0.1 1.2 0.4 8.5 11.6 4.2 12.8 4.5 4.7 1.1 15.2 2.3 4.8 3.2 8.4 17.7 0.9 19.8 23.1 2.2 8.1 5.1 4.5 3.2 7.9 0.1 15.2 22.1 9.2 4.9 2.1 9.9 4.4 8.4 3.6 4.6 9.3 3.3 2.9 11.1 5.7 13.5 5.3 31.6 9.4 6.2 6.0 8.5 1.3 0.4 0.8 14.0 0.3 5.6 8.4 4.3 9.9 26.2 10.7 13.2 36.8 3.6 4.8 1.3 6.9 5.7 8.4 1.2 0.1 0.0 0.7 3.5 0.1 0.4 1.2 0.2 0.3 0.1 0.2 0.5 0.0 0.1 3.6 0.3 0.1 0.4 16.0 20.5 13.8 20.6 16.6 3.6 8.8 8.4 17.0 11.1 FIG4 "ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3" ENSG00000112367 "FIG4 phosphoinositide 5-phosphatase" Q92562 6 109691312-109825428 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017823, HPA068859" Approved Approved "Vesicles,Lipid droplets" "Vesicles, Lipid droplets" "CAB017823: , HPA068859: " "prognostic unfavourable (5.91e-4)" "unprognostic (4.12e-2)" "prognostic favourable (8.42e-4)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (4.73e-4)" "unprognostic (7.06e-2)" "unprognostic (2.69e-1)" "unprognostic (8.67e-2)" "unprognostic (3.44e-3)" "unprognostic (4.22e-2)" "prognostic favourable (8.19e-4)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (5.45e-2)" "unprognostic (2.00e-2)" 11.0 13.5 14.5 12.2 30.3 14.0 14.4 13.5 35.3 12.4 13.2 11.0 5.0 8.3 11.3 17.0 11.7 10.5 13.4 10.1 14.5 18.5 13.2 8.7 19.2 16.6 17.6 17.7 12.2 9.9 25.4 15.4 12.6 19.0 11.6 14.6 9.7 17.0 12.0 12.1 9.2 10.7 14.7 16.0 17.3 11.4 12.6 12.9 18.1 12.6 8.5 15.0 12.5 10.5 15.5 15.9 12.8 20.0 8.0 7.7 9.8 6.2 6.5 9.8 11.7 10.4 14.4 6.2 8.1 11.7 6.7 18.0 4.8 6.6 16.8 5.2 13.1 4.7 9.6 6.4 15.6 10.2 11.7 9.4 6.5 4.8 9.6 8.8 8.4 7.4 8.4 11.4 7.9 13.6 5.5 7.2 9.4 5.8 9.0 7.6 5.1 3.2 6.3 4.5 5.8 11.3 15.5 10.9 10.2 5.3 7.8 16.4 5.6 14.7 9.5 4.2 3.6 6.1 6.9 3.4 2.4 8.1 22.3 6.3 3.8 11.5 20.0 12.8 7.7 19.7 6.0 14.6 5.7 7.3 15.9 15.5 7.0 6.8 8.7 8.0 13.5 6.9 6.6 9.8 14.5 30.3 13.5 35.3 14.5 18.5 17.6 17.7 19.0 12.9 FIS1 "CGI-135, Fis1, H_NH0132A01.6, TTC11" ENSG00000214253 "Fission, mitochondrial 1" Q9Y3D6 7 101239458-101252316 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017430 Approved Supported Mitochondria 590000 Mitochondria "HPA017430: AB_1848608" "unprognostic (1.45e-2)" "unprognostic (8.20e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.48e-2)" "unprognostic (1.63e-1)" "unprognostic (7.73e-2)" "unprognostic (6.54e-2)" "unprognostic (5.33e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-3)" "unprognostic (3.47e-2)" "prognostic favourable (1.08e-7)" "unprognostic (1.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" 35.1 46.8 53.4 22.3 49.9 32.7 35.8 26.0 60.0 30.3 34.4 57.9 38.0 30.0 31.1 42.7 35.6 47.0 39.4 78.6 52.6 44.8 39.6 58.3 27.8 23.6 65.3 37.8 41.2 56.6 39.5 37.1 34.0 45.1 29.3 26.3 28.8 45.2 43.8 120.5 29.7 29.2 32.4 87.9 28.1 31.1 30.4 44.1 21.3 47.1 48.8 22.6 30.5 29.3 73.0 73.4 63.6 67.4 55.6 72.8 87.9 24.7 29.2 21.9 31.4 25.3 33.9 15.0 26.9 32.8 24.6 21.2 20.1 40.8 24.3 36.0 36.9 14.6 15.3 43.5 13.8 18.8 22.2 11.0 42.5 26.6 30.2 20.5 17.1 32.2 41.0 17.2 26.4 44.5 23.1 33.4 37.0 113.9 31.9 37.0 24.3 28.4 15.6 12.3 53.2 37.2 28.7 28.4 33.3 12.8 61.9 18.2 20.6 23.3 36.4 28.9 18.6 29.9 28.6 28.3 21.6 14.0 26.8 23.3 37.7 58.9 67.4 63.6 63.2 65.5 65.1 72.2 61.0 59.7 73.4 73.0 60.7 63.5 51.4 55.6 59.0 61.4 72.8 87.9 53.4 49.9 26.0 60.0 52.6 44.8 65.3 37.8 45.1 44.1 FKBP11 FKBP19 ENSG00000134285 "FK506 binding protein 11" Q9NYL4 12 48921518-48926474 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 175.6;salivary gland: 62.0" "Cell line enhanced" "Detected in many" "HHSteC: 46.2;Karpas-707: 42.0;RPMI-8226: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 37.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041709 Enhanced Approved Centrosome Centrosome "HPA041709: AB_10794487" "unprognostic (7.45e-3)" "unprognostic (8.62e-2)" "unprognostic (2.40e-1)" "prognostic favourable (7.09e-4)" "unprognostic (1.70e-2)" "unprognostic (2.00e-1)" "unprognostic (3.46e-2)" "unprognostic (1.75e-1)" "unprognostic (7.64e-2)" "unprognostic (3.49e-3)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.15e-1)" "unprognostic (4.51e-1)" "unprognostic (2.79e-1)" "unprognostic (1.54e-1)" 5.6 4.6 1.1 8.2 1.4 3.7 3.7 0.9 2.2 7.5 6.9 0.9 21.6 9.2 4.4 12.9 4.4 4.8 8.1 3.4 1.3 2.4 4.8 38.4 5.8 16.6 1.0 1.3 3.7 175.6 0.2 12.3 3.3 1.6 4.8 6.3 1.9 62.0 20.9 1.4 1.7 7.6 2.9 1.0 18.7 10.0 1.9 0.9 2.2 4.7 4.9 14.5 8.2 4.3 11.1 8.3 1.1 0.3 5.1 37.6 7.3 2.1 2.8 0.5 0.7 12.6 19.1 1.0 16.6 23.9 18.4 21.8 10.7 12.0 32.4 0.5 27.2 8.9 5.8 7.3 9.6 6.8 1.2 1.2 3.0 0.1 46.2 0.6 0.9 21.3 14.2 14.1 26.3 10.4 0.4 42.0 6.7 6.0 4.8 1.1 1.4 5.3 13.3 0.8 42.0 2.3 0.4 6.9 2.0 5.5 8.3 3.7 0.5 1.0 8.3 3.6 0.7 0.3 0.3 24.6 20.3 16.4 2.2 0.7 5.9 0.9 0.2 0.6 22.5 0.3 37.6 11.1 15.6 17.7 0.3 4.8 9.4 14.4 1.1 5.1 0.1 8.3 6.4 7.3 1.1 1.4 0.9 2.2 1.3 2.4 1.0 1.3 1.6 0.9 FKBP1A "FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE" ENSG00000088832 "FK506 binding protein 1A" P62942 20 1368978-1393172 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Isomerase, Rotamase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 149.0;TIME: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 63.6;granulocytes: 88.4;monocytes: 94.3" "CAB004639, HPA051798" Uncertain 16000000 "CAB004639: AB_425434, HPA051798: " "unprognostic (4.09e-2)" "unprognostic (2.29e-1)" "unprognostic (5.22e-3)" "unprognostic (1.28e-2)" "unprognostic (2.66e-1)" "unprognostic (7.18e-3)" "prognostic unfavourable (3.44e-7)" "unprognostic (7.05e-3)" "unprognostic (2.76e-1)" "unprognostic (8.81e-2)" "unprognostic (5.12e-3)" "unprognostic (6.65e-2)" "prognostic unfavourable (6.69e-5)" "unprognostic (1.97e-2)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (1.47e-1)" 106.0 42.4 67.3 55.0 114.8 44.4 63.5 15.8 55.8 33.2 39.7 22.1 33.8 32.7 45.5 45.9 42.7 33.8 32.0 36.4 51.7 30.6 41.9 41.7 59.2 84.1 26.0 36.5 41.7 57.7 20.6 21.7 65.0 22.5 34.4 49.4 21.4 30.8 40.6 38.9 31.5 37.1 56.0 23.3 68.0 33.0 21.1 28.4 47.4 62.2 39.7 48.3 48.1 37.0 13.3 63.6 88.4 94.3 14.5 18.6 84.3 69.9 19.4 15.5 22.4 52.4 65.7 20.4 44.5 30.2 35.7 33.1 19.3 27.2 28.6 14.3 41.4 32.2 19.9 81.3 46.9 8.2 21.7 29.4 9.1 36.8 32.2 34.1 16.3 38.2 26.0 32.9 34.0 149.0 26.9 14.7 41.9 8.7 33.3 47.0 33.2 38.0 28.6 27.0 34.7 46.0 17.7 25.8 19.5 22.0 44.3 73.6 17.4 29.1 172.6 132.5 22.2 28.2 32.8 7.4 15.9 30.0 22.8 34.6 29.3 23.9 79.4 88.4 11.5 94.3 10.2 12.8 13.9 13.2 63.6 13.3 14.8 14.2 77.9 14.5 90.3 31.6 18.6 84.3 67.3 114.8 15.8 55.8 51.7 30.6 26.0 36.5 22.5 28.4 FKBP8 "FKBP38, FKBPr38" ENSG00000105701 "FK506 binding protein 8" Q14318 19 18531751-18544077 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 32.5;neutrophil: 31.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025346, HPA045177" Supported Supported "Endoplasmic reticulum,Mitochondria,Cytosol" Mitochondria "Endoplasmic reticulum, Cytosol" "CAB025346: , HPA045177: " "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (1.24e-4)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (9.22e-2)" "unprognostic (2.54e-2)" "unprognostic (2.26e-1)" "unprognostic (2.10e-2)" "unprognostic (1.49e-1)" "prognostic favourable (7.76e-4)" "unprognostic (8.51e-2)" "unprognostic (1.61e-1)" "unprognostic (2.97e-1)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (2.32e-1)" 44.3 38.1 75.9 27.5 82.1 82.5 26.5 43.4 113.7 35.2 31.9 41.2 34.6 31.1 31.4 27.2 48.7 39.3 34.5 43.4 69.6 62.1 28.9 42.7 34.3 31.1 55.3 54.3 56.1 60.4 28.8 42.2 36.6 51.2 36.5 12.9 31.9 73.1 46.1 56.7 35.1 31.6 34.6 46.3 36.7 31.9 49.5 26.9 32.1 38.8 24.2 30.7 36.3 45.8 4.3 4.3 32.5 6.9 3.1 6.6 9.1 36.6 26.3 20.6 39.1 21.3 33.5 51.7 29.7 31.6 22.7 31.5 24.9 50.0 21.0 48.3 36.4 19.9 12.7 41.3 6.4 25.6 60.3 19.6 34.3 29.9 36.7 19.4 43.2 43.7 39.9 20.4 13.0 23.3 41.1 50.0 19.7 61.0 35.2 58.1 42.1 38.2 37.0 17.1 71.8 30.5 24.0 22.9 41.7 20.8 17.2 37.0 20.2 56.7 27.1 28.4 26.0 55.4 22.5 38.3 21.9 24.4 64.3 31.2 25.2 6.3 5.6 32.5 6.0 5.8 5.5 4.1 6.1 6.6 4.3 4.3 4.7 5.3 31.0 3.1 6.9 4.3 6.0 9.1 75.9 82.1 43.4 113.7 69.6 62.1 55.3 54.3 51.2 26.9 FKRP "LGMD2I, MDC1C" ENSG00000181027 "Fukutin related protein" Q9H9S5 19 46746046-46776988 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cardiomyopathy, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043115, HPA060454" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA043115: , HPA060454: " "unprognostic (4.44e-2)" "unprognostic (5.20e-2)" "unprognostic (2.19e-2)" "unprognostic (8.37e-3)" "unprognostic (1.83e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "unprognostic (2.99e-2)" "unprognostic (4.59e-3)" "prognostic favourable (8.98e-4)" "unprognostic (3.53e-1)" "unprognostic (2.30e-2)" "unprognostic (2.53e-1)" "unprognostic (2.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.53e-2)" 13.7 10.7 12.4 12.5 17.5 12.6 9.6 7.4 25.2 10.5 11.5 12.8 13.7 7.8 15.7 8.7 8.3 12.7 10.1 13.1 9.8 12.2 10.7 10.8 11.6 11.0 11.5 11.1 13.3 13.2 12.9 16.9 16.5 14.1 13.6 7.3 13.0 17.8 13.2 23.6 9.6 9.7 13.4 9.1 14.7 10.3 13.0 11.1 8.8 13.5 7.8 7.9 12.3 10.2 6.9 5.0 5.4 4.2 5.6 4.5 2.4 8.4 18.0 12.4 8.6 10.9 12.2 11.0 21.5 14.5 8.8 14.0 11.4 14.7 7.5 12.1 12.3 8.9 4.6 10.0 8.1 14.9 15.3 8.0 8.7 7.2 9.7 6.2 13.7 13.5 8.7 10.9 10.7 11.5 7.9 7.7 8.9 3.8 4.5 15.1 12.1 4.5 12.2 7.6 2.8 5.6 18.1 8.5 16.1 10.8 5.2 7.0 6.4 4.9 11.9 13.2 13.9 4.8 17.2 8.2 9.8 7.2 10.7 5.0 17.5 3.4 4.2 2.5 4.1 2.5 2.8 4.6 3.0 4.5 2.6 6.9 3.7 4.5 5.4 5.6 2.6 5.0 1.6 2.4 12.4 17.5 7.4 25.2 9.8 12.2 11.5 11.1 14.1 11.1 FLRT1 "MGC21624, SPG68" ENSG00000126500 "Fibronectin leucine rich transmembrane protein 1" Q9NZU1 11 64103188-64119173 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.6;brain: 13.0" "Cell line enhanced" "Detected in some" "Karpas-707: 4.4;SCLC-21H: 6.0;SH-SY5Y: 14.9;THP-1: 11.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054589 Uncertain "Intracellular and membrane" "HPA054589: " "unprognostic (5.13e-3)" "unprognostic (1.55e-1)" "unprognostic (1.63e-1)" "unprognostic (8.65e-2)" "unprognostic (2.89e-1)" "unprognostic (9.55e-2)" "unprognostic (2.61e-3)" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (2.98e-1)" "unprognostic (4.64e-3)" "unprognostic (6.02e-2)" "unprognostic (1.79e-1)" "unprognostic (2.62e-2)" "unprognostic (5.62e-2)" "unprognostic (1.29e-3)" "unprognostic (4.37e-2)" 0.2 7.6 3.6 0.4 5.3 0.0 0.0 2.7 13.0 4.6 2.5 0.7 2.6 0.0 0.6 1.0 0.7 0.9 3.6 3.2 3.0 0.2 0.0 0.0 2.7 0.1 0.3 0.0 0.6 0.1 0.5 0.5 0.9 1.6 0.3 1.6 1.1 0.9 2.7 0.0 0.5 0.2 3.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 3.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.5 0.0 1.0 0.7 4.1 0.0 0.0 0.7 0.2 0.0 1.0 0.0 0.3 4.4 0.0 0.5 0.1 0.6 1.3 0.2 0.9 0.2 0.1 0.0 0.3 6.0 14.9 0.3 0.3 0.4 0.4 11.9 0.1 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.2 3.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FLRT3 ENSG00000125848 "Fibronectin leucine rich transmembrane protein 3" Q9NZU0 20 14322988-14337616 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.1" "Cell line enhanced" "Detected in some" "AF22: 15.3;hTCEpi: 28.9;RPTEC TERT1: 9.7;WM-115: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056033 Enhanced Supported "Plasma membrane,Cell Junctions,Cytosol" "Intracellular and membrane" 240000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA056033: " "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.98e-1)" "unprognostic (1.14e-3)" "unprognostic (2.30e-1)" "unprognostic (6.00e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (9.85e-5)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (1.54e-4)" "unprognostic (3.05e-1)" "prognostic favourable (1.49e-7)" "unprognostic (1.54e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-3)" "unprognostic (3.65e-1)" 7.3 4.3 3.4 2.2 7.4 0.1 2.7 27.5 18.9 3.8 5.0 0.7 3.2 12.4 2.6 5.5 2.5 2.7 5.6 1.6 9.3 4.1 43.1 28.9 26.2 0.2 2.3 5.3 11.9 2.3 4.6 2.1 2.0 2.9 12.7 1.0 1.9 1.5 16.4 2.1 6.9 6.0 3.9 2.3 0.8 9.7 1.7 0.7 4.8 8.5 1.8 0.4 12.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 15.3 0.0 0.0 0.0 0.0 1.5 0.4 0.1 0.0 8.4 3.1 0.0 0.5 0.3 4.3 0.0 4.5 0.1 0.0 0.9 0.0 0.2 0.1 1.3 0.0 0.0 2.7 28.9 0.0 5.4 0.0 0.0 0.1 2.9 0.2 1.9 0.0 5.0 0.0 0.0 0.1 0.0 9.7 1.8 0.3 3.1 0.0 0.0 4.8 0.2 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 7.4 27.5 18.9 9.3 4.1 2.3 5.3 2.9 0.7 FLT1 "FLT, VEGFR1" ENSG00000102755 "Fms related tyrosine kinase 1" P17948 13 28300344-28495145 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "placenta: 155.3" "Cell line enhanced" "Detected in some" "BJ: 17.0;BJ hTERT+: 13.5;HMC-1: 84.6;HUVEC TERT2: 15.3;WM-115: 30.3" "Cancer enhanced" "Detected in all" "renal cancer: 28.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1" "Group enriched" "Detected in many" 5 "B-cells: 3.7;granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011740, HPA014290, CAB068189, CAB068190" Enhanced Supported "Plasma membrane,Actin filaments" "Secreted to blood" 875697 54000 "Plasma membrane, Actin filaments" "CAB068189: , CAB068190: , HPA011740: AB_1858737, HPA014290: AB_1858738" "unprognostic (3.33e-2)" "unprognostic (3.52e-3)" "unprognostic (1.13e-3)" "unprognostic (5.02e-2)" "unprognostic (3.65e-1)" "unprognostic (5.03e-2)" "unprognostic (8.25e-2)" "unprognostic (2.27e-3)" "unprognostic (9.91e-2)" "unprognostic (6.61e-2)" "unprognostic (2.33e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (2.19e-4)" "unprognostic (4.20e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" 18.9 4.0 9.9 4.0 14.3 1.2 13.5 8.0 15.9 7.1 4.6 3.5 1.7 3.5 7.2 2.2 3.4 4.0 6.9 18.3 11.4 7.3 10.3 7.6 12.3 2.5 10.3 3.2 5.1 5.4 13.4 3.7 155.3 13.8 5.1 3.1 9.1 3.0 5.0 12.5 2.6 3.4 7.3 9.6 7.2 4.6 6.8 10.2 0.0 19.1 3.8 2.8 7.6 9.2 3.7 0.5 2.1 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 17.0 13.5 6.2 3.6 0.0 0.0 0.0 0.0 2.2 0.0 1.6 0.0 11.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 84.6 0.1 0.0 0.0 0.2 15.3 0.4 0.0 0.0 0.0 1.0 0.8 9.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.1 0.0 30.3 0.2 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.0 3.7 0.4 0.4 2.1 0.2 0.1 0.5 0.2 0.2 9.9 14.3 8.0 15.9 11.4 7.3 10.3 3.2 13.8 10.2 FLT3 "CD135, FLK2, STK1" ENSG00000122025 "Fms related tyrosine kinase 3" P36888 13 28003274-28100592 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.9;brain: 19.3;lymphoid tissue: 15.0" "Group enriched" "Detected in some" 11 "REH: 27.8;THP-1: 17.1" "Cancer enhanced" "Detected in some" "breast cancer: 1.8" "Region enhanced" "Detected in many" "cerebellum: 19.3" "Group enriched" "Detected in some" 11 "myeloid DC: 29.9;plasmacytoid DC: 12.1" "Lineage enriched" "Detected in many" 16 "dendritic cells: 29.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047539 Approved "Endoplasmic reticulum" 180000 "Endoplasmic reticulum" "HPA047539: " "unprognostic (2.19e-3)" "unprognostic (3.16e-3)" "unprognostic (6.54e-3)" "unprognostic (9.96e-2)" "unprognostic (3.88e-1)" "unprognostic (3.96e-7)" "unprognostic (7.99e-3)" "unprognostic (1.65e-2)" "unprognostic (5.37e-2)" "unprognostic (1.01e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (3.65e-1)" "unprognostic (3.91e-2)" "unprognostic (2.51e-1)" "unprognostic (2.22e-1)" 0.9 0.6 0.6 7.2 1.1 7.5 2.6 19.3 3.5 0.9 1.2 0.1 0.1 0.4 0.8 0.8 1.0 1.2 4.6 0.5 0.9 1.7 2.8 0.7 2.7 15.0 1.8 1.1 0.5 5.7 0.0 0.4 0.0 7.4 0.6 1.4 0.1 2.3 0.6 0.4 1.2 3.0 1.3 4.4 8.8 0.9 1.2 0.0 8.2 0.6 0.0 5.8 2.4 0.7 0.1 29.9 1.4 1.8 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.5 0.0 27.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 1.4 0.0 0.3 0.0 0.1 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.8 0.0 12.1 0.0 1.2 0.6 1.1 19.3 3.5 0.9 1.7 1.8 1.1 7.4 0.0 FLVCR2 "C14orf58, FLJ20371, MFSD7C" ENSG00000119686 "Feline leukemia virus subgroup C cellular receptor family member 2" Q9UPI3 14 75578617-75663214 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 45.7" "Cell line enhanced" "Detected in many" "ASC diff: 26.5;ASC TERT1: 11.5;BEWO: 35.4;MCF7: 12.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 11.3;intermediate monocyte: 12.1;myeloid DC: 6.2;non-classical monocyte: 8.9" "Group enriched" "Detected in many" 7 "dendritic cells: 6.2;monocytes: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037984 Enhanced "HPA037984: AB_10672733" "unprognostic (2.42e-1)" "unprognostic (4.85e-2)" "unprognostic (4.19e-2)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "unprognostic (4.44e-2)" "unprognostic (8.72e-2)" "unprognostic (2.78e-1)" "unprognostic (3.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.22e-1)" "unprognostic (4.80e-2)" "prognostic favourable (2.53e-5)" "unprognostic (6.69e-2)" "unprognostic (9.94e-2)" "unprognostic (9.38e-2)" "unprognostic (1.16e-1)" 5.6 11.6 1.4 6.5 2.6 3.0 2.4 0.7 2.4 2.5 24.1 1.9 0.9 12.5 1.4 2.9 2.4 2.0 2.6 3.0 1.7 1.0 8.3 19.0 11.5 7.7 4.8 0.7 2.4 0.8 0.8 4.1 25.6 5.0 2.3 5.2 30.9 8.7 2.5 7.6 5.1 45.7 2.8 6.0 17.5 1.1 15.6 2.6 1.1 3.2 5.6 3.3 2.2 4.2 0.1 6.2 0.5 12.1 0.3 1.3 3.0 1.7 1.3 0.4 1.9 26.5 11.5 35.4 0.3 1.4 1.5 1.2 2.9 0.2 0.0 0.1 0.1 0.2 4.6 0.1 0.6 8.9 0.3 0.0 1.3 6.1 2.1 0.0 0.3 5.3 3.7 1.9 1.1 0.3 0.1 0.2 4.8 12.2 0.0 0.9 0.8 2.1 0.0 1.2 0.0 1.7 2.4 0.0 0.0 0.9 3.9 0.7 2.1 4.7 4.1 1.9 0.7 1.0 0.0 0.3 0.5 0.0 5.5 1.1 0.3 0.0 11.3 0.5 0.3 12.1 1.0 0.0 0.9 0.3 6.2 0.1 0.7 0.1 0.3 0.3 8.9 0.1 1.3 3.0 1.4 2.6 0.7 2.1 1.7 1.0 4.8 0.7 5.0 2.6 FMNL1 "C17orf1, C17orf1B, FMNL" ENSG00000184922 "Formin like 1" O95466 17 45221444-45247320 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 107.4;lymphoid tissue: 56.6" "Cell line enhanced" "Detected in many" "Karpas-707: 49.5;MOLT-4: 33.9;U-266/70: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008129, HPA028288" Enhanced Approved Cytosol Cytosol "HPA008129: AB_1848963, HPA028288: AB_10612110" "unprognostic (1.90e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (8.60e-2)" "unprognostic (1.95e-2)" "unprognostic (1.24e-2)" "unprognostic (2.01e-1)" "unprognostic (1.58e-1)" "unprognostic (5.44e-2)" "unprognostic (6.06e-2)" "unprognostic (2.37e-1)" "unprognostic (4.07e-1)" "prognostic unfavourable (4.23e-8)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (3.46e-2)" "unprognostic (2.16e-1)" 8.6 3.8 10.7 29.7 9.6 107.4 7.5 8.1 16.1 4.6 5.2 4.2 0.8 5.8 2.6 5.8 4.5 6.1 9.1 5.8 13.4 6.0 4.2 3.6 22.2 38.1 6.1 6.4 3.1 3.6 3.6 7.4 7.4 7.2 4.3 4.1 3.3 8.4 2.3 2.5 4.2 14.9 4.3 6.2 45.9 6.6 2.7 3.3 56.6 3.9 4.1 22.8 11.3 4.6 3.5 4.3 22.3 5.6 5.4 7.6 3.5 4.1 8.1 0.0 0.4 0.0 1.8 0.4 0.5 1.1 3.1 2.3 0.3 1.8 12.8 4.2 0.1 0.7 0.0 0.1 1.0 22.5 1.1 7.4 12.1 0.6 8.7 19.3 26.3 1.4 0.3 4.0 1.7 0.0 0.6 49.5 2.2 2.7 33.9 20.0 0.4 0.2 21.5 2.9 22.9 0.8 0.5 2.6 1.2 2.5 0.4 0.9 2.3 15.8 1.0 0.1 2.9 0.4 18.2 41.3 18.2 13.1 0.3 15.8 0.6 6.8 5.1 8.2 7.0 5.6 4.7 3.5 5.5 7.6 4.3 3.3 3.6 4.8 22.3 5.4 4.2 2.5 6.0 3.5 10.7 9.6 8.1 16.1 13.4 6.0 6.1 6.4 7.2 3.3 FMO1 ENSG00000010932 "Flavin containing monooxygenase 1" Q01740 1 171248471-171285978 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 70.4" "Cell line enriched" "Detected in some" 7 "HSkMC: 21.5" "Cancer enriched" "Detected in many" 8 "renal cancer: 18.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 36 "naive B-cell: 3.5" "Lineage enriched" "Detected in single" 36 "B-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023680 Uncertain "HPA023680: AB_1848966" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (5.87e-2)" "unprognostic (1.34e-1)" "unprognostic (5.32e-3)" "unprognostic (1.89e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-1)" "unprognostic (9.16e-2)" "unprognostic (9.03e-2)" "unprognostic (1.36e-2)" "unprognostic (2.23e-1)" "prognostic favourable (2.81e-4)" "unprognostic (6.49e-4)" "unprognostic (1.40e-1)" "unprognostic (3.58e-1)" "unprognostic (1.37e-1)" 3.4 3.6 0.1 0.1 0.3 0.0 5.6 0.1 0.4 5.6 0.8 0.3 0.8 0.0 2.5 3.0 5.0 3.3 1.8 0.9 0.1 0.0 70.4 1.0 0.8 0.1 0.1 0.1 5.9 2.4 0.1 1.1 0.8 0.2 1.1 0.0 4.0 4.2 1.5 0.1 4.0 14.4 1.5 0.1 0.1 0.5 1.6 0.1 1.8 1.7 5.3 10.3 1.4 1.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.2 0.1 FMO2 ENSG00000094963 "Flavin containing monooxygenase 2" Q99518 1 171185208-171211230 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.0;esophagus: 35.3;lung: 53.0" "Group enriched" "Detected in some" 57 "ASC diff: 24.0;ASC TERT1: 10.9;HSkMC: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA028261 Approved "HPA028261: AB_10601012" "unprognostic (1.85e-2)" "unprognostic (3.14e-2)" "unprognostic (7.44e-2)" "unprognostic (3.75e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-3)" "unprognostic (3.00e-2)" "unprognostic (2.74e-1)" "unprognostic (1.58e-2)" "unprognostic (1.16e-1)" "unprognostic (4.28e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (3.83e-2)" 40.0 11.8 1.2 1.7 4.4 0.0 22.5 1.5 0.6 7.6 5.0 0.6 2.9 0.3 1.9 3.5 35.3 6.7 2.0 17.4 1.8 1.2 9.4 1.8 53.0 5.7 3.9 1.2 6.1 2.1 1.8 7.0 0.0 2.4 6.0 0.7 8.3 14.0 1.3 7.6 1.7 1.5 2.5 1.9 0.4 2.4 3.3 1.3 0.4 5.8 6.8 5.5 5.0 10.2 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 28.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 4.4 1.5 0.6 1.8 1.2 3.9 1.2 2.4 1.3 FMO3 ENSG00000007933 "Flavin containing monooxygenase 3" P31513 1 171090877-171117819 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 170.2" "Group enriched" "Detected in some" 4 "ASC diff: 24.8;ASC TERT1: 18.8" "Cancer enriched" "Detected in many" 13 "liver cancer: 94.9" "Region enriched" "Detected in single" 5 "pons and medulla: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA013750 Enhanced "HPA013750: AB_1848968" "unprognostic (1.87e-2)" "unprognostic (6.30e-2)" "unprognostic (1.00e-1)" "unprognostic (6.81e-3)" "unprognostic (2.64e-1)" "unprognostic (1.31e-3)" "prognostic favourable (3.46e-4)" "prognostic favourable (5.60e-5)" "unprognostic (2.95e-1)" "unprognostic (9.34e-2)" "unprognostic (3.02e-1)" "unprognostic (7.21e-2)" "prognostic unfavourable (1.13e-4)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (3.45e-1)" "unprognostic (7.27e-2)" 9.5 2.0 0.0 0.8 0.2 0.0 1.3 0.1 0.1 0.2 0.8 0.1 0.1 0.3 0.6 1.2 1.7 2.3 0.3 0.8 0.0 0.1 6.4 170.2 3.7 1.5 0.2 0.0 0.9 0.7 0.3 2.7 0.0 1.4 0.2 0.1 3.6 0.9 0.1 1.9 0.8 0.4 0.2 0.1 0.1 0.6 0.5 0.1 0.0 0.8 1.2 2.6 0.2 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 18.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.2 0.0 1.4 0.1 FMO4 FMO2 ENSG00000076258 "Flavin containing monooxygenase 4" P31512 1 171314208-171342084 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 33.8;liver: 42.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 7.2;EFO-21: 7.9;HSkMC: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA049100, HPA072438" Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA049100: , HPA072438: " "unprognostic (1.83e-2)" "unprognostic (1.17e-1)" "unprognostic (6.18e-2)" "unprognostic (3.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.13e-1)" "prognostic favourable (1.09e-4)" "prognostic favourable (7.45e-4)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (5.99e-2)" "unprognostic (2.90e-1)" "prognostic favourable (6.96e-4)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-3)" "unprognostic (1.95e-1)" 5.3 3.6 1.4 5.1 4.8 0.9 4.5 0.6 2.7 4.5 6.0 4.8 3.1 4.2 3.0 10.0 4.6 3.8 4.6 6.3 2.3 1.5 33.8 42.2 3.4 2.8 7.5 2.8 4.1 3.2 5.5 5.0 2.3 3.7 3.9 3.7 6.7 2.7 2.0 1.6 2.9 16.1 2.0 7.0 3.8 3.9 2.0 6.2 2.7 4.5 3.3 3.4 2.9 3.7 5.3 2.9 0.9 4.0 3.9 4.9 2.0 0.1 0.0 0.4 0.6 5.4 4.9 0.2 1.1 5.0 1.6 1.7 0.8 7.2 4.4 7.9 0.0 0.3 0.8 1.3 2.2 2.1 1.1 0.0 0.0 0.1 0.8 0.9 1.0 9.3 3.1 0.6 1.3 0.3 0.2 3.3 0.7 1.0 2.1 1.9 0.5 1.6 0.4 0.4 2.5 3.5 0.0 0.2 0.0 1.4 1.5 3.0 3.1 1.3 0.1 1.3 0.4 1.4 1.0 4.0 1.3 2.7 2.4 1.4 1.1 0.6 2.6 0.9 2.5 4.0 1.8 3.1 2.4 3.3 2.2 5.3 3.3 2.5 0.5 3.9 2.7 2.9 4.9 2.0 1.4 4.8 0.6 2.7 2.3 1.5 7.5 2.8 3.7 6.2 FMO5 ENSG00000131781 "Flavin containing monooxygenase 5" P49326 1 147175351-147243050 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 61.1;liver: 119.4;stomach 1: 38.6" "Cell line enhanced" "Detected in some" "Hep G2: 28.4;HMC-1: 6.4;THP-1: 7.2" "Cancer enriched" "Detected in many" 7 "liver cancer: 43.0" "Group enriched" "Detected in many" 6 "basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012373 Enhanced Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA012373: AB_1848975" "unprognostic (2.70e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (3.96e-2)" "unprognostic (2.43e-2)" "unprognostic (2.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-2)" "unprognostic (2.93e-1)" "unprognostic (1.13e-1)" "prognostic favourable (1.34e-6)" "unprognostic (3.77e-1)" "unprognostic (1.38e-1)" "unprognostic (1.85e-1)" "unprognostic (4.11e-2)" 1.1 2.4 1.1 1.9 5.5 0.2 8.6 0.6 4.5 1.3 61.1 1.5 0.8 12.5 1.0 1.3 0.7 1.1 8.5 1.0 1.3 0.5 9.0 119.4 17.0 0.8 17.1 0.5 1.0 11.9 8.8 4.9 0.6 5.2 1.9 8.2 0.5 9.7 0.6 0.4 4.2 53.6 0.9 7.1 1.2 38.6 1.2 6.0 0.2 1.1 1.5 0.5 1.9 0.8 9.2 4.9 6.2 12.1 1.0 2.0 3.6 0.1 0.7 0.5 0.0 1.9 0.5 0.6 0.4 0.3 0.2 0.6 0.4 1.5 0.3 0.5 0.4 0.3 0.0 0.0 0.0 1.0 0.1 1.1 0.0 28.4 0.6 0.9 6.4 0.9 0.1 0.3 0.0 0.4 0.1 0.1 1.1 0.9 0.2 0.5 2.0 0.5 0.3 0.3 0.2 2.4 0.4 0.4 0.2 0.6 1.9 0.9 1.4 7.2 0.7 0.0 0.2 0.6 0.0 0.2 0.0 0.2 0.7 0.3 0.2 6.2 12.1 3.5 2.0 5.6 0.3 3.6 0.5 0.6 4.9 9.2 0.3 1.3 1.2 1.0 1.6 2.4 1.4 3.6 1.1 5.5 0.6 4.5 1.3 0.5 17.1 0.5 5.2 6.0 FNDC3A "bA203I16.5, FNDC3, KIAA0970" ENSG00000102531 "Fibronectin type III domain containing 3A" Q9Y2H6 13 48975912-49209779 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008927, HPA012825" Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA008927: AB_1078899, HPA012825: AB_1848985" "unprognostic (1.54e-1)" "unprognostic (1.34e-3)" "unprognostic (8.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (2.91e-2)" "unprognostic (5.71e-2)" "unprognostic (6.17e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-2)" "unprognostic (4.03e-2)" "prognostic favourable (4.25e-4)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (9.60e-2)" "unprognostic (6.14e-2)" 13.9 27.2 16.9 14.8 24.9 10.0 17.4 19.4 15.0 25.3 22.3 14.6 32.0 17.8 22.4 32.2 10.6 18.2 17.9 14.0 15.0 23.1 20.4 43.0 18.1 12.0 14.6 14.8 25.0 37.4 14.1 59.0 79.8 15.7 15.6 16.2 15.1 22.5 31.6 9.1 9.2 24.7 17.5 14.8 16.2 18.5 18.8 16.6 13.2 34.2 11.6 12.7 17.8 15.4 6.6 7.6 8.7 6.9 3.9 7.9 3.2 4.4 5.1 18.9 4.9 24.0 30.3 3.7 21.0 28.1 20.3 14.8 6.9 10.9 3.4 3.9 15.8 4.9 11.2 7.1 29.6 8.4 8.7 5.5 14.8 12.8 14.5 5.1 0.9 15.5 10.0 17.9 20.9 20.8 6.8 8.3 22.0 1.8 5.0 10.2 9.3 4.3 4.8 7.5 6.2 17.1 8.3 7.2 11.9 7.9 7.1 14.9 3.8 10.1 16.4 10.6 7.3 9.7 14.8 10.2 5.3 3.1 7.9 6.6 10.8 3.4 5.7 3.6 5.2 4.0 7.5 6.6 6.1 4.4 3.6 4.9 7.9 6.7 8.7 3.9 6.9 7.6 4.7 3.2 16.9 24.9 19.4 14.5 15.0 23.1 14.6 14.8 15.7 16.6 FNDC3B "DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421" ENSG00000075420 "Fibronectin type III domain containing 3B" Q53EP0 3 172039628-172401665 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 22.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007859 Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA007859: AB_1078900" "unprognostic (7.18e-2)" "prognostic unfavourable (2.41e-5)" "unprognostic (6.03e-2)" "unprognostic (6.38e-2)" "prognostic unfavourable (6.94e-4)" "unprognostic (3.25e-2)" "prognostic unfavourable (9.85e-4)" "unprognostic (2.17e-3)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" "prognostic unfavourable (9.06e-5)" "unprognostic (3.50e-2)" "prognostic unfavourable (5.65e-7)" "unprognostic (4.35e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-2)" 39.6 22.1 4.0 16.5 5.7 18.2 27.3 2.9 5.1 20.8 18.4 4.2 20.9 7.5 28.9 21.7 13.2 12.3 18.3 18.9 4.9 4.2 17.6 35.6 23.1 10.9 6.7 2.3 26.4 30.7 12.3 21.4 64.1 5.9 15.1 11.5 13.4 27.7 19.8 22.0 8.1 13.1 17.8 6.6 17.5 15.0 10.5 5.0 4.8 21.2 10.5 12.8 25.4 25.8 0.6 2.7 22.7 5.0 2.4 2.6 1.8 12.1 14.1 9.8 11.9 30.8 21.3 23.8 17.5 19.8 11.9 16.2 7.7 27.0 1.1 47.0 26.4 7.2 3.4 14.2 20.9 6.9 2.5 1.7 9.1 21.3 31.1 15.6 27.5 21.5 7.3 22.1 21.1 31.6 2.8 8.9 12.5 3.8 0.6 6.9 5.6 5.8 1.4 10.2 5.9 13.0 10.8 0.6 3.0 16.7 8.7 14.5 8.2 8.0 45.6 16.7 7.7 21.1 13.8 18.6 20.7 2.4 17.6 9.0 16.4 7.8 5.0 11.4 2.6 3.0 1.1 0.6 0.8 1.4 2.7 0.0 0.9 1.6 22.7 2.4 1.5 0.4 0.7 1.8 4.0 5.7 2.9 5.1 4.9 4.2 6.7 2.3 5.9 5.0 FNDC4 "FLJ22362, FRCP1" ENSG00000115226 "Fibronectin type III domain containing 4" Q9H6D8 2 27491883-27495245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.9;liver: 57.6" "Cell line enhanced" "Detected in many" "AN3-CA: 16.9;ASC diff: 17.3;HUVEC TERT2: 20.7;SH-SY5Y: 16.2;TIME: 18.9;U-87 MG: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051804, HPA063581" Uncertain Approved Nucleoplasm,Aggresome,Cytosol "Intracellular and membrane" Nucleoplasm "Aggresome, Cytosol" "HPA051804: , HPA063581: " "unprognostic (2.57e-1)" "unprognostic (1.19e-3)" "unprognostic (3.87e-2)" "prognostic unfavourable (5.07e-4)" "unprognostic (1.46e-3)" "unprognostic (1.27e-1)" "unprognostic (4.77e-3)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (9.64e-2)" "unprognostic (8.28e-3)" "unprognostic (4.41e-2)" "unprognostic (1.28e-2)" "unprognostic (1.13e-2)" "unprognostic (5.74e-3)" "unprognostic (2.40e-3)" "prognostic unfavourable (6.11e-4)" 18.5 45.9 13.4 2.7 13.7 0.7 9.1 10.8 29.5 3.8 2.0 4.0 0.5 1.5 2.8 2.8 11.8 1.5 10.0 3.1 15.6 8.5 2.3 57.6 2.0 1.4 12.0 8.6 16.5 4.6 18.6 2.8 2.5 22.2 6.3 2.1 1.9 2.1 3.3 1.3 2.4 1.4 4.7 5.4 3.5 3.2 10.2 3.8 0.0 1.8 0.7 2.7 4.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.6 16.9 17.3 10.6 0.1 3.8 7.7 2.8 2.4 0.7 0.2 0.0 0.4 12.2 0.0 6.4 2.3 2.4 0.0 1.0 0.8 0.0 8.7 6.4 0.0 0.1 9.0 1.1 4.8 0.9 20.7 0.9 0.0 10.2 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.0 1.6 0.0 0.1 16.2 0.1 0.0 0.1 0.0 0.0 18.9 2.6 1.2 1.0 2.9 0.0 0.0 0.0 14.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.7 10.8 29.5 15.6 8.5 12.0 8.6 22.2 3.8 FNDC5 FRCP2 ENSG00000160097 "Fibronectin type III domain containing 5" Q8NAU1 1 32862268-32872482 "Predicted membrane proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 110.0;tongue: 33.3" "Cell line enriched" "Detected in some" 6 "RH-30: 31.9" "Group enriched" "Detected in many" 7 "glioma: 4.2;liver cancer: 10.0;testis cancer: 14.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051290 Enhanced "Intracellular and membrane" "HPA051290: " "unprognostic (4.36e-2)" "unprognostic (9.08e-3)" "unprognostic (7.62e-4)" "unprognostic (1.03e-2)" "unprognostic (3.77e-2)" "unprognostic (6.26e-2)" "unprognostic (5.68e-2)" "unprognostic (2.76e-2)" "unprognostic (1.45e-2)" "unprognostic (1.83e-1)" "unprognostic (3.15e-3)" "unprognostic (1.63e-1)" "unprognostic (9.07e-2)" "unprognostic (7.07e-3)" "unprognostic (1.13e-1)" "unprognostic (3.37e-3)" "unprognostic (1.33e-2)" 1.2 6.3 3.4 0.6 5.1 0.6 0.9 26.7 13.6 1.0 0.8 1.7 0.0 0.9 2.1 1.5 4.9 2.6 1.4 15.9 3.6 4.1 0.9 8.6 1.0 0.6 5.0 3.7 3.0 0.8 2.5 2.3 0.8 9.5 2.0 0.7 8.2 12.3 1.0 110.0 0.6 1.0 1.5 2.8 0.6 2.3 1.3 1.7 0.0 1.0 33.3 1.3 0.9 0.4 0.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.9 0.2 0.0 1.3 0.1 0.4 0.1 0.5 0.1 0.9 0.2 0.1 0.6 0.3 0.0 3.8 0.0 0.1 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.0 2.4 0.0 0.3 0.0 0.0 0.7 0.1 0.8 0.1 0.1 0.1 1.3 0.1 0.4 31.9 0.2 0.0 0.0 5.4 0.9 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.6 1.5 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 5.1 26.7 13.6 3.6 4.1 5.0 3.7 9.5 1.7 FNDC9 "C5orf40, MGC27121" ENSG00000172568 "Fibronectin type III domain containing 9" Q8TBE3 5 157341600-157345721 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "adrenal gland: 9.4;brain: 24.0;pituitary gland: 10.0" "Cell line enhanced" "Detected in some" "Daudi: 1.7;HeLa: 1.8;Karpas-707: 3.0;U-266/70: 1.6" "Cancer enriched" "Detected in single" 16 "glioma: 0.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "basal ganglia: 21.9;hypothalamus: 28.4" "Low region specificity" "Detected in all" HPA011115 Uncertain "HPA011115: AB_1079374" "unprognostic (2.35e-3)" "unprognostic (3.80e-2)" "unprognostic (2.93e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-3)" "unprognostic (3.40e-1)" "unprognostic (1.95e-1)" "unprognostic (1.68e-1)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (6.35e-6)" "unprognostic (3.63e-2)" "unprognostic (6.39e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" 0.6 9.4 3.9 1.5 21.1 2.0 0.6 9.1 24.0 0.5 1.1 0.0 0.0 0.6 0.6 0.9 0.5 0.6 0.6 0.7 1.9 22.0 0.7 0.6 0.5 0.9 1.3 3.8 0.5 0.5 0.5 10.0 0.6 5.8 0.6 1.2 0.0 0.5 0.6 0.6 0.6 0.8 0.8 1.3 0.6 0.6 0.5 0.4 0.0 0.6 0.0 0.5 0.6 0.0 0.5 0.3 0.8 0.8 0.0 1.9 0.1 0.0 0.2 0.4 0.4 0.0 0.0 0.4 1.0 0.0 0.2 0.0 0.2 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.0 0.3 0.3 1.6 0.0 1.0 0.3 0.0 0.1 0.0 0.0 0.8 1.9 0.2 0.1 0.0 0.6 1.3 0.0 0.5 0.8 1.5 0.2 0.0 0.8 0.3 0.0 0.1 3.9 21.1 9.1 13.3 1.9 22.0 1.3 3.8 5.8 0.4 FO681492.1 ENSG00000277758 10 47750864-47763592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.2;brain: 6.7;lung: 10.6" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 36.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.2" "Low lineage specificity" "Detected in many" "HPA036971, HPA036972, HPA064559" Approved Approved "Golgi apparatus" "Golgi apparatus" "HPA036971: , HPA036972: , HPA064559: " "unprognostic (2.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-2)" "unprognostic (5.70e-2)" "unprognostic (4.59e-1)" "unprognostic (2.51e-1)" "unprognostic (2.06e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (2.69e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-5)" "unprognostic (4.52e-2)" "unprognostic (5.13e-2)" "unprognostic (6.35e-2)" "unprognostic (1.11e-2)" 0.5 0.0 0.1 0.0 0.0 6.7 0.3 0.0 0.0 0.1 0.0 2.4 1.1 0.4 0.4 0.0 0.0 10.6 2.3 0.3 1.4 0.0 1.1 0.0 0.0 1.4 0.4 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.9 0.7 2.5 0.4 5.2 0.9 1.1 0.4 0.5 4.1 0.0 0.6 0.0 0.0 0.0 1.3 0.0 0.1 0.0 2.6 2.9 0.0 0.2 1.1 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.2 2.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 3.2 36.1 0.1 3.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.3 2.3 0.3 0.7 2.8 1.1 0.7 1.1 0.8 2.5 0.3 0.5 0.7 0.4 0.9 5.2 1.0 0.7 0.4 FOCAD "FLJ20375, KIAA1797" ENSG00000188352 Focadhesin Q5VW36 9 20658309-20995955 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 62.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 62.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055015 Uncertain Uncertain Mitochondria Mitochondria "HPA055015: " "unprognostic (3.05e-2)" "unprognostic (1.02e-1)" "prognostic favourable (3.25e-4)" "unprognostic (3.69e-3)" "unprognostic (4.14e-2)" "unprognostic (5.35e-2)" "prognostic unfavourable (4.41e-5)" "unprognostic (9.64e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-1)" "unprognostic (5.26e-2)" "unprognostic (9.15e-2)" "prognostic favourable (3.09e-8)" "unprognostic (1.90e-1)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (1.41e-2)" 3.6 9.0 4.5 3.6 7.2 1.9 3.9 8.7 9.0 4.9 4.8 15.0 3.6 1.8 3.9 6.3 3.6 7.4 3.6 5.3 7.1 7.3 3.8 3.6 3.7 3.6 4.4 3.6 3.6 5.5 10.4 11.8 4.1 62.1 5.6 5.6 6.8 5.8 3.7 5.1 4.2 3.6 4.7 3.6 3.6 4.2 3.6 3.6 3.6 11.8 3.6 3.6 3.6 3.6 3.4 6.9 8.9 5.7 4.5 7.1 3.1 16.1 11.2 12.2 9.1 11.4 13.1 6.4 9.6 15.4 6.8 7.9 7.4 5.6 6.6 5.1 13.7 5.6 10.5 19.0 12.0 29.4 7.8 5.2 13.8 9.1 5.9 8.6 6.7 12.1 13.1 6.8 11.2 26.1 0.1 9.8 11.4 6.2 6.4 16.2 9.6 11.3 0.0 5.5 4.4 10.6 7.0 8.1 4.1 6.3 10.9 2.6 6.8 5.0 15.9 0.0 4.5 7.5 8.7 2.4 13.5 7.5 0.0 12.1 4.0 8.9 2.8 8.0 5.3 5.7 7.1 2.7 4.7 5.1 6.9 3.4 4.2 5.0 2.2 4.5 3.1 2.8 4.3 3.1 4.5 7.2 8.7 9.0 7.1 7.3 4.4 3.6 62.1 3.6 FOLH1 "FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA" ENSG00000086205 "Folate hydrolase 1" Q04609 11 49146635-49208670 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.7;intestine: 111.2;prostate: 33.8" "Cell line enhanced" "Detected in some" "HAP1: 5.3;RPMI-8226: 3.7;SK-BR-3: 4.4;TIME: 2.8;WM-115: 5.3" "Cancer enriched" "Detected in many" 27 "prostate cancer: 142.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001451, HPA010593" Enhanced "CAB001451: AB_563979, HPA010593: AB_1079685" "unprognostic (1.33e-1)" "unprognostic (1.19e-1)" "unprognostic (1.24e-1)" "prognostic favourable (5.24e-5)" "unprognostic (2.55e-1)" "unprognostic (8.31e-2)" "prognostic favourable (4.25e-4)" "unprognostic (1.32e-1)" "unprognostic (2.09e-2)" "unprognostic (2.67e-3)" "unprognostic (2.13e-2)" "unprognostic (2.72e-1)" "prognostic unfavourable (1.30e-6)" "unprognostic (4.81e-2)" "unprognostic (7.27e-2)" "unprognostic (4.74e-3)" "unprognostic (4.04e-1)" 1.2 1.0 10.4 0.9 16.4 0.8 2.5 1.4 12.7 1.4 67.6 37.7 0.0 111.2 1.3 0.8 1.2 2.1 5.0 0.7 16.9 8.7 6.1 15.7 1.1 0.9 19.0 9.1 1.0 0.7 0.7 0.4 0.7 17.7 33.8 0.8 0.6 20.7 0.8 0.6 1.2 61.1 1.0 33.0 1.5 1.0 0.9 16.2 0.0 1.0 0.0 0.8 1.2 0.5 0.9 0.1 0.3 0.8 1.4 1.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.6 0.0 0.2 5.3 0.5 0.0 1.2 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 1.0 0.0 0.3 0.3 3.7 0.0 0.0 0.4 1.6 0.0 4.4 1.0 1.0 0.0 2.8 0.2 2.7 0.4 0.3 0.1 0.5 0.1 0.0 0.9 5.3 0.1 0.8 0.3 0.9 0.6 0.2 0.6 1.2 0.5 0.0 0.9 0.7 0.3 0.2 1.4 0.5 0.1 0.4 0.0 10.4 16.4 1.4 12.7 16.9 8.7 19.0 9.1 17.7 16.2 FOLR1 FOLR ENSG00000110195 "Folate receptor 1" P15328 11 72189558-72196323 "Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" Transport Receptor Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 157.6;salivary gland: 101.2" "Group enriched" "Detected in some" 7 "HeLa: 81.7;RPTEC TERT1: 86.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 259.5" "Region enriched" "Detected in many" 20 "pons and medulla: 157.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0" "Low region specificity" "Detected in all" HPA077030 Approved "Nuclear membrane" "Secreted to blood" 81000 "Nuclear membrane" "HPA077030: " "unprognostic (3.30e-1)" "unprognostic (2.19e-1)" "unprognostic (6.55e-2)" "unprognostic (3.49e-2)" "unprognostic (7.67e-3)" "unprognostic (1.98e-2)" "prognostic unfavourable (2.50e-4)" "unprognostic (1.18e-2)" "unprognostic (8.13e-2)" "unprognostic (2.47e-2)" "unprognostic (2.58e-2)" "unprognostic (2.87e-3)" "unprognostic (1.67e-1)" "unprognostic (2.52e-1)" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (2.69e-1)" 0.0 0.7 1.3 0.2 1.7 0.0 6.6 0.6 3.5 31.4 0.1 21.4 2.8 0.0 1.0 3.5 1.6 46.7 1.0 0.2 7.9 1.8 38.8 0.2 47.0 0.0 0.8 0.4 8.9 1.8 0.4 3.5 24.5 157.6 1.5 0.0 17.0 101.2 4.0 0.1 0.9 0.1 0.0 0.7 0.0 7.4 0.4 0.2 0.0 12.7 2.6 3.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 7.6 7.7 0.0 7.9 0.1 0.1 0.4 0.3 0.0 0.0 0.2 0.1 81.7 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.6 0.0 86.8 0.0 0.0 0.5 0.2 1.2 0.0 11.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.3 1.7 0.6 3.5 7.9 1.8 0.8 0.4 157.6 0.2 FP565260.3 ENSG00000277117 21 5022493-5040666 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell line enhanced" "Detected in many" "BEWO: 16.3;REH: 12.7;SiHa: 10.9" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 5.3" "Low lineage specificity" "Detected in many" HPA029179 Approved "Plasma membrane,Cytoplasmic bodies" "Plasma membrane, Cytoplasmic bodies" "HPA029179: " "unprognostic (3.34e-2)" "unprognostic (1.52e-1)" "unprognostic (2.82e-1)" "unprognostic (3.58e-4)" "unprognostic (6.66e-4)" "unprognostic (1.24e-2)" "unprognostic (1.12e-1)" "unprognostic (3.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (3.17e-1)" "unprognostic (3.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-1)" 1.5 0.2 0.6 3.4 4.5 2.4 1.9 0.4 7.0 2.6 2.0 9.2 0.6 4.3 0.8 1.7 1.4 2.1 2.6 2.9 2.2 2.5 2.3 1.2 4.5 4.2 3.1 0.2 1.8 0.0 0.0 1.9 4.3 1.3 1.6 0.1 1.3 1.0 0.7 3.1 2.8 0.7 2.6 2.3 4.1 0.5 3.6 0.0 1.0 1.9 5.7 1.6 1.2 5.3 0.9 0.0 3.0 0.0 1.1 0.8 0.2 0.6 0.0 1.1 0.3 0.7 16.3 1.3 1.0 0.2 0.0 3.9 0.7 8.7 2.6 0.0 3.1 1.0 1.2 0.2 0.2 0.8 0.0 0.5 2.1 0.2 6.7 6.4 0.1 1.7 0.9 0.8 0.9 1.0 0.3 0.1 2.2 0.0 4.0 0.6 5.3 12.7 0.4 8.9 0.4 5.5 0.7 0.0 10.9 9.7 0.1 2.9 9.0 0.3 0.0 2.5 0.0 0.2 6.0 6.1 5.7 6.9 3.8 1.5 0.0 0.6 0.0 0.0 3.0 0.3 2.9 0.5 0.2 0.7 5.3 0.1 0.5 0.0 0.0 0.6 0.9 1.1 0.8 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 213.3;lymphoid tissue: 64.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 34.2" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 213.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 213.3" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: , HPA061744: " "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 22.6 3.7 5.2 52.2 12.4 54.5 2.9 1.1 6.3 2.6 2.4 5.9 0.0 1.1 2.3 2.3 3.3 8.4 9.6 11.2 15.7 4.3 6.0 7.5 28.8 58.4 15.5 0.8 1.9 3.5 0.8 2.3 13.0 9.7 1.8 1.2 2.4 2.4 0.9 3.2 1.1 2.2 12.8 14.3 64.4 3.2 2.9 10.1 0.9 2.7 0.7 3.2 7.9 4.6 0.0 8.9 213.3 36.3 0.0 0.0 16.9 0.3 0.5 0.2 0.3 0.4 1.1 0.3 0.2 0.0 0.3 1.0 0.2 0.3 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.6 2.7 0.2 0.4 2.4 0.1 0.8 0.8 0.0 0.1 0.3 6.9 0.5 0.1 0.2 0.2 0.4 0.2 0.4 0.0 0.6 0.3 0.1 0.2 0.4 0.0 0.3 0.6 0.6 0.5 1.1 0.2 0.0 1.6 0.1 0.0 0.3 34.2 0.8 0.1 13.0 36.3 10.0 0.0 15.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 213.3 0.0 9.5 0.3 0.0 16.9 5.2 12.4 1.1 6.3 15.7 4.3 15.5 0.8 9.7 10.1 FRAS1 "FLJ14927, FLJ22031, KIAA1500" ENSG00000138759 "Fraser extracellular matrix complex subunit 1" Q86XX4 4 78057570-78544269 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 17.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 23.1;Hep G2: 13.9;RH-30: 13.3;SiHa: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051601 Approved "Intracellular and membrane" "HPA051601: " "unprognostic (1.33e-2)" "unprognostic (1.04e-2)" "unprognostic (9.37e-2)" "unprognostic (8.91e-2)" "unprognostic (2.97e-1)" "unprognostic (2.04e-1)" "unprognostic (1.45e-3)" "unprognostic (2.02e-2)" "unprognostic (1.07e-1)" "unprognostic (2.69e-2)" "unprognostic (2.09e-2)" "unprognostic (4.02e-2)" "prognostic favourable (4.69e-4)" "unprognostic (2.56e-1)" "unprognostic (1.10e-1)" "unprognostic (4.78e-3)" "unprognostic (6.09e-2)" 2.0 1.2 6.2 5.0 10.1 0.1 1.3 0.9 6.4 3.6 2.7 0.7 0.1 0.6 3.3 3.1 2.0 1.5 4.1 2.6 2.3 2.3 11.6 0.8 5.2 0.3 1.2 1.8 0.9 7.9 0.7 5.5 8.3 3.8 3.2 2.2 1.3 1.8 1.3 3.7 2.1 1.4 2.2 0.9 1.1 1.6 1.4 1.0 2.1 17.9 1.9 0.4 1.3 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.9 4.4 1.8 0.0 4.8 2.0 3.1 0.7 2.7 0.4 0.2 3.4 6.4 0.0 5.5 23.1 0.8 2.5 1.4 0.1 0.0 2.5 2.6 5.2 13.9 0.5 0.0 0.0 9.5 1.5 0.0 3.5 0.1 0.0 0.0 2.6 0.1 0.1 0.0 5.6 0.8 0.0 13.3 0.0 5.8 6.4 3.3 6.4 13.9 4.4 0.8 0.0 0.0 0.0 0.0 3.1 1.9 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 10.1 0.9 6.4 2.3 2.3 1.2 1.8 3.8 1.0 FREM2 DKFZp686J0811 ENSG00000150893 "FRAS1 related extracellular matrix protein 2" Q5SZK8 13 38687129-38887131 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 13.9;lung: 11.2;thyroid gland: 12.2" "Cell line enhanced" "Detected in some" "AF22: 15.5;HAP1: 10.4;MCF7: 7.5;RT4: 7.0;SK-BR-3: 6.3;WM-115: 5.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA028831 Uncertain Approved Cytosol 170000 Cytosol "HPA028831: AB_10603668" "unprognostic (1.71e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (1.10e-1)" "unprognostic (4.69e-1)" "unprognostic (6.24e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.25e-1)" "unprognostic (2.54e-1)" "prognostic favourable (2.23e-7)" "unprognostic (7.21e-2)" "unprognostic (1.40e-1)" "unprognostic (9.92e-2)" "unprognostic (3.14e-1)" 0.6 0.4 1.3 0.1 1.7 0.1 0.5 1.5 6.4 0.7 1.3 1.2 1.1 0.4 1.1 0.5 0.2 0.9 1.5 0.2 2.8 0.4 13.9 3.4 11.2 0.1 0.4 0.8 1.8 5.2 0.1 1.1 2.6 0.8 3.5 0.4 2.9 0.4 1.5 6.3 0.6 0.7 0.7 0.4 0.3 2.2 1.8 1.5 0.1 12.2 4.1 0.1 1.5 0.3 0.3 0.3 0.9 0.2 0.2 0.2 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 10.4 0.0 0.0 0.3 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 2.3 0.2 0.0 1.5 0.1 2.4 7.0 0.2 0.1 0.0 6.3 0.3 1.1 0.0 0.0 0.0 0.9 0.0 1.5 0.0 0.0 0.0 0.0 0.0 5.8 0.9 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.2 0.7 0.2 0.2 0.3 0.1 0.0 1.3 1.7 1.5 6.4 2.8 0.4 0.4 0.8 0.8 1.5 FRMD3 "EPB41L4O, MGC20553" ENSG00000172159 "FERM domain containing 3" A2A2Y4 9 83242990-83538546 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.5;skeletal muscle: 42.1" "Cell line enhanced" "Detected in some" "HEL: 11.6;RPMI-8226: 39.2;SCLC-21H: 14.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 27.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1" "Group enriched" "Detected in many" 6 "granulocytes: 3.8;monocytes: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017285 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA017285: " "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "unprognostic (6.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.93e-1)" "unprognostic (3.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.23e-1)" "unprognostic (5.87e-2)" "prognostic favourable (7.24e-4)" "unprognostic (3.12e-1)" "unprognostic (1.88e-1)" "prognostic favourable (1.79e-4)" "unprognostic (1.68e-3)" 12.7 4.6 3.5 2.8 2.3 3.0 16.8 2.0 3.0 4.6 7.1 1.7 14.3 1.9 5.5 9.8 4.1 1.9 2.9 48.5 3.2 4.5 11.7 0.7 2.9 0.9 3.6 1.7 1.4 1.4 8.9 6.1 8.7 2.9 5.1 4.1 5.3 2.1 35.3 42.1 1.6 10.9 3.5 2.8 4.3 2.2 6.1 0.8 0.0 8.8 11.1 0.7 3.8 5.0 0.6 0.6 3.8 4.7 0.4 0.6 9.2 0.0 2.2 1.9 0.1 0.4 0.1 0.1 2.0 0.1 0.0 0.0 0.2 2.6 0.4 2.4 0.9 0.1 0.1 0.0 0.0 0.1 0.1 11.6 2.5 1.4 0.1 0.0 0.1 0.5 0.0 0.0 0.1 1.3 0.0 0.0 2.5 0.3 0.0 0.0 0.2 3.6 0.0 1.5 39.2 3.2 5.1 14.5 7.0 0.7 0.1 0.4 0.8 0.4 2.2 0.1 0.3 0.0 1.4 0.2 0.1 0.0 0.5 3.8 1.4 0.0 2.8 0.0 0.4 4.7 0.6 0.5 0.2 0.1 0.4 0.6 0.1 0.0 3.8 0.4 2.1 0.6 0.0 9.2 3.5 2.3 2.0 3.0 3.2 4.5 3.6 1.7 2.9 0.8 FRRS1L "C9orf4, CG-6" ENSG00000260230 "Ferric chelate reductase 1 like" Q9P0K9 9 109130293-109167295 "Disease related genes, Predicted membrane proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.0;ovary: 15.2" "Cell line enhanced" "Detected in some" "AF22: 3.7;SH-SY5Y: 9.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071086 Enhanced "HPA071086: " "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (2.21e-1)" "unprognostic (9.01e-2)" "unprognostic (3.10e-1)" "unprognostic (8.12e-2)" "unprognostic (1.84e-1)" "unprognostic (9.94e-2)" "unprognostic (1.51e-1)" "unprognostic (9.21e-4)" "unprognostic (7.35e-3)" "unprognostic (7.02e-2)" "unprognostic (5.78e-3)" "unprognostic (5.89e-2)" "unprognostic (2.85e-1)" "unprognostic (5.38e-3)" 0.9 10.9 10.2 1.1 26.6 1.2 1.1 19.3 38.0 2.4 1.2 2.3 0.1 1.3 2.7 4.4 3.2 2.2 2.0 2.0 10.5 12.5 0.8 0.9 1.0 1.0 6.1 13.1 15.2 1.5 4.4 6.0 0.8 6.6 4.9 1.2 3.0 1.1 3.0 0.9 1.1 1.4 2.5 3.5 1.0 1.1 1.7 3.4 0.0 1.0 0.0 0.9 0.9 0.3 1.3 0.8 2.7 1.6 1.3 0.8 0.3 0.1 0.5 3.7 0.2 0.2 0.2 0.4 0.1 0.0 0.1 0.3 0.2 0.3 0.2 0.1 0.0 0.2 0.1 0.1 0.2 0.2 0.2 0.5 0.4 0.2 0.0 0.1 0.3 0.5 0.0 0.2 0.0 0.0 0.1 0.5 0.2 0.1 0.2 0.7 1.6 0.1 0.3 0.1 0.2 0.1 0.3 1.5 9.1 0.0 0.2 0.0 0.2 0.3 0.4 0.2 0.4 0.2 0.1 0.3 0.1 0.1 0.1 0.2 0.2 2.6 0.9 0.6 0.6 1.2 0.5 0.8 0.6 0.5 0.3 1.3 0.8 0.7 2.7 1.3 1.6 0.8 0.4 0.3 10.2 26.6 19.3 25.8 10.5 12.5 6.1 13.1 6.6 3.4 FSD1L "CCDC10, CSDUFD1, FSD1CL, FSD1NL" ENSG00000106701 "Fibronectin type III and SPRY domain containing 1 like" Q9BXM9 9 105447796-105552433 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035138 Approved Approved "Plasma membrane,Actin filaments" "Plasma membrane" "Actin filaments" "HPA035138: AB_10601324" "unprognostic (9.28e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.88e-3)" "unprognostic (3.93e-2)" "unprognostic (1.82e-2)" "unprognostic (3.17e-5)" "unprognostic (4.20e-2)" "unprognostic (5.65e-2)" "unprognostic (9.64e-3)" "unprognostic (2.66e-3)" "unprognostic (3.32e-2)" "unprognostic (8.28e-2)" "unprognostic (2.92e-1)" "unprognostic (1.87e-1)" "unprognostic (8.07e-2)" "unprognostic (1.22e-3)" 2.5 6.9 9.5 3.9 15.2 4.1 3.2 11.1 19.6 3.6 4.9 8.3 6.7 8.6 4.3 6.3 2.2 14.5 3.0 7.4 10.0 13.0 4.2 1.8 4.3 3.0 11.3 8.7 2.8 3.2 7.6 18.9 2.0 20.6 3.2 4.8 7.6 2.3 3.8 11.1 2.4 6.7 3.3 15.5 2.8 4.2 12.2 7.4 2.0 4.1 6.0 3.1 2.4 2.3 5.5 2.1 1.2 2.9 1.7 2.5 0.9 3.5 4.0 6.3 3.7 1.7 3.5 2.1 3.1 2.1 3.1 2.7 2.0 1.3 9.4 1.3 3.1 1.4 4.8 1.8 4.3 11.3 1.5 1.6 5.2 2.4 2.3 5.5 3.6 1.8 1.6 4.2 6.6 2.4 1.9 5.5 2.2 1.2 8.8 2.9 4.0 2.5 11.2 4.2 0.7 2.5 0.8 13.0 6.2 3.6 0.9 2.6 4.2 1.6 2.7 4.9 3.1 4.1 4.4 3.0 10.2 2.5 3.2 3.0 1.6 1.2 2.9 0.1 1.7 1.6 0.8 5.5 2.5 1.8 1.8 2.3 0.3 1.1 1.2 1.7 1.5 2.1 0.6 0.9 9.5 15.2 11.1 14.8 10.0 13.0 11.3 8.7 20.6 7.4 FURIN "FUR, PACE, PCSK3, SPC1" ENSG00000140564 "Furin, paired basic amino acid cleaving enzyme" P09958 15 90868592-90883458 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "liver: 118.4;placenta: 158.9;salivary gland: 337.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009499 Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" 41000 "Golgi apparatus" Nucleoplasm "CAB009499: AB_2105095" "unprognostic (2.46e-1)" "unprognostic (2.73e-2)" "unprognostic (7.33e-2)" "unprognostic (2.30e-2)" "unprognostic (4.11e-3)" "unprognostic (4.37e-2)" "unprognostic (8.11e-2)" "prognostic unfavourable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (9.92e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (4.52e-3)" "unprognostic (4.57e-2)" "unprognostic (4.46e-2)" "unprognostic (4.27e-3)" "unprognostic (8.20e-2)" 8.3 3.3 3.0 7.5 3.6 16.6 5.9 5.0 4.4 4.1 6.6 2.8 3.5 5.7 4.9 10.8 4.7 4.4 3.9 6.9 3.1 1.8 6.4 118.4 9.5 3.1 2.8 2.7 4.2 22.5 3.8 7.2 158.9 3.5 9.3 2.2 3.0 337.9 4.7 8.7 9.0 5.9 3.1 3.0 8.2 6.0 5.3 2.9 4.8 8.9 5.5 4.1 4.4 4.3 1.5 3.3 10.3 3.3 3.1 1.9 2.0 14.1 8.6 1.9 8.7 14.3 9.2 22.2 17.8 13.6 7.4 5.2 12.6 15.5 0.5 45.9 12.9 25.5 3.9 9.2 1.6 40.7 10.1 24.8 15.5 16.5 7.6 3.4 40.9 10.4 10.4 8.4 3.8 23.6 18.9 2.5 4.9 9.7 1.3 11.2 6.2 2.5 2.2 7.5 3.2 11.5 10.8 3.9 2.6 15.1 8.2 12.6 2.9 9.1 34.7 8.3 17.8 12.7 26.1 4.4 25.1 1.1 15.9 11.2 16.8 7.5 3.3 10.3 1.9 1.1 1.4 1.5 1.2 1.2 2.1 1.0 0.6 0.8 7.4 3.1 0.7 3.3 0.9 2.0 3.0 3.6 5.0 4.4 3.1 1.8 2.8 2.7 3.5 2.9 FUT2 "SE, Se2, SEC2, sej" ENSG00000176920 "Fucosyltransferase 2" Q10981 19 48695971-48705950 "Blood group antigen proteins, Enzymes, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.3;salivary gland: 58.1" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 40.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 8.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA014402 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA014402: AB_1849194" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (2.80e-3)" "unprognostic (4.63e-3)" "unprognostic (2.63e-1)" "prognostic favourable (5.83e-4)" "unprognostic (6.30e-3)" "unprognostic (6.55e-3)" "unprognostic (1.58e-1)" "unprognostic (8.44e-2)" "unprognostic (7.89e-2)" "unprognostic (5.11e-1)" "unprognostic (4.04e-2)" "unprognostic (6.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" 0.4 0.6 0.7 5.3 0.8 0.0 0.8 8.7 1.6 9.3 25.0 0.3 13.9 24.1 1.3 0.1 16.0 1.2 23.3 0.5 0.7 0.7 0.8 0.4 1.1 0.1 0.7 0.1 1.0 7.5 0.0 1.5 0.2 0.7 1.2 10.9 0.1 58.1 14.5 0.5 2.6 41.3 0.4 0.7 0.6 15.8 0.7 0.2 0.5 0.6 16.1 19.3 3.1 5.4 1.7 1.8 3.5 1.0 1.4 2.5 0.6 1.1 1.0 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.8 40.9 0.3 0.3 0.0 7.2 0.0 0.0 0.0 0.4 0.3 0.4 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.5 0.9 0.3 0.3 0.3 0.1 1.8 0.0 0.3 2.2 0.3 0.1 0.3 0.0 6.1 0.0 0.1 0.2 0.3 0.3 0.1 0.3 0.2 0.0 0.2 0.2 0.1 3.5 0.8 0.4 2.0 0.7 1.1 1.5 2.3 1.0 0.5 1.7 2.1 0.7 3.4 1.4 1.0 1.8 2.5 0.6 0.7 0.8 8.7 1.6 0.7 0.7 0.7 0.1 0.7 0.2 FUT3 "CD174, LE" ENSG00000171124 "Fucosyltransferase 3 (Lewis blood group)" P21217 19 5842888-5851474 "Blood group antigen proteins, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.6;intestine: 49.3;lymphoid tissue: 38.4" "Group enriched" "Detected in some" 4 "A-431: 30.2;RH-30: 10.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 41.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" HPA046966 Supported "HPA046966: " "prognostic unfavourable (6.86e-4)" "unprognostic (2.59e-1)" "unprognostic (1.06e-1)" "unprognostic (9.12e-2)" "unprognostic (8.58e-3)" "unprognostic (1.63e-3)" "unprognostic (3.88e-2)" "unprognostic (2.03e-2)" "unprognostic (4.02e-2)" "unprognostic (3.98e-2)" "unprognostic (4.21e-2)" "unprognostic (2.99e-1)" "prognostic favourable (8.22e-7)" "unprognostic (5.66e-3)" "unprognostic (9.56e-2)" "unprognostic (4.30e-2)" "unprognostic (1.07e-1)" 0.2 0.1 0.2 14.5 0.2 0.0 0.4 0.2 0.2 10.9 40.4 0.2 32.5 18.8 0.4 0.5 53.6 0.7 21.5 0.1 0.2 0.2 3.8 0.9 5.1 0.1 0.2 0.1 0.5 4.7 0.0 0.3 0.6 0.1 1.0 18.1 0.2 27.5 31.6 0.1 1.0 49.3 1.0 0.2 0.1 8.1 1.3 0.1 0.3 0.1 14.9 38.4 2.9 16.1 0.2 1.6 0.8 0.6 0.0 0.5 0.0 30.2 0.0 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.4 0.0 1.3 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 10.2 1.0 0.0 0.5 0.0 0.1 0.0 4.8 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.8 0.0 0.0 1.6 0.5 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 FUT4 "CD15, ELFT, FCT3A, FUC-TIV" ENSG00000196371 "Fucosyltransferase 4" P22083 11 94543840-94549898 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 71.3" "Cell line enhanced" "Detected in many" "HL-60: 20.4;NB-4: 13.2;THP-1: 25.8;U-937: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB000014, CAB016129" Enhanced Supported Vesicles Vesicles "CAB000014: , CAB016129: AB_626918" "unprognostic (6.36e-2)" "unprognostic (7.53e-2)" "unprognostic (4.70e-3)" "unprognostic (2.46e-3)" "unprognostic (1.46e-2)" "unprognostic (2.29e-2)" "unprognostic (1.66e-2)" "prognostic unfavourable (3.64e-4)" "unprognostic (7.26e-2)" "unprognostic (4.14e-1)" "unprognostic (4.81e-3)" "unprognostic (1.27e-1)" "unprognostic (9.08e-3)" "unprognostic (8.17e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (3.10e-3)" 5.5 2.4 5.5 6.1 6.2 71.3 6.3 3.0 6.0 4.4 8.3 6.7 4.7 10.9 5.9 2.5 3.0 4.6 7.5 3.7 6.2 2.2 4.1 3.0 6.0 5.4 8.1 2.5 4.9 11.4 1.4 2.9 3.4 4.8 3.4 8.3 3.8 6.3 2.9 1.7 1.9 10.1 5.8 5.7 6.5 9.7 2.9 4.5 10.4 2.9 1.9 3.1 4.4 3.0 0.7 1.9 2.5 3.9 0.8 1.9 0.8 1.6 0.8 1.0 0.0 3.1 2.8 5.1 1.4 0.7 1.3 1.5 6.9 2.2 0.0 3.5 2.4 0.8 1.6 0.1 1.2 10.5 1.6 5.2 1.1 0.1 1.6 20.4 4.6 2.4 0.0 1.7 0.0 2.0 5.2 0.0 1.5 0.7 4.2 13.2 1.9 1.9 3.8 0.0 0.0 1.4 1.1 1.4 0.5 0.8 2.1 0.8 1.2 25.8 1.9 1.0 2.9 0.0 0.5 0.6 0.3 0.0 0.9 18.3 0.6 2.0 3.1 2.5 1.1 1.5 0.7 0.6 1.0 1.3 1.8 0.7 1.1 0.7 1.7 0.8 3.9 1.9 1.9 0.8 5.5 6.2 3.0 6.0 6.2 2.2 8.1 2.5 4.8 4.5 FUT5 FUC-TV ENSG00000130383 "Fucosyltransferase 5" Q11128 19 5865826-5870540 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.6" "Cell line enhanced" "Detected in some" "MCF7: 1.8;SH-SY5Y: 2.9;U-266/70: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046966 Uncertain "HPA046966: " "unprognostic (7.72e-2)" "unprognostic (3.59e-1)" "unprognostic (5.03e-2)" "unprognostic (1.20e-1)" 0.2 0.1 1.0 0.1 0.5 3.6 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.3 0.3 1.1 0.4 0.3 0.2 1.1 0.1 0.2 0.9 0.2 0.5 0.1 0.3 0.1 0.1 0.1 0.4 0.1 1.2 0.5 0.1 0.1 0.8 0.2 0.1 1.6 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.5 0.3 0.0 0.7 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FUT6 "FCT3A, FLJ40754, FT1A, FucT-VI" ENSG00000156413 "Fucosyltransferase 6" P51993 19 5830610-5839731 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.8;intestine: 44.4;lymphoid tissue: 33.9;salivary gland: 37.0" "Group enriched" "Detected in some" 7 "Hep G2: 14.6;RPMI-8226: 5.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 3.7;neutrophil: 1.2;NK-cell: 2.1" "Group enriched" "Detected in many" 7 "granulocytes: 3.7;NK-cells: 2.1" "HPA043707, HPA046966" Approved Supported "Golgi apparatus" "Golgi apparatus" "HPA043707: , HPA046966: " "unprognostic (3.65e-2)" "unprognostic (3.00e-3)" "unprognostic (2.13e-3)" "unprognostic (2.78e-3)" "unprognostic (6.35e-2)" "prognostic favourable (2.12e-4)" "unprognostic (8.02e-2)" "unprognostic (6.68e-3)" "unprognostic (4.01e-2)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (4.94e-2)" "prognostic favourable (3.17e-8)" "unprognostic (1.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" 0.2 0.2 0.2 7.2 0.2 0.1 0.8 0.2 0.2 9.2 26.4 0.0 9.5 15.6 0.7 7.6 40.8 0.6 25.4 0.2 0.2 0.2 27.2 6.5 1.3 0.2 0.2 0.0 0.2 2.2 0.0 0.8 0.0 0.0 0.3 6.9 0.0 37.0 19.1 0.2 0.2 44.4 0.2 0.2 0.2 2.8 0.3 0.0 0.0 0.2 16.4 33.9 0.2 12.4 0.4 0.3 3.7 0.3 2.1 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.2 14.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 5.4 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.1 3.7 0.3 0.4 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.4 0.3 0.2 1.2 2.1 0.1 0.3 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 FUT8 ENSG00000033170 "Fucosyltransferase 8" Q9BYC5 14 65410592-65744121 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.5;NK-cells: 12.0;T-cells: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017129, HPA040863, HPA043410" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB017129: , HPA040863: , HPA043410: " "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (3.28e-2)" "unprognostic (1.65e-3)" "unprognostic (2.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.41e-1)" "unprognostic (8.81e-2)" "unprognostic (2.00e-2)" "unprognostic (1.33e-3)" "unprognostic (8.09e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-3)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" 7.2 7.6 16.2 12.0 21.1 3.3 9.4 24.1 18.1 6.7 9.8 29.1 16.1 15.4 8.7 5.0 6.5 14.0 10.1 5.2 19.8 12.9 6.2 2.9 7.0 11.2 20.5 11.2 7.2 10.5 6.2 5.2 18.8 17.3 5.4 10.4 7.1 33.7 13.7 3.5 4.9 15.1 9.5 39.8 8.5 27.6 13.1 23.6 8.4 7.5 2.4 15.2 14.4 5.6 13.5 2.2 0.5 1.7 12.0 8.2 2.5 34.9 6.9 3.3 30.7 14.8 11.2 20.8 11.2 17.2 7.8 8.7 5.4 12.9 9.3 9.6 11.1 2.6 7.9 3.1 12.0 34.5 3.4 9.4 2.5 7.0 7.6 2.1 7.7 28.1 2.0 10.8 5.1 19.8 3.4 7.9 5.6 18.0 9.9 5.1 4.5 24.2 6.8 2.9 5.3 14.0 9.8 7.1 5.3 6.0 2.8 2.4 2.8 3.4 43.1 10.3 11.0 4.5 9.1 15.9 6.0 22.2 20.8 3.7 3.2 0.5 1.7 0.5 3.5 0.6 3.5 13.5 5.6 5.1 2.2 6.8 6.1 6.0 0.2 12.0 1.1 2.2 8.2 2.5 16.2 21.1 24.1 17.3 19.8 12.9 20.5 11.2 17.3 23.6 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015984-96215612 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 37.7;stomach 1: 35.4" "Cell line enhanced" "Detected in some" "MCF7: 4.1;RT4: 9.4;SCLC-21H: 9.6;SK-BR-3: 5.4" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: " "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 1.1 1.7 18.5 1.1 22.5 1.1 1.9 37.7 28.6 1.1 1.1 10.7 0.0 4.1 1.4 1.2 1.1 1.4 1.1 1.1 20.0 6.2 1.2 1.1 1.1 1.1 10.2 24.0 1.1 8.0 1.1 0.9 1.7 13.8 1.5 1.2 0.0 1.1 1.5 1.2 1.1 1.1 1.1 10.2 1.1 35.4 1.1 16.5 0.0 1.2 0.0 1.1 2.2 0.4 0.3 0.2 1.5 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 9.4 9.6 0.2 0.0 5.4 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.8 0.2 0.0 0.2 0.0 0.0 18.5 22.5 37.7 28.6 20.0 6.2 10.2 24.0 13.8 16.5 FUZ "FLJ22688, Fy" ENSG00000010361 "Fuzzy planar cell polarity protein" Q9BT04 19 49806869-49817376 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 116.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041779, HPA042196" Approved Approved Cytosol Cytosol "HPA041779: AB_10793974, HPA042196: AB_10797383" "unprognostic (2.40e-3)" "unprognostic (1.31e-1)" "unprognostic (7.73e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (1.18e-2)" "unprognostic (4.36e-3)" "unprognostic (9.67e-2)" "unprognostic (1.47e-1)" "unprognostic (1.97e-2)" "unprognostic (1.06e-2)" "unprognostic (1.80e-1)" "prognostic favourable (1.50e-5)" "unprognostic (1.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.70e-1)" 5.6 7.8 7.4 2.1 8.4 4.7 4.1 5.4 9.0 6.5 3.8 11.3 3.5 3.7 6.1 6.6 3.4 17.8 4.7 4.5 7.7 5.8 9.0 3.0 4.4 4.1 7.8 5.6 9.8 7.0 5.6 5.2 3.6 6.8 4.5 1.7 4.8 6.2 7.1 15.1 2.0 3.2 3.8 7.9 3.6 4.6 116.2 8.1 5.4 6.8 3.4 3.2 3.5 3.0 5.7 12.3 14.9 4.0 3.0 4.6 2.4 0.0 6.5 6.1 7.9 5.4 6.2 1.6 3.0 3.3 5.2 7.1 0.5 10.7 1.8 6.4 2.9 2.8 1.5 5.7 2.3 6.1 12.4 7.4 4.4 0.0 6.5 4.5 4.3 6.5 3.8 10.1 2.4 4.4 1.8 5.3 2.5 0.4 8.8 9.5 10.2 3.4 15.2 4.4 4.2 5.8 1.4 17.2 19.9 0.6 6.6 10.6 3.7 2.8 2.3 4.4 3.9 1.1 1.1 15.3 15.2 4.9 4.9 0.1 5.3 5.4 4.0 14.9 4.6 1.9 3.6 4.6 2.8 3.7 3.2 5.7 3.5 4.0 8.9 3.0 1.3 12.3 3.2 2.4 7.4 8.4 5.4 9.0 7.7 5.8 7.8 5.6 6.8 8.1 FXYD1 PLM ENSG00000266964 "FXYD domain containing ion transport regulator 1" O00168 19 35138808-35143109 "Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8" "Cell line enhanced" "Detected in some" "ASC diff: 30.3;ASC TERT1: 8.8;HSkMC: 12.5" "Cancer enhanced" "Detected in many" "liver cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 11.7" "Group enriched" "Detected in many" 5 "B-cells: 11.7;T-cells: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026873 Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA026873: AB_1855471" "unprognostic (5.58e-3)" "unprognostic (6.60e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-2)" "prognostic unfavourable (6.91e-4)" "unprognostic (1.54e-2)" "unprognostic (1.72e-2)" "unprognostic (3.54e-3)" "unprognostic (8.13e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (2.66e-1)" "prognostic unfavourable (7.59e-8)" "unprognostic (9.97e-3)" "unprognostic (2.25e-1)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" 28.2 8.1 35.7 5.2 40.7 2.0 21.8 16.8 34.7 46.5 16.9 25.5 7.1 5.0 26.3 17.9 18.8 31.1 14.8 134.1 23.8 19.9 4.5 137.1 14.1 3.0 36.1 23.7 34.0 6.2 2.1 4.3 8.6 21.5 21.6 7.9 14.1 6.4 20.7 299.8 5.8 7.5 27.7 19.0 6.2 8.4 7.5 14.8 0.0 3.9 29.0 3.5 12.7 23.7 11.7 0.7 1.2 0.7 2.0 7.1 0.7 0.7 0.0 0.0 0.1 30.3 8.8 0.8 3.6 0.1 0.0 0.0 0.0 0.2 2.4 0.9 0.0 0.6 0.7 0.4 0.0 2.1 0.8 0.4 0.0 1.1 3.5 0.2 0.2 12.5 0.0 0.1 0.3 0.1 0.6 2.5 0.1 0.0 0.0 0.5 0.1 0.4 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.1 1.0 0.1 3.9 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.6 0.4 5.0 1.2 0.3 0.0 1.4 0.7 0.9 11.7 4.1 1.7 0.3 6.6 0.8 1.0 0.6 2.0 0.7 0.7 7.1 0.7 35.7 40.7 16.8 34.7 23.8 19.9 36.1 23.7 21.5 14.8 FXYD2 "ATP1G1, HOMG2, MGC12372" ENSG00000137731 "FXYD domain containing ion transport regulator 2" P54710 11 117800844-117828698 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Disease mutation, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 258.1;pancreas: 68.9;salivary gland: 91.7" "Group enriched" "Detected in some" 29 "MOLT-4: 137.7;RPTEC TERT1: 315.9" "Cancer enriched" "Detected in some" 8 "renal cancer: 49.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 14.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 9 "midbrain: 2.6" "HPA064218, HPA068838" Supported Approved Mitochondria 26000 Mitochondria "HPA064218: , HPA068838: " "unprognostic (4.11e-4)" "unprognostic (1.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-3)" "unprognostic (1.09e-3)" "unprognostic (2.30e-2)" "unprognostic (3.65e-2)" "unprognostic (4.62e-1)" "unprognostic (4.01e-2)" "unprognostic (4.91e-2)" "unprognostic (1.24e-2)" "unprognostic (2.64e-1)" "prognostic favourable (3.23e-9)" "unprognostic (3.22e-3)" "unprognostic (4.38e-2)" "unprognostic (4.62e-1)" "unprognostic (3.00e-2)" 0.3 0.2 0.2 0.2 0.1 0.0 0.7 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.3 2.8 0.3 0.3 54.7 0.2 0.1 0.2 258.1 2.2 0.2 0.6 0.1 0.0 0.4 68.9 0.0 0.3 0.6 0.1 0.3 0.0 0.1 91.7 0.1 0.1 0.2 0.3 0.1 0.1 0.4 0.2 0.2 0.0 9.5 0.2 0.3 0.4 0.2 0.6 0.4 3.2 0.0 1.1 8.4 14.1 2.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 137.7 0.0 0.0 0.0 0.0 0.0 0.2 315.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 1.1 0.2 1.8 14.1 0.2 0.4 5.1 4.1 0.0 8.4 0.0 3.2 1.6 2.0 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 0.0 FXYD3 "MAT-8, PLML" ENSG00000089356 "FXYD domain containing ion transport regulator 3" Q14802 19 35115879-35124324 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 160.2;salivary gland: 141.7" "Cell line enhanced" "Detected in some" "HaCaT: 88.3;hTCEpi: 160.7;RT4: 83.9;SK-BR-3: 82.6;WM-115: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.2" HPA010856 Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" Nucleoplasm "Plasma membrane" "HPA010856: AB_1078915" "unprognostic (2.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.37e-3)" "unprognostic (3.31e-3)" "unprognostic (6.38e-2)" "unprognostic (3.02e-1)" "unprognostic (2.64e-3)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (3.88e-1)" "prognostic unfavourable (1.15e-6)" "unprognostic (4.17e-2)" "unprognostic (2.08e-1)" "unprognostic (5.06e-2)" "unprognostic (7.69e-3)" 0.4 0.1 1.6 29.5 2.3 0.0 20.4 1.7 2.1 30.0 133.2 1.1 2.3 8.6 3.9 2.9 82.1 9.0 56.6 0.8 1.4 0.3 2.1 0.5 35.8 0.3 2.1 0.8 1.9 28.9 0.0 3.7 41.9 2.2 58.4 160.2 15.8 141.7 3.5 0.5 64.2 36.4 7.5 1.8 0.4 50.6 0.7 1.0 2.5 0.5 93.2 49.8 48.7 42.5 0.3 3.2 0.6 0.1 0.0 0.2 0.5 15.9 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.5 23.2 0.0 0.0 0.0 88.3 0.0 33.3 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 160.7 0.0 0.0 0.0 0.0 0.1 0.0 29.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 83.9 19.7 0.2 0.1 82.6 6.1 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 59.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.6 0.0 0.0 3.2 0.0 0.5 1.6 2.3 1.7 2.1 1.4 0.3 2.1 0.8 2.2 1.0 FXYD4 CHIF ENSG00000150201 "FXYD domain containing ion transport regulator 4" P59646 10 43371642-43376335 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 27 "kidney: 119.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.3;HSkMC: 1.0;hTCEpi: 1.3;RT4: 1.1;SK-BR-3: 1.0;U-266/84: 1.3" "Group enriched" "Detected in many" 5 "renal cancer: 10.7;urothelial cancer: 20.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058421 Enhanced "HPA058421: AB_2683714" "unprognostic (2.92e-3)" "unprognostic (5.25e-1)" "unprognostic (9.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (5.17e-2)" "unprognostic (2.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-1)" "unprognostic (2.09e-2)" 0.1 0.0 0.4 0.0 2.2 0.0 0.0 0.1 1.0 0.0 0.1 2.0 0.1 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.6 0.3 119.5 0.0 1.3 0.0 1.6 0.4 0.0 0.0 0.0 0.1 0.0 1.0 0.6 0.0 0.0 4.4 1.5 0.6 0.0 0.0 0.0 0.5 0.0 2.4 0.2 1.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.2 0.1 1.0 0.6 0.3 1.6 0.4 1.0 1.4 FXYD5 OIT2 ENSG00000089327 "FXYD domain containing ion transport regulator 5" Q96DB9 19 35154730-35169883 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA010817 Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA010817: AB_1849214" "unprognostic (3.97e-3)" "unprognostic (5.49e-2)" "unprognostic (6.37e-3)" "unprognostic (3.01e-1)" "unprognostic (2.50e-3)" "unprognostic (4.39e-3)" "unprognostic (4.68e-2)" "unprognostic (1.56e-3)" "unprognostic (3.85e-1)" "unprognostic (5.66e-3)" "unprognostic (4.78e-2)" "unprognostic (4.75e-2)" "prognostic unfavourable (3.71e-9)" "unprognostic (6.07e-2)" "unprognostic (7.88e-2)" "unprognostic (3.61e-2)" "unprognostic (1.74e-1)" 58.8 10.6 6.0 47.4 9.0 72.4 66.9 2.7 7.1 44.3 15.6 14.4 10.4 8.8 33.6 25.9 31.3 26.0 28.6 29.1 7.0 7.9 13.7 13.2 39.5 110.7 12.0 7.6 18.9 8.0 3.4 11.7 56.9 11.8 27.3 14.0 19.8 19.7 16.7 17.0 22.7 27.0 18.7 18.2 80.3 20.8 10.8 9.3 33.9 16.0 26.9 97.4 36.6 59.8 73.3 91.4 66.5 76.9 99.6 109.0 94.6 99.5 23.8 0.0 0.1 35.6 45.2 24.0 57.3 76.4 40.9 30.6 6.7 29.2 22.9 15.7 69.1 23.5 14.7 35.3 26.4 28.3 9.6 42.8 13.2 0.0 28.1 24.4 42.7 26.8 15.8 29.7 51.4 38.6 40.2 111.0 25.5 0.1 2.9 10.2 7.4 13.8 13.7 5.0 29.0 15.0 0.5 4.3 0.0 31.6 16.6 33.4 8.7 19.6 54.4 50.6 19.3 54.8 4.3 0.1 1.7 5.8 77.1 56.7 77.2 66.5 73.5 13.4 60.3 76.9 56.8 73.3 102.5 62.8 91.4 66.7 68.0 55.0 18.1 99.6 74.5 41.9 109.0 94.6 6.0 9.0 2.7 7.1 7.0 7.9 12.0 7.6 11.8 9.3 FXYD6 ENSG00000137726 "FXYD domain containing ion transport regulator 6" Q9H0Q3 11 117836976-117877486 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 142.8" "Cell line enhanced" "Detected in some" "AF22: 37.1;HAP1: 24.5;RH-30: 15.4;SCLC-21H: 56.2;SH-SY5Y: 32.1" "Cancer enriched" "Detected in all" 6 "glioma: 71.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "classical monocyte: 21.9" "Lineage enriched" "Detected in many" 6 "monocytes: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041334, HPA042284" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041334: AB_10970752, HPA042284: " "unprognostic (2.18e-3)" "unprognostic (2.70e-2)" "unprognostic (1.60e-2)" "prognostic unfavourable (1.05e-5)" "unprognostic (3.31e-2)" "unprognostic (1.15e-1)" "prognostic favourable (5.87e-4)" "unprognostic (4.51e-2)" "unprognostic (3.78e-2)" "unprognostic (1.07e-2)" "prognostic favourable (5.97e-4)" "unprognostic (3.44e-2)" "prognostic favourable (4.38e-5)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.60e-4)" 12.9 38.7 41.2 9.5 46.2 3.1 8.1 49.1 142.8 24.3 52.0 30.2 9.2 7.6 54.8 19.0 9.8 26.7 29.0 25.6 35.4 51.6 12.3 10.4 21.5 8.5 18.4 59.5 82.8 9.5 3.5 28.5 5.6 20.2 35.6 11.7 11.9 9.8 22.9 11.0 3.9 16.3 58.5 12.8 42.8 17.6 23.2 18.5 2.9 15.9 6.4 5.9 38.1 13.9 0.0 3.6 0.5 21.9 0.0 0.3 5.1 0.0 0.2 37.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 24.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 1.6 0.1 7.4 0.0 0.0 15.4 0.2 0.9 0.0 56.2 32.1 0.0 0.1 1.2 0.6 0.6 0.0 0.0 9.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 21.9 0.0 0.0 5.3 0.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 5.1 41.2 46.2 49.1 78.8 35.4 51.6 18.4 59.5 20.2 18.5 FXYD6-FXYD2 ENSG00000255245 "FXYD6-FXYD2 readthrough" 11 117820163-117876667 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "MOLT-4: 9.5;RPTEC TERT1: 10.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.3" "Low lineage specificity" "Detected in many" "HPA068838, HPA075209" Approved Approved "Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" "HPA068838: , HPA075209: " 2.8 2.7 7.4 1.8 12.4 1.8 2.7 4.2 22.2 6.0 4.5 7.9 1.4 1.8 11.4 5.2 2.5 3.9 6.6 3.0 4.8 2.9 23.0 2.8 3.1 2.1 2.5 16.5 10.2 9.6 2.4 4.2 2.5 4.6 9.4 2.0 2.2 19.5 2.2 2.9 2.5 3.0 13.7 2.5 4.2 2.9 3.6 4.3 0.0 2.9 0.5 2.3 10.1 2.8 0.0 0.5 0.0 1.1 0.8 1.3 0.7 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.7 0.0 0.0 0.4 0.0 10.9 0.0 0.6 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.3 0.0 0.4 0.3 0.0 0.8 0.0 0.5 0.0 0.7 7.4 12.4 4.2 22.2 4.8 2.9 2.5 16.5 4.6 4.3 FXYD7 ENSG00000221946 "FXYD domain containing ion transport regulator 7" P58549 19 35143250-35154301 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "blood: 24.4;brain: 76.1" "Cell line enhanced" "Detected in some" "HAP1: 3.1;HMC-1: 9.6;Karpas-707: 3.3;NTERA-2: 2.8;WM-115: 5.5" "Cancer enhanced" "Detected in some" "glioma: 4.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 24.4" "Group enriched" "Detected in many" 22 "B-cells: 8.1;NK-cells: 24.4;T-cells: 12.9" "Low region specificity" "Detected in all" HPA026916 Approved "HPA026916: AB_1849217" "unprognostic (1.25e-3)" "unprognostic (8.73e-3)" "unprognostic (4.64e-2)" "unprognostic (6.95e-4)" "unprognostic (8.47e-2)" "unprognostic (1.73e-2)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (1.90e-1)" "unprognostic (3.08e-2)" "unprognostic (5.70e-2)" "unprognostic (1.16e-1)" "unprognostic (6.90e-5)" "unprognostic (1.51e-2)" "unprognostic (3.32e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" 1.5 1.7 46.9 2.8 31.6 1.8 1.6 3.0 76.1 1.7 1.5 4.7 0.0 1.9 1.9 1.2 1.7 1.8 1.7 1.5 41.9 20.1 1.3 1.4 1.6 3.7 19.8 26.2 1.8 1.5 1.2 0.1 1.4 10.1 1.4 1.5 0.0 1.8 1.6 2.9 1.9 1.7 1.5 8.7 3.2 1.7 1.7 1.6 0.0 1.4 0.0 2.8 1.8 0.4 8.1 0.6 0.3 0.0 24.4 12.9 2.4 1.1 0.3 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.3 0.0 0.6 1.0 0.2 0.0 0.4 3.1 0.0 0.4 0.5 0.2 0.4 0.8 0.0 0.2 0.0 9.6 0.9 0.0 0.0 0.0 0.1 0.8 3.3 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.2 0.2 0.0 0.7 0.0 0.0 0.5 0.3 1.3 0.2 0.0 0.1 0.0 0.0 0.8 0.2 5.5 0.0 0.0 0.0 8.1 0.0 5.0 8.1 12.9 9.2 0.0 7.3 4.2 7.2 0.3 24.4 0.0 0.6 3.6 2.4 46.9 31.6 3.0 76.1 41.9 20.1 19.8 26.2 10.1 1.6 GABRA1 EJM5 ENSG00000022355 "Gamma-aminobutyric acid type A receptor alpha1 subunit" P14867 5 161847063-161899981 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 58.6" "Cell line enhanced" "Detected in some" "HEL: 3.6;SCLC-21H: 1.1;U-2 OS: 1.5;U-87 MG: 2.3;WM-115: 1.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022502, HPA055746" Enhanced Supported "CAB022502: , HPA055746: " "unprognostic (2.58e-2)" "unprognostic (4.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.31e-1)" "unprognostic (2.43e-1)" 1.0 2.6 8.5 1.0 21.9 1.0 1.0 35.2 58.6 1.0 1.0 1.8 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 10.5 8.8 1.0 1.0 1.0 1.0 6.7 22.0 1.0 1.0 1.0 0.1 1.0 7.4 1.2 1.0 0.2 1.0 1.1 1.0 1.0 1.0 1.0 1.3 1.1 1.5 1.1 0.0 0.0 1.0 0.0 1.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.6 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 21.9 35.2 49.8 10.5 8.8 6.7 22.0 7.4 0.0 GABRA6 ENSG00000145863 "Gamma-aminobutyric acid type A receptor alpha6 subunit" Q16445 5 161547063-161702593 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "brain: 96.4" "Group enriched" "Detected in some" 9 "AF22: 1.0;PC-3: 1.4;TIME: 1.0;U-266/70: 2.4" "Not detected" "Not detected" "Region enriched" "Detected in some" 36 "cerebellum: 96.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 40 "cerebellum: 1204.9" "Region enriched" "Detected in single" 44 "cerebellum: 189.6" CAB022462 Approved "CAB022462: " "unprognostic (3.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 0.1 0.0 0.0 0.0 0.0 2.6 0.0 GABRD ENSG00000187730 "Gamma-aminobutyric acid type A receptor delta subunit" O14764 1 2019298-2030758 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 87.0" "Cell line enhanced" "Detected in some" "EFO-21: 2.8;HMC-1: 2.5;MCF7: 8.2;NB-4: 5.2;SH-SY5Y: 3.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 87.0" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044371 Enhanced Uncertain "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA044371: " "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-8)" "unprognostic (6.34e-3)" "unprognostic (2.66e-3)" "unprognostic (1.04e-2)" "unprognostic (3.44e-3)" "unprognostic (2.14e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.99e-1)" "prognostic unfavourable (4.12e-8)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "unprognostic (5.16e-2)" 1.2 3.4 8.8 0.9 16.8 1.0 1.0 87.0 40.0 1.0 1.2 1.7 0.0 0.9 1.3 1.2 1.3 1.0 1.5 1.7 6.0 1.7 1.1 0.9 1.4 1.3 3.3 11.1 0.9 0.9 1.4 0.7 1.2 17.1 1.0 1.0 0.0 1.1 0.9 1.3 1.4 1.0 1.4 1.4 1.0 1.0 3.3 1.5 0.0 1.6 0.0 1.0 1.2 0.1 0.0 1.2 0.2 0.1 0.0 0.0 0.8 0.0 0.7 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 5.2 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.1 0.0 0.0 1.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.8 8.8 16.8 87.0 40.0 6.0 1.7 3.3 11.1 17.1 1.5 GABRP ENSG00000094755 "Gamma-aminobutyric acid type A receptor pi subunit" O00591 5 170763350-170814047 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.0;lymphoid tissue: 57.7" "Cell line enhanced" "Detected in many" "A-431: 44.6;EFO-21: 52.2;HeLa: 31.3;PC-3: 71.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 10.1" "Group enriched" "Detected in many" 6 "granulocytes: 10.1;monocytes: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB014883 Uncertain "CAB014883: " "unprognostic (3.98e-3)" "prognostic favourable (3.37e-4)" "unprognostic (8.34e-2)" "unprognostic (1.57e-1)" "unprognostic (8.90e-2)" "unprognostic (1.27e-1)" "unprognostic (7.89e-2)" "unprognostic (4.97e-3)" "unprognostic (3.72e-1)" "unprognostic (4.93e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.82e-1)" "unprognostic (5.92e-3)" "unprognostic (6.52e-3)" 1.5 0.5 0.5 1.3 0.5 1.1 31.6 0.5 1.1 18.5 1.7 0.6 2.6 2.6 30.4 9.9 37.0 2.2 8.6 1.0 0.5 0.4 6.9 3.8 2.5 0.5 0.5 0.5 1.1 4.3 0.0 2.4 5.5 0.6 6.8 0.4 0.8 25.5 3.2 2.0 10.0 3.9 0.5 0.5 0.8 5.0 1.0 0.5 2.5 0.6 3.1 57.7 1.2 20.0 0.9 1.1 10.1 6.1 0.2 1.3 3.1 44.6 2.0 2.2 1.5 0.1 0.9 5.2 0.8 0.3 0.1 0.1 8.0 5.1 0.7 52.2 0.2 16.2 1.3 0.1 0.1 0.7 1.6 2.9 31.3 1.1 0.1 1.0 2.5 0.3 0.6 0.6 0.4 0.3 12.0 5.7 0.1 1.4 1.9 1.0 18.4 71.4 2.8 1.4 1.7 3.0 2.4 1.8 0.8 16.5 0.8 0.5 0.9 0.5 1.9 4.1 15.2 3.4 3.3 2.2 1.3 1.3 0.5 2.9 0.6 10.1 2.3 6.8 0.5 1.7 1.3 0.3 0.5 0.4 0.7 0.9 0.7 0.6 5.4 0.2 6.1 1.1 0.7 3.1 0.5 0.5 0.5 0.6 0.5 0.4 0.5 0.5 0.6 0.5 GAL3ST4 FLJ12116 ENSG00000197093 "Galactose-3-O-sulfotransferase 4" Q96RP7 7 100159244-100168750 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.8" "Cell line enhanced" "Detected in many" "HaCaT: 8.5;HSkMC: 8.6;WM-115: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 26 "dendritic cells: 4.3;T-cells: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038137, HPA038138" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038137: AB_10697239, HPA038138: " "unprognostic (4.22e-2)" "unprognostic (2.97e-2)" "prognostic unfavourable (5.44e-4)" "unprognostic (8.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (2.57e-4)" "unprognostic (2.80e-1)" "unprognostic (2.25e-1)" "prognostic unfavourable (4.14e-4)" "unprognostic (3.98e-2)" "unprognostic (9.67e-2)" "unprognostic (1.89e-2)" "unprognostic (5.36e-2)" 3.9 5.4 8.4 4.2 9.4 1.0 4.1 1.5 10.9 7.8 6.5 18.6 0.4 4.1 9.0 3.7 8.4 6.3 5.9 4.9 8.0 3.8 1.8 1.0 5.3 2.9 11.9 4.7 7.6 1.5 1.6 4.6 9.8 8.1 6.5 7.0 4.2 24.9 4.3 1.9 27.8 8.9 10.6 14.9 2.7 2.8 4.4 10.2 37.8 2.0 2.4 3.9 7.3 10.6 0.1 4.3 0.3 0.1 0.2 15.0 2.2 0.0 0.6 4.0 1.8 3.6 7.0 7.5 2.1 2.2 1.3 1.7 0.4 0.2 0.7 0.5 7.3 8.5 0.2 1.2 0.4 0.0 0.4 0.2 0.1 0.2 2.4 0.4 2.4 8.6 3.3 3.9 0.4 2.5 1.1 0.1 2.3 0.2 2.7 0.1 1.3 0.9 2.1 1.8 0.1 0.0 0.3 0.2 1.7 0.6 0.0 4.5 0.0 0.2 2.2 0.2 1.2 0.3 0.1 0.1 0.1 1.6 1.4 0.4 29.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 4.4 0.3 0.0 0.1 15.0 4.5 0.3 0.2 0.1 4.3 1.1 2.2 8.4 9.4 1.5 10.9 8.0 3.8 11.9 4.7 8.1 10.2 GALC ENSG00000054983 Galactosylceramidase P54803 14 87837820-87993665 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism, Sphingolipid metabolism" "Glycosidase, Hydrolase" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 35.1;HMC-1: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022196 Approved "Intracellular and membrane" 16000 "CAB022196: " "unprognostic (1.27e-1)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (9.39e-2)" "unprognostic (3.08e-1)" "unprognostic (9.70e-2)" "unprognostic (1.73e-1)" "unprognostic (6.56e-2)" "unprognostic (8.44e-3)" "unprognostic (8.08e-2)" "unprognostic (1.84e-2)" "unprognostic (6.00e-2)" "unprognostic (2.13e-1)" "unprognostic (6.80e-2)" "unprognostic (2.72e-2)" 13.8 17.7 21.2 13.2 32.2 18.9 15.4 16.3 25.5 12.3 15.8 28.8 9.6 30.3 10.7 12.1 6.5 20.1 17.4 19.6 22.0 19.5 20.5 11.1 23.0 18.0 30.7 20.1 17.3 13.6 14.4 12.6 15.6 24.9 14.1 16.9 13.3 8.9 10.1 9.3 9.4 30.2 9.3 33.8 14.3 14.9 21.6 26.1 8.6 23.5 5.8 7.3 12.6 11.4 1.7 5.7 20.8 10.5 9.4 16.3 6.4 0.0 8.2 3.0 0.0 10.2 9.2 0.0 3.7 7.6 3.6 4.3 4.5 35.1 2.1 11.4 3.6 0.5 0.0 0.4 4.4 1.1 0.2 12.1 0.3 0.0 8.4 0.0 33.2 9.0 2.8 2.4 0.0 9.6 4.0 1.6 6.0 0.8 0.0 1.8 2.7 0.9 0.0 0.2 0.1 5.7 3.3 2.8 6.7 10.3 1.7 0.0 8.5 8.3 8.1 0.0 5.6 2.3 0.0 1.7 3.2 0.0 1.0 2.8 8.0 12.8 9.5 20.8 7.5 10.5 16.3 1.7 5.7 7.2 5.7 0.8 4.2 4.9 7.8 9.4 8.0 1.0 3.2 6.4 21.2 32.2 16.3 25.5 22.0 19.5 30.7 20.1 24.9 26.1 GALNT1 GalNAc-T1 ENSG00000141429 "Polypeptide N-acetylgalactosaminyltransferase 1" Q10472 18 35581117-35711834 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012628 Uncertain "Intracellular and membrane" 1600000 "HPA012628: AB_1849439" "unprognostic (9.81e-2)" "unprognostic (1.01e-1)" "unprognostic (4.39e-2)" "unprognostic (2.73e-1)" "unprognostic (2.08e-1)" "unprognostic (2.83e-2)" "unprognostic (1.96e-2)" "unprognostic (7.06e-2)" "unprognostic (2.03e-2)" "unprognostic (1.51e-2)" "unprognostic (3.00e-2)" "unprognostic (1.00e-1)" "unprognostic (3.47e-2)" "unprognostic (4.38e-2)" "unprognostic (2.74e-2)" "unprognostic (1.07e-2)" "unprognostic (8.60e-2)" 15.0 14.2 11.3 11.4 16.0 9.7 24.2 14.3 12.3 15.1 18.7 11.3 8.3 18.9 10.3 13.7 31.8 8.9 13.0 18.4 15.3 9.7 12.9 21.8 12.0 27.4 14.9 13.3 10.5 22.2 4.6 15.0 22.9 12.5 11.7 18.7 15.7 28.3 8.4 19.9 27.6 24.7 15.8 13.7 17.9 11.9 9.8 12.6 13.8 13.5 16.0 17.3 32.3 19.3 6.2 6.7 11.1 9.1 6.6 5.8 2.0 7.7 8.5 10.1 9.3 20.2 19.2 13.4 8.2 8.8 7.6 7.0 5.1 15.3 9.2 8.8 8.8 6.0 5.0 15.7 12.2 10.8 4.6 11.7 16.7 11.7 10.1 25.4 15.7 13.0 15.0 11.9 13.2 82.2 3.5 12.3 29.6 6.2 7.4 9.7 10.4 4.1 9.3 13.3 4.4 31.4 36.4 5.5 10.8 14.6 10.7 8.6 8.2 20.0 28.5 14.1 5.7 9.2 9.0 17.7 8.4 17.7 9.9 17.4 7.3 8.4 5.4 11.1 5.1 6.7 5.8 6.2 3.6 4.7 6.1 3.8 3.4 4.9 6.4 6.6 9.1 6.7 3.6 2.0 11.3 16.0 14.3 12.3 15.3 9.7 14.9 13.3 12.5 12.6 GALNT11 GalNAc-T11 ENSG00000178234 "Polypeptide N-acetylgalactosaminyltransferase 11" Q8NCW6 7 152025674-152122347 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Notch signaling pathway" "Glycosyltransferase, Transferase" Heterotaxy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 82.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039330 Uncertain "HPA039330: AB_10795249" "unprognostic (6.09e-2)" "unprognostic (1.22e-1)" "unprognostic (4.98e-2)" "unprognostic (3.48e-2)" "prognostic unfavourable (9.54e-4)" "unprognostic (1.76e-1)" "unprognostic (9.10e-3)" "unprognostic (1.56e-3)" "unprognostic (1.38e-1)" "unprognostic (3.65e-1)" "unprognostic (3.82e-2)" "unprognostic (1.64e-1)" "prognostic favourable (2.24e-6)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "unprognostic (2.97e-1)" "unprognostic (9.51e-2)" 10.7 9.4 11.1 5.1 18.7 3.8 10.4 20.8 21.8 9.1 7.5 11.4 7.1 5.1 9.6 9.2 9.8 8.3 9.3 9.2 11.4 9.3 82.0 7.1 9.6 4.9 7.0 13.4 10.6 29.7 19.3 10.5 15.9 34.1 12.0 6.5 21.7 7.8 9.8 8.8 8.3 6.9 9.5 6.5 8.5 7.6 7.3 4.4 4.6 12.5 5.6 6.4 9.4 8.1 6.3 8.3 8.2 12.5 15.7 19.3 8.7 10.5 9.4 14.0 15.6 32.5 32.1 14.4 8.4 9.6 7.1 6.7 7.6 11.1 0.0 22.0 13.6 5.0 6.6 11.9 8.8 8.7 9.8 2.1 8.6 6.7 10.7 9.4 11.2 28.2 15.4 5.9 5.0 12.8 10.6 0.1 17.7 9.1 8.1 8.6 11.5 7.6 0.0 6.1 0.3 23.4 16.3 12.5 16.6 14.0 6.8 11.3 10.1 8.2 11.5 9.6 3.4 12.0 9.2 3.1 4.0 0.1 19.9 9.2 32.6 5.8 8.3 8.2 19.3 9.4 19.0 6.3 10.7 17.7 8.3 3.8 9.2 14.0 4.4 15.7 12.5 2.5 7.9 8.7 11.1 18.7 20.8 21.8 11.4 9.3 7.0 13.4 34.1 4.4 GALNT14 "FLJ12691, GalNac-T10, GalNac-T14" ENSG00000158089 "Polypeptide N-acetylgalactosaminyltransferase 14" Q96FL9 2 30910467-31155202 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 42.7" "Cell line enhanced" "Detected in many" "A549: 12.9;RPMI-8226: 14.9;RPTEC TERT1: 22.0;RT4: 16.3" "Cancer enriched" "Detected in many" 7 "renal cancer: 45.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "neutrophil: 10.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030138 Approved "Nucleoplasm,Golgi apparatus" 9400 "Golgi apparatus" Nucleoplasm "HPA030138: " "unprognostic (5.69e-2)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (2.82e-3)" "unprognostic (3.85e-2)" "unprognostic (2.10e-2)" "unprognostic (3.32e-1)" "unprognostic (7.58e-2)" "unprognostic (1.96e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (5.18e-3)" "unprognostic (2.67e-2)" "unprognostic (2.56e-1)" "unprognostic (9.51e-3)" 1.2 1.5 1.5 0.9 3.7 4.3 1.1 1.8 9.6 1.4 0.6 1.8 0.3 0.6 0.6 1.0 10.2 1.1 3.7 0.4 1.6 1.5 42.7 1.2 0.6 2.6 1.2 2.3 0.9 2.7 7.6 5.7 0.2 0.9 1.7 0.2 2.1 1.7 0.2 0.4 1.9 3.1 0.7 0.8 1.8 0.6 1.6 0.3 0.1 1.1 1.0 4.2 2.0 1.4 1.4 0.0 10.6 0.0 0.0 0.0 0.1 10.9 12.9 0.0 0.0 0.0 0.0 0.0 3.6 1.9 2.4 0.3 0.0 0.0 10.2 3.7 0.2 0.0 0.4 0.5 0.4 0.3 1.3 5.7 0.0 0.0 0.0 8.2 0.0 0.0 2.3 0.0 8.5 0.0 0.0 9.1 0.0 5.0 0.0 0.0 6.1 0.0 7.1 0.0 14.9 22.0 16.3 12.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.2 0.9 2.8 0.0 0.0 5.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.1 1.5 3.7 1.8 9.6 1.6 1.5 1.2 2.3 0.9 0.3 GALNT18 "GalNAc-T18, GALNT15, GALNTL4, MGC71806" ENSG00000110328 "Polypeptide N-acetylgalactosaminyltransferase 18" Q6P9A2 11 11270876-11622005 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.5;HaCaT: 23.8;HBEC3-KT: 16.6;PC-3: 16.7;RPMI-8226: 17.4;SK-BR-3: 21.7;U-87 MG: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "gdT-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012955 Approved Approved Mitochondria 200000 Mitochondria "HPA012955: AB_1849460" "unprognostic (1.26e-1)" "unprognostic (2.80e-1)" "unprognostic (3.69e-2)" "prognostic unfavourable (1.29e-4)" "unprognostic (7.37e-2)" "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (6.68e-2)" "unprognostic (6.04e-2)" "unprognostic (2.05e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-1)" "unprognostic (2.66e-3)" "unprognostic (3.54e-2)" "unprognostic (1.63e-1)" "unprognostic (2.10e-1)" "unprognostic (1.81e-2)" 18.6 6.0 15.5 4.9 13.5 0.8 9.1 21.3 16.2 7.0 13.3 5.8 8.3 3.9 15.0 6.4 7.8 7.6 12.6 21.9 13.1 7.0 19.7 6.6 31.2 5.8 10.0 12.1 3.8 9.5 9.1 4.3 26.6 12.8 8.2 4.3 7.1 10.4 11.5 6.1 7.6 4.9 15.0 6.5 4.0 4.1 13.3 8.4 0.7 39.2 5.6 4.2 10.3 9.1 0.0 0.0 0.0 0.0 0.0 1.7 0.3 18.5 6.8 0.9 4.2 0.0 0.0 0.1 2.0 5.1 0.2 0.0 0.7 2.4 0.0 1.4 0.0 23.8 4.5 16.6 0.0 0.0 6.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 6.9 0.0 6.3 0.0 0.0 0.0 0.9 4.5 0.2 0.0 0.7 16.7 0.0 0.0 17.4 12.8 2.3 0.3 1.9 3.4 21.7 0.1 4.5 0.0 0.0 0.3 3.8 0.1 0.1 0.0 0.0 0.0 15.8 0.0 4.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 15.5 13.5 21.3 16.2 13.1 7.0 10.0 12.1 12.8 8.4 GALNT3 "GalNAc-T3, HFTC, HHS" ENSG00000115339 "Polypeptide N-acetylgalactosaminyltransferase 3" Q14435 2 165747591-165794682 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 32.5;HaCaT: 37.5;HBEC3-KT: 25.3;hTCEpi: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA007613 Enhanced Supported "Golgi apparatus" 88000 "Golgi apparatus" "HPA007613: AB_1078941" "unprognostic (1.95e-1)" "prognostic unfavourable (2.08e-4)" "unprognostic (1.16e-3)" "unprognostic (2.78e-1)" "unprognostic (3.22e-2)" "prognostic unfavourable (4.10e-4)" "unprognostic (4.13e-2)" "unprognostic (4.47e-2)" "unprognostic (2.74e-1)" "unprognostic (6.44e-2)" "unprognostic (3.62e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.57e-1)" 1.5 1.7 1.5 6.3 1.7 14.6 12.0 2.2 1.7 11.9 21.3 3.6 6.5 15.5 2.4 8.8 23.4 15.7 26.4 0.9 1.9 2.1 15.1 2.1 15.3 0.6 4.2 1.2 6.4 31.2 3.0 23.0 7.0 4.2 13.8 21.2 1.7 35.7 5.4 0.7 6.7 37.4 0.5 4.8 23.3 28.9 17.6 3.3 1.5 37.6 15.1 20.8 11.7 9.3 3.3 7.5 21.1 5.7 5.8 5.3 2.3 20.1 0.0 0.1 0.0 0.0 0.8 13.4 4.4 1.7 1.7 4.5 12.4 32.5 0.1 0.0 0.0 37.5 0.0 25.3 3.8 0.2 3.6 0.0 3.7 0.1 0.1 3.7 0.1 0.1 35.7 0.0 9.5 0.0 0.0 16.7 1.4 14.4 0.1 1.5 0.0 2.0 0.0 0.0 0.6 6.7 16.9 2.0 0.0 0.0 18.2 4.1 8.1 0.1 0.1 0.0 0.3 0.0 0.0 8.6 4.2 0.3 0.0 3.9 0.1 21.1 3.1 13.8 5.3 4.5 4.1 3.3 1.7 3.3 5.3 3.1 0.6 1.9 10.5 5.8 5.7 7.5 2.9 2.3 1.5 1.7 2.2 1.7 1.9 2.1 4.2 1.2 4.2 3.3 GALNT9 GALNAC-T9 ENSG00000182870 "Polypeptide N-acetylgalactosaminyltransferase 9" Q9HCQ5 12 132196372-132329349 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 52.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 26.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 2.6;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 9 "B-cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075016 Approved Vesicles Vesicles "HPA075016: " "unprognostic (1.13e-1)" "unprognostic (3.47e-2)" "unprognostic (1.47e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (6.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.32e-2)" "unprognostic (2.03e-1)" "unprognostic (1.64e-3)" "unprognostic (2.85e-1)" "unprognostic (6.62e-2)" "unprognostic (5.17e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (3.89e-2)" "unprognostic (5.69e-2)" 2.6 2.2 9.3 1.0 6.7 0.6 0.5 52.4 27.9 1.1 0.8 0.8 0.0 1.1 1.8 7.7 0.5 1.9 0.7 0.6 12.9 6.8 3.2 0.5 0.9 1.3 4.3 10.8 1.3 0.4 1.9 2.7 0.5 6.9 1.0 0.6 0.3 1.2 1.7 0.5 0.9 1.0 0.6 1.7 1.2 0.7 0.9 1.1 0.0 6.1 0.0 0.4 0.7 0.1 2.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 26.3 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 2.6 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.3 6.7 52.4 20.2 12.9 6.8 4.3 10.8 6.9 1.1 GALNTL5 "GalNAc-T5L, GALNT15" ENSG00000106648 "Polypeptide N-acetylgalactosaminyltransferase like 5" Q7Z4T8 7 151956379-152019934 "Disease related genes, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 45.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011140 Enhanced "HPA011140: AB_1078944" "unprognostic (2.33e-2)" "unprognostic (2.09e-1)" "unprognostic (1.55e-1)" 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 GCNT2 "bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3" ENSG00000111846 "Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)" Q8N0V5 6 10492223-10629368 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.1" "Cell line enhanced" "Detected in many" "EFO-21: 26.2;Hep G2: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 4 "basal ganglia: 54.8" "Low region specificity" "Detected in all" HPA026776 Approved Supported "Golgi apparatus" 560000 "Golgi apparatus" "HPA026776: AB_1849573" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (3.12e-1)" "unprognostic (1.42e-2)" "unprognostic (9.31e-2)" "unprognostic (2.51e-1)" "unprognostic (4.11e-2)" "unprognostic (2.39e-1)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (6.28e-4)" "unprognostic (3.96e-2)" "unprognostic (1.58e-3)" "unprognostic (6.54e-2)" "unprognostic (6.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" 2.0 0.9 2.5 7.9 2.8 0.7 12.7 7.6 1.9 6.0 13.0 2.0 0.9 7.8 5.6 1.3 3.7 1.7 2.8 11.8 2.2 2.4 19.6 14.3 10.4 3.3 2.4 0.4 0.9 5.5 1.0 6.2 3.1 4.0 21.9 3.7 8.1 7.4 0.9 2.3 2.5 25.1 2.6 2.2 4.2 8.3 9.0 2.9 0.9 2.4 1.2 7.2 2.0 3.0 2.1 2.5 4.2 3.1 0.5 0.4 0.7 4.2 3.5 1.2 2.9 0.0 0.0 3.5 0.0 3.1 0.8 0.2 6.2 3.1 2.4 26.2 0.0 0.1 0.3 3.2 1.8 1.6 0.9 0.5 1.8 10.9 0.0 1.1 2.9 0.0 0.0 0.3 0.0 6.9 0.3 0.0 0.3 0.0 0.0 2.2 3.9 2.4 0.1 2.4 3.8 9.3 2.3 2.6 1.8 0.0 9.2 8.8 0.1 0.4 5.9 0.5 0.4 0.0 3.4 0.0 0.0 1.7 0.5 0.2 1.4 4.2 3.1 1.3 0.3 2.3 0.1 2.1 0.3 0.4 2.5 1.3 0.4 0.4 0.2 0.5 0.8 0.6 0.2 0.7 2.5 2.8 7.6 1.9 2.2 2.4 2.4 0.4 4.0 2.9 GCNT3 "C2/4GnT, C2GnT-M, C2GnT2" ENSG00000140297 "Glucosaminyl (N-acetyl) transferase 3, mucin type" O95395 15 59594875-59640239 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 29.6;intestine: 103.3;salivary gland: 27.4" "Cell line enriched" "Detected in some" 5 "A549: 55.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 29.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011154 Enhanced Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA011154: AB_1078961" "unprognostic (5.09e-2)" "unprognostic (2.39e-1)" "unprognostic (5.92e-2)" "prognostic favourable (1.78e-4)" "unprognostic (3.99e-3)" "unprognostic (2.02e-2)" "prognostic unfavourable (6.49e-5)" "unprognostic (1.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.34e-1)" "unprognostic (1.64e-2)" "unprognostic (1.63e-1)" "unprognostic (4.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-2)" "unprognostic (4.65e-2)" "unprognostic (2.43e-1)" 0.3 0.5 0.3 8.8 0.4 0.0 0.3 0.3 0.3 5.3 37.6 0.3 0.3 25.4 1.3 0.4 8.7 0.7 29.6 0.3 0.3 0.2 9.9 0.4 0.7 0.3 0.3 0.3 1.1 1.7 0.0 0.4 1.0 0.5 1.0 33.4 0.3 27.4 0.3 0.3 0.2 103.3 0.9 0.3 0.3 6.5 1.7 0.3 0.5 0.7 5.2 15.5 0.7 14.0 1.2 1.4 3.4 0.8 1.1 0.7 0.1 0.0 55.8 0.0 0.0 0.0 0.4 0.0 0.0 2.9 0.0 0.0 2.3 2.3 0.2 9.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 11.2 0.0 0.1 0.1 0.1 1.3 0.2 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 3.9 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.1 0.1 0.2 3.5 0.1 0.0 2.6 0.8 0.6 0.7 0.4 0.4 0.6 0.5 0.3 0.2 1.2 0.4 0.6 3.4 1.1 0.4 1.4 0.5 0.1 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.5 0.3 GDE1 MIR16 ENSG00000006007 "Glycerophosphodiester phosphodiesterase 1" Q9NZC3 16 19501689-19522145 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074747 Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA074747: " "unprognostic (1.69e-1)" "unprognostic (5.13e-2)" "prognostic favourable (3.12e-4)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (4.10e-3)" "prognostic unfavourable (7.52e-5)" "unprognostic (2.10e-2)" "unprognostic (1.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.60e-3)" "unprognostic (9.92e-2)" "prognostic favourable (3.12e-5)" "unprognostic (8.36e-2)" "unprognostic (9.69e-3)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" 20.3 18.5 30.6 11.7 34.3 17.5 23.9 13.5 32.2 18.1 31.0 24.5 23.0 22.7 15.0 22.6 19.0 13.4 17.5 40.7 31.1 17.5 21.1 21.3 22.1 13.1 29.2 20.6 9.9 28.3 35.3 13.9 15.5 20.8 21.4 32.5 12.5 20.4 24.9 42.4 18.5 20.8 27.2 25.3 10.1 22.8 14.8 23.8 9.6 17.9 21.7 12.7 22.8 12.4 4.6 7.4 23.9 12.4 3.7 7.4 4.6 14.6 17.6 9.7 11.5 46.8 17.4 13.9 15.1 26.0 11.8 14.7 10.0 26.2 11.0 19.5 22.0 12.7 13.5 17.8 14.4 11.9 20.8 9.2 17.3 21.6 28.4 12.1 8.6 18.3 28.9 12.6 14.8 15.8 5.1 11.4 12.8 26.4 10.5 11.2 11.3 13.7 15.2 17.8 15.9 29.2 22.5 11.3 10.3 14.7 17.6 13.9 18.0 14.5 16.6 10.0 9.0 13.2 9.2 10.7 10.1 7.6 15.4 18.0 8.9 23.9 11.8 6.4 5.7 10.5 7.3 4.6 6.8 6.6 7.4 3.7 3.6 5.7 19.8 3.7 12.4 4.6 7.4 4.6 30.6 34.3 13.5 32.2 31.1 17.5 29.2 20.6 20.8 23.8 GDPD5 "GDE2, PP1665" ENSG00000158555 "Glycerophosphodiester phosphodiesterase domain containing 5" Q8WTR4 11 75434640-75525903 "Predicted membrane proteins" Neurogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.2;placenta: 41.7" "Cell line enhanced" "Detected in many" "EFO-21: 17.0;fHDF/TERT166: 16.2;HDLM-2: 33.2;U-2 OS: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Group enriched" "Detected in many" 5 "granulocytes: 9.3;T-cells: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065257, HPA066762, HPA069281" Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA065257: , HPA066762: , HPA069281: " "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-1)" "prognostic unfavourable (1.29e-4)" "unprognostic (1.48e-1)" "unprognostic (6.12e-2)" "unprognostic (9.97e-3)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-1)" "unprognostic (3.07e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (6.59e-9)" "unprognostic (8.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.65e-1)" 16.5 6.0 3.3 3.3 4.6 7.8 8.0 23.2 7.9 3.3 3.0 3.3 1.6 2.0 6.4 3.1 1.6 3.2 3.6 2.8 3.0 1.8 2.3 2.7 5.4 4.3 3.0 2.6 2.9 13.4 0.4 7.0 41.7 4.2 3.1 1.3 18.8 15.5 4.1 5.9 2.3 3.2 4.9 3.4 37.2 1.4 11.9 5.5 2.0 2.6 1.4 3.4 3.5 11.5 1.1 1.1 9.3 1.2 0.0 3.1 0.7 1.0 3.8 1.6 1.9 1.1 0.6 5.7 1.2 1.6 0.5 0.4 5.0 2.2 7.1 17.0 16.2 2.3 2.0 1.9 0.3 33.2 1.5 1.3 5.8 10.3 1.7 0.8 5.6 1.3 1.0 0.4 0.8 13.6 2.3 3.2 0.7 2.2 1.9 3.5 2.9 5.4 2.2 0.4 1.9 0.4 1.8 0.9 0.6 2.4 9.3 4.5 1.3 3.1 4.0 3.9 15.8 3.0 1.2 0.8 0.1 1.3 0.9 4.2 0.4 9.3 1.2 0.7 2.0 0.6 2.9 1.1 2.3 1.6 0.3 0.4 1.2 1.5 0.1 0.0 0.0 1.1 3.1 0.7 3.3 4.6 23.2 7.9 3.0 1.8 3.0 2.6 4.2 5.5 GFRA1 "GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1" ENSG00000151892 "GDNF family receptor alpha 1" P56159 10 116056925-116273467 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 16.7;BJ hTERT+ SV40 Large T+ RasG12V: 29.2;EFO-21: 17.8;fHDF/TERT166: 32.3;HBF TERT88: 24.4;MCF7: 21.3;U-251 MG: 19.9" "Cancer enriched" "Detected in many" 11 "breast cancer: 40.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043829 Uncertain Approved "Nucleoplasm,Golgi apparatus" 89000 "Golgi apparatus" Nucleoplasm "HPA043829: " "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (7.60e-2)" "unprognostic (1.06e-3)" "unprognostic (4.10e-2)" "unprognostic (6.95e-3)" "unprognostic (2.35e-3)" "unprognostic (1.48e-3)" "unprognostic (3.16e-1)" "unprognostic (2.06e-3)" "unprognostic (1.31e-2)" "unprognostic (2.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.20e-3)" "unprognostic (1.69e-1)" "unprognostic (2.27e-2)" "unprognostic (3.64e-2)" 24.0 4.3 6.3 9.5 13.8 0.3 26.8 0.8 8.4 12.5 14.9 1.8 5.9 2.2 6.7 23.4 11.1 12.7 11.5 6.4 4.8 6.7 7.0 21.9 3.2 7.4 9.5 2.7 10.0 7.3 2.2 3.9 0.3 2.9 12.1 4.8 3.4 5.4 6.6 7.5 6.8 7.2 9.8 3.4 5.8 7.8 5.3 1.9 2.6 2.6 10.7 8.1 10.5 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.7 0.0 0.0 0.0 0.0 2.9 0.1 16.7 29.2 0.0 0.0 0.0 17.8 32.3 0.0 0.0 0.0 24.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 4.2 0.0 0.0 0.0 0.0 2.2 21.3 2.6 0.0 1.8 0.0 0.0 0.7 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 19.9 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 13.8 0.8 4.6 4.8 6.7 9.5 2.7 2.9 1.9 GFRA3 GFRa-3 ENSG00000146013 "GDNF family receptor alpha 3" O60609 5 138252379-138274671 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 17 "SH-SY5Y: 26.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020731 Approved Uncertain "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA020731: AB_1849635" "unprognostic (1.22e-1)" "unprognostic (6.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.47e-3)" "unprognostic (2.77e-3)" "unprognostic (1.27e-1)" "unprognostic (7.65e-3)" "unprognostic (1.44e-1)" "unprognostic (1.33e-2)" "unprognostic (1.90e-5)" "unprognostic (2.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" 2.4 2.4 0.3 7.1 1.0 0.0 1.8 7.0 0.6 7.9 13.0 0.1 11.0 3.8 3.0 6.1 9.3 1.2 9.4 6.2 0.3 0.3 0.9 0.4 2.9 0.1 0.6 0.1 4.7 7.0 0.0 2.3 0.1 1.3 4.4 5.8 10.0 7.5 10.9 1.3 3.6 4.7 8.6 1.4 0.1 6.9 8.4 0.5 0.4 1.0 2.8 0.8 4.4 8.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.9 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.1 26.4 0.4 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 7.0 0.6 0.3 0.3 0.6 0.1 1.3 0.5 GFRAL "bA360D14.1, C6orf144, GRAL, UNQ9356" ENSG00000187871 "GDNF family receptor alpha like" Q6UXV0 6 55327469-55402493 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.9;blood: 2.2;liver: 2.4" "Cell line enhanced" "Detected in some" "HeLa: 1.6;Karpas-707: 1.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 10 "pons and medulla: 0.3" "Low region specificity" "Detected in many" HPA047372 Uncertain "HPA047372: " "unprognostic (2.31e-1)" 1.9 0.0 0.1 0.3 0.1 0.4 0.6 0.2 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.9 0.0 0.1 0.0 0.0 1.2 0.7 2.2 0.6 0.6 0.3 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.3 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.5 0.3 0.1 0.8 0.6 0.2 0.2 0.1 0.1 0.8 0.2 0.1 0.0 1.2 0.3 0.3 2.2 0.6 0.2 0.7 0.0 0.0 GGT1 "CD224, D22S672, D22S732, GGT" ENSG00000100031 "Gamma-glutamyltransferase 1" P19440 22 24583750-24629005 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Protease, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.1;seminal vesicle: 41.7" "Cell line enhanced" "Detected in many" "HDLM-2: 35.8;Karpas-707: 52.7;RPMI-8226: 51.8;RPTEC TERT1: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA045635, HPA047534, HPA065444" Supported Approved Vesicles "Intracellular and membrane" 4600000 Vesicles "HPA045635: , HPA047534: , HPA065444: " "unprognostic (8.13e-3)" "unprognostic (4.76e-1)" "unprognostic (8.29e-2)" "unprognostic (1.28e-2)" "unprognostic (3.70e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-3)" "unprognostic (1.68e-1)" "unprognostic (2.21e-1)" "prognostic favourable (7.44e-4)" "unprognostic (4.55e-2)" "unprognostic (2.55e-2)" "prognostic favourable (4.83e-4)" "unprognostic (1.44e-2)" "unprognostic (5.37e-2)" "unprognostic (1.74e-1)" "unprognostic (6.10e-2)" 1.6 0.5 1.7 1.7 2.2 2.7 8.2 2.3 2.6 7.3 7.9 1.6 23.7 22.3 1.4 19.9 1.2 0.8 12.2 2.0 1.8 1.2 54.1 29.2 14.3 3.2 1.7 1.6 1.3 17.3 0.0 1.6 1.4 2.2 14.7 2.4 1.4 8.7 41.7 0.9 1.1 20.9 1.7 1.9 4.7 6.6 5.0 2.1 2.4 4.8 1.6 5.5 2.1 1.1 3.3 7.5 15.9 14.6 6.6 8.6 6.6 0.2 19.4 0.2 0.0 0.0 0.1 0.5 0.1 0.6 0.2 0.2 2.6 4.3 0.2 4.3 0.0 2.8 1.4 0.2 0.1 35.8 2.9 0.1 8.6 14.1 1.5 0.3 12.0 0.4 0.2 0.6 0.4 0.1 2.0 52.7 0.2 0.4 0.3 14.6 1.4 0.2 0.2 2.2 51.8 48.2 0.6 0.2 0.3 0.1 9.4 0.2 9.4 11.1 2.2 3.5 2.3 10.9 0.3 15.8 6.0 0.2 7.4 15.1 0.1 5.2 14.6 0.4 1.4 6.8 5.2 3.3 7.7 3.4 7.5 0.3 1.0 1.9 15.9 6.6 5.5 0.1 8.6 6.6 1.7 2.2 2.3 2.6 1.8 1.2 1.7 1.6 2.2 2.1 GGT2 GGT ENSG00000133475 "Gamma-glutamyltransferase 2" P36268 22 21207973-21227637 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4" "Cell line enhanced" "Detected in some" "HDLM-2: 2.3;HeLa: 4.5;Karpas-707: 2.0;U-2197: 13.6" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045635, HPA047534, HPA065444" Supported Approved Vesicles Vesicles "HPA045635: , HPA047534: , HPA065444: " "unprognostic (4.27e-1)" "unprognostic (6.91e-2)" "unprognostic (7.03e-2)" "unprognostic (8.13e-2)" "unprognostic (1.01e-2)" "unprognostic (2.38e-5)" "unprognostic (1.05e-3)" "unprognostic (5.85e-4)" "unprognostic (7.97e-3)" "unprognostic (8.84e-2)" "unprognostic (1.16e-1)" "unprognostic (6.39e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-2)" "unprognostic (3.46e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.2 0.0 1.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 5.5 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.3 1.0 8.4 0.0 0.0 0.0 0.1 0.2 0.4 0.4 0.4 0.5 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.5 0.5 13.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.1 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.5 0.3 GGT6 FLJ90165 ENSG00000167741 "Gamma-glutamyltransferase 6" Q6P531 17 4556927-4560818 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.4;salivary gland: 52.7" "Group enriched" "Detected in some" 8 "RT4: 29.8;SK-BR-3: 10.2;T-47d: 31.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023362, HPA027213" Approved 33000 "HPA023362: AB_1848955, HPA027213: AB_10601326" "unprognostic (2.23e-2)" "unprognostic (1.20e-2)" "unprognostic (2.14e-3)" "unprognostic (4.51e-2)" "unprognostic (9.71e-2)" "unprognostic (7.67e-3)" "unprognostic (1.29e-1)" "prognostic favourable (4.35e-4)" "unprognostic (2.10e-1)" "unprognostic (2.33e-1)" "unprognostic (3.07e-2)" "unprognostic (5.06e-2)" "prognostic favourable (9.42e-7)" "unprognostic (1.56e-1)" "unprognostic (5.71e-2)" "unprognostic (9.17e-2)" "unprognostic (8.07e-3)" 0.3 0.4 0.3 12.7 0.3 0.0 3.2 0.3 0.4 4.1 24.9 0.4 1.0 17.0 0.9 15.9 25.2 3.0 7.7 0.3 0.3 0.1 18.8 0.6 4.2 0.3 0.3 0.3 1.5 28.6 0.0 1.0 0.4 0.4 5.7 12.7 0.4 52.7 3.7 0.3 25.2 40.4 2.8 0.3 0.3 8.7 0.8 0.3 1.0 0.7 19.6 18.8 16.5 8.2 0.6 0.7 3.5 0.5 0.6 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 29.8 0.1 0.1 0.0 10.2 0.0 31.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.5 0.2 0.4 0.3 0.2 0.3 0.5 0.3 0.1 0.6 0.5 0.4 1.9 0.6 0.5 0.7 0.4 0.0 0.3 0.3 0.3 0.4 0.3 0.1 0.3 0.3 0.4 0.3 GHR GHBP ENSG00000112964 "Growth hormone receptor" P10912 5 42423777-42721878 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4" "Group enriched" "Detected in some" 5 "HSkMC: 13.3;T-47d: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045339, HPA057705" Enhanced Supported "Plasma membrane,Cytosol,Cytoplasmic bodies" "Secreted to blood" 2200000 21000000 "Plasma membrane, Cytosol, Cytoplasmic bodies" "HPA045339: , HPA057705: " "unprognostic (2.18e-2)" "unprognostic (5.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.96e-2)" "unprognostic (3.12e-1)" "unprognostic (1.57e-1)" "prognostic favourable (2.73e-6)" "unprognostic (1.06e-1)" "unprognostic (3.92e-2)" "unprognostic (3.73e-2)" "unprognostic (6.15e-3)" "unprognostic (2.67e-2)" "unprognostic (1.67e-3)" "unprognostic (4.29e-4)" "unprognostic (7.82e-2)" "unprognostic (7.33e-4)" "unprognostic (8.35e-6)" 44.4 2.8 0.7 5.4 1.3 0.3 31.5 0.4 1.4 4.0 6.9 0.5 1.7 0.6 5.7 3.9 2.4 2.5 3.9 6.0 1.3 1.6 5.3 82.4 2.3 2.2 1.2 1.4 5.0 1.3 3.6 2.0 4.0 2.0 8.7 2.5 2.4 2.3 7.4 23.4 3.0 2.4 5.2 1.0 2.6 3.5 1.6 0.2 0.1 2.9 4.3 0.5 3.8 8.4 0.6 0.3 1.8 0.5 0.4 0.3 0.1 0.0 0.0 0.3 3.0 2.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 2.5 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 13.3 4.3 0.0 0.6 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 2.1 33.9 0.0 1.8 3.0 1.3 1.6 0.3 0.3 0.0 0.0 0.3 0.0 1.5 1.8 0.3 0.4 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.6 0.2 0.3 1.7 0.4 0.5 0.3 0.2 0.1 0.7 1.3 0.4 1.4 1.3 1.6 1.2 1.4 2.0 0.2 GIMAP1 "HIMAP1, IAN2, IMAP1, IMAP38" ENSG00000213203 "GTPase, IMAP family member 1" Q8WWP7 7 150716557-150724284 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 16.5;MOLT-4: 9.5;TIME: 4.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044887, HPA053441" Uncertain Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA044887: AB_10960351, HPA053441: " "unprognostic (1.60e-2)" "unprognostic (6.58e-3)" "unprognostic (8.21e-3)" "unprognostic (2.54e-3)" "unprognostic (1.10e-1)" "unprognostic (2.33e-3)" "prognostic favourable (1.09e-4)" "unprognostic (1.66e-2)" "unprognostic (3.54e-2)" "unprognostic (3.44e-1)" "unprognostic (4.60e-3)" "unprognostic (7.89e-2)" "unprognostic (1.77e-3)" "unprognostic (2.18e-1)" "prognostic unfavourable (6.12e-4)" "unprognostic (7.49e-2)" "unprognostic (1.96e-1)" 18.9 3.6 3.5 11.5 4.9 1.3 10.3 1.2 4.1 8.5 4.1 2.8 3.6 4.2 12.4 5.5 6.2 5.5 5.9 7.4 3.8 2.9 5.3 4.6 11.2 23.8 4.1 2.1 2.6 3.7 1.8 2.2 8.3 4.4 6.3 3.0 5.2 3.6 2.8 6.4 3.6 8.2 4.9 4.6 28.9 3.8 2.9 3.8 6.7 7.9 5.4 12.0 4.9 11.5 0.2 5.1 1.0 11.5 14.6 27.4 11.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 9.5 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.9 11.5 0.0 17.2 10.4 20.3 0.1 18.8 21.4 5.1 0.2 27.4 22.2 1.0 14.6 10.4 0.3 11.8 11.4 3.5 4.9 1.2 4.1 3.8 2.9 4.1 2.1 4.4 3.8 GIMAP1-GIMAP5 ENSG00000281887 "GIMAP1-GIMAP5 readthrough" 7 150716668-150743646 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.5" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 8.4;MOLT-4: 13.1;THP-1: 3.2;TIME: 6.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "monocytes: 15.5;NK-cells: 21.5;T-cells: 37.5" HPA053441 Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA053441: " 12.2 2.1 1.8 12.9 2.7 1.0 6.4 0.0 2.2 5.2 2.2 1.3 1.8 7.0 7.8 3.1 3.6 2.1 3.3 3.8 1.9 3.0 2.5 6.2 15.5 2.0 0.8 1.6 1.9 0.7 0.0 4.6 2.3 3.6 0.5 2.9 2.2 0.9 4.4 0.2 3.1 2.7 2.5 16.4 3.0 1.3 2.0 3.9 4.7 3.0 7.6 2.5 7.2 0.2 4.8 1.5 15.5 21.5 37.5 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 15.5 0.0 23.3 13.5 27.9 0.2 26.4 34.0 4.8 0.2 37.5 30.2 1.5 21.5 9.8 0.3 16.4 20.1 GINM1 "C6orf72, dJ12G14.2" ENSG00000055211 "Glycoprotein integral membrane 1" Q9NU53 6 149566294-149591748 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017210, HPA041679" Approved Approved "Nucleoli fibrillar center,Plasma membrane" 8700 "Nucleoli fibrillar center, Plasma membrane" "HPA017210: AB_1845743, HPA041679: " "unprognostic (6.09e-3)" "unprognostic (2.19e-2)" "unprognostic (2.38e-1)" "unprognostic (2.48e-1)" "unprognostic (7.24e-2)" "unprognostic (1.32e-3)" "unprognostic (3.18e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.64e-2)" "unprognostic (4.87e-2)" "unprognostic (4.79e-3)" 32.1 26.3 21.3 17.8 34.7 20.0 51.5 26.1 27.6 28.8 25.7 22.4 29.0 14.2 29.3 36.9 21.5 24.1 24.3 48.2 20.3 18.3 51.3 29.6 28.4 32.9 43.6 21.4 31.7 28.3 27.1 17.5 34.0 23.0 23.6 19.8 21.7 20.7 40.1 29.2 20.9 17.3 36.7 31.3 18.6 22.8 31.0 30.2 11.5 41.5 21.6 13.1 28.6 22.6 16.8 12.6 23.7 16.0 8.0 8.1 7.7 7.7 5.6 9.1 12.3 49.3 29.6 14.9 26.8 31.4 20.3 25.5 7.3 10.5 5.8 14.8 25.2 16.1 5.9 13.3 26.7 9.6 13.1 5.5 5.4 8.7 18.8 10.8 5.3 32.8 11.6 17.2 11.9 21.8 7.1 9.6 19.1 10.0 6.8 8.1 3.2 6.0 7.2 16.4 4.3 28.9 6.9 5.8 5.6 26.6 15.8 5.5 9.9 11.0 15.2 11.0 11.6 28.0 17.6 9.5 11.0 7.2 20.4 9.8 10.1 11.9 13.7 17.1 6.8 13.2 7.9 16.8 8.1 7.4 10.0 11.7 7.9 6.4 23.7 8.0 16.0 12.6 7.5 7.7 21.3 34.7 26.1 27.6 20.3 18.3 43.6 21.4 23.0 30.2 GJB1 "CMTX, CMTX1, CX32" ENSG00000169562 "Gap junction protein beta 1" P08034 X 71215194-71225516 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.4;liver: 114.4;pancreas: 37.1" "Group enriched" "Detected in some" 6 "Hep G2: 45.7;SK-MEL-30: 50.6" "Cancer enhanced" "Detected in many" "liver cancer: 163.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012994 Uncertain "CAB012994: AB_2533228" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (8.78e-2)" "unprognostic (2.71e-3)" "unprognostic (2.70e-1)" "unprognostic (4.11e-1)" "unprognostic (2.92e-1)" "unprognostic (3.68e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (7.36e-3)" "unprognostic (1.80e-1)" "prognostic favourable (2.85e-6)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (7.79e-2)" "unprognostic (4.97e-2)" 0.4 0.4 7.2 2.5 9.3 0.3 2.6 1.9 14.4 3.3 12.0 46.3 2.5 14.6 0.9 8.1 0.5 9.5 19.8 0.4 13.4 8.0 14.8 114.4 1.2 0.4 22.4 5.6 0.4 37.1 0.3 0.4 0.4 23.0 4.3 8.3 0.5 19.6 8.7 0.4 0.6 11.7 1.0 52.4 0.4 5.7 3.1 12.1 0.0 0.4 0.0 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 9.3 1.9 14.4 13.4 8.0 22.4 5.6 23.0 12.1 GJB6 "CX30, DFNA3, ED2, EDH, HED" ENSG00000121742 "Gap junction protein beta 6" O95452 13 20221962-20232395 "Disease related genes, Predicted membrane proteins" Hearing "Deafness, Disease mutation, Ectodermal dysplasia, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 50.5;esophagus: 97.1;tongue: 43.6" "Cell line enriched" "Detected in some" 9 "RT4: 63.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 145.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Lineage enhanced" "Detected in many" "T-cells: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014846 Supported "Cell Junctions" "Cell Junctions" "HPA014846: AB_1847135" "unprognostic (5.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.90e-4)" "unprognostic (7.90e-2)" "unprognostic (2.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.83e-1)" "unprognostic (8.96e-2)" "unprognostic (9.64e-2)" "unprognostic (2.82e-2)" "unprognostic (2.82e-2)" "unprognostic (3.54e-2)" "unprognostic (1.14e-11)" "unprognostic (8.99e-2)" "unprognostic (1.16e-1)" "unprognostic (6.35e-3)" "unprognostic (5.04e-2)" 1.2 1.0 15.3 1.1 17.0 50.5 3.3 9.0 15.9 16.9 1.0 1.9 0.0 1.0 1.6 1.1 97.1 1.2 1.8 1.0 16.3 7.9 1.0 1.0 1.1 1.4 11.1 11.3 1.0 1.0 1.0 0.7 1.0 9.2 1.1 1.1 0.0 8.7 1.0 1.0 18.7 1.0 1.0 3.7 1.1 1.2 1.7 6.0 7.9 4.1 43.6 15.7 6.3 30.9 1.4 0.0 1.2 0.0 0.0 5.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 1.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 63.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 1.4 2.7 1.5 1.2 0.0 0.0 0.0 5.7 0.6 15.3 17.0 9.0 15.9 16.3 7.9 11.1 11.3 9.2 6.0 GJC1 "CX45, GJA7" ENSG00000182963 "Gap junction protein gamma 1" P36383 17 44798448-44830816 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071788 Uncertain "Nucleoli,Cell Junctions,Cytosol" "Nucleoli, Cytosol" "Cell Junctions" "HPA071788: " "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (2.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (7.02e-2)" "unprognostic (4.01e-1)" "unprognostic (1.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.02e-1)" "unprognostic (1.64e-1)" "prognostic unfavourable (3.55e-8)" "unprognostic (5.18e-2)" "unprognostic (2.20e-1)" "unprognostic (8.52e-2)" "prognostic unfavourable (7.83e-4)" 7.3 0.8 2.2 4.1 3.4 1.0 4.7 8.2 4.2 14.8 23.0 2.8 7.0 1.6 24.2 3.1 3.2 5.0 5.4 10.0 3.3 1.8 1.5 0.9 6.5 2.3 2.5 4.0 2.2 1.3 2.6 0.7 28.5 3.4 8.2 2.8 3.7 1.7 17.0 5.4 1.9 4.8 27.5 2.2 0.9 7.8 8.0 2.9 1.4 5.3 2.9 1.7 12.6 10.4 1.2 1.0 4.7 1.0 1.9 1.0 0.4 17.6 9.1 23.0 7.9 3.0 4.7 9.0 19.6 15.5 21.1 22.7 5.3 9.8 0.1 1.0 18.3 4.6 11.9 6.1 29.8 0.1 8.9 0.1 4.9 0.6 1.9 0.1 0.8 3.3 0.6 16.1 5.3 7.2 0.8 0.2 12.2 0.1 2.8 1.8 10.3 7.8 16.7 29.2 0.1 5.1 7.4 4.4 10.0 2.2 0.1 6.6 4.8 2.8 6.0 18.7 18.1 8.5 16.6 0.1 4.6 13.1 6.5 0.1 17.5 4.7 1.0 1.1 0.9 0.6 0.8 0.9 0.7 0.6 0.3 1.2 0.9 1.0 3.9 1.9 0.7 1.0 0.6 0.4 2.2 3.4 8.2 4.2 3.3 1.8 2.5 4.0 3.4 2.9 GLCCI1 "FAM117C, GIG18, TSSN1" ENSG00000106415 "Glucocorticoid induced 1" Q86VQ1 7 7968794-8094272 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 55.7" "Cell line enhanced" "Detected in many" "Karpas-707: 17.4;U-266/70: 40.5;U-698: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001674, HPA005987" Approved Approved Nucleoli Nucleoli "HPA001674: AB_1078971, HPA005987: AB_1078970" "unprognostic (6.12e-2)" "unprognostic (7.81e-2)" "unprognostic (1.90e-1)" "unprognostic (1.45e-1)" "unprognostic (6.17e-3)" "unprognostic (1.02e-2)" "unprognostic (4.40e-1)" "unprognostic (1.68e-3)" "unprognostic (3.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.17e-3)" "unprognostic (3.35e-1)" "unprognostic (9.30e-2)" "unprognostic (2.14e-1)" "unprognostic (1.56e-1)" "unprognostic (3.09e-1)" "unprognostic (9.20e-3)" 4.6 4.3 5.6 19.1 12.5 7.6 4.1 26.6 8.0 5.4 4.9 3.4 0.9 5.7 3.4 1.8 3.0 2.8 3.9 2.2 3.7 4.1 3.9 3.8 18.4 13.8 3.1 5.6 5.1 2.3 8.0 6.5 9.3 4.4 3.2 4.7 3.1 6.3 2.0 3.0 7.5 5.6 2.5 3.2 9.2 6.4 14.2 3.7 55.7 20.7 1.9 15.9 7.7 3.3 3.1 2.4 3.7 0.4 4.7 4.5 0.7 2.3 0.3 3.9 0.9 1.2 1.7 0.8 2.0 2.8 1.2 1.1 1.2 0.8 6.4 0.5 1.6 0.4 3.5 1.0 1.5 3.2 2.7 1.9 4.9 0.8 1.9 3.0 2.8 0.8 1.3 0.7 2.6 1.0 6.9 17.4 2.0 1.3 1.3 3.0 9.6 2.3 6.8 2.9 3.4 1.1 2.7 6.4 12.6 3.0 3.8 0.2 4.5 7.8 0.8 2.2 0.9 1.9 1.0 40.5 12.9 18.3 2.3 3.2 1.6 3.7 0.1 1.5 2.7 0.4 2.5 1.8 2.8 2.0 0.1 3.1 1.6 1.8 1.2 4.7 0.1 2.4 4.5 0.7 5.6 12.5 26.6 8.0 3.7 4.1 3.1 5.6 4.4 3.7 GLG1 "CFR-1, ESL-1, MG-160" ENSG00000090863 "Golgi glycoprotein 1" Q92896 16 74447427-74607144 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010815 Supported Supported "Golgi apparatus" 1600000 "Golgi apparatus" "HPA010815: AB_2232486" "unprognostic (3.70e-2)" "prognostic unfavourable (1.99e-4)" "unprognostic (7.42e-2)" "unprognostic (3.30e-2)" "unprognostic (1.90e-1)" "unprognostic (5.02e-3)" "unprognostic (5.13e-3)" "unprognostic (9.45e-3)" "unprognostic (8.46e-2)" "unprognostic (1.61e-1)" "unprognostic (1.29e-1)" "unprognostic (8.85e-2)" "prognostic favourable (1.56e-7)" "unprognostic (3.54e-2)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (7.97e-4)" 30.8 30.4 24.0 23.9 38.8 13.9 29.9 25.8 35.9 40.2 27.3 43.4 27.2 22.2 44.1 29.7 22.8 33.3 40.8 38.1 23.3 26.3 37.5 28.2 28.3 28.9 32.0 28.9 55.7 44.9 72.8 28.0 55.9 31.8 32.8 24.7 27.0 27.5 36.3 38.3 25.3 25.1 41.2 31.4 25.9 26.0 37.5 31.8 35.6 37.0 17.2 25.1 30.6 30.7 10.2 15.6 11.5 14.2 13.8 25.7 13.4 17.7 20.9 18.9 20.3 62.2 46.6 16.0 22.5 30.1 20.6 28.4 19.1 44.3 9.5 31.5 50.4 27.1 12.8 27.4 27.5 4.6 7.8 6.7 14.6 24.6 27.7 10.9 5.6 33.6 15.8 28.8 25.7 42.3 7.6 12.2 20.1 29.3 6.2 9.5 18.0 6.8 15.2 12.7 23.9 14.6 8.8 8.1 11.8 35.1 11.7 10.1 15.3 13.9 41.2 23.1 19.4 17.9 14.2 17.5 14.9 18.4 34.2 10.7 20.2 2.2 14.1 11.5 17.0 13.6 17.2 9.2 22.4 19.0 15.0 10.2 25.7 19.8 7.5 13.8 14.2 15.6 17.6 13.4 24.0 38.8 25.8 35.9 23.3 26.3 32.0 28.9 31.8 31.8 GLIPR1 "GliPR, RTVP1" ENSG00000139278 "GLI pathogenesis related 1" P48060 12 75480680-75503853 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.8" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 40.4;LHCN-M2: 30.6;U-138 MG: 78.6;U-87 MG: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011014 Approved "Intracellular and membrane" "HPA011014: AB_1849714" "unprognostic (2.32e-3)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.41e-2)" "unprognostic (2.19e-1)" "unprognostic (3.31e-1)" "unprognostic (2.32e-3)" "unprognostic (4.09e-1)" "unprognostic (7.58e-2)" "unprognostic (3.10e-1)" "unprognostic (7.23e-2)" "unprognostic (1.54e-1)" "prognostic unfavourable (8.69e-9)" "unprognostic (9.06e-3)" "unprognostic (5.08e-2)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" 32.0 12.5 6.7 30.4 7.5 10.9 11.8 2.5 10.2 14.7 13.1 5.2 6.0 4.5 28.8 19.2 8.0 20.2 23.1 12.7 6.3 5.4 10.3 8.2 18.6 45.4 9.3 6.6 18.3 4.5 1.4 5.6 24.2 11.1 12.3 9.0 7.2 13.7 12.5 3.3 3.7 16.2 27.0 19.6 32.0 15.4 7.2 8.1 8.9 7.3 4.3 20.9 20.6 8.9 15.2 39.7 76.8 55.1 3.0 20.0 34.7 1.4 1.4 1.2 0.1 4.8 10.2 0.2 19.4 20.5 16.4 12.0 0.7 0.6 4.9 4.1 21.1 0.2 0.0 8.0 26.9 7.8 0.3 0.2 1.8 1.2 5.5 1.7 0.2 9.3 3.0 40.4 8.9 13.2 0.3 6.1 30.6 0.0 0.8 4.1 0.1 0.5 0.2 0.9 0.1 1.7 0.3 0.0 0.0 8.0 0.0 0.0 0.2 1.3 21.3 78.6 7.4 8.3 29.6 1.1 0.1 0.4 31.1 2.0 1.1 2.8 55.1 6.3 20.0 38.0 13.5 12.0 14.3 15.7 39.7 15.2 4.3 9.1 76.8 3.0 40.6 33.4 14.6 34.7 6.7 7.5 2.5 10.2 6.3 5.4 9.3 6.6 11.1 8.1 GLIPR1L2 MGC39497 ENSG00000180481 "GLIPR1 like 2" Q4G1C9 12 75391070-75432688 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 44.0" "Cell line enhanced" "Detected in some" "Hep G2: 5.7;SK-BR-3: 8.4;U-2 OS: 11.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039795, HPA039866" Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" Vesicles "Golgi apparatus, Cytosol" "HPA039795: AB_10805595, HPA039866: AB_10795235" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.27e-1)" "unprognostic (7.74e-2)" "unprognostic (1.33e-1)" "unprognostic (8.78e-3)" "unprognostic (2.29e-2)" "unprognostic (1.48e-1)" "unprognostic (2.82e-1)" "unprognostic (7.68e-3)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (5.91e-2)" "unprognostic (2.57e-2)" 1.3 3.1 5.5 1.2 10.4 0.8 3.0 2.9 5.8 2.2 1.2 4.2 2.9 1.0 2.7 4.2 1.4 3.5 1.5 2.5 5.5 4.6 2.5 1.9 2.7 1.1 6.6 3.9 7.7 3.0 7.3 5.2 1.3 6.2 2.3 0.8 2.0 1.4 3.6 2.4 2.2 1.2 1.5 8.1 1.9 1.0 44.0 5.0 1.4 2.8 0.5 0.8 1.7 1.4 1.4 2.6 2.0 0.7 1.0 3.4 0.6 0.3 0.5 0.3 0.5 4.3 2.5 0.7 0.6 0.5 0.2 0.3 0.1 0.4 0.3 1.5 0.4 0.2 0.1 0.1 0.4 0.8 0.3 0.1 0.6 5.7 3.2 0.5 0.1 0.8 1.3 0.6 2.3 0.2 0.3 0.7 1.1 0.1 0.6 0.4 0.3 0.2 0.1 0.1 0.3 0.1 0.4 1.1 0.6 0.7 8.4 2.4 2.5 0.2 1.2 1.0 11.1 1.2 0.4 1.0 1.0 0.3 0.4 0.3 0.8 1.8 0.3 0.5 1.1 0.2 0.7 1.1 1.2 2.0 0.4 1.4 2.2 3.3 2.0 1.0 0.7 2.6 3.4 0.6 5.5 10.4 2.9 5.8 5.5 4.6 6.6 3.9 6.2 5.0 GLMP "C1orf85, MGC31963, NCU-G1" ENSG00000198715 "Glycosylated lysosomal membrane protein" Q8WWB7 1 156290089-156295689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 60.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029121 Uncertain "HPA029121: AB_10600794" "unprognostic (2.46e-2)" "unprognostic (1.19e-2)" "unprognostic (5.68e-2)" "unprognostic (4.22e-3)" "unprognostic (3.71e-2)" "unprognostic (8.28e-2)" "prognostic unfavourable (6.35e-5)" "unprognostic (4.74e-2)" "unprognostic (2.17e-1)" "unprognostic (9.21e-3)" "unprognostic (1.33e-1)" "unprognostic (7.66e-3)" "unprognostic (7.68e-3)" "unprognostic (3.90e-2)" "unprognostic (1.96e-1)" "unprognostic (1.13e-1)" "unprognostic (4.20e-3)" 22.6 44.5 9.0 9.4 10.3 10.0 16.7 5.1 14.1 21.5 21.3 13.5 15.7 18.4 15.6 26.3 17.3 13.4 26.7 19.2 6.7 7.6 43.9 34.8 24.1 27.7 8.6 7.9 13.9 18.3 12.3 12.3 46.5 11.2 36.3 12.7 37.5 22.6 13.4 6.0 17.3 26.7 14.7 8.9 20.9 16.7 10.8 8.0 8.9 17.1 12.5 16.5 22.6 15.7 6.1 13.7 11.4 31.7 6.9 18.3 14.2 5.7 10.4 1.0 7.3 60.6 33.0 7.2 10.4 44.3 15.3 21.2 12.7 17.5 0.0 22.0 15.1 3.9 0.1 7.5 5.0 1.2 10.6 1.9 6.2 14.8 27.3 4.7 15.2 33.7 9.5 14.4 4.7 22.9 8.0 0.8 8.9 7.0 2.4 0.0 11.8 5.2 4.3 0.0 18.3 14.0 6.3 3.4 11.1 7.3 19.5 30.9 10.4 13.5 12.2 7.7 1.4 12.3 6.9 6.9 11.2 2.8 12.6 3.9 9.8 11.4 29.7 5.0 10.7 31.7 10.0 6.1 10.8 9.4 13.7 3.7 11.0 10.1 8.9 6.9 22.1 9.0 18.3 14.2 9.0 10.3 5.1 14.1 6.7 7.6 8.6 7.9 11.2 8.0 GLRB ENSG00000109738 "Glycine receptor beta" P48167 4 157076057-157172090 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.1;parathyroid gland: 37.0" "Cell line enhanced" "Detected in many" "AN3-CA: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 18 "dendritic cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052363 Approved "HPA052363: " "unprognostic (7.36e-2)" "unprognostic (6.53e-2)" "unprognostic (1.44e-1)" "unprognostic (2.59e-3)" "unprognostic (5.65e-2)" "unprognostic (1.18e-1)" "unprognostic (9.47e-2)" "unprognostic (1.52e-1)" "unprognostic (1.19e-2)" "unprognostic (2.99e-2)" "unprognostic (6.81e-2)" "unprognostic (1.48e-1)" "prognostic favourable (4.89e-4)" "unprognostic (4.32e-3)" "unprognostic (1.85e-1)" "unprognostic (5.61e-2)" "unprognostic (1.66e-2)" 4.5 7.2 12.6 1.5 20.9 0.7 10.3 15.9 43.1 9.4 2.3 2.8 0.1 1.1 3.3 5.4 1.5 7.4 3.5 9.9 18.3 17.3 4.1 1.6 3.4 0.8 11.1 21.3 1.8 14.2 37.0 6.7 2.9 16.5 6.5 1.4 0.7 16.7 5.2 3.3 1.5 1.2 4.0 6.1 0.6 2.2 1.9 4.5 0.0 1.5 0.5 0.7 1.9 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 5.0 2.2 6.1 18.5 12.0 4.9 0.0 10.1 6.5 5.0 9.4 0.0 15.7 0.0 2.4 10.2 0.0 4.6 1.6 9.4 0.0 6.1 3.1 2.4 0.2 5.5 3.9 0.0 4.3 1.4 8.7 1.3 4.4 0.0 0.0 9.0 0.0 0.4 0.0 0.4 1.3 0.0 8.4 0.0 13.4 0.9 6.7 4.1 0.0 4.8 0.8 4.4 1.0 6.6 3.0 8.8 5.0 9.8 0.0 0.0 0.0 7.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 12.6 20.9 15.9 43.1 18.3 17.3 11.1 21.3 16.5 4.5 GLT8D1 "AD-017, FLJ14611" ENSG00000016864 "Glycosyltransferase 8 domain containing 1" Q68CQ7 3 52694488-52706032 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010588 Approved Approved Mitochondria Mitochondria "HPA010588: AB_1078098" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (1.38e-2)" "prognostic favourable (2.76e-4)" "unprognostic (3.17e-2)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (1.82e-3)" "unprognostic (7.12e-2)" "unprognostic (9.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.07e-1)" "unprognostic (5.82e-3)" "unprognostic (2.42e-3)" "unprognostic (3.97e-1)" "unprognostic (3.34e-2)" "unprognostic (6.21e-2)" 18.6 23.7 16.1 14.5 20.9 4.7 21.0 15.3 19.9 29.3 17.3 18.3 22.1 14.6 23.5 26.8 14.1 31.9 19.9 19.3 16.6 17.0 23.2 39.4 16.8 16.0 17.9 14.4 32.4 23.6 24.3 40.8 34.7 18.1 21.1 18.9 19.7 22.0 25.2 11.5 13.0 15.2 18.7 17.4 14.8 16.0 43.3 21.6 17.5 37.8 11.6 14.7 21.8 16.8 8.6 15.7 20.5 8.4 20.1 16.3 6.6 8.1 9.8 19.8 15.6 44.1 56.1 11.1 20.7 32.1 18.3 21.1 4.5 15.6 7.0 5.9 36.0 9.3 12.5 21.3 24.3 12.5 9.1 6.5 17.9 20.7 21.1 9.7 20.6 32.2 19.0 15.7 20.4 27.2 8.3 16.1 24.0 8.4 6.5 15.0 10.1 18.4 5.0 11.3 23.4 21.4 9.0 8.2 14.0 17.3 8.4 14.0 14.2 12.9 19.8 13.3 10.4 19.2 11.5 18.2 20.7 7.7 23.3 15.6 16.7 20.5 8.4 14.1 13.3 5.7 13.2 8.6 16.0 14.3 8.1 6.4 16.3 11.5 4.8 20.1 6.0 15.7 10.6 6.6 16.1 20.9 15.3 19.9 16.6 17.0 17.9 14.4 18.1 21.6 GNE "IBM2, Uae1" ENSG00000159921 "Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase" Q9Y223 9 36214441-36277056 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.0;salivary gland: 45.3" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007045, HPA027258" Approved Supported Cytosol Cytosol "HPA007045: AB_1079003, HPA027258: AB_1849873" "unprognostic (7.54e-2)" "unprognostic (1.61e-2)" "unprognostic (1.07e-3)" "unprognostic (7.28e-2)" "unprognostic (7.00e-2)" "unprognostic (1.85e-2)" "unprognostic (2.78e-3)" "unprognostic (5.39e-2)" "unprognostic (1.73e-1)" "unprognostic (1.70e-2)" "unprognostic (2.88e-3)" "unprognostic (4.20e-2)" "prognostic favourable (9.28e-11)" "unprognostic (2.90e-1)" "unprognostic (8.28e-2)" "unprognostic (2.95e-1)" "unprognostic (1.72e-2)" 7.7 6.7 6.0 6.5 8.3 8.3 16.6 11.1 12.1 7.9 20.7 7.0 4.6 2.9 8.0 3.9 7.6 6.7 5.2 7.6 7.8 6.8 6.8 55.0 5.5 6.0 6.0 7.8 9.8 8.4 4.1 7.0 20.2 10.2 10.1 30.1 4.8 45.3 5.0 10.5 3.7 7.2 11.7 10.9 4.5 4.9 3.4 5.3 3.2 4.6 4.2 7.9 8.6 7.9 3.9 2.2 1.2 2.7 2.4 4.2 1.8 4.4 19.9 8.9 7.6 10.1 10.1 12.9 6.2 7.9 8.6 11.1 4.8 14.2 5.8 6.6 10.3 1.7 6.7 2.0 9.6 10.9 0.6 5.0 11.7 6.6 6.9 0.1 14.3 6.6 2.0 14.3 13.5 3.6 6.3 12.1 8.3 0.7 8.1 2.6 5.1 11.2 6.7 7.5 1.6 47.6 8.2 7.6 6.9 6.6 2.3 5.7 2.1 5.1 5.2 5.7 5.9 6.8 5.4 5.3 11.3 3.2 7.8 4.3 8.1 0.7 1.7 0.9 2.7 2.2 1.8 2.4 3.4 2.9 1.4 3.9 4.0 4.2 1.2 2.4 2.7 2.2 1.5 1.8 6.0 8.3 11.1 12.1 7.8 6.8 6.0 7.8 10.2 5.3 GNPTAB "GNPTA, KIAA1208, MGC4170" ENSG00000111670 "N-acetylglucosamine-1-phosphate transferase alpha and beta subunits" Q3T906 12 101745497-101830938 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cancer-related genes, Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014558, HPA042343" Approved Supported "Golgi apparatus" 47000 "Golgi apparatus" "HPA014558: , HPA042343: " "unprognostic (6.72e-2)" "unprognostic (1.66e-1)" "unprognostic (8.71e-3)" "prognostic favourable (8.48e-4)" "unprognostic (1.39e-1)" "unprognostic (8.37e-2)" "unprognostic (2.73e-1)" "unprognostic (8.57e-2)" "unprognostic (3.73e-2)" "unprognostic (1.09e-2)" "unprognostic (2.28e-2)" "unprognostic (2.00e-1)" "unprognostic (6.86e-2)" "unprognostic (3.44e-1)" "unprognostic (1.02e-1)" "unprognostic (5.44e-2)" "unprognostic (4.98e-2)" 15.2 6.5 21.9 11.9 23.0 15.2 12.2 13.9 25.6 14.0 21.3 10.3 5.9 10.3 9.0 6.5 11.7 7.1 11.0 15.9 17.9 13.7 11.0 7.3 19.6 20.3 14.4 13.0 6.6 11.4 29.9 9.0 10.8 10.9 15.6 22.5 11.3 37.6 10.2 10.8 18.1 14.5 11.7 13.1 15.4 15.2 7.4 10.8 24.5 10.5 8.6 12.6 14.7 14.8 3.9 5.8 5.9 3.4 14.2 16.4 2.7 8.3 8.1 3.0 5.1 25.6 12.2 9.4 11.9 24.6 11.8 15.5 6.2 5.9 17.5 8.6 16.3 10.9 14.0 15.3 18.5 8.2 7.3 7.5 7.5 8.8 4.8 6.8 15.2 9.4 8.5 11.2 6.6 20.7 11.6 5.2 11.0 12.7 20.4 9.6 10.4 5.9 4.8 15.5 23.5 19.0 21.7 6.6 5.4 19.8 14.1 28.0 14.5 4.5 20.3 11.2 6.1 9.3 6.6 14.3 14.6 10.0 12.7 10.1 6.9 5.9 3.1 3.4 16.4 2.9 5.4 2.4 3.6 8.9 5.8 3.9 4.6 7.1 1.2 14.2 3.4 5.8 2.6 2.7 21.9 23.0 13.9 25.6 17.9 13.7 14.4 13.0 10.9 10.8 GOLGA5 "golgin-84, GOLIM5, ret-II, rfg5" ENSG00000066455 "Golgin A5" Q8TBA6 14 92794231-92839963 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000992, HPA063876" Enhanced Supported Supported "Golgi apparatus" "Golgi apparatus" "HPA000992: AB_1079009, HPA063876: AB_2685140" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-1)" "unprognostic (2.77e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-1)" "unprognostic (1.78e-1)" "unprognostic (5.02e-2)" "unprognostic (1.15e-2)" "unprognostic (2.83e-2)" "unprognostic (7.67e-2)" "unprognostic (6.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.06e-2)" "unprognostic (2.49e-2)" 20.8 20.3 16.8 15.7 17.3 6.5 24.4 11.6 17.5 24.9 20.4 17.2 25.5 16.5 18.2 41.7 21.2 15.3 17.5 18.3 17.5 15.6 21.5 51.0 16.6 18.2 18.6 14.6 18.9 26.8 23.6 27.2 44.4 16.4 23.4 23.7 12.7 24.3 30.2 20.6 18.9 25.6 18.9 19.4 16.9 23.0 23.5 17.6 13.5 24.8 17.8 16.4 20.7 15.8 9.7 9.7 22.2 12.7 8.1 12.4 6.3 12.6 11.6 10.5 9.6 22.1 30.0 18.1 17.5 32.3 17.1 20.2 8.5 17.4 8.2 14.4 27.8 13.3 9.3 14.3 23.3 10.0 4.4 7.7 5.8 11.4 25.7 9.0 13.0 23.0 26.0 12.0 24.9 16.8 6.8 11.1 18.7 23.4 6.9 7.8 6.5 12.5 5.4 15.5 8.2 17.4 15.4 7.5 10.6 15.9 12.0 17.8 20.6 10.0 13.9 9.8 6.5 12.7 8.7 13.6 10.5 7.2 22.6 7.2 16.4 9.1 9.8 22.2 10.9 12.7 12.3 9.7 11.1 11.1 9.7 9.2 9.9 8.6 8.7 8.1 10.8 9.1 12.4 6.3 16.8 17.3 11.6 17.5 17.5 15.6 18.6 14.6 16.4 17.6 GOLGB1 "GCP, GCP372, giantin, GOLIM1" ENSG00000173230 "Golgin B1" Q14789 3 121663199-121749767 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011008, HPA011555" Enhanced Enhanced "Golgi apparatus" 35000 "Golgi apparatus" "HPA011008: AB_1079011, HPA011555: AB_1079010" "unprognostic (2.56e-2)" "unprognostic (7.69e-2)" "unprognostic (1.46e-1)" "unprognostic (6.57e-2)" "unprognostic (5.34e-2)" "unprognostic (5.96e-2)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (6.58e-2)" "unprognostic (7.49e-2)" "unprognostic (3.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.37e-1)" "unprognostic (9.90e-3)" "unprognostic (9.05e-2)" 16.7 22.3 17.6 12.5 24.0 12.8 25.7 22.3 28.0 24.6 16.8 8.2 27.1 12.7 16.5 35.0 15.9 14.0 14.0 16.6 16.8 10.3 19.7 17.2 13.4 8.5 26.1 14.5 20.9 23.4 26.2 39.4 24.4 17.7 28.0 18.4 12.5 21.5 29.3 11.7 20.5 20.6 21.3 30.6 14.8 16.6 12.1 20.7 9.0 19.3 12.9 10.1 17.2 13.6 3.6 5.8 16.4 4.4 3.9 5.0 1.5 12.4 10.0 10.0 6.5 19.3 21.0 6.3 8.1 17.9 7.9 8.9 8.8 4.6 2.7 6.8 15.1 5.8 5.9 8.8 9.3 3.9 11.3 7.7 12.1 12.1 11.5 8.5 10.6 17.1 21.0 4.9 12.4 9.9 3.5 6.2 8.2 8.9 2.5 6.2 6.5 10.6 3.4 7.9 6.4 11.7 12.9 7.1 7.9 10.0 7.1 10.5 8.8 9.6 13.7 7.5 4.6 3.3 5.8 11.7 6.9 4.6 10.2 4.2 2.8 1.7 4.4 4.3 5.0 2.2 4.0 3.6 4.0 3.6 2.7 3.2 3.7 4.0 16.4 3.9 1.7 5.8 3.8 1.5 17.6 24.0 22.3 28.0 16.8 10.3 26.1 14.5 17.7 20.7 GOLIM4 "GIMPC, GOLPH4, GPP130, P138" ENSG00000173905 "Golgi integral membrane protein 4" O00461 3 168008677-168095975 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 11.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001677, HPA002315" Enhanced Enhanced "Golgi apparatus" 730000 "Golgi apparatus" "HPA001677: AB_1079017, HPA002315: AB_1079018" "unprognostic (6.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.19e-1)" "unprognostic (6.27e-2)" "unprognostic (2.11e-1)" "unprognostic (4.76e-2)" "unprognostic (2.44e-1)" "unprognostic (5.17e-2)" "unprognostic (1.39e-1)" "unprognostic (6.46e-2)" "unprognostic (1.10e-1)" "unprognostic (6.31e-2)" "unprognostic (1.84e-3)" "unprognostic (9.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (9.62e-3)" 13.0 7.1 25.5 10.8 25.6 4.2 9.3 12.4 24.2 11.3 28.0 18.6 7.4 34.8 15.6 7.1 9.3 9.7 16.2 28.5 31.3 13.8 17.1 31.7 15.6 5.5 24.6 23.2 11.6 8.8 13.3 10.3 12.0 26.8 10.2 28.0 13.3 8.9 7.9 15.5 6.1 44.2 14.6 36.2 11.7 13.0 4.9 30.9 1.8 11.0 12.0 5.0 10.7 12.2 2.0 4.5 11.7 3.3 6.0 0.8 0.7 6.6 9.8 14.0 8.8 23.8 17.7 4.2 39.0 21.0 10.6 9.8 10.9 8.2 14.5 46.9 23.4 12.2 12.8 11.4 16.2 22.7 16.5 23.5 29.5 13.5 9.6 22.3 13.4 18.4 6.1 9.8 9.7 12.1 12.0 42.4 12.0 10.9 0.0 6.0 13.6 10.6 0.0 14.0 20.2 5.9 2.4 12.6 16.3 23.9 7.2 7.8 8.9 10.1 22.6 34.0 13.1 23.7 31.0 16.5 11.8 31.3 16.9 13.4 15.1 3.0 3.0 11.7 0.8 3.3 0.2 1.5 0.2 0.6 3.7 2.0 0.0 0.3 0.1 6.0 2.5 4.5 0.0 0.7 25.5 25.6 12.4 24.2 31.3 13.8 24.6 23.2 26.8 30.9 GOLT1B "CGI-141, GOT1, YMR292W" ENSG00000111711 "Golgi transport 1B" Q9Y3E0 12 21501781-21518408 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055909, HPA066383" Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA055909: , HPA066383: " "unprognostic (1.22e-2)" "unprognostic (3.07e-3)" "unprognostic (1.84e-1)" "unprognostic (3.65e-1)" "unprognostic (3.45e-1)" "unprognostic (5.37e-3)" "prognostic unfavourable (1.99e-8)" "unprognostic (2.24e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (2.32e-4)" "unprognostic (1.36e-1)" "prognostic unfavourable (4.83e-10)" "unprognostic (3.13e-1)" "unprognostic (2.14e-1)" "unprognostic (6.78e-2)" "unprognostic (1.04e-1)" 21.1 26.0 18.3 18.2 24.4 23.4 20.4 31.9 30.4 22.3 14.7 18.9 13.8 12.0 16.9 18.9 15.3 14.6 16.4 17.0 19.1 22.4 23.2 40.1 19.9 16.0 20.1 16.2 14.1 30.9 11.3 34.9 31.1 23.8 19.0 16.8 16.1 17.4 15.3 15.9 14.5 13.0 19.6 22.2 17.8 15.3 11.6 17.5 13.5 19.1 11.6 15.6 22.5 14.2 17.7 22.2 26.7 22.9 14.8 21.1 19.4 11.5 12.3 10.1 13.1 20.4 32.0 17.2 45.7 17.5 14.5 23.8 16.0 17.2 7.0 11.8 23.7 11.3 8.4 9.5 25.4 10.2 8.0 10.2 8.0 11.2 22.9 13.2 13.2 16.2 18.4 17.4 32.0 13.1 6.4 7.8 22.2 10.9 5.9 21.9 28.0 8.8 5.0 24.8 14.7 12.0 7.1 2.7 8.5 18.7 7.3 24.9 10.1 14.9 14.6 17.1 18.7 21.1 24.8 7.6 16.5 18.6 23.5 12.7 23.0 26.7 20.6 14.8 17.9 22.9 21.1 17.7 21.1 19.5 20.2 16.5 19.3 19.2 5.6 14.8 20.9 22.2 20.4 19.4 18.3 24.4 31.9 30.4 19.1 22.4 20.1 16.2 23.8 17.5 GOSR1 "GOLIM2, GOS-28, GOS28, GS28, P28" ENSG00000108587 "Golgi SNAP receptor complex member 1" O95249 17 30477362-30527592 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020590 Uncertain "HPA020590: AB_1850374" "unprognostic (1.54e-1)" "unprognostic (4.02e-1)" "unprognostic (4.59e-3)" "unprognostic (1.08e-1)" "unprognostic (3.41e-1)" "unprognostic (2.83e-2)" "unprognostic (4.98e-2)" "unprognostic (1.16e-2)" "unprognostic (1.71e-1)" "unprognostic (4.34e-2)" "unprognostic (9.93e-2)" "unprognostic (1.13e-1)" "prognostic favourable (2.26e-4)" "unprognostic (8.64e-2)" "unprognostic (3.68e-1)" "unprognostic (7.56e-2)" "unprognostic (1.14e-2)" 22.5 23.4 24.8 19.8 26.4 12.9 26.2 30.6 29.3 24.9 23.1 27.0 21.9 18.8 29.9 18.7 29.2 28.6 19.2 21.4 24.5 19.1 30.4 35.5 19.7 18.7 22.6 21.6 26.1 30.6 40.6 36.9 27.7 23.7 26.3 27.7 22.7 26.1 24.9 27.5 24.3 23.6 24.8 22.7 21.4 23.4 33.5 25.7 30.4 29.9 20.5 27.7 25.4 20.9 29.2 25.6 23.4 22.3 28.2 30.6 15.2 16.2 27.0 17.8 12.7 13.8 14.0 13.5 18.2 17.5 25.5 23.0 23.5 10.9 18.1 17.1 18.5 15.0 21.9 18.0 28.9 10.4 16.6 18.0 20.1 14.8 18.7 28.2 20.0 14.1 14.4 24.9 27.9 16.7 28.4 16.6 16.9 10.3 20.7 13.3 18.6 11.2 19.6 26.0 14.7 12.9 23.6 16.0 15.1 18.9 39.4 21.9 29.4 19.7 20.1 17.0 14.8 15.6 23.4 20.2 27.6 31.9 16.7 13.1 22.9 19.7 18.7 23.4 26.4 22.3 30.4 26.9 25.4 24.7 25.2 29.2 30.6 29.5 21.7 28.2 21.0 25.6 26.5 15.2 24.8 26.4 30.6 29.3 24.5 19.1 22.6 21.6 23.7 25.7 GOSR2 "Bos1, GS27" ENSG00000108433 "Golgi SNAP receptor complex member 2" O14653 17 46923075-46975524 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB017456, HPA048956, HPA054472" Uncertain Supported "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "CAB017456: AB_10532285, HPA048956: , HPA054472: " "unprognostic (3.28e-2)" "unprognostic (1.18e-1)" "unprognostic (1.49e-2)" "unprognostic (3.54e-2)" "unprognostic (1.30e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (3.80e-4)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (2.41e-2)" "unprognostic (7.23e-3)" "unprognostic (2.41e-1)" "unprognostic (2.46e-3)" "unprognostic (4.50e-1)" "unprognostic (3.07e-1)" "unprognostic (2.84e-3)" "unprognostic (4.29e-2)" 22.4 24.6 27.9 18.7 27.8 12.5 22.6 22.2 31.1 24.1 25.3 28.9 38.0 43.9 25.9 30.0 19.7 19.6 21.4 28.7 25.2 26.5 37.4 39.7 21.0 23.8 27.0 22.8 27.5 33.6 26.8 40.6 27.6 23.5 22.0 25.1 25.8 28.4 29.8 34.4 19.2 38.2 27.1 27.8 31.5 20.6 38.8 18.4 23.6 24.9 15.2 30.7 20.9 21.0 16.9 15.5 15.1 37.0 13.9 17.6 15.5 18.1 20.5 14.6 17.8 25.0 17.9 17.0 26.1 25.8 28.5 25.8 26.0 11.4 16.2 14.9 32.9 13.2 19.0 21.2 35.3 34.6 14.5 24.5 16.9 25.4 27.6 19.0 19.7 18.7 20.9 23.2 33.2 23.3 23.9 22.0 20.6 20.1 20.6 10.3 13.6 29.2 17.7 28.5 18.8 18.0 15.6 12.9 27.3 14.3 8.6 20.2 24.0 13.2 27.2 27.0 17.4 21.0 24.9 28.5 16.0 25.6 25.5 12.2 29.5 15.1 15.5 13.1 16.8 28.9 15.5 14.8 15.0 13.8 15.5 16.9 14.9 13.0 1.8 13.9 37.0 14.0 17.6 15.5 27.9 27.8 22.2 31.1 25.2 26.5 27.0 22.8 23.5 18.4 GP1BA "CD42b, GP1B, GPIbalpha" ENSG00000185245 "Glycoprotein Ib platelet alpha subunit" P07359 17 4932297-4935030 "CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation, von Willebrand disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 37.8" "Cell line enriched" "Detected in some" 24 "HEL: 39.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 7 "basophil: 7.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002496, HPA013316" Supported 2000000000 "CAB002496: AB_563748, HPA013316: AB_1855459" "unprognostic (4.87e-4)" "unprognostic (8.21e-2)" "unprognostic (2.81e-2)" "unprognostic (6.11e-3)" "unprognostic (1.50e-2)" "unprognostic (1.59e-3)" "unprognostic (7.30e-3)" "unprognostic (5.58e-2)" "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "unprognostic (6.54e-4)" "unprognostic (1.27e-1)" "unprognostic (4.85e-3)" "unprognostic (4.58e-3)" "unprognostic (2.56e-1)" "unprognostic (3.53e-4)" "unprognostic (8.35e-2)" 0.7 0.1 0.4 15.8 1.2 5.3 0.7 1.9 0.7 0.7 1.0 0.2 0.2 1.5 0.6 0.7 5.7 0.8 0.3 4.2 0.5 0.4 1.0 1.6 3.5 37.8 0.4 0.2 0.7 0.4 0.0 0.4 1.1 0.4 0.7 0.6 0.3 7.7 0.2 3.0 4.6 3.7 0.2 0.4 13.0 0.9 0.6 0.2 2.0 0.8 0.8 17.6 0.9 1.1 0.0 0.3 7.5 0.2 0.0 0.2 3.6 0.0 1.3 0.3 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 1.1 0.1 1.2 0.4 0.0 1.3 0.0 0.0 0.0 0.4 1.0 39.3 0.5 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.4 0.3 0.2 0.1 0.2 0.6 0.3 0.2 0.0 0.7 0.0 0.2 0.5 0.0 0.2 1.6 0.7 0.1 0.2 0.2 0.8 0.1 0.7 0.2 0.9 0.6 0.6 0.4 7.5 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 1.0 0.0 0.1 0.3 0.0 3.6 0.4 1.2 1.9 0.4 0.5 0.4 0.4 0.2 0.4 0.2 GP2 ZAP75 ENSG00000169347 "Glycoprotein 2" P55259 16 20309572-20327808 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 354 "pancreas: 1812.8" "Low cell line specificity" "Detected in some" "Cancer enriched" "Detected in many" 14 "pancreatic cancer: 320.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015739, HPA016668" Enhanced "Intracellular and membrane" 27000 "HPA015739: AB_1849905, HPA016668: AB_1849907" "unprognostic (2.14e-2)" "unprognostic (1.97e-2)" "unprognostic (5.68e-2)" "unprognostic (4.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.84e-1)" "unprognostic (6.35e-2)" "unprognostic (8.17e-3)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.1 0.0 5.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.4 1812.8 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.4 1.4 2.3 0.9 0.6 0.8 0.3 0.5 0.3 0.6 1.0 0.0 0.2 1.3 0.3 0.0 0.5 0.2 1.3 0.7 1.3 1.4 0.4 0.6 0.1 0.4 0.7 0.3 0.2 0.4 1.3 0.2 0.0 0.4 0.9 0.0 0.3 0.1 0.0 0.0 0.7 0.8 0.5 0.0 0.4 0.6 0.1 1.2 0.7 0.7 1.8 0.1 0.2 0.7 0.5 0.6 1.4 0.2 0.5 0.5 0.0 1.1 2.2 0.8 1.0 0.7 0.8 0.3 0.3 0.6 0.3 2.0 0.9 0.7 0.8 0.3 0.5 0.6 0.7 0.7 0.1 1.4 0.7 0.7 2.3 0.6 0.2 1.4 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 GP5 CD42d ENSG00000178732 "Glycoprotein V platelet" P40197 3 194394821-194398354 "CD markers, Plasma proteins, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.7" "Cell line enriched" "Detected in some" 9 "HEL: 18.6" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.2" "Group enriched" "Detected in many" 6 "dendritic cells: 1.1;T-cells: 2.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA072646 Uncertain Cytosol 400000000 Cytosol "HPA072646: " "unprognostic (3.74e-2)" "unprognostic (3.40e-1)" "unprognostic (5.22e-2)" "unprognostic (2.96e-2)" "unprognostic (1.74e-2)" "unprognostic (1.35e-3)" "unprognostic (1.69e-3)" "unprognostic (1.68e-1)" "unprognostic (3.41e-1)" "unprognostic (2.80e-2)" "unprognostic (1.65e-1)" "unprognostic (5.51e-2)" "unprognostic (1.21e-2)" "unprognostic (4.18e-2)" "unprognostic (3.14e-1)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" 0.3 0.0 0.4 2.1 0.5 1.6 0.3 0.3 0.3 0.6 0.3 0.3 0.3 0.0 0.3 0.3 0.3 2.5 0.3 0.3 0.4 0.6 0.3 0.6 0.9 3.7 0.3 0.3 0.8 0.3 0.0 0.4 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.1 0.9 0.3 0.3 1.7 0.2 0.3 0.3 0.3 1.0 0.3 1.9 0.3 0.5 0.1 1.1 0.2 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.4 0.1 0.1 2.0 2.2 0.1 0.0 0.0 1.1 0.0 0.4 0.4 0.5 0.3 0.3 0.4 0.6 0.3 0.3 0.3 0.3 GP6 GPVI ENSG00000088053 "Glycoprotein VI platelet" Q9HCN6 19 55013705-55038264 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.9" "Group enriched" "Detected in some" 12 "HEL: 13.5;K-562: 5.8;U-2 OS: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" HPA066482 Approved Approved Nucleoplasm "Intracellular and membrane" 28000000 Nucleoplasm "HPA066482: " "unprognostic (3.06e-3)" "unprognostic (4.58e-2)" "unprognostic (1.74e-5)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (7.50e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (4.18e-2)" "unprognostic (3.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.53e-1)" "unprognostic (2.62e-1)" "unprognostic (3.32e-2)" "unprognostic (5.44e-3)" "unprognostic (2.70e-2)" 0.3 0.3 0.8 0.4 1.4 4.4 0.9 4.6 1.6 1.3 0.4 0.3 0.3 0.1 1.1 0.3 2.1 0.5 0.5 5.4 0.7 0.9 0.4 1.5 1.4 0.3 0.3 0.3 0.6 0.3 0.6 0.3 2.8 0.3 0.6 0.4 2.0 0.7 3.0 0.3 3.2 0.3 0.3 0.3 8.9 0.1 4.2 1.0 0.3 0.6 0.3 0.3 0.7 1.8 0.0 0.3 1.3 0.2 0.0 0.1 4.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.6 0.2 0.0 0.2 0.2 0.5 13.5 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 5.8 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.1 0.0 0.1 0.2 0.1 0.4 0.2 0.2 0.1 3.9 0.1 0.0 0.3 0.0 0.4 0.1 0.4 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 4.0 0.8 1.4 4.6 1.6 0.7 0.9 0.3 0.3 0.3 1.0 GP9 "CD42a, GPIX" ENSG00000169704 "Glycoprotein IX platelet" P14770 3 129060767-129062406 "CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5" "Cell line enriched" "Detected in some" 14 "HEL: 42.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 8.8;neutrophil: 7.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063182 Enhanced 68000000 "HPA063182: " "unprognostic (1.70e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (3.80e-2)" "unprognostic (2.50e-2)" "unprognostic (3.24e-1)" "unprognostic (2.53e-2)" "unprognostic (8.47e-2)" "unprognostic (8.70e-2)" 0.2 0.1 0.1 0.1 0.1 10.0 0.1 0.0 0.6 0.4 0.5 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 5.0 0.8 0.1 0.1 0.4 4.8 0.0 0.8 0.2 0.5 0.1 0.0 0.3 1.5 0.4 0.1 0.4 0.2 0.0 0.6 0.2 0.0 0.1 0.0 0.1 24.5 0.3 2.2 0.0 0.0 0.6 0.6 0.0 0.6 3.0 0.1 1.5 8.8 0.6 0.0 0.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.6 0.1 0.1 0.3 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.0 7.5 0.0 0.0 1.5 0.0 27.1 0.1 0.1 0.0 0.6 0.8 0.1 0.8 0.2 0.4 0.0 GPA33 A33 ENSG00000143167 "Glycoprotein A33" Q99795 1 167052836-167166479 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 101.1" "Cell line enhanced" "Detected in some" "HL-60: 1.9;MOLT-4: 2.3;NB-4: 1.1;NTERA-2: 4.0;RPMI-8226: 2.9;THP-1: 1.1" "Cancer enriched" "Detected in many" 6 "colorectal cancer: 84.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 17.8;T-reg: 13.0" "Lineage enriched" "Detected in many" 7 "T-cells: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018858, CAB025943" Enhanced "CAB025943: , HPA018858: AB_1849909" "unprognostic (2.41e-2)" "unprognostic (1.71e-3)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (8.39e-4)" "unprognostic (1.55e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-2)" "unprognostic (9.63e-2)" "unprognostic (2.10e-2)" "unprognostic (9.44e-2)" "unprognostic (6.75e-2)" "unprognostic (5.22e-3)" "unprognostic (3.13e-1)" "unprognostic (9.68e-3)" "unprognostic (2.96e-3)" 0.2 0.2 0.2 12.1 0.2 0.0 0.2 0.2 0.2 0.2 46.9 0.2 0.1 31.6 0.2 0.1 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 1.2 1.6 0.2 0.1 0.2 0.2 0.0 0.2 0.3 0.2 0.2 43.5 0.2 0.3 0.1 0.2 0.2 101.1 1.4 0.2 0.6 0.2 0.2 0.1 0.6 0.2 0.1 0.6 0.2 0.2 1.7 1.7 0.1 2.5 0.1 17.8 4.6 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.1 4.0 0.1 0.0 0.0 2.9 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 2.5 1.1 0.1 7.6 3.9 1.7 1.7 17.8 2.4 0.1 0.1 1.6 0.0 13.0 4.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1 GPAA1 "GAA1, hGAA1" ENSG00000197858 "Glycosylphosphatidylinositol anchor attachment 1" O43292 8 144082590-144086216 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077224 Approved "HPA077224: " "unprognostic (2.53e-3)" "unprognostic (1.39e-1)" "unprognostic (3.06e-2)" "unprognostic (2.57e-2)" "unprognostic (2.49e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-3)" "unprognostic (2.64e-1)" "unprognostic (8.92e-2)" "unprognostic (1.67e-2)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (3.89e-1)" "unprognostic (1.27e-1)" "unprognostic (2.73e-2)" 25.2 35.3 23.0 15.9 25.5 32.1 20.0 19.9 43.7 23.6 24.4 27.1 32.3 28.2 26.3 38.3 23.2 24.0 31.1 35.0 20.3 17.4 29.3 47.2 24.9 31.4 19.9 19.0 23.8 46.6 36.4 17.1 32.9 25.1 23.1 10.7 27.4 46.0 35.4 28.5 23.3 31.0 16.3 22.3 21.9 23.0 24.6 16.1 24.0 29.0 22.2 18.6 19.3 18.6 17.2 41.0 21.7 33.3 24.7 34.5 26.1 16.2 28.7 6.7 21.0 15.6 13.3 23.3 16.6 16.6 14.0 14.6 11.9 26.9 8.8 24.3 18.0 20.2 4.4 16.5 2.0 14.9 15.1 13.9 13.4 8.7 15.1 6.8 20.9 14.6 15.5 14.3 10.0 11.5 10.1 31.4 13.4 57.1 13.1 6.3 6.7 69.8 9.2 8.5 42.2 12.1 11.4 11.6 16.0 21.8 28.1 12.2 18.0 19.2 7.6 13.0 22.6 7.3 18.6 17.5 13.5 5.9 23.0 8.4 17.7 11.8 24.8 21.7 34.5 29.9 23.7 15.5 17.4 27.1 23.1 17.2 17.3 24.1 5.8 24.7 33.3 41.0 15.0 26.1 23.0 25.5 19.9 43.7 20.3 17.4 19.9 19.0 25.1 16.1 GPAM "GPAT1, KIAA1560, MGC26846" ENSG00000119927 "Glycerol-3-phosphate acyltransferase, mitochondrial" Q9HCL2 10 112149864-112215377 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 107.3;liver: 56.6" "Cell line enhanced" "Detected in all" "ASC diff: 75.2;Hep G2: 20.2" "Cancer enriched" "Detected in all" 5 "liver cancer: 20.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046339, HPA060090" Approved Approved Mitochondria Mitochondria "HPA046339: , HPA060090: " "unprognostic (1.82e-1)" "unprognostic (6.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.30e-1)" "unprognostic (6.80e-2)" "unprognostic (8.75e-2)" "unprognostic (1.40e-2)" "unprognostic (2.16e-2)" "unprognostic (4.59e-1)" "unprognostic (4.80e-1)" "unprognostic (2.37e-2)" "unprognostic (5.44e-2)" "prognostic favourable (4.54e-6)" "unprognostic (2.84e-1)" "unprognostic (4.41e-2)" "unprognostic (2.52e-2)" "unprognostic (1.37e-1)" 107.3 17.2 11.4 2.6 12.1 1.8 30.8 6.6 11.0 2.0 3.2 6.5 5.1 2.2 4.1 32.1 2.4 1.9 3.0 5.8 12.2 2.9 2.4 56.6 2.2 2.3 7.2 7.3 3.5 2.8 3.2 2.3 1.8 5.6 2.3 2.6 12.0 6.8 2.9 3.6 1.8 3.3 3.4 3.8 1.7 2.4 2.8 7.2 2.8 6.1 2.4 2.3 3.2 1.6 3.2 2.0 0.5 1.2 1.1 3.4 1.0 2.7 2.1 2.8 3.7 75.2 2.7 3.7 2.6 3.0 1.9 1.5 4.9 1.6 1.9 1.4 1.8 3.5 4.5 2.2 3.6 1.4 2.4 1.8 2.3 20.2 2.3 3.1 1.0 13.1 3.8 3.4 7.0 1.6 2.3 1.7 2.2 1.5 2.6 2.4 2.3 2.9 2.7 7.4 1.4 1.2 1.9 1.2 3.6 3.6 1.7 4.1 1.8 1.1 1.2 2.2 1.3 2.7 4.2 1.8 2.0 4.1 2.6 2.7 1.6 0.0 1.0 0.5 2.5 1.2 3.2 1.9 1.9 1.9 1.2 3.2 2.0 3.4 0.0 1.1 1.0 2.0 1.9 1.0 11.4 12.1 6.6 11.0 12.2 2.9 7.2 7.3 5.6 7.2 GPAT4 "AGPAT6, DKFZp586M1819, LPAAT-zeta, TSARG7" ENSG00000158669 "Glycerol-3-phosphate acyltransferase 4" Q86UL3 8 41577187-41625001 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016471 Approved "HPA016471: AB_1844649" "unprognostic (3.05e-2)" "unprognostic (4.05e-2)" "unprognostic (4.24e-2)" "prognostic unfavourable (9.37e-4)" "unprognostic (7.45e-2)" "unprognostic (2.99e-3)" "unprognostic (5.08e-2)" "unprognostic (5.11e-2)" "unprognostic (3.79e-2)" "prognostic unfavourable (2.20e-4)" "unprognostic (1.98e-2)" "prognostic favourable (4.15e-4)" "unprognostic (1.73e-3)" "unprognostic (3.16e-2)" "unprognostic (3.35e-1)" "unprognostic (2.04e-2)" "prognostic favourable (5.65e-4)" 15.7 27.4 14.4 17.8 17.2 16.6 28.1 43.8 21.9 16.9 14.0 23.1 22.7 13.0 22.8 12.0 13.1 14.6 15.8 14.1 14.0 13.1 20.8 26.7 18.7 13.8 18.5 13.6 16.6 17.3 35.7 22.3 23.3 20.5 15.1 15.1 21.0 20.8 15.5 42.1 14.5 14.6 23.0 18.0 17.5 17.8 15.5 16.6 15.2 14.5 12.4 19.4 16.6 14.9 9.1 18.9 10.8 15.0 4.9 12.1 11.1 14.6 16.3 19.5 15.2 21.4 26.0 17.2 31.9 27.5 24.2 25.3 10.9 29.5 20.4 22.4 26.3 8.5 22.8 14.4 31.4 21.8 12.5 23.8 18.1 10.0 12.5 2.5 34.4 16.3 10.6 25.2 9.1 24.8 17.7 24.1 24.8 6.2 22.2 6.5 20.8 8.7 13.0 19.5 11.0 14.7 22.0 12.8 17.7 12.4 17.1 34.2 23.7 16.1 18.1 25.1 17.6 28.7 23.8 13.0 17.4 22.3 20.6 14.1 24.5 10.8 15.0 6.6 12.1 14.3 11.3 8.3 9.3 11.9 18.9 9.1 8.5 8.2 3.5 4.9 12.0 7.1 8.7 11.1 14.4 17.2 43.8 21.9 14.0 13.1 18.5 13.6 20.5 16.6 GPC1 glypican ENSG00000063660 "Glypican 1" P35052 2 240435671-240468078 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 142.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030571 Approved Supported "Plasma membrane,Cytosol" "Intracellular and membrane" 6500000 "Plasma membrane, Cytosol" "HPA030571: AB_10602322" "unprognostic (1.22e-2)" "unprognostic (2.53e-2)" "prognostic unfavourable (5.78e-5)" "prognostic unfavourable (1.55e-4)" "unprognostic (1.95e-1)" "unprognostic (1.83e-3)" "prognostic unfavourable (2.44e-6)" "unprognostic (1.00e-2)" "unprognostic (2.15e-1)" "unprognostic (5.08e-3)" "unprognostic (2.28e-1)" "unprognostic (4.38e-1)" "unprognostic (1.91e-1)" "unprognostic (4.40e-2)" "unprognostic (2.92e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-2)" 13.6 22.8 32.4 7.2 21.0 1.9 8.1 42.7 33.6 11.5 8.1 10.1 9.5 5.4 9.6 9.8 26.3 7.8 7.1 40.7 26.5 11.9 8.5 11.0 7.4 4.0 8.8 22.5 14.1 18.1 5.8 14.4 20.2 13.6 29.5 4.0 6.3 16.3 17.6 62.9 142.6 4.9 12.0 8.3 5.2 6.5 20.0 10.5 1.7 4.5 24.3 10.7 10.5 15.2 0.9 0.1 0.0 0.0 0.1 0.8 0.3 16.0 22.1 5.2 13.7 16.0 15.4 21.3 38.6 19.2 4.5 5.2 7.9 18.0 0.4 5.3 40.8 44.4 2.8 27.4 0.9 7.7 2.3 0.0 20.3 9.7 23.0 0.3 1.5 13.5 17.9 10.0 5.2 2.3 0.1 0.8 11.4 8.4 0.2 0.1 8.2 4.9 2.8 23.9 3.7 3.6 26.0 5.2 3.5 25.2 22.3 2.3 7.0 1.6 10.8 24.0 40.7 11.4 15.9 0.1 0.1 0.1 17.1 0.4 26.8 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.2 0.1 0.9 0.0 0.2 0.0 0.1 0.0 0.0 0.8 0.3 32.4 21.0 42.7 33.6 26.5 11.9 8.8 22.5 13.6 10.5 GPC3 "DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1" ENSG00000147257 "Glypican 3" P51654 X 133535745-133985895 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 262.7" "Group enriched" "Detected in some" 8 "HAP1: 53.1;Hep G2: 209.8" "Cancer enhanced" "Detected in all" "liver cancer: 269.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 5.0;naive CD8 T-cell: 3.5;NK-cell: 1.7" "Group enriched" "Detected in many" 12 "NK-cells: 1.7;T-cells: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006316 Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA006316: AB_1078994" "unprognostic (2.06e-1)" "unprognostic (2.36e-1)" "unprognostic (9.51e-2)" "unprognostic (4.17e-2)" "unprognostic (1.78e-1)" "unprognostic (1.46e-1)" "unprognostic (6.10e-2)" "unprognostic (1.17e-2)" "unprognostic (2.07e-2)" "unprognostic (3.92e-3)" "unprognostic (6.06e-2)" "unprognostic (1.71e-1)" "unprognostic (3.81e-3)" "prognostic unfavourable (4.83e-4)" "unprognostic (1.43e-1)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" 30.1 5.9 0.4 3.6 0.7 0.0 50.2 0.6 0.4 3.3 4.5 0.5 2.2 0.5 2.5 11.7 2.0 3.4 9.2 8.0 0.4 1.1 21.2 1.1 37.0 1.9 1.6 0.4 6.0 4.6 0.3 16.9 262.7 1.6 3.6 1.0 6.3 3.8 2.3 4.1 5.5 1.8 3.3 2.1 0.9 4.0 2.1 0.3 2.3 7.2 11.2 3.0 7.6 8.0 0.0 0.2 0.0 0.0 1.7 5.0 0.6 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 53.1 0.0 0.0 0.0 2.4 0.0 0.1 209.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 14.5 0.6 1.7 4.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.2 0.0 5.0 3.5 0.0 1.7 0.0 0.0 0.0 0.6 0.4 0.7 0.6 0.4 0.4 1.1 1.6 0.4 1.6 0.3 GPC4 K-glypican ENSG00000076716 "Glypican 4" O75487 X 133300103-133415490 "Plasma proteins, Predicted membrane proteins" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "AF22: 50.7;EFO-21: 17.4;HAP1: 29.1;NTERA-2: 26.6;RPTEC TERT1: 66.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030834, HPA030836" Approved Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" 170000 "Plasma membrane" Nucleoplasm "HPA030834: , HPA030836: AB_10601327" "unprognostic (9.60e-2)" "unprognostic (8.67e-2)" "unprognostic (2.29e-1)" "unprognostic (8.21e-2)" "unprognostic (8.51e-3)" "unprognostic (5.90e-3)" "unprognostic (5.68e-2)" "prognostic favourable (3.51e-4)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (5.87e-3)" "unprognostic (1.30e-1)" "prognostic favourable (1.25e-5)" "unprognostic (1.97e-1)" "unprognostic (2.89e-1)" "unprognostic (2.75e-1)" "unprognostic (2.72e-1)" 39.7 9.9 16.3 10.7 5.3 0.3 6.8 3.7 4.9 14.6 21.6 8.2 3.4 10.0 11.7 16.3 18.6 11.2 23.7 9.6 9.5 5.0 39.6 2.4 25.6 7.1 5.1 6.6 12.4 12.5 9.4 20.4 26.9 9.5 10.3 10.7 9.3 12.2 11.6 20.3 4.3 11.3 16.9 7.9 6.5 19.8 7.2 6.4 5.2 12.4 11.6 2.0 17.1 11.7 0.9 0.6 0.1 0.7 0.0 0.0 0.2 0.0 0.0 50.7 2.0 2.2 0.3 6.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 17.4 0.2 0.0 29.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 26.6 0.7 0.1 4.6 0.0 66.9 1.9 0.0 0.3 0.2 0.0 0.0 0.7 0.7 0.0 5.2 6.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 16.3 5.3 3.7 4.9 9.5 5.0 5.1 6.6 9.5 6.4 GPER1 "CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR" ENSG00000164850 "G protein-coupled estrogen receptor 1" Q99527 7 1082208-1093815 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 9.9;Daudi: 10.4;Hep G2: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 4.3;intermediate monocyte: 4.2;myeloid DC: 8.4" "Group enriched" "Detected in many" 18 "dendritic cells: 8.4;monocytes: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027052 Approved "HPA027052: AB_10612112" "unprognostic (4.74e-2)" "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "prognostic favourable (1.17e-4)" "unprognostic (2.17e-1)" "unprognostic (6.17e-2)" "unprognostic (3.45e-1)" "unprognostic (6.38e-2)" "unprognostic (2.40e-1)" "unprognostic (1.23e-1)" "unprognostic (1.42e-2)" "unprognostic (2.49e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.58e-1)" "unprognostic (7.26e-2)" "unprognostic (7.78e-2)" 14.2 10.9 12.1 3.6 13.2 1.2 11.5 5.1 11.1 6.4 7.1 5.6 3.5 2.0 5.4 1.8 5.5 4.8 3.2 6.0 8.3 6.2 7.4 19.5 25.6 6.4 8.6 8.7 3.3 4.0 1.8 4.7 13.3 6.1 6.8 3.7 5.2 4.2 11.8 8.6 2.8 2.6 5.5 4.1 6.5 23.9 2.2 8.6 1.3 16.5 2.3 2.8 6.4 7.2 0.3 8.4 0.0 4.3 0.0 0.0 1.6 0.9 0.3 0.2 9.9 2.4 2.4 1.0 5.7 3.8 1.8 3.3 0.2 0.2 10.4 0.9 7.1 0.5 0.1 0.0 0.2 2.1 1.8 0.0 1.2 19.0 0.3 0.1 0.6 1.3 0.0 1.1 0.0 0.5 0.1 0.1 0.4 0.6 0.0 0.3 1.9 6.8 0.9 0.0 0.0 0.2 0.0 0.1 3.9 0.0 0.4 2.1 0.2 0.1 1.4 0.4 2.6 6.0 1.8 0.0 0.0 3.6 3.3 0.1 0.2 0.0 4.3 0.0 0.0 4.2 0.0 0.3 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 1.6 12.1 13.2 5.1 11.1 8.3 6.2 8.6 8.7 6.1 8.6 GPI "AMF, NLK" ENSG00000105220 "Glucose-6-phosphate isomerase" P06744 19 34359480-34402413 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Gluconeogenesis, Glycolysis" "Cytokine, Growth factor, Isomerase" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018655, HPA024305, CAB040563, HPA052171" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" 140000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748" "unprognostic (1.03e-1)" "unprognostic (8.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.38e-2)" "unprognostic (4.52e-2)" "unprognostic (6.45e-3)" "unprognostic (1.95e-2)" "unprognostic (8.52e-3)" "unprognostic (3.18e-1)" "unprognostic (1.45e-1)" "unprognostic (4.93e-2)" "unprognostic (2.75e-1)" "unprognostic (3.24e-3)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (2.60e-3)" "unprognostic (2.88e-2)" 62.1 66.6 43.4 27.6 58.2 83.3 34.8 62.6 88.7 20.6 36.6 20.8 23.7 48.2 21.1 20.6 45.3 24.2 33.5 107.2 42.0 45.6 51.3 77.9 19.6 29.6 39.3 64.3 22.5 21.4 66.9 33.7 20.4 50.2 23.7 37.2 36.2 34.6 33.9 144.7 29.4 44.3 34.2 22.8 23.1 26.7 19.7 19.0 23.8 26.1 68.5 32.6 32.5 25.2 16.2 26.3 74.8 40.9 14.5 27.5 24.6 76.1 107.4 9.4 73.5 30.9 23.0 22.5 29.4 23.2 37.1 44.8 60.5 27.0 50.2 43.7 28.8 53.1 56.8 63.9 42.2 55.8 22.9 64.5 51.8 63.6 20.0 83.5 42.0 31.5 26.4 43.9 22.8 34.6 32.8 39.8 26.1 64.6 36.3 29.2 25.4 38.0 34.0 24.9 94.8 46.5 51.3 51.4 29.9 59.3 104.6 21.4 23.7 26.6 29.8 14.0 30.9 39.8 45.3 73.5 41.7 45.5 46.8 63.5 28.4 38.5 22.9 74.8 22.5 35.2 27.5 16.2 20.7 25.5 26.3 13.3 17.5 20.7 1.6 14.5 40.9 8.7 21.6 24.6 43.4 58.2 62.6 88.7 42.0 45.6 39.3 64.3 50.2 19.0 GPM6A GPM6 ENSG00000150625 "Glycoprotein M6A" P51674 4 175632934-176002664 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 249.7" "Group enriched" "Detected in some" 10 "AF22: 26.2;Daudi: 21.8;HAP1: 9.0;U-251 MG: 25.9" "Cancer enriched" "Detected in many" 107 "glioma: 110.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 22.2;naive B-cell: 9.1" "Lineage enriched" "Detected in many" 12 "B-cells: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017338 Supported "HPA017338: AB_1849933" "unprognostic (1.36e-4)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.34e-2)" "unprognostic (9.45e-2)" "unprognostic (1.34e-1)" "unprognostic (3.82e-5)" "unprognostic (2.24e-1)" "unprognostic (9.13e-3)" "unprognostic (1.06e-1)" "unprognostic (3.69e-2)" "unprognostic (7.73e-2)" "unprognostic (2.24e-2)" "unprognostic (3.53e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-3)" "unprognostic (2.60e-3)" 2.4 3.1 81.8 2.0 51.1 1.8 2.5 83.3 249.7 4.1 4.1 15.9 0.0 2.2 4.3 2.7 2.3 4.4 3.1 2.3 54.4 31.2 4.3 6.2 8.8 2.4 23.5 39.4 6.5 2.2 2.0 1.0 1.7 13.1 3.7 3.8 6.3 1.9 4.2 1.8 1.9 2.3 5.5 9.6 6.9 2.0 2.1 17.0 0.0 5.9 0.0 2.0 2.4 0.5 22.2 1.7 0.3 0.1 0.0 0.0 0.4 0.1 0.4 26.2 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.3 21.8 0.1 0.1 0.4 9.0 0.7 0.0 0.1 2.1 0.2 1.7 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.5 0.8 0.3 0.6 0.3 0.1 0.1 0.1 0.0 1.1 0.2 0.2 0.1 0.4 0.1 0.3 0.0 0.1 0.5 0.3 0.3 25.9 0.8 0.0 1.3 0.9 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.1 9.1 0.0 0.0 0.1 0.0 0.1 1.7 0.0 0.4 81.8 51.1 83.3 79.7 54.4 31.2 23.5 39.4 13.1 17.0 GPR1 ENSG00000183671 "G protein-coupled receptor 1" P46091 2 206175316-206218047 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.1" "Group enriched" "Detected in some" 4 "HHSteC: 52.5;hTCEpi: 23.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 10.7;pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010525 Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" "Plasma membrane" "Nucleoplasm, Vesicles" "HPA010525: AB_1078919" "unprognostic (5.32e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (2.25e-2)" "unprognostic (3.27e-5)" "unprognostic (1.36e-1)" "unprognostic (4.00e-3)" "unprognostic (1.49e-2)" "unprognostic (7.89e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-3)" "unprognostic (5.65e-2)" "unprognostic (4.29e-4)" "unprognostic (8.48e-4)" "unprognostic (1.21e-1)" "unprognostic (2.68e-2)" "unprognostic (3.06e-3)" 2.3 5.0 0.5 0.6 10.7 0.1 1.7 0.4 1.2 4.1 0.6 4.8 1.6 0.2 1.3 0.7 6.6 1.1 2.7 3.8 1.6 0.5 0.7 0.0 0.5 3.1 0.2 0.3 3.2 0.1 0.0 0.4 19.1 6.6 0.7 0.6 1.1 1.5 0.4 1.5 6.7 0.5 2.3 0.3 0.2 0.2 1.6 1.0 0.0 0.7 2.2 1.2 3.1 7.7 0.5 0.1 1.4 0.2 0.5 0.2 0.6 0.8 0.1 0.7 0.0 0.1 2.9 0.2 5.4 9.3 3.3 2.8 0.0 0.0 0.0 0.3 2.7 0.1 0.2 0.0 1.1 0.0 0.1 0.0 1.8 0.0 52.5 0.0 0.0 2.1 23.7 4.8 7.7 0.0 0.0 0.0 6.7 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 2.3 1.1 0.0 0.0 0.0 0.0 0.1 4.1 1.8 4.7 0.4 0.0 0.0 0.0 1.4 0.0 0.1 1.3 0.2 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.5 0.2 0.2 1.4 0.5 0.1 0.1 0.2 0.6 0.5 10.7 0.4 1.2 1.6 0.5 0.2 0.3 6.6 1.0 GPR108 LUSTR2 ENSG00000125734 "G protein-coupled receptor 108" Q9NPR9 19 6729914-6737603 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041924, HPA041951, HPA063863" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: " "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "prognostic favourable (1.04e-7)" "unprognostic (1.58e-1)" "unprognostic (5.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (4.23e-2)" "unprognostic (3.01e-2)" "unprognostic (7.89e-2)" "unprognostic (3.57e-2)" "prognostic favourable (1.29e-9)" "unprognostic (8.68e-3)" "unprognostic (2.95e-2)" "unprognostic (4.96e-3)" "unprognostic (4.13e-3)" 17.6 29.7 15.4 13.8 17.9 14.2 20.1 15.2 23.1 22.2 24.3 24.3 27.0 20.4 20.6 20.8 25.1 26.1 23.5 14.0 14.6 12.3 35.4 33.9 19.6 17.1 20.5 12.9 22.6 41.5 30.9 15.1 27.1 17.2 24.0 17.7 31.3 35.4 27.4 10.6 19.1 29.2 16.9 15.7 20.9 20.6 26.3 19.4 17.2 38.8 14.7 23.1 21.4 19.8 14.8 25.8 54.3 36.3 23.1 26.7 35.5 11.5 12.6 7.8 15.2 30.6 16.6 8.8 9.0 27.4 12.5 13.4 7.7 13.3 5.5 16.8 18.4 9.9 8.8 18.8 6.5 22.1 10.1 8.9 13.3 10.2 30.1 5.7 12.2 18.0 36.0 12.1 24.5 14.7 8.9 36.9 12.6 8.0 10.0 8.3 5.6 11.2 8.2 8.9 20.8 26.1 11.4 0.0 8.5 9.1 14.9 13.8 14.3 13.9 12.1 7.2 4.6 22.8 9.5 23.9 12.9 3.8 24.7 18.4 7.7 20.4 35.8 35.7 26.7 32.7 24.3 14.8 21.4 22.5 25.8 14.1 15.5 17.7 54.3 23.1 36.3 9.2 23.4 35.5 15.4 17.9 15.2 23.1 14.6 12.3 20.5 12.9 17.2 19.4 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: " "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavourable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favourable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 10.3 12.2 18.6 12.8 21.8 10.4 12.0 20.0 23.1 8.9 10.5 13.2 13.8 11.2 9.0 10.4 10.5 13.3 10.3 9.7 18.5 14.3 14.0 14.1 9.3 10.8 15.4 9.1 7.3 9.4 16.4 10.1 28.9 16.5 10.5 5.8 12.4 13.9 12.8 9.9 15.9 11.4 7.1 12.7 11.3 13.6 64.8 14.4 9.9 14.3 5.5 9.3 9.5 16.2 3.9 3.4 15.7 3.0 1.9 3.4 1.4 8.9 20.0 6.9 20.0 13.5 7.2 29.3 10.7 9.0 10.7 6.9 14.7 12.6 9.2 18.6 6.7 18.0 9.6 5.9 3.1 29.1 12.1 8.7 20.5 9.4 7.7 5.8 17.0 9.0 9.4 9.3 7.1 5.7 7.8 22.5 6.4 22.7 6.5 15.6 9.4 20.0 13.0 7.4 14.9 7.4 12.2 11.0 13.4 13.0 17.7 11.5 19.4 2.4 9.2 29.6 20.5 22.3 7.7 18.0 33.1 7.7 21.2 4.9 18.0 1.7 3.0 5.3 2.7 2.8 3.4 2.8 2.3 2.0 3.1 3.9 2.6 2.2 15.7 1.9 2.3 3.4 1.6 1.4 18.6 21.8 20.0 23.1 18.5 14.3 15.4 9.1 16.5 14.4 GPR157 FLJ12132 ENSG00000180758 "G protein-coupled receptor 157" Q5UAW9 1 9100305-9129170 "G-protein coupled receptors, Predicted membrane proteins" Differentiation "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.2" "Cell line enhanced" "Detected in many" "Karpas-707: 16.9;SK-BR-3: 33.2;U-266/70: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028697 Uncertain Uncertain "Nucleoli,Plasma membrane,Cell Junctions" Nucleoli "Plasma membrane, Cell Junctions" "HPA028697: AB_10601810" "unprognostic (2.83e-3)" "unprognostic (1.13e-2)" "unprognostic (5.91e-2)" "unprognostic (5.42e-2)" "unprognostic (2.13e-4)" "unprognostic (7.11e-2)" "unprognostic (7.52e-3)" "unprognostic (3.60e-2)" "unprognostic (9.20e-2)" "unprognostic (1.26e-1)" "unprognostic (9.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.02e-2)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-3)" 3.5 3.1 0.3 3.7 0.6 0.5 3.5 0.5 0.4 6.2 2.8 0.9 3.9 2.2 2.1 2.1 23.4 2.1 6.9 10.7 0.8 0.4 2.9 6.9 5.5 3.1 0.3 0.1 4.5 4.3 9.8 1.2 19.0 1.4 2.9 1.2 5.2 14.7 7.1 32.2 14.2 3.3 4.0 0.4 2.4 2.2 2.1 0.8 3.6 4.8 25.2 16.2 4.4 8.3 2.4 1.1 4.6 1.5 1.2 2.6 0.7 4.6 2.6 0.8 2.1 0.7 0.7 4.3 1.4 0.9 1.2 1.6 2.1 1.8 0.6 1.8 1.5 9.9 2.4 0.9 1.8 12.8 3.9 0.0 7.7 3.1 2.6 0.0 1.0 0.7 2.0 2.1 1.3 0.9 0.7 16.9 0.5 3.4 1.9 0.9 0.9 3.3 0.3 0.7 2.2 0.8 3.1 1.2 3.2 5.7 33.2 2.8 4.7 0.5 7.0 4.2 1.1 10.9 0.6 16.3 2.6 0.0 3.1 6.6 1.7 1.9 1.5 0.4 2.6 1.2 2.0 1.5 1.9 2.3 0.8 2.4 1.9 2.2 4.6 1.2 0.6 1.1 0.8 0.7 0.3 0.6 0.5 0.4 0.8 0.4 0.3 0.1 1.4 0.8 GPR162 "A-2, GRCA" ENSG00000250510 "G protein-coupled receptor 162" Q16538 12 6821545-6829972 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.6" "Cell line enhanced" "Detected in many" "AF22: 13.3;AN3-CA: 15.8;NTERA-2: 14.9;SH-SY5Y: 10.2;U-2 OS: 12.6" "Cancer enriched" "Detected in many" 6 "glioma: 16.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.3;intermediate monocyte: 3.7;neutrophil: 14.7" "Group enriched" "Detected in many" 6 "granulocytes: 14.7;monocytes: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055135 Enhanced Approved "Centriolar satellite" "Intracellular and membrane" "Centriolar satellite" "HPA055135: " "unprognostic (4.76e-2)" "unprognostic (8.00e-2)" "unprognostic (8.24e-3)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (2.38e-1)" "unprognostic (4.78e-2)" "unprognostic (2.25e-2)" "unprognostic (5.83e-3)" "unprognostic (1.18e-1)" "prognostic favourable (4.29e-5)" "unprognostic (3.82e-3)" "prognostic unfavourable (1.37e-6)" "unprognostic (3.10e-3)" "unprognostic (1.77e-1)" "unprognostic (3.22e-1)" "unprognostic (3.64e-2)" 2.7 6.7 19.6 4.2 13.2 1.5 2.4 41.3 47.6 2.1 3.4 4.7 0.8 3.1 3.8 2.8 1.9 16.9 5.7 4.2 25.9 18.4 1.4 3.7 6.0 1.7 9.9 17.7 2.0 1.7 5.3 8.4 4.3 10.2 2.1 3.0 3.6 1.3 2.1 1.6 1.7 4.2 5.7 5.3 2.8 2.0 1.2 3.6 0.1 1.1 0.0 1.1 2.4 0.5 0.0 1.8 14.7 6.3 0.0 0.0 1.7 0.0 3.0 13.3 15.8 1.5 1.0 0.0 1.0 3.5 3.0 1.8 0.3 0.0 0.0 0.1 1.9 0.1 2.1 0.0 1.5 0.0 0.9 1.5 0.1 0.0 2.3 0.3 0.0 2.4 0.0 4.6 0.2 8.1 0.7 0.1 1.1 0.0 0.4 1.1 14.9 0.1 0.0 1.7 2.7 1.0 0.0 1.1 10.2 0.0 0.0 0.4 0.1 3.9 5.4 2.1 12.6 1.1 1.8 0.0 0.9 0.0 2.2 2.7 0.2 0.0 6.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 14.7 0.0 1.3 1.6 0.0 1.7 19.6 13.2 41.3 32.4 25.9 18.4 9.9 17.7 10.2 3.6 GPR173 SREB3 ENSG00000184194 "G protein-coupled receptor 173" Q9NS66 X 53049091-53080615 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2" "Cell line enhanced" "Detected in many" "HAP1: 10.3" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003905 Approved "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "HPA003905: AB_1078922" "unprognostic (2.68e-1)" "unprognostic (2.33e-1)" "unprognostic (4.95e-3)" "prognostic unfavourable (2.88e-6)" "unprognostic (3.87e-2)" "unprognostic (8.58e-2)" "unprognostic (2.73e-1)" "unprognostic (1.47e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-2)" "prognostic favourable (2.33e-5)" "unprognostic (1.03e-1)" "prognostic unfavourable (2.47e-4)" "unprognostic (1.08e-4)" "unprognostic (2.83e-1)" "unprognostic (3.92e-2)" "unprognostic (6.95e-2)" 2.5 5.2 8.2 3.0 9.4 2.2 3.1 15.4 23.2 4.2 2.8 11.6 0.8 1.8 6.4 5.0 2.4 7.7 3.3 4.2 7.9 10.0 2.4 1.1 2.8 2.1 7.3 11.2 15.0 1.3 1.3 14.6 4.5 9.7 3.2 2.6 6.4 2.0 5.4 4.6 3.9 2.1 4.5 6.5 4.0 2.1 2.4 9.6 0.7 3.1 0.1 1.5 3.3 2.8 0.9 0.7 5.7 0.4 1.8 0.7 0.0 0.0 0.0 8.2 0.5 4.7 2.8 0.0 1.3 3.0 2.2 2.6 0.8 0.1 0.2 2.0 2.8 0.7 10.3 0.0 1.9 0.6 1.0 0.5 8.4 0.3 6.8 0.5 0.1 6.6 0.0 3.3 4.7 3.5 0.0 5.7 3.2 4.2 0.0 0.0 6.3 3.6 0.1 2.5 0.3 0.5 0.4 5.9 8.3 0.0 0.4 0.0 1.1 0.1 6.5 3.6 5.2 2.3 1.1 0.2 0.3 0.7 2.5 0.0 2.0 5.7 0.2 0.3 0.7 0.1 0.5 0.3 0.2 0.1 0.1 0.9 0.5 0.4 1.2 1.8 0.4 0.7 0.0 0.0 8.2 9.4 15.4 15.1 7.9 10.0 7.3 11.2 9.7 9.6 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell line enhanced" "Detected in many" "EFO-21: 38.4;HHSteC: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavourable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favourable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.3 12.3 2.2 12.7 0.8 2.2 0.1 3.1 1.2 0.8 11.3 0.4 0.0 38.4 0.4 0.6 9.0 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.2 0.0 0.0 1.1 0.0 2.1 0.0 6.0 2.5 0.2 2.8 0.6 0.0 0.0 13.4 5.8 3.5 0.0 0.0 0.4 5.7 9.5 0.8 1.4 0.8 11.0 0.0 0.2 1.1 0.0 1.4 6.0 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 GPRC5C RAIG-3 ENSG00000170412 "G protein-coupled receptor class C group 5 member C" Q9NQ84 17 74424851-74451653 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 76.2" "Cell line enhanced" "Detected in many" "Hep G2: 23.9;HMC-1: 42.1;RPTEC TERT1: 56.7;RT4: 26.2;T-47d: 31.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 31.1" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 10.2" "Group enriched" "Detected in many" 9 "dendritic cells: 10.2;monocytes: 4.7" "Region enriched" "Detected in many" 9 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA029776 Enhanced Uncertain "Nucleoplasm,Centriolar satellite,Cytosol" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA029776: AB_10602324" "unprognostic (1.48e-1)" "unprognostic (3.35e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-3)" "unprognostic (1.80e-2)" "unprognostic (1.09e-2)" "unprognostic (4.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (9.61e-3)" "unprognostic (1.05e-1)" "prognostic favourable (1.58e-5)" "unprognostic (7.58e-2)" "unprognostic (3.70e-2)" "unprognostic (2.75e-2)" "unprognostic (1.54e-3)" 4.3 4.1 5.2 2.2 5.3 0.0 7.7 31.1 5.7 19.7 15.4 4.4 17.0 10.0 5.8 9.9 5.3 12.5 17.6 7.7 5.3 2.6 43.8 46.1 11.5 2.8 4.8 4.9 12.3 76.2 12.0 3.4 4.5 6.1 15.1 6.2 18.0 16.8 11.7 25.4 9.2 15.2 3.9 4.6 5.1 44.7 4.4 4.1 1.9 42.2 10.2 3.5 12.6 8.0 0.7 10.2 0.1 4.7 0.0 0.1 0.3 4.6 16.6 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 21.4 0.0 13.2 0.1 14.7 2.2 0.3 0.0 0.0 2.7 0.0 1.2 23.9 4.9 0.0 42.1 0.4 7.6 0.0 0.0 0.0 1.2 0.3 0.0 5.2 0.1 4.5 2.7 19.4 0.0 0.0 1.0 56.7 26.2 8.0 0.7 0.8 1.8 0.0 31.9 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 2.0 0.6 0.1 0.0 1.7 0.1 0.0 3.4 0.0 0.7 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 4.7 10.2 0.0 0.3 5.2 5.3 31.1 5.7 5.3 2.6 4.8 4.9 6.1 4.1 GPSM2 "DFNB82, LGN, Pins" ENSG00000121957 "G protein signaling modulator 2" P81274 1 108875350-108934545 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 35.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007327, HPA008408, CAB018962" Uncertain Supported Cytosol Cytosol "CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939" "unprognostic (1.97e-1)" "unprognostic (6.80e-2)" "prognostic favourable (7.86e-5)" "unprognostic (1.37e-3)" "unprognostic (3.18e-2)" "unprognostic (1.97e-2)" "unprognostic (8.57e-6)" "unprognostic (7.12e-2)" "unprognostic (2.76e-2)" "unprognostic (3.92e-2)" "prognostic unfavourable (5.89e-4)" "unprognostic (7.55e-3)" "prognostic unfavourable (3.02e-4)" "unprognostic (6.27e-3)" "unprognostic (1.00e-1)" "unprognostic (5.14e-3)" "unprognostic (6.00e-2)" 3.8 4.0 16.6 4.4 17.9 13.9 8.5 10.1 20.6 7.5 13.6 17.9 2.5 8.0 6.9 4.3 30.4 2.9 3.1 3.0 15.2 14.1 2.6 1.9 6.6 5.8 19.7 9.0 2.4 2.4 4.0 2.1 7.6 19.6 6.3 15.4 1.3 7.0 5.7 8.0 35.6 10.1 10.6 25.1 2.0 5.3 11.4 18.8 14.1 2.3 23.5 12.1 6.5 10.6 1.8 1.6 8.6 1.2 0.7 4.4 0.4 40.7 5.9 13.4 10.6 13.5 8.1 10.1 8.2 20.8 10.2 15.7 6.3 10.5 9.3 2.2 11.4 8.9 8.6 21.5 13.1 9.6 5.8 6.9 11.4 6.9 1.8 9.2 6.3 1.5 44.0 11.0 43.9 10.8 5.2 14.1 21.8 12.7 7.3 4.7 3.4 9.9 6.5 21.7 2.5 8.8 6.4 10.2 8.9 11.2 22.9 8.6 9.0 8.9 6.7 7.8 12.3 20.8 15.4 6.3 5.8 9.2 12.5 15.3 36.2 0.1 1.2 8.6 0.8 0.9 0.5 0.7 0.6 1.1 1.6 1.8 1.1 0.8 1.6 0.7 0.4 0.7 4.4 0.4 16.6 17.9 10.1 13.6 15.2 14.1 19.7 9.0 19.6 18.8 GRAMD1A "FLJ90346, KIAA1533" ENSG00000089351 "GRAM domain containing 1A" Q96CP6 19 34994784-35026471 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008852, HPA012570" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA008852: AB_1079203, HPA012570: AB_2112577" "unprognostic (3.09e-2)" "unprognostic (4.62e-2)" "unprognostic (8.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.05e-1)" "unprognostic (2.87e-1)" "unprognostic (3.42e-3)" "unprognostic (5.96e-2)" "unprognostic (4.54e-1)" "unprognostic (5.70e-2)" "unprognostic (1.07e-2)" "unprognostic (2.91e-1)" "prognostic unfavourable (7.95e-12)" "unprognostic (2.04e-1)" "unprognostic (4.40e-1)" "unprognostic (2.90e-2)" "unprognostic (4.36e-2)" 15.6 19.1 14.6 21.4 14.0 17.1 19.4 13.8 18.1 16.8 13.2 10.4 17.4 13.0 16.9 12.9 7.8 17.2 13.8 17.2 15.9 12.0 13.3 11.0 27.5 42.0 13.7 12.2 21.8 44.1 11.5 14.9 14.1 16.6 15.6 7.5 11.5 45.3 17.2 35.7 6.8 10.9 21.3 12.8 21.1 16.1 11.7 12.1 17.9 12.7 11.5 12.1 17.3 21.4 1.1 4.1 13.1 14.9 3.8 5.5 2.5 5.4 42.3 8.3 16.4 9.7 11.1 6.9 6.6 10.9 8.9 8.8 16.0 4.7 3.1 13.2 9.9 3.6 8.6 13.0 3.4 13.1 15.0 9.1 10.5 14.7 19.5 6.4 14.5 19.6 8.1 6.3 10.8 28.8 9.9 2.1 6.1 5.2 14.6 7.9 13.0 4.7 13.9 2.6 3.8 9.5 1.0 12.5 25.2 6.7 5.1 10.9 7.7 7.1 15.6 14.3 7.4 2.9 9.4 2.3 7.8 7.5 9.4 7.1 10.5 13.1 4.5 3.6 2.9 7.3 5.5 0.5 3.9 2.1 4.1 1.1 2.9 4.2 9.8 3.8 14.9 1.4 3.1 2.5 14.6 14.0 13.8 18.1 15.9 12.0 13.7 12.2 16.6 12.1 GRAMD1B "KIAA1201, LINC01059" ENSG00000023171 "GRAM domain containing 1B" Q3KR37 11 123358428-123627774 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.7;brain: 55.2;intestine: 21.7" "Group enriched" "Detected in many" 4 "A549: 21.8;HDLM-2: 57.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008557 Approved Approved "Nucleoplasm,Nucleoli,Intermediate filaments" Nucleoli "Nucleoplasm, Intermediate filaments" "HPA008557: AB_1079197" "unprognostic (1.86e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.74e-3)" "unprognostic (8.15e-2)" "unprognostic (4.28e-2)" "unprognostic (2.69e-3)" "unprognostic (4.12e-3)" "unprognostic (1.40e-1)" "unprognostic (2.90e-2)" "unprognostic (9.60e-2)" "unprognostic (8.06e-2)" "prognostic unfavourable (4.30e-7)" "unprognostic (1.39e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" 1.4 67.7 15.5 3.1 16.0 11.8 1.1 55.2 25.0 1.2 3.1 5.1 5.9 21.7 1.2 6.6 0.9 2.9 8.1 4.3 13.6 7.5 10.4 1.3 1.9 3.6 6.8 15.1 7.6 2.0 0.6 6.7 5.0 14.4 1.1 1.2 11.9 1.3 2.5 1.8 0.8 15.6 1.3 4.1 2.7 7.8 10.6 5.1 3.4 3.7 0.0 2.7 1.5 0.8 0.1 11.5 0.6 2.0 2.6 2.7 0.7 0.0 21.8 1.2 0.0 0.1 0.2 3.6 7.2 5.2 1.6 0.6 0.9 0.1 1.3 3.8 3.6 0.0 2.3 0.0 1.7 57.6 2.0 0.0 9.8 0.2 0.0 7.5 0.0 0.4 0.0 2.8 0.0 0.6 0.0 0.0 1.3 0.1 1.2 2.5 2.8 8.2 3.9 3.5 2.3 0.1 0.0 7.2 5.9 1.7 0.1 0.0 0.2 4.2 4.3 8.7 1.4 1.5 0.3 0.0 0.0 0.0 1.8 7.9 0.4 0.0 2.0 0.6 0.7 1.0 0.4 0.0 2.7 2.1 3.0 0.1 0.3 0.3 0.2 2.6 1.0 11.5 1.1 0.7 15.5 16.0 55.2 25.0 13.6 7.5 6.8 15.1 14.4 5.1 GRAMD1C DKFZp434C0328 ENSG00000178075 "GRAM domain containing 1C" Q8IYS0 3 113828182-113947174 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4;HUVEC TERT2: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 5.1;naive B-cell: 4.1;neutrophil: 4.0" "Group enriched" "Detected in many" 11 "B-cells: 5.1;granulocytes: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012316 Approved Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA012316: AB_1849949" "unprognostic (2.73e-3)" "unprognostic (6.16e-3)" "unprognostic (3.27e-1)" "unprognostic (1.93e-1)" "unprognostic (5.50e-2)" "unprognostic (9.81e-3)" "unprognostic (1.43e-3)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (5.49e-2)" "prognostic favourable (4.22e-15)" "unprognostic (8.48e-2)" "unprognostic (9.96e-2)" "unprognostic (3.61e-2)" "unprognostic (2.09e-2)" 1.7 2.6 12.6 2.5 13.0 0.5 9.1 5.0 13.4 3.4 8.0 2.6 0.5 7.6 5.2 5.1 6.0 10.3 2.9 1.5 13.6 7.6 23.3 26.5 5.0 2.0 9.4 8.1 1.1 12.5 11.8 24.1 6.2 9.2 2.9 4.2 4.5 10.8 2.8 1.1 12.0 24.5 1.0 8.2 1.7 8.6 14.5 9.3 0.0 6.9 1.6 3.7 3.8 3.8 5.1 0.1 4.0 0.0 0.3 0.4 0.1 1.5 0.0 4.1 3.2 0.8 2.1 5.9 3.7 3.3 0.7 2.2 0.0 14.4 0.4 1.1 1.9 1.6 0.7 1.6 1.7 1.9 0.6 0.3 0.1 0.0 1.6 0.2 0.1 3.3 1.1 0.6 0.1 11.2 0.0 0.2 1.1 0.4 1.6 0.2 0.3 0.5 0.0 0.8 2.5 4.5 2.0 0.8 1.0 1.0 5.9 3.0 4.1 0.0 2.3 1.5 2.9 0.0 0.3 2.2 1.3 1.8 2.4 0.1 1.7 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.3 0.4 0.1 4.1 0.3 0.4 4.0 0.3 0.0 0.1 0.0 0.1 12.6 13.0 5.0 13.4 13.6 7.6 9.4 8.1 9.2 9.3 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159807-72197785 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 24.6;placenta: 49.2" "Group enriched" "Detected in some" 12 "BEWO: 58.1;SK-BR-3: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "myeloid DC: 2.3" "Lineage enriched" "Detected in single" 7 "dendritic cells: 2.3" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavourable (7.01e-4)" "unprognostic (7.29e-2)" 0.1 0.0 2.0 0.2 4.5 0.0 6.8 1.1 1.0 3.1 0.7 1.2 9.8 0.6 0.4 24.6 1.0 8.2 0.8 0.1 2.9 6.5 1.9 0.1 9.7 0.2 1.1 0.1 1.1 1.0 0.2 0.9 49.2 3.9 1.2 0.5 1.0 1.8 4.0 0.3 1.5 3.6 0.1 1.0 0.1 0.4 0.7 0.9 0.2 7.7 1.3 1.1 0.3 0.6 0.0 2.3 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 26.5 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.5 1.1 1.0 2.9 6.5 1.1 0.1 3.9 0.9 GRAMD2B "FLJ21313, GRAMD3, NS3TP2" ENSG00000155324 "GRAM domain containing 2B" Q96HH9 5 126360132-126496494 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 38.8;CAPAN-2: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.6;MAIT T-cell: 4.8;memory CD4 T-cell: 2.6;memory CD8 T-cell: 3.9;myeloid DC: 2.5;naive CD4 T-cell: 5.1;naive CD8 T-cell: 3.1;NK-cell: 1.7;plasmacytoid DC: 6.5;T-reg: 3.8" "Group enriched" "Detected in many" 6 "dendritic cells: 6.5;NK-cells: 1.7;T-cells: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009678, HPA010095" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Cytosol "Nucleoplasm, Golgi apparatus" "HPA009678: AB_2112580, HPA010095: AB_1849952" "unprognostic (2.34e-1)" "unprognostic (4.01e-1)" "unprognostic (4.63e-2)" "unprognostic (3.42e-2)" "unprognostic (6.82e-2)" "unprognostic (1.95e-2)" "unprognostic (6.76e-2)" "unprognostic (3.84e-2)" "unprognostic (9.90e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-2)" "unprognostic (3.78e-1)" "unprognostic (2.20e-3)" "unprognostic (3.56e-3)" "unprognostic (2.39e-1)" "unprognostic (9.24e-2)" "unprognostic (1.12e-2)" 8.3 12.0 30.8 5.2 31.6 1.3 29.5 10.2 25.3 27.5 21.8 38.7 9.7 22.5 24.0 11.9 7.7 26.8 8.7 9.2 38.8 15.9 25.9 18.0 7.8 5.1 21.8 28.3 21.1 6.8 9.0 7.2 44.3 26.4 14.2 23.4 14.9 15.5 20.9 2.8 17.5 26.1 17.6 29.7 4.3 12.9 3.3 31.8 3.6 35.6 3.7 8.6 11.6 11.1 0.8 6.5 0.5 0.7 1.7 5.1 2.1 21.1 1.2 1.0 4.7 21.3 7.4 6.4 22.1 38.8 10.5 14.3 1.0 26.0 0.0 9.5 24.8 5.4 0.3 8.9 11.2 1.8 1.5 1.0 2.4 1.3 5.0 0.0 0.7 12.4 4.0 9.6 3.2 0.0 0.0 0.0 18.2 2.1 0.0 0.3 1.1 1.5 0.4 6.3 5.0 14.1 23.4 0.4 0.0 4.0 2.3 6.9 8.0 1.3 1.8 2.1 0.7 3.8 4.1 1.4 1.1 0.0 0.4 0.0 6.3 0.5 0.5 0.0 4.6 0.7 4.8 0.8 2.6 3.9 2.5 0.4 5.1 3.1 0.5 1.7 0.5 6.5 3.8 2.1 30.8 31.6 10.2 25.3 38.8 15.9 21.8 28.3 26.4 31.8 GREB1 KIAA0575 ENSG00000196208 "Growth regulation by estrogen in breast cancer 1" Q4ZG55 2 11482341-11642788 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 74.9" "Cell line enhanced" "Detected in some" "AF22: 14.8;Hep G2: 14.0;MCF7: 21.9;SH-SY5Y: 14.9;T-47d: 50.6" "Cancer enhanced" "Detected in many" "prostate cancer: 17.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA024616, HPA027843, HPA028416" Uncertain Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344" "unprognostic (1.52e-2)" "unprognostic (4.63e-1)" "unprognostic (1.46e-1)" "prognostic favourable (1.05e-4)" "unprognostic (1.23e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-2)" "unprognostic (1.38e-1)" "unprognostic (3.68e-1)" "unprognostic (3.63e-2)" "unprognostic (7.51e-4)" "unprognostic (2.42e-2)" "unprognostic (3.34e-1)" "unprognostic (2.46e-3)" "unprognostic (4.80e-2)" 1.2 2.0 3.0 0.6 5.0 0.5 11.1 1.3 5.4 13.7 0.5 2.8 3.0 0.7 21.3 15.6 0.6 11.2 1.8 2.3 3.9 3.0 1.3 1.5 0.6 0.6 3.9 3.5 74.9 2.9 0.6 5.0 9.4 3.8 19.2 0.5 2.8 0.7 2.4 2.1 1.2 0.6 7.3 3.2 0.4 0.8 10.9 3.2 0.0 0.5 0.5 0.5 0.8 5.7 0.8 1.0 2.8 0.6 1.0 1.3 0.4 0.0 0.3 14.8 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.1 0.0 0.1 1.1 0.0 0.0 1.7 1.3 0.0 0.1 14.0 0.1 0.1 0.7 0.2 0.8 0.2 0.1 0.0 0.1 0.3 0.1 21.9 0.4 0.7 4.8 0.0 10.2 0.0 0.6 0.0 0.0 4.3 14.9 0.3 0.4 10.9 50.6 0.2 0.0 1.5 0.7 0.1 0.0 2.2 1.5 8.6 2.5 4.2 0.4 2.6 0.6 0.8 0.7 0.3 0.3 0.5 0.5 0.4 0.4 0.8 0.5 1.3 2.8 1.0 0.5 1.0 0.5 0.4 3.0 5.0 1.3 5.4 3.9 3.0 3.9 3.5 3.8 3.2 GRIA2 "GluA2, GLUR2, GLURB" ENSG00000120251 "Glutamate ionotropic receptor AMPA type subunit 2" P42262 4 157204182-157366075 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.9" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 19.4" "Group enriched" "Detected in some" 10 "breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008441 Enhanced "HPA008441: AB_1078983" "unprognostic (1.36e-1)" "unprognostic (9.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (3.87e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-3)" "unprognostic (7.40e-2)" "unprognostic (2.91e-5)" "unprognostic (2.42e-1)" "unprognostic (1.31e-1)" "unprognostic (1.82e-1)" "unprognostic (6.55e-2)" 1.2 6.5 36.9 1.3 39.1 1.1 2.0 22.1 95.9 8.2 1.3 5.6 0.0 1.2 13.5 9.8 1.2 9.6 1.2 1.2 30.1 15.7 1.5 1.1 1.4 1.2 10.0 30.6 1.7 2.2 1.2 10.5 1.2 7.1 1.8 1.2 0.1 2.1 3.0 1.2 1.1 1.2 6.1 6.9 1.3 1.5 2.1 8.8 0.0 1.2 0.0 1.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.4 2.7 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.1 0.0 0.0 0.6 0.0 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 39.1 22.1 41.2 30.1 15.7 10.0 30.6 7.1 8.8 GRID2 "GluD2, GluR-delta-2" ENSG00000152208 "Glutamate ionotropic receptor delta type subunit 2" O43424 4 92303622-93810157 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 45.1;testis: 38.2" "Group enriched" "Detected in some" 4 "U-2 OS: 12.6;U-266/70: 5.6" "Cancer enriched" "Detected in single" 7 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 130.6" "HPA056253, HPA058538" Enhanced "HPA056253: , HPA058538: " "unprognostic (2.78e-1)" "unprognostic (1.29e-4)" "unprognostic (7.23e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (3.50e-2)" "unprognostic (3.34e-1)" "unprognostic (6.92e-2)" "unprognostic (7.96e-3)" "unprognostic (4.36e-2)" "unprognostic (9.31e-2)" "unprognostic (7.38e-3)" 0.6 3.5 8.0 0.6 13.6 0.6 0.6 45.1 7.0 1.1 0.7 2.8 0.0 0.8 0.7 0.9 0.6 0.9 0.6 0.7 6.2 3.4 0.8 0.6 0.7 0.6 7.6 6.4 3.7 0.6 0.6 0.3 0.6 7.2 0.6 0.7 0.6 0.6 0.9 0.6 0.6 0.8 0.6 9.0 0.7 0.6 38.2 7.9 0.0 0.7 0.0 0.6 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 5.6 0.0 0.6 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 13.6 45.1 7.0 6.2 3.4 7.6 6.4 7.2 7.9 GRIK2 "GluK2, GLUR6, MRT6" ENSG00000164418 "Glutamate ionotropic receptor kainate type subunit 2" Q13002 6 101398788-102070083 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6" "Cell line enhanced" "Detected in some" "BJ: 11.4;BJ hTERT+: 19.0;fHDF/TERT166: 14.2;SiHa: 7.7;WM-115: 17.4" "Cancer enhanced" "Detected in some" "glioma: 3.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014395, HPA014623, CAB022463" Approved "Intracellular and membrane" "CAB022463: , HPA014395: AB_1850303, HPA014623: AB_1850305" "unprognostic (1.43e-3)" "unprognostic (1.26e-2)" "unprognostic (3.99e-2)" "unprognostic (3.20e-1)" "unprognostic (1.92e-1)" "unprognostic (3.48e-2)" "unprognostic (2.57e-1)" "unprognostic (4.32e-2)" "unprognostic (8.46e-2)" "unprognostic (9.19e-2)" "unprognostic (4.01e-2)" "unprognostic (1.36e-1)" "unprognostic (1.34e-5)" "unprognostic (1.94e-3)" "unprognostic (7.78e-2)" "unprognostic (1.09e-2)" "unprognostic (8.68e-4)" 0.8 3.9 16.1 1.1 22.5 1.0 0.8 40.6 22.8 3.1 1.2 1.6 0.0 1.4 1.2 2.5 1.2 0.9 1.5 7.6 9.1 11.4 1.9 0.6 0.7 0.6 4.1 17.0 1.1 5.2 0.5 13.0 4.3 8.5 2.1 1.2 0.4 2.0 2.6 1.8 3.8 1.5 0.9 2.7 1.1 0.8 1.8 5.3 0.0 6.3 0.0 0.4 1.1 0.9 1.4 1.2 2.7 0.7 1.2 0.9 0.4 0.0 0.1 2.4 0.2 2.6 0.1 0.0 11.4 19.0 0.6 0.4 0.0 0.2 0.1 0.0 14.2 3.9 7.4 0.0 0.2 0.0 0.0 1.2 6.5 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.3 4.2 0.0 0.0 0.1 2.1 0.1 0.0 0.3 0.0 0.5 0.0 2.5 5.0 7.7 0.0 0.4 0.0 0.7 0.0 1.6 0.3 0.1 0.9 0.0 0.0 0.0 1.1 0.0 17.4 2.5 0.7 0.7 0.6 0.7 0.4 0.7 0.6 0.4 0.2 1.4 0.8 0.9 2.7 1.2 0.7 1.2 0.3 0.4 16.1 22.5 40.6 21.9 9.1 11.4 4.1 17.0 8.5 5.3 GSG1L "KTSR5831, MGC18079, PRO19651" ENSG00000169181 "GSG1 like" Q6UXU4 16 27787535-28063509 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.6;heart muscle: 19.3" "Group enriched" "Detected in some" 7 "HMC-1: 13.3;THP-1: 4.9" "Cancer enriched" "Detected in some" 7 "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014479 Enhanced "HPA014479: AB_2247974" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (2.38e-1)" "unprognostic (7.06e-4)" "unprognostic (2.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.05e-2)" "unprognostic (6.68e-2)" "unprognostic (5.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.50e-1)" "unprognostic (6.66e-2)" "unprognostic (1.55e-1)" "unprognostic (3.13e-1)" "unprognostic (6.35e-2)" "unprognostic (9.77e-2)" 0.7 0.8 8.7 0.6 14.6 0.7 0.6 1.8 13.3 0.8 1.1 2.7 0.0 1.1 1.1 1.0 0.6 3.4 0.5 19.3 6.0 6.8 1.1 1.1 0.9 0.6 10.0 3.3 0.4 0.7 0.4 0.2 2.0 6.5 0.8 0.7 1.2 0.8 0.6 1.0 1.8 1.2 0.5 3.5 0.9 2.5 2.2 3.3 0.0 1.0 0.0 0.5 0.5 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.3 0.0 0.3 0.2 0.2 0.2 0.3 0.3 0.1 0.0 0.0 13.3 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.5 0.8 0.1 0.3 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.1 0.6 0.1 4.9 1.2 0.0 0.8 0.0 0.2 1.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 8.7 14.6 1.8 10.7 6.0 6.8 10.0 3.3 6.5 3.3 GSTCD FLJ13273 ENSG00000138780 "Glutathione S-transferase C-terminal domain containing" Q8NEC7 4 105708778-105847728 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 11.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046160, HPA061782" Approved Supported Nucleoplasm Nucleoplasm "HPA046160: AB_10961048, HPA061782: " "unprognostic (4.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.06e-3)" "unprognostic (4.44e-3)" "unprognostic (6.44e-2)" "unprognostic (6.43e-2)" "unprognostic (1.84e-3)" "unprognostic (4.30e-2)" "unprognostic (2.43e-1)" "unprognostic (1.53e-1)" "unprognostic (1.38e-2)" "unprognostic (5.46e-2)" "unprognostic (8.67e-2)" "unprognostic (8.59e-2)" "unprognostic (2.68e-1)" "unprognostic (1.32e-2)" "unprognostic (7.02e-2)" 6.5 6.1 7.6 7.2 10.1 9.3 11.2 11.0 9.7 8.2 7.3 8.4 5.7 5.2 9.3 10.0 10.0 8.8 7.7 5.6 7.4 7.8 10.3 5.7 6.3 9.4 7.5 6.5 7.2 6.3 7.6 13.1 7.2 10.0 8.2 8.3 14.4 7.4 7.6 5.6 6.9 5.9 8.4 10.5 6.9 6.6 20.5 6.4 15.1 10.7 5.4 9.8 7.1 7.1 2.0 1.9 11.4 1.9 1.9 2.2 0.9 7.6 7.0 15.9 13.8 4.1 5.4 12.0 10.8 5.6 13.5 12.2 6.4 14.8 9.2 5.6 4.6 6.4 18.1 11.4 19.0 13.7 5.4 7.7 6.7 8.7 1.8 14.1 5.3 2.9 5.8 12.2 9.5 8.2 14.8 8.4 11.3 6.3 14.7 5.3 8.7 8.8 10.2 9.4 5.2 14.7 5.6 13.0 5.8 8.4 12.0 4.6 10.8 5.7 6.1 10.0 10.5 6.2 8.4 3.1 6.7 5.2 6.2 7.3 13.6 0.9 1.4 0.6 1.3 1.7 1.5 1.5 1.2 0.4 1.4 2.0 1.4 2.2 11.4 1.9 1.9 1.9 0.2 0.9 7.6 10.1 11.0 9.7 7.4 7.8 7.5 6.5 10.0 6.4 GTF3C1 TFIIIC220 ENSG00000077235 "General transcription factor IIIC subunit 1" Q12789 16 27459555-27549913 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "gdT-cell: 20.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051617 Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA051617: " "unprognostic (6.46e-2)" "unprognostic (6.86e-3)" "unprognostic (2.16e-1)" "unprognostic (5.59e-2)" "unprognostic (6.65e-2)" "unprognostic (2.90e-2)" "prognostic unfavourable (8.73e-4)" "unprognostic (8.23e-2)" "unprognostic (9.25e-3)" "unprognostic (5.32e-2)" "prognostic favourable (9.56e-4)" "unprognostic (2.10e-1)" "prognostic favourable (1.25e-4)" "unprognostic (2.06e-1)" "unprognostic (5.67e-2)" "unprognostic (5.56e-3)" "unprognostic (8.23e-3)" 13.6 18.4 19.4 12.1 25.9 17.3 10.6 25.3 31.2 17.3 12.8 21.0 18.8 11.0 19.0 12.0 39.3 19.9 16.5 23.7 15.8 16.2 16.9 13.2 14.1 13.5 14.3 19.1 20.7 24.0 33.8 33.2 13.5 15.8 35.4 12.4 22.3 15.3 16.9 29.5 41.5 11.7 19.3 12.8 14.2 15.7 24.4 17.1 25.2 35.8 18.8 21.0 12.3 20.7 1.9 4.2 2.1 2.1 7.8 20.6 3.6 12.7 28.2 20.8 24.2 18.7 15.1 11.8 13.9 15.7 19.4 16.6 21.1 12.1 14.1 20.6 17.0 14.4 26.3 17.7 16.0 6.3 25.2 11.6 23.9 30.0 10.5 13.3 15.5 18.5 13.5 23.8 10.5 19.2 14.3 11.6 15.2 31.5 14.7 16.0 27.9 13.5 27.5 25.7 14.4 12.2 13.4 26.3 17.6 14.0 11.9 8.6 21.4 10.1 20.3 19.6 11.8 12.3 14.2 12.4 11.1 14.3 8.1 14.8 14.3 1.0 2.1 2.1 20.6 1.9 15.2 1.9 2.4 10.3 2.7 1.6 2.5 6.7 1.6 7.8 2.0 4.2 2.5 3.6 19.4 25.9 25.3 31.2 15.8 16.2 14.3 19.1 15.8 17.1 GTF3C3 "TFIIIC102, TFiiiC2-102" ENSG00000119041 "General transcription factor IIIC subunit 3" Q9Y5Q9 2 196763032-196799725 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069179 Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA069179: " "unprognostic (1.44e-1)" "unprognostic (2.63e-2)" "unprognostic (1.89e-1)" "unprognostic (4.52e-2)" "unprognostic (5.88e-2)" "unprognostic (3.64e-2)" "prognostic unfavourable (1.26e-6)" "unprognostic (1.92e-1)" "unprognostic (9.28e-2)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (5.62e-2)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.72e-1)" "unprognostic (1.70e-1)" "unprognostic (3.08e-2)" 19.3 20.3 14.9 14.3 20.0 34.6 23.4 17.3 21.2 17.3 15.3 16.3 14.1 13.1 19.7 18.7 18.1 17.5 21.5 16.1 12.6 11.7 16.2 16.6 15.1 20.0 20.9 16.4 20.3 23.5 21.5 30.8 20.4 23.4 17.2 18.3 11.8 17.7 15.0 22.6 23.9 20.1 18.3 22.3 19.4 18.0 17.5 20.3 29.8 18.6 19.1 18.7 19.5 25.4 14.3 11.8 16.3 15.0 12.6 14.3 7.4 11.1 12.0 21.6 16.4 10.5 14.4 23.9 18.6 12.5 18.6 17.6 26.4 17.6 23.1 14.6 11.9 16.3 21.6 18.1 24.0 26.1 20.5 29.0 33.6 24.0 18.1 25.0 22.2 20.1 18.9 15.6 21.2 17.5 32.9 33.7 10.1 20.5 24.7 20.6 14.1 22.3 20.1 17.9 15.8 13.9 26.8 16.0 17.1 14.4 11.9 15.5 11.3 19.1 15.2 15.9 13.2 12.8 16.5 20.5 25.0 17.0 17.9 18.6 14.6 16.3 11.0 10.8 11.2 10.5 13.4 12.6 11.5 12.2 11.8 14.3 14.3 12.9 7.1 12.6 15.0 10.4 12.4 7.4 14.9 20.0 17.3 21.2 12.6 11.7 20.9 16.4 23.4 20.3 GULP1 "CED-6, CED6, GULP" ENSG00000144366 "GULP, engulfment adaptor PTB domain containing 1" Q9UBP9 2 188291669-188595931 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid transport, Phagocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 86.0" "Cell line enhanced" "Detected in many" "AF22: 32.1;SH-SY5Y: 24.2;WM-115: 69.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA020587 Enhanced Approved Vesicles Vesicles "HPA020587: AB_1850452" "unprognostic (1.95e-1)" "unprognostic (3.32e-1)" "unprognostic (3.80e-2)" "unprognostic (5.19e-2)" "unprognostic (2.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.06e-1)" "unprognostic (9.28e-2)" "unprognostic (8.25e-3)" "unprognostic (2.23e-1)" "prognostic favourable (4.25e-6)" "prognostic unfavourable (6.17e-4)" "unprognostic (1.29e-1)" "unprognostic (7.33e-2)" "unprognostic (3.04e-4)" 8.0 15.0 3.1 7.6 9.8 0.0 9.7 0.7 8.0 22.6 11.8 2.2 14.4 6.5 23.3 40.6 11.5 10.4 8.9 5.1 2.5 4.8 11.4 1.0 9.0 1.2 2.4 4.5 17.9 32.3 23.9 3.7 86.0 14.3 14.3 3.8 19.4 10.7 16.1 5.9 5.0 10.5 15.1 2.8 3.2 11.9 17.0 2.2 0.3 8.0 6.1 3.1 11.3 20.2 0.6 0.4 1.5 1.9 0.6 0.2 0.3 3.7 9.3 32.1 7.1 5.0 4.9 6.0 5.2 8.8 8.5 6.9 5.8 18.5 0.0 3.9 4.2 2.5 6.4 0.4 6.2 0.0 4.3 7.9 6.9 0.0 4.6 0.0 0.0 3.0 1.1 4.0 4.3 3.9 6.6 0.1 5.8 0.5 0.0 0.1 8.1 14.4 0.0 7.6 3.8 17.0 1.6 0.1 24.2 0.0 4.3 11.1 1.4 0.0 1.9 2.6 1.2 8.6 2.9 0.0 0.0 0.0 1.4 0.0 69.9 1.3 1.9 0.4 0.2 1.1 0.1 0.3 0.1 0.1 0.4 0.6 0.2 0.2 1.5 0.6 0.7 0.2 0.1 0.3 3.1 9.8 0.7 8.0 2.5 4.8 2.4 4.5 14.3 2.2 GYPA "CD235a, GPA, MN, MNS" ENSG00000170180 "Glycophorin A (MNS blood group)" P02724 4 144109303-144140786 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 56.9" "Cell line enriched" "Detected in some" 4 "HEL: 55.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "CAB002658, HPA014811" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "CAB002658: , HPA014811: AB_1849827" "unprognostic (1.60e-1)" "unprognostic (2.47e-2)" 0.1 0.0 0.2 0.1 0.4 56.9 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 1.7 1.3 3.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 4.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.3 0.4 0.2 0.2 0.6 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.2 0.9 0.1 0.2 0.2 1.5 0.2 0.6 0.2 0.2 0.2 0.3 0.0 0.8 0.2 0.4 0.1 0.5 0.2 0.3 0.3 0.1 0.1 0.1 GYPC "CD236, CD236R, Ge, GPC, GYPD" ENSG00000136732 "Glycophorin C (Gerbich blood group)" P04921 2 126655933-126696670 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 61.5;K-562: 45.7;SK-MEL-30: 90.3;U-266/70: 51.0" "Cancer enhanced" "Detected in all" "melanoma: 66.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008965, CAB009445" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB009445: AB_2116251, HPA008965: AB_1078455" "unprognostic (1.63e-2)" "unprognostic (7.14e-3)" "unprognostic (8.39e-2)" "unprognostic (3.31e-3)" "unprognostic (4.19e-2)" "unprognostic (1.69e-2)" "unprognostic (8.82e-2)" "unprognostic (3.52e-1)" "unprognostic (1.19e-1)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (1.11e-1)" "unprognostic (2.05e-2)" "unprognostic (2.73e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-1)" "unprognostic (8.00e-3)" 44.5 21.7 3.9 34.5 5.3 95.0 99.8 1.3 4.3 20.7 24.8 5.9 9.8 5.0 20.3 26.0 22.9 18.5 21.4 61.2 4.4 3.4 15.2 6.3 29.5 75.8 8.0 3.7 37.4 18.7 1.7 5.5 17.5 5.6 24.5 5.5 13.8 13.0 15.5 48.9 11.3 15.2 34.8 8.3 41.1 13.5 13.4 4.6 28.5 11.6 29.9 22.5 37.1 38.8 21.2 9.9 4.2 7.7 14.7 41.4 21.8 0.1 0.0 22.1 0.0 16.4 14.4 0.0 3.3 25.6 4.0 11.9 0.0 0.0 0.0 0.0 9.2 0.0 12.0 0.0 1.3 10.5 0.0 37.1 0.0 0.0 61.5 12.9 0.1 32.3 0.0 3.2 0.0 0.1 45.7 30.7 9.6 0.0 0.0 20.5 6.6 0.0 2.4 1.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 90.3 0.0 35.3 8.9 15.2 0.1 1.0 0.1 51.0 33.0 0.0 7.3 18.8 13.7 0.1 5.9 0.4 32.3 7.7 36.4 18.9 29.3 39.1 9.9 21.2 41.4 40.4 4.2 14.7 4.7 5.5 35.1 21.8 3.9 5.3 1.3 4.3 4.4 3.4 8.0 3.7 5.6 4.6 HAPLN3 "EXLD1, HsT19883" ENSG00000140511 "Hyaluronan and proteoglycan link protein 3" Q96S86 15 88877288-88895626 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.4;lymphoid tissue: 23.6" "Cell line enhanced" "Detected in many" "HDLM-2: 20.6;U-2 OS: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 25.4" "Lineage enriched" "Detected in many" 5 "T-cells: 25.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039237 Uncertain Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" "Plasma membrane, Cytosol" "HPA039237: AB_10805357" "unprognostic (1.67e-2)" "unprognostic (1.04e-3)" "unprognostic (2.57e-1)" "unprognostic (2.53e-2)" "unprognostic (3.27e-1)" "unprognostic (2.24e-2)" "unprognostic (4.21e-1)" "unprognostic (3.82e-1)" "unprognostic (3.37e-3)" "unprognostic (7.37e-3)" "unprognostic (1.13e-3)" "unprognostic (4.30e-1)" "prognostic unfavourable (4.18e-13)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.12e-1)" 9.9 1.3 1.1 20.6 2.7 4.4 8.7 1.0 2.3 5.3 2.6 1.1 0.3 1.4 4.4 4.9 5.7 6.0 4.7 9.8 3.2 1.0 3.0 0.8 8.7 23.6 3.1 0.9 5.2 2.3 0.9 2.2 2.7 3.6 5.2 1.1 3.2 6.4 1.6 4.2 6.0 4.1 4.7 6.2 6.9 3.6 1.9 1.8 5.7 7.2 7.6 10.9 6.0 5.6 0.8 1.1 0.7 0.6 4.8 25.4 3.2 1.2 4.3 0.9 9.6 2.7 3.0 3.0 2.6 0.6 1.0 1.3 2.7 4.0 0.0 7.6 3.3 1.0 9.1 1.2 0.0 20.6 8.0 3.0 0.2 0.0 0.4 0.0 0.1 1.1 0.5 1.9 0.1 4.5 0.0 5.9 0.4 0.1 0.0 0.0 7.1 0.1 0.0 0.4 7.2 1.8 0.1 0.1 2.6 0.5 0.5 3.6 0.0 0.3 0.8 6.9 20.6 5.2 0.4 0.9 0.0 0.0 2.5 0.0 5.9 0.7 0.6 0.0 0.6 0.3 3.0 0.1 10.0 4.1 1.1 0.8 10.2 4.5 0.1 4.8 0.1 0.4 25.4 3.2 1.1 2.7 1.0 2.3 3.2 1.0 3.1 0.9 3.6 1.8 HAVCR1 "CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1" ENSG00000113249 "Hepatitis A virus cellular receptor 1" Q96D42 5 157029413-157059119 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 37.6" "Group enriched" "Detected in some" 6 "A549: 35.8;CACO-2: 43.0;RPTEC TERT1: 17.1" "Cancer enriched" "Detected in many" 12 "renal cancer: 26.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA007173, CAB075697" Uncertain Approved Vesicles Vesicles "CAB075697: , HPA007173: AB_1080282" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (6.99e-2)" "unprognostic (2.46e-3)" "unprognostic (4.75e-3)" "unprognostic (3.20e-2)" "unprognostic (3.21e-1)" "unprognostic (8.70e-4)" "unprognostic (3.81e-3)" "unprognostic (7.10e-3)" "prognostic unfavourable (7.81e-4)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "prognostic favourable (1.32e-4)" 0.4 0.1 0.2 1.0 0.2 0.9 0.2 0.2 0.2 0.2 6.7 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.5 0.2 0.3 0.2 37.6 0.5 0.6 0.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 5.3 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.5 0.5 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.3 0.2 1.3 1.2 2.0 1.8 2.1 3.4 2.3 0.0 35.8 0.1 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.0 43.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.0 1.8 0.5 0.7 1.1 1.0 0.8 1.8 0.9 1.2 1.3 3.4 2.5 1.3 2.1 0.8 0.8 2.8 2.3 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.2 0.2 HAVCR2 "CD366, FLJ14428, Tim-3, TIM3, TIMD3" ENSG00000135077 "Hepatitis A virus cellular receptor 2" Q8TDQ0 5 157085832-157142869 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 34.6" "Cell line enhanced" "Detected in some" "ASC diff: 5.7;HDLM-2: 17.0;HMC-1: 4.2;RPMI-8226: 13.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 13.2;intermediate monocyte: 14.5;myeloid DC: 34.6;NK-cell: 24.1;non-classical monocyte: 8.6" "Group enriched" "Detected in many" 6 "dendritic cells: 34.6;monocytes: 14.5;NK-cells: 24.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB026003 Enhanced 2900000 "CAB026003: " "unprognostic (2.50e-2)" "unprognostic (1.11e-2)" "unprognostic (5.18e-2)" "unprognostic (2.04e-3)" "unprognostic (3.79e-2)" "unprognostic (1.14e-1)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" "unprognostic (8.48e-2)" "unprognostic (5.13e-2)" "unprognostic (7.83e-2)" "unprognostic (1.89e-1)" "unprognostic (1.83e-2)" "unprognostic (2.13e-1)" "unprognostic (1.34e-1)" 16.8 8.6 9.3 16.0 12.3 10.3 6.5 8.4 10.7 5.1 5.3 15.5 1.8 4.1 3.9 5.9 4.2 5.3 11.4 4.8 9.8 9.3 23.3 8.9 19.8 21.7 15.5 7.5 4.4 3.8 2.4 5.5 14.3 11.3 4.2 6.5 4.1 6.2 3.1 3.3 3.1 6.0 7.2 24.8 23.1 4.2 5.8 12.1 4.7 3.8 2.9 11.1 10.3 2.9 0.3 34.6 3.1 14.5 24.1 3.8 9.7 0.0 0.1 0.1 0.1 5.7 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.1 3.8 0.2 0.0 0.1 0.0 0.0 0.0 17.0 0.0 0.8 0.0 0.0 0.0 0.0 4.2 0.2 0.3 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.1 2.8 0.2 0.0 0.0 2.2 13.8 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.7 0.3 0.2 0.0 0.3 1.1 0.1 0.1 0.4 0.1 3.1 13.2 0.0 3.8 14.5 0.8 0.3 1.6 2.0 34.6 0.1 2.0 2.9 0.7 24.1 8.6 4.1 3.1 9.7 9.3 12.3 8.4 10.7 9.8 9.3 15.5 7.5 11.3 12.1 HBD ENSG00000223609 "Hemoglobin subunit delta" P02042 11 5232678-5243657 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 233.7" "Group enriched" "Detected in some" 5 "HEL: 30.6;U-266/70: 41.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "CAB037087, HPA043234" Supported 11000000000 "CAB037087: AB_260051, HPA043234: " "unprognostic (1.32e-2)" "unprognostic (4.87e-2)" "unprognostic (4.14e-2)" "unprognostic (2.26e-3)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "unprognostic (1.04e-1)" "unprognostic (8.67e-2)" "unprognostic (2.83e-2)" "unprognostic (3.17e-1)" "unprognostic (6.24e-2)" "unprognostic (3.17e-1)" 1.6 0.2 0.4 0.3 0.6 233.7 0.8 0.1 0.5 0.2 0.2 1.5 0.0 0.2 0.4 0.2 0.9 0.5 0.2 4.3 1.3 0.4 1.4 3.9 22.5 0.2 1.0 0.0 1.1 0.2 0.2 1.3 12.0 0.8 0.5 0.2 1.0 0.9 0.2 1.0 0.2 0.2 0.2 0.4 29.6 0.2 0.2 0.0 1.2 4.4 0.0 0.4 1.7 11.9 0.0 0.5 0.8 0.0 0.0 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 30.6 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.6 7.3 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 31.6 0.4 0.6 0.1 0.5 1.3 0.4 1.0 0.0 0.8 0.0 HBEGF "DTR, DTS, HEGFL" ENSG00000113070 "Heparin binding EGF like growth factor" Q99075 5 140332843-140346631 "Predicted membrane proteins, Predicted secreted proteins" "Growth factor, Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBF TERT88: 23.8;TIME: 25.8;U-698: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.9;myeloid DC: 3.5;non-classical monocyte: 3.4" "Group enriched" "Detected in many" 5 "dendritic cells: 3.5;monocytes: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053243 Uncertain "Secreted to blood" 63733 "HPA053243: " "unprognostic (3.64e-1)" "unprognostic (3.05e-1)" "unprognostic (4.31e-2)" "unprognostic (5.09e-1)" "unprognostic (1.06e-2)" "prognostic unfavourable (2.41e-4)" "unprognostic (8.44e-3)" "unprognostic (3.51e-2)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (7.09e-4)" "prognostic favourable (6.00e-4)" "unprognostic (2.20e-2)" "unprognostic (6.77e-2)" "unprognostic (1.15e-1)" "unprognostic (1.54e-1)" "unprognostic (2.87e-2)" 31.1 7.0 5.5 18.0 7.5 17.0 22.4 6.8 5.8 8.1 11.1 13.0 5.7 2.6 12.1 13.8 25.3 6.3 32.8 24.3 7.7 6.2 6.9 5.6 36.0 2.7 10.5 4.2 6.5 4.1 4.6 7.3 8.9 8.1 7.8 9.1 6.7 7.0 6.4 14.3 9.8 8.2 20.6 14.1 3.4 13.7 6.4 8.4 1.2 8.5 27.6 13.4 18.2 10.3 0.7 3.5 0.1 4.9 0.0 0.3 0.4 8.4 0.6 1.3 3.1 0.6 0.2 1.0 8.2 3.2 15.6 12.9 4.8 9.2 0.1 6.5 2.0 2.6 1.6 13.9 23.8 0.5 1.4 0.1 1.8 0.6 0.4 0.5 0.4 0.3 17.6 17.0 6.9 7.7 0.0 1.3 3.3 0.6 0.7 3.9 1.1 2.3 1.5 5.0 0.2 9.7 1.1 0.4 0.5 2.4 0.3 2.8 0.5 2.2 25.8 8.9 7.4 2.8 18.3 0.1 0.6 34.7 11.3 4.1 11.5 0.0 0.8 0.0 0.0 4.9 0.0 0.7 0.1 0.0 3.5 0.0 0.3 0.1 0.1 0.0 3.4 0.6 0.0 0.4 5.5 7.5 6.8 5.8 7.7 6.2 10.5 4.2 8.1 8.4 HBS1L "DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038" ENSG00000112339 "HBS1 like translational GTPase" Q9Y450 6 134960378-135103056 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029728, HPA029729" Approved Approved "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "HPA029728: AB_10611112, HPA029729: AB_10601228" "unprognostic (3.68e-3)" "unprognostic (6.39e-2)" "prognostic favourable (6.77e-4)" "unprognostic (1.26e-1)" "unprognostic (2.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.89e-2)" "unprognostic (8.66e-2)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (1.23e-1)" "unprognostic (7.73e-2)" "unprognostic (3.84e-1)" "unprognostic (4.98e-2)" "unprognostic (1.47e-1)" "unprognostic (4.20e-2)" 16.9 18.6 17.5 13.0 27.3 31.8 18.0 23.2 34.7 16.7 14.9 18.2 9.2 10.1 15.6 10.8 20.0 13.8 12.0 22.3 18.4 18.8 17.4 28.4 11.7 16.3 21.1 16.0 15.6 20.4 19.5 25.4 18.7 33.6 14.2 13.5 11.0 17.1 14.1 66.4 14.7 15.3 18.6 25.0 14.4 14.2 14.0 17.1 42.5 17.5 19.9 18.5 16.3 13.6 25.2 28.4 38.4 24.6 32.9 38.4 28.3 14.8 10.0 20.9 30.3 19.2 17.1 16.0 30.1 26.0 28.7 35.6 16.7 11.2 25.8 13.6 26.6 11.2 29.2 22.1 44.9 26.2 20.0 78.9 28.4 22.4 23.1 48.7 21.6 16.9 16.9 27.2 33.4 23.7 42.1 21.8 30.3 14.1 29.9 12.3 13.5 10.9 28.1 23.3 17.6 17.7 14.2 20.7 14.1 20.6 21.6 21.4 18.0 29.4 22.4 20.4 21.3 25.2 31.8 49.7 35.8 43.8 31.1 25.4 25.3 38.4 24.6 25.4 23.4 22.1 26.3 25.2 28.1 23.8 28.4 22.6 38.4 31.6 11.2 32.9 21.1 22.6 32.9 28.3 17.5 27.3 23.2 34.7 18.4 18.8 21.1 16.0 33.6 17.1 HCST "DAP10, DKFZP586C1522, KAP10, PIK3AP" ENSG00000126264 "Hematopoietic cell signal transducer" Q9UBK5 19 35902480-35904377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 134.0;bone marrow: 84.0;lymphoid tissue: 79.1" "Cell line enhanced" "Detected in some" "HEL: 51.7;HL-60: 29.8;HMC-1: 34.5;THP-1: 39.1;U-937: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB034435, HPA063026" Enhanced Supported "Vesicles,Plasma membrane,Centriolar satellite" "Plasma membrane" "Vesicles, Centriolar satellite" "CAB034435: AB_2117803, HPA063026: " "unprognostic (1.40e-3)" "unprognostic (3.07e-2)" "unprognostic (3.04e-2)" "unprognostic (7.27e-3)" "unprognostic (1.23e-1)" "unprognostic (8.23e-3)" "unprognostic (1.85e-1)" "unprognostic (2.54e-1)" "prognostic favourable (6.70e-4)" "unprognostic (5.97e-2)" "unprognostic (1.94e-3)" "unprognostic (1.02e-1)" "prognostic unfavourable (1.59e-10)" "unprognostic (3.78e-1)" "unprognostic (3.25e-2)" "unprognostic (1.65e-1)" "unprognostic (1.56e-1)" 29.4 4.0 6.5 19.9 5.2 84.0 5.9 1.4 3.1 3.9 4.9 4.8 0.5 4.5 5.4 6.0 3.0 4.5 6.3 7.3 5.7 5.9 5.6 6.9 38.4 79.1 7.7 2.2 3.4 2.9 0.7 4.3 10.6 4.9 5.5 3.6 7.1 6.2 3.7 2.4 2.8 10.9 4.5 12.7 49.5 5.6 1.7 4.4 56.8 3.4 3.3 26.7 5.2 3.6 6.1 66.6 15.9 57.0 96.4 134.0 89.5 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.1 0.2 5.6 0.3 0.4 0.2 0.0 0.0 0.0 0.1 0.0 51.7 0.1 0.1 0.1 29.8 34.5 0.3 0.0 0.0 0.0 0.0 0.4 7.4 0.1 0.0 3.4 11.6 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.1 39.1 0.1 0.3 0.4 0.0 0.0 0.3 0.2 8.5 0.3 58.7 0.0 7.3 57.0 7.9 134.0 42.0 99.3 6.1 57.4 108.5 32.6 3.7 48.3 96.4 15.9 96.4 23.0 66.6 48.5 89.5 6.5 5.2 1.4 3.1 5.7 5.9 7.7 2.2 4.9 4.4 HDAC10 DKFZP761B039 ENSG00000100429 "Histone deacetylase 10" Q969S8 22 50245183-50251405 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, DNA damage, DNA recombination, DNA repair" Hydrolase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 18.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB045977 Supported "CAB045977: AB_11124034" "unprognostic (1.53e-1)" "prognostic favourable (4.46e-4)" "unprognostic (1.43e-2)" "prognostic favourable (2.45e-5)" "unprognostic (2.71e-2)" "unprognostic (3.70e-2)" "unprognostic (6.15e-3)" "unprognostic (5.48e-2)" "unprognostic (3.28e-1)" "unprognostic (2.56e-2)" "prognostic favourable (9.25e-4)" "unprognostic (4.93e-2)" "prognostic unfavourable (4.74e-11)" "unprognostic (2.21e-2)" "unprognostic (2.52e-2)" "unprognostic (1.43e-2)" "unprognostic (1.38e-3)" 8.9 9.3 10.1 14.7 10.3 16.9 6.8 10.9 8.8 8.6 13.9 4.7 14.6 12.9 7.7 13.5 10.2 7.9 13.1 4.0 8.4 6.1 11.4 15.1 8.2 12.5 4.9 8.8 7.8 15.0 6.4 13.2 7.0 6.1 10.2 3.7 8.8 18.6 12.9 9.2 12.1 14.2 7.1 4.4 17.1 14.2 2.4 4.7 16.1 9.3 7.6 19.2 8.2 7.7 1.1 3.1 5.4 4.2 1.1 1.9 2.5 4.1 2.3 0.6 3.4 3.0 2.3 7.6 2.7 2.4 1.6 0.9 4.3 4.5 2.7 3.9 2.1 6.9 1.4 4.1 0.3 3.4 3.9 5.8 6.1 7.2 5.2 6.8 18.9 4.9 3.0 1.5 0.9 2.9 4.0 4.1 1.4 12.8 3.8 17.0 1.4 5.1 9.1 2.2 16.7 2.5 7.0 1.8 4.5 2.8 1.0 4.8 7.8 11.0 4.7 2.7 3.9 4.6 1.6 5.1 1.7 2.3 4.4 4.3 2.1 0.8 4.0 5.4 1.9 4.2 1.6 1.0 0.9 1.2 3.1 1.1 0.8 1.0 2.0 1.1 2.3 2.7 1.6 2.5 10.1 10.3 10.9 8.8 8.4 6.1 4.9 8.8 6.1 4.7 HEATR5A "C14orf125, DKFZP434I1735" ENSG00000129493 "HEAT repeat containing 5A" Q86XA9 14 31291791-31420582 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 35.9" "Lineage enriched" "Detected in all" 6 "granulocytes: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049539 Uncertain "HPA049539: " "unprognostic (2.63e-1)" "unprognostic (2.24e-1)" "unprognostic (1.75e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "unprognostic (5.47e-3)" "unprognostic (3.97e-2)" "unprognostic (9.37e-2)" "unprognostic (8.02e-2)" "unprognostic (1.70e-1)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "prognostic favourable (1.11e-6)" "unprognostic (1.00e-1)" "unprognostic (5.93e-2)" "unprognostic (2.83e-2)" "unprognostic (6.00e-2)" 14.4 20.0 13.5 11.4 13.4 8.5 11.7 8.3 13.0 14.2 18.2 21.6 7.7 13.7 16.8 8.2 14.3 12.3 10.1 20.9 15.9 9.7 14.1 19.9 14.8 6.9 17.8 9.3 11.3 9.7 16.0 26.8 23.9 18.2 9.4 15.8 15.8 15.0 8.3 20.8 7.3 17.7 19.6 17.1 12.4 10.9 13.2 17.1 3.6 10.4 8.6 10.2 13.2 11.4 1.9 3.0 35.9 6.2 1.2 1.1 1.5 11.3 17.9 5.1 6.5 12.5 11.9 10.6 13.9 11.8 7.6 7.8 7.1 8.7 6.1 13.4 20.9 7.7 9.6 4.2 10.9 4.6 8.9 4.6 25.1 29.7 7.3 8.7 6.7 5.5 2.3 6.5 6.2 9.5 9.3 6.3 8.8 10.1 3.2 3.8 3.9 10.6 1.9 10.2 3.5 5.0 7.2 2.1 6.5 32.1 14.8 31.5 8.4 2.5 14.7 5.6 8.4 9.5 5.5 6.3 16.3 9.4 1.6 4.9 8.1 35.9 4.5 16.8 1.1 4.4 0.6 1.9 0.7 0.9 3.0 1.4 0.7 1.1 14.5 1.2 6.2 1.4 0.7 1.5 13.5 13.4 8.3 12.2 15.9 9.7 17.8 9.3 18.2 17.1 HECTD4 "C12orf51, FLJ34154, KIAA0614" ENSG00000173064 "HECT domain E3 ubiquitin protein ligase 4" 12 112160188-112382439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 43.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041062, HPA045473" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA041062: , HPA045473: " "unprognostic (9.27e-2)" "unprognostic (2.35e-1)" "unprognostic (6.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.38e-1)" "prognostic favourable (2.97e-4)" "unprognostic (3.52e-2)" "unprognostic (2.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.95e-2)" "unprognostic (1.06e-1)" "unprognostic (2.89e-2)" "unprognostic (2.81e-2)" "unprognostic (1.89e-1)" "unprognostic (1.58e-2)" "unprognostic (4.51e-3)" 6.8 7.1 11.3 6.3 16.3 26.6 7.7 43.3 22.7 8.9 9.0 14.0 10.8 5.4 11.1 10.0 10.0 9.0 6.5 6.6 10.1 10.3 7.4 6.3 7.3 8.1 11.4 13.7 10.9 10.1 13.8 14.0 8.0 17.2 12.3 7.4 9.4 8.7 9.6 12.9 16.6 7.0 8.8 13.0 7.4 8.8 14.6 12.7 8.3 12.8 5.0 7.7 8.3 9.0 2.9 2.4 2.8 1.2 1.0 1.8 0.7 5.6 10.6 8.5 7.5 11.6 7.9 4.9 4.1 3.9 5.3 4.5 10.3 1.9 5.9 3.8 6.7 5.7 11.1 5.4 4.0 7.6 10.0 8.4 11.2 5.7 4.1 5.9 8.2 6.5 6.6 8.2 5.4 8.1 10.4 4.6 5.1 6.2 7.0 12.5 4.0 7.9 9.5 4.3 3.8 4.3 8.9 13.9 9.5 9.6 9.4 3.6 7.1 8.4 11.7 6.3 4.6 6.5 5.5 15.7 5.9 6.6 5.1 3.9 3.9 2.8 1.2 0.6 1.8 0.5 1.2 1.1 0.6 0.9 0.8 2.9 1.0 0.9 1.4 1.0 1.1 2.4 0.1 0.7 11.3 16.3 43.3 22.7 10.1 10.3 11.4 13.7 17.2 12.7 HEG1 "HEG, KIAA1237" ENSG00000173706 "Heart development protein with EGF like domains 1" Q9ULI3 3 124965710-125055958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 46.1;HHSteC: 56.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010952, HPA011559" Approved Approved Vesicles "Intracellular and membrane" 360000000 Vesicles "HPA010952: , HPA011559: AB_1850580" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.48e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (9.80e-2)" "unprognostic (1.69e-1)" "unprognostic (8.33e-2)" "prognostic unfavourable (1.93e-5)" "unprognostic (1.11e-2)" "unprognostic (4.99e-2)" "unprognostic (6.20e-3)" "prognostic unfavourable (1.16e-4)" 23.6 8.2 5.8 12.1 8.4 0.7 16.4 2.6 8.9 12.2 9.6 14.7 8.0 3.9 12.0 7.3 9.0 11.4 29.6 36.3 6.9 5.5 8.9 5.5 42.4 7.7 9.7 4.7 8.1 16.6 14.2 4.0 17.4 11.6 7.2 6.5 26.2 7.1 7.4 6.2 4.3 7.9 14.4 11.9 11.5 7.5 11.3 6.5 3.0 29.1 10.8 8.7 13.0 15.6 1.0 0.9 1.2 3.9 7.3 4.0 1.1 2.0 2.1 14.7 1.2 18.2 16.2 5.5 17.3 22.6 19.2 21.1 15.0 0.2 0.6 11.8 46.1 3.6 2.2 8.4 23.2 1.6 1.1 0.3 11.1 1.8 56.0 0.4 22.4 19.7 2.4 25.0 5.9 18.7 0.0 0.2 5.8 0.3 0.9 0.0 2.5 1.3 1.3 11.1 0.0 3.3 0.3 0.2 1.3 38.3 2.6 1.5 6.2 0.9 28.9 10.8 12.1 38.9 7.3 1.5 4.7 0.0 20.4 1.6 21.1 1.2 0.3 0.0 4.0 3.6 2.7 0.9 1.6 3.6 0.7 1.0 2.4 1.5 0.0 7.3 3.9 0.9 0.5 1.1 5.8 8.4 2.6 8.9 6.9 5.5 9.7 4.7 11.6 6.5 HELZ "DHRC, HUMORF5, KIAA0054" ENSG00000198265 "Helicase with zinc finger" P42694 17 67070438-67245989 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028276 Approved Approved "Nucleoli,Plasma membrane,Actin filaments" Nucleoli "Plasma membrane, Actin filaments" "HPA028276: AB_10601814" "unprognostic (3.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.83e-2)" "unprognostic (4.71e-2)" "unprognostic (5.85e-2)" "unprognostic (5.31e-2)" "unprognostic (3.60e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-3)" "unprognostic (1.42e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" 17.9 12.9 11.2 14.3 14.3 17.7 12.6 24.3 17.7 14.4 14.0 11.6 12.9 7.9 17.0 13.0 9.1 11.1 11.5 11.1 12.0 9.7 11.8 17.3 14.8 14.6 10.7 6.2 20.5 13.9 34.1 33.5 19.2 16.5 11.9 10.9 12.2 12.4 10.9 18.9 9.0 15.6 12.2 13.5 17.3 11.7 16.4 12.7 34.1 15.3 8.8 13.9 15.3 11.9 4.8 4.4 4.3 4.9 4.0 11.0 3.2 7.5 7.6 9.2 9.5 11.7 6.5 14.2 6.7 6.7 8.8 9.7 11.0 6.0 15.6 5.6 9.0 8.0 17.6 8.5 14.2 6.0 5.5 19.9 8.3 9.0 5.6 16.4 12.2 7.7 8.2 8.7 11.1 13.6 13.8 10.0 7.4 9.6 21.1 5.7 5.6 7.3 14.3 16.8 6.8 7.1 10.7 9.3 8.5 10.6 8.9 11.6 10.5 10.2 12.2 11.4 13.1 6.2 6.0 8.2 9.6 11.8 5.6 10.2 11.8 3.6 4.9 4.3 8.8 4.5 11.0 2.9 5.4 5.3 4.4 4.8 3.3 4.5 3.7 4.0 2.9 3.6 4.8 3.2 11.2 14.3 24.3 17.7 12.0 9.7 10.7 6.2 16.5 12.7 HEPACAM "FLJ25530, GLIALCAM, hepaCAM" ENSG00000165478 "Hepatic and glial cell adhesion molecule" Q14CZ8 11 124919193-124936412 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Cell cycle, Growth arrest, Growth regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "adipose tissue: 17.3;brain: 64.7;liver: 19.6" "Cell line enriched" "Detected in single" 31 "Hep G2: 24.3" "Cancer enriched" "Detected in some" 12 "glioma: 29.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017613, CAB025486" Enhanced Approved Vesicles Vesicles "CAB025486: , HPA017613: AB_1850595" "unprognostic (3.22e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-1)" "unprognostic (6.41e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (2.25e-1)" "unprognostic (7.58e-2)" "unprognostic (1.33e-2)" "unprognostic (1.06e-6)" "unprognostic (2.62e-1)" "unprognostic (3.21e-1)" 17.3 1.8 25.6 1.7 25.7 1.5 2.6 8.5 64.7 1.6 1.8 55.4 0.0 1.6 1.6 1.7 1.6 1.6 1.6 1.7 31.0 10.8 1.6 19.6 1.6 1.7 30.3 22.4 1.5 1.6 1.5 0.6 1.5 27.9 1.6 1.8 0.0 1.7 2.1 1.6 1.6 1.6 1.6 21.5 1.5 1.6 1.7 35.5 0.0 1.6 0.0 2.3 1.5 0.3 1.5 1.2 3.0 1.4 2.0 1.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 1.1 1.2 1.1 1.2 1.5 1.5 1.4 1.0 1.2 1.3 1.7 1.5 1.3 2.0 1.4 1.0 1.1 1.5 25.6 25.7 8.5 29.7 31.0 10.8 30.3 22.4 27.9 35.5 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188586-93226524 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 43.4;kidney: 24.5;pituitary gland: 16.1" "Cell line enriched" "Detected in some" 37 "SCLC-21H: 61.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" 89000 "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favourable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.2 0.2 8.5 0.2 0.6 3.4 0.1 0.1 0.1 29.4 0.1 5.3 11.8 0.1 0.4 0.2 0.1 0.8 0.3 0.2 0.2 24.5 0.2 0.4 0.1 0.2 0.1 0.1 5.5 0.0 16.1 0.4 0.2 0.7 38.9 0.1 4.1 1.2 0.1 0.1 43.4 0.4 0.2 0.2 4.0 1.4 0.1 0.3 0.1 0.1 2.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 HEPH "CPL, KIAA0698" ENSG00000089472 Hephaestin Q9BQS7 X 66162549-66268867 "Predicted intracellular proteins, Predicted membrane proteins" "Copper transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 68.7" "Cell line enhanced" "Detected in some" "AF22: 14.0;HEL: 12.0;HSkMC: 18.2;K-562: 33.7;LHCN-M2: 13.9" "Cancer enhanced" "Detected in all" "colorectal cancer: 37.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA000553, HPA005824" Approved Approved "Nucleoplasm,Nuclear bodies" 1200000 "Nucleoplasm, Nuclear bodies" "HPA000553: , HPA005824: AB_1850603" "unprognostic (3.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.25e-2)" "unprognostic (4.25e-2)" "unprognostic (1.29e-3)" "unprognostic (2.25e-1)" "unprognostic (4.94e-2)" "unprognostic (6.17e-2)" "unprognostic (1.40e-2)" "unprognostic (3.35e-1)" "unprognostic (2.40e-3)" "unprognostic (1.19e-1)" "prognostic unfavourable (7.00e-6)" "unprognostic (3.08e-2)" "unprognostic (4.46e-2)" "unprognostic (1.04e-1)" "unprognostic (1.17e-2)" 4.0 12.2 8.3 10.9 9.3 0.0 3.9 3.7 10.1 11.6 38.4 9.7 8.9 32.9 18.3 9.0 7.5 8.7 21.4 14.8 8.1 5.0 3.7 1.4 7.1 1.3 9.2 10.2 10.2 1.0 0.9 2.5 0.9 8.5 11.0 33.5 11.4 3.0 14.5 0.5 2.8 68.7 34.8 6.7 4.4 8.6 3.2 8.8 0.0 3.2 2.7 1.1 11.2 6.4 0.0 0.2 0.0 0.0 0.0 0.6 0.5 0.0 0.0 14.0 1.1 0.0 0.0 0.4 3.5 0.1 0.0 0.0 8.3 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 3.9 0.0 12.0 0.0 0.0 0.1 0.1 0.0 18.2 0.0 0.0 0.0 0.0 33.7 0.3 13.9 0.0 0.0 0.3 6.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 8.1 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 8.3 9.3 3.7 10.1 8.1 5.0 9.2 10.2 8.5 8.8 HEPHL1 DKFZp686F22190 ENSG00000181333 "Hephaestin like 1" Q6MZM0 11 94021361-94113751 "Predicted membrane proteins" "Copper transport, Ion transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 68.0" "Cell line enhanced" "Detected in some" "BEWO: 1.4;HaCaT: 4.1;HBEC3-KT: 7.3" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 20.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in single" 21 "olfactory region: 1.4" "Not detected" "Not detected" HPA031517 Uncertain 51000000 "HPA031517: AB_10603769" "unprognostic (9.16e-2)" "prognostic unfavourable (4.94e-4)" "unprognostic (2.40e-1)" "unprognostic (3.26e-6)" "unprognostic (3.17e-1)" "unprognostic (3.45e-1)" "unprognostic (1.72e-2)" "unprognostic (6.71e-2)" "unprognostic (5.34e-1)" "unprognostic (1.09e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (1.00e-1)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.25e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 6.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 68.0 16.2 0.0 4.8 1.1 0.3 0.1 0.0 0.9 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.3 0.0 4.1 0.0 7.3 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.3 1.1 0.0 0.1 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HERC2 "D15F37S1, jdf2, p528" ENSG00000128731 "HECT and RLD domain containing E3 ubiquitin protein ligase 2" O95714 15 28111040-28322152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 32.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017188, HPA048389, HPA074166" Approved Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB017188: , HPA048389: , HPA074166: " "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.92e-1)" "unprognostic (6.64e-2)" "unprognostic (6.62e-2)" "unprognostic (5.74e-2)" "unprognostic (9.17e-2)" "unprognostic (2.08e-1)" "unprognostic (1.87e-1)" "unprognostic (4.11e-2)" "unprognostic (9.40e-3)" "unprognostic (3.60e-2)" "prognostic favourable (1.41e-7)" "unprognostic (7.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.34e-2)" "unprognostic (1.71e-1)" 2.5 3.3 3.2 2.2 4.5 3.9 3.1 7.0 5.7 3.2 4.6 2.7 4.4 1.7 2.8 4.1 2.1 4.6 3.5 3.6 3.3 1.6 2.5 2.1 3.8 8.5 3.6 9.2 3.5 2.7 3.0 3.0 2.3 3.3 8.2 3.1 3.1 4.1 4.1 2.3 3.4 3.2 5.6 2.4 3.3 2.3 1.0 1.1 0.5 0.4 0.2 1.1 0.4 5.1 10.1 7.0 2.9 5.9 4.4 2.0 3.7 4.4 4.8 4.6 5.2 0.6 5.1 4.5 6.3 5.2 7.4 3.6 3.5 3.1 4.8 32.6 11.7 1.7 2.2 7.6 2.6 3.7 2.9 5.7 7.1 6.3 12.5 2.1 4.5 2.3 1.7 2.5 2.1 4.4 6.1 10.0 0.4 1.6 11.1 7.8 4.5 8.9 2.5 2.9 3.0 9.0 9.4 8.9 5.8 3.4 5.5 1.4 1.9 4.8 4.1 3.6 4.7 0.0 0.4 0.5 1.1 0.1 0.6 0.5 0.2 0.5 1.1 1.0 0.9 0.5 0.0 0.2 0.3 0.9 0.4 0.4 HERC4 "DKFZP564G092, KIAA1593" ENSG00000148634 "HECT and RLD domain containing E3 ubiquitin protein ligase 4" Q5GLZ8 10 67921899-68075348 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 55.1;fHDF/TERT166: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045453, HPA070301" Uncertain Supported "Nucleoli fibrillar center,Cytosol" Cytosol "Nucleoli fibrillar center" "HPA045453: AB_10961917, HPA070301: " "unprognostic (3.66e-2)" "unprognostic (6.31e-2)" "unprognostic (1.58e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-1)" "unprognostic (4.23e-2)" "unprognostic (3.51e-2)" "unprognostic (1.01e-3)" "unprognostic (3.54e-1)" "unprognostic (8.57e-2)" "unprognostic (4.94e-3)" "unprognostic (2.25e-2)" "prognostic unfavourable (3.86e-5)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "unprognostic (3.98e-1)" "unprognostic (2.31e-2)" 25.3 29.4 21.9 28.0 28.4 14.6 22.7 30.5 24.9 24.2 20.5 22.2 26.7 20.0 28.1 24.3 22.2 19.2 20.2 20.5 21.9 22.7 20.6 24.5 20.6 30.2 30.9 14.8 24.5 17.1 25.2 35.6 23.8 26.8 19.4 23.9 17.8 17.7 24.1 19.6 20.9 25.8 23.0 28.7 27.0 17.3 22.2 33.6 23.6 19.5 13.8 28.3 24.7 47.9 7.7 10.4 13.5 9.3 9.9 11.5 6.5 22.4 8.0 5.1 8.5 13.2 18.1 4.6 55.1 34.1 20.7 13.4 4.5 10.6 7.9 4.3 61.8 11.9 5.6 8.1 28.0 5.2 2.7 3.6 13.3 3.5 7.0 4.4 6.5 8.9 9.5 11.0 9.8 12.8 3.8 4.0 31.9 9.6 3.1 5.2 3.0 14.0 4.2 2.1 2.8 9.4 6.4 2.4 2.8 17.9 7.7 7.8 4.8 5.6 17.4 10.9 6.1 26.8 9.4 2.8 3.3 5.0 20.0 8.6 3.7 13.5 9.3 11.1 8.2 7.9 11.5 7.7 9.1 9.8 10.4 7.5 8.8 9.0 11.7 9.9 7.6 2.7 10.6 6.5 21.9 28.4 30.5 24.9 21.9 22.7 30.9 14.8 26.8 33.6 HERC5 CEB1 ENSG00000138646 "HECT and RLD domain containing E3 ubiquitin protein ligase 5" Q9UII4 4 88457117-88506163 "Predicted membrane proteins" "Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.9" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 32.1;BJ hTERT+ SV40 Large T+ RasG12V: 44.4;SK-MEL-30: 19.0" "Cancer enhanced" "Detected in all" "testis cancer: 31.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043929 Supported "HPA043929: AB_10962492" "unprognostic (2.87e-1)" "unprognostic (2.10e-3)" "unprognostic (1.97e-1)" "prognostic unfavourable (4.46e-5)" "unprognostic (3.00e-1)" "unprognostic (1.06e-1)" "unprognostic (3.00e-2)" "unprognostic (2.58e-1)" "unprognostic (9.00e-2)" "unprognostic (9.89e-2)" "unprognostic (1.35e-1)" "unprognostic (2.54e-2)" "unprognostic (2.56e-1)" "unprognostic (2.23e-2)" "unprognostic (3.18e-2)" "unprognostic (7.54e-2)" "unprognostic (1.61e-1)" 12.3 4.8 4.1 6.8 6.1 11.6 6.6 1.2 4.0 9.8 5.2 4.0 2.6 2.8 19.1 5.9 3.1 6.0 4.2 3.5 4.2 3.4 5.1 6.8 6.0 11.3 3.9 3.7 13.3 8.7 8.9 7.4 7.6 5.3 7.8 1.9 4.5 7.7 4.4 2.9 2.5 4.7 9.9 5.3 8.0 4.4 48.9 4.1 13.2 5.9 1.5 5.2 7.3 8.7 5.2 5.8 18.1 6.0 5.6 19.5 3.7 2.5 1.2 0.7 0.1 0.1 0.3 9.9 0.2 3.7 32.1 44.4 0.3 6.9 0.1 1.7 0.0 0.5 4.7 0.7 2.7 15.7 2.9 4.1 4.6 0.1 0.3 5.0 1.9 0.3 0.2 8.0 0.0 0.2 0.1 10.0 0.6 0.2 15.3 6.2 2.6 0.8 15.4 12.7 0.6 0.5 0.5 0.2 4.2 5.2 0.1 19.0 0.4 2.8 0.1 0.4 0.0 0.1 2.0 13.8 12.1 0.1 3.1 3.7 0.3 7.7 5.2 8.0 6.0 6.0 6.6 5.2 6.8 4.9 1.9 3.7 4.3 3.7 18.1 5.6 5.2 5.8 19.5 3.7 4.1 6.1 1.2 4.0 4.2 3.4 3.9 3.7 5.3 4.1 HERC6 FLJ20637 ENSG00000138642 "HECT and RLD domain containing E3 ubiquitin protein ligase family member 6" Q8IVU3 4 88378739-88443111 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 46.0;BJ hTERT+ SV40 Large T+ RasG12V: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035846 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA035846: AB_10673487" "unprognostic (1.95e-2)" "unprognostic (2.71e-1)" "unprognostic (2.23e-2)" "unprognostic (2.67e-2)" "unprognostic (8.61e-2)" "unprognostic (2.98e-2)" "unprognostic (2.78e-2)" "unprognostic (3.27e-1)" "unprognostic (1.49e-1)" "unprognostic (5.95e-2)" "unprognostic (1.52e-2)" "unprognostic (6.22e-2)" "prognostic favourable (7.14e-5)" "unprognostic (1.80e-1)" "unprognostic (2.59e-1)" "unprognostic (8.43e-3)" "unprognostic (3.77e-2)" 8.0 7.5 7.8 7.2 10.2 7.3 6.3 2.1 14.6 13.6 6.3 5.9 3.4 5.4 13.2 9.6 23.9 10.4 11.2 9.8 7.7 8.4 10.4 5.0 8.3 4.6 7.3 15.8 9.8 6.3 5.2 8.4 7.1 8.5 9.1 6.5 7.2 28.4 5.7 2.9 4.3 7.1 8.5 5.6 8.0 7.3 3.9 5.3 9.0 5.9 7.6 7.8 7.2 13.8 3.6 2.7 4.5 6.4 5.6 13.4 4.2 2.5 1.7 0.1 0.3 0.1 1.5 0.5 0.3 8.6 46.0 34.3 0.1 3.2 0.0 0.6 0.8 0.9 4.2 2.2 3.0 5.2 0.8 2.4 1.4 0.2 1.5 4.2 1.6 2.1 0.5 3.5 0.1 1.3 0.0 0.5 1.0 1.5 1.9 1.3 0.6 0.8 1.3 0.0 0.1 3.1 3.1 0.1 1.1 3.2 1.0 5.1 1.9 0.7 0.4 0.6 0.8 0.1 0.8 0.1 0.0 0.0 2.1 0.9 2.1 4.4 3.1 4.5 6.7 3.1 13.4 3.6 9.4 6.5 2.7 2.7 7.5 5.1 1.9 5.6 6.4 0.3 11.8 4.2 7.8 10.2 2.1 14.6 7.7 8.4 7.3 15.8 8.5 5.3 HERPUD1 "HERP, KIAA0025, Mif1, SUP" ENSG00000051108 "Homocysteine inducible ER protein with ubiquitin like domain 1" Q15011 16 56932048-56944863 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 61.2;RPMI-8226: 76.8;U-266/70: 87.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037041, CAB037104, HPA040754, HPA041219" Approved Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268" "unprognostic (1.92e-1)" "unprognostic (3.47e-1)" "unprognostic (8.64e-2)" "unprognostic (3.93e-3)" "unprognostic (3.39e-1)" "unprognostic (5.00e-3)" "unprognostic (1.17e-1)" "unprognostic (9.69e-3)" "unprognostic (3.33e-1)" "unprognostic (2.56e-1)" "unprognostic (2.84e-1)" "unprognostic (3.50e-1)" "prognostic favourable (1.41e-9)" "unprognostic (1.06e-1)" "unprognostic (3.93e-2)" "unprognostic (2.19e-2)" "unprognostic (2.27e-3)" 22.7 38.8 16.2 35.6 20.7 21.6 39.4 17.7 20.0 30.1 32.1 20.0 48.8 21.4 21.6 51.6 15.0 20.2 32.5 28.8 15.8 15.5 42.9 57.7 30.4 40.0 25.6 12.5 44.8 148.6 37.6 26.7 26.2 25.6 49.5 32.3 35.3 108.6 76.1 34.6 18.3 24.7 17.6 24.2 38.3 37.2 10.6 20.8 9.6 64.2 20.4 53.8 24.4 25.9 50.8 121.9 29.0 39.5 22.4 33.4 46.5 4.4 4.9 4.8 10.0 11.2 14.6 17.2 10.6 16.9 13.7 10.7 6.8 10.2 18.1 13.6 10.2 7.7 8.2 3.7 13.6 10.4 4.9 1.5 8.2 24.5 61.2 3.2 8.1 17.7 35.8 6.2 19.7 10.4 2.4 25.9 38.2 3.7 6.1 6.7 3.1 11.1 4.2 12.2 76.8 29.4 5.0 5.3 6.1 9.2 45.4 46.9 5.0 12.2 6.3 5.7 5.7 5.0 4.2 87.6 28.5 28.3 8.1 4.5 7.4 23.9 39.5 18.0 16.1 31.0 17.4 50.8 17.5 21.1 30.6 37.8 11.4 17.4 29.0 22.4 21.5 121.9 33.4 46.5 16.2 20.7 17.7 20.0 15.8 15.5 25.6 12.5 25.6 20.8 HERPUD2 FLJ22313 ENSG00000122557 "HERPUD family member 2" Q9BSE4 7 35632659-35695571 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015630, HPA076087" Approved Approved Nucleoli Nucleoli "HPA015630: AB_1850609, HPA076087: " "unprognostic (1.85e-2)" "unprognostic (5.31e-3)" "unprognostic (2.76e-1)" "unprognostic (3.79e-1)" "unprognostic (3.46e-1)" "unprognostic (2.73e-2)" "unprognostic (2.48e-1)" "unprognostic (1.26e-1)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (2.30e-2)" "unprognostic (7.95e-2)" "unprognostic (5.13e-2)" "unprognostic (1.95e-1)" "unprognostic (5.42e-2)" "unprognostic (6.54e-2)" 22.7 13.7 19.2 25.6 21.7 34.3 21.9 25.0 21.7 24.2 20.3 18.6 18.8 16.1 24.3 17.1 21.2 19.9 26.4 16.6 17.5 14.0 17.6 25.3 22.7 33.7 16.7 18.3 37.0 31.4 18.0 22.5 21.6 15.4 21.6 19.3 19.5 19.6 23.8 17.9 20.9 20.5 23.9 18.5 24.1 18.0 39.5 18.3 34.3 22.5 15.4 23.2 25.0 22.0 5.7 5.9 19.2 9.2 12.1 12.2 4.8 18.5 7.0 13.3 13.0 20.0 15.3 10.8 13.2 18.6 8.6 9.7 8.4 22.2 13.3 21.1 16.7 23.4 7.4 9.5 13.4 8.9 9.5 9.2 8.6 5.6 17.2 9.3 11.8 19.1 17.2 10.8 17.7 14.2 14.4 17.9 14.9 7.8 10.6 15.3 11.2 9.7 12.8 16.1 10.7 11.2 8.3 11.1 18.4 16.7 15.9 11.4 16.0 11.3 16.6 13.5 15.6 13.1 10.5 24.9 28.3 14.1 13.0 14.4 24.8 5.8 6.8 19.2 10.6 7.6 12.2 4.4 9.5 11.3 5.9 5.7 5.9 8.0 11.7 12.1 9.2 3.6 8.6 4.8 19.2 21.7 25.0 21.7 17.5 14.0 16.7 18.3 15.4 18.3 HFE HLA-H ENSG00000010704 Hemochromatosis Q30201 6 26087281-26098343 "Disease related genes, Predicted membrane proteins" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017276, HPA053470" Approved Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA017276: AB_1850677, HPA053470: " "unprognostic (6.96e-2)" "unprognostic (7.87e-2)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (6.07e-3)" "unprognostic (7.58e-2)" "unprognostic (4.23e-1)" "unprognostic (1.77e-1)" "unprognostic (8.21e-3)" "unprognostic (1.78e-1)" "unprognostic (3.31e-3)" "unprognostic (1.82e-1)" "unprognostic (1.33e-2)" "unprognostic (2.12e-2)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.17e-1)" 7.2 13.7 2.2 4.4 2.7 0.0 6.2 1.2 2.5 6.7 7.1 3.5 10.3 4.2 6.8 13.9 7.6 5.2 13.3 8.9 2.0 1.4 5.4 12.8 9.0 16.1 2.3 2.0 8.1 16.2 14.6 2.2 7.6 4.3 12.6 5.3 13.7 7.0 8.1 3.1 3.2 5.8 10.4 3.2 14.4 6.1 4.9 1.2 2.0 7.7 3.9 5.0 8.6 5.2 3.5 4.6 1.9 10.5 0.2 2.2 3.4 8.1 18.7 0.3 9.1 13.8 10.6 0.0 5.8 14.0 7.5 11.9 1.5 16.6 0.8 15.9 9.6 5.2 0.0 6.9 9.6 2.1 0.1 0.2 4.4 1.2 2.7 0.0 0.3 11.0 2.0 8.2 0.7 5.1 0.3 0.2 6.4 3.3 0.0 0.1 0.4 0.0 1.1 0.0 0.1 6.2 5.4 0.0 0.0 3.5 0.0 5.0 26.6 0.8 3.9 5.3 0.5 5.3 5.1 0.1 0.1 0.1 7.9 0.1 11.4 1.2 10.5 0.0 1.7 10.2 1.3 3.5 1.7 2.2 4.6 1.5 0.4 1.2 1.9 0.2 8.2 0.3 0.3 3.4 2.2 2.7 1.2 2.5 2.0 1.4 2.3 2.0 4.3 1.2 HHATL "C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3" ENSG00000010282 "Hedgehog acyltransferase like" Q9HCP6 3 42692663-42702827 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "brain: 57.1;heart muscle: 184.7;skeletal muscle: 93.6" "Cell line enhanced" "Detected in some" "ASC diff: 1.1;HSkMC: 1.3;Karpas-707: 1.1;NTERA-2: 1.4;RPMI-8226: 4.1;THP-1: 1.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 25.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018174 Enhanced "HPA018174: AB_2116671" "unprognostic (1.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.20e-2)" "unprognostic (9.71e-2)" "unprognostic (7.94e-3)" "unprognostic (3.79e-2)" "unprognostic (8.80e-2)" "unprognostic (2.47e-1)" "unprognostic (5.98e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (9.68e-2)" "unprognostic (1.01e-1)" "unprognostic (2.89e-1)" "unprognostic (3.14e-1)" 1.5 1.6 12.9 1.3 29.0 1.3 1.9 2.3 15.2 1.5 1.4 36.5 0.0 1.3 1.7 1.5 2.7 2.0 1.5 184.7 14.5 8.9 1.4 1.3 1.5 1.4 51.6 10.5 1.4 1.8 1.4 0.9 1.4 25.9 1.9 1.4 5.4 4.7 1.4 93.6 1.6 1.4 1.4 57.1 1.4 1.3 1.7 39.9 0.0 9.3 7.2 1.4 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.3 0.0 1.4 0.0 0.5 0.0 4.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.5 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 29.0 2.3 15.2 14.5 8.9 51.6 10.5 25.9 39.9 HHIP "FLJ20992, HIP" ENSG00000164161 "Hedgehog interacting protein" Q96QV1 4 144646021-144745271 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.5;lung: 29.7" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 68.2;TIME: 78.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012616 Uncertain Approved Nucleoplasm "Secreted in other tissues" Nucleoplasm "HPA012616: AB_1850687" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (7.12e-3)" "unprognostic (8.18e-2)" "unprognostic (2.43e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-1)" "unprognostic (1.95e-2)" "unprognostic (4.20e-1)" "unprognostic (1.90e-2)" "unprognostic (1.89e-1)" "unprognostic (9.66e-3)" "unprognostic (7.13e-3)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (2.38e-1)" 4.0 5.2 9.9 1.7 22.2 2.3 1.1 2.3 16.0 3.4 6.5 31.5 0.0 5.5 4.1 8.1 1.0 1.2 3.0 1.1 16.0 6.3 2.4 12.7 29.7 1.0 21.6 9.9 2.2 4.8 1.0 1.1 1.0 17.5 9.8 6.8 4.4 1.3 6.2 1.3 1.1 8.2 1.3 12.3 1.0 11.2 3.7 26.5 2.3 1.6 0.0 1.0 7.1 1.0 0.1 2.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.6 68.2 0.0 0.0 1.0 0.0 9.6 0.0 0.9 0.6 0.1 13.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.7 0.0 0.8 0.0 0.5 0.4 0.0 2.0 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 2.6 0.0 0.0 9.9 22.2 2.3 16.0 16.0 6.3 21.6 9.9 17.5 26.5 HHLA2 "B7-H5, B7H7, B7y" ENSG00000114455 "HERV-H LTR-associating 2" Q9UM44 3 108296490-108378285 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 125.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.9;Karpas-707: 5.8" "Group enriched" "Detected in many" 12 "colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 5.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055478 Enhanced "HPA055478: " "unprognostic (1.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.11e-1)" "unprognostic (2.30e-1)" "unprognostic (1.59e-2)" "unprognostic (8.14e-5)" "unprognostic (1.76e-1)" "unprognostic (2.28e-1)" "unprognostic (1.08e-1)" "unprognostic (6.42e-3)" "unprognostic (1.24e-1)" "unprognostic (1.62e-3)" "unprognostic (1.47e-1)" "unprognostic (2.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.66e-2)" 0.2 0.2 0.3 4.3 0.3 0.0 0.2 0.2 0.3 0.3 39.6 0.2 0.2 25.5 0.2 0.5 0.2 0.9 8.5 0.2 0.3 0.3 7.8 0.4 2.2 0.2 0.3 0.2 0.6 1.2 0.0 0.3 0.2 0.2 0.2 25.2 0.2 0.2 0.2 0.2 0.1 125.2 0.3 0.5 0.3 2.5 1.9 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.3 5.1 1.2 1.5 0.3 0.5 0.7 0.4 0.6 0.4 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.5 3.5 0.4 0.3 0.4 0.1 0.4 1.2 0.0 0.0 7.9 0.2 0.2 2.7 0.5 0.0 1.7 1.0 0.0 0.0 0.0 0.0 0.1 0.7 5.8 0.0 0.5 0.8 3.0 1.2 0.6 0.7 0.3 1.6 0.1 0.3 1.4 1.4 1.4 0.1 0.3 0.3 0.4 0.3 0.3 1.5 0.5 0.4 3.1 1.4 0.8 0.1 0.9 0.2 1.2 0.3 1.1 0.1 0.4 0.1 0.3 0.2 0.5 5.1 0.3 0.2 0.1 0.5 0.3 1.5 0.1 0.0 0.7 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.2 0.2 HILPDA "C7orf68, FLJ21076, HIG-2, HIG2" ENSG00000135245 "Hypoxia inducible lipid droplet associated" Q9Y5L2 7 128455849-128458418 "Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4;esophagus: 71.4" "Cell line enhanced" "Detected in all" "SK-BR-3: 44.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010515 Approved Supported "Nucleoplasm,Lipid droplets" "Intracellular and membrane" "Lipid droplets" Nucleoplasm "HPA010515: AB_1850710" "unprognostic (1.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (2.27e-1)" "unprognostic (2.10e-2)" "unprognostic (2.70e-2)" "prognostic unfavourable (4.30e-11)" "unprognostic (9.20e-3)" "unprognostic (4.07e-3)" "unprognostic (2.49e-1)" "unprognostic (4.06e-3)" "unprognostic (2.15e-2)" "prognostic unfavourable (2.05e-7)" "unprognostic (2.23e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-2)" "unprognostic (1.27e-1)" 24.5 5.2 25.3 5.5 34.2 14.1 16.2 8.6 53.9 15.7 14.4 6.4 2.8 4.7 9.1 6.3 71.4 7.9 7.2 16.7 25.1 8.5 10.4 10.3 13.2 4.9 22.4 3.1 22.9 5.0 3.0 4.2 25.7 46.5 7.0 6.2 2.8 7.7 6.1 5.2 14.4 4.4 6.9 66.4 3.0 6.4 10.1 21.1 1.7 5.6 6.9 6.0 60.5 18.6 9.2 5.9 31.7 3.6 6.9 3.3 2.0 11.0 23.2 12.7 13.8 17.4 6.4 23.9 4.0 5.0 8.5 9.4 5.8 10.1 7.5 3.2 6.0 7.1 7.1 8.6 10.9 4.1 6.5 4.6 4.9 5.2 3.9 7.2 6.3 10.6 7.5 6.7 4.5 6.9 6.6 3.1 8.4 13.5 21.7 13.2 15.7 10.3 16.4 5.9 11.7 4.7 16.4 12.2 11.2 6.3 44.1 7.8 35.9 7.1 5.0 10.9 5.4 8.2 5.0 3.1 2.2 9.6 20.6 11.2 9.4 9.2 3.5 31.7 2.3 3.6 3.3 7.8 2.9 2.8 3.4 9.2 3.0 2.9 1.4 6.9 2.7 5.9 1.9 2.0 25.3 34.2 8.6 53.9 25.1 8.5 22.4 3.1 46.5 21.1 HIPK1 "KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2" ENSG00000163349 "Homeodomain interacting protein kinase 1" Q86Z02 1 113929192-113977869 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 90.1" "Cell line enhanced" "Detected in all" "MCF7: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016664 Approved Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome, Cytosol" "HPA016664: AB_1850725" "unprognostic (2.98e-1)" "unprognostic (3.94e-2)" "unprognostic (4.89e-3)" "unprognostic (2.52e-2)" "unprognostic (6.47e-2)" "unprognostic (9.84e-3)" "unprognostic (4.64e-3)" "unprognostic (7.22e-2)" "unprognostic (7.52e-2)" "unprognostic (1.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.15e-1)" "unprognostic (8.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.64e-1)" "unprognostic (1.94e-2)" "unprognostic (1.99e-2)" 15.1 16.8 21.2 14.7 23.0 90.1 13.6 38.1 20.4 20.4 14.4 20.7 14.5 10.2 15.5 14.2 18.7 27.3 17.5 27.9 22.9 17.2 14.8 13.8 19.3 14.7 15.0 16.4 18.7 16.8 20.7 23.8 13.8 21.3 14.4 15.2 20.7 13.0 14.9 19.7 18.5 13.4 15.1 18.3 15.9 14.8 33.5 21.3 47.2 23.3 13.1 15.5 17.3 26.7 2.3 6.2 9.8 4.2 4.3 6.0 2.3 8.1 6.6 9.2 7.0 10.8 5.7 6.2 5.6 6.8 8.0 7.7 7.6 3.1 10.9 7.7 8.9 5.5 11.8 6.6 11.6 7.9 6.0 15.9 8.3 8.0 9.0 12.7 19.7 6.1 9.6 10.2 10.5 11.8 10.8 11.8 11.5 61.5 16.6 7.2 9.4 5.9 10.1 27.0 3.8 7.2 7.0 4.1 5.4 10.2 11.0 7.2 6.4 18.3 11.5 7.9 10.7 12.8 8.5 7.4 5.8 9.5 8.8 10.3 17.9 3.4 4.2 8.2 5.5 3.7 5.2 1.7 4.9 4.9 3.1 2.3 5.0 6.0 9.8 4.3 2.6 6.2 3.6 2.3 21.2 23.0 38.1 20.4 22.9 17.2 15.0 16.4 21.3 21.3 HIPK2 ENSG00000064393 "Homeodomain interacting protein kinase 2" Q9H2X6 7 139561570-139777778 "Enzymes, Plasma proteins, Predicted membrane proteins" "Apoptosis, DNA damage, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Cell line enhanced" "Detected in many" "HDLM-2: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 17.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007611 Supported Supported Nucleoplasm Nucleoplasm "HPA007611: AB_1850730" "unprognostic (1.35e-3)" "unprognostic (1.49e-2)" "unprognostic (1.65e-1)" "unprognostic (7.65e-2)" "unprognostic (5.50e-2)" "unprognostic (9.44e-2)" "unprognostic (2.76e-1)" "unprognostic (4.66e-2)" "unprognostic (1.44e-1)" "unprognostic (2.76e-2)" "unprognostic (3.42e-3)" "unprognostic (4.58e-2)" "prognostic favourable (9.99e-4)" "unprognostic (1.38e-1)" "unprognostic (7.82e-2)" "unprognostic (3.93e-3)" "unprognostic (1.03e-2)" 19.6 9.8 58.8 7.4 53.6 14.4 12.6 8.5 39.8 5.5 7.4 54.5 5.2 8.2 4.7 5.2 10.2 9.9 5.5 30.5 60.0 39.9 28.2 17.5 8.6 5.3 66.1 16.4 6.6 12.3 17.2 7.6 10.8 26.4 10.7 5.8 9.4 11.5 7.1 21.6 3.2 6.2 4.8 56.2 7.3 15.4 2.6 38.6 1.7 10.4 2.8 4.9 6.8 7.4 0.6 0.5 17.8 2.9 0.2 1.4 0.5 4.1 18.2 8.4 5.2 20.7 14.8 1.0 2.2 2.2 2.5 2.6 1.3 2.2 0.0 5.3 4.2 0.2 3.8 5.9 6.4 42.0 1.6 18.7 3.0 6.5 11.6 5.1 5.1 22.6 3.9 11.7 17.6 6.3 10.8 5.2 19.5 3.1 6.4 3.7 2.1 12.5 7.7 4.6 0.5 11.6 0.7 5.1 4.7 5.1 0.1 2.6 2.9 2.1 21.2 8.9 4.3 10.3 11.1 25.4 15.1 3.7 18.3 2.7 4.8 17.8 1.1 2.7 0.2 0.9 0.3 0.6 0.5 0.1 0.5 0.3 1.4 0.4 1.5 0.2 2.9 0.2 0.0 0.5 58.8 53.6 8.5 25.2 60.0 39.9 66.1 16.4 26.4 38.6 HIPK3 "DYRK6, FIST3, PKY, YAK1" ENSG00000110422 "Homeodomain interacting protein kinase 3" Q9H422 11 33256672-33357023 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028069 Approved Supported "Nuclear bodies,Cytosol" Cytosol "Nuclear bodies" "HPA028069: AB_10601815" "unprognostic (2.41e-3)" "unprognostic (1.02e-1)" "unprognostic (4.61e-1)" "unprognostic (5.74e-2)" "unprognostic (2.09e-1)" "unprognostic (1.78e-2)" "unprognostic (1.63e-1)" "unprognostic (7.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.78e-1)" "unprognostic (2.18e-1)" "unprognostic (2.68e-1)" "unprognostic (3.29e-3)" "unprognostic (7.89e-3)" "unprognostic (1.80e-1)" "unprognostic (1.87e-1)" "unprognostic (2.48e-2)" 46.3 13.4 12.7 15.9 15.9 12.7 49.2 11.7 13.7 23.6 24.8 11.9 15.9 9.9 28.3 22.8 22.9 24.1 18.8 69.0 13.4 11.8 23.4 21.1 20.2 20.9 15.5 8.2 23.6 15.4 49.7 21.2 20.5 15.2 23.2 12.8 15.6 18.8 18.1 45.9 18.7 25.0 32.9 15.9 20.1 20.5 14.7 14.2 15.2 37.9 26.0 14.4 33.6 34.6 3.1 11.3 17.6 10.1 3.3 4.4 3.7 9.4 9.0 6.8 7.7 31.6 20.0 6.8 10.0 11.6 8.1 6.9 9.9 6.9 10.2 8.5 12.2 12.1 5.1 11.2 11.5 14.8 8.0 10.3 10.2 7.5 13.1 11.0 6.5 18.7 22.0 3.1 9.2 9.9 3.2 20.5 13.1 4.9 9.1 7.7 1.7 5.5 12.3 24.2 10.2 13.4 14.8 1.0 5.7 13.6 15.6 9.3 17.5 20.4 12.7 12.8 8.8 14.7 7.1 11.3 17.7 10.8 6.2 11.7 11.9 6.6 10.1 4.8 3.5 7.6 4.4 2.4 3.2 3.7 11.3 3.1 2.9 3.5 17.6 3.3 8.6 1.4 3.2 3.7 12.7 15.9 11.7 13.7 13.4 11.8 15.5 8.2 15.2 14.2 HLA-A ENSG00000206503 "Major histocompatibility complex, class I, A" "P16188, P04439, P13746" 6 29941260-29945884 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 154.8;fHDF/TERT166: 41.4;HBEC3-KT: 42.5;RPMI-8226: 40.3;U-266/70: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" CAB078470 Supported "Golgi apparatus,Plasma membrane" "Plasma membrane" "Golgi apparatus" "CAB078470: AB_10985125" "unprognostic (1.56e-2)" "unprognostic (9.14e-2)" "unprognostic (1.34e-2)" "prognostic favourable (9.59e-4)" "unprognostic (3.49e-1)" "unprognostic (1.21e-1)" "unprognostic (1.12e-1)" "unprognostic (7.28e-2)" "unprognostic (3.42e-2)" "prognostic favourable (6.47e-4)" "unprognostic (2.96e-1)" "unprognostic (3.24e-1)" "unprognostic (1.84e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.54e-2)" 69.4 57.5 16.0 69.1 18.2 41.2 40.8 9.1 20.7 54.4 92.6 20.4 28.6 105.7 38.4 76.2 48.4 27.8 92.3 59.1 14.6 16.6 80.5 47.6 112.0 90.5 19.5 8.9 57.2 30.0 22.5 33.3 38.7 22.7 64.1 38.5 52.4 28.3 19.2 44.0 110.4 129.4 30.3 22.8 150.0 115.9 26.6 12.3 71.1 62.3 38.5 97.7 86.4 41.0 23.0 10.9 65.8 25.2 25.9 46.7 45.4 154.8 3.9 0.0 0.0 25.0 23.6 0.1 0.1 0.3 0.2 0.2 0.0 0.0 0.4 0.0 41.4 3.8 0.0 42.5 0.0 0.3 1.5 27.0 1.2 0.8 1.4 0.0 1.8 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 2.4 0.3 0.4 3.3 0.3 40.3 29.0 31.8 0.0 1.4 3.5 0.0 1.4 0.1 3.6 0.5 2.3 0.1 0.7 0.4 41.3 10.5 8.7 0.0 22.8 0.0 65.8 25.2 35.4 38.3 17.9 28.8 23.0 29.6 34.4 4.1 14.9 21.7 29.7 47.9 25.9 19.8 10.9 46.7 45.4 16.0 18.2 9.1 20.7 14.6 16.6 19.5 8.9 22.7 12.3 HLA-B AS ENSG00000234745 "Major histocompatibility complex, class I, B" "P30486, Q29836, Q31610, Q31612, P01889, P30480" 6 31269491-31357188 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 69.9;EFO-21: 63.8;U-266/70: 161.8;U-698: 44.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" CAB015418 Enhanced "CAB015418: AB_831547" "unprognostic (2.87e-2)" "unprognostic (1.49e-1)" "unprognostic (4.90e-2)" "unprognostic (2.65e-2)" "unprognostic (1.86e-1)" "unprognostic (1.81e-1)" "unprognostic (5.16e-3)" "unprognostic (8.51e-2)" "prognostic favourable (2.90e-4)" "unprognostic (2.69e-3)" "unprognostic (3.05e-2)" "unprognostic (1.59e-1)" "unprognostic (9.28e-3)" "unprognostic (3.27e-1)" "unprognostic (7.83e-2)" "unprognostic (8.24e-3)" "unprognostic (3.67e-2)" 83.5 40.1 11.7 91.4 14.2 11.0 52.6 6.7 13.1 41.4 96.5 18.2 15.6 2.0 52.8 51.5 46.1 30.8 100.3 76.8 11.9 13.4 63.3 57.1 194.5 214.9 17.3 10.5 40.2 21.8 16.2 20.2 39.5 19.1 70.4 56.1 45.4 108.9 23.4 37.4 56.4 164.1 20.6 23.8 200.6 43.2 32.1 11.9 54.1 44.5 19.1 136.3 117.6 48.6 45.6 41.4 118.7 56.5 46.5 64.3 81.8 69.9 0.0 0.0 0.0 1.7 12.0 0.4 0.0 0.3 0.1 0.2 0.0 0.5 2.5 63.8 12.4 29.4 14.5 12.8 0.0 0.2 3.4 0.9 0.0 0.0 9.4 0.0 0.6 23.6 0.0 0.0 1.6 0.0 0.1 3.4 0.0 0.0 0.3 18.2 0.2 0.0 2.1 0.4 0.4 19.3 0.0 0.1 0.5 0.6 0.1 0.1 11.1 0.7 15.0 3.8 0.6 0.6 0.2 161.8 36.0 44.3 0.2 0.7 0.1 20.6 56.5 59.1 64.3 42.7 62.2 45.6 54.9 58.5 41.4 35.1 42.1 55.2 118.7 46.5 37.4 33.9 56.2 81.8 11.7 14.2 6.7 13.1 11.9 13.4 17.3 10.5 19.1 11.9 HLA-DMA "D6S222E, RING6" ENSG00000204257 "Major histocompatibility complex, class II, DM alpha" P28067 6 32948613-32969094 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "U-266/70: 15.3;U-698: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 4.1;intermediate monocyte: 4.0;memory B-cell: 6.8;myeloid DC: 7.9;naive B-cell: 7.0;plasmacytoid DC: 5.7" "Group enriched" "Detected in many" 12 "B-cells: 7.0;dendritic cells: 7.9;monocytes: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012750, HPA017295" Enhanced Approved Vesicles Vesicles "HPA012750: AB_1853926, HPA017295: " "unprognostic (1.69e-3)" "unprognostic (3.52e-2)" "unprognostic (8.03e-2)" "prognostic favourable (4.64e-5)" "unprognostic (3.99e-1)" "unprognostic (3.90e-2)" "unprognostic (1.60e-1)" "prognostic favourable (4.59e-4)" "unprognostic (7.01e-2)" "unprognostic (9.69e-2)" "unprognostic (6.66e-2)" "unprognostic (1.89e-1)" "unprognostic (2.12e-3)" "unprognostic (1.41e-1)" "unprognostic (4.95e-2)" "unprognostic (3.80e-1)" "unprognostic (2.14e-2)" 22.9 20.5 5.1 27.2 7.9 18.9 17.4 1.0 5.0 11.3 18.4 9.8 5.7 3.2 8.0 25.3 6.7 32.1 11.1 13.1 4.6 5.2 19.3 12.4 50.7 24.5 10.1 2.0 14.9 20.2 2.1 5.0 3.2 9.7 7.6 14.3 8.4 17.3 10.1 4.3 7.3 28.4 4.3 15.2 38.5 23.1 3.5 7.9 17.3 10.0 11.9 42.1 5.9 6.0 7.0 7.9 0.5 4.1 0.3 0.4 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.2 0.1 0.0 1.2 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.3 6.7 39.0 0.3 0.0 0.0 0.0 4.1 0.4 0.2 4.0 0.0 6.8 0.1 0.3 7.9 7.0 0.1 0.2 0.5 0.3 1.1 5.7 0.4 3.1 5.1 7.9 1.0 5.0 4.6 5.2 10.1 2.0 9.7 7.9 HLA-DMB "D6S221E, RING7" ENSG00000242574 "Major histocompatibility complex, class II, DM beta" P28068 6 32934629-32941070 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 13 "CAPAN-2: 7.2;Daudi: 10.1;EFO-21: 4.8;U-266/70: 3.8;U-698: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 19.9;dendritic cells: 11.5;monocytes: 11.9" "HPA012298, HPA077524" Supported Supported Vesicles Vesicles "HPA012298: AB_1853927, HPA077524: " "unprognostic (5.34e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-2)" "prognostic favourable (3.89e-5)" "unprognostic (3.07e-1)" "unprognostic (7.64e-3)" "unprognostic (4.00e-1)" "unprognostic (3.46e-3)" "unprognostic (6.99e-2)" "unprognostic (8.76e-2)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (6.82e-3)" "unprognostic (2.03e-1)" "unprognostic (4.14e-2)" "unprognostic (8.35e-2)" "unprognostic (5.60e-2)" 12.0 13.0 5.9 20.2 7.5 4.3 7.9 0.4 4.9 8.1 9.7 8.8 2.1 1.2 6.2 10.2 3.3 12.6 6.0 8.0 5.7 4.2 13.1 5.4 20.8 24.0 10.2 2.3 7.4 5.0 1.2 3.2 6.2 8.1 6.3 10.5 6.3 7.8 3.2 2.9 4.5 31.8 1.9 14.5 35.6 6.1 2.1 7.3 10.5 33.7 3.8 34.5 10.6 3.2 19.9 11.5 2.2 11.9 2.2 1.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 10.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.3 12.3 0.0 0.0 0.0 0.0 11.9 2.2 0.3 10.1 0.4 15.1 0.2 0.5 11.1 19.9 0.1 0.5 0.5 2.2 3.5 11.5 1.0 10.3 5.9 7.5 0.4 4.9 5.7 4.2 10.2 2.3 8.1 7.3 HLA-DOA "HLA-D0-alpha, HLA-DNA, HLA-DZA" ENSG00000204252 "Major histocompatibility complex, class II, DO alpha" P06340 6 33004178-33009612 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 30.6" "Cell line enhanced" "Detected in some" "Daudi: 6.3;HDLM-2: 4.5;REH: 20.2;U-698: 4.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 9.1;naive B-cell: 11.2" "Group enriched" "Detected in many" 9 "B-cells: 11.2;dendritic cells: 9.1;monocytes: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045038 Enhanced "HPA045038: AB_10959457" "unprognostic (8.02e-2)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" "unprognostic (1.19e-1)" "unprognostic (3.01e-1)" "unprognostic (3.83e-2)" "unprognostic (2.60e-1)" "unprognostic (9.86e-3)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (3.68e-1)" "unprognostic (4.39e-2)" "unprognostic (1.91e-1)" "unprognostic (9.95e-2)" "unprognostic (3.65e-2)" "unprognostic (8.70e-2)" "unprognostic (5.94e-2)" 5.7 5.7 2.2 18.4 3.9 2.0 5.1 1.5 2.1 4.5 4.0 8.3 2.2 5.1 4.6 6.0 2.7 4.6 4.8 9.3 2.8 3.1 10.0 3.4 18.1 24.7 5.5 2.0 5.7 2.9 3.3 3.3 1.0 5.4 5.4 4.7 4.0 4.5 3.2 1.2 2.5 12.3 2.4 9.6 25.5 4.5 1.2 3.9 14.7 3.8 3.2 30.6 3.4 3.1 11.2 9.1 0.3 4.4 0.1 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.4 0.0 7.4 0.0 0.3 9.1 11.2 0.1 0.9 0.3 0.1 2.0 2.8 0.7 1.4 2.2 3.9 1.5 2.1 2.8 3.1 5.5 2.0 5.4 3.9 HLA-DOB ENSG00000241106 "Major histocompatibility complex, class II, DO beta" P13765 6 32812763-32817048 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.1;lymphoid tissue: 33.0" "Group enriched" "Detected in some" 5 "Daudi: 32.7;U-698: 11.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "memory B-cell: 42.0;naive B-cell: 51.1" "Lineage enriched" "Detected in many" 19 "B-cells: 51.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA013846 Enhanced "HPA013846: AB_1853928" "prognostic favourable (4.29e-4)" "unprognostic (3.84e-2)" "unprognostic (7.12e-3)" "unprognostic (6.02e-2)" "unprognostic (1.74e-1)" "unprognostic (1.00e-2)" "unprognostic (4.48e-2)" "unprognostic (4.26e-3)" "unprognostic (6.95e-2)" "prognostic favourable (4.17e-5)" "unprognostic (2.37e-1)" "unprognostic (1.36e-1)" "prognostic unfavourable (3.15e-5)" "unprognostic (1.37e-1)" "unprognostic (1.64e-1)" "unprognostic (7.18e-2)" "unprognostic (2.46e-1)" 0.7 0.4 0.3 28.8 0.3 2.7 1.4 0.7 0.3 1.2 2.7 0.4 0.0 1.7 0.7 0.5 1.3 0.5 1.4 2.2 0.2 0.4 1.8 0.7 3.3 33.0 0.4 0.2 0.5 0.2 0.0 1.8 0.5 0.8 0.7 2.4 0.7 3.8 0.9 0.4 1.0 12.2 0.2 0.7 28.5 1.4 1.7 0.1 5.8 1.1 0.9 29.8 5.5 0.8 51.1 2.6 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 1.6 32.7 0.1 0.0 0.2 0.9 1.7 0.0 1.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.1 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.6 0.3 11.5 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.0 0.0 0.0 2.6 51.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.5 0.3 0.3 0.7 0.3 0.2 0.4 0.4 0.2 0.8 0.1 HLA-DPA1 HLA-DP1A ENSG00000231389 "Major histocompatibility complex, class II, DP alpha 1" P20036 6 33064569-33080775 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 59.5" "Cell line enhanced" "Detected in some" "Daudi: 15.4;HDLM-2: 47.5;REH: 12.1;U-698: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 16.3;intermediate monocyte: 37.8;memory B-cell: 30.0;myeloid DC: 59.5;naive B-cell: 26.7;non-classical monocyte: 23.2;plasmacytoid DC: 17.1" "Group enriched" "Detected in all" 8 "B-cells: 30.0;dendritic cells: 59.5;monocytes: 37.8" HPA017967 Enhanced Supported Vesicles 92000 Vesicles "HPA017967: AB_1853929" "unprognostic (8.93e-3)" "unprognostic (3.15e-2)" "unprognostic (3.64e-2)" "unprognostic (9.40e-3)" "unprognostic (9.07e-2)" "unprognostic (2.80e-2)" "unprognostic (5.69e-2)" "unprognostic (1.82e-2)" "unprognostic (7.28e-2)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.17e-1)" "unprognostic (4.69e-2)" "unprognostic (8.11e-2)" "unprognostic (1.06e-1)" 25.2 12.8 3.3 13.3 3.6 4.7 16.3 3.5 3.3 11.8 6.8 3.1 4.3 8.6 8.5 15.9 8.5 5.7 14.7 11.1 4.2 6.2 12.4 9.7 35.9 20.2 6.2 3.8 3.8 5.4 3.8 5.2 6.5 4.8 7.4 7.3 7.5 7.4 15.7 4.1 5.8 14.7 6.4 20.4 37.6 5.6 8.6 4.1 10.9 14.2 9.5 21.5 8.5 17.8 30.0 59.5 1.3 37.8 4.0 5.6 20.3 0.0 0.0 0.0 0.0 0.3 0.5 0.5 0.2 0.1 0.2 0.0 0.0 2.1 15.4 2.2 0.3 0.0 0.0 0.0 0.0 47.5 1.0 2.5 0.0 0.0 0.0 0.0 5.0 0.7 0.0 0.9 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 12.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.5 1.1 3.4 0.0 0.0 0.0 2.4 0.3 11.1 5.4 0.1 1.8 0.3 16.3 1.3 4.6 37.8 1.2 30.0 2.1 5.0 59.5 26.7 0.7 3.4 0.6 4.0 23.2 17.1 5.6 20.3 3.3 3.6 3.5 3.3 4.2 6.2 6.2 3.8 4.8 4.1 HLA-DPB1 HLA-DP1B ENSG00000223865 "Major histocompatibility complex, class II, DP beta 1" P04440 6 33075926-33087201 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 99.4" "Group enriched" "Detected in some" 6 "HDLM-2: 46.1;REH: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 90.1" "Group enriched" "Detected in all" 8 "B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6" "HPA011078, HPA058509" Approved Approved "Nucleoplasm,Cell Junctions" 730000 "Cell Junctions" Nucleoplasm "HPA011078: AB_1079378, HPA058509: " "unprognostic (5.44e-3)" "unprognostic (7.03e-3)" "unprognostic (9.84e-2)" "prognostic favourable (3.38e-4)" "unprognostic (9.43e-2)" "unprognostic (1.80e-2)" "unprognostic (1.52e-1)" "unprognostic (1.51e-3)" "unprognostic (1.77e-2)" "unprognostic (5.64e-2)" "unprognostic (1.57e-1)" "unprognostic (4.34e-1)" "unprognostic (4.35e-2)" "unprognostic (1.80e-1)" "unprognostic (4.17e-2)" "unprognostic (3.58e-2)" "unprognostic (1.85e-1)" 29.6 31.9 9.8 52.8 15.1 6.9 22.0 6.1 7.7 15.5 11.8 14.9 6.9 14.4 15.3 23.4 9.8 11.0 26.6 29.6 9.7 10.4 25.5 12.4 79.9 99.4 23.5 6.0 10.8 10.5 4.3 11.5 6.2 19.6 19.4 6.6 22.2 25.0 15.4 6.1 14.8 33.7 8.9 35.3 88.8 15.8 4.3 16.2 51.9 14.2 20.7 69.3 35.5 11.9 57.8 90.1 1.1 40.6 2.8 7.6 23.5 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.2 0.0 0.0 0.0 0.0 46.1 2.1 1.2 0.0 0.0 0.0 0.0 0.1 1.2 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.5 0.0 22.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 5.8 0.1 3.8 0.0 0.0 0.0 0.2 18.7 1.1 5.3 40.6 0.7 57.8 1.9 7.6 90.1 56.9 0.7 4.2 0.4 2.8 17.0 25.7 7.2 23.5 9.8 15.1 6.1 7.7 9.7 10.4 23.5 6.0 19.6 16.2 HLA-DQA1 "CELIAC1, HLA-DQA" ENSG00000196735 "Major histocompatibility complex, class II, DQ alpha 1" P01909 6 32628179-32647062 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 91.5;lymphoid tissue: 113.3" "Cell line enriched" "Detected in some" 7 "HDLM-2: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 91.5" "Group enriched" "Detected in many" 19 "B-cells: 43.3;dendritic cells: 91.5;monocytes: 32.1" HPA012315 Enhanced "HPA012315: AB_1853930" "unprognostic (4.24e-3)" "unprognostic (1.47e-2)" "unprognostic (1.43e-2)" "unprognostic (7.94e-3)" "unprognostic (1.72e-1)" "unprognostic (6.07e-2)" "unprognostic (3.26e-1)" "unprognostic (5.81e-3)" "unprognostic (2.84e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-2)" "unprognostic (1.15e-1)" "unprognostic (5.36e-2)" "unprognostic (6.74e-2)" "unprognostic (2.27e-1)" "unprognostic (7.43e-2)" "unprognostic (1.57e-1)" 44.6 8.9 3.9 63.5 6.9 0.7 14.8 1.2 3.1 11.4 13.6 7.4 6.1 0.0 10.6 45.5 8.1 6.1 23.7 4.4 3.8 4.9 23.8 17.2 69.0 48.2 8.7 2.6 16.4 5.1 0.0 6.5 3.7 8.9 5.8 22.1 14.8 11.4 1.2 7.6 11.3 26.1 4.2 19.5 97.0 17.3 2.1 6.7 113.3 8.5 0.5 63.6 42.3 6.6 43.3 91.5 0.4 32.1 1.0 2.9 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.1 0.0 0.0 0.0 0.0 0.0 172.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.0 0.1 19.1 3.1 0.0 0.0 0.1 14.8 0.0 0.3 32.1 0.1 42.8 0.4 2.3 91.5 43.3 0.0 0.6 0.4 1.0 8.1 22.7 2.9 15.8 3.9 6.9 1.2 3.1 3.8 4.9 8.7 2.6 8.9 6.7 HLA-DQB1 "CELIAC1, HLA-DQB, IDDM1" ENSG00000179344 "Major histocompatibility complex, class II, DQ beta 1" 6 32659467-32668383 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 74.6" "Cell line enriched" "Detected in some" 6 "HDLM-2: 111.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 27.8;intermediate monocyte: 24.1;memory B-cell: 30.9;myeloid DC: 68.2;naive B-cell: 35.6;plasmacytoid DC: 21.4" "Group enriched" "Detected in all" 6 "B-cells: 35.6;dendritic cells: 68.2;monocytes: 27.8" HPA013667 Enhanced Supported "Golgi apparatus,Rods & Rings" "Rods & Rings" "Golgi apparatus" "HPA013667: AB_1853932" "unprognostic (8.60e-3)" "unprognostic (1.91e-2)" "unprognostic (5.91e-2)" "unprognostic (9.85e-3)" "unprognostic (4.48e-1)" "unprognostic (5.30e-2)" "unprognostic (4.75e-2)" "unprognostic (1.06e-2)" "unprognostic (2.51e-2)" "unprognostic (1.48e-1)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.34e-2)" "unprognostic (3.13e-1)" "unprognostic (4.16e-1)" "unprognostic (2.43e-1)" "unprognostic (1.40e-1)" 23.9 10.0 3.5 40.4 3.0 9.0 17.0 1.0 4.9 11.0 18.8 8.8 4.5 0.0 9.9 42.6 9.6 8.0 21.7 12.7 4.1 5.3 35.4 9.9 61.2 61.1 6.1 4.2 6.3 4.0 0.0 9.2 4.0 7.9 11.3 10.7 13.5 11.8 5.6 7.8 12.4 27.6 4.6 15.5 74.5 32.7 4.6 2.9 63.5 13.3 7.9 74.6 37.9 7.4 35.6 68.2 4.6 27.8 1.5 7.1 31.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.4 0.0 3.6 0.0 3.6 0.0 111.8 2.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.6 2.0 0.0 0.0 0.1 0.1 0.0 13.4 0.3 12.3 9.3 0.0 0.0 0.0 27.8 4.6 2.4 24.1 1.1 30.9 1.2 3.7 68.2 35.6 0.0 1.1 1.9 1.5 6.6 21.4 7.1 31.9 3.5 3.0 1.0 4.9 4.1 5.3 6.1 4.2 7.9 2.9 HLA-DQB2 HLA-DXB ENSG00000232629 "Major histocompatibility complex, class II, DQ beta 2" P05538 6 32756098-32763534 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.6;skin 1: 25.8" "Group enriched" "Detected in some" 4 "Daudi: 1.0;HDLM-2: 3.6;U-266/70: 1.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1" "Group enriched" "Detected in many" 7 "B-cells: 3.0;dendritic cells: 3.1;monocytes: 1.2" HPA073187 Enhanced "HPA073187: " "prognostic favourable (5.55e-4)" "unprognostic (3.75e-3)" "unprognostic (2.16e-1)" "unprognostic (2.50e-2)" "unprognostic (2.10e-1)" "unprognostic (6.60e-2)" "unprognostic (8.15e-2)" "unprognostic (3.73e-3)" "unprognostic (6.48e-2)" "unprognostic (1.25e-1)" "unprognostic (3.74e-1)" "unprognostic (1.94e-1)" "unprognostic (6.66e-2)" "unprognostic (1.23e-1)" "unprognostic (4.10e-2)" "unprognostic (1.16e-1)" "unprognostic (6.92e-2)" 2.1 0.9 0.4 3.5 0.4 0.3 2.0 0.4 0.3 2.1 0.5 0.6 0.2 0.4 0.3 1.8 5.5 0.6 0.8 0.3 0.3 0.2 1.2 0.4 9.7 3.0 1.3 0.2 0.9 0.2 0.0 0.8 0.2 0.8 0.6 1.1 0.8 2.7 0.8 0.5 25.8 3.1 0.2 1.4 7.2 2.2 0.5 0.3 25.6 1.0 11.3 17.8 1.1 2.3 3.0 3.1 0.3 1.2 0.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.2 0.0 0.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.2 0.4 0.2 0.1 0.2 0.8 0.1 0.1 1.2 0.0 2.8 0.0 0.1 3.1 3.0 0.1 0.1 0.3 0.3 0.4 0.5 0.2 1.2 0.4 0.4 0.4 0.3 0.3 0.2 1.3 0.2 0.8 0.3 HLA-DRA HLA-DRA1 ENSG00000204287 "Major histocompatibility complex, class II, DR alpha" P01903 6 32439842-32445046 "Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 211.6" "Cell line enhanced" "Detected in some" "Daudi: 55.4;HDLM-2: 98.7;REH: 40.2;U-266/70: 24.3;U-698: 56.9;U-87 MG: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 29.8;intermediate monocyte: 46.8;memory B-cell: 59.4;naive B-cell: 61.7;non-classical monocyte: 28.0;plasmacytoid DC: 29.6" "Group enriched" "Detected in all" 5 "B-cells: 61.7;dendritic cells: 29.6;monocytes: 46.8" "Low region specificity" "Detected in all" "CAB002798, CAB015402, HPA050162, HPA053176" Enhanced 1600000 "CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070" "unprognostic (1.20e-3)" "unprognostic (4.70e-3)" "prognostic favourable (5.30e-4)" "unprognostic (3.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (2.77e-2)" "unprognostic (3.05e-2)" "unprognostic (3.92e-2)" "unprognostic (1.89e-1)" "unprognostic (1.35e-1)" "unprognostic (1.98e-1)" "unprognostic (4.42e-2)" "unprognostic (5.67e-2)" "unprognostic (2.52e-2)" 51.8 33.5 14.1 79.1 20.2 1.8 37.3 2.3 10.1 21.1 38.9 21.5 10.9 30.8 16.5 76.8 15.9 33.9 21.8 34.7 13.1 16.2 60.9 17.8 147.2 211.6 27.3 7.4 14.7 10.0 1.7 14.7 9.7 23.5 21.9 33.8 23.5 21.6 12.6 12.9 27.6 86.2 9.0 52.8 127.3 68.7 7.2 21.6 53.7 18.6 25.9 151.6 53.5 15.1 61.7 29.6 9.3 46.8 1.8 2.7 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 55.4 0.4 0.0 0.0 0.0 0.0 0.0 98.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 24.3 0.0 56.9 39.6 0.0 0.0 0.6 29.8 9.3 0.3 46.8 0.1 59.4 0.3 1.7 0.5 61.7 0.2 0.3 2.2 1.8 28.0 29.6 2.7 29.9 14.1 20.2 2.3 10.1 13.1 16.2 27.3 7.4 23.5 21.6 HLA-DRB1 HLA-DR1B ENSG00000196126 "Major histocompatibility complex, class II, DR beta 1" "P04229, Q29974, Q9GIY3, P01911" 6 32578769-32589848 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 95.6;lung: 95.9" "Cell line enhanced" "Detected in some" "HDLM-2: 154.0;HMC-1: 21.9;U-266/70: 20.5;U-698: 26.5;U-87 MG: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 95.6" "Group enriched" "Detected in all" 10 "B-cells: 41.3;dendritic cells: 95.6;monocytes: 52.5" "CAB015400, CAB034021, HPA043151" Enhanced "CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: " "unprognostic (3.69e-3)" "unprognostic (3.66e-3)" "unprognostic (1.80e-2)" "unprognostic (2.40e-3)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (5.28e-2)" "unprognostic (1.22e-3)" "unprognostic (8.56e-2)" "unprognostic (3.00e-2)" "unprognostic (1.23e-1)" "unprognostic (2.08e-1)" "unprognostic (2.28e-3)" "unprognostic (6.16e-2)" "unprognostic (1.19e-1)" "unprognostic (5.10e-2)" "unprognostic (1.53e-1)" 36.8 18.7 9.7 32.2 15.9 8.7 24.9 3.6 10.0 14.2 18.2 11.5 11.2 0.2 10.5 27.2 12.1 13.3 12.0 11.9 8.5 6.9 50.0 15.6 95.9 80.8 18.9 5.4 6.9 8.0 0.0 9.4 5.7 14.8 9.5 23.7 16.1 11.3 2.4 8.2 13.3 42.1 3.8 19.7 62.1 38.1 5.6 13.2 33.6 14.1 3.8 44.7 29.7 17.0 41.3 95.6 6.3 52.5 2.7 4.7 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.2 0.0 0.6 0.0 154.0 1.7 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 3.7 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.4 0.6 18.5 0.0 0.0 0.1 0.2 0.0 20.5 0.5 26.5 42.5 0.7 0.0 0.2 34.6 6.3 1.8 52.5 0.3 32.7 1.2 3.7 95.6 41.3 0.1 1.6 1.2 2.7 26.9 20.4 4.7 37.7 9.7 15.9 3.6 10.0 8.5 6.9 18.9 5.4 14.8 13.2 HLA-DRB5 ENSG00000198502 "Major histocompatibility complex, class II, DR beta 5" Q30154 6 32517343-32530287 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 71.8;lymphoid tissue: 64.8" "Group enriched" "Detected in some" 5 "HDLM-2: 109.4;HMC-1: 27.7;U-698: 32.7;U-87 MG: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 26.4" "Group enriched" "Detected in many" 10 "B-cells: 13.3;dendritic cells: 26.4;monocytes: 16.0" HPA043151 Supported "HPA043151: " "unprognostic (1.97e-3)" "unprognostic (4.74e-2)" "unprognostic (3.30e-2)" "prognostic favourable (7.89e-4)" "unprognostic (2.28e-2)" "unprognostic (4.68e-3)" "unprognostic (9.09e-3)" "unprognostic (2.08e-3)" "unprognostic (1.06e-2)" "unprognostic (5.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.87e-1)" "unprognostic (2.89e-2)" "unprognostic (1.45e-1)" "unprognostic (7.60e-3)" "unprognostic (9.72e-2)" "unprognostic (5.48e-2)" 21.8 14.2 2.9 22.1 3.9 3.7 16.2 2.0 3.2 16.7 21.7 7.0 6.4 2.3 8.7 22.1 9.5 12.6 6.6 9.1 4.3 4.0 32.2 9.3 71.8 60.4 7.3 0.8 4.9 4.9 0.0 6.0 4.9 5.4 9.5 10.2 11.2 9.0 2.7 7.4 8.8 34.7 4.7 12.2 64.8 40.3 4.6 4.5 15.3 9.5 11.2 27.6 21.8 6.5 13.3 26.4 1.5 16.0 0.9 1.8 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 109.4 1.1 0.0 0.0 0.0 0.0 0.1 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 9.6 0.0 0.6 0.1 0.3 0.0 7.4 0.1 32.7 43.2 0.3 0.0 0.0 10.1 1.5 0.4 16.0 0.0 10.5 0.4 1.1 26.4 13.3 0.0 0.5 0.3 0.9 8.1 5.9 1.8 15.4 2.9 3.9 2.0 3.2 4.3 4.0 7.3 0.8 5.4 4.5 HLA-E ENSG00000204592 "Major histocompatibility complex, class I, E" 6 30489467-30494205 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.1;U-266/70: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB024589, HPA031454" Enhanced Approved Vesicles Vesicles "CAB024589: AB_324025, HPA031454: " "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (9.20e-2)" "unprognostic (2.47e-3)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.14e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-2)" "unprognostic (1.35e-2)" "unprognostic (5.57e-2)" "unprognostic (2.04e-2)" "prognostic unfavourable (3.86e-4)" "unprognostic (2.90e-1)" "unprognostic (4.14e-2)" "unprognostic (1.75e-3)" "unprognostic (1.42e-3)" 81.4 19.4 12.6 42.9 16.9 81.7 49.9 6.5 14.9 37.6 32.7 23.2 15.5 2.1 41.2 30.6 40.1 28.2 44.0 36.7 15.1 13.3 34.8 56.5 129.7 76.7 19.9 10.5 29.1 14.6 33.9 11.6 33.1 24.9 32.2 28.6 33.9 23.1 27.5 34.8 97.2 36.8 22.9 21.7 97.1 50.5 18.1 14.6 35.0 45.7 36.4 72.4 45.9 33.3 23.0 7.8 90.2 28.9 23.2 37.1 56.3 11.2 1.8 0.7 6.7 25.1 19.9 0.0 0.0 0.0 0.0 0.0 4.6 22.9 7.4 11.4 10.0 13.9 1.5 5.8 0.0 7.4 4.8 8.7 2.2 0.0 0.0 0.0 3.2 15.6 10.8 8.0 0.0 0.0 1.1 0.1 6.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 9.7 10.1 6.4 0.0 0.5 7.7 6.2 0.0 0.0 15.0 11.1 7.0 0.0 0.0 1.4 35.5 20.3 2.9 0.0 6.6 18.5 56.6 14.0 52.5 37.0 24.6 31.5 23.0 28.1 37.1 7.8 22.5 28.5 28.4 90.2 23.2 28.9 6.6 29.4 56.3 12.6 16.9 6.5 14.9 15.1 13.3 19.9 10.5 24.9 14.6 HLA-G ENSG00000204632 "Major histocompatibility complex, class I, G" P17693 6 29826967-29831125 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" Immunity "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 66.0" "Cell line enriched" "Detected in single" 5 "CAPAN-2: 2.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" CAB016158 Enhanced "Secreted to blood" 32800000 "CAB016158: AB_627938" "unprognostic (1.13e-2)" "unprognostic (9.95e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (8.35e-2)" "unprognostic (1.35e-1)" "unprognostic (1.18e-3)" "unprognostic (2.51e-1)" "prognostic favourable (3.91e-5)" "unprognostic (6.34e-2)" "unprognostic (8.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.03e-2)" "unprognostic (6.56e-3)" "unprognostic (1.40e-1)" "unprognostic (1.52e-2)" "unprognostic (3.19e-3)" 0.2 0.1 0.0 0.5 0.1 0.2 0.3 0.1 0.1 0.2 0.5 0.1 0.0 1.2 0.2 0.6 0.1 0.1 0.2 0.3 0.2 0.0 0.5 0.2 2.8 0.7 0.1 0.1 0.3 1.9 0.1 15.2 66.0 0.1 0.2 0.2 0.3 0.4 0.6 0.2 0.2 0.8 0.1 0.2 1.2 0.9 2.2 0.2 1.3 0.4 0.2 0.2 0.2 0.3 0.3 0.3 2.2 0.9 0.2 1.2 5.7 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.0 2.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.6 0.9 1.2 0.7 0.5 1.2 0.3 0.1 0.5 0.3 0.3 0.6 1.2 2.2 0.2 0.6 0.1 0.5 5.7 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 HM13 "dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1" ENSG00000101294 "Histocompatibility minor 13" Q8TCT9 20 31514428-31577923 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045089, HPA056062" Enhanced Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA045089: AB_10962054, HPA056062: " "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (5.03e-2)" "unprognostic (1.59e-1)" "unprognostic (2.82e-1)" "unprognostic (5.87e-3)" "prognostic unfavourable (1.95e-5)" "unprognostic (2.66e-2)" "unprognostic (2.14e-2)" "unprognostic (2.55e-1)" "unprognostic (2.30e-1)" "unprognostic (8.10e-2)" "prognostic unfavourable (4.64e-12)" "unprognostic (3.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.85e-1)" "unprognostic (8.17e-2)" 25.2 34.3 9.2 20.1 11.1 19.8 36.4 10.2 17.5 37.9 17.0 13.2 64.7 18.1 23.3 40.7 39.2 21.4 24.1 17.9 9.3 13.0 30.2 121.3 25.5 38.7 10.8 9.8 20.8 132.3 24.4 28.6 45.9 14.5 22.4 16.3 15.4 149.6 84.3 13.1 15.0 17.8 17.9 11.0 22.0 25.3 11.7 9.0 15.5 33.5 21.5 30.5 18.1 21.4 16.7 48.2 50.1 65.3 19.4 29.8 52.6 24.6 26.0 10.5 15.5 47.9 30.8 36.2 42.2 39.5 28.9 29.8 51.6 29.7 15.9 56.9 46.0 45.1 14.7 28.4 19.0 8.0 19.9 35.2 19.0 31.0 53.3 20.0 14.1 28.1 18.5 24.4 33.4 22.3 15.5 63.3 26.7 29.1 17.1 14.4 12.1 44.6 10.9 49.5 74.2 27.8 13.2 13.8 16.7 43.2 41.6 34.1 32.3 19.1 27.0 43.9 23.4 44.2 23.7 40.9 24.3 12.6 59.9 72.2 38.7 18.4 65.3 31.8 21.7 64.0 29.8 16.7 20.5 20.9 46.0 12.6 13.8 16.2 50.1 19.4 58.6 48.2 18.1 52.6 9.2 11.1 10.2 17.5 9.3 13.0 10.8 9.8 14.5 9.0 HMOX1 "bK286B10, HO-1" ENSG00000100292 "Heme oxygenase 1" P09601 22 35380361-35394214 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 209.8" "Cell line enhanced" "Detected in many" "BEWO: 110.9;U-138 MG: 64.7;U-87 MG: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 17.7;intermediate monocyte: 40.5;non-classical monocyte: 53.4" "Lineage enriched" "Detected in many" 6 "monocytes: 53.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000635, CAB017444" Enhanced Uncertain "Golgi apparatus,Plasma membrane" 17000 "Golgi apparatus, Plasma membrane" "CAB017444: AB_10617276, HPA000635: AB_1079089" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.57e-2)" "unprognostic (2.47e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (7.56e-2)" "unprognostic (1.71e-1)" "unprognostic (4.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.95e-3)" "unprognostic (1.91e-1)" "unprognostic (4.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.54e-2)" 28.4 10.3 4.1 12.5 8.7 16.3 13.8 0.8 20.6 5.7 12.0 6.1 0.6 22.0 2.5 8.5 8.8 9.8 9.8 10.2 4.1 3.1 23.0 63.7 54.0 76.3 12.5 1.3 28.6 8.8 0.5 2.7 21.1 7.5 3.6 4.9 3.3 3.5 0.8 21.9 13.8 22.8 6.9 11.2 209.8 4.6 5.9 7.6 3.6 4.2 7.3 8.3 6.7 10.2 4.8 7.9 8.4 53.4 1.1 0.3 10.1 1.4 22.6 0.2 4.6 18.5 5.4 110.9 10.4 6.2 4.9 5.3 10.0 1.4 0.0 2.3 8.5 1.2 1.3 0.2 1.5 37.3 1.1 0.5 6.9 20.4 25.7 1.4 7.0 17.0 0.4 32.3 2.1 14.7 0.0 10.8 15.6 1.1 0.0 0.5 2.2 2.5 0.1 1.9 3.4 3.5 12.1 0.3 0.3 26.9 2.4 1.8 1.0 0.3 5.5 64.7 2.9 10.5 10.1 6.8 8.7 1.0 62.8 0.6 1.0 2.0 17.7 1.2 0.2 40.5 0.0 4.8 0.1 0.3 7.9 0.5 0.0 0.0 8.4 1.1 53.4 0.2 0.2 10.1 4.1 8.7 0.8 4.8 4.1 3.1 12.5 1.3 7.5 7.6 HMOX2 HO-2 ENSG00000103415 "Heme oxygenase 2" P30519 16 4474690-4510347 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025464, HPA040611" Supported Approved Vesicles,Cytosol 1200000 "Vesicles, Cytosol" "CAB025464: , HPA040611: AB_10961034" "unprognostic (3.33e-1)" "unprognostic (3.58e-2)" "unprognostic (1.11e-1)" "prognostic favourable (7.91e-4)" "unprognostic (2.74e-1)" "unprognostic (4.27e-2)" "unprognostic (6.23e-2)" "unprognostic (5.77e-2)" "unprognostic (1.43e-2)" "unprognostic (3.60e-1)" "unprognostic (7.74e-3)" "unprognostic (9.87e-2)" "prognostic favourable (8.98e-6)" "unprognostic (3.51e-2)" "unprognostic (4.14e-2)" "unprognostic (1.65e-2)" "unprognostic (2.64e-1)" 19.4 19.2 32.1 15.7 50.7 13.6 16.6 19.7 38.6 13.3 17.9 22.9 12.2 23.5 11.9 18.7 36.6 15.6 19.7 57.2 29.3 22.0 32.2 39.7 15.8 20.8 27.3 35.1 12.5 22.4 20.6 14.7 12.5 36.5 12.1 19.9 8.6 16.0 10.0 20.1 16.6 19.3 16.6 27.2 23.3 29.7 48.1 28.2 8.7 13.8 16.7 25.3 16.5 15.0 14.5 14.5 48.7 8.9 18.7 35.8 25.8 24.6 10.5 6.3 13.6 18.8 9.7 10.5 17.0 8.4 14.5 12.6 13.3 16.8 11.4 19.2 15.6 14.9 19.7 36.5 16.5 14.6 13.4 8.3 10.1 18.0 12.7 18.0 14.2 15.1 12.3 16.8 12.3 26.6 13.4 5.8 13.3 30.5 14.8 14.1 9.6 10.0 15.7 11.0 24.0 20.1 16.2 10.6 6.2 13.6 28.9 18.3 18.0 10.1 25.9 8.2 12.2 35.1 8.7 7.2 8.9 25.2 5.2 14.9 10.4 13.7 7.4 48.7 35.2 8.9 29.9 14.5 32.7 35.8 14.5 13.0 31.7 32.7 26.1 18.7 6.5 8.2 30.0 25.8 32.1 50.7 19.7 38.6 29.3 22.0 27.3 35.1 36.5 28.2 HOXC11 HOX3H ENSG00000123388 "Homeobox C11" O43248 12 53973126-53977643 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 7.0;skin 1: 9.2" "Cell line enhanced" "Detected in some" "AN3-CA: 23.0;BJ hTERT+: 11.6;HaCaT: 10.1;T-47d: 18.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA038291 Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038291: AB_10674552" "unprognostic (1.50e-3)" "unprognostic (1.93e-2)" "unprognostic (1.14e-2)" "unprognostic (1.51e-1)" "unprognostic (1.93e-3)" "unprognostic (1.17e-2)" "unprognostic (6.90e-3)" "unprognostic (1.32e-2)" "unprognostic (7.41e-3)" "unprognostic (4.46e-3)" "unprognostic (2.25e-1)" "unprognostic (3.26e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-1)" "unprognostic (1.82e-1)" 4.8 0.0 0.1 0.1 0.1 0.0 1.2 0.1 0.1 2.5 0.1 0.1 0.1 0.8 2.0 1.0 0.1 0.7 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.7 0.1 0.1 0.5 0.1 0.0 0.1 0.6 0.3 0.5 0.0 0.1 0.1 2.0 7.0 9.2 2.7 0.4 0.1 0.1 0.0 1.6 0.1 0.5 0.1 0.1 0.1 1.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.7 0.0 23.0 2.2 3.3 0.0 3.3 11.6 4.9 3.6 0.2 0.9 0.0 0.2 3.1 10.1 4.4 0.0 2.2 0.6 0.1 0.1 7.5 0.0 0.0 0.1 0.1 0.6 0.9 0.0 0.3 0.0 0.9 0.0 3.1 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.8 0.0 0.1 2.1 5.2 2.0 18.1 0.0 0.0 0.0 4.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 HPN TMPRSS1 ENSG00000105707 Hepsin P05981 19 35040506-35066571 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "kidney: 55.4;liver: 146.5;pancreas: 80.1" "Group enriched" "Detected in some" 9 "EFO-21: 19.4;Hep G2: 27.5;T-47d: 13.4" "Cancer enhanced" "Detected in many" "liver cancer: 127.5" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.2;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA006804 Approved 1000000 "HPA006804: AB_1079046" "unprognostic (6.74e-3)" "unprognostic (6.00e-2)" "unprognostic (4.10e-2)" "unprognostic (1.16e-1)" "unprognostic (2.72e-1)" "unprognostic (9.96e-2)" "unprognostic (4.22e-3)" "unprognostic (1.27e-1)" "unprognostic (4.13e-3)" "unprognostic (9.54e-2)" "unprognostic (3.54e-1)" "unprognostic (1.16e-1)" "prognostic favourable (5.45e-5)" "unprognostic (1.22e-1)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (7.96e-2)" 0.2 0.0 0.3 0.1 0.5 0.0 3.2 0.4 1.1 0.3 0.3 0.2 8.4 0.2 1.1 10.7 0.1 1.9 3.2 0.7 0.6 0.3 55.4 146.5 4.9 0.1 0.9 0.2 0.4 80.1 2.6 3.2 0.2 0.4 5.3 0.0 0.4 4.1 8.5 8.5 0.0 0.2 0.1 0.9 0.3 6.9 0.8 0.3 0.1 4.3 0.4 0.2 0.3 0.1 0.2 0.2 0.0 0.1 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.1 0.0 0.1 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 2.0 0.1 0.1 0.0 0.1 13.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 1.0 0.0 0.6 0.2 0.5 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.5 0.4 1.1 0.6 0.3 0.9 0.2 0.4 0.3 HPS3 "BLOC2S1, SUTAL" ENSG00000163755 "HPS3, biogenesis of lysosomal organelles complex 2 subunit 1" Q969F9 3 149129584-149173732 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Albinism, Disease mutation, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046281, HPA052778" Approved Approved "Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" "HPA046281: AB_10961641, HPA052778: " "unprognostic (1.47e-2)" "unprognostic (7.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.11e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "prognostic unfavourable (6.04e-4)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" "unprognostic (1.82e-2)" "unprognostic (1.08e-1)" "prognostic unfavourable (4.38e-4)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (3.06e-2)" 14.4 17.6 10.5 16.1 11.5 6.3 18.8 8.1 11.8 13.0 11.7 12.8 6.2 13.7 17.1 10.3 10.2 12.4 11.5 8.9 9.9 8.7 15.3 10.1 12.1 25.1 11.5 10.4 18.7 13.8 10.1 11.8 13.3 11.9 13.4 11.8 13.9 13.4 11.5 5.9 8.9 16.3 13.4 17.1 19.8 12.5 8.5 12.6 23.8 13.7 4.5 19.9 16.3 17.9 16.3 19.9 16.1 15.4 9.3 16.0 10.7 24.8 13.9 8.3 8.6 11.7 15.1 6.2 10.2 20.3 13.5 17.5 4.7 16.6 6.4 13.2 12.3 8.6 9.1 7.0 17.6 15.6 7.3 2.9 6.7 5.1 10.4 7.9 4.8 9.8 7.2 13.0 5.4 13.8 3.3 15.5 17.2 15.4 5.6 11.2 20.0 11.2 6.8 5.5 17.1 7.4 12.6 2.5 6.6 8.8 9.4 19.0 10.1 10.5 6.9 13.6 2.4 13.7 14.9 12.8 5.0 15.8 20.2 15.6 3.3 16.1 12.8 11.9 13.4 15.4 16.0 16.3 12.2 13.8 19.9 13.3 9.5 12.5 5.8 9.3 10.1 11.3 10.5 10.7 10.5 11.5 8.1 11.8 9.9 8.7 11.5 10.4 11.9 12.6 HRASLS "H-REV107, HRASLS1" ENSG00000127252 "HRAS like suppressor" 3 193241125-193277738 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "skeletal muscle: 40.9;testis: 42.1" "Cell line enhanced" "Detected in some" "HAP1: 8.5;NTERA-2: 7.4;PC-3: 16.5;RH-30: 7.2;SCLC-21H: 15.0;U-2 OS: 9.1;U-251 MG: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051179 Uncertain Approved "Focal adhesion sites,Cytosol" "Focal adhesion sites" Cytosol "HPA051179: " "unprognostic (3.01e-2)" "unprognostic (4.21e-2)" "unprognostic (7.93e-3)" "unprognostic (4.82e-3)" "unprognostic (2.79e-1)" "unprognostic (1.87e-1)" "unprognostic (9.97e-3)" "unprognostic (9.68e-3)" "unprognostic (1.84e-1)" "unprognostic (3.55e-1)" "unprognostic (1.77e-4)" "unprognostic (5.09e-2)" "unprognostic (1.38e-5)" "unprognostic (1.61e-2)" "prognostic favourable (4.36e-4)" "unprognostic (2.98e-3)" "unprognostic (1.13e-2)" 0.6 1.1 1.8 0.2 3.1 0.1 1.0 0.6 3.3 0.5 0.6 1.7 0.0 0.1 0.6 3.1 2.4 0.5 0.2 4.3 2.0 1.1 0.6 0.6 0.5 0.1 1.5 2.1 0.6 0.8 0.5 0.7 0.1 2.4 0.5 0.1 3.1 6.1 0.5 40.9 1.7 0.6 0.7 0.6 0.6 0.6 42.1 1.7 0.2 3.7 6.2 0.2 0.5 0.6 0.0 0.2 1.7 0.1 0.0 0.0 6.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.3 0.0 0.1 0.0 0.1 0.0 0.0 8.5 0.2 0.4 0.0 3.8 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.4 16.5 0.0 7.2 0.0 2.4 0.0 15.0 2.8 1.0 2.2 0.0 4.3 0.0 0.1 0.0 9.1 0.0 11.5 0.0 0.0 0.0 4.7 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 6.2 1.8 3.1 0.6 3.3 2.0 1.1 1.5 2.1 2.4 1.7 HRASLS2 FLJ20556 ENSG00000133328 "HRAS like suppressor 2" Q9NWW9 11 63552770-63563383 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 16.1;intestine: 42.5" "Cell line enriched" "Detected in some" 8 "U-266/70: 53.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory B-cell: 16.1;naive B-cell: 5.3" "Lineage enriched" "Detected in many" 12 "B-cells: 16.1" HPA058997 Approved Approved Mitochondria Mitochondria "HPA058997: " "unprognostic (4.76e-2)" "prognostic favourable (6.87e-4)" "unprognostic (1.20e-1)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (9.69e-2)" "unprognostic (3.91e-3)" "prognostic unfavourable (5.27e-5)" "unprognostic (1.56e-1)" "unprognostic (2.29e-1)" "unprognostic (1.38e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (1.57e-2)" 0.4 0.0 0.4 1.5 0.4 0.0 4.7 0.4 0.4 0.6 20.6 0.5 0.4 33.4 0.6 1.1 0.5 2.1 0.4 1.0 0.4 0.2 5.5 1.9 3.3 1.1 0.4 0.4 0.4 0.4 0.0 0.4 1.4 0.4 0.4 6.5 0.4 0.7 0.4 0.4 0.2 42.5 0.4 0.4 0.7 8.8 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.4 16.1 0.8 0.1 0.1 1.2 0.9 3.6 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.3 0.0 0.3 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 53.2 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.9 16.1 0.2 0.9 0.0 5.3 0.2 0.6 0.1 1.2 0.0 0.8 0.0 3.6 0.4 0.4 0.4 0.4 0.4 0.2 0.4 0.4 0.4 0.4 HRK DP5 ENSG00000135116 "Harakiri, BCL2 interacting protein" O00198 12 116856144-116881441 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.3;lymphoid tissue: 12.9;thyroid gland: 8.1" "Cell line enhanced" "Detected in some" "Daudi: 7.6;SCLC-21H: 6.5;SH-SY5Y: 5.6;SK-MEL-30: 14.9;U-698: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "eosinophil: 2.2;memory B-cell: 6.7;naive B-cell: 5.5" "Group enriched" "Detected in many" 45 "B-cells: 6.7;granulocytes: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB025973 Uncertain "CAB025973: " "unprognostic (9.38e-2)" "unprognostic (6.19e-2)" "unprognostic (1.14e-1)" "unprognostic (1.93e-3)" "unprognostic (2.54e-1)" "unprognostic (7.30e-2)" "unprognostic (1.82e-1)" "unprognostic (1.67e-2)" "unprognostic (1.10e-1)" "unprognostic (8.44e-3)" "unprognostic (1.28e-1)" "unprognostic (1.46e-1)" "unprognostic (7.24e-3)" "unprognostic (5.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.66e-1)" "unprognostic (9.42e-2)" 0.5 1.9 10.1 1.2 3.2 1.7 2.9 0.5 17.3 0.4 0.6 1.3 0.0 0.4 0.5 0.4 0.5 1.4 0.4 0.6 12.1 3.6 0.4 0.3 0.6 1.9 1.8 4.1 0.4 0.6 0.3 5.0 0.4 2.6 0.4 0.7 0.0 1.0 0.3 1.3 0.6 0.5 0.4 1.1 0.8 0.4 1.4 0.6 12.9 8.1 0.0 1.8 0.4 0.2 6.7 0.0 2.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.3 0.0 3.1 1.7 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.7 0.1 0.7 0.0 1.0 0.1 0.0 6.5 5.6 0.4 0.0 14.9 0.4 0.1 0.0 0.0 1.3 0.2 0.0 0.7 0.3 25.8 0.0 0.3 0.0 0.1 0.0 2.2 0.0 0.0 0.0 6.7 0.0 0.0 0.0 5.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 10.1 3.2 0.5 8.5 12.1 3.6 1.8 4.1 2.6 0.6 HS6ST2 ENSG00000171004 "Heparan sulfate 6-O-sulfotransferase 2" Q96MM7 X 132626016-132961395 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5;kidney: 17.3;ovary: 18.2" "Cell line enhanced" "Detected in some" "HEK 293: 19.3;HeLa: 13.1;RH-30: 28.0;RT4: 13.9;SH-SY5Y: 34.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 29.5" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Lineage enhanced" "Detected in single" "NK-cells: 1.8" "Low region specificity" "Detected in all" "HPA034625, HPA034626" Uncertain Uncertain Nucleoplasm Nucleoplasm "HPA034625: AB_10612119, HPA034626: " "unprognostic (7.62e-3)" "unprognostic (4.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.41e-1)" "unprognostic (3.24e-1)" "unprognostic (5.54e-2)" "unprognostic (1.44e-1)" "unprognostic (1.71e-2)" "unprognostic (1.14e-2)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-1)" "unprognostic (8.39e-5)" "unprognostic (1.36e-3)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "prognostic favourable (6.03e-4)" 0.4 3.2 6.5 0.9 29.5 0.1 2.6 3.0 6.7 1.0 0.8 0.8 0.6 0.3 4.5 3.2 5.0 2.5 0.5 0.4 4.1 9.1 17.3 0.2 1.0 0.3 3.5 0.9 18.2 6.5 0.1 1.3 9.9 3.3 5.4 1.2 0.0 1.1 1.6 6.7 0.3 0.2 2.0 3.3 0.2 1.1 7.9 0.7 0.7 0.6 1.7 2.7 2.3 0.6 0.0 0.0 0.0 0.0 1.8 0.6 0.0 4.3 0.0 6.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.0 0.0 0.0 6.4 0.0 0.2 9.1 0.0 0.0 0.0 19.3 0.0 13.1 0.0 0.0 0.0 0.0 0.3 8.5 0.0 0.0 0.4 0.0 0.0 0.0 3.1 0.1 0.0 4.9 0.2 0.0 28.0 0.0 5.6 13.9 0.7 34.9 6.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.0 9.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.5 29.5 3.0 5.8 4.1 9.1 3.5 0.9 3.3 0.7 HSD11B1L "SCDR10, SDR26C2" ENSG00000167733 "Hydroxysteroid 11-beta dehydrogenase 1 like" Q7Z5J1 19 5680604-5688523 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 34.4" "Cell line enhanced" "Detected in many" "SH-SY5Y: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049078 Supported Vesicles "Secreted in brain" Vesicles "HPA049078: " "unprognostic (2.34e-2)" "unprognostic (1.10e-1)" "unprognostic (4.73e-3)" "unprognostic (5.26e-2)" "unprognostic (9.37e-2)" "prognostic favourable (4.38e-4)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (1.18e-3)" "unprognostic (1.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.75e-1)" "unprognostic (5.77e-2)" "unprognostic (4.52e-1)" "unprognostic (1.73e-2)" 3.9 8.8 34.4 2.1 19.2 4.7 5.0 10.3 29.7 3.9 2.9 5.4 3.7 2.6 3.6 8.5 2.2 7.6 4.8 3.8 25.4 16.1 6.7 3.5 4.4 2.3 11.7 20.4 6.1 6.2 5.8 8.5 2.5 10.7 4.0 1.9 3.2 9.1 6.9 15.0 6.9 2.9 2.7 6.0 2.6 3.3 4.3 7.5 0.0 6.6 1.3 1.8 2.5 2.2 2.5 4.8 2.5 5.8 1.4 4.5 1.7 3.0 2.9 10.7 2.0 5.1 5.5 2.2 2.3 4.6 1.1 4.7 1.3 3.0 0.7 5.1 2.0 1.5 1.3 1.7 1.0 2.5 3.3 2.0 2.6 1.9 3.5 0.8 7.3 5.4 3.7 1.7 1.5 1.7 1.9 2.9 4.3 0.4 1.8 2.1 2.9 3.4 3.4 0.4 2.6 8.9 0.7 2.9 17.8 0.5 1.5 11.4 2.5 0.7 2.9 2.7 4.8 4.5 1.8 7.2 2.3 0.8 7.4 1.1 2.1 1.7 2.5 0.2 1.2 5.8 1.6 1.2 3.2 3.6 2.3 2.5 4.5 3.9 2.5 1.4 2.9 4.8 0.9 1.7 34.4 19.2 10.3 29.7 25.4 16.1 11.7 20.4 10.7 7.5 HSD11B2 SDR9C3 ENSG00000176387 "Hydroxysteroid 11-beta dehydrogenase 2" P80365 16 67430652-67437553 "Disease related genes, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 62.8;kidney: 119.9;salivary gland: 66.0" "Cell line enhanced" "Detected in some" "NTERA-2: 9.7;RPMI-8226: 11.5;RT4: 11.6;SCLC-21H: 12.8;SK-BR-3: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB032443, HPA042186, HPA056385" Enhanced Approved Vesicles Vesicles "CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110" "unprognostic (2.87e-3)" "unprognostic (5.24e-2)" "unprognostic (7.10e-2)" "unprognostic (6.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.14e-1)" "unprognostic (2.68e-2)" "unprognostic (2.07e-1)" "unprognostic (2.21e-3)" "unprognostic (2.25e-3)" "unprognostic (3.27e-2)" "unprognostic (2.34e-1)" "prognostic favourable (9.51e-5)" "unprognostic (7.20e-2)" "unprognostic (3.19e-1)" "unprognostic (1.55e-2)" "unprognostic (1.84e-1)" 0.4 1.0 0.6 22.2 2.3 0.0 3.2 2.0 1.7 4.8 42.8 0.3 1.3 9.4 3.8 3.6 2.5 2.4 8.3 0.5 0.5 0.1 119.9 1.2 2.3 0.7 0.3 0.8 4.8 2.1 0.0 0.4 42.3 1.1 3.7 24.5 0.4 66.0 1.4 0.4 13.8 62.8 4.3 0.3 1.5 2.1 1.4 1.3 0.5 3.8 3.3 1.6 1.5 4.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.9 0.4 1.2 0.1 1.5 3.1 0.0 0.0 0.1 0.1 5.1 1.1 0.0 2.3 0.1 6.5 4.3 0.4 0.0 0.0 1.5 0.0 0.5 5.4 0.5 0.6 0.0 1.5 2.6 0.2 0.1 0.0 0.3 0.0 0.0 3.1 0.1 0.1 9.7 0.8 0.0 0.1 11.5 0.4 11.6 12.8 0.8 0.7 11.5 0.5 5.5 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 2.3 2.0 1.7 0.5 0.1 0.3 0.8 1.1 1.3 HSD17B12 "KAR, SDR12C1" ENSG00000149084 "Hydroxysteroid 17-beta dehydrogenase 12" Q53GQ0 11 43680558-43856617 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016427 Approved 200000 "HPA016427: AB_1844347" "unprognostic (1.93e-1)" "unprognostic (1.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.14e-3)" "prognostic unfavourable (2.76e-4)" "unprognostic (2.99e-1)" "unprognostic (3.31e-2)" "unprognostic (9.16e-3)" "unprognostic (5.16e-2)" "unprognostic (7.54e-2)" "prognostic favourable (2.10e-8)" "unprognostic (6.87e-2)" "unprognostic (1.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.28e-2)" 27.2 32.6 33.5 16.6 31.9 10.5 30.4 12.8 33.1 26.3 30.7 31.4 29.3 32.0 22.3 25.3 24.3 20.1 28.0 36.9 30.9 31.1 42.9 59.8 25.8 19.9 38.5 21.4 22.4 26.4 66.6 29.4 19.4 45.7 26.4 29.4 26.6 25.3 22.9 16.1 18.2 30.8 23.3 44.9 23.5 25.6 17.6 24.4 15.2 32.4 32.5 17.5 19.4 18.6 12.8 18.7 9.8 12.7 13.5 15.0 9.6 8.9 14.5 16.2 16.4 54.4 51.7 10.6 22.9 22.6 16.0 17.5 17.6 18.7 22.3 16.3 20.6 35.0 11.2 28.9 19.8 4.1 20.9 10.3 8.2 15.3 27.6 31.9 29.5 31.7 22.3 16.1 46.0 22.1 9.7 37.2 13.8 5.1 8.4 14.2 29.6 10.6 14.4 24.0 25.2 30.5 22.0 5.9 13.3 30.8 26.0 22.4 18.6 25.8 21.2 17.3 6.8 44.9 26.8 19.2 24.1 13.3 18.8 5.7 13.0 6.1 12.2 5.5 11.0 12.7 11.7 11.0 8.8 9.2 18.7 12.8 15.0 12.9 9.8 13.5 6.5 15.1 5.0 9.6 33.5 31.9 12.8 30.8 30.9 31.1 38.5 21.4 45.7 24.4 HSD17B2 "HSD17, SDR9C2" ENSG00000086696 "Hydroxysteroid 17-beta dehydrogenase 2" P37059 16 82035004-82098534 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.1;liver: 52.9;placenta: 110.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 23.7;Hep G2: 18.8;hTERT-HME1: 11.3;RT4: 38.9;TIME: 21.8" "Cancer enhanced" "Detected in many" "liver cancer: 10.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "midbrain: 2.6;pons and medulla: 3.5" "Not detected" "Not detected" "HPA021826, HPA050235" Enhanced Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA021826: AB_10961148, HPA050235: " "unprognostic (1.50e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.48e-2)" "unprognostic (2.58e-1)" "unprognostic (1.77e-1)" "unprognostic (4.29e-2)" "unprognostic (2.60e-1)" "unprognostic (7.35e-2)" "unprognostic (6.05e-3)" "unprognostic (4.98e-2)" "unprognostic (7.35e-2)" "unprognostic (6.31e-4)" "unprognostic (5.39e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "prognostic favourable (3.83e-4)" 0.7 0.1 0.2 4.1 0.2 0.0 3.9 0.2 0.3 0.7 41.3 0.3 0.2 71.3 0.6 0.2 1.7 0.2 13.3 0.2 0.2 0.2 2.8 52.9 1.0 0.2 0.2 0.2 0.2 16.0 0.0 0.6 110.8 0.4 3.1 9.4 21.3 9.4 0.2 0.3 1.8 83.1 1.5 0.2 0.2 3.2 0.2 0.2 0.2 0.2 1.1 1.3 21.4 6.6 1.3 1.4 3.6 1.1 1.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.3 0.0 23.7 0.0 0.0 4.3 0.7 0.0 4.7 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.1 0.1 18.8 0.1 0.1 0.1 0.0 1.2 0.0 11.3 0.3 0.0 0.2 3.5 0.1 0.0 0.4 0.1 8.6 0.0 0.0 0.5 0.4 38.9 0.2 0.6 0.0 1.1 0.1 0.0 0.0 21.8 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 1.6 1.1 0.6 0.7 0.5 0.4 0.6 0.4 0.4 0.3 1.3 0.4 0.6 3.6 1.0 0.6 1.4 0.3 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 HSD17B3 SDR12C2 ENSG00000130948 "Hydroxysteroid 17-beta dehydrogenase 3" P37058 9 96235306-96302152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 41.9" "Group enriched" "Detected in some" 5 "HBEC3-KT: 4.9;HEL: 4.3;U-2 OS: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056833 Enhanced Supported Vesicles Vesicles "HPA056833: " "unprognostic (2.78e-1)" "unprognostic (6.61e-3)" "unprognostic (1.03e-1)" "unprognostic (5.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (3.08e-2)" "unprognostic (6.15e-2)" "unprognostic (1.74e-1)" "unprognostic (5.13e-2)" "unprognostic (3.26e-4)" "unprognostic (3.45e-1)" "unprognostic (5.48e-8)" "unprognostic (8.47e-3)" "unprognostic (1.15e-1)" "unprognostic (7.24e-2)" "unprognostic (3.11e-2)" 0.5 0.4 1.0 0.5 1.0 0.4 0.5 0.5 0.9 0.8 0.5 0.5 0.5 0.4 0.5 0.5 0.5 1.3 0.5 0.5 1.7 0.5 1.0 6.3 0.5 0.5 1.6 0.5 0.5 1.3 0.4 0.5 0.5 0.5 0.8 0.4 0.5 0.5 0.5 0.5 0.5 1.1 0.5 1.9 0.5 0.4 41.9 0.5 0.5 4.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.0 1.0 0.5 0.9 1.7 0.5 1.6 0.5 0.5 0.5 HSD17B7 "PRAP, SDR37C1" ENSG00000132196 "Hydroxysteroid 17-beta dehydrogenase 7" P56937 1 162790702-162812817 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.3;liver: 16.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047496 Approved "HPA047496: " "unprognostic (2.93e-1)" "unprognostic (1.36e-2)" "unprognostic (6.03e-2)" "unprognostic (1.12e-1)" "unprognostic (2.34e-1)" "unprognostic (1.63e-3)" "unprognostic (2.57e-1)" "unprognostic (2.51e-2)" "unprognostic (1.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.94e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (8.47e-5)" "unprognostic (6.25e-2)" "unprognostic (1.90e-1)" "unprognostic (6.35e-2)" "unprognostic (3.17e-2)" 1.9 9.2 1.4 2.0 1.0 0.7 4.3 1.4 1.9 2.8 2.9 3.1 2.1 4.4 4.7 2.2 1.6 1.6 1.9 2.6 2.2 16.8 4.3 3.7 1.5 3.6 2.6 2.5 4.1 1.8 2.8 4.0 3.1 1.3 2.0 3.6 3.1 1.8 3.2 2.9 2.9 0.6 2.8 3.9 2.2 2.8 12.5 9.6 15.8 7.4 7.0 16.3 10.5 6.8 7.0 18.5 8.2 10.7 11.5 12.1 2.7 8.9 5.4 10.8 9.6 22.0 16.4 6.3 2.3 11.0 16.8 23.7 5.7 7.1 9.0 4.1 5.3 15.1 8.9 7.3 7.3 6.9 13.2 21.0 6.9 8.9 7.8 11.3 4.6 4.8 9.5 7.9 11.7 8.7 5.3 11.1 10.5 19.2 10.9 15.8 8.2 4.4 4.3 4.2 7.0 9.4 5.3 2.5 5.9 3.8 5.3 6.9 6.8 16.2 4.0 0.6 6.1 15.8 6.0 11.2 13.9 6.1 14.6 12.5 10.5 13.4 6.5 10.9 13.0 13.1 5.0 7.0 7.4 9.6 16.3 10.5 HSD3B1 "HSD3B, HSDB3, SDR11E1" ENSG00000203857 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1" P14060 1 119507198-119515054 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Isomerase, Multifunctional enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 231.4" "Cell line enriched" "Detected in some" 9 "CACO-2: 37.0" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043261, HPA043264, HPA044028" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: , HPA043264: , HPA044028: " "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "prognostic favourable (4.59e-5)" 0.1 0.6 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 231.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 11.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 4.1 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 HSD3B2 SDR11E2 ENSG00000203859 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" P26439 1 119414931-119423035 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis "Isomerase, Multifunctional enzyme, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 223.2" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;TIME: 1.2;WM-115: 3.2" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Region enriched" "Detected in single" 198 "basal ganglia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043261, HPA043264, HPA044028" Supported Uncertain "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: , HPA043264: , HPA044028: " "unprognostic (3.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.80e-1)" "unprognostic (2.72e-2)" "unprognostic (8.87e-2)" "unprognostic (3.91e-2)" "unprognostic (3.43e-2)" "unprognostic (1.94e-1)" "unprognostic (6.51e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" 0.0 223.2 0.0 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.5 43.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.4 0.0 0.0 5.1 0.0 0.0 1.2 0.2 0.1 0.1 0.7 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSD3B7 "C(27)-3BETA-HSD, SDR11E3" ENSG00000099377 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7" Q9H2F3 16 30985207-30989152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis Oxidoreductase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.1" "Cell line enhanced" "Detected in many" "HDLM-2: 31.0;Hep G2: 22.7;HMC-1: 35.2;U-2197: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "basophil: 24.5;eosinophil: 13.5" "Lineage enriched" "Detected in single" 29 "granulocytes: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050521, HPA060847" Uncertain Enhanced "Lipid droplets" "Lipid droplets" "HPA050521: , HPA060847: " "unprognostic (5.41e-3)" "unprognostic (4.14e-3)" "prognostic unfavourable (5.95e-4)" "unprognostic (2.62e-2)" "unprognostic (5.06e-3)" "unprognostic (1.47e-2)" "unprognostic (3.52e-2)" "unprognostic (1.85e-1)" "unprognostic (2.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.20e-2)" "unprognostic (2.81e-1)" "prognostic unfavourable (1.60e-6)" "unprognostic (2.45e-1)" "unprognostic (1.12e-1)" "unprognostic (1.58e-1)" "unprognostic (1.79e-1)" 21.6 11.2 2.5 7.5 4.7 1.8 7.3 2.7 4.0 4.9 8.3 4.6 2.8 11.2 5.3 6.4 9.4 4.4 7.4 5.2 3.1 1.6 25.6 74.1 6.4 5.6 3.5 1.4 9.3 17.7 5.6 2.6 6.1 3.7 5.9 3.2 2.9 4.5 2.6 5.1 7.8 13.3 6.7 4.8 8.3 4.8 3.6 3.7 1.0 2.9 4.5 4.6 8.0 3.9 0.1 0.8 24.5 0.8 0.2 0.0 0.3 6.9 8.0 0.8 4.0 2.9 10.5 0.5 8.7 13.7 1.7 3.6 0.5 12.1 0.4 2.9 10.6 2.1 0.7 1.2 0.9 31.0 1.9 0.5 6.3 22.7 2.7 0.1 35.2 5.0 2.1 8.3 1.6 0.7 1.6 0.3 6.5 14.8 0.2 4.9 0.6 1.1 0.8 2.8 7.6 5.3 0.4 3.0 1.5 1.1 5.6 0.7 11.0 0.5 4.0 3.6 1.0 34.3 0.9 0.6 5.0 0.4 14.0 0.8 0.3 24.5 0.8 13.5 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.6 0.2 0.0 0.3 0.0 0.3 2.5 4.7 2.7 4.0 3.1 1.6 3.5 1.4 3.7 3.7 HSDL1 SDR12C3 ENSG00000103160 "Hydroxysteroid dehydrogenase like 1" Q3SXM5 16 84122146-84145192 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045745 Approved "Vesicles,Intermediate filaments,Mitochondria" Mitochondria "Vesicles, Intermediate filaments" "HPA045745: " "unprognostic (2.16e-1)" "unprognostic (4.32e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-3)" "unprognostic (3.66e-2)" "unprognostic (1.68e-1)" "prognostic unfavourable (3.50e-4)" "unprognostic (1.25e-2)" "unprognostic (7.43e-2)" "unprognostic (3.39e-2)" "unprognostic (6.42e-2)" "unprognostic (3.66e-1)" "prognostic favourable (4.20e-7)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.14e-2)" 6.0 13.4 16.9 5.6 22.1 3.1 10.2 16.5 18.7 9.7 5.8 9.0 6.7 5.1 11.3 9.4 6.7 11.1 6.0 13.1 14.5 19.5 9.1 4.1 7.6 6.8 11.5 13.2 19.6 4.3 12.6 16.7 7.6 20.8 8.6 6.1 10.5 6.3 10.0 15.2 6.5 4.9 9.4 7.4 7.0 5.3 13.5 8.7 8.6 23.2 5.0 7.5 6.6 6.2 7.4 3.1 14.5 6.6 4.2 6.5 4.4 5.6 6.5 30.2 10.3 11.0 7.9 7.6 7.3 6.8 9.1 4.8 7.3 9.7 11.6 13.0 6.4 3.9 16.3 6.3 14.5 2.4 10.0 5.6 4.3 16.5 11.5 8.6 10.1 6.1 10.6 12.7 8.3 10.8 11.5 14.6 17.9 13.9 18.7 8.6 15.3 6.8 18.4 10.6 4.3 8.7 6.2 14.2 10.8 18.0 2.9 19.7 18.0 5.1 9.2 10.3 12.4 7.4 5.7 23.3 18.4 18.9 12.0 6.3 9.3 14.5 5.2 11.7 4.4 3.8 5.6 5.4 4.7 5.2 3.1 7.4 6.1 6.5 6.2 4.2 6.6 0.0 5.6 4.4 16.9 22.1 16.5 18.7 14.5 19.5 11.5 13.2 20.8 8.7 HTATIP2 "CC3, FLJ26963, SDR44U1, TIP30" ENSG00000109854 "HIV-1 Tat interactive protein 2" Q9BUP3 11 20363685-20383783 "Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Differentiation, Host-virus interaction" "Developmental protein, Oxidoreductase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006417, HPA024321" Approved Supported Cytosol Cytosol "HPA006417: AB_1079091, HPA024321: AB_1851288" "unprognostic (8.05e-3)" "unprognostic (2.13e-1)" "unprognostic (9.31e-2)" "unprognostic (3.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.79e-3)" "prognostic unfavourable (2.86e-4)" "unprognostic (1.20e-3)" "unprognostic (1.05e-1)" "unprognostic (4.93e-2)" "prognostic unfavourable (6.18e-4)" "unprognostic (1.75e-1)" "prognostic unfavourable (8.01e-4)" "unprognostic (1.20e-1)" "unprognostic (9.42e-2)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" 16.3 28.1 8.5 11.9 16.3 6.3 26.3 3.2 10.6 9.4 50.4 16.2 10.8 52.2 6.8 13.0 23.1 5.7 17.6 9.5 10.8 9.9 21.5 41.8 19.5 16.2 24.3 8.0 6.8 11.9 17.9 27.4 22.9 12.4 13.9 32.2 3.3 16.5 9.2 19.4 14.8 74.6 12.1 15.0 19.6 29.4 10.6 14.6 6.6 23.9 17.2 12.1 17.8 26.7 16.4 17.4 69.4 30.6 13.5 30.6 23.8 23.4 38.9 0.8 0.0 12.0 9.1 8.7 10.3 10.1 7.9 9.5 22.5 20.7 5.3 21.0 12.7 33.0 0.0 6.2 7.6 61.1 4.8 6.6 38.5 0.0 28.8 2.4 31.5 13.1 44.1 6.4 10.1 22.6 16.2 7.0 14.7 22.0 0.0 1.5 12.6 19.4 5.0 0.0 19.3 10.8 13.1 10.6 0.1 33.2 13.2 15.6 27.6 12.4 27.4 5.7 12.5 11.4 0.2 7.5 9.3 0.1 0.1 16.7 24.4 43.7 30.6 37.3 15.5 27.5 17.5 14.9 18.0 16.5 17.4 16.4 15.8 15.5 69.4 13.5 28.3 5.1 30.6 23.8 8.5 16.3 3.2 10.6 10.8 9.9 24.3 8.0 12.4 14.6 HTRA2 "OMI, PARK13, PRSS25" ENSG00000115317 "HtrA serine peptidase 2" O43464 2 74529377-74533348 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" Apoptosis "Hydrolase, Protease, Serine protease" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004004, HPA006602, HPA027366" Uncertain Supported Mitochondria Mitochondria "CAB004004: AB_326421, HPA006602: , HPA027366: AB_1851301" "unprognostic (3.09e-1)" "unprognostic (4.06e-2)" "unprognostic (2.82e-1)" "unprognostic (2.58e-2)" "unprognostic (1.56e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (7.77e-8)" "unprognostic (2.12e-3)" "unprognostic (4.18e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-2)" "unprognostic (8.15e-2)" "unprognostic (7.23e-3)" "unprognostic (4.03e-1)" "unprognostic (1.73e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-2)" 16.4 12.7 10.6 14.9 11.3 18.9 12.9 10.7 17.7 12.3 12.8 12.6 9.7 12.6 12.9 6.9 10.7 10.6 9.0 12.9 11.6 8.7 13.1 11.4 11.3 13.2 10.8 11.9 18.7 12.9 10.5 9.0 10.4 13.5 11.6 5.5 10.2 13.1 9.2 17.6 9.0 12.6 11.8 9.1 17.3 11.8 13.9 12.6 12.2 16.8 12.6 9.3 10.4 15.2 12.9 9.4 5.9 8.1 5.5 7.8 7.0 7.9 4.9 5.7 4.9 7.9 3.2 15.2 6.9 3.6 4.2 2.4 9.1 3.5 7.2 5.4 3.9 9.0 6.7 7.9 1.1 16.2 13.4 14.4 4.7 8.0 7.4 6.7 10.6 3.8 5.3 7.9 6.7 5.2 18.9 10.7 3.1 5.2 12.4 14.2 4.7 14.2 8.5 16.1 7.9 3.4 3.2 6.6 7.9 3.7 8.5 13.2 3.9 6.6 3.7 7.3 9.0 14.7 15.4 13.1 4.3 4.7 6.3 10.7 5.8 5.9 8.1 4.8 7.3 6.2 7.8 12.9 7.3 6.2 9.4 11.6 6.3 6.4 3.2 5.5 4.7 6.6 7.4 7.0 10.6 11.3 10.7 17.7 11.6 8.7 10.8 11.9 13.5 12.6 HUWE1 "Ib772, KIAA0312, UREB1" ENSG00000086758 "HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase" Q7Z6Z7 X 53532096-53686729 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002548, CAB022718" Approved Enhanced Nucleoplasm,Cytosol 3400 "Nucleoplasm, Cytosol" "CAB022718: , HPA002548: AB_1080489" "unprognostic (4.73e-2)" "unprognostic (9.06e-2)" "unprognostic (1.31e-1)" "unprognostic (1.59e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (2.21e-1)" "unprognostic (3.56e-1)" "unprognostic (5.51e-2)" "unprognostic (1.33e-1)" "unprognostic (8.89e-2)" "unprognostic (8.10e-3)" "unprognostic (2.17e-1)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" 24.6 28.2 27.7 23.8 43.3 22.4 28.0 37.0 41.1 31.8 25.9 34.3 26.6 17.1 31.9 52.4 27.4 26.5 23.1 27.1 28.0 31.8 30.3 26.2 20.3 23.1 30.0 30.2 43.3 27.8 59.8 34.2 27.2 34.6 27.3 22.7 25.6 26.4 29.6 59.1 50.1 22.1 33.9 23.9 26.6 25.7 28.4 27.7 32.4 27.6 20.7 28.6 27.0 22.9 5.1 7.2 8.2 7.0 6.9 8.9 3.5 50.1 30.9 20.1 14.2 35.3 21.1 24.8 15.1 19.5 15.9 16.7 23.5 16.2 26.3 10.3 27.4 24.1 45.4 25.3 21.8 37.9 20.1 20.9 27.7 18.3 32.5 31.3 12.9 20.1 19.0 38.2 43.9 27.5 20.8 17.1 20.6 30.9 16.9 17.5 27.5 22.3 15.7 27.8 15.9 26.4 34.8 16.8 12.1 42.6 19.0 13.6 27.2 15.2 35.0 14.7 21.1 20.9 19.2 15.0 14.7 23.0 15.7 30.7 21.1 4.0 4.7 8.2 7.2 3.8 8.9 5.1 6.9 7.6 6.7 5.1 4.9 4.9 4.2 6.9 7.0 7.2 5.7 3.5 27.7 43.3 37.0 41.1 28.0 31.8 30.0 30.2 34.6 27.7 HYAL2 "LuCa-2, LUCA2" ENSG00000068001 "Hyaluronoglucosaminidase 2" Q12891 3 50317790-50322906 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 107.0" "Group enriched" "Detected in all" 4 "HUVEC TERT2: 67.2;TIME: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036436 Uncertain "HPA036436: AB_10670104" "unprognostic (9.97e-3)" "unprognostic (2.60e-1)" "unprognostic (1.44e-1)" "unprognostic (5.10e-3)" "unprognostic (3.44e-1)" "unprognostic (7.41e-2)" "unprognostic (7.93e-2)" "unprognostic (4.70e-1)" "unprognostic (1.44e-1)" "unprognostic (6.76e-2)" "unprognostic (2.36e-1)" "unprognostic (3.01e-1)" "unprognostic (2.63e-3)" "unprognostic (7.36e-2)" "unprognostic (2.72e-1)" "unprognostic (7.02e-3)" "unprognostic (5.62e-2)" 46.5 16.4 5.4 11.0 13.9 1.2 52.1 3.5 7.6 16.0 9.5 6.6 9.0 7.3 18.8 11.3 16.0 16.5 19.9 33.6 11.1 6.0 35.7 20.2 61.1 25.6 7.5 4.0 13.6 11.2 7.9 11.9 34.4 16.3 10.3 4.8 20.4 10.9 9.7 11.6 9.7 9.9 15.1 8.0 107.0 10.2 8.6 5.5 1.1 23.2 16.0 8.3 14.8 20.2 0.9 4.4 8.6 11.3 2.0 3.4 2.6 4.8 7.1 11.7 12.0 7.3 6.3 7.7 5.8 7.6 7.9 6.1 8.2 14.3 1.2 19.7 7.8 5.1 4.4 10.7 2.1 2.6 3.9 1.7 6.6 12.4 6.3 1.4 4.7 9.9 9.0 7.9 2.5 67.2 3.2 1.5 6.4 6.6 3.1 2.9 13.7 11.0 2.8 2.3 4.7 9.7 4.3 3.2 10.2 5.7 5.8 5.8 6.5 3.7 91.9 9.5 9.7 6.4 8.6 2.7 4.3 3.9 5.6 4.6 13.7 0.0 8.0 8.6 1.3 11.3 2.8 0.9 1.1 3.4 4.4 0.9 0.4 0.6 7.6 2.0 10.4 3.3 1.4 2.6 5.4 13.9 3.5 7.6 11.1 6.0 7.5 4.0 16.3 5.5 HYAL4 ENSG00000106302 "Hyaluronoglucosaminidase 4" Q2M3T9 7 123828983-123877478 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 7.1;skeletal muscle: 8.3" "Cell line enhanced" "Detected in some" "BEWO: 4.4;CAPAN-2: 7.1;RT4: 16.6" "Cancer enriched" "Detected in single" 48 "testis cancer: 8.4" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA029453 Uncertain "HPA029453: AB_10601432" "unprognostic (5.19e-5)" "unprognostic (4.18e-2)" "unprognostic (4.82e-2)" "unprognostic (2.20e-1)" "unprognostic (4.14e-2)" "unprognostic (2.60e-1)" "unprognostic (8.24e-2)" "unprognostic (5.26e-2)" "unprognostic (8.15e-3)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.19e-1)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (5.55e-3)" 0.1 0.3 0.0 0.0 0.0 0.7 0.2 0.0 0.5 0.0 0.1 0.0 0.1 0.4 0.4 0.2 0.0 0.4 0.0 0.0 0.6 0.1 0.4 0.0 0.0 0.1 0.6 0.0 0.1 7.1 0.2 0.0 1.2 0.0 8.3 1.4 0.2 0.0 0.1 1.0 0.2 3.4 0.4 1.5 1.0 0.1 1.3 0.6 3.3 0.6 1.0 0.9 0.1 0.3 0.6 0.1 0.4 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 7.1 0.3 0.3 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 16.6 0.2 0.1 0.0 0.9 0.0 0.4 0.2 2.4 0.1 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.6 0.5 0.5 0.4 0.5 0.5 0.2 1.3 0.7 0.9 3.3 1.0 0.6 0.6 0.3 0.1 ICA1 "ICA69, ICAp69" ENSG00000003147 "Islet cell autoantigen 1" Q05084 7 8113184-8262687 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 58.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.2;MCF7: 15.2;RT4: 17.8;SCLC-21H: 24.9;SH-SY5Y: 41.0;SK-BR-3: 19.5;T-47d: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "T-reg: 20.8" "Lineage enriched" "Detected in many" 8 "T-cells: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017646, HPA061452" Approved Supported Vesicles,Cytosol "Vesicles, Cytosol" "HPA017646: AB_1851382, HPA061452: " "unprognostic (1.39e-1)" "unprognostic (1.37e-1)" "unprognostic (3.74e-1)" "unprognostic (6.83e-3)" "unprognostic (9.49e-2)" "unprognostic (8.57e-3)" "unprognostic (1.37e-2)" "unprognostic (3.54e-1)" "unprognostic (7.61e-2)" "unprognostic (3.42e-1)" "unprognostic (5.84e-2)" "unprognostic (2.62e-1)" "prognostic favourable (4.23e-8)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (4.08e-2)" 8.9 6.1 12.6 4.2 15.3 11.7 13.0 19.4 24.2 10.7 13.2 2.5 8.7 7.7 5.5 8.5 5.8 8.1 10.4 25.7 7.7 7.8 9.1 5.3 9.2 6.9 4.8 12.4 1.6 58.6 13.2 13.5 4.6 10.5 13.7 14.3 2.5 21.2 8.3 2.8 7.0 10.4 3.7 2.8 7.6 17.9 16.0 3.2 0.8 8.1 4.1 5.5 9.6 4.1 0.3 1.7 2.4 1.6 0.7 20.8 1.1 0.0 0.3 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.3 16.2 0.1 1.6 0.0 0.0 0.3 0.7 0.0 0.0 2.4 3.4 0.3 0.0 0.1 2.8 0.5 0.0 1.1 0.0 0.0 11.8 9.5 0.0 0.0 15.2 0.1 0.0 3.7 0.1 0.0 0.0 7.0 6.9 17.8 24.9 41.0 0.0 19.5 0.2 15.8 5.1 6.9 0.0 0.3 0.0 0.3 5.1 2.4 0.0 0.0 2.2 3.4 0.5 1.6 0.1 0.2 0.5 0.4 0.2 3.9 0.3 1.7 0.3 0.2 0.1 2.4 0.7 0.2 0.4 20.8 1.1 12.6 15.3 19.4 24.2 7.7 7.8 4.8 12.4 10.5 3.2 ICAM1 "BB2, CD54" ENSG00000090339 "Intercellular adhesion molecule 1" P05362 19 10270835-10286615 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 68.3;lung: 91.3" "Cell line enhanced" "Detected in many" "HHSteC: 31.1;Karpas-707: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002126, CAB002142, HPA004877" Enhanced Uncertain "Plasma membrane,Cytosol" 3100000000 "Plasma membrane, Cytosol" "CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317" "prognostic favourable (7.09e-4)" "unprognostic (1.88e-1)" "unprognostic (1.94e-1)" "unprognostic (2.63e-2)" "unprognostic (3.25e-3)" "unprognostic (3.05e-1)" "unprognostic (1.45e-2)" "unprognostic (3.48e-1)" "unprognostic (3.18e-2)" "unprognostic (1.09e-2)" "unprognostic (1.49e-2)" "unprognostic (1.79e-1)" "prognostic unfavourable (1.32e-6)" "unprognostic (2.77e-1)" "unprognostic (2.16e-2)" "unprognostic (2.25e-1)" "unprognostic (3.70e-3)" 26.1 8.6 4.0 41.0 4.1 36.5 15.0 1.0 4.5 5.6 10.0 2.7 1.6 6.1 8.5 7.7 7.9 10.7 19.8 16.3 2.6 2.1 10.9 68.3 91.3 32.8 5.4 1.7 12.4 7.2 2.5 4.0 9.3 6.8 10.4 6.6 10.6 7.2 3.6 13.9 6.9 7.9 8.0 7.8 42.2 7.3 6.5 3.6 8.3 11.6 13.7 13.4 14.8 17.1 2.2 13.3 22.2 14.2 7.9 5.6 8.9 8.2 0.1 1.5 0.0 0.4 0.9 2.1 1.7 18.5 4.1 12.5 2.7 9.3 7.6 25.8 0.7 1.7 0.3 0.0 8.7 22.7 0.0 0.7 0.2 11.3 31.1 0.2 4.5 10.9 0.7 2.6 4.0 2.1 2.8 88.5 0.3 0.6 0.1 6.4 0.5 4.7 0.2 0.0 28.1 7.0 0.0 0.0 0.2 11.4 0.6 18.1 1.4 0.5 6.4 4.2 0.4 2.3 0.1 27.0 27.8 4.7 6.8 4.9 6.2 2.2 13.9 2.6 3.0 14.2 5.6 2.2 2.4 3.6 13.3 0.9 1.0 2.2 22.2 7.9 7.9 7.5 3.4 8.9 4.0 4.1 1.0 4.5 2.6 2.1 5.4 1.7 6.8 3.6 ICAM2 CD102 ENSG00000108622 "Intercellular adhesion molecule 2" P13598 17 64002594-64020634 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 74.5;lymphoid tissue: 63.9" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 163.3;TIME: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071155 Approved "Plasma membrane,Cytosol" 1200000000 "Plasma membrane" Cytosol "HPA071155: " "unprognostic (9.43e-3)" "unprognostic (3.31e-2)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (1.64e-3)" "unprognostic (1.34e-1)" "unprognostic (3.74e-1)" "unprognostic (8.28e-2)" "unprognostic (2.15e-1)" "unprognostic (4.18e-2)" "unprognostic (1.55e-2)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (3.93e-2)" "unprognostic (6.04e-2)" "unprognostic (2.29e-1)" 36.0 3.6 8.4 13.0 11.5 8.3 34.1 3.5 7.7 9.4 9.7 5.6 2.8 6.4 9.8 5.2 9.5 7.4 8.8 22.8 9.5 8.9 10.5 8.7 27.9 24.0 12.3 3.1 6.3 7.4 3.1 4.5 36.8 9.1 7.9 8.5 8.1 8.8 4.3 17.1 5.5 10.8 13.9 10.5 63.9 8.0 4.0 7.4 14.3 11.6 9.0 18.0 12.8 23.6 49.0 30.9 56.5 74.5 26.0 65.3 67.5 0.0 0.0 0.0 0.0 1.3 1.5 0.4 0.1 0.1 0.0 0.1 0.3 6.8 11.5 2.1 0.0 0.0 0.1 0.0 0.2 2.5 0.0 10.3 0.6 1.2 0.2 1.7 0.0 0.0 0.0 0.1 0.0 163.3 8.4 6.7 0.0 0.0 12.8 1.5 0.0 0.0 7.8 0.0 15.9 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 41.2 0.0 0.1 0.8 0.0 6.4 2.2 10.2 0.0 2.1 0.0 56.5 30.0 8.9 45.8 66.5 52.8 36.5 60.1 42.8 30.9 49.0 65.3 40.7 3.6 26.0 74.5 10.0 64.5 67.5 8.4 11.5 3.5 7.7 9.5 8.9 12.3 3.1 9.1 7.4 ICAM3 "CD50, CDW50, ICAM-R" ENSG00000076662 "Intercellular adhesion molecule 3" P32942 19 10333776-10339823 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5" "Cell line enhanced" "Detected in many" "Karpas-707: 64.3;NB-4: 41.4;RPMI-8226: 48.2;U-266/84: 34.1;U-937: 33.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 172.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 172.3" "CAB002498, HPA049820" Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" 370000000 Mitochondria "Nucleoplasm, Nuclear membrane" "CAB002498: AB_563593, HPA049820: " "unprognostic (6.85e-4)" "unprognostic (5.28e-3)" "unprognostic (3.09e-3)" "unprognostic (1.57e-2)" "unprognostic (5.34e-3)" "unprognostic (5.79e-6)" "unprognostic (5.05e-3)" "unprognostic (3.73e-2)" "unprognostic (1.73e-3)" "unprognostic (7.93e-2)" "unprognostic (3.45e-2)" "unprognostic (2.54e-1)" "unprognostic (5.62e-4)" "unprognostic (1.13e-1)" "unprognostic (1.06e-2)" "unprognostic (3.43e-1)" "unprognostic (1.84e-1)" 6.8 2.8 1.7 23.5 1.9 51.5 5.5 0.6 1.5 3.0 6.8 1.1 1.2 4.3 1.7 3.0 4.0 2.9 7.2 6.4 1.1 0.9 5.1 28.7 13.2 68.5 1.8 1.4 1.7 6.8 0.2 0.4 4.8 1.5 2.8 3.3 2.4 10.3 1.3 5.0 1.6 11.9 1.8 1.0 39.4 5.4 1.4 1.0 47.6 3.0 5.7 38.4 4.5 4.9 25.5 28.4 172.3 33.5 31.0 41.0 43.1 2.6 1.3 0.9 2.9 1.6 1.3 1.6 1.6 1.1 1.4 1.2 1.1 1.8 0.0 5.7 1.4 1.1 0.0 1.2 0.4 19.8 0.8 5.0 1.2 5.0 0.8 18.3 20.7 1.1 1.0 1.6 0.5 0.6 2.7 64.3 1.5 5.4 2.4 41.4 0.7 9.0 1.5 0.6 48.2 1.4 2.3 0.3 1.2 1.4 4.5 3.6 3.9 5.2 1.1 6.3 0.5 7.0 1.6 3.1 34.1 7.6 4.5 33.8 4.9 15.3 33.1 72.0 33.8 24.4 41.0 25.5 32.7 31.2 28.4 23.9 29.3 27.4 172.3 31.0 33.5 4.8 36.9 43.1 1.7 1.9 0.6 1.5 1.1 0.9 1.8 1.4 1.5 1.0 ICAM5 "TLCN, TLN" ENSG00000105376 "Intercellular adhesion molecule 5" Q9UMF0 19 10289981-10296778 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 32.6" "Cell line enhanced" "Detected in some" "HEL: 13.2;K-562: 10.5;RPMI-8226: 12.0;U-266/70: 14.5;U-87 MG: 8.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.8" "Group enriched" "Detected in many" 15 "amygdala: 22.5;basal ganglia: 24.3;cerebral cortex: 32.6;hippocampal formation: 23.0;olfactory region: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "amygdala: 111.1;basal ganglia: 75.7;cerebral cortex: 76.7;hippocampal formation: 105.7;olfactory region: 63.4" "Group enriched" "Detected in many" 14 "amygdala: 58.8;basal ganglia: 55.2;cerebral cortex: 67.5;hippocampal formation: 103.7;olfactory region: 57.5" "HPA008943, HPA009083, CAB025178" Enhanced 2400000 "CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094" "unprognostic (7.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.66e-2)" "unprognostic (4.24e-2)" "unprognostic (8.23e-3)" "unprognostic (2.58e-1)" "unprognostic (8.12e-2)" "unprognostic (9.99e-3)" "unprognostic (2.58e-1)" "unprognostic (2.44e-2)" "unprognostic (3.90e-3)" "unprognostic (9.89e-3)" "unprognostic (5.29e-5)" "unprognostic (6.47e-2)" "unprognostic (4.86e-2)" "unprognostic (5.44e-3)" "unprognostic (6.28e-3)" 0.8 0.9 22.5 0.8 24.3 2.0 0.9 0.0 32.6 0.8 0.8 1.0 0.0 0.8 0.8 0.8 0.8 0.9 0.8 1.0 23.0 1.4 1.1 0.8 3.6 1.2 0.9 15.9 1.4 0.8 0.8 0.1 1.1 0.0 0.9 0.8 0.0 0.8 0.9 0.8 0.8 1.0 0.8 0.1 1.0 1.0 1.9 1.6 0.0 0.8 0.0 0.9 0.8 0.3 0.0 0.0 0.4 0.0 0.0 0.4 0.0 2.8 0.0 0.0 6.1 0.0 0.0 0.1 4.3 0.7 0.1 0.4 0.0 0.1 4.6 1.9 0.0 5.3 0.2 0.0 0.0 0.1 0.9 13.2 4.2 0.4 0.1 0.0 2.6 0.0 0.5 0.1 0.0 0.0 10.5 0.1 0.0 0.6 0.0 1.8 0.0 4.3 0.1 0.0 12.0 0.2 0.0 0.8 0.1 1.9 0.1 0.3 2.2 0.0 0.0 1.3 0.0 0.6 0.0 14.5 2.3 2.6 8.6 0.0 1.3 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 24.3 0.0 32.6 23.0 1.4 0.9 15.9 0.0 1.6 ICOS "AILIM, CD278" ENSG00000163600 "Inducible T cell costimulator" Q9Y6W8 2 203936748-203961577 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8" "Group enriched" "Detected in some" 100 "HEL: 5.9;MOLT-4: 15.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 18.4" "Lineage enriched" "Detected in single" 58 "T-cells: 18.4" "Low region specificity" "Detected in single" "CAB032575, HPA034865" Approved Approved "Plasma membrane,Actin filaments" "Intracellular and membrane" "Plasma membrane" "Actin filaments" "CAB032575: AB_2122593, HPA034865: " "unprognostic (2.66e-2)" "unprognostic (2.13e-3)" "unprognostic (4.19e-4)" "unprognostic (2.35e-5)" "unprognostic (1.07e-1)" "prognostic favourable (1.80e-4)" "unprognostic (9.38e-2)" "unprognostic (2.89e-2)" "unprognostic (1.49e-2)" "unprognostic (3.51e-4)" "unprognostic (7.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.86e-5)" "unprognostic (7.05e-2)" "unprognostic (2.48e-2)" "unprognostic (1.93e-1)" "unprognostic (8.82e-3)" 1.5 0.3 0.2 15.6 0.2 13.8 0.7 0.2 0.2 0.8 1.2 0.0 0.2 0.5 1.2 0.5 1.1 1.2 1.6 0.5 0.2 0.2 1.0 0.8 4.0 19.4 0.3 0.0 0.6 0.3 0.0 0.4 0.1 0.1 0.7 1.1 0.7 2.9 0.0 0.2 0.6 6.2 0.3 0.4 6.1 1.0 0.6 0.0 51.8 1.4 2.4 28.9 3.0 0.9 0.0 0.0 0.0 0.0 0.3 18.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 2.9 0.0 10.5 4.6 0.0 0.0 11.0 5.0 0.0 0.3 0.0 0.0 18.4 3.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 0.1 0.0 ICOSLG "B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653" ENSG00000160223 "Inducible T cell costimulator ligand" O75144 21 44217014-44240966 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, B-cell activation, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.1" "Cell line enhanced" "Detected in many" "Daudi: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "CAB026037, HPA029179" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" 150000000 "Plasma membrane, Cytoplasmic bodies" "CAB026037: , HPA029179: " "unprognostic (3.03e-2)" "unprognostic (1.40e-4)" "unprognostic (3.52e-2)" "unprognostic (1.94e-2)" "unprognostic (6.74e-2)" "unprognostic (9.40e-2)" "unprognostic (6.94e-2)" "unprognostic (3.71e-1)" "unprognostic (1.40e-1)" "unprognostic (3.76e-2)" "unprognostic (1.40e-1)" "unprognostic (2.42e-1)" "unprognostic (3.00e-2)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.84e-1)" 2.3 3.0 5.3 3.9 7.1 14.1 2.3 2.3 5.9 2.9 2.3 2.3 2.3 1.8 2.3 2.3 4.0 2.7 3.5 3.7 8.8 3.7 5.3 2.7 2.3 6.5 6.5 2.3 2.3 2.3 0.0 2.3 2.3 2.3 2.3 1.2 2.3 2.3 2.3 2.3 5.5 2.9 2.3 8.4 3.2 4.2 2.3 2.3 2.3 2.3 2.3 4.5 2.4 2.6 6.5 1.6 1.0 0.8 0.5 1.1 0.4 0.3 3.3 0.1 2.8 0.8 1.1 7.7 0.7 0.6 0.4 0.2 5.6 0.4 14.0 2.1 0.3 4.2 1.9 1.3 0.2 1.4 1.4 0.4 2.7 1.6 0.7 6.0 10.3 1.1 1.9 0.9 0.9 0.8 2.3 1.3 0.2 3.6 0.3 7.9 2.0 3.5 11.9 0.9 8.2 0.6 7.4 1.4 0.0 9.3 13.2 0.3 3.8 8.6 0.8 0.4 3.3 0.3 0.2 12.1 8.2 11.7 4.3 5.6 1.8 0.6 0.8 0.4 0.3 0.8 0.3 3.7 0.8 0.5 0.5 6.5 0.8 1.1 1.0 0.5 0.5 1.6 0.4 0.4 5.3 7.1 2.3 2.3 8.8 3.7 6.5 2.3 2.3 2.3 IER3 "DIF-2, IEX-1, IEX-1L, PRG1" ENSG00000137331 "Immediate early response 3" P46695 6 30743199-30744554 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 142.2" "Group enriched" "Detected in some" 7 "A-431: 39.5;EFO-21: 14.9;HBEC3-KT: 49.2;RPTEC TERT1: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA043847 Approved "HPA043847: " "unprognostic (2.83e-3)" "unprognostic (9.04e-3)" "unprognostic (1.22e-1)" "unprognostic (2.78e-2)" "unprognostic (9.63e-3)" "prognostic unfavourable (5.57e-4)" "prognostic unfavourable (6.36e-5)" "unprognostic (1.38e-3)" "unprognostic (1.69e-1)" "unprognostic (9.28e-2)" "unprognostic (1.53e-3)" "unprognostic (1.19e-2)" "prognostic unfavourable (3.10e-7)" "unprognostic (1.76e-1)" "unprognostic (1.70e-1)" "unprognostic (2.71e-2)" "unprognostic (8.77e-2)" 30.1 24.1 1.9 43.2 1.5 3.0 6.1 0.8 2.7 21.5 9.0 4.7 77.8 2.7 7.3 12.5 47.2 10.0 16.7 22.8 2.1 1.3 17.9 15.9 20.1 6.0 3.1 0.5 11.2 17.7 2.7 3.8 10.3 5.1 9.9 2.7 6.4 10.8 142.2 5.8 14.2 4.2 7.2 5.4 12.1 18.6 5.5 1.7 3.9 4.5 37.1 27.8 33.9 22.5 0.4 0.0 1.6 0.4 0.0 0.4 0.0 39.5 0.0 0.0 4.6 1.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.9 2.5 0.0 0.0 49.2 0.0 0.1 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.6 6.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 1.5 0.8 1.8 2.1 1.3 3.1 0.5 5.1 1.7 IER3IP1 ENSG00000134049 "Immediate early response 3 interacting protein 1" Q9Y5U9 18 47152834-47176374 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Diabetes mellitus, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA010027 Supported Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA010027: AB_1079098" "unprognostic (6.13e-2)" "unprognostic (2.96e-2)" "unprognostic (3.82e-2)" "unprognostic (1.45e-2)" "unprognostic (1.11e-3)" "unprognostic (2.41e-1)" "prognostic unfavourable (6.47e-6)" "unprognostic (9.86e-2)" "unprognostic (5.13e-2)" "prognostic favourable (8.59e-4)" "unprognostic (6.44e-2)" "unprognostic (6.24e-3)" "unprognostic (1.53e-3)" "unprognostic (8.55e-2)" "unprognostic (2.71e-2)" "unprognostic (8.75e-2)" "unprognostic (1.27e-3)" 16.9 21.7 13.1 13.7 12.9 15.0 33.1 22.4 21.4 15.7 17.7 7.3 18.4 20.3 15.6 19.6 19.2 12.8 17.9 40.2 12.3 15.3 38.1 45.7 28.3 25.7 12.5 9.1 15.7 30.6 16.3 30.5 29.7 13.9 17.7 16.4 13.3 29.8 17.9 33.8 16.7 27.7 17.7 11.3 22.7 19.0 17.0 7.6 16.4 19.7 24.8 17.6 17.9 15.9 14.2 24.5 10.7 12.4 11.5 18.6 11.8 12.6 7.3 11.2 10.0 15.3 17.1 7.8 30.2 14.8 15.1 16.0 5.9 10.9 12.5 9.6 13.4 15.5 10.5 10.6 16.5 20.4 9.5 10.9 11.5 17.9 16.4 32.8 16.3 13.4 13.6 13.5 10.2 12.9 8.9 19.4 16.0 7.0 11.6 15.8 5.6 9.0 11.6 17.6 17.8 15.2 12.4 13.0 14.5 10.3 8.8 17.8 8.7 18.9 18.6 22.5 11.5 10.8 16.4 28.1 30.7 13.3 17.5 21.0 18.0 8.3 12.4 10.7 18.6 11.2 16.6 13.2 16.0 16.0 11.7 14.2 15.3 15.9 1.3 11.5 11.6 24.5 15.8 11.8 13.1 12.9 22.4 21.4 12.3 15.3 12.5 9.1 13.9 7.6 IFI27 "FAM14D, ISG12, P27" ENSG00000165949 "Interferon alpha inducible protein 27" 14 94104836-94116698 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 180.6;BJ hTERT+ SV40 Large T+ RasG12V: 159.8;EFO-21: 48.8;Karpas-707: 44.4;SK-MEL-30: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.4" "Group enriched" "Detected in many" 5 "monocytes: 9.4;T-cells: 4.1" HPA028875 Uncertain "HPA028875: AB_10601434" "unprognostic (1.15e-1)" "unprognostic (1.19e-1)" "unprognostic (2.43e-2)" "unprognostic (6.68e-2)" "unprognostic (4.74e-2)" "unprognostic (1.59e-2)" "unprognostic (6.78e-3)" "unprognostic (5.26e-2)" "unprognostic (2.10e-1)" "prognostic favourable (8.80e-4)" "unprognostic (1.13e-3)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (1.65e-1)" 37.0 13.5 9.7 21.1 12.7 14.8 22.8 5.7 8.4 14.0 38.1 6.6 10.2 12.7 18.9 24.7 31.9 17.1 53.5 25.9 11.2 8.9 12.8 12.1 61.3 4.6 12.5 9.7 8.1 4.8 0.3 5.5 39.7 12.7 9.0 23.2 9.7 15.5 7.1 15.0 12.6 14.2 12.0 12.0 64.0 72.0 20.9 7.3 7.9 8.9 28.4 18.5 9.2 11.4 0.1 1.2 0.6 9.4 0.4 4.1 2.5 15.3 0.0 0.1 0.0 0.0 1.9 0.1 0.2 0.7 180.6 159.8 0.3 12.8 0.1 48.8 9.9 0.5 0.0 0.0 7.1 0.1 0.3 0.0 0.1 0.0 1.2 0.0 0.0 0.1 0.1 31.4 0.0 24.9 0.0 44.4 0.0 0.0 0.1 0.0 0.0 2.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 50.0 0.0 0.2 0.0 0.0 0.2 28.8 0.0 0.8 1.2 0.2 0.0 0.0 0.1 0.0 1.9 0.6 0.5 9.4 0.5 0.0 4.1 1.1 1.2 0.1 0.0 0.7 0.1 0.4 2.8 0.2 3.4 2.5 9.7 12.7 5.7 8.4 11.2 8.9 12.5 9.7 12.7 7.3 IFI30 "GILT, IFI-30, IP-30, IP30, MGC32056" ENSG00000216490 "IFI30, lysosomal thiol reductase" P13284 19 18173162-18178117 "Predicted intracellular proteins, Predicted membrane proteins" Immunity Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 348.5" "Cell line enhanced" "Detected in many" "Daudi: 75.3;RPMI-8226: 81.6;SK-BR-3: 55.1;U-266/84: 90.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 348.5" "Group enriched" "Detected in all" 8 "dendritic cells: 145.5;granulocytes: 95.4;monocytes: 348.5" "Low region specificity" "Detected in many" HPA026650 Enhanced Supported Vesicles,Cytosol "Intracellular and membrane" 89000 "Vesicles, Cytosol" "HPA026650: AB_10602237" "unprognostic (4.66e-2)" "unprognostic (1.25e-4)" "unprognostic (2.35e-3)" "unprognostic (7.40e-2)" "unprognostic (1.76e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-3)" "unprognostic (2.40e-1)" "unprognostic (4.01e-2)" "unprognostic (9.19e-3)" "unprognostic (3.04e-1)" "unprognostic (1.19e-1)" "unprognostic (7.29e-11)" "unprognostic (3.50e-1)" "unprognostic (1.62e-2)" "unprognostic (3.39e-2)" "unprognostic (9.59e-3)" 104.2 31.0 5.8 85.5 10.8 28.3 13.9 1.2 5.2 5.3 17.4 6.5 3.2 23.3 5.0 13.7 9.3 15.9 13.1 16.2 5.0 4.0 37.5 60.4 109.7 139.5 12.0 0.8 15.0 14.6 2.0 7.6 123.2 11.0 8.6 18.2 9.2 18.7 4.3 7.2 10.1 28.5 18.9 13.3 140.6 19.4 5.7 7.9 20.6 15.6 9.6 41.2 24.5 8.2 24.3 145.5 95.4 348.5 1.7 1.0 213.4 12.7 6.7 0.0 4.4 1.3 1.8 12.1 1.4 1.8 3.9 10.1 15.2 22.8 75.3 11.6 4.3 10.0 8.0 2.9 0.4 20.0 5.7 0.8 12.5 21.5 12.8 2.2 5.8 7.8 6.8 6.4 2.2 0.2 10.6 47.3 1.9 24.9 1.0 0.2 2.5 6.7 7.3 0.5 81.6 11.6 0.4 0.6 0.8 23.4 55.1 1.3 3.7 0.9 0.3 6.7 4.0 13.8 1.4 1.6 90.3 42.9 18.7 14.9 1.0 2.0 228.9 95.4 1.0 348.5 1.0 24.3 0.7 0.8 145.5 16.8 0.5 0.6 52.5 1.7 230.0 4.3 1.0 213.4 5.8 10.8 1.2 5.2 5.0 4.0 12.0 0.8 11.0 7.9 IFI6 "6-16, FAM14C, G1P3, IFI-6-16, IFI616" ENSG00000126709 "Interferon alpha inducible protein 6" P09912 1 27666061-27672218 "Predicted membrane proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 225.6" "Group enriched" "Detected in many" 5 "BJ hTERT+ SV40 Large T+: 131.9;BJ hTERT+ SV40 Large T+ RasG12V: 154.2;EFO-21: 53.0;SK-MEL-30: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005543 Approved Approved Mitochondria Mitochondria "HPA005543: AB_1849342" "unprognostic (4.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (6.96e-2)" "unprognostic (9.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.06e-1)" "unprognostic (6.77e-3)" "unprognostic (5.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.92e-3)" "unprognostic (1.81e-1)" "unprognostic (8.40e-2)" "unprognostic (3.42e-2)" "unprognostic (1.72e-2)" 32.3 27.5 24.9 13.5 28.2 37.3 10.9 14.2 36.1 11.4 13.8 22.9 6.5 16.5 26.8 68.0 8.6 11.9 113.9 19.3 23.0 42.3 44.8 23.5 31.6 5.8 20.0 17.0 14.1 21.3 5.9 60.1 225.6 34.3 13.9 10.1 31.6 111.4 10.1 7.4 5.4 12.5 17.0 26.0 27.3 35.4 15.4 6.8 24.8 35.2 7.9 9.7 7.8 7.6 9.7 19.4 84.9 58.6 15.8 27.5 16.8 1.4 0.4 2.2 1.3 7.1 3.9 8.8 4.6 21.3 131.9 154.2 0.7 5.6 0.5 53.0 2.1 0.5 0.5 1.0 4.3 10.8 1.7 3.4 1.1 0.4 1.9 1.1 4.4 4.2 0.1 7.9 0.1 1.2 0.2 9.3 1.4 0.4 4.0 14.2 0.4 4.5 2.7 1.2 1.3 1.1 0.0 3.1 2.8 5.7 1.3 93.6 0.6 4.4 2.0 1.2 1.9 0.9 0.8 11.1 6.3 0.3 2.4 9.9 3.4 29.3 44.4 39.4 22.7 58.6 22.4 9.7 23.0 20.7 19.4 8.0 24.3 23.6 84.9 15.8 38.8 2.0 27.5 16.8 24.9 28.2 14.2 36.1 23.0 42.3 20.0 17.0 34.3 6.8 IFITM2 1-8D ENSG00000185201 "Interferon induced transmembrane protein 2" Q01629 11 307631-315272 "Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 875.3" "Cell line enhanced" "Detected in many" "HHSteC: 98.0;HMC-1: 111.9;HSkMC: 121.1;U-937: 86.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 875.3" "Lineage enriched" "Detected in all" 12 "granulocytes: 875.3" HPA004337 Uncertain "HPA004337: AB_1851427" "unprognostic (2.39e-2)" "unprognostic (2.69e-2)" "unprognostic (4.54e-1)" "unprognostic (1.65e-2)" "unprognostic (3.41e-2)" "unprognostic (1.86e-1)" "unprognostic (3.56e-2)" "unprognostic (3.87e-2)" "unprognostic (3.87e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-3)" "unprognostic (1.64e-2)" "prognostic unfavourable (2.37e-9)" "unprognostic (2.79e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" 101.0 25.2 14.3 95.5 20.9 56.3 143.6 8.2 16.6 70.8 40.2 10.9 14.3 9.5 63.6 46.1 56.0 70.8 28.5 91.1 13.3 10.8 83.0 326.2 141.9 255.5 29.3 3.3 106.5 31.1 68.6 18.9 48.0 21.1 54.3 17.7 39.1 20.1 37.7 72.7 20.1 24.0 63.2 21.7 233.4 28.4 38.5 15.6 12.5 83.4 26.2 35.4 98.0 119.7 27.5 21.6 875.3 74.9 52.8 33.3 47.1 4.1 12.8 35.3 0.2 23.0 66.8 0.1 13.0 25.1 7.4 17.2 0.4 38.1 0.0 31.6 66.2 8.5 0.1 2.2 3.1 0.0 5.3 12.7 14.5 14.1 98.0 20.4 111.9 121.1 0.4 2.1 1.1 24.3 0.5 42.0 5.3 28.4 0.1 74.8 4.3 29.9 14.0 3.7 0.2 68.6 0.0 0.1 0.8 9.6 11.1 3.9 16.1 7.3 63.7 1.1 4.0 5.8 0.2 0.1 0.6 0.6 2.1 86.9 3.9 77.9 19.8 138.8 33.3 53.2 24.6 27.5 30.0 29.4 21.6 24.5 26.0 28.1 875.3 52.8 74.9 9.1 15.8 47.1 14.3 20.9 8.2 16.6 13.3 10.8 29.3 3.3 21.1 15.6 IFNAR1 "IFNAR, IFRC" ENSG00000142166 "Interferon alpha and beta receptor subunit 1" P17181 21 33324477-33359862 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018015, HPA029226" Uncertain 100000 "HPA018015: AB_1851433, HPA029226: " "unprognostic (2.42e-3)" "unprognostic (2.95e-1)" "unprognostic (3.01e-1)" "unprognostic (1.15e-1)" "unprognostic (4.93e-2)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (3.02e-1)" "unprognostic (4.69e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (2.38e-1)" "unprognostic (9.38e-3)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (8.45e-2)" "unprognostic (3.06e-2)" 27.2 16.4 18.5 16.8 18.7 14.8 15.9 18.1 22.9 14.2 16.8 15.1 10.0 12.3 15.7 10.9 15.8 13.5 16.2 14.5 16.9 15.8 17.5 56.4 16.6 15.0 19.7 13.8 16.6 18.3 30.6 17.9 23.2 18.3 14.7 12.2 12.1 17.6 12.6 17.3 10.6 15.8 13.7 22.2 29.8 18.8 10.3 16.7 26.9 21.4 9.1 13.1 18.7 18.1 20.5 17.8 64.5 23.1 7.3 12.1 10.7 13.1 12.0 5.1 5.8 16.9 17.3 5.9 14.2 15.2 6.5 6.7 12.9 15.1 10.2 11.5 9.7 7.9 4.8 8.3 7.0 11.5 9.6 15.1 11.6 7.6 7.2 11.1 10.8 14.3 7.4 10.8 6.5 12.5 17.3 49.9 10.7 10.9 8.2 4.5 5.5 7.7 8.1 18.0 17.3 7.2 17.3 6.1 5.5 14.2 10.2 9.0 15.6 8.2 19.8 13.2 7.2 17.3 7.9 33.4 45.8 11.7 17.7 15.7 14.1 18.9 16.8 9.7 8.0 19.7 7.5 18.5 10.6 9.0 11.3 20.5 12.1 9.4 64.5 7.3 23.1 17.8 12.0 10.7 18.5 18.7 18.1 22.9 16.9 15.8 19.7 13.8 18.3 16.7 IFNGR1 "CD119, IFNGR" ENSG00000027697 "Interferon gamma receptor 1" P15260 6 137197484-137219449 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025889, HPA029213, HPA063871" Approved Approved "Plasma membrane" "Plasma membrane" "CAB025889: , HPA029213: AB_10601023, HPA063871: " "unprognostic (1.73e-1)" "unprognostic (8.86e-2)" "unprognostic (9.85e-3)" "unprognostic (1.71e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-1)" "unprognostic (6.97e-2)" "unprognostic (9.86e-2)" "unprognostic (1.57e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "prognostic unfavourable (5.48e-4)" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (1.81e-2)" "unprognostic (5.38e-3)" 69.5 22.2 17.4 36.9 23.5 37.7 65.3 8.4 18.5 23.6 27.1 27.8 13.8 28.0 19.2 21.2 23.0 20.3 25.9 53.7 20.6 17.4 19.3 66.4 58.7 86.9 33.8 13.2 19.2 17.5 9.2 12.8 47.0 29.9 20.1 22.8 11.6 24.5 18.0 25.3 24.0 46.7 22.5 45.7 69.1 20.3 14.1 26.3 14.5 22.8 19.7 38.2 25.0 22.3 12.2 39.4 92.3 65.4 5.4 29.7 52.3 4.9 4.7 6.2 8.0 41.1 21.7 5.2 14.1 20.8 9.1 12.4 30.7 9.6 4.9 22.4 8.1 30.5 5.5 14.2 12.8 10.5 7.6 7.7 5.8 45.4 23.2 23.9 11.4 47.8 57.5 7.6 12.4 11.4 6.4 8.3 6.9 5.5 3.8 11.0 5.1 3.8 11.8 6.5 7.3 15.9 23.2 6.3 9.7 17.3 10.2 12.7 3.6 15.8 15.9 8.9 6.5 11.6 7.4 6.2 5.8 5.5 4.6 15.9 8.6 16.5 65.4 43.3 14.1 63.0 29.7 10.9 8.0 11.8 39.4 12.2 5.2 5.8 92.3 5.4 44.1 10.1 5.6 52.3 17.4 23.5 8.4 18.5 20.6 17.4 33.8 13.2 29.9 26.3 IFNGR2 "AF-1, IFNGT1" ENSG00000159128 "Interferon gamma receptor 2" P38484 21 33402896-33479348 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 55.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001535 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA001535: AB_1078432" "unprognostic (9.58e-2)" "unprognostic (5.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (3.25e-4)" "unprognostic (3.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.53e-2)" "unprognostic (3.25e-2)" "unprognostic (9.49e-2)" "prognostic unfavourable (1.13e-10)" "unprognostic (6.74e-3)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (2.15e-3)" 27.2 13.4 11.9 20.8 12.6 45.1 64.4 4.6 18.0 12.5 21.6 5.7 13.0 18.5 10.6 14.1 21.9 11.5 15.2 17.7 11.1 10.1 14.6 20.2 26.3 46.3 8.7 9.4 13.0 21.7 7.1 12.6 20.5 12.2 14.9 11.7 12.1 21.9 11.7 13.1 16.7 20.0 15.3 18.1 27.4 30.3 14.1 7.2 7.9 18.1 19.4 18.9 14.8 26.8 13.2 7.7 55.1 22.8 0.3 3.3 13.8 3.0 2.6 1.3 2.7 3.7 6.4 4.3 8.6 6.3 2.0 3.3 3.0 1.7 5.2 4.8 5.2 2.3 2.7 6.0 1.1 20.0 16.9 1.5 1.1 2.7 2.5 7.5 4.7 4.8 4.0 3.4 3.5 5.1 7.9 2.5 2.7 0.9 1.8 5.1 4.9 16.4 4.4 4.1 4.3 2.2 4.1 1.8 4.6 4.3 0.5 8.2 1.6 4.8 8.6 2.5 5.4 2.1 2.1 5.5 7.5 6.7 2.2 6.7 11.8 12.9 22.2 14.8 0.1 22.0 0.1 11.5 1.3 0.1 7.7 13.2 3.3 1.4 55.1 0.3 22.8 2.4 1.4 13.8 11.9 12.6 4.6 18.0 11.1 10.1 8.7 9.4 12.2 7.2 IFNLR1 "CRF2/12, IFNLR, IL-28R1, IL28RA" ENSG00000185436 "Interferon lambda receptor 1" Q8IU57 1 24154157-24187959 "Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 29.5;U-266/84: 10.2;U-698: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.9" "Group enriched" "Detected in many" 5 "B-cells: 6.8;dendritic cells: 11.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA017319 Uncertain Approved Cytosol "Intracellular and membrane" Cytosol "HPA017319: AB_1851708" "prognostic favourable (5.12e-4)" "unprognostic (7.16e-2)" "unprognostic (8.61e-3)" "unprognostic (8.48e-2)" "unprognostic (8.09e-2)" "unprognostic (1.22e-2)" "unprognostic (7.28e-3)" "unprognostic (2.33e-1)" "unprognostic (5.10e-2)" "unprognostic (1.93e-1)" "unprognostic (5.51e-2)" "unprognostic (4.50e-1)" "unprognostic (3.66e-3)" "unprognostic (5.15e-2)" "unprognostic (1.69e-1)" "unprognostic (2.69e-1)" "unprognostic (1.10e-1)" 3.0 3.0 1.1 9.5 1.9 0.4 2.9 10.2 2.1 2.1 9.9 3.8 3.6 6.5 0.8 6.7 4.7 2.0 2.9 6.4 0.9 2.1 4.3 10.1 9.2 8.2 2.0 1.9 1.5 7.8 5.7 8.2 2.5 2.9 4.1 4.6 1.6 9.3 5.7 3.5 8.3 19.2 0.2 5.3 4.4 3.1 1.2 1.1 1.2 5.3 3.1 10.7 2.0 2.7 6.8 11.9 0.0 0.0 0.0 2.0 0.5 3.6 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.7 0.5 6.2 1.0 7.9 8.6 0.0 2.8 3.7 6.4 0.5 1.6 2.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 2.1 0.2 2.0 0.0 0.1 0.0 0.0 0.8 0.1 0.2 7.9 2.3 0.0 0.0 0.6 1.5 1.5 1.1 0.7 1.9 1.1 0.7 1.5 0.0 0.0 0.0 1.6 0.0 0.0 29.5 10.2 22.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 5.1 0.3 1.5 0.0 6.8 0.6 1.6 0.0 0.0 0.0 11.9 0.3 0.5 1.1 1.9 10.2 2.1 0.9 2.1 2.0 1.9 2.9 1.1 IFRD1 "PC4, TIS7" ENSG00000006652 "Interferon related developmental regulator 1" O00458 7 112422968-112481017 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 93.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "eosinophil: 25.6;neutrophil: 44.2" "Lineage enriched" "Detected in all" 12 "granulocytes: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024122 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA024122: AB_1851452" "unprognostic (2.29e-1)" "unprognostic (3.47e-1)" "unprognostic (1.10e-1)" "unprognostic (9.82e-3)" "unprognostic (1.36e-2)" "unprognostic (2.39e-1)" "unprognostic (5.73e-3)" "unprognostic (1.37e-1)" "unprognostic (2.48e-2)" "prognostic favourable (5.45e-4)" "unprognostic (6.41e-2)" "unprognostic (2.93e-3)" "unprognostic (1.50e-3)" "unprognostic (4.81e-2)" "unprognostic (1.98e-1)" "unprognostic (2.89e-1)" "unprognostic (4.70e-2)" 19.5 18.0 16.7 12.9 19.6 83.1 24.0 14.3 15.7 10.7 18.3 15.6 11.7 18.7 15.7 12.5 12.7 11.4 12.7 16.0 15.2 13.3 11.9 14.1 19.2 7.9 30.9 13.2 16.9 93.0 12.5 23.1 18.7 16.9 14.7 11.7 11.2 14.3 11.0 37.6 12.3 19.0 23.9 28.2 11.7 17.7 17.9 22.0 7.5 16.5 13.5 7.4 14.7 37.5 3.8 2.9 44.2 3.2 3.4 3.7 2.6 15.0 10.2 15.8 14.8 27.0 17.5 14.6 14.9 14.3 19.4 17.4 16.8 12.8 7.3 28.6 7.8 9.0 10.9 12.6 26.5 12.4 15.6 8.2 18.8 16.0 30.9 11.1 6.5 13.4 27.1 20.4 23.4 8.0 25.1 16.5 7.8 13.6 14.1 18.8 35.9 17.8 12.3 6.3 13.6 5.9 4.2 25.4 13.1 17.0 14.5 48.3 5.6 12.0 6.9 32.9 7.0 25.7 45.0 14.8 17.5 20.0 9.0 31.0 37.7 5.7 3.2 25.6 3.6 2.8 2.8 3.8 3.5 3.4 2.9 3.0 3.4 3.3 44.2 3.4 2.8 2.1 3.7 2.6 16.7 19.6 14.3 15.7 15.2 13.3 30.9 13.2 16.9 22.0 IFRD2 "IFNRP, SKMc15, SM15" ENSG00000214706 "Interferon related developmental regulator 2" Q12894 3 50287732-50292918 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068560 Approved "HPA068560: " "prognostic favourable (7.22e-4)" "unprognostic (5.19e-2)" "unprognostic (2.08e-2)" "unprognostic (8.61e-3)" "unprognostic (3.88e-1)" "unprognostic (2.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.24e-1)" "unprognostic (1.62e-1)" "unprognostic (2.01e-1)" "unprognostic (1.91e-2)" "unprognostic (7.78e-3)" "prognostic favourable (2.50e-4)" "unprognostic (3.07e-2)" "unprognostic (1.03e-1)" "unprognostic (1.58e-1)" "unprognostic (1.13e-1)" 11.0 10.0 5.2 10.8 7.7 6.9 15.4 9.0 6.6 7.9 13.7 6.4 21.2 10.7 6.9 7.7 11.8 8.0 17.0 23.9 4.9 4.5 11.1 41.1 8.4 6.5 7.8 3.5 9.8 34.7 10.2 7.6 6.7 7.1 15.6 8.3 8.0 23.7 22.3 39.2 7.8 12.0 8.5 4.9 9.4 18.4 9.9 6.9 7.4 15.8 24.3 8.5 7.8 7.5 17.5 17.8 3.9 16.9 18.5 25.2 15.2 22.7 23.6 6.5 20.5 6.7 7.7 15.1 17.6 9.6 21.6 15.3 19.3 23.5 15.6 13.0 12.1 13.4 13.6 28.1 11.2 14.8 27.2 22.5 31.1 22.7 13.3 22.8 14.2 7.1 24.2 22.5 28.4 18.3 14.2 12.9 12.7 21.4 14.9 26.8 16.4 45.9 9.7 9.5 35.6 12.9 13.8 11.6 11.1 11.1 30.8 11.1 14.6 21.9 13.2 18.1 22.7 31.2 35.4 9.1 15.5 13.4 14.3 30.0 26.3 3.9 12.5 1.7 17.9 16.9 25.2 17.5 18.9 17.1 17.8 17.3 20.2 18.3 1.1 18.5 9.3 17.5 14.9 15.2 5.2 7.7 9.0 6.6 4.9 4.5 7.8 3.5 7.1 6.9 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;parathyroid gland: 16.6;placenta: 12.2" "Group enriched" "Detected in some" 5 "AF22: 42.5;CACO-2: 10.7;Hep G2: 33.7" "Cancer enhanced" "Detected in many" "testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015713 Uncertain Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.2 0.6 3.5 0.4 2.1 0.2 1.7 10.8 4.6 1.0 0.5 3.3 0.0 0.3 1.6 0.4 0.2 1.4 0.4 0.4 3.2 2.6 0.6 0.2 0.3 0.2 2.5 1.7 1.7 0.3 16.6 2.9 12.2 2.6 0.5 0.3 0.6 0.2 0.5 0.5 0.4 0.3 0.6 2.2 0.3 0.4 4.7 2.7 3.7 1.7 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.1 10.8 4.6 3.2 2.6 2.5 1.7 2.6 2.7 IGDCC4 "LOC57722, NOPE" ENSG00000103742 "Immunoglobulin superfamily DCC subclass member 4" Q8TDY8 15 65381464-65423072 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 14.1" "Cell line enhanced" "Detected in some" "A549: 5.0;AF22: 10.2;CAPAN-2: 8.9;EFO-21: 5.1;HSkMC: 5.7;NTERA-2: 7.6" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008510, HPA008576" Approved Approved Approved Nucleoplasm,Cytosol 34000000 "Nucleoplasm, Cytosol" "HPA008510: , HPA008576: AB_1079496" "unprognostic (1.16e-1)" "unprognostic (9.38e-2)" "unprognostic (1.92e-2)" "unprognostic (1.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.77e-2)" "unprognostic (2.75e-3)" "unprognostic (9.94e-2)" "unprognostic (4.18e-2)" "unprognostic (3.65e-2)" "unprognostic (3.29e-2)" "unprognostic (6.36e-2)" "unprognostic (1.83e-8)" "unprognostic (3.30e-2)" "unprognostic (4.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.32e-3)" 1.7 6.2 8.3 3.7 5.0 0.2 1.3 2.0 4.9 6.1 1.4 8.0 0.0 1.0 2.3 7.2 2.6 2.9 6.7 2.2 6.2 4.1 0.6 0.3 0.7 1.1 5.6 3.1 13.3 0.7 0.2 2.4 8.2 6.1 0.9 1.2 1.6 1.5 1.3 14.1 1.5 1.7 3.1 5.0 0.5 1.9 2.5 6.5 0.0 4.6 4.0 1.5 4.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 10.2 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.4 0.6 8.9 0.0 5.1 0.4 0.0 2.5 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.4 0.0 0.0 5.7 0.0 0.5 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.8 7.6 0.0 0.0 2.5 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 4.1 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 5.0 2.0 3.9 6.2 4.1 5.6 3.1 6.1 6.5 IGF1R "CD221, IGFIR, IGFR, JTK13, MGC18216" ENSG00000140443 "Insulin like growth factor 1 receptor" P08069 15 98648971-98964530 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 7.7" "Group enriched" "Detected in many" 5 "granulocytes: 7.7;T-cells: 2.9" "Low region specificity" "Detected in all" "CAB010268, HPA045563" Approved Approved Vesicles 36000 Vesicles "CAB010268: AB_671792, HPA045563: " "unprognostic (1.30e-3)" "unprognostic (5.81e-3)" "unprognostic (1.53e-1)" "unprognostic (3.34e-2)" "unprognostic (2.65e-1)" "unprognostic (2.05e-2)" "unprognostic (1.29e-2)" "unprognostic (6.87e-2)" "unprognostic (2.64e-2)" "unprognostic (2.87e-2)" "unprognostic (8.56e-2)" "unprognostic (1.62e-1)" "prognostic favourable (3.75e-7)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" 8.4 12.7 11.5 5.9 13.5 16.3 18.5 23.0 15.7 15.3 13.4 10.4 22.7 4.2 15.3 16.3 9.2 18.9 7.7 11.6 11.7 7.3 17.0 2.0 11.0 4.9 8.0 11.8 23.2 22.5 4.7 13.8 17.5 9.5 21.7 7.2 16.7 12.5 23.2 9.1 13.0 7.5 18.1 8.0 7.3 10.7 12.0 11.5 10.7 16.1 7.0 5.6 12.8 21.6 1.0 0.4 7.7 0.6 1.0 2.9 0.7 3.3 16.5 11.6 0.2 5.8 4.2 7.7 3.7 7.4 1.2 1.1 7.1 8.8 0.8 10.7 7.2 15.8 5.1 15.0 1.0 0.0 5.2 12.5 18.5 14.2 5.1 6.6 1.3 6.6 7.1 2.1 10.2 4.1 0.6 2.9 5.7 23.4 2.5 4.4 10.8 0.9 4.0 9.0 3.0 3.5 20.3 3.9 17.3 26.7 1.5 14.4 8.1 3.1 11.3 1.1 15.0 3.0 5.8 1.0 4.4 2.7 2.2 4.9 2.8 4.0 0.6 1.8 0.9 0.6 0.6 0.4 0.8 0.3 0.4 1.0 2.9 1.0 7.7 1.0 0.5 0.3 0.0 0.7 11.5 13.5 23.0 15.7 11.7 7.3 8.0 11.8 9.5 11.5 IGF2 "C11orf43, FLJ44734, IGF-II" ENSG00000167244 "Insulin like growth factor 2" P01344 11 2129112-2149603 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism, Osteogenesis" "Growth factor, Hormone, Mitogen" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 330.5" "Cell line enhanced" "Detected in some" "CACO-2: 112.8;Hep G2: 77.4;LHCN-M2: 44.5;RH-30: 55.3;SH-SY5Y: 67.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007556, HPA007993" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" 609000000 1700000000 Vesicles "Nucleoplasm, Cytosol" "HPA007556: , HPA007993: AB_1851474" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" "unprognostic (7.08e-2)" "unprognostic (2.30e-3)" "unprognostic (2.59e-1)" "prognostic favourable (7.12e-4)" "unprognostic (7.92e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (3.69e-2)" "unprognostic (1.85e-1)" "unprognostic (1.79e-3)" "unprognostic (2.00e-2)" "unprognostic (8.98e-2)" "unprognostic (8.93e-3)" "unprognostic (5.78e-2)" 16.6 8.0 1.3 4.5 2.0 0.5 23.3 2.3 1.9 23.4 5.0 3.4 4.7 1.0 9.9 32.0 5.2 17.2 4.5 20.5 1.5 1.6 8.1 39.7 1.9 1.1 3.5 1.6 20.4 5.5 0.7 5.0 330.5 7.6 10.4 1.0 33.2 2.6 6.7 21.9 1.7 2.3 7.5 17.0 2.0 3.2 12.4 0.2 1.8 2.6 14.5 1.8 15.2 14.1 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 14.9 0.1 0.4 0.0 112.8 0.0 0.0 1.1 0.0 0.0 0.1 0.9 1.0 0.0 0.0 0.0 0.0 77.4 19.8 0.0 0.0 24.1 0.0 0.1 0.0 0.1 0.0 0.0 44.5 0.2 0.0 0.1 0.1 0.2 0.0 55.3 0.1 0.0 0.1 4.4 67.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 1.3 2.0 2.3 1.4 1.5 1.6 3.5 1.6 7.6 0.2 IGF2R "CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI" ENSG00000197081 "Insulin like growth factor 2 receptor" P11717 6 159969099-160113507 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 59.6;hTERT-HME1: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009661, HPA011332" Supported Enhanced "Golgi apparatus,Vesicles" 150000000 "Golgi apparatus, Vesicles" "CAB009661: AB_2122795, HPA011332: AB_1846276" "prognostic unfavourable (3.01e-4)" "prognostic unfavourable (2.92e-5)" "unprognostic (5.83e-2)" "unprognostic (1.72e-1)" "unprognostic (4.15e-1)" "unprognostic (3.25e-1)" "unprognostic (7.32e-3)" "unprognostic (2.32e-1)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.37e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (1.85e-1)" "prognostic unfavourable (6.08e-4)" 28.0 22.2 6.8 13.5 8.1 16.7 39.4 6.4 8.2 14.9 17.3 9.5 13.0 9.4 19.6 16.0 16.7 13.1 17.9 27.9 6.7 6.2 20.6 26.6 32.6 44.7 12.3 3.6 18.0 19.6 23.5 13.6 15.5 10.0 14.1 13.3 13.9 18.2 13.5 62.0 15.9 15.4 16.5 7.6 30.2 14.4 13.8 9.0 37.9 18.5 17.3 14.1 16.3 26.9 0.4 2.9 13.3 2.0 1.0 3.6 0.9 7.7 7.0 12.4 17.4 45.3 25.0 16.8 12.2 26.4 10.1 17.4 10.6 12.2 3.2 13.7 13.4 10.4 9.3 59.6 17.0 16.8 6.6 1.4 12.2 19.1 26.8 7.4 12.1 19.9 19.1 21.0 60.7 6.5 13.9 17.4 15.9 5.7 3.4 7.4 5.5 7.5 8.0 8.5 16.3 14.3 7.8 4.1 9.1 16.5 14.8 16.5 6.2 21.0 9.8 9.8 10.3 21.1 22.3 10.3 14.4 3.3 18.9 10.2 15.1 0.1 2.0 1.1 3.6 0.8 1.4 0.3 1.2 1.7 0.3 0.4 1.0 2.4 13.3 1.0 1.4 2.9 0.7 0.9 6.8 8.1 6.4 8.2 6.7 6.2 12.3 3.6 10.0 9.0 IGFALS ALS ENSG00000099769 "Insulin like growth factor binding protein acid labile subunit" P35858 16 1790413-1794971 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "liver: 107.6" "Cell line enhanced" "Detected in some" "Hep G2: 5.2;T-47d: 2.1;U-266/70: 5.1" "Cancer enhanced" "Detected in many" "liver cancer: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040692, HPA040948" Supported "Secreted to blood" 14650000000 44000000000 "HPA040692: AB_10794067, HPA040948: AB_10794999" "unprognostic (2.74e-3)" "unprognostic (1.95e-1)" "unprognostic (9.13e-2)" "prognostic unfavourable (6.06e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-2)" "prognostic favourable (5.97e-4)" "unprognostic (5.54e-4)" "unprognostic (3.00e-1)" "unprognostic (1.17e-1)" "unprognostic (9.06e-2)" "unprognostic (1.05e-2)" "unprognostic (1.10e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (4.39e-1)" "unprognostic (5.51e-2)" 0.1 0.0 0.1 0.1 0.2 0.2 0.1 0.8 0.2 0.1 0.4 0.1 0.1 0.2 0.2 0.1 0.1 0.2 7.4 0.1 0.1 0.2 0.2 107.6 0.4 0.1 0.1 0.1 0.1 0.8 0.0 0.2 0.1 0.4 0.1 0.0 1.4 0.6 0.1 0.2 0.2 0.1 0.1 0.3 0.1 5.0 0.5 0.1 1.7 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 5.2 0.0 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.9 1.0 0.0 1.2 0.2 0.5 0.2 0.0 1.3 0.5 1.5 0.0 0.0 0.4 0.3 0.3 0.0 0.7 2.1 0.2 0.2 0.4 1.4 0.2 0.2 5.1 1.8 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.2 0.1 0.2 0.1 0.1 0.4 0.1 IGFLR1 "FLJ22573, TMEM149, U2AF1L4" ENSG00000126246 "IGF like family receptor 1" Q9H665 19 35738801-35742453 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 121.2;liver: 46.2;lymphoid tissue: 40.7" "Cell line enhanced" "Detected in many" "HMC-1: 21.9;Karpas-707: 16.7;U-266/70: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 121.2" "Lineage enriched" "Detected in all" 4 "dendritic cells: 121.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA012369 Uncertain Approved "Focal adhesion sites" "Intracellular and membrane" "Focal adhesion sites" "HPA012369: AB_1858095" "unprognostic (5.97e-3)" "prognostic favourable (6.55e-4)" "unprognostic (1.94e-1)" "unprognostic (5.42e-2)" "unprognostic (8.31e-3)" "unprognostic (2.34e-4)" "unprognostic (6.71e-2)" "unprognostic (1.74e-2)" "unprognostic (1.87e-2)" "prognostic favourable (1.59e-5)" "unprognostic (1.44e-3)" "unprognostic (3.52e-1)" "unprognostic (8.72e-12)" "unprognostic (2.74e-1)" "unprognostic (1.22e-1)" "unprognostic (2.29e-1)" "unprognostic (3.32e-3)" 5.3 7.3 4.5 17.8 7.6 10.1 4.1 2.0 5.3 3.1 5.0 3.8 0.0 5.6 2.6 4.7 3.4 4.5 5.9 5.8 4.5 3.1 17.0 46.2 8.5 40.7 7.7 1.6 4.5 6.9 1.1 3.4 3.8 5.6 4.0 5.4 2.2 7.4 1.8 3.9 4.6 8.4 3.5 5.4 20.2 6.3 3.5 4.5 14.6 10.0 3.2 19.3 8.0 4.9 22.3 121.2 28.6 26.5 18.1 17.4 16.3 1.3 6.4 2.2 5.3 0.7 1.1 1.3 1.5 0.7 1.2 3.1 1.9 1.5 2.8 2.1 0.4 1.0 1.3 1.3 0.6 2.0 3.2 9.8 2.6 6.7 1.9 1.3 21.9 1.8 0.8 2.2 0.5 1.2 3.0 16.7 0.3 5.4 3.1 10.3 1.6 1.7 3.8 2.1 5.1 1.0 2.3 1.6 3.0 2.1 1.5 1.1 2.3 5.3 0.3 2.7 1.3 1.7 2.4 22.1 4.6 1.7 3.2 3.8 2.1 16.2 26.5 23.6 13.3 22.2 15.2 22.3 15.4 12.6 33.9 21.8 13.9 11.1 28.6 18.1 15.5 121.2 17.4 16.3 4.5 7.6 2.0 5.3 4.5 3.1 7.7 1.6 5.6 4.5 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;ovary: 21.1;testis: 39.9" "Cell line enhanced" "Detected in some" "A549: 5.9;HEL: 4.3;SK-MEL-30: 25.6;U-266/70: 8.9;U-266/84: 10.4" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 1.1 10.5 12.5 1.4 14.6 0.9 1.2 3.4 23.9 1.3 2.6 27.8 0.0 1.1 1.6 2.3 2.0 1.6 1.9 2.2 12.3 6.0 10.6 0.9 1.0 1.0 25.2 8.9 21.1 5.1 3.8 1.4 1.1 15.3 1.3 1.8 7.0 1.4 2.0 2.9 2.6 1.6 1.5 20.5 1.0 1.4 39.9 20.7 0.0 5.0 0.0 1.1 1.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 5.9 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 25.6 0.5 0.1 0.0 0.0 1.0 0.0 0.0 8.9 10.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.6 3.4 13.6 12.3 6.0 25.2 8.9 15.3 20.7 IGSF23 ENSG00000216588 "Immunoglobulin superfamily member 23" A1L1A6 19 44613630-44636781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 6.0;intestine: 19.9;liver: 20.6" "Cell line enhanced" "Detected in some" "CACO-2: 13.7;Hep G2: 8.1;SiHa: 6.3" "Cancer enriched" "Detected in some" 10 "liver cancer: 12.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.0" "HPA051811, HPA054591" Uncertain Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA051811: , HPA054591: " "unprognostic (1.54e-1)" "unprognostic (1.84e-3)" "unprognostic (5.74e-2)" "unprognostic (1.53e-3)" "unprognostic (4.58e-2)" "unprognostic (1.11e-1)" "prognostic favourable (7.20e-6)" "unprognostic (7.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.27e-2)" "unprognostic (2.93e-3)" "unprognostic (1.52e-1)" "unprognostic (1.19e-8)" "unprognostic (1.26e-1)" "unprognostic (6.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.85e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.8 0.1 0.1 12.2 0.1 0.5 0.1 0.1 0.1 0.6 0.1 0.1 0.4 20.6 0.1 0.1 0.1 0.1 0.1 3.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.1 0.1 0.0 19.9 0.1 0.6 0.1 0.0 1.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 6.0 1.2 0.0 0.0 0.2 0.4 0.8 0.0 0.5 0.0 0.0 0.7 0.5 0.6 0.0 0.6 13.7 0.4 0.0 1.0 0.4 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.3 8.1 0.0 0.0 0.1 0.4 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 6.3 2.2 0.0 0.3 0.0 2.5 0.4 0.5 0.6 0.0 1.2 0.0 0.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 IGSF3 "EWI-3, MGC117164, V8" ENSG00000143061 "Immunoglobulin superfamily member 3" O75054 1 116574399-116667755 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.9" "Cell line enhanced" "Detected in many" "HDLM-2: 61.2;WM-115: 59.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036305, HPA036306" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036305: , HPA036306: AB_10671245" "unprognostic (9.87e-2)" "unprognostic (3.64e-1)" "unprognostic (9.51e-2)" "prognostic unfavourable (1.98e-4)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (4.03e-6)" "unprognostic (9.40e-2)" "unprognostic (4.41e-1)" "unprognostic (2.42e-1)" "prognostic unfavourable (2.03e-4)" "unprognostic (4.18e-1)" "prognostic favourable (2.87e-6)" "unprognostic (5.29e-2)" "unprognostic (4.23e-2)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" 1.4 1.5 1.9 1.2 5.1 0.1 7.7 2.5 8.3 5.8 5.7 1.5 3.0 6.7 2.5 6.5 22.0 1.7 3.5 7.9 1.8 2.8 10.7 0.8 7.4 0.3 1.8 2.8 0.7 4.5 1.4 2.7 42.9 4.1 5.1 5.1 7.8 9.3 5.5 1.1 16.1 12.9 2.4 1.7 0.5 7.3 3.6 0.9 6.2 8.1 9.0 9.3 8.2 9.8 0.0 0.2 0.3 0.6 0.0 0.7 0.2 5.3 9.1 7.0 1.7 1.6 3.4 18.9 0.0 0.2 0.7 0.2 5.2 3.0 0.0 2.8 0.0 14.9 3.1 7.3 0.3 61.2 2.3 2.9 3.5 0.1 0.0 0.2 5.5 0.4 5.8 0.0 1.3 0.0 0.8 0.0 0.1 18.7 0.2 0.1 4.4 0.2 2.1 8.6 0.0 5.4 6.7 4.1 12.5 2.2 21.0 13.5 7.0 0.3 0.0 1.2 4.2 0.0 5.5 0.0 0.3 0.0 0.5 0.1 59.0 0.0 0.6 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 1.9 5.1 2.5 8.3 1.8 2.8 1.8 2.8 4.1 0.9 IGSF5 JAM4 ENSG00000183067 "Immunoglobulin superfamily member 5" Q9NSI5 21 39745407-39802096 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 5.8" "Cell line enhanced" "Detected in many" "T-47d: 10.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Cell type enriched" "Detected in single" 5 "neutrophil: 2.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.2" "Low region specificity" "Detected in all" HPA057282 Uncertain Approved "Focal adhesion sites" "Focal adhesion sites" "HPA057282: " "unprognostic (1.06e-1)" "unprognostic (2.53e-1)" "unprognostic (7.06e-2)" "unprognostic (9.73e-5)" "unprognostic (1.56e-2)" "unprognostic (3.15e-1)" "unprognostic (1.41e-1)" "unprognostic (2.18e-2)" "unprognostic (2.09e-1)" "unprognostic (8.35e-2)" "unprognostic (9.61e-2)" "unprognostic (4.01e-1)" "unprognostic (4.18e-1)" "unprognostic (3.75e-2)" "unprognostic (6.89e-2)" "unprognostic (1.07e-2)" 0.0 2.0 0.9 0.0 3.4 0.1 1.3 0.1 0.7 1.1 0.3 0.2 0.9 3.4 0.0 0.9 0.3 5.8 1.2 2.3 0.3 0.3 0.1 0.2 1.3 1.5 2.5 0.3 1.5 4.3 2.4 0.9 0.9 0.4 0.0 0.6 0.1 0.4 0.7 0.3 0.6 1.5 0.8 0.2 0.5 0.2 0.4 0.3 2.2 0.4 0.0 0.4 0.0 1.3 0.7 4.4 1.1 4.4 3.5 1.1 0.8 1.2 1.2 1.9 0.7 1.3 1.4 1.2 1.6 1.2 1.5 2.9 2.5 2.2 2.1 1.3 3.2 0.5 2.7 1.8 0.6 3.2 5.3 2.8 3.2 0.6 2.5 0.9 1.7 1.5 0.3 0.6 2.4 0.8 0.7 2.0 0.8 1.8 1.9 2.0 0.5 1.2 2.9 1.7 10.6 1.1 0.4 1.9 2.2 0.9 1.8 0.9 0.8 0.9 1.1 1.4 1.9 0.1 0.4 0.4 0.4 0.0 0.2 0.1 0.3 0.1 0.1 0.4 0.1 0.2 2.2 0.0 0.1 0.3 0.0 0.0 IGSF6 DORA ENSG00000140749 "Immunoglobulin superfamily member 6" O95976 16 21639537-21652660 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 96.8;lymphoid tissue: 49.7" "Cell line enhanced" "Detected in some" "THP-1: 2.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 96.8" "Lineage enhanced" "Detected in many" "granulocytes: 96.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041023, HPA041072" Uncertain "HPA041023: AB_10794434, HPA041072: AB_10794262" "unprognostic (7.94e-2)" "prognostic favourable (4.92e-4)" "unprognostic (1.18e-2)" "prognostic favourable (1.54e-5)" "unprognostic (3.27e-1)" "unprognostic (4.03e-2)" "unprognostic (2.31e-1)" "unprognostic (1.74e-2)" "unprognostic (1.35e-2)" "unprognostic (6.76e-2)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (8.12e-2)" "unprognostic (1.81e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-1)" "unprognostic (2.02e-1)" 17.8 3.9 5.0 16.7 7.7 2.0 2.0 0.9 5.1 2.3 5.8 3.8 0.0 4.1 1.1 2.7 1.2 2.1 1.3 3.6 4.7 2.7 1.7 8.5 16.2 30.2 6.5 0.2 3.5 1.4 0.8 1.1 6.5 5.9 2.1 1.6 0.8 3.6 2.1 0.7 0.9 3.5 1.3 10.6 49.7 2.4 0.6 6.2 3.4 1.2 0.9 2.1 1.5 1.0 0.2 18.7 96.8 28.5 0.2 0.1 12.7 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.6 1.6 0.1 0.1 0.4 0.1 0.1 0.1 1.0 0.0 0.4 0.0 0.7 0.0 1.5 1.1 0.1 0.0 0.1 0.0 0.2 0.5 0.4 0.1 0.5 0.7 0.8 0.6 0.0 1.7 0.0 0.6 0.3 0.8 0.5 0.3 0.3 0.1 0.2 0.3 2.0 0.4 1.7 0.1 0.1 0.9 0.8 0.4 1.3 0.6 0.8 0.3 0.0 23.7 3.4 0.0 28.5 0.0 0.2 0.0 0.0 18.7 0.0 0.0 0.1 96.8 0.2 18.6 4.0 0.0 12.7 5.0 7.7 0.9 5.1 4.7 2.7 6.5 0.2 5.9 6.2 IGSF8 "CD316, CD81P3, EWI2, PGRL" ENSG00000162729 "Immunoglobulin superfamily member 8" Q969P0 1 160091340-160098943 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.2" "Cell line enhanced" "Detected in all" "SK-MEL-30: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011917, HPA075970" Approved Supported Vesicles 190000 Vesicles "HPA011917: AB_1851536, HPA075970: " "unprognostic (4.08e-1)" "prognostic unfavourable (7.32e-4)" "unprognostic (1.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.46e-1)" "unprognostic (1.20e-1)" "unprognostic (1.71e-1)" "unprognostic (1.01e-3)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.31e-1)" "unprognostic (2.60e-2)" "unprognostic (2.35e-1)" "unprognostic (3.74e-3)" "unprognostic (1.75e-3)" 9.9 10.4 25.2 9.0 30.3 2.4 11.1 40.9 54.2 9.6 11.8 53.5 6.4 18.2 8.6 16.6 7.0 13.9 8.5 11.6 32.4 24.1 10.4 19.3 10.1 10.3 32.2 29.9 15.1 19.1 9.0 8.7 7.8 25.9 13.8 7.4 11.2 21.0 14.0 6.0 34.0 14.4 5.1 42.6 10.6 9.8 11.5 25.3 6.2 10.0 5.9 6.2 6.0 6.9 14.3 5.6 1.2 4.0 4.7 15.6 6.4 8.8 5.3 6.9 17.6 4.1 2.6 14.6 4.3 5.7 9.3 8.7 6.0 6.1 13.0 16.3 6.3 17.0 2.8 6.4 1.3 15.5 5.0 1.6 5.9 10.3 6.8 4.4 14.5 3.1 13.0 6.0 1.9 1.9 2.2 7.5 2.1 8.4 11.0 10.3 14.6 8.5 6.3 3.5 9.4 8.5 9.2 2.9 12.6 5.0 16.2 58.0 11.5 5.7 1.9 4.1 8.9 7.4 3.5 20.6 22.8 5.8 14.5 1.7 10.7 0.0 2.9 1.2 13.3 4.0 11.7 12.2 11.0 15.4 3.3 14.3 14.8 15.6 0.8 4.7 2.4 5.6 14.9 6.4 25.2 30.3 40.9 54.2 32.4 24.1 32.2 29.9 25.9 25.3 IGSF9 "IGSF9A, KIAA1355, Nrt1" ENSG00000085552 "Immunoglobulin superfamily member 9" Q9P2J2 1 159927039-159945604 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 65.3" "Cell line enhanced" "Detected in some" "BEWO: 15.0;HaCaT: 21.9;NTERA-2: 11.1;SCLC-21H: 19.6;SH-SY5Y: 10.0;T-47d: 11.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA037753 Uncertain "Intracellular and membrane" "HPA037753: AB_10672915" "unprognostic (5.73e-2)" "unprognostic (2.86e-2)" "unprognostic (1.06e-2)" "prognostic unfavourable (5.16e-4)" "unprognostic (3.30e-2)" "unprognostic (6.06e-3)" "unprognostic (8.93e-3)" "unprognostic (1.37e-1)" "unprognostic (5.73e-2)" "unprognostic (2.05e-1)" "unprognostic (2.04e-2)" "unprognostic (2.15e-2)" "unprognostic (6.03e-3)" "unprognostic (2.87e-1)" "unprognostic (8.60e-2)" "unprognostic (1.42e-1)" "unprognostic (2.17e-2)" 2.7 0.0 0.3 4.5 0.5 0.0 2.2 0.4 0.3 2.3 6.7 0.4 3.4 6.6 1.3 5.9 6.8 4.2 1.4 0.7 0.4 0.1 0.4 65.3 0.7 0.3 0.3 0.3 2.4 1.0 0.9 0.3 1.5 0.6 4.0 3.8 21.2 4.0 6.2 0.3 20.2 13.7 0.9 0.5 0.3 11.8 3.0 0.4 1.1 1.1 7.0 2.7 2.1 3.9 0.9 1.4 1.6 0.1 0.0 0.2 0.0 4.9 0.0 2.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 7.0 2.5 0.0 0.2 0.0 21.9 1.1 3.1 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 9.6 0.1 0.3 0.0 0.2 0.0 0.0 9.2 0.1 0.0 11.1 2.3 0.0 0.0 0.9 0.0 6.7 19.6 10.0 0.6 8.6 0.0 11.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 0.0 0.2 0.2 0.1 0.2 1.4 0.9 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.0 0.3 0.5 0.4 0.3 0.4 0.1 0.3 0.3 0.6 0.4 IGSF9B KIAA1030 ENSG00000080854 "Immunoglobulin superfamily member 9B" Q9UPX0 11 133908564-133956985 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.7" "Cell line enhanced" "Detected in some" "SCLC-21H: 17.9;SH-SY5Y: 9.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 39.7" "Cell type enriched" "Detected in single" 9 "T-reg: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010744, HPA010802" Uncertain Approved Cytosol Cytosol "HPA010744: , HPA010802: AB_1079194" "unprognostic (9.04e-4)" "unprognostic (1.74e-2)" "unprognostic (7.52e-3)" "unprognostic (4.38e-4)" "unprognostic (8.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" "unprognostic (1.38e-1)" "unprognostic (8.10e-2)" "unprognostic (2.81e-1)" "unprognostic (2.99e-4)" "unprognostic (3.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-1)" "unprognostic (9.14e-4)" "unprognostic (3.12e-3)" 2.2 2.1 4.9 3.7 6.8 0.7 1.2 39.7 12.4 7.4 6.8 2.4 4.6 1.1 7.7 4.3 5.9 7.6 4.9 13.4 2.9 3.1 1.1 0.5 1.8 1.6 2.1 4.0 2.4 2.1 1.5 6.2 1.3 3.8 4.2 2.4 6.1 2.1 6.4 5.0 2.4 2.4 12.8 1.6 1.8 3.7 5.0 2.3 0.0 4.9 2.6 1.2 5.2 3.1 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.3 1.2 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.0 2.6 1.6 0.8 0.5 3.2 2.6 0.0 0.1 2.9 2.5 0.0 0.0 0.0 0.2 0.7 3.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.8 0.4 0.3 2.0 0.1 0.0 0.0 0.0 0.3 0.0 17.9 9.1 0.1 0.2 0.0 1.8 0.0 0.0 1.3 1.4 1.1 0.8 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.2 4.9 6.8 39.7 9.7 2.9 3.1 2.1 4.0 3.8 2.3 IKBIP "FLJ31051, IKIP" ENSG00000166130 "IKBKB interacting protein" Q70UQ0 12 98613405-98645113 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038677, HPA038678, HPA061541" Enhanced Enhanced "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA038677: AB_2676146, HPA038678: AB_10672723, HPA061541: AB_2684555" "unprognostic (3.06e-1)" "unprognostic (1.06e-3)" "unprognostic (2.13e-1)" "unprognostic (4.34e-2)" "unprognostic (1.94e-3)" "unprognostic (1.65e-2)" "prognostic unfavourable (4.00e-5)" "unprognostic (6.28e-3)" "unprognostic (1.78e-1)" "unprognostic (3.83e-1)" "unprognostic (7.37e-2)" "unprognostic (2.26e-1)" "prognostic unfavourable (4.60e-9)" "unprognostic (7.37e-2)" "unprognostic (1.66e-1)" "unprognostic (3.46e-1)" "unprognostic (3.16e-2)" 21.0 8.9 3.7 12.2 4.6 3.6 13.6 1.1 4.0 17.0 12.3 1.7 6.0 3.3 9.5 10.2 8.5 7.3 11.0 23.6 4.0 3.7 17.0 25.3 16.1 14.0 4.2 1.7 12.8 5.8 4.1 12.6 22.1 6.3 12.2 6.1 3.6 7.6 6.7 10.0 3.2 6.2 13.3 5.2 30.6 5.3 5.8 3.8 15.2 19.8 6.2 7.8 15.1 26.2 3.3 3.7 19.8 4.3 3.7 2.4 1.1 3.2 10.1 11.5 7.1 27.7 29.3 10.1 53.2 32.7 14.1 18.0 2.1 3.2 10.7 9.1 32.7 7.0 4.4 20.4 23.9 3.1 6.8 4.1 6.5 15.1 10.6 7.5 8.2 21.9 4.4 16.2 14.6 19.8 6.2 4.2 34.6 2.9 3.4 17.5 4.3 8.7 3.0 16.6 5.4 23.2 3.7 1.7 5.5 15.2 1.0 8.4 3.3 9.5 18.5 30.1 10.7 13.2 13.6 4.6 4.8 8.0 8.9 7.0 21.6 6.0 4.3 12.6 2.1 3.3 2.4 3.3 1.3 2.1 3.7 2.2 1.4 1.5 19.8 3.7 3.7 2.6 1.6 1.1 3.7 4.6 1.1 4.0 4.0 3.7 4.2 1.7 6.3 3.8 IL10RB "CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2" ENSG00000243646 "Interleukin 10 receptor subunit beta" Q08334 21 33266358-33310187 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB020670, HPA047550" Approved Approved Cytosol 1300000 Cytosol "CAB020670: , HPA047550: " "unprognostic (8.43e-2)" "unprognostic (6.50e-2)" "unprognostic (5.88e-2)" "unprognostic (1.77e-1)" "unprognostic (1.48e-2)" "unprognostic (7.78e-2)" "unprognostic (1.97e-3)" "unprognostic (1.26e-1)" "unprognostic (5.69e-3)" "unprognostic (1.31e-1)" "unprognostic (1.19e-1)" "unprognostic (6.93e-2)" "prognostic unfavourable (5.62e-9)" "unprognostic (3.09e-1)" "unprognostic (2.76e-1)" "unprognostic (1.29e-2)" "unprognostic (1.05e-1)" 17.6 11.0 5.4 19.6 7.3 8.9 21.5 3.6 4.4 15.2 29.2 10.3 10.6 19.6 17.5 9.6 22.7 13.2 14.8 12.3 5.6 5.4 11.6 27.5 19.3 36.1 6.6 3.1 18.2 23.2 5.5 9.7 47.4 9.3 17.7 20.8 11.7 26.0 9.7 12.4 13.8 53.6 12.2 8.0 31.7 17.6 8.4 7.3 34.0 14.3 15.3 26.2 15.1 22.6 13.8 19.4 57.9 34.7 14.0 19.5 20.4 10.2 7.9 1.5 6.4 32.2 23.6 11.3 7.9 22.3 8.7 12.5 7.5 12.7 2.9 9.1 13.7 12.8 4.2 5.4 5.7 9.5 5.9 8.0 6.0 5.6 22.4 10.2 19.3 23.7 10.2 15.1 8.9 11.5 7.1 24.0 12.0 10.7 6.8 9.8 1.1 4.2 6.3 3.6 12.1 7.8 6.1 2.0 2.9 16.2 12.0 13.7 8.0 38.4 10.4 8.7 8.5 14.8 4.3 12.7 14.2 1.7 15.4 14.6 5.6 22.3 30.1 24.8 8.8 34.4 9.6 13.6 11.1 10.6 17.8 13.8 10.5 10.4 57.9 14.0 34.7 19.4 19.5 20.4 5.4 7.3 3.6 4.4 5.6 5.4 6.6 3.1 9.3 7.3 IL11RA ENSG00000137070 "Interleukin 11 receptor subunit alpha" Q14626 9 34650702-34661892 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Craniosynostosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 21.3;HSkMC: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013162, CAB032830, HPA036652" Supported "CAB032830: AB_2123745, HPA013162: , HPA036652: " "unprognostic (7.76e-2)" "unprognostic (7.63e-2)" "unprognostic (1.05e-1)" "unprognostic (6.76e-3)" "unprognostic (1.67e-1)" "unprognostic (1.39e-2)" "unprognostic (9.91e-2)" "unprognostic (1.52e-2)" "unprognostic (1.89e-2)" "unprognostic (4.02e-1)" "unprognostic (1.28e-3)" "unprognostic (1.96e-1)" "prognostic unfavourable (6.56e-4)" "unprognostic (2.14e-1)" "unprognostic (1.51e-1)" "unprognostic (2.93e-2)" "unprognostic (8.71e-2)" 9.6 4.4 6.8 8.5 10.1 5.2 9.4 13.0 8.7 24.4 15.6 23.2 3.4 9.8 14.2 9.2 8.8 12.6 17.7 38.2 7.1 5.9 6.1 14.1 8.6 13.4 9.7 12.7 11.5 3.7 18.6 6.3 8.2 9.8 12.4 5.1 30.9 11.9 7.8 12.6 28.5 9.9 23.6 6.6 9.9 7.9 9.2 11.9 3.4 14.5 18.1 9.5 13.6 10.7 2.5 2.7 3.4 2.7 1.9 6.0 3.3 1.4 3.2 7.0 7.0 10.0 18.0 3.3 8.0 11.1 5.2 7.4 1.1 2.6 1.4 2.1 21.3 2.8 2.0 2.8 2.3 13.1 5.3 4.4 11.4 0.6 5.0 1.5 2.5 23.1 3.6 2.8 1.0 3.2 1.7 3.3 6.6 0.9 2.0 10.4 1.4 2.0 3.1 1.5 1.5 1.7 1.3 2.0 7.2 1.0 2.2 2.9 5.7 5.8 3.1 2.5 5.7 1.8 0.0 2.2 1.4 0.6 6.5 1.7 11.7 3.4 2.2 0.0 3.2 2.7 4.4 1.9 6.0 4.7 2.7 2.5 5.9 3.8 0.6 1.9 0.6 1.1 3.2 3.3 6.8 10.1 13.0 8.7 7.1 5.9 9.7 12.7 9.8 11.9 IL12A "CLMF, IL-12A, NFSK, NKSF1, p35" ENSG00000168811 "Interleukin 12A" P29459 3 159988750-159996019 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 10.1" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 7.4;HDLM-2: 11.2;SK-BR-3: 16.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 5.1" "Group enriched" "Detected in many" 7 "B-cells: 5.1;granulocytes: 1.3;T-cells: 1.6" "Region enhanced" "Detected in single" "cerebral cortex: 2.7" "Low region specificity" "Detected in some" HPA001886 Uncertain "Secreted to blood" "HPA001886: AB_1079132" "unprognostic (6.23e-2)" "unprognostic (7.82e-5)" "unprognostic (1.25e-1)" "unprognostic (3.10e-2)" "unprognostic (4.22e-1)" "unprognostic (7.18e-2)" "unprognostic (4.18e-5)" "unprognostic (2.22e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (9.57e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (9.61e-2)" 0.7 1.4 3.4 1.6 6.2 3.3 2.0 2.6 5.6 0.5 1.6 1.0 0.0 1.5 1.2 0.8 10.1 5.7 0.6 1.4 3.1 2.2 1.2 0.6 5.2 2.9 3.2 1.7 1.6 1.1 0.1 1.0 0.4 5.4 0.9 1.3 0.2 2.1 1.1 0.4 0.2 1.5 0.8 2.7 2.8 1.2 0.9 4.1 0.0 0.5 0.5 2.1 0.9 1.1 5.1 0.1 1.3 0.3 0.0 1.6 0.3 2.7 0.3 0.4 2.3 0.0 0.1 0.2 3.1 1.9 3.5 7.4 1.2 0.1 0.0 0.2 0.5 0.3 0.8 0.5 3.3 11.2 3.9 0.1 0.1 0.8 2.5 0.6 5.2 0.6 0.9 6.3 2.4 1.1 0.0 1.9 2.2 0.0 0.1 0.0 0.3 1.6 2.2 0.0 0.4 0.4 0.2 0.1 1.1 0.0 16.8 0.4 0.8 1.2 0.8 0.9 0.8 2.1 5.7 1.2 0.0 0.0 1.4 5.1 0.7 0.0 0.1 1.3 0.9 0.3 1.4 1.3 0.4 1.6 0.1 5.1 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.3 3.4 6.2 2.6 5.6 3.1 2.2 3.2 1.7 5.4 4.1 IL12RB1 "CD212, IL12RB" ENSG00000096996 "Interleukin 12 receptor subunit beta 1" P42701 19 18058995-18098944 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 21.4" "Cell line enhanced" "Detected in some" "Daudi: 10.4;HDLM-2: 17.6;Karpas-707: 30.1;U-698: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074414 Approved "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA074414: " "unprognostic (7.70e-3)" "prognostic favourable (3.41e-4)" "unprognostic (9.08e-3)" "unprognostic (1.18e-4)" "unprognostic (2.91e-1)" "unprognostic (1.33e-3)" "unprognostic (2.27e-1)" "unprognostic (8.99e-2)" "unprognostic (1.65e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (2.94e-1)" "prognostic unfavourable (5.90e-5)" "unprognostic (1.49e-1)" "unprognostic (2.21e-2)" "unprognostic (4.34e-2)" "unprognostic (2.93e-2)" 1.9 1.5 1.3 17.5 2.1 5.6 1.2 0.5 1.0 0.9 3.4 2.4 1.1 2.9 1.0 2.4 1.3 1.5 2.5 1.4 1.3 1.2 1.8 1.8 5.0 16.0 2.0 0.2 1.1 1.3 1.2 1.1 2.4 1.4 1.7 2.0 1.1 6.6 0.2 0.9 1.0 8.0 1.0 2.4 21.4 2.3 0.7 2.2 10.1 1.3 0.7 16.9 3.8 1.0 4.9 5.9 6.2 14.0 16.2 28.6 9.0 0.2 0.1 0.1 0.2 0.0 0.1 0.5 0.1 0.1 0.2 0.6 0.2 1.0 10.4 0.1 0.1 0.2 0.1 0.0 0.0 17.6 0.2 1.2 0.3 0.2 0.4 0.7 1.7 0.0 0.0 0.3 0.1 0.0 0.2 30.1 0.0 0.1 4.9 0.2 0.1 0.1 3.5 0.1 0.4 0.0 0.0 0.2 0.1 0.2 0.2 0.2 0.2 5.7 0.2 0.3 0.3 0.1 0.1 3.6 5.4 8.8 0.4 6.0 0.7 3.3 5.1 3.6 22.8 14.0 28.6 4.9 15.5 18.3 5.9 3.7 8.7 15.2 6.2 16.2 13.2 3.5 20.5 9.0 1.3 2.1 0.5 1.0 1.3 1.2 2.0 0.2 1.4 2.2 IL12RB2 ENSG00000081985 "Interleukin 12 receptor subunit beta 2" Q99665 1 67307364-67396900 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.2;pancreas: 15.0" "Cell line enhanced" "Detected in some" "HMC-1: 4.4;SCLC-21H: 8.7;SK-MEL-30: 21.9;THP-1: 12.7" "Cancer enhanced" "Detected in many" "melanoma: 5.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 18.2" "Group enriched" "Detected in many" 42 "NK-cells: 18.2;T-cells: 6.1" "Region enhanced" "Detected in single" "olfactory region: 1.8" "Low region specificity" "Detected in all" HPA024168 Uncertain Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA024168: AB_1851629" "unprognostic (1.32e-1)" "unprognostic (1.54e-3)" "unprognostic (2.09e-1)" "unprognostic (2.68e-2)" "unprognostic (2.82e-2)" "unprognostic (1.09e-3)" "unprognostic (2.37e-2)" "unprognostic (3.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.38e-2)" "unprognostic (1.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.08e-3)" "unprognostic (1.82e-1)" "unprognostic (4.69e-2)" "unprognostic (7.11e-3)" "unprognostic (1.90e-1)" 3.8 1.0 1.8 3.1 3.6 1.5 3.7 0.6 7.7 2.4 1.0 0.0 0.0 0.7 0.8 1.1 3.2 0.9 1.1 5.2 9.6 1.1 1.5 1.4 1.8 4.3 1.0 6.0 0.8 15.0 0.9 0.8 14.1 1.6 1.2 0.9 1.3 7.2 1.7 11.4 2.1 1.4 1.0 1.0 2.5 1.0 2.3 0.0 1.1 1.1 3.2 1.6 1.4 1.2 0.0 0.0 0.2 0.0 18.2 6.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.1 2.0 1.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.4 0.0 0.0 21.9 0.0 12.7 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 2.7 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.2 18.2 0.0 0.0 3.9 1.0 1.8 3.6 0.6 7.7 9.6 1.1 1.0 6.0 1.6 0.0 IL13RA1 "CD213a1, IL-13Ra, NR4" ENSG00000131724 "Interleukin 13 receptor subunit alpha 1" P78552 X 118727572-118794539 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 6.9;eosinophil: 7.1;myeloid DC: 10.9;neutrophil: 19.0" "Group enriched" "Detected in many" 6 "dendritic cells: 10.9;granulocytes: 19.0;monocytes: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001587 Approved Nucleoplasm,Vesicles "Intracellular and membrane" 4500000 Vesicles Nucleoplasm "HPA001587: AB_1079133" "unprognostic (5.14e-3)" "unprognostic (4.72e-2)" "unprognostic (7.12e-2)" "unprognostic (7.75e-2)" "unprognostic (8.81e-3)" "unprognostic (3.82e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.44e-1)" "unprognostic (1.90e-1)" "unprognostic (8.21e-2)" "prognostic unfavourable (1.19e-8)" "unprognostic (1.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.82e-2)" "unprognostic (5.08e-2)" 31.5 17.5 9.3 15.3 13.3 2.1 19.8 3.6 10.2 16.6 23.8 12.6 7.2 18.9 16.6 18.0 33.0 15.4 17.7 17.5 11.4 9.4 22.7 73.3 27.7 33.9 15.2 6.0 25.2 12.9 9.5 16.1 15.2 13.4 15.3 25.2 14.5 21.8 13.0 22.3 10.2 37.7 16.3 24.5 17.4 18.5 9.9 11.9 4.8 24.0 20.1 20.0 16.5 15.4 1.9 10.9 19.0 6.9 0.0 0.1 1.7 8.2 10.2 4.9 13.4 11.1 33.1 8.8 17.3 24.1 8.3 10.8 5.9 15.3 0.0 30.5 23.8 7.9 5.3 7.3 9.2 45.1 4.1 1.4 9.3 15.1 6.8 0.1 3.6 30.1 6.7 11.3 13.9 17.2 4.4 0.9 11.7 12.1 0.0 2.2 4.4 9.9 0.0 12.0 0.0 12.4 9.0 1.8 1.7 27.2 10.0 6.8 6.4 7.8 21.9 16.2 7.7 27.2 13.5 0.2 4.1 0.0 35.7 4.2 6.8 0.0 6.9 7.1 0.0 1.7 0.0 1.9 0.0 0.0 10.9 1.8 0.0 0.0 19.0 0.0 0.6 1.9 0.1 1.7 9.3 13.3 3.6 10.2 11.4 9.4 15.2 6.0 13.4 11.9 IL13RA2 "CD213a2, CT19, IL-13R, IL13BP" ENSG00000123496 "Interleukin 13 receptor subunit alpha 2" Q14627 X 115003975-115019977 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 16.1;testis: 31.5" "Group enriched" "Detected in some" 9 "PC-3: 26.4;U-2197: 84.9;U-251 MG: 57.0;U-87 MG: 33.8" "Cancer enhanced" "Detected in many" "glioma: 17.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "olfactory region: 8.7" "Low region specificity" "Detected in many" "HPA045831, HPA067363" Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "Nucleoplasm, Vesicles" "HPA045831: , HPA067363: " "unprognostic (1.97e-1)" "unprognostic (2.83e-1)" "unprognostic (6.62e-4)" "unprognostic (7.39e-2)" "unprognostic (8.45e-2)" "unprognostic (1.80e-1)" "prognostic favourable (3.55e-4)" "unprognostic (3.54e-1)" "unprognostic (2.85e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-3)" "unprognostic (2.19e-2)" "unprognostic (1.53e-5)" "unprognostic (1.58e-1)" "unprognostic (1.63e-1)" "unprognostic (9.70e-3)" "unprognostic (1.20e-1)" 0.5 4.8 3.7 3.9 11.3 0.0 0.8 0.3 3.1 1.2 0.4 2.1 5.7 0.3 0.9 4.4 0.5 0.1 0.8 0.6 5.1 11.2 3.5 9.6 1.0 0.1 1.2 2.6 0.1 0.1 0.5 16.1 2.1 3.9 4.3 0.7 1.6 0.8 3.7 0.0 0.1 0.3 0.4 0.6 0.2 0.1 31.5 1.4 0.0 1.3 0.2 0.2 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.7 0.0 5.8 5.5 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.9 5.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.4 0.0 0.1 0.0 0.0 0.0 3.0 0.0 84.9 57.0 0.0 0.0 0.0 33.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 11.3 0.3 3.1 5.1 11.2 1.2 2.6 3.9 1.4 IL15RA "CD215, IL-15RA" ENSG00000134470 "Interleukin 15 receptor subunit alpha" Q13261 10 5943639-5978187 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.4;EFO-21: 17.9;HDLM-2: 32.1;HHSteC: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" CAB026215 Approved "Secreted to blood" "CAB026215: " "unprognostic (2.86e-2)" "unprognostic (8.41e-2)" "unprognostic (6.13e-2)" "unprognostic (4.45e-2)" "unprognostic (7.87e-2)" "unprognostic (5.49e-2)" "prognostic unfavourable (2.67e-6)" "unprognostic (5.09e-3)" "unprognostic (1.82e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (5.35e-4)" "unprognostic (6.18e-3)" "prognostic unfavourable (1.27e-12)" "unprognostic (4.43e-2)" "unprognostic (4.69e-2)" "unprognostic (4.08e-2)" "unprognostic (5.75e-2)" 20.5 5.6 2.2 13.0 4.1 6.4 33.9 1.4 2.6 12.7 15.6 1.6 7.7 10.1 10.9 9.4 14.3 10.6 18.7 19.2 2.6 1.9 7.8 17.5 35.7 15.2 4.0 2.0 8.7 9.6 0.9 3.9 15.5 3.6 13.2 7.4 6.4 8.9 9.4 9.2 7.6 18.8 10.8 2.7 18.8 10.3 5.0 2.7 3.5 13.9 7.5 9.8 12.9 17.3 7.0 4.2 6.3 19.5 6.8 18.7 6.7 6.9 1.0 0.0 0.3 9.1 2.2 1.8 3.5 7.6 4.7 4.9 0.1 29.4 0.8 17.9 6.6 6.6 0.8 5.2 1.0 32.1 1.4 0.8 1.7 0.5 18.3 0.4 0.2 1.8 1.7 2.5 0.1 11.4 8.5 9.8 0.1 3.6 1.4 3.4 0.2 3.2 4.1 0.0 5.6 1.1 0.5 0.0 0.0 5.3 0.5 0.2 2.5 3.2 4.5 0.1 0.5 12.7 4.7 8.9 2.3 0.1 2.2 5.2 0.3 6.3 16.0 3.9 12.3 19.5 18.7 7.0 9.5 12.5 4.2 3.3 4.1 7.1 4.7 6.8 11.7 0.0 10.2 6.7 2.2 4.1 1.4 2.6 2.6 1.9 4.0 2.0 3.6 2.7 IL17RA "CD217, CDw217, hIL-17R, IL-17RA, IL17R" ENSG00000177663 "Interleukin 17 receptor A" Q96F46 22 17084954-17115694 "CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.0" "Cell line enhanced" "Detected in many" "HL-60: 27.0;NB-4: 23.7;THP-1: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB024996 Enhanced Approved Nucleoplasm,Cytosol "Secreted - unknown location" 20000 "Nucleoplasm, Cytosol" "CAB024996: " "unprognostic (1.92e-1)" "unprognostic (3.15e-1)" "unprognostic (1.65e-2)" "unprognostic (9.83e-2)" "unprognostic (7.66e-2)" "unprognostic (5.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.22e-2)" "unprognostic (1.41e-2)" "unprognostic (8.52e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.96e-2)" "prognostic favourable (8.35e-4)" "unprognostic (2.16e-2)" "unprognostic (1.27e-1)" "unprognostic (6.51e-3)" 17.7 7.6 6.5 13.6 13.8 40.5 24.7 4.0 6.7 8.6 8.1 7.7 4.6 6.2 7.4 9.4 6.8 7.8 7.4 8.8 6.1 4.9 8.3 11.6 16.8 39.2 10.3 2.0 7.7 7.7 6.9 5.4 6.2 8.3 6.9 5.7 5.3 7.0 5.3 5.3 8.6 9.1 8.3 11.2 23.4 7.3 5.3 9.7 50.0 7.9 3.2 11.0 6.3 12.8 0.5 3.6 15.6 6.9 1.4 2.4 2.0 3.6 2.1 1.9 2.4 3.8 2.2 2.4 5.3 3.5 2.5 3.2 2.0 2.4 3.3 2.2 5.3 5.8 2.6 2.5 1.8 5.3 3.1 0.0 1.2 1.2 4.4 27.0 8.4 3.3 3.7 2.2 1.7 2.7 1.4 3.4 2.5 3.0 3.2 23.7 1.0 2.0 0.7 0.4 0.6 2.4 2.7 1.3 0.0 3.7 3.2 2.6 2.5 34.1 7.4 2.0 2.8 2.9 1.9 2.8 1.5 1.6 2.8 13.1 2.1 6.7 6.9 6.1 1.1 3.2 0.9 0.4 1.5 1.1 3.6 0.5 2.4 1.8 15.6 1.4 2.9 1.7 0.9 2.0 6.5 13.8 4.0 6.7 6.1 4.9 10.3 2.0 8.3 9.7 IL17RB "CRL4, EVI27, IL17BR, IL17RH1" ENSG00000056736 "Interleukin 17 receptor B" Q9NRM6 3 53846580-53865800 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 63.0;liver: 26.6" "Cell line enhanced" "Detected in many" "CACO-2: 11.9;Hep G2: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005482 Enhanced "Intracellular and membrane" "HPA005482: AB_1851656" "unprognostic (1.85e-3)" "unprognostic (4.22e-3)" "unprognostic (1.60e-3)" "unprognostic (2.86e-2)" "unprognostic (1.42e-2)" "unprognostic (6.20e-3)" "unprognostic (1.62e-2)" "unprognostic (6.09e-3)" "unprognostic (1.30e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" "unprognostic (4.27e-2)" "prognostic favourable (6.61e-4)" "unprognostic (8.10e-2)" "unprognostic (6.97e-2)" "unprognostic (5.29e-1)" "unprognostic (7.15e-3)" 1.1 2.1 13.4 2.2 12.2 0.9 9.2 15.1 14.7 17.1 5.8 6.8 0.0 5.1 5.0 1.3 1.9 3.2 2.4 2.5 17.1 7.4 63.0 26.6 3.5 2.3 11.9 6.4 1.8 5.3 1.4 3.9 1.2 11.2 2.5 6.1 1.9 4.1 1.0 1.4 2.3 5.1 1.2 11.3 1.4 3.4 2.5 15.2 0.0 2.9 0.0 1.0 1.7 1.0 0.9 1.1 4.1 0.6 0.5 3.1 0.5 0.9 1.8 2.7 2.0 0.0 0.0 4.3 1.8 0.0 0.0 0.0 11.9 0.8 2.7 0.6 0.6 0.5 7.3 0.0 0.0 0.9 2.1 3.5 3.6 34.5 0.0 3.2 1.9 0.0 0.0 0.0 0.0 0.0 2.8 1.3 0.0 2.4 0.5 1.3 7.3 1.5 1.0 1.1 3.1 0.8 3.1 3.9 2.2 6.0 1.4 1.1 5.6 1.2 1.4 1.8 2.0 1.6 2.2 2.8 3.2 1.7 1.6 1.9 1.0 4.1 0.6 0.2 1.0 0.6 0.6 0.5 2.1 0.6 0.2 0.9 0.8 0.9 0.3 0.5 0.2 1.1 3.1 0.5 13.4 12.2 15.1 14.7 17.1 7.4 11.9 6.4 11.2 15.2 IL17RC IL17-RL ENSG00000163702 "Interleukin 17 receptor C" Q8NAC3 3 9917074-9933630 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 27.6;ASC TERT1: 19.6;T-47d: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.6;myeloid DC: 4.8" "Group enriched" "Detected in many" 18 "dendritic cells: 4.8;monocytes: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019885, CAB026255" Approved "Intracellular and membrane" "CAB026255: , HPA019885: AB_1851664" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "unprognostic (1.38e-1)" "prognostic favourable (1.38e-4)" "unprognostic (2.58e-2)" "unprognostic (1.45e-3)" "unprognostic (8.60e-2)" "unprognostic (7.11e-2)" "unprognostic (1.38e-2)" "unprognostic (5.27e-2)" "unprognostic (4.30e-2)" "unprognostic (5.98e-2)" "unprognostic (9.35e-3)" "unprognostic (2.40e-1)" "unprognostic (2.63e-1)" "unprognostic (1.48e-1)" "unprognostic (2.83e-1)" 11.8 19.9 7.9 6.4 8.7 3.9 11.3 8.0 8.7 16.0 15.0 5.7 14.2 15.7 10.1 12.2 17.1 10.5 16.1 12.3 8.2 3.6 10.5 32.1 6.3 3.8 5.6 7.0 9.9 11.3 9.5 21.0 6.3 7.8 18.6 5.2 11.2 25.0 13.3 8.8 17.3 19.8 13.1 4.2 4.0 10.5 3.8 5.9 1.5 13.1 13.7 8.3 12.7 11.3 0.2 4.8 0.0 3.6 0.0 0.0 0.6 3.4 2.1 0.5 1.9 27.6 19.6 5.5 4.2 10.2 5.0 8.5 0.8 9.5 0.0 5.9 5.9 2.5 0.6 4.2 1.6 2.3 3.0 0.9 5.3 3.1 10.1 0.0 0.0 17.8 3.3 5.7 1.0 4.4 0.3 2.9 3.9 5.4 0.0 0.2 0.4 15.5 2.1 2.6 1.3 3.4 1.5 1.9 3.1 2.7 6.0 4.8 18.7 0.4 2.9 6.3 3.1 3.1 2.6 0.0 0.1 0.0 10.0 0.3 4.7 0.0 3.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.8 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.6 7.9 8.7 8.0 8.7 8.2 3.6 5.6 7.0 7.8 5.9 IL17RD "FLJ35755, IL-17RD, IL17RLM, SEF" ENSG00000144730 "Interleukin 17 receptor D" Q8NFM7 3 57089982-57170306 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 10.4;AN3-CA: 28.1;NTERA-2: 16.2;SH-SY5Y: 42.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039577, HPA043550" Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA039577: , HPA043550: " "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (2.31e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-2)" "unprognostic (9.62e-2)" "unprognostic (1.17e-2)" "unprognostic (1.60e-1)" "unprognostic (3.72e-1)" "unprognostic (2.11e-3)" "unprognostic (4.79e-2)" "unprognostic (1.25e-1)" "prognostic favourable (2.92e-9)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (2.63e-3)" "unprognostic (9.58e-3)" 2.7 1.3 5.2 1.8 6.5 0.4 8.9 2.8 6.1 14.7 7.7 7.6 7.4 0.9 18.5 13.7 3.4 8.4 6.1 3.0 4.8 3.6 7.1 0.5 1.1 0.7 4.0 2.4 12.6 1.4 20.8 14.0 0.7 5.7 8.1 2.5 10.2 7.2 10.8 1.0 2.6 1.8 14.7 7.2 3.1 2.2 11.2 3.1 0.0 1.0 2.2 1.4 8.9 5.2 0.6 0.6 1.5 0.5 0.6 0.4 0.0 1.5 0.3 10.4 28.1 0.0 0.2 1.7 0.1 0.1 0.1 0.3 0.2 0.7 0.0 0.0 0.5 0.1 2.0 0.4 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.2 0.4 0.0 0.0 0.5 0.2 0.0 0.0 16.2 0.8 0.0 3.7 0.0 2.1 0.4 0.2 42.7 0.4 0.6 1.2 0.3 0.0 0.3 0.5 0.7 0.5 1.6 0.0 0.0 0.0 0.2 0.0 0.7 1.4 0.5 0.3 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.6 0.4 0.4 1.5 0.6 0.3 0.6 0.3 0.0 5.2 6.5 2.8 4.0 4.8 3.6 4.0 2.4 5.7 3.1 IL17RE FLJ23658 ENSG00000163701 "Interleukin 17 receptor E" Q8NFR9 3 9902612-9916402 "Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 55.7" "Cell line enhanced" "Detected in some" "ASC diff: 10.8;ASC TERT1: 26.5;BEWO: 9.9;hTCEpi: 10.9;T-47d: 12.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 4 "cerebellum: 19.0" "Group enriched" "Detected in some" 8 "basophil: 3.1;MAIT T-cell: 1.9;memory CD8 T-cell: 2.0" "Group enriched" "Detected in many" 19 "granulocytes: 3.1;T-cells: 2.0" "Region enhanced" "Detected in single" "cerebellum: 1.7" HPA019011 Uncertain "Intracellular and membrane" "HPA019011: AB_1851667" "unprognostic (1.08e-2)" "unprognostic (7.58e-2)" "unprognostic (2.06e-1)" "unprognostic (1.43e-3)" "unprognostic (1.09e-1)" "unprognostic (9.81e-2)" "unprognostic (1.50e-1)" "unprognostic (8.43e-2)" "unprognostic (6.69e-2)" "unprognostic (6.31e-2)" "unprognostic (3.55e-3)" "unprognostic (4.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (2.85e-2)" 7.6 0.9 0.6 6.9 4.3 0.0 7.8 19.0 0.7 4.5 39.3 0.0 1.9 15.5 2.4 4.0 10.4 1.9 18.3 1.4 0.7 0.8 3.4 1.0 13.5 0.5 0.7 0.1 0.9 12.7 3.6 1.7 4.6 2.5 4.7 10.5 2.6 17.7 3.9 1.0 16.8 55.7 1.2 0.7 1.3 12.4 0.6 0.4 5.1 4.8 6.8 5.3 2.1 4.4 0.0 0.0 3.1 0.0 0.1 2.0 0.0 1.9 0.2 0.0 0.0 10.8 26.5 9.9 1.5 0.9 0.2 0.6 1.9 1.4 0.0 0.5 1.8 4.4 0.0 4.0 0.0 0.0 0.1 0.5 0.3 4.5 0.3 0.0 1.9 1.8 10.9 0.1 0.0 0.0 0.0 0.0 0.5 2.1 0.3 7.9 0.4 0.4 0.0 0.0 0.0 1.9 2.3 0.4 0.1 0.0 4.2 0.0 12.6 0.5 0.6 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 4.8 0.1 3.1 0.0 0.0 0.0 0.0 1.9 0.0 0.3 2.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 4.3 19.0 0.7 0.7 0.8 0.7 0.1 2.5 0.4 IL18R1 "CD218a, IL-1Rrp, IL1RRP" ENSG00000115604 "Interleukin 18 receptor 1" Q13478 2 102311529-102398775 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 39.3" "Cell line enhanced" "Detected in some" "HDLM-2: 13.5;HHSteC: 29.2;HMC-1: 19.6;U-937: 31.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 26.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA007615 Approved Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA007615: AB_1851675" "unprognostic (3.60e-3)" "unprognostic (9.75e-3)" "unprognostic (1.12e-3)" "unprognostic (3.01e-2)" "unprognostic (2.34e-3)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.74e-2)" "unprognostic (3.59e-1)" "unprognostic (7.86e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "prognostic unfavourable (4.52e-4)" "unprognostic (2.62e-1)" "unprognostic (1.62e-2)" "unprognostic (5.71e-2)" "unprognostic (2.48e-2)" 17.8 2.6 1.4 8.3 1.7 12.5 11.2 0.8 1.3 8.2 8.1 0.7 6.6 5.1 4.2 5.7 4.5 4.5 14.1 10.5 1.7 1.9 7.4 8.8 39.3 29.6 2.0 0.1 3.3 2.6 0.8 4.6 10.7 1.6 6.3 3.4 5.0 3.0 28.4 2.8 3.2 10.7 7.9 1.9 19.5 4.6 2.4 0.4 2.5 3.2 3.2 6.6 8.2 12.9 0.1 6.8 5.5 0.1 26.8 10.6 1.1 0.8 0.2 0.0 0.0 0.7 0.7 1.6 0.0 0.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 1.8 0.0 13.5 0.7 2.4 0.6 0.1 29.2 5.1 19.6 6.7 1.1 2.1 3.5 4.9 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.4 0.6 0.4 2.3 0.4 0.0 0.0 0.0 0.1 31.3 2.3 5.5 0.0 2.4 4.2 0.1 10.6 0.1 2.4 3.0 2.0 0.1 0.4 0.8 4.1 26.8 0.0 6.8 2.4 1.1 1.4 1.7 0.8 1.3 1.7 1.9 2.0 0.1 1.6 0.4 IL18RAP "AcPL, CD218b" ENSG00000115607 "Interleukin 18 receptor accessory protein" O95256 2 102418689-102452565 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.6;bone marrow: 50.2;lymphoid tissue: 29.8" "Cell line enriched" "Detected in some" 10 "U-937: 34.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 34.6" "Group enriched" "Detected in many" 108 "granulocytes: 22.5;NK-cells: 34.6;T-cells: 22.1" "Not detected" "Not detected" "Not detected" "Not detected" CAB025270 Enhanced "CAB025270: " "unprognostic (1.73e-3)" "unprognostic (6.27e-3)" "unprognostic (5.07e-3)" "unprognostic (4.64e-6)" "unprognostic (2.90e-1)" "unprognostic (1.18e-2)" "unprognostic (5.86e-5)" "unprognostic (5.09e-3)" "unprognostic (4.02e-2)" "unprognostic (1.57e-3)" "unprognostic (4.78e-2)" "unprognostic (5.31e-2)" "unprognostic (1.51e-2)" "unprognostic (2.71e-1)" "unprognostic (6.35e-2)" "unprognostic (8.56e-2)" "unprognostic (2.73e-2)" 3.6 0.3 0.2 6.1 0.5 50.2 0.9 0.3 0.4 1.2 4.8 0.5 0.0 1.2 1.2 2.1 0.8 3.8 3.0 2.1 0.2 0.2 0.9 2.6 9.6 16.4 0.9 0.0 1.1 0.4 0.0 0.9 0.8 0.2 0.6 0.9 1.5 0.8 0.3 0.6 0.2 8.1 1.0 1.0 29.8 1.5 1.3 0.0 1.3 0.8 0.9 3.5 2.5 1.3 0.0 0.2 22.5 0.0 34.6 22.1 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 1.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.2 0.0 0.0 6.1 15.7 0.0 22.1 0.0 2.0 4.2 0.1 0.0 0.0 0.5 22.5 34.6 0.0 0.2 0.1 2.0 0.2 0.5 0.3 0.4 0.2 0.2 0.9 0.0 0.2 0.0 IL1R1 "CD121A, D2S1473, IL1R, IL1RA" ENSG00000115594 "Interleukin 1 receptor type 1" P14778 2 102064544-102179874 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 93.4;ASC TERT1: 41.7;HHSteC: 29.3;HSkMC: 115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001237, HPA005823, CAB007779, HPA029560" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Secreted to blood" 1000000 "Nucleoplasm, Vesicles" "Plasma membrane, Cytosol" "CAB007779: AB_562073, HPA001237: , HPA005823: , HPA029560: " "unprognostic (6.16e-3)" "unprognostic (3.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (7.10e-2)" "unprognostic (2.01e-1)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (3.16e-1)" "unprognostic (4.26e-2)" "unprognostic (7.77e-2)" "prognostic unfavourable (6.92e-6)" "unprognostic (2.48e-2)" "unprognostic (6.95e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" 48.6 25.2 2.6 18.2 5.2 4.0 92.4 2.4 3.9 47.8 21.0 2.5 34.3 5.2 15.2 30.2 18.2 17.1 25.8 27.0 4.2 2.5 23.7 74.8 40.5 28.0 5.6 1.1 25.1 17.1 16.9 7.3 66.2 10.9 26.0 8.4 8.6 12.7 36.4 15.5 13.5 13.0 15.1 10.0 19.2 15.6 13.4 2.8 3.5 33.6 9.0 9.6 32.0 36.4 0.1 0.1 4.0 0.5 0.8 1.8 0.2 0.2 1.8 0.0 1.5 93.4 41.7 0.6 3.9 17.7 2.8 4.2 0.8 0.4 0.0 2.9 7.8 0.7 0.0 0.3 2.3 7.7 0.0 0.1 0.4 4.3 29.3 0.0 0.0 115.0 0.3 3.1 0.7 1.2 0.4 0.1 4.0 0.7 0.0 0.1 0.1 0.1 0.0 0.2 0.0 2.6 1.9 0.0 0.0 1.7 1.1 0.0 1.6 0.1 0.0 8.0 0.5 13.4 0.3 0.0 0.0 0.0 3.1 0.0 0.5 0.6 0.5 0.1 0.0 0.0 0.7 0.1 1.1 0.0 0.1 0.1 0.0 0.1 4.0 0.8 0.0 0.1 1.8 0.2 2.6 5.2 2.4 3.9 4.2 2.5 5.6 1.1 10.9 2.8 IL1R2 "CD121b, IL1RB" ENSG00000115590 "Interleukin 1 receptor type 2" P27930 2 101991844-102028544 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 73.2;lymphoid tissue: 74.1" "Cell line enriched" "Detected in some" 19 "HDLM-2: 100.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "midbrain: 9.2" "Cell type enriched" "Detected in some" 25 "neutrophil: 73.2" "Lineage enriched" "Detected in many" 25 "granulocytes: 73.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA027597, HPA027598" Uncertain "Secreted to blood" 7132500 21000000 "HPA027597: AB_10600768, HPA027598: AB_10601229" "unprognostic (3.54e-2)" "unprognostic (1.87e-1)" "unprognostic (1.21e-1)" "unprognostic (3.83e-2)" "unprognostic (6.59e-2)" "unprognostic (1.42e-1)" "unprognostic (6.36e-2)" "unprognostic (4.82e-3)" "unprognostic (1.62e-2)" "unprognostic (7.15e-2)" "unprognostic (8.20e-3)" "unprognostic (1.07e-1)" "prognostic unfavourable (5.58e-12)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "unprognostic (1.77e-1)" "unprognostic (6.62e-2)" 9.1 3.2 1.2 16.4 1.9 22.3 1.6 1.2 1.9 6.4 13.4 0.4 0.1 0.1 1.3 1.3 20.4 9.7 3.4 15.1 1.2 0.5 5.8 8.2 25.5 74.1 9.2 0.2 2.5 1.4 0.0 2.4 24.9 2.2 1.1 20.0 1.8 4.3 0.8 2.8 14.1 2.2 1.3 4.4 47.5 14.6 1.6 1.1 1.6 1.8 8.5 25.1 3.2 9.1 0.0 2.8 73.2 0.8 0.0 1.1 0.2 1.5 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.3 0.0 0.6 0.0 0.1 0.0 100.0 0.1 0.0 0.0 0.8 0.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 73.2 0.0 0.0 0.0 1.1 0.2 1.2 1.9 1.2 1.9 1.2 0.5 9.2 0.2 2.2 1.1 IL1RAP "C3orf13, IL-1RAcP, IL1R3" ENSG00000196083 "Interleukin 1 receptor accessory protein" Q9NPH3 3 190514051-190659750 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.5;liver: 91.8;placenta: 35.9" "Cell line enhanced" "Detected in many" "SK-MEL-30: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "neutrophil: 36.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035293 Uncertain Approved Vesicles,Cytosol "Secreted to blood" 260000000 "Vesicles, Cytosol" "HPA035293: AB_10671511" "unprognostic (6.48e-2)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (8.84e-3)" "unprognostic (2.35e-2)" "unprognostic (6.60e-2)" "unprognostic (2.62e-1)" "unprognostic (1.28e-1)" "prognostic unfavourable (1.31e-4)" "unprognostic (1.72e-1)" "prognostic unfavourable (2.16e-7)" "unprognostic (4.02e-3)" "unprognostic (9.06e-2)" "unprognostic (5.72e-2)" "prognostic unfavourable (6.29e-4)" 3.4 1.7 3.7 5.2 4.5 7.8 2.8 0.8 6.0 2.9 1.8 3.4 0.7 1.1 2.6 1.7 9.1 3.2 5.7 3.3 7.4 2.9 1.9 91.8 6.3 12.6 3.5 2.5 2.2 2.0 1.0 1.4 35.9 5.5 2.1 1.4 1.6 4.7 2.0 1.2 5.8 1.5 3.1 6.3 7.1 2.3 1.0 2.9 2.3 2.2 3.8 3.4 3.3 4.4 0.9 1.4 36.5 2.2 0.1 1.3 0.5 3.8 1.0 1.6 0.2 2.8 2.3 3.0 1.7 3.5 4.0 3.9 1.6 8.6 0.6 17.9 4.7 10.0 0.8 16.7 5.6 0.7 1.0 0.8 1.7 4.1 6.0 5.7 2.8 3.1 6.9 5.8 18.5 1.7 0.1 0.0 1.8 1.8 0.4 2.6 2.5 1.8 2.7 2.5 1.3 1.5 4.1 0.3 0.0 7.8 4.4 71.2 2.8 4.1 2.3 3.1 3.2 9.5 7.8 1.4 0.0 0.1 5.2 5.1 18.2 3.5 1.5 8.5 0.7 1.7 1.3 0.9 0.8 0.9 1.4 0.9 0.8 0.5 36.5 0.1 2.2 0.2 0.8 0.5 3.7 4.5 0.8 6.0 7.4 2.9 3.5 2.5 5.5 2.9 IL1RAPL2 "IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1" ENSG00000189108 "Interleukin 1 receptor accessory protein like 2" Q9NP60 X 104566315-105767829 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 8.0;parathyroid gland: 8.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.7;hTERT-HME1: 10.8;NTERA-2: 2.0;RT4: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036128, HPA036129" Uncertain "HPA036128: AB_10669983, HPA036129: AB_2674957" "unprognostic (1.62e-1)" "unprognostic (1.50e-1)" "unprognostic (1.66e-2)" "unprognostic (3.09e-1)" "unprognostic (1.48e-4)" "unprognostic (9.32e-3)" "unprognostic (1.67e-1)" "unprognostic (6.80e-5)" "unprognostic (1.78e-2)" "unprognostic (2.79e-3)" "unprognostic (5.91e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.84e-2)" 0.2 4.2 1.5 0.0 5.0 0.0 1.2 1.1 8.0 0.4 0.6 0.0 0.8 0.4 0.1 0.2 0.2 0.4 1.9 0.5 0.4 0.8 0.4 2.8 0.1 0.0 1.1 2.2 0.9 0.2 8.9 0.1 1.1 2.2 0.4 0.1 0.0 0.8 1.1 0.1 0.3 0.2 0.4 0.3 0.1 0.4 1.9 0.5 0.0 0.2 0.0 0.1 2.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.8 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 3.7 0.7 0.2 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.0 1.1 8.0 0.4 0.8 1.1 2.2 2.2 0.5 IL1RL1 "DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1" ENSG00000115602 "Interleukin 1 receptor like 1" Q01638 2 102311502-102352037 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 49.7;lung: 77.2;placenta: 95.0" "Group enriched" "Detected in some" 6 "HHSteC: 54.1;HMC-1: 80.5;HUVEC TERT2: 39.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.9" "Group enriched" "Detected in many" 5 "basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6" "Group enriched" "Detected in some" 59 "basophil: 17.1;eosinophil: 17.0" "Lineage enriched" "Detected in single" 59 "granulocytes: 17.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007406, HPA007917" Uncertain Supported "Plasma membrane,Focal adhesion sites,Cytosol" "Secreted to blood" 19074133 1700000 "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA007406: AB_1079128, HPA007917: AB_1079129" "unprognostic (7.25e-2)" "unprognostic (9.72e-2)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" "unprognostic (5.28e-2)" "unprognostic (1.98e-2)" "unprognostic (3.25e-3)" "unprognostic (2.07e-1)" "unprognostic (2.77e-1)" "unprognostic (4.50e-2)" "unprognostic (8.58e-2)" "unprognostic (9.74e-2)" "unprognostic (1.44e-1)" "unprognostic (1.32e-2)" "unprognostic (1.60e-2)" "unprognostic (1.17e-1)" "unprognostic (4.60e-3)" 10.7 7.5 1.4 2.0 11.4 0.9 6.9 0.5 6.6 2.6 3.1 0.1 0.1 1.3 1.7 0.9 2.7 0.8 7.8 16.6 5.6 1.8 49.7 6.2 77.2 1.4 3.8 0.0 0.7 2.8 0.8 1.8 95.0 14.6 1.9 2.3 1.0 0.7 5.7 2.8 1.1 2.0 3.3 5.0 1.0 6.7 0.8 0.3 0.0 5.6 0.7 0.9 6.0 2.6 0.0 0.0 17.1 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 3.3 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.0 1.3 0.1 0.0 0.0 9.5 0.1 0.1 54.1 0.4 80.5 1.1 0.3 1.3 8.7 39.3 0.1 0.1 0.1 0.0 0.1 1.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.2 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.1 17.1 0.0 17.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 11.4 0.5 6.6 5.6 1.8 3.8 0.0 14.6 0.3 IL1RL2 "IL1R-rp2, IL1RRP2" ENSG00000115598 "Interleukin 1 receptor like 2" Q9HB29 2 102186973-102240002 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 14.4" "Cell line enhanced" "Detected in some" "A-431: 11.1;ASC TERT1: 7.5;HaCaT: 5.3;HSkMC: 6.1;hTCEpi: 3.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA015485 Uncertain "HPA015485: AB_1851612" "unprognostic (6.70e-2)" "unprognostic (1.17e-1)" "unprognostic (6.57e-2)" "unprognostic (2.76e-4)" "unprognostic (3.42e-3)" "unprognostic (2.60e-1)" "unprognostic (3.13e-3)" "unprognostic (6.79e-2)" "unprognostic (9.10e-3)" "unprognostic (9.17e-2)" "unprognostic (4.61e-2)" "unprognostic (2.38e-1)" "unprognostic (1.05e-2)" "unprognostic (8.33e-3)" "unprognostic (3.80e-1)" "unprognostic (1.47e-1)" "unprognostic (7.65e-2)" 1.0 1.8 1.1 0.5 1.1 0.0 2.8 0.5 1.4 1.8 0.7 0.5 6.0 0.0 1.0 2.0 7.4 2.4 2.4 0.7 0.6 0.7 2.3 3.3 0.8 0.5 0.5 0.5 0.5 0.5 6.0 0.5 0.5 1.1 1.3 1.0 0.5 2.9 10.3 0.9 14.4 0.5 0.5 0.5 0.5 1.6 0.5 0.5 0.5 3.7 8.8 4.0 0.9 3.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 2.2 7.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 5.3 0.0 1.2 0.6 0.6 0.0 0.0 1.5 0.0 2.2 0.0 0.0 6.1 3.4 1.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.5 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.5 1.4 0.6 0.7 0.5 0.5 1.1 0.5 IL20RA "IL-20R1, ZCYTOR7" ENSG00000016402 "Interleukin 20 receptor subunit alpha" Q9UHF4 6 136999971-137045180 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 28.9" "Group enriched" "Detected in some" 6 "CAPAN-2: 9.6;HaCaT: 6.9;RT4: 11.4;SH-SY5Y: 11.1;T-47d: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB024990, HPA042281" Approved Approved Cytosol Cytosol "CAB024990: , HPA042281: AB_10806235" "unprognostic (3.75e-2)" "unprognostic (8.23e-2)" "unprognostic (1.96e-2)" "prognostic favourable (1.43e-6)" "unprognostic (1.57e-2)" "prognostic favourable (2.29e-5)" "unprognostic (9.87e-3)" "unprognostic (1.64e-1)" "unprognostic (2.43e-1)" "unprognostic (3.78e-1)" "unprognostic (8.03e-3)" "unprognostic (2.18e-1)" "unprognostic (1.85e-6)" "unprognostic (9.38e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-3)" "unprognostic (1.64e-3)" 0.6 7.0 2.0 1.6 5.9 0.1 21.2 4.4 2.8 13.9 3.5 4.3 0.6 2.4 5.5 3.7 6.4 13.6 7.9 5.9 3.6 3.0 0.4 0.8 4.7 0.1 3.7 2.3 5.4 16.3 0.2 1.8 0.4 4.6 7.3 3.7 3.5 11.8 7.8 0.5 28.9 1.3 2.9 5.5 0.0 4.9 2.9 3.3 1.0 2.2 3.7 5.6 5.6 9.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 9.6 0.0 0.1 1.4 6.9 1.2 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.4 1.4 0.0 0.4 0.0 0.0 11.4 0.7 11.1 0.5 0.0 0.0 10.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.9 4.4 2.8 3.6 3.0 3.7 2.3 4.6 3.3 IL20RB "DIRS1, FNDC6, IL-20R2, MGC34923" ENSG00000174564 "Interleukin 20 receptor subunit beta" Q6UXL0 3 136946230-137011085 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 64.5;skin 1: 61.2" "Cell line enriched" "Detected in some" 4 "hTCEpi: 104.1" "Group enriched" "Detected in many" 5 "cervical cancer: 54.5;head and neck cancer: 50.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 0.6" "Not detected" "Not detected" HPA063914 Approved Vesicles,Cytosol Vesicles Cytosol "HPA063914: " "unprognostic (1.35e-2)" "unprognostic (1.05e-1)" "unprognostic (7.43e-4)" "unprognostic (2.48e-4)" "unprognostic (2.74e-1)" "unprognostic (3.31e-1)" "unprognostic (7.43e-4)" "unprognostic (4.08e-3)" "unprognostic (7.64e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.44e-4)" "unprognostic (3.57e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.55e-1)" "unprognostic (3.55e-2)" "unprognostic (1.33e-2)" "unprognostic (5.57e-2)" 1.6 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.1 13.2 0.2 0.0 0.0 0.0 1.3 0.3 64.5 0.1 0.1 0.3 0.0 0.0 0.1 2.1 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.2 2.8 0.0 1.6 0.3 0.4 4.1 0.2 0.4 61.2 0.1 0.1 0.3 0.0 0.1 0.9 0.0 0.5 0.2 22.6 17.1 0.9 19.2 0.1 0.4 0.0 0.3 0.0 0.6 0.0 4.8 0.0 0.0 0.0 2.9 12.6 0.4 0.1 0.3 0.0 0.1 0.4 0.5 0.0 2.7 1.7 15.7 0.0 25.8 0.1 0.0 0.0 0.0 3.2 0.0 17.4 0.0 0.0 2.1 104.1 0.8 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 IL21R CD360 ENSG00000103522 "Interleukin 21 receptor" Q9HBE5 16 27402162-27452042 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 17.9;lymphoid tissue: 47.8" "Cell line enhanced" "Detected in some" "Daudi: 10.1;HDLM-2: 42.9;Karpas-707: 19.9;RH-30: 15.1;RPMI-8226: 24.0;U-266/70: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042296 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA042296: AB_10806236" "unprognostic (2.91e-2)" "unprognostic (2.65e-3)" "unprognostic (6.64e-4)" "unprognostic (1.58e-3)" "unprognostic (2.14e-1)" "prognostic favourable (7.29e-4)" "unprognostic (8.33e-2)" "unprognostic (2.06e-1)" "unprognostic (8.50e-6)" "unprognostic (2.26e-2)" "unprognostic (1.13e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-10)" "unprognostic (8.79e-2)" "unprognostic (4.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.58e-2)" 0.8 0.6 0.6 33.6 3.7 5.7 0.6 0.5 1.6 0.5 0.9 0.3 0.0 0.5 0.5 1.3 1.0 0.8 1.1 1.8 0.6 2.3 1.6 1.3 5.6 20.9 1.3 0.0 0.5 0.5 0.0 0.9 0.9 1.9 0.9 0.9 1.8 3.7 0.3 0.7 0.7 4.0 0.6 1.7 11.2 1.3 1.0 1.4 47.8 1.3 0.8 31.7 2.7 0.8 11.5 1.6 0.7 17.9 6.3 10.3 4.2 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.3 0.0 0.0 0.9 0.0 0.0 10.1 0.1 0.8 0.0 0.0 0.0 0.0 42.9 0.0 2.1 0.0 0.2 1.4 0.0 0.6 1.5 0.0 2.7 0.0 0.0 0.1 19.9 1.5 0.0 0.0 0.2 0.3 0.0 0.1 15.1 24.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.5 1.1 0.8 0.2 0.2 0.0 10.0 3.5 2.3 2.1 0.5 0.0 0.2 0.3 0.0 9.8 5.8 3.6 1.0 6.3 10.3 1.6 11.5 6.9 6.7 0.7 6.3 17.9 0.7 7.6 4.2 0.6 3.7 0.5 1.6 0.6 2.3 1.3 0.0 1.9 1.4 IL23R IL-23R ENSG00000162594 "Interleukin 23 receptor" Q5VWK5 1 67138907-67259979 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 18.1;lymphoid tissue: 11.0" "Cell line enhanced" "Detected in some" "HL-60: 2.6;HMC-1: 10.5;K-562: 3.9;U-2197: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "MAIT T-cell: 18.1" "Lineage enriched" "Detected in single" 35 "T-cells: 18.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA056427 Uncertain "HPA056427: " "unprognostic (4.01e-3)" "unprognostic (8.04e-2)" "unprognostic (3.49e-2)" "unprognostic (6.41e-2)" "unprognostic (1.96e-1)" "unprognostic (3.16e-3)" "unprognostic (1.57e-1)" "unprognostic (2.22e-3)" "unprognostic (1.71e-1)" "unprognostic (1.88e-1)" "unprognostic (1.66e-2)" "unprognostic (1.40e-1)" "unprognostic (8.64e-5)" "unprognostic (1.43e-1)" "unprognostic (3.02e-1)" "unprognostic (2.73e-2)" "unprognostic (6.41e-3)" 0.2 4.8 0.2 11.0 0.3 0.0 0.2 0.2 0.2 0.2 2.4 0.2 0.0 0.9 0.3 1.0 0.3 0.2 0.6 0.2 0.2 0.2 0.3 0.5 0.5 4.8 0.2 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.2 2.6 0.6 2.3 0.0 0.2 0.2 2.7 0.0 0.2 3.3 1.3 4.1 0.0 1.2 0.2 1.4 7.6 0.9 0.3 0.0 0.0 0.0 0.0 0.5 18.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 2.6 10.5 0.0 0.0 0.0 0.0 0.0 3.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 15.8 0.0 0.3 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 18.1 0.0 0.5 2.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 IL27RA "CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1" ENSG00000104998 "Interleukin 27 receptor subunit alpha" Q6UWB1 19 14031748-14053216 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 25.2;lymphoid tissue: 32.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA073441 Approved Vesicles 4100000 Vesicles "HPA073441: " "prognostic favourable (1.74e-6)" "unprognostic (1.99e-1)" "unprognostic (1.55e-1)" "unprognostic (6.09e-2)" "unprognostic (2.03e-3)" "unprognostic (2.28e-1)" "unprognostic (2.05e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.40e-3)" "unprognostic (9.92e-2)" "unprognostic (3.35e-2)" "prognostic unfavourable (2.58e-10)" "unprognostic (5.45e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.87e-3)" 8.4 2.1 2.8 26.0 2.7 3.5 20.6 3.0 3.5 3.5 3.9 1.1 2.7 3.6 3.6 2.0 3.4 4.2 4.1 5.8 3.8 3.6 4.8 2.1 11.8 25.3 2.6 2.3 2.3 3.5 8.1 1.1 2.0 2.5 5.0 3.4 1.2 7.4 2.1 2.8 2.6 9.0 3.0 2.5 18.0 4.1 2.4 1.6 32.3 4.9 2.2 28.3 6.0 6.8 14.6 18.2 5.3 19.7 19.1 25.2 16.9 8.1 3.5 3.6 4.8 0.3 1.9 1.5 3.8 8.0 7.0 10.1 1.7 6.7 0.1 4.1 3.4 1.6 5.6 2.2 5.5 15.7 3.9 19.9 0.8 2.9 0.6 9.5 0.3 1.8 0.9 3.3 0.7 2.8 13.7 14.9 0.3 11.4 7.1 20.7 4.7 2.5 6.2 2.1 7.6 4.3 1.9 3.2 1.7 4.9 0.3 5.5 6.2 5.8 4.4 0.7 8.8 7.1 4.1 15.5 7.4 7.2 0.6 19.4 4.6 5.3 19.7 0.5 22.9 16.3 20.2 14.6 22.7 18.9 18.2 12.8 25.2 19.4 1.5 19.1 7.5 6.8 19.9 16.9 2.8 2.7 3.0 3.5 3.8 3.6 2.6 2.3 2.5 1.6 IL2RA "CD25, IDDM10, IL2R" ENSG00000134460 "Interleukin 2 receptor subunit alpha" P01589 10 6010689-6062370 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 16.5;blood: 55.4;lymphoid tissue: 56.7" "Cell line enriched" "Detected in some" 59 "HDLM-2: 153.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 2.4" "Group enriched" "Detected in many" 6 "basophil: 30.3;T-reg: 55.4" "Group enriched" "Detected in many" 12 "granulocytes: 30.3;T-cells: 55.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002419, HPA054622" Enhanced 110000 "CAB002419: AB_563538, HPA054622: " "unprognostic (2.82e-1)" "unprognostic (8.10e-3)" "unprognostic (1.75e-2)" "unprognostic (5.86e-2)" "unprognostic (1.50e-1)" "unprognostic (1.45e-3)" "unprognostic (2.78e-2)" "unprognostic (2.73e-1)" "unprognostic (5.03e-2)" "unprognostic (6.32e-2)" "unprognostic (7.21e-2)" "unprognostic (2.07e-1)" "prognostic unfavourable (2.08e-9)" "unprognostic (2.10e-2)" "unprognostic (4.66e-2)" "unprognostic (2.22e-1)" "unprognostic (5.10e-2)" 16.5 2.5 0.3 10.9 0.6 0.1 1.4 0.3 0.3 0.6 3.1 0.1 0.0 1.3 0.8 4.9 1.9 0.8 2.2 1.9 0.4 0.5 2.6 1.3 4.0 50.4 0.5 0.0 0.6 1.0 0.0 1.8 1.8 2.4 1.1 1.6 3.4 2.2 0.5 0.8 0.6 10.3 3.5 2.2 56.7 1.4 0.4 0.0 4.5 4.2 2.0 16.8 5.0 0.6 3.6 0.0 30.3 0.0 2.9 55.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 153.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 30.3 0.0 4.5 0.1 0.0 0.5 3.6 6.8 0.7 0.0 1.5 0.5 0.0 0.2 2.9 0.0 0.0 55.4 0.7 0.3 0.6 0.3 0.3 0.4 0.5 0.5 0.0 2.4 0.0 IL2RB "CD122, IL15RB" ENSG00000100385 "Interleukin 2 receptor subunit beta" P14784 22 37125838-37175054 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.6;lymphoid tissue: 35.0;placenta: 58.5" "Cell line enriched" "Detected in some" 8 "HDLM-2: 104.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 14.7;NK-cell: 51.6" "Group enriched" "Detected in many" 32 "NK-cells: 51.6;T-cells: 14.7" "Region enriched" "Detected in single" 7 "basal ganglia: 1.6" "Low region specificity" "Detected in all" HPA062657 Enhanced "HPA062657: " "unprognostic (3.38e-3)" "unprognostic (1.21e-2)" "prognostic favourable (6.76e-4)" "prognostic favourable (3.18e-5)" "unprognostic (2.44e-2)" "unprognostic (9.69e-3)" "unprognostic (2.60e-1)" "unprognostic (5.22e-2)" "unprognostic (1.03e-3)" "unprognostic (5.37e-2)" "unprognostic (1.09e-1)" "unprognostic (2.74e-1)" "prognostic unfavourable (3.50e-7)" "unprognostic (4.63e-2)" "unprognostic (7.96e-2)" "unprognostic (3.94e-3)" "unprognostic (2.46e-2)" 2.2 1.0 0.8 20.5 0.8 12.3 1.6 0.6 0.7 1.3 5.5 0.6 1.4 1.8 4.3 2.8 2.6 1.8 5.8 3.7 0.7 0.8 1.9 6.0 7.4 20.8 0.8 0.2 1.5 1.0 0.0 1.1 58.5 0.7 3.5 1.8 2.9 3.7 2.1 0.9 4.0 7.3 0.6 1.1 35.0 2.3 1.1 0.2 21.0 2.1 1.8 28.7 4.0 1.5 0.3 0.0 1.0 0.1 51.6 14.7 7.9 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 104.1 0.1 0.2 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.8 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.8 0.0 0.1 7.5 12.8 0.0 0.1 0.0 0.1 1.0 0.0 0.1 14.7 0.1 8.1 0.1 3.3 8.2 0.0 0.3 1.1 4.3 0.3 51.6 0.1 0.0 6.8 7.9 0.8 0.8 0.6 0.7 0.7 0.8 0.8 0.2 0.7 0.2 IL2RG "CD132, CIDX, IMD4, SCIDX1" ENSG00000147168 "Interleukin 2 receptor subunit gamma" P31785 X 71107404-71112108 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 115.3;lymphoid tissue: 169.3" "Cell line enriched" "Detected in some" 6 "Karpas-707: 220.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA046641, HPA049691" Enhanced Approved Vesicles Vesicles "HPA046641: AB_2679733, HPA049691: " "unprognostic (2.97e-3)" "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "prognostic favourable (1.73e-4)" "unprognostic (8.25e-2)" "unprognostic (1.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.91e-3)" "unprognostic (1.23e-2)" "unprognostic (4.36e-1)" "unprognostic (1.45e-1)" "prognostic unfavourable (2.28e-7)" "unprognostic (1.73e-1)" "unprognostic (4.69e-2)" "unprognostic (4.89e-2)" "unprognostic (9.54e-2)" 5.8 1.3 1.4 39.5 1.4 12.8 3.6 0.8 0.9 2.9 16.6 0.9 0.9 8.2 3.0 2.1 5.3 3.1 5.3 2.6 1.4 1.5 3.7 4.7 13.6 70.4 1.8 0.6 2.9 1.5 0.0 1.2 5.3 1.5 3.2 20.8 2.9 10.4 1.8 1.6 2.7 28.6 1.5 2.9 58.7 6.0 2.0 0.9 169.3 3.3 4.2 61.4 7.6 3.1 51.9 30.6 65.6 19.7 94.6 115.3 99.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 17.2 1.2 0.0 0.1 0.0 0.0 0.0 14.4 0.0 2.2 0.0 0.0 0.0 8.9 0.4 0.0 0.0 0.0 0.0 0.0 3.8 220.5 0.0 0.0 31.9 17.4 0.0 0.0 7.3 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 12.6 22.2 11.1 0.2 37.0 0.0 35.2 8.5 13.4 107.2 19.7 105.6 51.9 97.7 110.4 20.3 51.6 68.0 84.9 65.6 94.6 13.5 30.6 115.3 99.0 1.4 1.4 0.8 0.9 1.4 1.5 1.8 0.6 1.5 0.9 IL31RA "CRL, CRL3, GLM-R, Glmr, IL-31RA" ENSG00000164509 "Interleukin 31 receptor A" Q8NI17 5 55851379-55922853 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;tongue: 6.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.9;HHSteC: 7.7;hTERT-HME1: 10.8;U-2 OS: 16.0;U-87 MG: 18.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 6 "amygdala: 10.3" "Group enriched" "Detected in some" 5 "classical monocyte: 2.2;myeloid DC: 1.2" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;monocytes: 2.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.5;hippocampal formation: 1.1" "HPA051532, HPA068114" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA051532: , HPA068114: " "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.13e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-3)" "unprognostic (7.34e-2)" "unprognostic (3.54e-1)" "unprognostic (5.38e-2)" "unprognostic (2.95e-3)" "unprognostic (7.75e-5)" "unprognostic (5.55e-2)" "unprognostic (2.65e-6)" "unprognostic (7.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.02e-1)" "unprognostic (1.76e-2)" 0.3 0.1 10.3 1.0 0.1 5.3 0.2 0.1 0.4 0.2 1.5 0.0 0.0 0.4 1.2 1.8 1.7 0.1 0.2 0.4 1.6 0.2 0.3 0.3 0.5 0.1 0.1 0.0 0.5 0.7 0.0 0.7 0.7 0.0 1.0 0.4 0.4 1.3 0.2 2.6 2.5 0.8 1.8 0.1 0.3 0.5 5.9 0.0 1.4 0.5 6.4 0.5 0.5 2.2 0.0 1.2 0.2 2.2 0.0 0.1 0.4 0.1 1.1 0.0 0.0 0.0 0.4 0.5 0.1 0.5 0.2 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 8.9 1.8 0.0 0.1 0.0 0.0 0.0 7.7 0.0 0.0 6.0 3.0 4.3 10.8 3.3 0.0 0.4 1.4 0.0 0.0 1.4 0.0 6.0 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.5 0.5 16.0 0.0 1.0 0.0 0.0 0.0 18.5 0.0 2.5 0.1 2.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 10.3 0.1 0.1 0.4 1.6 0.2 0.1 0.0 0.0 0.0 IL3RA CD123 ENSG00000185291 "Interleukin 3 receptor subunit alpha" P26951 X 1336616-1382689 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 163.1;breast: 50.7;vagina: 65.4" "Cell line enhanced" "Detected in some" "HDLM-2: 47.8;NB-4: 9.2;RPMI-8226: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 16 "basophil: 163.1;plasmacytoid DC: 49.1" "Group enriched" "Detected in many" 33 "dendritic cells: 49.1;granulocytes: 163.1" "HPA003539, CAB018374" Uncertain "CAB018374: AB_2233620, HPA003539: AB_1078438" "prognostic favourable (9.78e-4)" "prognostic favourable (4.27e-4)" "unprognostic (8.13e-2)" "unprognostic (9.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" "unprognostic (3.73e-2)" "unprognostic (5.77e-3)" "unprognostic (1.43e-1)" "unprognostic (1.50e-3)" "unprognostic (9.41e-2)" "unprognostic (2.85e-3)" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" 14.9 1.2 7.8 7.7 7.8 12.1 50.7 5.0 10.1 9.7 4.6 1.5 1.5 2.4 13.8 1.5 2.8 4.2 5.6 9.2 11.1 2.4 5.4 1.5 15.9 12.3 8.5 3.9 7.6 2.6 0.6 3.7 9.3 10.9 4.4 3.1 1.5 5.6 1.5 5.7 6.8 5.4 6.1 7.6 5.3 4.2 1.5 7.9 1.5 7.0 1.5 6.4 6.8 65.4 0.7 49.1 163.1 3.2 1.1 0.0 0.7 0.1 3.9 1.5 0.5 0.0 0.0 0.5 0.5 0.1 0.0 0.0 0.3 0.6 0.5 2.7 0.0 3.8 0.0 0.0 0.0 47.8 1.6 0.2 0.7 0.1 0.0 0.3 6.6 0.0 0.0 0.0 0.0 3.1 0.1 2.5 0.0 0.6 0.2 9.2 1.2 0.2 0.5 1.7 19.5 0.0 0.5 0.2 0.1 0.2 0.1 1.1 0.5 7.3 0.1 0.2 0.6 0.2 0.1 5.2 1.4 0.4 4.3 1.1 0.0 163.1 0.4 6.7 0.0 2.4 0.0 0.2 0.0 0.0 1.1 0.7 0.0 0.0 0.3 1.1 3.2 49.1 0.0 0.7 7.8 7.8 5.0 10.1 11.1 2.4 8.5 3.9 10.9 7.9 IL4R CD124 ENSG00000077238 "Interleukin 4 receptor" P24394 16 27313668-27364778 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 35.8;HBEC3-KT: 34.4;U-698: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 34.4" "Group enriched" "Detected in all" 6 "B-cells: 34.4;granulocytes: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004451, HPA050124, HPA070380" Enhanced Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" "Secreted to blood" 49000 "Plasma membrane" "Nucleoplasm, Centriolar satellite" "CAB004451: AB_626889, HPA050124: , HPA070380: " "unprognostic (6.80e-2)" "unprognostic (6.35e-2)" "unprognostic (2.84e-1)" "prognostic favourable (6.43e-4)" "unprognostic (1.12e-1)" "unprognostic (1.14e-1)" "unprognostic (2.33e-2)" "unprognostic (1.95e-3)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-1)" "unprognostic (1.97e-1)" "prognostic unfavourable (1.23e-5)" "unprognostic (1.49e-2)" "unprognostic (1.73e-1)" "unprognostic (1.36e-1)" "unprognostic (9.58e-2)" 20.7 14.8 8.7 31.6 10.6 36.9 12.0 4.4 7.7 20.8 30.3 5.9 11.5 10.9 18.0 12.8 24.7 13.6 25.1 12.3 6.7 4.4 13.3 39.1 40.9 44.8 10.8 1.7 14.7 11.3 3.8 5.5 16.1 10.1 18.8 15.1 12.3 7.7 11.5 7.2 9.9 18.6 39.6 13.6 31.8 21.1 10.4 9.8 9.1 8.6 13.7 38.4 31.6 15.4 34.4 1.6 11.9 2.6 3.3 4.0 1.8 11.3 3.0 1.9 3.9 0.9 4.5 4.1 7.2 8.3 2.9 2.3 6.1 31.4 35.8 9.0 11.3 12.1 2.1 34.4 2.5 31.0 1.0 6.7 1.8 9.3 13.0 1.8 19.1 6.9 13.9 13.2 7.9 15.4 2.9 3.0 4.6 5.0 0.1 5.4 2.4 2.6 0.1 14.9 2.9 13.3 13.0 0.6 0.3 1.0 6.9 1.5 2.6 6.9 23.0 6.5 2.9 5.8 5.0 1.8 0.5 33.3 0.7 6.0 0.0 0.5 2.6 4.7 1.7 1.1 1.3 7.7 2.6 1.7 1.6 34.4 4.0 1.9 11.9 3.3 0.6 1.6 1.8 1.8 8.7 10.6 4.4 7.7 6.7 4.4 10.8 1.7 10.1 9.8 IL6ST "CD130, GP130" ENSG00000134352 "Interleukin 6 signal transducer" P40189 5 55935095-55994993 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 57.0;BJ hTERT+: 58.0;HHSteC: 64.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 21.0" "Lineage enriched" "Detected in many" 5 "T-cells: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010558, CAB025784" Approved Supported "Golgi apparatus,Plasma membrane" "Secreted to blood" 100000000 "Plasma membrane" "Golgi apparatus" "CAB025784: , HPA010558: AB_1078439" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (3.95e-2)" "unprognostic (8.93e-2)" "unprognostic (3.99e-2)" "unprognostic (5.18e-2)" "unprognostic (9.53e-3)" "unprognostic (1.89e-2)" "unprognostic (2.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.59e-1)" "prognostic unfavourable (5.05e-4)" "unprognostic (3.69e-2)" "unprognostic (1.06e-1)" "unprognostic (1.80e-1)" "unprognostic (1.25e-1)" 44.8 34.2 24.7 25.5 23.4 8.8 76.9 15.9 22.9 38.1 23.9 15.0 29.0 8.7 26.1 24.9 22.7 23.1 31.1 31.9 21.9 19.7 37.2 71.2 36.3 70.0 25.8 14.7 42.1 16.4 35.8 36.2 97.0 22.5 31.9 17.1 20.0 26.3 33.0 27.1 12.5 20.6 36.6 33.8 35.5 19.7 13.7 20.3 19.4 37.6 12.5 18.7 33.7 51.1 0.7 2.1 0.9 3.8 0.8 21.0 4.0 9.4 11.8 3.8 9.1 27.3 57.0 15.8 28.2 58.0 15.2 22.7 16.5 9.0 0.3 21.1 17.4 4.1 3.0 8.4 31.2 0.8 3.0 2.2 9.7 13.6 64.9 0.2 4.5 49.9 4.6 33.0 16.1 34.7 1.6 39.8 17.5 1.6 0.4 0.4 0.6 3.9 0.5 10.7 5.4 8.3 5.6 2.0 3.4 11.4 3.8 11.6 19.0 1.5 55.7 5.9 6.7 23.8 14.8 9.8 4.2 0.3 15.8 0.4 15.3 0.2 3.8 0.1 0.8 3.5 0.4 0.7 4.9 0.8 2.1 0.6 21.0 5.9 0.9 0.8 0.6 1.8 3.4 4.0 24.7 23.4 15.9 22.9 21.9 19.7 25.8 14.7 22.5 20.3 IL7R CD127 ENSG00000168685 "Interleukin 7 receptor" P16871 5 35852695-35879603 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 70.3;intestine: 34.0;lung: 52.6;lymphoid tissue: 133.1" "Cell line enhanced" "Detected in many" "BJ: 21.7;fHDF/TERT166: 40.7;HBF TERT88: 37.4;REH: 84.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 19.2;MAIT T-cell: 70.3;memory CD4 T-cell: 39.9;memory CD8 T-cell: 28.0;naive CD4 T-cell: 34.5;naive CD8 T-cell: 22.5;NK-cell: 19.1" "Group enriched" "Detected in many" 33 "NK-cells: 19.1;T-cells: 70.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" CAB010215 Supported "Plasma membrane,Centriolar satellite" "Intracellular and membrane" 180000 "Plasma membrane, Centriolar satellite" "CAB010215: AB_673727" "unprognostic (2.93e-3)" "unprognostic (3.38e-2)" "unprognostic (3.82e-3)" "unprognostic (5.58e-3)" "unprognostic (3.06e-2)" "unprognostic (1.74e-1)" "unprognostic (2.51e-3)" "unprognostic (5.53e-2)" "unprognostic (1.12e-1)" "unprognostic (9.29e-3)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (1.76e-2)" "unprognostic (5.64e-2)" "unprognostic (3.27e-3)" "unprognostic (2.22e-1)" "unprognostic (1.78e-1)" 6.7 3.6 0.7 34.0 0.7 3.1 4.8 0.5 0.6 4.8 20.6 0.3 0.9 3.5 1.8 2.9 6.6 3.7 8.5 1.9 0.7 0.7 7.0 2.7 52.6 133.1 0.8 0.1 2.5 1.7 0.0 1.5 1.2 0.8 3.3 5.4 1.7 13.2 1.8 0.9 1.8 34.0 1.2 1.5 32.3 7.8 3.0 0.4 130.9 5.1 5.3 42.9 12.6 4.6 0.4 0.3 1.3 0.2 19.1 70.3 12.7 0.1 0.0 0.1 0.1 0.1 0.1 0.2 21.7 11.0 19.6 11.6 0.1 0.1 2.1 0.0 40.7 3.5 0.0 1.3 37.4 1.8 0.2 0.6 2.3 0.0 0.3 0.1 1.5 0.3 0.0 4.2 0.9 0.5 0.1 0.3 15.4 0.0 0.5 0.2 0.1 1.0 84.6 1.1 0.1 0.0 1.2 0.0 0.0 3.6 0.3 0.0 0.1 0.0 1.5 7.7 13.1 3.3 2.8 0.1 0.0 2.4 3.9 2.0 5.9 0.5 0.2 0.1 19.2 0.2 70.3 0.2 39.9 28.0 0.1 0.4 34.5 22.5 1.3 19.1 0.2 0.3 6.7 12.7 0.7 0.7 0.5 0.6 0.7 0.7 0.8 0.1 0.8 0.4 IL9R CD129 ENSG00000124334 "Interleukin 9 receptor" Q01113 X 155997581-156010817 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.3;urinary bladder: 10.9" "Cell line enriched" "Detected in some" 11 "HMC-1: 74.2" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.4" "Group enriched" "Detected in some" 6 "basal ganglia: 1.7;pons and medulla: 4.7;thalamus: 1.5" "Cell type enhanced" "Detected in many" "eosinophil: 6.3" "Group enriched" "Detected in many" 25 "B-cells: 4.1;granulocytes: 6.3;T-cells: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA063240, HPA064557" Approved "Intracellular and membrane" "HPA063240: , HPA064557: " "unprognostic (1.07e-2)" "unprognostic (3.27e-3)" "unprognostic (9.52e-3)" "unprognostic (4.13e-2)" "unprognostic (7.35e-2)" "unprognostic (3.26e-4)" "unprognostic (8.94e-2)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.82e-1)" "unprognostic (2.90e-2)" "unprognostic (2.04e-1)" "unprognostic (3.98e-8)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (4.07e-1)" "prognostic favourable (1.90e-7)" 0.3 0.1 0.3 1.1 1.7 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.7 3.0 0.3 0.5 0.4 0.9 0.3 0.3 0.2 0.3 0.5 1.3 3.2 0.3 0.3 0.3 0.3 0.0 0.3 0.3 4.7 0.4 1.2 0.3 0.4 0.3 0.3 0.4 2.4 0.3 0.3 3.5 0.8 0.3 1.5 0.3 0.4 0.3 2.9 10.9 0.3 4.1 0.0 6.3 0.0 0.1 2.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 6.8 0.0 0.0 0.0 0.1 74.2 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.3 2.6 1.3 0.0 0.0 0.1 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 1.8 0.8 1.3 0.0 4.1 0.0 0.0 1.8 0.1 0.0 0.0 2.4 0.3 0.3 1.7 0.4 0.3 0.3 0.2 0.3 0.3 4.7 1.5 ILDR1 "DFNB42, MGC50831" ENSG00000145103 "Immunoglobulin like domain containing receptor 1" Q86SU0 3 121987323-122022258 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 28.9;seminal vesicle: 27.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.5;HDLM-2: 9.6;MCF7: 5.9;RT4: 8.9;T-47d: 6.4;U-266/70: 7.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 5.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA018207 Approved "Intracellular and membrane" "HPA018207: AB_1851742" "unprognostic (2.69e-1)" "unprognostic (1.28e-2)" "unprognostic (9.24e-2)" "unprognostic (4.46e-3)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-2)" "unprognostic (2.80e-2)" "unprognostic (2.00e-1)" "unprognostic (2.04e-1)" "unprognostic (7.78e-2)" "unprognostic (2.37e-1)" "prognostic favourable (5.79e-9)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "unprognostic (3.25e-3)" "unprognostic (2.21e-2)" 0.3 1.5 0.3 0.7 0.4 0.0 1.8 0.3 0.3 8.6 5.6 0.3 28.9 2.0 1.6 17.2 5.9 3.4 4.7 0.3 0.3 0.2 8.0 0.4 2.9 0.3 0.3 0.3 0.9 16.5 14.8 4.1 2.6 0.4 4.9 5.0 1.3 10.6 27.8 0.3 1.7 2.4 0.3 0.3 1.1 0.3 1.5 0.3 0.9 5.1 1.9 3.7 5.6 1.6 5.1 0.5 1.5 0.7 0.1 1.0 0.4 3.4 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 7.5 1.3 0.1 0.0 1.2 0.0 0.0 0.0 9.6 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 5.9 0.0 0.1 0.1 0.0 0.0 0.1 2.7 3.4 8.9 0.3 0.1 0.0 0.9 0.1 6.4 0.0 0.0 0.0 0.0 0.0 0.1 7.4 1.6 1.3 0.0 0.2 0.1 0.6 0.7 0.1 0.2 0.4 0.2 5.1 0.2 0.3 0.5 3.4 0.4 0.3 1.5 0.1 0.2 0.4 1.0 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.4 0.3 ILDR2 C1orf32 ENSG00000143195 "Immunoglobulin like domain containing receptor 2" Q71H61 1 166895711-166975482 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;testis: 18.0" "Cell line enhanced" "Detected in some" "AF22: 9.8;MOLT-4: 5.1;U-2 OS: 12.6;U-251 MG: 6.6" "Cancer enhanced" "Detected in some" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012545, HPA012815" Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA012545: AB_2126894, HPA012815: " "unprognostic (9.14e-2)" "unprognostic (5.05e-2)" "unprognostic (8.27e-2)" "unprognostic (2.16e-1)" "unprognostic (5.89e-2)" "unprognostic (5.33e-2)" "unprognostic (2.89e-5)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (4.51e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (9.17e-2)" "unprognostic (5.87e-3)" "unprognostic (4.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 0.8 1.1 9.8 0.9 6.4 1.4 0.5 2.1 14.6 0.7 2.9 3.6 0.1 0.7 0.9 1.4 0.9 0.8 1.3 3.1 7.2 7.7 6.3 1.3 1.4 1.0 2.7 8.0 0.8 0.7 0.5 3.3 0.8 3.1 2.3 1.2 2.8 0.8 2.8 0.8 0.7 0.8 2.0 2.3 0.7 0.7 18.0 3.1 1.9 0.9 0.0 1.1 0.9 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.5 0.0 0.0 9.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 1.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 2.3 1.9 0.0 0.0 0.2 0.0 3.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 5.1 0.0 3.4 0.0 0.0 0.3 0.7 0.7 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 12.6 0.0 6.6 2.3 0.0 0.5 1.4 1.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.5 9.8 6.4 2.1 11.4 7.2 7.7 2.7 8.0 3.1 3.1 ILVBL "209L8, AHAS, FLJ39061, HACL1L, ILV2H, MGC1269, MGC19535" ENSG00000105135 "IlvB acetolactate synthase like" A1L0T0 19 15114984-15125785 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067682 Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA067682: " "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (3.72e-2)" "prognostic unfavourable (1.52e-4)" "unprognostic (8.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.04e-2)" "unprognostic (2.53e-1)" "unprognostic (3.83e-1)" "unprognostic (5.60e-2)" "unprognostic (1.77e-2)" "unprognostic (2.61e-1)" "prognostic favourable (1.91e-8)" "unprognostic (4.65e-2)" "unprognostic (1.68e-1)" "unprognostic (1.40e-1)" "unprognostic (2.40e-1)" 13.7 22.1 10.4 8.3 13.6 7.7 12.1 12.4 18.9 11.5 34.9 21.3 16.7 29.1 13.4 11.1 18.9 13.8 24.8 32.9 10.5 9.7 24.9 34.8 10.0 13.2 18.5 9.2 15.9 24.7 21.1 16.5 35.9 14.0 11.1 11.0 29.4 16.1 14.9 10.0 19.4 26.8 10.9 14.3 8.3 18.2 14.7 17.7 10.0 28.6 16.7 12.2 14.8 14.5 9.8 17.5 10.8 20.7 15.3 16.9 15.1 21.8 13.3 11.4 13.4 14.9 10.2 13.2 10.3 13.9 12.4 16.0 21.1 53.1 9.5 20.4 11.1 16.6 6.9 12.5 3.6 8.7 13.5 13.9 13.6 23.0 23.9 11.7 12.3 15.2 14.6 7.2 9.5 11.5 5.6 12.4 9.6 50.7 7.8 9.4 10.5 19.4 11.4 10.3 14.8 10.8 10.9 9.5 12.8 6.1 26.8 20.2 12.3 10.1 12.2 18.8 10.4 23.6 14.4 8.7 8.9 4.7 12.0 11.5 14.1 10.8 14.8 3.5 15.1 20.7 16.9 8.6 12.6 15.4 17.5 9.8 16.7 16.9 1.6 15.3 18.7 12.7 12.9 15.1 10.4 13.6 12.4 18.9 10.5 9.7 18.5 9.2 14.0 17.7 IMMP2L "IMMP2L-IT1, IMP2" ENSG00000184903 "Inner mitochondrial membrane peptidase subunit 2" Q96T52 7 110663051-111562517 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026711 Approved Approved Mitochondria Mitochondria "HPA026711: AB_1851760" "unprognostic (2.55e-2)" "unprognostic (1.40e-2)" "unprognostic (4.29e-1)" "unprognostic (1.04e-1)" "unprognostic (3.76e-2)" "prognostic unfavourable (1.89e-5)" "unprognostic (5.64e-3)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (5.68e-3)" "unprognostic (1.12e-1)" "unprognostic (1.09e-1)" "unprognostic (2.89e-3)" "unprognostic (1.32e-1)" "unprognostic (6.65e-2)" "unprognostic (1.79e-1)" "unprognostic (2.71e-1)" 12.4 12.4 7.9 7.3 10.8 2.9 11.8 5.4 9.1 12.4 11.1 5.7 10.6 5.2 23.8 10.4 8.0 11.5 5.8 8.6 7.1 6.0 23.8 17.7 7.4 4.4 5.7 6.1 14.4 10.0 13.4 15.7 8.0 6.3 13.8 5.8 31.6 11.6 15.8 18.6 7.5 10.9 14.4 5.6 5.3 9.8 9.0 5.6 8.2 16.7 8.3 9.5 11.0 9.2 18.1 11.7 5.8 8.4 24.3 15.1 5.1 7.8 4.7 2.8 11.7 7.6 7.7 5.0 5.4 5.5 3.6 3.8 2.3 9.2 12.9 14.9 4.7 4.4 3.0 10.9 6.0 8.0 3.1 4.4 18.7 6.4 11.6 8.1 0.5 13.4 14.5 1.5 10.1 4.7 14.1 10.0 2.7 5.4 10.8 9.1 2.8 7.4 2.3 23.5 6.7 13.2 3.3 3.3 10.4 2.3 11.1 30.0 4.5 4.7 3.0 5.6 5.8 5.6 6.5 5.7 1.5 7.9 6.1 3.8 29.3 5.8 5.1 1.6 6.4 6.4 11.4 16.3 10.8 7.2 9.4 18.1 15.1 10.5 0.2 24.3 8.4 11.7 6.4 5.1 7.9 10.8 5.4 9.1 7.1 6.0 5.7 6.1 6.3 5.6 IMPAD1 "FLJ20421, gPAPP, IMPA3" ENSG00000104331 "Inositol monophosphatase domain containing 1" Q9NX62 8 56957933-56993844 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009411 Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" 560000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA009411: AB_1079138" "unprognostic (1.62e-2)" "unprognostic (7.89e-3)" "unprognostic (6.58e-2)" "unprognostic (6.42e-2)" "unprognostic (2.00e-1)" "unprognostic (8.59e-2)" "unprognostic (1.88e-1)" "unprognostic (1.67e-2)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (4.24e-3)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (1.68e-3)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" 30.6 33.9 17.8 13.9 23.7 9.6 17.6 23.6 33.1 24.7 17.7 30.9 17.8 11.7 23.2 15.2 17.7 15.6 18.0 25.2 19.9 21.6 21.3 32.6 16.5 10.3 23.6 21.1 16.0 25.2 30.4 20.4 23.3 27.2 28.8 16.2 25.2 28.7 22.5 41.4 13.4 12.3 23.0 21.7 13.0 14.7 19.0 19.5 12.0 24.4 18.1 13.0 17.2 14.9 1.9 2.0 6.1 4.6 6.8 2.4 0.6 17.1 14.3 11.0 11.3 33.9 23.3 15.2 26.1 25.4 18.7 16.4 7.1 12.2 10.7 20.0 27.7 14.1 13.3 17.6 27.9 14.7 9.5 20.9 10.1 12.7 21.1 13.2 14.9 18.7 17.7 16.8 27.4 24.8 9.0 19.5 20.5 9.1 16.1 8.0 8.2 5.3 11.3 9.9 12.1 19.5 10.2 4.3 12.0 14.6 18.1 14.8 16.1 9.7 20.7 25.4 14.7 25.0 18.7 20.2 16.8 11.5 34.8 11.1 15.6 2.9 1.9 1.1 2.0 1.2 1.6 1.3 1.3 1.2 1.4 1.9 1.5 2.4 6.1 6.8 4.6 2.0 0.9 0.6 17.8 23.7 23.6 33.1 19.9 21.6 23.6 21.1 27.2 19.5 IMPG2 "IPM200, RP56" ENSG00000081148 "Interphotoreceptor matrix proteoglycan 2" Q9BZV3 3 101222546-101320560 "Disease related genes, Predicted membrane proteins" "Heparin-binding, Receptor" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 72.1" "Low cell line specificity" "Detected in some" "Cancer enriched" "Detected in single" 12 "ovarian cancer: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008779, HPA015907" Enhanced "HPA008779: , HPA015907: " "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (1.28e-1)" "unprognostic (4.80e-5)" "unprognostic (6.66e-4)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (6.59e-2)" "unprognostic (7.51e-3)" "unprognostic (1.28e-1)" "unprognostic (4.50e-9)" "unprognostic (7.12e-2)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (6.08e-2)" 0.2 0.3 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.1 0.1 0.3 0.3 0.1 16.5 0.2 0.3 0.3 0.6 0.3 0.1 0.1 0.4 0.5 0.1 0.4 0.2 0.1 0.4 0.1 0.4 0.2 0.2 72.1 0.2 0.1 0.2 0.2 0.4 0.3 0.2 0.6 0.5 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.6 0.1 1.0 0.1 1.1 0.3 0.0 0.1 0.0 1.1 1.3 0.4 1.0 0.1 0.1 0.2 0.3 0.5 0.0 0.1 0.1 1.0 0.1 0.0 0.3 0.1 1.1 0.3 0.3 0.5 0.4 0.1 0.1 0.3 1.9 1.3 0.7 0.2 0.0 1.7 0.0 1.2 0.9 0.1 0.2 0.2 0.0 0.3 0.2 0.0 0.1 0.7 0.3 1.6 0.2 0.0 0.0 0.1 0.2 0.4 1.4 1.2 0.6 0.4 0.7 0.6 1.0 0.2 0.0 0.0 1.2 0.6 0.1 0.3 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.3 1.0 1.1 0.1 0.1 0.1 0.0 0.2 0.4 0.2 0.2 0.3 0.6 0.5 0.1 0.4 0.1 INO80C "C18orf37, FLJ38183, hIes6, IES6" ENSG00000153391 "INO80 complex subunit C" Q6PI98 18 35452230-35497991 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 65.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA049060 Approved Approved "Nucleoli fibrillar center" "Nucleoli fibrillar center" "HPA049060: AB_2680617" "unprognostic (3.40e-1)" "prognostic favourable (3.58e-4)" "unprognostic (2.29e-1)" "prognostic unfavourable (2.62e-5)" "unprognostic (5.56e-2)" "unprognostic (9.68e-2)" "unprognostic (1.72e-3)" "unprognostic (2.03e-1)" "unprognostic (3.32e-3)" "unprognostic (2.08e-3)" "unprognostic (2.61e-1)" "unprognostic (6.94e-3)" "unprognostic (1.18e-1)" "unprognostic (5.82e-2)" "unprognostic (1.44e-2)" "unprognostic (5.14e-3)" "unprognostic (5.38e-2)" 6.7 7.7 12.4 13.0 16.7 19.4 7.8 10.9 11.0 7.1 10.6 7.3 4.5 8.7 6.4 7.1 20.1 6.8 10.4 11.8 10.8 12.9 9.5 9.9 8.4 11.3 7.9 9.2 4.6 5.7 2.7 17.8 26.3 8.0 6.0 10.8 11.5 13.2 5.2 18.2 19.8 11.7 5.3 6.7 14.2 15.0 65.5 8.1 11.1 9.1 19.2 13.5 8.2 10.5 17.5 23.9 24.5 14.3 8.1 14.9 8.2 15.6 10.2 9.3 5.0 3.3 8.5 10.2 6.0 4.5 9.5 12.8 12.5 13.3 25.6 13.0 3.9 10.8 17.8 38.5 8.6 7.5 9.7 32.6 12.4 13.5 7.5 18.7 20.9 3.8 11.1 24.6 13.4 27.4 9.8 9.6 15.2 16.1 12.0 16.0 12.0 6.2 9.3 6.6 8.6 19.9 20.1 13.0 8.9 10.0 10.9 7.5 10.7 15.2 18.1 10.8 4.8 8.4 10.8 8.5 8.9 45.5 8.8 17.4 6.5 13.9 11.1 24.5 9.4 14.3 9.2 17.5 13.1 12.2 15.8 13.0 13.3 11.0 17.0 8.1 12.4 23.9 14.9 8.2 12.4 16.7 10.9 11.0 10.8 12.9 7.9 9.2 8.0 8.1 INPP5F "hSac2, KIAA0966, SAC2" ENSG00000198825 "Inositol polyphosphate-5-phosphatase F" Q9Y2H2 10 119726097-119829278 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.7" "Cell line enhanced" "Detected in many" "AF22: 36.0;SH-SY5Y: 28.5;SK-MEL-30: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042605 Supported Vesicles Vesicles "HPA042605: AB_10793886" "unprognostic (2.65e-2)" "unprognostic (3.23e-1)" "unprognostic (3.42e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-2)" "unprognostic (1.57e-3)" "unprognostic (2.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.09e-2)" "unprognostic (2.09e-1)" "unprognostic (6.46e-2)" "unprognostic (7.78e-2)" "unprognostic (1.02e-1)" "unprognostic (9.91e-2)" "unprognostic (2.96e-2)" "unprognostic (6.21e-2)" 4.6 12.3 17.5 5.9 50.4 3.2 5.7 37.0 52.9 10.9 5.0 5.5 2.2 3.1 11.8 18.0 4.5 4.2 5.5 4.1 24.6 53.1 7.3 2.0 4.2 7.6 23.7 29.1 9.8 4.6 8.9 34.0 8.2 69.7 8.3 6.1 3.4 7.1 8.4 7.5 10.4 3.8 10.8 19.2 4.1 3.8 10.1 7.3 1.4 8.4 1.4 9.3 5.3 4.5 12.2 7.4 1.5 4.5 3.8 6.7 2.2 4.6 3.3 36.0 5.2 3.9 4.0 3.1 6.5 3.6 3.1 3.0 4.8 5.9 3.0 2.5 8.1 5.2 3.9 3.8 4.7 1.9 3.6 2.0 1.6 4.8 5.5 1.3 6.7 4.8 3.5 6.1 6.1 10.4 1.8 4.8 7.3 2.6 1.8 5.4 3.4 4.1 2.4 6.4 0.8 5.2 2.4 2.6 28.5 7.2 2.2 54.3 1.5 1.4 6.9 3.1 4.1 4.0 6.3 5.4 2.4 1.4 3.9 4.6 12.6 1.1 4.0 1.5 1.3 3.5 1.6 8.1 2.8 1.9 7.4 12.2 3.2 1.4 1.0 3.8 4.5 1.8 6.7 2.2 17.5 50.4 37.0 50.5 24.6 53.1 23.7 29.1 69.7 7.3 INPP5J "INPP5, PIB5PA, PIPP" ENSG00000185133 "Inositol polyphosphate-5-phosphatase J" Q15735 22 31122731-31134696 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 65.2;thyroid gland: 71.2" "Cell line enhanced" "Detected in many" "HL-60: 12.1;SK-BR-3: 26.2;T-47d: 16.5;U-698: 11.4" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 63.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034539 Approved Nucleoli,Cytosol Cytosol Nucleoli "HPA034539: AB_10670974" "unprognostic (1.76e-1)" "unprognostic (2.09e-1)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" "unprognostic (1.68e-1)" "unprognostic (1.19e-2)" "unprognostic (2.21e-3)" "prognostic favourable (1.47e-5)" "unprognostic (6.81e-2)" "unprognostic (1.86e-2)" "unprognostic (4.29e-4)" "unprognostic (1.47e-1)" "prognostic favourable (1.12e-7)" "unprognostic (2.79e-3)" "unprognostic (3.65e-2)" "unprognostic (2.14e-1)" "unprognostic (1.39e-2)" 0.8 0.9 4.6 0.8 6.3 0.5 3.7 27.4 13.4 1.5 6.4 0.8 16.7 7.9 1.3 0.8 1.0 1.0 1.0 9.5 7.4 2.0 9.5 0.5 1.5 0.7 2.3 4.6 0.8 5.3 65.2 3.7 0.5 5.5 3.5 2.2 5.6 15.5 19.2 1.6 1.7 21.7 1.2 0.9 0.6 3.8 1.6 1.1 0.0 71.2 0.0 0.7 1.1 0.9 0.3 2.4 0.0 0.4 0.0 0.0 0.2 1.3 1.3 0.8 1.4 0.2 0.1 0.7 0.5 0.5 2.6 2.6 0.7 0.8 0.0 0.6 0.2 1.5 1.6 0.7 1.1 0.0 4.2 0.0 5.5 0.2 0.5 12.1 0.1 0.1 0.8 2.2 0.2 0.1 1.1 1.8 0.0 4.0 0.1 0.0 1.4 0.2 0.0 0.3 2.8 1.1 1.6 6.4 4.8 1.0 26.2 0.3 16.5 1.0 0.0 0.1 4.8 0.5 0.3 0.0 2.0 11.4 0.4 0.0 2.0 0.0 0.4 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.2 4.6 6.3 27.4 13.4 7.4 2.0 2.3 4.6 5.5 1.1 INSIG1 "CL-6, MGC1405" ENSG00000186480 "Insulin induced gene 1" O15503 7 155297776-155310235 "Plasma proteins, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.4;liver: 143.2" "Cell line enhanced" "Detected in many" "Karpas-707: 152.5;RPMI-8226: 71.5" "Cancer enhanced" "Detected in all" "liver cancer: 142.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "intermediate monocyte: 45.7;non-classical monocyte: 81.4" "Lineage enriched" "Detected in all" 6 "monocytes: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071524 Approved Vesicles Vesicles "HPA071524: " "unprognostic (8.11e-2)" "unprognostic (3.22e-1)" "unprognostic (2.91e-1)" "unprognostic (1.47e-1)" "unprognostic (9.23e-2)" "unprognostic (3.83e-2)" "unprognostic (2.05e-2)" "unprognostic (3.06e-1)" "unprognostic (1.60e-2)" "unprognostic (1.52e-1)" "unprognostic (4.64e-2)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-1)" "prognostic unfavourable (9.62e-4)" "unprognostic (4.97e-2)" 18.4 9.2 8.5 8.3 8.8 9.7 14.1 10.1 14.3 6.0 7.4 21.8 7.5 12.5 5.2 8.3 15.6 4.6 8.0 5.6 10.8 11.6 6.4 143.2 18.5 6.9 8.6 8.3 16.4 27.2 4.6 5.2 17.5 23.9 15.9 6.7 11.9 31.4 3.1 2.4 10.5 14.2 5.1 19.2 4.5 13.4 8.2 8.3 10.7 3.3 6.1 6.9 11.2 5.6 10.0 13.6 10.7 81.4 4.0 12.7 12.5 18.9 3.5 9.4 5.9 25.0 33.4 5.2 1.5 21.6 4.5 30.1 2.1 27.5 12.4 4.4 11.7 10.3 6.4 11.2 5.4 3.8 18.9 3.3 6.5 0.0 12.3 5.7 56.0 20.8 6.2 34.9 3.2 6.0 6.2 152.5 5.8 9.8 28.0 15.1 9.8 2.2 5.2 0.0 71.5 35.7 9.4 7.0 5.6 5.0 3.6 7.9 3.5 19.3 6.8 5.0 1.5 9.5 3.9 37.2 6.5 11.0 22.2 22.5 4.6 3.1 4.9 2.1 8.7 45.7 4.4 7.7 6.0 7.4 13.6 10.0 5.9 6.7 10.7 4.0 81.4 7.7 12.7 12.5 8.5 8.8 10.1 14.3 10.8 11.6 8.6 8.3 23.9 8.3 INSR CD220 ENSG00000171105 "Insulin receptor" P06213 19 7112255-7294034 "CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Carbohydrate metabolism" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 64.5" "Cell line enhanced" "Detected in many" "Karpas-707: 30.6;U-266/70: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036302, HPA036303" Uncertain Approved "Vesicles,Plasma membrane" 72000 Vesicles "Plasma membrane" "HPA036302: , HPA036303: " "unprognostic (4.64e-2)" "unprognostic (2.42e-1)" "unprognostic (9.65e-3)" "unprognostic (9.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.15e-2)" "unprognostic (2.58e-1)" "unprognostic (5.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.05e-1)" "unprognostic (9.29e-2)" "unprognostic (1.86e-1)" "unprognostic (6.33e-2)" "unprognostic (3.45e-3)" "unprognostic (2.43e-1)" "unprognostic (2.75e-1)" "unprognostic (8.82e-2)" 13.9 14.7 7.1 3.5 8.2 4.5 12.0 12.0 8.2 10.3 15.2 11.7 10.6 8.4 15.5 6.1 4.7 13.1 7.7 17.7 6.4 5.8 18.7 32.5 5.3 2.2 10.1 4.9 28.3 64.5 11.6 11.6 26.2 8.0 10.5 8.9 11.0 12.0 10.6 15.1 7.3 16.0 10.6 6.8 47.3 8.7 6.9 9.7 2.2 17.1 5.0 3.2 11.3 16.0 1.1 8.8 5.1 10.5 0.8 0.7 1.3 3.7 2.1 1.9 2.9 10.6 3.7 6.4 2.1 1.9 1.2 1.2 5.3 4.3 4.7 5.3 3.8 1.0 4.6 0.9 0.7 0.0 3.7 0.0 1.5 11.5 4.6 2.2 3.8 5.7 2.4 0.1 2.8 2.1 5.7 30.6 0.9 1.7 1.6 3.8 1.8 3.3 16.3 1.1 4.1 0.1 15.5 3.7 2.8 3.8 2.0 2.1 0.9 10.8 2.0 2.2 1.4 4.7 2.8 22.6 12.3 10.9 2.6 3.8 0.0 2.0 8.2 5.1 0.2 7.8 0.3 0.8 0.3 0.1 8.8 1.1 0.7 0.1 1.7 0.8 10.5 7.4 0.0 1.3 7.1 8.2 12.0 8.2 6.4 5.8 10.1 4.9 8.0 9.7 INSRR IRR ENSG00000027644 "Insulin receptor related receptor" P14616 1 156840063-156859018 "Enzymes, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.5;brain: 5.9;kidney: 8.3" "Group enriched" "Detected in some" 7 "SCLC-21H: 5.4;SH-SY5Y: 18.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA025285 Uncertain "HPA025285: AB_1851814" "unprognostic (1.19e-1)" "unprognostic (7.69e-2)" "unprognostic (2.42e-2)" "unprognostic (6.76e-4)" "unprognostic (1.51e-1)" "unprognostic (9.07e-3)" "unprognostic (5.57e-2)" "unprognostic (1.75e-1)" "unprognostic (6.17e-2)" "unprognostic (5.57e-2)" "unprognostic (2.20e-2)" "unprognostic (7.00e-2)" "unprognostic (4.22e-5)" "unprognostic (2.82e-1)" "unprognostic (9.55e-2)" "unprognostic (2.75e-3)" "unprognostic (3.66e-2)" 0.9 5.5 0.0 0.3 5.9 0.1 0.8 1.9 1.4 1.9 0.1 0.0 0.0 0.1 2.7 0.1 0.1 0.6 0.3 1.9 0.5 1.3 8.3 0.1 0.1 0.4 0.8 0.6 0.3 0.9 0.1 1.7 0.4 5.6 2.7 0.1 2.1 0.6 0.5 0.4 0.1 0.2 0.3 0.0 0.2 3.0 4.2 0.4 0.3 0.3 0.0 0.8 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.4 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 1.9 1.4 0.5 1.3 0.8 0.6 5.6 0.4 INTS14 "C15orf44, DKFZP564O1664, VWA9" ENSG00000138614 "Integrator complex subunit 14" Q96SY0 15 65578753-65611289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040255, HPA040651" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria" "Nucleoplasm, Nuclear bodies, Mitochondria" "Nuclear membrane" "HPA040255: AB_10805710, HPA040651: AB_10796559" "unprognostic (2.92e-1)" "unprognostic (3.01e-1)" "unprognostic (2.78e-1)" "unprognostic (2.41e-1)" "unprognostic (4.06e-1)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (5.60e-2)" "unprognostic (2.57e-2)" "unprognostic (2.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.92e-2)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (1.30e-1)" 16.6 20.2 12.1 14.1 14.9 13.1 20.2 12.0 19.1 20.1 20.0 20.8 17.3 12.3 25.5 25.3 19.6 22.3 18.4 12.4 11.3 12.9 22.7 23.2 14.4 17.5 14.1 10.4 20.2 22.0 16.1 23.5 23.5 13.9 18.9 21.6 19.9 27.5 21.7 11.8 17.5 19.9 17.0 11.9 23.5 17.5 19.7 9.9 32.4 26.1 16.1 24.0 17.7 16.2 13.4 13.6 12.9 8.6 14.8 20.3 10.4 12.1 22.0 22.2 17.7 12.4 15.6 14.3 13.4 17.4 22.4 20.8 19.6 28.8 19.9 18.9 16.7 24.7 47.3 22.6 19.8 17.4 28.7 17.3 16.4 21.2 24.7 17.7 22.3 15.1 22.5 17.0 26.2 24.2 23.7 11.6 15.7 19.3 20.1 17.1 16.2 12.2 17.3 18.7 22.8 17.4 22.7 16.0 12.7 16.2 16.5 22.4 15.4 20.7 11.8 15.5 16.3 13.8 21.2 11.5 21.4 26.9 15.6 32.4 18.0 12.9 7.5 3.9 14.3 8.6 16.2 13.4 14.8 16.3 13.6 10.5 15.7 14.3 0.8 14.8 6.2 12.0 20.3 10.4 12.1 14.9 12.0 19.1 11.3 12.9 14.1 10.4 13.9 9.9 ISLR2 KIAA1465 ENSG00000167178 "Immunoglobulin superfamily containing leucine rich repeat 2" Q6UXK2 15 74100311-74138540 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;testis: 11.6" "Group enriched" "Detected in some" 12 "SCLC-21H: 26.9;SH-SY5Y: 40.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012930, HPA067333" Uncertain 66000 "HPA012930: , HPA067333: " "unprognostic (1.31e-2)" "unprognostic (3.27e-3)" "unprognostic (1.44e-2)" "unprognostic (8.65e-3)" "unprognostic (1.53e-3)" "unprognostic (7.73e-2)" "unprognostic (6.64e-2)" "unprognostic (1.46e-2)" "unprognostic (9.19e-3)" "unprognostic (1.72e-1)" "unprognostic (2.94e-2)" "unprognostic (2.46e-1)" "unprognostic (2.44e-4)" "unprognostic (1.31e-2)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" 1.6 2.1 7.5 1.0 16.8 0.4 1.5 2.0 25.9 2.4 1.2 0.1 0.0 1.1 3.9 0.6 1.2 2.0 1.6 6.3 3.5 4.8 0.5 0.5 1.2 2.6 0.7 7.2 0.6 1.3 1.3 0.6 0.6 1.7 0.7 0.9 3.0 0.9 1.1 3.0 1.0 2.0 1.8 0.3 1.5 1.0 11.6 3.4 0.0 0.7 2.1 0.6 0.9 0.4 1.1 0.9 2.5 0.7 0.5 0.4 0.2 0.0 0.1 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 26.9 40.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 1.5 0.7 0.2 0.4 0.3 0.2 0.5 0.3 0.2 0.2 1.1 0.4 0.4 2.5 0.5 0.4 0.9 0.2 0.2 7.5 16.8 2.0 20.3 3.5 4.8 0.7 7.2 1.7 3.4 ITFG1 "CDA08, LNKN-1, TIP" ENSG00000129636 "Integrin alpha FG-GAP repeat containing 1" Q8TB96 16 47154387-47464149 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015590, HPA019728" Approved Approved "Intermediate filaments,Aggresome" "Intracellular and membrane" 21000 "Intermediate filaments" Aggresome "HPA015590: AB_1846347, HPA019728: AB_1846348" "unprognostic (6.53e-3)" "unprognostic (9.26e-3)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.27e-1)" "unprognostic (1.39e-3)" "unprognostic (3.70e-2)" "unprognostic (9.32e-2)" "unprognostic (2.47e-1)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "prognostic favourable (1.95e-8)" "unprognostic (1.56e-2)" "unprognostic (1.61e-1)" "unprognostic (3.28e-2)" "unprognostic (4.62e-3)" 14.0 26.6 19.9 8.8 52.4 6.4 15.0 31.2 34.6 18.3 20.0 14.8 9.8 17.3 17.5 19.0 11.5 15.8 17.1 26.0 20.7 26.6 28.7 26.5 15.8 11.0 17.0 19.0 17.4 20.2 43.0 22.9 30.7 28.7 17.9 19.9 13.8 15.1 18.1 14.6 10.8 19.4 17.4 17.6 12.4 16.0 20.7 15.7 13.4 25.8 7.6 11.5 15.3 11.6 12.8 18.7 23.4 24.4 16.6 18.3 17.7 8.1 9.6 17.5 12.1 34.3 26.5 20.9 20.0 28.5 18.2 9.7 5.5 20.1 10.0 27.2 24.6 12.3 8.5 12.7 18.1 4.3 5.9 5.3 9.2 12.7 16.0 12.4 23.3 19.4 22.2 9.2 12.1 17.4 14.9 13.2 22.7 8.0 7.7 5.8 5.6 9.4 11.7 17.3 24.8 24.1 6.1 8.6 12.1 18.1 21.0 8.8 9.2 11.4 16.8 19.4 9.5 10.3 7.6 18.6 24.4 18.6 19.3 7.9 15.1 13.5 24.4 23.4 12.4 23.8 12.0 12.8 15.4 13.7 18.7 11.4 16.9 14.1 15.4 16.6 21.9 13.0 18.3 17.7 19.9 52.4 31.2 34.6 20.7 26.6 17.0 19.0 28.7 15.7 ITGA1 "CD49a, VLA1" ENSG00000213949 "Integrin subunit alpha 1" P56199 5 52787896-52959210 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 21.0;HHSteC: 25.8;WM-115: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.8" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;T-cells: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042555 Uncertain 2300000 "HPA042555: AB_10794281" "unprognostic (1.48e-1)" "unprognostic (1.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (1.38e-1)" "unprognostic (9.89e-3)" "unprognostic (2.74e-1)" "unprognostic (1.72e-1)" "unprognostic (1.79e-3)" "unprognostic (1.50e-2)" "unprognostic (2.62e-1)" "unprognostic (9.86e-2)" "prognostic unfavourable (2.24e-4)" "unprognostic (3.13e-3)" "unprognostic (2.06e-2)" "unprognostic (1.07e-2)" "unprognostic (1.62e-2)" 22.6 20.2 2.3 12.7 2.7 0.0 12.4 1.2 2.9 10.9 28.2 1.5 13.6 5.3 15.9 12.5 22.3 9.2 13.9 11.1 2.5 2.2 17.9 40.4 28.8 10.2 3.1 1.4 9.6 3.3 11.5 3.0 24.8 3.3 26.1 8.2 5.9 2.9 18.2 9.7 2.4 13.5 52.8 2.7 66.0 16.8 4.1 1.6 0.6 10.7 3.5 2.2 42.7 17.8 0.0 0.1 1.2 0.3 0.0 1.8 0.1 0.0 0.0 2.0 0.0 5.8 1.7 1.2 2.7 7.2 1.6 4.8 3.7 0.3 0.0 0.9 21.0 1.4 0.4 2.3 1.5 0.0 1.5 0.0 3.4 2.7 25.8 0.0 0.0 3.9 0.2 1.9 0.7 0.3 0.0 0.0 2.4 0.0 0.8 0.0 1.1 0.7 0.0 1.9 0.0 3.1 0.0 0.1 9.1 2.7 0.6 0.6 0.0 0.0 2.1 4.4 0.4 0.1 1.4 0.0 0.0 0.0 2.8 0.0 19.1 0.0 0.3 1.1 0.1 0.0 0.0 0.0 0.6 1.8 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.1 0.1 2.3 2.7 1.2 2.9 2.5 2.2 3.1 1.4 3.3 1.6 ITGA11 HsT18964 ENSG00000137809 "Integrin subunit alpha 11" Q9UKX5 15 68296533-68432162 "Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 41.9;endometrium 1: 59.6;smooth muscle: 30.2" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 66.9;U-138 MG: 46.5;WM-115: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Region enriched" "Detected in single" 4 "basal ganglia: 6.1" HPA051813 Uncertain 42000 "HPA051813: " "unprognostic (4.85e-2)" "unprognostic (3.51e-1)" "unprognostic (6.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-2)" "unprognostic (9.29e-3)" "unprognostic (6.63e-2)" "unprognostic (5.68e-3)" "unprognostic (3.36e-1)" "prognostic unfavourable (3.22e-7)" "unprognostic (8.38e-3)" "unprognostic (2.28e-4)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" 4.5 2.9 0.4 3.5 0.9 0.0 2.9 0.5 3.6 41.9 1.5 0.9 3.5 0.6 59.6 11.4 2.6 8.0 3.4 9.0 0.5 0.5 4.9 0.7 1.3 0.5 0.8 0.5 15.7 0.8 0.2 1.5 2.2 1.3 4.5 1.4 1.5 0.9 8.9 1.9 2.1 1.6 30.2 0.9 4.0 1.3 3.4 0.7 0.2 1.8 5.8 0.7 5.6 7.4 1.7 1.3 1.8 1.0 0.8 1.5 0.1 0.0 0.0 0.1 0.2 2.2 0.0 0.0 4.4 8.6 1.0 0.3 0.0 0.0 0.0 0.3 66.9 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.6 0.0 5.9 0.0 3.7 0.8 0.0 1.9 0.1 0.0 0.0 0.0 11.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 2.7 46.5 0.3 0.9 0.0 0.0 0.0 0.0 6.9 0.0 25.8 1.6 1.0 0.9 1.2 0.9 1.5 0.8 1.1 1.0 0.7 1.7 1.3 1.2 1.8 0.8 0.8 1.3 1.0 0.1 0.4 0.9 0.5 3.6 0.5 0.5 0.8 0.5 1.3 0.7 ITGA2 CD49b ENSG00000164171 "Integrin subunit alpha 2" P17301 5 52989326-53094779 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 30.1;HaCaT: 30.4;HUVEC TERT2: 28.0;TIME: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB017690, HPA060991, HPA063556" Enhanced Approved Nucleoplasm,Cytosol 46000000 Nucleoplasm Cytosol "CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "unprognostic (3.70e-2)" "unprognostic (2.67e-3)" "unprognostic (2.38e-2)" "unprognostic (1.87e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (1.02e-5)" "unprognostic (4.27e-1)" "unprognostic (3.88e-2)" "unprognostic (2.87e-2)" "unprognostic (1.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.11e-1)" 1.9 14.0 2.9 4.7 13.4 0.4 7.9 1.8 6.8 7.1 6.5 22.5 12.1 7.6 5.1 10.4 16.7 2.8 9.3 2.5 5.4 3.6 15.1 1.8 17.2 1.4 18.3 4.5 1.8 2.7 16.1 2.5 4.8 10.7 8.5 6.0 0.8 15.8 16.8 1.2 16.9 17.0 2.5 8.4 9.1 7.4 1.3 13.0 1.5 2.5 7.4 10.0 7.5 11.1 0.5 1.5 1.7 0.6 0.2 0.6 0.3 19.5 5.0 0.4 0.2 1.3 2.4 1.5 19.8 30.1 0.7 1.2 9.4 13.8 0.0 3.4 8.4 30.4 1.6 22.2 2.9 0.0 1.5 1.4 1.3 5.6 4.6 0.2 0.4 1.0 3.9 19.9 3.5 28.0 0.0 0.0 0.5 3.6 0.2 0.0 1.2 10.1 0.0 0.1 0.0 6.3 10.4 0.2 1.1 1.0 1.3 2.0 3.2 0.0 23.9 3.6 2.1 0.5 3.9 0.0 0.0 0.0 21.8 0.0 15.9 1.7 0.6 0.2 0.6 0.2 0.4 0.4 0.5 0.5 0.1 0.5 0.5 0.6 0.8 0.2 0.1 1.5 0.4 0.3 2.9 13.4 1.8 6.8 5.4 3.6 18.3 4.5 10.7 13.0 ITGA2B "CD41, CD41B, GP2B, PPP1R93" ENSG00000005961 "Integrin subunit alpha 2b" P08514 17 44372180-44389505 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8" "Group enriched" "Detected in some" 13 "HEL: 69.4;HMC-1: 118.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "basophil: 28.5" "Lineage enriched" "Detected in single" 54 "granulocytes: 28.5" "Low region specificity" "Detected in single" "CAB018611, HPA031168, HPA031169, HPA031170, HPA031171" Enhanced Approved "Plasma membrane" 1100000000 "Plasma membrane" "CAB018611: AB_2265153, HPA031168: AB_10670151, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773" "unprognostic (6.11e-2)" "unprognostic (3.23e-2)" "unprognostic (1.23e-1)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "unprognostic (3.98e-3)" "unprognostic (4.23e-5)" "unprognostic (1.25e-1)" "unprognostic (1.33e-2)" "unprognostic (7.22e-2)" "unprognostic (2.97e-3)" "unprognostic (1.30e-1)" "unprognostic (8.83e-9)" "unprognostic (7.82e-2)" "unprognostic (1.85e-1)" "unprognostic (1.95e-1)" "unprognostic (2.25e-1)" 0.7 0.2 1.4 0.4 1.0 15.2 0.6 3.8 2.4 1.2 0.9 0.4 0.4 0.1 1.1 25.2 0.7 1.9 1.4 10.6 0.9 1.6 1.0 0.4 6.5 0.5 0.7 0.8 2.1 2.5 0.1 2.5 1.9 1.1 0.6 0.3 0.6 0.4 1.6 0.8 0.1 0.6 0.4 0.8 22.8 0.2 3.0 0.4 0.4 5.2 1.0 0.6 0.7 1.9 0.0 0.5 28.5 0.2 0.0 0.2 11.1 0.0 0.1 0.7 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 69.4 0.0 0.6 0.0 0.0 118.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 7.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 28.5 0.2 2.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 11.1 1.4 1.0 3.8 2.4 0.9 1.6 0.7 0.8 1.1 0.4 ITGA3 "CD49c, GAP-B3, MSK18, VCA-2, VLA3a" ENSG00000005884 "Integrin subunit alpha 3" P26006 17 50055968-50090481 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 74.7;hTERT-HME1: 64.9;RPTEC TERT1: 65.8;U-138 MG: 65.1;U-87 MG: 112.1;WM-115: 67.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.1" "Lineage enriched" "Detected in single" 4 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008572, CAB018594" Enhanced Supported "Plasma membrane" 180000 "Plasma membrane" "CAB018594: AB_668044, HPA008572: AB_2668094" "unprognostic (3.24e-3)" "prognostic unfavourable (6.75e-4)" "unprognostic (9.51e-2)" "unprognostic (3.46e-3)" "unprognostic (3.45e-3)" "prognostic unfavourable (1.36e-4)" "unprognostic (8.28e-3)" "unprognostic (2.76e-3)" "unprognostic (1.26e-3)" "unprognostic (1.82e-2)" "prognostic unfavourable (5.95e-5)" "unprognostic (7.05e-2)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (2.35e-2)" 15.7 15.8 4.1 8.6 5.1 0.1 8.7 7.7 6.5 10.9 20.9 2.3 8.9 17.1 11.6 11.6 12.8 14.5 32.6 8.4 4.2 5.4 36.0 1.7 37.6 3.2 3.2 6.7 10.7 8.0 13.0 11.2 26.4 4.3 12.0 8.9 11.6 10.0 9.7 6.6 17.3 37.3 11.6 3.3 6.5 13.7 3.9 1.5 3.3 36.1 13.3 8.3 19.0 8.1 0.2 0.0 0.0 0.0 0.0 1.1 0.2 20.5 27.2 0.1 0.8 0.5 2.1 4.4 9.6 20.8 14.6 11.1 0.6 32.1 0.0 60.9 7.0 14.6 0.2 74.7 8.9 2.5 0.4 0.0 6.9 0.1 12.9 0.0 0.6 2.6 36.9 14.6 64.9 10.7 0.0 0.3 27.4 5.9 0.0 0.0 0.6 16.5 0.0 1.4 1.5 65.8 35.8 1.1 0.4 10.5 1.4 24.1 2.4 0.2 23.1 65.1 20.5 0.6 37.5 0.9 1.5 0.6 112.1 0.2 67.6 0.0 0.0 0.0 0.8 0.0 1.0 0.2 0.1 0.1 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 1.1 0.2 4.1 5.1 7.7 6.5 4.2 5.4 3.2 6.7 4.3 1.5 ITGA4 CD49d ENSG00000115232 "Integrin subunit alpha 4" P13612 2 181457202-181536187 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.4;lymphoid tissue: 101.6" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.7;HEL: 61.5;MOLT-4: 71.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 26.0" HPA074961 Approved "Plasma membrane" "Intracellular and membrane" 100000 "Plasma membrane" "HPA074961: " "unprognostic (5.31e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-2)" "unprognostic (3.94e-2)" "unprognostic (3.76e-1)" "prognostic favourable (8.29e-4)" "unprognostic (1.27e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-2)" "unprognostic (1.85e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (3.08e-5)" "unprognostic (2.26e-2)" "unprognostic (8.64e-3)" "unprognostic (2.49e-1)" "unprognostic (2.57e-2)" 3.8 1.7 1.3 39.7 1.1 19.2 3.2 2.4 1.9 6.7 4.8 0.5 1.1 3.8 3.0 3.1 2.9 2.1 6.9 1.7 2.9 1.3 3.0 2.5 13.6 33.7 1.2 0.5 1.8 1.6 0.0 1.3 7.1 0.9 3.8 4.9 2.9 7.5 2.0 1.0 1.5 11.6 2.4 1.6 36.0 4.4 1.2 0.2 101.6 2.6 1.5 14.3 6.0 4.1 11.0 19.1 38.4 38.3 8.8 15.9 16.2 0.0 0.2 1.0 0.0 9.1 13.8 0.0 8.9 11.2 4.8 10.1 0.0 0.0 7.1 0.0 38.7 5.3 3.1 0.1 5.8 0.0 0.7 61.5 0.2 0.0 0.9 27.2 1.5 9.8 0.0 0.3 0.0 0.4 0.0 10.4 3.0 0.0 71.7 19.1 0.8 0.0 15.7 4.5 1.0 0.0 0.0 1.6 0.6 0.0 0.0 0.3 0.0 18.0 4.8 1.5 0.9 0.1 1.8 20.4 15.1 4.0 0.8 13.5 20.6 6.7 16.2 38.4 12.9 38.3 9.7 11.0 14.6 15.9 19.1 10.0 8.5 10.4 2.1 8.8 37.5 5.0 3.7 16.2 1.3 1.1 2.4 1.9 2.9 1.3 1.2 0.5 0.9 0.2 ITGA5 "CD49e, FNRA" ENSG00000161638 "Integrin subunit alpha 5" P08648 12 54395261-54419460 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 137.7" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 140.8;TIME: 134.1;U-87 MG: 66.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 31.5" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 7 "basal ganglia: 9.3" "Low region specificity" "Detected in some" "HPA002642, CAB009008" Enhanced 23000000 "CAB009008: AB_647474, HPA002642: AB_1078469" "unprognostic (7.51e-3)" "prognostic unfavourable (4.07e-6)" "prognostic unfavourable (8.43e-4)" "unprognostic (1.58e-1)" "unprognostic (8.51e-3)" "prognostic unfavourable (2.91e-4)" "prognostic unfavourable (2.23e-5)" "prognostic unfavourable (2.44e-4)" "unprognostic (2.76e-2)" "unprognostic (6.19e-2)" "unprognostic (8.99e-2)" "unprognostic (8.28e-2)" "prognostic unfavourable (1.32e-8)" "unprognostic (2.11e-3)" "unprognostic (3.35e-2)" "prognostic unfavourable (8.89e-4)" "unprognostic (2.18e-3)" 23.3 7.9 2.1 32.2 2.8 9.2 30.5 1.2 2.2 16.0 66.9 2.2 19.0 3.4 19.3 13.8 18.2 12.0 12.4 20.3 2.9 0.8 4.6 15.2 20.4 9.2 3.2 1.2 13.6 5.3 3.7 1.8 57.7 3.3 26.6 10.2 4.9 4.4 28.9 10.0 8.8 14.9 137.7 3.5 3.1 19.7 6.6 2.5 3.0 7.3 5.8 4.5 82.1 20.6 0.1 22.2 31.5 22.9 9.1 5.6 12.4 6.6 2.4 4.6 0.0 14.3 30.5 12.0 30.0 31.2 30.9 22.8 1.6 1.5 0.0 21.9 31.3 1.0 1.2 8.3 21.4 0.0 1.2 2.9 3.3 0.1 19.8 9.0 4.6 22.0 4.1 36.2 27.9 140.8 2.4 0.0 17.5 0.6 1.3 10.1 1.8 1.9 1.4 3.1 0.6 4.9 0.1 0.0 0.0 6.0 0.4 0.2 0.7 8.1 134.1 37.6 6.7 9.2 12.4 0.0 0.3 0.0 66.9 8.6 12.2 5.6 22.9 0.1 5.6 10.0 4.4 0.0 4.2 4.2 22.2 0.1 3.1 2.6 31.5 9.1 7.6 1.2 1.7 12.4 2.1 2.8 1.2 2.2 2.9 0.8 3.2 1.2 3.3 2.5 ITGA6 CD49f ENSG00000091409 "Integrin subunit alpha 6" P23229 2 172427354-172506282 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 50.1;HaCaT: 55.2;HBEC3-KT: 108.5;hTCEpi: 47.3;hTERT-HME1: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 16.2" "Group enriched" "Detected in many" 34 "granulocytes: 16.2;NK-cells: 5.5;T-cells: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009009, HPA012696, HPA027582" Enhanced 45000000 "CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (2.59e-2)" "unprognostic (5.96e-2)" "unprognostic (4.93e-2)" "prognostic unfavourable (1.03e-4)" "unprognostic (1.19e-1)" "unprognostic (1.61e-3)" "unprognostic (9.34e-2)" "unprognostic (6.01e-2)" "unprognostic (1.85e-3)" "unprognostic (1.84e-1)" "prognostic favourable (2.35e-11)" "unprognostic (3.35e-2)" "unprognostic (3.32e-1)" "unprognostic (2.98e-2)" "unprognostic (1.21e-3)" 28.0 3.1 9.8 19.1 10.5 1.6 30.1 3.0 8.4 27.0 34.9 9.4 42.3 28.5 28.2 11.3 17.0 11.1 23.8 21.7 9.7 8.2 22.0 4.9 29.0 14.9 9.8 5.1 7.6 31.3 7.4 4.9 38.7 12.6 14.3 25.2 17.6 37.1 32.4 13.5 17.5 44.2 15.2 9.6 14.9 25.0 12.4 6.9 15.1 11.5 35.2 13.2 24.1 17.3 0.3 0.1 16.2 0.2 5.5 10.0 3.3 11.4 9.8 4.3 7.7 0.2 0.1 23.6 50.1 5.4 5.1 3.2 5.5 22.0 0.1 14.1 13.3 55.2 2.8 108.5 9.3 0.1 2.6 0.2 10.5 9.1 0.7 3.1 0.3 1.0 47.3 0.3 48.1 32.8 0.0 0.8 6.4 0.5 0.8 2.7 7.8 8.4 0.1 12.8 0.2 7.8 16.1 0.1 0.5 9.2 0.0 10.7 2.0 0.2 14.7 7.2 6.5 13.2 8.6 0.7 0.5 0.3 0.2 1.1 28.9 2.6 0.2 16.2 4.2 0.0 8.5 0.2 5.4 5.0 0.1 0.3 10.0 4.6 0.5 5.5 0.0 0.0 5.7 3.3 9.8 10.5 3.0 8.4 9.7 8.2 9.8 5.1 12.6 6.9 ITGA7 ENSG00000135424 "Integrin subunit alpha 7" Q13683 12 55684568-55716043 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Cell shape" "Integrin, Receptor" "Congenital muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 66.4;skeletal muscle: 81.3" "Cell line enhanced" "Detected in many" "ASC diff: 29.5;hTEC/SVTERT24-B: 27.9;LHCN-M2: 16.9;SK-MEL-30: 20.4;U-87 MG: 25.2" "Cancer enhanced" "Detected in all" "glioma: 35.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008427 Uncertain Approved "Nuclear speckles,Vesicles,Plasma membrane" 770000 "Plasma membrane" "Nuclear speckles, Vesicles" "HPA008427: AB_1851823" "unprognostic (4.71e-2)" "unprognostic (1.55e-1)" "unprognostic (2.00e-3)" "unprognostic (3.02e-3)" "unprognostic (2.50e-1)" "unprognostic (2.36e-1)" "unprognostic (1.66e-2)" "unprognostic (2.20e-1)" "unprognostic (2.20e-2)" "unprognostic (3.57e-1)" "prognostic favourable (1.75e-4)" "unprognostic (2.85e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-1)" "unprognostic (5.10e-1)" "unprognostic (2.98e-2)" "prognostic unfavourable (9.59e-5)" 46.2 3.4 6.1 7.2 6.8 0.9 20.6 3.6 7.6 6.3 22.4 5.7 5.9 6.6 15.1 13.5 11.6 12.9 14.8 66.4 7.8 2.6 3.1 4.1 3.4 2.9 3.9 7.6 5.1 1.9 3.4 3.1 1.0 5.7 8.9 3.7 5.6 3.3 14.6 81.3 3.6 7.2 33.3 4.5 2.4 10.3 2.9 5.3 0.2 6.5 10.6 2.2 13.6 14.1 0.5 1.7 0.0 1.0 0.0 0.8 0.3 0.1 1.7 3.2 5.2 29.5 5.9 0.3 2.2 3.7 5.0 5.2 3.5 2.8 0.9 3.2 1.4 0.4 2.2 0.1 4.5 0.1 1.6 0.3 1.1 1.3 0.2 0.1 1.1 8.3 0.0 27.9 0.1 0.0 0.4 0.6 16.9 2.1 0.1 1.2 9.0 0.2 0.0 12.2 0.2 0.1 0.0 0.4 1.2 0.2 0.0 20.4 0.3 5.7 0.0 0.5 5.5 0.3 3.5 1.3 0.9 0.3 25.2 3.4 0.3 0.0 0.7 0.0 0.4 1.0 0.0 0.1 0.0 0.8 1.7 0.5 0.3 0.4 0.0 0.0 1.0 0.6 0.0 0.3 6.1 6.8 3.6 7.6 7.8 2.6 3.9 7.6 5.7 5.3 ITGA8 ENSG00000077943 "Integrin subunit alpha 8" P53708 10 15513949-15720125 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein, Integrin, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 7.7;HMC-1: 18.5;HSkMC: 8.2;U-266/84: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003432 Approved 110000 "HPA003432: AB_1851825" "unprognostic (2.15e-1)" "unprognostic (1.22e-3)" "unprognostic (1.05e-2)" "unprognostic (2.03e-1)" "unprognostic (1.25e-2)" "unprognostic (8.44e-4)" "unprognostic (2.23e-1)" "unprognostic (6.13e-3)" "unprognostic (6.82e-2)" "unprognostic (3.80e-1)" "unprognostic (2.54e-2)" "unprognostic (1.27e-1)" "unprognostic (4.10e-3)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.03e-2)" 7.1 7.8 2.3 2.4 1.9 0.1 3.1 1.4 3.7 36.1 5.5 1.5 4.1 4.8 17.9 22.8 12.4 7.1 10.7 10.3 3.0 1.6 7.4 0.8 22.1 3.7 1.7 2.6 17.0 0.8 0.7 3.3 0.2 2.9 28.3 4.6 18.8 3.0 22.9 3.3 3.1 4.9 21.2 1.5 17.0 19.4 12.1 1.2 0.0 5.3 5.5 4.3 21.3 10.8 0.2 0.2 0.6 0.4 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 7.7 2.3 0.0 0.0 0.0 0.0 18.5 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 8.4 0.0 0.0 0.0 1.6 0.6 0.0 0.2 0.2 0.4 0.2 0.2 0.3 0.3 0.0 0.2 0.5 0.5 0.5 0.2 0.4 0.2 0.8 0.0 2.3 1.9 1.4 3.7 3.0 1.6 1.7 2.6 2.9 1.2 ITGA9 "ALPHA-RLC, ITGA4L, RLC" ENSG00000144668 "Integrin subunit alpha 9" Q13797 3 37452115-37823514 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 4.6;CACO-2: 10.6;HEL: 8.5;HMC-1: 5.0;SH-SY5Y: 12.7;WM-115: 6.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030609 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Intracellular and membrane" 250000 Vesicles "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA030609: AB_10600815" "unprognostic (2.35e-2)" "unprognostic (3.36e-2)" "unprognostic (5.58e-2)" "unprognostic (3.94e-2)" "unprognostic (4.48e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (8.87e-3)" "unprognostic (3.23e-1)" "unprognostic (2.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-2)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-2)" "unprognostic (3.16e-2)" 8.5 15.5 3.1 5.3 3.7 5.8 9.6 1.6 5.7 17.9 11.1 2.9 5.8 4.6 17.3 7.5 12.3 6.9 17.8 25.0 4.5 2.0 4.6 13.6 8.3 16.8 3.4 2.7 7.5 2.1 2.4 3.0 7.3 2.6 10.0 5.3 8.4 4.7 8.7 3.7 3.5 8.7 16.2 4.0 30.5 10.9 10.2 2.7 1.0 35.4 7.2 3.6 7.4 8.4 0.0 0.7 2.1 0.2 0.0 0.0 0.4 0.2 0.0 4.6 0.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 10.6 0.0 3.4 1.5 0.0 0.2 4.1 0.0 0.0 0.1 0.6 8.5 0.2 0.2 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.3 0.0 0.2 0.6 12.7 0.1 0.6 0.7 0.0 3.3 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.2 6.6 2.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 3.1 3.7 1.6 5.7 4.5 2.0 3.4 2.7 2.6 2.7 ITGAD "ADB2, CD11d" ENSG00000156886 "Integrin subunit alpha D" Q13349 16 31393312-31426505 "CD markers, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 25.4" "Cell line enhanced" "Detected in single" "NB-4: 1.7" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;NK-cell: 2.6" "Group enriched" "Detected in many" 19 "NK-cells: 2.6;T-cells: 1.1" "Low region specificity" "Detected in many" HPA026786 Uncertain "HPA026786: AB_10603773" "unprognostic (2.79e-2)" "unprognostic (2.39e-4)" "unprognostic (2.88e-2)" "unprognostic (3.24e-2)" "unprognostic (6.17e-2)" "unprognostic (1.79e-2)" "unprognostic (7.44e-4)" "unprognostic (6.99e-3)" "unprognostic (6.89e-3)" "unprognostic (5.02e-4)" "unprognostic (5.50e-2)" "unprognostic (1.67e-1)" "unprognostic (1.74e-1)" "unprognostic (3.80e-2)" "unprognostic (3.17e-1)" "unprognostic (8.10e-2)" "unprognostic (5.51e-2)" 0.3 0.1 0.1 1.0 0.1 2.5 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 1.2 0.0 0.4 0.2 0.2 0.2 0.1 0.1 0.1 1.2 0.7 4.0 0.1 0.0 1.6 0.1 0.0 0.1 1.2 0.0 0.1 0.0 0.2 1.5 0.0 1.3 0.1 0.3 0.0 0.2 25.4 0.1 0.2 0.0 0.4 0.1 0.0 1.4 0.2 0.1 0.0 0.0 0.0 0.0 2.6 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.7 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.6 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 ITGAE "CD103, HUMINAE" ENSG00000083457 "Integrin subunit alpha E" P38570 17 3714628-3801243 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.2;lung: 25.9;lymphoid tissue: 13.0" "Cell line enriched" "Detected in single" 21 "MOLT-4: 15.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MAIT T-cell: 3.1;memory CD8 T-cell: 7.4;T-reg: 1.9" "Lineage enriched" "Detected in many" 7 "T-cells: 7.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB026461, HPA036313" Approved 13000 "CAB026461: , HPA036313: AB_10795355" "unprognostic (9.81e-2)" "unprognostic (1.78e-3)" "unprognostic (7.86e-2)" "prognostic favourable (1.04e-4)" "unprognostic (2.17e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-1)" "unprognostic (8.02e-2)" "unprognostic (2.92e-2)" "unprognostic (1.10e-1)" "prognostic favourable (5.78e-4)" "unprognostic (3.34e-2)" "prognostic unfavourable (1.13e-8)" "unprognostic (8.40e-3)" "unprognostic (1.15e-1)" "unprognostic (1.82e-2)" "prognostic favourable (3.56e-4)" 3.6 0.2 0.3 13.0 0.6 8.0 0.9 0.2 0.2 0.6 9.6 0.2 0.0 4.9 0.4 0.4 2.0 1.5 2.7 0.2 0.5 0.4 0.3 0.3 25.9 8.1 0.3 0.0 0.9 1.2 0.5 0.4 0.1 0.2 1.2 2.0 0.2 1.8 3.9 0.3 0.6 20.2 2.0 0.7 1.4 3.6 1.6 0.1 3.1 1.0 1.5 5.3 1.9 2.5 0.2 0.1 0.0 1.0 0.0 7.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.7 15.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 1.0 3.1 0.2 1.0 7.4 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.9 0.9 0.3 0.6 0.2 0.2 0.5 0.4 0.3 0.0 0.2 0.1 ITGAL "CD11A, LFA-1" ENSG00000005844 "Integrin subunit alpha L" P20701 16 30472658-30523185 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Integrin, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.7;lymphoid tissue: 74.6" "Cell line enriched" "Detected in some" 4 "HMC-1: 119.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" CAB025011 Enhanced "Intracellular and membrane" 1100000 "CAB025011: " "unprognostic (1.10e-2)" "unprognostic (4.26e-3)" "unprognostic (3.72e-3)" "prognostic favourable (5.63e-5)" "unprognostic (2.88e-1)" "prognostic favourable (3.34e-4)" "unprognostic (1.63e-1)" "unprognostic (5.69e-3)" "prognostic favourable (5.57e-4)" "unprognostic (3.37e-2)" "unprognostic (4.98e-2)" "unprognostic (1.84e-1)" "prognostic unfavourable (2.69e-5)" "unprognostic (2.89e-1)" "unprognostic (3.05e-2)" "unprognostic (1.39e-1)" "unprognostic (1.71e-2)" 2.8 1.1 1.8 29.8 2.0 15.1 1.8 0.6 1.5 1.3 3.0 2.7 0.5 2.4 1.7 1.4 2.2 2.6 4.9 1.4 1.3 1.3 2.6 6.7 16.2 29.0 3.1 1.4 1.4 1.2 0.0 1.4 1.7 1.7 2.0 3.4 1.9 6.6 0.7 0.8 1.0 12.7 1.4 4.7 44.1 3.5 0.8 2.7 74.6 2.8 2.0 41.8 4.4 1.9 2.1 7.5 7.2 36.7 9.5 22.5 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 119.0 0.0 0.0 0.0 0.0 0.0 0.0 26.7 0.0 0.0 7.9 0.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 4.2 0.0 0.0 0.0 0.0 0.0 7.5 2.5 0.0 0.1 0.8 0.0 3.1 8.4 6.5 22.5 16.9 11.2 2.1 8.8 16.2 7.5 1.3 4.9 11.4 7.2 9.5 36.7 3.0 6.3 11.5 1.8 2.0 0.6 1.5 1.3 1.3 3.1 1.4 1.7 2.7 ITGAM "CD11b, CR3A, MAC-1" ENSG00000169896 "Integrin subunit alpha M" P11215 16 31259990-31332892 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Innate immunity" "Integrin, Receptor" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 93.7" "Group enriched" "Detected in some" 4 "HMC-1: 32.7;NB-4: 11.6;U-937: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 29.4;classical monocyte: 19.1;eosinophil: 23.8;gdT-cell: 12.2;intermediate monocyte: 7.6;neutrophil: 21.0;NK-cell: 18.8" "Low lineage specificity" "Detected in all" "HPA002274, CAB025091, CAB072870" Enhanced 900000 "CAB025091: , CAB072870: , HPA002274: AB_1078435" "unprognostic (1.82e-2)" "unprognostic (1.70e-2)" "unprognostic (8.78e-2)" "unprognostic (2.54e-2)" "unprognostic (2.40e-2)" "unprognostic (4.20e-2)" "prognostic unfavourable (3.43e-4)" "unprognostic (1.86e-1)" "unprognostic (1.73e-1)" "unprognostic (3.29e-3)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "prognostic unfavourable (6.93e-5)" "unprognostic (9.89e-2)" "prognostic unfavourable (6.93e-4)" "unprognostic (3.99e-2)" "unprognostic (5.03e-2)" 19.7 5.0 6.0 14.0 7.2 93.7 6.0 2.0 4.5 2.9 3.2 9.4 0.5 1.8 2.5 3.5 2.2 4.8 4.0 6.5 4.3 3.9 3.0 3.3 14.6 22.8 10.5 1.6 2.5 2.9 1.6 1.8 4.9 5.3 3.6 2.7 3.3 3.2 2.0 1.6 1.5 4.4 6.9 8.6 29.9 2.8 1.5 7.4 2.3 2.1 1.7 6.6 4.9 4.5 1.9 3.4 29.4 19.1 18.8 12.2 8.0 0.5 1.1 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.3 0.4 0.8 0.5 0.0 0.1 0.0 0.2 0.0 4.7 0.0 0.6 0.0 0.0 0.0 1.1 32.7 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 11.6 0.0 0.0 0.1 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.3 0.2 0.1 2.7 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 14.0 0.0 29.4 19.1 23.8 12.2 7.6 0.7 1.9 1.3 3.6 3.4 0.3 0.3 3.0 21.0 18.8 1.1 0.2 0.5 8.0 6.0 7.2 2.0 4.5 4.3 3.9 10.5 1.6 5.3 7.4 ITGAV "CD51, MSK8, VNRA, VTNR" ENSG00000138448 "Integrin subunit alpha V" P06756 2 186590065-186680901 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.7" "Group enriched" "Detected in many" 4 "granulocytes: 7.7;monocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002499, HPA004856" Supported Approved "Focal adhesion sites,Cytosol" 750000 "Focal adhesion sites, Cytosol" "CAB002499: AB_563594, HPA004856: AB_1846316" "unprognostic (4.03e-2)" "unprognostic (5.17e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" "prognostic unfavourable (2.08e-4)" "unprognostic (1.48e-2)" "unprognostic (6.95e-2)" "unprognostic (2.89e-1)" "prognostic unfavourable (5.07e-4)" "unprognostic (5.84e-2)" "unprognostic (2.67e-2)" "prognostic unfavourable (1.05e-6)" "unprognostic (2.61e-1)" "unprognostic (9.11e-2)" "unprognostic (8.07e-2)" 23.2 22.1 17.9 18.3 21.8 3.1 25.8 16.7 23.1 22.9 13.6 23.4 11.6 8.4 26.0 11.4 14.2 14.5 25.2 40.7 16.8 12.3 51.5 9.5 20.6 7.6 24.2 11.6 35.4 18.7 65.0 11.0 29.6 22.1 16.5 11.9 83.4 17.9 15.9 13.1 21.5 10.1 29.6 33.0 12.1 17.3 11.2 17.0 7.8 33.1 10.9 11.1 17.6 17.9 0.3 0.9 7.7 2.3 0.4 1.1 0.5 9.7 11.7 7.8 24.9 28.7 19.4 29.7 19.2 15.5 6.8 6.8 10.2 33.8 0.0 37.9 21.6 12.3 3.9 18.1 9.8 1.9 3.5 2.3 15.4 14.0 11.3 1.6 1.4 14.1 8.6 15.2 12.9 16.2 2.2 4.9 18.1 3.8 0.9 1.3 5.9 5.9 0.0 15.9 1.3 17.6 75.3 1.6 4.8 22.2 6.9 8.1 5.4 4.5 49.1 42.2 13.2 8.6 16.2 1.2 2.0 1.1 17.0 0.6 20.8 7.7 1.1 1.6 1.0 2.3 0.7 0.3 0.5 0.8 0.9 0.1 0.5 0.5 0.5 0.4 1.2 0.4 1.1 0.5 17.9 21.8 16.7 17.3 16.8 12.3 24.2 11.6 22.1 17.0 ITGAX CD11c ENSG00000140678 "Integrin subunit alpha X" P20702 16 31355134-31382997 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.9;blood: 31.7;lung: 33.2;lymphoid tissue: 46.3" "Cell line enriched" "Detected in some" 6 "HMC-1: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 10.1;eosinophil: 9.2;intermediate monocyte: 18.1;myeloid DC: 12.4;neutrophil: 31.7;NK-cell: 14.9;non-classical monocyte: 20.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004458, HPA004723, CAB072871" Enhanced "CAB004458: AB_626859, CAB072871: , HPA004723: AB_1846231" "unprognostic (9.75e-3)" "unprognostic (2.49e-2)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (1.89e-1)" "unprognostic (2.29e-2)" "unprognostic (1.27e-1)" "unprognostic (9.59e-2)" "unprognostic (8.06e-3)" "unprognostic (3.20e-1)" "unprognostic (7.75e-2)" "unprognostic (3.34e-1)" "prognostic unfavourable (1.37e-4)" "unprognostic (3.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.82e-1)" "unprognostic (2.95e-2)" 47.9 1.9 4.4 28.1 5.7 28.6 2.9 1.4 4.4 1.8 2.1 17.1 0.6 1.7 2.1 2.5 1.9 4.3 7.7 2.5 5.3 4.6 2.3 4.6 33.2 24.4 13.6 3.8 3.0 2.1 0.8 2.4 3.3 8.1 2.5 3.2 2.5 4.3 1.3 1.1 1.6 3.8 3.3 15.6 46.3 3.3 0.9 7.5 3.8 2.2 0.9 9.7 5.1 1.9 0.8 12.4 31.7 20.3 14.9 1.8 3.2 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.1 0.0 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.1 0.1 0.0 0.4 48.1 0.0 0.0 0.7 0.1 0.4 0.0 0.1 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.4 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.1 3.9 10.1 9.2 1.8 18.1 0.1 0.8 0.0 0.3 12.4 0.4 0.0 0.2 31.7 14.9 20.3 0.2 0.0 3.2 4.4 5.7 1.4 4.4 5.3 4.6 13.6 3.8 8.1 7.5 ITGB1 "CD29, FNRB, GPIIA, MDF2, MSK12" ENSG00000150093 "Integrin subunit beta 1" P05556 10 32900319-33005792 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003434, HPA059297, HPA069003" Enhanced Supported "Endoplasmic reticulum,Plasma membrane,Focal adhesion sites" 540000000 "Plasma membrane, Focal adhesion sites" "Endoplasmic reticulum" "CAB003434: AB_303570, HPA059297: , HPA069003: " "unprognostic (3.07e-2)" "prognostic unfavourable (5.01e-4)" "unprognostic (8.67e-2)" "unprognostic (4.36e-1)" "unprognostic (1.20e-2)" "unprognostic (3.87e-2)" "unprognostic (1.60e-2)" "prognostic unfavourable (3.36e-6)" "unprognostic (3.22e-1)" "unprognostic (2.36e-3)" "unprognostic (3.68e-3)" "unprognostic (2.42e-1)" "unprognostic (1.02e-3)" "unprognostic (1.25e-2)" "unprognostic (2.23e-1)" "unprognostic (2.48e-1)" "unprognostic (3.08e-2)" 95.2 30.6 13.7 32.1 19.7 9.7 107.7 6.5 14.8 55.1 61.3 17.0 80.2 20.2 84.2 56.2 59.9 45.0 49.8 68.7 15.0 14.4 47.3 85.8 55.4 34.5 23.0 11.1 47.4 37.4 17.6 35.2 83.3 19.5 53.1 32.2 18.6 30.3 76.2 58.0 19.5 42.3 109.3 30.1 59.8 45.4 26.9 18.8 12.7 36.8 27.6 19.4 92.7 47.4 31.3 9.1 4.3 27.1 21.9 68.4 26.2 47.4 69.7 37.6 41.7 90.9 78.3 32.8 159.7 92.6 76.1 69.6 15.6 111.2 12.8 28.9 133.9 33.2 11.3 90.9 84.9 12.6 9.2 15.4 33.2 18.2 64.0 3.4 15.3 79.3 49.7 80.0 32.6 93.4 10.6 5.7 125.4 7.8 5.9 3.5 8.4 35.4 3.9 27.9 2.3 108.5 13.8 8.9 22.3 49.8 8.5 35.8 11.4 12.4 104.5 98.0 56.9 69.6 53.2 5.2 1.1 7.2 72.2 14.6 38.4 1.6 9.8 4.3 25.5 17.8 6.0 31.3 54.6 37.5 9.1 8.6 7.1 19.1 2.3 21.9 27.1 3.7 68.4 26.2 13.7 19.7 6.5 14.8 15.0 14.4 23.0 11.1 19.5 18.8 ITGB2 "CD18, LFA-1, MAC-1, MFI7" ENSG00000160255 "Integrin subunit beta 2" P05107 21 44885953-44931989 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Integrin, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 159.7;bone marrow: 91.4;lymphoid tissue: 75.6" "Group enriched" "Detected in some" 5 "THP-1: 114.8;U-937: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008877, HPA016894" Enhanced Supported "Plasma membrane,Rods & Rings" 2500000 "Plasma membrane" "Rods & Rings" "HPA008877: AB_1846256, HPA016894: AB_1846257" "unprognostic (1.94e-2)" "unprognostic (7.66e-3)" "unprognostic (1.23e-1)" "unprognostic (6.21e-3)" "unprognostic (2.95e-2)" "unprognostic (9.73e-3)" "unprognostic (2.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.18e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (1.87e-3)" "unprognostic (1.42e-1)" "unprognostic (4.42e-2)" "unprognostic (2.65e-2)" "unprognostic (4.83e-2)" 59.1 9.8 9.0 47.5 16.8 91.4 8.4 1.7 8.0 5.6 7.4 12.2 1.2 6.3 4.9 9.0 4.8 10.7 10.3 9.7 7.2 6.4 8.1 7.0 32.9 73.8 14.3 2.9 6.6 5.1 1.1 3.3 12.7 12.1 6.9 4.2 5.2 8.8 2.7 3.0 4.1 13.2 12.3 18.3 75.6 7.6 4.2 12.2 53.5 4.5 2.2 29.0 15.7 4.2 9.5 76.0 104.6 122.9 41.0 57.4 159.7 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 2.4 19.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.3 0.0 0.4 0.0 15.0 3.9 0.2 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.5 17.0 18.0 0.0 0.3 0.2 3.5 9.3 0.7 0.0 0.0 0.2 0.5 0.3 0.3 0.0 114.8 0.3 0.0 1.0 0.0 0.5 0.1 0.8 0.4 0.0 85.3 0.1 10.5 122.9 85.7 57.4 84.1 25.8 6.7 28.4 39.5 76.0 9.5 19.1 32.0 104.6 41.0 81.0 11.6 20.7 159.7 9.0 16.8 1.7 8.0 7.2 6.4 14.3 2.9 12.1 12.2 ITGB3 "CD61, GP3A, GPIIIa" ENSG00000259207 "Integrin subunit beta 3" P05106 17 47253846-47311816 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 36.6" "Cell line enhanced" "Detected in some" "EFO-21: 45.5;HEL: 40.3;RPTEC TERT1: 26.2;U-87 MG: 20.6;WM-115: 65.7" "Group enriched" "Detected in many" 6 "melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 19 "basophil: 2.8;neutrophil: 2.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 2.8" HPA027852 Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" 710000000 "Plasma membrane" Nucleoplasm "HPA027852: AB_10601760" "unprognostic (1.13e-2)" "unprognostic (1.97e-3)" "unprognostic (2.47e-1)" "unprognostic (3.00e-2)" "unprognostic (1.91e-2)" "unprognostic (6.04e-3)" "unprognostic (3.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-1)" "unprognostic (6.35e-2)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.03e-2)" "unprognostic (2.72e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-3)" 10.0 0.6 1.0 6.2 2.5 2.7 7.0 0.4 1.6 4.6 13.6 0.9 2.4 2.2 9.7 5.7 6.4 6.4 2.8 8.5 0.7 0.6 16.0 3.7 5.2 1.2 2.3 0.1 4.6 0.6 0.7 1.6 23.5 1.6 6.4 4.8 1.8 2.5 11.5 4.9 2.4 5.0 17.0 1.8 9.5 3.6 2.6 0.6 0.2 36.6 1.9 0.9 11.0 7.8 0.1 0.0 2.8 0.1 0.0 0.0 9.5 0.0 0.4 0.1 0.0 2.3 1.0 0.0 1.2 6.0 2.6 2.4 0.0 0.0 0.1 45.5 0.3 0.0 0.0 0.0 3.4 0.8 0.0 40.3 0.1 0.0 1.9 0.0 0.0 0.9 0.0 15.2 0.3 11.3 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 1.0 0.0 26.2 0.0 0.0 0.1 1.5 0.0 8.2 0.0 0.0 12.3 0.5 0.6 0.3 2.8 0.0 0.0 0.2 20.6 0.0 65.7 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 9.5 1.0 2.5 0.4 1.6 0.7 0.6 2.3 0.1 1.6 0.6 ITGB4 CD104 ENSG00000132470 "Integrin subunit beta 4" P16144 17 75721328-75757818 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 117.5;HaCaT: 45.0;HBEC3-KT: 100.3;hTCEpi: 34.3;RT4: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB002422, CAB005258, HPA036348, HPA036349" Enhanced Supported "Plasma membrane,Cell Junctions" 79000 "Plasma membrane, Cell Junctions" "CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078" "unprognostic (3.17e-3)" "unprognostic (3.52e-1)" "unprognostic (4.19e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.11e-3)" "unprognostic (1.28e-1)" "prognostic unfavourable (7.18e-4)" "unprognostic (1.05e-1)" "unprognostic (4.14e-2)" "prognostic unfavourable (6.39e-4)" "unprognostic (1.02e-1)" "unprognostic (2.23e-2)" "unprognostic (1.65e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" 6.3 3.4 9.7 10.9 9.7 1.4 13.7 4.7 7.7 14.3 32.1 15.6 10.0 35.3 9.7 8.8 24.0 13.7 47.8 4.3 9.4 7.9 4.8 1.5 7.4 3.7 10.1 9.1 4.7 6.7 3.1 5.7 50.0 17.2 19.7 10.4 9.8 52.3 13.2 2.4 47.0 58.5 7.4 10.7 17.0 41.0 3.9 9.8 1.8 3.2 22.1 15.9 17.2 20.5 2.4 8.2 1.3 0.7 0.0 2.2 0.8 21.8 19.3 0.0 0.2 0.0 0.1 26.6 0.1 0.0 0.0 0.1 2.0 117.5 0.0 4.2 0.0 45.0 0.1 100.3 0.0 0.1 0.0 0.1 4.9 2.1 0.1 0.0 0.2 0.1 34.3 0.0 21.4 0.7 0.0 2.0 0.0 12.2 0.2 0.2 0.1 16.8 0.3 0.5 0.2 26.8 33.0 0.0 0.2 0.6 2.0 0.3 8.4 0.2 2.2 0.6 1.0 0.0 0.2 0.7 0.2 0.0 0.2 0.1 0.3 0.0 0.4 0.0 0.7 0.7 2.2 1.4 0.3 1.0 0.1 2.4 0.9 0.6 1.3 0.0 0.0 8.2 1.4 0.8 9.7 9.7 4.7 7.7 9.4 7.9 10.1 9.1 17.2 9.8 ITGB5 ENSG00000082781 "Integrin subunit beta 5" P18084 3 124761948-124901418 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 74.0;WM-115: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001820, CAB022050" Approved Approved "Plasma membrane,Mitochondria" 95000 "Plasma membrane, Mitochondria" "CAB022050: , HPA001820: AB_1079142" "unprognostic (2.63e-1)" "unprognostic (1.04e-1)" "unprognostic (3.57e-1)" "unprognostic (4.44e-2)" "unprognostic (1.37e-2)" "unprognostic (6.07e-2)" "unprognostic (3.49e-3)" "unprognostic (3.16e-3)" "unprognostic (1.68e-1)" "unprognostic (1.53e-2)" "prognostic unfavourable (1.40e-4)" "unprognostic (1.16e-1)" "unprognostic (2.16e-3)" "unprognostic (2.49e-3)" "unprognostic (1.12e-1)" "unprognostic (1.01e-1)" "unprognostic (4.38e-3)" 72.5 13.8 9.7 9.7 10.0 0.8 50.1 5.7 8.2 34.2 18.8 14.8 28.0 12.9 31.7 17.2 25.6 13.9 29.1 32.9 9.4 5.1 19.6 22.1 20.4 3.5 12.0 6.2 17.4 12.1 8.9 8.4 36.4 13.0 23.0 10.1 27.1 18.6 23.1 15.9 33.3 16.1 25.1 9.0 18.7 12.4 17.0 8.7 2.8 18.8 16.2 10.9 24.4 27.1 0.1 1.1 0.4 0.6 0.9 2.1 5.8 29.6 74.0 5.3 13.4 50.2 14.6 27.5 31.8 19.7 5.9 9.6 14.7 38.8 0.1 15.5 54.0 23.8 4.8 16.5 5.2 0.3 3.2 10.5 11.4 15.5 8.8 0.0 19.3 8.7 3.8 14.9 7.8 19.8 9.3 15.9 20.3 30.2 0.1 0.1 23.8 8.2 0.0 8.5 11.2 16.8 6.5 0.1 11.1 23.6 35.1 26.8 19.8 0.6 51.0 22.4 33.8 19.4 16.4 2.7 2.8 0.2 23.4 0.1 77.2 0.4 0.6 0.2 2.1 0.2 0.0 0.0 0.2 0.0 1.1 0.1 0.3 0.4 0.4 0.9 0.4 0.1 0.0 5.8 9.7 10.0 5.7 8.2 9.4 5.1 12.0 6.2 13.0 8.7 ITGB6 ENSG00000115221 "Integrin subunit beta 6" P18564 2 160099666-160200313 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Amelogenesis imperfecta, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 62.1" "Group enriched" "Detected in some" 5 "CAPAN-2: 36.6;RPTEC TERT1: 73.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA023626, CAB073536" Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" "Nucleoplasm, Cell Junctions" Centrosome "CAB073536: , HPA023626: " "unprognostic (1.27e-1)" "unprognostic (1.57e-2)" "unprognostic (6.90e-2)" "unprognostic (8.22e-3)" "unprognostic (3.61e-3)" "unprognostic (1.50e-2)" "unprognostic (1.72e-3)" "unprognostic (2.04e-2)" "unprognostic (1.72e-1)" "unprognostic (7.06e-2)" "prognostic unfavourable (5.03e-6)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (1.00e-1)" 0.3 0.3 0.3 3.1 0.3 0.0 8.7 0.3 0.3 4.1 8.3 0.1 4.5 3.5 2.1 2.5 18.7 1.2 12.0 0.7 0.3 0.3 62.1 0.3 28.8 0.1 0.3 0.1 1.5 3.8 7.0 2.2 18.7 0.2 7.5 3.0 0.1 3.8 4.8 31.5 1.9 11.7 2.0 0.3 0.3 7.9 0.6 0.1 0.1 4.9 6.8 5.9 12.8 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 36.6 0.0 0.2 0.0 7.5 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.4 0.0 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 73.2 12.1 0.0 0.0 0.0 11.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 ITGB7 ENSG00000139626 "Integrin subunit beta 7" P26010 12 53191318-53207307 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.3;lymphoid tissue: 37.6" "Group enriched" "Detected in some" 99 "Karpas-707: 288.3;RPMI-8226: 225.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA042277 Uncertain "Plasma membrane,Cytosol" 42000 "Plasma membrane, Cytosol" "HPA042277: AB_10793877" "unprognostic (5.34e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-3)" "unprognostic (1.40e-2)" "unprognostic (6.57e-4)" "unprognostic (3.51e-5)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.58e-1)" "unprognostic (2.18e-1)" "unprognostic (9.63e-3)" "unprognostic (3.36e-1)" "unprognostic (1.02e-2)" "unprognostic (2.16e-1)" "unprognostic (6.95e-2)" "unprognostic (9.34e-2)" "unprognostic (2.47e-4)" 1.8 1.4 1.4 29.1 1.8 7.5 1.5 0.6 1.2 1.8 8.7 2.9 0.8 6.7 2.3 2.8 6.6 2.0 5.6 1.4 1.5 1.0 5.4 5.1 4.9 26.4 1.9 1.0 1.1 1.3 0.7 1.7 1.8 2.4 2.7 5.6 2.1 10.7 2.2 1.0 6.4 15.1 1.5 2.0 26.7 4.3 0.9 2.0 7.8 3.6 4.4 37.6 4.6 3.0 10.1 15.4 31.3 1.9 7.5 23.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 288.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 225.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.2 0.2 0.1 0.0 22.6 1.9 31.3 19.3 0.5 14.3 10.1 19.4 23.0 15.4 8.3 16.3 17.1 0.5 7.5 0.1 4.2 22.7 5.2 1.4 1.8 0.6 1.2 1.5 1.0 1.9 1.0 2.4 2.0 ITGB8 ENSG00000105855 "Integrin subunit beta 8" P26012 7 20330702-20415754 "Cancer-related genes, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 16.3;EFO-21: 21.0;RPTEC TERT1: 32.6;WM-115: 46.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 105 "basophil: 13.8" "Lineage enriched" "Detected in single" 105 "granulocytes: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027796, HPA027797" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA027796: AB_10600299, HPA027797: AB_10600879" "unprognostic (8.32e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (5.63e-2)" "unprognostic (3.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.46e-1)" "unprognostic (4.36e-2)" "unprognostic (1.75e-2)" "unprognostic (2.49e-3)" "unprognostic (8.47e-2)" "prognostic favourable (1.77e-4)" "unprognostic (2.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.63e-2)" "unprognostic (6.92e-3)" 4.7 4.1 18.0 5.8 20.0 1.2 12.7 7.8 24.3 22.1 4.6 19.4 9.0 4.6 10.5 19.0 8.8 10.4 11.7 3.9 19.4 12.5 28.1 1.7 3.7 1.3 29.3 14.5 7.1 17.5 8.1 7.7 10.7 22.8 9.6 4.4 37.5 16.6 13.1 0.9 8.5 6.0 7.0 23.1 0.8 6.2 8.7 24.0 0.0 3.4 1.3 9.0 6.8 9.9 0.0 0.0 13.8 0.1 0.0 0.1 0.0 10.0 0.4 16.3 2.0 1.4 5.7 0.0 0.0 0.1 0.1 0.5 0.1 2.5 0.0 21.0 0.7 11.2 0.7 1.6 0.2 0.0 0.2 0.0 7.8 0.0 0.7 0.0 0.0 0.6 4.6 0.2 0.8 0.8 0.0 3.0 0.3 0.0 0.0 0.0 1.2 1.8 0.0 1.4 0.0 32.6 0.8 0.2 0.7 3.1 0.0 8.1 0.2 0.0 1.1 4.3 2.8 1.2 2.1 3.8 0.0 0.0 1.0 0.0 46.6 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 18.0 20.0 7.8 14.2 19.4 12.5 29.3 14.5 22.8 24.0 ITM2A "BRICD2A, E25A" ENSG00000078596 "Integral membrane protein 2A" O43736 X 79360384-79367667 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 100.7" "Cell line enriched" "Detected in some" 8 "MOLT-4: 187.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 26.5;eosinophil: 16.8;gdT-cell: 23.2;MAIT T-cell: 17.0;memory CD4 T-cell: 44.6;memory CD8 T-cell: 36.5;naive CD4 T-cell: 48.0;naive CD8 T-cell: 22.6;NK-cell: 25.2;T-reg: 32.4" "Group enriched" "Detected in many" 7 "granulocytes: 26.5;NK-cells: 25.2;T-cells: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000296 Approved "Golgi apparatus,Vesicles,Plasma membrane" Vesicles "Golgi apparatus, Plasma membrane" "HPA000296: " "unprognostic (1.05e-2)" "unprognostic (5.22e-3)" "unprognostic (2.77e-3)" "unprognostic (5.65e-2)" "unprognostic (1.73e-2)" "unprognostic (1.06e-3)" "prognostic favourable (3.66e-6)" "unprognostic (1.57e-1)" "unprognostic (4.94e-2)" "unprognostic (9.85e-2)" "unprognostic (1.33e-2)" "unprognostic (2.57e-1)" "unprognostic (1.04e-2)" "unprognostic (1.56e-1)" "unprognostic (3.31e-1)" "unprognostic (2.18e-1)" "unprognostic (4.30e-1)" 27.2 4.1 27.0 9.1 37.8 13.6 27.4 7.8 25.8 21.8 11.0 16.1 6.5 5.4 16.4 19.4 14.8 15.3 10.6 42.1 33.6 22.5 7.7 2.2 19.0 28.5 34.8 19.5 69.6 6.3 2.7 9.3 10.6 25.8 16.7 11.9 16.2 28.2 8.8 13.2 10.3 8.8 20.9 33.9 8.4 9.6 8.0 12.5 100.7 31.1 14.1 16.5 14.7 16.6 4.7 1.1 26.5 0.2 25.2 48.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.3 0.0 0.4 0.0 7.6 0.0 0.0 0.0 12.2 14.2 2.3 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 187.9 8.5 2.8 0.0 0.0 0.0 0.0 7.3 0.0 0.0 2.1 0.0 0.1 0.0 0.2 0.2 0.3 0.0 0.2 0.0 0.1 23.7 0.0 0.0 0.0 0.0 0.9 26.5 0.1 16.8 23.2 0.2 17.0 4.6 44.6 36.5 0.1 4.7 48.0 22.6 0.8 25.2 0.2 1.1 32.4 22.6 27.0 37.8 7.8 25.8 33.6 22.5 34.8 19.5 25.8 12.5 ITM2B "BRI, BRI2, BRICD2B, E25B, E3-16" ENSG00000136156 "Integral membrane protein 2B" Q9Y287 13 48233158-48270357 "Disease related genes, Predicted membrane proteins" "Amyloidosis, Deafness, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 346.2" "Cell line enhanced" "Detected in many" "HMC-1: 108.7;RPTEC TERT1: 154.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 236.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 236.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029292, HPA071992" Approved Enhanced "Golgi apparatus,Vesicles" "Intracellular and membrane" 2600000 "Golgi apparatus, Vesicles" "HPA029292: AB_10601917, HPA071992: " "unprognostic (4.66e-2)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.00e-1)" "unprognostic (4.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "unprognostic (9.88e-2)" "unprognostic (2.42e-1)" "unprognostic (5.89e-2)" "unprognostic (2.87e-2)" "prognostic favourable (3.73e-5)" "unprognostic (4.38e-2)" "unprognostic (4.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.22e-1)" 89.3 79.6 60.6 41.3 61.6 25.0 79.6 87.2 65.8 72.6 58.3 64.9 93.4 83.4 61.2 346.2 71.5 53.2 59.4 86.9 75.9 61.4 198.7 65.1 80.2 75.9 71.7 49.8 100.7 48.5 27.0 63.1 132.0 50.2 66.5 36.0 80.8 75.1 99.8 30.9 73.5 81.0 53.1 90.0 78.5 64.5 44.7 48.3 35.0 73.1 63.0 47.7 63.3 74.5 13.3 23.3 236.4 46.6 17.2 31.7 73.7 8.6 7.5 12.7 23.8 48.5 29.4 18.9 22.9 29.0 11.5 14.6 5.3 41.5 2.3 19.5 16.7 35.3 6.8 16.5 9.7 6.7 16.1 16.4 6.1 14.6 20.9 16.1 108.7 17.6 14.8 6.7 7.5 14.8 4.2 19.9 14.0 5.8 25.9 35.6 34.8 10.2 11.7 12.6 11.7 154.6 40.9 4.3 17.1 20.3 16.7 11.8 10.9 17.1 23.8 9.6 9.6 12.5 11.1 7.8 7.2 0.3 14.0 9.4 21.4 136.9 46.6 141.3 21.3 35.7 28.1 12.0 29.8 26.5 23.3 13.3 31.7 26.5 236.4 17.2 35.5 10.3 28.7 73.7 60.6 61.6 87.2 58.0 75.9 61.4 71.7 49.8 50.2 48.3 ITPRIP "bA127L20.2, DANGER, KIAA1754" ENSG00000148841 "Inositol 1,4,5-trisphosphate receptor interacting protein" Q8IWB1 10 104309698-104338404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 81.5" "Cell line enhanced" "Detected in many" "hTCEpi: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 24.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 24.1" "Low region specificity" "Detected in all" HPA043626 Uncertain Vesicles Vesicles "HPA043626: AB_10963078" "unprognostic (2.45e-2)" "unprognostic (3.06e-1)" "unprognostic (1.59e-2)" "unprognostic (3.22e-2)" "unprognostic (1.08e-2)" "unprognostic (4.20e-1)" "unprognostic (7.87e-2)" "prognostic unfavourable (3.59e-4)" "unprognostic (9.74e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (4.00e-2)" "unprognostic (5.37e-3)" "unprognostic (1.01e-3)" "unprognostic (2.65e-1)" "unprognostic (2.75e-1)" "unprognostic (2.11e-3)" 23.7 5.8 3.5 7.4 3.8 81.5 20.8 0.5 4.3 13.5 5.5 4.5 6.8 1.6 8.5 6.0 29.5 5.6 9.8 33.8 3.0 1.5 6.9 7.2 20.2 9.8 4.4 1.5 19.9 4.4 4.4 7.3 24.4 4.7 8.6 2.5 21.7 6.7 7.3 7.6 26.4 3.8 8.4 3.4 8.8 5.6 8.4 5.2 12.9 14.0 14.6 14.2 13.6 17.3 2.4 4.4 24.1 5.7 3.2 3.4 9.7 2.3 5.8 7.0 3.1 12.3 11.9 4.0 13.0 27.6 9.5 11.9 0.4 1.0 4.1 2.9 8.0 7.6 2.3 6.3 9.9 3.5 2.9 2.4 9.2 1.7 24.3 5.4 4.6 11.0 38.2 19.8 15.9 17.7 10.2 7.8 11.6 0.9 1.1 6.0 5.2 6.8 5.1 3.7 2.4 3.9 1.0 4.0 2.6 2.4 2.8 5.7 0.2 4.1 30.6 19.3 5.1 12.7 12.3 3.0 3.5 2.7 14.1 9.9 9.0 3.5 5.7 9.9 3.4 4.1 3.3 1.9 1.9 1.9 4.4 2.4 2.3 2.0 24.1 3.2 3.7 3.1 1.5 9.7 3.5 3.8 0.5 4.3 3.0 1.5 4.4 1.5 4.7 5.2 ITPRIPL2 "FLJ22994, LOC162073, MGC126798, MGC126800" ENSG00000205730 "ITPRIP like 2" Q3MIP1 16 19113932-19121629 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042011 Approved Centrosome Centrosome "HPA042011: " "unprognostic (1.07e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-2)" "unprognostic (9.64e-2)" "unprognostic (1.97e-1)" "unprognostic (2.20e-1)" "unprognostic (3.76e-2)" "unprognostic (6.72e-3)" "unprognostic (5.60e-2)" "unprognostic (1.90e-2)" "unprognostic (5.26e-3)" "unprognostic (4.24e-2)" "unprognostic (1.53e-1)" "unprognostic (7.23e-2)" "unprognostic (6.37e-2)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" 32.6 10.7 6.2 8.3 6.0 0.9 25.8 1.2 4.1 16.0 11.4 4.3 8.2 6.1 12.7 10.6 16.4 10.2 12.7 9.9 3.8 2.8 6.4 9.5 16.7 5.1 5.6 2.1 11.6 15.0 8.5 4.7 26.5 5.7 19.1 5.9 9.5 8.5 8.9 7.3 19.7 9.1 11.3 4.0 7.8 9.9 4.9 5.7 2.0 12.0 12.8 8.0 14.2 25.7 0.5 1.9 1.3 6.6 0.2 0.6 0.6 9.0 5.3 2.1 7.0 18.2 27.8 14.0 14.4 10.2 4.2 3.9 2.2 16.3 0.0 14.9 11.4 10.3 2.9 4.4 5.6 0.0 3.0 0.7 10.7 3.8 11.8 0.0 0.0 18.4 12.3 8.2 9.4 5.5 1.3 0.0 10.0 6.1 0.0 0.2 2.1 7.1 0.0 0.3 0.0 6.4 15.2 0.2 2.7 11.8 1.2 7.0 7.0 1.4 10.9 14.8 6.4 7.5 5.4 0.1 0.0 0.0 8.6 0.3 7.4 1.3 2.8 0.3 0.6 3.4 0.3 0.5 0.3 0.5 1.9 0.3 0.2 0.5 1.0 0.2 6.6 1.2 0.1 0.6 6.2 6.0 1.2 4.1 3.8 2.8 5.6 2.1 5.7 5.7 ITSN1 "ITSN, MGC134948, MGC134949, SH3D1A, SH3P17" ENSG00000205726 "Intersectin 1" Q15811 21 33642400-33899861 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Exocytosis, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 42.4;NTERA-2: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 5.9;eosinophil: 7.2;intermediate monocyte: 4.1;myeloid DC: 1.8;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 7 "dendritic cells: 1.8;granulocytes: 7.2;monocytes: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018007 Approved Supported "Plasma membrane" "Plasma membrane" "HPA018007: AB_1851836" "unprognostic (2.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (3.91e-1)" "unprognostic (1.81e-1)" "unprognostic (1.10e-1)" "unprognostic (3.94e-2)" "unprognostic (7.33e-3)" "unprognostic (1.31e-2)" "unprognostic (3.23e-1)" "unprognostic (3.25e-2)" "unprognostic (1.16e-2)" "unprognostic (6.78e-3)" "unprognostic (2.37e-1)" "unprognostic (6.02e-2)" "unprognostic (5.64e-2)" 47.4 14.9 24.9 8.9 24.5 5.7 21.7 24.2 24.8 15.5 11.2 10.2 12.3 8.3 17.9 11.8 11.0 13.6 18.5 18.3 24.6 12.1 10.7 23.1 9.5 5.9 12.1 20.4 19.2 4.9 8.4 7.7 22.0 21.1 14.2 10.6 11.4 6.9 21.9 18.0 11.0 9.0 17.4 11.1 13.4 10.3 11.2 15.0 2.4 9.3 4.0 3.9 13.1 12.5 0.0 1.8 7.2 6.3 0.1 0.7 1.1 12.7 5.3 25.8 8.5 12.1 11.7 42.4 12.9 12.5 7.6 7.3 20.2 9.7 3.0 10.5 15.4 4.9 15.3 8.9 8.2 1.2 6.7 3.6 11.0 9.4 9.2 2.5 3.6 11.5 8.1 14.2 7.9 20.0 4.7 2.1 12.1 2.9 3.5 3.4 38.2 4.1 4.6 12.4 6.2 11.3 5.2 4.9 5.3 18.5 3.8 4.6 4.7 2.5 18.0 8.5 11.6 6.6 4.4 2.6 7.1 2.8 7.7 8.1 9.4 0.0 5.9 7.2 0.4 4.1 0.5 0.0 0.7 0.2 1.8 0.0 0.3 0.1 0.3 0.1 6.3 0.4 0.0 1.1 24.9 24.5 24.2 24.8 24.6 12.1 12.1 20.4 21.1 15.0 IYD "C6orf71, DEHAL1, dJ422F24.1" ENSG00000009765 "Iodotyrosine deiodinase" Q6PHW0 6 150368892-150405969 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "thyroid gland: 212.3" "Group enriched" "Detected in some" 6 "CACO-2: 3.3;SK-BR-3: 8.2" "Cancer enriched" "Detected in many" 20 "thyroid cancer: 80.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "hippocampal formation: 8.1;thalamus: 2.6" "Low region specificity" "Detected in all" HPA059627 Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA059627: " "unprognostic (3.73e-4)" "unprognostic (2.93e-2)" "unprognostic (5.97e-2)" "unprognostic (1.95e-2)" "unprognostic (1.55e-1)" "unprognostic (2.98e-2)" "prognostic favourable (6.22e-4)" "unprognostic (1.11e-1)" "unprognostic (3.80e-2)" "unprognostic (1.17e-1)" "unprognostic (7.41e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-9)" "unprognostic (9.79e-3)" "unprognostic (2.04e-1)" "unprognostic (2.03e-2)" "unprognostic (2.18e-2)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 8.2 0.1 0.1 3.6 0.1 0.3 0.1 0.1 6.7 0.1 0.1 0.1 5.4 6.8 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.5 0.1 1.2 0.0 0.3 0.0 0.1 0.2 13.5 0.0 0.1 0.1 0.3 0.1 0.0 0.0 212.3 0.0 0.1 0.1 0.1 1.4 1.0 5.9 1.3 2.3 0.7 2.3 0.2 0.0 0.2 0.3 0.1 0.9 0.5 0.0 0.0 0.1 0.0 3.3 0.6 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.3 0.5 0.8 0.3 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.5 0.0 0.4 0.3 0.2 0.3 0.2 0.2 0.0 0.8 0.4 0.2 0.0 8.2 0.0 0.8 0.1 0.2 0.2 0.2 0.3 0.0 0.3 0.1 0.1 0.5 0.3 0.2 3.3 1.3 0.7 0.7 1.1 0.5 0.6 0.6 0.5 0.1 1.4 0.6 0.7 5.9 2.3 0.5 1.0 0.5 2.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.0 IZUMO1 "IZUMO, MGC34799, OBF" ENSG00000182264 "Izumo sperm-egg fusion 1" Q8IYV9 19 48740852-48746909 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 17.2" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;CAPAN-2: 2.6;HaCaT: 1.8;hTCEpi: 4.3;K-562: 2.0;RT4: 2.7;U-266/84: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038104 Enhanced "HPA038104: AB_10670655" "unprognostic (2.03e-1)" "unprognostic (1.86e-3)" "unprognostic (3.73e-2)" "unprognostic (1.37e-2)" "unprognostic (1.17e-2)" "unprognostic (7.92e-2)" "unprognostic (3.49e-2)" "unprognostic (2.53e-4)" "unprognostic (3.61e-2)" "unprognostic (1.69e-2)" "unprognostic (1.45e-1)" "unprognostic (4.83e-2)" "unprognostic (1.32e-2)" "unprognostic (3.68e-1)" "unprognostic (2.92e-1)" "unprognostic (4.31e-3)" "unprognostic (6.92e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 17.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 2.6 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 IZUMO2 "C19orf41, MGC33947, SCRL" ENSG00000161652 "IZUMO family member 2" Q6UXV1 19 50152548-50163195 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "testis: 33.0" "Cell line enhanced" "Detected in some" "EFO-21: 1.6;RH-30: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042143 Uncertain "HPA042143: AB_10794078" "unprognostic (1.21e-2)" "unprognostic (3.18e-2)" "unprognostic (4.31e-2)" "unprognostic (1.81e-1)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (8.75e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.0 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.1 0.8 0.1 0.0 0.1 0.0 0.1 0.0 JAG1 "AGS, AHD, AWS, CD339, HJ1, JAGL1" ENSG00000101384 "Jagged 1" P78504 20 10637684-10673999 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 55.8;hTERT-HME1: 34.5;U-251 MG: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010343, HPA021555" Supported Approved "Golgi apparatus,Plasma membrane" 14000000 "Golgi apparatus, Plasma membrane" "CAB010343: AB_649685, HPA021555: AB_1851969" "unprognostic (2.23e-1)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (4.15e-2)" "unprognostic (1.21e-1)" "unprognostic (6.42e-2)" "unprognostic (4.21e-2)" "unprognostic (8.94e-3)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "prognostic unfavourable (4.10e-6)" "unprognostic (5.48e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-1)" "unprognostic (1.66e-1)" "unprognostic (3.10e-1)" "unprognostic (1.41e-3)" 27.7 5.6 6.8 14.5 5.4 9.7 56.5 2.9 6.7 34.2 20.1 4.3 17.4 7.2 26.1 22.8 33.9 16.7 23.1 18.8 5.4 5.1 12.9 3.8 22.0 12.4 5.4 4.0 14.7 22.2 21.7 6.0 36.3 6.0 19.2 12.7 21.4 11.2 23.4 16.8 34.8 11.7 21.4 13.0 14.2 13.4 9.1 3.8 1.5 14.5 24.6 16.1 18.7 31.4 0.0 0.9 2.4 2.0 0.4 0.1 0.4 1.0 5.2 16.4 20.1 3.1 3.0 0.6 0.6 3.0 0.8 0.4 4.6 2.8 0.1 15.4 0.6 21.9 2.4 55.8 0.7 0.0 1.1 1.7 0.5 21.9 1.5 7.0 0.1 1.2 16.6 2.7 34.5 5.4 0.0 2.2 1.5 0.0 0.0 5.0 4.7 5.2 1.3 1.0 3.2 7.8 6.4 0.7 0.5 1.6 1.1 6.6 0.1 0.8 20.4 3.7 2.6 3.0 46.9 0.9 0.1 0.2 2.4 2.5 2.9 0.0 2.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 1.6 0.4 0.3 0.9 0.0 0.4 6.8 5.4 2.9 6.7 5.4 5.1 5.4 4.0 6.0 3.8 JAG2 ENSG00000184916 "Jagged 2" Q9Y219 14 105140981-105168824 "Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 36.0" "Cell line enhanced" "Detected in many" "HaCaT: 32.3;SCLC-21H: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025481, HPA030636, HPA050567" Approved Supported Vesicles,Cytosol 120000 Vesicles Cytosol "CAB025481: , HPA030636: AB_10602607, HPA050567: " "unprognostic (6.74e-2)" "unprognostic (4.49e-2)" "unprognostic (4.28e-2)" "unprognostic (6.97e-3)" "unprognostic (3.50e-1)" "unprognostic (2.13e-2)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-2)" "unprognostic (2.62e-1)" "unprognostic (1.67e-2)" "unprognostic (9.19e-2)" "unprognostic (8.47e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.39e-1)" "unprognostic (2.17e-1)" 11.5 2.5 5.4 3.5 6.3 1.3 11.4 6.4 8.4 4.2 3.0 3.5 5.2 3.2 7.5 8.4 8.1 5.0 4.4 9.5 5.6 6.4 3.0 1.5 6.6 2.4 4.5 5.3 2.7 5.8 4.3 15.9 6.8 8.7 7.1 1.7 5.9 12.2 6.9 16.8 36.0 4.3 3.2 2.9 3.7 3.8 4.2 3.0 2.7 4.2 11.0 4.1 5.2 5.6 0.0 0.0 0.0 0.0 0.5 0.3 0.0 8.4 3.4 0.2 0.8 0.0 0.0 10.5 0.1 0.1 0.0 0.0 2.8 10.5 0.0 7.3 0.0 32.3 2.1 10.8 0.0 1.1 5.0 0.0 9.3 0.0 0.1 0.0 2.0 0.1 5.3 0.0 1.2 2.6 2.0 0.0 0.0 3.8 0.0 0.0 1.0 1.2 2.6 2.0 3.6 0.1 2.2 16.6 0.5 2.9 0.7 0.1 8.2 1.2 8.9 0.0 0.9 0.0 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 5.4 6.3 6.4 8.4 5.6 6.4 4.5 5.3 8.7 3.0 JAKMIP1 "FLJ31564, Gababrbp, JAMIP1, MARLIN1" ENSG00000152969 "Janus kinase and microtubule interacting protein 1" Q96N16 4 6026199-6200591 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.5;brain: 37.4" "Cell line enhanced" "Detected in some" "Daudi: 9.7;HDLM-2: 5.4;MOLT-4: 27.0;SCLC-21H: 12.1;U-266/70: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 21 "gdT-cell: 14.9;MAIT T-cell: 6.5;memory CD4 T-cell: 6.7;memory CD8 T-cell: 13.0;naive CD8 T-cell: 6.2;T-reg: 19.5" "Lineage enriched" "Detected in single" 37 "T-cells: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044570 Uncertain "HPA044570: AB_2678995" "unprognostic (4.79e-2)" "unprognostic (3.46e-3)" "unprognostic (4.90e-2)" "unprognostic (1.73e-2)" "unprognostic (5.34e-2)" "unprognostic (3.86e-3)" "unprognostic (6.16e-2)" "unprognostic (6.69e-3)" "unprognostic (4.25e-4)" "unprognostic (7.14e-2)" "unprognostic (4.57e-3)" "unprognostic (1.13e-1)" "unprognostic (3.70e-8)" "unprognostic (1.85e-2)" "unprognostic (3.15e-1)" "unprognostic (4.23e-2)" "unprognostic (2.96e-3)" 1.3 8.5 15.7 2.3 35.0 2.6 1.0 2.5 37.4 1.0 1.5 2.7 0.0 1.2 1.1 1.0 1.1 1.0 1.7 1.0 15.6 14.7 1.0 1.1 1.9 4.7 10.8 13.3 1.6 1.6 1.0 3.8 1.0 7.2 7.4 1.3 0.1 2.0 1.1 1.0 1.0 1.7 1.3 4.3 2.9 1.7 5.9 7.6 0.0 1.4 0.0 1.8 2.3 0.1 0.1 0.0 0.0 0.0 0.5 19.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 27.0 0.0 2.2 1.6 1.4 0.0 0.7 0.0 0.0 12.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 6.5 0.1 6.7 13.0 0.0 0.1 0.5 6.2 0.0 0.5 0.0 0.0 19.5 2.5 15.7 35.0 2.5 21.2 15.6 14.7 10.8 13.3 7.2 7.6 JAKMIP2 "JAMIP2, KIAA0555" ENSG00000176049 "Janus kinase and microtubule interacting protein 2" Q96AA8 5 147585439-147782848 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0" "Cell line enhanced" "Detected in some" "AF22: 10.9;Karpas-707: 25.8;RH-30: 26.1;SCLC-21H: 12.3;SH-SY5Y: 8.5" "Cancer enriched" "Detected in some" 6 "glioma: 4.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 8.9;MAIT T-cell: 6.3;memory CD4 T-cell: 3.5;memory CD8 T-cell: 6.4;naive CD8 T-cell: 5.6;NK-cell: 7.4" "Group enriched" "Detected in many" 6 "NK-cells: 7.4;T-cells: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046929, HPA065023" Approved Supported "Golgi apparatus" "Golgi apparatus" "HPA046929: , HPA065023: " "unprognostic (3.69e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (3.58e-2)" "unprognostic (1.63e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (1.09e-1)" "unprognostic (3.69e-1)" "unprognostic (2.21e-4)" "unprognostic (1.28e-1)" "unprognostic (5.20e-8)" "unprognostic (1.54e-3)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 1.3 6.5 12.0 2.5 10.4 1.7 1.1 44.0 35.0 1.8 1.7 8.7 0.0 1.6 2.6 1.4 3.1 1.1 3.2 1.2 12.4 10.0 1.3 5.1 4.2 2.3 11.4 9.0 1.2 2.2 0.9 14.8 1.0 10.2 1.7 1.9 1.0 1.4 1.6 1.0 1.3 1.9 3.4 10.8 2.1 1.9 5.3 16.5 8.7 1.0 0.0 2.3 1.6 0.3 0.8 1.2 0.7 0.2 7.4 8.9 1.6 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.7 1.0 0.0 0.0 0.2 0.0 3.1 1.3 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 2.6 0.0 6.2 0.1 1.0 26.1 8.3 0.0 0.0 12.3 8.5 0.0 0.1 0.0 0.0 0.0 0.0 1.9 2.2 0.0 0.5 1.8 1.0 2.5 4.9 0.0 0.0 0.0 0.0 0.4 8.9 0.0 6.3 0.8 3.5 6.4 0.2 0.4 0.9 5.6 0.7 7.4 0.2 1.2 1.5 1.6 12.0 10.4 44.0 16.4 12.4 10.0 11.4 9.0 10.2 16.5 JAKMIP3 "bA140A10.5, C10orf14, C10orf39, FLJ37857, KIAA4091, NECC2" ENSG00000188385 "Janus kinase and microtubule interacting protein 3" Q5VZ66 10 132104671-132184809 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.8" "Cell line enhanced" "Detected in some" "A549: 4.5;RPMI-8226: 2.5;U-266/84: 10.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022872 Uncertain "HPA022872: AB_2249331" "unprognostic (1.75e-1)" "unprognostic (1.76e-2)" "unprognostic (4.55e-3)" "unprognostic (8.90e-2)" "unprognostic (2.72e-1)" "unprognostic (9.39e-2)" "unprognostic (2.31e-3)" "unprognostic (1.40e-1)" "unprognostic (2.22e-1)" "unprognostic (1.80e-1)" "unprognostic (5.28e-5)" "unprognostic (1.55e-2)" "unprognostic (5.71e-6)" "unprognostic (1.43e-1)" "unprognostic (2.11e-1)" "unprognostic (7.19e-4)" "unprognostic (1.59e-2)" 0.2 1.8 2.7 0.0 2.8 0.1 0.6 5.2 8.8 0.3 0.1 0.0 1.2 0.6 0.5 0.9 0.6 1.0 4.2 4.1 0.0 0.0 0.2 0.0 5.2 3.5 0.6 0.0 2.8 0.0 3.3 0.2 0.4 1.6 1.5 0.2 0.1 1.0 7.0 0.1 0.5 1.1 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.2 2.1 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.1 1.7 0.2 1.8 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.1 1.3 0.1 0.0 0.0 2.5 0.0 0.1 0.9 0.3 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.1 0.0 0.3 10.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 JAM2 "C21orf43, CD322, JAM-B, JAMB, VE-JAM" ENSG00000154721 "Junctional adhesion molecule 2" P57087 21 25639272-25717562 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.7" "Cell line enhanced" "Detected in some" "AF22: 18.9;BJ hTERT+: 12.0;HDLM-2: 11.8;U-138 MG: 13.6;U-87 MG: 10.0" "Cancer enriched" "Detected in all" 9 "glioma: 27.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028789, HPA077346" Supported "Nucleoplasm,Plasma membrane" 17000 "Plasma membrane" Nucleoplasm "HPA028789: , HPA077346: " "unprognostic (1.42e-1)" "unprognostic (6.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.51e-4)" "unprognostic (2.61e-2)" "unprognostic (4.55e-1)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.81e-1)" "unprognostic (8.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.18e-1)" "unprognostic (2.20e-1)" "unprognostic (4.85e-3)" 16.6 17.2 13.8 8.4 18.9 1.5 14.6 9.9 23.4 18.1 14.7 14.5 8.0 7.5 20.5 13.5 13.3 12.0 14.4 21.9 13.5 12.5 6.5 3.5 17.1 4.6 17.6 13.5 18.9 3.9 5.8 7.7 66.7 18.5 12.0 9.7 11.1 5.5 18.0 8.4 6.9 9.2 21.8 23.0 2.8 9.7 25.8 12.2 0.6 9.5 10.1 6.3 13.5 15.1 3.1 1.9 1.9 0.7 2.8 1.1 0.4 0.0 0.0 18.9 0.1 0.7 0.2 0.4 0.5 12.0 1.5 5.7 0.0 0.0 0.1 0.0 0.2 0.1 1.6 0.0 3.5 11.8 0.5 0.1 0.0 0.1 0.0 0.0 0.1 1.1 0.0 1.3 0.0 0.0 0.0 0.2 5.8 0.1 0.3 0.1 6.0 0.0 2.2 3.9 0.1 0.0 0.0 0.3 2.8 0.1 0.2 0.0 0.7 0.1 0.0 13.6 1.3 0.1 1.9 1.5 0.0 0.0 10.0 0.1 0.5 1.4 0.7 0.3 0.4 0.5 0.6 0.3 0.4 0.9 0.4 3.1 0.7 1.1 1.9 2.8 0.6 1.9 0.2 0.4 13.8 18.9 9.9 20.5 13.5 12.5 17.6 13.5 18.5 12.2 JAM3 "JAM-C, JAMC" ENSG00000166086 "Junctional adhesion molecule 3" Q9BX67 11 134068925-134152001 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 77.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 29.1;RH-30: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.2" "Group enriched" "Detected in many" 7 "B-cells: 8.2;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003417, HPA050434" Approved Enhanced "Golgi apparatus" "Secreted to blood" 570000 "Golgi apparatus" "HPA003417: AB_1851981, HPA050434: " "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (3.24e-1)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (3.73e-4)" "unprognostic (3.23e-3)" "unprognostic (2.17e-1)" "unprognostic (1.06e-3)" "prognostic unfavourable (2.68e-4)" 14.0 14.9 17.6 7.9 34.1 2.2 9.9 7.0 28.7 15.5 23.4 77.0 6.9 5.9 25.0 12.9 16.3 11.9 17.8 21.4 26.1 16.9 6.7 3.0 13.7 6.2 40.3 17.4 32.0 4.4 14.5 19.5 68.8 29.6 26.2 9.7 17.5 9.4 32.5 4.1 9.1 11.7 29.7 34.8 8.7 12.0 24.8 34.1 5.1 7.6 4.6 5.6 22.7 22.6 8.2 0.2 0.8 0.1 0.1 4.0 2.9 0.2 0.4 28.0 14.4 26.2 19.4 23.5 11.9 14.1 4.5 4.4 0.3 0.2 0.3 12.3 15.5 0.4 20.2 0.2 8.5 0.2 10.0 0.8 0.1 1.8 7.8 0.5 12.4 13.2 0.0 3.1 2.8 29.1 0.3 0.2 19.2 0.3 8.6 1.0 6.6 1.2 0.2 38.3 0.1 0.2 0.1 18.9 10.6 0.1 0.3 0.4 0.3 0.3 0.2 8.4 6.1 13.1 8.1 0.1 0.1 0.2 9.3 1.1 16.0 0.4 0.1 0.3 2.2 0.0 2.6 8.2 2.8 1.6 0.2 4.8 4.0 2.6 0.8 0.1 0.0 0.2 0.1 2.9 17.6 34.1 7.0 28.7 26.1 16.9 40.3 17.4 29.6 34.1 JAML "AMICA, AMICA1, Gm638" ENSG00000160593 "Junction adhesion molecule like" Q86YT9 11 118193740-118225094 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 202.6" "Cell line enriched" "Detected in some" 5 "HMC-1: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 202.6" "Group enriched" "Detected in many" 4 "dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0" "Region enriched" "Detected in single" 9 "cerebellum: 7.0" "Region enriched" "Detected in many" 12 "cerebellum: 113.6" HPA047919 Approved 1400000 "HPA047919: " "unprognostic (3.91e-3)" "unprognostic (1.55e-3)" "unprognostic (3.00e-2)" "unprognostic (1.28e-3)" "unprognostic (2.87e-3)" "prognostic favourable (3.11e-4)" "unprognostic (2.80e-1)" "prognostic favourable (3.92e-4)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (8.69e-2)" "unprognostic (5.08e-1)" "unprognostic (6.43e-3)" "unprognostic (8.96e-2)" "unprognostic (3.12e-2)" "unprognostic (4.10e-2)" "unprognostic (1.58e-2)" 6.7 2.1 0.9 23.1 1.1 6.6 2.1 5.3 0.8 4.1 8.4 0.7 1.3 6.1 3.8 9.6 4.0 3.1 8.9 3.1 0.9 0.9 3.4 4.3 34.4 43.2 3.7 0.5 2.1 1.8 0.0 2.7 4.2 2.3 3.4 8.3 6.7 6.7 1.1 1.0 2.2 14.0 4.7 1.8 43.4 3.9 1.9 0.6 14.3 2.6 5.9 25.0 9.8 3.0 0.3 60.5 202.6 59.0 1.4 25.2 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.0 5.8 59.0 202.6 3.9 36.6 25.2 0.3 7.0 7.4 60.5 0.1 8.3 6.7 126.6 1.4 17.1 46.6 11.1 40.1 0.9 1.1 5.3 0.8 0.9 0.9 3.7 0.5 2.3 0.6 JPH1 JP-1 ENSG00000104369 "Junctophilin 1" Q9HDC5 8 74234700-74321328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 97.2" "Cell line enhanced" "Detected in many" "MOLT-4: 10.2;RT4: 9.0;SK-BR-3: 24.3;T-47d: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008996, HPA009413, CAB013461" Enhanced Enhanced Nucleoplasm Nucleoplasm "CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163" "unprognostic (2.91e-3)" "unprognostic (3.01e-1)" "unprognostic (8.85e-2)" "unprognostic (8.73e-6)" "unprognostic (2.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.63e-2)" "prognostic favourable (5.77e-5)" "unprognostic (8.97e-2)" "unprognostic (1.30e-1)" "unprognostic (2.38e-1)" "unprognostic (5.99e-2)" "unprognostic (9.80e-2)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-2)" 1.7 0.6 1.8 0.7 5.7 0.5 0.8 13.7 3.1 0.8 1.9 0.8 0.4 0.8 1.5 1.7 1.8 0.6 0.6 3.3 2.1 0.7 0.8 0.5 2.2 0.5 1.0 4.2 0.5 3.5 1.1 0.4 1.1 2.4 1.8 2.8 0.0 1.3 0.8 97.2 0.7 0.9 1.4 2.4 0.5 0.9 0.9 2.3 2.4 1.2 21.5 1.4 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.4 0.1 3.1 0.0 1.0 0.0 4.6 3.9 3.1 1.0 0.0 5.9 0.0 3.7 0.0 0.5 2.0 0.2 0.6 2.6 0.0 2.9 0.0 0.5 0.0 0.3 2.8 10.2 0.0 6.8 2.0 5.2 3.9 0.0 0.1 9.0 5.2 0.7 0.0 24.3 1.2 17.3 0.1 0.0 1.2 1.7 0.4 1.0 0.0 0.0 0.0 2.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 5.7 13.7 3.1 2.1 0.7 1.0 4.2 2.4 2.3 JPH2 JP-2 ENSG00000149596 "Junctophilin 2" Q9BR39 20 44111695-44187578 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 72.6;smooth muscle: 55.7" "Cell line enhanced" "Detected in many" "CACO-2: 12.8;EFO-21: 16.1;fHDF/TERT166: 16.2;HeLa: 10.6;SiHa: 10.8;T-47d: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052646 Approved "HPA052646: " "unprognostic (1.57e-1)" "unprognostic (1.82e-2)" "unprognostic (2.61e-4)" "unprognostic (4.71e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (1.06e-2)" "unprognostic (2.45e-3)" "unprognostic (6.87e-2)" "unprognostic (9.16e-2)" "unprognostic (2.57e-2)" "unprognostic (9.73e-2)" "unprognostic (4.76e-2)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.67e-1)" "unprognostic (1.10e-2)" 3.0 0.8 0.1 5.5 0.3 0.1 2.7 0.1 0.6 13.6 21.6 0.5 10.2 1.4 20.2 6.1 13.5 11.6 14.4 24.3 0.1 0.1 0.9 0.1 1.8 0.3 1.2 0.3 5.0 0.3 0.1 0.3 2.3 1.3 11.6 2.2 5.4 2.1 14.6 72.6 1.2 4.4 55.7 0.5 0.5 7.3 1.5 0.1 0.0 0.9 11.8 1.8 22.1 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.6 0.2 0.0 0.3 0.3 1.5 2.0 3.7 4.9 2.2 12.8 5.3 0.0 16.1 16.2 9.4 0.0 0.4 2.0 0.0 0.0 0.0 10.6 0.0 0.2 0.0 0.0 0.8 0.9 2.5 3.7 0.0 0.0 0.0 6.7 3.8 0.0 0.1 0.2 1.2 1.7 3.3 0.0 0.3 0.0 0.0 0.0 10.8 3.2 0.0 10.5 0.0 0.2 2.1 2.3 0.3 4.3 0.0 0.0 0.0 0.2 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.6 0.1 0.1 1.2 0.3 1.3 0.1 JPH3 "CAGL237, HDL2, JP-3, JP3, TNRC22" ENSG00000154118 "Junctophilin 3" Q8WXH2 16 87601835-87698156 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 44.2" "Cell line enhanced" "Detected in some" "MCF7: 6.4;NTERA-2: 5.7;SH-SY5Y: 7.3;SiHa: 4.7;U-2 OS: 23.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076304 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA076304: " "unprognostic (8.97e-3)" "unprognostic (3.17e-2)" "unprognostic (1.57e-3)" "unprognostic (4.82e-3)" "unprognostic (3.43e-1)" "unprognostic (9.12e-2)" "unprognostic (1.68e-2)" "unprognostic (8.10e-2)" "unprognostic (5.53e-2)" "unprognostic (1.48e-1)" "unprognostic (5.61e-3)" "unprognostic (2.80e-2)" "unprognostic (1.28e-4)" "unprognostic (3.01e-2)" "unprognostic (2.09e-1)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" 1.3 3.6 27.2 1.6 24.1 1.1 1.2 18.9 44.2 1.5 1.4 1.2 0.0 1.4 1.3 1.2 2.4 1.4 1.2 1.2 30.9 14.6 1.2 1.2 1.2 1.2 8.3 12.2 1.1 1.5 1.2 4.4 1.2 6.4 1.3 1.3 0.8 1.2 1.7 1.1 1.2 1.7 1.3 3.3 1.2 1.5 1.8 3.5 0.0 1.2 0.0 1.2 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.4 0.0 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.5 7.3 4.7 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 27.2 24.1 18.9 30.3 30.9 14.6 8.3 12.2 6.4 3.5 JPH4 "JPHL1, KIAA1831" ENSG00000092051 "Junctophilin 4" Q96JJ6 14 23568035-23578800 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.7;seminal vesicle: 37.8" "Group enriched" "Detected in some" 6 "SCLC-21H: 9.9;SH-SY5Y: 24.6;U-2 OS: 18.6" "Cancer enhanced" "Detected in some" "glioma: 6.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.4;myeloid DC: 5.9" "Group enriched" "Detected in many" 14 "dendritic cells: 5.9;monocytes: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013492 Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB013492: " "unprognostic (3.30e-2)" "unprognostic (1.91e-3)" "unprognostic (5.05e-3)" "unprognostic (7.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.84e-1)" "unprognostic (3.77e-3)" "unprognostic (5.98e-4)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (3.89e-3)" "unprognostic (1.15e-2)" "unprognostic (3.15e-2)" "unprognostic (2.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.13e-2)" "unprognostic (4.96e-3)" 1.9 12.3 33.6 2.0 43.8 1.3 1.6 45.3 63.7 3.4 1.9 2.1 8.0 1.8 17.1 6.2 1.5 5.1 1.6 1.3 32.3 16.8 2.7 1.3 3.4 2.0 8.3 27.6 6.2 1.5 3.1 23.2 1.6 9.8 11.6 1.7 0.8 1.2 37.8 1.2 1.6 2.2 13.9 4.2 2.9 1.7 2.2 10.9 0.0 1.3 0.0 1.7 1.7 1.8 0.0 5.9 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.5 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 9.9 24.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 33.6 43.8 45.3 42.6 32.3 16.8 8.3 27.6 9.8 10.9 JTB "hJT, PAR" ENSG00000143543 "Jumping translocation breakpoint" O76095 1 153974269-153977688 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006514 Approved Approved "Vesicles,Actin filaments" Vesicles "Actin filaments" "HPA006514: AB_1079164" "unprognostic (1.33e-1)" "unprognostic (1.77e-1)" "unprognostic (8.01e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (3.40e-1)" "unprognostic (5.66e-3)" "unprognostic (8.62e-3)" "unprognostic (5.60e-2)" "prognostic favourable (7.87e-4)" "unprognostic (1.00e-3)" "unprognostic (8.16e-2)" "prognostic unfavourable (6.65e-9)" "unprognostic (1.36e-1)" "unprognostic (4.25e-1)" "unprognostic (5.48e-2)" "unprognostic (2.58e-3)" 23.9 30.2 28.5 23.0 32.7 43.2 32.6 30.7 32.3 31.8 36.0 23.6 51.3 35.9 25.1 41.0 30.4 26.1 37.1 36.2 25.4 23.9 34.2 81.1 27.7 34.7 27.7 19.8 26.9 106.8 24.8 49.8 30.0 24.4 33.4 36.0 24.9 100.6 45.9 42.1 23.4 45.6 21.6 20.5 35.9 42.4 15.3 25.2 30.5 58.5 32.0 34.0 25.2 33.0 47.4 54.1 60.7 43.0 30.4 46.4 30.2 39.5 27.4 11.8 21.6 38.8 24.1 33.3 28.9 28.2 19.3 19.5 26.3 32.9 37.8 41.0 33.4 36.2 29.8 22.2 15.8 35.6 59.6 21.9 32.6 26.6 40.7 42.2 33.8 22.9 42.0 20.3 24.1 22.8 32.5 27.8 13.5 68.8 30.4 54.2 25.3 48.3 32.2 16.1 75.9 24.4 21.7 32.4 32.8 22.9 66.5 38.7 41.8 61.4 17.8 9.6 16.5 28.9 36.8 41.5 46.3 41.0 23.6 40.6 20.6 32.6 43.0 60.7 29.4 30.3 35.5 47.4 41.1 46.4 33.4 45.2 42.4 33.7 39.9 30.4 33.4 54.1 33.6 30.2 28.5 32.7 30.7 32.3 25.4 23.9 27.7 19.8 24.4 25.2 KALRN "ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD" ENSG00000160145 "Kalirin RhoGEF kinase" O60229 3 124080023-124726325 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;retina: 31.2" "Cell line enhanced" "Detected in many" "CACO-2: 32.1;HEL: 19.6;SH-SY5Y: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.3" "Lineage enriched" "Detected in single" 5 "T-cells: 4.3" "Low region specificity" "Detected in many" "HPA011913, CAB026456" Approved Approved Nucleoplasm,Cytosol 110000 "Nucleoplasm, Cytosol" "CAB026456: , HPA011913: AB_1850494" "unprognostic (2.54e-2)" "unprognostic (3.43e-1)" "unprognostic (2.08e-1)" "unprognostic (3.12e-4)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (3.41e-2)" "unprognostic (8.58e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "unprognostic (2.26e-3)" "unprognostic (5.58e-2)" "unprognostic (2.67e-1)" "unprognostic (3.70e-2)" "unprognostic (2.81e-3)" 5.5 4.3 12.7 2.4 14.1 0.6 4.2 1.8 35.2 4.0 3.8 3.7 0.5 2.7 5.6 2.3 9.6 4.2 3.1 12.1 17.6 3.9 2.6 7.3 2.9 1.1 4.1 15.8 2.3 11.9 2.5 14.4 6.8 9.4 3.1 2.1 31.2 2.2 5.4 23.5 1.5 7.2 6.4 3.6 8.0 11.5 2.2 2.4 0.0 5.3 6.7 3.1 2.9 4.1 0.1 0.0 0.9 0.0 0.1 4.3 1.2 0.3 0.6 3.6 0.7 0.5 0.1 4.6 1.4 0.8 1.4 0.6 32.1 2.5 0.1 0.4 3.6 0.2 0.8 0.0 1.1 0.0 0.3 19.6 0.3 4.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.6 4.5 0.1 0.4 2.3 0.0 0.0 2.0 3.1 1.0 1.6 0.0 0.1 0.3 1.2 9.2 0.4 0.3 0.3 0.7 0.1 8.1 4.1 1.6 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.8 0.3 0.0 0.0 2.4 0.7 0.9 0.1 0.0 0.0 4.3 1.2 12.7 14.1 1.8 35.2 17.6 3.9 4.1 15.8 9.4 2.4 KANSL1L "C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2" ENSG00000144445 "KAT8 regulatory NSL complex subunit 1 like" A0AUZ9 2 210021423-210171383 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 178.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043102, HPA046790" Uncertain Approved Cytosol Cytosol "HPA043102: , HPA046790: " "unprognostic (3.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.04e-1)" "unprognostic (7.55e-3)" "unprognostic (1.45e-2)" "unprognostic (2.55e-3)" "unprognostic (5.52e-2)" "unprognostic (1.46e-1)" "unprognostic (5.99e-3)" "unprognostic (4.65e-2)" "unprognostic (5.89e-3)" "unprognostic (5.75e-2)" "unprognostic (5.95e-3)" "unprognostic (7.44e-2)" "unprognostic (4.60e-2)" "unprognostic (3.21e-2)" "unprognostic (1.30e-3)" 8.4 5.6 8.3 6.0 12.9 3.8 8.8 12.7 10.9 10.4 6.9 7.5 11.1 4.4 11.3 9.9 5.9 8.9 8.9 7.9 8.8 5.7 12.3 5.8 9.8 4.3 12.1 5.5 16.2 10.0 178.9 14.4 5.3 9.5 14.3 4.7 6.2 7.6 9.9 8.8 7.7 4.9 9.8 13.0 4.5 7.2 12.4 13.6 21.6 14.2 4.4 3.8 11.1 33.0 2.1 2.1 2.7 2.2 3.1 1.7 0.5 2.4 1.3 12.9 5.4 10.4 7.8 3.8 3.7 4.7 2.4 6.6 2.5 9.6 6.8 4.9 2.3 3.5 2.9 1.2 3.8 2.9 2.4 5.6 5.0 4.4 6.5 6.5 4.0 4.9 5.7 2.3 1.7 5.2 4.1 6.3 3.5 2.4 7.2 16.7 7.7 1.8 5.2 3.7 5.3 14.1 3.7 8.1 7.7 3.3 2.3 2.6 2.3 13.8 4.5 5.1 4.1 1.8 2.8 4.5 1.9 6.7 6.3 3.2 6.2 1.1 1.4 2.7 1.2 2.2 1.1 0.9 1.0 1.4 2.1 2.1 1.7 1.7 2.4 3.1 0.9 1.4 0.8 0.5 8.3 12.9 12.7 10.9 8.8 5.7 12.1 5.5 9.5 13.6 KCND1 Kv4.1 ENSG00000102057 "Potassium voltage-gated channel subfamily D member 1" Q9NSA2 X 48961378-48971569 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell line enhanced" "Detected in many" "HSkMC: 13.6;NB-4: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000524, HPA001066" Approved Uncertain Nucleoplasm Nucleoplasm "HPA000524: , HPA001066: AB_1079662" "unprognostic (6.00e-2)" "unprognostic (2.58e-1)" "unprognostic (1.01e-4)" "unprognostic (2.19e-4)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" "unprognostic (2.79e-1)" "unprognostic (8.13e-3)" "unprognostic (1.13e-2)" "unprognostic (2.41e-3)" "prognostic favourable (2.66e-6)" "unprognostic (2.61e-1)" "unprognostic (4.30e-11)" "unprognostic (3.13e-2)" "unprognostic (3.49e-1)" "unprognostic (7.64e-2)" "unprognostic (2.22e-3)" 4.9 2.4 4.2 3.4 4.7 6.0 2.2 16.8 7.8 5.1 2.2 6.3 1.9 2.0 5.0 3.8 1.4 7.4 6.3 2.9 6.9 2.5 2.5 1.8 3.0 3.1 3.1 3.5 4.6 1.4 1.8 3.0 2.5 10.4 3.3 2.1 2.6 1.2 6.0 0.7 1.6 2.6 6.6 6.5 4.2 2.5 3.0 2.7 1.1 2.3 0.5 3.6 3.0 3.0 0.6 1.3 1.4 0.1 0.0 0.8 0.1 0.4 2.0 0.8 4.8 6.6 5.2 1.6 1.0 4.2 2.9 1.9 1.3 0.6 1.6 3.5 3.2 0.6 0.8 0.4 2.8 2.7 3.2 1.5 2.0 0.1 2.4 0.4 3.0 13.6 1.8 5.3 0.6 1.0 1.1 3.7 2.1 3.6 0.4 10.8 2.6 0.7 1.3 0.9 1.6 3.2 1.5 0.5 2.2 0.9 0.0 2.2 2.1 1.6 2.5 0.6 2.7 0.6 0.2 3.0 3.9 3.9 1.8 3.9 2.1 0.0 0.1 0.0 0.5 0.0 0.3 0.6 0.2 0.8 0.0 0.1 0.2 0.0 1.4 0.0 0.0 1.3 0.0 0.1 4.2 4.7 16.8 7.8 6.9 2.5 3.1 3.5 10.4 2.7 KCNE2 "LQT6, MiRP1" ENSG00000159197 "Potassium voltage-gated channel subfamily E regulatory subunit 2" Q9Y6J6 21 34364024-34371389 "Disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "stomach 1: 66.8" "Cell line enhanced" "Detected in many" "Karpas-707: 4.2;SCLC-21H: 5.0;U-266/70: 4.1" "Cancer enriched" "Detected in some" 6 "stomach cancer: 2.9" "Region enhanced" "Detected in single" "pons and medulla: 3.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 30.5" "Not detected" "Not detected" "HPA029706, HPA051553" Enhanced "HPA029706: AB_2673159, HPA051553: AB_2681532" "unprognostic (5.29e-4)" "unprognostic (3.13e-1)" "unprognostic (6.69e-2)" "unprognostic (2.65e-5)" "unprognostic (7.45e-2)" "unprognostic (7.33e-3)" "unprognostic (5.77e-3)" "unprognostic (6.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.33e-2)" "unprognostic (9.30e-2)" "unprognostic (3.41e-2)" "unprognostic (2.19e-3)" "unprognostic (1.48e-1)" "unprognostic (3.97e-2)" "unprognostic (2.02e-1)" "unprognostic (8.81e-2)" 0.1 0.0 0.2 1.2 0.2 0.0 0.1 0.1 0.9 0.1 0.2 1.3 0.1 2.4 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.2 0.1 0.1 11.8 0.0 0.1 0.1 3.4 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 1.2 0.1 0.1 66.8 0.8 0.1 0.1 0.3 0.1 0.1 0.1 0.1 1.4 1.6 2.2 1.6 0.0 2.0 0.7 0.8 0.3 2.0 3.7 0.2 0.2 2.7 0.9 0.5 0.0 0.1 0.8 1.0 0.8 1.3 0.0 0.0 0.2 0.0 1.0 1.0 1.2 0.9 0.2 0.0 0.0 0.7 0.5 0.2 0.1 0.0 0.0 0.0 0.2 4.2 0.3 1.6 0.2 0.7 2.8 1.6 0.7 0.6 1.0 0.4 0.2 5.0 0.4 1.4 0.6 1.3 1.3 1.0 0.0 1.2 0.6 0.5 0.3 4.1 2.3 0.7 0.4 2.1 1.1 0.0 1.6 2.2 0.6 0.1 0.6 0.8 1.1 0.5 1.6 1.4 2.0 0.3 0.0 0.0 0.0 0.8 1.4 0.7 0.2 0.2 0.1 0.9 0.1 0.3 0.2 0.1 3.4 0.1 KCNE3 "HOKPP, MiRP2" ENSG00000175538 "Potassium voltage-gated channel subfamily E regulatory subunit 3" Q9Y6H6 11 74454841-74467729 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Brugada syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 63.7" "Cell line enhanced" "Detected in some" "CACO-2: 11.1;EFO-21: 10.5;HEL: 33.3;NB-4: 21.0;THP-1: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 47 "basophil: 16.8;classical monocyte: 16.2;eosinophil: 9.3;intermediate monocyte: 17.4;myeloid DC: 7.6;neutrophil: 22.4;non-classical monocyte: 14.0" "Group enriched" "Detected in many" 122 "dendritic cells: 7.6;granulocytes: 22.4;monocytes: 17.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA014849 Approved "HPA014849: AB_1852112" "unprognostic (1.61e-2)" "unprognostic (2.94e-1)" "unprognostic (1.11e-1)" "unprognostic (8.69e-2)" "unprognostic (3.58e-1)" "unprognostic (5.13e-2)" "prognostic unfavourable (2.28e-4)" "unprognostic (4.67e-3)" "unprognostic (4.89e-4)" "unprognostic (4.12e-3)" "unprognostic (2.56e-2)" "unprognostic (2.97e-2)" "unprognostic (1.45e-3)" "unprognostic (7.86e-2)" "unprognostic (1.33e-2)" "unprognostic (1.73e-1)" "unprognostic (2.00e-1)" 10.8 2.2 2.7 8.5 4.6 3.1 5.8 1.2 3.0 6.4 18.2 3.2 4.9 31.4 6.7 4.7 3.5 6.0 63.7 3.8 2.7 1.9 9.3 2.5 15.9 11.3 5.0 1.3 10.5 10.1 1.9 3.3 5.4 3.4 7.6 22.2 7.4 11.7 5.5 1.1 0.7 22.2 4.9 7.7 15.1 26.3 1.7 3.2 1.3 15.1 1.4 3.3 5.2 5.7 0.1 7.6 22.4 17.4 0.0 0.1 4.8 0.0 0.0 0.0 0.1 4.2 1.0 3.5 0.0 0.0 0.5 0.4 11.1 1.0 0.1 10.5 0.0 0.1 0.9 0.0 0.3 0.0 0.1 33.3 0.2 2.2 1.5 0.3 6.0 3.7 0.0 0.3 0.0 0.1 0.9 0.1 0.4 0.0 0.0 21.0 0.4 0.0 3.7 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.0 6.3 0.0 16.8 16.2 9.3 0.0 17.4 0.1 0.0 0.0 0.0 7.6 0.1 0.0 0.0 22.4 0.0 14.0 0.3 0.0 4.8 2.7 4.6 1.2 3.0 2.7 1.9 5.0 1.3 3.4 3.2 KCNE4 MiRP3 ENSG00000152049 "Potassium voltage-gated channel subfamily E regulatory subunit 4" Q8WWG9 2 223051814-223198399 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 27.0" "Cell line enriched" "Detected in some" 4 "AN3-CA: 59.6" "Cancer enhanced" "Detected in all" "breast cancer: 20.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011420 Approved Approved "Nuclear bodies,Microtubules" Microtubules "Nuclear bodies" "HPA011420: AB_1079170" "unprognostic (1.23e-1)" "unprognostic (2.02e-3)" "prognostic unfavourable (9.42e-5)" "unprognostic (2.17e-2)" "unprognostic (7.56e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (7.89e-2)" "prognostic unfavourable (2.02e-7)" "unprognostic (4.70e-3)" "unprognostic (1.20e-1)" "unprognostic (6.24e-3)" "unprognostic (9.08e-3)" 9.0 2.4 5.5 7.5 5.7 0.2 6.6 2.6 11.9 4.5 3.3 1.2 1.4 0.8 21.9 4.4 3.7 3.4 14.8 3.5 6.5 2.5 2.4 3.6 2.1 3.3 9.4 0.7 9.2 6.4 0.7 5.3 4.6 8.7 3.7 1.4 11.6 2.3 4.2 2.1 2.1 2.3 27.0 21.5 4.7 4.9 2.2 8.4 0.0 5.2 1.7 0.6 7.7 12.5 0.7 0.3 2.3 0.3 0.4 0.3 0.0 0.0 0.3 0.0 59.6 13.7 1.4 0.0 1.4 1.3 0.3 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 2.3 0.0 2.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.3 0.0 4.4 0.2 0.0 0.0 0.0 1.4 0.0 1.1 2.3 0.3 0.2 0.3 0.1 0.3 0.2 0.3 0.2 0.0 0.7 0.3 0.3 0.9 0.4 0.2 0.3 0.1 0.0 5.5 5.7 2.6 11.9 6.5 2.5 9.4 0.7 8.7 8.4 KCNE5 KCNE1L ENSG00000176076 "Potassium voltage-gated channel subfamily E regulatory subunit 5" Q9UJ90 X 109623700-109625172 "Disease related genes, Predicted membrane proteins" "Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5" "Cell line enhanced" "Detected in some" "HMC-1: 4.1;hTEC/SVTERT24-B: 5.4" "Group enriched" "Detected in some" 8 "glioma: 7.9;testis cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 5.6" "Group enriched" "Detected in many" 4 "dendritic cells: 5.6;monocytes: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042316 Uncertain Cytosol Cytosol "HPA042316: AB_10795397" "unprognostic (5.33e-2)" "unprognostic (2.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (2.14e-3)" "unprognostic (3.27e-2)" "unprognostic (9.46e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-3)" "unprognostic (7.83e-2)" "unprognostic (5.64e-6)" "unprognostic (5.10e-2)" "unprognostic (9.06e-2)" "unprognostic (1.36e-1)" "unprognostic (5.37e-3)" 4.8 1.1 6.4 1.3 11.3 6.8 1.2 6.0 6.6 1.0 0.6 8.2 0.0 0.7 0.8 1.3 1.2 0.5 2.4 2.2 8.9 8.1 0.7 0.7 0.8 0.8 14.3 1.6 1.7 0.4 0.4 0.2 2.5 29.5 1.9 0.5 0.1 0.6 2.3 3.2 1.1 0.8 0.9 7.3 1.4 0.6 1.2 0.3 8.5 0.6 2.6 0.8 0.8 0.2 0.0 5.6 0.0 1.7 0.1 0.8 0.3 0.9 0.0 0.2 0.4 0.1 0.1 0.1 1.9 0.4 0.7 0.7 0.1 0.4 0.4 0.0 0.4 0.8 0.0 2.2 0.9 0.2 0.4 2.6 2.6 1.8 0.1 0.0 4.1 0.6 1.4 5.4 1.3 0.4 0.0 0.1 0.5 0.0 0.8 3.3 0.0 0.1 0.2 0.1 0.1 0.7 0.1 0.2 0.4 1.2 0.0 1.1 0.0 2.5 1.2 1.8 0.9 1.0 2.4 0.5 0.6 0.3 1.2 1.2 0.5 0.0 0.7 0.0 0.8 1.7 0.0 0.0 0.1 0.1 5.6 0.0 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.3 6.4 11.3 6.0 6.5 8.9 8.1 14.3 1.6 29.5 0.3 KCNG1 "K13, KCNG, kH2, Kv6.1" ENSG00000026559 "Potassium voltage-gated channel modifier subfamily G member 1" Q9UIX4 20 51003656-51023129 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 25.8;endometrium 1: 48.3" "Cell line enhanced" "Detected in many" "hTCEpi: 26.3;U-138 MG: 20.0;WM-115: 16.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 27 "naive B-cell: 10.8" "Lineage enriched" "Detected in single" 87 "B-cells: 10.8" "Group enriched" "Detected in many" 5 "amygdala: 21.4;basal ganglia: 17.0;cerebral cortex: 15.2;hippocampal formation: 19.7" "Group enriched" "Detected in all" 4 "amygdala: 16.3;basal ganglia: 12.0;cerebral cortex: 22.5;hippocampal formation: 21.1" "HPA039530, HPA040024" Approved Approved Vesicles Vesicles "HPA039530: AB_10795144, HPA040024: AB_10796338" "unprognostic (1.19e-1)" "unprognostic (4.47e-2)" "unprognostic (8.70e-2)" "unprognostic (3.49e-2)" "unprognostic (4.07e-2)" "unprognostic (5.05e-4)" "unprognostic (2.53e-2)" "unprognostic (3.89e-3)" "unprognostic (3.64e-2)" "unprognostic (3.43e-2)" "unprognostic (8.74e-2)" "unprognostic (8.89e-2)" "unprognostic (1.83e-9)" "unprognostic (1.52e-1)" "unprognostic (7.42e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-2)" 0.5 4.5 13.3 2.9 7.0 0.3 0.7 2.3 11.9 9.6 2.4 1.6 25.8 0.6 48.3 2.8 3.7 11.9 1.9 1.0 7.9 2.9 0.5 0.4 0.5 3.0 2.0 9.5 0.9 3.7 1.3 0.8 9.3 6.7 5.6 1.3 0.7 1.4 18.3 0.3 0.5 7.2 5.8 1.0 3.5 0.8 5.4 2.6 0.0 0.5 0.0 1.4 2.8 3.4 10.8 0.0 0.0 0.1 0.0 0.0 0.1 0.4 1.7 1.3 6.4 0.7 1.7 0.1 5.6 0.0 3.3 2.6 0.1 0.1 0.0 3.5 1.6 1.6 0.8 1.6 3.4 0.2 2.1 0.0 6.2 0.0 11.7 0.0 0.2 3.4 26.3 12.6 12.9 0.8 0.1 0.0 0.3 6.3 0.0 0.1 6.7 11.6 0.0 0.0 0.0 0.0 1.9 1.9 7.3 12.2 14.3 9.2 1.0 0.9 0.3 20.0 11.8 0.1 1.6 0.0 0.0 0.0 5.9 0.4 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 13.3 7.0 2.3 11.9 7.9 2.9 2.0 9.5 6.7 2.6 KCNIP4 "CALP, KCHIP4, MGC44947" ENSG00000185774 "Potassium voltage-gated channel interacting protein 4" Q6PIL6 4 20728616-21948799 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 9.9;SCLC-21H: 7.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022862, HPA066717" Supported Approved Vesicles Vesicles "HPA022862: AB_1852654, HPA066717: " "unprognostic (8.08e-2)" "unprognostic (1.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (9.26e-2)" "unprognostic (1.49e-1)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.18e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (3.11e-1)" "unprognostic (1.03e-2)" "unprognostic (2.69e-1)" "unprognostic (4.59e-2)" "unprognostic (2.10e-2)" 1.1 3.6 15.8 2.2 28.3 1.0 0.9 22.4 38.9 15.0 4.2 1.8 0.0 2.4 9.6 1.1 5.6 3.9 2.6 1.8 11.9 16.2 7.8 0.7 1.1 1.1 11.6 19.3 1.9 1.0 0.5 5.1 1.8 16.9 1.0 5.2 3.5 1.4 0.8 1.3 2.3 5.5 7.8 3.9 1.1 1.3 1.3 3.5 0.0 8.9 0.0 0.5 2.7 1.1 0.3 0.7 0.0 0.7 0.8 0.7 0.3 1.7 1.5 2.1 2.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 1.9 1.6 3.3 1.4 0.5 0.9 0.0 0.1 0.0 0.4 2.3 1.2 2.5 1.1 0.0 3.2 0.5 0.0 0.7 0.0 1.4 0.6 2.0 1.1 0.0 0.6 2.7 1.9 2.8 1.4 0.8 4.1 1.3 9.9 0.9 7.7 4.6 1.4 1.7 2.1 0.9 1.2 2.1 1.1 1.5 2.3 3.1 1.0 0.1 1.2 3.6 2.7 1.7 0.0 0.3 0.0 0.2 0.7 0.7 0.2 0.1 0.2 0.7 0.3 0.5 0.5 0.0 0.8 0.5 0.3 0.2 0.3 15.8 28.3 22.4 33.0 11.9 16.2 11.6 19.3 16.9 3.5 KCNJ1 "Kir1.1, ROMK1" ENSG00000151704 "Potassium voltage-gated channel subfamily J member 1" P48048 11 128836315-128867373 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Bartter syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "kidney: 123.2" "Cell line enriched" "Detected in some" 40 "RPTEC TERT1: 50.6" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.4" "Region enriched" "Detected in single" 4 "basal ganglia: 2.3" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA026962 Enhanced "HPA026962: AB_10601934" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (1.14e-1)" "unprognostic (3.19e-1)" "unprognostic (7.55e-2)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (2.69e-1)" "unprognostic (1.46e-1)" "unprognostic (2.44e-2)" "unprognostic (6.47e-2)" "unprognostic (2.78e-1)" "unprognostic (6.05e-2)" "unprognostic (4.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.28e-1)" "unprognostic (7.81e-3)" 0.1 0.0 0.5 0.2 2.3 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 123.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.3 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.9 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 2.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KCNJ11 "BIR, Kir6.2" ENSG00000187486 "Potassium voltage-gated channel subfamily J member 11" Q14654 11 17385859-17389331 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 63.1" "Cell line enhanced" "Detected in many" "Daudi: 7.1;HEK 293: 13.4;MCF7: 10.7;SCLC-21H: 9.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA048891 Approved "HPA048891: " "unprognostic (1.95e-2)" "unprognostic (6.18e-3)" "unprognostic (7.79e-2)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (4.81e-5)" "unprognostic (1.83e-3)" "unprognostic (5.45e-2)" "unprognostic (8.09e-3)" "unprognostic (3.72e-3)" "unprognostic (9.23e-3)" "prognostic favourable (1.56e-4)" "unprognostic (4.05e-2)" "unprognostic (2.10e-2)" "unprognostic (1.67e-1)" "unprognostic (4.75e-2)" 2.5 1.1 2.9 1.0 7.8 0.8 2.7 13.6 7.8 1.0 1.1 0.7 4.9 1.4 1.1 2.1 1.7 1.1 1.1 6.2 3.5 2.4 1.3 0.9 1.3 1.2 2.7 5.2 0.8 8.7 2.7 3.3 0.7 3.5 2.5 1.0 0.1 1.2 7.6 63.1 1.0 1.1 0.8 1.7 1.0 4.6 0.8 1.9 0.0 4.1 4.5 1.0 0.9 1.1 0.8 0.4 1.4 0.3 0.8 0.4 0.4 1.5 2.3 0.3 4.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 2.5 0.2 7.1 0.2 0.0 0.3 4.8 0.1 0.3 1.6 13.4 3.6 0.9 0.8 0.1 0.4 0.3 0.1 0.3 0.0 0.1 0.0 3.7 3.8 0.0 10.7 0.7 0.1 1.0 0.3 1.4 1.7 2.0 0.4 0.9 9.1 0.8 0.0 3.5 0.0 4.6 0.2 0.0 0.0 1.2 0.0 0.1 0.2 6.0 0.9 0.0 1.0 0.0 1.4 0.3 0.2 0.4 0.3 0.3 0.7 0.4 0.4 0.1 0.8 0.4 0.4 1.3 0.8 0.1 0.4 0.3 0.4 2.9 7.8 13.6 7.8 3.5 2.4 2.7 5.2 3.5 1.9 KCNJ15 "IRKK, Kir1.3, Kir4.2" ENSG00000157551 "Potassium voltage-gated channel subfamily J member 15" Q99712 21 38155549-38307357 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 74.8;kidney: 99.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 28.0;HBEC3-KT: 26.9;LHCN-M2: 12.3;RPTEC TERT1: 26.8;RT4: 31.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 29.6" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 21 "neutrophil: 74.8" "Lineage enriched" "Detected in many" 21 "granulocytes: 74.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA016702 Approved Approved "Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Vesicles, Cytosol" "HPA016702: AB_1855560" "unprognostic (6.34e-2)" "unprognostic (5.04e-2)" "unprognostic (7.92e-2)" "unprognostic (2.07e-3)" "unprognostic (1.21e-1)" "unprognostic (3.54e-3)" "unprognostic (2.72e-3)" "unprognostic (3.03e-2)" "unprognostic (6.79e-2)" "unprognostic (2.89e-3)" "unprognostic (3.77e-2)" "unprognostic (1.95e-2)" "prognostic favourable (4.09e-10)" "unprognostic (9.46e-3)" "unprognostic (1.82e-1)" "unprognostic (5.27e-2)" "prognostic favourable (1.95e-4)" 6.0 0.3 0.4 5.3 0.3 3.2 1.4 0.2 0.3 3.5 0.4 0.2 27.1 0.2 0.5 12.8 6.0 0.8 17.7 1.0 0.2 0.1 99.7 1.5 34.1 0.8 0.5 0.2 0.6 16.7 0.0 0.3 1.0 0.6 4.0 0.0 0.2 14.4 26.8 1.0 1.7 0.2 0.9 0.4 6.8 10.7 1.1 0.2 0.4 36.8 3.2 1.9 11.3 4.3 0.0 0.2 74.8 3.5 0.0 0.0 0.7 0.6 0.0 0.1 0.2 5.5 28.0 0.2 0.4 1.9 0.0 0.0 0.0 0.2 0.1 0.0 2.9 9.4 0.0 26.9 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 8.2 2.7 7.0 1.5 1.3 0.1 0.2 12.3 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 26.8 31.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.1 1.4 0.0 0.7 0.1 0.0 2.2 1.6 0.1 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 0.7 0.4 0.3 0.2 0.3 0.2 0.1 0.5 0.2 0.6 0.2 KCNJ8 Kir6.1 ENSG00000121361 "Potassium voltage-gated channel subfamily J member 8" Q15842 12 21764955-21775581 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 60.1;pancreas: 47.6" "Cell line enhanced" "Detected in some" "CACO-2: 41.5;HSkMC: 8.4;SH-SY5Y: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "eosinophil: 4.5" "Lineage enriched" "Detected in single" 45 "granulocytes: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031066 Uncertain "HPA031066: AB_10602240" "unprognostic (8.12e-3)" "unprognostic (1.89e-1)" "prognostic unfavourable (9.29e-4)" "unprognostic (7.81e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-2)" "unprognostic (3.90e-2)" "unprognostic (3.66e-3)" "unprognostic (2.88e-2)" "prognostic unfavourable (1.62e-6)" "unprognostic (4.70e-3)" "unprognostic (9.61e-2)" "unprognostic (1.73e-2)" "unprognostic (3.54e-3)" 14.6 12.9 3.2 2.7 3.4 0.0 14.7 1.7 5.1 7.7 6.6 2.3 3.6 2.0 10.6 4.5 6.7 5.9 6.3 60.1 2.2 1.7 6.4 29.7 12.4 3.5 2.9 3.0 12.4 47.6 1.7 3.8 4.9 3.7 10.6 1.6 8.8 2.9 15.7 15.0 2.4 3.8 13.2 2.6 3.8 6.5 3.4 2.8 0.9 8.4 7.0 1.2 11.4 5.6 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 5.1 3.4 0.0 5.6 4.5 6.4 3.3 41.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.9 0.0 2.0 1.3 0.0 0.0 0.1 0.0 0.0 8.4 0.0 2.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 4.1 1.8 0.0 1.7 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.4 1.7 5.1 2.2 1.7 2.9 3.0 3.7 2.8 KCNK10 "K2p10.1, PPP1R97, TREK-2, TREK2" ENSG00000100433 "Potassium two pore domain channel subfamily K member 10" P57789 14 88180103-88326907 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 12.2;brain: 14.1;intestine: 11.6" "Cell line enhanced" "Detected in some" "AF22: 2.5;NTERA-2: 1.7;REH: 4.2;SCLC-21H: 7.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 67 "plasmacytoid DC: 12.2" "Lineage enriched" "Detected in single" 123 "dendritic cells: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030462 Approved "HPA030462: AB_10601919" "unprognostic (9.52e-3)" "unprognostic (1.17e-1)" "unprognostic (1.94e-2)" "unprognostic (1.08e-1)" "unprognostic (8.20e-2)" "unprognostic (1.45e-1)" "unprognostic (1.18e-1)" "unprognostic (2.25e-1)" "unprognostic (4.58e-1)" "unprognostic (1.23e-2)" "unprognostic (2.70e-1)" "unprognostic (2.45e-1)" "unprognostic (6.97e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-1)" "unprognostic (4.26e-3)" 0.4 1.1 7.4 1.2 6.9 0.9 0.5 14.1 11.2 0.4 3.2 5.6 0.0 11.6 0.3 0.3 2.2 0.4 0.5 0.4 7.2 4.5 5.7 0.4 0.6 0.7 5.0 5.7 0.4 3.5 0.4 0.9 0.3 6.4 0.5 2.1 0.0 0.5 0.3 0.4 0.4 5.7 0.5 5.0 0.6 6.7 1.3 2.3 0.0 0.4 0.5 1.3 0.5 0.4 0.0 12.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.7 0.2 4.2 0.1 0.0 0.1 0.1 7.7 0.3 0.1 0.1 0.0 0.0 1.0 0.1 0.1 1.4 0.2 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.1 7.4 6.9 14.1 11.2 7.2 4.5 5.0 5.7 6.4 2.3 KCNMA1 "KCa1.1, mSLO1, SLO" ENSG00000156113 "Potassium calcium-activated channel subfamily M alpha 1" Q12791 10 76869601-77638369 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 27.2;hTERT-HME1: 32.0;PC-3: 43.5;U-138 MG: 31.3;U-87 MG: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 5.5;memory B-cell: 1.7;non-classical monocyte: 3.7" "Group enriched" "Detected in many" 5 "B-cells: 1.7;monocytes: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054648 Approved "HPA054648: " "unprognostic (1.25e-1)" "unprognostic (2.23e-2)" "unprognostic (1.86e-2)" "unprognostic (5.29e-2)" "unprognostic (9.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.77e-1)" "unprognostic (2.81e-2)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (4.12e-3)" "unprognostic (1.20e-1)" "unprognostic (2.26e-2)" "unprognostic (1.42e-2)" "unprognostic (5.19e-2)" "unprognostic (1.42e-2)" "unprognostic (3.99e-3)" 6.0 8.1 12.5 8.8 13.6 1.1 7.1 8.2 18.5 36.3 39.0 5.7 27.9 4.8 54.0 19.7 20.7 18.3 15.6 2.7 10.8 8.2 2.0 6.6 4.0 6.2 7.4 16.5 7.0 4.1 0.7 10.1 3.3 10.1 30.1 13.2 6.6 24.0 47.6 37.1 1.8 8.6 55.1 6.8 10.4 14.8 2.6 4.9 0.4 1.4 2.7 2.5 21.7 12.6 1.7 0.6 0.3 5.5 0.0 0.0 0.3 0.0 8.1 0.0 0.1 1.3 7.0 0.1 27.2 24.3 6.6 3.2 1.8 0.1 0.0 0.2 20.3 0.0 0.0 15.9 4.0 16.1 0.1 0.0 0.0 0.0 12.7 0.0 0.1 4.9 2.9 10.5 32.0 2.6 0.0 0.0 11.6 0.3 0.5 0.0 0.5 43.5 0.0 1.0 0.0 4.2 0.0 2.5 0.3 0.0 0.6 0.0 3.3 0.0 17.6 31.3 3.5 5.6 24.0 0.0 0.0 0.0 30.6 0.0 12.2 0.0 0.2 0.0 0.0 5.5 0.0 1.7 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 3.7 0.0 0.0 0.3 12.5 13.6 8.2 18.5 10.8 8.2 7.4 16.5 10.1 4.9 KCNMB2 ENSG00000197584 "Potassium calcium-activated channel subfamily M regulatory beta subunit 2" Q9Y691 3 178272932-178844429 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 36.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.3;fHDF/TERT166: 2.5;SCLC-21H: 8.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" CAB022649 Uncertain "CAB022649: " "unprognostic (9.52e-2)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (1.04e-2)" "unprognostic (2.43e-2)" "unprognostic (6.97e-2)" "unprognostic (6.74e-2)" "unprognostic (2.15e-1)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (1.71e-2)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-4)" "unprognostic (7.85e-2)" 0.7 6.3 7.8 0.5 6.2 0.4 1.3 1.8 11.2 2.5 1.9 2.2 4.4 1.0 7.2 36.8 0.9 14.3 0.9 7.4 13.2 4.5 4.1 0.6 1.6 0.4 4.7 4.9 16.3 4.5 0.4 10.2 0.5 6.2 1.1 0.9 0.5 0.6 1.9 0.6 0.7 0.9 3.0 3.2 1.9 3.6 0.6 3.2 0.0 1.1 0.0 0.4 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 6.3 0.0 0.0 0.4 0.0 0.0 1.4 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 1.7 0.0 1.0 8.3 0.0 0.0 0.5 0.0 1.4 0.0 0.3 0.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 6.2 1.8 11.2 13.2 4.5 4.7 4.9 6.2 3.2 KCNMB3 "KCNMB2, KCNMBL" ENSG00000171121 "Potassium calcium-activated channel subfamily M regulatory beta subunit 3" Q9NPA1 3 179236691-179267002 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 10.9;NB-4: 7.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA015665, HPA019185" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA015665: AB_1852142, HPA019185: AB_1852144" "unprognostic (2.50e-1)" "unprognostic (1.32e-1)" "unprognostic (6.76e-5)" "unprognostic (2.65e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.59e-3)" "unprognostic (1.14e-1)" "unprognostic (9.15e-3)" "unprognostic (5.09e-2)" "unprognostic (1.87e-2)" "unprognostic (1.95e-5)" "unprognostic (5.93e-10)" "unprognostic (7.22e-2)" "unprognostic (4.72e-1)" "unprognostic (8.69e-2)" "unprognostic (3.49e-2)" 3.0 2.0 0.7 2.9 0.7 1.2 3.3 0.2 0.6 1.8 2.0 1.9 2.0 2.3 0.7 1.0 2.4 1.8 1.0 0.9 2.2 4.0 1.2 2.9 1.1 1.6 5.3 3.7 2.1 6.6 2.9 2.2 2.7 1.4 0.5 0.6 2.2 1.9 1.5 5.9 2.6 4.5 2.4 2.6 1.9 1.5 3.5 0.3 2.3 0.4 3.6 1.0 0.0 3.0 0.7 1.2 0.0 1.4 1.1 1.9 0.8 0.5 1.3 0.6 6.4 2.6 0.1 3.0 0.6 1.1 0.0 0.2 1.5 3.7 0.4 10.9 2.9 2.5 1.2 0.2 3.6 1.9 0.6 0.9 0.0 1.1 0.4 0.1 1.5 1.8 0.1 7.4 0.0 2.3 3.2 0.0 0.1 1.0 2.0 1.5 0.4 0.9 1.2 0.7 3.0 6.0 0.7 0.6 1.0 0.3 0.9 1.0 0.4 3.5 0.6 4.2 0.8 2.3 0.4 0.5 1.0 0.3 0.6 3.5 0.6 0.8 0.1 2.1 0.4 0.7 1.9 3.6 0.1 0.3 0.9 0.0 KCNMB4 ENSG00000135643 "Potassium calcium-activated channel subfamily M regulatory beta subunit 4" Q86W47 12 70366276-70434292 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 24.4;brain: 37.7" "Cell line enhanced" "Detected in many" "NTERA-2: 9.0;RH-30: 9.7;RT4: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA072287 Enhanced Approved Approved Cytosol Cytosol "HPA072287: " "unprognostic (3.90e-1)" "unprognostic (1.72e-2)" "unprognostic (2.69e-2)" "unprognostic (2.62e-2)" "unprognostic (6.98e-2)" "unprognostic (1.13e-3)" "unprognostic (1.85e-1)" "unprognostic (2.48e-2)" "unprognostic (3.50e-1)" "unprognostic (2.95e-2)" "unprognostic (3.75e-1)" "unprognostic (2.47e-2)" "unprognostic (2.19e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (1.05e-2)" 4.4 24.4 19.8 2.6 24.6 1.3 2.6 13.8 37.7 3.5 5.0 28.4 1.0 2.5 3.2 2.8 2.6 3.3 3.2 5.9 25.9 10.4 5.8 1.8 4.6 2.8 28.6 19.3 5.4 1.5 1.3 1.4 4.9 11.6 2.9 2.9 2.0 3.8 4.5 4.2 4.9 3.0 2.8 15.2 2.8 1.8 3.8 26.0 0.8 3.3 0.0 2.6 2.4 2.1 1.7 0.6 0.3 0.3 0.2 2.8 0.5 0.0 0.4 5.7 3.2 0.3 0.3 0.6 0.7 1.0 0.3 0.9 0.2 2.1 2.8 0.3 0.0 0.1 6.2 0.9 0.2 1.3 3.5 1.4 1.3 3.2 0.0 0.1 0.1 1.7 0.1 0.0 0.0 0.2 0.0 0.0 1.1 0.8 2.0 0.5 9.0 6.5 2.9 9.7 0.2 0.3 10.6 2.8 3.5 0.9 1.1 0.1 3.2 0.1 0.1 0.4 1.5 0.1 0.4 2.0 0.0 2.8 0.5 0.0 0.9 0.3 0.3 0.0 0.3 0.3 0.3 0.6 0.6 0.6 0.6 1.7 2.2 2.8 0.3 0.2 0.1 0.2 0.6 0.5 19.8 24.6 13.8 19.1 25.9 10.4 28.6 19.3 11.6 26.0 KCNN2 "hSK2, KCa2.2" ENSG00000080709 "Potassium calcium-activated channel subfamily N member 2" Q9H2S1 5 114360945-114496500 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 25.3;brain: 23.1;liver: 33.2" "Group enriched" "Detected in some" 5 "BJ: 14.7;NTERA-2: 5.6;SK-MEL-30: 10.4;THP-1: 18.3;U-937: 6.5" "Group enriched" "Detected in some" 7 "glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038221 Uncertain Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA038221: AB_10673044" "unprognostic (9.22e-3)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (4.61e-1)" "unprognostic (3.16e-1)" "unprognostic (4.25e-1)" 0.8 25.3 12.6 0.8 7.3 0.6 1.1 21.7 15.0 1.7 1.2 9.5 0.0 0.9 3.9 0.9 0.8 1.0 1.0 7.7 23.1 3.6 4.8 33.2 2.5 0.9 4.5 16.9 1.4 3.8 1.0 16.0 0.6 9.1 11.7 1.3 4.2 1.1 5.4 9.9 2.1 0.9 2.8 8.4 1.1 1.1 3.8 6.5 0.0 0.9 0.0 0.8 2.4 1.1 0.3 0.3 0.8 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 14.7 2.2 0.3 0.1 0.0 0.2 0.0 0.5 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.2 5.6 0.0 0.1 0.0 0.7 0.2 0.1 1.8 0.0 0.0 0.1 10.4 0.2 18.3 0.2 0.0 0.4 1.6 0.0 0.1 0.0 0.1 1.8 6.5 0.5 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.3 0.1 0.3 0.8 0.1 0.3 0.3 0.1 0.0 12.6 7.3 21.7 15.0 23.1 3.6 4.5 16.9 9.1 6.5 KCNQ1 "JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1" ENSG00000053918 "Potassium voltage-gated channel subfamily Q member 1" P51787 11 2444684-2849110 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, Deafness, Diabetes mellitus, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 78.2;ductus deferens: 88.1;seminal vesicle: 83.6" "Cell line enhanced" "Detected in some" "HMC-1: 22.3;RPMI-8226: 15.0;U-266/70: 8.9;U-937: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB018656, HPA048553" Enhanced "CAB018656: AB_2131551, HPA048553: " "unprognostic (6.02e-2)" "unprognostic (2.48e-1)" "unprognostic (6.39e-3)" "unprognostic (4.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.83e-1)" "unprognostic (3.46e-2)" "unprognostic (7.36e-2)" "unprognostic (8.07e-2)" "unprognostic (8.81e-2)" "unprognostic (1.58e-1)" "unprognostic (5.39e-2)" "unprognostic (2.46e-3)" "prognostic favourable (9.85e-4)" "unprognostic (3.99e-2)" "unprognostic (4.19e-2)" "unprognostic (5.27e-2)" 3.0 78.2 1.0 5.1 1.0 3.4 3.1 0.6 1.2 5.0 13.7 4.1 88.1 14.2 1.9 15.9 1.5 2.1 12.2 10.7 1.5 1.0 13.8 1.0 11.4 5.8 1.2 0.8 1.6 25.6 5.6 2.7 1.8 1.8 7.5 4.6 2.5 9.5 83.6 0.8 1.0 18.4 1.5 1.4 5.5 31.2 3.6 1.5 1.6 36.2 0.9 4.8 5.5 3.6 1.2 5.6 5.3 4.7 0.0 1.7 1.4 0.0 0.1 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 1.6 1.0 3.7 0.0 0.1 0.5 0.0 0.0 0.2 1.0 0.0 2.6 0.3 0.2 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.8 0.2 0.1 0.0 15.0 5.6 1.8 0.5 4.1 0.5 0.0 0.0 0.1 5.7 0.0 0.0 0.2 0.1 0.0 8.9 0.0 0.0 0.0 8.8 0.0 1.6 4.7 4.7 0.0 2.6 0.1 1.2 0.6 0.1 5.6 0.6 1.7 1.7 5.3 0.0 3.7 1.9 0.5 1.4 1.0 1.0 0.6 1.2 1.5 1.0 1.2 0.8 1.8 1.5 KCNQ2 "BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2" ENSG00000075043 "Potassium voltage-gated channel subfamily Q member 2" O43526 20 63400210-63472677 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.8" "Cell line enhanced" "Detected in some" "AF22: 8.3;AN3-CA: 13.7;NTERA-2: 7.6;SCLC-21H: 26.9;SH-SY5Y: 47.2" "Cancer enriched" "Detected in some" 9 "glioma: 8.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.2;T-reg: 1.5" "Lineage enriched" "Detected in single" 22 "T-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016642, HPA057112" Enhanced Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA016642: AB_1855555, HPA057112: " "unprognostic (2.35e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-4)" "unprognostic (8.21e-6)" "unprognostic (6.18e-2)" "unprognostic (7.58e-2)" "unprognostic (6.06e-2)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.96e-2)" "unprognostic (9.39e-2)" "unprognostic (1.43e-5)" "unprognostic (4.36e-2)" "unprognostic (1.02e-1)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" 1.2 10.0 18.7 1.3 21.4 1.2 1.2 24.1 50.8 1.2 1.3 2.4 0.0 1.3 1.2 1.3 1.2 1.7 1.7 1.2 15.4 10.0 1.2 1.2 1.2 1.2 8.4 14.1 1.2 1.9 1.2 9.2 1.2 8.9 2.8 1.2 0.0 1.2 1.2 1.2 1.2 1.3 1.2 2.6 1.2 1.3 6.9 4.2 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 8.3 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 26.9 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 1.5 0.0 18.7 21.4 24.1 31.2 15.4 10.0 8.4 14.1 8.9 4.2 KCNQ5 Kv7.5 ENSG00000185760 "Potassium voltage-gated channel subfamily Q member 5" Q9NR82 6 72621792-73198851 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9" "Cell line enhanced" "Detected in many" "BJ: 20.1;HL-60: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA016655 Enhanced Approved Vesicles Vesicles "HPA016655: AB_1855557" "unprognostic (4.91e-2)" "unprognostic (1.42e-1)" "unprognostic (4.96e-2)" "unprognostic (3.78e-2)" "unprognostic (2.69e-1)" "unprognostic (2.18e-2)" "unprognostic (3.57e-2)" "unprognostic (1.43e-1)" "unprognostic (6.09e-2)" "unprognostic (8.55e-2)" "unprognostic (7.96e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (1.08e-2)" "unprognostic (2.62e-1)" "unprognostic (8.16e-2)" "unprognostic (1.39e-3)" 0.7 2.8 4.2 3.0 14.9 6.6 1.1 0.6 19.6 0.6 0.9 0.0 0.0 0.8 0.7 0.6 1.7 1.0 0.9 0.6 6.9 2.7 0.6 0.8 0.8 3.4 3.0 7.5 0.7 0.6 0.6 0.5 1.0 23.0 2.4 0.9 2.2 2.1 1.9 26.1 0.6 0.9 1.7 0.9 2.0 0.8 2.0 0.7 1.6 6.9 0.4 3.1 1.2 0.7 2.7 0.5 1.2 0.0 2.2 1.7 0.2 2.5 0.6 0.0 0.1 0.0 0.9 0.0 20.1 3.0 3.0 2.6 0.0 0.0 12.0 0.0 6.8 0.4 0.1 1.2 3.6 0.1 4.2 13.1 0.0 0.0 0.5 17.6 0.0 0.2 0.5 8.6 9.0 0.0 0.7 8.3 5.9 0.1 0.0 7.5 0.7 4.2 0.0 0.6 8.2 1.1 0.0 3.4 1.6 0.0 0.0 8.2 2.5 1.3 0.0 12.5 5.5 0.0 13.3 8.7 0.2 5.5 0.1 8.5 0.7 1.2 0.0 0.0 0.2 0.0 1.1 2.7 0.5 1.5 0.5 1.4 1.7 1.2 0.0 2.2 0.0 0.0 0.0 0.2 4.2 14.9 0.6 19.6 6.9 2.7 3.0 7.5 23.0 0.7 KCTD8 ENSG00000183783 "Potassium channel tetramerization domain containing 8" Q6ZWB6 4 44173909-44448807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.5" "Cell line enhanced" "Detected in some" "HAP1: 4.0;NTERA-2: 2.8;PC-3: 1.7;SCLC-21H: 10.6;U-2 OS: 3.2" "Cancer enhanced" "Detected in some" "glioma: 0.9;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031562 Enhanced Approved Vesicles Vesicles "HPA031562: AB_10602609" "unprognostic (1.49e-2)" "unprognostic (7.70e-3)" "unprognostic (1.53e-1)" "unprognostic (4.15e-1)" "unprognostic (1.77e-2)" "unprognostic (1.48e-1)" "unprognostic (7.85e-2)" "unprognostic (2.62e-3)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (2.57e-3)" "unprognostic (8.72e-2)" "unprognostic (3.55e-2)" "unprognostic (2.44e-1)" 2.0 1.4 5.4 0.9 12.2 0.7 0.9 19.5 18.9 2.2 1.0 8.5 3.5 0.8 4.2 1.3 0.8 1.1 1.5 1.1 4.8 5.2 2.8 0.7 1.0 0.7 8.9 4.0 4.3 2.4 0.7 0.2 0.7 6.8 1.5 1.1 2.3 1.7 3.1 2.6 0.8 0.9 2.3 8.0 0.7 2.6 3.8 8.3 0.0 8.6 0.4 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.7 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 12.2 19.5 8.5 4.8 5.2 8.9 4.0 6.8 8.3 KDR "CD309, FLK1, VEGFR, VEGFR2" ENSG00000128052 "Kinase insert domain receptor" P35968 4 55078259-55125595 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 31.8;TIME: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB004028 Enhanced Supported "Plasma membrane" "Intracellular and membrane" 7400000 "Plasma membrane" "CAB004028: AB_2212507" "unprognostic (1.61e-1)" "unprognostic (2.03e-1)" "unprognostic (9.65e-2)" "unprognostic (1.97e-1)" "unprognostic (9.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.78e-3)" "unprognostic (2.59e-2)" "unprognostic (1.19e-2)" "unprognostic (1.10e-1)" "unprognostic (8.79e-3)" "unprognostic (1.34e-1)" "prognostic unfavourable (7.26e-4)" "unprognostic (4.00e-2)" "unprognostic (2.30e-1)" "unprognostic (3.22e-1)" "unprognostic (1.86e-1)" 19.7 6.2 1.8 4.4 3.1 0.4 20.5 1.1 2.2 11.4 6.0 1.8 11.5 2.3 28.8 10.2 5.2 9.5 6.2 12.1 2.3 1.7 7.8 10.4 13.2 14.1 3.1 2.9 6.0 8.1 8.0 6.8 34.5 3.9 9.5 1.4 27.6 7.1 10.3 5.3 3.0 3.8 7.7 2.6 4.4 4.2 5.3 1.2 0.5 20.0 5.3 3.0 4.4 12.0 0.1 0.1 0.7 0.0 0.2 0.2 0.1 0.0 0.0 1.7 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 3.7 0.0 0.0 0.3 0.0 0.0 0.2 31.8 0.0 0.0 0.2 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 1.8 3.1 1.1 2.2 2.3 1.7 3.1 2.9 3.9 1.2 KDSR "DHSR, FVT1, SDR35C1" ENSG00000119537 "3-ketodihydrosphingosine reductase" Q06136 18 63327726-63367510 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Cancer-related genes, Disease mutation, Palmoplantar keratoderma, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 37.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003673, HPA044884" Approved "CAB003673: AB_425440, HPA044884: " "unprognostic (4.44e-2)" "unprognostic (8.57e-2)" "unprognostic (2.52e-2)" "unprognostic (4.56e-2)" "unprognostic (5.88e-3)" "unprognostic (7.50e-3)" "unprognostic (1.80e-2)" "unprognostic (2.66e-1)" "unprognostic (2.97e-1)" "unprognostic (1.97e-1)" "unprognostic (2.70e-2)" "unprognostic (6.81e-2)" "prognostic favourable (9.53e-6)" "unprognostic (3.32e-2)" "unprognostic (5.77e-2)" "unprognostic (2.22e-1)" "unprognostic (2.16e-3)" 21.1 19.4 19.0 11.1 22.4 6.4 29.7 12.5 17.2 18.2 17.3 23.9 14.2 10.0 19.4 30.0 17.8 14.3 17.7 15.8 19.7 16.9 21.3 52.6 15.3 11.5 32.1 14.6 29.1 14.3 19.6 10.5 24.9 19.5 18.0 11.0 15.9 16.1 17.4 12.4 28.8 13.1 18.9 39.0 9.1 11.8 10.4 23.3 8.8 21.2 12.3 9.9 19.9 22.8 4.0 5.6 0.9 5.6 9.8 19.5 3.7 5.9 2.6 2.8 3.1 22.0 16.5 5.4 19.5 12.0 4.3 5.8 1.1 4.0 6.0 8.4 7.6 26.1 3.5 11.0 5.3 11.2 5.8 4.6 3.5 1.3 16.9 8.4 3.2 15.7 20.9 6.9 19.8 4.2 3.7 8.6 11.4 2.4 9.3 3.9 3.3 9.8 6.3 8.1 8.5 11.9 3.8 3.5 6.8 9.4 4.6 8.4 2.5 4.8 10.0 18.4 4.4 6.1 8.5 37.6 17.1 3.4 13.8 5.2 5.4 0.0 3.7 0.3 4.8 5.6 19.5 4.0 10.2 7.6 5.6 3.6 7.3 4.6 0.9 9.8 2.6 2.8 12.9 3.7 19.0 22.4 12.5 15.9 19.7 16.9 32.1 14.6 19.5 23.3 KEL "CD238, ECE3" ENSG00000197993 "Kell blood group, metallo-endopeptidase" P23276 7 142941114-142962681 "Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 21.1;testis: 36.4" "Group enriched" "Detected in some" 12 "HEL: 14.9;K-562: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA064442 Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA064442: " "unprognostic (5.78e-3)" "unprognostic (1.08e-5)" "unprognostic (5.29e-3)" "unprognostic (4.85e-3)" "unprognostic (9.68e-2)" "unprognostic (1.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "unprognostic (5.18e-2)" "unprognostic (1.08e-2)" "unprognostic (3.71e-2)" "unprognostic (3.57e-2)" "unprognostic (2.29e-3)" "unprognostic (9.24e-2)" "unprognostic (7.05e-2)" "unprognostic (3.32e-2)" "unprognostic (3.25e-3)" 0.2 0.0 0.9 2.5 1.1 21.1 0.2 0.2 0.4 0.4 0.2 0.3 0.2 0.0 0.2 0.2 0.6 0.1 0.2 0.2 1.4 0.7 0.4 0.2 1.4 5.0 2.0 0.2 0.2 0.2 0.0 0.2 1.1 0.3 0.2 0.0 0.3 2.5 0.2 0.2 0.0 0.5 0.2 4.4 3.8 0.0 36.4 0.3 0.4 0.2 0.2 3.7 0.2 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.1 0.1 0.0 0.0 0.5 0.2 0.3 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 1.1 0.2 0.4 1.4 0.7 2.0 0.2 0.3 0.3 KHDC1 "bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1" ENSG00000135314 "KH domain containing 1" Q4VXA5 6 73241314-73310365 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA029032 Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA029032: AB_10602914" "unprognostic (3.46e-1)" "unprognostic (2.20e-2)" "unprognostic (1.74e-1)" "unprognostic (2.73e-4)" "unprognostic (1.95e-1)" "unprognostic (2.18e-1)" "unprognostic (1.20e-1)" "unprognostic (7.54e-2)" "unprognostic (5.76e-2)" "unprognostic (6.27e-2)" "unprognostic (1.16e-1)" "unprognostic (4.97e-3)" "unprognostic (1.83e-4)" "unprognostic (8.18e-2)" "unprognostic (2.97e-1)" "unprognostic (2.14e-1)" "unprognostic (5.17e-3)" 2.9 2.9 10.3 2.0 12.9 0.9 2.2 8.8 14.6 4.7 1.3 2.6 1.2 0.6 3.9 3.3 2.7 6.2 2.6 3.4 8.5 8.4 1.3 0.4 1.8 3.1 8.6 5.7 7.4 4.4 5.0 9.6 1.5 4.7 4.4 1.4 2.9 1.3 3.6 2.7 1.0 1.1 2.4 6.2 0.9 2.9 8.2 4.1 5.4 5.9 1.7 3.4 2.2 2.1 2.7 2.6 3.8 0.2 2.5 5.2 2.0 2.8 4.2 0.8 2.2 4.0 4.5 2.0 5.6 5.4 8.7 12.8 4.0 2.2 6.1 2.2 2.4 2.8 5.8 1.1 6.6 5.8 4.2 4.1 3.4 0.0 5.1 1.9 0.1 5.8 2.4 8.6 2.4 1.9 3.0 7.3 3.4 6.8 0.4 1.8 3.8 8.3 0.9 0.0 4.9 1.3 0.1 10.3 2.1 3.2 0.1 0.2 0.1 6.1 0.1 1.8 4.0 1.1 5.9 12.5 7.5 4.4 0.1 1.7 0.6 3.8 0.2 0.0 4.4 0.0 2.6 2.7 2.8 4.9 0.7 1.9 2.2 3.4 0.0 2.5 0.0 2.6 5.2 2.0 10.3 12.9 8.8 12.4 8.5 8.4 8.6 5.7 4.7 4.1 KIAA0319 NMIG ENSG00000137261 KIAA0319 Q5VV43 6 24544104-24646155 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 23.5" "Cell line enhanced" "Detected in some" "A-431: 3.6;A549: 4.1;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 1.4;neutrophil: 5.0" "Group enriched" "Detected in many" 32 "B-cells: 1.4;granulocytes: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015607, HPA076313" Enhanced Supported Approved Vesicles "Secreted in brain" Vesicles "HPA015607: AB_1852299, HPA076313: " "unprognostic (1.64e-1)" "unprognostic (2.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (1.77e-1)" "unprognostic (1.72e-2)" "unprognostic (4.65e-2)" "unprognostic (9.70e-2)" "unprognostic (2.21e-5)" "unprognostic (7.88e-4)" "unprognostic (9.53e-4)" "unprognostic (1.44e-6)" "unprognostic (1.20e-1)" "unprognostic (6.97e-2)" "unprognostic (3.13e-1)" "unprognostic (3.41e-2)" 0.9 1.9 9.9 1.3 10.2 0.9 1.1 10.7 23.5 0.9 1.6 4.0 0.0 0.9 0.9 0.9 0.8 4.8 1.4 0.8 9.7 7.7 0.9 0.8 2.2 0.9 5.8 12.1 0.8 3.0 0.8 3.8 1.1 10.2 1.7 1.7 0.0 0.8 0.9 0.8 2.4 1.1 1.1 1.4 1.1 3.2 3.5 2.3 0.0 0.8 0.0 1.1 0.9 0.1 1.4 0.0 5.0 0.0 0.0 0.0 0.0 3.6 4.1 0.2 2.6 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 1.5 1.1 2.0 0.0 1.7 0.7 0.0 0.0 4.8 1.8 0.0 3.5 0.2 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.0 0.5 0.3 0.2 0.0 0.8 0.1 0.2 7.8 0.5 0.1 2.2 0.0 0.8 0.0 0.0 0.0 0.6 0.4 0.7 0.6 6.3 0.3 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 9.9 10.2 10.7 14.9 9.7 7.7 5.8 12.1 10.2 2.3 KIAA0319L "AAVR, KIAA1837" ENSG00000142687 "KIAA0319 like" Q8IZA0 1 35433490-35557950 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 27.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072692 Supported Supported "Nucleoli,Golgi apparatus" 870000 "Golgi apparatus" Nucleoli "HPA072692: " "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (4.23e-3)" "unprognostic (1.75e-1)" "unprognostic (1.30e-2)" "unprognostic (1.87e-1)" "prognostic unfavourable (5.92e-5)" "unprognostic (3.41e-3)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.79e-1)" "prognostic favourable (1.27e-4)" "unprognostic (1.47e-1)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (1.84e-1)" 10.6 23.5 20.3 10.6 29.0 9.9 20.1 21.9 37.2 19.2 17.7 24.1 17.0 18.1 19.7 19.2 14.4 25.1 15.7 30.7 19.4 20.0 27.5 32.1 21.3 11.0 19.4 20.1 13.0 32.8 38.5 28.1 21.1 23.0 25.3 21.3 24.5 33.9 20.5 27.4 13.8 19.8 12.7 16.6 17.1 23.3 14.0 17.5 11.9 29.3 11.9 17.4 12.9 12.0 2.3 3.2 27.1 11.0 5.5 3.5 4.5 6.1 9.2 19.2 15.1 26.0 18.4 18.2 8.4 18.0 12.3 18.3 9.9 25.1 6.9 23.3 9.2 12.4 14.1 13.6 14.1 11.0 10.3 9.4 11.3 10.9 20.4 7.7 13.0 25.8 17.5 14.2 18.5 20.1 12.3 10.1 16.7 6.2 4.6 6.5 21.7 5.5 5.2 16.3 8.6 20.4 15.2 4.2 11.9 12.2 14.7 25.1 15.4 11.0 20.5 8.5 9.2 7.1 13.0 15.0 12.0 4.6 21.6 10.2 8.4 4.5 11.0 5.0 3.0 3.6 2.9 2.0 2.5 2.8 3.2 2.3 3.5 2.5 27.1 5.5 2.2 2.1 2.3 4.5 20.3 29.0 21.9 37.2 19.4 20.0 19.4 20.1 23.0 17.5 KIAA1024 ENSG00000169330 KIAA1024 Q9UPX6 15 79432516-79472290 "Predicted membrane proteins" Angiogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 16.8;brain: 10.8" "Cell line enhanced" "Detected in many" "U-138 MG: 14.1" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in many" 5 "cerebellum: 10.8;pons and medulla: 8.5" "Group enriched" "Detected in some" 12 "eosinophil: 2.5;non-classical monocyte: 1.9" "Group enriched" "Detected in many" 12 "granulocytes: 2.5;monocytes: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011545 Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA011545: AB_1852361" "unprognostic (5.45e-5)" "unprognostic (3.26e-1)" "unprognostic (4.56e-3)" "unprognostic (2.12e-2)" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (4.49e-2)" "unprognostic (5.66e-2)" "unprognostic (2.90e-1)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "unprognostic (4.45e-2)" "unprognostic (6.66e-13)" "unprognostic (7.08e-2)" "unprognostic (2.73e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" 0.1 16.8 0.8 0.2 0.6 0.7 0.5 10.8 2.0 0.6 0.2 0.4 0.1 0.0 0.4 0.5 0.5 0.1 0.6 0.1 0.5 1.4 0.2 0.1 0.1 0.6 1.2 1.5 0.2 3.5 0.0 0.7 0.5 8.5 1.2 0.3 0.7 4.2 0.2 0.6 0.2 0.2 0.2 1.7 0.3 0.2 1.1 1.0 0.1 0.2 0.1 0.4 0.2 0.1 0.1 0.1 2.5 1.9 0.0 0.1 0.0 0.4 0.3 0.6 0.8 1.8 1.6 0.7 0.8 1.5 0.7 0.8 0.0 0.4 1.1 0.2 1.3 0.3 1.5 0.1 0.5 1.3 1.7 3.0 0.7 0.0 1.0 4.0 1.5 0.7 0.3 1.2 0.2 0.8 0.2 0.0 0.2 0.0 0.6 1.4 0.7 0.7 0.6 0.1 0.6 0.2 0.0 3.0 1.6 0.3 2.6 1.5 0.3 2.0 0.5 14.1 0.5 0.0 2.9 1.8 2.1 0.5 1.4 2.2 1.7 0.0 0.0 2.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.8 0.6 10.8 2.0 0.5 1.4 1.2 1.5 8.5 1.0 KIAA1024L ENSG00000186367 "KIAA1024 like" P59773 5 129748079-129766732 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 26.0" "Cell line enhanced" "Detected in some" "SH-SY5Y: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA013760 Uncertain "HPA013760: AB_1852363" "unprognostic (1.77e-1)" "unprognostic (5.13e-1)" 0.0 0.0 0.1 0.0 0.9 0.1 0.1 0.0 2.8 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.1 2.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 26.0 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 2.8 4.1 1.1 0.8 0.8 0.1 0.6 0.1 0.1 1.9 0.2 0.1 0.5 0.3 0.2 0.3 0.4 0.1 3.1 1.0 1.3 0.2 1.6 0.0 0.3 0.2 1.6 1.2 0.4 0.7 0.8 0.0 0.2 1.4 0.6 0.4 0.1 0.4 0.2 0.4 2.1 0.5 0.4 1.5 1.7 1.2 1.6 0.3 0.5 0.6 0.5 0.8 0.8 4.7 0.2 3.1 0.5 1.2 0.3 0.2 1.6 1.2 0.9 0.3 0.2 0.8 0.5 1.2 0.1 2.4 4.1 1.1 0.6 0.8 0.6 0.8 0.6 0.6 0.5 0.3 1.6 0.6 0.8 2.6 0.8 1.0 2.8 0.3 0.1 0.1 0.9 0.0 2.8 0.1 2.0 0.3 0.0 1.9 0.0 KIAA1109 "FLJ21404, FSA, KIAA1371, Tweek" ENSG00000138688 KIAA1109 Q2LD37 4 122152333-122362758 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038076 Approved Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA038076: AB_10670652" "unprognostic (2.53e-1)" "unprognostic (2.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.63e-3)" "unprognostic (1.04e-1)" "unprognostic (6.62e-2)" "unprognostic (7.61e-2)" "unprognostic (3.65e-2)" "unprognostic (2.38e-1)" "unprognostic (7.97e-2)" "prognostic favourable (4.33e-8)" "unprognostic (2.04e-1)" "unprognostic (3.55e-1)" "unprognostic (2.28e-2)" "unprognostic (2.29e-2)" 18.4 17.1 25.6 18.0 34.1 42.9 26.1 33.4 34.2 22.9 18.7 24.1 17.9 15.6 20.9 25.4 12.3 16.8 16.4 15.3 25.5 22.0 24.0 17.4 19.5 14.8 26.4 26.2 34.3 16.6 68.2 33.1 14.3 33.6 19.1 18.8 22.6 16.6 21.5 40.1 23.1 20.8 18.6 29.3 20.0 15.2 20.4 24.2 15.3 25.4 12.6 13.6 18.0 18.5 3.1 2.3 7.7 3.6 1.7 3.5 0.7 16.7 5.5 12.8 8.4 21.4 27.9 6.7 7.6 14.3 7.9 8.7 4.0 8.9 8.8 4.4 18.0 6.3 7.9 9.4 12.8 6.6 5.0 9.7 10.0 7.6 11.1 9.1 5.4 16.0 11.3 9.4 13.0 16.7 6.3 10.7 16.1 5.6 7.8 7.1 4.2 6.1 4.5 17.8 2.2 13.8 12.7 7.5 6.7 4.8 5.5 10.7 6.0 7.5 22.3 9.8 9.7 8.0 7.7 10.4 6.7 6.4 10.4 8.0 7.1 3.3 1.4 7.7 3.3 3.6 3.5 2.5 2.3 2.3 1.4 3.1 2.0 2.3 6.6 1.7 1.7 2.3 2.9 0.7 25.6 34.1 33.4 34.2 25.5 22.0 26.4 26.2 33.6 24.2 KIAA1324 "EIG121, maba1" ENSG00000116299 KIAA1324 Q6UXG2 1 109113679-109206781 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 79.8;salivary gland: 169.4" "Cell line enhanced" "Detected in some" "MCF7: 14.1;SCLC-21H: 9.1;SK-BR-3: 11.0;T-47d: 37.8;U-87 MG: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 7 "neutrophil: 33.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 33.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA029869, HPA070749" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA029869: AB_10794320, HPA070749: AB_2686304" "unprognostic (2.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.99e-2)" "prognostic favourable (2.14e-7)" "unprognostic (4.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-3)" "prognostic favourable (5.69e-5)" "unprognostic (2.79e-2)" "prognostic favourable (2.16e-4)" "unprognostic (3.50e-3)" "unprognostic (1.01e-1)" "unprognostic (2.22e-16)" "unprognostic (2.46e-1)" "unprognostic (1.75e-1)" "unprognostic (5.64e-2)" "unprognostic (8.02e-2)" 0.7 0.9 3.7 3.6 7.9 0.0 16.4 0.7 5.6 23.9 11.8 0.4 0.0 14.6 5.5 5.7 1.3 7.8 19.1 0.6 3.3 2.3 0.6 0.6 2.2 0.7 1.0 2.7 1.2 79.8 6.1 46.6 0.0 1.1 15.8 10.0 0.0 169.4 0.0 0.6 2.5 16.5 0.2 0.9 0.9 27.3 9.4 1.1 0.0 3.9 5.2 11.5 0.9 0.6 0.2 0.0 33.8 0.0 0.2 4.6 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 14.1 0.1 0.1 0.2 0.0 0.0 0.1 0.5 0.2 0.0 9.1 0.2 0.0 11.0 0.0 37.8 0.0 0.2 0.0 1.4 0.0 0.1 0.8 2.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.9 0.2 3.9 1.7 0.0 0.0 1.8 0.7 33.8 0.2 0.0 0.0 4.6 1.0 3.7 7.9 0.7 5.6 3.3 2.3 1.0 2.7 1.1 1.1 KIAA1324L "EIG121L, FLJ31340" ENSG00000164659 "KIAA1324 like" A8MWY0 7 86876906-87059699 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.9" "Cell line enhanced" "Detected in many" "AF22: 15.4;hTERT-HME1: 18.0;HUVEC TERT2: 15.0;K-562: 23.0;SCLC-21H: 19.2;SH-SY5Y: 14.4;TIME: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.8" "Group enriched" "Detected in many" 5 "B-cells: 2.7;NK-cells: 4.8;T-cells: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044527, HPA076093" Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA044527: AB_10963793, HPA076093: " "unprognostic (2.78e-2)" "unprognostic (9.37e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-4)" "unprognostic (3.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.33e-3)" "unprognostic (1.89e-1)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (6.82e-2)" "unprognostic (8.82e-3)" "unprognostic (3.86e-3)" "unprognostic (1.25e-1)" "unprognostic (4.32e-1)" "unprognostic (1.37e-1)" 11.1 4.5 7.7 2.3 17.3 1.0 6.5 15.6 15.8 4.0 5.0 28.9 1.2 1.8 4.3 1.0 4.5 3.9 5.0 5.5 10.8 8.7 2.9 1.5 24.4 3.8 22.4 10.4 2.7 5.5 11.7 13.5 9.0 22.7 7.6 6.5 2.4 3.6 6.3 3.5 3.4 2.7 6.4 23.5 6.4 4.1 3.6 21.7 0.0 6.1 1.0 4.0 5.9 2.8 2.7 0.9 0.4 0.0 4.8 5.8 0.7 0.9 0.0 15.4 0.0 0.2 0.0 4.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 3.9 0.3 0.0 1.7 0.0 0.0 3.7 0.3 11.8 4.1 1.3 0.1 0.1 1.5 1.3 0.0 0.0 18.0 15.0 23.0 0.4 1.7 4.7 0.3 0.0 8.4 3.9 0.0 1.0 2.4 1.6 6.9 19.2 14.4 4.1 5.4 1.7 1.6 0.3 17.7 0.2 6.1 0.1 0.0 8.5 5.0 0.1 4.5 0.0 0.2 0.0 0.0 0.4 0.7 0.0 5.8 0.9 2.1 1.3 0.4 2.7 2.2 1.2 0.0 4.8 0.0 0.9 0.7 0.7 7.7 17.3 15.6 15.8 10.8 8.7 22.4 10.4 22.7 21.7 KIAA1468 "FLJ33841, HsT3308, HsT885" ENSG00000134444 KIAA1468 Q9P260 18 62187255-62310217 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039708, HPA040038" Approved Approved "Nucleoplasm,Centriolar satellite,Cytosol" "Nucleoplasm, Centriolar satellite, Cytosol" "HPA039708: AB_10794753, HPA040038: AB_10793860" "unprognostic (1.33e-1)" "unprognostic (2.22e-1)" "unprognostic (3.98e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (4.03e-2)" "unprognostic (1.98e-3)" "unprognostic (2.44e-2)" "unprognostic (6.30e-2)" "unprognostic (3.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.36e-1)" "unprognostic (4.84e-3)" "unprognostic (2.47e-2)" "unprognostic (6.86e-2)" "unprognostic (3.54e-1)" "unprognostic (1.71e-2)" 11.7 13.3 14.8 15.7 31.6 18.3 17.8 25.7 25.9 14.3 16.5 14.3 16.6 13.8 13.9 18.3 36.5 11.8 13.9 10.3 12.5 14.4 14.8 11.5 11.8 15.8 13.7 16.0 12.8 12.6 20.2 20.0 11.9 22.8 18.5 21.7 13.5 18.8 14.1 11.8 29.6 15.5 11.1 11.4 17.1 18.0 8.0 16.8 18.3 14.4 16.6 22.0 15.5 21.7 3.7 3.5 6.0 3.5 4.0 4.7 1.9 7.7 7.0 8.6 8.2 9.2 10.8 9.2 13.9 11.6 12.4 13.8 3.6 7.2 5.3 7.2 12.2 16.1 12.2 8.3 15.4 4.8 7.6 4.4 7.9 8.2 8.2 8.5 6.3 8.0 10.2 10.6 6.5 8.5 3.3 5.4 13.1 4.5 5.2 7.3 5.0 6.0 6.5 10.8 6.2 14.2 15.5 12.3 6.5 8.3 12.3 7.1 6.3 9.3 10.8 13.4 4.2 5.8 6.9 16.0 2.9 5.2 9.4 9.2 10.6 5.0 3.5 4.1 4.1 3.0 3.3 3.0 3.8 3.9 3.5 3.7 4.1 4.7 6.0 4.0 2.5 2.4 4.4 1.9 14.8 31.6 25.7 25.9 12.5 14.4 13.7 16.0 22.8 16.8 KIAA1549L "C11orf41, C11orf69, G2, MGC34830" ENSG00000110427 "KIAA1549 like" Q6ZVL6 11 33376466-33674102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 30.4;parathyroid gland: 64.4" "Cell line enhanced" "Detected in many" "TIME: 22.7;U-138 MG: 30.0;WM-115: 20.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010132, HPA051594" Approved Nucleoplasm,Vesicles 27000 Nucleoplasm Vesicles "HPA010132: AB_1078313, HPA051594: " "unprognostic (3.02e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (1.34e-5)" "unprognostic (2.63e-1)" "unprognostic (7.92e-2)" "unprognostic (2.89e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-2)" "unprognostic (2.59e-4)" "unprognostic (8.88e-2)" "unprognostic (1.44e-1)" "unprognostic (3.62e-3)" "unprognostic (1.08e-3)" "unprognostic (8.46e-2)" "unprognostic (4.04e-1)" "unprognostic (1.09e-1)" 0.8 0.9 8.2 0.7 20.5 0.6 1.2 6.2 30.4 0.7 0.7 1.7 0.0 0.6 0.7 0.6 0.9 0.6 0.8 0.6 5.3 2.4 0.9 0.6 0.6 0.7 1.6 17.1 0.7 0.8 64.4 1.0 1.4 2.3 0.7 0.7 0.0 0.7 0.6 0.6 1.9 0.6 0.7 1.1 0.6 0.7 1.3 1.6 0.0 0.6 0.0 1.1 0.9 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 3.3 0.1 0.5 3.7 0.0 13.1 7.7 2.1 1.2 0.0 0.3 10.1 0.1 11.6 0.7 0.4 3.8 3.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.2 5.7 9.3 0.0 9.6 8.2 0.0 0.1 0.0 0.7 4.8 0.0 0.8 0.0 0.0 5.0 1.1 1.2 0.1 0.0 3.1 0.0 0.0 22.7 30.0 6.3 0.7 10.5 0.0 0.0 0.0 7.9 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.2 20.5 6.2 30.4 5.3 2.4 1.6 17.1 2.3 1.6 KIAA2013 "MGC33867, RP5-1077B9.1" ENSG00000116685 KIAA2013 Q8IYS2 1 11919591-11926428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052677, HPA060536" Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA052677: , HPA060536: " "unprognostic (3.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.63e-2)" "unprognostic (1.48e-1)" "unprognostic (2.02e-2)" "unprognostic (1.87e-2)" "unprognostic (5.51e-3)" "unprognostic (8.60e-2)" "unprognostic (5.26e-2)" "unprognostic (2.92e-1)" "unprognostic (1.10e-2)" "unprognostic (5.04e-2)" "unprognostic (6.05e-2)" "unprognostic (2.04e-2)" "unprognostic (2.94e-2)" "unprognostic (8.24e-3)" "unprognostic (3.74e-3)" 13.8 13.9 12.0 10.6 16.7 10.9 12.9 11.9 18.7 13.7 32.0 25.2 16.7 42.6 19.1 24.9 15.4 14.7 19.7 18.9 12.5 10.8 17.1 34.4 12.4 12.6 22.8 10.6 12.2 34.0 9.6 17.7 24.6 16.1 15.1 13.5 14.8 26.2 18.6 24.4 18.6 55.1 14.4 16.0 19.2 16.0 21.7 19.0 15.0 19.8 11.2 14.1 17.4 13.1 7.0 10.8 13.8 6.3 4.6 6.3 3.0 23.5 17.6 8.3 16.3 14.1 9.7 13.7 15.1 16.0 18.3 19.0 21.6 24.6 15.5 23.2 14.2 27.6 11.2 14.9 9.8 17.9 28.6 10.6 16.3 36.9 16.0 22.0 22.1 12.3 16.7 17.9 7.9 17.5 16.3 20.8 10.9 17.9 14.0 31.0 10.9 24.3 18.0 15.2 37.5 11.6 6.5 31.0 17.5 12.2 13.7 28.8 11.5 20.6 16.6 15.5 20.3 22.7 20.5 25.1 17.7 17.7 18.4 35.9 16.4 4.2 6.3 6.1 6.2 5.3 4.9 6.1 3.4 4.7 4.3 7.0 3.4 4.5 13.8 4.6 4.2 10.8 6.3 3.0 12.0 16.7 11.9 18.7 12.5 10.8 22.8 10.6 16.1 19.0 KIRREL1 "KIRREL, NEPH1" ENSG00000183853 "Kirre like nephrin family adhesion molecule 1" Q96J84 1 157993273-158100262 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "WM-115: 73.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030458 Approved 590000 "HPA030458: AB_10601438" "unprognostic (8.92e-2)" "prognostic unfavourable (1.87e-4)" "unprognostic (3.76e-1)" "unprognostic (1.07e-3)" "unprognostic (7.96e-3)" "unprognostic (3.62e-2)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (4.48e-2)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (1.12e-8)" "unprognostic (2.11e-3)" "unprognostic (5.24e-2)" "unprognostic (1.68e-1)" "prognostic unfavourable (2.85e-4)" 27.8 11.6 1.9 9.4 2.5 0.0 27.0 1.4 2.2 21.8 12.1 2.1 9.5 2.8 28.8 10.4 12.2 14.3 18.0 9.5 1.5 2.5 12.4 4.1 13.2 9.2 2.2 2.2 32.6 3.7 2.7 4.5 20.4 4.6 14.0 5.5 23.5 6.8 12.8 7.2 6.0 6.6 20.9 2.2 11.9 6.8 10.9 1.3 5.1 11.4 8.5 6.1 17.3 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 9.5 17.0 15.4 24.3 21.3 0.0 17.1 22.6 13.9 11.3 17.0 13.5 0.0 29.2 19.0 12.6 9.5 15.5 11.0 0.0 2.1 0.0 9.7 0.0 18.1 0.0 0.2 27.4 6.3 23.6 18.3 8.8 0.1 0.0 12.7 0.0 2.4 0.0 13.3 7.5 2.6 8.0 0.1 39.4 0.2 2.7 0.1 14.8 0.0 31.6 1.3 0.3 16.1 18.7 11.9 18.3 22.8 0.0 0.0 0.0 16.0 0.0 73.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.5 1.4 2.2 1.5 2.5 2.2 2.2 4.6 1.3 KIRREL2 "DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1" ENSG00000126259 "Kirre like nephrin family adhesion molecule 2" Q6UWL6 19 35855861-35867109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "pancreas: 38.5" "Cell line enhanced" "Detected in some" "HDLM-2: 15.5;HMC-1: 25.0;U-937: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 5 "T-cells: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA071587, HPA074326" Enhanced Supported "Centriolar satellite" "Intracellular and membrane" "Centriolar satellite" "HPA071587: , HPA074326: " "unprognostic (1.28e-2)" "unprognostic (1.80e-1)" "unprognostic (3.29e-2)" "unprognostic (3.16e-3)" "unprognostic (2.05e-3)" "unprognostic (2.29e-1)" "unprognostic (2.00e-1)" "unprognostic (1.72e-3)" "unprognostic (3.30e-2)" "unprognostic (5.56e-2)" "unprognostic (4.85e-2)" "unprognostic (2.62e-2)" "unprognostic (2.43e-6)" "unprognostic (1.72e-1)" "unprognostic (4.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.62e-2)" 0.2 0.0 0.4 0.3 0.8 0.0 0.0 0.2 1.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.5 0.2 0.4 0.0 38.5 0.0 0.9 0.1 0.5 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.2 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.5 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.8 0.5 0.0 0.1 0.0 0.1 2.2 0.0 0.0 15.5 0.0 0.0 0.0 0.2 0.0 0.0 25.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.4 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 3.1 1.0 0.0 0.0 0.0 0.0 3.9 0.0 0.6 1.0 0.2 0.0 0.0 0.0 0.3 0.0 5.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.8 0.2 1.2 0.7 0.0 0.2 0.4 0.5 0.2 KIRREL3 "KIAA1867, KIRRE, NEPH2" ENSG00000149571 "Kirre like nephrin family adhesion molecule 3" Q8IZU9 11 126423359-127003460 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 10.9;brain: 28.2" "Cell line enhanced" "Detected in some" "BJ: 18.7;BJ hTERT+: 11.0;BJ hTERT+ SV40 Large T+: 7.0;BJ hTERT+ SV40 Large T+ RasG12V: 7.4;fHDF/TERT166: 13.4;U-138 MG: 8.6;U-251 MG: 10.2" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 10.9" "Lineage enriched" "Detected in single" 12 "dendritic cells: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053324 Enhanced "Intracellular and membrane" "HPA053324: " "unprognostic (1.92e-1)" "unprognostic (5.29e-2)" "unprognostic (1.06e-1)" "unprognostic (4.72e-2)" "unprognostic (2.50e-2)" "unprognostic (1.09e-1)" "unprognostic (4.49e-3)" "unprognostic (6.23e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (7.05e-3)" "unprognostic (3.81e-2)" "unprognostic (4.06e-6)" "unprognostic (9.91e-3)" "unprognostic (1.15e-1)" "unprognostic (2.76e-2)" "unprognostic (2.92e-1)" 1.2 4.0 12.3 1.9 20.0 1.4 1.0 13.2 28.2 1.5 2.2 23.6 0.0 1.7 1.1 1.0 1.7 1.1 1.4 2.3 9.1 7.2 1.1 1.0 1.0 2.1 7.2 11.7 1.3 1.4 0.9 0.1 1.6 9.9 1.0 1.8 0.6 3.5 3.4 1.0 1.1 1.7 1.9 8.9 2.6 1.5 1.2 12.1 0.0 1.0 0.0 1.9 1.1 0.2 0.0 10.9 0.9 0.0 0.0 0.0 0.0 0.3 2.2 0.1 0.0 0.0 0.1 0.1 18.7 11.0 7.0 7.4 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 4.4 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.8 0.0 0.0 4.4 0.1 0.3 0.0 0.0 0.9 0.0 0.1 2.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 8.6 6.0 3.4 10.2 0.0 0.0 0.0 0.0 0.0 4.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 12.3 20.0 13.2 17.4 9.1 7.2 7.2 11.7 9.9 12.1 KISS1R "AXOR12, GPR54, HOT7T175" ENSG00000116014 "KISS1 receptor" Q969F8 19 917287-921015 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;lymphoid tissue: 12.4" "Cell line enhanced" "Detected in some" "K-562: 10.5;RPMI-8226: 25.7;SCLC-21H: 5.4;SH-SY5Y: 14.4" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;neutrophil: 1.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007156, HPA071913" Approved Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA007156: , HPA071913: " "unprognostic (1.54e-1)" "unprognostic (3.01e-2)" "unprognostic (9.42e-2)" "unprognostic (2.15e-1)" "unprognostic (8.46e-3)" "unprognostic (9.23e-2)" "unprognostic (1.65e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (7.17e-2)" "prognostic unfavourable (3.33e-6)" "unprognostic (1.87e-1)" "unprognostic (8.09e-3)" "unprognostic (1.05e-1)" "unprognostic (2.05e-2)" 0.2 0.2 2.1 2.1 4.1 0.2 0.3 0.1 4.7 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.1 0.2 0.1 0.1 1.0 6.8 1.4 0.1 0.3 12.4 1.1 0.1 0.4 3.6 0.1 2.0 1.0 0.8 0.2 0.2 0.3 0.3 0.1 0.1 0.1 0.7 0.5 1.0 2.4 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.5 0.1 0.6 0.0 1.8 0.0 0.0 2.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 2.8 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.2 0.1 0.0 0.4 0.3 0.7 0.0 25.7 0.0 0.0 5.4 14.4 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.7 0.0 0.0 0.1 2.0 0.6 1.8 0.0 0.0 0.0 0.1 0.0 2.1 4.1 0.1 1.5 1.0 6.8 1.1 0.1 0.8 0.1 KITLG "DFNA69, FPH2, Kitl, KL-1, MGF, SCF, SF, SLF" ENSG00000049130 "KIT ligand" P21583 12 88492793-88580851 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Cell adhesion" "Growth factor" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 81.7;SK-BR-3: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070395 Approved Approved Vesicles "Intracellular and membrane" 150000 Vesicles "HPA070395: " "unprognostic (7.13e-2)" "unprognostic (1.90e-1)" "unprognostic (5.00e-2)" "unprognostic (2.05e-1)" "unprognostic (2.70e-1)" "unprognostic (1.93e-2)" "prognostic unfavourable (4.01e-4)" "unprognostic (2.22e-3)" "unprognostic (5.61e-3)" "unprognostic (7.89e-2)" "unprognostic (5.47e-3)" "unprognostic (5.03e-2)" "prognostic favourable (5.81e-7)" "unprognostic (7.15e-2)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.54e-2)" 10.1 3.8 7.8 8.0 6.4 0.0 11.2 4.8 11.5 9.6 16.1 2.9 8.5 6.2 11.7 8.7 16.7 4.7 13.9 5.6 8.4 3.9 21.9 2.8 22.9 6.1 3.3 7.7 4.4 5.0 1.9 3.2 10.1 4.0 17.9 15.9 7.8 11.8 14.8 4.8 5.3 9.5 21.0 3.7 2.6 13.0 5.8 2.9 0.7 6.5 5.8 6.6 17.5 17.8 0.0 0.2 0.0 0.5 0.0 0.0 0.0 3.4 1.9 1.8 0.2 7.1 15.3 0.0 21.0 15.0 3.6 1.6 81.7 3.3 0.0 0.6 17.6 12.7 2.7 4.7 3.4 0.0 2.4 0.0 2.9 0.6 1.1 0.4 0.0 13.2 5.0 11.4 6.8 4.3 0.0 0.0 1.6 0.6 0.0 0.0 1.2 4.7 0.0 3.3 0.0 6.0 1.7 0.5 1.2 5.1 28.5 0.5 14.6 1.0 2.9 16.5 2.3 19.2 1.6 0.0 0.0 0.0 2.1 0.0 1.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 6.4 4.8 11.5 8.4 3.9 3.3 7.7 4.0 2.9 KLHL5 ENSG00000109790 "Kelch like family member 5" Q96PQ7 4 39045039-39126857 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 75.8;HHSteC: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013958 Approved "HPA013958: AB_1852590" "unprognostic (6.02e-2)" "unprognostic (3.94e-1)" "unprognostic (3.92e-1)" "unprognostic (7.54e-3)" "unprognostic (5.35e-2)" "unprognostic (3.43e-1)" "unprognostic (2.48e-2)" "unprognostic (3.98e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-1)" "unprognostic (6.04e-2)" "unprognostic (2.87e-2)" "unprognostic (1.42e-2)" "unprognostic (1.05e-2)" "unprognostic (2.28e-1)" "unprognostic (1.36e-1)" "unprognostic (3.24e-3)" 24.6 15.0 31.9 21.2 27.6 5.1 33.1 10.4 20.9 11.9 29.5 20.7 15.6 8.1 12.7 9.2 21.3 6.7 15.1 10.1 31.5 25.2 16.4 35.2 14.0 19.6 33.4 11.9 12.5 7.3 7.3 6.4 33.1 18.1 24.4 10.9 6.5 8.1 44.5 6.1 4.6 9.8 32.3 34.2 14.3 10.9 6.9 20.7 6.9 14.0 4.6 23.9 25.7 14.3 7.4 4.1 5.6 5.2 1.8 2.6 1.3 12.8 18.2 9.7 7.1 5.5 14.3 14.1 10.3 75.8 8.7 8.5 14.9 9.4 19.8 12.6 10.5 0.7 11.9 26.2 11.2 2.0 2.3 8.4 17.2 10.6 47.9 2.4 2.8 18.1 14.7 13.2 33.1 17.3 6.3 4.0 20.5 5.4 2.5 4.4 3.0 17.8 4.7 12.7 0.5 7.5 5.3 0.6 7.1 5.8 1.9 5.0 4.5 5.2 21.9 23.3 16.0 6.0 12.3 4.6 4.1 18.3 18.9 6.5 5.4 5.6 3.9 0.8 1.4 5.2 2.1 7.4 2.6 1.5 4.1 5.9 2.1 1.0 4.3 1.8 2.3 1.5 0.5 1.3 31.9 27.6 10.4 15.8 31.5 25.2 33.4 11.9 18.1 20.7 KLRB1 "CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A" ENSG00000111796 "Killer cell lectin like receptor B1" Q12918 12 9594551-9607886 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 178.9" "Cell line enhanced" "Detected in some" "HEL: 3.0;Karpas-707: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 178.9" "Group enriched" "Detected in many" 133 "NK-cells: 53.0;T-cells: 178.9" "Low region specificity" "Detected in all" HPA039113 Approved Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039113: AB_10674979" "prognostic favourable (3.51e-5)" "unprognostic (1.23e-3)" "unprognostic (7.03e-3)" "prognostic favourable (1.42e-5)" "unprognostic (1.69e-1)" "prognostic favourable (6.99e-5)" "unprognostic (1.54e-3)" "unprognostic (7.15e-3)" "unprognostic (4.12e-1)" "unprognostic (8.23e-3)" "unprognostic (3.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "prognostic favourable (5.61e-4)" "unprognostic (1.17e-2)" 3.8 0.8 0.8 22.8 0.8 18.6 2.1 0.5 0.6 2.9 9.1 0.0 1.3 5.0 1.8 3.7 2.6 1.8 7.3 1.3 0.7 0.8 3.8 4.9 11.8 23.7 1.1 0.2 2.0 1.0 0.0 0.9 2.1 0.8 1.8 3.9 0.9 4.8 1.4 0.9 0.8 20.4 0.6 1.8 25.2 4.4 1.3 0.2 6.2 1.9 2.9 17.7 5.5 2.0 0.1 0.3 0.8 0.2 53.0 178.9 18.5 0.0 0.0 1.5 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.1 0.0 0.2 1.9 0.0 0.0 0.2 0.0 3.0 0.0 0.4 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.8 0.8 0.6 0.5 0.0 1.1 0.2 0.9 0.0 0.5 0.4 0.6 0.6 0.7 0.1 0.3 0.2 0.0 1.6 0.0 0.4 0.7 0.6 0.4 1.5 0.0 1.8 0.9 0.5 0.1 0.0 43.1 0.1 178.9 0.1 25.6 28.1 0.1 0.1 1.5 8.7 0.8 53.0 0.2 0.3 5.7 18.5 0.8 0.8 0.5 0.6 0.7 0.8 1.1 0.2 0.8 0.2 KLRC1 "CD159a, NKG2, NKG2-A, NKG2-B" ENSG00000134545 "Killer cell lectin like receptor C1" P26715 12 10442264-10454685 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 64.3;lymphoid tissue: 22.1" "Cell line enhanced" "Detected in some" "HeLa: 9.3;Karpas-707: 3.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 45.7;NK-cell: 64.3" "Group enriched" "Detected in many" 42 "NK-cells: 64.3;T-cells: 45.7" HPA058052 Approved "Plasma membrane" "Plasma membrane" "HPA058052: " "unprognostic (8.17e-3)" "unprognostic (2.13e-2)" "unprognostic (1.48e-2)" "unprognostic (4.58e-7)" "unprognostic (3.57e-1)" "unprognostic (1.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-2)" "unprognostic (3.73e-4)" "unprognostic (4.13e-2)" "unprognostic (6.49e-2)" "unprognostic (2.54e-1)" "unprognostic (1.18e-4)" "unprognostic (1.88e-1)" "unprognostic (3.23e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-3)" 2.4 0.5 1.2 5.8 1.4 5.6 2.3 1.0 2.7 1.7 3.3 0.7 1.2 1.5 5.5 3.9 1.7 2.5 2.4 2.6 1.6 1.3 1.9 2.0 5.9 10.3 2.3 0.6 1.2 1.4 0.3 1.3 3.6 1.5 1.9 2.5 2.0 3.1 0.3 0.5 1.0 5.0 2.1 2.6 22.1 5.2 1.4 0.5 3.5 1.9 3.0 2.9 2.9 1.8 0.1 0.0 1.2 0.1 64.3 45.7 5.1 0.4 1.6 0.1 0.1 0.6 0.4 0.8 0.0 0.0 0.8 1.7 0.0 1.3 0.2 0.1 0.4 0.3 0.6 2.8 1.1 0.9 0.4 2.1 9.3 0.0 0.1 0.6 0.4 1.0 0.0 0.3 0.0 0.8 1.3 3.8 0.8 0.0 0.2 2.8 0.0 0.0 0.9 0.2 0.3 0.2 0.0 0.5 0.1 0.8 0.0 0.3 0.3 0.0 2.6 0.4 0.0 0.0 0.3 0.0 0.0 0.7 2.2 0.8 0.0 0.2 0.0 0.0 45.7 0.0 5.8 0.1 0.0 7.9 0.0 0.0 0.0 6.9 1.2 64.3 0.1 0.0 0.0 5.1 1.2 1.4 1.0 0.9 1.6 1.3 2.3 0.6 1.5 0.5 KLRC2 "CD159c, NKG2-C" ENSG00000205809 "Killer cell lectin like receptor C2" P26717 12 10426854-10442300 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.8;brain: 16.2" "Cell line enhanced" "Detected in some" "HEL: 6.1;HeLa: 19.0;HSkMC: 4.6;U-87 MG: 3.1" "Cancer enriched" "Detected in single" 8 "glioma: 3.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 10.7;NK-cell: 32.8" "Group enriched" "Detected in many" 92 "NK-cells: 32.8;T-cells: 10.7" HPA058052 Approved "Plasma membrane" "Plasma membrane" "HPA058052: " "unprognostic (9.05e-4)" "unprognostic (2.54e-2)" "unprognostic (3.77e-2)" "unprognostic (2.51e-3)" "unprognostic (2.83e-1)" "unprognostic (9.49e-4)" "unprognostic (1.27e-1)" "unprognostic (8.74e-2)" "unprognostic (2.88e-1)" "unprognostic (4.00e-3)" "unprognostic (2.88e-2)" "unprognostic (9.16e-3)" "unprognostic (1.55e-9)" "unprognostic (8.10e-2)" "unprognostic (2.34e-1)" "unprognostic (8.93e-2)" "unprognostic (5.31e-3)" 0.5 0.2 8.2 0.6 4.6 2.8 1.1 1.2 16.2 0.4 1.9 2.3 0.1 1.0 1.4 1.0 0.8 0.6 1.7 0.2 6.1 5.4 0.1 1.1 1.4 1.5 6.2 2.6 1.5 0.1 0.0 0.1 0.6 3.7 0.3 1.3 0.1 0.5 0.3 0.1 0.2 1.8 0.1 4.1 8.1 3.2 0.5 1.7 2.2 0.2 0.1 2.0 1.2 0.1 0.0 0.0 0.2 0.0 32.8 10.7 1.7 0.0 1.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 6.1 19.0 0.3 0.0 0.6 0.0 4.6 0.1 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.2 0.2 0.4 0.0 0.0 0.0 0.0 0.6 3.1 0.1 0.1 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 4.7 0.0 0.0 0.0 3.7 0.2 32.8 0.0 0.0 0.0 1.7 8.2 4.6 1.2 3.6 6.1 5.4 6.2 2.6 3.7 1.7 KLRC3 NKG2-E ENSG00000205810 "Killer cell lectin like receptor C3" Q07444 12 10412312-10420595 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 28.5;brain: 9.7;lymphoid tissue: 6.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.5;HEL: 2.2;HeLa: 11.8;HSkMC: 2.2;U-698: 3.2" "Cancer enriched" "Detected in single" 9 "glioma: 0.6" "Cell type enriched" "Detected in some" 5 "NK-cell: 28.5" "Lineage enriched" "Detected in many" 5 "NK-cells: 28.5" "HPA039910, HPA062570" Approved Uncertain Vesicles Vesicles "HPA039910: , HPA062570: " "unprognostic (8.92e-4)" "unprognostic (4.47e-2)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.07e-3)" "unprognostic (2.48e-1)" "unprognostic (3.22e-1)" "unprognostic (9.12e-2)" "unprognostic (3.52e-3)" "unprognostic (3.09e-1)" "unprognostic (1.08e-1)" "unprognostic (3.15e-1)" 0.1 0.0 4.6 0.2 2.4 2.5 0.0 0.2 9.7 0.0 0.6 1.2 0.7 0.0 0.1 0.3 0.9 0.0 3.7 2.9 0.0 0.6 0.8 2.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 2.1 6.9 0.7 0.1 0.1 1.0 0.1 0.0 0.0 0.0 0.3 0.0 28.5 5.6 1.5 0.0 0.0 0.2 0.7 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.2 11.8 0.1 0.0 0.3 0.0 2.2 0.0 0.0 0.2 0.0 0.4 0.2 0.5 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 4.4 0.3 28.5 0.0 0.0 0.0 1.5 KLRD1 CD94 ENSG00000134539 "Killer cell lectin like receptor D1" Q13241 12 10226058-10329600 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 85.5;lymphoid tissue: 31.0;pituitary gland: 44.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 67.2;memory CD8 T-cell: 28.0;naive CD8 T-cell: 30.3;NK-cell: 85.5" "Group enriched" "Detected in many" 63 "NK-cells: 85.5;T-cells: 67.2" "Not detected" "Not detected" HPA069688 Uncertain "HPA069688: " "unprognostic (3.75e-2)" "unprognostic (2.15e-3)" "unprognostic (4.95e-2)" "unprognostic (2.48e-3)" "unprognostic (2.13e-2)" "unprognostic (2.60e-3)" "unprognostic (2.26e-2)" "unprognostic (1.13e-1)" "unprognostic (8.94e-3)" "unprognostic (4.53e-3)" "unprognostic (8.78e-2)" "unprognostic (2.97e-2)" "unprognostic (1.47e-3)" "unprognostic (1.78e-1)" "unprognostic (3.07e-1)" "unprognostic (3.06e-1)" "unprognostic (1.37e-2)" 5.2 1.3 0.9 6.4 1.1 6.9 1.7 0.8 0.9 1.4 2.7 0.6 0.2 1.5 3.3 1.9 2.0 1.1 1.5 1.7 1.0 1.0 1.5 3.7 12.3 10.2 3.8 0.7 0.9 1.9 0.0 44.6 2.3 0.8 2.0 0.9 2.1 1.2 0.5 1.1 0.8 10.6 0.5 2.6 31.0 1.8 1.4 0.4 2.2 1.3 0.3 3.6 6.3 1.3 0.1 0.2 1.2 0.2 85.5 67.2 16.2 0.9 0.7 1.1 1.5 1.5 0.6 0.9 2.3 0.1 0.2 0.7 1.4 1.0 1.3 1.1 1.8 1.1 0.5 1.3 0.2 2.2 2.8 1.7 2.6 0.6 2.7 1.0 2.1 0.7 1.7 0.4 1.2 0.3 1.0 4.9 0.3 1.9 1.0 1.3 1.7 1.4 0.6 1.6 1.2 0.7 2.1 2.4 1.2 1.1 2.2 0.5 0.8 2.0 1.7 1.7 3.1 1.5 0.7 2.0 1.8 1.1 2.6 1.6 1.6 0.1 0.1 0.1 67.2 0.2 7.6 0.1 0.4 28.0 0.2 0.1 0.1 30.3 1.2 85.5 0.1 0.2 0.1 16.2 0.9 1.1 0.8 0.9 1.0 1.0 3.8 0.7 0.8 0.4 KLRG1 "2F1, CLEC15A, MAFA, MAFA-L" ENSG00000139187 "Killer cell lectin like receptor G1" Q96E93 12 8950044-9010760 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 83.1" "Group enriched" "Detected in many" 5 "HEL: 23.0;HUVEC TERT2: 8.1;NTERA-2: 15.8;U-937: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 71.3;MAIT T-cell: 83.1" "Lineage enriched" "Detected in many" 28 "T-cells: 83.1" "Low region specificity" "Detected in some" "HPA051403, HPA076494" Approved Enhanced Vesicles Vesicles "HPA051403: , HPA076494: " "unprognostic (1.54e-2)" "unprognostic (8.42e-4)" "unprognostic (1.06e-1)" "unprognostic (1.28e-1)" "unprognostic (2.94e-1)" "unprognostic (1.53e-4)" "unprognostic (3.05e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" "unprognostic (3.45e-3)" "unprognostic (6.88e-2)" "unprognostic (1.71e-2)" "unprognostic (2.05e-2)" "unprognostic (4.17e-2)" "unprognostic (4.96e-2)" "unprognostic (7.86e-2)" 15.4 3.9 4.4 7.3 5.8 5.6 5.7 12.3 5.0 3.2 3.5 7.1 0.8 1.7 5.6 4.2 2.2 2.6 7.7 5.1 4.4 5.8 3.2 6.4 5.5 17.3 8.3 3.4 2.7 1.9 1.5 5.6 1.5 5.5 4.8 4.7 5.6 3.5 1.8 3.1 2.2 5.0 3.9 5.5 19.0 3.6 2.2 6.8 6.8 2.9 2.3 11.1 8.3 2.6 0.5 1.3 2.4 0.6 2.9 83.1 14.0 0.1 2.2 1.2 1.7 2.0 0.4 1.1 0.3 0.3 0.2 0.7 0.7 0.7 3.1 0.1 0.3 0.2 2.8 0.3 0.3 2.2 1.4 23.0 0.3 1.2 0.5 0.7 1.2 1.4 0.3 0.3 0.0 8.1 1.0 0.3 0.1 0.5 0.5 1.6 15.8 1.5 0.9 0.7 0.0 0.3 0.3 0.3 3.1 0.7 0.4 0.9 0.2 1.0 0.5 0.5 0.7 0.4 1.0 1.0 2.7 1.7 1.4 14.5 0.2 2.4 0.3 0.2 71.3 0.4 83.1 0.5 15.8 43.4 1.3 0.5 4.3 29.9 0.9 2.9 0.6 0.5 1.2 14.0 4.4 5.8 12.3 5.0 4.4 5.8 8.3 3.4 5.5 6.8 KLRG2 "CLEC15B, FLJ44186" ENSG00000188883 "Killer cell lectin like receptor G2" A4D1S0 7 139452690-139483712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 9.7;thyroid gland: 22.1" "Cell line enhanced" "Detected in some" "BEWO: 11.0;HAP1: 11.5;NTERA-2: 6.1;SCLC-21H: 5.5;SK-BR-3: 23.5" "Cancer enriched" "Detected in many" 11 "testis cancer: 42.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018199 Uncertain Uncertain Nucleoplasm Nucleoplasm "HPA018199: AB_2133260" "unprognostic (2.50e-2)" "unprognostic (3.05e-2)" "unprognostic (9.82e-2)" "unprognostic (5.38e-8)" "unprognostic (2.41e-1)" "unprognostic (1.97e-2)" "unprognostic (3.13e-2)" "prognostic favourable (8.61e-4)" "unprognostic (2.14e-2)" "unprognostic (2.92e-1)" "unprognostic (5.19e-2)" "unprognostic (8.83e-2)" "unprognostic (1.10e-3)" "unprognostic (5.66e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-2)" "unprognostic (2.34e-2)" 0.2 0.1 0.0 0.0 0.3 0.0 2.4 0.0 0.8 1.0 0.0 0.2 0.0 0.0 0.2 0.7 7.3 0.2 0.0 0.0 0.0 0.0 4.5 0.0 6.2 0.0 0.1 0.0 0.0 0.2 6.5 0.9 0.7 0.3 0.2 0.1 0.3 9.7 0.3 0.1 4.7 0.0 1.5 1.4 0.0 0.2 2.3 0.0 0.9 22.1 2.6 2.3 0.8 2.4 0.4 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.2 0.0 1.6 11.5 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.1 0.0 0.2 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.8 0.0 6.1 0.1 0.0 0.0 0.0 0.4 0.1 5.5 0.3 1.7 23.5 0.0 5.2 1.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 KLRK1 "CD314, D12S2489E, KLR, NKG2-D, NKG2D" ENSG00000213809 "Killer cell lectin like receptor K1" P26718 12 10372353-10391874 "Cancer-related genes, CD markers, Predicted membrane proteins, Transporters" "Adaptive immunity, Differentiation, Immunity, Innate immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.8;lymphoid tissue: 30.7" "Cell line enriched" "Detected in some" 8 "U-698: 36.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 39 "gdT-cell: 49.4;MAIT T-cell: 18.5;memory CD8 T-cell: 44.0;naive CD8 T-cell: 44.3;NK-cell: 50.8" "Group enriched" "Detected in many" 47 "NK-cells: 50.8;T-cells: 49.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB021896, HPA068877" Enhanced Supported "Plasma membrane" 33000 "Plasma membrane" "CAB021896: , HPA068877: " "unprognostic (3.34e-4)" "unprognostic (2.65e-4)" "unprognostic (3.25e-1)" "unprognostic (2.59e-2)" "unprognostic (1.53e-1)" "unprognostic (1.01e-5)" "unprognostic (5.61e-4)" "unprognostic (1.00e-3)" "unprognostic (1.33e-1)" "unprognostic (9.22e-2)" "unprognostic (1.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-10)" "unprognostic (1.24e-2)" "unprognostic (6.32e-2)" "unprognostic (7.59e-2)" "unprognostic (7.08e-10)" 4.1 0.9 1.3 18.3 1.1 10.6 2.1 0.4 0.8 2.8 4.5 1.2 0.6 2.0 2.4 2.7 3.1 2.0 7.7 1.3 1.3 1.1 2.4 3.6 13.6 22.2 2.1 0.1 1.5 3.3 0.0 1.2 1.6 1.2 2.2 2.1 2.4 7.0 0.6 0.5 1.1 13.1 1.3 2.1 30.7 3.3 1.9 0.6 6.0 2.9 2.8 11.4 11.3 2.5 1.0 0.2 0.8 0.1 50.8 49.4 16.7 0.2 0.0 0.4 1.8 0.1 4.6 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.2 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 36.0 0.1 0.0 0.2 0.0 0.0 0.0 49.4 0.1 18.5 0.8 0.3 44.0 0.1 1.0 0.4 44.3 0.8 50.8 0.1 0.2 0.1 16.7 1.3 1.1 0.4 0.8 1.3 1.1 2.1 0.1 1.2 0.6 KMO ENSG00000117009 "Kynurenine 3-monooxygenase" O15229 1 241532134-241595642 "Enzymes, Predicted membrane proteins" "Pyridine nucleotide biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.3;liver: 58.6;placenta: 26.0" "Cell line enhanced" "Detected in some" "Daudi: 5.2;RPMI-8226: 7.6;RPTEC TERT1: 19.6;SK-BR-3: 10.1;U-698: 8.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 79 "classical monocyte: 5.2;intermediate monocyte: 14.7;memory B-cell: 16.1;myeloid DC: 5.3;naive B-cell: 20.3;non-classical monocyte: 14.7;plasmacytoid DC: 11.1" "Group enriched" "Detected in many" 97 "B-cells: 20.3;dendritic cells: 11.1;monocytes: 14.7" "Region enriched" "Detected in single" 4 "thalamus: 1.3" "Low region specificity" "Detected in single" "HPA031115, HPA056942" Enhanced "HPA031115: AB_10601924, HPA056942: " "unprognostic (4.27e-2)" "unprognostic (3.35e-2)" "unprognostic (3.95e-2)" "unprognostic (7.48e-3)" "unprognostic (8.37e-3)" "unprognostic (2.63e-1)" "unprognostic (9.79e-2)" "unprognostic (3.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.75e-3)" "unprognostic (8.07e-2)" "unprognostic (1.47e-1)" "prognostic unfavourable (6.49e-8)" "unprognostic (1.60e-2)" "unprognostic (3.65e-2)" "unprognostic (3.36e-2)" "unprognostic (6.81e-2)" 3.7 0.6 0.5 3.3 0.6 0.3 2.4 0.2 0.9 0.3 0.4 0.2 0.0 0.0 2.7 0.1 0.3 0.4 0.5 0.4 0.8 0.4 14.2 58.6 6.5 3.2 0.3 0.3 0.4 0.3 0.0 0.4 26.0 0.3 0.4 0.3 0.3 0.5 0.0 0.2 0.3 1.0 0.1 0.5 8.0 0.4 0.6 0.1 0.7 0.4 0.1 4.5 1.4 0.3 20.3 11.1 0.1 14.7 0.0 0.0 2.8 0.1 1.6 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.2 0.4 0.0 0.2 5.2 0.4 0.0 2.1 0.0 0.2 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.5 0.2 0.2 0.7 0.1 0.1 0.0 0.1 0.8 0.0 0.2 0.0 2.2 0.9 0.4 1.4 0.1 7.6 19.6 4.0 0.2 0.1 0.0 10.1 0.0 3.9 1.6 0.0 0.0 0.1 0.0 1.3 0.3 0.5 8.1 0.2 1.9 1.6 0.0 5.2 0.1 0.0 14.7 0.0 16.1 0.0 0.0 5.3 20.3 0.0 0.0 0.1 0.0 14.7 11.1 0.0 2.8 0.5 0.6 0.2 0.9 0.8 0.4 0.3 0.3 0.3 0.1 KMT2E "HDCMC04P, MLL5" ENSG00000005483 "Lysine methyltransferase 2E" Q8IZD2 7 105014179-105114361 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042866, HPA056125" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA042866: , HPA056125: " "unprognostic (1.05e-1)" "unprognostic (6.33e-2)" "unprognostic (6.49e-2)" "unprognostic (4.34e-1)" "unprognostic (1.94e-1)" "unprognostic (4.77e-2)" "unprognostic (2.20e-1)" "unprognostic (3.98e-3)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (3.53e-2)" "unprognostic (6.45e-2)" "prognostic unfavourable (3.80e-5)" "unprognostic (1.68e-1)" "unprognostic (1.53e-1)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" 22.7 11.8 18.6 24.5 23.5 44.8 20.9 41.6 22.4 26.4 20.9 18.6 21.7 14.7 25.3 15.8 16.5 18.6 18.2 16.8 20.6 15.1 14.2 11.6 22.8 20.1 22.7 17.4 33.5 15.6 20.5 20.1 18.7 18.6 21.2 20.5 17.6 19.6 19.2 21.3 25.7 18.5 26.2 23.1 21.6 17.9 12.9 27.2 24.6 21.7 15.1 22.7 26.6 21.4 38.2 24.7 72.9 20.8 20.3 30.6 14.7 14.8 10.5 22.3 19.1 13.8 16.6 5.7 11.4 17.1 9.6 11.9 8.5 13.7 12.4 11.4 13.4 11.6 12.3 11.3 16.0 19.9 7.1 12.5 13.8 7.3 13.0 16.7 15.7 11.6 10.6 13.3 14.4 17.4 17.0 35.5 13.6 11.7 26.7 14.3 7.8 8.5 23.0 13.7 14.3 9.5 15.1 12.8 15.4 15.8 13.6 8.6 5.9 10.0 21.4 22.8 15.9 26.0 11.3 27.1 21.4 28.6 15.0 12.8 15.6 48.5 18.0 39.4 30.6 13.6 30.3 35.6 28.4 26.1 12.8 38.2 28.0 26.0 72.9 20.3 20.8 24.7 23.6 14.7 18.6 23.5 41.6 22.4 20.6 15.1 22.7 17.4 18.6 27.2 KREMEN1 "KREMEN, KRM1" ENSG00000183762 "Kringle containing transmembrane protein 1" Q96MU8 22 29073078-29168333 "Disease related genes, Predicted membrane proteins" "Wnt signaling pathway" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 18.3;U-2197: 31.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058513 Approved "Nucleoplasm,Nuclear bodies,Cytosol" 400000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA058513: " 5.2 11.8 7.1 6.8 17.8 2.7 5.8 5.0 6.9 9.6 9.6 7.6 25.7 4.9 6.0 13.2 27.8 8.6 5.0 16.8 8.3 3.6 10.5 3.2 8.3 9.1 5.2 4.3 17.4 3.4 16.3 8.0 7.2 4.2 7.1 8.5 21.2 35.4 20.6 18.9 26.5 8.1 4.7 3.0 13.9 6.4 14.5 6.8 19.0 17.1 33.4 20.0 5.9 10.0 0.7 1.2 9.0 0.6 0.8 0.4 0.2 2.6 1.8 6.3 3.2 2.1 6.5 5.3 0.7 6.3 2.0 3.0 8.4 1.2 0.1 2.4 2.9 12.9 12.8 5.1 2.2 3.1 8.1 0.7 0.9 7.9 2.2 0.1 0.7 6.2 10.4 2.2 1.2 0.3 2.7 0.2 2.5 2.2 0.0 0.8 0.3 1.4 0.4 18.3 0.2 2.2 5.0 12.5 7.0 7.3 2.6 9.6 9.7 0.4 0.2 8.4 2.6 31.3 0.9 0.6 0.2 0.2 5.3 1.1 9.7 2.1 0.6 0.3 0.3 0.5 0.3 0.3 0.3 0.2 0.1 0.7 0.4 0.4 9.0 0.8 0.4 1.2 0.2 0.2 7.1 17.8 5.0 6.9 8.3 3.6 5.2 4.3 4.2 6.8 KREMEN2 "KRM2, MGC10791" ENSG00000131650 "Kringle containing transmembrane protein 2" Q8NCW0 16 2963944-2968383 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1;skin 1: 12.5" "Cell line enhanced" "Detected in many" "HMC-1: 19.9;MCF7: 10.0;RPMI-8226: 18.7;T-47d: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory B-cell: 3.2;naive B-cell: 3.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 6 "B-cells: 3.2;monocytes: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA003223 Uncertain Approved Nucleoli "Intracellular and membrane" Nucleoli "HPA003223: AB_1079217" "unprognostic (8.36e-2)" "unprognostic (4.65e-1)" "unprognostic (6.24e-3)" "unprognostic (4.61e-2)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (4.02e-3)" "prognostic unfavourable (8.98e-4)" "unprognostic (3.34e-2)" "unprognostic (1.57e-2)" "unprognostic (8.03e-2)" "unprognostic (8.57e-2)" "unprognostic (7.79e-12)" "unprognostic (6.69e-2)" "unprognostic (1.14e-1)" "unprognostic (1.46e-2)" "unprognostic (6.58e-3)" 0.2 0.1 1.6 2.0 0.7 1.7 0.2 0.2 3.0 1.8 0.4 0.2 4.5 0.3 0.3 0.8 3.8 0.6 0.3 0.2 1.9 0.3 0.2 0.2 0.2 0.8 0.7 0.2 0.2 0.4 0.0 0.2 0.2 0.3 1.6 0.0 1.9 1.6 0.2 0.6 12.5 0.6 0.2 1.7 0.9 0.5 2.1 0.2 13.1 0.2 1.8 6.8 0.2 0.6 3.2 0.3 0.0 1.4 0.0 0.0 0.0 1.2 0.8 0.3 7.1 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.9 1.1 5.2 1.4 0.0 5.9 0.9 0.5 0.0 0.8 0.8 0.3 1.7 1.7 0.0 0.4 19.9 0.2 0.0 0.0 0.1 0.0 2.1 2.1 0.0 10.0 1.2 2.3 2.0 1.5 3.1 8.2 18.7 0.0 0.2 2.1 1.2 1.4 3.2 3.2 10.1 1.9 0.1 0.6 8.7 0.7 0.4 3.7 0.8 3.1 0.3 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.6 0.7 0.2 2.3 1.9 0.3 0.7 0.2 0.3 0.2 KTN1 "CG1, KIAA0004, KNT" ENSG00000126777 "Kinectin 1" Q86UP2 14 55559072-55701526 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003178, CAB015331, HPA017876" Enhanced Enhanced "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652" "unprognostic (7.00e-3)" "unprognostic (2.99e-2)" "unprognostic (8.60e-2)" "unprognostic (5.50e-2)" "unprognostic (2.49e-1)" "prognostic unfavourable (6.83e-5)" "prognostic unfavourable (3.76e-4)" "unprognostic (1.75e-1)" "unprognostic (1.21e-2)" "unprognostic (1.01e-1)" "unprognostic (9.08e-2)" "unprognostic (8.72e-2)" "prognostic favourable (1.01e-6)" "unprognostic (1.27e-1)" "unprognostic (2.75e-1)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" 26.5 27.5 30.8 18.9 37.3 9.5 44.2 30.8 35.2 22.7 28.8 15.8 23.4 13.0 18.8 30.8 26.1 16.8 18.1 36.1 32.2 25.3 33.1 31.8 21.2 16.9 39.3 24.5 23.1 22.8 48.3 54.7 21.3 49.5 26.9 28.7 13.1 21.4 24.0 101.9 41.4 20.1 40.5 51.9 22.1 18.9 40.9 42.0 14.5 33.3 37.9 17.9 32.7 39.7 35.6 58.3 27.0 15.5 19.6 24.0 4.8 40.2 27.9 20.9 22.7 28.8 27.6 30.3 32.9 26.5 20.7 18.4 18.6 50.2 31.1 47.1 33.8 75.5 25.5 28.7 35.0 52.2 14.0 22.0 46.2 35.2 27.3 32.2 17.8 25.7 26.3 25.5 44.3 33.9 21.4 18.2 39.7 31.5 27.6 19.1 16.1 41.6 22.0 54.9 14.8 51.9 63.4 25.7 21.5 52.2 24.0 28.9 24.9 20.6 47.8 42.3 54.3 21.7 30.9 8.3 11.1 23.2 49.5 18.9 23.4 27.0 14.8 14.6 19.6 13.1 18.7 28.3 23.2 22.1 14.2 35.6 24.0 20.6 9.4 19.6 15.5 58.3 14.8 4.8 30.8 37.3 30.8 35.2 32.2 25.3 39.3 24.5 49.5 42.0 L1CAM "CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1" ENSG00000198910 "L1 cell adhesion molecule" P32004 X 153861514-153886174 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 29.6;brain: 54.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 72.2;BJ hTERT+ SV40 Large T+ RasG12V: 39.7;HeLa: 52.1;RPTEC TERT1: 42.4" "Cancer enhanced" "Detected in many" "melanoma: 34.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 1.0;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 7 "B-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010896 Enhanced Approved "Nucleoplasm,Plasma membrane" 59000000 Nucleoplasm "Plasma membrane" "CAB010896: AB_609903" "unprognostic (1.33e-3)" "unprognostic (3.43e-2)" "unprognostic (2.75e-1)" "prognostic unfavourable (8.51e-10)" "unprognostic (2.04e-2)" "prognostic unfavourable (3.81e-4)" "unprognostic (9.44e-2)" "prognostic unfavourable (2.36e-6)" "unprognostic (1.13e-1)" "unprognostic (9.12e-2)" "unprognostic (8.52e-3)" "unprognostic (8.02e-2)" "prognostic unfavourable (1.17e-4)" "unprognostic (3.07e-1)" "unprognostic (6.31e-2)" "unprognostic (1.69e-1)" "unprognostic (7.47e-3)" 4.4 29.6 19.9 8.0 21.9 1.2 1.7 54.5 43.6 2.8 16.3 1.5 2.0 4.9 1.7 3.0 5.3 2.6 3.2 5.2 11.2 20.6 12.3 1.3 1.3 3.7 7.3 22.4 1.4 3.0 1.0 6.1 1.4 19.3 3.5 5.7 6.2 5.9 10.8 1.6 9.9 7.6 6.1 3.5 1.7 4.8 1.5 3.4 0.0 1.2 1.3 2.6 2.3 3.9 2.2 0.0 0.0 0.0 0.0 0.3 0.2 17.6 1.3 5.4 0.0 0.0 0.0 2.3 25.0 72.2 24.2 39.7 7.1 0.1 0.0 23.9 0.1 0.7 0.6 0.4 12.7 0.0 0.1 0.0 52.1 1.1 0.0 0.0 4.0 0.1 0.3 3.6 2.5 0.0 0.0 0.0 0.1 23.9 0.0 0.5 1.2 0.9 0.0 31.7 0.1 42.4 0.3 15.9 10.4 14.0 12.5 10.2 1.3 0.3 0.0 0.0 10.6 1.1 11.9 0.2 0.3 0.1 0.1 0.2 20.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.9 21.9 54.5 30.2 11.2 20.6 7.3 22.4 19.3 3.4 LAG3 CD223 ENSG00000089692 "Lymphocyte activating 3" P18627 12 6772512-6778455 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.1;ovary: 28.4" "Cell line enriched" "Detected in single" 144 "HDLM-2: 55.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "pons and medulla: 2.7" "Cell type enhanced" "Detected in many" "gdT-cell: 11.3;MAIT T-cell: 9.2;memory CD8 T-cell: 10.0" "Lineage enriched" "Detected in single" 56 "T-cells: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002301, HPA013967" Enhanced "Secreted - unknown location" "CAB002301: AB_564101, HPA013967: AB_1846277" "unprognostic (9.39e-2)" "prognostic favourable (3.89e-4)" "unprognostic (8.88e-2)" "unprognostic (7.00e-3)" "unprognostic (1.08e-1)" "unprognostic (6.74e-3)" "unprognostic (8.85e-2)" "unprognostic (4.63e-3)" "unprognostic (1.94e-2)" "unprognostic (1.97e-3)" "unprognostic (8.71e-2)" "unprognostic (9.93e-2)" "prognostic unfavourable (4.62e-11)" "unprognostic (3.07e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" "unprognostic (8.19e-3)" 1.7 0.4 0.3 33.2 0.3 1.0 1.0 0.8 0.7 7.7 4.4 0.5 2.7 2.9 6.4 3.3 2.4 3.8 3.0 2.2 0.3 0.4 1.2 5.9 3.8 12.4 0.4 0.0 28.4 0.4 0.1 1.0 1.3 2.7 2.8 1.8 1.1 2.0 6.8 0.8 0.6 9.6 1.7 0.9 58.1 2.0 6.1 0.1 4.1 1.0 1.3 23.5 2.6 3.6 0.0 0.2 0.0 0.0 0.0 11.3 0.8 0.0 0.2 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 55.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 9.2 0.0 2.2 10.0 0.0 0.0 0.6 4.0 0.0 0.0 0.0 0.2 1.7 0.8 0.3 0.3 0.8 0.7 0.3 0.4 0.4 0.0 2.7 0.1 LAIR1 CD305 ENSG00000167613 "Leukocyte associated immunoglobulin like receptor 1" Q6GTX8 19 54351384-54370558 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.0" "Group enriched" "Detected in some" 5 "HMC-1: 6.5;Karpas-707: 16.7;THP-1: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA011155 Enhanced Supported "Plasma membrane" 130000 "Plasma membrane" "HPA011155: AB_1852685" "unprognostic (1.91e-1)" "unprognostic (1.12e-2)" "unprognostic (2.81e-2)" "unprognostic (1.25e-2)" "unprognostic (2.03e-2)" "unprognostic (4.38e-2)" "unprognostic (2.16e-2)" "unprognostic (1.74e-1)" "unprognostic (5.00e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavourable (5.01e-5)" "unprognostic (1.72e-1)" "unprognostic (2.72e-3)" "unprognostic (3.52e-2)" "unprognostic (5.22e-2)" 12.7 7.0 4.5 10.9 9.9 13.5 6.9 0.5 4.5 2.7 5.1 6.7 0.2 2.7 2.2 6.8 2.5 3.6 4.4 3.9 5.2 4.2 3.8 2.9 16.5 33.1 10.2 1.9 2.0 2.4 1.4 2.8 7.0 7.0 3.0 2.0 3.1 3.9 2.2 2.3 2.3 7.6 7.8 11.9 28.6 2.9 3.1 7.4 39.0 2.0 0.5 6.1 3.7 1.7 6.0 10.3 12.4 8.8 5.8 8.0 5.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 2.7 6.5 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 2.1 1.5 0.0 0.0 2.1 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 19.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 2.6 0.2 12.4 4.2 10.0 8.0 8.3 4.6 2.3 2.4 4.3 0.1 6.0 3.8 4.9 0.6 5.8 8.8 10.3 1.6 5.7 4.5 9.9 0.5 4.5 5.2 4.2 10.2 1.9 7.0 7.4 LAMP1 CD107a ENSG00000185896 "Lysosomal associated membrane protein 1" P11279 13 113297241-113323672 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004260, HPA014750" Supported 460000000 "CAB004260: AB_626851, HPA014750: AB_1846219" "unprognostic (3.98e-1)" "unprognostic (1.18e-1)" "unprognostic (7.55e-2)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "unprognostic (7.04e-3)" "unprognostic (9.26e-2)" "unprognostic (1.07e-1)" "unprognostic (5.80e-2)" "unprognostic (1.44e-2)" "unprognostic (2.91e-3)" "unprognostic (2.04e-1)" "prognostic favourable (4.15e-5)" "unprognostic (2.06e-2)" "unprognostic (2.22e-1)" "unprognostic (2.59e-1)" "unprognostic (1.54e-1)" 61.3 41.9 34.6 36.7 44.7 28.5 70.7 17.6 50.6 50.4 39.0 77.9 46.7 49.9 55.7 73.4 50.6 38.1 60.8 45.0 38.0 30.7 61.2 83.3 74.6 78.1 64.3 42.3 44.4 79.5 38.2 43.7 68.6 42.1 47.0 31.3 30.1 60.6 47.8 26.6 72.0 46.7 43.3 67.6 46.2 43.6 41.6 57.3 34.9 59.5 43.1 37.0 47.6 48.1 3.1 7.6 12.2 7.0 5.4 6.5 2.7 43.5 15.2 15.8 43.1 88.8 33.5 29.8 51.5 54.3 32.1 43.1 29.6 81.5 10.3 23.6 52.3 56.0 15.4 32.7 22.0 21.5 25.5 17.0 30.1 27.8 46.0 51.9 39.9 40.8 44.7 29.7 19.5 38.7 14.1 15.2 39.4 17.5 10.4 25.4 11.9 16.6 15.5 13.7 15.5 29.1 33.0 14.5 15.2 30.3 45.0 29.7 43.4 37.0 58.5 33.0 35.9 43.5 22.9 28.6 28.2 11.0 55.1 51.9 38.2 3.8 7.0 12.2 5.9 5.3 5.0 3.1 4.6 6.5 3.5 3.0 5.2 4.3 9.2 5.4 5.8 7.6 4.6 2.7 34.6 44.7 17.6 50.6 38.0 30.7 64.3 42.3 42.1 57.3 LAMP2 CD107b ENSG00000005893 "Lysosomal associated membrane protein 2" P13473 X 120427827-120469365 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Autophagy "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 112.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 112.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005272, HPA029100, HPA029101" Supported Approved "Vesicles,Plasma membrane" 820000000 "Vesicles, Plasma membrane" "CAB005272: AB_647855, HPA029100: AB_10795022, HPA029101: " "unprognostic (2.99e-3)" "unprognostic (5.26e-2)" "unprognostic (2.66e-3)" "unprognostic (1.74e-1)" "unprognostic (3.10e-1)" "unprognostic (2.50e-2)" "unprognostic (4.84e-1)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (9.73e-2)" "unprognostic (1.11e-2)" "unprognostic (2.50e-2)" "unprognostic (2.85e-1)" "unprognostic (6.78e-2)" "unprognostic (2.66e-1)" "unprognostic (5.53e-3)" 21.8 33.6 39.9 16.1 87.9 22.6 27.1 16.2 55.5 33.0 18.3 88.7 27.9 25.1 20.8 37.5 34.6 22.4 43.3 20.9 52.5 30.3 55.0 83.7 25.3 14.3 131.0 36.9 22.7 27.4 28.8 20.2 35.4 58.6 37.3 19.7 17.2 47.8 32.9 32.4 26.9 20.5 21.1 84.3 17.9 23.6 11.9 116.9 21.2 33.7 14.3 15.4 21.1 27.0 3.7 11.6 112.9 21.7 5.4 5.8 10.5 11.8 11.7 8.6 11.1 113.5 38.8 23.9 20.5 35.8 20.0 37.4 9.7 21.2 8.4 18.1 35.6 20.0 12.5 15.5 32.6 9.4 8.9 6.6 13.0 13.0 37.8 29.0 18.4 42.0 31.2 26.6 17.6 27.2 7.6 30.0 32.3 21.9 8.0 14.8 6.7 10.4 6.2 14.6 15.0 29.2 8.8 2.9 4.6 22.0 22.4 43.8 13.3 32.4 28.1 28.7 13.9 36.9 55.3 15.1 14.4 5.5 27.4 35.1 68.7 4.9 21.7 41.3 5.0 18.7 4.0 3.1 4.8 4.7 11.6 3.7 4.3 4.1 112.9 5.4 17.3 6.3 5.8 10.5 39.9 87.9 16.2 55.5 52.5 30.3 131.0 36.9 58.6 116.9 LAMP3 "CD208, DC-LAMP, DCLAMP, LAMP, TSC403" ENSG00000078081 "Lysosomal associated membrane protein 3" Q9UQV4 3 183122213-183163839 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 123.9" "Group enriched" "Detected in some" 6 "EFO-21: 57.2;HDLM-2: 14.5;HHSteC: 21.2;hTCEpi: 19.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 7.6" "Group enriched" "Detected in many" 8 "granulocytes: 7.6;T-cells: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB025133, HPA051467" Enhanced Enhanced Vesicles 47000 Vesicles "CAB025133: , HPA051467: " "unprognostic (1.43e-3)" "unprognostic (2.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.99e-3)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (7.67e-2)" "unprognostic (8.64e-2)" "unprognostic (4.95e-2)" "prognostic favourable (9.90e-4)" "unprognostic (1.80e-3)" "unprognostic (5.80e-2)" "prognostic unfavourable (1.89e-7)" "unprognostic (3.12e-1)" "unprognostic (4.13e-2)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" 0.5 0.7 0.4 14.1 0.4 0.0 0.5 0.3 0.4 1.0 0.6 0.1 0.6 0.4 0.4 1.0 2.5 0.5 0.8 0.4 0.4 0.4 0.8 0.6 123.9 11.2 0.4 0.1 0.4 8.3 0.0 0.6 1.0 0.6 1.0 1.7 0.2 6.8 1.9 0.4 1.9 1.4 0.8 0.5 2.0 0.8 8.4 0.0 21.3 8.3 3.1 11.3 3.3 0.9 0.4 0.0 7.6 0.1 0.8 6.6 1.1 3.4 0.1 0.0 0.5 0.0 0.0 2.8 0.0 0.9 0.6 0.1 0.8 1.8 0.0 57.2 0.2 0.5 1.2 2.1 0.1 14.5 1.7 0.0 0.1 0.1 21.2 0.0 0.5 0.3 19.4 0.0 2.5 2.6 0.1 3.4 0.1 0.0 0.8 0.1 0.1 0.8 0.0 0.0 0.2 0.0 1.1 0.2 0.1 0.2 0.1 1.5 1.1 0.1 2.7 0.0 1.0 0.1 0.0 1.2 4.3 0.1 0.0 0.0 0.0 0.4 0.1 7.6 0.4 0.0 3.2 0.1 2.7 1.7 0.0 0.4 3.5 2.0 1.9 0.8 0.1 0.0 6.6 1.1 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.1 0.6 0.0 LAMP5 "BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46" ENSG00000125869 "Lysosomal associated membrane protein family member 5" Q9UJQ1 20 9514358-9530524 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.1;brain: 105.2" "Cell line enhanced" "Detected in some" "Karpas-707: 92.7;SH-SY5Y: 17.0;THP-1: 32.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "basal ganglia: 105.2" "Cell type enriched" "Detected in some" 15 "plasmacytoid DC: 42.1" "Lineage enriched" "Detected in many" 30 "dendritic cells: 42.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA004802, HPA070765" Enhanced Uncertain "Mitotic spindle,Centriolar satellite,Cytosol" Cytosol "Mitotic spindle, Centriolar satellite" "HPA004802: AB_10603682, HPA070765: " "unprognostic (2.78e-2)" "unprognostic (3.90e-3)" "unprognostic (5.73e-4)" "unprognostic (5.47e-2)" "unprognostic (7.89e-2)" "unprognostic (2.67e-1)" "unprognostic (3.80e-3)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "prognostic unfavourable (6.46e-6)" "unprognostic (5.12e-3)" "unprognostic (3.74e-2)" "unprognostic (1.08e-2)" "unprognostic (4.49e-3)" 0.5 4.1 21.6 1.5 105.2 2.0 1.0 2.3 28.6 9.1 1.3 0.6 1.8 1.3 4.6 6.0 0.6 9.7 2.9 0.6 18.7 4.1 0.9 0.5 1.1 4.8 4.5 7.7 21.2 1.3 0.3 2.0 0.4 23.2 2.3 1.4 2.6 1.4 3.6 0.3 0.5 1.4 3.8 6.7 1.4 1.6 1.1 4.8 0.0 1.1 0.0 4.7 1.2 0.6 1.4 42.1 0.9 0.5 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 92.7 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.9 0.5 0.0 0.0 0.1 0.0 1.4 0.0 0.0 2.8 0.1 0.0 0.0 0.1 0.0 0.0 42.1 0.0 0.7 21.6 105.2 2.3 19.1 18.7 4.1 4.5 7.7 23.2 4.8 LARP4B "KIAA0217, LARP5" ENSG00000107929 "La ribonucleoprotein domain family member 4B" Q92615 10 806914-931705 "Predicted intracellular proteins, Predicted membrane proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036566, HPA042738" Approved Enhanced Cytosol Cytosol "HPA036566: AB_10673624, HPA042738: AB_2678137" "unprognostic (3.02e-3)" "unprognostic (1.43e-1)" "unprognostic (9.77e-2)" "unprognostic (4.80e-2)" "unprognostic (2.00e-2)" "unprognostic (3.13e-3)" "prognostic unfavourable (1.70e-4)" "unprognostic (8.95e-2)" "unprognostic (2.74e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-2)" "unprognostic (1.65e-1)" "unprognostic (1.40e-1)" "unprognostic (8.10e-3)" "unprognostic (1.62e-1)" "unprognostic (6.47e-2)" "unprognostic (2.54e-2)" 17.5 23.1 16.5 27.7 20.7 17.9 17.3 23.8 23.8 15.0 19.7 21.2 20.9 21.7 19.1 23.6 30.9 17.0 19.4 22.0 15.8 13.0 17.6 17.0 25.4 23.0 16.0 16.7 18.2 21.0 22.3 18.6 27.1 18.3 20.0 18.4 18.9 22.1 28.1 37.1 25.1 21.7 16.0 14.4 25.2 25.3 22.9 15.9 29.5 25.8 16.8 21.8 18.3 20.0 8.3 12.2 13.5 13.6 7.7 9.8 5.2 21.4 18.3 9.4 10.6 8.7 8.9 13.8 14.6 6.8 15.8 15.5 24.6 24.4 26.3 5.7 14.3 22.9 16.9 12.1 13.9 17.7 12.2 21.6 12.5 14.4 14.2 16.1 19.5 9.6 14.2 16.0 9.3 10.8 28.7 17.1 12.8 21.3 23.0 14.3 10.2 8.5 16.7 8.3 17.7 12.7 16.5 9.4 13.3 14.1 27.4 10.8 25.7 15.3 15.1 12.1 3.3 38.6 14.4 19.6 23.4 26.0 13.6 13.1 7.7 12.9 12.6 13.5 8.7 13.6 9.0 6.7 9.5 9.8 10.8 8.3 9.2 9.8 12.0 7.7 11.1 12.2 8.6 5.2 16.5 20.7 23.8 23.8 15.8 13.0 16.0 16.7 18.3 15.9 LAT LAT1 ENSG00000213658 "Linker for activation of T cells" O43561 16 28984826-28990783 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 10 "blood: 58.1;lymphoid tissue: 193.6" "Cell line enhanced" "Detected in some" "HEL: 30.3;HMC-1: 128.1;MOLT-4: 43.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 18 "basophil: 38.2;gdT-cell: 47.9;MAIT T-cell: 33.5;memory CD4 T-cell: 46.9;memory CD8 T-cell: 47.9;naive CD4 T-cell: 44.6;naive CD8 T-cell: 42.6;NK-cell: 15.7;T-reg: 58.1" "Group enriched" "Detected in many" 134 "granulocytes: 38.2;NK-cells: 15.7;T-cells: 58.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002223, HPA011157, CAB012978" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" 75000 "Plasma membrane" "Golgi apparatus" "CAB002223: AB_563852, CAB012978: , HPA011157: AB_1079237" "unprognostic (4.35e-3)" "unprognostic (5.17e-3)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-1)" "unprognostic (7.15e-5)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.25e-2)" "unprognostic (1.52e-3)" "unprognostic (5.33e-2)" "unprognostic (1.02e-8)" "unprognostic (1.04e-2)" "unprognostic (5.58e-2)" "unprognostic (3.25e-1)" "unprognostic (1.51e-4)" 4.8 1.8 1.6 27.6 3.0 8.5 2.5 6.6 2.3 3.9 10.8 2.0 2.0 4.9 7.7 3.1 4.3 4.2 5.8 3.1 1.9 1.9 6.0 3.3 7.8 33.2 1.7 1.7 3.0 2.7 1.4 6.0 2.8 1.8 8.5 2.8 3.1 12.2 5.4 2.0 5.8 9.0 3.1 1.9 13.9 5.1 2.3 1.7 193.6 7.3 4.6 50.3 6.4 5.4 0.2 0.2 38.2 0.2 15.7 58.1 26.8 0.1 0.3 0.2 0.3 0.6 0.3 0.7 0.8 0.2 0.2 0.3 0.3 0.4 0.1 1.1 0.3 0.4 0.4 0.2 0.1 0.2 0.5 30.3 0.7 0.5 0.1 0.9 128.1 0.3 0.6 0.2 0.1 0.1 0.3 3.6 0.1 0.8 43.6 6.0 0.5 0.4 0.4 0.1 3.8 0.3 0.2 0.8 0.1 0.1 0.3 0.3 0.4 5.0 0.5 0.6 2.9 0.6 0.2 1.2 1.0 0.4 7.7 0.4 0.5 38.2 0.2 0.1 47.9 0.2 33.5 0.2 46.9 47.9 0.1 0.2 44.6 42.6 2.3 15.7 0.1 0.2 58.1 26.8 1.6 3.0 6.6 2.3 1.9 1.9 1.7 1.7 1.8 1.7 LAX1 "FLJ20340, LAX" ENSG00000122188 "Lymphocyte transmembrane adaptor 1" Q8IWV1 1 203765176-203776233 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.7" "Group enriched" "Detected in some" 5 "Karpas-707: 11.4;U-266/70: 14.1;U-266/84: 31.7;U-698: 12.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 9.9;MAIT T-cell: 7.4;memory B-cell: 6.5;memory CD4 T-cell: 5.7;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.5;naive CD8 T-cell: 5.9;NK-cell: 4.6;T-reg: 6.0" "Group enriched" "Detected in many" 19 "B-cells: 6.5;NK-cells: 4.6;T-cells: 9.9" "Low region specificity" "Detected in all" "HPA002461, HPA003887, CAB025358" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Golgi apparatus" "CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240" "unprognostic (2.85e-3)" "unprognostic (3.83e-3)" "unprognostic (3.90e-4)" "unprognostic (3.65e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-5)" "unprognostic (2.99e-2)" "unprognostic (4.91e-2)" "unprognostic (4.36e-2)" "unprognostic (3.31e-3)" "unprognostic (4.77e-1)" "unprognostic (4.36e-1)" "unprognostic (4.23e-4)" "unprognostic (3.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" 1.6 0.6 0.4 19.9 0.4 1.3 1.3 0.4 0.4 1.8 3.4 0.0 0.2 2.1 1.2 1.1 4.5 1.1 3.8 0.6 0.4 0.4 1.0 0.8 6.3 17.4 0.4 0.0 0.7 0.6 0.0 0.5 0.1 0.0 2.2 2.6 1.1 5.7 1.5 0.5 1.0 5.5 1.1 0.5 11.7 3.4 1.0 0.0 22.7 1.1 0.7 26.7 6.3 2.8 6.5 0.0 0.3 0.0 4.6 9.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 11.4 0.0 0.0 3.7 0.0 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 31.7 12.1 0.0 0.9 0.0 0.0 0.0 0.3 9.9 0.0 7.4 6.5 5.7 7.3 0.0 1.5 4.5 5.9 0.0 4.6 0.0 0.0 6.0 2.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 LAYN "FLJ30977, FLJ31092" ENSG00000204381 Layilin Q6UX15 11 111540280-111561745 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 39.4;BJ hTERT+: 43.0;BJ hTERT+ SV40 Large T+ RasG12V: 27.4;fHDF/TERT166: 25.5;HSkMC: 25.3;U-138 MG: 29.6;U-2 OS: 21.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "myeloid DC: 10.3;T-reg: 11.8" "Group enriched" "Detected in many" 111 "dendritic cells: 10.3;T-cells: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040087 Approved Approved Cytosol Cytosol "HPA040087: AB_10793927" "unprognostic (2.27e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-3)" "unprognostic (1.96e-1)" "unprognostic (3.90e-2)" "unprognostic (1.83e-2)" "unprognostic (5.62e-3)" "unprognostic (1.99e-1)" "unprognostic (1.38e-1)" "unprognostic (7.75e-3)" "unprognostic (4.47e-2)" "unprognostic (1.18e-1)" "unprognostic (1.61e-2)" "unprognostic (5.01e-2)" "unprognostic (1.65e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-2)" 7.7 2.3 9.3 5.9 12.8 1.3 8.0 1.7 12.5 11.3 21.2 28.9 3.0 4.0 15.1 10.5 5.3 12.8 17.0 5.6 12.6 7.5 4.1 1.4 9.6 12.4 20.6 5.9 39.5 2.3 1.6 5.4 13.1 12.3 13.2 3.8 10.9 4.4 17.9 4.8 2.1 8.2 21.7 10.1 7.5 12.1 4.6 13.1 4.6 26.9 4.8 5.0 11.3 10.1 0.0 10.3 0.0 0.0 0.0 11.8 0.4 0.1 1.0 0.2 0.0 7.0 13.6 1.9 39.4 43.0 20.0 27.4 0.0 0.0 0.0 0.3 25.5 0.8 2.5 0.2 20.7 0.0 0.1 0.2 0.0 0.0 12.0 0.0 0.0 25.3 0.0 8.2 0.0 0.2 0.0 0.0 8.1 0.0 0.0 0.0 1.2 0.0 0.0 3.0 0.0 0.1 0.0 1.3 4.8 0.1 0.0 0.1 0.0 0.1 0.1 29.6 21.8 0.2 19.2 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 10.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 11.8 0.4 9.3 12.8 1.7 12.5 12.6 7.5 20.6 5.9 12.3 13.1 LCTL "FLJ33279, KLG, KLPH" ENSG00000188501 "Lactase like" Q6UWM7 15 66547179-66565979 "Cancer-related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.4" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;NTERA-2: 5.9;U-2 OS: 16.6;U-251 MG: 7.0" "Group enriched" "Detected in some" 5 "glioma: 1.5;melanoma: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA071640 Approved "Endoplasmic reticulum,Plasma membrane" "Plasma membrane" "Endoplasmic reticulum" "HPA071640: " "unprognostic (4.60e-2)" "unprognostic (5.46e-2)" "unprognostic (8.70e-2)" "unprognostic (1.56e-2)" "unprognostic (3.22e-3)" "unprognostic (3.53e-2)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (4.51e-3)" "unprognostic (4.44e-16)" "unprognostic (6.06e-2)" "unprognostic (3.39e-1)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" 0.4 0.7 6.0 0.9 4.3 3.1 0.4 0.7 3.1 0.4 0.5 3.1 0.0 1.4 0.8 0.9 0.7 0.3 1.0 0.4 3.3 1.2 0.4 0.4 0.4 1.0 5.3 3.1 0.6 0.7 0.2 0.4 0.3 4.9 0.4 0.3 1.1 0.6 0.3 3.0 2.6 0.7 0.4 10.4 0.8 0.7 1.5 2.3 0.0 0.5 0.0 0.2 0.3 0.3 0.9 0.6 3.9 0.7 1.0 0.5 0.2 0.3 0.3 3.2 0.3 0.1 0.1 0.8 0.8 0.0 0.1 0.4 0.4 0.4 0.5 6.4 0.2 0.7 0.0 0.0 0.2 0.2 0.2 0.7 1.0 1.6 0.0 0.2 0.4 0.4 0.0 0.3 0.0 0.0 0.4 0.4 0.2 0.1 0.3 0.4 5.9 0.1 0.2 3.5 0.3 0.0 0.4 0.4 0.3 0.1 0.3 1.8 0.4 0.5 0.4 1.7 16.6 0.6 7.0 0.2 0.2 0.2 2.2 0.7 3.0 1.6 0.7 0.5 0.5 0.4 0.3 0.4 0.5 0.3 0.2 0.9 0.5 0.4 3.9 1.0 0.4 0.6 0.5 0.2 6.0 4.3 0.7 2.7 3.3 1.2 5.3 3.1 4.9 2.3 LDAH "C2orf43, FLJ21820" ENSG00000118961 "Lipid droplet associated hydrolase" Q9H6V9 2 20684014-20823130 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034729, HPA034730" Approved Uncertain "Nuclear speckles,Cytosol" "Nuclear speckles, Cytosol" "HPA034729: AB_10603684, HPA034730: " "unprognostic (1.66e-1)" "unprognostic (2.82e-3)" "unprognostic (3.52e-3)" "unprognostic (1.36e-1)" "unprognostic (2.21e-2)" "unprognostic (6.34e-2)" "prognostic unfavourable (6.09e-6)" "unprognostic (3.57e-2)" "unprognostic (1.36e-1)" "unprognostic (1.27e-2)" "unprognostic (6.45e-2)" "unprognostic (2.44e-1)" "prognostic favourable (1.18e-4)" "unprognostic (1.05e-1)" "unprognostic (2.31e-1)" "unprognostic (2.22e-1)" "unprognostic (3.97e-2)" 10.4 23.6 8.7 13.3 18.7 4.9 10.6 3.1 11.7 10.5 12.5 8.2 8.8 9.9 12.7 13.2 10.4 7.6 8.4 6.9 7.7 8.6 20.3 14.8 8.1 12.3 7.9 8.3 10.8 10.0 15.1 22.4 15.4 9.6 9.6 14.5 10.4 10.8 9.9 2.0 8.8 9.9 11.4 9.7 17.2 10.3 10.0 8.5 22.9 9.4 4.6 15.4 13.6 10.0 9.8 6.5 1.1 5.8 6.0 8.5 4.2 10.0 10.6 23.8 0.0 10.2 14.2 14.9 8.7 6.2 8.1 6.0 10.0 6.4 13.1 0.0 6.7 8.5 18.5 7.4 8.6 15.1 8.7 18.5 8.5 16.8 9.9 14.1 4.8 11.7 11.3 7.2 1.9 15.5 25.2 9.6 14.2 6.5 20.6 10.8 14.9 0.0 16.3 19.1 14.8 16.6 14.4 13.2 20.7 5.9 10.8 10.0 8.4 10.5 13.3 7.1 3.6 8.6 5.6 11.8 20.9 5.8 13.1 14.6 12.5 1.1 3.5 0.3 8.5 5.8 5.2 9.8 8.3 6.9 6.5 6.6 7.5 7.3 0.3 6.0 4.5 6.3 6.4 4.2 8.7 18.7 3.1 11.7 7.7 8.6 7.9 8.3 9.6 8.5 LDLR LDLCQ2 ENSG00000130164 "Low density lipoprotein receptor" P01130 19 11089362-11133816 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Endocytosis, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 23.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009647, HPA013159" Approved 12000000 "HPA009647: AB_1079243, HPA013159: AB_1852775" "unprognostic (4.39e-1)" "unprognostic (1.93e-3)" "unprognostic (2.52e-1)" "unprognostic (2.76e-1)" "unprognostic (4.03e-2)" "unprognostic (1.17e-1)" "unprognostic (6.71e-2)" "unprognostic (4.26e-2)" "unprognostic (3.73e-1)" "unprognostic (1.47e-2)" "prognostic unfavourable (6.60e-5)" "unprognostic (1.19e-1)" "prognostic unfavourable (5.92e-4)" "unprognostic (1.62e-1)" "unprognostic (2.78e-2)" "unprognostic (9.83e-2)" "prognostic unfavourable (3.43e-4)" 24.6 50.7 6.1 13.7 5.6 11.9 20.0 4.7 9.1 15.4 10.3 17.2 4.8 12.3 14.0 6.5 33.6 12.2 27.2 11.3 7.4 5.0 5.3 33.4 28.7 5.2 4.2 4.9 42.4 26.7 9.6 4.3 9.7 18.9 11.3 6.6 7.1 11.4 4.6 3.2 12.5 15.1 15.1 14.6 8.7 19.5 6.3 9.1 2.1 4.8 17.5 13.2 13.2 13.8 0.4 1.0 23.6 1.7 1.6 3.7 1.8 27.0 12.6 15.6 7.4 21.3 40.7 5.3 5.9 22.7 10.6 23.2 13.1 25.9 9.2 23.3 11.3 21.5 7.9 46.9 5.1 6.5 1.5 4.4 8.7 11.7 31.5 4.6 25.4 50.4 17.6 35.8 7.8 11.5 9.1 53.2 7.9 10.2 5.8 5.9 16.7 17.0 4.1 11.4 11.6 26.1 21.8 3.7 3.8 5.0 11.3 0.9 4.8 10.8 12.4 9.2 6.7 5.8 10.6 6.6 5.4 5.6 10.8 10.9 20.9 23.6 1.7 0.1 3.7 1.6 0.9 0.4 1.5 1.1 1.0 0.4 1.6 1.5 0.6 1.6 0.5 0.4 1.0 1.8 6.1 5.6 4.7 9.1 7.4 5.0 4.2 4.9 18.9 9.1 LDLRAD1 ENSG00000203985 "Low density lipoprotein receptor class A domain containing 1" Q5T700 1 54007299-54018186 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 64.2;lung: 16.1;ovary: 20.5" "Group enriched" "Detected in some" 5 "CAPAN-2: 3.6;Hep G2: 14.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA052489 Enhanced Uncertain "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA052489: " "unprognostic (6.53e-3)" "unprognostic (2.05e-2)" "unprognostic (2.51e-1)" "prognostic favourable (9.21e-4)" "unprognostic (1.59e-2)" "unprognostic (1.67e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-1)" "unprognostic (8.07e-3)" "unprognostic (2.43e-1)" "unprognostic (2.86e-1)" "unprognostic (5.23e-1)" "unprognostic (4.27e-2)" 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.1 0.1 0.0 0.0 0.6 2.1 0.4 64.2 1.1 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 20.5 0.1 0.0 1.5 0.1 0.2 0.5 0.0 0.0 2.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.8 4.8 0.0 0.0 0.7 0.5 2.1 0.4 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 3.6 0.0 1.8 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.2 0.8 14.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.3 0.0 0.1 1.0 0.0 0.8 0.1 0.0 0.3 0.2 0.1 0.1 0.4 0.0 0.1 0.3 0.0 0.2 2.1 0.4 0.3 0.4 0.2 0.3 0.5 0.3 0.4 0.1 0.7 0.4 0.5 2.1 0.4 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 LDLRAD3 LRAD3 ENSG00000179241 "Low density lipoprotein receptor class A domain containing 3" Q86YD5 11 35943981-36232136 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.5" "Cell line enhanced" "Detected in many" "hTCEpi: 28.1;RH-30: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.1;non-classical monocyte: 7.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038251 Approved Approved "Cell Junctions" "Cell Junctions" "HPA038251: AB_10675790" "unprognostic (1.59e-3)" "prognostic unfavourable (2.24e-4)" "unprognostic (3.25e-2)" "unprognostic (4.08e-3)" "unprognostic (1.81e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-2)" "prognostic unfavourable (9.34e-6)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (1.68e-2)" "unprognostic (6.93e-2)" "prognostic unfavourable (5.05e-8)" "unprognostic (3.32e-2)" "unprognostic (9.21e-3)" "unprognostic (9.33e-2)" "prognostic unfavourable (2.14e-5)" 12.0 5.0 9.5 6.0 13.7 2.0 23.4 32.5 17.9 9.3 2.8 20.7 1.7 2.9 8.2 4.7 8.8 5.0 6.5 3.6 10.8 7.2 3.0 2.6 3.3 4.4 18.0 4.0 15.0 5.1 1.5 9.2 3.4 18.1 14.8 3.2 5.3 23.9 6.0 5.5 17.0 3.3 7.2 24.4 2.9 3.4 4.8 13.5 0.1 3.0 2.6 4.8 5.3 6.5 0.0 4.1 1.9 7.7 0.0 0.0 2.0 4.8 4.6 14.2 8.6 11.3 12.5 10.8 2.8 2.5 6.3 5.6 3.4 3.0 0.0 2.1 3.0 2.4 4.3 6.2 8.8 0.4 9.2 15.5 3.0 1.0 15.0 3.3 1.9 14.9 28.1 2.8 24.9 10.5 4.0 0.5 11.6 2.7 0.0 0.7 5.8 8.0 0.0 26.5 1.5 1.1 0.7 4.8 11.0 4.8 5.3 15.6 7.3 4.5 10.6 7.6 6.8 0.6 9.2 0.3 0.0 0.0 3.8 4.1 13.5 1.9 6.1 0.6 0.0 6.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 7.7 0.3 0.0 2.0 9.5 13.7 32.5 9.1 10.8 7.2 18.0 4.0 18.1 13.5 LDLRAD4 C18orf1 ENSG00000168675 "Low density lipoprotein receptor class A domain containing 4" O15165 18 13217498-13652755 "Predicted intracellular proteins, Predicted membrane proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.4;lymphoid tissue: 49.2" "Cell line enhanced" "Detected in many" "HEL: 15.5;MOLT-4: 47.4;REH: 14.3;U-698: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047633, HPA065246" Approved Supported Vesicles Vesicles "HPA047633: , HPA065246: " "unprognostic (2.52e-1)" "unprognostic (4.31e-3)" "unprognostic (5.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.64e-1)" "unprognostic (3.94e-3)" "unprognostic (9.73e-2)" "unprognostic (2.26e-2)" "unprognostic (2.21e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-1)" "unprognostic (3.64e-1)" "prognostic unfavourable (4.58e-4)" "unprognostic (2.51e-2)" "unprognostic (4.38e-2)" "unprognostic (6.58e-2)" "unprognostic (8.18e-2)" 8.3 6.6 9.6 11.5 22.0 11.9 7.5 10.3 22.9 8.6 6.1 45.4 4.3 9.8 12.9 5.2 5.6 11.0 7.8 17.8 14.6 10.7 3.9 10.4 5.9 11.6 19.9 12.5 3.6 6.2 4.6 8.3 8.0 23.5 10.4 3.3 3.7 4.8 8.3 19.0 4.8 10.9 7.5 30.7 8.9 7.6 8.9 21.2 49.2 5.2 2.5 8.5 7.9 6.7 8.2 8.2 17.2 11.0 12.5 14.5 6.2 0.1 0.2 0.9 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.2 0.0 0.0 0.0 7.7 0.8 15.5 3.2 0.2 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.0 1.2 47.4 0.6 1.2 5.4 14.3 0.1 0.6 0.0 0.8 1.1 1.6 0.2 1.0 0.0 2.1 4.7 1.4 0.8 5.5 0.1 1.0 2.2 0.2 11.9 0.0 3.5 3.1 12.7 10.3 3.4 10.2 10.3 8.9 7.2 9.7 8.8 5.1 8.2 14.5 12.6 17.2 12.5 11.0 8.2 5.2 6.2 9.6 22.0 10.3 20.6 14.6 10.7 19.9 12.5 23.5 21.2 LEMD1 "CT50, LEMP-1" ENSG00000186007 "LEM domain containing 1" Q68G75 1 205381378-205457091 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 13.1;testis: 34.8" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 29.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.6" "Group enriched" "Detected in some" 13 "cerebellum: 2.6;pons and medulla: 5.3" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045425 Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA045425: AB_10960538" "unprognostic (1.78e-1)" "unprognostic (2.00e-1)" "unprognostic (1.88e-2)" "unprognostic (4.20e-3)" "unprognostic (7.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.72e-2)" "unprognostic (1.01e-1)" "prognostic favourable (1.26e-4)" "prognostic unfavourable (1.70e-4)" "unprognostic (3.31e-1)" "unprognostic (5.66e-6)" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-2)" 0.2 0.2 0.2 0.0 0.3 0.0 0.3 2.6 0.2 0.4 1.4 0.0 3.8 0.6 1.0 13.1 1.0 1.5 0.7 0.2 0.2 0.3 0.9 0.2 0.4 0.0 0.3 0.0 0.6 0.6 0.0 0.6 4.7 5.3 0.3 0.0 0.3 3.2 0.4 0.2 0.3 1.4 0.1 0.2 0.2 0.3 34.8 0.0 0.0 4.8 2.2 2.6 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.7 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 29.2 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.2 0.3 2.6 0.2 0.2 0.3 0.3 0.0 5.3 0.0 LEMD2 "dJ482C21.1, NET25" ENSG00000161904 "LEM domain containing 2" Q8NC56 6 33771202-33789136 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017340 Supported Supported "Nuclear membrane" "Nuclear membrane" "HPA017340: AB_2296925" "unprognostic (9.01e-2)" "unprognostic (7.99e-2)" "unprognostic (1.18e-1)" "unprognostic (4.12e-2)" "unprognostic (2.98e-1)" "unprognostic (8.29e-3)" "unprognostic (6.53e-2)" "unprognostic (5.98e-2)" "unprognostic (4.42e-2)" "unprognostic (7.03e-2)" "unprognostic (1.67e-3)" "unprognostic (2.11e-2)" "prognostic unfavourable (1.12e-5)" "unprognostic (2.43e-1)" "unprognostic (7.54e-2)" "unprognostic (3.82e-2)" "unprognostic (7.12e-2)" 18.7 24.1 23.9 22.9 30.4 37.8 23.5 49.0 26.0 25.2 22.0 31.1 17.9 21.8 24.3 28.7 23.6 22.3 20.7 19.6 24.0 18.3 22.5 22.8 23.9 28.3 32.2 17.3 28.1 26.9 31.6 28.5 29.2 25.5 24.9 21.2 28.9 23.5 24.1 17.1 34.9 25.8 25.9 21.8 34.4 21.0 20.0 27.7 18.7 28.0 15.6 27.8 18.3 27.2 5.4 6.9 6.8 4.5 3.0 7.2 2.5 13.9 16.1 27.3 26.5 15.6 16.9 20.6 15.3 23.9 19.8 20.9 12.2 15.0 13.1 21.6 22.0 24.5 15.8 20.7 14.0 13.6 14.6 5.0 16.1 15.7 32.7 9.9 17.3 18.3 39.5 20.9 36.1 21.1 13.8 15.4 17.2 12.0 18.4 24.8 15.6 9.3 12.2 11.2 10.9 21.1 19.9 19.4 15.5 9.2 29.4 19.9 19.9 27.5 9.7 27.8 10.8 14.7 17.9 19.9 15.8 9.3 11.0 15.8 33.2 3.8 4.1 6.8 5.9 3.7 7.2 5.2 6.3 5.6 3.9 5.4 5.0 6.0 3.3 3.0 4.5 6.9 6.3 2.5 23.9 30.4 49.0 26.0 24.0 18.3 32.2 17.3 25.5 27.7 LENG8 "KIAA1932, MGC40108, pp13842" ENSG00000167615 "Leukocyte receptor cluster member 8" Q96PV6 19 54448887-54462037 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 100.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042004, HPA042056, HPA061571" Uncertain Supported Nucleoplasm Nucleoplasm "HPA042004: AB_10794642, HPA042056: AB_10795389, HPA061571: " "unprognostic (2.09e-2)" "unprognostic (3.24e-3)" "unprognostic (5.14e-3)" "unprognostic (2.19e-1)" "unprognostic (4.42e-2)" "prognostic favourable (7.59e-4)" "unprognostic (1.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.92e-2)" "unprognostic (4.45e-3)" "unprognostic (5.11e-3)" "unprognostic (8.85e-3)" "prognostic unfavourable (3.30e-7)" "unprognostic (3.64e-2)" "unprognostic (6.92e-2)" "unprognostic (1.71e-1)" "prognostic favourable (2.73e-6)" 58.7 37.3 45.7 53.2 47.3 48.4 30.7 81.5 55.3 37.9 32.9 48.1 54.4 78.1 56.3 66.3 22.9 44.8 39.2 24.1 42.2 21.6 35.0 22.7 36.2 45.8 52.1 30.2 50.3 62.7 13.8 46.4 27.4 38.1 41.9 22.1 48.9 66.7 59.1 36.5 37.2 75.5 35.6 34.3 80.0 53.2 32.6 57.5 24.8 42.2 18.7 33.5 31.5 32.0 4.0 5.6 8.0 1.9 1.7 1.6 0.6 14.2 11.2 14.3 7.3 4.5 7.3 7.6 12.0 1.8 2.3 4.5 9.1 20.7 11.2 5.2 9.7 19.0 4.6 5.5 1.7 18.9 100.6 17.1 30.8 6.3 5.0 2.6 13.8 16.5 8.5 1.4 5.7 3.4 13.0 16.2 2.9 5.0 10.5 13.3 3.3 2.6 17.0 4.2 15.8 5.9 4.2 11.6 6.0 1.3 8.9 2.7 8.6 3.7 16.5 10.1 10.5 1.6 12.7 15.3 7.2 4.5 8.3 18.3 6.6 3.9 1.9 2.3 1.6 1.2 1.6 1.4 0.8 1.5 1.0 4.0 1.5 1.1 8.0 1.7 0.9 5.6 1.0 0.6 45.7 47.3 81.5 55.3 42.2 21.6 52.1 30.2 38.1 57.5 LEPROTL1 "my047, Vps55" ENSG00000104660 "Leptin receptor overlapping transcript like 1" O95214 8 30095398-30177208 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047911 Uncertain "HPA047911: " "unprognostic (4.42e-2)" "unprognostic (1.33e-2)" "prognostic favourable (9.04e-4)" "unprognostic (1.92e-2)" "unprognostic (3.77e-2)" "unprognostic (4.56e-2)" "unprognostic (1.25e-3)" "unprognostic (5.24e-2)" "unprognostic (2.44e-1)" "unprognostic (4.73e-3)" "unprognostic (2.30e-1)" "unprognostic (9.44e-3)" "prognostic unfavourable (1.94e-5)" "unprognostic (3.03e-1)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (2.53e-1)" 26.2 41.7 16.1 23.4 19.9 33.4 34.3 18.8 27.5 15.6 19.8 16.3 12.0 15.8 18.8 19.6 15.4 15.8 18.2 27.3 21.5 18.0 21.6 32.3 23.5 60.0 16.3 18.5 17.8 26.7 14.4 14.3 56.0 18.9 14.3 19.2 19.3 17.0 16.9 10.2 17.0 20.6 17.3 21.2 27.2 17.6 24.5 15.0 49.8 14.2 10.0 25.0 17.1 14.4 7.2 21.4 43.7 27.6 19.4 74.4 46.5 16.4 19.3 29.4 22.2 14.9 11.4 12.5 23.2 17.8 15.3 24.9 15.8 17.3 9.9 20.8 19.9 15.6 21.1 15.9 24.4 13.8 12.5 30.5 15.3 28.9 22.8 10.7 24.8 13.2 16.8 16.9 10.9 19.1 30.2 17.4 17.8 19.9 24.7 12.8 22.5 12.1 17.7 11.7 10.9 19.0 19.3 7.6 24.0 13.0 13.0 21.9 12.1 10.8 15.9 10.5 50.5 8.6 17.3 7.5 9.6 19.9 14.7 21.0 23.3 41.9 22.8 30.9 29.0 22.1 37.7 7.2 51.0 35.6 15.8 6.8 74.4 54.8 43.7 19.4 27.6 21.4 62.6 46.5 16.1 19.9 18.8 27.5 21.5 18.0 16.3 18.5 18.9 15.0 LETM1 SLC55A1 ENSG00000168924 "Leucine zipper and EF-hand containing transmembrane protein 1" O95202 4 1811479-1856247 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011029, HPA011100" Supported Supported Mitochondria Mitochondria "HPA011029: AB_1852804, HPA011100: AB_1852802" "unprognostic (1.16e-1)" "unprognostic (1.80e-1)" "unprognostic (3.85e-2)" "unprognostic (5.04e-2)" "unprognostic (5.48e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (1.79e-4)" "unprognostic (1.37e-3)" "unprognostic (1.87e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.77e-4)" "prognostic favourable (8.90e-4)" "unprognostic (8.06e-3)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (2.42e-1)" 16.9 15.3 11.9 11.2 13.1 9.9 16.8 17.3 19.9 6.7 23.7 10.0 7.5 20.3 8.5 6.9 22.0 8.1 15.0 18.9 10.2 10.2 16.2 20.4 9.4 10.7 10.6 10.5 9.5 19.7 13.0 8.7 7.6 10.7 8.2 16.3 9.2 9.7 7.2 17.2 18.5 19.4 8.0 7.7 10.6 15.6 12.6 9.0 50.7 10.9 19.9 16.6 8.0 9.7 5.0 14.7 3.8 5.6 6.7 7.1 2.1 12.1 20.6 6.4 19.9 9.9 7.0 11.5 12.0 5.9 12.1 9.5 19.0 13.5 20.0 8.6 12.6 12.3 16.4 17.0 7.5 13.3 17.1 20.5 16.8 13.6 12.9 20.7 16.9 11.3 12.2 13.8 12.3 10.4 26.9 12.6 8.3 13.3 29.9 23.7 16.8 23.8 17.2 9.0 11.7 9.5 16.9 16.4 14.5 13.7 17.4 7.2 16.3 10.9 15.6 13.9 8.3 11.7 20.0 11.0 16.9 16.0 12.3 18.1 11.1 3.8 4.5 2.1 7.1 5.6 7.0 5.0 6.0 6.1 4.7 4.6 4.0 5.9 0.7 6.7 5.3 14.7 4.6 2.1 11.9 13.1 17.3 19.9 10.2 10.2 10.6 10.5 10.7 9.0 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.8;testis: 28.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 50.6" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 2.3 1.3 3.3 1.7 7.9 6.8 1.5 9.9 6.6 2.6 1.3 2.9 0.5 1.5 2.1 2.1 2.1 2.1 2.0 1.4 4.3 4.1 3.5 1.4 3.2 1.7 3.1 4.2 2.6 1.4 3.6 5.5 6.7 3.3 1.9 1.5 3.0 1.4 1.4 0.8 1.8 1.1 1.2 3.2 2.3 4.1 28.6 1.6 3.8 1.6 1.0 2.2 3.1 1.7 1.4 1.3 16.8 3.8 1.2 4.0 1.2 13.6 2.5 1.9 1.7 1.5 4.2 1.4 4.6 5.5 6.6 4.0 1.0 5.4 1.7 10.8 1.0 1.5 3.8 16.5 6.9 0.8 1.5 2.0 1.9 2.4 1.8 0.3 1.9 1.2 4.6 7.0 15.0 6.9 1.7 2.7 5.8 2.8 4.9 1.2 0.4 11.6 1.7 3.1 1.0 10.8 0.6 1.6 1.5 1.5 0.3 0.5 1.6 0.8 11.8 2.0 14.6 3.7 1.1 1.7 1.0 1.3 3.2 2.1 1.5 0.9 3.4 0.5 0.9 1.3 1.5 1.4 0.8 1.3 1.3 1.4 1.6 1.5 16.8 1.2 3.8 0.6 4.0 1.2 3.3 7.9 9.9 6.6 4.3 4.1 3.1 4.2 3.3 1.6 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: " "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favourable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favourable (3.16e-4)" 25.7 27.5 23.0 18.1 31.2 17.1 27.1 23.1 37.5 18.6 26.8 18.8 21.5 31.9 22.9 22.4 16.2 30.0 23.5 16.4 21.2 19.0 29.3 35.1 16.6 18.5 20.6 21.3 34.3 38.6 28.5 20.2 12.3 21.6 19.1 26.1 22.6 28.2 24.0 23.8 18.5 28.5 18.7 21.4 17.5 22.6 15.5 14.3 19.9 34.1 10.7 20.1 20.3 14.8 11.3 7.2 2.9 11.6 8.6 17.1 9.3 7.4 6.7 5.0 13.5 22.8 37.5 5.1 7.7 12.8 8.2 9.2 16.2 15.4 19.7 9.6 8.3 13.9 10.3 10.4 9.4 7.1 12.9 14.1 9.3 12.7 15.1 12.7 10.3 31.5 33.7 9.6 22.8 8.2 14.7 14.3 11.1 11.6 8.9 12.3 3.4 18.3 7.6 6.1 10.7 10.2 11.4 15.1 6.9 5.8 13.1 17.6 20.7 11.6 6.2 5.1 5.5 8.4 4.4 13.0 20.2 8.4 9.5 8.3 3.6 2.5 7.3 2.9 8.6 7.8 12.5 11.3 14.2 10.6 7.2 8.1 17.1 15.5 2.4 8.6 11.6 6.4 12.6 9.3 23.0 31.2 23.1 37.5 21.2 19.0 20.6 21.3 21.6 14.3 LIFR CD118 ENSG00000113594 "LIF receptor alpha" P42702 5 38474963-38608354 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 39.8;HHSteC: 17.0;SCLC-21H: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004478, CAB010252" Approved "Nuclear speckles,Golgi apparatus" "Intracellular and membrane" 74000 "Nuclear speckles" "Golgi apparatus" "CAB010252: AB_2128043, HPA004478: " "unprognostic (6.00e-3)" "unprognostic (2.53e-1)" "unprognostic (1.05e-1)" "unprognostic (2.81e-3)" "unprognostic (8.80e-2)" "unprognostic (7.13e-2)" "unprognostic (1.11e-1)" "prognostic favourable (1.92e-4)" "unprognostic (1.78e-1)" "unprognostic (9.80e-2)" "unprognostic (2.73e-3)" "unprognostic (1.06e-1)" "prognostic favourable (1.40e-7)" "unprognostic (3.69e-2)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" "unprognostic (1.65e-1)" 35.3 14.7 15.8 8.2 19.2 0.5 33.9 10.1 21.3 27.7 10.4 25.3 22.8 4.9 34.8 14.8 10.4 26.0 10.2 16.3 19.1 11.0 20.3 23.9 21.7 20.2 24.3 11.8 17.9 17.8 13.5 12.5 41.5 23.4 23.6 7.5 17.1 24.9 24.7 24.0 10.5 11.7 26.9 21.4 22.5 18.8 9.3 25.3 4.7 31.4 7.3 8.1 13.6 15.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 2.2 39.8 3.0 11.2 12.4 0.3 3.3 1.9 2.7 1.6 0.4 2.1 0.0 0.5 4.7 0.3 2.6 0.9 4.6 0.0 3.6 0.0 4.2 1.5 17.0 0.0 0.2 10.4 0.7 6.5 0.7 3.7 1.0 6.4 3.3 0.5 0.0 0.1 1.0 7.1 0.0 8.4 0.0 2.6 1.0 26.1 3.2 13.7 0.6 0.0 0.9 0.0 0.7 4.3 8.5 10.1 2.0 0.0 0.0 0.0 7.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 19.2 10.1 21.3 19.1 11.0 24.3 11.8 23.4 25.3 LILRA4 "CD85g, ILT7" ENSG00000239961 "Leukocyte immunoglobulin like receptor A4" P59901 19 54333185-54339150 "CD markers, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "blood: 49.7;brain: 12.5;lymphoid tissue: 16.8" "Cell line enriched" "Detected in single" 30 "RPMI-8226: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 21 "plasmacytoid DC: 49.7" "Lineage enriched" "Detected in many" 21 "dendritic cells: 49.7" HPA049418 Approved "HPA049418: " "unprognostic (5.11e-2)" "unprognostic (1.21e-4)" "unprognostic (2.65e-2)" "unprognostic (5.94e-2)" "unprognostic (1.44e-1)" "unprognostic (1.19e-3)" "unprognostic (7.62e-2)" "unprognostic (1.36e-3)" "unprognostic (1.08e-1)" "unprognostic (9.46e-2)" "unprognostic (4.90e-2)" "unprognostic (9.30e-2)" "unprognostic (8.28e-7)" "unprognostic (2.12e-2)" "unprognostic (1.17e-3)" "unprognostic (4.53e-1)" "unprognostic (5.86e-2)" 0.7 0.4 2.1 2.3 2.5 0.6 0.7 1.1 4.3 0.4 0.9 12.5 0.0 0.7 0.4 0.4 0.6 0.4 0.8 0.4 3.5 1.4 0.4 0.7 1.4 5.3 12.2 1.2 0.4 0.4 0.4 0.3 0.4 7.6 0.5 0.5 0.0 0.7 0.5 0.4 0.6 2.0 0.6 7.4 16.8 0.5 0.5 6.7 2.3 0.4 0.0 10.1 0.7 0.2 2.4 49.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.1 0.0 49.7 0.0 0.1 2.1 2.5 1.1 4.3 3.5 1.4 12.2 1.2 7.6 6.7 LILRB4 "CD85k, HM18, ILT3, LIR-5, LIR5" ENSG00000186818 "Leukocyte immunoglobulin like receptor B4" Q8NHJ6 19 54643889-54670359 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.8;lymphoid tissue: 33.1" "Cell line enriched" "Detected in some" 35 "Karpas-707: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 22.8" "Group enriched" "Detected in many" 69 "dendritic cells: 22.8;monocytes: 6.2" HPA052807 Approved 9900 "HPA052807: " "unprognostic (4.09e-2)" "unprognostic (5.75e-3)" "unprognostic (6.06e-2)" "unprognostic (1.91e-2)" "unprognostic (1.82e-1)" "unprognostic (1.55e-1)" "unprognostic (5.03e-2)" "unprognostic (3.53e-1)" "unprognostic (4.13e-2)" "unprognostic (1.52e-1)" "unprognostic (5.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.91e-2)" "unprognostic (1.08e-1)" "unprognostic (4.42e-2)" "unprognostic (4.51e-2)" "unprognostic (4.52e-2)" 15.4 4.3 5.1 20.1 7.4 4.5 3.1 0.8 5.9 1.6 3.6 12.8 0.0 4.0 1.0 4.7 2.1 4.2 4.4 3.9 5.3 5.3 3.1 3.9 12.3 33.1 10.8 1.9 1.7 1.6 1.5 2.4 4.2 6.6 1.7 5.5 2.9 3.8 1.4 0.8 0.9 5.4 2.1 15.1 18.0 2.8 1.3 6.9 3.1 2.3 0.7 6.1 13.8 0.8 0.2 22.8 0.1 6.2 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 94.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 6.2 0.0 0.1 0.0 0.0 7.0 0.2 0.0 0.0 0.1 0.1 4.8 22.8 0.0 1.8 5.1 7.4 0.8 4.5 5.3 5.3 10.8 1.9 6.6 6.9 LILRB5 "CD85c, LIR-8, LIR8" ENSG00000105609 "Leukocyte immunoglobulin like receptor B5" O75023 19 54249431-54257301 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 31.0;lymphoid tissue: 35.1" "Cell line enhanced" "Detected in some" "SiHa: 2.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA012069 Approved 36000000 "HPA012069: AB_1852873" "unprognostic (3.55e-3)" "unprognostic (5.38e-2)" "unprognostic (2.20e-2)" "unprognostic (7.03e-2)" "unprognostic (8.86e-2)" "unprognostic (5.44e-2)" "unprognostic (3.02e-5)" "unprognostic (6.80e-2)" "unprognostic (2.23e-1)" "unprognostic (2.33e-1)" "unprognostic (9.95e-2)" "unprognostic (8.68e-2)" "unprognostic (3.31e-1)" "unprognostic (2.07e-1)" "unprognostic (4.14e-2)" "unprognostic (1.42e-2)" "unprognostic (1.73e-1)" 23.6 8.3 0.7 5.4 0.8 0.8 31.0 0.6 0.6 2.1 11.9 0.5 1.6 5.2 1.2 16.2 5.8 4.9 6.2 10.0 0.7 0.8 2.1 22.8 8.6 13.3 0.8 0.0 4.1 2.7 0.7 1.0 5.6 0.7 4.0 5.5 3.6 2.9 1.1 6.1 2.0 9.0 5.9 0.9 35.1 2.4 3.9 0.0 1.2 2.6 4.9 1.3 10.6 1.8 0.9 0.7 3.1 0.9 0.9 0.5 0.3 0.4 0.0 0.8 0.5 0.1 0.1 1.0 1.0 0.3 0.4 0.0 0.3 0.6 0.2 0.4 0.1 1.4 0.3 0.5 0.0 0.5 0.9 1.1 1.7 0.4 0.5 0.6 0.6 0.5 0.3 0.1 0.3 0.5 0.6 1.0 0.2 0.0 0.3 0.3 0.6 0.0 0.6 0.7 0.6 0.2 0.8 0.5 0.9 2.3 0.8 0.7 0.7 0.0 0.3 0.8 0.7 0.5 0.6 0.3 1.1 0.1 0.4 0.3 0.2 3.1 0.9 0.4 0.4 0.6 0.3 0.4 0.5 0.3 0.3 0.9 0.4 0.4 2.3 0.9 0.8 0.7 0.3 0.3 0.7 0.8 0.6 0.6 0.7 0.8 0.8 0.0 0.7 0.0 LINGO1 "FLJ14594, LERN1, LRRN6A" ENSG00000169783 "Leucine rich repeat and Ig domain containing 1" Q96FE5 15 77613027-77820900 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 67.2" "Cell line enhanced" "Detected in some" "AF22: 13.2;AN3-CA: 11.0;HAP1: 16.6;HEK 293: 11.7;MCF7: 7.1;NTERA-2: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074653 Enhanced Approved "Plasma membrane" 8400 "Plasma membrane" "HPA074653: " "unprognostic (1.06e-1)" "unprognostic (7.07e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-2)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.84e-2)" "unprognostic (3.77e-2)" "unprognostic (3.40e-1)" "unprognostic (1.10e-1)" "unprognostic (7.36e-2)" "unprognostic (2.74e-2)" "prognostic unfavourable (3.23e-7)" "unprognostic (2.07e-1)" "unprognostic (7.06e-2)" "unprognostic (2.85e-1)" "unprognostic (2.59e-2)" 3.0 1.6 27.4 1.7 21.8 0.8 1.3 9.1 67.2 3.8 2.0 5.9 0.0 2.0 3.3 2.7 1.4 3.1 2.5 9.7 29.8 12.2 2.2 1.1 1.1 1.3 10.3 21.8 1.7 2.7 1.1 0.5 6.1 6.8 1.7 1.5 1.8 3.4 2.5 1.0 3.0 1.5 4.5 6.8 3.3 2.0 3.7 3.9 0.0 1.7 0.0 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 13.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 16.6 0.0 0.0 0.0 11.7 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.1 0.0 7.1 0.0 0.0 31.3 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.7 0.0 1.3 2.8 0.2 0.2 1.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 21.8 9.1 47.5 29.8 12.2 10.3 21.8 6.8 3.9 LINGO2 "LERN3, LRRN6C" ENSG00000174482 "Leucine rich repeat and Ig domain containing 2" Q7L985 9 27948078-28670286 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 10.5;smooth muscle: 11.4" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;hTERT-HME1: 2.3;SH-SY5Y: 13.4;U-87 MG: 2.3;WM-115: 5.9" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 8 "NK-cells: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA016633, CAB025361" Approved "CAB025361: , HPA016633: AB_1853362" "unprognostic (1.27e-1)" "unprognostic (3.58e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-4)" "unprognostic (9.86e-4)" "unprognostic (7.55e-3)" "unprognostic (2.67e-6)" "unprognostic (1.08e-1)" "unprognostic (2.38e-1)" "unprognostic (2.34e-2)" "unprognostic (3.74e-2)" "unprognostic (8.13e-2)" "unprognostic (1.07e-1)" "unprognostic (4.08e-2)" "unprognostic (2.30e-2)" "unprognostic (1.95e-4)" 0.0 0.3 1.8 0.0 1.7 0.0 0.0 1.0 3.4 0.3 0.0 0.0 10.5 1.0 0.0 0.4 1.0 0.0 1.4 4.1 0.6 0.0 0.0 0.0 0.6 0.0 0.0 2.7 0.6 1.8 0.6 0.0 0.0 1.9 0.0 0.0 0.0 11.4 0.3 0.0 0.4 1.8 3.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.4 1.7 0.0 0.5 0.3 3.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 1.1 0.3 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 13.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.3 0.0 5.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 1.7 LINGO3 "LERN2, LRRN6B" ENSG00000220008 "Leucine rich repeat and Ig domain containing 3" P0C6S8 19 2289784-2292024 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.9;brain: 15.7;lymphoid tissue: 7.1" "Cell line enriched" "Detected in some" 4 "HMC-1: 19.2" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Cell type enhanced" "Detected in some" "eosinophil: 6.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 6.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "basal ganglia: 34.0;cerebellum: 34.4;hippocampal formation: 11.5" "HPA043781, HPA059558" Enhanced Approved Mitochondria Mitochondria "HPA043781: , HPA059558: " "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (7.16e-3)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (7.45e-3)" "unprognostic (1.11e-2)" "unprognostic (3.19e-2)" "unprognostic (4.03e-4)" "unprognostic (2.35e-2)" "unprognostic (1.36e-2)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (1.05e-1)" "unprognostic (4.14e-2)" 0.1 0.2 2.2 3.1 15.7 2.8 0.0 4.6 2.9 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.2 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 1.2 0.0 0.4 7.1 1.2 0.1 0.0 0.0 0.0 0.0 1.0 0.1 6.9 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 2.1 19.2 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 2.5 0.2 0.1 1.8 0.0 4.7 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 1.9 0.1 6.9 0.4 0.0 0.4 0.5 0.0 0.2 0.1 1.0 0.1 0.0 2.9 0.3 0.1 0.0 0.6 0.0 LINGO4 LRRN6D ENSG00000213171 "Leucine rich repeat and Ig domain containing 4" Q6UY18 1 151800264-151806154 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 5.4;skeletal muscle: 17.7" "Group enriched" "Detected in some" 4 "HDLM-2: 4.0;Karpas-707: 1.1;SH-SY5Y: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA060781 Uncertain "HPA060781: " "unprognostic (2.71e-2)" "unprognostic (1.98e-1)" "unprognostic (1.33e-3)" "unprognostic (1.96e-1)" "unprognostic (8.65e-2)" "unprognostic (3.16e-2)" "unprognostic (1.49e-5)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (2.39e-1)" "unprognostic (1.94e-4)" "unprognostic (6.92e-2)" "unprognostic (3.94e-4)" "unprognostic (3.84e-1)" "unprognostic (1.65e-1)" "unprognostic (7.06e-2)" "unprognostic (5.60e-2)" 0.0 2.5 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.8 0.0 0.3 0.0 0.1 0.3 0.7 0.1 0.1 0.0 0.0 0.3 0.4 1.2 0.0 0.8 0.0 0.4 0.1 17.7 0.3 0.0 0.0 0.3 0.0 0.3 0.4 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LITAF "FLJ38636, PIG7, SIMPLE, TP53I7" ENSG00000189067 "Lipopolysaccharide induced TNF factor" Q99732 16 11547722-11636381 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 202.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 202.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 202.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006960 Approved Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA006960: AB_1079254" "unprognostic (2.26e-1)" "unprognostic (4.96e-2)" "unprognostic (2.32e-3)" "unprognostic (1.03e-1)" "prognostic unfavourable (2.02e-4)" "unprognostic (4.07e-2)" "unprognostic (8.75e-3)" "unprognostic (3.60e-1)" "unprognostic (6.15e-3)" "unprognostic (1.04e-1)" "unprognostic (4.61e-2)" "unprognostic (5.01e-1)" "unprognostic (1.85e-2)" "unprognostic (9.49e-2)" "prognostic unfavourable (6.25e-4)" "unprognostic (3.57e-2)" "unprognostic (1.60e-1)" 55.0 14.1 18.0 49.2 42.4 53.3 65.7 5.0 18.5 50.4 36.4 45.2 20.2 13.9 42.7 28.8 19.6 34.0 35.3 31.5 20.7 15.7 48.9 66.3 73.0 80.6 28.6 13.2 43.1 26.3 15.9 17.1 46.2 42.8 36.2 36.7 26.0 57.3 32.2 18.6 28.5 24.1 41.6 52.1 57.9 26.3 11.0 19.0 18.7 53.3 18.8 36.4 47.4 41.6 14.1 16.9 202.5 10.3 20.2 37.6 35.6 13.7 25.6 16.2 7.8 2.5 1.9 16.4 17.9 55.1 17.0 25.4 10.6 37.1 6.9 22.9 15.1 17.0 6.8 30.0 16.3 52.7 7.1 0.5 22.3 53.7 38.0 2.1 2.3 5.7 58.3 13.9 38.2 0.0 4.2 26.8 0.2 13.1 0.3 31.8 26.4 0.1 2.1 3.5 39.6 14.3 19.4 4.0 12.2 30.9 39.5 31.8 22.1 11.7 0.1 7.1 12.0 4.1 4.1 10.5 23.1 17.7 8.1 16.8 40.5 32.2 10.3 20.8 37.6 9.8 22.8 14.1 23.5 33.5 13.6 13.9 26.8 31.7 202.5 20.2 5.7 16.9 26.2 35.6 18.0 42.4 5.0 18.5 20.7 15.7 28.6 13.2 42.8 19.0 LMAN1 "ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60" ENSG00000074695 "Lectin, mannose binding 1" P49257 18 59327823-59359962 "Disease related genes, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002320, CAB037163" Supported Uncertain Cytosol 13000000 Cytosol "CAB037163: AB_532237, HPA002320: AB_1079256" "unprognostic (5.64e-2)" "unprognostic (8.96e-3)" "unprognostic (4.20e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (1.65e-1)" "unprognostic (5.40e-3)" "unprognostic (1.16e-1)" "unprognostic (2.03e-1)" "unprognostic (2.40e-2)" "unprognostic (1.06e-1)" "unprognostic (5.79e-2)" "unprognostic (4.28e-2)" "unprognostic (5.37e-3)" "unprognostic (7.05e-2)" "unprognostic (3.71e-3)" 6.2 7.7 2.6 4.5 3.0 1.6 5.7 4.6 1.8 9.8 3.9 5.7 6.7 7.4 6.6 6.5 3.8 8.0 2.7 3.0 9.1 26.2 7.0 2.7 2.8 8.1 15.3 12.7 9.7 7.1 8.2 5.0 8.4 6.1 6.9 3.4 6.1 4.6 3.5 4.8 7.5 2.1 12.3 3.9 4.7 5.6 6.9 8.2 4.0 3.4 9.0 9.8 3.8 18.7 11.1 11.9 9.9 27.8 48.2 24.0 33.9 48.7 23.0 30.8 11.0 18.2 3.3 24.2 40.2 23.1 16.9 19.2 41.9 12.7 10.8 10.9 14.9 22.8 33.1 37.8 16.8 32.1 23.2 22.2 45.6 23.1 18.3 37.3 22.3 5.0 10.9 7.8 8.2 13.8 12.4 21.7 36.2 12.8 14.2 8.1 8.9 17.1 16.8 19.2 12.4 14.8 19.0 37.4 13.1 11.9 19.6 28.5 14.2 16.2 39.3 20.1 30.5 4.0 2.3 0.6 7.2 3.4 9.8 6.9 7.9 7.5 3.1 4.7 7.6 7.5 0.3 9.0 1.9 8.2 8.7 3.8 LMAN2 "C5orf8, GP36B, VIP36" ENSG00000169223 "Lectin, mannose binding 2" Q12907 5 177331562-177351852 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003927 Approved 110000000 "HPA003927: AB_1079257" "unprognostic (5.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.87e-2)" "unprognostic (1.85e-3)" "unprognostic (6.25e-2)" "unprognostic (3.90e-3)" "unprognostic (2.88e-3)" "unprognostic (2.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.51e-3)" "unprognostic (4.56e-2)" "unprognostic (6.67e-2)" "prognostic unfavourable (8.53e-4)" "unprognostic (4.43e-2)" "unprognostic (6.13e-2)" "unprognostic (1.45e-2)" "unprognostic (2.32e-1)" 18.3 25.2 15.0 18.9 17.4 21.7 19.0 9.5 16.4 23.4 24.5 15.4 31.4 29.4 22.8 47.6 41.6 20.7 19.3 23.3 13.9 10.2 33.3 91.7 23.1 29.1 16.4 12.7 22.2 123.4 7.3 19.1 37.5 14.8 21.4 13.0 20.1 37.2 17.8 13.6 17.4 32.9 22.2 11.9 26.7 23.6 28.4 14.1 22.2 45.7 16.4 39.0 18.8 21.0 43.6 85.3 95.2 71.2 56.9 73.7 115.8 17.2 31.4 8.9 52.5 35.0 11.7 49.8 19.9 18.1 15.9 20.0 52.8 42.2 18.8 48.6 26.8 26.9 11.2 39.8 6.4 89.2 26.4 11.7 23.4 31.3 33.7 24.9 35.6 24.0 14.5 17.8 15.9 22.2 14.4 76.4 11.5 50.8 18.3 41.2 13.4 29.0 21.3 16.3 64.7 14.9 20.1 15.8 17.4 18.7 32.3 32.0 25.0 57.1 23.9 28.7 18.5 14.7 29.2 42.5 31.4 18.5 39.9 34.9 30.9 79.2 71.2 78.1 73.7 62.9 62.9 43.6 54.6 61.6 61.4 42.6 45.5 52.9 95.2 56.9 54.4 85.3 57.3 115.8 15.0 17.4 9.5 16.4 13.9 10.2 16.4 12.7 14.8 14.1 LMAN2L "DKFZp564L2423, VIPL" ENSG00000114988 "Lectin, mannose binding 2 like" Q9H0V9 2 96705929-96740064 "Disease related genes, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026600 Approved "HPA026600: AB_1852939" "unprognostic (3.02e-1)" "unprognostic (2.34e-1)" "unprognostic (2.17e-3)" "unprognostic (1.83e-2)" "unprognostic (2.19e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-2)" "unprognostic (4.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.80e-1)" "unprognostic (6.91e-3)" "unprognostic (1.16e-1)" "unprognostic (5.30e-2)" "unprognostic (8.14e-2)" "unprognostic (2.17e-1)" "unprognostic (1.52e-1)" "unprognostic (3.29e-1)" 10.1 11.1 10.4 11.8 15.5 1.6 17.0 22.9 11.5 15.5 12.4 13.3 9.9 6.4 15.9 20.3 9.9 19.9 10.2 14.3 11.3 13.6 20.2 18.1 10.8 6.0 11.6 9.9 24.9 15.8 12.6 19.8 12.9 11.4 16.9 12.2 14.6 12.4 16.4 14.5 9.8 9.4 17.7 8.4 8.1 9.9 13.7 11.2 8.6 26.4 8.0 8.2 10.5 24.0 15.0 15.7 20.1 13.7 10.4 25.7 13.4 9.5 15.5 12.1 12.5 15.4 7.4 11.1 9.0 11.2 19.0 20.8 26.3 7.3 4.6 34.1 22.0 11.7 17.2 14.0 24.1 12.2 9.4 4.0 10.5 22.1 9.7 6.9 6.8 8.4 13.4 14.4 4.6 11.0 9.0 9.6 11.9 6.5 4.9 6.5 6.5 16.9 10.4 10.0 5.2 15.5 5.0 7.7 4.0 10.1 7.8 8.9 9.3 12.2 8.0 15.2 10.9 11.9 11.7 6.3 20.4 3.9 8.9 8.2 12.3 20.1 13.7 16.5 11.3 7.5 25.7 15.0 13.3 15.1 11.0 12.6 16.4 13.7 7.4 10.4 10.8 15.7 10.7 13.4 10.4 15.5 22.9 11.5 11.3 13.6 11.6 9.9 11.4 11.2 LMLN "Gp63, LMNL1, Msp" ENSG00000185621 "Leishmanolysin like peptidase" Q96KR4 3 197960200-198043720 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016481, HPA028844" Uncertain Supported "Focal adhesion sites,Cytosol" Cytosol "Focal adhesion sites" "HPA016481: AB_1852955, HPA028844: AB_10602347" "unprognostic (2.54e-1)" "unprognostic (3.15e-1)" "unprognostic (7.63e-2)" "prognostic favourable (6.77e-4)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-1)" "unprognostic (6.36e-2)" "unprognostic (2.98e-1)" "unprognostic (4.82e-3)" "unprognostic (8.78e-2)" "unprognostic (7.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.63e-1)" 3.9 4.9 5.2 2.5 11.0 2.3 4.5 6.1 9.1 6.2 3.5 5.8 14.3 2.2 4.8 20.3 3.5 9.3 5.1 5.9 5.7 7.4 6.6 3.7 8.1 3.5 5.6 8.9 6.5 6.1 8.8 15.0 3.9 11.6 4.6 4.1 5.4 4.2 11.7 3.7 6.5 2.3 4.0 5.5 3.0 3.9 27.0 4.4 1.2 7.6 3.0 2.6 3.5 3.7 1.9 1.9 0.8 2.4 1.8 2.4 1.2 6.5 2.5 3.0 3.5 5.9 8.3 2.5 3.4 3.1 6.2 5.1 2.4 2.4 2.1 16.0 2.4 2.5 2.8 2.7 9.0 0.3 2.0 1.2 2.1 1.8 3.7 3.7 1.8 3.9 6.1 7.7 5.0 2.7 6.3 4.0 5.9 4.9 2.2 3.2 3.3 6.0 2.5 0.7 2.2 6.4 1.7 4.8 1.4 4.8 4.3 3.4 11.1 2.8 5.7 7.6 1.1 9.2 5.7 7.1 13.8 0.6 10.9 6.4 6.9 0.2 0.6 0.5 1.2 2.4 1.7 1.9 0.8 1.6 1.9 1.1 2.2 2.4 0.8 1.8 0.9 0.5 0.0 1.2 5.2 11.0 6.1 9.1 5.7 7.4 5.6 8.9 11.6 4.4 LMO7 "FBX20, FBXO20, KIAA0858" ENSG00000136153 "LIM domain 7" Q8WWI1 13 75620434-75859870 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 65.6" "Cell line enhanced" "Detected in many" "BJ: 54.7;fHDF/TERT166: 90.2;LHCN-M2: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.1" "Lineage enriched" "Detected in many" 5 "T-cells: 14.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 32.9;basal ganglia: 46.3;cerebral cortex: 39.4;hippocampal formation: 54.2" "HPA020923, HPA050184" Approved Supported "Actin filaments,Cytosol" "Actin filaments" Cytosol "HPA020923: AB_1852963, HPA050184: " "unprognostic (2.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.28e-1)" "prognostic unfavourable (5.12e-4)" "unprognostic (1.75e-2)" "unprognostic (1.44e-1)" "unprognostic (1.57e-2)" "unprognostic (1.97e-1)" "unprognostic (1.52e-2)" "unprognostic (3.42e-2)" "prognostic unfavourable (3.51e-4)" "unprognostic (2.14e-1)" "prognostic favourable (7.75e-12)" "unprognostic (2.49e-1)" "unprognostic (2.82e-1)" "unprognostic (1.08e-1)" "unprognostic (8.33e-2)" 2.2 2.2 10.1 6.3 32.6 0.9 2.5 2.7 13.2 6.7 24.3 0.5 2.4 17.5 2.3 7.8 42.5 4.0 16.3 65.6 9.8 2.5 21.7 19.9 57.0 2.6 2.3 8.8 5.5 6.8 6.2 3.1 10.9 1.1 7.6 8.9 2.7 14.3 7.0 44.4 8.6 55.0 2.1 2.0 1.5 16.7 4.7 4.1 16.2 25.7 36.3 23.7 4.6 15.4 2.4 1.1 3.0 0.5 0.5 14.1 2.6 12.1 6.9 0.2 0.2 14.4 10.2 2.4 54.7 27.0 13.9 15.1 16.9 15.7 1.0 4.2 90.2 11.8 3.0 2.6 16.1 16.3 0.7 7.4 36.7 15.8 4.1 2.3 3.9 7.0 5.1 6.0 6.9 5.8 0.2 0.0 84.9 4.7 1.8 1.0 0.3 10.4 1.1 25.5 0.2 5.9 2.8 0.8 1.9 9.9 1.7 2.2 2.2 1.7 8.8 34.4 6.4 4.1 13.3 3.7 2.7 4.3 10.1 2.6 15.6 3.0 0.2 2.4 0.7 0.5 0.9 1.1 3.2 1.0 0.4 2.4 14.1 8.5 0.1 0.5 0.3 1.1 1.2 2.6 10.1 32.6 2.7 13.2 9.8 2.5 2.3 8.8 1.1 4.1 LMTK2 "AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100" ENSG00000164715 "Lemur tyrosine kinase 2" Q8IWU2 7 98106885-98209633 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010657, HPA041836" Uncertain Approved "Nuclear speckles,Plasma membrane,Centriolar satellite,Cytosol" "Nuclear speckles, Centriolar satellite" "Plasma membrane, Cytosol" "HPA010657: AB_1079259, HPA041836: " "unprognostic (7.36e-2)" "unprognostic (3.16e-1)" "unprognostic (1.59e-1)" "unprognostic (2.60e-3)" "unprognostic (2.47e-2)" "unprognostic (2.45e-1)" "unprognostic (2.35e-2)" "unprognostic (1.23e-1)" "unprognostic (4.96e-1)" "prognostic unfavourable (8.03e-4)" "unprognostic (1.23e-1)" "unprognostic (4.65e-1)" "prognostic favourable (1.12e-7)" "unprognostic (1.88e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (6.38e-3)" 5.1 10.3 13.7 5.6 21.3 17.3 5.6 16.6 34.3 7.3 13.8 6.1 5.6 12.6 6.1 6.3 12.7 6.4 7.9 16.9 11.0 10.1 10.1 8.5 10.0 5.1 7.5 18.9 8.0 21.0 22.2 10.0 4.8 13.2 7.9 11.8 5.4 10.5 6.5 17.5 11.5 13.8 5.7 5.5 6.8 9.4 8.0 6.9 7.2 8.7 5.7 7.4 8.3 8.1 0.6 0.7 4.8 0.9 0.3 1.6 0.5 9.9 11.7 9.1 9.3 4.9 3.9 8.5 4.1 4.5 4.1 4.9 9.2 9.1 5.2 11.9 5.3 10.9 10.5 6.3 6.4 7.4 7.4 3.5 10.5 9.2 6.0 6.3 6.4 2.7 8.8 8.4 11.4 6.1 9.2 11.1 3.7 13.5 6.6 3.8 11.1 5.7 7.3 6.2 10.3 6.8 17.5 6.5 13.1 8.3 15.2 6.0 4.2 2.6 7.4 8.5 14.0 16.9 9.4 4.9 8.6 10.5 5.7 5.0 10.1 1.2 0.6 0.5 0.8 0.3 0.5 0.6 0.9 0.9 0.3 0.6 1.1 1.6 4.8 0.3 0.9 0.7 0.8 0.5 13.7 21.3 16.6 34.3 11.0 10.1 7.5 18.9 13.2 6.9 LMTK3 "KIAA1883, LMR3, PPP1R101, TYKLM3" ENSG00000142235 "Lemur tyrosine kinase 3" Q96Q04 19 48485271-48513189 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.1" "Cell line enhanced" "Detected in many" "HMC-1: 8.4;SK-BR-3: 10.0;U-266/70: 9.3;U-266/84: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040203, HPA077070" Enhanced Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA040203: AB_10671690, HPA077070: " "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (5.37e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-1)" "unprognostic (1.71e-2)" "unprognostic (5.67e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-3)" "unprognostic (5.71e-2)" "unprognostic (1.47e-1)" "prognostic favourable (3.18e-8)" "unprognostic (1.38e-1)" "unprognostic (3.22e-2)" "unprognostic (3.24e-1)" "unprognostic (6.11e-2)" 1.3 4.4 19.8 2.3 28.6 2.0 2.0 20.0 38.1 2.0 1.5 6.0 0.2 6.2 1.4 1.5 2.3 1.6 1.9 1.7 17.2 11.1 2.5 1.3 3.2 2.2 6.5 23.8 1.3 2.1 8.5 6.1 2.1 12.5 3.5 1.2 1.6 5.2 3.1 1.2 2.4 4.0 1.2 6.6 1.8 2.9 1.5 10.3 0.0 2.3 0.0 2.2 1.6 1.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 4.5 3.0 0.3 0.0 0.0 0.0 4.4 0.0 0.2 0.0 0.1 2.2 3.6 1.6 1.2 0.0 2.1 0.3 1.6 0.0 0.0 1.2 0.2 0.3 0.7 0.0 0.0 8.4 0.2 0.9 0.0 0.0 0.1 1.4 2.8 0.0 3.0 0.6 0.8 1.1 0.9 3.8 0.0 1.3 1.1 0.7 0.7 2.8 0.1 10.0 0.0 3.8 0.2 0.1 0.0 0.8 0.1 0.0 9.3 7.5 0.4 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 19.8 28.6 20.0 38.1 17.2 11.1 6.5 23.8 12.5 10.3 LNPEP "CAP, IRAP, P-LAP, PLAP" ENSG00000113441 "Leucyl and cystinyl aminopeptidase" Q9UIQ6 5 96935394-97037515 "Enzymes, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 104.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043642 Approved "Intracellular and membrane" 390000 "HPA043642: AB_10964137" "unprognostic (1.52e-1)" "unprognostic (5.39e-2)" "unprognostic (7.78e-2)" "unprognostic (1.53e-2)" "unprognostic (6.38e-2)" "unprognostic (6.59e-3)" "unprognostic (6.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.11e-1)" "unprognostic (3.54e-3)" "unprognostic (6.24e-2)" "unprognostic (2.08e-1)" "unprognostic (3.28e-1)" "unprognostic (4.13e-3)" "unprognostic (1.46e-1)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" 9.8 4.7 5.6 12.0 7.3 13.2 7.7 23.3 12.9 6.3 7.6 6.9 7.8 4.2 8.2 4.4 10.2 6.6 4.3 10.1 5.2 5.6 7.6 4.3 6.9 15.9 7.7 8.8 8.2 5.9 13.8 9.7 104.4 9.1 7.9 6.8 3.9 7.8 7.7 13.2 14.0 9.0 6.6 7.5 10.0 8.5 3.3 7.7 23.6 7.2 2.9 15.8 8.9 7.7 4.1 3.5 5.0 12.8 11.2 7.9 4.3 5.3 6.2 2.8 3.0 17.1 8.2 3.3 5.5 7.3 6.5 9.9 5.2 8.7 26.5 10.4 7.4 7.1 3.6 10.4 6.8 9.4 2.0 6.6 4.5 3.6 4.4 7.6 9.2 6.3 6.5 9.4 6.9 6.8 2.8 17.6 7.4 4.8 9.0 5.3 0.6 3.3 6.6 10.6 4.0 23.2 11.1 5.5 1.4 6.7 5.9 3.3 18.1 10.1 13.5 9.5 5.3 7.5 8.3 3.8 8.8 24.2 8.4 7.3 4.3 5.0 3.3 4.4 7.9 5.5 6.8 3.1 5.9 6.1 3.5 4.1 5.9 6.4 4.1 11.2 12.8 3.3 5.1 4.3 5.6 7.3 23.3 12.9 5.2 5.6 7.7 8.8 9.1 7.7 LNPK "KIAA1715, LNP, LNP1, Ul" ENSG00000144320 "Lunapark, ER junction formation factor" Q9C0E8 2 175923892-176002839 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014205 Approved Supported "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA014205: AB_2234186" "unprognostic (4.93e-2)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.85e-2)" "unprognostic (1.08e-2)" "unprognostic (8.73e-2)" "unprognostic (1.27e-1)" "unprognostic (3.15e-1)" "unprognostic (2.72e-2)" "unprognostic (3.13e-1)" "unprognostic (4.17e-3)" "unprognostic (1.63e-1)" "unprognostic (9.27e-2)" "unprognostic (2.35e-3)" "unprognostic (3.43e-2)" 14.2 10.8 13.4 8.4 16.0 29.4 11.3 12.9 26.5 15.0 13.3 13.4 7.1 8.6 11.9 7.7 15.1 8.2 9.1 13.6 13.8 16.1 9.8 16.3 8.1 7.6 19.9 14.2 12.8 6.4 16.8 22.8 9.4 21.1 12.0 11.9 10.1 8.6 10.1 33.5 13.5 8.4 11.3 26.2 6.6 8.9 25.4 14.6 16.4 10.3 14.8 8.7 12.2 15.1 7.1 6.7 11.6 7.3 9.7 11.6 5.2 8.5 4.3 10.3 14.6 21.8 13.6 5.1 25.3 12.2 11.8 16.7 6.0 10.1 8.6 14.5 11.2 9.5 9.7 6.7 16.5 13.0 9.9 9.7 5.6 5.3 5.1 16.4 12.0 11.2 6.4 11.5 5.7 2.1 9.9 11.5 16.2 5.6 10.8 6.5 3.3 8.4 10.9 10.4 6.3 5.0 7.9 11.9 12.1 11.1 6.4 8.5 9.5 5.4 3.2 58.8 8.7 19.6 11.8 6.8 12.4 7.1 18.2 5.4 10.9 5.7 6.6 11.6 8.1 7.3 9.5 7.1 7.2 8.9 6.0 5.0 7.2 11.2 5.6 9.7 6.7 6.7 11.6 5.2 13.4 16.0 12.9 23.3 13.8 16.1 19.9 14.2 21.1 14.6 LPAR2 "EDG-4, EDG4, LPA2" ENSG00000064547 "Lysophosphatidic acid receptor 2" Q9HBW0 19 19623668-19628930 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 43.7" "Cell line enhanced" "Detected in many" "HMC-1: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA019616 Approved "HPA019616: AB_1847988" "unprognostic (1.60e-2)" "unprognostic (1.83e-3)" "unprognostic (6.39e-2)" "unprognostic (1.19e-2)" "unprognostic (1.05e-1)" "unprognostic (2.29e-3)" "unprognostic (1.12e-2)" "unprognostic (1.82e-1)" "unprognostic (2.32e-1)" "unprognostic (1.05e-3)" "unprognostic (8.07e-2)" "unprognostic (6.03e-2)" "prognostic unfavourable (1.61e-7)" "prognostic favourable (1.43e-4)" "unprognostic (2.40e-1)" "unprognostic (5.87e-2)" "unprognostic (2.29e-2)" 3.4 1.2 2.2 12.6 1.9 26.1 4.6 1.3 2.4 6.5 7.9 1.4 13.8 5.1 2.4 3.9 10.5 4.4 17.9 1.9 2.2 4.0 7.0 2.4 11.0 17.7 2.4 1.1 6.1 27.3 7.4 4.0 4.2 2.7 8.2 4.3 7.4 12.3 12.3 1.6 7.2 16.4 1.1 2.8 31.4 19.2 43.7 1.1 18.5 23.2 10.0 21.1 4.9 4.1 3.8 1.1 6.7 1.0 1.7 15.9 4.1 12.7 1.4 15.2 3.4 3.9 1.9 13.1 0.8 1.2 0.6 1.1 9.1 12.3 8.3 8.5 1.2 13.5 2.3 4.6 0.6 3.5 3.9 1.9 2.6 0.6 0.5 3.0 31.8 2.1 11.5 0.6 0.9 0.3 1.8 3.2 0.5 20.8 1.8 5.1 15.1 5.9 8.1 1.2 3.7 9.4 18.8 5.4 10.1 3.4 2.8 1.9 7.1 19.4 3.8 2.9 2.5 5.3 1.2 1.5 4.2 2.8 0.6 22.2 1.4 0.1 0.6 2.2 6.1 0.7 11.2 3.8 14.0 8.0 0.4 2.0 12.8 9.2 6.7 1.7 1.0 1.1 15.9 4.1 2.2 1.9 1.3 2.4 2.2 4.0 2.4 1.1 2.7 1.1 LPCAT1 "AGPAT10, AGPAT9, AYTL2, FLJ12443" ENSG00000153395 "Lysophosphatidylcholine acyltransferase 1" Q8NF37 5 1456480-1523977 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 35.6" "Cell line enhanced" "Detected in many" "BEWO: 34.2;EFO-21: 32.9;PC-3: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012501, HPA022268" Enhanced Supported "Endoplasmic reticulum,Lipid droplets" "Endoplasmic reticulum" "Lipid droplets" "HPA012501: AB_1845224, HPA022268: AB_1845225" "unprognostic (5.33e-3)" "prognostic unfavourable (7.11e-5)" "unprognostic (3.11e-1)" "prognostic unfavourable (3.67e-4)" "unprognostic (3.13e-2)" "unprognostic (1.26e-2)" "prognostic unfavourable (1.88e-8)" "unprognostic (5.90e-2)" "unprognostic (6.37e-2)" "unprognostic (2.08e-2)" "prognostic favourable (4.90e-5)" "unprognostic (4.89e-2)" "prognostic unfavourable (2.64e-7)" "unprognostic (2.60e-1)" "unprognostic (3.13e-1)" "unprognostic (1.52e-1)" "unprognostic (4.03e-1)" 9.8 5.6 5.2 9.0 5.7 5.1 7.4 9.2 9.5 5.4 7.5 2.9 4.5 3.9 7.0 3.2 3.2 5.9 5.8 4.3 5.3 5.2 4.9 3.1 35.6 8.5 3.2 3.7 5.0 5.4 3.1 5.6 10.0 4.6 5.2 2.3 13.6 4.5 4.4 3.5 3.2 5.9 5.5 3.3 28.8 9.4 3.0 2.9 5.8 4.7 1.4 8.1 6.6 10.6 0.9 0.7 2.4 1.7 1.7 3.6 0.6 2.0 3.0 0.5 3.2 0.3 0.5 34.2 7.7 0.4 0.4 0.3 1.1 0.9 6.7 32.9 0.2 5.7 0.6 0.2 0.2 16.2 13.9 1.6 4.8 2.0 0.6 1.7 4.6 0.6 0.1 0.3 0.1 0.4 3.6 1.2 0.0 4.2 6.3 2.6 12.0 22.9 12.0 0.5 4.9 1.3 2.7 4.3 4.2 6.1 5.5 1.8 2.6 2.6 3.8 0.6 7.5 2.3 2.7 4.3 4.1 1.5 1.4 2.8 2.0 0.0 0.6 0.8 3.6 1.7 3.6 0.9 0.8 1.8 0.7 0.7 0.1 1.0 2.4 1.7 1.2 0.2 0.8 0.6 5.2 5.7 9.2 8.0 5.3 5.2 3.2 3.7 4.6 2.9 LRAT LCA14 ENSG00000121207 "Lecithin retinol acyltransferase" O95237 4 154626945-154753118 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "Acyltransferase, Transferase" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 82.4" "Cell line enriched" "Detected in some" 8 "NTERA-2: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 4.5" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA070726 Uncertain "Endoplasmic reticulum,Golgi apparatus" "Golgi apparatus" "Endoplasmic reticulum" "HPA070726: " "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (4.75e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.65e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-4)" "unprognostic (4.49e-6)" "unprognostic (6.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.98e-1)" 0.9 0.8 2.2 0.8 3.2 1.8 1.4 0.7 1.1 0.9 4.2 3.0 0.8 3.7 0.5 1.2 0.5 0.9 2.3 0.6 3.1 4.2 0.6 3.3 1.0 0.5 2.9 2.4 1.0 2.9 0.3 1.0 0.3 8.9 1.6 0.4 82.4 0.5 1.6 2.3 1.4 11.1 0.3 7.0 0.7 0.9 2.9 3.1 0.0 4.9 0.2 0.6 0.5 0.7 0.9 3.7 2.0 4.5 0.6 0.3 3.9 0.6 0.5 0.4 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.8 0.6 0.1 0.1 0.2 0.5 0.3 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.3 16.1 0.0 0.1 0.0 0.1 1.9 0.5 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.4 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.2 0.5 1.0 4.5 0.4 0.3 1.6 0.3 0.5 0.3 0.3 3.7 0.9 0.3 0.3 2.0 0.6 0.5 0.5 0.2 3.9 2.2 3.2 0.7 1.1 3.1 4.2 2.9 2.4 8.9 3.1 LRCH1 "CHDC1, KIAA1016" ENSG00000136141 "Leucine rich repeats and calponin homology domain containing 1" Q9Y2L9 13 46553168-46753040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 46.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021536 Approved Approved "Nucleoli,Actin filaments,Cytosol" "Actin filaments, Cytosol" Nucleoli "HPA021536: AB_1853258" "unprognostic (7.13e-3)" "prognostic unfavourable (6.24e-4)" "unprognostic (3.59e-2)" "unprognostic (8.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.37e-1)" "unprognostic (5.16e-2)" "prognostic unfavourable (6.67e-4)" "unprognostic (2.16e-1)" "prognostic unfavourable (5.75e-4)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "prognostic favourable (1.04e-4)" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-1)" "unprognostic (1.98e-2)" 17.9 5.0 6.5 20.3 5.9 7.2 15.2 46.4 7.2 17.5 14.6 4.6 11.5 7.0 24.6 9.8 10.6 11.9 14.1 8.0 6.3 5.9 13.8 10.9 14.3 13.5 6.6 4.9 9.5 5.1 5.2 13.1 24.1 8.0 12.8 9.3 8.4 11.3 14.5 5.3 18.1 12.0 20.9 8.5 13.7 14.6 5.0 6.0 31.7 7.8 6.4 13.7 16.6 18.3 6.2 2.3 1.8 2.0 5.1 3.6 1.8 4.6 6.7 6.1 6.3 4.5 8.6 15.7 8.0 10.5 10.0 9.5 15.1 8.0 15.0 2.2 7.5 6.8 4.6 8.1 14.5 15.4 4.3 13.4 2.7 7.0 5.6 8.7 23.0 5.4 6.4 9.2 11.3 8.6 2.6 4.5 7.3 9.0 9.3 10.9 3.4 3.6 5.1 6.6 4.0 18.6 4.9 9.7 9.7 4.5 4.5 12.0 3.4 11.7 8.1 5.9 4.0 7.3 7.6 0.8 2.3 6.7 6.9 7.6 7.1 1.5 2.0 1.8 3.6 1.6 2.1 5.3 2.7 2.6 1.9 6.2 2.1 2.1 0.7 5.1 1.2 2.3 1.9 1.8 6.5 5.9 46.4 7.2 6.3 5.9 6.6 4.9 8.0 6.0 LRCH3 MGC4126 ENSG00000186001 "Leucine rich repeats and calponin homology domain containing 3" Q96II8 3 197791226-197888436 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012380, HPA017299" Uncertain Enhanced Cytosol "Secreted - unknown location" Cytosol "HPA012380: AB_1853260, HPA017299: " "unprognostic (1.25e-1)" "unprognostic (4.92e-1)" "unprognostic (1.43e-1)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (8.26e-2)" "prognostic unfavourable (2.95e-4)" "unprognostic (3.29e-1)" "unprognostic (4.13e-1)" "unprognostic (9.85e-2)" "unprognostic (1.64e-1)" "unprognostic (2.06e-2)" "unprognostic (1.79e-3)" "unprognostic (3.29e-2)" "unprognostic (2.67e-1)" "unprognostic (5.59e-2)" "unprognostic (1.32e-1)" 16.4 14.0 19.3 23.4 19.1 11.0 18.0 37.5 19.1 21.9 19.0 28.2 15.6 11.0 24.7 14.8 15.6 18.3 16.7 18.2 15.9 14.5 12.6 14.2 14.8 23.4 19.7 13.1 27.5 12.9 23.7 26.0 15.2 15.4 20.4 16.7 23.6 15.6 22.4 23.0 15.7 15.9 28.3 15.9 18.7 15.0 20.2 20.4 27.0 13.5 9.5 26.0 20.3 18.0 6.9 2.8 22.6 4.8 4.9 6.0 3.3 18.2 6.5 17.6 10.9 21.3 24.3 6.8 13.3 16.1 16.2 19.0 15.4 9.6 10.0 20.9 16.3 12.0 14.7 12.9 21.8 8.0 9.1 16.6 9.7 13.1 14.5 12.7 13.1 16.6 7.8 15.4 19.7 19.1 10.4 16.6 15.2 15.5 9.5 5.5 12.1 13.7 10.0 11.0 7.2 8.6 10.8 8.7 9.5 16.1 12.2 12.8 21.4 11.2 18.6 13.5 7.8 16.3 13.3 15.4 13.8 9.1 12.8 18.1 12.7 22.6 3.4 7.0 5.9 4.8 4.5 6.9 4.6 5.0 2.8 5.7 4.3 6.0 2.3 4.9 4.6 2.6 4.4 3.3 19.3 19.1 37.5 19.1 15.9 14.5 19.7 13.1 15.4 20.4 LRCH4 "LRN, LRRN1" ENSG00000077454 "Leucine rich repeats and calponin homology domain containing 4" O75427 7 100574011-100586153 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 44.8;NB-4: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037667, HPA037668" Enhanced Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA037667: AB_10671882, HPA037668: AB_10672910" "unprognostic (2.41e-1)" "unprognostic (2.53e-2)" "prognostic unfavourable (1.61e-7)" "unprognostic (8.32e-3)" "unprognostic (2.76e-2)" "unprognostic (3.96e-3)" "unprognostic (8.98e-3)" "unprognostic (3.72e-2)" "unprognostic (2.52e-1)" "unprognostic (5.51e-2)" "unprognostic (2.63e-3)" "unprognostic (7.81e-2)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (7.96e-2)" "unprognostic (1.26e-2)" 11.4 15.2 14.5 32.0 25.7 52.7 13.8 19.7 22.2 12.0 14.0 16.4 11.8 22.0 12.3 9.6 14.4 14.0 15.9 10.2 16.2 9.1 16.1 12.2 20.8 39.1 25.8 13.1 23.7 17.3 8.9 22.8 26.4 19.2 14.6 7.2 18.3 23.5 13.0 15.8 15.0 27.8 8.1 25.7 54.5 14.9 43.3 23.1 31.1 20.0 6.8 25.2 9.9 12.0 5.9 6.2 24.2 8.4 1.4 7.3 2.9 7.8 4.4 4.4 4.0 2.6 2.0 8.4 7.6 3.4 4.5 3.6 7.3 11.4 5.6 8.5 2.2 6.7 2.1 3.2 1.2 5.6 5.9 6.5 5.2 3.5 8.4 11.2 44.8 3.4 3.4 3.7 2.1 4.5 8.0 11.7 3.1 14.7 12.8 69.2 4.6 5.2 14.3 3.6 6.9 3.4 2.7 5.7 8.6 3.6 11.6 8.8 7.8 24.4 7.0 6.1 11.0 8.4 4.5 11.9 5.6 5.1 4.7 27.7 10.4 12.6 8.4 11.9 5.2 6.8 4.7 4.7 5.1 5.9 6.2 5.9 7.3 5.9 24.2 1.4 4.7 5.9 5.2 2.9 14.5 25.7 19.7 22.2 16.2 9.1 25.8 13.1 19.2 23.1 LRFN2 "FIGLER2, KIAA1246, SALM1" ENSG00000156564 "Leucine rich repeat and fibronectin type III domain containing 2" Q9ULH4 6 40391586-40587465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 21.7" "Group enriched" "Detected in some" 5 "REH: 3.4;SH-SY5Y: 10.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 1.8;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;T-cells: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA076660 Enhanced Supported Vesicles Vesicles "HPA076660: " "unprognostic (1.93e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (4.58e-4)" "unprognostic (3.10e-1)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-3)" "unprognostic (4.94e-2)" "unprognostic (1.80e-1)" "unprognostic (9.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-1)" "unprognostic (2.98e-1)" "unprognostic (1.16e-1)" "unprognostic (2.66e-4)" 0.5 1.4 5.9 0.5 7.6 1.3 0.6 4.5 21.7 0.5 0.8 0.0 0.0 0.5 0.6 0.4 1.8 0.6 0.6 0.4 5.0 5.2 0.5 0.4 0.4 0.5 2.3 7.4 2.1 0.7 0.4 0.6 0.5 0.9 0.5 0.7 2.7 0.4 0.4 0.4 0.5 0.5 0.5 0.8 3.1 0.7 2.5 0.5 0.0 0.7 0.0 0.6 0.5 0.2 0.0 1.3 0.0 0.0 0.3 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 3.4 0.0 0.0 0.0 0.3 1.4 10.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.4 0.0 0.3 0.0 1.3 0.0 0.2 5.9 7.6 4.5 21.7 5.0 5.2 2.3 7.4 0.9 0.5 LRFN3 "FIGLER1, MGC2656, SALM4" ENSG00000126243 "Leucine rich repeat and fibronectin type III domain containing 3" Q9BTN0 19 35935358-35945767 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in single" 5 "T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048923 Approved "HPA048923: " "unprognostic (1.88e-1)" "unprognostic (7.22e-3)" "unprognostic (1.82e-1)" "unprognostic (4.90e-2)" "unprognostic (1.17e-1)" "unprognostic (7.37e-2)" "unprognostic (8.14e-2)" "unprognostic (2.34e-3)" "unprognostic (1.23e-2)" "unprognostic (1.48e-1)" "unprognostic (3.49e-3)" "unprognostic (1.74e-1)" "prognostic favourable (8.46e-7)" "unprognostic (6.84e-3)" "unprognostic (2.62e-1)" "unprognostic (4.07e-2)" "unprognostic (1.03e-1)" 7.2 4.8 6.5 3.6 10.6 0.2 3.8 13.8 17.1 5.9 4.6 3.2 2.9 7.5 7.4 2.6 4.3 5.1 5.4 3.8 6.3 5.1 4.5 6.9 8.9 2.1 3.8 9.4 9.3 7.1 8.1 9.3 3.2 5.0 5.7 3.2 4.4 7.7 7.6 6.5 5.3 7.2 5.8 2.2 5.0 6.3 7.7 2.9 3.2 3.9 2.2 2.1 4.9 5.0 0.5 0.1 0.0 0.0 0.0 2.9 0.5 10.1 11.6 5.3 8.2 11.1 5.9 2.5 4.3 5.5 4.1 4.2 2.0 4.8 5.8 9.0 5.1 3.8 2.3 4.8 2.4 11.6 4.5 0.6 2.5 2.2 4.3 0.3 9.0 6.5 6.6 2.5 2.6 5.0 1.7 8.6 3.8 7.4 4.6 0.2 4.1 5.1 6.1 3.1 0.2 3.0 3.8 6.8 9.1 5.9 4.5 3.5 3.6 2.8 6.3 9.6 8.6 8.7 6.6 3.4 3.4 0.2 8.6 3.1 6.6 0.0 0.0 0.0 2.7 0.0 2.9 0.3 2.2 2.6 0.0 0.5 1.4 0.5 0.0 0.0 0.0 0.1 1.1 0.5 6.5 10.6 13.8 17.1 6.3 5.1 3.8 9.4 5.0 2.9 LRFN4 "FIGLER6, MGC3103, SALM3." ENSG00000173621 "Leucine rich repeat and fibronectin type III domain containing 4" Q6PJG9 11 66856647-66860475 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 3.6" "Lineage enriched" "Detected in single" 4 "dendritic cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077570 Enhanced "HPA077570: " "unprognostic (2.25e-2)" "unprognostic (5.90e-3)" "unprognostic (7.51e-2)" "unprognostic (2.01e-2)" "unprognostic (4.35e-2)" "unprognostic (6.73e-2)" "unprognostic (1.80e-2)" "unprognostic (1.03e-3)" "unprognostic (6.56e-2)" "unprognostic (6.93e-2)" "unprognostic (5.69e-2)" "unprognostic (9.45e-2)" "unprognostic (1.93e-1)" "unprognostic (6.80e-3)" "unprognostic (1.81e-1)" "unprognostic (2.85e-1)" "unprognostic (3.53e-1)" 16.6 5.9 10.4 5.9 12.2 8.9 5.9 22.0 23.4 5.4 10.9 7.6 2.2 4.4 6.7 2.7 3.6 6.3 2.5 6.3 9.7 7.4 4.4 1.3 5.2 4.8 7.9 11.1 4.7 2.9 2.5 4.0 3.2 5.5 4.6 4.4 3.3 10.2 7.5 14.7 8.2 4.0 3.5 3.9 5.9 13.8 12.4 6.3 3.5 2.6 7.3 3.6 3.4 5.1 0.2 3.6 0.0 0.7 0.0 0.8 0.3 11.0 9.4 1.5 4.7 1.2 2.4 0.1 7.8 2.4 4.5 2.5 6.0 5.5 5.5 9.2 2.7 7.0 2.7 2.6 0.5 2.6 9.0 4.1 22.9 2.3 7.8 8.4 10.4 3.6 4.1 2.1 2.1 3.3 10.8 0.1 0.6 23.5 15.7 27.4 13.2 17.0 11.4 6.3 17.8 1.9 0.0 8.7 8.5 10.7 9.4 24.7 11.9 6.3 7.1 6.4 12.3 18.4 7.3 5.5 5.1 1.1 4.1 9.1 4.8 0.0 0.7 0.0 0.4 0.4 0.8 0.0 0.3 0.3 0.6 0.2 0.0 0.1 0.0 0.0 0.7 3.6 0.8 0.3 10.4 12.2 22.0 23.4 9.7 7.4 7.9 11.1 5.5 6.3 LRFN5 "C14orf146, FIGLER8, SALM5" ENSG00000165379 "Leucine rich repeat and fibronectin type III domain containing 5" Q96NI6 14 41607570-41904549 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;parathyroid gland: 38.4" "Cell line enhanced" "Detected in some" "AN3-CA: 17.3;HSkMC: 3.5;RPTEC TERT1: 5.9;SCLC-21H: 9.1;U-138 MG: 11.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001177 Uncertain "Intracellular and membrane" "HPA001177: AB_1079274" "unprognostic (5.23e-3)" "unprognostic (1.37e-1)" "unprognostic (5.10e-1)" "unprognostic (6.24e-2)" "unprognostic (2.39e-1)" "unprognostic (3.54e-1)" "unprognostic (1.31e-1)" "unprognostic (6.38e-3)" "unprognostic (2.61e-2)" "unprognostic (5.78e-2)" "unprognostic (2.70e-2)" "unprognostic (9.27e-2)" "unprognostic (6.02e-3)" "unprognostic (3.79e-3)" "unprognostic (1.98e-1)" "unprognostic (6.07e-3)" "unprognostic (2.92e-3)" 1.5 3.3 7.9 1.7 9.3 0.5 2.4 3.1 19.1 13.7 2.2 0.8 1.3 0.8 3.8 1.5 1.2 5.0 1.9 0.9 12.2 9.5 0.9 0.6 1.2 0.6 4.3 11.9 2.7 0.9 38.4 1.0 1.8 8.7 3.7 1.9 0.9 0.8 9.3 0.8 1.0 0.9 9.3 1.6 1.2 1.0 1.7 1.2 0.0 1.0 0.0 0.8 7.8 6.3 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.8 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.9 9.3 3.1 19.1 12.2 9.5 4.3 11.9 8.7 1.2 LRIG1 "DKFZP586O1624, LIG-1, LIG1" ENSG00000144749 "Leucine rich repeats and immunoglobulin like domains 1" Q96JA1 3 66378797-66501263 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 64.0" "Cell line enhanced" "Detected in many" "Daudi: 23.4;hTEC/SVTERT24-B: 18.3;U-698: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.7" "Lineage enhanced" "Detected in single" "T-cells: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011846 Approved Approved Cytosol 21000 Cytosol "HPA011846: " "unprognostic (6.41e-2)" "unprognostic (4.18e-2)" "unprognostic (4.35e-3)" "unprognostic (4.58e-2)" "unprognostic (2.12e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "prognostic favourable (3.01e-5)" "unprognostic (5.12e-1)" "unprognostic (7.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.18e-1)" "unprognostic (2.12e-1)" "unprognostic (8.79e-2)" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "prognostic unfavourable (1.50e-4)" 12.6 1.7 22.3 8.1 21.1 2.4 13.4 9.6 31.8 15.5 24.6 20.3 0.7 8.2 12.7 2.6 6.9 13.3 13.8 16.8 24.6 7.1 2.5 15.8 8.6 4.1 19.8 12.4 8.8 64.0 4.2 6.7 2.8 18.9 12.2 7.6 4.8 9.4 4.3 16.6 6.6 7.5 14.5 10.9 2.4 21.2 6.4 19.8 0.2 8.1 5.0 5.0 5.1 5.4 0.3 0.0 0.7 0.0 0.0 2.7 0.4 0.4 0.4 9.3 0.1 2.6 1.6 0.8 1.5 8.7 1.5 4.7 7.3 0.0 23.4 4.0 0.7 0.0 1.8 3.2 3.4 0.0 4.8 0.0 1.4 0.6 0.6 0.2 5.3 2.0 1.8 18.3 3.0 8.0 0.0 0.0 0.3 1.1 0.0 0.0 6.9 0.0 4.2 2.7 1.2 1.7 0.0 1.2 0.3 1.4 1.4 0.0 8.4 2.1 2.4 4.6 2.0 9.1 3.9 1.8 0.8 17.9 8.1 0.0 1.6 0.0 0.0 0.7 0.4 0.0 1.4 0.3 1.1 1.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 2.7 0.4 22.3 21.1 9.6 20.2 24.6 7.1 19.8 12.4 18.9 19.8 LRIG2 KIAA0806 ENSG00000198799 "Leucine rich repeats and immunoglobulin like domains 2" O94898 1 113073209-113132260 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015538 Uncertain Approved "Nucleoplasm,Golgi apparatus" 510000 "Golgi apparatus" Nucleoplasm "HPA015538: AB_2250170" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (9.08e-2)" "prognostic unfavourable (9.37e-4)" "unprognostic (4.72e-2)" "unprognostic (1.27e-3)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (3.27e-2)" "unprognostic (5.95e-2)" "unprognostic (1.03e-2)" "unprognostic (1.03e-2)" "unprognostic (1.27e-2)" "unprognostic (2.34e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" 8.3 7.7 10.1 11.4 10.6 4.7 10.7 15.6 10.0 11.6 9.2 16.1 6.0 10.8 15.1 14.9 7.8 9.2 8.2 7.3 9.3 9.1 9.2 6.3 8.0 9.7 13.0 6.7 15.0 8.5 13.4 11.6 10.1 9.2 9.3 8.6 14.6 9.0 11.2 13.1 16.6 9.5 8.9 11.6 10.1 8.1 9.4 13.4 10.4 12.6 5.0 10.7 8.6 10.7 4.4 2.6 4.9 2.5 4.8 3.9 1.7 4.4 2.4 6.7 5.1 6.5 6.7 3.9 2.8 4.2 3.4 5.8 3.5 2.8 4.5 5.0 3.6 5.0 4.6 3.0 5.8 3.1 2.7 4.8 4.6 1.7 6.6 5.7 2.3 6.5 5.5 5.4 7.1 4.4 5.7 4.3 4.2 3.2 5.8 6.1 6.3 4.0 5.3 8.4 2.2 3.3 3.0 4.8 3.9 5.0 3.3 6.4 2.5 6.5 6.6 6.4 3.5 8.7 4.5 4.8 2.2 4.6 6.8 3.6 5.9 4.9 2.5 1.5 3.1 2.0 3.5 3.1 3.4 3.2 1.9 4.4 3.9 3.6 1.7 4.8 2.1 2.6 2.6 1.7 10.1 10.6 15.6 10.0 9.3 9.1 13.0 6.7 9.2 13.4 LRIG3 "FLJ90440, KIAA3016" ENSG00000139263 "Leucine rich repeats and immunoglobulin like domains 3" Q6UXM1 12 58872149-58920522 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010773 Approved Approved Cytosol Cytosol "HPA010773: AB_1853275" "unprognostic (1.79e-1)" "unprognostic (2.71e-1)" "unprognostic (1.01e-2)" "unprognostic (3.88e-2)" "unprognostic (2.53e-1)" "unprognostic (3.46e-2)" "unprognostic (1.83e-2)" "unprognostic (1.34e-3)" "unprognostic (1.21e-1)" "unprognostic (1.92e-1)" "unprognostic (3.04e-2)" "unprognostic (4.25e-2)" "unprognostic (2.74e-3)" "unprognostic (2.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.46e-2)" 15.8 1.7 3.6 11.8 4.1 0.0 16.4 1.0 3.7 18.7 14.8 7.8 12.1 8.4 14.2 13.8 17.1 9.9 17.8 4.7 4.6 1.8 6.5 6.1 9.6 5.0 3.6 2.6 14.7 15.3 4.8 10.3 6.8 5.8 15.5 16.0 13.5 24.9 11.6 5.0 25.9 10.0 21.6 3.0 7.2 13.5 6.4 6.6 5.4 37.6 15.0 12.8 15.7 20.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 2.0 1.9 7.3 0.5 13.4 15.6 1.7 4.9 14.1 4.7 5.0 5.7 2.6 1.9 9.9 5.4 9.4 2.7 12.4 3.4 14.4 9.5 0.5 3.3 2.8 2.6 0.7 0.2 15.5 27.0 5.0 10.8 12.9 0.1 2.4 3.1 0.9 2.3 0.0 7.8 2.9 0.0 6.2 4.7 3.6 10.4 7.4 0.0 4.3 2.7 4.4 5.0 0.1 5.5 6.5 4.4 3.8 6.3 1.0 0.0 0.0 1.3 0.0 3.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 4.1 1.0 3.7 4.6 1.8 3.6 2.6 5.8 6.6 LRIT2 "AC022389.4, LRRC22" ENSG00000204033 "Leucine rich repeat, Ig-like and transmembrane domains 2" A6NDA9 10 84220495-84225589 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 25.4;skin 1: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "basal ganglia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037788 Enhanced "HPA037788: AB_10672393" "unprognostic (3.12e-1)" "unprognostic (1.09e-3)" "unprognostic (3.99e-1)" "unprognostic (9.44e-2)" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (2.41e-1)" 0.1 0.2 0.2 0.1 3.4 0.0 0.1 0.1 2.2 0.1 1.6 0.1 0.1 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 25.4 0.1 0.1 0.1 8.5 0.7 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.1 0.5 0.3 0.3 0.3 0.1 0.1 0.1 LRIT3 "CSNB1F, FIGLER4, FLJ44691" ENSG00000183423 "Leucine rich repeat, Ig-like and transmembrane domains 3" Q3SXY7 4 109848202-109872315 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 17.1" "Cell line enhanced" "Detected in some" "hTCEpi: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA013454 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA013454: AB_1853277" "unprognostic (5.41e-2)" "unprognostic (6.82e-2)" "unprognostic (4.20e-2)" "unprognostic (6.50e-2)" "unprognostic (3.42e-1)" "unprognostic (7.67e-3)" "unprognostic (1.54e-1)" "unprognostic (5.25e-2)" "unprognostic (3.16e-2)" "unprognostic (4.49e-2)" "unprognostic (6.92e-3)" "unprognostic (3.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.14e-2)" 0.6 0.6 0.7 0.6 1.2 0.4 1.7 2.0 1.3 1.2 0.6 0.6 0.6 0.3 0.7 1.8 0.6 1.0 0.6 0.6 0.8 0.7 4.4 0.7 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.6 0.6 0.6 0.9 0.5 17.1 0.8 0.6 1.6 3.2 0.6 0.6 0.6 0.8 0.2 1.3 0.6 0.6 0.8 0.6 0.6 0.6 0.6 0.1 0.3 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.0 0.6 0.6 0.0 0.1 1.3 0.1 0.2 0.3 1.6 0.3 0.4 0.2 0.1 1.3 0.0 0.0 2.0 0.1 0.3 0.1 0.3 0.6 0.0 0.0 0.9 1.0 0.2 0.2 0.6 0.0 0.2 1.0 0.3 0.5 0.0 0.0 0.4 0.0 0.1 1.2 0.0 0.3 0.3 0.6 0.3 0.6 1.0 0.0 0.3 0.9 0.3 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 1.2 2.0 1.3 0.8 0.7 0.6 0.6 0.6 0.6 LRMP JAW1 ENSG00000118308 "Lymphoid restricted membrane protein" Q12912 12 25004342-25108334 "Predicted intracellular proteins, Predicted membrane proteins" "Fertilization, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;lymphoid tissue: 69.5" "Group enriched" "Detected in some" 6 "Daudi: 94.1;REH: 32.7;U-698: 107.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA002967, HPA018505" Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA002967: AB_1079161, HPA018505: AB_1851988" "unprognostic (3.78e-2)" "unprognostic (2.59e-3)" "unprognostic (7.54e-2)" "unprognostic (7.08e-3)" "unprognostic (2.36e-1)" "unprognostic (1.48e-3)" "unprognostic (7.98e-2)" "unprognostic (4.08e-2)" "unprognostic (7.32e-2)" "unprognostic (1.15e-1)" "unprognostic (3.59e-2)" "unprognostic (7.97e-2)" "unprognostic (7.25e-3)" "unprognostic (7.72e-2)" "unprognostic (9.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.59e-2)" 5.5 1.4 15.1 51.7 2.9 19.2 4.6 0.4 5.6 1.9 3.6 2.1 0.9 3.2 1.4 1.8 3.9 2.3 3.0 1.7 8.1 1.8 5.5 2.3 5.6 57.8 3.5 4.7 2.3 15.1 0.4 2.1 1.7 7.4 2.8 3.5 1.3 4.1 2.1 0.8 2.7 13.2 1.8 5.3 27.6 3.6 0.7 2.8 67.0 3.6 1.7 69.5 10.4 5.7 17.4 5.7 51.8 12.2 12.0 7.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.1 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.0 5.6 0.0 0.0 0.0 7.2 8.3 0.0 0.0 0.1 0.0 0.0 1.1 6.3 0.0 0.0 7.9 13.4 0.0 0.0 32.7 0.0 9.3 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 0.0 0.0 6.2 1.1 107.6 0.0 3.2 0.0 17.0 5.4 51.8 6.5 10.5 5.4 17.4 4.1 6.6 5.7 13.3 7.1 6.9 39.3 12.0 12.2 5.4 0.7 4.7 15.1 2.9 0.4 5.6 8.1 1.8 3.5 4.7 7.4 2.8 LRP1 "A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A" ENSG00000123384 "LDL receptor related protein 1" Q07954 12 57128493-57213351 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 82.6;ASC TERT1: 83.9;fHDF/TERT166: 36.0;HSkMC: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "classical monocyte: 7.6;intermediate monocyte: 4.0;myeloid DC: 2.8;non-classical monocyte: 3.7" "Group enriched" "Detected in many" 20 "dendritic cells: 2.8;monocytes: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004182, CAB018621, HPA022903" Supported Approved Nucleoplasm,Vesicles "Intracellular and membrane" 88000000 Vesicles Nucleoplasm "CAB018621: AB_627893, HPA004182: , HPA022903: AB_10602426" "unprognostic (1.65e-1)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (2.71e-1)" "unprognostic (5.00e-2)" "unprognostic (4.33e-2)" "unprognostic (3.98e-1)" "unprognostic (8.68e-2)" "unprognostic (1.70e-1)" "unprognostic (3.37e-3)" "unprognostic (1.48e-1)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.52e-5)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (2.80e-2)" "prognostic unfavourable (1.29e-5)" 77.8 12.0 19.8 21.5 21.3 6.1 27.7 28.1 25.3 31.4 19.7 11.9 9.0 17.8 26.9 18.2 19.2 21.0 24.1 26.0 18.6 10.4 6.3 31.4 24.7 5.5 13.9 15.6 56.9 8.8 8.5 8.0 29.4 17.1 21.4 9.5 20.0 14.8 17.0 11.3 15.7 14.2 22.4 14.3 11.3 11.8 11.1 15.4 0.3 13.2 9.3 3.1 22.9 39.4 0.0 2.8 0.1 7.6 0.0 0.2 1.9 1.2 2.3 5.0 4.0 82.6 83.9 15.2 13.9 18.0 4.6 4.5 4.3 2.0 0.0 1.7 36.0 5.5 0.8 1.4 1.6 0.1 0.2 0.0 2.7 9.0 11.3 0.0 2.4 54.3 0.5 10.3 1.2 0.2 0.0 0.2 14.3 0.2 0.0 0.0 5.8 1.4 0.5 28.6 0.2 0.3 0.3 0.2 2.7 3.1 0.1 2.2 0.4 0.2 0.2 16.1 6.0 8.9 0.8 0.1 0.0 0.0 28.2 0.0 3.0 0.0 7.6 0.0 0.0 4.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.2 0.1 0.0 3.7 0.0 0.0 1.9 19.8 21.3 28.1 19.7 18.6 10.4 13.9 15.6 17.1 15.4 LRP10 "DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087" ENSG00000197324 "LDL receptor related protein 10" Q7Z4F1 14 22871613-22881580 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 29.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000932 Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA000932: AB_2281523" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (3.72e-2)" "unprognostic (4.59e-2)" "unprognostic (1.72e-1)" "unprognostic (5.01e-2)" "prognostic unfavourable (3.54e-7)" "prognostic unfavourable (9.17e-4)" "unprognostic (8.32e-2)" "unprognostic (1.48e-2)" "unprognostic (1.97e-2)" "unprognostic (4.55e-2)" "prognostic favourable (6.31e-5)" "unprognostic (3.06e-2)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (4.14e-2)" 33.1 20.1 12.7 26.0 13.1 23.7 37.2 5.8 10.3 32.0 52.4 16.2 41.0 31.7 39.0 46.8 66.1 27.1 65.1 27.7 13.6 6.0 46.5 63.3 34.1 30.0 14.2 8.1 30.7 36.6 31.4 11.7 32.0 14.4 36.9 19.0 22.6 36.1 41.1 21.2 32.9 65.9 32.0 11.2 26.1 37.9 19.1 12.9 20.7 46.9 34.1 36.2 43.3 42.8 3.8 2.3 29.7 2.6 2.4 6.3 3.4 15.4 18.8 4.1 10.8 56.5 32.8 14.1 24.4 46.5 15.4 21.4 5.7 54.9 8.1 12.2 55.0 22.1 2.7 27.9 6.1 13.2 2.9 2.8 10.3 4.0 25.2 6.4 25.8 35.8 32.7 23.1 12.0 28.1 3.4 31.3 20.7 17.8 1.8 1.9 0.9 25.4 4.0 4.2 8.0 16.5 27.5 0.3 4.5 13.5 26.0 10.6 13.6 4.6 29.3 23.8 6.8 12.3 10.0 14.7 8.7 3.7 12.3 2.6 10.1 5.9 2.2 15.8 5.1 2.3 5.0 3.8 6.3 6.0 2.3 2.7 5.5 3.1 29.7 2.4 2.6 1.9 6.0 3.4 12.7 13.1 5.8 10.3 13.6 6.0 14.2 8.1 14.4 12.9 LRP11 "bA350J20.3, MANSC3" ENSG00000120256 "LDL receptor related protein 11" Q86VZ4 6 149818798-149864026 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064002 Approved Mitochondria 640000 Mitochondria "HPA064002: " "prognostic unfavourable (2.31e-8)" "unprognostic (3.85e-3)" "unprognostic (1.68e-1)" "unprognostic (1.30e-2)" "unprognostic (5.17e-2)" "unprognostic (4.25e-3)" "prognostic unfavourable (2.01e-5)" "unprognostic (5.05e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (3.29e-1)" "unprognostic (2.63e-1)" "unprognostic (4.76e-2)" "unprognostic (2.47e-1)" "unprognostic (6.75e-2)" "unprognostic (1.34e-2)" "unprognostic (4.23e-2)" 12.0 16.5 17.8 4.4 26.9 1.6 11.2 17.9 25.6 14.0 11.5 15.1 9.4 10.5 10.6 14.8 20.2 20.2 10.5 8.0 19.7 19.3 18.2 9.0 12.1 2.2 15.0 16.9 15.3 17.2 46.2 15.2 14.7 20.6 23.3 11.4 10.8 14.2 12.3 8.1 20.2 8.7 10.9 13.3 3.6 14.4 7.2 15.6 0.8 20.8 13.8 6.4 17.3 14.2 3.5 1.0 0.0 1.7 0.0 0.7 0.1 9.7 8.5 6.5 5.7 14.5 26.5 1.3 10.2 19.8 7.1 8.6 2.5 20.3 0.1 13.9 15.9 25.9 7.3 18.5 5.1 15.6 7.3 4.6 31.3 11.2 8.9 4.7 0.1 16.5 36.0 9.1 18.1 10.9 9.4 4.3 8.4 16.7 0.1 0.1 3.9 8.5 5.0 9.7 2.3 12.8 19.9 8.6 5.7 32.1 17.9 6.0 14.7 9.7 8.5 8.9 2.1 18.6 7.7 0.0 3.1 2.3 16.1 4.7 5.1 0.0 0.1 0.0 0.2 0.4 0.0 3.5 0.7 0.6 1.0 0.6 0.2 0.3 0.0 0.0 1.7 0.0 0.0 0.1 17.8 26.9 17.9 25.6 19.7 19.3 15.0 16.9 20.6 15.6 LRP12 "FLJ12929, ST7" ENSG00000147650 "LDL receptor related protein 12" Q9Y561 8 104489231-104589024 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 22.6" "Lineage enriched" "Detected in many" 22 "granulocytes: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017245 Uncertain Approved "Nucleoli fibrillar center,Plasma membrane,Mitochondria" "Nucleoli fibrillar center, Plasma membrane, Mitochondria" "HPA017245: AB_1857532" "unprognostic (2.17e-1)" "unprognostic (6.80e-2)" "unprognostic (2.20e-1)" "prognostic unfavourable (2.67e-4)" "unprognostic (2.07e-1)" "unprognostic (2.15e-3)" "unprognostic (4.87e-4)" "unprognostic (2.96e-2)" "unprognostic (3.96e-1)" "unprognostic (4.59e-2)" "unprognostic (1.32e-1)" "unprognostic (3.39e-2)" "unprognostic (9.89e-2)" "unprognostic (7.56e-3)" "unprognostic (4.88e-2)" "unprognostic (1.45e-1)" "unprognostic (4.05e-3)" 6.1 5.3 10.7 4.0 23.4 2.1 4.7 11.3 16.3 7.4 5.1 4.3 5.1 3.3 18.2 4.5 4.6 6.9 8.1 14.2 8.7 6.5 7.2 1.6 4.8 1.6 4.6 9.5 6.9 5.4 13.0 11.0 5.6 7.1 7.4 5.3 3.3 5.0 6.8 11.8 5.1 3.1 20.2 4.1 3.8 3.8 5.0 5.2 18.0 7.4 3.4 2.4 6.2 5.4 0.0 0.3 22.6 0.4 0.4 1.0 0.2 7.4 4.3 8.9 15.6 10.1 8.1 2.0 21.4 21.4 7.5 10.5 0.9 7.4 0.0 8.6 20.2 3.3 3.6 9.1 16.1 13.8 3.4 11.6 2.0 0.3 6.3 0.1 9.4 10.7 6.5 12.5 10.2 3.8 2.4 0.0 26.7 1.2 10.6 0.2 2.2 7.6 0.8 8.7 1.6 6.0 0.3 11.4 7.0 6.8 0.3 18.2 2.1 2.3 10.6 20.6 13.4 6.6 13.7 10.1 7.9 0.0 11.1 0.0 22.5 22.6 0.2 3.5 0.1 0.4 1.0 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.3 0.3 0.0 0.2 10.7 23.4 11.3 16.3 8.7 6.5 4.6 9.5 7.1 5.2 LRP1B "LRP-DIT, LRPDIT" ENSG00000168702 "LDL receptor related protein 1B" Q9NZR2 2 140231423-142131701 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7;thyroid gland: 14.9" "Cell line enhanced" "Detected in some" "ASC diff: 4.2;HEK 293: 4.4;HeLa: 2.3;HSkMC: 2.1;U-138 MG: 4.9;U-87 MG: 2.5" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "myeloid DC: 1.4;plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Low region specificity" "Detected in all" "HPA069094, HPA074788" Approved Approved Vesicles 63000 Vesicles "HPA069094: , HPA074788: " "unprognostic (5.31e-4)" "unprognostic (3.68e-2)" "unprognostic (2.61e-1)" "unprognostic (7.36e-4)" "unprognostic (5.19e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-2)" "unprognostic (3.49e-1)" "unprognostic (3.75e-1)" "unprognostic (7.02e-3)" "unprognostic (1.64e-3)" "unprognostic (1.05e-1)" "unprognostic (2.94e-3)" "unprognostic (4.85e-3)" "unprognostic (1.52e-1)" "unprognostic (1.66e-2)" "unprognostic (1.36e-1)" 4.8 4.5 17.6 1.3 14.1 1.2 2.6 23.2 25.7 1.4 1.3 6.5 0.0 1.2 1.3 6.8 1.3 1.9 1.4 1.6 18.3 9.3 2.2 1.6 1.4 1.2 10.8 16.7 3.0 1.2 1.1 12.7 1.2 12.8 3.5 1.3 0.1 2.5 3.8 10.5 1.7 1.3 1.3 8.2 1.2 1.5 1.9 10.6 0.0 14.9 0.0 1.3 1.2 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.2 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.9 0.2 0.2 0.6 4.4 0.0 2.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.2 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 17.6 14.1 23.2 21.3 18.3 9.3 10.8 16.7 12.8 10.6 LRP2 "DBS, gp330" ENSG00000081479 "LDL receptor related protein 2" P98164 2 169127109-169362685 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endocytosis, Hearing, Neurogenesis, Transport" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 61.7;parathyroid gland: 61.4" "Group enriched" "Detected in some" 12 "AF22: 21.4;CACO-2: 35.6" "Group enriched" "Detected in many" 6 "breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005980, HPA064792" Enhanced Approved Vesicles,Mitochondria "Vesicles, Mitochondria" "HPA005980: AB_1079278, HPA064792: " "unprognostic (1.87e-1)" "unprognostic (1.04e-3)" "unprognostic (1.32e-3)" "unprognostic (3.65e-3)" "unprognostic (3.18e-2)" "unprognostic (1.60e-2)" "unprognostic (1.64e-3)" "unprognostic (2.99e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (4.09e-2)" "unprognostic (4.38e-1)" "prognostic favourable (3.43e-5)" "unprognostic (1.37e-1)" "unprognostic (4.21e-1)" "unprognostic (2.44e-2)" "unprognostic (1.62e-2)" 1.7 0.4 2.7 0.4 12.9 0.5 7.4 0.7 5.7 0.6 0.4 18.5 0.0 0.4 0.5 4.8 0.4 0.4 0.6 0.5 6.2 3.4 61.7 0.6 1.8 0.4 20.7 1.9 0.4 0.4 61.4 0.4 10.5 8.5 0.5 0.4 7.9 1.1 0.5 0.5 0.5 0.4 0.4 17.2 0.4 0.5 0.6 17.0 0.0 18.2 0.0 0.4 0.4 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.7 12.9 0.7 5.7 6.2 3.4 20.7 1.9 8.5 17.0 LRP3 "hLRp105, LRP-3" ENSG00000130881 "LDL receptor related protein 3" O75074 19 33177603-33208867 "Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 50.0" "Cell line enhanced" "Detected in many" "THP-1: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.8;non-classical monocyte: 2.6" "Lineage enriched" "Detected in single" 4 "monocytes: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041658 Approved "Lipid droplets" "Lipid droplets" "HPA041658: " "unprognostic (3.10e-1)" "unprognostic (2.55e-2)" "unprognostic (3.25e-2)" "unprognostic (1.45e-2)" "unprognostic (2.38e-2)" "unprognostic (1.80e-1)" "unprognostic (1.39e-1)" "unprognostic (3.14e-2)" "unprognostic (3.07e-2)" "unprognostic (4.67e-2)" "prognostic favourable (6.12e-7)" "unprognostic (1.34e-1)" "unprognostic (2.71e-3)" "unprognostic (4.36e-1)" "unprognostic (2.85e-2)" "unprognostic (2.40e-1)" "unprognostic (1.32e-1)" 23.5 16.6 28.3 5.1 33.1 15.3 15.6 14.2 41.2 12.1 7.8 6.6 4.4 7.1 11.2 8.8 7.4 12.4 8.2 10.9 27.6 13.0 4.2 15.5 5.3 3.2 15.4 19.4 50.0 16.8 9.8 10.3 3.8 11.0 15.5 3.4 10.0 14.4 12.7 21.9 5.0 6.6 10.6 6.3 4.8 7.0 5.6 7.7 0.0 9.5 4.7 3.1 9.0 9.1 0.0 0.0 0.6 2.8 0.5 0.1 0.7 0.0 20.4 5.6 20.2 14.1 5.4 4.2 5.2 5.1 4.8 1.8 5.8 0.2 0.0 13.7 6.4 0.0 5.4 0.5 0.4 0.0 11.0 0.0 4.6 20.4 5.4 7.3 0.7 8.0 4.8 1.3 0.7 3.9 0.0 0.0 6.1 18.8 0.0 8.2 11.5 1.0 0.0 2.6 0.0 0.0 8.1 12.4 18.7 8.4 0.0 1.5 8.6 25.8 0.0 10.0 9.0 14.9 2.9 0.0 0.0 0.1 0.0 12.3 2.9 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.5 2.6 0.0 0.0 0.7 28.3 33.1 14.2 41.2 27.6 13.0 15.4 19.4 11.0 7.7 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856868-46918642 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;skin 1: 33.0" "Cell line enhanced" "Detected in many" "AF22: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 1.2 1.9 16.0 1.3 20.3 0.5 2.1 7.3 23.7 3.0 5.4 11.6 0.6 3.9 2.1 1.3 2.4 2.0 2.5 7.2 20.4 5.8 1.2 0.7 3.4 0.5 9.6 12.6 5.4 2.7 9.3 3.3 3.1 14.5 2.7 4.1 1.3 2.1 3.0 4.4 33.0 5.3 2.0 9.7 4.2 9.6 1.6 19.0 0.0 2.9 1.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.6 17.3 5.2 10.8 2.9 4.0 0.7 1.5 2.3 2.6 2.2 0.0 0.0 1.1 8.9 3.1 9.6 5.9 1.8 0.0 8.1 0.8 3.0 5.3 2.3 0.1 1.5 3.7 3.4 3.6 0.9 2.0 0.7 0.0 1.3 0.6 0.1 0.2 9.4 0.7 1.2 5.9 0.0 0.2 2.2 0.0 11.4 0.9 0.0 2.8 0.2 0.4 0.1 4.7 2.9 5.3 1.6 0.0 0.0 0.3 3.5 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 20.3 7.3 17.3 20.4 5.8 9.6 12.6 14.5 19.0 LRP5 "BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPS, OPTA1, VBCH2" ENSG00000162337 "LDL receptor related protein 5" O75197 11 68312609-68449275 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Disease mutation, Osteogenesis imperfecta, Osteopetrosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.8" "Lineage enhanced" "Detected in single" "dendritic cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013001, HPA030505" Approved "CAB013001: AB_2533267, HPA030505: " "unprognostic (3.67e-1)" "unprognostic (2.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.13e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.94e-2)" "unprognostic (9.63e-2)" "unprognostic (2.54e-1)" "unprognostic (2.78e-1)" "unprognostic (6.82e-2)" "prognostic favourable (3.55e-10)" "unprognostic (2.28e-2)" "unprognostic (1.62e-2)" "unprognostic (1.58e-1)" "unprognostic (7.42e-2)" 15.9 14.7 3.1 6.8 4.0 1.1 25.6 1.6 3.7 13.5 14.9 5.3 16.8 20.4 12.4 11.8 8.7 10.1 29.8 14.3 2.9 2.1 12.5 49.4 12.9 4.8 2.9 2.6 11.8 30.8 8.1 6.9 12.7 5.2 13.3 5.3 11.6 35.3 22.0 7.4 8.9 23.5 15.4 3.1 3.6 12.7 3.6 3.4 9.2 17.2 10.4 8.3 11.2 17.5 0.1 2.8 0.0 0.0 0.7 0.1 0.0 9.9 34.0 3.7 8.4 7.0 3.9 15.8 4.6 4.0 2.8 2.5 19.1 34.5 0.0 29.6 5.9 12.8 3.3 12.3 0.4 1.6 7.5 7.0 17.4 24.7 7.2 5.0 0.6 5.6 4.2 0.1 4.6 7.9 12.2 0.5 2.0 22.4 7.5 20.1 6.5 13.9 9.5 10.1 16.0 4.7 26.9 3.6 7.3 12.2 16.5 13.3 11.5 11.7 10.3 0.0 3.1 3.8 5.1 2.1 0.2 2.0 0.0 3.1 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 2.8 0.0 0.0 3.1 4.0 1.6 3.7 2.9 2.1 2.9 2.6 5.2 3.4 LRP6 ADCAD2 ENSG00000070018 "LDL receptor related protein 6" O75581 12 12116025-12267012 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.7" "Lineage enhanced" "Detected in single" "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004490, HPA029925" Enhanced 270000 "CAB004490: AB_627894, HPA029925: AB_10601768" "unprognostic (1.80e-1)" "unprognostic (3.72e-1)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (6.11e-2)" "unprognostic (1.07e-1)" "unprognostic (4.56e-2)" "unprognostic (1.37e-2)" "unprognostic (3.35e-2)" "unprognostic (6.98e-2)" "unprognostic (1.82e-1)" "unprognostic (5.00e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-2)" "unprognostic (3.16e-1)" "unprognostic (1.23e-2)" "unprognostic (2.47e-1)" 7.6 5.3 7.3 5.6 10.1 1.2 9.9 11.6 8.2 16.7 8.7 7.4 5.8 6.8 14.2 8.2 5.0 8.7 9.3 7.3 8.1 4.7 11.7 17.9 10.9 2.4 5.5 8.7 13.1 10.1 21.5 11.2 18.4 7.8 8.8 6.9 9.9 13.3 11.9 10.8 6.9 5.9 9.6 5.5 2.7 8.5 7.9 8.2 4.2 10.3 7.3 3.6 7.5 14.1 0.4 0.0 0.0 0.0 0.0 1.7 0.0 4.2 11.9 9.3 4.7 5.9 3.9 8.3 7.4 4.8 4.1 4.9 5.8 3.3 0.0 3.6 4.7 3.7 13.0 3.3 7.8 0.0 4.9 4.1 4.6 3.1 2.1 5.7 3.1 3.0 2.1 6.2 4.8 4.3 5.5 0.0 2.7 2.7 4.0 1.0 15.6 2.2 5.1 9.1 1.0 6.3 6.6 2.0 6.3 7.1 2.3 6.0 1.8 3.3 7.7 3.3 14.0 2.6 5.3 0.0 0.0 2.0 3.2 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 7.3 10.1 11.6 8.2 8.1 4.7 5.5 8.7 7.8 8.2 LRP8 "APOER2, HSZ75190, LRP-8, MCI1" ENSG00000157193 "LDL receptor related protein 8" Q14114 1 53242364-53328070 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.5;thyroid gland: 48.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.2" "Group enriched" "Detected in many" 6 "dendritic cells: 3.2;T-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073031 Enhanced "Secreted in other tissues" 240000 "HPA073031: " "unprognostic (3.83e-2)" "unprognostic (6.06e-2)" "unprognostic (6.36e-2)" "prognostic unfavourable (3.46e-6)" "unprognostic (3.46e-1)" "unprognostic (6.13e-2)" "unprognostic (1.03e-3)" "prognostic unfavourable (7.02e-4)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (1.66e-1)" "unprognostic (9.11e-2)" "unprognostic (8.88e-16)" "unprognostic (7.73e-3)" "unprognostic (5.47e-2)" "unprognostic (6.98e-2)" "unprognostic (3.00e-2)" 2.6 1.9 7.0 5.5 7.1 5.8 1.9 13.0 15.1 1.8 1.8 2.7 0.3 1.4 2.0 2.8 6.1 3.6 2.3 1.9 7.6 8.0 1.4 0.8 3.2 5.6 5.8 7.9 1.3 0.9 0.8 4.2 5.0 6.6 1.5 2.4 11.9 1.4 1.6 0.8 1.5 1.5 2.9 3.8 2.3 1.3 22.5 3.4 1.7 48.7 2.4 4.9 1.7 2.0 0.3 3.2 0.0 0.4 0.0 1.6 0.2 10.0 21.6 8.4 12.2 5.9 5.7 10.9 12.5 10.4 18.9 13.3 5.9 12.1 16.6 14.6 8.4 17.3 6.7 14.4 9.0 12.1 6.5 9.3 24.6 10.3 6.0 16.8 16.7 1.6 1.6 20.7 11.3 14.8 3.6 7.3 2.8 12.6 10.3 7.8 15.7 15.8 18.3 12.5 14.3 7.4 8.6 19.3 7.3 5.9 33.8 8.0 4.0 11.4 11.9 5.0 8.0 10.8 24.9 11.6 18.0 6.8 24.7 23.3 28.4 0.0 0.4 0.0 1.0 0.0 1.6 0.3 0.6 0.4 0.5 0.2 0.2 0.2 0.0 0.0 0.0 3.2 1.4 0.2 7.0 7.1 13.0 12.7 7.6 8.0 5.8 7.9 6.6 3.4 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355247-194369743 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 48.1" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 47.8;U-138 MG: 9.3;U-87 MG: 25.8" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" 1800000 Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 3.3 0.5 0.5 3.1 0.6 0.0 5.3 0.5 0.5 4.6 2.1 0.2 0.0 0.4 3.5 0.3 1.0 1.3 2.0 1.8 0.5 0.5 0.5 0.5 2.5 0.8 0.5 0.0 3.1 0.8 0.0 0.5 48.1 0.3 0.6 4.2 0.7 1.6 0.0 1.0 9.1 0.8 0.7 0.5 1.3 1.9 0.9 0.0 1.1 1.8 7.7 7.7 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.4 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.3 1.5 1.2 0.0 0.0 0.0 0.0 25.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 LRRC24 LRRC14OS ENSG00000254402 "Leucine rich repeat containing 24" Q50LG9 8 144522377-144527032 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.9" "Cell line enhanced" "Detected in some" "MCF7: 4.1;SCLC-21H: 4.4;SH-SY5Y: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028171, HPA052250" Enhanced Approved Vesicles Vesicles "HPA028171: , HPA052250: " "unprognostic (1.75e-1)" "unprognostic (5.76e-2)" "unprognostic (2.33e-3)" "unprognostic (3.63e-2)" 2.5 4.0 5.1 1.4 9.3 1.7 1.5 12.3 16.9 2.3 2.1 1.6 0.6 2.0 2.5 1.7 1.7 2.8 1.3 1.5 4.5 7.9 2.2 1.6 2.0 1.4 4.5 8.4 4.5 3.2 9.3 8.4 1.5 5.9 11.4 1.1 10.3 2.8 3.2 2.3 1.7 2.0 1.6 2.1 2.2 1.9 1.5 1.3 0.6 1.6 1.0 1.1 1.4 1.6 0.0 0.5 0.0 0.1 0.1 0.5 0.0 0.3 0.8 0.6 1.5 0.8 0.5 1.8 0.5 0.6 0.6 0.6 0.2 1.6 0.8 3.4 0.2 0.1 0.0 0.0 0.1 1.2 2.2 0.5 1.0 0.3 0.6 0.0 1.0 0.7 0.4 0.5 0.1 0.3 0.9 0.1 0.1 4.1 1.2 1.6 0.1 0.8 1.8 0.1 0.6 0.1 0.5 4.4 12.2 0.4 0.1 0.4 3.7 1.3 0.0 0.1 1.2 0.4 0.2 1.0 0.1 0.1 0.6 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 9.3 12.3 16.9 4.5 7.9 4.5 8.4 5.9 1.3 LRRC25 "FLJ38116, MAPA" ENSG00000175489 "Leucine rich repeat containing 25" Q8N386 19 18391144-18397617 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 79.9;lymphoid tissue: 50.7" "Cell line enhanced" "Detected in some" "HMC-1: 5.1;THP-1: 4.7;U-937: 3.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "classical monocyte: 37.6;eosinophil: 41.2;intermediate monocyte: 61.8;myeloid DC: 27.9;neutrophil: 70.3;non-classical monocyte: 79.9" "Group enriched" "Detected in many" 50 "dendritic cells: 27.9;granulocytes: 70.3;monocytes: 79.9" "Low region specificity" "Detected in all" HPA029459 Approved 250000 "HPA029459: AB_10610005" "unprognostic (2.72e-2)" "unprognostic (6.08e-2)" "unprognostic (1.76e-2)" "unprognostic (2.07e-1)" "unprognostic (3.77e-2)" "unprognostic (9.15e-2)" "unprognostic (5.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.20e-2)" "unprognostic (4.63e-2)" "unprognostic (2.02e-1)" "unprognostic (1.73e-1)" "unprognostic (1.19e-3)" "unprognostic (5.77e-2)" "prognostic unfavourable (6.93e-4)" "unprognostic (1.74e-1)" "unprognostic (1.14e-1)" 12.7 7.0 2.1 14.6 3.0 19.5 5.2 0.6 1.2 1.6 3.4 2.7 0.4 2.3 1.6 5.4 1.5 3.4 3.5 6.4 1.6 1.3 4.1 10.0 10.5 30.7 2.6 0.4 3.2 1.7 0.1 1.3 5.5 2.5 3.5 1.7 2.7 2.5 0.6 2.0 1.1 3.9 4.3 2.7 50.7 2.1 2.2 1.7 2.5 1.4 0.6 3.0 4.5 2.8 1.1 27.9 70.3 79.9 0.6 0.2 21.2 0.2 0.0 0.3 0.4 0.1 0.2 0.7 0.3 0.3 0.1 0.3 0.4 0.5 0.5 0.2 0.0 0.3 0.3 0.1 0.2 0.1 0.2 2.0 0.8 2.5 2.5 1.1 5.1 1.5 0.1 0.0 0.1 0.0 0.2 1.3 0.0 0.5 0.0 1.2 0.6 0.1 0.2 0.1 1.3 0.3 0.1 0.2 0.2 0.0 0.1 0.3 0.5 4.7 1.1 0.6 0.4 0.4 0.3 0.3 0.1 0.2 0.6 3.9 0.2 5.8 37.6 41.2 0.1 61.8 0.2 0.9 0.0 0.1 27.9 1.1 0.0 0.0 70.3 0.6 79.9 3.9 0.1 21.2 2.1 3.0 0.6 1.2 1.6 1.3 2.6 0.4 2.5 1.7 LRRC26 bA350O14.10 ENSG00000184709 "Leucine rich repeat containing 26" Q2I0M4 9 137168758-137170051 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "salivary gland: 173.1" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 51.5" "Cancer enriched" "Detected in many" 5 "prostate cancer: 47.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 408 "plasmacytoid DC: 40.8" "Lineage enriched" "Detected in single" 408 "dendritic cells: 40.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA056312 Approved Supported "Nucleoli fibrillar center,Plasma membrane" "Plasma membrane" "Nucleoli fibrillar center" "HPA056312: " "unprognostic (1.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.04e-2)" "prognostic favourable (4.82e-6)" "unprognostic (3.39e-1)" "unprognostic (1.67e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "prognostic favourable (3.48e-4)" "unprognostic (3.27e-1)" "unprognostic (2.29e-1)" 0.1 0.0 0.0 1.3 0.0 0.0 2.1 0.7 0.1 0.3 6.8 0.0 11.2 1.2 0.3 0.1 0.7 0.3 0.4 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 15.4 0.4 0.0 173.1 20.0 0.0 1.3 4.0 0.0 0.0 0.1 1.0 0.0 0.0 0.7 0.0 10.3 4.6 0.0 0.1 0.0 40.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 8.5 0.0 51.5 0.0 0.0 0.4 0.1 0.2 2.5 0.0 1.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 LRRC3 C21orf102 ENSG00000160233 "Leucine rich repeat containing 3" Q9BY71 21 44455486-44462196 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 35.3;liver: 19.1" "Cell line enhanced" "Detected in many" "BEWO: 11.1;U-2 OS: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017975 Uncertain "HPA017975: AB_1853307" "unprognostic (1.36e-2)" "unprognostic (5.48e-3)" "unprognostic (1.49e-2)" "unprognostic (2.10e-4)" "unprognostic (1.55e-1)" "unprognostic (1.74e-2)" "unprognostic (7.20e-3)" "unprognostic (2.59e-1)" "unprognostic (4.61e-1)" "unprognostic (7.43e-2)" "unprognostic (1.37e-1)" "unprognostic (1.38e-2)" "unprognostic (1.74e-5)" "unprognostic (6.44e-2)" "unprognostic (2.01e-1)" "unprognostic (7.51e-2)" "unprognostic (6.66e-3)" 3.7 2.7 1.1 2.5 1.6 1.0 3.9 0.3 1.0 4.5 7.6 1.1 2.5 3.1 2.1 3.3 3.7 1.9 35.3 2.8 1.2 1.4 1.1 19.1 3.8 3.7 0.5 0.2 5.7 2.3 0.1 2.0 1.8 0.9 4.1 1.6 2.1 2.6 1.3 1.0 3.3 3.0 5.2 0.8 1.9 5.4 5.4 0.0 2.2 1.0 2.2 1.6 4.5 5.8 0.9 0.5 2.1 0.8 0.5 1.1 0.1 0.7 0.5 4.5 3.7 0.0 0.0 11.1 1.8 0.0 0.2 0.0 1.6 1.5 0.0 3.3 0.9 0.2 2.1 0.0 0.1 0.3 4.8 0.0 0.5 4.9 0.8 0.0 2.9 1.4 1.8 0.0 0.0 1.8 0.4 5.7 0.0 1.5 0.7 0.2 1.2 1.8 2.3 0.0 1.8 0.1 0.2 3.6 4.0 1.7 0.3 0.7 1.0 2.3 3.4 0.0 8.3 0.0 0.0 3.2 6.2 0.0 0.0 2.0 0.6 1.8 0.8 0.2 0.3 0.7 1.1 0.6 0.5 0.2 0.3 0.9 0.4 0.4 2.1 0.5 0.6 0.5 0.2 0.1 1.1 1.6 0.3 1.0 1.2 1.4 0.5 0.2 0.9 0.0 LRRC32 "D11S833E, GARP" ENSG00000137507 "Leucine rich repeat containing 32" Q14392 11 76657524-76670747 "Predicted intracellular proteins, Predicted membrane proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "ASC diff: 41.1;ASC TERT1: 25.3;HSkMC: 15.7;HUVEC TERT2: 17.8;U-2197: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "neutrophil: 1.0;T-reg: 3.1" "Group enriched" "Detected in many" 7 "granulocytes: 1.0;T-cells: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA055775, HPA058434" Enhanced Nucleoplasm "Intracellular and membrane" 19000 Nucleoplasm "HPA055775: , HPA058434: " "unprognostic (3.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (4.19e-3)" "unprognostic (1.16e-1)" "unprognostic (8.84e-2)" "unprognostic (1.39e-2)" "unprognostic (2.24e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.58e-1)" "unprognostic (9.86e-2)" "prognostic unfavourable (3.93e-5)" "unprognostic (7.99e-3)" "unprognostic (1.15e-2)" "unprognostic (5.22e-3)" "prognostic unfavourable (2.64e-4)" 50.5 16.5 5.4 8.0 11.3 1.9 35.1 4.6 9.1 19.8 12.4 4.4 3.5 7.0 15.2 10.4 11.1 10.8 22.6 18.0 7.6 3.5 19.5 8.5 51.8 4.7 10.2 4.3 19.9 8.7 7.9 7.0 40.5 10.1 12.6 5.1 16.6 5.2 9.4 29.0 9.9 7.7 13.0 5.7 21.2 8.1 8.6 8.7 0.6 16.6 9.7 2.1 19.8 25.1 0.2 0.0 1.0 0.0 0.0 3.1 9.6 0.0 0.0 0.4 0.0 41.1 25.3 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.8 0.0 0.0 15.7 0.0 1.4 0.0 17.8 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 2.6 0.3 37.7 0.0 0.0 0.0 0.6 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 3.1 9.6 5.4 11.3 4.6 9.1 7.6 3.5 10.2 4.3 10.1 8.7 LRRC37A KIAA0563 ENSG00000176681 "Leucine rich repeat containing 37A" A6NMS7 17 46292733-46337794 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 9.4;testis: 15.2" "Cell line enhanced" "Detected in many" "Daudi: 7.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles Vesicles "HPA042121: , HPA043056: , HPA045090: , HPA049080: " "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.22e-2)" "unprognostic (3.75e-2)" "unprognostic (6.02e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-2)" "unprognostic (5.23e-2)" "unprognostic (5.20e-2)" "unprognostic (8.22e-2)" "unprognostic (2.05e-1)" "unprognostic (2.65e-3)" "unprognostic (3.37e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-2)" "unprognostic (4.30e-2)" 0.9 0.4 1.4 2.0 1.8 1.4 1.7 2.6 1.7 0.7 0.9 0.5 1.1 0.4 1.1 1.0 0.5 1.1 1.5 1.2 0.9 0.6 0.9 1.5 0.6 1.2 0.9 0.5 2.1 0.7 1.3 1.0 1.0 0.9 9.4 1.8 1.3 0.6 0.8 1.2 0.8 15.2 1.2 0.9 1.1 1.1 1.4 1.7 2.1 1.4 2.1 1.5 0.2 0.2 0.2 1.5 0.2 0.3 0.0 0.5 0.1 0.4 0.1 0.2 3.5 0.3 7.8 0.3 0.2 0.3 0.0 0.0 0.0 0.5 1.2 0.4 3.9 2.7 0.6 0.0 0.2 0.0 1.0 0.0 0.0 0.5 0.2 0.5 0.9 0.0 0.3 0.7 1.2 0.0 2.7 2.8 1.8 0.0 1.8 0.4 1.0 0.2 0.6 0.1 0.5 3.6 1.2 1.4 2.3 0.4 0.2 3.5 2.5 0.5 1.2 2.4 2.2 2.1 1.1 1.0 1.0 1.0 0.9 0.8 0.8 1.5 1.1 1.4 1.3 1.1 1.9 2.1 1.4 1.7 1.0 0.2 LRRC37A2 FLJ45049 ENSG00000238083 "Leucine rich repeat containing 37 member A2" A6NM11 17 46511511-46555650 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.5" "Cell line enhanced" "Detected in some" "Daudi: 4.0;THP-1: 4.2" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "eosinophil: 2.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.9" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles Vesicles "HPA042121: , HPA043056: , HPA045090: , HPA049080: " "unprognostic (1.59e-2)" "unprognostic (3.75e-2)" "unprognostic (8.96e-2)" "unprognostic (6.35e-2)" "unprognostic (2.53e-1)" "unprognostic (2.97e-3)" "unprognostic (4.61e-3)" "unprognostic (1.63e-1)" "unprognostic (6.47e-2)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (8.00e-2)" "unprognostic (3.02e-7)" "unprognostic (8.40e-2)" "unprognostic (2.82e-1)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" 0.5 0.0 0.3 0.4 0.7 0.9 0.8 0.9 0.4 0.1 0.4 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.4 0.4 0.5 0.4 0.7 0.5 0.1 0.3 0.1 0.1 1.2 0.1 0.4 0.9 0.4 0.7 0.6 0.9 0.4 0.5 0.2 0.0 0.5 13.5 0.4 0.5 0.6 0.3 0.2 0.3 2.9 0.1 0.1 0.4 0.0 0.4 0.6 0.3 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.8 0.0 4.0 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.9 0.5 0.7 0.0 0.0 0.0 0.8 0.0 0.3 1.9 0.0 0.8 2.0 0.0 0.3 0.1 0.2 0.1 1.8 0.8 0.4 0.0 1.4 0.2 0.4 0.3 0.0 0.3 1.4 4.2 0.8 2.5 1.9 0.0 0.8 1.3 1.0 0.5 0.2 0.9 1.5 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 LRRC37A3 "FLJ34306, KIAA0563" ENSG00000176809 "Leucine rich repeat containing 37 member A3" O60309 17 64854312-64919480 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042121, HPA043056, HPA045090" Supported Approved Vesicles Vesicles "HPA042121: , HPA043056: , HPA045090: " "unprognostic (2.28e-1)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (4.73e-2)" "unprognostic (2.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.84e-2)" "unprognostic (2.27e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-2)" "unprognostic (5.31e-6)" "unprognostic (1.83e-1)" "prognostic unfavourable (3.25e-6)" "unprognostic (2.26e-1)" "unprognostic (4.89e-2)" "unprognostic (5.18e-2)" "unprognostic (7.43e-3)" 4.4 6.6 14.8 5.5 14.0 6.2 8.8 27.9 16.0 4.3 3.6 7.4 5.4 3.2 6.9 16.0 3.9 7.8 6.8 3.8 15.1 15.0 15.7 3.4 4.8 4.3 12.8 7.2 8.4 5.2 5.7 18.8 4.6 12.1 6.7 4.0 8.3 4.3 6.2 6.4 7.1 4.0 4.2 6.6 4.6 4.2 25.8 12.6 7.3 14.3 0.3 3.1 4.6 10.0 2.3 2.3 5.3 1.0 3.1 1.2 0.3 2.4 4.9 4.7 10.6 5.3 3.3 3.4 3.5 2.8 2.5 2.7 2.1 3.7 2.5 1.6 1.8 2.1 1.3 1.0 1.1 3.2 4.8 7.6 2.9 1.5 2.1 2.9 2.0 2.2 1.8 1.7 0.8 1.7 1.5 1.4 1.8 6.6 1.4 4.9 3.7 1.4 1.6 2.5 1.1 5.4 2.3 3.1 11.9 1.3 6.0 1.4 2.6 5.2 5.7 4.3 1.3 1.7 1.8 2.1 1.9 1.9 3.0 12.1 7.3 5.3 0.4 0.7 0.7 0.7 0.8 0.6 1.0 0.4 0.6 2.3 1.2 1.1 2.0 3.1 1.0 2.3 0.9 0.3 14.8 14.0 27.9 16.0 15.1 15.0 12.8 7.2 12.1 12.6 LRRC37B ENSG00000185158 "Leucine rich repeat containing 37B" Q96QE4 17 32007872-32053504 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 2.8;NK-cells: 6.4;T-cells: 4.9" HPA015135 Approved Approved Cytosol Cytosol "HPA015135: AB_1853309" "unprognostic (5.46e-3)" "unprognostic (2.56e-2)" "unprognostic (5.08e-2)" "unprognostic (5.30e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-1)" "unprognostic (3.60e-2)" "unprognostic (9.65e-3)" "unprognostic (5.06e-2)" "unprognostic (3.19e-2)" "unprognostic (1.72e-4)" "unprognostic (6.99e-2)" "unprognostic (5.72e-3)" "unprognostic (6.94e-2)" "unprognostic (3.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.36e-3)" 4.7 5.0 13.7 4.8 15.0 28.5 6.4 35.5 14.4 5.9 5.2 7.2 5.0 4.5 8.3 6.5 4.6 8.2 4.8 2.7 10.7 8.5 3.7 3.0 6.7 5.5 8.6 10.2 12.1 4.3 7.4 13.8 4.6 8.9 5.3 6.4 6.1 6.5 4.2 3.5 11.7 6.3 7.2 8.5 7.6 6.6 24.5 10.3 8.3 4.4 1.8 5.8 5.3 10.2 0.8 1.1 2.8 0.5 6.4 4.9 0.5 2.0 3.9 12.4 7.0 3.1 3.9 3.8 1.8 7.0 5.4 7.0 5.4 2.0 5.6 4.0 4.2 2.8 7.3 1.5 4.3 1.6 6.2 2.6 5.7 2.0 4.6 9.9 4.7 4.1 4.6 5.0 12.6 4.6 6.0 5.4 2.0 1.9 17.3 15.4 3.7 2.6 12.3 2.9 4.5 3.1 5.2 2.3 3.9 4.7 3.1 6.4 8.1 16.1 3.8 3.8 2.6 8.5 4.6 5.4 7.6 5.5 2.7 10.1 2.7 0.0 0.4 2.8 1.1 0.5 2.1 0.2 2.2 3.0 0.8 0.8 3.0 0.8 1.1 6.4 0.2 1.1 4.9 0.5 13.7 15.0 35.5 14.4 10.7 8.5 8.6 10.2 8.9 10.3 LRRC38 ENSG00000162494 "Leucine rich repeat containing 38" Q5VT99 1 13474977-13514048 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 16.0;skeletal muscle: 60.8" "Cell line enhanced" "Detected in some" "EFO-21: 3.8;MOLT-4: 14.2;PC-3: 10.3;U-138 MG: 16.6" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 7 "cerebellum: 4.1;cerebral cortex: 3.0;pons and medulla: 1.1" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 1.8" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038778 Approved "HPA038778: AB_10673294" "unprognostic (5.13e-2)" "unprognostic (3.98e-1)" "unprognostic (3.12e-1)" "unprognostic (3.88e-1)" "unprognostic (5.49e-2)" "unprognostic (1.45e-3)" "unprognostic (1.72e-1)" "unprognostic (2.70e-1)" "unprognostic (9.70e-2)" "unprognostic (4.23e-1)" "unprognostic (7.81e-2)" "unprognostic (4.47e-2)" "unprognostic (1.05e-1)" 0.4 16.0 0.1 0.1 0.3 0.2 0.7 4.1 3.0 0.2 0.2 0.2 0.0 0.2 0.2 1.4 0.4 0.2 0.2 1.0 0.2 0.1 0.2 0.1 0.2 0.2 0.4 0.3 0.2 0.1 0.2 0.1 0.7 1.1 0.4 0.2 0.8 0.5 0.2 60.8 0.8 0.2 0.2 6.8 0.2 0.2 0.5 0.0 5.7 0.2 10.0 0.3 0.2 0.5 0.1 1.8 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 10.3 0.0 0.1 1.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 16.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.3 4.1 3.0 0.2 0.1 0.4 0.3 1.1 0.0 LRRC3B LRP15 ENSG00000179796 "Leucine rich repeat containing 3B" Q96PB8 3 26622806-26710776 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 21.3;skeletal muscle: 17.4;testis: 12.0" "Group enriched" "Detected in some" 4 "NTERA-2: 5.4;REH: 2.5;THP-1: 3.2" "Group enriched" "Detected in some" 9 "endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015568 Approved "HPA015568: AB_1853282" "unprognostic (1.22e-2)" "unprognostic (2.94e-1)" "unprognostic (1.87e-1)" "unprognostic (7.42e-2)" "unprognostic (8.82e-4)" "unprognostic (2.84e-2)" "unprognostic (1.55e-1)" "unprognostic (2.77e-1)" "unprognostic (1.91e-4)" "unprognostic (3.31e-2)" "unprognostic (2.63e-1)" "unprognostic (1.60e-1)" "unprognostic (2.82e-1)" 0.8 0.9 15.5 0.7 13.6 0.6 1.6 18.5 21.3 0.8 1.2 2.2 0.0 0.8 2.3 0.7 1.5 1.6 0.7 1.4 9.5 7.3 0.8 0.8 0.8 0.6 8.7 5.6 2.9 0.6 0.7 0.8 0.7 5.7 0.8 1.9 3.0 1.9 1.1 17.4 0.7 1.2 2.0 4.9 0.8 1.5 12.0 1.7 0.0 0.7 0.1 0.7 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.4 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.5 13.6 18.5 10.1 9.5 7.3 8.7 5.6 5.7 1.7 LRRC3C ENSG00000204913 "Leucine rich repeat containing 3C" A6NJW4 17 39941474-39944747 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "parathyroid gland: 1.9;testis: 3.0" "Group enriched" "Detected in some" 6 "HDLM-2: 2.1;Karpas-707: 3.8;U-266/70: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA071271 Uncertain "HPA071271: " "unprognostic (1.59e-1)" "unprognostic (6.57e-2)" "unprognostic (6.17e-2)" "unprognostic (2.81e-1)" "unprognostic (3.16e-4)" "unprognostic (9.20e-2)" "unprognostic (4.27e-1)" "unprognostic (6.00e-2)" "unprognostic (1.24e-1)" "unprognostic (2.14e-1)" "unprognostic (1.90e-2)" 0.2 0.0 0.3 0.3 0.2 0.1 0.2 0.0 0.2 0.6 0.1 0.0 0.4 0.3 0.0 0.8 0.0 0.6 0.2 0.0 0.2 0.5 0.2 0.0 0.1 0.3 0.1 1.9 0.0 0.0 0.4 0.0 0.3 0.2 0.1 0.4 0.1 0.1 0.2 0.0 0.2 3.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.4 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC4 NAG14 ENSG00000128594 "Leucine rich repeat containing 4" Q9HBW1 7 128027071-128032107 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2" "Group enriched" "Detected in some" 6 "AF22: 10.5;NTERA-2: 23.3;REH: 21.4;SCLC-21H: 11.9;SH-SY5Y: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 14.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051100 Approved "Golgi apparatus" 1100000 "Golgi apparatus" "HPA051100: " "unprognostic (7.98e-2)" "unprognostic (6.15e-3)" "unprognostic (2.85e-2)" "prognostic favourable (8.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.34e-3)" "unprognostic (3.43e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (7.63e-2)" "unprognostic (3.23e-2)" "unprognostic (1.72e-1)" "prognostic favourable (6.98e-4)" "unprognostic (4.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-1)" "unprognostic (5.84e-3)" 2.6 7.7 11.6 2.9 13.1 10.0 0.8 22.3 33.2 2.3 1.1 3.2 0.7 0.9 3.4 0.5 4.0 7.3 3.4 2.0 10.1 6.6 4.6 2.2 6.3 1.9 5.1 15.5 5.5 0.6 8.6 1.5 4.7 3.1 0.9 0.8 1.7 1.5 3.5 1.0 0.5 1.0 1.9 3.4 4.7 1.5 6.3 2.9 0.8 0.8 3.6 2.4 1.5 2.0 0.0 0.0 14.3 0.6 0.0 0.1 0.1 0.0 0.1 10.5 0.0 0.4 0.0 0.0 0.6 0.0 0.9 0.3 0.0 0.0 0.0 0.7 0.9 1.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.0 1.2 0.0 0.1 0.0 23.3 0.0 21.4 0.0 0.2 0.1 0.0 11.9 7.4 0.0 0.0 0.9 0.0 2.3 0.3 0.7 0.1 0.1 0.5 0.0 0.0 0.0 0.1 0.0 1.5 0.5 0.3 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.3 0.0 0.6 0.0 0.0 0.1 11.6 13.1 22.3 28.4 10.1 6.6 5.1 15.5 3.1 2.9 LRRC4B "DKFZp761A179, HSM, LRIG4" ENSG00000131409 "Leucine rich repeat containing 4B" Q9NT99 19 50516892-50568045 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.9" "Cell line enhanced" "Detected in some" "HMC-1: 21.7;SH-SY5Y: 18.9;U-2 OS: 17.8;WM-115: 6.7" "Group enriched" "Detected in many" 9 "glioma: 36.5;testis cancer: 9.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058986 Uncertain 2300000 "HPA058986: " "unprognostic (1.52e-2)" "unprognostic (1.14e-1)" "unprognostic (4.46e-2)" "unprognostic (4.48e-2)" "unprognostic (3.56e-1)" "unprognostic (5.39e-4)" "unprognostic (2.70e-2)" "unprognostic (1.11e-1)" "unprognostic (5.28e-2)" "unprognostic (4.61e-3)" "unprognostic (1.11e-3)" "unprognostic (3.41e-1)" "unprognostic (3.15e-5)" "unprognostic (4.29e-2)" "unprognostic (2.61e-1)" "unprognostic (3.64e-1)" "unprognostic (2.17e-1)" 3.0 8.8 28.7 2.3 24.6 1.2 1.3 21.7 52.9 13.4 2.3 4.0 0.0 2.3 9.4 1.4 3.3 3.6 2.8 2.5 23.4 22.9 1.7 1.7 3.6 2.7 17.8 20.6 2.8 1.7 1.3 8.8 6.9 12.8 2.2 1.4 2.2 2.3 2.8 1.7 1.7 3.2 3.1 15.0 1.9 2.4 2.3 8.5 0.0 1.8 0.0 1.9 3.2 3.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 3.5 0.3 0.0 0.6 0.1 0.0 5.6 0.0 5.9 0.0 0.1 0.0 0.0 0.0 18.9 0.0 0.0 3.7 0.0 0.1 0.0 0.0 17.8 0.0 0.0 0.4 0.0 0.0 0.1 0.2 6.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 28.7 24.6 21.7 31.9 23.4 22.9 17.8 20.6 12.8 8.5 LRRC4C "KIAA1580, NGL-1" ENSG00000148948 "Leucine rich repeat containing 4C" Q9HCJ2 11 40114203-41459773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 31.5" "Group enriched" "Detected in some" 6 "AF22: 16.9;U-2 OS: 18.6" "Cancer enhanced" "Detected in some" "glioma: 3.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "naive B-cell: 1.7" "Lineage enriched" "Detected in single" 18 "B-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054800, HPA075816" Approved Approved Cytosol Cytosol "HPA054800: , HPA075816: " "unprognostic (4.86e-3)" "unprognostic (3.43e-2)" "unprognostic (7.62e-3)" "unprognostic (4.87e-3)" "unprognostic (6.48e-2)" "unprognostic (1.42e-1)" "unprognostic (2.84e-1)" "unprognostic (4.64e-2)" "unprognostic (1.93e-1)" "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (4.90e-13)" "unprognostic (5.05e-4)" "unprognostic (5.21e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-3)" 1.6 5.7 20.2 1.6 23.7 0.5 2.6 3.6 31.5 5.3 1.9 3.3 0.0 1.1 2.3 1.0 1.2 1.3 1.8 2.6 16.7 8.7 0.9 2.1 1.6 1.4 7.5 10.3 1.6 1.0 4.3 3.2 0.5 8.7 1.5 1.6 1.3 1.4 3.0 0.7 0.7 1.3 2.4 6.0 1.3 0.9 0.9 7.9 0.0 4.0 0.0 1.6 1.1 1.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 23.7 3.6 16.4 16.7 8.7 7.5 10.3 8.7 7.9 LRRC53 ENSG00000162621 "Leucine rich repeat containing 53" A6NM62 1 74469878-74512614 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 2.9" "Cell line enriched" "Detected in single" 17 "SCLC-21H: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA054062 Uncertain "HPA054062: " "unprognostic (3.67e-1)" 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.6 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.5 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 LRRC59 "FLJ21675, PRO1855" ENSG00000108829 "Leucine rich repeat containing 59" Q96AG4 17 50375059-50397553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030827, HPA030829" Enhanced Enhanced "Endoplasmic reticulum" 5400000 "Endoplasmic reticulum" "HPA030827: AB_10602704, HPA030829: AB_10670045" "unprognostic (4.73e-2)" "unprognostic (2.15e-2)" "prognostic favourable (2.60e-4)" "unprognostic (5.63e-3)" "unprognostic (2.80e-1)" "prognostic unfavourable (1.00e-5)" "prognostic unfavourable (3.12e-6)" "unprognostic (1.88e-3)" "unprognostic (9.95e-2)" "unprognostic (5.62e-3)" "prognostic unfavourable (6.87e-4)" "unprognostic (3.68e-2)" "prognostic unfavourable (1.19e-6)" "unprognostic (2.77e-1)" "unprognostic (1.44e-1)" "unprognostic (3.39e-3)" "prognostic unfavourable (1.90e-5)" 20.7 40.5 10.6 21.8 14.5 28.4 16.3 11.5 21.6 28.2 30.0 11.4 28.8 19.6 17.2 24.9 23.5 15.8 22.8 17.4 10.2 8.8 22.1 74.7 23.0 15.9 12.7 11.5 15.8 87.9 15.4 11.6 35.3 10.8 17.7 31.5 10.0 48.6 26.2 16.0 11.2 27.3 22.0 8.9 19.0 30.7 18.2 10.4 18.0 22.8 22.4 20.8 13.7 17.0 8.6 14.9 14.4 19.6 5.9 9.1 9.0 62.1 47.4 13.7 20.5 23.2 27.4 24.5 51.0 28.5 47.8 42.3 108.4 18.0 27.2 35.1 58.1 22.7 33.9 43.5 57.1 14.4 49.4 47.6 26.9 57.9 48.8 46.8 22.7 24.1 35.4 51.2 59.6 35.2 44.0 25.9 31.3 42.3 32.9 22.2 15.4 69.6 28.2 43.9 52.0 26.0 31.8 33.5 27.8 17.6 19.8 25.9 33.4 25.5 37.6 55.5 23.0 51.2 66.4 39.1 32.0 35.2 37.7 31.8 34.8 14.4 15.7 13.4 7.4 19.6 9.1 8.6 7.5 8.9 14.9 6.4 5.0 6.3 8.0 5.9 18.6 12.1 7.5 9.0 10.6 14.5 11.5 21.6 10.2 8.8 12.7 11.5 10.8 10.4 LRRC66 ENSG00000188993 "Leucine rich repeat containing 66" Q68CR7 4 51993702-52017620 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 50.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.5;CAPAN-2: 5.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014549, HPA027839" Uncertain "HPA014549: AB_1853062, HPA027839: AB_10602705" "unprognostic (1.10e-1)" "unprognostic (4.87e-2)" "unprognostic (8.62e-2)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.87e-1)" "unprognostic (2.57e-2)" "unprognostic (4.83e-3)" "unprognostic (2.93e-1)" "unprognostic (4.09e-3)" "unprognostic (1.61e-2)" "unprognostic (1.89e-1)" "unprognostic (6.31e-3)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (3.05e-1)" "unprognostic (4.06e-1)" 0.5 0.1 0.8 2.6 1.0 0.0 0.5 1.4 0.9 0.5 11.3 0.5 0.5 19.6 0.5 0.5 0.5 0.5 1.6 0.6 0.8 0.8 0.9 0.5 0.5 0.5 0.8 0.5 0.5 0.5 0.5 3.1 0.5 0.5 0.5 5.2 0.5 0.5 0.5 6.7 0.0 50.2 0.5 0.6 0.5 4.6 0.7 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.2 0.4 0.7 1.9 4.5 0.2 0.7 1.1 0.4 0.8 0.2 5.7 0.0 0.1 1.1 0.0 0.3 0.3 0.3 1.8 0.7 0.0 0.2 0.0 0.2 0.1 0.1 1.7 1.0 0.9 0.3 0.4 0.0 0.0 2.2 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.2 0.2 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.4 1.2 0.1 0.7 0.5 0.7 0.0 0.1 0.1 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 1.4 0.9 0.8 0.8 0.8 0.5 0.5 0.5 LRRC70 "LOC100130733, SLRN" ENSG00000186105 "Leucine rich repeat containing 70" Q7Z2Q7 5 62578735-62581448 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 18 "HUVEC TERT2: 17.9;TIME: 9.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.0" "Group enriched" "Detected in many" 20 "granulocytes: 1.5;NK-cells: 3.0;T-cells: 1.3" "Low region specificity" "Detected in all" HPA013409 Uncertain "HPA013409: AB_10601911" "unprognostic (1.60e-1)" "unprognostic (1.27e-2)" "unprognostic (4.04e-1)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.17e-4)" "unprognostic (3.03e-1)" "unprognostic (3.77e-2)" "unprognostic (1.60e-1)" "unprognostic (2.19e-1)" "unprognostic (4.15e-1)" "unprognostic (7.40e-4)" "unprognostic (5.67e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" 18.4 1.6 1.3 3.2 2.1 5.9 18.0 0.9 2.2 9.5 4.2 0.0 3.4 1.5 5.3 2.4 5.4 4.2 6.7 4.6 2.0 1.6 10.0 5.9 3.9 5.9 1.7 0.2 5.7 2.2 2.6 4.8 9.6 2.7 6.8 2.7 2.8 2.4 1.1 2.8 4.9 3.5 6.5 3.4 25.2 2.3 4.9 1.8 3.5 10.4 4.1 1.5 6.1 17.6 0.0 0.0 1.5 0.0 3.0 1.3 0.2 0.2 0.0 0.2 0.1 0.5 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 17.9 0.2 0.7 0.0 0.1 0.5 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.1 0.0 9.7 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.3 0.2 1.5 3.0 0.0 0.0 0.0 0.2 1.3 2.1 0.9 2.2 2.0 1.6 1.7 0.2 2.7 1.8 LRRC8B "KIAA0231, TA-LRRP" ENSG00000197147 "Leucine rich repeat containing 8 VRAC subunit B" Q6P9F7 1 89524836-89597864 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8" "Cell line enhanced" "Detected in many" "HAP1: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017950 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA017950: AB_1853346" "unprognostic (2.50e-2)" "unprognostic (3.93e-2)" "prognostic favourable (7.15e-4)" "prognostic unfavourable (9.99e-4)" "unprognostic (1.22e-1)" "unprognostic (5.24e-2)" "unprognostic (3.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-2)" "unprognostic (1.72e-1)" "unprognostic (8.80e-3)" "unprognostic (2.30e-2)" "unprognostic (1.85e-1)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" 8.1 18.0 13.0 4.4 19.3 3.0 6.6 2.5 27.8 3.8 5.6 15.4 0.5 7.4 2.6 6.9 5.0 4.3 6.2 3.3 15.3 6.5 4.9 4.8 5.8 4.9 8.8 17.1 2.6 8.5 12.4 5.1 2.4 8.3 5.6 6.8 4.4 5.0 1.6 5.9 6.9 4.9 3.6 16.2 4.3 6.4 17.4 8.2 3.1 6.1 2.7 5.9 3.3 3.3 3.0 2.4 1.5 2.2 0.9 3.7 1.6 8.4 3.2 2.4 8.3 12.0 7.2 9.6 0.2 2.4 1.1 1.5 5.1 5.1 0.7 3.4 1.2 4.4 21.9 1.9 1.4 4.1 4.4 16.3 2.2 4.4 1.2 7.8 11.6 4.0 7.0 0.9 3.6 11.7 18.2 5.6 1.3 4.5 3.9 3.7 13.6 4.8 8.6 1.1 3.0 2.7 10.5 6.9 11.0 4.6 11.2 7.9 6.8 3.7 3.8 0.9 5.6 2.6 2.6 4.2 3.3 4.1 1.3 1.9 2.0 1.4 2.2 1.5 1.1 1.1 1.7 3.0 2.1 1.7 2.4 2.3 3.7 2.9 0.7 0.9 1.2 2.1 3.4 1.6 13.0 19.3 2.5 27.5 15.3 6.5 8.8 17.1 8.3 8.2 LRRC8D "FLJ10470, LRRC5" ENSG00000171492 "Leucine rich repeat containing 8 VRAC subunit D" Q7L1W4 1 89821014-89936611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014745 Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA014745: AB_1853348" "unprognostic (2.92e-3)" "unprognostic (9.50e-2)" "unprognostic (1.06e-3)" "prognostic unfavourable (3.21e-5)" "unprognostic (4.98e-2)" "unprognostic (7.03e-2)" "unprognostic (7.71e-3)" "unprognostic (7.74e-2)" "unprognostic (9.67e-2)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" "unprognostic (2.77e-1)" "unprognostic (4.91e-2)" "unprognostic (9.52e-3)" "unprognostic (1.23e-1)" "unprognostic (2.65e-2)" "unprognostic (9.61e-2)" 4.4 26.3 15.7 11.0 24.0 9.6 9.7 8.8 21.3 9.7 13.1 46.2 4.3 14.1 7.7 8.1 6.7 5.9 6.0 5.5 24.5 16.9 19.8 17.6 7.1 17.0 34.7 20.3 4.6 9.6 6.8 16.2 7.5 24.5 4.3 14.0 7.5 17.8 4.6 7.8 5.0 13.6 8.6 38.5 16.8 8.3 7.5 31.6 11.8 12.1 4.3 14.8 8.9 3.4 5.8 7.8 3.0 8.8 10.5 14.3 8.4 24.3 15.9 6.5 15.4 11.7 9.9 22.1 16.7 25.3 9.5 12.0 6.8 6.2 19.3 19.1 27.7 32.1 14.9 20.0 12.1 15.0 8.3 22.6 14.4 14.4 22.9 25.7 7.1 6.2 16.7 8.1 17.7 16.1 12.3 6.1 10.3 7.3 10.6 16.7 11.3 14.6 14.5 9.5 13.8 24.0 8.7 12.2 8.5 20.8 21.6 46.2 5.1 25.6 7.1 10.2 3.5 20.8 12.6 7.5 12.7 11.6 3.9 32.6 9.0 0.0 7.1 1.2 6.2 8.8 10.3 5.8 14.3 7.4 6.8 5.3 13.8 10.2 3.0 10.5 6.6 7.8 13.8 8.4 15.7 24.0 8.8 21.3 24.5 16.9 34.7 20.3 24.5 31.6 LRRC8E FLJ23420 ENSG00000171017 "Leucine rich repeat containing 8 VRAC subunit E" Q6NSJ5 19 7888505-7902021 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 23.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA020466 Uncertain "HPA020466: AB_1853352" "unprognostic (3.79e-2)" "unprognostic (2.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-3)" "unprognostic (8.28e-3)" "unprognostic (7.64e-2)" "unprognostic (1.71e-2)" "unprognostic (3.36e-1)" "unprognostic (8.38e-2)" "unprognostic (3.98e-6)" "unprognostic (1.11e-1)" "unprognostic (2.30e-2)" "unprognostic (3.29e-2)" "unprognostic (3.21e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-1)" 2.2 7.6 0.6 0.9 0.6 1.5 4.4 0.3 0.5 4.3 1.1 0.3 15.3 0.4 2.2 6.3 8.3 1.7 3.8 0.9 0.3 0.3 3.1 10.4 5.1 0.3 0.6 0.3 1.0 7.7 2.4 1.3 14.2 0.5 4.1 0.7 1.7 19.6 7.4 2.9 13.4 1.0 0.9 0.6 0.3 3.3 1.3 0.3 0.3 4.2 7.4 7.8 3.3 5.6 3.0 1.6 5.0 1.4 3.2 2.1 0.4 14.1 3.7 0.1 0.4 0.7 3.6 2.3 6.2 5.4 10.0 7.8 4.9 3.2 0.5 4.8 6.0 11.3 4.8 6.0 9.5 0.2 5.6 0.2 1.7 4.8 2.6 0.3 0.4 5.9 8.7 6.6 4.9 1.2 4.0 0.5 1.2 7.1 0.1 0.4 1.1 13.5 0.8 0.1 0.4 7.6 13.1 0.4 0.2 4.8 6.6 0.2 8.0 0.3 1.9 3.1 5.6 8.4 3.6 0.9 1.8 0.3 23.1 0.5 1.0 3.9 1.4 1.4 1.6 1.2 2.0 1.9 1.3 1.2 0.5 3.0 1.6 2.1 5.0 3.2 1.3 1.6 1.2 0.4 0.6 0.6 0.3 0.5 0.3 0.3 0.6 0.3 0.5 0.3 LRRN1 FIGLER3 ENSG00000175928 "Leucine rich repeat neuronal 1" Q6UXK5 3 3799437-3847703 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.5" "Cell line enhanced" "Detected in some" "AF22: 53.7;CAPAN-2: 19.0;HAP1: 16.0;NTERA-2: 31.9;U-266/84: 11.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 2.1;memory B-cell: 1.0;neutrophil: 2.6" "Group enriched" "Detected in many" 8 "B-cells: 1.0;granulocytes: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011071 Enhanced 1400000 "HPA011071: AB_1853355" "unprognostic (1.27e-2)" "unprognostic (4.87e-1)" "unprognostic (1.32e-2)" "unprognostic (3.30e-3)" "unprognostic (2.01e-2)" "unprognostic (3.02e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (3.34e-1)" "unprognostic (2.96e-1)" "unprognostic (2.85e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-3)" "unprognostic (1.86e-3)" "unprognostic (1.67e-1)" "unprognostic (1.75e-1)" "unprognostic (7.25e-2)" 1.4 0.8 12.5 1.1 19.0 2.4 7.6 13.8 32.5 7.1 0.9 5.0 0.3 1.9 4.7 2.5 1.9 2.9 4.6 0.7 11.1 9.4 1.3 0.7 2.1 0.9 8.5 6.1 10.0 3.8 14.2 2.7 0.9 22.2 7.7 1.0 11.5 8.9 8.2 9.2 2.2 2.6 3.2 8.3 1.8 1.8 10.3 10.7 8.7 4.8 0.7 1.7 10.6 1.5 1.0 0.0 2.6 0.0 0.1 0.2 0.0 0.0 0.0 53.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 16.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.5 0.0 31.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 6.5 0.0 0.6 5.6 11.1 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 1.0 0.0 0.2 0.0 0.3 0.0 0.1 2.6 0.1 0.0 0.0 0.0 0.0 12.5 19.0 13.8 10.3 11.1 9.4 8.5 6.1 22.2 10.7 LRRN2 "FIGLER7, GAC1, LRANK1, LRRN5" ENSG00000170382 "Leucine rich repeat neuronal 2" O75325 1 204617170-204685733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3" "Cell line enhanced" "Detected in some" "HEL: 7.1;NTERA-2: 14.2;RPMI-8226: 22.1;T-47d: 7.9" "Group enriched" "Detected in many" 6 "breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029124 Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA029124: AB_10601545" "unprognostic (2.16e-2)" "unprognostic (1.93e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (2.59e-7)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.89e-2)" "unprognostic (1.21e-1)" "unprognostic (4.63e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (1.68e-2)" "unprognostic (1.43e-2)" "unprognostic (7.33e-2)" "unprognostic (1.88e-1)" "unprognostic (1.59e-3)" 4.9 6.6 11.8 3.7 16.5 2.4 3.3 9.7 20.3 1.9 7.9 5.3 1.0 1.9 3.9 0.8 2.4 10.2 6.1 6.0 11.7 12.8 7.3 0.7 2.5 2.9 6.3 13.8 3.3 1.4 19.1 9.7 1.3 8.1 1.6 7.5 12.2 2.8 3.7 2.2 0.7 3.3 9.9 3.1 6.3 1.4 3.8 6.1 3.2 2.8 0.0 1.3 2.1 1.5 0.4 0.1 1.7 0.3 0.7 0.8 0.2 0.0 3.3 2.7 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.1 7.1 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 1.1 0.0 14.2 0.1 0.2 0.0 22.1 0.0 0.1 1.9 0.3 4.3 0.1 0.0 7.9 0.0 0.0 0.0 3.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.2 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.4 0.1 0.2 0.7 0.7 0.0 0.1 0.8 0.2 11.8 16.5 9.7 15.7 11.7 12.8 6.3 13.8 8.1 6.1 LRRN3 "FIGLER5, FLJ11129, NLRR3" ENSG00000173114 "Leucine rich repeat neuronal 3" Q9H3W5 7 111091006-111125454 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.5;brain: 23.8" "Cell line enhanced" "Detected in some" "AF22: 14.6;BJ: 8.2;BJ hTERT+: 18.0;SH-SY5Y: 26.2;T-47d: 14.3" "Group enriched" "Detected in many" 7 "glioma: 17.5;thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4" "Lineage enriched" "Detected in single" 98 "T-cells: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043820, HPA046792" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043820: , HPA046792: " "unprognostic (4.93e-2)" "unprognostic (4.55e-2)" "unprognostic (5.92e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-2)" "unprognostic (4.78e-3)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.84e-2)" "unprognostic (4.85e-3)" "unprognostic (1.08e-2)" "unprognostic (3.29e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (7.23e-2)" 7.8 26.5 12.7 1.6 21.2 1.1 2.1 20.0 23.8 3.6 1.4 1.9 0.8 1.0 1.0 3.1 1.9 1.3 1.6 9.0 10.4 10.7 0.9 2.7 8.7 3.6 7.7 13.0 7.9 1.5 0.7 4.9 6.7 9.0 4.7 1.6 0.8 1.9 6.4 4.0 0.8 2.1 1.0 2.9 2.0 0.9 16.4 6.3 8.8 22.3 0.0 4.4 1.6 1.3 0.2 0.0 0.1 0.0 0.0 20.3 4.0 0.0 0.0 14.6 1.7 6.8 2.9 0.0 8.2 18.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 7.1 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 26.2 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.0 20.3 18.4 0.1 0.0 0.0 0.0 0.2 4.0 12.7 21.2 20.0 23.8 10.4 10.7 7.7 13.0 9.0 6.3 LRRN4CL ENSG00000177363 "LRRN4 C-terminal like" Q8ND94 11 62686402-62689899 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 5.6;ASC TERT1: 18.7;HHSteC: 14.6;HSkMC: 7.9;LHCN-M2: 9.5" "Cancer enriched" "Detected in many" 5 "melanoma: 26.5" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA050317 Enhanced Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA050317: AB_2681084" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (2.84e-1)" "unprognostic (9.95e-3)" "unprognostic (2.61e-2)" "unprognostic (4.03e-3)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (3.04e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-7)" "unprognostic (2.73e-2)" "unprognostic (6.12e-2)" "unprognostic (4.53e-3)" "unprognostic (1.86e-2)" 15.7 4.8 0.2 5.0 0.6 0.6 11.6 0.6 0.9 27.2 12.1 0.1 3.5 2.1 27.0 14.0 19.1 11.4 6.7 9.3 0.3 0.2 0.8 0.2 3.1 1.8 0.3 0.6 24.9 2.1 0.4 1.2 4.4 2.2 10.8 2.5 17.8 3.2 6.7 17.0 6.8 4.3 15.1 1.9 0.3 5.7 8.5 0.0 0.0 3.5 10.4 2.4 18.2 11.2 0.9 0.6 3.3 0.8 0.8 0.6 0.1 0.0 0.0 0.2 0.2 5.6 18.7 0.2 2.0 2.9 0.2 1.0 0.2 0.1 0.1 0.2 3.2 0.3 0.1 0.0 0.3 0.1 0.2 0.3 0.1 0.1 14.6 0.2 0.1 7.9 0.1 0.4 0.0 0.0 0.2 0.1 9.5 0.0 0.2 0.4 0.4 0.1 0.1 1.3 0.3 0.0 0.1 0.6 0.2 0.2 0.2 0.6 0.1 0.2 0.2 1.7 0.1 2.0 0.1 0.2 0.1 0.2 1.1 0.2 0.0 0.9 0.8 0.3 0.4 0.3 0.3 0.4 0.4 0.3 0.1 0.9 0.5 0.6 3.3 0.8 0.4 0.6 0.2 0.1 0.2 0.6 0.6 0.9 0.3 0.2 0.3 0.6 2.2 0.0 LRRTM1 FLJ32082 ENSG00000162951 "Leucine rich repeat transmembrane neuronal 1" Q86UE6 2 80288351-80304749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.8;salivary gland: 19.8" "Cell line enhanced" "Detected in some" "AF22: 2.1;CAPAN-2: 3.2;NTERA-2: 2.1;SH-SY5Y: 4.6;U-266/70: 1.6" "Group enriched" "Detected in many" 11 "endometrial cancer: 8.8;ovarian cancer: 16.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062660 Approved "HPA062660: " "unprognostic (2.47e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (5.63e-2)" "unprognostic (6.67e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-1)" "unprognostic (8.16e-2)" "unprognostic (6.03e-3)" "unprognostic (7.10e-4)" "unprognostic (3.16e-2)" "unprognostic (1.90e-1)" "unprognostic (4.96e-4)" 0.7 2.2 8.1 1.0 17.8 0.5 0.6 0.5 17.6 1.5 2.2 2.7 0.1 1.7 1.7 1.2 1.1 2.8 0.9 1.3 10.7 6.3 0.9 0.7 0.7 0.5 2.5 7.8 0.9 0.5 0.5 1.3 0.5 1.8 0.9 1.1 1.7 19.8 2.8 0.5 0.7 1.9 1.1 2.1 0.5 0.9 0.7 2.4 0.0 2.9 0.0 0.6 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 17.8 0.5 17.6 10.7 6.3 2.5 7.8 1.8 2.4 LRRTM3 ENSG00000198739 "Leucine rich repeat transmembrane neuronal 3" Q86VH5 10 66926006-67099830 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6" "Cell line enhanced" "Detected in some" "AF22: 3.7;Daudi: 2.2;HAP1: 10.6;NTERA-2: 2.3;RPMI-8226: 1.8" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA070444, HPA078598" Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA070444: , HPA078598: " "unprognostic (1.21e-2)" "unprognostic (4.85e-2)" "unprognostic (1.12e-1)" "unprognostic (4.02e-2)" "unprognostic (1.15e-4)" "unprognostic (8.11e-2)" "unprognostic (4.77e-1)" 0.9 7.3 12.9 1.0 18.7 0.9 0.9 19.7 29.1 1.7 0.9 3.2 0.0 1.0 1.2 0.9 1.4 0.9 0.9 0.9 7.0 6.5 1.0 0.9 1.4 0.9 3.7 16.0 8.0 3.7 0.9 26.6 0.9 4.5 1.2 0.9 0.0 1.0 1.2 1.0 0.9 1.1 1.0 2.8 0.9 0.9 1.9 5.9 0.0 0.9 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.4 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 18.7 19.7 21.3 7.0 6.5 3.7 16.0 4.5 5.9 LRTM2 ENSG00000166159 "Leucine rich repeats and transmembrane domains 2" Q8N967 12 1820267-1836752 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "brain: 18.7" "Group enriched" "Detected in some" 8 "HEL: 9.0;SCLC-21H: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA055094, HPA062745" Uncertain Approved Cytosol Cytosol "HPA055094: , HPA062745: " "unprognostic (1.84e-3)" "unprognostic (4.83e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (5.49e-2)" "unprognostic (1.60e-1)" "unprognostic (1.34e-3)" "unprognostic (2.25e-1)" "unprognostic (1.24e-1)" "unprognostic (6.20e-4)" "unprognostic (2.21e-1)" "unprognostic (8.02e-2)" 0.7 0.7 5.1 0.7 12.3 0.7 0.7 0.8 18.7 0.7 0.7 1.7 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 3.3 5.0 0.7 0.7 0.7 0.7 1.7 10.5 0.7 0.7 0.7 0.1 0.7 4.7 0.7 0.7 0.1 0.7 0.8 0.7 0.7 0.7 0.7 1.7 0.7 0.8 0.9 4.3 0.0 0.7 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.3 0.8 18.7 3.3 5.0 1.7 10.5 4.7 4.3 LRTOMT "CFAP111, COMT2, DFNB63, LRRC51" ENSG00000184154 "Leucine rich transmembrane and O-methyltransferase domain containing" "Q8WZ04, Q96E66" 11 72080331-72110782 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Hearing, Neurotransmitter degradation" "Methyltransferase, Transferase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 49.8;testis: 47.8" "Cell line enhanced" "Detected in many" "T-47d: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA039949 Approved Uncertain Microtubules Microtubules "HPA039949: AB_10960708" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (1.85e-2)" "prognostic favourable (7.70e-4)" "unprognostic (8.09e-2)" "unprognostic (9.07e-2)" "unprognostic (1.42e-1)" "unprognostic (1.90e-1)" "unprognostic (4.22e-2)" "prognostic favourable (5.36e-4)" "unprognostic (6.12e-2)" "unprognostic (8.43e-2)" "unprognostic (2.64e-2)" "unprognostic (1.58e-1)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" 3.5 3.7 10.6 2.0 11.1 2.1 7.1 3.7 8.9 7.1 4.2 14.0 6.1 3.2 6.0 13.6 3.5 49.8 5.3 2.6 8.8 7.6 9.0 6.2 6.2 2.6 7.7 8.5 8.5 7.0 7.1 8.9 4.4 10.6 7.5 6.2 7.3 4.3 4.7 5.2 4.5 2.5 4.8 7.7 3.2 3.6 47.8 8.9 3.1 9.3 2.4 3.5 3.5 2.6 4.3 4.2 9.2 2.9 10.1 6.2 2.0 2.6 9.8 6.2 5.0 5.4 4.8 1.5 3.1 2.5 2.8 2.5 4.7 14.3 3.4 4.8 5.3 5.3 4.4 7.5 3.2 6.4 4.3 2.5 4.5 3.3 0.9 2.0 2.7 2.1 3.8 4.3 3.3 1.0 2.7 5.3 4.1 9.4 6.0 4.0 3.1 2.6 7.3 6.3 5.2 11.0 3.2 5.8 4.5 6.1 14.1 7.5 27.8 2.4 4.7 3.0 4.2 8.0 2.1 5.7 6.2 4.0 2.9 1.7 3.3 2.3 2.9 5.0 3.1 2.8 3.2 4.2 3.3 2.6 1.7 4.3 3.0 3.0 9.2 10.1 1.8 4.2 6.2 2.0 10.6 11.1 3.7 8.9 8.8 7.6 7.7 8.5 10.6 8.9 LSAMP "IGLON3, LAMP" ENSG00000185565 "Limbic system-associated membrane protein" Q13449 3 115802363-117139389 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.4" "Cell line enhanced" "Detected in some" "AF22: 6.8;SH-SY5Y: 13.9;WM-115: 33.8" "Cancer enhanced" "Detected in many" "glioma: 13.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054051, HPA076122" Enhanced Cytosol 200000000 Cytosol "HPA054051: , HPA076122: " "unprognostic (4.18e-2)" "unprognostic (2.54e-1)" "unprognostic (9.97e-3)" "unprognostic (6.03e-2)" "unprognostic (9.63e-2)" "unprognostic (4.15e-3)" "unprognostic (6.81e-2)" "unprognostic (2.70e-2)" "unprognostic (5.71e-2)" "unprognostic (6.82e-3)" "unprognostic (1.26e-1)" "unprognostic (6.03e-2)" "unprognostic (1.92e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (5.23e-5)" "unprognostic (1.31e-2)" 2.3 12.7 21.9 4.3 23.7 1.1 1.6 43.4 48.4 17.8 5.5 16.6 0.0 1.9 4.4 2.8 3.4 2.9 11.3 2.1 23.7 18.8 2.5 1.0 8.5 4.0 17.6 21.5 4.8 11.1 0.6 3.1 1.2 18.3 21.1 3.5 1.2 1.7 6.2 0.7 4.6 1.9 3.3 13.1 1.7 3.2 3.9 21.3 0.0 4.2 0.0 5.2 7.3 3.4 1.6 0.4 3.0 0.8 0.3 1.0 0.3 0.2 2.2 6.8 0.2 0.7 2.1 0.7 0.6 0.3 0.2 0.7 0.2 0.4 0.5 0.2 3.5 0.1 0.1 0.1 0.3 0.5 0.1 0.2 0.7 0.3 0.1 0.5 0.3 1.7 0.0 0.8 0.1 0.0 0.3 2.3 0.0 0.2 0.7 0.6 2.6 0.8 0.2 0.1 0.1 1.7 1.6 1.6 13.9 0.0 0.1 2.1 0.2 0.8 0.1 1.5 1.3 1.7 0.4 1.4 1.8 0.2 0.4 0.2 33.8 3.0 0.8 1.4 0.9 0.5 1.0 0.7 0.6 0.5 0.2 1.6 1.0 0.7 2.8 0.3 0.6 0.4 0.5 0.3 21.9 23.7 43.4 23.7 23.7 18.8 17.6 21.5 18.3 21.3 LSMEM1 "C7orf53, FLJ39575" ENSG00000181016 "Leucine rich single-pass membrane protein 1" Q8N8F7 7 112480853-112491062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "skeletal muscle: 51.3;tongue: 19.2" "Cell line enhanced" "Detected in many" "HeLa: 12.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "cerebellum: 3.6" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA013753, HPA047988" Uncertain Enhanced Cytosol Cytosol "HPA013753: AB_1848926, HPA047988: " "unprognostic (6.87e-2)" "unprognostic (5.94e-2)" "unprognostic (2.79e-2)" "unprognostic (2.77e-2)" "unprognostic (1.38e-1)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (6.68e-2)" "unprognostic (3.54e-2)" "unprognostic (2.80e-3)" "unprognostic (1.47e-6)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (4.25e-2)" "unprognostic (3.42e-2)" 1.1 0.7 0.6 0.6 0.6 0.8 0.9 3.6 0.7 0.6 0.6 0.6 0.6 1.3 0.6 1.7 0.7 0.4 0.6 2.1 0.7 0.8 1.4 3.5 1.8 0.6 0.7 0.6 0.6 2.8 0.3 0.9 0.6 0.6 0.9 0.8 0.6 1.9 0.6 51.3 0.8 0.8 0.6 0.6 1.9 0.8 1.1 0.6 0.6 0.9 19.2 1.5 0.6 0.6 0.0 0.1 2.7 0.1 0.0 0.2 2.2 0.8 1.3 0.7 2.8 2.8 3.1 0.1 1.3 0.9 0.6 0.5 2.2 1.8 1.2 1.9 0.3 0.7 0.8 0.9 1.2 0.6 0.8 0.8 12.3 2.2 1.3 1.2 0.6 2.2 3.7 0.8 0.8 0.7 0.9 2.8 0.4 1.0 1.0 3.6 0.6 0.9 0.4 0.2 0.6 2.4 1.4 2.6 1.4 2.2 1.1 1.5 0.4 0.5 0.5 2.8 1.0 0.8 1.0 0.8 1.7 1.1 0.8 0.8 0.8 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 2.2 0.6 0.6 3.6 0.7 0.7 0.8 0.7 0.6 0.6 0.6 LSR "ILDR3, LISCH7" ENSG00000105699 "Lipolysis stimulated lipoprotein receptor" Q86X29 19 35248330-35267964 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 106.3;pancreas: 98.6" "Cell line enhanced" "Detected in many" "A-431: 89.3;CACO-2: 39.1;CAPAN-2: 41.6;HaCaT: 37.5;RT4: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007270 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 2100000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA007270: AB_1079253" "unprognostic (3.90e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (2.67e-3)" "unprognostic (2.28e-2)" "unprognostic (6.07e-3)" "unprognostic (1.55e-1)" "unprognostic (9.84e-2)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (3.42e-2)" "prognostic favourable (8.09e-4)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-2)" "unprognostic (1.54e-2)" 5.0 11.2 2.9 20.9 4.0 0.9 12.4 2.0 4.5 8.7 32.8 4.0 24.4 29.5 6.5 21.4 20.3 10.6 58.2 2.6 3.4 3.1 15.7 106.3 21.1 17.0 4.1 2.6 4.8 98.6 6.2 13.4 36.6 7.1 11.2 15.4 40.9 26.2 33.8 1.9 16.8 39.5 1.8 3.8 9.1 46.7 21.0 1.9 3.4 24.0 20.1 20.9 9.9 9.5 5.3 0.3 5.9 0.2 6.1 7.1 3.2 89.3 1.5 0.1 0.2 0.2 0.1 16.2 0.2 0.3 0.4 0.3 39.1 41.6 3.5 13.8 0.2 37.5 8.3 13.7 0.0 5.4 15.1 0.0 1.2 17.3 0.3 0.0 0.1 0.2 15.3 0.3 4.5 0.1 14.1 3.2 0.2 31.7 0.1 0.1 12.8 0.5 0.7 0.1 9.7 8.6 36.2 7.1 0.2 7.5 24.4 6.7 20.9 0.5 0.0 0.7 8.6 0.5 0.4 5.1 9.0 8.1 0.6 0.1 2.2 5.9 0.2 0.2 3.3 0.0 3.3 5.3 7.1 6.7 0.1 4.1 5.5 6.0 0.1 6.1 0.0 0.3 4.8 3.2 2.9 4.0 2.0 4.5 3.4 3.1 4.1 2.6 7.1 1.9 LTBR "D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3" ENSG00000111321 "Lymphotoxin beta receptor" P36941 12 6375045-6391571 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 24.6;intermediate monocyte: 22.9;myeloid DC: 17.6;neutrophil: 15.8;non-classical monocyte: 16.4" "Group enriched" "Detected in many" 32 "dendritic cells: 17.6;granulocytes: 15.8;monocytes: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026202, HPA061617" Uncertain Supported "Golgi apparatus" "Golgi apparatus" "CAB026202: , HPA061617: " "unprognostic (2.60e-2)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.23e-2)" "unprognostic (3.01e-2)" "unprognostic (3.24e-3)" "prognostic unfavourable (5.13e-4)" "unprognostic (2.08e-2)" "unprognostic (2.24e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-3)" "unprognostic (1.91e-1)" "prognostic unfavourable (5.92e-4)" "unprognostic (3.66e-2)" "unprognostic (9.84e-3)" "unprognostic (6.91e-2)" "unprognostic (2.86e-1)" 32.7 24.8 6.0 13.6 8.1 3.6 77.6 2.7 4.8 25.0 25.1 4.9 31.3 18.9 26.7 19.5 34.9 18.1 29.8 15.2 9.5 3.3 39.4 85.2 38.7 21.7 8.1 2.6 28.3 79.8 18.1 10.6 27.0 8.4 31.3 13.7 16.9 31.3 27.0 19.1 25.2 43.6 28.2 12.5 23.3 24.5 14.3 5.7 4.2 45.8 33.6 19.1 27.0 23.0 0.0 17.6 15.8 24.6 0.6 0.1 8.0 17.4 23.6 0.0 7.6 46.9 35.3 16.3 12.1 28.2 18.5 19.1 10.8 27.2 0.0 7.4 26.4 20.2 0.0 25.6 7.3 0.0 0.0 10.3 9.7 6.1 75.2 0.7 17.4 51.7 47.5 13.1 37.1 16.8 9.8 0.1 21.1 16.2 0.0 4.9 0.2 13.0 0.0 1.2 0.0 27.5 20.1 0.1 0.1 11.4 22.7 25.5 3.8 18.9 10.4 6.5 7.4 23.9 12.9 0.0 0.0 0.0 2.7 6.4 23.8 1.4 24.6 0.1 0.0 22.9 0.0 0.0 0.0 0.0 17.6 0.0 0.1 0.1 15.8 0.6 16.4 4.2 0.0 8.0 6.0 8.1 2.7 4.8 9.5 3.3 8.1 2.6 8.4 5.7 LTC4S MGC33147 ENSG00000213316 "Leukotriene C4 synthase" Q16873 5 179793980-179796647 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Leukotriene biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.3" "Cell line enriched" "Detected in some" 10 "HMC-1: 50.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 8.5;eosinophil: 31.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 31.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044688 Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" Nucleoplasm "Endoplasmic reticulum, Cytosol" "HPA044688: " "unprognostic (8.94e-2)" "unprognostic (2.40e-2)" "unprognostic (9.35e-3)" "unprognostic (3.57e-2)" "unprognostic (1.24e-2)" "unprognostic (9.40e-2)" "unprognostic (4.53e-5)" "unprognostic (2.27e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (2.65e-1)" "unprognostic (1.98e-2)" "unprognostic (4.62e-1)" 9.0 6.7 3.5 2.8 3.5 8.6 4.6 1.7 5.0 6.9 5.0 9.4 5.4 3.6 8.7 10.4 4.2 13.0 15.7 11.3 3.9 3.1 6.2 2.3 28.3 8.0 6.8 4.2 5.8 2.4 2.0 3.2 2.9 4.3 5.6 1.9 3.3 7.4 11.6 2.7 3.5 5.7 4.5 6.3 6.7 5.0 3.3 3.9 0.8 5.3 5.6 3.2 3.6 3.9 0.1 4.5 31.3 0.3 2.2 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 5.1 0.0 0.2 0.2 0.3 50.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 8.5 0.2 31.3 0.5 0.3 1.7 0.1 1.2 0.8 4.5 0.1 0.2 0.5 0.1 2.2 0.0 0.2 0.1 0.3 3.5 3.5 1.7 5.0 3.9 3.1 6.8 4.2 4.3 3.9 LTK TYK1 ENSG00000062524 "Leukocyte receptor tyrosine kinase" P29376 15 41503638-41513887 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.1" "Cell line enhanced" "Detected in some" "HEL: 5.3;NB-4: 10.3;RH-30: 5.0;THP-1: 15.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "MAIT T-cell: 8.3;plasmacytoid DC: 7.0" "Group enriched" "Detected in many" 10 "dendritic cells: 7.0;T-cells: 8.3" "Low region specificity" "Detected in many" HPA059545 Uncertain Approved Vesicles Vesicles "HPA059545: " "unprognostic (9.47e-4)" "unprognostic (5.52e-4)" "unprognostic (1.51e-1)" "unprognostic (2.49e-1)" "unprognostic (4.12e-1)" "unprognostic (5.65e-3)" "unprognostic (1.74e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.81e-3)" "unprognostic (9.36e-3)" "unprognostic (5.36e-2)" "unprognostic (4.68e-2)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" 1.0 0.5 0.5 5.1 1.6 3.1 0.5 2.0 3.2 0.6 8.2 0.5 1.9 10.6 1.3 1.1 1.2 0.3 2.0 2.2 0.5 0.1 3.5 4.3 15.1 0.6 0.5 0.5 1.0 0.5 1.0 0.7 8.9 0.5 0.7 4.8 4.3 11.7 0.5 2.0 0.9 10.7 0.5 0.5 5.5 8.3 2.4 0.8 0.5 0.7 0.5 2.2 0.6 0.7 0.7 7.0 0.0 0.0 0.0 8.3 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.6 0.9 1.3 2.4 0.0 0.0 0.1 0.7 0.0 2.9 0.0 0.4 0.2 1.4 5.3 0.0 0.0 2.3 0.0 0.0 0.4 0.4 0.0 0.1 0.0 2.0 0.0 2.0 0.0 0.0 10.3 0.4 0.2 0.2 5.0 0.1 0.0 0.0 0.5 3.3 0.1 0.2 0.0 0.2 15.8 0.0 0.0 0.2 0.2 0.0 0.4 0.2 0.2 0.0 0.5 0.9 0.0 0.0 0.0 0.6 0.0 8.3 0.7 0.5 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 7.0 0.0 0.2 0.5 1.6 2.0 3.2 0.5 0.1 0.5 0.5 0.5 0.8 LY6D E48 ENSG00000167656 "Lymphocyte antigen 6 family member D" Q14210 8 142784880-142786592 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 236.9;skin 1: 111.6;tongue: 316.2" "Cell line enriched" "Detected in some" 20 "A-431: 55.8" "Group enriched" "Detected in many" 7 "cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA024755, HPA064317" Enhanced 92000 "HPA024755: AB_1853410, HPA064317: AB_2685244" "unprognostic (2.13e-2)" "unprognostic (7.48e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-2)" "unprognostic (8.97e-2)" "unprognostic (1.51e-2)" "unprognostic (3.84e-1)" "unprognostic (5.11e-2)" "prognostic unfavourable (1.94e-6)" "unprognostic (8.68e-2)" "prognostic unfavourable (1.20e-4)" "unprognostic (2.50e-1)" "unprognostic (3.97e-1)" "unprognostic (5.40e-4)" "unprognostic (1.06e-1)" 0.2 3.7 0.2 0.2 0.2 0.1 3.7 0.2 0.2 23.0 0.2 0.2 0.2 0.1 2.1 0.2 236.9 0.1 0.5 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 1.3 0.2 1.2 0.1 0.2 18.1 0.2 0.4 111.6 0.2 0.9 0.2 0.2 2.0 0.2 0.2 0.9 0.2 316.2 61.8 6.3 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 1.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 LY6G5C "C6orf20, G5c, NG33" ENSG00000204428 "Lymphocyte antigen 6 family member G5C" Q5SRR4 6 31676684-31684040 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6" "Cell line enhanced" "Detected in some" "ASC diff: 3.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038690 Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" Nucleoplasm Cytosol "HPA038690: AB_10673286" "unprognostic (1.51e-2)" "unprognostic (7.26e-2)" "unprognostic (7.19e-2)" "prognostic favourable (1.07e-4)" "unprognostic (4.83e-1)" "unprognostic (6.91e-2)" "unprognostic (1.33e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-2)" "unprognostic (5.63e-2)" "unprognostic (3.74e-5)" "unprognostic (5.84e-2)" "unprognostic (3.78e-4)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.88e-2)" "unprognostic (1.39e-2)" 0.4 0.0 0.5 2.1 2.5 1.1 0.3 4.6 3.8 0.0 0.0 0.2 0.3 0.4 0.0 0.5 2.0 0.8 0.4 0.7 0.0 0.9 0.5 1.2 0.3 0.4 2.5 0.0 1.0 0.4 0.1 0.0 0.2 0.0 1.3 0.3 0.3 0.0 0.4 0.8 1.2 2.1 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.4 2.1 3.1 0.1 0.1 0.1 0.3 0.3 0.8 0.0 2.4 1.5 0.1 0.1 0.6 0.0 0.0 0.9 2.7 1.4 1.1 0.0 0.5 0.0 0.3 1.2 0.0 0.0 0.7 1.7 0.0 0.0 1.5 0.1 0.0 2.3 0.4 0.1 0.0 1.0 0.4 0.8 0.1 0.5 0.3 0.2 0.9 0.0 0.5 0.1 1.8 0.0 0.2 1.0 1.8 0.1 0.4 0.5 0.5 2.3 1.5 0.6 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 LY6G6D "C6orf23, G6D, Ly6-D, MEGT1, NG25" ENSG00000244355 "Lymphocyte antigen 6 family member G6D" O95868 6 31715356-31717804 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "seminal vesicle: 7.4;skin 1: 21.4" "Cell line enriched" "Detected in some" 4 "HEL: 6.1" "Cancer enriched" "Detected in some" 22 "colorectal cancer: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 6.8" HPA054412 Uncertain "Intracellular and membrane" "HPA054412: " "unprognostic (5.48e-2)" "unprognostic (1.25e-1)" "unprognostic (2.81e-2)" "unprognostic (2.13e-1)" 0.6 0.2 0.1 0.0 0.7 0.2 0.1 0.0 0.6 5.1 2.7 0.3 1.7 0.1 0.5 0.0 0.3 0.2 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.4 5.6 0.6 0.3 0.3 7.4 0.1 21.4 0.0 1.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.2 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 6.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.7 0.0 0.6 0.5 0.0 0.1 0.0 0.4 0.0 LY6G6F "C6orf21, G6f, LY6G6D, NG32" ENSG00000204424 "Lymphocyte antigen 6 family member G6F" Q5SQ64 6 31706885-31710595 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.0;bone marrow: 4.0;lung: 3.3;lymphoid tissue: 4.3" "Cell line enriched" "Detected in single" 138 "HEL: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" HPA008053 Uncertain 12000000 "HPA008053: AB_1840160" "unprognostic (3.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.66e-3)" 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 1.1 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 4.3 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 LY6K "CT97, FLJ35226, HSJ001348" ENSG00000160886 "Lymphocyte antigen 6 family member K" Q17RY6 8 142700111-142705127 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.3" "Cell line enhanced" "Detected in many" "A-431: 28.2;BJ: 30.6;HeLa: 33.3;SiHa: 47.9;U-2197: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "neutrophil: 5.3" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.3" "HPA017770, CAB075742, CAB075743" Enhanced Supported "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" "Plasma membrane" Nucleoplasm "CAB075742: , CAB075743: , HPA017770: AB_1853414" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (1.48e-1)" "unprognostic (7.23e-3)" "unprognostic (3.47e-2)" "unprognostic (2.39e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (9.17e-5)" "unprognostic (4.18e-2)" "unprognostic (6.89e-2)" "unprognostic (9.75e-2)" "unprognostic (1.40e-1)" "unprognostic (5.27e-5)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.61e-2)" 6.6 0.4 1.4 0.3 1.8 0.4 7.6 0.9 3.8 1.8 1.6 0.1 9.8 0.5 0.7 0.8 10.9 0.8 1.2 1.2 1.5 1.9 2.0 0.2 0.6 1.9 1.7 0.0 0.7 0.4 0.0 0.3 6.3 1.0 1.1 0.1 0.1 1.4 7.0 6.3 4.3 0.2 0.6 1.1 0.3 0.4 39.3 0.2 0.2 1.1 4.5 6.8 1.0 3.2 0.1 0.1 5.3 0.2 0.4 0.2 0.0 28.2 0.5 0.0 1.5 0.6 1.9 0.3 30.6 3.6 9.5 5.7 0.0 0.2 0.0 2.6 3.4 2.5 0.0 1.7 8.0 0.3 0.0 0.0 33.3 0.0 0.4 0.0 0.0 2.8 5.0 7.0 9.1 0.8 0.0 0.1 17.8 0.2 0.0 0.0 1.0 0.4 0.0 0.1 0.0 1.5 0.3 0.8 0.1 47.9 0.6 9.3 0.1 0.0 1.2 0.4 2.8 64.7 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.5 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 5.3 0.4 0.1 0.1 0.0 0.0 1.4 1.8 0.9 1.7 1.5 1.9 1.7 0.0 1.0 0.2 LY75 "CD205, CLEC13B, DEC-205" ENSG00000054219 "Lymphocyte antigen 75" O60449 2 159803355-159904749 "CD markers, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 28.8;lymphoid tissue: 61.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.3;HDLM-2: 9.7;Karpas-707: 41.3;RT4: 14.0;THP-1: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB001450, HPA049108, HPA054073" Enhanced Approved "Golgi apparatus" 960000 "Golgi apparatus" "CAB001450: AB_563525, HPA049108: , HPA054073: " "unprognostic (7.29e-3)" "unprognostic (1.92e-3)" "unprognostic (3.15e-1)" "unprognostic (1.52e-2)" "unprognostic (4.60e-3)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (6.24e-2)" "unprognostic (2.80e-1)" "unprognostic (2.36e-1)" "unprognostic (8.74e-3)" "unprognostic (3.92e-1)" "prognostic unfavourable (2.39e-5)" "unprognostic (2.66e-1)" "unprognostic (4.89e-2)" "unprognostic (1.94e-2)" "prognostic favourable (3.86e-4)" 3.5 1.8 1.9 21.4 2.6 4.9 6.1 1.2 1.8 4.5 9.3 2.0 1.0 10.8 2.1 1.9 4.5 5.0 10.7 2.8 1.8 1.7 2.8 1.2 10.3 33.9 2.5 1.1 1.6 2.3 0.2 1.9 0.8 2.4 2.0 7.2 1.3 7.2 1.3 0.8 6.5 28.8 1.3 3.4 17.2 3.8 1.1 3.0 61.9 10.7 3.6 17.1 6.9 3.8 5.8 4.3 5.9 2.6 7.5 8.0 2.3 1.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 10.3 7.1 0.3 0.0 0.2 0.0 0.0 0.0 9.7 0.0 2.0 0.0 0.0 0.2 1.6 0.0 0.1 0.0 0.2 0.1 5.3 0.0 41.3 0.0 0.0 0.0 2.6 0.2 0.0 2.7 0.0 1.7 3.1 14.0 0.0 0.0 3.3 2.4 0.0 0.0 10.4 7.9 0.0 0.0 0.0 0.0 6.3 1.0 1.4 0.0 3.6 0.0 3.4 2.0 3.5 6.5 2.6 7.1 5.8 5.9 7.5 4.3 4.5 6.7 8.0 5.9 7.5 1.0 1.5 4.3 2.3 1.9 2.6 1.2 1.8 1.8 1.7 2.5 1.1 2.4 3.0 LY75-CD302 ENSG00000248672 "LY75-CD302 readthrough" 2 159771851-159904710 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 17.0;lymphoid tissue: 37.5" "Cell line enhanced" "Detected in some" "CACO-2: 5.6;HDLM-2: 5.8;Karpas-707: 22.2;RT4: 9.4;TIME: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA049108 Uncertain "HPA049108: " "unprognostic (2.53e-1)" "unprognostic (1.55e-1)" "unprognostic (2.33e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-2)" "unprognostic (1.68e-4)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (3.32e-1)" "unprognostic (4.47e-2)" "unprognostic (1.88e-1)" 1.1 1.2 0.9 12.5 1.0 5.9 2.1 1.0 1.0 1.1 5.0 0.5 0.0 4.5 0.9 0.4 1.3 1.1 5.8 1.1 1.0 1.1 1.0 1.0 5.6 20.2 0.9 0.0 1.0 1.1 0.0 1.0 0.4 0.7 1.0 3.6 0.0 2.7 0.0 1.0 1.3 17.0 0.2 1.2 9.9 1.1 1.0 1.1 37.5 4.6 1.5 9.8 1.5 1.2 1.7 10.0 6.9 4.2 0.9 2.7 3.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 5.6 2.6 0.7 0.2 0.1 0.0 0.0 0.0 0.0 5.8 0.0 3.3 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.3 0.0 2.6 0.0 22.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 9.4 0.0 0.0 2.4 0.5 0.0 0.0 0.7 5.3 0.0 0.0 0.0 0.0 1.9 0.4 0.7 0.0 1.3 0.0 3.0 3.7 4.4 1.7 4.2 2.7 1.5 1.6 2.0 10.0 1.7 1.9 1.4 6.9 0.9 1.8 2.0 1.8 3.1 0.9 1.0 1.0 1.0 1.0 1.1 0.9 0.0 0.7 1.1 LY9 "CD229, hly9, mLY9, SLAMF3" ENSG00000122224 "Lymphocyte antigen 9" Q9HBG7 1 160796074-160828261 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 30.8;intestine: 11.3;lymphoid tissue: 43.7;urinary bladder: 28.6" "Cell line enhanced" "Detected in some" "Daudi: 7.2;Karpas-707: 14.6;U-266/70: 37.2;U-266/84: 14.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 30.6;MAIT T-cell: 30.7;memory B-cell: 15.2;memory CD4 T-cell: 26.8;memory CD8 T-cell: 29.6;naive B-cell: 13.9;naive CD4 T-cell: 30.5;naive CD8 T-cell: 30.8;plasmacytoid DC: 18.6;T-reg: 19.7" "Group enriched" "Detected in many" 4 "B-cells: 15.2;dendritic cells: 18.6;T-cells: 30.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA050917 Approved 23000 "HPA050917: " "unprognostic (8.04e-4)" "unprognostic (2.31e-5)" "unprognostic (8.08e-3)" "unprognostic (1.20e-3)" "unprognostic (9.83e-3)" "unprognostic (1.87e-5)" "unprognostic (1.16e-2)" "unprognostic (3.84e-3)" "unprognostic (1.23e-2)" "unprognostic (2.89e-3)" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (2.70e-3)" "unprognostic (8.69e-2)" "unprognostic (9.47e-2)" "unprognostic (3.49e-2)" "unprognostic (6.88e-2)" 2.8 0.5 0.4 20.9 0.4 6.9 2.7 0.4 0.4 1.4 3.7 0.2 0.4 2.4 0.9 0.8 3.5 1.0 2.0 0.9 0.4 0.4 1.7 1.3 6.1 35.3 0.4 0.0 1.1 0.5 0.0 0.5 0.2 0.1 1.0 2.3 1.0 6.5 0.4 0.4 0.8 11.3 0.1 0.7 25.3 3.4 1.1 0.0 35.7 1.6 1.8 43.7 28.6 1.2 15.2 18.6 0.6 0.2 5.2 30.8 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 1.1 0.2 0.0 0.0 0.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 37.2 14.3 0.1 0.0 2.0 0.0 0.2 0.2 0.1 30.6 0.2 30.7 15.2 26.8 29.6 1.3 13.9 30.5 30.8 0.6 5.2 0.2 18.6 19.7 12.9 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.1 0.0 LYPD3 C4.4A ENSG00000124466 "LY6/PLAUR domain containing 3" O95274 19 43460787-43465660 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 110.5;lymphoid tissue: 75.2;skin 1: 86.4;tongue: 70.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.5;HaCaT: 29.4;MCF7: 32.8;RT4: 31.5;SK-BR-3: 47.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 235.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.9" "Group enriched" "Detected in many" 10 "dendritic cells: 3.5;granulocytes: 3.0;T-cells: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041529, HPA041797, HPA077859" Enhanced Approved "Endoplasmic reticulum,Vesicles" 9700000 "Endoplasmic reticulum, Vesicles" "HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: " "unprognostic (1.07e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (2.80e-1)" "unprognostic (2.67e-2)" "unprognostic (4.90e-3)" "prognostic unfavourable (7.86e-5)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (1.07e-3)" "unprognostic (5.13e-2)" "unprognostic (8.79e-2)" "unprognostic (1.11e-1)" "unprognostic (2.96e-3)" 0.3 0.4 0.3 0.4 0.3 0.8 5.8 0.3 0.3 28.0 0.3 0.3 0.3 0.0 2.1 0.7 110.5 0.5 0.3 0.3 0.3 0.0 0.4 0.3 0.3 0.3 0.3 0.3 0.8 0.3 0.0 0.3 7.4 0.3 1.4 0.0 0.5 21.7 0.3 0.6 86.4 0.4 0.8 0.3 0.3 0.1 0.3 0.3 1.9 0.3 70.6 75.2 4.1 48.3 0.2 3.5 3.0 0.4 0.1 7.9 1.9 11.0 0.1 0.0 0.2 0.1 0.0 4.6 0.4 1.1 0.4 0.5 0.1 12.5 0.0 0.5 0.3 29.4 0.0 1.3 0.2 0.0 0.0 0.2 1.5 0.2 0.1 0.0 0.2 0.5 11.1 0.0 0.1 0.0 0.0 0.0 0.0 32.8 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.3 31.5 0.0 0.0 0.1 47.3 0.5 5.2 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 1.6 0.2 4.2 1.6 3.5 0.0 7.9 6.7 3.0 0.1 0.0 0.4 1.2 1.9 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 LYPD5 FLJ30469 ENSG00000159871 "LY6/PLAUR domain containing 5" Q6UWN5 19 43795929-43827206 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "placenta: 39.6;skin 1: 39.8;tongue: 34.7" "Cell line enhanced" "Detected in some" "A-431: 5.8;BEWO: 9.0;HaCaT: 9.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Group enriched" "Detected in many" 4 "monocytes: 3.8;T-cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042511, HPA054670" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042511: AB_10794279, HPA054670: " "unprognostic (4.27e-3)" "prognostic favourable (5.84e-4)" "unprognostic (4.63e-2)" "unprognostic (8.42e-3)" "unprognostic (4.80e-2)" "unprognostic (2.91e-3)" "unprognostic (3.96e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-3)" "unprognostic (1.19e-1)" "unprognostic (1.83e-3)" "unprognostic (8.30e-2)" "unprognostic (2.02e-1)" "unprognostic (7.53e-3)" "unprognostic (4.08e-2)" 1.5 1.2 3.4 2.1 7.9 0.7 4.2 2.4 8.8 5.7 1.4 3.5 0.5 1.2 1.3 2.4 7.8 1.6 1.9 1.3 3.9 4.8 0.9 1.0 3.4 1.4 4.5 4.0 0.8 0.9 1.1 1.4 39.6 9.3 1.3 1.5 0.7 2.1 1.5 0.7 39.8 1.1 1.9 3.3 5.9 1.3 7.4 2.7 0.6 1.4 34.7 3.4 2.4 5.4 0.4 0.0 0.5 3.8 0.0 1.2 0.5 5.8 0.0 0.3 0.0 0.1 0.0 9.0 0.4 0.0 0.8 1.0 0.6 2.0 0.3 1.1 0.7 9.3 0.0 1.0 0.5 1.0 0.0 0.2 0.6 0.0 2.5 0.1 0.1 2.8 2.6 0.4 1.1 0.3 0.1 0.3 0.0 0.3 0.2 0.1 0.6 1.9 0.0 0.1 0.1 0.6 0.9 0.7 0.2 1.2 1.4 0.0 0.6 0.2 0.8 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.0 1.2 0.0 0.0 3.8 0.3 0.0 0.8 0.1 0.0 0.4 0.4 1.2 0.5 0.0 1.4 0.0 0.0 0.5 3.4 7.9 2.4 8.8 3.9 4.8 4.5 4.0 9.3 2.7 LYPLA1 LPL1 ENSG00000120992 "Lysophospholipase I" O75608 8 54046367-54102017 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050941, HPA063151" Enhanced Approved Nucleoplasm,Cytosol 1700000 "Nucleoplasm, Cytosol" "HPA050941: , HPA063151: " "unprognostic (2.62e-2)" "unprognostic (1.28e-2)" "unprognostic (3.25e-3)" "unprognostic (9.42e-2)" "unprognostic (9.48e-2)" "unprognostic (3.56e-1)" "unprognostic (9.58e-2)" "unprognostic (2.05e-2)" "unprognostic (6.52e-3)" "unprognostic (3.76e-2)" "prognostic unfavourable (2.34e-4)" "unprognostic (2.58e-1)" "unprognostic (2.15e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (2.56e-3)" 14.1 17.7 7.2 12.2 8.9 13.4 16.4 10.8 15.2 10.7 14.6 6.9 4.7 15.4 8.0 11.1 30.4 8.0 11.9 27.1 6.8 6.8 31.1 37.3 13.6 23.4 7.3 4.9 12.3 24.3 9.0 7.4 51.1 12.0 15.3 15.2 17.0 23.3 7.1 26.4 22.1 17.6 10.4 6.3 14.0 14.9 64.8 4.1 21.3 13.3 19.3 19.7 24.6 17.3 29.1 37.1 42.7 40.4 27.1 29.2 35.1 30.3 17.2 22.4 20.1 8.1 13.3 28.3 18.2 10.5 16.8 15.9 12.4 29.5 53.3 21.3 11.8 20.4 31.5 30.3 23.6 19.3 17.2 37.1 11.0 19.9 13.4 22.7 50.3 11.6 26.7 13.1 29.5 43.6 37.6 16.2 23.4 8.0 34.5 17.3 33.3 7.9 20.9 11.8 24.4 26.0 41.2 11.8 20.1 12.8 23.9 27.9 34.9 20.3 20.9 10.2 14.9 17.6 16.8 22.6 34.0 48.1 13.8 24.1 19.9 31.4 33.1 42.7 19.1 31.1 19.0 29.1 18.2 18.4 37.1 23.9 18.4 17.8 19.5 27.1 40.4 23.8 29.2 35.1 7.2 8.9 10.8 15.2 6.8 6.8 7.3 4.9 12.0 4.1 LYSMD3 FLJ13542 ENSG00000176018 "LysM domain containing 3" Q7Z3D4 5 90515611-90529584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018024 Approved Approved Cytosol Cytosol "HPA018024: AB_2138525" "unprognostic (4.50e-2)" "unprognostic (1.85e-2)" "prognostic favourable (3.83e-4)" "unprognostic (5.59e-2)" "unprognostic (5.61e-2)" "unprognostic (9.80e-3)" "unprognostic (3.99e-2)" "unprognostic (4.66e-2)" "unprognostic (6.23e-2)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (2.02e-1)" "prognostic favourable (9.25e-4)" "unprognostic (1.81e-1)" "unprognostic (8.48e-2)" "unprognostic (4.97e-3)" "unprognostic (9.46e-2)" 12.7 14.0 8.9 11.1 10.5 9.3 11.1 16.0 11.2 15.8 14.1 4.7 16.2 11.8 13.1 9.3 12.0 11.2 12.8 15.7 10.2 8.9 21.1 33.6 15.6 12.9 11.9 6.1 19.1 13.1 24.5 31.1 19.0 12.2 12.9 10.8 7.3 13.3 21.2 16.6 6.4 17.4 10.5 12.1 14.6 9.5 6.6 12.7 18.5 18.8 9.0 11.4 15.4 12.5 6.4 7.3 27.7 9.4 11.9 10.4 7.4 10.3 7.0 9.0 9.5 14.0 14.4 8.9 16.6 18.2 11.6 19.1 5.9 10.7 12.9 7.2 14.6 5.3 13.8 16.3 22.8 9.4 8.7 9.8 8.7 9.6 14.6 8.1 16.6 10.5 11.5 10.6 17.8 16.6 9.3 19.7 12.9 9.2 9.4 4.7 4.5 11.9 8.8 15.2 18.5 12.7 7.1 2.7 5.5 9.8 7.5 13.5 8.6 7.7 20.6 7.0 10.0 15.4 12.0 22.5 14.2 11.0 11.9 14.0 10.9 27.7 7.7 11.6 6.5 9.4 10.4 6.4 7.5 7.9 7.3 5.4 10.3 8.8 11.5 11.9 9.3 3.5 8.1 7.4 8.9 10.5 16.0 11.2 10.2 8.9 11.9 6.1 12.2 12.7 LYSMD4 FLJ33008 ENSG00000183060 "LysM domain containing 4" Q5XG99 15 99715697-99733561 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029152, HPA059824" Approved Approved "Actin filaments,Cytosol" "Actin filaments" Cytosol "HPA029152: AB_10602033, HPA059824: " "unprognostic (2.43e-3)" "unprognostic (1.30e-2)" "unprognostic (1.53e-1)" "unprognostic (2.81e-1)" "unprognostic (4.07e-3)" "unprognostic (3.80e-2)" "unprognostic (1.53e-3)" "unprognostic (3.75e-1)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (6.35e-3)" "unprognostic (9.77e-2)" "unprognostic (1.02e-2)" "unprognostic (2.06e-1)" "unprognostic (9.23e-2)" "unprognostic (3.29e-2)" "unprognostic (3.30e-1)" 8.8 4.7 5.8 11.6 8.7 4.7 11.1 8.6 14.1 9.5 6.4 7.8 3.6 8.1 9.3 11.4 11.4 5.5 8.3 9.2 7.1 5.6 4.7 6.6 7.0 3.9 4.7 5.7 7.8 6.5 14.9 5.4 5.0 6.7 6.3 5.9 8.3 15.9 7.7 12.3 25.2 6.5 6.9 7.9 4.5 5.6 6.8 6.3 5.4 4.1 11.1 6.3 4.6 8.4 3.1 4.8 8.0 4.0 1.0 6.2 3.4 3.8 3.7 7.6 4.4 8.5 7.7 4.5 4.5 3.1 3.9 5.7 9.2 3.5 4.3 2.7 4.1 11.5 5.9 7.2 4.5 0.9 10.6 2.8 7.5 6.3 4.9 2.0 5.4 4.4 10.7 3.5 4.2 5.2 6.8 5.5 2.5 4.6 5.3 5.6 5.0 4.2 3.7 5.4 2.1 6.9 10.2 4.4 3.9 8.2 2.5 4.3 1.7 3.9 6.6 3.2 8.7 4.3 1.8 7.4 9.8 3.5 4.1 5.0 3.4 0.0 2.0 8.0 3.8 3.3 2.9 1.8 5.2 4.5 1.1 3.1 6.2 2.8 0.7 1.0 4.0 4.8 5.0 3.4 5.8 8.7 8.6 14.1 7.1 5.6 4.7 5.7 6.7 6.3 LYVE1 "LYVE-1, XLKD1" ENSG00000133800 "Lymphatic vessel endothelial hyaluronan receptor 1" Q9Y5Y7 11 10556966-10611689 "Plasma proteins, Predicted membrane proteins" Transport Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 87.6" "Cell line enriched" "Detected in some" 12 "HUVEC TERT2: 42.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.0;neutrophil: 1.7" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB025860, HPA042953" Supported 3000000000 "CAB025860: , HPA042953: " "unprognostic (9.83e-2)" "unprognostic (1.52e-1)" "unprognostic (1.87e-1)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "unprognostic (1.94e-1)" "unprognostic (7.80e-2)" "prognostic unfavourable (1.07e-4)" "unprognostic (7.53e-2)" "unprognostic (4.09e-2)" "prognostic unfavourable (6.98e-5)" "unprognostic (1.67e-2)" "unprognostic (2.51e-1)" "unprognostic (1.07e-1)" "unprognostic (2.43e-3)" 51.8 28.6 3.3 7.4 4.2 0.4 23.0 2.8 2.8 7.9 26.4 2.4 2.9 5.3 5.3 20.8 17.7 17.2 8.0 19.8 3.8 2.0 18.0 31.1 15.7 47.7 3.2 1.6 11.0 5.4 1.6 3.6 56.6 6.2 15.2 8.0 6.0 4.8 4.7 15.4 5.1 17.8 25.5 2.9 87.6 8.4 11.9 2.5 0.0 21.4 9.1 2.7 25.9 10.9 0.7 0.0 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 42.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 4.2 2.8 1.8 3.8 2.0 3.2 1.6 6.2 2.5 M6PR "CD-M6PR, CD-MPR" ENSG00000003056 "Mannose-6-phosphate receptor, cation dependent" P20645 12 8940363-8949955 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 127.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034464, HPA040445" Approved 280000 "CAB034464: AB_2139108, HPA040445: " "unprognostic (2.43e-1)" "unprognostic (1.22e-1)" "unprognostic (1.74e-2)" "unprognostic (1.54e-1)" "unprognostic (3.00e-1)" "unprognostic (1.89e-2)" "prognostic unfavourable (3.89e-4)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "unprognostic (5.82e-3)" "unprognostic (1.44e-2)" "unprognostic (6.82e-2)" "unprognostic (4.53e-3)" "unprognostic (3.79e-2)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (3.98e-1)" 37.9 40.5 24.7 40.7 27.6 34.8 32.3 21.8 39.6 25.6 28.3 26.3 27.9 20.8 37.4 26.2 30.0 29.2 28.0 36.5 23.3 22.8 37.2 50.6 42.8 46.8 27.4 23.0 30.1 40.0 31.3 24.8 34.0 24.2 27.8 35.2 26.1 37.0 29.4 32.3 27.7 36.9 31.7 26.5 56.1 31.6 33.9 25.2 43.1 46.9 24.4 44.8 34.3 27.2 17.6 47.4 75.4 74.6 22.1 30.4 57.5 14.7 23.0 15.4 17.3 27.2 13.1 46.4 19.4 22.5 26.7 29.4 24.5 35.9 25.7 7.1 20.4 22.3 21.8 19.3 30.8 127.8 12.0 45.0 19.3 18.3 32.3 48.8 85.4 19.7 23.0 28.6 36.2 14.5 12.7 17.1 23.1 14.4 17.5 16.3 53.6 9.8 16.9 33.9 14.2 20.6 37.3 3.5 15.8 21.4 20.3 25.6 5.1 31.3 14.6 22.1 26.4 26.5 28.4 21.6 37.7 29.4 25.6 29.8 16.1 75.4 40.3 42.9 26.9 64.5 29.7 17.6 30.4 28.0 47.4 14.5 22.5 25.4 5.9 22.1 74.6 28.2 23.9 57.5 24.7 27.6 21.8 39.6 23.3 22.8 27.4 23.0 24.2 25.2 MACF1 "ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF" ENSG00000127603 "Microtubule-actin crosslinking factor 1" Q9UPN3 1 39081316-39487177 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" Actin-binding "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013713, HPA068064, HPA068103" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" "Plasma membrane, Cell Junctions, Actin filaments" "HPA013713: AB_10600821, HPA068064: , HPA068103: " "unprognostic (2.71e-1)" "unprognostic (3.14e-2)" "unprognostic (5.18e-2)" "unprognostic (1.02e-2)" "unprognostic (9.00e-2)" "unprognostic (6.19e-3)" "unprognostic (1.32e-1)" "unprognostic (7.40e-3)" "unprognostic (5.45e-2)" "unprognostic (1.23e-1)" "unprognostic (1.34e-1)" "unprognostic (3.98e-1)" "prognostic favourable (2.77e-5)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (8.57e-2)" "unprognostic (4.22e-2)" 24.1 22.6 41.4 21.4 44.0 21.2 25.2 62.6 54.0 37.1 42.2 35.3 22.7 11.9 66.5 33.6 20.3 28.0 31.5 39.0 35.9 32.7 27.2 24.4 53.5 21.2 41.1 28.6 41.5 25.0 46.2 37.1 22.8 40.5 26.3 18.2 23.3 26.0 32.0 40.8 59.2 18.4 56.7 37.0 29.7 22.9 17.7 39.0 13.3 34.5 17.9 16.0 28.0 34.8 4.8 2.6 4.9 2.8 6.4 13.7 2.0 12.4 15.2 18.8 8.4 16.6 17.2 8.1 17.2 23.3 10.7 10.6 9.1 15.1 6.5 18.1 24.4 8.3 3.3 12.3 14.9 12.5 9.2 11.6 11.3 14.7 19.0 10.7 5.0 11.7 12.7 29.6 15.9 37.7 17.0 8.9 41.8 4.1 6.0 13.9 25.9 9.0 11.4 28.7 1.2 55.7 13.5 10.4 10.6 6.8 4.6 16.4 2.0 10.6 42.4 17.5 14.1 8.3 30.1 5.3 5.1 7.8 28.6 10.1 16.0 4.9 1.5 3.8 13.7 2.7 6.7 2.3 6.8 8.6 1.9 4.8 5.4 6.8 1.3 6.4 2.8 2.6 2.9 2.0 41.4 44.0 62.6 54.0 35.9 32.7 41.1 28.6 40.5 39.0 MADCAM1 MACAM1 ENSG00000099866 "Mucosal vascular addressin cell adhesion molecule 1" Q13477 19 489176-505342 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 19.9;lymphoid tissue: 27.2" "Cell line enhanced" "Detected in some" "HEK 293: 3.6;Hep G2: 4.3;U-266/70: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "neutrophil: 10.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 10.3" CAB075699 Enhanced 41000000 "CAB075699: " "unprognostic (2.30e-1)" "unprognostic (7.81e-2)" "unprognostic (5.52e-2)" "unprognostic (1.56e-1)" "unprognostic (7.56e-2)" "unprognostic (6.26e-4)" "unprognostic (1.68e-2)" "unprognostic (2.17e-4)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" "unprognostic (2.44e-2)" "unprognostic (1.09e-1)" "unprognostic (2.54e-4)" "unprognostic (2.42e-1)" "unprognostic (4.95e-3)" "unprognostic (9.80e-2)" "unprognostic (2.07e-2)" 1.4 0.9 4.6 27.2 5.2 0.9 1.1 6.8 6.3 0.7 5.6 0.9 1.2 5.1 0.9 3.3 1.6 0.6 19.9 0.7 3.6 2.9 0.7 0.9 0.8 3.2 2.4 3.1 0.7 3.3 2.9 2.9 0.9 2.7 0.9 5.0 0.5 1.3 0.7 1.5 0.9 12.1 0.8 2.4 13.7 5.0 1.6 3.2 1.0 2.3 0.0 0.8 0.7 1.5 1.0 0.4 10.3 0.4 0.4 1.2 0.1 0.8 0.1 0.3 1.2 1.1 0.1 1.4 0.3 0.2 0.4 0.1 0.8 0.5 0.5 2.4 0.2 1.3 0.2 0.0 0.1 2.8 3.6 0.0 2.2 4.3 0.1 0.1 2.7 1.2 0.2 0.3 0.0 0.0 0.7 1.9 0.4 2.6 0.2 1.3 0.4 2.0 0.7 0.0 0.2 0.0 0.6 1.7 0.4 0.2 0.3 0.1 0.1 0.0 0.0 1.4 0.3 1.0 0.2 4.8 1.7 0.9 0.2 1.2 0.1 0.0 0.4 1.0 0.5 0.4 0.6 0.6 0.4 0.3 0.1 1.0 1.2 1.2 10.3 0.4 0.3 0.4 0.0 0.1 4.6 5.2 6.8 6.3 3.6 2.9 2.4 3.1 2.7 3.2 MADD "DENN, KIAA0358, RAB3GEP" ENSG00000110514 "MAP kinase activating death domain" Q8WXG6 11 47269161-47330031 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038568 Uncertain Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038568: AB_10795030" "unprognostic (3.16e-1)" "unprognostic (1.81e-1)" "unprognostic (8.51e-3)" "prognostic favourable (6.62e-5)" "unprognostic (1.27e-1)" "unprognostic (6.36e-3)" "unprognostic (4.82e-3)" "unprognostic (1.16e-1)" "unprognostic (1.91e-1)" "unprognostic (3.78e-2)" "prognostic favourable (5.69e-5)" "unprognostic (1.53e-1)" "unprognostic (3.55e-1)" "unprognostic (8.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.76e-1)" "prognostic favourable (8.25e-4)" 7.7 18.2 18.3 11.5 27.6 16.9 8.7 66.3 46.5 9.2 10.8 15.5 13.1 8.6 9.4 8.9 6.9 9.4 8.6 13.8 20.2 18.4 9.8 7.7 11.0 13.2 15.5 19.8 14.0 12.2 18.8 26.7 11.2 20.7 12.5 12.0 16.0 10.2 14.0 16.1 14.0 9.8 10.5 11.3 12.3 13.2 19.4 11.0 14.6 8.4 6.0 12.2 11.0 7.8 3.5 4.1 20.8 5.8 4.5 5.7 4.4 6.3 13.3 14.6 13.0 10.0 7.0 3.3 9.0 12.1 11.5 12.5 9.7 6.0 13.6 2.9 9.9 12.7 11.8 6.3 10.0 15.0 12.0 24.1 24.7 8.3 7.2 16.3 33.2 6.7 6.8 6.0 7.6 10.5 15.4 10.0 10.1 9.0 7.7 17.6 8.7 9.2 10.6 23.5 8.9 5.9 30.6 23.1 15.1 11.6 13.7 7.9 10.8 12.4 8.9 10.8 6.8 15.3 6.0 11.9 12.3 7.7 10.0 11.6 10.1 20.8 2.6 4.8 4.8 4.6 4.2 3.5 3.4 4.0 4.1 3.3 4.0 3.1 0.7 4.5 5.8 2.2 5.7 4.4 18.3 27.6 66.3 44.6 20.2 18.4 15.5 19.8 20.7 11.0 MAG "GMA, S-MAG, SIGLEC-4A, SIGLEC4A" ENSG00000105695 "Myelin associated glycoprotein" P20916 19 35292125-35313804 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 113.6" "Cell line enriched" "Detected in some" 22 "WM-115: 28.1" "Cancer enriched" "Detected in some" 7 "glioma: 20.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 15 "dendritic cells: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009345, HPA012499" Enhanced "CAB009345: AB_670104, HPA012499: AB_1854238" "unprognostic (2.70e-3)" "unprognostic (2.70e-2)" "unprognostic (8.06e-3)" "unprognostic (1.23e-1)" "unprognostic (6.93e-2)" "unprognostic (3.74e-1)" "unprognostic (1.50e-1)" "unprognostic (2.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.00e-1)" "unprognostic (5.62e-2)" "unprognostic (5.18e-4)" "unprognostic (6.29e-2)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.66e-1)" 1.5 2.3 19.5 1.4 29.9 1.4 1.5 3.6 90.8 1.5 1.4 97.0 0.0 1.4 1.6 1.4 1.5 5.1 1.4 1.4 36.7 19.1 1.5 1.6 1.7 1.5 48.9 18.0 21.8 1.4 1.4 0.1 1.7 38.0 1.5 1.4 0.0 1.4 1.7 1.4 1.4 1.5 1.4 113.6 1.6 1.4 1.7 38.1 0.0 1.8 0.0 1.5 1.4 0.1 0.4 6.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 6.4 0.0 0.1 19.5 29.9 3.6 38.5 36.7 19.1 48.9 18.0 38.0 38.1 MAGEA4 "CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336" ENSG00000147381 "MAGE family member A4" P43358 X 151912509-151925170 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "placenta: 12.1;testis: 23.5" "Cell line enhanced" "Detected in some" "A-431: 61.4;AN3-CA: 38.3;HMC-1: 73.1;U-266/84: 113.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021942, CAB040535" Enhanced Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "CAB040535: , HPA021942: AB_1853490" "unprognostic (7.90e-3)" "unprognostic (6.66e-3)" "unprognostic (5.39e-1)" "unprognostic (1.36e-1)" "unprognostic (5.81e-2)" "unprognostic (2.94e-2)" "unprognostic (4.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.4 0.0 0.0 38.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 73.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 19.6 0.0 0.3 15.6 113.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 MAGED4 "KIAA1859, MAGE-E1, MAGE1, MGC3210" ENSG00000154545 "MAGE family member D4" Q96JG8 X 52184823-52192268 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.1;pituitary gland: 7.5" "Cell line enhanced" "Detected in some" "A549: 4.7;ASC TERT1: 4.4;Hep G2: 12.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 3.1" "Group enriched" "Detected in many" 21 "B-cells: 3.1;dendritic cells: 1.3;T-cells: 1.6" HPA003554 Uncertain "HPA003554: AB_1853497" "unprognostic (7.71e-2)" "unprognostic (8.21e-2)" "unprognostic (4.07e-4)" "unprognostic (6.15e-2)" 1.3 2.1 5.5 1.3 6.1 0.4 3.1 0.8 4.6 2.0 1.0 2.4 0.0 0.4 1.9 0.4 0.4 0.4 1.9 1.6 5.1 4.8 1.1 0.6 0.4 0.4 3.7 5.5 1.2 1.0 0.4 7.5 1.7 3.7 1.2 1.2 0.3 1.1 1.4 0.9 0.4 0.4 2.0 5.2 0.8 0.5 0.6 1.2 0.0 0.4 0.0 0.4 0.4 0.4 3.1 1.3 0.0 0.0 0.0 1.6 0.3 0.0 4.7 0.8 0.8 0.0 4.4 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.9 0.0 0.0 12.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.9 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 1.6 0.0 3.1 0.5 0.2 0.0 0.0 0.0 1.3 1.5 0.3 5.5 6.1 0.8 4.6 5.1 4.8 3.7 5.5 3.7 1.2 MAGED4B ENSG00000187243 "MAGE family member D4B" Q96JG8 X 52061827-52069248 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3" "Cell line enhanced" "Detected in many" "AF22: 24.3;NTERA-2: 19.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive B-cell: 8.1" "Group enriched" "Detected in many" 30 "B-cells: 8.1;dendritic cells: 5.4;T-cells: 5.0" HPA003554 Approved "HPA003554: AB_1853497" "unprognostic (7.75e-2)" "unprognostic (2.19e-1)" "unprognostic (2.37e-2)" "unprognostic (7.01e-6)" "unprognostic (6.45e-2)" 0.5 2.8 7.4 1.6 13.5 0.0 1.2 1.9 19.3 5.5 1.4 1.2 7.2 0.5 0.4 3.1 2.9 0.1 5.2 18.1 0.2 0.0 0.3 0.5 5.6 5.7 2.5 0.0 7.2 2.3 3.6 0.7 2.9 1.6 0.0 0.5 1.9 3.8 6.9 0.3 2.4 0.3 1.7 0.5 1.6 1.0 8.1 5.4 0.0 0.0 0.2 5.0 0.8 0.0 1.0 24.3 8.0 6.9 5.3 8.1 13.7 9.6 3.6 7.1 0.0 1.7 0.0 2.8 15.2 0.0 9.9 0.0 2.1 0.0 1.6 0.0 0.0 11.1 5.5 0.0 3.2 11.9 0.0 7.7 0.2 6.8 0.0 0.1 6.3 1.0 2.6 0.0 19.9 0.7 0.0 14.3 0.0 2.6 0.0 1.0 15.1 0.0 0.0 1.9 0.0 0.0 0.9 6.7 10.1 0.0 0.0 0.0 0.0 0.5 8.8 0.0 11.8 0.0 0.0 0.0 0.2 0.0 0.5 2.7 2.4 1.3 0.0 8.1 0.0 0.5 0.0 0.2 0.0 5.4 5.0 0.8 MAGEH1 APR1 ENSG00000187601 "MAGE family member H1" Q9H213 X 55452105-55453566 "Predicted membrane proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "epididymis: 207.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011324 Uncertain Approved Nucleoli Nucleoli "HPA011324: AB_1853499" "unprognostic (2.50e-1)" "unprognostic (3.01e-1)" "unprognostic (4.07e-2)" "prognostic unfavourable (1.37e-4)" "unprognostic (3.95e-2)" "unprognostic (8.50e-2)" "unprognostic (1.13e-2)" "unprognostic (9.93e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "prognostic favourable (2.60e-4)" "unprognostic (6.37e-2)" "unprognostic (1.81e-2)" "unprognostic (1.29e-3)" "unprognostic (1.90e-1)" "unprognostic (3.95e-2)" "unprognostic (2.52e-1)" 8.3 13.2 21.5 7.6 21.6 3.0 8.1 19.9 29.7 13.5 7.5 14.4 13.8 5.2 13.3 207.1 5.2 19.2 8.3 10.2 22.8 32.1 11.4 8.7 10.2 9.0 19.8 20.6 16.1 11.9 9.0 22.5 9.2 17.9 20.8 5.9 11.4 8.9 19.6 5.7 5.6 6.3 11.8 17.2 8.1 9.3 18.2 15.3 10.8 12.4 5.2 7.5 8.5 10.0 9.4 14.0 9.5 8.5 8.3 26.0 9.4 0.0 2.5 14.8 0.0 23.9 14.5 0.2 16.0 14.8 4.4 11.9 0.0 3.3 0.0 22.0 16.0 2.2 5.6 6.0 7.0 18.4 0.9 4.9 0.0 2.0 7.9 0.2 6.4 12.0 0.5 2.5 1.8 6.7 2.7 19.8 4.8 9.5 13.1 4.2 4.2 3.0 8.3 1.8 10.4 8.0 0.0 0.1 11.2 0.0 4.3 6.6 2.1 3.7 7.8 6.1 7.1 3.7 0.8 11.8 14.8 2.0 11.4 6.9 7.7 5.0 4.4 9.5 11.3 6.8 10.1 9.4 18.7 12.9 6.7 8.8 26.0 16.1 0.6 8.3 8.5 14.0 24.7 9.4 21.5 21.6 19.9 28.4 22.8 32.1 19.8 20.6 17.9 15.3 MAL ENSG00000172005 "Mal, T cell differentiation protein" P21145 2 95025677-95053996 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "esophagus: 447.4" "Cell line enhanced" "Detected in some" "HDLM-2: 44.8;MOLT-4: 62.7;RPTEC TERT1: 227.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 42.0;naive CD4 T-cell: 57.9;naive CD8 T-cell: 26.4;T-reg: 40.1" "Lineage enriched" "Detected in many" 44 "T-cells: 57.9" "Low region specificity" "Detected in all" HPA065691 Approved "Golgi apparatus,Centrosome" "Golgi apparatus" Centrosome "HPA065691: " "unprognostic (1.57e-3)" "unprognostic (2.64e-2)" "unprognostic (1.08e-2)" "prognostic unfavourable (5.18e-6)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (5.13e-2)" "unprognostic (2.35e-2)" "unprognostic (1.06e-1)" "unprognostic (3.59e-1)" "unprognostic (4.61e-2)" "unprognostic (3.89e-2)" "prognostic favourable (3.96e-9)" "unprognostic (1.91e-1)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.57e-1)" 2.3 2.0 14.3 3.5 21.8 3.7 2.0 1.8 20.6 35.8 3.7 43.2 0.4 2.0 1.8 3.4 447.4 3.4 2.2 3.3 18.2 8.3 53.1 1.7 4.3 5.9 27.4 13.2 2.0 1.9 1.6 0.2 2.2 11.8 2.5 2.9 2.8 42.5 3.9 2.0 3.7 2.4 2.1 27.6 3.2 9.3 1.7 27.2 35.0 5.8 56.1 90.1 2.6 64.8 0.6 0.2 0.4 0.1 1.3 57.9 13.7 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.7 0.0 0.0 0.0 0.0 0.0 22.2 227.3 5.7 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.4 0.6 42.0 7.5 0.0 0.5 57.9 26.4 0.4 1.3 0.0 0.2 40.1 13.7 14.3 21.8 1.8 20.6 18.2 8.3 27.4 13.2 11.8 27.2 MALL BENE ENSG00000144063 "Mal, T cell differentiation protein like" Q13021 2 110083870-110116566 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 107.7;intestine: 142.1;lung: 72.9" "Cell line enhanced" "Detected in some" "A-431: 40.0;A549: 39.2;CAPAN-2: 54.2;fHDF/TERT166: 59.5;HaCaT: 42.2;PC-3: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 9.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.3" "Low region specificity" "Detected in single" HPA051410 Uncertain "HPA051410: " "unprognostic (5.17e-1)" "unprognostic (4.15e-2)" "unprognostic (2.92e-1)" "unprognostic (3.53e-1)" "unprognostic (1.92e-2)" "unprognostic (1.66e-1)" "unprognostic (2.22e-1)" "unprognostic (4.46e-2)" "unprognostic (6.50e-2)" "unprognostic (6.82e-2)" "prognostic unfavourable (1.23e-4)" "unprognostic (2.37e-1)" "unprognostic (7.27e-2)" "unprognostic (2.23e-1)" "unprognostic (2.84e-1)" "unprognostic (2.80e-1)" "unprognostic (6.50e-3)" 5.5 1.0 0.9 11.1 2.1 0.1 7.7 0.4 1.1 22.5 46.4 0.2 1.3 41.2 6.0 2.7 107.7 2.8 6.7 10.8 1.7 1.0 1.9 1.1 72.9 3.7 1.1 0.2 1.6 2.9 49.8 1.0 3.7 3.6 5.5 19.0 1.6 11.2 1.5 2.1 11.1 142.1 5.1 4.2 2.0 1.8 2.2 0.4 0.6 5.6 45.8 63.8 7.8 35.4 0.9 0.7 9.3 0.7 2.1 1.0 0.5 40.0 39.2 0.0 0.1 0.0 0.0 0.1 7.7 0.4 0.0 0.0 6.4 54.2 0.1 19.7 59.5 42.2 0.0 2.3 0.0 0.1 0.0 0.3 1.1 0.0 0.3 0.0 0.1 0.9 2.1 0.1 0.0 19.4 0.0 0.0 0.0 1.4 0.0 0.1 0.0 23.9 0.0 0.0 0.1 5.1 2.2 0.1 0.0 0.0 1.4 0.1 0.0 0.2 19.9 0.0 0.1 0.1 0.1 0.0 0.0 4.6 0.0 0.0 0.0 9.3 0.7 1.0 0.4 0.4 0.4 0.7 0.8 0.7 0.3 0.9 0.5 1.0 4.4 2.1 0.2 0.7 0.6 0.5 0.9 2.1 0.4 1.1 1.7 1.0 1.1 0.2 3.6 0.4 MALRD1 "bA265G8.2, C10orf112, Diet1" ENSG00000204740 "MAM and LDL receptor class A domain containing 1" Q5VYJ5 10 19048771-19790401 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "intestine: 60.5" "Cell line enriched" "Detected in some" 10 "Karpas-707: 31.2" "Cancer enhanced" "Detected in some" "stomach cancer: 1.1" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035732, HPA038106, HPA046848" Uncertain Enhanced "Golgi apparatus" "Golgi apparatus" "HPA035732: , HPA038106: , HPA046848: " "unprognostic (9.03e-3)" "unprognostic (1.38e-1)" "unprognostic (2.40e-2)" "unprognostic (4.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (2.74e-2)" "unprognostic (5.57e-2)" "unprognostic (5.01e-1)" "unprognostic (1.00e-1)" "unprognostic (3.55e-1)" "unprognostic (7.69e-2)" "unprognostic (3.16e-2)" "unprognostic (9.80e-2)" "unprognostic (8.90e-2)" "unprognostic (3.13e-2)" "unprognostic (3.78e-4)" 0.5 0.8 2.0 0.3 2.0 0.4 0.6 0.3 0.9 0.8 19.4 0.6 0.1 25.2 1.3 2.3 0.3 0.3 0.4 1.3 1.6 0.8 1.3 0.3 0.9 0.2 0.8 0.0 1.1 0.3 0.1 4.7 0.4 0.8 0.9 0.2 1.4 0.5 0.4 0.5 0.4 60.5 1.3 0.7 0.3 0.5 1.7 0.7 2.6 0.6 0.3 0.1 0.5 0.5 0.0 3.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 31.2 0.0 3.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.0 3.6 0.0 0.0 2.0 2.0 0.3 0.9 1.6 0.8 0.8 0.0 0.8 0.7 MAMDC4 "AEGP, DKFZp434M1411" ENSG00000177943 "MAM domain containing 4" Q6UXC1 9 136850943-136860799 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;liver: 48.9" "Cell line enhanced" "Detected in many" "BEWO: 18.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 10 "cerebellum: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB026377, HPA059977" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB026377: , HPA059977: " "unprognostic (2.79e-1)" "unprognostic (7.90e-2)" "unprognostic (4.09e-3)" "unprognostic (6.86e-2)" "unprognostic (8.33e-2)" "unprognostic (2.66e-4)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (7.37e-2)" "prognostic favourable (1.88e-6)" "unprognostic (8.22e-3)" "unprognostic (1.58e-2)" "unprognostic (1.22e-3)" "unprognostic (9.22e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" 2.0 1.6 1.2 1.9 1.5 1.4 1.2 14.9 1.2 1.2 2.3 1.2 1.2 5.0 1.2 1.2 1.2 1.7 1.2 1.6 1.2 0.4 2.6 48.9 1.2 2.5 1.2 1.2 1.2 3.4 0.5 7.2 1.2 1.2 3.2 0.9 1.2 3.5 1.4 1.7 1.5 6.1 1.2 1.2 5.1 2.3 6.5 1.2 1.2 5.1 1.2 1.2 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 1.5 2.5 1.4 2.8 0.6 0.1 18.5 2.7 0.3 0.3 0.6 2.0 1.6 1.3 0.6 0.7 2.2 0.3 1.3 0.0 2.0 0.9 0.8 5.2 2.2 1.2 0.1 4.8 0.8 1.7 1.4 0.6 0.6 2.6 1.2 0.2 4.1 0.9 3.6 1.4 0.7 1.6 0.4 2.4 0.9 1.3 1.6 2.0 0.5 1.2 1.1 4.3 0.8 0.8 7.5 4.7 1.5 0.4 3.1 1.6 0.4 1.7 1.9 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 14.9 1.2 1.2 0.4 1.2 1.2 1.2 1.2 MAN1A1 ENSG00000111885 "Mannosidase alpha class 1A member 1" P33908 6 119177209-119349761 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.2" "Cell line enhanced" "Detected in many" "ASC diff: 59.0;Hep G2: 41.4;Karpas-707: 46.2;U-266/70: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037058, HPA053198, HPA063561" Uncertain Supported "Golgi apparatus" 390000000 "Golgi apparatus" "CAB037058: AB_477183, HPA053198: , HPA063561: " "unprognostic (1.50e-1)" "unprognostic (7.36e-3)" "unprognostic (4.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.95e-2)" "unprognostic (2.19e-1)" "unprognostic (3.33e-3)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" "unprognostic (5.11e-2)" "unprognostic (1.68e-3)" "unprognostic (4.62e-1)" "unprognostic (2.37e-2)" "unprognostic (3.49e-2)" "unprognostic (2.25e-1)" "unprognostic (6.89e-2)" "unprognostic (3.40e-1)" 41.8 19.8 5.8 10.5 17.4 8.1 32.2 1.5 7.9 12.3 23.3 3.2 3.6 17.4 11.3 12.0 10.6 9.5 22.0 10.4 5.0 3.3 23.4 74.2 16.4 16.8 2.8 5.7 10.3 22.0 3.4 6.4 26.1 3.7 14.7 9.9 10.5 41.0 5.3 7.1 9.6 36.3 19.7 3.5 20.9 10.0 8.7 3.7 8.8 15.2 10.3 9.1 21.2 36.4 1.4 5.5 6.0 1.1 1.9 4.7 0.6 0.0 0.0 0.7 0.0 59.0 26.1 1.4 1.4 8.6 1.0 2.6 4.0 0.5 8.8 0.0 5.4 0.1 1.5 0.0 1.3 13.0 4.0 7.3 0.8 41.4 5.9 0.0 3.7 17.8 1.1 8.8 5.4 0.7 25.5 46.2 8.3 1.2 0.3 0.0 0.4 2.1 2.4 0.9 13.3 2.8 7.3 3.0 4.4 0.0 0.1 0.0 2.1 0.9 5.1 3.6 3.3 6.7 3.2 62.4 8.8 17.4 10.7 0.1 2.1 6.0 0.6 2.0 2.4 1.1 4.7 1.4 1.3 1.3 0.6 0.9 0.8 1.9 3.8 1.9 0.9 5.5 1.4 0.6 5.8 17.4 1.5 7.9 5.0 3.3 2.8 5.7 3.7 3.7 MAN1A2 MAN1B ENSG00000198162 "Mannosidase alpha class 1A member 2" O60476 1 117367449-117528872 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 122.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034559, HPA057364" Enhanced Enhanced "Golgi apparatus" 1100000 "Golgi apparatus" "HPA034559: AB_10671229, HPA057364: " "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-3)" "unprognostic (2.15e-1)" "unprognostic (3.11e-2)" "unprognostic (9.70e-2)" "unprognostic (1.95e-2)" "unprognostic (8.01e-2)" "unprognostic (8.19e-3)" "prognostic favourable (4.08e-4)" "unprognostic (1.41e-1)" "unprognostic (4.38e-2)" "unprognostic (6.84e-2)" "unprognostic (1.45e-1)" "unprognostic (7.39e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-2)" 11.1 9.7 13.9 9.1 15.8 3.8 9.7 11.9 15.2 14.4 10.7 8.5 9.4 8.1 15.8 10.7 11.5 12.2 9.2 11.0 11.2 9.2 11.8 16.4 8.1 9.9 12.0 13.9 11.2 27.4 21.7 9.6 122.4 11.3 11.2 9.5 8.3 11.1 10.5 10.5 7.5 9.0 13.7 10.4 10.4 10.3 10.1 14.4 16.1 19.4 6.9 9.8 13.6 9.8 3.7 4.4 4.0 2.7 6.0 9.8 2.4 14.1 6.2 10.6 9.1 14.0 16.9 34.1 11.8 18.5 5.3 5.0 4.7 8.2 10.6 21.9 15.1 8.5 4.9 10.0 12.1 13.3 7.4 6.3 8.7 5.2 8.5 9.9 14.5 11.3 10.8 8.1 7.1 15.8 10.1 16.4 11.1 27.6 6.0 3.1 5.4 6.5 5.4 23.1 7.2 7.3 19.4 5.8 8.5 11.7 12.6 9.3 6.2 6.3 15.0 12.1 9.9 8.5 12.0 11.2 7.6 7.2 15.9 7.9 28.5 1.3 2.7 4.0 5.2 2.1 6.2 3.3 4.3 4.3 2.3 3.7 3.6 5.2 2.1 6.0 1.7 4.4 9.8 2.4 13.9 15.8 11.9 15.2 11.2 9.2 12.0 13.9 11.3 14.4 MAN1B1 "ERManI, MANA-ER, MRT15" ENSG00000177239 "Mannosidase alpha class 1B member 1" Q9UKM7 9 137086927-137109187 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051516 Approved Uncertain Vesicles 540000 Vesicles "HPA051516: " "unprognostic (1.21e-2)" "unprognostic (4.66e-1)" "unprognostic (1.25e-3)" "unprognostic (4.67e-3)" "unprognostic (2.27e-1)" "unprognostic (3.70e-3)" "prognostic unfavourable (1.45e-4)" "unprognostic (1.59e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-2)" "unprognostic (5.93e-3)" "unprognostic (1.75e-1)" "unprognostic (3.55e-2)" "unprognostic (2.28e-1)" "unprognostic (5.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.44e-3)" 20.4 25.4 19.7 13.5 23.7 9.8 18.6 21.6 36.1 24.3 21.6 24.5 20.6 19.8 22.7 28.1 23.1 28.9 25.9 19.5 20.5 21.5 24.3 32.7 20.4 19.9 18.6 25.2 24.2 32.6 23.6 25.1 30.8 18.0 21.2 12.0 22.0 32.7 23.1 12.2 25.4 17.8 18.5 16.4 22.2 21.8 30.3 18.2 19.9 25.1 12.7 19.3 21.0 16.0 13.0 23.0 16.3 24.4 18.0 21.9 18.5 7.2 17.1 5.9 16.9 22.5 19.4 19.8 12.3 26.1 16.5 14.6 8.3 22.9 6.6 41.4 20.6 25.0 3.5 11.9 3.0 9.1 6.0 2.9 15.4 9.6 21.2 5.1 11.4 22.9 22.6 9.6 8.1 10.9 8.0 10.9 11.6 14.7 5.4 12.1 7.9 17.2 3.1 10.0 20.9 13.2 3.6 6.9 6.2 18.2 19.4 12.6 21.5 10.9 15.3 24.4 9.1 18.0 14.4 4.4 3.6 4.3 29.4 6.5 21.0 7.9 20.1 16.3 21.9 21.8 20.5 13.0 17.3 20.6 23.0 11.0 17.0 17.0 5.9 18.0 24.4 16.1 21.5 18.5 19.7 23.7 21.6 36.1 20.5 21.5 18.6 25.2 18.0 18.2 MAN1C1 HMIC ENSG00000117643 "Mannosidase alpha class 1C member 1" Q9NR34 1 25617468-25786207 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 12.5;HSkMC: 46.0;U-266/70: 13.7" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.3" "Lineage enriched" "Detected in many" 5 "T-cells: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048352 Uncertain Uncertain Nucleoplasm,Vesicles 1200000 "Nucleoplasm, Vesicles" "HPA048352: " "unprognostic (2.75e-1)" "unprognostic (5.45e-3)" "unprognostic (5.71e-3)" "unprognostic (2.05e-2)" "unprognostic (1.95e-1)" "unprognostic (8.90e-3)" "unprognostic (4.78e-2)" "prognostic favourable (7.55e-4)" "unprognostic (1.80e-1)" "unprognostic (5.70e-2)" "prognostic favourable (4.79e-4)" "unprognostic (2.51e-1)" "unprognostic (9.09e-3)" "unprognostic (3.18e-2)" "unprognostic (7.23e-2)" "unprognostic (7.44e-2)" "unprognostic (5.18e-2)" 4.6 4.5 4.2 3.0 3.8 0.0 2.2 9.9 8.8 8.6 3.6 1.2 6.6 2.5 2.4 3.9 7.3 3.4 5.2 3.2 10.3 12.1 3.2 4.0 4.2 7.1 0.7 4.4 7.8 8.3 7.2 1.2 1.8 7.5 0.9 2.7 1.9 8.0 6.0 7.0 3.1 1.0 10.7 3.2 4.3 4.0 1.0 0.6 1.1 1.6 0.8 8.3 1.1 0.0 0.1 12.5 2.6 9.3 7.3 3.6 0.1 2.4 0.6 0.2 0.2 0.0 0.1 0.1 0.9 0.1 1.1 0.1 0.2 3.9 0.5 0.2 0.1 0.0 1.1 2.1 5.2 46.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.6 0.0 2.3 3.2 0.0 0.2 7.7 0.2 0.1 0.2 7.3 0.2 0.3 1.9 0.6 1.0 1.5 0.0 0.0 0.7 8.4 0.3 13.7 0.0 0.0 1.9 4.4 0.6 0.4 1.6 0.7 0.6 1.0 0.8 0.4 3.6 1.6 0.6 1.0 8.3 4.8 1.1 0.8 1.3 0.4 0.8 1.1 MAN2A1 "GOLIM7, MANA2" ENSG00000112893 "Mannosidase alpha class 2A member 1" Q16706 5 109689366-109869625 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022377, HPA026896" Enhanced Supported "Golgi apparatus" 70000000 "Golgi apparatus" "CAB022377: , HPA026896: AB_1853512" "unprognostic (1.62e-2)" "unprognostic (4.06e-2)" "unprognostic (1.25e-2)" "unprognostic (6.96e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-2)" "unprognostic (4.20e-2)" "unprognostic (3.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.73e-2)" "unprognostic (1.23e-1)" "unprognostic (6.77e-3)" "unprognostic (2.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.11e-3)" "unprognostic (5.31e-3)" 7.6 17.5 10.9 7.7 21.8 5.7 7.4 1.9 13.2 8.4 11.2 46.8 2.4 17.2 9.2 1.8 7.7 6.2 10.6 4.2 11.7 4.8 9.5 20.7 8.5 7.8 29.9 10.4 7.5 16.7 20.1 3.4 8.7 19.8 4.7 11.9 5.6 9.0 6.0 8.7 7.0 14.4 11.2 23.1 6.9 8.9 7.5 30.6 15.0 9.0 1.8 7.8 10.9 6.2 3.3 2.7 5.8 6.7 0.9 5.5 1.6 7.2 6.7 8.4 3.6 16.1 14.2 31.4 16.1 26.6 9.2 16.6 7.9 11.7 5.2 10.4 20.9 8.6 4.5 16.7 20.1 5.6 3.4 10.6 5.0 7.2 9.1 4.8 5.8 12.1 6.9 14.7 19.5 18.1 2.8 30.5 21.6 3.6 9.0 1.3 6.0 2.4 3.5 13.1 23.0 7.3 11.5 1.2 1.1 7.6 6.8 4.6 6.7 4.2 19.3 18.2 8.0 9.8 10.4 16.3 21.1 4.4 14.0 6.2 10.1 5.8 2.9 0.9 3.0 3.8 1.9 3.3 4.5 4.9 2.7 2.9 5.5 4.8 2.1 0.9 6.7 2.5 4.1 1.6 10.9 21.8 1.9 13.2 11.7 4.8 29.9 10.4 19.8 30.6 MAN2A2 "HsT19662, MANA2X" ENSG00000196547 "Mannosidase alpha class 2A member 2" P49641 15 90902218-90922584 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.4;neutrophil: 10.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077930 Approved "Cytoplasmic bodies" 30000000 "Cytoplasmic bodies" "HPA077930: " "unprognostic (5.17e-2)" "unprognostic (9.80e-2)" "unprognostic (2.43e-2)" "unprognostic (2.41e-1)" "unprognostic (2.58e-1)" "unprognostic (1.86e-2)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" "unprognostic (3.41e-1)" "unprognostic (2.27e-1)" "unprognostic (5.06e-3)" "unprognostic (1.09e-2)" "prognostic unfavourable (8.95e-4)" "unprognostic (7.55e-3)" "unprognostic (1.13e-1)" "unprognostic (8.36e-2)" "unprognostic (2.33e-2)" 17.8 12.1 15.9 11.5 24.3 58.1 17.3 33.7 31.2 7.2 9.9 52.4 6.3 12.0 8.9 9.8 7.6 8.0 9.4 22.7 17.8 14.0 8.1 16.7 13.3 12.4 31.6 19.7 9.7 24.0 13.0 15.2 12.4 31.0 9.2 9.0 17.2 20.6 12.6 41.8 14.8 13.0 7.6 33.1 19.1 12.4 12.7 28.3 3.8 13.8 2.7 9.1 7.5 10.7 1.5 2.1 10.0 3.2 0.1 1.4 1.5 5.7 5.9 4.2 10.0 12.7 3.4 8.2 4.2 3.9 4.4 3.4 4.8 4.3 0.8 10.4 4.9 6.5 4.4 2.4 2.7 14.2 10.4 39.2 9.0 3.2 4.2 5.7 21.3 2.5 4.6 5.3 4.3 5.7 14.7 5.1 2.0 7.8 3.7 11.3 1.4 1.8 5.1 4.0 6.0 5.5 13.8 10.2 5.9 5.8 10.9 8.2 5.1 18.7 4.9 3.6 3.9 4.4 5.5 8.0 24.4 2.1 4.2 8.3 6.1 8.4 1.6 0.6 1.4 1.1 0.9 1.0 0.6 0.8 0.3 1.5 0.4 0.4 10.0 0.1 3.2 2.1 1.3 1.5 15.9 24.3 33.7 31.2 17.8 14.0 31.6 19.7 31.0 28.3 MANBAL dJ1141E15.2 ENSG00000101363 "Mannosidase beta like" Q9NQG1 20 37289638-37317260 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052348 Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA052348: " "unprognostic (1.86e-2)" "unprognostic (9.15e-2)" "unprognostic (1.85e-1)" "unprognostic (2.45e-2)" "unprognostic (3.12e-1)" "unprognostic (2.21e-3)" "prognostic unfavourable (7.07e-4)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (9.61e-2)" "unprognostic (2.83e-1)" "unprognostic (3.43e-1)" "prognostic favourable (3.62e-4)" "unprognostic (1.06e-1)" "unprognostic (1.86e-1)" "unprognostic (8.03e-2)" "unprognostic (2.70e-2)" 17.3 25.2 19.6 10.7 27.6 2.9 29.8 11.4 32.7 22.5 22.1 15.9 21.9 17.0 26.7 29.7 22.1 28.9 23.3 13.9 20.8 20.1 19.0 14.5 15.1 19.3 18.9 23.2 28.5 21.4 15.1 16.9 16.1 22.1 24.0 20.3 27.5 16.6 32.9 7.1 19.8 15.6 33.5 13.4 11.1 18.7 17.6 11.2 9.8 23.2 13.7 13.7 20.5 28.3 18.0 21.7 25.4 19.3 14.5 17.3 11.1 16.9 33.5 17.0 17.1 28.0 20.4 14.8 23.8 24.9 23.1 18.2 39.4 23.3 4.4 28.6 28.9 23.5 16.1 37.2 15.9 3.3 16.7 4.6 14.1 34.9 30.3 4.9 2.9 22.2 26.5 21.5 35.6 16.1 7.4 4.9 23.0 20.0 6.1 6.5 13.5 31.4 3.7 22.4 5.1 21.9 23.8 16.4 18.7 24.2 36.4 19.6 24.5 7.9 17.6 42.6 16.0 23.9 18.3 6.5 8.8 3.6 30.6 2.7 22.0 9.2 17.0 23.7 11.8 19.3 13.6 18.0 14.2 14.0 15.5 17.8 17.3 16.6 25.4 14.5 15.1 21.7 9.3 11.1 19.6 27.6 11.4 32.7 20.8 20.1 18.9 23.2 22.1 11.2 MANEA "FLJ12838, mandaselin" ENSG00000172469 "Mannosidase endo-alpha" Q5SRI9 6 95577543-95609457 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011046, HPA011069" Enhanced Supported "Golgi apparatus" 87000 "Golgi apparatus" "HPA011046: AB_1079303, HPA011069: AB_1079304" "unprognostic (6.00e-2)" "unprognostic (7.81e-2)" "prognostic favourable (3.04e-4)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (5.03e-2)" "unprognostic (2.98e-3)" "unprognostic (2.74e-1)" "unprognostic (5.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.44e-1)" "unprognostic (9.07e-2)" "unprognostic (2.86e-3)" "unprognostic (5.18e-2)" "unprognostic (3.08e-1)" "unprognostic (9.68e-2)" "unprognostic (7.47e-2)" 18.0 8.1 6.0 6.7 6.9 2.4 14.4 8.3 6.0 9.6 9.5 5.0 5.8 7.7 7.5 8.2 11.5 7.2 7.1 9.3 6.5 6.2 14.6 44.9 9.8 12.3 8.9 6.7 10.4 8.0 10.9 13.5 7.4 7.8 9.2 8.0 4.5 8.1 7.6 3.8 5.9 9.5 6.0 11.6 13.2 10.7 7.1 6.9 17.9 11.7 5.9 9.7 11.2 7.5 6.6 3.4 8.5 5.7 3.8 10.4 3.3 3.7 3.2 12.2 9.9 20.3 23.9 4.7 10.6 9.7 6.2 9.3 3.6 9.5 7.2 13.2 6.8 6.2 8.4 7.0 14.2 12.4 7.6 9.8 3.0 5.9 7.1 12.7 8.7 23.6 8.2 7.3 5.1 14.4 15.0 16.8 13.1 2.6 7.4 5.4 1.8 3.2 8.9 12.2 10.7 9.4 6.6 9.8 5.3 5.9 4.3 3.7 6.8 12.0 13.0 6.2 4.4 11.1 10.3 12.6 7.4 8.9 11.0 11.2 14.0 8.5 3.3 1.9 4.8 5.7 6.8 6.6 5.9 5.5 3.4 3.3 6.9 4.6 0.7 3.8 4.9 1.3 10.4 3.3 6.0 6.9 8.3 6.0 6.5 6.2 8.9 6.7 7.8 6.9 MANSC1 "FLJ10298, LOH12CR3" ENSG00000111261 "MANSC domain containing 1" Q9H8J5 12 12326056-12350541 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 29.9;RPTEC TERT1: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 24 "neutrophil: 37.5" "Lineage enriched" "Detected in many" 36 "granulocytes: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007955, HPA007956" Approved Approved "Golgi apparatus,Vesicles" 28000000 "Golgi apparatus, Vesicles" "HPA007955: AB_1079306, HPA007956: AB_1079305" "unprognostic (5.41e-3)" "unprognostic (3.10e-2)" "unprognostic (1.24e-1)" "unprognostic (5.46e-3)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-2)" "unprognostic (8.47e-2)" "unprognostic (9.18e-2)" "unprognostic (5.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.03e-1)" "prognostic favourable (3.30e-5)" "unprognostic (1.15e-2)" "unprognostic (4.46e-2)" "unprognostic (3.65e-1)" "unprognostic (1.03e-2)" 13.1 8.8 9.7 5.1 13.7 4.2 14.7 10.1 18.4 13.5 17.8 7.5 12.9 13.4 15.1 14.1 27.3 11.2 19.3 7.9 9.2 7.6 9.5 7.6 8.4 6.6 6.9 9.0 11.3 26.4 18.5 19.5 11.0 9.0 15.0 18.5 12.8 42.6 15.2 3.6 13.3 13.3 14.4 5.8 8.4 21.3 9.1 6.2 0.0 9.5 16.7 18.2 12.6 12.9 0.2 0.2 37.5 0.5 0.2 1.0 0.1 0.2 3.3 1.0 0.0 3.4 3.3 3.6 2.3 2.7 1.2 1.5 2.7 10.7 0.0 2.5 2.2 0.4 4.2 1.9 0.9 0.0 3.8 4.7 4.1 2.2 0.6 0.7 1.4 2.1 3.1 0.7 0.5 29.9 3.0 0.0 0.4 6.2 0.0 0.3 3.7 1.8 0.1 0.0 0.1 15.5 10.9 1.4 5.9 1.2 10.0 3.4 9.0 3.0 11.7 1.7 1.4 0.4 3.1 0.2 0.1 1.6 1.2 0.0 1.2 1.5 0.5 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.2 1.0 0.1 37.5 0.2 0.1 0.0 0.0 0.1 9.7 13.7 10.1 18.4 9.2 7.6 6.9 9.0 9.0 6.2 MANSC4 ENSG00000205693 "MANSC domain containing 4" A6NHS7 12 27762738-27771276 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 3.3;testis: 5.9" "Cell line enhanced" "Detected in some" "HaCaT: 2.2;HUVEC TERT2: 5.1;PC-3: 2.6;U-2 OS: 1.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 13 "T-cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039454, HPA039682" Uncertain "HPA039454: , HPA039682: AB_10805483" "unprognostic (1.13e-1)" "unprognostic (4.74e-2)" "unprognostic (2.34e-2)" "unprognostic (2.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (2.25e-4)" "unprognostic (1.96e-1)" "unprognostic (2.49e-2)" "unprognostic (2.87e-3)" "unprognostic (2.50e-3)" "unprognostic (7.15e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-2)" "unprognostic (1.21e-1)" "unprognostic (2.10e-2)" 0.1 0.0 0.2 0.6 0.5 0.1 0.5 3.3 0.2 0.2 0.0 0.2 0.5 0.0 0.0 0.2 0.0 0.0 0.2 1.2 0.7 0.0 0.8 1.9 0.1 0.7 0.6 0.0 2.0 2.0 0.2 0.0 0.0 0.4 0.0 0.3 0.2 0.0 0.2 0.1 0.1 5.9 0.2 1.4 0.1 0.2 0.1 0.0 0.0 0.0 0.1 1.7 0.2 0.1 0.8 0.0 0.1 0.7 0.2 0.8 0.4 0.0 0.0 0.3 1.7 0.3 0.1 0.0 0.2 2.2 0.0 0.0 0.0 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 5.1 0.3 0.1 0.0 0.0 0.1 0.0 0.4 2.6 0.2 0.1 0.0 0.0 1.1 0.1 0.0 0.2 0.7 0.0 0.4 1.0 1.2 0.2 1.8 0.4 0.2 0.5 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 MAOA ENSG00000189221 "Monoamine oxidase A" P21397 X 43654907-43746824 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" Oxidoreductase "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 39.5;HHSteC: 74.2;HSkMC: 18.6;hTCEpi: 20.9;RT4: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.0;MAIT T-cell: 1.3" "Group enriched" "Detected in many" 10 "monocytes: 1.0;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009437, HPA054807, HPA059299" Enhanced Enhanced Mitochondria,Cytosol Mitochondria Cytosol "CAB009437: AB_2137260, HPA054807: , HPA059299: " "unprognostic (9.54e-3)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" "unprognostic (3.07e-1)" "unprognostic (6.75e-2)" "unprognostic (3.32e-1)" "unprognostic (9.51e-2)" "unprognostic (6.89e-3)" "unprognostic (2.21e-1)" "unprognostic (4.29e-2)" "unprognostic (3.94e-1)" "unprognostic (3.54e-1)" "unprognostic (1.45e-3)" "unprognostic (1.16e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-2)" "unprognostic (2.98e-3)" 72.3 11.0 8.2 10.2 7.8 0.3 35.2 3.3 6.1 12.4 85.7 2.8 10.7 53.6 12.5 6.2 36.6 12.0 14.7 37.8 6.7 8.3 77.8 45.9 34.4 5.2 11.1 6.1 14.2 24.4 9.6 1.5 79.8 8.7 26.2 39.9 6.2 49.1 12.9 12.5 11.2 90.1 23.6 3.4 2.1 19.3 5.5 4.7 0.0 68.6 9.7 3.9 35.3 35.1 0.0 0.0 0.1 1.0 0.0 1.3 0.1 0.0 0.8 0.1 2.3 39.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 1.4 5.3 0.0 0.0 0.5 1.6 0.1 4.2 74.2 0.0 4.0 18.6 20.9 0.0 10.9 4.7 0.0 0.1 1.3 0.6 0.0 0.1 0.3 1.2 0.0 0.0 0.1 5.3 30.6 0.7 1.8 0.0 0.0 0.0 0.1 0.0 2.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.1 8.2 7.8 3.3 6.1 6.7 8.3 11.1 6.1 8.7 4.7 MAOB ENSG00000069535 "Monoamine oxidase B" P27338 X 43766611-43882447 "Enzymes, FDA approved drug targets, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 104.9" "Group enriched" "Detected in some" 7 "Hep G2: 20.2;SiHa: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002328, CAB037200" Enhanced 3600000 "CAB037200: AB_1841012, HPA002328: AB_1854062" "unprognostic (1.19e-2)" "unprognostic (1.36e-1)" "unprognostic (5.16e-2)" "unprognostic (1.85e-2)" "unprognostic (4.39e-2)" "unprognostic (2.69e-2)" "unprognostic (5.61e-2)" "unprognostic (4.37e-2)" "unprognostic (1.56e-1)" "unprognostic (1.04e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-2)" "unprognostic (9.74e-2)" "unprognostic (5.35e-3)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (1.90e-3)" 25.0 18.2 24.8 3.9 34.8 0.5 16.5 5.5 24.5 12.0 18.9 20.3 15.6 24.9 38.0 20.0 11.4 34.9 15.4 32.4 21.2 46.9 41.8 104.9 10.9 2.3 24.4 19.9 56.0 4.1 15.6 8.9 9.4 26.8 30.1 6.3 3.0 38.0 55.9 34.8 3.0 30.5 35.9 39.1 1.3 8.4 5.2 21.3 0.2 1.8 8.2 2.8 12.1 8.5 0.0 0.0 0.0 0.1 0.0 1.0 1.2 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 2.6 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 20.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 1.8 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.5 39.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.2 24.8 34.8 5.5 24.5 21.2 46.9 24.4 19.9 26.8 21.3 MAP3K1 "MAPKKK1, MEKK, MEKK1" ENSG00000095015 "Mitogen-activated protein kinase kinase kinase 1" Q13233 5 56815574-56896152 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 27.0;THP-1: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in many" 6 "olfactory region: 22.5" "Low region specificity" "Detected in all" "CAB004500, HPA046509" Approved Approved Cytosol Cytosol "CAB004500: AB_627926, HPA046509: " "unprognostic (1.77e-1)" "unprognostic (1.71e-2)" "unprognostic (4.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.48e-2)" "unprognostic (5.39e-3)" "unprognostic (5.20e-3)" "unprognostic (2.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-2)" "unprognostic (6.73e-2)" "unprognostic (1.97e-3)" "unprognostic (2.18e-2)" "unprognostic (1.58e-1)" "unprognostic (9.92e-3)" "unprognostic (1.11e-1)" 6.7 4.9 5.4 14.6 4.8 15.2 14.9 8.0 4.5 7.6 6.7 5.4 7.3 4.3 7.1 9.4 12.7 7.2 5.9 4.3 3.7 3.2 9.5 4.4 8.8 21.4 6.4 3.1 8.4 9.2 6.3 7.9 8.1 4.5 8.3 4.5 12.6 15.4 9.7 3.5 21.8 11.2 4.0 3.8 21.3 5.5 8.5 5.1 11.7 19.2 6.6 18.2 6.0 11.7 6.6 2.8 6.7 7.2 2.7 5.8 2.3 6.4 3.9 6.2 4.1 1.0 0.8 10.4 1.2 1.7 3.9 5.5 18.4 4.9 5.8 0.4 1.5 3.4 5.1 2.3 5.4 2.0 2.2 3.2 1.7 8.6 2.5 5.1 9.0 1.0 2.5 1.2 1.9 1.7 2.8 10.5 1.0 2.8 3.5 6.9 2.8 0.5 5.6 4.4 19.9 6.8 6.8 2.6 27.0 3.8 4.8 11.0 13.2 25.2 4.9 0.3 3.3 1.4 2.3 7.7 3.9 11.1 0.6 3.0 6.6 6.7 4.5 1.0 1.2 6.8 1.2 6.6 3.8 1.8 2.8 5.1 2.5 0.9 2.6 2.7 7.2 1.5 5.8 2.3 5.4 4.8 8.0 4.5 3.7 3.2 6.4 3.1 4.5 5.1 MAPKAPK2 ENSG00000162889 "Mitogen-activated protein kinase-activated protein kinase 2" P49137 1 206684944-206734283 "Cancer-related genes, Enzymes, Predicted membrane proteins" "DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 18.7" "Lineage enriched" "Detected in all" 6 "dendritic cells: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010297, HPA045556, HPA063708, HPA064435" Approved Supported Nucleoplasm,Centrosome Nucleoplasm Centrosome "CAB010297: AB_2250405, HPA045556: , HPA063708: , HPA064435: " "unprognostic (7.93e-2)" "unprognostic (1.83e-1)" "unprognostic (5.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-2)" "prognostic unfavourable (1.93e-4)" "unprognostic (9.85e-2)" "unprognostic (1.68e-1)" "unprognostic (2.00e-1)" "unprognostic (1.01e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (4.58e-6)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (6.96e-2)" "unprognostic (3.29e-2)" 23.0 25.3 11.6 21.2 15.7 58.6 23.9 11.1 14.5 19.3 25.6 17.2 14.5 25.7 20.0 18.5 23.5 17.3 26.0 89.2 12.3 8.7 33.7 26.7 26.7 21.5 16.7 6.5 23.3 19.1 16.9 22.8 13.6 15.7 20.2 14.4 17.8 19.8 14.4 62.9 18.3 32.9 18.3 14.6 37.7 23.1 21.3 14.6 26.9 24.3 25.2 28.2 22.9 46.1 1.1 18.7 3.2 1.1 2.3 1.6 0.5 20.9 8.3 11.5 12.9 34.0 20.0 14.3 14.6 33.1 22.3 21.1 15.8 10.2 10.1 10.2 29.4 15.9 8.6 15.5 16.1 11.7 6.5 16.9 10.3 10.2 26.3 24.9 56.6 27.5 19.9 21.4 23.7 18.2 19.4 45.9 18.0 26.0 10.0 18.0 13.3 11.6 25.8 24.1 3.2 16.8 12.8 9.2 11.9 17.2 29.1 20.2 14.1 24.2 17.3 20.1 17.0 23.3 19.8 59.8 53.1 8.2 22.8 15.2 6.6 1.1 0.7 1.4 1.6 1.1 1.5 1.0 1.2 1.5 0.6 1.1 0.6 1.1 3.2 2.3 1.0 18.7 1.4 0.5 11.6 15.7 11.1 14.5 12.3 8.7 16.7 6.5 15.7 14.6 MAPKAPK3 "3pK, MAPKAP3" ENSG00000114738 "Mitogen-activated protein kinase-activated protein kinase 3" Q16644 3 50611520-50649297 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 86.7;skeletal muscle: 70.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 30.2;eosinophil: 23.0;intermediate monocyte: 50.0;myeloid DC: 27.1;neutrophil: 20.5;non-classical monocyte: 61.4;plasmacytoid DC: 16.9" "Group enriched" "Detected in all" 5 "dendritic cells: 27.1;granulocytes: 23.0;monocytes: 61.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058275 Supported Nucleoplasm Nucleoplasm "HPA058275: " "unprognostic (6.46e-3)" "unprognostic (1.84e-1)" "prognostic favourable (8.08e-5)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (9.96e-2)" "unprognostic (8.77e-3)" "unprognostic (7.68e-3)" "unprognostic (1.11e-1)" "unprognostic (5.87e-2)" "unprognostic (2.19e-3)" "unprognostic (1.01e-1)" "prognostic favourable (1.90e-8)" "unprognostic (2.15e-2)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.69e-1)" 8.9 16.1 5.6 9.3 7.2 30.4 6.3 1.9 6.2 5.5 9.5 7.1 7.5 9.9 5.5 8.6 16.8 5.1 8.5 86.7 4.8 3.7 17.9 11.9 11.0 15.1 7.2 4.1 8.7 24.2 11.2 9.0 9.0 6.0 7.6 6.7 10.9 12.4 9.2 70.1 17.6 12.0 5.2 5.9 12.5 9.0 4.0 5.2 25.9 22.6 40.9 14.3 6.1 7.5 3.0 27.1 23.0 61.4 7.3 6.4 19.5 23.0 7.1 3.0 8.5 4.6 11.5 6.7 5.6 8.0 8.7 7.4 11.1 21.5 9.3 5.7 18.7 8.2 20.5 22.1 7.8 20.4 4.9 48.7 10.2 10.1 9.1 35.0 25.9 9.1 13.8 20.2 27.5 7.6 13.6 6.1 18.2 9.4 14.9 35.3 11.2 29.5 6.6 7.2 13.9 40.3 13.2 5.6 4.0 5.0 14.2 6.4 8.9 21.7 5.5 6.8 15.7 35.3 13.8 4.1 7.6 7.7 36.4 55.1 2.8 6.4 30.2 23.0 5.5 50.0 5.4 3.0 6.2 6.4 27.1 1.8 4.9 5.5 20.5 7.3 61.4 16.9 5.2 19.5 5.6 7.2 1.9 6.2 4.8 3.7 7.2 4.1 6.0 5.2 MAPKAPK5 PRAK ENSG00000089022 "Mitogen-activated protein kinase-activated protein kinase 5" Q8IW41 12 111841978-111902238 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004546, HPA015515" Supported Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB004546: AB_627910, HPA015515: AB_1853569" "unprognostic (6.45e-2)" "unprognostic (7.29e-2)" "unprognostic (1.27e-3)" "unprognostic (1.09e-2)" "unprognostic (5.52e-2)" "unprognostic (3.76e-2)" "prognostic unfavourable (2.98e-8)" "unprognostic (1.88e-1)" "unprognostic (3.09e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (3.20e-1)" "unprognostic (6.03e-2)" "unprognostic (3.39e-2)" "unprognostic (9.41e-2)" "unprognostic (3.25e-2)" 20.7 26.2 21.4 17.5 26.4 24.1 21.7 23.7 28.3 17.3 28.8 26.1 21.9 26.3 25.8 22.8 20.8 17.5 22.7 20.7 17.7 15.2 21.7 21.5 18.9 19.4 22.3 20.4 21.3 24.5 19.8 20.4 21.0 17.3 18.7 32.9 23.6 23.3 20.5 33.2 23.0 28.4 21.1 18.0 18.4 19.8 16.7 22.0 19.3 20.5 15.1 19.3 19.9 16.5 4.9 4.1 3.2 11.4 3.9 6.8 2.5 15.1 20.2 19.5 16.4 14.1 14.3 29.7 15.2 18.4 23.4 16.2 26.0 12.5 22.9 11.3 17.9 15.2 25.6 15.9 22.0 15.2 14.0 20.4 14.0 20.8 17.1 25.6 14.5 15.1 22.9 22.3 26.6 17.1 28.1 9.1 17.0 17.0 25.4 40.5 27.7 14.2 25.2 14.2 22.0 18.6 22.0 24.1 20.4 17.3 29.5 21.1 23.8 29.3 14.9 13.3 13.4 13.6 19.0 18.6 22.7 27.1 16.2 18.7 18.8 1.3 4.8 3.2 6.5 3.5 3.5 4.9 4.3 4.7 3.3 4.0 6.8 5.1 2.5 3.9 11.4 4.1 6.6 2.5 21.4 26.4 23.7 28.3 17.7 15.2 22.3 20.4 17.3 22.0 MARC2 "FLJ20605, MOSC2" ENSG00000117791 "Mitochondrial amidoxime reducing component 2" Q969Z3 1 220748225-220784815 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.3;parathyroid gland: 63.3" "Cell line enhanced" "Detected in many" "T-47d: 21.6;TIME: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 14.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015085, HPA017572" Enhanced "HPA015085: AB_1848780, HPA017572: AB_1848778" "unprognostic (8.17e-2)" "unprognostic (1.92e-2)" "unprognostic (1.80e-1)" "unprognostic (1.66e-2)" "unprognostic (1.16e-1)" "unprognostic (8.20e-2)" "prognostic favourable (1.40e-10)" "unprognostic (4.78e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-1)" "unprognostic (1.90e-1)" "unprognostic (2.05e-2)" "prognostic favourable (3.09e-4)" "unprognostic (1.45e-1)" "unprognostic (1.81e-1)" "unprognostic (2.39e-2)" "unprognostic (6.23e-2)" 8.1 8.2 5.5 4.6 5.9 0.1 9.5 2.7 5.6 4.4 19.4 3.7 5.0 16.7 4.8 6.6 6.7 3.8 10.3 10.2 5.0 3.7 38.2 73.3 12.5 2.2 4.0 5.7 9.2 12.7 63.3 4.3 3.5 8.0 6.4 5.9 6.9 24.3 3.9 8.8 2.0 36.4 8.1 1.9 4.5 9.1 7.4 2.7 0.4 19.6 6.2 2.9 5.5 9.0 2.2 0.0 14.1 0.1 0.0 0.0 0.1 5.5 4.6 2.5 3.2 6.2 2.9 1.9 4.0 7.0 4.9 4.9 3.1 7.0 0.0 2.8 3.8 0.7 0.0 5.5 4.6 0.0 9.5 0.0 9.0 6.4 5.8 2.6 0.0 4.9 8.6 1.8 0.0 13.2 3.5 0.0 3.0 1.3 0.0 9.1 4.0 4.7 0.0 7.8 0.1 17.1 6.0 1.4 3.7 6.3 0.0 8.6 21.6 3.4 20.0 0.0 3.0 6.4 7.0 1.2 0.0 0.0 1.0 0.0 0.0 14.1 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 5.9 2.7 5.6 5.0 3.7 4.0 5.7 8.0 2.7 MARCO "SCARA2, SR-A6" ENSG00000019169 "Macrophage receptor with collagenous structure" Q9UEW3 2 118942166-118994660 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 66.3;lung: 65.6;lymphoid tissue: 58.7" "Cell line enhanced" "Detected in some" "HaCaT: 3.9;THP-1: 5.6;U-2 OS: 6.0;U-266/70: 3.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 15.8;intermediate monocyte: 26.7" "Lineage enriched" "Detected in many" 5 "monocytes: 26.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063793 Enhanced Approved "Golgi apparatus,Vesicles" 24000000 "Golgi apparatus" Vesicles "HPA063793: " "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" "unprognostic (5.96e-3)" "unprognostic (3.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.58e-2)" "unprognostic (3.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (6.27e-3)" "unprognostic (5.13e-2)" "unprognostic (2.24e-3)" "unprognostic (1.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (6.55e-2)" 22.8 11.7 0.8 29.6 1.1 0.9 3.3 2.3 1.3 0.3 2.8 0.9 0.0 0.6 0.3 12.9 5.2 13.8 0.8 10.8 0.6 0.4 1.6 66.3 65.6 29.3 1.3 3.1 4.7 0.4 0.2 0.8 2.3 2.7 4.5 0.7 1.0 2.9 0.8 6.8 1.1 1.3 9.6 1.7 58.7 2.2 2.8 0.6 0.0 3.0 0.5 0.4 8.8 1.1 0.0 5.0 0.3 26.7 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 3.9 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.6 0.0 0.0 6.0 0.9 0.0 3.6 0.0 0.2 0.0 1.3 0.0 0.0 15.8 0.0 0.0 26.7 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.3 0.0 3.2 0.4 0.0 3.4 0.8 1.1 2.3 1.3 0.6 0.4 1.3 3.1 2.7 0.6 MARK3 "CTAK1, KP78, PAR-1A" ENSG00000075413 "Microtubule affinity regulating kinase 3" P27448 14 103385392-103503831 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 14 "eosinophil: 42.2" "Lineage enriched" "Detected in many" 23 "granulocytes: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024652 Approved "HPA024652: AB_1853582" "unprognostic (6.86e-2)" "unprognostic (2.93e-1)" "unprognostic (7.70e-2)" "unprognostic (3.48e-2)" "unprognostic (8.41e-2)" "unprognostic (1.50e-1)" "unprognostic (2.31e-3)" "unprognostic (2.21e-1)" "prognostic unfavourable (1.14e-4)" "unprognostic (2.29e-3)" "unprognostic (3.66e-2)" "unprognostic (1.55e-2)" "unprognostic (1.13e-1)" "unprognostic (4.71e-2)" "unprognostic (1.34e-1)" "unprognostic (1.33e-2)" "unprognostic (1.60e-1)" 20.8 31.9 24.6 20.9 29.5 62.7 19.7 59.1 30.2 25.3 20.8 33.2 19.9 17.4 28.5 28.4 24.4 23.1 22.2 33.6 24.9 22.4 20.3 20.1 25.9 20.8 29.6 23.3 24.6 30.7 28.1 30.9 20.5 27.4 19.3 20.0 23.6 18.3 23.1 40.9 19.9 19.2 26.8 20.9 26.8 26.9 24.1 30.3 29.1 25.8 23.1 23.0 20.8 29.0 1.2 1.2 42.2 1.1 0.8 1.8 0.4 13.2 16.1 23.5 17.7 28.2 22.1 20.3 23.6 24.9 28.6 27.5 12.6 20.9 15.8 15.0 22.1 25.0 25.6 25.4 36.4 18.4 11.3 20.4 17.1 15.8 53.2 23.3 13.6 25.6 23.6 23.1 47.4 26.4 21.0 37.0 21.4 35.6 15.9 20.7 17.2 24.3 20.9 24.0 12.7 25.3 28.3 20.7 20.6 25.0 17.2 22.9 23.4 20.0 22.8 15.4 10.9 28.6 21.0 24.0 30.4 19.0 18.7 18.7 20.7 0.4 1.1 42.2 1.1 0.8 0.9 1.2 1.6 1.8 1.1 0.9 1.8 1.4 3.1 0.8 0.7 1.2 1.6 0.4 24.6 29.5 59.1 30.2 24.9 22.4 29.6 23.3 27.4 30.3 MARK4 "FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D" ENSG00000007047 "Microtubule affinity regulating kinase 4" Q96L34 19 45079288-45305283 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039186 Approved Supported Cytosol Cytosol "HPA039186: AB_10796223" "unprognostic (1.64e-1)" "unprognostic (1.95e-1)" "unprognostic (1.57e-3)" "prognostic unfavourable (8.31e-8)" "unprognostic (2.02e-1)" "prognostic unfavourable (3.05e-5)" "unprognostic (1.90e-1)" "unprognostic (2.16e-2)" "unprognostic (6.26e-2)" "unprognostic (5.64e-3)" "unprognostic (1.24e-3)" "unprognostic (7.50e-2)" "unprognostic (3.80e-2)" "unprognostic (6.89e-2)" "unprognostic (7.23e-2)" "unprognostic (4.65e-2)" "unprognostic (3.02e-2)" 11.8 13.0 19.4 10.3 26.0 8.4 15.2 21.9 28.6 11.4 10.2 9.0 12.9 6.6 14.0 17.5 13.5 12.9 13.4 14.7 22.2 15.7 8.7 13.5 11.7 10.5 14.3 21.6 21.0 16.8 13.7 12.9 12.1 15.0 12.2 6.3 14.1 12.1 14.2 40.7 20.6 7.5 14.1 10.8 12.4 10.3 32.1 12.3 11.2 10.5 11.5 9.4 13.7 17.9 1.0 2.8 3.5 2.9 1.8 4.3 1.2 8.8 3.8 15.0 10.9 10.7 17.1 4.2 6.6 10.3 9.8 9.2 2.3 5.1 4.3 5.6 12.0 6.0 10.6 9.6 5.5 7.8 8.7 8.5 4.6 8.2 19.7 2.1 7.4 21.2 13.7 8.2 9.5 13.1 10.8 10.7 10.6 7.4 7.5 6.7 6.4 3.3 29.3 4.9 2.8 9.3 7.2 28.1 12.4 9.7 8.6 5.0 4.1 12.4 10.6 8.8 6.7 6.0 4.2 12.0 9.5 4.8 9.4 4.0 7.0 3.5 2.9 0.7 3.4 2.2 0.7 0.9 1.2 4.3 0.8 1.0 2.3 2.6 2.9 1.8 2.0 2.8 2.4 1.2 19.4 26.0 21.9 22.7 22.2 15.7 14.3 21.6 15.0 12.3 MARS "CMT2U, MetRS, SPG70" ENSG00000166986 "Methionyl-tRNA synthetase" P56192 12 57475445-57517569 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004125, CAB017097" Supported Approved Enhanced Cytosol 21000 Cytosol "CAB017097: , HPA004125: AB_1079312" "prognostic unfavourable (1.73e-4)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.57e-2)" "unprognostic (4.90e-3)" "prognostic unfavourable (4.55e-7)" "unprognostic (8.47e-2)" "unprognostic (1.73e-1)" "unprognostic (4.03e-2)" "unprognostic (2.85e-2)" "unprognostic (3.77e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (1.13e-2)" "unprognostic (1.96e-1)" "unprognostic (1.13e-1)" "unprognostic (2.06e-2)" 23.8 26.7 35.1 27.3 29.1 23.0 19.8 25.1 36.0 17.4 23.9 23.1 23.9 17.3 23.3 36.3 29.5 17.9 16.1 25.0 28.0 29.5 20.5 45.9 24.3 25.1 40.1 25.5 25.8 48.3 35.7 34.0 22.2 30.9 25.6 24.7 19.8 26.0 30.0 24.5 18.4 20.1 33.7 30.7 30.7 31.3 29.6 30.9 21.4 26.9 22.3 34.3 24.3 27.9 12.9 29.3 19.0 27.0 14.1 18.9 15.5 16.5 23.0 15.4 26.7 17.3 10.5 28.4 23.7 27.8 25.1 26.9 24.7 18.4 29.1 15.7 28.7 18.8 35.1 30.6 26.3 25.2 15.2 20.5 8.6 13.9 38.5 30.9 23.6 15.3 47.6 28.7 74.4 17.9 31.7 62.4 17.4 22.9 27.6 23.3 29.1 25.4 24.0 116.3 30.1 18.9 13.0 20.6 20.9 12.3 18.9 32.8 25.0 40.5 13.2 9.1 26.9 13.1 14.0 57.2 57.8 35.1 22.3 23.5 31.0 12.1 14.6 19.0 18.9 27.0 17.2 12.9 12.9 17.1 29.3 7.7 11.1 15.2 7.2 14.1 21.8 28.4 13.1 15.5 35.1 29.1 25.1 36.0 28.0 29.5 40.1 25.5 30.9 30.9 MAST1 "KIAA0973, SAST" ENSG00000105613 "Microtubule associated serine/threonine kinase 1" Q9Y2H9 19 12833951-12874951 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 51.0" "Cell line enhanced" "Detected in many" "AN3-CA: 14.8;SCLC-21H: 26.2;SH-SY5Y: 13.0;U-266/70: 10.7" "Cancer enhanced" "Detected in many" "glioma: 3.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 3.6;T-reg: 2.0" "Lineage enriched" "Detected in single" 8 "T-cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028181, HPA073106" Enhanced Approved Vesicles Vesicles "HPA028181: AB_10603872, HPA073106: " "unprognostic (6.32e-2)" "unprognostic (3.66e-2)" "unprognostic (3.93e-2)" "unprognostic (2.83e-5)" "unprognostic (1.72e-1)" "unprognostic (4.19e-2)" "unprognostic (2.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "unprognostic (8.89e-3)" "unprognostic (3.43e-2)" "unprognostic (3.84e-3)" "unprognostic (1.19e-1)" "unprognostic (7.04e-2)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" 1.2 5.2 20.4 1.7 13.6 1.6 1.5 51.0 40.1 1.1 1.5 1.4 0.0 1.7 1.3 1.2 1.3 1.2 1.6 1.3 16.1 16.3 1.2 1.3 1.2 1.3 8.8 19.5 1.5 1.6 1.2 10.4 1.2 19.9 1.2 1.3 1.6 1.3 1.2 1.2 4.1 1.6 1.3 4.2 1.2 1.5 3.9 2.7 0.0 1.2 0.0 1.3 1.2 0.2 0.4 0.0 0.0 0.2 0.0 3.6 0.1 2.2 1.0 0.9 14.8 0.0 0.0 1.2 0.1 0.1 0.2 0.6 0.5 0.9 3.6 1.6 0.0 0.0 4.3 0.0 0.0 2.5 2.9 0.3 3.6 1.6 0.0 0.7 0.7 0.3 0.0 0.5 0.5 0.0 3.1 1.9 0.0 0.5 1.5 0.4 4.4 4.5 9.8 2.9 5.1 0.2 0.1 26.2 13.0 0.5 0.9 2.6 2.4 1.3 0.0 1.8 2.8 2.0 0.4 10.7 8.5 2.1 3.3 2.0 0.1 0.0 0.2 0.0 0.0 0.2 3.6 0.1 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 2.0 0.1 20.4 13.6 51.0 34.3 16.1 16.3 8.8 19.5 19.9 2.7 MAST2 "KIAA0807, MAST205" ENSG00000086015 "Microtubule associated serine/threonine kinase 2" Q6P0Q8 1 45786987-46036124 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 4.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039722, HPA040155" Approved Approved Cytosol Cytosol "HPA039722: AB_10795294, HPA040155: AB_10793957" "unprognostic (7.80e-2)" "unprognostic (3.02e-2)" "unprognostic (5.77e-2)" "unprognostic (1.52e-1)" "unprognostic (3.82e-1)" "unprognostic (3.17e-2)" "prognostic unfavourable (4.31e-8)" "unprognostic (8.86e-2)" "unprognostic (2.34e-2)" "unprognostic (1.98e-1)" "unprognostic (1.60e-1)" "unprognostic (1.75e-1)" "prognostic unfavourable (6.85e-13)" "unprognostic (4.82e-3)" "unprognostic (2.43e-1)" "unprognostic (9.73e-2)" "unprognostic (4.90e-1)" 8.9 4.3 7.0 9.9 8.1 3.7 7.1 7.1 11.8 13.6 15.2 8.4 6.6 11.2 16.7 7.7 8.8 9.5 9.9 25.5 5.0 7.6 4.8 6.1 5.9 4.4 8.9 7.3 19.8 3.6 9.1 10.5 5.5 10.1 13.9 13.9 7.2 8.3 8.6 83.3 5.5 21.3 14.9 5.8 2.5 9.0 24.8 4.8 3.5 5.7 27.4 7.5 16.3 10.6 0.5 1.9 1.4 4.3 1.4 1.4 0.5 15.2 12.4 12.5 9.6 16.4 23.6 13.9 16.3 11.8 15.1 16.9 14.2 5.0 23.9 7.7 19.9 7.6 15.1 9.3 16.0 11.5 8.1 10.8 14.0 13.0 14.3 5.8 13.9 18.1 12.1 25.3 20.3 14.1 8.3 7.3 18.0 10.4 8.4 6.0 10.3 14.2 12.4 21.0 4.5 7.8 8.3 17.5 10.4 19.2 25.1 8.2 11.4 5.7 13.7 29.3 18.9 15.3 16.1 10.0 8.9 8.7 19.6 7.9 12.1 0.0 1.1 1.4 1.4 0.6 1.4 0.2 0.7 1.4 1.9 0.5 0.5 1.0 0.0 1.4 4.3 0.1 0.0 0.5 7.0 8.1 7.1 11.8 5.0 7.6 8.9 7.3 10.1 4.8 MAVS "Cardif, IPS-1, KIAA1271, VISA" ENSG00000088888 "Mitochondrial antiviral signaling protein" Q7Z434 20 3846799-3876123 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009187, HPA049850, HPA053524" Enhanced Enhanced Mitochondria 230000 Mitochondria "CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177" "unprognostic (1.30e-2)" "unprognostic (4.51e-2)" "unprognostic (2.17e-1)" "unprognostic (6.67e-2)" "unprognostic (1.42e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-3)" "unprognostic (2.23e-2)" "unprognostic (2.30e-2)" "unprognostic (5.95e-2)" "prognostic favourable (3.81e-4)" "unprognostic (1.92e-1)" "prognostic favourable (4.13e-5)" "unprognostic (4.97e-2)" "unprognostic (3.03e-1)" "unprognostic (3.12e-2)" "unprognostic (7.39e-2)" 15.9 13.9 13.0 15.5 17.7 10.8 25.5 17.7 15.7 12.3 18.5 17.2 15.1 17.2 14.9 10.6 17.3 13.8 12.2 15.4 12.3 8.0 13.3 13.9 18.1 17.4 19.9 9.0 18.9 22.5 23.4 13.7 12.0 13.8 13.1 18.6 13.6 15.3 22.4 39.4 22.1 17.0 17.1 13.7 12.7 15.8 5.9 17.1 15.1 14.6 14.0 14.3 18.2 21.6 5.1 5.6 6.4 6.9 5.9 4.8 4.6 17.2 20.1 8.2 10.2 22.6 15.5 6.4 10.5 13.4 11.2 8.2 15.7 11.2 7.5 6.4 14.7 21.8 9.8 15.7 11.5 4.6 4.7 14.4 7.4 24.9 12.5 9.0 6.1 15.6 13.4 18.9 11.3 11.3 16.2 5.8 10.9 15.6 13.6 7.7 5.2 11.1 10.3 11.4 7.5 11.9 17.4 6.2 6.4 11.9 23.3 10.0 12.4 8.4 17.0 15.3 5.7 18.0 12.1 11.9 14.2 5.3 6.1 11.1 7.7 4.4 6.9 6.1 4.8 5.1 3.6 3.8 3.8 3.7 4.4 5.1 4.4 4.4 6.4 5.9 5.5 5.6 3.0 4.6 13.0 17.7 17.7 15.7 12.3 8.0 19.9 9.0 13.8 17.1 MBOAT7 "BB1, hMBOA-7, LENG4, LPIAT" ENSG00000125505 "Membrane bound O-acyltransferase domain containing 7" Q96N66 19 54173412-54189882 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "basophil: 15.7;eosinophil: 30.6;neutrophil: 30.0" "Lineage enriched" "Detected in many" 10 "granulocytes: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055967 Approved Approved Cytosol Cytosol "HPA055967: " "unprognostic (1.89e-2)" "unprognostic (2.60e-2)" "unprognostic (2.60e-1)" "unprognostic (3.31e-1)" "unprognostic (3.54e-2)" "unprognostic (5.95e-2)" "prognostic unfavourable (5.55e-6)" "prognostic unfavourable (5.13e-4)" "unprognostic (5.36e-2)" "unprognostic (2.31e-2)" "unprognostic (1.08e-2)" "unprognostic (2.81e-1)" "prognostic unfavourable (6.62e-5)" "unprognostic (1.31e-1)" "unprognostic (4.75e-2)" "unprognostic (3.95e-1)" "prognostic favourable (4.31e-4)" 10.7 63.1 16.8 14.8 24.2 15.9 7.9 11.3 37.8 10.3 17.7 9.2 15.6 30.3 10.5 8.0 10.5 11.5 14.3 6.9 18.5 23.4 10.5 11.6 11.5 14.7 10.0 18.8 15.1 24.4 23.8 12.4 11.9 21.6 11.4 6.1 8.1 10.8 28.8 7.9 10.0 28.5 6.5 9.2 14.4 16.4 30.8 6.8 7.6 12.7 5.0 6.3 22.6 17.5 0.3 2.9 30.6 2.1 0.9 0.5 0.8 14.0 8.4 1.3 13.8 4.5 3.6 12.2 24.7 8.8 5.7 11.3 4.8 16.0 3.6 11.1 5.3 28.8 0.0 5.0 1.1 5.0 16.4 3.9 9.0 3.1 4.4 8.9 56.5 6.6 3.4 2.8 1.9 10.2 14.5 11.6 2.0 8.5 2.6 3.1 5.8 17.9 8.3 2.4 7.4 5.7 17.0 0.5 3.7 16.5 10.0 5.0 10.2 0.8 20.4 12.1 4.3 3.6 9.7 5.3 9.2 1.5 17.4 6.3 8.0 15.7 2.1 30.6 0.2 1.5 0.5 0.2 0.2 0.2 2.9 0.3 0.1 0.2 30.0 0.9 0.8 0.8 0.2 0.8 16.8 24.2 11.3 37.8 18.5 23.4 10.0 18.8 21.6 6.8 MBTPS1 "KIAA0091, PCSK8, S1P, SKI-1" ENSG00000140943 "Membrane bound transcription factor peptidase, site 1" Q14703 16 84053761-84116906 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Protease, Serine protease" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056109 Supported "HPA056109: " "unprognostic (1.50e-1)" "unprognostic (9.73e-2)" "unprognostic (1.58e-1)" "unprognostic (3.10e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (2.50e-1)" "unprognostic (2.02e-1)" "unprognostic (1.47e-1)" "unprognostic (1.59e-1)" "unprognostic (1.00e-2)" "unprognostic (2.19e-1)" "prognostic favourable (2.21e-5)" "unprognostic (2.62e-1)" "unprognostic (2.92e-1)" "unprognostic (6.63e-2)" "unprognostic (6.88e-2)" 26.6 25.3 15.2 17.9 32.0 13.2 27.2 29.9 30.2 27.5 23.6 20.5 21.5 15.8 33.5 22.2 18.8 29.2 20.4 31.5 15.7 18.2 23.4 28.9 22.1 17.1 14.8 15.9 34.3 32.6 47.5 38.7 28.5 15.9 24.0 21.2 33.1 29.7 26.8 16.2 18.7 19.0 25.9 11.4 21.8 23.5 17.7 16.1 24.0 36.7 16.7 23.2 26.1 19.6 10.9 11.5 12.8 14.3 14.4 16.7 15.4 15.2 19.4 17.5 24.2 41.2 33.5 13.7 25.7 39.9 22.8 17.3 13.7 22.7 14.7 26.8 36.9 16.9 15.9 17.9 25.4 13.2 17.9 10.7 18.8 19.2 19.9 25.9 23.7 34.4 25.9 21.0 18.1 29.6 13.9 13.0 13.8 26.5 14.2 14.5 16.2 13.9 18.5 9.3 10.6 18.5 12.7 13.3 16.7 49.7 13.8 19.2 43.2 23.9 31.4 23.7 17.4 14.1 12.1 16.5 30.5 28.2 17.3 15.8 14.4 6.6 14.3 12.8 15.8 12.1 16.2 10.9 13.6 14.7 11.5 9.9 16.7 14.8 4.1 14.4 9.8 6.4 8.7 15.4 15.2 32.0 29.9 30.2 15.7 18.2 14.8 15.9 15.9 16.1 MCAM "CD146, MUC18" ENSG00000076706 "Melanoma cell adhesion molecule" P43121 11 119308529-119321521 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "HUVEC TERT2: 125.3;TIME: 122.3;WM-115: 97.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002147, HPA008848" Enhanced Approved "Plasma membrane" 2600000000 "Plasma membrane" "CAB002147: AB_563499, HPA008848: AB_1078445" "unprognostic (6.45e-2)" "prognostic unfavourable (7.61e-4)" "unprognostic (7.03e-2)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (8.42e-2)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.58e-1)" "unprognostic (9.39e-2)" "prognostic unfavourable (5.14e-4)" "unprognostic (8.75e-3)" "unprognostic (7.84e-2)" "unprognostic (2.31e-1)" "unprognostic (2.79e-3)" 88.2 8.9 6.4 18.5 10.3 0.4 86.1 17.7 13.4 22.3 33.2 13.3 11.7 8.3 40.1 32.5 27.6 29.3 50.9 32.0 7.1 8.2 7.5 3.8 23.8 13.0 7.4 8.1 23.6 6.2 54.5 3.9 47.4 11.1 22.9 9.7 25.0 9.4 44.9 21.1 10.5 15.6 67.1 6.5 9.6 25.0 18.4 5.4 2.2 13.1 15.7 4.8 55.0 24.3 0.8 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.5 0.5 0.0 2.5 0.0 2.6 0.3 0.0 3.3 1.5 1.9 0.1 0.1 10.7 1.1 0.3 4.3 0.9 1.7 6.0 1.5 0.1 12.0 2.1 5.9 0.0 0.0 1.7 0.0 4.6 2.1 125.3 4.0 0.1 0.6 0.0 0.1 1.0 2.2 0.4 0.1 16.7 3.5 3.0 0.0 1.4 0.4 9.6 0.2 27.5 0.4 0.1 122.3 0.3 17.9 0.0 9.6 0.2 0.2 0.0 4.9 0.0 97.3 0.0 0.0 0.0 0.0 0.0 2.2 0.8 0.6 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 6.4 10.3 17.7 13.4 7.1 8.2 7.4 8.1 11.1 5.4 MCEMP1 "C19orf59, MGC132456" ENSG00000183019 "Mast cell expressed membrane protein 1" Q8IX19 19 7676628-7679826 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 36.5;bone marrow: 30.9;lung: 66.4;lymphoid tissue: 24.2" "Group enriched" "Detected in some" 6 "THP-1: 18.8;U-937: 58.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 2.9" "Group enriched" "Detected in some" 5 "classical monocyte: 36.5;neutrophil: 16.6" "Group enriched" "Detected in many" 5 "granulocytes: 16.6;monocytes: 36.5" HPA014731 Enhanced "HPA014731: AB_1845619" "unprognostic (4.84e-2)" "unprognostic (9.81e-4)" "unprognostic (2.41e-1)" "unprognostic (4.36e-2)" "unprognostic (8.85e-3)" "unprognostic (2.62e-3)" "unprognostic (5.57e-3)" "unprognostic (1.42e-1)" "unprognostic (2.19e-1)" "unprognostic (4.36e-2)" "unprognostic (1.77e-2)" "unprognostic (3.50e-1)" "unprognostic (2.69e-5)" "unprognostic (1.15e-2)" "unprognostic (7.37e-2)" "unprognostic (1.93e-2)" "unprognostic (7.95e-2)" 2.2 0.3 0.3 10.0 0.5 30.9 0.5 0.4 0.9 0.1 0.3 0.0 0.0 0.1 0.1 0.2 0.3 1.2 0.2 4.8 0.2 0.2 0.6 1.3 66.4 11.8 2.9 0.0 0.4 0.4 0.0 0.1 0.8 0.6 0.4 0.0 0.1 0.6 0.0 0.2 0.1 0.3 2.4 0.9 24.2 0.6 0.7 0.3 0.3 0.7 0.0 0.1 0.5 2.9 0.0 5.3 16.6 36.5 0.2 0.1 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.0 36.5 0.9 0.1 2.1 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.1 16.6 0.2 0.1 0.3 0.1 11.6 0.3 0.5 0.4 0.9 0.2 0.2 2.9 0.0 0.6 0.3 MCL1 "BCL2L3, Mcl-1" ENSG00000143384 "MCL1, BCL2 family apoptosis regulator" Q07820 1 150574551-150579738 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "U-698: 328.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002781, HPA008455, HPA031125, CAB068195" Approved Enhanced Mitochondria Mitochondria "CAB002781: , CAB068195: , HPA008455: AB_1079334, HPA031125: AB_10602026" "unprognostic (3.82e-2)" "unprognostic (8.79e-2)" "unprognostic (9.15e-2)" "unprognostic (2.05e-2)" "unprognostic (1.34e-1)" "unprognostic (3.91e-2)" "unprognostic (3.16e-2)" "unprognostic (2.43e-2)" "unprognostic (1.29e-1)" "unprognostic (8.60e-2)" "unprognostic (1.57e-2)" "unprognostic (1.65e-2)" "prognostic unfavourable (7.16e-4)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "unprognostic (4.87e-2)" "unprognostic (4.46e-2)" 67.7 37.1 19.0 59.3 21.6 134.5 46.3 15.3 18.9 35.9 38.5 19.0 23.9 21.2 36.1 27.6 56.5 57.2 73.3 32.5 20.4 14.9 30.5 76.7 61.8 52.4 28.2 11.4 32.1 41.9 20.3 27.7 59.4 26.7 34.0 30.7 31.0 36.0 24.5 39.8 45.7 50.2 38.9 26.4 51.1 44.3 19.8 23.0 32.3 45.4 53.3 57.4 40.6 59.4 5.0 6.2 42.1 8.0 3.8 11.1 3.9 9.8 5.0 9.4 5.6 19.1 20.2 12.9 12.1 12.4 12.7 10.3 6.3 8.1 12.5 7.1 8.6 13.2 7.1 14.4 12.8 10.3 4.9 5.1 8.1 7.2 15.1 8.6 11.6 11.0 16.6 12.4 24.2 13.9 11.4 18.2 16.6 10.8 4.2 6.6 17.4 8.9 6.5 7.6 6.5 14.0 7.1 7.3 9.9 8.6 11.7 15.5 7.4 13.3 17.1 8.1 8.5 5.1 15.1 23.3 27.3 328.0 13.9 6.8 10.6 7.6 8.0 18.8 6.1 6.5 7.2 5.0 8.0 6.7 6.2 4.6 9.6 7.2 42.1 3.8 5.8 3.7 11.1 3.9 19.0 21.6 15.3 18.9 20.4 14.9 28.2 11.4 26.7 23.0 MCOLN1 "ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1" ENSG00000090674 "Mucolipin 1" Q9GZU1 19 7522626-7534009 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Ion channel" "Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 30.9;monocytes: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031763, CAB032637, HPA069495" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: " "unprognostic (5.51e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-2)" "unprognostic (3.30e-2)" "unprognostic (2.66e-1)" "unprognostic (4.07e-2)" "unprognostic (8.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.79e-2)" "unprognostic (1.47e-1)" "prognostic favourable (5.60e-5)" "unprognostic (1.36e-1)" "prognostic favourable (5.67e-4)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" 18.9 27.5 10.1 10.3 11.9 10.0 10.3 8.2 19.7 7.7 9.6 11.2 7.2 9.6 8.8 9.5 11.2 8.4 11.7 11.7 9.0 9.2 11.5 20.6 17.9 20.6 10.6 10.0 7.8 10.5 9.8 26.0 17.9 13.6 8.8 6.9 9.7 9.2 8.0 14.2 13.9 8.0 9.5 10.4 38.3 8.9 6.5 9.4 7.0 6.2 7.6 5.1 12.5 8.7 1.3 6.2 30.9 28.9 2.8 2.7 4.4 6.3 6.5 3.2 10.8 18.7 6.0 9.2 11.9 9.6 14.4 12.5 5.0 5.6 3.5 14.7 8.0 2.9 5.4 4.1 4.3 6.9 11.9 3.1 6.4 4.0 16.4 3.6 14.0 8.5 9.6 13.8 2.4 6.1 5.9 15.9 8.3 2.1 4.9 3.6 7.1 14.1 6.8 5.4 7.6 5.4 5.5 8.3 10.2 5.1 9.0 15.0 5.4 6.3 7.5 6.9 3.9 27.8 8.8 12.3 18.8 2.5 11.1 5.0 10.3 30.9 13.7 29.7 2.3 27.5 2.0 1.1 2.0 1.9 5.6 1.3 1.9 2.0 12.2 2.8 28.9 6.2 2.7 4.4 10.1 11.9 8.2 19.7 9.0 9.2 10.6 10.0 13.6 9.4 MCTP1 FLJ22344 ENSG00000175471 "Multiple C2 and transmembrane domain containing 1" Q6DN14 5 94703741-95284575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 49.2;brain: 42.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 20.7;Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 41 "basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 52 "dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019018 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA019018: AB_1853665" "unprognostic (1.20e-2)" "unprognostic (6.70e-4)" "unprognostic (1.77e-2)" "unprognostic (1.03e-2)" "unprognostic (1.16e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" "unprognostic (1.86e-1)" "unprognostic (6.99e-2)" "unprognostic (5.31e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-6)" "unprognostic (5.38e-2)" "unprognostic (3.65e-2)" "unprognostic (2.89e-3)" "unprognostic (4.43e-2)" 49.2 2.7 6.5 11.4 42.4 36.9 18.3 18.3 16.5 6.9 7.2 0.3 4.4 5.0 11.1 9.2 6.5 4.1 16.7 4.6 8.5 7.4 3.0 3.8 11.3 5.5 4.1 3.8 3.3 3.4 3.1 5.2 7.1 3.9 5.9 7.3 1.0 4.3 2.7 5.1 4.5 4.8 10.9 5.7 8.2 5.3 4.0 8.1 5.5 5.0 21.2 4.3 17.3 12.6 0.3 10.1 18.7 19.2 0.2 0.2 3.3 0.1 2.0 1.3 0.0 19.9 8.0 0.0 0.1 9.8 0.9 3.2 0.0 5.2 7.2 7.7 0.0 0.0 0.1 0.1 1.1 0.0 1.4 4.3 4.8 0.0 2.6 8.9 5.8 2.9 0.0 3.6 13.1 20.7 0.1 28.3 7.4 0.2 0.5 6.8 1.6 8.2 0.3 0.0 28.0 21.3 11.3 4.0 0.2 0.6 0.0 14.6 0.0 8.4 0.1 3.6 5.6 0.1 1.6 2.0 0.0 0.0 16.9 14.9 3.5 11.5 12.9 5.8 0.0 19.2 0.0 0.3 0.0 0.1 10.1 0.1 0.2 0.0 18.7 0.2 17.6 5.3 0.0 3.3 6.5 42.4 18.3 12.2 8.5 7.4 4.1 3.8 3.9 8.1 MCTP2 "FLJ11175, FLJ33303" ENSG00000140563 "Multiple C2 and transmembrane domain containing 2" Q6DN12 15 94231538-94483952 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.6" "Cell line enhanced" "Detected in many" "HEL: 14.2;HMC-1: 11.7;U-698: 15.5;U-87 MG: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA051176, HPA070541" Uncertain Enhanced Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA051176: , HPA070541: " "unprognostic (1.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.63e-2)" "unprognostic (7.15e-4)" "unprognostic (3.57e-2)" "unprognostic (2.66e-3)" "unprognostic (3.45e-2)" "unprognostic (3.68e-3)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (2.97e-1)" "unprognostic (1.80e-1)" "prognostic unfavourable (2.18e-5)" "unprognostic (5.87e-2)" "unprognostic (4.36e-1)" "unprognostic (1.76e-3)" "unprognostic (9.41e-2)" 5.3 4.1 0.8 19.7 1.7 12.6 2.7 0.7 1.5 5.4 12.3 0.0 6.9 5.6 4.0 9.5 5.7 4.5 10.3 4.6 1.0 2.2 3.6 2.3 12.4 18.4 2.5 0.8 3.8 10.0 5.3 24.4 17.1 0.6 6.8 10.2 2.5 16.8 9.6 0.8 4.0 10.9 4.0 0.9 41.6 3.7 1.7 0.4 3.0 8.7 4.1 12.9 6.2 14.8 2.7 0.1 21.2 0.5 6.8 4.4 1.1 2.4 0.0 0.0 0.0 0.0 0.0 1.7 1.3 0.8 0.2 0.1 1.6 3.1 7.1 0.3 0.0 5.6 0.1 4.6 0.0 1.3 0.5 14.2 1.9 0.8 1.0 2.9 11.7 0.8 5.7 0.1 5.8 0.0 0.5 4.0 0.0 0.0 1.3 7.9 0.5 2.6 3.2 0.1 2.7 0.3 7.4 1.4 0.3 0.1 2.4 0.9 0.0 0.2 0.0 0.0 1.2 0.0 0.0 8.6 0.1 15.5 17.7 7.7 0.8 3.2 0.5 7.7 4.4 0.1 2.1 2.2 1.2 1.9 0.0 2.7 0.5 1.9 21.2 6.8 0.5 0.1 0.0 1.1 0.8 1.7 0.7 1.5 1.0 2.2 2.5 0.8 0.6 0.4 MDFIC "HIC, MDFIC1" ENSG00000135272 "MyoD family inhibitor domain containing" Q9P1T7 7 114922154-115019202 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA030716 Approved Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" "Nucleoplasm, Golgi apparatus" "HPA030716: AB_10671364" "unprognostic (1.24e-3)" "unprognostic (4.15e-1)" "unprognostic (2.38e-2)" "unprognostic (2.29e-2)" "unprognostic (1.39e-1)" "unprognostic (3.13e-3)" "unprognostic (1.73e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (6.38e-3)" "unprognostic (3.68e-2)" "prognostic unfavourable (3.65e-4)" "unprognostic (6.13e-3)" "unprognostic (7.10e-2)" "unprognostic (1.42e-1)" "unprognostic (3.55e-1)" 39.4 21.1 4.6 29.3 4.6 5.1 62.4 2.5 4.0 18.4 15.5 5.1 13.9 3.7 22.8 8.8 18.2 7.7 9.7 15.9 4.4 4.7 8.3 8.6 17.5 48.0 4.7 4.1 11.2 5.9 15.2 6.6 11.2 13.6 11.9 5.8 11.2 14.4 19.4 13.7 8.1 9.4 16.7 13.7 28.3 6.6 4.0 3.4 17.8 16.1 11.2 24.1 18.0 25.4 3.6 8.1 1.1 2.5 2.7 6.9 1.2 0.0 4.8 6.3 0.0 13.5 18.7 2.7 24.0 28.9 5.5 7.0 0.1 14.3 3.4 0.3 15.7 2.8 1.9 4.1 9.5 11.8 5.6 0.0 5.9 0.0 6.9 7.3 4.9 15.6 4.0 12.5 3.9 3.6 0.0 23.2 18.7 0.0 0.0 0.6 5.1 5.4 0.0 18.6 7.2 5.6 5.8 0.2 0.0 10.4 9.8 10.8 3.1 6.6 10.3 20.5 5.8 38.0 11.5 9.5 0.0 0.0 14.4 0.0 17.5 0.2 1.5 1.1 3.0 1.9 4.6 3.6 6.9 6.4 2.4 3.2 4.0 3.4 0.1 2.7 2.5 8.1 5.6 1.2 4.6 4.6 2.5 4.0 4.4 4.7 4.7 4.1 13.6 3.4 MDGA2 MAMDC1 ENSG00000139915 "MAM domain containing glycosylphosphatidylinositol anchor 2" Q7Z553 14 46840092-47674954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 8.6;testis: 7.9" "Cell line enhanced" "Detected in some" "AF22: 7.9;T-47d: 3.9;U-138 MG: 8.6;U-2 OS: 6.2;U-87 MG: 3.4;WM-115: 5.3" "Cancer enhanced" "Detected in single" "melanoma: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003084 Uncertain "HPA003084: AB_1079302" "unprognostic (3.27e-1)" "unprognostic (5.38e-2)" "unprognostic (9.13e-2)" "unprognostic (8.92e-3)" "unprognostic (6.36e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.49e-3)" "unprognostic (3.62e-3)" "unprognostic (3.06e-2)" "unprognostic (5.89e-1)" 0.2 0.3 1.4 0.0 1.5 0.0 0.2 0.4 8.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.3 2.2 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 3.3 0.0 0.5 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.9 0.0 0.0 8.6 6.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 MDM1 ENSG00000111554 "Mdm1 nuclear protein" Q8TC05 12 68272443-68332381 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA040411, HPA041594" Uncertain Supported Centrosome,Cytosol Centrosome Cytosol "HPA040411: AB_10805711, HPA041594: AB_10793968" "unprognostic (7.41e-2)" "prognostic favourable (6.01e-4)" "unprognostic (8.58e-2)" "unprognostic (2.62e-3)" "unprognostic (1.21e-1)" "unprognostic (3.50e-3)" "unprognostic (4.24e-3)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" "unprognostic (2.92e-1)" "unprognostic (2.56e-3)" "unprognostic (3.13e-2)" "unprognostic (4.29e-3)" "unprognostic (1.29e-1)" "unprognostic (2.84e-1)" "unprognostic (4.63e-2)" "unprognostic (5.23e-3)" 7.0 6.7 11.5 11.9 11.4 15.4 10.0 8.2 12.7 11.9 28.7 9.6 12.4 5.1 15.2 12.7 5.4 20.3 6.5 6.7 12.3 10.0 8.8 4.9 6.8 12.8 11.4 10.5 10.9 11.3 8.8 22.8 6.0 14.9 12.3 11.1 9.0 6.8 15.9 3.8 4.2 9.0 18.8 11.4 9.5 9.8 20.7 12.4 14.6 11.0 5.3 13.4 17.0 8.9 7.1 4.0 13.3 17.2 6.0 8.1 5.4 4.9 4.1 8.0 7.7 4.0 5.4 6.1 6.6 3.7 10.6 9.8 4.9 2.3 11.4 4.4 3.0 5.1 5.4 3.5 12.1 14.9 5.2 25.0 5.3 3.4 6.1 13.8 9.9 2.4 4.6 7.1 6.9 5.9 4.7 12.8 6.1 3.6 19.5 9.8 4.2 5.1 19.2 7.1 3.3 5.0 4.3 7.3 3.9 6.4 3.8 6.5 9.2 10.0 3.1 8.5 3.7 5.3 6.0 6.7 19.5 7.7 4.5 9.0 5.4 6.0 4.7 13.3 5.0 11.1 8.1 6.8 6.4 5.2 4.0 7.1 7.7 6.2 3.1 6.0 17.2 2.3 5.9 5.4 11.5 11.4 8.2 12.7 12.3 10.0 11.4 10.5 14.9 12.4 MED17 "CRSP6, CRSP77, DRIP80, SRB4, TRAP80" ENSG00000042429 "Mediator complex subunit 17" Q9NVC6 11 93784227-93814963 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA046619 Approved "Nuclear speckles,Cytosol" "Nuclear speckles" Cytosol "HPA046619: " "prognostic unfavourable (4.94e-4)" "unprognostic (2.92e-1)" "unprognostic (2.72e-3)" "unprognostic (1.38e-1)" "unprognostic (6.71e-2)" "unprognostic (1.42e-1)" "prognostic unfavourable (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.48e-3)" "unprognostic (7.73e-2)" "unprognostic (1.41e-1)" "unprognostic (4.59e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-1)" "unprognostic (2.22e-1)" "unprognostic (5.56e-3)" "unprognostic (1.48e-1)" 9.0 7.4 5.8 9.9 8.0 9.5 9.2 13.9 10.7 10.7 10.2 9.0 9.4 4.3 12.1 7.5 7.9 10.4 7.3 11.5 6.3 5.4 6.4 4.6 8.2 8.1 9.5 7.3 13.8 9.9 5.4 13.1 9.5 6.1 8.2 4.9 8.0 9.4 6.6 9.3 10.2 14.0 7.7 7.7 13.9 12.1 7.9 8.8 20.7 7.8 5.5 9.8 11.2 11.6 10.5 6.8 10.8 5.7 10.2 8.5 5.1 3.0 1.0 2.6 5.6 3.2 0.4 5.1 6.7 2.3 4.5 2.8 5.3 6.3 5.0 11.3 0.6 9.4 2.4 1.4 1.2 6.0 2.7 5.6 3.4 1.5 1.7 9.4 9.5 1.3 3.3 3.3 2.2 1.8 5.0 3.0 2.7 0.9 11.2 2.7 4.9 0.8 8.6 7.6 4.1 2.7 2.1 9.2 11.7 5.6 4.7 2.8 7.0 2.3 6.1 7.0 5.6 9.3 5.8 4.7 9.1 3.6 1.8 6.7 8.0 4.9 4.6 10.8 6.4 5.7 7.6 10.5 8.2 8.0 6.0 9.0 8.5 4.8 4.7 10.2 3.3 6.8 8.1 5.1 5.8 8.0 13.9 7.9 6.3 5.4 9.5 7.3 6.1 8.8 MED23 "CRSP130, CRSP3, DRIP130, Sur2" ENSG00000112282 "Mediator complex subunit 23" Q9ULK4 6 131573966-131628229 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070341 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA070341: " "unprognostic (1.11e-2)" "unprognostic (4.66e-2)" "unprognostic (5.51e-3)" "unprognostic (1.80e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (6.62e-3)" "unprognostic (4.47e-1)" "unprognostic (1.64e-1)" "unprognostic (6.81e-3)" "unprognostic (1.44e-2)" "unprognostic (3.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (2.21e-1)" "unprognostic (2.44e-2)" "unprognostic (2.53e-2)" 14.0 17.1 12.1 19.7 12.7 21.8 16.3 23.0 17.6 14.7 12.3 12.1 17.8 12.7 21.6 13.3 14.9 14.6 10.2 10.2 11.7 8.3 12.2 9.6 13.1 15.4 15.9 12.3 20.5 18.7 23.9 16.1 12.3 11.3 13.9 14.4 12.3 19.8 16.8 14.8 15.0 15.4 14.3 11.0 13.7 14.9 13.1 13.3 22.7 18.0 7.4 16.7 16.2 20.7 6.0 6.8 8.8 5.7 15.0 10.9 4.6 5.1 5.8 13.8 17.4 17.2 13.2 12.7 13.1 14.9 12.1 17.7 6.0 7.3 11.6 9.6 13.4 9.4 7.4 8.5 18.9 13.1 10.3 12.1 10.6 10.2 12.5 20.0 20.7 11.5 10.2 13.4 13.7 15.0 15.5 12.2 12.8 8.0 15.1 12.6 6.6 5.8 13.7 8.6 6.9 9.4 7.7 10.4 9.4 9.3 13.1 8.5 3.6 14.1 15.1 9.0 10.3 14.4 11.9 13.0 8.7 16.7 11.1 9.2 12.1 4.5 5.3 8.8 7.3 5.7 10.9 6.0 7.2 8.0 6.8 5.2 7.4 6.7 4.5 15.0 3.9 3.6 7.8 4.6 12.1 12.7 23.0 17.6 11.7 8.3 15.9 12.3 11.3 13.3 MEGF8 "C19orf49, EGFL4, FLJ22365, SBP1" ENSG00000105429 "Multiple EGF like domains 8" Q7Z7M0 19 42325609-42378769 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049248 Approved 370000000 "HPA049248: " "unprognostic (5.52e-3)" "unprognostic (1.52e-1)" "unprognostic (5.35e-2)" "unprognostic (1.66e-2)" "unprognostic (1.20e-1)" "unprognostic (4.63e-2)" "unprognostic (3.25e-2)" "unprognostic (8.58e-2)" "unprognostic (9.25e-2)" "unprognostic (3.64e-2)" "prognostic favourable (6.03e-4)" "unprognostic (4.33e-2)" "prognostic favourable (2.17e-7)" "unprognostic (1.18e-1)" "unprognostic (7.34e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" 15.7 10.6 17.0 5.6 22.5 3.0 8.1 22.9 31.3 8.3 7.7 13.6 8.6 6.5 9.2 9.9 6.3 8.5 6.9 13.1 15.8 16.3 11.6 5.2 6.1 5.0 12.8 15.2 12.1 6.9 28.8 8.4 8.2 11.7 10.9 6.2 9.1 9.9 11.7 12.0 8.1 6.7 9.1 8.4 8.3 5.9 6.0 12.2 3.2 8.5 6.1 4.6 7.0 9.2 2.0 1.5 1.7 2.1 2.2 1.1 0.6 6.8 12.1 12.7 3.1 28.7 13.6 4.7 6.0 8.4 3.5 5.4 2.4 6.5 5.9 12.9 8.2 3.7 9.2 7.7 3.4 7.0 8.2 4.2 5.8 3.8 11.0 6.0 5.4 16.4 7.9 4.1 6.4 11.7 6.2 2.7 6.4 4.4 1.4 3.7 6.5 2.0 5.7 11.4 1.4 9.4 9.0 6.7 16.6 7.3 4.0 7.8 4.0 13.4 17.4 7.2 7.2 2.3 8.0 6.3 3.4 3.3 7.9 3.6 17.1 1.7 1.7 1.4 1.1 2.1 1.1 1.0 0.8 0.5 1.5 2.0 0.8 0.8 1.1 2.2 2.0 1.3 0.9 0.6 17.0 22.5 22.9 30.3 15.8 16.3 12.8 15.2 11.7 12.2 MEGF9 EGFL5 ENSG00000106780 "Multiple EGF like domains 9" Q9H1U4 9 120600813-120714470 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.1" "Group enriched" "Detected in many" 5 "granulocytes: 19.1;monocytes: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014319, HPA050238" Approved Approved Nucleoplasm,Cytosol 32000000 Nucleoplasm Cytosol "HPA014319: AB_1848035, HPA050238: " "unprognostic (1.18e-1)" "unprognostic (5.33e-2)" "unprognostic (1.84e-1)" "unprognostic (1.75e-2)" "unprognostic (3.30e-1)" "unprognostic (3.68e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-2)" "unprognostic (3.63e-2)" "unprognostic (1.13e-2)" "unprognostic (5.92e-2)" "unprognostic (4.97e-2)" "prognostic favourable (5.48e-11)" "unprognostic (1.90e-2)" "unprognostic (1.50e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" 15.0 9.6 22.4 9.9 21.7 15.4 12.8 27.9 26.2 11.7 6.7 29.3 2.1 6.4 6.1 5.5 12.8 12.8 7.9 6.1 24.6 16.4 12.5 33.8 17.9 7.0 28.6 16.0 9.3 5.4 15.6 6.8 4.8 22.6 8.4 5.8 21.4 7.8 6.6 6.0 19.0 6.5 8.1 21.1 12.9 7.2 3.1 25.8 3.2 25.5 4.6 5.6 11.3 9.6 0.3 2.2 19.1 5.7 0.3 0.6 1.3 2.8 11.3 9.9 3.0 13.8 8.5 3.2 2.9 2.5 0.8 1.1 0.6 1.7 10.6 4.5 2.8 12.4 14.2 5.1 2.1 8.6 4.1 1.4 21.1 4.6 5.9 4.2 9.1 4.0 15.5 4.9 3.9 6.9 3.3 5.1 8.2 8.2 8.3 1.5 0.4 3.0 6.4 11.0 4.5 20.3 9.3 9.8 8.3 3.5 2.8 8.3 8.6 4.3 8.1 3.0 1.7 10.9 4.4 9.3 10.9 3.5 4.2 5.0 16.9 0.4 5.7 3.6 0.6 1.9 0.2 0.3 0.6 0.5 2.2 0.3 0.5 0.4 19.1 0.3 3.0 0.2 0.5 1.3 22.4 21.7 27.9 21.5 24.6 16.4 28.6 16.0 22.6 25.8 MELK KIAA0175 ENSG00000165304 "Maternal embryonic leucine zipper kinase" Q14680 9 36572862-36677683 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 4.8" "Lineage enriched" "Detected in many" 5 "T-cells: 4.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA017214 Uncertain "HPA017214: AB_1853798" "unprognostic (5.03e-2)" "unprognostic (9.57e-2)" "unprognostic (2.27e-2)" "unprognostic (3.42e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "prognostic unfavourable (2.91e-7)" "prognostic unfavourable (3.99e-4)" "unprognostic (1.26e-2)" "unprognostic (1.60e-2)" "prognostic unfavourable (4.58e-4)" "unprognostic (4.69e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (8.86e-3)" "unprognostic (1.37e-1)" "unprognostic (2.40e-1)" "unprognostic (1.35e-1)" 1.5 1.1 0.3 11.4 0.6 7.7 2.6 0.2 0.8 2.1 5.9 0.3 0.1 4.5 1.2 1.5 12.2 0.4 1.6 1.3 0.5 0.4 1.2 1.3 2.0 8.3 0.4 0.1 0.7 0.8 0.0 0.3 6.3 0.5 0.7 7.8 0.4 2.3 0.1 0.9 2.8 4.6 1.9 1.0 5.2 2.9 11.3 0.4 42.4 0.5 7.2 12.6 1.5 3.3 0.1 0.6 1.0 0.1 0.4 4.8 0.5 35.4 18.2 24.6 14.5 3.4 5.9 14.3 26.3 18.6 36.9 45.6 14.0 14.0 11.9 8.5 12.9 12.2 21.4 16.5 40.8 32.3 8.5 9.3 21.7 13.9 1.3 14.4 11.8 2.1 3.0 28.5 16.2 18.6 11.9 19.0 30.2 11.8 17.9 6.8 19.6 14.3 16.6 16.6 7.6 11.3 12.0 16.7 12.4 14.0 13.5 8.5 11.3 6.9 9.1 19.9 25.2 16.8 23.9 3.7 13.5 17.8 12.6 10.7 27.0 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.8 1.0 0.0 0.0 0.0 0.6 0.0 0.4 0.1 0.6 4.8 0.5 0.3 0.6 0.2 0.8 0.5 0.4 0.4 0.1 0.5 0.4 MEMO1 "C2orf4, CGI-27, MEMO" ENSG00000162959 "Mediator of cell motility 1" Q9Y316 2 31865060-32011230 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042603, HPA057952" Approved Approved Vesicles Vesicles "HPA042603: AB_10806243, HPA057952: " "unprognostic (1.33e-1)" "unprognostic (1.28e-3)" "unprognostic (1.81e-1)" "unprognostic (2.94e-5)" "unprognostic (1.02e-2)" "unprognostic (3.96e-2)" "unprognostic (2.24e-4)" "unprognostic (1.70e-2)" "unprognostic (6.73e-2)" "unprognostic (8.37e-3)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (5.95e-9)" "unprognostic (6.57e-2)" "unprognostic (2.26e-1)" "unprognostic (3.77e-2)" "unprognostic (4.23e-2)" 9.3 14.9 11.5 12.1 24.2 22.4 8.3 23.5 21.5 9.1 9.5 9.4 12.5 9.4 8.9 9.8 19.6 7.8 7.6 19.8 12.9 10.1 9.2 20.0 8.2 16.2 10.2 13.8 6.7 10.2 9.3 13.0 11.4 12.1 11.4 12.0 11.6 9.9 10.5 31.3 11.0 8.9 11.0 9.8 12.4 9.8 33.0 9.1 32.4 8.2 3.9 18.4 14.2 10.6 6.9 17.0 11.4 18.2 8.7 12.0 6.8 31.8 13.9 15.5 14.4 13.7 19.5 27.7 27.4 17.3 15.8 12.3 18.8 18.2 34.0 8.9 18.9 16.2 18.3 24.1 21.1 22.5 10.0 24.5 9.1 22.9 19.1 24.5 20.5 14.5 15.8 15.5 15.9 24.8 17.6 15.7 27.4 14.0 29.2 50.3 22.7 17.5 19.9 17.6 26.3 31.3 31.4 13.1 24.2 14.1 34.5 21.7 14.5 29.6 22.6 22.1 24.3 17.5 30.1 16.5 24.8 29.0 20.1 35.3 17.2 1.2 11.8 11.4 5.6 16.3 4.3 6.9 7.0 6.8 17.0 5.3 5.0 5.1 9.7 8.7 18.2 6.5 12.0 6.8 11.5 24.2 23.5 21.5 12.9 10.1 10.2 13.8 12.1 9.1 MEP1A PPHA ENSG00000112818 "Meprin A subunit alpha" Q16819 6 46793390-46839782 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 52 "intestine: 243.0" "Cell line enhanced" "Detected in some" "BEWO: 3.0;CACO-2: 6.9;Hep G2: 1.8;NB-4: 3.0;RPMI-8226: 3.4;SH-SY5Y: 2.1;U-2197: 2.0" "Cancer enriched" "Detected in many" 5 "colorectal cancer: 38.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025163, HPA029416" Enhanced 990000 "CAB025163: , HPA029416: AB_10600823" "unprognostic (1.83e-1)" "unprognostic (2.81e-4)" "unprognostic (2.03e-1)" "unprognostic (8.53e-2)" "unprognostic (8.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-2)" "unprognostic (5.27e-4)" "unprognostic (2.05e-1)" "unprognostic (2.35e-2)" "unprognostic (1.42e-1)" "unprognostic (2.11e-1)" "unprognostic (1.11e-3)" "unprognostic (1.45e-1)" "unprognostic (1.91e-2)" "unprognostic (4.70e-3)" "unprognostic (1.68e-1)" 0.1 0.1 0.1 4.7 0.1 0.0 0.1 0.1 0.1 0.1 100.5 0.1 0.1 51.7 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 19.8 0.1 0.2 0.1 0.1 0.1 243.0 0.2 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 MEP1B ENSG00000141434 "Meprin A subunit beta" Q16820 18 32185069-32220404 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 167 "intestine: 241.5" "Cell line enhanced" "Detected in some" "SCLC-21H: 10.3" "Group enriched" "Detected in some" 5 "pancreatic cancer: 3.0;stomach cancer: 0.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029119 Enhanced "Secreted to digestive system" 120000 "HPA029119: " "unprognostic (1.33e-1)" "unprognostic (6.72e-2)" "unprognostic (2.79e-2)" "unprognostic (1.00e-1)" "unprognostic (3.50e-4)" "unprognostic (1.27e-1)" "unprognostic (1.74e-2)" "unprognostic (4.30e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.55e-1)" "unprognostic (8.31e-4)" "unprognostic (4.74e-2)" "unprognostic (3.39e-1)" "unprognostic (2.71e-1)" "unprognostic (3.39e-2)" "unprognostic (3.75e-2)" 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.3 0.1 0.1 78.8 0.0 0.0 54.5 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 241.5 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.1 0.4 0.3 0.3 0.0 1.4 0.5 0.2 0.0 0.0 0.5 0.6 0.0 2.0 1.0 0.3 0.2 0.1 0.5 1.4 1.7 0.5 0.0 0.2 0.0 0.0 0.0 0.7 0.9 1.1 0.7 0.6 0.4 1.3 0.3 0.0 0.7 0.0 0.1 0.4 1.1 0.2 0.0 1.9 1.3 4.0 1.3 0.0 1.8 1.7 2.9 0.0 0.7 10.3 2.3 0.8 0.2 0.3 0.4 3.0 0.9 1.3 0.8 3.4 0.0 0.5 2.2 0.5 2.6 0.0 0.5 0.0 0.3 0.3 1.0 0.1 1.3 1.1 0.7 1.4 0.4 0.1 1.2 0.3 0.2 0.0 0.1 0.2 0.5 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 MERTK "c-Eyk, mer, RP38, Tyro12" ENSG00000153208 "MER proto-oncogene, tyrosine kinase" Q12866 2 111898479-112029561 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation, Proto-oncogene, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 20.8;Hep G2: 21.6;HUVEC TERT2: 21.5;RT4: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "intermediate monocyte: 10.3;non-classical monocyte: 6.4" "Lineage enriched" "Detected in single" 48 "monocytes: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036196, HPA075622" Approved Approved "Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol" 29000000 "Plasma membrane" "Endoplasmic reticulum, Midbody, Cytosol" "HPA036196: AB_10670676, HPA075622: " "unprognostic (2.17e-2)" "unprognostic (8.10e-2)" "unprognostic (4.85e-2)" "unprognostic (2.68e-1)" "unprognostic (2.44e-1)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "prognostic favourable (4.74e-4)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (6.22e-2)" "unprognostic (3.72e-1)" "prognostic favourable (4.43e-5)" "unprognostic (5.13e-2)" "unprognostic (2.11e-1)" "unprognostic (5.86e-2)" "unprognostic (2.05e-2)" 20.1 55.1 13.1 12.5 17.8 1.9 31.8 6.2 13.8 10.8 13.8 6.8 27.7 11.5 11.3 25.4 8.4 12.8 11.7 7.1 16.5 6.3 14.2 18.9 12.7 30.3 8.1 10.1 12.9 9.0 23.9 14.3 18.4 18.6 14.1 7.9 20.4 6.8 24.9 6.4 6.4 12.8 13.6 12.2 38.4 12.3 17.3 9.8 1.7 9.9 2.0 8.4 14.1 26.6 0.0 0.2 0.1 10.3 0.0 0.0 0.3 0.5 0.9 4.3 9.7 0.2 0.1 6.9 0.0 0.1 0.5 1.0 20.8 1.3 0.1 4.6 0.0 0.1 5.7 0.0 0.8 0.8 3.0 3.7 0.0 21.6 0.1 0.1 0.8 0.2 0.0 5.0 0.3 21.5 1.1 2.0 1.6 0.9 0.0 4.9 2.7 3.4 1.4 1.2 1.6 10.9 12.9 0.1 4.1 0.1 0.3 1.7 0.0 0.2 3.2 0.6 2.0 0.0 0.0 1.7 2.5 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 6.4 0.1 0.0 0.3 13.1 17.8 6.2 13.8 16.5 6.3 8.1 10.1 18.6 9.8 MET "DFNB97, HGFR, RCCP2" ENSG00000105976 "MET proto-oncogene, receptor tyrosine kinase" P08581 7 116672390-116798386 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 45.4;CAPAN-2: 49.6;EFO-21: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1" "Low region specificity" "Detected in many" "CAB005282, CAB018577, HPA055607" Approved Supported "Plasma membrane,Cytosol" "Secreted to blood" 178550000 70000000 "Plasma membrane, Cytosol" "CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: " "unprognostic (1.60e-2)" "unprognostic (7.71e-2)" "unprognostic (2.53e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-3)" "prognostic unfavourable (6.75e-4)" "unprognostic (1.68e-1)" "unprognostic (3.22e-2)" "unprognostic (3.81e-2)" "unprognostic (2.52e-2)" "prognostic unfavourable (1.21e-7)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (5.53e-2)" "unprognostic (8.88e-2)" "unprognostic (2.01e-2)" "unprognostic (2.20e-1)" 16.2 1.1 1.8 4.5 2.3 4.3 11.2 0.9 15.2 9.9 6.5 2.4 2.4 4.4 7.5 5.2 5.1 4.6 12.3 5.4 5.7 1.8 20.1 30.2 15.6 1.4 3.6 2.1 2.0 9.3 0.7 8.1 24.4 2.6 8.0 6.6 34.1 12.2 8.4 12.8 7.2 8.6 4.0 2.3 5.7 10.6 2.7 2.4 0.5 21.4 7.0 2.1 10.1 15.0 0.2 0.3 1.2 0.2 0.3 0.4 0.0 45.4 26.1 0.0 0.1 2.0 2.0 1.8 26.0 10.6 14.0 11.8 5.4 49.6 2.0 43.3 16.3 12.0 4.5 24.7 28.7 0.1 5.6 0.0 27.1 4.7 0.3 0.0 0.0 2.6 9.8 9.1 30.1 9.6 0.9 0.2 25.9 1.0 0.0 0.0 3.9 26.7 0.0 22.0 0.0 24.6 5.2 3.8 0.0 10.7 3.4 10.1 0.0 0.2 17.7 20.9 7.4 11.0 20.1 0.5 4.0 0.2 23.0 0.0 2.9 1.1 0.2 0.4 0.4 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.2 0.3 0.1 0.3 0.1 0.0 1.8 2.3 0.9 15.2 5.7 1.8 3.6 2.1 2.6 2.4 METTL21A "FAM119A, HCA557b, HSPA-KMT, LOC151194" ENSG00000144401 "Methyltransferase like 21A" Q8WXB1 2 207580631-207625928 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034712 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034712: AB_10670160" "unprognostic (1.41e-1)" "unprognostic (1.50e-1)" "unprognostic (4.56e-2)" "unprognostic (2.09e-3)" "unprognostic (2.00e-1)" "unprognostic (1.64e-2)" "prognostic unfavourable (1.87e-5)" "unprognostic (4.80e-2)" "unprognostic (2.30e-2)" "unprognostic (2.47e-3)" "unprognostic (6.65e-2)" "unprognostic (2.33e-2)" "prognostic unfavourable (5.43e-4)" "unprognostic (5.01e-2)" "unprognostic (3.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.05e-1)" 10.4 9.1 16.5 13.8 18.2 20.2 14.6 14.0 16.9 9.0 9.3 8.7 3.8 8.1 10.0 8.4 6.7 8.3 7.1 13.2 16.3 15.4 11.1 20.9 8.9 15.4 25.8 10.6 12.0 10.6 11.6 10.1 12.7 20.2 8.8 9.2 8.8 8.4 7.1 19.5 9.0 8.3 8.3 19.2 15.4 12.3 7.1 18.8 18.5 15.2 6.2 14.8 10.1 24.3 25.2 14.8 25.9 20.6 7.5 14.4 8.3 7.9 7.5 12.5 9.4 5.5 5.8 24.2 4.5 5.5 7.3 7.4 14.3 12.8 11.5 9.9 3.4 4.6 17.8 5.9 6.0 6.7 12.2 13.5 12.0 23.4 9.8 17.6 13.7 5.2 7.9 3.6 6.1 8.1 19.3 6.8 4.8 12.9 17.7 30.2 20.6 5.3 13.1 5.2 16.8 10.4 6.8 14.8 12.1 9.6 3.4 9.3 4.6 26.2 4.2 6.3 13.9 5.8 7.8 10.1 12.7 23.8 10.4 13.9 9.4 13.8 14.4 25.9 5.0 13.9 8.3 25.2 7.6 7.1 11.8 21.6 14.4 9.2 5.0 7.5 20.6 14.8 5.9 8.3 16.5 18.2 14.0 16.9 16.3 15.4 25.8 10.6 20.2 18.8 METTL7A DKFZP586A0522 ENSG00000185432 "Methyltransferase like 7A" Q9H8H3 12 50923472-50932517 "Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 126.5;thyroid gland: 120.3" "Cell line enhanced" "Detected in many" "ASC diff: 75.5;Karpas-707: 75.4;RPMI-8226: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 29.7;classical monocyte: 12.7;eosinophil: 25.8;intermediate monocyte: 14.2;memory B-cell: 13.6;myeloid DC: 11.5;naive B-cell: 14.7;non-classical monocyte: 20.2;plasmacytoid DC: 10.1" "Low lineage specificity" "Detected in all" HPA017434 Supported "Lipid droplets" 140000 "Lipid droplets" "HPA017434: AB_1853835" "unprognostic (2.31e-2)" "unprognostic (2.82e-2)" "unprognostic (9.85e-3)" "unprognostic (9.43e-2)" "unprognostic (1.52e-1)" "unprognostic (3.38e-2)" "unprognostic (1.09e-3)" "unprognostic (2.68e-3)" "unprognostic (5.48e-2)" "unprognostic (9.94e-2)" "unprognostic (2.57e-2)" "unprognostic (4.49e-2)" "prognostic favourable (0.00e+0)" "unprognostic (8.64e-2)" "unprognostic (5.94e-2)" "unprognostic (1.39e-1)" "unprognostic (1.22e-2)" 38.3 35.2 25.3 10.3 32.1 4.4 44.8 22.7 21.5 21.4 36.6 17.8 15.6 18.3 16.1 13.0 19.9 29.1 25.2 12.8 27.1 12.6 43.0 126.5 26.4 24.5 29.3 22.2 29.0 35.6 11.9 10.5 7.9 26.5 13.6 20.0 13.0 19.0 14.2 16.1 10.9 22.3 19.4 32.2 16.0 28.1 17.3 25.9 3.6 120.3 9.4 16.0 29.1 15.8 14.7 11.5 29.7 20.2 3.8 3.7 5.4 0.2 0.0 1.8 10.9 75.5 21.7 23.8 0.2 1.8 0.1 0.3 0.9 1.0 12.8 0.9 0.8 1.5 1.1 1.2 0.0 1.3 2.8 3.1 2.3 7.3 16.4 0.7 6.6 22.6 0.1 0.1 0.0 5.0 1.8 75.4 0.7 0.0 0.6 3.3 8.9 0.0 0.7 0.1 41.6 3.5 13.5 4.2 6.9 0.2 7.4 0.2 21.6 0.7 2.9 0.1 0.2 0.9 0.0 3.8 0.6 5.7 1.4 1.5 0.0 29.7 12.7 25.8 1.0 14.2 0.6 13.6 0.4 0.8 11.5 14.7 0.1 0.7 0.8 3.8 20.2 10.1 3.7 5.4 25.3 32.1 22.7 20.0 27.1 12.6 29.3 22.2 26.5 25.9 MFAP3 ENSG00000037749 "Microfibril associated protein 3" P55082 5 154038906-154220478 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015883, HPA049198" Approved Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" Nucleoplasm "HPA015883: AB_1853840, HPA049198: " "unprognostic (6.02e-2)" "prognostic unfavourable (4.28e-4)" "unprognostic (1.58e-3)" "unprognostic (2.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.07e-2)" "unprognostic (1.53e-2)" "unprognostic (7.00e-2)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (9.35e-3)" 21.3 7.6 5.8 8.0 12.2 7.9 11.3 12.6 11.4 11.1 8.3 6.3 7.8 7.2 14.1 7.3 11.6 7.5 8.9 9.2 7.2 6.8 9.5 9.4 10.9 6.8 6.4 7.1 9.4 6.3 27.2 9.6 15.0 8.8 7.8 8.4 9.5 8.8 6.4 13.2 6.4 9.5 11.7 8.9 7.9 7.4 8.3 7.0 9.1 11.3 6.3 9.2 12.2 10.1 3.0 10.6 14.6 10.3 7.7 9.6 5.4 9.5 12.5 21.3 22.3 19.2 18.0 20.9 17.4 18.6 18.1 23.5 18.8 21.8 13.8 20.1 16.3 21.6 20.0 21.7 29.0 6.2 13.1 9.0 19.2 6.8 18.3 16.1 10.6 19.4 21.5 21.7 18.5 25.3 10.3 15.0 15.7 6.3 8.9 3.7 11.0 7.4 8.6 25.2 12.6 11.7 13.6 22.0 24.5 19.0 21.5 17.1 22.6 8.0 23.0 23.6 16.5 13.0 17.6 15.0 19.3 13.0 12.0 11.2 18.5 8.1 10.3 14.6 6.5 9.8 9.6 3.0 5.6 4.9 10.6 3.0 7.4 5.4 8.4 7.7 7.0 3.8 4.9 5.4 5.8 12.2 12.6 11.4 7.2 6.8 6.4 7.1 8.8 7.0 MFAP3L "KIAA0626, NYD-sp9" ENSG00000198948 "Microfibril associated protein 3 like" O75121 4 169986597-170033031 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 32.9" "Cell line enhanced" "Detected in many" "HMC-1: 14.3;RT4: 23.4;SK-BR-3: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 7.9;eosinophil: 2.1;neutrophil: 4.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017986, HPA062306" Approved Supported "Nucleoplasm,Cell Junctions" "Intracellular and membrane" Nucleoplasm "Cell Junctions" "HPA017986: AB_1853842, HPA062306: " "unprognostic (8.04e-3)" "unprognostic (8.67e-3)" "unprognostic (3.74e-1)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (7.92e-2)" "unprognostic (3.50e-2)" "unprognostic (3.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.33e-1)" "unprognostic (3.96e-1)" "unprognostic (7.58e-2)" "prognostic favourable (1.42e-8)" "unprognostic (6.59e-3)" "unprognostic (2.12e-1)" "unprognostic (1.62e-4)" "unprognostic (2.40e-3)" 2.1 3.4 15.0 1.3 19.6 2.7 10.2 4.9 19.4 11.4 2.1 21.1 4.2 1.0 4.9 32.9 1.2 4.0 2.6 1.9 15.4 11.1 25.6 29.5 2.7 1.2 21.8 10.0 1.1 1.6 5.7 3.3 5.5 21.1 2.9 2.2 17.5 2.0 11.7 4.2 19.7 1.1 3.9 16.4 1.7 1.3 30.6 20.8 0.0 2.8 0.2 1.0 11.9 1.5 0.0 0.7 7.9 0.8 0.0 0.8 6.9 0.2 3.5 1.9 1.9 1.6 0.8 0.7 3.8 0.5 1.8 1.6 1.2 0.2 0.0 0.1 5.9 1.8 6.8 0.8 0.8 0.0 2.6 0.0 3.7 1.4 0.9 0.0 14.3 1.1 2.1 0.2 0.6 0.2 0.5 0.7 3.6 2.0 0.6 0.5 2.0 3.0 0.0 1.1 0.0 5.1 23.4 1.6 3.5 3.2 21.6 6.9 1.2 0.0 0.1 1.8 7.1 3.5 7.3 0.3 0.0 0.0 4.8 0.7 7.1 7.9 0.2 2.1 0.8 0.8 0.4 0.0 0.7 0.2 0.3 0.0 0.3 0.1 4.9 0.0 0.0 0.7 0.1 6.9 15.0 19.6 4.9 15.4 15.4 11.1 21.8 10.0 21.1 20.8 MFF "C2orf33, GL004" ENSG00000168958 "Mitochondrial fission factor" Q9GZY8 2 227325151-227357836 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010968, HPA074625" Enhanced Supported Mitochondria Mitochondria "HPA010968: AB_1845714, HPA074625: " "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "unprognostic (2.16e-1)" "unprognostic (1.15e-2)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "prognostic unfavourable (1.20e-4)" "unprognostic (3.07e-2)" "unprognostic (1.32e-1)" "unprognostic (6.07e-2)" "unprognostic (3.00e-2)" "unprognostic (6.24e-3)" "unprognostic (5.50e-2)" "unprognostic (1.00e-1)" "unprognostic (2.70e-2)" "unprognostic (1.51e-1)" "unprognostic (3.22e-1)" 20.2 23.9 31.6 18.0 27.6 22.3 21.3 25.7 38.4 19.6 22.5 26.5 14.7 22.1 21.9 20.9 21.5 18.0 17.1 40.5 27.8 28.4 33.7 24.4 16.6 27.1 30.2 20.2 25.7 27.6 25.0 19.3 17.7 28.0 20.6 22.5 25.6 20.6 27.6 37.4 16.7 18.6 22.9 33.4 16.9 18.8 97.0 20.6 25.9 19.8 22.2 23.3 20.7 17.8 40.2 34.9 59.9 33.8 29.3 44.1 33.1 22.8 19.6 24.2 33.3 31.3 30.2 32.1 22.8 30.9 27.9 29.8 21.4 16.4 13.1 27.3 24.9 19.0 39.8 29.0 37.9 27.7 31.9 27.6 50.8 53.5 41.4 26.7 24.8 27.0 38.3 26.4 28.3 24.0 24.0 39.4 24.6 23.1 28.2 41.1 32.8 20.8 25.6 30.6 25.3 40.7 21.6 25.7 24.1 50.1 23.3 33.3 14.9 26.5 16.2 27.2 23.0 40.1 25.3 32.1 21.8 26.3 35.9 23.8 36.9 42.4 32.9 59.9 32.8 33.8 35.3 40.2 34.5 32.0 34.5 38.2 36.6 31.0 31.0 29.3 30.6 34.9 44.1 33.1 31.6 27.6 25.7 38.4 27.8 28.4 30.2 20.2 28.0 20.6 MFN2 "CMT2A2, CPRP1, KIAA0214, MARF" ENSG00000116688 "Mitofusin 2" O95140 1 11980181-12013514 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy, Unfolded protein response" Hydrolase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 100.9;skeletal muscle: 111.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030554 Uncertain "HPA030554: AB_10603018" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-1)" "unprognostic (4.38e-2)" "unprognostic (8.36e-2)" "unprognostic (9.71e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (3.45e-1)" "unprognostic (2.19e-2)" "unprognostic (1.43e-1)" "unprognostic (3.55e-1)" "prognostic favourable (2.36e-8)" "unprognostic (4.69e-2)" "unprognostic (2.76e-1)" "unprognostic (8.84e-3)" "unprognostic (2.12e-1)" 12.8 10.1 16.4 8.9 20.3 17.2 10.1 15.9 32.1 8.7 17.0 17.0 11.2 16.5 12.1 8.7 20.1 9.0 9.0 100.9 17.9 16.0 14.8 20.4 10.6 8.0 18.8 19.3 10.2 9.0 22.0 9.3 12.9 20.8 14.1 13.2 16.5 10.7 23.7 111.1 18.8 25.7 22.9 15.7 10.2 14.0 11.3 10.9 7.3 18.7 28.5 12.1 16.3 10.6 7.3 8.9 18.5 16.9 5.8 10.2 13.4 25.8 15.9 18.0 23.6 18.3 13.8 20.9 20.5 19.0 28.2 22.0 26.1 17.3 19.0 22.2 24.8 27.8 29.7 47.6 25.3 68.9 22.6 27.2 25.5 20.3 18.9 27.6 17.1 17.3 36.7 39.6 36.7 19.8 28.1 16.8 20.8 13.0 16.7 12.6 12.4 23.3 19.6 26.2 17.7 16.9 17.3 21.0 13.7 24.0 25.7 23.7 13.9 16.6 19.8 18.9 18.9 28.6 21.4 20.0 21.0 31.1 22.4 31.0 20.4 8.5 10.3 7.1 9.6 13.5 10.2 7.3 7.2 8.6 8.9 6.6 6.3 8.0 18.5 5.8 16.9 4.6 8.0 13.4 16.4 20.3 15.9 32.1 17.9 16.0 18.8 19.3 20.8 10.9 MFSD1 "FLJ14153, UG0581B09" ENSG00000118855 "Major facilitator superfamily domain containing 1" Q9H3U5 3 158732198-158829719 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057924, HPA065858" Approved Approved Nucleoplasm,Nucleoli 14000 Nucleoplasm Nucleoli "HPA057924: , HPA065858: " "unprognostic (9.94e-2)" "unprognostic (3.12e-3)" "unprognostic (3.54e-2)" "unprognostic (1.00e-1)" "unprognostic (2.16e-2)" "unprognostic (7.37e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (2.52e-1)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (2.92e-1)" "prognostic favourable (5.60e-5)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (4.66e-2)" "unprognostic (2.57e-1)" 26.2 29.5 11.4 22.0 11.8 17.2 24.2 9.1 14.0 18.7 15.7 13.4 18.9 13.2 18.3 20.6 37.0 18.4 17.5 17.7 10.8 10.3 20.7 24.8 24.9 39.8 15.7 11.7 15.3 16.8 16.5 16.8 18.3 13.6 14.7 11.5 14.5 34.5 17.9 9.2 18.6 16.8 15.0 14.5 29.1 19.9 15.0 14.3 11.3 18.7 16.3 16.7 23.8 24.1 10.5 45.3 42.6 49.6 5.4 7.3 35.3 14.7 6.3 1.6 4.9 8.6 8.1 10.2 23.1 10.4 8.2 8.1 2.6 14.6 4.1 17.0 14.8 7.7 4.0 5.1 7.7 16.4 10.7 11.1 4.8 1.1 9.3 40.9 27.8 12.1 6.7 7.4 2.0 6.4 8.6 8.5 14.6 3.4 2.5 12.0 1.6 16.2 5.5 2.4 36.3 3.0 3.9 4.8 7.2 17.1 13.2 4.1 10.4 16.0 21.1 11.8 4.5 17.4 11.3 27.1 19.0 2.3 14.8 29.6 8.2 14.0 49.6 42.6 7.3 38.5 6.6 10.5 5.8 6.5 45.3 8.5 6.4 7.0 17.6 5.4 31.6 14.7 6.8 35.3 11.4 11.8 9.1 14.0 10.8 10.3 15.7 11.7 13.6 14.3 MFSD11 "FLJ20226, FLJ22196" ENSG00000092931 "Major facilitator superfamily domain containing 11" O43934 17 76735865-76781449 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022001 Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA022001: AB_2297599" "unprognostic (2.84e-2)" "unprognostic (1.22e-1)" "unprognostic (2.43e-2)" "prognostic unfavourable (7.69e-4)" "unprognostic (4.87e-2)" "unprognostic (1.17e-1)" "unprognostic (1.78e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-3)" "unprognostic (1.68e-2)" "unprognostic (2.06e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-1)" "unprognostic (1.18e-2)" "unprognostic (6.98e-2)" "prognostic unfavourable (7.90e-4)" 17.2 20.7 13.9 14.3 21.3 15.6 18.7 20.4 25.0 18.0 20.9 19.6 16.9 17.4 18.8 18.8 24.1 13.4 14.3 23.5 13.3 14.8 13.3 19.2 17.4 22.0 20.1 16.1 14.4 17.4 24.6 27.9 27.4 18.1 14.8 22.8 32.8 21.3 17.3 26.8 20.8 17.7 16.8 17.9 19.0 21.7 28.6 19.7 15.6 18.0 16.8 18.6 16.8 21.6 8.0 14.9 16.7 16.1 6.3 18.3 8.2 13.5 7.7 9.1 8.7 19.6 11.9 10.7 12.1 11.2 11.7 10.4 15.6 24.9 11.1 10.3 12.3 13.4 6.4 6.3 12.2 5.1 12.9 11.1 14.7 10.7 9.4 5.9 11.0 14.2 10.3 15.0 6.8 22.2 13.2 16.5 14.8 10.4 13.3 9.7 3.8 4.5 10.5 11.9 22.9 9.0 10.1 8.9 15.0 11.5 16.5 10.3 28.9 9.1 15.6 21.4 10.5 13.4 10.1 18.4 7.3 16.7 16.5 5.2 14.1 11.2 14.1 11.3 15.2 16.1 6.4 7.5 13.6 15.3 14.9 8.0 8.5 10.6 16.7 6.3 12.5 10.7 18.3 8.2 13.9 21.3 20.4 25.0 13.3 14.8 20.1 16.1 18.1 19.7 MFSD12 "C19orf28, MGC20700, PP3501" ENSG00000161091 "Major facilitator superfamily domain containing 12" Q6NUT3 19 3538261-3574290 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 58.3;WM-115: 111.4" "Cancer enriched" "Detected in all" 7 "melanoma: 124.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042149, HPA043088" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA042149: , HPA043088: " "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "prognostic favourable (5.66e-6)" "unprognostic (1.56e-2)" "unprognostic (6.51e-2)" "prognostic unfavourable (6.61e-4)" "prognostic unfavourable (2.34e-4)" "unprognostic (3.19e-2)" "unprognostic (9.12e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.13e-1)" "prognostic favourable (7.70e-4)" "unprognostic (1.95e-1)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" 25.9 13.0 15.4 19.0 14.4 23.5 9.3 10.4 22.9 8.1 8.9 24.3 11.2 12.5 10.2 12.7 11.1 14.3 10.0 7.6 23.9 12.8 38.0 21.5 13.8 15.2 20.7 10.0 9.7 19.8 15.7 11.9 46.6 15.6 10.2 5.7 13.5 23.7 10.5 8.1 43.6 13.8 9.9 18.6 19.7 14.1 7.5 16.1 37.0 9.1 6.1 11.8 7.9 7.8 2.4 12.9 2.6 7.9 0.5 3.1 1.6 16.6 13.5 3.3 8.8 6.9 5.4 12.0 10.2 5.5 12.0 13.2 5.7 5.7 4.7 7.8 5.4 10.5 4.3 5.3 4.3 10.3 12.2 2.7 43.2 5.9 8.7 5.9 9.3 4.8 8.0 12.3 2.9 3.2 13.1 6.8 3.0 10.0 5.8 10.6 6.2 11.0 4.2 4.8 19.9 5.0 7.2 12.7 6.4 20.3 9.5 58.3 3.2 12.4 13.3 5.4 8.1 22.2 11.6 7.9 4.4 4.3 24.1 15.2 111.4 0.1 4.0 2.6 2.1 7.9 2.1 2.4 3.1 1.6 2.8 1.7 2.7 2.1 1.3 0.5 7.6 12.9 0.5 1.6 15.4 14.4 10.4 22.9 23.9 12.8 20.7 10.0 15.6 16.1 MFSD13A "bA18I14.8, C10orf77, FLJ22529, TMEM180" ENSG00000138111 "Major facilitator superfamily domain containing 13A" Q14CX5 10 102461395-102477045 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018031 Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA018031: AB_2204891" "unprognostic (2.24e-2)" "prognostic favourable (8.29e-4)" "unprognostic (7.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.79e-1)" "unprognostic (2.11e-1)" "unprognostic (9.16e-3)" "unprognostic (4.70e-2)" "unprognostic (4.03e-2)" "unprognostic (8.10e-2)" "unprognostic (2.04e-1)" "unprognostic (3.82e-2)" "prognostic unfavourable (8.51e-4)" "unprognostic (1.66e-3)" "unprognostic (2.44e-1)" "unprognostic (2.74e-1)" "unprognostic (4.02e-2)" 3.8 3.3 8.8 5.9 15.7 9.0 2.6 18.0 18.7 2.4 7.0 8.5 0.4 10.2 4.3 1.8 3.0 2.4 4.7 5.2 9.0 6.5 3.3 5.7 14.1 5.6 7.9 8.7 2.3 5.1 2.8 4.4 7.2 8.2 3.1 6.4 3.9 3.0 2.3 3.9 17.4 7.5 4.9 5.2 6.9 7.1 5.8 8.6 2.3 5.7 1.8 6.7 3.1 2.5 5.0 7.5 5.5 7.2 2.2 5.8 3.4 9.3 4.3 3.3 7.9 0.3 0.3 5.1 1.9 4.9 3.7 8.7 8.5 12.9 8.4 9.8 0.7 11.7 6.1 5.0 1.4 10.5 5.5 10.3 6.1 4.4 8.5 5.2 10.1 4.3 2.1 2.1 3.8 4.3 2.3 4.6 0.3 1.9 8.7 3.4 5.6 4.2 10.6 0.5 1.4 1.7 2.5 8.2 7.8 1.8 1.0 4.2 4.8 3.5 1.3 1.7 2.1 2.1 2.6 1.6 4.1 10.9 9.6 8.6 2.4 0.7 7.2 5.5 5.2 5.3 5.2 5.0 5.0 4.1 7.5 2.8 5.2 5.8 4.4 2.2 3.0 0.8 1.4 3.4 8.8 15.7 18.0 18.7 9.0 6.5 7.9 8.7 8.2 8.6 MFSD6 FLJ20160 ENSG00000151690 "Major facilitator superfamily domain containing 6" Q6ZSS7 2 190408355-190509205 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022274 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" Cytosol "Nucleoplasm, Actin filaments" "HPA022274: AB_2142776" "unprognostic (9.47e-2)" "unprognostic (7.01e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-2)" "unprognostic (2.49e-1)" "unprognostic (4.13e-3)" "unprognostic (1.78e-2)" "unprognostic (3.08e-2)" "unprognostic (3.92e-1)" "unprognostic (3.77e-1)" "unprognostic (9.54e-2)" "unprognostic (2.08e-1)" "prognostic favourable (1.05e-4)" "unprognostic (3.46e-2)" "unprognostic (3.27e-1)" "unprognostic (9.14e-2)" "unprognostic (9.18e-2)" 12.3 26.9 20.8 9.3 23.3 4.2 13.8 19.4 33.1 15.3 20.0 29.0 29.0 12.6 7.1 22.3 26.6 13.0 10.3 11.1 25.4 26.5 7.4 2.0 16.9 8.7 36.2 22.9 3.5 10.9 28.2 35.7 5.6 43.1 15.7 19.0 12.2 19.2 29.6 3.8 18.9 15.4 9.5 36.7 12.7 20.2 4.9 18.3 13.0 25.5 10.8 12.7 13.3 13.6 2.4 2.6 8.1 2.0 3.3 5.6 1.2 10.5 6.5 0.2 2.3 4.8 6.2 9.0 5.4 11.0 3.7 4.7 2.4 13.4 16.5 2.6 11.3 17.9 3.2 9.5 4.2 33.4 4.9 8.8 6.4 1.2 1.9 3.4 2.8 0.9 17.3 5.4 3.6 1.3 2.2 18.4 0.9 4.0 16.0 0.7 1.5 7.0 3.6 0.5 14.1 7.0 19.3 21.0 5.4 7.7 18.2 10.5 5.9 4.0 5.4 0.6 1.3 7.2 8.3 8.4 3.5 5.9 6.0 7.2 2.9 8.1 2.0 0.6 2.6 0.6 2.7 2.4 3.5 3.6 2.6 1.3 1.6 3.6 0.1 3.3 0.9 1.3 5.6 1.2 20.8 23.3 19.4 33.1 25.4 26.5 36.2 22.9 43.1 18.3 MGAM MGA ENSG00000257335 Maltase-glucoamylase O43451 7 141907813-142106747 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 155.5" "Cell line enhanced" "Detected in some" "A549: 3.6;BJ hTERT+: 3.2;HL-60: 5.3;U-937: 8.5;WM-115: 2.0" "Cancer enriched" "Detected in some" 7 "renal cancer: 4.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "neutrophil: 14.1" "Lineage enriched" "Detected in single" 104 "granulocytes: 14.1" "Region enriched" "Detected in single" 12 "olfactory region: 3.1" HPA002270 Enhanced 68000 "HPA002270: AB_1079366" "unprognostic (1.02e-2)" "unprognostic (1.45e-1)" "unprognostic (1.13e-1)" "unprognostic (6.95e-3)" "unprognostic (2.80e-1)" "unprognostic (7.81e-2)" "unprognostic (7.32e-3)" "unprognostic (3.83e-2)" "unprognostic (4.97e-1)" "unprognostic (2.17e-2)" "unprognostic (6.86e-2)" "unprognostic (1.99e-1)" "prognostic favourable (6.16e-5)" "unprognostic (1.82e-1)" "unprognostic (2.82e-1)" "unprognostic (1.34e-3)" "unprognostic (3.03e-1)" 0.9 0.2 0.3 0.8 0.2 6.9 0.3 0.2 0.2 0.2 59.4 0.1 7.6 25.2 0.2 36.0 0.2 1.0 0.1 0.3 0.2 0.2 8.7 0.4 2.1 0.1 0.3 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.6 0.0 0.1 0.2 3.2 0.2 0.1 155.5 0.1 0.3 8.3 0.7 4.3 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 14.1 0.1 0.0 0.0 0.0 0.0 3.6 0.2 0.1 0.0 0.0 0.4 0.1 3.2 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.3 1.0 0.4 0.1 0.3 0.0 0.1 0.0 8.5 2.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.1 MGAM2 ENSG00000257743 "Maltase-glucoamylase 2 (putative)" Q2M2H8 7 142111749-142222324 "Enzymes, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 61.2;pancreas: 15.6;salivary gland: 35.4" "Cell line enriched" "Detected in single" 7 "RH-30: 5.0" "Group enriched" "Detected in some" 11 "colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Low region specificity" "Detected in all" HPA055697 Enhanced Approved Vesicles,Cytosol Vesicles Cytosol "HPA055697: " "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-3)" "unprognostic (5.65e-2)" "unprognostic (2.19e-2)" "unprognostic (1.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-2)" "unprognostic (5.93e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-1)" "unprognostic (5.50e-4)" "unprognostic (7.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.71e-2)" "unprognostic (9.33e-2)" 0.2 0.1 0.1 2.5 0.1 0.2 1.3 0.1 0.1 0.1 28.8 0.0 0.0 15.0 0.1 0.4 0.1 0.3 7.0 0.1 0.1 0.1 0.1 0.2 0.4 0.0 0.4 0.0 0.1 15.6 0.0 0.1 0.0 0.1 0.1 1.4 0.7 35.4 0.0 0.1 0.2 61.2 0.0 0.5 1.5 0.7 1.0 0.0 0.0 0.1 1.7 0.8 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.0 MGARP "C4orf49, CESP-1, HUMMR, OSAP" ENSG00000137463 "Mitochondria localized glutamic acid rich protein" Q8TDB4 4 139266163-139280338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 88.9;retina: 30.7" "Cell line enhanced" "Detected in some" "BJ: 10.5;fHDF/TERT166: 15.6;HHSteC: 12.7;HUVEC TERT2: 31.7" "Cancer enhanced" "Detected in some" "renal cancer: 4.1" "Group enriched" "Detected in many" 4 "basal ganglia: 4.5;cerebellum: 8.0" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" HPA015994 Enhanced Supported Mitochondria Mitochondria "HPA015994: " "unprognostic (2.68e-1)" "unprognostic (1.73e-1)" "unprognostic (8.18e-2)" "unprognostic (4.25e-2)" "unprognostic (3.54e-2)" "unprognostic (3.11e-2)" "unprognostic (3.42e-2)" "unprognostic (1.02e-3)" "unprognostic (2.90e-2)" "unprognostic (4.96e-2)" "unprognostic (1.50e-2)" "unprognostic (1.31e-1)" "unprognostic (4.08e-2)" "unprognostic (1.47e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-2)" "unprognostic (2.36e-1)" 3.2 88.9 1.0 0.5 4.5 0.4 1.2 8.0 1.2 3.6 1.0 2.1 1.1 0.4 2.6 3.0 0.5 0.8 1.3 6.1 0.8 1.4 1.0 0.4 0.5 0.6 1.0 0.0 20.1 0.5 0.4 15.3 0.5 1.5 2.0 0.5 30.7 0.4 2.0 0.6 0.5 0.4 2.3 0.7 0.6 0.4 5.9 0.5 0.0 0.5 0.0 0.5 2.1 1.0 0.5 0.0 0.0 0.3 0.5 1.7 0.3 0.0 0.5 0.3 0.2 0.8 0.4 0.0 10.5 0.0 1.5 0.0 0.0 0.1 0.0 0.1 15.6 0.2 2.2 0.0 0.9 0.0 1.0 0.0 0.0 0.1 12.7 0.1 0.1 3.8 0.3 1.7 0.1 31.7 0.2 0.2 2.6 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.6 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.2 4.4 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.7 0.4 0.0 0.3 1.6 0.7 0.0 0.5 0.2 0.0 0.3 0.3 1.0 4.5 8.0 1.2 0.8 1.4 1.0 0.0 1.5 0.5 MGAT1 "GLCNAC-TI, GLYT1, GNT-1, GnTI, MGAT" ENSG00000131446 "Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase" P26572 5 180784782-180815652 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017432 Approved 7200000 "HPA017432: AB_1853851" "unprognostic (1.12e-1)" "unprognostic (1.34e-2)" "unprognostic (3.38e-2)" "unprognostic (2.11e-1)" "unprognostic (3.91e-2)" "unprognostic (6.70e-2)" "unprognostic (4.39e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-1)" "unprognostic (2.98e-1)" "unprognostic (3.70e-3)" "unprognostic (6.44e-2)" "prognostic unfavourable (8.65e-4)" "unprognostic (4.15e-2)" "unprognostic (3.52e-2)" "unprognostic (5.68e-2)" "unprognostic (5.00e-2)" 67.7 20.9 14.9 30.8 20.1 25.5 53.3 15.6 19.3 22.3 29.0 14.6 22.4 24.8 26.1 26.8 31.2 26.4 19.8 26.4 16.1 10.6 20.8 55.6 42.7 50.5 25.6 10.3 27.2 37.1 8.5 20.8 84.9 17.7 26.6 15.3 24.1 28.4 21.8 18.5 22.9 35.1 20.7 31.1 45.7 24.5 19.2 21.9 27.0 32.1 16.9 29.8 38.2 39.1 13.2 40.8 37.7 54.9 16.5 24.9 47.2 14.1 14.2 7.8 16.7 41.5 18.9 27.4 33.8 41.6 21.2 26.5 20.3 11.7 12.1 19.0 32.6 17.0 4.2 50.4 12.6 65.1 11.7 10.6 8.2 15.7 20.2 9.7 34.9 21.9 24.2 17.1 17.1 18.3 6.1 21.8 18.9 20.1 9.1 13.9 7.6 18.4 11.1 11.5 15.9 8.1 16.9 6.7 8.1 14.1 14.6 27.9 11.2 17.4 19.6 25.9 11.6 11.0 15.2 41.3 34.1 10.6 21.1 19.7 13.0 19.5 54.9 25.3 22.4 45.9 24.9 13.2 16.4 18.7 40.8 12.1 14.4 16.0 37.7 16.5 35.1 38.9 18.8 47.2 14.9 20.1 15.6 19.3 16.1 10.6 25.6 10.3 17.7 21.9 MGAT4C HGNT-IV-H ENSG00000182050 "MGAT4 family member C" Q9UBM8 12 85955666-86838904 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0" "Group enriched" "Detected in some" 13 "NTERA-2: 10.9;SCLC-21H: 4.8" "Cancer enriched" "Detected in single" 19 "thyroid cancer: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016418 Approved "HPA016418: AB_1853854" "unprognostic (5.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.32e-4)" "unprognostic (1.07e-1)" "unprognostic (9.64e-2)" "unprognostic (5.94e-3)" "unprognostic (1.88e-1)" "unprognostic (8.05e-2)" "unprognostic (1.89e-1)" "unprognostic (6.32e-3)" "unprognostic (3.51e-2)" "unprognostic (6.85e-10)" "unprognostic (3.15e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" "unprognostic (4.74e-3)" 1.0 3.0 5.5 1.0 12.3 1.1 0.9 4.9 12.8 1.3 1.2 2.5 0.4 0.9 1.0 10.9 1.1 1.1 1.2 3.6 9.4 3.9 1.0 0.9 1.0 0.9 3.0 9.3 0.9 0.9 0.9 25.9 0.8 10.6 1.1 1.2 0.0 0.9 2.4 0.8 1.0 1.0 1.0 4.3 0.9 1.0 7.8 5.1 0.0 18.0 0.0 0.8 0.9 0.6 0.5 0.3 0.8 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.0 10.9 0.1 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.1 0.8 0.2 0.1 0.3 0.2 0.0 5.5 12.3 4.9 12.8 9.4 3.9 3.0 9.3 10.6 5.1 MGAT5 GNT-V ENSG00000152127 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase" Q09328 2 134119983-134454621 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010919 Approved 96000 "HPA010919: AB_10601864" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.21e-2)" "unprognostic (3.65e-1)" "unprognostic (3.76e-1)" "unprognostic (4.45e-3)" "unprognostic (3.41e-3)" "unprognostic (5.68e-2)" "unprognostic (8.63e-3)" "unprognostic (1.59e-1)" "unprognostic (2.64e-1)" "unprognostic (5.97e-2)" "unprognostic (1.81e-2)" "unprognostic (9.27e-2)" "unprognostic (2.17e-2)" "unprognostic (1.91e-1)" 8.4 9.8 13.0 21.7 15.7 12.0 8.0 21.3 17.6 9.0 13.2 17.2 4.6 14.2 8.5 6.3 8.2 17.5 15.1 33.9 13.9 17.5 14.3 4.9 9.3 20.1 23.6 11.6 11.3 11.1 18.8 7.9 22.0 28.0 7.9 13.8 8.3 11.9 9.1 3.2 6.6 19.2 10.1 28.7 23.1 15.0 6.6 13.2 16.5 10.3 5.1 28.9 11.0 9.2 7.5 1.8 2.3 0.8 2.4 3.1 1.1 10.0 4.0 10.3 7.3 9.2 17.6 7.2 13.4 20.5 5.4 4.6 1.6 5.0 16.1 10.3 10.6 3.5 8.0 6.3 10.4 15.7 4.7 9.0 5.2 21.0 6.0 8.7 32.2 4.8 6.6 11.4 7.1 40.4 4.6 11.0 9.8 6.4 4.7 4.1 4.7 10.0 5.8 12.1 10.1 4.2 12.3 17.0 21.0 4.3 3.7 25.6 2.9 6.1 18.2 17.2 9.1 12.4 7.0 3.1 1.4 6.1 14.4 12.6 27.2 1.2 0.7 1.8 1.6 0.7 2.7 5.6 3.1 2.1 0.6 7.5 1.3 1.6 2.3 2.4 0.8 1.8 1.9 1.1 13.0 15.7 21.3 17.2 13.9 17.5 23.6 11.6 28.0 13.2 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B" Q3V5L5 17 76868456-76950393 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 28.1" "Cell line enhanced" "Detected in many" "A549: 21.6;SCLC-21H: 11.1;U-138 MG: 13.1;U-2 OS: 14.2" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: " "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 1.1 1.2 9.3 1.1 13.4 1.0 0.9 4.4 28.1 1.0 0.9 1.1 0.0 0.8 1.1 0.7 0.9 1.0 0.9 0.8 5.5 2.8 0.9 0.7 1.0 0.9 2.3 8.1 1.2 0.8 1.0 0.6 1.1 2.6 0.8 0.8 1.1 0.8 0.8 0.7 0.9 0.9 0.8 0.7 1.4 1.0 2.3 1.7 0.0 0.8 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 21.6 4.4 2.2 0.0 0.0 2.3 0.3 0.9 7.9 4.7 0.0 0.5 0.0 1.7 1.0 0.1 1.0 0.2 2.1 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.2 1.4 0.1 0.0 0.0 1.0 0.0 0.0 1.2 2.2 3.0 3.8 4.5 6.2 0.0 11.1 4.2 3.8 1.7 3.4 0.1 0.1 4.0 13.1 14.2 0.2 4.1 0.0 0.0 0.5 0.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 13.4 4.4 27.4 5.5 2.8 2.3 8.1 2.6 1.7 MGST1 "GST12, MGST-I" ENSG00000008394 "Microsomal glutathione S-transferase 1" P10620 12 16347142-16609259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 382.8" "Cell line enhanced" "Detected in many" "ASC diff: 335.0;ASC TERT1: 129.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 46.1;myeloid DC: 34.1" "Group enriched" "Detected in many" 15 "dendritic cells: 34.1;monocytes: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044840 Enhanced Approved "Endoplasmic reticulum,Mitochondria" Mitochondria "Endoplasmic reticulum" "HPA044840: AB_10965550" "unprognostic (4.57e-2)" "unprognostic (4.80e-3)" "unprognostic (5.82e-2)" "unprognostic (2.92e-3)" "unprognostic (3.97e-3)" "unprognostic (1.03e-1)" "unprognostic (8.19e-2)" "unprognostic (1.03e-1)" "unprognostic (4.82e-2)" "unprognostic (3.42e-1)" "unprognostic (1.37e-3)" "unprognostic (2.20e-1)" "prognostic unfavourable (7.45e-4)" "unprognostic (9.90e-2)" "unprognostic (4.61e-1)" "prognostic favourable (1.97e-4)" "unprognostic (4.19e-1)" 127.9 106.0 18.5 10.8 32.6 9.5 116.8 10.3 14.0 9.3 39.7 9.6 2.6 17.0 4.1 6.4 19.5 6.9 26.6 12.1 19.6 13.9 56.9 382.8 42.0 2.7 18.9 8.9 3.1 12.4 0.8 5.3 8.7 18.4 23.5 28.3 3.0 14.7 8.2 8.9 7.0 15.5 11.5 20.1 0.9 10.3 6.8 12.0 0.0 69.9 13.9 3.6 32.6 37.2 0.2 34.1 2.7 46.1 0.0 0.2 13.0 0.0 30.0 7.1 8.3 335.0 129.3 0.0 24.6 25.2 13.4 20.9 11.3 50.2 0.0 3.0 31.4 0.1 18.6 39.3 12.2 0.0 2.5 10.2 16.6 39.9 78.3 19.8 0.0 83.9 43.9 40.9 43.2 23.5 7.2 0.0 28.8 6.1 0.0 8.0 59.7 23.8 0.0 4.2 13.5 30.2 59.3 1.3 1.0 38.4 24.6 1.0 26.6 11.2 14.8 13.8 1.8 27.1 31.7 0.0 0.0 0.0 45.5 31.6 0.4 2.7 46.1 0.4 0.0 7.0 0.1 0.2 0.0 0.0 34.1 0.0 0.0 0.0 1.5 0.0 1.5 9.6 0.2 13.0 18.5 32.6 10.3 14.0 19.6 13.9 18.9 8.9 18.4 12.0 MIA3 "FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077" ENSG00000154305 "MIA family member 3, ER export factor" Q5JRA6 1 222618086-222668012 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055922, HPA056816" Supported Enhanced Vesicles "Intracellular and membrane" 750000 Vesicles "HPA055922: , HPA056816: " "unprognostic (1.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.43e-1)" "unprognostic (6.60e-2)" "unprognostic (1.86e-2)" "unprognostic (8.57e-2)" "unprognostic (1.28e-3)" "unprognostic (5.41e-2)" "unprognostic (2.56e-1)" "unprognostic (5.65e-2)" "unprognostic (6.73e-2)" "unprognostic (1.39e-2)" "prognostic unfavourable (3.73e-4)" "unprognostic (3.57e-2)" "unprognostic (1.83e-1)" "unprognostic (8.62e-3)" "unprognostic (3.26e-1)" 20.5 24.1 21.4 17.4 23.7 25.8 25.0 32.8 25.0 23.3 19.3 10.0 26.2 18.7 23.5 24.4 15.7 18.1 18.5 19.5 18.4 17.4 19.5 63.7 18.4 19.0 17.0 18.8 23.4 34.1 30.2 34.7 22.7 25.6 30.1 23.1 9.9 32.8 31.7 25.5 16.5 23.2 21.3 22.9 23.0 36.6 29.3 19.6 19.5 25.6 19.5 19.3 26.8 19.8 18.6 14.9 29.4 20.1 22.0 18.3 11.1 11.8 9.0 14.0 21.3 44.5 22.4 23.5 17.0 25.5 18.9 22.5 9.3 12.3 9.7 16.3 19.3 20.3 14.9 15.7 19.4 16.8 9.3 13.4 9.3 14.5 40.8 23.0 16.3 20.5 15.1 18.0 31.9 19.7 17.2 23.9 14.2 7.1 17.9 14.9 15.5 12.9 12.2 38.0 23.5 9.7 11.8 15.2 16.0 17.5 15.9 14.2 17.0 15.1 14.3 12.8 9.8 21.6 18.1 27.3 17.3 12.2 16.0 11.1 16.8 23.6 14.6 29.4 17.4 19.5 18.3 18.3 15.0 17.0 10.4 18.6 17.8 17.4 24.8 22.0 20.1 14.9 16.0 11.1 21.4 23.7 32.8 25.0 18.4 17.4 17.0 18.8 25.6 19.6 MICAL3 KIAA0819 ENSG00000243156 "Microtubule associated monooxygenase, calponin and LIM domain containing 3" Q7RTP6 22 17787649-18024559 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Exocytosis" "Actin-binding, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 10.0;memory B-cell: 3.3;naive B-cell: 5.2" "Group enriched" "Detected in many" 6 "B-cells: 5.2;granulocytes: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000639, HPA003421, HPA034882" Approved Supported "Nucleoplasm,Plasma membrane,Midbody ring,Cytosol" "Nucleoplasm, Midbody ring" "Plasma membrane, Cytosol" "HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: " "unprognostic (1.65e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-2)" "unprognostic (2.00e-2)" "unprognostic (7.68e-2)" "unprognostic (2.06e-1)" "unprognostic (4.71e-2)" "unprognostic (3.07e-3)" "unprognostic (3.41e-1)" "unprognostic (1.01e-1)" "unprognostic (4.58e-1)" "unprognostic (3.82e-1)" "unprognostic (8.86e-3)" "unprognostic (1.36e-2)" "unprognostic (1.23e-1)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" 10.1 9.0 15.4 20.7 19.2 10.2 9.6 62.2 25.0 12.8 22.4 30.0 8.8 8.3 30.3 14.0 13.8 28.6 9.5 23.7 15.4 13.8 8.7 16.8 6.1 15.2 21.6 15.6 20.2 10.2 30.4 11.0 11.9 19.4 11.8 16.5 14.2 8.0 14.8 28.0 14.7 13.2 26.1 20.9 12.2 11.1 15.7 22.6 3.0 10.4 7.8 20.8 14.7 15.1 5.2 0.3 10.0 0.1 1.3 1.1 0.2 13.7 15.1 8.0 13.0 6.0 7.8 9.7 12.1 13.2 17.2 13.6 14.4 1.9 15.4 6.2 16.5 15.9 11.8 14.0 16.7 14.9 11.2 16.0 16.1 6.0 4.0 7.1 8.6 6.3 11.2 18.1 19.2 10.0 17.5 9.9 6.3 12.3 6.7 4.4 5.5 9.9 9.4 12.0 0.7 13.8 9.7 21.2 8.3 17.1 10.9 25.8 4.3 3.0 17.6 17.7 11.4 12.1 25.2 6.5 11.5 20.6 15.4 3.2 50.7 10.0 0.0 0.1 0.5 0.1 0.8 3.3 0.6 0.5 0.1 5.2 0.3 0.2 0.2 1.3 0.0 0.3 1.1 0.2 15.4 19.2 62.2 25.0 15.4 13.8 21.6 15.6 19.4 22.6 MICB PERB11.2 ENSG00000204516 "MHC class I polypeptide-related sequence B" Q29980 6 31494881-31511124 "Disease related genes, Predicted membrane proteins" "Adaptive immunity, Cytolysis, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 26.5" "Cell line enhanced" "Detected in many" "U-266/70: 11.4;U-266/84: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA064618 Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA064618: " "unprognostic (3.63e-3)" "unprognostic (8.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.51e-2)" "unprognostic (8.44e-2)" "unprognostic (5.94e-2)" "prognostic unfavourable (7.04e-5)" "unprognostic (2.05e-1)" "unprognostic (2.61e-1)" "unprognostic (1.67e-3)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (4.94e-9)" "unprognostic (1.91e-3)" "unprognostic (2.80e-2)" "unprognostic (9.72e-2)" "unprognostic (1.21e-2)" 3.3 1.2 0.8 9.1 0.8 6.1 3.5 3.0 1.0 1.8 1.6 0.9 0.0 1.0 2.1 1.3 2.1 1.1 1.7 2.2 1.0 0.6 2.9 1.3 6.9 7.8 1.2 0.8 1.3 2.9 0.2 0.6 0.8 1.2 1.1 1.9 1.1 1.9 0.7 0.8 1.0 5.0 1.7 1.5 11.7 1.4 2.3 1.1 8.1 2.4 0.7 8.1 3.2 26.5 2.2 2.1 4.1 4.8 1.9 4.4 1.9 2.4 0.8 0.0 0.0 1.5 2.4 0.0 1.7 1.6 2.2 2.8 0.0 0.3 2.7 6.1 3.1 0.6 0.7 2.8 0.8 2.4 2.6 3.2 0.4 1.1 0.5 1.0 2.6 3.1 0.6 3.7 2.2 1.4 3.3 5.8 2.6 0.0 0.9 4.2 0.3 0.4 3.3 0.0 5.8 2.5 0.1 0.0 0.0 1.1 0.0 0.5 1.5 1.1 1.4 1.7 0.0 1.4 0.0 11.4 26.1 6.1 0.4 8.6 3.6 4.1 3.1 4.0 2.9 3.6 3.6 2.2 2.9 3.9 2.1 2.0 1.6 3.1 3.1 1.9 4.8 1.3 4.4 1.9 0.8 0.8 3.0 1.0 1.0 0.6 1.2 0.8 1.2 1.1 MICU3 "DKFZp313A0139, EFHA2" ENSG00000155970 "Mitochondrial calcium uptake family member 3" Q86XE3 8 17027238-17122644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 11.9;HBF TERT88: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024048, HPA024771, HPA024779" Uncertain "HPA024048: AB_1848021, HPA024771: AB_1848022, HPA024779: AB_1848023" "unprognostic (2.99e-2)" "unprognostic (7.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.80e-2)" "unprognostic (1.19e-1)" "unprognostic (7.49e-2)" "unprognostic (2.25e-2)" "unprognostic (9.01e-5)" "unprognostic (9.82e-2)" "unprognostic (2.80e-1)" "unprognostic (1.11e-3)" "unprognostic (8.45e-2)" "unprognostic (2.32e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (4.65e-2)" 9.1 11.7 13.7 3.3 18.7 1.4 7.0 34.1 32.3 8.6 4.1 7.7 1.9 2.0 10.4 7.0 5.1 5.4 6.0 6.6 15.4 12.0 7.3 14.8 5.5 4.1 10.5 15.1 12.9 4.6 13.9 13.3 22.1 19.8 9.5 3.5 5.8 5.2 7.5 5.4 2.4 2.7 9.1 10.2 6.9 3.5 7.9 6.3 1.8 7.9 1.3 3.2 6.1 7.5 1.4 0.0 0.1 0.0 0.8 0.9 0.0 0.0 1.1 5.6 2.1 4.3 6.5 1.4 8.3 11.9 6.4 5.2 0.0 0.2 0.1 1.7 4.3 0.0 2.5 1.7 12.1 0.0 1.5 0.0 0.0 2.0 7.5 0.0 0.3 4.9 0.0 5.4 5.5 2.4 0.3 1.6 6.0 0.0 0.7 1.0 4.0 1.4 0.0 2.6 0.0 4.4 0.0 9.2 4.4 0.0 0.0 3.3 0.0 0.0 3.1 2.8 1.1 0.4 1.5 1.6 1.2 2.8 5.2 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.4 0.0 0.0 1.4 0.9 0.7 0.0 0.8 0.0 0.0 0.0 0.0 13.7 18.7 34.1 24.3 15.4 12.0 10.5 15.1 19.8 6.3 MID1 "FXY, OS, RNF59, TRIM18" ENSG00000101871 "Midline 1" O15344 X 10445310-10833654 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 56.8;AF22: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002878, HPA003715" Approved Approved "Centriolar satellite" "Centriolar satellite" "HPA002878: , HPA003715: AB_1079384" "unprognostic (1.99e-1)" "unprognostic (2.81e-1)" "unprognostic (4.66e-2)" "unprognostic (2.79e-1)" "unprognostic (2.78e-1)" "unprognostic (2.61e-1)" "prognostic unfavourable (3.06e-4)" "unprognostic (1.19e-1)" "unprognostic (3.61e-1)" "unprognostic (2.09e-1)" "unprognostic (2.87e-1)" "unprognostic (9.43e-2)" "unprognostic (1.25e-3)" "unprognostic (9.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.12e-3)" "unprognostic (5.88e-2)" 13.4 3.6 6.5 10.4 8.4 0.3 8.6 16.3 7.1 17.5 21.5 3.8 11.7 7.7 17.9 11.3 12.2 7.7 13.1 13.2 6.2 4.2 7.9 4.9 10.4 4.2 4.5 3.7 12.0 4.8 2.7 6.6 7.8 4.9 14.6 12.8 15.9 7.1 19.1 2.8 3.9 8.7 30.6 2.6 1.3 5.3 6.5 4.1 0.8 6.2 7.1 5.8 17.1 20.5 1.0 0.7 3.3 0.0 0.0 0.1 0.1 12.2 56.8 43.0 6.6 2.5 3.6 5.3 7.7 6.4 7.9 8.1 10.4 3.7 4.1 2.5 7.0 8.4 3.5 5.3 5.9 0.2 5.1 0.9 8.1 0.2 1.1 0.0 0.2 4.1 2.8 5.2 5.5 7.6 0.6 0.7 3.1 1.9 1.6 0.1 13.7 4.1 1.2 11.0 0.0 5.8 11.3 3.0 1.1 3.3 9.7 3.6 6.7 0.0 4.8 2.6 0.3 13.3 6.7 0.6 0.3 0.1 5.6 0.0 12.8 0.1 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.1 6.5 8.4 16.3 5.2 6.2 4.2 4.5 3.7 4.9 4.1 MIEF1 "FLJ20232, MiD51, SMCR7L" ENSG00000100335 "Mitochondrial elongation factor 1" Q9NQG6 22 39499432-39518132 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061059 Approved "Intermediate filaments,Mitochondria" "Intermediate filaments, Mitochondria" "HPA061059: " "unprognostic (5.35e-2)" "unprognostic (2.66e-2)" "unprognostic (2.86e-3)" "unprognostic (1.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (1.95e-3)" "unprognostic (1.85e-2)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (6.65e-2)" "prognostic favourable (3.96e-5)" "unprognostic (1.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.30e-1)" 14.9 12.6 14.5 15.1 14.9 16.2 12.3 17.3 21.3 10.0 15.1 12.3 12.9 17.5 12.1 12.9 13.9 10.9 14.2 11.6 13.0 12.9 19.6 26.2 10.8 15.5 13.6 15.9 12.1 14.3 16.6 8.3 12.6 12.1 10.6 14.2 12.5 15.6 14.1 16.7 11.5 16.6 10.3 10.8 18.0 11.7 43.1 10.7 15.9 12.6 11.1 16.6 11.5 13.8 7.1 8.1 5.9 8.3 8.7 9.2 7.6 7.9 8.0 8.8 14.0 8.4 9.2 10.2 7.6 9.1 8.8 8.1 13.1 4.2 22.1 6.4 8.2 10.1 19.9 10.6 11.0 9.4 18.4 9.1 11.3 13.3 16.3 32.1 12.1 12.0 12.9 7.8 16.7 9.3 16.0 12.2 8.7 5.4 10.1 8.9 8.2 8.8 13.9 12.5 22.6 10.1 9.7 8.1 6.7 8.5 14.7 21.8 6.5 11.7 9.0 8.3 11.8 7.4 9.3 22.4 23.3 22.6 9.6 14.1 12.7 0.6 7.4 5.9 7.6 8.3 9.2 7.0 7.3 7.2 8.1 7.1 8.1 7.5 0.7 8.7 7.8 4.5 6.3 7.6 14.5 14.9 17.3 21.3 13.0 12.9 13.6 15.9 12.1 10.7 MIEF2 "MGC23130, MiD49, SMCR7" ENSG00000177427 "Mitochondrial elongation factor 2" Q96C03 17 18260534-18266552 "Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 18.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042334 Uncertain "HPA042334: AB_10794418" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (7.56e-3)" "unprognostic (1.30e-1)" "unprognostic (8.28e-2)" "unprognostic (2.34e-1)" "unprognostic (1.73e-1)" "unprognostic (1.28e-2)" "unprognostic (3.62e-2)" "prognostic favourable (1.75e-7)" "unprognostic (4.68e-2)" "unprognostic (1.39e-1)" "unprognostic (2.40e-2)" "unprognostic (3.06e-2)" 4.9 8.7 5.4 4.2 6.7 3.3 5.3 12.0 13.5 9.7 6.0 7.6 13.3 7.0 6.7 11.0 9.0 9.0 9.0 13.2 5.3 6.6 9.7 5.1 6.2 4.7 4.7 10.3 11.7 7.0 7.9 9.2 7.5 7.2 7.5 3.7 7.2 10.4 7.7 34.9 8.0 6.3 6.6 4.0 5.6 6.3 3.7 5.4 5.3 11.9 11.8 5.7 7.5 6.6 4.7 4.1 8.7 5.7 10.9 5.3 2.9 18.4 5.5 2.1 4.4 1.6 1.8 3.5 6.2 3.7 5.6 2.7 7.9 5.8 2.7 6.8 3.3 14.0 1.5 4.9 2.8 2.5 8.0 0.9 8.9 3.6 2.7 0.4 2.2 1.8 5.1 2.7 2.0 2.3 2.1 0.7 2.0 5.1 2.3 1.9 1.7 2.8 3.3 5.7 3.2 7.6 3.4 1.5 3.3 4.9 6.2 2.7 14.4 1.7 2.6 3.9 6.1 5.8 3.0 2.9 1.7 0.7 5.4 0.9 2.0 2.4 2.4 8.7 5.3 2.5 4.7 3.1 4.1 4.4 2.8 4.7 5.0 4.7 4.0 10.9 5.7 4.1 4.8 2.9 5.4 6.7 12.0 13.5 5.3 6.6 4.7 10.3 7.2 5.4 MIGA1 "FAM73A, FLJ35093" ENSG00000180488 "Mitoguardin 1" Q8NAN2 1 77779624-77879539 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017589 Approved Supported Mitochondria Mitochondria "HPA017589: AB_1848409" "unprognostic (3.27e-1)" "unprognostic (1.19e-2)" "unprognostic (7.31e-3)" "unprognostic (4.62e-3)" "unprognostic (2.40e-1)" "unprognostic (3.48e-2)" "unprognostic (2.70e-2)" "unprognostic (7.27e-2)" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (6.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.89e-1)" "unprognostic (1.68e-1)" "unprognostic (4.71e-2)" "unprognostic (4.75e-2)" 11.7 11.0 12.2 6.9 23.7 8.1 19.2 18.1 25.4 10.5 8.2 20.3 7.2 9.7 12.0 7.5 8.7 9.1 10.3 8.6 15.7 16.1 20.2 11.2 8.3 6.6 19.2 19.7 12.7 8.9 28.0 13.9 10.1 26.4 13.3 8.0 7.6 12.1 9.6 15.7 7.6 10.6 10.1 29.9 7.5 9.8 7.6 18.8 5.9 21.8 5.1 5.9 10.5 8.1 6.2 3.7 7.3 6.8 5.8 6.7 3.2 8.5 5.5 3.5 4.4 8.6 11.2 9.2 12.4 5.9 7.3 7.5 6.1 5.9 3.7 13.8 8.5 5.9 4.7 7.3 13.9 5.4 4.8 4.3 6.8 2.8 8.8 4.0 3.4 8.0 8.0 14.9 10.9 7.3 2.4 5.1 11.0 1.3 3.9 2.3 3.0 6.9 2.1 8.5 1.9 8.8 9.3 7.0 5.7 5.7 8.7 15.8 3.3 2.6 11.7 10.5 4.9 15.8 12.9 3.0 4.3 2.3 9.3 3.5 4.5 7.3 5.5 6.6 5.9 6.8 6.2 4.6 4.7 4.7 3.7 6.2 6.7 5.9 3.5 5.8 4.3 3.0 4.3 3.2 12.2 23.7 18.1 25.4 15.7 16.1 19.2 19.7 26.4 18.8 MIGA2 "C9orf54, FAM73B, FLJ00199, FLJ14596" ENSG00000148343 "Mitoguardin 2" Q7L4E1 9 129036621-129072082 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041363 Approved Approved "Cell Junctions,Cytosol" Cytosol "Cell Junctions" "HPA041363: AB_10794664" "unprognostic (2.10e-1)" "unprognostic (4.82e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (1.01e-1)" "unprognostic (3.93e-2)" "unprognostic (3.07e-3)" "unprognostic (2.90e-2)" "prognostic favourable (3.04e-6)" "unprognostic (1.12e-2)" "unprognostic (1.44e-3)" "unprognostic (8.57e-3)" "unprognostic (1.25e-1)" "unprognostic (4.63e-2)" "unprognostic (4.15e-3)" 10.1 14.3 7.7 11.5 10.2 17.3 6.8 17.6 16.0 5.6 17.2 8.9 14.6 23.7 7.6 8.7 11.5 7.1 13.3 24.4 7.9 11.6 7.6 7.4 5.2 7.5 9.0 10.9 8.4 6.8 7.5 8.5 3.1 9.4 9.3 5.5 8.7 11.1 12.3 13.0 9.8 21.6 9.0 7.6 7.1 9.9 7.0 7.2 8.0 9.6 5.3 10.8 10.0 9.8 2.8 3.9 8.5 3.1 1.2 6.5 2.2 4.0 8.3 2.6 13.0 7.1 3.7 5.7 7.2 5.5 8.4 5.3 7.1 8.4 6.1 3.3 5.6 19.2 3.5 5.4 1.3 5.6 5.1 4.4 16.1 5.2 7.9 4.9 10.1 5.2 4.3 7.5 3.9 5.7 6.4 2.6 4.5 10.6 4.9 10.3 5.9 12.0 10.2 7.6 10.0 4.4 7.8 8.2 5.8 8.0 12.9 4.5 9.2 5.4 5.7 5.4 6.2 9.1 5.5 3.5 5.0 5.6 7.7 4.0 6.4 8.5 2.6 2.4 3.0 3.1 6.5 2.3 2.2 3.9 2.9 2.8 2.2 1.3 4.8 1.2 1.7 3.9 1.9 2.2 7.7 10.2 17.6 16.0 7.9 11.6 9.0 10.9 9.4 7.2 MILR1 "Allergin-1, C17orf60, MCA-32" ENSG00000271605 "Mast cell immunoglobulin like receptor 1" Q7Z6M3 17 64449037-64468643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.5;CAPAN-2: 46.0;Daudi: 22.5;REH: 17.9;U-698: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014347 Enhanced 130000 "HPA014347: AB_1845597" "unprognostic (8.40e-2)" "unprognostic (9.77e-2)" "unprognostic (9.28e-3)" "unprognostic (3.27e-1)" "unprognostic (1.17e-1)" "unprognostic (1.21e-2)" "unprognostic (1.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.25e-1)" "unprognostic (3.31e-2)" "unprognostic (5.99e-3)" "unprognostic (4.78e-2)" "prognostic unfavourable (5.07e-6)" "unprognostic (2.51e-2)" "unprognostic (7.12e-3)" "unprognostic (1.09e-1)" "unprognostic (5.99e-2)" 8.4 6.7 6.6 22.3 12.6 13.1 5.0 1.5 6.7 6.8 3.9 11.8 0.6 3.7 3.0 6.9 3.4 4.2 7.3 6.2 7.4 5.4 4.3 3.2 11.4 24.6 13.9 2.3 3.9 2.9 2.5 3.1 13.6 9.8 4.4 7.7 5.6 5.0 2.0 1.6 1.9 7.1 6.7 18.6 24.2 3.1 2.2 11.2 2.2 3.8 3.1 17.7 7.1 3.4 9.4 21.5 28.0 18.7 0.6 0.4 5.2 2.8 0.6 0.0 0.1 1.7 17.5 0.3 0.0 1.8 0.3 3.8 0.1 46.0 22.5 1.0 0.2 0.5 0.0 0.7 1.1 0.1 0.0 0.5 0.3 0.0 0.3 1.5 15.0 1.7 0.1 5.5 0.7 1.7 1.5 2.7 10.9 0.0 0.2 3.0 0.1 3.1 17.9 3.0 9.3 0.6 0.3 0.1 0.0 1.5 0.2 2.9 0.1 12.6 5.9 0.2 0.6 0.1 1.1 0.2 0.0 24.1 12.2 2.6 0.0 28.0 18.7 1.0 0.4 15.4 0.3 9.4 0.2 0.3 11.9 6.5 0.3 0.4 5.7 0.6 9.6 21.5 0.2 5.2 6.6 12.6 1.5 6.7 7.4 5.4 13.9 2.3 9.8 11.2 MINOS1 "C1orf151, FLJ36999, Mic10, MIO10, RP5-1056L3.2" ENSG00000173436 "Mitochondrial inner membrane organizing system 1" Q5TGZ0 1 19596977-19629821 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059930 Enhanced Supported Mitochondria Mitochondria "HPA059930: " "unprognostic (3.84e-2)" "unprognostic (8.74e-3)" "unprognostic (2.66e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.98e-2)" "prognostic unfavourable (7.23e-4)" "unprognostic (2.88e-1)" "unprognostic (8.74e-2)" "unprognostic (3.96e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.24e-3)" "unprognostic (7.13e-2)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "prognostic favourable (8.11e-4)" 10.1 9.7 22.0 8.1 21.3 5.4 12.6 20.4 22.2 17.7 16.3 7.2 7.5 10.6 14.5 13.7 15.1 15.2 13.7 25.4 18.3 21.4 19.8 12.5 9.7 8.3 20.6 15.5 14.0 13.3 14.5 16.6 8.3 17.0 17.2 18.3 9.3 13.8 17.8 25.2 10.1 17.4 18.2 12.1 8.9 11.4 5.0 11.8 7.7 13.7 20.3 11.8 13.9 10.9 7.0 8.4 9.0 10.5 3.7 11.3 8.9 7.5 10.5 6.0 6.5 11.5 10.9 3.7 6.6 7.4 7.8 7.9 7.3 7.0 6.4 5.5 8.7 5.6 10.3 8.7 12.6 9.7 7.2 5.6 16.8 10.1 5.1 8.7 4.2 8.9 14.3 7.7 9.5 11.3 12.0 4.8 11.6 13.4 4.4 11.4 5.1 13.3 4.4 7.2 8.5 19.1 4.6 12.4 5.5 7.3 5.9 5.7 5.8 4.9 7.5 6.1 4.7 7.7 6.5 3.1 5.1 6.6 4.8 16.6 5.7 5.6 8.1 9.0 6.4 10.5 5.8 7.0 8.7 7.0 8.2 6.7 11.3 8.1 5.5 3.7 10.5 8.4 7.8 8.9 22.0 21.3 20.4 22.2 18.3 21.4 20.6 15.5 17.0 11.8 MKNK1 MNK1 ENSG00000079277 "MAP kinase interacting serine/threonine kinase 1" Q9BUB5 1 46557408-46616843 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 72.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB027355, CAB037310, HPA071293" Approved Supported Nucleoplasm Nucleoplasm "CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: " "unprognostic (4.05e-3)" "prognostic favourable (7.05e-4)" "unprognostic (5.28e-2)" "unprognostic (3.47e-2)" "unprognostic (1.64e-1)" "unprognostic (7.38e-2)" "prognostic unfavourable (1.24e-5)" "unprognostic (3.50e-2)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (1.50e-1)" "unprognostic (2.14e-2)" "prognostic unfavourable (1.51e-5)" "unprognostic (7.02e-2)" "unprognostic (3.19e-2)" "unprognostic (4.67e-1)" "unprognostic (5.67e-3)" 17.6 12.0 10.7 16.2 10.5 16.8 12.1 13.7 12.3 9.2 12.6 11.0 9.6 9.7 11.9 13.3 12.2 11.1 11.4 12.3 10.8 7.0 9.4 10.8 16.1 16.3 9.9 9.8 10.7 72.3 8.6 11.3 15.4 11.0 9.9 13.3 11.9 10.6 7.7 12.8 10.2 12.7 13.3 8.1 25.6 11.7 7.6 8.7 12.5 8.8 15.8 10.9 10.9 14.5 4.9 6.0 33.3 12.1 5.0 22.0 6.1 19.3 13.1 8.7 9.6 7.8 11.6 11.6 9.8 9.8 11.9 16.2 15.1 8.0 12.8 12.1 9.8 23.5 14.5 16.0 12.7 21.9 12.9 27.0 15.0 12.9 12.2 14.4 22.0 15.2 11.1 15.5 8.5 13.9 14.1 9.4 6.4 12.7 10.3 12.9 5.9 15.6 9.5 18.2 12.8 12.7 20.3 6.1 5.5 18.9 17.1 15.8 11.5 16.1 11.2 4.3 0.9 13.5 10.9 8.0 13.3 10.9 8.4 18.6 7.9 3.9 12.1 14.3 7.5 11.5 22.0 4.6 6.6 6.8 6.0 4.9 4.8 7.0 33.3 5.0 8.1 4.4 4.4 6.1 10.7 10.5 13.7 12.3 10.8 7.0 9.9 9.8 11.0 8.7 MLANA MART1 ENSG00000120215 Melan-A Q16655 9 5890802-5910606 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 191.5" "Cell line enriched" "Detected in single" 384 "SK-MEL-30: 120.4" "Cancer enriched" "Detected in single" 556 "melanoma: 277.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB000057, HPA048662" Enhanced "CAB000057: AB_442107, HPA048662: " "unprognostic (2.52e-2)" "unprognostic (6.87e-2)" "unprognostic (5.20e-2)" "unprognostic (5.61e-2)" "unprognostic (2.58e-2)" "unprognostic (1.46e-1)" "unprognostic (4.53e-1)" "unprognostic (3.32e-1)" "unprognostic (2.82e-2)" "unprognostic (1.71e-3)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (8.01e-2)" "unprognostic (5.78e-2)" "unprognostic (9.43e-2)" 0.1 0.1 0.1 0.2 0.1 0.6 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 191.5 1.2 0.1 0.2 31.5 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.3 2.1 1.6 3.5 1.2 1.8 1.5 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.5 1.2 0.8 1.4 0.8 1.1 1.4 1.3 1.2 0.4 2.1 1.4 1.5 2.9 1.8 1.1 1.6 0.6 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 MLLT10 AF10 ENSG00000078403 "MLLT10, histone lysine methyltransferase DOT1L cofactor" P55197 10 21524675-21743630 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005747 Enhanced Supported Nucleoplasm Nucleoplasm "HPA005747: AB_1079393" "unprognostic (6.58e-2)" "unprognostic (1.57e-1)" "unprognostic (7.32e-2)" "unprognostic (1.47e-2)" "unprognostic (1.31e-2)" "prognostic favourable (8.75e-4)" "unprognostic (1.03e-3)" "unprognostic (9.56e-3)" "unprognostic (9.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.69e-2)" "unprognostic (7.85e-2)" "unprognostic (6.57e-2)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" 16.3 12.1 11.7 18.4 14.3 21.9 12.8 25.4 13.6 19.0 17.0 12.0 13.6 8.5 26.3 12.8 14.7 14.5 13.7 15.8 10.2 8.5 12.3 13.5 12.3 11.6 10.5 9.9 21.4 12.3 16.6 23.2 20.3 11.8 12.6 11.3 14.6 13.2 16.3 13.4 18.7 12.1 18.7 11.2 10.6 11.4 71.2 14.3 14.6 18.1 9.7 15.2 18.5 19.6 5.5 6.9 12.0 6.8 5.3 7.2 2.8 14.3 12.2 18.9 13.1 12.0 15.1 20.7 9.1 5.8 11.4 11.2 13.0 15.4 17.2 5.1 10.1 13.5 20.8 12.2 11.5 11.9 12.0 26.6 10.6 18.7 14.8 0.6 17.2 11.2 14.6 9.5 11.0 15.1 28.4 13.4 9.0 11.1 20.7 12.5 7.7 3.9 18.0 10.1 14.4 11.0 6.8 6.6 18.4 12.1 14.5 20.4 6.8 18.5 13.6 7.2 12.6 14.3 9.0 11.7 13.4 19.2 8.3 10.3 5.5 10.6 6.8 12.0 5.3 4.6 5.2 5.0 6.2 5.7 5.6 5.5 7.2 6.7 5.8 5.3 5.2 6.9 4.6 2.8 11.7 14.3 25.4 13.6 10.2 8.5 10.5 9.9 11.8 14.3 MME "CALLA, CD10, NEP" ENSG00000196549 "Membrane metalloendopeptidase" P08473 3 155024124-155183729 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.1;intestine: 136.0;kidney: 64.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 95.0;BJ hTERT+: 142.9;HSkMC: 92.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 129 "neutrophil: 61.1" "Lineage enriched" "Detected in single" 129 "granulocytes: 61.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 26.8" "CAB000013, HPA052583, HPA056072" Enhanced 99000 "CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027" "unprognostic (1.36e-1)" "unprognostic (1.02e-3)" "unprognostic (8.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.78e-2)" "unprognostic (6.52e-3)" "unprognostic (1.20e-1)" "unprognostic (1.67e-2)" "unprognostic (8.67e-2)" "unprognostic (1.96e-1)" "unprognostic (7.30e-3)" "unprognostic (1.31e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-1)" "unprognostic (7.29e-2)" "unprognostic (1.06e-2)" "unprognostic (1.37e-2)" 26.5 0.4 0.4 3.4 7.4 1.9 14.7 0.4 0.7 4.8 65.6 0.1 18.4 74.0 2.8 8.1 0.7 0.9 8.5 1.8 0.3 0.4 64.9 11.5 13.7 3.0 2.1 0.2 0.9 0.6 0.0 0.6 35.0 8.6 18.3 0.4 1.3 3.7 11.3 11.7 1.4 136.0 0.6 0.9 2.7 0.7 1.0 1.2 13.2 1.0 5.3 2.3 3.4 4.9 0.1 0.4 61.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 38.6 95.0 0.2 21.2 142.9 10.8 28.1 0.0 0.0 23.4 0.0 18.8 0.0 0.7 0.8 26.1 0.0 0.1 0.0 0.0 0.0 30.9 0.0 0.0 92.1 0.1 5.8 41.6 8.2 0.0 0.0 17.3 0.1 0.0 0.1 0.9 0.1 38.8 18.2 0.1 0.6 0.2 0.0 0.2 0.0 0.0 4.1 0.0 0.0 23.3 46.7 0.1 15.9 3.7 0.0 0.0 30.8 5.6 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 61.1 0.0 0.0 0.4 0.0 0.0 0.4 7.4 0.4 0.7 0.3 0.4 2.1 0.2 8.6 1.2 MMGT1 "EMC5, TMEM32" ENSG00000169446 "Membrane magnesium transporter 1" Q8N4V1 X 135962070-135974063 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032037 Approved "HPA032037: AB_10670705" "prognostic unfavourable (8.54e-4)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (1.90e-2)" "unprognostic (2.23e-3)" "unprognostic (8.94e-3)" "unprognostic (2.61e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-1)" "unprognostic (3.87e-1)" "unprognostic (2.35e-1)" "unprognostic (2.38e-1)" "prognostic favourable (1.94e-5)" "unprognostic (6.08e-2)" "unprognostic (2.94e-2)" "unprognostic (1.05e-1)" "unprognostic (1.29e-2)" 25.6 13.4 12.2 11.4 21.3 25.6 16.7 13.7 22.7 19.5 18.7 17.0 10.0 12.5 24.8 17.9 18.5 17.0 15.4 18.0 12.1 18.0 19.4 10.7 18.8 19.2 14.4 12.3 18.6 14.8 18.4 20.8 13.5 15.8 17.5 17.1 17.2 16.5 15.6 28.0 14.2 13.9 21.0 18.8 14.5 16.5 7.2 9.8 23.3 23.6 12.9 14.2 24.6 15.3 8.6 11.7 9.7 14.3 10.7 15.3 9.7 13.6 8.2 8.4 13.2 17.5 16.9 10.9 15.4 14.9 13.0 25.9 9.6 21.3 9.0 30.6 16.6 12.4 21.1 11.5 20.3 10.1 12.1 5.6 10.6 6.1 12.9 12.6 9.9 13.7 20.8 21.9 16.0 9.7 7.6 18.9 14.7 14.2 9.3 8.5 5.9 12.9 8.6 13.4 16.9 12.0 7.4 12.3 11.2 8.2 9.9 21.1 8.3 7.7 9.9 16.0 9.5 23.3 20.7 11.6 16.2 9.8 13.7 18.8 18.3 9.7 12.3 7.2 9.5 12.5 12.5 8.6 13.1 11.5 11.7 6.2 12.8 12.2 6.2 10.7 14.3 8.0 15.3 9.7 12.2 21.3 13.7 22.7 12.1 18.0 14.4 12.3 15.8 9.8 MMP14 MT1-MMP ENSG00000157227 "Matrix metallopeptidase 14" P50281 14 22836557-22849027 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 98.0;HHSteC: 92.7;HSkMC: 94.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009918, HPA051432" Approved Approved "Intermediate filaments,Cytosol" 570000 Cytosol "Intermediate filaments" "CAB009918: AB_2250767, HPA051432: " "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (4.28e-2)" "unprognostic (1.12e-2)" "unprognostic (3.05e-3)" "unprognostic (5.91e-3)" "unprognostic (1.95e-1)" "prognostic unfavourable (9.48e-4)" "unprognostic (3.82e-3)" "unprognostic (7.31e-2)" "prognostic unfavourable (1.34e-4)" "unprognostic (5.02e-2)" "unprognostic (6.69e-2)" "unprognostic (1.00e-2)" "unprognostic (3.41e-3)" 60.9 10.5 2.4 16.6 4.7 0.2 64.2 2.2 3.2 56.3 35.0 8.2 12.7 12.0 53.1 24.1 47.0 21.9 39.6 17.5 3.4 1.8 16.8 9.0 29.8 16.9 5.8 2.9 39.3 11.2 34.4 4.7 73.5 16.4 39.1 11.3 27.1 24.4 16.7 20.4 37.0 22.9 28.5 20.7 22.5 18.2 26.3 4.6 5.4 22.3 14.6 16.7 52.5 53.9 0.1 0.7 0.0 0.7 0.0 0.0 0.1 7.9 0.1 2.4 0.1 98.0 62.3 45.0 25.1 50.6 7.6 13.6 2.3 29.9 0.1 14.0 26.4 20.3 0.0 26.1 9.8 0.1 0.1 3.7 0.1 0.5 92.7 0.0 0.1 94.2 15.8 31.7 27.2 46.0 0.1 0.2 17.9 0.1 0.0 9.0 1.5 4.3 0.3 8.6 0.0 6.9 13.7 0.0 0.0 16.4 0.0 54.4 0.1 8.1 40.7 61.9 5.3 18.0 28.6 0.1 0.1 0.1 37.7 0.0 35.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 4.7 2.2 3.2 3.4 1.8 5.8 2.9 16.4 4.6 MMP15 "MT2-MMP, MTMMP2, SMCP-2" ENSG00000102996 "Matrix metallopeptidase 15" P51511 16 58025566-58046901 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.2" "Cell line enhanced" "Detected in many" "BEWO: 36.8;Hep G2: 19.1;SK-BR-3: 18.5;WM-115: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 2.9" "Lineage enriched" "Detected in single" 30 "dendritic cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002611, HPA040390" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "CAB002611: , HPA040390: " "unprognostic (1.76e-2)" "unprognostic (7.32e-2)" "unprognostic (2.69e-1)" "unprognostic (6.85e-2)" "unprognostic (3.09e-1)" "unprognostic (1.68e-1)" "unprognostic (6.88e-3)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (1.24e-2)" "unprognostic (4.81e-2)" "unprognostic (1.81e-1)" "prognostic favourable (8.54e-8)" "unprognostic (3.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "prognostic favourable (3.08e-4)" 5.9 2.3 2.0 5.5 3.0 0.1 7.7 3.7 7.2 3.3 19.5 4.2 16.3 22.6 2.9 1.7 2.5 3.6 15.9 17.6 2.3 3.7 8.4 26.4 6.1 2.0 2.5 2.2 2.1 10.3 7.3 5.2 28.5 10.4 3.6 8.2 9.5 4.7 14.7 3.4 2.3 43.2 3.4 3.4 5.2 14.7 28.0 2.1 1.1 26.8 2.5 2.2 3.3 4.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 5.7 4.3 2.3 11.8 2.4 0.1 36.8 0.5 0.3 2.1 0.4 3.4 14.8 0.0 7.0 0.6 8.1 1.9 1.7 0.6 0.0 3.9 0.0 1.9 19.1 3.1 0.1 7.7 1.2 3.0 0.3 0.9 1.4 4.7 0.0 0.7 2.8 0.2 0.9 6.7 1.2 2.8 0.3 3.1 6.5 2.1 0.6 4.1 7.7 18.5 3.5 2.0 3.1 1.3 0.1 3.7 1.4 0.5 0.0 0.0 0.1 0.7 0.9 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 3.0 3.7 7.2 2.3 3.7 2.5 2.2 10.4 2.1 MMP16 "C8orf57, DKFZp761D112, MT3-MMP" ENSG00000156103 "Matrix metallopeptidase 16" P51512 8 88032009-88328025 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.9" "Cell line enhanced" "Detected in many" "AN3-CA: 20.0;HUVEC TERT2: 8.7;SH-SY5Y: 11.1;U-138 MG: 9.5;WM-115: 19.5" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023693 Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" Cytosol Vesicles "HPA023693: AB_1854025" "unprognostic (2.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.31e-2)" "unprognostic (2.39e-3)" "unprognostic (1.45e-3)" "unprognostic (2.46e-1)" "unprognostic (2.61e-1)" "unprognostic (9.42e-2)" "unprognostic (2.92e-1)" "unprognostic (2.09e-8)" "unprognostic (6.90e-3)" "unprognostic (1.16e-1)" "unprognostic (3.62e-1)" "unprognostic (2.19e-3)" 2.4 1.3 11.0 1.4 6.8 0.5 4.9 8.3 15.9 5.3 2.2 2.9 0.7 0.8 4.9 2.1 1.7 2.1 7.3 2.7 8.7 6.9 0.8 0.9 1.0 1.0 5.5 9.1 3.3 2.1 1.5 1.7 3.0 6.3 3.2 1.7 0.6 1.2 2.4 0.7 1.1 1.3 4.0 4.6 1.5 1.4 1.5 5.5 0.0 3.2 0.7 1.0 2.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.4 20.0 0.7 1.4 0.0 7.3 1.0 2.1 1.2 0.0 0.0 0.0 0.0 3.3 0.0 3.9 0.0 2.5 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.3 1.0 0.0 3.0 0.9 8.7 0.0 0.7 1.1 0.0 0.0 0.0 1.1 2.0 0.2 0.4 0.0 0.4 0.0 0.1 11.1 0.0 0.0 0.1 0.8 0.0 4.8 9.5 5.4 0.1 2.7 0.0 0.0 0.0 3.8 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 6.8 8.3 14.1 8.7 6.9 5.5 9.1 6.3 5.5 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226654-35277000 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.5" "Cell line enhanced" "Detected in some" "A549: 19.6;CACO-2: 29.9;EFO-21: 8.8;RPTEC TERT1: 13.5;U-2 OS: 10.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 38.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 91.3" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favourable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.6 1.3 4.0 0.4 7.8 0.6 0.4 38.5 8.9 0.7 0.3 1.3 0.2 2.8 1.6 0.9 0.2 2.8 0.6 1.0 2.7 3.2 8.6 0.9 6.1 0.3 1.8 1.5 0.9 8.0 0.0 3.8 0.6 1.7 2.2 0.1 0.5 0.4 6.0 0.2 1.5 1.7 2.5 0.9 0.6 0.7 0.4 1.4 0.2 0.8 0.2 0.2 0.5 0.2 0.8 0.4 2.2 0.8 0.6 1.2 0.3 0.3 19.6 0.0 0.1 0.1 0.0 0.6 1.1 1.2 2.1 1.1 29.9 5.3 0.0 8.8 1.3 0.3 4.6 0.0 0.9 0.1 0.2 1.0 0.5 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 7.5 1.3 0.0 0.1 0.0 13.5 0.1 7.8 5.4 1.4 0.5 0.2 0.3 0.1 0.3 4.2 10.1 1.0 0.4 0.1 0.1 0.0 0.9 0.1 0.6 1.0 0.6 0.1 1.0 0.7 1.2 0.6 0.7 0.8 0.4 0.8 0.6 0.6 2.2 0.6 0.8 0.2 0.0 0.3 4.0 7.8 38.5 5.3 2.7 3.2 1.8 1.5 1.7 1.4 MOG "BTN6, BTNL11" ENSG00000204655 "Myelin oligodendrocyte glycoprotein" Q16653 6 29656981-29672372 "Disease related genes, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 47 "brain: 106.4" "Group enriched" "Detected in some" 7 "BEWO: 3.4;HEK 293: 2.1" "Cancer enriched" "Detected in single" 45 "glioma: 15.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021873 Enhanced "HPA021873: AB_1854055" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (3.00e-4)" "unprognostic (4.89e-2)" "unprognostic (4.90e-2)" 1.9 1.7 22.1 1.7 35.1 1.7 1.7 3.1 30.0 1.7 1.9 79.5 0.0 1.7 1.7 1.7 1.7 1.7 1.7 1.7 40.2 19.6 2.0 1.7 1.8 1.7 49.2 17.1 2.0 1.7 1.7 0.0 1.8 39.8 1.8 2.1 0.0 1.7 2.2 1.7 1.7 2.0 1.7 106.4 1.7 1.7 2.0 46.4 0.0 1.7 0.0 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 22.1 35.1 3.1 30.0 40.2 19.6 49.2 17.1 39.8 46.4 MOGAT1 "DGAT2L, DGAT2L1, MGAT1" ENSG00000124003 "Monoacylglycerol O-acyltransferase 1" Q96PD6 2 222671786-222709930 "Enzymes, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "gallbladder: 40.9" "Cell line enhanced" "Detected in single" "Hep G2: 1.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 0.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 3.4" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA049944 Uncertain "HPA049944: " "unprognostic (6.32e-2)" "unprognostic (2.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.41e-1)" "unprognostic (4.28e-3)" "unprognostic (4.39e-2)" "unprognostic (4.32e-2)" "unprognostic (9.44e-2)" "unprognostic (1.91e-1)" "unprognostic (8.59e-2)" "unprognostic (3.07e-3)" "unprognostic (4.99e-2)" "unprognostic (3.89e-1)" "unprognostic (9.03e-3)" 2.3 0.1 0.6 0.1 0.5 0.1 1.3 0.2 0.9 0.3 0.6 0.5 0.2 0.0 1.0 1.1 0.5 0.1 40.9 0.8 0.5 0.2 5.7 7.6 1.1 0.3 0.2 0.9 0.1 1.5 2.3 0.4 0.0 0.9 0.2 0.1 0.0 1.4 2.6 0.5 1.6 0.2 0.1 0.3 0.1 1.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 1.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.6 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.5 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.6 0.5 0.2 0.9 0.5 0.2 0.2 0.9 0.9 0.0 MOGAT2 "DGAT2L5, FLJ22644, MGAT2" ENSG00000166391 "Monoacylglycerol O-acyltransferase 2" Q3SYC2 11 75717819-75732958 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 90.2;liver: 40.5" "Group enriched" "Detected in some" 7 "Hep G2: 8.4;RPMI-8226: 5.6" "Cancer enhanced" "Detected in many" "liver cancer: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA028834 Uncertain "HPA028834: AB_10601865" "unprognostic (5.63e-2)" "unprognostic (2.71e-2)" "unprognostic (6.37e-2)" "unprognostic (6.88e-3)" "unprognostic (1.15e-4)" "unprognostic (2.66e-3)" "unprognostic (1.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.42e-2)" "unprognostic (1.12e-1)" "unprognostic (4.21e-2)" "unprognostic (3.02e-1)" "unprognostic (1.24e-5)" "unprognostic (2.13e-3)" "unprognostic (1.84e-2)" "unprognostic (2.13e-1)" "unprognostic (2.83e-3)" 0.1 0.0 0.1 4.8 0.1 0.0 2.1 0.1 0.1 0.2 34.0 0.1 1.4 22.3 0.1 0.1 0.2 0.0 2.6 0.1 0.1 0.0 0.2 40.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 7.0 0.1 0.4 2.2 0.4 0.9 90.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 5.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 MOGAT3 "DC7, DGAT2L2, MGAT3" ENSG00000106384 "Monoacylglycerol O-acyltransferase 3" Q86VF5 7 101195007-101201021 "Enzymes, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 61.6;liver: 16.0" "Group enriched" "Detected in some" 6 "CACO-2: 4.7;Hep G2: 15.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.0;liver cancer: 11.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" HPA011940 Approved Approved Centrosome Centrosome "HPA011940: AB_1854057" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (7.14e-2)" "unprognostic (6.11e-2)" "unprognostic (3.20e-1)" "unprognostic (9.54e-3)" "unprognostic (9.36e-2)" "unprognostic (3.08e-1)" "unprognostic (1.05e-3)" "unprognostic (1.87e-1)" "unprognostic (1.23e-1)" "unprognostic (9.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.59e-2)" 0.2 0.1 0.2 2.6 0.2 0.4 0.2 0.2 0.2 0.2 17.3 0.2 0.2 19.7 0.2 0.5 0.2 0.1 0.2 0.2 0.2 0.1 0.9 16.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 7.1 0.2 0.2 0.2 0.2 0.1 61.6 0.4 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.7 1.2 5.3 0.9 1.9 1.2 0.3 0.6 0.2 0.2 0.5 0.0 0.1 0.4 0.6 0.0 0.0 0.0 4.7 1.1 0.3 0.6 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.6 0.6 15.8 0.2 0.5 0.6 0.1 0.1 0.0 0.1 0.1 0.2 0.6 0.1 0.3 0.3 0.5 0.2 0.6 0.3 0.1 0.4 0.7 0.6 0.3 0.3 0.3 0.6 0.1 0.3 0.3 0.8 0.9 0.2 1.0 0.5 0.4 0.2 0.1 1.7 0.6 1.4 2.2 0.9 1.1 1.0 0.7 0.7 1.0 0.8 0.7 0.5 1.7 0.9 1.2 5.3 1.9 0.6 1.2 0.5 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 MOGS "CWH41, DER7, GCS1" ENSG00000115275 "Mannosyl-oligosaccharide glucosidase" Q13724 2 74461057-74465410 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011322, HPA011969" Approved Supported "Endoplasmic reticulum" 88000000 "Endoplasmic reticulum" "HPA011322: , HPA011969: AB_1849579" "unprognostic (5.66e-2)" "unprognostic (1.98e-2)" "prognostic unfavourable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (4.67e-2)" "unprognostic (2.04e-1)" "prognostic unfavourable (2.34e-6)" "unprognostic (1.48e-2)" "unprognostic (2.66e-2)" "unprognostic (3.32e-2)" "unprognostic (6.21e-2)" "unprognostic (4.36e-1)" "prognostic unfavourable (2.79e-8)" "unprognostic (1.40e-2)" "unprognostic (3.06e-2)" "unprognostic (2.66e-1)" "unprognostic (7.59e-3)" 15.8 12.8 8.7 15.2 10.6 8.5 13.1 11.3 12.1 13.9 19.4 10.8 24.9 36.5 14.2 15.8 15.5 13.4 16.4 11.2 7.7 6.1 14.8 40.5 17.2 15.6 9.2 7.9 14.2 30.6 20.4 15.7 35.8 8.3 15.9 11.2 11.7 24.5 25.3 14.1 17.4 35.8 9.8 7.1 22.4 22.3 11.9 8.1 17.6 18.9 11.4 19.5 14.1 12.9 3.9 3.4 2.3 4.4 12.7 5.1 2.5 22.1 19.7 13.1 12.6 27.0 19.1 40.1 18.2 26.3 27.6 26.6 36.0 23.7 24.0 16.2 18.3 22.3 19.7 20.5 17.1 20.7 19.1 11.2 12.8 27.6 22.3 26.3 22.6 11.1 32.9 19.5 19.1 30.9 19.5 23.3 12.1 27.6 14.2 20.2 17.3 11.0 16.3 29.1 31.1 15.0 13.8 10.8 14.1 8.6 36.1 23.6 17.5 14.2 22.0 12.7 22.2 18.4 24.0 36.0 14.8 10.6 20.0 21.5 17.2 2.3 4.0 1.1 5.0 2.5 5.1 2.5 4.2 4.5 3.4 3.9 3.7 2.4 0.7 12.7 4.4 3.2 3.8 2.5 8.7 10.6 11.3 12.1 7.7 6.1 9.2 7.9 8.3 8.1 MOSPD2 MGC26706 ENSG00000130150 "Motile sperm domain containing 2" Q8NHP6 X 14873441-14922327 "Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 30.2" "Group enriched" "Detected in all" 4 "granulocytes: 30.2;monocytes: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003334 Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA003334: AB_2146004" "unprognostic (2.74e-1)" "unprognostic (4.39e-2)" "unprognostic (6.52e-2)" "unprognostic (2.29e-1)" "unprognostic (7.57e-2)" "unprognostic (6.39e-2)" "prognostic unfavourable (8.91e-4)" "unprognostic (1.51e-1)" "unprognostic (7.24e-2)" "unprognostic (4.21e-3)" "unprognostic (1.00e-1)" "unprognostic (8.64e-2)" "unprognostic (1.04e-1)" "unprognostic (4.56e-1)" "unprognostic (1.37e-1)" "unprognostic (2.69e-1)" "unprognostic (1.96e-2)" 11.2 7.1 11.9 10.4 20.8 12.4 8.5 8.0 18.0 11.3 6.2 24.6 8.5 7.4 9.1 9.9 11.9 6.5 10.9 5.9 16.7 11.1 8.6 8.3 12.2 11.1 33.0 13.8 10.4 7.8 6.6 11.5 14.1 33.9 7.1 8.1 4.9 18.5 6.4 3.7 21.4 7.3 8.0 40.4 12.0 7.3 5.6 27.0 7.8 13.1 6.2 9.2 7.8 10.6 2.3 2.7 30.2 8.4 4.3 2.3 2.7 5.6 7.5 5.7 3.1 19.2 12.2 6.1 12.9 12.1 9.2 11.1 3.8 6.9 7.1 3.6 21.5 9.1 7.1 5.4 12.2 5.4 6.4 2.4 7.2 3.5 11.9 4.7 7.1 11.0 7.8 8.2 11.0 8.1 3.2 10.3 8.7 2.4 4.7 3.9 3.9 6.9 4.4 7.6 6.0 7.5 3.8 1.8 4.3 9.8 4.6 20.8 4.0 6.9 8.2 8.8 3.7 29.5 4.9 6.2 5.7 4.8 11.4 3.9 11.9 7.8 8.3 3.9 2.0 7.9 2.1 1.2 1.8 1.2 2.7 2.3 2.0 2.3 30.2 4.3 8.4 1.1 1.9 2.7 11.9 20.8 8.0 18.0 16.7 11.1 33.0 13.8 33.9 27.0 MOSPD3 "CDS3, NET30" ENSG00000106330 "Motile sperm domain containing 3" O75425 7 100612102-100615384 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041137, HPA048240" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041137: AB_10803996, HPA048240: " "unprognostic (1.24e-1)" "unprognostic (8.98e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.25e-2)" "unprognostic (1.80e-2)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (9.88e-2)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (8.65e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" 13.8 22.3 13.0 7.7 12.8 17.4 9.8 9.0 16.9 14.7 9.1 14.5 13.9 9.9 12.0 12.9 22.5 12.0 14.9 10.2 11.2 10.8 19.3 29.8 11.1 18.5 10.6 11.6 13.1 17.1 6.7 9.8 7.8 12.0 12.9 4.8 14.9 19.1 11.3 11.3 24.4 10.6 10.3 9.5 11.8 14.7 37.0 9.9 16.6 12.2 13.6 16.8 12.4 13.4 11.6 17.9 22.2 16.7 20.9 29.7 8.0 5.9 8.1 6.5 11.2 3.4 2.5 4.6 4.5 5.4 4.7 4.8 7.4 8.0 3.7 10.0 4.1 4.6 3.8 6.5 0.8 9.7 5.0 3.8 6.0 11.1 4.4 2.9 14.9 7.2 5.6 4.0 2.4 8.0 9.0 7.7 4.8 17.6 8.3 22.6 5.9 12.2 7.7 6.7 8.9 7.4 8.9 3.6 21.3 8.5 13.1 4.5 8.0 8.8 9.1 9.2 14.4 18.9 4.3 6.0 5.7 2.5 9.1 33.1 11.2 18.5 16.7 22.2 18.8 12.4 22.2 11.6 21.8 21.8 17.9 11.3 13.0 13.5 12.3 20.9 8.5 12.0 29.7 8.0 13.0 12.8 9.0 16.9 11.2 10.8 10.6 11.6 12.0 9.9 MOXD1 "dJ248E1.1, DKFZP564G202, MOX" ENSG00000079931 "Monooxygenase DBH like 1" Q6UVY6 6 132296055-132401545 "Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 57.2;smooth muscle: 41.1" "Cell line enhanced" "Detected in some" "ASC diff: 37.6;ASC TERT1: 30.3;BJ: 22.9;fHDF/TERT166: 42.6;HBF TERT88: 27.5;U-2197: 68.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 47 "memory B-cell: 4.9;naive B-cell: 2.8;plasmacytoid DC: 7.8" "Group enriched" "Detected in many" 58 "B-cells: 4.9;dendritic cells: 7.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035740 Approved Approved Cytosol Cytosol "HPA035740: AB_10610141" "unprognostic (1.74e-1)" "unprognostic (1.28e-1)" "unprognostic (8.05e-2)" "unprognostic (9.87e-3)" "unprognostic (5.62e-2)" "prognostic favourable (7.09e-5)" "unprognostic (5.77e-2)" "unprognostic (2.48e-1)" "unprognostic (6.55e-2)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" "unprognostic (9.54e-2)" "unprognostic (2.56e-3)" "prognostic unfavourable (3.72e-4)" "unprognostic (2.92e-2)" "unprognostic (6.24e-2)" "unprognostic (1.73e-2)" 1.9 19.5 13.4 3.8 12.5 0.2 1.4 0.3 16.0 17.2 7.7 6.7 7.3 2.7 57.2 7.8 17.4 1.9 15.1 3.2 9.8 1.1 21.4 1.2 15.3 2.9 1.0 6.4 2.4 1.7 0.1 4.3 3.3 0.2 17.6 4.9 0.9 10.6 21.5 0.4 7.4 4.5 41.1 0.8 3.2 3.1 3.1 4.6 0.8 1.5 7.7 7.7 9.4 8.6 4.9 7.8 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.9 0.0 37.6 30.3 0.0 22.9 15.6 8.4 14.7 0.0 0.2 0.1 0.0 42.6 0.0 0.3 0.1 27.5 0.0 4.2 0.0 0.0 0.0 0.3 0.0 0.0 7.2 0.0 16.9 0.5 0.0 0.0 1.7 4.9 0.0 0.0 0.0 0.7 0.1 0.2 0.1 0.0 10.3 0.0 0.6 0.0 0.0 0.1 0.5 0.0 1.2 0.1 3.9 3.6 68.2 11.9 0.9 0.0 0.0 9.7 0.0 11.2 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.3 13.4 12.5 0.3 16.0 9.8 1.1 1.0 6.4 0.2 4.6 MPC1 "BRP44L, CGI-129, dJ68L15.3, SLC54A1" ENSG00000060762 "Mitochondrial pyruvate carrier 1" Q9Y5U8 6 166364919-166383013 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.8;liver: 129.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045119, HPA055790" Enhanced Enhanced Mitochondria Mitochondria "HPA045119: AB_10960421, HPA055790: " "unprognostic (3.30e-2)" "prognostic favourable (1.45e-4)" "unprognostic (5.24e-3)" "unprognostic (1.68e-1)" "unprognostic (3.17e-2)" "unprognostic (2.85e-2)" "unprognostic (7.61e-2)" "prognostic favourable (1.29e-4)" "unprognostic (3.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.11e-3)" "unprognostic (5.64e-2)" "prognostic favourable (4.79e-11)" "unprognostic (4.13e-2)" "unprognostic (1.03e-1)" "unprognostic (7.48e-2)" "unprognostic (8.45e-2)" 13.1 9.4 27.1 7.2 28.5 10.9 12.2 12.3 21.6 12.4 21.1 26.1 8.3 18.8 8.4 10.5 16.0 8.3 9.5 149.8 27.6 21.5 56.1 129.7 10.0 8.7 39.2 18.3 10.5 14.9 12.4 9.4 5.4 23.8 10.3 19.9 11.5 23.0 10.5 63.3 9.2 16.9 11.0 43.3 9.2 19.7 5.0 25.8 9.0 18.6 43.9 9.9 10.6 8.1 12.2 26.5 32.2 43.7 13.9 24.5 17.1 6.5 1.9 8.1 28.1 23.8 13.7 12.1 7.6 12.3 11.9 11.6 10.0 4.6 13.8 13.7 11.7 6.3 12.2 9.5 8.4 9.3 20.9 6.8 10.1 33.1 9.9 26.4 9.0 10.9 13.5 9.7 7.0 9.6 23.8 22.0 7.3 10.4 18.3 48.9 4.2 9.3 10.1 13.6 34.5 22.1 5.2 25.6 22.8 8.7 38.2 8.7 9.0 39.6 6.6 6.9 7.2 24.4 7.7 15.1 10.3 11.5 6.3 32.6 11.0 18.6 23.0 32.2 16.4 35.3 15.4 12.2 19.4 17.6 26.5 9.2 18.2 17.4 20.4 13.9 43.7 15.7 24.5 17.1 27.1 28.5 12.3 21.6 27.6 21.5 39.2 18.3 23.8 25.8 MPC2 "BRP44, DKFZP564B167, SLC54A2" ENSG00000143158 "Mitochondrial pyruvate carrier 2" O95563 1 167916729-167937040 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 111.7" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056091 Uncertain "HPA056091: " "unprognostic (3.25e-1)" "unprognostic (6.82e-2)" "unprognostic (8.79e-3)" "unprognostic (4.15e-2)" "unprognostic (3.47e-1)" "unprognostic (1.02e-1)" "unprognostic (6.01e-2)" "unprognostic (1.53e-1)" "unprognostic (7.93e-2)" "unprognostic (3.36e-3)" "unprognostic (1.44e-3)" "unprognostic (1.08e-2)" "unprognostic (9.13e-2)" "unprognostic (2.39e-1)" "unprognostic (6.95e-2)" "unprognostic (5.43e-2)" "unprognostic (1.67e-1)" 13.5 22.5 22.6 11.5 21.6 33.5 23.0 15.0 25.3 11.7 26.8 12.1 10.2 27.1 7.8 12.5 12.2 9.9 25.2 46.2 19.0 17.7 46.4 92.9 9.9 11.4 18.8 16.7 9.6 14.7 9.6 18.4 9.9 13.5 34.4 24.8 11.9 20.6 10.8 45.0 9.3 26.3 13.1 16.5 7.4 29.6 111.7 11.4 12.7 11.9 23.5 10.9 11.2 8.1 23.4 28.7 45.3 18.5 27.4 40.2 37.2 18.2 17.5 7.7 17.5 19.3 17.9 1.7 29.9 16.8 14.1 16.5 40.5 10.2 31.7 21.7 17.0 14.8 10.4 16.1 14.6 40.5 15.6 13.8 17.8 32.1 13.0 14.9 10.2 11.5 14.8 25.3 14.6 12.3 17.0 18.6 25.1 8.4 22.0 15.3 12.8 21.9 11.6 14.1 25.1 93.5 15.9 12.3 12.5 17.2 20.4 16.4 36.7 19.2 11.3 15.2 11.2 22.1 13.7 24.7 28.1 34.8 39.0 13.5 8.0 41.0 16.6 45.3 23.7 14.6 25.3 23.4 29.3 25.0 28.7 20.6 27.7 26.5 31.8 27.4 18.5 20.7 40.2 37.2 22.6 21.6 15.0 25.3 19.0 17.7 18.8 16.7 13.5 11.4 MPEG1 MPG1 ENSG00000197629 "Macrophage expressed 1" Q2M385 11 59208510-59212951 "Predicted membrane proteins, Transporters" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.3;lymphoid tissue: 108.6" "Cell line enhanced" "Detected in some" "Daudi: 2.8;HMC-1: 1.3;THP-1: 3.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 47.3;intermediate monocyte: 38.9;myeloid DC: 26.6;non-classical monocyte: 41.6;plasmacytoid DC: 38.3" "Group enriched" "Detected in many" 6 "dendritic cells: 38.3;monocytes: 47.3" HPA046801 Approved "HPA046801: " "unprognostic (1.24e-1)" "unprognostic (2.17e-3)" "unprognostic (1.05e-2)" "unprognostic (2.00e-2)" "unprognostic (3.38e-2)" "unprognostic (2.79e-3)" "unprognostic (7.82e-2)" "unprognostic (1.41e-2)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (5.48e-2)" "unprognostic (3.51e-1)" "unprognostic (1.48e-1)" "unprognostic (9.38e-2)" "unprognostic (2.48e-2)" "unprognostic (1.76e-1)" "unprognostic (5.86e-2)" 17.6 6.4 2.2 27.7 2.1 3.6 5.9 1.3 1.8 3.3 9.5 4.9 0.9 9.0 3.2 13.2 3.7 4.9 8.2 7.7 2.2 2.3 7.0 17.3 13.1 51.3 2.6 1.0 4.2 2.7 0.8 2.3 13.4 2.5 5.6 10.0 8.9 7.5 2.4 2.9 2.6 20.6 6.0 3.9 108.6 4.0 3.2 1.7 18.5 3.7 5.5 23.0 11.0 2.7 2.9 38.3 7.0 47.3 0.2 0.1 29.1 0.0 0.0 0.2 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.5 0.5 0.0 0.5 0.4 0.7 0.0 0.5 0.3 0.5 0.2 0.0 0.0 0.0 3.7 0.4 0.0 0.2 0.4 0.0 0.9 0.1 0.5 0.0 0.2 0.1 0.0 47.3 1.4 0.1 38.9 0.1 2.4 0.0 0.0 26.6 2.9 0.0 0.0 7.0 0.2 41.6 38.3 0.1 29.1 2.2 2.1 1.3 1.8 2.2 2.3 2.6 1.0 2.5 1.7 MPHOSPH10 "CT90, MPP10, MPP10P, PPP1R106" ENSG00000124383 "M-phase phosphoprotein 10" O00566 2 71130314-71150101 "Predicted intracellular proteins, Predicted membrane proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035059, HPA035060, HPA049907" Enhanced Enhanced Nucleoli Nucleoli "HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: " "unprognostic (3.20e-3)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (5.77e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (3.58e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-3)" "unprognostic (6.13e-2)" "unprognostic (3.50e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (3.89e-7)" "unprognostic (1.24e-1)" "unprognostic (2.91e-1)" "unprognostic (2.47e-1)" "unprognostic (2.23e-2)" 20.5 17.6 21.8 20.2 28.0 21.2 23.7 26.7 25.7 23.5 17.6 12.6 22.0 16.5 22.3 26.7 30.6 19.4 17.1 20.4 21.6 20.3 22.2 27.5 15.5 21.9 30.4 22.7 25.4 20.7 20.0 36.7 18.5 26.3 24.0 18.4 8.1 21.8 28.8 48.4 24.4 16.8 25.0 25.0 22.0 17.6 13.7 29.8 22.3 20.4 26.3 24.4 22.2 22.2 13.5 12.8 8.7 17.3 12.4 17.4 8.4 14.8 11.2 14.5 17.3 13.6 12.8 19.8 16.6 13.2 13.7 10.2 20.1 11.0 20.9 10.4 11.6 13.9 18.2 11.7 18.4 14.4 14.6 25.1 8.9 45.8 11.8 32.4 20.2 11.0 15.1 11.3 15.1 11.6 36.2 16.7 13.6 15.9 26.0 32.9 24.1 12.8 21.7 22.7 24.7 11.1 16.2 17.7 13.7 11.1 25.7 16.0 13.0 14.5 12.0 16.3 17.5 15.5 21.0 14.2 16.0 34.3 14.0 27.1 16.3 8.7 9.9 7.2 12.4 13.6 16.0 13.5 15.7 14.8 11.7 12.3 17.4 15.3 1.4 12.4 17.3 12.8 13.2 8.4 21.8 28.0 26.7 25.7 21.6 20.3 30.4 22.7 26.3 29.8 MPIG6B "C6orf25, G6b, G6b-B, NG31" ENSG00000204420 "Megakaryocyte and platelet inhibitory receptor G6b" O95866 6 31718594-31726714 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.2" "Cell line enriched" "Detected in single" 17 "HEL: 11.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "NK-cell: 3.0;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 4 "dendritic cells: 1.8;NK-cells: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA054404, HPA073017" Approved "Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" 7400000 "Endoplasmic reticulum, Golgi apparatus" "Plasma membrane, Cytosol" "HPA054404: , HPA073017: " "unprognostic (1.45e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (6.53e-2)" "unprognostic (3.53e-2)" "unprognostic (2.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (1.82e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-2)" "unprognostic (1.71e-2)" 0.8 0.2 0.0 1.2 0.5 5.3 0.7 0.1 0.4 1.0 0.9 0.0 0.0 0.9 1.0 0.8 2.0 0.7 1.5 7.4 0.2 0.0 0.4 0.5 7.6 2.8 1.0 0.0 2.7 0.2 0.2 0.2 1.4 0.7 0.9 0.2 1.1 1.8 0.3 1.2 10.5 0.8 1.9 0.6 33.2 0.4 2.7 0.1 1.2 1.0 1.4 0.8 1.6 1.6 0.2 1.8 0.5 0.1 3.0 0.1 5.7 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.5 3.0 0.1 1.8 0.0 5.7 0.0 0.5 0.1 0.4 0.2 0.0 1.0 0.0 0.7 0.1 MPL "CD110, TPOR" ENSG00000117400 "MPL proto-oncogene, thrombopoietin receptor" P40238 1 43337849-43352772 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.6" "Cell line enriched" "Detected in single" 78 "HEL: 40.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Region enhanced" "Detected in single" "cerebral cortex: 1.4" "Low region specificity" "Detected in all" HPA007619 Supported "Nuclear membrane,Plasma membrane" "Plasma membrane" "Nuclear membrane" "HPA007619: AB_1854080" "unprognostic (2.74e-1)" "unprognostic (6.56e-2)" "unprognostic (2.95e-1)" "unprognostic (8.71e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.22e-2)" "unprognostic (5.83e-2)" "unprognostic (1.03e-1)" "unprognostic (5.94e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-4)" "unprognostic (2.39e-1)" "unprognostic (3.26e-1)" "unprognostic (1.03e-4)" "unprognostic (1.42e-1)" 1.1 0.3 0.9 0.5 0.8 2.0 0.9 0.5 2.2 0.6 0.6 0.5 0.5 0.3 0.9 1.7 0.9 2.1 0.5 3.9 0.8 0.6 0.5 0.5 2.0 0.5 0.9 0.5 6.6 1.1 0.6 0.6 2.2 0.5 1.5 0.7 0.5 0.5 0.7 0.6 0.4 1.2 2.1 2.5 8.6 0.5 2.1 0.5 0.5 2.2 2.4 0.5 0.9 0.5 0.0 0.0 1.6 0.3 0.0 0.0 4.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 40.7 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.0 0.9 0.8 0.5 2.2 0.8 0.6 0.9 0.5 0.5 0.5 MPPE1 PGAP5 ENSG00000154889 "Metallophosphoesterase 1" Q53F39 18 11882622-11909223 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, GPI-anchor biosynthesis, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 22.1;neutrophil: 66.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 66.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 10 "basal ganglia: 104.4" HPA012639 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA012639: AB_1854088" "unprognostic (9.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-1)" "unprognostic (7.92e-3)" "prognostic unfavourable (1.35e-4)" "unprognostic (1.00e-2)" "unprognostic (4.46e-1)" "unprognostic (1.61e-1)" "prognostic favourable (6.45e-7)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (7.79e-2)" "unprognostic (6.15e-2)" 15.0 13.7 11.8 16.5 16.0 19.9 15.2 11.4 20.9 14.1 16.4 20.1 18.2 13.5 18.7 22.1 13.4 15.8 23.6 17.2 11.5 14.4 23.7 20.8 24.7 29.0 19.8 12.2 11.7 24.6 22.2 16.5 15.2 14.1 13.1 17.2 14.8 16.8 26.6 19.3 22.4 19.7 14.0 15.1 17.5 17.7 6.7 14.8 22.7 37.1 14.6 17.6 14.9 13.9 4.5 8.5 66.2 9.5 6.3 6.0 6.7 4.3 6.2 4.7 11.5 13.7 16.2 4.5 10.3 14.9 6.1 9.7 11.6 12.3 8.6 22.8 9.9 4.7 3.3 5.8 5.8 9.4 5.6 2.4 12.5 2.6 19.2 11.0 17.8 23.9 7.7 5.4 3.9 3.6 3.1 8.3 10.2 10.1 8.1 7.4 3.3 1.7 3.3 3.0 10.4 10.0 6.6 6.7 3.8 9.6 7.6 9.0 5.6 14.4 7.4 12.4 4.8 11.9 5.7 13.0 11.4 10.8 9.3 5.8 12.2 4.1 9.5 22.1 6.0 7.7 4.3 4.0 3.7 5.6 8.5 4.5 4.5 5.7 66.2 6.3 5.2 6.7 5.8 6.7 11.8 16.0 11.4 20.9 11.5 14.4 19.8 12.2 14.1 14.8 MPZ "CMT1, CMT1B, CMT2I, CMT2J, HMSNIB" ENSG00000158887 "Myelin protein zero" P25189 1 161304735-161309972 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 118.7;retina: 60.6" "Cell line enriched" "Detected in some" 5 "WM-115: 66.6" "Cancer enriched" "Detected in many" 11 "melanoma: 83.9" "Region enriched" "Detected in many" 4 "midbrain: 118.7" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.9" "Group enriched" "Detected in some" 5 "olfactory region: 3.6;pons and medulla: 1.4" "Region enriched" "Detected in single" 57 "midbrain: 262.7" HPA068925 Enhanced "HPA068925: " "unprognostic (6.77e-2)" "unprognostic (2.98e-1)" "unprognostic (9.27e-2)" "unprognostic (1.46e-1)" "unprognostic (3.35e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.33e-1)" "unprognostic (7.88e-3)" "unprognostic (1.51e-1)" "unprognostic (6.62e-8)" "unprognostic (6.75e-2)" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (8.32e-2)" 14.3 12.6 2.2 3.4 2.9 1.3 4.7 6.0 2.2 4.5 6.1 2.6 9.9 2.6 1.7 7.5 8.7 1.5 4.3 7.2 2.4 4.3 3.2 7.9 3.1 1.3 118.7 0.7 1.9 2.2 0.5 7.4 0.8 28.4 7.3 5.0 60.6 6.4 15.6 4.2 2.3 6.3 5.6 40.9 6.8 2.1 2.7 0.8 0.2 2.8 26.3 3.0 9.3 3.3 0.1 0.0 1.9 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.9 0.4 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.7 0.5 0.1 0.0 0.6 0.2 0.0 0.3 0.0 0.3 0.1 12.3 0.4 1.4 1.2 1.4 0.0 2.0 0.1 0.9 3.1 0.0 1.4 0.0 0.2 2.4 0.5 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 6.3 0.0 3.0 0.9 0.1 0.1 0.8 0.0 0.3 0.3 0.3 1.6 5.6 66.6 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.2 0.1 2.2 2.9 6.0 2.2 2.4 4.3 118.7 0.7 28.4 0.8 MPZL1 "FLJ21047, PZR" ENSG00000197965 "Myelin protein zero like 1" O95297 1 167721192-167791919 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 51.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026966, HPA063538" Approved Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA026966: AB_10600931, HPA063538: " "unprognostic (6.54e-2)" "unprognostic (9.26e-3)" "unprognostic (4.59e-2)" "unprognostic (4.88e-1)" "unprognostic (2.18e-1)" "unprognostic (2.57e-2)" "prognostic unfavourable (4.27e-6)" "prognostic unfavourable (3.98e-4)" "unprognostic (1.22e-1)" "unprognostic (3.41e-2)" "unprognostic (2.59e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (3.99e-7)" "unprognostic (3.55e-1)" "unprognostic (2.35e-1)" "prognostic unfavourable (8.08e-4)" "unprognostic (4.21e-2)" 34.4 19.1 13.6 21.4 13.9 3.2 42.0 14.3 13.7 32.2 27.3 15.4 15.9 18.5 34.8 25.2 32.1 30.1 34.3 29.2 12.0 14.0 22.2 20.9 22.2 20.7 14.4 10.0 38.3 25.4 13.7 24.3 34.0 14.3 28.3 28.2 28.0 51.7 19.4 11.0 17.7 26.6 30.5 13.0 19.6 21.3 27.7 10.9 9.7 29.0 25.8 28.0 33.6 35.0 4.2 12.5 51.4 8.9 2.9 2.4 3.0 18.1 26.5 20.8 16.1 67.2 30.5 65.8 28.4 36.7 18.6 23.2 48.9 25.3 6.4 33.3 35.9 30.6 20.7 31.4 15.8 14.5 11.2 5.3 14.1 11.7 41.8 6.2 3.4 27.9 39.7 29.6 33.4 24.7 19.7 13.5 22.0 6.0 20.9 7.4 13.2 11.4 12.8 17.9 28.3 28.5 17.6 12.0 19.9 25.2 26.3 14.6 14.2 3.3 28.0 21.4 9.6 27.3 15.3 20.2 31.3 29.8 30.6 7.3 3.3 1.9 8.1 5.4 0.8 6.8 0.4 4.2 0.8 1.2 10.9 2.5 2.4 0.8 51.4 2.9 8.9 12.5 0.1 3.0 13.6 13.9 14.3 13.7 12.0 14.0 14.4 10.0 14.3 10.9 MPZL2 "EVA, EVA1" ENSG00000149573 "Myelin protein zero like 2" O60487 11 118253403-118264536 "Predicted membrane proteins" "Cell adhesion" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 24.8;EFO-21: 27.3;HaCaT: 34.1;RT4: 64.9;TIME: 71.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 9.3;intermediate monocyte: 7.2;myeloid DC: 13.4;neutrophil: 10.9" "Group enriched" "Detected in many" 10 "dendritic cells: 13.4;granulocytes: 10.9;monocytes: 9.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA060740 Approved Approved "Cell Junctions" "Cell Junctions" "HPA060740: " "unprognostic (1.74e-1)" "unprognostic (6.02e-2)" "unprognostic (8.23e-2)" "unprognostic (3.28e-3)" "unprognostic (9.95e-3)" "unprognostic (1.56e-1)" "unprognostic (2.11e-3)" "unprognostic (3.58e-1)" "unprognostic (7.39e-2)" "unprognostic (5.45e-2)" "prognostic unfavourable (1.14e-4)" "unprognostic (1.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.07e-2)" "unprognostic (1.80e-1)" "prognostic favourable (1.62e-4)" "unprognostic (2.08e-2)" 11.7 1.7 1.5 2.8 1.5 0.0 17.1 1.5 1.6 31.0 8.5 1.0 26.3 4.4 6.8 17.8 103.8 13.4 12.3 4.7 2.4 1.5 11.7 7.9 21.7 1.8 2.4 0.6 7.4 4.6 10.2 9.2 1.5 4.0 17.8 8.7 6.2 21.6 32.8 7.8 11.4 4.4 5.6 4.3 1.3 10.0 3.7 1.3 5.7 21.7 52.3 41.1 29.4 37.4 0.0 13.4 10.9 9.3 0.3 1.0 2.8 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 24.8 0.0 27.3 0.0 34.1 0.0 7.9 0.0 0.0 1.9 0.0 0.3 7.1 0.0 0.0 0.0 0.0 18.8 0.0 0.6 17.8 0.0 0.0 0.0 10.2 0.0 0.0 0.3 0.0 0.0 0.0 1.2 3.1 64.9 0.0 0.0 1.1 12.7 0.0 5.4 0.1 71.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 9.3 2.3 0.1 7.2 1.0 0.0 0.5 0.4 13.4 0.0 0.6 0.7 10.9 0.3 1.0 0.2 0.2 2.8 1.5 1.5 1.5 1.6 2.4 1.5 2.4 0.6 4.0 1.3 MPZL3 ENSG00000160588 "Myelin protein zero like 3" Q6UWV2 11 118226690-118252350 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.6;HMC-1: 19.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 11.4;eosinophil: 33.0;MAIT T-cell: 10.6;neutrophil: 30.6" "Group enriched" "Detected in many" 8 "granulocytes: 33.0;T-cells: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029116 Approved "Golgi apparatus" "Golgi apparatus" "HPA029116: AB_10610142" "unprognostic (2.54e-2)" "unprognostic (1.24e-1)" "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (3.13e-3)" "unprognostic (1.52e-1)" "unprognostic (8.74e-3)" "unprognostic (2.86e-2)" "unprognostic (9.82e-2)" "unprognostic (1.90e-1)" "prognostic unfavourable (4.98e-4)" "unprognostic (4.86e-2)" "unprognostic (1.58e-2)" "unprognostic (1.89e-1)" "unprognostic (3.90e-1)" "prognostic favourable (3.64e-4)" "unprognostic (1.20e-1)" 3.5 0.7 0.8 3.6 3.0 5.2 7.1 6.9 1.4 9.2 5.5 0.5 8.4 4.3 5.2 6.8 28.5 4.4 8.7 1.4 0.8 1.0 4.7 9.4 10.6 4.4 0.8 0.4 1.5 9.0 7.4 12.4 2.6 2.4 5.3 5.1 1.4 19.6 11.1 1.0 23.1 8.3 1.5 1.2 5.4 5.6 2.6 0.4 5.8 7.3 27.1 32.6 6.5 12.8 0.6 2.8 33.0 2.1 2.8 10.6 1.7 3.2 0.4 0.0 0.5 0.0 0.0 0.5 0.4 0.0 0.0 0.1 11.0 17.6 3.2 8.5 0.0 4.5 0.8 3.7 0.1 0.1 1.3 2.0 0.9 5.3 0.1 2.6 19.9 0.2 9.3 0.0 3.7 5.9 2.5 1.8 0.0 11.1 1.2 1.4 1.6 0.8 0.0 0.0 4.7 6.8 4.1 2.3 0.2 4.4 5.8 0.3 10.4 1.4 2.8 0.1 0.9 0.0 0.1 0.3 3.2 2.0 0.1 0.1 0.2 11.4 2.1 33.0 2.6 1.2 10.6 0.6 4.2 3.5 2.8 0.6 3.2 2.5 30.6 2.8 0.8 0.3 2.8 1.7 0.8 3.0 6.9 1.4 0.8 1.0 0.8 0.4 2.4 0.4 MR1 HLALS ENSG00000153029 "Major histocompatibility complex, class I-related" Q95460 1 181033425-181061938 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048304 Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA048304: " "unprognostic (6.89e-2)" "unprognostic (1.54e-1)" "unprognostic (1.31e-2)" "unprognostic (1.96e-1)" "unprognostic (8.66e-3)" "unprognostic (4.37e-2)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.18e-1)" "unprognostic (3.49e-2)" "unprognostic (6.41e-2)" "unprognostic (1.05e-2)" "unprognostic (7.40e-3)" "unprognostic (4.69e-2)" "unprognostic (2.39e-1)" "unprognostic (1.07e-2)" 10.5 13.8 5.3 10.2 7.1 7.7 8.3 1.7 5.5 8.6 8.2 5.3 6.8 5.3 10.4 10.9 12.6 8.6 13.2 8.9 5.2 3.1 10.5 10.7 16.6 16.2 5.9 5.0 13.9 5.1 12.4 17.6 11.5 5.1 13.2 6.3 12.3 8.1 8.6 3.8 10.1 7.8 9.6 6.1 14.9 6.7 5.5 6.2 23.2 13.6 7.1 18.4 16.4 9.6 12.9 15.6 24.0 22.2 14.9 14.3 11.1 3.6 2.5 0.0 2.2 15.8 19.2 6.7 7.3 20.1 6.1 10.5 1.0 15.0 4.5 15.3 13.1 9.7 0.3 8.6 5.4 13.6 2.4 6.5 2.9 4.5 5.3 5.3 19.6 12.6 23.9 9.1 9.9 0.6 12.1 12.2 11.8 4.0 5.5 3.8 0.0 0.4 6.3 0.1 12.5 6.7 10.8 0.1 0.2 3.9 7.1 5.1 7.5 11.3 3.8 6.0 0.8 10.4 3.6 20.3 6.9 8.4 5.6 7.1 0.5 24.0 17.9 18.1 14.3 22.2 12.7 12.1 13.0 12.7 15.6 12.9 9.7 14.3 13.4 14.9 18.7 8.4 13.6 11.1 5.3 7.1 1.7 5.5 5.2 3.1 5.9 5.0 5.1 6.2 MRAP "B27, C21orf61, FALP" ENSG00000170262 "Melanocortin 2 receptor accessory protein" Q8TCY5 21 32291813-32314784 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adipose tissue: 28.3;adrenal gland: 52.7;breast: 68.6" "Group enriched" "Detected in some" 6 "Hep G2: 4.5;HSkMC: 5.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "basal ganglia: 2.6" "Cell type enhanced" "Detected in many" "NK-cell: 5.5" "Low lineage specificity" "Detected in many" HPA011024 Uncertain "HPA011024: AB_10599292" "unprognostic (1.38e-1)" "unprognostic (1.55e-3)" "unprognostic (1.53e-1)" "unprognostic (1.11e-1)" "unprognostic (9.53e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (1.80e-2)" "unprognostic (4.12e-1)" "unprognostic (6.30e-6)" "unprognostic (3.32e-2)" "unprognostic (2.37e-1)" "unprognostic (1.18e-1)" "unprognostic (5.76e-2)" 28.3 52.7 0.0 1.6 2.6 0.0 68.6 0.3 0.1 0.0 3.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.4 1.6 0.0 0.0 0.1 0.6 0.2 1.8 0.2 0.1 0.8 0.1 0.0 0.0 1.1 0.3 0.1 0.1 0.2 1.7 0.0 0.9 0.2 1.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.1 0.6 4.3 1.8 1.5 0.0 0.5 5.5 1.8 0.1 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.8 0.0 5.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.1 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.9 0.5 0.7 1.8 0.7 1.2 0.5 1.4 0.8 1.6 0.0 5.5 0.3 1.5 1.8 0.1 0.0 2.6 0.3 0.1 0.0 0.0 0.2 0.1 0.3 0.0 MRC1 "bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1" ENSG00000260314 "Mannose receptor C-type 1" P22897 10 17809344-17911170 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 44.8;lymphoid tissue: 37.8" "Group enriched" "Detected in some" 19 "MOLT-4: 17.2;TIME: 16.0" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "myeloid DC: 8.2" "Lineage enriched" "Detected in single" 15 "dendritic cells: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA004114, HPA045134, CAB068203" Enhanced 130000000 "CAB068203: , HPA004114: AB_1846270, HPA045134: AB_2679228" "unprognostic (2.20e-1)" "unprognostic (2.07e-1)" "unprognostic (1.03e-2)" "unprognostic (2.58e-1)" "unprognostic (5.62e-2)" "unprognostic (4.30e-1)" "unprognostic (6.36e-3)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (6.05e-2)" "unprognostic (5.61e-2)" "unprognostic (4.12e-1)" "unprognostic (2.94e-2)" "unprognostic (4.97e-2)" "unprognostic (3.05e-2)" "unprognostic (1.74e-2)" "unprognostic (7.02e-2)" 34.8 8.3 0.3 6.2 1.2 0.0 19.8 0.7 0.6 5.2 11.2 0.6 0.9 2.2 4.5 10.4 4.2 1.3 7.9 13.4 0.9 12.4 16.4 44.8 37.8 1.0 0.0 3.6 5.1 1.8 2.4 15.4 3.1 5.5 5.1 7.0 0.7 1.9 5.1 0.0 6.5 8.2 1.4 30.6 2.2 7.1 0.8 0.8 6.5 3.5 0.7 7.5 5.1 0.0 8.2 0.1 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.1 0.0 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.2 MRC2 "CD280, CLEC13E, ENDO180, KIAA0709" ENSG00000011028 "Mannose receptor C type 2" Q9UBG0 17 62627401-62693597 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 46.4;fHDF/TERT166: 31.5;HSkMC: 29.9;U-138 MG: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041991 Enhanced 28000000 "HPA041991: AB_10794166" "unprognostic (3.22e-1)" "unprognostic (2.19e-1)" "unprognostic (4.45e-2)" "unprognostic (2.59e-2)" "unprognostic (4.29e-2)" "unprognostic (2.67e-2)" "unprognostic (6.21e-2)" "unprognostic (1.80e-1)" "unprognostic (7.39e-2)" "prognostic unfavourable (1.68e-4)" "unprognostic (7.70e-2)" "unprognostic (7.75e-2)" "prognostic unfavourable (4.94e-7)" "unprognostic (5.25e-2)" "unprognostic (6.13e-2)" "unprognostic (3.00e-2)" "unprognostic (1.93e-2)" 14.7 5.7 2.4 14.7 5.2 3.2 27.3 1.4 3.4 30.4 7.0 6.5 18.7 4.4 31.7 46.3 15.7 15.7 37.2 44.1 2.5 2.6 8.7 2.2 46.8 2.5 3.4 4.0 33.6 4.7 0.9 11.3 5.4 6.8 25.7 1.9 35.1 10.9 17.1 7.3 19.0 7.1 28.7 8.2 9.7 5.8 13.3 2.5 4.8 4.6 21.2 5.3 18.1 18.1 0.0 0.6 0.2 0.0 0.0 1.0 0.0 0.0 8.5 4.6 6.1 12.7 23.0 0.7 46.4 27.1 6.7 8.1 0.5 0.1 0.0 3.3 31.5 3.9 0.8 3.8 1.9 5.7 1.3 3.8 6.2 0.0 19.1 4.8 0.0 29.9 2.0 5.9 0.6 3.0 2.2 0.0 9.4 1.4 1.2 16.6 1.0 0.5 4.7 3.3 0.0 0.7 0.1 0.7 12.1 3.1 0.1 0.0 0.1 19.3 15.5 47.7 19.5 8.3 8.2 0.0 0.0 0.0 15.0 4.9 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 1.0 0.9 0.2 0.0 0.0 0.0 0.9 0.0 2.4 5.2 1.4 3.4 2.5 2.6 3.4 4.0 6.8 2.5 MRS2 MRS2L ENSG00000124532 "MRS2, magnesium transporter" Q9HD23 6 24402908-24426194 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017642 Uncertain "HPA017642: " "unprognostic (2.12e-3)" "unprognostic (1.22e-1)" "unprognostic (5.64e-3)" "prognostic unfavourable (5.32e-4)" "unprognostic (7.23e-2)" "unprognostic (8.57e-2)" "unprognostic (1.82e-1)" "unprognostic (1.20e-1)" "unprognostic (3.89e-3)" "prognostic favourable (5.14e-11)" "unprognostic (8.75e-2)" "unprognostic (2.94e-2)" "unprognostic (8.32e-2)" "unprognostic (2.53e-1)" "unprognostic (8.56e-2)" "prognostic unfavourable (8.03e-4)" "unprognostic (1.55e-3)" 14.3 18.6 13.0 16.3 16.1 6.2 18.4 27.4 17.8 11.8 14.5 10.9 15.2 15.7 11.5 15.9 14.5 10.3 12.8 34.1 15.6 13.7 24.4 17.7 11.4 14.0 14.9 15.1 13.8 24.1 16.3 18.9 19.1 14.4 14.1 16.6 16.3 16.9 22.3 47.7 14.0 15.0 12.2 12.1 15.4 15.4 7.9 11.4 11.1 17.4 20.9 14.9 13.9 11.6 11.5 19.4 5.4 15.2 11.2 12.4 9.6 13.2 7.5 9.6 17.1 6.1 5.7 20.8 6.2 7.4 8.0 7.2 30.0 6.2 7.9 25.2 5.3 8.3 9.6 11.8 8.6 9.5 16.8 12.7 6.5 34.3 9.1 14.0 11.3 9.0 9.6 7.9 6.3 8.2 17.6 0.0 8.7 10.3 13.3 13.6 25.2 7.1 0.1 1.7 17.5 34.9 13.7 14.9 9.1 10.2 32.0 16.8 16.2 10.0 3.7 3.4 5.3 7.1 11.7 14.4 23.7 10.8 4.3 17.1 14.1 2.3 13.1 5.4 9.5 15.2 12.4 11.5 10.2 10.4 19.4 8.2 11.5 10.6 1.5 11.2 13.5 11.4 8.7 9.6 13.0 16.1 27.4 17.8 15.6 13.7 14.9 15.1 14.4 11.4 MRVI1 "IRAG, JAW1L" ENSG00000072952 "Murine retrovirus integration site 1 homolog" Q9Y6F6 11 10573091-10693988 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 17.6;BJ: 12.4;BJ hTERT+: 14.4;fHDF/TERT166: 5.6;REH: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 18.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 18.5" "Region enriched" "Detected in many" 5 "thalamus: 8.3" "Low region specificity" "Detected in many" HPA008704 Uncertain Approved "Nuclear bodies,Cytosol" 280000 Cytosol "Nuclear bodies" "HPA008704: AB_1079413" "unprognostic (2.18e-1)" "unprognostic (3.40e-2)" "unprognostic (2.86e-3)" "prognostic favourable (5.78e-4)" "unprognostic (5.30e-1)" "unprognostic (3.37e-3)" "unprognostic (1.04e-2)" "unprognostic (1.87e-1)" "unprognostic (5.63e-3)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (6.98e-2)" "prognostic unfavourable (9.70e-4)" "unprognostic (3.72e-2)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (9.97e-3)" 15.7 6.3 19.4 12.4 22.0 1.5 6.6 4.4 13.7 31.6 26.7 15.5 10.7 6.3 42.1 17.1 27.1 19.6 23.2 6.3 13.8 12.0 5.3 1.7 5.5 2.9 21.3 10.6 16.4 1.9 2.8 1.8 8.7 18.2 24.8 12.9 37.6 3.3 29.0 4.1 4.0 9.4 47.3 12.1 3.5 16.4 8.3 10.3 0.0 4.5 2.3 1.8 27.3 10.4 0.7 0.4 18.5 4.1 0.0 0.0 0.5 0.1 0.0 3.5 0.0 17.6 3.5 0.1 12.4 14.4 0.0 0.0 0.3 1.4 0.0 0.1 5.6 0.1 0.0 0.2 0.1 0.1 0.1 0.6 0.0 0.1 0.2 0.0 0.2 4.0 0.3 0.0 0.1 1.0 0.5 0.1 0.2 0.0 0.1 0.2 0.4 0.0 5.4 0.0 0.2 0.0 0.0 0.0 2.6 0.0 2.1 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.8 0.0 0.6 1.7 1.2 0.0 2.9 0.0 0.5 0.0 0.0 0.4 0.7 0.0 0.0 18.5 0.0 4.1 0.1 0.0 0.5 19.4 22.0 4.4 13.2 13.8 12.0 21.3 10.6 18.2 10.3 MS4A12 "FLJ20217, Ms4a10" ENSG00000071203 "Membrane spanning 4-domains A12" Q9NXJ0 11 60492778-60507430 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "intestine: 64.7;lymphoid tissue: 28.6" "Cell line enhanced" "Detected in some" "HeLa: 1.5;LHCN-M2: 2.1;NTERA-2: 3.0;RH-30: 4.2;U-2 OS: 1.7" "Cancer enriched" "Detected in some" 8 "colorectal cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA048616, HPA057657" Enhanced Approved "Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoli, Endoplasmic reticulum, Golgi apparatus" "HPA048616: , HPA057657: " "unprognostic (2.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.49e-1)" "unprognostic (3.26e-1)" "unprognostic (2.83e-1)" "unprognostic (9.20e-3)" 0.1 0.0 0.1 28.6 0.1 0.0 0.1 0.1 0.1 0.1 57.7 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 64.7 0.1 0.1 0.1 0.1 0.0 0.2 1.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 3.0 0.0 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 MS4A13 ENSG00000204979 "Membrane spanning 4-domains A13" Q5J8X5 11 60515413-60542721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 85 "testis: 8.4" "Group enriched" "Detected in some" 5 "U-2 OS: 2.0;U-266/70: 6.2;U-266/84: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045017, HPA063626" Uncertain "HPA045017: AB_10962976, HPA063626: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.7 0.0 6.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A6A "CD20L3, MS4A6" ENSG00000110077 "Membrane spanning 4-domains A6A" Q9H2W1 11 60172014-60184666 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 112.4;lymphoid tissue: 89.5" "Cell line enriched" "Detected in some" 9 "THP-1: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 32.4;classical monocyte: 112.4;intermediate monocyte: 35.6;myeloid DC: 65.3;plasmacytoid DC: 46.3" "Group enriched" "Detected in many" 96 "dendritic cells: 65.3;granulocytes: 32.4;monocytes: 112.4" HPA011391 Approved "HPA011391: AB_10603876" "unprognostic (1.17e-1)" "prognostic favourable (6.33e-4)" "unprognostic (2.35e-2)" "unprognostic (1.21e-2)" "unprognostic (1.00e-1)" "unprognostic (8.51e-2)" "unprognostic (2.33e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (3.20e-1)" "unprognostic (4.75e-3)" "unprognostic (1.06e-1)" "unprognostic (4.66e-2)" "unprognostic (3.94e-2)" "unprognostic (2.97e-2)" 29.3 17.8 12.3 18.3 26.7 9.1 18.1 2.8 14.6 10.2 14.9 4.7 4.0 9.0 7.0 28.3 8.7 11.3 21.0 23.1 10.7 6.9 18.0 35.6 23.0 89.5 22.2 2.4 7.7 6.0 2.4 8.8 21.5 20.5 9.6 19.0 10.2 11.8 6.3 6.0 5.1 20.4 17.2 32.0 78.1 8.5 8.3 19.4 8.5 7.0 6.7 15.4 21.5 6.3 0.7 65.3 32.4 112.4 0.2 0.3 61.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 2.8 3.7 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 32.4 112.4 0.7 0.1 35.6 0.3 0.7 0.2 0.1 65.3 0.1 0.1 0.1 7.4 0.2 2.3 46.3 0.1 61.3 12.3 26.7 2.8 14.6 10.7 6.9 22.2 2.4 20.5 19.4 MS4A7 "CD20L4, CFFM4, MS4A8" ENSG00000166927 "Membrane spanning 4-domains A7" Q9GZW8 11 60378482-60395951 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in all" 4 "blood: 132.8;lymphoid tissue: 126.7" "Cell line enriched" "Detected in some" 24 "THP-1: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 71.2;non-classical monocyte: 132.8" "Lineage enriched" "Detected in many" 11 "monocytes: 132.8" "Low region specificity" "Detected in all" "HPA017418, CAB026387" Approved "CAB026387: , HPA017418: AB_1854137" "unprognostic (1.43e-1)" "unprognostic (2.60e-3)" "unprognostic (3.24e-2)" "unprognostic (9.67e-2)" "unprognostic (2.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.04e-1)" "unprognostic (9.51e-2)" "unprognostic (3.02e-2)" "unprognostic (4.85e-2)" "unprognostic (5.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.43e-2)" "unprognostic (4.59e-2)" "unprognostic (3.90e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" 24.2 11.9 4.4 15.1 4.9 2.0 9.7 1.3 3.5 5.9 7.4 4.2 2.9 5.2 4.2 11.0 4.0 4.8 15.2 11.3 5.1 3.9 6.8 22.3 29.7 19.1 4.6 1.3 3.2 3.4 2.3 6.2 13.3 5.0 5.9 7.5 8.4 5.3 3.4 2.2 2.3 8.1 4.8 9.9 126.7 4.3 6.0 3.5 7.0 3.3 2.3 5.6 9.7 3.9 2.0 11.9 0.9 132.8 0.1 0.1 10.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.3 0.2 0.0 49.9 0.0 0.0 0.0 0.1 0.1 0.1 0.1 1.2 0.0 1.6 0.0 0.5 18.8 0.2 0.1 71.2 0.1 2.0 0.0 0.0 11.9 1.8 0.0 0.0 0.9 0.1 132.8 0.3 0.0 10.9 4.4 4.9 1.3 3.5 5.1 3.9 4.6 1.3 5.0 3.5 MSLN "CAK1, MPF" ENSG00000102854 Mesothelin Q13421 16 760762-768865 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 85.5;lung: 88.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 102.3;EFO-21: 15.8;HeLa: 31.2;hTCEpi: 22.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 343.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 9.0" "Group enriched" "Detected in many" 59 "dendritic cells: 9.0;monocytes: 2.6" "Low region specificity" "Detected in many" "CAB002216, HPA017172" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" 14000000 Vesicles Nucleoplasm "CAB002216: AB_563874, HPA017172: AB_1853819" "unprognostic (1.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.06e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (3.95e-2)" "unprognostic (2.46e-1)" "unprognostic (9.47e-2)" "unprognostic (8.57e-2)" "unprognostic (4.69e-2)" "prognostic unfavourable (6.66e-4)" "unprognostic (2.63e-1)" "prognostic favourable (5.91e-4)" "unprognostic (2.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.14e-2)" "unprognostic (3.35e-2)" 36.5 0.0 0.4 6.7 0.5 0.7 0.3 0.1 0.4 5.4 5.4 0.8 26.8 2.1 4.8 18.9 3.1 85.5 9.6 4.3 0.4 0.3 2.6 0.2 88.5 0.4 0.6 0.0 22.3 0.4 0.0 0.6 13.7 0.9 1.9 1.2 0.2 14.4 33.1 0.0 0.5 0.7 1.0 0.8 0.1 3.7 2.1 0.0 0.1 0.1 0.6 7.8 1.4 1.3 0.0 9.0 0.0 2.6 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.5 1.8 0.4 1.4 102.3 0.0 15.8 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 31.2 1.1 0.9 0.0 0.0 0.0 22.7 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.4 0.4 0.5 0.1 0.4 0.4 0.3 0.6 0.0 0.9 0.0 MSMO1 "DESP4, ERG25, SC4MOL" ENSG00000052802 "Methylsterol monooxygenase 1" Q15800 4 165327623-165343160 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 171.6" "Cell line enhanced" "Detected in all" "CAPAN-2: 61.6;HBEC3-KT: 61.1;Karpas-707: 69.6;RPTEC TERT1: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056127 Enhanced "HPA056127: " "unprognostic (5.76e-2)" "prognostic unfavourable (2.97e-4)" "unprognostic (3.35e-2)" "unprognostic (7.85e-2)" "unprognostic (1.74e-1)" "unprognostic (1.20e-2)" "unprognostic (7.14e-2)" "unprognostic (1.75e-2)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" "unprognostic (3.22e-3)" "unprognostic (2.28e-1)" "prognostic favourable (9.21e-4)" "unprognostic (2.39e-1)" "unprognostic (1.56e-2)" "unprognostic (3.54e-1)" "unprognostic (1.40e-1)" 5.0 26.5 17.1 6.7 23.7 3.5 21.5 7.7 29.6 15.6 12.6 22.8 4.0 22.6 6.1 31.5 44.9 7.1 7.4 5.8 18.8 20.8 16.3 171.6 30.0 6.4 13.1 18.6 18.0 7.5 10.9 7.0 7.4 41.1 19.1 10.8 12.1 10.6 4.7 2.2 22.5 20.7 5.7 33.5 4.3 10.3 15.8 12.5 4.3 7.5 17.6 12.9 8.6 17.7 21.2 10.1 6.2 9.8 12.1 20.8 15.8 14.3 3.5 33.8 6.1 16.8 53.8 6.3 5.8 26.4 7.5 20.9 6.7 61.6 7.1 3.5 7.0 11.8 16.9 61.1 8.4 6.0 10.4 3.2 3.6 20.7 33.7 5.8 4.5 33.3 40.2 27.7 17.2 9.7 5.6 69.6 12.4 7.4 5.1 9.4 19.4 3.5 2.7 3.7 21.4 67.1 16.8 6.7 5.0 9.0 13.0 5.4 6.0 7.2 11.1 3.5 6.2 3.1 3.9 12.8 13.5 9.4 7.4 5.9 4.7 6.2 4.6 4.5 19.0 5.9 14.2 21.2 18.3 17.6 7.8 18.9 20.0 20.8 3.4 12.1 9.8 10.1 15.8 15.8 17.1 23.7 7.7 29.6 18.8 20.8 13.1 18.6 41.1 12.5 MSR1 "CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII" ENSG00000038945 "Macrophage scavenger receptor 1" P21757 8 16107878-16567490 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "adipose tissue: 88.1;lung: 70.4" "Group enriched" "Detected in many" 7 "BJ hTERT+: 47.1;REH: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 16.0" "Lineage enriched" "Detected in many" 5 "monocytes: 16.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA000272, CAB032491" Enhanced 25000 "CAB032491: AB_672722, HPA000272: AB_1846269" "unprognostic (8.19e-3)" "unprognostic (4.87e-2)" "unprognostic (1.93e-2)" "unprognostic (2.10e-1)" "unprognostic (9.24e-2)" "unprognostic (1.32e-2)" "unprognostic (5.85e-3)" "unprognostic (2.89e-1)" "unprognostic (9.70e-2)" "unprognostic (1.62e-2)" "unprognostic (7.19e-2)" "unprognostic (8.82e-2)" "unprognostic (2.76e-2)" "unprognostic (9.16e-2)" "unprognostic (7.39e-2)" "unprognostic (6.85e-2)" "unprognostic (4.69e-2)" 88.1 9.0 2.2 6.1 4.5 3.7 6.9 10.4 3.3 4.5 3.1 1.8 1.0 2.1 3.1 6.2 2.4 4.5 11.4 8.0 3.8 3.1 9.5 13.6 70.4 6.9 4.3 0.8 6.7 3.8 1.2 2.6 10.4 7.7 3.2 3.9 4.5 6.2 2.3 3.2 1.6 4.0 6.5 11.9 10.9 2.5 4.9 3.1 1.5 2.2 1.7 0.7 10.8 1.8 1.5 1.0 3.0 16.0 0.3 1.3 0.5 0.6 0.9 1.3 0.6 0.6 0.6 0.6 0.3 47.1 0.1 0.2 1.6 0.1 1.5 2.4 0.4 0.3 0.3 0.4 0.9 0.2 1.9 1.9 1.8 1.8 0.4 1.0 1.1 0.3 0.3 0.3 0.7 0.0 0.7 1.4 0.9 1.8 0.6 0.6 0.2 0.6 17.8 1.0 0.4 0.9 2.7 1.0 0.5 0.4 1.2 0.1 0.1 0.5 1.1 1.2 0.5 4.9 1.2 4.8 3.7 3.2 0.5 0.6 1.0 1.1 3.1 0.5 0.9 16.0 0.4 0.9 0.7 0.7 1.0 1.5 1.3 0.9 3.0 0.3 7.8 0.5 0.6 0.5 2.2 4.5 10.4 2.7 3.8 3.1 4.3 0.8 7.7 3.1 MST1R "CD136, CDw136, PTK8, RON" ENSG00000164078 "Macrophage stimulating 1 receptor" Q04912 3 49887002-49903873 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.7;intestine: 34.3;skin 1: 28.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 35.3;HaCaT: 19.5;HBEC3-KT: 21.2;hTCEpi: 29.8;RT4: 22.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Lineage enhanced" "Detected in single" "T-cells: 2.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007657, HPA008180, CAB008972" Enhanced Approved Cytosol Cytosol "CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291" "unprognostic (3.84e-3)" "unprognostic (3.86e-1)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.82e-2)" "unprognostic (2.32e-1)" "unprognostic (8.07e-3)" "unprognostic (1.54e-2)" "unprognostic (4.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.24e-3)" "unprognostic (2.28e-1)" "unprognostic (8.08e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-1)" "unprognostic (8.00e-3)" "prognostic favourable (2.33e-5)" 1.7 0.1 0.4 7.5 0.6 0.0 2.4 0.5 0.7 1.8 20.5 0.7 2.0 11.2 1.2 1.3 6.1 0.6 27.7 0.9 0.5 0.1 1.4 0.4 5.0 1.1 0.4 0.6 0.5 4.1 0.0 1.3 0.8 0.9 1.7 9.7 2.5 2.1 0.4 0.5 28.7 34.3 0.7 0.4 0.6 19.1 1.9 0.4 7.7 1.3 6.0 4.5 4.3 3.5 0.2 0.0 0.0 0.0 0.6 2.1 0.0 12.7 4.9 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.2 35.3 0.5 3.1 0.2 19.5 0.0 21.2 0.0 0.3 0.3 0.0 8.4 0.3 0.3 0.0 0.4 0.1 29.8 0.1 4.2 0.0 0.2 0.1 0.0 1.7 0.0 0.0 0.1 10.3 0.8 0.0 0.3 13.0 22.8 0.3 0.0 3.6 8.2 0.0 6.5 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.4 0.6 0.5 0.7 0.5 0.1 0.4 0.6 0.9 0.4 MT-ND4L "MTND4L, NAD4L, ND4L" ENSG00000212907 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L" P03901 MT 10470-10766 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 434.4;skeletal muscle: 294.4" "Cell line enhanced" "Detected in all" "HeLa: 879.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075648 Approved Mitochondria Mitochondria "HPA075648: " "unprognostic (5.81e-2)" "unprognostic (3.46e-2)" "unprognostic (2.76e-2)" "unprognostic (7.91e-2)" "unprognostic (5.64e-2)" "unprognostic (1.05e-1)" "prognostic favourable (4.47e-4)" "unprognostic (1.97e-1)" "unprognostic (4.04e-2)" "unprognostic (4.63e-3)" "unprognostic (6.61e-2)" "unprognostic (7.38e-3)" "unprognostic (1.39e-1)" "unprognostic (3.09e-1)" "unprognostic (3.73e-1)" "unprognostic (2.97e-2)" "unprognostic (5.68e-2)" 101.1 71.9 102.4 20.3 114.5 13.2 39.4 41.5 73.3 39.4 83.8 48.0 26.1 34.1 30.7 23.9 23.4 187.5 102.7 79.1 123.5 185.7 20.2 13.1 88.6 26.2 43.4 29.7 18.5 30.9 34.2 80.0 43.2 75.4 294.4 31.8 38.4 38.6 59.2 16.1 62.5 27.5 24.6 24.4 25.8 14.3 200.8 111.2 434.4 139.9 112.1 153.0 66.8 96.4 89.7 161.9 164.8 567.3 119.4 71.4 207.0 51.9 32.5 59.4 149.1 89.1 239.3 84.9 139.8 183.9 25.1 221.6 64.7 94.2 103.6 172.0 879.2 276.9 83.3 176.8 154.7 209.0 227.1 61.9 216.8 65.0 94.8 171.6 119.0 172.3 67.2 226.9 40.8 108.4 39.0 69.8 106.4 172.8 203.7 49.1 66.5 101.6 160.9 69.4 114.4 222.6 207.8 85.3 106.2 124.8 79.2 155.3 72.7 127.4 61.2 240.6 39.8 434.4 139.9 290.0 102.4 110.6 140.6 166.9 110.0 117.5 86.1 200.8 132.4 153.0 78.4 112.1 99.4 111.2 79.0 66.8 MTCH2 SLC25A50 ENSG00000109919 "Mitochondrial carrier 2" Q9Y6C9 11 47617315-47642623 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038390 Approved Supported Mitochondria 55000 Mitochondria "HPA038390: AB_10669723" "unprognostic (4.94e-2)" "unprognostic (3.29e-1)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (4.27e-1)" "unprognostic (7.63e-3)" "unprognostic (1.80e-1)" "unprognostic (7.03e-2)" "unprognostic (1.51e-1)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "prognostic favourable (9.05e-6)" "unprognostic (1.12e-2)" "unprognostic (8.75e-2)" "unprognostic (2.25e-1)" "unprognostic (1.77e-1)" 13.6 19.6 15.6 12.8 20.3 8.3 12.5 14.1 21.3 10.4 22.3 19.3 8.7 28.3 12.6 15.1 21.6 9.9 11.6 15.0 14.0 13.8 40.8 74.8 9.1 13.9 15.2 12.2 9.3 14.4 16.8 9.3 9.5 15.4 11.8 24.7 13.6 13.4 10.0 31.4 12.1 33.9 16.1 11.4 11.4 10.1 44.2 10.2 15.1 15.5 24.9 16.4 11.6 10.7 13.7 25.7 7.9 21.3 12.1 13.6 17.5 19.0 20.9 17.9 24.1 21.2 19.6 13.2 20.6 18.9 27.9 26.5 16.5 19.4 26.3 11.2 25.3 24.0 32.1 27.2 34.1 13.1 29.9 15.0 29.8 33.0 29.2 31.3 15.2 22.2 21.5 18.5 27.8 25.2 27.8 15.8 34.0 27.7 23.9 23.5 19.3 31.7 22.4 27.2 18.9 32.3 24.7 21.3 15.0 28.3 28.6 14.6 41.1 14.7 20.9 25.8 22.5 42.6 26.5 16.9 19.1 29.7 21.3 27.3 23.0 5.9 19.8 7.9 12.7 21.3 12.0 13.7 11.1 11.7 25.7 10.9 9.7 11.2 1.9 12.1 17.0 16.9 13.6 17.5 15.6 20.3 14.1 21.3 14.0 13.8 15.2 12.2 15.4 10.2 MTDH "3D3, AEG-1, LYRIC" ENSG00000147649 Metadherin Q86UE4 8 97644179-97728770 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010932, HPA015104, CAB068204, CAB068205" Supported Enhanced "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB068204: , CAB068205: , HPA010932: AB_1079422, HPA015104: AB_1854173" "unprognostic (1.01e-3)" "unprognostic (1.41e-2)" "unprognostic (2.05e-2)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.24e-2)" "unprognostic (4.08e-2)" "prognostic unfavourable (7.76e-4)" "unprognostic (1.25e-1)" "unprognostic (2.08e-1)" "prognostic unfavourable (5.36e-4)" "unprognostic (1.20e-1)" "prognostic unfavourable (3.82e-4)" "unprognostic (3.84e-3)" "unprognostic (3.88e-2)" "unprognostic (2.77e-1)" "unprognostic (1.40e-1)" 26.5 28.5 17.2 28.3 21.9 44.5 29.0 21.8 20.2 27.5 24.9 20.7 24.7 23.2 31.6 28.6 27.6 23.6 23.5 23.6 18.7 16.6 24.3 97.8 21.9 31.4 26.5 19.6 26.7 22.7 27.1 18.0 13.4 23.0 24.0 22.8 16.4 22.3 21.2 49.8 19.5 32.7 29.5 34.6 35.8 21.8 19.0 24.8 40.0 30.5 22.7 27.5 27.5 35.7 26.2 42.4 17.4 26.6 19.2 20.9 10.1 38.2 19.8 13.0 17.8 21.6 22.9 6.4 34.4 29.3 22.0 17.1 11.7 28.6 35.4 38.8 33.7 25.5 31.5 23.8 30.8 37.7 16.5 65.0 21.5 13.8 26.2 34.0 30.3 17.5 24.1 26.6 60.7 25.3 42.4 62.9 23.3 15.8 57.3 9.4 8.0 24.2 37.6 15.4 51.4 14.3 22.0 19.7 14.7 24.4 21.5 26.9 32.9 21.9 26.2 31.3 11.3 28.7 25.3 35.1 38.2 35.9 28.7 40.0 27.3 17.4 26.6 13.4 14.2 17.8 20.1 26.2 20.4 20.9 32.6 18.6 20.8 18.4 3.8 19.2 19.5 42.4 11.7 10.1 17.2 21.9 21.8 20.2 18.7 16.6 26.5 19.6 23.0 24.8 MTFR2 "DUFD1, FAM54A" ENSG00000146410 "Mitochondrial fission regulator 2" Q6P444 6 136231024-136250335 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.2;lymphoid tissue: 16.8;testis: 13.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029792, HPA029794" Approved Uncertain Vesicles Vesicles "HPA029792: AB_10600210, HPA029794: AB_10600535" "unprognostic (6.49e-3)" "unprognostic (6.29e-2)" "unprognostic (1.65e-1)" "prognostic unfavourable (9.64e-4)" "unprognostic (3.93e-1)" "unprognostic (1.75e-2)" "unprognostic (4.60e-6)" "prognostic unfavourable (8.28e-4)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.27e-2)" "unprognostic (6.54e-2)" "unprognostic (1.11e-16)" "unprognostic (8.82e-3)" "unprognostic (1.55e-1)" "unprognostic (4.10e-2)" "unprognostic (3.64e-2)" 1.7 0.9 0.6 5.1 1.5 15.2 0.9 0.9 1.1 0.8 2.9 0.8 0.4 2.8 0.7 0.9 4.5 0.5 1.7 1.0 0.6 0.6 2.5 0.7 1.5 6.4 0.8 0.4 0.9 0.7 0.0 0.7 3.2 1.2 0.7 4.1 0.6 1.3 0.4 1.4 1.9 3.2 0.9 1.1 3.8 1.9 13.5 0.4 16.8 0.4 3.2 5.8 1.1 1.4 1.6 3.0 0.1 2.9 0.0 2.6 1.1 7.1 5.6 4.8 8.9 0.8 1.4 8.6 9.5 6.6 11.3 15.9 9.9 5.9 18.7 5.8 3.8 11.2 10.8 7.0 16.9 10.4 8.3 14.7 4.1 9.0 0.5 26.9 13.9 1.1 1.5 12.6 8.1 6.1 15.8 14.6 8.4 9.6 15.1 22.6 4.8 6.9 13.9 7.7 9.4 4.8 5.6 3.8 3.8 6.0 10.6 5.4 4.4 18.6 3.3 5.6 5.9 19.8 14.5 5.5 13.0 12.4 3.2 18.4 8.6 0.0 0.6 0.0 1.2 2.9 0.4 1.6 1.6 2.6 3.0 1.3 0.2 1.3 0.1 0.0 2.3 2.2 2.2 1.1 0.6 1.5 0.9 1.1 0.6 0.6 0.8 0.4 1.2 0.4 MTHFD1 "MTHFC, MTHFD" ENSG00000100714 "Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1" P11586 14 64388031-64463457 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis" "Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 121.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000704, HPA001290, HPA015006, HPA050052" Approved Enhanced Cytosol 250000 Cytosol "HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: " "unprognostic (3.58e-2)" "unprognostic (5.50e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.37e-1)" "unprognostic (7.01e-2)" "unprognostic (8.85e-3)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" "unprognostic (2.29e-2)" "prognostic unfavourable (6.96e-4)" "unprognostic (1.84e-1)" "prognostic favourable (5.93e-5)" "unprognostic (2.45e-2)" "unprognostic (1.75e-1)" "unprognostic (7.30e-2)" "unprognostic (2.29e-2)" 18.9 9.0 8.1 8.4 18.1 9.7 12.2 5.7 15.9 7.1 9.3 9.0 4.0 7.5 8.5 6.9 12.0 6.7 6.4 10.6 8.4 6.5 20.5 121.6 6.8 9.2 8.0 10.4 10.1 13.4 13.1 5.6 5.6 10.0 5.5 11.4 9.3 11.6 5.6 26.5 7.6 7.3 8.8 6.9 8.3 7.9 2.3 7.4 15.6 8.6 14.0 12.5 8.7 7.3 21.1 12.8 0.5 13.2 12.8 14.9 8.4 72.1 41.1 15.6 34.0 16.8 13.7 25.3 28.3 19.5 36.8 36.5 39.9 33.3 30.4 13.4 16.8 35.5 48.2 28.2 43.1 30.1 31.7 37.6 41.2 30.2 12.4 28.8 20.5 10.7 9.1 32.8 17.8 22.9 28.0 25.0 27.8 59.9 46.4 16.9 28.6 43.6 37.1 54.3 27.5 27.6 42.3 33.8 13.1 47.4 25.8 14.2 40.1 14.6 14.1 27.8 48.1 25.5 33.9 16.7 20.5 53.5 25.4 33.4 31.4 0.2 8.2 0.1 8.1 13.2 10.9 21.1 9.0 9.9 12.8 11.6 7.6 10.1 0.5 12.8 10.3 3.2 14.9 8.4 8.1 18.1 5.7 15.9 8.4 6.5 8.0 10.4 10.0 7.4 MTHFD1L "DKFZP586G1517, FLJ21145, FTHFSDC1" ENSG00000120254 "Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like" Q6UB35 6 150865549-151101887 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "One-carbon metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015006, HPA029040, HPA029041, HPA050052, HPA074911" Approved Supported Mitochondria Mitochondria "HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: , HPA074911: " "unprognostic (3.66e-2)" "prognostic unfavourable (1.68e-5)" "unprognostic (1.02e-1)" "prognostic unfavourable (7.28e-4)" "unprognostic (3.25e-1)" "prognostic unfavourable (5.10e-4)" "prognostic unfavourable (8.33e-5)" "unprognostic (6.35e-3)" "unprognostic (2.45e-1)" "unprognostic (1.44e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "unprognostic (1.11e-2)" "unprognostic (2.93e-2)" "unprognostic (3.51e-1)" "unprognostic (2.91e-1)" "prognostic unfavourable (8.69e-5)" 10.4 10.6 8.0 12.1 8.1 12.2 7.1 32.4 10.5 6.5 6.2 7.8 10.2 3.4 8.5 7.2 6.4 8.0 7.3 10.7 7.5 7.9 9.5 6.9 17.1 11.0 12.3 7.6 22.2 13.7 7.1 9.1 15.5 8.5 5.0 9.1 12.7 3.4 10.5 2.5 5.7 4.7 10.9 10.2 8.7 5.6 13.6 6.6 6.7 12.2 5.0 11.4 8.7 5.1 1.1 3.0 0.2 0.8 1.0 5.0 0.6 11.8 10.3 13.5 33.2 3.5 12.4 33.0 18.7 20.5 18.9 23.2 20.8 11.2 43.8 12.5 28.5 12.7 21.6 18.2 23.4 18.0 19.6 18.3 18.4 19.0 22.3 33.3 3.0 14.6 23.3 18.2 33.3 31.4 43.2 23.0 19.4 25.0 16.3 6.9 13.7 9.6 19.6 10.1 19.5 12.7 5.8 13.5 10.0 24.7 11.0 15.3 3.4 23.3 23.8 12.6 27.7 28.0 26.5 19.1 17.8 45.7 21.0 31.2 16.3 0.2 0.7 0.0 0.8 0.8 1.3 0.8 1.9 2.1 3.0 1.1 1.8 1.9 0.0 1.0 0.8 1.5 5.0 0.6 8.0 8.1 32.4 9.5 7.5 7.9 12.3 7.6 8.5 6.6 MTUS1 "ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1" ENSG00000129422 "Microtubule associated scaffold protein 1" Q9ULD2 8 17643795-17800917 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 29.1;AN3-CA: 25.6;HUVEC TERT2: 75.5;SK-MEL-30: 21.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 2.2;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6" "Lineage enriched" "Detected in single" 21 "T-cells: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067903, HPA069795" Enhanced Nucleoli,Microtubules "Nucleoli, Microtubules" "HPA067903: , HPA069795: " "unprognostic (3.20e-1)" "unprognostic (3.29e-1)" "prognostic favourable (1.05e-4)" "unprognostic (2.50e-2)" "unprognostic (2.27e-1)" "unprognostic (7.72e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-3)" "unprognostic (2.44e-1)" "unprognostic (9.73e-2)" "unprognostic (7.93e-3)" "unprognostic (3.33e-1)" "prognostic favourable (2.76e-4)" "unprognostic (2.04e-1)" "unprognostic (2.38e-2)" "unprognostic (2.53e-3)" "unprognostic (2.43e-1)" 45.0 20.8 20.9 6.8 38.2 0.4 21.8 51.0 27.7 19.8 19.0 56.5 9.9 16.9 16.9 12.6 20.3 12.8 20.0 44.3 27.4 17.3 14.4 29.3 20.9 4.4 34.7 18.0 28.2 47.1 43.8 15.0 36.1 33.7 17.5 21.1 10.3 24.3 14.0 49.7 12.2 17.4 20.5 48.3 8.2 21.4 6.5 49.3 0.7 15.7 10.9 7.5 21.4 26.7 0.2 0.0 0.0 0.0 0.0 4.8 1.0 5.3 29.1 4.7 25.6 0.0 0.1 8.6 0.2 1.9 0.1 0.6 2.1 1.9 0.7 2.2 0.0 5.6 7.8 2.7 0.2 3.9 3.3 0.0 5.0 13.8 1.7 0.0 0.1 2.4 4.2 0.6 8.6 75.5 0.0 11.1 0.0 1.4 1.0 1.4 6.8 0.7 0.0 4.3 2.8 1.5 11.1 2.4 0.5 3.7 6.8 21.4 4.9 0.0 15.4 0.0 6.4 0.0 0.0 1.5 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 2.2 0.6 0.0 0.2 4.8 3.6 0.0 0.0 0.0 0.0 0.0 1.0 20.9 38.2 51.0 27.7 27.4 17.3 34.7 18.0 33.7 49.3 MTX1 "MTX, MTXN" ENSG00000173171 "Metaxin 1" Q13505 1 155208699-155213824 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011543 Uncertain Supported Mitochondria Mitochondria "HPA011543: AB_1853824" "unprognostic (2.57e-1)" "unprognostic (9.51e-3)" "unprognostic (3.27e-1)" "unprognostic (5.98e-3)" "unprognostic (1.60e-1)" "unprognostic (2.62e-2)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.28e-2)" "unprognostic (1.71e-1)" "unprognostic (6.78e-2)" "prognostic unfavourable (3.39e-4)" "unprognostic (1.30e-2)" "unprognostic (1.70e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-2)" 15.4 19.8 11.6 9.9 12.6 22.9 15.8 5.7 18.1 15.8 15.9 12.2 14.8 12.4 14.9 13.9 18.0 21.4 13.5 11.8 10.8 10.0 24.4 36.4 12.8 18.7 11.8 12.9 14.0 26.3 23.4 12.0 28.4 11.7 12.3 12.7 14.6 20.7 19.2 10.4 13.8 13.7 12.7 10.2 17.1 14.7 60.0 9.0 14.5 19.3 14.3 18.0 11.6 11.5 14.4 23.1 43.8 26.8 12.2 14.0 14.4 17.2 28.4 9.1 12.9 17.0 15.4 28.8 8.9 18.1 26.6 18.5 35.3 28.9 14.2 29.6 20.5 17.3 13.3 25.2 9.7 10.4 31.4 9.0 22.7 34.0 26.9 16.6 12.7 19.6 23.6 27.4 18.5 23.4 18.2 7.1 15.7 41.9 18.6 20.9 18.1 33.0 15.4 5.7 33.8 23.9 15.0 14.9 18.5 11.1 35.2 10.2 28.5 27.0 9.7 12.7 14.4 8.4 15.0 13.7 11.4 14.5 16.8 8.6 13.5 10.2 26.8 6.3 9.8 13.7 9.2 14.4 12.1 10.3 23.1 12.4 12.1 10.9 43.8 12.2 7.9 12.4 14.0 14.4 11.6 12.6 5.7 18.1 10.8 10.0 11.8 12.9 11.7 9.0 MUC1 "ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM" ENSG00000185499 "Mucin 1, cell surface associated" P15941 1 155185824-155192916 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 168.1;kidney: 158.5;lung: 143.5" "Group enriched" "Detected in many" 7 "CAPAN-2: 139.8;RPTEC TERT1: 107.3;T-47d: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.0" "Group enriched" "Detected in many" 10 "granulocytes: 1.3;T-cells: 4.0" "CAB000036, CAB001986, HPA004179, HPA007235, HPA008855" Enhanced Supported "Plasma membrane" "Secreted in other tissues" 4900000 "Plasma membrane" "CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283" "unprognostic (4.74e-2)" "unprognostic (2.84e-2)" "unprognostic (2.19e-1)" "unprognostic (8.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.70e-1)" "unprognostic (2.61e-3)" "unprognostic (6.34e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "prognostic unfavourable (4.60e-4)" "unprognostic (4.75e-1)" "unprognostic (2.05e-2)" "unprognostic (1.13e-1)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (1.21e-1)" 1.5 0.7 0.8 12.6 1.2 0.9 12.6 0.4 0.7 31.6 15.9 1.2 2.4 2.9 10.5 9.8 51.8 18.7 168.1 0.8 0.5 0.3 158.5 2.0 143.5 0.3 0.5 0.3 14.9 74.2 0.0 4.7 15.5 2.1 6.1 16.1 0.8 17.0 5.9 0.8 1.8 3.6 2.8 0.7 0.6 105.0 4.3 0.5 0.7 15.7 10.5 47.8 12.3 5.2 0.0 0.2 1.3 0.1 0.0 4.0 0.2 1.8 0.9 0.6 0.5 0.4 0.5 0.2 0.6 1.5 0.7 1.9 0.0 139.8 0.0 10.2 1.1 2.8 0.1 0.0 0.2 1.2 0.1 0.2 11.8 0.0 0.3 0.0 4.4 1.2 0.2 0.3 0.2 0.2 1.0 1.9 0.5 14.2 0.1 0.1 0.4 0.2 0.2 0.0 3.4 107.3 0.1 0.6 0.2 3.4 5.9 0.1 47.1 0.6 0.2 0.4 0.8 1.3 0.1 2.2 1.1 0.0 0.7 0.1 0.1 1.3 0.1 0.0 0.0 0.0 0.8 0.0 2.3 0.4 0.2 0.0 0.3 0.7 0.0 0.0 0.0 0.0 4.0 0.2 0.8 1.2 0.4 0.7 0.5 0.3 0.5 0.3 2.1 0.5 MUC12 MUC11 ENSG00000205277 "Mucin 12, cell surface associated" Q9UKN1 7 100969623-101018949 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 35.6" "Cell line enhanced" "Detected in single" "NTERA-2: 1.7" "Cancer enriched" "Detected in some" 7 "colorectal cancer: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA023835 Enhanced "HPA023835: AB_1854199" "unprognostic (1.38e-1)" "unprognostic (2.09e-1)" "unprognostic (2.80e-2)" "unprognostic (1.60e-1)" "unprognostic (3.84e-4)" "unprognostic (4.40e-2)" "unprognostic (1.30e-3)" "unprognostic (1.84e-2)" "unprognostic (1.40e-1)" "unprognostic (6.52e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (3.33e-7)" "unprognostic (8.42e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-1)" "unprognostic (7.54e-2)" 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 35.6 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 MUC13 DRCC1 ENSG00000173702 "Mucin 13, cell surface associated" Q9H3R2 3 124905442-124953819 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "intestine: 334.4" "Cell line enhanced" "Detected in some" "A549: 8.0;CACO-2: 6.9;CAPAN-2: 14.9;Karpas-707: 8.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 198.4;stomach cancer: 152.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045163 Enhanced "Secreted to digestive system" "HPA045163: AB_10960396" "unprognostic (8.42e-2)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.55e-3)" "unprognostic (2.93e-1)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (3.48e-2)" "unprognostic (2.94e-1)" "unprognostic (5.10e-2)" "unprognostic (2.02e-1)" "unprognostic (9.64e-2)" "prognostic unfavourable (9.73e-5)" "unprognostic (2.05e-3)" "unprognostic (1.10e-1)" "unprognostic (2.29e-1)" "unprognostic (1.42e-1)" 0.5 0.6 0.5 16.4 0.5 0.0 0.5 0.5 0.5 0.5 83.1 0.0 0.0 79.9 0.5 0.3 0.5 0.5 16.7 0.5 0.5 0.5 3.3 8.7 0.5 0.0 0.5 0.0 0.5 1.8 0.0 0.5 0.1 0.1 0.5 40.6 0.1 0.5 0.0 0.5 0.5 334.4 1.0 0.5 0.5 4.1 0.5 0.0 0.1 0.5 0.0 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.0 0.1 6.9 14.9 0.0 0.9 0.2 1.1 0.0 0.0 0.0 0.1 0.2 0.0 1.7 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.1 0.0 0.0 1.1 0.0 1.2 0.1 0.1 2.7 0.0 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.4 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.0 0.1 0.0 MUC15 ENSG00000169550 "Mucin 15, cell surface associated" Q8N387 11 26559033-26572233 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 265.1;placenta: 56.8;thyroid gland: 77.8" "Cell line enhanced" "Detected in some" "BEWO: 7.9;K-562: 9.8;SK-BR-3: 16.7;U-266/70: 6.6;U-266/84: 17.6" "Cancer enriched" "Detected in many" 11 "thyroid cancer: 56.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebellum: 1.3;thalamus: 1.5" "Low region specificity" "Detected in all" "HPA026110, HPA073304" Enhanced "Intracellular and membrane" "HPA026110: AB_1854200, HPA073304: " "unprognostic (1.49e-1)" "unprognostic (2.08e-3)" "unprognostic (7.71e-5)" "unprognostic (5.09e-3)" "unprognostic (2.77e-2)" "unprognostic (3.04e-2)" "unprognostic (6.58e-2)" "unprognostic (1.12e-1)" "unprognostic (9.44e-3)" "unprognostic (1.98e-1)" "unprognostic (7.27e-3)" "unprognostic (4.96e-3)" "unprognostic (1.09e-1)" "unprognostic (5.70e-2)" "unprognostic (4.54e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 3.9 0.0 0.0 9.3 0.0 0.1 265.1 11.0 1.0 0.1 0.1 0.0 0.0 5.2 0.1 4.8 0.1 0.0 0.0 0.1 1.8 0.0 2.1 56.8 0.0 0.8 0.0 0.0 14.4 1.0 0.0 12.0 0.0 0.0 0.0 0.0 0.2 4.1 0.0 1.1 77.8 8.1 1.7 3.0 6.5 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 9.8 0.1 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.6 0.0 16.7 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 6.6 17.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC16 "CA125, FLJ14303" ENSG00000181143 "Mucin 16, cell surface associated" Q8WXI7 19 8848844-8981342 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 6.6;cervix, uterine: 19.3;fallopian tube: 6.7;salivary gland: 6.3" "Cell line enhanced" "Detected in some" "A-431: 15.5;CAPAN-2: 5.5;HaCaT: 5.3;HeLa: 26.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB055172, HPA065600" Enhanced "Secreted in other tissues" "CAB055172: AB_2148831, HPA065600: " "unprognostic (8.66e-2)" "unprognostic (3.89e-2)" "unprognostic (5.37e-2)" "unprognostic (3.07e-1)" "unprognostic (1.76e-2)" "unprognostic (3.01e-3)" "unprognostic (3.83e-3)" "unprognostic (1.31e-2)" "unprognostic (1.00e-2)" "unprognostic (1.86e-1)" "unprognostic (1.89e-3)" "unprognostic (1.81e-1)" "unprognostic (2.60e-8)" "unprognostic (3.50e-2)" "unprognostic (2.86e-1)" "unprognostic (1.43e-1)" "unprognostic (3.68e-3)" 6.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.3 0.0 0.0 2.4 0.0 0.2 6.7 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.4 2.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC17 ENSG00000169876 "Mucin 17, cell surface associated" Q685J3 7 101020072-101058745 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 299 "intestine: 125.2" "Cell line enhanced" "Detected in single" "BEWO: 1.3" "Group enriched" "Detected in some" 29 "colorectal cancer: 6.1;pancreatic cancer: 4.9;stomach cancer: 22.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031634 Enhanced "Intracellular and membrane" "HPA031634: AB_10603021" "unprognostic (2.37e-2)" "unprognostic (2.41e-1)" "unprognostic (8.17e-3)" "unprognostic (5.57e-3)" "unprognostic (6.07e-2)" "unprognostic (8.79e-8)" "unprognostic (1.28e-1)" "unprognostic (2.47e-2)" 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 64.7 0.0 0.0 15.8 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 2.5 0.0 0.1 0.0 0.1 0.1 125.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 MUC21 "bCX31G15.2, C6orf205" ENSG00000204544 "Mucin 21, cell surface associated" Q5SSG8 6 30983718-30989903 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 251.5;lymphoid tissue: 126.1" "Cell line enriched" "Detected in single" 14 "Karpas-707: 4.2" "Group enriched" "Detected in many" 9 "cervical cancer: 6.8;head and neck cancer: 6.6;lung cancer: 13.9;stomach cancer: 7.0;thyroid cancer: 5.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.0" HPA052028 Enhanced "HPA052028: " "unprognostic (2.27e-2)" "unprognostic (4.85e-3)" "unprognostic (5.24e-3)" "unprognostic (1.68e-2)" "unprognostic (2.68e-2)" "unprognostic (2.98e-3)" "unprognostic (1.32e-4)" "unprognostic (1.05e-1)" "unprognostic (1.53e-1)" "unprognostic (3.24e-2)" "unprognostic (7.81e-2)" 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 34.7 0.2 0.0 0.0 0.2 1.3 0.2 251.5 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.7 0.2 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 16.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.0 0.2 33.7 126.1 0.2 33.2 0.0 0.0 1.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC3A MUC3 ENSG00000169894 "Mucin 3A, cell surface associated" Q02505 7 100949555-100968346 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 84.4;intestine: 138.0" "Cell line enhanced" "Detected in some" "CACO-2: 12.0;CAPAN-2: 4.0;MCF7: 2.6;U-2 OS: 2.3" "Cancer enhanced" "Detected in many" "stomach cancer: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA010871 Uncertain "Intracellular and membrane" "HPA010871: AB_1854201" "unprognostic (1.12e-2)" "unprognostic (3.78e-2)" "unprognostic (1.75e-1)" "unprognostic (4.22e-3)" "unprognostic (2.91e-1)" "unprognostic (5.16e-2)" "unprognostic (2.06e-1)" "unprognostic (5.29e-3)" "unprognostic (2.87e-1)" "unprognostic (1.33e-1)" "unprognostic (7.01e-2)" "unprognostic (2.99e-1)" "unprognostic (6.50e-3)" "unprognostic (8.73e-2)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" "unprognostic (4.51e-2)" 0.1 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 31.4 0.0 0.0 23.3 0.0 0.0 0.0 0.0 84.4 0.8 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.5 6.7 0.0 0.0 0.0 2.4 0.0 138.0 0.1 0.0 0.0 1.4 0.0 0.0 19.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 12.0 4.0 0.0 0.1 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 2.6 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.6 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC4 ENSG00000145113 "Mucin 4, cell surface associated" Q99102 3 195746765-195812277 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.5;lymphoid tissue: 57.2" "Cell line enhanced" "Detected in single" "BEWO: 1.5" "Cancer enhanced" "Detected in many" "cervical cancer: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005895, CAB013536" Approved "Secreted in other tissues" "CAB013536: , HPA005895: AB_1079427" "unprognostic (4.16e-3)" "unprognostic (1.00e-2)" "unprognostic (6.79e-2)" "unprognostic (1.11e-2)" "unprognostic (3.03e-2)" "unprognostic (5.16e-2)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (3.19e-1)" "unprognostic (4.22e-3)" "unprognostic (6.68e-3)" "unprognostic (5.30e-2)" "unprognostic (2.43e-3)" "unprognostic (3.19e-1)" "unprognostic (6.78e-2)" "unprognostic (3.46e-3)" "unprognostic (9.97e-3)" 0.4 0.4 0.0 28.7 0.0 0.4 0.4 0.0 0.4 13.4 21.5 0.0 0.0 0.4 1.4 0.4 13.0 1.7 0.4 0.4 0.0 0.0 0.4 0.4 10.3 0.4 0.0 0.0 0.5 0.4 0.4 0.0 6.2 0.2 10.0 1.9 0.0 5.5 0.4 0.4 0.4 1.7 0.4 0.0 0.4 2.4 0.5 0.0 0.5 0.4 6.1 57.2 6.5 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 MUL1 "C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218" ENSG00000090432 "Mitochondrial E3 ubiquitin protein ligase 1" Q969V5 1 20499448-20508161 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026827 Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA026827: AB_10601137" "unprognostic (1.39e-1)" "unprognostic (2.73e-2)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (6.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.31e-2)" "unprognostic (5.86e-3)" "unprognostic (4.05e-1)" "unprognostic (9.10e-2)" "prognostic favourable (6.15e-14)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" 13.3 15.9 10.3 12.9 12.3 20.6 20.4 9.2 22.2 13.1 15.8 19.0 8.0 11.6 18.2 10.7 17.2 17.0 18.5 26.2 11.7 12.5 20.5 20.1 16.3 12.1 16.8 9.5 17.5 26.8 21.9 13.0 21.6 17.6 13.9 13.3 14.3 15.3 18.1 26.7 17.4 19.5 17.0 11.7 13.6 15.2 14.1 11.6 18.5 15.1 14.6 14.0 16.3 13.6 23.2 26.0 31.9 30.4 25.2 32.1 27.5 16.9 16.4 9.5 19.6 20.6 11.6 10.3 16.9 20.2 21.0 20.3 10.1 28.2 12.8 18.9 23.8 25.9 17.0 24.4 15.3 12.7 13.5 9.8 11.1 14.6 24.3 13.4 16.8 18.9 32.2 21.5 22.4 13.7 12.7 15.6 22.8 8.6 8.0 9.0 9.7 15.7 7.9 11.9 16.5 24.7 9.5 9.7 14.3 15.1 16.2 20.7 11.4 12.9 15.4 20.5 11.8 17.8 15.1 18.3 15.9 13.8 16.1 18.2 19.0 26.3 26.5 31.9 30.9 30.4 32.1 23.2 23.6 31.4 26.0 21.5 27.1 26.3 24.0 25.2 25.4 20.1 32.1 27.5 10.3 12.3 9.2 22.2 11.7 12.5 16.8 9.5 17.6 11.6 MVD MPD ENSG00000167508 "Mevalonate diphosphate decarboxylase" P53602 16 88651935-88663161 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041404, HPA048250" Uncertain Approved "Cell Junctions,Cytosol" 30000 Cytosol "Cell Junctions" "HPA041404: , HPA048250: " "unprognostic (1.67e-1)" "unprognostic (3.05e-1)" "unprognostic (2.42e-1)" "prognostic favourable (2.17e-4)" "unprognostic (1.89e-1)" "unprognostic (9.56e-2)" "unprognostic (9.26e-3)" "unprognostic (8.33e-2)" "unprognostic (6.68e-2)" "unprognostic (5.47e-2)" "unprognostic (2.51e-1)" "unprognostic (6.22e-2)" "unprognostic (1.19e-3)" "unprognostic (4.12e-2)" "unprognostic (1.69e-1)" "unprognostic (2.11e-1)" "unprognostic (5.00e-2)" 11.9 18.5 15.8 16.9 19.7 7.6 12.5 21.7 27.9 10.8 19.4 17.1 10.8 39.6 8.4 7.3 30.0 7.4 8.7 11.9 17.2 18.2 9.2 25.9 14.6 12.6 14.6 17.3 11.1 19.0 11.0 7.8 7.6 24.5 13.7 5.1 10.8 16.1 8.7 27.8 18.3 20.7 6.6 23.8 11.1 21.2 23.0 14.6 4.3 9.2 18.6 12.2 7.3 13.8 15.0 17.6 2.5 8.9 18.1 18.1 9.4 14.6 9.4 15.7 10.2 5.3 11.8 8.9 7.3 7.6 5.0 4.2 24.8 37.1 7.1 11.7 4.3 21.8 7.0 38.6 1.4 4.4 11.9 5.2 5.2 37.7 10.8 3.3 3.7 9.3 7.4 13.2 4.2 5.3 14.4 3.9 2.7 34.2 11.1 16.8 18.9 9.2 11.7 4.5 18.3 14.6 9.2 15.9 5.3 18.1 4.1 5.3 20.6 14.8 11.3 4.6 9.4 8.2 4.1 10.8 4.8 24.2 5.6 16.2 7.6 2.5 8.2 1.5 18.1 8.6 13.5 10.3 12.1 11.9 9.5 15.0 9.4 11.5 1.1 18.1 8.9 17.6 12.6 9.4 15.8 19.7 21.7 27.9 17.2 18.2 14.6 17.3 24.5 14.6 MXRA8 DKFZp586E2023 ENSG00000162576 "Matrix remodeling associated 8" Q9BRK3 1 1352689-1361777 "Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.4;BJ: 49.0;BJ hTERT+: 23.0;fHDF/TERT166: 24.3;HSkMC: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "naive CD8 T-cell: 9.8" "Lineage enriched" "Detected in single" 98 "T-cells: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053958, HPA055780" Uncertain Approved Nucleoli 450000 Nucleoli "HPA053958: , HPA055780: " "unprognostic (1.39e-1)" "unprognostic (2.85e-1)" "unprognostic (7.31e-3)" "unprognostic (1.26e-2)" "unprognostic (1.94e-3)" "unprognostic (2.61e-1)" "unprognostic (6.75e-2)" "unprognostic (2.03e-1)" "unprognostic (4.22e-2)" "unprognostic (5.38e-2)" "unprognostic (2.97e-2)" "unprognostic (7.13e-2)" "prognostic unfavourable (3.43e-6)" "prognostic unfavourable (9.93e-4)" "unprognostic (1.55e-1)" "unprognostic (2.89e-2)" "prognostic unfavourable (9.87e-4)" 45.6 5.3 2.3 11.4 4.6 1.1 25.2 3.9 3.8 34.8 14.3 4.8 6.2 6.5 34.0 16.3 13.7 14.4 20.5 12.7 3.6 1.1 7.6 3.5 13.4 5.6 2.6 2.6 30.4 3.7 1.6 6.0 25.0 5.4 23.4 2.3 36.6 8.4 12.3 15.5 10.9 8.6 22.0 4.5 9.5 8.7 16.4 2.9 0.3 13.9 11.8 4.5 22.3 17.8 0.0 0.0 0.0 0.0 0.0 9.8 0.3 1.3 0.3 0.4 0.3 5.9 16.4 14.8 49.0 23.0 5.8 6.9 2.6 1.1 0.5 0.2 24.3 1.0 0.3 0.0 1.1 1.0 0.4 0.4 0.8 4.1 15.4 0.0 0.5 19.5 0.0 2.1 0.0 0.0 5.7 0.4 7.3 0.1 0.1 0.1 4.8 1.6 0.2 0.1 0.1 0.0 0.2 1.1 3.1 0.1 0.4 0.0 3.8 0.2 0.4 0.2 8.2 7.6 0.1 1.1 0.1 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 9.8 0.0 0.0 0.0 0.0 0.0 0.3 2.3 4.6 3.9 2.7 3.6 1.1 2.6 2.6 5.4 2.9 MYC "bHLHe39, c-Myc, MYCC" ENSG00000136997 "MYC proto-oncogene, bHLH transcription factor" P01106 8 127735434-127741434 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 129.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000084, CAB010307, HPA055893, HPA066556" Approved Enhanced Nucleoplasm Nucleoplasm "CAB000084: , CAB010307: AB_631274, HPA055893: , HPA066556: " "unprognostic (1.45e-2)" "unprognostic (4.00e-3)" "unprognostic (3.94e-3)" "unprognostic (2.41e-3)" "unprognostic (8.14e-2)" "unprognostic (3.36e-3)" "unprognostic (5.80e-2)" "unprognostic (4.94e-3)" "unprognostic (1.59e-1)" "prognostic unfavourable (7.52e-4)" "unprognostic (5.19e-3)" "unprognostic (9.86e-3)" "prognostic unfavourable (5.49e-8)" "unprognostic (7.85e-2)" "unprognostic (4.66e-2)" "unprognostic (2.48e-1)" "prognostic unfavourable (4.96e-5)" 67.4 20.8 3.2 46.6 7.1 16.3 36.0 1.2 5.0 23.9 23.3 3.8 11.8 11.1 23.8 14.4 47.6 59.5 32.4 23.7 5.8 2.2 11.2 36.6 16.0 40.5 5.8 1.2 38.7 64.6 2.1 7.4 14.9 9.8 20.6 11.3 6.1 14.4 21.8 69.6 78.5 17.2 21.3 12.0 38.3 24.7 16.3 3.8 40.2 9.0 48.4 27.1 28.9 37.3 25.5 8.8 1.0 10.3 20.9 55.2 22.0 7.1 13.8 1.2 12.3 20.0 23.7 3.6 8.6 3.7 10.7 9.0 18.8 18.7 72.9 12.0 5.1 15.5 63.9 27.8 7.1 17.2 22.3 43.9 23.4 24.5 18.4 30.7 7.0 16.5 61.5 7.2 57.0 12.3 64.8 38.6 5.3 20.5 50.1 66.8 3.4 27.6 27.9 5.2 129.7 9.0 7.4 84.9 8.0 4.0 33.5 22.2 13.6 20.2 14.9 8.1 9.6 6.2 10.7 0.7 1.2 35.2 7.1 34.3 4.0 0.7 10.3 0.1 8.6 9.1 43.4 25.5 31.1 18.6 8.8 20.6 55.2 34.8 1.0 20.9 6.1 0.3 24.8 22.0 3.2 7.1 1.2 3.6 5.8 2.2 5.8 1.2 9.8 3.8 MYCT1 "FLJ21269, MTLC" ENSG00000120279 "MYC target 1" Q8N699 6 152697895-152724567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 45.9;TIME: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 39 "eosinophil: 20.4" "Lineage enriched" "Detected in single" 190 "granulocytes: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047992 Supported Nucleoplasm,Vesicles 69000 Nucleoplasm Vesicles "HPA047992: " "unprognostic (2.92e-1)" "unprognostic (1.82e-1)" "unprognostic (5.95e-2)" "unprognostic (2.06e-1)" "unprognostic (6.73e-2)" "unprognostic (6.80e-2)" "unprognostic (4.64e-3)" "unprognostic (6.78e-2)" "unprognostic (9.90e-2)" "unprognostic (2.10e-1)" "unprognostic (2.66e-2)" "unprognostic (2.18e-2)" "prognostic unfavourable (4.73e-4)" "unprognostic (1.26e-3)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (3.36e-2)" 37.3 3.1 4.1 4.4 6.3 1.1 27.5 3.0 7.7 16.2 8.4 1.5 5.2 3.1 14.5 9.4 14.4 6.8 9.1 17.2 5.1 4.2 6.9 11.1 24.1 4.9 5.8 1.9 8.2 2.5 3.4 2.7 17.4 6.6 8.8 5.3 8.3 4.0 3.7 14.2 4.8 5.5 10.8 5.4 39.4 4.6 7.7 5.2 0.6 12.5 11.0 2.8 17.0 12.3 0.1 0.0 20.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 45.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.2 0.2 0.5 0.0 0.4 0.0 5.7 0.0 0.0 0.0 0.4 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 4.1 6.3 3.0 7.7 5.1 4.2 5.8 1.9 6.6 5.2 MYEOV OCIM ENSG00000172927 "Myeloma overexpressed" Q96EZ4 11 69294138-69367726 "Predicted membrane proteins" Proto-oncogene "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.4;breast: 16.9;esophagus: 17.3" "Cell line enhanced" "Detected in some" "A-431: 57.8;A549: 27.8;CAPAN-2: 8.5;U-2 OS: 12.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" HPA012949 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA012949: AB_1854241" "unprognostic (1.42e-2)" "unprognostic (8.56e-2)" "unprognostic (7.07e-2)" "unprognostic (3.36e-1)" "unprognostic (5.60e-2)" "unprognostic (7.28e-3)" "unprognostic (7.58e-3)" "prognostic unfavourable (2.00e-4)" "unprognostic (3.49e-1)" "unprognostic (6.33e-2)" "prognostic unfavourable (1.54e-7)" "unprognostic (2.83e-1)" "prognostic unfavourable (1.48e-5)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (3.35e-1)" "unprognostic (3.69e-2)" 29.4 0.2 0.0 2.4 0.0 0.2 16.9 0.1 0.0 2.6 1.1 0.0 0.4 0.4 0.5 8.1 17.3 0.0 1.3 0.1 0.0 0.2 0.2 8.6 0.1 0.2 0.0 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.1 0.6 0.9 2.0 0.0 0.6 4.9 0.8 0.1 0.0 0.3 10.7 0.4 0.0 0.1 0.1 5.3 13.6 0.2 4.7 0.5 0.0 0.0 0.1 1.0 0.3 2.1 57.8 27.8 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 8.5 0.2 2.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.7 0.8 0.0 0.0 1.2 0.0 0.0 0.0 2.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 1.0 0.1 0.8 0.0 12.8 0.0 0.6 0.1 0.6 0.1 0.0 0.2 1.1 0.0 0.1 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 MYLK "MLCK, MLCK1, MYLK1, smMLCK" ENSG00000065534 "Myosin light chain kinase" Q15746 3 123610049-123884331 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 191.1" "Cell line enhanced" "Detected in many" "BJ: 36.5;BJ hTERT+: 55.2;fHDF/TERT166: 45.0;HBF TERT88: 29.0;RPTEC TERT1: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7" "Group enriched" "Detected in many" 13 "dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020789, HPA031677, HPA048055" Enhanced Enhanced "Plasma membrane,Actin filaments" 3000000 "Actin filaments" "Plasma membrane" "CAB020789: , HPA031677: AB_10794617, HPA048055: " "unprognostic (2.80e-2)" "unprognostic (5.05e-2)" "unprognostic (5.55e-2)" "unprognostic (2.85e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.40e-1)" "unprognostic (8.21e-2)" "unprognostic (1.58e-1)" "prognostic unfavourable (2.04e-6)" "unprognostic (5.26e-3)" "unprognostic (9.60e-2)" "unprognostic (3.00e-1)" "prognostic unfavourable (4.46e-4)" 14.9 4.9 4.5 19.8 10.9 0.0 14.4 0.8 5.8 77.1 107.3 22.0 93.2 9.4 111.2 48.3 96.0 56.3 40.6 6.6 4.7 3.2 8.3 5.4 13.2 6.5 25.8 2.8 50.2 1.6 0.5 1.1 8.0 16.0 85.1 27.6 6.0 17.6 158.6 1.6 4.8 33.3 191.1 28.8 7.4 38.7 17.4 13.0 0.2 4.1 2.5 3.4 137.1 21.3 0.2 2.8 4.5 1.3 0.0 0.2 17.3 2.5 7.7 2.1 1.3 2.1 0.4 0.9 36.5 55.2 23.6 17.0 1.6 1.4 0.1 8.2 45.0 0.9 0.9 0.3 29.0 0.0 0.1 20.3 0.2 5.0 11.0 0.1 1.9 6.8 0.7 4.6 6.9 1.8 0.2 0.1 17.5 0.3 0.0 0.5 2.2 1.0 2.3 1.2 6.6 59.6 1.4 0.3 1.1 3.7 0.4 0.6 0.2 0.0 6.7 7.2 2.6 1.7 5.9 0.6 0.7 0.0 18.5 0.2 1.8 3.6 1.3 0.3 0.1 0.2 0.0 0.2 0.0 0.0 2.8 0.1 0.2 0.1 4.5 0.0 0.0 2.7 0.1 17.3 4.5 10.9 0.8 5.8 4.7 3.2 25.8 2.8 16.0 13.0 MYLK3 "caMLCK, MLCK" ENSG00000140795 "Myosin light chain kinase 3" Q32MK0 16 46703369-46790407 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1" "Cell line enhanced" "Detected in some" "BEWO: 9.5;HEL: 28.5;K-562: 4.4;SK-BR-3: 6.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "cerebral cortex: 9.8;hippocampal formation: 5.7" "Region enriched" "Detected in some" 5 "hippocampal formation: 5.2" HPA073447 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA073447: " "unprognostic (6.01e-4)" "unprognostic (2.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.77e-2)" "unprognostic (1.84e-1)" "unprognostic (2.94e-3)" "unprognostic (2.60e-1)" "unprognostic (4.73e-2)" "unprognostic (3.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.58e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-2)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.97e-1)" 0.0 0.1 0.7 0.0 1.7 0.1 0.0 0.1 0.2 0.2 0.0 3.8 0.0 0.0 0.1 3.4 2.0 0.8 0.1 62.2 1.5 1.4 0.4 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.2 6.6 1.0 0.0 0.0 1.3 0.0 20.8 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.3 0.0 0.1 31.1 1.1 0.1 0.0 1.2 0.9 2.6 0.7 1.2 0.7 0.2 0.0 0.1 0.1 0.1 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 1.5 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.0 6.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.0 2.5 0.7 0.6 0.6 0.4 0.4 0.7 0.5 0.5 0.3 1.2 0.7 0.7 2.6 1.2 0.5 0.9 0.3 0.2 0.7 1.7 0.1 0.2 1.5 1.4 0.1 0.4 6.6 0.3 MYLK4 SgK085 ENSG00000145949 "Myosin light chain kinase family member 4" Q86YV6 6 2663629-2750966 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 23.6;tongue: 63.6" "Cell line enriched" "Detected in some" 6 "HEL: 12.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA015860 Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoli, Vesicles" "HPA015860: AB_2147922" "unprognostic (1.75e-1)" "unprognostic (2.04e-1)" "unprognostic (1.87e-1)" "unprognostic (5.22e-3)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (7.48e-2)" "unprognostic (2.80e-1)" "unprognostic (5.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.91e-1)" "unprognostic (2.74e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-1)" "unprognostic (1.19e-2)" "unprognostic (4.63e-2)" 0.5 0.3 0.3 0.3 0.4 0.4 0.8 1.4 0.7 0.3 0.3 0.3 0.3 0.1 0.3 0.5 1.0 0.2 0.3 1.0 0.5 0.5 2.6 0.3 0.5 0.3 0.4 0.3 0.3 1.1 0.7 0.7 0.4 0.4 0.4 0.1 0.4 2.4 0.4 23.6 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.0 63.6 1.5 0.5 0.3 0.1 0.8 0.3 0.3 0.9 1.4 0.1 0.3 0.1 0.6 1.1 1.0 1.2 0.6 0.7 1.5 0.5 0.4 0.5 1.0 1.0 1.6 0.8 1.9 0.2 0.4 0.7 0.2 0.6 12.4 0.6 0.1 0.3 0.3 0.6 1.5 0.5 0.1 1.2 0.5 0.1 0.1 0.3 0.5 0.1 1.3 0.2 0.0 0.9 0.0 0.0 0.8 0.3 1.0 0.6 0.3 0.2 0.5 0.4 0.8 0.7 0.5 0.1 0.2 0.4 0.4 0.2 0.1 0.2 0.3 1.2 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.2 1.4 0.2 0.1 0.6 0.1 0.3 0.9 0.3 0.8 0.1 0.1 0.3 0.4 1.4 0.7 0.5 0.5 0.4 0.3 0.4 0.3 MYOF "FER1L3, KIAA1207" ENSG00000138119 Myoferlin Q9NZM1 10 93306429-93482317 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 15.9;non-classical monocyte: 18.0" "Group enriched" "Detected in many" 65 "dendritic cells: 6.2;monocytes: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014245 Enhanced Supported "Vesicles,Plasma membrane" 14000 Vesicles "Plasma membrane" "HPA014245: AB_1848495" "unprognostic (3.41e-2)" "unprognostic (3.85e-1)" "unprognostic (2.88e-2)" "unprognostic (7.44e-2)" "unprognostic (3.50e-2)" "unprognostic (8.57e-3)" "unprognostic (3.48e-2)" "unprognostic (7.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavourable (1.40e-4)" "unprognostic (1.55e-1)" "unprognostic (5.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.94e-2)" "unprognostic (9.17e-2)" "unprognostic (9.18e-2)" 27.5 7.3 2.1 8.9 4.1 0.2 21.7 1.3 2.7 27.0 12.3 5.1 16.0 2.0 27.2 17.7 27.2 16.2 11.4 7.2 3.5 2.1 12.2 1.7 18.7 7.5 5.8 2.5 12.7 3.3 16.1 4.2 31.9 15.0 20.7 12.8 10.1 14.9 17.4 5.7 22.4 6.8 49.0 9.4 10.0 8.8 5.7 4.4 1.5 15.7 14.2 9.4 35.0 20.0 0.0 6.2 0.1 18.0 0.0 0.1 1.1 35.7 33.8 3.6 2.3 25.3 56.3 10.2 31.5 75.3 19.2 19.0 8.2 28.1 0.0 12.6 57.5 54.7 0.2 32.2 14.2 0.2 0.1 0.0 13.2 0.3 8.8 0.0 0.0 29.6 11.2 12.9 53.0 49.7 0.0 0.0 45.1 5.7 0.0 0.1 0.2 30.2 0.0 2.6 0.0 49.8 44.7 0.0 0.0 21.5 4.5 7.9 22.4 0.7 62.1 28.3 1.9 18.6 18.3 0.0 0.0 0.0 20.9 0.4 33.3 0.0 4.3 0.0 0.0 15.9 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.1 0.0 18.0 2.1 0.1 1.1 2.1 4.1 1.3 2.7 3.5 2.1 5.8 2.5 15.0 4.4 MYRF "C11orf9, MRF, Ndt80, pqn-47" ENSG00000124920 "Myelin regulatory factor" Q9Y2G1 11 61752642-61788518 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.7;stomach 1: 57.2" "Cell line enhanced" "Detected in some" "A549: 18.3;CACO-2: 30.5;CAPAN-2: 17.6;EFO-21: 23.9;Hep G2: 12.9;HHSteC: 13.7;U-2 OS: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018310 Approved Nucleoplasm,Cytosol 550000 Nucleoplasm Cytosol "HPA018310: AB_1845534" "unprognostic (3.51e-2)" "unprognostic (3.34e-1)" "unprognostic (1.56e-1)" "unprognostic (5.39e-2)" "unprognostic (1.54e-1)" "unprognostic (3.65e-2)" "unprognostic (1.34e-1)" "unprognostic (9.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "prognostic unfavourable (2.01e-4)" "unprognostic (8.91e-3)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" 4.6 1.3 16.4 2.1 42.9 1.4 1.5 3.3 38.5 3.7 4.3 96.7 0.0 12.8 6.9 1.6 2.0 8.0 22.4 1.5 29.2 13.9 4.5 5.8 15.8 1.2 54.3 19.9 5.8 19.7 1.2 0.2 2.6 35.7 1.2 4.0 11.6 1.7 1.6 1.0 1.4 11.4 5.4 53.8 1.3 57.2 3.0 51.4 0.0 1.2 0.0 1.2 1.3 0.3 0.0 0.0 0.2 0.3 0.5 2.1 0.5 1.3 18.3 3.3 1.0 0.0 0.0 0.1 0.1 0.0 0.7 0.8 30.5 17.6 0.6 23.9 0.0 0.8 1.0 0.1 1.3 0.1 0.3 0.1 0.4 12.9 13.7 0.0 0.3 0.3 0.2 0.4 0.0 0.1 5.6 0.2 0.1 0.3 0.0 0.6 0.9 2.4 0.0 0.1 1.2 8.1 0.1 0.1 0.6 0.1 1.3 0.3 0.4 0.1 0.6 0.2 10.6 0.2 0.3 0.3 0.1 0.1 0.1 1.2 0.2 0.0 0.0 0.2 2.1 0.3 1.2 0.0 0.7 1.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.5 16.4 42.9 3.3 29.3 29.2 13.9 54.3 19.9 35.7 51.4 MYRFL "bcm1377, C12orf15, C12orf28, FLJ25056" ENSG00000166268 "Myelin regulatory factor-like" Q96LU7 12 69825304-69959097 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "intestine: 56.1" "Cell line enhanced" "Detected in some" "NTERA-2: 6.8;SK-BR-3: 3.4;T-47d: 15.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049340 Approved Approved Nucleoli "Intracellular and membrane" Nucleoli "HPA049340: AB_2680719" "unprognostic (2.95e-2)" "unprognostic (6.25e-2)" "unprognostic (2.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.18e-2)" "unprognostic (2.34e-1)" "unprognostic (5.45e-2)" "unprognostic (6.50e-2)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (3.08e-1)" "unprognostic (8.99e-2)" "unprognostic (1.91e-2)" "unprognostic (3.89e-2)" "unprognostic (2.07e-2)" "unprognostic (1.17e-1)" "unprognostic (9.96e-2)" 0.3 0.3 0.5 0.0 0.6 0.0 0.5 3.6 0.6 0.1 20.7 0.0 0.4 21.4 0.1 0.9 0.1 0.1 0.7 0.2 0.4 0.2 2.0 0.3 0.2 0.2 0.5 0.2 0.0 0.8 0.0 1.0 0.3 0.7 0.6 0.1 0.3 1.3 0.4 0.0 1.6 56.1 0.1 1.0 0.1 0.1 2.4 0.5 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.8 0.0 0.1 0.0 1.1 1.0 0.0 0.3 0.1 0.0 3.4 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.4 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 3.6 0.6 0.4 0.2 0.5 0.2 0.7 0.5 N4BP2L2 "CG005, PFAAP5" ENSG00000244754 "NEDD4 binding protein 2 like 2" Q92802 13 32432417-32538885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039338, HPA039434, HPA059327" Approved Approved Nucleoplasm Nucleoplasm "HPA039338: , HPA039434: AB_10673143, HPA059327: " "unprognostic (1.13e-1)" "unprognostic (1.72e-1)" "unprognostic (3.15e-1)" "unprognostic (5.81e-2)" "unprognostic (6.83e-2)" "unprognostic (6.51e-2)" "unprognostic (8.95e-2)" "unprognostic (6.29e-3)" "unprognostic (6.04e-2)" "unprognostic (1.87e-1)" "unprognostic (2.71e-3)" "unprognostic (2.67e-2)" "unprognostic (4.73e-3)" "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (4.03e-3)" 24.4 22.6 22.8 27.3 28.0 17.4 29.7 43.4 34.0 34.1 25.2 18.0 31.6 13.9 38.3 25.8 19.5 26.3 22.1 30.3 23.7 18.8 23.7 25.4 26.2 20.1 30.2 23.3 38.5 19.5 19.1 75.7 20.6 24.6 28.1 23.3 15.5 22.4 27.3 49.3 23.0 21.4 28.7 39.8 24.3 23.1 14.7 29.6 31.4 27.8 21.1 20.4 29.4 27.1 12.7 10.2 23.0 12.5 14.2 17.7 7.7 8.2 5.8 18.8 13.2 15.8 19.8 15.4 16.0 15.7 13.4 12.5 10.7 21.8 10.4 9.1 16.1 14.3 18.3 14.9 17.0 22.2 8.1 20.9 12.9 11.6 24.1 22.5 10.1 20.7 19.9 11.6 14.9 20.0 15.1 10.5 19.4 9.8 18.9 19.6 18.4 7.7 14.3 17.5 10.3 16.5 10.4 7.3 15.8 11.6 12.8 22.8 13.5 26.4 15.9 8.5 8.7 7.7 8.0 8.0 8.4 8.5 9.7 15.8 12.6 23.0 8.6 19.7 12.4 9.6 17.0 12.7 14.4 12.4 7.7 11.4 17.7 15.2 15.4 14.2 12.5 10.2 13.3 7.7 22.8 28.0 43.4 34.0 23.7 18.8 30.2 23.3 24.6 29.6 NAA25 "C12orf30, FLJ13089" ENSG00000111300 "N(alpha)-acetyltransferase 25, NatB auxiliary subunit" Q14CX7 12 112026689-112109022 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039322 Approved Supported "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA039322: AB_10697548" "unprognostic (1.26e-1)" "unprognostic (1.31e-1)" "unprognostic (3.91e-2)" "prognostic unfavourable (2.26e-4)" "unprognostic (1.91e-1)" "unprognostic (6.87e-2)" "prognostic unfavourable (5.53e-5)" "unprognostic (9.09e-3)" "unprognostic (3.24e-2)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (8.34e-2)" "prognostic unfavourable (1.32e-8)" "unprognostic (2.44e-2)" "unprognostic (2.01e-1)" "unprognostic (9.34e-2)" "unprognostic (9.18e-2)" 12.8 11.4 12.7 12.3 19.3 18.4 14.9 21.0 17.0 10.4 11.7 17.9 11.2 8.3 18.1 10.3 14.7 11.3 8.5 10.7 11.6 10.7 8.0 10.2 9.0 12.9 21.7 12.4 15.8 15.1 14.3 13.5 11.4 16.3 11.7 9.4 15.6 9.5 10.5 25.9 15.7 8.8 11.9 16.7 10.3 9.2 10.8 17.9 8.7 12.5 10.8 14.2 10.2 12.1 4.7 5.5 0.5 3.6 2.3 7.0 2.5 10.4 10.4 9.8 7.5 5.4 9.5 11.8 9.9 8.0 12.5 8.3 10.9 5.4 18.3 9.9 7.9 12.6 21.9 8.2 16.7 10.4 15.0 14.9 10.6 9.6 9.1 21.0 9.3 8.3 10.4 14.2 14.4 10.6 21.7 2.3 11.1 8.6 12.3 15.8 15.1 12.5 13.5 10.0 12.6 9.4 17.5 12.5 6.9 11.4 12.9 9.4 12.8 8.6 8.5 10.1 9.2 11.2 13.6 9.7 18.6 21.5 13.3 9.4 9.9 0.0 2.7 0.5 4.0 3.1 6.1 4.1 4.7 3.6 5.4 4.7 7.0 6.5 0.1 2.3 3.6 5.5 3.6 2.5 12.7 19.3 21.0 17.0 11.6 10.7 21.7 12.4 16.3 17.9 NAALAD2 "GCPIII, NAALADASE2" ENSG00000077616 "N-acetylated alpha-linked acidic dipeptidase 2" Q9Y3Q0 11 90131515-90192894 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 44.1" "Group enriched" "Detected in some" 5 "CACO-2: 19.7;SH-SY5Y: 6.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 2.4" "Lineage enriched" "Detected in single" 12 "monocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060820, HPA065419" Approved Approved Nucleoplasm Nucleoplasm "HPA060820: , HPA065419: " "unprognostic (1.68e-1)" "unprognostic (2.66e-3)" "unprognostic (1.49e-1)" "unprognostic (4.52e-3)" "unprognostic (4.73e-3)" "unprognostic (2.97e-1)" "unprognostic (3.82e-3)" "unprognostic (1.77e-2)" "unprognostic (2.44e-1)" "unprognostic (2.30e-1)" "unprognostic (3.30e-2)" "unprognostic (8.00e-2)" "unprognostic (9.97e-4)" "unprognostic (1.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.63e-2)" "unprognostic (2.93e-1)" 7.7 13.0 5.3 1.8 9.9 1.1 3.1 2.1 9.8 7.8 2.1 3.7 2.8 1.3 10.3 5.4 1.8 4.7 3.7 2.5 5.5 7.4 2.7 1.7 2.8 1.6 6.5 5.0 12.9 2.5 0.9 44.1 8.8 11.9 5.2 2.2 5.8 1.9 3.7 2.1 1.5 2.1 3.5 6.2 4.4 1.8 16.6 7.4 0.0 1.7 1.7 1.2 1.8 3.8 0.0 0.1 0.0 2.4 0.0 0.1 0.1 0.1 0.2 1.9 0.1 0.6 0.1 2.4 0.1 0.1 0.1 0.0 19.7 0.7 0.3 0.2 0.0 0.3 1.4 0.0 0.0 0.0 0.4 1.8 0.4 1.7 0.2 0.1 0.1 2.3 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.3 1.9 0.2 0.3 0.0 0.2 0.0 0.0 0.2 6.6 0.0 0.2 0.0 0.2 0.4 2.5 0.1 1.6 0.4 0.3 1.1 0.3 0.3 0.7 0.3 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.1 0.1 5.3 9.9 2.1 9.8 5.5 7.4 6.5 5.0 11.9 7.4 NAALADL2 ENSG00000177694 "N-acetylated alpha-linked acidic dipeptidase like 2" Q58DX5 3 174438573-175810552 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 29.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.5;BJ hTERT+: 4.1;fHDF/TERT166: 4.8;WM-115: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA012413, HPA017425, CAB025586" Approved Enhanced Nucleoplasm Nucleoplasm "CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275" "unprognostic (7.28e-3)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (1.60e-1)" "unprognostic (2.56e-1)" "unprognostic (2.56e-1)" "unprognostic (2.29e-4)" "unprognostic (3.44e-3)" "unprognostic (5.70e-2)" "unprognostic (7.42e-2)" "unprognostic (7.85e-3)" "unprognostic (9.49e-2)" "unprognostic (3.66e-6)" "unprognostic (7.11e-2)" "unprognostic (1.48e-1)" "unprognostic (9.05e-2)" "unprognostic (2.22e-2)" 4.9 2.3 2.2 4.6 3.7 0.8 7.0 1.9 2.7 8.3 8.3 5.4 23.8 2.4 9.7 10.5 2.3 5.0 8.9 5.4 2.5 1.8 7.0 3.7 3.3 1.3 2.3 2.0 5.4 3.9 20.6 3.0 6.4 4.0 9.6 3.3 4.4 17.0 29.3 1.8 3.2 6.6 6.0 3.6 2.6 4.5 1.9 2.9 4.9 3.5 2.6 1.7 8.7 5.0 0.1 1.7 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.2 0.0 3.5 11.5 0.1 2.3 4.1 0.5 0.7 0.1 1.2 0.0 0.4 4.8 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 3.2 0.6 0.1 0.0 0.4 0.0 0.1 2.3 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.1 1.7 0.2 0.0 0.0 0.2 0.2 0.8 3.1 0.1 0.5 2.2 0.1 0.1 0.5 0.0 0.0 0.0 1.5 0.0 4.5 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.1 0.0 1.7 0.0 0.0 2.2 3.7 1.9 2.7 2.5 1.8 2.3 2.0 4.0 2.9 NAGPA "APAA, UCE" ENSG00000103174 "N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase" Q9UK23 16 5024844-5034141 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064055 Approved 3600000 "HPA064055: " "unprognostic (9.93e-2)" "unprognostic (1.61e-2)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (7.12e-3)" "unprognostic (3.30e-3)" "prognostic unfavourable (4.67e-4)" "unprognostic (1.05e-2)" "unprognostic (2.98e-2)" "unprognostic (1.35e-1)" "unprognostic (9.51e-3)" "unprognostic (9.41e-2)" "prognostic unfavourable (2.67e-5)" "unprognostic (1.26e-1)" "unprognostic (6.09e-2)" "unprognostic (7.47e-2)" "unprognostic (1.02e-1)" 8.3 6.3 9.9 9.0 20.1 8.7 4.7 4.7 25.0 6.8 8.5 4.6 5.8 11.4 6.2 4.7 6.1 4.8 5.6 5.0 15.3 5.3 7.2 7.6 7.6 9.1 5.0 9.5 4.2 7.3 7.6 4.9 6.8 6.6 4.9 5.1 4.0 6.0 6.2 6.7 8.5 9.2 5.5 4.4 10.9 12.4 2.7 5.5 4.3 5.1 2.6 5.6 6.0 4.4 9.5 26.5 5.1 20.9 5.1 9.9 9.7 1.5 5.9 1.0 6.4 2.5 3.3 6.7 4.4 7.9 5.8 7.3 4.9 12.3 0.6 5.6 6.0 4.6 2.7 4.9 1.7 7.2 8.3 2.1 3.8 31.8 8.2 5.3 9.3 5.0 5.1 3.8 1.7 9.0 6.8 8.8 3.5 6.7 2.4 14.2 3.1 6.3 6.4 2.4 11.6 3.7 2.3 2.6 3.5 3.5 8.8 9.0 6.0 6.5 6.6 6.4 4.6 14.8 3.3 4.8 3.7 1.4 3.0 8.1 5.3 1.2 20.9 5.1 9.9 18.2 7.9 9.5 9.8 8.8 26.5 8.3 8.1 7.4 0.6 5.1 11.7 6.8 8.7 9.7 9.9 20.1 4.7 25.0 15.3 5.3 5.0 9.5 6.6 5.5 NAT8L "FLJ37478, Hcml3" ENSG00000185818 "N-acetyltransferase 8 like" Q8N9F0 4 2059512-2069089 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 45.9;brain: 45.9;testis: 11.8" "Cell line enhanced" "Detected in many" "NB-4: 14.4;SCLC-21H: 18.6;SK-MEL-30: 14.8" "Group enriched" "Detected in many" 6 "endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 28 "dendritic cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040677 Approved Mitochondria Mitochondria "HPA040677: AB_10794745" "unprognostic (1.32e-2)" "unprognostic (8.62e-2)" "unprognostic (3.02e-3)" "prognostic unfavourable (1.01e-5)" "unprognostic (2.56e-1)" "unprognostic (2.63e-4)" "unprognostic (6.58e-2)" "unprognostic (1.79e-1)" "unprognostic (2.90e-2)" "unprognostic (4.54e-1)" "unprognostic (3.70e-2)" "unprognostic (7.06e-2)" "unprognostic (1.78e-3)" "unprognostic (7.24e-3)" "unprognostic (1.14e-2)" "unprognostic (2.10e-2)" "unprognostic (1.35e-2)" 45.9 2.0 23.5 1.3 28.3 1.2 7.9 16.4 45.9 1.2 1.5 7.4 0.3 1.3 1.6 2.8 1.3 2.4 1.3 2.1 20.8 12.9 8.2 1.2 1.2 1.4 16.4 12.6 1.4 3.9 1.2 5.6 1.3 12.8 2.4 1.3 1.2 3.8 3.2 7.3 2.4 1.5 1.4 6.5 1.5 1.6 11.8 8.2 0.0 1.6 0.0 1.2 1.2 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 6.5 3.6 7.2 0.7 0.0 4.1 0.1 0.0 0.2 0.0 2.9 0.2 0.0 1.3 0.0 0.1 8.0 0.0 0.1 0.0 9.4 0.1 1.4 4.6 1.2 9.9 4.9 0.0 0.1 0.0 0.0 0.0 7.7 0.0 0.2 4.3 0.1 14.4 10.1 2.9 0.5 1.7 0.2 0.1 0.3 18.6 6.2 4.7 0.0 14.8 0.5 5.8 0.0 0.0 2.4 0.1 3.8 0.0 0.0 0.1 0.0 4.2 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 23.5 28.3 16.4 32.7 20.8 12.9 16.4 12.6 12.8 8.2 NBAS NAG ENSG00000151779 "Neuroblastoma amplified sequence" A2RRP1 2 15166909-15561330 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036817 Approved Approved "Nuclear membrane,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nuclear membrane, Nucleoli" "HPA036817: AB_10670925" "unprognostic (1.72e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (2.45e-1)" "prognostic unfavourable (1.10e-4)" "unprognostic (3.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.33e-1)" "unprognostic (1.55e-1)" "unprognostic (1.53e-2)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-1)" "prognostic unfavourable (5.84e-5)" 16.8 18.1 23.2 16.3 30.9 21.9 22.5 21.5 28.3 21.9 17.1 20.6 17.4 13.3 27.1 23.4 14.1 18.7 13.5 21.6 20.9 21.5 19.1 16.9 15.4 16.3 19.3 20.8 24.1 28.6 34.1 35.5 16.2 24.9 16.9 17.7 16.8 22.9 19.0 26.5 23.4 20.5 21.0 18.1 18.1 19.0 31.4 16.7 23.8 20.1 14.6 20.0 14.4 15.2 5.3 6.0 3.2 8.7 9.4 9.9 3.6 5.4 7.2 8.0 5.5 20.9 23.0 8.2 10.1 11.1 7.9 8.0 7.2 7.9 7.0 2.3 15.3 6.6 8.6 12.7 9.4 6.9 5.5 26.6 6.4 20.1 21.5 6.9 13.6 15.1 10.1 10.4 17.5 16.2 20.6 8.0 12.0 6.7 5.7 15.5 6.9 6.9 6.0 14.0 8.3 16.3 7.4 4.7 7.7 8.6 7.1 12.7 5.0 6.3 14.0 10.0 6.2 7.1 7.3 12.0 10.2 9.9 17.8 8.1 8.9 1.4 5.7 3.2 7.6 3.9 9.5 5.3 5.9 9.9 5.2 5.1 5.9 6.1 1.0 9.4 8.7 6.0 6.9 3.6 23.2 30.9 21.5 28.3 20.9 21.5 19.3 20.8 24.9 16.7 NBEA "BCL8B, FLJ10197, KIAA1544, LYST2" ENSG00000172915 Neurobeachin Q8NFP9 13 34942287-35673022 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 41.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039730, HPA040385" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytosol" "HPA039730: AB_10794202, HPA040385: AB_10795523" "unprognostic (1.80e-2)" "unprognostic (2.90e-1)" "unprognostic (4.99e-2)" "unprognostic (3.89e-4)" "unprognostic (3.59e-1)" "unprognostic (2.04e-1)" "unprognostic (8.75e-2)" "unprognostic (6.95e-3)" "unprognostic (5.01e-1)" "unprognostic (7.43e-2)" "unprognostic (1.03e-3)" "unprognostic (2.45e-1)" "prognostic favourable (7.86e-8)" "unprognostic (2.28e-2)" "unprognostic (9.35e-2)" "unprognostic (1.17e-1)" "unprognostic (6.46e-2)" 3.9 11.9 12.2 2.7 20.6 1.0 8.2 32.6 28.5 7.4 9.8 3.9 10.9 2.7 10.3 6.2 6.2 9.4 5.4 11.7 13.5 10.6 6.6 1.7 3.6 2.6 6.9 22.2 10.4 5.7 9.3 25.0 1.5 14.2 11.9 4.8 13.3 7.0 14.2 8.5 2.0 3.8 11.4 4.7 5.1 4.8 7.7 6.0 6.1 9.6 0.7 2.4 7.1 6.4 1.1 1.3 0.0 0.5 0.4 1.4 0.1 0.0 2.3 5.4 3.0 0.4 0.0 0.1 3.4 5.3 4.0 3.3 0.0 0.5 1.4 0.0 5.8 0.1 1.8 0.7 8.5 0.7 1.8 0.0 1.6 0.5 0.3 0.9 2.2 0.9 0.6 0.0 0.4 0.7 0.0 9.7 0.5 1.0 0.5 0.0 2.3 0.9 0.6 2.3 0.4 4.6 1.0 3.1 41.2 2.5 0.0 1.7 0.9 0.2 0.0 1.0 0.6 0.0 0.7 0.9 0.2 0.7 2.6 0.3 2.1 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.1 0.2 0.0 1.1 1.4 1.3 0.0 0.4 0.0 1.3 0.0 0.1 12.2 20.6 32.6 18.4 13.5 10.6 6.9 22.2 14.2 6.0 NCAM1 "CD56, NCAM" ENSG00000149294 "Neural cell adhesion molecule 1" P13591 11 112961247-113278436 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 110.6;heart muscle: 67.7" "Cell line enhanced" "Detected in some" "HEL: 19.1;RH-30: 43.1;SCLC-21H: 35.1;SH-SY5Y: 17.2;U-138 MG: 24.0;WM-115: 25.4" "Cancer enriched" "Detected in many" 8 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 14 "NK-cell: 27.2" "Lineage enriched" "Detected in many" 14 "NK-cells: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000142, CAB018071, HPA039835" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" 2800000000 "Plasma membrane" Cytosol "CAB000142: , CAB018071: AB_627129, HPA039835: " "unprognostic (7.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.77e-2)" "unprognostic (2.18e-2)" "unprognostic (2.91e-1)" "unprognostic (1.74e-3)" "unprognostic (2.82e-1)" "unprognostic (4.42e-3)" "unprognostic (2.13e-1)" "unprognostic (1.63e-2)" "prognostic favourable (9.11e-6)" "unprognostic (8.13e-2)" "prognostic unfavourable (8.20e-4)" "unprognostic (2.97e-2)" "unprognostic (2.24e-1)" "unprognostic (3.75e-2)" "unprognostic (5.82e-5)" 3.5 36.4 22.7 3.0 35.7 1.8 2.1 20.2 110.6 13.3 9.0 55.8 0.3 3.4 24.7 3.0 4.8 8.3 3.6 67.7 22.5 19.2 2.3 2.6 2.0 1.7 45.0 27.1 21.9 2.3 1.1 9.1 1.4 38.8 8.4 4.6 5.5 2.5 10.9 14.6 1.8 5.3 25.6 27.6 3.4 6.7 2.9 39.2 0.0 16.9 0.7 1.7 7.0 6.5 0.0 0.0 0.4 0.1 27.2 2.0 0.9 0.0 0.0 6.7 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.4 0.1 0.1 0.9 6.0 6.3 0.1 0.0 0.0 0.0 0.1 3.8 19.1 0.0 0.0 0.7 0.0 3.1 4.1 0.0 0.0 6.1 0.0 0.0 0.3 6.7 0.0 0.0 1.6 0.5 0.1 0.0 43.1 3.1 0.0 0.0 35.1 17.2 0.0 0.1 0.0 0.0 0.2 0.0 24.0 11.2 0.1 10.0 0.0 0.1 0.0 2.7 9.0 25.4 0.0 0.1 0.0 2.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.4 27.2 0.0 0.0 0.1 0.9 22.7 35.7 20.2 41.6 22.5 19.2 45.0 27.1 38.8 39.2 NCEH1 "AADACL1, KIAA1363, NCEH" ENSG00000144959 "Neutral cholesterol ester hydrolase 1" Q6PIU2 3 172630249-172711218 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 69.4;LHCN-M2: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 15.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026888, HPA043873" Enhanced Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA026888: AB_10601557, HPA043873: " "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (5.74e-2)" "unprognostic (1.27e-1)" "unprognostic (6.88e-3)" "unprognostic (5.41e-2)" "unprognostic (3.29e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "prognostic unfavourable (8.25e-5)" "unprognostic (5.29e-2)" "unprognostic (2.96e-2)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (2.81e-2)" "unprognostic (2.28e-1)" 17.0 14.8 6.5 7.1 23.8 6.0 5.1 14.3 30.1 4.1 9.8 2.3 1.4 3.5 3.9 2.9 4.4 3.5 6.0 14.6 13.2 9.6 18.8 4.2 17.0 11.2 6.6 11.4 2.5 4.0 6.3 4.2 5.7 17.7 6.0 10.7 4.3 8.2 4.2 6.6 2.7 4.1 2.9 5.0 9.1 10.9 2.0 4.0 1.9 3.9 3.1 9.3 5.1 3.4 3.0 10.6 4.8 15.1 2.8 2.3 4.8 22.8 13.3 0.4 0.7 0.8 0.8 1.9 17.2 11.5 11.4 6.7 3.3 69.4 1.9 26.0 10.4 4.6 0.4 8.4 26.7 6.4 1.0 1.3 2.1 2.5 0.9 3.4 4.8 0.4 0.8 7.8 11.8 7.6 0.3 1.6 32.4 1.9 0.5 1.2 0.6 10.9 0.5 1.3 2.3 20.4 3.1 0.3 0.1 10.4 11.0 2.3 3.7 1.6 20.7 17.6 2.6 8.2 31.2 2.0 3.7 1.6 13.1 3.3 13.3 4.8 15.1 0.5 2.3 9.6 1.5 3.0 1.5 1.6 10.6 1.9 1.5 1.8 0.5 2.8 6.2 0.6 1.3 4.8 6.5 23.8 14.3 30.1 13.2 9.6 6.6 11.4 17.7 4.0 NCLN "NET59, NICALIN" ENSG00000125912 Nicalin Q969V3 19 3185563-3209575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006625 Approved Approved "Nucleoplasm,Lipid droplets" 12000 "Lipid droplets" Nucleoplasm "HPA006625: AB_1079453" "unprognostic (4.32e-2)" "unprognostic (1.88e-1)" "unprognostic (1.89e-1)" "prognostic favourable (1.19e-4)" "unprognostic (8.55e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (2.15e-4)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (9.38e-2)" "unprognostic (2.02e-2)" "unprognostic (1.26e-3)" "prognostic unfavourable (8.37e-5)" "prognostic favourable (8.82e-5)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" 15.8 27.4 10.2 18.2 15.3 31.1 10.2 21.2 23.6 9.3 20.4 14.7 14.9 32.9 12.7 7.2 14.1 11.0 15.5 10.5 12.2 8.5 13.3 48.3 15.5 19.8 9.7 9.0 12.1 41.3 9.5 11.5 11.3 10.8 13.3 9.7 13.0 18.7 9.9 16.3 14.9 27.8 9.5 8.0 20.6 18.9 17.2 12.1 11.8 11.8 11.8 13.2 9.4 11.8 5.3 17.8 8.8 12.2 4.3 7.7 7.1 27.1 31.8 7.9 24.6 7.8 6.5 20.6 30.0 12.6 22.6 18.4 43.1 15.8 16.5 26.1 19.7 32.3 9.4 22.8 5.0 21.5 21.5 11.5 19.6 29.3 15.6 20.5 21.5 11.3 14.5 18.2 9.9 12.5 29.4 18.5 10.3 24.1 17.8 21.9 22.4 22.5 28.7 8.4 26.2 13.3 18.7 17.1 16.9 12.1 22.6 19.0 16.4 23.6 16.9 19.7 17.1 32.0 36.2 23.2 21.0 12.7 20.7 26.3 30.1 1.1 11.9 8.8 6.9 12.2 6.1 5.3 4.2 7.7 8.7 4.4 4.6 6.1 7.3 4.3 4.9 17.8 3.8 7.1 10.2 15.3 21.2 23.6 12.2 8.5 9.7 9.0 10.8 12.1 NCMAP "C1orf130, FLJ42528, MP11" ENSG00000184454 "Non-compact myelin associated protein" Q5T1S8 1 24556111-24609328 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 28.8;placenta: 21.2" "Cell line enhanced" "Detected in some" "A549: 4.0;RPTEC TERT1: 3.3;T-47d: 7.9;U-266/70: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013656 Uncertain "HPA013656: AB_2275006" "unprognostic (3.38e-2)" "unprognostic (3.52e-2)" "unprognostic (2.79e-1)" "prognostic favourable (2.83e-6)" "unprognostic (3.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (4.14e-1)" "unprognostic (1.73e-1)" "unprognostic (2.41e-2)" "unprognostic (1.04e-1)" "unprognostic (3.28e-3)" "unprognostic (9.88e-2)" "unprognostic (9.53e-2)" "unprognostic (1.63e-2)" "unprognostic (7.27e-3)" 0.6 0.2 0.6 0.5 0.7 0.6 4.6 0.2 0.7 1.3 7.0 1.3 0.0 6.3 0.5 1.8 0.5 1.1 15.0 0.5 0.8 0.6 2.2 5.8 4.7 0.2 1.0 0.1 0.2 28.8 0.0 9.1 21.2 0.8 2.1 0.2 1.3 13.4 0.0 0.6 0.6 7.5 0.2 2.2 0.3 5.7 0.2 1.1 0.2 5.3 0.7 1.4 0.9 0.3 1.4 1.0 2.7 0.9 0.7 0.8 0.1 0.2 4.0 0.1 0.1 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.2 1.7 0.4 1.0 0.0 0.3 0.6 0.0 0.0 0.2 0.1 0.4 0.3 1.9 0.0 0.2 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.5 0.0 0.4 0.2 0.4 0.2 0.0 0.4 0.1 1.1 3.3 1.0 0.4 0.3 0.2 0.3 0.0 7.9 0.2 0.5 0.2 0.3 0.5 0.2 6.3 0.8 0.1 0.1 0.2 0.3 2.7 0.9 0.6 0.5 0.3 0.4 0.8 0.5 0.4 0.2 1.4 0.7 0.8 2.0 0.7 0.4 1.0 0.3 0.1 0.6 0.7 0.2 0.7 0.8 0.6 1.0 0.1 0.8 1.1 NCR1 "CD335, LY94, NK-p46, NKP46" ENSG00000189430 "Natural cytotoxicity triggering receptor 1" O76036 19 54906150-54916140 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 5.5;lymphoid tissue: 13.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA049311 Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA049311: " "unprognostic (3.92e-2)" "unprognostic (2.21e-3)" "unprognostic (1.67e-1)" "unprognostic (2.87e-4)" "unprognostic (2.89e-1)" "unprognostic (6.32e-4)" "unprognostic (2.22e-2)" "unprognostic (3.29e-1)" "unprognostic (1.07e-1)" "unprognostic (1.89e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-5)" "unprognostic (1.82e-2)" "unprognostic (5.92e-2)" "unprognostic (3.81e-3)" "unprognostic (6.05e-3)" 1.4 0.2 0.1 3.7 0.4 2.1 0.3 0.1 0.3 0.3 2.1 0.0 0.5 0.1 1.2 1.3 0.3 0.2 2.1 1.9 0.2 0.2 0.3 2.5 5.5 3.8 0.2 0.0 0.2 0.1 0.1 0.2 0.4 0.0 0.6 0.2 1.0 0.4 0.1 0.3 0.5 3.4 1.2 0.2 13.9 0.3 0.4 0.0 2.0 0.3 0.1 2.6 0.7 0.3 0.2 0.2 1.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.2 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.4 0.1 0.3 0.2 0.2 0.2 0.0 0.0 0.0 NCR2 "CD336, LY95, NK-p44" ENSG00000096264 "Natural cytotoxicity triggering receptor 2" O95944 6 41335655-41350887 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.5;intestine: 3.3;lymphoid tissue: 3.7" "Cell line enhanced" "Detected in some" "HMC-1: 1.7;MOLT-4: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "NK-cell: 2.5;plasmacytoid DC: 8.5" "Group enriched" "Detected in many" 13 "dendritic cells: 8.5;NK-cells: 2.5" HPA067249 Uncertain "HPA067249: " "unprognostic (5.81e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.12e-2)" "unprognostic (1.65e-1)" 0.1 0.1 0.1 1.9 0.1 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 2.8 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.2 0.0 0.1 2.5 0.1 0.0 0.6 0.1 0.3 0.0 1.2 0.1 1.7 3.7 0.0 0.1 0.0 8.5 0.0 0.0 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 8.5 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NCR3LG1 "B7-H6, DKFZp686O24166" ENSG00000188211 "Natural killer cell cytotoxicity receptor 3 ligand 1" Q68D85 11 17351726-17377341 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9;parathyroid gland: 15.4" "Cell line enhanced" "Detected in many" "HL-60: 28.8;K-562: 16.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.5" "Lineage enriched" "Detected in single" 4 "T-cells: 2.5" HPA024137 Uncertain 7300 "HPA024137: AB_1859534" "unprognostic (1.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.52e-2)" "unprognostic (1.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.05e-1)" "unprognostic (7.03e-5)" "unprognostic (6.24e-2)" "unprognostic (1.09e-1)" "unprognostic (3.59e-1)" "unprognostic (2.62e-1)" "unprognostic (2.36e-1)" "prognostic favourable (4.21e-12)" "unprognostic (7.88e-3)" "unprognostic (1.72e-1)" "unprognostic (3.52e-3)" "unprognostic (1.36e-1)" 2.4 1.4 1.6 2.2 9.4 3.1 1.4 14.9 14.1 1.7 6.2 1.1 0.0 8.1 2.1 1.1 2.0 3.5 2.4 2.4 1.9 2.9 5.0 1.3 2.7 1.1 1.5 5.3 3.2 2.2 15.4 7.9 0.9 4.3 1.5 9.6 3.6 2.0 1.4 1.2 2.0 10.1 2.1 1.2 1.3 2.4 4.2 0.4 0.4 4.9 1.0 1.4 1.6 2.1 0.0 0.3 0.0 0.6 0.0 2.5 0.1 2.1 0.7 4.9 0.7 1.7 4.7 0.3 1.5 2.9 2.1 5.1 3.9 0.8 12.2 0.2 1.7 2.2 8.0 2.0 1.7 2.1 13.3 11.1 5.1 3.9 7.2 28.8 0.5 3.8 1.0 3.0 7.3 2.3 16.3 0.0 0.7 0.2 2.7 2.5 0.2 1.2 0.9 2.6 0.1 1.7 0.7 5.3 2.0 1.7 0.4 1.5 1.2 6.4 3.3 0.4 0.7 1.2 0.8 1.3 2.4 14.1 2.2 9.7 1.0 0.0 0.6 0.0 0.6 0.3 2.5 0.0 0.1 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.1 1.6 9.4 14.9 14.1 1.9 2.9 1.5 5.3 4.3 0.4 NCSTN "APH2, KIAA0253" ENSG00000162736 Nicastrin Q92542 1 160343272-160358952 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021982, HPA054846, HPA070642" Approved Approved Cytosol 120000 Cytosol "CAB021982: , HPA054846: , HPA070642: " "unprognostic (1.08e-1)" "unprognostic (5.22e-3)" "unprognostic (1.51e-1)" "unprognostic (2.89e-2)" "unprognostic (1.19e-2)" "unprognostic (2.22e-2)" "unprognostic (1.69e-3)" "unprognostic (2.89e-1)" "unprognostic (3.30e-2)" "unprognostic (3.62e-2)" "unprognostic (8.21e-2)" "unprognostic (2.06e-2)" "prognostic unfavourable (7.75e-9)" "unprognostic (1.36e-3)" "unprognostic (3.15e-1)" "unprognostic (3.14e-2)" "unprognostic (4.89e-2)" 25.6 23.8 12.7 15.3 20.9 12.8 23.3 15.8 24.3 21.8 24.1 39.0 16.5 31.7 24.1 23.3 23.3 19.9 19.5 23.7 13.8 13.9 25.3 37.8 24.7 19.8 28.2 14.2 29.5 41.3 38.9 21.8 63.3 21.5 18.5 24.6 25.1 49.2 19.6 24.2 20.2 38.5 20.7 25.4 25.8 21.4 22.4 22.8 20.3 25.9 13.6 20.6 26.1 20.1 12.5 28.8 27.0 30.5 13.1 11.1 16.8 10.5 12.9 22.3 18.2 68.3 34.6 24.6 21.6 39.6 21.0 24.7 10.0 30.9 7.8 45.0 44.2 17.9 10.1 20.6 17.8 12.3 8.8 7.4 16.0 15.1 27.1 15.9 33.9 35.1 20.5 20.0 20.9 30.7 13.6 22.3 29.9 7.4 5.6 8.3 18.2 7.2 7.7 13.7 21.8 29.4 14.6 7.4 16.8 23.3 26.6 15.8 23.8 39.7 24.7 15.7 10.3 10.9 16.4 28.9 40.9 7.7 24.6 10.1 28.7 17.8 29.9 25.0 11.1 30.5 10.4 12.5 9.5 9.5 28.8 11.2 9.9 9.4 27.0 13.1 27.9 16.9 10.0 16.8 12.7 20.9 15.8 24.3 13.8 13.9 28.2 14.2 21.5 22.8 NDN "HsT16328, PWCR" ENSG00000182636 "Necdin, MAGE family member" Q99608 15 23685400-23687330 "Plasma proteins, Predicted membrane proteins" "Growth regulation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 20.7;ASC diff: 20.4;HSkMC: 27.5;NTERA-2: 16.5;U-2 OS: 30.8;U-266/70: 19.5;U-266/84: 18.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.5;plasmacytoid DC: 4.3" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074457 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA074457: " "unprognostic (3.49e-1)" "unprognostic (1.65e-1)" "unprognostic (4.20e-1)" "unprognostic (2.19e-2)" "unprognostic (2.71e-1)" "unprognostic (9.04e-2)" "unprognostic (6.79e-2)" "unprognostic (3.51e-1)" "unprognostic (3.11e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (4.05e-2)" "prognostic unfavourable (4.52e-4)" "unprognostic (1.89e-2)" "unprognostic (8.10e-2)" "unprognostic (1.96e-1)" "unprognostic (6.81e-2)" 29.9 35.5 19.2 7.7 39.1 1.3 25.0 2.6 28.2 32.7 12.9 12.9 8.1 8.0 29.9 17.7 12.3 21.4 19.1 20.3 18.1 40.3 6.9 3.0 10.3 8.9 14.8 17.6 50.7 7.1 2.1 23.2 22.4 19.0 18.8 8.1 16.5 9.2 29.3 9.2 4.7 8.4 23.5 11.8 11.8 8.6 16.4 7.3 7.1 8.4 8.7 4.9 13.1 17.3 0.0 4.3 0.0 0.8 0.4 0.0 0.0 0.0 0.0 20.7 0.0 20.4 7.8 0.0 13.1 0.0 0.3 3.6 0.0 0.0 0.0 0.0 3.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 12.0 27.5 0.0 3.8 0.0 0.0 0.4 0.0 6.7 0.0 9.8 0.0 16.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 3.5 0.0 0.0 1.0 30.8 0.0 0.0 19.5 18.1 0.0 2.1 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.6 4.3 0.0 0.0 19.2 39.1 2.6 28.2 18.1 40.3 14.8 17.6 19.0 7.3 NDRG2 "KIAA1248, SYLD" ENSG00000165795 "NDRG family member 2" Q9UN36 14 21016763-21070872 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 310.5;skeletal muscle: 253.0" "Cell line enhanced" "Detected in many" "Hep G2: 27.9;HMC-1: 20.0" "Cancer enhanced" "Detected in all" "glioma: 78.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "myeloid DC: 54.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 54.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002896, HPA003590, CAB017491" Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" 150000 "Centriolar satellite" "Nucleoplasm, Cytosol" "CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458" "unprognostic (9.27e-3)" "unprognostic (2.97e-3)" "unprognostic (1.26e-2)" "unprognostic (5.09e-3)" "unprognostic (2.00e-2)" "unprognostic (2.92e-2)" "prognostic favourable (6.71e-4)" "unprognostic (1.85e-3)" "unprognostic (5.57e-2)" "unprognostic (3.46e-2)" "unprognostic (1.69e-1)" "unprognostic (5.10e-2)" "prognostic favourable (1.43e-12)" "unprognostic (1.46e-1)" "unprognostic (5.56e-2)" "unprognostic (6.11e-2)" "unprognostic (4.19e-2)" 19.3 45.3 140.2 4.8 135.1 1.4 50.3 93.5 110.0 35.5 21.0 89.6 23.8 12.2 30.7 44.4 37.3 29.5 21.5 45.2 103.6 86.1 24.3 84.8 13.7 7.7 128.9 73.5 79.7 15.5 35.6 6.0 8.1 95.4 23.7 18.8 8.9 310.5 37.3 253.0 18.9 12.0 22.0 73.0 21.1 11.2 5.2 71.2 0.4 13.6 53.4 16.1 13.9 19.3 1.8 54.5 0.4 1.8 0.7 5.4 4.0 5.3 1.1 3.4 6.4 0.5 0.0 0.5 0.1 2.2 2.0 1.1 7.4 10.0 0.3 2.0 0.1 8.8 15.4 3.1 2.7 0.0 5.5 6.9 1.2 27.9 0.7 0.6 20.0 6.1 6.7 0.4 0.9 0.0 13.9 0.6 0.3 4.6 2.4 1.9 9.1 0.4 7.1 0.3 1.6 3.8 13.6 0.0 9.9 1.5 1.7 7.0 13.5 4.0 0.0 0.6 10.9 0.2 0.2 3.1 2.2 0.1 0.9 0.1 2.3 0.0 1.8 0.2 2.4 0.4 3.2 1.8 3.6 3.3 54.5 1.3 5.4 4.0 0.4 0.7 0.0 1.9 2.4 4.0 140.2 135.1 93.5 110.0 103.6 86.1 128.9 73.5 95.4 71.2 NDRG4 "KIAA1180, SMAP-8" ENSG00000103034 "NDRG family member 4" Q9ULP0 16 58462846-58513628 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6" "Cell line enhanced" "Detected in many" "EFO-21: 19.0;HUVEC TERT2: 12.1;SCLC-21H: 28.7" "Cancer enriched" "Detected in many" 6 "glioma: 23.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015313, HPA017587" Enhanced Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA015313: AB_1854343, HPA017587: AB_1854344" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" "unprognostic (9.03e-3)" "unprognostic (1.59e-2)" "unprognostic (3.97e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (6.07e-2)" "unprognostic (1.02e-1)" "unprognostic (4.84e-3)" "unprognostic (5.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.22e-2)" "unprognostic (8.51e-2)" "unprognostic (4.45e-2)" "unprognostic (7.17e-2)" 3.6 59.2 28.7 2.9 49.4 1.6 2.3 65.4 134.1 3.8 3.5 11.0 15.6 3.4 10.2 5.1 10.0 3.9 3.4 112.6 30.5 32.0 2.3 1.9 6.5 3.4 33.7 35.4 2.1 2.6 10.8 11.6 2.6 81.2 2.1 3.2 8.7 2.9 18.2 5.3 3.9 3.2 8.7 11.7 11.7 2.6 19.9 7.4 0.0 2.6 0.3 3.5 2.7 8.0 1.5 0.1 0.2 0.0 0.1 0.9 0.2 0.1 9.6 9.2 1.8 0.2 1.7 0.7 3.0 4.7 1.4 0.9 3.6 2.5 0.2 19.0 2.3 0.8 0.7 0.5 1.3 0.0 1.9 0.4 1.6 2.6 2.6 0.1 0.1 2.1 0.2 0.9 0.0 12.1 0.1 0.1 1.3 2.4 0.9 0.1 0.8 7.1 0.2 2.5 0.2 0.4 6.0 28.7 10.8 0.3 0.8 0.1 0.3 0.1 4.3 1.2 3.6 0.3 0.4 0.5 0.2 3.1 6.6 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.2 28.7 49.4 65.4 63.4 30.5 32.0 33.7 35.4 81.2 7.4 NDST1 "HSST, NST1" ENSG00000070614 "N-deacetylase and N-sulfotransferase 1" P52848 5 150485818-150558211 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Multifunctional enzyme, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "dendritic cells: 5.5;granulocytes: 7.2;monocytes: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060532 Approved 1000000 "HPA060532: " "unprognostic (1.36e-1)" "unprognostic (5.54e-3)" "unprognostic (1.48e-1)" "prognostic unfavourable (6.99e-4)" "unprognostic (1.77e-1)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.47e-2)" "unprognostic (2.73e-1)" "prognostic unfavourable (5.13e-4)" "unprognostic (4.97e-3)" "unprognostic (6.92e-2)" "unprognostic (7.45e-2)" "unprognostic (2.46e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.08e-2)" 26.3 15.5 17.3 9.9 20.2 4.9 21.3 8.6 28.3 12.9 10.2 41.7 7.3 9.3 11.8 10.0 25.5 11.0 16.9 19.6 17.9 14.4 11.4 49.2 25.2 6.1 28.5 13.8 17.3 28.9 16.5 4.7 10.0 26.1 11.3 7.3 10.8 25.4 13.5 15.3 24.9 14.7 14.3 32.8 30.1 10.2 12.6 19.6 1.4 17.3 11.9 9.8 10.5 11.5 0.6 5.5 7.2 6.5 0.1 0.6 2.9 9.8 8.7 14.6 17.7 14.7 14.7 14.7 18.1 23.8 18.1 27.2 25.8 10.4 6.7 18.4 36.0 16.9 7.8 36.7 12.1 0.8 12.2 7.9 5.7 4.0 10.9 5.9 14.5 20.0 15.3 21.8 9.9 24.6 7.5 2.4 17.6 8.3 0.7 1.8 6.8 10.4 11.4 12.2 2.9 10.6 10.0 4.4 15.4 10.9 34.3 14.5 18.3 1.4 12.0 31.0 28.1 13.4 14.8 5.4 1.4 2.5 25.4 9.2 11.9 1.7 6.5 4.4 0.1 2.3 0.0 0.6 0.0 0.6 5.5 0.1 0.1 0.2 7.2 0.1 5.5 0.4 0.0 2.9 17.3 20.2 8.6 28.3 17.9 14.4 28.5 13.8 26.1 19.6 NDST2 "HSST2, NST2" ENSG00000166507 "N-deacetylase and N-sulfotransferase 2" P52849 10 73801911-73811798 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 50.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA051515 Approved Approved Cytosol 72000 Cytosol "HPA051515: " "unprognostic (8.84e-2)" "unprognostic (7.57e-2)" "unprognostic (2.53e-2)" "unprognostic (9.43e-3)" "unprognostic (5.69e-1)" "unprognostic (1.07e-2)" "unprognostic (5.83e-3)" "unprognostic (2.16e-2)" "unprognostic (8.19e-2)" "unprognostic (1.61e-2)" "unprognostic (2.23e-5)" "unprognostic (1.49e-2)" "unprognostic (4.08e-7)" "unprognostic (3.71e-2)" "unprognostic (3.69e-2)" "unprognostic (5.93e-2)" "unprognostic (9.06e-2)" 12.6 14.6 7.9 19.2 11.3 37.5 11.8 30.2 12.2 16.6 10.7 13.8 13.4 8.9 18.4 14.8 14.4 12.8 15.5 9.3 9.6 8.4 11.0 9.4 14.7 21.9 7.3 8.8 15.1 12.3 17.3 26.5 14.1 9.2 13.6 10.5 14.7 20.1 17.2 16.4 15.1 14.4 13.4 7.5 31.8 11.8 13.5 9.2 35.3 12.2 8.2 19.3 12.3 13.3 3.1 6.8 5.8 5.3 2.2 7.1 3.2 4.3 3.6 7.4 11.4 9.2 10.6 3.8 5.0 10.8 5.8 6.0 1.9 5.3 3.9 3.1 9.6 5.0 3.6 5.3 4.8 10.3 3.6 3.9 2.7 3.0 16.2 4.9 50.2 10.1 6.5 10.1 10.4 7.6 3.6 14.9 7.4 3.3 5.8 5.5 2.1 15.2 3.5 3.7 2.4 5.0 3.0 2.5 4.2 4.5 10.6 3.5 8.1 7.6 12.2 2.9 3.5 3.9 3.6 7.5 3.3 5.1 3.4 7.6 2.3 1.4 5.3 2.1 5.5 3.7 6.5 2.5 4.7 4.8 4.0 3.1 5.6 7.1 5.8 2.2 3.5 6.8 3.1 3.2 7.9 11.3 30.2 12.2 9.6 8.4 7.3 8.8 9.2 9.2 NDUFA1 "CI-MWFE, MWFE" ENSG00000125356 "NADH:ubiquinone oxidoreductase subunit A1" O15239 X 119871487-119876662 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 144.8;skeletal muscle: 138.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029768, HPA054359" Enhanced Supported Mitochondria,Cytosol Mitochondria Cytosol "HPA029768: , HPA054359: " "unprognostic (1.72e-1)" "unprognostic (3.00e-3)" "unprognostic (3.12e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (7.34e-3)" "unprognostic (1.56e-1)" "unprognostic (8.20e-3)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (8.11e-3)" "unprognostic (4.77e-2)" "prognostic favourable (3.48e-4)" "unprognostic (1.16e-1)" "unprognostic (3.62e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-3)" 24.5 30.1 37.9 20.1 42.5 25.2 23.8 27.9 37.8 19.7 38.4 8.7 27.3 41.0 13.5 25.8 21.6 15.9 24.8 144.8 30.1 28.5 46.0 40.2 21.1 22.2 34.6 32.8 14.6 40.4 22.7 21.7 15.4 29.5 17.9 31.1 15.5 38.4 29.6 138.8 12.1 34.6 19.3 31.5 17.1 28.1 7.7 21.1 9.2 16.2 67.4 16.7 14.0 14.9 66.3 90.5 96.3 85.7 49.8 75.5 73.8 34.5 37.3 26.7 28.4 32.2 20.4 33.4 27.3 24.9 19.2 23.9 20.8 28.9 28.1 42.1 28.5 33.4 37.4 26.2 22.0 38.9 51.7 29.2 68.1 46.7 25.0 44.6 32.5 33.2 35.7 20.4 15.9 23.8 15.8 43.8 26.3 61.1 31.7 42.3 39.4 66.7 32.1 25.4 84.6 57.8 49.2 19.5 25.7 56.1 69.6 37.4 17.6 52.6 30.6 16.4 16.6 34.0 53.2 40.4 50.0 36.8 29.7 53.0 20.2 96.3 79.0 91.6 60.2 80.4 57.1 66.3 67.1 62.8 84.0 52.7 56.1 65.7 94.6 49.8 85.7 90.5 75.5 73.8 37.9 42.5 27.9 37.8 30.1 28.5 34.6 32.8 29.5 21.1 NDUFA13 "B16.6, CDA016, CGI-39, GRIM-19, GRIM19" ENSG00000186010 "NADH:ubiquinone oxidoreductase subunit A13" Q9P0J0 19 19515736-19529054 "Disease related genes, Predicted membrane proteins" "Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 116.3;testis: 140.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041213 Supported Supported Mitochondria Mitochondria "HPA041213: AB_10794988" "unprognostic (2.87e-1)" "unprognostic (2.88e-3)" "unprognostic (9.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-2)" "unprognostic (5.78e-2)" "unprognostic (6.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.81e-1)" "unprognostic (1.83e-3)" "unprognostic (1.26e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-2)" "unprognostic (1.33e-1)" "unprognostic (2.37e-1)" "unprognostic (2.15e-2)" "unprognostic (2.15e-2)" 17.9 16.9 20.0 11.7 23.9 15.4 14.4 20.7 25.2 11.0 19.2 8.7 16.5 16.5 9.7 19.6 12.2 11.7 12.9 68.0 16.4 13.9 18.9 20.8 8.4 11.9 19.9 22.3 10.6 17.8 10.6 12.1 12.1 20.0 12.9 11.9 9.8 15.2 15.5 79.7 9.5 14.9 12.1 13.4 10.1 15.0 140.2 16.2 7.6 11.3 28.1 8.4 9.6 10.2 73.7 74.9 61.4 76.8 44.8 72.7 116.3 33.7 24.9 46.0 45.8 47.0 38.2 43.2 40.2 44.5 45.3 44.3 40.3 50.7 44.9 94.6 48.5 27.4 32.6 43.6 18.7 27.4 73.7 34.3 39.7 49.4 42.1 64.4 48.4 51.2 39.7 31.8 36.7 32.6 37.8 64.3 36.0 67.1 76.4 64.0 46.9 69.4 43.9 29.9 68.6 66.1 48.5 43.8 55.4 40.9 48.2 40.0 29.8 88.7 33.9 44.5 15.1 51.8 49.9 45.8 36.0 48.3 39.2 50.0 32.4 61.4 76.8 57.8 51.2 72.9 45.5 73.7 58.9 56.0 74.9 60.5 56.9 51.1 26.9 44.8 60.8 61.2 72.7 116.3 20.0 23.9 20.7 25.2 16.4 13.9 19.9 22.3 20.0 16.2 NDUFA3 B9 ENSG00000170906 "NADH:ubiquinone oxidoreductase subunit A3" O95167 19 54102728-54109257 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046976 Supported "HPA046976: AB_10960994" "unprognostic (3.04e-2)" "unprognostic (4.12e-3)" "unprognostic (9.53e-2)" "unprognostic (5.95e-2)" "unprognostic (6.73e-2)" "unprognostic (3.14e-2)" "unprognostic (3.91e-1)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.00e-2)" "prognostic favourable (9.65e-4)" "unprognostic (9.91e-2)" "unprognostic (3.24e-3)" "unprognostic (7.79e-2)" "unprognostic (1.33e-1)" "unprognostic (7.24e-2)" "prognostic favourable (4.80e-4)" 17.7 20.8 47.4 15.4 50.9 21.8 22.0 17.3 36.5 12.8 22.6 13.7 21.5 31.8 11.7 25.1 15.8 17.1 20.0 66.1 40.9 33.1 29.7 37.2 20.8 26.9 43.3 31.1 12.9 34.0 22.2 25.5 12.3 29.5 15.9 25.8 13.9 27.0 24.7 95.7 42.4 27.6 15.7 26.8 14.7 23.7 32.6 19.6 16.1 19.5 34.7 16.6 16.3 15.1 20.9 27.3 21.7 16.7 17.1 16.4 18.8 6.6 5.8 5.8 8.0 7.7 7.1 4.6 5.7 6.3 4.6 5.2 7.4 4.9 5.3 3.9 5.0 4.2 4.6 11.0 2.1 8.0 24.2 5.9 7.8 8.2 5.5 6.6 2.4 4.5 10.9 4.0 5.3 8.3 3.2 3.8 4.7 21.5 6.1 7.7 4.9 11.2 2.7 3.1 11.2 3.4 16.8 9.6 5.1 5.3 12.8 3.1 14.9 6.5 7.4 6.1 3.0 2.6 9.3 5.9 4.4 3.1 6.7 6.2 2.9 17.2 16.3 21.7 15.0 16.7 15.0 20.9 15.5 15.6 15.8 19.8 16.3 16.4 15.9 17.1 13.7 27.3 15.4 18.8 47.4 50.9 17.3 36.5 40.9 33.1 43.3 31.1 29.5 19.6 NDUFA4 "CI-9k, MLRQ" ENSG00000189043 "NDUFA4, mitochondrial complex associated" O00483 7 10931951-10940256 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.9;skeletal muscle: 151.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055323 Supported Mitochondria 18000 Mitochondria "HPA055323: " "unprognostic (1.83e-1)" "unprognostic (6.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (2.16e-1)" "unprognostic (4.97e-3)" "unprognostic (3.85e-1)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.90e-2)" "unprognostic (8.65e-3)" "unprognostic (1.74e-1)" "prognostic favourable (4.61e-8)" "unprognostic (1.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-3)" "unprognostic (2.08e-1)" 21.9 22.0 72.8 13.6 55.3 19.8 27.0 33.1 74.4 20.5 18.3 12.0 16.8 25.1 16.9 29.6 15.8 20.2 16.7 149.9 56.1 32.1 46.2 46.7 15.9 13.5 47.6 48.9 17.1 23.7 18.9 5.6 11.4 33.0 23.1 20.4 14.1 36.0 31.1 151.6 12.1 17.3 21.4 26.3 13.6 23.6 7.4 23.2 6.8 20.4 60.1 15.6 15.8 11.6 29.0 41.1 52.8 39.6 21.7 37.5 48.0 12.6 21.8 37.2 42.7 21.1 19.8 17.1 16.1 15.3 15.1 13.3 27.3 34.8 24.7 15.3 23.1 22.4 24.7 19.1 16.5 12.2 18.0 20.7 25.6 25.4 18.4 28.5 20.4 21.3 19.3 18.5 16.4 21.0 30.7 33.6 31.5 24.4 12.7 25.1 40.7 44.2 17.3 26.5 27.7 38.3 27.5 23.3 24.2 25.5 73.5 14.5 46.4 35.0 18.3 18.1 24.9 25.9 26.5 20.4 26.1 28.3 24.9 30.9 56.0 52.8 32.5 44.4 23.4 38.6 27.4 29.0 32.7 29.3 41.1 22.0 34.1 29.7 7.4 21.7 39.6 38.5 37.5 48.0 72.8 55.3 33.1 74.4 56.1 32.1 47.6 48.9 33.0 23.2 NDUFA4L2 "FLJ26118, NUOMS" ENSG00000185633 "NDUFA4, mitochondrial complex associated like 2" Q9NRX3 12 57234903-57240715 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 82.5;skin 1: 93.4" "Cell line enriched" "Detected in many" 7 "AN3-CA: 54.1" "Cancer enhanced" "Detected in all" "renal cancer: 356.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4;T-reg: 2.8" "Group enriched" "Detected in many" 24 "B-cells: 2.4;T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055323 Approved Mitochondria Mitochondria "HPA055323: " "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (2.11e-3)" "unprognostic (3.23e-3)" "unprognostic (5.06e-2)" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (3.53e-1)" "unprognostic (6.67e-2)" "unprognostic (5.79e-2)" "unprognostic (2.13e-1)" "unprognostic (2.89e-1)" "prognostic unfavourable (1.37e-5)" "unprognostic (9.10e-3)" "unprognostic (1.31e-1)" "unprognostic (6.41e-2)" "unprognostic (2.74e-2)" 24.5 9.6 8.3 4.9 15.5 1.3 11.5 7.7 10.4 19.1 4.4 8.3 1.1 4.6 4.6 5.4 82.5 3.6 11.0 30.9 9.8 7.3 5.4 4.2 12.7 4.6 10.9 10.7 6.1 6.7 4.6 6.2 42.7 13.2 6.8 2.4 13.7 10.3 7.4 19.0 93.4 4.7 5.6 5.6 29.9 4.3 3.0 8.9 0.7 12.0 14.8 11.9 10.2 31.4 2.4 0.1 0.0 0.0 0.0 2.8 0.3 0.3 0.5 0.1 54.1 2.2 1.3 0.1 0.8 0.6 0.2 0.5 0.0 0.6 2.1 2.3 0.8 0.4 0.3 0.4 0.0 1.1 0.1 0.2 0.1 0.0 7.8 1.6 0.8 5.0 1.0 0.1 1.9 0.0 0.2 2.9 0.1 1.0 0.4 0.0 0.1 0.9 0.8 0.4 4.1 0.0 0.0 2.9 1.0 0.1 0.1 1.8 0.6 5.7 0.2 0.5 0.0 0.4 0.2 4.1 1.3 0.9 2.0 3.8 0.3 0.0 0.0 0.0 0.6 0.0 0.0 2.4 0.7 0.0 0.1 0.4 1.1 0.0 0.0 0.0 0.0 0.0 2.8 0.3 8.3 15.5 7.7 10.4 9.8 7.3 10.9 10.7 13.2 8.9 NDUFA9 "CI-39k, NDUFS2L, SDR22E1" ENSG00000139180 "NADH:ubiquinone oxidoreductase subunit A9" Q16795 12 4649095-4694317 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042268, HPA073212" Supported Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA042268: AB_2677922, HPA073212: " "unprognostic (2.26e-1)" "unprognostic (7.85e-3)" "unprognostic (3.67e-2)" "unprognostic (1.84e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (9.64e-3)" "unprognostic (3.02e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (3.45e-2)" "unprognostic (1.16e-1)" "prognostic favourable (2.57e-7)" "unprognostic (7.80e-2)" "unprognostic (1.71e-1)" "unprognostic (1.93e-2)" "prognostic favourable (5.75e-4)" 10.7 13.2 11.0 10.1 17.8 21.2 11.7 15.3 20.7 9.2 22.1 12.0 8.6 20.9 10.1 11.0 13.4 8.4 8.5 41.3 11.6 11.0 23.7 22.1 8.5 11.8 12.7 9.9 8.4 10.4 10.4 12.2 9.5 16.2 9.9 22.7 12.1 13.3 10.1 66.6 10.6 18.9 11.7 8.3 11.5 13.6 5.8 9.3 14.4 10.2 30.7 12.8 8.2 8.8 36.8 43.5 14.6 41.5 25.8 35.9 59.6 10.7 19.5 9.6 12.7 7.1 7.1 27.9 8.3 8.4 16.0 12.2 42.2 21.7 12.2 4.4 8.9 18.2 13.9 12.2 10.5 23.6 24.4 11.9 20.7 31.9 15.6 17.4 12.9 9.0 11.9 10.9 14.9 12.0 8.3 23.1 11.8 20.9 17.3 20.0 24.8 16.2 24.5 14.2 12.7 22.0 24.7 7.0 7.8 10.4 28.1 14.5 5.8 16.6 8.4 12.2 24.8 11.1 19.1 4.5 5.3 20.1 12.7 10.8 13.3 14.6 35.8 13.3 27.7 41.5 28.0 36.8 29.0 30.2 42.3 26.2 25.3 26.2 3.1 25.8 32.2 43.5 35.9 59.6 11.0 17.8 15.3 20.7 11.6 11.0 12.7 9.9 16.2 9.3 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 161.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" Mitochondria "Nuclear speckles" "HPA063737: " "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favourable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 38.3 48.3 47.8 22.4 43.1 30.2 22.1 30.9 53.6 12.4 39.7 13.4 28.1 36.4 14.8 39.2 23.2 15.9 20.0 142.2 38.4 35.7 51.2 64.6 28.1 24.9 40.6 36.0 16.5 48.5 9.9 30.6 13.2 41.8 19.3 26.9 22.9 54.1 35.9 161.6 12.6 32.9 25.9 31.3 19.3 29.4 10.0 26.4 11.9 21.6 48.9 21.3 17.1 16.3 61.7 98.6 116.1 93.9 45.1 70.1 95.0 27.9 56.7 46.1 29.7 30.2 22.6 21.1 34.5 19.4 20.5 19.0 34.1 47.6 25.3 32.1 19.3 35.0 26.3 28.0 18.5 39.7 60.3 48.9 89.0 40.7 24.0 38.6 28.0 27.8 17.0 21.4 19.0 18.2 26.5 52.0 28.0 105.8 38.1 34.6 23.3 69.5 34.1 43.8 37.5 51.0 69.3 30.8 22.4 67.6 41.1 43.8 61.6 60.4 40.7 13.0 24.8 26.1 23.0 41.1 64.2 56.1 39.3 28.6 26.9 58.1 93.9 67.8 43.7 63.5 50.2 61.7 64.7 49.8 82.6 52.0 65.4 60.4 116.1 45.1 58.1 98.6 70.1 95.0 47.8 43.1 30.9 53.6 38.4 35.7 40.6 36.0 41.8 26.4 NDUFB11 "ESSS, Np15, NP17.3" ENSG00000147123 "NADH:ubiquinone oxidoreductase subunit B11" Q9NX14 X 47142216-47145504 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030367 Supported Approved Mitochondria Mitochondria "HPA030367: AB_10603882" "unprognostic (2.20e-1)" "unprognostic (6.77e-3)" "unprognostic (1.39e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (8.84e-2)" "unprognostic (3.31e-2)" "unprognostic (2.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (3.27e-1)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (8.46e-3)" 16.9 33.4 26.1 21.2 24.8 25.2 29.2 18.9 29.7 17.6 23.3 10.5 24.7 24.2 14.3 25.1 23.3 18.8 24.0 64.4 22.4 20.6 24.4 48.8 18.1 36.5 22.5 22.0 14.9 50.9 15.6 24.5 14.2 24.4 18.1 21.2 13.0 37.0 30.2 164.0 17.3 22.8 16.0 18.3 19.2 22.8 9.7 12.3 30.4 38.5 53.6 21.2 14.3 20.5 58.9 69.0 22.2 44.7 27.7 54.6 59.5 19.5 29.1 23.0 26.6 19.9 17.1 24.5 14.3 16.6 23.4 22.7 31.0 24.0 24.1 12.3 15.5 25.1 25.9 15.1 15.6 23.3 69.2 13.8 39.8 25.6 20.0 23.1 21.3 18.7 13.9 20.2 13.4 17.4 16.5 31.8 13.1 44.2 27.2 64.1 36.0 53.6 29.7 22.8 54.8 23.7 20.9 42.5 31.4 27.1 31.2 21.5 44.8 30.4 13.2 16.4 22.3 30.4 16.6 31.4 27.4 27.0 17.8 14.5 21.8 22.2 44.7 19.8 34.0 32.0 42.2 58.9 48.4 39.0 52.8 52.8 54.6 43.6 9.5 27.7 23.7 69.0 51.0 59.5 26.1 24.8 18.9 29.7 22.4 20.6 22.5 22.0 24.4 12.3 NDUFB3 B12 ENSG00000119013 "NADH:ubiquinone oxidoreductase subunit B3" O43676 2 201071433-201085750 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034596 Approved "HPA034596: AB_10602712" "unprognostic (5.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.85e-1)" "prognostic unfavourable (7.24e-4)" "unprognostic (1.41e-3)" "unprognostic (6.29e-2)" "unprognostic (8.81e-3)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-2)" "unprognostic (9.40e-3)" "unprognostic (9.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.27e-2)" 16.9 19.9 23.4 13.9 23.6 10.1 14.7 13.5 33.3 10.4 27.1 8.2 16.8 23.8 8.4 18.9 21.1 8.6 13.0 57.5 24.2 19.9 35.2 25.8 10.4 12.6 25.6 29.7 6.8 13.0 15.3 13.2 10.9 20.8 11.7 23.8 8.8 21.8 11.7 113.9 8.6 21.2 10.8 19.2 13.4 17.5 17.2 17.8 10.8 11.6 39.1 16.9 9.4 12.0 40.5 55.8 66.2 52.9 36.4 47.3 27.2 24.8 20.3 30.7 17.4 26.3 22.6 26.4 29.0 18.3 21.4 23.5 45.5 30.8 17.9 36.0 23.7 23.5 25.0 35.3 32.7 36.8 58.7 41.5 49.2 53.6 16.9 59.8 24.3 22.0 26.7 25.0 14.9 27.5 37.8 35.3 33.8 28.9 42.8 66.4 20.5 67.4 31.3 25.5 55.1 45.6 37.9 30.7 22.3 22.1 23.4 36.3 21.8 53.3 27.6 20.6 27.4 21.7 31.1 27.0 53.5 60.6 37.2 35.1 23.8 43.5 37.7 40.0 32.7 51.7 36.3 40.5 38.5 37.8 45.8 31.4 33.8 41.2 66.2 36.4 52.9 55.8 47.3 27.2 23.4 23.6 13.5 33.3 24.2 19.9 25.6 29.7 20.8 17.8 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596309-120602500 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051739 Enhanced Supported "Nuclear membrane,Mitochondria" Mitochondria "Nuclear membrane" "HPA051739: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favourable (1.79e-4)" 25.5 68.2 37.6 20.1 37.7 22.4 59.4 40.7 51.6 25.6 37.2 19.1 25.6 33.6 23.2 32.2 30.2 24.3 27.8 130.2 32.5 30.8 53.3 46.9 25.4 42.0 37.3 29.4 25.8 36.5 34.1 32.8 18.5 36.7 26.8 34.8 24.6 33.9 29.5 195.7 27.3 30.6 37.6 32.4 22.6 28.7 26.6 25.6 31.1 25.9 64.8 25.4 32.3 29.1 64.5 73.4 52.1 60.5 39.1 79.7 49.0 51.9 37.9 45.3 45.4 28.7 34.2 36.9 29.2 38.8 38.0 42.0 36.8 39.9 26.4 59.3 32.7 50.3 34.9 37.2 28.7 40.4 40.3 40.8 39.8 37.0 17.4 35.8 48.3 30.8 49.7 18.5 24.4 47.4 24.1 40.6 40.8 40.7 70.8 51.9 36.1 103.9 41.0 25.9 58.0 61.6 32.5 51.1 52.4 34.2 38.4 62.2 64.7 57.2 36.3 33.7 44.3 14.2 40.7 50.2 45.2 79.8 53.1 50.4 45.5 46.2 46.2 52.1 45.5 60.5 47.4 64.5 63.5 51.3 58.4 47.2 54.8 53.4 28.1 39.1 60.5 73.4 79.7 49.0 37.6 37.7 40.7 51.6 32.5 30.8 37.3 29.4 36.7 25.6 NDUFB5 "CI-SGDH, MGC12314, SGDH" ENSG00000136521 "NADH:ubiquinone oxidoreductase subunit B5" O43674 3 179604690-179627647 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005640 Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA005640: AB_1079461" "unprognostic (6.76e-2)" "unprognostic (1.09e-2)" "unprognostic (6.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-1)" "unprognostic (7.35e-3)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "unprognostic (4.46e-2)" "unprognostic (5.96e-3)" "unprognostic (4.83e-2)" "unprognostic (7.11e-2)" "prognostic favourable (3.32e-5)" "unprognostic (3.05e-1)" "unprognostic (1.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" 32.2 39.6 41.3 16.0 44.6 12.1 27.2 20.0 45.7 23.7 32.3 22.0 21.2 43.7 16.2 15.4 26.4 20.0 20.5 86.9 34.1 31.7 48.1 42.3 17.8 21.7 39.4 33.6 22.1 23.2 31.1 18.7 21.3 37.6 19.6 29.9 24.8 35.8 21.3 96.3 17.5 38.5 21.3 30.9 20.4 24.9 21.8 18.4 22.7 27.7 47.3 18.5 26.5 17.3 27.7 41.4 19.5 44.9 14.6 25.0 26.7 23.2 6.5 16.3 19.7 21.5 29.0 22.1 14.8 18.7 21.2 21.4 19.6 17.0 20.4 44.9 12.5 25.8 17.6 19.6 21.4 42.1 14.7 21.9 11.9 16.3 19.8 26.1 17.4 26.7 25.4 11.9 19.9 24.3 18.4 29.7 22.7 16.6 15.0 20.3 23.5 26.5 16.7 18.9 63.1 38.3 18.0 11.6 19.5 9.0 50.6 34.9 77.1 42.6 15.6 14.0 13.3 19.1 35.2 39.5 40.9 30.1 22.6 28.0 19.9 19.5 29.9 14.4 13.9 37.6 22.1 27.7 20.0 17.0 41.4 19.5 20.8 21.0 6.7 14.6 44.9 24.0 25.0 26.7 41.3 44.6 20.0 45.7 34.1 31.7 39.4 33.6 37.6 18.4 NDUFB6 "B17, CI" ENSG00000165264 "NADH:ubiquinone oxidoreductase subunit B6" O95139 9 32552999-32573184 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044001, HPA053334" Supported Enhanced Mitochondria Mitochondria "HPA044001: AB_10959448, HPA053334: " "unprognostic (4.09e-1)" "prognostic favourable (3.18e-4)" "unprognostic (1.81e-2)" "unprognostic (1.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-3)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "prognostic favourable (7.47e-10)" "unprognostic (2.70e-1)" "unprognostic (1.82e-1)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" 21.9 26.8 33.9 17.7 31.8 16.0 18.7 22.6 28.3 13.7 21.9 15.5 17.3 26.5 16.8 17.4 18.6 15.4 15.9 58.6 27.6 27.9 32.8 36.6 13.9 15.4 28.4 27.2 14.1 19.5 15.4 17.8 15.5 22.9 15.1 18.2 14.6 22.7 16.1 87.2 14.6 25.5 16.4 25.9 13.5 20.0 28.9 17.1 19.2 22.2 34.4 14.5 14.1 13.5 26.0 38.8 77.4 27.3 22.2 27.5 26.5 29.8 18.4 20.5 23.4 13.9 13.0 13.1 20.0 16.4 18.5 20.5 18.0 13.5 22.3 20.9 13.8 17.0 19.3 22.1 14.0 30.6 30.9 53.0 28.2 18.5 13.6 26.4 13.7 13.4 10.8 16.7 12.7 16.7 16.9 25.2 20.7 17.3 35.5 62.4 21.6 40.9 24.5 17.2 20.6 20.7 11.3 20.6 23.3 23.2 26.7 13.5 25.2 20.5 14.8 20.3 30.7 22.3 29.4 11.2 21.0 36.2 33.9 18.6 9.5 25.0 25.8 33.3 21.0 23.1 20.2 26.0 22.4 21.6 27.6 21.8 23.0 24.3 77.4 22.2 27.3 38.8 27.5 26.5 33.9 31.8 22.6 28.3 27.6 27.9 28.4 27.2 22.9 17.1 NDUFB8 "ASHI, CI-ASHI" ENSG00000166136 "NADH:ubiquinone oxidoreductase subunit B8" O95169 10 100523740-100530000 "Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003886 Supported Approved Mitochondria Mitochondria "HPA003886: AB_1079463" "unprognostic (4.07e-2)" "unprognostic (1.95e-3)" "unprognostic (2.28e-1)" "unprognostic (7.33e-2)" "unprognostic (4.88e-2)" "unprognostic (5.78e-2)" "unprognostic (3.02e-1)" "unprognostic (6.46e-2)" "unprognostic (8.33e-2)" "unprognostic (9.09e-2)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-2)" 35.2 39.8 86.7 27.0 67.4 35.6 26.1 39.3 81.5 25.4 37.7 23.8 23.1 38.8 24.7 42.3 36.8 28.8 28.2 110.0 70.6 62.8 50.4 50.6 19.8 28.1 63.9 54.1 27.7 36.3 31.5 31.4 19.9 49.9 26.6 36.2 25.7 39.7 34.5 88.5 24.3 33.8 41.5 38.9 22.1 31.5 12.0 41.4 18.3 28.3 49.2 27.8 25.2 21.5 76.6 88.6 62.2 74.4 60.5 105.9 129.7 41.8 70.6 38.2 67.7 28.9 28.1 42.2 28.6 62.2 44.0 47.7 95.7 48.8 44.4 25.8 32.0 50.2 28.5 46.5 35.0 29.1 72.9 31.2 59.9 77.4 39.2 63.7 53.8 34.6 42.0 43.9 59.2 48.1 32.4 28.2 37.8 50.8 61.4 80.2 25.5 65.9 42.9 41.7 58.5 51.5 47.9 26.4 37.1 21.0 40.2 41.5 59.7 57.1 32.2 25.2 28.5 26.8 50.0 51.2 46.5 55.1 50.0 67.5 28.0 35.1 74.4 62.2 59.0 72.9 69.5 76.6 73.6 67.8 80.4 64.1 79.8 76.7 17.1 60.5 61.4 88.6 105.9 129.7 86.7 67.4 39.3 81.5 70.6 62.8 63.9 54.1 49.9 41.4 NDUFC1 KFYI ENSG00000109390 "NADH:ubiquinone oxidoreductase subunit C1" O43677 4 139266880-139302551 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044556 Approved Supported Mitochondria Mitochondria "HPA044556: AB_10794402" "unprognostic (6.07e-2)" "unprognostic (4.61e-3)" "unprognostic (1.76e-2)" "prognostic favourable (8.23e-5)" "unprognostic (7.11e-2)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.60e-2)" "unprognostic (3.58e-2)" "unprognostic (1.17e-2)" "prognostic favourable (9.96e-4)" "unprognostic (2.33e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "prognostic favourable (7.25e-4)" 7.4 17.0 15.2 6.4 15.8 5.6 8.3 12.2 15.7 8.5 13.1 11.8 7.0 15.2 6.6 12.0 11.7 8.3 7.7 55.5 12.4 14.6 20.3 17.1 8.4 6.7 13.0 12.1 9.7 13.1 11.4 14.3 8.9 10.0 8.1 12.6 11.3 10.9 10.5 164.1 9.1 16.4 7.2 10.4 10.5 11.9 27.1 8.5 6.1 11.6 57.6 9.4 7.0 7.3 32.7 40.0 40.8 24.4 12.8 31.4 26.1 8.6 3.6 10.6 13.1 7.6 8.3 8.4 10.7 7.1 7.9 6.0 6.4 10.8 3.8 3.9 7.5 5.1 20.6 7.0 6.3 5.4 6.6 6.0 7.1 10.2 9.5 5.0 3.3 11.9 10.5 7.5 11.1 7.8 13.8 16.2 5.4 6.1 7.3 12.3 8.1 4.9 6.2 6.5 28.7 12.7 5.6 8.9 6.8 7.6 9.4 4.9 10.3 9.7 3.8 7.8 3.7 5.4 6.0 13.0 22.9 9.5 8.4 13.1 6.2 16.0 24.4 40.8 21.7 17.3 17.3 28.3 24.4 23.2 24.0 32.7 31.4 23.1 15.4 12.8 18.8 40.0 28.3 26.1 15.2 15.8 12.2 15.7 12.4 14.6 13.0 12.1 10.0 8.5 NDUFC2 "B14.5b, HLC-1" ENSG00000151366 "NADH:ubiquinone oxidoreductase subunit C2" O95298 11 78068304-78080219 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria Mitochondria "HPA038873: AB_10673480, HPA056195: " "unprognostic (7.32e-2)" "unprognostic (5.91e-3)" "unprognostic (4.00e-2)" "unprognostic (6.14e-2)" "unprognostic (1.94e-1)" "unprognostic (8.97e-2)" "unprognostic (1.60e-1)" "unprognostic (4.23e-3)" "unprognostic (4.75e-3)" "unprognostic (3.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "prognostic favourable (5.00e-5)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (4.18e-2)" "unprognostic (3.61e-3)" 55.0 70.8 40.8 23.3 44.4 32.3 46.2 51.4 58.4 22.5 41.1 31.2 68.0 63.4 31.8 32.8 41.8 35.6 31.9 60.4 41.0 44.5 37.5 89.6 30.1 36.4 43.2 47.0 27.3 48.4 25.3 34.7 31.8 40.8 27.3 20.3 29.7 79.5 59.0 122.8 29.0 55.3 23.7 41.1 24.5 36.6 28.6 23.2 26.9 63.5 43.7 23.3 31.9 24.1 50.3 78.2 70.3 73.2 44.5 46.3 81.2 36.1 45.2 24.6 15.5 23.4 14.8 30.3 44.3 26.6 35.2 25.1 121.1 40.7 21.7 81.3 20.9 38.2 18.5 26.0 13.5 41.1 52.3 23.3 46.9 95.3 40.0 50.9 23.2 20.4 24.2 27.0 10.2 23.9 45.9 36.6 19.6 62.4 33.2 91.8 27.7 57.1 29.1 46.8 73.3 26.6 54.5 34.8 30.8 31.5 65.0 22.8 51.5 42.3 31.2 34.3 42.3 81.7 37.9 33.7 66.1 49.9 19.5 30.6 32.8 65.8 73.2 70.3 39.4 58.2 36.2 50.3 45.6 41.5 77.2 45.5 39.6 41.3 21.0 44.5 48.0 78.2 46.3 81.2 40.8 44.4 51.4 58.4 41.0 44.5 43.2 47.0 40.8 23.2 NDUFC2-KCTD14 ENSG00000259112 "NDUFC2-KCTD14 readthrough" E9PQ53 11 78016971-78079865 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 10.3;EFO-21: 8.4;RPMI-8226: 7.4;U-2 OS: 12.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria Mitochondria "HPA038873: AB_10673480, HPA056195: " 7.1 11.3 6.3 5.8 7.9 9.7 8.9 13.8 11.7 9.6 7.4 5.5 13.8 27.3 8.8 5.9 9.5 9.7 5.6 11.3 7.7 7.1 6.9 18.7 6.6 6.7 6.4 9.1 6.6 8.8 5.4 5.6 5.6 7.7 8.4 6.3 5.1 18.0 11.8 10.1 5.7 10.6 5.9 5.9 5.9 15.9 4.9 3.7 4.5 12.7 8.3 4.8 4.6 6.1 30.7 37.7 30.7 33.7 16.5 33.2 39.7 0.0 2.1 0.6 0.6 0.6 0.0 1.3 1.5 0.9 1.2 2.9 10.3 1.2 0.2 8.4 0.0 0.3 1.7 0.0 0.7 5.9 0.0 1.2 0.0 0.0 0.7 0.8 2.1 0.0 0.3 0.3 1.8 0.9 0.3 0.1 0.2 0.0 3.0 1.1 5.2 0.3 1.0 0.1 7.4 0.0 0.0 1.5 2.3 0.0 1.1 3.3 0.6 1.1 0.9 0.5 12.9 4.2 0.0 1.2 1.4 2.9 0.8 0.3 1.4 22.5 33.7 30.7 24.5 24.1 19.3 30.7 22.8 23.0 37.7 23.7 20.5 21.5 10.0 16.5 25.7 37.5 33.2 39.7 6.3 7.9 13.8 11.7 7.7 7.1 6.4 9.1 7.7 3.7 NECTIN1 "CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12" ENSG00000110400 "Nectin cell adhesion molecule 1" Q15223 11 119623408-119729084 "CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 55.3;skin 1: 73.5" "Cell line enhanced" "Detected in many" "HaCaT: 58.1;hTCEpi: 36.2;RT4: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016135, HPA026846" Approved "Secreted in other tissues" 97000000 "CAB016135: AB_626865, HPA026846: AB_1846226" "unprognostic (1.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.11e-1)" "unprognostic (3.87e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-2)" "unprognostic (2.25e-3)" "unprognostic (2.03e-1)" "unprognostic (3.76e-2)" "unprognostic (3.42e-1)" "unprognostic (3.58e-2)" "unprognostic (3.28e-1)" "unprognostic (3.59e-3)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (9.62e-2)" 3.1 3.0 7.7 3.0 11.1 11.9 5.3 8.4 20.8 6.6 7.3 27.3 2.4 9.6 2.3 2.0 55.3 2.9 2.5 3.0 16.1 8.2 3.0 2.4 2.5 1.7 12.7 10.6 1.8 10.8 2.4 4.1 8.2 10.1 5.9 7.8 6.3 8.7 4.4 1.6 73.5 6.9 3.1 14.3 2.2 3.2 1.3 12.4 2.5 1.8 25.3 20.8 17.3 14.8 0.1 4.8 1.0 1.5 0.1 0.1 0.2 4.0 3.4 3.2 4.6 1.7 0.5 22.7 1.6 1.5 1.4 1.0 7.1 13.9 5.4 6.7 1.9 58.1 8.2 29.6 0.6 12.7 1.2 0.7 1.1 3.3 0.7 3.6 9.1 0.5 36.2 4.4 16.2 4.1 0.1 28.9 1.8 10.6 0.0 2.2 10.6 4.7 0.3 19.4 6.5 1.3 39.4 7.8 17.7 5.5 14.6 0.5 13.3 0.5 2.2 1.2 4.6 10.0 1.4 5.3 6.6 0.0 0.4 3.0 2.8 0.0 0.3 0.2 0.1 0.5 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 1.0 0.1 1.5 4.8 0.0 0.2 7.7 11.1 8.4 20.8 16.1 8.2 12.7 10.6 10.1 12.4 NECTIN2 "CD112, HVEB, PRR2, PVRL2, PVRR2" ENSG00000130202 "Nectin cell adhesion molecule 2" Q92692 19 44846175-44889228 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 11.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012759, CAB026138, HPA073459" Enhanced Approved "Nucleoli fibrillar center,Cell Junctions" 3400000 "Nucleoli fibrillar center, Cell Junctions" "CAB026138: , HPA012759: AB_1846227, HPA073459: " "unprognostic (3.30e-2)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (7.45e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-2)" "unprognostic (6.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.97e-1)" "unprognostic (6.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (2.15e-1)" "unprognostic (1.61e-1)" "unprognostic (8.19e-2)" "unprognostic (2.05e-1)" 29.5 28.2 7.9 15.6 7.7 5.6 38.0 4.5 9.0 24.2 34.0 9.3 22.3 24.2 23.2 27.4 33.6 16.7 54.1 21.9 10.5 8.1 29.0 53.7 39.6 23.0 8.2 6.8 25.5 20.6 22.5 15.9 45.8 11.2 25.8 14.8 22.9 24.4 28.9 14.6 18.3 42.9 13.8 8.4 31.4 26.2 38.7 5.8 3.8 32.2 19.2 24.1 21.6 31.4 0.0 3.3 11.5 2.6 0.0 0.3 0.7 17.8 21.4 27.7 32.7 14.0 8.5 32.2 15.3 18.9 27.1 31.3 44.1 39.3 0.1 20.7 17.7 24.5 24.5 12.6 21.6 0.7 12.8 10.8 7.4 28.5 33.7 0.1 29.0 14.9 5.1 12.9 10.5 35.0 17.6 0.1 13.5 32.5 0.1 1.2 23.0 6.4 1.0 9.4 0.7 32.1 22.1 1.3 3.7 19.0 28.9 6.5 22.5 10.6 34.9 7.4 26.3 5.5 11.2 2.2 6.4 0.1 13.6 2.3 19.3 1.5 2.6 11.5 0.0 0.9 0.3 0.0 0.1 0.0 3.3 0.0 0.0 0.0 2.4 0.0 0.5 0.3 0.0 0.7 7.9 7.7 4.5 9.0 10.5 8.1 8.2 6.8 11.2 5.8 NECTIN3 "CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3" ENSG00000177707 "Nectin cell adhesion molecule 3" Q9NQS3 3 111070071-111275563 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 94.2" "Cell line enhanced" "Detected in many" "TIME: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009869, HPA011038" Approved Approved "Centriolar satellite" 20000000 "Centriolar satellite" "CAB009869: AB_2284699, HPA011038: AB_1079719" "unprognostic (3.76e-2)" "unprognostic (3.81e-3)" "unprognostic (1.74e-1)" "unprognostic (1.97e-2)" "unprognostic (1.02e-1)" "unprognostic (9.77e-2)" "unprognostic (3.26e-3)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (3.94e-2)" "unprognostic (5.33e-2)" "unprognostic (7.04e-2)" "prognostic favourable (9.82e-7)" "unprognostic (2.01e-1)" "unprognostic (1.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.05e-1)" 5.6 4.0 5.4 4.4 6.0 0.0 4.5 1.3 8.9 4.6 12.6 6.5 2.8 17.8 5.0 2.2 3.5 5.4 4.4 4.8 6.3 5.0 6.9 16.4 5.6 1.9 6.0 4.1 9.2 4.7 1.9 1.9 94.2 5.5 6.9 12.6 10.7 3.4 4.8 2.3 1.8 18.9 7.2 8.9 1.8 13.2 27.6 4.5 0.4 24.1 2.0 1.4 5.4 7.7 0.1 0.0 0.3 0.0 0.2 1.7 0.7 0.0 9.9 32.9 2.1 13.3 24.7 2.0 21.6 22.9 13.4 11.5 9.1 4.6 0.0 7.2 30.6 0.1 9.2 3.1 24.7 0.2 2.4 0.0 3.5 0.6 22.5 1.5 0.3 12.5 1.3 8.9 8.6 11.2 0.0 8.7 28.9 0.0 2.1 0.0 9.2 3.6 0.0 16.3 0.0 8.4 5.2 0.8 6.0 0.4 0.0 4.5 0.3 0.1 46.6 17.0 7.1 3.1 12.9 4.8 0.0 0.0 10.7 0.0 15.7 0.0 0.0 0.3 0.1 0.0 1.2 0.0 1.7 1.0 0.0 0.1 0.3 0.4 0.0 0.2 0.0 0.0 0.1 0.7 5.4 6.0 1.3 8.9 6.3 5.0 6.0 4.1 5.5 4.5 NECTIN4 "LNIR, nectin-4, PRR4, PVRL4" ENSG00000143217 "Nectin cell adhesion molecule 4" Q96NY8 1 161070995-161089599 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.1;placenta: 46.6;skin 1: 39.3" "Cell line enhanced" "Detected in some" "BEWO: 27.9;HaCaT: 18.0;MCF7: 11.2;SK-BR-3: 23.4;T-47d: 15.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA010775 Enhanced Supported "Plasma membrane" "Secreted in other tissues" 11000 "Plasma membrane" "HPA010775: AB_1079720" "unprognostic (1.09e-3)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (1.11e-2)" "unprognostic (5.69e-3)" "unprognostic (2.09e-2)" "unprognostic (6.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-3)" "unprognostic (1.13e-1)" "unprognostic (2.24e-8)" "unprognostic (2.98e-2)" "unprognostic (2.43e-1)" "unprognostic (3.68e-2)" "unprognostic (4.97e-2)" 0.2 0.1 0.1 0.8 0.1 0.1 7.7 0.1 0.1 9.8 0.6 0.1 5.4 0.2 1.5 3.7 40.1 1.4 5.6 0.1 0.1 0.1 1.3 0.2 3.1 0.0 0.1 0.0 0.5 4.4 0.0 0.3 46.6 0.1 7.8 0.7 0.1 13.5 5.5 0.1 39.3 0.4 2.0 0.1 0.1 4.5 0.2 0.0 0.5 0.1 22.7 23.1 12.6 18.5 0.2 0.3 3.6 0.1 0.1 0.2 0.0 5.1 0.1 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.1 0.0 7.1 0.0 0.1 0.0 18.0 0.0 0.6 0.1 0.0 0.2 0.0 0.4 5.2 0.0 0.0 0.3 0.0 7.2 1.5 1.8 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.1 0.1 23.4 0.0 15.2 0.0 0.0 0.0 1.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.1 1.2 0.2 0.0 0.1 0.2 0.2 0.0 0.3 0.2 0.1 0.1 3.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 NEGR1 "IGLON4, KILON, MGC46680, Ntra" ENSG00000172260 "Neuronal growth regulator 1" Q7Z3B1 1 71395940-72282734 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.5" "Cell line enhanced" "Detected in many" "ASC diff: 15.8;TIME: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011894 Uncertain Approved "Vesicles,Actin filaments,Cytosol" 390000000 "Vesicles, Actin filaments, Cytosol" "HPA011894: AB_1854363" "unprognostic (2.60e-1)" "unprognostic (1.89e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (7.99e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.94e-2)" "unprognostic (8.15e-2)" "unprognostic (8.73e-2)" "unprognostic (3.38e-2)" "unprognostic (1.36e-1)" "unprognostic (3.31e-5)" "unprognostic (5.89e-3)" "unprognostic (1.31e-1)" "unprognostic (1.43e-3)" "unprognostic (2.11e-4)" 17.5 7.8 18.1 7.6 16.3 2.2 7.3 24.1 41.5 8.0 14.7 2.6 2.4 3.8 7.1 5.9 13.6 5.9 13.5 10.7 11.2 14.8 8.8 1.1 5.4 2.4 8.7 26.3 8.4 6.0 1.5 4.6 4.1 5.9 9.9 10.3 3.2 3.6 7.6 5.9 5.5 6.3 25.5 10.2 1.5 7.6 4.4 3.0 0.3 3.8 1.5 1.6 20.1 9.1 0.5 3.3 1.1 0.4 0.4 0.4 0.1 0.2 0.1 0.4 0.2 15.8 12.5 0.1 11.0 4.1 6.1 7.4 0.1 0.1 0.2 0.1 12.1 0.3 0.0 0.0 13.2 0.2 0.1 0.1 2.2 0.1 1.3 0.2 0.3 6.0 0.0 5.1 0.9 7.1 0.1 0.5 11.2 0.1 0.1 0.2 1.8 6.3 7.6 11.8 0.2 1.0 0.2 0.8 1.0 3.8 0.1 0.1 0.1 0.2 16.1 1.3 13.4 0.6 13.6 0.3 0.2 0.1 3.0 7.3 4.7 1.1 0.4 0.3 0.4 0.2 0.3 0.3 0.3 0.3 3.1 0.5 0.3 0.3 0.8 0.4 0.4 3.3 0.2 0.1 18.1 16.3 24.1 31.8 11.2 14.8 8.7 26.3 5.9 3.0 NELL2 NRP2 ENSG00000184613 "Neural EGFL like 2" Q99435 12 44508275-44921848 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.8;brain: 73.3;fallopian tube: 35.1" "Cell line enhanced" "Detected in some" "AF22: 40.9;NTERA-2: 16.1;SCLC-21H: 29.7;U-266/70: 10.9;U-266/84: 10.8;U-698: 14.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 33.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8" "Lineage enriched" "Detected in many" 11 "T-cells: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035714, HPA035715" Uncertain Approved Vesicles "Secreted to blood" 4700000 Vesicles "HPA035714: , HPA035715: AB_10669602" "unprognostic (4.25e-3)" "unprognostic (4.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (7.18e-2)" "unprognostic (5.85e-2)" "unprognostic (2.59e-2)" "unprognostic (4.85e-2)" "unprognostic (2.80e-1)" "prognostic favourable (5.56e-4)" "unprognostic (1.19e-1)" "unprognostic (1.71e-5)" "unprognostic (8.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.60e-3)" "unprognostic (3.75e-2)" 2.0 10.5 22.4 6.1 24.8 4.2 1.6 15.7 73.3 14.9 2.9 3.6 0.0 15.3 1.9 0.8 1.3 35.1 1.7 0.8 40.2 20.4 1.2 1.1 3.4 11.2 6.6 27.0 1.0 1.1 0.6 18.4 0.8 7.5 18.8 1.8 9.3 1.5 1.8 0.7 5.0 8.6 2.2 2.6 3.8 2.1 2.2 2.4 0.4 4.4 0.0 9.1 2.3 2.0 0.0 0.0 0.1 0.0 3.3 36.8 8.5 0.1 0.0 40.9 1.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.1 4.9 0.0 0.1 9.7 0.0 0.0 0.0 10.6 0.1 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 16.1 5.3 0.0 4.9 0.0 0.0 0.0 29.7 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.1 1.5 0.0 0.7 10.9 10.8 14.7 0.1 0.1 0.2 0.0 0.0 0.0 1.6 0.0 8.5 0.0 10.3 18.1 0.0 0.0 24.5 36.8 0.1 3.3 0.0 0.0 0.1 8.5 22.4 24.8 15.7 50.4 40.2 20.4 6.6 27.0 7.5 2.4 NEO1 "HsT17534, IGDCC2, NGN, NTN1R2" ENSG00000067141 "Neogenin 1" Q92859 15 73051710-73305206 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009320, HPA027804, HPA027805, HPA027806" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" 280000000 "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006" "unprognostic (1.90e-1)" "unprognostic (2.38e-2)" "unprognostic (7.60e-3)" "unprognostic (3.76e-2)" "unprognostic (5.44e-1)" "unprognostic (3.83e-2)" "unprognostic (8.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.22e-1)" "unprognostic (3.30e-2)" "unprognostic (5.51e-2)" "unprognostic (8.05e-2)" "prognostic favourable (4.39e-4)" "unprognostic (1.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-2)" "unprognostic (3.75e-1)" 7.3 5.8 19.2 6.2 22.4 1.2 11.4 12.7 23.9 13.4 30.0 44.5 14.8 17.9 14.2 7.2 8.0 15.4 13.4 6.8 20.1 14.1 16.2 5.9 10.7 2.7 27.1 15.7 17.5 11.5 44.4 6.9 1.5 19.3 23.1 36.9 16.0 11.5 25.5 17.9 24.6 19.0 16.0 22.3 3.6 15.1 9.0 22.5 2.1 12.5 3.8 4.7 10.1 9.5 0.0 0.3 1.4 0.3 0.8 3.1 0.3 3.7 18.2 21.8 14.4 13.2 3.9 5.4 1.4 1.7 3.6 0.7 2.7 18.4 1.0 2.1 4.0 0.8 15.2 8.3 1.5 6.6 11.2 12.2 0.2 2.5 3.8 0.3 0.4 9.5 15.5 0.7 7.1 0.0 0.0 23.4 0.8 11.2 4.3 0.2 20.8 1.5 10.0 11.7 2.4 6.9 10.0 9.9 14.0 17.1 7.6 9.0 8.0 2.2 0.0 16.8 9.0 5.4 3.9 10.0 18.5 2.6 3.6 3.5 4.7 0.0 0.3 0.4 1.8 0.0 3.1 0.0 1.1 1.4 0.0 0.0 0.6 0.5 1.4 0.8 0.0 0.3 0.0 0.3 19.2 22.4 12.7 23.9 20.1 14.1 27.1 15.7 19.3 22.5 NEPRO "C3orf17, DKFZP434F2021, NET17" ENSG00000163608 "Nucleolus and neural progenitor protein" Q6NW34 3 113002440-113019861 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069654 Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA069654: " "unprognostic (8.45e-3)" "unprognostic (3.84e-2)" "unprognostic (1.14e-1)" "prognostic unfavourable (1.13e-4)" "unprognostic (2.29e-2)" "unprognostic (2.43e-2)" "prognostic unfavourable (4.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (4.98e-2)" "unprognostic (1.72e-2)" "unprognostic (9.29e-3)" "unprognostic (5.40e-2)" "unprognostic (1.69e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (3.28e-2)" 15.1 12.3 12.6 12.9 19.8 15.9 15.5 22.8 21.3 14.4 12.8 15.3 11.6 12.3 15.4 19.0 12.7 12.8 13.0 14.0 13.2 12.5 12.4 10.3 11.3 19.3 14.2 13.7 14.8 16.5 13.4 18.2 12.4 15.6 12.4 9.8 11.5 13.5 15.1 28.1 18.2 13.6 16.0 17.5 17.5 14.2 19.1 12.8 21.9 20.0 16.4 15.5 17.5 10.9 3.8 3.4 2.9 3.0 7.9 6.4 2.7 9.9 8.3 13.3 10.0 4.4 8.0 7.1 9.6 6.1 5.3 3.6 7.6 6.6 13.3 5.3 3.1 10.6 9.7 4.3 7.5 2.6 6.1 20.3 7.4 5.6 8.0 12.9 7.5 12.5 7.8 4.4 11.2 4.6 6.9 10.7 3.9 6.4 11.0 7.6 13.9 10.7 9.1 10.6 6.9 6.1 8.9 9.2 13.6 5.5 6.9 15.9 8.0 11.1 9.4 7.5 7.4 2.7 6.8 10.6 8.1 15.6 12.0 10.2 5.3 2.9 2.3 2.7 4.4 3.0 4.5 3.8 5.1 3.7 3.4 3.1 6.4 6.3 1.5 7.9 1.2 2.4 2.2 2.7 12.6 19.8 22.8 21.3 13.2 12.5 14.2 13.7 15.6 12.8 NETO1 "BCTL1, BTCL1" ENSG00000166342 "Neuropilin and tolloid like 1" Q8TDF5 18 72742314-72868146 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 47.9" "Cell line enhanced" "Detected in some" "MOLT-4: 14.8;REH: 14.5;RPMI-8226: 23.2;RT4: 15.4;SCLC-21H: 20.5;U-2 OS: 7.5" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 27 "memory B-cell: 1.6;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 38 "B-cells: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA064630 Approved "Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" "HPA064630: " "unprognostic (4.02e-2)" "unprognostic (4.08e-3)" "unprognostic (2.75e-1)" "unprognostic (1.55e-2)" "unprognostic (6.04e-2)" "unprognostic (1.35e-5)" "unprognostic (4.05e-1)" "unprognostic (4.73e-2)" "unprognostic (3.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (3.70e-2)" "unprognostic (3.35e-2)" "unprognostic (1.59e-1)" "unprognostic (9.13e-3)" 2.0 0.8 9.1 1.3 18.3 1.0 1.7 0.4 47.9 0.9 0.9 0.7 0.0 0.8 0.9 0.9 1.0 0.8 0.9 1.4 15.9 3.9 1.0 0.8 0.9 3.8 3.0 15.1 0.8 0.8 1.0 0.3 0.8 5.0 0.9 1.1 3.9 1.1 0.8 0.8 1.2 0.8 0.8 1.1 4.0 0.9 2.0 2.8 0.8 2.3 0.0 2.7 1.2 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.8 0.0 6.7 0.0 14.5 0.0 23.2 3.6 15.4 20.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 18.3 0.4 22.8 15.9 3.9 3.0 15.1 5.0 2.8 NETO2 "FLJ10430, NEOT2" ENSG00000171208 "Neuropilin and tolloid like 2" Q8NC67 16 47077703-47143997 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.6;lymphoid tissue: 23.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013180 Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA013180: AB_1854383" "unprognostic (2.67e-2)" "unprognostic (3.46e-2)" "unprognostic (3.90e-1)" "unprognostic (1.51e-3)" "unprognostic (2.25e-1)" "unprognostic (5.26e-3)" "unprognostic (1.10e-2)" "unprognostic (5.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (3.98e-1)" "prognostic unfavourable (5.53e-6)" "unprognostic (3.48e-2)" "unprognostic (1.66e-1)" "unprognostic (6.79e-2)" "unprognostic (1.32e-1)" 3.3 6.7 6.9 6.9 23.6 2.4 3.4 11.8 15.8 1.8 9.5 2.1 0.6 1.9 2.8 0.9 5.6 1.1 5.5 2.4 8.3 5.9 2.5 0.9 5.3 6.6 4.9 7.1 2.0 9.8 11.6 1.4 3.8 13.5 1.4 2.8 10.1 2.6 1.6 4.5 1.7 2.7 1.9 2.5 23.8 1.9 8.6 4.7 1.9 10.0 3.1 6.8 4.2 2.5 1.0 2.1 0.9 3.3 0.3 2.2 0.7 24.7 27.6 40.0 0.1 5.9 34.5 6.6 24.6 3.9 21.9 11.9 5.7 15.9 6.1 15.2 5.2 11.1 25.5 24.5 27.0 0.0 16.4 4.9 9.8 6.1 7.3 15.8 13.1 20.7 16.4 8.8 12.4 14.5 7.3 7.6 14.0 6.7 9.0 8.6 19.2 20.3 0.0 7.8 12.4 15.4 5.3 26.3 19.1 32.5 2.5 3.6 0.5 11.6 7.0 0.0 0.0 0.0 0.1 8.2 6.7 13.6 17.8 11.2 17.6 0.9 3.3 0.1 0.1 1.6 1.3 1.0 1.3 0.1 2.1 0.4 0.0 0.1 0.9 0.3 1.5 0.2 2.2 0.7 6.9 23.6 11.8 15.8 8.3 5.9 4.9 7.1 13.5 4.7 NFAM1 CNAIP ENSG00000235568 "NFAT activating protein with ITAM motif 1" Q8NET5 22 42380410-42432395 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.0;bone marrow: 28.0;lymphoid tissue: 35.2" "Cell line enriched" "Detected in some" 4 "THP-1: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 34.0" "Group enriched" "Detected in many" 4 "granulocytes: 34.0;monocytes: 17.5" "Group enriched" "Detected in many" 4 "basal ganglia: 2.9;hypothalamus: 3.7;midbrain: 7.4;pons and medulla: 7.8;thalamus: 8.3" HPA031812 Uncertain "HPA031812: AB_10603121" "unprognostic (9.77e-3)" "unprognostic (2.77e-3)" "unprognostic (8.21e-2)" "prognostic favourable (6.16e-4)" "unprognostic (4.83e-2)" "unprognostic (8.76e-3)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "unprognostic (9.12e-3)" "unprognostic (9.97e-2)" "unprognostic (1.13e-1)" "unprognostic (1.00e-1)" "unprognostic (8.12e-3)" "unprognostic (1.75e-1)" "unprognostic (4.42e-2)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" 10.9 3.1 1.7 12.3 3.1 28.0 2.0 0.9 1.9 2.2 1.8 4.0 0.7 1.5 1.4 4.2 2.0 3.3 2.8 4.8 1.8 2.2 2.5 9.9 12.1 35.2 2.4 0.6 1.5 1.7 0.4 1.3 4.4 2.7 2.5 1.4 2.4 2.0 1.8 1.1 1.6 3.3 3.0 4.8 27.7 1.7 1.4 2.5 2.8 1.5 1.2 3.7 3.1 1.5 0.0 6.1 34.0 17.5 0.0 0.1 7.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.4 0.2 0.0 0.1 0.0 0.0 0.3 0.1 4.4 0.0 0.0 0.1 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.1 17.5 0.9 0.0 12.2 0.1 0.0 0.0 0.0 6.1 0.0 0.0 0.0 34.0 0.0 10.6 0.1 0.0 7.3 1.7 3.1 0.9 1.9 1.8 2.2 2.4 0.6 2.7 2.5 NFASC "FLJ46866, KIAA0756, NF, NRCAML" ENSG00000163531 Neurofascin O94856 1 204828651-205022822 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.6" "Cell line enhanced" "Detected in some" "BJ: 13.2;BJ hTERT+ SV40 Large T+: 9.6;fHDF/TERT166: 23.9;SCLC-21H: 11.2;U-138 MG: 31.0;U-87 MG: 15.3" "Cancer enhanced" "Detected in many" "glioma: 8.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008832 Enhanced 2100000 "HPA008832: AB_1854411" "unprognostic (1.71e-1)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (3.39e-2)" "unprognostic (6.65e-2)" "unprognostic (1.18e-2)" "unprognostic (3.71e-3)" "unprognostic (3.37e-1)" "unprognostic (6.34e-3)" "unprognostic (2.79e-1)" "prognostic favourable (3.21e-5)" "unprognostic (3.76e-1)" "prognostic unfavourable (2.93e-5)" "unprognostic (1.56e-3)" "unprognostic (1.91e-1)" "unprognostic (6.90e-2)" "unprognostic (5.26e-3)" 4.9 8.7 21.1 3.9 25.9 0.6 3.8 22.3 37.3 4.6 7.8 49.6 1.1 5.1 9.1 10.4 11.3 12.0 6.6 17.4 19.5 10.8 10.7 2.4 5.7 2.6 27.9 25.2 11.9 6.4 1.6 11.7 11.2 28.7 8.7 6.8 8.1 2.6 18.4 3.3 4.2 5.6 15.3 17.5 6.8 5.3 2.0 34.0 0.0 3.0 0.2 3.4 8.9 7.9 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.2 0.4 0.0 13.2 0.0 9.6 2.9 0.0 0.0 0.0 0.0 23.9 6.3 0.2 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 6.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 1.0 0.0 0.0 0.0 11.2 0.6 0.0 0.6 0.0 0.1 0.0 0.0 31.0 6.7 0.0 0.0 0.0 0.0 0.0 15.3 0.0 7.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 25.9 22.3 35.0 19.5 10.8 27.9 25.2 28.7 34.0 NFXL1 HOZFP ENSG00000170448 "Nuclear transcription factor, X-box binding like 1" Q6ZNB6 4 47847233-47914667 "Predicted membrane proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059132 Approved Approved Nucleoplasm Nucleoplasm "HPA059132: " "unprognostic (5.37e-2)" "unprognostic (2.89e-1)" "unprognostic (5.14e-3)" "unprognostic (6.13e-2)" "unprognostic (1.81e-2)" "unprognostic (4.33e-2)" "prognostic unfavourable (9.28e-4)" "unprognostic (1.13e-2)" "unprognostic (6.26e-3)" "unprognostic (8.48e-3)" "unprognostic (8.34e-2)" "unprognostic (4.47e-2)" "unprognostic (4.72e-3)" "unprognostic (8.89e-2)" "unprognostic (3.15e-1)" "unprognostic (6.67e-2)" "unprognostic (8.01e-2)" 8.3 5.8 7.8 7.2 8.7 6.5 10.8 19.1 9.4 10.1 7.4 6.2 12.2 7.8 13.3 19.2 9.7 9.6 6.9 5.5 6.7 5.5 7.4 9.5 7.4 6.5 7.0 9.6 10.9 12.8 11.9 19.6 8.7 7.6 9.0 8.6 5.3 12.4 10.2 7.1 9.3 7.4 8.8 8.8 7.5 8.2 21.3 7.0 5.9 17.2 4.4 7.7 9.2 10.9 2.5 1.9 5.6 2.3 1.5 3.5 1.7 5.4 3.5 3.9 8.0 7.3 12.2 13.2 3.7 5.3 6.1 7.6 5.8 12.5 4.3 7.2 2.5 5.6 9.9 7.5 7.3 3.3 3.9 4.7 6.4 10.6 9.6 11.3 9.4 7.9 10.0 4.2 25.2 5.3 8.3 5.4 6.3 5.2 8.9 5.4 9.3 5.4 8.0 7.5 7.2 7.8 10.4 12.3 5.9 2.8 7.9 5.4 5.5 3.3 4.3 8.0 5.1 3.7 8.3 8.8 5.3 8.8 4.7 6.4 7.0 0.0 1.7 1.7 2.3 2.3 2.8 2.2 3.2 2.5 1.6 2.5 3.5 3.4 5.6 1.5 1.1 1.9 2.0 1.7 7.8 8.7 19.1 9.4 6.7 5.5 7.0 9.6 7.6 7.0 NGFR "CD271, p75NTR, TNFRSF16" ENSG00000064300 "Nerve growth factor receptor" P08138 17 49495293-49515017 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Apoptosis, Biological rhythms, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "RH-30: 54.7;WM-115: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 4.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 4.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basal ganglia: 13.1;hypothalamus: 8.2;pons and medulla: 3.7" "CAB000143, CAB001995, HPA004765" Enhanced Approved "Nucleoplasm,Plasma membrane" 100000 Nucleoplasm "Plasma membrane" "CAB000143: , CAB001995: , HPA004765: AB_1079233" "unprognostic (6.25e-3)" "unprognostic (1.06e-3)" "unprognostic (3.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-2)" "unprognostic (2.26e-1)" "unprognostic (8.22e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-2)" "unprognostic (4.10e-3)" "unprognostic (1.85e-2)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (4.01e-2)" "unprognostic (3.06e-2)" "unprognostic (2.77e-3)" "prognostic unfavourable (3.40e-4)" 30.9 24.0 1.2 9.2 7.4 1.0 11.7 6.1 4.5 7.6 9.4 10.4 7.9 3.2 6.8 15.0 11.3 12.6 10.8 22.2 2.4 2.9 4.8 29.1 1.4 11.6 13.8 1.3 7.6 6.2 2.8 6.7 16.7 15.9 17.7 3.4 20.2 17.2 9.7 4.8 8.4 5.0 10.7 22.4 18.9 4.9 12.2 4.4 0.4 25.8 7.4 7.0 13.1 6.8 0.0 4.2 0.0 0.4 0.0 0.5 0.2 0.0 0.0 1.7 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.4 1.2 0.0 0.1 0.2 0.1 0.0 1.0 0.1 0.0 0.1 5.8 0.0 0.1 0.4 0.0 0.0 0.0 7.9 0.1 0.0 0.0 1.0 0.0 1.0 54.7 0.0 0.0 0.0 0.5 0.3 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.9 0.1 2.7 0.0 0.0 0.0 0.0 0.5 60.7 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 4.2 0.0 0.2 1.2 7.4 6.1 4.0 2.4 2.9 13.8 1.3 15.9 4.4 NGLY1 "FLJ11005, PNG1" ENSG00000151092 "N-glycanase 1" Q96IV0 3 25718944-25790039 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036825 Approved "Intracellular and membrane" "HPA036825: AB_10672231" "unprognostic (3.65e-2)" "unprognostic (8.65e-2)" "prognostic favourable (1.17e-5)" "unprognostic (2.96e-2)" "unprognostic (1.72e-2)" "unprognostic (1.59e-2)" "prognostic unfavourable (1.96e-6)" "unprognostic (2.20e-1)" "unprognostic (2.34e-1)" "unprognostic (3.73e-3)" "unprognostic (2.55e-1)" "unprognostic (4.23e-2)" "unprognostic (4.92e-3)" "unprognostic (1.07e-2)" "unprognostic (2.47e-1)" "unprognostic (9.08e-2)" "unprognostic (1.89e-2)" 10.7 14.4 11.4 19.6 11.4 12.9 15.0 17.1 15.0 9.5 12.4 6.9 11.7 10.5 10.2 13.8 13.2 8.4 10.5 14.3 12.0 9.0 12.8 18.1 13.9 17.4 9.5 12.5 10.6 20.7 9.0 11.3 8.7 11.0 10.9 15.2 7.8 12.4 18.0 46.6 9.0 11.2 8.7 10.1 14.6 11.9 42.0 9.0 18.0 10.3 10.9 18.1 11.5 10.6 26.1 39.7 19.9 10.8 22.6 14.7 10.3 12.2 10.5 5.9 12.4 11.4 10.4 8.4 10.5 8.9 13.3 12.0 6.5 9.3 31.2 12.0 8.9 5.5 19.8 5.5 18.1 14.7 8.4 23.2 8.0 10.5 12.6 21.3 12.7 9.3 7.5 14.6 13.6 14.2 21.9 22.4 13.5 5.3 25.3 12.6 7.9 19.0 25.9 7.7 22.2 12.2 15.1 3.6 4.4 15.3 14.7 9.7 13.9 17.8 9.6 10.5 10.8 12.6 13.5 27.7 23.8 21.7 12.6 23.1 8.2 19.9 10.8 18.9 13.7 10.1 14.7 26.1 13.8 12.6 16.3 21.7 14.0 13.6 12.8 22.6 8.4 39.7 10.4 10.3 11.4 11.4 17.1 15.0 12.0 9.0 9.5 12.5 11.0 9.0 NIF3L1 "ALS2CR1, CALS-7, MDS015" ENSG00000196290 "NGG1 interacting factor 3 like 1" Q9GZT8 2 200889327-200903930 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036335, HPA036336, HPA061466" Supported Approved Vesicles 8700000 Vesicles "HPA036335: AB_10696654, HPA036336: AB_2675068, HPA061466: " "unprognostic (6.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.72e-1)" "prognostic unfavourable (9.52e-5)" "unprognostic (2.48e-2)" "unprognostic (5.92e-2)" "prognostic unfavourable (2.51e-6)" "unprognostic (1.94e-1)" "unprognostic (8.53e-3)" "unprognostic (6.75e-3)" "unprognostic (3.12e-2)" "unprognostic (2.65e-2)" "unprognostic (6.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.83e-1)" "unprognostic (6.04e-3)" "unprognostic (8.61e-2)" 12.8 21.6 14.4 17.8 29.1 7.2 19.6 21.1 31.0 14.9 16.9 19.3 10.0 12.9 16.0 21.8 17.2 18.4 11.5 16.5 19.6 14.2 19.5 17.6 12.1 19.0 15.1 13.4 17.8 15.6 20.8 12.0 18.0 25.6 14.3 22.9 16.3 16.5 17.0 21.4 16.8 15.2 15.2 17.9 18.7 16.2 15.2 13.2 20.8 16.3 15.8 24.8 15.1 12.4 20.3 18.5 32.6 21.3 20.2 23.9 14.4 15.1 16.5 27.0 16.5 12.3 15.6 18.6 16.8 18.0 35.9 29.1 25.8 17.8 12.3 16.3 14.3 16.9 38.3 22.1 38.6 16.3 36.3 18.4 29.3 27.4 11.1 21.6 12.8 13.0 21.5 23.6 22.7 11.9 26.8 12.6 21.0 20.0 26.5 27.1 31.7 29.3 15.9 15.1 24.0 18.9 16.0 17.1 20.3 14.4 14.7 19.8 14.5 19.9 6.1 17.4 16.3 15.4 15.1 11.5 21.7 26.7 16.8 17.8 16.5 32.6 14.5 18.4 18.3 21.3 19.2 20.3 21.1 23.2 17.8 15.6 23.9 19.7 4.9 20.2 17.8 18.5 19.2 14.4 14.4 29.1 21.1 31.0 19.6 14.2 15.1 13.4 25.6 13.2 NIM1K "MGC42105, NIM1" ENSG00000177453 "NIM1 serine/threonine protein kinase" Q8IY84 5 43192071-43280850 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 23.7;pituitary gland: 9.7" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 4.4;HDLM-2: 4.8;PC-3: 5.5;U-87 MG: 6.0" "Cancer enriched" "Detected in some" 11 "glioma: 6.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 10 "dendritic cells: 1.2;T-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007695 Uncertain Approved Cytosol Cytosol "HPA007695: " "unprognostic (7.97e-2)" "unprognostic (9.79e-2)" "unprognostic (8.74e-2)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.17e-1)" "unprognostic (2.40e-1)" "unprognostic (4.35e-2)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (8.84e-4)" "unprognostic (1.25e-1)" "unprognostic (1.55e-5)" "unprognostic (2.18e-1)" "unprognostic (2.66e-1)" "unprognostic (6.46e-3)" "unprognostic (4.98e-3)" 1.4 3.5 9.4 1.6 10.9 0.9 1.3 4.9 23.7 1.6 1.4 6.3 0.0 1.1 1.2 1.6 1.6 1.4 1.5 1.8 8.7 7.7 1.4 1.2 3.6 1.2 5.6 5.8 1.2 1.5 1.2 9.7 1.8 6.4 1.4 1.7 1.7 2.3 2.4 2.0 1.8 1.2 1.3 4.9 1.0 3.0 1.4 8.1 0.0 2.7 0.0 1.0 1.1 0.8 0.1 1.2 0.0 0.0 0.2 3.2 0.0 0.2 0.6 0.1 0.1 0.9 0.5 0.0 1.0 3.1 1.1 4.4 0.1 0.0 0.4 0.6 0.8 0.3 0.6 0.0 2.7 4.8 0.3 0.1 0.6 0.2 1.6 0.2 0.6 1.9 0.1 0.5 0.0 0.0 0.2 0.3 0.9 0.2 0.3 0.2 0.0 5.5 0.2 0.3 0.5 0.1 0.7 0.9 0.1 1.7 0.5 0.3 0.4 1.5 0.0 0.9 0.8 0.7 0.7 1.6 0.4 0.3 6.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 1.2 3.2 0.0 9.4 10.9 4.9 11.6 8.7 7.7 5.6 5.8 6.4 8.1 NINJ2 ENSG00000171840 "Ninjurin 2" Q9NZG7 12 564296-663779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.7;brain: 43.6" "Cell line enhanced" "Detected in some" "HEL: 40.5;MOLT-4: 68.4;THP-1: 14.4;U-698: 13.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA058980 Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA058980: " "unprognostic (1.16e-1)" "unprognostic (2.19e-1)" "unprognostic (9.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.37e-1)" "prognostic favourable (5.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.90e-3)" "unprognostic (4.60e-2)" "unprognostic (4.98e-3)" "unprognostic (5.88e-2)" "unprognostic (5.12e-2)" "unprognostic (2.68e-2)" "unprognostic (9.05e-2)" "unprognostic (1.03e-2)" "unprognostic (3.51e-3)" "unprognostic (1.23e-1)" 11.8 1.4 9.8 9.2 14.1 27.8 9.2 2.4 18.5 7.3 5.0 43.6 1.6 4.6 2.9 3.3 8.4 3.8 4.7 7.9 16.4 8.7 1.4 13.8 31.3 10.8 21.8 10.2 0.8 1.8 0.9 1.1 3.9 17.2 2.7 4.5 2.9 4.5 2.8 20.1 6.7 3.9 4.8 26.4 8.8 3.6 3.9 21.1 3.6 2.6 2.2 9.2 9.0 3.9 5.6 14.9 34.2 17.7 5.7 44.7 9.1 0.4 0.1 0.0 0.4 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.8 3.2 0.0 0.1 1.6 0.0 0.0 0.0 0.0 2.2 0.0 40.5 9.7 0.4 0.0 1.1 1.6 0.6 0.0 0.0 0.0 0.8 2.3 6.9 0.0 0.0 68.4 2.2 0.7 0.0 1.8 0.0 0.2 0.7 0.0 0.0 0.0 7.6 0.0 0.0 0.0 14.4 0.2 0.0 0.4 2.6 0.0 0.0 1.0 13.0 0.1 7.5 0.0 2.0 17.7 14.1 10.5 13.7 3.1 5.6 11.8 11.1 14.9 4.5 2.6 5.5 34.2 5.7 11.2 7.8 44.7 9.1 9.8 14.1 2.4 18.5 16.4 8.7 21.8 10.2 17.2 21.1 NIPA2 SLC57A2 ENSG00000140157 "Non imprinted in Prader-Willi/Angelman syndrome 2" Q8N8Q9 15 22838641-22868384 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067160, HPA071342" Approved Approved "Golgi apparatus" "Golgi apparatus" "HPA067160: , HPA071342: " "unprognostic (2.88e-3)" "unprognostic (1.82e-1)" "unprognostic (9.34e-3)" "unprognostic (1.17e-1)" "unprognostic (4.49e-1)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.22e-2)" "unprognostic (2.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (2.94e-1)" "unprognostic (7.75e-3)" "unprognostic (3.53e-2)" "unprognostic (1.59e-1)" "unprognostic (3.22e-2)" "unprognostic (2.93e-2)" 19.3 26.9 18.6 26.1 22.2 22.1 19.9 17.7 28.2 16.8 30.0 16.6 23.9 28.4 21.7 18.3 26.5 16.1 21.3 17.4 16.7 21.3 26.3 27.8 22.5 35.0 17.9 13.8 19.0 30.8 21.1 24.7 31.3 18.5 20.6 30.1 20.0 26.9 14.0 18.8 16.4 37.1 18.2 13.5 43.9 21.4 19.5 13.1 27.9 21.1 19.2 31.5 22.2 17.2 38.1 40.3 27.2 26.5 22.1 24.6 21.5 29.8 30.5 15.6 18.4 15.0 17.1 17.7 33.5 29.7 23.1 27.0 22.5 19.0 29.5 21.4 19.3 24.0 28.7 16.9 23.5 31.3 18.6 26.4 20.4 18.2 22.4 37.4 25.1 16.8 19.1 19.0 19.8 26.9 39.5 35.4 29.5 11.8 11.9 17.5 18.3 28.2 25.9 26.6 22.4 22.1 36.7 21.0 22.2 25.6 25.4 28.2 23.1 35.2 27.9 30.5 19.9 22.1 67.9 28.1 40.7 31.9 23.3 37.9 26.2 27.2 21.4 18.0 21.4 26.5 24.4 38.1 19.3 23.5 26.2 32.7 18.4 18.7 15.8 22.1 24.9 40.3 24.6 21.5 18.6 22.2 17.7 28.2 16.7 21.3 17.9 13.8 18.5 13.1 NIPAL1 "DKFZp686A06115, NPAL1" ENSG00000163293 "NIPA like domain containing 1" Q6NVV3 4 47914142-48040173 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.8" "Cell line enhanced" "Detected in many" "A-431: 10.9;CAPAN-2: 9.8;HaCaT: 12.9;HBEC3-KT: 9.3;RT4: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA036765 Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA036765: AB_10672366" "unprognostic (3.03e-1)" "unprognostic (4.55e-2)" "unprognostic (2.34e-3)" "unprognostic (2.18e-2)" "unprognostic (1.12e-2)" "unprognostic (3.57e-1)" "unprognostic (9.55e-2)" "unprognostic (4.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (3.71e-3)" "unprognostic (1.34e-1)" "unprognostic (9.03e-7)" "unprognostic (2.55e-1)" "unprognostic (3.73e-1)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" 0.5 0.4 0.4 5.4 1.4 0.0 2.2 0.8 0.7 3.6 9.1 0.1 0.0 3.3 0.4 6.3 18.5 1.1 1.8 0.6 0.7 0.7 4.6 10.7 0.5 0.0 0.4 0.2 0.8 6.6 2.9 5.5 30.8 0.7 3.0 8.9 1.2 5.3 0.6 0.7 17.1 12.6 1.0 0.6 0.4 4.3 0.8 0.3 0.2 2.0 9.8 11.2 4.2 5.3 1.0 1.4 1.4 0.8 0.6 0.9 0.0 10.9 0.2 0.0 0.0 0.0 0.0 1.8 2.1 2.0 1.5 2.8 6.5 9.8 0.0 1.5 0.0 12.9 1.9 9.3 4.1 0.1 2.4 0.0 0.1 0.4 0.0 0.1 0.1 0.1 3.5 0.1 2.3 0.5 0.1 0.0 2.2 4.1 0.1 0.1 1.6 2.9 0.0 0.0 0.0 5.5 14.9 1.0 0.3 1.0 3.6 1.6 2.3 0.0 4.1 0.1 3.9 0.0 0.2 0.1 0.1 0.0 0.2 0.0 4.1 0.9 0.8 0.5 0.8 0.4 0.6 0.4 0.5 0.3 0.1 1.0 0.7 0.9 1.4 0.6 0.5 1.4 0.3 0.0 0.4 1.4 0.8 0.7 0.7 0.7 0.4 0.2 0.7 0.3 NKAIN2 "FAM77B, TCBA1" ENSG00000188580 "Sodium/potassium transporting ATPase interacting 2" Q5VXU1 6 123804141-124825657 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 43.2" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.8;HEK 293: 6.4;HEL: 8.0;Karpas-707: 13.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 4.3" "Lineage enriched" "Detected in single" 44 "granulocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045860 Approved Cytosol Cytosol "HPA045860: AB_10983192" "unprognostic (3.09e-2)" "unprognostic (1.06e-2)" "unprognostic (2.33e-2)" "unprognostic (4.53e-3)" "unprognostic (5.67e-2)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.19e-1)" "unprognostic (5.41e-3)" "unprognostic (2.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.95e-3)" "unprognostic (3.63e-3)" "unprognostic (1.77e-1)" "unprognostic (1.66e-1)" "unprognostic (1.63e-1)" 2.2 1.6 12.9 1.1 12.1 1.9 1.3 17.3 43.2 1.4 1.7 24.9 0.0 1.1 1.2 1.6 1.4 1.4 1.3 2.6 17.5 8.8 1.3 1.2 1.3 1.3 18.1 10.9 1.2 1.0 1.0 1.1 1.2 18.0 1.4 1.3 0.5 1.1 1.3 4.8 1.1 1.5 1.5 42.9 1.1 1.0 1.6 16.1 0.0 1.2 0.5 1.3 1.5 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.0 0.0 0.0 0.5 0.0 0.0 1.6 0.2 0.0 0.5 0.0 0.0 13.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 12.1 17.3 15.3 17.5 8.8 18.1 10.9 18.0 16.1 NKAIN3 "FAM77D, FLJ39630" ENSG00000185942 "Sodium/potassium transporting ATPase interacting 3" Q8N8D7 8 62248591-62999652 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.4;HeLa: 1.9;PC-3: 2.5;REH: 2.5;RT4: 1.6;SCLC-21H: 4.9" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018833 Enhanced "HPA018833: " "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (1.12e-2)" "unprognostic (1.83e-1)" "unprognostic (3.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.81e-3)" "unprognostic (4.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.22e-2)" "unprognostic (3.15e-2)" "unprognostic (1.58e-1)" 0.8 3.4 13.7 1.2 15.5 0.8 1.0 0.6 9.7 1.3 1.4 6.9 0.0 0.7 1.7 0.7 0.8 1.1 0.8 1.1 15.1 1.6 0.8 0.9 0.7 0.8 2.3 7.5 0.9 0.7 0.7 0.8 1.0 7.3 1.0 0.8 0.3 5.9 1.4 2.2 0.7 2.3 0.7 7.3 0.9 0.9 1.9 7.1 0.0 0.8 0.0 0.7 2.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 2.5 0.0 0.0 0.0 1.6 4.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 15.5 0.6 9.7 15.1 1.6 2.3 7.5 7.3 7.1 NKG7 "GIG1, GMP-17" ENSG00000105374 "Natural killer cell granule protein 7" Q16617 19 51371606-51372715 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 270.6;bone marrow: 108.2" "Group enriched" "Detected in some" 5 "NB-4: 58.8;THP-1: 17.5;U-937: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 270.6;MAIT T-cell: 113.5;memory CD8 T-cell: 168.7;naive CD8 T-cell: 130.3;NK-cell: 166.7" "Group enriched" "Detected in all" 46 "NK-cells: 166.7;T-cells: 270.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071454 Approved Vesicles Vesicles "HPA071454: " "unprognostic (1.56e-2)" "unprognostic (1.05e-2)" "unprognostic (6.54e-2)" "prognostic favourable (7.42e-6)" "unprognostic (1.27e-2)" "unprognostic (3.25e-3)" "unprognostic (2.96e-3)" "unprognostic (2.14e-1)" "unprognostic (3.22e-3)" "unprognostic (3.89e-3)" "unprognostic (3.39e-1)" "unprognostic (9.93e-2)" "prognostic unfavourable (3.32e-6)" "unprognostic (7.62e-3)" "unprognostic (2.61e-1)" "unprognostic (1.30e-2)" "unprognostic (6.44e-3)" 7.4 1.8 1.3 11.2 1.7 108.2 3.3 0.7 1.0 2.9 2.2 0.8 0.4 2.2 5.4 6.3 3.8 1.8 10.6 6.0 1.2 1.2 3.2 9.4 26.1 31.0 2.3 0.7 4.1 2.6 0.0 1.8 9.3 1.3 6.8 1.6 6.2 3.5 0.9 5.6 1.0 7.6 2.5 2.8 63.3 2.5 1.9 0.2 7.3 3.1 2.0 16.0 5.1 2.3 1.1 3.2 4.5 4.7 166.7 270.6 141.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.6 0.2 0.0 0.0 6.2 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.7 58.8 0.0 0.1 1.4 3.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 17.5 0.1 0.0 0.0 0.2 0.0 0.8 0.2 0.3 0.0 15.3 0.0 2.2 1.3 0.5 270.6 4.7 113.5 1.1 34.1 168.7 3.2 0.5 11.5 130.3 4.5 166.7 3.6 2.5 0.6 141.5 1.3 1.7 0.7 1.0 1.2 1.2 2.3 0.7 1.3 0.2 NLGN1 KIAA1070 ENSG00000169760 "Neuroligin 1" Q8N2Q7 3 173396284-174286644 "Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 15.9;HUVEC TERT2: 15.5;RH-30: 16.6;WM-115: 16.9" "Group enriched" "Detected in some" 9 "glioma: 3.8;melanoma: 2.2;renal cancer: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006572, HPA006680" Approved Uncertain "Nuclear bodies,Plasma membrane" 40000 "Plasma membrane" "Nuclear bodies" "HPA006572: , HPA006680: AB_1854400" "unprognostic (2.81e-1)" "unprognostic (9.86e-2)" "unprognostic (3.08e-5)" "unprognostic (7.52e-5)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (6.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.78e-1)" "unprognostic (8.07e-2)" "unprognostic (3.21e-3)" "unprognostic (1.86e-2)" "unprognostic (1.97e-1)" "unprognostic (4.08e-2)" "unprognostic (8.81e-2)" "unprognostic (2.41e-3)" "unprognostic (5.37e-2)" 3.9 2.4 13.4 1.4 9.4 0.6 1.6 20.2 26.9 6.3 3.2 5.6 0.0 1.0 4.3 5.0 4.8 5.9 3.3 5.7 8.8 9.1 5.6 0.6 1.2 1.0 6.3 7.8 2.8 2.0 0.6 6.9 1.4 6.8 4.4 2.2 4.3 0.9 5.9 0.7 1.0 1.6 8.2 4.6 0.7 2.0 11.1 8.9 0.0 2.2 0.4 0.8 5.1 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 7.6 8.1 0.0 3.2 8.0 0.4 0.5 0.0 0.3 0.0 0.1 15.9 0.0 2.3 0.0 0.8 0.0 3.7 1.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 15.5 0.0 1.0 0.1 0.0 0.0 0.0 4.5 1.1 0.0 16.6 3.8 3.0 0.0 1.6 1.0 0.0 0.0 7.7 0.4 0.0 1.9 8.6 0.8 6.2 7.0 7.4 0.0 0.0 2.9 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 9.4 20.2 10.9 8.8 9.1 6.3 7.8 6.8 8.9 NLGN2 KIAA1366 ENSG00000169992 "Neuroligin 2" Q8NFZ4 17 7404874-7419860 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.0" "Cell line enhanced" "Detected in many" "AF22: 26.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Low region specificity" "Detected in all" "HPA055321, HPA069278" Enhanced Approved Mitochondria Mitochondria "HPA055321: , HPA069278: " "unprognostic (1.31e-1)" "unprognostic (1.87e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-3)" "unprognostic (2.92e-1)" "unprognostic (1.56e-1)" "unprognostic (6.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.58e-3)" "unprognostic (1.23e-2)" "prognostic unfavourable (3.44e-4)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (5.50e-3)" "unprognostic (1.81e-2)" 13.0 10.9 31.3 9.9 45.3 2.4 7.4 32.7 47.0 16.9 11.3 18.3 9.5 4.4 25.3 16.4 9.0 13.8 15.5 6.6 28.8 16.0 5.7 3.3 6.2 6.1 13.9 27.5 24.3 7.4 20.7 8.3 8.5 21.3 11.6 5.9 11.2 6.5 19.2 6.3 8.7 5.4 24.3 19.4 7.5 5.9 4.8 15.9 0.0 4.8 1.7 5.0 9.8 11.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 4.2 6.0 26.4 15.2 8.1 11.3 0.6 7.1 11.2 12.1 11.1 1.3 1.5 0.0 3.5 9.8 2.4 4.9 2.9 6.5 6.4 4.9 1.8 5.4 1.0 4.1 1.8 6.5 9.1 2.4 9.9 1.6 4.1 1.7 3.4 5.0 4.0 0.8 1.8 4.5 2.8 7.6 3.2 0.8 3.5 0.9 0.4 10.6 3.3 1.5 1.8 4.3 0.2 5.6 10.4 13.3 6.5 3.4 4.0 1.3 0.7 10.8 1.7 3.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.3 45.3 32.7 37.2 28.8 16.0 13.9 27.5 21.3 15.9 NLGN3 "ASPGX1, AUTSX1, HNL3, KIAA1480" ENSG00000196338 "Neuroligin 3" Q9NZ94 X 71144831-71171201 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Asperger syndrome, Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.9" "Cell line enhanced" "Detected in some" "AF22: 10.9;NTERA-2: 7.9;SH-SY5Y: 4.3" "Cancer enriched" "Detected in many" 19 "glioma: 37.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003183, HPA004066" Enhanced Supported "Golgi apparatus,Cell Junctions" "Intracellular and membrane" "Golgi apparatus, Cell Junctions" "HPA003183: AB_1079469, HPA004066: " "unprognostic (4.06e-2)" "unprognostic (1.77e-1)" "unprognostic (1.59e-2)" "unprognostic (2.38e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-1)" "unprognostic (6.52e-2)" "unprognostic (1.63e-1)" "unprognostic (7.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (6.18e-2)" "unprognostic (4.27e-9)" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (2.22e-5)" "unprognostic (9.01e-2)" 1.4 8.9 16.3 1.6 19.4 2.2 1.3 11.5 45.9 3.2 1.6 30.0 0.1 1.1 4.2 8.1 1.5 6.0 2.4 2.1 15.7 9.7 1.2 0.9 1.3 1.2 12.7 13.1 6.1 1.2 1.4 1.1 1.5 15.2 7.9 1.4 1.6 1.6 16.0 0.8 1.6 1.6 2.9 12.9 1.4 1.5 3.8 12.3 0.0 1.0 0.0 1.1 1.5 1.3 0.2 0.1 3.3 0.3 0.3 0.5 0.0 0.1 0.8 10.9 0.3 2.6 1.1 1.9 0.3 0.1 0.0 0.2 0.1 0.5 0.8 0.8 0.1 0.2 0.4 0.0 0.2 0.7 1.3 0.5 0.5 0.1 0.0 0.2 0.9 0.6 0.1 0.3 0.0 0.1 0.7 2.1 0.1 0.6 0.7 1.7 7.9 0.0 0.9 0.4 0.5 0.0 1.2 2.7 4.3 0.3 0.0 0.9 0.0 0.5 0.3 0.2 1.3 0.4 0.0 1.7 1.5 0.6 0.3 0.4 0.6 0.3 0.3 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.5 0.1 3.3 0.3 0.0 0.1 0.1 0.0 16.3 19.4 11.5 23.1 15.7 9.7 12.7 13.1 15.2 12.3 NLGN4X "HLNX, KIAA1260, NLGN, NLGN4" ENSG00000146938 "Neuroligin 4, X-linked" Q8N0W4 X 5840637-6228863 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Asperger syndrome, Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 56.3" "Group enriched" "Detected in some" 4 "AF22: 30.9;NTERA-2: 24.4" "Cancer enhanced" "Detected in many" "glioma: 8.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 6 "B-cells: 1.5" HPA001651 Approved "HPA001651: AB_1079470" "unprognostic (2.21e-1)" "unprognostic (4.01e-2)" "unprognostic (1.11e-1)" "unprognostic (8.57e-2)" "unprognostic (1.28e-1)" "unprognostic (1.52e-1)" "unprognostic (1.36e-1)" "unprognostic (1.04e-1)" "unprognostic (1.67e-1)" "unprognostic (9.49e-2)" "unprognostic (1.48e-2)" "unprognostic (9.32e-2)" "unprognostic (5.10e-3)" "unprognostic (7.16e-4)" "unprognostic (6.70e-2)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" 4.9 2.3 8.3 2.8 10.7 0.3 3.4 12.2 19.2 8.2 3.6 3.7 0.4 2.1 3.7 1.0 1.3 3.4 4.0 5.4 7.9 9.9 0.8 2.2 1.9 1.7 5.6 6.4 16.8 0.9 12.3 2.6 5.4 5.7 2.0 3.2 2.1 1.5 3.3 0.7 1.2 2.9 5.6 4.3 3.2 1.9 3.9 3.9 56.3 1.0 0.0 1.1 3.6 1.8 1.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 3.9 0.0 24.4 0.0 0.0 0.0 0.0 2.2 6.2 1.5 1.9 0.0 0.0 0.0 3.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 8.3 10.7 12.2 14.7 7.9 9.9 5.6 6.4 5.7 3.9 NLGN4Y KIAA0951 ENSG00000165246 "Neuroligin 4, Y-linked" Q8NFZ3 Y 14522573-14845650 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.8;seminal vesicle: 15.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 19.6;fHDF/TERT166: 15.0;HDLM-2: 17.5;hTCEpi: 13.1;U-138 MG: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.0;memory CD4 T-cell: 1.7" "Group enriched" "Detected in many" 12 "B-cells: 3.0;T-cells: 1.7" HPA001651 Approved "Intracellular and membrane" "HPA001651: AB_1079470" "unprognostic (2.31e-1)" "unprognostic (9.19e-2)" "unprognostic (2.84e-5)" "unprognostic (7.85e-2)" "unprognostic (6.46e-2)" "unprognostic (8.80e-3)" "unprognostic (7.71e-2)" "unprognostic (6.26e-2)" "unprognostic (5.89e-2)" "unprognostic (7.20e-3)" "unprognostic (1.88e-1)" "unprognostic (5.65e-2)" 1.4 1.9 4.7 1.4 18.7 0.4 1.3 11.2 23.8 0.4 2.5 11.2 2.4 1.2 0.4 4.0 4.3 0.4 4.8 0.8 4.9 5.7 2.0 4.4 1.3 2.7 3.7 0.0 0.5 3.3 0.4 2.9 0.9 12.6 12.6 3.1 7.2 2.2 15.3 0.6 1.3 2.0 3.7 3.5 1.1 1.5 1.3 0.0 2.5 2.6 4.0 2.5 6.0 0.0 3.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.3 19.6 1.2 1.6 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 3.1 17.5 0.0 0.0 0.0 2.9 2.1 0.0 0.0 6.8 13.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 1.2 0.0 4.0 0.0 0.0 1.3 0.0 4.7 7.5 2.6 0.0 0.0 0.0 0.0 0.0 0.4 5.6 14.4 0.0 0.0 3.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.0 1.7 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 4.7 18.7 11.2 23.8 4.9 5.7 3.7 0.0 12.6 0.0 NOL6 "bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22" ENSG00000165271 "Nucleolar protein 6" Q9H6R4 9 33461441-33473930 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055891, HPA061002" Supported Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA055891: , HPA061002: " "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (2.37e-1)" "unprognostic (5.23e-2)" "unprognostic (2.32e-1)" "unprognostic (2.67e-1)" "prognostic unfavourable (4.83e-5)" "unprognostic (7.37e-3)" "unprognostic (8.26e-2)" "unprognostic (3.03e-2)" "unprognostic (2.09e-1)" "unprognostic (4.24e-2)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (2.06e-1)" "prognostic unfavourable (9.49e-4)" "unprognostic (4.09e-1)" 15.3 14.9 13.3 17.7 19.7 21.0 14.9 16.8 30.8 16.0 11.4 14.6 9.0 10.3 15.3 11.9 21.1 12.8 18.2 13.1 12.4 10.6 13.8 41.6 13.5 15.8 10.1 11.4 20.5 20.5 22.7 18.2 15.4 19.2 17.5 14.8 12.5 15.5 15.5 23.4 23.5 11.3 17.0 7.3 17.6 13.0 19.0 7.8 13.8 13.2 19.7 20.9 12.4 14.5 4.2 7.1 0.3 8.4 3.9 6.0 3.4 15.5 22.5 8.6 19.4 13.5 9.3 14.7 17.4 13.1 20.4 17.2 24.8 5.7 27.2 8.0 19.5 10.9 24.9 25.0 21.6 17.2 10.3 14.0 26.2 13.7 13.3 31.8 20.5 10.2 20.8 27.0 26.1 13.3 22.7 10.5 16.2 13.7 17.8 32.0 31.0 20.6 15.4 8.5 14.1 15.8 18.7 10.2 14.0 14.5 18.8 6.2 7.6 18.6 14.9 12.6 17.0 15.8 30.3 10.0 13.9 23.0 11.1 16.9 14.4 0.0 4.0 0.3 5.4 8.4 6.0 4.2 4.1 5.2 7.1 3.6 5.1 4.8 0.2 3.9 7.9 3.8 4.0 3.4 13.3 19.7 16.8 30.8 12.4 10.6 10.1 11.4 19.2 7.8 NOMO1 PM5 ENSG00000103512 "NODAL modulator 1" Q15155 16 14833681-14896160 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 40.0" "Cell line enhanced" "Detected in many" "AN3-CA: 20.6;Hep G2: 36.6;RPMI-8226: 23.3;SiHa: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB025192, HPA046697, HPA061174" Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB025192: , HPA046697: , HPA061174: " "unprognostic (5.33e-3)" "unprognostic (1.60e-1)" "unprognostic (5.27e-1)" "unprognostic (1.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.51e-1)" "unprognostic (4.18e-3)" "unprognostic (2.08e-2)" "unprognostic (2.28e-1)" "unprognostic (2.76e-1)" "unprognostic (2.08e-2)" "unprognostic (8.31e-2)" "unprognostic (1.30e-2)" "unprognostic (1.09e-1)" "unprognostic (1.50e-2)" "unprognostic (2.51e-2)" "prognostic unfavourable (3.15e-4)" 4.2 3.3 4.4 10.1 11.1 0.8 4.6 7.9 10.2 2.4 3.7 5.4 1.5 1.4 6.1 3.6 3.4 8.3 2.8 12.9 5.2 6.4 11.3 8.9 4.1 3.4 4.6 10.6 11.7 40.0 1.2 3.3 9.1 6.6 5.9 10.3 2.7 4.1 5.9 12.2 6.9 7.0 9.0 3.5 1.8 5.9 15.0 2.8 1.5 9.9 1.5 2.4 2.6 1.9 1.2 3.8 5.2 4.0 1.4 1.0 1.0 0.3 12.5 15.7 20.6 0.0 1.5 10.2 1.3 3.1 3.8 3.9 0.2 0.9 1.3 0.9 2.8 0.2 2.8 0.1 3.9 1.9 0.0 1.2 16.7 36.6 13.6 1.8 0.9 0.2 0.2 2.0 2.2 2.9 7.1 0.8 17.7 0.0 0.4 0.0 0.0 0.0 0.8 1.4 23.3 0.0 0.7 0.3 11.6 42.3 0.0 0.2 17.2 0.1 0.4 0.5 0.0 1.8 14.5 0.0 0.6 1.5 0.9 0.7 0.5 5.2 0.6 0.6 0.3 1.2 0.7 0.2 0.3 0.9 0.5 1.2 0.5 0.8 1.6 1.4 4.0 3.8 1.0 1.0 4.4 11.1 7.9 10.2 5.2 6.4 4.6 10.6 6.6 2.8 NOMO2 "NOMO, PM5" ENSG00000185164 "NODAL modulator 2" Q5JPE7 16 18417325-18562211 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA046697, HPA061174" Approved "HPA046697: , HPA061174: " "unprognostic (2.58e-3)" "unprognostic (4.11e-3)" "unprognostic (2.58e-2)" "unprognostic (9.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.85e-2)" "unprognostic (4.80e-2)" "unprognostic (9.37e-2)" "unprognostic (1.34e-1)" "unprognostic (3.47e-2)" "unprognostic (1.09e-2)" "unprognostic (1.78e-1)" "unprognostic (1.78e-3)" "unprognostic (2.22e-1)" "unprognostic (3.42e-2)" "unprognostic (8.39e-2)" "unprognostic (1.54e-2)" 5.6 6.0 5.0 3.6 6.7 3.6 4.4 11.0 13.2 5.4 6.3 5.0 6.0 10.1 4.4 4.5 3.2 16.0 5.5 8.4 4.6 8.2 6.9 2.7 6.0 4.5 21.4 19.6 6.7 8.4 6.7 6.1 5.8 5.6 12.8 5.6 4.4 7.0 4.4 4.3 7.2 3.2 6.6 4.4 5.6 3.7 10.6 20.9 13.2 13.0 7.3 20.1 15.5 13.7 19.6 7.5 20.9 29.3 17.8 22.7 24.1 28.9 20.5 25.6 17.1 21.2 16.4 87.4 42.0 15.9 16.0 16.8 18.0 12.8 12.7 7.0 21.1 61.3 40.8 16.9 50.9 18.7 22.1 23.9 21.7 22.4 9.8 36.7 24.2 41.4 6.2 37.4 14.5 8.1 13.2 10.1 44.1 30.5 11.6 10.4 8.6 18.7 25.4 15.5 20.2 36.1 20.8 12.2 9.6 24.8 16.5 18.8 21.2 8.7 28.0 17.7 17.0 13.2 11.1 10.1 13.5 11.1 10.9 10.6 13.7 13.9 13.0 7.7 9.2 11.8 12.8 7.3 13.0 20.9 20.1 15.5 NOMO3 ENSG00000103226 "NODAL modulator 3" P69849 16 16232495-16294814 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046697, HPA061174" Approved "HPA046697: , HPA061174: " "unprognostic (1.21e-1)" "unprognostic (1.41e-2)" "unprognostic (6.46e-2)" "unprognostic (2.31e-1)" "unprognostic (3.99e-2)" "unprognostic (1.33e-1)" "unprognostic (9.81e-2)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (8.02e-2)" "unprognostic (6.25e-2)" "unprognostic (8.43e-2)" "unprognostic (7.86e-3)" "unprognostic (1.82e-1)" "unprognostic (1.65e-1)" "unprognostic (1.10e-2)" "unprognostic (1.22e-1)" 2.9 3.0 4.9 2.0 7.9 8.1 4.5 6.0 10.6 3.0 2.8 3.7 3.2 1.8 3.8 3.9 3.9 2.1 1.5 11.6 3.6 3.9 2.2 2.9 3.3 2.2 2.7 4.2 2.5 16.2 2.1 3.5 3.8 7.5 2.2 4.8 3.0 3.1 3.4 10.4 7.5 2.5 2.3 2.8 5.2 4.0 6.0 0.8 0.8 2.7 3.5 3.6 3.2 1.7 0.2 0.1 0.0 0.9 0.1 0.4 0.2 0.7 3.1 0.3 2.7 0.9 4.9 0.4 0.4 0.5 1.7 0.8 1.5 1.7 2.1 2.6 0.0 0.7 1.1 2.1 0.4 0.6 2.6 0.0 4.1 9.7 1.5 2.1 2.7 0.6 3.1 3.6 1.1 0.4 1.5 1.8 1.3 6.1 0.7 3.1 0.5 1.7 1.6 0.3 2.2 1.1 1.2 0.5 1.3 0.4 2.1 0.1 0.4 0.5 1.9 0.5 1.1 2.6 0.4 2.7 0.7 1.9 0.5 2.1 1.1 0.0 0.9 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.2 4.9 7.9 6.0 10.6 3.6 3.9 2.7 4.2 7.5 0.8 NOTCH1 TAN1 ENSG00000148400 "Notch 1" P46531 9 136494433-136545786 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 24.5;HMC-1: 21.3;hTCEpi: 23.6;MOLT-4: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.8" "Group enriched" "Detected in many" 4 "granulocytes: 8.8;NK-cells: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008112, CAB022466, HPA067168" Supported Approved Nucleoplasm 8100000 Nucleoplasm "CAB008112: AB_2153490, CAB022466: , HPA067168: " "unprognostic (1.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.16e-1)" "unprognostic (8.38e-3)" "unprognostic (3.04e-1)" "unprognostic (1.13e-1)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (5.74e-3)" "unprognostic (5.50e-3)" "unprognostic (8.78e-2)" "unprognostic (8.50e-2)" "prognostic unfavourable (5.45e-4)" "unprognostic (2.14e-2)" "unprognostic (1.92e-1)" "unprognostic (5.65e-2)" "unprognostic (8.84e-2)" 20.0 4.0 10.0 14.5 10.4 14.6 12.8 3.8 18.8 12.8 14.2 19.9 8.2 9.8 11.2 5.1 13.3 9.6 13.1 9.6 10.7 5.8 9.4 7.2 17.4 13.7 11.6 7.5 9.2 17.8 3.7 5.6 8.5 9.3 12.1 5.7 10.4 14.2 11.8 8.2 32.3 10.8 7.7 6.6 20.7 8.6 4.1 9.9 34.8 9.4 10.2 10.9 12.3 22.2 0.6 1.1 8.8 1.0 2.7 1.3 0.9 4.4 7.3 6.1 3.0 0.2 0.5 7.6 2.2 0.6 1.3 0.4 1.0 0.5 5.9 4.6 1.7 24.5 2.0 10.0 0.2 13.5 1.1 3.3 3.0 0.4 3.4 3.5 21.3 0.3 23.6 1.7 3.7 7.8 1.4 1.1 0.8 7.9 37.4 5.7 5.1 3.4 7.7 4.9 11.0 0.9 3.7 0.0 0.4 3.2 3.4 1.4 2.1 5.6 11.5 3.2 4.7 3.1 2.4 1.2 1.0 2.4 2.2 2.5 16.5 0.7 1.0 2.8 1.3 0.4 0.8 0.4 0.6 1.0 0.6 0.6 0.4 1.1 8.8 2.7 0.4 1.1 0.4 0.9 10.0 10.4 3.8 11.7 10.7 5.8 11.6 7.5 9.3 9.9 NOTCH2 ENSG00000134250 "Notch 2" Q04721 1 119911553-120069626 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048743 Approved Supported "Nucleoplasm,Plasma membrane" 67000000 "Nucleoplasm, Plasma membrane" "HPA048743: " "unprognostic (1.33e-1)" "unprognostic (1.43e-2)" "unprognostic (2.66e-1)" "unprognostic (1.40e-3)" "unprognostic (7.98e-2)" "unprognostic (4.01e-2)" "unprognostic (1.22e-1)" "unprognostic (7.32e-2)" "unprognostic (1.18e-2)" "prognostic unfavourable (5.24e-4)" "prognostic unfavourable (9.48e-4)" "unprognostic (3.86e-2)" "unprognostic (6.12e-3)" "unprognostic (1.55e-2)" "unprognostic (2.65e-2)" "unprognostic (1.12e-2)" "unprognostic (7.35e-3)" 12.0 7.3 6.0 9.4 6.8 4.4 10.6 3.0 5.6 14.5 7.6 4.4 11.3 1.6 12.3 11.8 13.4 11.4 12.8 7.9 6.8 2.3 5.5 11.4 10.6 5.7 5.3 7.6 15.5 27.6 6.1 3.3 10.3 6.5 9.9 5.2 9.4 17.7 10.0 9.3 17.2 6.1 12.4 6.2 11.5 5.8 15.7 4.4 8.0 11.4 8.6 6.6 9.6 13.0 4.2 5.2 7.7 9.6 1.5 1.7 2.0 14.9 5.0 7.8 6.0 32.7 28.0 7.8 11.4 15.7 15.2 16.5 4.6 4.0 0.3 9.6 21.5 5.7 12.4 10.1 24.3 17.9 7.9 8.6 13.6 0.4 12.2 9.0 2.3 22.4 6.6 45.6 30.4 7.7 0.1 19.0 18.3 16.7 3.8 2.5 10.1 5.6 2.5 27.6 9.6 8.0 9.5 0.3 3.9 15.4 14.5 8.2 8.0 3.1 27.1 19.9 13.7 29.8 17.8 7.9 3.9 4.4 29.2 8.3 18.9 5.6 6.4 6.4 1.5 6.6 1.7 4.2 1.3 1.1 5.2 3.9 1.0 1.7 7.7 1.5 9.6 4.2 0.8 2.0 6.0 6.8 3.0 5.6 6.8 2.3 5.3 7.6 6.5 4.4 NOTCH3 "CADASIL, CASIL" ENSG00000074181 "Notch 3" Q9UM47 19 15159038-15200981 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 27.9;MCF7: 27.4;U-87 MG: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 10 "dendritic cells: 2.4;granulocytes: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005393, HPA044392" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" 18000000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB005393: AB_2151246, HPA044392: " "unprognostic (4.97e-2)" "unprognostic (3.89e-2)" "unprognostic (7.06e-3)" "prognostic unfavourable (5.92e-4)" "unprognostic (9.20e-2)" "unprognostic (1.73e-2)" "unprognostic (2.72e-1)" "unprognostic (9.04e-2)" "unprognostic (3.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (3.13e-1)" "prognostic unfavourable (2.53e-7)" "unprognostic (3.35e-2)" "unprognostic (8.34e-3)" "unprognostic (4.40e-2)" "unprognostic (2.00e-3)" 35.9 3.7 4.7 6.4 6.4 0.5 53.7 2.7 7.5 25.9 7.3 6.2 9.2 3.7 22.9 23.1 33.8 14.6 22.7 25.0 4.6 3.6 9.2 1.6 16.2 11.7 5.0 6.4 14.1 6.9 10.1 4.9 37.3 6.4 13.4 3.0 8.3 11.4 11.4 16.6 48.3 6.2 11.0 2.8 11.8 5.5 10.1 3.9 44.4 14.9 36.7 10.3 14.9 24.6 0.1 2.4 1.0 0.1 0.1 0.1 0.0 5.2 3.3 27.9 12.7 3.9 3.2 12.6 4.2 0.2 0.2 0.1 6.3 5.5 0.1 3.3 7.7 6.2 5.0 0.1 0.2 0.0 1.3 0.1 5.2 1.4 1.9 0.0 0.5 3.6 3.1 6.5 0.7 0.3 0.2 0.2 0.5 27.4 6.3 0.0 16.3 0.0 0.0 1.6 0.1 0.0 16.9 0.8 9.0 0.0 15.9 0.0 16.9 0.0 0.0 0.8 9.1 0.1 0.1 0.0 0.3 0.0 19.5 0.1 0.4 1.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.0 2.4 0.0 0.0 4.7 6.4 2.7 7.5 4.6 3.6 5.0 6.4 6.4 3.9 NOX4 "KOX, KOX-1" ENSG00000086991 "NADPH oxidase 4" Q9NPH5 11 89324356-89498187 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 65.2" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 15.4;TIME: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015475 Approved Nucleoplasm Nucleoplasm "HPA015475: AB_1854574" "unprognostic (2.91e-2)" "unprognostic (1.08e-1)" "unprognostic (1.74e-3)" "unprognostic (6.58e-3)" "unprognostic (1.92e-1)" "unprognostic (2.33e-1)" "unprognostic (8.83e-3)" "unprognostic (8.95e-3)" "unprognostic (3.80e-1)" "unprognostic (6.88e-2)" "unprognostic (1.56e-2)" "unprognostic (1.73e-1)" "prognostic favourable (6.14e-4)" "unprognostic (1.99e-4)" "unprognostic (9.71e-2)" "unprognostic (5.69e-2)" "unprognostic (3.03e-3)" 7.5 0.6 0.2 0.6 0.6 0.3 6.5 0.3 0.5 1.2 0.9 1.1 0.4 0.3 7.3 2.5 1.5 0.8 1.3 6.9 0.6 0.2 65.2 0.3 1.2 0.3 0.3 0.2 0.7 1.1 3.8 0.8 1.7 1.0 2.6 0.4 0.8 2.6 0.9 5.1 1.1 0.5 3.5 1.2 0.4 0.4 1.0 0.0 0.0 1.7 1.7 0.4 2.1 1.1 0.4 0.3 1.7 0.3 0.8 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 15.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.2 0.3 0.0 34.4 0.1 2.7 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.4 0.3 0.3 1.7 0.8 0.2 0.3 0.2 0.0 0.2 0.6 0.3 0.5 0.6 0.2 0.3 0.2 1.0 0.0 NPC1 SLC65A1 ENSG00000141458 "NPC intracellular cholesterol transporter 1" O15118 18 23506184-23586898 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6" "Cell line enhanced" "Detected in all" "hTERT-HME1: 70.3;U-87 MG: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 32.7" "Group enriched" "Detected in all" 4 "dendritic cells: 32.7;T-cells: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026618, CAB070132, HPA077445" Approved Supported Nucleoplasm,Vesicles 27000 "Nucleoplasm, Vesicles" "CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: " "unprognostic (1.74e-1)" "unprognostic (1.53e-3)" "unprognostic (2.67e-1)" "unprognostic (1.25e-1)" "unprognostic (3.20e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (2.26e-6)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (7.36e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-3)" "unprognostic (2.78e-2)" "unprognostic (1.89e-1)" "unprognostic (2.73e-2)" "unprognostic (1.38e-1)" "unprognostic (2.08e-3)" 13.4 38.8 17.4 11.2 30.9 26.4 15.8 7.1 25.1 10.1 8.7 65.6 3.4 10.2 11.1 11.7 12.8 8.2 11.2 7.1 23.4 14.3 9.9 10.3 17.8 13.0 46.0 15.4 12.0 7.9 51.8 9.9 18.9 27.7 9.7 8.9 12.0 25.4 10.1 13.7 17.0 12.2 10.9 41.4 11.5 12.0 9.5 38.4 7.0 8.3 5.3 10.7 10.8 10.8 3.6 32.7 3.8 5.8 4.6 14.5 4.1 5.3 10.6 4.5 7.4 14.9 11.6 10.5 9.3 20.2 9.9 21.4 7.1 7.8 4.5 7.2 13.4 15.0 5.8 15.9 8.8 3.5 4.6 1.6 9.6 16.0 21.4 6.1 7.3 11.1 15.8 20.8 70.3 9.7 4.8 12.0 11.0 8.1 2.5 3.6 3.2 9.6 3.6 7.2 11.2 23.0 13.3 1.9 3.7 11.1 16.1 13.7 4.0 4.8 12.5 21.0 4.1 8.3 8.0 7.5 23.1 3.1 46.2 5.4 9.4 1.8 4.1 3.8 14.5 3.8 9.8 2.4 5.9 9.9 1.7 3.6 2.7 7.3 3.7 4.6 5.8 32.7 7.7 4.1 17.4 30.9 7.1 25.1 23.4 14.3 46.0 15.4 27.7 38.4 NPDC1 "CAB-, CAB1, DKFZp586J0523" ENSG00000107281 "Neural proliferation, differentiation and control 1" Q9NQX5 9 137039470-137046203 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 8.4;MAIT T-cell: 10.7;memory CD4 T-cell: 13.2;memory CD8 T-cell: 13.6;T-reg: 10.4" "Lineage enriched" "Detected in many" 7 "T-cells: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008189 Approved Approved Nucleoplasm,Cytosol 180000 Nucleoplasm Cytosol "HPA008189: AB_1854584" "unprognostic (6.94e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (2.01e-5)" "prognostic favourable (6.19e-5)" "unprognostic (2.06e-1)" "unprognostic (4.83e-3)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (8.65e-2)" "unprognostic (1.53e-1)" "prognostic favourable (3.18e-4)" "unprognostic (2.40e-1)" "unprognostic (2.65e-2)" "unprognostic (1.23e-2)" "unprognostic (2.35e-1)" "unprognostic (4.20e-2)" "unprognostic (8.84e-2)" 35.4 21.7 33.1 11.9 35.5 4.1 21.6 59.7 65.6 27.8 27.1 18.4 23.8 22.2 26.7 10.8 11.6 25.4 32.3 20.4 34.5 35.3 12.7 5.9 18.9 11.5 25.1 49.0 12.0 28.6 17.2 47.7 20.1 29.5 73.1 13.3 10.6 58.0 35.5 19.0 17.7 23.0 16.4 30.3 32.4 59.6 10.4 14.5 0.8 11.5 8.6 7.2 12.8 20.2 0.1 2.0 0.5 0.4 0.1 13.6 2.6 9.4 11.4 2.8 18.4 6.6 6.7 0.7 20.4 6.4 4.6 1.8 4.6 5.2 9.4 15.5 7.8 35.6 2.4 5.5 0.5 7.6 11.6 3.8 29.2 3.3 9.5 3.3 0.0 4.7 8.6 2.5 5.0 11.8 0.2 0.2 0.9 35.9 0.2 0.3 6.1 19.0 5.6 0.0 36.0 7.7 6.1 22.7 15.7 5.4 18.2 12.2 39.3 4.7 20.2 3.4 6.2 24.2 6.2 0.0 0.1 0.3 5.0 0.3 2.9 0.0 0.4 0.5 8.4 0.0 10.7 0.1 13.2 13.6 0.7 0.0 0.3 2.3 0.0 0.1 0.0 2.0 10.4 2.6 33.1 35.5 59.7 65.6 34.5 35.3 25.1 49.0 29.5 14.5 NPHP4 "KIAA0673, POC10, SLSN4" ENSG00000131697 "Nephrocystin 4" O75161 1 5862811-5992473 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063852, HPA065526" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies, Vesicles" "HPA063852: , HPA065526: " "unprognostic (1.82e-1)" "unprognostic (1.57e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (5.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.08e-2)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (1.23e-2)" "unprognostic (7.49e-3)" "unprognostic (9.00e-2)" "unprognostic (1.75e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" 5.6 4.7 7.3 4.7 11.2 7.2 4.9 6.3 12.0 5.4 3.5 4.9 8.9 4.4 5.2 11.9 3.7 17.4 5.7 3.7 6.6 3.9 4.5 2.5 6.7 4.6 2.8 6.4 7.0 4.9 7.1 17.8 3.7 5.4 4.5 2.9 8.3 4.1 5.7 3.7 9.6 4.5 5.3 3.5 4.6 4.3 11.4 3.7 5.8 14.9 3.7 2.6 4.3 4.5 0.5 0.4 2.6 1.0 0.5 0.8 0.4 7.5 4.2 5.6 4.4 5.1 7.4 4.4 4.0 4.1 5.6 4.4 4.0 6.7 4.0 10.0 4.5 7.1 2.8 6.8 2.8 4.9 6.4 3.3 7.7 3.6 3.5 6.6 5.2 5.9 3.4 6.6 4.2 3.9 6.1 4.3 2.5 5.6 8.0 6.6 0.9 4.5 6.9 3.6 6.5 2.5 1.0 17.9 5.5 6.2 4.6 6.6 6.1 7.2 3.5 8.1 3.4 13.3 4.8 5.2 6.8 4.0 3.4 8.3 2.1 2.6 1.0 0.0 0.5 0.2 0.8 0.3 0.5 0.0 0.4 0.5 0.4 0.0 1.4 0.5 0.8 0.3 0.2 0.4 7.3 11.2 6.3 12.0 6.6 3.9 2.8 6.4 5.4 3.7 NPHS1 "CNF, NPHN" ENSG00000161270 "NPHS1, nephrin" O60500 19 35825964-35869287 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Myogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 20.2;pancreas: 21.8" "Cell line enriched" "Detected in some" 4 "HMC-1: 5.3" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB035555 Enhanced "CAB035555: " "unprognostic (3.42e-2)" "unprognostic (1.53e-1)" "unprognostic (1.96e-1)" "unprognostic (3.53e-2)" "unprognostic (1.65e-1)" "unprognostic (2.39e-2)" "unprognostic (6.47e-3)" "unprognostic (2.25e-2)" "unprognostic (1.58e-1)" "unprognostic (1.69e-1)" "unprognostic (3.32e-2)" "unprognostic (3.17e-1)" "unprognostic (3.83e-5)" "unprognostic (4.30e-2)" "unprognostic (4.38e-2)" "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 3.4 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.9 0.0 0.0 0.1 0.1 2.4 0.0 0.1 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.8 0.0 0.3 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.4 0.1 0.0 0.1 0.0 0.0 NPHS2 "PDCN, SRN1" ENSG00000116218 "NPHS2, podocin" Q9NP85 1 179550539-179575952 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 143 "kidney: 66.5" "Cell line enriched" "Detected in single" 24 "NTERA-2: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB037267, HPA049486" Enhanced "CAB037267: AB_261982, HPA049486: " "unprognostic (6.77e-2)" "unprognostic (9.71e-2)" "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPA1 "morpheus, NPIP" ENSG00000183426 "Nuclear pore complex interacting protein family member A1" Q9UND3 16 14922802-14952060 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.1" "Cell line enhanced" "Detected in many" "HHSteC: 33.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 16 "B-cells: 2.3;granulocytes: 1.7;T-cells: 1.3" HPA053611 Supported Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (2.77e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-2)" "unprognostic (2.29e-2)" "unprognostic (9.21e-2)" "unprognostic (1.65e-2)" "unprognostic (5.12e-2)" "unprognostic (1.08e-1)" "unprognostic (8.82e-3)" "unprognostic (3.65e-2)" "unprognostic (1.74e-7)" "unprognostic (2.28e-1)" "unprognostic (8.76e-2)" "unprognostic (1.73e-2)" "unprognostic (2.66e-5)" 5.1 6.0 5.9 3.8 4.9 4.2 4.8 33.1 8.3 5.0 5.8 1.8 15.6 0.0 3.0 16.3 2.7 4.6 7.0 6.2 6.6 3.0 4.3 5.4 3.7 25.2 4.7 1.1 13.6 3.0 7.8 3.3 2.5 11.7 7.9 16.3 3.0 12.4 3.8 5.0 3.2 6.5 6.1 4.1 5.0 4.0 2.3 0.0 1.7 0.1 0.1 1.3 0.7 0.1 5.2 24.1 9.3 0.0 0.4 4.2 9.2 6.4 8.5 7.6 3.6 5.7 1.5 13.2 12.7 4.2 11.1 1.2 8.7 4.7 4.2 0.0 8.1 19.2 33.5 11.5 2.7 18.6 18.2 7.0 12.8 4.1 1.2 6.4 9.6 11.1 0.0 6.1 0.2 0.2 4.5 0.1 2.1 13.6 11.1 1.0 9.2 4.9 0.6 10.4 1.9 10.1 0.8 11.3 0.5 0.2 2.9 3.8 2.7 3.0 0.4 0.7 5.7 1.7 0.0 0.0 0.8 0.0 1.3 2.3 0.3 1.2 0.0 1.3 0.6 0.4 0.0 0.1 0.1 0.0 0.7 0.7 NPIPA2 ENSG00000254852 "Nuclear pore complex interacting protein family member A2" E9PIF3 16 14748066-14765413 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 11.8" "Cell line enhanced" "Detected in some" "BEWO: 12.0;NB-4: 4.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " 1.6 1.2 1.3 1.1 1.5 0.9 1.8 11.8 3.8 0.6 3.2 0.6 1.7 2.7 1.1 2.4 0.8 1.3 1.8 1.5 0.6 0.5 1.6 0.9 1.0 2.6 1.2 2.3 4.1 1.1 2.2 2.6 3.1 1.0 4.2 4.1 1.0 0.8 1.3 0.9 1.6 5.9 1.2 0.8 3.3 1.5 1.6 0.0 0.1 0.1 0.0 0.5 0.0 0.4 0.4 0.3 0.0 0.4 0.3 12.0 1.0 0.5 0.1 0.3 0.4 1.7 0.0 1.1 0.9 1.4 0.3 0.0 0.1 0.9 0.7 0.8 0.9 0.2 0.4 0.2 2.8 0.1 1.6 1.6 1.2 0.3 0.8 0.8 0.2 2.3 1.3 4.1 0.8 0.5 1.3 0.8 0.2 0.7 0.6 1.1 0.6 0.4 0.7 1.7 0.0 1.0 0.9 0.4 0.3 0.0 0.5 0.4 0.3 0.3 1.4 0.6 1.0 0.1 0.1 0.0 0.5 0.0 0.3 0.7 0.5 0.1 0.0 1.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 NPIPA3 ENSG00000224712 "Nuclear pore complex interacting protein family member A3" F8WFD2 16 14708944-14726338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 13.2" "Cell line enhanced" "Detected in some" "HSkMC: 5.0;NB-4: 11.2;SK-MEL-30: 16.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (1.44e-1)" "unprognostic (7.83e-3)" "unprognostic (8.12e-3)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" "unprognostic (5.69e-3)" "unprognostic (3.11e-2)" "unprognostic (4.58e-3)" "unprognostic (4.87e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (1.67e-3)" "unprognostic (1.20e-3)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" "unprognostic (1.71e-2)" 1.3 1.4 1.8 2.3 1.3 1.9 1.2 13.2 5.0 0.8 2.9 0.5 2.4 2.2 1.1 2.8 6.4 1.0 2.2 1.8 1.1 0.8 1.2 1.0 1.1 2.8 1.5 7.2 4.1 1.3 2.3 2.6 1.9 2.9 5.3 3.2 3.4 1.2 1.0 1.0 1.3 1.8 1.4 1.0 1.9 1.6 0.1 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.6 0.1 0.3 0.0 0.1 1.5 0.5 0.0 0.4 0.4 0.0 2.1 3.5 0.2 1.3 0.1 0.1 2.3 0.3 0.1 0.0 0.4 0.7 0.4 0.2 0.1 0.5 5.0 0.7 1.3 0.2 0.1 0.1 0.3 0.3 1.2 0.0 11.2 0.9 0.0 0.1 0.0 0.0 3.1 1.0 0.5 0.5 0.0 0.2 16.1 0.2 0.0 0.5 0.6 0.1 0.0 0.1 0.0 0.2 0.1 1.9 0.1 2.0 1.6 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPA5 ENSG00000183793 "Nuclear pore complex interacting protein family member A5" E9PKD4 16 15363624-15381047 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 25.3" "Cell line enhanced" "Detected in many" "THP-1: 15.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (4.19e-4)" "unprognostic (5.85e-2)" "unprognostic (5.92e-2)" "unprognostic (7.85e-2)" "unprognostic (6.58e-2)" "unprognostic (9.02e-3)" "unprognostic (1.57e-2)" "unprognostic (4.34e-3)" "unprognostic (1.85e-1)" "unprognostic (2.85e-1)" "unprognostic (9.18e-2)" "unprognostic (4.02e-2)" 2.0 2.7 4.9 0.8 4.0 3.2 3.3 25.3 6.6 3.2 4.5 2.4 8.0 8.4 4.0 5.8 4.8 4.2 5.5 5.7 1.9 2.5 4.5 2.4 3.6 5.5 4.0 7.6 8.9 1.0 3.3 2.4 1.6 2.5 4.6 13.9 2.1 2.6 2.5 2.7 2.3 8.8 2.9 1.0 2.8 2.5 0.8 0.3 0.1 0.1 1.1 0.7 0.1 0.9 1.4 4.9 0.7 9.2 9.7 0.7 1.9 4.6 6.4 6.5 2.0 0.8 2.0 0.5 4.9 2.0 1.7 4.9 3.3 3.9 1.9 2.6 5.8 9.7 1.3 0.6 3.6 1.9 8.4 2.5 3.4 3.3 2.7 1.5 6.1 1.0 2.0 3.2 6.8 0.9 0.7 0.7 0.6 5.4 1.9 0.0 0.7 5.4 2.4 6.0 2.4 15.5 7.7 0.0 2.5 7.5 0.4 4.3 6.0 7.2 0.9 3.7 1.3 0.1 0.1 0.0 0.1 0.0 0.7 0.8 0.4 0.2 0.3 0.4 0.2 0.1 0.0 1.1 0.1 0.1 0.1 0.1 NPIPA7 ENSG00000214967 "Nuclear pore complex interacting protein family member A7" E9PJI5 16 16379055-16393954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 38.6;THP-1: 33.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "B-cells: 1.7;T-cells: 1.9" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (1.17e-2)" 3.6 5.7 3.0 2.8 3.0 3.7 2.9 19.7 4.0 3.2 5.1 3.1 3.7 10.1 5.3 5.5 6.2 1.9 3.8 3.4 4.4 5.9 3.8 5.2 1.7 5.1 8.8 12.4 18.0 3.2 6.1 9.0 6.6 3.2 2.6 13.8 4.2 3.9 1.6 6.3 4.2 6.1 6.8 4.3 4.1 3.3 1.7 0.1 0.2 0.1 0.4 1.9 0.2 3.0 6.8 8.2 3.1 4.9 4.0 5.4 6.4 2.5 7.4 3.9 7.1 4.9 7.8 5.2 6.7 9.5 5.7 6.6 5.5 2.2 1.7 7.7 20.9 10.3 4.6 2.7 38.6 7.0 25.5 4.0 8.7 3.7 4.5 10.0 8.0 13.1 6.2 15.9 5.6 2.3 9.2 5.5 4.4 12.1 13.2 10.6 5.7 5.1 11.8 5.4 8.5 33.1 3.2 7.1 3.4 3.2 5.4 2.1 7.5 6.3 4.1 8.6 3.1 0.2 0.1 0.0 1.9 0.0 0.4 1.5 1.2 1.9 0.0 1.7 0.2 0.3 0.0 0.4 0.1 0.1 0.4 0.2 NPIPA8 LCR16a9 ENSG00000214940 "Nuclear pore complex interacting protein family member A8" P0DM63 16 18317942-18336736 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 14.1" "Cell line enhanced" "Detected in some" "Daudi: 17.8;EFO-21: 17.8;HMC-1: 66.0;SCLC-21H: 16.1;THP-1: 17.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (1.68e-1)" "unprognostic (3.60e-2)" "unprognostic (2.81e-1)" 2.6 7.9 2.0 1.3 2.8 3.9 2.3 14.1 10.8 1.4 5.5 0.0 0.6 0.0 0.9 5.1 0.0 2.6 3.4 1.9 1.1 1.0 2.4 1.5 0.5 6.0 1.1 7.6 6.6 4.8 2.3 1.3 1.5 6.5 1.5 4.6 1.7 0.0 0.2 4.4 1.4 2.1 1.6 0.0 3.8 0.5 1.8 0.5 1.7 0.6 0.1 1.1 0.3 0.0 0.6 0.0 0.1 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.1 3.1 17.8 17.8 0.1 0.0 7.0 2.1 0.0 0.0 0.0 0.0 0.5 0.5 3.0 0.0 66.0 0.1 0.0 0.0 0.0 1.3 6.9 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.7 10.9 0.5 0.0 0.0 16.1 5.1 0.0 0.1 0.1 0.0 17.8 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 5.7 4.9 0.4 0.0 0.6 0.0 0.6 0.0 1.1 1.8 0.5 0.2 0.3 0.2 0.7 0.4 1.7 0.1 0.0 0.5 0.0 0.3 NPIPB11 ENSG00000254206 "Nuclear pore complex interacting protein family member B11" E5RHQ5 16 29381354-29404029 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 12.3" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 3.1" "Low lineage specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (6.82e-2)" "unprognostic (2.99e-1)" "unprognostic (1.93e-3)" "unprognostic (1.42e-1)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "unprognostic (3.06e-1)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (1.36e-1)" "unprognostic (5.57e-4)" "unprognostic (7.41e-2)" "unprognostic (2.94e-6)" "unprognostic (2.79e-1)" "unprognostic (1.98e-1)" "unprognostic (5.96e-3)" "unprognostic (4.79e-5)" 2.0 1.0 1.9 3.2 2.5 5.3 1.9 5.9 2.4 1.6 1.8 2.3 2.1 4.2 1.7 2.9 2.1 1.8 2.4 1.9 2.7 3.5 1.9 7.4 1.5 4.4 1.6 0.7 2.3 1.2 2.3 2.0 2.8 0.5 5.1 8.8 3.1 0.9 1.7 5.5 3.2 4.5 2.9 1.0 1.0 1.9 3.1 0.7 1.4 0.5 0.4 1.1 0.2 1.9 1.6 2.9 4.2 2.2 1.7 4.0 1.8 0.8 1.6 0.7 2.1 3.7 12.3 2.8 0.9 3.4 2.3 2.7 1.7 2.8 3.2 2.6 4.9 3.5 1.1 3.3 6.5 1.0 2.2 1.7 2.4 0.8 3.4 3.6 1.5 4.3 2.7 10.5 5.1 3.5 4.3 1.2 3.7 1.8 1.4 3.8 1.9 0.5 2.6 1.4 1.4 4.2 3.8 4.0 1.7 2.9 2.5 3.3 2.1 10.0 2.2 4.2 2.9 0.2 0.5 0.1 1.0 0.0 0.2 0.5 0.5 0.8 0.7 3.1 1.1 1.1 1.4 0.4 0.4 0.2 0.0 0.2 NPIPB12 ENSG00000169203 "Nuclear pore complex interacting protein family, member B12" 16 29483642-29505999 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 58.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (3.83e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-2)" "unprognostic (1.77e-1)" "unprognostic (7.92e-2)" "unprognostic (1.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.20e-2)" "unprognostic (2.42e-1)" "unprognostic (6.08e-2)" "unprognostic (1.28e-2)" "unprognostic (6.28e-7)" "unprognostic (3.32e-2)" "unprognostic (4.11e-2)" "unprognostic (2.33e-1)" "unprognostic (2.14e-4)" 4.4 2.8 3.2 7.5 4.2 11.3 3.7 10.1 6.3 4.1 5.0 4.4 4.3 7.9 2.9 3.3 4.7 4.3 3.9 3.4 4.7 8.2 5.3 10.8 2.9 5.6 3.8 4.7 5.8 3.5 4.6 4.9 7.8 3.7 8.1 23.7 6.2 3.5 4.0 9.0 4.2 5.3 6.7 5.3 3.1 4.0 9.0 2.2 14.5 3.0 12.6 3.7 0.9 9.2 9.3 7.5 19.4 9.2 5.4 14.1 5.6 1.6 2.9 2.5 8.0 19.2 15.4 10.2 4.5 12.1 12.8 8.9 3.8 10.0 9.5 11.5 10.7 15.7 8.4 12.4 22.6 8.6 7.1 6.2 6.6 3.2 11.5 13.3 4.5 15.2 8.8 58.4 11.6 6.8 21.6 3.2 14.9 6.8 6.7 8.2 5.7 3.1 13.9 8.1 6.8 15.6 8.1 18.7 7.0 12.9 10.6 7.4 7.1 15.2 7.6 22.5 8.6 14.5 3.0 1.1 3.7 1.0 0.9 3.4 2.1 2.4 2.0 9.0 2.9 1.9 8.1 12.6 2.3 2.2 1.5 0.9 NPIPB13 ENSG00000198064 "Nuclear pore complex interacting protein family, member B13" A6NJU9 16 30222937-30254510 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (7.11e-3)" "unprognostic (4.08e-2)" "unprognostic (1.83e-1)" "unprognostic (1.89e-3)" "unprognostic (4.87e-2)" "unprognostic (2.49e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (7.69e-2)" "unprognostic (3.67e-1)" "unprognostic (1.41e-1)" "unprognostic (3.09e-7)" "unprognostic (1.86e-2)" "unprognostic (2.98e-1)" "unprognostic (3.17e-1)" "unprognostic (2.58e-2)" 1.8 1.1 1.9 2.3 2.0 6.5 2.3 7.6 3.3 2.3 2.3 1.7 2.4 6.2 2.0 1.9 1.7 1.5 2.4 1.6 1.6 2.3 2.7 4.2 1.5 2.7 1.4 4.8 2.9 1.7 2.8 2.5 2.8 1.7 3.5 9.0 3.3 0.4 1.4 3.9 3.5 1.8 2.8 2.1 1.4 2.2 1.3 0.6 0.8 1.6 1.9 3.2 0.5 3.3 7.8 2.0 6.8 2.0 2.4 3.8 0.6 0.0 0.7 0.3 0.9 4.5 4.6 3.4 1.4 3.9 4.2 1.8 1.1 2.8 1.7 5.0 8.7 4.1 0.9 6.8 4.3 3.0 2.7 3.0 1.9 1.3 2.1 7.2 1.6 7.0 2.9 6.4 2.7 2.0 6.0 1.0 2.7 2.1 5.5 2.4 2.4 0.9 2.6 1.2 2.2 1.8 3.4 4.0 3.9 3.6 1.9 2.8 3.2 6.1 3.8 3.0 1.9 0.1 1.6 0.2 3.2 0.4 1.6 0.4 1.3 1.3 0.5 1.3 1.4 0.4 0.8 1.9 1.6 0.6 0.4 0.5 NPIPB15 "LOC440348, NPIPL2" ENSG00000196436 "Nuclear pore complex interacting protein family member B15" A6NHN6 16 74377878-74392080 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 18.6" "Cell line enhanced" "Detected in many" "T-47d: 13.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "memory B-cell: 4.0" "Lineage enriched" "Detected in single" 5 "B-cells: 4.0" "HPA011188, HPA053611" Supported Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (2.23e-2)" "unprognostic (3.48e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-1)" "unprognostic (9.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" "unprognostic (5.53e-2)" "unprognostic (2.41e-2)" "unprognostic (7.73e-2)" "unprognostic (4.58e-3)" "unprognostic (1.53e-1)" "unprognostic (2.81e-2)" "unprognostic (1.97e-1)" "unprognostic (7.34e-3)" "unprognostic (2.53e-1)" "unprognostic (1.14e-3)" 1.8 1.2 0.8 0.5 1.3 2.9 3.8 4.5 1.5 2.1 6.2 4.1 1.1 0.0 3.0 2.1 2.1 1.1 1.1 0.8 3.1 8.4 2.4 2.6 0.8 1.8 6.1 4.4 5.2 2.7 7.1 11.2 6.1 1.1 3.0 4.1 5.3 1.5 0.9 3.1 4.3 18.6 4.4 2.2 1.4 1.8 4.0 0.2 0.8 0.3 0.6 0.6 0.5 2.7 0.1 2.7 1.6 3.2 2.3 0.6 1.8 2.6 2.1 5.9 1.6 0.1 4.6 0.0 3.6 5.2 0.0 2.2 1.6 0.0 2.9 0.1 6.2 2.7 1.5 1.9 9.4 3.1 4.7 4.2 3.2 0.0 0.3 1.9 1.7 4.2 1.0 0.0 0.6 0.0 1.0 2.6 3.1 0.0 1.8 3.8 0.0 6.9 0.0 4.5 13.4 2.2 0.2 2.0 5.5 0.0 1.0 6.4 1.8 1.1 2.7 1.3 1.4 0.0 0.3 0.2 0.6 0.0 0.0 4.0 0.2 0.6 0.2 0.7 0.2 0.0 0.8 0.6 0.1 0.1 0.0 0.5 NPIPB2 ENSG00000234719 "Nuclear pore complex interacting protein family, member B2" A6NJ64 16 11927373-11976643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.2;U-266/70: 21.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA053611 Supported Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (8.80e-2)" "unprognostic (4.83e-1)" "unprognostic (5.20e-2)" "unprognostic (8.24e-2)" "unprognostic (2.45e-1)" "unprognostic (4.34e-2)" "unprognostic (1.37e-1)" "unprognostic (2.73e-1)" "unprognostic (5.92e-2)" "unprognostic (3.01e-3)" "unprognostic (2.80e-2)" "unprognostic (2.21e-1)" "unprognostic (4.89e-3)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (2.25e-1)" "unprognostic (2.58e-2)" 3.4 3.8 3.8 3.6 5.0 1.8 3.0 4.6 8.2 3.6 2.7 4.9 13.8 3.4 4.9 10.3 1.6 3.3 4.2 2.7 8.2 2.9 4.9 2.3 4.0 4.9 3.0 1.7 4.5 6.6 11.0 3.5 2.4 3.6 3.3 2.9 3.8 6.1 13.2 3.1 6.8 3.9 4.8 3.5 2.7 2.2 17.4 2.4 10.2 6.1 1.8 1.9 2.1 2.8 2.7 2.2 0.7 3.1 3.5 2.7 1.0 0.1 1.4 1.6 0.9 3.6 6.3 2.4 1.8 3.0 0.8 0.4 1.0 1.4 0.9 0.6 1.8 0.3 1.1 1.4 1.7 0.8 1.5 0.4 1.4 1.5 6.3 0.9 0.4 0.3 3.2 1.8 4.0 0.2 0.1 4.1 0.5 2.0 0.2 0.5 0.4 1.3 1.8 0.1 12.2 0.6 0.8 2.2 0.0 4.2 0.2 0.0 0.3 2.6 0.4 0.3 0.2 0.3 0.2 21.5 6.9 1.0 2.5 0.3 1.0 0.0 3.1 0.6 1.0 0.2 0.2 2.7 1.7 1.3 2.2 1.6 2.7 0.6 0.7 3.5 0.5 2.2 0.0 1.0 3.8 5.0 4.6 8.2 8.2 2.9 3.0 1.7 3.6 2.4 NPIPB3 "KIAA0220, NPIPL3" ENSG00000169246 "Nuclear pore complex interacting protein family member B3" Q92617 16 21402237-21448567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 53.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (2.68e-2)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.38e-1)" "unprognostic (8.01e-2)" "unprognostic (9.97e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-2)" "unprognostic (3.14e-1)" "unprognostic (3.91e-1)" "unprognostic (1.65e-1)" "unprognostic (4.66e-5)" "unprognostic (1.50e-7)" "unprognostic (1.30e-1)" "unprognostic (3.02e-2)" "unprognostic (5.94e-2)" "unprognostic (9.00e-4)" 7.3 5.0 8.2 8.6 9.8 32.4 8.8 15.5 8.8 6.4 7.6 6.9 5.2 12.4 6.2 6.4 6.8 5.5 9.6 7.2 8.2 9.6 7.9 18.1 6.7 6.7 5.9 4.0 9.5 5.0 9.8 8.2 11.7 5.6 19.7 36.9 9.6 6.1 7.6 14.6 7.1 7.3 9.7 7.9 5.2 6.6 5.3 9.0 6.5 3.6 3.4 5.7 0.4 13.5 12.3 8.4 14.7 11.4 6.5 25.1 9.4 3.3 5.0 5.6 19.0 16.7 19.7 9.4 12.8 15.5 5.5 13.9 4.6 11.0 7.8 8.6 17.0 53.2 10.2 15.7 16.7 3.5 6.0 12.0 15.4 6.6 15.7 26.2 6.8 24.3 16.6 38.6 15.5 14.4 26.5 8.8 11.6 10.0 7.9 10.7 8.2 5.4 12.9 9.8 12.7 7.6 10.8 23.8 13.1 2.2 13.6 13.9 9.7 17.8 9.4 13.9 12.5 6.5 3.6 2.6 5.7 2.7 2.3 4.4 3.0 2.9 2.2 5.3 3.9 2.6 3.9 3.4 2.0 9.0 2.0 0.4 NPIPB4 ENSG00000185864 "Nuclear pore complex interacting protein family member B4" C9JG80 16 21834569-21880827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skin 1: 31.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (3.09e-3)" "unprognostic (3.51e-3)" "unprognostic (4.01e-2)" "unprognostic (1.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-3)" "unprognostic (2.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (3.66e-1)" "unprognostic (1.76e-1)" "unprognostic (4.05e-3)" "unprognostic (6.04e-8)" "unprognostic (3.37e-1)" "unprognostic (7.78e-2)" "unprognostic (2.32e-1)" "unprognostic (5.46e-3)" 5.5 3.7 4.4 7.0 4.6 23.5 6.1 10.4 5.4 5.1 6.5 4.5 5.4 22.4 4.5 5.7 4.9 4.2 5.0 4.0 5.4 6.6 6.0 10.7 3.8 5.9 5.3 3.3 5.4 3.8 6.6 8.2 5.5 3.2 7.1 31.2 8.6 3.5 4.4 10.1 7.3 4.3 7.9 7.5 4.1 5.4 6.3 3.7 4.7 2.5 5.2 2.3 0.3 7.1 9.6 9.2 7.2 6.6 9.6 15.6 8.7 2.7 3.0 4.9 20.4 10.1 13.7 6.7 7.6 8.1 5.1 7.4 5.9 5.5 4.6 5.4 24.5 27.0 4.4 22.4 14.5 7.2 9.1 7.9 13.2 6.4 11.7 12.0 4.4 20.7 8.5 14.1 11.2 5.4 12.9 5.6 7.9 3.3 7.0 9.3 5.6 5.8 6.8 4.7 8.9 6.7 14.1 15.8 7.9 7.6 7.5 6.3 5.8 14.5 5.0 10.7 7.3 4.7 2.5 0.7 1.8 1.0 1.3 2.2 2.3 1.1 0.4 6.3 1.8 1.9 3.0 5.2 1.2 3.7 0.6 0.3 NPIPB5 ENSG00000243716 "Nuclear pore complex interacting protein family member B5" A8MRT5 16 22479121-22536521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (7.52e-4)" "unprognostic (2.08e-1)" "unprognostic (2.32e-2)" "unprognostic (9.43e-3)" "unprognostic (3.96e-1)" "unprognostic (2.64e-3)" "unprognostic (2.40e-3)" "unprognostic (4.20e-2)" "unprognostic (1.65e-1)" "unprognostic (4.19e-2)" "unprognostic (1.09e-1)" "unprognostic (3.87e-2)" "unprognostic (1.90e-10)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (3.86e-2)" "unprognostic (3.76e-5)" 10.8 7.0 13.4 34.7 12.0 30.6 10.4 18.3 13.4 9.6 10.8 9.6 12.5 7.7 8.6 33.3 7.2 8.4 6.6 8.4 24.1 6.1 8.7 6.1 13.6 19.3 17.5 16.7 9.9 10.1 6.4 8.7 7.2 13.7 10.5 12.1 14.6 12.2 22.9 17.8 54.2 17.1 6.8 9.7 16.3 8.9 10.6 11.8 7.0 14.4 6.8 14.2 8.0 10.0 11.7 7.0 8.3 3.5 4.4 5.9 1.3 10.8 9.5 6.0 7.7 10.4 9.7 14.4 6.7 2.3 4.2 5.3 13.4 18.3 15.0 12.4 8.8 9.7 14.1 9.5 7.5 18.5 5.1 5.8 25.0 25.8 10.0 31.3 9.7 11.8 7.3 10.2 18.8 7.4 15.9 24.3 5.1 18.5 13.8 42.0 16.9 4.1 15.2 4.4 17.9 7.6 6.3 6.7 5.7 8.2 11.6 5.6 6.8 10.8 25.0 13.4 6.1 11.1 11.2 13.5 6.3 19.5 5.6 22.8 6.0 6.7 3.5 2.7 5.5 1.7 2.3 8.6 5.2 3.7 2.0 11.7 5.9 4.9 8.3 4.4 3.2 7.0 2.4 1.3 13.4 12.0 18.3 13.4 24.1 6.1 17.5 16.7 13.7 11.8 NPIPB6 ENSG00000198156 "Nuclear pore complex interacting protein family member B6" E9PJ23 16 28342555-28363508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 26.8" "Cell line enhanced" "Detected in many" "A549: 5.9;BEWO: 5.5;hTCEpi: 5.8;NB-4: 5.8;RPMI-8226: 5.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 3.1;naive B-cell: 1.8" "Lineage enriched" "Detected in single" 5 "B-cells: 3.1" "HPA011188, HPA053611" Approved Approved Nucleoplasm Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (1.99e-1)" "unprognostic (1.81e-2)" "unprognostic (7.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.86e-2)" "unprognostic (2.43e-1)" "unprognostic (3.21e-1)" "unprognostic (1.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.79e-4)" "unprognostic (3.20e-1)" "unprognostic (8.36e-2)" "unprognostic (4.78e-1)" "unprognostic (1.04e-3)" 0.2 0.0 0.9 0.3 1.4 0.5 0.6 1.8 0.9 0.4 0.5 0.3 0.7 1.0 0.1 0.9 0.1 0.1 1.1 0.7 0.1 0.1 0.2 0.4 0.7 1.2 0.2 0.4 0.9 0.2 0.7 0.6 0.2 0.5 0.6 1.8 0.3 0.4 0.9 0.6 0.6 26.8 0.6 0.2 0.2 0.3 3.1 0.1 0.1 0.0 0.1 0.6 0.5 0.2 5.9 2.8 0.6 1.4 0.3 5.5 0.3 0.5 0.1 0.5 0.2 2.4 1.9 0.5 0.2 0.7 0.3 0.5 0.3 1.3 0.5 1.4 1.1 0.0 0.0 1.7 0.4 0.9 5.8 0.4 1.3 0.1 0.2 4.7 0.0 1.4 0.5 5.8 1.6 0.2 3.1 2.5 5.9 0.1 0.1 0.7 1.2 0.2 0.3 0.6 1.2 0.4 0.5 0.7 2.3 0.5 0.4 2.2 2.2 0.7 0.2 0.9 0.2 0.0 0.0 0.0 0.3 0.0 0.0 3.1 0.6 0.5 0.0 1.8 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.5 NPIPB7 "LOC440350, NPIPL1" ENSG00000233232 "Nuclear pore complex interacting protein family member B7" O75200 16 28456372-28471175 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 14.9" "Cell line enhanced" "Detected in some" "BEWO: 6.1;hTCEpi: 2.4;U-266/70: 1.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "HPA011188, HPA053611" Approved Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "unprognostic (8.35e-2)" "unprognostic (1.94e-1)" "unprognostic (1.94e-1)" "unprognostic (7.43e-2)" "unprognostic (3.07e-3)" "unprognostic (3.35e-2)" "unprognostic (3.44e-1)" "unprognostic (2.78e-2)" "unprognostic (3.62e-2)" "unprognostic (3.04e-2)" "unprognostic (4.40e-1)" "unprognostic (2.22e-1)" "unprognostic (7.73e-2)" "unprognostic (2.03e-2)" 0.0 0.0 0.5 0.2 0.9 0.1 0.1 2.3 0.5 0.1 0.3 0.3 0.3 0.3 0.0 0.2 0.1 0.1 0.5 0.8 0.0 0.0 0.2 0.4 0.3 0.5 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.8 0.2 0.1 0.2 0.1 0.1 14.9 0.4 0.1 0.1 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 6.1 0.0 0.2 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.4 0.4 0.2 0.0 0.0 0.1 0.0 0.9 0.1 1.0 0.6 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.4 0.1 0.0 1.6 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 NPIPB8 ENSG00000255524 "Nuclear pore complex interacting protein family member B8" E9PQR5 16 28637654-28658682 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 14.4" "Cell line enriched" "Detected in single" 29 "hTCEpi: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011188, HPA053611" Uncertain Approved Nucleoplasm Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (8.28e-2)" "unprognostic (1.88e-1)" "unprognostic (1.10e-1)" "unprognostic (5.78e-2)" "unprognostic (1.05e-2)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" 0.4 0.7 0.0 0.6 0.3 0.5 0.5 1.6 0.4 0.3 0.9 2.2 0.6 0.7 0.5 0.3 0.1 0.1 0.1 0.0 0.3 1.1 0.6 0.3 0.1 1.1 1.1 0.1 1.3 0.2 1.1 0.4 1.3 0.4 0.9 0.7 2.2 0.2 0.1 0.6 0.7 14.4 1.0 0.4 0.5 0.6 0.6 0.3 0.1 0.1 0.5 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.6 0.2 21.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.0 NPIPB9 ENSG00000196993 "Nuclear pore complex interacting protein family member B9" F8W1W9 16 28751787-28772807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "testis: 13.6" "Cell line enhanced" "Detected in many" "hTCEpi: 7.9;U-266/70: 6.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "HPA011188, HPA053611" Approved Approved Nucleoplasm Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (7.38e-2)" "unprognostic (6.63e-4)" "unprognostic (6.63e-2)" "unprognostic (5.05e-2)" "unprognostic (5.53e-2)" "unprognostic (4.44e-2)" "unprognostic (1.53e-1)" "unprognostic (9.36e-2)" "unprognostic (7.52e-2)" "unprognostic (2.84e-1)" "unprognostic (2.86e-1)" "unprognostic (2.31e-1)" "unprognostic (4.71e-2)" 0.6 0.3 1.7 0.9 1.8 1.6 0.4 2.7 1.4 0.4 1.0 0.0 1.1 2.4 0.4 1.5 0.6 0.2 2.2 1.3 0.4 0.4 0.4 1.5 1.7 1.4 0.2 0.5 1.4 0.4 1.2 0.8 0.9 0.9 1.1 2.8 0.8 0.8 2.2 1.1 0.5 13.6 1.7 1.0 0.3 0.7 3.1 0.1 0.5 0.2 1.8 0.7 0.3 0.4 3.9 1.1 0.6 0.5 1.3 3.2 0.0 0.1 0.0 0.0 0.4 2.1 1.5 1.1 0.0 0.4 0.7 0.2 0.1 0.4 1.9 0.7 0.0 0.8 0.1 2.5 2.7 0.1 7.9 0.6 1.5 0.0 0.4 2.4 0.2 2.9 0.8 3.3 1.6 0.9 3.3 0.0 1.5 0.0 0.3 0.1 0.0 0.2 0.4 0.2 2.2 1.1 0.0 0.0 2.8 1.9 0.6 6.6 2.8 2.0 0.1 0.9 0.5 0.0 0.2 0.0 0.7 0.0 0.2 3.1 0.4 0.1 0.1 1.2 0.3 0.1 0.5 1.8 0.2 0.0 0.3 0.3 NPR1 "ANPa, ANPRA, GUCY2A, NPRA" ENSG00000169418 "Natriuretic peptide receptor 1" P16066 1 153678637-153693992 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "cGMP biosynthesis" "Lyase, Receptor, Vasoactive" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 98.4" "Cell line enriched" "Detected in some" 6 "ASC diff: 59.1" "Cancer enhanced" "Detected in all" "ovarian cancer: 39.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "olfactory region: 23.0" "Region enhanced" "Detected in many" "olfactory region: 11.1" HPA031087 Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA031087: AB_10601975" "unprognostic (2.54e-1)" "unprognostic (3.03e-3)" "unprognostic (6.31e-2)" "prognostic unfavourable (3.97e-4)" "unprognostic (1.55e-1)" "unprognostic (6.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.03e-1)" "unprognostic (2.46e-1)" "unprognostic (3.27e-2)" "prognostic favourable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (6.69e-2)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" "unprognostic (4.06e-1)" "unprognostic (1.74e-2)" 41.1 4.3 0.5 5.9 0.9 0.1 98.4 0.5 0.8 8.1 8.2 0.3 7.3 1.2 16.8 11.1 8.7 25.0 9.3 19.6 0.9 0.5 28.7 3.7 34.8 8.6 0.7 0.0 19.5 4.2 7.8 4.5 11.8 2.5 4.9 1.5 2.0 2.0 9.0 6.9 3.4 4.6 15.6 2.2 1.2 5.0 6.4 0.2 0.8 7.6 5.1 1.1 11.6 26.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 59.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.8 0.0 7.1 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.5 0.8 0.9 0.5 0.7 0.0 2.5 0.2 NPR3 "ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC" ENSG00000113389 "Natriuretic peptide receptor 3" P17342 5 32689070-32791724 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.0;fHDF/TERT166: 10.3;HeLa: 36.7;HSkMC: 23.8;U-138 MG: 10.1" "Cancer enhanced" "Detected in many" "renal cancer: 19.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA052702 Supported Approved Cytosol Cytosol "HPA052702: " "unprognostic (8.56e-3)" "unprognostic (1.54e-2)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (7.64e-3)" "unprognostic (2.66e-3)" "unprognostic (1.68e-2)" "unprognostic (9.28e-2)" "unprognostic (6.78e-3)" "unprognostic (1.76e-1)" "unprognostic (6.07e-2)" "unprognostic (3.46e-3)" "prognostic favourable (5.43e-6)" "unprognostic (6.00e-4)" "unprognostic (5.74e-2)" "unprognostic (2.80e-2)" "unprognostic (3.38e-2)" 26.9 3.5 0.4 0.4 1.5 1.9 2.7 0.2 0.8 4.5 5.3 0.3 1.4 0.3 4.2 3.3 6.8 2.5 3.9 16.4 0.4 0.5 54.2 7.6 24.2 0.5 0.2 0.8 1.9 0.7 0.3 0.7 5.3 3.1 8.8 0.5 7.3 1.2 18.1 9.5 3.7 1.4 1.8 0.3 4.5 1.0 1.5 0.0 1.1 11.0 13.4 1.4 5.5 4.5 1.4 0.9 7.3 0.6 1.1 1.1 0.2 0.1 1.9 0.1 0.1 1.1 17.0 0.0 4.5 0.8 0.2 0.2 0.0 0.1 0.0 0.1 10.3 0.0 2.2 0.0 0.5 0.0 0.0 0.2 36.7 0.0 3.4 0.0 0.1 23.8 0.2 1.2 3.2 0.1 0.0 0.3 1.5 0.3 0.0 0.2 0.0 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 6.1 0.0 0.1 0.0 0.1 10.1 0.1 0.8 0.1 0.1 0.0 0.0 1.6 0.0 0.1 0.3 0.6 0.4 0.8 0.3 0.5 0.9 0.7 0.5 0.0 1.4 0.9 1.1 7.3 1.1 0.1 0.9 0.4 0.2 0.4 1.5 0.2 0.8 0.4 0.5 0.2 0.8 3.1 0.0 NPTN "GP55, GP65, np55, np65, SDFR1, SDR1" ENSG00000156642 Neuroplastin Q9Y639 15 73560014-73634134 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051497, HPA072453" Approved Approved "Cytokinetic bridge,Mitochondria" 21000 Mitochondria "Cytokinetic bridge" "HPA051497: , HPA072453: " "unprognostic (9.30e-3)" "unprognostic (1.70e-1)" "unprognostic (5.01e-2)" "unprognostic (4.14e-1)" "unprognostic (3.11e-2)" "unprognostic (7.42e-3)" "unprognostic (9.74e-2)" "unprognostic (9.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.68e-1)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "unprognostic (1.60e-3)" "unprognostic (5.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" 20.8 24.9 49.0 17.8 72.9 6.9 22.5 55.3 84.5 30.3 36.2 11.9 28.1 33.2 52.3 39.9 34.2 35.2 30.5 48.4 43.6 38.3 32.7 18.2 27.2 15.9 30.3 47.8 21.0 23.8 35.9 18.3 30.3 40.0 45.3 36.6 22.7 25.9 54.9 12.1 19.5 39.8 75.3 16.8 16.7 27.1 18.8 20.4 6.3 28.7 18.5 16.6 32.7 25.9 3.0 3.9 19.7 13.3 2.5 4.9 7.3 17.7 32.0 18.4 13.5 37.7 34.1 25.8 41.0 67.3 47.4 42.2 21.7 57.1 10.3 24.5 58.9 73.9 29.6 34.2 27.3 18.4 19.6 8.2 16.3 19.2 26.8 12.5 22.9 27.8 30.2 30.6 18.6 25.1 4.6 11.8 33.8 14.2 5.5 7.7 17.0 11.4 9.1 21.1 8.7 64.5 26.3 11.3 3.5 39.7 22.2 26.3 20.0 17.2 28.3 36.9 24.8 21.1 23.8 10.3 19.2 8.9 34.2 19.6 25.2 3.6 10.0 9.5 4.9 13.3 4.0 3.0 2.8 4.4 3.7 2.3 2.9 3.3 19.7 2.5 9.6 3.9 3.0 7.3 49.0 72.9 55.3 84.5 43.6 38.3 30.3 47.8 40.0 20.4 NPY1R NPYR ENSG00000164128 "Neuropeptide Y receptor Y1" P25929 4 163323961-163344832 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 55.2" "Cell line enriched" "Detected in some" 18 "HEL: 50.2" "Cancer enriched" "Detected in many" 13 "breast cancer: 65.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029903 Approved Nucleoplasm,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoplasm "HPA029903: AB_10601276" "prognostic favourable (7.68e-5)" "unprognostic (9.14e-3)" "unprognostic (1.55e-1)" "unprognostic (5.09e-2)" "unprognostic (2.60e-1)" "unprognostic (9.29e-2)" "unprognostic (5.28e-3)" "unprognostic (2.26e-1)" "unprognostic (4.14e-2)" "unprognostic (2.50e-1)" "unprognostic (1.89e-2)" "unprognostic (5.92e-2)" "unprognostic (7.39e-2)" "unprognostic (1.92e-3)" "unprognostic (5.48e-2)" "unprognostic (1.74e-1)" "unprognostic (2.21e-1)" 18.0 15.9 5.2 1.5 17.1 0.2 17.5 0.9 11.4 6.2 3.1 0.7 3.9 0.7 5.0 5.4 2.3 4.3 2.4 2.6 7.1 4.2 16.6 8.3 1.2 7.2 1.5 5.8 1.8 14.5 1.1 3.9 2.7 3.5 1.9 2.4 2.0 11.0 4.5 1.5 5.0 0.9 3.1 3.7 55.2 1.2 2.7 6.0 0.0 4.4 1.4 0.6 3.4 3.3 0.5 0.3 1.2 0.4 0.3 1.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.6 0.0 1.9 0.7 0.4 1.2 0.5 0.1 0.6 0.4 0.7 0.9 0.0 0.5 0.7 1.2 1.1 0.3 0.2 0.3 0.3 0.0 5.2 17.1 0.9 11.4 7.1 4.2 1.5 5.8 3.5 6.0 NRCAM "Bravo, KIAA0343" ENSG00000091129 "Neuronal cell adhesion molecule" Q92823 7 108147623-108456717 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.0" "Cell line enhanced" "Detected in some" "A549: 26.0;AF22: 25.2;EFO-21: 47.1;HMC-1: 50.3;SH-SY5Y: 31.0" "Cancer enriched" "Detected in all" 7 "glioma: 57.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD8 T-cell: 5.5" "Lineage enriched" "Detected in single" 15 "T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012606 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" 70000000 Nucleoplasm "Vesicles, Plasma membrane" "HPA012606: AB_1854636" "unprognostic (2.66e-1)" "unprognostic (2.65e-1)" "unprognostic (2.52e-3)" "unprognostic (2.18e-2)" "unprognostic (4.08e-3)" "unprognostic (1.01e-2)" "unprognostic (4.47e-3)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "unprognostic (4.81e-2)" "unprognostic (9.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.22e-2)" "unprognostic (9.70e-3)" "unprognostic (6.42e-2)" "unprognostic (6.51e-3)" "unprognostic (3.28e-2)" 2.5 28.7 24.5 2.3 23.7 1.2 1.6 16.6 82.0 5.0 1.6 10.5 9.5 1.5 2.6 26.6 1.5 3.7 6.3 1.1 19.1 15.9 5.8 1.3 2.7 1.6 11.8 21.2 2.1 21.5 1.2 14.6 6.4 21.7 1.6 1.6 0.7 2.4 12.1 1.0 1.6 1.5 1.6 10.8 4.2 2.3 2.2 9.9 0.0 4.0 0.0 2.9 1.5 0.8 0.1 0.0 0.3 0.0 0.0 5.5 0.6 0.0 26.0 25.2 0.0 3.1 0.6 0.5 0.1 0.1 0.2 0.4 10.5 0.0 0.0 47.1 0.2 0.1 0.5 0.4 0.2 0.0 3.3 0.0 0.2 0.2 0.0 0.2 50.3 4.2 0.0 0.0 0.1 16.2 0.0 0.2 0.4 9.7 0.1 0.0 3.4 0.0 0.0 7.4 8.5 5.8 0.0 4.9 31.0 0.3 0.0 0.5 0.0 0.0 17.2 1.1 0.2 0.0 4.2 0.0 0.1 0.2 0.1 0.0 14.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.6 24.5 23.7 16.6 34.7 19.1 15.9 11.8 21.2 21.7 9.9 NRDE2 "C14orf102, FLJ14051" ENSG00000119720 "NRDE-2, necessary for RNA interference, domain containing" Q9H7Z3 14 90267856-90332137 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047050, HPA050583" Uncertain Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA047050: , HPA050583: " "unprognostic (1.24e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-1)" "unprognostic (3.02e-1)" "unprognostic (4.51e-2)" "unprognostic (1.08e-2)" "unprognostic (9.60e-2)" "unprognostic (8.91e-3)" "unprognostic (1.10e-1)" "unprognostic (4.88e-3)" "unprognostic (3.26e-3)" "unprognostic (1.35e-2)" "unprognostic (2.31e-3)" "unprognostic (8.27e-2)" "unprognostic (6.56e-2)" "unprognostic (3.13e-2)" "unprognostic (3.49e-2)" 7.3 9.1 7.3 7.7 10.1 16.4 8.0 17.6 9.3 6.9 8.1 10.8 4.4 13.5 14.6 8.0 8.1 7.7 6.3 6.3 6.2 5.4 7.4 9.8 7.1 6.8 8.2 4.2 8.7 7.2 10.6 13.8 11.6 8.5 7.0 6.5 10.8 9.2 6.1 23.5 11.1 9.7 7.3 8.4 8.5 7.9 7.1 8.7 11.3 9.4 4.8 8.3 9.2 10.2 3.3 3.5 6.0 2.7 2.2 2.6 0.6 1.3 2.6 3.6 2.2 0.5 1.9 2.5 2.6 1.8 1.9 2.1 3.2 2.3 2.3 1.4 2.5 3.4 2.0 3.4 3.6 4.4 3.3 3.0 8.6 2.2 1.0 8.0 4.2 3.5 2.5 1.8 1.1 1.6 1.4 3.6 1.7 2.5 3.6 3.4 1.2 2.1 3.2 5.3 0.9 1.1 5.2 3.3 3.9 1.1 6.9 1.7 3.1 3.3 2.2 2.9 1.3 1.7 1.1 3.0 3.2 2.5 2.7 1.5 3.3 4.5 2.7 3.4 2.6 1.5 2.0 2.5 1.9 2.1 1.3 3.3 1.9 2.2 6.0 2.2 1.2 3.5 1.6 0.6 7.3 10.1 17.6 9.3 6.2 5.4 8.2 4.2 8.5 8.7 NRG1 "GGF, HGL, HRG, NDF, NRG1-IT2" ENSG00000157168 "Neuregulin 1" Q02297 8 31639386-32767959 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.3" "Cell line enhanced" "Detected in many" "A549: 38.9;BJ: 26.6;fHDF/TERT166: 29.8;HBF TERT88: 26.2;hTEC/SVTERT24-B: 27.9;hTERT-HME1: 29.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "classical monocyte: 22.8" "Lineage enriched" "Detected in many" 5 "monocytes: 22.8" "Low region specificity" "Detected in all" HPA010964 Uncertain Approved Nucleoplasm "Secreted to blood" Nucleoplasm "HPA010964: AB_1854641" "unprognostic (5.76e-3)" "unprognostic (8.60e-2)" "unprognostic (1.96e-4)" "unprognostic (2.67e-1)" "unprognostic (1.94e-4)" "unprognostic (4.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.72e-2)" "unprognostic (2.98e-1)" "unprognostic (5.65e-2)" "unprognostic (7.99e-2)" "unprognostic (8.49e-2)" "unprognostic (4.47e-2)" "unprognostic (1.31e-1)" "unprognostic (2.88e-1)" "unprognostic (5.40e-2)" "unprognostic (7.83e-2)" 0.7 2.1 4.6 5.0 3.3 1.2 8.8 14.8 8.1 10.6 4.2 0.3 2.1 3.5 2.5 1.1 3.7 2.0 4.8 2.2 4.7 15.4 11.5 23.6 5.7 0.6 6.2 3.5 2.9 0.9 0.8 23.9 0.2 28.3 3.2 5.4 3.6 2.5 1.6 0.2 4.3 5.7 1.1 2.5 1.7 3.1 6.4 0.8 0.2 13.8 7.2 2.2 7.2 3.5 0.0 4.9 0.8 22.8 0.0 0.0 4.6 0.1 38.9 0.7 0.0 0.3 0.8 0.0 26.6 18.9 22.1 16.9 0.0 0.8 0.0 4.9 29.8 21.0 0.2 10.6 26.2 0.0 0.2 0.5 0.5 0.5 0.1 0.0 0.0 0.3 1.1 27.9 29.3 12.7 0.0 0.1 7.9 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 16.3 1.1 1.1 1.3 2.0 0.0 0.0 0.0 0.0 9.2 15.4 4.7 24.5 14.8 0.0 0.0 0.2 7.9 0.0 1.8 0.0 22.8 0.2 0.0 2.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.6 4.6 3.3 14.8 8.1 4.7 15.4 6.2 3.5 28.3 0.8 NRG2 "Don-1, HRG2, NTAK" ENSG00000158458 "Neuregulin 2" O14511 5 139846779-140043299 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.3" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;Karpas-707: 5.5;PC-3: 14.5;RPTEC TERT1: 7.4;SCLC-21H: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 4 "T-cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038935, HPA047973" Approved Supported Nucleoplasm,Nucleoli "Secreted to blood" Nucleoplasm Nucleoli "HPA038935: AB_10672833, HPA047973: " "unprognostic (8.66e-4)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (6.04e-2)" "unprognostic (3.22e-1)" "unprognostic (2.96e-2)" "unprognostic (8.66e-3)" "unprognostic (1.11e-1)" "unprognostic (3.99e-1)" "unprognostic (1.88e-1)" "unprognostic (4.26e-3)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (3.64e-3)" "unprognostic (9.54e-2)" "unprognostic (2.23e-2)" "unprognostic (2.07e-2)" 4.5 4.5 4.0 1.4 7.0 0.6 4.4 27.3 5.1 13.1 2.3 3.8 2.6 1.0 3.0 2.9 3.7 7.6 7.6 1.5 4.2 3.5 1.3 0.6 1.2 2.1 5.2 3.4 15.9 3.2 15.8 7.7 1.1 4.1 4.5 0.9 2.9 13.6 4.7 6.0 5.0 1.0 5.1 3.6 3.3 1.1 2.7 4.9 0.0 0.8 1.0 1.5 4.8 3.7 0.4 0.1 0.0 0.1 0.0 2.1 0.1 0.0 1.9 0.2 8.3 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.0 0.4 0.0 2.4 0.4 0.2 0.1 4.7 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.5 0.2 0.0 5.5 0.0 0.4 0.0 0.0 0.1 14.5 0.1 0.0 0.0 7.4 1.7 5.5 3.3 0.0 3.2 3.3 0.0 0.0 0.2 2.5 0.4 0.0 1.6 1.1 0.0 0.0 3.6 0.0 0.7 0.0 0.0 0.0 2.1 0.1 0.5 0.1 0.2 0.4 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.1 0.0 0.1 4.0 7.0 27.3 5.1 4.2 3.5 5.2 3.4 4.1 4.9 NRG3 ENSG00000185737 "Neuregulin 3" P56975 10 81875314-82987179 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6" "Cell line enhanced" "Detected in some" "AF22: 1.5;HEK 293: 3.3;HUVEC TERT2: 1.6;SK-MEL-30: 7.2;U-2 OS: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075789 Uncertain Vesicles "Secreted in brain" Vesicles "HPA075789: " "unprognostic (6.15e-3)" "unprognostic (2.43e-2)" "unprognostic (1.65e-5)" "unprognostic (1.89e-1)" "unprognostic (7.03e-4)" "unprognostic (1.85e-2)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" "unprognostic (9.33e-2)" "unprognostic (1.82e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-2)" "unprognostic (3.31e-4)" "unprognostic (1.04e-1)" "unprognostic (7.68e-3)" "unprognostic (7.27e-4)" 0.9 1.5 15.6 1.2 8.2 0.6 2.8 1.9 30.6 0.8 0.9 4.8 0.0 0.8 0.7 0.7 0.9 8.0 5.3 0.9 14.5 6.2 1.2 1.5 1.6 0.8 4.9 8.0 0.7 0.9 0.7 1.6 1.2 6.5 0.9 0.9 3.1 5.0 1.1 0.7 0.8 0.9 0.9 5.6 0.8 0.8 3.3 6.0 0.0 0.9 0.0 0.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 8.2 1.9 12.8 14.5 6.2 4.9 8.0 6.5 6.0 NRG4 HRG4 ENSG00000169752 "Neuregulin 4" Q8WWG1 15 75935969-76059795 "Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 36.6" "Cell line enhanced" "Detected in some" "HeLa: 8.5;HL-60: 3.1;THP-1: 2.9;U-698: 2.8;U-937: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 4 "cerebellum: 282.0" HPA010957 Uncertain "Secreted to digestive system" "HPA010957: AB_1079504" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (3.94e-2)" "unprognostic (1.67e-2)" "unprognostic (5.66e-2)" "unprognostic (4.10e-2)" "unprognostic (1.12e-2)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (2.82e-5)" "unprognostic (1.91e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-5)" "unprognostic (8.28e-2)" "unprognostic (7.45e-2)" "unprognostic (1.08e-2)" "unprognostic (2.06e-1)" 0.4 0.5 3.5 0.2 1.3 0.8 0.3 6.9 2.7 0.3 0.4 0.5 0.0 0.2 0.3 2.1 0.8 2.2 0.2 0.4 1.4 1.0 0.5 1.1 0.7 0.2 0.5 1.8 0.3 36.6 0.2 2.5 0.8 2.1 1.2 0.3 0.0 1.5 0.3 4.8 0.6 0.3 0.2 0.5 0.4 3.0 6.3 0.3 0.0 0.4 0.5 0.2 0.5 0.3 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 1.8 0.8 0.0 1.3 0.4 0.1 0.0 0.1 1.5 0.1 8.5 0.4 0.0 3.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 2.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 5.2 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.3 6.9 2.7 1.4 1.0 0.5 1.8 2.1 0.3 NRK DKFZp686A17109 ENSG00000123572 "Nik related kinase" Q7Z2Y5 X 105822543-105958610 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 42.2;placenta: 64.8" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 32.4;HSkMC: 6.2;RH-30: 7.3;RPTEC TERT1: 19.9" "Cancer enriched" "Detected in some" 8 "testis cancer: 6.1" "Region enriched" "Detected in single" 10 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 28 "cerebellum: 16.0" "Low region specificity" "Detected in many" HPA017238 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA017238: AB_1854645" "unprognostic (2.64e-4)" "unprognostic (9.82e-2)" "unprognostic (5.98e-3)" "unprognostic (5.52e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (1.35e-2)" "unprognostic (6.08e-2)" "unprognostic (3.24e-2)" "unprognostic (5.28e-3)" "unprognostic (1.47e-3)" "unprognostic (1.14e-1)" "unprognostic (4.28e-2)" "unprognostic (6.80e-3)" 2.6 12.7 0.4 2.7 0.4 0.0 0.8 4.3 0.3 3.5 1.5 0.1 4.6 0.0 4.3 15.6 1.6 1.3 7.5 2.9 0.4 0.4 9.9 0.4 0.5 0.0 0.3 0.0 42.2 0.5 0.0 2.9 64.8 0.2 22.0 0.1 0.0 2.1 1.6 0.4 0.4 0.5 2.8 0.4 0.3 0.9 10.6 0.0 0.0 0.5 3.1 0.3 1.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 6.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 7.3 0.0 19.9 0.4 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 4.3 0.3 0.4 0.4 0.3 0.0 0.2 0.0 NRP1 "CD304, NRP, VEGF165R" ENSG00000099250 "Neuropilin 1" O14786 10 33177492-33336262 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 69.8;TIME: 58.0;U-87 MG: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 14 "plasmacytoid DC: 24.0" "Lineage enriched" "Detected in many" 14 "dendritic cells: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004511, HPA030278" Approved "Secreted in other tissues" 720000000 "CAB004511: AB_2282634, HPA030278: AB_10601976" "unprognostic (3.19e-1)" "prognostic unfavourable (7.10e-5)" "unprognostic (1.50e-2)" "unprognostic (3.80e-2)" "prognostic unfavourable (5.79e-4)" "unprognostic (6.17e-2)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (6.66e-2)" "unprognostic (2.52e-1)" "unprognostic (1.82e-1)" "unprognostic (4.78e-2)" "prognostic unfavourable (3.87e-4)" "prognostic unfavourable (1.22e-5)" "unprognostic (3.83e-2)" "unprognostic (5.48e-2)" "unprognostic (7.79e-2)" 69.9 15.0 4.9 13.6 4.9 0.7 53.8 1.3 5.6 25.1 17.6 2.4 16.4 6.7 29.8 21.9 14.7 17.0 23.3 50.5 17.2 5.9 47.1 27.4 47.1 30.1 3.5 3.2 27.1 14.1 11.7 6.4 44.3 3.6 25.2 7.8 24.3 11.8 31.6 22.3 9.1 14.6 19.1 5.5 38.7 9.8 15.6 2.8 5.9 30.4 24.6 7.9 22.3 23.8 0.4 24.0 0.3 1.7 0.6 0.4 0.4 8.7 34.0 1.7 0.1 33.2 37.2 0.2 35.2 34.3 17.8 19.1 4.3 20.9 0.1 4.2 69.8 2.4 2.1 10.2 14.5 0.1 1.7 0.0 3.9 7.3 11.7 3.1 0.2 44.4 1.7 42.2 19.1 48.2 0.1 0.2 34.6 14.7 0.2 0.5 0.8 32.3 1.4 3.8 0.1 16.7 0.1 0.8 0.4 3.6 2.7 0.1 0.1 0.4 58.0 25.4 6.0 30.5 23.7 0.1 0.1 0.1 69.5 4.0 22.9 0.2 1.7 0.3 0.3 0.3 0.4 0.4 0.3 0.3 1.4 0.3 0.4 0.3 0.3 0.6 0.1 24.0 0.3 0.4 4.9 4.9 1.3 5.6 17.2 5.9 3.5 3.2 3.6 2.8 NRP2 VEGF165R2 ENSG00000118257 "Neuropilin 2" O60462 2 205681990-205798133 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Heparin-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.2;HUVEC TERT2: 30.0;TIME: 28.6;U-251 MG: 58.5;U-87 MG: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;naive B-cell: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039980, HPA054974" Enhanced Supported "Vesicles,Plasma membrane" "Secreted in other tissues" 15000000 "Vesicles, Plasma membrane" "HPA039980: AB_10795517, HPA054974: " "unprognostic (4.28e-2)" "unprognostic (1.17e-1)" "unprognostic (8.12e-3)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (1.57e-2)" "unprognostic (9.36e-2)" "unprognostic (3.70e-1)" "unprognostic (2.15e-3)" "unprognostic (2.90e-2)" "unprognostic (2.56e-3)" "unprognostic (4.17e-1)" "prognostic unfavourable (7.68e-7)" "unprognostic (2.22e-3)" "unprognostic (5.45e-2)" "unprognostic (6.41e-3)" "prognostic unfavourable (7.80e-5)" 24.3 14.5 8.7 11.4 7.4 2.6 7.8 1.2 7.0 34.4 35.4 3.9 8.4 3.5 33.7 4.6 24.8 13.1 25.8 4.4 11.5 8.3 3.4 6.2 15.8 4.9 8.9 3.9 33.0 1.4 2.5 6.6 29.9 9.0 18.6 7.0 27.7 2.6 21.0 2.5 3.3 8.2 44.7 8.6 4.7 17.1 3.4 5.2 2.6 7.3 6.0 3.0 39.3 24.6 1.4 0.5 0.0 1.8 0.0 0.0 0.5 0.6 14.1 9.0 0.0 8.2 2.6 2.6 2.2 4.3 2.8 2.7 13.3 34.2 0.0 3.4 7.1 5.4 0.4 4.3 4.6 0.0 1.9 0.1 0.6 0.1 22.2 0.0 0.5 19.5 3.3 3.9 3.5 30.0 0.0 0.0 1.9 0.0 0.0 0.0 11.3 2.5 0.0 0.5 3.1 5.7 0.0 8.1 0.3 0.3 0.0 20.2 0.0 0.1 28.6 12.4 0.1 3.2 58.5 0.0 0.0 0.8 27.6 0.0 25.9 0.0 1.8 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.7 7.4 1.2 3.8 11.5 8.3 8.9 3.9 9.0 5.2 NRROS "ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030" ENSG00000174004 "Negative regulator of reactive oxygen species" Q86YC3 3 196639686-196662004 "Predicted membrane proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 30.4" "Cell line enhanced" "Detected in some" "HMC-1: 34.1;Karpas-707: 21.1;MOLT-4: 17.9;NB-4: 42.0;RPMI-8226: 20.8;THP-1: 18.5;U-937: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 7.4;classical monocyte: 1.9;eosinophil: 3.3;intermediate monocyte: 2.0;myeloid DC: 2.5;non-classical monocyte: 1.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.5;granulocytes: 7.4;monocytes: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031586 Uncertain "HPA031586: AB_10601543" "unprognostic (5.28e-2)" "unprognostic (8.92e-3)" "unprognostic (1.02e-1)" "unprognostic (3.05e-2)" "unprognostic (2.23e-1)" "unprognostic (1.41e-3)" "unprognostic (1.05e-1)" "unprognostic (9.67e-2)" "unprognostic (3.20e-2)" "prognostic unfavourable (9.63e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (6.73e-3)" "unprognostic (1.47e-1)" "unprognostic (7.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" 17.0 3.6 3.8 9.3 4.4 30.4 12.4 1.6 3.1 4.7 3.3 4.0 1.0 3.0 7.6 7.1 2.7 4.2 5.8 8.5 3.1 2.7 4.3 3.4 13.4 23.0 4.3 1.3 2.6 2.6 1.2 2.3 12.4 3.4 4.5 2.2 5.7 3.8 2.2 3.1 3.1 6.9 4.9 5.2 22.5 3.4 2.8 4.8 15.6 3.5 2.4 8.8 6.3 3.5 0.6 2.5 7.4 2.0 0.6 0.7 1.2 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 2.2 0.1 0.0 0.3 0.0 0.0 1.2 0.0 16.2 0.0 0.0 0.1 13.2 34.1 0.1 0.0 0.5 0.2 1.3 1.6 21.1 0.3 0.0 17.9 42.0 1.4 0.0 4.8 0.0 20.8 0.0 0.1 0.1 0.0 0.0 0.0 8.5 0.0 18.5 0.1 0.1 0.0 0.6 0.0 8.5 12.7 3.7 1.1 23.4 0.2 7.4 1.9 3.3 0.7 2.0 0.2 0.6 0.5 0.4 2.5 0.5 0.2 0.4 0.0 0.6 1.9 0.3 0.5 1.2 3.8 4.4 1.6 3.1 3.1 2.7 4.3 1.3 3.4 4.8 NRSN2 "C20orf98, dJ1103G7.6" ENSG00000125841 "Neurensin 2" Q9GZP1 20 346782-359660 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015967 Approved Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA015967: AB_1854647" "unprognostic (5.67e-2)" "unprognostic (3.47e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (4.05e-2)" "unprognostic (4.48e-2)" "unprognostic (1.48e-1)" "unprognostic (4.96e-2)" "unprognostic (5.92e-2)" "prognostic favourable (1.61e-4)" "unprognostic (6.96e-2)" "unprognostic (1.96e-3)" "unprognostic (2.94e-2)" "unprognostic (1.96e-1)" "unprognostic (7.85e-3)" "unprognostic (1.73e-3)" 8.4 18.6 34.3 6.0 39.3 0.9 7.2 22.7 70.9 12.8 6.6 11.0 4.9 3.5 12.5 16.0 6.1 13.4 9.3 13.5 31.1 24.9 10.1 1.8 8.7 4.1 17.1 28.5 18.3 10.5 26.5 16.3 10.1 27.8 12.2 6.1 12.8 13.3 16.5 1.4 5.0 3.8 16.3 8.7 5.7 5.3 12.8 6.8 1.3 14.9 2.5 4.2 9.4 4.8 9.4 4.8 1.5 1.1 3.4 3.9 1.5 18.7 22.9 13.8 13.0 18.3 20.5 5.4 12.5 24.2 22.7 22.9 12.6 0.4 0.0 4.4 23.1 8.3 11.1 1.9 14.5 0.1 11.2 6.8 10.9 23.8 18.5 0.2 1.1 23.2 1.5 16.2 2.7 15.6 13.4 12.2 19.9 3.3 0.3 5.8 10.6 11.8 10.7 7.7 0.9 22.7 0.1 28.2 20.3 14.9 4.4 21.4 18.3 7.0 10.4 24.4 12.9 0.9 15.2 2.2 0.4 5.1 3.2 0.2 12.8 0.0 1.1 1.5 3.8 0.3 1.1 7.2 1.1 3.9 2.1 9.4 1.6 2.7 0.0 3.4 0.4 4.8 0.9 1.5 34.3 39.3 22.7 70.9 31.1 24.9 17.1 28.5 27.8 6.8 NRXN1 "Hs.22998, KIAA0578" ENSG00000179915 "Neurexin 1" "P58400, Q9ULB1" 2 49918505-51225575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Angiogenesis, Cell adhesion" "Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 81.9" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 28.3" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071400 Supported "Plasma membrane" "Intracellular and membrane" 620000 "Plasma membrane" "HPA071400: " "unprognostic (7.01e-2)" "unprognostic (9.96e-2)" "unprognostic (7.68e-2)" "unprognostic (1.74e-4)" "unprognostic (2.46e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.85e-1)" "unprognostic (8.19e-2)" "unprognostic (6.37e-4)" "unprognostic (2.85e-2)" "unprognostic (6.68e-7)" "unprognostic (3.40e-2)" "unprognostic (1.75e-1)" "unprognostic (5.57e-2)" "unprognostic (1.99e-3)" 2.1 3.2 22.4 2.1 20.3 1.4 1.7 56.5 81.9 2.8 5.1 3.0 0.5 2.1 2.1 3.7 3.0 1.4 2.2 3.8 16.9 13.8 1.5 1.6 1.5 1.4 8.3 25.9 2.1 2.3 1.3 4.8 1.1 12.6 2.5 3.8 2.0 3.5 9.3 1.3 2.0 3.1 2.1 6.5 1.3 2.3 6.5 4.7 0.0 1.4 0.0 1.4 2.0 1.6 0.0 0.0 4.4 0.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.2 0.0 0.0 28.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 2.4 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.3 0.0 0.0 0.0 0.0 22.4 20.3 56.5 33.2 16.9 13.8 8.3 25.9 12.6 4.7 NRXN3 "C14orf60, KIAA0743" ENSG00000021645 "Neurexin 3" "Q9HDB5, Q9Y4C0" 14 78170373-79868290 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 8.2;RT4: 20.3;SK-BR-3: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.2" "Low region specificity" "Detected in all" HPA002727 Approved 520000 "HPA002727: AB_1079468" "unprognostic (7.96e-2)" "unprognostic (5.70e-4)" "unprognostic (8.18e-3)" "unprognostic (2.19e-2)" "unprognostic (2.31e-4)" "unprognostic (9.56e-2)" "unprognostic (2.80e-1)" "unprognostic (2.99e-3)" "unprognostic (1.12e-2)" "unprognostic (7.91e-2)" "unprognostic (2.40e-2)" "unprognostic (2.61e-1)" "prognostic favourable (1.83e-7)" "unprognostic (4.81e-2)" "unprognostic (2.61e-1)" "unprognostic (3.61e-2)" "unprognostic (2.91e-1)" 1.8 7.5 15.1 4.1 24.7 1.1 2.8 75.3 36.9 6.3 12.3 2.6 7.3 3.6 4.7 2.8 6.7 3.9 3.9 2.3 12.7 9.4 2.3 1.3 4.0 1.3 11.9 20.2 1.4 4.5 1.7 9.2 2.3 14.7 9.5 6.0 7.8 4.1 15.7 1.1 2.9 5.6 25.5 8.6 7.4 6.9 7.5 4.3 0.0 1.2 0.0 1.2 8.1 2.1 0.5 0.3 2.2 0.4 0.4 0.2 0.1 0.0 0.0 6.3 0.0 0.1 0.2 0.0 2.5 1.8 8.2 6.2 2.1 0.0 0.1 0.0 0.2 2.4 0.0 0.2 5.7 2.3 5.1 0.0 0.2 0.0 0.6 0.0 0.0 1.5 0.2 3.6 1.2 2.1 0.0 0.1 0.1 0.0 0.2 0.2 1.4 0.0 0.2 0.0 0.0 4.4 20.3 1.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.1 5.4 0.0 2.6 0.0 0.0 0.0 1.5 0.3 4.5 2.2 0.4 0.5 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.5 0.2 0.2 1.6 0.4 0.2 0.3 0.1 0.1 15.1 24.7 75.3 36.9 12.7 9.4 11.9 20.2 14.7 4.3 NSDHL "H105e3, SDR31E1, XAP104" ENSG00000147383 "NAD(P) dependent steroid dehydrogenase-like" Q15738 X 152830967-152869729 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000248, HPA000571" Enhanced Enhanced "Endoplasmic reticulum,Lipid droplets" "Endoplasmic reticulum" "Lipid droplets" "HPA000248: AB_1079507, HPA000571: AB_1079506" "unprognostic (1.84e-1)" "prognostic favourable (5.65e-4)" "unprognostic (2.66e-1)" "unprognostic (1.81e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (5.04e-4)" "unprognostic (1.03e-1)" "unprognostic (5.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.62e-2)" "unprognostic (2.63e-1)" "prognostic favourable (6.09e-5)" "unprognostic (3.53e-2)" "unprognostic (1.36e-1)" "unprognostic (3.91e-2)" "unprognostic (4.79e-2)" 17.4 24.8 11.0 7.7 10.5 6.0 20.4 7.7 15.0 13.4 23.4 13.9 20.5 13.3 10.4 35.7 36.2 11.9 7.4 16.7 14.3 11.4 11.6 38.1 9.9 8.7 9.7 10.4 9.8 7.9 9.8 6.9 7.9 18.9 12.0 10.7 7.9 12.2 17.7 6.9 14.5 24.0 9.9 14.2 7.3 9.6 8.6 9.3 6.0 11.0 22.2 17.0 7.5 16.1 16.2 17.5 16.4 17.7 17.0 17.3 13.0 43.6 16.1 21.9 11.4 18.9 14.4 12.4 8.7 11.7 15.9 20.3 22.2 23.9 21.6 29.4 11.8 22.5 28.5 40.2 14.1 7.2 16.3 8.8 15.7 22.4 13.8 8.8 7.2 17.6 15.6 31.1 7.9 14.7 14.6 9.8 12.0 19.3 8.7 11.5 8.7 19.4 6.5 15.9 17.7 33.0 18.1 7.9 9.0 7.8 11.7 9.2 7.7 11.3 12.4 7.4 12.3 17.8 16.7 13.9 9.3 37.2 13.7 13.8 7.0 16.4 17.7 15.8 15.6 16.2 15.7 16.2 15.6 13.5 17.5 12.9 11.4 12.6 1.9 17.0 12.1 15.6 17.3 13.0 11.0 10.5 7.7 15.0 14.3 11.4 9.7 10.4 18.9 9.3 NSG2 "CALY3, HMP19, Nsg2" ENSG00000170091 "Neuronal vesicle trafficking associated 2" Q9Y328 5 174045604-174243501 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 120.8" "Group enriched" "Detected in some" 58 "SCLC-21H: 21.3;SH-SY5Y: 34.3" "Cancer enriched" "Detected in some" 8 "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046531, HPA056191" Enhanced Enhanced "Golgi apparatus" "Golgi apparatus" "HPA046531: , HPA056191: " "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (3.27e-1)" "unprognostic (3.36e-5)" "unprognostic (1.93e-1)" "unprognostic (2.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.07e-1)" "unprognostic (3.29e-1)" "unprognostic (1.76e-1)" "unprognostic (3.86e-3)" "unprognostic (8.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.02e-2)" "unprognostic (5.20e-2)" "unprognostic (9.31e-4)" "unprognostic (1.55e-1)" 1.7 23.1 31.6 3.0 92.4 1.4 1.4 19.7 120.8 1.4 3.6 5.0 0.0 2.8 1.4 1.7 1.5 1.4 1.6 1.6 27.3 40.2 1.6 1.4 1.6 1.4 20.2 27.6 1.4 2.0 1.4 0.9 1.4 22.5 1.4 4.1 0.8 1.4 1.5 1.4 1.4 3.8 2.5 4.6 1.4 3.3 5.0 11.7 0.0 1.8 0.0 1.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 92.4 19.7 49.8 27.3 40.2 20.2 27.6 22.5 11.7 NT5E "CALJA, CD73, eN, eNT, NT5" ENSG00000135318 "5'-nucleotidase ecto" P21589 6 85449584-85495791 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 108.8;TIME: 63.0;U-87 MG: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3" "Group enriched" "Detected in many" 47 "B-cells: 19.9;T-cells: 17.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017357 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 1600000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017357: AB_1846330" "unprognostic (1.92e-2)" "unprognostic (4.44e-3)" "unprognostic (1.54e-1)" "unprognostic (1.57e-3)" "unprognostic (9.33e-2)" "unprognostic (1.82e-3)" "unprognostic (1.20e-2)" "prognostic unfavourable (6.66e-4)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.32e-5)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "prognostic unfavourable (1.02e-4)" "unprognostic (3.49e-2)" "unprognostic (2.26e-1)" "unprognostic (2.78e-1)" 12.2 3.2 9.3 7.7 11.6 0.5 16.6 1.1 6.9 58.8 13.9 3.6 8.1 18.6 33.3 14.8 7.6 12.2 15.4 6.1 5.7 5.5 8.8 26.0 3.4 6.8 6.3 6.6 25.4 1.4 1.6 9.3 42.2 5.3 16.4 15.6 15.3 4.6 17.8 5.7 4.5 14.9 35.3 6.3 7.0 6.0 12.4 4.2 1.6 26.5 7.3 7.1 16.6 20.2 19.9 0.0 0.2 0.0 0.4 17.3 3.9 5.4 2.9 5.0 0.1 11.5 36.7 0.0 35.5 38.9 17.5 32.9 0.0 54.5 0.0 12.8 31.0 2.8 0.0 35.7 41.7 0.0 0.0 0.0 0.8 0.6 5.7 0.0 0.0 9.4 0.4 35.7 22.8 14.5 0.0 0.1 108.8 0.9 0.0 0.0 0.1 3.9 0.1 1.1 0.1 37.9 2.4 0.0 0.6 0.4 2.2 12.0 0.0 0.9 63.0 14.3 0.1 18.0 57.7 2.7 1.7 0.0 98.1 0.0 44.8 0.0 0.0 0.2 2.0 0.0 3.5 13.4 2.3 6.6 0.0 19.9 2.4 17.3 0.2 0.4 0.0 0.0 0.8 3.9 9.3 11.6 1.1 6.9 5.7 5.5 6.3 6.6 5.3 4.2 NTM "CEPU-1, HNT, IGLON2, NTRI" ENSG00000182667 Neurotrimin Q9P121 11 131370478-132336822 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.2" "Cell line enhanced" "Detected in many" "LHCN-M2: 37.7;U-138 MG: 15.0;U-2 OS: 26.0;WM-115: 51.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 157 "plasmacytoid DC: 15.6" "Lineage enriched" "Detected in single" 157 "dendritic cells: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB024875 Enhanced "Intracellular and membrane" 58000000 "CAB024875: " "unprognostic (1.52e-2)" "unprognostic (4.38e-3)" "unprognostic (1.61e-2)" "unprognostic (1.89e-1)" "unprognostic (4.25e-1)" "unprognostic (1.07e-1)" "unprognostic (9.99e-3)" "unprognostic (9.61e-2)" "unprognostic (1.26e-2)" "unprognostic (2.52e-2)" "unprognostic (4.29e-2)" "unprognostic (1.79e-2)" "prognostic unfavourable (1.10e-8)" "unprognostic (4.60e-3)" "unprognostic (1.37e-1)" "unprognostic (2.94e-1)" "unprognostic (9.31e-3)" 14.0 5.0 22.5 2.7 22.5 0.9 3.5 39.0 63.0 2.4 4.7 31.2 0.0 3.0 2.0 1.4 9.0 1.7 9.1 15.9 23.4 13.7 1.6 1.1 22.6 1.2 29.3 20.8 0.9 1.7 7.5 0.6 1.4 29.6 1.6 4.2 8.7 3.3 3.4 1.5 5.9 4.1 4.6 66.2 1.3 1.8 1.4 29.1 0.0 1.5 0.3 1.2 3.8 1.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 7.1 0.0 11.1 5.9 3.6 2.1 0.0 0.0 0.0 0.0 6.1 0.1 0.0 13.3 3.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 11.8 14.1 2.3 0.0 0.1 37.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 6.4 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 2.4 15.0 26.0 0.7 9.4 0.0 0.0 0.0 0.0 0.0 51.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 22.5 22.5 39.0 25.8 23.4 13.7 29.3 20.8 29.6 29.1 NTRK1 "MTC, TRK, TRKA" ENSG00000198400 "Neurotrophic receptor tyrosine kinase 1" P04629 1 156815640-156881850 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 15.8;blood: 32.3;brain: 28.3" "Cell line enriched" "Detected in some" 4 "HMC-1: 41.1" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Region enriched" "Detected in many" 5 "pons and medulla: 28.3" "Cell type enriched" "Detected in single" 127 "basophil: 32.3" "Lineage enriched" "Detected in single" 323 "granulocytes: 32.3" "Region enhanced" "Detected in some" "basal ganglia: 8.2" "Low region specificity" "Detected in all" "CAB004606, HPA035799, HPA076570" Approved Approved Vesicles,Cytosol 140000 "Vesicles, Cytosol" "CAB004606: AB_628397, HPA035799: , HPA076570: " "unprognostic (5.89e-3)" "unprognostic (7.56e-2)" "unprognostic (2.74e-2)" "unprognostic (5.99e-3)" "unprognostic (7.26e-2)" "unprognostic (1.43e-3)" "unprognostic (1.56e-1)" "unprognostic (7.42e-3)" "unprognostic (7.63e-2)" "unprognostic (1.35e-1)" "unprognostic (6.73e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-11)" "unprognostic (2.18e-3)" "unprognostic (3.79e-2)" "unprognostic (1.07e-1)" "unprognostic (4.89e-1)" 1.0 15.8 0.5 0.8 6.0 0.9 0.4 0.0 0.7 0.9 1.1 0.1 0.0 0.8 1.6 2.0 0.7 0.6 2.1 1.5 0.0 1.2 2.9 0.2 1.9 0.3 2.1 0.6 0.3 0.3 0.3 1.1 0.5 28.3 2.2 0.2 3.1 1.2 0.5 0.7 0.2 0.4 1.1 1.2 0.2 1.0 2.4 1.5 0.4 0.3 0.0 0.4 0.7 0.8 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.6 0.0 6.6 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 2.1 0.7 0.0 0.0 0.0 1.1 0.0 0.6 1.2 0.0 0.1 0.0 0.0 0.7 9.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 32.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.0 0.0 0.6 0.0 1.2 2.1 0.6 28.3 1.5 NTRK2 TRKB ENSG00000148053 "Neurotrophic receptor tyrosine kinase 2" Q16620 9 84668551-85027070 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Epilepsy, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 133.8;thyroid gland: 63.4" "Cell line enhanced" "Detected in some" "AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.6;SH-SY5Y: 13.3" "Group enriched" "Detected in many" 5 "glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007637, CAB010346" Enhanced Approved Cytosol 13000000 Cytosol "CAB010346: AB_2155274, HPA007637: AB_1080385" "unprognostic (2.75e-3)" "unprognostic (3.48e-2)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-2)" "unprognostic (1.29e-2)" "unprognostic (9.16e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (4.25e-2)" "unprognostic (2.18e-2)" "unprognostic (2.66e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-3)" 19.8 2.7 66.1 2.0 56.7 1.2 33.2 15.1 133.8 6.4 4.4 27.4 0.0 1.4 3.0 3.3 5.6 3.7 18.7 5.8 61.0 30.7 12.5 2.1 6.3 2.7 32.4 41.4 6.6 18.9 1.6 3.0 2.1 34.1 3.8 3.1 2.0 8.6 11.9 2.0 7.2 1.6 3.0 22.1 6.5 1.4 2.4 34.1 0.0 63.4 2.6 3.4 3.5 3.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.6 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.6 0.8 0.9 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 66.1 56.7 15.1 45.6 61.0 30.7 32.4 41.4 34.1 34.1 NTRK3 TRKC ENSG00000140538 "Neurotrophic receptor tyrosine kinase 3" Q16288 15 87859751-88256768 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8" "Cell line enriched" "Detected in some" 8 "U-138 MG: 47.4" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009233, HPA027484, HPA048065" Approved Supported "Nuclear membrane,Nucleoli" 11000000 Nucleoli "Nuclear membrane" "CAB009233: AB_632555, HPA027484: , HPA048065: " "unprognostic (1.27e-3)" "unprognostic (1.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.04e-2)" "unprognostic (1.65e-1)" "unprognostic (3.34e-1)" "unprognostic (3.18e-2)" "unprognostic (2.23e-2)" "unprognostic (2.34e-1)" "unprognostic (3.91e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-3)" "unprognostic (6.45e-3)" "unprognostic (1.06e-2)" "unprognostic (1.26e-2)" "unprognostic (2.49e-3)" 20.8 7.4 22.0 2.5 28.1 1.5 6.2 30.4 41.8 7.0 4.0 8.4 1.3 2.0 12.4 6.7 3.4 9.5 3.9 5.5 22.0 11.1 5.1 2.0 5.7 3.1 11.2 18.7 5.1 2.9 1.6 7.9 2.8 14.7 6.8 4.7 8.0 11.5 8.7 1.9 2.9 2.5 7.7 13.7 4.1 3.0 13.8 13.7 0.0 2.5 0.7 4.3 7.1 4.8 0.7 0.4 1.3 0.5 0.5 0.8 0.0 0.0 5.9 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.9 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.1 1.2 0.5 0.4 0.3 0.1 0.2 0.4 0.3 0.3 0.1 0.7 0.4 0.4 1.3 0.5 0.1 0.4 0.8 0.0 22.0 28.1 30.4 28.9 22.0 11.1 11.2 18.7 14.7 13.7 NUAK2 "FLJ90349, SNARK" ENSG00000163545 "NUAK family kinase 2" Q9H093 1 205302059-205321791 "Enzymes, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.4" "Cell line enhanced" "Detected in many" "BEWO: 24.3;CACO-2: 12.9;RPMI-8226: 18.7;RPTEC TERT1: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 42.4" "Group enriched" "Detected in all" 4 "B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA008958 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA008958: AB_1080040" "unprognostic (2.24e-2)" "unprognostic (6.33e-2)" "unprognostic (1.17e-1)" "prognostic unfavourable (3.01e-7)" "unprognostic (8.24e-3)" "unprognostic (1.58e-2)" "unprognostic (3.00e-2)" "unprognostic (1.08e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "prognostic favourable (7.94e-6)" "unprognostic (3.71e-2)" "unprognostic (3.17e-2)" "unprognostic (4.90e-2)" "unprognostic (5.80e-2)" "unprognostic (4.54e-2)" "unprognostic (1.61e-1)" 1.4 2.8 0.8 12.5 2.4 8.3 0.9 9.2 1.5 18.9 10.4 3.9 2.4 13.6 2.7 3.8 31.3 3.4 1.3 1.1 1.7 1.0 14.5 3.6 16.2 20.3 5.5 1.5 3.3 13.2 0.1 2.3 7.2 2.0 1.5 7.5 9.8 9.7 2.0 0.7 12.9 15.4 0.9 2.7 10.4 2.0 5.6 2.4 5.5 14.5 20.1 31.7 2.8 24.6 15.3 3.6 42.4 5.6 5.7 10.7 5.4 2.2 12.3 7.5 0.3 0.2 0.3 24.3 2.9 3.0 8.1 3.3 12.9 0.4 3.7 1.8 0.8 4.5 1.7 4.4 3.5 0.0 0.2 0.0 0.7 2.2 5.2 0.0 0.0 1.4 3.3 4.7 2.8 0.3 0.5 0.9 1.5 0.5 0.0 0.0 4.8 0.4 0.0 0.5 18.7 22.2 0.0 1.1 0.1 0.8 3.5 0.3 3.6 0.0 0.9 2.9 1.4 0.3 4.6 6.6 1.0 2.3 0.4 0.0 1.1 3.4 5.6 13.2 3.9 4.2 2.8 14.2 4.8 4.6 3.6 15.3 10.7 8.1 42.4 5.7 4.1 1.4 2.8 5.4 0.8 2.4 9.2 1.5 1.7 1.0 5.5 1.5 2.0 2.4 NUDC NudC ENSG00000090273 "Nuclear distribution C, dynein complex regulator" Q9Y266 1 26900238-26946862 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027183, HPA028105" Enhanced Enhanced Cytosol 18000 Cytosol "HPA027183: AB_10600086, HPA028105: AB_10601988" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.61e-2)" "unprognostic (6.52e-3)" "unprognostic (2.30e-2)" "unprognostic (2.04e-1)" "prognostic unfavourable (1.21e-6)" "unprognostic (1.11e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-2)" "unprognostic (3.82e-1)" "unprognostic (3.26e-2)" "unprognostic (2.90e-2)" "unprognostic (1.55e-1)" "unprognostic (2.53e-1)" "unprognostic (5.10e-2)" 30.7 57.9 49.9 25.8 44.9 31.8 30.9 40.1 59.0 30.5 35.7 32.0 31.7 25.8 30.0 53.0 26.6 69.2 28.2 41.8 39.3 41.0 28.2 46.8 26.4 27.3 39.6 49.7 34.5 44.7 36.7 32.3 29.2 38.6 34.2 23.7 25.0 35.0 43.9 65.6 30.8 22.9 39.0 32.9 29.2 36.6 41.4 35.9 30.0 36.8 24.8 29.5 37.6 84.4 73.7 69.0 63.1 62.8 57.9 71.8 64.8 42.5 44.6 23.4 32.5 18.7 16.9 26.6 34.2 21.1 46.1 34.1 40.8 29.8 35.8 30.3 23.4 33.5 49.7 45.1 35.7 27.7 51.6 44.5 45.4 69.9 33.1 46.8 32.9 18.1 29.5 55.5 35.9 33.8 63.3 20.2 31.1 36.9 47.0 60.7 61.5 57.9 49.4 29.7 36.5 39.2 16.9 39.1 29.3 37.2 23.8 30.1 23.1 29.0 33.3 33.0 39.4 41.2 43.8 40.5 63.7 43.2 35.6 66.3 37.0 63.1 60.3 57.5 69.1 62.8 69.7 72.0 70.4 65.3 59.8 73.7 70.0 71.8 41.0 57.9 60.0 69.0 66.5 64.8 49.9 44.9 40.1 59.0 39.3 41.0 39.6 49.7 38.6 35.9 NUP188 KIAA0169 ENSG00000095319 "Nucleoporin 188" Q5SRE5 9 128947699-129007096 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061750, HPA063942" Approved Uncertain Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA061750: , HPA063942: " "unprognostic (4.64e-1)" "unprognostic (6.91e-3)" "unprognostic (2.36e-1)" "prognostic favourable (5.20e-5)" "unprognostic (9.50e-2)" "unprognostic (4.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.91e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (7.78e-2)" "unprognostic (4.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.68e-2)" "unprognostic (2.87e-1)" "unprognostic (2.81e-3)" "unprognostic (3.53e-3)" 10.2 11.1 7.6 12.6 9.2 14.3 14.0 13.3 8.7 9.2 9.3 10.1 9.6 5.8 9.8 6.7 16.6 8.3 7.6 9.2 5.6 6.3 8.1 9.6 13.1 16.6 6.5 6.7 10.8 13.3 12.6 13.6 9.1 7.3 9.5 9.3 11.2 9.9 8.3 10.9 16.4 9.0 11.0 7.7 12.2 9.5 60.3 7.3 26.5 9.2 11.3 17.3 8.5 10.5 6.1 7.9 6.3 10.7 6.0 12.0 7.0 10.8 20.7 17.2 23.4 13.0 13.0 15.4 15.2 12.0 27.9 18.6 24.9 8.7 19.0 5.7 16.7 32.1 38.5 18.8 20.9 15.2 18.5 16.9 38.7 19.7 8.3 28.8 17.1 9.0 8.9 29.3 15.0 16.0 37.0 13.5 19.7 27.4 24.6 11.8 23.0 19.9 22.6 37.2 19.3 8.6 12.3 24.2 11.7 39.4 15.0 5.8 16.5 10.6 12.9 23.2 16.5 23.3 27.2 11.6 21.3 25.7 13.5 18.5 17.1 6.3 5.3 1.9 9.3 10.7 12.0 6.1 7.9 9.0 7.9 5.9 8.1 8.6 0.8 6.0 5.9 3.3 9.5 7.0 7.6 9.2 13.3 8.7 5.6 6.3 6.5 6.7 7.3 7.3 NUP210 "FLJ22389, GP210, KIAA0906, POM210" ENSG00000132182 "Nucleoporin 210" Q8TEM1 3 13316235-13420309 "Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.0;lymphoid tissue: 44.2" "Cell line enhanced" "Detected in many" "RPMI-8226: 46.4;U-266/84: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066888 Approved 28000 "HPA066888: " "unprognostic (3.17e-2)" "unprognostic (2.09e-1)" "unprognostic (2.53e-1)" "unprognostic (3.60e-2)" "unprognostic (2.33e-1)" "unprognostic (9.72e-3)" "prognostic unfavourable (6.03e-6)" "unprognostic (1.30e-1)" "unprognostic (3.15e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (1.96e-3)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.59e-2)" "unprognostic (1.63e-2)" 1.6 4.1 4.0 25.6 5.2 31.0 3.7 12.6 6.7 1.7 4.2 8.0 3.3 4.9 1.8 7.0 5.6 2.9 4.0 2.0 4.1 5.3 6.8 13.8 5.3 25.6 4.9 3.5 1.4 11.4 7.2 10.9 4.3 4.5 4.2 3.9 6.3 6.8 4.4 7.2 3.8 16.4 1.6 3.6 25.3 5.6 6.6 6.1 44.2 6.5 3.1 23.1 5.6 1.8 6.7 6.8 1.0 3.9 6.2 9.3 3.6 8.3 14.7 7.3 18.9 0.0 0.0 29.1 0.1 0.0 1.8 0.0 7.5 13.7 33.9 11.7 0.0 4.9 16.1 0.0 0.6 27.2 12.0 13.1 16.7 7.9 0.0 42.0 4.8 0.0 0.0 0.0 0.0 0.0 20.3 36.5 0.0 20.9 22.3 16.7 8.4 3.0 0.0 0.0 46.4 3.5 7.8 8.4 8.4 10.5 14.1 4.4 13.5 35.0 0.1 0.0 2.5 0.0 6.4 37.1 51.4 29.6 0.0 23.5 0.0 0.0 2.9 1.0 9.3 3.9 7.4 6.7 6.7 9.0 6.4 4.5 5.6 7.3 0.1 6.2 2.4 6.8 5.6 3.6 4.0 5.2 12.6 6.7 4.1 5.3 4.9 3.5 4.5 6.1 NUP210L ENSG00000143552 "Nucleoporin 210 like" Q5VU65 1 153992685-154155116 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 42.7" "Cell line enriched" "Detected in single" 43 "MCF7: 18.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA047195, HPA064245, HPA066707" Enhanced Approved "Nuclear bodies" "Nuclear bodies" "HPA047195: , HPA064245: , HPA066707: " "unprognostic (2.11e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.80e-2)" "unprognostic (1.63e-2)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.79e-3)" "unprognostic (3.45e-2)" "unprognostic (5.57e-2)" "unprognostic (4.51e-4)" "unprognostic (1.15e-1)" "unprognostic (9.35e-10)" "unprognostic (4.20e-2)" "unprognostic (3.78e-2)" "unprognostic (7.45e-2)" "unprognostic (4.09e-2)" 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.9 0.1 0.1 1.5 0.0 0.0 1.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.4 0.6 0.1 0.0 0.8 0.9 0.4 0.1 0.1 0.1 3.4 0.2 0.1 0.1 42.7 0.0 0.3 0.3 0.0 0.1 1.2 0.1 0.6 0.6 1.8 0.2 0.9 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.3 0.1 0.2 0.6 0.4 0.5 0.0 0.5 0.8 0.3 1.8 0.9 0.0 0.6 0.7 0.0 0.1 0.3 0.1 0.9 0.1 0.2 0.1 0.0 0.6 0.0 NUP93 KIAA0095 ENSG00000102900 "Nucleoporin 93" Q8N1F7 16 56730105-56850286 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017937 Uncertain "HPA017937: AB_1854726" "unprognostic (6.31e-2)" "unprognostic (3.22e-2)" "unprognostic (1.41e-1)" "unprognostic (8.85e-2)" "unprognostic (3.99e-3)" "unprognostic (2.78e-3)" "prognostic unfavourable (1.72e-6)" "unprognostic (9.18e-2)" "unprognostic (9.35e-3)" "unprognostic (5.22e-2)" "unprognostic (4.55e-2)" "unprognostic (1.97e-1)" "unprognostic (2.66e-2)" "unprognostic (3.71e-1)" "unprognostic (1.85e-1)" "unprognostic (9.68e-2)" "unprognostic (3.74e-2)" 14.2 12.2 14.8 15.6 29.7 33.7 12.6 16.8 29.1 12.7 12.4 14.4 4.4 7.2 15.0 9.8 16.8 12.0 8.6 11.5 26.1 11.2 9.9 6.9 12.6 19.1 13.1 16.7 13.4 9.8 16.5 9.6 14.1 23.8 13.9 14.5 23.0 10.4 10.2 15.5 16.3 11.2 14.5 20.7 17.8 11.1 29.3 13.9 28.0 27.4 10.4 22.5 11.5 13.2 12.0 16.9 54.1 21.3 15.1 14.6 11.9 19.1 23.8 21.6 23.5 8.3 9.1 23.9 16.8 13.7 41.8 28.7 32.7 19.2 30.1 16.9 15.8 34.4 40.9 23.9 41.3 9.2 22.3 20.1 17.2 26.7 10.2 26.6 24.1 9.1 10.5 28.3 17.9 24.0 24.3 6.0 20.6 13.7 35.7 22.9 27.4 26.7 43.4 36.4 30.4 16.2 12.8 19.1 12.6 43.8 15.4 13.8 11.7 16.6 16.0 19.9 22.3 16.6 19.0 10.4 14.2 50.2 14.0 25.2 19.4 5.1 14.3 54.1 11.9 21.3 14.6 12.0 9.1 12.9 16.9 11.6 9.5 13.2 3.6 15.1 20.9 8.8 11.0 11.9 14.8 29.7 16.8 29.1 26.1 11.2 13.1 16.7 23.8 13.9 NUS1 "C6orf68, MGC7199, NgBR, TANGO14" ENSG00000153989 "NUS1 dehydrodolichyl diphosphate synthase subunit" Q96E22 6 117675502-117710640 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Angiogenesis, Differentiation, Lipid metabolism" "Developmental protein, Receptor, Transferase" "Congenital disorder of glycosylation, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027504 Supported Approved "Vesicles,Plasma membrane" Vesicles "Plasma membrane" "HPA027504: AB_10603124" "unprognostic (1.21e-2)" "prognostic unfavourable (6.99e-4)" "unprognostic (1.09e-2)" "unprognostic (2.31e-1)" "unprognostic (1.21e-1)" "unprognostic (8.26e-3)" "unprognostic (1.42e-3)" "unprognostic (2.42e-2)" "unprognostic (8.62e-2)" "unprognostic (2.99e-1)" "unprognostic (2.62e-1)" "unprognostic (8.35e-2)" "unprognostic (1.00e-1)" "unprognostic (2.27e-1)" "unprognostic (3.22e-2)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" 8.4 10.2 14.7 9.3 14.7 7.0 10.0 8.8 13.4 29.6 9.2 6.8 2.0 7.1 9.6 13.5 9.5 8.8 7.1 8.2 12.7 9.9 13.1 17.4 9.5 8.4 16.4 15.7 8.8 28.9 15.0 20.0 10.6 16.2 9.6 9.3 7.1 13.8 14.9 7.9 6.1 14.4 8.5 7.3 9.1 10.6 5.6 12.2 7.2 16.5 3.1 8.7 9.1 18.0 2.4 8.1 3.3 4.9 4.1 4.5 2.3 10.0 7.4 16.1 18.0 16.3 21.4 39.6 18.5 19.3 15.5 17.9 16.8 11.3 23.9 20.1 17.0 9.2 23.9 18.1 28.9 17.9 22.0 27.3 12.5 30.1 25.1 34.4 16.1 18.7 20.6 16.9 34.7 15.9 32.6 21.3 23.1 11.4 16.1 21.9 18.7 13.6 15.6 11.6 17.1 30.7 10.1 19.1 15.1 11.1 14.5 13.6 9.2 36.1 13.9 9.6 11.9 15.3 26.5 29.6 22.1 25.4 22.7 26.5 19.1 3.3 3.0 1.8 3.1 3.0 4.5 2.4 3.7 4.1 3.2 2.1 3.1 4.0 0.2 4.1 4.9 8.1 3.4 2.3 14.7 14.7 8.8 13.4 12.7 9.9 16.4 15.7 16.2 12.2 NXPE1 "FAM55A, MGC34290" ENSG00000095110 "Neurexophilin and PC-esterase domain family member 1" Q8N323 11 114521645-114559895 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "intestine: 44.0;lymphoid tissue: 20.4" "Cell line enhanced" "Detected in single" "U-138 MG: 1.0" "Cancer enriched" "Detected in single" 23 "colorectal cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049133 Enhanced "Intracellular and membrane" "HPA049133: AB_2680647" "unprognostic (2.81e-1)" "unprognostic (2.19e-3)" "unprognostic (3.40e-3)" "unprognostic (4.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (1.76e-1)" 0.1 0.0 0.1 20.4 0.1 0.0 0.1 0.1 0.1 0.1 44.0 0.1 0.1 0.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 36.9 0.1 0.3 0.1 0.1 0.0 4.4 1.0 0.1 0.1 0.0 2.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 OCA2 "BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P" ENSG00000104044 "OCA2 melanosomal transmembrane protein" Q04671 15 27754875-28099358 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Albinism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.9;skin 1: 12.3" "Group enriched" "Detected in some" 6 "SH-SY5Y: 5.8;SK-MEL-30: 22.2" "Cancer enriched" "Detected in many" 17 "melanoma: 19.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA036402 Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA036402: " "unprognostic (6.07e-3)" "unprognostic (1.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.82e-2)" "unprognostic (4.60e-4)" "unprognostic (7.11e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (3.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.96e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-6)" "unprognostic (2.61e-1)" "unprognostic (4.21e-1)" "unprognostic (3.28e-2)" "unprognostic (2.28e-2)" 0.4 0.1 0.9 1.3 4.8 0.0 0.3 0.2 2.9 2.4 0.3 3.6 0.2 0.0 0.4 1.7 2.9 1.6 0.5 0.2 1.3 3.6 0.4 0.4 1.2 3.1 0.3 0.4 0.4 0.2 0.0 1.0 2.9 9.5 0.9 0.2 37.9 1.9 2.7 0.4 12.3 0.2 0.2 0.2 2.0 0.1 2.6 0.2 0.3 7.0 0.5 1.5 0.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.5 0.0 0.0 0.1 5.8 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 4.8 0.2 2.9 1.3 3.6 0.3 0.4 9.5 0.2 OCIAD1 "Asrij, FLJ20455, OCIA, TPA018" ENSG00000109180 "OCIA domain containing 1" Q9NX40 4 48805212-48861817 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044803 Approved Approved Mitochondria Mitochondria "HPA044803: AB_10961287" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" "unprognostic (4.82e-2)" "unprognostic (7.39e-2)" "unprognostic (1.69e-1)" "unprognostic (4.17e-2)" "unprognostic (2.53e-1)" "unprognostic (1.60e-1)" "unprognostic (4.10e-1)" "unprognostic (2.83e-3)" "unprognostic (1.34e-1)" "unprognostic (5.42e-2)" "unprognostic (1.47e-3)" "unprognostic (9.23e-2)" "unprognostic (2.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.16e-2)" 28.8 43.6 59.9 24.7 73.5 21.8 35.9 55.3 82.2 37.4 37.6 36.1 35.4 33.5 34.1 49.3 28.1 41.6 29.9 47.9 62.7 61.9 57.8 79.0 27.7 32.0 51.4 60.7 40.4 34.6 52.4 53.5 29.0 53.6 34.8 39.6 29.1 34.8 36.4 53.5 23.9 30.1 33.4 51.0 23.7 31.0 23.7 35.1 29.1 55.1 37.2 31.0 31.6 24.0 33.2 35.9 30.7 33.6 41.9 43.2 30.0 24.9 18.3 37.8 25.8 37.4 45.2 29.1 40.9 64.0 42.1 49.3 17.9 71.0 28.9 40.9 35.9 21.9 35.7 37.8 51.1 24.0 24.0 45.1 18.6 14.5 55.4 46.4 48.9 48.2 55.4 33.0 40.7 43.0 50.2 16.3 48.8 17.0 39.8 46.4 31.1 17.3 27.8 36.7 30.6 81.5 25.3 22.2 40.8 20.1 15.9 45.2 32.2 40.7 32.5 27.9 32.2 19.2 50.9 42.2 58.4 45.6 33.9 37.3 34.0 17.6 26.0 30.7 30.5 28.5 41.6 33.2 34.7 36.2 32.5 29.3 43.2 37.2 21.2 41.9 33.6 35.9 29.0 30.0 59.9 73.5 55.3 82.2 62.7 61.9 51.4 60.7 53.6 35.1 ODR4 "C1orf27, FLJ20505, odr-4, TTG1" ENSG00000157181 "Odr-4 GPCR localization factor homolog" Q5SWX8 1 186375838-186421378 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015988, HPA031352" Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA015988: AB_1845644, HPA031352: " "unprognostic (1.19e-2)" "unprognostic (4.23e-2)" "unprognostic (1.12e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (2.11e-1)" "unprognostic (8.57e-2)" "unprognostic (8.11e-3)" "prognostic favourable (9.92e-4)" "unprognostic (1.15e-2)" "unprognostic (9.85e-2)" "unprognostic (2.18e-2)" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (4.20e-2)" 11.9 15.9 18.2 7.0 22.9 12.2 13.7 27.7 18.7 13.9 10.3 11.4 16.2 12.5 9.6 16.6 9.5 9.1 10.3 11.8 14.3 11.3 16.1 20.0 10.4 6.1 21.9 14.0 12.1 26.5 44.8 26.5 13.4 16.0 16.1 12.8 9.7 18.3 15.3 10.3 9.5 14.8 9.0 21.3 10.1 12.8 8.1 19.1 9.0 19.0 10.1 6.9 10.4 9.7 4.1 8.6 4.4 11.8 10.6 6.2 4.6 8.0 9.1 10.2 8.0 12.4 11.9 19.3 13.2 8.4 8.6 8.6 17.9 18.7 5.8 15.9 6.5 20.9 7.4 7.1 8.4 5.1 7.6 5.4 11.6 10.1 11.5 8.9 6.7 9.0 14.4 10.0 16.2 9.2 20.2 11.7 10.4 8.5 6.3 8.8 14.0 3.1 7.2 6.9 15.8 17.1 8.3 7.3 11.4 10.0 21.7 15.4 18.9 7.7 8.4 12.1 7.6 8.3 12.3 14.3 8.6 9.0 6.7 4.8 10.9 1.5 10.5 2.7 3.8 10.0 5.5 4.1 4.8 5.0 8.6 3.1 6.0 4.6 4.4 10.6 11.8 5.4 6.2 4.6 18.2 22.9 27.7 18.7 14.3 11.3 21.9 14.0 16.0 19.1 OGFOD3 "C17orf101, FLJ22222" ENSG00000181396 "2-oxoglutarate and iron dependent oxygenase domain containing 3" Q6PK18 17 82389223-82418637 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052099 Uncertain Approved Nucleoplasm Nucleoplasm "HPA052099: AB_2681725" "unprognostic (1.12e-2)" "unprognostic (5.85e-2)" "unprognostic (9.66e-2)" "unprognostic (9.69e-2)" "unprognostic (4.11e-3)" "unprognostic (2.09e-1)" "unprognostic (2.80e-2)" "unprognostic (1.99e-1)" "unprognostic (5.41e-2)" "unprognostic (7.15e-2)" "unprognostic (8.05e-3)" "unprognostic (2.95e-1)" "prognostic favourable (5.72e-4)" "unprognostic (7.43e-2)" "unprognostic (1.40e-1)" "unprognostic (7.08e-2)" "unprognostic (1.02e-1)" 12.9 18.0 7.6 11.3 10.4 10.2 12.1 15.4 13.7 12.0 11.1 14.3 21.8 11.5 14.7 24.9 10.7 15.0 19.0 20.9 7.2 8.5 13.7 16.8 14.4 12.3 9.1 11.9 15.1 30.0 15.3 20.4 12.8 9.0 13.8 6.6 13.9 21.8 22.9 24.4 11.3 11.6 13.4 10.7 10.5 13.0 9.8 8.6 6.9 18.8 17.0 12.8 11.6 12.0 10.1 18.5 3.1 10.3 5.2 10.9 5.2 12.4 15.7 5.3 17.6 10.2 13.0 9.2 12.8 11.9 13.3 13.7 16.8 17.1 8.5 10.3 9.8 9.3 4.5 10.7 5.5 6.7 14.1 13.1 12.0 21.2 9.2 15.0 15.4 10.4 8.0 6.1 5.3 13.8 16.4 6.7 3.8 11.7 10.1 15.6 5.0 19.1 6.9 10.3 13.0 7.5 11.7 11.5 22.8 22.0 20.1 10.3 11.9 19.7 10.6 25.1 15.8 9.8 16.2 12.0 1.0 8.1 15.6 8.8 12.9 0.1 10.3 3.1 5.4 9.4 6.1 10.1 7.8 10.9 18.5 8.8 9.4 7.8 1.3 5.2 6.3 9.6 2.9 5.2 7.6 10.4 15.4 13.7 7.2 8.5 9.1 11.9 9.0 8.6 OLR1 "CLEC8A, LOX-1, SCARE1" ENSG00000173391 "Oxidized low density lipoprotein receptor 1" P78380 12 10158301-10172138 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Inflammatory response" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;lung: 46.8;placenta: 53.4" "Cell line enhanced" "Detected in some" "CACO-2: 32.0;HaCaT: 16.8;HHSteC: 33.8;hTCEpi: 15.5;SiHa: 64.4;SK-BR-3: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5" "Low region specificity" "Detected in all" HPA050798 Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" "Nucleoplasm, Plasma membrane" Vesicles "HPA050798: AB_2756318" "unprognostic (2.30e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "prognostic unfavourable (8.24e-5)" "unprognostic (6.34e-2)" "unprognostic (6.07e-3)" "unprognostic (5.40e-2)" "unprognostic (2.64e-1)" "unprognostic (1.97e-2)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (4.94e-3)" "unprognostic (3.47e-2)" "unprognostic (1.48e-2)" "unprognostic (1.42e-1)" 2.0 1.9 6.0 14.1 10.3 10.6 2.0 1.3 10.2 1.9 0.5 21.3 0.0 0.8 1.0 0.9 0.5 1.2 3.9 1.1 8.5 6.7 6.9 1.8 46.8 0.5 16.4 4.4 0.4 1.6 2.8 1.9 53.4 12.3 1.4 0.7 0.2 2.0 0.7 0.4 0.5 0.8 1.2 28.5 0.6 1.4 2.8 10.5 0.0 1.5 0.0 0.6 4.3 0.4 0.5 5.9 3.3 1.5 0.3 0.3 1.1 1.8 0.1 0.0 0.1 0.0 0.0 4.4 3.1 0.5 1.9 0.7 32.0 0.0 0.3 0.0 4.1 16.8 0.0 0.1 1.3 0.0 0.0 0.0 1.6 0.0 33.8 0.0 0.0 0.2 15.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 64.4 25.6 0.0 7.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 1.5 2.7 0.2 0.2 0.3 0.3 0.3 0.2 5.9 0.5 0.3 0.3 3.3 0.3 0.4 0.8 0.2 1.1 6.0 10.3 1.3 7.4 8.5 6.7 16.4 4.4 12.3 10.5 OPA3 "FLJ22187, MGA3" ENSG00000125741 "OPA3, outer mitochondrial membrane lipid metabolism regulator" Q9H6K4 19 45527427-45602212 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044881 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA044881: AB_10964052" "unprognostic (3.37e-1)" "unprognostic (3.89e-2)" "unprognostic (2.66e-1)" "unprognostic (5.71e-3)" "unprognostic (1.24e-2)" "unprognostic (2.87e-2)" "prognostic unfavourable (5.60e-4)" "unprognostic (3.14e-3)" "unprognostic (4.53e-2)" "unprognostic (8.06e-3)" "unprognostic (1.72e-3)" "unprognostic (8.73e-2)" "prognostic favourable (9.30e-12)" "unprognostic (5.85e-2)" "unprognostic (1.94e-1)" "unprognostic (3.82e-2)" "unprognostic (1.81e-1)" 21.6 14.8 8.5 9.4 15.9 7.9 21.8 8.5 13.1 6.2 8.9 7.2 5.7 8.4 10.5 7.7 11.3 7.6 9.8 21.8 9.8 9.6 15.9 16.4 19.3 9.7 11.0 4.5 8.9 9.3 23.9 12.3 11.4 18.4 7.9 8.7 12.1 8.2 9.4 19.7 12.5 9.7 10.2 12.4 12.0 9.2 15.7 11.1 5.3 11.8 9.7 9.6 9.5 30.3 6.7 7.8 7.4 13.0 10.9 6.2 4.5 11.3 14.5 5.8 5.8 3.9 4.8 8.9 7.4 6.9 8.0 8.5 6.7 8.2 9.8 5.4 7.4 9.1 9.7 10.2 7.0 17.9 9.8 15.2 8.1 6.9 7.0 10.7 19.8 7.2 7.9 8.8 9.7 5.6 12.9 11.1 5.4 7.0 8.3 4.4 5.1 10.0 8.3 5.2 5.3 6.2 20.6 4.4 5.2 9.5 8.8 4.0 4.9 6.1 12.1 6.8 7.8 5.6 12.6 7.5 13.8 8.2 6.6 7.7 10.2 6.0 7.4 3.8 5.3 10.5 5.6 6.7 4.8 4.5 7.8 5.6 6.0 5.9 7.4 10.9 13.0 7.3 6.2 4.5 8.5 15.9 8.5 13.1 9.8 9.6 11.0 4.5 18.4 11.1 OPALIN "HTMP10, TMEM10, TMP10" ENSG00000197430 "Oligodendrocytic myelin paranodal and inner loop protein" Q96PE5 10 96343216-96359365 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "brain: 69.7" "Group enriched" "Detected in some" 11 "MOLT-4: 2.2;REH: 4.5" "Cancer enriched" "Detected in single" 36 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014372 Supported "HPA014372: AB_2158172" "unprognostic (1.18e-1)" 1.5 1.5 35.0 1.5 42.1 1.6 1.5 2.8 69.7 1.5 1.5 52.5 0.0 1.5 1.5 1.5 1.5 1.5 1.5 1.5 40.1 15.1 1.5 1.5 1.5 1.5 19.9 17.8 1.5 1.5 1.5 0.0 1.5 13.8 1.5 1.5 0.0 1.5 1.5 1.5 1.5 1.5 1.5 17.8 1.5 1.5 1.5 29.5 0.0 1.5 0.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 42.1 2.8 33.4 40.1 15.1 19.9 17.8 13.8 29.5 OPRM1 MOR1 ENSG00000112038 "Opioid receptor mu 1" P35372 6 154010496-154246867 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 37.9" "Cell line enriched" "Detected in single" 24 "SH-SY5Y: 12.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 37.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014509, HPA067435" Enhanced Supported "HPA014509: AB_1854801, HPA067435: " "unprognostic (7.34e-2)" "unprognostic (6.91e-2)" 0.5 3.4 7.0 0.6 17.5 1.8 0.9 37.9 7.6 0.5 0.6 0.8 0.0 0.6 0.7 1.4 3.7 0.5 1.0 0.5 2.6 2.3 0.5 0.5 0.5 0.9 0.6 9.3 0.8 0.7 0.4 0.6 0.5 5.2 0.7 0.4 0.0 0.6 0.2 0.9 1.8 0.5 0.3 1.9 0.6 1.0 8.0 0.5 0.0 1.0 0.0 0.3 0.5 0.5 0.5 0.2 2.1 0.1 0.1 0.7 0.0 0.1 0.0 0.2 0.4 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.2 0.4 0.4 0.1 0.0 0.3 0.3 0.2 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.3 0.5 0.1 0.5 0.0 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.3 12.8 0.0 0.0 0.3 0.3 0.1 0.3 0.4 0.1 0.3 0.1 0.4 0.2 0.1 0.3 0.1 0.0 0.2 0.1 0.6 0.6 0.0 0.7 0.2 0.3 0.5 0.1 0.5 0.4 0.1 2.1 0.1 0.0 0.2 0.3 0.0 7.0 17.5 37.9 7.6 2.6 2.3 0.6 9.3 5.2 0.5 OR51E1 "GPR136, GPR164, OR51E1P, OR52A3P" ENSG00000180785 "Olfactory receptor family 51 subfamily E member 1" Q8TCB6 11 4643420-4655488 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 10.0;prostate: 12.1" "Cell line enriched" "Detected in single" 114 "SCLC-21H: 14.1" "Cancer enriched" "Detected in many" 21 "prostate cancer: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB019995, HPA051439" Approved "CAB019995: AB_10283600, HPA051439: " "unprognostic (6.67e-3)" "unprognostic (2.34e-3)" "unprognostic (9.71e-2)" "unprognostic (4.87e-5)" "unprognostic (3.55e-2)" "unprognostic (9.80e-3)" "unprognostic (1.76e-1)" "unprognostic (2.30e-3)" "unprognostic (2.00e-2)" "unprognostic (3.94e-3)" "unprognostic (7.36e-2)" "unprognostic (6.15e-2)" "prognostic unfavourable (1.23e-6)" "unprognostic (2.72e-3)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (2.86e-1)" 7.6 0.0 0.6 1.9 0.8 0.0 5.1 0.1 0.6 0.9 2.6 0.1 0.1 0.4 2.5 0.3 0.8 0.8 0.7 4.8 0.1 0.2 1.6 0.1 0.1 1.9 0.6 0.1 1.0 0.1 0.2 1.0 10.0 0.6 12.1 1.1 0.8 4.4 0.8 2.4 0.3 2.1 1.3 1.8 0.1 0.9 0.3 0.1 0.1 0.9 0.9 0.4 1.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.1 0.6 0.1 0.2 0.6 0.1 0.6 0.1 ORC3 "IMAGE50150, LATHEO, ORC3L" ENSG00000135336 "Origin recognition complex subunit 3" Q9UBD5 6 87590067-87667453 "Predicted intracellular proteins, Predicted membrane proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039553, HPA053748" Enhanced Supported Nucleoplasm Nucleoplasm "HPA039553: , HPA053748: " "unprognostic (9.38e-3)" "unprognostic (2.38e-1)" "unprognostic (3.74e-2)" "prognostic unfavourable (2.89e-5)" "unprognostic (8.63e-2)" "unprognostic (1.28e-1)" "unprognostic (1.39e-2)" "unprognostic (2.15e-1)" "unprognostic (1.16e-1)" "unprognostic (2.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.07e-2)" "prognostic unfavourable (7.23e-4)" "unprognostic (1.33e-1)" "unprognostic (2.92e-2)" "unprognostic (3.38e-3)" "unprognostic (1.09e-1)" 16.9 22.6 17.6 11.4 23.1 8.9 18.7 33.9 24.4 18.1 10.7 12.1 12.4 8.1 16.5 19.6 11.0 18.1 11.2 21.7 17.8 19.6 16.7 17.3 12.4 15.2 17.6 19.4 24.8 11.8 27.8 30.0 17.6 28.5 16.4 12.9 11.5 11.0 14.2 23.6 12.2 11.4 13.8 19.8 15.4 10.0 26.8 19.4 29.0 18.6 15.3 15.3 17.0 11.1 15.1 9.7 14.9 17.1 15.1 20.6 11.1 8.3 11.2 21.1 15.9 16.3 17.3 15.7 17.1 15.3 20.1 28.4 15.6 10.6 16.8 23.1 11.6 15.4 23.6 13.6 27.8 20.5 16.1 15.5 16.9 16.0 8.8 17.3 5.3 15.3 10.9 22.8 20.0 12.2 34.9 17.9 18.9 10.6 7.3 9.1 14.8 12.7 16.9 28.5 10.2 15.5 12.1 15.2 11.1 13.4 8.1 12.9 11.1 15.1 10.0 10.3 9.8 20.8 20.1 8.7 18.8 11.5 13.5 17.8 15.4 14.9 8.8 9.5 11.4 14.2 16.8 15.1 16.3 14.2 7.2 12.9 20.6 17.2 5.9 15.1 17.1 9.7 15.4 11.1 17.6 23.1 33.9 24.4 17.8 19.6 17.6 19.4 28.5 19.4 OSBPL5 "KIAA1534, ORP5" ENSG00000021762 "Oxysterol binding protein like 5" Q9H0X9 11 3087116-3166739 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 3.1;gdT-cell: 9.3;intermediate monocyte: 4.4;memory CD8 T-cell: 3.4;myeloid DC: 2.7;naive CD8 T-cell: 3.6;NK-cell: 10.0;non-classical monocyte: 10.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038335, HPA038712, HPA058727" Approved Enhanced Vesicles Vesicles "HPA038335: , HPA038712: AB_10675949, HPA058727: AB_2683799" "unprognostic (6.02e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (3.69e-2)" "unprognostic (8.22e-3)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (4.03e-3)" "unprognostic (1.29e-1)" "unprognostic (3.49e-3)" "unprognostic (2.16e-3)" "unprognostic (9.44e-2)" "unprognostic (2.78e-2)" "unprognostic (1.22e-1)" "unprognostic (6.50e-2)" "unprognostic (7.67e-2)" "unprognostic (2.60e-1)" 17.6 7.0 4.2 10.3 6.2 17.8 20.7 4.4 8.8 24.7 15.6 7.5 24.0 9.0 17.1 15.9 8.1 12.6 13.8 10.0 4.6 6.5 8.1 2.7 12.9 10.5 6.9 6.4 9.6 8.4 2.4 6.5 7.8 9.8 15.9 5.2 9.0 17.1 17.5 28.0 17.8 9.6 20.1 11.9 20.3 10.2 4.4 6.3 36.5 9.3 9.6 3.8 14.3 17.7 0.0 2.7 1.0 10.1 10.0 9.3 3.9 1.7 2.7 3.2 3.7 9.7 4.5 0.0 8.8 4.3 3.5 2.5 0.0 5.1 0.0 2.7 4.9 6.5 0.6 2.4 0.5 1.7 2.5 7.3 8.7 0.0 7.9 6.5 1.1 7.0 2.9 1.2 1.3 2.4 2.5 0.0 1.7 4.9 14.2 36.3 2.3 5.7 7.4 4.4 1.0 1.4 1.6 5.4 0.6 3.6 12.9 3.3 5.3 17.3 8.0 4.5 6.1 10.6 1.5 1.8 0.0 0.2 4.7 12.3 5.6 0.2 3.1 1.0 9.3 4.4 1.2 0.0 1.0 3.4 2.7 0.0 0.6 3.6 0.4 10.0 10.1 1.2 0.1 3.9 4.2 6.2 4.4 8.8 4.6 6.5 6.9 6.4 9.8 6.3 OSBPL8 "MST120, MSTP120, ORP8, OSBP10" ENSG00000091039 "Oxysterol binding protein like 8" Q9BZF1 12 76351797-76559809 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001309 Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA001309: AB_1079530" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.77e-1)" "unprognostic (1.70e-1)" "unprognostic (5.20e-2)" "unprognostic (1.23e-1)" "unprognostic (6.55e-3)" "unprognostic (2.84e-1)" "unprognostic (7.88e-2)" "unprognostic (1.61e-2)" "prognostic unfavourable (9.79e-4)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (5.63e-3)" "unprognostic (2.96e-1)" "unprognostic (1.16e-1)" "unprognostic (3.19e-3)" 29.3 11.4 13.9 18.4 41.9 23.1 17.2 13.7 20.2 20.0 11.5 6.8 8.4 7.5 18.5 10.7 20.1 10.4 15.0 19.3 13.4 12.9 30.2 15.2 20.5 22.7 12.1 13.2 14.9 11.2 12.4 16.5 14.4 13.9 16.2 9.7 9.2 15.8 11.1 21.5 22.9 12.6 15.5 14.8 24.9 12.4 12.8 14.7 41.0 11.7 10.6 24.8 18.0 24.5 11.7 15.8 57.2 15.0 9.9 10.9 8.1 12.3 7.9 17.6 12.5 24.6 34.8 11.2 19.1 26.7 12.2 11.2 11.4 5.1 17.3 10.9 22.6 5.2 13.1 11.0 18.5 14.8 11.6 46.5 7.8 6.8 15.2 29.4 19.0 18.3 21.0 18.2 22.8 10.5 31.8 8.0 20.1 8.5 19.6 14.0 8.6 7.9 10.3 24.1 9.9 9.4 10.5 9.7 10.1 16.3 6.0 11.8 4.5 18.0 24.6 19.9 9.9 20.4 10.2 8.0 12.6 19.1 7.5 16.6 11.5 27.5 15.0 20.1 9.0 10.8 8.5 11.7 9.6 7.3 13.2 11.6 8.7 7.1 57.2 9.9 11.7 15.8 10.9 8.1 13.9 41.9 13.7 19.9 13.4 12.9 12.1 13.2 13.9 14.7 OSCAR ENSG00000170909 "Osteoclast associated, immunoglobulin-like receptor" Q8IYS5 19 54094668-54102692 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2" "Cell line enhanced" "Detected in some" "EFO-21: 13.3;HHSteC: 9.1;hTERT-HME1: 4.7;NB-4: 5.3;U-937: 16.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 34 "classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2" "Group enriched" "Detected in many" 75 "dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073996 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 72000000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA073996: " "unprognostic (9.09e-2)" "unprognostic (6.79e-3)" "unprognostic (8.47e-3)" "unprognostic (2.14e-1)" "unprognostic (2.12e-2)" "unprognostic (9.04e-2)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.05e-2)" "unprognostic (3.01e-1)" "prognostic unfavourable (2.71e-5)" "unprognostic (1.84e-1)" "unprognostic (2.88e-2)" "unprognostic (9.69e-2)" "unprognostic (4.28e-2)" 4.5 1.0 1.4 3.8 2.8 18.9 1.4 0.4 1.5 1.3 0.9 3.5 0.0 0.4 0.7 1.3 1.2 2.2 2.3 1.1 3.8 1.9 1.0 1.7 40.4 4.7 3.5 0.4 1.2 0.7 0.3 0.5 2.2 4.0 0.8 0.7 1.0 1.3 0.8 0.7 1.9 1.0 2.8 5.6 20.2 1.3 0.6 2.4 1.7 1.0 0.0 1.2 1.7 3.1 0.0 9.4 18.3 20.6 0.0 0.2 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.4 0.0 13.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 9.1 0.7 0.0 0.0 0.2 0.6 4.7 0.0 0.0 0.4 0.1 0.1 0.0 5.3 0.3 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 3.8 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.5 0.5 16.5 0.0 0.0 20.6 11.7 0.1 12.8 0.0 0.0 0.1 0.2 9.4 0.0 0.0 0.0 18.3 0.0 11.2 0.4 0.1 7.0 1.4 2.8 0.4 1.4 3.8 1.9 3.5 0.4 4.0 2.4 OSMR OSMRB ENSG00000145623 "Oncostatin M receptor" Q99650 5 38845858-38945596 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 38.9;HSkMC: 48.2;U-2197: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017278 Approved Approved Nucleoli "Intracellular and membrane" 21000000 Nucleoli "HPA017278: AB_1854818" "unprognostic (6.34e-3)" "prognostic unfavourable (4.87e-4)" "unprognostic (2.58e-1)" "unprognostic (2.11e-1)" "unprognostic (2.18e-3)" "unprognostic (1.13e-1)" "unprognostic (8.00e-3)" "unprognostic (5.70e-2)" "unprognostic (1.79e-3)" "unprognostic (1.72e-3)" "unprognostic (1.60e-3)" "unprognostic (1.12e-1)" "prognostic unfavourable (3.96e-6)" "unprognostic (1.88e-2)" "unprognostic (1.49e-2)" "unprognostic (4.43e-1)" "unprognostic (1.75e-2)" 41.1 18.0 7.3 18.7 9.4 0.3 31.0 3.1 9.4 14.1 13.7 2.8 4.6 4.4 14.4 12.9 14.7 14.5 22.4 22.4 5.4 3.5 19.7 23.6 25.7 31.7 9.0 1.3 33.6 10.1 6.6 10.5 40.1 13.3 20.8 8.6 9.2 17.2 11.1 13.0 12.5 8.0 32.5 15.6 23.5 11.5 10.8 6.9 3.6 17.5 10.4 11.3 40.4 43.6 0.6 0.6 1.6 0.4 0.7 0.6 0.1 7.5 9.8 1.6 4.2 18.1 38.9 5.7 12.4 19.7 12.2 16.4 0.0 20.6 0.0 5.9 13.1 10.5 2.1 15.2 19.7 0.0 1.2 0.5 7.7 7.4 20.6 0.0 0.1 48.2 9.1 27.3 23.5 1.8 0.0 0.0 7.7 2.0 0.0 0.0 0.2 3.2 0.0 0.5 0.0 24.5 2.2 0.0 0.0 27.9 0.0 0.0 8.6 0.0 2.9 29.8 11.3 38.5 6.5 0.0 0.0 0.0 23.9 0.0 6.4 1.6 0.4 0.4 0.5 0.3 0.2 0.3 0.3 0.1 0.1 0.6 0.4 0.6 1.0 0.7 0.1 0.6 0.2 0.1 7.3 9.4 3.1 9.4 5.4 3.5 9.0 1.3 13.3 6.9 OSTM1 "GL, HSPC019" ENSG00000081087 "Osteopetrosis associated transmembrane protein 1" Q86WC4 6 108041409-108165854 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Osteopetrosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010851 Uncertain Approved Nucleoplasm,Vesicles,Cytosol 130000 Cytosol "Nucleoplasm, Vesicles" "HPA010851: AB_1079533" "prognostic unfavourable (4.36e-4)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (1.72e-3)" "prognostic unfavourable (4.26e-4)" "unprognostic (9.40e-2)" "unprognostic (2.56e-1)" "unprognostic (2.25e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (1.34e-6)" "prognostic unfavourable (1.20e-4)" "unprognostic (2.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" 26.3 21.9 9.0 18.1 13.5 5.5 16.7 13.7 17.2 14.4 17.8 12.8 9.9 8.4 21.8 10.3 14.1 15.0 13.5 23.2 10.4 16.5 22.0 15.9 17.0 17.2 11.0 10.5 15.6 9.7 11.8 26.0 24.7 20.0 15.4 12.4 29.7 10.8 19.0 18.0 10.4 12.9 24.7 13.1 21.7 14.3 11.1 10.7 13.6 12.4 8.1 13.9 21.0 19.4 10.8 12.4 20.9 28.1 14.5 16.4 16.9 2.2 6.5 7.8 11.3 23.3 7.6 11.0 16.2 16.3 11.9 19.8 3.9 3.7 5.1 13.4 11.3 4.2 7.6 5.5 18.4 11.7 6.0 10.7 4.2 4.8 18.1 11.8 25.1 11.1 13.8 14.6 11.7 6.0 8.5 18.7 19.2 3.1 2.5 2.7 3.1 5.0 4.2 11.2 2.7 8.5 5.9 0.8 4.6 13.1 3.3 29.0 3.8 17.1 7.3 10.4 3.8 23.0 22.9 7.2 12.3 4.4 30.8 8.0 23.0 16.8 13.9 15.2 15.0 19.9 16.0 10.8 12.8 16.4 12.4 6.2 12.0 15.0 20.9 14.5 28.1 8.9 15.4 16.9 9.0 13.5 13.7 17.2 10.4 16.5 11.0 10.5 20.0 10.7 OTOF "DFNB6, DFNB9, FER1L2" ENSG00000115155 Otoferlin Q9HC10 2 26457203-26558698 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Hearing "Deafness, Disease mutation, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "bone marrow: 13.8;brain: 26.8" "Cell line enriched" "Detected in some" 17 "HDLM-2: 26.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "basal ganglia: 26.8" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;memory CD8 T-cell: 1.6" "Lineage enhanced" "Detected in single" "T-cells: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012410 Approved "HPA012410: AB_1854836" "unprognostic (4.01e-3)" "unprognostic (7.85e-2)" "unprognostic (8.95e-2)" "unprognostic (7.20e-5)" "unprognostic (1.82e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.61e-2)" "unprognostic (1.78e-2)" "unprognostic (1.26e-1)" "unprognostic (2.97e-3)" "unprognostic (4.85e-14)" "unprognostic (1.33e-2)" "unprognostic (5.19e-1)" "unprognostic (9.65e-2)" "unprognostic (8.96e-5)" 0.5 0.7 5.5 0.8 26.8 13.8 0.2 0.4 2.2 0.3 0.4 0.3 0.0 1.1 0.2 0.1 0.4 0.3 0.9 0.2 1.6 2.0 0.1 0.2 0.6 0.5 0.6 0.7 0.2 0.1 0.1 0.0 0.2 1.1 0.3 0.3 0.0 0.3 0.2 0.7 0.2 0.7 0.4 0.7 1.2 0.5 1.4 2.6 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.6 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 5.5 26.8 0.4 2.2 1.6 2.0 0.6 0.7 1.1 2.6 OXGR1 "aKGR, GPR80, GPR99, P2RY15, P2Y15" ENSG00000165621 "Oxoglutarate receptor 1" Q96P68 13 96985719-96994730 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 7.0" "Cell line enhanced" "Detected in some" "RT4: 7.6;SK-BR-3: 3.5;T-47d: 1.7;U-2 OS: 4.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "myeloid DC: 2.9;plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA067673 Supported "Plasma membrane" "Plasma membrane" "HPA067673: " "unprognostic (1.83e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-1)" "unprognostic (6.97e-4)" "unprognostic (7.23e-2)" "unprognostic (1.52e-1)" "unprognostic (8.38e-2)" "unprognostic (2.16e-1)" "unprognostic (1.16e-1)" "unprognostic (2.22e-2)" "unprognostic (4.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.54e-1)" "unprognostic (9.68e-2)" 2.1 0.0 0.7 1.7 0.2 0.0 6.7 0.0 2.0 1.6 3.0 0.1 0.6 4.0 3.2 2.5 0.0 0.0 0.8 0.8 7.0 0.0 0.5 0.0 0.7 0.0 0.6 0.0 0.3 1.2 0.5 2.4 4.9 0.3 0.1 4.3 0.5 0.5 1.6 0.3 0.1 0.0 0.8 0.9 1.8 0.9 0.0 5.2 0.1 0.5 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.6 0.0 0.2 0.0 3.5 0.0 1.7 0.0 0.0 0.0 4.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.0 0.1 0.8 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.1 0.0 0.0 5.2 0.0 0.1 P2RX4 P2X4 ENSG00000135124 "Purinergic receptor P2X 4" Q99571 12 121209857-121234106 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039494 Enhanced "HPA039494: AB_10969132" "unprognostic (4.02e-3)" "unprognostic (1.06e-1)" "unprognostic (5.43e-2)" "prognostic favourable (6.30e-10)" "unprognostic (2.98e-2)" "unprognostic (2.52e-1)" "unprognostic (2.06e-3)" "unprognostic (1.68e-1)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (7.71e-2)" "unprognostic (2.18e-1)" "unprognostic (1.81e-2)" "unprognostic (1.13e-1)" "unprognostic (6.06e-2)" "unprognostic (1.42e-2)" "unprognostic (4.76e-3)" 14.1 7.8 4.9 6.5 4.7 4.8 13.8 24.0 8.1 11.3 16.3 8.8 5.5 13.4 6.3 5.5 5.6 8.4 8.6 6.1 3.9 3.4 10.2 13.2 11.6 16.1 6.0 3.5 9.9 22.7 15.7 8.4 25.9 5.8 7.7 13.9 7.0 15.7 9.5 2.3 4.1 17.6 8.4 6.8 11.5 11.2 4.2 5.0 4.2 7.1 2.8 7.1 7.8 5.8 2.7 6.1 17.1 14.2 5.6 6.1 7.2 2.2 6.3 0.1 7.9 4.1 3.8 19.7 2.4 12.7 3.3 5.8 3.7 9.3 1.6 7.1 7.7 0.9 2.1 1.2 1.6 7.9 4.6 1.0 0.1 3.3 9.9 2.8 17.0 4.6 2.5 3.2 4.3 11.4 2.8 5.9 2.5 11.9 1.5 2.0 2.0 5.1 1.6 11.4 12.2 1.1 3.9 2.0 3.8 5.5 3.2 21.3 16.0 5.3 0.6 4.5 3.8 0.4 1.3 8.4 9.6 1.5 9.2 3.5 4.4 17.1 13.0 2.1 4.2 14.2 4.2 2.7 6.1 3.4 6.1 1.5 4.5 2.2 0.1 5.6 12.2 1.4 3.9 7.2 4.9 4.7 24.0 8.1 3.9 3.4 6.0 3.5 5.8 5.0 P2RX5 "LRH-1, P2X5" ENSG00000083454 "Purinergic receptor P2X 5" Q93086 17 3672199-3696404 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4" "Cell line enhanced" "Detected in many" "Daudi: 24.0;Karpas-707: 15.5;RPMI-8226: 27.0;U-698: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 18 "memory B-cell: 28.1;naive B-cell: 30.4" "Lineage enriched" "Detected in many" 19 "B-cells: 30.4" "HPA021948, HPA067827" Supported Supported Cytosol Cytosol "HPA021948: AB_1854878, HPA067827: " "unprognostic (1.08e-3)" "unprognostic (9.16e-2)" "unprognostic (1.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.79e-1)" "unprognostic (1.06e-1)" "unprognostic (8.33e-2)" "unprognostic (4.34e-1)" "unprognostic (1.24e-1)" "unprognostic (1.14e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.99e-8)" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (3.50e-2)" "unprognostic (3.63e-2)" 0.6 0.3 2.2 32.0 4.9 4.8 0.5 4.1 5.1 0.3 1.4 0.0 0.4 0.9 0.2 0.2 2.4 0.2 0.8 4.9 1.8 3.0 0.8 0.4 1.0 39.1 1.5 2.1 0.2 0.8 0.1 1.2 0.2 1.7 0.5 1.2 0.0 5.4 0.1 11.4 0.2 12.0 0.4 0.6 29.6 1.8 0.6 0.2 9.3 0.5 1.9 27.6 2.2 0.3 30.4 0.1 0.7 0.0 0.0 1.6 1.6 3.8 3.2 0.0 0.0 0.1 0.6 0.0 4.0 1.8 0.4 1.3 2.4 4.7 24.0 2.4 1.9 2.0 8.6 0.0 0.8 0.4 1.5 1.2 8.5 2.9 0.6 1.6 2.1 1.0 0.9 0.1 5.6 0.0 0.2 15.5 8.7 0.0 10.8 3.6 2.4 9.7 0.4 0.0 27.0 0.1 2.9 2.0 0.0 3.3 1.1 1.8 1.0 1.5 0.0 0.0 2.2 0.1 0.7 5.5 11.7 22.3 0.0 2.3 0.2 0.0 0.0 0.7 1.1 0.0 1.6 28.1 1.0 0.8 0.1 30.4 0.1 0.1 0.0 0.0 0.0 0.0 0.5 1.6 2.2 4.9 4.1 5.1 1.8 3.0 1.5 2.1 1.7 0.2 P2RX6 "MGC129625, P2RXL1, P2X6, P2XM" ENSG00000099957 "Purinergic receptor P2X 6" O15547 22 21009808-21028830 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 12.4" "Cell line enhanced" "Detected in some" "LHCN-M2: 8.2;RH-30: 5.1;U-87 MG: 14.6" "Cancer enhanced" "Detected in some" "melanoma: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028776, HPA028777" Approved Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA028776: , HPA028777: " "unprognostic (1.81e-2)" "unprognostic (5.15e-3)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.28e-2)" "unprognostic (1.79e-5)" "unprognostic (1.70e-2)" "unprognostic (6.20e-2)" "unprognostic (1.49e-1)" "unprognostic (2.59e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-2)" "unprognostic (2.88e-10)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (7.33e-2)" "unprognostic (2.39e-3)" 0.2 1.6 0.0 0.2 0.2 0.0 0.0 0.9 3.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 1.1 1.9 0.2 0.8 0.1 0.0 0.2 0.0 0.6 0.3 0.0 0.0 1.6 1.1 0.2 0.0 0.1 1.1 12.4 0.0 0.0 0.0 0.8 2.3 0.1 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.8 0.3 0.1 0.0 1.0 0.1 2.0 0.8 1.5 0.0 0.0 0.0 1.4 0.5 1.7 0.0 0.1 0.1 0.3 0.0 2.2 0.8 0.0 3.6 0.0 3.0 0.4 0.0 1.5 0.1 0.0 2.4 0.7 8.2 0.0 0.0 0.4 0.0 0.0 0.0 5.1 0.2 0.0 0.0 0.2 3.8 1.5 0.1 0.7 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.3 0.0 0.0 14.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 P2RY6 P2Y6 ENSG00000171631 "Pyrimidinergic receptor P2Y6" Q15077 11 73264505-73298617 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 36.4;lymphoid tissue: 31.1;placenta: 38.0" "Cell line enhanced" "Detected in some" "AN3-CA: 32.9;EFO-21: 10.4;MCF7: 15.3;SK-BR-3: 26.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "myeloid DC: 10.9;plasmacytoid DC: 36.4" "Lineage enriched" "Detected in many" 20 "dendritic cells: 36.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022740, HPA074751" Enhanced "CAB022740: , HPA074751: " "unprognostic (2.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.04e-2)" "unprognostic (5.54e-3)" "unprognostic (4.18e-3)" "unprognostic (1.94e-2)" "unprognostic (3.93e-3)" "unprognostic (4.00e-3)" "unprognostic (1.86e-4)" "unprognostic (3.08e-1)" "unprognostic (1.25e-2)" "unprognostic (2.18e-1)" "prognostic unfavourable (2.50e-7)" "unprognostic (1.48e-2)" "unprognostic (1.38e-3)" "unprognostic (7.67e-2)" "unprognostic (1.05e-1)" 2.5 1.8 2.7 8.3 3.5 0.8 1.5 0.5 3.2 2.5 2.1 3.1 0.0 3.0 1.2 2.6 2.9 1.6 2.4 2.7 1.8 1.0 6.2 3.7 3.0 4.8 2.3 1.7 2.1 1.7 0.5 2.7 38.0 2.8 2.1 2.2 5.9 2.0 0.9 2.9 0.9 4.9 3.4 3.8 31.1 1.9 0.8 3.5 3.3 5.0 1.8 3.1 4.1 1.6 0.0 36.4 0.1 1.8 1.5 0.1 1.0 0.7 7.8 0.0 32.9 0.0 0.0 6.8 0.1 0.0 0.1 0.1 7.1 0.1 0.0 10.4 0.3 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 3.7 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.1 15.3 0.1 1.3 0.1 0.0 0.0 0.0 0.9 5.4 0.0 0.1 0.5 1.4 26.6 0.0 6.3 1.4 0.1 1.3 0.1 1.0 0.1 0.3 0.0 0.0 1.3 2.1 0.0 0.0 1.1 0.0 0.0 1.8 0.1 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.1 1.5 0.6 36.4 0.0 1.0 2.7 3.5 0.5 3.2 1.8 1.0 2.3 1.7 2.8 3.5 P4HTM "EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4" ENSG00000178467 "Prolyl 4-hydroxylase, transmembrane" Q9NXG6 3 48989886-49007154 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007199 Supported Uncertain Vesicles,Cytosol "Vesicles, Cytosol" "HPA007199: AB_1855272" "unprognostic (1.95e-2)" "unprognostic (3.12e-2)" "unprognostic (9.47e-2)" "prognostic favourable (8.18e-4)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-2)" "prognostic favourable (3.28e-5)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (2.60e-2)" "unprognostic (9.65e-3)" 7.4 25.5 22.1 6.4 28.5 4.7 8.9 17.6 32.9 13.5 10.8 15.9 13.8 10.4 9.7 18.9 5.4 34.7 13.0 18.6 23.0 26.5 14.1 5.4 10.6 5.6 18.7 20.3 11.4 29.9 20.8 35.7 9.6 15.7 15.5 6.7 14.1 16.0 16.5 10.0 4.3 7.8 7.0 14.3 6.3 15.7 11.7 16.4 3.4 21.5 3.3 6.7 7.5 6.1 9.8 7.8 6.7 7.6 4.9 14.4 4.8 3.8 10.5 2.0 0.0 5.9 7.0 0.1 6.9 9.1 5.2 5.6 2.3 20.7 3.3 7.2 8.4 2.0 4.4 2.3 1.5 12.3 7.8 0.0 15.6 0.0 15.7 3.2 0.1 4.0 2.3 5.2 0.4 5.8 0.0 14.3 2.5 16.4 0.4 0.4 2.8 12.4 0.0 0.0 19.2 9.2 5.9 8.2 0.1 7.7 8.3 0.0 7.3 5.3 4.0 3.1 2.7 7.7 5.4 20.4 11.2 0.0 23.0 0.3 3.2 6.7 7.6 4.8 6.4 2.7 8.7 7.0 11.6 10.3 7.8 9.8 12.0 8.3 0.8 4.9 3.6 1.4 14.4 4.8 22.1 28.5 17.6 32.9 23.0 26.5 18.7 20.3 15.7 16.4 PAAF1 "FLJ11848, Rpn14, WDR71" ENSG00000175575 "Proteasomal ATPase associated factor 1" Q9BRP4 11 73876699-73931124 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039952, HPA040020" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039952: AB_10793925, HPA040020: " "unprognostic (3.13e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.13e-2)" "unprognostic (4.51e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (1.74e-1)" "unprognostic (4.48e-1)" "unprognostic (2.30e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (2.73e-1)" "unprognostic (4.42e-1)" 9.5 12.8 32.4 6.9 30.6 5.2 12.3 18.0 23.2 11.7 8.7 34.4 7.6 7.8 11.5 17.2 10.0 13.9 8.0 9.9 30.5 27.4 16.0 13.8 7.9 7.6 37.4 19.6 17.8 19.8 16.8 10.1 7.7 25.4 14.5 11.5 12.9 9.9 14.5 11.9 12.8 7.8 12.1 38.9 7.1 6.8 18.8 27.0 8.2 13.0 2.1 11.1 7.9 6.3 22.6 19.3 22.1 15.1 16.5 22.6 15.1 5.6 13.1 11.9 9.3 13.0 13.4 6.8 9.7 11.3 15.6 11.1 25.6 4.5 17.1 15.2 9.9 13.0 14.5 11.7 23.2 12.7 9.0 17.4 12.9 21.0 15.6 16.2 6.7 13.7 18.4 17.0 20.9 11.7 21.0 14.7 14.4 11.0 14.3 16.9 5.5 10.3 13.3 31.8 27.9 11.5 9.8 12.7 14.9 11.5 7.7 30.0 23.1 9.2 8.4 11.0 7.0 15.5 9.4 18.2 20.4 34.8 7.7 10.6 11.4 22.1 15.1 17.4 16.0 9.5 17.5 22.6 17.5 16.2 19.3 18.8 22.6 19.4 1.3 16.5 3.4 14.0 19.6 15.1 32.4 30.6 18.0 22.3 30.5 27.4 37.4 19.6 25.4 27.0 PACRG "FLJ32724, Glup, HAK005771, PARK2CRG" ENSG00000112530 "Parkin coregulated" Q96M98 6 162727132-163315492 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 30.3;pituitary gland: 55.9;testis: 44.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066293 Enhanced "HPA066293: " "unprognostic (3.06e-2)" "unprognostic (1.81e-2)" "unprognostic (1.59e-1)" "unprognostic (1.56e-2)" "unprognostic (2.48e-1)" "unprognostic (1.84e-1)" "unprognostic (6.26e-4)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "unprognostic (3.34e-1)" "unprognostic (8.31e-3)" "unprognostic (1.48e-1)" "prognostic favourable (2.55e-6)" "unprognostic (1.00e-1)" "unprognostic (3.68e-2)" "unprognostic (8.35e-2)" "unprognostic (2.93e-3)" 0.7 2.3 8.6 1.0 15.5 4.7 1.8 2.3 10.6 2.3 1.1 6.5 4.4 1.2 4.7 8.6 2.7 30.3 4.3 10.7 10.3 12.1 6.8 4.1 5.5 1.4 4.7 9.4 3.8 3.4 2.0 55.9 0.4 17.7 3.2 2.3 2.0 2.5 3.4 1.8 4.3 0.7 1.9 3.7 1.5 1.7 44.6 5.9 0.0 3.7 0.0 0.9 4.5 0.9 1.7 1.1 6.0 2.0 0.1 3.3 0.5 0.7 2.5 1.1 1.6 0.0 1.0 1.8 0.6 2.3 0.0 0.5 5.0 0.5 4.6 0.6 0.0 2.6 1.2 0.0 2.6 0.0 1.7 0.0 2.5 0.0 0.0 0.6 0.8 2.1 0.0 0.8 0.0 0.0 0.7 0.9 0.5 0.1 0.3 1.7 0.0 4.3 0.8 0.0 0.0 5.5 5.3 10.5 4.7 0.0 0.0 0.0 0.0 1.5 1.8 1.0 0.5 0.0 0.4 2.1 0.7 1.7 0.5 1.2 2.0 4.3 2.0 1.4 1.9 0.6 1.4 0.9 2.6 1.2 0.3 1.7 3.3 1.6 6.0 0.1 0.2 1.1 1.1 0.5 8.6 15.5 2.3 10.6 10.3 12.1 4.7 9.4 17.7 5.9 PALD1 "KIAA1274, PALD" ENSG00000107719 "Phosphatase domain containing, paladin 1" Q9ULE6 10 70478821-70568449 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 13.3;Daudi: 16.0;NB-4: 15.3;RPMI-8226: 19.4;U-698: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 8.6" "Lineage enriched" "Detected in single" 27 "dendritic cells: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015696, HPA017343" Uncertain "HPA015696: AB_1852399, HPA017343: AB_1852397" "unprognostic (1.11e-1)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.51e-1)" "unprognostic (7.94e-2)" "unprognostic (2.52e-3)" "unprognostic (4.52e-3)" "unprognostic (3.55e-2)" "unprognostic (4.96e-2)" "unprognostic (3.34e-2)" "unprognostic (6.56e-2)" "unprognostic (2.48e-1)" "unprognostic (8.20e-3)" "unprognostic (2.73e-2)" "unprognostic (9.27e-2)" "unprognostic (2.46e-1)" "unprognostic (8.81e-3)" 10.8 6.2 12.5 7.6 20.9 3.4 6.3 9.8 13.9 4.8 11.4 20.5 4.0 4.4 6.2 2.5 7.5 8.2 7.5 8.9 13.4 10.2 4.6 1.9 16.5 13.2 20.1 6.9 5.3 7.8 2.5 5.2 12.0 16.9 5.8 3.9 9.7 6.5 3.8 7.9 6.8 6.8 7.7 17.2 15.3 7.8 4.2 16.8 3.1 7.5 3.1 12.4 5.8 3.3 0.2 8.6 0.0 0.0 0.0 0.3 0.0 0.0 3.9 4.5 13.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 1.6 0.1 16.0 3.4 0.0 0.0 7.3 0.0 0.3 0.0 8.3 0.0 0.4 0.3 1.4 5.3 0.0 0.0 0.0 0.4 0.0 1.9 0.8 2.2 0.1 1.3 2.7 15.3 4.7 0.0 8.1 0.0 19.4 1.2 0.0 4.4 3.3 0.2 0.0 0.3 0.0 1.1 0.3 0.0 6.2 0.0 0.5 0.1 0.0 15.7 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.0 8.6 0.0 0.0 12.5 20.9 9.8 13.2 13.4 10.2 20.1 6.9 16.9 16.8 PAM "PAL, PHM" ENSG00000145730 "Peptidylglycine alpha-amidating monooxygenase" P19021 5 102753981-103031105 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 304.2" "Cell line enhanced" "Detected in many" "ASC diff: 76.6;fHDF/TERT166: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026119, HPA042260" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted in other tissues" 59000000 "Golgi apparatus, Cytosol" "CAB026119: , HPA042260: " "unprognostic (4.30e-3)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "prognostic favourable (1.63e-4)" "unprognostic (4.23e-2)" "unprognostic (6.30e-2)" "prognostic unfavourable (6.20e-4)" "unprognostic (7.58e-2)" "unprognostic (6.62e-2)" "unprognostic (2.71e-1)" "unprognostic (9.91e-2)" "unprognostic (3.18e-1)" "unprognostic (1.86e-2)" "unprognostic (1.08e-1)" "unprognostic (9.79e-2)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" 16.5 24.5 8.2 6.5 16.4 0.8 17.3 6.6 16.5 74.9 14.0 5.4 9.5 5.8 21.3 83.8 11.7 10.6 11.5 304.2 8.8 23.5 13.7 2.1 13.2 5.8 10.0 7.6 17.0 16.4 49.5 18.3 26.3 15.5 13.4 9.5 8.7 53.8 29.4 22.0 8.5 8.5 18.5 4.8 8.9 17.2 7.2 4.6 1.8 21.7 13.2 7.3 15.8 15.3 0.5 2.0 10.1 5.3 16.2 14.1 6.3 14.9 2.2 27.6 12.2 76.6 45.9 11.0 42.6 63.8 12.6 38.5 7.3 19.9 0.0 9.2 98.2 5.1 1.5 18.7 34.9 1.8 6.2 3.1 9.0 2.3 11.6 0.9 3.4 25.1 8.1 9.2 7.0 26.0 0.1 2.1 35.7 3.0 0.0 0.4 4.9 8.3 1.1 15.4 8.3 48.7 1.7 13.1 9.0 18.1 1.1 11.1 4.7 1.0 20.0 40.1 10.4 18.8 12.6 4.7 1.1 0.0 46.0 4.2 34.5 1.9 5.3 0.1 14.1 0.9 10.0 0.5 8.5 10.4 2.0 0.3 2.9 4.8 10.1 16.2 1.9 1.1 12.1 6.3 8.2 16.4 6.6 16.5 8.8 23.5 10.0 7.6 15.5 4.6 PAPD7 "LAK-1, POLK, POLS, TRF4, TRF4-1" ENSG00000112941 "Poly(A) RNA polymerase D7, non-canonical" Q5XG87 5 6713007-6757048 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045487, HPA046742" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA045487: AB_2679346, HPA046742: AB_2679781" "unprognostic (1.45e-1)" "unprognostic (2.96e-1)" "unprognostic (2.08e-2)" "unprognostic (2.12e-3)" "unprognostic (7.57e-2)" "unprognostic (1.30e-2)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (2.62e-1)" "unprognostic (9.78e-2)" "unprognostic (3.10e-3)" "unprognostic (3.73e-2)" "prognostic unfavourable (7.99e-5)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.60e-2)" "prognostic favourable (8.55e-4)" 13.5 7.9 9.6 13.9 11.1 25.8 16.3 22.7 12.3 15.1 16.6 10.6 14.8 9.5 13.2 8.0 12.2 11.3 11.4 8.6 10.7 7.3 9.7 19.9 13.2 14.1 14.8 5.8 18.5 13.3 13.2 12.2 10.0 9.0 11.6 8.3 10.2 17.0 10.6 10.4 16.7 13.1 13.9 7.9 14.8 10.1 11.1 11.7 25.4 11.3 11.3 11.6 12.5 34.9 1.9 3.8 0.7 0.7 0.5 2.3 0.8 16.3 11.1 13.7 16.8 9.9 8.9 19.7 11.1 14.0 13.9 15.8 11.5 9.1 12.0 8.6 13.7 12.2 11.1 8.6 12.8 13.4 7.1 6.1 35.1 6.2 6.2 9.2 9.3 6.0 7.5 15.5 10.0 8.1 8.2 15.9 11.3 9.0 12.5 12.0 7.4 8.7 11.3 11.6 3.0 5.5 9.4 13.6 10.4 26.6 12.9 7.6 7.8 5.1 7.1 16.7 17.5 14.6 15.5 15.2 6.3 10.6 10.8 8.6 10.3 0.0 0.7 0.7 2.1 0.4 2.3 1.9 1.7 1.6 1.2 1.5 1.9 1.7 0.4 0.5 0.6 3.8 1.8 0.8 9.6 11.1 22.7 12.3 10.7 7.3 14.8 5.8 9.0 11.7 PAPOLA PAP ENSG00000090060 "Poly(A) polymerase alpha" P51003 14 96501433-96567111 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001788 Supported Supported Nucleoplasm Nucleoplasm "HPA001788: AB_1079564" "unprognostic (3.18e-1)" "unprognostic (1.30e-1)" "unprognostic (9.69e-2)" "unprognostic (7.26e-2)" "unprognostic (9.10e-2)" "unprognostic (5.10e-3)" "prognostic unfavourable (2.41e-5)" "unprognostic (2.12e-2)" "unprognostic (2.82e-2)" "unprognostic (1.38e-3)" "unprognostic (3.13e-1)" "unprognostic (1.22e-3)" "unprognostic (3.37e-1)" "unprognostic (1.65e-1)" "unprognostic (1.77e-1)" "unprognostic (1.08e-2)" "unprognostic (4.05e-1)" 35.8 43.4 49.1 45.7 51.6 54.5 39.7 61.2 60.5 41.0 45.1 25.2 45.6 34.9 43.8 48.3 42.0 38.7 35.6 71.8 46.3 39.6 40.0 50.2 37.1 44.7 48.1 39.7 58.2 52.9 50.2 68.7 54.5 45.6 45.1 45.8 24.0 39.2 45.5 46.4 35.5 45.5 38.9 41.9 50.9 40.4 53.0 55.7 53.0 54.8 34.8 49.6 44.9 119.5 26.4 23.0 39.0 23.5 25.2 23.4 19.8 32.0 31.0 39.9 40.0 28.9 32.7 90.8 29.4 31.8 35.0 33.7 35.8 33.2 43.5 33.9 34.4 27.8 13.0 40.5 62.8 35.9 21.1 35.1 23.5 35.1 29.9 45.9 35.6 29.8 35.5 39.1 35.0 39.1 32.9 39.9 33.7 46.7 35.9 23.3 27.2 35.3 38.4 48.6 25.2 34.9 51.2 41.0 27.2 39.2 30.8 28.6 43.7 40.4 31.1 24.7 19.7 27.8 35.8 31.5 47.1 38.4 40.0 35.2 41.4 39.0 19.7 32.7 15.5 23.5 20.4 23.8 19.6 22.6 23.0 26.4 23.4 21.8 27.4 25.2 22.6 15.2 18.7 19.8 49.1 51.6 61.2 60.5 46.3 39.6 48.1 39.7 45.6 55.7 PAPOLG FLJ12972 ENSG00000115421 "Poly(A) polymerase gamma" Q9BWT3 2 60756230-60802085 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017795, HPA035349, HPA035350" Approved Enhanced Nucleoplasm Nucleoplasm "CAB017795: , HPA035349: , HPA035350: " "unprognostic (1.83e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "unprognostic (3.39e-2)" "unprognostic (5.56e-2)" "unprognostic (3.54e-1)" "unprognostic (6.72e-4)" "unprognostic (2.49e-1)" "unprognostic (6.97e-3)" "unprognostic (6.83e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-1)" "prognostic unfavourable (4.21e-4)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (2.62e-2)" 12.3 9.5 11.6 11.6 11.9 5.8 9.9 19.4 15.3 10.2 8.2 9.8 7.8 6.8 12.1 6.2 10.1 9.0 10.2 8.5 15.1 10.1 8.6 6.9 9.4 14.8 10.9 11.3 17.1 9.9 13.3 18.9 11.8 12.5 9.6 9.2 7.7 11.1 8.7 13.1 11.7 9.7 9.9 21.0 15.0 9.1 14.2 11.0 23.1 27.5 6.6 14.3 10.9 11.1 6.1 3.7 13.2 6.9 9.4 9.7 4.1 5.1 4.8 9.0 7.3 11.6 8.7 8.6 5.7 5.6 4.9 5.2 8.1 4.4 7.4 6.0 4.4 8.7 12.7 5.4 9.2 12.8 6.8 9.4 4.7 5.7 7.0 9.8 6.5 6.5 6.4 5.9 12.4 7.8 9.2 7.0 5.4 4.1 11.3 6.7 14.3 4.4 9.3 16.0 6.6 5.3 4.9 5.3 7.4 9.1 5.7 5.1 3.8 6.0 7.3 6.3 7.6 4.7 5.3 7.0 4.1 18.0 5.1 11.2 4.5 13.2 4.1 8.7 6.7 4.3 8.3 5.9 7.2 6.0 3.7 6.1 7.9 7.3 10.6 9.4 6.9 3.3 9.7 4.1 11.6 11.9 19.4 15.3 15.1 10.1 10.9 11.3 12.5 11.0 PAPPA2 "PAPP-A2, PAPPE, PLAC3" ENSG00000116183 "Pappalysin 2" Q9BXP8 1 176463171-176845605 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "placenta: 406.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 20.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018412, HPA018430" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted in female reproductive system" "Endoplasmic reticulum, Vesicles" "HPA018412: AB_1854962, HPA018430: AB_1854961" "unprognostic (2.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-2)" "unprognostic (9.04e-2)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.00e-2)" "unprognostic (3.54e-2)" "unprognostic (1.29e-2)" "unprognostic (4.39e-2)" "unprognostic (2.85e-2)" "unprognostic (1.52e-4)" "unprognostic (1.85e-1)" "unprognostic (8.18e-4)" "unprognostic (4.35e-2)" 0.6 0.0 0.6 0.2 0.2 0.0 3.0 0.8 0.3 5.0 0.6 0.2 0.2 0.0 0.3 0.2 0.2 0.2 1.1 0.2 0.2 0.1 11.6 0.7 0.2 0.2 0.2 0.2 0.2 1.5 0.0 1.2 406.4 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.3 0.5 0.2 1.0 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.2 4.5 2.2 3.7 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.8 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.3 1.7 1.4 0.1 0.6 0.3 0.4 0.0 20.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.8 0.3 0.2 0.1 0.2 0.2 0.3 0.2 PAQR4 FLJ30002 ENSG00000162073 "Progestin and adipoQ receptor family member 4" Q8N4S7 16 2969245-2973489 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.4;parathyroid gland: 32.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "non-classical monocyte: 6.7" "Lineage enriched" "Detected in single" 8 "monocytes: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068394 Approved Vesicles Vesicles "HPA068394: " "unprognostic (1.93e-1)" "unprognostic (2.75e-1)" "unprognostic (6.73e-2)" "unprognostic (1.30e-3)" "unprognostic (8.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavourable (6.86e-4)" "unprognostic (2.62e-2)" "unprognostic (7.59e-2)" "unprognostic (9.65e-3)" "unprognostic (5.21e-2)" "unprognostic (8.59e-2)" "prognostic unfavourable (3.01e-6)" "prognostic favourable (1.70e-4)" "unprognostic (1.36e-1)" "unprognostic (3.79e-2)" "unprognostic (6.06e-3)" 3.1 3.2 14.1 5.2 19.2 10.3 2.3 8.0 26.3 2.4 4.8 49.6 1.3 4.9 1.8 1.0 4.2 3.0 5.5 4.2 24.1 11.7 1.7 1.6 3.9 6.3 30.6 11.1 0.4 6.6 32.8 0.9 2.2 19.1 9.6 4.5 16.8 17.0 1.3 12.3 12.3 4.9 2.8 54.4 3.2 7.4 1.6 20.3 3.6 1.5 3.5 7.8 2.1 1.7 0.5 0.9 0.1 6.7 0.0 0.4 0.5 12.7 10.9 12.3 17.8 2.0 3.7 4.1 4.8 5.9 9.0 8.6 6.5 13.7 12.8 6.6 5.6 18.0 12.8 7.6 3.7 13.5 5.6 3.9 21.3 8.9 0.2 8.3 14.2 0.9 4.0 4.9 1.2 5.9 7.6 34.7 7.7 25.6 11.9 8.9 10.4 7.5 23.9 16.2 41.2 6.1 4.4 28.4 13.2 18.0 17.5 13.1 18.7 12.9 3.6 15.8 9.7 7.3 6.8 15.2 10.5 17.0 7.0 11.3 17.3 0.0 1.0 0.1 0.4 0.5 0.0 0.5 0.2 0.1 0.9 0.1 0.0 0.3 0.1 0.0 6.7 0.5 0.1 0.5 14.1 19.2 8.0 21.2 24.1 11.7 30.6 11.1 19.1 20.3 PAQR8 "C6orf33, LMPB1, MPRB" ENSG00000170915 "Progestin and adipoQ receptor family member 8" Q8TEZ7 6 52361421-52407777 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.2" "Cell line enhanced" "Detected in many" "Hep G2: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064625 Supported "Golgi apparatus,Plasma membrane" "Plasma membrane" "Golgi apparatus" "HPA064625: " "prognostic favourable (4.61e-4)" "unprognostic (7.39e-3)" "unprognostic (2.77e-3)" "unprognostic (8.23e-2)" "unprognostic (4.33e-1)" "unprognostic (4.08e-3)" "unprognostic (2.66e-2)" "unprognostic (5.67e-2)" "unprognostic (6.37e-2)" "unprognostic (4.30e-3)" "unprognostic (2.10e-1)" "unprognostic (5.55e-2)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (2.12e-1)" "unprognostic (3.14e-2)" "prognostic favourable (6.40e-4)" 2.4 3.5 25.6 6.6 32.4 1.3 2.2 14.9 31.0 4.2 28.9 35.5 14.2 14.5 4.4 6.7 13.7 5.4 4.9 2.9 27.3 17.5 5.3 1.5 5.8 7.2 48.5 15.8 19.5 2.5 3.7 1.8 5.5 28.2 3.8 28.1 1.9 1.9 28.5 1.1 2.7 25.1 5.2 69.2 4.8 24.1 3.1 36.5 3.1 2.6 0.4 6.0 7.3 3.3 1.0 6.0 2.0 2.6 7.0 16.3 3.2 0.6 0.6 7.0 3.0 4.3 7.0 4.8 2.1 7.9 1.3 2.9 2.6 2.4 0.7 0.8 1.4 0.3 0.9 3.4 2.1 9.4 1.2 4.2 0.6 26.5 1.2 1.1 0.6 1.9 0.4 0.9 5.0 7.5 0.9 4.2 5.4 0.9 2.7 3.8 3.6 0.3 7.3 1.1 1.7 8.2 2.0 2.7 5.7 0.5 0.2 8.0 0.2 9.4 3.1 2.7 1.1 0.8 1.2 1.2 1.6 1.0 2.5 10.9 14.0 2.0 2.6 1.3 2.5 0.5 3.8 0.9 7.6 5.2 6.0 1.0 16.3 7.6 0.5 7.0 0.5 3.0 4.7 3.2 25.6 32.4 14.9 22.8 27.3 17.5 48.5 15.8 28.2 36.5 PARL "PRO2207, PSARL, PSARL1, RHBDS1" ENSG00000175193 "Presenilin associated rhomboid like" Q9H300 3 183829271-183884933 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA019545 Approved Approved Mitochondria Mitochondria "HPA019545: AB_1855796" "unprognostic (2.10e-1)" "unprognostic (1.53e-3)" "unprognostic (5.88e-2)" "unprognostic (1.17e-2)" "unprognostic (5.76e-2)" "unprognostic (9.55e-2)" "unprognostic (3.17e-3)" "unprognostic (8.97e-2)" "unprognostic (1.81e-1)" "unprognostic (3.62e-3)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (4.28e-2)" "unprognostic (5.49e-2)" "unprognostic (2.58e-1)" "unprognostic (1.73e-1)" "prognostic favourable (9.11e-5)" 24.2 20.6 26.2 19.2 30.1 21.2 30.4 22.1 29.6 22.7 29.0 24.4 19.4 21.5 20.2 43.8 21.4 19.6 21.2 30.9 23.1 23.4 27.0 26.7 20.3 26.5 28.4 20.3 20.3 47.5 22.0 20.6 18.5 19.5 22.1 31.3 25.9 35.1 33.4 41.2 22.3 27.0 38.1 19.4 22.3 24.5 22.2 18.9 22.1 20.7 25.4 24.3 23.2 18.2 21.5 45.4 44.3 50.0 21.5 25.9 35.4 32.1 15.3 11.3 9.6 11.0 12.7 23.5 12.1 16.4 23.3 18.3 46.9 16.8 14.3 26.9 15.3 14.3 18.0 18.6 26.3 20.4 22.1 21.6 10.2 25.6 16.6 21.4 18.3 17.2 23.9 16.3 20.0 16.5 12.2 13.4 19.1 34.8 40.9 52.5 30.3 15.7 18.1 22.1 26.0 21.7 26.9 11.4 16.3 14.4 46.4 29.5 47.7 40.7 9.7 8.7 18.9 17.9 30.7 26.9 18.2 33.0 16.6 21.9 10.4 27.6 50.0 44.3 19.0 35.4 21.7 21.5 21.6 22.1 45.4 19.9 25.9 21.1 14.5 21.5 26.2 27.0 24.4 35.4 26.2 30.1 22.1 29.6 23.1 23.4 28.4 20.3 19.5 18.9 PARM1 "Cipar1, DKFZP564O0823, WSC4" ENSG00000169116 "Prostate androgen-regulated mucin-like protein 1" Q6UWI2 4 74933095-75050115 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 23.9;Karpas-707: 23.4;U-266/70: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 10.1;myeloid DC: 4.6;naive B-cell: 6.4" "Group enriched" "Detected in many" 15 "B-cells: 10.1;dendritic cells: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038236 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles, Cytosol" "HPA038236: AB_10675789" "unprognostic (2.57e-2)" "unprognostic (5.20e-2)" "unprognostic (1.26e-3)" "unprognostic (8.61e-2)" "unprognostic (1.44e-1)" "unprognostic (8.49e-3)" "unprognostic (3.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.73e-1)" "unprognostic (9.74e-2)" "unprognostic (9.44e-2)" "unprognostic (3.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (1.78e-4)" "unprognostic (2.23e-1)" 23.1 21.5 5.7 25.0 15.2 0.3 16.4 1.3 29.4 18.7 36.0 1.2 28.5 2.8 20.3 18.0 5.8 12.2 11.5 39.8 6.9 13.0 27.5 1.1 15.1 10.2 3.3 10.3 11.9 29.2 23.2 32.1 16.1 4.8 35.0 45.8 70.2 25.6 27.6 7.4 6.2 8.3 29.3 2.4 9.7 5.5 11.2 1.2 6.3 79.8 3.7 8.0 24.9 19.7 10.1 4.6 0.1 0.5 0.0 0.0 0.7 0.5 1.0 0.9 0.0 23.9 0.1 0.1 0.0 0.1 0.0 0.0 2.0 0.2 0.0 0.1 0.0 0.0 7.8 0.0 0.0 0.1 1.7 0.0 0.0 0.0 4.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 23.4 0.4 0.2 2.5 0.1 2.2 1.4 0.0 2.1 5.9 0.1 4.8 1.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.4 1.5 0.1 2.1 26.2 2.5 6.6 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.5 0.0 10.1 0.0 0.0 4.6 6.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.7 5.7 15.2 1.3 29.4 6.9 13.0 3.3 10.3 4.8 1.2 PARP16 "C15orf30, FLJ20509, FLJ25281, pART15" ENSG00000138617 "Poly(ADP-ribose) polymerase family member 16" Q8N5Y8 15 65234460-65300618 "Enzymes, Predicted membrane proteins" "Unfolded protein response" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017081 Approved "HPA017081: AB_10963218" "unprognostic (1.17e-2)" "unprognostic (6.51e-3)" "unprognostic (2.82e-2)" "unprognostic (6.37e-2)" "unprognostic (7.38e-2)" "unprognostic (2.88e-2)" "unprognostic (3.05e-2)" "unprognostic (6.82e-2)" "unprognostic (2.18e-1)" "unprognostic (2.70e-1)" "unprognostic (1.00e-1)" "unprognostic (1.78e-1)" "unprognostic (3.41e-3)" "unprognostic (1.11e-1)" "unprognostic (2.71e-1)" "unprognostic (1.01e-1)" "unprognostic (9.61e-2)" 8.9 14.2 12.0 13.1 11.6 8.0 20.4 32.2 17.7 18.6 12.8 5.6 11.9 9.3 13.1 8.5 10.5 12.0 8.7 7.2 9.7 5.3 9.0 18.1 11.5 14.0 11.5 6.2 17.6 11.3 12.7 8.5 9.2 9.1 11.5 10.4 7.5 10.3 21.4 5.4 10.8 9.7 17.7 8.0 9.3 11.0 7.6 12.0 15.1 9.5 6.3 12.4 14.0 25.6 10.1 4.4 14.1 5.3 10.3 14.2 6.0 3.8 4.0 4.4 6.9 3.6 3.8 1.9 1.7 4.7 5.0 5.2 3.2 3.5 12.5 4.9 2.2 6.3 20.3 2.5 3.7 4.5 8.1 2.1 4.3 4.5 6.8 5.7 4.0 4.4 4.2 1.3 5.1 4.6 5.1 4.8 4.3 4.6 11.8 6.1 2.0 5.4 21.9 8.0 9.5 3.5 3.5 7.6 5.1 5.5 5.3 4.5 6.2 5.2 1.8 5.9 4.5 3.3 2.7 8.9 10.5 16.4 4.9 8.5 2.7 14.1 3.3 10.0 11.6 5.3 12.9 7.8 11.2 11.8 4.4 10.1 14.2 10.5 13.0 10.3 5.2 3.9 9.2 6.0 12.0 11.6 32.2 17.7 9.7 5.3 11.5 6.2 9.1 12.0 PARVA "FLJ10793, FLJ12254, MXRA2" ENSG00000197702 "Parvin alpha" 11 12377185-12530801 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "MAIT T-cell: 4.0;memory CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 40 "T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005964 Approved Supported "Actin filaments,Focal adhesion sites,Cytosol" "Actin filaments, Focal adhesion sites" Cytosol "HPA005964: AB_1079569" "unprognostic (3.87e-2)" "unprognostic (7.38e-2)" "unprognostic (3.30e-2)" "prognostic favourable (1.76e-4)" "unprognostic (7.37e-3)" "unprognostic (1.38e-2)" "unprognostic (6.78e-2)" "prognostic unfavourable (8.19e-4)" "unprognostic (1.76e-2)" "unprognostic (2.80e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-2)" "unprognostic (6.73e-2)" "unprognostic (6.58e-3)" "unprognostic (1.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.82e-2)" 30.5 8.3 7.1 14.4 6.5 0.0 44.0 3.9 8.3 29.2 39.2 3.5 25.8 6.9 40.5 17.6 27.0 17.2 35.2 21.3 6.4 5.3 15.3 10.7 13.2 8.5 5.3 7.8 22.7 16.2 10.1 6.3 16.3 5.5 31.7 16.4 18.3 13.4 35.1 6.4 7.7 13.1 55.9 5.0 8.4 24.2 8.4 2.8 0.4 10.5 8.1 5.0 38.8 33.4 0.0 0.0 0.0 0.0 0.0 4.0 0.1 7.6 7.6 7.1 9.2 36.4 28.3 16.6 29.4 30.3 20.8 19.5 5.6 12.0 0.0 9.8 53.4 4.7 0.0 15.3 24.8 0.1 3.8 0.0 10.8 4.2 28.0 0.0 0.2 22.3 6.2 8.7 13.7 25.8 0.0 0.0 30.9 4.6 0.0 0.0 3.3 6.6 0.0 17.8 0.0 11.5 7.5 1.1 0.0 22.6 9.1 15.1 4.3 0.2 31.9 25.1 10.5 13.5 8.0 0.0 0.0 0.0 13.9 0.0 27.6 0.0 0.0 0.0 0.5 0.0 4.0 0.0 1.3 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 7.1 6.5 3.9 8.3 6.4 5.3 5.3 7.8 5.5 2.8 PARVB CGI-56 ENSG00000188677 "Parvin beta" Q9HBI1 22 43999211-44172949 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.1" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 43.7;RPMI-8226: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062601, HPA072217" Enhanced Approved Cytosol 90000000 Cytosol "HPA062601: , HPA072217: " "unprognostic (2.41e-1)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.83e-2)" "unprognostic (2.10e-3)" "unprognostic (7.65e-3)" "unprognostic (1.28e-1)" "unprognostic (1.73e-2)" "unprognostic (2.28e-1)" "unprognostic (6.46e-2)" "unprognostic (1.03e-2)" "unprognostic (6.45e-2)" "unprognostic (1.28e-2)" "unprognostic (4.87e-3)" "unprognostic (3.19e-2)" "unprognostic (4.19e-2)" "unprognostic (7.05e-3)" 15.9 10.7 6.4 9.7 7.3 16.8 17.4 3.1 8.3 8.0 7.2 3.5 6.3 3.7 8.6 8.7 7.3 6.8 5.3 28.5 5.6 8.8 7.3 7.3 12.6 19.7 8.0 6.3 13.4 4.8 8.6 9.3 10.2 5.8 7.8 4.4 9.3 5.3 7.2 82.1 5.1 6.3 11.9 8.3 15.2 5.4 5.7 4.5 2.3 4.9 22.4 7.9 11.7 26.0 6.3 14.1 4.8 6.4 0.7 2.2 8.3 6.3 7.5 0.1 5.3 8.0 10.2 0.0 8.9 5.5 5.8 4.4 7.8 3.8 0.0 4.9 23.8 0.2 12.7 0.5 3.2 8.9 7.9 27.1 13.2 0.0 13.4 20.4 24.4 15.9 6.7 4.2 0.0 43.7 9.7 18.6 6.3 4.2 0.1 13.4 2.7 5.2 0.0 0.2 42.7 0.1 0.1 6.9 4.8 2.3 0.4 22.4 4.4 8.3 27.2 5.3 5.7 8.2 0.9 4.6 4.0 0.2 23.4 6.0 29.3 4.5 6.1 1.4 1.0 6.4 1.6 6.0 1.7 1.4 6.8 6.3 0.4 0.9 4.8 0.7 2.6 14.1 2.2 8.3 6.4 7.3 3.1 8.3 5.6 8.8 8.0 6.3 5.8 4.5 PARVG ENSG00000138964 "Parvin gamma" Q9HBI0 22 44172956-44219533 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.4;bone marrow: 31.2;lymphoid tissue: 27.7" "Group enriched" "Detected in some" 4 "HL-60: 43.8;NB-4: 16.9;THP-1: 24.8;U-937: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031833, HPA031834" Uncertain "HPA031833: , HPA031834: AB_10601242" "unprognostic (9.83e-3)" "unprognostic (2.30e-2)" "unprognostic (2.06e-1)" "prognostic favourable (4.44e-6)" "unprognostic (2.79e-1)" "unprognostic (1.57e-2)" "unprognostic (2.14e-1)" "unprognostic (3.19e-2)" "unprognostic (7.02e-2)" "unprognostic (2.17e-1)" "unprognostic (3.87e-2)" "unprognostic (3.36e-1)" "prognostic unfavourable (3.43e-6)" "unprognostic (3.73e-1)" "unprognostic (1.35e-2)" "unprognostic (1.09e-1)" "unprognostic (9.89e-2)" 8.0 2.9 3.5 22.2 6.9 31.2 2.7 1.2 3.1 3.5 3.5 4.9 0.8 2.7 1.9 2.7 1.9 3.1 4.5 3.5 4.2 3.3 3.1 3.1 13.1 20.3 8.9 1.5 1.6 2.0 0.5 2.1 2.3 5.4 2.6 2.7 2.5 5.2 1.0 1.0 1.7 10.1 2.2 10.8 27.7 3.1 1.7 5.6 19.7 2.4 0.0 18.8 4.5 5.9 8.4 18.5 27.4 23.6 4.8 6.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 43.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 16.9 0.0 0.0 3.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 24.8 0.0 0.0 4.7 0.1 0.0 0.1 0.0 0.1 0.0 20.6 0.7 3.6 23.6 25.3 5.5 21.3 5.5 8.3 3.3 6.0 18.5 8.4 3.7 4.2 27.4 4.8 22.6 12.6 4.4 14.2 3.5 6.9 1.2 3.1 4.2 3.3 8.9 1.5 5.4 5.6 PAX6 "AN, AN2, D11S812E, WAGR" ENSG00000007372 "Paired box 6" P26367 11 31784779-31818062 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.3;retina: 29.4" "Cell line enhanced" "Detected in some" "AF22: 11.6;AN3-CA: 15.0;HEK 293: 14.1;HeLa: 11.0;U-251 MG: 12.3" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Region enriched" "Detected in all" 5 "cerebellum: 78.3" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 5 "cerebellum: 61.0;olfactory region: 41.2" "Low region specificity" "Detected in all" "HPA030775, CAB034143" Enhanced Supported Enhanced Nucleoplasm Nucleoplasm "CAB034143: AB_1127044, HPA030775: AB_10601243" "unprognostic (2.89e-1)" "unprognostic (2.98e-2)" "unprognostic (8.34e-2)" "unprognostic (3.85e-2)" "unprognostic (4.42e-2)" "unprognostic (7.82e-2)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.24e-3)" "unprognostic (1.68e-1)" "unprognostic (1.20e-2)" "unprognostic (3.91e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" 0.8 2.0 12.6 0.8 10.4 1.1 1.0 78.3 23.5 0.8 1.1 9.3 0.0 3.5 0.8 1.8 0.8 0.8 0.8 0.8 16.0 3.7 0.9 0.9 0.7 0.9 3.9 9.1 0.8 15.8 0.8 4.6 0.8 10.8 0.8 1.4 29.4 0.8 0.9 1.9 1.6 2.0 0.8 16.1 0.8 19.4 2.8 9.8 0.0 0.8 0.0 1.0 1.1 0.3 0.2 0.2 1.6 0.4 0.4 0.5 0.1 0.0 0.2 11.6 15.0 3.7 5.0 4.5 0.0 0.0 0.1 0.0 0.9 2.7 0.1 4.8 1.6 0.3 1.3 0.0 0.2 0.0 14.1 6.6 11.0 6.2 0.0 0.3 0.0 0.0 0.5 0.1 0.3 0.0 5.3 0.0 0.2 0.0 2.7 0.4 0.2 7.6 0.0 5.5 0.1 0.6 0.4 0.5 0.0 0.3 0.1 0.0 3.4 0.0 0.0 3.9 0.3 0.0 12.3 0.0 0.1 0.0 6.2 0.0 0.0 1.6 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.2 0.2 0.2 0.3 1.0 0.4 0.4 0.2 0.1 0.1 12.6 10.4 78.3 12.2 16.0 3.7 3.9 9.1 10.8 9.8 PBXIP1 HPIP ENSG00000163346 "PBX homeobox interacting protein 1" Q96AQ6 1 154944076-154956123 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "Karpas-707: 156.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006949 Approved Approved Vesicles,Cytosol Vesicles Cytosol "HPA006949: AB_1079572" "unprognostic (6.17e-2)" "unprognostic (6.82e-2)" "prognostic unfavourable (2.73e-4)" "unprognostic (8.94e-2)" "unprognostic (2.16e-1)" "prognostic favourable (7.19e-4)" "unprognostic (1.62e-1)" "prognostic favourable (8.99e-4)" "unprognostic (1.21e-1)" "unprognostic (2.46e-1)" "prognostic favourable (2.64e-4)" "unprognostic (1.20e-2)" "prognostic favourable (9.22e-6)" "unprognostic (3.89e-1)" "unprognostic (4.15e-1)" "unprognostic (2.26e-1)" "unprognostic (1.26e-3)" 25.3 48.1 35.4 24.9 54.9 13.7 19.9 18.3 31.4 26.8 36.2 26.1 28.1 25.5 28.3 29.8 23.6 22.8 31.1 21.9 46.6 28.6 18.1 13.3 22.6 28.6 41.8 34.4 50.1 17.6 42.4 56.7 21.2 47.8 26.4 14.3 38.6 20.7 48.3 57.2 13.2 28.6 52.6 29.0 27.5 28.1 15.9 33.8 27.9 33.1 22.4 26.8 37.5 25.7 9.2 4.0 42.9 6.6 13.0 46.8 14.4 0.9 2.6 4.2 2.8 14.8 4.6 3.1 3.5 7.8 1.7 3.4 0.7 3.5 4.3 11.4 4.2 3.7 1.0 2.2 1.2 2.3 1.6 0.9 3.5 2.7 6.8 1.1 12.0 7.0 3.7 2.1 0.4 6.4 0.5 156.1 4.2 1.5 2.3 3.7 1.6 2.0 2.7 6.1 9.3 4.7 1.9 0.7 5.4 4.5 1.4 3.5 4.4 5.0 6.0 1.7 1.2 1.0 1.0 21.4 17.9 1.0 6.1 1.7 1.3 26.7 2.5 42.9 11.0 3.6 30.4 9.2 29.5 17.2 2.2 5.7 19.7 12.1 23.7 13.0 6.6 4.0 46.8 14.4 35.4 54.9 18.3 31.4 46.6 28.6 41.8 34.4 47.8 33.8 PCDH1 pc42 ENSG00000156453 "Protocadherin 1" Q08174 5 141853111-141879246 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.7;HaCaT: 37.1;HUVEC TERT2: 19.5;RT4: 25.4;TIME: 25.3;WM-115: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047720, HPA050538" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" 270000 "Nucleoplasm, Cell Junctions" Nucleoli "HPA047720: AB_2680130, HPA050538: " "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (5.30e-2)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (4.16e-2)" "prognostic unfavourable (4.96e-5)" "unprognostic (1.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (3.61e-4)" "unprognostic (2.43e-1)" "prognostic favourable (7.55e-5)" "unprognostic (2.05e-1)" "unprognostic (4.16e-2)" "unprognostic (3.13e-2)" "unprognostic (1.91e-1)" 22.4 4.5 14.8 7.4 17.6 1.4 19.0 16.1 25.6 8.3 22.2 7.3 11.4 20.6 7.0 7.0 26.9 9.7 6.8 8.9 11.6 7.4 14.9 13.0 18.9 3.4 8.8 16.9 2.5 11.0 1.3 5.2 32.5 9.2 11.1 14.4 6.0 23.7 12.3 7.4 17.3 15.8 7.5 7.5 1.6 22.8 1.5 9.8 0.0 9.1 3.9 8.8 8.6 11.7 0.0 0.0 0.3 0.0 0.0 2.2 0.5 6.3 0.3 2.7 2.9 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.5 29.7 0.0 15.3 0.2 37.1 3.4 2.7 0.0 0.0 0.1 0.0 0.1 0.0 2.5 0.0 0.1 0.0 6.2 0.0 0.4 19.5 0.0 3.2 0.0 5.1 0.1 0.0 11.3 5.1 0.1 0.0 4.3 2.2 25.4 0.3 0.6 0.1 8.1 6.5 6.5 0.1 25.3 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.2 0.0 18.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.5 14.8 17.6 16.1 25.6 11.6 7.4 8.8 16.9 9.2 9.8 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149315-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0;placenta: 31.1;seminal vesicle: 23.6" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 15.8;MOLT-4: 13.2;TIME: 31.4;U-138 MG: 8.5;U-251 MG: 7.2" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: " "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 1.9 7.6 17.9 1.5 35.5 1.2 1.3 1.7 48.0 3.3 1.5 23.2 4.5 1.3 3.1 1.9 1.6 2.6 1.9 1.8 17.5 12.6 3.7 1.3 2.0 1.2 13.2 16.3 4.1 1.4 1.2 1.7 31.1 13.6 14.7 1.5 1.3 1.8 23.6 1.2 1.3 1.7 2.0 6.8 1.2 1.3 2.9 19.2 0.9 1.5 0.0 1.2 3.6 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 5.1 0.0 0.1 0.0 0.0 4.9 2.7 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.2 0.0 2.4 0.0 13.2 0.0 0.0 0.1 0.3 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 31.4 8.5 0.0 0.0 7.2 0.0 0.0 0.0 0.5 0.0 4.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.9 35.5 1.7 27.7 17.5 12.6 13.2 16.3 13.6 19.2 PCDH11X "PCDH-X, PCDH11, PCDHX, PPP1R119" ENSG00000102290 "Protocadherin 11 X-linked" Q9BZA7 X 91779261-92623230 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 7.0;ovary: 12.6;parathyroid gland: 5.2" "Group enriched" "Detected in some" 5 "AF22: 4.2;AN3-CA: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA077495 Approved "HPA077495: " "unprognostic (4.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.39e-4)" "unprognostic (1.18e-1)" "unprognostic (8.20e-3)" "unprognostic (6.32e-2)" "unprognostic (9.10e-2)" "unprognostic (6.19e-2)" "unprognostic (4.58e-1)" "unprognostic (1.58e-1)" "unprognostic (2.45e-2)" "unprognostic (3.86e-1)" 0.0 0.3 2.6 0.1 7.0 0.0 0.2 0.0 4.8 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 4.2 0.0 0.0 0.0 0.2 1.3 12.6 0.0 5.2 0.3 1.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDH12 VE-cadherin-2 ENSG00000113555 "Protocadherin 12" Q9NPG4 5 141943585-141969741 "Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Disease mutation, Epilepsy, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.9" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 13.8;Karpas-707: 34.3" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.0" "Lineage enriched" "Detected in single" 35 "monocytes: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051242 Uncertain "Secreted to blood" 720000 "HPA051242: " "unprognostic (6.62e-2)" "unprognostic (6.94e-2)" "unprognostic (4.74e-3)" "unprognostic (4.12e-2)" "unprognostic (3.99e-1)" "unprognostic (3.25e-1)" "unprognostic (4.35e-1)" "unprognostic (1.88e-2)" "unprognostic (4.29e-2)" "unprognostic (2.76e-1)" "unprognostic (9.99e-2)" "unprognostic (3.87e-1)" "prognostic unfavourable (2.56e-4)" "unprognostic (1.11e-2)" "unprognostic (5.21e-2)" "unprognostic (9.37e-2)" "unprognostic (9.33e-2)" 7.9 2.9 0.5 0.7 0.6 0.0 3.1 2.2 0.6 1.3 0.8 0.7 1.3 0.0 0.7 1.2 1.8 4.6 0.5 0.4 3.7 2.1 9.0 0.7 0.4 0.9 0.6 1.4 2.5 17.9 1.1 0.4 0.6 1.0 1.6 0.5 1.0 2.6 0.3 11.3 1.0 0.1 4.8 0.1 2.1 1.1 0.1 0.2 0.0 7.0 0.0 0.1 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 13.8 0.0 34.3 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.1 1.5 0.0 0.1 0.2 0.3 0.0 0.0 0.2 0.0 0.9 0.9 0.2 0.0 0.4 0.0 0.2 0.1 0.0 0.2 5.5 1.2 0.0 0.4 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.1 0.2 PCDH15 "CDHR15, DFNB23, USH1F" ENSG00000150275 "Protocadherin related 15" Q96QU1 10 53802771-55627942 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Hearing" "Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.4;retina: 25.1" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;HUVEC TERT2: 1.7;U-2 OS: 2.7;U-266/70: 8.1" "Cancer enriched" "Detected in single" 9 "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074437 Supported "Intracellular and membrane" "HPA074437: " "unprognostic (1.38e-1)" "unprognostic (3.39e-1)" "unprognostic (8.15e-5)" "unprognostic (3.07e-3)" "unprognostic (2.79e-1)" "unprognostic (9.15e-4)" "unprognostic (2.02e-1)" "unprognostic (3.89e-2)" "unprognostic (1.12e-3)" "unprognostic (1.31e-3)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (7.66e-3)" 0.7 27.4 9.7 0.9 7.4 0.6 0.5 4.3 10.9 0.7 0.7 5.6 0.0 0.8 0.6 1.1 0.6 0.6 0.6 0.9 10.5 5.8 11.0 0.5 3.7 1.8 6.0 3.2 0.5 0.5 0.4 6.9 0.7 8.7 0.7 0.5 25.1 0.6 0.5 0.4 0.5 0.8 0.5 5.7 1.3 0.9 4.4 7.9 0.0 0.6 0.0 1.2 1.5 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.7 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.1 0.0 0.0 1.5 2.7 0.0 0.0 8.1 0.8 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.7 7.4 4.3 7.1 10.5 5.8 6.0 3.2 8.7 7.9 PCDH17 "PCDH68, PCH68" ENSG00000118946 "Protocadherin 17" O14917 13 57631810-57729311 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;lymphoid tissue: 32.7" "Cell line enhanced" "Detected in some" "AF22: 15.8;HEK 293: 9.9;U-87 MG: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026817 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" 31000 Cytosol "Vesicles, Plasma membrane" "HPA026817: AB_1855044" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-1)" "unprognostic (6.52e-2)" "unprognostic (6.98e-3)" "unprognostic (1.95e-2)" "unprognostic (8.26e-4)" "unprognostic (3.56e-1)" "unprognostic (2.38e-2)" "unprognostic (2.82e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "prognostic unfavourable (3.31e-5)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.40e-2)" 2.0 2.4 8.0 2.1 11.2 0.3 0.9 4.6 18.2 2.9 1.2 6.2 0.3 1.1 2.6 1.3 1.7 2.5 3.6 2.3 6.5 12.1 1.6 1.4 13.5 0.9 7.4 4.8 0.8 6.2 2.0 1.0 4.7 4.4 1.2 1.2 1.1 1.0 1.1 1.8 0.6 0.7 2.6 4.4 32.7 1.8 8.9 7.7 0.0 3.4 0.4 0.8 3.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.7 0.0 0.0 1.8 0.0 0.0 0.0 9.9 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.4 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 0.0 1.0 0.0 0.0 0.0 6.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 11.2 4.6 7.8 6.5 12.1 7.4 4.8 4.4 7.7 PCDH18 "KIAA1562, PCDH68L" ENSG00000189184 "Protocadherin 18" Q9HCL0 4 137518918-137532494 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 35.0;ASC diff: 42.3;ASC TERT1: 47.1;BJ hTERT+: 20.7;fHDF/TERT166: 33.4;HHSteC: 31.2;HSkMC: 47.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.3;memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017976 Approved Approved "Golgi apparatus,Cytosol" 1200000 Cytosol "Golgi apparatus" "HPA017976: AB_1855045" "unprognostic (2.77e-1)" "unprognostic (1.86e-2)" "unprognostic (3.73e-3)" "unprognostic (9.19e-2)" "unprognostic (1.59e-1)" "unprognostic (3.39e-2)" "unprognostic (2.36e-1)" "unprognostic (4.30e-2)" "unprognostic (1.97e-3)" "unprognostic (2.20e-2)" "unprognostic (8.76e-2)" "unprognostic (9.45e-2)" "prognostic unfavourable (3.21e-4)" "unprognostic (1.79e-2)" "unprognostic (6.27e-2)" "unprognostic (1.89e-1)" "prognostic unfavourable (4.71e-4)" 28.4 3.5 4.2 7.2 4.0 0.0 16.2 2.0 2.7 30.4 13.3 2.1 9.8 6.0 34.0 8.7 11.2 8.6 14.9 8.9 2.7 3.6 5.4 3.0 5.9 2.6 5.2 1.4 14.9 2.4 1.8 3.5 29.0 5.4 23.3 9.5 21.8 6.3 9.5 10.3 5.1 9.0 25.4 5.4 4.0 5.5 9.7 4.0 1.0 8.2 7.7 1.9 17.5 16.3 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 35.0 0.0 42.3 47.1 0.0 6.3 20.7 1.2 1.8 0.0 0.0 0.0 0.0 33.4 0.0 8.1 0.1 0.6 0.0 0.2 0.0 0.0 0.0 31.2 0.0 0.0 47.9 0.0 2.2 0.9 0.2 0.0 0.1 0.6 0.0 0.9 0.0 0.0 0.6 2.6 1.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 16.4 1.0 3.3 0.1 0.0 0.0 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.2 4.0 2.0 2.7 2.7 3.6 5.2 1.4 5.4 4.0 PCDH19 "EFMR, EIEE9, KIAA1313" ENSG00000165194 "Protocadherin 19" Q8TAB3 X 100291644-100410273 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 27.1" "Cell line enriched" "Detected in some" 6 "AF22: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027533 Approved Approved Cytosol Cytosol "HPA027533: AB_10602043" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (5.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (4.77e-2)" "unprognostic (3.64e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-1)" "unprognostic (2.79e-1)" "unprognostic (9.77e-3)" "unprognostic (2.82e-3)" "unprognostic (1.53e-1)" "unprognostic (1.80e-4)" "unprognostic (1.37e-1)" 4.9 1.1 19.8 1.3 10.5 0.7 3.7 1.0 22.5 5.5 4.0 1.9 0.0 1.2 3.8 1.3 2.9 2.2 2.0 1.6 27.1 12.8 1.4 0.9 1.0 1.3 3.7 14.2 3.6 1.1 1.2 2.1 1.0 7.3 1.4 5.5 6.4 2.1 1.6 2.4 3.3 1.8 3.1 3.7 0.8 2.0 2.3 1.0 0.0 1.1 0.7 0.9 2.3 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 19.6 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 3.4 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 10.5 1.0 22.5 27.1 12.8 3.7 14.2 7.3 1.0 PCDH7 "BH-Pcdh, PPP1R120" ENSG00000169851 "Protocadherin 7" O60245 4 30720415-31146805 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 16.4;RH-30: 46.0;RT4: 24.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011866, HPA046521" Uncertain Enhanced "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA011866: AB_1855047, HPA046521: " "unprognostic (1.87e-1)" "unprognostic (8.88e-2)" "unprognostic (4.48e-2)" "unprognostic (3.32e-1)" "unprognostic (1.38e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-2)" "prognostic unfavourable (6.46e-5)" "unprognostic (1.96e-1)" "unprognostic (8.39e-2)" "unprognostic (1.02e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-4)" "prognostic unfavourable (6.42e-4)" "unprognostic (1.55e-1)" "unprognostic (7.65e-2)" "unprognostic (1.56e-2)" 2.0 3.2 11.9 4.9 11.5 0.4 3.0 1.2 25.3 23.2 18.4 1.7 34.3 3.1 15.3 22.9 13.0 8.9 7.4 16.7 13.4 11.9 2.2 1.2 2.8 1.4 8.0 11.0 4.5 1.1 0.5 0.8 0.5 11.7 9.9 7.3 6.2 1.6 32.2 0.9 10.1 5.3 23.7 5.3 15.3 14.2 1.2 4.4 0.0 3.9 1.3 1.4 20.1 7.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 5.5 7.6 11.5 11.2 0.0 1.4 0.0 0.7 0.3 0.7 9.9 0.0 0.0 0.0 5.7 0.4 14.4 1.3 0.0 16.4 0.0 10.4 0.0 11.9 0.2 0.0 6.7 3.4 0.3 4.1 2.8 0.0 0.0 3.4 0.0 0.0 0.0 3.3 1.5 0.0 46.0 0.0 0.3 24.2 0.3 0.1 0.1 0.4 0.5 0.7 2.5 0.0 9.3 2.4 2.5 0.0 0.0 0.0 0.0 7.2 0.0 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 11.5 1.2 24.9 13.4 11.9 8.0 11.0 11.7 4.4 PCDH8 "ARCADLIN, PAPC" ENSG00000136099 "Protocadherin 8" O95206 13 52842889-52848641 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 20.6" "Cell line enriched" "Detected in some" 4 "AF22: 22.5" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010509 Uncertain Uncertain "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA010509: AB_10601384" "unprognostic (3.50e-3)" "unprognostic (6.48e-2)" "unprognostic (1.40e-1)" "unprognostic (9.11e-4)" "unprognostic (2.12e-2)" "unprognostic (1.97e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-1)" "unprognostic (3.59e-1)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" 0.8 0.9 11.5 1.1 18.6 0.8 0.8 0.4 20.6 0.9 1.0 1.1 0.0 0.9 1.0 0.8 0.8 0.8 0.8 0.8 18.2 4.8 0.8 0.8 0.9 0.8 3.6 8.4 0.8 0.8 0.8 1.4 0.8 0.8 1.7 0.9 0.8 0.8 0.8 1.4 0.8 1.1 0.9 0.9 0.8 1.2 2.3 2.5 0.0 1.4 0.0 0.8 0.9 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 1.6 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.6 0.4 20.6 18.2 4.8 3.6 8.4 0.8 2.5 PCDH9 ENSG00000184226 "Protocadherin 9" Q9HC56 13 66302834-67230445 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 16.5;brain: 47.0" "Cell line enhanced" "Detected in many" "AF22: 12.4;LHCN-M2: 20.3;TIME: 23.6;U-698: 31.0" "Cancer enriched" "Detected in single" 8 "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive B-cell: 16.5" "Lineage enriched" "Detected in many" 7 "B-cells: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015581 Approved Nucleoplasm,Centrosome 1300000 "Nucleoplasm, Centrosome" "HPA015581: AB_1855048" "unprognostic (1.77e-1)" "unprognostic (8.36e-2)" "unprognostic (9.12e-3)" "unprognostic (4.42e-5)" "unprognostic (7.54e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-1)" "unprognostic (1.38e-1)" "unprognostic (2.35e-1)" "unprognostic (8.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.14e-1)" "unprognostic (8.47e-4)" "unprognostic (6.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.35e-4)" 4.5 3.2 18.4 1.1 24.7 4.1 1.5 6.7 47.0 1.8 1.3 7.8 0.0 0.9 1.0 2.1 1.0 1.1 2.4 5.7 15.0 10.0 3.5 2.3 2.3 1.4 21.4 11.0 1.4 2.0 0.7 1.3 0.7 16.6 2.5 1.3 0.0 1.0 5.6 2.0 0.9 1.0 1.2 11.0 1.6 1.7 1.6 18.9 0.7 1.8 0.0 1.4 1.1 0.6 16.5 1.0 2.5 0.0 0.7 0.1 0.2 0.0 9.3 12.4 0.0 3.3 2.6 0.0 1.8 0.1 1.3 0.5 0.0 0.0 2.7 0.0 1.4 0.0 1.0 0.3 0.6 0.0 4.9 0.1 0.1 0.0 3.2 0.3 0.1 6.1 0.3 1.5 2.5 1.0 0.3 0.1 20.3 0.7 5.6 0.0 0.1 1.2 8.5 0.4 0.0 0.2 0.0 1.6 0.6 0.0 0.1 0.1 0.0 0.0 23.6 0.7 0.6 2.9 0.9 3.6 0.0 31.0 5.3 0.0 2.4 2.5 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 16.5 0.1 0.1 0.1 0.7 0.0 1.0 0.0 0.2 18.4 24.7 6.7 24.6 15.0 10.0 21.4 11.0 16.6 18.9 PCDHA1 ENSG00000204970 "Protocadherin alpha 1" Q9Y5I3 5 140786136-141012347 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.1;testis: 3.1" "Cell line enriched" "Detected in some" 7 "T-47d: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035969 Enhanced Approved "Plasma membrane" "Secreted - unknown location" "Plasma membrane" "HPA035969: AB_10673492" "unprognostic (2.76e-5)" "unprognostic (1.19e-1)" "unprognostic (3.74e-2)" "unprognostic (1.09e-4)" "unprognostic (7.38e-2)" "unprognostic (2.86e-2)" "unprognostic (2.26e-3)" "unprognostic (1.25e-2)" "unprognostic (1.91e-2)" "unprognostic (1.81e-1)" "unprognostic (9.01e-5)" "unprognostic (2.46e-2)" "unprognostic (1.91e-1)" "unprognostic (7.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (1.29e-1)" 0.2 1.5 4.6 0.2 4.4 0.1 0.2 3.3 7.1 0.2 0.3 0.7 0.5 0.1 0.2 0.2 0.4 0.1 5.0 3.7 0.6 0.1 0.2 0.3 3.4 0.2 0.2 1.0 1.4 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.6 0.2 3.4 0.2 0.3 3.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.0 0.0 0.2 1.8 14.1 0.5 0.0 1.5 1.0 0.7 0.1 0.0 0.1 0.0 0.4 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA11 "CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11" ENSG00000249158 "Protocadherin alpha 11" Q9Y5I1 5 140868183-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.3;parathyroid gland: 4.7" "Cell line enhanced" "Detected in some" "AN3-CA: 16.5;EFO-21: 8.6;MCF7: 4.4;T-47d: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077160 Approved "Vesicles,Cell Junctions,Cytoplasmic bodies" "Vesicles, Cell Junctions" "Cytoplasmic bodies" "HPA077160: " "unprognostic (1.54e-2)" "unprognostic (1.83e-3)" "unprognostic (2.75e-1)" "unprognostic (2.59e-1)" "unprognostic (6.98e-3)" "unprognostic (1.36e-1)" "unprognostic (9.28e-3)" "unprognostic (2.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (3.13e-4)" "unprognostic (9.91e-5)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (3.26e-2)" 0.1 0.6 1.0 0.1 1.6 0.0 0.2 7.0 9.3 1.3 0.0 0.0 0.6 0.1 0.0 0.2 1.0 0.0 0.8 1.0 1.2 0.0 0.8 0.0 0.3 0.0 3.3 4.7 1.6 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.9 16.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 8.6 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.1 0.0 4.4 0.0 0.0 3.6 3.1 0.0 0.0 0.0 0.4 1.9 0.8 2.2 0.0 1.8 0.4 5.8 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA12 PCDH-ALPHA12 ENSG00000251664 "Protocadherin alpha 12" Q9UN75 5 140875302-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6" "Cell line enhanced" "Detected in some" "A549: 10.0;AN3-CA: 4.0;hTCEpi: 6.2;PC-3: 7.6;RT4: 7.5;SH-SY5Y: 4.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA035812 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA035812: " "unprognostic (3.95e-2)" "unprognostic (7.74e-2)" "unprognostic (7.55e-2)" "unprognostic (3.87e-2)" "unprognostic (2.74e-2)" "unprognostic (2.24e-2)" "unprognostic (2.08e-2)" "unprognostic (4.29e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-4)" "unprognostic (3.18e-4)" "unprognostic (1.11e-1)" "unprognostic (3.21e-3)" "unprognostic (6.97e-2)" 1.0 1.7 0.9 0.3 1.2 0.0 0.9 14.6 3.7 3.5 0.4 1.1 0.0 0.1 1.0 0.5 0.2 1.9 4.3 0.3 1.0 0.7 3.8 1.7 5.7 0.2 0.5 0.8 0.3 2.4 0.9 4.6 0.0 2.3 0.4 0.1 1.5 5.7 0.3 0.1 0.2 0.2 0.6 0.8 0.2 0.3 2.1 0.2 0.0 3.4 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 2.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.4 7.6 0.0 0.0 0.0 0.3 7.5 0.3 4.3 0.0 0.9 0.1 1.6 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.2 14.6 3.7 1.0 0.7 0.5 0.8 2.3 0.2 PCDHA2 ENSG00000204969 "Protocadherin alpha 2" Q9Y5H9 5 140794852-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3" "Cell line enhanced" "Detected in some" "AF22: 9.5;SH-SY5Y: 2.7;T-47d: 2.6;WM-115: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA035653 Uncertain "HPA035653: AB_10670969" "unprognostic (3.54e-2)" "unprognostic (5.87e-2)" "unprognostic (3.27e-2)" "unprognostic (8.39e-3)" "unprognostic (4.61e-2)" "unprognostic (4.16e-3)" "unprognostic (1.23e-1)" "unprognostic (4.30e-2)" "unprognostic (3.35e-3)" "unprognostic (5.64e-6)" "unprognostic (2.17e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-3)" "unprognostic (3.42e-1)" 1.1 1.4 3.7 0.3 4.4 0.2 1.7 7.3 4.5 1.1 0.5 1.2 0.0 0.8 3.5 0.2 0.2 1.1 1.6 0.8 3.8 1.6 1.5 0.2 0.9 0.5 2.8 4.9 1.9 1.7 0.5 4.1 0.2 3.1 1.2 0.3 0.1 0.8 0.2 0.6 0.7 0.9 1.0 1.3 0.6 1.0 2.5 3.8 0.0 0.6 0.0 0.2 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 9.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 1.4 2.7 0.0 0.6 0.4 2.6 0.0 0.2 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 4.4 7.3 4.5 3.8 1.6 2.8 4.9 3.1 3.8 PCDHA4 "CNR1, CNRN1, CRNR1, PCDH-ALPHA4" ENSG00000204967 "Protocadherin alpha 4" Q9UN74 5 140806929-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1" "Cell line enhanced" "Detected in some" "A549: 8.9;AF22: 8.7;EFO-21: 7.6;T-47d: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043180, HPA073478" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "HPA043180: AB_10806381, HPA073478: " "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (2.85e-1)" "unprognostic (5.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.14e-2)" "unprognostic (2.56e-1)" "unprognostic (7.90e-3)" "unprognostic (7.14e-3)" "unprognostic (7.00e-2)" "unprognostic (5.06e-3)" "unprognostic (6.94e-5)" "unprognostic (5.01e-3)" "unprognostic (6.21e-2)" "unprognostic (3.98e-1)" "unprognostic (6.29e-3)" "unprognostic (4.79e-2)" 0.9 0.8 5.1 0.9 6.5 3.2 1.7 12.1 8.7 2.1 1.1 1.6 0.4 0.9 2.3 2.0 0.6 1.6 5.1 1.2 4.5 3.2 2.0 0.6 1.7 1.5 1.9 2.1 1.1 4.1 1.0 1.4 0.7 3.9 1.8 1.1 0.4 1.1 1.3 1.1 2.0 0.9 1.1 3.0 1.1 1.0 1.4 2.4 0.0 1.3 0.1 0.7 1.3 0.8 1.5 1.3 2.0 0.7 0.8 1.1 0.0 0.2 8.9 8.7 0.4 0.1 0.3 0.3 0.2 0.1 0.1 0.1 0.2 1.8 0.3 7.6 0.2 0.3 0.0 0.1 0.2 0.2 0.1 0.3 0.6 0.3 0.1 0.3 0.5 0.4 2.3 0.2 0.4 0.5 0.2 1.2 0.3 0.2 0.2 0.3 2.5 1.2 0.2 0.2 0.3 0.3 0.4 0.4 3.7 0.1 1.9 0.8 7.6 0.3 0.9 1.9 1.2 0.7 0.2 0.5 0.2 0.2 0.3 0.4 0.8 1.8 0.7 0.7 1.1 0.4 0.8 0.8 0.8 0.7 0.3 1.5 0.8 1.1 2.0 0.8 0.7 1.3 0.6 0.0 5.1 6.5 12.1 6.6 4.5 3.2 1.9 2.1 3.9 2.4 PCDHA5 "CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5" ENSG00000204965 "Protocadherin alpha 5" Q9Y5H7 5 140821604-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 13.6" "Cell line enhanced" "Detected in some" "A549: 2.6;EFO-21: 7.3;T-47d: 7.5;WM-115: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" HPA044557 Approved Approved "Nuclear speckles,Plasma membrane,Mitochondria" "Plasma membrane" "Nuclear speckles, Mitochondria" "HPA044557: AB_10970597" "unprognostic (4.95e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-1)" "unprognostic (8.81e-4)" "unprognostic (5.10e-2)" "unprognostic (6.25e-3)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (2.46e-2)" "unprognostic (4.49e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-4)" "unprognostic (9.30e-4)" "unprognostic (1.07e-1)" "unprognostic (1.39e-1)" "unprognostic (8.17e-5)" "unprognostic (2.11e-1)" 0.9 1.2 3.4 0.5 3.6 0.6 0.6 13.6 10.2 0.6 0.6 0.4 0.0 0.5 1.2 0.5 0.4 0.5 1.1 0.3 1.6 2.0 1.1 0.4 0.7 0.4 1.3 5.1 0.6 1.2 0.4 2.5 0.4 2.3 0.6 0.5 0.0 0.4 0.4 0.4 0.5 0.5 0.7 1.1 0.4 0.7 0.9 0.1 0.0 0.5 0.0 0.3 0.5 0.2 0.6 0.6 1.6 0.5 0.3 0.3 0.2 0.0 2.6 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 7.5 0.1 0.1 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.5 0.5 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.6 0.3 0.4 0.6 0.2 0.2 3.4 3.6 13.6 7.2 1.6 2.0 1.3 5.1 2.3 0.1 PCDHA6 "CNR2, CNRS2, CRNR2, PCDH-ALPHA6" ENSG00000081842 "Protocadherin alpha 6" Q9UN73 5 140827958-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.7;pituitary gland: 11.2" "Cell line enhanced" "Detected in some" "AF22: 2.9;EFO-21: 12.4;U-2 OS: 5.2;WM-115: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059326, HPA078110" Enhanced Approved Vesicles "Intracellular and membrane" Vesicles "HPA059326: , HPA078110: " "unprognostic (1.15e-1)" "unprognostic (7.00e-2)" "unprognostic (5.07e-1)" "unprognostic (2.79e-1)" "unprognostic (4.39e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-4)" "unprognostic (4.23e-3)" "unprognostic (8.38e-2)" "unprognostic (2.55e-1)" "unprognostic (1.23e-3)" "unprognostic (3.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.66e-3)" "unprognostic (2.56e-1)" "unprognostic (5.66e-3)" "unprognostic (3.55e-2)" 1.1 1.8 2.9 0.8 7.1 0.4 1.6 10.2 10.7 1.9 0.7 2.3 0.0 1.2 2.9 2.3 0.4 1.6 1.6 0.5 3.8 3.8 2.3 0.4 1.1 0.7 4.6 4.1 2.1 3.7 4.7 11.2 0.4 3.6 1.3 0.7 1.6 0.7 0.5 0.4 0.6 1.3 1.4 3.4 0.8 0.7 1.4 3.2 0.0 0.9 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 2.1 1.3 0.6 0.0 1.9 0.0 5.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.1 10.2 9.6 3.8 3.8 4.6 4.1 3.6 3.2 PCDHA8 ENSG00000204962 "Protocadherin alpha 8" Q9Y5H6 5 140841187-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 6.2" "Group enriched" "Detected in some" 6 "AN3-CA: 17.8;SCLC-21H: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA044585 Uncertain "HPA044585: AB_10793953" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.35e-1)" "unprognostic (1.95e-1)" "unprognostic (4.20e-2)" "unprognostic (9.67e-2)" "unprognostic (8.58e-3)" "unprognostic (7.87e-4)" "unprognostic (5.62e-3)" "unprognostic (2.22e-2)" "unprognostic (5.48e-1)" "unprognostic (1.20e-2)" 0.2 1.6 1.0 0.2 2.3 0.2 0.2 6.2 4.7 0.4 0.4 1.4 0.0 0.3 0.8 0.2 0.3 0.3 0.4 0.2 1.2 1.2 0.5 0.3 0.4 0.3 1.0 3.6 0.7 0.9 0.2 1.8 0.3 2.8 0.3 0.5 0.7 0.5 0.2 0.2 0.2 0.4 0.7 1.1 0.2 0.2 1.7 1.3 0.0 0.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 17.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 5.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.3 6.2 4.7 1.2 1.2 1.0 3.6 2.8 1.3 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell line enhanced" "Detected in some" "A549: 8.5;EFO-21: 3.6;hTCEpi: 11.0;PC-3: 6.2;SCLC-21H: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA052775: " "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.5 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.6 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.0 0.0 0.0 0.5 0.4 4.9 2.3 0.0 0.6 0.0 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 PCDHAC2 PCDH-ALPHA-C2 ENSG00000243232 "Protocadherin alpha subfamily C, 2" Q9Y5I4 5 140966235-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 14.1;parathyroid gland: 52.5" "Cell line enriched" "Detected in some" 4 "AN3-CA: 36.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA076190 Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA076190: " "unprognostic (1.47e-1)" "unprognostic (3.58e-3)" "unprognostic (2.59e-1)" "unprognostic (5.31e-4)" "unprognostic (3.89e-1)" "unprognostic (1.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-1)" "unprognostic (2.13e-2)" "unprognostic (2.45e-1)" "unprognostic (1.41e-1)" "unprognostic (2.30e-1)" "unprognostic (4.46e-4)" "unprognostic (9.90e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-3)" 1.1 1.7 5.7 1.0 9.2 0.5 0.7 13.6 14.1 1.5 0.9 2.3 0.0 0.7 1.2 0.6 0.6 0.8 3.2 1.2 4.5 5.2 0.9 1.3 2.5 2.2 2.9 6.4 0.7 0.9 52.5 3.1 2.2 3.8 0.9 0.9 2.7 1.1 0.7 0.6 0.6 0.7 1.4 2.0 2.1 1.0 2.4 1.7 0.0 1.6 0.0 1.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.7 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.7 3.9 0.0 0.0 0.1 0.0 8.2 0.0 0.5 0.0 0.0 0.1 5.3 0.0 1.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.4 1.3 0.0 0.0 0.0 1.3 0.0 1.6 6.4 0.0 0.0 0.0 1.4 0.2 0.0 0.7 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.2 13.6 14.1 4.5 5.2 2.9 6.4 3.8 1.7 PCDHB1 PCDH-BETA1 ENSG00000171815 "Protocadherin beta 1" Q9Y5F3 5 141051135-141059344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053921 Uncertain "HPA053921: " "unprognostic (5.54e-2)" "unprognostic (1.60e-2)" "unprognostic (9.01e-4)" "unprognostic (8.65e-2)" "unprognostic (8.00e-2)" "unprognostic (7.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (8.17e-5)" "unprognostic (3.38e-2)" "unprognostic (9.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.77e-4)" 0.1 0.3 0.3 0.1 0.5 1.0 0.1 0.1 0.2 0.5 0.5 0.4 0.1 0.6 0.1 1.8 0.0 0.1 0.4 0.4 0.7 0.1 0.2 0.4 0.2 0.1 1.1 0.7 1.9 0.0 0.1 0.0 0.5 0.0 4.9 0.8 0.5 0.0 0.3 0.3 0.8 1.8 0.3 0.0 0.1 0.1 1.3 0.7 2.5 0.6 1.0 0.6 0.2 0.8 0.4 0.7 1.1 0.2 0.2 1.1 1.1 0.2 0.1 0.1 1.6 1.4 1.1 1.6 0.3 1.5 0.0 0.1 0.2 0.9 1.2 1.1 1.9 0.7 0.1 1.4 1.2 0.2 0.3 0.2 0.2 0.2 0.8 2.6 0.2 1.4 0.7 0.9 1.2 0.4 1.2 1.0 0.8 0.1 1.0 2.2 0.7 0.1 1.8 1.3 0.6 0.5 1.2 1.0 0.7 0.8 0.6 1.5 0.6 1.0 1.1 1.0 1.2 2.3 0.6 0.7 0.5 0.4 0.5 0.7 0.5 0.4 0.2 1.3 0.6 0.5 2.5 1.0 0.4 0.7 0.3 0.2 PCDHB10 ENSG00000120324 "Protocadherin beta 10" Q9UN67 5 141192353-141195642 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 7.1;ASC TERT1: 7.0;EFO-21: 15.0;U-2197: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA013445 Uncertain "HPA013445: AB_1855054" "unprognostic (1.08e-1)" "unprognostic (8.41e-2)" "unprognostic (4.03e-2)" "unprognostic (1.51e-2)" "unprognostic (1.94e-1)" "unprognostic (7.30e-2)" "unprognostic (1.81e-2)" "unprognostic (2.74e-1)" "unprognostic (2.61e-2)" "unprognostic (3.96e-3)" "unprognostic (2.16e-1)" "unprognostic (3.25e-1)" "unprognostic (5.40e-3)" "unprognostic (4.56e-2)" "unprognostic (3.11e-2)" "unprognostic (1.76e-1)" "unprognostic (1.83e-3)" 4.2 5.4 5.7 1.9 15.5 0.5 3.9 5.8 14.3 5.1 4.5 5.3 0.4 1.8 8.8 5.2 2.9 3.3 4.7 3.2 5.7 5.1 2.5 1.1 4.1 1.2 4.2 5.8 6.1 1.6 6.7 8.2 2.5 7.6 5.1 2.5 2.7 2.3 4.7 1.7 1.8 2.1 8.8 6.4 2.0 2.1 1.8 4.8 0.0 1.9 0.4 1.0 6.9 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 3.9 7.1 7.0 0.2 0.4 3.8 0.1 0.3 0.0 0.3 0.2 15.0 1.1 0.1 0.8 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.8 2.7 0.0 0.0 0.3 0.0 4.5 1.4 0.1 0.1 0.1 0.1 0.2 0.8 2.5 0.0 0.5 0.0 2.8 5.7 4.6 0.2 0.6 3.0 0.2 1.5 3.8 2.2 7.5 1.1 0.0 0.0 0.0 4.7 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 15.5 5.8 12.9 5.7 5.1 4.2 5.8 7.6 4.8 PCDHB11 "ME2, PCDH-BETA11" ENSG00000197479 "Protocadherin beta 11" Q9Y5F2 5 141199582-141203779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 8.0;EFO-21: 11.6;U-2 OS: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA045042 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA045042: " "unprognostic (1.32e-1)" "unprognostic (3.47e-2)" "unprognostic (7.21e-2)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.42e-1)" "unprognostic (6.78e-2)" "unprognostic (1.29e-2)" "unprognostic (1.07e-1)" "unprognostic (2.89e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" "unprognostic (1.37e-2)" "unprognostic (9.79e-2)" "unprognostic (6.47e-3)" 13.6 2.4 2.8 2.0 4.1 1.1 3.4 8.8 5.0 8.6 3.1 1.4 0.0 1.4 4.9 3.4 4.1 3.1 3.1 3.0 1.4 1.8 5.0 1.3 2.9 1.0 1.5 3.7 11.0 12.0 15.8 3.6 2.2 3.0 4.5 1.7 6.8 3.3 3.6 2.0 2.9 1.8 5.1 1.6 2.2 2.9 2.6 1.3 0.0 2.8 2.3 1.1 5.5 4.2 1.2 1.0 2.8 0.9 1.4 0.8 0.1 0.0 0.2 2.5 8.0 0.1 0.3 1.7 0.2 0.8 0.0 0.0 0.0 0.2 0.0 11.6 0.7 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.2 0.2 0.3 0.0 0.0 0.1 0.1 2.0 0.4 0.2 0.0 0.2 0.3 0.4 0.0 3.1 0.0 0.1 0.3 3.3 0.5 1.8 0.2 1.0 1.9 0.0 0.4 0.1 4.2 3.3 0.1 0.1 0.1 0.1 2.1 0.2 2.0 2.2 0.9 0.8 0.8 0.5 0.5 0.6 0.6 0.5 0.3 1.2 0.5 0.7 2.8 1.4 0.4 1.0 0.4 0.1 2.8 4.1 8.8 5.0 1.4 1.8 1.5 3.7 3.0 1.3 PCDHB12 PCDH-BETA12 ENSG00000120328 "Protocadherin beta 12" Q9Y5F1 5 141208697-141212571 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 4.7;ASC diff: 4.6;EFO-21: 5.3;RH-30: 5.7;U-2 OS: 4.4;U-2197: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA045042 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA045042: " "unprognostic (1.43e-2)" "unprognostic (3.22e-3)" "unprognostic (4.18e-3)" "unprognostic (8.43e-2)" "unprognostic (3.95e-3)" "unprognostic (7.87e-3)" "unprognostic (1.46e-1)" "unprognostic (2.95e-2)" "unprognostic (3.63e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (2.94e-2)" "unprognostic (4.37e-3)" "unprognostic (3.22e-3)" "unprognostic (4.97e-3)" "unprognostic (3.83e-2)" "unprognostic (6.41e-3)" 4.2 2.5 4.4 1.9 5.0 0.4 3.4 9.1 7.5 5.8 3.3 2.5 1.5 1.3 8.0 3.5 1.8 4.9 3.9 3.9 3.1 2.2 2.6 1.5 3.6 0.9 3.0 6.4 8.3 4.0 3.6 13.9 2.0 3.7 4.5 1.8 3.2 1.9 3.9 1.8 1.6 1.7 6.8 3.9 2.6 2.1 3.1 2.7 0.0 1.9 1.2 0.9 3.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.7 4.6 2.7 0.7 0.1 3.3 0.3 0.4 0.0 0.0 0.0 5.3 0.5 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.4 0.0 1.2 1.2 0.3 0.0 0.0 0.1 1.0 0.8 5.7 0.0 0.0 0.0 2.8 1.6 0.0 0.0 1.0 3.7 0.8 0.3 0.7 4.4 4.3 0.1 0.0 0.0 0.0 2.8 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 5.0 9.1 7.5 3.1 2.2 3.0 6.4 3.7 2.7 PCDHB14 PCDH-BETA14 ENSG00000120327 "Protocadherin beta 14" Q9Y5E9 5 141222932-141227759 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 13.9;SiHa: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007692, HPA045248" Uncertain Approved Vesicles Vesicles "HPA007692: , HPA045248: AB_10959599" "unprognostic (2.57e-3)" "unprognostic (1.96e-1)" "unprognostic (1.34e-1)" "unprognostic (8.97e-2)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" "unprognostic (2.11e-2)" "unprognostic (2.38e-2)" "unprognostic (6.60e-2)" "unprognostic (2.57e-2)" "unprognostic (1.13e-1)" "unprognostic (2.07e-2)" "prognostic unfavourable (6.09e-4)" "unprognostic (2.58e-1)" "unprognostic (3.12e-2)" "unprognostic (3.77e-2)" "unprognostic (3.90e-2)" 5.3 5.5 6.6 2.7 9.4 0.9 5.7 9.3 13.9 8.7 5.7 6.8 0.8 1.7 11.5 7.6 5.2 5.3 5.9 6.0 6.8 4.7 3.8 2.9 4.0 1.6 3.8 6.6 6.9 6.0 14.2 14.2 3.7 6.1 6.7 3.2 5.4 4.8 6.3 3.2 10.3 2.2 7.8 4.3 3.1 3.3 3.2 4.0 0.0 3.0 4.3 1.6 7.1 4.9 0.3 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.0 3.2 5.9 5.3 6.3 0.4 0.4 5.2 0.5 1.6 0.1 1.0 0.2 4.3 1.4 0.3 0.7 1.0 0.5 0.0 0.1 0.0 1.2 0.1 0.2 0.2 0.2 1.1 4.6 0.1 0.2 0.6 0.0 5.6 2.3 0.5 0.4 0.0 0.4 1.1 3.5 4.0 0.0 0.1 0.2 7.3 13.9 11.3 0.3 1.2 6.0 0.4 1.6 2.1 1.9 8.1 2.1 0.0 0.1 0.1 4.4 0.1 3.5 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.2 0.3 0.7 0.0 0.0 0.0 0.1 0.0 6.6 9.4 9.3 13.9 6.8 4.7 3.8 6.6 6.1 4.0 PCDHB15 PCDH-BETA15 ENSG00000113248 "Protocadherin beta 15" Q9Y5E8 5 141245349-141249365 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 9.2;LHCN-M2: 7.6;WM-115: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "HPA007172, CAB026471, HPA074676" Uncertain Approved Mitochondria Mitochondria "CAB026471: , HPA007172: AB_1079576, HPA074676: " "unprognostic (1.39e-1)" "unprognostic (1.58e-1)" "unprognostic (7.37e-3)" "unprognostic (1.75e-1)" "unprognostic (2.06e-2)" "unprognostic (6.19e-2)" "unprognostic (1.60e-1)" "unprognostic (4.12e-2)" "unprognostic (1.87e-2)" "unprognostic (7.58e-2)" "unprognostic (7.01e-2)" "unprognostic (6.00e-2)" "unprognostic (9.37e-2)" "unprognostic (1.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" 8.6 3.6 7.9 5.5 8.4 0.6 4.0 15.1 17.1 8.5 5.3 8.0 0.3 1.5 12.9 6.0 3.5 7.2 4.7 8.6 5.9 4.1 3.8 2.6 5.4 2.0 4.9 6.0 13.6 5.7 2.7 5.7 3.6 8.9 6.4 2.6 3.7 3.1 5.1 2.9 2.6 2.7 9.1 9.4 5.6 4.8 9.1 7.6 0.0 4.5 4.4 1.6 5.6 5.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.1 9.2 1.1 2.5 2.6 0.1 0.7 1.8 0.1 0.5 0.0 0.5 0.0 1.8 1.4 0.2 0.2 0.0 0.3 0.0 0.0 0.0 1.0 0.3 0.3 0.0 0.0 1.1 2.1 0.1 0.3 0.4 0.1 1.7 7.6 0.0 0.0 0.2 2.2 0.1 0.3 0.6 0.0 0.6 0.0 0.5 1.3 0.3 0.5 2.4 0.4 0.0 0.0 0.7 1.0 2.9 0.1 0.1 1.2 0.0 1.2 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 8.4 15.1 7.3 5.9 4.1 4.9 6.0 8.9 7.6 PCDHB16 "KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a" ENSG00000272674 "Protocadherin beta 16" Q9NRJ7 5 141181399-141186399 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.5" "Cell line enhanced" "Detected in some" "AN3-CA: 11.9;T-47d: 6.6;U-138 MG: 26.3;U-2197: 7.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA014668 Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA014668: AB_1855055" "unprognostic (3.44e-3)" "unprognostic (4.03e-2)" "unprognostic (8.14e-2)" "unprognostic (8.60e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-2)" "unprognostic (1.17e-1)" "unprognostic (4.03e-2)" "unprognostic (3.13e-2)" "unprognostic (7.55e-3)" "unprognostic (3.49e-2)" "unprognostic (9.57e-2)" "unprognostic (3.55e-2)" "unprognostic (7.49e-3)" "unprognostic (2.00e-2)" "unprognostic (7.92e-3)" "unprognostic (2.83e-3)" 3.7 2.6 2.1 1.4 2.7 0.2 2.5 9.7 3.1 8.4 1.1 5.3 0.0 0.4 6.4 6.2 3.3 2.8 2.5 4.5 1.8 2.5 1.0 3.2 0.5 1.7 0.4 9.8 2.6 10.9 17.5 1.5 3.4 6.2 1.1 7.1 2.2 1.1 3.6 1.5 1.1 3.5 2.5 1.1 0.5 2.3 5.0 0.0 3.1 0.0 0.3 6.5 3.3 0.9 1.0 1.4 0.6 0.9 0.8 0.1 0.0 0.0 0.6 11.9 5.3 3.8 0.3 0.5 2.7 0.0 0.2 0.0 0.2 0.0 4.4 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.1 6.4 0.3 0.0 0.0 0.9 0.1 0.0 2.2 0.0 0.3 0.1 0.4 1.7 0.2 0.4 2.0 6.6 0.0 0.3 26.3 1.3 7.0 1.3 0.0 0.0 0.0 6.3 0.0 3.3 0.7 0.5 0.4 0.6 0.5 0.3 0.6 0.5 0.6 0.3 0.9 0.8 0.6 1.4 0.9 0.6 1.0 0.5 0.1 PCDHB2 PCDH-BETA2 ENSG00000112852 "Protocadherin beta 2" Q9Y5E7 5 141094578-141098703 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 13.4;AN3-CA: 28.8;EFO-21: 16.4;U-138 MG: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007548 Enhanced Approved Nucleoplasm Nucleoplasm "HPA007548: " "unprognostic (2.94e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-4)" "unprognostic (1.31e-1)" "unprognostic (3.03e-3)" "unprognostic (7.01e-2)" "unprognostic (5.52e-2)" "unprognostic (2.24e-1)" "unprognostic (3.99e-1)" "unprognostic (2.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (6.99e-4)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (4.84e-4)" 7.3 3.0 3.4 1.6 8.6 0.8 5.5 5.7 13.3 3.9 4.4 7.0 0.0 2.1 6.7 2.1 4.0 2.8 4.4 4.3 4.1 1.9 2.9 0.8 6.2 1.0 3.2 5.1 4.3 2.7 0.9 5.3 2.4 4.8 5.9 2.8 4.0 3.8 1.7 1.9 4.3 2.6 4.3 8.4 1.6 1.9 12.1 5.0 0.0 2.8 1.2 0.9 4.4 2.6 0.2 0.2 0.8 0.1 0.5 0.4 0.3 0.2 1.9 13.4 28.8 3.7 1.8 6.2 0.5 2.1 0.0 0.0 0.3 0.1 0.5 16.4 0.9 0.0 0.6 0.1 0.0 0.1 0.4 0.0 0.0 3.8 0.0 0.0 1.3 0.9 0.0 0.0 0.2 0.3 0.4 0.4 4.0 0.1 3.7 0.0 5.9 3.8 0.0 9.9 0.1 1.5 0.0 7.4 2.0 0.0 1.8 4.2 8.2 2.4 1.5 12.7 3.9 5.9 1.9 0.2 0.0 0.1 2.8 0.1 7.5 0.5 0.1 0.0 0.4 0.1 0.0 0.1 0.4 0.1 0.0 0.2 0.1 0.2 0.8 0.5 0.1 0.2 0.0 0.3 3.4 8.6 5.7 11.0 4.1 1.9 3.2 5.1 4.8 5.0 PCDHB3 PCDH-BETA3 ENSG00000113205 "Protocadherin beta 3" Q9Y5E6 5 141100473-141103827 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.3" "Cell line enhanced" "Detected in some" "EFO-21: 12.1;HAP1: 3.7;SH-SY5Y: 16.2;U-138 MG: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050296 Uncertain Supported Vesicles Vesicles "HPA050296: " "unprognostic (2.72e-2)" "unprognostic (7.47e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-4)" "unprognostic (9.34e-3)" "unprognostic (3.42e-2)" "unprognostic (2.29e-2)" "unprognostic (3.17e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (8.52e-3)" "unprognostic (3.45e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-3)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (5.18e-4)" 5.7 4.6 3.1 2.6 9.3 0.4 5.9 3.8 6.2 4.8 2.5 2.2 1.3 1.4 8.0 3.0 1.3 3.1 3.1 3.6 3.8 3.0 4.9 0.8 3.3 1.0 3.0 3.8 5.6 3.9 4.4 17.3 1.8 4.0 5.4 2.1 3.4 2.4 2.4 1.9 2.0 2.1 3.8 3.0 1.5 1.8 11.6 2.0 0.0 2.1 2.3 0.7 2.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.3 2.1 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.2 0.0 3.7 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.4 0.0 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.6 16.2 0.0 0.2 0.0 2.0 0.1 0.0 5.7 0.8 0.6 0.3 0.3 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.3 3.8 6.2 3.8 3.0 3.0 3.8 4.0 2.0 PCDHB4 PCDH-BETA4 ENSG00000081818 "Protocadherin beta 4" Q9Y5E5 5 141121799-141125623 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "SCLC-21H: 12.7;SH-SY5Y: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "T-reg: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" HPA014466 Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" "Plasma membrane, Cytosol" "Intermediate filaments" "HPA014466: AB_1855058" "unprognostic (2.60e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (8.60e-3)" "unprognostic (4.03e-1)" "unprognostic (6.44e-2)" "unprognostic (2.44e-1)" "unprognostic (8.66e-2)" "unprognostic (1.52e-1)" "unprognostic (6.70e-3)" "unprognostic (1.44e-1)" "unprognostic (2.82e-3)" "unprognostic (1.11e-3)" "unprognostic (2.17e-1)" "unprognostic (3.32e-4)" "unprognostic (5.18e-3)" 7.1 5.3 13.0 2.0 12.0 0.6 5.9 11.3 11.4 8.0 3.4 12.9 0.1 1.9 12.3 9.1 4.0 5.8 5.7 4.3 10.9 6.3 4.1 1.3 5.1 1.4 13.1 11.3 9.9 18.2 7.3 5.1 0.9 11.0 6.1 2.7 3.7 5.0 5.1 3.8 3.1 2.6 7.9 21.1 2.0 2.6 1.6 12.3 0.0 2.8 1.5 1.1 5.6 5.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 2.1 0.4 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 12.7 8.5 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 13.0 12.0 11.3 11.4 10.9 6.3 13.1 11.3 11.0 12.3 PCDHB5 "DKFZp586B0217, PCDH-BETA5" ENSG00000113209 "Protocadherin beta 5" Q9Y5E4 5 141135218-141138625 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 12.2;NTERA-2: 11.6;RH-30: 9.2;SCLC-21H: 10.8;T-47d: 11.4;U-138 MG: 21.5;U-2 OS: 9.6;WM-115: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA013191 Approved "HPA013191: AB_1855059" "unprognostic (2.21e-1)" "unprognostic (4.71e-2)" "unprognostic (4.05e-3)" "unprognostic (1.81e-1)" "unprognostic (2.84e-2)" "unprognostic (5.23e-2)" "unprognostic (2.27e-2)" "unprognostic (1.76e-1)" "unprognostic (9.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.06e-3)" "unprognostic (6.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.55e-3)" 3.8 4.6 8.1 1.6 10.7 0.7 3.6 7.7 11.0 9.0 2.9 7.9 3.6 1.2 10.4 9.2 2.5 7.5 4.9 4.9 7.9 4.1 6.6 2.3 4.0 1.1 3.6 7.1 14.9 11.2 6.3 7.6 1.6 6.4 7.6 1.4 6.9 5.6 5.9 3.0 1.9 1.5 5.7 5.2 2.2 2.4 6.1 5.9 0.0 6.6 0.7 1.0 4.4 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.6 12.2 0.2 0.9 0.5 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 6.3 0.0 0.0 6.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 9.2 0.0 0.0 0.0 10.8 0.3 0.0 0.1 3.7 11.4 2.7 0.0 21.5 9.6 3.5 0.0 0.0 0.0 0.0 1.1 0.0 9.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.1 10.7 7.7 10.5 7.9 4.1 3.6 7.1 6.4 5.9 PCDHB6 PCDH-BETA6 ENSG00000113211 "Protocadherin beta 6" Q9Y5E3 5 141150022-141153287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 13.4" "Cell line enhanced" "Detected in some" "EFO-21: 16.5;SH-SY5Y: 7.0;T-47d: 5.3;U-2197: 7.5;WM-115: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029566 Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA029566: AB_10601385" "unprognostic (3.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.81e-1)" "unprognostic (8.05e-2)" "unprognostic (7.65e-3)" "unprognostic (2.82e-1)" "unprognostic (1.73e-3)" "unprognostic (9.64e-3)" "unprognostic (8.62e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (6.33e-2)" "prognostic unfavourable (5.52e-4)" "unprognostic (8.60e-4)" "unprognostic (2.31e-2)" "unprognostic (7.08e-3)" "unprognostic (6.52e-2)" 2.5 2.4 3.9 1.0 5.1 0.4 2.5 4.2 8.4 2.3 1.5 2.6 0.0 0.6 4.5 3.7 0.7 2.1 1.4 1.6 3.5 1.9 1.6 1.4 1.7 0.7 2.6 3.6 3.7 1.5 13.4 6.4 1.5 2.9 1.5 0.9 0.7 2.5 1.5 1.4 2.4 1.0 3.0 3.3 1.5 0.9 5.4 3.1 0.0 1.1 1.0 0.7 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 16.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 7.0 0.0 0.1 3.5 5.3 2.1 0.0 0.6 1.3 7.5 0.0 0.0 0.0 0.0 3.8 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.1 4.2 8.4 3.5 1.9 2.6 3.6 2.9 3.1 PCDHB7 PCDH-BETA7 ENSG00000113212 "Protocadherin beta 7" Q9Y5E2 5 141172619-141176383 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 5.3;EFO-21: 6.4;U-138 MG: 4.3;U-2197: 12.8;U-87 MG: 4.4;WM-115: 4.3" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059271 Approved "HPA059271: " "unprognostic (2.13e-1)" "unprognostic (4.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.97e-1)" "unprognostic (5.95e-2)" "unprognostic (3.69e-4)" "unprognostic (1.04e-2)" "unprognostic (2.78e-2)" "unprognostic (8.42e-2)" "unprognostic (1.32e-1)" "unprognostic (1.57e-3)" "unprognostic (2.29e-1)" "unprognostic (1.83e-3)" "unprognostic (2.35e-2)" "unprognostic (2.34e-1)" "unprognostic (1.48e-1)" "unprognostic (5.78e-4)" 5.8 2.5 4.0 2.7 3.4 0.4 4.3 3.7 4.9 8.1 3.1 8.9 0.0 1.5 11.6 5.0 1.4 5.0 4.6 3.6 4.0 1.8 3.0 1.4 4.9 1.9 3.0 2.7 7.5 1.5 1.6 8.1 1.1 4.5 4.8 1.7 7.0 1.5 3.4 1.4 1.6 2.3 9.0 3.9 3.6 1.8 3.6 5.1 0.0 3.3 0.9 1.0 6.2 5.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.6 5.3 2.6 0.0 0.3 0.7 0.1 0.1 0.0 0.1 0.0 6.4 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 1.9 1.3 0.4 0.0 1.0 2.8 0.0 0.9 4.3 0.8 12.8 0.1 0.0 0.0 0.0 4.4 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 3.7 4.9 4.0 1.8 3.0 2.7 4.5 5.1 PCDHB8 "PCDH-BETA8, PCDH3I" ENSG00000120322 "Protocadherin beta 8" Q9UN66 5 141177790-141180529 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 13.8;T-47d: 20.4;U-138 MG: 8.1;U-2197: 22.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA057773 Uncertain "HPA057773: " "unprognostic (1.16e-3)" "unprognostic (1.56e-1)" "unprognostic (5.33e-2)" "unprognostic (1.72e-1)" "unprognostic (7.56e-2)" "unprognostic (2.02e-2)" "unprognostic (5.72e-3)" "unprognostic (5.82e-4)" "unprognostic (3.54e-2)" "unprognostic (5.52e-3)" "unprognostic (1.95e-2)" "unprognostic (2.42e-1)" "unprognostic (2.62e-2)" "unprognostic (1.11e-2)" "unprognostic (8.09e-2)" "unprognostic (3.12e-2)" "unprognostic (6.30e-4)" 2.3 1.2 0.9 0.3 1.3 0.0 1.5 0.8 2.7 1.3 0.8 0.0 3.7 1.8 0.9 1.1 1.7 1.5 1.1 0.6 1.3 0.1 1.8 0.0 0.8 2.9 1.5 1.2 2.2 0.4 0.9 0.3 0.6 0.8 0.1 0.9 0.2 1.9 1.4 0.3 0.3 2.5 0.5 0.0 0.5 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.5 1.6 0.1 0.1 5.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 1.1 4.0 0.1 0.0 0.0 0.0 0.3 0.0 5.4 0.0 0.0 0.0 4.0 1.0 0.0 0.0 0.7 20.4 0.0 0.5 8.1 4.1 22.4 0.0 0.0 0.0 0.0 2.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHB9 "PCDH-BETA9, PCDH3H" ENSG00000177839 "Protocadherin beta 9" Q9Y5E1 5 141187127-141191541 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.9" "Cell line enhanced" "Detected in some" "ASC diff: 10.5;ASC TERT1: 9.8;SH-SY5Y: 14.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA013445 Uncertain "HPA013445: AB_1855054" "unprognostic (1.85e-2)" "unprognostic (3.27e-2)" "unprognostic (2.73e-1)" "unprognostic (8.97e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.12e-1)" "unprognostic (6.78e-3)" "unprognostic (1.34e-2)" "unprognostic (4.46e-2)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (1.86e-4)" "unprognostic (1.71e-1)" "unprognostic (9.80e-2)" "unprognostic (1.17e-1)" "unprognostic (8.01e-2)" 1.9 1.9 5.3 0.3 4.1 0.3 1.6 1.8 10.9 3.6 1.0 3.2 0.0 0.2 2.8 4.7 0.9 2.3 1.6 2.0 5.9 0.9 0.2 1.4 0.2 1.2 3.1 4.7 1.7 2.1 6.6 1.1 4.1 1.1 0.6 1.2 1.4 0.8 0.7 0.9 1.0 2.6 4.6 0.6 0.5 1.2 2.5 0.0 0.8 0.3 0.2 0.7 1.0 0.5 0.2 1.9 0.2 0.9 1.3 0.0 0.0 0.0 0.9 6.0 10.5 9.8 0.2 0.1 3.5 0.4 0.5 0.0 1.0 0.4 4.0 0.1 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.9 0.0 0.0 0.0 0.0 2.6 2.9 0.9 0.5 0.7 0.3 0.4 2.7 5.5 0.0 0.5 0.1 2.1 14.5 0.6 0.1 1.0 2.8 0.2 0.9 5.9 0.5 4.9 1.2 0.1 0.0 0.0 3.2 0.2 2.2 1.1 0.2 0.5 0.2 0.1 0.1 0.2 0.4 1.3 0.0 0.5 0.3 0.3 1.9 0.9 0.1 0.2 0.2 0.0 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 6.9;T-47d: 11.3;WM-115: 5.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 1.4 1.3 2.7 0.9 11.7 1.0 1.1 6.8 7.9 1.4 1.2 2.7 0.5 1.0 2.8 3.9 1.3 1.1 0.8 3.9 3.5 2.8 1.2 0.5 1.2 1.0 2.5 2.5 2.9 2.5 2.8 6.1 2.3 5.4 1.5 0.9 2.4 1.1 1.0 1.7 1.5 0.6 1.8 2.4 1.1 0.8 2.7 1.1 0.0 1.3 0.6 0.7 1.2 0.9 1.2 0.9 2.7 0.5 0.8 1.0 0.2 0.1 0.4 0.5 1.9 1.2 2.0 0.3 1.7 1.1 0.5 1.0 0.4 0.2 0.5 2.8 1.0 0.2 0.2 0.3 1.1 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.2 1.7 0.5 0.0 0.7 0.1 0.2 0.8 6.9 0.1 0.2 0.8 0.3 0.3 3.0 2.6 0.3 0.3 0.3 1.7 2.1 0.2 0.9 1.7 11.3 0.4 0.8 3.2 0.7 1.6 0.4 0.3 1.0 0.2 3.8 0.2 5.1 2.7 0.5 0.5 0.7 0.4 0.4 0.7 0.7 0.5 0.2 1.2 1.0 0.8 1.1 0.8 0.5 0.9 0.6 0.2 2.7 11.7 6.8 6.1 3.5 2.8 2.5 2.5 5.4 1.1 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 33.7" "Cell line enhanced" "Detected in many" "AF22: 12.0;HSkMC: 13.5;T-47d: 16.0;U-2197: 9.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 5.2 4.2 7.9 1.6 11.4 1.2 2.7 2.4 33.7 3.6 2.9 9.8 1.2 2.4 3.0 2.4 4.3 3.6 3.7 2.3 9.1 4.4 2.0 6.5 3.5 1.7 5.1 7.2 3.6 1.9 1.4 2.4 7.4 5.3 3.6 2.6 4.9 4.1 4.6 2.0 4.7 2.9 3.1 6.7 2.5 4.7 2.0 6.5 0.0 4.9 1.5 3.3 2.5 3.5 0.9 1.1 1.5 0.7 0.8 1.0 0.2 0.0 0.0 12.0 6.1 5.3 2.3 5.7 2.0 0.1 2.9 4.7 0.2 0.7 0.6 7.9 2.9 0.3 2.8 1.9 2.3 0.7 0.0 0.0 0.3 0.0 2.1 1.2 0.2 13.5 0.3 2.0 0.8 1.1 0.0 0.1 7.3 0.0 0.1 0.3 1.1 0.1 0.1 1.0 0.0 2.0 0.0 1.6 0.6 0.3 0.0 0.3 16.0 1.5 2.6 5.5 0.3 9.4 0.1 0.2 0.9 0.1 2.8 0.0 0.3 1.5 0.3 0.3 1.0 0.4 1.0 0.6 0.4 0.6 0.1 0.9 0.4 0.9 0.9 0.8 0.7 1.1 0.3 0.2 7.9 11.4 2.4 8.5 9.1 4.4 5.1 7.2 5.3 6.5 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 "Protocadherin gamma subfamily A, 11" Q9Y5H2 5 141421047-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell line enhanced" "Detected in many" "ASC diff: 14.9;ASC TERT1: 16.1;HSkMC: 11.5;REH: 9.6;SK-MEL-30: 12.4;WM-115: 25.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.13e-2)" "unprognostic (1.78e-3)" "unprognostic (9.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.68e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.16e-3)" "unprognostic (1.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.97e-1)" "unprognostic (2.22e-1)" "unprognostic (3.03e-2)" "unprognostic (3.74e-2)" "unprognostic (3.54e-1)" "unprognostic (4.34e-3)" "unprognostic (1.89e-1)" 3.4 2.5 7.4 2.8 9.4 0.5 2.1 4.1 8.5 2.4 2.5 8.5 0.0 1.2 2.6 1.7 3.1 2.1 2.1 3.4 11.6 1.9 1.9 1.2 2.3 1.8 4.5 5.2 3.8 2.3 1.3 1.9 8.3 5.0 2.5 1.5 3.3 2.8 3.4 2.8 6.6 1.2 3.3 4.9 1.6 1.8 2.2 7.1 0.1 3.4 0.6 1.7 1.7 2.2 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.4 14.9 16.1 0.5 3.2 6.2 2.5 4.0 0.0 0.1 0.3 5.4 3.2 2.1 0.1 0.3 4.0 0.1 1.4 0.0 0.0 0.0 2.5 0.2 0.0 11.5 0.1 4.4 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 9.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.3 1.8 4.5 0.5 0.1 0.4 0.0 0.0 0.2 0.0 0.1 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 7.4 9.4 4.1 8.5 11.6 1.9 4.5 5.2 5.0 7.1 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430589-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9" "Cell line enhanced" "Detected in some" "BJ: 7.6;BJ hTERT+: 12.6;fHDF/TERT166: 18.7;HHSteC: 6.1;HSkMC: 14.0;TIME: 6.0" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 5.1 12.7 14.8 2.8 18.9 0.7 2.4 4.7 13.8 4.9 1.8 8.6 0.6 1.4 5.4 2.3 3.5 2.7 11.3 6.5 15.7 5.6 3.1 2.8 6.5 1.6 4.7 7.3 6.2 3.6 2.0 2.7 6.5 8.4 3.5 1.7 3.4 1.7 4.9 1.9 5.1 1.5 5.3 8.4 3.7 2.2 1.6 12.4 0.4 3.0 0.6 1.7 4.5 3.6 3.7 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.6 1.2 0.1 7.6 12.6 0.0 0.0 0.0 0.0 0.4 0.0 18.7 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.0 14.0 0.0 3.7 0.0 4.4 0.0 0.0 2.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 6.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.8 18.9 4.7 10.4 15.7 5.6 4.7 7.3 8.4 12.4 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ: 5.4;fHDF/TERT166: 6.4;HSkMC: 5.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA038625: " "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 5.1 4.3 6.7 2.1 8.0 0.6 4.2 5.2 12.6 6.6 2.6 4.6 1.0 0.9 6.5 5.7 2.4 5.5 5.5 11.1 6.5 4.6 3.3 2.4 4.6 1.1 6.0 2.3 15.3 8.4 9.2 10.6 2.2 7.8 5.3 1.4 13.8 3.3 5.8 2.6 2.9 1.4 5.2 5.6 1.9 2.1 10.4 3.5 0.0 4.3 1.2 1.1 3.2 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 3.9 9.9 0.1 5.4 2.1 0.5 0.9 0.1 0.1 0.1 0.7 6.4 0.2 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.1 0.2 0.1 0.3 2.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.1 1.4 0.3 0.2 0.8 0.0 0.3 0.7 0.0 3.6 0.1 0.7 0.0 3.3 0.9 0.5 0.3 0.1 0.0 0.4 0.0 2.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 8.0 5.2 7.2 6.5 4.6 6.0 2.3 7.8 3.5 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 "Protocadherin gamma subfamily A, 3" Q9Y5H0 5 141343829-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "AF22: 11.0;BJ: 3.6;EFO-21: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (6.47e-2)" "unprognostic (4.79e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.53e-2)" "unprognostic (1.03e-1)" "unprognostic (2.35e-1)" "unprognostic (1.85e-1)" "unprognostic (7.44e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (2.32e-3)" "unprognostic (7.12e-3)" "unprognostic (3.31e-2)" "unprognostic (2.52e-4)" 4.0 4.5 11.7 1.4 10.5 0.7 2.5 6.9 13.7 4.7 1.3 7.9 0.0 0.7 4.5 3.5 1.5 2.9 3.5 12.2 8.5 5.8 2.5 2.5 2.6 1.0 6.6 7.7 8.6 3.6 1.8 6.3 5.7 8.7 3.0 1.3 4.6 2.9 3.2 1.5 1.9 1.1 3.6 6.0 1.5 1.2 5.2 3.8 0.0 3.3 1.3 1.0 1.7 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.1 0.2 1.5 0.0 3.6 0.3 0.0 0.1 0.0 0.0 0.1 8.9 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 10.5 6.9 13.7 8.5 5.8 6.6 7.7 8.7 3.8 PCDHGA4 PCDH-GAMMA-A4 ENSG00000262576 "Protocadherin gamma subfamily A, 4" Q9Y5G9 5 141355025-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.2;BJ: 5.6;HSkMC: 5.9;HUVEC TERT2: 5.6;U-87 MG: 8.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 7 "T-cells: 1.9" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.27e-2)" "unprognostic (4.55e-3)" "unprognostic (2.00e-2)" "unprognostic (6.54e-4)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (1.20e-2)" "unprognostic (5.62e-2)" "unprognostic (3.76e-1)" "unprognostic (6.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.94e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.31e-4)" 5.4 4.7 6.5 1.8 8.3 0.5 3.0 8.5 11.2 4.8 2.0 10.4 1.5 1.2 5.0 3.0 1.9 3.4 3.1 4.8 6.3 5.9 2.0 2.7 3.6 0.9 5.6 8.1 5.8 6.7 8.5 3.4 2.8 6.1 4.1 1.4 3.5 4.3 4.2 1.5 1.8 1.2 5.0 5.9 1.3 1.4 2.7 4.0 0.0 2.6 2.7 0.9 2.3 2.5 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 1.0 0.6 4.5 10.2 0.0 5.6 4.5 0.3 1.1 0.0 0.1 0.9 1.9 4.7 0.1 0.1 0.2 0.6 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.4 5.9 0.2 0.1 0.0 5.6 0.2 0.3 2.4 0.8 0.3 0.2 0.2 0.2 0.3 1.6 0.1 0.3 0.0 0.8 1.7 0.2 0.3 1.1 2.1 0.0 3.6 2.4 0.7 3.1 0.4 0.2 0.3 0.2 8.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.3 8.5 9.3 6.3 5.9 5.6 8.1 6.1 4.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.1" "Group enriched" "Detected in some" 7 "ASC diff: 18.4;ASC TERT1: 7.3" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 4.0 2.7 6.1 1.8 9.1 0.9 3.9 19.1 9.6 9.0 2.7 7.7 4.1 1.0 7.6 3.2 3.3 4.7 4.5 4.9 6.9 4.0 1.5 1.2 3.3 1.3 3.2 3.8 6.6 1.7 3.3 3.7 2.7 4.6 5.6 1.6 4.1 2.5 4.0 1.5 3.0 1.5 4.3 6.3 1.4 1.7 1.7 3.7 0.0 1.8 0.9 1.0 2.5 4.2 0.9 0.8 1.6 0.6 1.9 0.7 0.2 0.0 0.4 0.3 0.1 18.4 7.3 0.0 0.8 0.1 0.1 0.3 0.0 0.0 0.8 0.3 0.3 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 1.8 0.2 0.0 0.0 0.6 0.1 0.6 0.7 0.3 0.5 0.7 0.1 0.3 0.9 0.6 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.3 1.6 0.0 1.0 0.6 0.2 1.0 0.7 0.1 1.0 0.1 0.3 0.2 0.7 1.5 0.6 0.6 0.7 0.3 0.3 0.6 0.6 0.4 0.1 0.9 0.7 0.7 1.6 1.9 0.2 0.8 0.4 0.2 6.1 9.1 19.1 9.6 6.9 4.0 3.2 3.8 4.6 3.7 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373914-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6" "Cell line enhanced" "Detected in some" "SCLC-21H: 11.0;T-47d: 6.4;WM-115: 13.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 4.1 3.8 6.1 2.3 8.4 0.8 2.9 19.6 10.8 7.9 3.4 8.3 2.9 1.0 6.9 4.7 2.6 4.3 3.6 3.7 5.0 4.3 2.8 1.7 3.3 1.4 2.9 4.7 9.7 2.5 2.5 4.5 6.9 3.3 4.0 1.6 5.8 4.1 5.3 2.1 4.7 1.5 6.1 2.8 2.8 1.7 2.2 2.9 0.2 3.8 1.2 1.5 4.6 3.6 1.3 0.7 2.8 0.6 0.5 0.8 0.2 0.1 0.3 3.1 0.5 1.5 5.3 0.1 2.3 0.8 1.2 1.2 0.0 0.2 2.1 3.0 3.6 0.5 0.1 0.5 0.8 0.0 0.3 0.0 0.3 0.3 0.8 0.1 0.1 5.7 0.4 0.3 0.1 1.8 0.3 1.3 0.4 0.5 0.7 1.8 0.3 0.1 1.5 0.4 0.0 0.4 0.1 11.0 0.9 0.1 0.3 0.7 6.4 0.1 5.4 0.9 0.4 0.8 0.8 0.4 1.8 0.4 0.9 0.7 13.7 1.8 0.6 0.3 0.8 0.3 0.3 0.8 0.6 0.2 0.1 1.3 0.3 0.5 2.8 0.5 0.3 0.7 0.5 0.2 6.1 8.4 19.6 10.8 5.0 4.3 2.9 4.7 3.3 2.9 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ hTERT+: 17.3;SH-SY5Y: 15.5;T-47d: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 1.7 2.0 3.1 1.3 9.0 0.6 2.1 5.3 14.9 3.5 3.0 7.1 2.1 1.0 4.2 4.1 2.2 3.3 1.9 3.0 5.1 3.3 3.2 1.9 2.2 1.0 5.1 6.6 4.7 2.5 4.6 3.4 4.8 5.4 3.7 1.5 5.8 2.6 3.3 1.6 3.8 1.2 3.0 6.3 1.3 1.4 2.1 5.1 0.0 6.6 1.5 1.0 2.4 2.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 1.9 0.0 5.8 9.9 0.0 2.6 17.3 3.5 5.2 0.0 0.0 0.4 4.3 0.5 0.1 0.0 0.1 2.9 0.0 0.3 0.0 0.4 0.1 1.0 0.0 0.0 4.3 0.1 0.0 0.6 1.4 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 15.5 0.0 0.1 0.1 6.8 0.0 5.2 0.1 0.1 2.5 0.0 0.1 1.5 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.0 5.3 7.7 5.1 3.3 5.1 6.6 5.4 5.1 PCDHGA8 "KIAA0327, PCDH-GAMMA-A8" ENSG00000253767 "Protocadherin gamma subfamily A, 8" Q9Y5G5 5 141390157-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 7.1" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 2.9;neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.28e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (4.10e-2)" "unprognostic (7.68e-2)" "unprognostic (2.30e-2)" "unprognostic (1.83e-2)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.35e-2)" "unprognostic (1.49e-3)" "unprognostic (7.59e-2)" "unprognostic (3.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.99e-3)" 0.6 0.7 0.8 0.7 0.6 2.5 0.7 2.3 2.2 1.2 1.2 1.0 7.1 0.4 2.3 1.5 2.1 0.7 0.9 2.0 1.4 0.5 0.5 0.9 1.1 0.7 0.5 0.4 2.6 0.6 0.2 1.9 1.4 3.5 0.9 0.8 0.4 0.8 0.5 2.2 2.5 1.1 0.7 1.6 0.7 0.7 1.0 1.3 1.1 2.4 0.4 0.6 0.6 1.2 0.7 0.4 2.9 0.4 0.5 0.3 0.1 0.3 0.2 1.1 0.6 1.1 2.6 0.6 2.4 1.6 1.7 0.7 0.2 0.4 1.1 1.0 1.8 0.4 0.0 0.0 1.3 0.3 0.2 0.3 0.5 0.3 0.1 0.4 0.8 1.4 0.1 0.5 0.1 0.4 0.2 0.9 0.2 0.2 0.5 0.7 2.7 0.1 1.0 0.2 0.1 0.1 0.3 0.7 0.7 0.3 0.9 0.4 1.2 1.7 2.5 2.6 0.9 0.6 0.2 0.3 0.3 0.4 1.3 0.4 1.3 2.9 0.4 0.5 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.2 0.3 2.8 0.5 0.3 0.4 0.2 0.1 0.8 0.6 2.3 2.2 1.4 0.5 0.5 0.4 3.5 1.3 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 "Protocadherin gamma subfamily A, 9" Q9Y5G4 5 141402932-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 5.9;HSkMC: 6.6;TIME: 7.2;U-87 MG: 8.3" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.98e-2)" "unprognostic (7.47e-3)" "unprognostic (9.86e-3)" "unprognostic (2.22e-1)" "unprognostic (4.68e-2)" "unprognostic (4.96e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (1.87e-3)" "unprognostic (2.26e-1)" "unprognostic (1.79e-1)" "unprognostic (4.48e-3)" "unprognostic (1.94e-2)" "unprognostic (8.83e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-2)" 5.6 5.4 12.0 2.6 12.6 0.9 3.7 11.5 17.3 6.9 2.7 11.2 0.1 2.1 7.6 3.9 4.8 6.3 6.5 3.2 10.3 8.5 3.0 2.8 5.0 2.1 9.6 7.1 9.1 3.0 3.8 3.0 3.6 10.9 5.2 2.7 7.7 3.8 7.3 1.9 5.5 2.0 5.9 13.0 3.6 2.9 2.0 5.9 0.0 4.6 1.4 2.5 4.8 3.7 0.5 0.3 1.0 0.5 0.2 1.0 0.0 0.0 0.3 1.0 2.5 0.2 0.5 0.4 1.2 0.0 1.0 1.1 0.4 0.6 2.0 5.9 3.1 0.1 0.2 0.3 1.1 0.1 0.5 0.0 0.2 0.0 1.8 0.1 0.4 6.6 0.3 0.6 0.5 1.6 0.1 0.3 0.5 0.6 0.3 0.7 0.3 0.1 0.3 0.7 0.0 0.3 0.3 0.7 1.8 0.6 0.1 0.8 1.5 0.7 7.2 0.5 0.5 0.1 3.9 0.3 0.1 0.1 8.3 0.2 1.4 1.0 0.5 0.3 1.0 0.3 0.6 0.3 0.4 0.2 0.1 0.5 0.4 0.7 1.0 0.2 0.2 0.3 0.1 0.0 12.0 12.6 11.5 16.2 10.3 8.5 9.6 7.1 10.9 5.9 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 32.2;pituitary gland: 13.7" "Cell line enhanced" "Detected in some" "ASC diff: 14.9;ASC TERT1: 7.7;T-47d: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: , HPA076182: " "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 2.3 2.7 8.2 1.4 7.5 1.0 2.1 4.3 32.2 2.5 1.4 9.4 0.1 1.2 3.7 2.0 1.7 1.9 2.1 2.2 7.6 5.7 2.1 1.3 2.4 1.2 5.5 5.0 4.1 2.8 1.4 13.7 1.6 7.0 2.5 1.4 2.6 1.7 3.1 1.1 1.4 1.3 3.0 6.9 1.4 1.2 1.5 5.6 0.0 2.5 0.0 1.2 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 2.1 1.8 0.0 14.9 7.7 0.1 1.4 3.6 0.5 0.8 0.2 0.5 0.5 4.7 0.5 0.6 0.4 0.2 0.5 0.0 0.9 0.0 0.2 1.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.2 0.2 3.3 1.9 0.4 0.3 0.2 0.0 0.0 2.8 0.1 0.0 0.0 1.1 0.8 0.0 0.9 0.1 9.6 0.0 1.1 0.2 1.6 1.2 0.0 0.0 2.6 0.3 2.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.5 4.3 9.6 7.6 5.7 5.5 5.0 7.0 5.6 PCDHGB2 PCDH-GAMMA-B2 ENSG00000253910 "Protocadherin gamma subfamily B, 2" Q9Y5G2 5 141360042-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8" "Cancer enriched" "Detected in many" 5 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077526" Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane, Cytosol" Nucleoplasm "HPA008755: AB_1079577, HPA010580: , HPA077526: " "unprognostic (7.14e-3)" "unprognostic (8.79e-3)" "unprognostic (3.21e-2)" "unprognostic (2.17e-1)" "prognostic unfavourable (8.67e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-4)" "unprognostic (2.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.78e-1)" "unprognostic (1.05e-1)" "unprognostic (8.46e-3)" "unprognostic (4.59e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.29e-1)" "unprognostic (3.36e-4)" 4.9 3.6 11.3 2.2 9.7 0.9 3.7 8.7 12.2 7.2 2.4 11.6 0.3 1.2 9.2 3.2 3.2 5.6 6.2 4.6 9.3 7.0 2.7 2.7 5.4 1.4 7.0 8.6 9.0 2.6 7.5 3.0 3.9 7.3 4.4 2.8 3.1 2.4 4.4 1.9 2.9 2.1 5.0 7.0 2.2 2.0 1.8 7.8 0.1 2.6 1.3 1.4 2.8 3.3 0.9 0.9 0.5 0.0 0.0 0.7 0.0 0.1 0.3 2.1 0.2 14.4 10.5 0.1 2.2 3.0 0.6 3.4 0.0 0.3 3.8 1.0 1.7 0.5 0.5 0.3 1.0 0.0 0.2 0.0 0.3 0.4 0.6 0.2 0.2 2.7 0.5 0.2 0.1 1.7 0.2 1.2 8.5 0.4 2.9 0.6 0.1 0.9 7.8 2.7 0.2 0.2 0.3 1.6 1.7 0.2 0.4 0.4 3.1 0.2 6.0 3.0 0.7 4.6 3.9 0.2 2.2 0.7 3.3 1.0 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.4 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.0 0.9 0.0 0.0 11.3 9.7 8.7 10.6 9.3 7.0 7.0 8.6 7.3 7.8 PCDHGB3 PCDH-GAMMA-B3 ENSG00000262209 "Protocadherin gamma subfamily B, 3" Q9Y5G1 5 141370264-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 13.2;ASC TERT1: 10.7;TIME: 6.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008755, HPA010580, HPA035822, HPA035823" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA035822: , HPA035823: " "unprognostic (6.93e-3)" "unprognostic (9.10e-4)" "unprognostic (1.35e-1)" "unprognostic (7.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (7.83e-2)" "unprognostic (1.92e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.81e-2)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (3.89e-2)" "unprognostic (2.80e-3)" 4.1 1.7 3.3 1.6 6.5 0.5 3.1 3.5 5.6 3.0 3.0 7.2 0.7 0.7 4.9 3.7 3.3 3.3 2.9 4.6 3.3 2.3 2.9 2.0 2.5 3.7 1.9 3.8 5.2 4.2 4.6 5.4 2.3 2.6 2.6 2.2 3.1 6.6 2.6 1.9 3.3 1.4 4.3 2.9 2.4 2.3 1.5 2.8 0.3 3.4 3.2 3.5 2.7 4.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.4 0.3 13.2 10.7 0.2 1.4 2.4 0.9 1.1 0.0 0.0 2.2 0.4 4.3 0.6 0.0 0.3 0.7 0.0 0.3 0.0 0.3 0.1 0.6 0.1 0.0 2.6 0.6 0.2 0.1 1.2 0.3 1.0 0.3 0.4 0.7 1.0 0.1 0.1 1.8 0.7 0.0 0.2 0.1 3.0 0.6 0.0 0.0 0.3 0.8 0.0 6.7 0.6 0.1 0.7 0.7 0.3 2.0 0.2 0.6 0.6 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 6.5 3.5 5.6 3.3 2.3 1.9 3.8 2.6 2.8 PCDHGB4 "CDH20, FIB2, PCDH-GAMMA-B4" ENSG00000253953 "Protocadherin gamma subfamily B, 4" Q9UN71 5 141387698-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 28.5;TIME: 14.3" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "NK-cell: 1.6" "Lineage enriched" "Detected in single" 7 "NK-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (3.33e-1)" "unprognostic (1.83e-3)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-2)" "unprognostic (9.25e-3)" "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (1.74e-1)" "unprognostic (1.29e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.70e-2)" "unprognostic (2.62e-1)" "unprognostic (1.13e-1)" "unprognostic (3.27e-2)" 2.4 2.2 2.4 0.7 4.2 0.0 1.2 1.8 2.1 2.6 1.4 0.2 3.2 3.5 1.1 2.1 0.8 2.8 2.3 4.1 2.9 3.3 2.1 0.0 1.8 5.1 1.9 3.0 2.5 6.2 2.6 0.7 3.0 3.1 1.2 3.4 0.3 1.9 2.0 0.6 0.4 0.9 3.6 0.2 1.6 2.0 0.0 0.2 0.0 0.0 1.6 0.2 0.2 0.0 0.7 7.0 0.0 4.6 5.9 0.8 6.8 28.5 2.8 1.9 0.0 0.0 0.2 5.5 0.2 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 1.6 1.8 0.0 0.0 5.7 0.0 2.7 0.0 4.3 0.2 0.0 0.0 0.0 0.6 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 3.6 2.6 14.3 3.8 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 PCDHGB5 PCDH-GAMMA-B5 ENSG00000276547 "Protocadherin gamma subfamily B, 5" Q9Y5G0 5 141397987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 11.2" "Cell line enhanced" "Detected in many" "ASC diff: 32.2;ASC TERT1: 24.3;BJ hTERT+ SV40 Large T+: 13.9;BJ hTERT+ SV40 Large T+ RasG12V: 15.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (2.71e-3)" "unprognostic (1.95e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (2.35e-1)" "unprognostic (1.20e-1)" "unprognostic (3.64e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.29e-1)" "unprognostic (1.69e-4)" "unprognostic (9.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.25e-4)" 2.1 1.9 0.8 0.3 3.2 0.0 3.6 2.0 4.3 1.4 0.4 2.5 1.9 0.0 2.1 2.5 1.1 2.1 0.8 1.9 0.0 1.6 3.1 6.8 2.6 0.9 1.5 4.9 2.8 11.2 2.1 9.5 1.5 2.2 0.2 3.7 3.2 3.2 1.4 2.6 0.0 1.9 3.0 0.5 0.7 1.0 2.2 0.8 3.5 0.0 0.7 1.9 1.4 0.5 0.2 0.0 0.3 0.0 1.9 0.1 0.0 1.1 0.1 0.0 32.2 24.3 0.6 8.5 0.0 13.9 15.6 1.3 4.6 4.8 11.1 9.4 6.4 0.0 3.5 7.8 0.0 1.4 0.0 0.0 0.0 3.3 0.0 3.1 8.5 0.7 0.8 4.5 4.2 0.1 0.0 0.4 3.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 0.0 9.0 0.0 4.3 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.3 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 "Protocadherin gamma subfamily B, 6" Q9Y5F9 5 141408021-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell line enhanced" "Detected in some" "AF22: 18.2;EFO-21: 6.2;HSkMC: 4.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (2.63e-1)" "unprognostic (7.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-2)" "unprognostic (3.51e-1)" "unprognostic (1.11e-1)" "unprognostic (4.77e-2)" "unprognostic (9.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.27e-1)" "unprognostic (1.21e-2)" "unprognostic (7.71e-4)" 6.7 7.2 8.8 2.6 9.9 1.6 4.4 6.1 26.6 5.8 4.1 10.1 0.3 1.8 7.2 5.7 3.0 5.1 4.4 4.6 8.9 5.7 3.2 9.4 4.4 2.2 6.9 4.4 13.3 5.2 16.1 4.7 6.8 5.9 4.0 2.3 9.0 5.3 5.9 5.7 4.7 2.2 4.8 4.1 4.0 2.5 2.1 6.7 0.3 6.1 1.9 2.1 4.2 5.1 0.8 0.5 3.2 0.4 0.5 0.9 0.2 0.0 0.1 18.2 0.1 0.6 0.7 0.9 1.6 0.0 0.4 1.0 0.2 0.2 1.5 6.2 1.0 0.3 0.0 0.3 1.2 0.0 0.3 0.0 0.2 0.1 1.5 0.1 0.1 4.2 2.0 0.9 0.1 0.6 0.1 0.3 0.1 0.3 0.1 1.2 0.8 0.0 0.2 0.1 0.1 2.9 0.2 0.2 0.3 0.0 0.1 0.1 1.4 0.4 2.9 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.8 1.1 0.4 0.2 0.9 0.3 0.2 0.6 0.4 0.2 0.1 0.8 0.4 0.3 3.2 0.5 0.3 0.5 0.2 0.2 8.8 9.9 6.1 7.9 8.9 5.7 6.9 4.4 5.9 6.7 PCDHGB7 "ME6, PCDH-GAMMA-B7" ENSG00000254122 "Protocadherin gamma subfamily B, 7" Q9Y5F8 5 141417645-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "AN3-CA: 42.5;HSkMC: 13.5" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (1.22e-2)" "unprognostic (2.55e-2)" "unprognostic (7.39e-3)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (8.40e-2)" "unprognostic (4.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.88e-2)" "unprognostic (3.05e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-2)" 10.1 9.8 12.6 3.8 13.5 0.8 8.0 19.1 12.9 10.2 7.0 16.1 1.2 2.3 11.6 5.0 6.8 7.8 9.2 8.5 14.5 7.9 5.4 3.5 11.6 2.6 10.4 7.3 17.3 5.5 9.5 5.3 11.0 9.4 8.3 3.8 15.5 7.1 12.0 5.6 6.8 3.2 10.5 20.1 5.3 4.5 4.2 14.3 0.6 8.4 3.0 2.3 4.6 6.9 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 42.5 1.0 0.2 0.4 2.8 0.3 1.0 2.1 0.0 2.6 0.3 2.3 5.6 0.7 0.1 0.5 1.0 0.0 0.3 0.0 0.0 0.0 3.2 0.2 0.0 13.5 0.3 0.8 0.4 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 4.7 0.9 0.0 0.1 0.0 4.6 6.3 0.1 0.0 0.0 0.4 0.4 5.5 5.1 0.1 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 12.6 13.5 19.1 12.9 14.5 7.9 10.4 7.3 9.4 14.3 PCDHGC3 "PC-43, PC43, PCDH-GAMMA-C3, PCDH2" ENSG00000240184 "Protocadherin gamma subfamily C, 3" Q9UN70 5 141475947-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 99.3" "Cell line enhanced" "Detected in many" "ASC diff: 43.0;ASC TERT1: 41.2;HSkMC: 40.4;U-138 MG: 51.8;WM-115: 77.2" "Group enriched" "Detected in all" 6 "glioma: 55.0;melanoma: 20.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 15.2" "Lineage enriched" "Detected in single" 22 "dendritic cells: 15.2" "HPA008755, HPA010580, HPA077289" Approved Approved "Plasma membrane" 74000 "Plasma membrane" "HPA008755: AB_1079577, HPA010580: , HPA077289: " "unprognostic (2.52e-1)" "unprognostic (4.83e-3)" "unprognostic (1.17e-1)" "unprognostic (6.76e-2)" "unprognostic (3.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "prognostic unfavourable (6.19e-4)" "unprognostic (2.03e-1)" "unprognostic (2.22e-1)" "prognostic unfavourable (8.18e-4)" "unprognostic (3.72e-2)" "unprognostic (5.66e-2)" "unprognostic (9.55e-2)" "prognostic unfavourable (6.00e-4)" 14.9 15.0 52.8 7.0 49.0 0.5 11.2 30.1 99.3 28.0 8.7 38.9 2.4 3.8 20.6 27.6 12.8 15.7 14.6 11.0 40.2 25.2 7.1 8.0 20.9 4.2 32.0 24.9 16.6 4.4 18.8 7.9 17.7 25.8 17.1 10.2 17.3 8.4 20.1 5.8 18.3 5.6 19.8 28.1 5.3 6.6 4.8 24.1 0.9 5.4 6.4 7.1 8.6 11.1 0.6 15.2 0.0 0.0 0.0 0.1 0.0 2.7 1.6 10.7 2.8 43.0 41.2 0.1 14.0 37.5 7.0 7.5 0.0 2.7 9.3 9.1 24.4 10.2 1.4 4.4 6.7 0.0 4.2 0.0 0.2 0.2 13.3 0.1 0.3 40.4 6.7 10.4 8.6 4.6 0.0 0.3 17.5 5.1 0.2 1.0 0.4 0.0 6.3 21.7 0.0 3.7 3.0 3.5 15.2 3.7 0.1 23.0 8.7 13.0 5.6 51.8 2.7 10.1 15.1 0.0 0.1 0.1 12.4 0.0 77.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 15.2 0.0 0.0 52.8 49.0 30.1 38.9 40.2 25.2 32.0 24.9 25.8 24.1 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 23.6" "Cell line enhanced" "Detected in some" "REH: 9.7;SCLC-21H: 8.2;SH-SY5Y: 15.9" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: " "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.7 2.9 5.7 0.7 9.5 0.5 0.8 23.6 21.9 1.0 1.1 2.3 0.0 0.6 0.9 1.2 0.8 1.0 1.0 1.3 4.1 10.1 0.6 0.6 1.0 0.9 3.3 4.5 0.8 1.2 0.8 1.3 0.8 8.6 0.8 0.8 1.9 1.0 0.7 1.2 1.5 0.7 0.9 2.3 0.8 0.7 1.5 0.8 0.0 0.7 0.0 1.0 0.6 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.2 0.2 0.8 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.3 0.9 0.9 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.0 1.5 0.0 9.7 0.6 0.0 0.0 0.1 8.2 15.9 0.1 0.0 0.2 0.1 0.3 0.1 0.9 0.1 0.2 0.7 0.2 0.0 0.2 0.6 0.1 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.5 23.6 15.6 4.1 10.1 3.3 4.5 8.6 0.8 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489121-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 43.7" "Cell line enhanced" "Detected in some" "U-138 MG: 16.3;U-251 MG: 7.0;U-87 MG: 10.0" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4" "HPA008755, HPA010580, HPA076140" Supported Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: , HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 1.0 1.1 7.4 1.1 34.5 0.9 1.1 3.0 43.7 1.1 1.0 2.8 0.0 0.9 1.4 1.3 1.0 1.2 1.2 2.8 11.8 2.8 0.9 0.9 1.1 0.9 2.2 10.0 1.1 1.0 1.0 1.1 1.0 2.3 1.3 1.0 0.0 0.9 1.6 1.6 1.5 0.9 2.0 0.8 1.0 1.0 1.3 1.1 0.0 1.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.7 0.2 0.8 0.6 0.5 0.6 0.0 0.0 0.5 1.6 2.4 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.9 0.8 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.2 0.1 16.3 0.2 0.2 7.0 0.0 0.0 0.0 10.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 34.5 3.0 39.2 11.8 2.8 2.2 10.0 2.3 1.1 PCLO "ACZ, DKFZp779G1236, KIAA0559" ENSG00000186472 "Piccolo presynaptic cytomatrix protein" Q9Y6V0 7 82754013-83162930 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.3" "Group enriched" "Detected in some" 28 "REH: 61.0;U-2 OS: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015858, HPA029579, CAB079012" Approved Supported Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles, Plasma membrane" "CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044" "unprognostic (1.32e-2)" "unprognostic (1.99e-1)" "unprognostic (9.33e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (4.49e-3)" "unprognostic (6.14e-2)" "unprognostic (4.61e-2)" "unprognostic (1.82e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" "unprognostic (4.79e-6)" "unprognostic (5.15e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-5)" "unprognostic (6.62e-5)" 3.1 7.9 8.8 0.8 26.3 0.4 4.7 50.3 19.4 3.2 3.9 1.6 0.4 2.9 1.0 7.3 2.3 2.0 1.9 2.2 9.8 5.7 8.2 0.6 1.8 0.6 4.6 12.6 1.9 4.0 11.4 19.2 1.0 9.1 4.9 3.5 3.6 2.5 5.0 0.6 2.6 2.4 0.7 5.3 1.1 2.9 4.5 4.4 0.0 8.4 0.0 0.8 1.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.1 1.3 0.5 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.4 0.0 2.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 1.1 61.0 1.0 0.0 0.4 0.2 1.1 0.8 0.0 0.6 0.1 0.7 0.1 0.0 0.0 70.0 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.8 26.3 50.3 19.4 9.8 5.7 4.6 12.6 9.1 4.4 PCMT1 ENSG00000120265 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase" P22061 6 149749443-149811420 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003239 Approved Supported Cytosol 8200000 Cytosol "HPA003239: AB_1079580" "prognostic unfavourable (4.02e-7)" "prognostic unfavourable (9.58e-4)" "unprognostic (1.35e-2)" "prognostic unfavourable (4.27e-4)" "unprognostic (1.02e-1)" "prognostic unfavourable (1.88e-4)" "prognostic unfavourable (2.58e-4)" "unprognostic (1.91e-2)" "unprognostic (1.58e-2)" "unprognostic (9.02e-2)" "unprognostic (6.45e-2)" "unprognostic (6.77e-2)" "unprognostic (6.14e-2)" "unprognostic (4.38e-1)" "unprognostic (1.70e-1)" "unprognostic (2.17e-2)" "prognostic unfavourable (6.38e-4)" 19.1 18.4 35.7 13.0 43.0 28.5 19.3 33.5 58.3 20.2 16.9 19.2 12.4 14.7 16.0 22.2 17.9 15.8 11.0 43.9 35.0 38.8 21.3 29.5 15.1 14.6 35.1 46.0 16.2 14.6 16.4 15.5 17.2 57.4 22.1 18.1 11.6 17.2 21.4 69.5 14.7 13.6 19.6 28.6 12.0 12.7 29.1 19.2 18.1 19.3 15.9 17.9 14.4 13.7 31.6 53.0 51.2 58.0 30.0 37.4 51.6 21.4 17.0 17.4 21.8 37.5 31.0 19.4 35.3 20.2 28.1 35.5 49.3 16.4 27.2 30.0 29.8 26.8 29.9 35.2 40.6 18.9 43.3 41.5 32.0 48.2 25.1 49.4 51.1 15.4 26.1 32.0 34.6 26.5 59.3 26.7 33.5 63.9 24.0 37.7 14.2 19.1 19.9 22.6 19.5 27.3 15.8 33.2 12.8 26.8 42.8 22.9 25.9 35.2 19.7 16.6 21.0 31.4 38.3 16.9 26.2 27.8 26.1 33.0 32.8 40.0 58.0 51.2 30.2 53.6 30.1 31.6 30.6 32.7 53.0 24.2 28.5 32.5 30.8 30.0 52.2 23.9 37.4 51.6 35.7 43.0 33.5 58.3 35.0 38.8 35.1 46.0 57.4 19.2 PCSK4 "DKFZp434B217, MGC34749, PC4, SPC5" ENSG00000115257 "Proprotein convertase subtilisin/kexin type 4" Q6UW60 19 1481428-1490752 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "testis: 50.7" "Cell line enhanced" "Detected in some" "AN3-CA: 9.9;HMC-1: 5.3;U-266/70: 10.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.2;plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.7;T-cells: 1.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA005572 Uncertain "HPA005572: AB_1855087" "unprognostic (1.00e-2)" "unprognostic (9.12e-2)" "unprognostic (2.36e-3)" "prognostic favourable (9.45e-5)" "unprognostic (5.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.78e-1)" "unprognostic (6.34e-3)" "unprognostic (2.94e-1)" "unprognostic (8.29e-3)" "unprognostic (1.93e-2)" "unprognostic (7.44e-2)" "unprognostic (6.56e-2)" "unprognostic (3.82e-2)" "unprognostic (1.71e-2)" "unprognostic (3.57e-2)" "unprognostic (7.03e-2)" 0.5 1.2 2.5 0.6 3.4 0.9 0.7 0.6 1.8 1.2 0.9 1.8 2.5 2.5 0.8 2.2 0.7 4.2 1.0 0.4 2.5 2.1 1.7 2.0 0.8 0.6 1.0 2.0 0.8 3.8 1.4 4.2 0.5 2.3 1.2 0.4 2.4 1.3 2.4 0.5 0.8 1.1 0.6 1.2 0.7 1.2 50.7 1.8 1.2 2.0 0.0 0.4 0.7 0.6 0.0 1.7 0.0 0.3 0.0 1.2 0.1 0.8 0.5 1.7 9.9 0.2 0.3 2.6 0.7 0.2 0.1 0.3 0.9 1.4 0.0 1.0 0.0 1.1 0.0 0.0 0.0 0.6 0.2 0.4 1.4 1.3 0.7 0.0 5.3 0.8 0.0 0.0 0.1 0.2 1.6 2.5 0.0 0.0 0.2 0.4 0.1 0.5 1.7 0.1 0.2 0.6 0.0 0.0 2.0 0.2 0.4 0.1 3.6 0.5 0.0 0.8 0.1 0.2 0.0 10.9 1.9 0.3 0.5 0.9 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.2 0.0 0.0 1.2 0.1 0.0 0.0 0.0 1.7 0.0 0.1 2.5 3.4 0.6 1.8 2.5 2.1 1.0 2.0 2.3 1.8 PCSK5 "PC5, PC6, SPC6" ENSG00000099139 "Proprotein convertase subtilisin/kexin type 5" Q92824 9 75890644-76362339 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Pregnancy "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 157.6;intestine: 71.5" "Cell line enhanced" "Detected in many" "BEWO: 15.5;HaCaT: 21.8;RH-30: 14.4;RPTEC TERT1: 20.2;U-2 OS: 31.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "basophil: 157.6;neutrophil: 57.4" "Lineage enriched" "Detected in all" 12 "granulocytes: 157.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031072 Approved Supported "Golgi apparatus" "Secreted to blood" "Golgi apparatus" "HPA031072: AB_10602190" "unprognostic (3.28e-2)" "unprognostic (1.44e-1)" "unprognostic (4.13e-4)" "unprognostic (4.08e-2)" "unprognostic (7.43e-3)" "unprognostic (3.17e-1)" "unprognostic (2.07e-3)" "unprognostic (9.39e-2)" "unprognostic (1.15e-1)" "unprognostic (5.92e-2)" "unprognostic (2.81e-2)" "unprognostic (6.80e-2)" "prognostic unfavourable (9.61e-5)" "unprognostic (2.99e-1)" "unprognostic (3.21e-2)" "unprognostic (3.22e-2)" "unprognostic (1.77e-5)" 15.8 3.8 2.9 13.7 2.8 1.5 9.5 2.4 3.2 8.5 51.8 2.9 4.5 19.7 6.5 13.9 9.6 7.8 22.9 6.7 3.8 2.4 3.7 1.9 7.7 5.6 2.3 3.1 17.2 3.4 9.5 3.2 7.7 3.5 4.5 6.7 3.3 5.0 5.8 4.0 4.8 71.5 6.9 3.5 2.5 3.3 5.1 2.4 18.0 6.4 14.2 4.5 7.1 11.4 11.7 12.2 157.6 4.4 12.6 12.7 0.8 1.1 0.8 2.4 1.6 1.5 0.5 15.5 2.1 0.2 0.1 0.0 8.2 0.9 0.3 0.6 0.2 21.8 1.1 0.6 0.1 0.2 1.9 2.8 1.6 0.7 0.4 0.8 1.3 2.9 0.2 0.5 0.2 4.5 3.2 1.0 1.5 5.1 3.2 4.9 10.6 0.9 0.6 14.4 0.8 20.2 1.2 0.2 0.2 3.3 0.7 0.2 1.2 3.5 3.5 0.7 31.5 1.8 0.9 0.2 0.1 0.4 2.4 1.2 12.0 157.6 4.2 16.2 9.7 2.3 8.3 8.8 9.8 8.9 1.9 11.7 9.9 12.7 57.4 12.6 4.4 12.2 8.4 0.8 2.9 2.8 2.4 3.2 3.8 2.4 2.3 3.1 3.5 2.4 PDCD1 "CD279, hSLE1, PD-1, PD1, SLEB2" ENSG00000188389 "Programmed cell death 1" Q15116 2 241849881-241858908 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Immunity" "FDA approved drug targets, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.6;lymphoid tissue: 21.5" "Group enriched" "Detected in some" 14 "MOLT-4: 9.3;RPMI-8226: 9.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 4.1;MAIT T-cell: 3.9;memory CD4 T-cell: 6.8;memory CD8 T-cell: 11.6;T-reg: 3.5" "Lineage enriched" "Detected in single" 93 "T-cells: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035981, CAB038418, CAB076386" Enhanced "CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664" "unprognostic (2.90e-3)" "unprognostic (4.50e-3)" "unprognostic (7.78e-2)" "prognostic favourable (9.44e-5)" "unprognostic (7.18e-3)" "unprognostic (1.31e-3)" "unprognostic (3.83e-2)" "unprognostic (7.33e-2)" "unprognostic (5.82e-3)" "unprognostic (3.75e-2)" "unprognostic (6.57e-2)" "unprognostic (3.94e-1)" "prognostic unfavourable (3.48e-7)" "unprognostic (1.20e-2)" "unprognostic (3.10e-1)" "unprognostic (5.35e-2)" "unprognostic (5.06e-3)" 1.4 0.4 0.0 21.5 0.7 3.0 0.5 0.1 0.3 1.2 1.9 0.0 0.0 0.4 0.5 1.6 2.0 0.8 1.7 9.2 0.2 0.5 1.3 0.5 5.6 16.6 0.1 0.3 0.7 1.0 0.2 1.9 0.3 0.4 1.3 0.2 1.2 3.0 0.5 0.2 0.2 4.9 0.4 0.3 9.5 1.9 0.4 0.2 16.6 1.9 3.0 20.1 1.3 0.8 0.1 0.0 0.0 0.0 0.0 11.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 9.3 0.0 0.0 0.0 0.0 0.1 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 3.9 0.1 6.8 11.6 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 3.5 1.5 0.0 0.7 0.1 0.1 0.2 0.5 0.1 0.3 0.4 0.2 PDCD1LG2 "B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2" ENSG00000197646 "Programmed cell death 1 ligand 2" Q9BQ51 9 5510570-5571254 "Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 25.4;BJ hTERT+: 39.9;HDLM-2: 30.5;TIME: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA013411 Approved Approved Cytosol "Secreted - unknown location" 34000000 Cytosol "HPA013411: AB_1855102" "unprognostic (3.93e-2)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (6.68e-3)" "unprognostic (7.66e-2)" "unprognostic (6.77e-2)" "unprognostic (5.72e-2)" "unprognostic (2.91e-1)" "unprognostic (1.68e-1)" "unprognostic (4.37e-3)" "unprognostic (5.79e-2)" "unprognostic (5.29e-2)" "prognostic unfavourable (1.15e-4)" "unprognostic (5.00e-2)" "unprognostic (4.66e-2)" "unprognostic (2.01e-1)" "unprognostic (7.51e-3)" 15.2 1.8 1.2 7.7 1.4 0.2 9.5 0.7 1.2 7.0 1.9 2.3 0.0 0.8 2.9 7.2 3.9 3.8 4.0 5.8 1.2 1.3 2.5 6.4 13.3 10.8 1.6 0.5 4.1 1.8 0.5 1.1 12.9 1.9 5.0 2.5 2.4 2.9 1.7 5.5 3.6 2.5 4.6 3.7 19.5 1.9 4.2 1.2 8.1 3.5 3.5 8.1 6.0 5.4 0.5 0.9 4.1 3.6 0.0 3.0 0.7 2.0 0.0 0.0 0.0 1.7 2.0 0.0 25.4 39.9 12.3 14.9 0.0 0.1 0.0 0.0 10.3 0.2 0.0 3.4 12.2 30.5 0.0 0.0 0.0 0.0 9.9 0.0 0.0 1.8 0.0 5.7 6.7 8.0 0.0 3.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 17.6 8.8 0.5 4.2 7.0 0.4 0.0 0.0 5.0 0.0 1.0 4.1 0.9 0.0 1.4 3.6 1.9 0.5 2.2 0.9 0.9 0.3 0.0 1.0 2.0 0.0 0.5 0.0 3.0 0.7 1.2 1.4 0.7 1.2 1.2 1.3 1.6 0.5 1.9 1.2 PDGFRA "CD140a, GAS9, PDGFR2" ENSG00000134853 "Platelet derived growth factor receptor alpha" P16234 4 54229097-54298247 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 81.5" "Cell line enhanced" "Detected in some" "ASC diff: 81.0;ASC TERT1: 37.9;BJ hTERT+: 47.0;fHDF/TERT166: 32.7;HHSteC: 27.4;HSkMC: 68.9" "Cancer enhanced" "Detected in all" "glioma: 30.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004947, CAB018143" Supported Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" 150000 "Nucleoplasm, Plasma membrane, Cell Junctions" "CAB018143: AB_2162351, HPA004947: " "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "unprognostic (4.59e-3)" "unprognostic (1.60e-1)" "unprognostic (8.92e-2)" "prognostic favourable (9.33e-4)" "unprognostic (1.24e-1)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (2.18e-2)" "unprognostic (2.18e-1)" "unprognostic (7.01e-2)" "prognostic unfavourable (9.79e-6)" "unprognostic (9.58e-3)" "unprognostic (9.87e-2)" "unprognostic (2.16e-2)" "unprognostic (1.72e-3)" 35.0 12.4 12.6 16.1 7.6 0.9 17.2 2.4 20.1 33.2 19.1 9.2 6.4 9.6 27.6 14.6 21.9 22.5 16.2 15.3 8.9 7.4 22.8 8.4 24.1 26.9 9.2 4.0 81.5 6.8 1.6 2.1 25.1 7.2 18.6 15.2 19.2 8.5 8.3 11.9 7.0 17.4 19.7 8.8 51.6 13.6 19.0 9.3 0.5 11.3 12.8 4.3 35.9 24.6 0.9 0.4 2.5 0.4 0.3 0.8 0.3 0.0 0.0 0.2 0.1 81.0 37.9 0.1 4.2 47.0 0.0 0.1 11.2 0.0 0.1 0.1 32.7 0.1 3.2 0.0 0.0 0.4 0.1 0.1 0.1 0.2 27.4 0.0 0.0 68.9 0.0 5.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.3 0.1 6.6 0.0 0.1 0.0 0.1 0.0 0.1 14.8 0.5 16.2 0.0 0.0 0.0 0.1 0.4 0.0 0.3 2.5 0.4 0.2 0.5 0.2 0.2 0.6 0.8 0.4 0.0 0.9 0.7 0.4 2.3 0.3 0.3 0.4 0.2 0.3 12.6 7.6 2.4 7.3 8.9 7.4 9.2 4.0 7.2 9.3 PDGFRB "CD140b, JTK12, PDGFR, PDGFR1" ENSG00000113721 "Platelet derived growth factor receptor beta" P09619 5 150113837-150155872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Chemotaxis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 169.0;ASC TERT1: 58.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.9;non-classical monocyte: 4.1" "Group enriched" "Detected in many" 8 "monocytes: 4.1;T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003842, CAB018144, HPA028499" Enhanced Supported "Golgi apparatus,Vesicles" 35000000 Vesicles "Golgi apparatus" "CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018" "unprognostic (4.75e-2)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (3.27e-1)" "unprognostic (5.61e-2)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (2.12e-2)" "unprognostic (2.57e-3)" "unprognostic (6.72e-2)" "unprognostic (1.25e-1)" "prognostic unfavourable (5.87e-8)" "unprognostic (3.13e-3)" "unprognostic (1.25e-2)" "unprognostic (5.47e-2)" "prognostic unfavourable (8.11e-4)" 61.8 10.4 8.3 11.0 9.1 0.5 66.1 4.6 10.4 73.1 15.7 6.7 6.9 5.1 44.3 17.3 21.7 26.1 51.7 24.2 8.2 3.9 17.0 4.6 28.9 21.5 7.9 8.1 46.5 7.5 10.4 7.7 46.4 7.7 24.2 6.3 22.9 11.2 19.3 29.8 20.3 11.2 29.8 5.0 19.6 9.2 21.5 6.7 1.4 21.4 16.0 7.3 23.6 35.1 0.4 0.1 0.0 4.1 0.0 2.9 0.6 0.0 0.0 1.0 0.0 169.0 58.5 0.3 5.9 24.5 4.1 7.0 0.6 0.0 0.0 0.7 16.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.4 24.0 0.0 0.0 26.3 0.0 5.7 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 1.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 2.2 2.8 0.3 0.0 0.0 0.0 4.1 0.0 0.1 0.0 0.0 0.0 2.9 0.6 0.0 0.4 0.1 0.8 0.1 0.1 0.0 1.3 0.0 0.0 4.1 0.0 0.0 0.6 8.3 9.1 4.6 10.4 8.2 3.9 7.9 8.1 7.7 6.7 PDIA6 "ERp5, P5, TXNDC7" ENSG00000143870 "Protein disulfide isomerase family A member 6" Q15084 2 10783391-10837977 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034347, HPA034652, HPA034653" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" 53000000 "Endoplasmic reticulum, Cytosol" "CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982" "unprognostic (8.16e-2)" "prognostic unfavourable (1.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (1.20e-4)" "prognostic unfavourable (3.63e-5)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" "unprognostic (5.25e-3)" "unprognostic (6.03e-3)" "unprognostic (1.68e-1)" "prognostic unfavourable (2.51e-6)" "unprognostic (6.59e-2)" "unprognostic (2.34e-1)" "unprognostic (1.38e-2)" "unprognostic (3.69e-3)" 26.9 32.7 16.7 25.0 29.9 19.9 28.7 11.3 16.8 33.4 26.1 13.9 53.7 20.4 30.4 76.1 27.1 25.5 22.4 32.7 14.2 13.9 42.1 118.4 30.4 36.3 17.8 12.7 26.5 141.6 24.9 23.3 39.5 19.0 22.6 30.1 14.6 53.4 45.0 15.7 16.1 28.4 26.5 14.3 35.1 30.9 12.4 19.5 18.1 97.9 20.1 29.7 21.9 30.6 45.2 61.0 52.0 46.2 51.5 52.2 59.7 33.9 36.9 52.9 82.9 68.1 58.9 94.0 82.7 76.8 43.4 58.5 52.3 67.1 55.2 58.2 80.8 27.9 39.7 69.2 46.7 43.2 31.3 44.7 28.9 84.9 73.7 45.8 33.6 42.5 53.2 42.0 75.8 97.8 38.4 119.1 42.8 40.2 17.6 47.5 44.1 29.2 42.3 53.9 99.9 61.8 41.1 33.9 67.9 32.6 47.8 46.4 16.9 77.7 48.0 40.8 52.1 36.7 47.8 112.4 69.3 35.8 55.1 57.6 57.0 52.0 44.4 20.5 47.5 46.2 52.2 45.2 37.7 44.7 48.6 33.1 18.4 31.0 8.1 51.5 33.9 61.0 37.7 59.7 16.7 29.9 11.3 16.8 14.2 13.9 17.8 12.7 19.0 19.5 PDIK1L CLIK1L ENSG00000175087 "PDLIM1 interacting kinase 1 like" Q8N165 1 26111165-26125543 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064157 Supported Nucleoplasm Nucleoplasm "HPA064157: " "unprognostic (1.09e-1)" "unprognostic (1.81e-3)" "unprognostic (2.99e-3)" "unprognostic (2.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.34e-3)" "unprognostic (3.93e-2)" "unprognostic (1.72e-3)" "unprognostic (7.29e-3)" "unprognostic (1.08e-1)" "unprognostic (2.42e-2)" "unprognostic (3.59e-1)" "unprognostic (1.34e-2)" "unprognostic (4.24e-3)" "unprognostic (2.94e-1)" "unprognostic (4.47e-1)" "unprognostic (1.78e-2)" 7.0 6.0 8.6 6.2 12.3 19.9 11.5 17.8 15.9 8.6 8.9 7.1 7.6 9.5 7.8 6.4 11.4 7.5 5.8 4.8 8.5 10.6 8.5 11.3 6.7 8.0 9.3 9.9 10.2 15.3 10.7 9.9 5.6 11.5 6.8 10.6 6.1 10.2 8.9 7.7 9.4 9.7 6.5 8.3 8.3 10.2 7.8 9.3 19.1 22.2 6.7 8.8 8.8 8.0 6.7 9.3 11.0 6.1 5.6 10.4 5.2 5.5 2.1 5.8 7.3 2.2 3.0 1.9 1.4 2.0 3.7 2.4 1.4 7.9 11.6 4.2 2.1 4.1 7.8 2.9 3.6 4.1 5.2 10.3 3.3 1.5 3.4 10.8 6.2 1.6 4.2 3.3 6.7 3.3 12.2 11.6 1.2 3.1 15.7 4.8 2.6 3.1 8.4 5.3 13.9 2.5 4.3 9.3 7.9 5.6 7.1 7.2 4.0 3.7 3.1 4.1 3.6 5.2 4.5 17.3 17.1 8.8 4.3 13.4 3.8 11.0 5.0 4.2 6.7 4.6 6.2 6.7 9.4 7.4 9.3 5.6 10.0 8.0 0.5 5.6 6.1 3.5 10.4 5.2 8.6 12.3 17.8 15.9 8.5 10.6 9.3 9.9 11.5 9.3 PDLIM5 "Enh, LIM" ENSG00000163110 "PDZ and LIM domain 5" Q96HC4 4 94451857-94668227 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 129.6;skeletal muscle: 173.0" "Low cell line specificity" "Detected in all" "Cancer enriched" "Detected in all" 8 "prostate cancer: 132.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 51.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 51.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013511, HPA016740, HPA020026" Enhanced Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" 2200000 "Nucleoplasm, Plasma membrane, Focal adhesion sites" "CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154" "unprognostic (6.20e-2)" "unprognostic (1.94e-1)" "unprognostic (2.81e-2)" "unprognostic (1.08e-2)" "unprognostic (6.61e-2)" "unprognostic (2.24e-1)" "unprognostic (1.33e-1)" "unprognostic (2.46e-2)" "unprognostic (7.60e-2)" "unprognostic (2.65e-1)" "unprognostic (1.18e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (2.11e-2)" "unprognostic (3.15e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" 11.6 4.8 6.2 4.2 6.1 8.7 9.8 3.4 5.8 12.7 11.0 3.7 7.1 5.6 37.5 12.9 14.0 10.2 11.0 129.6 5.3 5.2 12.9 13.9 5.6 5.3 5.4 4.5 10.3 8.1 3.4 6.8 18.9 10.2 15.3 5.4 12.6 15.3 12.5 173.0 5.6 15.8 22.1 4.9 7.0 5.6 5.5 3.7 1.0 5.3 52.9 9.5 17.7 7.1 3.2 5.6 51.1 12.2 2.7 3.9 3.8 8.6 25.7 10.0 3.9 22.1 15.2 3.9 21.2 17.6 12.2 9.8 23.7 19.3 3.4 21.7 21.2 9.0 13.6 19.8 20.4 6.1 5.7 12.7 16.8 8.9 31.9 4.1 11.4 20.4 17.5 29.1 22.7 27.3 5.4 3.8 25.8 8.5 4.2 1.4 3.4 10.8 2.0 7.4 3.1 13.6 27.8 5.0 6.7 11.5 26.5 5.9 3.1 1.3 34.2 31.8 5.0 13.7 12.8 2.6 3.4 3.5 17.3 3.0 7.4 51.1 6.8 5.9 3.8 11.8 3.1 3.2 3.7 3.9 5.6 2.5 2.5 3.2 6.8 2.7 12.2 1.9 3.4 3.8 6.2 6.1 3.4 3.9 5.3 5.2 5.4 4.5 10.2 3.7 PDPN "aggrus, Gp38, GP40, PA2.26, T1A-2" ENSG00000162493 Podoplanin Q86YL7 1 13583465-13617957 "Predicted membrane proteins" "Cell shape" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.8" "Cell line enhanced" "Detected in some" "AF22: 29.8;EFO-21: 71.6;HAP1: 49.7;HHSteC: 44.1;NTERA-2: 23.0;TIME: 47.6" "Cancer enhanced" "Detected in many" "testis cancer: 102.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.1" "HPA007534, CAB008376, HPA073453" Enhanced Approved Vesicles Vesicles "CAB008376: AB_592530, HPA007534: AB_1857718, HPA073453: " "unprognostic (1.75e-1)" "unprognostic (3.19e-2)" "unprognostic (6.03e-2)" "unprognostic (3.61e-2)" "unprognostic (2.73e-2)" "unprognostic (1.05e-2)" "unprognostic (3.85e-2)" "unprognostic (5.23e-2)" "unprognostic (9.21e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-2)" "unprognostic (5.62e-3)" "unprognostic (9.20e-3)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" "unprognostic (2.78e-2)" 27.7 2.0 6.3 29.8 10.9 0.5 30.3 5.0 6.7 21.4 12.8 11.0 4.1 2.5 16.8 15.3 8.9 19.8 23.7 18.6 5.7 6.5 1.9 0.8 17.8 10.4 10.0 2.4 18.4 3.9 0.7 2.3 71.8 13.5 11.3 6.4 26.6 6.0 8.6 21.9 10.0 7.6 18.6 17.5 0.7 15.1 9.7 7.9 3.2 5.7 9.7 9.9 27.3 28.9 0.4 0.2 3.1 0.4 0.3 0.4 0.1 0.0 0.0 29.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 71.6 1.7 0.1 49.7 8.8 0.0 0.1 9.1 0.0 0.0 0.0 44.1 0.0 0.0 6.0 16.5 3.7 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.6 8.4 7.2 0.1 0.0 0.0 0.0 0.1 17.9 0.0 0.0 1.0 0.4 0.6 0.2 0.2 0.2 0.4 0.3 0.3 0.2 0.4 0.4 0.3 3.1 0.3 0.2 0.2 0.2 0.1 6.3 10.9 5.0 4.8 5.7 6.5 10.0 2.4 13.5 7.9 PDZK1IP1 "DD96, MAP17, SPAP" ENSG00000162366 "PDZK1 interacting protein 1" Q13113 1 47183593-47191044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "kidney: 281.3" "Group enriched" "Detected in some" 6 "EFO-21: 30.8;RPTEC TERT1: 102.0" "Cancer enhanced" "Detected in all" "renal cancer: 340.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA014907 Enhanced Approved "Nuclear speckles,Cytosol" Cytosol "Nuclear speckles" "HPA014907: AB_1855166" "unprognostic (2.97e-1)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "prognostic unfavourable (6.92e-4)" "unprognostic (8.14e-3)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.65e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (3.45e-4)" "unprognostic (2.64e-2)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (1.75e-3)" "unprognostic (1.89e-1)" 2.7 1.2 0.6 2.4 0.6 3.9 4.1 0.6 0.6 9.2 9.1 0.6 0.6 2.2 1.3 4.8 30.4 2.9 23.9 0.7 0.5 0.0 281.3 1.6 7.2 0.5 0.6 0.5 2.3 16.8 0.0 0.6 3.2 0.6 2.1 3.4 0.8 33.9 12.4 0.7 19.9 9.5 0.5 0.5 0.7 9.0 1.4 0.6 1.1 1.0 18.3 18.5 4.1 8.3 0.1 0.5 2.1 1.1 0.2 0.3 42.4 10.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.4 0.0 30.8 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 102.0 0.0 0.0 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.1 0.2 0.0 0.5 0.3 42.4 0.6 0.6 0.6 0.6 0.5 0.0 0.6 0.5 0.6 0.6 PEAR1 "FLJ00193, JEDI, MEGF12" ENSG00000187800 "Platelet endothelial aggregation receptor 1" Q5VY43 1 156893698-156916434 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.9;HBEC3-KT: 13.5;HHSteC: 10.2;HUVEC TERT2: 23.8;TIME: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035217 Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" 35000000 "Nucleoplasm, Cell Junctions" Centrosome "HPA035217: AB_10669902" "unprognostic (1.02e-1)" "unprognostic (1.84e-5)" "unprognostic (4.77e-2)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.48e-1)" "unprognostic (5.62e-2)" "unprognostic (5.93e-2)" "unprognostic (1.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.17e-1)" "unprognostic (5.04e-1)" "prognostic unfavourable (4.31e-4)" "unprognostic (1.20e-2)" "unprognostic (3.37e-3)" "unprognostic (8.51e-2)" "unprognostic (2.64e-2)" 18.5 7.1 1.8 3.0 5.1 2.8 29.2 1.2 2.9 16.5 5.8 2.7 6.3 2.3 15.9 10.5 6.6 8.9 10.3 11.1 2.7 1.8 6.8 3.8 12.0 10.1 3.2 2.1 10.6 3.2 1.7 3.9 15.5 3.7 9.6 1.4 15.5 4.1 5.5 11.4 4.4 4.1 9.6 3.1 12.2 4.1 8.1 1.5 0.6 10.5 5.8 2.1 6.7 11.5 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.2 1.3 0.3 0.0 0.0 1.7 0.0 5.2 8.9 2.2 1.3 0.1 0.2 0.0 0.2 3.9 0.1 0.0 13.5 0.6 0.0 0.0 6.5 0.2 0.3 10.2 0.0 0.0 5.3 0.0 3.0 0.7 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 38.4 0.0 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 1.8 5.1 1.2 2.9 2.7 1.8 3.2 2.1 3.7 1.5 PECAM1 CD31 ENSG00000261371 "Platelet and endothelial cell adhesion molecule 1" 17 64319415-64413776 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 77.7;blood: 88.4;placenta: 65.7" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 118.2;TIME: 81.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 88.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004690 Enhanced "HPA004690: AB_1078462" "unprognostic (2.79e-1)" "unprognostic (2.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (4.42e-3)" "unprognostic (2.84e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-1)" "unprognostic (7.25e-2)" "unprognostic (4.53e-2)" "unprognostic (9.68e-2)" "prognostic unfavourable (8.98e-5)" "unprognostic (9.72e-3)" "unprognostic (9.57e-2)" "unprognostic (1.56e-1)" "unprognostic (4.16e-2)" 77.7 2.5 2.2 10.2 3.3 3.8 26.5 1.2 3.6 14.2 9.2 1.6 3.7 3.5 15.2 7.6 12.3 4.7 12.2 13.8 2.2 13.4 3.5 50.2 10.7 3.0 0.3 7.4 2.3 2.7 1.2 65.7 3.7 10.2 4.9 4.6 2.9 3.0 21.2 2.0 4.8 11.6 2.8 13.9 3.4 6.4 2.0 7.8 15.7 10.0 7.8 15.2 16.2 5.0 21.0 53.3 88.4 5.2 10.0 24.2 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 118.2 0.3 8.9 0.0 0.0 4.8 1.2 0.0 1.2 0.2 2.3 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.2 81.3 0.1 0.0 0.1 0.0 0.5 0.9 1.0 0.2 1.0 0.0 6.2 34.8 28.9 2.8 57.2 2.7 3.6 0.3 6.7 21.0 5.0 5.4 10.0 53.3 5.2 88.4 12.0 0.2 24.2 PEX11B ENSG00000131779 "Peroxisomal biogenesis factor 11 beta" O96011 1 145911350-145918837 "Disease related genes, Predicted membrane proteins" "Peroxisome biogenesis" "Peroxisome biogenesis disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA017150, HPA050104" Supported Supported Vesicles Vesicles "HPA017150: , HPA050104: " "unprognostic (4.59e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.29e-1)" "unprognostic (3.62e-1)" "unprognostic (1.18e-1)" "prognostic unfavourable (2.67e-4)" "prognostic favourable (6.85e-4)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (2.10e-1)" "unprognostic (8.48e-2)" "unprognostic (6.96e-2)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (7.62e-3)" "unprognostic (4.28e-1)" 12.0 17.3 25.9 13.3 29.5 8.5 24.4 25.1 39.6 19.9 18.2 17.3 21.3 18.4 16.2 27.2 21.6 20.1 14.7 17.9 25.8 28.1 25.4 19.8 14.9 18.4 24.0 20.3 19.7 23.2 20.4 16.4 17.3 26.9 18.2 21.7 15.7 19.0 20.9 23.7 20.6 17.2 16.1 14.7 18.7 18.4 18.0 14.8 21.4 20.3 17.2 25.3 16.7 13.9 42.5 42.8 32.0 29.6 29.5 37.0 34.1 11.2 10.3 9.2 9.0 21.5 16.9 9.5 11.4 15.1 14.9 11.6 4.7 13.2 10.6 12.4 16.1 13.7 8.0 17.0 10.5 11.7 6.0 6.4 6.8 12.1 30.3 19.4 12.0 22.1 21.2 10.1 10.0 19.0 11.7 17.5 23.5 17.8 14.8 18.5 3.3 12.7 13.8 13.8 23.1 25.6 8.0 6.4 10.5 8.6 16.6 10.3 22.9 30.2 16.8 10.1 8.1 13.1 8.2 19.0 21.9 14.9 17.0 11.0 6.9 32.0 29.6 20.6 28.7 26.3 31.2 42.5 32.9 31.0 32.0 37.2 37.0 33.5 14.7 29.5 25.8 42.8 34.8 34.1 25.9 29.5 25.1 39.6 25.8 28.1 24.0 20.3 26.9 14.8 PEX11G ENSG00000104883 "Peroxisomal biogenesis factor 11 gamma" Q96HA9 19 7476875-7497449 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.7;EFO-21: 8.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069817 Uncertain "HPA069817: " "unprognostic (2.26e-2)" "unprognostic (6.44e-2)" "unprognostic (1.47e-2)" "prognostic favourable (3.60e-4)" "unprognostic (1.01e-1)" "unprognostic (4.09e-3)" "prognostic favourable (3.27e-4)" "unprognostic (4.84e-2)" "unprognostic (1.97e-1)" "unprognostic (3.16e-1)" "unprognostic (2.32e-2)" "unprognostic (1.29e-1)" "prognostic favourable (1.83e-9)" "unprognostic (1.21e-3)" "unprognostic (1.67e-1)" "unprognostic (1.56e-1)" "unprognostic (1.19e-2)" 4.8 10.0 4.3 2.2 4.5 1.8 4.0 2.4 5.7 2.6 5.6 6.4 7.3 10.7 2.9 12.7 3.6 5.5 7.8 2.8 4.0 3.5 7.7 17.8 3.5 3.1 5.1 5.7 4.7 8.1 2.6 4.0 2.9 4.8 5.1 2.6 7.1 6.4 9.1 2.8 4.4 9.2 2.6 4.9 4.1 6.1 22.4 3.6 1.5 5.1 3.0 3.8 3.8 2.6 2.7 2.8 14.1 3.3 6.4 1.4 1.6 2.5 5.0 1.2 4.4 3.6 2.1 6.8 1.5 1.0 1.2 1.2 1.8 8.7 1.5 8.4 0.7 4.5 0.9 1.6 0.4 0.7 1.9 0.9 1.4 0.5 3.2 0.1 5.2 4.1 1.9 1.1 1.7 0.8 2.3 0.1 1.4 1.4 0.9 0.9 0.3 2.9 0.2 0.3 0.2 3.2 3.4 3.3 2.9 2.3 0.4 0.6 7.2 1.6 0.0 0.2 0.7 4.3 0.2 2.6 1.8 0.9 0.8 0.1 0.9 14.1 3.3 12.0 1.4 3.1 0.9 2.1 1.0 0.5 2.8 2.7 1.0 0.8 10.3 6.4 2.8 1.8 0.3 1.6 4.3 4.5 2.4 5.7 4.0 3.5 5.1 5.7 4.8 3.6 PEX14 ENSG00000142655 "Peroxisomal biogenesis factor 14" O75381 1 10472288-10630758 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046104, HPA049231" Supported Supported "Nucleoli fibrillar center,Peroxisomes" Peroxisomes "Nucleoli fibrillar center" "HPA046104: , HPA049231: " "unprognostic (7.23e-3)" "unprognostic (7.93e-2)" "unprognostic (3.50e-2)" "unprognostic (1.48e-2)" "unprognostic (3.66e-1)" "unprognostic (1.61e-1)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (5.32e-2)" "unprognostic (2.32e-1)" "unprognostic (5.85e-2)" "unprognostic (1.31e-1)" "unprognostic (3.05e-3)" "unprognostic (9.67e-3)" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (3.75e-2)" 14.9 11.6 14.3 12.2 22.3 8.3 13.1 15.7 35.0 11.8 14.8 18.6 8.3 18.0 14.4 10.4 22.6 14.8 12.2 17.8 14.4 16.2 13.3 25.9 13.6 11.6 13.0 16.1 15.7 15.3 13.6 14.2 17.7 22.4 21.9 10.5 14.8 20.0 31.0 22.1 14.6 20.9 10.7 11.1 11.2 12.8 18.7 11.4 11.4 13.5 11.6 17.3 38.7 13.6 4.2 5.0 7.3 3.8 4.2 8.4 3.6 15.4 14.6 12.5 13.7 9.2 8.7 8.1 17.9 15.1 20.0 19.1 15.4 28.9 11.3 18.0 13.7 18.6 13.0 17.3 9.6 15.8 21.2 13.9 15.9 21.1 13.9 15.6 20.0 10.5 14.0 15.1 14.0 12.8 21.7 11.7 9.0 12.8 14.9 20.6 12.8 17.2 16.2 10.4 16.2 15.8 10.3 14.9 17.0 17.3 14.5 16.1 13.3 11.2 12.3 14.7 15.5 14.1 15.2 16.8 13.6 22.1 16.1 21.7 15.6 1.9 3.8 7.3 8.4 2.8 5.3 4.2 4.4 6.2 4.7 3.9 5.8 5.2 0.6 4.2 2.5 5.0 5.2 3.6 14.3 22.3 15.7 35.0 14.4 16.2 13.0 16.1 22.4 11.4 PEX16 ENSG00000121680 "Peroxisomal biogenesis factor 16" Q9Y5Y5 11 45909669-45918812 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043286 Approved "HPA043286: AB_10794179" "unprognostic (2.48e-1)" "unprognostic (1.95e-2)" "unprognostic (8.14e-2)" "unprognostic (3.15e-2)" "unprognostic (1.76e-1)" "unprognostic (1.53e-1)" "unprognostic (9.06e-3)" "unprognostic (9.06e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (3.48e-3)" "unprognostic (1.51e-1)" "unprognostic (6.75e-3)" "unprognostic (5.72e-3)" "unprognostic (2.71e-1)" "unprognostic (1.00e-1)" "prognostic favourable (9.06e-4)" 14.6 17.6 23.7 13.0 23.5 24.3 12.0 10.6 29.2 9.7 19.6 21.3 13.4 24.8 11.0 13.0 13.8 15.1 14.0 15.4 22.9 17.0 14.8 28.9 11.9 19.9 21.2 14.3 12.7 31.6 12.8 18.6 10.9 17.4 11.9 7.3 13.3 24.1 18.8 9.2 16.5 22.2 8.3 19.9 16.8 15.2 16.7 11.5 18.3 16.0 12.5 18.4 13.8 10.3 36.9 32.4 24.4 31.5 27.4 38.9 29.6 8.3 12.5 3.8 10.4 7.0 8.6 11.3 6.8 9.5 9.7 8.1 13.5 6.4 14.4 9.0 6.7 17.0 3.9 14.1 2.0 13.0 15.3 9.1 15.8 11.3 21.7 14.2 23.2 13.8 12.6 6.0 9.2 10.3 7.5 17.4 6.1 24.1 10.7 19.1 9.3 13.7 10.7 9.3 16.4 6.2 14.2 10.0 13.4 8.0 15.9 13.4 23.9 12.2 9.2 10.5 12.2 22.6 12.2 27.9 18.4 9.7 10.5 9.2 10.2 19.7 30.7 24.4 35.5 31.5 32.4 36.9 34.6 34.5 32.4 32.7 31.5 32.6 22.5 27.4 24.2 29.7 38.9 29.6 23.7 23.5 10.6 29.2 22.9 17.0 21.2 14.3 17.4 11.5 PEX2 "PAF-1, PMP35, PXMP3, RNF72, ZWS3" ENSG00000164751 "Peroxisomal biogenesis factor 2" P28328 8 76980258-77001044 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010983, HPA011410, HPA027729" Approved Supported Vesicles Vesicles "HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416" "unprognostic (6.42e-2)" "unprognostic (2.90e-2)" "unprognostic (4.64e-2)" "unprognostic (2.35e-1)" "unprognostic (9.91e-2)" "unprognostic (2.33e-1)" "unprognostic (6.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.16e-2)" "unprognostic (1.37e-1)" "unprognostic (2.85e-2)" "unprognostic (2.07e-2)" "unprognostic (9.57e-3)" "unprognostic (2.48e-1)" "unprognostic (9.49e-2)" "unprognostic (3.06e-2)" "unprognostic (1.09e-3)" 21.3 30.9 25.4 17.9 23.8 17.3 30.7 20.7 24.6 24.3 23.8 24.1 65.7 22.5 25.7 24.3 21.6 24.1 18.0 22.1 26.9 20.7 31.3 25.3 20.4 27.8 29.8 18.3 20.5 26.4 21.2 32.6 17.4 25.9 25.8 22.9 24.9 28.7 63.6 32.4 17.4 27.2 25.7 30.5 23.1 27.0 14.7 30.9 32.2 34.4 19.0 23.4 24.2 23.5 17.3 17.1 52.4 22.9 28.3 22.3 24.2 27.7 9.4 15.3 15.4 16.4 20.6 8.0 20.8 23.8 16.1 17.8 5.9 24.9 15.8 31.1 18.7 10.7 10.4 15.8 19.6 29.1 8.6 19.3 8.7 9.0 11.1 15.9 15.3 23.1 13.4 12.2 14.6 17.5 10.5 15.2 16.8 8.3 28.0 9.5 9.0 8.5 5.1 12.2 13.1 18.7 19.7 5.4 14.2 13.4 61.0 11.3 19.0 11.5 17.5 14.8 19.5 19.0 10.3 28.3 16.4 27.6 18.8 8.5 16.4 52.4 20.3 35.8 22.3 20.8 19.9 17.3 15.6 17.9 16.9 17.2 20.6 19.6 14.1 28.3 22.9 17.1 17.4 24.2 25.4 23.8 20.7 24.6 26.9 20.7 29.8 18.3 25.9 30.9 PEX26 FLJ20695 ENSG00000215193 "Peroxisomal biogenesis factor 26" Q7Z412 22 18077920-18131138 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB070429 Approved "CAB070429: AB_11154363" "unprognostic (2.25e-1)" "unprognostic (5.75e-3)" "prognostic favourable (9.92e-4)" "unprognostic (1.77e-3)" "unprognostic (5.46e-2)" "unprognostic (1.30e-1)" "prognostic unfavourable (3.10e-4)" "unprognostic (1.59e-2)" "unprognostic (5.34e-2)" "unprognostic (8.19e-2)" "unprognostic (1.88e-2)" "unprognostic (1.96e-1)" "prognostic favourable (1.38e-4)" "unprognostic (3.17e-3)" "unprognostic (4.53e-2)" "unprognostic (1.37e-1)" "unprognostic (2.49e-1)" 13.2 16.2 16.7 11.8 18.2 16.5 11.1 14.7 22.0 10.1 28.9 13.6 11.5 28.6 12.3 9.3 14.4 12.0 14.7 11.5 17.1 16.5 14.8 17.8 10.1 11.8 14.7 20.0 10.8 21.8 18.6 14.5 8.3 16.3 10.3 24.3 13.1 12.3 11.1 11.7 11.4 29.0 12.0 10.2 11.9 14.4 5.8 11.1 15.1 13.8 9.6 11.7 11.0 11.3 4.8 7.3 3.8 6.0 4.4 7.0 2.8 17.0 9.4 11.3 10.4 15.3 7.9 18.4 11.5 12.5 11.7 11.2 13.7 14.5 12.0 12.6 19.6 17.6 17.6 18.1 10.0 18.9 15.2 22.2 12.6 13.4 11.4 26.7 20.5 11.2 11.2 18.9 17.8 17.3 22.9 9.1 16.2 28.1 19.9 10.1 13.2 16.8 17.5 13.3 3.7 17.1 20.8 20.6 15.2 19.7 12.6 15.2 19.1 9.3 21.5 23.7 10.6 12.5 13.6 19.8 14.6 15.7 10.4 14.0 17.0 2.2 4.0 3.8 5.8 2.5 4.6 3.4 4.8 7.0 3.7 4.8 5.5 3.8 3.0 4.4 6.0 7.3 1.8 2.8 16.7 18.2 14.7 22.0 17.1 16.5 14.7 20.0 16.3 11.1 PEX3 ENSG00000034693 "Peroxisomal biogenesis factor 3" P56589 6 143450807-143490010 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042830, HPA058006" Supported Supported Nucleoplasm,Peroxisomes "Nucleoplasm, Peroxisomes" "HPA042830: AB_10794918, HPA058006: AB_2683576" "unprognostic (3.52e-3)" "unprognostic (6.28e-2)" "unprognostic (1.81e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (4.16e-1)" "unprognostic (8.45e-2)" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "prognostic favourable (3.80e-4)" "unprognostic (1.87e-1)" "unprognostic (7.30e-2)" "unprognostic (3.80e-2)" "unprognostic (2.12e-1)" 10.1 47.5 13.7 14.0 15.5 3.3 14.5 17.3 17.7 13.6 8.5 12.1 14.0 7.0 12.5 16.4 21.1 12.5 9.0 15.8 14.3 11.4 22.7 29.2 9.6 10.3 13.7 15.9 14.4 8.6 16.2 14.8 22.2 17.4 15.0 8.1 10.4 12.8 15.7 12.6 14.6 8.8 12.7 14.6 8.7 11.3 14.4 12.7 10.1 19.3 13.5 11.6 11.9 15.1 18.2 8.7 7.8 9.6 12.0 18.7 8.1 14.4 3.6 7.6 16.0 12.7 12.5 9.6 13.0 10.6 18.0 22.0 23.4 9.4 25.4 15.5 13.9 12.3 10.5 18.4 22.3 14.7 12.9 17.9 7.3 15.0 11.7 28.9 7.3 15.2 12.6 17.3 13.0 9.9 15.2 11.7 17.2 10.2 14.6 11.7 4.9 13.0 11.2 17.2 10.9 22.1 6.3 11.8 4.2 17.3 15.0 11.5 7.5 9.6 9.0 12.9 11.1 22.0 15.4 8.4 10.6 25.4 16.9 20.0 10.1 7.8 5.1 4.9 13.2 8.0 15.1 18.2 14.1 13.1 7.9 15.4 18.7 17.9 0.8 12.0 9.6 8.7 16.5 8.1 13.7 15.5 17.3 17.7 14.3 11.4 13.7 15.9 17.4 12.7 PFDN1 PFD1 ENSG00000113068 "Prefoldin subunit 1" O60925 5 140245039-140303121 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006499 Approved Approved "Nucleoli,Plasma membrane,Cytosol" 10000 "Plasma membrane, Cytosol" Nucleoli "HPA006499: AB_1079596" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.11e-2)" "unprognostic (5.66e-3)" "prognostic unfavourable (8.81e-5)" "unprognostic (2.12e-2)" "unprognostic (2.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (4.10e-1)" "unprognostic (8.60e-3)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.00e-1)" 36.1 24.8 39.5 18.8 38.8 26.4 25.8 28.5 48.7 23.1 27.0 29.3 15.8 20.9 28.2 29.6 26.8 22.5 18.6 46.7 38.2 34.7 32.7 20.2 24.2 21.6 38.8 35.3 20.6 18.1 26.5 19.9 26.9 45.6 24.3 23.0 19.8 23.1 24.4 69.5 20.9 22.0 32.1 37.1 23.1 19.2 19.6 24.1 23.7 24.4 28.7 25.5 23.0 19.2 38.9 36.3 45.6 46.4 39.5 45.1 37.2 38.5 18.1 32.4 18.6 21.2 21.8 31.3 52.8 26.3 40.7 45.3 38.6 24.7 26.0 53.4 28.1 14.4 23.4 51.9 47.9 27.5 23.6 23.1 18.6 24.9 24.9 47.5 18.1 23.2 27.6 34.5 36.4 44.6 20.7 17.1 34.1 17.2 32.3 32.6 21.4 27.2 22.8 46.1 19.1 45.4 17.7 18.3 19.4 39.6 34.8 30.2 23.7 28.1 57.3 28.7 28.5 16.9 47.2 16.6 42.7 67.5 29.0 31.4 33.3 43.2 31.1 45.6 33.4 46.4 35.3 38.9 38.4 38.4 36.3 35.9 38.5 34.6 5.1 39.5 44.1 33.9 45.1 37.2 39.5 38.8 28.5 48.7 38.2 34.7 38.8 35.3 45.6 24.1 PFN2 ENSG00000070087 "Profilin 2" P35080 3 149964904-150050788 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 89.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035611, CAB037073" Enhanced "CAB037073: AB_1079600, HPA035611: AB_10672870" "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.07e-3)" "prognostic unfavourable (2.93e-4)" "unprognostic (1.77e-2)" "prognostic unfavourable (3.42e-4)" "prognostic unfavourable (2.19e-7)" "unprognostic (4.11e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-2)" "unprognostic (2.96e-3)" "unprognostic (4.86e-3)" "unprognostic (6.82e-2)" "unprognostic (1.25e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.99e-1)" 9.2 13.9 59.1 6.7 49.6 1.3 12.8 35.1 89.7 14.5 10.3 22.8 11.6 8.8 21.4 54.1 9.0 33.8 12.5 15.4 64.8 39.9 39.8 8.7 6.6 2.6 36.1 44.6 21.8 11.7 15.7 12.9 7.4 33.6 23.4 10.0 11.7 15.8 23.9 75.0 2.9 11.7 20.5 30.5 5.5 8.5 9.4 15.9 2.3 34.4 9.1 3.7 15.2 6.8 2.7 0.3 1.5 0.3 1.6 9.7 3.1 76.8 26.8 64.6 26.4 14.4 49.4 17.3 24.7 37.6 39.1 45.5 10.0 62.2 0.0 52.3 54.0 0.8 26.8 35.1 56.8 2.4 15.9 0.9 14.6 28.6 19.3 4.3 1.2 31.0 29.8 38.3 50.0 22.7 0.2 3.1 40.5 28.5 3.7 0.2 28.2 35.6 4.3 48.0 0.3 28.8 39.3 35.2 36.3 12.2 5.9 33.2 9.4 0.6 16.4 18.6 26.2 31.0 31.8 4.1 0.3 2.0 40.4 0.2 22.7 1.2 0.3 0.5 2.9 0.1 6.0 2.7 6.3 5.3 0.1 1.5 9.7 5.7 1.5 1.6 0.1 0.3 1.6 3.1 59.1 49.6 35.1 87.5 64.8 39.9 36.1 44.6 33.6 15.9 PGLYRP2 "PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like" ENSG00000161031 "Peptidoglycan recognition protein 2" Q96PD5 19 15468645-15498956 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 95.8" "Group enriched" "Detected in some" 6 "MCF7: 10.6;T-47d: 10.7" "Cancer enriched" "Detected in some" 16 "liver cancer: 42.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033468, HPA046311, HPA075237" Supported Approved "Cell Junctions" "Secreted to blood" 160000000000 "Cell Junctions" "CAB033468: AB_1127187, HPA046311: , HPA075237: " "unprognostic (7.39e-3)" "unprognostic (1.52e-2)" "unprognostic (5.22e-2)" "unprognostic (8.79e-2)" "unprognostic (3.97e-1)" "unprognostic (4.88e-4)" "unprognostic (5.93e-3)" "unprognostic (6.48e-2)" "unprognostic (1.99e-1)" "unprognostic (1.18e-2)" "unprognostic (3.15e-2)" "unprognostic (2.40e-1)" "unprognostic (6.66e-16)" "unprognostic (6.35e-3)" "unprognostic (2.80e-1)" "unprognostic (2.45e-2)" "unprognostic (2.81e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 3.6 7.1 0.6 3.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.6 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 3.6 0.7 0.3 2.6 2.4 2.5 0.3 1.6 1.3 0.2 0.0 3.6 3.7 2.5 0.6 7.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PGRMC1 HPR6.6 ENSG00000101856 "Progesterone receptor membrane component 1" O00264 X 119236245-119244466 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 163.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002877, HPA064724" Enhanced Enhanced "Nucleoli,Endoplasmic reticulum" 6000000 "Endoplasmic reticulum" Nucleoli "HPA002877: AB_1079602, HPA064724: " "unprognostic (6.97e-2)" "unprognostic (1.99e-1)" "unprognostic (1.72e-1)" "unprognostic (4.35e-1)" "unprognostic (6.51e-2)" "prognostic unfavourable (3.02e-4)" "unprognostic (1.58e-3)" "unprognostic (9.28e-2)" "unprognostic (4.66e-2)" "unprognostic (6.20e-2)" "unprognostic (3.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-3)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 25.0 46.0 37.7 11.9 36.9 5.6 60.2 21.8 37.8 36.2 30.5 30.9 42.9 27.0 39.9 71.4 15.0 38.9 20.1 10.0 38.6 50.4 58.7 163.9 15.6 8.8 38.1 29.6 24.7 10.9 23.8 15.5 12.3 35.3 33.5 22.5 22.1 17.5 53.7 5.7 12.5 42.9 22.0 46.9 10.0 18.9 14.2 27.1 6.9 24.7 12.2 7.7 21.3 17.3 3.6 9.9 11.4 11.8 4.8 8.0 28.7 26.8 17.0 33.4 38.4 72.2 34.7 21.7 40.6 47.3 21.6 26.9 20.5 33.0 7.7 44.5 42.1 21.5 36.4 17.0 29.1 8.2 41.8 8.7 16.3 23.0 12.0 14.3 4.7 35.7 9.6 26.2 13.6 13.9 9.2 4.8 25.3 28.7 10.7 10.5 87.5 28.7 12.8 20.9 11.2 28.5 20.5 31.2 13.9 29.7 49.4 15.9 11.4 9.2 10.7 15.1 22.2 53.2 38.2 5.1 9.3 8.4 41.1 22.8 28.6 9.2 11.8 11.4 5.5 11.3 7.3 3.6 7.5 8.0 9.9 3.1 7.7 6.3 5.7 4.8 10.0 7.1 7.6 28.7 37.7 36.9 21.8 37.2 38.6 50.4 38.1 29.6 35.3 27.1 PGRMC2 "DG6, PMBP" ENSG00000164040 "Progesterone receptor membrane component 2" O15173 4 128269237-128288829 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041172, HPA058652" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" 64000 "Nuclear bodies, Plasma membrane, Cytosol" "HPA041172: AB_2677345, HPA058652: AB_2683786" "unprognostic (6.16e-2)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "prognostic favourable (3.62e-4)" "unprognostic (6.03e-2)" "unprognostic (6.57e-3)" "unprognostic (2.53e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (8.24e-2)" "unprognostic (9.04e-2)" "unprognostic (3.80e-2)" "prognostic favourable (9.60e-4)" "unprognostic (3.12e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-2)" "unprognostic (6.03e-2)" 47.9 29.5 18.3 13.3 20.4 12.8 38.3 17.7 19.3 27.3 46.6 14.8 42.5 46.8 26.1 20.2 32.8 21.1 31.2 27.2 18.4 18.4 36.5 64.7 22.4 13.6 17.4 18.5 24.1 41.6 25.6 34.4 95.6 18.0 29.4 24.8 22.0 29.8 33.4 17.9 46.0 69.1 29.5 16.3 16.7 35.1 19.3 19.2 15.3 33.1 15.7 16.2 35.1 33.8 3.2 6.0 4.7 2.5 2.6 4.8 1.4 23.5 8.7 16.0 12.9 69.6 36.7 16.1 32.3 36.1 24.0 32.1 9.0 24.3 16.6 37.9 41.5 13.7 14.6 16.0 30.2 9.5 8.4 11.1 22.9 17.0 88.1 16.1 8.3 28.8 32.4 20.1 24.9 21.5 18.5 21.0 34.4 7.3 14.8 7.5 12.6 7.8 11.9 12.8 11.4 35.4 8.3 12.7 12.0 18.1 20.5 18.3 15.8 7.3 39.8 20.3 16.6 20.7 14.9 24.3 19.7 17.8 22.2 14.4 13.8 4.7 2.5 4.6 3.9 2.1 1.9 3.2 4.8 3.9 1.4 2.7 4.4 4.0 2.2 2.6 1.8 6.0 4.7 1.4 18.3 20.4 17.7 19.3 18.4 18.4 17.4 18.5 18.0 19.2 PHKG1 PHKG ENSG00000164776 "Phosphorylase kinase catalytic subunit gamma 1" Q16816 7 56080283-56092996 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 105.6;tongue: 32.9" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in many" 18 "glioma: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012057 Enhanced "HPA012057: AB_1855305" "unprognostic (2.00e-3)" "unprognostic (1.09e-1)" "unprognostic (7.09e-3)" "unprognostic (5.87e-3)" "unprognostic (2.19e-1)" "unprognostic (1.54e-2)" "unprognostic (1.31e-1)" "unprognostic (6.69e-3)" "unprognostic (2.10e-1)" "unprognostic (1.99e-1)" "unprognostic (9.14e-4)" "unprognostic (1.92e-1)" "unprognostic (7.97e-9)" "unprognostic (6.61e-3)" "unprognostic (2.34e-1)" "unprognostic (1.12e-2)" "unprognostic (3.85e-2)" 2.0 1.5 4.9 0.8 6.1 1.1 1.5 6.0 5.8 0.7 2.6 6.5 0.0 1.0 0.9 1.5 3.2 0.9 1.1 11.8 4.1 2.9 0.6 0.7 0.9 0.8 3.5 3.9 1.0 0.8 1.2 0.6 0.6 6.8 1.4 0.8 0.0 1.6 0.8 105.6 1.6 0.9 1.1 3.6 0.8 0.8 0.7 4.8 0.0 0.6 32.9 1.2 1.8 0.3 1.3 0.6 3.3 0.7 0.3 1.9 0.2 2.9 2.1 0.5 1.7 3.1 5.3 1.4 0.3 0.6 1.0 0.8 0.7 1.3 0.8 0.5 1.0 1.5 1.2 0.2 0.8 0.8 2.1 0.8 2.9 0.7 0.8 1.5 3.2 3.3 2.2 1.6 0.7 0.3 2.2 3.9 0.1 1.3 2.2 5.5 1.0 1.3 1.2 0.3 1.0 0.6 1.9 1.5 1.6 0.3 2.1 0.1 1.1 1.9 0.8 0.5 1.7 4.4 1.1 1.8 0.7 2.2 1.2 1.4 1.0 0.4 0.5 0.0 0.8 0.2 1.9 0.3 1.2 0.3 0.2 1.3 0.6 0.6 3.3 0.3 0.7 0.6 0.5 0.2 4.9 6.1 6.0 5.8 4.1 2.9 3.5 3.9 6.8 4.8 PHKG2 ENSG00000156873 "Phosphorylase kinase catalytic subunit gamma 2" P15735 16 30748270-30761176 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 44.5;testis: 95.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065618, HPA068751" Supported Cytosol Cytosol "HPA065618: AB_2685520, HPA068751: AB_2686025" "unprognostic (7.63e-3)" "prognostic favourable (7.90e-4)" "prognostic unfavourable (9.92e-4)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (5.81e-2)" "unprognostic (3.72e-2)" "prognostic favourable (1.90e-4)" "unprognostic (6.45e-2)" "unprognostic (1.25e-2)" "prognostic favourable (8.02e-4)" "unprognostic (6.15e-2)" "unprognostic (5.27e-2)" "unprognostic (1.36e-2)" "unprognostic (2.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" 4.3 8.3 8.7 6.9 8.0 15.9 5.8 9.1 12.0 4.7 7.9 7.3 9.0 6.8 5.6 7.8 5.3 6.8 7.2 6.4 9.0 9.3 8.2 11.0 5.8 6.8 8.6 9.2 4.7 5.1 17.3 8.5 6.3 11.8 7.7 7.6 6.4 7.0 9.9 6.4 8.4 7.3 6.3 5.8 6.9 7.2 95.4 7.3 5.5 8.6 5.5 7.7 5.2 4.7 8.8 21.2 44.5 22.7 23.5 16.8 17.6 13.5 8.9 7.5 9.2 7.1 5.7 16.9 9.5 14.3 13.0 14.9 7.7 6.8 11.7 11.3 9.8 13.0 7.8 12.1 10.5 6.3 21.7 6.4 14.8 21.6 10.9 9.9 9.2 7.7 6.6 12.5 5.9 13.2 8.7 6.8 9.4 31.2 11.7 14.6 10.3 10.4 15.8 11.7 15.6 14.9 15.3 10.1 7.0 7.7 21.5 9.1 16.9 8.6 7.8 8.0 8.9 10.0 8.7 13.8 7.5 8.0 15.9 19.4 6.5 14.0 22.7 44.5 16.2 22.4 13.3 8.8 11.6 16.4 21.2 8.5 10.4 12.1 18.2 23.5 15.9 18.2 16.8 17.6 8.7 8.0 9.1 12.0 9.0 9.3 8.6 9.2 11.8 7.3 PHTF1 PHTF ENSG00000116793 "Putative homeodomain transcription factor 1" Q9UMS5 1 113696831-113759489 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059486 Approved "Nucleoli,Nuclear bodies" "Nuclear bodies" Nucleoli "HPA059486: " "unprognostic (1.52e-1)" "unprognostic (3.33e-1)" "unprognostic (2.58e-2)" "unprognostic (4.54e-2)" "unprognostic (5.92e-2)" "unprognostic (1.62e-2)" "unprognostic (6.55e-2)" "unprognostic (1.30e-1)" "unprognostic (3.30e-3)" "unprognostic (1.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (1.21e-6)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" 6.5 10.4 11.5 7.9 8.6 19.5 11.8 31.6 15.1 7.1 5.4 4.0 7.6 4.5 6.6 9.6 3.4 13.1 8.8 8.2 10.1 12.4 8.9 10.1 10.8 11.9 8.2 12.9 4.0 8.2 15.3 20.9 8.5 10.4 5.8 6.5 8.2 5.2 6.9 5.5 2.4 4.9 8.4 6.4 10.5 8.0 33.8 6.6 3.4 6.1 2.4 7.7 8.1 6.3 3.0 4.5 6.0 2.6 4.3 5.7 1.7 12.7 6.7 19.1 10.1 9.5 8.6 5.0 11.8 15.7 10.6 17.4 7.3 10.4 3.7 16.8 8.1 7.1 7.2 4.7 12.2 15.2 7.2 8.9 14.1 8.4 7.9 10.9 12.6 7.2 1.3 14.1 3.1 19.5 5.3 17.0 12.8 19.0 0.1 11.0 15.1 10.9 11.5 28.7 7.3 17.0 5.6 13.4 12.4 13.2 6.5 7.0 2.6 8.8 20.5 8.3 11.5 15.3 11.4 23.8 24.2 6.9 20.5 9.5 22.6 3.0 2.6 4.9 3.0 1.3 2.3 3.0 3.7 3.7 4.5 1.6 0.1 2.6 6.0 4.3 1.7 3.0 5.7 1.7 11.5 8.6 31.6 15.1 10.1 12.4 8.2 12.9 10.4 6.6 PI16 "CD364, dJ90K10.5, MGC45378, MSMBBP" ENSG00000164530 "Peptidase inhibitor 16" Q6UXB8 6 36948263-36964837 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 87.2" "Group enriched" "Detected in some" 4 "Daudi: 9.0;fHDF/TERT166: 8.3" "Cancer enhanced" "Detected in many" "glioma: 15.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 29.9" "Lineage enriched" "Detected in many" 5 "T-cells: 29.9" "Low region specificity" "Detected in some" "Region enhanced" "Detected in single" "midbrain: 6.0" HPA076574 Approved "Secreted to blood" 3600000000 "HPA076574: " "unprognostic (6.24e-3)" "unprognostic (6.00e-3)" "unprognostic (7.34e-2)" "unprognostic (9.53e-2)" "unprognostic (3.38e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-2)" "unprognostic (5.06e-2)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (3.25e-2)" "unprognostic (4.46e-2)" "unprognostic (1.59e-3)" "unprognostic (5.82e-2)" "unprognostic (2.31e-1)" "unprognostic (1.28e-1)" "unprognostic (8.76e-2)" 22.2 1.7 2.9 1.4 8.8 0.3 27.9 0.7 4.5 62.7 4.5 21.4 22.5 0.8 11.1 27.0 10.5 5.3 17.4 43.1 4.6 3.5 0.8 0.5 3.7 1.1 9.0 3.9 2.8 2.5 0.6 3.3 1.2 9.3 15.0 3.4 87.2 4.0 14.2 5.5 19.8 2.0 55.5 13.7 0.8 8.5 8.3 9.3 0.1 8.3 8.7 4.8 32.7 49.8 0.7 0.2 0.2 0.0 5.7 29.9 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 9.0 0.5 8.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.3 9.8 2.9 0.0 0.7 3.4 1.0 0.2 5.7 0.0 0.2 29.9 1.7 2.9 8.8 0.7 4.5 4.6 3.5 9.0 3.9 9.3 9.3 PIANP "C12orf53, DKFZp547D2210, PANP" ENSG00000139200 "PILR alpha associated neural protein" Q8IYJ0 12 6693792-6700800 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.0;HAP1: 8.0;NTERA-2: 16.9;SH-SY5Y: 15.9;U-2 OS: 8.9" "Cancer enhanced" "Detected in many" "glioma: 14.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 7 "T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010631 Enhanced Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA010631: AB_10603680" "unprognostic (1.82e-1)" "unprognostic (9.21e-3)" "unprognostic (1.62e-2)" "unprognostic (7.65e-2)" "unprognostic (1.34e-1)" "unprognostic (3.03e-2)" "unprognostic (6.58e-2)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (6.41e-3)" "unprognostic (1.92e-2)" "unprognostic (3.89e-1)" "unprognostic (3.30e-3)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" 1.5 8.3 28.0 2.2 55.7 1.2 1.5 27.4 52.8 7.2 2.7 2.6 0.5 1.9 11.6 4.1 1.8 2.2 3.3 1.5 19.5 26.2 1.5 1.1 1.5 2.4 11.0 20.9 1.8 1.7 1.2 4.0 1.5 9.0 3.4 2.0 1.7 2.2 8.7 1.3 1.7 2.2 8.1 4.6 1.6 2.1 4.4 8.3 0.0 1.4 0.0 1.7 1.8 2.5 0.3 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.4 6.0 1.2 0.2 0.3 0.2 1.6 8.0 4.2 3.8 0.1 0.2 0.1 0.0 2.8 0.2 8.0 0.2 2.0 0.2 1.0 0.3 0.2 0.0 0.2 0.3 0.3 1.0 0.0 1.7 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 16.9 0.0 1.1 0.0 0.1 0.1 0.1 2.2 15.9 0.0 0.1 0.0 0.0 0.0 0.0 4.3 8.9 4.5 1.1 0.2 0.0 0.3 5.9 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.7 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 55.7 27.4 27.8 19.5 26.2 11.0 20.9 9.0 8.3 PIAS2 "ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4" ENSG00000078043 "Protein inhibitor of activated STAT 2" O75928 18 46803224-46920160 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068792 Enhanced Supported Nucleoplasm Nucleoplasm "HPA068792: " "unprognostic (9.59e-3)" "unprognostic (2.14e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-2)" "unprognostic (1.25e-1)" "unprognostic (6.39e-2)" "unprognostic (1.05e-3)" "unprognostic (3.67e-2)" "unprognostic (1.05e-1)" "unprognostic (3.71e-3)" "unprognostic (1.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.58e-1)" "unprognostic (6.92e-2)" "prognostic unfavourable (1.27e-4)" "unprognostic (1.71e-1)" 5.6 6.7 9.8 4.7 12.7 7.0 6.1 16.7 13.5 4.7 5.6 8.1 8.0 3.7 6.0 8.8 4.7 5.3 5.5 7.5 8.4 8.1 7.4 6.6 4.9 6.5 7.9 8.5 5.8 5.0 19.3 10.4 4.8 12.1 7.7 8.1 8.2 5.9 7.9 15.6 8.5 4.8 5.7 7.6 6.5 5.3 61.6 9.1 7.5 9.2 4.1 5.8 5.3 4.6 6.8 5.1 2.9 4.4 4.8 6.7 2.1 11.8 4.9 5.6 7.9 5.6 7.0 2.6 6.3 5.0 5.5 5.1 5.7 4.5 12.0 3.5 4.7 4.0 11.1 6.6 7.8 5.9 4.1 7.4 4.7 6.7 5.5 12.3 5.3 7.2 4.1 4.8 5.1 4.9 5.4 3.1 10.8 6.4 7.2 7.2 6.0 3.1 13.1 11.9 0.1 5.0 9.2 10.6 8.2 5.7 3.7 4.1 5.5 5.5 6.2 11.8 5.1 4.0 4.6 9.3 4.6 15.3 8.8 13.3 11.5 1.5 4.4 2.8 5.4 3.4 3.8 4.1 4.8 6.1 5.0 6.8 6.7 5.7 2.9 4.8 3.0 5.1 4.2 2.1 9.8 12.7 16.7 13.5 8.4 8.1 7.9 8.5 12.1 9.1 PIEZO1 "FAM38A, KIAA0233" ENSG00000103335 "Piezo type mechanosensitive ion channel component 1" Q92508 16 88715338-88785220 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047185 Uncertain "HPA047185: " "unprognostic (1.76e-1)" "prognostic unfavourable (2.37e-4)" "unprognostic (1.77e-1)" "unprognostic (1.12e-2)" "unprognostic (4.08e-2)" "unprognostic (2.34e-2)" "unprognostic (2.64e-2)" "prognostic unfavourable (2.36e-5)" "unprognostic (4.39e-2)" "prognostic unfavourable (3.78e-4)" "unprognostic (3.51e-2)" "unprognostic (3.05e-2)" "prognostic unfavourable (8.89e-7)" "unprognostic (2.04e-1)" "unprognostic (3.59e-2)" "unprognostic (2.86e-2)" "unprognostic (3.74e-1)" 34.6 7.3 5.7 19.2 9.8 24.2 59.0 5.7 6.5 13.8 25.2 7.4 20.3 7.5 13.6 8.2 16.5 12.4 15.4 7.2 6.7 4.3 15.8 18.1 21.2 14.7 10.3 2.5 9.1 6.9 7.0 2.1 17.8 9.1 15.9 4.9 11.9 15.7 16.7 4.2 15.4 12.9 29.2 8.9 18.6 13.2 3.0 7.5 6.7 10.5 9.9 13.3 17.8 39.3 2.5 9.4 3.1 11.6 0.9 8.5 3.6 10.3 10.7 1.6 8.0 7.3 8.0 40.4 25.4 11.4 9.4 3.6 15.4 17.5 8.6 17.8 12.2 22.5 3.5 9.1 1.9 8.3 14.3 14.5 18.5 12.1 11.1 6.5 2.4 6.5 5.0 7.3 6.1 11.3 19.6 11.0 5.4 67.2 8.0 22.7 3.8 6.6 19.3 2.4 21.5 4.2 15.4 3.3 0.9 33.2 17.6 4.4 23.9 19.2 30.5 22.6 13.1 15.1 12.8 2.2 5.0 5.2 17.8 11.7 13.3 1.7 5.1 3.1 8.5 9.3 7.9 2.5 6.1 5.5 9.4 2.5 1.0 2.7 0.1 0.9 11.6 1.7 4.7 3.6 5.7 9.8 5.7 6.5 6.7 4.3 10.3 2.5 9.1 7.5 PIEZO2 "C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771" ENSG00000154864 "Piezo type mechanosensitive ion channel component 2" Q9H5I5 18 10666483-11148762 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Cell line enhanced" "Detected in some" "AF22: 9.4;BJ hTERT+ SV40 Large T+: 10.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HeLa: 23.4;U-266/70: 14.9;U-698: 9.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA015986, HPA031974, HPA031975, HPA040616" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA015986: AB_1848395, HPA031974: AB_10603675, HPA031975: , HPA040616: " "unprognostic (1.36e-1)" "unprognostic (1.92e-1)" "unprognostic (9.21e-2)" "unprognostic (2.53e-2)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.87e-2)" "unprognostic (4.34e-3)" "unprognostic (6.55e-2)" "unprognostic (3.89e-2)" "unprognostic (6.06e-2)" "unprognostic (2.23e-1)" "prognostic unfavourable (9.57e-7)" "unprognostic (1.12e-3)" "unprognostic (1.09e-1)" "unprognostic (9.04e-2)" "unprognostic (1.83e-2)" 0.9 0.3 3.1 0.9 2.3 0.0 1.9 0.1 3.6 0.9 3.3 0.0 0.3 1.6 5.8 0.8 5.9 0.0 5.2 2.1 0.9 4.5 7.4 0.5 5.8 0.6 1.7 0.0 0.6 0.0 3.4 1.3 0.0 3.3 0.0 0.8 0.9 1.9 10.3 2.7 1.4 0.9 1.3 0.2 4.6 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.1 9.4 0.0 0.0 0.0 0.0 0.5 2.7 10.5 14.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 6.7 0.0 0.3 0.0 23.4 5.5 3.3 0.0 0.0 0.0 0.1 2.7 0.7 3.2 0.0 0.2 1.6 0.0 0.1 0.0 2.9 0.0 0.0 0.0 4.1 0.0 3.2 8.1 0.0 0.1 0.0 0.5 0.0 2.7 0.0 0.0 3.8 0.2 0.5 14.9 0.1 9.7 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIGA GPI3 ENSG00000165195 "Phosphatidylinositol glycan anchor biosynthesis class A" P37287 X 15319451-15335580 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001174 Approved "HPA001174: " "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "unprognostic (5.90e-2)" "unprognostic (7.92e-2)" "unprognostic (2.05e-1)" "unprognostic (2.16e-1)" "unprognostic (2.99e-3)" "unprognostic (2.24e-2)" "unprognostic (7.37e-3)" "unprognostic (3.93e-3)" "prognostic unfavourable (7.64e-4)" "unprognostic (1.85e-3)" "unprognostic (5.97e-3)" "unprognostic (2.24e-1)" "unprognostic (3.94e-1)" "unprognostic (2.12e-2)" "unprognostic (1.18e-2)" 6.9 6.1 6.8 5.0 8.6 16.1 7.0 7.6 10.0 6.0 6.8 9.6 5.8 3.5 6.2 7.5 9.9 5.6 7.8 6.2 8.0 5.4 7.5 11.0 14.4 5.9 9.6 6.4 7.0 9.9 8.5 5.2 10.8 16.7 5.9 7.5 7.0 11.5 9.1 4.2 10.9 4.8 5.2 10.2 5.7 7.2 5.3 9.4 4.7 8.6 8.5 8.7 11.6 6.6 2.9 3.9 16.7 7.6 1.5 4.4 2.4 12.4 7.7 8.0 4.1 2.4 2.4 6.6 3.2 5.2 7.2 6.9 8.4 5.5 5.8 2.7 2.6 4.9 13.3 10.8 11.8 5.2 9.1 5.0 9.5 4.9 4.1 7.1 2.6 3.4 7.3 9.3 14.8 4.5 5.4 6.3 4.3 7.8 7.9 2.6 4.2 8.6 2.8 11.5 9.2 5.1 8.4 5.6 8.6 6.5 5.9 12.6 6.0 6.2 3.8 5.4 2.2 11.9 6.5 4.8 6.1 9.0 8.3 5.0 6.8 16.7 3.6 3.9 2.7 6.0 3.8 2.9 4.4 2.7 3.9 2.2 4.0 3.1 5.2 1.5 7.6 2.5 3.8 2.4 6.8 8.6 7.6 10.0 8.0 5.4 9.6 6.4 16.7 9.4 PIGF ENSG00000151665 "Phosphatidylinositol glycan anchor biosynthesis class F" Q07326 2 46580937-46617119 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051389 Uncertain "HPA051389: " "unprognostic (3.85e-3)" "unprognostic (5.42e-2)" "unprognostic (1.11e-3)" "unprognostic (8.18e-2)" "unprognostic (2.56e-1)" "unprognostic (4.52e-3)" "prognostic unfavourable (1.39e-5)" "unprognostic (4.97e-2)" "unprognostic (9.29e-3)" "unprognostic (6.08e-2)" "unprognostic (5.89e-2)" "unprognostic (9.40e-2)" "unprognostic (1.02e-1)" "unprognostic (7.30e-3)" "unprognostic (1.84e-1)" "unprognostic (6.04e-2)" "unprognostic (6.71e-2)" 14.4 30.9 18.5 13.9 19.3 6.9 17.7 13.6 17.9 14.0 17.3 19.0 19.6 16.3 20.1 29.4 17.1 15.3 14.8 12.4 16.6 19.4 20.8 15.9 13.6 11.8 20.6 12.8 13.2 21.0 17.7 37.8 15.5 21.5 14.9 19.8 14.9 28.6 13.4 16.4 11.4 16.5 8.3 25.4 15.2 14.9 25.0 23.0 11.0 25.8 15.3 14.7 18.4 13.5 13.6 17.8 9.2 15.9 9.5 13.2 6.0 14.1 8.2 18.0 9.3 23.0 24.8 11.0 15.5 10.8 7.3 7.5 4.1 10.5 7.2 31.5 11.3 11.4 16.8 12.8 14.8 24.0 17.7 16.6 6.4 22.3 13.2 10.1 11.9 17.0 19.3 11.1 16.3 19.8 14.7 19.9 27.0 3.6 7.9 9.6 14.2 13.6 8.0 15.0 17.7 21.2 14.1 12.3 14.1 7.4 10.7 18.7 5.9 11.2 11.9 9.1 10.5 13.7 15.7 9.5 12.6 12.5 9.4 18.9 19.9 3.0 12.3 9.2 9.8 15.9 10.1 11.1 11.3 9.3 12.9 13.6 8.8 11.1 5.3 9.5 15.0 17.8 13.2 6.0 18.5 19.3 13.6 17.9 16.6 19.4 20.6 12.8 21.5 23.0 PIGH GPI-H ENSG00000100564 "Phosphatidylinositol glycan anchor biosynthesis class H" Q14442 14 67581955-67600287 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Autism spectrum disorder, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031624 Approved "HPA031624: AB_10601046" "unprognostic (1.59e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (5.80e-2)" "unprognostic (3.47e-2)" "unprognostic (8.25e-3)" "unprognostic (8.69e-3)" "unprognostic (3.26e-3)" "unprognostic (1.19e-1)" "unprognostic (2.73e-1)" "unprognostic (6.17e-3)" "unprognostic (1.39e-1)" "prognostic favourable (2.68e-7)" "unprognostic (7.42e-2)" "unprognostic (1.42e-2)" "unprognostic (7.00e-2)" "unprognostic (3.73e-1)" 9.7 22.7 15.1 8.8 15.9 18.6 18.5 21.5 18.8 21.8 10.1 11.9 11.5 10.3 10.6 30.6 10.2 9.2 15.6 12.5 14.0 17.2 28.0 18.3 9.1 11.0 19.5 11.3 16.7 21.4 56.0 9.4 17.9 17.8 24.1 9.8 21.0 19.9 17.2 19.5 12.7 12.7 13.1 19.2 11.1 12.2 23.6 14.5 13.5 31.5 7.4 10.5 10.8 10.7 31.8 14.4 24.4 20.4 23.5 29.9 16.8 13.9 9.2 8.8 18.3 19.7 7.6 7.5 7.7 9.5 10.9 10.7 14.7 4.9 9.7 7.8 5.3 10.3 15.5 11.1 12.2 14.4 20.6 10.0 7.8 15.0 15.6 7.4 12.2 11.0 14.3 8.3 12.7 6.9 22.5 6.9 7.9 12.2 10.7 12.2 1.6 24.9 3.6 8.9 5.7 11.6 11.7 11.1 13.3 5.9 11.4 18.9 13.1 7.4 3.5 11.1 14.0 14.3 9.2 13.2 8.5 6.6 8.6 15.7 15.2 17.9 12.6 24.4 23.1 16.6 29.9 29.6 24.4 21.5 12.3 31.8 25.7 24.0 6.0 23.5 20.4 14.4 22.3 16.8 15.1 15.9 21.5 18.8 14.0 17.2 19.5 11.3 17.8 14.5 PIGK "GPI8, hGPI8" ENSG00000142892 "Phosphatidylinositol glycan anchor biosynthesis class K" Q92643 1 77088990-77219430 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056383, HPA057040" Uncertain "Intracellular and membrane" "HPA056383: , HPA057040: " "unprognostic (2.43e-2)" "unprognostic (2.60e-1)" "unprognostic (4.07e-2)" "unprognostic (2.24e-2)" "unprognostic (3.65e-1)" "unprognostic (1.15e-1)" "prognostic unfavourable (4.68e-4)" "unprognostic (1.07e-1)" "unprognostic (5.19e-1)" "unprognostic (1.12e-1)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (1.76e-2)" "unprognostic (3.37e-1)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "unprognostic (8.12e-3)" 14.5 17.4 13.8 8.0 20.4 10.2 17.1 14.8 22.9 14.2 11.4 17.4 9.6 9.2 14.6 13.8 10.7 13.0 13.6 20.0 15.4 17.7 25.4 19.0 12.3 10.6 17.7 11.7 13.7 14.1 24.9 23.1 11.2 23.8 15.9 12.9 11.2 11.9 12.9 11.9 7.6 11.6 14.5 19.9 14.7 11.6 9.6 17.2 14.6 22.3 8.1 9.8 12.9 9.4 5.2 7.6 7.6 4.4 8.9 12.8 6.3 5.6 6.6 5.5 7.0 31.9 24.0 9.0 11.5 15.9 12.1 17.4 5.5 5.8 5.0 11.9 20.3 5.1 7.0 9.8 22.1 10.2 7.2 6.7 7.2 5.1 7.1 14.9 6.0 14.4 5.3 12.9 11.2 17.8 8.2 17.1 18.6 3.8 4.7 6.0 4.9 11.1 5.5 16.3 6.3 15.4 4.1 4.7 4.4 10.9 10.0 12.5 4.8 8.5 10.1 19.6 7.7 10.5 11.7 7.8 10.8 5.0 14.5 18.9 7.7 6.9 4.1 7.6 8.3 4.4 8.4 5.2 8.5 7.0 7.6 4.1 10.7 9.5 2.0 8.9 4.2 5.2 12.8 6.3 13.8 20.4 14.8 22.9 15.4 17.7 17.7 11.7 23.8 17.2 PIGN "MDC4, PIG-N" ENSG00000197563 "Phosphatidylinositol glycan anchor biosynthesis class N" O95427 18 61905255-62187118 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039922, HPA040374" Approved Enhanced "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039922: AB_10805597, HPA040374: AB_10794738" "unprognostic (1.93e-2)" "unprognostic (1.71e-1)" "prognostic favourable (6.51e-4)" "unprognostic (1.03e-1)" "unprognostic (9.99e-2)" "unprognostic (3.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.99e-1)" "unprognostic (1.64e-2)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.81e-1)" "unprognostic (1.78e-1)" "unprognostic (6.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.75e-2)" "unprognostic (2.71e-1)" 12.6 14.1 8.3 10.2 13.2 13.7 13.5 10.5 12.4 15.1 13.2 16.6 12.2 12.0 18.3 12.7 33.2 9.2 11.0 12.8 9.6 7.8 11.2 15.9 9.0 9.5 10.4 8.8 12.9 16.6 19.7 27.2 17.1 11.9 15.2 15.7 14.7 20.3 13.7 15.2 19.0 12.7 9.6 15.4 9.3 17.4 16.2 12.2 18.6 15.3 12.7 18.6 16.8 18.1 13.1 13.4 14.8 10.0 16.3 11.5 4.5 16.8 10.1 10.1 12.8 12.6 17.1 13.5 16.8 13.2 11.0 13.2 13.1 17.2 18.7 24.6 12.7 23.3 13.5 14.2 17.5 15.5 9.1 11.4 15.6 10.2 9.0 23.3 13.3 10.0 9.5 11.1 13.0 13.9 13.4 28.0 12.1 15.3 11.6 7.1 17.1 9.4 12.5 18.8 18.1 13.6 26.0 11.5 11.8 22.4 15.9 7.1 25.2 14.9 15.7 22.4 16.4 8.8 12.5 29.7 27.6 9.3 12.3 13.3 21.8 11.4 10.0 7.6 9.6 8.5 9.9 10.3 9.7 9.2 10.8 13.1 11.2 11.5 14.8 16.3 9.0 13.4 7.8 4.5 8.3 13.2 10.5 12.4 9.6 7.8 10.4 8.8 11.9 12.2 PIGP "DCRC, DSCR5, DSRC" ENSG00000185808 "Phosphatidylinositol glycan anchor biosynthesis class P" P57054 21 37059170-37073170 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026921 Uncertain Approved Vesicles Vesicles "HPA026921: AB_1847874" "unprognostic (4.47e-3)" "unprognostic (9.45e-2)" "unprognostic (3.03e-1)" "unprognostic (2.40e-1)" "unprognostic (2.85e-2)" "unprognostic (1.92e-2)" "unprognostic (1.92e-2)" "unprognostic (5.54e-2)" "unprognostic (1.55e-1)" "unprognostic (1.22e-2)" "unprognostic (4.21e-3)" "unprognostic (1.12e-2)" "unprognostic (1.96e-2)" "unprognostic (1.93e-1)" "unprognostic (5.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.55e-2)" 20.0 30.3 12.3 7.9 13.4 4.2 18.0 6.9 14.3 13.1 13.8 15.6 23.1 9.9 11.7 60.6 12.5 13.9 15.2 27.8 12.3 15.2 19.0 27.4 14.7 9.9 16.1 9.8 15.0 45.4 23.9 28.9 16.2 17.9 21.3 14.3 16.6 22.2 17.4 25.0 7.0 12.8 24.0 24.8 10.1 14.8 19.3 8.4 16.3 20.3 17.3 9.9 17.2 9.2 18.2 16.7 1.7 11.1 8.7 19.3 8.7 9.5 4.5 9.6 5.8 17.3 11.4 6.4 7.7 14.3 7.0 7.9 6.0 20.2 13.1 17.3 11.6 7.7 7.9 8.8 7.4 13.6 13.8 29.8 5.7 8.3 10.5 8.8 6.5 10.3 16.6 12.6 15.8 12.0 17.7 23.5 15.4 6.3 11.7 9.7 7.3 11.1 11.4 4.9 13.8 17.6 5.3 19.7 11.8 21.8 16.4 29.2 14.0 19.3 6.2 5.2 2.5 6.0 7.0 31.3 34.0 15.0 15.0 11.3 17.0 0.2 7.1 1.7 11.3 10.4 14.0 18.2 14.5 12.1 11.1 15.3 19.3 16.7 1.0 8.7 11.1 16.7 10.7 8.7 12.3 13.4 6.9 14.3 12.3 15.2 16.1 9.8 17.9 8.4 PIGQ "GPI1, hGPI1" ENSG00000007541 "Phosphatidylinositol glycan anchor biosynthesis class Q" Q9BRB3 16 566995-584136 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039105, HPA039828, HPA061414" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: " "unprognostic (1.23e-2)" "unprognostic (6.12e-3)" "unprognostic (2.81e-1)" "unprognostic (2.65e-2)" "unprognostic (1.09e-2)" "unprognostic (2.42e-1)" "unprognostic (9.58e-2)" "unprognostic (8.05e-2)" "unprognostic (2.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (8.98e-2)" "prognostic favourable (2.53e-6)" "unprognostic (2.73e-1)" "unprognostic (2.60e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" 13.9 15.7 12.8 8.7 13.9 48.4 8.4 12.8 20.6 8.4 9.7 11.4 16.7 15.4 10.9 23.3 7.2 10.0 13.6 7.4 10.5 11.1 18.9 12.5 13.0 6.2 9.1 13.2 10.4 29.3 18.1 15.3 8.4 9.4 11.2 4.1 15.4 15.5 17.6 12.4 12.8 8.1 5.5 7.2 10.3 13.6 15.3 8.2 11.8 18.4 4.2 7.9 9.8 6.7 5.6 10.5 5.9 6.0 5.5 5.3 3.9 8.5 12.9 4.6 6.4 3.0 1.8 8.7 9.0 3.5 3.9 4.2 9.0 8.0 4.5 11.8 2.0 13.7 2.1 4.0 0.8 13.0 18.9 6.9 14.0 6.4 5.8 6.0 6.5 3.2 6.0 6.5 1.3 3.6 15.4 2.6 1.3 11.1 11.1 6.9 6.2 13.3 21.5 3.8 10.4 3.5 3.4 8.3 13.2 10.2 4.7 6.5 10.7 4.1 8.7 6.6 8.4 7.4 6.2 9.9 2.9 3.6 2.2 3.2 6.4 1.2 4.8 3.0 5.3 5.6 4.6 4.4 4.6 5.1 4.9 5.6 5.1 3.1 5.9 5.5 6.0 10.5 4.2 3.9 12.8 13.9 12.8 20.6 10.5 11.1 9.1 13.2 9.4 8.2 PIGR ENSG00000162896 "Polymeric immunoglobulin receptor" P01833 1 206928518-206946466 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 139.0;intestine: 320.1;salivary gland: 398.1" "Cell line enriched" "Detected in some" 5 "EFO-21: 28.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 731.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA006154, CAB009454, HPA012012" Enhanced "Intracellular and membrane" 1900000000 "CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371" "prognostic favourable (1.22e-5)" "unprognostic (7.42e-2)" "unprognostic (4.78e-3)" "prognostic favourable (2.57e-4)" "unprognostic (2.31e-2)" "unprognostic (6.71e-2)" "unprognostic (1.13e-1)" "unprognostic (3.07e-2)" "unprognostic (6.45e-2)" "unprognostic (1.19e-1)" "unprognostic (5.23e-2)" "unprognostic (2.13e-1)" "prognostic favourable (5.08e-5)" "unprognostic (1.83e-1)" "unprognostic (1.41e-1)" "unprognostic (6.92e-3)" "unprognostic (3.39e-2)" 0.3 0.3 0.3 74.2 0.3 0.0 6.9 0.3 0.3 35.1 232.8 0.6 0.4 158.9 2.6 0.5 2.6 0.7 139.0 0.3 0.3 0.3 52.5 5.0 25.1 0.3 0.3 0.3 0.6 4.2 0.0 0.9 0.4 0.3 3.0 75.6 0.4 398.1 0.6 0.4 0.4 320.1 2.0 0.3 0.4 25.3 0.6 0.3 0.4 0.4 23.9 22.5 4.9 0.6 3.4 1.1 1.4 0.5 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 28.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 1.4 0.2 0.0 0.2 0.0 4.9 0.1 1.3 0.6 2.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.4 0.2 0.3 1.0 0.0 0.1 0.0 1.4 0.5 0.3 0.4 0.2 0.5 3.4 0.3 0.3 1.1 3.4 0.5 0.5 1.4 0.5 0.3 0.9 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 PIGV FLJ20477 ENSG00000060642 "Phosphatidylinositol glycan anchor biosynthesis class V" Q9NUD9 1 26787472-26798398 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054181 Approved "Endoplasmic reticulum,Cytosol" Cytosol "Endoplasmic reticulum" "HPA054181: " "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.32e-3)" "unprognostic (1.96e-2)" "unprognostic (2.02e-2)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.61e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (8.40e-2)" "unprognostic (4.44e-2)" "prognostic favourable (7.60e-7)" "unprognostic (1.71e-1)" "unprognostic (4.24e-1)" "unprognostic (8.92e-2)" "unprognostic (5.96e-3)" 6.2 14.6 8.1 5.3 8.9 4.6 9.2 6.1 10.3 10.5 7.5 9.9 9.3 7.3 8.3 14.7 8.7 10.6 8.9 4.4 7.2 6.6 10.6 24.6 6.8 5.1 11.6 6.8 9.0 13.5 15.8 13.5 9.3 9.7 11.5 8.4 6.6 9.9 10.6 5.0 10.1 10.7 7.1 7.5 7.2 7.7 31.3 10.0 7.2 20.0 8.2 7.8 9.3 7.6 8.3 9.7 23.5 12.9 18.0 19.1 9.2 9.3 5.6 4.5 3.9 8.8 10.9 3.8 6.5 15.3 6.1 7.5 3.1 19.3 5.5 5.9 8.0 16.7 2.4 7.5 7.6 9.4 4.0 4.8 7.5 7.7 9.9 8.8 12.0 11.2 31.2 8.4 10.3 4.6 8.8 8.9 11.0 5.2 4.3 5.0 6.8 4.5 3.1 5.3 10.5 9.7 2.4 6.5 3.5 6.3 3.2 6.2 10.8 4.4 7.7 11.1 4.8 5.4 2.2 3.1 2.1 3.0 9.1 9.4 6.5 23.5 10.3 7.7 13.3 10.1 19.1 7.4 9.0 13.0 9.7 8.3 9.1 11.1 12.5 18.0 12.9 3.8 7.7 9.2 8.1 8.9 6.1 10.3 7.2 6.6 11.6 6.8 9.7 10.0 PIGX FLJ20522 ENSG00000163964 "Phosphatidylinositol glycan anchor biosynthesis class X" Q8TBF5 3 196639775-196736007 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029409 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA029409: AB_10610280" "unprognostic (8.83e-2)" "prognostic favourable (2.12e-4)" "unprognostic (2.14e-1)" "unprognostic (2.42e-3)" "unprognostic (9.25e-2)" "unprognostic (2.00e-1)" "prognostic unfavourable (7.45e-5)" "unprognostic (1.91e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.02e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.53e-1)" "unprognostic (1.46e-1)" "unprognostic (2.01e-1)" 19.1 13.7 25.1 12.7 25.5 9.3 19.2 16.9 25.8 13.1 15.5 13.1 7.8 12.3 15.2 18.5 16.6 12.6 12.7 13.9 23.2 25.4 18.1 12.5 15.6 27.0 24.8 13.4 10.9 16.0 28.1 18.2 17.7 14.5 18.6 17.1 16.3 12.9 18.5 18.6 12.3 11.8 17.1 21.7 18.4 10.6 9.0 14.2 24.6 15.5 10.6 14.7 13.6 10.7 1.7 3.2 34.5 4.4 3.6 2.1 1.5 21.9 10.0 13.1 9.2 13.9 10.6 7.5 9.9 12.0 12.2 12.7 9.7 14.3 10.8 33.3 9.9 12.1 11.2 9.4 15.1 9.8 10.4 8.9 6.9 6.5 12.9 10.0 16.7 7.9 14.8 9.8 9.3 6.6 6.1 21.7 11.1 19.9 25.8 13.0 5.9 11.3 14.0 15.5 15.6 12.6 7.4 12.7 14.1 16.7 11.5 13.6 39.8 9.4 3.4 11.7 5.1 12.8 15.2 27.4 31.5 20.4 10.6 12.3 12.0 15.5 3.0 34.5 1.5 4.4 1.3 1.7 1.4 2.1 3.2 1.7 1.6 1.4 8.6 3.6 4.4 1.4 1.7 1.5 25.1 25.5 16.9 25.8 23.2 25.4 24.8 13.4 14.5 14.2 PIGY MGC14156 ENSG00000255072 "Phosphatidylinositol glycan anchor biosynthesis class Y" Q3MUY2 4 88521573-88521789 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "blood: 38.4;intestine: 10.6" "Group enriched" "Detected in some" 6 "AF22: 8.8;hTEC/SVTERT24-B: 10.7;MOLT-4: 18.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA059018 Uncertain "HPA059018: " 1.4 2.9 0.5 1.1 1.2 1.1 1.2 1.8 1.4 2.0 10.6 1.1 2.1 1.1 1.7 1.1 1.1 1.6 0.1 0.3 1.1 1.7 1.1 1.1 1.1 1.3 1.4 1.1 1.2 1.1 1.1 1.1 1.1 1.1 3.1 1.1 1.1 1.1 2.3 1.2 1.3 1.1 1.5 1.1 1.4 1.3 24.8 38.4 21.0 26.6 24.3 33.1 35.9 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.0 16.3 26.0 21.0 27.3 26.6 28.5 24.8 27.9 27.5 38.4 19.8 30.1 29.1 4.5 24.3 21.6 14.2 33.1 35.9 PILRA FDF03 ENSG00000085514 "Paired immunoglobin like type 2 receptor alpha" Q9UKJ1 7 100367530-100400099 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "blood: 138.4" "Cell line enhanced" "Detected in some" "ASC diff: 20.5;HMC-1: 18.4;NB-4: 13.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 138.4" "Group enriched" "Detected in many" 5 "granulocytes: 138.4;monocytes: 87.3" HPA056132 Approved "Secreted to blood" "HPA056132: " "unprognostic (5.53e-2)" "prognostic favourable (2.99e-4)" "unprognostic (7.61e-2)" "unprognostic (2.88e-1)" "unprognostic (2.20e-1)" "unprognostic (5.88e-2)" "unprognostic (1.44e-1)" "unprognostic (2.85e-1)" "unprognostic (3.01e-3)" "unprognostic (9.95e-2)" "unprognostic (8.57e-2)" "unprognostic (4.56e-2)" "prognostic unfavourable (1.61e-4)" "unprognostic (3.47e-2)" "unprognostic (3.17e-2)" "unprognostic (1.99e-1)" "unprognostic (4.80e-2)" 18.6 5.4 7.2 32.3 7.2 19.4 8.2 15.6 6.2 6.1 4.5 10.6 2.3 3.8 4.8 10.0 2.6 7.5 8.4 6.5 7.7 4.4 8.5 8.0 31.9 30.1 11.0 2.6 5.7 5.1 4.3 9.2 13.2 11.9 6.6 4.9 7.1 3.1 4.1 2.5 2.6 3.9 8.6 18.4 29.5 3.1 6.4 10.7 3.3 5.3 1.1 3.3 9.8 5.4 0.1 24.0 138.4 87.3 0.5 0.2 22.9 0.2 0.2 0.4 0.5 20.5 1.4 0.1 0.1 1.0 0.1 0.3 0.0 0.3 0.4 1.2 0.2 0.6 0.1 0.1 0.0 0.9 0.7 0.4 0.8 0.1 0.2 0.8 18.4 1.4 0.3 0.1 0.4 0.2 0.2 1.2 0.1 0.6 1.4 13.8 0.4 0.2 0.4 0.0 0.3 0.8 0.4 0.5 0.2 0.0 5.1 0.4 0.1 4.2 0.4 0.9 0.9 0.5 0.2 1.8 1.3 0.4 0.2 1.6 0.3 21.3 48.4 1.4 0.2 70.2 0.1 0.1 0.0 0.0 24.0 0.0 0.0 0.1 138.4 0.5 87.3 0.4 0.1 22.9 7.2 7.2 15.6 6.2 7.7 4.4 11.0 2.6 11.9 10.7 PILRB "FDFACT1, FDFACT2" ENSG00000121716 "Paired immunoglobin-like type 2 receptor beta" Q9UKJ0 7 100352176-100367733 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.1" "Cell line enhanced" "Detected in all" "SK-BR-3: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 51.1;neutrophil: 34.8" "Group enriched" "Detected in many" 8 "granulocytes: 51.1;monocytes: 16.8" HPA026750 Approved Approved Mitochondria "Intracellular and membrane" Mitochondria "HPA026750: AB_10670828" "unprognostic (8.33e-3)" "unprognostic (9.31e-2)" "unprognostic (1.32e-2)" "unprognostic (9.15e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (3.62e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-1)" "unprognostic (8.76e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "prognostic unfavourable (1.42e-4)" "unprognostic (4.85e-3)" "unprognostic (1.66e-1)" "unprognostic (4.40e-2)" "unprognostic (3.35e-3)" 10.6 11.3 8.2 11.2 8.2 11.2 10.2 25.2 10.3 9.9 8.2 8.2 8.2 11.4 10.3 12.6 8.2 10.0 8.8 8.2 8.2 5.0 18.6 17.6 8.2 13.2 8.2 8.2 12.1 12.9 19.0 27.6 9.8 8.2 13.6 10.2 8.2 12.0 10.7 12.3 15.8 10.1 8.2 10.5 16.7 9.2 80.1 8.2 8.2 18.3 8.2 11.0 9.9 8.2 0.3 4.3 51.1 16.8 4.0 2.9 4.7 13.7 11.6 13.4 23.2 14.9 3.4 13.0 8.3 3.7 5.9 5.8 8.2 16.0 11.2 15.9 4.3 14.8 7.4 8.8 4.1 9.2 10.8 10.4 39.0 7.1 3.3 10.4 26.9 4.3 10.4 8.0 16.4 5.0 11.0 27.4 4.2 18.5 16.3 54.1 5.8 6.2 9.6 3.9 11.4 26.9 22.6 12.5 9.0 7.1 79.5 9.8 13.9 16.1 11.9 21.3 13.6 13.6 10.7 16.5 21.1 13.6 5.9 15.5 12.5 4.1 8.5 51.1 2.9 14.0 1.7 0.1 0.3 1.8 4.3 0.3 0.3 0.7 34.8 4.0 16.8 0.1 0.1 4.7 8.2 8.2 25.2 10.3 8.2 5.0 8.2 8.2 8.2 8.2 PIM2 ENSG00000102096 "Pim-2 proto-oncogene, serine/threonine kinase" Q9P1W9 X 48913182-48919024 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 63.4;lymphoid tissue: 71.2" "Group enriched" "Detected in many" 5 "HDLM-2: 58.9;Karpas-707: 73.0;RPMI-8226: 71.9;U-266/70: 133.0;U-266/84: 117.5" "Cancer enriched" "Detected in all" 6 "testis cancer: 171.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000285 Approved Cytosol Cytosol "HPA000285: AB_1079619" "unprognostic (2.34e-3)" "prognostic favourable (4.05e-5)" "unprognostic (8.04e-2)" "unprognostic (7.30e-2)" "unprognostic (6.41e-3)" "unprognostic (2.74e-3)" "unprognostic (2.84e-1)" "unprognostic (5.23e-2)" "unprognostic (2.47e-2)" "unprognostic (4.01e-2)" "unprognostic (1.33e-3)" "unprognostic (2.73e-1)" "prognostic unfavourable (1.17e-11)" "unprognostic (3.36e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-1)" "unprognostic (4.38e-2)" 3.6 3.4 4.3 37.2 7.2 30.4 3.4 7.1 7.9 4.5 13.4 2.1 2.2 29.5 2.8 4.3 10.0 5.6 8.3 3.1 5.6 6.7 5.2 5.4 10.6 59.7 3.8 4.6 5.4 3.0 1.0 4.9 2.4 6.7 3.6 17.7 6.1 16.9 4.9 1.5 3.0 19.2 2.2 3.1 71.2 14.7 5.7 1.3 39.4 4.8 3.6 47.9 24.6 3.3 26.0 2.9 46.9 3.0 17.0 63.4 13.2 1.8 1.5 0.8 1.6 0.3 0.2 1.2 1.1 1.4 1.6 1.4 1.4 1.3 7.8 0.5 0.5 1.1 2.6 1.0 1.5 58.9 2.1 9.4 1.6 1.4 0.7 2.2 6.4 0.6 0.9 1.6 1.0 0.5 10.0 73.0 0.9 1.3 0.8 4.7 17.8 2.4 1.0 0.5 71.9 1.6 0.2 0.5 0.8 1.2 0.8 0.8 2.0 3.1 0.3 0.3 0.2 0.3 1.1 133.0 117.5 15.0 1.5 2.0 0.3 46.9 1.5 14.3 12.5 1.9 21.2 26.0 34.4 17.6 2.5 15.9 36.9 23.0 38.3 17.0 3.0 2.9 63.4 13.2 4.3 7.2 7.1 7.9 5.6 6.7 3.8 4.6 6.7 1.3 PISD "dJ858B16.2, PSDC" ENSG00000241878 "Phosphatidylserine decarboxylase" Q9UG56 22 31618491-31662432 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031090, HPA031091" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA031090: AB_10600114, HPA031091: AB_10600893" "unprognostic (7.96e-2)" "unprognostic (5.41e-3)" "unprognostic (2.60e-1)" "unprognostic (8.31e-2)" "unprognostic (5.61e-2)" "unprognostic (4.55e-3)" "unprognostic (2.44e-3)" "unprognostic (8.13e-3)" "unprognostic (6.37e-3)" "unprognostic (1.23e-1)" "unprognostic (1.11e-3)" "unprognostic (1.70e-2)" "unprognostic (4.18e-3)" "unprognostic (1.91e-2)" "unprognostic (4.85e-2)" "unprognostic (3.92e-2)" "prognostic favourable (5.27e-5)" 38.3 12.3 9.5 15.1 10.9 20.9 18.5 34.5 12.3 5.9 7.3 6.2 7.4 11.4 9.6 14.4 7.0 10.0 9.5 6.9 6.4 6.9 11.9 8.4 12.9 14.6 8.3 10.1 7.5 10.9 6.0 11.7 38.1 8.6 8.2 3.3 7.7 7.9 7.9 6.4 10.2 8.0 6.2 5.8 16.5 9.7 17.8 7.7 4.2 10.6 5.3 9.8 6.2 7.0 6.9 11.0 28.6 12.9 5.7 6.8 7.9 10.4 9.6 2.9 2.9 8.9 3.4 6.7 8.5 6.8 6.0 6.5 13.9 3.3 6.3 9.1 4.3 11.8 3.9 7.6 1.0 6.9 8.4 6.6 5.9 11.4 18.5 13.7 17.3 6.4 4.3 10.7 4.6 5.3 19.0 3.7 3.4 39.0 5.9 5.9 2.8 4.0 8.4 3.2 6.3 3.8 9.2 7.2 4.2 4.9 16.0 5.5 13.2 7.5 10.3 7.6 9.0 4.8 7.9 4.5 6.2 7.8 7.2 9.2 6.0 9.9 12.9 9.3 6.8 9.5 6.5 6.9 4.9 5.7 11.0 6.3 6.7 5.5 28.6 5.7 5.0 5.4 4.7 7.9 9.5 10.9 34.5 12.3 6.4 6.9 8.3 10.1 8.6 7.7 PJVK DFNB59 ENSG00000204311 Pejvakin Q0ZLH3 2 178451346-178461409 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 6.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042621 Supported Mitochondria Mitochondria "HPA042621: AB_10797503" "unprognostic (4.01e-2)" "unprognostic (4.28e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-1)" "unprognostic (7.21e-3)" "unprognostic (9.36e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-1)" "unprognostic (8.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.90e-3)" "unprognostic (9.13e-2)" "prognostic unfavourable (8.92e-4)" "unprognostic (1.22e-1)" "unprognostic (1.47e-1)" "unprognostic (2.41e-2)" "unprognostic (8.06e-3)" 2.2 1.4 2.5 1.0 3.5 0.7 4.4 1.3 3.7 2.1 1.5 1.2 3.5 0.7 3.5 7.2 2.2 2.6 2.6 1.0 2.7 2.2 2.1 2.2 1.0 1.3 2.8 4.4 7.0 1.0 1.4 3.9 1.0 2.0 2.3 0.9 2.4 2.1 2.7 2.7 3.5 1.3 1.7 2.7 1.0 0.9 35.2 1.3 1.0 2.3 1.7 1.2 1.6 1.2 1.5 6.5 0.6 0.3 0.4 1.3 0.1 0.4 3.1 4.0 3.2 5.4 5.9 2.1 2.5 2.5 2.3 3.5 1.2 5.2 3.6 2.6 1.5 1.5 2.9 1.6 1.5 1.1 1.1 1.1 4.3 0.7 5.2 0.9 0.3 5.5 3.9 2.6 5.6 2.6 0.6 2.2 2.6 0.5 3.4 2.2 4.8 1.3 4.4 3.0 2.1 3.6 1.6 2.8 2.4 1.2 0.6 1.0 1.2 1.0 1.7 2.6 1.0 0.8 0.3 7.3 4.5 1.1 1.2 2.0 1.0 0.0 0.3 0.0 0.3 0.2 0.4 0.8 0.4 0.2 0.1 1.5 1.3 0.7 0.6 0.4 0.0 6.5 0.0 0.1 2.5 3.5 1.3 3.7 2.7 2.2 2.8 4.4 2.0 1.3 PKD1L1 PRO19563 ENSG00000158683 "Polycystin 1 like 1, transient receptor potential channel interacting" Q8TDX9 7 47774652-47948491 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" Heterotaxy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 13.4;tongue: 16.7" "Group enriched" "Detected in some" 8 "T-47d: 6.3;U-266/70: 16.7;U-266/84: 6.0" "Cancer enhanced" "Detected in single" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020422, HPA022424" Uncertain "HPA020422: AB_1855434, HPA022424: AB_1855435" "unprognostic (5.47e-2)" "unprognostic (5.33e-3)" "unprognostic (1.49e-2)" "unprognostic (9.74e-2)" "unprognostic (4.03e-2)" "unprognostic (6.31e-2)" "unprognostic (2.52e-2)" "unprognostic (1.11e-1)" "unprognostic (9.63e-3)" "unprognostic (7.96e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" "unprognostic (1.88e-4)" "unprognostic (1.88e-3)" "unprognostic (2.56e-1)" "unprognostic (2.50e-1)" "unprognostic (1.90e-1)" 5.4 0.2 1.0 2.3 1.8 0.2 1.6 1.3 1.1 1.2 0.8 0.7 0.1 2.0 2.5 1.6 0.9 0.6 1.0 7.4 0.8 1.5 0.5 1.1 13.4 1.2 0.9 0.1 0.6 0.3 0.1 1.2 2.0 1.0 0.3 0.9 10.0 2.6 0.1 6.4 0.7 0.7 1.7 1.0 0.8 0.4 3.8 0.1 0.9 1.2 16.7 1.4 2.2 1.4 0.0 0.2 0.0 0.8 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.2 0.0 0.1 0.3 6.3 0.0 0.0 0.0 0.9 0.0 0.0 16.7 6.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 1.8 1.3 1.1 0.8 1.5 0.9 0.1 1.0 0.1 PKHD1 "ARPKD, FCYT, FPC, TIGM1" ENSG00000170927 "PKHD1, fibrocystin/polyductin" P08F94 6 51615300-52087625 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 19.8;kidney: 49.4;pancreas: 32.9" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 15.4" "Group enriched" "Detected in some" 5 "pancreatic cancer: 1.4;renal cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031227 Enhanced "HPA031227: AB_10602068" "unprognostic (6.34e-3)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" "unprognostic (1.35e-1)" "unprognostic (3.80e-2)" "unprognostic (1.29e-2)" "unprognostic (4.03e-2)" "unprognostic (6.42e-2)" "unprognostic (7.08e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-2)" "unprognostic (2.62e-2)" "prognostic favourable (9.74e-8)" "unprognostic (2.33e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.48e-2)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.0 5.6 0.0 0.1 19.8 0.1 0.1 6.3 0.1 0.1 0.1 49.4 2.5 0.1 0.0 0.1 0.0 0.1 32.9 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 1.2 0.1 0.4 0.1 0.1 0.1 0.1 0.5 1.4 0.0 0.0 0.1 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 15.4 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 PKHD1L1 ENSG00000205038 "PKHD1 like 1" Q86WI1 8 109362477-109530330 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "thyroid gland: 91.7" "Cell line enhanced" "Detected in some" "HHSteC: 4.1;HUVEC TERT2: 2.3;TIME: 4.6;U-266/70: 4.3" "Group enriched" "Detected in some" 18 "endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Group enriched" "Detected in some" 9 "memory B-cell: 1.8;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 10 "B-cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044458 Uncertain 5100000 "HPA044458: " "unprognostic (9.07e-3)" "unprognostic (3.35e-2)" "unprognostic (1.37e-2)" "prognostic favourable (7.61e-4)" "unprognostic (5.57e-2)" "unprognostic (1.30e-2)" "unprognostic (2.91e-2)" "unprognostic (3.45e-2)" "unprognostic (3.31e-2)" "unprognostic (1.98e-1)" "unprognostic (9.65e-3)" "unprognostic (1.92e-1)" "unprognostic (7.76e-6)" "unprognostic (4.56e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-3)" "unprognostic (2.73e-2)" 12.4 1.5 0.1 4.2 0.1 0.4 2.6 0.0 0.2 13.8 5.7 0.1 2.1 1.1 3.5 8.9 2.5 11.5 3.5 5.2 0.1 0.1 0.8 0.8 16.9 22.5 0.4 0.0 3.5 0.7 0.2 0.4 0.2 1.1 1.4 1.6 4.2 1.7 1.5 2.0 0.9 2.0 3.2 0.2 0.3 0.8 1.6 0.0 0.0 91.7 2.9 1.1 2.1 3.2 1.8 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 4.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 1.1 0.0 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 4.4" "Lineage enriched" "Detected in single" 5 "T-cells: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: " "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavourable (8.33e-4)" "prognostic unfavourable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 0.9 0.7 0.7 9.4 0.6 19.5 1.3 2.6 0.8 1.3 2.9 0.3 0.5 1.9 0.8 1.5 7.2 0.2 1.5 1.4 0.7 0.7 0.8 1.0 1.3 6.2 0.8 0.2 0.3 1.3 0.0 0.7 4.3 0.4 0.6 0.8 0.3 1.3 0.2 1.6 3.4 3.2 0.6 1.0 4.4 2.7 61.4 0.2 42.8 0.3 9.2 12.7 0.7 2.0 0.8 0.4 0.3 0.5 0.4 4.4 1.0 24.6 17.3 6.8 9.7 0.1 0.3 18.3 19.2 4.6 12.2 11.7 13.4 14.7 15.4 8.6 2.1 31.7 4.7 6.1 2.2 19.8 15.6 7.8 15.6 11.7 0.0 8.7 22.3 0.2 0.5 7.2 1.9 2.5 22.4 27.4 3.9 37.0 24.4 24.2 11.1 9.2 26.6 15.1 29.8 2.3 5.4 12.9 13.6 9.3 24.2 7.2 13.8 17.4 2.3 16.4 20.8 23.9 20.0 20.8 15.4 26.5 6.2 11.7 19.0 0.0 0.4 0.3 0.3 0.3 0.0 0.8 0.5 0.5 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.1 4.4 1.0 0.7 0.6 2.6 0.8 0.7 0.7 0.8 0.2 0.4 0.2 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 35.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: , HPA057913: " "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favourable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 21.9 20.7 12.2 21.2 13.7 33.5 27.6 25.6 16.6 28.6 39.3 12.6 15.1 22.9 20.0 20.2 28.2 17.1 13.3 16.2 10.3 8.9 15.9 15.9 26.0 16.4 13.7 8.7 27.2 18.9 24.6 29.7 20.8 13.3 19.6 23.6 14.1 19.5 25.1 15.9 17.5 49.0 17.5 12.5 18.0 15.9 12.4 16.2 29.1 20.3 14.4 13.1 21.9 22.0 4.0 3.7 35.7 4.5 1.4 3.0 1.0 23.3 9.2 18.2 10.9 12.2 13.9 11.8 13.8 12.8 15.6 16.2 9.7 16.8 9.2 16.5 13.1 18.4 17.7 10.5 21.3 3.3 12.9 6.8 19.0 8.3 10.7 6.7 2.0 11.4 11.0 12.2 14.8 17.7 11.3 6.7 16.7 4.7 7.7 5.8 9.1 10.7 7.4 27.7 3.8 13.8 46.0 8.8 5.8 20.7 12.0 17.8 8.9 6.1 16.5 13.2 11.9 16.9 14.4 3.7 3.2 6.3 5.5 6.6 5.0 4.9 4.5 6.8 2.6 2.5 2.3 3.3 2.3 2.4 2.1 4.0 3.0 2.6 35.7 1.4 3.2 3.7 1.8 1.0 12.2 13.7 25.6 16.6 10.3 8.9 13.7 8.7 13.3 16.2 PLA2G15 "GXVPLA2, LLPL, LYPLA3" ENSG00000103066 "Phospholipase A2 group XV" Q8NCC3 16 68245304-68261062 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041702, HPA041727" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" 20000000 "Nucleoplasm, Vesicles" "HPA041702: AB_10794486, HPA041727: AB_10793931" "unprognostic (3.47e-2)" "unprognostic (9.99e-2)" "unprognostic (1.54e-3)" "unprognostic (6.84e-3)" "unprognostic (1.38e-2)" "unprognostic (1.65e-2)" "unprognostic (4.12e-3)" "unprognostic (3.16e-1)" "unprognostic (2.12e-2)" "unprognostic (1.84e-2)" "unprognostic (2.56e-1)" "unprognostic (9.29e-2)" "unprognostic (2.45e-3)" "unprognostic (2.98e-2)" "unprognostic (5.40e-3)" "unprognostic (6.28e-2)" "unprognostic (3.47e-2)" 23.8 9.1 9.6 6.6 9.4 5.6 19.7 16.4 16.1 5.4 6.2 10.0 4.7 5.0 7.7 11.2 5.7 7.2 8.5 31.3 7.9 8.6 24.1 11.8 15.9 23.1 7.5 9.2 7.4 6.4 11.3 9.2 24.4 7.7 6.2 5.7 8.5 7.6 5.8 39.9 10.0 5.3 8.2 6.8 16.2 6.2 9.3 6.2 11.3 10.4 6.8 4.9 9.1 5.0 3.7 8.8 9.4 18.2 1.3 4.5 7.7 4.7 5.0 4.0 12.7 19.2 14.1 9.3 11.8 15.7 17.8 15.0 11.7 8.8 8.6 14.8 16.7 7.3 4.3 5.0 8.2 2.4 6.5 2.5 4.9 9.3 10.3 2.3 12.7 9.6 5.7 17.8 2.8 10.8 3.6 4.6 11.4 10.2 3.2 7.0 2.5 5.8 4.7 5.8 26.6 8.9 4.4 1.3 2.6 15.7 4.7 9.7 12.3 11.5 8.8 15.5 7.6 20.1 7.3 17.2 14.6 10.4 14.2 6.6 5.9 9.4 14.4 9.3 3.1 16.8 3.2 3.3 3.4 4.5 8.8 3.7 4.5 3.7 0.6 1.3 18.2 7.8 3.2 7.7 9.6 9.4 16.4 16.1 7.9 8.6 7.5 9.2 7.7 6.2 PLA2G16 "AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754." ENSG00000176485 "Phospholipase A2 group XVI" P53816 11 63573195-63616883 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 113.6" "Cell line enhanced" "Detected in many" "A549: 32.3;ASC diff: 36.7;CAPAN-2: 59.1;HAP1: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 52.4" "Group enriched" "Detected in many" 5 "dendritic cells: 52.4;T-cells: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058997 Uncertain Uncertain Mitochondria Mitochondria "HPA058997: " "unprognostic (5.18e-2)" "unprognostic (3.67e-2)" "unprognostic (7.92e-2)" "unprognostic (3.89e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.13e-1)" "unprognostic (3.06e-2)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "prognostic unfavourable (5.58e-6)" "unprognostic (6.38e-2)" "unprognostic (1.93e-3)" "unprognostic (1.62e-1)" "unprognostic (1.75e-1)" "prognostic favourable (2.54e-5)" "unprognostic (2.35e-1)" 113.6 15.2 32.0 4.4 39.4 1.6 33.9 4.8 30.2 6.1 7.2 46.6 6.1 4.0 5.0 11.5 5.9 13.9 12.9 39.0 37.6 25.2 24.7 28.9 13.5 4.5 58.4 22.2 30.9 13.2 15.1 8.1 16.2 30.5 5.9 3.7 8.8 10.1 13.2 37.8 2.4 7.5 8.0 70.4 6.4 10.2 17.8 48.9 0.1 17.1 11.1 2.3 8.0 4.7 2.1 52.4 0.4 6.2 5.3 16.0 6.4 20.4 32.3 0.9 0.0 36.7 6.3 5.9 0.7 6.5 5.4 2.7 7.3 59.1 0.0 13.6 1.6 1.0 30.6 1.6 4.1 25.2 1.2 0.3 7.8 1.2 21.9 0.0 0.3 3.8 0.1 13.5 0.5 8.5 0.3 2.3 5.7 3.5 0.0 0.1 2.6 10.4 0.0 0.0 2.0 17.1 2.9 0.4 2.4 4.4 12.4 6.7 26.9 1.0 12.5 2.4 0.1 8.2 1.8 9.7 6.3 0.0 9.8 0.0 0.2 0.0 6.2 0.0 16.0 2.4 8.8 2.1 3.7 11.6 1.7 0.3 1.2 9.4 0.4 5.3 0.1 52.4 2.4 6.4 32.0 39.4 4.8 21.9 37.6 25.2 58.4 22.2 30.5 48.9 PLA2G6 "iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9" ENSG00000184381 "Phospholipase A2 group VI" O60733 22 38111495-38205690 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" "Calmodulin-binding, Hydrolase" "Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 31.4;HMC-1: 20.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001171 Approved Approved "Centriolar satellite,Cytosol" "Centriolar satellite, Cytosol" "HPA001171: AB_1079145" "unprognostic (5.26e-2)" "prognostic favourable (7.29e-4)" "unprognostic (8.74e-2)" "unprognostic (6.27e-2)" "unprognostic (3.83e-1)" "unprognostic (3.70e-3)" "unprognostic (8.67e-3)" "unprognostic (9.55e-2)" "unprognostic (3.48e-1)" "unprognostic (1.91e-1)" "unprognostic (2.37e-3)" "unprognostic (4.95e-2)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (3.00e-1)" "unprognostic (1.48e-1)" "prognostic favourable (1.55e-4)" 16.2 17.7 15.6 8.5 20.5 13.1 15.6 15.9 26.3 14.8 7.9 36.9 18.5 9.8 16.3 20.5 8.7 21.6 25.3 6.3 19.7 7.2 18.1 8.6 9.0 12.4 19.3 16.7 21.3 12.8 24.2 12.7 6.8 19.5 17.6 6.3 12.9 20.2 17.4 7.4 18.1 8.7 7.8 14.9 12.1 9.5 30.0 23.2 16.3 45.7 4.1 11.3 12.1 11.2 1.8 5.4 4.1 0.9 8.8 5.7 1.9 0.7 2.8 3.0 7.7 10.0 4.9 8.1 0.9 0.9 0.8 1.1 3.1 1.8 5.8 6.6 2.3 3.6 3.4 1.9 1.0 8.9 13.1 31.4 3.8 3.5 2.8 3.5 20.1 16.1 4.3 2.8 4.4 1.0 5.1 10.6 1.5 4.6 6.5 2.1 2.5 1.8 4.8 1.1 4.5 2.9 6.9 5.7 2.4 1.3 3.1 7.1 3.2 2.5 1.2 2.6 4.4 1.1 0.5 17.4 3.1 3.1 3.7 4.0 1.5 4.1 0.9 0.4 3.8 0.3 1.9 1.8 3.1 5.7 1.5 1.5 1.4 3.9 3.3 8.8 0.6 5.4 3.7 1.9 15.6 20.5 15.9 26.3 19.7 7.2 19.3 16.7 19.5 23.2 PLA2R1 "CLEC13C, PLA2-R, PLA2G1R, PLA2IR" ENSG00000153246 "Phospholipase A2 receptor 1" Q13018 2 159932006-160062610 "Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 46.1" "Cell line enhanced" "Detected in many" "ASC diff: 9.4;ASC TERT1: 12.7;BJ hTERT+: 10.1;TIME: 29.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 19.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB068217, CAB068218" Approved Approved Cytosol "Secreted to blood" 99000 Cytosol "CAB068217: , CAB068218: " "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (4.91e-3)" "unprognostic (6.01e-2)" "unprognostic (9.71e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (9.38e-3)" "unprognostic (4.30e-3)" "unprognostic (2.82e-1)" "unprognostic (2.14e-2)" "prognostic unfavourable (3.08e-4)" "unprognostic (2.62e-1)" "unprognostic (6.58e-2)" "unprognostic (2.02e-1)" 4.6 2.1 0.6 2.3 1.1 0.0 9.4 19.5 1.9 11.3 7.0 1.0 2.4 2.4 17.8 4.7 4.7 4.8 6.9 2.7 0.7 1.0 15.0 0.9 2.3 1.8 0.8 0.7 8.7 0.8 14.5 2.6 6.6 3.3 3.3 2.0 7.8 46.1 2.0 0.8 9.6 9.4 5.7 2.5 3.0 1.6 1.3 0.2 0.3 27.6 6.6 5.1 4.5 9.4 0.6 0.6 2.3 0.8 1.0 0.6 0.2 0.1 1.0 0.4 0.0 9.4 12.7 0.0 4.2 10.1 0.8 1.1 0.0 2.1 0.0 0.2 4.4 2.0 0.0 3.0 0.9 0.0 0.0 0.0 7.1 0.0 0.7 0.0 0.0 5.1 3.4 1.2 1.3 5.8 0.0 0.0 1.4 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 7.3 1.4 0.0 1.6 0.1 29.2 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.5 0.5 0.5 0.6 0.5 0.4 0.3 0.3 0.6 0.6 0.6 2.3 1.0 0.8 0.6 0.4 0.2 0.6 1.1 19.5 1.9 0.7 1.0 0.8 0.7 3.3 0.2 PLAUR "CD87, UPAR, URKR" ENSG00000011422 "Plasminogen activator, urokinase receptor" Q03405 19 43646095-43670547 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 118.0;bone marrow: 165.0" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 49.4;U-251 MG: 70.2;U-87 MG: 61.3;WM-115: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 118.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050843, CAB073533" Uncertain Supported "Plasma membrane" "Intracellular and membrane" 760000 "Plasma membrane" "CAB073533: , HPA050843: " "unprognostic (9.28e-2)" "unprognostic (9.65e-3)" "unprognostic (1.39e-1)" "unprognostic (1.29e-3)" "unprognostic (3.59e-3)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "prognostic unfavourable (2.33e-5)" "unprognostic (8.08e-3)" "unprognostic (4.30e-2)" "unprognostic (2.29e-3)" "unprognostic (5.30e-2)" "prognostic unfavourable (7.83e-9)" "unprognostic (4.99e-2)" "unprognostic (1.66e-1)" "unprognostic (5.45e-2)" "unprognostic (9.33e-2)" 25.2 3.6 3.0 23.6 4.8 165.0 6.3 2.2 6.1 10.7 7.5 4.4 1.8 3.3 9.5 6.0 8.6 10.6 23.0 11.5 4.5 3.2 5.1 6.1 39.4 8.1 6.0 1.1 11.9 4.3 2.5 4.4 12.2 6.9 6.1 6.0 4.6 11.0 3.7 7.9 3.5 7.3 7.2 7.1 12.6 12.0 6.3 6.3 2.5 4.4 7.7 7.0 22.7 14.9 0.2 21.3 118.0 50.5 0.6 0.9 21.0 14.0 4.9 4.5 0.3 4.0 14.4 2.7 29.6 30.1 18.7 23.5 0.4 16.6 0.5 7.5 18.3 6.0 1.2 7.3 20.9 0.9 0.9 2.6 7.4 0.6 5.1 3.1 34.3 14.8 1.4 49.4 7.4 20.6 2.7 0.6 17.9 1.0 3.4 8.4 1.4 10.6 3.9 3.0 1.0 5.8 0.7 0.2 3.9 13.2 3.0 3.9 0.6 9.8 21.1 41.3 21.2 18.9 70.2 0.6 1.4 0.1 61.3 5.8 59.7 7.2 48.9 72.4 0.7 41.5 0.8 0.2 0.9 0.6 21.3 0.1 0.3 0.4 118.0 0.6 50.5 6.8 0.3 21.0 3.0 4.8 2.2 6.1 4.5 3.2 6.0 1.1 6.9 6.3 PLD3 HU-K4 ENSG00000105223 "Phospholipase D family member 3" Q8IV08 19 40348456-40380439 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 149.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 149.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012800, CAB020812" Approved Supported "Endoplasmic reticulum,Cytosol" 490000 "Endoplasmic reticulum, Cytosol" "CAB020812: , HPA012800: AB_1855330" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.64e-3)" "unprognostic (2.56e-3)" "unprognostic (2.06e-3)" "unprognostic (2.68e-1)" "unprognostic (4.52e-2)" "unprognostic (3.89e-2)" "unprognostic (1.09e-1)" "unprognostic (4.60e-2)" "prognostic favourable (6.44e-4)" "unprognostic (4.34e-2)" "prognostic favourable (2.21e-4)" "unprognostic (3.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (6.42e-2)" 45.7 57.5 44.6 23.1 79.0 12.8 21.9 35.5 126.1 31.2 23.5 25.4 17.1 22.6 26.3 35.0 18.3 30.0 30.8 33.0 46.4 73.4 22.1 25.6 49.7 25.2 44.7 53.9 44.8 42.5 32.9 122.1 38.9 62.2 29.6 16.1 31.6 35.3 37.2 27.4 24.2 23.5 25.6 28.6 48.9 23.0 17.0 19.3 11.9 20.6 11.2 12.9 27.3 20.7 3.6 23.0 149.2 24.6 9.7 7.8 16.8 13.9 43.2 28.0 44.0 77.9 37.1 21.3 34.7 35.4 25.2 28.9 8.2 15.8 6.1 36.4 30.1 6.5 6.7 13.6 11.0 22.6 24.6 6.5 14.8 10.3 53.2 2.7 75.0 70.6 28.5 19.2 13.2 21.1 23.0 24.6 18.1 18.3 4.7 13.0 18.2 8.9 6.0 21.3 24.9 12.9 10.5 20.1 33.4 16.6 10.3 18.5 14.2 47.0 37.2 21.3 10.2 18.0 7.7 25.6 27.3 6.3 34.2 10.9 13.1 149.2 24.6 35.3 7.8 12.8 6.4 3.6 6.2 6.9 23.0 3.1 6.5 6.5 2.5 9.7 5.7 3.3 6.1 16.8 44.6 79.0 35.5 126.1 46.4 73.4 44.7 53.9 62.2 19.3 PLD4 C14orf175 ENSG00000166428 "Phospholipase D family member 4" Q96BZ4 14 104924816-104937790 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "blood: 229.9" "Group enriched" "Detected in some" 5 "HMC-1: 34.0;RPMI-8226: 24.4;THP-1: 61.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 229.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 229.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051512 Uncertain 2000000 "HPA051512: " "unprognostic (4.50e-3)" "unprognostic (1.78e-4)" "unprognostic (7.12e-2)" "unprognostic (5.30e-3)" "unprognostic (5.54e-2)" "unprognostic (2.91e-3)" "unprognostic (2.56e-1)" "unprognostic (4.76e-3)" "unprognostic (1.45e-3)" "unprognostic (1.19e-3)" "unprognostic (3.45e-3)" "unprognostic (3.89e-1)" "unprognostic (6.90e-3)" "unprognostic (8.94e-2)" "unprognostic (2.83e-1)" "unprognostic (1.28e-2)" "unprognostic (2.41e-1)" 0.7 1.6 8.9 6.7 8.8 15.0 1.9 5.7 10.0 1.5 1.3 23.1 0.1 5.6 1.5 0.5 1.1 2.8 3.5 0.8 8.7 8.4 1.2 0.9 2.6 14.4 14.5 3.4 0.9 1.6 1.0 2.8 1.2 9.0 2.1 0.8 1.5 4.6 2.3 0.5 0.9 5.5 0.9 19.0 11.6 3.5 0.8 9.2 2.7 1.0 0.0 11.2 3.9 0.9 14.7 229.9 43.4 17.7 1.7 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 8.6 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 2.8 43.4 0.0 11.9 0.1 14.7 0.0 0.0 35.1 12.3 0.1 0.0 0.6 1.7 17.7 229.9 0.0 4.4 8.9 8.8 5.7 9.6 8.7 8.4 14.5 3.4 9.0 9.2 PLD5 FLJ40773 ENSG00000180287 "Phospholipase D family member 5" Q8N7P1 1 242082986-242524696 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 54.8;retina: 37.7" "Cell line enhanced" "Detected in some" "A549: 3.9;AF22: 13.7;HDLM-2: 6.8;SH-SY5Y: 3.8;U-2 OS: 4.7" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Region enriched" "Detected in all" 4 "cerebellum: 54.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028389, HPA050367" Approved Vesicles,Mitochondria,Cytosol Mitochondria "Vesicles, Cytosol" "HPA028389: AB_10602145, HPA050367: " "unprognostic (5.20e-2)" "unprognostic (1.05e-1)" "unprognostic (9.14e-2)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (8.77e-2)" "unprognostic (4.36e-1)" "unprognostic (1.95e-1)" "unprognostic (2.08e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-5)" "unprognostic (2.79e-2)" "unprognostic (4.46e-1)" "unprognostic (3.44e-3)" "unprognostic (2.18e-1)" 1.1 5.4 5.0 0.4 3.7 0.4 1.6 54.8 7.6 2.2 0.8 7.7 0.0 0.4 3.5 0.9 1.6 1.8 0.8 0.8 4.4 4.6 1.5 0.5 0.8 3.3 5.4 2.5 6.6 3.1 1.4 7.2 1.5 12.7 2.7 0.6 37.7 2.2 9.3 0.8 0.6 0.5 2.9 6.0 2.2 0.8 4.2 6.2 0.0 1.0 0.0 1.5 0.4 1.0 0.4 0.2 1.0 0.2 0.3 0.4 0.0 0.0 3.9 13.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 6.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.5 2.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.4 0.3 0.4 1.0 0.3 0.2 0.2 0.2 0.0 5.0 3.7 54.8 5.5 4.4 4.6 5.4 2.5 12.7 6.2 PLD6 ENSG00000179598 "Phospholipase D family member 6" Q8N2A8 17 17200995-17206315 "Predicted membrane proteins" "Differentiation, Lipid degradation, Lipid metabolism, Meiosis, Spermatogenesis" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.1" "Cell line enhanced" "Detected in many" "HAP1: 25.4;REH: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.6;NK-cells: 5.0;T-cells: 11.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049345 Approved "HPA049345: " "unprognostic (1.71e-1)" "unprognostic (6.80e-3)" "unprognostic (3.21e-2)" "unprognostic (1.39e-1)" "unprognostic (2.95e-2)" "unprognostic (8.21e-2)" "unprognostic (1.31e-1)" "unprognostic (7.83e-2)" "unprognostic (9.01e-2)" "unprognostic (1.48e-1)" "prognostic favourable (1.05e-4)" "unprognostic (1.32e-1)" "unprognostic (1.04e-1)" "unprognostic (6.08e-2)" "unprognostic (1.56e-1)" "unprognostic (3.51e-1)" "unprognostic (2.24e-1)" 5.0 5.9 4.8 2.3 12.5 2.4 5.1 18.2 9.6 6.7 5.8 4.5 2.9 2.3 4.4 7.2 2.6 6.5 3.6 5.5 4.9 8.1 3.4 4.6 2.5 5.2 5.0 4.1 10.4 16.2 6.8 6.3 3.7 5.6 7.5 2.5 5.1 4.5 6.5 3.7 3.2 2.2 3.4 4.0 3.0 3.7 37.1 1.7 2.0 3.3 1.7 4.1 5.9 3.3 5.6 1.3 0.5 0.4 5.0 11.4 4.0 4.2 3.3 0.1 3.7 1.4 0.6 0.2 1.3 2.2 2.5 1.5 3.8 1.2 9.3 2.0 1.3 1.1 25.4 0.7 2.4 5.7 7.4 8.9 2.5 6.8 6.5 6.6 3.7 1.2 2.7 1.5 6.1 0.6 7.9 0.2 2.8 5.3 4.9 9.4 0.0 4.5 18.8 1.8 6.8 2.2 0.3 14.6 6.0 1.7 2.4 4.4 2.3 10.7 0.7 0.1 0.2 5.5 2.7 1.2 4.3 0.0 3.0 6.8 5.2 0.3 0.4 0.2 2.8 0.3 9.2 5.6 10.7 5.6 0.1 4.3 11.4 5.1 0.5 5.0 0.2 1.3 7.6 4.0 4.8 12.5 18.2 9.6 4.9 8.1 5.0 4.1 5.6 1.7 PLET1 C11orf34 ENSG00000188771 "Placenta expressed transcript 1" Q6UQ28 11 112248479-112260860 "Predicted membrane proteins" Differentiation "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 2.8" "Cell line enhanced" "Detected in single" "AN3-CA: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA040237 Uncertain "HPA040237: AB_10793960" "unprognostic (8.70e-2)" "unprognostic (1.75e-1)" "unprognostic (8.51e-3)" "unprognostic (5.19e-2)" 0.2 0.7 0.0 0.2 0.0 1.1 0.2 0.3 0.1 0.5 0.2 0.0 0.2 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.3 0.5 0.0 1.2 0.1 0.1 0.0 0.2 0.0 0.5 2.8 0.3 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.7 0.0 0.5 0.1 0.0 0.7 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.4 0.0 0.6 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.4 0.0 0.2 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.5 0.0 0.2 0.3 0.0 0.1 0.0 0.7 0.0 0.7 0.0 0.1 0.0 0.0 0.7 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 PLIN1 PLIN ENSG00000166819 "Perilipin 1" O60240 15 89664365-89679427 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adipose tissue: 187.5;breast: 62.6" "Cell line enriched" "Detected in single" 176 "ASC diff: 68.8" "Cancer enhanced" "Detected in many" "breast cancer: 8.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA024299, CAB033821, CAB037333" Enhanced Uncertain Peroxisomes 8900 Peroxisomes "CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467" "unprognostic (4.62e-2)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.67e-1)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (9.89e-3)" "unprognostic (3.54e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-2)" "unprognostic (8.00e-3)" "unprognostic (2.28e-3)" "unprognostic (2.62e-6)" "unprognostic (5.56e-2)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "unprognostic (4.85e-2)" 187.5 2.6 1.8 7.1 1.3 0.3 62.6 0.8 0.8 0.3 10.6 1.6 0.4 0.4 0.3 1.9 0.5 0.4 7.4 8.3 2.7 0.6 0.6 5.8 0.3 2.8 0.8 1.5 0.4 1.4 0.3 0.1 0.3 1.0 0.4 1.1 0.0 7.6 1.5 7.2 2.2 2.2 0.6 0.4 0.3 0.5 1.6 1.8 0.0 0.7 8.0 0.3 1.5 1.5 0.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 68.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.8 1.3 0.8 0.7 2.7 0.6 0.8 1.5 1.0 1.8 PLN "CMD1P, PLB" ENSG00000198523 Phospholamban P26678 6 118548298-118560730 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 337.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.4;Karpas-707: 1.6;NB-4: 1.9;U-2197: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 1.3;naive CD4 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005597, HPA026900" Enhanced "CAB005597: AB_2252716, HPA026900: AB_1855314" "unprognostic (2.49e-1)" "unprognostic (5.67e-2)" "unprognostic (1.96e-3)" "unprognostic (4.81e-2)" "unprognostic (1.20e-1)" "unprognostic (5.54e-2)" "unprognostic (2.35e-3)" "unprognostic (4.66e-2)" "unprognostic (3.97e-1)" "unprognostic (8.98e-2)" "unprognostic (8.98e-2)" "unprognostic (3.28e-1)" "prognostic unfavourable (4.11e-4)" "unprognostic (2.98e-3)" "unprognostic (1.80e-1)" "unprognostic (2.11e-1)" "prognostic unfavourable (5.59e-4)" 9.0 1.8 0.4 2.7 0.5 0.0 5.4 0.4 0.6 22.3 22.2 0.0 9.8 2.0 21.1 22.3 27.3 11.6 29.8 337.5 0.4 0.5 6.4 0.4 5.3 0.8 0.7 1.4 18.6 0.5 0.1 0.4 0.1 1.4 14.4 3.9 0.0 1.6 6.0 68.4 1.5 14.0 30.8 1.2 0.6 6.5 12.3 0.0 0.0 2.8 23.7 0.8 32.2 6.6 0.3 0.0 1.3 0.4 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.4 0.2 0.0 0.0 0.3 0.6 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.3 0.5 0.2 0.0 0.2 1.6 0.1 0.0 0.0 1.9 0.1 0.0 0.0 0.1 1.0 0.0 0.7 0.2 0.8 0.4 0.1 0.0 0.4 0.0 0.5 0.3 0.2 1.3 0.3 0.2 0.3 0.5 0.0 1.1 0.1 0.0 0.4 1.3 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.3 1.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.6 0.4 0.5 0.7 1.4 1.4 0.0 PLOD2 LH2 ENSG00000152952 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2" O00469 3 146069440-146163653 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.1" "Cell line enhanced" "Detected in many" "HBF TERT88: 85.3;U-87 MG: 76.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB025898, HPA069126" Approved Uncertain Nucleoli,Cytosol "Intracellular and membrane" "Nucleoli, Cytosol" "CAB025898: , HPA069126: " "unprognostic (8.68e-2)" "prognostic unfavourable (1.97e-4)" "unprognostic (2.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.34e-2)" "unprognostic (1.29e-3)" "prognostic unfavourable (7.64e-10)" "prognostic unfavourable (1.42e-4)" "unprognostic (2.97e-2)" "unprognostic (3.36e-2)" "unprognostic (6.27e-3)" "unprognostic (2.24e-1)" "prognostic unfavourable (4.99e-11)" "prognostic unfavourable (2.83e-4)" "unprognostic (6.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.41e-3)" 36.7 14.1 11.2 18.0 12.1 0.7 28.5 7.9 13.5 8.8 25.2 5.1 8.3 21.6 14.8 7.5 12.0 8.0 22.3 16.6 12.5 8.2 16.4 73.1 9.3 3.0 10.7 4.8 17.7 14.4 13.9 7.8 41.0 13.0 11.1 16.1 7.2 7.7 11.3 4.8 3.2 24.7 24.2 19.4 3.2 13.6 6.3 10.9 6.1 47.6 3.5 3.0 21.8 28.7 0.0 0.0 1.5 0.3 0.0 0.0 1.9 17.0 12.2 3.8 1.2 13.9 15.0 9.7 60.4 18.5 32.9 62.1 0.9 1.7 0.0 11.8 10.2 3.6 4.4 51.9 85.3 0.0 7.0 4.2 11.9 8.4 35.8 0.0 0.0 26.2 7.5 28.5 13.9 45.4 5.6 0.2 58.1 6.2 0.0 0.0 2.4 5.2 0.0 2.5 0.0 13.8 0.8 1.9 0.0 48.1 5.2 5.1 14.1 0.5 57.0 40.8 12.4 12.9 36.0 18.5 2.6 0.0 76.0 0.0 7.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 11.2 12.1 7.9 13.5 12.5 8.2 10.7 4.8 13.0 10.9 PLPPR2 "LPPR2, PRG-4" ENSG00000105520 "Phospholipid phosphatase related 2" Q96GM1 19 11355386-11365698 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 32.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048973 Uncertain Approved Nucleoplasm Nucleoplasm "HPA048973: " "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (6.45e-4)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (7.10e-2)" "unprognostic (1.37e-1)" "unprognostic (9.60e-2)" "unprognostic (1.72e-1)" "prognostic favourable (6.82e-4)" "unprognostic (2.23e-1)" "prognostic unfavourable (7.46e-11)" "unprognostic (1.99e-2)" "unprognostic (1.46e-1)" "unprognostic (4.37e-2)" "unprognostic (1.17e-1)" 12.0 17.1 32.5 10.5 39.9 14.1 6.6 17.7 51.2 14.0 11.1 10.8 5.1 6.0 12.7 8.4 8.4 9.7 13.7 10.4 37.0 22.3 5.5 18.0 10.0 5.4 11.8 17.9 15.2 12.4 11.7 22.7 11.5 12.3 18.5 5.1 11.8 13.1 15.1 23.1 16.2 5.7 16.8 10.5 10.6 9.3 7.6 9.4 0.5 7.7 4.4 3.3 9.8 8.1 0.0 2.9 32.3 7.2 0.0 0.3 2.3 8.7 5.4 3.0 12.5 12.7 12.2 0.8 15.6 14.6 9.7 9.9 1.0 1.6 1.7 9.3 19.9 1.6 1.7 4.7 5.2 4.6 3.2 0.5 3.8 1.0 6.6 0.5 17.8 10.9 8.5 8.3 1.6 6.5 8.4 14.0 8.1 12.9 0.2 2.4 3.3 30.4 0.2 0.4 4.8 4.5 4.1 3.2 10.8 6.5 5.6 3.3 8.1 11.2 7.5 22.0 4.7 37.1 8.2 8.7 5.3 0.6 21.3 8.0 8.6 0.8 7.2 3.7 0.3 6.7 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 32.3 0.0 4.4 0.1 0.3 2.3 32.5 39.9 17.7 51.2 37.0 22.3 11.8 17.9 12.3 9.4 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821977 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6" "Group enriched" "Detected in some" 6 "NB-4: 23.5;THP-1: 49.8" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: , HPA057034: " "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.7 0.7 20.5 1.2 30.0 18.2 2.1 0.1 21.3 0.9 0.7 0.7 0.0 0.7 1.3 0.7 0.7 12.6 1.1 0.7 14.4 13.1 0.7 0.7 2.6 0.9 3.9 14.9 1.0 0.7 0.7 0.1 0.8 4.7 0.9 0.7 0.1 0.7 0.8 0.9 0.8 1.0 0.7 1.1 0.9 0.9 3.0 3.1 0.0 0.7 0.0 0.7 0.8 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 4.8 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.4 0.0 0.1 0.9 0.0 0.0 0.0 2.0 0.0 0.6 0.0 0.2 1.6 0.1 0.6 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.4 0.0 23.5 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.2 0.1 0.0 0.0 2.1 49.8 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 3.8 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.0 0.1 21.3 14.4 13.1 3.9 14.9 4.7 3.1 PLSCR3 ENSG00000187838 "Phospholipid scramblase 3" Q9NRY6 17 7389727-7394843 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048387, HPA068609" Supported Supported Mitochondria Mitochondria "HPA048387: , HPA068609: " "unprognostic (1.86e-2)" "unprognostic (5.29e-2)" "unprognostic (2.29e-2)" "unprognostic (1.56e-2)" "unprognostic (4.36e-2)" "unprognostic (5.02e-2)" "unprognostic (2.27e-2)" "unprognostic (9.71e-2)" "unprognostic (1.75e-3)" "unprognostic (1.91e-1)" "unprognostic (1.11e-2)" "unprognostic (1.77e-2)" "unprognostic (2.11e-5)" "unprognostic (1.24e-2)" "unprognostic (1.48e-1)" "unprognostic (1.97e-1)" "unprognostic (2.55e-2)" 21.9 11.5 6.2 17.8 6.1 5.2 31.0 4.4 7.9 24.0 12.7 7.4 16.3 5.6 29.2 22.0 21.6 15.6 17.7 25.3 5.6 5.7 15.3 12.9 25.0 67.2 5.8 7.6 19.9 10.0 10.1 9.0 17.3 8.4 15.4 6.3 10.2 12.5 17.8 16.1 17.8 10.5 21.4 13.1 29.0 11.6 8.6 6.4 12.1 12.2 26.0 21.0 21.5 20.1 12.9 9.5 1.9 13.3 6.6 30.8 12.1 14.2 3.2 2.7 8.4 10.3 18.1 3.6 13.0 11.9 11.1 10.4 4.9 3.3 3.6 10.6 18.6 19.5 3.4 21.2 5.6 9.8 1.9 3.4 4.3 3.4 13.9 1.2 4.5 13.1 14.4 11.1 16.7 17.1 2.0 2.8 14.4 7.3 3.8 1.0 2.5 9.2 7.8 2.3 3.8 10.4 9.2 2.4 8.1 6.6 4.8 3.0 8.2 0.6 27.8 7.6 7.8 8.7 5.4 3.2 3.6 1.4 11.9 4.3 8.8 1.9 10.0 1.1 16.8 13.3 17.1 12.9 30.5 17.1 9.5 12.0 25.2 15.0 1.0 6.6 10.9 1.1 30.8 12.1 6.2 6.1 4.4 7.9 5.6 5.7 5.8 7.6 8.4 6.4 PLSCR4 ENSG00000114698 "Phospholipid scramblase 4" Q9NRQ2 3 146192339-146251179 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 24.8;ASC TERT1: 19.5;HUVEC TERT2: 20.0;TIME: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002276 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA002276: AB_1855479" "unprognostic (3.73e-3)" "unprognostic (4.03e-2)" "unprognostic (9.83e-2)" "prognostic unfavourable (3.90e-4)" "unprognostic (2.62e-1)" "unprognostic (6.77e-3)" "unprognostic (1.19e-1)" "unprognostic (4.36e-2)" "unprognostic (7.33e-2)" "unprognostic (2.49e-1)" "unprognostic (2.50e-1)" "unprognostic (4.17e-2)" "prognostic unfavourable (4.13e-4)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" "unprognostic (8.13e-3)" "unprognostic (2.97e-3)" 40.5 29.6 19.4 5.9 20.4 1.7 53.3 19.1 23.4 25.1 17.7 14.8 10.8 4.6 21.9 13.9 15.8 28.0 29.4 20.3 23.1 13.8 16.9 43.4 24.2 16.7 13.7 14.6 25.2 13.0 3.8 11.7 35.9 21.8 17.9 16.9 15.9 14.8 18.2 8.7 11.1 9.3 25.0 28.7 18.4 11.0 16.8 16.6 0.9 25.1 8.9 4.5 23.3 28.7 0.0 0.2 0.0 0.2 1.3 0.0 0.5 0.0 3.6 0.6 0.0 24.8 19.5 0.1 4.4 6.0 2.0 4.3 0.4 4.8 0.0 4.8 8.2 0.5 0.9 0.4 1.1 0.0 0.0 1.9 3.0 0.5 11.3 0.0 0.5 11.8 0.6 4.1 1.2 20.0 0.1 0.3 2.9 0.1 0.0 0.0 0.8 1.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 7.5 0.0 1.4 0.3 0.2 41.2 4.2 1.0 9.2 0.8 0.1 0.0 0.0 1.0 0.0 3.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.5 19.4 20.4 19.1 23.4 23.1 13.8 13.7 14.6 21.8 16.6 PLSCR5 ENSG00000231213 "Phospholipid scramblase family member 5" A0PG75 3 146576555-146606216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.8;intestine: 1.8;parathyroid gland: 5.6" "Cell line enhanced" "Detected in single" "HSkMC: 1.3" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047249 Uncertain "HPA047249: " 0.1 0.0 0.5 0.1 1.8 0.0 0.1 0.1 0.3 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.2 0.1 0.4 0.1 0.1 0.1 5.6 0.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 1.8 0.1 0.1 0.1 0.0 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.1 0.3 0.1 0.5 0.4 0.1 0.1 0.1 PLVAP "FELS, gp68, PV-1, PV1" ENSG00000130300 "Plasmalemma vesicle associated protein" Q9BX97 19 17351448-17377350 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.3" "Cell line enriched" "Detected in some" 28 "EFO-21: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 22.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA002279 Supported Approved "Plasma membrane,Centrosome,Cytosol" 53000 Cytosol "Plasma membrane, Centrosome" "HPA002279: AB_1079636" "unprognostic (3.19e-1)" "unprognostic (8.22e-2)" "unprognostic (7.87e-2)" "unprognostic (2.38e-2)" "unprognostic (1.93e-2)" "unprognostic (2.49e-3)" "unprognostic (4.17e-3)" "unprognostic (1.01e-1)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" "unprognostic (8.96e-2)" "unprognostic (4.24e-3)" "unprognostic (4.70e-3)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (8.17e-2)" 128.3 9.8 0.8 16.4 0.9 0.0 56.3 0.4 1.5 28.7 29.8 3.2 12.8 20.2 32.0 19.8 27.4 16.6 43.1 18.9 1.1 0.4 33.7 4.6 13.1 34.6 0.9 0.5 14.3 22.9 13.8 16.1 12.6 2.7 26.1 5.2 26.3 16.0 10.4 20.7 11.5 23.7 13.5 1.2 77.8 22.1 9.5 0.7 3.8 88.3 13.9 15.2 30.1 87.7 0.0 22.1 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.0 0.4 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 22.1 0.0 0.3 0.8 0.9 0.4 1.5 1.1 0.4 0.9 0.5 2.7 0.7 PLXDC1 "TEM3, TEM7" ENSG00000161381 "Plexin domain containing 1" Q8IUK5 17 39063303-39154394 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+: 12.9;MOLT-4: 4.0;U-87 MG: 8.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012805 Approved "Intracellular and membrane" 6000000 "HPA012805: AB_1857893" "unprognostic (4.28e-1)" "unprognostic (3.55e-1)" "unprognostic (2.56e-2)" "unprognostic (2.15e-1)" "unprognostic (9.50e-2)" "unprognostic (1.13e-2)" "unprognostic (2.35e-2)" "unprognostic (2.23e-2)" "unprognostic (4.07e-3)" "unprognostic (6.07e-3)" "unprognostic (4.62e-3)" "unprognostic (8.69e-2)" "prognostic unfavourable (9.15e-8)" "unprognostic (9.37e-3)" "unprognostic (1.72e-2)" "unprognostic (2.42e-1)" "unprognostic (2.33e-2)" 6.1 3.5 6.6 5.7 13.8 1.4 10.0 13.3 13.8 6.9 5.1 5.0 5.9 2.4 15.1 7.8 14.6 10.4 17.1 18.4 7.6 6.3 3.7 1.0 5.0 6.0 7.8 6.3 18.2 4.3 1.3 3.1 2.7 7.5 5.2 3.7 19.7 4.0 6.6 8.4 5.1 5.0 13.2 3.7 2.3 4.5 6.0 4.8 27.8 3.4 10.5 10.8 5.9 5.2 0.3 2.0 1.0 0.3 2.2 4.9 1.6 0.1 0.0 0.2 2.0 0.4 0.0 0.3 0.2 12.9 1.0 0.6 0.2 3.1 0.2 0.3 0.4 0.3 0.3 0.2 0.7 0.1 1.0 0.4 1.0 0.1 0.3 0.5 0.1 0.5 0.2 0.5 0.1 0.0 0.0 0.9 0.1 1.5 4.0 0.4 0.5 0.0 0.5 0.7 0.5 0.0 0.1 2.0 0.2 0.1 0.3 0.0 0.3 0.3 0.0 1.6 0.9 0.6 0.3 0.2 0.1 0.2 8.4 0.5 0.2 0.5 0.3 0.2 3.8 0.1 3.3 0.2 1.3 1.4 0.0 0.3 4.9 4.9 1.0 2.2 0.1 2.0 0.1 1.6 6.6 13.8 13.3 13.8 7.6 6.3 7.8 6.3 7.5 4.8 PLXDC2 "FLJ14623, TEM7R" ENSG00000120594 "Plexin domain containing 2" Q6UX71 10 19816239-20289856 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HHSteC: 12.4;U-2197: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 21.2;intermediate monocyte: 12.6;myeloid DC: 13.3;neutrophil: 31.4;non-classical monocyte: 12.7" "Group enriched" "Detected in many" 14 "dendritic cells: 13.3;granulocytes: 31.4;monocytes: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017268, HPA070793" Approved Supported "Nuclear bodies" 560000000 "Nuclear bodies" "HPA017268: AB_10965928, HPA070793: " "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (3.05e-1)" "unprognostic (3.31e-2)" "unprognostic (2.99e-1)" "unprognostic (1.94e-2)" "unprognostic (1.57e-1)" "unprognostic (5.32e-2)" "unprognostic (7.52e-2)" "unprognostic (1.89e-1)" "unprognostic (1.35e-1)" "unprognostic (5.44e-2)" "unprognostic (3.91e-3)" "unprognostic (8.71e-2)" "unprognostic (3.35e-1)" "unprognostic (2.66e-2)" 31.7 13.1 15.9 8.2 20.6 5.5 25.5 3.8 12.4 14.5 9.1 17.9 11.5 4.9 14.2 9.2 11.1 11.5 20.4 14.5 16.8 8.3 12.9 3.9 21.9 5.4 26.1 9.6 11.3 4.2 17.0 5.6 5.5 16.7 10.3 5.7 8.7 9.8 9.7 6.1 21.1 8.0 18.0 27.7 10.5 6.0 7.8 22.7 0.4 10.5 12.3 3.6 11.9 17.7 0.0 13.3 31.4 21.2 1.5 1.1 5.4 0.0 0.0 3.3 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.9 1.3 1.1 0.0 0.0 0.5 1.7 5.3 0.2 12.4 0.0 0.0 4.2 0.3 0.0 1.5 0.0 0.1 1.1 0.6 0.7 0.3 0.1 2.2 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.1 1.4 0.2 0.0 0.5 0.6 0.0 4.9 2.6 29.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.0 21.2 4.1 0.5 12.6 1.1 0.0 0.0 0.1 13.3 0.0 0.0 0.0 31.4 1.5 12.7 0.6 0.0 5.4 15.9 20.6 3.8 12.4 16.8 8.3 26.1 9.6 16.7 22.7 PLXNA1 "NOV, PLXN1" ENSG00000114554 "Plexin A1" Q9UIW2 3 126988594-127037392 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007499, CAB012483" Uncertain Supported Nucleoplasm,Cytosol 2600000 Nucleoplasm Cytosol "CAB012483: , HPA007499: AB_1079637" "unprognostic (1.87e-1)" "unprognostic (1.11e-1)" "unprognostic (4.38e-2)" "unprognostic (1.19e-2)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "prognostic unfavourable (4.13e-6)" "unprognostic (1.79e-2)" "unprognostic (9.06e-2)" "prognostic unfavourable (1.35e-4)" "unprognostic (3.77e-2)" "unprognostic (7.45e-2)" "prognostic unfavourable (5.64e-5)" "unprognostic (4.50e-3)" "unprognostic (7.62e-3)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 4.6 2.1 4.4 3.8 2.5 0.0 3.1 5.2 9.3 3.6 2.5 2.5 2.5 1.6 3.8 5.2 3.7 3.3 2.7 10.2 6.2 5.3 2.5 5.3 6.3 3.1 2.9 5.0 5.0 4.9 18.7 2.5 4.9 3.9 3.7 0.7 2.5 7.9 4.1 5.6 8.8 2.5 2.9 2.5 5.6 2.3 5.2 2.5 2.5 3.2 2.5 2.5 3.5 12.6 0.6 0.0 0.0 0.9 0.0 1.1 0.5 17.7 8.4 9.3 7.4 12.3 13.8 14.9 10.6 9.1 6.1 6.1 27.9 8.3 2.0 16.0 11.4 27.5 4.8 20.8 2.5 2.8 7.5 0.2 4.9 7.2 8.1 2.1 1.5 13.8 14.6 11.3 8.8 3.0 10.2 3.7 6.5 10.3 4.1 3.9 9.0 7.5 5.5 23.9 5.5 5.3 35.8 8.3 9.1 7.7 7.3 10.1 11.7 13.5 11.2 9.8 12.6 17.8 11.1 2.2 1.5 3.9 14.1 4.0 10.3 0.0 0.0 0.0 0.7 0.1 1.1 0.5 0.6 0.3 0.0 0.6 0.3 0.4 0.0 0.0 0.9 0.0 0.8 0.5 4.4 2.5 5.2 9.3 6.2 5.3 2.9 5.0 3.9 2.5 PLXNA2 "FLJ11751, FLJ30634, KIAA0463, OCT, PLXN2" ENSG00000076356 "Plexin A2" O75051 1 208022242-208244320 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 39.9" "Cell line enhanced" "Detected in many" "BEWO: 18.3;HaCaT: 18.9;HUVEC TERT2: 24.1;TIME: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009763 Approved 580000 "CAB009763: AB_2166388" "unprognostic (8.25e-2)" "unprognostic (3.91e-2)" "unprognostic (8.85e-2)" "unprognostic (2.77e-2)" "unprognostic (8.66e-2)" "unprognostic (2.07e-1)" "unprognostic (1.97e-2)" "unprognostic (4.84e-2)" "unprognostic (6.88e-3)" "unprognostic (7.06e-2)" "unprognostic (2.61e-1)" "unprognostic (8.41e-2)" "unprognostic (4.49e-3)" "unprognostic (1.26e-1)" "unprognostic (5.40e-2)" "unprognostic (1.27e-2)" "unprognostic (2.40e-1)" 7.2 2.4 8.3 2.9 11.8 1.0 3.9 27.5 14.7 4.7 10.5 2.5 2.0 8.2 5.4 3.0 13.2 4.6 7.0 6.0 9.7 4.0 4.3 2.7 12.0 1.6 3.7 10.9 16.9 39.9 2.0 2.8 10.2 6.7 4.2 8.8 5.7 3.7 4.5 7.6 10.8 9.0 12.0 2.9 1.7 11.0 1.2 3.9 0.4 7.2 4.7 4.4 8.3 9.1 0.2 0.7 1.1 0.7 0.0 0.4 0.2 2.1 1.2 2.4 0.3 2.7 5.2 18.3 1.7 1.0 1.0 0.1 0.0 0.0 0.0 3.4 1.3 18.9 0.0 10.7 0.3 0.6 0.3 0.0 2.3 1.2 1.1 0.0 0.0 1.4 3.4 0.8 5.0 24.1 0.0 0.0 10.5 0.2 0.0 0.0 0.3 3.2 0.0 2.4 1.5 2.0 1.3 0.7 4.3 2.0 1.5 1.9 0.1 0.0 55.3 0.3 0.6 2.0 3.4 0.1 0.0 0.0 2.2 0.0 0.9 0.0 0.7 1.1 0.2 0.2 0.3 0.0 0.0 0.2 0.7 0.2 0.0 0.4 1.0 0.0 0.3 0.0 0.0 0.2 8.3 11.8 27.5 14.7 9.7 4.0 3.7 10.9 6.7 3.9 PLXNA3 "6.3, Plxn3, PLXN4, SEX, XAP-6" ENSG00000130827 "Plexin A3" P51805 X 154458281-154477779 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058989 Approved "Nucleoplasm,Vesicles,Plasma membrane" 58000 "Vesicles, Plasma membrane" Nucleoplasm "HPA058989: " "unprognostic (2.79e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-3)" "unprognostic (8.04e-3)" "unprognostic (1.63e-1)" "unprognostic (9.05e-3)" "unprognostic (1.06e-2)" "unprognostic (2.25e-1)" "unprognostic (2.42e-1)" "unprognostic (6.26e-2)" "unprognostic (1.05e-1)" "unprognostic (4.10e-2)" "unprognostic (1.38e-3)" "unprognostic (2.30e-1)" "unprognostic (3.00e-1)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" 6.9 7.6 9.8 6.6 9.3 3.5 13.3 25.9 7.4 8.1 6.2 13.8 7.3 7.2 8.6 9.2 5.3 8.3 7.9 6.6 10.5 8.0 5.1 2.5 7.2 7.1 8.7 3.6 16.4 9.9 5.1 35.2 7.4 8.2 9.2 4.8 6.1 13.8 7.5 2.9 19.5 7.2 8.2 8.4 7.0 10.0 5.8 9.8 4.6 9.3 1.8 7.2 6.3 16.4 1.8 0.5 2.7 0.5 2.1 1.0 0.3 8.1 1.6 4.8 12.2 5.1 6.5 6.5 11.7 2.5 2.7 3.8 6.1 3.5 1.5 6.3 12.5 7.2 4.9 5.7 1.0 0.7 3.6 1.5 19.1 3.3 4.0 0.7 6.8 8.8 4.2 4.1 0.3 3.1 3.8 1.3 4.3 10.1 1.4 6.2 1.5 3.7 5.3 0.4 0.5 3.7 5.4 10.2 5.3 4.3 7.8 1.9 4.7 1.7 7.7 6.0 5.5 0.6 4.9 0.9 0.1 2.1 11.2 1.1 1.6 2.7 0.5 0.8 0.8 0.4 0.6 1.8 1.0 0.8 0.1 1.2 0.6 0.8 1.4 2.1 0.3 0.5 0.7 0.3 9.8 9.3 25.9 7.4 10.5 8.0 8.7 3.6 8.2 9.8 PLXNA4 "DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B" ENSG00000221866 "Plexin A4" Q9HCM2 7 132123332-132648688 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.2;breast: 34.7" "Cell line enhanced" "Detected in some" "ASC diff: 14.9;HMC-1: 9.9;RH-30: 10.7;TIME: 32.6" "Cancer enhanced" "Detected in many" "glioma: 3.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029919, HPA052141, HPA075592" Approved Approved "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA029919: AB_10671093, HPA052141: , HPA075592: " "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (2.08e-2)" "prognostic unfavourable (1.61e-6)" "unprognostic (5.76e-2)" "unprognostic (1.21e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-2)" "unprognostic (2.19e-1)" "unprognostic (7.99e-2)" "unprognostic (7.64e-2)" "unprognostic (1.14e-1)" "unprognostic (1.69e-5)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (5.90e-2)" "unprognostic (1.42e-3)" 23.2 5.1 8.7 3.5 9.0 1.1 34.7 3.9 15.1 16.2 2.0 1.0 0.8 1.5 2.3 1.0 7.7 3.0 4.2 6.9 9.7 7.2 2.0 1.3 1.8 2.5 4.0 6.6 6.2 1.0 1.0 1.6 6.7 6.6 1.4 2.1 0.7 1.2 2.4 1.7 4.1 1.4 5.1 1.5 2.4 2.8 2.4 1.8 0.0 3.3 0.0 1.3 2.1 9.4 0.0 6.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.1 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 9.9 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 10.7 1.1 0.0 0.0 0.2 5.6 0.0 0.0 0.0 0.0 0.0 32.6 3.3 0.1 0.7 0.2 0.0 0.0 0.0 3.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.0 6.1 0.0 0.0 8.7 9.0 3.9 15.1 9.7 7.2 4.0 6.6 6.6 1.8 PLXNB1 "KIAA0407, PLXN5, SEP" ENSG00000164050 "Plexin B1" O43157 3 48403854-48430051 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040586 Enhanced "Intracellular and membrane" 55000000 "HPA040586: AB_10794034" "unprognostic (1.31e-3)" "unprognostic (7.09e-2)" "unprognostic (9.63e-2)" "unprognostic (8.13e-2)" "unprognostic (3.65e-1)" "prognostic favourable (5.03e-4)" "unprognostic (1.06e-1)" "unprognostic (4.29e-2)" "unprognostic (3.45e-2)" "unprognostic (1.01e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-2)" "prognostic favourable (2.77e-5)" "unprognostic (4.01e-2)" "unprognostic (1.61e-1)" "unprognostic (6.98e-2)" "prognostic favourable (7.60e-4)" 5.8 3.6 23.1 3.7 34.0 1.4 7.5 11.5 25.6 8.4 9.0 47.4 7.2 10.6 10.8 6.7 14.3 25.0 11.3 7.8 26.3 7.4 17.1 14.8 10.8 2.0 48.7 19.3 11.1 24.9 9.1 9.9 7.6 28.9 12.5 6.2 8.8 11.5 18.7 1.0 21.0 9.9 8.5 22.6 6.3 10.1 3.2 34.7 1.4 19.9 3.6 3.0 11.3 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.9 9.1 5.4 3.4 2.7 18.7 2.5 1.4 1.4 0.9 6.0 11.2 0.0 9.1 1.7 8.8 1.9 19.8 0.3 5.0 0.4 0.0 9.5 11.3 5.0 3.9 1.7 4.9 17.4 0.3 4.1 2.3 0.7 0.4 1.4 5.0 0.7 3.4 16.2 1.1 4.4 1.9 0.6 8.6 13.1 4.7 10.1 3.1 18.9 2.8 10.1 3.3 4.5 1.5 4.4 2.1 2.8 0.1 0.0 0.1 0.3 1.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 34.0 11.5 25.6 26.3 7.4 48.7 19.3 28.9 34.7 PLXNB2 "KIAA0315, MM1, PLEXB2" ENSG00000196576 "Plexin B2" O15031 22 50274979-50307627 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "classical monocyte: 7.2;intermediate monocyte: 14.3;myeloid DC: 6.0;non-classical monocyte: 16.1;plasmacytoid DC: 5.6" "Group enriched" "Detected in many" 30 "dendritic cells: 6.0;monocytes: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003100 Uncertain 51000000 "HPA003100: AB_1079638" "unprognostic (4.43e-3)" "unprognostic (1.34e-1)" "unprognostic (2.16e-1)" "unprognostic (1.35e-3)" "unprognostic (6.28e-2)" "unprognostic (4.96e-2)" "unprognostic (2.69e-2)" "unprognostic (1.10e-1)" "unprognostic (2.37e-1)" "prognostic unfavourable (7.37e-4)" "unprognostic (8.47e-3)" "unprognostic (9.84e-2)" "unprognostic (3.05e-2)" "prognostic favourable (4.75e-4)" "unprognostic (1.61e-2)" "unprognostic (9.41e-3)" "unprognostic (6.05e-2)" 14.1 27.0 10.8 13.9 9.6 5.5 14.4 43.5 12.8 23.1 19.6 15.0 39.8 22.2 25.9 28.0 27.8 26.7 56.2 12.0 11.9 5.8 31.6 20.3 21.0 18.6 8.3 9.3 32.2 23.3 10.5 19.6 29.6 11.6 27.7 7.7 26.5 26.7 31.0 5.0 24.7 23.6 22.5 9.5 33.6 39.5 19.3 9.5 3.4 45.9 19.6 20.2 23.2 21.9 0.1 6.0 0.3 16.1 0.1 0.3 4.5 17.6 27.4 13.8 19.5 7.7 9.2 24.0 26.1 12.5 8.3 8.3 18.2 24.8 12.7 29.3 17.7 34.5 2.1 17.3 1.8 2.6 11.6 2.2 44.0 13.7 20.3 0.4 12.6 15.7 25.3 8.4 6.3 7.3 3.5 3.6 7.9 29.2 0.2 5.0 3.8 6.8 14.8 23.7 4.5 9.2 49.0 6.5 12.4 23.8 82.0 6.4 30.6 17.6 14.5 18.9 28.5 9.4 8.9 1.8 0.2 2.3 15.3 0.7 25.5 0.0 7.2 0.0 0.0 14.3 0.1 0.1 0.0 0.0 6.0 0.0 0.0 0.1 0.3 0.1 16.1 5.6 0.3 4.5 10.8 9.6 43.5 12.8 11.9 5.8 8.3 9.3 11.6 9.5 PLXNB3 "PLEXB3, PLEXR, PLXN6" ENSG00000198753 "Plexin B3" Q9ULL4 X 153764196-153779346 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.3;salivary gland: 28.9" "Cell line enhanced" "Detected in many" "WM-115: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.7" "Lineage enhanced" "Detected in single" "dendritic cells: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048046 Enhanced 17000 "HPA048046: " "prognostic unfavourable (6.13e-4)" "unprognostic (2.60e-1)" "unprognostic (9.10e-4)" "unprognostic (2.30e-2)" "unprognostic (1.45e-1)" "unprognostic (8.53e-2)" "unprognostic (1.15e-3)" "unprognostic (1.29e-1)" "unprognostic (1.23e-1)" "unprognostic (2.17e-1)" "unprognostic (2.66e-1)" "unprognostic (8.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.68e-2)" "unprognostic (1.14e-1)" "unprognostic (9.73e-3)" "unprognostic (1.98e-2)" 3.7 17.4 15.5 2.9 34.9 1.5 4.5 16.1 46.3 3.5 14.8 45.8 1.8 3.3 8.1 5.3 6.4 3.8 6.1 3.1 19.9 9.4 1.3 1.3 2.1 1.4 39.7 17.3 1.3 5.6 1.1 0.6 1.4 18.4 9.0 3.2 2.8 28.9 10.7 1.4 11.3 3.4 8.9 25.6 1.3 4.4 7.2 40.2 0.0 1.3 0.2 1.2 6.8 3.8 0.1 2.7 0.0 0.0 0.7 0.0 0.7 4.8 0.5 0.6 0.4 0.6 0.4 0.3 4.5 0.9 0.6 1.6 0.0 0.1 0.0 2.9 1.2 0.5 0.0 3.8 0.5 0.1 0.0 3.0 5.4 3.4 1.3 0.0 0.3 1.0 2.8 2.8 1.8 1.8 0.2 1.7 1.2 3.9 0.0 0.7 0.1 7.5 1.4 0.5 0.0 0.7 2.2 1.3 4.1 0.2 4.2 10.1 5.6 0.0 7.9 4.7 2.4 3.7 5.6 1.6 0.4 0.1 10.2 0.2 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 2.7 0.0 0.7 15.5 34.9 16.1 20.8 19.9 9.4 39.7 17.3 18.4 40.2 PLXNC1 "CD232, VESPR" ENSG00000136040 "Plexin C1" O60486 12 94148723-94307675 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.5;retina: 40.6" "Cell line enhanced" "Detected in many" "HAP1: 14.9;SK-MEL-30: 18.5;U-266/70: 29.4;U-266/84: 30.6" "Cancer enhanced" "Detected in all" "melanoma: 24.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.2" "Group enriched" "Detected in many" 4 "granulocytes: 14.2;monocytes: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026155, HPA066899" Uncertain Approved Mitochondria 82000 Mitochondria "CAB026155: , HPA066899: " "unprognostic (1.49e-1)" "unprognostic (4.01e-2)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (2.33e-1)" "unprognostic (3.24e-2)" "unprognostic (4.67e-3)" "unprognostic (2.80e-2)" "unprognostic (3.49e-1)" "unprognostic (4.64e-2)" "unprognostic (1.78e-2)" "unprognostic (2.38e-1)" "unprognostic (4.02e-2)" "unprognostic (5.33e-3)" "unprognostic (3.19e-2)" "unprognostic (6.85e-3)" "unprognostic (5.48e-2)" 6.6 7.5 7.1 16.1 6.9 12.6 3.9 16.8 8.6 8.0 5.1 3.1 0.8 3.1 7.3 2.2 4.9 4.3 8.3 4.1 6.3 15.2 3.2 2.0 15.2 43.5 4.5 7.7 13.0 2.3 0.5 6.3 7.5 5.2 4.3 5.4 40.6 3.7 3.7 2.9 6.6 5.0 5.7 4.9 28.6 3.4 12.1 3.3 8.6 3.3 2.7 10.2 9.6 6.5 2.4 2.5 14.2 6.7 0.9 1.7 1.5 0.4 0.2 1.2 0.2 0.7 0.5 0.1 0.6 0.8 0.8 2.3 4.0 0.0 9.5 0.0 0.9 0.0 14.9 0.6 0.5 6.6 0.3 0.5 0.2 2.7 8.3 1.9 3.3 8.2 0.0 0.9 0.4 0.0 0.2 11.7 0.2 0.1 0.4 1.0 2.5 0.5 1.5 0.4 5.2 0.0 0.7 1.0 0.7 0.1 0.1 18.5 0.0 1.6 0.3 0.2 1.1 0.1 0.3 29.4 30.6 0.6 0.1 5.2 0.6 0.0 3.0 12.2 1.4 5.2 1.6 2.4 1.6 1.7 2.5 1.4 1.4 1.5 14.2 0.9 6.7 0.9 1.0 1.5 7.1 6.9 16.8 8.6 6.3 15.2 4.5 7.7 5.2 3.3 PLXND1 KIAA0620 ENSG00000004399 "Plexin D1" Q9Y4D7 3 129555175-129606818 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 70.5;HSkMC: 51.3;HUVEC TERT2: 60.0;TIME: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 11.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 37.7;basal ganglia: 29.6;cerebral cortex: 27.0;hippocampal formation: 28.7" "Low region specificity" "Detected in many" CAB020819 Approved 58000000 "CAB020819: " "unprognostic (8.97e-3)" "unprognostic (1.95e-1)" "unprognostic (6.30e-2)" "unprognostic (8.35e-2)" "unprognostic (1.28e-2)" "unprognostic (3.00e-3)" "unprognostic (6.35e-2)" "unprognostic (4.51e-2)" "unprognostic (3.69e-1)" "unprognostic (3.02e-3)" "unprognostic (3.78e-2)" "unprognostic (2.08e-1)" "prognostic unfavourable (5.93e-7)" "unprognostic (1.30e-1)" "unprognostic (3.21e-2)" "unprognostic (3.17e-2)" "unprognostic (1.00e-2)" 35.3 13.5 10.8 17.4 19.5 11.0 47.9 2.7 14.3 31.7 9.7 18.5 7.2 3.0 21.1 16.2 10.9 20.0 19.6 25.8 9.3 8.2 16.2 14.5 33.0 37.0 25.9 7.2 10.5 8.4 11.9 7.2 54.6 14.4 11.2 8.7 31.9 8.2 14.2 10.4 9.5 11.6 26.1 19.1 22.1 9.4 7.0 17.4 28.6 18.0 14.4 11.2 19.1 16.8 0.0 3.9 0.1 11.7 2.8 7.6 1.5 1.6 9.9 8.2 2.8 70.5 30.4 17.1 7.3 21.4 4.5 5.2 2.3 1.4 0.3 31.4 26.1 0.1 4.5 0.1 1.3 0.3 0.5 6.8 5.0 10.3 8.0 2.2 1.9 51.3 0.3 4.6 0.4 60.0 2.4 0.2 6.0 5.2 0.4 7.4 2.0 1.3 7.9 5.6 8.5 1.8 0.3 4.8 0.2 1.8 0.6 2.7 2.6 10.1 70.3 3.8 5.1 0.1 5.4 0.3 0.3 3.3 1.3 4.9 3.2 0.0 11.7 0.0 1.9 5.3 7.6 0.0 1.4 1.5 3.0 0.0 0.0 0.2 0.1 2.8 4.9 3.9 0.0 1.5 10.8 19.5 2.7 14.3 9.3 8.2 25.9 7.2 14.4 17.4 PMEL "D12S53E, gp100, Pmel17, SI, SIL, SILV" ENSG00000185664 "Premelanosome protein" P40967 12 55954105-55973317 "Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 230.1" "Cell line enriched" "Detected in some" 66 "SK-MEL-30: 431.8" "Cancer enriched" "Detected in many" 500 "melanoma: 2481.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031649 Enhanced Supported "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" 14000000 "Endoplasmic reticulum" "Golgi apparatus" "HPA031649: " "unprognostic (4.63e-1)" "unprognostic (8.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.60e-1)" "unprognostic (5.90e-2)" "unprognostic (6.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.46e-3)" "unprognostic (6.44e-2)" "unprognostic (1.21e-1)" "unprognostic (5.12e-2)" "unprognostic (3.98e-1)" "prognostic favourable (3.70e-4)" "unprognostic (2.86e-2)" "unprognostic (1.54e-1)" "unprognostic (7.60e-2)" "unprognostic (1.04e-1)" 0.9 0.1 0.4 0.4 0.5 0.4 3.4 0.4 0.5 38.2 1.0 0.4 0.5 0.4 11.8 0.4 0.4 0.2 0.6 0.5 0.4 0.0 0.6 1.8 0.7 1.9 0.4 0.4 1.6 0.6 0.9 0.4 0.9 0.4 0.5 0.2 230.1 1.1 0.4 0.6 46.8 0.6 1.3 0.8 0.4 0.2 1.5 0.4 0.4 0.4 0.6 0.6 0.5 0.8 1.3 2.3 2.1 1.4 0.2 1.9 0.6 0.7 0.0 0.2 0.0 4.4 0.0 6.5 0.0 0.0 0.1 0.1 0.6 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 431.8 0.2 0.4 0.0 0.0 0.3 0.0 0.4 0.1 0.5 0.1 0.0 0.1 0.0 0.0 1.4 0.7 0.3 0.0 1.9 1.3 0.5 0.4 0.0 0.9 1.1 0.1 2.1 0.2 0.4 2.3 0.4 0.6 0.4 0.5 0.4 0.5 0.4 0.0 0.4 0.4 0.4 0.4 PMEPA1 "STAG1, TMEPAI" ENSG00000124225 "Prostate transmembrane protein, androgen induced 1" Q969W9 20 57648392-57711536 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Signal transduction inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 60.4;prostate: 67.3" "Cell line enhanced" "Detected in many" "SiHa: 39.5;U-2 OS: 25.8;U-251 MG: 90.8;WM-115: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "naive B-cell: 5.2;plasmacytoid DC: 18.4" "Group enriched" "Detected in many" 7 "B-cells: 5.2;dendritic cells: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072291 Supported Vesicles "Intracellular and membrane" Vesicles "HPA072291: " "unprognostic (2.72e-3)" "prognostic unfavourable (2.45e-4)" "unprognostic (5.77e-2)" "unprognostic (1.73e-1)" "unprognostic (6.61e-2)" "unprognostic (2.11e-3)" "unprognostic (3.13e-2)" "prognostic unfavourable (4.73e-5)" "unprognostic (5.53e-1)" "unprognostic (1.32e-3)" "unprognostic (7.83e-3)" "unprognostic (2.02e-1)" "prognostic unfavourable (2.87e-7)" "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (9.87e-3)" "prognostic unfavourable (7.60e-4)" 27.0 7.8 7.5 10.6 34.8 1.3 9.5 2.6 12.6 60.4 10.8 11.0 4.2 4.4 22.1 6.7 7.1 7.7 21.8 10.7 7.5 8.6 5.3 1.7 8.5 4.5 10.2 5.9 6.2 18.6 2.6 5.6 3.0 12.1 67.3 5.7 21.3 11.6 13.3 17.4 6.8 7.6 17.6 8.1 4.0 5.3 3.2 9.1 1.3 5.4 6.0 6.2 8.4 13.0 5.2 18.4 0.1 0.3 0.0 1.6 0.4 5.9 14.5 0.4 0.7 0.4 0.0 0.1 0.9 0.0 0.3 0.1 0.2 18.8 0.0 3.5 1.4 23.0 0.3 19.4 0.2 0.1 0.7 0.0 4.0 0.0 0.3 0.0 0.1 0.2 10.9 0.8 2.4 2.5 0.1 0.2 1.2 12.3 0.7 0.1 1.8 1.8 0.0 7.0 2.1 4.7 0.0 3.4 2.7 39.5 23.5 2.7 3.6 0.7 6.3 3.5 25.8 0.3 90.8 1.1 0.1 0.0 1.6 0.2 45.8 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.6 0.2 0.0 5.2 1.6 0.9 0.1 0.0 0.0 18.4 0.4 0.4 7.5 34.8 2.6 12.6 7.5 8.6 10.2 5.9 12.1 9.1 PNKD "BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, PDC, PKND1, TAHCCP2" ENSG00000127838 "Paroxysmal nonkinesigenic dyskinesia" Q8N490 2 218270392-218346793 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010134, HPA017068" Approved Enhanced Mitochondria 31000 Mitochondria "HPA010134: AB_1079645, HPA017068: AB_1855495" "unprognostic (3.15e-3)" "unprognostic (1.80e-2)" "unprognostic (5.86e-3)" "unprognostic (1.89e-2)" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.37e-1)" "unprognostic (7.51e-2)" "unprognostic (3.29e-1)" "unprognostic (7.67e-2)" "prognostic unfavourable (5.13e-5)" "unprognostic (7.98e-2)" "unprognostic (2.17e-1)" "unprognostic (9.61e-2)" "unprognostic (1.44e-3)" 21.8 28.3 33.2 15.9 41.0 13.4 16.4 26.6 51.1 29.8 27.5 14.3 28.9 18.1 14.6 37.0 13.3 28.3 30.4 37.3 31.0 26.5 42.4 107.0 23.4 34.2 33.2 23.6 18.1 18.8 22.3 15.6 28.1 26.8 34.8 25.1 15.9 27.3 27.1 33.8 12.9 15.9 16.6 25.7 18.0 29.5 23.3 20.6 11.6 29.7 15.3 16.3 19.0 13.4 64.0 32.7 44.9 35.4 38.4 43.3 38.9 15.2 20.0 14.7 23.0 22.1 18.7 27.1 9.6 20.8 22.8 25.7 32.8 15.1 17.9 19.3 16.0 15.8 28.2 18.0 16.1 37.1 35.2 26.0 36.6 48.4 24.2 16.8 11.6 25.4 17.8 15.6 4.5 24.6 19.1 23.3 20.2 43.7 21.8 40.1 14.6 20.5 21.5 14.8 14.9 26.2 23.2 14.2 12.0 6.9 46.9 27.3 15.6 16.3 15.2 9.5 16.3 11.2 13.0 9.7 9.9 19.2 24.2 27.7 11.4 33.7 35.4 44.9 32.1 34.1 30.4 64.0 35.1 38.3 32.7 52.0 38.8 37.3 9.8 38.4 31.0 30.4 43.3 38.9 33.2 41.0 26.6 51.1 31.0 26.5 33.2 23.6 26.8 20.6 PNLDC1 "dJ195P10.2, FLJ40240" ENSG00000146453 "PARN like, ribonuclease domain containing 1" Q8NA58 6 159800249-159820704 "Enzymes, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 26.7" "Cell line enhanced" "Detected in some" "AN3-CA: 1.8;HAP1: 2.3;hTCEpi: 3.8;RPMI-8226: 2.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basal ganglia: 5.7;cerebral cortex: 3.9" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.8;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA052026 Uncertain "HPA052026: " "unprognostic (1.58e-1)" "unprognostic (3.88e-2)" "unprognostic (1.01e-2)" "unprognostic (2.39e-3)" "unprognostic (8.47e-3)" "unprognostic (3.55e-2)" "unprognostic (2.04e-1)" "unprognostic (4.24e-1)" "unprognostic (1.01e-1)" "unprognostic (5.37e-2)" "unprognostic (4.19e-1)" "unprognostic (9.98e-2)" "unprognostic (2.69e-9)" "unprognostic (1.14e-2)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.24e-1)" 0.6 0.5 0.6 0.5 5.7 0.4 1.4 0.2 3.9 0.3 0.3 0.3 0.0 0.2 0.3 1.3 0.2 3.6 0.3 0.2 0.7 0.2 0.8 0.8 0.5 0.4 0.4 0.7 0.8 2.3 0.3 0.3 0.3 0.3 0.4 0.3 0.0 1.2 0.4 0.5 1.4 0.3 0.3 0.4 0.5 0.3 26.7 0.3 0.5 0.4 0.3 0.7 0.2 0.0 0.1 1.7 0.0 1.8 0.4 1.0 0.4 0.0 0.4 0.2 1.8 1.0 0.0 1.1 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.2 0.3 0.1 2.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.0 3.8 0.0 0.1 0.0 0.1 0.8 0.2 0.1 0.8 0.1 0.9 0.8 0.1 0.0 2.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.2 0.3 0.0 0.3 0.7 0.1 0.0 0.6 0.1 0.0 0.2 0.0 0.1 1.8 0.0 0.0 0.2 0.0 0.7 0.1 1.0 0.1 0.0 0.4 0.0 1.7 0.5 0.4 0.6 5.7 0.2 3.9 0.7 0.2 0.4 0.7 0.3 0.3 PNPLA6 "iPLA2delta, NTE, SPG39, sws" ENSG00000032444 "Patatin like phospholipase domain containing 6" Q8IY17 19 7534004-7561764 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007522 Uncertain "HPA007522: AB_1079649" "unprognostic (2.73e-1)" "unprognostic (1.02e-1)" "unprognostic (1.52e-1)" "unprognostic (3.23e-2)" "unprognostic (2.78e-1)" "prognostic favourable (5.25e-4)" "unprognostic (3.53e-3)" "unprognostic (1.50e-1)" "unprognostic (2.07e-2)" "unprognostic (1.62e-1)" "prognostic favourable (3.51e-5)" "unprognostic (3.36e-1)" "prognostic favourable (7.53e-4)" "unprognostic (3.10e-3)" "unprognostic (3.50e-1)" "unprognostic (3.25e-1)" "unprognostic (2.17e-1)" 12.9 19.7 25.9 25.0 29.3 22.3 17.8 22.1 35.8 10.2 15.9 26.1 10.0 26.3 13.7 6.3 16.4 12.6 14.0 12.0 22.6 19.1 17.1 13.7 30.4 17.6 36.3 19.2 12.5 14.2 15.6 21.6 13.9 29.2 13.4 8.9 15.8 13.7 14.3 27.0 15.3 28.7 14.5 23.5 28.3 12.2 31.3 33.0 7.1 14.7 6.1 8.8 15.9 14.7 3.8 7.3 21.8 19.0 5.0 3.9 4.1 13.0 31.6 6.2 15.0 10.9 15.8 14.4 17.0 17.5 13.3 12.3 7.4 18.1 10.8 29.0 22.0 16.8 5.3 16.0 6.9 26.3 12.2 7.1 16.9 5.5 12.6 7.9 22.3 13.7 9.3 17.1 9.9 26.1 5.8 14.9 11.8 6.2 8.7 10.4 6.8 29.0 7.0 3.7 12.7 11.8 12.5 7.9 13.7 14.5 6.6 18.5 5.8 11.4 27.6 16.1 9.5 22.1 17.8 17.7 11.4 4.8 27.1 9.4 15.1 7.9 6.1 21.8 3.5 12.1 3.5 3.8 2.5 3.8 7.3 2.8 2.2 2.9 1.9 5.0 19.0 2.4 3.9 4.1 25.9 29.3 22.1 35.8 22.6 19.1 36.3 19.2 29.2 33.0 PNPLA7 "C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2" ENSG00000130653 "Patatin like phospholipase domain containing 7" Q6ZV29 9 137459953-137550534 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in some" 23 "HMC-1: 42.8" "Cancer enhanced" "Detected in many" "prostate cancer: 9.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6;T-reg: 3.5" "Group enriched" "Detected in many" 5 "B-cells: 3.6;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009130 Uncertain Uncertain "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "HPA009130: AB_2268411" "unprognostic (1.49e-1)" "unprognostic (1.40e-2)" "unprognostic (3.61e-3)" "unprognostic (2.38e-2)" "unprognostic (3.68e-2)" "unprognostic (6.69e-3)" "unprognostic (2.72e-3)" "unprognostic (5.14e-4)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "prognostic favourable (2.24e-5)" "unprognostic (1.09e-1)" "unprognostic (2.23e-3)" "unprognostic (2.42e-1)" "unprognostic (6.80e-2)" "unprognostic (8.81e-2)" "unprognostic (3.45e-3)" 9.3 5.6 10.6 2.8 11.0 2.8 6.3 17.0 11.4 6.4 4.5 6.7 3.8 3.1 7.6 2.1 2.2 5.8 4.7 4.8 8.4 2.6 2.3 7.4 4.1 5.4 9.7 9.7 9.7 17.7 3.3 7.1 1.1 6.6 14.7 2.1 5.4 18.7 4.8 19.1 15.4 4.8 7.2 6.7 5.4 9.6 1.8 11.6 0.4 7.6 4.2 2.8 7.8 3.7 3.6 0.7 0.0 0.4 0.0 3.5 0.5 0.0 0.5 0.1 0.2 0.4 0.3 0.2 0.4 0.4 0.1 0.1 0.0 0.2 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.8 0.4 0.4 0.4 0.1 0.2 0.2 42.8 0.6 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.8 0.1 0.7 0.0 0.4 1.0 0.7 1.3 0.0 0.1 0.8 0.2 0.0 0.3 0.1 1.9 0.6 0.3 0.0 0.0 0.2 0.0 0.4 0.1 0.1 0.6 0.4 0.0 0.0 0.4 0.0 0.8 0.3 0.0 0.8 0.5 0.4 0.7 3.6 1.2 0.9 0.0 0.0 0.1 0.4 3.5 0.5 10.6 11.0 17.0 11.4 8.4 2.6 9.7 9.7 6.6 11.6 PNPLA8 "IPLA2-2, IPLA2G, iPLA2gamma" ENSG00000135241 "Patatin like phospholipase domain containing 8" Q9NP80 7 108470422-108569666 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020083 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA020083: AB_1851849" "unprognostic (4.48e-2)" "unprognostic (3.37e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (4.61e-1)" "unprognostic (2.73e-2)" "unprognostic (3.48e-2)" "unprognostic (3.32e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (2.49e-1)" "prognostic favourable (1.86e-6)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (4.28e-3)" "unprognostic (1.24e-1)" 21.5 35.7 29.3 12.4 28.9 51.5 15.0 15.6 27.2 15.4 13.4 9.5 9.3 8.6 13.4 13.7 18.3 9.7 15.9 17.9 23.0 22.1 23.1 24.6 16.7 12.0 20.7 17.5 15.6 10.1 20.7 33.4 25.2 23.2 14.4 11.4 6.0 11.4 13.9 29.8 11.4 10.8 15.3 20.3 19.5 11.1 10.8 21.1 16.1 22.6 13.0 15.3 22.5 12.8 20.0 19.3 16.7 26.8 14.6 12.5 13.7 14.0 6.3 11.2 10.0 25.0 17.2 16.6 13.4 23.7 11.0 18.4 6.1 8.1 7.8 16.9 13.1 5.3 19.0 8.5 16.8 11.7 5.2 5.3 10.4 4.5 18.3 3.7 11.1 15.6 16.2 14.8 13.7 14.8 6.3 22.5 13.7 9.2 8.6 8.8 4.9 9.0 3.2 11.8 16.6 13.2 17.8 9.3 13.1 12.8 13.9 16.0 5.8 6.3 12.0 18.2 8.1 27.0 7.3 19.1 19.3 11.6 17.3 5.7 11.7 14.1 19.7 16.7 10.5 21.8 12.5 20.0 10.3 10.3 19.3 18.7 11.2 10.7 16.5 14.6 26.8 7.6 12.5 13.7 29.3 28.9 15.6 27.2 23.0 22.1 20.7 17.5 23.2 21.1 PODXL "Gp200, PC, PCLP" ENSG00000128567 "Podocalyxin like" O00592 7 131500262-131558217 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 36.0;NTERA-2: 48.7;TIME: 54.4;U-251 MG: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220" Enhanced Approved "Vesicles,Plasma membrane,Centriolar satellite" 43000000 "Plasma membrane, Centriolar satellite" Vesicles "CAB016169: AB_628165, CAB062558: , CAB068219: , CAB068220: , HPA002110: AB_1855512, HPA045507: AB_2679356" "unprognostic (1.26e-1)" "unprognostic (7.68e-2)" "unprognostic (8.28e-3)" "unprognostic (6.46e-3)" "unprognostic (5.16e-3)" "unprognostic (5.85e-2)" "unprognostic (1.63e-2)" "unprognostic (1.05e-1)" "unprognostic (7.95e-3)" "unprognostic (3.52e-1)" "unprognostic (9.20e-3)" "unprognostic (3.40e-1)" "prognostic favourable (2.89e-4)" "unprognostic (2.56e-1)" "unprognostic (8.78e-3)" "unprognostic (3.55e-2)" "unprognostic (1.03e-1)" 8.8 4.9 8.2 3.8 8.9 0.8 7.6 4.8 13.5 11.7 5.0 4.6 16.0 2.8 14.5 2.7 4.4 22.1 7.9 19.3 6.7 6.7 30.6 3.0 14.7 2.6 7.2 5.9 6.1 20.4 7.5 4.0 12.5 15.2 4.5 3.7 15.5 9.1 27.8 5.7 3.8 4.8 12.8 8.1 2.9 4.6 3.5 6.6 0.0 14.0 5.2 2.5 6.1 8.3 1.1 0.3 2.2 0.3 0.4 0.8 0.3 5.0 2.4 4.1 1.8 0.1 0.0 0.3 0.6 0.5 1.8 0.7 12.3 7.9 0.0 11.8 36.0 3.6 4.0 0.0 1.2 0.6 2.0 0.0 15.0 0.2 0.1 0.4 0.4 0.0 0.0 6.5 0.0 14.5 1.2 0.2 1.5 1.4 0.0 0.0 48.7 4.9 2.0 7.3 1.5 0.2 2.2 3.7 0.9 4.4 0.5 0.0 0.4 0.1 54.4 0.7 2.9 7.4 21.6 0.3 0.5 0.1 2.8 2.0 4.3 0.7 0.3 2.2 0.6 0.2 0.5 0.3 0.5 0.8 0.0 1.1 0.4 0.4 1.1 0.4 0.2 0.3 0.4 0.3 8.2 8.9 4.8 13.5 6.7 6.7 7.2 5.9 15.2 6.6 PODXL2 "endoglycan, PODLX2" ENSG00000114631 "Podocalyxin like 2" Q9NZ53 3 127629181-127672809 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.8" "Cell line enhanced" "Detected in many" "RPMI-8226: 32.0;SCLC-21H: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024934, HPA042265" Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "CAB024934: , HPA042265: " "unprognostic (2.07e-2)" "unprognostic (2.34e-1)" "unprognostic (7.02e-2)" "unprognostic (1.07e-2)" "unprognostic (9.74e-2)" "unprognostic (1.79e-2)" "unprognostic (8.97e-3)" "unprognostic (1.81e-1)" "unprognostic (3.89e-1)" "unprognostic (2.67e-1)" "unprognostic (4.05e-3)" "unprognostic (3.48e-1)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.67e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-3)" 3.0 16.1 19.1 2.6 19.7 1.8 8.1 31.4 42.8 3.0 8.3 9.0 1.6 6.6 4.5 2.5 2.8 4.3 4.4 2.5 22.2 37.3 4.5 1.6 2.1 2.2 21.3 17.5 10.8 12.0 1.2 20.9 1.3 31.5 12.0 7.6 8.7 21.4 2.4 2.8 4.6 6.1 2.0 17.0 2.1 12.2 16.4 7.7 0.6 4.1 1.6 2.7 2.1 0.9 1.6 2.6 0.1 0.8 0.2 2.7 0.7 0.1 3.8 10.6 25.1 0.0 0.0 15.7 1.2 0.0 2.2 0.4 7.9 0.4 9.3 9.5 0.1 0.0 8.6 0.0 0.2 0.0 17.7 0.1 8.8 7.9 0.3 21.0 21.6 0.4 1.8 0.0 0.0 0.6 12.2 0.0 0.8 4.7 0.1 0.0 15.9 18.7 0.0 0.3 32.0 3.1 1.0 47.6 26.8 11.3 24.4 20.7 6.2 10.7 0.1 0.0 4.9 0.4 7.4 0.0 0.0 7.3 0.2 13.7 7.0 0.0 0.2 0.0 0.8 0.8 1.1 1.6 2.7 0.7 0.0 1.3 1.3 0.6 0.1 0.2 0.0 2.6 1.7 0.7 19.1 19.7 31.4 33.8 22.2 37.3 21.3 17.5 31.5 7.7 POMGNT1 "FLJ20277, LGMD2O, MEB, MGAT1.2" ENSG00000085998 "Protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)" Q8WZA1 1 46188682-46220305 "Disease related genes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044518 Approved 6300000 "HPA044518: AB_10795985" "unprognostic (4.59e-3)" "unprognostic (1.59e-1)" "unprognostic (2.13e-1)" "unprognostic (1.80e-1)" "unprognostic (2.24e-1)" "unprognostic (3.20e-1)" "prognostic unfavourable (3.52e-4)" "unprognostic (1.82e-1)" "unprognostic (5.74e-2)" "unprognostic (5.37e-2)" "prognostic favourable (4.27e-4)" "unprognostic (5.86e-2)" "unprognostic (4.39e-2)" "unprognostic (4.99e-3)" "unprognostic (1.72e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" 12.8 17.8 17.9 8.2 26.7 2.8 14.3 12.9 21.6 13.9 9.7 29.5 11.1 12.4 11.7 19.1 9.2 15.8 12.4 43.6 18.8 16.7 19.1 19.2 13.8 7.1 39.4 18.0 10.0 17.2 47.1 19.4 16.6 24.7 21.1 10.7 13.0 13.8 17.2 29.7 13.3 11.3 16.3 36.3 11.7 12.5 16.1 25.0 7.7 22.4 7.5 9.1 11.3 9.0 3.2 6.4 1.6 5.2 9.4 6.2 1.9 13.1 14.1 17.3 16.7 19.1 20.9 22.3 17.7 29.9 24.2 19.1 8.0 11.0 12.2 29.4 29.3 7.5 12.3 25.3 14.6 15.9 14.0 9.6 12.6 12.0 16.7 7.4 9.5 21.0 33.2 27.0 25.2 24.6 11.3 7.9 39.4 9.1 13.0 5.3 14.3 19.8 9.5 17.7 11.4 21.3 16.3 6.5 23.6 16.4 19.0 24.7 12.6 10.5 17.9 18.2 16.2 20.6 33.9 20.1 22.3 5.6 27.8 7.3 19.3 0.0 1.6 1.6 5.1 2.8 3.5 2.1 3.4 4.0 2.2 3.2 6.2 4.8 0.0 9.4 5.2 6.4 3.3 1.9 17.9 26.7 12.9 21.6 18.8 16.7 39.4 18.0 24.7 25.0 POMK "FLJ23356, SgK196" ENSG00000185900 "Protein-O-mannose kinase" Q9H5K3 8 43093506-43123434 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013321 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA013321: AB_2668809" "unprognostic (1.66e-2)" "unprognostic (1.12e-2)" "unprognostic (1.27e-1)" "unprognostic (4.37e-2)" "unprognostic (1.29e-1)" "unprognostic (4.62e-2)" "unprognostic (5.56e-2)" "unprognostic (2.42e-1)" "unprognostic (2.50e-1)" "unprognostic (8.10e-2)" "unprognostic (1.23e-3)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (7.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.10e-2)" 4.7 5.5 9.8 5.6 14.3 12.5 5.1 12.3 18.6 6.9 4.8 8.3 2.2 4.5 6.9 4.4 7.1 6.2 4.8 3.8 7.7 7.0 3.4 4.5 5.5 6.0 4.8 11.1 5.8 9.3 6.3 7.4 6.1 10.5 5.6 5.9 6.1 6.8 4.0 6.2 7.1 5.6 6.4 6.7 7.6 6.8 7.1 7.2 7.5 7.4 3.2 7.4 4.6 5.0 2.6 2.6 6.7 2.9 1.0 3.3 1.3 3.5 7.5 5.8 15.1 2.8 3.4 5.5 2.1 3.1 5.5 4.0 5.5 9.1 4.9 4.6 3.8 5.8 8.2 6.3 5.3 1.9 1.4 13.9 5.5 2.4 2.0 4.7 7.8 3.8 2.7 7.3 5.3 5.4 3.2 14.8 3.7 1.6 9.9 2.0 11.8 1.0 6.8 6.8 2.8 1.5 9.8 5.6 4.1 9.1 3.1 3.0 9.7 3.2 7.4 8.4 8.4 8.6 4.2 4.8 8.5 9.3 3.5 3.2 9.9 0.8 2.9 1.9 2.3 2.4 3.3 1.8 1.3 1.3 2.6 2.6 1.8 2.3 6.7 1.0 1.5 2.5 1.1 1.3 9.8 14.3 12.3 18.6 7.7 7.0 4.8 11.1 10.5 7.2 POMT2 LGMD2N ENSG00000009830 "Protein O-mannosyltransferase 2" Q9UKY4 14 77274956-77320884 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003663 Uncertain "HPA003663: AB_1079655" "unprognostic (2.15e-1)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (2.40e-4)" "unprognostic (7.10e-3)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-3)" "unprognostic (1.94e-3)" "unprognostic (8.50e-3)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.75e-3)" "unprognostic (3.46e-2)" 6.7 10.8 10.4 6.8 11.4 3.8 7.7 12.5 13.3 6.8 6.3 18.0 9.8 4.6 6.9 17.1 5.7 8.7 6.9 7.7 9.3 7.7 8.1 8.3 6.2 3.0 11.7 6.2 7.6 10.6 14.7 16.1 11.4 9.7 7.3 5.8 8.2 10.1 12.3 17.0 4.3 4.6 7.8 8.4 5.2 5.6 30.9 14.4 2.5 11.5 4.9 3.8 5.7 5.0 1.4 1.9 0.8 1.9 0.0 1.7 0.4 10.6 13.6 13.3 15.0 9.5 7.6 10.6 9.4 7.7 14.0 12.0 6.7 9.6 3.1 7.6 8.8 11.9 6.2 9.4 9.8 4.7 8.5 1.9 6.8 5.5 11.6 2.1 6.4 7.7 10.0 13.1 12.9 8.1 5.0 7.5 9.2 21.0 3.6 10.3 3.7 11.6 3.6 12.9 2.9 14.6 7.8 11.2 11.0 6.1 10.4 7.8 10.7 4.5 6.7 10.6 16.8 12.2 8.2 4.9 9.6 1.4 5.4 3.3 9.3 0.0 0.4 0.0 1.7 1.9 0.4 1.4 0.0 0.3 0.9 0.2 0.1 0.0 0.8 0.0 0.8 1.9 0.0 0.4 10.4 11.4 12.5 13.3 9.3 7.7 11.7 6.2 9.7 14.4 POR "CYPOR, FLJ26468" ENSG00000127948 "Cytochrome p450 oxidoreductase" P16435 7 75899200-75986855 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.4" "Cell line enhanced" "Detected in all" "SK-BR-3: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004372, HPA010136" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "CAB004372: AB_627391, HPA010136: AB_1079657" "unprognostic (1.89e-1)" "unprognostic (1.53e-1)" "unprognostic (2.81e-3)" "unprognostic (8.67e-2)" "prognostic unfavourable (8.54e-4)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (4.32e-2)" "unprognostic (1.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (9.31e-2)" "unprognostic (1.71e-1)" "unprognostic (3.94e-2)" "unprognostic (9.89e-2)" 12.8 48.2 7.4 7.5 10.8 3.6 15.0 5.3 16.4 11.0 20.8 9.6 32.1 24.9 9.0 8.2 13.4 12.8 9.9 8.4 7.1 7.2 12.0 78.4 13.7 9.9 5.2 10.1 14.4 12.8 12.1 18.5 18.6 7.1 9.3 5.3 10.8 7.8 58.7 13.1 10.0 24.3 7.0 5.2 11.7 9.8 22.4 5.0 8.2 33.3 9.9 8.6 9.8 10.2 5.7 20.6 26.7 18.4 11.2 9.9 13.9 12.7 27.9 12.8 23.7 48.5 18.4 21.4 5.3 17.5 10.1 14.1 20.9 56.7 12.2 4.9 11.6 6.2 16.8 8.4 4.3 10.4 12.4 5.6 8.2 38.7 33.7 5.6 10.1 37.8 10.6 13.3 9.7 9.4 16.9 5.3 9.1 18.7 6.1 10.1 15.9 15.8 8.7 8.4 13.1 11.4 15.4 13.4 12.8 14.4 73.3 19.3 21.0 9.6 8.4 9.5 10.5 14.3 10.5 5.2 8.0 8.3 13.4 8.6 12.2 26.7 18.4 25.3 9.9 17.7 8.3 5.4 8.4 9.2 20.6 5.7 8.4 7.1 24.3 11.2 13.0 5.8 8.7 13.9 7.4 10.8 5.3 16.4 7.1 7.2 5.2 10.1 7.1 5.0 PPFIA1 "LIP.1, LIPRIN" ENSG00000131626 "PTPRF interacting protein alpha 1" Q13136 11 70270700-70385312 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 78.4;SK-MEL-30: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017032, HPA042271" Uncertain Supported "Focal adhesion sites,Cytosol" Cytosol "Focal adhesion sites" "CAB017032: , HPA042271: " "unprognostic (1.89e-1)" "unprognostic (1.28e-2)" "unprognostic (6.27e-2)" "unprognostic (9.92e-2)" "unprognostic (1.18e-1)" "prognostic unfavourable (5.58e-4)" "unprognostic (7.20e-3)" "unprognostic (2.20e-1)" "unprognostic (3.02e-2)" "unprognostic (5.45e-3)" "prognostic unfavourable (8.26e-4)" "unprognostic (1.14e-1)" "prognostic favourable (3.76e-4)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (2.14e-2)" 28.9 18.6 20.9 17.5 20.8 20.8 40.5 22.8 24.1 15.9 18.3 27.7 18.5 15.5 26.2 20.4 19.4 16.9 23.9 19.3 19.7 12.0 18.1 15.5 25.4 15.9 18.9 17.8 21.0 17.7 21.2 34.1 24.9 20.7 13.8 16.3 21.9 19.0 18.5 38.7 24.2 17.8 18.4 30.0 14.7 15.6 29.8 22.5 17.0 25.2 10.0 13.6 18.7 18.6 2.6 2.8 10.0 4.8 1.1 2.2 1.0 78.4 10.6 9.7 6.6 9.1 5.7 10.3 9.2 7.5 11.5 7.6 20.0 7.0 7.3 12.0 7.4 11.4 8.2 7.9 9.9 4.9 5.7 5.9 11.1 6.4 9.3 7.7 7.2 7.2 12.7 14.7 12.1 7.4 9.9 6.0 9.9 10.7 5.3 4.6 5.8 9.1 6.1 24.5 6.4 5.6 10.8 9.5 6.4 13.7 17.3 45.1 11.6 8.2 10.1 11.5 9.0 15.9 9.7 7.3 4.6 10.3 9.5 5.4 13.4 0.0 3.6 1.7 1.3 1.9 2.2 2.6 2.2 1.9 2.8 2.3 1.7 1.0 10.0 1.1 4.8 2.8 2.1 1.0 20.9 20.8 22.8 21.4 19.7 12.0 18.9 17.8 20.7 22.5 PPIL3 CyPJ ENSG00000240344 "Peptidylprolyl isomerase like 3" Q9H2H8 2 200870907-200889303 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040765, HPA062187" Approved Supported Nucleoplasm 35000 Nucleoplasm "HPA040765: , HPA062187: " "unprognostic (8.96e-3)" "unprognostic (6.07e-2)" "unprognostic (5.34e-2)" "unprognostic (8.16e-2)" "unprognostic (2.69e-2)" "unprognostic (9.61e-2)" "unprognostic (8.31e-2)" "unprognostic (8.05e-2)" "unprognostic (1.40e-2)" "prognostic favourable (1.19e-4)" "unprognostic (5.23e-2)" "unprognostic (6.60e-2)" "prognostic unfavourable (5.16e-4)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" "unprognostic (2.21e-2)" "unprognostic (4.87e-2)" 12.4 17.9 18.1 15.5 19.2 24.2 21.1 20.1 20.2 19.4 16.4 18.4 21.1 12.7 17.2 24.3 25.4 19.1 15.9 17.6 17.5 21.8 15.9 19.4 15.9 23.7 20.0 11.8 31.4 16.7 11.9 17.4 15.5 23.0 19.5 16.6 16.3 13.8 15.8 13.4 14.7 15.7 16.8 23.2 20.2 15.7 18.2 13.0 26.3 23.7 19.4 25.5 28.6 13.6 23.4 21.7 18.7 14.1 20.6 20.6 10.7 7.9 7.1 22.0 9.5 17.3 37.1 7.2 12.8 13.8 14.7 14.9 5.2 15.2 7.6 13.5 13.7 10.5 7.6 15.5 13.2 16.2 18.5 32.4 19.9 35.0 8.9 31.0 16.5 13.4 15.3 12.0 19.1 9.8 25.6 18.8 18.8 12.7 23.8 24.7 13.4 11.4 9.0 12.3 12.1 19.4 12.4 9.1 8.5 12.9 12.2 20.5 10.2 14.1 13.3 21.3 12.0 12.6 10.5 20.6 19.5 36.1 16.2 13.9 13.4 18.7 12.7 12.7 12.7 10.8 18.5 23.4 15.6 13.7 21.7 18.9 19.1 20.6 3.0 20.6 14.1 17.9 20.1 10.7 18.1 19.2 20.1 20.2 17.5 21.8 20.0 11.8 23.0 13.0 PPM1L PP2CE ENSG00000163590 "Protein phosphatase, Mg2+/Mn2+ dependent 1L" Q5SGD2 3 160755602-161078907 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "HDLM-2: 34.9;U-266/70: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019891, HPA019953" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA019891: AB_1855631, HPA019953: AB_2170360" "prognostic unfavourable (4.90e-4)" "unprognostic (7.29e-3)" "unprognostic (2.01e-1)" "unprognostic (2.59e-2)" "unprognostic (8.03e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (1.63e-2)" "unprognostic (2.49e-2)" "unprognostic (1.92e-1)" "unprognostic (4.51e-2)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (9.13e-3)" "unprognostic (2.07e-1)" 7.7 8.5 7.4 3.5 11.5 3.3 6.3 15.8 23.2 11.3 7.0 5.5 1.1 3.0 6.2 3.7 8.7 6.1 12.6 9.9 6.3 7.8 8.4 6.0 4.6 1.9 8.0 10.1 3.7 5.4 33.6 26.3 11.5 13.8 9.6 5.9 5.6 18.9 3.7 25.7 7.6 3.6 16.4 4.6 3.4 8.4 2.8 3.7 5.6 14.4 9.6 3.5 16.6 10.8 0.7 1.3 4.9 7.6 1.1 2.6 2.0 1.1 0.7 4.0 2.1 2.3 0.0 2.5 0.2 0.1 0.4 0.1 0.2 0.2 0.2 0.4 0.1 3.6 3.3 0.2 0.1 34.9 3.5 3.4 3.3 0.4 0.1 2.1 4.0 0.4 1.6 0.1 0.2 0.2 0.1 5.5 0.0 1.8 0.8 0.2 2.3 0.8 4.1 0.7 0.8 0.1 3.7 4.8 4.1 2.0 2.3 0.1 2.7 2.1 0.2 0.4 0.4 0.3 1.3 34.9 0.1 1.9 0.6 1.7 0.8 0.7 2.3 4.9 2.6 5.5 0.2 0.2 0.6 1.7 1.3 0.7 1.0 1.8 0.2 1.1 7.6 0.8 0.0 2.0 7.4 11.5 15.8 17.9 6.3 7.8 8.0 10.1 13.8 3.7 PPP1R3A "GM, PPP1R3" ENSG00000154415 "Protein phosphatase 1 regulatory subunit 3A" Q16821 7 113876777-114075920 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "heart muscle: 24.1;skeletal muscle: 69.4;tongue: 75.4" "Cell line enriched" "Detected in single" 64 "THP-1: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 19 "thalamus: 1.2" "Low region specificity" "Detected in some" "HPA070440, HPA073138" Enhanced "HPA070440: , HPA073138: " "unprognostic (8.96e-3)" 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.7 0.0 0.0 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.4 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 75.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP1R3F Hb2E ENSG00000049769 "Protein phosphatase 1 regulatory subunit 3F" Q6ZSY5 X 49269843-49301461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "T-reg: 15.3" "Lineage enriched" "Detected in single" 16 "T-cells: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000244, HPA000918" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000244: , HPA000918: AB_2268692" "unprognostic (6.69e-2)" "unprognostic (2.87e-2)" "unprognostic (4.98e-4)" "unprognostic (1.83e-2)" "unprognostic (6.48e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.91e-2)" "unprognostic (2.89e-1)" "prognostic favourable (1.85e-6)" "unprognostic (5.99e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "unprognostic (2.76e-1)" "unprognostic (7.96e-2)" "unprognostic (1.55e-1)" 3.0 7.6 15.9 3.7 13.8 2.7 2.3 17.2 21.2 4.3 3.5 7.6 4.5 2.4 4.7 15.9 5.4 6.7 3.6 16.1 16.0 13.1 3.3 2.8 3.4 4.6 12.3 5.4 7.5 2.6 4.4 8.6 2.4 9.1 4.6 1.7 5.3 5.3 6.1 24.0 3.1 3.1 4.1 11.3 5.1 2.9 4.5 7.3 3.5 5.5 1.9 3.0 3.5 4.8 0.4 0.3 0.0 0.9 0.4 15.3 0.5 2.6 5.4 4.8 5.3 6.6 4.7 2.3 3.1 4.8 2.1 3.3 3.8 3.1 3.1 0.6 2.3 4.2 1.8 1.3 1.1 17.0 5.9 0.3 3.1 0.3 4.3 0.4 1.9 3.3 3.9 2.2 1.7 0.5 0.8 1.3 2.5 9.3 1.2 4.2 14.7 10.2 6.9 4.1 1.0 2.1 1.2 5.6 4.8 1.6 0.6 8.0 4.8 2.7 2.5 5.9 1.2 5.2 2.3 3.9 4.8 2.1 2.0 6.6 7.5 0.0 0.2 0.0 0.2 0.4 1.0 0.4 3.0 1.0 0.2 0.1 2.4 1.1 0.0 0.4 0.9 0.3 15.3 0.5 15.9 13.8 17.2 19.3 16.0 13.1 12.3 5.4 9.1 7.3 PQLC2L C3orf55 ENSG00000174899 "PQ loop repeat containing 2 like" A1A4F0 3 157543246-157677749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.8;breast: 36.0" "Cell line enhanced" "Detected in some" "ASC diff: 33.6;ASC TERT1: 18.6;EFO-21: 12.7;HSkMC: 12.1;LHCN-M2: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA054395 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA054395: " "unprognostic (1.25e-1)" "unprognostic (1.19e-1)" "unprognostic (6.80e-2)" "unprognostic (1.41e-2)" "unprognostic (3.80e-3)" "unprognostic (1.65e-3)" "unprognostic (1.83e-5)" "unprognostic (2.29e-2)" "unprognostic (2.67e-1)" "unprognostic (3.56e-2)" "unprognostic (3.34e-2)" "unprognostic (4.59e-3)" "unprognostic (7.47e-7)" "unprognostic (1.17e-3)" "unprognostic (2.75e-1)" "unprognostic (4.81e-2)" "unprognostic (7.56e-3)" 29.8 1.6 0.2 1.8 1.3 0.1 36.0 0.0 0.8 5.3 4.1 0.0 0.0 0.1 1.3 2.0 3.1 1.8 4.3 5.6 0.3 1.2 4.5 0.1 8.4 1.6 0.5 0.1 0.4 1.4 0.1 5.9 2.6 1.3 3.9 1.4 4.6 4.5 1.0 4.8 2.2 1.6 3.4 0.3 0.1 3.8 2.7 0.0 0.0 11.8 3.0 0.5 4.2 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 0.0 0.0 33.6 18.6 0.0 1.7 3.5 0.7 1.0 0.0 2.4 0.0 12.7 5.3 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 2.6 0.0 0.0 12.1 0.6 5.2 0.3 5.3 0.3 0.0 16.9 0.1 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.1 2.1 0.0 0.1 0.1 1.1 0.0 4.8 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 1.3 0.0 0.8 0.3 1.2 0.5 0.1 1.3 0.0 PREB SEC12 ENSG00000138073 "Prolactin regulatory element binding" Q9HCU5 2 27130756-27134675 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013582, HPA014133" Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA013582: AB_1855694, HPA014133: AB_1855695" "unprognostic (2.32e-1)" "unprognostic (2.11e-1)" "unprognostic (2.66e-2)" "unprognostic (1.61e-1)" "unprognostic (2.01e-2)" "unprognostic (1.21e-2)" "unprognostic (4.96e-3)" "unprognostic (1.44e-1)" "unprognostic (9.89e-2)" "unprognostic (1.21e-3)" "unprognostic (1.24e-2)" "unprognostic (2.69e-1)" "unprognostic (2.33e-3)" "unprognostic (5.13e-2)" "unprognostic (4.14e-2)" "unprognostic (5.25e-2)" "unprognostic (1.28e-2)" 18.7 17.1 11.4 14.4 12.3 7.9 15.7 13.8 16.9 18.5 15.5 14.9 29.1 13.4 23.6 51.1 15.1 17.6 14.2 19.5 13.8 12.5 21.2 70.1 12.9 15.3 13.0 11.8 27.3 31.5 13.8 17.0 21.5 12.9 16.2 13.2 14.8 42.3 22.4 46.3 11.0 17.3 19.4 11.6 19.8 14.9 15.6 10.1 17.6 19.6 16.3 19.5 15.1 14.2 22.1 35.1 45.8 28.3 28.9 27.0 27.2 15.1 15.2 8.8 14.0 19.3 7.5 16.4 10.9 11.0 15.9 11.2 14.2 9.5 18.8 11.6 10.8 8.7 17.3 13.8 8.7 14.1 15.8 15.4 7.7 30.7 28.5 17.6 14.6 7.3 16.7 15.0 17.3 10.3 11.3 17.0 13.6 17.5 16.3 13.7 9.2 16.2 15.4 17.8 88.1 10.5 8.0 20.0 10.8 10.6 21.9 15.7 9.8 30.3 6.1 8.5 12.4 7.4 12.2 37.9 15.8 22.8 14.3 20.1 16.2 28.2 28.3 45.8 24.7 23.4 27.0 22.1 21.1 25.0 29.5 20.1 20.5 21.1 12.0 28.9 24.3 35.1 22.8 27.2 11.4 12.3 13.8 16.9 13.8 12.5 13.0 11.8 12.9 10.1 PRIMA1 PRIMA ENSG00000175785 "Proline rich membrane anchor 1" Q86XR5 14 93718298-93788481 "Predicted membrane proteins" "Neurotransmitter degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 26.2" "Cell line enhanced" "Detected in some" "HAP1: 7.3;Hep G2: 4.7;NTERA-2: 3.0;SCLC-21H: 12.9;SH-SY5Y: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 16.2" "Low region specificity" "Detected in all" "HPA046671, HPA060047" Approved Approved "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoli, Cytosol" "HPA046671: , HPA060047: " "unprognostic (3.60e-2)" "unprognostic (1.97e-1)" "unprognostic (7.54e-2)" "prognostic unfavourable (6.99e-5)" "unprognostic (1.03e-2)" "unprognostic (3.73e-2)" "unprognostic (1.07e-1)" "unprognostic (5.81e-2)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (8.94e-2)" "unprognostic (6.61e-3)" "prognostic unfavourable (2.62e-7)" "unprognostic (2.33e-2)" "unprognostic (2.67e-1)" "unprognostic (7.94e-4)" "unprognostic (4.57e-3)" 4.6 6.0 4.2 5.9 16.7 0.4 2.4 4.5 8.2 7.7 26.2 21.7 4.2 4.6 7.9 7.9 13.7 10.7 3.3 4.8 5.8 3.3 1.2 0.7 1.0 0.7 20.2 4.0 6.9 1.2 0.6 0.3 2.2 15.5 8.6 7.6 9.9 4.6 10.2 0.7 2.1 11.6 14.9 24.3 0.7 12.1 1.8 14.7 0.0 1.3 0.9 4.4 4.7 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.3 0.0 0.0 0.2 0.4 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.0 0.0 0.0 0.0 0.3 0.0 0.0 12.9 7.3 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 16.7 4.5 8.2 5.8 3.3 20.2 4.0 15.5 14.7 PRKAA2 "AMPK, AMPKa2, PRKAA" ENSG00000162409 "Protein kinase AMP-activated catalytic subunit alpha 2" P54646 1 56645322-56715335 "Enzymes, Predicted membrane proteins, Transporters" "Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 39.1;skeletal muscle: 40.2" "Cell line enhanced" "Detected in many" "HEK 293: 8.5;RPTEC TERT1: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044540 Approved Supported "Nuclear speckles,Golgi apparatus" "Nuclear speckles" "Golgi apparatus" "HPA044540: " "unprognostic (4.17e-3)" "unprognostic (1.62e-2)" "unprognostic (4.17e-1)" "prognostic unfavourable (4.80e-4)" "unprognostic (9.35e-2)" "unprognostic (1.92e-3)" "prognostic unfavourable (5.30e-4)" "unprognostic (7.30e-2)" "unprognostic (3.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-1)" "unprognostic (8.64e-2)" "prognostic favourable (4.95e-5)" "unprognostic (1.30e-2)" "unprognostic (4.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.85e-1)" 2.4 2.1 3.7 1.2 6.3 0.7 4.1 7.2 8.1 2.2 5.5 1.2 2.4 1.2 3.0 3.2 6.3 3.5 2.6 39.1 4.2 2.9 14.5 1.4 2.0 0.8 2.4 6.2 2.5 2.6 10.4 2.6 1.2 5.0 4.6 2.2 6.0 4.5 3.5 40.2 1.4 2.1 7.2 1.9 1.9 3.2 1.7 0.8 0.0 4.0 12.3 0.8 4.4 2.1 0.2 0.0 1.0 0.1 0.1 0.1 0.0 0.0 3.7 2.0 0.0 0.7 0.5 2.3 1.8 1.4 2.5 4.3 3.8 4.7 0.0 0.6 0.6 0.0 7.8 0.0 7.1 0.0 8.5 0.0 6.9 5.2 0.0 0.0 0.1 0.6 0.0 3.5 0.3 0.8 0.0 0.0 1.0 0.1 0.0 0.0 5.5 5.4 0.0 0.0 0.0 14.0 1.2 2.0 5.4 5.7 0.1 0.0 3.2 0.0 0.0 1.5 2.3 2.7 6.3 0.0 0.0 0.0 4.5 0.0 1.1 0.5 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 3.7 6.3 7.2 8.1 4.2 2.9 2.4 6.2 5.0 0.8 PRND "dJ1068H6.4, DOPPEL, DPL, PrPLP" ENSG00000171864 "Prion like protein doppel" Q9UKY0 20 4721910-4728460 "Predicted membrane proteins, Transporters" Fertilization Prion "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 80.2" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 2.2;NTERA-2: 3.1;U-698: 1.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Region enriched" "Detected in single" 28 "pons and medulla: 6.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA043373 Enhanced "HPA043373: " "unprognostic (1.69e-1)" "unprognostic (3.66e-2)" "unprognostic (2.24e-2)" "unprognostic (8.46e-2)" "unprognostic (3.40e-2)" "unprognostic (3.47e-3)" "unprognostic (3.01e-1)" "unprognostic (6.41e-2)" "unprognostic (2.00e-2)" "unprognostic (1.56e-1)" "unprognostic (3.10e-1)" "unprognostic (5.85e-2)" "unprognostic (2.02e-3)" "unprognostic (6.11e-2)" "unprognostic (2.86e-1)" "unprognostic (2.45e-2)" "unprognostic (1.63e-3)" 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 1.1 0.7 0.2 0.0 2.5 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 6.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.1 80.2 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.9 0.5 2.2 0.5 0.6 0.4 0.1 0.2 0.4 0.1 0.3 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.2 0.3 0.0 0.0 0.6 0.0 2.2 0.0 1.1 0.2 0.2 0.1 0.3 3.1 0.0 0.2 0.0 0.0 0.3 0.4 0.3 0.4 0.0 0.1 0.1 0.3 0.1 0.4 0.3 0.6 0.4 0.1 0.3 0.1 1.3 0.2 0.2 0.0 2.2 0.5 0.5 0.3 0.3 0.2 0.6 0.4 0.2 0.2 0.9 0.3 0.3 1.4 0.6 0.5 0.5 0.3 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 6.0 0.0 PRNP "AltPrP, CD230, CJD, GSS, PRIP, PRP" ENSG00000171867 "Prion protein" P04156 20 4686236-4701590 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Growth arrest" Prion "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 108.1" "Lineage enriched" "Detected in all" 6 "granulocytes: 108.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042754, HPA043398" Enhanced Approved "Nuclear membrane,Vesicles,Cytosol" "Intracellular and membrane" 2200000 "Nuclear membrane, Cytosol" Vesicles "HPA042754: AB_10964203, HPA043398: " "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "prognostic unfavourable (2.96e-4)" "prognostic unfavourable (4.64e-4)" "prognostic unfavourable (2.52e-4)" "unprognostic (1.94e-2)" "prognostic unfavourable (7.41e-5)" "unprognostic (7.60e-3)" "unprognostic (2.50e-1)" "unprognostic (7.12e-2)" "unprognostic (3.44e-1)" "unprognostic (1.04e-1)" "unprognostic (6.75e-2)" "unprognostic (7.28e-3)" "unprognostic (3.37e-1)" "unprognostic (2.04e-1)" "unprognostic (1.69e-2)" 24.6 27.3 63.4 14.2 73.1 19.8 30.5 87.5 116.1 42.0 43.4 61.6 8.5 10.6 36.3 17.7 23.0 24.1 31.4 54.1 64.6 48.9 38.5 22.2 22.2 14.7 47.2 65.6 49.6 11.8 20.7 24.9 18.7 71.6 43.8 20.9 34.1 17.1 45.0 21.8 26.7 13.5 40.8 53.1 20.3 18.1 19.1 51.4 2.9 25.6 11.8 16.4 27.0 22.3 4.6 10.5 108.1 11.7 3.6 16.7 10.0 24.2 20.0 4.6 7.1 37.3 22.8 4.1 40.2 57.9 19.5 19.9 6.6 18.8 4.4 9.3 78.3 56.5 5.0 54.7 36.6 3.6 4.3 0.0 2.3 20.6 45.9 7.9 1.8 20.6 78.9 83.4 65.2 16.7 2.3 15.8 22.4 5.4 3.1 4.8 3.7 29.8 3.8 12.2 4.0 9.8 4.3 5.4 0.8 11.4 16.0 57.1 3.3 4.1 25.1 31.8 14.6 17.7 32.6 7.3 14.7 14.8 25.6 5.8 114.4 108.1 11.7 0.8 11.9 9.7 16.7 4.2 9.8 9.4 10.5 4.6 5.8 6.8 0.7 3.6 7.6 3.7 11.4 10.0 63.4 73.1 87.5 90.4 64.6 48.9 47.2 65.6 71.6 51.4 PROCR "CCD41, CD201, EPCR" ENSG00000101000 "Protein C receptor" Q9UNN8 20 35172073-35216240 "Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 77.8" "Cell line enhanced" "Detected in many" "HMC-1: 64.9;HUVEC TERT2: 101.2;TIME: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039461 Enhanced 1600000000 "HPA039461: AB_10673359" "unprognostic (1.51e-1)" "unprognostic (1.03e-1)" "unprognostic (4.12e-2)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (4.69e-2)" "unprognostic (4.69e-2)" "unprognostic (1.84e-1)" "unprognostic (1.52e-1)" "unprognostic (4.76e-2)" "unprognostic (5.22e-2)" "unprognostic (4.27e-1)" "prognostic unfavourable (7.62e-6)" "unprognostic (3.37e-2)" "unprognostic (2.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.19e-2)" 51.0 11.9 2.3 10.1 3.2 4.4 24.6 2.9 2.3 16.8 25.0 3.1 14.1 8.7 27.7 44.5 19.4 17.3 13.4 27.4 2.7 2.4 11.7 3.8 10.6 30.3 3.1 2.1 19.3 11.5 2.7 4.7 77.8 7.4 15.5 12.3 16.4 4.2 14.0 17.7 10.4 14.0 20.0 5.8 22.1 10.4 9.1 2.0 0.6 12.1 13.0 3.9 25.8 14.9 1.6 7.3 4.1 1.7 3.4 14.6 2.0 2.4 14.5 0.0 1.5 16.0 13.1 3.4 3.4 14.9 5.6 11.0 18.7 12.7 0.4 10.7 3.4 8.0 3.3 21.7 4.7 0.1 4.5 5.3 3.5 0.7 3.9 0.2 64.9 11.1 8.1 26.6 22.2 101.2 1.8 0.7 5.8 0.8 0.1 0.2 2.0 15.0 0.1 2.8 0.0 9.6 0.9 0.4 0.2 1.8 3.9 3.0 1.3 0.8 59.8 14.6 7.4 5.5 5.7 0.0 0.1 0.1 16.8 5.4 3.0 4.1 1.5 0.9 8.3 1.7 14.6 1.0 2.6 5.2 7.3 1.6 0.7 6.3 4.1 3.4 1.4 1.2 2.0 2.0 2.3 3.2 2.9 2.3 2.7 2.4 3.1 2.1 7.4 2.0 PROM1 "AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4" ENSG00000007062 "Prominin 1" O43490 4 15963076-16084378 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 52.4;salivary gland: 71.0" "Cell line enhanced" "Detected in some" "AF22: 13.5;CACO-2: 25.1;CAPAN-2: 10.7;EFO-21: 24.5;NTERA-2: 36.4;RPTEC TERT1: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA004922, CAB011525, HPA031053" Enhanced "CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: " "unprognostic (6.33e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-1)" "unprognostic (3.39e-1)" "unprognostic (2.81e-1)" "unprognostic (2.16e-1)" "unprognostic (2.39e-1)" "unprognostic (6.64e-2)" "unprognostic (2.18e-2)" "unprognostic (2.17e-1)" "unprognostic (1.21e-2)" "unprognostic (9.06e-2)" "prognostic favourable (2.56e-5)" "unprognostic (2.16e-2)" "unprognostic (1.02e-1)" "unprognostic (9.38e-2)" "unprognostic (1.17e-1)" 0.5 0.5 2.5 11.5 2.2 1.3 11.2 1.0 2.2 20.1 13.8 2.3 1.6 5.2 4.7 3.1 1.8 1.9 12.6 2.7 3.1 2.1 30.2 1.6 3.6 0.1 2.3 0.6 1.6 10.7 0.0 1.8 12.7 2.1 1.6 7.4 52.4 71.0 2.9 0.7 1.1 13.5 1.7 1.8 0.6 10.9 5.0 0.9 0.3 1.7 3.8 10.2 3.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 10.7 0.3 24.5 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 36.4 0.0 0.9 0.0 0.0 33.7 0.0 4.2 1.4 0.0 0.8 1.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.5 2.2 1.0 2.2 3.1 2.1 2.3 0.6 2.1 0.9 PROS1 PROS ENSG00000184500 "Protein S" P07225 3 93873033-93974066 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis" "Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 114.6" "Cell line enhanced" "Detected in many" "ASC diff: 42.5;ASC TERT1: 31.6;HSkMC: 28.6;SK-MEL-30: 45.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 6 "pons and medulla: 24.2" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007724, HPA023974" Approved "Secreted to blood" 3400000000 "HPA007724: AB_1079688, HPA023974: AB_1855738" "unprognostic (2.00e-2)" "unprognostic (2.81e-2)" "unprognostic (9.21e-2)" "unprognostic (8.03e-3)" "unprognostic (3.35e-2)" "unprognostic (2.41e-1)" "unprognostic (6.48e-2)" "unprognostic (3.07e-1)" "unprognostic (5.18e-2)" "unprognostic (3.12e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (1.10e-1)" "prognostic unfavourable (8.35e-4)" "unprognostic (4.90e-2)" "unprognostic (1.05e-2)" "prognostic unfavourable (4.42e-5)" 16.0 3.9 2.5 3.8 3.8 0.1 15.5 0.8 2.8 7.4 8.0 4.1 2.8 3.9 7.6 9.5 10.9 8.5 11.3 30.2 4.0 3.1 17.6 114.6 17.3 13.7 4.3 1.8 23.9 2.7 10.1 6.2 10.2 24.2 6.8 8.5 9.3 5.6 4.3 5.6 8.5 6.5 8.3 4.8 8.8 4.9 5.5 2.2 0.1 10.6 6.9 3.3 8.0 9.5 0.0 0.8 1.9 0.8 0.1 0.4 6.8 0.3 2.4 2.5 10.2 42.5 31.6 0.8 1.5 3.5 0.8 3.1 6.0 0.9 0.2 9.3 2.3 0.1 0.8 0.6 1.1 0.1 2.7 16.5 1.1 16.9 3.6 0.6 0.8 28.6 0.6 1.8 0.6 3.5 11.4 0.2 16.5 0.2 0.1 0.0 2.0 2.4 0.3 2.0 0.0 9.0 0.0 3.8 7.0 1.8 0.0 45.8 0.1 8.0 3.0 6.8 1.5 3.7 0.8 0.0 0.1 0.0 21.0 10.5 9.8 0.0 0.8 0.7 0.1 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 1.9 0.1 0.2 0.0 0.2 6.8 2.5 3.8 0.8 2.8 4.0 3.1 4.3 1.8 24.2 2.2 PRPS1 "CMTX5, DFN2, DFNX1" ENSG00000147224 "Phosphoribosyl pyrophosphate synthetase 1" P60891 X 107628424-107651026 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Deafness, Disease mutation, Gout, Mental retardation, Neurodegeneration, Neuropathy, Non-syndromic deafness, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA043760 Uncertain 140000 "HPA043760: " "unprognostic (4.47e-2)" "unprognostic (6.18e-2)" "unprognostic (2.57e-2)" "unprognostic (4.19e-3)" "unprognostic (2.30e-3)" "unprognostic (2.56e-3)" "unprognostic (3.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.46e-1)" "unprognostic (9.73e-2)" "unprognostic (1.91e-2)" "unprognostic (4.11e-2)" "unprognostic (2.85e-2)" "unprognostic (4.57e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-2)" "unprognostic (5.25e-2)" 16.8 19.0 18.8 18.7 22.4 33.5 13.0 27.0 30.3 13.5 12.1 20.5 7.0 7.3 16.6 10.4 11.8 17.6 9.6 19.9 19.0 26.5 18.5 45.1 14.9 25.4 21.8 17.5 21.4 17.8 20.0 18.2 10.0 26.9 14.9 12.4 15.0 11.2 12.4 31.2 8.4 10.8 20.0 19.3 19.4 10.8 11.3 13.6 32.3 29.9 11.3 28.6 16.9 10.7 18.2 8.5 12.6 8.7 14.4 22.1 11.6 20.2 30.2 13.4 15.5 7.5 5.9 4.6 59.7 12.4 34.0 28.8 13.0 8.7 33.5 25.9 21.7 8.3 39.9 12.3 34.9 16.6 24.8 17.8 30.0 16.9 6.9 33.0 13.3 6.7 7.2 20.6 13.5 11.6 28.4 40.6 15.7 10.9 22.3 17.8 48.5 26.1 26.0 21.5 26.9 13.3 11.7 22.1 11.9 29.6 17.9 12.0 8.2 13.8 6.9 22.1 10.4 24.2 23.6 13.9 22.7 36.5 11.4 35.8 13.8 4.8 5.2 12.6 15.7 8.2 17.6 17.0 19.7 19.3 6.2 18.2 22.1 18.7 3.1 14.4 8.7 8.5 20.1 11.6 18.8 22.4 27.0 30.3 19.0 26.5 21.8 17.5 26.9 13.6 PRRC1 FLJ32875 ENSG00000164244 "Proline rich coiled-coil 1" Q96M27 5 127517609-127555089 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039212 Supported Approved Vesicles 80000 Vesicles "HPA039212: AB_10794634" "prognostic unfavourable (9.35e-5)" "unprognostic (9.01e-2)" "unprognostic (5.26e-3)" "unprognostic (6.36e-2)" "unprognostic (2.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" "unprognostic (6.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-3)" "unprognostic (5.53e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-1)" "unprognostic (2.83e-1)" "unprognostic (3.45e-3)" "unprognostic (2.19e-1)" 19.1 22.3 9.2 13.3 10.2 14.3 19.3 12.7 11.0 24.0 23.3 13.0 24.5 19.5 26.5 21.9 23.0 17.6 18.0 17.2 8.5 8.5 26.5 40.0 17.1 21.1 11.3 8.3 25.2 55.7 28.0 38.6 42.3 10.8 18.2 21.9 17.2 47.6 24.5 13.1 21.3 36.7 17.8 12.5 19.4 18.4 18.0 11.9 30.4 23.4 16.7 28.3 21.7 19.7 14.3 13.3 11.5 11.6 10.1 20.7 9.7 13.0 13.4 20.1 15.2 27.2 34.9 23.5 23.1 26.0 20.7 32.9 22.9 15.4 14.6 24.2 36.8 11.9 15.6 28.7 32.2 20.2 10.9 12.7 13.5 19.8 15.7 11.7 16.7 23.8 21.1 21.9 25.7 22.0 10.9 18.0 23.9 14.8 22.9 12.7 11.5 17.7 8.9 26.6 18.9 16.3 16.5 14.7 11.4 18.1 19.8 17.0 21.2 15.4 25.9 19.1 14.3 22.2 16.2 15.2 11.3 19.2 22.5 18.8 18.7 11.5 9.9 7.7 16.8 11.6 20.7 14.3 14.0 14.5 13.3 10.2 15.6 13.8 3.0 10.1 10.8 9.0 10.9 9.7 9.2 10.2 12.7 11.0 8.5 8.5 11.3 8.3 10.8 11.9 PRRG1 PRGP1 ENSG00000130962 "Proline rich and Gla domain 1" O14668 X 37349275-37457295 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078129 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA078129: " "unprognostic (8.82e-2)" "prognostic unfavourable (4.65e-4)" "unprognostic (8.34e-2)" "unprognostic (2.08e-3)" "unprognostic (1.92e-1)" "unprognostic (5.11e-3)" "unprognostic (2.24e-2)" "unprognostic (7.23e-3)" "unprognostic (1.01e-2)" "unprognostic (1.74e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (8.21e-2)" "prognostic favourable (2.05e-7)" "unprognostic (1.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.48e-1)" 11.6 5.5 12.0 3.1 22.0 0.7 5.8 2.6 18.7 6.7 5.7 35.9 4.6 4.1 6.2 2.5 5.9 4.0 12.4 8.5 17.9 10.7 14.9 10.7 6.3 2.5 31.0 9.9 6.2 2.6 1.2 2.3 10.6 21.3 5.1 6.0 3.0 3.9 11.6 19.3 3.1 4.3 7.5 43.4 4.0 3.4 2.4 23.7 0.0 11.6 2.9 1.6 5.9 4.5 0.6 0.2 2.6 1.7 0.2 0.4 0.1 14.7 3.4 2.7 2.7 9.2 7.5 1.2 6.2 8.4 2.3 4.0 8.1 9.5 0.0 10.9 4.9 4.8 7.4 4.7 3.9 0.0 2.4 2.6 3.5 2.7 11.3 0.0 3.4 11.6 4.0 4.4 3.7 11.7 1.2 0.0 7.8 1.1 0.0 0.0 3.3 7.0 0.0 6.1 0.0 38.6 0.7 0.0 0.0 4.6 7.3 2.8 0.0 1.6 8.3 3.5 2.1 6.8 1.9 0.0 0.0 0.0 3.5 0.0 3.3 2.6 1.7 0.1 0.2 0.5 0.2 0.6 0.1 0.3 0.1 0.4 0.2 0.4 0.8 0.2 0.2 0.2 0.2 0.1 12.0 22.0 2.6 13.9 17.9 10.7 31.0 9.9 21.3 23.7 PRRG2 PRGP2 ENSG00000126460 "Proline rich and Gla domain 2" O14669 19 49580646-49591015 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 8.6;CAPAN-2: 12.0;RT4: 9.2;SK-BR-3: 10.8;T-47d: 11.6;U-266/84: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010702 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA010702: AB_1079693" "unprognostic (2.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (1.04e-2)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (5.60e-1)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.67e-1)" "prognostic favourable (3.82e-9)" "unprognostic (4.89e-2)" "unprognostic (1.46e-1)" "unprognostic (6.58e-3)" "unprognostic (3.68e-2)" 0.9 0.4 0.5 1.1 0.6 0.0 4.8 1.1 1.3 4.0 14.3 0.4 17.5 8.3 1.9 9.6 13.7 3.3 9.8 0.7 0.5 0.4 15.0 12.1 5.2 0.4 0.7 0.4 1.9 13.4 13.8 16.1 8.6 0.7 5.4 5.3 0.7 24.9 14.6 1.2 10.1 23.2 1.4 0.5 1.0 7.1 1.7 0.4 2.1 21.9 9.8 7.8 4.2 4.2 1.2 4.2 2.1 0.9 0.0 1.4 0.4 8.6 0.3 0.2 0.7 1.1 0.0 3.7 0.2 0.0 0.3 0.3 1.7 12.0 0.5 1.3 0.1 7.0 0.2 6.8 0.3 0.8 0.9 0.4 0.5 0.6 0.7 0.3 0.9 0.7 6.0 0.2 0.2 2.7 0.2 0.6 0.0 1.9 0.1 0.7 0.5 1.1 0.2 0.3 6.7 5.3 9.2 1.9 0.2 1.0 10.8 0.1 11.6 0.1 0.4 0.7 0.5 0.3 0.1 4.2 14.0 0.4 0.1 0.3 0.3 0.0 0.9 0.4 1.4 0.1 0.7 1.2 0.6 0.6 0.1 0.7 0.8 0.7 2.1 0.0 0.7 4.2 0.6 0.4 0.5 0.6 1.1 1.3 0.5 0.4 0.7 0.4 0.7 0.4 PRRG3 TMG3 ENSG00000130032 "Proline rich and Gla domain 3" Q9BZD7 X 151695124-151705924 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.4;epididymis: 10.3" "Cell line enhanced" "Detected in some" "HeLa: 2.7;HMC-1: 2.2;NTERA-2: 4.1;U-2197: 2.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060566 Uncertain "HPA060566: " "unprognostic (1.85e-1)" "unprognostic (1.21e-1)" "unprognostic (7.71e-2)" "unprognostic (1.77e-2)" "unprognostic (4.42e-4)" "unprognostic (7.24e-2)" "unprognostic (2.29e-2)" "unprognostic (1.28e-1)" "unprognostic (2.06e-2)" "unprognostic (5.11e-2)" "unprognostic (3.01e-2)" "unprognostic (2.26e-1)" "unprognostic (1.98e-2)" "unprognostic (7.69e-2)" "unprognostic (4.64e-2)" "unprognostic (1.57e-1)" "unprognostic (1.84e-2)" 3.1 0.2 5.6 1.2 12.4 0.4 2.0 1.0 10.2 9.2 1.1 1.0 0.1 0.3 3.0 10.3 4.0 1.0 3.3 1.6 5.3 11.6 0.4 0.1 2.0 0.2 3.2 5.3 3.9 0.1 0.4 1.3 1.3 5.3 1.1 1.0 1.4 1.3 0.4 3.3 2.5 0.5 2.4 1.2 2.6 0.6 0.6 0.7 0.1 0.7 0.6 0.4 1.4 2.4 1.2 1.4 3.8 1.8 2.4 1.4 1.0 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.2 0.0 0.0 0.0 1.2 0.4 0.3 0.2 0.0 0.4 0.1 0.2 0.0 0.1 0.0 0.1 2.7 0.4 0.2 0.3 2.2 0.3 0.0 0.1 0.2 0.0 0.1 0.5 0.2 0.3 0.1 0.5 4.1 0.1 0.2 0.0 0.1 0.1 0.5 1.0 0.4 0.0 0.3 0.1 0.2 0.2 0.1 0.5 0.5 2.3 0.1 0.1 1.4 0.1 0.3 0.2 0.1 3.8 1.3 1.3 1.2 1.2 1.4 1.1 0.9 0.9 1.0 1.2 1.3 1.1 3.1 2.4 1.8 1.4 1.1 1.0 5.6 12.4 1.0 10.2 5.3 11.6 3.2 5.3 5.3 0.7 PRRG4 TMG4 ENSG00000135378 "Proline rich and Gla domain 4" Q9BZD6 11 32829943-32858123 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 30.4;hTCEpi: 16.4;SK-BR-3: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "neutrophil: 13.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009040, HPA024566" Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA009040: AB_1079694, HPA024566: AB_2237712" "unprognostic (3.30e-1)" "unprognostic (3.68e-2)" "unprognostic (1.14e-1)" "unprognostic (6.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (3.45e-2)" "unprognostic (2.06e-1)" "unprognostic (4.13e-1)" "unprognostic (3.24e-2)" "unprognostic (2.22e-3)" "unprognostic (3.22e-1)" "unprognostic (2.26e-3)" "unprognostic (3.16e-2)" "unprognostic (1.99e-1)" "unprognostic (2.41e-1)" "unprognostic (1.26e-2)" 1.4 1.4 1.1 3.3 1.7 2.8 7.9 0.7 0.8 7.5 15.7 1.0 13.5 5.3 2.0 5.8 27.6 3.9 5.6 2.1 1.5 1.5 15.7 16.7 10.3 0.5 2.6 0.1 2.0 3.3 1.3 10.6 22.0 1.7 8.9 4.6 2.2 12.7 17.1 1.0 15.4 15.8 1.7 1.7 2.2 3.9 1.0 1.8 3.5 21.0 20.1 12.0 5.6 16.6 0.3 0.5 13.2 2.6 0.3 0.2 0.5 7.3 0.3 0.0 0.1 0.1 0.0 3.2 0.0 3.7 0.8 1.6 3.5 7.3 0.0 0.2 0.0 30.4 0.8 1.9 0.3 0.2 5.0 1.5 1.1 0.2 0.0 0.5 1.4 0.2 16.4 0.3 0.1 0.0 0.0 0.5 0.3 3.3 0.6 3.3 0.3 0.9 0.0 0.0 0.9 5.6 9.4 1.0 0.1 5.1 12.8 1.5 9.2 7.2 0.1 0.4 0.5 1.7 0.7 3.3 2.3 0.0 0.9 4.2 1.4 0.7 2.6 0.2 0.1 0.9 0.1 0.1 0.1 0.1 0.5 0.3 0.1 0.2 13.2 0.3 0.8 0.2 0.1 0.5 1.1 1.7 0.7 0.8 1.5 1.5 2.6 0.1 1.7 1.8 PRRT2 "DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC" ENSG00000167371 "Proline rich transmembrane protein 2" Q7Z6L0 16 29811382-29815892 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Dystonia, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 86.7" "Cell line enhanced" "Detected in many" "AF22: 19.9;REH: 15.2;U-138 MG: 13.7" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 11 "NK-cells: 7.3" "HPA014447, HPA019203" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA014447: AB_1855786, HPA019203: " "unprognostic (7.60e-3)" "unprognostic (3.00e-1)" "unprognostic (8.32e-3)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (1.19e-3)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (9.30e-2)" "unprognostic (1.93e-1)" "unprognostic (4.45e-2)" "unprognostic (3.26e-2)" "unprognostic (3.43e-8)" "unprognostic (1.22e-1)" "unprognostic (1.17e-1)" "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" 3.7 7.2 27.2 2.8 40.5 0.8 2.1 86.7 53.6 10.1 6.0 6.0 3.1 6.2 20.7 8.3 4.4 10.2 10.3 5.3 18.9 13.0 2.1 0.9 5.7 3.5 5.5 33.2 35.7 2.4 8.6 17.6 7.1 18.0 16.2 2.6 5.2 4.6 14.4 4.3 3.1 6.8 10.3 7.4 1.8 7.3 9.9 10.2 0.0 2.8 0.3 1.6 5.1 10.7 0.2 0.0 0.5 0.2 7.3 0.6 0.3 0.3 1.2 19.9 7.4 1.0 3.8 0.5 2.4 4.0 0.8 0.9 1.1 2.3 0.2 0.5 3.3 2.0 2.7 0.4 0.3 5.3 1.6 1.3 8.9 0.8 0.2 0.0 0.3 3.4 0.1 1.4 0.1 1.0 0.2 1.6 0.6 3.3 0.5 0.6 5.7 1.0 15.2 1.1 0.4 0.1 0.7 4.3 4.5 0.2 2.9 0.4 7.4 0.1 1.1 13.7 4.8 0.8 1.3 3.4 0.4 0.1 5.4 0.1 0.5 0.5 0.0 0.1 0.2 0.1 0.3 0.1 0.6 0.4 0.0 0.2 0.4 0.2 0.2 7.3 0.2 0.0 0.1 0.3 27.2 40.5 86.7 53.6 18.9 13.0 5.5 33.2 18.0 10.2 PRSS48 ESSPL ENSG00000189099 "Serine protease 48" Q7RTY5 4 151277171-151291453 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.0;skin 1: 1.9;testis: 4.1" "Cell line enhanced" "Detected in some" "HHSteC: 1.4;LHCN-M2: 1.3;PC-3: 1.5;RT4: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053801 Uncertain "Secreted in male reproductive system" "HPA053801: " "unprognostic (9.68e-2)" "unprognostic (1.35e-2)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.76e-2)" "unprognostic (4.10e-2)" 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.5 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 PRSS8 ENSG00000052344 "Serine protease 8" Q16651 16 31131433-31135762 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 123.2;salivary gland: 143.7" "Cell line enhanced" "Detected in some" "BEWO: 57.3;CACO-2: 37.6;CAPAN-2: 25.8;hTCEpi: 37.0;SK-BR-3: 43.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "pons and medulla: 3.4" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA030436 Uncertain "Secreted - unknown location" 3500000 "HPA030436: AB_10602291" "unprognostic (1.88e-1)" "unprognostic (2.97e-1)" "unprognostic (9.34e-2)" "unprognostic (4.08e-1)" "unprognostic (6.83e-2)" "unprognostic (5.07e-3)" "unprognostic (5.78e-2)" "unprognostic (2.05e-1)" "unprognostic (2.26e-1)" "unprognostic (4.51e-2)" "unprognostic (8.74e-3)" "unprognostic (1.58e-1)" "prognostic favourable (2.05e-10)" "unprognostic (1.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.31e-1)" "unprognostic (3.63e-3)" 0.3 0.2 0.3 11.5 0.3 0.0 7.6 0.7 0.4 8.0 72.6 0.6 12.8 31.6 3.4 46.7 37.2 2.8 45.3 0.3 0.4 0.3 48.0 20.3 30.0 0.3 0.3 0.3 1.3 46.3 2.7 2.6 93.1 3.4 11.4 14.7 1.1 143.7 7.4 0.3 29.7 123.2 0.5 0.3 0.3 37.0 1.8 0.3 11.3 33.4 18.4 26.7 2.6 13.4 0.2 0.0 1.0 0.3 0.0 0.2 0.0 14.2 0.0 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.0 0.0 37.6 25.8 0.0 0.3 0.0 17.0 0.0 16.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 37.0 0.0 0.5 0.0 0.4 0.0 0.0 15.3 0.1 0.3 4.7 0.0 0.1 0.0 0.2 1.7 3.0 0.2 0.1 0.0 43.5 0.0 9.9 0.2 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.4 0.4 0.3 0.3 0.3 3.4 0.3 PRTG "FLJ25756, IGDCC5" ENSG00000166450 Protogenin Q2VWP7 15 55611546-55743090 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 16.5;thyroid gland: 23.9" "Cell line enriched" "Detected in many" 6 "AF22: 57.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 18 "monocytes: 1.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA032138 Approved "Vesicles,Plasma membrane,Cytosol" Cytosol "Vesicles, Plasma membrane" "HPA032138: AB_10669675" "unprognostic (2.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.32e-1)" "unprognostic (4.64e-2)" "unprognostic (2.07e-2)" "unprognostic (4.96e-4)" "unprognostic (1.82e-4)" "unprognostic (1.31e-1)" "unprognostic (3.19e-1)" "unprognostic (4.76e-3)" "unprognostic (1.37e-1)" "unprognostic (5.32e-2)" "unprognostic (5.67e-2)" "unprognostic (2.42e-6)" "unprognostic (8.81e-2)" "unprognostic (3.17e-2)" "unprognostic (2.70e-1)" 1.3 2.2 1.5 1.1 1.8 0.6 2.4 1.2 2.2 4.7 1.4 3.6 1.1 0.7 11.0 4.6 0.7 2.4 1.0 1.3 1.6 1.6 2.6 0.6 5.0 0.6 3.0 2.0 4.5 0.6 6.4 2.7 6.5 4.3 1.4 0.9 16.5 0.9 1.4 3.9 0.6 0.9 2.9 3.5 0.5 1.5 6.5 2.3 0.0 23.9 0.8 0.9 1.2 1.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.5 1.2 57.4 1.2 0.0 0.0 5.8 0.4 1.7 1.4 2.1 9.6 0.3 0.0 2.4 0.0 0.0 0.2 0.1 2.0 0.0 3.0 0.4 0.4 3.6 0.4 0.4 0.0 0.2 0.0 0.6 1.0 1.0 1.0 0.0 0.8 0.8 0.0 0.0 2.3 1.4 0.0 9.1 0.0 1.1 0.1 0.7 3.3 0.5 0.7 3.1 0.2 0.1 0.1 0.8 0.6 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.5 1.8 1.2 2.2 1.6 1.6 3.0 2.0 4.3 2.3 PRUNE2 "A214N16.3, bA214N16.3, BMCC1, BNIPXL, C9orf65, KIAA0367" ENSG00000106772 "Prune homolog 2" Q8WUY3 9 76611376-76906087 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 89.3" "Cell line enhanced" "Detected in many" "ASC diff: 21.5;LHCN-M2: 33.6;RH-30: 29.1;RPTEC TERT1: 16.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA022470, HPA031079" Uncertain "HPA022470: AB_1845832, HPA031079: AB_10603230" "unprognostic (1.21e-1)" "unprognostic (3.65e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (3.23e-1)" "unprognostic (2.43e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-2)" "unprognostic (3.60e-1)" "unprognostic (8.69e-2)" "unprognostic (2.11e-2)" "unprognostic (9.79e-2)" "prognostic favourable (1.37e-6)" "unprognostic (7.75e-2)" "unprognostic (1.06e-1)" "unprognostic (3.25e-3)" "unprognostic (3.80e-4)" 6.1 18.3 14.1 10.2 28.9 2.6 3.1 47.9 34.5 7.8 45.6 16.4 18.5 5.8 23.9 14.9 26.4 19.0 12.8 5.6 14.6 13.8 12.1 2.2 4.5 2.6 30.4 14.8 3.6 4.0 4.2 22.3 3.7 18.9 37.2 14.9 11.3 10.2 50.8 7.8 2.3 12.5 89.3 19.5 3.8 21.3 4.2 29.5 0.0 1.4 4.6 2.6 38.1 13.8 0.7 1.9 1.8 2.8 1.2 0.6 0.7 0.0 0.0 0.6 0.0 21.5 10.4 0.0 0.7 1.4 2.4 5.9 0.1 0.0 0.1 1.6 1.8 0.0 0.0 0.0 7.5 0.1 1.1 2.5 1.4 0.0 3.5 0.0 0.1 12.0 0.0 10.9 0.3 5.8 0.0 8.5 33.6 0.0 1.7 0.7 1.6 0.0 0.1 29.1 0.1 16.5 0.0 7.2 0.0 0.0 0.1 1.9 0.0 0.3 4.8 5.8 0.3 14.0 0.4 9.1 1.2 0.0 4.7 0.1 0.0 1.2 2.2 0.3 0.1 2.8 0.6 0.0 0.2 0.0 1.9 0.7 0.0 0.0 1.8 1.2 1.2 0.4 0.0 0.7 14.1 28.9 47.9 20.7 14.6 13.8 30.4 14.8 18.9 29.5 PSCA ENSG00000167653 "Prostate stem cell antigen" O43653 8 142670308-142682724 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 72.6;stomach 1: 230.2;urinary bladder: 112.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.5;HeLa: 22.2;RT4: 31.8;SK-BR-3: 8.1" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 785.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA030783, HPA056418" Approved Supported "Plasma membrane" "Plasma membrane" "HPA030783: , HPA056418: " "unprognostic (1.21e-3)" "unprognostic (1.76e-3)" "unprognostic (3.20e-1)" "unprognostic (2.24e-1)" "unprognostic (1.77e-2)" "unprognostic (7.57e-2)" "unprognostic (1.93e-2)" "unprognostic (7.81e-3)" "unprognostic (8.25e-3)" "unprognostic (2.13e-1)" "prognostic unfavourable (5.60e-5)" "unprognostic (6.82e-2)" "unprognostic (2.38e-3)" "unprognostic (4.93e-2)" "unprognostic (2.68e-1)" "unprognostic (3.07e-1)" "unprognostic (1.06e-3)" 0.4 0.2 0.0 0.2 0.0 0.2 0.3 0.0 0.2 7.0 2.4 0.7 0.1 0.6 0.3 0.2 72.6 1.1 21.2 0.1 0.0 0.0 2.6 0.1 3.0 0.2 0.0 0.0 0.1 0.3 0.1 0.5 17.2 0.0 30.1 0.7 0.1 11.7 0.6 0.1 0.8 1.5 18.9 0.0 0.2 230.2 0.2 0.0 0.0 0.1 9.3 35.1 112.0 54.5 0.0 0.8 0.0 0.3 0.0 0.0 0.0 5.3 0.3 0.0 0.0 1.1 3.7 5.5 2.5 0.5 1.1 0.9 0.0 11.5 0.0 0.2 0.2 1.1 0.0 0.2 0.6 0.3 0.0 0.0 22.2 0.0 0.0 0.0 0.7 3.2 4.1 2.4 0.0 0.0 0.0 0.0 0.8 2.9 0.8 0.3 0.6 0.6 0.3 0.0 0.4 0.5 31.8 0.1 0.2 2.6 8.1 1.7 0.1 0.1 0.5 0.8 0.9 1.5 0.0 1.0 0.0 0.0 1.5 0.4 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: " "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavourable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favourable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 16.3 15.3 21.0 13.4 34.9 19.2 15.7 15.5 24.7 16.5 26.2 66.1 9.5 26.6 14.2 15.4 19.0 12.6 17.1 9.9 28.6 18.2 19.7 16.9 16.9 10.8 42.1 20.7 13.5 15.0 21.8 9.2 22.7 31.8 13.6 25.6 15.0 16.8 13.4 13.0 24.7 27.9 14.6 61.9 14.6 16.3 16.8 39.7 15.4 19.7 8.7 15.9 17.2 13.5 9.0 24.4 38.1 34.0 11.7 10.5 17.1 14.2 21.9 20.5 8.1 28.7 20.5 18.7 21.0 24.1 21.5 27.2 27.2 35.7 9.3 13.9 19.9 38.0 17.2 15.9 23.6 21.2 10.7 10.6 14.9 13.2 26.5 10.7 20.8 21.0 28.9 17.8 22.0 17.2 11.8 19.0 20.1 28.3 8.1 13.9 8.9 16.3 10.3 17.4 11.8 30.0 30.3 11.4 15.2 22.9 21.5 18.7 26.6 23.9 18.2 21.9 18.1 17.9 9.9 12.4 18.2 9.4 18.4 13.0 13.3 29.2 27.1 27.1 7.2 30.8 7.0 7.2 7.0 5.9 24.4 9.0 6.6 6.4 38.1 11.7 34.0 12.8 10.5 17.1 21.0 34.9 15.5 24.7 28.6 18.2 42.1 20.7 31.8 39.7 PSEN2 "AD3L, AD4, PS2, STM2" ENSG00000143801 "Presenilin 2" P49810 1 226870184-226896105 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013634, HPA038005" Supported Nucleoplasm Nucleoplasm "CAB013634: , HPA038005: " "unprognostic (3.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.94e-1)" "unprognostic (3.86e-2)" "unprognostic (6.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.72e-2)" "unprognostic (1.31e-1)" "unprognostic (9.98e-2)" "unprognostic (2.73e-2)" "unprognostic (8.25e-3)" "unprognostic (8.53e-3)" "unprognostic (8.45e-2)" "unprognostic (1.17e-1)" "unprognostic (8.36e-2)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" 8.9 13.2 9.5 5.9 7.9 1.2 8.1 16.6 10.7 9.2 9.2 5.9 7.3 9.4 16.4 9.0 9.4 8.7 12.0 9.7 6.5 10.8 7.8 7.7 9.0 11.6 8.1 9.3 13.1 31.6 14.0 15.2 7.6 14.8 12.8 6.9 15.9 9.6 13.4 22.1 6.8 12.2 17.0 4.9 10.6 7.1 21.8 5.3 1.4 6.0 7.2 7.0 9.0 7.2 5.1 7.7 19.4 18.7 12.3 3.4 3.1 8.9 13.4 4.0 12.4 5.5 1.8 6.7 7.6 14.9 9.5 7.3 10.5 11.5 0.1 10.3 9.7 4.6 7.1 7.2 3.9 9.6 12.9 6.1 9.5 6.8 9.2 4.7 10.0 5.3 8.1 11.4 6.2 4.4 10.4 4.1 5.5 7.5 0.1 5.4 12.3 11.1 0.1 14.7 14.4 8.4 7.6 7.0 11.7 6.1 16.9 30.2 14.5 6.0 4.8 6.8 5.7 6.2 9.5 16.4 24.1 0.4 12.0 1.5 8.9 19.4 5.7 12.1 3.2 6.5 3.4 5.1 1.1 2.9 7.7 2.6 0.6 1.7 1.2 12.3 18.7 0.6 1.4 3.1 9.5 7.9 16.6 10.7 6.5 10.8 8.1 9.3 14.8 5.3 PSENEN PEN2 ENSG00000205155 "Presenilin enhancer gamma-secretase subunit" Q9NZ42 19 35745114-35747519 "Disease related genes, Predicted membrane proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA047435 Enhanced "HPA047435: " "unprognostic (1.96e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.64e-1)" "unprognostic (2.01e-1)" "unprognostic (2.79e-1)" "unprognostic (1.03e-3)" "unprognostic (3.21e-2)" "unprognostic (1.41e-1)" "unprognostic (3.51e-3)" "unprognostic (2.30e-1)" "unprognostic (5.36e-2)" "prognostic unfavourable (8.70e-4)" "unprognostic (6.85e-2)" "unprognostic (1.80e-1)" "unprognostic (2.10e-1)" "unprognostic (5.41e-3)" 16.8 22.9 25.5 14.7 24.0 12.5 23.1 8.1 27.6 26.1 22.8 30.0 26.6 16.3 19.7 56.6 23.1 95.2 19.5 20.8 24.3 25.5 40.2 51.7 21.8 20.4 23.4 19.2 20.4 27.8 21.4 21.1 17.1 24.0 17.7 26.6 21.4 34.9 23.6 17.4 15.1 23.3 19.6 25.5 21.7 17.5 100.3 17.7 23.3 28.2 20.3 24.3 16.5 14.7 19.7 58.0 92.5 39.8 14.2 23.8 33.8 23.2 48.0 19.0 22.6 38.0 23.4 11.3 12.5 28.7 30.1 32.2 13.0 45.7 12.9 30.9 25.7 14.0 17.2 22.4 28.1 19.6 13.5 8.7 11.7 12.2 33.6 13.6 15.2 23.9 40.0 34.7 28.4 29.2 13.3 29.5 33.1 27.0 15.3 16.0 14.9 12.7 14.9 7.8 22.8 59.1 12.2 16.2 25.2 17.3 36.2 10.7 23.6 30.2 11.5 22.8 13.6 15.7 20.0 21.8 25.4 14.8 39.7 12.8 18.1 19.3 36.4 32.6 23.8 39.8 22.4 19.7 17.6 20.3 26.7 18.1 13.6 17.3 92.5 14.2 31.1 58.0 17.6 33.8 25.5 24.0 8.1 27.6 24.3 25.5 23.4 19.2 24.0 17.7 PSG9 "PSG11, PSGII" ENSG00000183668 "Pregnancy specific beta-1-glycoprotein 9" Q00887 19 43211791-43269530 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 205 "placenta: 299.0" "Cell line enhanced" "Detected in some" "BJ: 6.1;BJ hTERT+ SV40 Large T+: 5.4;HBF TERT88: 11.2;T-47d: 5.1;U-2197: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" HPA046327 Supported "Secreted in female reproductive system" "HPA046327: " "unprognostic (9.32e-2)" "unprognostic (3.28e-1)" "unprognostic (2.15e-1)" 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.2 299.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.4 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 6.1 3.4 5.4 2.8 0.1 0.1 0.0 0.2 1.7 0.3 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.7 5.1 0.0 0.3 0.2 2.6 11.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.0 PSKH1 ENSG00000159792 "Protein serine kinase H1" P11801 16 67893272-67929678 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053927 Approved Approved Nucleoplasm Nucleoplasm "HPA053927: AB_2682312" "unprognostic (2.57e-2)" "unprognostic (8.91e-3)" "unprognostic (1.88e-1)" "unprognostic (5.79e-2)" "unprognostic (3.26e-1)" "unprognostic (3.89e-1)" "unprognostic (1.64e-1)" "unprognostic (1.29e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-2)" "unprognostic (9.85e-3)" "unprognostic (8.32e-2)" "prognostic favourable (4.28e-10)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (4.15e-2)" "unprognostic (3.90e-3)" 14.3 18.3 13.6 14.0 16.6 4.8 15.1 13.3 13.3 11.0 14.7 17.7 24.0 14.0 19.2 14.6 17.7 20.2 19.3 17.8 12.2 8.4 18.8 15.1 13.1 10.4 16.2 12.7 21.2 35.3 33.2 13.0 9.8 16.1 14.3 11.4 16.2 19.0 14.8 19.9 14.0 15.2 16.3 11.3 12.8 19.1 31.7 15.0 12.5 14.9 12.9 8.6 14.8 18.7 4.0 5.2 4.5 5.8 5.2 5.6 3.5 7.3 13.1 14.9 16.5 23.3 11.8 9.7 8.8 13.5 9.4 8.4 9.9 10.6 6.9 13.5 14.9 11.2 8.6 9.1 3.2 2.7 9.6 7.9 9.7 12.5 16.0 7.5 4.8 21.7 15.8 11.1 11.8 13.7 12.0 3.0 9.7 16.4 10.2 4.8 14.3 8.2 15.7 5.7 14.3 11.1 9.2 13.0 15.5 27.4 7.5 9.0 13.8 13.7 12.0 10.6 3.8 8.8 4.4 9.1 4.8 14.9 12.8 5.1 11.6 0.0 4.3 4.5 5.6 5.8 3.8 4.0 3.9 5.3 5.2 3.5 3.4 4.3 2.7 5.2 3.6 3.8 2.3 3.5 13.6 16.6 13.3 13.3 12.2 8.4 16.2 12.7 16.1 15.0 PSKH2 ENSG00000147613 "Protein serine kinase H2" Q96QS6 8 86048373-86088621 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "kidney: 1.9;placenta: 1.2;testis: 2.0" "Cell line enriched" "Detected in single" 18 "HEL: 13.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015095, HPA056839" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA015095: AB_1855815, HPA056839: " "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PSMD1 "P112, Rpn2, S1" ENSG00000173692 "Proteasome 26S subunit, non-ATPase 1" Q99460 2 231056864-231172827 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021092, HPA036736, HPA036737" Enhanced Approved "Nucleoplasm,Actin filaments" 49000 Nucleoplasm "Actin filaments" "CAB021092: AB_10123242, HPA036736: AB_2675278, HPA036737: AB_2675279" "unprognostic (9.32e-3)" "unprognostic (2.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.81e-2)" "unprognostic (2.71e-1)" "unprognostic (1.78e-2)" "prognostic unfavourable (8.63e-12)" "prognostic unfavourable (2.34e-4)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "unprognostic (3.09e-3)" "unprognostic (2.49e-1)" "unprognostic (8.91e-3)" "unprognostic (1.10e-2)" "unprognostic (6.26e-2)" "unprognostic (4.16e-2)" "unprognostic (1.70e-3)" 21.9 25.5 21.5 19.0 27.8 14.4 18.4 22.3 29.0 17.3 20.6 16.2 15.3 21.7 24.3 17.6 25.3 16.1 13.0 34.9 31.8 22.1 20.9 27.8 16.8 16.3 20.3 27.2 16.4 10.9 73.9 24.6 28.5 34.0 18.7 23.7 15.0 16.7 21.1 75.5 20.2 17.9 27.2 17.5 18.7 17.4 16.8 17.8 20.6 17.3 23.7 22.3 17.8 16.4 14.3 21.2 23.5 26.7 25.6 21.6 15.4 28.8 31.5 35.5 27.7 37.0 26.7 34.4 38.5 40.1 39.0 39.7 38.2 28.9 22.7 36.3 42.9 27.8 49.3 35.9 53.3 34.3 26.4 41.9 25.9 43.8 19.1 36.9 36.4 23.0 17.8 41.9 22.3 45.9 57.9 17.2 46.2 28.1 28.8 21.2 45.7 25.2 24.5 54.5 21.7 28.7 30.0 23.7 21.3 30.8 27.9 18.8 22.1 21.8 42.8 31.1 32.8 37.5 36.5 14.9 21.9 40.4 48.0 28.5 35.5 23.5 19.2 14.6 19.2 25.9 19.0 14.3 18.3 16.9 21.2 12.0 14.9 16.8 10.8 25.6 26.7 12.1 21.6 15.4 21.5 27.8 22.3 27.6 31.8 22.1 20.3 27.2 34.0 17.8 PSMD2 "MGC14274, P97, Rpn1, S2, TRAP2" ENSG00000175166 "Proteasome 26S subunit, non-ATPase 2" Q13200 3 184298709-184309054 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 107.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045192 Approved 380000 "HPA045192: AB_10961324" "unprognostic (1.06e-2)" "unprognostic (1.69e-2)" "unprognostic (6.82e-2)" "unprognostic (2.43e-2)" "unprognostic (2.96e-1)" "prognostic unfavourable (9.98e-4)" "prognostic unfavourable (6.63e-7)" "prognostic unfavourable (1.55e-4)" "unprognostic (1.69e-1)" "unprognostic (4.68e-2)" "unprognostic (1.51e-2)" "unprognostic (1.32e-1)" "unprognostic (4.25e-3)" "unprognostic (1.53e-1)" "unprognostic (9.12e-2)" "unprognostic (1.13e-2)" "unprognostic (2.74e-3)" 21.6 33.7 31.7 20.8 28.7 23.2 16.3 22.2 31.5 19.4 20.4 17.9 20.6 16.5 22.6 16.8 25.3 18.8 15.7 39.2 27.1 21.2 22.9 28.5 18.3 18.6 23.8 29.7 16.5 16.4 28.2 18.9 25.2 25.0 18.8 22.2 15.7 19.0 22.2 107.0 22.9 16.4 26.2 15.1 19.0 19.2 34.1 17.7 20.1 19.2 28.4 25.2 18.1 24.8 28.3 53.2 37.0 40.4 34.7 35.3 42.7 109.9 29.0 23.3 39.6 28.3 16.0 28.5 62.5 42.8 69.1 40.1 40.3 19.6 29.0 92.4 46.0 31.6 34.7 61.0 87.9 50.5 26.7 31.3 27.5 25.0 15.7 21.2 27.9 18.3 19.1 66.0 41.6 41.6 22.0 27.1 56.9 36.3 22.2 13.0 36.4 48.2 26.1 33.1 30.5 29.7 29.3 20.0 17.3 44.6 38.5 22.3 54.8 19.0 51.9 43.1 54.4 34.4 130.8 30.4 66.3 54.3 55.6 26.8 30.7 20.3 40.4 37.0 31.1 36.1 30.7 28.3 30.6 35.3 53.2 23.4 30.5 30.3 12.3 34.7 37.2 22.7 29.8 42.7 31.7 28.7 22.2 31.5 27.1 21.2 23.8 29.7 25.0 17.7 PTGFRN "CD315, CD9P-1, EWI-F, FLJ11001, FPRP, KIAA1436, SMAP-6" ENSG00000134247 "Prostaglandin F2 receptor inhibitor" Q9P2B2 1 116910057-116990358 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 45.3;WM-115: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017074 Approved 86000 "HPA017074: AB_1855888" "unprognostic (1.18e-1)" "unprognostic (2.11e-3)" "unprognostic (3.03e-1)" "unprognostic (8.58e-2)" "unprognostic (3.20e-1)" "unprognostic (2.91e-2)" "unprognostic (1.48e-3)" "unprognostic (3.39e-2)" "unprognostic (1.76e-2)" "unprognostic (7.28e-2)" "unprognostic (2.77e-2)" "unprognostic (5.28e-2)" "prognostic unfavourable (3.98e-4)" "unprognostic (1.61e-1)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "unprognostic (4.15e-2)" 6.9 14.9 3.7 8.4 4.7 0.0 6.3 1.2 6.6 17.1 26.2 2.5 10.1 6.5 23.9 10.7 23.5 17.8 20.5 29.5 3.0 2.6 3.4 5.3 4.4 1.7 2.8 6.1 15.6 17.1 4.0 3.5 24.6 3.2 13.3 13.2 8.1 13.3 15.0 2.4 12.4 15.3 27.8 3.0 2.5 8.7 6.3 2.2 2.8 5.9 13.5 9.7 15.2 15.3 0.0 3.0 0.0 1.1 0.3 0.9 0.3 11.6 3.0 5.6 12.9 1.0 2.6 0.8 0.8 1.3 4.7 1.8 2.1 2.6 0.0 11.0 3.1 20.8 12.5 22.3 3.0 0.1 7.6 0.8 7.6 3.2 0.3 0.0 1.2 11.6 20.2 0.6 11.2 9.0 4.7 0.0 7.1 14.8 0.0 1.6 6.5 0.0 0.0 30.7 0.0 15.7 9.6 2.7 6.3 23.9 16.9 6.7 14.8 3.6 23.1 6.9 10.4 11.3 7.3 0.0 0.0 0.0 45.3 0.0 33.5 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.7 0.3 3.7 4.7 1.2 6.6 3.0 2.6 2.8 6.1 3.2 2.2 PTGIS "CYP8A1, PGIS" ENSG00000124212 "Prostaglandin I2 synthase" Q16647 20 49503874-49568146 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Isomerase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 88.2" "Group enriched" "Detected in some" 4 "ASC diff: 17.4;ASC TERT1: 17.5;U-2197: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009517, HPA014193, HPA052244" Enhanced Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: " "unprognostic (7.68e-2)" "unprognostic (1.90e-1)" "unprognostic (5.09e-3)" "unprognostic (1.38e-2)" "unprognostic (1.80e-2)" "unprognostic (1.74e-1)" "unprognostic (1.21e-2)" "unprognostic (1.29e-2)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (2.45e-2)" "unprognostic (5.22e-2)" "prognostic unfavourable (4.74e-8)" "unprognostic (2.29e-2)" "unprognostic (7.61e-2)" "unprognostic (4.89e-3)" "prognostic unfavourable (9.99e-5)" 18.2 2.5 0.6 8.0 1.3 0.1 28.3 0.2 1.6 23.3 14.6 0.5 6.5 1.7 36.5 21.7 13.2 32.0 36.3 23.8 0.3 0.5 3.0 3.8 7.5 1.6 0.5 0.9 51.2 1.3 0.2 0.5 1.0 1.0 27.2 3.7 3.2 3.7 4.6 7.0 3.2 4.4 88.2 1.4 0.3 8.7 16.2 0.3 0.0 6.7 5.6 1.7 64.2 36.1 1.0 0.8 2.7 0.6 0.8 0.5 0.1 0.0 0.0 0.7 0.0 17.4 17.5 0.2 0.3 2.1 0.0 0.0 0.0 0.0 0.0 6.9 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 53.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.6 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.1 1.0 0.4 0.5 2.7 0.8 0.3 0.8 0.2 0.1 0.6 1.3 0.2 1.6 0.3 0.5 0.5 0.9 1.0 0.3 PTK7 CCK4 ENSG00000112655 "Protein tyrosine kinase 7 (inactive)" Q13308 6 43076268-43161719 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Wnt signaling pathway" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "plasmacytoid DC: 13.8" "Lineage enriched" "Detected in many" 9 "dendritic cells: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003222 Approved "Secreted to blood" 10000000 "HPA003222: AB_1079713" "unprognostic (1.80e-1)" "unprognostic (7.49e-3)" "unprognostic (6.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.65e-1)" "unprognostic (1.15e-2)" "unprognostic (5.85e-3)" "unprognostic (9.81e-3)" "unprognostic (1.47e-3)" "unprognostic (7.15e-2)" "unprognostic (5.11e-3)" "unprognostic (8.17e-2)" "unprognostic (3.37e-2)" "unprognostic (1.73e-1)" "unprognostic (3.61e-1)" "unprognostic (9.12e-2)" "unprognostic (5.70e-3)" 5.4 1.8 1.4 3.5 3.4 0.8 12.2 3.5 4.9 30.9 4.8 3.4 8.9 2.1 37.7 36.9 11.7 14.3 14.5 3.5 2.2 3.9 10.1 0.8 18.7 4.3 1.3 2.7 42.6 16.3 9.0 9.0 20.9 4.2 18.2 3.3 13.9 15.0 10.9 0.4 13.6 3.4 16.4 3.2 12.4 4.6 14.9 1.4 28.7 19.3 8.1 6.2 9.5 17.6 0.0 13.8 0.3 0.0 0.7 1.5 0.8 2.1 0.6 21.1 35.1 22.7 23.3 30.0 22.6 36.5 19.8 25.4 19.0 7.6 0.0 17.9 26.3 24.5 9.4 21.5 12.6 0.1 11.7 2.0 4.3 25.5 34.5 0.0 0.1 33.3 19.5 26.1 8.3 2.5 1.3 0.0 9.0 1.6 7.6 3.0 9.8 1.7 7.7 30.0 0.0 15.3 10.5 12.1 23.0 3.6 0.3 11.7 12.9 4.6 1.6 21.2 13.4 0.1 12.2 0.1 0.2 0.7 4.9 0.0 3.5 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 1.5 0.2 0.7 0.0 13.8 0.0 0.8 1.4 3.4 3.5 4.9 2.2 3.9 1.3 2.7 4.2 1.4 PTPMT1 "DUSP23, MOSP, PLIP" ENSG00000110536 "Protein tyrosine phosphatase, mitochondrial 1" Q8WUK0 11 47565430-47573461 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040348, HPA043932" Approved Supported Mitochondria Mitochondria "HPA040348: , HPA043932: " "unprognostic (6.61e-2)" "unprognostic (2.09e-1)" "unprognostic (1.28e-1)" "unprognostic (2.37e-3)" "unprognostic (1.02e-1)" "unprognostic (1.26e-2)" "prognostic unfavourable (3.04e-5)" "unprognostic (3.29e-2)" "unprognostic (2.77e-2)" "unprognostic (1.93e-3)" "unprognostic (6.76e-2)" "unprognostic (1.72e-1)" "unprognostic (2.68e-3)" "unprognostic (1.21e-1)" "unprognostic (5.39e-1)" "unprognostic (2.17e-2)" "unprognostic (1.75e-1)" 24.0 24.5 22.3 13.1 23.2 19.8 23.3 16.5 25.2 15.7 14.8 18.5 17.5 14.6 14.7 21.4 14.3 16.9 17.9 17.1 18.5 21.9 20.1 21.8 25.1 16.7 23.1 16.2 15.7 39.3 18.3 18.7 21.8 14.4 15.8 11.5 20.1 26.4 19.5 23.4 11.2 13.1 12.7 17.6 14.7 16.9 44.6 10.3 10.8 19.9 15.7 15.0 11.0 11.5 20.4 40.8 22.1 24.4 15.4 17.5 16.8 22.0 12.5 1.5 10.0 11.6 8.9 4.3 13.0 12.3 13.0 12.4 20.7 11.8 15.9 14.4 9.7 18.9 10.3 13.5 13.9 19.4 31.0 7.3 25.6 26.0 17.0 14.2 9.7 8.8 15.3 6.1 18.7 9.2 18.6 12.2 9.5 41.6 12.1 18.3 9.3 23.2 22.2 8.4 13.5 15.6 14.1 9.3 11.4 19.7 7.2 11.7 33.5 15.3 9.9 9.7 14.8 15.6 19.5 18.6 12.4 10.8 7.6 12.3 5.8 6.0 24.4 22.1 16.0 20.9 15.4 20.4 15.2 17.3 27.7 18.0 15.2 14.4 1.9 15.4 19.4 40.8 17.5 16.8 22.3 23.2 16.5 25.2 18.5 21.9 23.1 16.2 14.4 10.3 PTPN1 PTP1B ENSG00000196396 "Protein tyrosine phosphatase, non-receptor type 1" P18031 20 50510321-50585241 "Enzymes, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009329, HPA012542, CAB015217" Approved Enhanced "Endoplasmic reticulum" 11000 "Endoplasmic reticulum" "CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915" "unprognostic (1.67e-1)" "unprognostic (7.78e-2)" "unprognostic (1.48e-1)" "unprognostic (1.05e-2)" "unprognostic (1.14e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-3)" "unprognostic (3.95e-2)" "unprognostic (2.40e-2)" "unprognostic (6.47e-3)" "unprognostic (5.87e-2)" "unprognostic (1.67e-1)" "unprognostic (1.66e-2)" "unprognostic (6.70e-2)" "unprognostic (2.99e-2)" "unprognostic (1.49e-1)" "unprognostic (2.58e-2)" 22.1 22.2 12.1 31.9 16.0 35.3 17.9 12.9 16.6 18.2 17.8 18.8 14.2 10.5 20.0 16.6 23.2 17.1 18.0 20.5 15.8 9.0 43.8 16.7 42.7 36.1 14.1 14.1 21.8 12.2 31.2 18.8 28.3 18.7 20.0 14.8 21.0 16.3 15.0 41.0 18.6 21.9 16.9 15.8 45.3 17.5 23.5 13.3 26.9 15.7 13.9 42.8 20.0 18.4 15.9 9.4 18.8 16.4 3.9 10.7 6.4 20.7 10.5 12.7 8.7 8.3 11.5 18.0 14.0 13.3 41.1 15.0 30.8 43.8 10.3 24.9 12.9 18.5 10.1 40.1 26.2 15.3 9.0 14.6 10.2 16.2 16.6 15.1 20.0 13.4 28.2 18.5 22.8 23.6 25.3 9.5 22.3 11.5 16.2 12.0 6.7 14.4 14.4 14.8 9.8 23.7 15.6 10.2 11.7 20.1 25.5 22.6 16.5 16.2 35.0 35.9 14.4 16.1 17.3 10.4 8.4 12.6 22.5 10.3 13.2 12.0 5.6 18.8 10.7 9.5 7.9 15.9 9.0 8.2 5.5 13.7 7.7 8.3 12.2 3.9 16.4 9.4 7.1 6.4 12.1 16.0 12.9 16.6 15.8 9.0 14.1 14.1 18.7 13.3 PTPN2 "PTPT, TC-PTP, TCELLPTP, TCPTP" ENSG00000175354 "Protein tyrosine phosphatase, non-receptor type 2" P17706 18 12785478-12929643 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015004, HPA046176" Enhanced Supported Nucleoplasm Nucleoplasm "HPA015004: AB_2669131, HPA046176: AB_2679569" "unprognostic (5.83e-3)" "unprognostic (8.50e-2)" "unprognostic (5.85e-2)" "unprognostic (7.21e-3)" "unprognostic (8.94e-3)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (1.68e-1)" "unprognostic (2.37e-3)" "prognostic favourable (1.37e-4)" "unprognostic (1.06e-2)" "unprognostic (1.75e-2)" "prognostic unfavourable (1.20e-8)" "unprognostic (3.19e-1)" "unprognostic (6.84e-3)" "unprognostic (2.17e-1)" "unprognostic (4.61e-3)" 16.7 12.5 12.6 27.0 14.3 33.7 19.9 32.6 19.2 14.7 15.0 7.8 17.8 12.9 12.2 14.9 17.0 13.7 15.7 12.8 13.1 6.8 13.6 20.5 21.6 30.3 15.3 10.3 22.1 28.2 10.4 27.2 13.3 13.8 14.4 17.1 7.9 26.3 16.0 13.1 16.0 15.3 11.8 24.7 24.2 13.1 9.4 15.9 61.3 14.7 11.7 28.9 16.5 15.8 29.1 32.8 19.9 28.0 31.7 29.2 19.6 13.0 7.9 9.3 3.1 10.6 19.2 9.0 8.7 19.4 18.7 16.8 17.2 18.9 20.5 14.7 9.0 7.8 15.1 23.9 24.7 7.9 9.1 14.5 6.9 17.9 14.7 33.9 13.8 16.1 22.7 17.0 33.8 9.5 14.0 27.9 15.0 14.9 33.8 28.0 11.1 9.3 11.4 14.6 23.2 15.7 20.9 16.7 8.7 17.7 10.4 15.1 8.7 19.5 7.2 23.8 23.0 17.7 18.8 8.9 8.9 29.6 11.2 18.7 9.9 11.5 28.0 19.9 21.0 24.6 28.2 29.1 24.8 23.1 32.8 20.3 18.3 20.0 10.2 31.7 22.8 28.0 29.2 19.6 12.6 14.3 32.6 19.2 13.1 6.8 15.3 10.3 13.8 15.9 PTPN5 "PTPSTEP, STEP, STEP61" ENSG00000110786 "Protein tyrosine phosphatase, non-receptor type 5" P54829 11 18727928-18792721 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "brain: 70.0" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HMC-1: 3.6;NTERA-2: 5.7" "Group enriched" "Detected in some" 6 "glioma: 1.6;testis cancer: 2.0" "Region enhanced" "Detected in many" "basal ganglia: 70.0" "Cell type enriched" "Detected in single" 9 "basophil: 1.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031014, HPA072091" Supported Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA031014: AB_10669550, HPA072091: " "unprognostic (1.23e-1)" "unprognostic (2.91e-2)" "unprognostic (8.93e-3)" "unprognostic (1.09e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-2)" "unprognostic (5.83e-3)" "unprognostic (3.59e-1)" "unprognostic (4.91e-2)" "unprognostic (2.59e-1)" "unprognostic (2.00e-1)" "unprognostic (3.58e-1)" "unprognostic (8.44e-4)" "unprognostic (4.21e-3)" "unprognostic (3.90e-2)" "unprognostic (9.39e-2)" "unprognostic (8.49e-2)" 2.5 1.6 16.3 1.1 70.0 1.1 1.2 0.9 47.5 1.5 1.1 0.4 0.0 1.1 1.2 1.0 1.3 1.7 1.4 4.3 9.1 8.6 1.1 0.9 2.7 1.1 3.5 16.0 2.5 1.2 1.5 0.5 0.9 6.1 1.6 1.4 0.0 1.3 1.7 1.8 1.0 1.4 1.4 2.1 1.3 1.3 3.4 9.3 0.0 1.2 0.0 1.0 1.5 0.3 0.1 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.0 3.6 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 5.7 0.3 0.0 0.1 0.1 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.3 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 70.0 0.9 25.1 9.1 8.6 3.5 16.0 6.1 9.3 PTPRA "HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA" ENSG00000132670 "Protein tyrosine phosphatase, receptor type A" P18433 20 2864184-3039076 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029412, CAB034366, HPA069480" Approved Approved Nucleoplasm,Vesicles 21000 Vesicles Nucleoplasm "CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: " "unprognostic (1.39e-1)" "unprognostic (2.05e-1)" "unprognostic (4.58e-2)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.62e-1)" "unprognostic (5.43e-3)" "unprognostic (5.34e-2)" "unprognostic (1.55e-1)" "unprognostic (3.24e-1)" "unprognostic (7.33e-2)" "unprognostic (1.16e-1)" "prognostic favourable (3.29e-6)" "unprognostic (1.25e-1)" "unprognostic (4.02e-1)" "unprognostic (1.60e-2)" "unprognostic (4.19e-1)" 21.9 18.5 55.6 14.3 48.6 16.4 23.3 44.5 56.0 29.7 19.7 37.5 9.4 14.7 26.3 18.7 22.7 26.5 21.3 14.0 45.9 41.1 22.1 13.5 21.6 16.9 38.0 46.7 28.6 14.9 41.5 23.4 29.0 52.5 23.5 20.0 18.5 16.7 21.8 8.2 21.0 15.3 25.7 52.6 17.9 16.3 27.4 30.4 20.6 32.4 8.5 20.4 22.9 19.2 7.7 5.7 7.9 6.7 6.2 11.0 3.7 20.5 12.6 36.3 11.1 40.2 73.4 7.7 15.5 30.3 19.2 23.5 15.0 28.6 13.5 12.2 20.7 22.1 14.6 22.1 21.7 20.8 9.4 19.2 5.3 19.0 14.4 19.2 9.1 32.8 22.9 15.8 16.7 26.5 19.2 17.3 19.0 8.4 22.2 21.8 14.0 10.1 17.0 17.6 16.8 16.4 16.0 20.1 19.3 15.0 25.5 23.0 15.9 16.5 18.9 17.1 8.5 19.1 13.6 12.7 17.6 17.8 7.9 18.2 16.0 7.9 4.8 7.5 11.0 4.8 9.0 7.7 7.4 7.9 3.7 5.1 7.4 9.0 6.0 6.2 6.7 5.7 8.1 3.7 55.6 48.6 44.5 56.0 45.9 41.1 38.0 46.7 52.5 30.4 PTPRB PTPB ENSG00000127329 "Protein tyrosine phosphatase, receptor type B" P23467 12 70515866-70637440 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 11.1;HUVEC TERT2: 27.5;TIME: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "memory B-cell: 3.5" "Lineage enriched" "Detected in single" 7 "B-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004782, HPA067868" Uncertain Approved "Vesicles,Plasma membrane,Cell Junctions" 6700000 "Plasma membrane" "Vesicles, Cell Junctions" "CAB004782: , HPA067868: " "unprognostic (3.18e-1)" "unprognostic (2.99e-6)" "unprognostic (1.56e-1)" "unprognostic (1.80e-1)" "unprognostic (3.55e-2)" "unprognostic (1.77e-2)" "prognostic favourable (6.05e-4)" "unprognostic (4.59e-1)" "unprognostic (2.22e-2)" "unprognostic (1.85e-1)" "unprognostic (2.28e-2)" "unprognostic (1.40e-1)" "prognostic favourable (1.02e-4)" "unprognostic (2.91e-2)" "unprognostic (7.18e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" 23.5 7.0 4.5 5.5 7.0 0.1 22.9 3.6 6.1 11.3 8.0 4.3 7.1 5.3 17.1 8.5 5.8 8.2 11.4 17.6 6.2 5.1 18.7 12.0 39.9 3.3 6.9 4.6 5.5 4.4 4.9 5.7 23.3 7.8 6.1 8.2 16.0 3.6 7.1 11.8 4.7 7.4 13.3 7.3 22.9 5.2 3.7 4.3 0.7 14.0 12.2 2.6 6.5 14.7 3.5 0.1 0.2 0.0 0.4 0.3 0.2 1.9 0.1 0.8 0.1 0.0 0.0 0.4 0.4 1.9 1.0 2.4 0.0 1.5 0.7 11.1 0.3 6.8 0.1 0.3 3.5 0.5 0.3 0.1 0.7 0.4 0.1 0.3 0.0 0.0 0.3 2.7 0.0 27.5 1.5 0.4 0.6 0.0 0.0 0.0 1.0 0.4 0.0 0.7 0.3 5.1 0.7 0.0 0.4 0.7 0.0 1.6 0.0 0.6 40.2 0.4 0.4 0.1 2.3 0.5 0.3 0.3 0.2 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.3 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 4.5 7.0 3.6 6.1 6.2 5.1 6.9 4.6 7.8 4.3 PTPRC "CD45, GP180, LCA, T200" ENSG00000081237 "Protein tyrosine phosphatase, receptor type C" 1 198638457-198757476 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 116.9;lymphoid tissue: 172.5" "Cell line enhanced" "Detected in some" "Daudi: 51.0;HEL: 28.8;HL-60: 26.0;MOLT-4: 38.5;THP-1: 21.4;U-266/70: 23.9;U-266/84: 21.6;U-698: 30.6;U-937: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000052, HPA000440, CAB002800, CAB056154, CAB068221" Enhanced Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: , CAB068221: , HPA000440: AB_1078468" "unprognostic (1.51e-2)" "unprognostic (1.24e-2)" "unprognostic (5.10e-3)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (3.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.08e-2)" "unprognostic (3.95e-1)" "prognostic unfavourable (2.42e-4)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (6.41e-2)" "unprognostic (7.06e-2)" 9.8 2.9 3.4 48.0 6.2 36.1 4.3 1.3 3.5 3.1 5.6 2.8 0.5 4.9 2.9 3.9 4.8 5.6 8.8 4.9 3.9 4.5 4.4 5.2 27.5 93.2 7.9 1.3 2.9 2.1 0.3 2.5 4.5 5.3 4.2 5.8 3.3 10.7 1.0 1.7 2.5 22.2 4.5 13.2 89.3 6.5 2.3 5.3 172.5 4.6 3.9 53.2 13.1 3.7 28.5 42.8 94.7 103.8 53.7 76.1 116.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 51.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 28.8 0.0 0.0 0.0 26.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.8 0.0 0.0 38.5 15.7 0.1 0.1 1.1 0.1 0.1 0.0 0.0 0.3 0.4 0.0 0.1 0.1 0.0 21.4 0.3 0.0 0.2 0.1 0.1 23.9 21.6 30.6 0.0 23.3 0.1 20.8 52.0 56.3 76.1 99.7 64.5 28.5 52.9 72.7 42.8 26.8 60.2 60.3 94.7 53.7 103.8 6.4 54.6 116.9 3.4 6.2 1.3 3.5 3.9 4.5 7.9 1.3 5.3 5.3 PTPRD "HPTP, PTPD" ENSG00000153707 "Protein tyrosine phosphatase, receptor type D" P23468 9 8314246-10612723 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;parathyroid gland: 37.5" "Cell line enhanced" "Detected in some" "AF22: 23.0;HAP1: 5.0;HSkMC: 7.8;NTERA-2: 5.6;RH-30: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054829 Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" 2500000 Vesicles Nucleoplasm "HPA054829: " "unprognostic (4.74e-1)" "unprognostic (4.79e-2)" "unprognostic (1.44e-2)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (9.90e-2)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (1.91e-2)" "unprognostic (2.13e-2)" "unprognostic (7.52e-3)" "unprognostic (2.62e-1)" "prognostic favourable (7.45e-6)" "unprognostic (3.56e-4)" "unprognostic (7.59e-2)" "unprognostic (4.84e-2)" "unprognostic (3.08e-3)" 2.6 1.7 19.7 1.5 19.2 1.1 1.1 27.9 32.1 5.6 5.4 21.7 0.2 4.0 3.6 1.8 1.5 3.6 2.6 3.0 18.0 13.5 11.4 4.2 3.4 0.9 17.9 22.3 12.7 1.7 37.5 4.4 9.4 15.1 3.3 5.3 1.9 1.1 2.0 1.0 1.2 4.6 2.8 29.7 1.4 1.7 2.5 18.5 0.0 3.2 0.0 1.0 2.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 23.0 0.0 0.3 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 2.6 4.7 0.6 0.0 0.0 0.0 0.2 7.8 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 2.7 0.0 5.6 1.4 2.8 8.5 0.0 2.1 0.0 3.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.7 19.2 27.9 32.1 18.0 13.5 17.9 22.3 15.1 18.5 PTPRE PTPE ENSG00000132334 "Protein tyrosine phosphatase, receptor type E" P23469 10 127907061-128085855 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 91.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 19.9;NB-4: 15.0;TIME: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 91.0;plasmacytoid DC: 65.7" "Group enriched" "Detected in all" 11 "dendritic cells: 65.7;granulocytes: 91.0;monocytes: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015870, HPA021872" Supported Approved "Intermediate filaments" "Intermediate filaments" "HPA015870: AB_1855759, HPA021872: AB_1855760" "unprognostic (5.23e-2)" "unprognostic (1.37e-1)" "unprognostic (1.99e-1)" "unprognostic (7.11e-2)" "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (6.50e-2)" "unprognostic (4.49e-2)" "unprognostic (2.11e-1)" "unprognostic (2.56e-2)" "unprognostic (8.71e-3)" "unprognostic (2.00e-1)" "prognostic unfavourable (4.08e-5)" "unprognostic (1.52e-1)" "unprognostic (6.71e-3)" "unprognostic (2.49e-2)" "unprognostic (5.59e-2)" 16.8 18.5 12.5 24.0 12.5 39.5 11.0 7.4 15.3 4.8 9.2 14.5 1.6 9.6 5.1 8.1 8.8 6.2 10.7 12.3 15.0 12.2 4.4 4.8 22.5 20.0 12.5 6.5 4.3 3.1 3.4 6.5 8.0 9.8 4.5 9.8 4.8 7.0 3.1 1.9 4.9 12.7 7.7 14.3 26.4 7.7 4.3 10.9 11.4 6.6 6.1 12.2 10.0 5.0 1.2 65.7 91.0 25.5 4.0 5.4 4.9 2.0 0.4 0.2 0.0 1.2 0.2 3.6 0.0 0.0 0.8 1.7 0.8 12.0 1.5 1.3 1.0 1.1 1.0 5.8 0.3 1.8 0.9 0.1 0.7 0.0 2.0 7.4 5.6 0.4 3.3 2.9 5.9 19.9 0.0 0.9 1.2 1.8 2.2 15.0 0.1 0.7 8.8 1.2 2.9 3.3 8.6 0.0 1.2 3.4 0.6 0.1 0.3 9.4 37.5 0.8 0.8 3.7 4.1 0.4 0.6 2.1 5.5 5.8 0.0 17.4 25.5 19.3 5.4 9.0 3.2 0.9 2.4 3.6 13.3 1.2 1.7 2.9 91.0 4.0 6.8 65.7 3.5 4.9 12.5 12.5 7.4 12.7 15.0 12.2 12.5 6.5 9.8 10.9 PTPRF LAR ENSG00000142949 "Protein tyrosine phosphatase, receptor type F" P10586 1 43525187-43623666 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 53.7;SK-BR-3: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012710 Uncertain Approved "Golgi apparatus" "Intracellular and membrane" 95000000 "Golgi apparatus" "HPA012710: AB_1855933" "unprognostic (8.20e-2)" "unprognostic (2.41e-2)" "unprognostic (3.01e-2)" "unprognostic (9.17e-2)" "unprognostic (8.34e-2)" "unprognostic (1.11e-1)" "prognostic unfavourable (3.47e-4)" "unprognostic (4.59e-1)" "unprognostic (1.51e-1)" "unprognostic (4.97e-2)" "unprognostic (4.68e-2)" "unprognostic (7.07e-2)" "unprognostic (1.99e-2)" "prognostic favourable (7.03e-4)" "unprognostic (2.33e-1)" "unprognostic (3.19e-2)" "unprognostic (2.58e-1)" 37.1 5.5 22.4 10.4 18.1 0.9 30.7 6.8 19.5 14.2 34.3 16.8 34.4 30.7 12.3 33.4 41.4 32.2 20.0 6.3 17.2 15.0 12.0 45.6 15.7 5.8 17.2 18.5 10.4 25.3 17.5 10.3 38.1 16.1 30.9 23.1 5.9 41.9 23.6 2.9 46.8 35.5 16.8 11.2 2.0 21.8 4.3 15.8 4.6 12.5 11.7 14.9 21.4 21.3 0.9 0.0 0.2 0.0 0.0 0.0 0.7 30.4 14.6 9.6 11.3 2.2 0.1 53.7 17.5 7.0 14.5 12.4 15.5 41.5 0.0 4.9 7.6 23.9 11.1 38.5 17.6 0.3 13.9 0.1 10.0 14.1 6.8 0.2 0.2 2.2 22.2 20.8 34.6 21.5 4.7 1.4 5.3 17.6 0.2 0.2 14.5 4.0 10.6 17.0 0.7 5.6 46.1 14.3 5.3 17.4 61.4 2.3 17.7 3.2 16.9 0.3 23.2 1.4 23.3 0.6 0.5 0.0 1.4 0.7 45.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 22.4 18.1 6.8 19.5 17.2 15.0 17.2 18.5 16.1 15.8 PTPRG "PTPG, RPTPG" ENSG00000144724 "Protein tyrosine phosphatase, receptor type G" P23470 3 61561569-62297613 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 35.5;HSkMC: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000546, HPA064237" Uncertain Approved "Plasma membrane" 520000000 "Plasma membrane" "HPA000546: , HPA064237: " "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (3.26e-1)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (5.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-1)" "prognostic favourable (3.10e-6)" "unprognostic (9.91e-2)" "unprognostic (3.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" 22.2 18.0 12.9 10.1 10.7 1.2 26.1 8.1 16.4 17.2 13.9 5.2 12.0 5.6 15.8 19.0 6.4 13.1 15.7 12.4 24.5 9.9 20.2 8.2 38.9 10.2 8.3 10.5 16.6 6.0 58.6 11.9 13.1 15.1 11.3 8.9 23.3 7.9 17.2 19.2 6.6 8.4 17.4 12.7 9.2 8.7 11.4 5.0 0.1 21.7 7.0 3.2 10.0 14.6 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 11.4 0.0 35.5 18.1 5.5 7.0 11.6 7.5 10.2 5.3 0.2 0.2 4.1 8.3 0.1 5.5 5.5 12.0 0.6 3.1 0.5 0.0 6.1 11.9 2.9 0.0 26.3 2.2 10.7 13.0 8.1 0.0 7.0 6.8 3.0 0.0 0.0 7.0 0.0 4.6 3.5 0.2 7.8 3.3 0.8 1.8 1.7 0.0 2.7 0.0 0.1 18.5 10.6 10.1 16.9 5.9 2.2 2.6 0.0 8.1 1.3 12.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 12.9 10.7 8.1 16.4 24.5 9.9 8.3 10.5 15.1 5.0 PTPRH SAP-1 ENSG00000080031 "Protein tyrosine phosphatase, receptor type H" Q9HD43 19 55181248-55209506 "Enzymes, Predicted membrane proteins" Apoptosis "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "gallbladder: 29.6;intestine: 84.3;lymphoid tissue: 21.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.0;HHSteC: 10.4;K-562: 12.1;PC-3: 8.2;SK-MEL-30: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.5" "Lineage enhanced" "Detected in single" "monocytes: 1.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042300 Approved Mitochondria Mitochondria "HPA042300: AB_10796900" "unprognostic (1.87e-1)" "unprognostic (1.10e-1)" "unprognostic (2.59e-1)" "unprognostic (7.57e-3)" "unprognostic (5.01e-3)" "unprognostic (8.14e-2)" "unprognostic (1.15e-1)" "unprognostic (1.96e-3)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-11)" "unprognostic (4.08e-3)" "unprognostic (2.47e-1)" "unprognostic (1.52e-2)" "unprognostic (1.57e-1)" 0.5 8.9 0.5 5.2 0.7 0.0 0.5 0.5 1.0 0.7 39.9 0.6 0.5 30.1 0.5 0.5 0.6 0.0 29.6 0.5 1.3 1.6 0.6 7.8 0.6 0.5 3.0 0.5 0.6 2.8 0.0 3.0 0.6 0.5 1.0 9.6 0.6 0.5 0.5 0.5 0.0 84.3 0.7 6.9 21.2 10.2 0.5 0.5 0.5 0.5 1.0 0.8 1.1 2.4 0.0 0.7 0.0 1.5 0.0 0.0 0.0 5.6 3.5 0.0 1.4 1.1 3.1 0.1 0.1 3.0 0.6 1.2 1.5 8.0 0.0 0.3 0.5 0.0 0.0 0.0 0.7 0.0 0.1 0.4 0.1 4.0 10.4 0.0 4.1 0.8 2.5 2.0 3.1 0.1 12.1 0.5 0.0 0.0 0.0 0.2 0.0 8.2 0.0 0.0 0.4 0.0 0.0 0.3 0.8 0.0 3.6 18.2 0.0 1.6 0.0 0.8 1.2 0.4 0.0 0.0 3.0 0.0 0.9 0.1 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.7 0.5 0.5 1.3 1.6 3.0 0.5 0.5 0.5 PTPRJ "CD148, DEP1, HPTPeta" ENSG00000149177 "Protein tyrosine phosphatase, receptor type J" Q12913 11 47980558-48170841 "CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 25.3;RPTEC TERT1: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Group enriched" "Detected in all" 4 "granulocytes: 12.2;monocytes: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006026 Approved "Intracellular and membrane" 840000000 "HPA006026: AB_1078446" "unprognostic (1.46e-1)" "unprognostic (2.21e-1)" "unprognostic (1.55e-1)" "unprognostic (3.83e-2)" "unprognostic (3.20e-2)" "unprognostic (2.99e-2)" "unprognostic (6.58e-2)" "unprognostic (2.15e-1)" "unprognostic (9.64e-3)" "unprognostic (3.79e-3)" "unprognostic (5.16e-2)" "unprognostic (1.89e-1)" "prognostic favourable (1.13e-5)" "unprognostic (1.09e-2)" "unprognostic (7.98e-2)" "unprognostic (9.18e-2)" "unprognostic (2.00e-1)" 5.6 3.7 10.4 17.7 13.9 22.6 5.6 4.9 9.5 6.1 9.0 8.8 12.3 8.4 3.9 7.6 2.9 5.0 6.7 5.2 9.5 9.2 13.3 12.2 12.2 22.6 10.8 9.4 3.0 9.1 21.1 14.5 20.3 8.3 7.8 8.1 12.9 12.9 9.0 4.6 4.3 13.4 5.5 6.7 33.0 13.8 3.1 9.9 6.7 18.8 0.9 9.7 6.0 3.9 1.0 1.8 12.2 5.3 1.2 2.1 0.9 3.5 13.4 5.9 3.2 0.9 2.1 2.0 3.6 2.6 6.3 4.7 0.8 19.8 3.3 25.3 9.1 2.7 9.2 0.9 7.7 21.7 2.5 0.9 16.6 1.2 5.8 1.2 20.6 1.5 0.3 1.7 0.4 3.8 1.2 2.1 2.2 7.6 0.0 7.4 4.6 2.1 0.7 0.7 1.7 24.6 5.2 4.0 1.2 10.0 5.7 9.0 6.3 9.1 12.4 5.0 5.2 10.0 10.9 0.5 0.7 5.5 5.7 3.8 18.1 0.9 1.5 3.4 2.1 2.5 1.4 1.0 1.2 1.5 1.0 0.7 1.0 1.3 12.2 1.2 5.3 1.8 1.1 0.9 10.4 13.9 4.9 9.4 9.5 9.2 10.8 9.4 8.3 9.9 PTPRK R-PTP-kappa ENSG00000152894 "Protein tyrosine phosphatase, receptor type K" Q15262 6 127968779-128520674 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6" "Group enriched" "Detected in many" 7 "B-cells: 4.8;T-cells: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054056, HPA054822" Uncertain Supported "Vesicles,Plasma membrane,Cell Junctions" 13000000 "Cell Junctions" "Vesicles, Plasma membrane" "HPA054056: , HPA054822: " "unprognostic (3.15e-2)" "unprognostic (1.07e-2)" "unprognostic (5.79e-3)" "unprognostic (4.95e-3)" "unprognostic (1.89e-2)" "unprognostic (7.26e-2)" "unprognostic (3.27e-1)" "unprognostic (6.06e-2)" "unprognostic (2.04e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (1.99e-4)" "unprognostic (1.46e-1)" "prognostic favourable (9.33e-5)" "unprognostic (2.10e-1)" "unprognostic (1.55e-1)" "unprognostic (2.59e-1)" "unprognostic (9.32e-2)" 12.0 5.2 18.6 10.7 20.3 1.2 20.9 4.7 24.4 12.2 21.9 25.6 11.2 25.7 12.1 10.3 9.1 13.2 29.6 11.4 17.2 12.6 13.3 23.6 17.4 5.7 20.5 19.3 15.6 25.7 11.4 12.2 17.4 14.9 16.3 23.4 3.9 18.3 17.5 9.1 13.5 27.4 14.6 17.1 6.4 24.6 2.7 23.7 15.3 10.1 6.5 7.6 18.4 15.1 4.8 0.0 0.0 0.0 0.4 1.6 0.2 4.4 4.8 2.9 0.2 6.1 8.2 2.9 12.1 23.5 5.0 4.6 8.0 3.7 0.0 3.7 11.1 12.7 3.0 9.6 7.1 13.4 4.9 0.1 7.4 11.1 7.5 0.0 0.4 6.0 8.9 10.5 14.4 13.7 0.0 0.2 12.3 9.0 6.8 0.0 3.0 6.2 24.5 6.2 0.8 12.4 9.2 15.3 0.0 12.5 14.0 0.7 3.8 0.3 23.1 7.9 5.5 15.3 10.9 0.1 1.6 0.0 10.1 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 4.8 0.4 1.6 0.0 0.4 0.0 0.0 0.1 0.2 18.6 20.3 4.7 24.4 17.2 12.6 20.5 19.3 14.9 23.7 PTPRM "hR-PTPu, PTPRL1, RPTPU" ENSG00000173482 "Protein tyrosine phosphatase, receptor type M" P28827 18 7566782-8406861 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 7.2" "Group enriched" "Detected in many" 50 "dendritic cells: 2.7;T-cells: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003891, CAB022442, CAB022443" Supported Approved "Plasma membrane" 76000000 "Plasma membrane" "CAB022442: , CAB022443: , HPA003891: " "unprognostic (2.59e-1)" "prognostic unfavourable (8.65e-5)" "unprognostic (4.89e-2)" "unprognostic (1.00e-1)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (3.41e-2)" "unprognostic (7.62e-2)" "unprognostic (2.74e-2)" "unprognostic (1.56e-2)" "unprognostic (9.64e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-3)" "unprognostic (9.41e-2)" "unprognostic (2.63e-2)" "prognostic favourable (1.07e-4)" 31.4 14.1 9.5 6.3 22.2 0.6 23.6 10.4 17.2 11.0 13.6 6.2 28.1 4.7 15.4 10.9 8.1 13.6 18.1 33.5 10.5 15.0 16.9 6.5 22.0 7.8 8.5 12.0 15.7 7.6 16.3 21.9 18.3 23.2 10.6 6.6 18.3 7.4 21.8 26.0 7.3 8.7 14.1 9.3 12.1 11.0 12.2 9.1 2.9 31.1 7.3 6.3 18.6 25.3 0.0 2.7 0.0 0.0 0.0 7.2 1.4 1.5 11.3 5.4 0.0 34.8 24.1 13.1 13.8 12.2 9.3 13.8 10.3 2.4 0.0 13.6 16.6 0.1 0.0 4.8 12.9 0.1 2.5 0.0 7.5 5.0 9.9 0.0 0.1 27.4 10.2 5.1 14.7 9.3 0.0 4.7 7.4 0.2 4.5 0.1 0.9 2.5 0.1 4.7 20.9 22.8 19.4 0.4 3.0 0.4 0.0 11.6 0.0 0.0 9.6 19.2 12.1 9.1 2.4 0.4 0.1 0.0 16.4 0.0 3.5 0.0 0.0 0.0 4.5 0.0 1.8 0.0 6.0 7.2 0.1 0.0 1.7 3.1 0.0 0.0 0.0 2.7 1.0 1.4 9.5 22.2 10.4 17.2 10.5 15.0 8.5 12.0 23.2 9.1 PTPRN "IA-2, ICA512" ENSG00000054356 "Protein tyrosine phosphatase, receptor type N" Q16849 2 219289623-219309648 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Receptor "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.6;pancreas: 28.9;pituitary gland: 43.4" "Group enriched" "Detected in some" 8 "U-2 OS: 19.8;U-87 MG: 73.7" "Group enriched" "Detected in some" 12 "glioma: 5.3;pancreatic cancer: 18.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007152, HPA007179" Enhanced Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA007152: , HPA007179: AB_1079714" "unprognostic (1.43e-1)" "unprognostic (1.33e-4)" "unprognostic (2.91e-3)" "unprognostic (5.83e-3)" "prognostic unfavourable (1.45e-7)" "unprognostic (3.64e-2)" "unprognostic (1.24e-4)" "unprognostic (1.58e-3)" "unprognostic (1.02e-1)" "unprognostic (6.20e-4)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.28e-10)" "unprognostic (1.43e-2)" "unprognostic (2.49e-1)" "unprognostic (1.10e-2)" "unprognostic (8.61e-2)" 1.7 22.3 19.3 4.7 35.7 1.7 1.3 17.3 89.6 1.2 2.4 2.5 0.0 2.5 1.5 1.2 1.5 1.3 1.5 1.4 21.6 40.1 1.5 1.2 1.4 1.3 14.4 19.8 1.3 28.9 1.2 43.4 1.4 22.0 1.4 1.9 3.1 1.2 1.3 1.2 2.0 2.5 2.4 3.5 1.3 6.0 1.4 2.1 0.0 1.5 0.0 1.2 2.7 0.0 0.1 0.3 0.2 0.0 0.0 0.6 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.1 2.5 0.0 6.1 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 4.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.2 73.7 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.6 3.7 19.3 35.7 17.3 54.0 21.6 40.1 14.4 19.8 22.0 2.1 PTPRN2 "IA-2beta, ICAAR, KIAA0387, phogrin" ENSG00000155093 "Protein tyrosine phosphatase, receptor type N2" Q92932 7 157539056-158587788 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Protein phosphatase, Receptor" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6;pancreas: 51.3" "Cell line enhanced" "Detected in some" "AF22: 15.3;HDLM-2: 21.5;NB-4: 22.1;SCLC-21H: 12.2;SH-SY5Y: 12.4;THP-1: 10.8;U-87 MG: 15.1" "Cancer enhanced" "Detected in all" "prostate cancer: 40.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006900, HPA007255, HPA026656" Enhanced Approved Vesicles Vesicles "HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912" "unprognostic (2.42e-1)" "unprognostic (4.17e-2)" "unprognostic (7.82e-2)" "unprognostic (2.69e-2)" "prognostic unfavourable (9.37e-5)" "unprognostic (7.12e-3)" "unprognostic (1.04e-1)" "unprognostic (4.55e-2)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-2)" "unprognostic (1.39e-1)" "prognostic favourable (8.68e-4)" "unprognostic (2.60e-2)" "unprognostic (1.48e-1)" "unprognostic (1.43e-3)" "unprognostic (6.16e-2)" 2.1 10.5 20.1 1.7 33.9 1.0 1.1 6.2 40.6 1.7 4.6 2.9 0.0 5.1 2.0 2.9 1.5 6.9 4.7 1.9 18.2 21.3 2.0 1.2 3.1 2.1 11.3 22.3 5.8 51.3 0.5 20.0 1.5 10.3 10.2 3.7 1.5 3.4 2.6 0.8 0.7 4.2 1.6 5.3 7.7 24.2 2.2 5.2 0.0 5.6 0.3 1.7 2.8 0.6 3.4 1.3 14.8 1.1 1.5 3.5 1.1 0.0 0.2 15.3 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.6 0.2 0.0 0.4 0.0 0.0 21.5 0.2 0.0 0.0 2.5 0.6 0.0 0.0 1.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.2 6.3 22.1 3.0 0.7 0.0 0.7 0.1 0.0 0.0 12.2 12.4 0.0 0.0 0.0 0.0 10.8 3.2 5.0 1.9 0.0 0.3 0.1 0.0 0.0 15.1 9.0 3.6 8.7 1.1 1.6 0.9 0.1 0.3 2.3 1.5 1.1 1.3 3.4 1.4 0.9 14.8 1.5 0.0 0.2 3.5 1.1 20.1 33.9 6.2 40.6 18.2 21.3 11.3 22.3 10.3 5.2 PTPRO "GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2" ENSG00000151490 "Protein tyrosine phosphatase, receptor type O" Q16827 12 15322397-15597399 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1;intestine: 28.5;kidney: 21.6" "Cell line enhanced" "Detected in some" "NTERA-2: 9.3;SCLC-21H: 5.7;SH-SY5Y: 11.2;THP-1: 4.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 8.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 5.2;intermediate monocyte: 10.5;memory B-cell: 8.3;myeloid DC: 7.4;naive B-cell: 7.0;naive CD4 T-cell: 2.9;non-classical monocyte: 10.5;plasmacytoid DC: 9.5" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "olfactory region: 215.3" "Low region specificity" "Detected in many" HPA034525 Enhanced "Intracellular and membrane" "HPA034525: AB_10669785" "unprognostic (3.68e-2)" "unprognostic (3.49e-1)" "unprognostic (9.64e-2)" "unprognostic (1.25e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-1)" "unprognostic (5.93e-3)" "unprognostic (5.37e-2)" "unprognostic (2.03e-1)" "unprognostic (3.72e-2)" "unprognostic (2.00e-1)" "unprognostic (5.43e-2)" "unprognostic (4.89e-2)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 3.3 1.2 16.2 3.1 26.1 0.6 1.1 1.0 15.3 1.7 10.4 1.5 0.0 2.0 4.5 2.1 0.8 1.2 1.6 0.7 11.3 10.6 21.6 1.6 6.7 3.2 4.8 8.8 0.7 0.6 0.6 3.8 4.4 4.0 0.7 28.5 1.1 0.8 1.1 0.5 0.7 1.9 7.1 2.6 3.6 1.0 0.9 3.5 0.0 0.5 0.0 3.5 1.7 0.5 8.3 9.5 0.0 10.5 0.1 2.9 2.7 0.0 0.1 0.5 0.4 0.6 0.1 0.2 0.0 0.0 0.9 2.2 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.3 0.1 0.2 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.7 9.3 0.1 0.0 0.0 0.1 0.2 0.3 5.7 11.2 1.3 0.0 0.1 0.1 4.6 0.0 0.1 0.4 0.0 0.4 1.4 0.1 0.4 0.1 0.3 1.7 0.0 5.2 0.0 0.0 10.5 0.0 8.3 1.7 0.4 7.4 7.0 2.9 1.3 0.0 0.1 10.5 9.5 1.3 2.7 16.2 26.1 1.0 15.3 11.3 10.6 4.8 8.8 4.0 3.5 PTPRQ DFNB84 ENSG00000139304 "Protein tyrosine phosphatase, receptor type Q" 12 80402178-80680271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6;urinary bladder: 19.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.2;BJ: 6.1;HBF TERT88: 4.3;RH-30: 4.8;RT4: 5.3;U-2197: 5.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 24 "basal ganglia: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053245 Uncertain Approved Cytosol Cytosol "HPA053245: " "unprognostic (9.10e-2)" "unprognostic (1.63e-1)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (1.37e-1)" "unprognostic (1.93e-2)" "unprognostic (1.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-2)" "unprognostic (1.78e-1)" "unprognostic (4.47e-11)" "unprognostic (8.51e-3)" "unprognostic (1.47e-1)" "unprognostic (1.73e-2)" "unprognostic (2.66e-2)" 4.6 0.2 0.3 1.0 12.6 0.0 5.2 0.2 0.3 1.7 1.3 0.0 1.6 0.0 0.5 4.7 1.6 4.1 0.5 1.3 0.4 0.5 6.5 0.2 5.4 2.1 0.2 0.0 0.9 0.6 0.0 1.1 6.4 0.0 6.5 0.0 0.0 0.4 0.5 0.5 0.3 0.2 4.0 0.2 0.2 0.2 5.8 0.0 0.0 3.9 0.0 0.6 19.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.2 0.0 6.1 1.3 1.9 1.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.9 0.0 0.8 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 5.3 0.0 0.0 3.0 0.1 0.0 0.3 0.0 0.0 0.5 0.1 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.6 0.2 0.3 0.4 0.5 0.2 0.0 0.0 0.0 PTPRR "EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ" ENSG00000153233 "Protein tyrosine phosphatase, receptor type R" Q15256 12 70638073-70920843 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 56.1" "Group enriched" "Detected in some" 5 "HDLM-2: 14.0;RT4: 26.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in all" 5 "cerebellum: 100.5" "Low region specificity" "Detected in all" "CAB011461, HPA011851, HPA071067" Uncertain Supported "Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: " "unprognostic (4.98e-2)" "unprognostic (1.91e-2)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "unprognostic (3.63e-3)" "unprognostic (3.48e-5)" "unprognostic (5.44e-3)" "unprognostic (1.77e-3)" "unprognostic (1.13e-1)" "unprognostic (9.01e-2)" "unprognostic (1.37e-3)" "unprognostic (8.06e-2)" "unprognostic (1.10e-2)" "unprognostic (1.92e-2)" "unprognostic (4.78e-2)" "unprognostic (2.72e-1)" "prognostic favourable (1.40e-5)" 0.4 3.8 18.8 1.6 11.3 0.3 0.4 56.1 20.9 0.5 11.2 0.1 0.0 5.1 8.4 0.3 0.4 0.5 1.9 0.4 8.6 4.9 0.4 0.4 0.4 0.4 1.3 13.2 0.4 0.6 0.3 0.9 0.7 3.3 0.5 7.8 0.8 0.4 2.1 0.4 0.4 11.3 4.9 3.1 0.4 4.4 0.4 1.4 0.0 0.4 0.0 0.3 4.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.3 0.0 0.5 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 26.7 0.1 4.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.8 11.3 56.1 20.9 8.6 4.9 1.3 13.2 3.3 1.4 PTPRS ENSG00000105426 "Protein tyrosine phosphatase, receptor type S" Q13332 19 5158495-5340803 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 40.7;HaCaT: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 82 "plasmacytoid DC: 13.4" "Lineage enriched" "Detected in single" 82 "dendritic cells: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054747 Approved "Plasma membrane,Cytosol" "Secreted - unknown location" 92000000 "Plasma membrane, Cytosol" "HPA054747: " "unprognostic (8.14e-2)" "unprognostic (4.59e-3)" "unprognostic (2.57e-2)" "unprognostic (9.20e-2)" "unprognostic (2.15e-1)" "unprognostic (6.96e-3)" "unprognostic (6.85e-2)" "unprognostic (2.36e-1)" "unprognostic (3.12e-3)" "unprognostic (1.86e-1)" "prognostic favourable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.70e-4)" "unprognostic (2.80e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-1)" "unprognostic (3.46e-2)" 59.1 17.3 14.4 9.4 14.8 3.1 32.0 27.6 53.3 28.7 11.4 29.6 14.4 4.6 21.4 15.4 13.3 24.0 22.2 18.6 15.9 15.1 10.7 6.9 13.9 8.6 20.5 12.1 29.2 38.4 10.5 16.6 4.3 12.0 23.1 3.6 28.9 21.5 20.1 11.9 23.8 6.5 17.5 13.8 8.3 12.7 10.8 18.7 4.4 21.1 7.2 7.5 19.1 22.7 0.0 13.4 0.0 0.0 0.0 0.1 0.0 3.6 20.9 18.9 40.7 8.7 7.1 2.5 6.3 7.5 7.7 6.3 0.2 2.0 0.0 15.0 10.6 41.3 5.0 0.0 3.4 0.4 8.0 0.0 8.6 13.0 4.0 0.0 4.7 7.5 1.8 1.6 0.3 0.2 5.8 0.0 3.1 15.4 1.6 3.9 10.6 8.9 0.0 4.2 0.0 1.5 7.3 14.5 19.9 6.0 1.1 11.5 7.3 1.5 0.8 6.9 11.9 15.7 7.6 2.1 0.0 12.0 3.5 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 14.4 14.8 27.6 17.6 15.9 15.1 20.5 12.1 12.0 18.7 PTPRT "KIAA0283, RPTPrho" ENSG00000196090 "Protein tyrosine phosphatase, receptor type T" O14522 20 42072752-43189970 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 23.5;fallopian tube: 17.0" "Cell line enhanced" "Detected in some" "BEWO: 4.5;RPMI-8226: 1.2;SCLC-21H: 2.9;U-266/70: 1.0" "Cancer enhanced" "Detected in many" "breast cancer: 5.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017336, CAB069423" Approved "CAB069423: AB_1622602, HPA017336: AB_1855943" "unprognostic (7.17e-3)" "unprognostic (1.02e-1)" "unprognostic (5.61e-3)" "unprognostic (1.08e-2)" "unprognostic (5.95e-2)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (1.31e-2)" "unprognostic (6.93e-2)" "unprognostic (2.00e-1)" "unprognostic (1.37e-6)" "unprognostic (3.16e-1)" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" 0.6 0.8 5.0 0.6 11.1 0.5 4.6 1.6 23.5 1.6 0.7 0.9 0.0 1.2 0.5 1.8 0.5 17.0 0.7 0.8 4.7 6.5 0.6 0.9 2.1 1.0 2.2 12.6 0.5 0.9 0.5 4.1 4.6 5.1 0.8 0.6 0.5 2.0 4.6 0.5 0.8 1.0 0.5 1.4 0.7 1.8 2.8 0.9 4.9 0.5 0.0 1.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 11.1 1.6 22.6 4.7 6.5 2.2 12.6 5.1 0.9 PTPRU "FMI, hPTP-J, PCP-2, PTP, PTPRO" ENSG00000060656 "Protein tyrosine phosphatase, receptor type U" Q92729 1 29236516-29326813 "Enzymes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011476, HPA039832" Approved "CAB011476: AB_442989, HPA039832: AB_10793923" "unprognostic (7.81e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-3)" "unprognostic (6.13e-2)" "prognostic unfavourable (7.92e-4)" "prognostic unfavourable (8.32e-4)" "unprognostic (3.17e-1)" "unprognostic (1.83e-2)" "unprognostic (1.13e-1)" "unprognostic (4.55e-3)" "unprognostic (3.39e-3)" "unprognostic (6.83e-2)" "unprognostic (1.19e-2)" "unprognostic (6.82e-2)" "unprognostic (4.92e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-1)" 6.0 3.2 3.1 1.7 5.8 0.6 16.0 6.7 12.7 24.8 3.7 2.6 6.1 1.3 9.5 4.7 3.9 14.5 7.0 8.9 4.5 5.1 3.9 7.0 11.4 1.2 5.2 5.3 12.2 12.0 12.1 8.1 14.3 21.4 11.0 2.3 18.7 11.3 17.9 14.7 7.3 1.7 6.5 6.6 2.4 4.5 4.4 0.9 0.3 4.9 2.1 2.0 12.2 17.6 0.4 0.0 0.0 0.5 0.0 0.2 0.0 3.1 4.3 0.2 0.6 12.1 0.4 39.7 3.4 3.0 0.1 0.2 3.7 14.1 0.5 6.7 0.6 17.1 15.7 11.0 0.0 0.2 7.9 0.6 4.8 15.7 5.1 0.0 0.7 5.6 5.9 0.0 1.0 0.1 0.1 0.5 3.1 5.2 0.2 0.1 6.5 2.0 0.0 4.6 0.2 4.8 15.8 13.4 17.4 3.4 10.8 2.3 6.4 0.7 2.8 0.6 3.9 1.0 0.4 0.3 0.4 0.0 7.8 0.7 0.8 0.0 0.2 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.1 5.8 6.7 12.7 4.5 5.1 5.2 5.3 21.4 0.9 PTPRZ1 "phosphacan, PTP18, PTPRZ, PTPZ, RPTPB" ENSG00000106278 "Protein tyrosine phosphatase, receptor type Z1" P23471 7 121873089-122062036 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 118.1" "Group enriched" "Detected in some" 9 "AF22: 92.1;NTERA-2: 25.6;WM-115: 40.3" "Cancer enriched" "Detected in many" 14 "glioma: 175.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015103 Enhanced Approved Vesicles,Cytosol "Secreted in brain" 950000 Cytosol Vesicles "HPA015103: AB_1855946" "unprognostic (8.49e-4)" "unprognostic (3.96e-3)" "unprognostic (4.11e-2)" "unprognostic (1.37e-1)" "unprognostic (9.18e-2)" "unprognostic (2.41e-2)" "unprognostic (8.30e-3)" "unprognostic (3.78e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (9.17e-4)" "unprognostic (1.83e-1)" "unprognostic (8.72e-6)" "unprognostic (2.00e-1)" "unprognostic (2.16e-1)" "unprognostic (8.77e-2)" "prognostic unfavourable (9.36e-4)" 2.0 2.5 33.1 2.3 44.1 1.5 4.0 15.4 118.1 2.4 2.2 19.3 0.0 1.9 1.6 2.0 7.0 1.7 1.9 2.0 39.6 15.9 1.6 1.6 2.1 1.5 18.6 17.8 2.0 3.3 1.5 1.6 1.6 67.6 2.1 2.3 0.8 2.4 2.0 1.5 19.3 1.9 2.4 76.6 2.1 9.8 1.7 23.6 0.0 1.5 1.8 3.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 1.1 0.0 0.1 0.0 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 44.1 15.4 39.6 39.6 15.9 18.6 17.8 67.6 23.6 PTRH2 "BIT1, CFAP37, CGI-147, PTH2" ENSG00000141378 "Peptidyl-tRNA hydrolase 2" Q9Y3E5 17 59674636-59707626 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Apoptosis Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012897 Supported Supported Mitochondria Mitochondria "HPA012897: AB_1855949" "unprognostic (2.26e-1)" "unprognostic (2.80e-2)" "unprognostic (1.02e-2)" "unprognostic (3.89e-2)" "unprognostic (1.31e-2)" "unprognostic (3.38e-2)" "prognostic unfavourable (1.50e-4)" "unprognostic (6.38e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (2.72e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.01e-8)" "unprognostic (5.43e-3)" "unprognostic (6.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.49e-2)" 15.9 22.9 17.1 12.4 17.1 9.9 20.7 12.5 22.1 15.6 17.2 11.8 16.3 11.6 14.3 36.7 16.4 13.8 13.1 12.6 19.3 17.8 14.8 34.7 12.1 12.5 16.7 15.2 14.2 19.9 10.3 18.3 13.6 21.0 15.9 20.7 8.1 13.7 18.7 23.3 11.4 11.0 16.8 17.1 15.5 14.3 15.7 18.1 9.0 11.8 13.5 16.9 13.0 10.5 15.6 21.6 12.6 29.3 13.1 15.5 13.0 19.8 37.9 12.2 11.1 23.2 20.0 13.1 19.1 16.9 16.4 24.0 24.4 15.6 14.4 29.0 16.0 19.8 26.2 24.6 23.9 27.7 35.7 25.7 19.7 44.8 35.8 22.7 14.6 22.5 32.1 25.4 29.6 27.2 28.6 16.1 24.3 47.9 19.4 18.5 10.5 30.0 10.6 20.5 21.0 27.3 28.6 15.8 20.5 9.9 10.8 23.4 25.2 16.2 17.9 21.4 21.7 12.8 20.7 20.9 23.2 21.4 14.1 14.2 16.3 1.9 25.8 1.1 9.2 24.4 12.4 15.6 10.8 10.4 18.5 13.1 15.5 11.1 12.6 13.1 29.3 21.6 12.3 13.0 17.1 17.1 12.5 22.1 19.3 17.8 16.7 15.2 21.0 18.1 PTTG1IP "C21orf1, C21orf3, PBF" ENSG00000183255 "PTTG1 interacting protein" P53801 21 44849585-44873903 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034146, HPA061827" Uncertain Supported Nucleoplasm 380000 Nucleoplasm "CAB034146: AB_1568894, HPA061827: " "unprognostic (1.78e-2)" "prognostic unfavourable (8.61e-4)" "unprognostic (5.24e-3)" "unprognostic (3.18e-2)" "unprognostic (1.68e-2)" "unprognostic (2.03e-2)" "unprognostic (3.59e-2)" "unprognostic (1.22e-2)" "unprognostic (1.98e-2)" "unprognostic (3.77e-2)" "prognostic unfavourable (2.28e-4)" "unprognostic (9.30e-2)" "unprognostic (3.17e-2)" "prognostic unfavourable (5.40e-4)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.90e-1)" 47.1 52.1 46.7 33.6 48.7 29.6 53.3 20.9 38.7 50.1 47.2 57.0 29.3 43.6 53.2 47.6 36.2 40.4 50.9 59.9 51.8 31.0 75.6 71.9 58.2 38.8 59.6 30.2 49.6 39.8 23.4 27.3 111.6 43.0 40.5 41.4 50.0 46.0 57.7 30.8 32.1 72.8 51.8 45.8 38.8 58.9 35.2 52.6 19.8 62.4 25.1 25.3 48.2 60.0 5.3 40.5 58.1 35.6 12.5 16.8 37.2 30.8 17.4 20.6 19.6 40.4 23.6 16.7 28.2 40.2 22.9 22.2 37.4 42.3 4.2 108.0 44.0 14.2 9.4 18.0 22.1 7.2 10.4 32.9 11.0 32.8 39.5 12.5 11.2 36.3 29.7 24.9 17.4 49.2 16.5 11.1 70.7 13.3 9.1 12.8 21.9 21.9 9.0 21.2 20.3 98.8 10.8 15.6 24.1 31.4 34.5 61.2 26.7 21.0 67.5 29.1 17.0 22.6 43.3 10.6 9.9 5.3 19.5 28.2 26.0 58.1 35.6 20.8 10.3 28.9 16.8 5.3 13.4 10.8 40.5 5.0 13.0 8.9 49.4 12.5 30.4 18.4 16.8 37.2 46.7 48.7 20.9 35.7 51.8 31.0 59.6 30.2 43.0 52.6 PVR "CD155, HVED, Necl-5, NECL5, PVS, Tage4" ENSG00000073008 "Poliovirus receptor" P15151 19 44643798-44663583 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 65.6" "Cell line enhanced" "Detected in many" "TIME: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 5 "dendritic cells: 5.6;monocytes: 8.1" HPA012568 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Secreted - unknown location" 940000000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA012568: AB_1846248" "unprognostic (2.90e-3)" "prognostic unfavourable (1.29e-4)" "unprognostic (3.36e-1)" "unprognostic (2.34e-1)" "unprognostic (7.89e-2)" "unprognostic (2.45e-3)" "unprognostic (3.06e-2)" "prognostic unfavourable (9.30e-4)" "unprognostic (9.05e-3)" "unprognostic (1.69e-1)" "unprognostic (2.09e-3)" "unprognostic (2.64e-3)" "unprognostic (1.69e-1)" "unprognostic (4.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-3)" "prognostic unfavourable (2.75e-4)" 10.0 13.9 7.4 7.5 8.1 4.7 9.2 11.0 11.0 6.5 10.6 6.5 4.1 13.7 11.3 5.7 6.6 8.8 9.2 23.5 5.8 10.0 10.6 65.6 14.8 2.4 6.0 6.5 10.4 15.9 9.9 20.7 15.5 9.7 10.4 7.7 6.6 8.5 6.9 19.8 5.5 13.0 11.1 7.0 4.8 12.3 6.0 7.2 2.3 8.5 10.8 3.7 8.3 6.7 0.0 5.6 1.2 8.1 0.6 0.4 2.2 21.5 15.1 1.5 6.1 1.8 2.2 2.6 36.4 10.2 12.0 13.7 8.8 9.2 0.0 21.0 10.5 14.2 5.1 13.8 8.0 2.6 9.9 3.8 9.5 5.9 12.7 1.4 8.3 2.9 6.8 10.5 20.7 13.0 1.8 0.0 5.5 1.9 1.3 1.3 3.4 11.2 0.0 6.9 2.0 25.7 6.6 6.5 7.6 23.1 14.5 5.1 8.2 3.7 52.7 14.5 17.9 10.7 28.4 0.0 2.1 0.0 11.6 7.4 8.2 0.0 6.4 0.0 0.2 6.6 0.0 0.0 0.0 0.4 5.6 0.0 0.2 0.1 1.2 0.6 8.1 0.5 0.0 2.2 7.4 8.1 11.0 11.0 5.8 10.0 6.0 6.5 9.7 7.2 PVRIG "C7orf15, CD112R, MGC2463" ENSG00000213413 "PVR related immunoglobulin domain containing" Q6DKI7 7 100218241-100221490 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 51.7;lymphoid tissue: 21.0" "Group enriched" "Detected in some" 28 "Daudi: 37.2;MOLT-4: 40.5;U-698: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 32 "gdT-cell: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8" "Group enriched" "Detected in many" 37 "B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7" "Low region specificity" "Detected in all" HPA047497 Uncertain Approved "Nucleoli,Endoplasmic reticulum" "Nucleoli, Endoplasmic reticulum" "HPA047497: " "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.21e-3)" "unprognostic (5.13e-2)" "unprognostic (9.89e-2)" "unprognostic (1.53e-3)" "unprognostic (1.35e-3)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.81e-1)" "unprognostic (5.58e-2)" "unprognostic (5.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.17e-1)" "unprognostic (2.43e-2)" "unprognostic (4.12e-1)" "unprognostic (2.71e-3)" 0.5 0.1 0.4 5.6 0.7 1.2 0.4 0.4 1.1 0.4 0.5 0.7 0.4 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.0 0.5 0.9 0.9 15.9 0.4 0.4 0.6 0.5 0.0 0.4 0.4 0.8 0.4 0.0 0.4 0.7 0.4 2.0 0.0 8.9 0.4 0.4 21.0 1.4 0.6 0.4 18.0 0.5 0.4 4.2 1.0 0.4 24.8 0.2 1.0 0.1 42.9 51.7 17.5 0.1 0.8 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 40.5 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.1 0.1 0.0 43.5 0.1 51.7 24.8 28.9 42.9 0.1 19.3 32.6 32.2 1.0 42.9 0.1 0.2 22.8 17.5 0.4 0.7 0.4 0.4 0.4 0.0 0.4 0.4 0.8 0.4 QARS ENSG00000172053 "Glutaminyl-tRNA synthetase" P47897 3 49095932-49105135 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Epilepsy, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036986, HPA036987" Enhanced Enhanced Cytosol 21000 Cytosol "HPA036986: AB_10672344, HPA036987: AB_2675418" "prognostic favourable (1.43e-4)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (1.10e-2)" "unprognostic (5.13e-3)" "unprognostic (6.62e-3)" "unprognostic (6.53e-3)" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (2.51e-1)" "unprognostic (4.33e-1)" "unprognostic (9.14e-2)" "prognostic favourable (5.60e-6)" "unprognostic (2.73e-3)" "unprognostic (1.65e-1)" "unprognostic (2.74e-2)" "unprognostic (3.11e-1)" 20.9 16.3 9.7 19.3 10.2 18.4 22.7 15.8 13.2 17.6 27.3 13.1 27.7 17.2 12.3 19.8 35.1 16.4 20.0 22.0 9.8 9.6 27.1 26.0 15.0 33.9 12.4 7.2 21.6 33.8 20.3 13.7 25.7 9.6 16.2 29.9 15.2 31.7 28.7 33.3 26.7 31.8 16.7 11.2 21.1 16.9 30.1 11.3 36.8 16.5 34.8 33.3 19.4 18.5 20.4 40.0 8.9 32.3 21.8 24.0 19.6 18.6 19.0 31.6 45.3 40.8 44.4 32.6 20.7 47.4 41.2 40.5 23.9 24.2 57.6 13.3 34.3 23.7 44.9 34.1 29.6 16.4 35.9 45.4 30.4 41.8 21.5 36.9 28.0 46.7 29.9 31.7 27.0 44.9 20.2 25.6 30.1 10.0 26.6 33.1 27.2 29.6 17.5 26.6 42.5 27.6 27.8 11.6 32.4 18.4 46.7 28.6 38.7 43.1 25.9 18.8 26.6 30.9 23.1 22.1 37.6 32.3 19.2 33.3 11.9 8.9 23.1 8.7 13.5 32.3 18.1 20.4 16.8 14.9 40.0 15.2 15.5 15.4 2.6 21.8 26.1 16.9 24.0 19.6 9.7 10.2 15.8 13.2 9.8 9.6 12.4 7.2 9.6 11.3 QSOX1 QSCN6 ENSG00000116260 "Quiescin sulfhydryl oxidase 1" O00391 1 180154834-180204030 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 172.2" "Cell line enhanced" "Detected in many" "HHSteC: 194.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042127, HPA056243" Uncertain Supported "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" 3200000000 "Golgi apparatus" Vesicles "HPA042127: , HPA056243: " "unprognostic (1.13e-1)" "unprognostic (2.62e-3)" "unprognostic (2.46e-1)" "unprognostic (2.49e-2)" "unprognostic (2.00e-2)" "unprognostic (2.73e-1)" "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.07e-2)" "unprognostic (2.80e-3)" "prognostic unfavourable (1.86e-5)" "unprognostic (3.25e-1)" "unprognostic (2.14e-1)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" 15.9 18.7 8.0 14.5 9.5 30.1 12.6 7.3 13.6 23.5 25.3 13.8 24.9 19.8 17.8 44.9 36.8 18.9 91.9 54.4 10.1 9.0 15.4 23.1 42.3 19.5 8.5 9.1 46.5 59.8 6.2 13.5 172.2 13.4 28.0 24.5 12.1 20.6 19.4 18.4 12.3 19.0 33.9 15.5 13.4 52.8 50.3 9.1 6.7 7.8 18.2 18.3 35.8 26.1 2.9 19.2 20.4 25.5 8.0 7.1 11.4 41.5 5.9 1.4 17.7 18.1 37.5 70.5 44.2 44.7 37.8 26.7 0.6 13.4 0.6 27.5 35.3 9.0 1.7 11.9 18.5 2.4 2.7 1.3 3.5 1.8 194.6 4.5 12.8 20.0 5.4 40.3 48.4 55.6 1.8 6.5 24.9 7.2 0.9 8.4 4.8 17.0 1.8 3.2 1.0 6.2 11.9 5.1 5.2 12.9 17.6 8.5 3.2 21.5 65.4 47.4 18.6 31.7 37.3 4.8 7.8 1.1 18.0 14.6 14.2 5.8 25.5 9.5 7.1 14.7 5.3 2.9 4.8 5.0 19.2 1.8 4.4 4.3 20.4 8.0 13.1 3.9 5.5 11.4 8.0 9.5 7.3 13.6 10.1 9.0 8.5 9.1 13.4 9.1 QSOX2 "DKFZp762A2013, QSCN6L1, SOXN" ENSG00000165661 "Quiescin sulfhydryl oxidase 2" Q6ZRP7 9 136206333-136245841 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012716, HPA017280" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" 5700000 "Golgi apparatus" Nucleoplasm "HPA012716: AB_2173315, HPA017280: " "unprognostic (7.29e-2)" "unprognostic (7.35e-3)" "unprognostic (6.23e-2)" "unprognostic (5.28e-2)" "unprognostic (1.49e-1)" "unprognostic (4.46e-3)" "unprognostic (1.10e-3)" "unprognostic (4.48e-2)" "unprognostic (1.20e-1)" "unprognostic (4.06e-3)" "unprognostic (5.96e-2)" "unprognostic (2.56e-2)" "prognostic unfavourable (9.64e-6)" "unprognostic (1.23e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.10e-2)" 7.2 8.0 8.4 15.9 14.1 16.0 7.3 30.3 10.6 5.8 5.8 9.4 8.9 6.0 8.1 13.2 5.6 8.1 5.5 7.0 7.6 7.1 7.0 9.2 6.5 19.1 11.0 6.7 9.4 21.7 12.1 29.2 5.8 9.6 6.1 6.7 7.9 6.5 4.9 5.1 12.4 10.3 8.1 7.1 14.6 7.6 11.7 10.1 8.3 12.1 6.0 16.7 5.4 6.4 3.4 0.8 1.6 0.3 0.4 0.8 0.2 7.2 17.7 14.7 19.5 8.3 10.1 18.6 9.3 10.4 18.1 16.7 13.2 15.8 11.2 15.3 12.4 23.6 17.4 13.4 14.7 16.5 8.7 6.0 29.3 14.5 11.8 17.8 9.2 8.0 13.6 17.9 21.8 13.2 14.4 30.3 9.6 12.3 6.6 11.9 17.4 11.3 12.2 19.1 18.3 6.2 6.6 15.8 11.9 14.6 11.6 7.8 8.3 10.4 7.5 22.0 16.0 18.0 21.1 10.7 14.3 24.7 14.7 9.4 20.5 1.6 0.3 0.7 0.5 0.0 0.8 1.9 0.6 0.2 0.1 3.4 0.2 0.4 0.1 0.4 0.0 0.8 0.3 0.2 8.4 14.1 30.3 10.6 7.6 7.1 11.0 6.7 9.6 10.1 RAB18 ENSG00000099246 "RAB18, member RAS oncogene family" Q9NP72 10 27504174-27542237 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025928 Uncertain 210000 "HPA025928: AB_1855997" "unprognostic (9.45e-3)" "unprognostic (7.71e-2)" "unprognostic (2.95e-1)" "unprognostic (6.71e-2)" "unprognostic (3.37e-2)" "unprognostic (1.28e-2)" "unprognostic (8.59e-3)" "unprognostic (1.17e-1)" "unprognostic (3.64e-1)" "unprognostic (1.27e-2)" "unprognostic (8.97e-2)" "unprognostic (3.22e-1)" "unprognostic (1.71e-3)" "unprognostic (9.55e-2)" "unprognostic (1.01e-1)" "unprognostic (1.39e-1)" "unprognostic (8.48e-2)" 29.3 45.2 36.4 20.8 45.1 58.3 38.3 34.0 42.9 26.8 25.3 24.5 26.6 25.0 25.7 32.8 40.6 20.0 20.6 40.3 40.9 42.5 36.6 38.9 22.4 17.8 35.9 42.2 24.6 23.8 27.0 33.3 34.8 43.5 32.5 27.4 21.8 26.2 27.9 49.1 33.8 27.2 28.1 38.2 21.6 27.4 25.0 26.8 24.2 32.8 28.7 24.0 25.7 28.5 6.4 10.3 49.6 14.2 11.3 24.8 11.1 21.8 15.6 19.0 13.7 32.3 18.5 12.7 33.8 15.6 29.6 28.3 15.0 14.7 8.9 14.5 29.0 14.7 12.4 21.6 24.4 13.6 11.3 12.6 15.2 19.1 23.4 5.4 15.3 24.2 41.2 18.4 10.7 22.7 7.1 18.5 24.8 14.2 11.9 3.7 8.2 7.3 8.8 31.5 10.8 28.0 12.3 10.3 12.5 16.7 19.1 21.4 38.4 11.4 22.5 13.6 16.9 25.7 19.5 8.1 14.8 11.3 23.3 31.9 7.5 44.9 13.8 33.5 11.3 12.6 24.8 6.4 9.9 12.2 10.3 6.3 8.4 9.9 49.6 11.3 14.2 6.7 10.5 11.1 36.4 45.1 34.0 42.9 40.9 42.5 35.9 42.2 43.5 26.8 RABAC1 "PRA1, PRAF1, YIP3" ENSG00000105404 "Rab acceptor 1" Q9UI14 19 41956681-41959390 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019320, HPA029171" Supported Approved "Nuclear membrane,Nucleoli fibrillar center" "Nuclear membrane" "Nucleoli fibrillar center" "CAB019320: , HPA029171: AB_10602121" "unprognostic (7.70e-2)" "unprognostic (5.18e-2)" "unprognostic (1.11e-1)" "unprognostic (2.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (1.93e-1)" "unprognostic (3.41e-2)" "unprognostic (1.19e-2)" "unprognostic (3.32e-3)" "unprognostic (9.69e-2)" "unprognostic (1.76e-1)" "unprognostic (8.92e-2)" "unprognostic (2.31e-1)" "unprognostic (6.97e-2)" "unprognostic (7.45e-2)" 44.2 45.4 42.3 36.7 42.5 29.6 43.5 30.9 53.1 43.6 40.5 32.0 45.3 47.8 46.8 32.4 36.2 30.4 39.8 32.2 39.5 45.9 46.0 92.3 35.7 53.0 44.7 33.4 37.5 88.1 18.5 48.6 51.0 39.9 33.8 19.1 23.3 68.8 40.5 52.2 31.6 43.4 32.0 38.4 32.2 60.6 28.3 31.9 38.8 56.1 28.7 32.4 31.4 47.5 54.5 59.6 114.0 58.1 33.2 57.2 64.1 17.0 46.9 6.8 17.6 46.3 26.6 9.0 50.9 27.0 12.5 17.7 8.3 11.2 49.4 26.4 30.1 12.8 4.2 16.0 5.2 18.2 27.5 7.2 13.8 14.3 24.8 6.3 20.0 25.8 15.9 8.4 6.2 17.4 3.1 64.4 11.5 26.3 11.0 5.7 8.3 30.5 15.0 14.5 9.5 11.9 12.8 12.5 18.2 13.4 29.2 12.3 10.9 5.3 33.8 22.5 14.8 21.7 7.3 57.3 19.1 17.1 32.5 11.8 24.1 86.2 58.1 76.4 57.2 30.5 48.1 54.5 52.0 49.8 33.8 49.9 35.3 47.6 114.0 33.2 29.6 59.6 55.8 64.1 42.3 42.5 30.9 53.1 39.5 45.9 44.7 33.4 39.9 31.9 RABGAP1L "FLJ38519, HHL, KIAA0471, TBC1D18" ENSG00000152061 "RAB GTPase activating protein 1 like" "B7ZAP0, Q5R372" 1 174159410-174995308 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 89.4" "Cell line enhanced" "Detected in all" "Daudi: 45.9;Karpas-707: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054695 Uncertain "HPA054695: " "unprognostic (2.57e-2)" "unprognostic (7.77e-2)" "unprognostic (6.78e-2)" "unprognostic (6.89e-3)" "unprognostic (1.54e-2)" "unprognostic (6.96e-3)" "unprognostic (8.55e-2)" "prognostic favourable (1.16e-4)" "unprognostic (2.66e-2)" "unprognostic (3.51e-2)" "unprognostic (2.66e-2)" "unprognostic (1.98e-1)" "unprognostic (9.14e-3)" "unprognostic (6.69e-2)" "unprognostic (2.14e-1)" "unprognostic (5.03e-2)" "unprognostic (2.46e-1)" 9.9 5.4 27.2 19.9 22.7 16.2 9.5 31.4 34.1 9.6 11.8 9.5 8.9 12.8 9.0 10.4 11.2 11.5 13.1 89.4 21.2 14.5 10.2 9.6 15.3 22.2 13.7 26.1 18.0 13.4 10.8 25.1 22.2 19.0 7.5 12.8 15.0 13.3 6.8 6.0 10.0 16.3 8.2 28.0 15.8 13.3 16.9 10.7 9.6 7.4 5.4 27.9 15.1 8.8 10.7 16.0 31.0 48.9 22.6 12.1 9.3 5.2 2.7 2.2 2.3 5.9 8.6 4.7 6.2 5.5 2.7 3.7 2.6 19.2 45.9 4.4 4.8 6.8 1.8 4.2 3.9 12.7 3.0 11.4 3.9 4.1 3.6 5.1 4.7 6.7 2.9 2.1 3.0 6.1 6.7 30.4 4.4 1.9 3.9 4.8 12.9 1.7 13.8 4.2 15.3 5.3 24.0 6.2 3.7 5.9 10.0 4.0 4.9 6.1 8.4 3.7 3.4 3.9 3.6 26.5 8.6 28.7 3.9 3.4 2.7 4.4 15.0 31.0 8.1 24.3 7.1 10.7 10.0 9.8 11.8 7.9 5.0 7.5 26.5 22.6 48.9 16.0 12.1 9.3 27.2 22.7 31.4 34.1 21.2 14.5 13.7 26.1 19.0 10.7 RAD51B "hREC2, R51H2, RAD51L1, REC2" ENSG00000182185 "RAD51 paralog B" O15315 14 67819779-68730218 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016191, HPA051869" Enhanced Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "CAB016191: AB_2238209, HPA051869: " "unprognostic (9.10e-3)" "unprognostic (5.45e-2)" "unprognostic (4.92e-1)" "unprognostic (6.65e-2)" "unprognostic (2.38e-2)" "unprognostic (4.85e-2)" "unprognostic (6.42e-3)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (6.80e-3)" "unprognostic (1.47e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.49e-2)" "unprognostic (6.79e-2)" "unprognostic (8.13e-3)" 5.1 4.9 4.2 4.6 10.1 9.2 8.2 2.0 5.6 8.2 4.3 11.6 11.2 1.7 10.8 13.8 7.0 6.0 6.4 3.4 5.6 3.2 4.3 3.2 5.0 6.6 9.2 4.0 10.0 5.7 8.0 10.0 8.0 7.5 7.0 4.0 9.4 18.7 3.8 2.4 7.1 5.8 6.7 7.3 6.9 3.7 3.4 7.3 12.6 4.9 4.6 12.1 7.7 8.3 13.6 6.6 14.0 5.9 7.8 10.1 4.8 12.2 4.8 5.4 3.3 5.1 8.7 3.4 6.2 4.8 6.9 8.9 3.4 16.7 15.1 4.1 3.8 11.1 3.4 9.9 9.5 6.7 3.5 7.2 4.4 2.7 2.7 6.0 7.3 4.4 7.7 7.9 8.4 6.2 5.8 7.0 5.6 9.5 11.8 2.1 3.2 4.9 13.3 6.5 5.5 5.4 3.5 3.7 2.4 5.0 1.8 10.7 8.4 5.5 1.6 8.5 8.2 6.6 5.1 3.4 3.4 12.0 4.6 10.7 4.7 14.0 5.9 5.4 8.6 4.7 7.1 13.6 8.2 9.2 6.5 11.5 10.1 9.7 0.7 7.8 4.5 6.6 9.1 4.8 4.2 10.1 2.0 5.6 5.6 3.2 9.2 4.0 7.5 7.3 RAET1E "bA350J20.7, LETAL, ULBP4" ENSG00000164520 "Retinoic acid early transcript 1E" Q8TD07 6 149883375-149898102 "Predicted intracellular proteins, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 39.7;lymphoid tissue: 22.5;tongue: 19.8" "Cell line enhanced" "Detected in some" "HBEC3-KT: 15.5;HeLa: 21.4;hTCEpi: 15.5;SiHa: 7.4;U-87 MG: 6.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA054022 Supported "Focal adhesion sites,Cytosol" "Intracellular and membrane" "Focal adhesion sites" Cytosol "HPA054022: " "unprognostic (1.67e-2)" "unprognostic (2.10e-1)" "unprognostic (3.49e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "unprognostic (2.71e-2)" "unprognostic (1.36e-3)" "unprognostic (4.80e-4)" "unprognostic (1.11e-1)" "unprognostic (3.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (7.47e-5)" "unprognostic (2.41e-2)" "unprognostic (3.18e-2)" "unprognostic (3.17e-2)" "unprognostic (1.06e-1)" 1.6 0.5 0.2 0.5 0.2 0.0 1.4 0.2 0.2 10.4 0.3 0.2 0.2 0.2 0.8 0.6 39.7 0.6 0.2 0.2 0.2 0.0 2.8 0.2 0.6 0.2 0.2 0.2 0.6 0.2 0.1 0.2 0.5 0.2 0.4 0.3 0.2 7.0 0.2 0.7 14.6 0.3 0.3 0.2 0.6 0.2 0.5 0.3 0.3 0.2 19.8 22.5 1.3 12.6 0.6 0.4 2.3 0.6 0.5 0.7 0.1 1.5 0.9 0.0 0.0 0.1 1.3 0.1 0.1 0.9 0.1 0.3 0.0 3.7 0.0 2.1 3.0 1.6 0.0 15.5 0.2 0.4 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.3 15.5 0.9 3.2 0.1 0.0 1.3 0.9 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.3 0.7 0.2 0.0 7.4 2.0 0.0 1.1 0.0 2.9 1.1 0.4 0.1 0.9 0.0 0.0 0.0 6.7 0.3 0.0 2.0 0.6 0.4 0.4 0.3 0.2 0.2 0.6 0.3 0.1 0.6 0.7 0.4 2.3 0.5 0.2 0.4 0.3 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.3 RAET1G ULBP5 ENSG00000203722 "Retinoic acid early transcript 1G" Q6H3X3 6 149916878-149923121 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.2;tongue: 18.4" "Cell line enhanced" "Detected in many" "HeLa: 22.9;hTCEpi: 18.3;SiHa: 9.0;U-87 MG: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA062673 Supported Vesicles "Secreted - unknown location" Vesicles "HPA062673: " "unprognostic (4.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-3)" "unprognostic (1.49e-1)" "unprognostic (4.61e-3)" "prognostic unfavourable (5.35e-4)" "unprognostic (3.05e-1)" "unprognostic (1.57e-1)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.33e-1)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" "unprognostic (8.85e-2)" "unprognostic (9.11e-2)" 2.5 10.0 0.3 0.6 0.3 0.0 2.5 0.2 1.0 5.6 0.6 0.5 1.4 0.2 0.8 4.3 21.2 0.5 1.2 0.9 0.4 0.2 2.3 0.2 1.3 0.1 0.3 0.1 1.9 0.1 0.1 1.2 0.1 0.5 2.9 0.1 0.8 3.9 2.2 0.4 4.3 0.5 1.8 0.9 0.2 0.6 0.5 0.2 0.2 0.7 18.4 10.7 2.8 5.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 1.0 0.0 1.3 1.9 1.7 0.0 0.6 2.4 1.0 1.5 0.0 1.2 0.0 0.4 1.3 2.0 0.7 4.0 0.8 0.2 1.2 0.4 22.9 0.0 0.5 0.0 0.0 2.6 18.3 2.8 1.3 0.4 0.2 0.1 0.4 1.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.8 2.4 0.3 0.2 9.0 0.3 0.0 0.3 0.2 1.3 0.5 0.4 1.1 0.6 0.0 0.0 0.0 7.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 1.0 0.4 0.2 0.3 0.1 0.5 0.2 RAMP1 ENSG00000132329 "Receptor activity modifying protein 1" O60894 2 237858893-237912114 "FDA approved drug targets, Predicted membrane proteins" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 91.6;pancreas: 94.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.8;HDLM-2: 37.1;PC-3: 43.2;SH-SY5Y: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "NK-cell: 30.0" "Lineage enriched" "Detected in many" 16 "NK-cells: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057814 Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA057814: " "unprognostic (1.13e-2)" "unprognostic (5.96e-2)" "unprognostic (3.03e-3)" "unprognostic (3.69e-1)" "unprognostic (4.29e-1)" "unprognostic (1.75e-1)" "prognostic favourable (7.61e-4)" "unprognostic (2.54e-1)" "unprognostic (3.49e-1)" "unprognostic (5.45e-3)" "unprognostic (2.32e-1)" "unprognostic (1.43e-1)" "unprognostic (2.46e-3)" "prognostic unfavourable (1.68e-4)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (2.08e-3)" 3.5 13.8 22.4 9.4 23.9 1.2 1.6 7.8 22.5 34.1 38.8 9.9 8.9 24.9 91.6 21.7 8.9 29.1 19.0 61.7 19.6 15.4 3.1 13.4 3.1 3.3 18.0 12.7 8.4 94.7 1.0 1.6 4.5 14.6 25.5 3.5 1.5 1.5 25.1 62.4 2.4 14.4 51.8 19.5 2.4 14.2 4.3 17.1 0.0 1.1 5.4 2.0 18.3 14.0 0.1 0.4 0.2 0.0 30.0 1.8 1.4 7.7 0.0 0.1 0.0 3.4 5.2 0.3 0.5 0.9 0.5 0.4 0.0 12.8 0.0 0.1 0.2 0.0 2.0 0.0 0.0 37.1 1.0 0.0 0.0 0.2 10.4 0.0 0.0 4.0 6.1 0.0 0.0 0.0 0.0 0.1 1.0 0.7 0.0 0.3 0.1 43.2 0.0 0.4 0.2 0.0 0.0 0.4 54.4 0.8 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.2 0.1 0.2 30.0 0.0 0.0 0.0 1.4 22.4 23.9 7.8 15.3 19.6 15.4 18.0 12.7 14.6 17.1 RAMP2 ENSG00000131477 "Receptor activity modifying protein 2" O60895 17 42758447-42763041 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 46.0;EFO-21: 30.7;HUVEC TERT2: 13.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 18 "dendritic cells: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052020 Approved Vesicles Vesicles "HPA052020: " "unprognostic (8.64e-2)" "unprognostic (2.12e-2)" "unprognostic (8.03e-2)" "unprognostic (1.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.13e-3)" "unprognostic (2.68e-2)" "unprognostic (1.04e-1)" "unprognostic (4.50e-2)" "unprognostic (5.18e-2)" "unprognostic (1.02e-2)" "unprognostic (6.79e-2)" "unprognostic (1.28e-2)" "unprognostic (6.96e-3)" "unprognostic (4.42e-2)" "unprognostic (2.20e-1)" "unprognostic (1.25e-1)" 48.6 7.1 8.6 7.6 9.6 0.2 43.4 3.4 15.4 35.1 9.7 10.8 6.1 5.2 49.5 24.2 19.5 17.0 20.4 23.9 9.6 8.5 18.8 14.6 51.5 17.3 13.8 7.7 17.3 9.6 5.6 6.1 56.1 12.5 24.9 9.1 71.1 12.8 12.2 16.2 15.6 11.5 30.9 8.8 15.6 9.2 10.9 3.0 3.9 20.0 30.1 11.7 13.2 23.1 0.0 6.4 0.0 0.1 0.0 0.3 0.0 0.0 0.4 1.9 0.0 46.0 2.3 1.5 0.3 0.7 3.8 1.8 4.2 0.0 0.0 30.7 1.1 0.0 1.7 0.0 3.3 0.0 0.0 0.0 0.3 1.3 1.1 0.0 0.0 1.6 0.0 0.6 0.1 13.8 0.0 0.1 0.2 0.0 0.2 0.3 8.9 0.0 0.0 0.0 0.0 0.2 0.2 1.9 3.8 1.0 0.0 6.3 0.4 1.2 2.5 7.4 2.7 0.1 0.9 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.3 0.0 8.6 9.6 3.4 15.4 9.6 8.5 13.8 7.7 12.5 3.0 RANBP17 ENSG00000204764 "RAN binding protein 17" Q9H2T7 5 170861870-171300015 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029568, HPA029569" Uncertain Approved "Nuclear membrane,Nuclear bodies,Cytosol" "Nuclear bodies" "Nuclear membrane, Cytosol" "HPA029568: AB_10599825, HPA029569: AB_10601571" "unprognostic (4.63e-2)" "unprognostic (2.63e-3)" "unprognostic (1.06e-1)" "unprognostic (8.28e-2)" "unprognostic (1.75e-3)" "unprognostic (5.12e-3)" "unprognostic (1.50e-1)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" "unprognostic (1.64e-2)" "unprognostic (2.19e-3)" "unprognostic (2.72e-1)" "unprognostic (1.35e-1)" "unprognostic (2.56e-3)" 1.6 4.9 1.3 1.8 2.1 0.8 1.8 10.4 3.6 1.8 2.0 2.9 1.1 1.5 5.3 2.8 1.0 2.2 2.7 1.5 1.4 2.2 2.4 1.8 4.1 2.4 1.5 1.7 1.8 7.2 3.6 9.4 5.0 5.3 2.4 2.3 5.4 5.1 2.7 1.0 1.1 2.6 2.4 3.1 1.0 2.5 16.3 0.4 0.1 4.7 0.1 1.4 1.5 1.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 1.1 5.4 4.5 1.5 0.5 3.4 3.9 1.8 2.8 1.7 2.3 0.0 0.1 3.3 3.8 0.0 0.0 1.7 5.7 0.0 4.3 1.1 2.1 0.0 1.5 0.0 0.0 4.4 0.3 0.3 0.0 2.6 0.4 0.0 1.6 2.7 0.0 0.0 0.4 0.5 0.0 3.5 0.0 0.9 1.4 0.3 2.0 0.0 5.4 2.8 0.9 1.5 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 2.1 10.4 3.6 1.4 2.2 1.5 1.7 5.3 0.4 RASGEF1B "FLJ31695, GPIG4" ENSG00000138670 "RasGEF domain family member 1B" Q0VAM2 4 81426393-82044244 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 12.2;Daudi: 15.6;Karpas-707: 10.5;NTERA-2: 7.2;SCLC-21H: 7.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 7.7;memory B-cell: 6.4;naive B-cell: 8.8;non-classical monocyte: 12.4;plasmacytoid DC: 18.0" "Group enriched" "Detected in many" 5 "B-cells: 8.8;dendritic cells: 18.0;monocytes: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044574 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044574: AB_10794292" "unprognostic (3.24e-1)" "prognostic favourable (6.40e-4)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (1.19e-1)" "prognostic favourable (1.49e-5)" "unprognostic (4.42e-2)" "unprognostic (6.31e-2)" "unprognostic (4.43e-1)" "unprognostic (4.85e-2)" "unprognostic (1.13e-2)" "unprognostic (3.88e-2)" "prognostic favourable (4.21e-6)" "unprognostic (4.19e-3)" "unprognostic (1.44e-2)" "unprognostic (3.19e-2)" "unprognostic (6.04e-2)" 11.7 5.3 12.2 8.4 18.9 22.2 14.3 3.5 8.4 7.6 8.0 10.0 2.6 10.8 3.0 9.9 10.9 6.6 10.1 4.9 6.2 8.2 9.4 32.8 19.1 9.2 13.0 3.5 3.3 2.5 1.7 12.6 10.3 38.3 3.8 6.0 6.1 9.7 4.2 3.5 20.3 10.7 5.0 8.7 13.2 12.2 1.9 19.3 8.0 3.9 4.7 8.5 4.8 5.6 8.8 18.0 0.8 12.4 2.5 2.0 0.7 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 12.2 0.3 15.6 0.0 0.0 0.3 1.0 0.1 0.0 0.1 2.3 1.3 1.0 0.5 0.5 0.3 0.7 0.2 0.5 0.0 0.5 0.0 0.2 10.5 0.0 0.5 5.0 0.5 7.2 3.2 1.5 0.1 5.9 0.5 0.2 7.0 0.1 0.0 2.2 0.0 1.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.0 4.7 1.1 0.2 0.2 0.4 2.1 0.2 1.4 7.7 1.5 6.4 1.1 1.1 1.7 8.8 2.0 1.9 0.8 2.5 12.4 18.0 0.3 0.7 12.2 18.9 3.5 8.4 6.2 8.2 13.0 3.5 38.3 19.3 RBL1 "cp107, p107, PRB1" ENSG00000080839 "RB transcriptional corepressor like 1" P28749 20 36996349-37095995 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA054962, HPA056525" Enhanced Enhanced Nucleoplasm Nucleoplasm "HPA054962: AB_2682652, HPA056525: AB_2683165" "unprognostic (1.97e-1)" "unprognostic (2.47e-2)" "unprognostic (1.30e-2)" "unprognostic (3.70e-3)" "unprognostic (2.13e-1)" "unprognostic (1.51e-1)" "unprognostic (6.25e-5)" "unprognostic (6.91e-2)" "unprognostic (7.19e-3)" "unprognostic (1.20e-1)" "unprognostic (4.49e-3)" "unprognostic (3.23e-2)" "prognostic unfavourable (2.52e-6)" "unprognostic (3.15e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-2)" "unprognostic (1.26e-1)" 5.0 4.3 4.9 12.3 7.1 20.4 4.8 16.6 7.8 5.1 5.6 5.5 5.9 4.0 8.1 3.0 7.7 4.4 3.6 4.0 4.0 3.6 3.3 3.0 4.5 11.1 6.5 2.2 7.8 6.0 5.9 5.9 8.3 5.7 4.4 6.1 5.3 4.8 2.7 10.2 5.3 5.9 5.9 7.1 6.9 4.6 8.2 5.5 19.6 5.3 6.1 11.4 4.7 7.1 5.0 5.1 2.2 1.9 3.6 7.4 1.6 12.0 7.9 9.9 6.6 2.5 3.3 6.3 14.1 6.3 12.2 12.7 8.3 6.8 13.5 4.1 5.8 11.9 8.8 9.1 20.5 4.7 4.7 13.3 9.3 7.0 1.5 17.1 9.3 1.6 1.2 16.1 5.7 6.8 9.7 13.1 6.9 5.1 15.9 5.7 2.9 7.7 10.4 29.4 10.2 2.8 6.0 2.3 5.9 15.4 8.9 4.1 5.7 12.4 4.5 21.7 8.3 19.8 12.2 4.4 7.7 13.7 15.5 12.1 10.6 1.4 1.2 2.2 5.0 1.4 4.2 5.0 5.6 4.5 2.2 3.9 6.0 4.8 0.6 3.6 1.9 5.1 7.4 1.6 4.9 7.1 16.6 7.8 4.0 3.6 6.5 2.2 5.7 5.5 RCAN2 "DSCR1L1, ZAKI-4" ENSG00000172348 "Regulator of calcineurin 2" Q14206 6 46220736-46491972 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 98.8" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 24.7;HDLM-2: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 34 "gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 43 "T-cells: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053880 Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA053880: " "unprognostic (2.82e-1)" "unprognostic (7.76e-2)" "unprognostic (4.13e-2)" "unprognostic (1.14e-1)" "unprognostic (5.55e-3)" "unprognostic (4.52e-2)" "unprognostic (1.29e-3)" "unprognostic (1.86e-3)" "unprognostic (2.26e-1)" "unprognostic (4.33e-1)" "prognostic favourable (2.48e-4)" "unprognostic (1.37e-1)" "prognostic favourable (1.12e-6)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" 13.7 7.2 13.2 4.3 33.4 0.8 5.9 19.5 51.8 10.9 10.6 13.4 2.3 5.5 7.3 27.6 13.9 7.8 18.0 98.8 14.7 24.2 17.5 4.0 8.3 2.6 38.3 27.1 13.5 6.2 47.7 6.7 1.1 60.3 13.8 12.2 27.9 5.5 14.9 29.3 5.9 7.7 14.2 17.0 4.1 14.0 3.5 11.0 0.0 10.8 14.4 4.1 15.9 8.8 0.0 0.0 0.1 0.1 0.0 4.8 0.8 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.4 5.9 0.4 0.0 0.0 0.0 0.0 0.3 24.7 0.0 0.0 0.0 0.1 49.7 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 1.1 0.1 0.1 5.5 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 2.6 4.8 0.0 0.0 0.0 3.7 0.1 0.0 0.1 0.0 0.0 0.8 13.2 33.4 19.5 51.8 14.7 24.2 38.3 27.1 60.3 11.0 RCN3 RLP49 ENSG00000142552 "Reticulocalbin 3" Q96D15 19 49527618-49546962 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 52.2;ASC TERT1: 36.1;BJ: 57.0;BJ hTERT+ SV40 Large T+ RasG12V: 33.0;fHDF/TERT166: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA043134, HPA050402" Uncertain Approved "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" "Endoplasmic reticulum, Vesicles" "HPA043134: , HPA050402: " "unprognostic (7.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.77e-3)" "unprognostic (8.87e-2)" "unprognostic (3.36e-3)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (1.16e-1)" "unprognostic (7.47e-2)" "unprognostic (9.75e-2)" "unprognostic (2.85e-1)" "unprognostic (3.86e-2)" "prognostic unfavourable (5.80e-12)" "unprognostic (5.26e-2)" "unprognostic (3.90e-2)" "unprognostic (1.56e-2)" "unprognostic (4.20e-3)" 19.6 10.9 3.7 18.2 5.3 3.2 15.6 7.2 6.6 36.3 10.7 2.0 9.6 22.2 28.2 33.9 11.4 10.7 26.2 18.2 3.4 3.5 12.6 18.6 12.6 4.4 3.3 2.8 29.5 5.1 2.1 9.0 18.0 6.0 19.4 7.0 10.7 6.2 8.2 10.6 8.2 23.7 16.8 2.9 21.3 7.8 17.3 4.2 1.8 9.9 9.8 7.9 21.5 21.6 0.6 0.5 3.9 0.4 2.3 9.7 1.6 0.5 0.8 0.5 30.3 52.2 36.1 0.3 57.0 14.8 21.5 33.0 0.7 0.2 0.2 3.4 49.8 0.0 1.4 0.1 10.3 0.0 0.4 3.2 0.2 1.6 18.3 0.0 7.5 20.3 0.0 15.0 0.0 8.2 1.4 0.1 17.5 0.6 0.0 0.3 0.2 3.9 0.1 0.7 0.9 0.2 0.0 0.3 1.9 0.0 0.2 0.0 0.2 2.0 19.2 0.3 9.6 24.9 0.0 2.8 8.3 0.5 1.4 1.8 2.4 0.0 0.3 2.2 0.9 0.0 1.0 0.6 2.5 0.9 0.5 0.4 9.7 3.2 3.9 2.3 0.4 0.4 1.9 1.6 3.7 5.3 7.2 6.6 3.4 3.5 3.3 2.8 6.0 4.2 RDH10 SDR16C4 ENSG00000121039 "Retinol dehydrogenase 10" Q8IZV5 8 73294612-73325281 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 134.3" "Cell line enhanced" "Detected in many" "ASC diff: 46.6;BJ: 33.4;CACO-2: 29.8;HDLM-2: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.4" "Group enriched" "Detected in many" 5 "granulocytes: 4.4;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049199 Supported "Lipid droplets" "Lipid droplets" "HPA049199: " "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (8.86e-2)" "unprognostic (2.52e-1)" "unprognostic (2.45e-2)" "unprognostic (1.13e-2)" "unprognostic (1.14e-1)" "unprognostic (2.80e-2)" "unprognostic (7.87e-2)" "unprognostic (7.98e-2)" "unprognostic (1.18e-3)" "unprognostic (8.88e-3)" "unprognostic (1.13e-2)" "unprognostic (4.38e-2)" "unprognostic (1.67e-1)" "unprognostic (2.98e-3)" "unprognostic (6.23e-2)" 18.3 3.2 2.7 9.5 3.3 0.7 11.8 1.7 2.8 8.2 18.7 2.9 10.0 13.6 5.9 5.8 9.4 4.4 21.9 9.6 2.3 2.4 19.6 37.5 8.7 4.8 4.1 1.7 4.9 14.8 3.7 17.9 20.9 8.7 12.4 6.4 134.3 22.6 5.7 3.4 4.4 34.1 14.0 6.9 5.6 15.3 8.0 2.1 2.0 3.5 7.3 6.5 12.8 6.5 0.6 0.7 4.4 0.6 0.2 2.3 0.5 4.1 12.1 1.3 5.6 46.6 3.4 12.4 33.4 5.4 1.3 2.2 29.8 12.0 2.9 4.4 18.6 11.1 6.1 4.8 2.7 33.5 15.3 5.2 12.0 9.1 1.8 2.4 5.7 2.0 6.2 5.2 4.9 4.9 5.9 4.3 2.2 1.8 2.5 1.0 1.6 5.9 2.2 1.4 1.7 9.0 6.0 0.8 1.0 2.8 20.8 1.7 4.1 1.3 7.4 2.0 3.4 9.1 2.5 2.8 2.9 2.4 1.6 2.2 4.6 4.4 0.6 1.1 1.2 0.3 0.7 0.6 1.3 1.4 0.7 0.1 2.3 1.2 0.8 0.2 0.5 0.2 0.7 0.5 2.7 3.3 1.7 1.8 2.3 2.4 4.1 1.7 8.7 2.1 RDH16 "RODH-4, SDR9C8" ENSG00000139547 "Retinol dehydrogenase 16 (all-trans)" O75452 12 56951431-56959374 "Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 59 "liver: 114.6" "Group enriched" "Detected in some" 6 "HaCaT: 3.4;hTCEpi: 7.6" "Cancer enriched" "Detected in many" 20 "liver cancer: 44.0" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA038518 Enhanced "HPA038518: AB_10672713" "unprognostic (5.42e-3)" "unprognostic (4.20e-2)" "unprognostic (2.99e-2)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" "prognostic favourable (2.16e-5)" "unprognostic (8.83e-3)" "unprognostic (1.04e-1)" "unprognostic (2.84e-1)" "unprognostic (6.85e-2)" "unprognostic (6.10e-1)" "unprognostic (7.99e-12)" "unprognostic (2.24e-1)" "unprognostic (1.29e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 114.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.8 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.6 0.1 0.0 7.6 0.0 0.8 0.0 0.1 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.3 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.2 RDM1 "MGC33977, RAD52B" ENSG00000278023 "RAD52 motif containing 1" Q8NG50 17 35918066-35930773 "Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.7;lymphoid tissue: 6.2;testis: 24.0" "Cell line enhanced" "Detected in many" "CACO-2: 10.6;T-47d: 17.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 5.7" "Group enriched" "Detected in many" 14 "NK-cells: 1.5;T-cells: 5.7" "Low region specificity" "Detected in all" "HPA024794, HPA067546" Enhanced Supported Nucleoli,Cytosol Nucleoli Cytosol "HPA024794: AB_1856039, HPA067546: " "unprognostic (9.36e-2)" "unprognostic (2.40e-2)" "unprognostic (8.00e-2)" "unprognostic (4.57e-3)" "unprognostic (1.91e-2)" "unprognostic (1.26e-1)" "unprognostic (2.06e-4)" "unprognostic (5.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.71e-2)" "unprognostic (2.58e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-8)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (7.00e-3)" "unprognostic (1.53e-1)" 0.0 0.0 0.9 0.9 1.2 0.6 0.0 0.0 1.8 0.0 0.9 0.1 0.0 1.3 0.2 0.7 0.3 0.1 0.3 0.0 1.0 0.1 0.0 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.2 0.2 1.7 0.0 0.0 0.0 0.0 1.1 1.5 0.1 0.2 0.1 1.1 24.0 0.0 6.2 0.3 0.0 2.8 0.0 0.0 0.1 0.2 0.0 0.0 1.5 5.7 0.3 6.0 7.1 1.3 2.5 0.1 0.0 2.1 1.4 0.1 0.8 1.3 10.6 6.0 6.6 2.9 0.4 0.9 4.1 1.7 4.1 1.5 8.3 4.2 1.8 0.0 0.0 0.2 3.0 0.0 0.8 0.5 0.4 0.1 1.8 0.0 0.6 2.4 2.3 2.3 0.9 2.6 0.8 0.0 0.0 1.6 3.4 4.8 0.8 1.9 1.8 2.6 17.4 0.4 0.0 0.1 2.1 0.0 0.4 5.5 2.0 2.3 3.4 2.4 1.1 0.0 0.0 0.0 1.4 0.0 2.3 0.1 1.6 5.7 0.2 0.0 0.0 0.7 0.0 1.5 0.0 0.0 1.5 0.3 RECK "hRECK, ST15" ENSG00000122707 "Reversion inducing cysteine rich protein with kazal motifs" O95980 9 36036433-36124451 "Plasma proteins, Predicted membrane proteins" "Wnt signaling pathway" "Protease inhibitor, Serine protease inhibitor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 54.0;ASC TERT1: 43.3;BJ: 16.8;BJ hTERT+: 24.2;HSkMC: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025109, HPA071729" Supported Supported "Plasma membrane" 37000000 "Plasma membrane" "CAB025109: , HPA071729: " "unprognostic (3.42e-1)" "unprognostic (4.01e-3)" "unprognostic (5.50e-2)" "unprognostic (5.05e-4)" "unprognostic (8.87e-2)" "unprognostic (8.47e-2)" "unprognostic (2.24e-1)" "unprognostic (2.23e-1)" "unprognostic (3.75e-2)" "unprognostic (1.51e-2)" "unprognostic (9.06e-2)" "unprognostic (8.48e-2)" "unprognostic (7.45e-2)" "prognostic unfavourable (7.31e-4)" "unprognostic (2.68e-2)" "unprognostic (1.50e-2)" "unprognostic (3.60e-2)" 15.9 8.9 6.9 6.3 8.2 1.5 31.7 9.1 7.8 18.9 10.2 8.5 6.2 4.3 18.4 7.5 13.7 12.0 15.6 11.3 8.4 4.9 6.9 6.7 16.7 6.1 8.3 4.9 17.2 3.9 3.7 7.8 12.7 8.3 12.3 7.6 10.5 7.8 8.9 5.7 8.7 7.7 17.3 7.9 8.1 9.8 7.9 8.5 8.4 10.5 9.8 6.2 17.8 16.8 3.5 3.7 1.2 5.5 3.6 8.9 3.1 0.3 0.6 2.1 1.1 54.0 43.3 0.0 16.8 24.2 1.2 2.9 0.0 0.0 0.6 1.6 14.8 0.1 0.4 0.3 1.7 1.0 0.9 0.6 0.7 0.0 4.3 0.0 2.9 19.3 0.4 1.8 0.7 3.8 0.0 0.5 3.1 0.0 1.6 0.2 0.7 0.5 1.7 1.6 0.0 0.8 0.0 0.2 1.1 0.3 0.2 0.6 0.0 2.2 11.4 2.3 0.8 1.5 0.9 0.7 0.8 0.7 1.4 2.2 1.5 1.2 3.3 0.9 5.4 3.5 6.1 1.7 7.1 5.7 3.7 3.5 8.9 6.4 0.5 3.6 5.5 2.1 3.2 3.1 6.9 8.2 9.1 7.8 8.4 4.9 8.3 4.9 8.3 8.5 REEP1 "C2orf23, FLJ13110, SPG31, Yip2a" ENSG00000068615 "Receptor accessory protein 1" Q9H902 2 86213993-86338083 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 38.6" "Cell line enhanced" "Detected in many" "BEWO: 36.7;HAP1: 8.0;RPMI-8226: 8.2;SCLC-21H: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058061 Enhanced "HPA058061: " "unprognostic (1.94e-2)" "unprognostic (1.61e-3)" "unprognostic (2.03e-2)" "unprognostic (2.60e-1)" "unprognostic (2.29e-2)" "unprognostic (5.10e-2)" "unprognostic (6.63e-2)" "unprognostic (9.07e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "unprognostic (6.15e-2)" "unprognostic (2.35e-1)" "unprognostic (2.56e-2)" "unprognostic (6.77e-2)" "unprognostic (2.94e-2)" "unprognostic (1.19e-1)" "unprognostic (1.07e-3)" 3.4 6.3 10.1 2.0 16.1 0.5 5.1 6.8 29.4 2.4 19.2 2.5 2.2 4.4 9.8 3.9 6.1 8.3 3.8 9.9 9.0 20.4 2.3 1.5 2.8 0.9 13.9 10.2 1.1 9.1 10.0 7.7 2.5 21.1 6.3 5.1 4.9 1.0 12.6 16.0 1.5 4.5 19.5 4.1 1.9 4.8 38.6 3.0 0.0 1.2 1.8 1.0 10.2 3.4 0.4 0.5 0.2 0.0 0.0 0.6 0.7 0.0 0.0 1.2 1.5 0.0 0.0 36.7 0.0 0.0 2.4 0.2 1.3 0.0 0.0 1.7 0.0 2.6 8.0 0.0 2.1 0.0 4.3 0.0 2.8 0.2 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.3 0.0 0.0 3.5 8.2 0.1 0.1 17.3 1.7 1.8 0.8 0.1 2.7 0.5 0.0 0.0 1.3 0.7 3.3 3.9 2.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.0 0.5 0.0 0.7 10.1 16.1 6.8 19.7 9.0 20.4 13.9 10.2 21.1 3.0 REEP2 "C5orf19, SGC32445, SPG72, Yip2d" ENSG00000132563 "Receptor accessory protein 2" Q9BRK0 5 138439017-138446969 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.9" "Cell line enhanced" "Detected in many" "AN3-CA: 41.4;SCLC-21H: 17.3;SH-SY5Y: 19.6;U-87 MG: 15.6" "Cancer enriched" "Detected in many" 9 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 21 "dendritic cells: 1.0;T-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031813, HPA076571" Enhanced "HPA031813: , HPA076571: " "prognostic favourable (7.83e-5)" "unprognostic (1.11e-2)" "unprognostic (3.97e-6)" "unprognostic (3.70e-3)" "prognostic unfavourable (6.65e-4)" "unprognostic (5.43e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-1)" "prognostic favourable (9.31e-4)" "unprognostic (5.93e-2)" "unprognostic (3.70e-3)" "unprognostic (9.78e-2)" "unprognostic (6.54e-3)" "unprognostic (7.54e-2)" "unprognostic (1.47e-3)" "unprognostic (6.19e-3)" "unprognostic (1.13e-3)" 5.2 10.9 27.2 3.4 27.2 1.2 2.0 37.0 58.9 3.0 4.4 5.9 0.4 2.8 3.7 2.6 5.6 2.8 3.6 10.5 29.3 32.1 1.6 1.0 1.5 1.4 27.9 19.6 3.5 2.9 2.8 13.9 1.6 25.8 6.1 3.3 7.9 2.1 9.9 15.6 2.0 3.1 13.6 9.7 1.2 2.2 4.5 6.3 0.0 1.4 0.5 1.5 4.1 1.1 0.0 1.0 0.0 0.0 0.0 3.2 0.3 0.2 3.1 11.9 41.4 1.8 4.6 0.0 3.6 1.6 4.9 5.6 2.2 0.4 0.0 0.6 4.4 0.2 11.2 2.3 3.8 1.2 9.9 0.0 0.8 5.4 4.4 0.0 0.0 1.5 0.1 2.8 0.2 0.9 0.0 3.0 1.6 1.8 1.0 0.7 7.3 0.1 4.0 1.1 0.0 0.9 0.0 17.3 19.6 1.2 0.0 3.0 1.1 0.4 0.1 2.8 2.9 2.6 6.6 7.7 4.8 0.3 15.6 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 3.2 0.3 27.2 27.2 37.0 35.6 29.3 32.1 27.9 19.6 25.8 6.3 REEP4 "C8orf20, FLJ22246, FLJ22277, PP432, Yip2c" ENSG00000168476 "Receptor accessory protein 4" Q9H6H4 8 22138020-22141951 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042683 Approved Approved Cytosol Cytosol "HPA042683: AB_2571730" "unprognostic (2.38e-1)" "unprognostic (9.96e-3)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (3.41e-2)" "unprognostic (7.75e-2)" "prognostic unfavourable (4.14e-5)" "unprognostic (1.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" "unprognostic (7.15e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (2.88e-5)" "unprognostic (5.72e-2)" "unprognostic (1.06e-1)" "unprognostic (2.25e-1)" "unprognostic (6.65e-2)" 6.3 4.3 3.9 9.2 6.2 18.1 22.9 2.3 4.3 12.8 11.9 6.9 4.0 8.4 5.6 5.4 39.8 5.5 11.1 4.5 3.4 2.9 5.2 6.4 18.0 16.5 7.2 2.5 4.9 11.0 3.2 5.6 35.8 5.7 9.2 8.8 4.5 11.0 6.0 3.0 43.1 8.6 5.2 7.5 19.9 12.3 19.1 6.8 14.5 10.8 20.4 24.9 12.4 20.8 4.4 17.7 25.9 23.6 9.8 10.9 10.2 12.2 25.4 8.2 12.9 3.5 3.6 14.5 11.0 6.2 14.4 13.2 14.6 12.4 14.9 14.4 6.0 31.5 9.8 18.9 7.4 8.3 11.2 16.0 13.4 14.9 3.9 7.3 24.7 3.3 36.6 10.9 9.3 8.7 12.5 52.1 7.4 18.7 18.9 26.5 11.9 15.9 10.7 6.8 30.5 6.5 13.2 6.6 12.1 8.9 10.4 15.8 20.6 11.2 9.0 9.5 15.6 21.3 15.4 11.9 9.0 9.8 10.8 16.6 18.9 17.7 23.6 25.9 10.9 23.0 8.5 4.4 9.6 9.1 17.7 2.2 4.5 5.9 6.8 9.8 15.3 6.9 6.1 10.2 3.9 6.2 2.3 4.3 3.4 2.9 7.2 2.5 5.7 6.8 REEP5 "C5orf18, D5S346, DP1, TB2, Yip2e" ENSG00000129625 "Receptor accessory protein 5" Q00765 5 112876379-112922539 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003895, HPA069960" Approved Approved "Endoplasmic reticulum" 13000 "Endoplasmic reticulum" "HPA003895: AB_1845723, HPA069960: " "unprognostic (3.26e-3)" "unprognostic (2.60e-1)" "unprognostic (2.71e-1)" "prognostic favourable (5.23e-6)" "unprognostic (8.29e-2)" "unprognostic (1.44e-2)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (2.85e-1)" "unprognostic (3.75e-2)" "unprognostic (7.75e-2)" "unprognostic (5.90e-2)" "prognostic favourable (2.05e-5)" "unprognostic (2.88e-2)" "unprognostic (4.14e-2)" "unprognostic (1.83e-1)" "unprognostic (3.24e-2)" 22.7 35.7 39.7 14.2 47.9 7.3 46.2 33.9 65.2 32.3 21.6 23.1 33.2 17.1 19.7 45.7 16.7 22.1 20.6 42.3 37.9 45.8 50.9 50.6 26.6 13.9 37.8 37.2 25.0 56.7 45.5 21.8 41.3 72.7 34.8 20.7 20.7 49.0 32.4 31.9 20.8 18.9 18.5 33.1 19.0 22.0 10.0 21.7 6.3 84.6 20.1 18.1 22.0 19.9 38.8 42.8 55.3 63.4 23.4 39.1 44.7 19.2 16.7 6.2 13.6 30.1 26.6 21.1 17.8 17.5 19.2 19.7 14.2 26.2 7.5 35.3 21.9 19.0 14.2 28.2 20.3 36.5 18.8 8.0 13.3 11.2 27.9 6.5 13.9 17.4 28.4 15.6 15.7 24.0 4.6 17.2 25.8 18.2 3.0 11.6 8.8 12.1 4.0 17.7 21.8 50.8 21.2 11.2 8.6 24.1 48.3 17.5 55.7 11.8 25.2 17.3 6.5 23.6 24.2 18.3 22.3 6.4 30.1 12.0 8.8 34.7 50.7 49.3 33.6 54.7 35.3 38.8 27.2 31.9 42.8 32.4 12.6 23.3 55.3 23.4 63.4 31.2 39.1 44.7 39.7 47.9 33.9 65.2 37.9 45.8 37.8 37.2 72.7 21.7 REEP6 "C19orf32, DP1L1, FLJ25383, Yip2f" ENSG00000115255 "Receptor accessory protein 6" Q96HR9 19 1490747-1497927 "Disease related genes, Predicted membrane proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 90.8;liver: 119.0;testis: 71.2" "Cell line enhanced" "Detected in many" "CACO-2: 15.8;Hep G2: 15.0;K-562: 41.8;T-47d: 34.9" "Cancer enhanced" "Detected in all" "liver cancer: 114.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA003895, HPA048015" Enhanced Supported "Endoplasmic reticulum" 26000 "Endoplasmic reticulum" "HPA003895: AB_1845723, HPA048015: " "unprognostic (1.21e-1)" "unprognostic (1.56e-1)" "unprognostic (7.76e-2)" "unprognostic (1.63e-3)" "unprognostic (3.24e-1)" "unprognostic (2.43e-2)" "unprognostic (1.92e-1)" "unprognostic (6.85e-2)" "unprognostic (7.38e-2)" "unprognostic (4.56e-1)" "unprognostic (1.49e-1)" "unprognostic (1.93e-1)" "unprognostic (1.40e-2)" "unprognostic (2.17e-1)" "unprognostic (8.08e-2)" "unprognostic (2.83e-1)" "unprognostic (5.38e-2)" 2.4 20.1 4.1 0.7 5.9 0.6 3.9 3.1 6.0 1.4 41.7 2.8 4.4 60.2 1.0 5.7 2.7 1.4 7.6 0.9 4.5 1.9 6.1 119.0 0.6 0.7 2.6 2.1 1.7 10.1 0.5 2.2 0.7 2.1 4.9 0.7 27.4 5.6 11.8 0.7 1.7 90.8 1.1 1.6 0.6 1.3 71.2 1.1 0.3 1.6 1.1 2.1 3.2 1.2 1.0 4.2 0.1 4.8 5.8 7.1 2.3 2.0 2.5 0.8 10.3 1.6 0.5 11.5 0.5 0.1 0.5 0.5 15.8 6.4 1.1 3.6 0.3 2.1 2.7 0.1 0.2 0.5 1.1 6.0 0.3 15.0 1.2 0.4 2.0 1.3 1.1 0.0 0.3 0.3 41.8 1.5 0.1 7.9 0.5 1.3 3.8 5.6 1.5 0.3 2.6 3.0 0.9 0.2 5.6 2.8 4.0 1.7 34.9 1.6 0.9 0.8 1.6 2.4 0.4 5.0 1.4 0.1 3.5 2.6 2.3 0.0 1.5 0.0 7.1 1.7 3.8 0.1 2.1 1.5 2.5 1.0 2.8 3.2 0.1 5.8 4.8 4.2 2.0 2.3 4.1 5.9 3.1 6.0 4.5 1.9 2.6 2.1 2.1 1.1 RELL1 ENSG00000181826 "RELT like 1" Q8IUW5 4 37590800-37686376 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013377 Approved Supported "Plasma membrane,Microtubules" "Plasma membrane, Microtubules" "HPA013377: AB_1844403" "unprognostic (1.70e-1)" "unprognostic (1.70e-1)" "unprognostic (4.78e-2)" "unprognostic (5.30e-2)" "unprognostic (6.80e-2)" "unprognostic (7.28e-2)" "unprognostic (7.35e-2)" "unprognostic (2.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (7.88e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (6.15e-2)" "unprognostic (1.71e-2)" 21.1 3.0 5.5 6.2 9.7 28.8 19.3 6.4 6.5 8.4 10.4 6.5 2.8 7.2 8.3 7.8 9.8 7.3 9.7 12.1 5.1 5.0 4.9 5.5 10.4 14.6 9.1 2.1 8.9 4.0 2.6 3.2 20.7 17.9 6.2 7.5 8.1 5.3 5.0 10.1 11.5 8.6 11.1 28.2 10.9 14.7 4.1 5.3 6.0 18.1 9.6 6.6 15.6 13.3 0.1 3.2 16.1 4.0 0.9 1.7 1.3 2.8 3.7 9.0 6.4 6.2 5.2 7.1 5.1 5.3 4.5 5.7 11.4 3.5 0.6 3.9 4.7 2.7 2.9 5.4 7.1 0.0 1.5 1.1 3.1 9.8 3.7 4.2 2.9 7.0 4.4 5.5 5.5 18.0 2.2 2.9 3.3 2.4 4.4 2.2 1.8 1.1 1.6 32.6 1.5 4.4 4.2 2.0 5.6 4.7 3.5 4.5 12.1 1.4 21.4 9.1 5.3 6.9 5.7 1.5 1.6 4.8 8.3 6.7 6.9 0.0 4.0 2.5 1.3 0.8 1.2 0.1 1.2 1.1 1.6 0.0 1.1 1.7 16.1 0.9 0.5 3.2 1.1 1.3 5.5 9.7 6.4 6.5 5.1 5.0 9.1 2.1 17.9 5.3 RELL2 "C5orf16, FLJ90583" ENSG00000164620 "RELT like 2" Q8NC24 5 141636950-141641077 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 27.6" "Cell line enhanced" "Detected in many" "HMC-1: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077928 Uncertain Vesicles Vesicles "HPA077928: " "unprognostic (3.27e-2)" "unprognostic (8.46e-2)" "unprognostic (2.12e-1)" "unprognostic (4.95e-3)" "unprognostic (1.91e-3)" "unprognostic (7.12e-2)" "unprognostic (1.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.69e-2)" "unprognostic (2.12e-2)" "unprognostic (6.76e-4)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (7.85e-2)" "unprognostic (8.74e-3)" "unprognostic (4.31e-2)" "unprognostic (6.58e-2)" 2.0 4.5 6.9 2.4 12.3 2.2 2.3 12.5 27.6 1.4 2.3 2.3 0.0 2.5 1.3 1.8 2.7 1.2 2.4 1.6 10.8 14.5 3.3 1.8 2.7 4.7 17.8 8.4 1.1 2.2 27.6 9.4 7.4 24.9 2.2 2.1 1.7 3.7 1.8 1.0 4.2 1.8 2.2 3.8 5.4 2.3 4.6 2.5 4.6 2.8 1.7 5.0 2.9 0.9 2.5 7.8 1.2 3.5 0.1 5.4 1.9 0.9 3.0 3.0 5.7 2.4 0.7 1.4 2.6 4.8 8.4 12.5 11.3 1.1 0.1 1.2 3.9 4.6 2.8 10.9 2.2 2.7 1.8 6.9 6.5 5.6 3.9 2.2 20.0 1.6 6.8 7.8 5.7 2.3 2.4 3.6 1.9 1.4 4.0 0.8 3.5 1.5 0.2 0.6 4.7 2.7 2.7 5.0 5.5 2.3 11.0 1.8 3.8 5.2 2.0 6.5 2.9 5.1 4.4 2.1 5.7 16.2 3.5 9.6 4.1 0.0 1.4 0.0 3.0 3.5 1.1 2.5 3.2 3.0 2.3 1.5 2.9 1.6 1.2 0.1 2.5 7.8 5.4 1.9 6.9 12.3 12.5 27.6 10.8 14.5 17.8 8.4 24.9 2.5 RELT "FLJ14993, TNFRSF19L" ENSG00000054967 "RELT, TNF receptor" Q969Z4 11 73376264-73397474 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 92.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062824, HPA071518" Supported Nucleoplasm Nucleoplasm "HPA062824: , HPA071518: " "unprognostic (3.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.80e-3)" "unprognostic (9.92e-3)" "unprognostic (1.67e-3)" "unprognostic (1.17e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-1)" "unprognostic (8.42e-2)" "unprognostic (4.13e-2)" "prognostic unfavourable (4.07e-11)" "unprognostic (1.64e-1)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (1.69e-1)" 3.5 2.2 3.5 11.7 8.8 92.2 2.8 3.5 5.7 1.4 2.1 7.4 0.0 2.7 1.9 2.5 3.2 1.6 4.1 5.3 4.0 5.2 2.0 2.0 8.4 18.2 8.3 3.9 1.5 1.6 1.8 3.1 4.1 13.9 1.7 2.0 2.3 4.6 1.3 22.1 2.5 5.6 2.8 14.3 18.1 2.5 3.0 4.6 4.8 1.8 3.9 9.0 3.3 2.1 4.7 6.8 12.1 19.2 0.3 1.1 3.1 5.6 5.7 4.4 4.4 0.5 0.6 5.1 6.3 3.9 7.3 4.4 5.4 2.5 10.4 20.8 4.1 8.4 2.8 3.1 2.6 6.3 5.4 9.9 7.1 2.0 1.2 9.8 17.4 0.7 1.3 7.7 2.0 2.6 7.4 13.9 2.0 5.4 7.0 10.1 4.0 7.1 13.9 7.8 9.1 1.4 2.4 5.9 5.6 5.4 4.9 6.6 2.7 8.4 3.6 9.2 6.5 15.2 11.2 4.9 3.8 11.5 5.6 9.6 9.7 0.4 7.0 12.1 0.5 14.3 1.1 4.7 0.6 1.0 6.8 3.7 0.8 0.4 11.6 0.3 19.2 6.8 0.2 3.1 3.5 8.8 3.5 5.7 4.0 5.2 8.3 3.9 13.9 4.6 RER1 ENSG00000157916 "Retention in endoplasmic reticulum sorting receptor 1" O15258 1 2391775-2405444 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037240, HPA051400" Supported Supported "Golgi apparatus" "Golgi apparatus" "CAB037240: AB_2179604, HPA051400: " "unprognostic (2.90e-2)" "unprognostic (3.35e-2)" "unprognostic (3.17e-2)" "unprognostic (2.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (1.53e-2)" "unprognostic (1.24e-1)" "unprognostic (2.28e-1)" "unprognostic (2.72e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (8.23e-8)" "unprognostic (1.01e-1)" "unprognostic (5.41e-2)" "unprognostic (1.06e-1)" "unprognostic (3.27e-2)" 31.2 59.8 21.6 26.6 24.8 21.2 40.5 22.6 31.1 30.6 40.2 34.6 34.6 34.1 34.0 39.4 63.0 27.0 44.2 31.3 21.0 18.0 44.9 125.8 28.3 39.6 26.8 24.8 31.3 55.8 29.8 31.8 44.8 23.5 30.0 47.5 29.7 57.7 36.9 36.7 35.5 51.5 32.3 24.6 38.6 34.3 35.7 25.3 26.9 36.6 38.5 41.7 28.3 37.3 40.6 62.3 86.1 63.0 36.3 57.3 65.4 38.1 21.8 26.2 29.3 48.3 57.6 19.5 56.9 52.1 51.6 51.9 30.7 59.5 27.0 48.2 58.5 41.4 30.3 35.0 65.9 33.8 27.8 30.1 46.0 29.4 52.3 33.3 37.7 46.5 35.7 53.5 47.6 47.0 35.9 46.7 59.9 27.2 23.6 24.4 17.1 52.9 27.7 25.6 34.9 46.0 18.5 21.6 24.9 31.8 75.7 44.8 29.9 24.8 32.3 40.3 22.8 71.0 41.8 44.4 49.5 48.7 42.5 49.0 20.3 46.5 58.5 66.4 50.3 63.0 46.1 40.6 44.7 53.7 53.9 35.1 33.9 41.6 86.1 36.3 61.8 62.3 57.3 65.4 21.6 24.8 22.6 31.1 21.0 18.0 26.8 24.8 23.5 25.3 RET "CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51" ENSG00000165731 "Ret proto-oncogene" P07949 10 43077027-43130351 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 63.9" "Cell line enhanced" "Detected in some" "MCF7: 17.6;NB-4: 11.6;SH-SY5Y: 89.7;THP-1: 26.8" "Cancer enhanced" "Detected in many" "breast cancer: 11.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 6.7" "Group enriched" "Detected in many" 13 "dendritic cells: 2.1;monocytes: 6.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 6 "midbrain: 95.5" "CAB002581, HPA008356, HPA008495" Approved Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" 260000 "Golgi apparatus, Cytosol" "Plasma membrane" "CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: " "unprognostic (7.94e-2)" "unprognostic (3.68e-2)" "unprognostic (4.49e-1)" "prognostic unfavourable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (9.13e-4)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (2.86e-1)" "unprognostic (2.01e-1)" "unprognostic (1.54e-3)" "unprognostic (4.43e-1)" "unprognostic (9.35e-5)" "unprognostic (1.64e-3)" "unprognostic (8.28e-2)" "unprognostic (3.67e-3)" "unprognostic (2.02e-2)" 1.8 15.2 1.1 1.8 1.3 0.7 1.2 4.1 9.0 1.9 3.1 0.9 1.1 1.5 0.9 0.6 1.2 0.7 1.0 1.2 1.5 5.8 1.0 11.7 0.7 0.8 17.5 1.2 0.8 1.3 63.9 6.3 0.8 16.8 2.2 1.5 2.8 13.6 2.0 4.5 1.1 2.6 1.1 2.8 0.6 2.1 2.0 0.0 0.1 0.8 5.1 0.6 1.9 1.4 0.2 2.1 0.0 6.7 0.0 0.3 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 11.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 89.7 0.0 0.0 0.0 1.2 26.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 6.7 2.1 0.3 0.4 1.1 1.3 4.1 9.0 1.5 5.8 17.5 1.2 16.8 0.0 RETREG1 "FAM134B, FLJ20152, JK1" ENSG00000154153 "Reticulophagy regulator 1" Q9H6L5 5 16473038-16617058 "Disease related genes, Predicted membrane proteins" Autophagy "Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 45.0;skeletal muscle: 78.5" "Cell line enhanced" "Detected in many" "ASC diff: 16.4;HSkMC: 18.1;MOLT-4: 11.9;RPTEC TERT1: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 4.0;T-cells: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012077 Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA012077: " "unprognostic (1.63e-2)" "unprognostic (1.98e-1)" "unprognostic (1.80e-2)" "unprognostic (1.84e-2)" "unprognostic (4.96e-2)" "unprognostic (9.17e-3)" "unprognostic (2.66e-2)" "unprognostic (1.90e-1)" "unprognostic (4.35e-2)" "unprognostic (4.41e-2)" "unprognostic (1.37e-2)" "unprognostic (1.48e-1)" "prognostic favourable (5.25e-10)" "unprognostic (3.75e-1)" "unprognostic (9.96e-2)" "unprognostic (5.62e-2)" "unprognostic (2.58e-1)" 9.8 2.0 8.5 3.7 11.2 1.1 8.7 9.6 19.6 7.4 12.4 14.9 0.3 6.5 2.3 5.4 2.0 4.1 7.1 45.0 11.2 9.4 30.3 21.8 4.9 3.1 13.2 11.4 1.7 19.0 17.7 8.0 6.7 18.5 5.9 16.9 1.5 3.9 3.0 78.5 5.6 12.8 1.5 16.8 1.6 6.1 5.7 15.4 14.1 3.6 12.5 2.3 2.0 4.4 0.9 0.1 4.0 0.4 0.1 4.4 0.6 0.8 0.3 0.1 2.1 16.4 2.0 9.6 0.1 2.1 1.9 2.6 1.4 0.1 0.2 1.5 0.0 2.4 4.8 0.5 0.6 2.4 2.2 0.0 7.2 0.0 0.1 3.1 0.0 18.1 7.4 0.3 2.0 0.0 0.0 0.1 0.7 0.6 11.9 0.0 0.5 0.3 1.9 0.0 0.7 16.6 0.5 10.9 1.3 0.6 0.7 7.8 3.6 1.4 0.0 1.5 0.2 4.0 1.8 0.4 0.0 0.0 9.3 10.8 3.9 4.0 0.4 0.1 0.6 0.0 1.6 0.0 1.5 0.8 0.1 0.9 4.4 2.7 2.3 0.1 0.1 0.0 1.9 0.6 8.5 11.2 9.6 14.4 11.2 9.4 13.2 11.4 18.5 15.4 RETREG3 "DKFZp686B1036, FAM134C, FLJ33806" ENSG00000141699 "Reticulophagy regulator family member 3" Q86VR2 17 42579513-42610623 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016492 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Nuclear membrane" Cytosol "HPA016492: AB_1853027" "unprognostic (6.79e-2)" "unprognostic (1.29e-2)" "unprognostic (2.78e-1)" "prognostic favourable (1.61e-4)" "unprognostic (5.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.53e-2)" "unprognostic (2.21e-1)" "unprognostic (2.61e-1)" "unprognostic (2.58e-2)" "unprognostic (1.00e-2)" "unprognostic (2.51e-1)" "prognostic unfavourable (6.82e-4)" "unprognostic (1.24e-1)" "unprognostic (5.68e-1)" "unprognostic (9.64e-3)" "unprognostic (5.43e-2)" 23.2 17.4 11.9 15.8 15.6 5.8 16.3 23.1 21.9 17.0 18.8 13.2 15.5 13.1 25.4 20.9 21.6 15.0 20.8 10.0 11.2 12.3 16.0 28.7 16.2 19.0 11.3 9.8 17.4 43.2 19.6 16.5 29.4 13.7 19.4 16.1 32.5 24.6 14.1 18.5 31.1 17.5 15.7 7.8 24.0 17.1 27.2 8.5 29.9 17.8 16.7 26.3 14.8 17.1 14.1 7.8 22.6 11.4 13.7 27.8 16.6 6.4 20.2 8.9 14.4 22.9 12.7 12.7 9.3 12.7 11.1 13.1 9.5 14.1 14.3 13.1 15.1 25.5 11.4 14.0 10.8 15.3 10.9 5.8 12.3 16.9 15.7 9.9 15.0 19.4 19.2 12.1 12.4 11.9 11.8 14.3 8.7 11.2 14.5 14.5 5.6 5.0 7.9 13.8 14.6 12.7 21.0 16.0 11.0 10.0 8.2 14.1 23.2 7.8 14.9 12.1 7.4 11.9 8.8 24.6 29.2 12.7 11.0 6.4 9.1 22.6 8.0 17.7 24.2 10.0 21.2 13.0 20.0 23.0 7.8 14.1 19.8 22.2 7.2 13.7 11.4 7.7 27.8 16.6 11.9 15.6 23.1 21.9 11.2 12.3 11.3 9.8 13.7 8.5 RETSAT FLJ20296 ENSG00000042445 "Retinol saturase" Q6NUM9 2 85342088-85354620 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 86.1" "Cell line enhanced" "Detected in many" "ASC diff: 64.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007961, HPA046513" Uncertain Uncertain Nucleoli Nucleoli "HPA007961: AB_1079802, HPA046513: " "unprognostic (6.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.29e-1)" "unprognostic (5.84e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "prognostic favourable (4.23e-4)" "unprognostic (1.89e-1)" "unprognostic (2.16e-1)" "unprognostic (3.59e-2)" "unprognostic (1.77e-2)" "unprognostic (1.59e-1)" "prognostic favourable (1.95e-10)" "unprognostic (2.73e-2)" "unprognostic (5.34e-1)" "unprognostic (8.24e-3)" "unprognostic (9.90e-2)" 65.7 24.8 7.7 9.8 9.1 0.9 35.6 5.6 9.3 7.4 46.5 12.4 12.7 49.0 6.8 12.3 16.7 5.0 17.7 7.3 7.4 5.7 20.6 51.9 7.2 5.1 10.2 7.7 5.5 11.5 13.1 3.5 5.7 8.9 10.1 22.6 10.0 12.5 7.6 24.3 14.3 86.1 7.0 12.7 4.0 18.2 9.2 10.1 3.5 27.2 13.9 9.3 9.9 9.0 3.8 5.6 5.3 10.0 6.5 9.2 4.1 15.9 9.3 5.4 12.5 64.5 12.1 7.0 11.7 14.5 7.1 10.0 6.4 11.2 5.6 9.7 9.3 13.4 7.2 20.4 7.0 6.9 5.0 2.7 7.6 15.7 15.5 5.3 6.2 15.8 28.0 9.1 12.2 11.8 2.9 13.5 13.2 3.4 3.8 2.8 1.7 11.4 2.5 10.7 7.3 12.6 9.4 2.6 4.4 9.8 18.8 31.8 8.8 0.9 9.2 8.0 4.4 7.5 6.1 7.3 6.8 2.2 9.9 6.4 5.5 0.0 5.1 2.4 7.0 5.5 9.2 3.8 5.6 8.8 5.6 2.5 3.8 4.0 5.3 6.5 10.0 4.0 5.8 4.1 7.7 9.1 5.6 9.3 7.4 5.7 10.2 7.7 8.9 10.1 RGMB "DRAGON, FLJ90406" ENSG00000174136 "Repulsive guidance molecule BMP co-receptor b" Q6NW40 5 98768650-98798643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 67.0;fHDF/TERT166: 36.7;HBF TERT88: 47.5;LHCN-M2: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.3" "Group enriched" "Detected in many" 12 "B-cells: 4.1;T-cells: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016993 Approved Nucleoplasm 150000 Nucleoplasm "HPA016993: AB_1856216" "unprognostic (1.50e-2)" "unprognostic (3.77e-2)" "unprognostic (9.03e-2)" "unprognostic (8.92e-2)" "unprognostic (2.88e-1)" "unprognostic (5.27e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-2)" "unprognostic (8.24e-2)" "unprognostic (2.19e-1)" "unprognostic (3.60e-3)" "unprognostic (9.00e-2)" "unprognostic (3.88e-2)" "unprognostic (3.90e-2)" "unprognostic (6.40e-2)" "unprognostic (4.20e-2)" "unprognostic (3.78e-3)" 8.3 7.2 14.0 9.9 11.7 0.8 14.4 18.0 23.9 8.8 19.7 5.6 9.9 19.0 8.4 5.7 17.7 10.1 8.9 8.8 9.8 14.4 3.9 6.6 10.8 4.1 7.2 13.3 20.1 15.4 9.0 12.3 5.1 11.5 19.2 28.5 6.8 18.4 15.6 23.1 28.1 22.9 10.6 11.6 6.2 34.5 13.3 5.6 1.0 13.5 7.2 7.7 9.7 15.7 4.1 0.1 0.5 0.2 0.3 8.3 1.6 1.8 1.3 18.7 1.7 5.6 9.7 2.6 67.0 29.8 29.9 21.1 0.9 0.8 1.0 2.8 36.7 1.8 2.1 5.8 47.5 3.3 2.8 0.0 1.5 1.0 2.8 0.1 0.0 8.0 2.0 19.5 6.0 5.4 0.0 0.7 34.8 1.7 0.0 0.0 1.4 4.3 2.7 11.4 1.8 1.1 1.7 8.1 4.1 0.9 2.0 3.1 1.7 0.0 13.2 19.0 3.9 12.2 30.4 1.8 2.2 1.4 7.2 0.0 4.1 0.0 0.0 0.2 0.3 0.2 1.4 3.1 3.9 1.3 0.1 4.1 8.3 3.9 0.5 0.3 0.0 0.0 5.3 1.6 14.0 11.7 18.0 21.5 9.8 14.4 7.2 13.3 11.5 5.6 RGS9BP "FLJ45744, PERRS, R9AP, RGS9" ENSG00000186326 "Regulator of G protein signaling 9 binding protein" Q6ZS82 19 32675407-32678300 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 38.3;skeletal muscle: 15.8" "Cell line enhanced" "Detected in some" "HEL: 10.4;HMC-1: 2.8" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 6.8" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;memory CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA049791 Enhanced Approved "Plasma membrane" "Plasma membrane" "HPA049791: " "unprognostic (2.82e-2)" "unprognostic (6.99e-3)" "unprognostic (2.44e-3)" "unprognostic (1.20e-7)" "unprognostic (1.49e-1)" "unprognostic (1.21e-2)" "unprognostic (1.17e-2)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (6.71e-2)" "unprognostic (6.74e-2)" "unprognostic (3.89e-2)" "unprognostic (1.63e-3)" "unprognostic (2.29e-1)" "unprognostic (8.22e-2)" "unprognostic (5.23e-2)" "unprognostic (5.34e-2)" 0.4 0.5 0.8 0.3 1.1 0.3 0.4 0.2 0.7 0.3 0.4 1.4 0.2 0.4 0.3 0.6 1.1 0.4 0.3 6.7 1.0 0.8 0.9 0.3 0.9 0.3 1.1 0.3 0.3 0.4 0.4 0.6 0.4 6.8 1.3 0.3 38.3 0.5 0.6 15.8 0.6 0.3 7.4 1.3 0.4 0.4 0.9 0.9 0.1 0.4 4.3 0.3 2.3 1.0 0.0 0.3 0.0 0.9 0.5 1.5 0.0 0.2 0.2 0.0 0.9 0.5 0.2 0.5 0.0 0.5 0.3 0.2 0.2 0.3 0.4 0.5 0.1 0.0 1.8 0.1 0.1 0.5 0.2 10.4 0.3 0.0 0.2 0.3 2.8 0.0 0.5 0.0 0.4 0.0 0.9 1.5 0.2 0.4 0.0 1.7 0.0 2.0 0.1 0.4 0.2 0.0 0.1 0.3 0.1 0.0 1.1 0.1 1.0 0.5 0.0 0.5 0.7 0.2 0.3 0.6 0.7 0.1 0.3 0.6 0.8 0.0 0.3 0.0 1.4 0.9 0.0 0.0 0.2 1.5 0.3 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.8 1.1 0.2 0.7 1.0 0.8 1.1 0.3 6.8 0.9 RHBDD1 DKFZp547E052 ENSG00000144468 "Rhomboid domain containing 1" Q8TEB9 2 226835581-226999215 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Differentiation, Spermatogenesis" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013972, HPA057125" Approved Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA013972: AB_2178629, HPA057125: " "unprognostic (1.42e-1)" "unprognostic (5.37e-2)" "unprognostic (3.26e-1)" "unprognostic (5.23e-2)" "unprognostic (2.57e-1)" "unprognostic (2.91e-1)" "unprognostic (1.17e-2)" "unprognostic (2.07e-2)" "unprognostic (1.18e-1)" "unprognostic (9.40e-2)" "unprognostic (4.74e-3)" "unprognostic (4.97e-2)" "unprognostic (1.16e-1)" "unprognostic (1.79e-1)" "unprognostic (1.09e-1)" "unprognostic (9.77e-2)" "unprognostic (3.04e-2)" 12.7 14.8 10.8 16.7 16.0 11.0 13.6 8.3 13.0 13.8 14.3 21.2 9.4 11.0 20.6 16.3 13.6 15.4 12.4 14.5 11.4 9.0 13.6 16.9 12.6 17.7 17.6 11.0 18.8 20.4 18.6 17.1 10.5 13.0 15.7 12.4 13.1 14.3 15.5 13.9 13.0 17.5 15.6 16.5 17.3 13.2 25.6 14.7 56.6 17.3 8.8 18.9 18.7 15.4 19.9 16.6 9.8 15.5 8.8 12.5 8.5 5.1 4.4 4.7 7.2 14.3 14.2 0.0 12.2 9.8 6.0 6.9 3.8 8.9 4.8 10.2 12.3 6.0 0.0 12.7 11.6 12.3 4.9 7.0 2.9 3.4 15.4 7.5 4.1 13.3 18.6 11.5 25.1 4.6 18.9 12.6 6.3 9.8 12.7 3.8 0.0 4.7 5.5 0.0 7.0 4.9 6.2 4.6 3.5 6.7 2.4 9.0 6.8 8.6 6.1 2.8 6.2 10.5 3.5 14.1 6.6 34.7 8.9 9.1 8.0 8.1 11.1 9.8 6.1 15.5 9.7 17.3 9.6 7.5 13.7 19.9 10.8 8.9 2.5 8.8 10.3 16.6 12.5 8.5 10.8 16.0 8.3 13.0 11.4 9.0 17.6 11.0 13.0 14.7 RHBDD2 "NPD007, RHBDL7" ENSG00000005486 "Rhomboid domain containing 2" Q6NTF9 7 75842602-75888926 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045074, HPA051960" Uncertain Enhanced "Golgi apparatus" "Golgi apparatus" "HPA045074: AB_10965705, HPA051960: AB_2681673" "unprognostic (2.75e-1)" "unprognostic (3.89e-2)" "prognostic unfavourable (3.31e-5)" "unprognostic (9.79e-2)" "prognostic unfavourable (1.81e-4)" "unprognostic (2.05e-2)" "unprognostic (1.18e-2)" "unprognostic (2.37e-3)" "unprognostic (1.55e-1)" "unprognostic (2.75e-1)" "unprognostic (5.11e-2)" "unprognostic (1.87e-2)" "prognostic favourable (8.68e-6)" "unprognostic (3.73e-1)" "unprognostic (6.53e-2)" "unprognostic (1.89e-1)" "unprognostic (1.03e-1)" 12.3 50.9 44.3 9.2 64.6 12.1 12.1 14.4 68.3 17.9 11.9 18.5 43.8 18.2 8.5 31.8 14.2 22.6 12.5 14.1 48.5 69.1 18.5 21.7 22.1 8.9 33.6 29.9 12.3 23.6 81.3 56.5 10.6 37.1 15.8 9.1 23.0 22.8 57.3 6.0 14.4 12.5 7.0 16.2 9.5 15.3 15.5 10.7 9.5 34.3 4.2 7.6 10.0 9.6 11.1 13.5 76.4 14.0 13.2 27.4 12.2 7.4 24.6 11.1 22.4 6.5 4.2 4.6 4.5 17.8 10.3 8.7 13.3 20.6 2.8 4.0 8.5 12.2 7.3 5.3 3.2 8.5 14.4 2.5 15.5 12.7 17.9 4.2 23.2 9.2 13.1 11.6 5.2 6.6 5.7 18.3 8.7 49.6 8.0 23.7 10.8 14.1 5.9 7.7 21.4 16.9 13.4 14.7 29.3 16.8 35.7 17.1 23.3 8.0 6.2 16.2 13.5 10.6 9.3 15.2 5.3 4.4 16.1 6.7 19.7 76.4 14.0 17.6 18.9 13.9 16.6 11.1 21.3 16.7 13.5 10.8 18.0 15.3 24.0 13.2 7.9 11.1 27.4 12.2 44.3 64.6 14.4 68.3 48.5 69.1 33.6 29.9 37.1 10.7 RHBDL2 FLJ20435 ENSG00000158315 "Rhomboid like 2" Q9NX52 1 38885807-38941799 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 26.0;HaCaT: 13.5;RT4: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA043807 Approved "HPA043807: AB_10961118" "unprognostic (3.34e-2)" "unprognostic (2.96e-1)" "unprognostic (4.57e-2)" "unprognostic (2.56e-1)" "unprognostic (7.26e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-3)" "unprognostic (5.81e-2)" "unprognostic (2.36e-1)" "unprognostic (2.87e-1)" "unprognostic (4.07e-3)" "unprognostic (1.23e-1)" "unprognostic (7.47e-9)" "unprognostic (1.11e-2)" "unprognostic (2.46e-1)" "unprognostic (4.12e-2)" "unprognostic (4.20e-2)" 1.4 0.0 2.9 6.7 2.7 0.0 1.5 0.4 4.0 5.5 14.9 1.7 0.4 0.7 1.9 0.7 18.9 0.7 6.9 4.9 4.2 2.1 0.5 0.4 2.1 1.5 4.9 0.7 1.2 2.4 0.0 0.4 1.0 1.6 3.1 14.7 0.8 8.2 0.4 0.4 13.4 0.9 0.9 7.9 0.6 12.3 8.4 0.4 1.3 0.4 12.2 16.4 6.9 8.2 1.7 2.1 5.3 1.7 0.9 0.9 0.7 8.0 3.2 0.2 0.1 0.1 1.0 0.9 0.4 0.1 0.6 0.0 0.5 26.0 0.2 1.9 3.7 13.5 0.0 4.8 0.3 0.1 0.1 0.1 2.0 1.7 0.5 0.0 0.3 0.6 0.6 3.9 0.0 0.8 0.0 0.2 0.5 0.0 0.0 0.1 0.2 0.7 0.1 0.1 0.0 0.0 26.1 0.2 0.1 2.8 6.6 0.2 3.4 0.2 0.5 2.9 0.3 0.2 0.2 0.2 0.3 0.3 2.5 0.4 0.1 3.6 1.7 1.1 0.8 1.1 0.4 1.7 0.6 0.5 1.9 1.1 0.7 0.7 5.3 0.9 0.7 2.1 0.9 0.7 2.9 2.7 0.4 1.5 4.2 2.1 4.9 0.7 1.6 0.4 RHEX "C1orf186, FLJ16052" ENSG00000263961 "Regulator of hemoglobinization and erythroid cell expansion" Q6ZWK4 1 206052723-206102459 "Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 117.7" "Cell line enriched" "Detected in some" 5 "HMC-1: 185.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 42.8;ovarian cancer: 41.1" "Cell type enriched" "Detected in some" 51 "basophil: 117.7" "Lineage enriched" "Detected in many" 51 "granulocytes: 117.7" "Low region specificity" "Detected in all" HPA037859 Supported "Plasma membrane" "Plasma membrane" "HPA037859: AB_10697084" "unprognostic (9.26e-3)" "unprognostic (1.91e-2)" "unprognostic (9.66e-2)" "unprognostic (1.65e-2)" "unprognostic (2.06e-2)" "unprognostic (5.27e-3)" "unprognostic (9.55e-2)" "unprognostic (3.04e-3)" "unprognostic (2.36e-1)" "unprognostic (1.31e-2)" "unprognostic (1.35e-1)" "unprognostic (7.20e-3)" "unprognostic (1.89e-2)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (3.77e-2)" "unprognostic (2.80e-3)" 4.3 0.0 0.0 3.9 0.0 0.0 1.8 0.0 0.0 13.1 3.1 0.0 12.1 0.9 6.2 8.2 3.4 1.6 16.2 0.4 0.0 6.8 1.8 5.2 4.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 9.4 3.3 2.9 0.0 16.9 1.5 0.2 4.0 7.0 0.0 0.4 2.4 1.1 0.0 0.6 0.0 1.7 2.5 4.3 10.0 0.3 2.2 117.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.1 0.0 8.4 185.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 37.2 0.0 0.0 0.0 0.0 0.2 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 117.7 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 RHOT1 "ARHT1, FLJ11040, MIRO-1" ENSG00000126858 "Ras homolog family member T1" Q8IXI2 17 32142454-32253374 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010687, CAB068223, CAB068224" Supported "CAB068223: , CAB068224: , HPA010687: AB_1079813" "unprognostic (3.28e-2)" "unprognostic (4.02e-3)" "unprognostic (6.85e-2)" "unprognostic (3.53e-1)" "unprognostic (1.57e-2)" "unprognostic (5.49e-2)" "unprognostic (1.59e-3)" "unprognostic (1.59e-2)" "unprognostic (7.02e-3)" "unprognostic (1.29e-1)" "unprognostic (1.38e-1)" "unprognostic (5.05e-1)" "unprognostic (1.01e-2)" "unprognostic (2.97e-2)" "unprognostic (2.58e-1)" "unprognostic (3.90e-1)" "unprognostic (4.08e-2)" 17.0 26.6 20.9 14.4 21.8 16.0 17.7 23.0 26.7 16.3 15.1 12.7 13.8 10.1 16.2 14.5 15.8 12.8 10.2 23.9 23.2 19.3 17.4 15.4 16.5 11.0 19.1 25.8 19.5 14.7 28.7 19.2 17.2 17.5 16.8 10.7 14.0 14.8 22.7 21.9 21.5 15.6 16.3 21.8 10.7 13.8 11.8 17.4 18.2 24.5 12.1 9.5 14.3 22.1 4.9 8.5 8.6 9.3 5.2 3.7 4.0 7.8 15.0 13.3 13.2 15.7 17.2 7.6 12.9 11.2 14.9 15.7 7.5 5.1 10.0 13.2 11.1 14.2 18.8 7.7 17.7 7.9 14.7 11.6 9.7 11.0 23.0 16.2 8.8 9.4 24.1 12.1 15.6 12.3 26.9 8.9 12.5 5.8 28.4 11.7 9.8 7.1 15.9 20.2 17.9 10.1 4.6 11.9 10.8 14.0 8.0 21.4 19.9 20.5 9.0 10.3 10.5 11.6 9.0 12.8 12.2 11.3 12.0 14.6 17.2 4.6 9.3 8.6 3.4 7.7 3.7 3.2 3.6 3.4 8.5 4.9 2.9 3.6 5.1 5.2 7.0 2.5 2.1 4.0 20.9 21.8 23.0 26.7 23.2 19.3 19.1 25.8 17.5 17.4 RHOT2 "ARHT2, C16orf39, MIRO-2" ENSG00000140983 "Ras homolog family member T2" Q8IXI1 16 668086-674174 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012624, HPA012895" Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA012624: AB_1856272, HPA012895: AB_1856271" "unprognostic (1.59e-1)" "unprognostic (8.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.50e-2)" "unprognostic (1.09e-1)" "prognostic favourable (5.01e-4)" "unprognostic (4.68e-3)" "unprognostic (4.66e-2)" "unprognostic (3.41e-2)" "unprognostic (7.55e-2)" "unprognostic (7.87e-3)" "unprognostic (3.25e-1)" "prognostic favourable (5.43e-4)" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (1.24e-1)" "unprognostic (2.17e-2)" 15.2 22.8 19.9 26.4 22.3 25.8 16.4 33.3 22.6 14.6 27.2 14.7 19.5 29.5 16.4 27.6 17.3 17.3 28.5 26.5 18.4 11.5 21.8 23.0 15.7 23.4 20.1 20.5 17.3 25.1 18.1 25.3 17.7 19.9 23.3 8.9 30.5 31.7 20.2 21.9 25.3 25.1 13.8 10.4 27.0 24.5 15.8 15.3 20.2 22.1 14.6 20.8 16.6 16.3 11.0 16.4 16.9 18.6 8.7 20.1 13.2 9.4 18.1 10.6 16.3 5.3 5.5 18.8 15.8 7.4 13.5 10.3 25.2 14.5 10.5 11.3 6.4 17.7 7.5 15.0 3.4 15.0 31.0 12.6 22.4 18.0 9.8 11.5 17.2 8.9 12.9 10.0 5.8 9.5 22.8 8.9 7.1 38.5 12.1 12.8 26.0 12.5 28.2 11.8 22.0 8.6 17.9 22.9 27.1 14.8 19.6 8.6 20.2 18.1 15.3 10.5 16.9 8.9 11.3 23.8 15.0 14.7 6.9 11.0 14.9 4.5 16.1 16.9 20.1 18.6 12.2 10.1 16.0 15.9 15.9 11.0 12.2 10.3 13.8 8.7 14.3 16.4 18.0 13.2 19.9 22.3 33.3 22.6 18.4 11.5 20.1 20.5 19.9 15.3 RIC1 "bA207C16.1, KIAA1432" ENSG00000107036 "RIC1 homolog, RAB6A GEF complex partner 1" Q4ADV7 9 5629025-5776557 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051578 Supported "HPA051578: " "unprognostic (1.78e-1)" "unprognostic (4.08e-2)" "unprognostic (3.13e-2)" "unprognostic (2.47e-2)" "unprognostic (4.51e-2)" "unprognostic (8.87e-2)" "unprognostic (8.59e-2)" "unprognostic (1.90e-1)" "unprognostic (3.87e-2)" "unprognostic (7.16e-2)" "unprognostic (8.96e-2)" "unprognostic (3.92e-2)" "unprognostic (3.74e-1)" "unprognostic (3.50e-2)" "unprognostic (4.67e-2)" "unprognostic (1.28e-1)" "unprognostic (5.77e-2)" 16.3 11.7 7.4 24.7 9.0 13.1 21.6 16.0 8.2 15.5 15.3 8.1 24.9 11.5 18.7 16.7 16.2 13.8 14.0 11.5 7.3 5.8 10.1 11.4 15.9 23.4 9.1 6.8 16.6 16.9 13.9 8.6 20.2 9.3 12.4 11.2 11.2 20.8 21.5 38.6 18.2 18.7 18.0 8.6 20.1 12.4 12.7 10.1 32.1 14.8 16.8 21.4 17.3 22.2 3.0 3.1 1.9 4.0 3.5 2.0 1.6 7.7 4.5 7.9 5.4 9.3 10.8 6.6 11.1 10.3 7.7 10.0 4.1 1.7 17.5 1.4 11.4 3.7 6.0 6.1 10.7 30.5 3.9 38.2 9.5 4.4 7.7 5.9 7.0 10.1 4.2 5.2 8.2 9.1 2.2 21.0 6.3 1.9 4.9 10.8 4.0 2.3 9.5 5.2 7.0 4.0 3.0 2.2 5.4 6.0 3.8 3.1 3.4 10.1 8.7 6.2 7.8 3.5 5.2 5.8 7.3 22.0 2.5 2.3 2.1 0.8 2.4 1.9 1.4 4.0 1.8 3.0 1.7 2.0 2.2 1.3 1.1 1.6 1.3 3.5 1.9 3.1 2.0 1.6 7.4 9.0 16.0 8.2 7.3 5.8 9.1 6.8 9.3 10.1 RIC3 "AYST720, FLJ11608, PRO1385" ENSG00000166405 "RIC3 acetylcholine receptor chaperone" Q7Z5B4 11 8106093-8169055 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 3.7;NTERA-2: 7.0;SCLC-21H: 11.7;SH-SY5Y: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065016 Approved "Intracellular and membrane" "HPA065016: " "unprognostic (2.51e-3)" "unprognostic (2.32e-1)" "unprognostic (1.21e-1)" "unprognostic (6.98e-4)" "unprognostic (3.22e-2)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.43e-2)" "unprognostic (1.59e-2)" "unprognostic (1.48e-2)" "unprognostic (4.45e-4)" "unprognostic (1.28e-1)" "unprognostic (2.23e-9)" "unprognostic (4.37e-2)" "unprognostic (5.53e-2)" "unprognostic (1.35e-1)" "unprognostic (2.52e-2)" 2.1 14.5 14.6 8.2 18.5 2.6 8.6 25.3 20.8 4.7 7.0 8.4 11.3 2.9 11.6 28.0 5.0 8.1 4.9 8.2 9.8 10.5 6.6 2.2 4.7 9.3 9.8 17.0 17.4 12.0 22.7 23.2 1.0 16.4 15.3 3.3 9.8 13.1 14.7 6.7 17.4 5.7 9.3 10.1 6.9 6.2 7.7 9.9 0.4 17.1 1.9 8.8 7.7 4.0 12.8 1.5 2.9 1.5 1.8 6.9 0.8 0.0 1.3 2.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.6 0.0 0.0 0.0 3.7 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 7.0 0.0 0.0 0.0 0.0 0.7 0.0 11.7 8.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.2 1.6 0.7 0.0 0.0 0.1 0.0 0.1 2.9 0.6 1.2 2.2 0.8 1.5 11.0 4.6 2.4 0.6 12.8 6.9 5.9 1.8 1.8 1.5 1.5 2.5 0.8 14.6 18.5 25.3 19.1 9.8 10.5 9.8 17.0 16.4 9.9 RMDN2 "FAM82A, FAM82A1, FLJ32954, RMD2" ENSG00000115841 "Regulator of microtubule dynamics 2" Q96LZ7 2 37923187-38067142 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 38.4" "Cell line enhanced" "Detected in many" "HSkMC: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA034705, HPA034706" Enhanced Supported "Golgi apparatus,Mitotic spindle,Cytosol" "Mitotic spindle, Cytosol" "Golgi apparatus" "HPA034705: , HPA034706: AB_10696362" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.76e-1)" "unprognostic (3.06e-2)" "prognostic favourable (2.63e-4)" "unprognostic (7.85e-2)" "unprognostic (9.96e-2)" "unprognostic (7.50e-2)" "unprognostic (1.94e-1)" "unprognostic (2.88e-2)" "unprognostic (5.08e-3)" "unprognostic (1.20e-1)" "unprognostic (4.34e-3)" "unprognostic (3.34e-1)" 4.6 38.4 6.1 8.7 6.8 1.9 8.9 6.2 8.2 6.3 9.7 1.8 5.9 6.8 7.0 9.2 3.7 4.3 5.5 4.6 5.9 3.5 6.6 24.0 8.2 3.3 3.2 5.1 3.2 4.2 3.2 8.6 3.1 4.6 8.1 8.7 5.2 5.7 10.2 5.0 2.9 14.7 7.7 4.8 14.1 4.6 15.6 4.0 2.1 4.7 3.6 2.1 4.3 9.0 7.5 6.0 4.8 8.0 6.3 6.1 2.3 3.3 3.9 2.6 1.7 11.9 12.2 1.5 7.1 9.2 3.6 3.7 1.0 11.2 2.3 3.1 10.6 3.9 0.9 4.8 4.5 4.6 2.6 4.0 1.5 3.4 6.2 0.0 4.1 17.4 3.8 4.9 0.7 2.0 4.7 2.0 6.4 1.3 0.7 4.0 5.1 3.9 0.0 0.6 0.4 9.3 3.0 2.0 7.8 5.6 0.6 6.3 1.2 5.4 2.8 5.0 5.3 2.6 2.8 3.9 6.7 4.7 5.9 0.9 5.0 0.0 4.9 1.0 4.0 8.0 6.1 7.5 1.9 2.5 3.3 5.0 2.0 4.3 4.8 6.3 6.1 6.0 0.2 2.3 6.1 6.8 6.2 8.2 5.9 3.5 3.2 5.1 4.6 4.0 RMDN3 "FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3" ENSG00000137824 "Regulator of microtubule dynamics 3" Q96TC7 15 40735884-40755851 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009975, HPA074840" Supported Enhanced "Cytokinetic bridge,Mitochondria" Mitochondria "Cytokinetic bridge" "HPA009975: AB_1078811, HPA074840: " "unprognostic (2.54e-2)" "unprognostic (3.53e-1)" "unprognostic (2.35e-2)" "unprognostic (3.97e-3)" "unprognostic (1.50e-1)" "unprognostic (2.50e-3)" "unprognostic (2.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.94e-3)" "prognostic favourable (6.70e-8)" "unprognostic (1.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.79e-3)" "unprognostic (2.04e-3)" 22.9 17.3 29.0 12.4 26.4 16.0 15.5 22.6 29.6 15.2 14.6 20.7 9.3 34.4 10.2 10.5 14.9 15.4 14.7 12.1 27.2 21.1 14.7 28.4 27.8 11.1 26.0 29.3 12.0 21.6 17.6 7.3 15.3 18.4 14.1 6.7 10.6 25.3 13.4 12.7 12.9 39.6 9.6 29.4 9.8 14.4 12.2 22.9 7.8 16.1 11.6 8.5 13.6 10.4 7.6 25.5 2.5 9.7 28.1 14.4 10.6 8.4 7.7 9.3 16.0 7.7 7.3 16.3 22.1 8.6 15.7 11.5 27.7 9.5 7.2 29.4 11.4 29.2 10.3 16.4 0.6 19.0 14.7 23.2 22.7 13.6 29.0 15.5 18.5 14.1 14.8 11.1 9.2 10.5 24.2 20.0 5.9 17.1 11.6 10.0 7.4 15.4 18.3 11.2 16.8 11.5 14.3 22.5 8.2 17.5 23.7 8.2 18.6 16.9 16.4 17.1 12.2 22.8 18.4 15.3 17.8 11.5 12.2 16.6 18.6 1.9 6.2 2.5 14.4 8.2 12.6 7.6 10.5 13.0 6.8 6.7 8.2 8.9 1.0 28.1 9.7 25.5 9.1 10.6 29.0 26.4 22.6 26.9 27.2 21.1 26.0 29.3 18.4 22.9 RMND1 "bA351K16.3, C6orf96, FLJ20627, RMD1" ENSG00000155906 "Required for meiotic nuclear division 1 homolog" Q9NWS8 6 151404762-151452181 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031397, HPA031398, HPA031399" Approved Supported Mitochondria Mitochondria "HPA031397: , HPA031398: , HPA031399: AB_10601156" "unprognostic (1.12e-1)" "unprognostic (4.45e-2)" "unprognostic (9.70e-3)" "unprognostic (6.67e-2)" "unprognostic (2.65e-2)" "prognostic unfavourable (6.96e-4)" "unprognostic (1.50e-3)" "unprognostic (6.56e-2)" "unprognostic (1.02e-1)" "unprognostic (1.73e-1)" "unprognostic (2.03e-1)" "unprognostic (3.57e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (9.74e-2)" "unprognostic (1.04e-1)" 12.9 15.7 9.0 6.8 12.1 4.0 17.0 14.5 15.6 10.5 12.8 7.7 6.4 13.2 10.9 11.7 8.3 12.2 8.0 11.4 9.9 11.7 34.0 29.1 7.8 8.2 10.1 13.5 15.7 9.9 6.9 11.2 14.4 14.0 8.0 11.5 10.5 7.3 8.0 10.9 7.9 14.9 11.2 8.9 6.9 8.0 8.6 7.0 11.2 18.9 6.0 9.5 10.6 11.9 11.3 7.2 6.8 12.2 13.2 11.3 5.0 8.0 3.7 8.3 17.2 11.2 25.5 11.3 12.7 12.3 9.8 13.6 10.6 6.1 7.7 9.1 8.1 7.0 15.2 7.9 17.1 8.8 12.1 12.1 5.9 21.7 22.9 27.1 3.9 17.8 10.2 14.0 21.4 12.7 13.2 6.2 14.9 26.3 9.2 8.7 6.1 7.4 10.5 10.2 9.5 13.9 3.6 13.9 13.4 9.0 11.4 15.1 19.1 17.5 7.2 7.7 10.1 16.0 9.9 6.4 8.4 8.8 19.3 21.2 8.9 2.1 5.9 6.8 7.1 8.2 11.2 11.3 8.5 9.9 7.2 9.0 11.2 10.2 2.9 13.2 12.2 3.3 11.3 5.0 9.0 12.1 14.5 15.6 9.9 11.7 10.1 13.5 14.0 7.0 RNASEK MGC71993 ENSG00000219200 "Ribonuclease K" Q6P5S7 17 7012417-7014532 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044708 Uncertain "HPA044708: AB_10962051" "unprognostic (7.59e-2)" "unprognostic (2.22e-2)" "unprognostic (5.63e-2)" "unprognostic (5.92e-2)" "unprognostic (9.73e-3)" "unprognostic (4.82e-2)" "unprognostic (3.65e-1)" "unprognostic (1.55e-1)" "unprognostic (1.44e-1)" "unprognostic (6.50e-3)" "prognostic favourable (1.92e-4)" "unprognostic (2.93e-3)" "unprognostic (1.72e-3)" "unprognostic (1.81e-1)" "unprognostic (1.77e-2)" "unprognostic (1.14e-1)" "unprognostic (2.33e-3)" 61.6 116.2 79.8 55.0 81.4 86.1 114.0 49.9 121.1 56.4 50.2 41.5 64.3 54.0 50.7 51.3 60.4 67.0 65.9 90.9 79.4 95.6 92.6 85.2 111.9 141.9 76.7 69.2 57.2 72.7 61.5 98.7 56.3 76.3 53.3 41.6 51.0 69.4 64.6 74.0 60.1 50.2 50.5 82.8 80.7 51.0 61.3 34.7 62.8 64.6 56.6 55.5 63.2 47.0 52.7 92.8 191.8 97.9 34.9 39.2 73.7 32.7 55.1 24.9 42.4 65.0 59.1 22.2 34.1 61.3 45.2 51.3 23.1 31.2 23.6 34.6 66.3 49.4 30.5 41.9 24.4 47.3 80.3 23.2 44.9 37.5 74.7 14.5 115.9 73.5 51.0 53.1 30.4 53.5 20.2 50.7 53.9 31.0 19.9 48.5 17.1 48.2 23.6 14.3 26.9 58.3 29.5 12.8 45.8 28.9 20.8 60.3 26.9 26.5 48.5 47.8 20.7 58.9 42.7 41.4 40.4 10.0 74.3 33.9 38.7 67.6 97.9 114.1 35.0 86.6 34.7 52.7 39.2 35.4 73.9 49.1 31.9 30.5 191.8 34.9 81.4 92.8 38.4 73.7 79.8 81.4 49.9 121.1 79.4 95.6 76.7 69.2 76.3 34.7 RNASEK-C17orf49 ENSG00000161939 "RNASEK-C17orf49 readthrough" 17 7012635-7017520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.3" "Cell line enhanced" "Detected in many" "HBEC3-KT: 5.2;THP-1: 6.1;U-87 MG: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA022961, HPA024457" Uncertain Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (4.08e-2)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (9.37e-5)" "unprognostic (4.19e-1)" "unprognostic (1.71e-1)" "unprognostic (7.91e-2)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.77e-3)" "unprognostic (8.26e-3)" "unprognostic (8.58e-3)" "unprognostic (3.00e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.78e-1)" 4.8 4.8 2.8 3.5 3.5 5.3 2.9 3.6 4.0 2.0 2.8 0.4 1.5 1.4 4.9 3.3 2.3 2.7 3.2 6.3 2.5 3.3 6.6 14.5 16.7 20.3 2.9 2.4 2.4 7.9 1.4 4.7 2.5 1.8 1.8 1.4 0.4 1.6 5.0 4.2 1.9 6.3 2.3 1.7 9.1 1.6 6.4 0.7 4.1 2.0 4.6 3.4 2.3 1.6 1.9 4.0 7.5 4.3 0.9 1.7 2.8 1.1 3.5 0.5 0.5 0.0 0.0 1.1 2.3 1.9 2.8 2.1 2.3 1.0 1.8 0.2 0.0 0.6 0.7 5.2 0.7 0.0 4.3 0.0 2.9 1.0 2.7 0.0 0.6 0.0 0.0 1.6 0.0 0.7 0.6 0.0 0.0 1.2 1.9 2.2 2.2 1.2 1.4 0.0 0.0 0.7 0.7 0.5 1.8 0.0 0.0 0.2 0.6 6.1 0.0 0.0 0.2 3.5 0.9 0.0 0.8 0.2 6.8 0.5 0.0 3.6 4.3 3.4 1.2 3.0 1.7 1.9 1.5 0.8 3.8 1.8 1.4 1.2 7.5 0.9 3.1 4.0 0.9 2.8 2.8 3.5 3.6 4.0 2.5 3.3 2.9 2.4 1.8 0.7 RNF112 "BFP, ZNF179" ENSG00000128482 "Ring finger protein 112" Q9ULX5 17 19411125-19417276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;fHDF/TERT166: 4.7;SCLC-21H: 4.7;SH-SY5Y: 8.2;U-87 MG: 26.9" "Cancer enriched" "Detected in some" 8 "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015970 Supported Approved "Nuclear speckles" "Nuclear speckles" "HPA015970: AB_1859103" "unprognostic (1.16e-1)" "unprognostic (3.74e-1)" "unprognostic (8.43e-5)" "unprognostic (3.65e-2)" "unprognostic (2.96e-2)" "unprognostic (6.02e-2)" "unprognostic (1.27e-1)" "unprognostic (2.88e-1)" "unprognostic (4.26e-1)" "unprognostic (5.02e-2)" "unprognostic (3.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.31e-9)" "unprognostic (1.32e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" "unprognostic (4.24e-1)" 2.5 8.1 11.3 2.3 15.9 0.6 1.8 47.5 29.1 1.2 3.6 1.4 0.0 2.9 2.0 6.9 1.1 1.5 4.4 2.3 12.4 8.2 1.2 0.7 1.7 1.4 3.9 14.1 1.3 0.8 0.5 1.9 1.1 3.1 10.2 4.4 1.6 1.3 3.5 2.1 1.9 3.6 3.5 2.9 1.7 2.1 2.0 3.7 0.0 0.9 0.0 0.8 2.8 1.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 4.1 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.0 1.7 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.1 0.1 0.1 0.0 0.0 4.7 8.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 26.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 15.9 47.5 15.9 12.4 8.2 3.9 14.1 3.1 3.7 RNF121 FLJ11099 ENSG00000137522 "Ring finger protein 121" Q9H920 11 71928701-71997597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046041 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA046041: AB_10965850" "unprognostic (1.36e-2)" "unprognostic (8.84e-2)" "unprognostic (9.72e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.38e-2)" "unprognostic (1.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (6.54e-2)" "unprognostic (1.85e-2)" "unprognostic (1.90e-1)" "prognostic favourable (2.72e-6)" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (2.57e-2)" "unprognostic (1.70e-1)" 9.8 14.1 18.5 14.0 14.9 6.5 14.1 18.5 16.6 12.6 13.0 12.4 22.4 18.5 17.9 26.3 10.6 14.3 10.8 13.1 11.7 11.7 20.2 16.9 9.4 8.9 12.4 13.4 15.0 15.6 24.1 19.4 18.9 12.1 13.5 13.1 15.7 18.0 19.5 19.2 11.8 18.7 14.1 10.1 10.1 12.8 16.3 13.6 8.9 15.6 8.1 15.3 11.9 10.4 5.9 6.9 8.8 5.5 5.6 7.0 5.1 5.0 10.9 11.3 8.3 11.0 8.6 7.9 9.3 10.1 14.8 15.6 21.3 11.2 4.7 8.2 10.5 11.9 12.4 11.2 16.0 6.7 7.2 7.9 10.7 10.5 8.2 6.8 6.7 8.1 10.1 16.0 9.7 26.4 11.8 5.0 13.0 11.4 4.6 7.8 7.8 11.1 5.9 23.9 4.3 16.8 9.9 8.0 8.6 12.1 10.4 17.0 12.0 5.0 16.4 10.5 10.0 7.0 7.8 6.1 5.5 5.3 9.2 4.4 9.3 8.8 4.1 4.0 5.6 5.5 7.0 5.9 4.7 4.5 3.9 2.2 5.3 5.9 2.1 5.6 3.9 6.9 3.9 5.1 18.5 14.9 18.5 16.6 11.7 11.7 12.4 13.4 12.1 13.6 RNF122 FLJ12526 ENSG00000133874 "Ring finger protein 122" Q9H9V4 8 33547755-33567125 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 66.3" "Cell line enhanced" "Detected in many" "HEK 293: 38.8;Karpas-707: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003888 Uncertain "HPA003888: AB_1079822" "unprognostic (2.36e-2)" "unprognostic (3.13e-1)" "unprognostic (2.09e-2)" "unprognostic (9.19e-3)" "unprognostic (2.46e-1)" "unprognostic (8.78e-3)" "unprognostic (1.71e-2)" "unprognostic (5.46e-1)" "unprognostic (3.33e-1)" "unprognostic (1.82e-1)" "unprognostic (6.95e-2)" "prognostic favourable (5.37e-4)" "prognostic unfavourable (4.50e-7)" "unprognostic (4.45e-2)" "unprognostic (1.95e-1)" "prognostic unfavourable (1.88e-4)" "unprognostic (7.15e-2)" 23.6 14.6 2.3 15.9 5.9 6.5 13.4 16.7 4.4 8.3 8.2 3.2 3.1 2.5 8.8 10.3 9.3 20.0 13.3 28.5 6.7 2.1 4.4 7.1 25.0 10.1 4.3 0.7 66.3 5.6 3.4 3.2 2.8 12.3 12.8 5.1 5.5 5.1 5.8 31.9 6.4 8.3 14.4 14.4 13.3 7.9 9.6 2.5 8.1 4.3 17.3 11.4 20.6 11.8 5.0 14.2 7.4 9.9 1.8 1.6 0.3 0.3 2.0 10.4 4.3 0.9 0.3 1.4 0.6 0.9 1.3 2.1 0.3 0.4 4.8 3.2 1.6 0.3 2.2 0.9 0.7 0.3 38.8 1.0 0.5 2.7 0.6 0.3 7.9 1.0 0.8 0.7 0.5 4.1 0.9 25.1 1.0 0.9 4.2 3.2 5.7 1.1 4.6 2.0 3.7 1.5 0.6 2.0 11.7 0.7 0.2 1.5 0.4 1.3 2.4 1.8 1.6 3.2 0.7 10.1 5.7 8.8 1.1 1.3 0.2 4.6 0.9 7.4 1.5 4.5 1.3 2.9 0.9 1.1 0.8 5.0 1.5 1.6 6.7 1.8 9.9 14.2 0.6 0.3 2.3 5.9 16.7 4.4 6.7 2.1 4.3 0.7 12.3 2.5 RNF128 "FLJ23516, GRAIL" ENSG00000133135 "Ring finger protein 128, E3 ubiquitin protein ligase" Q8TEB7 X 106693794-106796993 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.6;liver: 48.4;thyroid gland: 38.4" "Cell line enhanced" "Detected in some" "BEWO: 17.9;CAPAN-2: 14.8;Hep G2: 12.6;RPTEC TERT1: 13.0;RT4: 37.2;WM-115: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019675 Uncertain "HPA019675: " "unprognostic (1.78e-1)" "unprognostic (1.44e-2)" "unprognostic (1.23e-1)" "unprognostic (1.88e-3)" "unprognostic (1.92e-4)" "unprognostic (2.14e-3)" "unprognostic (2.37e-2)" "unprognostic (1.02e-1)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (1.55e-2)" "unprognostic (1.75e-2)" "prognostic unfavourable (1.07e-7)" "unprognostic (1.11e-2)" "unprognostic (7.61e-2)" "unprognostic (6.30e-2)" "unprognostic (5.30e-3)" 1.4 20.6 2.4 2.2 7.2 0.0 3.0 0.7 4.2 0.5 24.4 0.9 0.4 24.2 0.2 2.2 4.0 0.3 27.2 0.6 2.8 5.1 24.4 48.4 6.7 0.0 2.4 2.1 0.7 14.5 0.0 11.0 10.5 4.0 3.4 7.8 0.0 25.4 0.8 3.0 3.6 54.6 0.9 1.1 0.2 17.9 0.3 1.0 1.1 38.4 2.3 2.7 10.2 3.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 4.5 0.0 0.0 0.0 1.5 0.8 17.9 0.0 0.1 0.0 0.0 7.8 14.8 0.0 0.0 0.2 5.6 0.0 0.0 0.0 0.0 8.7 0.0 0.1 12.6 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 13.0 37.2 0.0 0.0 0.0 0.9 0.9 0.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 6.5 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 7.2 0.7 4.2 2.8 5.1 2.4 2.1 4.0 1.0 RNF13 RZF ENSG00000082996 "Ring finger protein 13" O43567 3 149812708-149962139 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 72.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064784 Approved Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA064784: " "unprognostic (1.27e-1)" "unprognostic (2.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (8.49e-2)" "unprognostic (4.36e-3)" "unprognostic (1.72e-1)" "unprognostic (1.25e-1)" "unprognostic (6.94e-3)" "unprognostic (1.13e-1)" "prognostic favourable (2.00e-8)" "unprognostic (2.95e-1)" "unprognostic (4.11e-2)" "unprognostic (2.17e-1)" "unprognostic (1.79e-1)" 24.0 21.3 30.6 19.0 39.4 9.8 28.5 19.9 30.4 19.0 17.7 39.9 16.2 14.3 16.8 33.7 16.8 15.9 20.4 16.4 40.5 29.7 35.8 39.2 31.7 19.6 60.9 26.8 18.1 19.6 23.5 14.9 32.4 40.7 25.5 20.3 19.5 36.1 20.9 18.0 18.4 16.3 20.4 102.2 25.5 17.0 12.5 51.2 13.3 32.1 18.8 15.9 21.4 16.5 8.8 15.7 72.4 31.5 7.8 8.5 14.6 19.4 12.1 8.2 9.3 32.3 19.8 13.7 10.8 27.8 10.4 15.5 10.6 28.0 8.1 15.8 13.2 18.5 11.0 13.8 14.7 9.9 8.0 9.7 5.6 10.3 21.5 10.4 13.9 20.9 26.3 8.8 23.9 11.5 3.0 16.5 9.3 10.9 7.5 6.9 5.5 9.5 5.4 8.8 34.3 20.2 9.1 4.3 12.5 8.9 13.4 34.7 25.5 11.1 12.0 14.2 5.7 15.0 6.9 28.0 18.4 16.7 11.9 9.8 7.6 12.9 20.3 16.6 6.8 25.2 8.5 8.8 7.6 7.6 15.7 8.3 7.3 7.5 72.4 7.8 31.5 11.2 8.3 14.6 30.6 39.4 19.9 29.2 40.5 29.7 60.9 26.8 40.7 51.2 RNF130 "G1RZFP, GOLIATH, GP" ENSG00000113269 "Ring finger protein 130" Q86XS8 5 179911651-180072118 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 17.0;classical monocyte: 38.1;eosinophil: 24.6;intermediate monocyte: 27.5;myeloid DC: 31.1;neutrophil: 68.1;non-classical monocyte: 23.8;plasmacytoid DC: 22.9" "Group enriched" "Detected in all" 11 "dendritic cells: 31.1;granulocytes: 68.1;monocytes: 38.1" "Low region specificity" "Detected in all" HPA014499 Approved "HPA014499: AB_1856328" "unprognostic (2.01e-1)" "prognostic favourable (6.32e-4)" "unprognostic (2.43e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.62e-2)" "unprognostic (2.83e-1)" "unprognostic (2.02e-3)" "unprognostic (2.93e-2)" "unprognostic (1.78e-1)" "unprognostic (4.00e-2)" "unprognostic (2.81e-1)" "unprognostic (1.14e-1)" "unprognostic (8.41e-2)" "unprognostic (4.17e-2)" "unprognostic (4.32e-1)" "unprognostic (1.38e-2)" 36.3 16.3 23.5 16.3 32.5 29.5 24.0 19.0 25.3 26.0 16.7 56.0 19.0 10.6 18.5 12.0 10.6 19.5 21.9 17.0 27.8 21.1 20.7 64.4 25.5 19.1 50.2 20.3 21.7 28.6 11.0 16.7 19.8 30.3 16.3 16.1 15.8 30.6 28.3 17.3 7.9 12.1 22.2 58.2 20.4 20.5 7.3 38.8 2.5 14.3 6.3 10.3 20.7 13.3 1.2 31.1 68.1 38.1 4.0 2.0 20.3 7.9 5.8 28.6 20.9 27.9 15.2 5.4 6.2 7.8 6.8 7.4 1.8 6.8 0.0 19.2 10.8 0.8 19.9 12.6 7.5 0.1 17.7 15.6 3.2 4.0 7.1 3.8 41.0 14.3 6.7 0.5 3.9 11.1 3.2 0.1 6.8 12.0 7.1 12.1 7.8 8.9 16.0 6.6 0.0 8.6 1.4 17.4 7.8 11.6 6.3 24.0 9.1 9.0 8.6 11.6 4.6 8.1 6.6 0.0 6.1 1.6 1.4 30.1 9.0 17.0 38.1 24.6 2.0 27.5 1.9 1.2 0.9 1.0 31.1 1.2 1.0 1.2 68.1 4.0 23.8 22.9 0.1 20.3 23.5 32.5 19.0 25.3 27.8 21.1 50.2 20.3 30.3 38.8 RNF144A "hUIP4, KIAA0161, RNF144, UBCE7IP4" ENSG00000151692 "Ring finger protein 144A" P50876 2 6917392-7068286 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.5" "Cell line enhanced" "Detected in many" "HMC-1: 50.4;SH-SY5Y: 15.3;SK-MEL-30: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.7" "Group enriched" "Detected in many" 7 "granulocytes: 8.7;T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049939 Approved Approved Vesicles Vesicles "HPA049939: " "unprognostic (1.78e-1)" "unprognostic (2.53e-3)" "unprognostic (8.37e-2)" "prognostic unfavourable (6.00e-4)" "unprognostic (6.57e-2)" "prognostic favourable (6.96e-4)" "unprognostic (7.04e-6)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "unprognostic (5.64e-1)" "unprognostic (9.11e-2)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "prognostic unfavourable (7.32e-5)" "unprognostic (1.30e-2)" "unprognostic (3.01e-1)" "unprognostic (1.82e-3)" 12.9 28.8 13.3 4.2 21.2 12.1 11.1 45.5 20.7 17.3 5.2 28.7 9.0 3.0 26.0 8.3 4.7 8.4 7.5 8.0 15.6 11.6 7.5 1.8 5.7 7.9 26.5 12.2 20.0 29.7 21.5 12.5 6.2 13.2 8.7 5.7 5.9 4.0 7.4 8.7 5.7 4.1 12.2 21.8 21.1 2.8 5.0 27.1 3.4 3.2 1.2 5.8 5.8 6.5 0.1 0.2 8.7 0.1 0.8 4.1 0.6 0.3 2.2 11.7 2.4 2.6 5.5 9.0 0.0 0.0 0.4 1.1 0.0 0.2 1.1 1.3 0.1 0.2 3.8 0.0 0.0 0.6 1.0 14.9 0.1 4.4 0.1 0.2 50.4 8.7 0.0 0.8 0.0 0.0 6.4 0.2 0.0 1.8 7.6 0.6 4.3 5.3 5.9 8.5 0.9 0.3 3.9 3.9 15.3 0.2 1.5 15.1 0.6 0.9 0.0 1.5 4.0 4.1 1.7 4.1 1.3 0.0 5.8 3.3 5.5 1.5 0.1 8.7 2.1 0.0 3.0 0.1 2.1 1.5 0.2 0.1 4.1 2.8 0.4 0.8 0.0 0.0 0.8 0.6 13.3 21.2 45.5 20.3 15.6 11.6 26.5 12.2 13.2 27.1 RNF144B "bA528A10.3, IBRDC2, P53RFP" ENSG00000137393 "Ring finger protein 144B" Q7Z419 6 18387350-18468874 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 54.7;hTCEpi: 17.4;HUVEC TERT2: 16.1;TIME: 16.1;U-698: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 28.8" "Group enriched" "Detected in many" 9 "dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046013, HPA054127, HPA072469" Uncertain Approved Nucleoli,Mitochondria Nucleoli Mitochondria "CAB046013: AB_11126028, HPA054127: , HPA072469: " "unprognostic (2.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.48e-3)" "unprognostic (5.89e-2)" "unprognostic (1.18e-2)" "unprognostic (6.55e-2)" "unprognostic (2.87e-3)" "unprognostic (2.44e-2)" "unprognostic (2.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "unprognostic (3.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" 16.3 2.0 4.6 11.1 6.8 15.7 21.1 5.1 7.5 8.0 4.2 2.8 4.6 1.5 6.8 7.5 9.4 9.0 6.8 8.7 5.3 4.3 13.8 11.4 39.0 11.1 8.3 2.3 4.2 3.7 3.0 2.3 11.1 8.8 12.8 2.3 8.3 16.9 6.2 36.8 19.2 3.7 4.9 9.2 37.1 4.3 3.3 6.9 5.8 32.9 11.4 12.2 7.3 6.6 2.0 7.9 15.6 28.8 0.2 0.7 2.6 1.3 0.2 0.1 0.0 0.0 0.6 2.9 1.5 1.6 3.2 3.5 0.0 0.1 54.7 15.0 0.6 4.7 0.0 4.6 4.6 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.8 17.4 1.2 3.9 16.1 0.0 0.0 0.8 0.5 0.4 0.0 0.4 0.3 0.2 0.5 3.3 9.8 3.0 0.5 0.0 0.3 7.0 5.2 8.2 0.1 16.1 2.5 0.5 0.2 0.3 0.0 0.0 46.0 0.3 0.1 0.2 0.1 9.1 5.1 0.2 16.4 0.7 2.0 0.3 0.3 5.6 1.6 0.7 0.4 15.6 0.2 28.8 7.9 0.2 2.6 4.6 6.8 5.1 7.5 5.3 4.3 8.3 2.3 8.8 6.9 RNF149 FLJ90504 ENSG00000163162 "Ring finger protein 149" Q8NC42 2 101271219-101308701 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 123.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 123.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 123.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011424 Approved Approved "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA011424: AB_1079825" "unprognostic (2.56e-2)" "unprognostic (4.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (3.17e-2)" "unprognostic (5.17e-3)" "unprognostic (4.16e-2)" "unprognostic (4.77e-3)" "unprognostic (5.61e-2)" "unprognostic (1.43e-2)" "unprognostic (5.69e-3)" "unprognostic (1.51e-1)" "prognostic unfavourable (2.04e-8)" "unprognostic (1.39e-1)" "unprognostic (6.16e-2)" "unprognostic (2.70e-1)" "prognostic favourable (2.91e-4)" 20.3 13.4 7.9 29.0 10.9 32.9 13.5 7.9 10.8 12.5 16.6 10.8 11.4 12.3 11.3 12.8 28.9 14.3 14.5 12.1 9.5 9.4 15.1 19.6 24.5 47.4 13.7 6.2 14.3 21.1 14.3 10.6 19.4 11.2 11.1 12.0 12.8 15.8 8.1 8.8 20.2 16.8 9.6 13.9 65.0 13.8 15.2 9.7 17.0 12.7 13.1 24.4 14.9 17.2 2.1 9.3 123.7 21.3 2.3 9.0 9.9 9.6 5.7 4.3 5.5 16.3 16.4 25.5 12.0 15.8 16.2 18.3 14.4 25.6 2.8 14.5 11.8 19.7 6.1 12.2 15.1 8.4 8.4 6.0 5.1 24.3 21.8 6.4 9.7 15.0 20.1 19.2 12.7 29.5 5.2 9.0 16.2 8.2 8.6 6.5 3.0 10.4 5.6 7.2 11.1 19.1 23.7 5.7 4.2 7.2 17.9 17.3 4.8 8.7 19.5 8.2 4.7 12.2 2.6 18.3 10.7 0.1 2.6 9.0 6.0 5.8 13.0 14.8 8.2 20.4 7.4 2.1 7.3 8.1 4.8 1.5 5.1 5.3 123.7 2.3 21.3 9.3 9.0 9.9 7.9 10.9 7.9 10.8 9.5 9.4 13.7 6.2 11.2 9.7 RNF150 KIAA1214 ENSG00000170153 "Ring finger protein 150" Q9ULK6 4 140859807-141212877 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 13.5;fHDF/TERT166: 17.3;SH-SY5Y: 25.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037987 Uncertain "Intracellular and membrane" "HPA037987: AB_10669512" "prognostic favourable (1.41e-4)" "unprognostic (1.95e-2)" "unprognostic (8.26e-3)" "unprognostic (2.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.38e-2)" "unprognostic (2.38e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (9.32e-2)" "unprognostic (3.10e-3)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (3.88e-3)" "unprognostic (9.68e-2)" "unprognostic (1.32e-3)" "unprognostic (2.41e-2)" 12.3 14.4 9.2 4.1 26.2 0.9 7.6 13.2 9.6 12.2 18.9 2.5 5.1 1.5 14.1 13.0 8.3 14.5 4.4 18.6 8.0 5.1 10.3 1.5 2.0 3.6 3.2 6.7 12.8 2.8 0.9 18.1 2.6 4.7 10.2 4.8 17.2 30.3 13.6 18.9 1.6 5.0 19.2 4.4 7.7 6.3 2.3 3.8 0.6 7.3 5.9 3.7 12.4 5.8 0.1 0.9 0.4 1.1 0.1 0.1 0.1 0.2 0.3 3.1 2.9 13.5 1.0 0.1 5.4 2.2 1.7 0.8 0.0 0.1 0.0 0.7 17.3 0.0 6.9 0.1 1.0 0.0 3.3 0.0 7.8 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 3.5 0.1 1.8 1.3 2.1 8.1 0.1 1.9 0.0 1.5 25.2 0.4 0.2 1.2 0.1 0.0 0.0 8.9 3.7 5.7 2.5 0.2 0.0 0.0 0.1 0.0 6.6 0.4 1.1 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.9 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.0 0.1 9.2 26.2 13.2 9.6 8.0 5.1 3.2 6.7 4.7 3.8 RNF167 DKFZP566H073 ENSG00000108523 "Ring finger protein 167" Q9H6Y7 17 4940008-4945222 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049810 Approved "HPA049810: " "unprognostic (1.13e-1)" "unprognostic (5.12e-2)" "unprognostic (2.29e-3)" "unprognostic (1.63e-2)" "unprognostic (3.43e-2)" "unprognostic (7.32e-2)" "unprognostic (2.18e-1)" "unprognostic (6.77e-2)" "unprognostic (7.46e-2)" "unprognostic (2.07e-2)" "prognostic favourable (2.03e-6)" "unprognostic (2.16e-1)" "prognostic favourable (4.47e-4)" "unprognostic (7.62e-2)" "unprognostic (1.93e-1)" "unprognostic (3.26e-1)" "unprognostic (1.12e-1)" 30.5 45.9 45.8 32.1 47.0 40.7 38.3 37.9 67.9 44.3 43.5 54.6 49.2 42.7 43.1 55.8 51.6 44.0 47.4 40.1 43.1 39.9 44.1 84.1 35.6 38.7 43.7 43.6 42.6 52.4 52.8 40.7 49.0 41.2 43.6 46.7 38.5 49.1 51.7 56.5 51.6 51.1 42.4 46.4 47.1 42.7 42.0 33.1 53.9 55.1 47.3 47.6 48.1 40.7 25.6 18.2 54.4 26.7 27.6 53.0 37.9 23.7 34.5 15.0 18.4 37.0 18.5 22.4 14.7 20.5 31.1 24.6 24.0 10.9 17.6 28.6 24.2 36.5 26.1 28.5 23.2 16.9 41.9 30.0 43.5 23.6 28.0 14.1 63.2 21.7 45.1 32.3 30.8 20.0 11.7 60.0 24.8 17.0 22.3 17.6 17.9 22.2 15.3 14.9 21.8 35.8 19.9 11.8 14.7 13.5 23.2 19.5 22.2 14.4 12.2 18.6 12.3 16.6 27.9 19.9 20.2 5.8 25.6 20.3 19.4 22.4 21.4 54.4 53.0 22.6 41.1 25.6 40.6 52.7 18.2 24.0 28.5 42.3 52.1 27.6 26.7 18.0 37.7 37.9 45.8 47.0 37.9 67.9 43.1 39.9 43.7 43.6 41.2 33.1 RNF170 "ADSA, DKFZP564A022, SNAX1" ENSG00000120925 "Ring finger protein 170" Q96K19 8 42849637-42897290 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050931, HPA054621" Uncertain "HPA050931: , HPA054621: " "unprognostic (3.06e-2)" "unprognostic (4.20e-1)" "unprognostic (9.54e-2)" "unprognostic (6.37e-2)" "unprognostic (4.59e-2)" "unprognostic (2.84e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (3.23e-2)" "unprognostic (1.17e-1)" "unprognostic (2.59e-1)" "unprognostic (3.03e-2)" "unprognostic (1.61e-3)" "unprognostic (4.13e-3)" "unprognostic (2.00e-1)" "unprognostic (1.49e-1)" "unprognostic (2.13e-1)" 8.9 13.6 14.3 8.7 17.0 2.2 13.0 15.3 18.8 8.6 10.9 17.5 15.0 10.2 9.8 15.6 14.5 9.7 9.5 8.1 13.7 14.3 17.0 19.4 9.3 8.4 15.7 18.2 13.4 10.8 15.5 16.6 19.0 19.7 11.5 11.7 12.5 12.0 11.5 10.5 14.9 11.3 7.9 21.8 8.8 10.6 7.8 14.2 5.5 29.4 8.0 9.6 10.4 10.6 8.5 11.1 2.6 7.2 5.6 8.0 5.9 6.8 11.2 11.5 5.8 18.8 19.4 6.9 8.3 11.5 7.8 8.5 5.3 22.5 8.4 10.1 7.8 5.9 6.1 8.3 6.7 5.7 6.5 9.7 5.0 5.6 10.5 1.2 7.0 16.8 12.9 5.9 12.4 8.4 8.7 10.0 12.5 2.0 10.2 5.7 5.4 4.0 5.4 15.3 4.7 12.6 6.7 3.0 9.0 7.8 5.6 13.9 14.6 5.6 12.1 8.5 3.7 11.2 2.6 16.2 15.4 9.4 11.5 4.1 8.5 1.7 7.2 2.6 4.0 7.1 5.6 8.5 6.3 6.9 10.7 5.1 7.7 5.5 0.7 5.6 6.5 11.1 8.0 5.9 14.3 17.0 15.3 18.8 13.7 14.3 15.7 18.2 19.7 14.2 RNF180 ENSG00000164197 "Ring finger protein 180" Q86T96 5 64165844-64372869 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 54.0" "Cell line enriched" "Detected in some" 7 "RPMI-8226: 24.9" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006897 Approved Approved Cytosol Cytosol "HPA006897: AB_1856348" "unprognostic (7.46e-2)" "unprognostic (3.90e-3)" "unprognostic (3.19e-2)" "unprognostic (8.62e-2)" "unprognostic (2.45e-1)" "unprognostic (2.72e-1)" "unprognostic (5.57e-2)" "unprognostic (2.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (3.68e-2)" "prognostic favourable (6.81e-5)" "unprognostic (2.01e-2)" "unprognostic (3.35e-2)" "unprognostic (1.81e-2)" "unprognostic (9.81e-3)" 8.1 8.1 9.9 3.1 12.8 1.6 6.3 6.0 13.0 10.1 7.1 5.5 20.1 3.4 12.7 11.8 6.9 8.1 7.3 10.4 7.4 10.6 12.4 7.2 6.1 3.4 9.4 9.3 12.0 6.6 54.0 16.1 2.0 10.7 11.5 3.0 11.3 7.3 16.4 4.4 6.6 3.2 15.0 11.0 5.1 5.0 8.1 7.1 0.0 20.6 2.5 2.4 10.9 7.9 2.4 1.0 4.2 1.8 2.0 4.2 0.3 0.0 0.1 1.3 0.0 0.0 0.0 0.3 1.1 0.5 1.1 0.6 0.0 0.1 0.0 0.1 0.8 0.2 0.0 0.5 0.2 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.2 0.1 2.6 0.0 0.1 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.5 1.3 0.1 3.3 24.9 1.8 0.3 0.3 0.1 0.0 0.3 0.0 1.3 0.1 0.1 0.0 3.2 0.1 2.8 0.0 0.0 0.0 0.5 0.0 3.5 3.0 1.8 4.2 1.9 0.6 2.5 1.4 3.0 3.2 0.6 2.4 4.2 3.9 2.6 2.0 0.8 1.0 1.8 0.3 9.9 12.8 6.0 11.7 7.4 10.6 9.4 9.3 10.7 7.1 RNF183 MGC4734 ENSG00000165188 "Ring finger protein 183" Q96D59 9 113297093-113303376 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 19.0;kidney: 9.5" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 20.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA057675 Uncertain "HPA057675: " "unprognostic (1.23e-2)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "prognostic favourable (7.95e-6)" "unprognostic (2.56e-1)" "unprognostic (1.75e-2)" "unprognostic (1.54e-3)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.98e-1)" "prognostic favourable (3.51e-4)" "unprognostic (5.50e-2)" "unprognostic (8.84e-2)" "unprognostic (9.61e-2)" "unprognostic (2.53e-3)" 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 1.9 0.2 0.2 1.2 19.0 5.1 1.2 6.2 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.8 0.3 6.9 0.2 0.0 0.1 0.1 0.0 0.0 0.0 3.7 4.3 0.1 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF215 ENSG00000099999 "Ring finger protein 215" Q9Y6U7 22 30368811-30421771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029427, HPA056498" Approved Approved Nucleoli,Microtubules Microtubules Nucleoli "HPA029427: , HPA056498: " "unprognostic (1.24e-2)" "unprognostic (3.20e-1)" "unprognostic (3.67e-4)" "unprognostic (8.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (1.97e-1)" "unprognostic (5.32e-2)" "unprognostic (1.03e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-2)" "prognostic unfavourable (6.37e-10)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (3.17e-1)" "unprognostic (1.78e-2)" 9.8 7.1 17.5 7.3 12.6 8.0 8.0 20.7 24.5 10.1 7.8 7.3 11.9 10.4 14.0 13.0 6.4 10.6 13.3 7.7 11.3 14.4 8.5 8.0 6.9 6.5 10.4 15.2 10.8 15.4 12.6 7.9 9.0 10.7 12.3 5.2 11.2 8.8 11.8 7.4 7.9 5.5 10.9 8.1 8.8 6.9 10.0 5.5 2.2 10.3 1.6 5.0 7.9 8.0 4.8 3.5 3.5 2.1 6.1 4.8 0.9 4.5 9.6 10.1 16.3 9.9 10.4 10.0 7.8 7.1 7.8 4.9 2.6 5.1 1.8 14.2 6.3 5.7 6.1 9.0 6.4 10.6 7.4 3.2 10.4 3.4 13.6 2.4 13.0 14.1 11.1 13.5 7.3 9.2 2.6 8.8 9.4 7.3 1.7 5.7 3.1 10.7 8.2 5.8 7.2 10.3 7.0 4.4 11.4 7.8 5.8 5.8 5.3 2.7 12.7 21.4 9.5 6.1 4.6 9.4 2.3 2.4 12.6 1.8 8.2 1.9 2.1 3.5 2.5 1.9 2.5 2.7 2.6 2.0 1.1 4.8 4.8 4.3 1.6 6.1 1.7 3.5 1.3 0.9 17.5 12.6 20.7 24.5 11.3 14.4 10.4 15.2 10.7 5.5 RNF217 "C6orf172, dJ84N20.1, IBRDC1, MGC26996" ENSG00000146373 "Ring finger protein 217" Q8TC41 6 124962545-125092633 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 63.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.9;myeloid DC: 1.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029598 Uncertain "HPA029598: AB_10602297" "unprognostic (2.96e-2)" "unprognostic (2.34e-3)" "unprognostic (8.07e-2)" "unprognostic (8.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (7.22e-3)" "unprognostic (4.94e-2)" "unprognostic (6.69e-2)" "unprognostic (2.47e-1)" "unprognostic (2.61e-1)" "prognostic unfavourable (4.60e-5)" "unprognostic (8.29e-4)" "unprognostic (2.16e-1)" "unprognostic (7.52e-2)" "prognostic unfavourable (1.92e-4)" 9.6 3.5 3.3 4.2 4.7 10.5 14.6 3.8 3.5 8.0 7.7 5.7 6.4 2.3 5.9 5.6 6.2 7.5 12.1 6.5 3.8 1.7 2.5 6.3 7.3 3.7 4.3 2.9 11.5 3.8 63.3 4.0 12.0 3.4 6.4 2.3 6.0 6.0 6.9 10.1 10.9 3.1 13.0 2.3 2.6 4.5 7.4 5.7 0.1 7.4 3.6 1.6 8.7 13.6 0.0 1.2 0.6 1.9 0.3 0.2 0.3 4.1 4.2 1.5 0.5 5.4 2.1 8.5 5.7 7.7 3.9 5.1 0.0 3.9 0.0 7.9 5.4 6.0 0.9 5.1 5.5 0.0 4.8 2.3 6.3 1.3 5.2 0.0 0.2 5.9 4.7 2.9 8.6 4.4 11.6 0.0 6.8 0.0 0.0 0.0 1.3 1.1 0.1 5.9 0.0 4.0 1.9 0.7 0.0 2.5 0.6 2.1 4.1 0.6 6.9 3.2 10.3 0.0 12.1 0.0 0.0 0.0 2.4 0.0 3.8 0.6 1.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.0 0.3 3.3 4.7 3.8 3.5 3.8 1.7 4.3 2.9 3.4 5.7 RNF222 ENSG00000189051 "Ring finger protein 222" A6NCQ9 17 8390704-8397826 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 15.7;lymphoid tissue: 9.4;tongue: 13.6" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 12.3" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048916 Uncertain "HPA048916: " "unprognostic (2.49e-1)" "unprognostic (4.19e-2)" "unprognostic (2.32e-2)" "unprognostic (8.19e-4)" "unprognostic (2.81e-1)" "unprognostic (5.30e-2)" "unprognostic (2.02e-1)" "unprognostic (3.93e-2)" "unprognostic (9.55e-2)" "unprognostic (7.02e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-3)" "unprognostic (5.82e-2)" "unprognostic (6.70e-2)" "unprognostic (5.98e-3)" "unprognostic (3.97e-2)" 0.1 0.0 0.1 0.1 0.1 1.8 0.5 0.1 0.1 3.1 0.1 0.1 0.1 0.0 0.6 0.1 15.7 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.1 1.8 0.1 0.1 6.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 13.6 9.4 0.1 5.5 0.4 0.5 2.0 0.5 0.2 1.0 0.1 1.1 0.0 0.0 0.2 0.1 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 12.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 1.6 0.5 1.0 0.3 0.2 0.2 0.2 0.3 0.1 0.1 0.4 0.6 1.0 2.0 0.2 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 RNF24 G1L ENSG00000101236 "Ring finger protein 24" Q9Y225 20 3927309-4015582 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 59.0;bone marrow: 59.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 59.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 59.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011900 Approved Supported "Golgi apparatus" "Golgi apparatus" "HPA011900: AB_10671089" "unprognostic (6.61e-2)" "unprognostic (6.56e-2)" "unprognostic (1.72e-1)" "unprognostic (1.17e-2)" "unprognostic (8.79e-2)" "unprognostic (9.24e-2)" "prognostic unfavourable (3.81e-5)" "unprognostic (2.65e-1)" "unprognostic (5.87e-2)" "unprognostic (2.66e-2)" "unprognostic (5.19e-3)" "unprognostic (3.42e-1)" "prognostic unfavourable (2.67e-7)" "unprognostic (1.18e-2)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (1.24e-1)" 9.1 9.3 13.1 11.6 13.0 59.4 14.8 12.3 16.2 9.2 6.6 8.4 17.0 4.7 9.1 20.6 8.1 8.0 9.3 7.4 13.0 10.5 9.5 3.2 14.5 14.1 10.5 9.9 9.3 5.9 5.3 8.2 5.6 9.4 9.9 5.8 5.4 9.8 14.9 3.2 11.4 5.3 9.0 12.8 14.8 7.6 6.3 7.6 6.3 8.8 4.5 6.0 9.4 15.5 1.1 4.6 59.0 5.8 1.7 1.8 2.4 8.0 3.7 5.4 4.8 20.7 35.3 1.9 6.7 14.4 6.8 9.8 2.4 7.9 1.7 1.5 13.6 5.4 2.1 7.5 11.5 1.2 1.7 14.9 6.5 1.9 18.2 29.7 5.9 11.8 2.4 18.1 15.5 6.3 18.8 4.1 11.0 2.2 4.9 7.3 8.2 5.2 5.6 4.7 1.4 3.8 4.4 5.2 4.2 18.9 11.5 5.0 4.0 10.7 9.7 17.0 5.6 11.5 8.0 3.5 3.6 0.7 8.8 10.4 5.3 20.7 5.8 11.8 0.9 2.1 0.9 0.3 1.8 1.4 4.6 1.1 1.2 1.4 59.0 1.7 2.8 0.2 0.8 2.4 13.1 13.0 12.3 13.5 13.0 10.5 10.5 9.9 9.4 7.6 RNF43 "DKFZp781H0392, FLJ20315, URCC" ENSG00000108375 "Ring finger protein 43" Q68DV7 17 58352500-58417595 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 14.9;Hep G2: 29.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 41.7" "Region enriched" "Detected in many" 7 "cerebellum: 30.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA008079 Uncertain "HPA008079: AB_1856371" "unprognostic (2.53e-1)" "unprognostic (1.09e-1)" "unprognostic (7.46e-2)" "unprognostic (2.56e-1)" "unprognostic (1.10e-1)" "unprognostic (4.33e-2)" "unprognostic (1.39e-1)" "unprognostic (3.62e-1)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (5.69e-2)" "unprognostic (3.79e-1)" "prognostic favourable (6.04e-9)" "unprognostic (3.61e-3)" "unprognostic (2.56e-1)" "unprognostic (3.58e-1)" "unprognostic (1.04e-2)" 0.4 9.4 2.2 6.2 3.5 1.9 4.5 30.6 4.3 3.4 26.4 0.9 21.3 18.5 1.7 9.1 10.0 3.9 8.1 3.3 1.9 1.3 8.0 7.0 6.1 2.7 0.8 1.1 1.6 13.2 3.0 13.3 8.7 4.1 8.0 16.3 3.8 13.7 19.0 0.5 8.9 29.0 0.9 0.8 0.9 4.9 3.1 0.7 3.0 1.8 5.7 6.6 4.0 4.4 0.9 1.1 1.7 1.8 5.6 3.6 1.2 0.7 10.4 1.9 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 14.9 5.0 4.2 5.3 0.0 2.9 0.4 4.0 0.0 8.8 7.3 3.4 0.5 29.2 0.0 4.2 3.0 0.0 8.2 0.0 1.3 0.0 0.3 3.6 0.0 0.1 2.2 3.9 0.3 0.7 6.9 0.0 2.2 3.7 5.6 1.2 0.3 0.9 0.4 0.3 1.3 1.2 0.0 0.1 1.2 0.0 0.0 3.8 1.7 3.3 0.4 0.4 2.4 1.7 0.2 1.6 3.1 0.8 3.2 0.9 2.5 3.6 0.4 0.9 2.3 3.0 0.8 5.6 1.8 1.1 1.2 1.2 2.2 3.5 30.6 4.3 1.9 1.3 0.8 1.1 4.1 0.7 RNFT1 PTD016 ENSG00000189050 "Ring finger protein, transmembrane 1" Q5M7Z0 17 59952240-59964761 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013739 Approved Nucleoli Nucleoli "HPA013739: AB_1856382" "unprognostic (1.61e-1)" "unprognostic (2.83e-1)" "prognostic favourable (6.57e-4)" "unprognostic (3.04e-2)" "unprognostic (6.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "prognostic favourable (7.48e-4)" "unprognostic (5.42e-2)" "unprognostic (3.45e-1)" "unprognostic (8.26e-3)" "unprognostic (9.44e-3)" "unprognostic (1.19e-3)" "unprognostic (1.44e-2)" "unprognostic (2.05e-1)" "prognostic favourable (2.57e-4)" "unprognostic (2.60e-1)" 7.9 6.2 2.8 5.3 4.3 3.8 4.2 5.1 3.7 3.1 4.0 2.4 3.7 5.3 2.7 8.1 4.6 3.2 3.1 4.1 3.1 2.2 4.7 12.0 5.0 4.4 2.9 3.1 3.5 7.5 4.7 6.1 4.4 3.4 4.5 4.8 4.2 5.1 3.0 6.7 2.7 7.6 3.0 3.4 4.1 3.9 45.5 3.0 5.9 6.1 4.3 6.0 5.1 3.7 9.5 10.1 20.2 17.1 8.9 7.7 7.9 4.8 2.2 2.3 3.1 7.6 5.7 4.5 6.2 3.3 4.8 6.0 6.9 1.9 7.2 10.4 5.1 5.6 7.2 4.7 8.4 6.8 7.8 6.0 5.8 6.2 5.6 9.3 9.3 6.3 2.5 4.5 2.0 4.9 17.3 4.4 4.1 6.2 3.8 4.5 0.9 5.1 5.2 17.4 4.1 3.9 3.4 1.4 2.7 8.9 2.1 12.3 10.2 17.8 3.5 9.4 8.4 5.5 5.2 6.5 18.0 4.2 6.5 5.2 4.7 17.3 11.8 20.2 5.6 13.9 7.7 9.5 5.2 6.3 10.1 6.1 6.8 6.1 5.7 8.9 17.1 6.7 6.5 7.9 2.8 4.3 5.1 3.7 3.1 2.2 2.9 3.1 3.4 3.0 ROBO1 "DUTT1, FLJ21882, SAX3" ENSG00000169855 "Roundabout guidance receptor 1" Q9Y6N7 3 78597240-79767815 "Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013524, HPA052968, HPA074461" Uncertain Enhanced "Plasma membrane" 6500000 "Plasma membrane" "CAB013524: , HPA052968: , HPA074461: " "unprognostic (2.89e-1)" "unprognostic (6.42e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-1)" "unprognostic (4.77e-2)" "unprognostic (1.61e-3)" "prognostic unfavourable (9.88e-4)" "unprognostic (2.44e-1)" "unprognostic (2.92e-2)" "unprognostic (2.00e-1)" "unprognostic (6.40e-2)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (6.77e-2)" "unprognostic (1.91e-1)" "unprognostic (2.39e-2)" "unprognostic (1.16e-2)" 12.5 10.1 15.5 10.7 30.2 0.4 7.3 12.5 22.0 15.9 9.4 14.7 1.6 3.5 10.5 8.2 13.7 5.6 8.6 9.0 12.3 12.4 3.7 4.0 8.3 9.3 14.7 8.9 18.4 2.3 2.1 29.6 8.4 12.2 14.5 6.9 8.5 5.5 13.8 4.5 21.8 5.4 11.4 8.1 9.2 5.0 10.8 15.7 14.0 5.5 8.8 18.8 13.2 14.1 1.0 0.7 0.0 0.4 0.1 3.1 0.1 0.0 10.9 10.4 16.6 14.5 9.6 0.5 8.3 11.2 6.6 5.6 0.2 4.6 0.0 0.0 10.3 4.3 12.6 8.6 8.3 0.1 16.0 6.3 21.6 17.0 3.5 0.1 1.6 15.9 11.8 25.0 11.9 6.6 0.8 19.7 6.8 5.1 0.0 0.0 13.2 3.9 0.3 10.9 0.1 0.0 3.5 8.1 5.5 17.9 4.1 6.6 12.7 0.1 0.1 22.1 9.7 13.1 14.0 0.7 0.0 0.0 20.1 0.0 18.3 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.7 0.3 0.0 3.1 0.0 0.1 0.4 0.0 0.0 0.1 15.5 30.2 12.5 13.6 12.3 12.4 14.7 8.9 12.2 15.7 ROBO2 KIAA1568 ENSG00000185008 "Roundabout guidance receptor 2" Q9HCK4 3 75906695-77649964 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1" "Group enriched" "Detected in some" 5 "BJ hTERT+: 14.9;HEL: 40.7" "Cancer enhanced" "Detected in many" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013371 Approved Approved "Nucleoplasm,Centriolar satellite" 660000 "Nucleoplasm, Centriolar satellite" "HPA013371: AB_1856391" "unprognostic (1.14e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.82e-2)" "unprognostic (5.93e-3)" "unprognostic (3.87e-1)" "unprognostic (2.83e-3)" "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (2.90e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (9.65e-3)" 1.1 3.3 6.4 0.8 13.8 0.3 1.1 19.0 26.1 3.6 1.3 2.2 0.0 0.9 2.9 0.8 6.2 0.4 3.1 1.0 6.3 6.5 2.5 1.8 12.3 1.8 9.6 5.5 9.4 2.2 6.8 2.1 6.4 9.9 1.9 0.8 4.8 2.1 7.8 0.4 3.0 1.2 1.9 7.8 3.6 1.1 4.5 3.6 3.6 0.4 4.2 3.0 2.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.9 4.2 0.0 0.1 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 4.8 40.7 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 2.6 4.6 0.0 0.0 0.5 6.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 13.8 19.0 11.3 6.3 6.5 9.6 5.5 9.9 3.6 ROBO3 "FLJ21044, HGPPS, HGPS, RBIG1" ENSG00000154134 "Roundabout guidance receptor 3" Q96MS0 11 124865386-124881470 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.1" "Cell line enriched" "Detected in some" 11 "AF22: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 1.4" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Low region specificity" "Detected in all" HPA071053 Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA071053: " "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "unprognostic (4.95e-3)" "unprognostic (3.42e-2)" "unprognostic (3.84e-2)" "unprognostic (6.25e-2)" "unprognostic (6.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (7.15e-2)" "unprognostic (3.75e-8)" "unprognostic (7.27e-3)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (4.91e-3)" 2.4 1.5 1.5 0.5 1.4 1.3 1.7 0.5 3.1 0.8 0.9 0.5 0.5 1.9 1.8 20.1 0.5 2.1 0.5 1.5 1.5 0.6 0.7 0.5 1.7 0.8 1.1 1.1 7.4 0.5 0.2 0.5 1.5 1.0 1.0 0.2 1.0 1.7 0.5 2.6 0.2 2.2 4.5 0.7 3.0 0.8 1.0 0.5 0.8 1.1 0.5 0.5 0.5 1.0 0.0 1.3 1.4 0.3 0.0 0.8 0.0 0.0 0.0 20.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.7 1.0 0.0 1.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.3 0.4 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 1.3 0.8 0.0 1.5 1.4 0.5 2.7 1.5 0.6 1.1 1.1 1.0 0.5 ROBO4 "ECSM4, FLJ20798, MRB" ENSG00000154133 "Roundabout guidance receptor 4" Q8WZ75 11 124883691-124898500 "Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 63.4;TIME: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065212 Approved "Plasma membrane" 340000000 "Plasma membrane" "HPA065212: " "unprognostic (2.86e-1)" "unprognostic (9.35e-2)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (3.82e-2)" "unprognostic (6.97e-2)" "prognostic favourable (4.85e-4)" "unprognostic (7.94e-2)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.73e-3)" "unprognostic (2.17e-1)" "unprognostic (1.17e-2)" "prognostic unfavourable (8.73e-4)" "unprognostic (1.55e-1)" "unprognostic (4.63e-1)" "unprognostic (5.15e-2)" 33.3 4.5 4.0 5.6 4.5 0.6 21.6 2.0 5.5 11.1 4.4 4.3 3.7 2.8 10.8 7.8 5.3 7.7 8.5 15.5 4.9 3.0 10.6 6.5 24.9 5.8 4.7 2.8 5.9 3.5 3.8 3.8 23.6 5.5 6.0 1.8 9.2 2.9 4.5 12.5 4.5 4.7 8.4 3.6 33.3 4.3 3.9 3.3 1.0 11.6 9.8 2.5 6.2 5.9 0.0 1.2 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.1 0.3 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.7 63.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.9 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.0 4.5 2.0 5.5 4.9 3.0 4.7 2.8 5.5 3.3 ROR1 NTRKR1 ENSG00000185483 "Receptor tyrosine kinase like orphan receptor 1" Q01973 1 63774022-64181498 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Receptor, Transferase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 31.2" "Cell line enhanced" "Detected in many" "ASC diff: 19.4;ASC TERT1: 24.3;CACO-2: 16.6;HHSteC: 18.5;HSkMC: 19.9;NTERA-2: 20.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "cerebellum: 13.0" "Group enriched" "Detected in some" 5 "NK-cell: 3.3;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 5 "dendritic cells: 1.1;NK-cells: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA057016 Approved Microtubules "Intracellular and membrane" 2800000 Microtubules "HPA057016: " "unprognostic (5.15e-2)" "unprognostic (1.19e-2)" "unprognostic (3.65e-2)" "unprognostic (1.03e-2)" "unprognostic (6.24e-2)" "unprognostic (1.61e-1)" "unprognostic (7.11e-3)" "unprognostic (1.41e-1)" "unprognostic (4.06e-1)" "unprognostic (3.84e-1)" "unprognostic (3.20e-2)" "unprognostic (2.02e-2)" "unprognostic (3.64e-3)" "unprognostic (1.48e-2)" "unprognostic (1.52e-1)" "unprognostic (5.87e-2)" "unprognostic (5.15e-2)" 5.5 1.7 1.3 3.5 2.7 0.4 3.4 13.0 2.8 16.7 8.8 2.2 4.4 2.0 14.2 5.0 4.9 5.5 10.7 10.6 1.3 1.1 3.6 0.8 9.7 1.1 1.0 2.4 8.3 9.8 31.2 3.6 2.9 3.0 10.9 3.9 7.9 2.8 6.3 2.1 4.5 4.1 17.8 1.1 3.1 9.2 2.7 0.9 1.8 1.5 4.6 2.1 10.2 8.8 0.4 1.1 0.1 0.1 3.3 0.1 0.0 7.0 5.5 2.8 0.3 19.4 24.3 1.9 1.3 3.8 0.7 2.0 16.6 2.2 0.1 3.2 3.2 1.5 0.0 1.3 0.5 0.0 1.7 0.0 0.7 0.2 18.5 0.0 0.0 19.9 5.1 10.2 12.0 0.3 0.0 0.1 5.1 0.1 0.1 0.0 20.2 2.8 0.1 0.1 4.3 4.1 0.1 1.6 6.5 0.4 0.1 2.9 0.0 0.0 3.8 1.5 2.9 10.8 2.8 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.1 3.3 0.1 1.1 0.0 0.0 1.3 2.7 13.0 2.8 1.3 1.1 1.0 2.4 3.0 0.9 ROR2 "BDB, BDB1, NTRKR2" ENSG00000169071 "Receptor tyrosine kinase like orphan receptor 2" Q01974 9 91563091-91950162 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 12.0;HHSteC: 31.7;HSkMC: 26.4;U-266/70: 18.3;U-266/84: 12.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "pons and medulla: 6.6" "Cell type enriched" "Detected in single" 6 "MAIT T-cell: 3.9" "Lineage enriched" "Detected in single" 6 "T-cells: 3.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 13.5" HPA021868 Uncertain "HPA021868: AB_1856406" "unprognostic (9.38e-3)" "unprognostic (4.69e-1)" "unprognostic (2.26e-1)" "unprognostic (8.48e-3)" "unprognostic (1.23e-1)" "unprognostic (2.38e-1)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (8.03e-2)" "unprognostic (2.03e-1)" "unprognostic (5.76e-2)" "unprognostic (2.66e-1)" "prognostic unfavourable (9.86e-7)" "unprognostic (2.16e-3)" "unprognostic (9.13e-2)" "prognostic unfavourable (4.28e-8)" "unprognostic (1.25e-2)" 4.4 4.3 0.7 5.3 1.1 0.0 3.6 0.2 0.8 23.4 20.7 2.9 11.1 1.9 29.1 9.1 8.0 8.1 18.7 8.5 1.0 0.9 2.0 0.5 4.2 0.7 0.3 0.0 19.1 3.1 20.3 1.3 7.1 6.6 20.3 2.1 11.0 1.2 13.1 1.1 2.9 6.2 30.0 0.3 4.7 10.5 5.2 0.3 2.6 7.9 1.9 3.3 23.7 18.1 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.1 12.0 0.0 2.6 0.2 3.4 0.2 3.1 2.0 3.8 0.0 0.0 0.0 0.0 0.6 0.1 2.5 0.0 0.8 0.0 2.0 0.0 9.2 0.0 31.7 0.0 0.0 26.4 0.0 2.7 0.0 0.0 6.6 0.0 0.0 0.2 0.0 1.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.5 0.2 0.0 0.0 7.1 0.1 0.0 0.0 2.4 1.0 0.0 18.3 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.2 0.8 1.0 0.9 0.3 0.0 6.6 0.3 ROS1 "c-ros-1, MCF3, ROS" ENSG00000047936 "ROS proto-oncogene 1, receptor tyrosine kinase" P08922 6 117288300-117425855 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 38.6;lung: 20.2" "Group enriched" "Detected in some" 5 "HSkMC: 9.3;hTCEpi: 19.3;LHCN-M2: 13.4" "Cancer enriched" "Detected in some" 13 "lung cancer: 6.9" "Group enriched" "Detected in some" 10 "cerebral cortex: 7.4;olfactory region: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049098, HPA072424" Uncertain Approved Vesicles Vesicles "HPA049098: , HPA072424: " "unprognostic (8.18e-2)" "unprognostic (4.64e-3)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (7.57e-2)" "unprognostic (2.05e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (2.79e-2)" "unprognostic (1.00e-2)" "unprognostic (2.42e-1)" "unprognostic (5.20e-2)" "unprognostic (1.56e-12)" "unprognostic (1.09e-2)" "unprognostic (2.81e-1)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" 0.3 0.2 0.2 0.0 0.4 0.0 0.2 0.2 7.4 0.2 0.4 0.0 7.9 0.0 0.2 38.6 0.2 0.2 0.0 0.2 0.2 0.2 0.4 0.2 20.2 0.0 0.2 2.5 0.2 0.2 0.0 0.3 0.7 0.0 0.2 0.3 0.0 0.2 2.3 0.2 0.7 0.3 0.0 0.2 0.2 0.3 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 9.3 19.3 0.2 1.7 0.0 0.0 0.0 13.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.8 0.0 2.3 1.5 0.1 1.8 0.0 0.0 0.0 1.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 7.4 0.2 0.2 0.2 2.5 0.0 0.0 RPAP1 "DKFZP727M111, FLJ12732, KIAA1403, MGC858" ENSG00000103932 "RNA polymerase II associated protein 1" Q9BWH6 15 41517176-41544269 "Predicted intracellular proteins, Predicted membrane proteins" Transcription "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041739 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041739: " "unprognostic (8.83e-3)" "unprognostic (2.78e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (1.97e-1)" "unprognostic (8.61e-2)" "unprognostic (1.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-2)" "unprognostic (7.02e-2)" "unprognostic (3.73e-2)" "unprognostic (3.26e-1)" "unprognostic (2.46e-1)" "prognostic unfavourable (9.32e-4)" "unprognostic (4.30e-3)" 10.1 10.2 12.8 8.5 12.4 4.7 8.1 7.8 15.6 7.8 10.2 12.6 7.9 8.5 10.7 6.0 12.3 10.4 6.9 9.5 10.9 6.1 6.7 10.8 7.3 9.8 12.3 10.1 12.4 9.4 12.9 9.4 8.7 11.9 9.4 7.1 9.5 9.8 9.2 27.0 10.3 8.0 10.1 8.0 9.1 9.4 12.6 11.8 11.2 8.3 7.9 10.7 11.2 8.4 5.9 4.5 0.0 5.9 4.9 7.2 3.3 7.1 8.5 11.7 12.3 9.8 7.1 9.9 7.0 6.1 9.1 9.0 23.1 6.5 5.6 11.6 7.8 16.9 21.1 10.3 7.8 9.8 10.2 10.6 11.9 10.1 6.2 8.6 6.7 7.2 13.1 10.9 7.6 10.2 24.6 6.4 8.4 4.5 9.3 5.3 20.6 7.9 16.9 10.1 6.0 4.0 16.8 10.7 14.4 9.0 9.5 4.8 15.6 10.8 9.3 14.4 9.4 14.3 11.2 10.8 29.6 6.3 10.3 9.4 13.5 0.0 2.6 0.0 7.2 3.5 6.6 4.8 4.3 4.5 4.5 5.9 6.1 5.3 0.0 4.9 5.9 2.9 4.4 3.3 12.8 12.4 7.8 15.6 10.9 6.1 12.3 10.1 11.9 11.8 RPAP2 "C1orf82, FLJ13150, Rtr1" ENSG00000122484 "RNA polymerase II associated protein 2" Q8IXW5 1 92298965-92402056 "Enzymes, Predicted membrane proteins" "Transcription, Transcription regulation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046443 Approved Supported Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA046443: " "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.71e-2)" "unprognostic (4.12e-2)" "unprognostic (4.96e-3)" "unprognostic (5.73e-2)" "unprognostic (1.23e-3)" "unprognostic (3.29e-2)" "unprognostic (8.01e-3)" "unprognostic (4.09e-2)" "unprognostic (2.59e-1)" "unprognostic (6.09e-2)" "unprognostic (7.02e-4)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.62e-3)" "unprognostic (4.10e-2)" 6.8 7.0 7.8 7.3 10.5 12.0 7.6 27.2 11.6 8.4 6.3 7.1 7.2 6.6 11.1 11.5 5.6 6.3 5.5 5.9 8.1 8.6 8.1 10.6 5.2 8.2 7.7 6.7 8.2 8.6 9.4 16.1 6.7 11.7 7.6 5.8 6.4 7.2 7.1 10.5 10.7 6.3 7.4 9.9 7.6 6.4 6.7 8.7 12.8 9.4 6.5 6.3 6.6 7.6 4.4 3.5 4.9 2.4 4.0 4.8 1.2 6.2 3.8 6.7 6.1 5.5 7.1 5.7 4.9 3.4 3.2 2.7 2.7 2.8 9.3 8.5 3.6 4.3 5.5 3.2 5.0 6.3 4.0 5.7 6.9 3.6 3.3 9.8 5.7 3.6 3.9 4.2 4.1 3.4 5.8 6.2 4.9 3.2 8.3 6.2 5.2 4.3 6.2 8.9 4.0 4.2 5.6 6.2 4.6 8.0 7.3 4.0 3.9 7.5 6.0 4.9 6.2 5.6 6.9 6.0 7.0 4.9 3.4 6.2 3.3 4.8 2.4 1.9 4.1 1.7 4.8 3.4 3.2 3.5 1.8 4.4 3.5 3.8 4.9 4.0 1.9 3.5 2.8 1.2 7.8 10.5 27.2 11.6 8.1 8.6 7.7 6.7 11.7 8.7 RPGR "COD1, CORDX1, CRD, RP15, RP3" ENSG00000156313 "Retinitis pigmentosa GTPase regulator" Q92834 X 38269163-38327564 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Guanine-nucleotide releasing factor" "Cancer-related genes, Ciliopathy, Cone-rod dystrophy, Deafness, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 55.4" "Cell line enhanced" "Detected in many" "HL-60: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 15.3" "HPA001593, HPA073455" Approved Supported "Golgi apparatus" "Golgi apparatus" "HPA001593: AB_1079835, HPA073455: " "unprognostic (3.22e-2)" "unprognostic (1.16e-2)" "unprognostic (5.04e-2)" "unprognostic (1.08e-1)" "unprognostic (3.20e-1)" "unprognostic (9.94e-2)" "unprognostic (3.46e-2)" "unprognostic (6.32e-2)" "unprognostic (2.04e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-6)" "unprognostic (1.93e-1)" "unprognostic (7.59e-2)" "unprognostic (8.96e-3)" "unprognostic (1.61e-3)" 16.4 5.9 6.1 7.1 9.0 17.4 13.8 7.2 7.0 8.3 8.4 7.1 2.5 5.1 8.8 9.4 5.4 20.8 9.4 6.3 7.2 9.4 4.9 4.9 10.7 7.8 8.9 4.2 7.9 7.2 3.8 55.4 6.3 14.6 5.9 6.4 6.3 3.7 4.8 13.3 4.3 6.2 8.3 9.9 5.1 4.9 11.6 5.7 5.8 8.3 3.6 5.4 7.7 10.9 1.9 2.6 15.3 2.6 1.6 3.1 1.7 3.3 4.4 2.5 2.3 2.9 4.1 1.9 4.2 4.9 3.1 3.6 1.9 1.7 4.9 1.4 2.7 3.2 3.0 1.3 4.3 5.2 5.5 1.8 2.1 3.9 2.6 22.5 4.3 5.9 1.8 6.2 7.0 14.1 2.3 0.0 4.2 1.3 6.6 12.6 6.5 5.6 4.9 8.6 4.6 2.7 2.2 1.9 3.7 4.6 1.9 5.0 1.2 3.9 16.4 3.4 6.0 8.0 5.0 1.4 2.7 4.3 8.0 4.4 4.6 1.4 2.6 5.7 1.4 2.3 3.1 1.9 1.7 1.8 2.6 1.8 2.5 2.0 15.3 1.6 1.8 1.8 1.9 1.7 6.1 9.0 7.2 7.0 7.2 9.4 8.9 4.2 14.6 5.7 RPL9 L9 ENSG00000163682 "Ribosomal protein L9" P32969 4 39452521-39458949 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003372 Approved Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" 24000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA003372: AB_1079843" "unprognostic (1.08e-3)" "unprognostic (2.14e-1)" "unprognostic (1.24e-1)" "unprognostic (8.06e-3)" "unprognostic (5.59e-2)" "unprognostic (1.27e-2)" "unprognostic (3.16e-2)" "unprognostic (2.14e-1)" "unprognostic (8.58e-2)" "unprognostic (6.68e-2)" "unprognostic (2.50e-2)" "unprognostic (7.85e-2)" "prognostic unfavourable (7.34e-4)" "unprognostic (1.34e-1)" "unprognostic (2.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-2)" 52.6 35.2 42.2 73.9 44.4 179.1 202.3 35.7 51.6 63.0 59.8 34.5 42.2 69.8 50.4 226.8 49.9 48.1 69.7 58.2 42.3 27.6 47.4 73.2 35.8 48.7 34.7 51.7 158.5 126.2 37.4 44.7 38.7 42.5 47.8 59.1 31.7 93.7 71.4 66.3 62.9 38.8 49.5 34.0 45.2 46.5 56.9 25.9 36.0 63.2 70.1 59.0 46.0 56.6 118.3 72.5 26.2 41.4 63.0 145.0 148.9 3.2 2.8 122.4 2.8 6.6 9.0 4.7 57.6 87.0 71.9 54.6 8.0 65.4 142.9 6.6 57.9 65.1 5.4 6.2 78.7 52.0 115.0 4.5 24.1 7.8 8.5 9.3 37.8 11.9 180.9 4.4 82.7 5.4 109.2 66.7 5.0 4.3 77.5 9.8 109.2 3.8 71.6 122.7 4.9 89.4 3.7 4.6 48.8 1.9 47.3 7.3 104.4 6.7 4.1 3.0 4.6 83.7 7.9 102.5 143.9 124.1 83.1 86.9 3.3 26.2 41.4 12.3 52.1 40.1 101.2 118.3 102.2 71.4 57.2 103.8 145.0 111.7 6.9 63.0 31.2 72.5 77.0 148.9 42.2 44.4 35.7 51.6 42.3 27.6 34.7 51.7 42.5 25.9 RPN1 OST1 ENSG00000163902 "Ribophorin I" P04843 3 128619970-128681075 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009748, HPA026828, HPA051520" Enhanced Enhanced "Endoplasmic reticulum" 8200000 "Endoplasmic reticulum" "CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521" "unprognostic (4.83e-2)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (7.67e-2)" "unprognostic (2.36e-1)" "unprognostic (2.12e-2)" "prognostic unfavourable (4.80e-4)" "unprognostic (2.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.28e-2)" "unprognostic (4.58e-3)" "unprognostic (2.87e-1)" "unprognostic (7.68e-2)" "unprognostic (7.86e-2)" "unprognostic (1.52e-2)" "unprognostic (1.44e-1)" "unprognostic (9.74e-2)" 52.3 37.5 22.2 26.6 23.8 24.4 48.2 20.9 31.4 45.8 40.8 31.9 58.8 28.5 38.3 110.2 32.2 38.3 38.8 47.1 23.0 28.0 55.4 174.0 47.4 50.6 26.4 18.3 37.8 62.9 43.5 36.9 58.3 24.3 31.4 41.1 28.6 54.1 55.5 34.4 24.0 37.0 33.5 31.8 48.0 33.7 26.9 23.3 34.3 69.1 27.3 36.5 32.7 39.7 26.7 53.1 64.4 43.5 23.4 45.1 53.3 60.8 33.2 27.7 51.0 75.1 50.3 62.8 52.5 69.0 69.8 81.3 68.7 57.3 38.1 49.5 75.7 61.3 44.7 46.7 68.3 27.3 28.7 67.2 24.7 56.4 82.8 54.4 35.4 41.7 54.7 45.9 67.9 54.4 27.6 51.1 45.7 55.6 30.2 59.8 35.1 30.4 33.0 37.3 91.6 48.3 36.6 42.7 24.6 43.1 44.7 53.1 47.8 56.4 35.4 36.1 28.2 52.7 38.9 55.2 43.4 40.7 59.2 40.6 52.0 38.8 43.5 35.7 37.3 40.0 45.1 26.7 30.7 33.8 43.5 18.3 19.1 29.2 64.4 23.4 40.2 53.1 30.5 53.3 22.2 23.8 20.9 31.4 23.0 28.0 26.4 18.3 24.3 23.3 RPN2 "RIBIIR, RPN-II, RPNII, SWP1" ENSG00000118705 "Ribophorin II" P04844 20 37178410-37241623 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008297, CAB019277, HPA025922" Enhanced Supported "Endoplasmic reticulum" 2800000 "Endoplasmic reticulum" "CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458" "unprognostic (9.59e-3)" "unprognostic (5.22e-2)" "unprognostic (1.66e-2)" "unprognostic (1.06e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-2)" "prognostic unfavourable (1.38e-4)" "unprognostic (1.82e-2)" "unprognostic (1.09e-1)" "unprognostic (2.58e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "prognostic unfavourable (1.44e-10)" "unprognostic (2.83e-1)" "unprognostic (6.99e-2)" "unprognostic (2.03e-1)" "prognostic unfavourable (2.44e-4)" 29.2 47.6 16.6 24.2 19.6 30.1 34.8 13.2 21.4 34.3 30.5 23.3 52.6 24.0 38.3 70.3 35.1 29.5 34.8 36.3 14.2 14.1 52.9 105.7 38.7 53.0 19.1 14.7 33.3 72.2 38.2 28.7 110.3 19.8 33.3 34.7 43.1 64.6 49.1 32.9 26.0 43.2 30.2 15.6 47.5 35.7 43.5 14.5 27.9 56.8 26.4 42.3 27.8 27.7 48.1 96.3 55.8 70.1 60.8 72.3 92.9 36.5 33.1 34.7 46.2 48.2 36.2 68.9 48.5 57.7 62.2 52.9 105.0 64.3 28.7 59.4 62.5 53.5 35.9 57.7 56.7 13.3 22.2 32.8 38.7 70.0 46.6 51.7 55.0 34.1 57.7 49.3 51.3 59.6 50.3 93.6 43.5 33.1 29.8 52.8 28.0 47.1 27.1 64.4 94.1 42.6 34.9 28.7 30.7 58.8 142.0 56.4 70.1 87.1 38.5 70.7 43.1 36.8 42.1 56.3 67.2 30.2 69.3 35.1 57.0 55.8 70.1 45.1 62.8 66.6 72.3 48.1 59.2 62.8 78.7 37.4 53.8 55.5 13.0 60.8 53.7 96.3 52.9 92.9 16.6 19.6 13.2 21.4 14.2 14.1 19.1 14.7 19.8 14.5 RPRML MGC43894 ENSG00000179673 "Reprimo like" Q8N4K4 17 46978156-46979248 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 27.0" "Cell line enhanced" "Detected in some" "AF22: 2.6;Daudi: 15.8;HEK 293: 4.9;NTERA-2: 2.5;SCLC-21H: 2.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Group enriched" "Detected in many" 13 "amygdala: 44.0;basal ganglia: 29.6;cerebral cortex: 41.6;hippocampal formation: 38.9;olfactory region: 24.9" "Region enhanced" "Detected in many" "basal ganglia: 311.4" HPA062668 Uncertain "HPA062668: " "unprognostic (7.79e-4)" "unprognostic (1.66e-2)" "unprognostic (8.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.31e-1)" "unprognostic (8.93e-4)" "unprognostic (2.78e-2)" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" 0.8 0.6 6.6 0.6 27.0 0.6 0.8 3.6 16.5 0.6 0.8 0.0 0.0 0.8 0.6 2.5 0.6 0.7 0.6 0.6 4.9 1.3 0.7 0.6 0.6 0.6 0.8 10.1 0.6 0.6 0.6 0.1 0.6 0.0 0.8 0.6 0.4 0.7 0.6 3.9 1.0 0.8 0.6 0.0 0.7 1.3 0.7 2.7 0.0 0.6 0.0 0.6 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.5 0.6 0.9 0.3 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 27.0 3.6 11.6 4.9 1.3 0.8 10.1 0.0 2.7 RPS10 "MGC88819, S10" ENSG00000124614 "Ribosomal protein S10" P46783 6 34417454-34426125 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA047268, HPA048084" Approved Approved Cytosol 170000 Cytosol "HPA047268: , HPA048084: " "unprognostic (1.92e-1)" "unprognostic (1.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.78e-1)" "unprognostic (8.92e-3)" "unprognostic (3.79e-2)" "unprognostic (9.72e-3)" "unprognostic (1.93e-2)" "unprognostic (4.30e-3)" "unprognostic (2.04e-1)" "unprognostic (3.59e-1)" "unprognostic (3.82e-1)" "prognostic unfavourable (2.57e-6)" "unprognostic (4.98e-2)" "unprognostic (7.66e-2)" "unprognostic (1.94e-1)" "unprognostic (2.45e-1)" 84.5 76.6 68.1 142.7 49.5 158.8 142.0 35.9 54.3 130.3 132.7 48.2 97.2 65.1 149.8 103.9 169.7 113.6 74.7 84.9 51.3 44.1 80.7 122.5 96.3 180.1 54.8 31.9 189.4 323.2 20.3 59.1 88.0 39.5 129.7 64.5 59.4 248.9 75.5 153.2 131.9 76.4 105.6 49.4 132.5 85.3 66.7 41.0 110.5 151.0 158.8 127.4 127.1 169.7 150.1 105.0 31.6 61.5 83.1 176.2 227.6 99.0 64.2 66.8 151.4 115.1 169.8 110.5 81.7 113.1 135.1 97.8 155.7 50.6 191.5 84.7 90.5 74.8 124.6 139.8 81.4 80.3 222.1 85.7 70.8 147.5 159.3 135.4 92.2 187.6 243.7 94.6 179.7 117.8 146.0 97.1 100.9 154.6 110.1 203.5 100.7 94.7 104.4 78.2 180.6 101.5 109.6 111.7 68.4 58.7 99.1 226.2 128.8 347.0 80.8 60.9 78.0 69.3 132.7 80.4 179.0 160.5 33.2 176.1 109.3 31.6 61.5 18.8 78.9 50.6 116.3 150.1 136.2 111.1 88.7 147.7 176.2 136.7 13.6 83.1 47.2 105.0 90.2 227.6 68.1 49.5 35.9 54.3 51.3 44.1 54.8 31.9 39.5 41.0 RPS15A S15A ENSG00000134419 "Ribosomal protein S15a" P62244 16 18781295-18790383 "Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047103 Supported 22000000 "HPA047103: AB_10959516" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.53e-2)" "unprognostic (6.75e-2)" "unprognostic (5.40e-2)" "unprognostic (2.61e-1)" "unprognostic (3.96e-2)" "unprognostic (1.19e-1)" "unprognostic (4.18e-3)" "unprognostic (1.75e-1)" "prognostic unfavourable (7.29e-7)" "unprognostic (1.07e-1)" "unprognostic (2.02e-1)" "unprognostic (1.07e-1)" "unprognostic (6.32e-2)" 83.1 51.1 31.1 76.8 26.9 127.4 168.2 32.4 36.8 118.7 99.8 31.2 47.1 35.3 94.8 67.2 117.9 63.6 69.9 63.0 25.0 22.1 61.4 111.7 79.1 161.0 30.6 27.4 192.1 242.7 20.9 37.1 77.0 29.8 106.5 55.9 47.9 103.5 45.2 101.7 98.8 96.9 83.8 34.6 99.5 63.6 57.1 21.0 146.4 106.8 103.1 112.8 144.4 105.7 166.6 89.0 21.9 66.7 94.8 204.0 229.6 78.0 79.0 122.4 83.5 153.5 277.7 94.2 78.5 122.0 110.2 87.8 109.4 88.6 180.6 161.8 108.4 75.7 115.1 161.2 127.6 72.4 196.3 78.9 94.5 269.7 197.4 131.4 64.8 266.6 262.0 90.4 188.6 136.4 113.1 105.8 116.7 184.6 132.2 169.5 114.2 83.2 182.6 113.6 228.8 133.9 73.7 88.3 69.1 60.8 127.2 123.8 114.6 207.0 96.3 51.8 50.2 53.7 76.5 96.6 123.0 161.6 66.7 134.4 59.0 21.9 66.7 19.2 91.7 48.2 133.6 166.6 161.2 128.1 89.0 136.5 204.0 158.3 11.4 94.8 44.1 83.2 121.6 229.6 31.1 26.9 32.4 36.8 25.0 22.1 30.6 27.4 29.8 21.0 RPS6KA3 "CLS, HU-3, MRX19, RSK, RSK2" ENSG00000177189 "Ribosomal protein S6 kinase A3" P51812 X 20149911-20267519 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003221, CAB003853, CAB013520" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.80e-2)" "unprognostic (4.26e-2)" "unprognostic (3.53e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (1.61e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (5.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (4.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-1)" 19.7 12.5 9.9 23.0 12.5 8.2 16.5 15.2 12.1 11.4 23.2 4.4 22.1 13.7 12.4 10.1 13.6 12.7 15.7 21.3 9.7 8.8 14.1 25.8 21.6 34.0 9.9 10.0 12.7 14.0 36.6 9.8 11.0 10.2 14.5 18.8 7.7 14.3 11.3 45.2 11.7 23.7 16.1 11.7 25.8 11.8 4.8 9.7 29.4 13.5 15.0 18.2 20.3 19.0 4.2 8.6 12.5 6.9 8.3 11.3 2.7 12.6 22.2 8.4 4.3 8.2 14.5 2.5 11.0 16.8 8.2 11.3 25.1 16.4 8.3 3.8 11.5 9.0 9.6 9.3 15.3 7.0 7.6 9.8 14.0 67.5 8.4 19.0 10.2 9.2 7.5 12.9 16.3 29.8 6.4 23.9 8.6 6.0 12.3 5.8 6.0 13.4 6.6 17.8 9.6 7.1 10.6 3.9 3.8 14.8 4.5 16.0 0.0 5.7 16.6 9.0 6.3 28.5 6.2 19.1 11.6 9.3 17.0 9.5 21.2 12.5 4.7 9.5 6.3 6.9 11.3 2.9 7.3 6.9 7.0 4.2 5.0 6.0 7.5 8.3 6.9 8.6 3.5 2.7 9.9 12.5 15.2 12.1 9.7 8.8 9.9 10.0 10.2 9.7 RPTOR "KIAA1303, KOG1, Mip1, raptor" ENSG00000141564 "Regulatory associated protein of MTOR complex 1" Q8N122 17 80544819-80966371 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013514, HPA064306" Approved Enhanced Vesicles,Lysosomes "Vesicles, Lysosomes" "CAB013514: AB_2533523, HPA064306: " "unprognostic (5.09e-3)" "unprognostic (1.01e-1)" "unprognostic (1.79e-1)" "unprognostic (1.90e-1)" "unprognostic (1.38e-1)" "unprognostic (9.75e-2)" "unprognostic (3.34e-3)" "unprognostic (1.17e-2)" "unprognostic (9.63e-2)" "unprognostic (8.80e-2)" "unprognostic (4.40e-3)" "unprognostic (8.46e-2)" "unprognostic (6.03e-2)" "unprognostic (1.19e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-2)" "unprognostic (1.77e-2)" 13.6 12.3 10.5 11.1 14.5 10.2 9.3 17.5 21.0 12.6 13.1 19.0 9.6 12.2 15.0 9.3 14.2 12.5 8.0 15.5 10.8 10.5 8.3 12.9 11.0 9.0 12.2 9.9 12.8 9.8 14.3 14.1 9.7 12.7 12.0 7.4 15.2 10.4 13.9 23.7 12.3 11.0 13.6 9.5 11.6 11.1 10.3 12.7 16.7 10.2 11.1 11.9 14.3 10.5 2.1 1.9 3.1 2.4 1.7 3.8 1.2 9.6 19.3 4.6 8.2 6.6 5.7 8.6 7.3 6.7 11.6 8.7 15.1 8.6 8.1 5.8 8.9 5.9 7.4 9.8 6.6 2.9 12.0 12.5 10.7 13.6 6.7 11.2 8.9 8.4 6.7 11.9 6.9 11.5 15.5 3.3 6.5 5.3 10.7 4.7 4.9 15.5 5.1 8.4 6.6 3.4 11.0 9.1 9.2 8.9 14.3 8.1 9.3 8.2 5.2 24.5 10.4 7.7 9.3 5.2 1.9 8.0 14.9 5.9 14.9 3.1 0.9 0.0 3.8 2.4 2.5 2.1 1.6 1.8 1.9 1.1 2.3 2.2 0.0 1.7 1.3 1.1 3.6 1.2 10.5 14.5 17.5 21.0 10.8 10.5 12.2 9.9 12.7 12.7 RRBP1 "ES/130, hES" ENSG00000125844 "Ribosome binding protein 1" Q9P2E9 20 17613678-17682295 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 136.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 18.8;plasmacytoid DC: 23.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009026, HPA011924" Enhanced Enhanced "Endoplasmic reticulum" 44000 "Endoplasmic reticulum" "HPA009026: AB_1079852, HPA011924: AB_1856476" "unprognostic (1.56e-3)" "unprognostic (2.26e-3)" "unprognostic (8.46e-2)" "prognostic favourable (1.41e-4)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-2)" "unprognostic (3.03e-1)" "unprognostic (5.09e-2)" "unprognostic (6.63e-2)" "unprognostic (9.21e-3)" "unprognostic (1.54e-1)" "prognostic unfavourable (9.38e-4)" 19.9 18.3 6.7 16.1 11.2 5.9 13.8 4.9 7.4 22.1 23.6 17.8 49.5 18.5 16.3 24.4 17.1 12.3 37.3 15.8 7.8 6.3 27.1 88.9 20.5 10.6 13.0 5.6 23.4 136.1 24.7 18.4 51.4 10.4 19.4 16.7 14.8 84.2 56.0 7.7 11.0 32.2 13.0 13.3 20.4 30.0 12.1 12.2 5.0 32.8 11.6 19.2 18.7 18.9 0.9 23.5 18.8 4.7 5.7 2.5 1.5 31.0 22.2 6.7 14.9 30.8 33.3 35.1 48.8 41.1 20.7 28.1 49.3 29.4 12.0 16.5 46.0 31.4 7.1 39.6 16.9 5.6 5.5 13.9 6.4 50.9 44.2 5.1 17.5 44.0 11.9 33.4 19.8 20.3 5.8 11.7 30.9 14.1 2.0 11.7 7.8 21.5 3.6 17.7 41.3 17.4 10.6 3.4 2.5 27.7 65.9 20.0 11.5 7.8 36.4 44.2 16.5 22.9 16.0 21.6 16.3 3.9 16.7 5.6 22.4 5.4 4.7 18.8 2.5 2.9 1.7 0.5 0.8 1.4 2.4 0.9 0.8 0.9 4.2 5.7 4.0 23.5 0.7 1.5 6.7 11.2 4.9 7.4 7.8 6.3 13.0 5.6 10.4 12.2 RRM2 ENSG00000171848 "Ribonucleotide reductase regulatory subunit M2" P31350 2 10120698-10131419 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA replication" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 120.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in many" 6 "T-cells: 10.4" HPA056994 Enhanced Supported Cytosol Cytosol "HPA056994: " "unprognostic (2.10e-2)" "unprognostic (1.62e-1)" "unprognostic (6.40e-3)" "unprognostic (4.42e-3)" "unprognostic (5.70e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (1.39e-5)" "unprognostic (1.04e-3)" "unprognostic (6.67e-3)" "unprognostic (4.53e-2)" "prognostic unfavourable (1.62e-4)" "unprognostic (5.11e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (2.24e-1)" "unprognostic (1.38e-1)" "unprognostic (2.09e-2)" 4.7 2.2 0.4 32.6 0.4 29.0 4.2 0.4 0.9 3.5 9.3 0.4 0.4 5.2 2.1 1.7 21.6 0.7 5.0 3.3 0.4 0.5 2.0 3.9 5.7 16.4 0.6 0.1 0.9 2.9 0.0 0.7 5.4 0.3 1.0 10.6 0.1 2.9 0.0 0.5 2.8 11.3 3.2 0.8 19.8 5.4 8.0 0.0 120.9 0.8 22.3 33.1 3.8 5.2 1.4 0.3 0.6 0.2 1.8 10.4 2.6 29.1 17.7 25.0 17.1 2.2 4.1 24.8 47.7 23.6 34.1 37.1 29.5 14.0 26.8 6.6 14.9 14.3 40.5 24.6 41.8 60.0 15.6 51.6 17.0 26.0 0.1 38.2 24.8 1.4 0.5 41.7 3.5 27.5 21.6 79.5 42.4 22.0 42.2 20.5 20.2 20.7 31.8 54.6 18.4 16.7 22.2 24.8 20.4 39.2 27.9 4.8 15.0 6.9 9.6 26.1 38.0 19.5 66.8 51.6 40.5 54.7 18.5 32.4 37.5 0.3 0.1 0.1 3.7 0.0 0.0 1.4 2.6 2.9 0.2 0.4 0.2 1.2 0.6 1.8 0.2 0.3 10.4 2.6 0.4 0.4 0.4 0.9 0.4 0.5 0.6 0.1 0.3 0.0 RRM2B p53R2 ENSG00000048392 "Ribonucleotide reductase regulatory TP53 inducible subunit M2B" Q7LG56 8 102204502-102239118 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, DNA replication" Oxidoreductase "Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006854, HPA028812" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB006854: , HPA028812: AB_10602246" "unprognostic (7.76e-3)" "unprognostic (4.14e-2)" "unprognostic (9.41e-3)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "unprognostic (1.28e-1)" "unprognostic (5.51e-2)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (9.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-2)" "unprognostic (4.32e-1)" "unprognostic (1.47e-1)" "unprognostic (2.52e-1)" "unprognostic (7.17e-2)" 11.8 18.6 11.7 11.5 11.4 4.3 9.3 8.5 13.5 9.5 10.1 9.8 9.5 10.2 8.2 10.8 8.0 9.7 8.2 11.3 17.5 12.8 17.5 15.1 15.8 12.6 14.9 10.6 9.7 9.5 34.7 24.8 11.6 23.1 11.2 11.1 7.7 9.7 10.9 34.6 7.4 7.6 8.2 26.1 10.6 7.1 6.6 9.4 6.3 37.1 8.1 13.1 10.7 7.0 7.4 6.2 18.3 8.4 3.0 3.3 2.8 5.6 10.1 12.0 7.1 17.0 16.4 9.6 13.2 16.0 7.1 8.3 3.6 4.6 36.4 12.5 14.6 2.1 5.8 13.4 10.1 5.9 6.3 9.1 4.3 7.6 13.8 2.8 19.5 20.8 25.3 7.8 11.9 19.8 6.7 5.6 22.7 5.6 4.8 5.3 6.7 7.5 3.1 4.9 7.3 16.5 6.5 3.0 6.0 6.9 3.7 7.9 9.9 6.3 15.1 11.0 21.4 7.6 3.6 5.9 5.4 33.1 16.2 4.3 11.6 10.0 5.1 5.3 2.2 4.5 3.3 5.6 2.0 2.8 6.2 7.4 2.3 2.5 18.3 3.0 8.4 1.8 1.4 2.8 11.7 11.4 8.5 13.5 17.5 12.8 14.9 10.6 23.1 9.4 RRNAD1 "C1orf66, CGI-41, METTL25B" ENSG00000143303 "Ribosomal RNA adenine dimethylase domain containing 1" Q96FB5 1 156728442-156736960 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047426 Approved Approved Nucleoli,Cytosol Nucleoli Cytosol "HPA047426: " "unprognostic (2.12e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (5.60e-5)" "unprognostic (2.00e-1)" "unprognostic (1.86e-2)" "unprognostic (2.75e-1)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (1.98e-1)" "unprognostic (2.89e-3)" "unprognostic (2.24e-1)" "unprognostic (2.76e-1)" "unprognostic (2.14e-1)" "unprognostic (3.35e-2)" "unprognostic (1.49e-1)" "unprognostic (5.03e-3)" 14.1 19.4 12.4 22.6 19.0 8.7 19.1 15.3 18.8 17.6 25.7 20.8 31.2 22.5 20.3 22.9 18.4 24.4 20.2 12.5 13.3 10.9 15.9 25.8 14.5 14.4 19.9 14.5 24.5 29.2 24.3 18.8 20.5 16.1 21.8 14.8 20.2 22.5 24.5 21.9 23.9 26.6 12.9 14.7 18.5 19.3 25.9 17.7 11.9 30.3 13.5 15.9 21.7 27.9 4.9 5.9 7.0 4.0 6.5 8.6 2.9 5.9 11.8 8.7 8.5 23.6 10.8 13.3 4.5 13.8 7.8 5.9 6.3 27.5 10.2 13.5 7.1 25.5 12.2 10.6 3.1 20.1 10.2 6.1 11.1 4.7 14.8 9.0 16.8 16.7 20.3 7.7 14.8 6.5 14.6 22.9 4.1 14.4 4.6 10.7 10.1 3.6 7.6 5.8 23.5 9.2 6.4 11.4 16.4 8.0 16.4 9.7 21.7 19.5 6.2 4.8 6.0 7.5 6.0 26.8 26.2 12.5 5.4 10.2 5.8 6.7 3.3 4.7 6.8 2.5 6.9 3.4 6.6 4.8 5.9 4.9 5.3 6.0 7.0 6.5 4.0 2.2 8.6 2.9 12.4 19.0 15.3 18.8 13.3 10.9 19.9 14.5 16.1 17.7 RRP12 KIAA0690 ENSG00000052749 "Ribosomal RNA processing 12 homolog" Q5JTH9 10 97356358-97426076 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049945, HPA074403" Supported "Nucleoli,Vesicles,Plasma membrane,Cytosol" Nucleoli "Vesicles, Plasma membrane, Cytosol" "HPA049945: , HPA074403: " "unprognostic (2.79e-1)" "unprognostic (7.65e-2)" "unprognostic (5.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.42e-1)" "unprognostic (1.73e-1)" "prognostic unfavourable (3.12e-8)" "unprognostic (2.64e-1)" "unprognostic (1.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.94e-2)" "unprognostic (1.82e-1)" "prognostic unfavourable (2.54e-5)" "unprognostic (2.58e-2)" "unprognostic (3.32e-1)" "unprognostic (4.81e-2)" "unprognostic (6.99e-3)" 7.1 8.4 5.9 7.4 11.9 62.6 4.6 3.8 15.7 4.1 4.0 5.4 2.9 5.2 6.4 3.9 7.1 6.4 6.4 8.4 4.4 7.2 4.4 9.3 5.6 6.0 5.9 6.1 6.0 16.4 9.6 10.6 3.9 9.6 5.5 3.6 4.1 6.6 3.9 31.7 8.2 3.8 5.3 3.2 7.1 5.3 13.9 6.1 4.6 4.9 7.2 5.4 4.2 4.3 3.4 4.3 19.3 11.1 1.2 2.4 3.7 15.8 21.1 5.6 12.1 4.3 5.1 12.4 10.0 6.0 10.4 8.1 22.9 14.7 17.4 13.0 6.3 20.4 15.4 11.6 7.0 9.4 18.5 13.4 7.9 17.8 7.2 20.9 17.7 5.3 16.4 25.6 23.7 5.8 19.2 11.7 5.9 20.5 14.1 13.5 24.2 14.3 15.6 7.7 17.2 7.2 8.8 7.6 16.2 8.0 7.7 10.0 18.6 10.9 7.6 7.0 12.0 15.6 31.5 23.9 20.8 20.5 10.0 26.9 7.4 0.2 7.3 4.6 2.0 9.3 2.4 2.9 1.2 1.6 4.3 3.4 1.9 2.1 19.3 1.2 11.1 3.6 0.8 3.7 5.9 11.9 3.8 15.7 4.4 7.2 5.9 6.1 9.6 6.1 RTBDN FLJ36353 ENSG00000132026 Retbindin Q9BSG5 19 12825478-12835428 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 17.3;pituitary gland: 25.8;retina: 57.0" "Cell line enhanced" "Detected in some" "SCLC-21H: 8.0;SH-SY5Y: 5.3;U-266/84: 20.6;U-87 MG: 4.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 1.7;neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA052511 Approved "Endoplasmic reticulum" "Secreted in other tissues" "Endoplasmic reticulum" "HPA052511: " "unprognostic (4.55e-4)" "unprognostic (3.94e-3)" "unprognostic (2.18e-1)" "unprognostic (1.54e-4)" "unprognostic (3.33e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" "unprognostic (2.45e-2)" "unprognostic (2.02e-2)" "unprognostic (3.55e-1)" "unprognostic (6.48e-2)" "unprognostic (7.04e-3)" "unprognostic (7.66e-9)" "unprognostic (3.55e-2)" "unprognostic (1.00e-1)" "unprognostic (7.05e-2)" "unprognostic (2.24e-2)" 0.3 6.9 10.2 0.5 3.4 0.9 0.3 2.7 17.3 0.2 0.9 0.4 0.0 1.0 0.3 1.5 0.3 0.3 0.4 0.3 7.3 5.1 0.2 0.4 0.5 0.4 2.8 2.8 0.3 2.5 0.2 25.8 0.3 4.0 0.4 0.9 57.0 0.3 0.3 0.3 0.5 1.0 0.6 1.0 0.4 2.5 3.5 0.0 7.0 0.4 0.0 0.4 0.3 0.0 0.3 0.2 1.8 0.2 0.4 0.2 0.0 0.9 0.1 0.1 0.6 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.3 0.1 0.8 0.9 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.4 0.8 0.0 0.1 2.3 0.0 0.0 0.4 0.2 0.0 1.2 2.6 0.0 0.1 0.0 0.0 0.9 1.1 0.7 0.1 1.0 0.0 0.0 8.0 5.3 0.1 0.1 0.4 2.7 0.7 0.0 0.8 1.0 0.7 0.1 1.2 20.6 3.9 4.7 0.0 0.0 1.7 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.2 1.8 0.4 0.2 0.2 0.1 0.0 10.2 3.4 2.7 8.6 7.3 5.1 2.8 2.8 4.0 0.0 RTL1 "HUR1, Mar1, MART1, PEG11, SIRH2" ENSG00000254656 "Retrotransposon Gag like 1" A6NKG5 14 100880655-100884847 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 5.0;brain: 7.6;placenta: 8.3" "Cell line enriched" "Detected in some" 31 "SH-SY5Y: 118.2" "Cancer enhanced" "Detected in some" "melanoma: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 2.1" "HPA066979, HPA077601" Enhanced Approved Cytosol Cytosol "HPA066979: , HPA077601: " "unprognostic (1.61e-1)" "unprognostic (3.30e-1)" "unprognostic (1.26e-1)" "unprognostic (1.42e-3)" "unprognostic (2.10e-1)" 0.0 5.0 0.2 0.0 0.9 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 1.8 1.3 0.1 0.0 0.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTN2 "NSP2, NSPL1, SPG12" ENSG00000125744 "Reticulon 2" O75298 19 45485289-45497061 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "skeletal muscle: 155.7;tongue: 43.2" "Cell line enhanced" "Detected in many" "RH-30: 23.2;RT4: 23.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 9.1;eosinophil: 3.5;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 11 "dendritic cells: 2.4;granulocytes: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034941, HPA034948" Approved Approved "Nuclear speckles" 16000 "Nuclear speckles" "HPA034941: AB_10671358, HPA034948: " "unprognostic (3.08e-1)" "unprognostic (1.42e-1)" "unprognostic (6.68e-3)" "unprognostic (5.07e-3)" "unprognostic (1.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.89e-2)" "unprognostic (3.09e-1)" "unprognostic (6.44e-2)" "unprognostic (5.10e-3)" "unprognostic (2.96e-2)" "prognostic unfavourable (5.58e-6)" "unprognostic (4.34e-1)" "unprognostic (3.23e-1)" "unprognostic (2.21e-1)" "unprognostic (2.03e-1)" 3.4 3.1 6.9 1.9 9.0 1.3 3.4 5.9 10.4 2.5 4.2 1.0 3.7 1.8 3.4 6.7 5.4 2.0 3.5 5.4 7.4 4.8 1.4 1.7 2.6 2.2 4.8 3.7 1.0 2.5 2.2 1.6 11.4 4.6 5.1 1.6 2.6 6.5 4.8 155.7 2.6 1.8 3.3 1.4 2.6 1.9 1.2 1.0 0.0 1.8 43.2 3.5 4.2 1.5 0.1 2.4 9.1 0.5 0.3 0.0 0.5 1.9 2.6 4.5 3.5 7.8 9.6 8.9 4.4 10.5 2.7 5.3 5.3 1.7 1.7 6.1 4.7 3.7 2.9 2.1 0.8 4.0 4.3 11.6 1.9 3.9 3.4 0.7 13.2 10.5 1.1 1.2 2.2 5.0 6.3 3.2 8.1 1.5 0.0 2.1 3.3 3.4 2.0 23.2 9.3 1.5 23.0 12.7 12.2 0.9 21.4 6.7 16.8 4.6 4.4 7.8 2.4 0.2 0.9 1.8 4.3 3.8 2.1 2.7 3.9 9.1 0.2 3.5 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.3 0.5 2.4 0.0 0.5 6.9 9.0 5.9 10.4 7.4 4.8 4.8 3.7 4.6 1.0 RTN3 "ASYIP, HAP, NSPL2, NSPLII, RTN3-A1" ENSG00000133318 "Reticulon 3" O95197 11 63681446-63759891 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 122.2;brain: 149.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 122.2" "Group enriched" "Detected in all" 6 "granulocytes: 122.2;monocytes: 42.2" "Low region specificity" "Detected in all" "HPA015649, HPA015650" Enhanced Supported "Endoplasmic reticulum" 620000 "Endoplasmic reticulum" "HPA015649: AB_1856498, HPA015650: AB_1856499" "unprognostic (8.11e-3)" "unprognostic (8.51e-2)" "unprognostic (3.61e-2)" "unprognostic (7.88e-3)" "unprognostic (1.41e-1)" "unprognostic (1.74e-2)" "prognostic unfavourable (1.30e-6)" "unprognostic (5.49e-2)" "unprognostic (1.25e-1)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (1.07e-1)" "prognostic favourable (9.87e-4)" "unprognostic (1.60e-2)" "unprognostic (2.54e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-2)" 43.6 19.6 72.2 11.9 71.6 22.3 21.5 55.9 149.6 21.7 20.0 50.2 9.3 12.3 14.8 19.7 12.4 21.0 13.1 12.8 78.3 72.9 22.0 19.9 17.7 7.3 72.6 53.5 11.9 20.7 36.4 14.0 14.1 109.9 12.9 18.8 12.7 30.4 18.9 10.8 22.6 14.6 18.6 66.0 9.2 12.8 10.3 39.2 6.8 40.9 5.1 10.7 13.1 8.9 3.3 14.7 122.2 42.2 4.6 7.4 28.1 30.9 22.9 27.6 26.3 51.2 36.4 11.0 28.2 30.1 25.0 26.8 19.9 68.8 36.7 48.2 42.2 32.0 39.5 13.9 33.0 29.5 21.1 46.9 33.6 13.9 42.6 41.7 37.9 24.0 41.2 30.3 33.9 33.7 26.5 59.6 21.9 25.4 22.0 46.4 32.2 26.0 29.3 19.3 67.6 49.2 17.6 58.7 34.0 45.7 50.4 52.6 55.6 34.4 31.3 14.9 20.2 51.7 21.5 38.0 32.7 29.4 57.4 34.7 15.7 40.1 42.2 52.8 4.9 21.1 5.3 3.3 5.0 4.9 14.7 2.3 3.7 4.0 122.2 4.6 25.1 8.8 7.4 28.1 72.2 71.6 55.9 118.2 78.3 72.9 72.6 53.5 109.9 39.2 RTN4R NOGOR ENSG00000040608 "Reticulon 4 receptor" Q9BZR6 22 20241415-20283246 "Disease related genes, Predicted membrane proteins" Receptor "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 12.0;brain: 33.2" "Cell line enhanced" "Detected in many" "NB-4: 20.0;REH: 28.2;SCLC-21H: 17.2;SK-MEL-30: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 12.0" "Lineage enriched" "Detected in many" 9 "T-cells: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB012443 Supported "Plasma membrane,Actin filaments,Focal adhesion sites" 1300000 "Plasma membrane, Focal adhesion sites" "Actin filaments" "CAB012443: " "unprognostic (1.28e-1)" "unprognostic (1.28e-2)" "unprognostic (8.29e-2)" "unprognostic (6.58e-2)" "unprognostic (3.49e-1)" "prognostic unfavourable (7.73e-4)" "unprognostic (2.19e-1)" "unprognostic (1.56e-1)" "unprognostic (3.44e-1)" "unprognostic (8.90e-3)" "unprognostic (1.21e-2)" "unprognostic (9.89e-2)" "unprognostic (1.80e-2)" "unprognostic (1.34e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-2)" "unprognostic (3.07e-1)" 0.8 1.1 10.9 1.2 7.0 1.3 0.7 33.2 24.6 0.8 1.7 1.2 0.3 3.9 4.9 0.5 0.9 1.3 0.6 1.4 8.8 3.1 0.9 4.0 1.7 1.1 1.4 6.8 1.1 2.7 0.6 1.6 1.1 4.9 1.2 0.6 0.7 1.3 1.2 0.8 5.2 1.8 0.7 2.8 5.9 2.3 1.1 0.5 0.1 1.1 0.4 0.7 0.7 0.7 0.1 1.3 0.0 0.0 0.7 12.0 1.7 4.1 2.0 1.2 3.0 0.0 0.0 0.6 0.4 0.0 0.3 0.1 3.2 1.1 0.2 1.4 0.0 6.8 0.7 1.7 0.0 0.1 7.3 0.1 1.8 0.4 0.7 0.1 0.2 0.0 2.2 0.0 0.2 0.0 0.2 0.2 0.0 5.8 2.1 20.0 4.7 3.6 28.2 0.0 0.2 0.2 1.7 17.2 2.8 2.0 1.4 13.4 1.6 0.5 0.0 0.2 8.1 0.0 0.1 0.0 0.5 0.5 0.2 4.1 0.0 0.0 0.0 0.0 5.1 0.0 12.0 0.0 4.5 5.1 0.2 0.1 2.7 5.7 0.0 0.7 0.0 1.3 3.1 1.7 10.9 7.0 33.2 20.1 8.8 3.1 1.4 6.8 4.9 0.5 RTP3 "LTM1, TMEM7, Z3CXXC3" ENSG00000163825 "Receptor transporter protein 3" Q9BQQ7 3 46497491-46500949 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 91 "liver: 43.3" "Cell line enriched" "Detected in some" 9 "SiHa: 14.8" "Group enriched" "Detected in some" 17 "liver cancer: 22.9;testis cancer: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA075932 Uncertain Mitochondria Mitochondria "HPA075932: " "unprognostic (2.09e-1)" "unprognostic (1.64e-1)" "prognostic favourable (3.11e-6)" "unprognostic (1.08e-1)" "unprognostic (1.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTP4 "IFRG28, Z3CXXC4" ENSG00000136514 "Receptor transporter protein 4" Q96DX8 3 187368332-187372076 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 9.1;HDLM-2: 10.0;Karpas-707: 8.2;REH: 8.0;SK-MEL-30: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA064887, HPA071189" Uncertain Supported Nucleoplasm Nucleoplasm "HPA064887: , HPA071189: " "unprognostic (1.45e-2)" "unprognostic (2.46e-2)" "unprognostic (1.30e-1)" "unprognostic (1.44e-2)" "unprognostic (6.35e-2)" "unprognostic (3.24e-1)" "unprognostic (2.32e-1)" "unprognostic (3.78e-1)" "unprognostic (1.18e-1)" "unprognostic (6.87e-2)" "prognostic unfavourable (6.83e-4)" "unprognostic (1.34e-1)" "unprognostic (5.49e-2)" "unprognostic (3.44e-2)" "unprognostic (2.95e-2)" "prognostic favourable (4.35e-4)" "prognostic favourable (1.45e-4)" 7.7 4.6 3.2 6.9 3.6 0.7 5.9 1.0 3.1 8.1 13.3 6.0 3.8 9.2 6.7 7.1 6.2 11.3 7.6 2.9 3.1 3.0 8.6 8.8 8.0 12.0 3.8 3.0 6.4 9.7 0.3 3.0 5.9 3.3 10.1 6.1 7.7 10.8 5.6 0.9 2.2 23.2 5.2 5.4 13.5 8.0 1.9 1.5 16.8 10.5 4.3 8.6 10.5 4.7 5.1 6.0 4.7 10.5 12.4 16.2 5.6 2.5 0.0 0.0 0.0 1.2 4.3 0.1 0.0 1.0 1.7 1.5 0.0 9.1 1.2 0.0 1.0 3.0 0.0 0.1 0.0 10.0 0.0 0.0 0.0 0.1 1.6 0.0 2.3 1.0 0.0 0.3 0.0 0.3 0.0 8.2 0.0 0.0 5.8 0.0 0.0 0.0 8.0 0.0 6.6 2.1 6.5 0.0 0.0 0.0 0.2 15.5 0.0 4.0 0.1 0.1 0.2 0.0 0.1 6.6 2.1 0.0 0.0 2.2 5.0 4.7 6.9 4.7 10.4 8.5 10.2 5.1 8.3 9.4 6.0 4.8 6.4 7.4 2.1 12.4 10.5 0.1 16.2 5.6 3.2 3.6 1.0 3.1 3.1 3.0 3.8 3.0 3.3 1.5 RTP5 "C2orf85, CXXC11, FLJ33590, Z3CXXC5" ENSG00000188011 "Receptor transporter protein 5 (putative)" Q14D33 2 241869600-241873823 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 44.8" "Group enriched" "Detected in some" 29 "MOLT-4: 3.6;SCLC-21H: 7.2" "Cancer enriched" "Detected in single" 10 "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA050902 Enhanced "HPA050902: " "unprognostic (3.26e-2)" "unprognostic (5.38e-4)" "unprognostic (2.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.01e-1)" "unprognostic (9.40e-4)" "unprognostic (8.68e-3)" "unprognostic (2.04e-1)" "unprognostic (6.34e-4)" "unprognostic (3.30e-1)" "unprognostic (9.01e-3)" "unprognostic (3.91e-1)" "unprognostic (9.08e-8)" "unprognostic (1.81e-1)" "unprognostic (1.77e-1)" "unprognostic (2.68e-2)" "unprognostic (3.72e-2)" 0.8 0.8 27.9 1.1 44.8 1.9 0.7 0.2 13.5 0.7 0.7 2.1 0.0 0.9 0.7 0.7 0.7 0.7 0.8 0.8 32.9 24.9 0.7 0.7 0.8 2.4 3.1 4.8 0.7 0.9 0.7 0.0 0.7 7.3 0.7 0.7 0.0 0.9 0.7 0.7 0.7 0.7 0.7 2.1 1.1 0.8 0.7 1.5 0.0 0.7 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 44.8 0.2 12.7 32.9 24.9 3.1 4.8 7.3 1.5 RYK "D3S3195, JTK5, JTK5A, RYK1" ENSG00000163785 "Receptor-like tyrosine kinase" 3 134065303-134250744 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034117, HPA045503, HPA075430" Uncertain Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "CAB034117: AB_2183048, HPA045503: , HPA075430: " "unprognostic (7.84e-2)" "unprognostic (5.82e-2)" "unprognostic (2.22e-2)" "unprognostic (2.34e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.60e-4)" "unprognostic (2.60e-2)" "unprognostic (6.59e-2)" "unprognostic (1.62e-1)" "unprognostic (1.07e-3)" "unprognostic (9.66e-2)" "unprognostic (2.42e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-1)" "unprognostic (3.43e-1)" "unprognostic (2.85e-2)" 23.8 13.2 8.5 12.1 9.3 6.3 27.5 10.6 9.5 26.5 19.3 12.7 18.2 8.8 25.8 19.1 21.1 16.7 15.8 17.1 8.1 6.7 12.9 12.7 12.4 9.1 10.8 7.3 39.7 17.7 14.1 17.9 18.8 8.6 26.9 12.1 16.4 15.2 21.5 15.3 15.5 13.3 28.6 8.4 13.8 14.3 20.3 10.0 13.6 23.2 11.4 15.2 27.5 31.9 2.8 0.7 6.7 1.6 3.1 4.3 1.1 25.6 6.8 21.6 16.5 27.9 29.7 16.7 17.0 39.7 22.8 25.7 21.6 19.7 5.0 28.4 21.0 24.1 15.3 21.5 32.7 8.4 6.9 13.3 7.4 13.9 21.8 6.5 11.8 19.6 25.3 14.1 28.4 19.0 4.6 2.5 22.3 12.2 9.0 8.4 18.2 8.2 4.4 16.6 10.5 18.7 19.0 10.6 15.7 20.7 15.1 25.8 18.9 11.8 14.0 18.9 17.2 19.7 13.7 1.1 1.3 2.7 12.0 10.9 13.3 6.7 1.6 3.1 2.5 1.6 2.9 1.5 4.2 3.0 0.7 2.8 4.3 3.4 0.6 3.1 1.6 0.0 1.0 1.1 8.5 9.3 10.6 9.5 8.1 6.7 10.8 7.3 8.6 10.0 S100A10 "42C, ANX2LG, CAL1L, CLP11, P11" ENSG00000197747 "S100 calcium binding protein A10" P60903 1 151982915-151994390 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 148.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 148.1;monocytes: 89.2;T-cells: 85.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003340, CAB025484" Enhanced Approved Mitochondria 230000 Mitochondria "CAB025484: , HPA003340: AB_1856531" "unprognostic (2.13e-1)" "unprognostic (1.51e-3)" "unprognostic (1.01e-1)" "unprognostic (3.15e-1)" "unprognostic (6.20e-2)" "prognostic unfavourable (3.33e-4)" "prognostic unfavourable (1.00e-4)" "prognostic unfavourable (2.66e-5)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "prognostic unfavourable (3.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavourable (3.80e-8)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (3.84e-4)" 36.7 19.9 7.3 12.1 9.4 4.5 30.7 7.3 10.7 19.0 42.3 8.4 7.3 23.4 7.3 10.1 87.1 8.5 10.7 16.7 7.3 4.4 19.1 10.2 33.5 7.3 7.3 7.3 11.5 7.3 1.6 7.3 18.7 11.1 8.5 49.8 9.5 21.1 7.3 7.3 21.8 21.7 14.0 9.6 7.3 8.6 61.4 7.3 7.3 7.3 22.1 13.6 8.1 37.7 17.8 148.1 21.4 89.2 25.9 85.4 74.8 70.5 72.4 0.2 15.0 81.9 109.3 54.0 40.0 54.0 35.9 36.4 130.0 98.3 0.0 38.9 69.7 123.3 20.6 155.5 33.5 12.7 5.9 8.6 32.9 30.5 29.4 3.2 7.4 28.4 131.1 39.1 45.0 79.3 0.1 0.2 47.6 61.2 0.6 20.6 9.7 80.5 0.0 14.0 1.4 151.1 21.0 0.6 0.5 65.3 23.4 30.4 51.7 8.3 84.2 17.2 43.1 81.4 27.9 1.9 0.4 12.1 101.1 2.9 60.2 21.4 89.2 21.0 33.3 54.4 35.2 17.8 52.6 42.3 148.1 8.6 19.6 29.5 3.2 25.9 46.5 24.2 85.4 74.8 7.3 9.4 7.3 10.7 7.3 4.4 7.3 7.3 11.1 7.3 SAA2-SAA4 ENSG00000255071 "SAA2-SAA4 readthrough" 11 18231423-18248635 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 15.9;cervix, uterine: 10.6;liver: 44.4" "Cell line enhanced" "Detected in some" "A-431: 6.7;CAPAN-2: 1.5;EFO-21: 3.9;HaCaT: 2.7;RPTEC TERT1: 1.5;SiHa: 1.5" "Cancer enriched" "Detected in many" 13 "liver cancer: 39.9" "Cell type enriched" "Detected in single" 10 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 10 "B-cells: 1.0" HPA060139 Uncertain "HPA060139: " "prognostic favourable (4.56e-4)" "unprognostic (1.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (1.23e-3)" "unprognostic (9.41e-3)" "unprognostic (1.96e-2)" "unprognostic (1.96e-1)" "unprognostic (8.27e-3)" "unprognostic (3.17e-2)" "unprognostic (7.30e-2)" "prognostic unfavourable (2.92e-8)" "unprognostic (1.92e-1)" "unprognostic (2.72e-1)" 15.9 0.6 0.0 0.7 0.0 0.0 2.7 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 44.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.5 0.0 3.9 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAMD5 dJ875H10.1 ENSG00000203727 "Sterile alpha motif domain containing 5" Q5TGI4 6 147508927-147737547 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 8.5;Hep G2: 32.6;K-562: 21.9;RH-30: 15.4;WM-115: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067811 Uncertain Supported Vesicles Vesicles "HPA067811: " "unprognostic (4.16e-2)" "unprognostic (4.52e-2)" "unprognostic (9.65e-3)" "unprognostic (1.41e-2)" "unprognostic (1.82e-2)" "unprognostic (5.88e-2)" "prognostic unfavourable (2.23e-4)" "unprognostic (2.31e-1)" "unprognostic (1.54e-1)" "unprognostic (1.61e-2)" "unprognostic (8.55e-3)" "unprognostic (3.09e-2)" "unprognostic (5.40e-3)" "unprognostic (1.72e-1)" "unprognostic (4.51e-2)" "unprognostic (9.82e-3)" "unprognostic (1.50e-1)" 1.6 2.2 1.6 3.4 5.7 0.2 4.9 1.4 4.7 3.9 7.1 0.7 1.9 3.6 10.9 2.2 15.9 1.7 6.6 2.4 2.7 3.4 26.5 12.8 8.0 0.5 1.9 2.2 1.4 2.4 17.3 13.9 14.6 14.1 3.0 10.1 9.8 4.9 3.3 0.8 3.6 5.4 4.0 1.3 1.7 5.5 10.9 2.6 0.0 3.0 6.3 6.5 2.6 3.9 0.7 0.5 1.8 0.4 0.6 0.5 0.1 5.5 0.7 0.7 1.1 0.0 0.0 0.0 1.8 0.7 0.1 0.1 8.5 0.0 0.3 1.9 0.0 0.0 0.1 1.3 0.2 0.0 1.0 0.4 0.7 32.6 0.1 0.0 0.7 0.0 0.0 0.1 0.0 3.6 21.9 0.3 2.5 0.0 0.0 0.0 0.1 1.5 0.0 15.4 3.3 0.0 1.2 0.3 0.0 0.5 0.1 1.4 0.0 0.0 2.5 0.2 0.8 0.2 0.6 0.0 0.5 0.0 0.0 0.0 10.8 1.8 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.1 0.7 0.5 0.4 1.1 0.6 0.4 0.5 0.2 0.1 1.6 5.7 1.4 4.7 2.7 3.4 1.9 2.2 14.1 2.6 SARAF "MGC8721, TMEM66" ENSG00000133872 "Store-operated calcium entry associated regulatory factor" Q96BY9 8 30063012-30083208 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040400 Supported "Endoplasmic reticulum,Rods & Rings" 17000 "Endoplasmic reticulum" "Rods & Rings" "HPA040400: " "unprognostic (1.11e-1)" "unprognostic (4.78e-2)" "unprognostic (4.27e-3)" "unprognostic (1.38e-3)" "unprognostic (7.86e-3)" "unprognostic (1.91e-1)" "unprognostic (2.32e-1)" "prognostic favourable (5.28e-4)" "unprognostic (1.98e-1)" "unprognostic (1.74e-2)" "unprognostic (8.03e-2)" "unprognostic (6.70e-3)" "unprognostic (1.06e-2)" "unprognostic (5.09e-2)" "unprognostic (3.88e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-1)" 30.7 80.7 58.1 37.3 69.0 57.8 62.1 45.8 89.0 40.9 32.8 35.8 49.3 26.9 35.0 65.9 20.2 42.9 39.5 34.3 57.5 80.9 38.7 67.0 39.1 77.7 59.1 49.8 60.6 67.8 44.6 48.9 61.6 53.4 45.6 28.1 26.1 69.4 45.5 29.7 18.4 30.7 30.4 62.4 36.4 38.7 21.3 35.4 50.3 50.0 16.0 36.0 35.4 37.3 36.9 30.2 96.2 36.9 29.0 99.7 91.0 21.7 15.5 19.7 13.0 33.8 23.5 15.0 26.9 38.7 23.4 30.3 8.3 24.4 14.7 39.6 29.2 19.3 19.8 22.3 19.3 7.8 14.4 20.2 11.0 10.7 34.0 6.4 24.1 36.6 41.9 26.3 21.7 32.5 23.6 31.6 17.7 8.2 23.6 10.6 17.4 16.8 19.0 13.0 20.2 32.5 8.9 8.5 30.3 23.5 23.4 30.1 20.2 13.6 23.1 15.7 45.0 7.1 8.8 22.3 20.3 13.4 38.9 17.5 25.4 96.2 30.1 50.8 41.3 28.9 45.2 27.0 59.4 47.5 30.2 36.9 99.7 67.4 58.4 29.0 36.9 25.1 53.5 91.0 58.1 69.0 45.8 89.0 57.5 80.9 59.1 49.8 53.4 35.4 SAYSD1 "C6orf64, FLJ11101" ENSG00000112167 "SAYSVFN motif domain containing 1" Q9NPB0 6 39104064-39115189 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 52.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007959 Approved Supported Vesicles Vesicles "HPA007959: AB_1078359" "unprognostic (2.65e-1)" "unprognostic (1.49e-2)" "unprognostic (2.03e-2)" "unprognostic (2.58e-1)" "unprognostic (3.70e-1)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (1.96e-2)" "unprognostic (6.50e-2)" "unprognostic (1.82e-3)" "unprognostic (5.08e-2)" "unprognostic (9.90e-2)" "unprognostic (2.54e-2)" "unprognostic (1.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.27e-1)" "unprognostic (2.00e-3)" 8.2 7.2 7.2 5.7 8.7 5.9 11.2 7.1 9.0 7.9 7.3 8.1 6.9 8.8 7.9 10.5 6.5 8.1 9.3 6.7 7.3 6.9 8.1 8.3 6.3 8.2 9.3 6.5 8.4 9.5 4.9 6.1 6.1 7.0 8.5 7.2 6.4 11.1 8.0 5.6 6.6 8.6 6.3 7.0 6.8 6.9 52.7 7.3 18.2 8.4 5.1 9.0 6.2 7.7 14.8 9.3 19.4 12.2 11.7 19.1 9.5 11.4 7.4 6.7 7.9 11.1 14.7 6.9 5.3 5.8 6.4 6.8 10.6 8.2 10.4 7.7 6.9 7.9 5.8 5.0 6.8 6.5 10.5 6.8 4.5 9.2 9.0 7.7 10.3 10.1 12.4 2.5 6.4 5.9 11.5 6.4 7.2 15.7 12.2 12.8 5.8 3.8 1.7 8.2 4.1 13.4 8.1 18.9 7.6 9.2 8.0 8.1 13.1 10.2 7.6 8.5 6.2 2.6 6.8 0.1 3.2 12.8 4.9 11.2 6.2 7.6 9.0 19.4 12.2 12.2 14.2 13.1 13.3 11.0 9.3 14.8 19.1 15.8 4.3 11.7 11.9 7.4 17.3 9.5 7.2 8.7 7.1 9.0 7.3 6.9 9.3 6.5 7.0 7.3 SBK2 SGK069 ENSG00000187550 "SH3 domain binding kinase family member 2" P0C263 19 55529733-55537089 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 27 "heart muscle: 45.7;tongue: 20.8" "Cell line enhanced" "Detected in some" "A549: 4.3;Hep G2: 3.1;MCF7: 4.4;NTERA-2: 8.7;RH-30: 8.1;U-2 OS: 4.8" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030631 Enhanced "HPA030631: AB_10602088" "unprognostic (1.33e-1)" "unprognostic (1.85e-3)" "unprognostic (4.57e-1)" "unprognostic (3.49e-1)" "unprognostic (5.43e-3)" "unprognostic (4.18e-3)" "unprognostic (2.08e-1)" "unprognostic (6.58e-2)" "unprognostic (1.05e-1)" 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.1 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.7 20.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.4 1.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.3 4.4 0.0 0.0 8.7 0.0 0.0 8.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SBK3 SgK110 ENSG00000231274 "SH3 domain binding kinase family member 3" P0C264 19 55540656-55545543 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 24.2" "Cell line enhanced" "Detected in some" "A549: 9.2;CACO-2: 3.2;CAPAN-2: 5.4;NTERA-2: 2.5;RH-30: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA078322 Approved Mitochondria Mitochondria "HPA078322: " "unprognostic (2.15e-1)" "unprognostic (1.99e-3)" "unprognostic (2.71e-1)" "unprognostic (1.39e-3)" "unprognostic (7.52e-2)" "unprognostic (2.83e-1)" "unprognostic (5.47e-5)" "unprognostic (4.64e-3)" "unprognostic (7.24e-2)" "unprognostic (1.65e-1)" "unprognostic (3.38e-1)" "unprognostic (3.08e-3)" "unprognostic (1.21e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.79e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.1 24.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.8 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.3 3.2 5.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.0 0.0 0.0 2.5 0.6 0.2 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 1.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCAF11 "CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP" ENSG00000139218 "SR-related CTD associated factor 11" Q99590 12 45919131-45992120 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038862, HPA045456, HPA046345" Supported Enhanced "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA038862: AB_10672830, HPA045456: , HPA046345: " "unprognostic (2.83e-2)" "unprognostic (4.10e-2)" "unprognostic (2.01e-1)" "unprognostic (5.88e-2)" "unprognostic (1.19e-1)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (9.00e-2)" "unprognostic (1.37e-2)" "unprognostic (1.30e-2)" "unprognostic (4.10e-2)" "unprognostic (2.15e-2)" "unprognostic (6.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.76e-1)" "unprognostic (4.30e-2)" "unprognostic (4.13e-2)" 34.4 17.0 17.5 34.1 19.5 46.1 25.8 19.1 17.9 29.0 24.5 12.4 29.0 17.0 25.1 25.9 25.8 21.0 21.1 33.6 15.8 16.6 27.9 32.2 27.8 29.9 19.2 12.5 31.7 21.3 32.7 26.8 23.0 20.6 26.5 21.4 15.3 24.3 31.0 35.4 24.1 30.7 25.5 21.7 38.1 17.4 22.7 20.6 42.3 27.8 21.9 28.6 29.1 33.9 18.4 19.2 32.8 13.6 12.9 15.3 7.9 15.0 13.7 17.0 14.1 11.7 16.1 15.8 17.8 14.5 15.4 11.2 49.0 16.5 31.5 20.1 18.8 14.9 17.4 14.3 17.5 17.3 11.8 29.4 18.2 12.8 9.2 30.8 19.8 13.3 15.4 13.2 20.0 15.8 22.4 17.4 19.4 14.2 23.0 17.2 13.2 18.7 18.8 22.8 15.9 14.6 19.2 9.8 10.1 19.7 16.9 9.5 15.6 33.3 19.5 15.9 13.1 11.9 9.4 12.6 9.3 51.6 13.3 66.3 6.0 20.9 13.0 17.3 14.7 12.5 13.3 17.7 13.9 14.1 9.8 18.4 15.3 13.7 32.8 12.9 13.6 19.2 12.4 7.9 17.5 19.5 19.1 17.9 15.8 16.6 19.2 12.5 20.6 20.6 SCAMP4 FLJ33847 ENSG00000227500 "Secretory carrier membrane protein 4" Q969E2 19 1905214-1926013 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043284 Approved Approved "Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane" "Golgi apparatus, Vesicles" "Lipid droplets, Plasma membrane" "HPA043284: AB_10806501" "unprognostic (1.60e-1)" "unprognostic (3.62e-1)" "unprognostic (5.04e-2)" "prognostic favourable (4.40e-6)" "unprognostic (2.58e-1)" "unprognostic (4.58e-1)" "prognostic unfavourable (1.92e-5)" "unprognostic (2.04e-1)" "unprognostic (1.58e-1)" "unprognostic (2.55e-1)" "unprognostic (3.01e-3)" "unprognostic (5.66e-2)" "prognostic favourable (3.56e-4)" "unprognostic (6.16e-2)" "unprognostic (1.58e-1)" "unprognostic (3.93e-2)" "unprognostic (1.03e-1)" 17.3 16.5 17.1 16.0 21.7 10.2 18.4 16.5 28.2 19.5 13.2 46.3 21.1 19.3 16.3 20.4 22.0 37.2 19.4 8.5 19.3 19.5 19.9 21.5 19.3 13.9 22.1 14.6 23.7 28.0 12.7 23.2 24.2 27.6 19.5 9.8 21.4 41.1 21.4 9.1 19.2 18.9 12.1 42.1 17.2 21.8 15.9 20.3 10.3 23.8 10.6 18.2 15.7 13.9 6.4 14.2 2.5 5.9 7.1 5.0 3.7 22.8 22.9 10.4 25.4 21.0 13.1 12.5 14.9 13.9 16.3 19.9 18.6 22.1 9.4 14.5 11.9 27.4 9.9 15.1 6.1 14.8 8.9 6.5 8.1 17.8 27.0 6.5 10.1 20.1 9.6 14.2 8.6 11.1 14.8 10.7 9.4 27.4 8.7 12.7 17.1 7.7 10.9 7.6 14.2 20.1 20.3 14.8 19.5 9.4 22.7 12.4 22.1 17.1 11.8 20.1 13.9 35.9 15.7 26.0 25.6 8.4 26.6 11.0 12.9 1.9 5.2 2.0 5.0 5.9 2.7 6.4 3.5 3.2 5.7 4.6 2.1 3.7 2.5 7.1 5.0 14.2 2.7 3.7 17.1 21.7 16.5 28.2 19.3 19.5 22.1 14.6 27.6 20.3 SCAMP5 MGC24969 ENSG00000198794 "Secretory carrier membrane protein 5" Q8TAC9 15 74957219-75021496 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 39.4;SH-SY5Y: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 24 "plasmacytoid DC: 20.0" "Lineage enriched" "Detected in single" 24 "dendritic cells: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046645 Enhanced "HPA046645: AB_2679734" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-2)" "unprognostic (2.74e-1)" "unprognostic (4.46e-2)" "unprognostic (2.56e-1)" "unprognostic (4.13e-1)" "unprognostic (2.34e-1)" "unprognostic (8.37e-2)" "prognostic favourable (5.67e-5)" "unprognostic (9.82e-2)" "prognostic favourable (1.34e-6)" "unprognostic (7.27e-2)" "unprognostic (3.01e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-2)" 2.1 11.1 29.2 2.5 35.7 1.7 2.1 57.5 87.0 1.5 3.3 7.5 0.0 20.6 3.3 2.4 1.3 3.1 3.3 2.8 32.4 32.1 8.9 2.6 1.9 4.0 23.9 27.8 3.6 16.7 27.0 7.4 3.8 31.1 2.6 3.1 10.7 4.1 1.9 0.8 1.6 14.7 2.1 11.9 3.6 8.2 5.6 5.6 0.0 3.8 0.0 5.3 5.5 0.7 0.2 20.0 0.8 0.1 0.3 0.2 0.2 0.6 8.0 1.7 5.5 0.1 0.1 0.2 0.2 0.2 1.8 0.6 2.1 4.0 11.9 3.8 0.4 0.5 6.8 0.4 0.6 1.8 0.8 1.5 0.8 10.9 1.2 0.3 5.1 0.6 0.9 0.4 0.1 0.7 0.1 9.8 0.4 6.4 0.4 4.3 5.9 3.1 0.2 1.4 2.8 0.4 3.7 39.4 22.0 8.7 6.0 11.9 3.4 14.5 0.5 0.5 3.8 0.8 0.5 0.9 0.9 1.1 1.4 9.2 2.1 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.8 0.3 0.1 20.0 0.0 0.2 29.2 35.7 57.5 64.8 32.4 32.1 23.9 27.8 31.1 5.6 SCAP KIAA0199 ENSG00000114650 "SREBF chaperone" Q12770 3 47413694-47477126 "Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004713 Approved "HPA004713: AB_1079868" "unprognostic (4.02e-2)" "unprognostic (2.56e-1)" "unprognostic (1.91e-1)" "unprognostic (4.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.26e-1)" "unprognostic (8.74e-2)" "unprognostic (3.85e-2)" "unprognostic (1.28e-2)" "unprognostic (7.10e-2)" "prognostic favourable (7.14e-4)" "unprognostic (4.07e-2)" "prognostic favourable (4.33e-5)" "unprognostic (3.15e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (7.06e-3)" 11.1 47.4 15.9 10.7 21.4 11.3 15.0 23.7 28.7 13.8 18.2 22.6 13.9 17.8 17.7 14.8 17.8 16.0 14.5 10.9 16.9 11.5 13.5 34.1 11.3 17.1 15.6 12.2 18.8 22.1 26.3 15.2 16.9 17.3 13.1 16.0 19.3 16.0 14.2 15.6 26.2 17.1 14.9 11.6 15.0 15.5 19.5 18.5 18.8 15.4 9.4 12.0 18.5 13.6 6.7 7.7 18.3 6.4 7.5 10.5 4.7 10.5 14.9 16.2 24.9 29.3 15.5 28.7 10.3 15.3 17.3 16.4 19.8 17.3 17.5 15.1 17.6 11.4 22.6 21.8 18.0 12.0 16.3 30.2 20.9 21.3 28.5 18.0 18.1 19.4 23.4 21.9 24.2 14.7 20.5 12.2 13.9 14.8 19.7 26.7 16.8 22.2 11.6 14.8 21.0 13.7 20.8 11.2 20.8 15.2 19.3 10.0 16.8 19.9 12.6 16.0 19.1 21.9 14.4 12.1 13.1 10.2 15.1 16.7 11.7 5.8 6.4 6.7 7.8 5.7 10.5 6.6 6.6 7.0 7.7 6.7 7.5 7.3 18.3 7.5 4.5 6.2 8.0 4.7 15.9 21.4 23.7 28.7 16.9 11.5 15.6 12.2 17.3 18.5 SCARA3 "APC7, CSR, CSR1, MSLR1, MSRL1" ENSG00000168077 "Scavenger receptor class A member 3" Q6AZY7 8 27633868-27676776 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 52.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 49.6;HeLa: 54.6;HUVEC TERT2: 37.8;U-2 OS: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029861, HPA047386" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" "Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA029861: , HPA047386: " "unprognostic (2.24e-1)" "unprognostic (5.36e-3)" "unprognostic (2.68e-3)" "unprognostic (1.36e-1)" "unprognostic (1.48e-2)" "unprognostic (1.17e-1)" "unprognostic (4.31e-1)" "unprognostic (1.60e-1)" "unprognostic (3.58e-2)" "unprognostic (1.45e-1)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (3.41e-2)" "unprognostic (1.78e-2)" "unprognostic (4.95e-2)" "unprognostic (6.31e-3)" "unprognostic (6.03e-3)" 7.5 4.6 16.4 9.0 27.3 0.4 10.6 10.3 26.8 19.9 11.2 7.7 14.2 3.4 33.8 9.4 14.5 52.2 18.4 4.8 16.2 13.0 3.8 2.7 7.8 7.4 16.4 10.3 13.1 2.8 2.2 3.6 11.8 21.2 12.4 5.4 8.6 13.7 42.6 1.1 6.0 5.1 40.5 21.8 2.0 5.9 3.9 12.1 3.2 19.2 4.7 13.2 11.3 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 16.1 2.5 0.0 13.5 49.6 11.3 6.5 10.2 7.0 5.2 5.9 4.2 0.0 15.3 13.0 12.1 0.0 12.0 3.3 0.0 1.4 4.7 54.6 0.2 1.4 0.0 0.0 20.8 0.7 10.8 0.5 37.8 0.0 0.0 3.9 2.9 0.0 0.0 3.4 6.2 0.0 0.0 0.0 2.2 7.2 0.0 1.6 1.5 8.6 0.0 8.4 0.1 13.4 5.8 35.0 21.4 3.4 0.0 0.0 0.0 9.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 27.3 10.3 22.5 16.2 13.0 16.4 10.3 21.2 12.1 SCARA5 "FLJ23907, MGC45780, NET33" ENSG00000168079 "Scavenger receptor class A member 5" Q6ZMJ2 8 27869882-27992727 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Iron transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 20 "ASC diff: 72.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 117 "plasmacytoid DC: 17.3" "Lineage enriched" "Detected in single" 173 "dendritic cells: 17.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA024661 Approved 1500000 "HPA024661: AB_1853902" "unprognostic (2.76e-2)" "unprognostic (7.20e-3)" "unprognostic (1.44e-2)" "unprognostic (3.53e-2)" "unprognostic (2.34e-2)" "unprognostic (4.62e-2)" "unprognostic (2.01e-1)" "unprognostic (2.15e-1)" "unprognostic (9.13e-2)" "unprognostic (2.40e-1)" "unprognostic (4.21e-2)" "unprognostic (1.10e-1)" "unprognostic (7.09e-6)" "unprognostic (3.48e-2)" "unprognostic (2.29e-1)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" 26.9 1.7 0.7 4.6 0.5 0.0 18.5 0.6 1.1 9.2 17.3 0.4 14.3 3.8 2.3 31.0 23.6 8.8 13.5 42.4 0.7 0.1 0.8 1.6 8.2 3.6 2.8 0.6 5.2 2.6 0.0 2.3 18.5 4.1 9.8 16.4 34.3 11.4 3.6 6.1 13.0 9.8 37.2 1.4 1.1 11.0 12.3 0.3 0.5 9.1 15.9 2.2 28.4 54.6 0.0 17.3 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 72.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.1 0.7 0.5 0.6 1.1 0.7 0.1 2.8 0.6 4.1 0.3 SCARB1 "CD36L1, CLA-1, CLA1, SR-BI, SRB1" ENSG00000073060 "Scavenger receptor class B member 1" Q8WTV0 12 124776856-124882668 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 173.1;liver: 93.7;placenta: 65.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 24.9" "Group enriched" "Detected in many" 5 "dendritic cells: 24.9;monocytes: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066285, CAB070124, HPA072449" Enhanced Approved Vesicles Vesicles "CAB070124: AB_10107658, HPA066285: , HPA072449: " "unprognostic (9.70e-3)" "unprognostic (4.94e-3)" "unprognostic (1.32e-1)" "unprognostic (4.79e-2)" "unprognostic (1.65e-3)" "unprognostic (4.21e-3)" "prognostic unfavourable (1.83e-5)" "prognostic unfavourable (4.02e-4)" "unprognostic (2.30e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-2)" "unprognostic (4.99e-2)" "prognostic unfavourable (1.49e-5)" "unprognostic (3.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.81e-1)" "unprognostic (4.13e-1)" 21.2 173.1 7.9 3.5 21.4 1.8 25.0 4.3 10.1 4.7 28.6 13.4 1.1 8.8 4.3 3.5 2.8 4.7 8.0 3.2 7.4 5.1 2.2 93.7 5.8 5.3 6.3 5.1 14.3 2.9 3.3 4.4 65.9 9.4 4.3 4.9 10.7 8.6 2.3 3.0 6.3 21.3 4.4 5.7 5.0 2.7 7.7 11.4 0.5 4.0 1.1 5.6 3.6 10.0 3.1 24.9 1.2 6.5 0.2 0.4 2.5 9.1 22.2 7.2 28.5 4.8 10.3 0.0 6.4 7.4 8.0 5.1 26.5 29.3 26.5 18.7 4.4 14.0 18.4 43.4 3.8 12.6 18.6 7.4 21.9 42.7 16.3 12.7 6.5 17.6 8.8 15.3 10.9 21.9 14.1 11.4 1.4 18.2 3.9 17.1 6.6 23.0 16.6 5.8 53.0 0.7 12.8 13.6 5.3 35.2 47.5 32.9 26.6 14.5 2.1 1.3 8.7 6.5 10.0 2.7 1.1 4.4 5.2 15.5 12.5 0.0 6.5 0.0 0.2 3.7 0.2 3.1 0.1 0.4 8.2 1.7 0.1 0.1 1.2 0.2 0.5 24.9 0.0 2.5 7.9 21.4 4.3 10.1 7.4 5.1 6.3 5.1 9.4 11.4 SCARB2 "CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII" ENSG00000138760 "Scavenger receptor class B member 2" Q14108 4 76158733-76234536 "Disease related genes, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 87.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 18.3;granulocytes: 6.2;monocytes: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015415, HPA018014" Supported Approved Cytosol Cytosol "CAB015415: AB_831511, HPA018014: AB_1852881" "prognostic unfavourable (2.82e-5)" "unprognostic (2.73e-2)" "unprognostic (4.09e-2)" "unprognostic (4.96e-2)" "unprognostic (4.17e-3)" "unprognostic (1.12e-3)" "unprognostic (2.08e-1)" "unprognostic (5.48e-2)" "unprognostic (4.06e-1)" "unprognostic (1.25e-2)" "unprognostic (4.11e-2)" "unprognostic (1.67e-1)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (6.88e-2)" "unprognostic (5.06e-2)" "unprognostic (3.89e-2)" 33.6 20.6 30.7 13.0 32.9 4.1 34.1 22.9 42.8 40.1 34.9 63.7 21.4 22.7 26.8 37.0 20.3 24.9 34.5 29.7 35.7 30.3 29.0 51.6 43.8 21.7 43.9 31.6 37.0 32.3 47.5 14.5 41.0 44.1 44.2 32.7 23.1 40.3 34.1 54.3 16.5 27.6 24.4 70.5 26.7 36.1 16.1 40.7 6.2 39.2 16.5 10.8 31.7 40.3 2.6 18.3 6.2 15.3 0.7 3.0 3.6 5.6 4.5 7.1 13.8 87.5 42.7 6.1 19.2 44.0 16.7 31.2 8.1 15.8 0.0 15.2 41.0 4.8 5.1 11.9 17.8 24.6 5.7 0.5 4.1 3.8 21.4 3.0 2.0 31.6 12.0 17.8 10.2 29.9 2.7 28.9 25.8 8.7 0.2 0.6 1.6 4.4 3.6 14.6 4.9 11.8 3.8 17.0 17.6 16.4 11.4 16.5 5.1 2.9 19.7 17.0 8.5 14.0 5.9 26.9 16.9 0.0 19.7 3.9 25.0 6.2 8.8 2.1 1.8 15.3 1.9 2.6 1.5 1.1 5.2 2.0 1.8 3.0 1.5 0.7 14.7 18.3 1.8 3.6 30.7 32.9 22.9 41.1 35.7 30.3 43.9 31.6 44.1 40.7 SCARF2 "HUMZD58C02, SREC-II, SREC2" ENSG00000244486 "Scavenger receptor class F member 2" Q96GP6 22 20424815-20437826 "Disease related genes, Predicted membrane proteins" "Cell adhesion" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 13.9;SH-SY5Y: 15.5;SK-MEL-30: 15.4;U-138 MG: 21.4;U-2 OS: 22.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035079 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" 360000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA035079: AB_10670287" "unprognostic (2.12e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-3)" "unprognostic (2.29e-1)" "unprognostic (2.92e-1)" "unprognostic (7.68e-2)" "unprognostic (7.87e-2)" "unprognostic (8.27e-2)" "unprognostic (2.18e-2)" "unprognostic (1.68e-1)" "unprognostic (2.94e-1)" "prognostic unfavourable (2.78e-5)" "unprognostic (4.38e-3)" "unprognostic (3.18e-2)" "unprognostic (3.00e-3)" "prognostic unfavourable (4.28e-4)" 6.5 2.4 0.0 4.1 0.3 0.1 9.2 0.0 1.2 10.6 3.2 0.4 2.9 1.4 8.1 6.6 1.8 2.6 11.3 3.4 0.6 3.2 1.1 5.9 5.1 0.8 0.4 12.6 1.6 0.0 0.6 5.6 0.9 5.5 0.0 9.2 1.1 6.8 1.8 2.2 1.9 9.9 0.5 5.3 1.4 2.5 0.0 0.0 5.4 3.3 1.4 7.1 10.9 0.1 0.1 0.9 0.0 0.0 1.8 0.0 0.4 0.2 3.1 5.4 1.9 2.6 1.2 13.9 5.7 3.3 1.7 0.0 0.0 0.2 8.1 6.7 0.1 1.8 0.0 0.4 0.4 11.7 1.1 0.2 2.5 11.6 0.0 0.6 4.6 0.0 1.6 0.8 1.7 0.1 0.1 1.2 0.5 0.0 0.2 4.2 1.8 0.3 8.9 0.0 0.0 0.0 1.3 15.5 0.0 0.0 15.4 0.5 0.0 2.0 21.4 22.4 0.5 3.1 0.6 0.2 0.2 0.1 0.3 10.6 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 1.8 0.0 SCART1 CD163c-alpha ENSG00000214279 "Scavenger receptor family member expressed on T cells 1" Q4G0T1 10 133453928-133523558 "Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.6" "Group enriched" "Detected in some" 5 "HMC-1: 7.1;NB-4: 6.5;THP-1: 2.1;U-266/84: 7.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA043101 Supported "HPA043101: AB_10797026" "unprognostic (4.32e-2)" "unprognostic (2.15e-2)" "unprognostic (1.13e-2)" "unprognostic (2.40e-2)" "unprognostic (7.42e-2)" "unprognostic (8.20e-4)" "unprognostic (1.29e-3)" "unprognostic (4.28e-3)" "unprognostic (2.63e-2)" "unprognostic (1.68e-1)" "unprognostic (2.91e-1)" "unprognostic (2.24e-2)" "unprognostic (6.24e-5)" "unprognostic (8.53e-2)" "unprognostic (1.25e-1)" "unprognostic (5.03e-2)" "unprognostic (1.94e-1)" 0.3 0.2 0.0 0.3 0.5 1.6 0.0 0.4 4.8 0.1 0.3 0.2 0.0 1.3 0.9 0.0 0.4 0.0 0.9 0.0 5.6 0.7 0.2 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.3 0.3 0.0 0.2 0.8 0.4 0.2 0.2 0.7 1.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.1 0.2 0.2 0.0 0.4 0.3 0.8 0.4 0.2 1.2 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.2 0.0 0.3 0.4 0.8 0.1 0.0 0.0 0.2 7.1 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.1 0.3 0.3 6.5 0.2 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.1 0.0 0.1 0.4 0.0 0.4 0.5 7.1 1.1 0.0 0.0 0.3 0.8 0.2 0.3 0.3 0.1 1.2 0.3 0.4 0.6 0.1 0.4 0.3 0.4 0.2 0.2 0.4 0.3 0.1 0.0 SCCPDH "CGI-49, NET11" ENSG00000143653 "Saccharopine dehydrogenase (putative)" Q8NBX0 1 246724047-246768137 "Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 95.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 17 "basophil: 95.3" "Lineage enriched" "Detected in all" 22 "granulocytes: 95.3" "Low region specificity" "Detected in all" "HPA050775, HPA076030" Enhanced Approved Vesicles 2100000 Vesicles "HPA050775: , HPA076030: " "unprognostic (4.25e-1)" "unprognostic (3.11e-1)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (2.83e-2)" "unprognostic (6.43e-2)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (5.51e-2)" "unprognostic (1.93e-1)" "unprognostic (3.60e-1)" "unprognostic (2.70e-2)" "unprognostic (9.63e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.93e-2)" 14.1 25.8 15.7 6.4 17.5 13.4 11.3 11.3 20.5 10.9 11.7 24.7 8.5 15.1 12.0 8.5 4.8 14.4 9.7 15.8 15.6 19.8 23.0 67.3 9.3 7.3 26.1 15.0 10.6 12.7 15.0 12.7 14.1 21.7 18.1 12.2 7.3 7.4 16.7 23.9 10.7 15.3 10.8 62.1 5.1 12.4 65.1 17.5 8.5 18.2 7.3 4.8 25.0 13.2 1.4 2.3 95.3 3.2 4.2 3.0 2.1 12.8 12.6 9.2 5.5 11.0 14.0 0.1 10.1 14.1 17.1 14.3 7.7 36.3 6.8 13.3 11.6 4.2 7.8 3.0 17.6 9.5 2.8 11.6 11.5 15.3 10.4 22.5 10.0 9.3 1.4 11.5 1.2 18.3 14.4 0.0 17.0 3.1 23.4 28.6 13.8 10.0 19.7 11.8 0.0 52.5 30.4 10.5 11.8 13.7 0.6 8.9 10.2 23.5 11.9 7.9 7.1 19.2 26.0 34.1 11.7 4.1 13.5 30.7 10.4 95.3 3.2 5.5 2.5 2.8 3.0 1.4 0.7 2.1 1.3 1.1 1.0 3.0 0.8 4.2 1.8 2.3 0.5 2.1 15.7 17.5 11.3 20.5 15.6 19.8 26.1 15.0 21.7 17.5 SCIMP "C17orf87, DTFT5783, FLJ32580, MGC163426, MGC163428, UNQ5783" ENSG00000161929 "SLP adaptor and CSK interacting membrane protein" Q6UWF3 17 5208961-5234860 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 49.6;lymphoid tissue: 84.9" "Cell line enhanced" "Detected in many" "HeLa: 6.8;U-698: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "classical monocyte: 22.3;intermediate monocyte: 47.8;memory B-cell: 30.6;myeloid DC: 16.8;naive B-cell: 23.0;non-classical monocyte: 49.6" "Group enriched" "Detected in many" 8 "B-cells: 30.6;dendritic cells: 16.8;monocytes: 49.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006117 Enhanced "HPA006117: AB_1858633" "unprognostic (2.53e-2)" "unprognostic (7.88e-3)" "unprognostic (1.26e-2)" "unprognostic (5.79e-3)" "unprognostic (1.10e-1)" "unprognostic (3.87e-2)" "unprognostic (7.96e-2)" "unprognostic (1.73e-2)" "unprognostic (4.93e-2)" "unprognostic (2.99e-1)" "unprognostic (1.35e-1)" "unprognostic (8.05e-2)" "unprognostic (3.33e-2)" "unprognostic (2.07e-1)" "unprognostic (4.42e-2)" "unprognostic (1.77e-1)" "unprognostic (9.95e-2)" 6.1 2.8 1.3 19.5 1.5 1.7 1.7 0.9 1.1 1.5 2.3 3.2 0.2 2.0 1.4 2.2 3.8 2.0 3.1 2.5 1.3 1.5 3.2 10.0 10.8 55.1 2.1 0.2 2.4 1.6 0.0 1.5 2.2 3.6 1.9 1.8 2.2 4.5 0.2 1.4 1.1 9.9 2.3 3.9 84.9 1.8 1.0 1.0 3.0 1.5 0.7 31.9 3.6 1.3 30.6 16.8 4.0 49.6 1.1 0.4 11.1 1.2 2.0 3.1 4.6 0.1 0.0 3.4 1.4 0.0 0.0 0.0 0.9 2.7 6.3 1.3 0.0 1.5 0.0 0.0 0.0 0.8 2.8 2.4 6.8 0.8 0.0 0.4 1.0 0.0 0.3 0.0 0.3 0.0 0.1 1.7 0.0 2.0 3.0 1.0 1.4 2.0 2.7 0.7 0.7 0.0 0.8 2.4 1.1 2.4 0.8 1.7 3.4 3.1 0.4 0.5 1.7 1.9 0.8 1.0 0.5 14.0 1.9 0.7 0.9 2.5 22.3 0.5 0.3 47.8 0.3 30.6 0.2 0.2 16.8 23.0 0.4 0.3 4.0 1.1 49.6 0.7 0.2 11.1 1.3 1.5 0.9 1.1 1.3 1.5 2.1 0.2 3.6 1.0 SCN3A Nav1.3 ENSG00000153253 "Sodium voltage-gated channel alpha subunit 3" Q9NY46 2 165087522-165204067 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 13.6;brain: 28.5;pituitary gland: 13.7" "Cell line enhanced" "Detected in some" "Karpas-707: 8.5;MOLT-4: 24.1;RPTEC TERT1: 12.1;SH-SY5Y: 5.4" "Cancer enriched" "Detected in some" 6 "glioma: 3.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "memory B-cell: 8.4;naive B-cell: 13.6" "Lineage enriched" "Detected in single" 38 "B-cells: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035396 Approved "HPA035396: " "unprognostic (1.80e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (1.50e-2)" "unprognostic (6.69e-2)" "unprognostic (1.10e-2)" "unprognostic (4.96e-4)" "unprognostic (2.46e-1)" "unprognostic (1.48e-1)" "unprognostic (1.90e-1)" "unprognostic (1.21e-4)" "unprognostic (4.55e-2)" "unprognostic (5.87e-3)" "unprognostic (2.88e-2)" "unprognostic (6.85e-2)" "unprognostic (2.66e-1)" "unprognostic (4.93e-2)" 2.6 4.0 16.7 1.9 28.5 1.0 2.5 19.6 19.7 2.1 2.1 0.8 0.0 1.2 1.4 0.7 1.5 1.4 1.8 2.1 9.8 11.3 1.8 1.0 1.0 2.7 4.8 9.8 1.8 1.7 2.3 13.7 0.8 9.1 0.9 2.1 0.0 0.7 1.4 0.9 0.5 1.9 1.7 4.0 1.8 2.7 1.8 4.9 2.0 1.3 0.0 3.5 1.7 0.5 13.6 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 2.3 0.0 0.0 0.1 0.0 0.0 0.2 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.1 0.0 24.1 0.0 0.0 2.0 0.1 1.1 0.0 12.1 0.0 3.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.7 0.0 1.3 0.4 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 13.6 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.1 16.7 28.5 19.6 17.2 9.8 11.3 4.8 9.8 9.1 4.9 SCN3B HSA243396 ENSG00000166257 "Sodium voltage-gated channel beta subunit 3" Q9NY72 11 123629187-123655244 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 70.3" "Group enriched" "Detected in some" 4 "CACO-2: 2.9;hTCEpi: 9.4;RH-30: 4.2;SCLC-21H: 9.4;SH-SY5Y: 7.0" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041707 Approved "Intermediate filaments,Cytosol" "Intermediate filaments" Cytosol "HPA041707: " "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (8.13e-4)" "unprognostic (3.93e-3)" "unprognostic (7.05e-2)" "unprognostic (3.29e-3)" "unprognostic (5.64e-2)" "unprognostic (3.34e-4)" "unprognostic (1.72e-1)" "unprognostic (1.13e-2)" "unprognostic (9.16e-4)" "unprognostic (4.01e-1)" "unprognostic (1.89e-4)" "unprognostic (2.01e-2)" "unprognostic (9.01e-2)" "unprognostic (8.23e-2)" "unprognostic (1.43e-2)" 2.2 8.5 17.7 1.5 23.5 1.3 2.0 2.8 70.3 1.6 1.5 1.2 0.0 1.6 1.5 1.5 1.5 1.8 1.4 1.9 26.2 13.2 1.6 1.0 1.4 1.2 5.2 18.8 1.7 1.9 3.9 12.6 1.1 3.8 1.8 1.6 3.7 1.2 1.4 5.8 1.7 1.5 2.1 1.5 1.3 1.4 2.2 1.2 0.0 3.7 0.0 1.2 1.1 0.4 1.2 1.3 2.7 0.6 1.1 0.8 0.1 0.0 0.2 0.3 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.0 2.9 0.1 0.3 1.4 0.4 0.2 1.0 0.1 0.1 0.1 0.6 0.0 0.5 0.3 0.1 0.0 0.5 0.4 9.4 0.1 0.1 0.3 0.4 0.5 0.0 0.1 0.1 0.2 0.8 0.1 0.2 4.2 0.0 0.0 0.2 9.4 7.0 0.6 0.1 0.0 0.0 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.6 0.6 0.5 0.6 0.4 0.4 0.7 0.7 0.7 0.3 1.2 0.5 0.8 2.7 1.1 0.5 1.3 0.4 0.1 17.7 23.5 2.8 39.5 26.2 13.2 5.2 18.8 3.8 1.2 SCN4B LQT10 ENSG00000177098 "Sodium voltage-gated channel beta subunit 4" Q8IWT1 11 118133377-118152888 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;skeletal muscle: 25.6" "Cell line enhanced" "Detected in some" "AN3-CA: 3.8;HBEC3-KT: 2.9;NTERA-2: 4.3;SH-SY5Y: 1.7;U-2 OS: 3.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 11 "basal ganglia: 731.2" "Region enhanced" "Detected in many" "basal ganglia: 122.8" HPA017293 Approved "HPA017293: AB_2184174" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.07e-1)" "unprognostic (9.82e-3)" "unprognostic (9.17e-3)" "unprognostic (1.20e-2)" "unprognostic (1.23e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-2)" "unprognostic (1.07e-1)" "unprognostic (2.07e-2)" "unprognostic (2.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.31e-4)" 20.5 5.4 1.9 1.2 36.4 0.1 6.1 11.7 21.7 2.4 2.6 2.0 0.5 2.4 3.7 1.8 5.4 5.5 3.2 11.0 3.1 2.9 1.4 0.6 8.7 2.0 5.3 2.1 0.7 5.0 6.4 2.4 1.9 28.7 2.1 2.2 4.3 2.8 2.6 25.6 3.8 4.6 7.0 5.5 0.5 3.0 0.8 8.7 1.5 10.4 9.5 1.1 3.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.3 2.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 36.4 11.7 21.7 3.1 2.9 5.3 2.1 28.7 8.7 SCNN1A "ENaCalpha, SCNN1" ENSG00000111319 "Sodium channel epithelial 1 alpha subunit" P37088 12 6346843-6377730 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 100.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 70.2;HBEC3-KT: 47.1;hTCEpi: 20.2;RPTEC TERT1: 24.6;RT4: 26.4;SK-BR-3: 22.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 8 "pons and medulla: 9.4" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 1.7;neutrophil: 4.4;plasmacytoid DC: 3.0;T-reg: 1.3" "Group enriched" "Detected in many" 5 "dendritic cells: 3.0;granulocytes: 4.4;T-cells: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA012743 Enhanced "HPA012743: AB_1856627" "unprognostic (1.68e-1)" "unprognostic (4.16e-2)" "unprognostic (1.62e-1)" "unprognostic (2.19e-1)" "unprognostic (5.16e-2)" "unprognostic (6.77e-3)" "unprognostic (3.09e-2)" "unprognostic (2.62e-2)" "unprognostic (5.13e-2)" "prognostic unfavourable (8.86e-4)" "prognostic unfavourable (2.30e-4)" "unprognostic (5.56e-2)" "prognostic favourable (9.21e-8)" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.01e-2)" 0.9 3.7 0.4 7.5 0.4 0.0 10.1 0.4 0.9 22.0 20.6 2.2 60.9 5.6 8.1 15.7 47.3 19.3 7.0 0.4 1.1 0.1 100.4 2.2 53.6 0.4 0.5 0.4 5.9 14.2 0.0 10.2 1.6 9.4 15.0 21.5 6.2 53.1 55.5 0.6 14.4 11.8 1.0 0.4 0.4 20.3 2.8 0.4 0.9 74.7 21.1 41.3 10.3 13.8 0.0 3.0 4.4 0.5 0.0 1.7 0.3 4.9 0.9 0.0 0.4 0.0 0.1 4.2 0.0 0.0 0.0 0.0 1.4 70.2 0.0 0.1 0.0 3.2 0.0 47.1 0.0 0.0 0.0 0.0 3.9 0.7 5.1 0.0 0.0 1.2 20.2 0.0 14.8 0.0 0.0 0.0 0.1 0.4 0.0 0.0 4.1 0.1 0.0 0.0 0.1 24.6 26.4 0.2 0.0 0.5 22.8 0.0 5.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.0 0.0 0.2 0.6 0.5 0.0 1.7 0.3 4.4 0.0 0.1 3.0 1.3 0.3 0.4 0.4 0.4 0.9 1.1 0.1 0.5 0.4 9.4 0.4 SCNN1D "dNaCh, ENaCdelta" ENSG00000162572 "Sodium channel epithelial 1 delta subunit" P51172 1 1280436-1292029 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 11.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA026884 Enhanced Supported "Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" "HPA026884: AB_10601501" "unprognostic (2.08e-2)" "unprognostic (2.08e-1)" "unprognostic (7.39e-4)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic favourable (1.60e-4)" "unprognostic (1.44e-2)" "unprognostic (1.81e-1)" "unprognostic (2.08e-2)" "unprognostic (1.14e-1)" "prognostic favourable (1.32e-4)" "unprognostic (5.27e-2)" "prognostic unfavourable (6.67e-5)" "unprognostic (3.13e-1)" "unprognostic (4.18e-2)" "unprognostic (2.13e-1)" "unprognostic (7.06e-2)" 3.2 3.8 4.0 1.9 5.1 3.6 1.2 12.8 6.3 1.7 2.0 7.0 3.2 1.1 1.1 3.9 1.5 1.5 4.1 3.3 1.4 3.2 1.5 2.5 3.1 4.6 3.0 0.8 5.9 1.3 2.3 0.2 8.6 2.4 3.9 4.6 5.1 1.0 3.2 3.8 2.4 10.2 1.3 0.7 0.7 1.8 0.5 0.9 0.0 0.2 0.0 0.8 0.2 0.6 5.0 1.9 5.2 1.4 0.8 0.9 3.3 1.0 1.7 1.9 0.9 2.8 3.5 1.8 1.5 0.8 0.9 0.8 0.3 6.6 3.0 0.4 5.9 1.3 1.4 0.1 3.6 2.3 1.1 2.6 0.0 0.5 2.4 8.4 0.4 1.8 1.4 2.4 1.0 3.7 9.3 0.4 0.8 0.7 0.2 2.7 3.8 1.4 1.5 2.2 6.6 1.8 1.4 3.1 2.6 4.9 1.1 11.3 0.7 2.9 2.8 6.1 3.5 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.2 SCO1 SCOD1 ENSG00000133028 "SCO1, cytochrome c oxidase assembly protein" O75880 17 10672474-10698375 "Disease related genes, Predicted membrane proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021565, HPA021579" Enhanced "HPA021565: AB_1856631, HPA021579: AB_1856632" "unprognostic (6.11e-3)" "unprognostic (2.88e-1)" "unprognostic (5.12e-3)" "unprognostic (1.09e-2)" "unprognostic (1.92e-2)" "unprognostic (7.52e-2)" "unprognostic (5.01e-2)" "unprognostic (3.02e-2)" "unprognostic (7.09e-3)" "unprognostic (1.83e-2)" "unprognostic (2.43e-3)" "unprognostic (3.84e-2)" "prognostic favourable (9.69e-7)" "unprognostic (4.94e-3)" "unprognostic (3.54e-2)" "prognostic unfavourable (7.44e-4)" "unprognostic (3.12e-2)" 18.2 20.8 12.2 13.7 16.5 9.7 14.8 9.3 18.6 11.8 21.6 14.4 15.3 23.3 15.5 14.0 17.5 11.3 14.0 29.3 10.4 13.0 23.9 30.9 10.7 13.0 12.0 12.1 12.5 12.3 15.2 15.7 19.0 13.3 14.1 18.3 12.9 13.3 16.0 25.4 12.3 22.8 16.5 9.8 12.4 13.7 12.1 12.2 15.1 17.7 11.6 16.5 14.4 12.6 13.0 14.6 13.8 18.1 10.1 13.9 11.2 17.0 25.7 10.6 14.3 12.8 11.3 22.3 19.0 10.1 17.6 16.8 13.3 10.4 30.6 20.4 16.9 19.0 20.9 18.1 19.7 15.8 26.5 15.5 17.0 18.1 18.6 10.7 11.6 14.2 12.0 16.6 26.3 12.3 15.8 5.6 17.6 10.0 14.8 11.4 23.4 13.0 17.6 13.4 13.6 22.2 13.4 5.6 16.2 22.6 13.9 19.6 17.9 7.8 14.3 13.4 11.5 14.2 19.9 8.6 8.6 11.4 10.8 13.7 14.5 5.7 14.8 13.8 11.7 17.2 12.9 13.0 10.5 12.1 14.6 9.7 13.3 13.9 4.9 10.1 18.1 10.4 13.3 11.2 12.2 16.5 9.3 18.6 10.4 13.0 12.0 12.1 13.3 12.2 SCO2 "MYP6, SCO1L" ENSG00000130489 "SCO2, cytochrome c oxidase assembly protein" O43819 22 50523568-50525606 "Disease related genes, Predicted membrane proteins" Chaperone "Cardiomyopathy, Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA046943, HPA056254" Approved Approved Mitochondria Mitochondria "HPA046943: , HPA056254: " "unprognostic (8.79e-2)" "unprognostic (4.44e-2)" "unprognostic (1.62e-1)" "unprognostic (6.14e-3)" "unprognostic (3.74e-1)" "unprognostic (5.86e-3)" "unprognostic (1.27e-3)" "unprognostic (1.32e-1)" "unprognostic (4.05e-3)" "unprognostic (6.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.95e-1)" "prognostic unfavourable (1.67e-4)" "unprognostic (5.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.64e-1)" "unprognostic (4.51e-2)" 13.0 11.6 8.8 20.6 9.0 27.9 16.6 15.2 14.7 8.1 25.1 4.5 7.9 21.6 7.4 9.0 19.7 22.9 10.1 19.7 8.8 10.9 21.3 28.0 14.9 12.3 7.4 11.3 8.0 18.4 2.6 8.9 10.0 7.2 7.7 6.6 5.5 22.1 4.6 9.9 14.3 18.8 8.1 8.0 13.9 8.9 8.4 5.0 6.9 12.2 13.8 14.1 10.1 6.9 17.4 23.8 7.0 7.9 11.7 22.1 15.1 14.9 14.2 6.8 9.2 6.8 9.2 10.3 10.1 8.2 13.4 11.7 17.5 8.4 20.3 7.9 8.0 17.8 6.9 11.7 2.4 5.7 38.0 6.5 21.9 23.0 15.7 17.1 12.6 13.7 17.8 6.9 5.8 8.9 7.2 27.7 5.7 27.9 8.4 34.3 7.1 23.5 14.0 8.7 22.8 10.2 10.5 10.3 12.7 11.4 32.5 23.2 12.6 16.4 10.6 11.7 11.3 13.1 11.1 13.2 6.7 9.1 15.9 13.2 10.0 5.2 6.3 2.9 22.1 7.3 20.9 17.4 18.6 21.8 10.6 15.4 14.6 17.0 7.0 11.7 7.9 23.8 15.4 15.1 8.8 9.0 15.2 14.7 8.8 10.9 7.4 11.3 7.2 5.0 SCO2 ENSG00000284194 "SCO2, cytochrome c oxidase assembly protein" 22 50523568-50526439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 17.6;bone marrow: 13.0" "Cell line enhanced" "Detected in many" "RPMI-8226: 13.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA046943, HPA056254" Uncertain Approved Mitochondria Mitochondria "HPA046943: , HPA056254: " 2.4 1.1 0.7 6.3 0.6 13.0 6.7 0.6 1.2 1.5 2.3 0.0 1.1 0.6 0.6 0.7 4.6 0.8 2.4 4.3 0.1 2.8 4.2 3.7 9.3 0.4 0.0 1.2 0.8 0.0 0.0 0.9 0.6 1.6 0.5 0.1 4.2 0.2 0.7 1.8 3.5 1.6 1.7 5.7 1.9 0.4 0.6 10.6 1.0 1.4 2.6 1.6 0.7 10.3 17.6 10.4 12.6 4.0 10.3 10.7 4.0 2.7 0.1 2.6 0.0 0.5 2.3 2.8 1.9 2.4 1.9 0.4 3.7 6.9 2.0 0.9 2.5 1.0 0.0 0.0 1.3 10.6 3.5 0.7 0.4 4.9 9.3 2.8 3.3 1.2 1.2 0.5 0.4 4.4 9.4 1.4 1.5 1.1 9.8 1.4 4.1 6.4 0.7 13.5 1.8 1.1 0.6 2.3 1.2 0.4 9.5 1.4 7.2 3.1 1.7 3.7 2.9 2.4 8.0 2.5 9.6 3.9 2.1 1.6 8.4 12.6 8.7 7.2 7.3 8.7 10.3 9.4 7.8 17.6 8.9 6.9 5.5 10.4 4.0 6.8 12.6 10.3 10.7 SDC1 "CD138, SDC, SYND1, syndecan" ENSG00000115884 "Syndecan 1" P18827 2 20200797-20225433 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 113.2;placenta: 228.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 60.9;hTCEpi: 56.3;U-251 MG: 58.0;U-266/70: 60.1;U-266/84: 126.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 17 "memory B-cell: 3.9" "Lineage enriched" "Detected in single" 40 "B-cells: 3.9" "Group enriched" "Detected in some" 4 "cerebellum: 10.7;olfactory region: 5.9" "Not detected" "Not detected" "CAB002424, HPA006185, HPA067477" Enhanced Supported "Focal adhesion sites" "Secreted to blood" 63100000 1600000 "Focal adhesion sites" "CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: " "prognostic unfavourable (2.22e-4)" "unprognostic (6.80e-3)" "unprognostic (6.80e-2)" "unprognostic (7.84e-2)" "prognostic unfavourable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (4.02e-2)" "unprognostic (6.32e-2)" "unprognostic (1.70e-1)" "unprognostic (3.66e-1)" "unprognostic (2.27e-3)" "unprognostic (1.79e-1)" "unprognostic (1.63e-1)" "unprognostic (1.94e-2)" "unprognostic (4.27e-1)" "unprognostic (1.62e-2)" "unprognostic (1.52e-1)" 0.8 3.4 0.5 5.4 0.6 0.0 4.5 0.8 0.7 21.4 18.3 0.5 3.5 14.3 2.3 8.7 103.7 1.6 55.3 0.3 0.4 0.5 68.5 113.2 15.8 6.3 1.9 0.4 1.6 7.0 0.6 0.6 228.8 0.7 13.3 6.2 1.5 16.0 5.2 0.5 69.5 21.9 4.3 0.4 3.7 16.3 2.6 0.4 1.5 3.5 62.3 48.4 30.0 37.7 3.9 0.0 0.0 0.0 0.0 0.0 0.5 30.8 17.3 5.5 13.8 1.5 0.2 17.3 8.6 8.3 8.1 6.8 3.6 18.8 0.0 3.2 6.1 30.4 2.4 60.9 5.4 0.1 1.6 0.0 1.6 18.5 1.3 1.3 0.1 0.8 56.3 7.2 17.3 0.8 0.7 12.1 4.3 18.4 0.0 0.3 4.9 33.5 0.6 2.0 23.3 10.3 46.3 1.6 12.8 6.5 43.9 1.9 4.3 0.3 1.3 32.1 10.3 1.1 58.0 60.1 126.7 0.1 9.6 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 0.8 0.7 0.4 0.5 1.9 0.4 0.7 0.4 SDC2 "CD362, fibroglycan, HSPG, HSPG1, SYND2" ENSG00000169439 "Syndecan 2" P34741 8 96493351-96611780 "CD markers, Predicted membrane proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 115.1;thyroid gland: 111.2" "Cell line enhanced" "Detected in many" "AF22: 101.9;EFO-21: 47.8;fHDF/TERT166: 44.1;RPTEC TERT1: 53.2;U-138 MG: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 13.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025123, HPA044416" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB025123: , HPA044416: " "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (3.61e-2)" "unprognostic (6.52e-3)" "unprognostic (4.18e-2)" "unprognostic (2.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.89e-2)" "unprognostic (4.56e-1)" "unprognostic (1.48e-1)" "unprognostic (6.16e-2)" "unprognostic (1.56e-2)" "unprognostic (1.45e-3)" "unprognostic (1.91e-1)" "unprognostic (2.50e-2)" "unprognostic (1.23e-1)" 43.2 9.9 13.9 9.1 16.9 2.5 17.0 12.7 8.4 43.4 18.7 7.3 21.2 5.8 21.9 15.3 13.3 21.0 15.0 19.1 12.0 12.6 23.9 115.1 14.4 4.4 9.7 9.3 45.9 16.8 1.6 24.0 31.3 10.7 25.9 10.7 51.4 6.3 28.1 9.4 6.5 9.6 34.3 9.5 7.5 11.9 8.7 9.3 0.5 111.2 13.8 3.5 35.9 26.3 0.0 1.3 13.9 1.9 0.0 0.2 0.5 0.0 0.0 101.9 0.0 36.8 34.4 0.1 14.7 17.5 8.6 9.5 3.0 0.0 0.0 47.8 44.1 0.0 17.6 0.2 7.4 0.0 6.9 0.0 9.8 37.4 1.1 0.2 0.4 13.3 0.4 19.4 0.5 0.3 9.6 0.0 3.5 0.8 0.0 2.5 10.8 0.1 0.1 16.0 0.3 53.2 8.7 3.0 7.9 0.0 0.0 0.7 4.3 11.4 8.0 49.4 15.1 0.2 8.2 0.9 0.0 0.1 15.7 0.0 15.4 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 13.9 0.0 0.1 0.0 0.0 0.5 13.9 16.9 12.7 8.4 12.0 12.6 9.7 9.3 10.7 9.3 SDC3 "N-syndecan, SYND3" ENSG00000162512 "Syndecan 3" O75056 1 30869467-30908761 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 51.6;WM-115: 71.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017087, CAB025786, HPA048085" Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB025786: , HPA017087: AB_1857706, HPA048085: " "unprognostic (1.42e-3)" "unprognostic (5.52e-2)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-2)" "unprognostic (1.87e-1)" "unprognostic (1.79e-3)" "unprognostic (2.83e-1)" "prognostic favourable (2.36e-4)" "unprognostic (9.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.65e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (6.45e-2)" "unprognostic (2.74e-1)" "unprognostic (9.80e-3)" "unprognostic (1.46e-1)" 17.9 48.8 35.4 11.6 44.7 1.9 9.2 10.4 53.1 20.4 20.8 21.7 10.9 6.9 25.6 7.1 9.8 13.7 15.9 11.1 26.8 32.2 4.7 11.5 12.0 15.4 36.1 16.4 6.2 4.4 6.1 5.4 9.7 34.1 14.8 8.1 8.2 8.6 29.2 17.7 5.7 9.1 33.1 28.3 45.3 9.3 2.4 15.5 2.6 5.5 1.7 4.2 14.4 6.0 1.2 1.0 3.2 2.5 2.1 1.2 0.9 2.7 2.0 16.1 7.5 12.4 3.0 3.1 6.7 9.5 3.2 1.9 0.3 2.5 0.2 17.0 18.7 3.6 1.7 1.5 2.0 1.4 1.3 0.0 0.8 0.4 11.9 0.0 1.8 7.1 7.3 0.2 3.1 3.9 1.3 0.2 6.1 2.9 0.1 0.1 8.1 2.3 0.1 15.3 0.6 3.9 2.9 6.3 4.0 8.4 1.1 51.6 1.2 1.1 4.4 4.0 6.8 0.5 1.5 0.0 0.1 0.2 0.4 0.0 71.8 3.2 1.3 1.0 0.8 2.5 1.2 0.8 0.8 0.9 0.9 1.2 1.0 1.0 2.5 2.1 1.8 1.0 0.9 0.9 35.4 44.7 10.4 29.5 26.8 32.2 36.1 16.4 34.1 15.5 SDC4 "amphiglycan, ryudocan, SYND4" ENSG00000124145 "Syndecan 4" P31431 20 45325288-45348424 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 141.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005716, CAB013240" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" "Golgi apparatus" "Plasma membrane" "CAB013240: AB_2533250, HPA005716: AB_1080160" "unprognostic (1.34e-2)" "unprognostic (1.80e-1)" "unprognostic (1.71e-2)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (5.93e-2)" "unprognostic (2.68e-1)" "unprognostic (2.95e-2)" "prognostic unfavourable (4.20e-4)" "unprognostic (1.97e-1)" "prognostic favourable (2.44e-7)" "unprognostic (3.00e-1)" "unprognostic (2.18e-1)" "prognostic favourable (2.67e-4)" "unprognostic (7.42e-2)" 15.9 26.2 19.9 15.7 24.3 3.5 40.5 6.9 20.1 20.4 24.8 19.2 9.0 13.3 17.6 14.7 42.4 27.4 26.2 19.5 19.8 12.1 56.6 141.1 56.7 4.8 23.5 20.5 14.7 36.6 6.2 12.5 23.0 30.9 19.5 22.3 21.8 47.6 17.5 25.5 45.5 13.8 38.7 23.0 9.0 46.9 33.7 15.7 2.0 26.5 25.2 23.5 34.4 16.4 0.7 2.8 2.0 3.1 1.4 8.1 1.2 22.6 2.9 1.6 0.1 40.4 24.9 69.8 29.0 39.6 32.8 23.6 34.5 57.9 0.0 13.0 36.4 29.4 1.1 73.7 40.0 6.5 1.0 0.7 2.4 13.4 44.1 0.1 1.2 33.5 49.4 13.5 33.1 4.3 1.1 0.0 18.9 22.5 0.0 2.0 2.9 9.1 0.0 14.6 0.0 54.0 30.2 0.6 2.3 39.8 24.7 7.1 17.9 1.3 8.1 25.1 20.9 2.5 18.6 1.2 0.9 0.1 39.5 2.3 14.9 2.0 3.1 0.7 1.3 1.1 4.1 0.6 4.1 1.6 2.8 0.7 0.9 1.1 1.6 1.4 1.1 2.5 8.1 1.2 19.9 24.3 6.9 20.1 19.8 12.1 23.5 20.5 30.9 15.7 SDHD "cybS, PGL, PGL1" ENSG00000204370 "Succinate dehydrogenase complex subunit D" O14521 11 112086773-112120013 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport, Tricarboxylic acid cycle" "Cancer-related genes, Disease mutation, FDA approved drug targets, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA045727 Approved "Intracellular and membrane" "HPA045727: AB_10963114" "unprognostic (9.13e-2)" "unprognostic (3.51e-2)" "unprognostic (4.47e-3)" "unprognostic (4.21e-2)" "unprognostic (1.93e-1)" "unprognostic (4.98e-2)" "unprognostic (5.69e-2)" "unprognostic (2.50e-1)" "unprognostic (1.83e-3)" "unprognostic (7.10e-2)" "unprognostic (3.03e-2)" "unprognostic (1.80e-1)" "prognostic favourable (1.99e-10)" "unprognostic (5.14e-2)" "unprognostic (1.58e-2)" "unprognostic (1.56e-2)" "unprognostic (7.51e-2)" 20.9 23.1 17.1 21.7 19.4 10.9 19.6 14.1 18.4 18.1 33.6 14.2 23.9 36.0 22.7 17.5 35.2 17.3 17.9 42.5 15.1 13.7 66.6 75.4 19.1 23.3 17.1 15.1 18.6 23.2 22.5 16.1 20.1 18.0 23.7 33.9 15.7 32.6 21.7 65.4 15.5 61.2 24.0 15.3 22.8 22.2 8.8 14.8 21.7 46.2 33.9 24.6 23.5 20.3 55.5 74.7 62.1 91.7 46.1 53.7 68.9 16.8 17.3 11.8 17.9 44.2 35.5 19.8 20.6 29.3 21.6 27.1 59.9 44.3 30.7 63.7 27.7 42.4 36.8 29.1 26.5 27.2 18.5 29.2 12.9 31.8 34.4 45.9 22.2 39.1 32.3 25.7 41.2 30.4 30.1 42.4 26.7 21.2 27.5 41.5 16.0 43.0 25.5 31.4 57.2 44.2 41.3 17.1 11.3 28.9 39.0 20.5 40.1 33.1 23.7 21.1 27.7 23.4 18.9 12.6 16.1 56.2 12.0 60.2 20.1 46.1 73.0 48.7 41.4 91.7 44.1 55.5 44.5 43.1 74.7 45.6 53.7 49.8 62.1 46.1 70.7 36.8 44.2 68.9 17.1 19.4 14.1 18.4 15.1 13.7 17.1 15.1 18.0 14.8 SDK1 FLJ31425 ENSG00000146555 "Sidekick cell adhesion molecule 1" Q7Z5N4 7 3301448-4269000 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.0;BEWO: 9.9;RPTEC TERT1: 8.3;RT4: 10.3;SH-SY5Y: 7.3;U-2 OS: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 28 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 28 "granulocytes: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011392 Approved Approved Cytosol 2700000 Cytosol "HPA011392: AB_1856648" "unprognostic (2.39e-1)" "unprognostic (1.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.83e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.23e-1)" "unprognostic (9.93e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-1)" "prognostic favourable (4.08e-4)" "unprognostic (2.16e-1)" "unprognostic (2.49e-2)" "unprognostic (7.84e-2)" "unprognostic (1.59e-1)" "unprognostic (8.44e-2)" "unprognostic (1.37e-1)" 5.8 1.1 2.2 6.1 1.7 1.4 5.8 0.9 3.1 16.6 6.2 1.4 6.8 1.8 6.1 10.9 2.9 4.5 4.8 1.9 3.4 2.2 3.9 0.7 7.0 8.7 1.6 1.4 4.3 22.4 1.5 6.3 2.9 2.1 6.9 2.4 5.6 2.6 9.4 1.8 2.9 4.2 16.5 1.9 16.3 3.6 7.7 1.9 1.8 1.5 3.6 3.4 9.5 13.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.0 1.7 8.0 0.0 0.0 0.0 9.9 0.0 0.0 0.4 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.8 0.0 0.2 0.0 4.6 0.0 0.3 0.2 4.0 0.0 0.0 1.6 0.0 0.3 0.5 0.6 0.0 0.0 3.9 2.0 0.0 0.0 2.7 0.0 5.6 5.6 0.0 8.3 10.3 5.0 7.3 0.0 0.0 0.0 0.0 2.5 0.2 0.0 12.4 0.0 3.4 0.0 0.0 0.0 0.0 1.6 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 2.2 1.7 0.9 3.1 3.4 2.2 1.6 1.4 2.1 1.9 SDK2 "FLJ10832, KIAA1514" ENSG00000069188 "Sidekick cell adhesion molecule 2" Q58EX2 17 73334384-73644089 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 13.6" "Cell line enhanced" "Detected in some" "AF22: 14.8;BEWO: 12.1;RPMI-8226: 4.9;U-2 OS: 5.1;U-266/70: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.7;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 5 "B-cells: 2.7;dendritic cells: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014725 Approved Nucleoplasm 2000000 Nucleoplasm "HPA014725: AB_2183303" "unprognostic (7.22e-4)" "unprognostic (5.57e-2)" "unprognostic (1.70e-1)" "unprognostic (7.00e-3)" "unprognostic (1.62e-2)" "unprognostic (3.18e-1)" "unprognostic (3.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.98e-1)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (7.69e-2)" "unprognostic (3.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.38e-1)" "unprognostic (1.37e-2)" "unprognostic (6.64e-2)" 0.4 0.6 2.1 5.3 1.2 0.7 2.6 0.5 2.7 8.9 0.5 0.6 0.0 0.0 3.1 5.1 0.9 3.5 1.4 3.5 1.7 4.1 1.1 0.5 4.2 4.8 1.6 0.0 0.8 0.4 0.0 1.9 3.7 1.9 2.6 0.3 2.2 2.0 1.4 0.4 0.5 0.5 0.3 3.0 3.6 0.6 13.6 0.0 0.1 1.8 1.1 2.9 0.7 7.2 2.7 2.3 0.0 0.0 0.2 0.5 0.0 0.0 2.1 14.8 4.2 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.9 0.0 0.5 0.0 4.9 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 4.4 1.8 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 2.7 0.5 0.4 0.0 0.2 0.0 2.3 0.0 0.0 2.1 1.2 0.5 2.5 1.7 4.1 1.6 0.0 1.9 0.0 SDR16C5 "EPHD-2, RDH-E2, RDHE2" ENSG00000170786 "Short chain dehydrogenase/reductase family 16C member 5" Q8N3Y7 8 56300010-56320776 "Enzymes, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 19.9;HaCaT: 9.9;hTCEpi: 16.4;T-47d: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 36 "memory B-cell: 9.1;naive B-cell: 2.5" "Lineage enriched" "Detected in single" 56 "B-cells: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025224 Enhanced "HPA025224: AB_1856163" "unprognostic (1.66e-1)" "unprognostic (8.88e-2)" "unprognostic (9.46e-2)" "unprognostic (4.18e-4)" "unprognostic (8.83e-3)" "prognostic favourable (7.88e-4)" "unprognostic (1.66e-1)" "unprognostic (2.51e-1)" "unprognostic (2.42e-1)" "unprognostic (1.78e-3)" "unprognostic (2.39e-1)" "unprognostic (2.48e-5)" "unprognostic (2.55e-1)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (1.71e-1)" 0.3 0.2 2.0 2.0 1.9 0.0 7.4 0.9 6.2 8.1 5.9 0.2 0.0 1.7 0.2 0.0 27.5 0.2 1.5 0.2 0.6 1.2 0.2 0.2 34.0 0.3 1.4 2.9 0.2 0.3 0.0 0.5 0.0 10.6 0.3 3.0 0.2 9.2 0.0 0.3 35.9 16.9 0.2 0.4 0.2 12.9 0.5 0.2 0.0 0.2 25.8 21.1 1.0 11.5 9.1 0.0 0.0 0.0 0.0 0.1 0.1 3.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 9.9 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.4 0.0 2.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 7.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 1.9 0.9 6.2 0.6 1.2 1.4 2.9 10.6 0.2 SDSL "cSDH, SDS-RS1" ENSG00000139410 "Serine dehydratase like" Q96GA7 12 113422237-113438276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 53.2" "Cell line enhanced" "Detected in many" "HMC-1: 22.2;MCF7: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 6.5;intermediate monocyte: 7.1;myeloid DC: 13.2;plasmacytoid DC: 12.8" "Group enriched" "Detected in many" 8 "dendritic cells: 13.2;monocytes: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005740 Approved Approved Cytosol Cytosol "HPA005740: AB_10601486" "unprognostic (1.34e-1)" "unprognostic (8.33e-2)" "unprognostic (3.62e-2)" "unprognostic (3.54e-2)" "unprognostic (2.24e-2)" "unprognostic (6.17e-3)" "unprognostic (1.57e-1)" "unprognostic (6.46e-2)" "unprognostic (8.22e-2)" "unprognostic (2.00e-2)" "prognostic favourable (8.58e-4)" "unprognostic (2.93e-1)" "prognostic favourable (3.09e-5)" "unprognostic (2.22e-2)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (7.33e-2)" 3.1 15.3 4.2 3.8 5.1 1.4 2.8 1.5 7.1 2.6 7.1 5.5 6.2 10.0 2.5 9.7 1.3 4.6 5.2 7.2 3.6 6.1 15.5 53.2 2.8 2.8 9.5 4.2 4.6 15.3 5.0 7.6 3.1 7.8 4.2 5.0 4.6 4.9 4.5 2.1 0.7 7.8 2.9 8.8 3.0 5.2 7.0 2.6 1.5 20.3 1.3 1.6 4.0 1.5 1.1 13.2 0.3 7.1 1.3 0.2 1.7 3.5 14.0 1.9 5.8 0.4 0.8 1.4 2.0 0.5 2.2 1.8 5.9 3.8 0.1 10.5 3.3 3.6 0.9 4.7 0.7 8.4 3.5 9.0 3.4 2.5 11.8 1.1 22.2 1.9 6.7 5.4 8.0 3.2 6.9 2.7 2.6 38.0 0.0 4.5 2.0 6.0 0.0 2.9 6.7 5.7 4.4 0.6 0.2 8.6 9.8 8.3 12.0 10.2 2.9 2.7 5.2 11.9 1.8 0.6 0.5 0.1 11.4 3.7 3.3 0.1 6.5 0.0 0.0 7.1 0.0 1.1 0.0 0.0 13.2 0.1 0.0 0.0 0.3 1.3 0.9 12.8 0.2 1.7 4.2 5.1 1.5 7.1 3.6 6.1 9.5 4.2 7.8 2.6 SEC11A "SEC11L1, sid2895, SPC18, SPCS4A" ENSG00000140612 "SEC11 homolog A, signal peptidase complex subunit" P67812 15 84669538-84716716 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047533 Approved "Nuclear membrane,Golgi apparatus" 7400000 "Nuclear membrane" "Golgi apparatus" "HPA047533: " "unprognostic (8.81e-3)" "unprognostic (1.97e-1)" "unprognostic (3.19e-2)" "prognostic favourable (1.94e-5)" "unprognostic (3.39e-2)" "prognostic unfavourable (5.99e-5)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-2)" "unprognostic (6.17e-2)" "unprognostic (6.24e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "prognostic favourable (2.95e-4)" "unprognostic (7.89e-2)" 65.5 43.6 18.7 23.3 17.3 36.4 42.6 11.2 15.5 44.4 38.5 23.0 38.8 20.7 41.8 57.9 40.3 27.3 33.2 30.8 18.7 18.4 56.5 68.2 44.7 41.1 24.7 12.6 55.7 70.9 21.2 41.7 46.0 18.4 44.4 28.0 28.5 43.5 36.2 51.9 23.3 33.3 39.7 31.5 38.4 29.5 28.2 19.7 33.2 74.6 39.3 32.1 49.8 37.8 29.1 44.3 32.6 48.4 34.3 45.9 46.3 23.6 51.1 37.7 58.3 47.8 59.7 29.0 37.8 44.1 31.1 37.2 54.7 58.7 11.8 24.9 46.5 51.6 52.3 31.7 33.8 28.9 38.6 34.3 58.2 51.3 41.5 25.8 38.9 41.1 39.9 21.4 34.8 43.9 34.1 31.6 41.9 55.5 10.5 56.1 40.1 22.0 13.2 48.8 38.3 69.8 66.3 18.5 41.6 31.4 35.2 85.1 34.4 60.0 29.9 31.5 23.7 26.9 46.0 31.1 58.9 16.6 34.2 45.5 24.6 20.7 43.8 24.1 28.4 47.3 28.5 29.1 35.4 30.4 43.8 26.6 30.2 30.9 32.6 34.3 48.4 44.3 45.9 46.3 18.7 17.3 11.2 15.5 18.7 18.4 24.7 12.6 18.4 19.7 SEC11C "SEC11L3, SPC21, SPCS4C" ENSG00000166562 "SEC11 homolog C, signal peptidase complex subunit" Q9BY50 18 59139477-59158836 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 132.6" "Cell line enhanced" "Detected in many" "HDLM-2: 58.2;Karpas-707: 62.8;RPMI-8226: 127.1;U-266/70: 64.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026816, HPA047533" Approved Approved "Nuclear membrane,Golgi apparatus" "Nuclear membrane" "Golgi apparatus" "HPA026816: AB_10602089, HPA047533: " "unprognostic (1.47e-2)" "unprognostic (2.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.44e-2)" "unprognostic (3.13e-3)" "unprognostic (4.48e-3)" "unprognostic (2.95e-1)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.80e-2)" "unprognostic (1.72e-1)" "unprognostic (6.25e-2)" "unprognostic (3.83e-2)" "unprognostic (4.63e-2)" "unprognostic (2.58e-1)" "unprognostic (1.15e-1)" 5.9 18.4 30.1 18.6 29.7 11.3 16.0 14.9 25.2 12.2 18.7 24.4 27.8 27.5 9.1 58.0 10.7 9.2 11.1 7.2 27.7 33.9 19.0 66.8 13.0 22.0 41.8 21.3 7.0 96.8 14.6 46.6 8.1 27.1 48.8 16.4 10.0 132.6 34.1 4.3 7.9 21.1 6.6 51.3 23.6 28.4 6.4 25.3 7.3 35.9 8.6 23.4 18.9 5.9 33.6 50.0 10.6 17.6 17.3 34.4 32.6 8.6 10.4 5.7 8.8 3.5 0.6 7.3 7.9 6.7 9.7 5.9 7.3 4.7 19.9 12.4 4.7 9.3 8.9 5.9 5.6 58.2 12.2 6.4 7.3 22.4 10.6 21.0 9.7 2.0 14.1 6.0 16.2 3.2 7.3 62.8 3.4 10.2 8.6 8.4 5.7 6.4 7.9 5.6 127.1 6.3 7.3 26.6 10.5 4.7 19.1 26.6 8.6 15.5 2.5 11.8 4.9 4.1 9.4 64.0 47.1 19.5 11.7 14.3 14.4 10.6 13.1 9.4 25.9 15.5 33.1 33.6 27.3 25.2 13.5 17.4 14.3 19.5 2.0 17.3 17.6 50.0 34.4 32.6 30.1 29.7 14.9 25.2 27.7 33.9 41.8 21.3 27.1 25.3 SEC22B "ERS-24, sec22b, SEC22L1" ENSG00000265808 "SEC22 homolog B, vesicle trafficking protein (gene/pseudogene)" O75396 1 120150898-120176515 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079017 Approved 980000 "CAB079017: " "unprognostic (2.21e-1)" "unprognostic (2.29e-2)" "unprognostic (5.02e-2)" "unprognostic (8.52e-2)" "unprognostic (1.13e-1)" "unprognostic (7.88e-2)" "unprognostic (1.54e-1)" "unprognostic (3.08e-1)" "unprognostic (3.30e-2)" "prognostic favourable (4.58e-4)" "unprognostic (1.21e-1)" "unprognostic (1.29e-1)" "prognostic unfavourable (3.34e-4)" "unprognostic (5.80e-2)" "unprognostic (2.48e-1)" "unprognostic (1.52e-2)" "unprognostic (2.15e-1)" 11.9 12.0 7.4 8.9 8.3 6.2 10.3 7.6 10.2 12.3 8.5 8.2 15.5 10.0 11.1 18.3 7.3 7.0 10.1 7.7 6.3 10.7 23.6 8.8 9.2 7.6 9.1 10.1 19.6 11.1 25.6 24.8 8.8 11.8 11.2 9.8 19.4 13.4 8.2 6.7 12.4 9.2 7.2 8.9 10.2 7.1 8.3 10.9 11.4 6.3 9.4 11.1 7.8 12.4 16.1 25.1 16.6 14.5 17.8 10.7 9.8 3.2 6.3 9.8 36.8 26.0 8.4 23.4 19.4 16.5 30.6 5.3 4.3 6.3 11.5 14.7 4.1 6.0 6.3 22.7 7.9 5.5 7.1 18.6 9.2 21.1 9.6 8.7 25.3 8.1 21.2 11.5 10.1 4.6 13.5 22.2 19.2 8.9 5.1 9.2 8.7 8.4 14.8 6.9 12.6 7.6 6.5 7.1 8.3 12.1 12.3 6.3 11.1 13.9 22.7 10.8 39.4 15.2 9.3 6.3 9.7 35.1 8.6 25.0 17.4 16.6 14.1 13.3 14.9 17.8 12.4 15.0 13.6 10.0 11.0 15.3 17.0 25.1 14.5 13.1 16.1 11.7 10.7 SEC22C "MGC13261, MGC5373, SEC22L3" ENSG00000093183 "SEC22 homolog C, vesicle trafficking protein" Q9BRL7 3 42547969-42601080 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031242 Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA031242: " "unprognostic (1.68e-1)" "unprognostic (4.86e-2)" "unprognostic (1.01e-1)" "unprognostic (2.67e-1)" "unprognostic (9.37e-3)" "unprognostic (2.11e-1)" "prognostic unfavourable (3.04e-5)" "unprognostic (1.15e-1)" "unprognostic (3.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.58e-2)" "unprognostic (2.57e-1)" "prognostic favourable (1.35e-7)" "unprognostic (2.59e-1)" "unprognostic (3.30e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-3)" 25.3 20.9 27.6 13.4 30.5 28.0 28.8 19.0 30.5 24.1 21.1 32.8 17.4 28.4 26.2 25.8 16.4 22.2 17.4 22.6 27.5 25.4 22.5 14.1 24.6 18.9 34.7 24.6 29.0 26.6 23.8 23.7 17.7 27.6 36.4 14.5 25.7 23.3 25.1 15.4 14.5 31.6 24.9 49.2 15.8 20.7 32.0 25.6 14.5 23.5 11.8 15.2 18.4 17.6 11.5 10.3 18.8 10.7 9.9 19.4 9.2 12.1 11.5 16.0 14.4 32.1 30.3 4.4 22.2 20.4 21.3 22.5 8.1 18.2 11.9 9.1 23.0 6.5 12.4 18.7 19.2 16.5 14.0 18.5 19.4 9.2 25.5 10.2 19.0 18.0 22.9 26.6 28.4 24.2 18.3 20.9 20.9 7.9 12.2 9.4 10.1 17.1 6.3 11.4 10.4 17.5 10.0 9.4 13.5 16.9 12.5 15.6 24.2 9.5 22.1 19.4 15.5 29.4 21.4 17.6 26.6 11.2 21.1 13.0 18.0 8.7 10.7 18.8 13.7 7.7 19.4 11.5 17.7 16.1 9.9 9.8 15.2 13.4 6.0 9.9 8.0 10.3 14.2 9.2 27.6 30.5 19.0 30.5 27.5 25.4 34.7 24.6 27.6 25.6 SEC61B ENSG00000106803 "Sec61 translocon beta subunit" P60468 9 99222064-99230615 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049407 Approved Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA049407: " "unprognostic (1.11e-1)" "unprognostic (5.99e-3)" "unprognostic (3.46e-1)" "prognostic favourable (1.26e-5)" "unprognostic (1.96e-1)" "unprognostic (4.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.09e-1)" "unprognostic (6.67e-2)" "unprognostic (1.87e-2)" "unprognostic (2.90e-2)" "unprognostic (7.07e-2)" "unprognostic (1.22e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-1)" "unprognostic (6.87e-2)" "unprognostic (2.75e-1)" 26.2 39.8 20.3 27.1 20.7 41.1 37.2 12.6 20.2 36.5 26.2 15.8 47.9 28.5 32.1 52.7 29.3 26.8 26.4 19.8 19.3 17.7 42.0 153.0 31.9 49.3 19.9 14.8 31.6 175.5 13.6 38.5 36.3 17.7 28.9 19.8 21.3 116.6 50.8 16.9 20.5 31.2 21.0 20.1 41.4 29.7 19.9 16.8 43.8 49.3 29.2 35.9 24.5 24.0 36.9 173.3 71.5 48.5 31.0 52.5 47.1 37.9 37.3 43.0 42.7 42.7 54.7 52.1 56.6 59.5 53.7 46.9 53.2 30.0 52.1 43.4 51.7 47.0 30.1 45.2 25.9 54.8 41.9 27.2 36.3 75.0 93.0 46.6 35.1 48.8 69.9 42.2 37.8 65.4 42.6 102.0 50.5 69.8 42.3 68.4 34.4 87.6 41.2 36.6 67.2 58.0 27.4 44.9 31.8 31.7 73.9 72.5 28.6 64.6 45.7 38.5 45.9 64.1 47.0 55.0 37.0 33.3 64.1 30.2 25.3 71.5 48.5 44.5 39.1 38.4 52.5 36.9 43.3 39.3 49.4 25.0 27.5 30.1 40.6 31.0 33.2 173.3 38.3 47.1 20.3 20.7 12.6 20.2 19.3 17.7 19.9 14.8 17.7 16.8 SEC61G SSS1 ENSG00000132432 "Sec61 translocon gamma subunit" P60059 7 54752250-54759974 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "glioma: 333.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053196 Uncertain "HPA053196: " "unprognostic (1.39e-2)" "unprognostic (4.51e-3)" "unprognostic (5.26e-3)" "unprognostic (1.82e-2)" "unprognostic (2.46e-2)" "prognostic unfavourable (4.64e-7)" "prognostic unfavourable (3.85e-6)" "unprognostic (2.09e-2)" "unprognostic (2.17e-1)" "unprognostic (2.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.53e-1)" "prognostic unfavourable (6.60e-8)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (7.95e-3)" "unprognostic (8.43e-2)" 32.5 38.0 31.5 33.4 27.2 35.3 44.2 21.6 27.1 48.0 45.9 18.7 52.6 28.2 35.0 90.5 41.3 29.3 34.4 49.7 26.4 29.0 48.9 99.1 33.3 33.6 27.5 22.4 33.3 114.9 15.9 65.6 45.8 24.5 33.2 45.1 24.0 70.6 55.9 35.1 25.0 42.2 37.3 25.0 40.9 33.8 33.5 23.4 37.9 54.8 56.0 39.1 48.4 30.9 24.2 108.6 37.1 24.1 18.9 34.4 20.7 50.5 29.1 40.6 42.4 41.3 52.1 25.5 79.6 50.7 42.9 76.7 40.8 32.4 43.3 42.8 60.8 37.4 34.3 57.0 89.5 39.2 30.2 28.4 58.7 46.3 59.0 50.2 28.7 39.1 49.5 43.4 74.8 55.9 42.0 104.9 90.3 25.4 25.7 88.4 56.4 52.1 19.9 24.6 71.1 52.1 30.4 37.4 47.3 33.7 75.5 34.6 38.6 51.2 46.1 36.2 49.7 148.0 60.6 44.8 41.4 81.2 75.7 30.1 70.2 37.1 23.3 19.4 25.7 22.2 34.4 24.2 29.4 27.2 25.5 17.6 21.0 24.8 7.6 18.9 24.1 108.6 26.8 20.7 31.5 27.2 21.6 27.1 26.4 29.0 27.5 22.4 24.5 23.4 SECTM1 K12 ENSG00000141574 "Secreted and transmembrane 1" Q8WVN6 17 82321024-82334074 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.9;intestine: 103.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.8;BJ hTERT+: 27.0;BJ hTERT+ SV40 Large T+: 20.8;PC-3: 21.4;SiHa: 36.8;U-2197: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 45.9" "Group enriched" "Detected in many" 13 "granulocytes: 45.9;monocytes: 16.2" HPA051214 Approved "Secreted - unknown location" 26000000 "HPA051214: " "unprognostic (2.42e-1)" "unprognostic (2.95e-2)" "unprognostic (1.56e-1)" "unprognostic (2.69e-2)" "unprognostic (4.29e-2)" "unprognostic (1.15e-2)" "unprognostic (4.55e-2)" "unprognostic (9.39e-2)" "unprognostic (3.17e-3)" "unprognostic (7.75e-3)" "unprognostic (2.10e-2)" "unprognostic (1.95e-1)" "unprognostic (4.30e-2)" "unprognostic (1.43e-1)" "unprognostic (4.31e-3)" "unprognostic (2.84e-1)" "unprognostic (1.01e-1)" 13.5 1.8 1.1 15.7 2.1 3.7 10.6 0.7 2.1 6.4 33.2 1.0 1.3 26.2 6.1 4.9 6.1 6.5 4.7 6.1 2.3 0.8 16.8 3.9 11.2 21.7 1.5 0.6 7.8 2.5 0.0 1.3 6.1 3.5 8.6 9.4 2.1 20.2 2.2 4.9 6.6 103.1 5.5 4.2 24.0 9.4 2.1 1.4 2.3 5.1 7.0 7.7 7.8 16.2 0.0 2.3 45.9 16.2 0.0 0.1 1.1 5.9 1.3 0.0 0.4 10.5 26.8 0.5 2.9 27.0 20.8 20.5 0.6 12.2 0.0 0.1 8.7 18.1 0.0 1.2 0.8 1.9 0.0 2.5 9.3 1.6 8.1 0.0 0.0 11.4 2.7 1.1 0.4 0.6 0.0 0.0 13.2 0.2 0.0 0.0 0.0 21.4 0.0 0.1 0.3 6.0 0.0 1.3 0.1 36.8 20.0 0.4 1.6 0.5 0.1 2.2 0.2 28.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 9.6 0.0 0.1 16.2 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.0 45.9 0.0 14.8 1.0 0.0 1.1 1.1 2.1 0.7 2.1 2.3 0.8 1.5 0.6 3.5 1.4 SEL1L2 "C20orf50, DKFZp434C1826" ENSG00000101251 "SEL1L2 ERAD E3 ligase adaptor subunit" Q5TEA6 20 13849247-13996443 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059121 Approved "HPA059121: " "unprognostic (6.70e-2)" "unprognostic (1.64e-2)" "unprognostic (2.72e-3)" "unprognostic (2.19e-1)" "unprognostic (8.51e-2)" "unprognostic (5.33e-2)" "unprognostic (2.13e-2)" "unprognostic (2.54e-1)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (2.43e-2)" "unprognostic (3.62e-2)" "unprognostic (3.12e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SEL1L3 KIAA0746 ENSG00000091490 "SEL1L family member 3" Q68CR1 4 25747427-25863760 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 48.0" "Cell line enhanced" "Detected in many" "Daudi: 68.0;U-698: 44.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 45.9" "Group enriched" "Detected in many" 5 "memory B-cell: 20.8;naive B-cell: 20.8;plasmacytoid DC: 17.9" "Group enriched" "Detected in many" 4 "B-cells: 20.8;dendritic cells: 17.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 191.0" "HPA040045, HPA058792" Approved Enhanced Nucleoplasm Nucleoplasm "HPA040045: AB_10796116, HPA058792: " "unprognostic (1.01e-2)" "unprognostic (2.03e-1)" "unprognostic (3.06e-3)" "unprognostic (1.44e-2)" "unprognostic (2.43e-3)" "unprognostic (1.80e-1)" "unprognostic (1.26e-2)" "unprognostic (1.39e-1)" "unprognostic (5.33e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (5.11e-1)" "unprognostic (4.77e-2)" "unprognostic (7.21e-3)" "unprognostic (1.32e-1)" "unprognostic (2.28e-2)" "prognostic favourable (4.33e-4)" 5.4 3.3 4.0 36.3 5.6 2.3 3.8 45.9 6.4 13.7 19.3 1.5 1.5 19.3 2.2 18.1 6.2 3.6 22.0 2.4 3.3 2.8 6.9 3.6 14.3 27.7 2.1 1.7 3.1 48.0 10.9 2.9 13.7 3.0 4.2 16.7 12.9 23.1 1.0 1.3 1.7 30.3 3.4 2.1 33.5 24.6 2.2 1.1 2.8 12.5 3.8 46.7 14.8 2.2 20.8 17.9 0.4 0.1 3.7 4.3 1.4 5.0 5.5 4.1 1.3 0.6 0.8 0.6 2.5 6.8 1.9 6.2 3.4 23.4 68.0 12.0 17.1 3.2 3.0 10.8 2.6 3.6 1.7 0.7 9.0 4.6 17.6 9.3 0.4 1.4 8.7 6.8 2.6 25.5 4.4 0.0 1.3 3.8 0.0 0.6 11.7 4.9 0.3 22.3 9.4 15.0 16.9 10.1 1.9 16.6 0.2 1.7 0.8 11.5 11.1 0.1 8.1 0.1 7.1 0.4 0.1 44.4 30.9 3.9 4.6 0.4 0.1 0.0 2.8 0.0 3.4 20.8 3.5 3.1 0.7 20.8 1.5 2.4 0.3 3.7 0.1 17.9 4.3 1.4 4.0 5.6 45.9 6.4 3.3 2.8 2.1 1.7 3.0 1.1 SELE "CD62E, ELAM, ELAM1, ESEL" ENSG00000007908 "Selectin E" P16581 1 169722641-169764705 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 50.0" "Cell line enriched" "Detected in single" 5 "HUVEC TERT2: 5.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB002143 Enhanced 640000000 "CAB002143: AB_563608" "unprognostic (2.39e-1)" "unprognostic (2.16e-2)" "unprognostic (1.37e-2)" "unprognostic (2.09e-2)" "unprognostic (1.61e-1)" "unprognostic (1.40e-2)" "unprognostic (1.59e-1)" "unprognostic (2.94e-1)" "unprognostic (3.63e-1)" "unprognostic (3.88e-1)" "unprognostic (9.74e-2)" "unprognostic (4.32e-2)" "unprognostic (1.56e-2)" "unprognostic (8.13e-3)" "unprognostic (4.69e-2)" "unprognostic (4.63e-2)" "unprognostic (2.55e-1)" 14.9 2.7 0.9 30.4 1.2 0.2 8.3 0.3 1.0 13.7 2.7 1.9 4.4 0.4 18.1 3.2 6.7 20.1 7.4 4.4 0.9 0.9 2.5 4.9 10.6 2.0 1.2 0.0 9.8 1.4 21.0 3.1 0.9 5.4 21.2 1.9 4.3 2.0 4.6 2.2 3.7 2.4 13.1 4.8 0.2 3.4 5.6 0.5 0.9 9.0 50.0 15.5 16.4 4.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.9 1.2 0.3 1.0 0.9 0.9 1.2 0.0 5.4 0.5 SELENOK SELK ENSG00000113811 "Selenoprotein K" Q9Y6D0 3 53884410-53891988 "Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 78.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 78.6" "Low region specificity" "Detected in all" HPA008196 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA008196: AB_1856665" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (3.85e-1)" "prognostic favourable (7.18e-4)" "unprognostic (9.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.02e-2)" "prognostic favourable (3.76e-4)" "unprognostic (2.75e-1)" "unprognostic (5.21e-2)" "unprognostic (8.34e-2)" "unprognostic (1.14e-1)" "unprognostic (3.40e-2)" "unprognostic (8.43e-2)" "unprognostic (8.12e-2)" "unprognostic (9.35e-2)" "unprognostic (2.56e-3)" 20.4 33.5 29.2 19.0 30.2 38.8 24.1 19.7 21.7 18.9 20.5 20.9 28.3 17.3 15.8 49.4 15.0 16.3 17.1 43.2 25.3 26.2 27.6 38.5 18.0 15.1 32.8 16.8 24.8 72.6 20.0 33.0 18.4 27.9 19.3 22.1 27.3 34.2 20.6 41.0 11.5 20.4 16.7 30.1 16.9 18.4 16.8 27.4 8.7 37.7 18.6 20.3 20.2 18.7 12.4 13.4 78.6 10.9 9.9 15.2 15.4 8.6 5.9 12.9 9.6 19.9 12.2 15.2 12.5 14.6 14.8 18.3 13.2 13.3 13.1 5.6 8.1 5.4 14.4 8.3 13.6 22.9 20.4 8.1 26.5 31.2 17.7 10.7 19.7 7.0 14.8 10.7 14.6 13.3 7.9 35.5 14.3 9.8 6.9 13.1 13.4 22.2 4.5 8.1 24.4 18.5 15.1 7.0 20.2 8.0 11.9 12.4 7.8 17.6 8.4 10.1 11.6 25.0 17.6 24.5 28.7 11.5 15.2 14.1 15.1 78.6 8.9 21.9 15.2 9.4 14.6 12.4 14.1 15.1 7.5 9.9 12.3 14.1 19.6 9.9 10.9 13.4 14.3 15.4 29.2 30.2 19.7 21.6 25.3 26.2 32.8 16.8 27.9 27.4 SELENOS "AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP" ENSG00000131871 "Selenoprotein S" Q9BQE4 15 101270817-101277500 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "plasmacytoid DC: 96.1" "Lineage enriched" "Detected in all" 5 "dendritic cells: 96.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010025 Approved Enhanced "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA010025: AB_1079900" "unprognostic (1.90e-1)" "unprognostic (4.03e-2)" "unprognostic (1.06e-1)" "prognostic favourable (1.33e-4)" "unprognostic (2.42e-2)" "unprognostic (3.74e-3)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (9.83e-2)" "prognostic favourable (5.19e-4)" "unprognostic (2.42e-3)" "unprognostic (4.42e-1)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" "unprognostic (2.66e-2)" 25.1 34.7 16.3 19.6 17.1 18.0 38.3 11.4 15.6 22.8 33.7 20.7 51.6 33.2 21.6 33.7 24.8 20.5 21.9 35.0 15.6 14.6 30.9 58.2 27.0 24.5 24.6 13.4 19.3 80.9 14.6 27.5 38.2 21.2 23.5 37.8 16.5 58.0 42.1 28.3 20.6 41.5 21.8 26.8 27.5 26.8 44.4 18.7 9.7 34.0 22.5 26.4 21.0 30.9 10.0 96.1 17.5 14.8 14.3 17.2 9.6 9.3 14.9 13.4 11.9 29.5 20.9 11.2 28.6 21.9 20.0 20.2 17.7 22.8 7.1 10.6 25.3 26.7 14.5 12.9 13.1 12.9 19.4 12.0 13.4 18.3 46.8 9.0 13.9 18.2 36.9 13.3 39.8 14.9 12.0 81.0 21.3 15.1 6.5 14.0 10.2 9.7 8.4 11.0 15.5 20.1 22.5 7.6 19.1 19.9 18.8 39.8 14.0 20.5 15.7 18.9 12.4 25.3 21.7 58.8 49.1 10.3 20.6 10.8 22.7 17.5 10.8 12.3 16.0 12.9 15.4 10.0 12.4 17.2 9.3 7.0 9.4 14.0 3.7 14.3 14.8 96.1 10.9 9.6 16.3 17.1 11.4 15.6 15.6 14.6 24.6 13.4 21.2 18.7 SELENOT SELT ENSG00000198843 "Selenoprotein T" P62341 3 150602875-150630445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039780 Approved "HPA039780: AB_10805594" "unprognostic (1.13e-1)" "unprognostic (4.03e-2)" "unprognostic (2.78e-1)" "unprognostic (1.92e-1)" "unprognostic (3.31e-1)" "unprognostic (1.34e-2)" "unprognostic (2.65e-3)" "unprognostic (1.49e-1)" "unprognostic (8.96e-2)" "unprognostic (5.79e-3)" "unprognostic (6.30e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-3)" "unprognostic (4.91e-2)" "unprognostic (4.08e-2)" "unprognostic (1.58e-1)" "unprognostic (3.41e-2)" 29.7 52.6 39.9 32.1 44.1 54.5 31.0 33.9 48.2 29.9 29.7 37.7 26.7 29.7 29.2 41.8 30.3 31.2 23.5 32.7 41.6 47.4 47.0 52.5 31.1 44.5 41.3 28.2 27.7 34.2 30.6 46.6 50.8 48.0 31.8 36.7 30.2 31.5 33.0 30.5 20.0 38.5 33.4 50.0 49.8 28.5 23.6 31.9 32.3 45.7 23.0 43.2 34.3 23.1 32.1 34.0 54.5 43.2 26.5 42.3 71.0 47.9 19.9 12.9 11.5 19.9 19.5 24.4 38.2 28.3 26.5 18.1 31.5 28.3 27.2 39.1 28.3 16.6 20.0 23.9 40.8 22.7 16.7 28.3 12.2 14.7 21.8 16.6 21.5 16.8 19.2 23.6 20.6 28.6 6.5 80.3 38.6 29.5 22.0 9.6 13.8 21.4 15.9 16.2 45.3 22.9 28.8 13.8 8.5 22.9 14.4 15.1 27.5 19.9 26.8 14.4 9.0 25.9 35.1 56.3 28.8 37.6 19.6 30.3 12.2 41.9 43.2 36.4 38.5 35.0 42.3 32.1 32.0 35.2 34.0 26.7 25.3 32.0 54.5 26.5 37.7 24.1 33.5 71.0 39.9 44.1 33.9 48.2 41.6 47.4 41.3 28.2 48.0 31.9 SELL "CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR" ENSG00000188404 "Selectin L" P14151 1 169690667-169711698 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 227.5;lymphoid tissue: 77.8" "Cell line enhanced" "Detected in some" "Daudi: 7.3;EFO-21: 7.1;MOLT-4: 13.4;U-266/70: 25.2;U-698: 11.7;U-937: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002144, HPA051972" Enhanced Uncertain Cytosol 8100000000 Cytosol "CAB002144: AB_563862, HPA051972: " "prognostic favourable (3.76e-4)" "prognostic favourable (2.25e-4)" "unprognostic (1.52e-2)" "unprognostic (2.89e-2)" "unprognostic (7.87e-3)" "prognostic favourable (6.43e-4)" "unprognostic (1.39e-3)" "unprognostic (3.43e-1)" "unprognostic (2.70e-3)" "prognostic favourable (3.14e-4)" "unprognostic (1.42e-1)" "unprognostic (4.21e-2)" "prognostic unfavourable (4.96e-5)" "unprognostic (4.76e-2)" "unprognostic (8.71e-3)" "unprognostic (9.57e-2)" "unprognostic (1.01e-1)" 6.9 0.9 2.0 25.1 4.6 30.3 1.5 1.1 2.5 0.9 1.4 1.1 0.0 0.4 1.0 1.1 4.2 3.2 5.4 4.1 2.5 2.2 2.3 2.5 11.4 77.8 5.2 0.2 0.8 1.0 10.7 7.9 3.4 2.7 1.2 1.3 3.8 12.1 0.1 0.9 0.8 8.8 2.9 5.2 67.7 1.7 1.0 2.3 43.8 1.9 1.3 64.0 8.1 6.1 40.4 40.7 227.5 49.7 130.8 69.5 90.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.2 7.3 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 5.0 0.9 0.3 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.8 13.4 0.1 0.0 0.2 5.1 0.1 0.3 4.1 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 25.2 0.0 11.7 1.3 7.3 0.1 170.8 49.7 88.6 16.5 11.2 4.5 33.8 30.7 17.0 40.7 40.4 69.5 39.6 227.5 130.8 4.5 32.8 52.7 90.1 2.0 4.6 1.1 2.5 2.5 2.2 5.2 0.2 2.7 2.3 SELP "CD62, CD62P, GMP140, GRMP, PADGEM, PSEL" ENSG00000174175 "Selectin P" P16109 1 169588849-169630193 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 37 "EFO-21: 24.7;HEL: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "basophil: 6.0;neutrophil: 2.4;T-reg: 8.9" "Group enriched" "Detected in many" 8 "granulocytes: 6.0;T-cells: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002145, HPA002655, HPA005990" Enhanced 830000000 "CAB002145: AB_563984, HPA002655: AB_1078480, HPA005990: AB_1078479" "unprognostic (3.37e-2)" "unprognostic (2.98e-4)" "unprognostic (4.11e-1)" "unprognostic (1.46e-1)" "unprognostic (9.26e-2)" "prognostic favourable (3.12e-4)" "unprognostic (5.30e-4)" "unprognostic (4.14e-2)" "unprognostic (3.59e-1)" "unprognostic (1.74e-1)" "unprognostic (1.93e-2)" "unprognostic (6.61e-2)" "unprognostic (1.19e-1)" "unprognostic (8.24e-3)" "unprognostic (1.74e-2)" "unprognostic (7.85e-3)" "unprognostic (1.66e-1)" 14.2 2.1 0.4 8.4 0.4 1.0 10.9 0.4 0.4 14.8 3.7 0.6 7.5 3.3 10.6 6.2 5.6 7.7 7.0 9.6 0.4 0.4 7.5 4.6 11.3 12.9 0.4 0.4 5.0 1.5 3.8 2.8 7.4 1.3 14.8 2.9 24.7 3.4 4.3 3.7 2.3 5.2 10.5 1.0 1.9 3.5 3.1 0.3 1.4 4.9 7.7 13.0 11.5 27.2 0.9 0.1 6.0 0.5 0.4 8.9 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.0 0.5 0.7 0.0 0.2 0.0 0.9 0.6 0.3 0.0 0.2 0.2 0.1 2.4 0.4 0.0 0.1 8.9 8.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.3 0.3 SELPLG "CD162, PSGL-1" ENSG00000110876 "Selectin P ligand" Q14242 12 108622277-108633959 "Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 126.9;lymphoid tissue: 60.5" "Cell line enhanced" "Detected in some" "HDLM-2: 28.0;HMC-1: 27.2;Karpas-707: 42.6;RPMI-8226: 59.2;U-266/70: 69.5;U-266/84: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" CAB002431 Enhanced "CAB002431: AB_563509" "unprognostic (2.32e-2)" "prognostic favourable (1.46e-4)" "unprognostic (3.64e-3)" "unprognostic (1.02e-2)" "unprognostic (6.32e-2)" "prognostic favourable (6.94e-4)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "prognostic favourable (2.92e-4)" "unprognostic (2.26e-1)" "unprognostic (2.12e-2)" "unprognostic (3.24e-1)" "prognostic unfavourable (5.86e-4)" "unprognostic (5.88e-2)" "unprognostic (2.37e-2)" "prognostic favourable (2.74e-4)" "unprognostic (5.44e-2)" 10.6 5.5 11.3 25.3 8.9 10.7 4.2 2.2 12.5 5.8 5.4 27.2 0.1 5.0 2.9 4.1 5.0 6.8 9.6 5.9 12.1 9.6 4.6 3.9 23.3 46.8 16.2 5.4 2.1 2.9 1.3 3.1 7.3 11.5 3.0 5.2 3.4 5.2 2.5 1.8 2.7 10.3 6.7 19.6 60.5 6.0 2.1 13.5 26.0 3.1 2.8 18.0 14.8 3.0 2.2 50.9 126.9 68.4 28.1 63.2 77.1 0.1 0.0 0.3 0.1 0.1 0.3 0.1 1.0 1.0 0.3 0.3 0.0 0.4 0.1 0.3 1.5 0.0 0.0 0.0 0.3 28.0 0.0 9.9 0.0 0.0 0.0 7.0 27.2 0.3 0.1 0.5 0.1 0.0 0.1 42.6 1.3 0.0 5.6 4.0 0.0 0.3 0.0 0.1 59.2 0.6 0.0 0.0 0.0 0.1 0.0 0.4 0.0 8.9 0.3 0.5 0.1 0.7 0.2 69.5 43.3 1.2 0.3 14.9 0.4 126.9 28.1 88.8 43.8 49.5 35.8 2.0 41.8 37.4 29.4 2.2 32.4 34.1 125.8 28.1 68.4 50.9 63.2 77.1 11.3 8.9 2.2 12.5 12.1 9.6 16.2 5.4 11.5 13.5 SEMA4A "CORD10, FLJ12287, SEMAB, SemB" ENSG00000196189 "Semaphorin 4A" Q9H3S1 1 156147366-156177752 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Angiogenesis, Differentiation, Immunity, Neurogenesis" "Developmental protein" "Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 46.8" "Cell line enhanced" "Detected in some" "Karpas-707: 54.6;U-698: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 26.4;eosinophil: 25.2;intermediate monocyte: 29.5;myeloid DC: 40.3;neutrophil: 46.8;non-classical monocyte: 15.6" "Group enriched" "Detected in many" 12 "dendritic cells: 40.3;granulocytes: 46.8;monocytes: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA069136 Supported 2400000 "HPA069136: " "unprognostic (1.90e-1)" "unprognostic (2.39e-2)" "unprognostic (4.24e-1)" "unprognostic (5.20e-2)" "unprognostic (8.04e-2)" "prognostic favourable (1.09e-4)" "unprognostic (1.97e-1)" "unprognostic (2.50e-2)" "unprognostic (3.51e-1)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavourable (8.20e-4)" "unprognostic (8.77e-2)" "unprognostic (4.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.28e-2)" 4.5 1.0 19.2 21.4 17.6 23.1 6.5 2.9 19.2 5.6 4.7 2.5 10.3 2.6 2.1 37.0 19.8 5.7 8.3 2.9 8.4 12.7 11.6 1.7 11.7 28.7 6.3 12.2 3.6 2.9 1.4 2.5 7.4 4.8 10.2 4.4 24.6 19.5 13.7 1.9 21.6 3.0 2.7 2.7 17.5 7.1 2.5 3.5 11.0 24.0 9.3 30.8 7.3 10.1 3.1 40.3 46.8 29.5 0.9 1.9 11.4 4.4 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 2.8 0.1 0.2 4.2 0.3 3.5 0.1 1.2 0.0 0.1 0.0 0.1 0.1 6.4 0.4 0.2 3.3 0.0 0.1 0.3 0.4 54.6 0.2 5.3 0.0 2.2 1.2 0.0 0.2 0.1 1.8 6.5 8.6 0.0 0.1 0.0 6.9 0.3 7.9 8.2 0.3 0.0 0.0 0.0 0.0 10.6 1.0 23.8 0.2 6.1 0.1 3.0 26.4 25.2 0.9 29.5 1.9 3.1 0.3 1.8 40.3 2.8 0.0 0.3 46.8 0.9 15.6 5.8 0.3 11.4 19.2 17.6 2.9 19.2 8.4 12.7 6.3 12.2 4.8 3.5 SEMA4B "KIAA1745, MGC131831, SEMAC, SemC" ENSG00000185033 "Semaphorin 4B" 15 90160604-90229679 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 51.8;RPTEC TERT1: 32.1;RT4: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 14.7;naive B-cell: 11.8;neutrophil: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 14.7;granulocytes: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013372 Approved Approved "Nucleoplasm,Vesicles,Cell Junctions" "Cell Junctions" "Nucleoplasm, Vesicles" "HPA013372: AB_1856670" "unprognostic (3.33e-2)" "unprognostic (5.96e-2)" "unprognostic (2.23e-2)" "unprognostic (2.50e-2)" "unprognostic (7.78e-2)" "unprognostic (4.48e-2)" "unprognostic (6.34e-3)" "prognostic unfavourable (1.25e-4)" "unprognostic (2.04e-1)" "unprognostic (9.31e-2)" "unprognostic (1.58e-3)" "unprognostic (4.67e-2)" "prognostic unfavourable (3.33e-8)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (3.57e-2)" "unprognostic (7.09e-2)" 7.0 19.8 13.1 13.7 16.7 7.1 13.6 9.1 13.1 16.2 21.7 9.4 18.2 24.0 9.0 12.3 56.7 16.3 20.3 13.8 13.3 7.6 18.6 32.1 11.6 10.0 13.4 11.1 17.0 19.8 9.4 10.8 14.6 15.4 18.1 10.0 15.4 21.3 15.7 4.0 29.0 22.2 13.5 18.8 16.3 22.4 8.3 14.8 12.8 32.7 15.5 27.2 31.6 24.6 14.7 0.9 4.0 2.0 0.3 0.7 1.0 5.8 15.9 1.2 3.8 1.1 0.8 8.8 1.8 3.9 2.2 2.4 1.9 51.8 4.1 20.1 1.3 27.8 1.0 25.8 1.8 23.6 3.3 5.4 3.9 2.6 4.4 0.6 2.5 3.1 11.3 2.4 5.1 2.5 2.6 6.6 1.2 4.3 1.4 2.3 5.4 14.6 1.7 0.9 9.0 32.1 34.9 3.8 3.9 6.3 10.2 2.4 7.1 1.6 5.6 1.8 3.4 3.7 4.0 9.6 11.5 2.0 17.1 4.5 1.8 0.0 2.0 0.3 0.7 1.2 0.5 14.7 0.5 0.4 0.9 11.8 0.4 0.5 4.0 0.3 2.0 0.1 0.1 1.0 13.1 16.7 9.1 13.1 13.3 7.6 13.4 11.1 15.4 14.8 SEMA4C "Semacl1, Semaf, SEMAI" ENSG00000168758 "Semaphorin 4C" Q9C0C4 2 96859716-96870757 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "BEWO: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011090 Approved 400000 "HPA011090: AB_2185705" "unprognostic (1.25e-1)" "unprognostic (4.95e-2)" "prognostic unfavourable (3.53e-5)" "unprognostic (7.10e-2)" "unprognostic (4.46e-2)" "unprognostic (1.57e-2)" "unprognostic (4.20e-3)" "unprognostic (3.08e-1)" "unprognostic (2.16e-1)" "unprognostic (3.56e-2)" "unprognostic (1.82e-1)" "unprognostic (3.57e-1)" "prognostic unfavourable (9.50e-7)" "unprognostic (4.78e-3)" "unprognostic (3.09e-1)" "unprognostic (7.31e-2)" "unprognostic (4.08e-1)" 14.2 7.9 7.7 9.0 13.9 2.3 10.6 17.5 22.0 16.7 23.0 27.1 12.9 6.4 23.6 8.2 11.7 19.7 12.5 13.7 9.8 7.5 6.9 7.7 8.9 7.4 25.1 12.2 17.0 7.9 6.1 6.4 33.8 12.8 16.0 5.2 12.8 13.9 18.7 5.2 13.5 8.1 21.6 15.4 22.0 9.7 3.9 14.8 1.8 7.5 6.1 8.4 19.7 20.5 0.0 2.2 1.3 3.7 3.9 2.3 0.9 2.1 3.1 10.3 11.1 2.4 3.0 82.9 3.7 4.6 3.7 3.7 3.1 3.7 0.0 6.1 2.3 2.3 2.8 1.9 1.8 4.0 3.3 1.4 2.5 5.9 5.4 0.6 3.9 5.1 1.5 3.4 2.9 2.7 9.4 3.2 3.5 11.2 0.0 4.7 13.5 3.0 3.3 5.4 3.6 1.3 4.5 6.3 9.1 3.0 6.9 16.5 2.3 5.8 0.8 6.1 7.8 8.6 3.8 0.0 0.2 0.0 2.9 4.7 10.0 1.3 0.1 0.0 1.8 0.8 2.3 0.0 0.7 1.3 0.0 0.0 1.4 0.4 0.0 3.9 3.7 2.2 0.8 0.9 7.7 13.9 17.5 22.0 9.8 7.5 25.1 12.2 12.8 14.8 SEMA4D "C9orf164, CD100, coll-4, FLJ39737, SEMAJ" ENSG00000187764 "Semaphorin 4D" Q92854 9 89360787-89498130 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.1;skeletal muscle: 43.3" "Cell line enhanced" "Detected in many" "HDLM-2: 42.9;HMC-1: 33.1;MOLT-4: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015662, HPA023277" Approved Supported "Endoplasmic reticulum,Vesicles" 4100000 Vesicles "Endoplasmic reticulum" "HPA015662: AB_1856671, HPA023277: AB_1856672" "unprognostic (2.94e-2)" "prognostic favourable (4.17e-4)" "unprognostic (1.12e-2)" "unprognostic (8.22e-2)" "unprognostic (1.41e-1)" "unprognostic (1.76e-3)" "unprognostic (1.27e-1)" "unprognostic (1.58e-1)" "unprognostic (7.79e-2)" "unprognostic (2.74e-1)" "unprognostic (3.18e-3)" "unprognostic (1.50e-2)" "unprognostic (2.29e-3)" "unprognostic (3.05e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-1)" "prognostic favourable (4.06e-5)" 3.9 5.6 18.0 18.6 20.7 14.3 3.6 7.7 20.9 4.0 5.9 54.0 3.1 6.1 3.9 7.4 9.3 6.6 7.2 4.9 28.2 18.8 8.4 2.0 6.7 32.0 42.6 15.0 4.1 4.6 4.9 5.3 3.2 27.5 4.9 5.8 2.9 6.7 4.2 43.3 8.8 9.6 3.3 107.1 19.2 9.4 6.1 23.3 25.3 4.9 3.1 27.6 8.3 5.3 2.6 4.6 21.2 4.1 4.7 14.0 7.8 4.0 3.0 2.8 4.1 0.1 0.2 6.5 0.4 0.2 0.8 0.6 2.0 4.6 15.5 1.7 0.0 2.1 2.5 1.2 0.3 42.9 2.5 6.5 1.0 0.2 0.5 8.6 33.1 0.1 0.9 0.2 0.1 1.6 1.5 10.6 0.0 6.7 38.9 10.8 6.9 0.1 12.4 0.9 4.3 5.5 4.2 6.7 4.4 1.1 3.6 0.1 3.4 4.7 1.0 0.0 2.6 0.3 2.0 11.9 5.1 2.2 2.0 10.5 2.5 7.3 4.1 20.4 13.3 3.8 8.0 2.6 10.6 11.1 1.5 1.6 12.2 14.0 21.2 4.7 4.1 4.6 9.5 7.8 18.0 20.7 7.7 20.9 28.2 18.8 42.6 15.0 27.5 23.3 SEMA4F "SEMAM, SEMAW" ENSG00000135622 "Ssemaphorin 4F" O95754 2 74654228-74683853 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064095, HPA065969" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" Nucleoplasm "Plasma membrane, Centrosome" "HPA064095: , HPA065969: " "unprognostic (9.69e-2)" "unprognostic (8.88e-3)" "unprognostic (1.58e-2)" "prognostic unfavourable (5.94e-5)" "prognostic unfavourable (6.96e-4)" "unprognostic (1.23e-2)" "unprognostic (1.61e-3)" "unprognostic (6.95e-2)" "unprognostic (9.01e-3)" "unprognostic (6.53e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "prognostic unfavourable (9.74e-6)" "unprognostic (2.60e-2)" "unprognostic (8.08e-2)" "prognostic favourable (6.94e-4)" "unprognostic (4.69e-2)" 8.1 5.1 15.5 3.5 15.5 1.3 5.7 12.9 21.3 5.2 3.8 3.3 2.3 1.9 6.6 6.7 2.7 5.6 3.5 4.9 17.2 12.2 4.8 2.1 8.1 5.1 5.3 16.5 9.1 4.6 13.7 10.2 3.5 7.8 5.2 4.2 3.6 5.0 5.7 3.0 4.9 3.0 7.0 5.7 4.7 4.3 7.2 3.8 2.9 4.7 1.3 4.9 3.5 4.7 2.8 0.2 1.4 0.4 2.5 5.6 2.1 7.1 4.9 5.3 7.5 8.7 4.8 3.3 5.0 10.4 9.1 8.4 2.0 4.1 2.4 5.4 7.9 2.1 7.7 8.5 10.1 6.3 6.6 4.2 2.0 4.0 3.1 0.9 6.7 4.4 7.4 6.1 3.2 3.9 0.3 0.1 5.3 2.1 3.8 0.7 2.9 4.7 0.0 6.9 0.0 7.1 3.4 3.3 8.0 7.2 3.0 9.0 3.5 0.5 4.2 15.5 7.5 3.7 9.1 5.8 5.8 0.3 18.9 0.3 8.3 0.5 0.2 1.4 5.6 0.1 3.2 2.8 3.0 4.9 0.2 2.1 3.3 3.9 0.8 2.5 0.4 0.1 2.2 2.1 15.5 15.5 12.9 21.3 17.2 12.2 5.3 16.5 7.8 3.8 SEMA4G "FLJ20590, KIAA1619" ENSG00000095539 "Semaphorin 4G" Q9NTN9 10 100969518-100985871 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.0;liver: 33.9" "Group enriched" "Detected in many" 4 "A549: 13.7;CACO-2: 13.1;Hep G2: 47.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038362, HPA077752" Uncertain Uncertain "Vesicles,Lipid droplets" "Intracellular and membrane" 840000 "Vesicles, Lipid droplets" "HPA038362: AB_10669524, HPA077752: " "unprognostic (3.90e-3)" "unprognostic (9.43e-3)" "unprognostic (2.84e-1)" "unprognostic (1.13e-2)" "unprognostic (5.55e-2)" "unprognostic (8.11e-2)" "unprognostic (3.28e-1)" "unprognostic (3.71e-2)" "unprognostic (3.63e-1)" "unprognostic (1.41e-2)" "unprognostic (3.09e-2)" "unprognostic (3.14e-1)" "unprognostic (3.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.05e-2)" 1.2 5.0 8.2 9.2 5.6 0.2 1.9 17.8 9.0 2.5 34.3 4.9 3.2 25.9 2.1 16.6 1.8 3.1 25.9 1.6 4.9 5.0 9.5 33.9 2.9 1.2 4.2 4.6 9.2 21.3 3.7 4.4 2.2 7.8 8.6 42.3 4.8 4.3 6.1 1.2 7.1 44.0 2.5 2.5 1.8 10.4 2.5 3.7 0.1 9.8 0.5 0.5 2.3 2.4 2.4 1.0 0.4 0.4 0.0 1.3 0.0 0.0 13.7 3.5 1.5 2.2 0.7 3.0 0.5 1.5 0.7 0.7 13.1 2.2 0.2 1.8 0.6 0.9 3.4 0.6 0.6 0.3 2.1 0.7 1.1 47.9 5.7 0.5 0.4 3.7 0.8 0.7 0.4 1.9 1.3 0.1 1.1 0.8 0.2 0.5 0.5 0.8 1.3 0.3 0.6 3.2 0.4 1.1 5.5 0.5 0.9 1.4 3.8 0.6 1.3 0.4 1.6 0.4 0.1 0.4 0.2 0.2 0.4 0.4 0.4 0.0 0.4 0.4 0.3 0.0 0.2 2.4 0.4 1.3 1.0 0.6 0.4 0.2 0.0 0.0 0.2 0.3 0.1 0.0 8.2 5.6 17.8 9.0 4.9 5.0 4.2 4.6 7.8 3.7 SEMA5A "SEMAF, semF" ENSG00000112902 "Semaphorin 5A" Q13591 5 9035026-9546075 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 29.0;fHDF/TERT166: 16.7;RT4: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in single" 11 "dendritic cells: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA004632 Approved "HPA004632: AB_1079905" "unprognostic (1.48e-1)" "unprognostic (1.68e-2)" "unprognostic (1.40e-2)" "unprognostic (6.67e-2)" "unprognostic (3.65e-1)" "prognostic favourable (2.45e-4)" "unprognostic (7.02e-2)" "unprognostic (1.75e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (3.10e-2)" "unprognostic (8.15e-2)" "prognostic favourable (3.66e-8)" "unprognostic (8.51e-3)" "unprognostic (1.27e-2)" "unprognostic (3.57e-1)" "unprognostic (3.01e-2)" 7.1 2.0 13.2 9.8 11.1 0.4 13.4 2.4 12.5 18.5 12.4 11.9 4.5 4.2 12.5 4.2 5.3 4.5 7.6 12.5 14.5 13.0 15.9 6.7 22.1 11.5 11.8 7.4 2.7 6.1 4.3 8.5 9.4 13.0 4.4 10.6 9.2 4.4 7.3 1.9 6.2 7.2 9.1 12.6 8.1 2.8 1.8 9.9 0.3 3.5 4.5 5.0 10.1 9.7 0.0 6.5 0.2 0.0 0.1 0.5 0.0 0.0 0.0 6.7 0.0 4.7 6.7 0.0 10.4 29.0 2.2 1.1 0.0 0.0 0.0 0.0 16.7 9.4 0.0 0.6 1.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.3 2.4 10.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.6 0.5 0.0 0.0 0.4 0.8 30.4 1.4 0.1 0.0 0.0 8.9 0.0 0.0 0.0 10.4 0.2 0.0 0.2 0.0 0.0 0.0 9.6 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 6.5 0.1 0.0 13.2 11.1 2.4 9.7 14.5 13.0 11.8 7.4 13.0 9.9 SEMA5B "FLJ10372, KIAA1445, SEMAG, SemG" ENSG00000082684 "Semaphorin 5B" Q9P283 3 122909193-123028605 "Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;heart muscle: 11.7" "Cell line enhanced" "Detected in some" "AF22: 41.4;NTERA-2: 8.0;SH-SY5Y: 11.0" "Cancer enhanced" "Detected in many" "renal cancer: 18.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066548 Enhanced Supported Cytosol Cytosol "HPA066548: " "unprognostic (7.34e-2)" "unprognostic (1.84e-3)" "unprognostic (1.92e-4)" "unprognostic (3.01e-2)" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "unprognostic (4.72e-2)" "unprognostic (1.58e-2)" "unprognostic (7.66e-3)" "unprognostic (2.87e-2)" "unprognostic (4.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavourable (7.57e-4)" "unprognostic (1.31e-3)" "unprognostic (5.96e-2)" "unprognostic (6.12e-2)" "unprognostic (2.12e-1)" 1.5 1.2 12.0 0.7 12.3 0.3 1.1 0.8 13.6 2.1 1.5 4.3 0.4 1.9 2.8 5.5 1.5 3.0 4.7 11.7 13.0 3.3 6.1 1.4 2.2 1.1 2.5 3.3 1.3 3.1 1.1 2.5 5.0 2.0 1.8 1.8 6.0 0.9 3.1 1.6 1.2 1.3 3.8 1.7 0.5 0.7 1.1 5.7 0.1 2.2 2.5 1.3 3.3 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 41.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 11.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.0 12.3 0.8 13.2 13.0 3.3 2.5 3.3 2.0 5.7 SEMA6A "HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ" ENSG00000092421 "Semaphorin 6A" Q9H2E6 5 116443616-116574934 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.2" "Cell line enhanced" "Detected in some" "AF22: 14.5;AN3-CA: 17.3;BEWO: 15.1;HAP1: 20.3;NTERA-2: 45.2;RT4: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031264, HPA031265, HPA031267" Approved Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" 180000 Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA031264: , HPA031265: AB_10610423, HPA031267: " "unprognostic (3.79e-2)" "unprognostic (3.91e-1)" "unprognostic (1.82e-2)" "unprognostic (6.81e-2)" "unprognostic (2.69e-2)" "unprognostic (3.77e-1)" "prognostic unfavourable (4.39e-4)" "unprognostic (1.64e-1)" "unprognostic (4.71e-2)" "unprognostic (5.82e-2)" "unprognostic (1.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.62e-3)" "unprognostic (1.92e-1)" "unprognostic (6.21e-3)" "unprognostic (7.32e-3)" 12.7 37.4 12.6 4.9 34.7 3.6 10.6 18.7 26.5 6.9 19.6 31.2 0.8 19.2 6.1 3.4 3.9 6.2 12.8 5.0 17.2 12.9 6.1 6.0 17.8 4.5 35.9 13.9 13.1 10.3 2.2 4.4 30.2 32.2 6.6 17.5 2.6 15.1 3.2 7.6 5.6 24.0 6.3 48.2 8.2 5.4 6.6 31.4 0.5 6.7 1.6 2.7 4.6 5.9 1.6 0.7 0.1 0.4 0.0 1.3 0.0 0.1 0.0 14.5 17.3 0.1 0.0 15.1 0.2 0.1 0.0 0.1 0.8 0.6 0.6 0.6 0.2 0.1 20.3 0.0 0.0 0.6 3.0 0.2 0.2 4.9 0.2 0.2 1.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.2 1.4 45.2 0.1 2.6 9.5 0.6 7.5 12.9 4.1 1.5 0.1 0.2 7.7 5.6 1.0 0.3 1.4 1.2 0.1 0.5 0.2 0.2 0.3 0.2 0.7 5.3 0.0 0.4 0.0 1.2 0.0 0.1 1.6 1.3 0.0 0.3 1.2 0.4 0.5 0.1 0.0 0.2 0.7 0.1 0.0 12.6 34.7 18.7 24.0 17.2 12.9 35.9 13.9 32.2 31.4 SEMA6B "SEM-SEMA-Y, SEMA-VIB, SEMAN, semaZ" ENSG00000167680 "Semaphorin 6B" Q9H3T3 19 4542593-4559808 "Plasma proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.9" "Cell line enhanced" "Detected in some" "Hep G2: 35.6;HMC-1: 58.8;HUVEC TERT2: 24.0;TIME: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025157, HPA055778, HPA058523" Enhanced 180000 "CAB025157: , HPA055778: , HPA058523: " "unprognostic (4.03e-1)" "unprognostic (9.69e-3)" "unprognostic (6.38e-3)" "unprognostic (2.15e-1)" "unprognostic (1.15e-1)" "unprognostic (7.94e-2)" "unprognostic (2.10e-1)" "unprognostic (4.34e-3)" "unprognostic (6.61e-2)" "unprognostic (1.90e-1)" "unprognostic (4.21e-2)" "unprognostic (2.82e-1)" "prognostic unfavourable (3.29e-5)" "unprognostic (1.26e-1)" "unprognostic (1.81e-2)" "prognostic unfavourable (1.45e-4)" "unprognostic (9.55e-2)" 23.2 9.3 27.2 12.1 24.2 7.9 9.7 16.9 42.9 3.8 4.7 1.7 0.3 4.8 4.1 3.1 3.6 2.5 7.0 12.8 30.3 11.5 3.7 5.2 13.1 18.6 9.5 0.8 5.1 4.8 1.7 3.1 9.9 11.0 4.3 1.8 2.7 1.4 2.2 9.3 3.3 4.8 7.9 6.4 17.5 2.5 2.5 8.8 0.0 6.0 3.7 2.0 8.3 24.4 0.0 0.0 0.7 0.4 0.0 0.0 0.0 2.0 7.1 0.6 6.2 0.0 0.3 0.1 0.0 0.2 0.6 0.1 0.0 0.6 0.0 6.8 0.0 1.3 1.8 0.0 0.2 0.0 0.3 0.0 0.1 35.6 0.1 0.0 58.8 2.2 0.0 0.0 0.0 24.0 0.4 0.1 0.2 1.8 0.0 0.0 7.8 0.1 0.1 14.0 0.1 0.5 0.0 5.2 0.5 0.0 0.5 3.8 0.9 0.3 30.3 0.9 11.3 0.1 5.1 0.4 0.0 0.1 0.2 0.3 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 27.2 24.2 16.9 27.9 30.3 11.5 9.5 0.8 11.0 8.8 SEMA6C KIAA1869 ENSG00000143434 "Semaphorin 6C" Q9H3T2 1 151131685-151146664 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 124.1;tongue: 43.4" "Cell line enhanced" "Detected in many" "AF22: 11.7;HUVEC TERT2: 20.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076150, HPA077625" Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" 290000 "Nucleoplasm, Plasma membrane" "Nucleoli fibrillar center, Cytosol" "HPA076150: , HPA077625: " "unprognostic (6.97e-2)" "unprognostic (8.40e-2)" "unprognostic (1.56e-3)" "prognostic unfavourable (3.27e-4)" "unprognostic (2.79e-1)" "unprognostic (2.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" "unprognostic (4.25e-2)" "prognostic favourable (3.06e-5)" "unprognostic (3.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.12e-2)" "unprognostic (9.49e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" 3.2 1.9 2.3 1.5 3.0 1.3 3.4 16.8 5.8 4.2 2.6 1.5 0.8 6.7 4.1 3.5 3.2 2.9 3.9 12.7 2.3 3.5 3.0 3.3 1.9 3.4 1.7 3.3 4.8 1.7 1.7 4.3 1.6 2.7 2.8 1.6 3.4 3.1 1.9 124.1 3.4 5.2 3.6 1.1 1.3 1.6 15.0 0.6 0.5 1.3 43.4 2.9 2.2 3.6 0.9 0.6 0.7 0.0 0.1 1.4 0.2 0.7 0.8 11.7 4.5 4.9 1.6 1.0 0.8 0.4 0.8 1.1 0.2 0.5 0.5 3.4 2.7 1.1 1.1 0.4 0.7 1.0 3.4 6.1 0.5 0.9 0.6 0.1 2.3 2.8 1.4 1.0 0.5 20.4 0.5 0.6 1.9 0.4 1.0 0.8 5.2 1.3 7.2 2.6 0.2 0.4 0.3 5.9 7.7 1.1 0.5 0.9 1.3 1.0 9.5 2.0 2.8 2.9 0.4 4.9 0.9 5.0 0.5 0.2 0.7 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.2 0.0 0.0 0.9 0.5 0.0 0.5 0.1 0.0 0.6 0.3 0.2 2.3 3.0 16.8 5.8 2.3 3.5 1.7 3.3 2.7 0.6 SEMA6D "FLJ11598, KIAA1479" ENSG00000137872 "Semaphorin 6D" Q8NFY4 15 47184101-47774223 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.8;placenta: 36.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 13.9;SCLC-21H: 12.3;SH-SY5Y: 11.4;U-266/70: 9.1" "Cancer enhanced" "Detected in many" "glioma: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043109 Approved "Golgi apparatus,Plasma membrane" "Intracellular and membrane" 480000 "Plasma membrane" "Golgi apparatus" "HPA043109: AB_10793941" "unprognostic (2.00e-1)" "unprognostic (4.62e-2)" "unprognostic (3.10e-2)" "unprognostic (3.83e-3)" "unprognostic (1.38e-1)" "unprognostic (3.85e-2)" "unprognostic (1.98e-1)" "unprognostic (2.17e-3)" "unprognostic (1.24e-1)" "unprognostic (5.36e-2)" "unprognostic (7.96e-4)" "unprognostic (1.42e-1)" "prognostic favourable (5.96e-5)" "unprognostic (3.74e-2)" "unprognostic (8.56e-2)" "unprognostic (3.30e-3)" "unprognostic (2.39e-4)" 5.3 1.9 10.3 3.7 16.7 0.8 5.3 5.4 17.1 5.3 14.7 15.3 4.3 18.9 2.1 2.9 2.0 5.2 4.0 8.3 10.3 11.2 14.2 3.0 8.2 2.2 14.0 13.6 25.0 14.8 16.2 6.1 36.7 15.9 4.8 12.0 10.0 4.4 8.5 15.6 3.1 40.8 3.4 12.7 2.5 3.4 2.6 11.0 0.2 6.3 1.5 1.1 3.1 9.6 0.5 0.0 1.9 0.6 0.0 0.8 0.0 0.0 0.0 2.3 0.0 1.3 1.1 0.2 0.5 13.9 0.3 0.0 0.3 0.1 1.9 0.0 3.5 7.2 2.9 0.9 0.1 0.9 1.7 0.0 4.2 0.0 3.7 0.0 0.1 1.0 7.6 0.0 0.5 0.9 0.1 3.0 0.4 0.7 2.3 0.6 4.4 0.0 1.4 0.1 2.1 1.0 0.9 12.3 11.4 0.1 0.9 3.8 0.4 0.0 0.0 6.4 0.3 0.2 0.0 9.1 0.0 2.1 1.7 0.2 1.6 0.0 0.6 0.0 0.5 0.0 0.0 0.5 0.3 0.8 0.0 0.0 0.1 0.2 1.9 0.0 0.0 0.0 0.0 0.0 10.3 16.7 5.4 17.1 10.3 11.2 14.0 13.6 15.9 11.0 SEMA7A "CD108, H-Sema-L, SEMAL" ENSG00000138623 "Semaphorin 7A (John Milton Hagen blood group)" O75326 15 74409289-74433958 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Differentiation, Inflammatory response, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;lymphoid tissue: 34.7;placenta: 54.0" "Cell line enhanced" "Detected in many" "HMC-1: 99.7;hTEC/SVTERT24-B: 39.1;U-251 MG: 57.5;U-87 MG: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 8.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008210, HPA042273" Uncertain Uncertain Vesicles 29000000 Vesicles "HPA008210: , HPA042273: AB_10806234" "unprognostic (2.00e-1)" "unprognostic (2.72e-1)" "unprognostic (2.02e-2)" "unprognostic (5.81e-2)" "unprognostic (6.49e-2)" "unprognostic (8.61e-2)" "unprognostic (2.54e-2)" "unprognostic (4.18e-3)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (5.18e-3)" "unprognostic (1.44e-1)" "prognostic unfavourable (2.45e-11)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (6.25e-2)" "unprognostic (2.57e-2)" 2.2 1.9 5.4 10.4 13.8 12.8 1.4 22.9 27.3 1.3 1.8 19.9 1.4 2.7 4.3 1.8 3.2 1.2 3.3 1.4 10.8 5.7 1.4 1.5 4.4 19.0 28.5 5.7 5.9 0.9 6.4 1.9 54.0 28.6 1.4 1.8 7.8 1.7 3.5 1.4 4.7 6.0 2.0 36.4 34.7 3.7 23.6 15.4 9.0 1.1 0.4 19.7 4.6 1.7 1.4 1.8 8.9 0.0 0.8 0.2 0.0 5.7 0.0 1.7 0.5 2.2 7.4 14.3 26.5 10.7 5.6 8.6 2.2 9.4 0.0 1.5 12.0 1.7 0.5 1.7 5.8 0.4 0.3 10.3 0.0 2.8 0.5 0.3 99.7 5.2 0.0 39.1 2.2 0.0 5.9 3.6 18.1 0.4 1.4 3.4 1.8 4.0 0.2 1.1 1.5 2.3 2.4 0.1 0.1 0.2 4.8 2.1 0.3 2.1 1.0 10.5 7.0 5.0 57.5 0.6 0.4 0.1 33.6 1.2 0.5 3.9 0.0 8.9 0.2 0.0 0.2 1.4 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.8 0.0 1.8 0.0 0.0 5.4 13.8 22.9 27.3 10.8 5.7 28.5 5.7 28.6 15.4 SERAC1 FLJ14917 ENSG00000122335 "Serine active site containing 1" Q96JX3 6 158109515-158168280 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025715, HPA025716" Enhanced "HPA025715: AB_1856697, HPA025716: AB_2185128" "unprognostic (1.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (2.17e-1)" "unprognostic (6.92e-2)" "unprognostic (2.04e-2)" "unprognostic (1.20e-3)" "unprognostic (2.50e-2)" "unprognostic (1.75e-1)" "unprognostic (1.61e-2)" "unprognostic (4.46e-1)" "unprognostic (5.98e-2)" "unprognostic (6.11e-3)" "unprognostic (4.21e-2)" "unprognostic (7.56e-2)" "unprognostic (1.34e-2)" "unprognostic (4.03e-2)" 4.8 12.8 10.4 2.9 10.7 1.1 5.9 12.3 11.7 5.6 5.8 11.9 3.2 5.5 8.0 6.9 10.6 4.3 7.0 5.6 8.0 7.8 8.7 5.3 5.0 3.4 9.1 11.8 4.5 17.5 4.4 7.2 4.4 8.9 7.7 6.0 3.8 7.4 7.5 9.2 7.7 5.5 10.9 9.4 4.3 6.3 10.7 7.7 3.4 9.9 2.5 4.8 6.7 5.9 0.9 5.4 2.7 5.9 2.4 2.7 2.4 3.8 5.7 9.4 11.4 6.9 4.9 4.4 4.9 5.2 8.7 11.4 3.1 1.6 1.9 3.7 10.1 3.4 9.1 3.6 7.5 2.1 5.3 6.0 2.5 5.2 7.0 2.8 2.8 3.4 7.0 6.8 7.0 5.7 5.1 1.4 7.7 1.7 2.4 3.1 4.1 3.0 1.7 6.8 2.3 9.5 3.4 6.8 5.1 5.3 6.4 4.6 3.1 4.3 6.5 6.0 4.6 13.7 10.5 1.5 2.7 1.7 4.2 3.3 5.8 2.0 5.0 1.3 2.3 5.9 2.7 0.7 1.7 2.2 5.4 0.9 1.7 2.1 2.7 2.4 3.8 1.5 1.8 2.4 10.4 10.7 12.3 11.7 8.0 7.8 9.1 11.8 8.9 7.7 SERF1A "4F5, FAM2A, H4F5, SERF1, SMAM1" ENSG00000172058 "Small EDRK-rich factor 1A" O75920 5 70900665-70918530 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA075271 Approved "Nuclear bodies" "Nuclear bodies" "HPA075271: " "unprognostic (1.14e-1)" "unprognostic (3.00e-2)" "unprognostic (9.58e-2)" "unprognostic (3.07e-1)" "unprognostic (1.73e-1)" "unprognostic (3.81e-3)" "unprognostic (1.29e-3)" "unprognostic (1.40e-2)" "unprognostic (2.55e-2)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (4.13e-2)" "unprognostic (2.11e-1)" "unprognostic (1.98e-2)" "unprognostic (1.22e-2)" "unprognostic (9.53e-2)" 1.3 1.2 6.4 1.8 5.0 3.0 1.5 5.3 7.2 1.2 1.8 0.2 3.1 7.8 1.8 1.1 3.7 1.6 5.4 5.2 4.1 0.4 1.9 3.3 4.9 2.6 2.6 3.2 2.5 0.8 2.4 3.5 2.1 1.2 1.9 2.8 1.4 3.1 3.5 2.4 2.0 2.8 4.4 0.6 5.8 1.6 7.3 2.6 2.8 1.2 2.1 6.3 0.9 3.6 0.3 3.2 4.5 3.0 4.3 6.3 1.0 0.8 0.9 1.4 1.2 1.5 3.2 6.3 2.6 1.0 1.7 1.1 2.4 1.5 3.2 3.6 2.0 1.7 1.5 0.7 1.3 2.0 1.4 0.7 1.0 2.6 0.5 2.0 2.4 1.7 9.5 11.3 2.3 1.0 0.5 4.5 5.0 3.2 3.0 9.7 2.9 10.0 0.5 9.9 6.3 1.3 8.6 3.8 1.2 2.9 1.4 0.8 1.0 3.2 1.9 0.5 8.7 1.0 0.3 2.8 4.2 1.2 5.1 4.9 4.0 6.3 0.5 7.3 4.7 3.9 2.8 2.1 0.8 2.6 3.0 0.9 SERF1B "FAM2B, H4F5C" ENSG00000205572 "Small EDRK-rich factor 1B" O75920 5 70025247-70043113 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 23.8;SiHa: 38.9;SK-MEL-30: 25.9;WM-115: 20.6" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA075271 Approved "Nuclear bodies" "Nuclear bodies" "HPA075271: " "unprognostic (1.00e-1)" "unprognostic (2.52e-4)" "unprognostic (2.60e-2)" "unprognostic (1.07e-2)" "unprognostic (1.61e-1)" "unprognostic (2.32e-1)" "unprognostic (5.98e-2)" "unprognostic (4.92e-3)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-4)" "unprognostic (1.22e-1)" "unprognostic (2.16e-2)" "unprognostic (2.44e-2)" "unprognostic (7.82e-2)" "unprognostic (6.74e-2)" "unprognostic (3.52e-1)" 3.7 2.4 7.6 1.6 8.3 2.6 2.6 5.7 10.4 2.9 3.4 0.9 3.2 22.7 5.0 1.6 4.7 3.1 6.6 6.7 8.4 1.6 3.5 3.2 7.5 2.5 3.9 11.6 4.0 2.0 4.7 3.9 7.8 5.1 4.1 2.7 2.6 10.3 5.5 3.9 5.7 20.5 4.9 1.4 7.9 3.0 7.0 6.4 10.9 4.5 5.7 8.7 1.8 11.5 0.2 1.7 2.2 8.5 6.4 8.4 3.4 6.1 2.1 1.8 0.3 1.1 1.1 23.8 5.2 3.3 0.9 0.7 3.6 2.9 0.3 6.4 0.4 0.6 0.5 0.7 1.1 0.4 12.7 0.7 0.1 0.6 0.4 1.6 0.2 0.1 10.9 6.6 1.7 0.2 1.2 6.6 4.8 1.3 0.5 8.5 6.3 38.9 1.8 25.9 17.2 3.1 18.4 10.0 0.7 0.4 0.6 0.7 1.1 9.0 0.6 0.0 20.6 0.3 0.9 10.9 6.4 3.0 6.9 6.0 8.2 5.8 3.5 7.0 8.7 5.8 2.5 5.7 4.5 6.4 5.8 1.8 SERP1 "FLJ43424, RAMP4" ENSG00000120742 "Stress associated endoplasmic reticulum protein 1" Q9Y6X1 3 150541994-150603228 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 119.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038970 Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA038970: " "unprognostic (8.81e-3)" "unprognostic (2.35e-3)" "unprognostic (1.91e-1)" "unprognostic (7.29e-3)" "unprognostic (3.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.57e-2)" "unprognostic (2.35e-3)" "unprognostic (6.16e-2)" "unprognostic (1.77e-3)" "prognostic unfavourable (1.03e-5)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (2.55e-2)" "unprognostic (2.75e-2)" "unprognostic (4.75e-2)" "unprognostic (1.78e-1)" 24.5 34.2 23.1 22.4 22.6 25.4 38.0 12.5 18.4 38.6 26.7 15.6 59.9 21.4 20.2 56.7 29.6 28.1 25.1 15.1 17.4 16.5 27.7 93.6 38.1 47.8 17.5 15.6 31.5 137.6 21.1 33.0 33.2 14.7 32.9 23.8 15.6 103.1 58.9 9.7 18.1 33.5 15.6 18.9 42.9 38.4 17.8 16.0 38.4 51.3 17.3 33.6 31.2 29.8 49.6 67.9 76.4 89.1 36.8 68.2 90.5 32.4 7.0 10.6 8.0 15.7 18.4 24.5 23.2 15.0 12.7 15.0 18.1 14.3 26.2 44.9 16.7 15.9 17.2 12.0 16.9 16.1 14.9 27.8 6.0 18.3 30.7 25.0 18.7 10.9 21.5 7.3 36.9 14.8 13.5 37.1 10.8 14.0 21.1 21.8 20.0 18.1 27.6 8.1 81.5 15.3 10.4 18.4 15.7 8.9 19.7 35.1 17.3 24.6 14.3 6.1 11.2 13.1 17.8 119.6 34.1 35.2 11.1 24.6 5.6 62.2 88.3 76.4 52.9 81.8 68.2 49.6 56.9 53.3 67.5 47.9 56.7 52.1 64.4 36.8 89.1 67.9 54.3 90.5 23.1 22.6 12.5 18.4 17.4 16.5 17.5 15.6 14.7 16.0 SERP2 "bA269C23.1, C13orf21" ENSG00000151778 "Stress associated endoplasmic reticulum protein family member 2" Q8N6R1 13 44373665-44397714 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.7" "Cell line enhanced" "Detected in some" "LHCN-M2: 5.8;SH-SY5Y: 8.1;U-2197: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "basophil: 6.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038970 Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA038970: " "unprognostic (6.55e-2)" "unprognostic (1.55e-1)" "unprognostic (4.10e-2)" "unprognostic (2.06e-1)" "unprognostic (9.62e-2)" "unprognostic (1.72e-2)" "unprognostic (2.85e-1)" "unprognostic (3.48e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (1.34e-3)" "unprognostic (1.12e-2)" "prognostic favourable (1.94e-4)" "unprognostic (1.48e-1)" "unprognostic (6.60e-2)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" 1.7 3.2 30.0 2.0 34.1 0.8 4.0 14.3 40.7 2.7 2.3 3.9 1.3 4.2 4.8 12.4 1.7 3.0 1.8 14.6 24.8 20.9 2.6 1.8 2.0 2.3 19.0 15.6 5.9 2.8 1.9 2.4 1.2 10.1 4.1 2.1 2.0 2.0 5.8 1.4 1.4 3.2 3.4 10.4 1.1 2.4 15.3 6.4 1.2 2.1 0.4 2.1 1.4 1.0 0.0 0.0 6.0 0.0 1.3 0.3 0.2 0.0 0.0 3.3 0.0 0.5 2.8 0.0 0.6 0.9 3.6 2.4 0.0 0.0 0.0 2.9 2.7 0.1 0.0 0.0 3.5 0.0 0.1 0.6 0.0 0.1 3.1 0.1 0.0 0.4 0.0 2.6 0.0 0.5 0.0 0.0 5.8 0.0 0.0 0.3 3.7 0.0 0.0 0.0 0.0 1.1 0.0 3.9 8.1 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.2 7.4 0.0 0.0 0.2 0.0 1.7 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.2 30.0 34.1 14.3 37.2 24.8 20.9 19.0 15.6 10.1 6.4 SERPINA10 "PZI, ZPI" ENSG00000140093 "Serpin family A member 10" Q9UK55 14 94280455-94293271 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 223 "liver: 169.5" "Cell line enriched" "Detected in many" 8 "Hep G2: 20.7" "Cancer enriched" "Detected in some" 51 "liver cancer: 40.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048739 Approved Nucleoplasm,Cytosol "Secreted to blood" 3955000000 5900000000 Nucleoplasm Cytosol "HPA048739: " "unprognostic (7.14e-2)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-1)" "prognostic favourable (9.00e-4)" "unprognostic (6.11e-2)" "unprognostic (2.81e-4)" "unprognostic (2.31e-4)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (7.93e-3)" 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 169.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.1 0.1 0.2 0.0 0.6 0.3 2.0 0.7 0.8 0.7 0.5 0.5 0.6 0.9 0.9 2.5 0.6 2.2 0.3 0.4 0.3 2.4 0.5 1.4 0.9 1.4 2.1 0.7 20.7 0.5 1.7 1.2 0.7 0.5 0.3 0.8 1.1 0.5 1.4 1.1 0.3 1.4 1.1 0.9 0.6 0.9 1.1 0.9 0.5 0.7 1.0 0.9 0.5 0.5 0.2 1.5 0.9 0.5 0.8 0.4 0.7 0.6 1.2 0.5 1.0 1.0 1.9 0.5 0.7 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SERPINB13 "headpin, HUR7, hurpin, PI13" ENSG00000197641 "Serpin family B member 13" Q9UIV8 18 63586989-63604639 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1" "Group enriched" "Detected in some" 132 "HaCaT: 64.1;hTCEpi: 24.4" "Cancer enhanced" "Detected in many" "cervical cancer: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052630, HPA057129" Enhanced Approved "Nuclear speckles,Cytosol" 59000 "Nuclear speckles, Cytosol" "HPA052630: , HPA057129: " "unprognostic (3.49e-2)" "unprognostic (3.73e-1)" "unprognostic (1.11e-1)" "unprognostic (7.27e-2)" "unprognostic (2.28e-1)" "unprognostic (4.29e-2)" "unprognostic (2.81e-1)" "unprognostic (6.04e-3)" 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.1 37.7 0.1 0.0 0.0 0.1 3.1 0.1 70.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 10.9 0.1 0.2 5.7 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.0 0.1 107.2 54.2 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERTM1 C13orf36 ENSG00000180440 "Serine rich and transmembrane domain containing 1" A2A2V5 13 36673912-36697839 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3" "Group enriched" "Detected in some" 5 "HAP1: 2.6;HEK 293: 3.1;NTERA-2: 7.9;SH-SY5Y: 4.6" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.7" "Group enriched" "Detected in many" 7 "amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054814, HPA070485" Uncertain Enhanced Vesicles Vesicles "HPA054814: , HPA070485: " "unprognostic (8.71e-2)" "unprognostic (2.11e-1)" "unprognostic (5.58e-3)" "unprognostic (4.66e-3)" "unprognostic (4.05e-3)" "unprognostic (5.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.63e-2)" "unprognostic (1.00e-8)" "unprognostic (2.51e-2)" "unprognostic (5.60e-2)" "unprognostic (4.44e-2)" 5.0 1.8 13.9 0.5 10.1 0.5 1.2 0.3 30.2 16.4 0.7 1.3 1.8 0.6 30.9 13.5 0.5 25.3 0.5 0.6 26.5 2.0 0.6 0.5 5.6 0.5 1.5 11.6 14.5 0.8 1.0 11.2 0.5 2.4 0.9 0.5 8.2 0.5 1.2 0.5 0.6 0.6 17.4 0.9 0.5 0.9 1.5 0.0 0.0 9.3 0.0 0.5 1.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 3.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 10.1 0.3 21.6 26.5 2.0 1.5 11.6 2.4 0.0 SETDB1 "ESET, KG1T, KIAA0067, KMT1E, TDRD21" ENSG00000143379 "SET domain bifurcated 1" Q15047 1 150926263-150964744 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "U-698: 88.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018142, HPA058484" Uncertain Supported Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA018142: AB_1856757, HPA058484: " "unprognostic (1.07e-1)" "unprognostic (4.08e-1)" "unprognostic (8.02e-2)" "unprognostic (2.24e-3)" "unprognostic (1.65e-2)" "unprognostic (9.57e-2)" "prognostic unfavourable (8.88e-4)" "unprognostic (6.03e-2)" "unprognostic (9.94e-3)" "unprognostic (7.13e-2)" "unprognostic (1.21e-1)" "unprognostic (6.65e-2)" "prognostic unfavourable (4.25e-4)" "unprognostic (1.59e-1)" "unprognostic (3.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" 16.9 15.4 9.5 21.2 15.9 16.9 17.7 21.6 18.2 18.6 15.4 25.2 18.6 13.0 22.8 18.9 15.6 16.8 14.0 10.9 9.6 8.5 13.3 12.7 15.6 20.7 15.3 13.2 23.9 17.6 21.0 15.4 18.4 13.7 14.9 16.8 20.6 16.1 18.5 20.0 18.0 17.1 17.9 13.7 21.9 15.0 33.5 14.2 24.5 18.6 12.0 20.7 18.6 16.3 11.2 12.8 6.9 14.9 7.6 9.1 5.3 5.7 6.7 9.8 6.4 4.7 6.3 16.3 4.8 5.5 6.9 5.9 4.5 8.0 11.4 6.6 5.3 7.3 9.1 5.1 5.5 5.5 11.3 6.4 6.9 5.2 6.7 11.3 6.1 8.2 5.8 5.7 9.2 8.1 10.8 9.3 4.9 11.1 7.8 6.6 13.4 5.4 9.1 6.3 8.4 5.3 6.6 7.1 13.0 7.3 8.6 5.8 9.3 15.4 5.4 4.0 4.2 4.4 6.7 9.7 10.4 88.6 4.2 4.0 3.9 6.8 10.7 6.9 8.3 14.9 8.7 8.7 7.4 9.1 12.8 11.2 8.3 8.3 6.5 7.6 10.6 8.6 4.7 5.3 9.5 15.9 21.6 18.2 9.6 8.5 15.3 13.2 13.7 14.2 SEZ6 ENSG00000063015 "Seizure related 6 homolog" Q53EL9 17 28954901-29006440 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.3" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 36.1" "Cancer enriched" "Detected in many" 11 "glioma: 16.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 2.8;neutrophil: 5.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011777 Enhanced "HPA011777: AB_1856758" "unprognostic (3.99e-2)" "unprognostic (1.24e-1)" "unprognostic (5.75e-3)" "unprognostic (5.33e-3)" "unprognostic (1.84e-2)" "unprognostic (1.76e-3)" "unprognostic (2.82e-2)" "unprognostic (2.22e-2)" "unprognostic (3.07e-1)" "unprognostic (4.75e-2)" "unprognostic (1.22e-3)" "unprognostic (3.15e-3)" "unprognostic (3.63e-6)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (1.45e-1)" "unprognostic (3.15e-3)" 1.2 2.0 18.8 1.4 67.3 1.6 1.1 43.5 48.2 1.1 1.6 3.1 0.0 2.4 1.1 1.5 1.2 1.2 1.1 1.2 10.5 10.0 1.2 1.1 1.3 1.2 4.9 9.4 1.1 1.9 1.1 4.9 1.2 9.1 1.3 1.8 3.3 1.2 1.2 1.4 1.4 1.4 1.3 2.7 1.2 1.7 1.6 5.4 0.0 1.2 0.0 1.1 1.3 0.0 0.8 0.9 5.7 0.5 0.5 0.9 0.4 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 36.1 6.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.8 0.5 0.9 0.2 0.5 0.9 0.8 0.4 0.5 0.6 0.5 0.6 0.7 5.7 0.5 0.5 0.9 0.2 0.4 18.8 67.3 43.5 18.8 10.5 10.0 4.9 9.4 9.1 5.4 SEZ6L ENSG00000100095 "Seizure related 6 homolog like" Q9BYH1 22 26169474-26383597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 60.8" "Group enriched" "Detected in some" 7 "SCLC-21H: 30.0;SH-SY5Y: 8.0" "Group enriched" "Detected in some" 6 "glioma: 14.6;pancreatic cancer: 3.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 7.4;myeloid DC: 7.2;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 73 "dendritic cells: 7.2;monocytes: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045135 Approved Vesicles 2400000 Vesicles "HPA045135: " "unprognostic (1.01e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.49e-2)" "unprognostic (6.47e-2)" "unprognostic (4.19e-1)" "unprognostic (1.09e-2)" "unprognostic (5.02e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-3)" "unprognostic (7.80e-2)" "unprognostic (2.40e-6)" "unprognostic (4.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.39e-4)" "unprognostic (3.18e-1)" 1.2 12.5 26.4 1.6 11.3 1.3 1.1 20.1 60.8 2.4 1.3 4.3 0.0 1.5 1.1 1.1 1.1 1.1 1.2 2.5 39.1 23.6 1.1 1.1 1.3 1.1 11.2 25.5 1.1 2.7 1.0 3.8 1.1 15.0 1.3 1.4 0.0 1.3 1.2 1.1 1.2 1.6 1.4 5.3 1.3 2.9 1.4 5.4 0.0 1.2 0.0 1.1 1.2 0.2 0.0 7.2 0.0 7.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 30.0 8.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.5 26.4 11.3 20.1 29.3 39.1 23.6 11.2 25.5 15.0 5.4 SEZ6L2 "FLJ90517, PSK-1" ENSG00000174938 "Seizure related 6 homolog like 2" Q6UXD5 16 29871159-29899547 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.6;pituitary gland: 36.3" "Cell line enhanced" "Detected in many" "EFO-21: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064471 Enhanced 3900000 "HPA064471: " "unprognostic (2.56e-2)" "prognostic unfavourable (7.46e-4)" "prognostic unfavourable (1.31e-4)" "unprognostic (2.11e-1)" "prognostic unfavourable (5.24e-4)" "unprognostic (1.27e-1)" "unprognostic (1.67e-2)" "unprognostic (2.71e-2)" "unprognostic (8.22e-2)" "unprognostic (1.85e-1)" "unprognostic (1.43e-3)" "unprognostic (8.31e-2)" "unprognostic (1.04e-1)" "unprognostic (8.22e-2)" "unprognostic (2.30e-1)" "unprognostic (2.12e-1)" "unprognostic (1.08e-1)" 2.1 21.0 21.0 1.8 27.6 0.8 4.0 42.4 52.6 11.4 4.5 7.7 0.2 9.2 6.1 1.4 1.2 4.2 8.8 1.4 18.5 32.8 3.3 0.9 4.5 1.4 15.6 27.6 2.5 34.7 32.7 36.3 3.2 31.4 13.3 3.6 5.4 18.1 4.7 1.5 2.5 5.5 4.3 12.3 1.8 14.9 7.2 7.4 0.0 1.6 0.0 1.9 4.2 0.9 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.5 4.4 0.3 4.2 0.0 0.2 3.0 5.5 2.6 5.2 2.9 6.5 20.6 2.1 30.2 6.6 1.9 1.7 1.3 1.6 0.0 3.7 0.3 3.8 13.3 11.5 0.0 13.3 12.9 2.5 6.1 1.6 0.4 0.6 13.4 2.6 22.2 0.0 0.0 6.7 7.6 0.0 0.0 0.5 4.7 1.9 20.1 16.1 1.8 14.2 0.8 13.3 19.3 0.2 17.5 8.6 0.1 0.3 1.5 1.3 0.1 21.2 3.3 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.0 21.0 27.6 42.4 52.6 18.5 32.8 15.6 27.6 31.4 7.4 SFXN5 "BBG-TCC, SLC56A5" ENSG00000144040 "Sideroflexin 5" Q8TD22 2 72942036-73075619 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.3;liver: 31.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015473, HPA056866" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA015473: AB_1856794, HPA056866: " "unprognostic (7.75e-2)" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-3)" "unprognostic (1.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "prognostic favourable (2.26e-6)" "unprognostic (1.57e-1)" "unprognostic (8.51e-2)" "unprognostic (3.50e-1)" "unprognostic (3.23e-1)" "unprognostic (3.97e-1)" "unprognostic (1.43e-2)" 4.0 10.1 26.1 4.9 24.6 12.8 3.1 10.1 28.3 3.4 6.6 12.9 3.7 7.6 3.2 18.4 2.7 5.2 4.4 3.6 25.3 12.7 12.7 31.4 3.7 3.6 16.0 18.6 2.9 2.7 3.4 3.1 4.5 14.9 5.2 6.8 2.6 2.1 5.4 6.3 3.2 7.3 4.5 9.6 5.2 5.1 2.9 13.3 1.6 4.3 1.7 3.7 5.0 2.1 3.0 4.2 6.4 8.9 5.8 1.3 2.1 3.4 7.3 11.6 8.9 2.8 1.8 4.2 6.9 3.9 11.0 5.8 11.2 8.7 2.0 7.2 7.2 3.0 9.0 9.9 5.2 8.3 5.8 8.4 7.2 14.7 3.5 4.3 9.2 4.8 2.7 7.7 0.9 6.4 7.3 1.7 2.9 6.6 1.2 6.5 14.3 4.7 8.0 9.6 2.5 6.4 8.0 7.5 2.1 6.4 3.3 2.6 1.7 2.2 4.6 3.3 11.0 4.7 7.9 3.0 2.9 2.4 11.5 7.9 4.0 4.8 8.9 4.2 0.9 3.9 1.3 1.6 0.5 1.0 4.2 3.0 0.6 0.8 6.4 5.8 4.3 2.9 1.0 2.1 26.1 24.6 10.1 26.3 25.3 12.7 16.0 18.6 14.9 13.3 SGCA "A2, adhalin, ADL, DMDA2, LGMD2D, SCARMD1" ENSG00000108823 "Sarcoglycan alpha" Q16586 17 50164214-50175931 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 144.7" "Cell line enriched" "Detected in some" 15 "LHCN-M2: 41.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 7 "cerebellum: 3.0" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.4;memory B-cell: 5.3;myeloid DC: 3.8;naive B-cell: 5.2;non-classical monocyte: 3.1" "Group enriched" "Detected in many" 19 "B-cells: 5.3;dendritic cells: 3.8;monocytes: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007537 Uncertain "Intracellular and membrane" "HPA007537: AB_1079944" "unprognostic (1.34e-1)" "unprognostic (2.30e-2)" "unprognostic (1.89e-3)" "unprognostic (1.25e-1)" "unprognostic (9.87e-2)" "unprognostic (2.43e-2)" "unprognostic (9.25e-2)" "unprognostic (1.22e-2)" "unprognostic (1.15e-1)" "unprognostic (1.91e-1)" "unprognostic (7.01e-2)" "unprognostic (2.57e-1)" "unprognostic (2.07e-3)" "unprognostic (4.96e-2)" "unprognostic (2.16e-1)" "unprognostic (2.95e-1)" "unprognostic (1.15e-2)" 2.8 0.6 0.1 2.5 0.2 0.2 0.8 3.0 0.4 6.8 10.0 0.0 8.6 1.6 7.9 10.5 10.8 3.4 10.7 32.2 0.2 0.1 0.6 0.9 5.7 0.3 0.2 0.3 3.4 0.5 0.2 0.1 1.9 0.4 10.9 1.1 7.1 2.3 8.0 144.7 2.6 3.0 30.3 0.3 0.7 5.7 1.4 0.0 0.0 1.6 39.8 2.3 20.1 4.3 5.3 3.8 0.2 3.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 41.3 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.2 0.0 2.4 0.0 5.3 0.0 0.0 3.8 5.2 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.7 0.1 0.2 3.0 0.1 0.2 0.1 0.2 0.3 0.4 0.0 SGCB "A3b, LGMD2E, SGC" ENSG00000163069 "Sarcoglycan beta" Q16585 4 52020706-52038482 "Disease related genes, Predicted membrane proteins" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011422, HPA058656" Enhanced Approved Cytosol Cytosol "HPA011422: AB_1856795, HPA058656: " "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (1.03e-1)" "unprognostic (1.60e-3)" "unprognostic (9.80e-2)" "unprognostic (3.42e-2)" "unprognostic (3.57e-3)" "unprognostic (1.86e-2)" "unprognostic (2.84e-2)" "unprognostic (6.04e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic favourable (5.53e-6)" "unprognostic (3.74e-2)" "unprognostic (1.03e-1)" "unprognostic (1.97e-2)" "prognostic unfavourable (7.61e-4)" 17.7 13.2 17.6 5.4 19.0 0.5 8.8 18.6 20.7 14.9 18.3 17.5 3.7 7.7 17.1 7.0 13.2 11.5 11.6 32.4 16.5 14.5 20.5 6.4 9.0 3.4 20.4 12.9 12.6 4.0 29.9 17.5 13.9 17.9 15.4 9.9 7.9 7.8 17.0 54.1 4.4 8.7 21.8 24.7 6.3 9.0 9.2 20.3 0.9 7.9 10.4 2.8 13.5 11.8 4.3 1.7 0.9 2.0 0.5 6.6 2.0 3.5 4.3 9.0 3.4 34.7 26.2 3.2 19.8 25.5 11.2 11.8 1.1 4.7 0.9 3.8 26.1 1.7 6.6 7.3 12.0 5.8 2.5 0.0 4.1 2.1 14.2 2.0 1.1 28.8 5.1 9.7 5.6 14.7 0.0 0.0 23.8 1.3 4.6 0.0 3.2 6.5 0.0 4.8 0.0 9.4 1.2 5.3 9.2 12.6 0.6 4.3 1.6 1.3 14.8 16.6 5.6 7.7 17.6 4.8 6.2 1.7 12.3 0.7 19.0 0.4 2.0 0.1 3.9 0.8 3.7 4.3 4.6 4.1 0.9 3.6 3.3 4.1 0.9 0.5 0.6 1.7 6.6 2.0 17.6 19.0 18.6 17.5 16.5 14.5 20.4 12.9 17.9 20.3 SGCE DYT11 ENSG00000127990 "Sarcoglycan epsilon" O43556 7 94524204-94656572 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2" "Group enriched" "Detected in many" 4 "B-cells: 9.2;T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074790 Approved "Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane" 50000 "Vesicles, Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA074790: " "unprognostic (3.16e-3)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-3)" "unprognostic (1.12e-1)" "prognostic unfavourable (1.61e-5)" "unprognostic (1.19e-2)" "unprognostic (2.82e-2)" "unprognostic (6.93e-2)" "unprognostic (3.37e-1)" "unprognostic (6.80e-3)" "unprognostic (9.69e-2)" "unprognostic (5.71e-2)" "prognostic unfavourable (1.35e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" 22.4 35.7 16.9 7.5 19.0 0.6 23.2 23.6 18.5 22.5 20.5 16.8 14.0 5.3 23.6 16.8 11.1 17.1 19.0 19.3 17.7 14.3 12.9 8.9 17.3 9.0 21.5 12.9 59.3 12.9 8.7 23.1 31.9 15.0 15.6 9.7 11.2 11.9 22.7 6.1 3.5 8.0 28.1 20.9 15.8 11.2 13.2 17.5 2.9 15.4 6.9 4.4 22.7 16.1 9.2 0.3 0.6 0.1 1.4 2.9 0.5 3.8 12.0 12.2 19.7 19.4 36.5 2.2 14.5 29.3 12.4 18.8 7.5 22.8 3.6 20.7 25.6 2.5 18.3 6.4 16.9 0.6 9.9 0.3 11.8 8.1 15.2 1.1 0.0 29.4 9.0 18.2 23.8 8.7 0.0 28.8 14.4 12.0 0.0 0.0 9.3 9.5 5.4 15.1 7.6 24.0 3.8 7.7 6.2 0.0 16.1 18.4 5.6 0.1 0.0 39.2 13.1 3.6 22.4 14.9 18.5 4.4 14.6 0.0 22.0 0.6 0.1 0.1 2.9 0.1 1.2 6.4 0.9 1.4 0.1 9.2 0.3 1.0 0.5 1.4 0.1 0.3 0.2 0.5 16.9 19.0 23.6 18.5 17.7 14.3 21.5 12.9 15.0 17.5 SGCG "A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE" ENSG00000102683 "Sarcoglycan gamma" Q13326 13 23180952-23325165 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 40.9;skeletal muscle: 53.3;tongue: 44.3" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 37.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA007476 Enhanced "HPA007476: AB_1079946" "unprognostic (5.19e-2)" "unprognostic (8.28e-2)" "unprognostic (5.15e-3)" "unprognostic (1.64e-4)" "unprognostic (3.00e-3)" "unprognostic (3.61e-2)" "unprognostic (8.14e-3)" "unprognostic (1.46e-1)" "unprognostic (2.29e-1)" "unprognostic (4.49e-1)" "unprognostic (6.05e-2)" "unprognostic (2.23e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (2.98e-3)" "unprognostic (1.07e-1)" 8.6 0.1 0.1 0.2 0.1 0.0 2.9 0.2 0.6 0.1 0.4 0.1 0.1 0.0 0.1 3.8 2.6 0.3 0.3 40.9 0.3 0.1 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.1 1.6 0.1 0.1 0.1 1.2 0.1 0.5 2.1 0.1 53.3 1.3 0.2 0.1 0.1 0.1 0.4 0.6 0.1 0.1 0.7 44.3 3.3 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 37.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.2 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.6 0.3 0.1 0.1 0.1 0.1 0.1 SGCZ ZSG1 ENSG00000185053 "Sarcoglycan zeta" Q96LD1 8 14089864-15238339 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.2;ovary: 11.3;pituitary gland: 7.3" "Cell line enhanced" "Detected in some" "Daudi: 2.2;REH: 2.5" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "amygdala: 5.6;basal ganglia: 9.5;cerebellum: 21.2;cerebral cortex: 6.8;pons and medulla: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA017585 Uncertain "HPA017585: AB_1856799" "unprognostic (3.83e-1)" "unprognostic (1.41e-1)" "unprognostic (5.87e-4)" "unprognostic (1.21e-1)" 1.1 0.4 5.6 0.5 9.5 0.6 2.6 21.2 6.8 0.8 0.7 0.0 0.0 0.7 0.9 1.4 0.4 0.5 0.7 0.5 1.4 2.2 1.0 0.7 0.4 0.4 1.3 2.3 11.3 0.7 0.4 7.3 0.5 5.3 0.8 0.5 0.1 0.4 0.6 0.4 0.9 0.5 0.9 3.2 0.5 0.7 1.4 1.1 0.0 0.4 0.0 0.5 1.5 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.6 9.5 21.2 6.8 1.4 2.2 1.3 2.3 5.3 1.1 SGPL1 SPL ENSG00000166224 "Sphingosine-1-phosphate lyase 1" O95470 10 70815961-70881173 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021125, HPA023086" Enhanced Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA021125: AB_1856803, HPA023086: AB_1856804" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (3.07e-2)" "unprognostic (2.13e-1)" "unprognostic (2.34e-1)" "unprognostic (7.60e-2)" "unprognostic (2.98e-2)" "unprognostic (2.88e-1)" "unprognostic (1.06e-1)" "unprognostic (1.70e-2)" "unprognostic (2.12e-1)" "unprognostic (9.52e-2)" "unprognostic (3.42e-1)" "unprognostic (2.14e-1)" "unprognostic (9.21e-2)" "unprognostic (4.68e-3)" 9.6 11.2 12.0 20.2 11.4 4.9 24.4 10.8 10.6 16.2 17.1 16.0 21.9 13.3 15.5 16.8 26.7 13.5 13.4 8.3 11.3 9.8 18.2 27.1 10.4 20.1 11.9 9.5 10.0 34.6 15.4 10.2 11.3 10.4 16.1 15.6 7.6 15.0 19.5 7.6 28.6 32.5 12.1 15.7 22.9 10.3 15.3 11.0 14.7 17.6 12.8 18.0 21.4 26.8 5.6 9.7 8.9 24.8 10.9 11.5 6.6 10.5 14.1 13.6 15.5 3.7 4.9 9.0 6.2 6.7 6.8 8.9 15.3 23.4 9.5 7.4 6.3 17.8 11.7 12.5 9.7 15.2 6.2 0.9 7.2 18.2 14.2 4.1 8.6 9.2 21.2 9.1 24.0 4.2 2.8 8.3 9.6 11.7 5.0 2.8 6.1 7.8 6.5 10.4 3.5 10.8 44.8 9.3 11.3 12.4 19.1 11.3 9.9 3.0 8.1 6.1 16.2 4.7 11.9 3.4 4.7 4.4 6.1 7.7 4.3 0.6 11.5 7.9 11.5 20.3 10.4 4.7 7.5 9.4 9.7 5.6 5.7 9.0 8.9 10.9 24.8 5.4 6.8 6.6 12.0 11.4 10.8 10.4 11.3 9.8 11.9 9.5 10.4 11.0 SH3TC1 FLJ20356 ENSG00000125089 "SH3 domain and tetratricopeptide repeats 1" Q8TE82 4 8182072-8241803 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 15.0;MOLT-4: 26.0;SK-MEL-30: 14.9;U-2197: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 14.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;dendritic cells: 14.5;monocytes: 8.6" "Low region specificity" "Detected in many" "HPA038132, HPA056807" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA038132: AB_10673041, HPA056807: " "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "unprognostic (1.61e-3)" "unprognostic (5.46e-2)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.59e-2)" "unprognostic (4.24e-2)" "unprognostic (2.46e-1)" "unprognostic (3.77e-3)" "unprognostic (1.15e-2)" "unprognostic (4.29e-2)" 16.8 4.2 3.7 12.7 7.6 7.5 8.5 0.9 4.0 5.7 3.2 8.6 3.3 1.9 3.2 7.9 9.7 3.9 10.0 4.5 6.6 3.5 19.9 11.2 10.1 14.2 7.4 1.0 2.8 8.6 1.1 3.3 5.8 7.2 5.9 2.4 6.4 5.9 6.0 2.0 3.3 5.6 4.1 9.6 17.0 9.6 1.7 5.8 24.4 5.6 3.8 14.5 9.9 6.3 6.5 14.5 1.0 8.6 0.4 2.0 2.6 2.1 3.4 0.1 0.0 0.0 0.3 2.5 0.2 0.2 0.3 0.4 1.7 1.3 3.0 3.0 0.0 1.3 0.0 6.4 0.0 7.9 0.1 0.0 2.7 2.8 2.6 0.0 0.4 0.1 8.0 0.1 6.5 15.0 0.4 4.2 0.3 2.4 26.0 2.1 0.1 2.8 1.7 0.8 0.8 0.3 0.4 0.2 1.4 0.9 0.3 14.9 0.0 0.5 6.1 0.0 1.7 11.3 0.2 0.1 0.6 2.6 0.1 1.2 2.0 0.0 7.5 1.0 0.7 6.9 0.7 4.2 1.5 0.9 6.2 6.5 0.7 0.6 0.2 0.4 8.6 14.5 2.0 2.6 3.7 7.6 0.9 4.0 6.6 3.5 7.4 1.0 7.2 5.8 SHISA2 "bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166" ENSG00000180730 "Shisa family member 2" Q6UWI4 13 26044597-26051031 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8" "Cell line enhanced" "Detected in some" "LHCN-M2: 13.8;NTERA-2: 10.0;RH-30: 32.0;U-2197: 20.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049752, HPA050172" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA049752: , HPA050172: " "unprognostic (2.08e-2)" "unprognostic (3.00e-1)" "unprognostic (2.41e-1)" "unprognostic (9.71e-2)" "unprognostic (6.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-1)" "prognostic favourable (3.30e-4)" "unprognostic (4.03e-2)" "unprognostic (3.10e-1)" "unprognostic (7.45e-2)" "unprognostic (2.17e-2)" "prognostic favourable (2.43e-4)" "unprognostic (5.56e-3)" "unprognostic (2.09e-1)" "unprognostic (3.46e-1)" "unprognostic (1.51e-2)" 0.3 0.0 0.7 0.0 2.0 0.0 12.9 0.0 0.5 1.5 0.0 0.4 0.0 7.9 0.0 0.0 0.3 0.0 2.0 0.6 3.0 0.0 3.7 0.1 1.1 0.0 0.0 0.0 1.7 0.0 0.4 0.0 1.9 0.0 10.2 1.0 0.3 0.0 3.5 0.0 1.6 0.9 20.8 0.3 0.0 0.0 0.8 0.6 2.2 1.1 1.0 5.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.6 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.2 2.6 1.0 0.0 0.0 1.2 0.7 0.0 0.0 13.8 0.7 1.4 0.3 10.0 5.0 0.0 32.0 0.2 1.2 4.5 0.3 0.0 0.2 0.0 3.5 0.4 0.1 1.1 0.0 0.5 20.0 4.3 0.0 0.0 0.0 0.0 0.0 2.7 2.2 0.4 1.7 0.6 0.7 1.0 0.6 1.7 0.7 0.3 0.8 3.9 5.6 1.6 1.0 1.1 0.6 0.7 0.4 SHISA3 hShisa3 ENSG00000178343 "Shisa family member 3" A0PJX4 4 42397839-42402487 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 30.0" "Group enriched" "Detected in some" 7 "AN3-CA: 69.1;PC-3: 40.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "memory B-cell: 2.1;naive B-cell: 2.4" "Lineage enriched" "Detected in single" 25 "B-cells: 2.4" "Region enriched" "Detected in single" 24 "olfactory region: 63.3" "Low region specificity" "Detected in some" HPA054754 Approved "Lipid droplets,Cytosol" Cytosol "Lipid droplets" "HPA054754: " "unprognostic (9.04e-3)" "unprognostic (3.47e-3)" "unprognostic (1.37e-1)" "unprognostic (1.80e-2)" "unprognostic (1.26e-1)" "unprognostic (6.78e-3)" "unprognostic (1.26e-2)" "unprognostic (2.86e-1)" "unprognostic (3.04e-1)" "unprognostic (1.37e-3)" "unprognostic (3.42e-2)" "unprognostic (1.95e-1)" "unprognostic (5.99e-2)" "unprognostic (5.32e-2)" "unprognostic (3.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.99e-3)" 4.5 2.1 1.0 2.3 3.5 0.1 1.8 0.7 1.3 0.9 5.0 0.1 2.9 2.9 0.3 6.2 8.6 0.4 4.2 12.9 0.9 1.5 30.0 1.0 4.7 15.4 8.3 0.7 1.4 0.3 0.1 0.5 0.2 3.3 2.6 4.1 0.3 1.2 1.5 3.4 0.4 8.4 10.7 1.0 0.6 3.5 2.0 2.2 0.0 4.6 2.6 1.1 6.8 4.7 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 69.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 7.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 3.1 40.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 3.5 0.7 1.3 0.9 1.5 8.3 0.7 3.3 2.2 SHISA4 "C1orf40, hShisa4, TMEM58" ENSG00000198892 "Shisa family member 4" Q96DD7 1 201888680-201892306 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 175.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "eosinophil: 18.3;intermediate monocyte: 6.4;neutrophil: 8.2;non-classical monocyte: 7.8" "Group enriched" "Detected in many" 9 "granulocytes: 18.3;monocytes: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061273, HPA067885" Uncertain "HPA061273: , HPA067885: " "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (1.48e-3)" "unprognostic (2.12e-3)" "unprognostic (6.59e-2)" "unprognostic (8.29e-3)" "unprognostic (7.06e-2)" "unprognostic (5.00e-2)" "unprognostic (2.32e-1)" "unprognostic (1.44e-1)" "unprognostic (8.29e-2)" "unprognostic (2.32e-2)" "unprognostic (1.63e-3)" "unprognostic (1.20e-1)" "unprognostic (1.82e-1)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" 5.2 15.8 22.2 3.8 18.8 2.5 3.3 9.6 34.8 4.7 3.3 29.1 2.1 2.7 4.4 4.5 4.0 3.9 4.7 14.7 17.5 14.6 4.1 3.8 4.0 2.7 19.2 14.8 6.8 4.1 4.1 3.8 3.8 21.3 6.2 2.9 7.2 12.1 5.1 175.2 4.2 3.2 4.7 14.0 3.4 3.2 4.2 8.2 0.0 6.3 18.8 2.7 3.9 2.6 0.0 0.7 18.3 7.8 0.0 1.5 0.5 1.2 9.4 1.1 6.7 10.2 6.1 1.0 8.2 13.4 3.4 4.8 1.6 2.5 0.0 11.2 10.1 2.4 0.1 1.3 2.2 1.0 0.6 0.1 2.8 1.1 7.2 0.0 6.0 6.2 3.0 4.4 2.2 6.2 0.1 0.3 6.0 1.1 0.0 0.0 0.7 11.4 0.1 0.0 1.8 3.3 3.6 0.4 6.1 2.9 1.3 8.3 3.8 0.8 6.2 4.8 4.8 2.7 4.2 1.6 1.3 0.0 7.9 0.0 8.4 0.0 1.4 18.3 1.5 6.4 0.6 0.0 0.3 0.3 0.7 0.0 0.0 0.3 8.2 0.0 7.8 0.0 0.0 0.5 22.2 18.8 9.6 34.8 17.5 14.6 19.2 14.8 21.3 8.2 SHISA5 "hShisa5, SCOTIN" ENSG00000164054 "Shisa family member 5" Q8N114 3 48467798-48504826 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042295 Approved "HPA042295: AB_10794794" "unprognostic (3.52e-3)" "unprognostic (4.79e-2)" "unprognostic (1.71e-1)" "unprognostic (3.98e-2)" "unprognostic (8.58e-3)" "unprognostic (2.48e-1)" "prognostic unfavourable (3.72e-6)" "unprognostic (3.82e-3)" "unprognostic (8.76e-3)" "unprognostic (1.21e-3)" "unprognostic (1.39e-1)" "unprognostic (1.75e-1)" "prognostic unfavourable (8.64e-5)" "unprognostic (1.11e-1)" "unprognostic (6.08e-3)" "unprognostic (3.81e-3)" "unprognostic (1.74e-2)" 35.7 27.1 31.9 32.0 30.9 28.2 32.1 16.4 39.2 32.5 27.3 23.5 18.8 29.6 35.8 33.8 54.3 43.2 35.0 27.5 26.7 31.5 40.7 57.9 36.4 34.7 22.9 19.8 41.7 23.0 20.5 27.2 84.2 24.7 38.8 20.1 49.1 26.5 37.7 12.9 21.6 35.8 33.3 18.4 43.1 28.0 19.6 18.0 35.5 37.2 28.3 35.2 45.0 34.5 33.2 23.1 127.1 41.6 17.9 47.1 56.0 13.0 26.7 15.8 25.2 30.1 38.7 80.6 21.7 39.8 49.2 36.6 29.3 33.3 18.1 23.9 37.6 17.3 17.4 28.0 13.8 21.4 12.0 16.5 18.1 23.5 50.7 11.3 31.7 39.5 32.6 39.6 27.6 36.8 10.2 22.1 26.2 28.4 12.7 20.4 28.8 21.5 8.9 7.0 24.5 25.0 83.8 4.7 2.6 14.1 15.1 28.4 17.4 16.9 28.9 17.6 19.7 29.8 20.7 16.8 13.5 15.8 24.9 22.0 17.1 23.4 41.6 32.8 47.1 36.1 41.7 24.1 39.4 42.9 23.1 33.2 32.2 33.2 127.1 17.9 39.5 17.5 45.8 56.0 31.9 30.9 16.4 39.2 26.7 31.5 22.9 19.8 24.7 18.0 SHISA6 FLJ45455 ENSG00000188803 "Shisa family member 6" Q6ZSJ9 17 11241263-11564063 "Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;cervix, uterine: 22.4" "Cell line enriched" "Detected in some" 7 "NTERA-2: 7.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023440 Uncertain "HPA023440: AB_1848945" "unprognostic (1.70e-1)" "unprognostic (2.78e-2)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "prognostic unfavourable (8.41e-4)" "unprognostic (3.11e-2)" "unprognostic (1.71e-1)" "unprognostic (8.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (9.63e-2)" "unprognostic (1.27e-1)" "unprognostic (2.40e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.20e-2)" "unprognostic (2.47e-2)" 2.2 0.7 5.8 0.6 5.5 0.2 1.2 9.8 7.5 22.4 0.9 2.5 1.9 0.4 4.2 2.4 0.9 1.7 0.5 1.1 12.1 9.9 2.5 0.2 1.5 0.2 11.8 2.9 0.6 1.4 6.0 0.0 0.3 13.6 5.9 0.8 0.8 0.2 10.1 1.0 0.5 0.4 1.2 9.6 0.2 6.0 2.9 2.1 0.0 0.7 0.0 0.2 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 9.8 4.9 12.1 9.9 11.8 2.9 13.6 2.1 SHISA7 ENSG00000187902 "Shisa family member 7" A6NL88 19 55428740-55442863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 24.9" "Group enriched" "Detected in some" 5 "HEL: 6.5;HMC-1: 6.9;THP-1: 3.5" "Cancer enriched" "Detected in single" 9 "glioma: 2.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058935 Uncertain Approved Cytosol Cytosol "HPA058935: " "unprognostic (3.98e-2)" "unprognostic (5.81e-2)" "unprognostic (1.16e-1)" "unprognostic (1.28e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.08e-1)" "unprognostic (4.40e-1)" "unprognostic (7.17e-2)" "unprognostic (2.11e-3)" "unprognostic (1.22e-2)" "unprognostic (6.87e-7)" "unprognostic (7.53e-3)" "unprognostic (2.82e-1)" "unprognostic (3.29e-4)" "unprognostic (4.04e-1)" 0.7 1.7 11.3 0.7 16.7 2.6 0.7 4.0 24.9 0.7 0.8 7.2 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 11.2 8.2 0.7 0.7 0.7 0.7 8.3 3.1 0.7 0.8 0.7 2.4 0.7 5.5 0.7 0.8 0.0 0.7 0.7 0.7 0.8 0.8 0.7 4.0 0.7 0.8 2.2 14.6 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 6.5 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 1.2 0.6 0.0 1.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 16.7 4.0 10.9 11.2 8.2 8.3 3.1 5.5 14.6 SHISA8 "C22orf17, Orf26" ENSG00000234965 "Shisa family member 8" B8ZZ34 22 41909554-41914667 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 42.2" "Cell line enriched" "Detected in some" 7 "HEK 293: 20.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 15 "cerebellum: 42.2" "Cell type enhanced" "Detected in single" "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 17 "B-cells: 1.7" "Group enriched" "Detected in some" 5 "cerebellum: 8.7;olfactory region: 19.4" "Group enriched" "Detected in all" 4 "cerebellum: 61.4;olfactory region: 45.2" HPA059173 Uncertain "HPA059173: " "unprognostic (8.76e-2)" "unprognostic (2.98e-4)" "unprognostic (1.03e-1)" "prognostic favourable (2.76e-4)" "unprognostic (4.42e-2)" "unprognostic (1.45e-3)" "unprognostic (4.40e-1)" "unprognostic (1.16e-2)" "unprognostic (2.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.45e-3)" "unprognostic (2.16e-1)" "unprognostic (1.12e-1)" "unprognostic (8.59e-2)" "unprognostic (2.60e-2)" "unprognostic (6.22e-4)" "unprognostic (7.84e-2)" 0.1 9.4 0.5 1.6 0.5 0.2 0.1 42.2 2.7 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.3 0.3 0.5 0.2 0.2 0.1 0.1 3.0 0.3 1.7 0.1 0.1 0.1 0.8 0.0 2.2 0.2 0.0 1.5 1.8 0.2 0.8 0.5 0.8 0.0 0.3 2.7 0.7 0.2 0.0 0.0 0.1 0.0 3.8 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 42.2 2.7 0.5 0.2 0.3 1.7 2.2 0.0 SHISAL1 KIAA1644 ENSG00000138944 "Shisa like 1" Q3SXP7 22 44243667-44312851 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9" "Cell line enhanced" "Detected in some" "SiHa: 16.7;U-2197: 37.9;U-87 MG: 22.0;WM-115: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051178 Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA051178: " "unprognostic (4.07e-3)" "unprognostic (9.01e-2)" "unprognostic (1.83e-1)" "unprognostic (1.14e-1)" "unprognostic (6.54e-2)" "unprognostic (1.22e-1)" "unprognostic (7.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.10e-3)" "unprognostic (1.93e-3)" "unprognostic (1.33e-1)" "unprognostic (1.99e-1)" "unprognostic (1.51e-7)" "unprognostic (1.48e-2)" "unprognostic (2.41e-1)" "unprognostic (1.99e-4)" "unprognostic (1.10e-4)" 0.7 1.3 13.8 1.3 3.6 0.0 0.5 1.6 13.0 22.5 7.7 0.5 6.9 1.4 34.2 4.5 1.5 1.9 2.3 0.5 5.4 9.1 0.5 0.5 0.6 0.5 3.6 0.5 1.7 0.6 0.1 0.8 5.7 0.5 5.8 1.5 0.5 0.5 8.9 0.5 0.4 0.8 31.9 0.5 0.5 0.5 1.5 0.5 0.5 0.5 0.5 0.5 11.9 3.3 0.0 0.1 0.7 0.0 0.2 0.1 0.0 0.0 0.1 1.6 0.5 0.0 0.0 0.0 0.4 1.1 1.1 0.6 0.0 0.0 0.0 0.0 1.0 0.0 2.3 0.1 0.1 0.0 1.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 6.1 0.0 16.7 0.0 0.1 0.0 0.1 0.0 6.2 0.9 37.9 0.2 0.0 0.0 0.0 22.0 0.0 12.7 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 0.0 13.8 3.6 1.6 11.8 5.4 9.1 3.6 0.5 0.5 0.5 SHISAL2A "FAM159A, MGC52498" ENSG00000182183 "Shisa like 2A" Q6UWV7 1 52633344-52669683 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 10.8;lymphoid tissue: 25.4" "Cell line enhanced" "Detected in some" "Daudi: 5.3;Karpas-707: 12.7;NB-4: 3.6;RPMI-8226: 16.7" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "hypothalamus: 8.8" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 10.8;NK-cells: 5.7;T-cells: 7.9" "Region enhanced" "Detected in single" "hypothalamus: 4.7" "Low region specificity" "Detected in many" HPA030744 Uncertain "HPA030744: AB_10963060" "unprognostic (7.94e-6)" "unprognostic (8.50e-3)" "unprognostic (8.29e-3)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (9.67e-4)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (2.22e-2)" "unprognostic (4.45e-2)" "unprognostic (2.98e-2)" "unprognostic (1.20e-1)" "unprognostic (1.31e-3)" "unprognostic (7.27e-2)" "unprognostic (2.79e-1)" "unprognostic (6.50e-2)" "unprognostic (2.64e-2)" 0.6 0.4 1.0 25.4 1.4 3.5 0.5 1.3 2.0 1.3 1.2 1.2 0.0 1.0 1.1 1.9 1.0 0.9 1.3 0.3 0.9 8.8 0.8 0.4 1.2 20.4 2.8 0.2 0.2 0.7 0.0 3.2 0.5 1.2 0.7 0.9 0.6 3.7 1.0 0.7 0.2 5.7 0.6 2.1 12.1 1.2 1.2 0.7 3.5 1.3 0.3 24.0 3.2 0.4 10.8 0.1 1.9 0.0 5.7 7.9 1.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 3.6 2.1 0.0 0.0 0.0 16.7 0.1 0.0 0.5 0.0 1.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 7.9 0.0 4.5 10.7 7.2 6.4 0.1 10.8 5.0 3.1 0.0 5.7 0.0 0.1 2.2 1.8 1.0 1.4 1.3 2.0 0.9 8.8 2.8 0.2 1.2 0.7 SHISAL2B FAM159B ENSG00000145642 "Shisa like 2B" A6NKW6 5 64690308-64718090 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 7.3;pancreas: 16.1;stomach 1: 7.7" "Group enriched" "Detected in some" 4 "NTERA-2: 5.8;RPTEC TERT1: 12.1" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 3.9" "Group enriched" "Detected in some" 14 "basal ganglia: 1.9;hypothalamus: 7.3;pons and medulla: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011778 Enhanced "HPA011778: AB_1848382" "unprognostic (5.83e-2)" "unprognostic (9.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.84e-2)" "unprognostic (3.25e-1)" "unprognostic (5.01e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.97e-1)" "unprognostic (4.84e-2)" "unprognostic (5.36e-5)" "unprognostic (1.44e-1)" "unprognostic (1.98e-1)" "unprognostic (5.60e-1)" "unprognostic (6.99e-2)" 0.1 0.0 0.3 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.3 0.2 0.0 0.2 0.0 0.2 0.0 0.2 16.1 0.0 0.1 0.5 4.9 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.6 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 12.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.2 0.3 7.3 0.2 0.0 4.9 0.2 SI ENSG00000090402 Sucrase-isomaltase P14410 3 164978898-165078495 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 123 "intestine: 181.4" "Cell line enhanced" "Detected in some" "BEWO: 2.8;CACO-2: 4.0;HeLa: 3.1;NB-4: 3.3;RPMI-8226: 4.8;SH-SY5Y: 2.9" "Cancer enhanced" "Detected in some" "stomach cancer: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011897 Enhanced "HPA011897: AB_1856840" "unprognostic (2.71e-2)" "unprognostic (1.62e-2)" "unprognostic (2.68e-1)" "unprognostic (2.05e-1)" "unprognostic (4.41e-2)" 0.1 0.1 0.1 1.4 0.1 0.0 0.1 0.1 0.1 0.1 93.3 0.0 0.0 94.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 5.4 0.0 0.1 0.0 0.1 0.1 181.4 0.0 0.1 0.1 0.1 0.7 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.6 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 SIDT2 CGI-40 ENSG00000149577 "SID1 transmembrane family member 2" Q8NBJ9 11 117178733-117197445 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 83.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 25.6;non-classical monocyte: 41.6" "Lineage enriched" "Detected in many" 6 "monocytes: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052352 Approved "HPA052352: " "unprognostic (3.83e-1)" "unprognostic (4.30e-2)" "unprognostic (9.92e-2)" "unprognostic (1.03e-1)" "unprognostic (3.01e-2)" "unprognostic (1.69e-1)" "unprognostic (3.34e-1)" "unprognostic (1.84e-1)" "unprognostic (1.39e-1)" "unprognostic (3.12e-1)" "unprognostic (2.67e-3)" "unprognostic (1.29e-1)" "prognostic unfavourable (4.18e-5)" "unprognostic (2.74e-2)" "unprognostic (2.20e-1)" "unprognostic (4.36e-2)" "unprognostic (5.22e-3)" 23.9 12.1 9.6 12.5 15.9 7.0 23.5 16.2 18.0 12.7 19.2 28.0 19.4 27.1 16.6 14.3 8.7 13.0 15.6 14.9 11.2 10.0 10.0 21.2 29.7 21.3 15.0 14.5 30.6 83.9 12.0 17.4 13.8 17.4 24.5 14.9 14.1 25.5 16.7 11.1 19.5 31.7 18.2 25.4 17.3 35.4 13.8 13.0 6.2 15.4 8.4 12.5 16.1 9.7 7.3 3.5 0.5 41.6 0.4 0.6 2.8 4.3 4.6 5.7 7.9 19.1 17.2 18.8 7.9 10.4 5.1 4.7 12.3 17.5 4.6 12.6 20.7 4.8 5.5 6.1 4.2 6.8 6.6 3.0 8.1 9.0 9.9 2.7 8.4 21.2 6.8 6.5 7.1 10.2 6.1 10.4 11.8 9.5 3.8 3.2 2.6 3.5 2.9 3.9 13.1 6.7 4.8 1.7 4.2 8.4 20.6 1.3 16.6 3.3 6.3 6.7 4.4 4.4 1.8 7.3 2.6 4.8 3.8 5.7 4.9 0.1 4.2 0.1 0.6 25.6 0.5 5.7 0.3 0.4 3.5 7.3 0.5 0.4 0.5 0.4 41.6 1.9 0.4 2.8 9.6 15.9 16.2 18.0 11.2 10.0 15.0 14.5 17.4 13.0 SIGIRR "IL-1R8, TIR8" ENSG00000185187 "Single Ig and TIR domain containing" Q6IA17 11 405716-417455 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 67.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023188 Approved Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center, Cytosol" "HPA023188: AB_1856856" "unprognostic (6.21e-3)" "prognostic favourable (7.44e-5)" "unprognostic (7.30e-2)" "prognostic favourable (1.34e-5)" "unprognostic (6.85e-2)" "prognostic favourable (9.08e-4)" "unprognostic (4.03e-1)" "unprognostic (1.39e-2)" "unprognostic (8.44e-2)" "unprognostic (1.67e-1)" "unprognostic (2.32e-2)" "unprognostic (1.31e-1)" "prognostic favourable (7.61e-6)" "unprognostic (1.00e-3)" "unprognostic (1.76e-1)" "unprognostic (7.63e-2)" "prognostic favourable (1.54e-5)" 11.0 3.2 11.8 19.3 12.3 18.1 17.7 2.4 12.3 10.7 16.9 11.2 16.2 18.6 11.0 14.5 13.7 16.3 12.8 12.9 11.1 10.1 29.4 67.0 14.9 25.6 11.7 8.5 9.6 22.7 10.0 7.3 6.2 15.6 14.2 9.2 15.2 22.1 13.4 6.4 4.5 20.4 11.2 17.7 28.7 17.7 7.4 10.2 12.4 15.4 8.8 18.0 11.3 13.3 11.4 12.9 17.4 16.7 27.8 38.9 22.8 7.8 21.5 1.3 7.5 1.2 6.4 15.7 1.2 1.8 3.6 3.2 9.9 49.4 2.2 5.8 6.8 11.3 3.5 4.0 0.6 6.7 13.1 4.3 4.3 0.2 4.0 3.5 7.5 3.4 0.8 0.6 0.5 10.5 4.4 0.1 1.0 26.4 10.4 12.2 7.8 11.8 13.4 0.0 7.7 2.6 5.3 13.3 6.5 0.1 7.3 9.4 9.3 2.9 12.1 1.2 1.5 1.8 0.0 2.7 4.5 5.4 4.9 8.3 4.2 17.4 13.0 11.2 38.9 13.9 30.9 11.4 32.5 33.7 12.9 8.6 29.8 28.9 7.0 27.8 16.7 4.9 29.9 22.8 11.8 12.3 2.4 12.3 11.1 10.1 11.7 8.5 15.6 10.2 SIGLEC1 "CD169, dJ1009E24.1, FLJ00051, FLJ00055, FLJ00073, FLJ32150, sialoadhesin, SIGLEC-1, SN" ENSG00000088827 "Sialic acid binding Ig like lectin 1" Q9BZZ2 20 3686970-3707128 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Endocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.7" "Cell line enriched" "Detected in single" 18 "THP-1: 6.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "classical monocyte: 4.1;intermediate monocyte: 2.5;myeloid DC: 1.9;plasmacytoid DC: 1.2" "Group enriched" "Detected in many" 20 "dendritic cells: 1.9;monocytes: 4.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA053457 Supported "Intracellular and membrane" 110000 "HPA053457: " "unprognostic (2.05e-1)" "unprognostic (9.27e-3)" "unprognostic (3.83e-4)" "unprognostic (4.87e-3)" "unprognostic (3.40e-2)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (6.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.68e-1)" "unprognostic (1.40e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (8.69e-5)" "unprognostic (8.71e-2)" "prognostic unfavourable (4.36e-4)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" 11.6 8.0 1.5 4.5 2.0 7.0 4.7 1.5 1.9 1.5 4.4 1.5 1.5 2.9 1.5 1.5 3.1 4.2 5.3 3.5 1.5 0.1 2.9 4.9 9.7 35.7 2.1 1.5 1.6 1.5 0.0 1.5 12.2 3.0 1.5 4.1 1.8 6.3 1.5 3.2 1.5 5.9 4.6 1.5 12.0 2.9 1.5 1.5 2.8 1.9 3.4 1.8 4.8 1.7 0.0 1.9 0.0 4.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 2.5 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 1.5 2.0 1.5 1.9 1.5 0.1 2.1 1.5 3.0 1.5 SIGLEC10 "MGC126774, PRO940, SIGLEC-10, SLG2" ENSG00000142512 "Sialic acid binding Ig like lectin 10" Q96LC7 19 51410021-51417803 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 99.9;lymphoid tissue: 74.6" "Cell line enhanced" "Detected in some" "Daudi: 20.8;HEL: 10.6;HMC-1: 8.5;NB-4: 6.5;U-698: 15.3;U-937: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 99.9;intermediate monocyte: 33.9;non-classical monocyte: 66.7" "Group enriched" "Detected in many" 14 "granulocytes: 99.9;monocytes: 66.7" "CAB025807, HPA027093" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" Cytosol "Plasma membrane, Actin filaments" "CAB025807: , HPA027093: AB_1856858" "unprognostic (7.18e-2)" "unprognostic (3.90e-3)" "unprognostic (1.11e-2)" "unprognostic (3.67e-2)" "unprognostic (3.95e-2)" "unprognostic (9.41e-2)" "unprognostic (8.18e-2)" "unprognostic (2.11e-1)" "unprognostic (3.16e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "unprognostic (3.12e-1)" "prognostic unfavourable (4.74e-5)" "unprognostic (2.73e-1)" "unprognostic (1.69e-2)" "unprognostic (1.39e-1)" "unprognostic (9.05e-2)" 2.6 6.2 4.5 24.6 9.8 9.1 1.4 0.7 4.9 2.7 3.7 5.7 0.0 5.3 1.3 0.7 2.2 2.7 2.7 1.6 3.3 3.0 2.6 7.2 7.7 74.6 6.6 1.8 1.2 2.4 0.2 2.5 1.1 7.7 2.6 3.3 0.7 2.3 0.7 0.6 0.9 9.6 3.2 7.4 37.0 3.1 0.9 4.8 2.0 1.2 0.2 13.2 4.8 1.3 5.8 5.1 99.9 66.7 0.0 0.1 4.4 0.1 0.0 0.4 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.9 20.8 0.6 0.0 0.4 0.0 0.1 0.0 6.4 1.5 10.6 0.2 0.1 0.0 4.8 8.5 0.0 0.0 0.1 0.0 0.0 0.5 1.0 0.0 0.4 0.1 6.5 0.6 0.3 1.3 0.1 0.4 0.0 0.2 0.3 0.3 0.3 0.1 0.2 0.1 3.9 0.5 0.5 1.0 0.4 0.2 1.0 0.2 15.3 0.4 8.8 0.3 1.5 5.6 99.9 0.1 33.9 0.0 5.8 0.0 0.0 5.1 3.6 0.0 0.0 11.5 0.0 66.7 0.2 0.1 4.4 4.5 9.8 0.7 4.9 3.3 3.0 6.6 1.8 7.7 4.8 SIGLEC11 ENSG00000161640 "Sialic acid binding Ig like lectin 11" Q96RL6 19 49948985-49961172 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "lymphoid tissue: 11.3;ovary: 36.6" "Cell line enriched" "Detected in some" 15 "HEL: 15.0" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA052132, HPA060278" Approved Uncertain "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA052132: , HPA060278: " "unprognostic (1.07e-1)" "unprognostic (2.85e-3)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (3.35e-2)" "unprognostic (9.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.20e-1)" "unprognostic (8.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.41e-1)" "unprognostic (9.95e-3)" "unprognostic (5.38e-2)" 0.4 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.1 36.6 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 11.3 1.8 0.5 0.0 0.0 0.3 0.0 0.6 0.5 2.6 3.3 0.8 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.2 15.0 0.2 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.4 0.2 0.1 0.3 0.1 0.1 0.2 0.3 0.1 0.0 0.2 0.2 0.5 1.0 2.6 0.1 3.3 0.1 0.5 0.2 0.1 0.5 0.6 0.1 0.2 1.4 0.8 3.3 0.3 0.0 0.3 SIGLEC14 ENSG00000254415 "Sialic acid binding Ig like lectin 14" Q08ET2 19 51642553-51646801 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 48.7;bone marrow: 13.3;lymphoid tissue: 21.6" "Cell line enriched" "Detected in some" 4 "HMC-1: 46.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 25.8;intermediate monocyte: 29.7;myeloid DC: 15.9;neutrophil: 48.7;non-classical monocyte: 21.3" "Group enriched" "Detected in many" 6 "dendritic cells: 15.9;granulocytes: 48.7;monocytes: 29.7" HPA014377 Uncertain 18000000 "HPA014377: AB_2189277" "unprognostic (3.05e-1)" "unprognostic (1.75e-1)" "unprognostic (6.47e-3)" "unprognostic (1.60e-1)" "unprognostic (3.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (9.77e-3)" "unprognostic (9.28e-2)" "unprognostic (6.73e-2)" "unprognostic (1.02e-1)" "unprognostic (4.28e-3)" "unprognostic (8.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.34e-1)" "unprognostic (1.89e-1)" 1.6 1.6 0.6 13.0 0.5 13.3 0.5 0.0 0.3 0.6 0.6 0.0 0.4 0.0 0.2 1.7 1.0 0.8 0.6 0.6 0.4 1.4 5.1 6.2 1.3 0.1 0.3 0.0 0.1 0.9 0.4 0.4 0.7 0.1 0.0 0.0 4.0 0.9 1.9 21.6 0.7 1.3 0.2 7.0 2.2 0.2 4.9 15.9 48.7 29.7 0.1 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.7 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 3.6 25.8 0.4 0.0 29.7 0.0 4.9 0.0 0.0 15.9 4.8 0.0 0.0 48.7 0.1 21.3 2.9 0.0 7.6 SIGLEC15 "CD33L3, HsT1361" ENSG00000197046 "Sialic acid binding Ig like lectin 15" Q6ZMC9 18 45825512-45844080 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 5.9" "Group enriched" "Detected in some" 7 "PC-3: 8.5;U-87 MG: 25.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 5.9;myeloid DC: 2.1" "Group enriched" "Detected in many" 40 "dendritic cells: 2.1;monocytes: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053509 Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA053509: " "unprognostic (3.89e-3)" "unprognostic (1.87e-2)" "unprognostic (1.77e-1)" "unprognostic (7.18e-3)" "unprognostic (2.27e-1)" "unprognostic (8.07e-2)" "unprognostic (5.91e-2)" "unprognostic (2.71e-1)" "unprognostic (9.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-2)" "unprognostic (7.65e-2)" "unprognostic (6.55e-2)" "unprognostic (1.42e-1)" "unprognostic (6.06e-2)" "unprognostic (4.40e-2)" "prognostic favourable (9.14e-5)" 1.1 0.3 0.1 4.3 0.1 0.0 3.0 0.2 0.1 2.1 0.2 0.0 0.0 1.6 0.3 0.0 0.3 0.3 3.4 1.9 0.1 0.1 0.5 1.4 2.0 0.9 0.1 0.0 0.5 0.2 0.0 0.1 1.1 0.0 1.1 0.1 0.1 0.2 0.2 0.7 0.3 2.5 3.2 0.1 3.7 0.9 0.3 0.0 1.2 0.2 0.0 2.6 4.2 0.2 0.0 2.1 0.0 5.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 0.8 0.1 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.3 0.0 0.0 0.0 25.7 0.6 0.0 0.0 5.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 SIGLEC5 "CD170, CD33L2, OB-BP2, SIGLEC-5" ENSG00000105501 "Sialic acid binding Ig like lectin 5" O15389 19 51611927-51645545 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 46.7;bone marrow: 13.5" "Group enriched" "Detected in some" 6 "HMC-1: 34.9;U-937: 14.5" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.7" "Cell type enhanced" "Detected in many" "neutrophil: 46.7" "Group enriched" "Detected in many" 6 "granulocytes: 46.7;monocytes: 13.7" "HPA009085, CAB024900" Supported "CAB024900: , HPA009085: AB_1079965" "unprognostic (1.83e-1)" "unprognostic (1.94e-1)" "unprognostic (2.02e-2)" "unprognostic (1.03e-2)" "unprognostic (4.39e-2)" "unprognostic (1.62e-2)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (3.28e-1)" "unprognostic (7.44e-2)" "unprognostic (1.01e-1)" "unprognostic (4.05e-1)" "unprognostic (3.71e-4)" "unprognostic (4.37e-2)" "unprognostic (3.55e-3)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" 1.2 0.4 0.4 6.4 0.5 13.5 0.2 0.1 0.2 0.1 0.3 0.0 0.2 0.0 0.2 0.1 0.3 0.3 0.3 0.2 0.2 1.2 1.5 2.5 0.5 0.1 0.2 0.0 0.2 0.5 0.2 0.4 0.4 0.0 0.0 0.1 3.4 0.5 0.7 5.9 0.3 0.7 0.2 1.9 0.8 0.1 0.8 4.7 46.7 13.7 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 34.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 3.6 6.4 0.1 0.0 7.5 0.0 0.8 0.0 0.0 4.7 0.7 0.0 0.0 46.7 0.2 13.7 1.5 0.0 2.0 SIGLEC6 "CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6" ENSG00000105492 "Sialic acid binding Ig like lectin 6" O43699 19 51519525-51531856 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "placenta: 87.4" "Cell line enriched" "Detected in some" 7 "HMC-1: 100.5" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 33 "B-cells: 6.5;dendritic cells: 6.8;granulocytes: 2.3" "HPA009084, HPA018198" Enhanced "Intracellular and membrane" "HPA009084: AB_1079967, HPA018198: AB_1856868" "unprognostic (1.97e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (9.31e-3)" "unprognostic (8.46e-4)" "unprognostic (2.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.64e-1)" "unprognostic (8.96e-2)" "unprognostic (2.03e-1)" "unprognostic (6.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.15e-2)" "unprognostic (4.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.57e-3)" 1.8 0.0 0.0 5.6 0.0 0.1 0.8 0.0 0.1 1.2 1.7 0.0 0.3 0.9 2.0 1.2 1.5 0.5 8.6 0.4 0.0 0.0 0.4 0.1 4.2 1.5 0.0 0.0 0.1 0.3 0.1 0.1 87.4 0.0 3.7 1.5 0.5 1.4 1.0 0.2 1.3 6.0 3.1 0.0 1.3 1.7 1.0 0.0 0.3 0.2 1.0 2.6 2.2 1.9 6.5 6.8 2.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.2 100.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.4 2.8 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SIGLEC8 "MGC59785, SAF2, SIGLEC-8, SIGLEC8L" ENSG00000105366 "Sialic acid binding Ig like lectin 8" Q9NYZ4 19 51450847-51458456 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 63.0" "Cell line enriched" "Detected in some" 45 "HMC-1: 57.4" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 42 "eosinophil: 63.0" "Lineage enriched" "Detected in single" 623 "granulocytes: 63.0" HPA012556 Uncertain Uncertain Cytosol Cytosol "HPA012556: AB_1856869" "unprognostic (1.27e-1)" "unprognostic (1.88e-4)" "unprognostic (1.28e-1)" "unprognostic (6.70e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-2)" "unprognostic (7.84e-2)" "unprognostic (2.51e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-1)" "unprognostic (1.10e-1)" "unprognostic (4.19e-1)" "unprognostic (8.62e-3)" "unprognostic (7.18e-2)" "unprognostic (6.02e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" 0.6 6.7 5.8 2.4 8.4 0.7 2.3 0.7 7.0 1.4 2.9 7.4 0.0 2.9 1.0 1.1 1.1 1.1 2.7 0.3 8.6 4.8 0.4 1.6 4.1 9.6 8.3 3.6 0.3 0.7 0.7 1.2 0.1 7.5 1.0 2.8 0.1 1.1 0.9 0.3 0.8 4.5 1.5 14.8 9.2 2.1 0.5 6.2 0.6 0.7 0.0 4.1 2.0 0.7 0.0 0.0 63.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 57.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.5 0.1 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.8 8.4 0.7 5.6 8.6 4.8 8.3 3.6 7.5 6.2 SIGLEC9 CD329 ENSG00000129450 "Sialic acid binding Ig like lectin 9" Q9Y336 19 51124908-51136651 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.7;lymphoid tissue: 25.1" "Group enriched" "Detected in some" 10 "Karpas-707: 20.7;RPMI-8226: 14.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "classical monocyte: 40.6;intermediate monocyte: 36.5;myeloid DC: 34.1;neutrophil: 42.7;non-classical monocyte: 22.9" "Group enriched" "Detected in many" 12 "dendritic cells: 34.1;granulocytes: 42.7;monocytes: 40.6" HPA010682 Uncertain 220000 "HPA010682: AB_1079968" "unprognostic (2.31e-1)" "unprognostic (3.99e-2)" "unprognostic (1.03e-2)" "unprognostic (1.36e-1)" "unprognostic (4.69e-2)" "unprognostic (6.86e-2)" "unprognostic (5.10e-2)" "unprognostic (2.10e-1)" "unprognostic (1.31e-1)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (7.03e-3)" "prognostic unfavourable (6.17e-5)" "unprognostic (6.56e-2)" "unprognostic (7.38e-3)" "unprognostic (2.95e-1)" "unprognostic (1.73e-1)" 8.5 5.7 6.6 17.0 12.6 7.6 7.4 0.9 5.0 1.7 2.5 4.0 0.0 1.6 1.4 2.8 1.1 3.7 4.9 2.9 6.2 2.3 4.5 5.5 9.0 15.8 8.4 0.7 3.2 1.8 5.8 1.5 7.5 8.1 1.6 2.4 1.3 2.3 0.9 0.8 0.9 2.6 6.1 8.8 25.1 2.0 1.9 9.6 0.8 1.4 0.0 2.3 3.7 1.2 0.0 34.1 42.7 40.6 0.5 3.2 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.8 1.3 0.0 2.5 40.6 0.3 3.2 36.5 1.8 0.0 0.5 1.2 34.1 0.0 0.1 0.6 42.7 0.5 22.9 1.8 0.1 14.4 6.6 12.6 0.9 5.0 6.2 2.3 8.4 0.7 8.1 9.6 SIGMAR1 "OPRS1, SR-BP1" ENSG00000147955 "Sigma non-opioid intracellular receptor 1" Q99720 9 34634722-34637809 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Receptor "Amyotrophic lateral sclerosis, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013470, HPA018002, HPA024071" Approved "CAB013470: AB_2533521, HPA018002: AB_1854802, HPA024071: AB_1854803" "unprognostic (1.39e-1)" "unprognostic (2.64e-1)" "unprognostic (1.56e-1)" "unprognostic (1.95e-1)" "unprognostic (8.06e-2)" "unprognostic (3.71e-2)" "unprognostic (4.89e-2)" "unprognostic (2.50e-2)" "unprognostic (2.58e-2)" "unprognostic (2.01e-3)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (2.78e-2)" "unprognostic (2.46e-1)" "unprognostic (2.39e-1)" "unprognostic (6.44e-3)" "prognostic unfavourable (3.42e-4)" 15.3 19.7 9.2 9.8 14.5 8.5 13.0 9.4 16.1 17.0 18.2 13.4 13.3 23.0 18.6 13.4 18.6 17.4 17.1 12.1 9.4 12.0 14.2 89.1 9.6 14.5 10.7 10.7 20.1 22.9 15.0 8.3 17.8 14.0 18.9 13.2 15.7 12.0 19.6 7.7 16.8 24.9 15.1 9.2 9.8 14.6 9.4 9.3 9.6 11.8 15.0 15.8 16.4 15.2 14.0 23.8 12.4 19.3 13.1 32.6 20.1 40.7 36.2 12.5 41.0 46.5 32.3 16.2 29.7 20.1 26.2 24.3 22.6 17.8 20.0 17.7 32.2 25.5 16.0 33.7 5.7 34.8 43.3 19.1 53.9 24.7 30.6 32.8 16.6 32.6 36.1 28.9 35.9 19.8 7.1 37.1 28.1 0.2 19.9 47.6 15.8 47.0 23.3 14.0 56.2 23.9 8.1 14.8 16.6 29.5 21.1 15.6 25.0 22.4 16.7 21.8 17.5 22.9 4.4 10.3 16.2 0.5 22.5 28.6 45.0 10.5 19.1 12.4 22.2 18.4 24.2 14.0 32.6 26.7 23.8 10.8 27.8 22.6 5.4 13.1 19.3 17.5 29.9 20.1 9.2 14.5 9.4 16.1 9.4 12.0 10.7 10.7 14.0 9.3 SIK1 "msk, SNF1LK" ENSG00000142178 "Salt inducible kinase 1" P57059 21 43414483-43427189 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell cycle, Differentiation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 34.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.7;HeLa: 27.8;hTCEpi: 21.5;LHCN-M2: 21.6;U-266/84: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 10 "B-cells: 2.0;dendritic cells: 1.6" "CAB023801, HPA038211, HPA078064" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB023801: , HPA038211: , HPA078064: " "unprognostic (4.06e-2)" "unprognostic (9.38e-2)" "unprognostic (3.31e-3)" "unprognostic (3.00e-1)" "unprognostic (5.02e-2)" "unprognostic (7.97e-3)" "unprognostic (1.51e-1)" "unprognostic (7.30e-3)" "unprognostic (2.35e-3)" "unprognostic (4.97e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-1)" "unprognostic (3.89e-1)" "unprognostic (9.94e-3)" "unprognostic (3.88e-2)" "unprognostic (2.89e-1)" "unprognostic (1.82e-1)" 8.8 2.3 3.0 3.6 3.0 5.9 7.5 3.0 3.0 13.5 3.0 3.0 3.0 0.0 3.0 3.0 12.9 5.5 10.7 7.1 3.0 0.8 3.0 12.3 5.4 3.0 3.0 3.0 13.7 7.3 3.5 5.7 8.2 3.0 3.9 0.1 3.0 4.6 9.8 5.0 34.5 3.0 3.3 3.0 4.0 5.3 3.0 3.0 3.0 3.9 3.0 3.0 10.5 6.1 2.0 1.6 0.0 0.1 0.0 0.1 0.1 0.5 1.7 2.0 0.0 0.1 0.8 0.7 0.9 0.3 1.6 1.3 2.4 0.0 2.4 0.7 0.2 11.1 1.6 16.7 1.0 0.1 0.5 0.7 27.8 0.9 2.3 0.7 0.1 1.0 21.5 0.4 5.1 0.3 0.1 0.5 21.6 0.1 0.4 1.7 0.8 1.5 0.0 0.3 2.5 1.9 6.3 0.0 0.0 10.9 1.8 0.4 1.1 0.3 3.7 0.4 2.0 0.1 0.0 4.3 15.7 0.4 4.6 2.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.1 0.5 0.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 3.0 3.0 3.0 3.0 3.0 0.8 3.0 3.0 3.0 3.0 SIK1B ENSG00000275993 "Salt inducible kinase 1B (putative)" 21 6111134-6123739 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 29.9;Karpas-707: 40.7;LHCN-M2: 28.0;SiHa: 29.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 6 "B-cells: 1.6;dendritic cells: 5.0;monocytes: 1.7" "HPA038211, HPA078064" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA038211: , HPA078064: " "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.57e-2)" "unprognostic (8.85e-2)" "unprognostic (3.32e-2)" "unprognostic (2.44e-1)" "unprognostic (6.58e-3)" "unprognostic (2.62e-2)" "unprognostic (6.56e-2)" "unprognostic (3.15e-2)" "unprognostic (5.52e-3)" "unprognostic (1.01e-2)" "unprognostic (9.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.41e-1)" "unprognostic (2.69e-3)" "unprognostic (7.41e-2)" 9.7 13.7 0.4 3.0 1.7 8.4 5.2 0.4 3.1 2.9 3.0 1.3 4.6 0.9 3.1 1.9 6.8 1.0 15.5 6.2 1.5 1.7 12.3 8.5 1.2 1.8 0.6 10.2 11.2 1.6 2.2 3.2 2.6 5.1 2.3 7.6 3.9 14.3 9.1 2.9 6.1 1.7 2.1 2.0 5.0 1.7 1.0 1.0 0.9 5.6 3.2 7.1 2.7 1.6 5.0 0.0 1.7 0.3 0.5 0.1 3.1 15.7 1.2 1.0 0.2 0.1 2.8 0.4 0.2 0.6 0.3 17.6 2.3 1.1 0.5 0.0 0.3 1.8 0.0 0.2 2.8 0.6 2.4 29.9 3.3 1.1 0.4 0.2 0.4 13.9 1.6 9.1 0.6 0.9 40.7 28.0 1.5 0.3 0.7 1.7 1.8 0.6 7.2 4.7 1.6 5.4 1.5 0.7 29.4 1.9 1.6 0.3 1.3 0.8 0.4 1.6 0.6 6.5 5.6 12.2 0.5 4.5 1.0 1.9 0.0 0.1 0.0 0.1 0.8 0.5 1.6 0.0 0.1 0.7 1.6 0.1 0.1 0.0 0.3 1.7 5.0 0.0 0.1 SIK2 "DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2" ENSG00000170145 "Salt inducible kinase 2" Q9H0K1 11 111602391-111730853 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016026 Approved Approved "Golgi apparatus" "Golgi apparatus" "HPA016026: AB_1857321" "unprognostic (2.35e-1)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (1.10e-2)" "unprognostic (1.59e-2)" "unprognostic (4.81e-2)" "prognostic favourable (4.93e-4)" "unprognostic (6.41e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.72e-3)" "unprognostic (9.27e-2)" "prognostic favourable (1.17e-9)" "unprognostic (1.23e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-3)" "unprognostic (2.13e-2)" 32.8 10.7 10.1 6.6 17.2 4.0 22.5 10.6 17.3 10.0 9.9 15.1 5.2 7.7 9.5 7.0 7.9 9.7 12.7 14.5 10.5 10.3 14.6 24.4 13.6 5.4 9.7 9.9 16.4 37.8 22.0 28.6 7.5 11.9 8.4 8.3 14.9 15.4 8.6 35.1 8.7 7.7 8.7 9.6 5.8 19.6 4.2 13.0 4.4 11.1 7.9 5.8 8.6 10.0 2.2 2.7 2.8 3.6 2.2 3.5 2.1 5.8 3.9 6.8 7.3 34.0 10.1 4.0 5.1 7.3 3.9 4.5 13.1 6.2 4.6 7.1 5.9 8.3 5.3 3.8 5.1 3.4 2.2 5.0 3.4 6.4 7.4 4.8 3.3 9.8 5.7 5.7 7.4 4.6 4.6 6.7 6.1 2.7 5.0 4.4 2.3 3.9 6.7 7.3 5.5 8.7 5.3 3.2 7.5 7.5 3.1 3.0 7.5 3.9 6.4 8.6 5.2 5.5 7.0 1.9 1.5 9.7 2.8 6.8 5.8 1.1 3.3 2.8 3.5 3.6 1.9 2.0 2.5 2.5 2.7 2.2 1.4 2.0 1.4 2.2 2.9 1.5 2.4 2.1 10.1 17.2 10.6 16.4 10.5 10.3 9.7 9.9 11.9 13.0 SIK3 "FLJ12240, KIAA0999, L19, QSK" ENSG00000160584 "SIK family kinase 3" 11 116843402-117098437 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045245, HPA048161" Enhanced Enhanced Nucleoplasm Nucleoplasm "HPA045245: , HPA048161: " "unprognostic (3.19e-2)" "unprognostic (3.31e-1)" "unprognostic (2.78e-2)" "unprognostic (8.21e-2)" "unprognostic (1.31e-1)" "unprognostic (2.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.46e-2)" "unprognostic (1.28e-3)" "unprognostic (1.89e-1)" "prognostic favourable (1.12e-5)" "unprognostic (1.82e-1)" "unprognostic (6.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.28e-2)" 13.0 12.2 24.7 13.8 36.9 14.3 13.5 24.0 34.4 13.5 16.6 40.5 10.4 10.9 18.6 9.9 13.7 16.6 12.8 16.0 23.7 16.2 13.9 17.6 13.7 11.9 25.8 24.4 22.4 19.5 29.4 18.4 16.3 23.9 11.4 11.7 10.6 11.7 15.6 16.9 11.3 14.0 18.4 17.2 14.2 14.5 26.0 38.0 10.4 22.1 6.9 12.9 14.5 12.9 2.4 1.7 3.9 3.7 1.6 1.8 0.7 7.7 6.0 9.6 10.1 8.3 8.9 15.3 5.9 10.7 4.7 5.3 14.6 9.0 9.2 9.7 10.9 12.2 7.9 8.6 6.6 25.3 5.0 20.7 6.6 9.0 7.7 7.4 8.2 9.8 5.0 10.0 16.2 6.2 9.9 6.9 6.4 2.6 6.6 8.0 5.3 4.5 8.5 5.5 7.3 6.5 1.5 9.3 7.5 16.0 7.0 3.2 4.6 7.8 7.1 5.8 7.4 9.6 5.9 4.9 3.5 11.8 5.4 12.2 7.8 3.9 1.1 0.0 1.0 1.5 1.8 0.4 0.9 0.4 1.7 2.4 0.3 0.1 2.6 1.6 3.7 0.1 0.1 0.7 24.7 36.9 24.0 32.2 23.7 16.2 25.8 24.4 23.9 38.0 SIRPA "BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2" ENSG00000198053 "Signal regulatory protein alpha" P78324 20 1894167-1940592 "CD markers, Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.2" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 42.3;RPTEC TERT1: 30.7;SK-MEL-30: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 10.1;eosinophil: 20.9;myeloid DC: 6.3;neutrophil: 23.5" "Group enriched" "Detected in many" 134 "dendritic cells: 6.3;granulocytes: 23.5;monocytes: 10.1" "CAB002776, CAB015122, HPA054437, HPA058511" Enhanced 170000000 "CAB002776: , CAB015122: AB_677430, HPA054437: AB_2682488, HPA058511: AB_2683738" "unprognostic (9.78e-2)" "unprognostic (2.67e-1)" "unprognostic (3.07e-1)" "unprognostic (1.23e-1)" "unprognostic (5.56e-2)" "unprognostic (1.58e-1)" "unprognostic (1.15e-3)" "unprognostic (4.19e-3)" "unprognostic (3.48e-2)" "unprognostic (2.84e-3)" "unprognostic (3.69e-1)" "unprognostic (3.33e-2)" "unprognostic (2.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.55e-2)" "unprognostic (3.55e-2)" "unprognostic (2.24e-2)" 23.2 21.7 36.9 24.9 38.8 19.9 14.0 39.1 69.2 9.5 6.7 22.8 3.0 14.1 6.4 11.2 7.2 9.1 14.6 11.9 29.3 18.5 9.6 16.1 22.0 10.3 18.8 50.3 9.7 6.1 2.2 5.5 13.8 14.7 4.9 8.2 9.5 15.0 8.9 5.5 13.6 11.7 11.4 18.0 9.6 5.2 3.9 20.4 1.0 4.1 2.2 8.8 13.2 6.9 0.0 6.3 23.5 10.1 0.0 0.0 3.4 3.4 7.5 3.8 7.0 9.1 8.6 0.5 18.1 15.4 4.9 1.5 4.7 0.1 0.0 4.4 42.3 3.4 3.0 21.0 2.0 0.0 2.1 0.0 0.9 2.6 11.1 7.0 8.7 7.7 9.9 4.2 5.1 15.3 0.4 4.7 6.6 0.2 0.0 9.8 4.2 3.4 0.0 6.7 4.7 30.7 0.0 0.5 1.1 2.4 0.0 35.6 1.2 22.6 22.8 21.9 11.4 14.1 8.9 0.0 0.0 0.0 6.8 22.7 2.4 0.1 10.1 20.9 0.0 2.7 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 23.5 0.0 1.0 0.4 0.0 3.4 36.9 38.8 39.1 68.6 29.3 18.5 18.8 50.3 14.7 20.4 SIRPB1 "CD172b, SIRP-BETA-1" ENSG00000101307 "Signal regulatory protein beta 1" "O00241, Q5TFQ8" 20 1563521-1620061 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 137.6" "Group enriched" "Detected in some" 4 "HMC-1: 24.7;NB-4: 32.8;THP-1: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 137.6" "Group enriched" "Detected in many" 6 "granulocytes: 137.6;monocytes: 43.6" HPA047463 Uncertain Uncertain Vesicles 33000000 Vesicles "HPA047463: " "unprognostic (1.88e-2)" "unprognostic (6.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (5.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (7.18e-2)" "unprognostic (4.11e-3)" "unprognostic (9.12e-2)" "unprognostic (6.31e-2)" "unprognostic (4.57e-2)" "unprognostic (2.65e-3)" "unprognostic (5.76e-2)" "unprognostic (2.39e-3)" "unprognostic (5.00e-3)" "unprognostic (1.19e-2)" 23.7 1.8 2.3 18.7 5.4 31.9 1.8 2.7 3.2 1.1 1.4 1.9 0.1 1.0 1.0 0.5 0.9 2.5 7.6 7.2 2.3 1.6 1.5 7.5 19.4 19.5 6.6 0.7 1.9 0.9 0.1 1.5 3.8 3.7 1.2 1.2 1.7 1.8 0.6 0.9 0.9 2.6 2.1 7.2 28.7 1.2 1.2 3.9 2.5 0.9 0.4 2.9 4.1 1.9 0.2 15.2 137.6 43.6 0.7 1.0 19.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.3 24.7 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 32.8 0.1 1.5 0.0 0.0 0.0 4.9 0.1 0.0 0.1 0.1 0.0 0.2 0.0 25.4 0.7 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.5 6.0 0.1 0.5 43.6 72.5 0.6 36.3 0.9 0.2 0.6 0.5 15.2 0.2 0.8 0.5 137.6 0.7 29.5 14.5 1.0 19.2 2.3 5.4 2.7 3.2 2.3 1.6 6.6 0.7 3.7 3.9 SIRPB2 "dJ776F14.2, PTPN1L, PTPNS1L3" ENSG00000196209 "Signal regulatory protein beta 2" Q5JXA9 20 1470741-1491587 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.5;lymphoid tissue: 21.2" "Cell line enhanced" "Detected in some" "A-431: 5.2;HBEC3-KT: 4.5;HMC-1: 9.1;hTCEpi: 9.8;HUVEC TERT2: 4.8;THP-1: 8.6;TIME: 4.3;U-937: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 13 "classical monocyte: 19.8;eosinophil: 12.3;intermediate monocyte: 12.8;myeloid DC: 8.8;neutrophil: 29.5;non-classical monocyte: 9.7" "Group enriched" "Detected in many" 194 "dendritic cells: 8.8;granulocytes: 29.5;monocytes: 19.8" "Low region specificity" "Detected in all" "HPA011548, HPA048032" Uncertain Approved "Nuclear bodies" 100000 "Nuclear bodies" "HPA011548: , HPA048032: " "unprognostic (3.22e-2)" "unprognostic (5.57e-2)" "unprognostic (2.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.75e-1)" "unprognostic (2.38e-1)" "unprognostic (2.43e-1)" "unprognostic (3.50e-5)" "unprognostic (3.59e-3)" "unprognostic (9.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" 8.1 4.2 5.8 15.8 11.0 8.1 5.2 0.8 6.5 2.8 2.4 3.3 0.0 1.3 1.9 4.5 2.6 3.1 5.2 2.7 5.9 3.1 2.6 2.5 9.5 17.3 9.2 1.7 1.4 1.6 0.7 1.4 10.0 7.9 1.8 2.5 2.4 2.8 1.0 1.2 1.5 3.3 5.5 13.1 21.2 2.0 1.8 9.1 1.0 1.7 0.3 4.3 6.4 3.9 0.0 8.8 29.5 19.8 0.0 0.0 6.4 5.2 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.3 0.0 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 9.1 0.0 9.8 0.0 0.2 4.8 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 8.6 4.3 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 9.2 0.1 1.2 19.8 12.3 0.0 12.8 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 29.5 0.0 9.7 0.3 0.0 6.4 5.8 11.0 0.8 6.5 5.9 3.1 9.2 1.7 7.9 9.1 SIT1 SIT ENSG00000137078 "Signaling threshold regulating transmembrane adaptor 1" Q9Y3P8 9 35649295-35650950 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 56.9;lymphoid tissue: 80.9" "Group enriched" "Detected in some" 5 "Daudi: 40.5;HDLM-2: 25.0;U-698: 36.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 42 "gdT-cell: 21.3;MAIT T-cell: 36.3;memory B-cell: 37.1;memory CD4 T-cell: 45.0;memory CD8 T-cell: 39.8;naive B-cell: 30.9;naive CD4 T-cell: 31.5;naive CD8 T-cell: 31.0;plasmacytoid DC: 33.9;T-reg: 56.9" "Group enriched" "Detected in many" 50 "B-cells: 37.1;dendritic cells: 33.9;T-cells: 56.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA018506 Enhanced "HPA018506: " "unprognostic (4.28e-3)" "prognostic favourable (6.56e-4)" "unprognostic (8.01e-3)" "prognostic favourable (1.94e-6)" "unprognostic (1.18e-1)" "prognostic favourable (1.14e-4)" "unprognostic (1.75e-2)" "unprognostic (9.34e-3)" "prognostic favourable (8.17e-4)" "unprognostic (2.00e-2)" "unprognostic (1.55e-1)" "unprognostic (2.57e-1)" "prognostic unfavourable (1.75e-5)" "unprognostic (2.23e-1)" "unprognostic (1.47e-1)" "unprognostic (8.87e-2)" "unprognostic (6.34e-2)" 0.8 0.4 0.2 13.8 0.2 0.7 0.6 0.2 0.2 0.6 1.3 0.3 0.5 1.3 0.8 0.4 1.8 0.5 1.3 0.9 0.2 0.2 1.2 0.5 1.6 25.4 0.2 0.2 0.4 0.4 0.0 0.3 0.2 0.3 0.7 1.0 0.4 2.3 0.3 0.4 0.4 11.9 0.2 0.4 23.5 2.1 0.3 0.1 80.9 0.9 0.7 17.9 2.6 0.7 37.1 33.9 0.8 0.2 0.1 56.9 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.5 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 36.9 0.0 0.0 0.0 0.1 0.2 0.1 21.3 0.1 36.3 37.1 45.0 39.8 0.3 30.9 31.5 31.0 0.8 0.1 0.1 33.9 56.9 19.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 SLAMF1 "CD150, SLAM" ENSG00000117090 "Signaling lymphocytic activation molecule family member 1" Q13291 1 160608100-160647295 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Cell adhesion, Host-virus interaction, Immunity, Innate immunity, Phagocytosis" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 97.8" "Cell line enriched" "Detected in single" 111 "HDLM-2: 57.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 24.1" "Group enriched" "Detected in many" 10 "B-cells: 8.8;T-cells: 24.1" "CAB002438, HPA069319" Enhanced "Secreted to blood" 590000 "CAB002438: AB_564011, HPA069319: " "unprognostic (2.99e-3)" "unprognostic (3.33e-4)" "unprognostic (2.93e-4)" "unprognostic (1.38e-4)" "unprognostic (5.87e-2)" "unprognostic (6.06e-5)" "unprognostic (1.64e-2)" "unprognostic (1.70e-3)" "unprognostic (1.69e-2)" "unprognostic (2.74e-4)" "unprognostic (6.12e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-7)" "unprognostic (2.46e-1)" "unprognostic (8.46e-2)" "unprognostic (1.22e-1)" "unprognostic (2.18e-2)" 2.5 0.3 0.3 14.2 0.3 4.4 1.4 0.2 0.3 1.2 2.3 0.4 0.5 2.2 0.5 1.2 2.2 0.8 2.3 1.3 0.2 0.2 2.0 1.0 4.0 14.8 0.2 0.1 0.6 0.9 0.0 0.5 2.3 0.3 1.1 2.1 0.6 4.1 0.6 0.8 1.1 7.6 1.0 0.5 10.6 2.4 0.4 0.2 97.8 1.5 1.9 26.3 3.5 1.1 8.8 1.6 0.2 0.1 0.0 24.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.1 0.0 4.2 0.0 24.1 6.2 17.2 12.1 0.1 8.8 6.6 1.6 0.2 0.0 0.0 1.6 21.5 3.5 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.1 0.3 0.2 SLAMF6 "CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000" ENSG00000162739 "SLAM family member 6" Q96DU3 1 160485030-160523262 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 51.9" "Group enriched" "Detected in some" 5 "Daudi: 32.6;U-698: 48.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA051363, HPA051903" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA051363: , HPA051903: " "prognostic favourable (9.42e-4)" "prognostic favourable (2.78e-4)" "unprognostic (8.65e-2)" "prognostic favourable (9.53e-4)" "unprognostic (5.85e-2)" "prognostic favourable (7.34e-5)" "unprognostic (3.16e-3)" "unprognostic (9.78e-2)" "prognostic favourable (1.25e-4)" "unprognostic (2.31e-3)" "unprognostic (2.09e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (2.09e-6)" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.33e-2)" "unprognostic (8.21e-3)" 3.9 0.8 0.4 21.0 0.4 1.2 1.0 0.4 0.4 1.1 3.8 0.3 0.4 1.1 1.0 0.6 2.3 1.6 2.8 1.2 0.4 0.4 2.1 1.6 4.7 51.9 0.6 0.4 0.6 0.8 0.0 0.6 1.7 0.7 1.4 1.5 1.5 5.6 1.0 0.5 0.7 11.9 0.4 0.8 29.6 2.3 0.9 0.2 12.9 1.8 0.6 30.4 4.1 1.3 15.2 0.3 8.4 1.0 15.9 28.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.1 48.1 0.0 0.2 0.0 2.5 0.1 8.4 22.9 0.3 15.8 14.7 14.6 28.6 0.1 15.2 8.2 16.4 1.0 15.9 1.0 0.3 16.8 7.4 0.4 0.4 0.4 0.4 0.4 0.4 0.6 0.4 0.7 0.2 SLAMF7 "19A, CD319, CRACC, CS1" ENSG00000026751 "SLAM family member 7" Q9NQ25 1 160739057-160754821 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.9;lymphoid tissue: 45.0" "Cell line enriched" "Detected in some" 5 "U-266/70: 78.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015445, HPA055945, HPA061654" Enhanced Approved Vesicles 620000 Vesicles "CAB015445: AB_1121905, HPA055945: , HPA061654: " "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (1.84e-3)" "unprognostic (2.12e-3)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (7.87e-2)" "unprognostic (7.19e-2)" "unprognostic (2.46e-2)" "prognostic favourable (3.93e-4)" "unprognostic (1.08e-1)" "unprognostic (8.13e-2)" "prognostic unfavourable (8.57e-5)" "unprognostic (1.35e-1)" "unprognostic (3.91e-2)" "unprognostic (1.02e-1)" "unprognostic (1.50e-2)" 5.5 1.0 0.7 28.6 0.7 2.3 3.4 0.6 0.7 4.1 11.9 0.2 0.4 11.1 1.9 1.3 6.7 1.6 6.2 1.0 0.7 0.7 2.4 3.1 10.2 24.6 0.8 0.4 2.5 2.2 0.0 0.9 1.3 0.6 1.8 10.2 2.9 15.1 4.8 0.9 2.0 15.8 0.8 1.2 45.0 11.0 1.5 0.4 5.9 2.1 4.2 38.7 11.5 2.6 3.7 27.4 1.1 14.9 17.3 32.9 8.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 2.1 0.0 0.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 78.8 6.7 0.0 2.2 0.0 0.0 0.0 1.6 0.3 32.9 11.0 25.4 3.7 3.5 22.4 7.2 0.6 1.1 13.6 1.1 17.3 14.9 27.4 0.0 8.7 0.7 0.7 0.6 0.7 0.7 0.7 0.8 0.4 0.6 0.4 SLAMF8 "BLAME, CD353, SBBI42" ENSG00000158714 "SLAM family member 8" Q9P0V8 1 159826750-159837249 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;HL-60: 3.5;U-138 MG: 4.9;U-87 MG: 2.7;U-937: 2.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 12.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA067601 Enhanced "HPA067601: " "unprognostic (1.04e-1)" "unprognostic (8.80e-3)" "unprognostic (5.12e-2)" "unprognostic (2.14e-3)" "unprognostic (3.07e-2)" "unprognostic (3.22e-2)" "unprognostic (7.87e-2)" "unprognostic (4.29e-1)" "unprognostic (2.20e-2)" "unprognostic (4.56e-2)" "unprognostic (6.47e-2)" "unprognostic (1.77e-1)" "prognostic unfavourable (5.42e-5)" "unprognostic (3.50e-1)" "unprognostic (4.42e-2)" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" 16.9 4.6 1.5 20.1 3.4 0.4 5.4 8.2 1.6 3.1 6.0 1.4 0.6 4.6 1.8 4.2 3.1 3.6 6.1 7.1 5.2 1.7 7.8 2.2 19.6 44.1 4.1 0.7 3.8 2.0 0.1 4.2 5.4 5.0 2.7 7.1 3.0 4.2 1.0 2.2 3.1 7.0 5.4 4.1 22.7 3.1 2.4 2.7 9.7 4.8 3.0 12.7 8.6 2.8 0.0 12.1 0.5 6.6 8.1 3.8 2.8 0.0 0.1 0.0 0.0 0.5 4.1 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.8 0.0 0.1 1.8 0.0 0.0 0.0 3.5 0.6 1.4 0.0 0.3 0.1 0.0 0.0 0.8 0.2 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.6 0.0 4.9 0.2 0.0 0.9 0.0 0.0 0.0 2.7 2.5 0.0 0.0 5.1 0.0 3.2 6.6 0.2 0.0 1.1 3.8 12.1 0.0 0.2 2.6 0.5 8.1 0.4 0.1 0.0 2.8 1.5 3.4 8.2 1.6 5.2 1.7 4.1 0.7 5.0 2.7 SLAMF9 "CD2F-10, CD84-H1, SF2001" ENSG00000162723 "SLAM family member 9" Q96A28 1 159951492-159954254 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "adipose tissue: 20.3;blood: 5.5" "Cell line enhanced" "Detected in some" "HBEC3-KT: 6.5;HEL: 8.9;PC-3: 3.6;SK-MEL-30: 3.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "myeloid DC: 5.5" "Lineage enriched" "Detected in single" 9 "dendritic cells: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035153 Uncertain "HPA035153: AB_10670586" "unprognostic (1.05e-1)" "unprognostic (1.54e-5)" "unprognostic (6.12e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (7.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.22e-2)" "unprognostic (2.46e-1)" "unprognostic (3.54e-4)" "unprognostic (5.27e-4)" "unprognostic (5.47e-2)" "unprognostic (6.17e-5)" "unprognostic (8.97e-3)" "unprognostic (1.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.37e-1)" 20.3 0.0 0.1 2.3 0.1 1.1 0.9 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.7 1.0 0.1 0.4 0.1 0.0 0.1 2.6 1.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.2 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.7 0.2 2.9 0.1 0.5 0.1 0.7 0.5 2.9 0.5 0.1 5.5 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 6.5 0.0 0.0 0.0 8.9 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 3.9 0.7 1.5 0.0 1.3 1.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "kidney: 143.2" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 23.7" "Cancer enhanced" "Detected in single" "renal cancer: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 1.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.0 0.0 0.3 0.0 1.0 0.0 0.0 1.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 143.2 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.0 0.3 1.0 1.4 1.5 0.1 0.3 0.3 0.4 1.4 0.1 SLC13A1 "NAS1, NaSi-1" ENSG00000081800 "Solute carrier family 13 member 1" Q9BZW2 7 123113531-123199986 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sulfate transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 67.5" "Cell line enhanced" "Detected in single" "BEWO: 1.0" "Cancer enriched" "Detected in single" 219 "renal cancer: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 0.9" "Low region specificity" "Detected in all" "HPA053615, HPA062714" Enhanced "HPA053615: , HPA062714: " "unprognostic (1.86e-1)" "prognostic favourable (8.95e-5)" "unprognostic (1.71e-1)" "unprognostic (3.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 67.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.0 0.9 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.2 0.3 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.8 0.1 0.6 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC13A4 "SUT-1, SUT1" ENSG00000164707 "Solute carrier family 13 member 4" Q9UKG4 7 135681237-135729258 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 85.4;placenta: 44.8;retina: 23.5" "Cell line enriched" "Detected in some" 6 "HDLM-2: 25.1" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 85.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA048582 Approved "HPA048582: " "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (9.70e-3)" "unprognostic (1.78e-1)" "unprognostic (7.69e-2)" "unprognostic (3.96e-6)" "unprognostic (3.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.56e-3)" "unprognostic (9.23e-2)" "unprognostic (2.89e-1)" "unprognostic (1.87e-1)" "unprognostic (2.30e-6)" "unprognostic (1.53e-1)" "unprognostic (3.07e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" 0.3 0.4 0.7 0.3 1.4 0.3 0.4 4.0 8.9 1.2 0.3 34.0 0.0 0.3 0.4 0.3 4.1 0.8 0.4 0.4 12.3 0.8 0.3 0.4 0.4 0.3 1.4 5.4 0.4 0.5 0.4 1.4 44.8 85.4 0.3 0.3 23.5 1.0 0.4 0.3 0.4 0.3 0.4 5.1 0.3 0.3 5.4 0.5 0.0 0.3 0.0 1.9 0.3 1.8 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 25.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 1.4 4.0 8.9 12.3 0.8 1.4 5.4 85.4 0.5 SLC13A5 "INDY, NACT" ENSG00000141485 "Solute carrier family 13 member 5" Q86YT5 17 6684713-6713567 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 65 "liver: 150.4;salivary gland: 153.9" "Cell line enriched" "Detected in single" 61 "Hep G2: 35.0" "Cancer enriched" "Detected in some" 15 "liver cancer: 27.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044343 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044343: AB_10961771" "unprognostic (8.46e-3)" "unprognostic (3.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.75e-2)" "unprognostic (7.33e-2)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (8.79e-3)" "unprognostic (1.32e-1)" "unprognostic (3.23e-1)" "unprognostic (1.26e-3)" "unprognostic (1.30e-3)" "unprognostic (3.78e-11)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (2.05e-2)" "unprognostic (2.04e-1)" 0.2 0.8 1.0 0.1 1.9 0.1 0.2 0.6 2.3 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.9 0.1 0.1 0.9 0.7 0.4 150.4 0.1 0.2 0.8 1.2 0.3 0.2 0.1 0.2 0.1 0.6 0.1 0.1 0.0 153.9 0.1 0.1 0.1 0.1 0.1 0.2 0.9 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.9 0.6 2.3 0.9 0.7 0.8 1.2 0.6 0.0 SLC16A3 "MCT3, MCT4" ENSG00000141526 "Solute carrier family 16 member 3" O15427 17 82228397-82261129 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "CAB017490, HPA021451" Approved Supported "Nuclear membrane,Plasma membrane" "Plasma membrane" "Nuclear membrane" "CAB017490: AB_2189333, HPA021451: AB_1853663" "unprognostic (2.49e-1)" "prognostic unfavourable (6.07e-4)" "unprognostic (4.31e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-3)" "unprognostic (4.26e-3)" "prognostic unfavourable (1.19e-7)" "prognostic unfavourable (2.02e-5)" "unprognostic (2.52e-1)" "unprognostic (2.09e-2)" "unprognostic (4.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavourable (3.71e-7)" "unprognostic (2.27e-1)" "unprognostic (4.00e-2)" "unprognostic (8.00e-2)" "unprognostic (1.36e-2)" 10.4 4.8 3.9 16.9 5.2 11.2 8.8 1.0 5.2 8.0 10.5 3.8 1.7 8.0 4.8 4.7 12.4 5.0 10.4 7.4 4.1 3.8 10.9 3.7 19.0 14.2 9.6 0.6 8.3 3.9 1.4 3.6 36.7 8.4 6.9 4.3 42.9 8.1 4.8 81.2 2.1 8.0 4.5 8.0 17.3 13.9 12.7 6.9 3.9 8.7 7.3 11.0 13.0 7.4 3.7 10.3 40.4 12.4 9.9 6.2 5.4 11.4 5.7 0.1 0.1 2.5 8.3 11.4 47.9 29.5 34.0 38.7 2.7 30.0 0.1 37.7 33.7 4.1 4.1 69.4 14.3 20.6 0.2 21.8 42.6 50.0 43.9 32.0 27.0 17.0 10.2 22.9 10.5 18.5 0.1 6.8 29.5 3.1 0.3 31.6 0.4 46.6 0.1 0.5 7.5 18.0 0.5 0.7 0.3 46.0 41.0 0.5 5.9 27.0 31.9 67.9 1.1 1.0 49.9 22.0 0.3 1.0 33.3 20.3 0.5 17.5 12.4 34.6 4.1 11.7 6.2 3.7 3.5 4.6 10.3 2.8 1.8 2.2 40.4 9.9 11.8 6.1 3.0 5.4 3.9 5.2 1.0 5.2 4.1 3.8 9.6 0.6 8.4 6.9 SLC19A1 "FOLT, RFC1" ENSG00000173638 "Solute carrier family 19 member 1" P41440 21 45493572-45544411 "Cancer-related genes, Predicted membrane proteins, Transporters" "Antiport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 37.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024802 Approved Approved "Plasma membrane" "Plasma membrane" "HPA024802: AB_10602892" "unprognostic (4.31e-3)" "prognostic unfavourable (4.15e-4)" "unprognostic (5.23e-2)" "unprognostic (2.02e-1)" "unprognostic (3.11e-1)" "unprognostic (3.04e-2)" "unprognostic (7.34e-2)" "unprognostic (2.87e-3)" "unprognostic (4.04e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "unprognostic (2.39e-1)" "prognostic unfavourable (1.07e-10)" "unprognostic (1.44e-1)" "unprognostic (2.31e-1)" "unprognostic (7.97e-5)" "unprognostic (3.10e-1)" 9.0 7.8 7.1 8.2 13.5 10.5 12.5 9.6 8.9 5.0 9.7 6.0 9.4 31.2 4.3 4.6 2.3 4.6 3.5 3.2 7.1 6.1 4.7 14.1 13.9 14.1 8.7 4.4 8.1 5.4 1.8 3.5 32.9 11.5 4.7 2.0 17.8 6.0 3.5 3.5 6.1 16.5 2.3 5.9 11.7 5.7 3.4 3.4 11.8 9.6 2.8 4.1 3.1 3.1 0.9 4.9 37.6 6.4 0.4 1.1 2.4 10.4 9.5 1.9 7.8 0.6 0.8 15.6 4.9 0.8 4.5 2.9 22.0 9.7 9.7 9.8 1.2 5.4 3.9 3.6 1.1 8.9 19.0 20.5 5.2 15.3 2.7 13.3 3.2 1.0 2.7 4.9 1.6 3.7 24.4 4.3 1.6 11.7 18.1 12.4 11.2 11.2 24.6 2.2 28.3 2.0 6.3 11.7 10.3 5.5 9.1 4.2 6.9 15.8 4.5 5.9 7.4 1.6 8.0 1.8 6.5 8.8 2.6 21.8 4.7 0.6 6.4 8.5 0.3 6.0 1.1 0.9 0.5 0.7 4.9 0.3 0.8 0.5 37.6 0.4 3.7 1.5 1.0 2.4 7.1 13.5 9.6 8.9 7.1 6.1 8.7 4.4 11.5 3.4 SLC19A3 THTR2 ENSG00000135917 "Solute carrier family 19 member 3" Q9BZV2 2 227683763-227718031 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.2;breast: 78.2;placenta: 27.5" "Cell line enhanced" "Detected in some" "ASC diff: 14.1;BEWO: 7.2;CACO-2: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038898 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA038898: AB_10673481" "unprognostic (3.37e-2)" "unprognostic (3.59e-5)" "unprognostic (1.95e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (4.67e-2)" "unprognostic (3.12e-3)" "unprognostic (7.28e-2)" "unprognostic (8.20e-2)" "unprognostic (1.68e-1)" "unprognostic (1.71e-2)" "unprognostic (7.01e-3)" 48.2 0.6 2.2 1.8 2.4 1.2 78.2 1.5 1.9 0.5 6.1 1.0 0.5 7.7 0.6 0.4 0.6 0.6 8.9 1.9 2.3 2.4 2.1 16.0 5.6 1.3 3.0 0.7 0.9 1.3 0.2 0.3 27.5 2.6 0.5 1.6 0.7 0.9 0.2 0.7 1.6 4.5 0.5 2.6 0.5 0.5 0.6 1.5 0.0 0.5 0.4 0.4 1.0 2.3 2.6 1.8 8.6 1.8 4.3 1.1 0.4 0.3 1.6 0.3 1.0 14.1 0.4 7.2 0.1 0.2 0.3 0.6 18.4 0.5 0.4 0.2 0.1 0.5 0.5 0.5 0.8 0.1 1.2 0.1 0.9 0.7 1.7 0.2 0.2 3.2 0.4 0.1 0.9 0.0 0.2 0.8 0.0 1.8 0.1 0.6 3.2 0.3 0.3 0.2 0.2 0.2 0.3 1.0 0.1 0.5 2.0 0.5 0.3 0.2 0.5 0.5 0.5 4.1 0.3 0.2 0.1 0.6 1.4 0.3 0.4 8.6 1.8 1.7 1.0 1.2 0.6 1.6 0.8 0.9 0.4 2.6 1.0 1.1 6.1 4.3 1.1 1.8 0.4 0.4 2.2 2.4 1.5 1.9 2.3 2.4 3.0 0.7 2.6 1.5 SLC1A3 "EA6, EAAT1, GLAST" ENSG00000079215 "Solute carrier family 1 member 3" P43003 5 36606355-36688334 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 188.6" "Cell line enhanced" "Detected in many" "AF22: 21.2;CACO-2: 34.1;HaCaT: 25.8" "Cancer enriched" "Detected in all" 21 "glioma: 168.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4" "Group enriched" "Detected in many" 39 "dendritic cells: 3.4;monocytes: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002573, HPA037467, HPA037468" Enhanced Supported Approved Nucleoli,Mitochondria Mitochondria Nucleoli "CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371" "unprognostic (1.23e-1)" "unprognostic (2.15e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (7.70e-2)" "unprognostic (3.89e-3)" "unprognostic (2.36e-1)" "unprognostic (1.24e-1)" "unprognostic (2.84e-2)" "unprognostic (4.17e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.17e-2)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" 17.3 10.3 76.1 5.9 70.6 3.1 6.3 45.8 188.6 6.9 3.2 26.3 0.0 2.1 2.8 2.3 7.2 5.4 5.9 12.0 57.9 27.3 3.1 3.6 4.7 8.6 32.7 39.6 8.6 4.0 2.6 3.7 12.7 28.5 3.3 2.6 1.9 3.0 4.4 7.6 5.5 2.3 4.1 29.4 5.8 2.9 2.7 33.6 0.0 2.6 0.7 4.5 4.8 1.2 0.0 3.4 0.0 4.3 0.0 0.0 0.8 0.4 0.1 21.2 1.8 2.1 5.9 13.5 0.0 0.0 0.8 1.8 34.1 1.7 0.0 10.3 0.3 25.8 6.2 2.8 0.9 0.3 12.7 0.0 0.1 0.0 0.4 0.4 0.1 10.9 12.8 5.2 2.1 0.0 0.0 0.1 3.6 0.0 0.0 0.0 2.5 2.1 0.0 0.1 0.0 0.0 1.3 1.8 0.0 2.1 6.2 0.3 0.0 1.0 0.0 1.9 3.1 0.0 7.5 0.0 0.0 0.0 8.6 14.3 4.8 0.0 4.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 76.1 70.6 45.8 57.8 57.9 27.3 32.7 39.6 28.5 33.6 SLC1A6 EAAT4 ENSG00000105143 "Solute carrier family 1 member 6" P48664 19 14950034-15022990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 52.1;testis: 23.3" "Cell line enhanced" "Detected in some" "HAP1: 6.4;NTERA-2: 5.3;U-698: 24.1" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 5.2" "Region enriched" "Detected in many" 5 "cerebellum: 52.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 152.9" "Low region specificity" "Detected in all" "HPA041505, HPA044066" Enhanced Supported "Plasma membrane,Intermediate filaments" "Plasma membrane" "Intermediate filaments" "HPA041505: , HPA044066: " "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.94e-3)" "unprognostic (8.90e-2)" "unprognostic (6.52e-4)" "unprognostic (1.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.11e-2)" "unprognostic (9.92e-2)" "unprognostic (1.35e-1)" "unprognostic (5.57e-2)" "prognostic unfavourable (6.88e-6)" 0.4 0.5 3.2 0.5 9.6 1.2 0.8 52.1 12.8 0.4 0.5 0.6 0.0 0.6 0.8 4.2 0.4 0.5 0.5 0.4 4.8 4.0 0.4 0.5 0.5 0.5 1.6 3.4 0.6 0.9 0.6 0.0 4.3 3.0 0.9 0.6 0.1 0.7 0.9 0.5 9.2 0.5 0.5 1.4 0.7 0.5 23.3 0.9 0.0 0.6 0.0 0.6 0.4 0.0 2.0 0.7 2.2 0.7 0.5 0.6 0.1 0.1 0.0 0.3 0.3 0.2 0.2 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 1.2 6.4 0.1 0.1 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.5 0.0 0.3 5.3 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.2 0.2 2.5 0.0 0.3 0.1 0.0 0.3 1.0 0.2 0.1 0.4 0.1 24.1 0.1 0.3 0.1 1.6 0.7 0.5 0.6 0.4 0.4 1.0 0.5 0.3 0.3 2.0 0.6 0.6 2.2 0.5 0.4 0.7 0.3 0.1 3.2 9.6 52.1 6.5 4.8 4.0 1.6 3.4 3.0 0.9 SLC20A2 "Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1" ENSG00000168575 "Solute carrier family 20 member 2" Q08357 8 42416475-42541926 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 90.6" "Cell line enhanced" "Detected in all" "CAPAN-2: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026540 Approved "HPA026540: AB_1855408" "prognostic unfavourable (7.67e-4)" "unprognostic (3.22e-1)" "unprognostic (3.24e-2)" "unprognostic (2.27e-2)" "unprognostic (2.12e-2)" "unprognostic (2.95e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-1)" "unprognostic (2.95e-1)" "unprognostic (7.62e-2)" "unprognostic (2.06e-1)" "unprognostic (3.43e-2)" "prognostic favourable (1.01e-4)" "unprognostic (2.13e-1)" "unprognostic (1.27e-1)" "unprognostic (5.86e-2)" "unprognostic (4.95e-2)" 7.3 5.2 12.2 6.3 17.8 2.3 8.0 24.2 22.2 8.5 14.2 28.6 4.9 28.0 10.9 6.8 19.4 15.4 9.4 37.3 16.7 17.3 11.3 23.1 9.3 4.1 22.4 14.4 5.7 30.2 15.1 8.1 8.3 32.8 8.4 11.8 19.0 90.6 11.6 69.9 12.6 18.2 12.1 21.6 4.7 8.8 11.1 18.3 5.6 48.6 19.8 10.5 14.6 11.5 3.2 5.2 3.1 3.0 9.6 7.5 4.1 17.7 4.9 6.7 5.6 3.9 3.2 15.0 16.4 28.4 8.5 21.2 13.2 47.5 6.0 19.2 14.6 29.3 3.8 16.6 15.0 1.4 3.0 9.6 1.8 7.5 5.5 3.4 4.4 3.5 15.1 8.8 8.7 4.2 9.1 4.9 16.1 4.9 6.0 5.5 6.7 3.1 5.1 7.4 6.3 7.7 17.5 1.8 7.0 4.4 7.7 4.5 6.2 5.9 12.9 18.4 6.3 4.4 8.8 3.3 7.2 4.3 5.7 6.7 9.9 3.1 3.0 0.3 5.6 2.2 6.3 3.1 6.0 5.2 5.2 3.2 7.5 5.6 1.2 9.6 1.9 3.0 5.8 4.1 12.2 17.8 24.2 19.9 16.7 17.3 22.4 14.4 32.8 18.3 SLC23A1 "SLC23A2, SVCT1, YSPL3" ENSG00000170482 "Solute carrier family 23 member 1" Q9UHI7 5 139367196-139384553 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 24.8;intestine: 94.3;liver: 25.4" "Cell line enhanced" "Detected in some" "CACO-2: 8.0;HDLM-2: 6.9;Hep G2: 11.4;Karpas-707: 9.5;RPMI-8226: 9.2;U-266/70: 14.6" "Group enriched" "Detected in many" 5 "endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA047612 Enhanced "HPA047612: " "unprognostic (4.00e-3)" "unprognostic (2.66e-3)" "unprognostic (2.63e-2)" "unprognostic (1.75e-3)" "unprognostic (1.93e-1)" "unprognostic (6.36e-6)" "unprognostic (7.41e-2)" "unprognostic (6.55e-2)" "unprognostic (5.88e-2)" "unprognostic (3.90e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-2)" "unprognostic (4.16e-2)" "unprognostic (1.55e-2)" "unprognostic (3.65e-3)" 0.3 0.0 0.3 0.5 0.5 0.8 0.3 0.3 0.3 2.3 22.1 0.3 0.8 11.6 0.3 1.6 0.3 24.8 1.8 0.3 0.3 0.3 18.0 25.4 0.6 0.4 0.3 0.3 0.4 0.9 0.0 0.3 0.3 0.4 2.7 0.3 0.3 1.0 0.6 0.3 1.0 94.3 0.3 0.3 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.2 4.4 0.7 0.1 0.0 0.3 0.0 0.3 1.8 0.3 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 8.0 1.1 4.9 2.6 0.0 0.2 0.0 0.0 0.1 6.9 0.1 0.1 0.6 11.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.2 4.7 0.9 0.1 0.1 5.7 0.2 9.2 0.4 0.3 0.2 0.3 0.2 1.7 0.0 4.4 0.1 0.3 0.3 0.2 0.1 0.0 14.6 1.7 6.4 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.0 1.2 0.2 0.0 0.7 0.0 0.1 4.4 0.3 0.0 0.3 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.3 SLC25A11 "OGC, SLC20A4" ENSG00000108528 "Solute carrier family 25 member 11" Q02978 17 4937130-4940251 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021167 Approved 17000 "HPA021167: AB_1857021" "unprognostic (8.58e-2)" "unprognostic (4.06e-3)" "unprognostic (9.43e-2)" "unprognostic (2.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (4.86e-1)" "unprognostic (9.48e-2)" "prognostic favourable (6.41e-6)" "unprognostic (2.84e-1)" "prognostic favourable (2.84e-9)" "unprognostic (1.26e-1)" "unprognostic (1.37e-1)" "unprognostic (1.70e-2)" "unprognostic (1.09e-1)" 11.8 17.5 17.8 11.9 20.8 10.3 11.7 18.2 34.3 11.1 15.7 16.3 10.3 17.3 12.4 10.1 18.9 16.1 14.3 82.1 19.8 17.7 24.2 22.6 10.6 13.3 19.5 16.3 12.1 15.3 16.0 12.3 13.3 18.7 12.0 13.7 22.2 16.8 15.6 100.8 16.9 14.6 13.0 13.8 12.8 12.3 5.2 9.6 17.4 14.6 42.4 14.0 15.1 10.5 26.9 50.1 39.3 53.9 42.7 32.4 51.4 16.4 44.5 22.7 22.1 22.3 13.9 16.0 18.6 19.2 32.7 27.2 27.8 8.2 25.5 25.3 18.1 32.9 29.5 33.7 13.0 32.2 37.4 28.0 24.6 24.1 22.9 12.0 34.1 19.9 21.9 28.8 24.5 22.6 12.3 24.9 27.6 29.6 38.6 11.9 11.9 29.8 35.1 14.0 23.1 25.2 17.2 20.3 21.1 23.4 26.5 21.3 24.6 19.1 15.2 14.7 9.6 19.8 35.5 13.3 8.0 9.6 28.9 20.4 36.1 32.7 53.9 39.3 32.4 53.0 30.0 26.9 25.1 28.9 50.1 23.0 25.3 27.5 35.1 42.7 47.8 33.3 29.1 51.4 17.8 20.8 18.2 34.3 19.8 17.7 19.5 16.3 18.7 9.6 SLC25A22 "EIEE3, FLJ13044, GC1, NET44" ENSG00000177542 "Solute carrier family 25 member 22" Q9H936 11 790475-798333 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.0;pancreas: 43.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014662 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA014662: AB_10600808" "unprognostic (1.01e-2)" "unprognostic (2.12e-1)" "unprognostic (7.28e-2)" "unprognostic (4.68e-2)" "unprognostic (2.09e-3)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (8.67e-3)" "unprognostic (4.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.97e-3)" "unprognostic (2.61e-2)" "unprognostic (8.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" 4.9 5.2 23.3 8.3 19.0 5.7 2.7 32.2 45.0 3.5 4.1 3.4 2.5 10.3 3.2 2.3 4.4 5.0 3.8 3.2 27.8 13.2 4.1 14.2 4.6 7.5 9.6 22.8 4.8 43.0 4.0 13.4 4.4 13.5 5.2 2.9 4.6 11.4 4.2 1.1 5.8 8.5 3.3 2.8 5.3 6.8 6.6 2.6 3.5 3.1 3.0 5.1 4.5 2.4 2.5 3.1 4.0 5.7 3.6 7.2 2.3 23.2 15.1 8.9 7.9 3.7 6.8 8.4 11.1 9.4 12.4 7.9 14.9 16.0 7.0 8.4 9.3 20.6 9.8 13.4 2.8 13.1 17.9 6.4 7.4 9.1 16.1 10.3 10.8 6.8 8.1 9.4 10.1 5.7 13.0 11.0 5.5 14.1 10.7 9.7 19.2 23.2 12.7 4.8 16.5 7.4 3.9 43.9 19.7 6.4 15.4 7.9 7.4 5.2 5.5 13.9 9.3 6.4 10.4 9.7 5.6 8.9 16.7 9.2 8.3 0.0 2.4 4.0 6.6 5.6 4.2 2.5 4.1 7.2 3.1 2.1 2.5 4.2 1.5 3.6 5.7 0.9 2.2 2.3 23.3 19.0 32.2 37.4 27.8 13.2 9.6 22.8 13.5 2.6 SLC25A26 ENSG00000144741 "Solute carrier family 25 member 26" Q70HW3 3 66133610-66388116 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026887 Supported Supported Mitochondria Mitochondria "HPA026887: AB_2189921" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (7.83e-2)" "unprognostic (7.94e-2)" "unprognostic (5.38e-2)" "unprognostic (1.53e-1)" "unprognostic (3.54e-1)" "unprognostic (9.21e-2)" "unprognostic (8.43e-2)" "prognostic favourable (1.73e-5)" "unprognostic (4.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-1)" 11.8 12.9 20.2 8.5 14.8 13.3 16.5 7.9 27.2 10.3 12.6 15.8 9.2 9.7 11.1 12.9 14.3 13.1 10.1 19.5 16.9 12.8 15.7 22.7 10.0 15.2 17.6 11.8 20.0 21.2 16.2 11.6 11.9 14.6 10.8 13.4 12.6 16.1 12.6 29.8 16.5 11.0 16.8 14.3 11.4 12.7 18.3 12.6 12.0 19.0 14.2 12.9 13.4 10.8 12.0 12.2 3.6 7.1 10.5 14.4 9.1 6.3 6.1 3.8 7.7 8.4 8.7 8.0 5.3 10.1 7.2 6.8 8.1 8.5 6.5 3.2 9.7 4.7 4.4 9.9 7.4 6.7 10.3 9.8 4.9 11.7 10.2 13.8 8.4 11.9 19.6 5.7 13.7 5.3 4.3 8.7 8.6 7.9 5.7 15.8 11.1 3.6 6.0 6.9 11.0 5.9 4.7 2.9 8.9 7.7 6.7 12.6 5.6 10.9 6.0 7.6 7.2 9.5 9.3 12.9 16.7 8.4 10.4 13.2 8.2 1.3 6.8 3.6 10.9 7.1 9.9 12.0 12.1 11.1 12.2 10.2 14.4 12.3 0.4 10.5 4.1 11.6 11.1 9.1 20.2 14.8 7.9 27.2 16.9 12.8 17.6 11.8 14.6 12.6 SLC25A3 PHC ENSG00000075415 "Solute carrier family 25 member 3" Q00325 12 98593591-98606379 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 233.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045709 Supported Mitochondria 5500000 Mitochondria "HPA045709: AB_10965843" "unprognostic (1.16e-2)" "unprognostic (4.68e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-1)" "unprognostic (1.56e-2)" "unprognostic (6.38e-2)" "unprognostic (3.25e-3)" "unprognostic (9.41e-2)" "unprognostic (4.98e-2)" "unprognostic (6.43e-2)" "unprognostic (5.65e-2)" "unprognostic (7.40e-2)" "prognostic favourable (8.11e-7)" "unprognostic (3.45e-1)" "unprognostic (2.99e-1)" "unprognostic (8.66e-3)" "unprognostic (4.72e-2)" 35.7 71.2 23.6 38.3 27.2 24.6 48.9 25.1 50.2 29.8 69.6 22.4 33.8 53.9 38.5 35.9 54.6 30.1 55.1 233.5 22.9 25.3 60.2 72.6 47.0 75.5 27.8 26.0 39.6 59.7 55.5 29.1 34.2 31.6 33.8 53.3 30.9 53.5 33.5 190.6 33.8 76.0 46.7 19.6 35.6 51.4 16.9 15.1 42.0 41.5 125.8 44.4 38.5 31.9 46.8 82.3 33.4 78.5 43.3 56.6 76.3 75.6 59.1 78.4 64.9 71.4 118.8 101.1 66.4 88.5 86.1 72.0 106.1 39.8 103.4 39.5 80.4 65.2 79.5 89.7 90.8 38.9 63.4 61.6 43.6 70.3 88.0 72.1 49.0 112.3 80.3 62.5 90.0 121.5 66.4 30.7 102.6 56.4 66.9 80.5 72.6 97.1 76.5 81.7 114.7 111.3 76.0 40.3 54.0 79.5 71.5 109.6 96.6 78.9 81.6 48.0 45.3 52.6 66.4 52.0 61.1 72.3 37.8 42.6 61.7 24.4 59.5 33.4 40.1 77.2 47.4 46.8 45.7 44.3 82.3 33.3 47.9 45.3 26.4 43.3 78.5 50.3 56.6 76.3 23.6 27.2 25.1 50.2 22.9 25.3 27.8 26.0 31.6 15.1 SLC25A33 "BMSC-MCP, MGC4399, PNC1" ENSG00000171612 "Solute carrier family 25 member 33" Q9BSK2 1 9539482-9585179 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049982 Uncertain "HPA049982: " "unprognostic (1.61e-1)" "prognostic favourable (4.86e-4)" "unprognostic (2.94e-2)" "unprognostic (4.80e-2)" "unprognostic (1.89e-1)" "unprognostic (6.75e-2)" "unprognostic (5.18e-2)" "prognostic favourable (7.02e-4)" "unprognostic (1.88e-3)" "unprognostic (1.07e-1)" "unprognostic (8.59e-2)" "unprognostic (2.77e-1)" "unprognostic (4.55e-3)" "unprognostic (7.27e-2)" "unprognostic (1.19e-1)" "unprognostic (4.25e-2)" "unprognostic (3.77e-2)" 14.6 5.3 11.3 3.8 15.3 11.0 13.0 8.4 20.6 4.1 6.6 6.5 3.5 3.4 4.6 18.9 4.5 3.5 5.6 6.1 9.4 12.2 13.9 15.1 6.1 4.6 15.1 8.7 3.3 8.5 4.5 6.4 2.3 12.6 6.3 5.6 10.5 7.0 3.8 16.8 2.6 3.4 4.1 10.4 3.3 4.7 16.0 7.0 4.2 7.6 2.8 5.1 4.1 2.5 2.0 1.6 6.1 1.1 1.3 1.9 0.4 4.3 2.0 5.8 8.9 4.8 2.7 3.7 4.2 4.0 7.2 6.4 4.5 3.4 12.8 5.2 3.5 1.9 14.6 2.8 9.0 9.8 9.2 12.5 2.9 17.6 10.4 12.4 10.0 3.3 5.0 7.2 3.5 4.2 12.1 6.7 4.0 4.6 7.8 8.5 7.2 4.9 10.6 6.1 8.2 4.6 2.5 10.2 6.6 4.8 14.8 12.5 5.4 9.2 1.8 4.6 6.0 6.1 5.4 7.9 14.7 21.5 3.3 13.9 5.5 6.1 0.9 0.3 1.5 1.1 1.0 2.0 1.1 0.9 1.6 1.0 1.9 1.9 1.3 1.3 1.0 1.5 0.2 0.4 11.3 15.3 8.4 20.6 9.4 12.2 15.1 8.7 12.6 7.0 SLC25A39 "CGI-69, FLJ22407" ENSG00000013306 "Solute carrier family 25 member 39" Q9BZJ4 17 44319625-44324870 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Heme biosynthesis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026785 Approved "HPA026785: AB_10601715" "unprognostic (8.10e-2)" "unprognostic (2.46e-1)" "unprognostic (1.41e-2)" "unprognostic (1.29e-1)" "unprognostic (6.04e-2)" "unprognostic (2.35e-3)" "prognostic unfavourable (5.90e-5)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.95e-1)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "prognostic favourable (3.58e-5)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.22e-1)" "unprognostic (3.21e-2)" 14.6 36.5 17.8 19.0 19.4 101.0 21.9 15.4 18.1 18.8 29.8 17.4 22.9 30.2 16.0 20.5 43.2 19.1 24.5 19.3 16.4 18.5 58.8 69.8 25.0 29.8 18.6 15.6 25.1 63.3 27.2 24.6 33.5 17.1 23.4 19.9 20.6 39.9 26.5 13.7 25.6 28.7 13.5 17.6 28.8 23.8 39.7 16.2 18.0 46.4 36.4 29.3 16.8 18.6 34.0 35.2 11.2 27.4 43.9 30.2 31.0 43.5 27.7 8.7 36.3 16.9 13.1 30.3 14.5 13.2 19.0 14.7 27.3 21.2 23.5 25.7 20.5 22.5 27.0 44.1 6.7 27.4 43.3 12.3 25.1 49.7 18.5 21.3 27.0 19.9 39.3 17.7 22.8 19.3 36.1 37.6 16.0 82.4 26.8 20.8 17.0 76.9 32.4 24.0 67.2 32.6 23.3 58.9 22.0 16.8 26.9 29.4 51.7 18.3 13.8 24.9 34.9 42.4 28.3 23.6 28.3 21.5 22.4 16.7 15.0 11.2 19.5 9.4 26.6 27.3 30.2 34.0 28.9 28.6 30.5 25.3 29.9 27.4 2.9 43.9 27.4 35.2 26.6 31.0 17.8 19.4 15.4 18.1 16.4 18.5 18.6 15.6 17.1 16.2 SLC25A44 "FLJ90431, KIAA0446" ENSG00000160785 "Solute carrier family 25 member 44" Q96H78 1 156193932-156212796 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065411 Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA065411: " "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-1)" "unprognostic (2.44e-3)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.72e-2)" "unprognostic (8.92e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "prognostic favourable (2.49e-4)" "unprognostic (3.37e-2)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (2.67e-1)" "unprognostic (8.13e-2)" "unprognostic (2.37e-1)" 14.3 9.0 15.9 9.3 23.1 10.2 8.9 18.6 31.9 9.1 10.4 19.7 6.6 16.8 8.1 11.1 9.0 7.8 10.7 10.6 16.1 16.7 25.9 31.2 10.6 8.7 14.4 18.1 7.1 8.3 17.7 10.9 7.8 22.5 8.7 11.1 9.3 7.0 9.5 12.8 9.1 13.9 10.8 13.5 13.3 8.4 8.9 12.1 10.6 9.7 6.0 11.2 9.7 7.9 3.7 6.3 33.8 9.1 4.2 4.9 5.6 10.2 17.5 8.6 11.3 18.8 10.1 6.8 11.0 16.2 20.0 16.4 17.1 9.3 8.1 9.7 16.4 15.3 31.4 12.9 17.8 9.3 10.5 7.4 11.2 10.3 14.4 9.6 13.7 14.3 11.4 20.2 12.3 16.2 7.7 13.5 13.7 18.4 10.0 6.8 20.3 18.2 6.4 8.7 13.9 26.2 12.2 13.4 18.2 12.8 23.4 14.6 17.6 15.8 13.1 11.6 9.8 13.0 13.1 13.8 10.5 12.3 12.8 10.1 11.4 6.5 8.4 8.7 4.7 9.1 4.9 3.7 3.8 4.4 6.3 2.4 3.1 3.7 33.8 4.2 7.1 2.8 3.3 5.6 15.9 23.1 18.6 31.9 16.1 16.7 14.4 18.1 22.5 12.1 SLC25A46 ENSG00000164209 "Solute carrier family 25 member 46" Q96AG3 5 110738136-110765161 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039601, HPA071582" Approved Supported Mitochondria Mitochondria "HPA039601: , HPA071582: " "unprognostic (1.86e-1)" "unprognostic (3.29e-1)" "prognostic favourable (8.41e-4)" "unprognostic (4.91e-2)" "unprognostic (2.27e-2)" "unprognostic (2.25e-1)" "unprognostic (2.34e-1)" "unprognostic (1.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.97e-2)" "unprognostic (1.67e-1)" "unprognostic (2.40e-1)" "unprognostic (2.25e-2)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "prognostic unfavourable (2.52e-4)" "unprognostic (1.98e-1)" 16.9 15.6 11.9 12.7 19.3 11.3 13.6 17.6 25.7 12.5 14.0 12.2 8.5 15.7 13.4 9.5 16.4 9.5 10.0 20.8 10.4 10.0 18.7 22.0 11.4 13.7 14.5 14.8 10.2 12.4 12.7 20.2 11.5 27.7 10.2 14.7 8.3 14.2 10.7 55.6 13.0 15.4 13.9 15.0 12.1 12.9 15.8 12.3 20.4 12.5 14.3 17.5 13.1 10.9 14.6 15.1 20.2 17.3 17.7 16.3 14.9 12.4 9.6 9.1 7.4 21.2 20.0 3.7 15.6 20.3 17.9 22.4 13.2 10.6 33.6 16.0 18.2 10.3 14.4 25.8 20.3 21.5 8.3 14.4 14.0 9.5 18.9 12.6 14.5 16.9 7.6 21.1 14.9 11.1 10.9 21.1 18.5 10.0 18.3 5.3 6.8 9.7 9.0 20.4 25.0 11.4 14.6 16.1 11.9 13.5 10.4 16.4 11.4 10.4 14.6 15.8 8.0 14.3 18.7 40.6 25.4 25.2 16.4 14.7 8.4 20.2 14.7 11.5 12.3 17.3 12.4 14.1 13.7 12.6 15.1 14.6 14.8 14.8 6.2 17.7 15.2 10.6 16.3 14.9 11.9 19.3 17.6 25.7 10.4 10.0 14.5 14.8 27.7 12.3 SLC26A10 ENSG00000135502 "Solute carrier family 26 member 10" Q8NG04 12 57619527-57626151 "Predicted membrane proteins, Transporters" "Antiport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 8.5" "Cell line enhanced" "Detected in some" "HEK 293: 3.4;NTERA-2: 5.5;RH-30: 4.3;SH-SY5Y: 7.8;U-266/70: 5.3" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Region enhanced" "Detected in single" "cerebellum: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA044719 Uncertain "HPA044719: AB_10962362" "unprognostic (1.16e-1)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (8.82e-2)" "unprognostic (1.86e-1)" "unprognostic (1.89e-2)" "unprognostic (7.92e-2)" "unprognostic (1.45e-1)" "unprognostic (3.12e-2)" "unprognostic (1.89e-1)" "unprognostic (6.12e-5)" "unprognostic (3.22e-3)" "unprognostic (2.65e-12)" "unprognostic (1.28e-2)" "unprognostic (3.80e-1)" "unprognostic (7.34e-3)" "unprognostic (1.40e-1)" 2.0 0.7 0.4 0.5 0.9 0.0 0.4 3.8 0.9 0.4 0.8 0.4 0.4 0.0 2.9 1.2 0.4 1.9 1.8 8.5 0.4 0.2 0.4 0.4 0.4 0.5 0.4 0.4 0.9 0.4 0.0 0.4 0.4 0.4 2.1 0.5 0.4 0.8 1.6 2.6 0.1 1.1 1.9 0.4 0.7 0.6 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.0 0.0 0.0 0.5 1.1 0.2 0.7 0.3 0.1 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.2 0.0 3.4 0.4 0.2 0.7 0.7 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 4.3 0.0 0.0 0.0 2.2 7.8 0.0 0.0 0.5 0.1 0.6 0.0 0.6 1.3 0.6 0.0 5.3 0.5 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 3.8 0.9 0.4 0.2 0.4 0.4 0.4 0.4 SLC27A1 "ACSVL5, FATP, FATP1, FLJ00336, MGC71751" ENSG00000130304 "Solute carrier family 27 member 1" Q6PCB7 19 17468769-17506168 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 17.5;SK-MEL-30: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076520 Approved "Plasma membrane,Mitochondria,Cytosol" "Plasma membrane" "Mitochondria, Cytosol" "HPA076520: " "unprognostic (1.48e-3)" "unprognostic (3.03e-2)" "unprognostic (5.72e-3)" "unprognostic (5.84e-2)" "unprognostic (2.16e-3)" "unprognostic (4.36e-2)" "unprognostic (8.56e-2)" "unprognostic (3.36e-2)" "unprognostic (9.03e-2)" "unprognostic (1.85e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "prognostic favourable (4.70e-4)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" 14.5 14.3 13.1 5.2 13.9 2.0 9.3 20.1 19.3 11.8 6.4 44.1 10.1 4.6 8.9 6.4 5.9 14.7 11.0 18.3 12.9 10.0 5.2 5.2 8.5 6.7 22.0 17.2 23.2 14.5 26.1 9.8 7.5 16.1 11.0 2.6 9.6 26.7 13.0 24.2 13.7 3.7 5.5 13.4 7.1 10.9 9.6 19.3 1.3 9.9 4.7 5.3 6.9 8.8 0.5 7.4 0.3 9.9 1.7 3.2 4.6 3.6 1.8 2.5 6.0 17.5 9.8 2.1 2.6 6.9 3.0 4.5 0.2 11.2 1.2 5.0 4.3 4.4 0.2 4.1 0.7 1.4 0.8 0.7 0.2 1.3 3.4 0.3 4.0 9.0 2.9 3.0 1.2 2.0 0.4 0.7 1.9 1.5 1.9 2.9 0.7 3.2 2.8 2.0 0.8 1.9 1.1 0.8 1.8 1.8 0.9 28.9 3.2 0.9 1.2 5.9 3.8 4.6 1.8 2.5 1.8 0.4 6.0 3.1 4.1 0.0 9.9 0.3 1.7 4.7 3.2 0.5 1.2 2.1 7.2 0.3 1.6 2.1 0.0 1.7 1.8 7.4 0.7 4.6 13.1 13.9 20.1 19.3 12.9 10.0 22.0 17.2 16.1 19.3 SLC27A2 "ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS" ENSG00000140284 "Solute carrier family 27 member 2" O14975 15 50182196-50236395 "Enzymes, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 168.1" "Cell line enhanced" "Detected in many" "A549: 18.9;HaCaT: 34.0;HeLa: 17.5;HL-60: 24.4;NB-4: 16.5;RT4: 17.3" "Cancer enhanced" "Detected in many" "liver cancer: 49.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 27 "basophil: 27.3" "Lineage enriched" "Detected in many" 27 "granulocytes: 27.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 6 "hippocampal formation: 2.5" HPA026089 Enhanced "HPA026089: AB_1857060" "unprognostic (3.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (2.10e-2)" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (4.06e-3)" "unprognostic (3.33e-1)" "unprognostic (1.89e-1)" "unprognostic (6.38e-3)" "unprognostic (4.83e-2)" "unprognostic (1.82e-1)" "prognostic favourable (7.48e-6)" "unprognostic (5.01e-3)" "unprognostic (4.08e-1)" "unprognostic (1.22e-2)" "prognostic favourable (6.40e-4)" 1.1 8.1 0.7 4.1 0.8 1.2 3.4 1.5 1.0 0.5 4.2 0.4 1.3 2.5 0.2 17.5 1.2 2.6 1.3 0.2 1.1 1.1 39.4 168.1 1.7 0.8 0.3 1.0 0.7 6.3 2.0 10.4 7.4 3.0 1.2 4.0 3.2 0.6 0.3 0.2 0.6 5.3 0.1 0.3 0.4 0.4 0.7 0.1 0.1 1.0 0.2 1.3 1.4 0.8 0.1 0.0 27.3 0.0 1.0 0.5 0.2 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.5 9.8 2.6 0.0 0.2 0.4 34.0 8.7 0.2 0.9 13.3 10.7 14.0 17.5 8.8 0.1 24.4 10.0 0.0 0.8 0.0 0.0 0.0 4.2 0.0 0.0 3.0 0.6 16.5 0.6 0.7 0.0 0.0 0.6 1.8 17.3 15.7 1.0 3.3 0.4 0.0 1.8 8.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 27.3 0.0 0.4 0.4 0.0 0.4 0.1 0.4 0.4 0.0 0.1 0.1 0.1 0.2 1.0 0.0 0.0 0.5 0.2 0.7 0.8 1.5 1.0 1.1 1.1 0.3 1.0 3.0 0.1 SLC27A3 "ACSVL3, FATP3, MGC4365" ENSG00000143554 "Solute carrier family 27 member 3" Q5K4L6 1 153774354-153780157 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 35.0;MCF7: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA006935, HPA067508" Enhanced Enhanced "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA006935: AB_1080003, HPA067508: " "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (1.34e-1)" "unprognostic (3.57e-2)" "unprognostic (2.70e-2)" "unprognostic (4.85e-2)" "unprognostic (6.08e-2)" "unprognostic (3.18e-2)" "unprognostic (4.22e-2)" "unprognostic (3.39e-2)" "prognostic favourable (5.23e-4)" "unprognostic (4.67e-2)" "prognostic unfavourable (6.33e-4)" "unprognostic (1.95e-1)" "unprognostic (4.41e-1)" "unprognostic (2.59e-1)" "unprognostic (2.08e-1)" 20.7 3.7 4.9 6.4 4.3 3.7 15.0 7.5 6.6 11.1 11.6 3.6 7.9 3.5 10.1 39.1 9.4 9.5 9.2 7.0 3.5 2.4 12.2 19.5 21.1 7.0 3.5 4.7 13.6 5.7 4.5 6.7 9.7 3.3 11.6 6.1 4.6 7.7 9.7 3.6 11.0 6.8 10.5 1.8 6.9 14.4 15.4 3.4 3.5 8.6 10.3 5.5 9.7 9.4 0.6 5.9 13.7 8.7 2.2 2.2 2.5 3.9 0.2 1.7 0.8 35.0 6.8 3.0 1.5 3.0 0.6 0.8 2.3 1.8 0.5 4.1 1.6 12.2 1.6 1.4 0.4 0.3 2.3 0.8 2.1 0.9 4.2 1.4 2.8 4.5 4.6 0.2 0.8 4.7 0.3 0.7 0.2 18.5 0.1 4.0 4.0 1.9 7.0 0.3 0.4 0.9 0.4 3.4 3.8 0.8 8.1 1.5 2.1 4.0 1.1 0.8 1.7 4.3 0.0 1.3 1.1 0.1 2.0 4.7 0.6 7.2 8.7 13.7 2.1 7.3 1.5 0.5 1.0 2.2 5.9 0.6 0.5 1.1 1.7 2.2 7.2 1.0 0.3 2.5 4.9 4.3 7.5 6.6 3.5 2.4 3.5 4.7 3.3 3.4 SLC29A1 ENT1 ENSG00000112759 "Solute carrier family 29 member 1 (Augustine blood group)" Q99808 6 44219505-44234151 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 117.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 25 "eosinophil: 117.2" "Lineage enriched" "Detected in many" 25 "granulocytes: 117.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012384 Approved "HPA012384: AB_1857073" "unprognostic (1.82e-2)" "unprognostic (1.41e-2)" "unprognostic (1.81e-1)" "unprognostic (2.49e-3)" "unprognostic (2.76e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (2.96e-4)" "unprognostic (1.38e-2)" "unprognostic (4.60e-2)" "unprognostic (9.02e-2)" "unprognostic (1.34e-1)" 42.9 40.9 5.8 9.4 9.6 17.9 57.2 10.4 15.2 21.2 35.8 5.9 6.9 5.2 19.8 11.7 22.8 14.9 24.4 46.8 5.4 6.4 14.7 23.2 15.3 14.4 5.5 8.4 12.5 35.8 8.7 15.2 23.2 9.8 21.4 7.4 18.0 15.7 8.4 53.0 23.8 12.4 39.0 5.3 11.4 33.0 8.8 4.8 53.9 18.8 17.2 11.1 28.7 20.7 0.5 4.7 117.2 4.5 0.3 0.9 0.7 16.5 16.5 11.8 18.9 18.1 1.7 70.4 12.2 4.8 17.1 11.7 17.9 6.8 33.6 12.3 3.6 20.6 21.0 14.7 10.3 19.1 19.3 29.0 11.4 23.3 2.9 32.6 28.1 2.2 3.7 25.1 8.8 42.8 39.2 19.9 9.3 18.2 26.9 21.9 17.9 11.0 18.0 23.8 40.7 9.9 9.7 15.2 19.6 3.5 11.9 8.6 16.1 20.7 64.8 9.4 15.4 12.7 23.1 13.6 17.6 42.9 5.7 26.7 11.3 1.8 1.4 117.2 0.6 4.5 0.4 0.5 0.3 0.4 0.8 0.3 0.1 0.3 0.2 0.3 3.6 4.7 0.9 0.7 5.8 9.6 10.4 15.2 5.4 6.4 5.5 8.4 9.8 4.8 SLC2A11 "GLUT10, GLUT11" ENSG00000133460 "Solute carrier family 2 member 11" Q9BYW1 22 23856703-23886309 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042960, HPA071184" Uncertain Uncertain "Nucleoplasm,Cell Junctions" "Cell Junctions" Nucleoplasm "HPA042960: , HPA071184: " "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (3.69e-2)" "unprognostic (6.97e-2)" "unprognostic (7.93e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-2)" "unprognostic (1.60e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "prognostic favourable (3.83e-4)" "unprognostic (2.32e-1)" "prognostic favourable (5.77e-7)" "unprognostic (1.25e-1)" "unprognostic (1.70e-1)" "unprognostic (3.85e-1)" "unprognostic (6.29e-2)" 4.3 7.8 8.5 6.1 15.3 3.5 6.2 22.9 17.0 4.1 4.9 6.4 17.2 3.9 7.7 9.0 2.8 5.0 5.2 8.5 11.0 13.4 19.5 4.9 4.5 7.1 9.5 10.9 6.6 28.8 18.6 14.0 21.0 9.7 7.6 6.0 10.4 6.1 11.4 13.6 4.2 4.8 10.4 9.6 5.3 6.1 4.5 6.2 1.6 9.2 2.4 6.4 4.5 5.3 2.2 4.6 1.5 1.1 1.2 1.6 0.3 2.6 1.3 1.7 7.6 1.7 3.5 0.8 1.6 2.0 1.8 1.3 1.8 1.8 3.4 0.9 2.2 2.2 3.2 0.9 1.0 2.4 2.9 1.7 2.8 2.6 2.5 1.6 1.8 1.3 3.2 2.7 2.3 0.7 0.7 7.6 1.0 2.8 0.3 0.7 2.5 2.1 4.6 0.2 3.8 5.6 0.7 4.1 2.4 0.8 12.1 2.7 6.3 0.8 0.5 0.7 1.2 0.7 0.8 7.2 2.0 3.4 1.5 1.2 1.8 1.5 0.4 0.9 0.9 1.1 0.7 2.1 0.8 0.8 0.2 2.2 1.6 1.1 1.2 1.2 0.7 4.6 0.2 0.3 8.5 15.3 22.9 17.0 11.0 13.4 9.5 10.9 9.7 6.2 SLC2A14 "GLUT14, SLC2A3P3" ENSG00000173262 "Solute carrier family 2 member 14" Q8TDB8 12 7812512-7891148 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis, Sugar transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 52.4" "Group enriched" "Detected in some" 4 "BEWO: 14.6;CACO-2: 23.7;Hep G2: 6.1" "Cancer enriched" "Detected in single" 35 "testis cancer: 7.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.9" HPA006539 Supported Approved "Plasma membrane" "Plasma membrane" "HPA006539: AB_1078984" "unprognostic (2.52e-1)" "unprognostic (4.74e-3)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (1.82e-3)" "unprognostic (8.62e-2)" "unprognostic (7.15e-2)" "unprognostic (1.89e-1)" "unprognostic (9.91e-3)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "unprognostic (8.46e-4)" "unprognostic (3.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.26e-2)" "unprognostic (1.22e-2)" 0.4 3.1 0.1 0.1 0.6 3.0 0.4 0.1 0.2 0.4 0.4 0.3 0.1 0.0 0.3 0.8 0.8 0.1 0.3 0.1 0.2 0.3 0.1 2.0 0.2 0.2 0.1 0.1 2.7 7.4 0.0 0.6 0.5 0.3 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.0 52.4 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.6 0.4 6.9 0.7 1.3 1.7 0.2 0.0 0.4 0.3 0.3 0.2 0.8 14.6 0.0 0.0 0.0 0.2 23.7 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.4 0.6 6.1 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.1 0.1 0.1 2.7 0.0 0.2 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.0 1.5 0.3 0.1 0.6 0.4 0.1 0.1 0.1 0.3 0.3 0.0 0.3 5.5 0.7 1.8 1.0 0.2 1.2 0.5 1.0 0.8 0.4 0.6 0.7 0.9 6.9 1.3 0.2 0.3 1.7 0.2 0.1 0.6 0.1 0.2 0.2 0.3 0.1 0.1 0.3 0.2 SLC30A5 "FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1" ENSG00000145740 "Solute carrier family 30 member 5" Q8TAD4 5 69093646-69131069 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035373 Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA035373: AB_10794630" "unprognostic (9.81e-3)" "unprognostic (3.33e-1)" "unprognostic (2.82e-2)" "unprognostic (8.16e-2)" "unprognostic (1.65e-1)" "unprognostic (3.88e-2)" "unprognostic (1.16e-3)" "unprognostic (2.47e-2)" "unprognostic (4.65e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (2.92e-1)" "unprognostic (1.49e-1)" "unprognostic (2.53e-2)" "unprognostic (2.07e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" 19.4 22.1 14.4 19.4 15.7 13.3 29.7 14.9 18.5 25.0 20.9 13.2 33.7 19.7 24.3 32.4 20.5 20.3 23.5 25.4 14.5 15.4 28.6 39.2 24.3 23.7 15.5 13.1 25.4 50.5 29.6 38.1 34.3 13.9 24.5 19.8 17.6 36.8 35.3 17.1 21.2 25.0 18.1 13.2 20.1 20.3 18.1 12.7 22.1 33.5 18.8 19.6 18.2 28.9 8.3 13.2 12.4 6.9 5.6 9.1 3.3 15.6 12.2 11.3 19.9 29.9 23.1 36.0 24.9 22.6 15.7 24.1 11.2 19.8 20.8 31.7 16.9 17.0 15.7 18.9 26.7 24.8 18.1 23.2 15.4 18.2 24.1 14.5 25.8 15.6 25.0 16.2 19.3 15.2 13.9 24.9 20.0 19.8 19.1 30.3 12.9 13.9 15.4 14.4 37.5 23.5 14.7 20.3 16.1 19.7 19.8 33.7 19.1 32.4 13.8 10.3 13.3 25.6 24.6 22.6 27.7 16.2 20.2 26.5 25.2 12.4 6.7 10.7 6.1 6.8 6.5 8.3 9.1 8.9 8.4 6.3 8.4 7.1 5.9 5.6 6.9 13.2 6.1 3.3 14.4 15.7 14.9 18.5 14.5 15.4 15.5 13.1 13.9 12.7 SLC30A8 "ZnT-8, ZNT8" ENSG00000164756 "Solute carrier family 30 member 8" Q8IWU4 8 116950273-117176714 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pancreas: 37.1" "Group enriched" "Detected in some" 34 "U-266/70: 29.8;U-266/84: 20.8" "Group enriched" "Detected in some" 28 "breast cancer: 10.6;pancreatic cancer: 15.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA076165 Enhanced "HPA076165: " "unprognostic (2.14e-2)" "unprognostic (1.48e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (5.38e-2)" "unprognostic (5.57e-2)" "unprognostic (4.38e-1)" "unprognostic (3.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.66e-2)" "unprognostic (6.51e-3)" "unprognostic (2.15e-2)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (9.16e-3)" 0.1 0.0 0.1 0.1 0.4 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.1 0.1 0.1 0.1 37.1 0.0 0.3 0.1 0.1 0.1 0.0 5.0 6.4 0.1 0.1 0.3 0.4 0.1 0.1 0.1 0.6 2.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.5 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 29.8 20.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 SLC35A4 ENSG00000176087 "Solute carrier family 35 member A4" "Q96G79, L0R6Q1" 5 140564456-140569103 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062210 Approved Nucleoplasm Nucleoplasm "HPA062210: " "unprognostic (3.01e-3)" "unprognostic (1.35e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-2)" "unprognostic (1.91e-3)" "unprognostic (9.63e-2)" "unprognostic (3.61e-2)" "unprognostic (9.32e-2)" "unprognostic (1.78e-2)" "unprognostic (2.87e-1)" "prognostic favourable (4.56e-5)" "unprognostic (2.96e-2)" "unprognostic (3.04e-2)" "unprognostic (2.06e-2)" "unprognostic (1.55e-1)" 22.0 30.4 12.3 18.6 17.1 8.4 19.6 14.0 21.8 18.2 25.5 24.9 22.6 19.2 18.2 19.8 30.3 20.6 26.0 25.7 13.1 10.3 35.1 39.2 23.1 22.5 16.0 11.1 19.0 28.3 28.2 14.9 24.6 19.4 20.4 26.5 20.5 32.6 15.9 54.3 28.3 30.6 19.8 13.0 28.5 21.7 30.5 15.3 26.0 29.2 28.0 27.5 18.3 18.0 15.4 32.8 15.8 36.9 26.9 27.6 32.4 15.3 46.1 18.4 34.7 25.3 15.9 27.5 22.3 15.1 27.3 28.8 55.7 17.7 45.4 27.7 21.0 17.0 0.0 32.7 23.5 55.2 25.2 33.9 45.0 0.2 18.0 33.2 25.6 21.0 25.6 27.2 24.3 23.3 26.2 45.8 27.0 28.4 34.5 14.4 12.5 23.5 25.7 37.3 39.3 20.4 30.4 20.6 27.5 28.3 47.1 22.0 39.1 14.2 27.3 24.6 17.1 24.4 25.0 19.1 44.7 19.1 18.1 37.5 28.5 7.5 26.9 15.8 27.6 36.9 26.3 14.3 22.1 24.7 32.8 15.4 25.9 23.0 9.9 26.9 33.3 12.0 14.7 32.4 12.3 17.1 14.0 21.8 13.1 10.3 16.0 11.1 19.4 15.3 SLC35A5 FLJ20730 ENSG00000138459 "Solute carrier family 35 member A5" Q9BS91 3 112561709-112585577 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035519, HPA057964" Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA035519: AB_10601487, HPA057964: " "unprognostic (7.89e-2)" "unprognostic (2.33e-1)" "unprognostic (7.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (7.09e-2)" "unprognostic (1.45e-1)" "unprognostic (4.78e-2)" "unprognostic (8.60e-3)" "unprognostic (2.60e-1)" "unprognostic (8.21e-2)" "unprognostic (3.51e-1)" "prognostic favourable (4.10e-5)" "unprognostic (2.26e-1)" "unprognostic (1.97e-1)" "unprognostic (8.05e-2)" "unprognostic (3.42e-1)" 13.4 17.7 19.4 11.2 22.1 4.4 13.0 14.2 24.1 15.0 13.6 32.7 9.7 14.9 15.2 15.0 13.0 13.3 13.8 9.6 22.9 22.0 18.2 18.0 12.8 12.4 37.8 19.5 16.9 12.6 17.9 17.6 17.2 27.5 14.8 14.8 14.4 11.7 13.4 5.5 8.0 15.5 14.1 42.9 12.7 12.5 15.4 26.6 11.6 23.8 6.4 13.1 13.2 10.4 12.0 15.2 15.7 20.1 5.2 11.5 7.8 11.2 10.2 17.5 10.6 23.0 21.8 10.1 18.4 13.4 15.9 18.2 7.6 12.9 10.2 15.8 16.1 14.2 12.7 8.8 19.9 7.7 6.2 12.8 9.8 6.6 19.0 11.4 12.3 18.9 17.7 14.0 8.6 14.1 7.3 12.6 21.7 4.0 8.6 7.3 11.8 10.9 7.7 6.5 10.5 19.5 8.4 10.2 13.9 11.9 5.9 20.8 7.8 8.0 15.8 23.1 12.7 4.9 8.5 8.9 12.7 17.8 17.2 9.5 16.9 8.4 12.6 15.7 8.9 19.8 8.3 12.0 8.5 7.0 15.2 11.5 11.5 9.4 11.2 5.2 20.1 7.2 8.4 7.8 19.4 22.1 14.2 24.1 22.9 22.0 37.8 19.5 27.5 26.6 SLC35B2 UGTrel4 ENSG00000157593 "Solute carrier family 35 member B2" Q8TB61 6 44254096-44257890 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029638 Approved Approved Vesicles Vesicles "HPA029638: AB_10602402" "prognostic unfavourable (7.90e-4)" "unprognostic (2.47e-3)" "unprognostic (2.30e-1)" "unprognostic (1.39e-2)" "unprognostic (2.36e-1)" "unprognostic (1.65e-2)" "prognostic unfavourable (8.59e-5)" "unprognostic (3.84e-1)" "unprognostic (2.51e-1)" "unprognostic (7.03e-3)" "unprognostic (4.27e-2)" "prognostic favourable (6.07e-4)" "unprognostic (3.60e-2)" "unprognostic (1.13e-1)" "unprognostic (4.07e-1)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" 18.0 28.2 14.8 12.6 15.0 10.7 17.7 16.2 24.8 18.3 18.9 35.8 19.0 13.0 22.6 23.4 14.3 18.6 27.1 17.7 15.2 10.9 32.3 35.5 16.1 12.9 17.1 14.6 16.7 38.1 27.4 11.1 26.1 19.8 19.0 20.2 23.8 49.6 20.4 17.5 15.6 16.4 20.5 24.7 18.4 20.6 16.3 18.7 12.2 19.3 17.8 17.6 19.6 14.3 12.9 14.4 21.8 8.6 10.8 21.1 10.2 25.9 14.9 18.7 35.9 30.8 32.6 13.7 28.5 47.1 28.0 34.5 13.1 24.2 5.8 25.7 35.1 24.8 12.7 32.0 19.8 17.2 16.5 11.7 11.8 15.6 28.8 24.9 19.0 33.4 33.7 25.7 12.7 20.5 16.6 25.1 33.5 30.5 9.1 20.8 8.3 17.4 9.2 12.1 29.6 30.2 19.3 23.4 22.4 14.0 15.6 32.0 28.9 22.8 20.3 22.1 14.7 22.0 24.7 19.4 22.1 13.5 29.5 19.9 44.9 21.8 8.6 13.2 21.1 6.5 17.8 12.9 11.9 16.1 7.7 7.7 11.0 14.2 0.7 10.8 2.3 14.4 9.6 10.2 14.8 15.0 16.2 24.8 15.2 10.9 17.1 14.6 19.8 18.7 SLC35C1 "FLJ11320, FUCT1" ENSG00000181830 "Solute carrier family 35 member C1" Q96A29 11 45804072-45813015 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064001 Enhanced Supported "Golgi apparatus" "Golgi apparatus" "HPA064001: " "unprognostic (2.62e-2)" "unprognostic (5.16e-2)" "unprognostic (7.82e-2)" "unprognostic (1.57e-2)" "prognostic unfavourable (9.68e-4)" "unprognostic (8.22e-2)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "unprognostic (4.09e-2)" "unprognostic (2.73e-1)" "unprognostic (7.68e-2)" "unprognostic (1.83e-3)" "unprognostic (2.18e-1)" "prognostic favourable (3.64e-4)" "unprognostic (2.30e-2)" 14.9 4.8 5.1 7.2 4.5 1.5 14.3 4.4 7.3 7.0 13.8 4.4 4.9 17.4 7.1 3.2 22.5 6.1 8.8 5.3 5.4 3.9 6.0 74.7 7.1 7.1 3.9 3.6 4.9 11.4 4.9 7.8 10.5 5.6 6.0 9.8 3.6 15.5 7.0 8.5 3.4 17.4 6.8 5.0 6.5 13.4 7.4 4.8 5.6 5.2 7.0 10.9 9.4 8.6 4.7 8.3 9.9 10.5 4.3 16.7 8.6 5.3 13.8 3.1 8.0 10.2 10.4 10.6 11.6 10.1 6.8 7.5 6.2 8.7 5.0 5.5 13.2 14.1 6.6 6.8 3.2 13.0 7.9 2.8 11.0 11.2 22.5 5.5 8.8 12.3 8.3 5.2 5.6 8.8 6.4 7.5 7.1 11.5 2.8 4.3 14.0 19.5 3.8 5.3 11.8 7.6 13.3 3.1 4.5 8.6 8.3 4.8 7.4 2.9 13.4 14.2 8.3 24.9 8.3 5.5 12.9 2.5 10.2 7.3 7.7 5.0 10.2 9.9 10.2 10.5 11.1 4.7 16.7 13.4 8.3 3.6 8.5 7.4 1.6 4.3 6.9 7.2 10.8 8.6 5.1 4.5 4.4 7.3 5.4 3.9 3.9 3.6 5.6 4.8 SLC35E1 FLJ14251 ENSG00000127526 "Solute carrier family 35 member E1" Q96K37 19 16549831-16572382 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016570, HPA062214" Approved Enhanced "Golgi apparatus" "Golgi apparatus" "HPA016570: AB_2190214, HPA062214: " "unprognostic (1.76e-2)" "unprognostic (2.81e-1)" "unprognostic (7.31e-2)" "unprognostic (2.92e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.35e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (9.07e-2)" "unprognostic (3.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (2.54e-1)" "unprognostic (3.75e-2)" 15.2 12.7 11.9 9.3 12.3 10.3 13.5 11.7 19.2 15.1 12.4 8.7 22.4 9.7 11.3 10.3 14.2 11.2 13.7 12.6 9.3 9.7 11.6 20.1 13.5 9.5 8.3 7.9 11.9 34.5 25.8 14.4 23.9 10.7 17.9 9.4 11.4 23.7 21.4 23.1 14.3 13.4 10.0 5.9 9.7 17.0 6.4 7.2 14.0 13.8 12.3 13.9 15.2 14.1 5.9 3.2 7.9 5.0 4.5 5.2 2.9 17.7 7.0 5.1 11.2 18.8 14.6 11.9 12.9 13.8 10.6 12.6 8.2 12.7 9.3 20.8 20.1 11.9 13.7 14.5 12.1 10.6 19.7 8.4 8.1 9.6 15.1 13.9 10.1 11.6 17.1 11.7 17.6 10.2 12.9 12.6 14.0 16.9 10.1 6.4 5.9 23.8 9.8 7.7 10.9 10.9 11.5 8.5 8.4 8.9 14.3 7.9 10.0 6.8 11.1 14.2 7.0 19.0 14.8 16.3 17.4 10.5 20.9 14.8 8.7 5.0 3.9 7.9 4.1 2.5 5.2 5.9 4.3 3.6 2.7 2.8 3.2 2.5 4.8 4.5 5.0 3.2 4.8 2.9 11.9 12.3 11.7 19.2 9.3 9.7 8.3 7.9 10.7 7.2 SLC36A1 "LYAAT-1, PAT1, TRAMD3" ENSG00000123643 "Solute carrier family 36 member 1" Q7Z2H8 5 151437046-151492381 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 15.9;classical monocyte: 6.6;neutrophil: 14.5" "Group enriched" "Detected in many" 5 "granulocytes: 15.9;monocytes: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035937 Approved "HPA035937: AB_10672995" "unprognostic (5.49e-2)" "unprognostic (4.04e-2)" "unprognostic (1.24e-1)" "unprognostic (8.27e-3)" "unprognostic (1.91e-1)" "unprognostic (2.02e-1)" "prognostic unfavourable (6.30e-5)" "unprognostic (1.86e-1)" "unprognostic (2.44e-1)" "unprognostic (1.29e-3)" "unprognostic (5.08e-2)" "unprognostic (2.78e-1)" "prognostic unfavourable (1.83e-6)" "unprognostic (2.66e-2)" "unprognostic (1.03e-2)" "unprognostic (2.49e-1)" "unprognostic (1.42e-1)" 5.6 4.7 5.1 6.0 11.1 19.3 4.4 43.3 15.3 3.8 11.1 5.0 11.6 32.5 4.6 3.8 5.4 3.8 8.3 3.7 4.2 4.1 7.3 3.5 6.0 4.5 6.0 6.8 4.0 6.5 32.1 6.3 4.4 13.9 9.9 17.5 4.1 5.1 7.6 7.6 3.9 28.7 5.2 4.1 9.2 4.8 11.2 5.0 7.1 3.7 3.6 4.2 7.2 4.5 1.7 2.1 15.9 6.6 0.3 1.9 0.8 3.8 6.7 3.5 2.3 8.9 6.5 19.1 11.3 6.4 7.9 8.9 15.4 5.7 9.0 6.7 13.5 9.6 11.1 7.0 7.8 2.5 9.7 2.8 10.9 5.1 11.4 6.6 15.3 4.7 8.2 6.6 4.4 6.9 6.3 7.9 6.6 4.2 1.9 3.3 3.5 6.3 0.0 8.5 3.5 2.0 5.8 3.2 6.1 7.0 8.5 4.0 6.4 9.7 6.9 10.5 5.9 17.0 6.3 3.7 5.2 5.8 6.7 11.6 6.9 15.9 6.6 2.5 1.2 2.8 0.8 1.6 1.1 1.9 2.1 1.7 0.9 0.8 14.5 0.3 2.8 0.4 1.1 0.8 5.1 11.1 43.3 15.3 4.2 4.1 6.0 6.8 13.9 5.0 SLC38A3 "G17, SN1" ENSG00000188338 "Solute carrier family 38 member 3" Q99624 3 50205246-50221486 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 107.8" "Group enriched" "Detected in some" 4 "Hep G2: 31.7;SCLC-21H: 10.5" "Cancer enriched" "Detected in many" 9 "liver cancer: 140.0" "Cell type enhanced" "Detected in some" "basophil: 5.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031871 Approved Microtubules,Cytosol Cytosol Microtubules "HPA031871: " "unprognostic (2.14e-1)" "unprognostic (2.10e-1)" "unprognostic (8.60e-2)" "unprognostic (6.19e-4)" "unprognostic (7.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.34e-2)" "unprognostic (2.30e-2)" "unprognostic (4.68e-3)" "unprognostic (1.46e-1)" "unprognostic (2.06e-1)" "unprognostic (5.71e-2)" "unprognostic (1.23e-3)" "unprognostic (1.90e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.96e-1)" 0.7 0.3 3.4 0.3 5.2 0.5 0.7 2.4 10.5 0.3 0.3 10.3 0.0 0.7 0.4 0.4 0.6 0.4 0.4 2.0 4.1 1.5 107.8 0.3 0.4 3.4 4.0 2.4 11.6 1.8 0.7 0.6 7.8 0.4 0.3 22.2 0.9 0.3 10.4 0.5 0.4 0.3 4.7 0.3 0.9 0.7 5.2 0.0 0.6 1.9 0.4 0.3 0.0 1.1 1.0 5.6 0.8 1.5 0.8 0.2 0.0 0.0 0.8 4.8 0.0 0.0 1.2 0.0 0.0 0.9 0.4 2.9 0.1 0.1 0.8 0.0 0.0 1.2 0.0 0.6 0.1 0.4 0.0 0.6 31.7 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.4 0.5 0.0 0.4 0.3 0.0 0.1 0.2 10.5 0.9 0.5 0.1 0.0 1.3 0.2 0.0 0.2 0.9 0.0 0.6 0.3 0.0 0.1 0.1 0.2 0.1 5.6 0.8 0.9 0.6 0.2 0.4 0.7 0.5 0.4 0.2 1.1 0.6 0.8 3.3 1.5 0.2 1.0 0.4 0.2 SLC38A7 FLJ10815 ENSG00000103042 "Solute carrier family 38 member 7" Q9NVC3 16 58665109-58685104 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041777 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA041777: AB_10796782" "unprognostic (2.16e-3)" "unprognostic (2.30e-2)" "unprognostic (6.23e-3)" "prognostic favourable (6.87e-4)" "unprognostic (3.49e-1)" "unprognostic (8.08e-3)" "unprognostic (9.76e-3)" "unprognostic (6.34e-3)" "unprognostic (1.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.77e-1)" "unprognostic (4.90e-2)" "prognostic favourable (2.87e-4)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (7.50e-2)" "unprognostic (4.93e-3)" 7.0 11.1 10.6 6.7 10.0 2.7 7.2 7.7 13.7 6.2 5.3 10.6 6.8 4.8 6.0 7.4 6.0 4.2 6.5 13.8 7.2 7.2 7.4 12.1 5.2 4.3 6.1 11.0 4.7 5.0 16.9 10.2 8.4 8.3 5.2 6.9 8.9 6.1 5.6 9.6 5.3 4.9 8.5 5.8 10.3 5.4 27.1 6.6 4.2 8.0 8.1 5.1 6.5 6.3 2.8 6.1 2.5 8.6 2.3 5.2 6.6 4.3 6.8 6.8 10.4 14.2 8.5 12.8 10.3 12.0 14.5 10.2 6.4 6.8 2.7 5.9 14.3 10.6 6.5 7.2 8.6 1.7 5.9 3.1 5.7 10.3 21.5 6.5 9.0 17.1 15.2 10.1 6.7 14.9 9.2 4.2 10.5 5.2 2.5 3.8 7.4 10.2 9.4 7.3 7.5 6.4 10.1 5.0 7.6 15.5 10.7 4.5 5.0 2.7 11.6 8.0 6.1 13.8 3.1 6.2 4.0 3.2 10.8 3.9 5.9 0.2 8.6 2.5 5.2 8.4 3.1 1.9 3.3 3.8 6.1 2.8 2.7 2.9 0.8 2.3 7.5 2.1 2.2 6.6 10.6 10.0 7.7 13.7 7.2 7.2 6.1 11.0 8.3 6.6 SLC39A11 C17orf26 ENSG00000133195 "Solute carrier family 39 member 11" Q8N1S5 17 72645949-73092712 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021455 Approved Nucleoplasm Nucleoplasm "HPA021455: " "unprognostic (2.29e-2)" "unprognostic (2.75e-1)" "unprognostic (1.25e-1)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (3.45e-3)" "unprognostic (2.30e-1)" "unprognostic (1.57e-3)" "unprognostic (5.26e-2)" "unprognostic (1.17e-1)" "unprognostic (4.96e-3)" "unprognostic (3.85e-2)" 10.4 7.4 12.4 7.8 17.9 10.7 10.8 5.3 14.4 9.3 13.3 19.8 6.6 11.5 4.8 9.6 13.0 5.6 8.6 4.2 13.3 6.3 7.9 21.9 8.2 4.8 27.8 6.6 2.8 23.8 3.1 3.8 7.0 15.3 5.3 13.8 6.7 16.6 5.2 3.7 11.2 12.7 5.7 15.7 6.5 27.6 4.1 22.5 6.0 20.6 3.6 8.6 8.3 7.6 6.0 14.9 9.8 16.2 8.7 6.9 6.3 4.2 7.8 0.9 3.8 6.8 5.5 5.3 4.6 4.1 2.1 2.8 2.9 19.4 5.3 4.7 4.6 3.7 1.3 2.3 3.2 5.7 2.7 4.9 2.0 3.3 4.1 5.2 47.6 4.7 4.4 4.3 2.5 2.1 2.5 6.7 2.6 6.0 3.3 11.4 0.7 3.3 2.2 3.5 4.4 3.5 4.4 2.2 3.0 2.4 18.4 2.7 12.6 7.3 1.8 4.2 3.9 3.5 2.8 5.4 2.4 3.7 6.8 10.7 2.4 5.5 16.2 9.8 6.9 15.4 4.6 6.0 5.3 5.2 14.9 3.9 3.8 5.2 2.5 8.7 11.9 10.5 6.5 6.3 12.4 17.9 5.3 14.4 13.3 6.3 27.8 6.6 15.3 22.5 SLC39A14 "KIAA0062, NET34, ZIP14" ENSG00000104635 "Solute carrier family 39 member 14" Q15043 8 22367249-22434129 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Disease mutation, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 135.5;pancreas: 77.2" "Cell line enhanced" "Detected in all" "BJ hTERT+: 68.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016508 Approved Approved "Endoplasmic reticulum,Golgi apparatus,Plasma membrane" 950000 "Endoplasmic reticulum, Golgi apparatus, Plasma membrane" "HPA016508: AB_1857148" "unprognostic (1.67e-1)" "unprognostic (6.67e-3)" "prognostic favourable (5.00e-5)" "unprognostic (9.83e-3)" "unprognostic (9.21e-3)" "unprognostic (8.99e-3)" "unprognostic (1.99e-1)" "unprognostic (2.91e-2)" "unprognostic (4.95e-2)" "unprognostic (5.66e-2)" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "prognostic unfavourable (3.79e-7)" "unprognostic (4.88e-2)" "unprognostic (8.73e-2)" "unprognostic (1.63e-2)" "unprognostic (1.11e-3)" 15.0 16.1 2.6 7.7 5.4 0.1 45.5 2.4 6.1 3.6 13.7 1.9 2.8 31.6 6.7 2.8 3.9 5.6 9.8 41.1 2.8 2.4 10.4 135.5 4.8 5.3 3.7 1.9 10.6 77.2 3.0 6.4 4.0 9.2 5.1 11.4 4.1 20.2 4.4 46.1 4.4 18.2 14.1 4.7 2.3 16.2 5.9 2.8 0.7 25.1 2.1 1.4 11.3 19.0 5.0 1.8 2.5 0.5 2.9 8.7 3.9 10.6 14.3 4.0 8.0 14.3 12.1 8.7 15.4 68.2 24.1 38.0 47.3 10.1 10.7 8.7 18.0 11.8 19.7 19.2 39.7 11.1 11.2 8.5 11.4 47.7 34.1 5.8 9.4 12.9 15.6 42.7 29.8 10.7 7.4 10.9 12.2 4.9 8.8 3.7 24.3 11.0 12.6 7.5 22.8 8.8 4.6 6.8 10.6 15.7 6.7 31.8 5.4 8.5 5.9 30.0 15.2 18.8 15.7 6.3 5.7 14.0 42.4 7.8 17.4 0.0 0.5 2.5 8.3 0.1 8.7 5.0 4.8 6.3 1.8 2.6 5.7 7.6 0.2 2.9 0.1 0.8 3.8 3.9 2.6 5.4 2.4 6.1 2.8 2.4 3.7 1.9 9.2 2.8 SLC39A2 ZIP2 ENSG00000165794 "Solute carrier family 39 member 2" Q9NP94 14 20999255-21001871 "Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8" "Cell line enriched" "Detected in single" 70 "HaCaT: 22.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030489, HPA073231" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" "Plasma membrane" "Cytoplasmic bodies" "HPA030489: AB_10601488, HPA073231: " "unprognostic (2.76e-2)" "unprognostic (4.86e-2)" "unprognostic (9.72e-2)" "unprognostic (2.37e-1)" "unprognostic (2.46e-1)" "unprognostic (2.71e-1)" "unprognostic (3.42e-1)" "unprognostic (1.70e-1)" "unprognostic (4.43e-1)" "unprognostic (6.20e-3)" "unprognostic (3.31e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-2)" "unprognostic (1.91e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-1)" "unprognostic (2.30e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 1.3 0.3 0.4 5.6 1.2 0.0 44.3 0.0 0.8 0.0 13.0 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.4 0.2 1.0 0.2 8.5 0.8 0.4 2.7 50.6 0.1 23.8 0.1 0.2 0.1 0.1 0.0 0.1 0.0 1.3 0.1 6.1 3.3 1.2 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 22.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.4 0.0 0.2 0.1 0.2 0.0 SLC39A3 ZIP3 ENSG00000141873 "Solute carrier family 39 member 3" Q9BRY0 19 2732204-2740152 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 88.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042139, HPA058526" Uncertain Approved Vesicles Vesicles "HPA042139: AB_10793875, HPA058526: " "unprognostic (1.81e-1)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "prognostic favourable (9.76e-5)" "unprognostic (2.26e-1)" "unprognostic (2.44e-2)" "unprognostic (9.88e-3)" "unprognostic (1.01e-1)" "unprognostic (6.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.37e-3)" "unprognostic (4.07e-2)" "unprognostic (1.75e-3)" "unprognostic (9.22e-3)" "unprognostic (6.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.80e-2)" 11.1 15.5 13.3 8.3 18.0 23.9 13.3 10.6 28.0 12.7 10.8 14.0 8.3 10.2 14.3 19.5 10.5 14.6 10.5 11.7 14.4 13.0 11.0 23.6 9.0 11.7 11.5 12.9 11.0 11.9 17.8 15.5 10.6 14.9 10.8 8.8 10.7 12.4 11.7 11.2 8.1 9.4 14.0 11.1 12.9 9.3 50.1 8.8 13.0 12.5 6.8 9.4 14.2 7.8 24.4 38.0 29.6 17.5 13.1 17.5 15.4 11.6 9.5 7.2 17.6 14.9 10.2 7.3 8.5 10.1 15.8 16.2 10.2 7.6 7.2 5.5 14.6 9.5 10.9 11.4 9.9 0.0 7.8 31.9 7.0 10.3 16.4 26.4 46.7 9.1 18.4 11.7 9.6 8.0 34.9 32.4 10.5 7.5 12.9 19.8 7.6 12.7 17.1 4.7 21.6 7.5 9.2 9.9 9.0 7.4 5.3 17.8 9.3 34.6 4.9 11.0 6.1 17.2 12.4 8.8 13.8 6.9 8.3 88.8 13.1 16.4 17.5 29.6 17.5 16.1 15.4 24.4 15.4 14.9 23.4 24.4 12.9 14.5 7.8 13.1 15.5 38.0 9.7 15.4 13.3 18.0 10.6 28.0 14.4 13.0 11.5 12.9 14.9 8.8 SLC3A1 "ATR1, CSNU1, D2H, NBAT, RBAT" ENSG00000138079 "Solute carrier family 3 member 1" Q07837 2 44275458-44321494 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 66.0;kidney: 191.5;pancreas: 36.8" "Cell line enriched" "Detected in some" 17 "RPTEC TERT1: 48.7" "Cancer enriched" "Detected in many" 7 "renal cancer: 61.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038360, HPA071102" Enhanced Approved "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA038360: , HPA071102: " "unprognostic (1.67e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (2.76e-2)" "unprognostic (1.34e-1)" "unprognostic (3.90e-1)" "unprognostic (8.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "prognostic favourable (3.67e-7)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (3.77e-1)" "unprognostic (1.58e-4)" 0.2 0.1 0.2 0.7 0.2 0.0 0.2 0.7 0.2 0.3 28.4 0.1 0.1 18.8 1.3 4.6 0.2 0.2 17.9 0.1 0.2 0.2 191.5 5.3 0.2 0.1 0.2 0.1 0.2 36.8 0.0 0.2 0.5 0.1 0.3 3.7 0.2 0.1 0.1 0.2 0.2 66.0 0.1 0.2 0.2 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.2 4.0 1.3 2.0 1.3 1.6 2.7 0.3 0.0 0.9 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.2 48.7 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.1 1.3 1.3 1.0 2.6 1.3 1.9 1.9 2.5 1.4 0.4 4.0 2.5 2.7 2.0 1.6 0.6 1.3 0.9 0.3 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 0.1 0.1 SLC3A2 "4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE" ENSG00000168003 "Solute carrier family 3 member 2" P08195 11 62856102-62888875 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 129.8;SiHa: 132.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010455, HPA017980" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" 210000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB010455: AB_638288, HPA017980: " "unprognostic (1.79e-1)" "unprognostic (9.61e-3)" "unprognostic (3.59e-1)" "unprognostic (7.87e-3)" "unprognostic (2.06e-1)" "unprognostic (2.41e-3)" "prognostic unfavourable (8.17e-4)" "unprognostic (2.09e-3)" "unprognostic (2.62e-1)" "unprognostic (4.16e-2)" "unprognostic (2.29e-2)" "unprognostic (3.71e-1)" "prognostic favourable (8.22e-4)" "unprognostic (2.92e-2)" "unprognostic (5.52e-3)" "unprognostic (3.49e-3)" "prognostic unfavourable (1.48e-4)" 28.5 30.8 34.6 23.0 36.8 62.4 30.8 18.7 34.8 26.0 26.8 25.3 30.4 34.3 29.2 41.2 31.2 23.8 19.9 14.7 31.3 27.1 71.4 31.8 33.5 17.8 37.8 24.1 29.9 39.2 138.6 19.3 75.5 32.9 28.3 13.9 52.5 39.0 27.5 32.5 32.1 33.8 19.6 38.0 21.9 28.2 33.4 30.8 13.6 33.7 33.4 22.2 20.6 56.6 16.6 73.9 11.6 36.2 20.3 39.8 37.3 16.1 68.1 6.9 21.6 8.4 6.8 64.4 28.1 10.8 14.8 13.0 65.1 30.6 17.8 31.2 16.5 56.0 12.7 55.1 7.9 32.3 12.0 12.7 49.6 28.7 78.4 14.9 18.6 14.8 129.8 18.0 55.0 8.6 24.6 39.4 9.0 77.8 15.3 19.0 11.6 23.0 15.9 10.5 34.7 10.3 9.0 11.9 5.7 132.3 49.6 95.4 17.8 19.6 15.7 15.0 22.4 22.0 19.8 49.0 54.3 56.4 14.7 23.5 42.8 8.5 36.2 11.6 30.1 34.8 39.8 14.4 27.7 30.8 22.1 16.6 23.5 25.2 7.5 20.3 27.6 73.9 26.2 37.3 34.6 36.8 18.7 34.7 31.3 27.1 37.8 24.1 32.9 30.8 SLC41A3 FLJ20473 ENSG00000114544 "Solute carrier family 41 member 3" Q96GZ6 3 126006355-126101561 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045847 Approved Supported "Plasma membrane" "Plasma membrane" "HPA045847: " "unprognostic (1.77e-1)" "unprognostic (3.35e-2)" "unprognostic (1.11e-1)" "unprognostic (3.37e-2)" "unprognostic (7.68e-3)" "unprognostic (2.20e-1)" "prognostic unfavourable (1.49e-7)" "unprognostic (1.36e-1)" "unprognostic (3.23e-2)" "unprognostic (2.82e-3)" "unprognostic (5.74e-2)" "unprognostic (3.57e-1)" "prognostic favourable (6.04e-7)" "unprognostic (1.26e-1)" "unprognostic (5.88e-2)" "unprognostic (2.85e-1)" "unprognostic (7.54e-2)" 11.2 20.2 21.3 10.7 20.7 5.3 22.2 29.8 43.4 18.6 10.6 12.6 12.1 10.1 21.1 32.9 10.8 24.0 16.3 17.1 17.9 20.6 14.0 8.5 9.5 14.3 17.1 16.5 31.2 17.6 19.7 16.9 10.9 21.4 12.5 10.9 18.6 16.7 14.5 25.5 10.7 8.9 17.1 11.7 8.8 10.7 30.5 6.0 27.7 18.0 11.5 10.4 12.3 11.9 9.0 8.6 9.3 8.2 13.0 18.8 5.6 17.5 7.3 12.0 10.1 34.2 20.1 18.1 10.0 17.5 14.0 16.6 9.6 16.0 12.9 19.1 19.8 13.8 4.4 17.5 12.3 12.4 13.8 7.0 13.6 13.8 28.3 12.7 7.8 19.4 21.5 8.4 17.4 19.3 5.8 10.8 18.4 9.4 14.0 10.4 9.1 11.3 7.4 12.4 17.4 16.7 13.0 9.3 10.1 15.5 5.0 42.6 5.1 17.1 13.2 13.1 10.1 19.8 11.3 8.2 6.7 6.3 11.9 5.7 11.9 9.3 5.7 3.9 11.2 8.2 9.1 9.0 10.6 11.5 8.6 8.4 9.2 8.7 1.2 13.0 5.1 8.4 18.8 5.6 21.3 20.7 29.8 43.4 17.9 20.6 17.1 16.5 21.4 6.0 SLC43A3 "DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1" ENSG00000134802 "Solute carrier family 43 member 3" Q8NBI5 11 57406954-57427580 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 149.9;thyroid gland: 69.0" "Cell line enhanced" "Detected in many" "HL-60: 69.9;HMC-1: 61.7;RPMI-8226: 78.8;WM-115: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in many" 4 "olfactory region: 12.7" "Low region specificity" "Detected in all" "HPA030551, HPA077244" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA030551: AB_10604094, HPA077244: " "unprognostic (2.64e-1)" "unprognostic (7.63e-2)" "unprognostic (9.67e-3)" "unprognostic (7.41e-3)" "unprognostic (6.59e-3)" "unprognostic (5.30e-3)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.26e-1)" "unprognostic (5.73e-2)" "unprognostic (3.97e-2)" "prognostic unfavourable (3.97e-13)" "unprognostic (8.16e-2)" "unprognostic (1.77e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-1)" 32.3 6.3 2.5 12.4 4.3 18.8 16.8 2.2 3.0 11.9 9.6 3.6 2.4 2.7 10.1 6.5 12.6 8.9 11.4 12.5 3.1 1.5 4.2 149.9 16.5 8.8 4.0 1.8 16.0 7.2 1.2 1.8 5.1 3.4 11.6 4.2 9.4 12.2 3.1 15.4 11.0 6.2 10.3 4.7 11.6 6.9 6.8 2.3 10.4 69.0 11.5 13.8 20.3 15.4 2.7 23.6 6.1 36.8 1.1 7.8 14.0 39.3 0.0 2.3 0.0 7.7 11.3 0.1 3.0 13.1 4.5 7.8 0.0 8.6 22.8 1.4 7.2 22.7 6.6 4.0 9.1 0.1 0.0 35.4 13.5 0.0 15.6 69.9 61.7 33.9 0.1 43.9 0.5 12.6 40.4 22.0 17.5 0.0 14.6 44.9 3.4 0.7 30.4 0.4 78.8 10.8 0.0 5.4 0.0 8.7 0.2 36.7 3.4 10.6 6.7 0.2 11.8 29.9 8.6 0.0 0.1 5.7 27.1 25.4 75.2 3.2 28.8 6.1 5.7 34.5 6.5 2.7 4.0 7.8 23.6 2.0 3.1 3.2 2.5 1.1 36.8 23.6 6.9 14.0 2.5 4.3 2.2 3.0 3.1 1.5 4.0 1.8 3.4 2.3 SLC46A1 "HCP1, MGC9564, PCFT" ENSG00000076351 "Solute carrier family 46 member 1" Q96NT5 17 28394756-28407197 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.7" "Cell line enriched" "Detected in many" 5 "CACO-2: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011614 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB011614: AB_2270597" "unprognostic (1.10e-1)" "unprognostic (8.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.59e-2)" "prognostic unfavourable (5.62e-4)" "unprognostic (9.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.36e-2)" "unprognostic (1.94e-1)" "unprognostic (3.80e-2)" "unprognostic (1.04e-3)" "unprognostic (6.15e-2)" "unprognostic (2.10e-3)" "unprognostic (2.16e-1)" "unprognostic (2.94e-1)" "unprognostic (2.15e-1)" "unprognostic (1.04e-1)" 3.1 17.8 4.6 2.5 7.0 1.3 5.1 13.2 5.2 2.9 43.8 5.2 9.4 45.4 2.2 4.5 1.8 6.7 3.0 2.2 4.4 6.0 3.8 17.9 3.2 4.9 4.0 4.0 4.4 5.0 8.1 7.8 5.0 5.0 3.7 2.7 6.1 5.7 5.8 2.0 2.0 52.7 2.6 4.6 4.9 2.3 2.2 4.2 2.2 4.0 0.4 1.2 2.4 2.4 2.7 2.6 7.1 5.9 2.9 1.7 0.8 1.7 7.3 2.4 4.0 2.0 0.4 7.6 2.0 1.5 1.7 1.9 66.1 2.1 0.2 1.2 1.1 5.6 2.7 4.6 1.4 4.2 6.4 0.0 4.5 5.6 0.7 0.0 3.3 0.9 8.5 1.8 5.3 0.1 2.8 0.4 0.3 2.3 0.0 0.2 1.4 0.9 0.1 2.0 0.8 1.3 3.8 6.5 3.4 14.2 6.6 0.9 5.1 1.1 0.2 0.2 2.9 0.4 2.1 3.0 3.4 0.1 0.4 0.4 1.5 7.1 1.6 1.1 0.8 5.9 1.4 2.7 0.9 0.7 2.6 1.7 1.0 1.7 2.3 2.9 4.3 1.1 1.6 0.8 4.6 7.0 13.2 5.2 4.4 6.0 4.0 4.0 5.0 4.2 SLC47A1 "FLJ10847, MATE1" ENSG00000142494 "Solute carrier family 47 member 1" Q96FL8 17 19495385-19579034 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.6;kidney: 51.1;liver: 44.9" "Cell line enhanced" "Detected in many" "A549: 13.0;AN3-CA: 10.3;Hep G2: 24.9;U-266/70: 19.4" "Cancer enhanced" "Detected in many" "renal cancer: 37.4" "Region enhanced" "Detected in many" "pons and medulla: 11.4" "Group enriched" "Detected in some" 7 "eosinophil: 12.2;plasmacytoid DC: 6.9" "Group enriched" "Detected in many" 7 "dendritic cells: 6.9;granulocytes: 12.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021987 Enhanced "HPA021987: AB_1857185" "unprognostic (1.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-1)" "prognostic favourable (5.54e-8)" "unprognostic (7.87e-2)" "unprognostic (8.34e-2)" "unprognostic (2.92e-2)" "prognostic favourable (1.88e-5)" "unprognostic (4.84e-2)" "unprognostic (6.89e-2)" "unprognostic (6.75e-2)" "unprognostic (1.60e-1)" "prognostic favourable (1.06e-5)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.91e-2)" "unprognostic (9.40e-2)" 2.2 45.6 0.8 0.4 2.2 1.1 0.6 1.0 3.1 13.2 1.2 3.7 1.3 0.7 7.6 12.2 0.9 2.4 1.7 3.5 4.7 0.5 51.1 44.9 3.0 3.5 0.9 2.5 5.0 0.2 0.2 7.2 0.3 11.4 2.6 0.5 4.3 1.1 5.5 12.1 10.4 0.6 3.5 2.3 1.9 0.5 15.5 0.6 0.9 4.7 5.7 1.2 0.6 4.5 0.1 6.9 12.2 1.3 0.0 0.7 0.4 0.0 13.0 0.3 10.3 0.3 0.0 0.0 0.3 0.3 1.6 1.4 0.0 0.4 0.1 2.5 1.8 0.0 4.6 0.3 0.4 0.0 6.1 0.1 6.9 24.9 0.1 0.1 0.3 0.2 2.3 1.2 0.2 3.6 0.0 0.0 0.0 1.8 0.0 0.2 1.4 0.5 0.1 0.1 0.1 0.0 0.8 2.5 2.1 4.3 0.0 1.1 4.4 1.1 0.0 0.1 0.5 0.2 1.2 19.4 7.6 0.0 0.5 0.1 2.2 0.2 1.3 12.2 0.3 1.0 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.7 0.3 0.0 0.2 6.9 0.0 0.4 0.8 2.2 1.0 3.1 4.7 0.5 0.9 2.5 11.4 0.6 SLC48A1 "FLJ20489, hHRG-1, HRG1" ENSG00000211584 "Solute carrier family 48 member 1" Q6P1K1 12 47753916-47782753 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 90.7" "Cell line enhanced" "Detected in many" "EFO-21: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065396, HPA073994" Approved Supported Vesicles Vesicles "HPA065396: , HPA073994: " "unprognostic (9.60e-2)" "prognostic favourable (4.27e-4)" "unprognostic (1.13e-2)" "unprognostic (1.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "prognostic unfavourable (9.39e-5)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (9.88e-2)" "unprognostic (1.54e-2)" "unprognostic (6.63e-3)" "prognostic favourable (1.34e-6)" "unprognostic (1.45e-1)" "unprognostic (5.96e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-2)" 16.2 13.5 27.8 5.0 33.5 7.7 10.7 12.5 39.5 13.1 8.3 90.7 6.7 5.6 11.9 12.7 13.9 21.9 11.5 12.8 32.7 20.8 18.5 6.3 11.7 4.9 44.1 27.9 35.6 10.6 24.3 6.4 13.2 38.6 9.3 8.2 7.4 13.2 18.1 16.7 14.7 5.3 12.7 44.5 11.3 7.7 5.1 39.7 4.9 35.6 6.1 6.0 9.9 7.6 7.1 8.5 23.7 11.9 1.2 5.4 4.0 4.5 14.0 2.2 16.7 14.7 6.3 4.9 3.2 7.1 3.1 3.2 4.4 12.2 2.7 42.0 8.9 17.9 2.8 3.7 2.4 22.7 2.8 19.0 11.7 6.0 8.4 5.0 11.3 3.7 7.6 4.4 5.4 8.6 4.9 11.1 1.9 9.3 2.4 5.2 1.5 6.9 2.3 0.6 14.8 12.4 12.0 2.9 1.3 4.3 5.4 3.0 18.0 4.7 4.7 4.4 5.9 8.3 2.3 9.0 5.5 0.8 5.7 24.1 2.6 0.0 11.9 7.8 3.6 8.5 3.2 7.1 4.4 3.7 8.5 6.3 5.4 4.4 23.7 1.2 4.8 1.6 3.4 4.0 27.8 33.5 12.5 39.5 32.7 20.8 44.1 27.9 38.6 39.7 SLC51B OSTbeta ENSG00000186198 "Solute carrier family 51 beta subunit" Q86UW2 15 65045370-65053396 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 85.0" "Group enriched" "Detected in some" 10 "CACO-2: 16.5;EFO-21: 11.1;Hep G2: 13.8" "Cancer enhanced" "Detected in many" "liver cancer: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008398, HPA008533" Enhanced Approved Vesicles,Mitochondria Mitochondria Vesicles "HPA008398: , HPA008533: AB_1854824" "unprognostic (6.18e-2)" "unprognostic (6.75e-3)" "unprognostic (1.66e-1)" "unprognostic (1.31e-2)" "unprognostic (5.88e-2)" "unprognostic (9.49e-2)" "unprognostic (9.77e-3)" "unprognostic (1.81e-2)" "unprognostic (3.35e-2)" "unprognostic (2.76e-1)" "unprognostic (2.24e-1)" "unprognostic (4.34e-2)" "prognostic favourable (8.46e-5)" "unprognostic (5.87e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.17e-2)" 0.4 0.5 0.4 3.8 0.6 0.0 0.4 0.4 0.8 14.0 34.9 0.4 0.4 28.1 0.9 3.3 0.4 1.0 0.5 0.4 0.5 0.6 7.5 2.4 1.6 0.4 0.6 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.8 9.5 0.4 0.4 0.8 0.4 0.1 85.0 0.4 0.4 0.4 0.2 4.1 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.7 0.1 0.0 0.5 0.3 0.0 1.4 0.2 0.7 0.0 0.1 0.4 0.0 0.0 0.2 0.0 16.5 0.0 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 13.8 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.3 0.4 0.4 0.0 0.0 0.8 0.4 0.0 0.6 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.2 0.0 0.0 0.1 0.3 0.7 0.0 0.1 0.0 0.0 0.3 0.4 0.6 0.4 0.4 0.5 0.6 0.6 0.4 0.4 0.4 SLC52A2 "D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2" ENSG00000185803 "Solute carrier family 52 member 2" Q9HAB3 8 144354135-144361286 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Host cell receptor for virus entry, Receptor" "Deafness, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063036 Approved "HPA063036: " "unprognostic (7.80e-3)" "prognostic unfavourable (7.55e-4)" "unprognostic (2.15e-1)" "unprognostic (2.94e-1)" "unprognostic (3.09e-2)" "unprognostic (3.94e-2)" "prognostic unfavourable (2.04e-6)" "unprognostic (7.74e-3)" "unprognostic (9.20e-2)" "unprognostic (2.24e-2)" "unprognostic (4.85e-2)" "unprognostic (3.99e-2)" "prognostic unfavourable (1.23e-4)" "unprognostic (3.12e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" 16.0 12.8 7.3 13.2 8.8 9.9 23.7 19.2 10.5 10.9 18.1 7.5 19.3 19.6 10.7 19.9 14.6 7.4 16.3 8.0 7.7 9.0 14.7 12.4 10.7 10.7 13.0 5.9 10.6 22.4 7.9 10.9 19.5 9.5 10.8 9.3 7.2 21.3 14.1 7.0 12.6 17.8 8.5 7.9 15.2 16.8 17.0 7.4 11.5 12.4 11.6 14.6 8.6 13.1 7.7 9.0 9.2 7.4 5.7 6.3 1.9 12.6 18.2 2.6 6.8 4.9 3.6 13.2 9.8 6.9 8.9 7.1 14.5 15.3 6.0 16.1 7.0 15.1 4.3 7.5 1.9 7.4 10.3 10.4 10.5 13.1 15.8 3.8 9.0 5.0 9.1 8.1 6.7 5.1 14.3 7.7 4.6 36.9 5.9 10.1 5.6 50.4 11.0 3.1 13.6 7.2 9.3 8.1 9.6 12.1 12.5 11.3 9.9 5.0 7.3 7.3 16.6 18.2 14.0 3.9 5.3 4.6 12.1 9.5 8.4 1.2 4.2 9.2 5.9 6.1 3.7 4.2 4.7 6.3 5.2 7.7 4.6 3.1 1.4 5.7 7.4 9.0 5.7 1.9 7.3 8.8 19.2 10.5 7.7 9.0 13.0 5.9 9.5 7.4 SLC5A11 "KST1, SGLT6, SMIT2" ENSG00000158865 "Solute carrier family 5 member 11" Q8WWX8 16 24845841-24911628 "Predicted membrane proteins" "Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 48.0;intestine: 21.8" "Group enriched" "Detected in some" 6 "Hep G2: 18.4;Karpas-707: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035331 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA035331: AB_10601489" "unprognostic (2.57e-1)" "unprognostic (7.90e-3)" "unprognostic (1.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.90e-2)" "unprognostic (8.08e-2)" "unprognostic (2.85e-1)" "unprognostic (2.85e-3)" "unprognostic (6.68e-2)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (1.58e-1)" "unprognostic (8.07e-2)" "unprognostic (1.45e-3)" 0.6 0.6 4.3 0.6 21.8 0.5 2.8 1.9 11.2 0.6 1.7 29.7 0.0 10.9 0.6 0.5 0.5 0.6 1.4 0.7 12.1 7.4 9.9 1.0 0.6 0.7 48.0 2.4 0.6 0.5 0.5 0.2 0.5 18.3 0.6 0.8 0.0 0.6 0.8 0.7 0.5 21.8 0.5 34.7 0.6 0.6 0.8 22.9 0.0 0.6 0.0 0.7 0.6 0.1 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 5.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.3 21.8 1.9 8.0 12.1 7.4 48.0 2.4 18.3 22.9 SLC5A6 SMVT ENSG00000138074 "Solute carrier family 5 member 6" Q9Y289 2 27199587-27212958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.0;placenta: 51.7" "Cell line enhanced" "Detected in all" "BEWO: 68.0;SK-BR-3: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036958 Approved Approved "Cell Junctions" "Cell Junctions" "HPA036958: AB_10672343" "unprognostic (5.85e-2)" "unprognostic (8.32e-3)" "unprognostic (1.38e-1)" "unprognostic (2.61e-3)" "unprognostic (9.38e-2)" "unprognostic (7.14e-2)" "unprognostic (3.20e-3)" "unprognostic (7.92e-2)" "unprognostic (6.96e-2)" "unprognostic (9.80e-2)" "unprognostic (2.05e-2)" "unprognostic (7.46e-2)" "prognostic unfavourable (3.60e-7)" "unprognostic (2.40e-3)" "unprognostic (1.20e-2)" "unprognostic (4.56e-3)" "unprognostic (4.18e-2)" 20.9 4.6 5.0 7.6 8.5 8.5 15.9 7.9 8.1 4.0 6.4 5.6 6.4 10.9 7.4 36.7 5.5 5.9 6.3 3.5 5.3 5.7 5.9 64.0 6.0 6.4 7.0 8.1 5.6 6.0 4.5 4.2 51.7 7.1 4.8 6.6 5.6 6.7 10.6 7.9 4.6 7.6 4.9 4.4 4.8 4.8 17.5 6.1 5.8 5.1 4.3 13.0 4.6 10.1 6.8 10.0 2.0 9.0 6.3 10.4 5.8 16.4 17.0 10.9 14.3 10.1 3.7 68.0 6.0 4.1 9.1 6.3 25.1 5.9 11.4 9.1 3.2 9.2 23.3 6.9 6.4 8.8 13.7 20.2 7.3 38.4 12.0 25.9 10.6 12.7 5.9 11.2 8.7 8.2 29.5 4.7 5.8 33.8 8.8 12.6 31.4 6.2 14.8 12.8 16.5 5.2 15.8 9.2 13.6 6.5 73.1 8.6 16.2 5.6 3.7 10.1 13.8 6.1 16.0 7.9 18.0 18.1 5.5 18.2 14.1 0.1 6.5 2.0 8.5 7.3 10.4 6.8 8.3 8.2 9.7 6.7 8.5 10.1 0.3 6.3 9.0 10.0 8.2 5.8 5.0 8.5 7.9 8.1 5.3 5.7 7.0 8.1 7.1 6.1 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 77.6;retina: 95.9" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 10.1" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: , HPA052726: " "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.6 0.5 3.0 0.4 5.8 0.5 0.5 2.1 5.8 0.5 0.5 2.5 0.0 1.8 0.5 0.9 0.4 4.2 0.5 1.0 3.1 2.4 77.6 13.2 0.9 0.5 3.4 4.1 0.5 0.4 0.4 1.0 0.5 4.8 0.5 0.5 95.9 0.5 0.5 0.6 0.6 0.8 0.4 5.7 0.5 0.5 1.1 2.1 0.0 4.9 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.2 0.1 0.0 0.0 0.0 0.4 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 10.1 0.1 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.3 0.2 1.0 0.0 0.4 1.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.3 3.0 5.8 2.1 5.8 3.1 2.4 3.4 4.1 4.8 2.1 SLC6A6 TAUT ENSG00000131389 "Solute carrier family 6 member 6" P31641 3 14402576-14489349 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 76.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 33.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015028, HPA016488" Enhanced Approved "Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "HPA015028: AB_1857200, HPA016488: AB_1857202" "unprognostic (8.25e-2)" "unprognostic (7.29e-3)" "unprognostic (2.63e-2)" "prognostic favourable (5.22e-5)" "prognostic unfavourable (5.75e-8)" "unprognostic (4.14e-2)" "prognostic unfavourable (8.78e-4)" "unprognostic (2.58e-1)" "unprognostic (2.56e-1)" "unprognostic (3.81e-1)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-2)" "unprognostic (9.65e-2)" "unprognostic (1.90e-1)" 10.2 25.9 5.7 18.0 16.5 46.4 8.1 11.1 12.2 11.3 9.5 8.7 3.6 8.5 14.5 4.4 7.0 7.0 14.5 23.2 5.6 4.6 16.6 2.3 18.6 12.9 18.0 7.6 31.3 2.8 3.8 9.6 18.0 13.3 5.0 4.1 76.4 15.7 7.7 26.6 16.8 22.2 8.2 11.1 20.3 14.0 4.0 12.6 6.2 10.4 11.3 11.2 8.8 6.1 1.6 1.9 33.2 6.9 0.7 3.9 2.3 4.6 17.1 6.2 4.7 8.0 2.5 12.7 6.9 27.5 8.2 6.1 6.2 7.9 13.4 6.4 10.9 3.7 4.2 5.7 7.4 1.5 5.2 12.7 22.5 9.3 0.2 3.4 27.5 1.3 1.7 7.5 1.9 8.9 7.1 2.7 7.2 4.9 9.7 6.7 9.5 5.0 6.9 7.3 20.9 45.1 9.6 11.4 4.1 5.2 2.8 1.5 10.6 1.9 22.5 10.5 5.6 2.6 5.0 3.0 3.4 4.9 24.5 6.8 32.1 2.5 5.1 5.0 1.3 4.2 0.7 1.6 1.4 1.7 1.9 0.9 0.2 0.3 33.2 0.7 6.9 0.7 3.9 2.3 5.7 16.5 11.1 12.2 5.6 4.6 18.0 7.6 13.3 12.6 SLC7A6 "KIAA0245, LAT-2, LAT3, y+LAT-2" ENSG00000103064 "Solute carrier family 7 member 6" Q92536 16 68264516-68301823 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050713 Uncertain Approved "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA050713: " "unprognostic (6.35e-2)" "unprognostic (4.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-2)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (1.89e-3)" "unprognostic (7.82e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-3)" "prognostic unfavourable (1.84e-4)" 25.9 7.6 5.4 12.9 6.7 6.9 18.7 9.0 8.0 5.3 7.1 3.4 6.7 3.6 5.5 14.0 4.0 7.1 4.7 13.1 5.3 3.3 5.4 2.3 9.8 16.3 3.3 4.6 3.0 3.2 2.5 11.1 16.3 5.4 6.6 10.8 9.0 5.8 5.1 58.8 8.4 9.4 8.3 3.4 9.4 5.3 5.2 3.7 31.8 15.0 8.0 19.6 5.7 8.0 7.2 16.2 5.9 3.6 6.7 12.6 1.7 9.3 9.5 7.1 7.6 21.1 12.7 20.0 11.0 8.0 16.4 13.8 40.8 7.1 18.6 8.7 14.1 14.3 13.8 13.7 17.9 3.8 9.9 9.9 18.8 12.9 3.9 11.6 9.0 8.5 12.0 12.8 6.4 11.0 14.5 3.3 8.9 5.0 15.2 8.1 5.3 3.5 19.3 4.5 15.6 5.7 8.2 10.5 5.7 31.7 8.9 3.7 13.3 6.3 16.1 10.9 8.3 9.1 13.7 7.1 13.3 21.2 6.9 8.6 7.3 2.5 3.6 3.0 4.9 1.7 6.1 6.6 7.3 4.6 3.4 7.2 12.6 7.4 5.9 6.7 1.4 16.2 3.1 1.7 5.4 6.7 9.0 8.0 5.3 3.3 3.3 4.6 5.4 3.7 SLC7A8 "LAT2, LPI-PC1" ENSG00000092068 "Solute carrier family 7 member 8" Q9UHI5 14 23125295-23183674 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 204.0" "Cell line enhanced" "Detected in many" "AF22: 21.1;ASC diff: 22.2;BEWO: 38.7;CACO-2: 21.4;K-562: 40.5;NTERA-2: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 7.6;eosinophil: 13.2;naive CD8 T-cell: 3.5" "Group enriched" "Detected in many" 46 "granulocytes: 13.2;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046015, HPA051950, HPA060672" Enhanced "CAB046015: AB_2239464, HPA051950: , HPA060672: " "unprognostic (1.50e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-1)" "unprognostic (1.03e-2)" "unprognostic (1.12e-2)" "unprognostic (3.03e-2)" "prognostic unfavourable (1.97e-4)" "prognostic favourable (3.15e-4)" "unprognostic (1.24e-1)" "unprognostic (2.37e-1)" "unprognostic (1.39e-3)" "unprognostic (9.44e-2)" "unprognostic (7.00e-2)" "unprognostic (2.96e-2)" "unprognostic (8.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (1.52e-4)" 10.5 5.9 4.6 3.0 6.6 1.3 11.0 10.9 10.7 12.7 5.9 2.5 28.2 11.7 23.0 7.2 13.2 21.7 6.2 3.1 7.8 3.0 37.6 3.0 6.2 5.8 2.4 5.6 33.7 9.1 204.0 16.7 19.8 6.9 13.0 5.1 31.2 9.5 50.9 23.6 11.2 8.8 7.5 1.9 10.0 19.3 10.5 4.7 0.3 12.8 5.2 4.9 15.2 14.5 0.1 0.0 13.2 0.1 0.0 3.5 1.7 0.4 0.0 21.1 0.0 22.2 2.7 38.7 2.1 8.5 0.0 0.6 21.4 1.1 0.1 0.3 4.6 3.6 2.8 1.1 0.1 0.0 2.0 0.1 0.0 0.0 8.7 0.0 12.0 19.1 10.6 0.3 0.2 1.7 40.5 0.0 0.4 0.3 0.0 0.2 21.1 15.8 0.0 0.2 4.0 0.2 7.9 2.6 0.1 0.0 3.7 10.0 13.4 0.1 0.1 0.7 0.5 0.2 0.0 0.1 4.6 0.0 2.4 0.0 0.1 7.6 0.1 13.2 0.0 0.1 1.1 0.1 0.9 0.1 0.0 0.0 0.9 3.5 0.4 0.0 0.0 0.0 0.5 1.7 4.6 6.6 10.9 10.7 7.8 3.0 2.4 5.6 6.9 4.7 SLC8B1 "FLJ22233, NCKX6, NCLX, SLC24A6" ENSG00000089060 "Solute carrier family 8 member B1" Q6J4K2 12 113298759-113359493 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sensory transduction, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040668 Approved "HPA040668: AB_10793861" "prognostic favourable (9.52e-4)" "unprognostic (1.58e-1)" "unprognostic (1.27e-1)" "unprognostic (4.30e-1)" "unprognostic (1.93e-2)" "unprognostic (2.80e-3)" "unprognostic (1.90e-1)" "unprognostic (6.52e-2)" "unprognostic (1.84e-1)" "unprognostic (2.68e-2)" "unprognostic (2.60e-1)" "unprognostic (5.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.54e-3)" "unprognostic (9.39e-2)" "unprognostic (1.14e-1)" "prognostic favourable (5.02e-4)" 12.6 43.9 7.2 15.0 9.5 12.0 11.0 5.5 7.8 11.8 11.1 9.0 7.9 7.7 9.0 10.9 9.3 7.2 10.4 9.2 6.5 3.7 10.6 18.6 12.2 26.2 8.2 4.5 35.1 13.2 5.5 9.3 15.5 7.0 10.0 7.5 6.2 10.4 9.6 7.1 11.2 14.1 9.3 9.6 20.8 7.6 13.9 8.0 29.5 8.2 8.1 14.4 8.4 10.8 3.1 11.4 18.5 14.7 3.3 18.8 8.4 12.2 2.7 1.6 3.6 8.4 5.8 5.3 3.9 12.4 5.6 5.5 2.8 10.2 3.3 9.2 5.8 10.0 5.2 2.9 2.7 7.7 1.5 6.3 6.0 3.0 13.9 16.4 14.2 5.9 8.9 6.4 2.8 12.8 13.2 1.7 3.1 2.8 5.0 13.3 2.9 7.0 1.9 2.2 3.8 6.0 17.5 0.1 2.8 11.6 23.4 2.8 3.7 6.5 26.5 3.9 4.6 11.1 2.5 2.1 5.0 2.4 4.8 9.3 3.0 2.4 9.6 18.5 5.0 14.7 6.4 2.2 9.2 4.9 11.4 3.1 18.8 8.6 6.3 3.3 14.1 8.5 10.9 8.4 7.2 9.5 5.5 7.8 6.5 3.7 8.2 4.5 7.0 8.0 SLC9A1 "APNH, NHE1, PPP1R143" ENSG00000090020 "Solute carrier family 9 member A1" P19634 1 27098815-27166981 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Deafness, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 60.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022371, HPA048532, HPA052891" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981" "unprognostic (6.18e-2)" "unprognostic (1.59e-1)" "unprognostic (2.21e-1)" "unprognostic (8.48e-2)" "prognostic unfavourable (7.47e-4)" "unprognostic (2.70e-2)" "unprognostic (4.33e-3)" "unprognostic (3.18e-2)" "unprognostic (9.74e-2)" "prognostic unfavourable (7.10e-4)" "unprognostic (3.44e-2)" "unprognostic (6.95e-2)" "unprognostic (2.05e-2)" "unprognostic (1.27e-2)" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-2)" 7.1 11.3 7.5 9.9 10.1 7.3 8.4 11.7 18.9 8.7 14.0 5.0 26.9 20.7 10.6 6.8 10.3 7.1 24.4 13.4 4.6 5.3 7.3 2.4 11.2 5.8 5.0 6.7 6.9 6.4 13.4 8.0 42.5 14.8 8.5 10.2 10.1 60.7 55.4 3.8 9.2 24.7 8.1 3.9 10.5 45.6 8.3 4.9 6.0 8.0 6.5 9.0 18.8 8.4 0.9 0.6 5.5 1.5 0.4 4.2 1.8 13.5 4.7 4.4 4.5 10.1 7.3 27.3 11.1 17.1 9.8 10.7 5.6 8.8 6.1 9.6 14.6 17.0 4.3 27.7 6.1 7.3 4.0 9.3 3.0 2.4 30.7 5.5 7.1 9.1 13.4 16.5 23.0 16.2 2.6 6.0 14.4 8.1 2.8 2.9 6.2 9.7 5.0 3.9 2.8 5.1 20.5 5.1 1.6 9.4 12.8 5.6 5.9 3.4 17.4 10.4 4.2 9.7 6.1 5.4 3.4 1.8 11.2 6.1 6.0 0.1 1.5 1.5 1.9 0.9 4.2 0.2 2.2 2.0 0.6 0.9 1.4 1.7 5.5 0.4 1.5 0.1 0.8 1.8 7.5 10.1 11.7 18.9 4.6 5.3 5.0 6.7 14.8 4.9 SLCO1A2 "OATP, OATP-A, OATP1A2, SLC21A3" ENSG00000084453 "Solute carrier organic anion transporter family member 1A2" P46721 12 21264600-21419594 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5" "Cell line enhanced" "Detected in some" "NTERA-2: 13.7;RPMI-8226: 9.5;U-266/70: 20.5;U-266/84: 8.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071152 Supported "Plasma membrane" "Plasma membrane" "HPA071152: " "unprognostic (5.43e-3)" "unprognostic (2.33e-1)" "unprognostic (1.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.53e-1)" "unprognostic (3.82e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (8.82e-2)" "unprognostic (1.66e-4)" "unprognostic (2.52e-2)" "unprognostic (3.20e-1)" "unprognostic (1.24e-1)" 0.2 0.1 3.3 0.0 3.4 0.0 3.6 3.4 17.9 0.1 0.1 1.9 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.9 4.1 2.5 1.1 11.2 2.7 0.6 3.0 4.0 0.2 2.3 0.5 0.5 1.2 9.7 0.7 0.0 14.2 14.5 0.0 0.4 0.4 0.2 0.0 2.9 0.4 0.4 1.6 1.4 0.0 0.3 0.0 0.3 0.4 0.1 1.3 0.7 4.3 0.4 1.1 2.3 0.2 2.1 0.5 0.8 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 3.0 1.7 0.1 2.1 0.1 0.2 0.2 0.1 0.4 0.5 0.7 0.0 0.5 1.1 0.0 0.3 0.2 0.0 1.4 0.1 0.1 0.1 3.5 1.4 0.0 2.1 0.3 0.1 13.7 0.1 0.1 0.2 9.5 0.0 2.1 1.9 2.3 0.0 0.2 0.2 2.7 0.7 0.0 0.0 1.4 0.7 0.3 20.5 8.2 0.1 0.2 0.2 0.1 0.6 0.4 0.3 1.4 0.3 2.3 1.3 2.2 1.5 0.1 1.0 2.1 1.6 4.3 1.1 0.1 0.7 1.8 0.2 3.3 3.4 3.4 5.0 4.1 2.5 3.0 4.0 9.7 1.4 SLF1 "ANKRD32, BRCTD1, BRCTx, DKFZp564C0469, DKFZp761C121" ENSG00000133302 "SMC5-SMC6 complex localization factor 1" Q9BQI6 5 94618347-94739436 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HeLa: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040793, HPA054213" Uncertain Approved Nucleoplasm Nucleoplasm "HPA040793: AB_10796560, HPA054213: " "unprognostic (7.56e-2)" "unprognostic (1.45e-2)" "unprognostic (2.44e-3)" "unprognostic (1.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-5)" "unprognostic (1.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (6.57e-6)" "unprognostic (3.27e-2)" "unprognostic (2.83e-1)" "unprognostic (1.77e-1)" "unprognostic (8.32e-2)" 3.4 3.6 9.8 4.5 14.1 6.3 4.0 17.6 14.7 3.4 4.0 2.1 2.7 4.3 3.7 3.3 3.7 4.8 4.6 4.7 6.1 6.2 3.8 3.1 3.4 6.5 3.1 9.8 6.3 4.7 3.3 7.9 3.4 5.3 3.0 5.2 1.7 3.4 3.1 3.4 7.8 6.7 3.3 5.1 5.9 3.2 14.8 4.8 9.2 4.0 3.4 5.2 3.5 3.4 5.3 1.9 10.8 1.9 1.5 4.6 1.0 3.0 4.0 5.7 5.3 1.8 2.2 3.6 4.7 2.5 5.5 7.7 2.1 4.2 4.8 3.2 1.4 4.2 4.6 3.8 7.4 1.6 3.8 3.2 34.1 1.8 0.5 1.6 3.6 1.1 1.1 4.8 2.1 2.2 3.5 3.0 4.7 2.8 4.5 2.2 5.9 2.2 2.8 6.4 5.2 1.7 2.4 5.8 5.7 5.7 2.5 2.0 3.3 4.8 1.6 2.6 3.6 3.7 6.2 2.3 4.6 3.9 4.1 4.7 5.2 1.0 1.9 1.1 2.6 1.5 1.4 3.1 3.9 4.6 1.2 5.3 1.8 2.4 10.8 1.5 1.2 1.9 2.2 1.0 9.8 14.1 17.6 14.7 6.1 6.2 3.1 9.8 5.3 4.8 SLF2 "C10orf6, FAM178A, FLJ10512, FLJ25012" ENSG00000119906 "SMC5-SMC6 complex localization factor 2" Q8IX21 10 100912569-100965136 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "RH-30: 58.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038499, HPA057568" Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038499: AB_10672520, HPA057568: " "unprognostic (9.05e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-2)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (2.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.66e-2)" "unprognostic (1.54e-2)" "unprognostic (1.16e-3)" "unprognostic (2.85e-1)" "unprognostic (4.90e-2)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" 9.8 20.2 19.5 17.1 26.6 12.1 11.3 21.4 21.4 12.2 10.7 22.0 13.0 9.4 20.9 56.1 9.4 17.3 9.6 11.6 17.8 14.2 10.9 10.2 11.6 15.6 29.4 17.3 29.4 12.3 11.6 26.8 17.4 18.3 14.5 12.1 7.8 10.3 16.0 17.9 15.1 11.5 12.9 22.7 22.0 9.9 26.7 31.3 14.7 11.3 10.5 13.2 10.8 19.9 13.8 9.5 8.6 8.9 10.9 14.0 5.6 9.7 8.0 11.8 12.2 6.2 8.5 4.5 10.3 7.3 9.7 11.8 5.8 6.8 9.0 6.4 4.3 9.9 8.1 3.4 11.8 10.2 6.5 8.4 5.3 11.4 4.6 10.7 9.9 3.9 5.0 7.4 8.0 6.2 5.8 9.0 14.1 6.5 7.2 5.9 5.3 6.0 7.1 58.3 3.1 3.8 5.0 2.5 5.1 6.5 1.7 11.8 10.3 3.9 8.0 11.4 9.5 7.0 11.7 7.2 10.7 7.5 7.8 12.4 5.9 6.8 8.9 8.6 14.0 8.8 12.2 11.1 10.8 11.5 6.5 13.8 12.0 10.6 4.6 10.9 8.8 9.5 9.8 5.6 19.5 26.6 21.4 21.4 17.8 14.2 29.4 17.3 18.3 31.3 SLFN12L ENSG00000205045 "Schlafen family member 12 like" Q6IEE8 17 35464249-35537861 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.4" "Cell line enhanced" "Detected in some" "HDLM-2: 19.4;Karpas-707: 13.7;U-266/70: 4.9;U-266/84: 4.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 9.5;MAIT T-cell: 8.8;memory CD4 T-cell: 6.3;memory CD8 T-cell: 8.0;naive CD4 T-cell: 4.8;naive CD8 T-cell: 5.2;NK-cell: 6.8;T-reg: 4.7" "Group enriched" "Detected in many" 7 "NK-cells: 6.8;T-cells: 9.5" HPA024447 Uncertain "HPA024447: AB_1856614" "unprognostic (1.93e-3)" "unprognostic (2.10e-4)" "unprognostic (3.77e-2)" "unprognostic (2.67e-2)" "unprognostic (8.18e-3)" "unprognostic (2.98e-5)" "unprognostic (4.59e-3)" "unprognostic (2.75e-2)" "unprognostic (6.82e-2)" "unprognostic (1.67e-2)" "unprognostic (9.51e-2)" "unprognostic (1.78e-1)" "unprognostic (2.25e-6)" "unprognostic (2.30e-1)" "unprognostic (3.88e-2)" "unprognostic (7.02e-2)" "unprognostic (8.88e-3)" 7.2 0.9 1.0 11.2 1.2 6.6 2.7 0.8 1.4 1.6 3.0 0.9 1.2 3.9 3.6 3.0 2.3 2.0 3.8 1.4 1.1 1.1 1.8 1.8 9.1 10.6 1.7 0.5 1.3 1.2 0.5 1.0 0.6 2.9 1.8 2.0 2.1 6.2 1.3 0.9 1.2 7.0 1.1 1.9 18.4 3.0 0.8 1.1 5.8 2.8 2.1 16.3 2.3 2.0 0.4 0.3 1.1 0.4 6.8 9.5 1.9 0.5 0.2 0.2 0.2 0.1 0.0 0.2 0.2 0.0 0.6 1.4 0.1 0.4 0.5 0.1 0.0 0.3 0.0 0.0 0.7 19.4 0.1 1.2 0.7 0.1 0.0 0.4 0.2 0.3 0.1 0.2 0.0 0.1 0.3 13.7 0.1 0.0 0.4 0.3 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.3 0.1 0.4 0.1 0.1 0.1 1.9 0.5 0.3 1.2 0.5 0.2 4.9 4.3 0.1 0.2 0.3 0.5 0.8 0.4 0.9 9.5 0.1 8.8 0.3 6.3 8.0 0.3 0.4 4.8 5.2 1.1 6.8 0.1 0.3 4.7 1.9 1.0 1.2 0.8 1.4 1.1 1.1 1.7 0.5 2.9 1.1 SLIT2 "SLIL3, Slit-2" ENSG00000145147 "Slit guidance ligand 2" O94813 4 20253260-20620561 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 27.9;BJ hTERT+: 56.0;BJ hTERT+ SV40 Large T+: 27.3;fHDF/TERT166: 31.7;HBF TERT88: 31.6;HEK 293: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 4 "monocytes: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB007590, HPA019511, HPA023088" Uncertain "Secreted in other tissues" "CAB007590: , HPA019511: AB_1857226, HPA023088: AB_1857227" "unprognostic (1.44e-1)" "unprognostic (4.54e-2)" "unprognostic (3.26e-2)" "unprognostic (6.13e-2)" "unprognostic (9.01e-3)" "unprognostic (6.49e-2)" "unprognostic (1.71e-1)" "unprognostic (4.78e-2)" "unprognostic (1.73e-1)" "unprognostic (6.16e-3)" "unprognostic (5.32e-2)" "unprognostic (4.30e-2)" "prognostic favourable (6.51e-4)" "unprognostic (4.93e-3)" "unprognostic (6.80e-3)" "unprognostic (1.74e-1)" "unprognostic (7.16e-4)" 4.7 18.1 2.8 3.8 9.8 0.0 6.3 0.6 11.5 18.3 7.1 1.2 5.0 1.5 16.7 6.5 6.9 9.1 6.3 5.2 4.5 6.7 8.6 1.0 22.8 1.2 2.4 6.2 6.1 1.7 0.5 6.5 16.8 4.2 9.1 3.6 3.5 4.5 11.6 1.5 2.4 3.0 17.1 1.5 23.1 6.5 3.3 1.0 0.6 6.3 0.7 1.2 8.6 11.0 0.0 0.0 0.3 1.4 0.0 0.0 0.1 0.0 0.0 15.2 0.0 10.8 10.0 0.4 27.9 56.0 27.3 10.3 0.1 0.0 0.0 0.9 31.7 0.3 4.2 2.1 31.6 0.0 25.0 0.0 0.1 0.0 2.2 0.2 0.0 2.3 0.0 17.7 5.3 9.3 0.0 0.0 1.1 0.0 0.0 0.1 0.5 2.0 16.1 0.1 0.0 0.2 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.5 10.2 1.4 9.8 15.2 0.0 0.0 0.0 0.2 0.0 5.5 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.1 2.8 9.8 0.6 11.5 4.5 6.7 2.4 6.2 4.2 1.0 SLITRK1 "KIAA1910, LRRC12" ENSG00000178235 "SLIT and NTRK like family member 1" Q96PX8 13 83877205-83882393 "Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 30.6" "Group enriched" "Detected in some" 4 "A-431: 7.4;AF22: 3.1;LHCN-M2: 2.7" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012414 Enhanced "Secreted in brain" 270000 "HPA012414: AB_1857229" "unprognostic (2.29e-1)" "unprognostic (4.32e-1)" "unprognostic (4.71e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (7.95e-2)" 0.9 1.3 16.7 0.9 9.5 0.9 1.0 2.0 30.6 1.2 1.0 6.3 0.0 1.0 1.0 1.0 0.9 0.9 1.0 0.9 16.9 7.3 1.0 0.9 0.9 0.9 7.3 14.9 0.9 3.1 0.9 3.1 0.9 5.8 0.9 1.0 0.1 1.0 1.4 1.0 0.9 0.9 0.9 3.7 0.9 1.0 1.0 8.5 0.0 0.9 0.0 0.9 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 3.1 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 9.5 2.0 21.5 16.9 7.3 7.3 14.9 5.8 8.5 SLITRK3 KIAA0848 ENSG00000121871 "SLIT and NTRK like family member 3" O94933 3 165186720-165197109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;liver: 12.8" "Cell line enhanced" "Detected in some" "AF22: 6.5;HAP1: 5.4;Karpas-707: 1.5;SCLC-21H: 3.5" "Cancer enriched" "Detected in single" 22 "glioma: 7.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017636, HPA048042" Enhanced Approved Mitochondria 1400000 Mitochondria "HPA017636: AB_1857232, HPA048042: " "unprognostic (8.91e-2)" "unprognostic (1.44e-1)" "unprognostic (4.08e-2)" "unprognostic (1.96e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-1)" "unprognostic (9.59e-2)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" "unprognostic (2.22e-1)" "unprognostic (6.74e-3)" "unprognostic (5.03e-1)" "unprognostic (2.38e-1)" "unprognostic (8.03e-4)" 0.6 0.6 7.4 2.0 12.0 0.4 0.5 10.6 17.4 9.9 3.0 1.5 0.3 1.1 12.1 2.0 7.6 12.6 0.8 1.0 13.2 5.5 0.6 12.8 0.9 0.5 3.7 6.5 2.5 0.4 0.4 0.3 0.4 4.2 3.3 3.1 0.3 0.8 9.6 0.9 0.5 1.5 6.2 2.3 0.4 0.8 1.0 2.4 0.0 0.6 0.0 0.5 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 1.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 12.0 10.6 15.7 13.2 5.5 3.7 6.5 4.2 2.4 SLITRK4 DKFZp547M2010 ENSG00000179542 "SLIT and NTRK like family member 4" Q8IW52 X 143622790-143635777 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 15.7;brain: 21.8" "Cell line enhanced" "Detected in some" "HeLa: 8.0;HHSteC: 4.2;LHCN-M2: 3.0;T-47d: 12.3;U-2 OS: 4.7" "Cancer enhanced" "Detected in many" "renal cancer: 3.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "basophil: 11.4;classical monocyte: 4.7;intermediate monocyte: 3.0;myeloid DC: 3.7;non-classical monocyte: 3.2" "Group enriched" "Detected in many" 67 "dendritic cells: 3.7;granulocytes: 11.4;monocytes: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000431 Enhanced Uncertain Microtubules 320000 Microtubules "HPA000431: " "unprognostic (1.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.63e-2)" "unprognostic (1.15e-3)" "unprognostic (4.09e-1)" "unprognostic (1.75e-2)" "unprognostic (3.79e-3)" "unprognostic (1.21e-1)" "unprognostic (1.97e-2)" "unprognostic (1.86e-1)" "unprognostic (3.64e-2)" "unprognostic (9.61e-2)" "unprognostic (6.02e-2)" "unprognostic (1.02e-5)" "unprognostic (1.29e-2)" "unprognostic (7.75e-2)" "unprognostic (9.23e-3)" 5.9 15.7 13.6 0.6 12.1 1.7 3.3 21.3 21.8 8.5 1.0 0.2 0.1 0.3 2.1 4.7 1.1 1.1 0.6 3.0 17.0 1.2 5.1 0.8 1.1 0.6 1.2 16.1 6.1 1.5 0.1 0.8 0.7 5.0 2.6 0.6 0.0 1.7 2.3 6.9 3.3 1.0 1.6 2.7 0.9 1.0 1.8 1.7 0.0 1.3 0.0 0.2 1.1 1.1 0.0 3.7 11.4 4.7 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 4.2 0.6 0.8 2.0 0.0 1.5 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.3 1.3 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 4.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.9 13.6 12.1 21.3 21.8 17.0 1.2 1.2 16.1 5.0 1.7 SLITRK5 "bA364G4.2, KIAA0918, LRRC11" ENSG00000165300 "SLIT and NTRK like family member 5" O94991 13 87672615-87696272 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4" "Cell line enhanced" "Detected in some" "AF22: 11.2;HeLa: 5.5;U-138 MG: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013843 Uncertain Supported "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA013843: AB_1857233" "unprognostic (1.92e-1)" "unprognostic (1.01e-2)" "unprognostic (3.82e-1)" "unprognostic (7.11e-4)" "unprognostic (6.94e-2)" "unprognostic (8.57e-3)" "unprognostic (1.63e-1)" "unprognostic (8.58e-3)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.10e-2)" "unprognostic (1.81e-2)" "unprognostic (2.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" 0.1 0.3 3.3 0.1 6.8 0.1 0.2 3.1 9.2 0.4 0.2 0.0 0.1 1.0 0.2 6.7 0.1 0.1 4.8 4.2 0.0 0.0 0.2 0.1 2.6 0.6 0.8 0.0 0.0 0.0 1.8 0.3 7.4 3.1 0.2 0.2 0.0 0.0 1.0 0.1 0.5 0.2 2.0 0.3 0.0 0.4 0.7 1.4 1.6 0.3 1.4 0.4 0.1 0.0 1.2 11.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 2.0 1.3 5.5 0.0 0.8 0.0 0.0 2.5 0.2 0.0 1.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 2.8 1.4 1.0 0.3 0.2 0.4 0.0 1.7 0.3 0.0 0.3 0.0 0.8 2.6 0.0 3.9 0.0 0.0 0.6 1.7 0.0 0.0 3.5 0.1 1.1 1.1 0.3 0.4 0.4 0.2 0.4 0.4 0.4 0.3 0.1 0.7 0.4 0.3 1.6 1.4 0.3 1.4 0.2 0.1 SLITRK6 FLJ22774 ENSG00000184564 "SLIT and NTRK like family member 6" Q9H5Y7 13 85792787-85806683 "Disease related genes, Predicted membrane proteins" "Hearing, Sensory transduction, Vision" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8" "Cell line enhanced" "Detected in some" "hTCEpi: 13.3;RT4: 45.6;WM-115: 10.7" "Cancer enhanced" "Detected in many" "breast cancer: 21.1" "Group enriched" "Detected in many" 4 "basal ganglia: 11.1;cerebellum: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "thalamus: 24.7" "Low region specificity" "Detected in many" "HPA014491, HPA014513" Uncertain Supported "Plasma membrane" 9500 "Plasma membrane" "HPA014491: AB_10601603, HPA014513: " "unprognostic (6.14e-2)" "unprognostic (5.21e-3)" "unprognostic (1.40e-1)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "prognostic unfavourable (8.52e-4)" "unprognostic (6.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.69e-1)" "unprognostic (4.82e-2)" "unprognostic (7.60e-2)" "unprognostic (7.92e-2)" "unprognostic (3.31e-5)" "unprognostic (5.60e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (2.51e-2)" 0.4 0.3 0.3 2.7 11.1 0.0 2.9 4.9 0.3 1.0 4.5 0.0 0.2 2.8 0.7 3.4 3.6 0.3 1.1 1.9 0.3 1.3 0.3 1.1 3.1 0.0 0.6 0.0 0.3 0.4 0.0 0.4 4.1 0.8 24.2 5.8 1.7 22.8 1.8 0.3 4.5 7.2 22.4 0.4 0.2 1.2 0.5 1.8 0.0 0.6 3.4 0.7 27.8 5.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.2 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 13.3 0.0 1.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 45.6 0.4 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.1 4.9 0.3 0.3 1.3 0.6 0.0 0.8 1.8 SLMAP "KIAA1601, SLAP" ENSG00000163681 "Sarcolemma associated protein" Q14BN4 3 57755450-57929168 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 133.6;urinary bladder: 114.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002357, HPA002358" Enhanced Approved "Endoplasmic reticulum" 12000 "Endoplasmic reticulum" "HPA002357: AB_1080023, HPA002358: AB_1080021" "unprognostic (3.70e-1)" "unprognostic (2.87e-2)" "unprognostic (1.82e-3)" "unprognostic (3.43e-2)" "unprognostic (3.34e-1)" "unprognostic (6.18e-2)" "unprognostic (1.47e-2)" "prognostic unfavourable (7.98e-4)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (2.59e-3)" "unprognostic (1.06e-1)" "prognostic favourable (1.58e-6)" "unprognostic (8.18e-2)" "unprognostic (1.93e-1)" "unprognostic (1.92e-2)" "unprognostic (6.08e-2)" 10.6 10.7 7.0 22.4 11.1 7.4 12.0 10.2 7.2 26.5 50.3 5.8 24.7 9.8 43.0 19.5 44.0 21.3 15.0 58.2 6.5 5.6 8.0 7.8 8.0 7.2 6.9 6.0 21.4 5.8 16.0 8.0 7.7 6.8 47.8 12.2 8.7 8.6 37.7 26.1 9.4 23.3 133.6 6.0 7.2 27.2 14.9 6.8 11.2 11.1 12.1 6.3 114.2 26.4 5.9 5.1 15.8 5.5 7.1 5.9 4.5 21.8 12.3 10.5 15.2 15.9 16.0 14.4 20.1 20.9 14.2 13.7 29.6 32.5 14.6 9.6 16.0 12.0 18.8 26.9 18.6 16.2 10.8 25.4 17.4 23.1 15.4 25.1 14.2 11.5 21.6 17.4 32.5 16.2 20.7 13.3 14.4 7.1 17.1 12.9 15.8 23.9 7.1 11.6 14.5 29.0 23.8 6.0 7.1 26.3 20.0 12.4 10.8 15.9 19.1 15.7 12.5 19.8 26.1 15.4 26.3 20.0 14.1 21.9 14.6 7.5 5.5 15.8 5.9 3.6 4.9 5.9 4.6 5.0 5.1 4.5 5.4 5.5 13.4 7.1 3.6 2.9 5.1 4.5 7.0 11.1 10.2 7.2 6.5 5.6 6.9 6.0 6.8 6.8 SLN "MGC12301, MGC125854, MGC125855" ENSG00000170290 Sarcolipin O00631 11 107707378-107719693 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 446.6" "Cell line enhanced" "Detected in some" "BEWO: 3.0;HSkMC: 6.5;Karpas-707: 3.1;PC-3: 2.9;SCLC-21H: 2.0;U-2 OS: 3.0" "Group enriched" "Detected in many" 13 "glioma: 21.6;head and neck cancer: 22.4;prostate cancer: 4.5" "Region enhanced" "Detected in some" "basal ganglia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "basal ganglia: 19.0" "Low region specificity" "Detected in many" CAB011628 Approved Microtubules Microtubules "CAB011628: AB_2195046" "unprognostic (6.85e-2)" "unprognostic (6.18e-8)" "unprognostic (2.60e-1)" "unprognostic (3.66e-2)" "unprognostic (2.40e-3)" "unprognostic (4.12e-3)" "unprognostic (5.28e-3)" "unprognostic (1.31e-2)" "unprognostic (2.76e-1)" "unprognostic (6.35e-2)" "unprognostic (1.68e-1)" "prognostic unfavourable (3.52e-9)" "unprognostic (3.27e-2)" "unprognostic (2.54e-1)" "unprognostic (5.09e-4)" "unprognostic (3.77e-2)" 4.8 0.5 0.2 0.0 1.9 0.0 0.1 0.4 1.0 0.0 0.2 0.0 0.0 0.0 0.0 5.3 9.1 0.1 0.0 72.9 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.1 2.3 0.0 0.4 4.3 0.0 446.6 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.9 40.1 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.4 0.5 0.2 0.0 0.2 0.6 0.1 0.2 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.4 0.3 6.5 0.0 0.8 0.0 0.0 0.1 3.1 0.0 0.4 0.3 0.4 0.1 2.9 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.2 1.2 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 1.9 0.4 1.0 0.2 0.0 0.0 0.0 0.1 0.0 SMAD2 "JV18-1, MADH2, MADR2" ENSG00000175387 "SMAD family member 2" Q15796 18 47808957-47931146 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025507, HPA067203, CAB073546" Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "CAB025507: , CAB073546: , HPA067203: " "unprognostic (1.55e-1)" "unprognostic (2.49e-1)" "unprognostic (1.43e-2)" "unprognostic (9.82e-3)" "unprognostic (9.88e-2)" "unprognostic (1.06e-1)" "prognostic unfavourable (9.44e-5)" "unprognostic (1.91e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-3)" "unprognostic (6.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.20e-3)" "unprognostic (2.68e-1)" "unprognostic (6.13e-2)" "unprognostic (3.20e-2)" "unprognostic (6.28e-2)" 38.5 39.2 29.0 26.2 25.9 19.6 31.4 19.5 28.9 28.8 34.2 29.4 28.9 21.5 26.6 26.3 33.5 28.8 25.7 31.1 26.1 27.1 26.4 20.9 28.3 23.8 30.9 24.3 36.6 28.1 25.7 24.4 34.8 28.6 27.8 29.8 31.7 29.7 28.7 33.9 28.0 26.4 34.6 35.4 34.1 26.3 29.2 26.2 60.7 46.1 23.6 31.5 35.1 35.7 12.0 21.8 28.9 24.7 24.5 25.9 19.7 22.4 32.2 19.7 19.0 31.5 38.5 22.5 24.5 29.4 25.6 29.9 12.3 21.5 34.9 17.6 31.0 24.8 22.1 27.3 34.3 37.9 11.3 29.6 48.7 19.9 36.7 41.1 30.3 28.4 35.3 21.9 50.7 28.2 13.7 29.3 31.4 14.6 28.2 19.8 9.6 7.7 20.6 28.7 23.8 57.4 38.7 18.2 21.4 29.5 20.2 24.0 15.3 27.4 31.5 38.0 21.9 10.3 17.8 28.7 27.5 30.4 26.3 28.1 27.7 28.9 22.6 25.0 16.9 24.7 21.2 12.0 23.1 20.9 21.8 9.4 25.8 19.8 22.7 24.5 20.8 15.5 25.9 19.7 29.0 25.9 19.5 28.9 26.1 27.1 30.9 24.3 28.6 26.2 SMAGP "hSMAGP, MGC149453, MGC149454" ENSG00000170545 "Small cell adhesion glycoprotein" Q0VAQ4 12 51244558-51270890 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.4" "Cell line enhanced" "Detected in many" "BEWO: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039711 Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA039711: AB_10674985" "unprognostic (2.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.96e-2)" "unprognostic (3.63e-3)" "prognostic unfavourable (5.36e-4)" "unprognostic (3.01e-1)" "unprognostic (1.63e-3)" "unprognostic (6.26e-2)" "unprognostic (7.48e-2)" "unprognostic (9.11e-2)" "prognostic unfavourable (4.38e-4)" "unprognostic (1.46e-1)" "prognostic favourable (2.24e-4)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.99e-2)" "unprognostic (1.52e-1)" 7.5 6.9 0.9 11.3 1.7 0.9 26.3 1.1 1.3 13.1 22.6 0.9 5.3 6.9 8.0 13.6 53.4 3.2 21.8 6.0 1.0 1.0 10.9 4.3 17.6 14.2 1.5 0.4 5.2 14.9 4.6 1.9 50.0 3.0 4.8 24.3 2.6 10.2 6.9 3.6 12.6 8.5 3.4 4.3 11.5 14.1 4.8 0.7 1.2 4.2 28.7 33.1 7.9 24.6 22.5 2.6 8.6 3.7 12.3 9.5 3.5 24.7 7.6 0.9 0.8 3.4 13.5 41.9 19.1 19.3 9.8 6.1 15.1 26.1 0.3 3.4 11.8 8.8 5.4 7.4 13.7 1.2 4.4 3.3 0.9 5.0 9.4 0.8 3.2 8.7 5.7 21.2 19.2 23.5 2.6 1.4 15.7 21.8 4.0 3.0 3.9 29.6 0.2 0.3 0.9 14.2 5.7 1.0 1.2 4.1 16.8 3.0 14.5 1.2 8.1 10.9 10.4 0.5 11.6 0.5 0.7 0.5 16.1 8.2 5.9 1.9 3.7 6.4 9.5 2.4 6.1 22.5 4.2 6.9 2.6 17.6 3.9 7.0 8.6 12.3 2.6 1.5 2.7 3.5 0.9 1.7 1.1 1.3 1.0 1.0 1.5 0.4 3.0 0.7 SMCO2 "C12orf70, LOC341346" ENSG00000165935 "Single-pass membrane protein with coiled-coil domains 2" A6NFE2 12 27466810-27502185 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 2.3;testis: 3.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;HDLM-2: 5.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014366 Uncertain "HPA014366: AB_1845544" "unprognostic (2.64e-2)" "unprognostic (3.11e-1)" "unprognostic (1.33e-2)" "unprognostic (4.10e-2)" "unprognostic (4.44e-3)" "unprognostic (1.98e-2)" "unprognostic (7.86e-3)" "unprognostic (5.44e-3)" "unprognostic (2.81e-1)" "unprognostic (8.86e-2)" "unprognostic (9.21e-5)" "unprognostic (2.59e-1)" "unprognostic (7.02e-3)" "unprognostic (5.48e-2)" "unprognostic (3.01e-1)" "unprognostic (3.65e-1)" "unprognostic (1.69e-1)" 0.2 0.3 0.2 1.7 0.1 0.1 0.4 0.3 0.5 0.1 0.4 0.0 0.1 0.0 2.3 0.0 0.8 0.0 0.3 0.4 0.0 0.7 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.1 2.1 0.0 0.4 0.0 0.0 1.5 3.1 0.0 1.9 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.2 0.1 0.0 0.2 2.5 0.2 0.1 0.1 1.8 0.0 3.8 0.0 0.9 0.0 0.6 0.2 0.6 1.1 5.4 0.0 0.2 0.9 0.0 0.0 2.0 0.4 1.1 0.6 0.7 3.1 1.9 0.0 1.6 0.0 0.3 0.9 2.2 1.0 1.9 0.9 0.0 0.0 0.6 0.8 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.7 1.6 0.7 1.8 3.0 0.1 0.3 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMCO3 "C12orf69, LOC440087" ENSG00000179256 "Single-pass membrane protein with coiled-coil domains 3" A2RU48 12 14804650-14814182 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 13.3" "Cell line enhanced" "Detected in some" "AN3-CA: 6.2;HHSteC: 2.1;HUVEC TERT2: 1.8" "Cancer enhanced" "Detected in some" "prostate cancer: 3.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA040574, HPA047804" Uncertain "HPA040574: , HPA047804: " "unprognostic (1.16e-1)" "unprognostic (2.09e-4)" "unprognostic (2.40e-4)" "unprognostic (5.10e-2)" "unprognostic (3.88e-2)" "unprognostic (6.45e-2)" "unprognostic (4.43e-2)" "unprognostic (2.86e-2)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" "unprognostic (7.31e-2)" "unprognostic (3.66e-2)" "unprognostic (1.48e-8)" "unprognostic (2.85e-1)" "unprognostic (7.53e-3)" "unprognostic (2.05e-1)" "unprognostic (1.38e-1)" 1.3 0.8 0.2 0.2 0.2 0.3 0.6 0.2 0.4 13.3 0.6 0.2 0.2 0.0 1.3 0.7 0.8 0.8 3.7 2.3 0.2 0.1 6.6 2.8 4.3 0.9 0.6 0.7 1.2 0.6 3.1 0.7 4.0 1.4 2.1 0.1 5.1 0.2 3.2 2.2 0.3 0.4 0.2 2.5 3.3 0.4 0.6 0.2 0.2 8.5 0.9 0.2 1.1 1.6 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.1 0.5 6.2 0.7 0.0 0.6 0.8 0.0 0.0 0.0 0.2 0.7 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.5 0.6 0.3 2.1 0.0 0.1 1.4 0.0 0.0 0.5 1.8 0.3 0.2 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.5 0.3 0.0 0.2 0.2 0.2 0.2 0.0 0.4 1.5 0.4 0.0 0.5 0.7 0.1 0.1 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.2 0.2 0.4 0.2 0.1 0.6 0.7 1.4 0.2 SMCO4 "C11orf75, FN5" ENSG00000166002 "Single-pass membrane protein with coiled-coil domains 4" Q9NRQ5 11 93478472-93543508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 124.3" "Cell line enhanced" "Detected in many" "Karpas-707: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041120 Uncertain "HPA041120: " "unprognostic (7.45e-2)" "unprognostic (1.70e-3)" "unprognostic (2.54e-1)" "unprognostic (1.01e-2)" "unprognostic (1.58e-1)" "unprognostic (6.47e-2)" "unprognostic (8.56e-2)" "unprognostic (1.93e-1)" "unprognostic (3.43e-1)" "unprognostic (5.51e-1)" "unprognostic (4.23e-2)" "unprognostic (9.45e-2)" "prognostic unfavourable (5.81e-7)" "unprognostic (1.61e-1)" "unprognostic (3.05e-1)" "unprognostic (1.55e-2)" "unprognostic (5.01e-2)" 6.1 19.0 4.3 10.0 7.3 1.6 6.2 2.5 4.5 5.0 10.6 4.5 11.5 16.1 5.4 4.6 5.5 9.4 9.3 13.4 4.5 7.9 10.9 33.5 9.0 9.1 6.2 4.0 6.4 17.9 1.1 15.7 3.5 5.7 13.1 8.0 6.0 124.3 10.3 6.2 5.5 21.2 4.8 5.0 16.7 12.2 9.9 4.5 5.4 34.3 3.1 8.6 3.7 5.1 4.2 29.7 11.4 57.3 5.6 5.4 15.7 3.4 6.5 9.6 2.8 3.6 5.7 6.4 9.3 2.6 4.4 8.0 11.5 15.1 9.4 11.6 8.6 2.0 8.8 1.2 2.6 26.4 8.0 2.3 12.2 26.5 3.7 9.0 11.7 5.5 5.2 2.1 1.7 7.2 5.5 50.6 1.5 7.2 9.1 17.9 10.2 9.6 17.7 6.0 4.7 8.1 8.6 1.5 8.1 7.8 11.3 0.7 4.5 12.6 4.0 4.7 17.3 15.4 8.4 2.0 0.2 7.3 3.4 17.7 1.7 6.8 51.3 1.2 0.8 57.3 3.5 4.2 5.4 1.5 28.8 3.0 0.7 0.6 11.4 5.6 52.1 29.7 2.0 15.7 4.3 7.3 2.5 4.5 4.5 7.9 6.2 4.0 5.7 4.5 SMDT1 "C22orf32, DDDD, dJ186O1.1, EMRE" ENSG00000183172 "Single-pass membrane protein with aspartate rich tail 1" Q9H4I9 22 42079691-42084284 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032117, HPA060340" Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA032117: AB_10601093, HPA060340: " "unprognostic (1.11e-2)" "unprognostic (1.46e-3)" "unprognostic (5.77e-2)" "prognostic favourable (5.32e-8)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (2.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.84e-2)" "prognostic favourable (5.87e-4)" "unprognostic (2.96e-1)" "prognostic favourable (2.36e-9)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (9.72e-3)" 8.7 12.3 20.3 14.6 18.0 15.3 19.9 19.5 17.9 15.2 12.9 10.2 14.7 11.0 13.0 20.2 16.4 15.7 10.7 21.3 15.8 16.2 14.1 18.4 10.1 14.4 16.3 12.4 23.2 21.6 11.3 12.9 9.8 9.9 16.4 12.1 15.5 37.0 15.9 26.4 10.4 18.0 9.8 13.3 10.6 12.9 10.9 7.9 15.2 23.4 18.7 16.1 14.9 16.9 5.4 5.0 2.3 3.5 2.9 5.9 3.0 2.2 1.5 3.0 3.7 5.7 4.1 2.4 0.8 4.1 5.1 4.4 2.9 2.2 5.8 1.0 4.3 2.5 4.0 4.3 3.3 1.5 6.6 1.9 3.2 4.1 7.1 3.5 2.5 3.2 7.3 2.0 4.2 5.0 3.1 5.1 3.5 5.8 4.9 5.3 1.1 3.3 4.3 2.7 8.4 6.4 2.6 3.8 2.5 2.0 4.6 5.0 3.9 3.8 2.0 2.2 2.4 1.9 1.5 3.5 3.8 6.9 3.3 3.4 1.6 2.3 3.5 1.6 2.7 1.7 3.7 3.7 5.4 2.8 5.0 5.4 5.9 3.9 0.3 2.9 2.5 3.8 3.0 3.0 20.3 18.0 19.5 17.9 15.8 16.2 16.3 12.4 9.9 7.9 SMG8 "C17orf71, FLJ10587, FLJ23205" ENSG00000167447 "SMG8, nonsense mediated mRNA decay factor" Q8ND04 17 59209400-59215247 "Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024841 Approved Approved Nucleoplasm Nucleoplasm "HPA024841: AB_10600790" "unprognostic (2.68e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-3)" "unprognostic (9.91e-2)" "unprognostic (8.59e-2)" "unprognostic (1.35e-2)" "prognostic unfavourable (3.72e-5)" "unprognostic (1.91e-1)" "unprognostic (1.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.18e-3)" "unprognostic (4.65e-2)" "unprognostic (9.37e-2)" "unprognostic (4.31e-2)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.75e-1)" 14.7 17.9 11.9 9.4 15.1 15.0 13.8 14.5 19.8 12.9 9.6 15.4 14.8 9.2 15.9 11.7 13.9 14.1 8.1 11.5 11.3 13.2 11.6 12.5 9.9 13.6 12.3 13.3 19.0 11.4 13.8 12.8 18.5 16.1 11.7 9.7 13.2 12.7 11.9 13.7 13.3 11.3 11.8 9.8 15.9 11.9 18.3 11.6 24.2 13.3 9.0 15.5 12.0 9.2 7.8 10.8 15.3 17.8 7.0 7.9 6.2 10.3 14.7 11.7 11.6 14.6 12.3 15.7 15.0 15.5 21.2 18.5 9.9 9.2 15.2 23.7 14.4 12.6 18.6 14.1 20.5 20.1 17.7 17.4 8.5 14.3 16.8 16.9 15.1 16.1 17.4 15.5 11.6 13.9 21.0 8.1 14.6 23.0 16.4 7.9 11.4 14.4 11.0 17.3 14.4 10.0 7.5 10.3 16.7 10.5 5.8 12.5 17.8 11.9 13.3 8.0 18.4 8.6 13.5 16.2 22.5 17.8 10.2 9.0 13.0 15.3 14.2 6.6 6.7 17.8 7.9 7.8 6.2 6.3 10.8 4.8 6.3 5.6 3.4 7.0 17.6 3.6 5.8 6.2 11.9 15.1 14.5 19.8 11.3 13.2 12.3 13.3 16.1 11.6 SMG9 "C19orf61, FLJ12886" ENSG00000105771 "SMG9, nonsense mediated mRNA decay factor" Q9H0W8 19 43727992-43754990 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041763, HPA042096" Uncertain Approved Mitochondria,Cytosol "Mitochondria, Cytosol" "HPA041763: , HPA042096: " "unprognostic (2.22e-1)" "unprognostic (1.32e-1)" "unprognostic (7.41e-2)" "unprognostic (6.46e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-2)" "prognostic unfavourable (2.15e-5)" "unprognostic (2.71e-1)" "unprognostic (4.11e-2)" "unprognostic (9.24e-3)" "unprognostic (3.88e-2)" "unprognostic (8.76e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (8.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "prognostic favourable (8.09e-4)" 10.0 14.6 18.1 16.9 24.5 12.4 14.9 25.0 24.8 13.2 12.0 21.6 11.5 13.4 11.6 13.8 11.2 10.9 11.7 9.4 16.5 15.6 10.2 8.5 11.9 19.3 36.0 14.2 10.2 8.1 14.9 14.2 16.6 23.1 14.7 11.0 9.2 14.0 12.7 9.1 12.3 11.7 13.9 20.4 17.1 14.2 40.9 29.6 13.2 10.8 4.1 19.3 11.1 12.0 9.2 8.0 3.6 12.2 4.6 8.3 10.7 12.5 13.9 10.2 6.5 7.2 10.2 6.8 18.0 10.8 20.2 15.3 9.7 16.8 13.8 8.9 12.3 5.5 11.9 10.0 13.2 10.6 6.7 24.9 9.9 6.5 8.4 18.7 13.6 5.4 8.6 14.6 15.8 8.2 18.6 12.3 9.3 9.0 19.8 5.3 4.9 9.4 10.6 8.4 6.2 10.7 10.4 17.1 8.4 18.8 14.3 10.6 8.6 10.4 9.9 31.7 18.6 11.6 13.7 6.0 12.9 16.5 9.5 14.4 25.7 1.0 6.1 3.6 6.3 9.0 5.6 9.2 6.4 5.3 8.0 6.7 8.3 5.7 1.5 4.6 12.2 7.0 4.6 10.7 18.1 24.5 25.0 24.8 16.5 15.6 36.0 14.2 23.1 29.6 SMIM1 Vel ENSG00000235169 "Small integral membrane protein 1 (Vel blood group)" B2RUZ4 1 3772761-3775982 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HEL: 36.5;Hep G2: 15.8;K-562: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 10 "eosinophil: 26.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 26.7" "Low region specificity" "Detected in all" HPA069088 Enhanced 420000 "HPA069088: " "unprognostic (9.50e-3)" "unprognostic (7.19e-4)" "unprognostic (5.40e-2)" "unprognostic (2.10e-2)" "unprognostic (2.50e-3)" "unprognostic (3.25e-1)" "unprognostic (2.63e-3)" "unprognostic (2.13e-2)" "unprognostic (2.31e-2)" "unprognostic (9.85e-2)" "unprognostic (2.90e-1)" "unprognostic (1.87e-1)" "unprognostic (2.25e-2)" "unprognostic (7.10e-2)" "unprognostic (2.91e-2)" "unprognostic (5.56e-2)" "unprognostic (1.32e-2)" 1.6 2.2 0.9 0.7 1.3 27.8 2.2 2.2 1.7 6.1 2.9 3.4 9.1 1.0 1.7 7.7 3.7 2.1 3.7 23.5 1.7 1.6 8.4 6.6 2.4 3.4 2.1 1.7 8.0 5.5 2.0 9.3 2.7 3.0 9.0 0.3 5.6 18.5 17.2 1.3 1.1 1.3 4.9 4.0 2.1 3.3 23.5 1.6 0.5 6.9 1.1 1.5 4.6 4.2 2.5 0.3 26.7 1.2 0.1 2.5 1.4 0.1 0.6 0.8 1.5 0.0 0.0 2.8 0.4 0.6 0.0 0.0 1.6 2.0 0.1 3.7 0.0 0.8 0.2 0.7 0.0 3.3 1.9 36.5 0.0 15.8 1.3 0.0 0.7 1.0 0.5 0.2 0.3 0.0 18.2 0.6 0.0 3.6 0.0 1.1 0.2 3.6 0.0 0.0 5.2 1.9 0.4 0.9 3.6 0.1 3.7 2.6 3.9 2.0 0.2 0.0 0.4 0.0 0.0 1.6 0.4 0.1 0.0 0.0 0.1 2.6 1.2 26.7 0.7 0.6 0.3 1.6 1.0 0.3 0.3 2.5 2.5 1.1 1.9 0.1 0.2 0.3 0.7 1.4 0.9 1.3 2.2 1.7 1.7 1.6 2.1 1.7 3.0 1.6 SMIM11A "C21orf51, FAM165B, SMIM11" ENSG00000205670 "Small integral membrane protein 11A" P58511 21 34375480-34407866 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA051321 Uncertain Approved "Focal adhesion sites" "Focal adhesion sites" "HPA051321: " "unprognostic (2.62e-2)" "unprognostic (4.28e-2)" "unprognostic (1.27e-1)" "unprognostic (5.86e-3)" "unprognostic (1.90e-1)" "unprognostic (1.66e-1)" "unprognostic (3.04e-1)" "unprognostic (4.48e-2)" "unprognostic (1.13e-1)" "unprognostic (2.74e-1)" "unprognostic (8.84e-2)" "unprognostic (4.83e-3)" 2.1 6.7 7.8 1.4 7.4 1.0 5.0 4.4 9.5 2.9 4.1 2.2 4.3 6.0 1.4 6.3 4.8 8.8 6.9 6.1 5.1 4.5 5.0 3.3 6.7 5.0 3.8 5.2 4.1 2.4 3.7 6.2 4.8 2.9 16.4 2.6 4.6 3.7 6.5 3.7 17.0 1.7 12.1 5.0 4.3 2.2 4.6 6.5 6.3 4.8 3.4 11.8 3.6 7.5 8.8 0.0 5.9 6.2 5.2 0.0 0.0 4.6 5.7 6.0 6.1 7.5 14.5 4.2 0.3 5.6 0.0 0.1 8.4 26.9 16.9 3.1 0.0 3.6 4.7 3.9 7.2 0.1 8.9 0.0 4.8 10.2 13.5 12.3 3.7 5.6 2.2 3.8 12.4 17.4 4.8 7.1 20.5 2.6 2.4 5.3 10.4 0.1 8.5 12.2 15.5 5.0 0.0 14.1 1.7 4.0 10.1 10.5 12.8 5.1 4.3 6.8 6.9 0.3 3.0 6.3 1.8 4.8 2.7 4.6 3.4 5.0 6.5 2.5 4.6 2.5 0.7 3.4 1.2 1.2 11.8 3.6 SMIM11B ENSG00000273590 "Small integral membrane protein 11B" Q8TCY0 21 7744962-7777853 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 19.7" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA051321 Uncertain Approved "Focal adhesion sites" "Focal adhesion sites" "HPA051321: " "unprognostic (1.99e-1)" "unprognostic (1.78e-1)" "unprognostic (1.35e-1)" 2.2 1.9 1.4 1.4 2.5 0.6 1.8 1.0 2.3 2.8 4.9 1.5 0.3 1.1 5.8 4.0 4.0 0.3 2.2 3.4 0.9 0.0 0.2 1.8 0.0 1.1 2.1 5.4 0.8 0.7 0.9 0.8 1.7 0.0 1.1 0.4 1.2 19.7 11.2 10.3 11.6 9.5 17.6 10.5 13.9 0.5 8.4 17.1 12.9 15.9 10.2 7.9 11.2 5.5 6.4 0.5 3.9 12.1 4.7 11.0 2.0 15.9 12.4 2.4 4.5 9.3 19.8 10.4 8.2 13.5 21.5 8.7 15.7 8.9 6.2 10.4 3.6 23.0 20.1 7.3 5.8 10.3 16.2 12.4 0.1 9.4 5.2 17.4 17.8 3.3 15.4 0.8 15.9 7.4 12.8 6.6 6.7 9.2 0.4 6.6 3.5 2.4 10.3 8.9 18.8 11.5 28.4 9.0 5.0 11.6 10.3 14.1 8.7 16.1 16.0 14.7 14.8 11.2 19.7 17.6 15.7 3.1 9.5 9.1 10.8 13.9 10.5 SMIM12 "C1orf212, FLJ90372" ENSG00000163866 "Small integral membrane protein 12" Q96EX1 1 34712737-34859816 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065331 Approved Approved Mitochondria Mitochondria "HPA065331: " "unprognostic (2.21e-1)" "unprognostic (2.26e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.18e-4)" "unprognostic (2.64e-1)" "unprognostic (2.05e-1)" "unprognostic (5.71e-2)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "prognostic favourable (1.15e-5)" "unprognostic (7.33e-2)" "unprognostic (6.70e-2)" "unprognostic (3.58e-2)" "unprognostic (2.52e-2)" 26.6 28.8 16.4 19.0 21.9 16.0 21.0 14.2 27.1 12.2 22.6 14.2 12.4 22.6 14.8 15.5 22.4 13.9 15.7 25.5 15.6 21.7 31.7 61.5 17.1 21.4 19.0 18.7 13.3 25.5 10.9 15.3 19.3 19.8 11.3 21.8 15.4 17.3 16.8 32.2 15.7 23.1 23.9 13.8 19.2 17.0 13.7 13.1 20.3 18.1 20.1 20.1 15.7 16.8 25.7 38.5 54.4 35.1 25.5 36.6 35.3 21.6 16.6 18.7 13.6 24.5 19.3 13.0 23.6 20.6 30.5 26.4 16.7 27.7 22.8 21.3 24.2 21.9 23.7 31.7 23.5 27.6 16.7 40.5 26.6 19.9 22.8 44.1 24.0 29.3 31.0 33.1 26.9 31.1 28.7 31.1 26.9 15.8 21.3 22.8 30.2 21.7 18.2 18.3 29.6 27.0 22.8 18.0 14.2 21.9 20.7 33.2 14.1 12.5 29.1 21.0 21.5 32.0 27.6 17.5 24.1 23.1 19.8 26.4 13.7 36.4 34.7 54.4 31.1 35.1 36.6 25.4 29.2 33.9 38.5 25.7 24.4 31.4 22.8 25.5 28.0 27.6 32.5 35.3 16.4 21.9 14.2 27.1 15.6 21.7 19.0 18.7 19.8 13.1 SMIM13 C6orf228 ENSG00000224531 "Small integral membrane protein 13" P0DJ93 6 11094033-11138733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA065706 Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" "Nucleoplasm, Nuclear membrane, Golgi apparatus" "HPA065706: " "unprognostic (6.89e-2)" "unprognostic (1.22e-1)" "unprognostic (1.58e-1)" "unprognostic (7.11e-3)" "unprognostic (4.01e-1)" "unprognostic (2.57e-1)" "unprognostic (3.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (6.66e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (1.03e-5)" "unprognostic (1.04e-2)" "unprognostic (2.76e-1)" "unprognostic (9.22e-2)" "unprognostic (3.45e-2)" 5.7 4.2 7.5 2.8 13.0 2.0 4.5 13.3 26.4 4.3 3.2 7.7 1.1 3.1 4.6 3.2 8.5 3.0 3.7 5.7 6.5 2.8 3.9 8.7 5.2 2.3 9.5 8.3 3.8 3.2 7.6 2.8 11.4 14.3 4.3 3.3 2.8 5.3 4.6 9.1 13.7 3.9 4.7 4.9 5.1 3.4 9.4 8.1 1.7 3.9 2.1 2.6 3.3 4.9 0.5 2.4 1.3 0.4 1.2 1.0 0.4 5.6 4.9 7.6 6.4 7.9 9.1 8.0 15.9 6.8 8.2 9.2 6.5 1.8 7.1 21.7 5.1 5.0 15.8 5.6 14.9 3.9 11.5 7.4 5.5 5.1 10.6 13.7 1.7 10.8 15.6 8.4 11.1 8.7 10.4 3.0 15.6 3.1 5.8 8.0 3.6 4.3 7.7 14.1 9.9 5.0 4.5 17.8 9.8 3.3 11.0 18.6 2.7 5.7 12.3 12.5 9.0 5.1 10.6 5.5 18.4 10.2 2.9 5.8 19.1 1.3 0.3 0.3 1.0 0.4 0.8 0.5 0.4 0.5 0.6 0.3 0.1 0.9 0.1 1.2 0.3 2.4 0.6 0.4 7.5 13.0 13.3 19.6 6.5 2.8 9.5 8.3 14.3 8.1 SMIM14 "C4orf34, FLJ13289" ENSG00000163683 "Small integral membrane protein 14" Q96QK8 4 39546330-39639090 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 19.0;Daudi: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051299 Uncertain "HPA051299: " "unprognostic (3.13e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-2)" "prognostic favourable (2.63e-4)" "unprognostic (6.48e-2)" "prognostic favourable (3.00e-6)" "prognostic favourable (3.47e-4)" "unprognostic (2.67e-2)" "unprognostic (1.54e-1)" "unprognostic (8.30e-2)" "unprognostic (1.22e-1)" "unprognostic (7.18e-2)" "prognostic favourable (2.07e-4)" "unprognostic (6.66e-2)" "unprognostic (1.33e-1)" "unprognostic (9.50e-2)" "unprognostic (4.92e-3)" 13.6 34.5 13.0 10.0 12.2 2.4 18.1 13.2 14.5 20.9 19.8 16.1 28.2 7.6 10.0 22.1 12.9 13.4 12.0 7.4 13.3 14.8 14.9 59.9 11.9 18.5 15.5 10.1 13.7 35.5 12.9 23.8 8.2 18.4 18.3 19.3 12.4 26.8 27.9 4.2 8.6 11.4 10.4 17.0 12.8 23.4 9.2 12.3 4.3 16.4 6.6 23.2 11.6 11.6 32.4 30.3 13.2 17.4 12.1 6.8 11.7 2.8 5.1 2.6 2.5 17.5 19.0 4.4 3.9 5.4 1.8 2.7 1.8 11.4 74.2 3.8 4.7 1.1 0.5 0.9 1.7 1.2 0.5 0.0 2.1 2.7 5.4 0.4 0.6 6.9 3.4 2.0 1.3 2.7 0.6 2.3 3.1 9.2 0.6 1.2 1.2 3.5 2.7 0.1 0.6 3.9 2.7 1.7 2.3 4.7 6.7 1.6 5.5 0.9 10.1 4.6 0.9 5.6 0.7 7.4 1.4 0.3 7.5 0.7 1.7 13.2 17.4 7.9 6.1 14.6 6.8 30.9 4.5 5.6 18.4 32.4 3.3 5.0 12.4 12.1 13.8 30.3 2.4 11.7 13.0 12.2 13.2 14.5 13.3 14.8 15.5 10.1 18.4 12.3 SMIM17 ENSG00000268182 "Small integral membrane protein 17" P0DL12 19 56643145-56655766 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 6 "brain: 26.5" "Cell line enhanced" "Detected in some" "AF22: 5.3;HEK 293: 5.2;RH-30: 4.2;SCLC-21H: 4.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "HPA071857, HPA071861" Enhanced Approved Vesicles Vesicles "HPA071857: , HPA071861: " "unprognostic (1.32e-1)" "unprognostic (2.82e-1)" "unprognostic (1.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.62e-1)" "unprognostic (4.57e-2)" "unprognostic (5.84e-2)" "unprognostic (3.00e-2)" "unprognostic (2.51e-1)" "unprognostic (6.50e-2)" "unprognostic (4.64e-2)" "unprognostic (9.02e-3)" "unprognostic (3.46e-3)" "unprognostic (6.26e-2)" "unprognostic (1.01e-1)" "unprognostic (3.71e-3)" "unprognostic (7.51e-3)" 1.8 1.2 7.0 0.6 10.4 0.8 2.4 4.5 17.3 0.9 1.1 0.9 0.0 1.0 2.2 4.8 1.2 1.5 1.0 1.7 6.0 13.8 1.3 0.8 1.3 0.7 5.9 7.7 1.8 1.2 0.5 2.2 1.1 26.5 1.7 1.2 0.4 1.3 2.6 1.1 1.9 0.7 1.4 2.7 1.0 0.7 1.6 0.1 0.0 1.1 0.0 0.8 0.5 0.5 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.2 0.0 5.3 1.5 1.2 0.9 1.1 0.7 0.6 1.2 0.3 0.0 0.2 0.4 0.8 0.3 0.3 0.1 0.4 0.7 0.0 5.2 3.1 0.6 0.8 0.8 2.4 0.4 1.7 0.7 0.0 1.4 0.5 0.1 0.0 1.1 0.0 2.8 0.3 0.0 0.6 1.5 4.2 0.1 0.7 0.0 4.8 0.9 1.2 0.1 0.7 0.0 0.8 0.8 1.8 0.2 0.5 0.5 0.3 0.8 1.3 0.6 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 10.4 4.5 17.3 6.0 13.8 5.9 7.7 26.5 0.1 SMIM18 ENSG00000253457 "Small integral membrane protein 18" P0DKX4 8 30638600-30646064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 18.8;pituitary gland: 10.7" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 14.2" "Cancer enriched" "Detected in single" 8 "glioma: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066648 Supported Uncertain Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA066648: " "unprognostic (2.19e-2)" "unprognostic (9.37e-2)" "unprognostic (3.31e-1)" "unprognostic (4.24e-2)" "unprognostic (1.66e-1)" "unprognostic (2.60e-1)" "unprognostic (7.29e-2)" "unprognostic (4.70e-1)" "unprognostic (8.91e-3)" "unprognostic (1.05e-1)" "unprognostic (2.36e-1)" "unprognostic (6.08e-2)" "unprognostic (4.01e-3)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (4.14e-1)" 0.6 3.2 5.2 0.7 6.6 2.7 0.6 18.8 18.7 0.6 0.7 0.4 0.0 0.6 0.7 0.6 0.7 0.7 0.8 0.9 10.9 10.7 2.9 0.7 0.6 0.6 5.7 7.5 0.7 1.8 0.6 10.7 0.6 11.7 0.7 0.8 0.2 0.6 0.6 0.6 0.7 0.7 0.6 4.6 0.7 0.8 0.7 1.4 0.0 0.7 0.0 0.6 0.6 0.0 2.9 4.1 3.0 2.3 0.2 4.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.4 0.0 0.0 0.0 3.0 1.9 1.9 3.7 1.3 3.6 2.9 2.3 2.1 0.9 2.9 3.0 4.3 2.1 0.2 2.3 4.1 2.9 0.3 5.2 6.6 18.8 9.7 10.9 10.7 5.7 7.5 11.7 1.4 SMIM19 C8orf40 ENSG00000176209 "Small integral membrane protein 19" Q96E16 8 42541155-42555193 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011145, HPA074830" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA011145: AB_1078360, HPA074830: " "unprognostic (2.12e-2)" "unprognostic (2.33e-3)" "unprognostic (4.01e-2)" "unprognostic (1.85e-2)" "unprognostic (1.42e-1)" "unprognostic (6.68e-3)" "unprognostic (7.04e-3)" "unprognostic (1.76e-2)" "unprognostic (4.84e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (2.67e-2)" "prognostic favourable (1.74e-6)" "unprognostic (5.10e-2)" "unprognostic (9.70e-3)" "unprognostic (9.64e-2)" "unprognostic (2.93e-3)" 23.7 26.9 20.2 19.2 17.2 12.7 31.2 21.1 23.9 17.5 23.2 12.4 25.2 14.0 16.1 39.3 23.2 27.3 27.9 41.9 18.2 15.6 35.6 61.9 22.1 23.4 17.4 16.5 21.5 40.2 18.0 12.8 16.0 13.6 17.7 16.7 17.7 42.7 20.4 50.6 19.8 31.3 26.6 17.2 18.0 19.5 26.4 9.8 21.4 34.9 30.8 15.8 26.5 13.2 28.1 41.4 25.7 17.0 29.7 29.2 15.2 13.4 10.0 22.0 18.9 13.5 16.2 7.0 10.5 14.5 8.6 10.2 2.4 30.1 14.8 4.4 8.8 9.7 11.4 6.8 8.9 11.8 9.5 12.6 6.8 5.4 27.6 8.8 3.2 13.2 5.9 7.1 23.0 7.7 9.9 34.1 8.5 13.1 6.4 13.4 26.0 6.9 7.3 15.7 25.0 21.6 10.0 4.6 16.9 10.7 11.6 31.5 24.5 16.9 9.6 5.4 4.6 14.8 6.8 32.5 17.9 19.5 22.8 14.4 14.2 25.7 17.0 11.5 19.3 12.4 23.2 28.1 24.9 23.5 25.1 27.5 23.9 22.9 6.0 29.7 10.3 41.4 29.2 15.2 20.2 17.2 21.1 23.9 18.2 15.6 17.4 16.5 13.6 9.8 SMIM2 "C13orf44, MGC5590" ENSG00000139656 "Small integral membrane protein 2" Q9BVW6 13 44143543-44161257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 15.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 5.8;SiHa: 4.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA026891, HPA077071" Enhanced Uncertain "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA026891: AB_10602924, HPA077071: " "unprognostic (4.34e-2)" "unprognostic (8.70e-2)" "unprognostic (1.07e-1)" "unprognostic (4.87e-5)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (3.26e-1)" "unprognostic (1.26e-1)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.10e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.05e-2)" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.2 0.8 0.9 0.1 2.9 0.1 0.2 0.3 1.2 0.2 0.2 0.9 0.4 0.1 0.0 0.2 0.1 0.7 0.0 0.3 0.2 0.2 0.0 0.6 0.0 1.0 0.1 2.2 0.2 0.2 0.1 0.4 15.9 0.1 0.0 0.2 0.1 0.5 0.0 0.0 0.2 1.8 0.4 0.0 1.2 1.1 1.3 0.3 0.0 0.0 1.4 0.0 5.8 1.4 0.0 2.1 0.3 2.3 1.5 0.0 3.6 0.0 2.2 1.6 0.0 2.3 0.0 2.6 0.0 2.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 1.5 0.0 0.9 1.6 1.3 0.1 0.3 0.0 0.6 3.1 1.6 4.5 2.0 3.0 0.1 0.2 0.5 0.0 1.1 1.7 0.3 0.0 0.1 0.9 1.7 0.5 1.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.1 0.0 0.0 0.0 SMIM20 "C4orf52, MITRAC7, PNX" ENSG00000250317 "Small integral membrane protein 20" Q8N5G0 4 25861830-25929874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016552 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA016552: AB_1859536" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" "unprognostic (1.78e-1)" "unprognostic (6.52e-3)" "unprognostic (1.55e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.02e-1)" "unprognostic (5.42e-2)" "unprognostic (2.86e-1)" "prognostic favourable (8.97e-5)" "unprognostic (5.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.53e-1)" "unprognostic (5.12e-3)" 14.9 20.5 21.8 15.6 26.7 7.1 25.0 11.4 28.0 12.9 16.4 8.3 12.8 24.1 13.7 46.4 11.9 15.1 22.5 33.7 17.9 16.2 27.1 22.7 18.5 26.0 19.2 14.3 19.5 50.0 8.7 10.0 9.5 22.8 13.6 16.1 11.3 20.4 15.7 51.3 6.9 23.8 24.0 22.6 12.7 18.8 17.7 13.5 9.3 21.3 15.3 14.5 14.5 15.9 27.1 21.4 13.3 20.3 18.1 31.1 18.2 12.7 10.7 14.4 13.9 16.0 34.8 19.2 12.4 15.2 10.7 13.7 9.5 22.7 21.0 21.7 13.8 3.7 16.7 15.9 15.1 11.9 13.3 12.1 7.8 18.0 27.1 14.4 8.1 24.6 32.0 13.7 20.8 8.2 19.3 6.9 13.2 8.2 15.6 24.5 27.2 16.0 12.9 18.8 13.5 23.9 9.4 18.6 17.3 8.0 5.6 27.4 11.6 20.5 13.7 11.7 13.8 13.1 15.8 13.6 11.2 22.0 17.7 15.3 14.7 13.3 18.2 8.4 15.7 20.3 20.5 27.1 22.7 19.7 20.5 26.8 31.1 24.7 9.2 18.1 15.2 21.4 23.2 18.2 21.8 26.7 11.4 28.0 17.9 16.2 19.2 14.3 22.8 13.5 SMIM21 C18orf62 ENSG00000206026 "Small integral membrane protein 21" Q3B7S5 18 75409476-75427703 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 48 "testis: 8.2" "Cell line enhanced" "Detected in some" "U-2197: 1.2;U-87 MG: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041686 Enhanced "HPA041686: AB_10961179" "unprognostic (7.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 1.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM22 ENSG00000267795 "Small integral membrane protein 22" K7EJ46 16 4788397-4796491 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.3" "Group enriched" "Detected in some" 7 "CAPAN-2: 72.8;RT4: 26.8;SCLC-21H: 19.0;SK-BR-3: 54.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA077331 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA077331: " "unprognostic (6.55e-2)" "unprognostic (4.12e-2)" "unprognostic (4.84e-2)" "unprognostic (3.69e-3)" "unprognostic (7.82e-2)" "unprognostic (3.84e-2)" "unprognostic (4.63e-2)" "unprognostic (2.67e-2)" "unprognostic (6.20e-2)" "unprognostic (3.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (1.73e-3)" 0.8 0.0 0.8 14.4 0.8 0.2 10.9 0.8 0.8 10.8 47.0 0.9 37.8 27.5 2.5 12.1 2.6 18.0 28.1 0.8 0.8 0.0 6.2 0.9 6.8 0.8 0.8 0.8 2.8 36.2 0.0 12.1 4.1 0.8 10.2 28.1 0.8 42.2 35.3 0.8 2.2 54.3 1.7 0.8 0.8 41.7 27.2 0.8 1.0 0.9 2.8 4.5 18.5 3.6 1.9 1.5 3.9 1.3 0.9 1.6 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 72.8 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.2 0.0 0.2 0.1 6.2 0.3 26.8 19.0 0.3 0.1 54.7 0.0 4.3 0.0 0.0 0.2 0.2 0.3 0.0 0.1 0.1 0.1 0.0 0.2 0.1 3.9 1.3 1.6 1.3 0.5 0.6 0.7 1.3 0.6 0.3 1.9 1.6 0.7 3.3 0.9 0.6 1.5 0.9 0.3 0.8 0.8 0.8 0.8 0.8 0.0 0.8 0.8 0.8 0.8 SMIM24 "C19orf77, HSPC323" ENSG00000095932 "Small integral membrane protein 24" O75264 19 3473986-3480542 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 160.8;intestine: 204.2;kidney: 76.9" "Cell line enhanced" "Detected in some" "CACO-2: 45.8;HEL: 21.6;Hep G2: 34.2;MOLT-4: 32.6;REH: 17.9;U-937: 25.7" "Cancer enhanced" "Detected in many" "renal cancer: 78.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "NK-cell: 8.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA045046, HPA056027" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA045046: AB_10964444, HPA056027: AB_2683012" "unprognostic (2.18e-4)" "unprognostic (4.63e-1)" "unprognostic (5.68e-2)" "unprognostic (9.60e-2)" "unprognostic (1.93e-1)" "unprognostic (6.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (1.64e-1)" "unprognostic (2.85e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "prognostic favourable (4.13e-10)" "unprognostic (1.68e-2)" "unprognostic (2.14e-1)" "unprognostic (8.36e-2)" "unprognostic (3.11e-2)" 0.2 0.1 0.7 0.6 0.9 7.0 0.3 0.2 2.2 0.2 137.0 0.4 2.4 71.4 0.2 160.8 0.3 0.3 46.7 0.3 0.4 0.5 76.9 7.2 0.3 0.3 0.4 0.6 0.3 1.6 0.0 0.9 0.2 0.3 0.3 2.0 0.2 0.3 0.4 0.2 0.3 204.2 0.2 0.6 0.4 24.8 1.2 0.3 8.8 0.2 0.2 0.2 0.2 0.2 3.2 2.4 3.0 0.0 8.6 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 45.8 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.2 34.2 0.0 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 32.6 4.6 0.0 0.0 17.9 0.0 1.2 0.4 0.0 0.4 0.7 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.8 0.0 25.7 0.0 3.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.1 0.6 0.7 1.7 0.0 8.6 0.0 2.4 2.1 1.1 0.7 0.9 0.2 2.2 0.4 0.5 0.4 0.6 0.3 0.3 SMIM26 "LINC00493, LOC388789" ENSG00000232388 "Small integral membrane protein 26" A0A096LP01 20 18567347-18569563 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068733 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA068733: " "unprognostic (1.20e-2)" "unprognostic (5.85e-2)" "unprognostic (2.83e-1)" "unprognostic (8.06e-2)" "unprognostic (2.68e-1)" "unprognostic (1.65e-1)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.67e-3)" "unprognostic (2.16e-1)" "unprognostic (2.68e-2)" "unprognostic (2.40e-2)" "unprognostic (2.02e-1)" "unprognostic (3.18e-1)" "prognostic favourable (7.84e-5)" 6.8 13.2 8.4 6.8 11.6 9.9 15.6 9.2 13.2 8.8 8.8 5.0 11.9 8.6 9.0 20.4 9.3 11.2 10.8 15.0 9.2 13.2 16.4 6.7 13.4 9.2 10.9 17.2 29.4 6.9 10.6 7.4 14.7 9.5 9.7 6.9 16.8 15.7 32.3 7.7 10.9 11.7 8.9 6.2 8.3 5.4 10.8 7.7 12.0 18.7 9.6 11.4 12.6 49.2 52.0 75.1 42.9 29.6 49.8 37.5 23.4 30.5 22.9 24.0 21.1 29.1 27.1 17.5 20.7 20.3 23.3 18.8 27.1 23.2 20.1 18.8 25.8 21.6 28.6 23.1 10.0 27.3 30.9 14.2 62.0 40.5 20.2 23.7 24.7 38.2 23.1 37.2 30.5 22.6 21.9 25.1 28.8 23.8 55.8 13.2 36.9 15.6 27.1 31.7 45.5 23.5 23.0 24.6 18.4 35.5 67.6 26.0 29.9 15.9 14.3 15.2 17.8 18.3 21.3 51.3 25.8 13.0 13.1 10.8 34.8 42.9 32.2 33.2 36.2 34.7 49.2 45.0 37.6 52.0 45.1 49.8 46.7 75.1 29.6 33.3 48.6 45.4 37.5 SMIM29 "C6orf1, LBH, MGC57858" ENSG00000186577 "Small integral membrane protein 29" Q86T20 6 34246380-34249470 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 67.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA037659, HPA037660" Uncertain "HPA037659: , HPA037660: AB_10671881" "unprognostic (2.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.35e-2)" "unprognostic (2.10e-1)" "unprognostic (3.23e-1)" "unprognostic (1.93e-3)" "unprognostic (1.36e-2)" "unprognostic (2.62e-1)" "unprognostic (4.12e-2)" "prognostic favourable (7.98e-4)" "unprognostic (9.32e-2)" "prognostic unfavourable (4.38e-4)" "unprognostic (3.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.16e-2)" "unprognostic (3.66e-1)" 9.6 18.5 42.0 10.4 21.8 9.9 12.4 14.8 36.8 10.5 7.6 15.2 4.6 7.1 9.1 24.4 13.3 11.5 12.3 19.0 34.6 34.4 7.9 6.0 13.3 13.5 35.7 16.5 8.8 10.7 7.0 12.2 10.0 25.7 9.7 4.8 12.5 7.5 13.6 7.8 29.2 6.7 8.3 23.9 15.2 9.4 5.2 14.0 5.8 15.2 8.3 11.0 16.0 9.3 22.4 10.4 67.8 15.0 9.8 15.8 11.0 8.7 9.8 1.9 11.6 24.4 20.4 2.0 9.1 19.3 8.4 10.3 2.4 3.4 4.9 7.3 8.1 5.4 3.7 8.7 2.5 12.7 6.3 3.6 2.4 6.7 13.5 4.3 23.0 11.0 8.3 11.9 12.6 13.4 4.7 24.7 19.1 5.6 4.6 7.9 0.7 7.2 1.6 1.3 7.6 10.0 11.4 9.4 4.5 0.9 6.5 23.7 4.8 5.1 9.8 19.2 5.3 22.1 7.6 15.7 22.1 1.6 11.2 8.6 27.9 15.3 15.0 67.8 15.8 10.7 10.3 22.4 12.6 13.5 10.4 21.8 8.7 12.5 38.7 9.8 7.6 8.8 15.3 11.0 42.0 21.8 14.8 36.8 34.6 34.4 35.7 16.5 25.7 14.0 SMIM3 "C5orf62, MSTP150, NID67" ENSG00000256235 "Small integral membrane protein 3" Q9BZL3 5 150777946-150796734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 24.4;blood: 22.3;bone marrow: 11.4;pancreas: 45.7" "Cell line enhanced" "Detected in many" "ASC diff: 63.1;ASC TERT1: 30.9;LHCN-M2: 28.6;U-87 MG: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075345 Approved Vesicles Vesicles "HPA075345: " "unprognostic (2.33e-1)" "unprognostic (4.05e-2)" "unprognostic (1.35e-2)" "unprognostic (2.70e-2)" "unprognostic (9.45e-2)" "unprognostic (5.65e-2)" "unprognostic (4.57e-3)" "unprognostic (1.47e-1)" "unprognostic (3.90e-1)" "unprognostic (2.05e-2)" "unprognostic (9.71e-3)" "unprognostic (3.46e-3)" "prognostic unfavourable (1.15e-8)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "unprognostic (2.16e-1)" "unprognostic (1.46e-3)" 24.4 5.4 6.1 3.3 5.6 11.4 3.9 3.3 6.2 2.2 3.1 1.8 0.7 1.3 3.0 2.9 2.2 3.0 3.3 3.4 2.6 1.2 2.9 1.1 3.6 0.7 3.0 1.0 3.2 45.7 1.2 1.8 6.4 6.2 3.2 2.3 1.3 1.8 3.3 2.5 2.2 3.9 3.7 2.6 1.9 2.9 1.7 4.3 1.8 2.7 0.7 0.7 3.8 1.8 0.3 18.4 22.3 13.3 3.6 7.2 11.6 2.0 0.6 1.1 9.2 63.1 30.9 2.4 7.9 16.9 2.8 11.7 3.1 5.3 0.0 0.4 8.0 1.6 1.8 1.7 4.3 0.0 0.5 2.9 0.4 1.4 11.2 2.8 20.9 25.8 3.5 8.2 3.8 0.9 0.7 0.0 28.6 1.5 4.1 3.9 0.5 1.8 2.2 0.1 0.0 3.1 1.5 0.2 0.7 1.1 0.1 2.3 3.8 17.8 1.5 13.0 2.3 10.1 4.0 0.0 0.0 0.0 46.9 10.9 1.6 17.9 13.3 22.3 7.2 5.3 4.3 0.3 5.1 4.9 6.2 0.0 5.0 4.3 13.9 3.6 4.8 18.4 0.7 11.6 6.1 5.6 3.3 6.2 2.6 1.2 3.0 1.0 6.2 4.3 SMIM34A ENSG00000243627 "Small integral membrane protein 34A" A8MWV9 21 34418715-34423966 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 9.6" "Cell line enhanced" "Detected in some" "HDLM-2: 4.4;SK-MEL-30: 1.2;U-87 MG: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA029085 Uncertain "HPA029085: AB_10669867" 0.3 0.1 0.3 0.3 0.5 0.2 2.9 1.6 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.3 0.3 2.1 0.3 0.6 0.3 0.2 9.6 0.5 0.9 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.7 0.3 0.3 0.3 0.7 1.0 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.7 0.0 0.6 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.5 1.6 0.3 0.3 0.2 0.3 0.3 0.3 0.3 SMIM34B ENSG00000278961 "Small integral membrane protein 34B" A8MWV9 21 7784482-7793954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 4.5;kidney: 16.1" "Cell line enhanced" "Detected in some" "HDLM-2: 6.4;SK-MEL-30: 2.6;U-87 MG: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 3.1;myeloid DC: 1.7" "Low lineage specificity" "Detected in many" HPA029085 Uncertain "HPA029085: AB_10669867" 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.4 16.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 3.1 0.6 0.0 0.0 0.4 1.1 0.2 0.2 0.0 0.0 0.0 0.3 0.2 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.5 0.6 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 2.6 1.2 0.3 0.0 0.0 0.5 0.4 0.0 1.1 0.1 0.0 2.5 0.3 0.1 0.0 0.5 3.1 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.4 SMIM4 C3orf78 ENSG00000168273 "Small integral membrane protein 4" Q8WVI0 3 52534013-52579237 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 90.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047771 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA047771: " "unprognostic (3.76e-3)" "unprognostic (3.19e-2)" "unprognostic (4.54e-2)" "unprognostic (4.89e-1)" "unprognostic (2.40e-1)" "unprognostic (1.48e-2)" "unprognostic (9.89e-2)" "prognostic favourable (1.78e-5)" "unprognostic (3.25e-2)" "unprognostic (4.25e-2)" "prognostic favourable (5.00e-4)" "unprognostic (6.35e-2)" "prognostic favourable (1.63e-4)" "unprognostic (8.72e-3)" "unprognostic (2.28e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-2)" 11.1 47.3 6.8 9.3 12.0 4.1 15.9 10.3 13.4 6.0 8.7 3.2 16.0 7.5 5.2 16.3 5.5 5.0 13.0 90.6 8.4 6.1 12.2 9.3 21.7 26.5 8.5 6.9 19.1 28.3 6.2 22.1 4.1 17.4 10.6 6.7 10.5 25.8 19.1 66.8 6.7 7.9 17.0 9.1 5.7 8.5 14.1 7.6 1.8 17.3 30.8 5.3 7.0 5.3 13.7 26.2 8.8 24.7 11.0 16.9 10.4 22.7 8.0 9.3 23.6 11.0 5.7 19.1 10.3 4.8 11.9 10.4 9.7 6.1 9.8 4.7 4.3 12.0 3.0 8.3 4.8 6.5 24.2 9.2 22.8 19.6 16.7 11.0 12.9 12.3 5.1 10.0 7.3 10.8 12.2 14.7 8.0 9.9 10.1 15.3 15.9 17.0 7.0 9.0 19.4 6.6 10.0 10.1 12.8 20.2 6.7 19.5 6.9 9.2 9.5 6.6 21.7 31.1 20.9 17.2 18.7 21.5 36.2 20.5 9.0 3.5 24.7 8.8 10.8 18.7 10.5 13.7 15.6 13.2 26.2 12.5 16.9 15.2 0.9 11.0 7.5 14.0 14.9 10.4 6.8 12.0 10.3 13.4 8.4 6.1 8.5 6.9 17.4 7.6 SMIM5 C17orf109 ENSG00000204323 "Small integral membrane protein 5" Q71RC9 17 75633434-75641404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.2" "Cell line enhanced" "Detected in some" "HEL: 3.1;MCF7: 14.1;SK-BR-3: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 51 "plasmacytoid DC: 54.2" "Lineage enriched" "Detected in many" 51 "dendritic cells: 54.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065332, HPA071268" Approved Approved "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA065332: , HPA071268: " "unprognostic (6.97e-2)" "prognostic favourable (5.52e-4)" "unprognostic (2.13e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (1.05e-4)" "unprognostic (3.29e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-1)" "unprognostic (2.66e-2)" "unprognostic (3.52e-3)" "unprognostic (1.10e-1)" "prognostic favourable (1.12e-4)" "unprognostic (2.64e-1)" "unprognostic (4.94e-2)" "unprognostic (8.26e-2)" "unprognostic (2.58e-1)" 0.4 0.6 2.1 1.8 10.7 9.9 1.4 1.1 7.5 4.0 4.4 23.5 2.1 9.8 0.7 0.8 14.3 5.5 4.7 5.1 3.7 2.2 13.6 0.5 2.5 1.1 8.8 4.8 1.3 1.1 0.4 1.1 1.9 16.9 1.9 2.8 2.5 8.4 2.2 0.4 7.8 9.5 2.1 10.1 2.4 11.0 0.9 8.9 0.4 9.3 0.9 3.6 4.4 7.3 0.0 54.2 1.0 0.0 0.0 0.0 4.0 2.4 1.6 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.2 3.1 0.4 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 14.1 0.1 0.1 0.1 0.2 0.4 0.5 0.1 0.0 2.8 1.2 0.1 0.0 6.4 0.0 0.9 0.2 0.1 0.3 0.2 0.1 0.2 0.3 0.0 0.1 0.1 0.6 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 54.2 0.0 4.0 2.1 10.7 1.1 7.5 3.7 2.2 8.8 4.8 16.9 8.9 SMIM6 C17orf110 ENSG00000259120 "Small integral membrane protein 6" P0DI80 17 75646243-75647977 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 22.0;fallopian tube: 19.1;stomach 1: 26.5;testis: 20.6" "Cell line enhanced" "Detected in some" "A549: 13.3;CACO-2: 4.3;CAPAN-2: 4.1;EFO-21: 10.3;HEL: 7.5;Hep G2: 4.0;RPTEC TERT1: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 22.0" "Lineage enriched" "Detected in single" 46 "dendritic cells: 22.0" HPA065721 Uncertain Approved Nucleoplasm Nucleoplasm "HPA065721: " "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (7.07e-2)" "prognostic favourable (1.49e-4)" "unprognostic (3.42e-1)" "unprognostic (1.22e-2)" "unprognostic (6.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-3)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "unprognostic (8.06e-2)" "prognostic favourable (4.09e-4)" "unprognostic (2.77e-1)" "unprognostic (1.38e-1)" "unprognostic (2.58e-2)" "prognostic favourable (1.64e-4)" 0.2 0.1 2.4 0.6 4.1 0.6 0.1 0.6 6.1 1.8 5.3 12.3 3.2 7.9 0.9 2.2 0.2 19.1 15.8 0.1 4.0 2.1 13.5 5.2 1.8 0.3 5.3 4.1 0.4 7.3 1.7 0.1 0.4 5.4 0.3 5.5 0.1 0.2 2.9 0.1 0.2 9.4 0.0 9.1 0.2 26.5 20.6 3.1 0.0 0.1 0.2 0.2 1.1 0.8 0.0 22.0 0.0 0.0 0.4 0.0 0.2 0.8 13.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.3 4.1 0.0 10.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 7.5 0.3 4.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.8 2.2 0.2 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.3 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 22.0 0.0 0.2 2.4 4.1 0.6 6.1 4.0 2.1 5.3 4.1 5.4 3.1 SMIM8 "C6orf162, dJ102H19.2, DKFZP586E1923" ENSG00000111850 "Small integral membrane protein 8" Q96KF7 6 87322583-87399749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007401, HPA067453" Approved Approved Vesicles Vesicles "HPA007401: AB_1078357, HPA067453: " "unprognostic (2.54e-1)" "unprognostic (5.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.90e-1)" "unprognostic (1.56e-2)" "unprognostic (3.16e-2)" "unprognostic (3.09e-2)" "unprognostic (6.17e-2)" "unprognostic (5.31e-2)" "unprognostic (6.12e-3)" "unprognostic (1.86e-5)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (2.01e-1)" "unprognostic (3.06e-2)" "unprognostic (2.86e-2)" "unprognostic (4.01e-1)" 7.8 9.0 13.3 6.3 14.6 9.0 9.1 15.6 15.6 7.4 8.3 7.6 8.5 8.8 11.4 12.2 6.5 7.1 4.7 10.3 17.9 12.5 10.4 12.0 5.6 9.1 12.0 10.8 10.5 8.0 6.1 19.2 5.8 11.9 7.9 8.1 7.8 7.2 7.3 16.2 5.4 7.9 11.3 10.2 6.5 6.3 7.4 8.0 11.0 7.5 4.7 6.5 6.5 8.7 16.0 8.9 13.4 8.4 7.7 18.7 8.5 4.3 3.9 7.9 13.6 4.6 5.3 3.5 4.8 3.7 4.1 7.9 2.6 4.0 8.9 5.8 4.8 5.4 6.3 3.6 7.9 7.8 6.8 13.0 4.3 5.2 4.4 13.4 4.7 4.9 5.1 4.2 4.5 5.8 14.5 14.9 4.6 3.2 8.1 10.8 4.8 5.9 13.1 11.7 5.0 5.2 4.3 13.5 5.6 7.1 4.3 7.7 3.9 13.6 5.6 2.2 6.2 9.1 4.7 6.7 10.9 5.8 7.0 6.5 6.4 5.2 8.1 13.1 10.7 7.7 10.6 16.0 12.6 12.8 8.9 10.4 18.7 16.2 13.4 7.7 8.4 7.5 15.5 8.5 13.3 14.6 15.6 15.6 17.9 12.5 12.0 10.8 11.9 8.0 SMIM9 CXorf68 ENSG00000203870 "Small integral membrane protein 9" A6NGZ8 X 154823348-154834662 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 4 "testis: 4.1" "Cell line enhanced" "Detected in single" "Daudi: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060970 Uncertain "HPA060970: " "unprognostic (2.63e-5)" 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 SMLR1 ENSG00000256162 "Small leucine rich protein 1" H3BR10 6 130827406-130837135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "intestine: 33.8;liver: 67.3" "Cell line enriched" "Detected in some" 12 "Hep G2: 41.5" "Cancer enriched" "Detected in some" 20 "liver cancer: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066060 Uncertain "HPA066060: " "unprognostic (1.73e-1)" "unprognostic (7.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.32e-2)" "unprognostic (2.35e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (6.43e-3)" "unprognostic (2.68e-3)" "unprognostic (3.29e-1)" 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 14.0 0.0 0.0 7.8 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.1 2.3 67.3 0.1 0.0 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 SMPD4 "FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3" ENSG00000136699 "Sphingomyelin phosphodiesterase 4" Q9NXE4 2 130151392-130182750 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046279, HPA049426" Approved Approved "Nuclear membrane,Cytosol" "Nuclear membrane" Cytosol "HPA046279: , HPA049426: " "unprognostic (5.02e-2)" "unprognostic (9.61e-3)" "unprognostic (6.31e-2)" "prognostic unfavourable (7.47e-5)" "unprognostic (1.69e-1)" "unprognostic (8.80e-2)" "prognostic unfavourable (8.37e-6)" "unprognostic (3.27e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.49e-2)" "prognostic unfavourable (1.73e-4)" "prognostic unfavourable (8.16e-8)" "unprognostic (1.74e-1)" "unprognostic (2.28e-1)" "unprognostic (1.47e-3)" "unprognostic (2.09e-1)" 13.2 16.1 12.4 17.1 20.7 39.1 14.8 22.1 25.1 19.9 15.8 31.4 15.3 15.5 22.5 14.1 19.3 19.5 12.7 13.4 13.2 16.0 14.3 18.5 14.7 20.5 21.3 12.2 22.2 22.2 24.1 31.2 24.3 19.5 16.3 16.7 17.7 17.1 15.2 17.0 17.5 15.2 18.3 16.0 16.4 14.5 23.6 21.6 27.9 22.8 19.6 27.1 16.9 16.6 10.5 9.8 14.5 11.4 11.7 15.2 9.7 31.7 15.7 19.8 14.6 10.2 7.5 25.8 16.9 12.6 25.0 20.9 45.4 16.3 20.7 15.0 17.0 18.1 25.3 22.4 17.4 27.4 24.4 23.3 16.9 36.0 8.7 26.0 14.9 8.8 15.0 28.0 11.2 14.4 28.9 16.8 13.9 17.2 27.1 13.1 30.4 20.9 28.8 15.1 22.5 10.6 15.1 27.6 15.4 16.7 20.4 7.4 13.9 11.4 11.1 21.4 20.8 14.0 19.8 14.7 16.4 27.8 19.3 14.9 15.2 1.8 9.3 14.5 13.9 11.4 15.2 9.5 10.4 12.4 9.8 10.5 10.2 11.4 4.5 11.7 8.0 6.4 9.4 9.7 12.4 20.7 22.1 25.1 13.2 16.0 21.3 12.2 19.5 21.6 SMYD4 "KIAA1936, ZMYND21" ENSG00000186532 "SET and MYND domain containing 4" Q8IYR2 17 1779485-1830634 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030059 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA030059: AB_2191728" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (2.47e-1)" "unprognostic (4.23e-2)" "unprognostic (1.13e-2)" "unprognostic (3.66e-2)" "unprognostic (4.03e-2)" "unprognostic (1.04e-1)" "unprognostic (1.79e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-3)" "unprognostic (9.26e-3)" "unprognostic (3.63e-2)" "unprognostic (1.33e-2)" "unprognostic (7.35e-2)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" 10.6 10.0 8.6 13.8 9.6 4.8 11.0 16.3 11.8 9.9 10.8 9.6 9.6 11.5 15.3 8.7 6.3 10.1 7.1 11.0 6.3 6.1 6.1 7.4 8.5 10.4 7.4 6.7 15.5 21.7 5.4 11.3 7.7 9.2 10.1 8.3 10.7 14.1 15.5 19.3 10.6 12.9 10.0 9.2 10.0 7.6 9.2 8.2 12.8 9.1 5.6 12.2 10.8 12.8 6.1 6.3 11.5 4.3 4.1 7.9 3.0 6.0 11.3 11.4 8.1 7.8 5.4 13.3 9.8 5.7 10.5 10.8 18.0 5.2 16.1 6.7 4.0 11.7 10.8 6.4 13.1 4.6 10.9 5.9 12.0 4.8 3.9 5.9 5.8 3.8 5.8 10.7 9.5 5.1 6.1 6.3 8.1 3.7 10.9 4.2 5.2 5.6 13.5 5.8 4.1 4.2 7.3 4.7 6.5 9.1 3.8 9.4 5.5 3.7 5.0 10.3 5.3 8.6 8.5 4.4 5.9 5.8 5.8 5.3 10.0 11.5 3.6 3.2 7.9 4.3 6.5 6.1 4.6 5.0 2.1 3.8 5.3 7.6 2.1 4.1 3.3 6.3 4.8 3.0 8.6 9.6 16.3 11.8 6.3 6.1 7.4 6.7 9.2 8.2 SNAP23 "HsT17016, SNAP23A, SNAP23B" ENSG00000092531 "Synaptosome associated protein 23" O00161 15 42491233-42545356 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 102.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001214, CAB037083, CAB037317" Approved Supported "Plasma membrane" 12000000 "Plasma membrane" "CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (3.76e-3)" "unprognostic (2.42e-2)" "unprognostic (1.65e-1)" "unprognostic (9.67e-3)" "unprognostic (1.60e-1)" "unprognostic (2.60e-1)" "unprognostic (2.93e-1)" "unprognostic (7.31e-2)" "unprognostic (1.36e-1)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (8.95e-2)" "unprognostic (1.10e-1)" "unprognostic (3.93e-2)" 29.9 24.0 15.2 28.4 20.5 14.3 28.6 11.1 17.5 20.8 30.8 21.6 27.7 23.0 38.9 18.6 20.3 21.3 18.7 24.6 16.6 11.7 22.8 23.0 28.0 35.4 27.3 10.5 24.6 19.8 10.4 17.7 81.6 18.9 24.1 24.5 16.3 37.0 25.8 32.8 15.3 40.8 22.8 23.4 41.6 22.1 25.1 21.3 20.1 20.3 18.1 35.1 25.5 53.7 17.2 22.9 102.0 36.3 10.3 11.5 23.0 17.1 7.7 14.7 14.3 24.1 19.1 22.6 21.7 16.4 12.8 15.6 25.2 6.8 8.4 28.6 13.3 14.7 16.3 12.7 18.3 14.1 9.4 39.8 8.4 23.6 17.5 15.9 38.3 15.2 10.0 11.5 19.6 49.1 29.8 8.7 17.4 5.9 19.0 16.5 12.4 6.0 35.0 8.7 13.7 18.0 15.5 2.3 9.4 15.6 14.3 13.7 20.5 23.0 38.6 13.0 17.7 15.6 21.3 18.7 33.1 44.6 15.7 32.5 16.7 30.2 24.7 102.0 8.4 36.3 9.8 17.2 8.9 8.2 22.9 15.4 11.5 8.8 56.2 10.3 34.4 9.5 9.8 23.0 15.2 20.5 11.1 17.5 16.6 11.7 27.3 10.5 18.9 21.3 SNN ENSG00000184602 Stannin O75324 16 11668414-11679159 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Cell line enhanced" "Detected in many" "AF22: 30.9;REH: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011055 Approved Approved Cytosol Cytosol "HPA011055: AB_1857326" "unprognostic (1.94e-1)" "unprognostic (7.26e-2)" "unprognostic (2.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "prognostic unfavourable (1.85e-6)" "unprognostic (4.51e-2)" "unprognostic (3.45e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (2.14e-1)" "prognostic favourable (1.83e-5)" "unprognostic (4.91e-2)" "unprognostic (2.09e-1)" "unprognostic (3.58e-1)" "unprognostic (4.72e-2)" 29.2 16.6 34.7 10.0 51.5 11.0 13.7 27.2 52.2 6.9 4.4 11.2 1.8 4.9 6.8 11.5 10.5 5.9 12.0 13.2 33.0 15.5 7.0 5.1 9.2 15.0 29.8 25.2 9.8 4.7 4.5 4.6 4.5 15.6 8.1 3.3 6.9 9.9 12.9 29.1 4.5 4.4 6.6 15.2 17.4 4.6 2.2 11.4 6.1 9.5 4.8 14.2 9.3 6.1 7.0 9.0 24.1 20.3 0.3 3.0 7.4 2.9 2.9 30.9 8.4 20.5 5.8 3.0 1.2 2.7 3.7 3.8 4.7 2.1 3.1 12.7 4.2 5.9 9.2 3.6 2.9 0.8 2.1 10.2 3.1 6.1 5.5 0.7 6.2 5.1 16.8 2.0 4.2 6.8 1.6 4.9 3.4 5.0 8.1 2.3 16.0 2.1 28.9 4.1 21.2 3.5 8.8 18.4 7.4 7.0 9.3 4.5 3.7 6.1 6.1 4.3 9.0 25.2 1.3 1.9 1.2 7.3 2.5 8.7 5.4 0.0 9.5 6.9 0.3 16.3 0.3 7.0 1.6 0.7 9.0 6.8 3.0 2.1 24.1 0.3 20.3 3.6 0.9 7.4 34.7 51.5 27.2 39.3 33.0 15.5 29.8 25.2 15.6 11.4 SNORC "ASCL830, C2orf82, UNQ830" ENSG00000182600 "Secondary ossification center associated regulator of chondrocyte maturation" Q6UX34 2 232857270-232878708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.9;breast: 19.6" "Cell line enriched" "Detected in some" 14 "Hep G2: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "basophil: 6.3" "Lineage enriched" "Detected in single" 18 "granulocytes: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA052824 Uncertain Approved Nucleoplasm,Nucleoli "Intracellular and membrane" "Nucleoplasm, Nucleoli" "HPA052824: " "unprognostic (4.58e-3)" "unprognostic (1.31e-1)" "unprognostic (2.47e-2)" "prognostic unfavourable (3.56e-4)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (3.06e-1)" "unprognostic (4.71e-1)" "unprognostic (1.23e-3)" "unprognostic (3.52e-1)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (4.30e-7)" "unprognostic (1.83e-3)" "unprognostic (8.15e-2)" "unprognostic (1.58e-2)" "unprognostic (1.33e-2)" 1.4 1.5 4.8 0.8 6.4 1.5 19.6 2.8 9.0 0.3 2.4 9.3 0.0 2.7 0.7 2.0 0.3 0.4 0.3 0.4 8.8 7.8 1.2 2.1 1.3 1.7 11.9 7.0 0.5 4.2 0.7 0.3 0.9 9.1 3.0 1.1 0.0 3.2 0.6 2.8 10.8 2.0 0.6 27.9 1.4 1.3 6.2 7.4 0.0 0.9 0.0 0.5 0.5 0.0 0.0 0.0 6.3 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.8 0.6 1.0 1.5 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.4 1.3 0.3 0.2 35.5 0.5 0.0 1.0 0.0 0.8 0.2 0.5 0.9 0.1 0.1 0.1 0.1 0.1 0.3 0.0 1.4 0.2 0.3 0.2 0.0 0.5 0.1 0.5 0.2 0.0 1.3 0.0 1.6 0.5 0.1 0.5 0.5 0.4 2.3 2.5 0.1 0.0 0.8 0.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.4 2.8 9.0 8.8 7.8 11.9 7.0 9.1 7.4 SNPH bA314N13.5 ENSG00000101298 Syntaphilin O15079 20 1266316-1309328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.5;naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 9 "T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049393 Approved Uncertain "Cytokinetic bridge,Mitochondria" Mitochondria "Cytokinetic bridge" "HPA049393: " "unprognostic (1.43e-2)" "unprognostic (2.55e-2)" "unprognostic (2.28e-1)" "unprognostic (8.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.56e-2)" "unprognostic (5.33e-2)" "unprognostic (3.08e-2)" "unprognostic (3.15e-2)" "prognostic favourable (6.97e-5)" "unprognostic (1.03e-1)" "unprognostic (6.94e-3)" "unprognostic (2.45e-2)" "unprognostic (1.55e-1)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" 2.9 5.0 26.7 3.0 22.5 1.6 1.8 14.4 36.2 3.5 3.5 3.1 5.9 3.1 4.5 3.9 3.6 4.7 4.8 4.7 26.8 15.3 2.1 0.9 2.6 3.1 12.8 17.5 2.4 6.1 6.2 5.8 1.7 17.1 5.5 2.2 3.1 9.9 19.2 6.1 1.9 3.1 8.1 3.8 2.1 5.1 2.7 4.4 0.1 4.5 0.1 2.0 3.6 1.6 0.1 0.4 0.0 0.0 0.0 3.5 1.2 2.2 6.8 0.1 6.9 8.2 4.5 0.0 4.1 5.4 4.6 2.1 0.2 0.7 0.4 2.4 5.0 1.2 1.1 5.8 0.9 1.5 1.9 4.4 1.1 0.1 4.3 0.0 7.1 2.9 2.8 4.7 0.9 5.8 0.8 0.2 4.2 0.0 0.4 0.2 2.4 5.8 0.0 1.4 0.1 6.2 3.2 0.4 2.1 4.0 0.2 5.9 0.4 0.1 10.0 7.5 5.5 6.5 1.2 0.6 1.2 0.0 4.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.6 0.1 0.8 0.9 0.1 0.1 3.5 3.2 0.0 0.0 0.0 0.4 0.4 1.2 26.7 22.5 14.4 36.2 26.8 15.3 12.8 17.5 17.1 4.4 SNRNP40 "HPRP8BP, PRP8BP, PRPF8BP, SPF38, WDR57" ENSG00000060688 "Small nuclear ribonucleoprotein U5 subunit 40" Q96DI7 1 31259568-31296782 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026527, HPA027345" Supported Supported "Nuclear speckles" "Nuclear speckles" "HPA026527: AB_1858814, HPA027345: AB_2239703" "unprognostic (2.31e-3)" "unprognostic (5.63e-2)" "unprognostic (5.24e-3)" "unprognostic (1.36e-1)" "unprognostic (1.14e-3)" "unprognostic (1.28e-2)" "prognostic unfavourable (4.73e-6)" "unprognostic (2.14e-2)" "unprognostic (2.43e-2)" "unprognostic (2.50e-1)" "unprognostic (1.22e-1)" "unprognostic (8.57e-2)" "unprognostic (2.34e-2)" "unprognostic (1.78e-2)" "unprognostic (5.93e-2)" "unprognostic (4.31e-2)" "unprognostic (6.24e-2)" 20.2 23.1 13.2 19.6 20.2 25.2 21.2 24.1 21.8 20.9 20.1 30.0 20.9 16.2 25.6 23.0 23.4 23.0 15.4 17.8 14.3 15.4 18.8 19.1 17.4 31.6 31.5 14.0 26.7 15.8 15.0 20.2 21.9 23.5 20.8 22.8 20.2 17.9 22.4 22.6 20.8 19.9 22.0 22.3 27.3 18.7 31.3 21.3 44.0 24.4 17.0 38.2 20.0 19.4 33.7 32.8 27.5 33.8 36.7 44.3 47.8 20.6 15.6 29.2 24.0 14.7 12.1 20.0 17.4 17.3 31.9 31.7 22.4 21.1 27.0 17.2 13.7 19.9 44.0 20.8 33.1 28.7 32.4 39.8 22.5 24.4 18.1 43.6 18.2 11.3 16.7 31.1 23.5 25.8 37.0 16.1 18.4 14.8 32.1 25.7 52.3 22.6 25.6 41.2 20.8 13.6 17.1 20.0 19.5 27.7 14.5 32.8 14.4 28.0 17.8 18.0 26.3 24.8 33.0 13.1 16.1 37.3 14.6 41.0 29.2 26.0 26.7 27.5 37.2 33.8 42.6 33.7 36.4 36.6 32.8 30.9 39.2 44.3 5.9 36.7 30.3 27.9 37.4 47.8 13.2 20.2 24.1 21.8 14.3 15.4 31.5 14.0 23.5 21.3 SNX19 "CHET8, KIAA0254" ENSG00000120451 "Sorting nexin 19" Q92543 11 130875436-130916509 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013447 Uncertain Supported Mitochondria Mitochondria "HPA013447: AB_1857347" "unprognostic (8.79e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (1.56e-1)" "unprognostic (2.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (9.19e-2)" "unprognostic (3.43e-2)" "unprognostic (4.05e-2)" "unprognostic (2.89e-1)" "unprognostic (4.97e-2)" "prognostic favourable (3.56e-5)" "unprognostic (1.05e-1)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (1.55e-2)" 22.3 23.1 24.0 16.9 30.6 10.0 17.2 18.0 38.0 17.1 23.8 35.6 25.3 17.1 22.9 32.5 17.9 19.8 20.4 22.6 22.8 22.2 24.1 25.6 17.5 15.3 31.0 15.3 20.6 26.6 32.9 28.5 18.5 28.0 21.7 22.2 23.7 23.1 27.2 26.4 19.0 17.8 26.0 30.8 18.5 22.3 36.2 28.2 24.6 31.1 12.1 18.1 23.0 16.4 5.9 5.4 11.3 6.6 3.6 6.2 5.2 6.7 7.4 9.6 13.4 28.9 20.4 6.3 18.0 21.4 9.1 9.5 8.4 13.0 6.4 12.6 19.8 12.3 1.4 12.9 11.7 10.3 5.8 11.6 7.4 0.0 21.0 0.0 9.1 23.2 16.0 9.3 10.2 11.1 10.2 0.0 19.4 4.9 9.4 7.7 2.9 9.5 7.2 9.1 3.7 9.9 12.2 9.4 8.7 7.7 12.4 6.1 22.0 7.3 14.7 12.8 9.5 10.4 10.5 2.2 0.0 0.0 5.3 7.7 14.6 11.3 6.0 4.4 4.8 6.4 6.2 5.9 4.7 5.7 5.3 4.4 5.6 4.4 3.6 3.6 6.6 5.4 4.1 5.2 24.0 30.6 18.0 38.0 22.8 22.2 31.0 15.3 28.0 28.2 SOGA3 "C6orf174, dJ403A15.3" ENSG00000214338 "SOGA family member 3" Q5TF21 6 127472794-127519191 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;pituitary gland: 11.9" "Cell line enhanced" "Detected in some" "AF22: 7.4;SCLC-21H: 23.9;SH-SY5Y: 13.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 6 "T-cells: 2.3" "HPA035388, HPA035389" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA035388: , HPA035389: AB_10669857" "unprognostic (1.70e-1)" "unprognostic (3.56e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (8.58e-3)" "unprognostic (8.45e-2)" "unprognostic (7.31e-4)" "unprognostic (5.65e-3)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" "unprognostic (1.59e-1)" "unprognostic (3.30e-2)" "unprognostic (1.72e-1)" "unprognostic (8.26e-3)" 0.8 2.8 5.0 1.8 5.3 0.4 0.4 11.4 15.3 1.0 0.8 3.7 0.0 0.5 2.1 0.2 2.0 1.0 1.9 0.8 4.2 4.5 0.6 0.6 1.7 0.8 6.7 5.0 3.3 1.7 0.2 11.9 1.2 7.9 1.1 0.6 0.7 1.1 0.5 0.3 1.0 1.9 0.6 11.4 1.4 3.9 1.8 4.3 0.0 1.9 0.0 0.3 1.6 0.8 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.2 3.3 7.4 1.1 0.0 0.6 0.3 0.7 0.9 0.9 2.3 0.2 0.3 0.4 0.2 0.1 0.0 0.8 0.0 0.6 0.7 0.1 0.6 0.0 0.1 0.0 0.2 0.1 1.2 0.0 3.6 0.0 0.0 0.3 0.2 0.5 0.5 4.8 0.0 3.3 0.8 0.4 1.8 0.0 0.1 0.0 23.9 13.7 0.0 0.0 0.1 0.0 0.3 0.2 5.9 1.2 0.4 1.7 0.2 0.1 0.1 4.5 1.1 5.8 0.0 0.0 0.0 0.3 0.0 0.4 0.3 2.3 0.8 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.0 5.3 11.4 8.2 4.2 4.5 6.7 5.0 7.9 4.3 SORCS1 sorCS1 ENSG00000108018 "Sortilin related VPS10 domain containing receptor 1" Q8WY21 10 106573663-107164534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 18.5" "Group enriched" "Detected in some" 12 "RH-30: 33.2;SH-SY5Y: 43.3" "Cancer enhanced" "Detected in some" "melanoma: 3.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 24 "intermediate monocyte: 2.4" "Lineage enriched" "Detected in single" 24 "monocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011948 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA011948: AB_1857366" "unprognostic (5.86e-3)" "unprognostic (8.45e-3)" "unprognostic (1.55e-2)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (2.92e-2)" "unprognostic (3.52e-2)" "unprognostic (5.58e-2)" "unprognostic (6.82e-3)" "unprognostic (5.81e-2)" "unprognostic (6.48e-4)" "unprognostic (2.51e-2)" "unprognostic (8.89e-3)" "unprognostic (2.22e-1)" "unprognostic (2.69e-4)" 1.4 5.8 6.0 4.5 14.1 0.4 1.8 0.5 13.2 2.2 10.7 1.1 1.9 1.4 2.1 1.2 2.0 3.2 2.8 4.2 2.6 4.7 8.0 0.5 0.5 1.9 2.1 6.6 1.2 3.0 0.6 1.2 0.4 3.3 2.7 3.6 6.5 2.4 4.9 0.8 2.3 4.5 2.7 2.1 1.7 3.4 2.3 2.7 0.2 18.5 1.1 2.7 4.7 3.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 33.2 0.0 0.0 0.0 0.0 43.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 14.1 0.5 11.3 2.6 4.7 2.1 6.6 3.3 2.7 SORCS2 KIAA1329 ENSG00000184985 "Sortilin related VPS10 domain containing receptor 2" Q96PQ0 4 7192538-7742836 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1" "Cell line enhanced" "Detected in some" "EFO-21: 6.5;HaCaT: 16.3;HMC-1: 12.3;RPMI-8226: 7.2;SiHa: 11.7;THP-1: 6.9;U-937: 7.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061916 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA061916: " "unprognostic (1.38e-1)" "unprognostic (6.32e-2)" "unprognostic (1.91e-2)" "unprognostic (4.37e-2)" "unprognostic (4.91e-3)" "unprognostic (1.82e-2)" "unprognostic (4.60e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-3)" "prognostic unfavourable (3.55e-4)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "prognostic unfavourable (3.09e-4)" "unprognostic (2.17e-3)" "unprognostic (5.37e-2)" "unprognostic (2.09e-1)" "unprognostic (7.27e-3)" 4.9 2.6 12.0 6.4 16.6 3.3 1.8 4.8 22.4 13.8 4.0 32.1 3.2 3.1 6.0 8.2 4.7 3.5 7.1 3.2 10.7 6.9 7.4 5.2 8.3 2.0 9.9 11.2 7.4 1.7 0.8 2.7 0.9 11.2 7.5 2.6 7.5 2.6 5.3 2.4 1.9 4.2 11.5 11.2 1.3 1.9 3.4 11.3 0.8 6.2 2.2 2.7 5.2 3.7 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.9 1.1 0.2 0.1 0.0 0.0 0.1 0.0 1.4 0.4 0.1 0.5 0.0 6.5 4.1 16.3 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.2 0.1 0.0 12.3 0.2 3.6 5.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.3 0.7 0.0 1.3 7.2 0.2 0.0 0.7 0.6 11.7 0.0 0.0 0.0 6.9 0.0 4.2 1.2 0.0 0.1 0.0 0.0 0.0 1.4 7.1 0.2 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 12.0 16.6 4.8 17.7 10.7 6.9 9.9 11.2 11.2 11.3 SORL1 "C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1" ENSG00000137642 "Sortilin related receptor 1" Q92673 11 121452203-121633693 "Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Endocytosis, Transport" Receptor "Alzheimer disease, Amyloidosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 44.1;Daudi: 20.7;RT4: 31.2;U-698: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 43.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011500, HPA031321" Uncertain "Secreted to blood" "CAB011500: AB_443414, HPA031321: " "unprognostic (1.54e-1)" "unprognostic (1.74e-1)" "unprognostic (4.08e-2)" "unprognostic (9.53e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-2)" "unprognostic (1.59e-2)" "unprognostic (1.59e-3)" "unprognostic (1.74e-1)" "unprognostic (1.86e-2)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "prognostic favourable (1.80e-7)" "unprognostic (2.48e-1)" "unprognostic (1.87e-1)" "unprognostic (5.07e-2)" "unprognostic (1.21e-2)" 5.6 5.0 17.3 17.0 24.9 30.7 10.5 28.3 40.8 34.8 12.7 36.0 9.9 8.6 4.5 7.2 5.7 29.4 5.8 3.0 22.4 18.7 15.0 41.4 10.0 14.8 28.6 21.9 7.3 6.1 19.9 17.7 2.1 24.0 16.0 12.7 6.4 14.7 20.0 1.5 3.9 13.0 3.8 27.8 21.3 7.9 4.1 23.4 11.1 10.3 0.2 16.3 15.8 6.7 2.0 5.6 43.8 5.4 6.7 10.8 6.1 0.4 2.4 2.3 0.3 0.0 0.0 2.3 0.1 0.7 0.1 0.0 3.6 44.1 20.7 2.7 0.5 14.6 2.8 2.1 0.0 0.0 0.8 0.0 3.3 5.0 0.0 8.8 0.0 0.0 2.4 0.0 8.2 0.0 0.0 0.2 0.0 2.9 2.1 4.5 2.7 3.3 2.3 0.1 0.4 4.9 31.2 1.6 0.4 4.6 6.7 0.0 6.5 2.8 0.1 0.0 1.6 0.3 0.0 0.0 0.0 43.0 0.0 11.8 0.1 13.0 5.4 19.1 8.0 2.3 10.8 0.7 9.0 7.2 2.2 2.0 8.6 7.6 43.8 6.7 2.8 5.6 6.3 6.1 17.3 24.9 28.3 40.8 22.4 18.7 28.6 21.9 24.0 23.4 SORT1 "Gp95, NT3" ENSG00000134243 "Sortilin 1" Q99523 1 109309568-109397951 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Endocytosis, Osteogenesis, Transport" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.1;epididymis: 75.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.0;non-classical monocyte: 10.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006889, CAB011498" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Cytosol" "Plasma membrane" "CAB011498: AB_2192606, HPA006889: AB_1080056" "unprognostic (2.10e-2)" "unprognostic (7.46e-2)" "prognostic favourable (7.74e-6)" "unprognostic (4.12e-1)" "unprognostic (9.41e-2)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.23e-4)" "unprognostic (3.34e-3)" "unprognostic (4.27e-2)" "unprognostic (9.44e-2)" "unprognostic (2.42e-2)" "unprognostic (1.28e-2)" "unprognostic (1.23e-3)" "unprognostic (1.45e-2)" "unprognostic (2.15e-1)" "unprognostic (3.95e-1)" "unprognostic (4.46e-3)" 22.9 6.5 24.0 6.2 35.5 10.1 15.5 6.4 40.6 10.1 15.2 50.3 18.1 11.5 11.9 75.2 22.0 14.8 9.5 31.8 45.2 19.8 21.1 3.7 19.2 3.6 57.9 22.8 3.6 9.3 24.2 5.7 22.9 27.1 10.3 14.4 12.2 11.8 24.8 36.4 8.3 11.3 14.6 71.1 5.4 9.5 21.6 42.2 1.1 22.5 5.1 5.4 8.7 8.2 0.0 4.5 2.3 10.0 0.4 0.0 1.7 11.6 4.7 11.8 14.3 34.4 6.8 34.0 8.7 13.9 8.6 9.2 12.1 4.3 0.1 11.1 3.6 2.9 13.9 6.9 12.4 0.3 6.6 3.2 7.6 13.0 13.5 0.0 10.6 17.1 1.1 10.5 2.3 1.3 24.1 1.2 12.0 12.4 8.2 0.2 4.4 1.9 9.2 27.8 5.6 16.4 8.5 12.1 6.9 5.1 34.2 36.7 14.4 2.0 0.3 1.8 7.0 0.3 14.5 11.6 9.5 0.0 3.1 0.0 7.5 0.0 7.1 2.3 0.0 9.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.9 0.4 10.0 1.6 0.0 1.7 24.0 35.5 6.4 33.9 45.2 19.8 57.9 22.8 27.1 42.2 SPACA1 SAMP32 ENSG00000118434 "Sperm acrosome associated 1" Q9HBV2 6 88047789-88066832 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 99 "testis: 49.2" "Cell line enhanced" "Detected in single" "HSkMC: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026744, HPA043297" Enhanced "HPA026744: AB_2194642, HPA043297: AB_2678413" "unprognostic (4.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPACA3 "ALLP17, CT54, LYC3, LYZL3, SLLP1" ENSG00000141316 "Sperm acrosome associated 3" Q8IXA5 17 32970376-32997877 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "pancreas: 15.0;testis: 45.6" "Cell line enriched" "Detected in some" 17 "U-266/70: 45.9" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 3.9" "Lineage enriched" "Detected in single" 4 "B-cells: 3.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "basal ganglia: 0.4" HPA023633 Enhanced "Secreted in male reproductive system" "HPA023633: AB_1857407" "unprognostic (6.48e-2)" "unprognostic (2.83e-1)" "unprognostic (1.30e-1)" "unprognostic (7.08e-2)" "unprognostic (1.16e-2)" "unprognostic (1.31e-2)" "unprognostic (3.37e-1)" "unprognostic (5.91e-2)" "unprognostic (1.68e-1)" "unprognostic (5.70e-4)" "unprognostic (3.86e-2)" "unprognostic (1.79e-1)" "unprognostic (4.63e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 15.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 45.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.9 0.9 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SPAG4 "CT127, SUN4" ENSG00000061656 "Sperm associated antigen 4" Q9NPE6 20 35615892-35621049 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 54.3" "Cell line enhanced" "Detected in many" "EFO-21: 16.8;U-87 MG: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA048393, HPA061789" Approved "HPA048393: , HPA061789: " "unprognostic (1.05e-1)" "unprognostic (5.61e-2)" "prognostic unfavourable (1.09e-5)" "prognostic favourable (9.52e-8)" "prognostic unfavourable (6.31e-5)" "unprognostic (1.05e-1)" "unprognostic (2.56e-3)" "unprognostic (1.21e-2)" "unprognostic (2.29e-1)" "unprognostic (4.77e-2)" "unprognostic (4.49e-3)" "unprognostic (1.98e-1)" "prognostic unfavourable (1.28e-4)" "unprognostic (3.59e-2)" "unprognostic (1.66e-1)" "unprognostic (1.79e-1)" "prognostic favourable (6.66e-4)" 1.7 2.9 1.6 4.8 1.4 3.8 3.7 0.4 5.3 2.7 13.9 0.2 3.3 4.0 1.5 4.4 2.8 2.5 3.4 2.6 1.1 2.0 3.1 3.0 3.2 4.9 1.3 1.6 5.2 54.3 3.2 5.0 7.0 2.3 2.6 2.0 2.8 4.5 2.5 0.4 0.4 3.4 1.2 2.9 6.9 4.6 16.9 1.5 0.0 1.3 0.0 7.5 7.2 1.8 0.9 3.9 0.0 0.7 0.0 1.0 0.4 2.3 1.0 0.5 1.4 1.3 0.6 6.7 1.0 1.1 0.9 1.4 2.4 5.1 0.2 16.8 1.3 0.7 0.3 3.2 1.1 2.5 0.5 1.9 2.2 2.4 6.6 1.3 3.3 3.2 0.6 1.0 0.8 1.9 0.5 4.7 2.4 4.9 0.5 3.7 0.0 4.6 0.3 0.5 6.6 1.7 1.0 0.3 2.4 1.1 0.8 1.8 3.4 0.6 2.0 4.8 0.7 1.0 0.9 9.0 3.5 1.9 30.5 0.5 0.7 0.0 0.1 0.0 0.0 0.7 0.5 0.9 0.1 0.4 0.4 0.0 0.5 0.0 0.0 0.0 0.0 3.9 1.0 0.4 1.6 1.4 0.4 5.3 1.1 2.0 1.3 1.6 2.3 1.5 SPAST "ADPSP, FSP2, KIAA1083, SPG4" ENSG00000021574 Spastin Q9UBP0 2 32063547-32157637 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis" "Allosteric enzyme, Developmental protein, Isomerase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017311 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA017311: AB_1857415" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (5.33e-2)" "unprognostic (3.90e-2)" "unprognostic (3.75e-2)" "unprognostic (4.00e-2)" "prognostic unfavourable (1.62e-4)" "unprognostic (3.26e-2)" "unprognostic (2.35e-2)" "unprognostic (7.39e-2)" "unprognostic (5.98e-2)" "unprognostic (3.52e-1)" "prognostic unfavourable (4.15e-4)" "unprognostic (5.71e-2)" "unprognostic (3.04e-1)" "unprognostic (1.53e-2)" "unprognostic (1.13e-1)" 12.7 9.6 18.4 14.8 16.4 13.4 9.8 21.1 21.9 14.7 12.7 15.1 12.5 11.5 12.3 8.7 11.1 10.4 10.2 6.2 20.2 18.5 9.4 14.6 9.7 18.9 20.6 10.0 15.1 10.9 11.8 12.3 11.5 17.5 10.3 12.0 6.8 9.3 13.7 15.4 11.5 17.6 11.6 27.0 15.5 9.7 14.4 14.6 21.5 13.4 6.2 13.8 11.3 10.1 5.0 7.1 9.5 9.0 6.6 7.6 4.3 10.6 7.7 12.6 12.4 8.0 9.4 11.4 5.9 8.7 6.2 5.6 10.4 9.3 18.6 5.5 8.2 7.6 12.4 6.0 7.7 12.5 7.5 20.5 4.2 12.7 7.3 14.2 14.4 5.2 7.9 7.9 7.6 13.7 16.6 6.3 6.8 4.5 22.8 12.0 13.1 4.5 12.1 17.8 12.1 8.4 6.6 18.0 19.3 10.0 8.5 9.8 5.5 9.8 11.8 6.9 10.6 6.1 6.9 9.5 17.7 15.1 7.5 12.3 8.2 3.4 6.3 6.7 3.6 9.0 5.2 5.0 5.8 5.6 7.1 3.9 5.9 6.0 9.5 6.6 6.3 3.2 7.6 4.3 18.4 16.4 21.1 15.8 20.2 18.5 20.6 10.0 17.5 14.6 SPATA3 TSARG1 ENSG00000173699 "Spermatogenesis associated 3" Q8NHX4 2 230990324-231025055 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "testis: 82.0" "Cell line enhanced" "Detected in some" "BEWO: 3.6;U-698: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 13 "cerebellum: 11.0" HPA018254 Enhanced "HPA018254: AB_1857419" "unprognostic (6.94e-3)" "unprognostic (6.98e-2)" "unprognostic (9.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1.5 0.2 0.2 0.3 0.0 0.1 0.3 0.2 0.1 0.0 0.2 3.6 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.0 0.1 0.5 0.1 1.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.9 0.0 0.2 0.7 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.7 0.0 0.2 0.0 1.1 0.3 0.1 0.1 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.4 0.2 0.3 0.2 0.2 0.1 0.3 0.3 0.0 0.2 0.5 0.0 0.0 1.5 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31D1 "FAM75D1, FLJ46321" ENSG00000214929 "SPATA31 subfamily D member 1" Q6ZQQ2 9 81988772-81995256 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 134 "testis: 13.3" "Cell line enriched" "Detected in single" 5 "HDLM-2: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047897 Uncertain "HPA047897: " "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31E1 "C9orf79, FAM75E1, FLJ35866" ENSG00000177992 "SPATA31 subfamily E member 1" Q6ZUB1 9 87882826-87888899 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 139 "testis: 18.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.4;hTEC/SVTERT24-B: 1.2;Karpas-707: 1.1;SCLC-21H: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA024253 Enhanced "HPA024253: AB_1845839" "unprognostic (2.16e-1)" "unprognostic (2.29e-2)" "unprognostic (4.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA9 "FLJ35906, NYD-SP16" ENSG00000145757 "Spermatogenesis associated 9" Q9BWV2 5 95652181-95698711 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.5" "Cell line enhanced" "Detected in some" "ASC diff: 2.7;HaCaT: 2.8;NB-4: 2.3;THP-1: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 20 "eosinophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA010848, HPA076967" Approved Approved Mitochondria Mitochondria "HPA010848: AB_1857422, HPA076967: " "unprognostic (4.46e-2)" "unprognostic (4.02e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (9.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.33e-2)" "unprognostic (2.08e-1)" "unprognostic (3.27e-2)" "unprognostic (7.58e-2)" "unprognostic (1.28e-2)" "unprognostic (3.08e-2)" "unprognostic (9.49e-13)" "unprognostic (3.39e-1)" "unprognostic (2.37e-1)" "unprognostic (1.26e-2)" "unprognostic (2.87e-2)" 0.9 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 2.7 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.1 0.0 0.5 0.3 2.8 0.0 0.0 0.0 0.2 0.5 1.7 0.2 0.0 0.6 0.5 0.4 1.6 0.0 0.6 0.0 0.5 1.7 0.0 2.1 0.0 0.7 2.3 0.8 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.4 0.0 3.9 0.0 0.7 0.2 0.5 0.4 0.0 0.2 0.0 0.0 0.4 1.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SPCS1 "HSPC033, SPC1, SPC12, YJR010C-A" ENSG00000114902 "Signal peptidase complex subunit 1" Q9Y6A9 3 52704955-52711146 "Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046091, HPA055273" Supported Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA046091: AB_10959614, HPA055273: " "unprognostic (5.47e-2)" "unprognostic (4.04e-1)" "prognostic favourable (9.28e-4)" "unprognostic (5.93e-2)" "unprognostic (6.88e-2)" "unprognostic (1.10e-2)" "unprognostic (3.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (5.56e-2)" "unprognostic (3.89e-1)" "unprognostic (1.15e-1)" "prognostic favourable (2.90e-4)" "unprognostic (5.96e-2)" "unprognostic (1.80e-1)" "unprognostic (3.58e-1)" "unprognostic (3.09e-2)" 31.0 53.4 39.7 28.5 41.5 27.5 42.2 24.2 55.3 39.1 46.3 40.8 46.3 47.8 34.9 53.2 39.1 33.9 35.6 39.4 38.0 47.0 62.3 98.7 37.1 68.9 47.2 38.1 34.7 112.1 30.5 48.8 50.9 41.7 41.0 41.6 38.4 87.7 57.8 43.2 34.3 53.4 34.2 48.3 37.4 45.7 57.1 25.5 42.6 55.2 38.3 52.0 36.6 30.2 40.2 123.4 48.5 27.8 22.2 34.1 43.1 21.2 20.1 19.2 24.8 31.0 25.3 32.0 29.5 27.1 26.8 24.1 21.1 31.1 22.8 13.0 26.7 20.5 19.4 27.6 26.1 30.3 23.3 26.8 33.5 29.4 35.1 37.3 44.5 20.7 36.2 29.5 32.2 21.7 22.8 72.3 27.3 20.6 29.4 37.8 36.5 41.9 12.0 17.9 114.5 39.4 26.2 13.9 31.3 29.1 31.2 39.2 34.9 42.7 20.4 24.2 22.7 43.3 34.8 79.8 118.9 32.1 37.6 41.2 31.5 45.3 26.0 48.5 27.8 26.0 32.8 40.2 34.1 30.5 28.4 29.0 32.2 32.8 19.8 22.2 27.8 123.4 33.9 43.1 39.7 41.5 24.2 55.3 38.0 47.0 47.2 38.1 41.7 25.5 SPEM2 C17orf74 ENSG00000184560 "SPEM family member 2" Q0P670 17 7425615-7427568 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 45.9" "Cell line enhanced" "Detected in some" "HDLM-2: 1.2;hTEC/SVTERT24-B: 1.0;U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023649 Uncertain "HPA023649: AB_1845606" "unprognostic (3.00e-1)" "unprognostic (3.88e-1)" "unprognostic (1.12e-4)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPG11 "FLJ21439, KIAA1840" ENSG00000104133 "SPG11, spatacsin vesicle trafficking associated" Q96JI7 15 44562696-44663678 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040412, HPA040947" Approved Supported "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoli "HPA040412: AB_10795418, HPA040947: AB_10796232" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.98e-3)" "unprognostic (1.99e-1)" "unprognostic (9.31e-2)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (2.26e-3)" "unprognostic (2.58e-2)" "unprognostic (9.19e-2)" "prognostic favourable (6.28e-5)" "unprognostic (8.73e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.06e-2)" 23.8 24.6 16.6 26.4 22.2 25.8 23.4 21.2 21.2 20.8 26.0 31.7 25.8 17.9 18.6 28.1 22.9 19.0 20.2 19.3 16.1 15.2 22.0 25.1 22.6 26.9 26.3 15.6 20.5 25.5 33.4 25.9 15.7 22.1 22.3 21.6 18.7 22.7 26.6 19.0 31.8 26.2 21.5 22.1 39.2 22.8 22.1 23.1 35.8 30.9 12.6 26.0 23.0 19.4 12.8 7.1 13.6 13.0 6.7 8.3 3.8 8.1 5.5 14.2 13.8 22.2 21.9 10.2 8.6 11.1 8.4 10.8 6.7 7.9 6.0 10.8 11.4 18.7 9.8 13.2 8.3 18.0 6.0 13.8 13.1 10.1 15.7 13.7 12.7 16.7 15.1 6.9 19.9 11.9 17.5 15.5 11.9 7.1 6.1 12.7 7.5 7.6 8.1 11.9 6.5 17.9 21.4 9.3 10.9 9.4 15.0 8.0 14.2 18.8 12.9 11.2 5.6 13.9 10.3 15.5 13.7 12.0 11.5 18.2 11.4 6.0 8.8 12.3 7.8 10.2 8.3 10.9 6.5 5.8 6.9 12.8 5.4 6.4 13.6 6.7 13.0 7.1 6.6 3.8 16.6 22.2 21.2 21.2 16.1 15.2 26.3 15.6 22.1 23.1 SPI1 "OF, PU.1, SFPI1, SPI-1, SPI-A" ENSG00000066336 "Spi-1 proto-oncogene" P17947 11 47354860-47378576 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 100.3;lymphoid tissue: 70.2" "Cell line enhanced" "Detected in some" "HEL: 18.7;HL-60: 32.9;HMC-1: 61.4;NB-4: 55.5;THP-1: 43.2;U-937: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 45.4;neutrophil: 24.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 45.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004079, HPA044653" Enhanced Supported Nucleoplasm Nucleoplasm "CAB004079: AB_10692379, HPA044653: " "unprognostic (4.45e-2)" "unprognostic (3.31e-3)" "unprognostic (2.92e-2)" "unprognostic (1.66e-2)" "unprognostic (5.97e-2)" "unprognostic (3.33e-2)" "unprognostic (5.28e-2)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (2.79e-1)" "unprognostic (3.36e-1)" "unprognostic (1.78e-1)" "prognostic unfavourable (2.07e-5)" "unprognostic (1.20e-1)" "unprognostic (4.95e-2)" "unprognostic (2.40e-1)" "unprognostic (4.92e-2)" 24.4 8.1 6.7 35.7 15.2 100.3 9.0 1.5 6.6 3.6 5.2 8.6 0.0 7.6 3.2 6.2 4.0 8.5 7.7 15.7 5.6 5.1 5.8 11.9 37.2 51.1 12.6 1.6 6.1 3.5 0.9 3.6 10.1 9.6 4.5 3.9 3.9 6.4 2.6 3.3 5.0 10.5 7.6 12.1 70.2 5.8 5.4 10.5 9.6 3.7 2.7 16.8 9.1 5.7 1.0 4.6 45.4 9.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 32.9 61.4 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 55.5 0.0 0.0 10.1 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 43.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 17.5 0.0 24.4 0.0 3.6 5.4 45.4 0.0 7.8 0.0 1.0 0.0 0.0 4.6 0.8 0.0 0.0 24.8 0.0 9.1 0.2 0.0 1.5 6.7 15.2 1.5 6.6 5.6 5.1 12.6 1.6 9.6 10.5 SPIN3 TDRD27 ENSG00000204271 "Spindlin family member 3" Q5JUX0 X 56818298-56995827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000727 Uncertain Approved Nucleoplasm Nucleoplasm "HPA000727: AB_2196121" "unprognostic (3.12e-3)" "unprognostic (2.32e-1)" "unprognostic (7.45e-3)" "prognostic unfavourable (3.49e-4)" "unprognostic (1.20e-2)" "unprognostic (1.67e-2)" "unprognostic (6.85e-4)" "prognostic favourable (6.79e-4)" "unprognostic (1.70e-2)" "unprognostic (1.30e-1)" "unprognostic (2.48e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-2)" "unprognostic (6.53e-2)" "unprognostic (8.51e-2)" "unprognostic (1.98e-2)" "prognostic favourable (6.30e-4)" 5.7 7.6 10.5 4.8 10.7 0.4 9.4 28.6 14.2 7.8 4.6 7.3 9.2 4.8 10.4 8.3 4.5 7.4 5.5 3.8 9.2 6.6 5.3 5.0 5.4 6.7 6.6 10.3 11.3 10.2 4.4 12.4 4.1 9.6 10.4 7.0 6.5 7.5 7.5 4.2 4.7 6.6 7.6 5.0 6.1 7.5 4.3 8.3 0.3 6.0 1.4 6.9 8.2 6.2 2.7 1.6 3.3 1.5 4.7 4.5 2.2 4.2 6.3 3.6 0.0 6.9 6.2 2.8 3.7 1.9 2.5 2.9 3.7 5.5 0.0 2.6 3.1 5.1 5.6 2.2 3.2 0.0 1.3 0.5 16.8 2.5 3.8 0.0 4.8 5.3 4.7 2.7 4.3 1.6 2.6 8.4 4.4 2.7 0.0 3.4 7.3 6.0 0.0 3.0 1.7 3.4 5.0 7.2 5.0 3.9 3.9 4.0 9.6 1.0 1.1 4.3 6.7 7.2 2.0 3.5 2.4 0.0 4.2 0.0 3.3 3.3 1.0 1.9 0.2 1.5 1.7 2.7 3.9 1.6 1.6 0.9 4.5 1.1 0.0 4.7 0.1 0.2 1.0 2.2 10.5 10.7 28.6 13.4 9.2 6.6 6.6 10.3 9.6 8.3 SPINT1 "HAI, MANSC2" ENSG00000166145 "Serine peptidase inhibitor, Kunitz type 1" O43278 15 40844018-40858207 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 121.0" "Cell line enhanced" "Detected in many" "BEWO: 51.3;HaCaT: 58.6;hTCEpi: 41.7;RT4: 47.5;SK-BR-3: 88.0;T-47d: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006903, HPA031178" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" 3400000 "Plasma membrane, Cytosol" Nucleoplasm "HPA006903: AB_1079038, HPA031178: " "prognostic unfavourable (6.97e-4)" "unprognostic (1.00e-3)" "unprognostic (3.00e-3)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (3.19e-1)" "unprognostic (5.94e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-3)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.01e-1)" "prognostic favourable (1.37e-7)" "unprognostic (5.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.45e-3)" "unprognostic (2.17e-2)" 2.2 0.5 0.9 11.6 1.2 0.0 12.6 2.9 0.8 12.9 64.4 1.2 38.6 31.9 3.6 25.5 71.1 6.4 30.7 0.8 0.8 0.7 27.9 1.5 18.5 3.7 0.9 0.6 3.4 25.0 28.8 9.7 85.5 1.3 17.5 17.9 3.2 50.8 24.0 0.6 39.1 121.0 2.3 1.0 3.1 17.6 1.9 0.7 4.8 15.4 26.9 44.3 12.8 21.5 5.1 19.0 15.3 10.9 3.6 1.8 3.8 18.8 0.1 0.0 0.1 0.0 0.0 51.3 0.3 0.4 0.6 0.3 30.0 31.5 0.0 22.5 0.0 58.6 4.8 28.2 0.4 0.1 1.6 0.8 0.5 1.6 0.3 3.3 14.9 0.0 41.7 0.6 2.6 2.3 0.4 0.1 0.0 14.6 0.1 2.5 5.8 2.7 1.9 0.0 3.7 28.4 47.5 12.6 0.6 1.4 88.0 2.3 42.0 2.4 0.0 0.0 0.3 0.1 0.0 0.1 3.5 0.1 0.1 2.4 0.1 0.0 10.9 7.9 0.3 9.3 0.5 5.1 1.8 0.8 19.0 3.9 0.7 0.2 15.3 3.6 9.6 2.3 0.2 3.8 0.9 1.2 2.9 0.8 0.8 0.7 0.9 0.6 1.3 0.7 SPINT2 "HAI-2, Kop" ENSG00000167642 "Serine peptidase inhibitor, Kunitz type 2" O43291 19 38244035-38292614 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 81.3;CAPAN-2: 120.0;hTCEpi: 66.8;RPTEC TERT1: 89.5;RT4: 69.4;SK-BR-3: 78.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011101, CAB018969" Approved Uncertain "Plasma membrane,Intermediate filaments,Cytosol" "Plasma membrane, Intermediate filaments, Cytosol" "CAB018969: , HPA011101: AB_1079039" "unprognostic (5.13e-2)" "unprognostic (1.06e-3)" "unprognostic (1.40e-1)" "unprognostic (6.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.03e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.04e-1)" "prognostic favourable (3.41e-4)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (2.68e-2)" 1.5 7.2 11.9 15.1 14.0 10.7 29.2 14.3 20.8 24.0 46.3 4.7 63.2 38.3 7.1 44.9 60.6 30.4 51.8 3.3 10.4 22.9 47.5 2.8 25.6 10.3 9.3 14.6 15.3 78.7 30.2 82.7 77.3 11.0 29.6 40.3 15.3 143.1 61.6 0.7 41.7 82.3 13.1 5.6 9.4 34.1 87.0 2.8 15.0 95.6 32.0 37.5 27.1 25.0 23.1 73.9 70.7 17.9 2.6 13.2 17.6 81.3 59.1 0.3 0.3 0.0 0.0 38.7 1.5 0.1 0.1 0.2 41.8 120.0 0.6 6.6 0.4 27.0 4.2 57.9 0.1 0.7 4.9 15.3 1.5 0.0 0.1 0.1 0.0 0.0 66.8 0.0 28.3 0.2 0.3 0.0 0.1 63.0 2.4 0.2 5.9 16.6 8.3 0.0 36.6 89.5 69.4 22.3 0.3 24.2 78.7 0.2 35.1 10.1 0.0 0.1 0.4 0.3 0.3 5.5 7.0 4.5 0.1 1.0 0.1 57.2 17.9 70.7 0.5 12.5 1.1 20.0 6.5 3.2 41.7 23.1 13.2 11.9 7.8 2.6 8.4 73.9 2.5 17.6 11.9 14.0 14.3 20.8 10.4 22.9 9.3 14.6 11.0 2.8 SPN "CD43, GPL115, LSN" ENSG00000197471 Sialophorin P16150 16 29662979-29670876 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7" "Cell line enhanced" "Detected in some" "HEL: 54.9;HL-60: 48.8;HMC-1: 27.5;MOLT-4: 18.9;THP-1: 26.4;U-937: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 52.1" "Low lineage specificity" "Detected in all" "CAB002666, HPA055244" Enhanced Approved "Plasma membrane" "Plasma membrane" "CAB002666: , HPA055244: " "prognostic favourable (1.40e-4)" "unprognostic (1.63e-3)" "unprognostic (3.14e-2)" "prognostic favourable (3.08e-5)" "unprognostic (2.68e-2)" "unprognostic (2.49e-3)" "unprognostic (4.02e-2)" "unprognostic (4.17e-2)" "prognostic favourable (1.88e-4)" "unprognostic (1.70e-1)" "unprognostic (4.67e-2)" "unprognostic (2.68e-1)" "unprognostic (2.61e-2)" "unprognostic (4.52e-2)" "unprognostic (4.14e-2)" "unprognostic (5.85e-2)" "unprognostic (4.72e-2)" 5.7 1.0 1.2 12.9 2.7 33.1 1.6 0.7 1.5 1.3 2.8 2.6 0.0 2.3 1.5 0.6 1.9 1.7 2.8 3.9 1.2 1.4 1.8 1.9 25.0 18.3 3.7 0.2 1.0 1.6 0.2 1.0 0.8 2.3 1.6 2.6 1.6 5.0 0.6 0.8 1.6 6.8 1.0 4.6 15.9 2.0 0.6 1.9 79.7 1.6 1.7 17.4 2.6 1.4 1.0 8.8 3.5 52.1 17.5 26.5 10.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.9 0.0 0.4 0.0 48.8 27.5 0.0 0.0 0.0 0.0 0.0 17.1 13.4 0.1 0.0 18.9 12.2 0.0 0.0 17.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.1 0.0 0.0 0.0 0.0 0.0 0.9 7.2 0.0 34.8 0.0 2.4 5.5 3.5 26.5 24.3 14.5 1.0 10.7 18.1 8.8 0.3 7.6 13.2 0.9 17.5 52.1 7.0 9.1 10.7 1.2 2.7 0.7 1.5 1.2 1.4 3.7 0.2 2.3 1.9 SPPL2A "IMP3, PSL2" ENSG00000138600 "Signal peptide peptidase like 2A" Q8TCT8 15 50702266-50765808 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036062, HPA067304" Enhanced Supported Vesicles Vesicles "HPA036062: AB_10611670, HPA067304: " "unprognostic (1.66e-1)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (5.82e-3)" "unprognostic (3.71e-1)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" "unprognostic (1.88e-1)" "unprognostic (2.22e-2)" "unprognostic (6.36e-2)" "unprognostic (2.04e-2)" "unprognostic (4.00e-2)" "unprognostic (3.11e-2)" "unprognostic (2.26e-2)" "unprognostic (1.44e-2)" "unprognostic (6.96e-2)" "unprognostic (3.66e-1)" 20.5 23.5 6.9 18.0 8.6 15.0 23.3 6.2 8.1 16.4 29.3 10.8 15.3 24.9 14.5 17.9 18.7 13.0 14.9 37.6 7.8 5.3 23.3 44.8 19.2 23.9 8.3 6.1 13.2 32.7 61.0 11.8 32.2 14.4 14.7 26.9 14.9 21.7 15.5 63.1 15.8 39.2 20.5 8.5 21.2 18.3 10.2 7.4 21.6 15.6 17.4 17.7 19.7 13.9 9.8 19.4 24.0 27.3 11.9 15.4 22.4 15.2 26.5 10.3 13.7 40.9 24.4 16.3 24.6 41.3 22.6 32.3 30.7 17.7 9.5 18.4 48.1 23.0 12.4 14.9 25.3 19.4 7.6 18.0 18.2 15.9 33.8 11.1 29.4 21.2 27.5 18.7 30.3 22.2 13.5 37.4 29.8 35.2 5.2 4.3 4.5 6.0 6.5 16.1 20.8 31.1 35.5 8.3 9.4 14.8 28.6 16.6 20.3 22.1 27.0 36.6 14.7 23.4 28.9 15.2 26.0 10.5 16.5 18.8 24.9 21.2 26.9 24.0 15.4 24.6 9.7 9.8 12.6 13.9 19.4 9.3 7.2 11.5 19.4 11.9 27.3 17.1 15.4 22.4 6.9 8.6 6.2 8.1 7.8 5.3 8.3 6.1 14.4 7.4 SPPL3 "DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4" ENSG00000157837 "Signal peptide peptidase like 3" Q8TCT6 12 120762510-120904371 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004194, HPA059958" Uncertain Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA004194: , HPA059958: " "unprognostic (3.29e-1)" "unprognostic (2.29e-2)" "unprognostic (3.39e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-1)" "unprognostic (7.96e-3)" "prognostic unfavourable (1.29e-5)" "unprognostic (3.17e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (2.66e-1)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (7.54e-2)" "unprognostic (9.40e-2)" 17.8 15.3 18.9 12.8 23.1 13.9 19.4 21.8 31.4 25.2 20.4 25.6 18.4 14.0 23.1 13.3 39.5 23.3 18.2 13.9 17.4 18.3 18.3 14.9 20.8 21.5 19.2 20.6 25.9 19.6 42.4 14.3 21.9 16.5 16.9 21.7 19.1 19.2 22.7 13.8 48.3 18.5 23.5 17.1 19.0 14.2 34.7 20.8 25.2 24.7 22.2 20.6 19.8 29.3 4.1 6.3 7.3 2.9 2.8 4.4 1.5 12.3 12.3 18.7 11.7 24.8 16.8 13.2 9.5 28.4 20.5 16.5 12.8 12.7 11.4 0.1 16.5 15.2 19.1 20.5 21.3 9.0 11.7 9.8 7.4 9.7 26.2 11.2 12.7 16.8 32.9 17.6 16.5 20.1 10.7 5.7 17.6 10.9 14.9 9.0 12.5 8.8 8.9 15.8 8.1 16.1 35.2 12.8 13.8 18.1 8.4 14.3 25.2 7.8 14.9 9.5 13.0 5.8 7.1 13.4 24.0 11.1 14.2 9.4 15.7 7.3 2.9 2.6 3.2 2.8 4.4 3.2 4.0 4.0 4.9 4.1 3.9 4.3 5.5 2.8 2.4 6.3 3.1 1.5 18.9 23.1 21.8 31.4 17.4 18.3 19.2 20.6 16.5 20.8 SPRED1 "FLJ33903, PPP1R147" ENSG00000166068 "Sprouty related EVH1 domain containing 1" Q7Z699 15 38252326-38357249 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.3;non-classical monocyte: 4.0" "Lineage enriched" "Detected in many" 4 "monocytes: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042193, HPA061805" Approved Supported Nucleoplasm Nucleoplasm "HPA042193: AB_10794079, HPA061805: " "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (2.46e-1)" "prognostic favourable (7.08e-4)" "unprognostic (1.20e-1)" "unprognostic (2.38e-1)" "unprognostic (1.21e-3)" "unprognostic (5.71e-2)" "unprognostic (3.84e-2)" "unprognostic (2.81e-3)" "unprognostic (9.27e-3)" "unprognostic (3.33e-1)" "prognostic unfavourable (7.37e-5)" "prognostic unfavourable (8.29e-5)" "unprognostic (6.04e-2)" "unprognostic (5.77e-2)" "unprognostic (1.01e-1)" 17.6 9.5 21.2 9.5 24.2 1.1 12.4 8.6 24.6 13.9 12.3 14.7 2.9 9.1 12.5 7.2 7.1 8.1 15.3 8.0 18.2 14.0 10.4 6.3 18.9 7.5 16.1 12.9 10.0 5.3 11.7 6.2 15.3 13.8 10.2 12.3 10.2 8.0 10.3 4.1 6.9 9.4 10.6 16.5 9.8 11.5 9.0 13.7 2.3 33.7 5.4 5.5 9.2 11.8 0.0 1.0 0.2 4.0 0.2 0.3 0.1 5.0 4.0 28.8 5.2 10.1 18.5 2.3 12.1 11.8 6.2 7.8 3.5 4.0 0.0 4.5 9.6 4.1 2.9 7.8 12.2 0.7 0.9 5.8 2.6 3.3 12.4 3.1 16.7 12.0 3.9 11.7 10.9 4.8 5.3 5.7 14.6 1.3 1.2 2.3 5.7 10.4 0.0 6.1 3.2 9.7 8.0 1.3 6.3 3.3 1.6 12.2 1.3 0.7 8.6 15.1 7.7 9.1 7.1 5.0 3.2 7.6 10.7 1.3 24.1 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.2 0.2 4.0 0.0 0.0 0.1 21.2 24.2 8.6 20.3 18.2 14.0 16.1 12.9 13.8 13.7 SPRED2 "FLJ21897, FLJ31917, Spred-2" ENSG00000198369 "Sprouty related EVH1 domain containing 2" Q7Z698 2 65310851-65432637 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 3.2;plasmacytoid DC: 7.7" "Group enriched" "Detected in many" 4 "dendritic cells: 7.7;NK-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038256, HPA064394" Approved Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038256: , HPA064394: " "unprognostic (1.49e-1)" "unprognostic (5.95e-3)" "unprognostic (3.46e-2)" "unprognostic (4.40e-3)" "unprognostic (8.94e-2)" "unprognostic (1.63e-1)" "unprognostic (2.90e-2)" "unprognostic (9.94e-2)" "unprognostic (9.07e-2)" "unprognostic (4.25e-1)" "unprognostic (5.05e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-2)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (7.21e-3)" "unprognostic (5.43e-2)" 25.1 13.5 21.0 19.3 17.8 6.7 26.2 26.2 28.9 16.9 18.9 9.0 5.8 17.2 20.1 12.3 12.8 13.8 18.3 17.5 19.0 14.3 16.1 28.1 22.0 14.8 15.3 19.0 18.3 20.6 29.5 15.1 18.1 20.5 15.1 18.7 15.1 17.9 13.6 9.6 13.6 20.7 13.7 16.5 11.0 22.6 8.1 12.9 40.3 22.1 10.4 17.1 21.2 30.5 0.1 7.7 1.2 1.2 3.2 1.2 1.5 26.6 14.1 15.4 15.6 20.0 20.1 11.1 8.0 11.8 5.2 7.1 18.5 7.6 20.5 4.2 9.9 9.0 8.7 17.9 10.5 23.5 6.4 4.2 3.7 19.9 10.1 13.0 8.7 16.0 10.6 18.3 17.6 3.2 18.2 8.0 8.3 18.0 10.1 12.2 7.6 16.5 8.1 13.9 10.6 16.0 22.5 6.6 23.4 8.4 7.2 21.3 6.8 11.1 5.0 13.1 17.6 11.6 12.7 15.9 6.4 33.6 21.2 12.6 25.2 0.0 0.4 0.0 1.2 1.2 0.1 0.0 0.2 1.0 0.8 0.1 0.2 0.3 1.2 3.2 0.6 7.7 0.0 1.5 21.0 17.8 26.2 26.7 19.0 14.3 15.3 19.0 20.5 12.9 SPRED3 ENSG00000188766 "Sprouty related EVH1 domain containing 3" Q2MJR0 19 38388421-38399587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.7" "Cell line enhanced" "Detected in many" "TIME: 15.0;U-87 MG: 9.6" "Cancer enhanced" "Detected in many" "glioma: 3.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071521 Uncertain "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA071521: " "unprognostic (1.09e-1)" "unprognostic (1.88e-3)" "unprognostic (8.71e-3)" "unprognostic (3.35e-3)" "unprognostic (3.70e-2)" "unprognostic (2.00e-3)" "unprognostic (2.09e-3)" "unprognostic (7.77e-3)" "unprognostic (1.49e-1)" "unprognostic (9.22e-3)" "unprognostic (1.69e-2)" "unprognostic (3.09e-2)" "unprognostic (1.40e-11)" "unprognostic (6.21e-4)" "unprognostic (3.67e-1)" "unprognostic (1.04e-3)" "unprognostic (8.45e-3)" 2.0 1.2 4.3 2.7 10.1 0.9 1.2 2.8 10.7 0.9 0.6 1.7 0.0 4.7 1.2 1.2 0.9 0.7 2.0 1.1 5.0 4.7 1.2 0.4 0.9 0.5 2.8 4.6 0.5 2.9 4.5 5.8 0.8 4.7 1.2 0.8 0.9 0.8 1.1 0.9 2.3 3.7 2.3 1.7 0.5 1.3 1.7 0.9 0.0 1.8 0.0 0.6 0.9 0.8 0.8 0.7 2.2 0.6 0.9 0.5 0.3 0.2 1.1 3.9 3.2 0.6 1.9 2.2 7.7 5.1 2.6 2.4 0.4 0.8 0.2 2.8 2.6 0.1 0.6 0.9 2.3 0.7 1.4 0.0 0.2 0.4 1.4 2.1 0.1 1.3 0.9 6.0 1.8 8.0 0.6 1.4 7.8 0.4 0.0 0.1 1.8 3.9 0.9 1.4 0.1 5.6 0.6 0.2 3.0 0.1 0.2 0.3 0.6 0.1 15.0 2.8 8.8 2.3 4.2 0.6 0.2 0.5 9.6 0.3 4.8 1.6 0.6 0.4 0.4 0.2 0.3 0.3 0.5 0.3 0.1 0.8 0.4 0.3 2.2 0.9 0.5 0.7 0.2 0.3 4.3 10.1 2.8 9.8 5.0 4.7 2.8 4.6 4.7 0.9 SPRY1 hSPRY1 ENSG00000164056 "Sprouty RTK signaling antagonist 1" O43609 4 123396795-123403760 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 139.1" "Cell line enhanced" "Detected in many" "AF22: 29.6;AN3-CA: 59.8;ASC diff: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 29.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013538, HPA051369, HPA070554" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" Nucleoplasm "CAB013538: AB_2533452, HPA051369: , HPA070554: " "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.06e-1)" "unprognostic (7.15e-2)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (1.36e-1)" "unprognostic (9.43e-2)" "unprognostic (6.99e-2)" "unprognostic (4.32e-1)" "unprognostic (4.06e-1)" "unprognostic (3.11e-2)" "unprognostic (8.77e-3)" "unprognostic (1.21e-3)" "unprognostic (4.48e-2)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" 139.1 12.6 3.3 14.7 4.3 5.8 69.0 4.9 3.5 28.5 24.8 1.9 18.0 4.5 18.6 28.0 38.1 19.1 27.1 34.1 2.6 1.7 10.2 6.4 23.1 9.1 3.3 2.8 32.2 9.8 17.0 9.5 15.6 2.9 25.0 8.8 11.8 14.6 16.5 48.1 25.5 8.1 20.7 2.8 7.1 11.6 28.4 1.5 13.0 29.6 16.3 8.6 60.8 39.9 29.9 0.7 2.8 0.1 6.1 15.5 0.9 1.8 0.5 29.6 59.8 24.3 16.5 1.9 0.1 1.5 0.1 0.6 1.8 3.1 0.0 13.3 0.8 0.3 0.7 1.4 0.2 0.0 3.0 0.6 0.0 9.2 6.9 4.1 0.0 6.7 0.7 0.2 0.6 2.5 0.5 0.5 1.4 0.2 4.8 10.3 7.1 9.8 2.1 3.2 0.0 4.0 4.3 4.5 3.8 0.0 6.0 5.7 0.6 0.0 6.1 0.3 0.0 0.1 0.8 0.3 0.0 0.0 0.4 0.8 0.9 0.0 0.1 2.8 0.5 0.0 15.5 9.6 1.8 4.2 0.0 29.9 2.7 2.9 0.1 6.1 0.0 0.7 0.0 0.9 3.3 4.3 4.9 3.5 2.6 1.7 3.3 2.8 2.9 1.5 SPRY2 hSPRY2 ENSG00000136158 "Sprouty RTK signaling antagonist 2" O43597 13 80335976-80340951 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 68.8;SK-MEL-30: 37.4;WM-115: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 7.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037205, HPA042198" Approved Supported "Actin filaments,Microtubules" "Actin filaments, Microtubules" "CAB037205: AB_261923, HPA042198: " "unprognostic (9.37e-3)" "unprognostic (3.71e-2)" "unprognostic (1.10e-1)" "unprognostic (9.12e-3)" "unprognostic (3.80e-2)" "unprognostic (8.99e-2)" "unprognostic (3.95e-3)" "unprognostic (2.43e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-1)" "unprognostic (1.53e-1)" "unprognostic (4.28e-2)" "unprognostic (1.56e-2)" "unprognostic (9.89e-2)" "unprognostic (3.22e-1)" "unprognostic (1.04e-1)" "unprognostic (1.86e-2)" 44.5 20.4 23.2 9.8 21.9 20.8 45.0 41.2 29.3 26.5 22.7 18.6 10.5 14.3 17.1 15.5 16.9 23.8 25.4 28.2 22.7 15.0 15.0 22.3 21.8 9.2 20.8 22.7 14.4 22.1 7.1 10.2 11.5 33.9 16.2 23.0 19.0 28.0 16.8 25.4 14.4 18.1 19.7 30.4 23.6 14.5 6.0 20.2 3.7 15.6 13.1 5.3 16.7 20.5 0.6 1.8 3.9 0.0 7.5 1.7 0.4 0.4 1.9 21.8 68.8 28.9 19.0 1.5 17.5 8.0 4.0 4.8 8.7 2.6 0.0 3.0 7.2 1.6 1.2 3.5 4.5 0.0 3.9 3.0 1.1 2.2 6.6 15.6 1.2 8.4 3.8 6.8 16.7 7.7 1.0 0.0 9.0 0.3 2.1 7.1 8.6 5.0 6.3 29.0 0.0 7.5 2.9 0.2 12.1 1.4 0.8 37.4 1.6 14.0 11.2 3.7 1.4 7.8 3.3 0.0 0.0 0.0 25.6 6.0 35.0 0.0 0.0 3.9 0.8 0.0 0.3 0.6 0.0 1.7 1.8 0.0 0.1 0.3 0.1 7.5 0.0 0.3 0.0 0.4 23.2 21.9 41.2 29.3 22.7 15.0 20.8 22.7 33.9 20.2 SPRY3 HSPRY3 ENSG00000168939 "Sprouty RTK signaling antagonist 3" O43610 X 155767812-155782459 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell line enhanced" "Detected in many" "AN3-CA: 8.4;EFO-21: 4.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB013505 Uncertain Approved Nucleoli,Cytosol Cytosol Nucleoli "CAB013505: " "unprognostic (3.70e-2)" "unprognostic (4.39e-1)" "unprognostic (5.24e-2)" "unprognostic (3.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.20e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "unprognostic (3.68e-3)" "unprognostic (1.52e-4)" "unprognostic (1.21e-2)" "unprognostic (9.60e-2)" "unprognostic (5.26e-2)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (5.44e-2)" "unprognostic (3.49e-2)" 1.6 2.1 1.3 0.4 1.8 2.8 1.2 7.5 1.5 1.3 0.8 1.2 1.5 5.8 0.8 1.1 0.8 0.9 1.3 1.5 0.9 0.7 0.9 0.3 1.1 2.8 0.4 1.3 1.1 1.9 0.9 1.4 1.1 1.2 1.2 0.4 1.1 1.2 1.2 1.4 0.7 0.1 1.0 0.5 0.8 0.7 0.0 0.5 0.4 0.5 0.2 0.2 0.0 0.5 0.2 2.3 8.4 1.7 0.8 0.0 2.0 1.3 0.6 1.0 0.2 1.4 0.0 4.1 1.1 0.3 0.9 0.6 0.6 0.2 0.4 1.0 2.1 0.1 0.7 0.4 0.4 2.0 1.1 0.8 0.5 1.3 0.1 0.6 1.6 0.3 0.2 0.3 0.8 0.0 0.5 0.2 2.0 0.9 0.7 0.6 0.6 1.0 0.0 0.5 0.5 0.6 2.1 0.6 0.9 0.3 0.6 0.6 0.1 1.8 2.0 1.0 1.1 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.5 0.0 0.0 SPRY4 ENSG00000187678 "Sprouty RTK signaling antagonist 4" Q9C004 5 142310427-142326455 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 35.2;WM-115: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008086, HPA055471, HPA072661" Enhanced Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "CAB008086: AB_2195454, HPA055471: , HPA072661: " "unprognostic (9.54e-3)" "prognostic unfavourable (7.12e-4)" "unprognostic (2.18e-1)" "unprognostic (1.16e-1)" "unprognostic (8.70e-2)" "unprognostic (3.23e-2)" "unprognostic (3.98e-3)" "unprognostic (1.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.48e-1)" "unprognostic (9.89e-2)" "prognostic unfavourable (2.20e-4)" "unprognostic (6.29e-3)" "unprognostic (3.63e-2)" "unprognostic (4.59e-2)" "unprognostic (8.21e-2)" 27.3 20.8 9.0 6.8 9.0 0.7 32.9 6.2 8.3 7.1 8.0 4.9 3.6 8.7 8.3 6.2 4.9 6.5 11.3 17.1 7.4 8.0 12.5 11.5 24.3 3.7 6.5 7.6 5.7 7.4 10.6 28.7 21.8 8.5 13.0 7.5 10.7 4.6 7.3 10.6 3.6 11.7 8.8 6.7 10.7 7.8 2.4 3.9 0.2 17.8 4.0 2.4 12.7 29.1 0.0 0.9 0.0 0.0 0.2 0.1 0.0 1.1 1.8 17.1 35.2 10.2 7.4 4.7 12.8 4.4 2.1 2.2 1.8 1.7 0.0 9.5 3.1 0.9 0.0 3.7 2.5 0.0 0.0 0.0 0.0 7.5 3.5 0.0 0.0 6.1 0.0 5.6 3.1 2.0 4.3 0.0 7.5 1.4 0.0 4.6 8.0 12.2 0.4 2.4 0.4 6.1 11.0 0.2 5.4 0.2 1.6 14.6 0.1 0.7 2.8 4.5 0.1 0.9 11.5 0.0 0.6 0.0 7.1 0.0 49.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 9.0 9.0 6.2 8.3 7.4 8.0 6.5 7.6 8.5 3.9 SPTLC1 "hLCB1, HSAN1, HSN1, LCB1, SPTI" ENSG00000090054 "Serine palmitoyltransferase long chain base subunit 1" O15269 9 92000087-92115384 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010860, CAB018747, HPA063907" Supported Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: " "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.47e-1)" "unprognostic (3.51e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (4.22e-3)" "unprognostic (1.27e-1)" "unprognostic (4.06e-1)" "unprognostic (3.55e-3)" "unprognostic (8.37e-2)" "prognostic favourable (1.36e-6)" "unprognostic (1.13e-1)" "unprognostic (2.41e-2)" "unprognostic (4.28e-1)" "unprognostic (1.49e-1)" 16.4 17.7 13.3 11.4 17.1 9.9 16.8 19.9 17.6 20.3 17.2 20.9 18.1 14.0 17.3 15.1 30.5 19.2 15.5 11.4 13.9 15.3 19.0 13.5 14.8 10.6 18.0 12.2 35.3 15.8 23.6 23.1 28.3 20.5 14.5 18.8 12.0 18.5 13.3 9.4 20.1 17.8 15.1 20.8 10.7 16.0 19.8 14.1 9.7 26.2 16.0 16.5 17.4 20.9 9.3 21.0 21.1 22.1 10.2 15.2 16.0 18.1 16.4 11.4 9.5 27.9 21.7 19.7 19.1 24.4 16.5 17.9 10.3 37.9 10.0 12.2 24.1 47.6 12.3 16.2 19.2 11.5 7.1 9.2 9.3 10.0 21.0 15.2 12.5 19.6 19.6 17.0 18.6 15.0 21.5 12.5 18.7 19.5 9.5 3.8 15.3 12.0 10.6 13.8 7.6 16.4 11.1 9.3 8.6 25.7 19.7 11.6 10.1 9.0 19.0 16.1 12.4 18.5 13.3 9.0 12.3 5.6 19.2 7.5 19.3 14.6 22.1 11.9 11.5 21.6 11.0 8.9 11.6 11.6 21.0 9.3 14.2 10.7 21.1 10.2 19.2 10.8 15.2 16.0 13.3 17.1 19.9 17.6 13.9 15.3 18.0 12.2 20.5 14.1 SPTLC2 "hLCB2a, KIAA0526, LCB2, LCB2A" ENSG00000100596 "Serine palmitoyltransferase long chain base subunit 2" O15270 14 77505997-77616773 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027552 Approved Mitochondria Mitochondria "HPA027552: AB_10601717" "unprognostic (3.16e-1)" "unprognostic (2.82e-2)" "unprognostic (1.24e-1)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (1.46e-2)" "unprognostic (3.09e-1)" "unprognostic (4.05e-1)" "unprognostic (1.98e-2)" "unprognostic (2.51e-1)" "prognostic favourable (6.69e-8)" "unprognostic (1.29e-2)" "unprognostic (2.35e-1)" "unprognostic (4.94e-2)" "unprognostic (1.32e-1)" 30.0 12.8 15.4 11.4 27.0 27.3 25.6 6.9 18.5 15.3 17.0 32.4 8.5 13.4 10.2 7.6 22.8 13.7 11.1 7.8 20.8 14.1 17.1 7.2 12.2 17.5 33.1 13.3 10.2 7.6 12.8 9.8 18.8 21.2 8.2 18.8 6.0 16.6 9.6 5.5 11.3 15.8 11.0 47.6 23.5 18.8 4.7 34.9 10.0 10.3 8.8 12.0 13.2 17.1 4.8 18.2 15.1 18.2 10.0 4.2 6.9 11.9 7.9 6.1 6.6 6.3 7.9 10.3 17.8 13.2 12.3 12.9 10.0 26.7 12.0 4.5 18.1 14.8 16.1 10.0 18.7 5.2 4.7 33.9 6.1 5.9 5.3 3.4 11.3 5.1 4.9 8.0 8.9 17.3 6.6 5.8 7.0 10.3 9.0 11.7 3.9 7.1 9.7 6.2 4.1 14.2 26.9 5.9 7.4 6.4 21.5 6.7 26.4 6.3 10.8 11.3 8.1 4.1 4.1 3.3 5.4 8.1 7.5 12.2 6.4 8.8 18.2 15.1 3.8 13.8 3.5 4.1 3.2 4.2 18.2 4.8 2.2 3.6 11.2 10.0 16.7 6.5 3.3 6.9 15.4 27.0 6.9 18.5 20.8 14.1 33.1 13.3 21.2 34.9 SPTLC3 "C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L" ENSG00000172296 "Serine palmitoyltransferase long chain base subunit 3" Q9NUV7 20 13008979-13169103 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 154.0" "Cell line enhanced" "Detected in many" "Karpas-707: 16.0;RPTEC TERT1: 21.4;U-2197: 14.9;U-87 MG: 28.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "pons and medulla: 10.5" "Group enriched" "Detected in some" 5 "MAIT T-cell: 3.0;NK-cell: 4.1" "Group enriched" "Detected in many" 13 "NK-cells: 4.1;T-cells: 3.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA044247, HPA048079" Enhanced Approved Microtubules Microtubules "HPA044247: , HPA048079: " "unprognostic (6.81e-2)" "unprognostic (7.76e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (5.43e-2)" "unprognostic (2.12e-1)" "unprognostic (5.70e-2)" "unprognostic (7.99e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "prognostic unfavourable (6.02e-4)" "unprognostic (5.08e-2)" "prognostic favourable (4.51e-7)" "unprognostic (2.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.18e-1)" 3.2 4.5 1.3 1.6 2.2 0.0 4.3 1.7 1.7 4.3 5.0 2.2 4.4 8.3 4.8 9.6 5.6 3.4 5.8 4.8 2.0 1.5 15.6 11.9 5.7 0.7 2.5 2.2 4.3 3.8 10.2 4.2 154.0 10.5 4.5 3.8 3.8 7.8 5.8 1.0 25.1 9.0 3.0 6.9 1.9 2.2 4.2 1.4 5.7 24.3 3.6 1.9 4.8 6.0 0.0 0.2 0.1 0.0 4.1 3.0 0.2 0.6 1.1 0.8 0.0 7.0 10.1 5.4 0.0 1.5 1.0 4.1 8.7 4.4 0.0 0.5 0.2 12.0 0.0 3.3 1.4 0.0 0.0 0.0 2.8 12.3 0.6 0.0 0.1 5.7 10.4 4.0 1.3 0.6 0.0 16.0 11.3 0.2 0.0 0.0 0.0 1.4 1.1 2.0 7.0 21.4 8.6 0.0 0.1 0.1 1.1 0.0 8.9 0.2 1.5 4.5 1.5 14.9 1.0 0.1 0.0 0.0 28.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 3.0 0.0 0.4 0.1 0.0 0.0 0.7 0.1 0.1 4.1 0.0 0.2 0.0 0.2 1.3 2.2 1.7 1.7 2.0 1.5 2.5 2.2 10.5 1.4 SPTSSB "ADMP, C3orf57, ssSPTb" ENSG00000196542 "Serine palmitoyltransferase small subunit B" Q8NFR3 3 161344792-161372880 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 68.6;skin 1: 27.5;stomach 1: 42.0" "Group enriched" "Detected in some" 11 "MCF7: 155.3;RT4: 41.2" "Cancer enhanced" "Detected in many" "urothelial cancer: 24.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 12 "NK-cell: 68.6" "Lineage enriched" "Detected in many" 12 "NK-cells: 68.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047712 Approved "Nuclear speckles" "Nuclear speckles" "HPA047712: " "unprognostic (2.09e-1)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "unprognostic (1.34e-2)" "unprognostic (4.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (5.10e-2)" "unprognostic (6.37e-3)" "unprognostic (2.72e-1)" "unprognostic (4.08e-2)" "unprognostic (5.37e-4)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (9.51e-3)" 1.4 0.4 2.0 0.7 3.4 0.5 6.4 8.9 18.5 4.0 0.9 1.6 0.0 0.5 1.0 0.4 5.1 0.6 1.5 0.4 2.2 2.2 0.7 0.6 0.3 1.0 2.0 6.2 0.4 1.5 0.3 0.3 0.3 12.0 12.4 0.8 0.2 8.0 0.4 0.4 27.5 0.5 1.4 1.1 1.1 42.0 0.3 0.4 0.1 0.4 2.1 1.7 23.5 5.4 0.0 0.0 0.2 0.0 68.6 5.6 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 155.3 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 41.2 0.2 1.6 0.0 5.6 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.6 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.2 68.6 0.0 0.0 0.0 0.5 2.0 3.4 8.9 18.5 2.2 2.2 2.0 6.2 12.0 0.4 SRPRB "APMCF1, SR-beta" ENSG00000144867 "SRP receptor beta subunit" Q9Y5M8 3 133784033-133825772 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 104.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011173 Approved Approved "Plasma membrane" 54000 "Plasma membrane" "HPA011173: AB_1857484" "unprognostic (5.44e-2)" "unprognostic (1.32e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-2)" "unprognostic (2.61e-1)" "unprognostic (2.02e-2)" "prognostic unfavourable (3.12e-5)" "unprognostic (1.99e-1)" "unprognostic (3.60e-2)" "unprognostic (6.07e-3)" "unprognostic (8.45e-2)" "unprognostic (1.31e-2)" "unprognostic (3.79e-2)" "unprognostic (5.08e-2)" "unprognostic (7.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.26e-2)" 10.4 15.7 8.7 10.2 9.3 5.8 12.5 5.2 10.2 14.4 11.3 5.1 33.2 8.9 8.0 25.6 16.8 9.1 11.0 10.9 9.0 10.7 17.2 56.3 9.2 17.3 10.4 7.7 8.9 104.0 11.7 15.6 7.7 8.8 9.5 13.4 7.6 53.3 29.9 10.6 8.6 7.4 10.3 7.4 9.5 12.5 14.7 5.4 6.3 16.5 10.2 13.7 8.7 10.4 15.4 20.0 3.8 15.2 14.3 29.0 18.0 12.2 9.9 6.3 20.0 26.4 18.3 11.8 25.9 13.5 14.4 12.5 18.0 9.5 23.2 38.4 19.8 17.9 19.6 14.0 13.7 15.7 15.8 20.7 9.8 17.1 32.1 32.4 16.9 16.5 23.6 13.1 38.9 12.2 17.6 27.0 15.4 17.8 11.1 15.4 12.0 17.1 13.6 11.8 49.5 17.4 8.4 20.9 8.7 19.8 18.5 7.2 21.0 15.1 12.1 14.2 8.4 22.4 13.8 34.8 34.6 35.0 12.7 21.6 15.9 3.8 11.6 1.4 21.4 15.2 29.0 15.4 18.3 19.0 13.2 13.4 18.0 21.2 0.8 14.3 9.9 20.0 10.6 18.0 8.7 9.3 5.2 10.2 9.0 10.7 10.4 7.7 8.8 5.4 SSBP2 HSPC116 ENSG00000145687 "Single stranded DNA binding protein 2" P81877 5 81413021-81751797 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 89.9" "Cell line enhanced" "Detected in many" "MOLT-4: 36.2;REH: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020834, HPA068605" Approved Supported Nucleoplasm Nucleoplasm "CAB020834: , HPA068605: " "unprognostic (4.62e-2)" "unprognostic (1.96e-3)" "unprognostic (1.12e-1)" "unprognostic (1.46e-2)" "unprognostic (1.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (1.56e-1)" "unprognostic (7.78e-3)" "unprognostic (2.36e-3)" "unprognostic (6.01e-2)" "unprognostic (1.01e-2)" "unprognostic (3.04e-3)" "unprognostic (6.56e-2)" "unprognostic (9.81e-2)" "unprognostic (4.39e-3)" 18.9 11.5 16.3 11.1 24.3 11.0 20.0 49.8 21.3 26.5 18.8 13.6 11.1 5.2 27.0 27.2 21.3 26.4 14.2 26.3 16.1 22.8 10.3 3.2 11.3 15.4 19.9 16.2 33.1 8.7 42.4 31.0 11.7 20.9 16.1 11.7 20.0 14.6 19.5 16.3 19.6 10.3 26.1 20.6 8.9 13.6 6.9 21.5 89.9 12.8 11.7 19.9 19.0 18.5 16.2 8.1 26.2 12.2 25.6 15.2 7.9 1.0 1.9 24.7 14.0 14.2 21.7 1.5 5.1 4.7 4.8 4.9 0.0 2.0 17.0 0.3 6.0 0.1 6.7 2.7 4.6 7.2 2.9 3.5 4.1 0.0 8.0 1.7 9.5 22.2 23.9 0.8 4.6 2.0 2.3 8.4 5.1 2.4 36.2 2.9 3.4 1.0 54.5 5.6 13.0 2.5 0.9 12.8 11.6 5.4 6.1 1.8 8.9 5.0 1.3 1.9 3.1 3.5 1.3 8.8 6.8 28.5 6.4 3.1 1.2 20.7 8.6 26.2 2.4 7.6 3.8 9.9 7.7 4.3 8.1 16.2 15.2 5.3 12.5 25.6 12.2 2.6 3.4 7.9 16.3 24.3 49.8 21.3 16.1 22.8 19.9 16.2 20.9 21.5 SSPN "KRAG, SPN1, SPN2" ENSG00000123096 Sarcospan Q14714 12 26121991-26299290 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 20.6;ASC TERT1: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "memory B-cell: 29.7" "Lineage enriched" "Detected in many" 21 "B-cells: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066432 Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA066432: " "unprognostic (4.82e-2)" "unprognostic (1.63e-1)" "unprognostic (2.03e-1)" "unprognostic (6.49e-2)" "unprognostic (2.04e-1)" "unprognostic (2.45e-1)" "unprognostic (6.11e-2)" "unprognostic (1.44e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" "unprognostic (1.37e-2)" "prognostic unfavourable (2.77e-5)" "unprognostic (2.64e-3)" "unprognostic (3.86e-2)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" 12.5 6.8 13.9 6.6 12.6 0.1 11.5 16.5 11.4 24.9 12.7 11.1 4.1 2.7 14.6 10.3 11.4 15.0 14.3 26.2 21.0 6.1 3.8 1.4 5.4 4.5 17.2 8.7 21.5 4.7 2.9 4.8 2.5 20.9 14.5 7.3 7.8 6.8 21.1 38.7 3.6 6.3 20.1 20.4 4.9 6.7 5.8 19.0 3.2 10.0 15.4 6.5 18.2 10.8 29.7 0.0 1.4 0.0 0.0 0.2 0.3 0.6 1.1 3.1 0.0 20.6 11.9 0.2 6.1 8.5 0.8 2.4 0.0 7.5 0.0 1.3 8.3 2.4 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 7.4 0.7 2.7 0.6 0.3 0.0 0.1 6.4 1.4 0.4 1.8 6.9 2.0 0.2 8.5 2.3 1.9 6.3 0.3 6.0 2.3 0.4 5.9 0.6 0.3 2.2 2.9 1.5 2.9 1.5 0.2 0.8 0.1 4.5 0.0 7.4 0.0 0.0 1.2 0.0 0.0 0.2 29.7 0.0 0.0 0.0 6.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 13.9 12.6 16.5 11.4 21.0 6.1 17.2 8.7 20.9 19.0 SSR1 TRAPA ENSG00000124783 "Signal sequence receptor subunit 1" P43307 6 7268306-7347446 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011276, HPA017062" Enhanced Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA011276: AB_1857503, HPA017062: AB_1857505" "unprognostic (2.27e-1)" "unprognostic (2.10e-1)" "unprognostic (5.98e-3)" "unprognostic (1.57e-2)" "unprognostic (3.10e-2)" "unprognostic (1.79e-1)" "prognostic unfavourable (4.92e-4)" "unprognostic (7.83e-2)" "unprognostic (2.27e-2)" "unprognostic (4.72e-2)" "unprognostic (1.68e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (5.79e-6)" "unprognostic (3.17e-1)" "unprognostic (2.56e-2)" "unprognostic (6.51e-3)" "unprognostic (2.19e-2)" 37.8 38.5 22.5 35.8 25.7 37.3 29.9 30.8 24.1 41.6 26.9 28.6 35.7 27.4 33.2 34.2 38.7 25.7 27.7 27.8 21.6 29.8 41.4 99.0 30.0 41.7 25.1 18.8 36.5 53.6 21.7 40.3 37.1 24.7 26.0 33.3 25.9 55.8 39.9 24.2 21.8 31.5 32.6 31.4 40.1 28.2 18.6 24.6 32.0 36.8 28.2 34.6 34.3 26.0 22.8 60.3 33.8 50.3 24.9 33.9 54.1 19.8 20.2 15.7 29.0 42.6 30.4 24.5 45.8 37.8 31.3 37.8 27.6 16.5 26.8 81.1 46.7 17.9 18.8 26.1 43.4 27.9 15.9 28.5 23.8 57.3 44.3 52.6 32.4 26.8 28.8 35.8 73.9 34.4 31.9 32.3 34.4 23.8 14.3 13.9 13.2 23.0 19.5 19.7 100.1 27.3 28.3 21.2 9.9 27.8 15.4 42.5 25.0 23.3 30.4 33.8 25.8 26.1 39.1 33.4 49.5 21.6 16.4 29.8 61.7 33.8 50.3 33.2 26.9 36.8 33.9 22.8 30.1 30.1 60.3 17.7 28.8 28.8 28.4 24.9 31.1 42.0 31.8 54.1 22.5 25.7 30.8 24.1 21.6 29.8 25.1 18.8 24.7 24.6 SSR4 TRAPD ENSG00000180879 "Signal sequence receptor subunit 4" P51571 X 153793516-153798505 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 699.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045209 Enhanced 600000 "HPA045209: AB_10961407" "unprognostic (3.56e-2)" "unprognostic (1.32e-2)" "unprognostic (4.00e-3)" "prognostic favourable (1.76e-4)" "unprognostic (8.74e-2)" "unprognostic (5.57e-2)" "unprognostic (7.99e-2)" "unprognostic (4.58e-2)" "unprognostic (2.10e-1)" "unprognostic (5.04e-3)" "unprognostic (5.74e-3)" "unprognostic (8.76e-2)" "prognostic unfavourable (5.51e-6)" "unprognostic (8.18e-2)" "unprognostic (2.24e-1)" "unprognostic (6.01e-2)" "unprognostic (5.33e-2)" 17.4 30.0 13.2 29.5 22.6 37.5 46.0 12.2 20.6 30.4 31.7 9.0 152.0 30.7 19.1 81.4 21.4 18.3 30.2 40.7 23.0 17.7 21.8 48.0 42.1 136.9 14.5 11.6 18.4 699.0 7.2 67.7 30.3 26.0 24.0 24.0 11.7 83.7 192.6 12.1 16.9 24.1 19.5 26.3 37.9 43.6 19.6 8.2 15.3 22.6 21.0 29.4 27.7 20.0 67.1 171.0 50.7 58.6 62.0 78.7 108.1 34.3 44.2 15.0 84.2 80.9 43.1 31.4 29.4 43.5 30.6 41.7 54.9 30.4 48.9 77.8 44.5 34.0 26.1 27.3 11.1 19.9 22.3 13.8 41.4 43.0 70.1 37.8 36.7 53.6 38.0 26.3 35.9 32.8 15.1 104.0 23.7 61.4 21.5 56.4 9.1 72.1 24.2 19.5 90.6 38.6 41.0 29.3 24.2 17.4 30.1 31.8 19.5 81.7 27.2 18.0 19.9 34.7 38.1 154.4 75.5 57.3 38.3 64.7 30.1 50.7 58.6 26.1 63.6 44.4 78.7 67.1 65.5 62.9 58.5 56.6 57.0 58.4 9.3 62.0 35.5 171.0 47.9 108.1 13.2 22.6 12.2 20.6 23.0 17.7 14.5 11.6 26.0 8.2 ST14 "HAI, MT-SP1, PRSS14, SNC19, TMPRSS14" ENSG00000149418 "Suppression of tumorigenicity 14" Q9Y5Y6 11 130159562-130210376 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 94.1" "Cell line enhanced" "Detected in some" "CACO-2: 35.7;CAPAN-2: 72.1;HaCaT: 50.5;RPMI-8226: 47.3;SK-BR-3: 33.4;T-47d: 50.5;U-698: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 18.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047014 Approved Nucleoplasm,Vesicles 220000 "Nucleoplasm, Vesicles" "HPA047014: " "unprognostic (1.17e-1)" "unprognostic (1.15e-1)" "unprognostic (9.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.20e-1)" "unprognostic (3.97e-2)" "unprognostic (5.29e-1)" "unprognostic (3.21e-1)" "unprognostic (1.03e-3)" "unprognostic (2.25e-1)" "prognostic favourable (5.03e-11)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.28e-2)" "unprognostic (5.60e-2)" 10.1 1.8 0.7 21.9 1.8 0.5 5.5 0.8 1.4 8.9 48.6 0.5 23.8 33.8 2.8 16.9 38.9 9.7 32.4 1.1 0.5 0.5 30.5 3.2 9.5 7.5 1.8 0.6 3.6 34.3 8.4 9.5 12.7 1.5 12.1 15.4 0.7 25.1 15.8 0.7 17.8 94.1 1.2 1.8 4.0 16.7 2.1 1.5 5.2 24.0 20.1 28.4 8.3 14.9 3.8 18.2 2.3 2.7 0.0 0.1 0.8 26.2 0.0 0.0 0.1 0.0 0.0 14.3 0.0 0.0 0.0 0.0 35.7 72.1 26.0 2.7 0.0 50.5 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.1 0.2 0.1 0.0 0.0 47.3 4.7 21.5 2.9 0.0 0.2 33.4 0.0 50.5 5.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 34.4 0.0 8.0 0.0 0.0 2.7 2.3 0.0 1.5 0.1 3.8 0.0 0.0 4.5 2.3 0.0 0.0 0.3 0.0 0.2 18.2 0.0 0.8 0.7 1.8 0.8 1.4 0.5 0.5 1.8 0.6 1.5 1.5 ST3GAL3 "MRT12, SIAT6" ENSG00000126091 "ST3 beta-galactoside alpha-2,3-sialyltransferase 3" Q11203 1 43705824-43931165 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 71.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051102 Uncertain "Intracellular and membrane" "HPA051102: AB_2681344" "unprognostic (8.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (3.20e-1)" "unprognostic (9.72e-2)" "unprognostic (7.01e-2)" "unprognostic (4.39e-2)" "unprognostic (2.33e-2)" "unprognostic (1.38e-3)" "unprognostic (7.00e-2)" "unprognostic (3.68e-3)" "unprognostic (1.67e-2)" "unprognostic (1.30e-1)" "unprognostic (4.35e-1)" "unprognostic (6.60e-2)" 11.6 9.0 13.0 8.9 16.5 9.9 12.8 15.5 20.4 9.0 10.3 9.0 8.0 3.2 10.8 10.7 8.7 8.3 7.2 16.9 12.8 13.9 6.7 9.1 7.2 7.6 12.0 10.4 13.3 7.5 6.9 10.9 6.7 11.6 8.8 5.1 9.0 8.0 13.9 71.5 7.4 3.8 15.9 7.7 6.0 5.9 14.5 10.3 3.2 8.1 17.8 4.8 8.1 7.0 7.1 7.0 5.8 4.2 4.7 7.6 6.1 2.4 1.9 14.4 6.8 11.3 14.3 1.8 9.4 19.6 8.8 8.5 1.7 4.0 4.6 4.9 12.1 2.4 1.3 6.2 10.6 5.3 3.2 8.7 6.1 4.6 9.5 3.9 4.4 7.6 4.7 6.4 14.1 6.9 5.1 8.5 16.3 1.6 4.0 7.5 5.7 5.0 6.8 1.9 3.1 7.1 1.6 5.8 8.6 3.7 1.4 8.2 2.2 19.0 6.6 5.3 2.5 8.6 9.5 6.8 3.9 4.3 7.8 9.5 9.8 2.9 4.2 2.5 6.8 2.5 6.1 4.5 4.4 5.1 3.0 7.1 7.6 5.7 5.8 4.7 3.7 7.0 5.2 6.1 13.0 16.5 15.5 20.4 12.8 13.9 12.0 10.4 11.6 10.3 ST3GAL4 "CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ" ENSG00000110080 "ST3 beta-galactoside alpha-2,3-sialyltransferase 4" Q11206 11 126355640-126440344 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 74.2" "Cell line enhanced" "Detected in many" "SK-MEL-30: 44.7;WM-115: 101.5" "Cancer enhanced" "Detected in all" "melanoma: 57.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6" "Group enriched" "Detected in many" 11 "dendritic cells: 29.6;granulocytes: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049827 Approved "Intracellular and membrane" "HPA049827: " "unprognostic (8.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (6.93e-2)" "unprognostic (8.33e-2)" "unprognostic (3.80e-2)" "unprognostic (2.71e-3)" "unprognostic (1.90e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (3.16e-3)" "unprognostic (2.79e-2)" "unprognostic (1.28e-1)" "unprognostic (8.36e-3)" "unprognostic (8.78e-3)" 7.8 38.0 6.2 6.5 12.2 7.8 12.9 4.0 13.6 8.3 27.0 26.4 5.1 2.0 6.0 42.1 25.5 6.0 11.4 26.5 8.6 6.2 16.7 11.5 12.4 9.0 18.7 9.0 39.3 5.1 0.8 5.6 74.2 13.8 12.1 31.5 35.7 14.4 8.0 1.9 5.6 3.8 11.0 23.0 17.0 4.8 18.8 12.4 2.2 6.1 4.3 10.1 21.1 13.2 0.1 29.6 31.3 2.6 1.2 1.7 1.8 4.8 4.0 3.2 2.7 9.4 7.8 7.9 5.6 10.9 5.1 3.5 2.3 8.4 1.4 4.3 8.9 7.6 6.6 3.7 4.0 5.2 1.9 12.4 10.1 2.7 6.1 14.8 25.4 6.2 5.9 7.7 12.2 6.8 7.7 3.7 6.3 20.0 4.7 15.2 2.0 26.5 4.8 9.8 0.6 1.1 14.0 6.0 3.8 6.2 37.7 44.7 13.1 9.8 2.5 12.3 2.8 8.7 10.6 0.3 0.8 0.7 5.6 22.8 101.5 31.3 1.6 0.2 1.7 2.6 1.6 0.1 0.6 1.1 6.6 0.0 0.1 0.8 22.8 1.2 1.2 29.6 0.0 1.8 6.2 12.2 4.0 13.6 8.6 6.2 18.7 9.0 13.8 12.4 ST3GAL5 "SIAT9, SIATGM3S, ST3GalV" ENSG00000115525 "ST3 beta-galactoside alpha-2,3-sialyltransferase 5" Q9UNP4 2 85837120-85905199 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 40.1" "Cell line enhanced" "Detected in many" "AN3-CA: 25.6;RT4: 21.7;SK-MEL-30: 17.9;U-266/84: 18.9" "Cancer enhanced" "Detected in all" "thyroid cancer: 41.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034708, HPA040425, HPA068928" Uncertain Approved Vesicles Vesicles "HPA034708: AB_10601594, HPA040425: , HPA068928: " "unprognostic (7.90e-2)" "unprognostic (1.61e-2)" "unprognostic (3.84e-2)" "unprognostic (2.93e-2)" "unprognostic (1.27e-1)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (5.81e-3)" "unprognostic (1.38e-1)" "unprognostic (6.45e-2)" "unprognostic (5.03e-3)" "unprognostic (3.43e-2)" "prognostic unfavourable (2.25e-7)" "unprognostic (2.22e-1)" "unprognostic (5.74e-2)" "prognostic favourable (4.99e-4)" "prognostic favourable (4.48e-4)" 8.0 40.1 15.3 7.2 18.5 4.1 4.2 9.9 34.9 3.3 3.8 18.8 0.0 2.7 8.0 2.9 2.9 4.9 11.8 2.1 14.8 12.0 2.4 7.0 18.0 11.5 14.0 13.4 7.2 2.9 1.5 7.4 24.1 18.1 4.8 5.0 18.7 4.8 2.2 9.5 5.0 3.4 6.2 18.0 11.1 4.1 9.0 13.4 5.5 36.7 0.4 6.9 30.9 7.8 2.5 1.1 1.3 6.1 1.4 1.8 0.5 0.1 12.5 1.1 25.6 10.6 5.7 3.8 2.7 8.4 2.7 2.4 0.2 9.1 0.3 0.0 4.6 0.4 1.6 2.9 3.3 0.1 1.5 0.2 0.5 0.4 8.5 0.1 3.7 3.2 0.4 1.0 0.4 6.4 0.3 14.2 8.6 0.8 0.8 1.4 0.1 0.0 1.6 8.1 5.0 1.4 21.7 1.8 1.8 0.1 0.0 17.9 0.1 0.5 2.1 0.0 1.3 0.0 0.2 14.3 18.9 0.2 2.0 2.6 12.9 0.9 1.8 0.1 1.4 6.1 1.8 2.5 0.8 0.9 1.1 1.5 0.7 0.8 1.3 1.4 5.1 0.4 0.3 0.5 15.3 18.5 9.9 21.9 14.8 12.0 14.0 13.4 18.1 13.4 ST3GAL6 "SIAT10, ST3GALVI" ENSG00000064225 "ST3 beta-galactoside alpha-2,3-sialyltransferase 6" Q9Y274 3 98732236-98821201 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 46.7" "Group enriched" "Detected in many" 4 "RPMI-8226: 35.7;SK-MEL-30: 42.2" "Cancer enhanced" "Detected in many" "melanoma: 17.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 20.7;neutrophil: 25.8" "Group enriched" "Detected in many" 144 "dendritic cells: 10.6;granulocytes: 25.8;monocytes: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018792 Approved 3000000 "HPA018792: AB_10964349" "unprognostic (1.25e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-3)" "unprognostic (4.17e-2)" "unprognostic (5.20e-3)" "unprognostic (3.82e-2)" "unprognostic (1.23e-2)" "unprognostic (2.30e-3)" "unprognostic (2.40e-1)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "unprognostic (4.32e-1)" "unprognostic (3.91e-3)" "unprognostic (6.15e-3)" "unprognostic (9.44e-2)" "unprognostic (9.47e-3)" "unprognostic (6.79e-4)" 11.5 7.5 5.9 3.6 8.3 2.4 6.0 14.4 8.2 4.9 3.6 6.7 1.9 2.2 2.4 11.3 2.4 6.0 2.4 21.8 7.1 5.9 12.2 46.7 7.1 3.5 9.5 4.3 1.7 4.7 1.1 4.6 20.1 10.1 3.5 3.0 6.3 15.9 2.3 6.5 14.4 2.2 2.3 17.4 3.0 4.6 1.8 7.4 14.3 3.1 2.2 2.8 1.6 1.9 0.0 10.6 25.8 7.7 0.0 0.1 1.8 0.1 0.5 0.7 1.0 1.3 0.4 4.9 0.1 0.6 0.5 0.9 3.3 0.2 2.3 1.3 0.0 0.8 1.5 0.7 0.4 0.0 1.0 0.1 0.2 5.8 5.7 4.9 9.3 0.6 0.0 1.4 2.6 5.5 0.0 2.4 0.5 0.0 0.8 8.4 1.3 1.3 0.4 0.5 35.7 1.3 0.0 1.5 7.6 1.9 0.2 42.2 0.1 8.8 4.2 1.1 0.9 0.3 0.4 9.5 0.7 0.0 1.8 7.0 4.0 7.4 7.7 20.7 0.0 4.1 0.0 0.0 0.0 0.0 10.6 0.0 0.1 0.0 25.8 0.0 2.0 2.4 0.0 1.8 5.9 8.3 14.4 8.2 7.1 5.9 9.5 4.3 10.1 7.4 ST6GAL2 "KIAA1877, SIAT2, St6gal2, St6GalII" ENSG00000144057 "ST6 beta-galactoside alpha-2,6-sialyltransferase 2" Q96JF0 2 106801600-106887108 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7;thyroid gland: 34.0" "Cell line enhanced" "Detected in some" "A549: 5.7;NTERA-2: 4.9;PC-3: 6.5;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014459 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA014459: AB_1857528" "unprognostic (2.08e-1)" "unprognostic (5.80e-2)" "unprognostic (1.55e-1)" "unprognostic (4.63e-2)" "unprognostic (6.44e-3)" "unprognostic (1.62e-1)" "unprognostic (2.35e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-4)" "unprognostic (4.56e-3)" "unprognostic (7.04e-2)" "unprognostic (1.84e-2)" "unprognostic (7.01e-4)" "unprognostic (4.70e-4)" "unprognostic (4.06e-2)" "unprognostic (2.83e-1)" "unprognostic (2.07e-2)" 1.2 0.7 14.1 0.7 5.6 1.5 1.3 2.3 16.7 2.1 1.5 4.1 1.7 0.7 3.7 1.9 2.7 1.2 12.7 1.9 5.4 4.0 1.1 3.4 1.2 0.9 3.8 7.1 0.9 0.5 0.5 0.3 2.3 4.2 1.6 3.3 0.0 1.6 1.6 0.7 1.3 0.7 2.8 1.9 0.6 0.9 7.9 1.5 0.0 34.0 1.6 0.8 1.5 1.4 0.7 0.6 1.8 0.5 1.0 0.7 0.5 0.0 5.7 3.2 0.1 0.0 0.0 0.1 0.3 0.0 1.3 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.9 6.5 0.0 0.0 10.2 0.2 0.0 6.8 4.4 0.0 0.1 0.0 0.0 0.1 0.0 8.3 0.1 0.2 0.0 10.9 0.2 0.1 0.0 0.0 0.0 1.4 0.5 0.4 0.6 0.3 0.5 0.4 0.4 0.5 0.2 0.7 0.5 0.7 1.8 1.0 0.3 0.6 0.5 0.5 14.1 5.6 2.3 14.8 5.4 4.0 3.8 7.1 4.2 1.5 ST6GALNAC1 "SIAT7A, ST6GalNAcI" ENSG00000070526 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1" Q9NSC7 17 76624761-76643838 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 69.4" "Cell line enhanced" "Detected in some" "EFO-21: 6.1;HaCaT: 6.8;HEL: 10.9;K-562: 32.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 25 "T-cells: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014767, HPA014975" Enhanced Approved "Nucleoplasm,Golgi apparatus" 1200000 "Golgi apparatus" Nucleoplasm "HPA014767: , HPA014975: AB_1857529" "unprognostic (4.59e-2)" "unprognostic (8.60e-3)" "unprognostic (5.32e-3)" "unprognostic (1.86e-3)" "unprognostic (6.31e-3)" "prognostic favourable (2.54e-5)" "unprognostic (1.39e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.58e-2)" "unprognostic (8.64e-3)" "unprognostic (2.81e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (5.87e-3)" "unprognostic (5.58e-2)" 1.4 0.3 1.2 13.9 2.6 0.7 1.3 0.8 3.2 20.4 50.9 3.1 0.3 19.8 6.3 1.8 19.6 1.5 26.6 4.1 1.6 1.3 0.4 1.1 5.7 1.1 1.8 1.2 2.0 1.1 0.1 0.4 1.7 3.7 2.6 69.4 0.1 20.8 1.4 0.9 0.6 49.0 1.9 1.5 6.0 23.9 4.0 0.6 0.0 0.5 4.5 21.6 1.9 2.6 0.0 0.0 0.4 0.0 0.0 11.2 1.1 0.1 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 6.1 0.0 6.8 0.0 1.8 0.0 0.0 0.0 10.9 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 32.6 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.2 0.2 0.0 0.0 4.2 0.0 0.4 0.0 0.0 0.0 1.4 1.1 1.2 2.6 0.8 3.2 1.6 1.3 1.8 1.2 3.7 0.6 ST6GALNAC3 SIAT7C ENSG00000184005 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3" Q8NDV1 1 76074719-76634601 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 18.2;HUVEC TERT2: 23.1;SK-MEL-30: 31.5;TIME: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054566, HPA055399" Uncertain Enhanced Nucleoplasm Nucleoplasm "HPA054566: , HPA055399: " "unprognostic (7.85e-2)" "unprognostic (1.78e-1)" "unprognostic (2.99e-2)" "unprognostic (2.70e-4)" "unprognostic (2.76e-2)" "unprognostic (2.21e-2)" "unprognostic (6.55e-3)" "unprognostic (7.31e-2)" "unprognostic (2.14e-1)" "unprognostic (4.57e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (9.97e-4)" "unprognostic (3.33e-4)" "unprognostic (5.44e-2)" "unprognostic (1.92e-1)" "unprognostic (3.44e-4)" 20.7 2.9 7.0 3.6 13.0 5.3 13.9 3.8 9.7 4.3 4.0 13.4 2.0 1.8 10.7 2.1 3.8 4.2 4.7 7.8 8.8 6.0 14.9 3.9 7.5 5.1 16.3 3.6 4.7 2.2 12.6 4.3 5.7 12.9 2.5 4.7 2.8 2.3 3.5 3.3 1.9 2.7 8.3 19.0 3.0 3.0 1.2 12.5 0.0 23.2 1.5 1.7 5.5 5.2 5.9 3.0 5.2 8.3 0.4 1.9 2.6 0.1 0.0 18.2 0.0 0.3 0.0 0.0 0.0 2.1 0.3 0.2 5.8 0.0 0.3 1.2 0.1 0.0 0.0 0.2 0.1 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.8 0.8 0.0 0.0 0.0 1.4 4.5 0.0 0.0 31.5 0.0 0.1 10.2 0.1 1.4 0.0 1.6 0.0 0.0 0.0 0.0 4.1 2.7 0.0 8.3 3.7 0.0 2.9 0.0 3.3 0.5 0.8 3.0 5.9 1.9 1.9 5.2 0.4 5.3 0.0 0.0 2.6 7.0 13.0 3.8 9.7 8.8 6.0 16.3 3.6 12.9 12.5 ST6GALNAC4 "SIAT3C, SIAT7D, ST6GALNACIV" ENSG00000136840 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4" Q9H4F1 9 127907886-127917038 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;pancreas: 61.0" "Cell line enhanced" "Detected in many" "HDLM-2: 34.9;RPMI-8226: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "plasmacytoid DC: 58.8" "Lineage enriched" "Detected in many" 9 "dendritic cells: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009042 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA009042: AB_1079963" "unprognostic (2.05e-3)" "unprognostic (2.32e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-2)" "unprognostic (3.18e-1)" "unprognostic (2.32e-1)" "prognostic unfavourable (8.63e-7)" "unprognostic (1.62e-2)" "unprognostic (4.26e-1)" "prognostic unfavourable (5.12e-4)" "unprognostic (1.04e-1)" "unprognostic (3.04e-1)" "prognostic unfavourable (8.39e-4)" "unprognostic (1.30e-3)" "unprognostic (2.72e-1)" "unprognostic (2.64e-2)" "unprognostic (2.03e-2)" 8.0 7.8 5.6 7.9 5.6 26.2 12.1 9.8 8.5 9.2 9.3 4.8 28.9 11.7 8.7 9.6 6.9 8.7 12.2 18.4 5.2 3.4 9.4 5.0 13.5 9.7 4.2 4.7 14.9 61.0 2.4 9.4 4.3 4.8 6.1 5.4 4.8 9.3 30.0 12.6 4.0 9.7 6.1 3.9 18.2 7.2 4.3 4.7 4.7 6.3 5.9 12.5 8.9 8.3 6.7 58.8 0.8 3.2 4.3 3.4 2.4 3.1 5.4 1.4 6.9 9.7 7.4 1.0 5.5 6.1 5.6 3.3 3.0 5.8 20.1 8.4 6.8 7.7 2.8 5.8 0.9 34.9 2.4 6.4 17.2 11.4 11.9 0.5 6.7 9.1 6.2 5.0 4.5 14.9 4.6 13.5 2.7 1.4 1.2 0.7 1.6 13.3 6.0 3.6 49.4 5.7 0.1 11.8 2.6 8.0 17.3 1.0 3.5 4.1 10.6 4.6 5.3 14.3 8.6 21.9 11.3 6.3 9.2 2.8 0.6 0.8 2.1 0.0 2.9 1.9 3.3 6.7 1.8 3.4 2.8 4.9 2.3 3.1 0.2 4.3 3.2 58.8 3.3 2.4 5.6 5.6 9.8 8.5 5.2 3.4 4.2 4.7 4.8 4.7 ST6GALNAC6 "SIAT7F, ST6GALNACVI" ENSG00000160408 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6" Q969X2 9 127885321-127905408 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "NK-cells: 12.7;T-cells: 16.0" HPA018890 Approved "Intracellular and membrane" "HPA018890: AB_1857531" "unprognostic (2.27e-1)" "unprognostic (5.23e-2)" "unprognostic (2.81e-1)" "unprognostic (4.54e-2)" "unprognostic (1.81e-2)" "unprognostic (5.71e-2)" "unprognostic (1.36e-1)" "unprognostic (4.84e-2)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.24e-3)" "unprognostic (3.31e-2)" "unprognostic (3.29e-1)" "unprognostic (1.10e-2)" "unprognostic (9.85e-2)" "unprognostic (3.46e-2)" "unprognostic (2.67e-2)" 39.3 12.9 45.1 9.7 40.8 7.7 59.6 23.4 37.4 17.2 44.5 8.7 18.6 5.5 14.8 27.3 21.0 31.1 17.8 22.8 38.2 17.0 13.2 18.1 23.5 13.7 18.3 28.3 39.4 19.1 12.7 7.8 10.8 13.6 12.8 72.9 9.6 14.5 22.0 18.9 9.8 9.8 21.9 9.6 18.7 12.1 6.9 15.9 2.3 9.6 9.1 11.2 16.7 29.2 3.3 1.1 2.7 2.8 12.7 16.0 6.5 3.5 3.3 6.4 11.6 52.0 28.1 2.5 9.2 21.1 13.5 11.0 5.4 3.0 3.7 4.0 20.9 6.1 8.3 6.8 6.2 17.5 4.6 3.8 5.3 5.6 13.6 1.1 6.3 28.5 8.4 9.8 4.4 13.3 3.6 4.5 17.3 3.0 2.3 6.0 2.8 5.8 7.2 8.0 4.4 10.7 0.7 4.1 6.0 6.3 2.6 2.3 3.0 7.7 8.0 8.0 4.8 8.8 5.0 5.5 3.4 6.8 7.5 1.3 2.7 2.7 0.7 0.1 16.0 1.1 11.7 3.3 10.3 11.5 1.0 2.6 6.5 8.4 0.4 12.7 2.8 1.1 15.3 6.5 45.1 40.8 23.4 37.4 38.2 17.0 18.3 28.3 13.6 15.9 ST7 "ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7" ENSG00000004866 "Suppression of tumorigenicity 7" Q9NRC1 7 116953238-117230103 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 101.1" "HPA038325, HPA038326" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038325: AB_10671740, HPA038326: AB_10672644" "unprognostic (3.40e-2)" "unprognostic (1.04e-1)" "unprognostic (1.33e-1)" "unprognostic (4.70e-2)" "unprognostic (1.09e-1)" "unprognostic (8.18e-2)" "unprognostic (3.32e-2)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (4.45e-3)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "prognostic favourable (3.39e-5)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (8.41e-2)" "unprognostic (3.40e-2)" 11.1 20.0 12.9 5.0 18.0 12.0 12.3 63.0 25.7 16.7 10.7 9.2 21.6 9.8 12.3 31.2 8.5 15.8 10.0 19.8 10.9 12.3 23.1 31.5 20.0 5.4 11.1 18.7 15.9 30.8 17.6 30.1 21.8 14.9 11.7 10.1 11.0 24.9 19.3 10.1 9.7 9.7 11.3 8.1 9.1 13.5 15.9 8.2 2.9 23.8 7.6 7.0 10.0 9.8 2.6 6.2 1.6 3.3 7.6 10.6 3.2 13.0 7.5 12.3 10.7 14.3 9.8 5.7 10.3 13.0 10.6 15.8 10.0 15.5 3.4 11.3 9.0 10.7 10.5 11.0 14.4 4.6 15.1 10.2 12.6 8.9 9.9 11.5 17.5 7.5 11.2 13.7 9.6 11.1 15.0 24.6 10.0 7.5 0.1 8.8 11.8 9.0 2.9 8.3 14.3 11.3 7.0 18.4 15.1 11.7 51.5 13.6 4.4 9.5 8.4 12.4 4.9 13.4 10.1 15.5 11.8 12.8 10.1 10.3 12.4 1.6 3.3 0.4 8.3 1.2 5.9 2.6 5.1 7.3 6.2 0.9 3.5 3.6 0.1 7.6 1.2 6.2 10.6 3.2 12.9 18.0 63.0 25.7 10.9 12.3 11.1 18.7 14.9 8.2 ST7L "FAM4B, FLJ20284, ST7R, STLR" ENSG00000007341 "Suppression of tumorigenicity 7 like" Q8TDW4 1 112523518-112620825 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042324, HPA075418" Uncertain Approved Centrosome Centrosome "HPA042324: AB_10794273, HPA075418: " "unprognostic (2.99e-2)" "unprognostic (1.07e-2)" "prognostic favourable (8.34e-5)" "prognostic unfavourable (8.96e-4)" "unprognostic (3.30e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-6)" "unprognostic (2.24e-3)" "prognostic unfavourable (5.16e-4)" "prognostic favourable (3.04e-5)" "unprognostic (2.98e-2)" "unprognostic (6.91e-2)" "unprognostic (5.72e-2)" "unprognostic (4.12e-3)" "unprognostic (3.68e-2)" "unprognostic (3.26e-2)" "unprognostic (3.27e-2)" 7.7 9.3 5.7 5.5 9.0 8.6 8.2 12.1 7.9 8.1 6.9 10.0 7.2 5.5 10.0 7.8 6.1 7.9 6.0 8.6 5.6 5.9 6.3 7.6 5.7 5.3 6.1 5.1 9.4 11.6 5.2 12.8 6.4 6.3 7.3 8.0 9.4 7.0 9.0 10.2 8.9 6.2 7.9 6.4 5.2 5.8 49.0 7.0 4.6 11.8 4.6 5.6 6.8 7.7 4.2 3.5 0.3 2.1 6.9 5.2 1.9 4.8 1.5 8.6 6.1 11.8 11.7 2.1 6.2 4.7 2.6 3.9 2.7 4.8 2.1 2.5 2.5 3.4 10.1 8.0 4.1 3.1 6.0 5.9 7.5 1.8 6.8 4.9 6.3 2.1 2.0 3.1 6.4 8.6 3.4 6.8 10.9 1.9 2.6 1.9 3.9 5.3 4.2 4.5 0.7 5.4 5.9 6.3 3.9 3.3 4.7 4.4 3.5 3.0 8.3 6.1 6.0 7.9 6.0 1.8 1.3 2.1 5.5 8.0 13.4 0.1 1.8 0.2 2.4 2.1 3.9 4.2 3.6 1.8 1.7 1.8 5.2 2.8 0.3 6.9 1.6 3.5 2.4 1.9 5.7 9.0 12.1 7.9 5.6 5.9 6.1 5.1 6.3 7.0 ST8SIA1 "SIAT8, SIAT8A" ENSG00000111728 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1" Q92185 12 22063773-22437041 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.2" "Cell line enhanced" "Detected in some" "AF22: 9.0;ASC TERT1: 6.0;RPTEC TERT1: 4.6;SK-MEL-30: 8.3;WM-115: 8.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;T-cells: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026775 Approved "HPA026775: AB_1857534" "unprognostic (1.98e-1)" "unprognostic (5.76e-3)" "unprognostic (1.79e-1)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-3)" "unprognostic (1.76e-2)" "unprognostic (1.07e-2)" "unprognostic (3.07e-1)" "unprognostic (1.99e-1)" "unprognostic (6.37e-3)" "unprognostic (2.80e-2)" "unprognostic (1.07e-8)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (5.28e-2)" "unprognostic (3.16e-2)" 1.7 7.6 7.0 5.3 6.2 2.3 5.9 20.2 13.0 3.5 5.4 2.3 2.3 0.4 4.5 1.4 3.0 2.3 2.4 4.4 7.6 8.5 1.1 0.6 3.8 8.6 7.6 6.5 2.6 1.2 7.2 0.6 0.4 9.4 6.6 3.5 1.5 3.2 4.4 1.0 4.3 2.1 6.3 10.9 2.7 2.1 1.0 4.8 0.2 1.4 0.5 9.2 6.7 3.1 0.3 0.2 1.2 0.2 0.3 3.0 0.6 0.0 0.5 9.0 0.0 1.4 6.0 0.9 0.0 0.0 0.1 0.4 0.3 0.1 1.1 0.0 0.0 0.4 0.0 0.2 0.6 0.0 0.0 1.1 0.1 0.1 0.0 0.3 0.1 0.5 0.9 0.1 0.9 0.2 0.0 0.6 0.2 0.0 1.2 0.3 2.3 0.0 0.0 0.2 0.2 4.6 0.0 0.1 0.2 0.0 0.1 8.3 0.7 0.1 0.0 0.7 0.9 0.1 1.4 0.7 0.5 0.7 1.4 0.1 8.9 1.2 0.2 0.2 0.4 0.1 0.9 0.1 2.9 2.3 0.1 0.3 0.4 1.0 0.9 0.3 0.2 0.2 3.0 0.6 7.0 6.2 20.2 13.0 7.6 8.5 7.6 6.5 9.4 4.8 ST8SIA3 SIAT8C ENSG00000177511 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3" O43173 18 57350813-57371731 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 24.0" "Group enriched" "Detected in some" 42 "NTERA-2: 5.9;SCLC-21H: 10.1;SH-SY5Y: 11.4" "Group enriched" "Detected in some" 11 "glioma: 0.9;pancreatic cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063398, HPA066783" Enhanced Supported "Golgi apparatus" "Golgi apparatus" "HPA063398: , HPA066783: " "unprognostic (1.75e-1)" "unprognostic (7.85e-2)" "unprognostic (1.41e-2)" "unprognostic (5.50e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.82e-1)" 0.1 4.5 3.4 0.1 12.0 0.0 0.0 7.9 24.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 1.1 0.0 3.8 4.8 0.1 0.2 0.1 0.0 1.2 0.0 4.2 0.0 3.5 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 10.1 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STAB1 "CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1" ENSG00000010327 "Stabilin 1" Q9NY15 3 52495338-52524495 "Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 90.8" "Group enriched" "Detected in some" 47 "HUVEC TERT2: 33.1;NB-4: 45.7;TIME: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 68 "classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8" "Group enriched" "Detected in many" 69 "dendritic cells: 2.8;monocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005434 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 60000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA005434: AB_1080097" "unprognostic (1.18e-1)" "unprognostic (2.89e-1)" "prognostic unfavourable (7.59e-4)" "unprognostic (3.63e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-2)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.38e-1)" "unprognostic (4.00e-3)" "unprognostic (2.66e-2)" "unprognostic (3.19e-1)" "prognostic unfavourable (3.88e-7)" "unprognostic (3.16e-2)" "unprognostic (9.40e-2)" "unprognostic (4.70e-2)" "unprognostic (1.08e-1)" 39.5 37.6 8.0 26.7 12.8 6.5 41.3 3.2 6.8 13.1 23.4 6.9 4.2 16.1 13.6 26.4 9.7 15.5 16.8 19.7 5.4 4.2 19.2 35.8 21.7 80.7 9.1 2.7 9.9 7.1 4.9 11.9 32.1 10.2 13.5 18.0 23.7 10.4 9.7 8.0 5.1 18.7 18.3 7.2 90.8 11.6 9.7 8.7 2.6 11.9 11.4 11.1 15.9 15.4 0.0 2.8 0.0 10.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 33.1 0.1 0.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 6.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 8.0 12.8 3.2 6.8 5.4 4.2 9.1 2.7 10.2 8.7 STAB2 "DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2" ENSG00000136011 "Stabilin 2" Q8WWQ8 12 103587273-103766727 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 71.3" "Cell line enhanced" "Detected in some" "BEWO: 15.7;HaCaT: 4.3;RH-30: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA026871 Enhanced Supported Cytosol 210000 Cytosol "HPA026871: AB_1857536" "unprognostic (5.66e-3)" "unprognostic (7.51e-2)" "unprognostic (3.31e-1)" "unprognostic (3.84e-2)" "unprognostic (8.47e-2)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (2.81e-1)" "unprognostic (5.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.05e-1)" "unprognostic (9.72e-4)" "unprognostic (1.37e-2)" "unprognostic (5.00e-1)" "unprognostic (1.26e-1)" "unprognostic (2.06e-1)" 0.6 0.2 0.1 0.5 0.1 0.4 0.5 0.1 0.1 0.7 1.4 0.1 0.1 0.1 1.1 1.1 2.5 0.9 0.6 0.4 0.1 0.1 0.1 11.7 0.5 19.9 0.1 0.1 0.4 0.2 0.0 0.2 0.4 0.2 0.5 0.2 0.1 2.1 0.3 0.1 0.2 0.3 0.2 0.1 71.3 0.3 1.5 0.1 0.2 0.7 0.5 0.4 0.3 0.4 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.7 0.2 0.0 0.0 15.7 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 4.3 0.0 0.0 0.0 0.0 1.1 0.4 0.7 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.7 0.5 0.1 2.5 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.1 0.3 0.1 0.6 0.8 0.4 0.0 1.1 0.2 0.2 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 STARD3 "es64, MLN64" ENSG00000131748 "StAR related lipid transfer domain containing 3" Q14849 17 39637065-39663484 "Cancer-related genes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "SK-BR-3: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017021, HPA024307, HPA073948" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB017021: , HPA024307: , HPA073948: " "unprognostic (1.11e-1)" "unprognostic (2.14e-2)" "unprognostic (6.35e-2)" "unprognostic (8.92e-3)" "unprognostic (2.09e-2)" "unprognostic (2.94e-1)" "prognostic unfavourable (3.60e-5)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (6.25e-3)" "unprognostic (5.88e-2)" "prognostic unfavourable (7.70e-4)" "unprognostic (1.33e-1)" "unprognostic (5.22e-2)" "unprognostic (8.51e-3)" "unprognostic (3.00e-2)" 22.2 34.8 23.3 27.5 28.0 33.5 22.8 27.7 30.1 17.1 23.7 38.1 21.7 26.6 20.6 20.7 22.4 25.6 27.7 17.8 21.0 16.8 18.2 24.0 27.0 31.5 28.5 25.7 21.5 32.7 21.9 23.7 26.9 25.7 19.0 9.7 17.9 21.4 26.7 20.8 24.5 34.2 15.8 27.8 32.3 25.3 26.7 26.1 33.0 21.1 15.1 24.8 28.8 18.7 15.3 23.2 35.3 21.2 21.4 25.3 17.4 7.8 12.3 5.5 9.9 6.7 8.2 8.3 6.4 8.3 8.3 7.6 7.3 12.8 6.9 13.9 5.8 14.9 3.4 7.5 1.9 9.4 12.6 4.7 5.4 8.4 9.5 9.5 10.5 8.9 6.2 9.4 4.5 8.0 10.9 9.0 7.6 6.9 8.9 9.0 6.1 6.8 7.1 9.6 10.3 5.7 8.8 7.0 7.6 4.8 87.9 15.8 10.3 11.4 7.6 11.7 8.1 12.8 11.9 8.6 10.6 5.5 10.4 10.3 12.0 12.5 21.2 29.3 25.3 19.6 18.5 11.9 18.3 19.0 23.2 15.3 18.4 16.9 35.3 21.4 15.6 10.8 20.4 17.4 23.3 28.0 27.7 30.1 21.0 16.8 28.5 25.7 25.7 26.1 STIM1 "D11S4896E, GOK" ENSG00000167323 "Stromal interaction molecule 1" Q13586 11 3854527-4093210 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA011088, HPA012123, CAB037128, CAB037288" Enhanced Enhanced "Endoplasmic reticulum" 4900000 "Endoplasmic reticulum" "CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882" "unprognostic (2.06e-1)" "unprognostic (9.75e-2)" "unprognostic (1.34e-1)" "unprognostic (3.85e-3)" "unprognostic (3.13e-2)" "unprognostic (4.12e-1)" "unprognostic (3.43e-1)" "unprognostic (1.59e-1)" "unprognostic (2.25e-1)" "unprognostic (7.41e-2)" "unprognostic (1.86e-1)" "unprognostic (2.88e-2)" "unprognostic (9.35e-2)" "unprognostic (1.40e-1)" "unprognostic (2.73e-1)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" 20.8 9.9 15.5 28.9 19.9 23.1 53.1 14.1 16.8 20.5 21.2 8.5 16.5 9.2 20.6 20.3 35.1 19.8 35.6 14.3 10.3 10.5 13.2 29.0 21.6 34.0 7.7 10.3 21.7 21.2 27.7 9.4 18.1 9.0 18.2 13.7 23.5 46.9 17.0 49.4 22.1 16.0 22.5 8.7 23.2 15.6 20.1 6.0 39.7 34.2 26.6 23.4 19.5 21.7 11.1 8.5 17.1 20.6 17.6 18.2 13.3 14.7 19.2 6.0 10.4 28.5 24.8 8.3 13.3 13.5 9.5 11.7 8.6 4.9 15.7 13.8 18.3 27.0 7.6 7.8 7.9 12.8 11.4 25.2 7.3 12.9 23.3 20.3 14.6 28.2 19.4 13.8 33.9 12.3 15.2 29.9 9.7 3.4 19.1 7.4 2.4 6.8 4.8 8.5 14.7 15.0 8.7 1.2 5.5 18.9 12.1 7.1 4.5 11.5 12.6 17.4 5.8 17.0 9.1 32.3 24.3 8.0 14.5 8.5 9.9 12.4 9.5 17.1 17.3 13.0 13.9 7.3 12.6 18.2 8.5 11.1 14.3 12.8 15.2 17.6 20.6 7.5 12.8 13.3 15.5 19.9 14.1 16.7 10.3 10.5 7.7 10.3 9.0 6.0 STIM2 ENSG00000109689 "Stromal interaction molecule 2" Q9P246 4 26857678-27025381 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 71.5;U-698: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036933, CAB037196, HPA057511" Supported "CAB037196: AB_1841195, HPA036933: , HPA057511: " "unprognostic (7.09e-2)" "unprognostic (8.80e-3)" "unprognostic (1.60e-3)" "unprognostic (2.58e-2)" "unprognostic (2.83e-1)" "unprognostic (5.29e-3)" "prognostic unfavourable (3.97e-5)" "unprognostic (1.53e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "prognostic favourable (5.01e-4)" "unprognostic (6.81e-2)" "unprognostic (1.45e-2)" "unprognostic (2.60e-2)" "unprognostic (7.55e-2)" "unprognostic (3.17e-1)" "unprognostic (2.17e-3)" 13.5 11.0 15.2 23.3 19.9 15.1 16.0 12.0 16.8 12.3 11.9 12.6 10.2 18.0 13.4 20.3 7.6 12.7 22.3 9.6 14.9 8.8 16.9 12.2 17.9 25.1 12.5 13.1 20.7 14.3 10.2 17.3 9.4 18.8 14.7 14.4 25.2 14.8 7.1 8.2 16.0 19.7 9.8 10.2 24.0 14.8 8.7 12.6 19.2 14.6 6.5 23.5 15.9 10.3 7.9 7.3 11.0 7.5 2.7 6.8 1.8 4.4 5.8 5.5 8.8 5.1 3.7 5.7 8.3 3.0 5.7 5.7 4.3 12.3 18.1 4.6 3.4 4.1 4.0 10.8 5.7 4.3 6.9 5.3 8.9 3.8 4.0 9.6 4.6 4.2 4.9 6.7 3.1 5.7 4.6 3.6 10.7 4.8 7.5 9.5 5.9 8.0 71.5 10.4 4.1 4.0 9.6 11.0 3.9 6.6 4.7 2.4 2.5 7.0 6.2 7.7 4.1 5.1 6.6 8.7 8.2 33.3 7.7 9.5 10.9 11.0 2.5 1.7 6.0 2.0 3.8 6.0 6.5 5.0 1.7 7.9 6.8 5.9 4.0 2.7 7.5 7.3 3.3 1.8 15.2 19.9 12.0 16.8 14.9 8.8 12.5 13.1 18.8 12.6 STIMATE "MGC52022, TMEM110" ENSG00000213533 "STIM activating enhancer" Q86TL2 3 52836219-52897596 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA051855 Uncertain Approved Cytosol Cytosol "HPA051855: " "unprognostic (1.45e-1)" "unprognostic (7.93e-3)" "unprognostic (2.19e-1)" "unprognostic (2.49e-2)" "unprognostic (2.29e-3)" "unprognostic (3.87e-2)" "unprognostic (9.31e-2)" "unprognostic (7.55e-4)" "unprognostic (3.34e-1)" "unprognostic (6.55e-2)" "unprognostic (3.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.33e-2)" "unprognostic (1.00e-1)" "unprognostic (1.76e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" 12.0 13.0 8.9 12.0 13.9 26.4 12.8 11.6 16.1 12.5 10.7 17.8 8.8 7.8 14.4 7.9 9.2 17.7 9.6 8.3 9.5 6.7 9.9 34.7 15.2 18.1 9.9 8.1 12.2 19.2 7.7 8.9 7.8 13.0 10.2 6.7 13.0 12.8 11.5 17.9 10.5 10.1 16.5 10.2 14.9 11.2 8.4 9.5 18.0 11.8 6.8 13.2 12.5 12.5 1.7 4.0 1.7 5.8 0.7 4.6 1.4 6.8 5.9 9.1 15.7 20.7 13.1 18.3 10.0 11.2 13.6 12.4 7.3 7.1 6.7 2.0 11.4 6.4 10.7 9.7 9.5 14.7 8.2 10.8 7.5 11.2 13.8 16.2 8.3 10.4 13.5 15.1 6.8 11.0 3.7 6.7 11.3 5.6 8.8 9.1 8.2 12.2 4.8 7.0 4.5 6.4 8.8 2.0 6.8 10.1 6.9 9.4 5.9 14.1 11.1 10.8 6.4 14.1 11.8 12.9 8.3 6.2 9.4 16.4 8.2 0.0 3.3 1.7 2.2 5.8 1.8 1.7 3.5 2.4 4.0 1.5 1.9 1.4 0.3 0.7 5.5 2.3 4.6 1.4 8.9 13.9 11.6 16.1 9.5 6.7 9.9 8.1 13.0 9.5 STK17A DRAK1 ENSG00000164543 "Serine/threonine kinase 17a" Q9UEE5 7 43582758-43626786 "Enzymes, Plasma proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 43.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA018138, HPA037979" Uncertain Approved "Nuclear speckles,Plasma membrane" "Nuclear speckles" "Plasma membrane" "HPA018138: , HPA037979: AB_10795247" "unprognostic (1.81e-3)" "unprognostic (1.08e-2)" "unprognostic (2.67e-1)" "unprognostic (5.41e-2)" "unprognostic (5.11e-2)" "unprognostic (3.35e-2)" "unprognostic (1.03e-2)" "unprognostic (9.15e-3)" "unprognostic (2.07e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (2.99e-3)" "unprognostic (3.76e-2)" "unprognostic (3.08e-1)" "unprognostic (1.97e-3)" "unprognostic (3.66e-1)" 7.1 10.1 6.1 43.3 8.2 20.2 8.4 7.9 7.2 4.8 9.3 3.7 2.0 6.1 5.3 4.2 10.1 4.7 8.6 17.7 5.7 5.6 6.7 8.1 15.2 36.6 6.6 2.6 7.3 14.3 1.5 6.3 37.2 5.7 6.2 5.3 3.6 8.6 3.4 10.7 4.8 12.3 5.8 5.3 27.8 11.0 9.0 2.8 30.1 7.3 6.8 37.7 10.3 8.1 10.8 1.4 11.5 0.9 12.7 11.4 2.9 4.5 5.7 5.2 3.5 6.5 8.6 2.1 16.5 17.8 9.0 9.2 4.9 3.3 7.3 26.0 13.7 9.4 3.9 21.9 12.6 18.0 4.4 6.5 4.3 6.1 4.8 11.2 4.4 7.0 25.8 11.9 10.9 16.8 7.6 25.2 10.3 2.1 18.2 5.2 8.0 18.7 6.3 3.3 14.5 15.7 3.4 2.8 6.3 7.4 3.4 4.8 4.0 5.7 16.8 19.6 7.5 11.6 18.4 15.3 7.6 10.6 19.9 9.9 31.2 0.7 0.4 11.5 5.8 0.2 5.8 10.8 6.1 9.7 0.3 10.1 11.4 10.2 6.4 12.7 0.9 1.4 3.2 2.9 6.1 8.2 7.9 5.9 5.7 5.6 6.6 2.6 5.7 2.8 STK17B DRAK2 ENSG00000081320 "Serine/threonine kinase 17b" O94768 2 196133566-196176503 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2" "Cell line enhanced" "Detected in many" "Daudi: 35.5;HMC-1: 36.0;Karpas-707: 33.4;U-698: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in many" 6 "cerebellum: 71.1" "Low region specificity" "Detected in all" HPA034858 Enhanced Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA034858: AB_10670981" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (3.68e-2)" "unprognostic (3.61e-2)" "unprognostic (3.63e-2)" "unprognostic (7.43e-3)" "unprognostic (1.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.14e-1)" "unprognostic (9.90e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.72e-8)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.64e-2)" "unprognostic (5.80e-2)" 21.0 4.1 3.2 42.8 3.8 103.4 10.1 3.2 3.3 8.2 18.8 1.1 3.8 8.5 3.4 3.9 8.9 6.3 8.6 5.7 3.3 2.2 7.2 2.9 26.2 53.7 2.3 1.8 3.1 5.0 0.7 3.8 6.5 1.7 6.8 5.7 3.5 16.7 6.1 3.4 10.9 31.8 5.3 2.7 59.3 6.0 4.6 1.4 72.2 7.5 7.0 56.2 11.3 6.0 16.9 13.6 62.0 27.0 10.3 28.4 19.0 3.1 2.2 3.3 1.2 14.7 5.6 3.7 7.6 11.4 8.3 8.7 6.6 1.1 35.5 7.0 4.3 2.2 1.4 3.2 10.2 6.2 3.8 3.3 2.8 0.6 4.4 13.4 36.0 7.1 3.2 10.3 5.4 3.4 2.6 33.4 20.6 1.7 17.4 30.4 1.9 5.1 2.9 20.3 10.7 4.9 7.5 1.2 1.3 1.9 1.9 1.6 1.3 7.0 4.1 8.1 4.0 5.8 4.2 13.7 22.2 38.7 6.1 4.6 3.6 35.9 19.7 40.2 12.0 20.7 15.3 13.3 21.5 14.5 13.6 16.9 28.4 23.1 62.0 10.3 27.0 9.7 18.5 19.0 3.2 3.8 3.2 3.3 3.3 2.2 2.3 1.8 1.7 1.4 STK40 "MGC4796, SgK495" ENSG00000196182 "Serine/threonine kinase 40" Q8N2I9 1 36339624-36385896 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.2" "Group enriched" "Detected in all" 5 "granulocytes: 19.2;monocytes: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008026 Uncertain Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA008026: AB_1857603" "unprognostic (3.32e-1)" "unprognostic (3.00e-1)" "unprognostic (6.47e-2)" "unprognostic (4.55e-1)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (2.69e-3)" "unprognostic (6.09e-2)" "unprognostic (2.09e-1)" "unprognostic (5.96e-2)" "prognostic favourable (5.59e-4)" "unprognostic (1.19e-1)" "unprognostic (2.75e-2)" "unprognostic (7.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" 22.9 7.2 9.8 15.3 9.4 9.2 26.5 8.9 11.1 10.2 19.1 7.4 16.7 9.4 11.8 12.2 22.3 11.3 18.2 25.6 10.0 7.1 14.3 23.5 16.6 15.4 13.1 7.4 22.2 34.4 9.2 14.7 19.2 12.1 15.7 9.1 9.0 25.1 17.7 53.9 17.2 10.8 26.0 10.3 17.2 17.0 32.0 8.9 9.2 14.6 20.7 16.6 19.5 26.6 2.4 2.7 19.2 8.5 1.6 2.9 2.4 7.0 3.1 15.6 16.2 11.1 6.4 8.8 7.2 9.8 8.7 9.4 17.1 10.2 30.0 5.9 6.7 7.1 14.2 3.1 6.4 13.0 11.1 19.6 2.9 21.8 11.0 11.4 26.2 5.8 11.8 6.7 3.5 5.4 24.0 10.9 5.4 11.1 11.8 15.1 10.0 4.3 13.6 10.6 19.9 5.4 8.0 19.1 9.7 5.5 8.7 23.9 5.9 13.5 9.0 5.5 11.5 16.1 15.8 11.4 6.4 25.3 28.6 10.0 18.0 1.0 3.0 4.9 2.6 6.7 2.9 2.3 1.7 1.7 2.7 2.4 1.0 1.5 19.2 1.6 8.5 2.6 1.0 2.4 9.8 9.4 8.9 11.1 10.0 7.1 13.1 7.4 12.1 8.9 STOM "BND7, EPB7, EPB72" ENSG00000148175 Stomatin P27105 9 121338988-121370304 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 104.0;hTCEpi: 85.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010961, HPA011419" Approved Enhanced "Vesicles,Plasma membrane,Cytosol" 140000000 "Plasma membrane" "Vesicles, Cytosol" "HPA010961: AB_1080111, HPA011419: AB_1080109" "unprognostic (1.11e-1)" "unprognostic (2.15e-2)" "unprognostic (5.27e-2)" "unprognostic (7.93e-2)" "unprognostic (5.68e-3)" "unprognostic (1.65e-2)" "unprognostic (9.20e-3)" "unprognostic (7.86e-2)" "unprognostic (1.76e-1)" "unprognostic (3.59e-2)" "unprognostic (3.32e-1)" "unprognostic (1.26e-1)" "unprognostic (5.23e-2)" "unprognostic (9.15e-3)" "unprognostic (2.27e-2)" "unprognostic (7.82e-2)" "unprognostic (2.99e-2)" 96.0 27.5 29.3 29.7 41.6 89.2 78.6 15.0 19.4 28.7 46.4 23.2 14.6 14.4 35.7 26.7 34.9 28.2 45.2 46.4 27.2 18.5 35.4 114.4 66.0 40.2 24.2 15.1 31.5 11.8 21.0 11.3 77.0 28.1 36.8 16.7 27.7 23.0 28.3 50.6 25.4 25.0 50.4 37.8 48.3 34.5 17.4 23.3 4.4 29.6 25.1 16.1 56.6 51.8 1.4 8.6 5.2 13.2 33.2 43.4 25.8 1.4 9.7 0.8 4.4 104.0 29.9 0.0 25.9 25.7 7.3 11.5 1.2 1.9 11.8 6.4 32.2 2.5 5.4 24.0 13.0 7.2 2.2 27.4 21.3 3.7 56.4 10.1 5.8 49.5 85.0 11.4 15.2 26.0 5.9 15.8 15.8 7.7 0.3 7.7 11.8 3.0 1.4 0.0 25.6 5.7 0.2 1.0 0.1 21.6 19.2 11.1 6.5 8.4 33.0 16.9 5.3 16.8 2.4 6.7 7.3 0.7 6.5 10.2 9.0 3.4 8.5 0.9 43.4 13.2 42.8 1.4 22.0 38.9 8.6 1.1 4.1 22.0 5.2 33.2 9.0 1.5 2.0 25.8 29.3 41.6 15.0 19.4 27.2 18.5 24.2 15.1 28.1 23.3 STOML1 "FLJ36370, hUNC-24, SLP-1, STORP" ENSG00000067221 "Stomatin like 1" Q9UBI4 15 73978923-73994622 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042353 Approved Approved Cytosol Cytosol "HPA042353: AB_10797387" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (7.76e-2)" "unprognostic (4.54e-3)" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.78e-1)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.30e-3)" "unprognostic (2.26e-3)" "unprognostic (2.14e-1)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.67e-2)" 11.1 10.2 19.2 6.2 18.8 4.2 8.1 7.8 35.3 7.7 6.9 8.3 3.1 5.9 4.6 6.0 7.0 6.2 9.1 14.4 19.0 18.0 4.5 6.1 6.9 8.7 13.4 14.3 9.0 9.9 6.8 8.5 7.9 10.2 7.0 3.7 4.0 7.7 9.7 13.2 7.3 6.5 7.7 12.3 6.3 7.9 6.7 5.9 6.2 10.4 3.6 5.6 6.2 4.4 6.1 11.0 2.2 15.5 6.8 9.4 5.3 3.6 6.9 4.2 5.7 8.5 5.4 3.5 11.8 4.6 6.4 5.4 2.0 20.3 3.6 18.7 9.5 12.2 3.9 8.3 2.0 12.1 4.3 3.7 5.8 2.2 8.4 2.4 3.0 9.6 6.5 10.1 9.6 6.0 9.0 7.0 9.3 5.5 4.6 1.8 2.0 5.5 2.8 4.2 5.5 13.7 4.0 8.0 5.2 5.3 7.1 7.5 5.9 2.8 9.2 14.8 4.8 16.9 15.7 7.2 3.5 1.9 13.6 7.6 7.5 0.7 4.0 2.2 5.3 7.0 4.4 4.3 4.4 7.0 6.2 6.1 8.9 9.4 2.0 6.8 15.5 11.0 7.4 5.3 19.2 18.8 7.8 35.3 19.0 18.0 13.4 14.3 10.2 5.9 STOML3 "Epb7.2l, SRO" ENSG00000133115 "Stomatin like 3" Q8TAV4 13 38965925-38991066 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2" "Cell line enriched" "Detected in single" 39 "AF22: 18.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "olfactory region: 29.0" "Low region specificity" "Detected in all" "HPA012892, HPA071011" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA012892: AB_1857610, HPA071011: " "unprognostic (2.64e-1)" "unprognostic (1.91e-2)" "prognostic favourable (1.49e-4)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "unprognostic (4.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.14e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-2)" "unprognostic (3.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.22e-1)" 0.1 0.1 2.9 0.1 3.8 0.1 0.2 0.0 0.2 1.7 0.2 6.6 0.0 0.2 1.1 8.1 0.1 31.7 0.1 0.1 4.4 4.1 0.1 0.1 9.2 0.1 0.0 0.0 7.6 0.1 0.1 0.0 0.3 9.7 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.6 2.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.8 0.0 0.2 4.4 4.1 0.0 0.0 9.7 2.1 STON2 "STN2, STNB2" ENSG00000140022 "Stonin 2" Q8WXE9 14 81260656-81436465 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 42.8;HMC-1: 24.3;Karpas-707: 22.0;RT4: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;intermediate monocyte: 3.6" "Lineage enriched" "Detected in single" 4 "monocytes: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003086 Enhanced Supported Nucleoli,Cytosol 9800 Cytosol Nucleoli "HPA003086: AB_2302748" "unprognostic (5.28e-2)" "unprognostic (9.83e-3)" "unprognostic (1.34e-1)" "prognostic unfavourable (4.96e-4)" "unprognostic (2.50e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.55e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (3.30e-1)" "unprognostic (9.88e-2)" "unprognostic (9.19e-2)" "unprognostic (5.82e-3)" "unprognostic (1.37e-1)" "unprognostic (6.15e-2)" "unprognostic (1.44e-1)" 6.1 1.2 26.8 1.5 23.5 5.6 11.5 2.0 22.4 4.3 5.3 18.1 1.6 4.7 1.8 6.7 11.3 13.6 7.1 4.0 26.1 11.6 17.5 3.7 5.0 1.3 10.3 11.5 3.7 1.3 0.6 7.9 4.3 9.6 2.6 6.1 7.9 4.6 3.8 9.5 9.2 4.9 2.2 4.5 18.7 6.8 4.0 15.9 0.3 13.1 4.9 3.4 6.8 6.6 0.0 0.5 0.8 3.6 0.0 0.1 3.2 1.7 1.3 4.7 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.1 4.2 1.5 0.0 2.2 0.0 11.8 6.5 14.7 0.0 0.2 2.3 42.8 7.9 1.6 0.0 0.0 24.3 0.6 13.0 0.0 4.4 0.0 15.7 22.0 0.4 2.6 2.1 0.0 4.7 1.1 0.0 6.9 1.3 3.1 17.7 11.5 0.7 5.2 0.2 0.0 0.6 0.1 0.1 0.9 3.6 3.9 1.0 2.5 4.5 0.0 3.2 0.1 1.1 0.0 2.4 0.0 0.1 3.6 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.0 3.2 26.8 23.5 2.0 17.5 26.1 11.6 10.3 11.5 9.6 15.9 STRA6 FLJ12541 ENSG00000137868 "Stimulated by retinoic acid 6" Q9BX79 15 74179466-74212267 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport Receptor "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix, uterine: 22.7;placenta: 88.6;retina: 42.8" "Cell line enhanced" "Detected in some" "A549: 16.2;CAPAN-2: 46.0;SH-SY5Y: 28.6;WM-115: 69.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040839 Approved "HPA040839: AB_10794881" "unprognostic (1.20e-2)" "unprognostic (4.99e-2)" "unprognostic (3.71e-2)" "unprognostic (3.55e-3)" "unprognostic (1.37e-1)" "unprognostic (2.09e-2)" "unprognostic (4.38e-3)" "unprognostic (1.67e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (5.35e-2)" "unprognostic (3.89e-1)" "unprognostic (7.91e-13)" "unprognostic (2.90e-2)" "unprognostic (2.03e-1)" "unprognostic (1.51e-2)" "unprognostic (1.91e-1)" 0.2 1.6 0.2 0.5 0.3 0.0 1.1 0.2 0.5 22.7 0.1 0.3 1.6 0.0 6.9 2.8 1.0 5.0 0.7 0.3 0.4 0.2 7.3 0.0 0.3 1.1 0.1 0.3 0.6 0.2 0.0 5.3 88.6 0.7 5.0 0.0 42.8 0.6 2.6 0.1 0.4 0.2 0.3 1.5 0.3 0.1 2.8 0.1 0.9 0.2 1.4 1.9 1.8 2.3 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.2 16.2 0.9 0.0 0.0 0.0 2.7 0.5 0.1 0.0 0.0 5.6 46.0 0.0 11.1 0.0 1.6 0.9 0.0 0.0 0.0 0.0 1.4 0.6 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.9 0.2 1.4 0.0 0.2 0.0 0.0 0.0 1.5 8.7 28.6 0.0 1.6 0.0 0.1 0.0 0.0 0.1 3.8 0.3 0.7 0.0 0.1 0.0 0.3 0.0 69.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.4 0.4 0.2 0.1 0.3 0.7 0.1 STRN4 "PPP2R6C, ZIN" ENSG00000090372 "Striatin 4" Q9NRL3 19 46719507-46746994 "Predicted intracellular proteins, Predicted membrane proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043051, HPA043527, HPA056706" Supported Approved Cytosol 34000 Cytosol "HPA043051: , HPA043527: AB_10959664, HPA056706: " "unprognostic (3.57e-2)" "unprognostic (7.96e-2)" "unprognostic (2.13e-2)" "unprognostic (7.39e-2)" "unprognostic (1.81e-1)" "unprognostic (1.96e-2)" "prognostic unfavourable (6.06e-8)" "unprognostic (8.31e-3)" "unprognostic (5.34e-2)" "prognostic unfavourable (2.98e-4)" "unprognostic (1.56e-1)" "unprognostic (9.41e-3)" "unprognostic (4.86e-3)" "unprognostic (6.74e-2)" "unprognostic (4.06e-2)" "unprognostic (6.04e-2)" "unprognostic (1.84e-1)" 21.8 13.7 22.6 17.8 26.6 27.0 18.7 10.5 34.9 15.3 18.0 17.9 17.8 19.0 19.9 12.6 23.8 16.9 17.0 20.7 23.1 13.4 15.8 11.4 17.4 16.2 15.1 21.4 16.9 26.6 12.7 12.3 22.2 11.8 17.3 11.3 15.7 25.2 18.4 16.6 22.0 20.6 18.5 12.8 22.9 20.2 48.8 15.7 15.0 14.6 11.6 15.5 18.4 16.6 3.1 3.3 10.1 9.8 1.5 1.2 5.7 21.1 28.2 24.8 18.3 7.1 7.9 17.4 18.3 9.9 19.0 16.7 20.9 18.9 10.6 11.1 15.1 15.0 11.7 17.8 7.6 15.2 23.9 23.3 18.6 17.8 22.8 18.8 25.5 12.8 17.9 12.2 16.9 16.9 20.3 13.9 7.9 14.4 20.9 49.4 18.7 13.3 19.2 15.0 8.2 12.7 38.2 30.7 32.8 25.8 24.1 12.1 18.1 21.3 22.8 14.4 21.5 9.8 27.0 17.6 25.1 15.7 12.5 11.8 29.6 3.1 6.5 2.9 1.2 9.8 0.3 1.7 1.0 0.8 3.3 3.1 0.5 1.1 10.1 1.5 6.0 3.0 0.3 5.7 22.6 26.6 10.5 34.9 23.1 13.4 15.1 21.4 11.8 15.7 STX10 "hsyn10, SYN10" ENSG00000104915 "Syntaxin 10" O60499 19 13144058-13150383 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035303, HPA056439" Approved Approved "Golgi apparatus" "Golgi apparatus" "HPA035303: AB_10671932, HPA056439: " "unprognostic (1.72e-2)" "unprognostic (2.26e-2)" "unprognostic (1.62e-2)" "unprognostic (6.73e-2)" "unprognostic (2.40e-1)" "unprognostic (1.21e-2)" "unprognostic (2.54e-3)" "prognostic favourable (8.26e-4)" "unprognostic (4.09e-1)" "unprognostic (3.66e-2)" "unprognostic (4.57e-2)" "unprognostic (9.21e-2)" "prognostic unfavourable (1.69e-7)" "unprognostic (2.39e-3)" "unprognostic (7.95e-2)" "unprognostic (2.23e-1)" "unprognostic (2.98e-2)" 18.7 23.1 19.3 24.2 21.1 43.7 23.0 30.0 24.7 22.9 28.3 15.8 23.7 32.2 20.1 19.1 33.2 17.9 23.3 26.1 22.0 14.8 22.5 28.8 25.4 26.7 25.1 21.4 22.0 18.8 19.1 19.9 16.7 22.4 20.9 14.5 17.4 31.1 16.6 19.4 32.3 26.7 23.4 18.8 34.4 26.1 7.4 23.0 26.8 25.0 20.8 23.4 22.2 30.3 9.7 28.3 63.4 39.0 6.7 12.0 16.7 28.2 21.5 15.4 40.3 16.3 17.2 5.2 15.8 15.9 14.4 15.6 9.8 25.4 19.4 23.9 19.6 21.8 13.3 20.3 8.3 32.5 24.1 17.4 43.9 20.0 12.6 20.0 18.7 17.1 17.3 17.4 11.4 18.3 9.1 10.0 9.9 27.2 29.3 37.3 16.1 36.0 33.1 16.0 27.7 13.6 13.3 17.8 36.8 16.7 19.3 36.2 13.0 19.4 17.0 22.4 11.6 43.0 22.0 23.2 20.5 15.8 29.0 50.3 17.5 8.6 39.0 26.6 11.9 29.1 10.1 8.9 10.6 12.0 28.3 9.7 9.8 9.5 63.4 6.7 32.5 7.7 11.7 16.7 19.3 21.1 30.0 24.7 22.0 14.8 25.1 21.4 22.4 23.0 STX12 "STX13, STX14" ENSG00000117758 "Syntaxin 12" Q86Y82 1 27773183-27824452 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041038, HPA055300" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA041038: AB_10794261, HPA055300: " "unprognostic (3.47e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-1)" "unprognostic (8.16e-3)" "unprognostic (2.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.26e-2)" "unprognostic (3.52e-1)" "unprognostic (1.14e-2)" "unprognostic (2.78e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-1)" "unprognostic (1.91e-2)" "unprognostic (8.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "unprognostic (2.24e-1)" 38.5 20.2 32.2 16.3 29.6 6.3 22.9 25.8 35.9 20.3 19.4 27.3 23.5 22.9 20.4 42.1 25.7 15.0 25.9 15.3 31.2 31.9 23.2 18.5 31.2 16.3 35.5 29.0 15.2 19.5 16.7 19.6 21.1 32.3 20.8 21.4 11.6 17.7 22.2 14.2 17.1 20.9 23.1 36.9 20.0 38.7 9.0 19.9 6.3 67.0 11.0 13.9 19.4 14.8 7.6 14.2 10.1 21.7 5.2 6.4 8.3 8.6 4.2 11.3 7.3 21.5 26.2 5.8 18.3 27.1 16.9 19.2 5.1 11.3 9.5 19.8 24.5 7.3 7.4 9.1 17.0 8.3 8.8 5.4 4.6 5.1 16.9 5.9 11.3 24.5 11.2 23.7 13.6 27.1 7.0 9.5 18.4 3.1 5.1 4.5 4.7 5.9 3.2 9.0 5.7 14.9 14.3 12.7 6.9 8.6 7.4 13.2 5.1 5.3 29.1 8.6 4.9 19.5 6.3 5.7 4.1 5.4 14.0 9.1 12.0 10.1 19.6 7.5 3.7 21.7 6.4 7.6 4.4 5.7 14.2 6.5 4.9 4.1 9.3 5.2 21.0 7.0 4.4 8.3 32.2 29.6 25.8 31.8 31.2 31.9 35.5 29.0 32.3 19.9 STX16 "hsyn16, SYN16" ENSG00000124222 "Syntaxin 16" O14662 20 58651253-58679526 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA041019, HPA042033" Uncertain Enhanced Vesicles Vesicles "HPA041019: AB_10964273, HPA042033: AB_10963935" "unprognostic (7.52e-2)" "unprognostic (1.91e-1)" "unprognostic (7.96e-2)" "unprognostic (1.35e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "prognostic unfavourable (4.18e-4)" "unprognostic (7.32e-2)" "unprognostic (5.11e-2)" "unprognostic (3.51e-2)" "unprognostic (2.80e-3)" "unprognostic (2.41e-2)" "prognostic unfavourable (1.11e-16)" "unprognostic (3.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.56e-1)" "unprognostic (5.89e-2)" 22.1 24.5 41.9 25.3 46.7 36.7 22.3 54.5 43.2 21.9 23.3 35.0 35.9 20.3 30.3 36.9 18.8 26.7 23.4 17.3 36.8 22.4 18.6 20.0 20.5 32.8 43.0 32.8 29.2 23.1 18.5 33.0 20.5 34.0 24.6 21.1 20.9 27.9 28.5 25.9 41.5 23.6 29.4 33.0 31.0 21.7 22.2 42.9 16.6 23.7 15.7 24.7 24.2 24.3 4.7 4.3 14.1 6.2 5.6 6.1 4.0 14.4 8.5 11.2 10.9 20.7 22.1 15.6 18.0 12.2 18.5 11.5 16.5 21.2 16.7 25.2 12.8 21.5 10.2 21.4 15.4 7.8 10.8 10.4 22.3 19.9 20.6 14.8 23.6 24.5 32.9 12.4 18.9 18.6 12.0 14.9 14.9 33.8 11.4 17.9 4.5 14.5 10.6 10.5 11.4 14.1 10.8 7.4 11.3 19.0 33.6 32.3 13.4 19.7 19.7 30.6 14.8 11.6 19.7 30.9 14.3 9.3 22.5 11.5 12.7 14.1 6.2 5.2 5.0 5.6 5.6 2.6 4.5 3.5 4.1 4.7 6.1 5.5 14.0 5.6 4.1 4.3 4.8 4.0 41.9 46.7 54.5 43.2 36.8 22.4 43.0 32.8 34.0 42.9 STX18 Ufe1 ENSG00000168818 "Syntaxin 18" Q9P2W9 4 4415742-4542346 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 98.6" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "endometrial cancer: 43.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003019 Approved Approved "Plasma membrane" "Plasma membrane" "HPA003019: AB_1857622" "unprognostic (2.33e-1)" "unprognostic (1.65e-1)" "prognostic favourable (2.84e-4)" "prognostic favourable (6.33e-8)" "unprognostic (4.21e-1)" "unprognostic (6.77e-2)" "unprognostic (6.17e-3)" "unprognostic (2.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-2)" "prognostic favourable (7.03e-4)" "unprognostic (1.92e-2)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" "prognostic favourable (4.69e-4)" 14.0 17.6 12.4 16.0 18.4 9.2 11.0 11.2 15.9 98.6 19.7 19.5 12.2 15.0 46.5 11.9 11.5 38.9 16.1 11.0 11.3 14.2 24.2 14.0 9.8 10.4 14.5 12.3 12.4 18.5 12.2 24.1 17.5 17.3 12.3 11.9 12.7 12.2 14.7 19.0 11.0 19.6 13.5 14.8 14.2 15.0 28.5 10.3 18.1 10.1 9.8 15.0 11.8 12.3 11.2 25.5 7.1 13.0 10.8 13.4 9.3 14.0 9.2 10.9 11.1 9.4 13.8 14.6 16.2 14.9 15.6 13.0 19.3 20.6 18.8 39.2 15.0 7.6 19.3 9.5 15.4 7.8 9.6 11.8 12.1 23.3 14.1 20.4 10.0 12.9 8.3 13.2 9.6 13.1 11.3 16.7 11.1 7.5 18.5 14.5 14.5 19.1 16.7 8.2 14.9 16.0 8.6 13.9 12.3 12.2 8.2 14.2 12.0 10.0 14.8 9.4 10.3 8.6 17.4 12.0 18.2 21.7 11.5 15.8 11.7 4.8 10.6 7.1 10.9 10.4 13.4 11.2 10.1 9.9 16.0 9.3 8.5 9.8 2.1 10.8 13.0 25.5 9.1 9.3 12.4 18.4 11.2 15.9 11.3 14.2 14.5 12.3 17.3 10.3 STX1A "HPC-1, p35-1, STX1" ENSG00000106089 "Syntaxin 1A" Q16623 7 73699206-73719672 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Neurotransmitter transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 73.7;pituitary gland: 26.9" "Cell line enhanced" "Detected in many" "SCLC-21H: 49.9;U-87 MG: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.5;T-reg: 2.4" "Lineage enriched" "Detected in single" 6 "T-cells: 2.5" "Group enriched" "Detected in many" 5 "amygdala: 253.0;basal ganglia: 94.3;cerebral cortex: 362.2;hippocampal formation: 251.5" "Group enriched" "Detected in all" 8 "amygdala: 69.4;cerebral cortex: 158.6;hippocampal formation: 149.3" "CAB008372, HPA069176" Enhanced "Intracellular and membrane" "CAB008372: AB_592786, HPA069176: " "unprognostic (5.12e-3)" "prognostic unfavourable (3.63e-4)" "unprognostic (3.94e-2)" "prognostic unfavourable (1.94e-5)" "unprognostic (3.12e-3)" "unprognostic (1.88e-1)" "unprognostic (3.02e-8)" "unprognostic (1.11e-2)" "unprognostic (6.97e-2)" "unprognostic (3.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.70e-3)" "unprognostic (4.18e-6)" "unprognostic (2.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-3)" "unprognostic (6.20e-2)" 1.4 5.6 27.4 2.4 20.9 7.6 1.4 33.7 73.7 1.7 2.6 1.3 0.8 3.7 2.8 1.8 1.7 2.3 5.5 1.2 22.0 8.3 1.1 1.2 1.8 1.4 4.0 28.0 2.2 5.7 1.5 26.9 2.2 2.6 1.9 2.1 0.1 1.9 1.8 1.1 1.9 3.5 2.6 1.3 1.3 6.2 2.0 0.7 0.0 1.6 0.0 1.1 2.8 1.1 0.4 0.0 0.1 0.2 0.0 2.5 2.7 1.5 7.3 1.2 3.5 1.6 4.2 0.8 5.0 3.3 2.1 1.4 2.5 4.3 1.9 0.7 3.5 1.3 1.7 3.1 1.6 3.4 1.3 0.6 2.6 1.4 1.8 0.8 1.8 2.5 1.4 14.6 5.1 3.6 1.6 2.3 3.9 3.7 0.6 7.1 0.9 16.7 0.0 0.8 1.9 1.7 1.3 49.9 7.9 1.5 4.2 1.0 1.4 0.6 13.6 10.3 3.4 7.9 13.3 1.3 0.8 0.9 33.2 0.7 12.1 0.0 0.2 0.0 2.5 0.0 0.9 0.4 0.4 0.6 0.0 0.1 0.8 0.3 0.1 0.0 0.0 0.0 2.4 2.7 27.4 20.9 33.7 49.9 22.0 8.3 4.0 28.0 2.6 0.7 STX1B "STX1B1, STX1B2" ENSG00000099365 "Syntaxin 1B" P61266 16 30989256-31010661 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 64.9" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 9.7;hTEC/SVTERT24-B: 11.8" "Cancer enriched" "Detected in some" 7 "glioma: 5.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079008" Supported Approved "CAB079008: , HPA069176: " "unprognostic (1.43e-3)" "unprognostic (5.27e-2)" "unprognostic (2.40e-4)" "unprognostic (3.90e-3)" "unprognostic (3.98e-2)" "unprognostic (1.90e-2)" "unprognostic (2.21e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-1)" "unprognostic (3.72e-3)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (7.93e-2)" "unprognostic (1.57e-2)" 1.6 1.9 12.7 1.9 31.8 1.3 1.8 45.8 64.9 1.2 1.4 2.9 0.0 1.4 2.7 4.2 1.9 1.4 1.3 2.1 10.5 10.0 1.4 2.5 1.2 2.4 6.8 26.2 1.3 1.3 1.3 2.2 1.2 39.3 1.8 1.4 1.0 1.9 2.8 1.3 4.0 1.8 2.5 3.8 2.2 1.3 3.2 4.5 0.0 1.3 0.0 2.3 1.3 0.7 0.6 0.3 1.3 0.4 0.5 1.7 0.1 0.1 3.2 5.0 0.8 0.5 0.2 0.2 4.4 6.7 5.5 9.7 0.0 3.6 0.8 0.2 5.8 0.8 2.2 0.6 6.6 2.6 0.4 0.4 2.6 2.5 0.4 0.2 3.1 1.8 0.2 11.8 1.1 0.0 0.5 0.2 5.8 1.3 2.0 0.2 2.5 0.3 7.2 0.2 0.2 0.5 0.0 6.8 4.3 0.5 0.2 0.0 0.8 0.1 0.9 3.2 2.6 0.4 0.2 0.3 0.2 0.3 3.5 0.3 0.1 0.9 0.4 0.7 0.3 0.2 0.1 0.5 1.7 0.3 0.1 0.6 0.3 0.4 1.3 0.5 0.1 0.3 0.2 0.1 12.7 31.8 45.8 60.5 10.5 10.0 6.8 26.2 39.3 4.5 STX2 "EPIM, EPM, STX2A, STX2B, STX2C" ENSG00000111450 "Syntaxin 2" P32856 12 130789600-130839266 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038189, HPA069176, CAB079007" Uncertain Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB079007: , HPA038189: , HPA069176: " "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (3.38e-2)" "unprognostic (9.85e-2)" "unprognostic (2.11e-2)" "unprognostic (4.16e-2)" "unprognostic (2.83e-1)" "unprognostic (7.62e-2)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavourable (5.15e-5)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.63e-2)" "unprognostic (3.41e-3)" 15.9 14.5 16.0 15.4 13.4 8.8 27.0 12.5 18.7 13.1 18.8 15.3 8.8 6.1 18.1 15.4 9.6 19.4 14.5 16.4 15.5 11.4 12.2 12.0 18.3 11.9 12.7 12.4 16.0 10.7 11.9 16.3 18.0 17.9 10.2 10.2 9.8 5.2 15.7 6.3 6.1 10.7 23.5 24.8 12.3 11.7 23.2 12.3 9.7 12.6 6.9 9.4 13.5 22.2 2.6 1.6 4.6 2.4 1.4 3.1 0.9 4.7 9.5 13.8 10.7 12.8 29.1 1.4 20.1 16.2 24.9 16.5 2.6 3.3 6.1 3.2 22.0 1.3 12.6 3.3 25.9 9.2 4.3 3.2 8.3 7.4 13.8 4.7 8.0 10.8 4.1 12.1 9.7 12.2 12.7 5.7 21.2 2.8 6.6 4.8 9.2 13.1 7.0 9.0 3.2 13.7 1.0 13.2 12.9 10.2 0.9 8.5 3.2 3.0 16.4 14.3 10.1 15.7 8.8 4.2 3.3 4.0 16.5 5.2 11.2 4.6 2.2 2.8 2.4 2.4 2.4 2.6 2.7 2.7 1.5 1.7 2.9 3.1 3.0 1.4 1.2 1.6 1.9 0.9 16.0 13.4 12.5 18.7 15.5 11.4 12.7 12.4 17.9 12.3 STX3 STX3A ENSG00000166900 "Syntaxin 3" Q13277 11 59713456-59805882 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 14.3;eosinophil: 28.1;neutrophil: 25.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 28.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002191, HPA069176" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA002191: AB_1080165, HPA069176: " "unprognostic (2.24e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-3)" "unprognostic (1.02e-1)" "unprognostic (2.84e-2)" "unprognostic (2.36e-3)" "prognostic unfavourable (8.41e-7)" "unprognostic (1.64e-1)" "unprognostic (3.00e-1)" "unprognostic (7.71e-3)" "unprognostic (2.07e-2)" "unprognostic (5.55e-2)" "prognostic favourable (1.14e-6)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" "unprognostic (4.02e-2)" "unprognostic (1.17e-2)" 10.8 16.3 5.3 14.1 8.3 23.4 22.6 11.5 10.7 10.7 19.9 4.9 27.8 23.8 14.2 16.4 12.8 6.8 21.1 9.4 6.2 6.0 25.0 6.4 26.5 15.1 8.7 10.2 12.0 14.8 16.7 21.2 33.6 6.8 12.6 22.9 54.7 16.0 19.8 7.3 11.4 19.7 11.4 7.2 14.5 19.5 11.4 6.2 2.1 12.8 9.3 6.4 11.4 12.2 0.9 2.7 28.1 2.5 0.2 1.4 0.9 12.0 7.1 0.2 3.4 6.2 3.6 9.8 6.5 11.1 15.0 18.6 32.3 11.4 3.4 12.5 4.7 13.6 18.8 6.7 18.4 3.0 4.0 3.7 5.0 10.0 16.6 12.5 36.5 6.6 14.5 11.6 14.1 11.9 32.4 7.1 6.5 7.0 0.1 9.2 18.4 5.9 4.3 12.5 5.6 28.2 28.7 8.2 12.7 2.8 14.3 49.2 15.7 8.6 16.7 6.5 14.2 8.9 5.6 8.4 14.6 6.9 9.0 8.2 8.6 14.3 2.5 28.1 1.0 0.7 1.1 0.3 1.4 0.6 2.7 0.9 1.3 0.4 25.7 0.2 0.4 0.4 0.0 0.9 5.3 8.3 11.5 10.7 6.2 6.0 8.7 10.2 6.8 6.2 STX4 "p35-2, STX4A" ENSG00000103496 "Syntaxin 4" Q12846 16 31032889-31042975 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001330 Approved Enhanced "Plasma membrane" "Plasma membrane" "HPA001330: AB_1080167" "unprognostic (2.31e-3)" "prognostic favourable (3.65e-4)" "unprognostic (3.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.75e-3)" "unprognostic (5.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.01e-2)" "unprognostic (3.12e-1)" "unprognostic (1.16e-2)" "prognostic unfavourable (2.88e-9)" "unprognostic (6.90e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.26e-2)" 26.5 28.2 28.6 23.8 29.6 14.1 23.5 24.2 28.0 21.4 24.0 24.4 16.9 28.3 24.1 19.8 26.4 19.6 23.7 24.6 26.7 18.0 21.7 25.2 25.8 22.5 38.1 22.3 22.7 19.3 33.6 14.9 27.0 32.4 19.8 22.0 14.0 21.3 21.8 30.3 32.7 26.7 27.7 26.1 31.4 22.7 10.7 31.5 19.2 21.3 17.3 26.7 25.4 29.4 11.9 14.8 20.6 18.2 18.2 14.9 8.6 18.2 26.2 5.9 13.2 20.0 20.4 12.7 16.9 29.9 18.1 18.7 8.0 19.9 12.4 22.0 29.9 13.3 5.5 19.7 17.4 22.2 16.8 8.9 18.3 21.8 22.7 10.3 30.1 19.4 13.8 31.3 23.4 24.0 10.4 14.5 32.1 28.7 9.7 15.9 12.3 14.1 8.3 17.8 16.1 18.0 13.6 4.9 9.3 14.9 15.4 6.2 12.3 13.7 25.7 18.4 8.2 20.6 9.4 15.6 12.6 5.4 27.7 16.7 11.1 14.6 17.7 20.6 14.9 18.2 12.9 9.7 12.5 14.5 14.8 11.9 9.5 12.2 18.5 18.2 15.8 8.6 6.8 8.6 28.6 29.6 24.2 28.0 26.7 18.0 38.1 22.3 32.4 31.5 STX5 "SED5, STX5A" ENSG00000162236 "Syntaxin 5" Q13190 11 62806897-62832088 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001358 Uncertain Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA001358: AB_1080119" "unprognostic (3.51e-2)" "unprognostic (4.23e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-3)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-2)" "unprognostic (3.30e-1)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (1.67e-2)" "unprognostic (3.42e-2)" "unprognostic (2.79e-1)" "unprognostic (2.86e-2)" "unprognostic (8.22e-3)" 21.3 20.0 17.5 16.2 17.0 28.3 22.6 33.0 24.2 26.9 19.6 17.6 40.9 17.2 21.6 36.4 22.3 23.7 20.1 17.7 17.6 15.7 22.3 42.6 21.0 17.7 18.6 16.7 29.3 33.7 22.8 20.2 37.4 17.4 27.9 18.2 20.6 47.3 32.2 17.1 26.4 23.0 19.2 16.0 24.0 22.1 16.1 19.7 29.1 33.7 16.4 29.0 22.5 22.3 9.4 10.0 24.9 10.4 9.5 9.7 4.7 17.3 11.1 14.9 13.2 20.5 22.7 13.8 17.1 24.1 28.9 23.4 8.3 17.2 11.1 16.0 24.3 18.2 12.9 16.2 21.4 25.8 12.3 9.6 14.9 16.9 24.8 11.4 14.8 18.7 18.5 25.7 31.2 14.0 8.7 30.9 15.3 20.9 15.4 18.5 5.0 16.4 15.9 14.4 29.5 13.0 9.2 11.2 9.5 13.8 21.9 26.1 24.2 15.4 15.0 21.1 11.1 24.2 10.9 28.3 15.9 11.7 16.9 8.0 12.8 8.2 8.8 24.9 8.5 10.4 7.4 8.7 6.7 8.2 8.1 9.4 6.4 6.2 14.0 9.5 9.1 10.0 9.7 4.7 17.5 17.0 33.0 24.2 17.6 15.7 18.6 16.7 17.4 19.7 STX6 ENSG00000135823 "Syntaxin 6" O43752 1 180972712-181023121 "Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038557, HPA038558" Approved Enhanced "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038557: AB_2676082, HPA038558: AB_10672716" "unprognostic (1.11e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.09e-3)" "unprognostic (2.23e-1)" "unprognostic (1.05e-2)" "prognostic unfavourable (6.24e-5)" "unprognostic (2.12e-1)" "unprognostic (6.12e-2)" "unprognostic (4.48e-3)" "unprognostic (4.18e-2)" "unprognostic (1.62e-1)" "prognostic unfavourable (1.93e-8)" "unprognostic (2.59e-1)" "unprognostic (1.59e-1)" "unprognostic (2.46e-1)" "unprognostic (1.00e-1)" 12.2 10.4 17.6 14.1 18.9 2.9 12.4 21.7 25.5 13.4 10.4 15.5 7.2 9.8 11.3 10.7 22.2 10.3 9.6 8.1 18.6 13.2 11.6 6.5 15.3 12.7 18.5 13.1 11.5 5.5 9.2 6.8 15.0 16.1 10.1 11.1 6.4 10.7 9.6 5.7 16.5 9.9 11.8 15.0 11.6 10.5 7.3 20.0 14.1 15.3 7.3 17.8 16.3 15.6 1.7 5.1 5.9 3.6 0.4 3.2 1.4 9.8 11.1 11.0 14.6 11.6 13.7 18.6 12.7 16.4 10.0 8.6 10.3 9.9 10.0 17.6 13.9 17.7 9.9 22.4 11.8 7.2 7.3 6.7 8.4 10.0 11.5 9.5 8.7 12.4 20.6 16.9 17.5 20.2 12.3 7.1 13.3 14.2 9.1 9.0 17.1 5.6 8.0 13.4 14.4 11.9 24.8 15.6 16.6 13.3 25.7 13.9 15.6 8.7 16.6 13.9 7.3 12.9 10.2 12.1 6.7 7.3 6.8 9.4 8.1 5.9 3.6 4.5 1.8 2.9 1.9 1.7 2.6 2.7 5.1 1.7 3.2 2.4 3.4 0.4 2.5 1.7 3.2 1.4 17.6 18.9 21.7 19.1 18.6 13.2 18.5 13.1 16.1 20.0 STX7 ENSG00000079950 "Syntaxin 7" O15400 6 132445867-132513198 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 13.0;classical monocyte: 16.5;eosinophil: 15.0;intermediate monocyte: 18.0;memory B-cell: 26.9;myeloid DC: 19.5;naive B-cell: 35.1;neutrophil: 26.4;non-classical monocyte: 18.2;plasmacytoid DC: 23.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001467, CAB062564" Enhanced Supported Lysosomes 850000 Lysosomes "CAB062564: , HPA001467: AB_1857623" "unprognostic (1.91e-3)" "unprognostic (1.06e-3)" "unprognostic (2.67e-2)" "unprognostic (7.95e-3)" "unprognostic (1.21e-1)" "unprognostic (2.04e-1)" "prognostic unfavourable (1.60e-4)" "unprognostic (4.52e-2)" "unprognostic (4.46e-1)" "unprognostic (4.19e-2)" "unprognostic (2.84e-1)" "unprognostic (2.79e-1)" "unprognostic (1.65e-3)" "unprognostic (2.16e-1)" "unprognostic (2.06e-1)" "unprognostic (1.67e-1)" "unprognostic (8.42e-2)" 28.9 14.3 27.8 26.4 24.3 13.0 21.1 27.2 29.4 17.3 21.8 25.0 11.8 25.1 22.2 14.1 23.8 16.0 23.2 23.8 24.9 23.6 35.0 12.6 22.6 47.8 28.3 22.2 22.7 13.0 12.5 13.4 31.9 31.2 18.6 20.5 16.3 20.2 19.3 16.3 17.8 26.7 20.6 42.1 29.0 19.2 8.2 27.7 9.0 21.9 15.2 46.5 21.2 19.9 35.1 23.5 26.4 18.2 2.9 3.9 8.5 7.1 7.2 12.3 8.7 24.7 22.1 9.6 14.2 14.7 14.8 21.4 12.6 12.0 35.7 14.0 17.2 9.4 10.8 13.1 20.0 12.3 12.8 13.6 6.4 13.3 19.8 9.1 10.3 12.6 12.4 15.1 13.8 16.1 14.5 12.9 16.8 10.0 4.2 7.5 4.7 8.5 10.0 9.5 10.2 24.7 8.4 10.1 3.1 6.4 10.6 38.2 7.2 8.8 27.7 8.6 8.8 18.7 15.0 12.4 7.2 15.4 12.1 7.4 9.6 13.0 16.5 15.0 3.7 18.0 1.5 26.9 2.7 2.5 19.5 35.1 2.0 2.4 26.4 2.9 18.2 23.5 3.9 8.5 27.8 24.3 27.2 29.4 24.9 23.6 28.3 22.2 31.2 27.7 STX8 CARB ENSG00000170310 "Syntaxin 8" Q9UNK0 17 9250471-9576591 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001540 Approved Approved "Nuclear bodies,Golgi apparatus,Cytosol" "Golgi apparatus" "Nuclear bodies, Cytosol" "HPA001540: AB_1080168" "unprognostic (8.68e-2)" "unprognostic (2.29e-2)" "unprognostic (2.53e-1)" "unprognostic (4.14e-3)" "unprognostic (3.36e-1)" "unprognostic (1.58e-2)" "unprognostic (6.91e-2)" "unprognostic (1.19e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (1.86e-3)" "unprognostic (2.54e-1)" "unprognostic (1.45e-2)" "unprognostic (2.89e-2)" "unprognostic (1.89e-1)" "unprognostic (1.77e-2)" "unprognostic (1.51e-1)" 28.6 24.7 26.0 16.5 25.9 23.7 28.1 20.2 33.6 28.3 28.9 23.7 21.9 15.8 36.9 42.5 26.3 19.9 18.1 28.4 20.8 21.1 29.6 29.9 18.7 19.4 23.9 22.4 24.4 30.0 14.9 21.0 20.0 29.0 24.5 23.7 25.8 40.6 26.0 38.4 20.9 20.3 28.4 25.3 19.7 23.2 43.9 20.2 30.0 29.2 17.8 21.4 23.3 23.0 35.4 45.2 48.5 46.2 49.0 59.3 55.7 11.2 19.5 22.4 9.6 27.5 31.9 7.9 16.7 17.9 15.2 19.0 6.8 8.9 13.4 12.8 28.2 14.7 11.4 23.7 23.1 22.9 16.4 8.3 4.9 14.4 36.6 6.6 17.9 29.0 35.1 15.2 22.7 18.9 3.7 6.9 16.6 6.1 13.2 11.5 5.0 10.9 21.2 16.4 8.3 21.1 10.2 2.0 11.5 9.5 6.0 15.5 6.6 8.8 23.7 14.8 9.0 8.0 18.1 6.5 6.3 5.8 21.5 14.7 13.7 31.7 46.2 48.5 42.2 38.4 38.4 35.4 45.6 46.5 45.2 32.2 29.2 34.3 14.0 49.0 39.2 38.0 59.3 55.7 26.0 25.9 20.2 33.6 20.8 21.1 23.9 22.4 29.0 20.2 STXBP1 "hUNC18, MUNC18-1, rbSec1, UNC18" ENSG00000136854 "Syntaxin binding protein 1" P61764 9 127579370-127696027 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 127.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 47.1;SK-MEL-30: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.4" "Lineage enriched" "Detected in single" 7 "T-cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008209, HPA023483, CAB034434" Enhanced Approved Nucleoplasm,Cytosol 6400 "Nucleoplasm, Cytosol" "CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625" "unprognostic (2.32e-2)" "unprognostic (7.33e-2)" "unprognostic (3.85e-2)" "prognostic unfavourable (4.78e-4)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.47e-4)" "prognostic unfavourable (5.73e-4)" "unprognostic (2.87e-2)" "unprognostic (2.31e-1)" "unprognostic (3.08e-3)" "prognostic favourable (9.81e-4)" "unprognostic (1.30e-2)" "unprognostic (1.67e-1)" "unprognostic (2.68e-2)" "unprognostic (5.51e-2)" "unprognostic (7.66e-2)" "unprognostic (3.36e-3)" 14.1 16.0 32.4 4.7 42.2 1.5 5.1 86.8 127.4 8.1 4.6 6.5 1.9 3.7 13.2 4.7 6.3 17.9 6.7 12.7 35.0 31.5 7.1 2.7 16.8 3.7 24.6 55.5 14.3 13.2 8.1 22.3 7.9 61.9 6.5 5.3 12.6 8.1 6.6 5.0 5.6 4.6 11.7 13.3 5.9 5.2 5.4 5.3 0.0 10.7 0.9 4.3 5.7 7.6 0.0 0.5 0.0 0.4 0.0 3.4 0.6 4.0 8.5 8.2 9.2 18.6 16.0 7.4 14.3 7.3 8.6 7.6 0.4 4.8 4.0 8.0 9.3 1.4 7.2 8.8 10.6 9.2 4.8 5.4 23.1 1.5 9.4 0.5 4.7 12.1 4.9 22.6 11.0 10.2 5.4 6.2 14.5 7.5 3.8 1.7 7.0 11.8 2.3 3.9 9.7 7.1 0.2 47.1 22.9 24.1 11.9 40.8 1.8 1.7 15.2 9.8 5.0 19.2 5.3 13.4 22.1 5.4 19.2 5.8 9.0 0.0 0.4 0.0 0.8 0.1 0.3 0.0 2.2 3.4 0.5 0.0 1.4 1.7 0.0 0.0 0.1 0.3 0.3 0.6 32.4 42.2 86.8 87.7 35.0 31.5 24.6 55.5 61.9 5.3 STYK1 "DKFZp761P1010, NOK, SuRTK106" ENSG00000060140 "Serine/threonine/tyrosine kinase 1" Q6J9G0 12 10618939-10674318 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.8;stomach 1: 16.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.2;HDLM-2: 10.8;HMC-1: 11.9;HUVEC TERT2: 16.4;TIME: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "NK-cell: 12.5" "Lineage enriched" "Detected in many" 7 "NK-cells: 12.5" "Region enhanced" "Detected in single" "basal ganglia: 2.3" "Not detected" "Not detected" "HPA040468, HPA048569" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA040468: , HPA048569: " "unprognostic (2.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-1)" "unprognostic (3.11e-2)" "unprognostic (3.35e-2)" "unprognostic (6.85e-2)" "unprognostic (5.08e-3)" "unprognostic (3.37e-1)" "unprognostic (3.50e-1)" "unprognostic (2.21e-3)" "unprognostic (1.02e-1)" "unprognostic (1.70e-14)" "unprognostic (5.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" 0.6 0.3 2.6 2.3 10.6 1.0 3.8 0.1 13.4 2.2 14.4 0.7 0.5 2.1 0.5 1.1 8.9 1.9 6.2 0.1 1.8 1.6 0.5 0.3 1.2 2.4 1.8 4.2 0.4 0.3 0.0 8.4 3.4 2.1 10.6 15.8 0.0 7.8 2.6 0.2 2.6 10.3 0.6 0.6 1.0 16.0 0.3 0.7 0.0 0.4 0.6 2.8 4.3 3.6 0.0 0.0 0.4 0.0 12.5 1.9 0.2 2.9 0.1 0.0 0.4 0.0 0.0 0.9 4.8 0.5 2.2 2.1 1.6 18.2 0.2 3.1 1.2 0.8 0.9 5.0 4.8 10.8 0.3 0.7 1.3 0.1 0.0 1.4 11.9 0.2 0.2 3.4 0.2 16.4 0.2 0.2 5.2 1.7 0.1 0.8 2.7 1.3 0.0 1.4 0.2 1.6 9.4 0.6 0.0 2.7 2.9 0.0 2.3 0.3 15.2 0.6 2.5 0.3 0.6 0.0 0.6 0.1 2.1 0.1 3.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.4 12.5 0.0 0.0 0.0 0.2 2.6 10.6 0.1 13.4 1.8 1.6 1.8 4.2 2.1 0.7 SUCO "C1orf9, CH1, OPT, SLP1" ENSG00000094975 "SUN domain containing ossification factor" Q9UBS9 1 172532349-172611833 "Predicted membrane proteins" Osteogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047251 Approved Approved "Nucleoli fibrillar center,Cytosol" 14000 "Nucleoli fibrillar center, Cytosol" "HPA047251: " "unprognostic (1.28e-2)" "unprognostic (6.38e-3)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (3.80e-2)" "prognostic unfavourable (2.86e-4)" "unprognostic (4.57e-2)" "unprognostic (1.92e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.20e-2)" "unprognostic (7.05e-2)" 8.8 9.2 8.0 6.2 9.8 43.4 9.0 7.9 8.4 8.9 7.6 6.5 48.6 6.1 8.1 39.5 8.3 9.9 7.3 8.0 7.6 8.3 11.2 8.0 6.4 5.5 7.5 5.1 13.4 24.7 16.9 24.7 18.2 8.7 9.0 5.9 9.4 13.0 52.5 2.8 8.7 22.9 6.1 8.8 7.1 8.0 14.3 8.0 11.1 11.0 6.0 7.1 10.7 9.1 9.5 7.7 11.3 6.7 10.4 8.9 4.6 15.7 7.1 20.6 18.4 10.6 10.2 23.3 19.1 11.2 12.2 14.9 12.6 16.8 7.9 11.6 10.9 24.9 8.8 7.5 21.0 4.5 6.3 6.2 4.4 7.7 12.4 9.8 8.9 9.2 7.7 15.0 12.3 10.5 4.0 11.3 18.3 3.7 6.5 6.7 18.7 16.5 6.6 11.9 5.0 18.9 22.1 11.1 14.3 8.8 15.3 16.8 15.0 10.7 13.7 11.1 11.7 10.6 19.4 17.1 13.7 14.3 10.7 5.2 17.3 9.4 6.6 11.3 8.6 6.0 8.3 8.3 7.8 7.2 5.4 9.5 8.7 8.9 6.1 10.4 6.7 7.7 5.6 4.6 8.0 9.8 7.9 8.4 7.6 8.3 7.5 5.1 8.7 8.0 SUN1 "FLJ12407, KIAA0810, UNC84A" ENSG00000164828 "Sad1 and UNC84 domain containing 1" O94901 7 816615-896435 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Meiosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008346, HPA008461" Enhanced Enhanced "Nuclear membrane" "Nuclear membrane" "HPA008346: AB_1080462, HPA008461: AB_1080461" "unprognostic (2.70e-2)" "unprognostic (1.51e-2)" "unprognostic (1.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.25e-1)" "unprognostic (2.57e-3)" "unprognostic (1.82e-1)" "unprognostic (1.67e-1)" "unprognostic (4.57e-2)" "unprognostic (3.32e-2)" "unprognostic (1.69e-1)" "unprognostic (8.10e-2)" "unprognostic (1.08e-2)" "unprognostic (1.47e-2)" "unprognostic (4.63e-2)" "unprognostic (1.34e-1)" "unprognostic (9.33e-2)" 29.8 14.5 18.2 17.2 23.6 4.0 26.0 49.6 28.9 31.1 22.5 23.6 18.9 18.1 47.1 22.6 24.2 28.5 20.0 40.8 16.6 14.9 19.4 13.4 19.6 11.6 15.9 21.3 39.6 22.4 37.5 26.8 25.3 18.0 18.8 16.8 27.6 19.5 19.7 56.7 46.1 17.9 33.6 15.3 17.6 23.9 36.4 15.4 11.8 20.1 31.0 17.8 20.3 25.3 8.0 8.1 7.6 10.2 6.7 13.2 6.5 38.9 10.5 12.8 20.7 14.1 20.2 12.4 9.9 16.6 18.4 18.9 9.0 44.0 9.3 10.3 13.5 49.2 10.4 17.5 18.0 4.0 10.4 3.0 15.5 8.4 18.1 4.6 7.7 10.0 20.9 14.7 24.5 13.4 12.5 7.0 18.4 13.5 3.0 7.6 17.7 12.2 6.6 7.0 8.7 18.8 12.6 24.6 16.0 12.5 25.7 9.5 20.3 4.7 10.1 17.0 15.5 17.6 16.2 6.5 7.5 5.8 11.6 3.9 23.3 7.6 10.2 2.6 4.7 8.8 5.0 8.0 9.2 5.3 8.1 6.8 13.2 8.2 0.6 6.7 6.3 1.6 7.7 6.5 18.2 23.6 49.6 28.9 16.6 14.9 15.9 21.3 18.0 15.4 SUN2 UNC84B ENSG00000100242 "Sad1 and UNC84 domain containing 2" Q9UH99 22 38734725-38794143 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001209 Supported Supported "Nuclear membrane" "Nuclear membrane" "HPA001209: AB_1080465" "unprognostic (9.76e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" "unprognostic (5.09e-2)" "unprognostic (1.36e-1)" "unprognostic (5.57e-2)" "unprognostic (1.94e-2)" "unprognostic (2.37e-2)" "unprognostic (3.14e-2)" "unprognostic (1.25e-3)" "unprognostic (8.15e-2)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (8.10e-2)" "unprognostic (2.33e-2)" 59.3 22.9 28.7 41.7 58.7 84.6 66.9 17.6 43.8 33.7 33.6 57.5 24.2 29.0 47.3 23.3 41.4 42.5 25.3 32.3 37.8 19.3 24.4 47.1 37.7 56.8 73.6 25.4 44.8 44.1 10.5 14.8 22.7 42.5 31.2 16.3 14.9 39.1 35.0 48.6 31.0 31.6 35.3 37.1 46.3 35.2 30.2 68.0 42.6 26.9 20.1 36.0 47.0 35.9 6.4 6.0 14.0 13.9 13.3 25.5 11.8 24.6 11.5 11.5 12.8 35.0 8.7 15.0 17.0 19.9 20.2 17.2 10.3 28.0 7.8 20.8 24.1 18.5 3.8 12.6 8.3 27.0 15.5 5.1 12.4 9.3 21.3 17.1 53.3 7.3 10.7 9.7 9.1 16.0 6.3 44.2 10.9 7.9 9.5 14.8 1.1 7.4 15.8 16.1 23.4 5.0 12.1 10.2 3.8 18.9 21.1 10.0 14.1 32.1 26.8 14.7 12.9 12.9 22.0 32.7 10.2 8.2 27.3 20.6 24.6 14.0 7.4 9.7 25.5 8.8 16.5 6.3 16.2 20.6 6.0 6.4 17.1 20.1 8.0 13.3 13.9 3.7 11.0 11.8 28.7 58.7 17.6 43.8 37.8 19.3 73.6 25.4 42.5 68.0 SUN3 "MGC33329, SUNC1" ENSG00000164744 "Sad1 and UNC84 domain containing 3" Q8TAQ9 7 47987148-48029119 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 30.9" "Cell line enriched" "Detected in some" 7 "U-2 OS: 21.5" "Cancer enhanced" "Detected in single" "testis cancer: 2.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA008344, HPA076890" Enhanced Approved "Golgi apparatus" "Golgi apparatus" "HPA008344: AB_1857656, HPA076890: " "unprognostic (5.11e-2)" "unprognostic (4.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.61e-4)" "unprognostic (2.31e-2)" "unprognostic (5.62e-2)" "unprognostic (1.35e-2)" "unprognostic (2.24e-2)" "unprognostic (1.59e-5)" "unprognostic (4.88e-1)" "unprognostic (1.47e-1)" "unprognostic (2.65e-1)" "unprognostic (1.81e-2)" "unprognostic (1.64e-1)" "unprognostic (3.48e-1)" "unprognostic (2.58e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 1.5 0.1 0.7 1.2 0.3 0.2 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.3 21.5 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.4 1.2 0.1 0.1 0.7 0.4 0.4 0.0 0.8 0.5 0.2 1.5 0.7 0.1 0.2 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SUN5 "dJ726C3.1, SPAG4L, TSARG4" ENSG00000167098 "Sad1 and UNC84 domain containing 5" Q8TC36 20 32983773-33004433 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 361 "testis: 36.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048529 Enhanced "HPA048529: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SURF1 ENSG00000148290 "SURF1, cytochrome c oxidase assembly factor" Q15526 9 133351755-133356676 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease mutation, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033946 Uncertain "CAB033946: AB_2302648" "unprognostic (1.87e-1)" "unprognostic (7.76e-3)" "unprognostic (1.34e-2)" "unprognostic (4.26e-3)" "unprognostic (3.43e-1)" "unprognostic (2.58e-1)" "unprognostic (1.35e-1)" "unprognostic (7.68e-2)" "unprognostic (3.00e-1)" "unprognostic (4.75e-2)" "unprognostic (1.11e-2)" "unprognostic (2.66e-1)" "prognostic favourable (6.92e-9)" "unprognostic (3.91e-2)" "unprognostic (2.13e-1)" "unprognostic (4.58e-2)" "unprognostic (1.98e-1)" 12.8 18.2 23.7 10.0 24.2 11.5 17.2 14.2 19.5 11.8 19.9 15.0 18.0 15.0 11.3 32.6 17.7 17.5 13.5 20.7 18.7 15.3 22.9 38.1 13.4 15.2 19.3 24.6 13.3 54.4 18.8 13.4 15.2 12.4 16.0 17.3 13.5 23.1 18.8 25.1 12.7 18.4 20.0 13.8 12.9 19.6 16.6 10.3 14.9 17.4 11.6 16.7 15.5 12.7 16.3 11.6 18.9 9.7 5.0 12.4 4.5 4.7 11.0 8.5 12.0 21.0 11.8 18.5 5.8 14.2 9.8 8.6 14.8 16.6 6.4 8.5 9.1 14.1 10.4 14.0 7.9 11.7 6.8 6.5 15.6 11.5 24.9 10.3 7.0 13.9 24.7 6.8 16.8 7.6 6.7 13.5 10.7 20.9 12.9 10.7 9.5 11.3 9.0 12.8 20.1 16.2 10.2 8.4 23.3 13.3 17.6 14.9 25.7 7.9 6.1 12.2 7.6 8.3 5.8 16.7 24.8 8.0 11.5 5.1 12.2 8.4 9.7 18.9 5.9 6.4 7.2 16.3 9.0 8.1 8.8 12.2 12.4 7.1 10.0 5.0 5.6 11.6 11.6 4.5 23.7 24.2 14.2 19.5 18.7 15.3 19.3 24.6 12.4 10.3 SUSD1 DKFZP761E1824 ENSG00000106868 "Sushi domain containing 1" Q6UWL2 9 112040785-112175408 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 22.9;HEL: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 24.9" "Lineage enriched" "Detected in many" 4 "dendritic cells: 24.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048554 Approved Approved Nucleoplasm "Intracellular and membrane" 530000 Nucleoplasm "HPA048554: " "unprognostic (2.25e-1)" "unprognostic (4.02e-2)" "unprognostic (1.42e-2)" "unprognostic (1.62e-1)" "unprognostic (9.29e-3)" "unprognostic (5.27e-2)" "unprognostic (1.69e-2)" "unprognostic (3.73e-2)" "unprognostic (1.23e-2)" "unprognostic (1.29e-3)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "prognostic favourable (3.63e-6)" "unprognostic (2.14e-3)" "unprognostic (8.38e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" 9.6 13.9 9.1 9.7 13.9 14.1 8.4 3.1 15.3 7.6 10.2 2.7 11.6 8.6 5.7 9.8 4.8 6.7 7.6 11.2 6.1 16.4 15.5 4.4 11.5 15.7 8.3 8.2 3.3 8.1 9.4 8.2 23.3 7.4 5.8 11.4 8.1 10.7 12.8 2.9 3.6 9.9 9.3 5.1 14.5 12.2 5.8 3.5 9.6 5.6 1.4 6.6 13.1 4.6 0.2 24.9 5.8 2.7 1.7 1.6 1.1 1.3 8.6 6.1 0.0 4.5 3.0 19.7 5.5 7.3 7.7 10.0 17.0 11.5 0.1 6.2 9.5 3.9 2.2 1.0 5.8 22.9 1.8 25.8 6.3 11.5 5.5 6.7 8.3 3.7 0.8 4.3 0.1 18.0 14.0 1.1 4.8 1.6 0.9 4.2 2.0 1.4 5.7 1.4 0.0 1.8 4.5 2.2 5.2 3.0 0.6 0.0 1.0 7.4 13.6 0.1 2.9 0.8 0.0 0.3 0.3 0.5 5.4 2.7 1.7 3.5 1.4 5.8 1.6 1.6 0.5 0.1 0.4 1.1 1.0 0.2 0.2 1.2 0.5 1.7 2.7 24.9 0.1 1.1 9.1 13.9 3.1 15.3 6.1 16.4 8.3 8.2 7.4 3.5 SUSD2 "BK65A6.2, FLJ22778" ENSG00000099994 "Sushi domain containing 2" Q9UGT4 22 24181259-24189110 "Predicted membrane proteins" Receptor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 100.1" "Cell line enriched" "Detected in some" 31 "SK-BR-3: 135.7" "Cancer enhanced" "Detected in all" "testis cancer: 64.5" "Region enhanced" "Detected in many" "pons and medulla: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA004117 Enhanced Approved "Plasma membrane" 3600000 "Plasma membrane" "HPA004117: AB_1857674" "unprognostic (5.24e-3)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-2)" "unprognostic (5.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.89e-2)" "unprognostic (5.87e-2)" "unprognostic (1.20e-2)" "unprognostic (9.74e-3)" "unprognostic (8.97e-2)" "prognostic unfavourable (3.29e-5)" "unprognostic (2.72e-2)" "unprognostic (2.82e-2)" "unprognostic (1.88e-2)" "unprognostic (3.33e-3)" 6.0 4.2 0.3 1.4 0.9 0.5 11.3 3.8 1.4 10.5 10.5 2.5 1.3 7.8 7.1 8.3 2.8 6.9 5.3 10.8 0.6 2.9 19.5 1.2 100.1 1.4 0.6 2.6 2.6 2.4 1.3 3.6 3.5 9.6 2.8 1.0 2.2 7.9 4.0 3.0 11.8 32.4 2.4 3.0 1.6 2.5 1.9 0.7 0.1 12.7 5.9 1.5 2.3 4.7 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.7 1.5 0.0 0.0 2.9 3.8 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.2 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.2 0.0 0.0 3.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 2.0 0.1 135.7 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 3.8 1.4 0.6 2.9 0.6 2.6 9.6 0.7 SUSD3 MGC26847 ENSG00000157303 "Sushi domain containing 3" Q96L08 9 93058688-93085138 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.8;testis: 64.8" "Cell line enhanced" "Detected in some" "Daudi: 50.6;MCF7: 12.3;NB-4: 25.8;RPMI-8226: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042310 Uncertain Approved Nucleoplasm Nucleoplasm "HPA042310: AB_10796902" "prognostic favourable (5.13e-4)" "unprognostic (5.42e-2)" "unprognostic (3.65e-1)" "unprognostic (8.34e-3)" "unprognostic (9.06e-2)" "unprognostic (2.84e-2)" "unprognostic (2.94e-2)" "unprognostic (7.41e-3)" "unprognostic (5.06e-2)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (3.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.39e-3)" "unprognostic (5.33e-2)" 3.2 1.0 3.3 16.9 3.2 18.7 8.0 1.2 3.2 8.3 3.3 8.5 0.6 2.2 11.6 12.8 1.9 18.2 1.9 1.0 2.4 2.7 18.5 13.9 3.8 25.8 4.0 2.3 20.9 0.8 0.2 3.2 1.4 3.7 1.8 0.9 3.0 7.5 1.5 0.4 1.6 9.7 3.0 5.4 20.2 1.9 64.8 3.1 13.9 2.5 0.8 19.9 3.0 3.7 20.4 9.2 16.7 3.9 2.2 52.8 17.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.1 1.1 0.4 50.6 0.2 0.2 0.1 0.8 0.0 0.0 4.4 0.0 6.9 0.0 0.7 3.4 0.0 1.6 3.5 0.2 0.0 0.0 0.0 2.0 11.2 0.0 12.3 0.0 25.8 0.6 1.5 2.1 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.7 11.6 0.1 0.0 0.0 0.0 0.0 2.3 1.2 3.1 0.0 0.0 0.1 0.1 3.9 16.7 5.7 3.4 6.4 20.4 30.1 10.5 9.2 14.4 52.8 21.3 1.3 2.2 0.6 0.8 39.8 17.0 3.3 3.2 1.2 3.2 2.4 2.7 4.0 2.3 3.7 3.1 SUSD4 FLJ10052 ENSG00000143502 "Sushi domain containing 4" Q5VX71 1 223220819-223364202 "Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.0;esophagus: 33.8" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;RPTEC TERT1: 8.3;SCLC-21H: 28.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 7.4;naive CD4 T-cell: 11.7" "Lineage enriched" "Detected in single" 66 "T-cells: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058296 Uncertain Approved Vesicles "Intracellular and membrane" Vesicles "HPA058296: " "unprognostic (2.90e-1)" "unprognostic (2.90e-3)" "unprognostic (1.27e-3)" "prognostic unfavourable (4.28e-4)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (7.53e-3)" "unprognostic (1.82e-3)" "unprognostic (7.94e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-3)" "unprognostic (1.36e-1)" "unprognostic (6.51e-6)" "unprognostic (3.64e-2)" "unprognostic (5.11e-2)" "unprognostic (3.03e-1)" "unprognostic (7.11e-2)" 0.8 5.2 15.9 1.5 33.0 0.9 8.1 9.9 21.3 3.4 0.9 4.0 4.7 1.5 0.9 24.3 33.8 3.6 1.3 9.6 30.6 14.6 13.7 4.0 3.2 1.9 6.8 12.8 27.8 7.6 8.3 16.5 1.0 6.6 4.4 0.8 1.2 13.2 5.7 1.2 3.5 0.9 0.9 2.4 0.8 7.6 5.1 3.8 0.3 1.5 8.1 13.8 2.7 9.1 0.0 0.0 0.0 0.1 0.1 11.7 1.8 4.2 0.4 0.1 0.0 0.0 0.0 0.1 0.5 0.2 0.7 0.5 4.4 1.3 0.0 1.4 0.1 7.0 0.2 1.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.4 0.0 0.3 3.2 3.0 0.0 0.1 0.8 0.0 0.1 0.0 8.3 1.9 28.5 0.3 0.0 2.3 0.0 1.8 0.2 0.0 1.2 5.1 0.0 2.5 0.5 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.1 6.0 0.0 7.4 1.9 0.0 0.0 11.7 2.1 0.0 0.1 0.0 0.0 1.0 1.8 15.9 33.0 9.9 17.9 30.6 14.6 6.8 12.8 6.6 3.8 SUSD5 KIAA0527 ENSG00000173705 "Sushi domain containing 5" O60279 3 33150042-33219215 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 14.5;HUVEC TERT2: 36.0;LHCN-M2: 13.9;TIME: 14.2" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.9;neutrophil: 1.5" "Group enriched" "Detected in many" 9 "B-cells: 1.9;granulocytes: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052788 Uncertain Uncertain "Golgi apparatus,Vesicles" 4300000 "Golgi apparatus, Vesicles" "HPA052788: " "unprognostic (1.81e-1)" "unprognostic (1.52e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-3)" "unprognostic (1.39e-3)" "unprognostic (4.05e-2)" "unprognostic (3.72e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-3)" "unprognostic (6.45e-2)" "unprognostic (8.46e-2)" "unprognostic (1.89e-2)" 7.6 2.5 7.0 1.5 6.1 0.4 2.5 2.0 13.2 11.0 2.6 4.6 2.3 1.5 7.0 6.5 2.3 7.9 13.1 5.7 6.4 8.1 2.6 1.1 3.0 4.4 6.9 6.9 6.4 1.2 1.0 1.3 0.5 6.3 1.9 2.2 3.7 1.3 10.7 2.2 2.8 2.7 7.7 4.6 3.9 3.3 4.7 3.3 0.0 5.3 2.9 8.1 3.0 3.5 1.9 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.5 0.6 0.3 0.8 0.1 0.0 4.4 1.5 14.5 4.9 0.0 0.0 0.0 4.1 1.1 0.0 6.3 2.0 6.0 0.1 7.0 0.0 1.0 0.0 0.1 0.0 0.0 0.6 1.1 9.3 1.8 36.0 0.0 0.0 13.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 1.1 0.8 0.8 14.2 0.0 6.9 0.5 2.1 0.0 0.3 0.0 0.1 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.9 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.1 7.0 6.1 2.0 13.2 6.4 8.1 6.9 6.9 6.3 3.3 SUSD6 KIAA0247 ENSG00000100647 "Sushi domain containing 6" Q92537 14 69611596-69715142 "Predicted membrane proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030464 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA030464: AB_10601128" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "unprognostic (1.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.46e-2)" "unprognostic (2.17e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-1)" "unprognostic (3.66e-3)" "unprognostic (1.10e-2)" "unprognostic (6.70e-2)" "prognostic favourable (2.16e-4)" "unprognostic (1.10e-2)" "unprognostic (5.35e-2)" "unprognostic (1.30e-2)" "unprognostic (2.34e-1)" 25.4 17.4 9.2 26.0 11.9 40.2 19.5 36.4 12.3 12.1 25.0 15.5 14.8 17.2 13.0 31.0 27.0 16.1 19.6 13.2 11.4 8.4 16.7 11.6 30.9 25.3 15.1 8.2 13.4 20.9 13.7 14.6 14.1 13.9 16.0 13.4 14.6 26.6 17.5 10.6 22.5 36.7 14.0 14.1 30.9 17.3 9.1 12.9 12.7 23.4 14.8 27.4 16.4 15.3 4.1 5.3 23.1 9.1 2.9 4.2 5.0 10.6 2.8 4.0 3.7 8.3 6.1 7.4 6.1 12.8 3.5 3.4 3.3 9.5 12.6 6.9 7.6 15.0 2.3 12.5 3.3 21.5 1.7 10.2 2.2 5.4 13.4 1.6 26.5 9.8 12.4 5.8 10.9 7.1 3.1 11.2 4.8 5.2 2.4 4.4 0.8 2.9 4.2 3.5 5.0 6.7 5.5 1.7 2.7 5.0 14.6 2.2 5.9 4.6 10.9 8.1 4.8 5.1 2.4 7.8 1.7 8.9 5.2 5.7 4.2 8.9 7.5 8.3 4.1 7.3 4.2 3.9 3.6 2.5 5.3 4.1 3.5 2.5 23.1 2.9 9.1 3.0 3.2 5.0 9.2 11.9 36.4 12.3 11.4 8.4 15.1 8.2 13.9 12.9 SYBU "FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL" ENSG00000147642 Syntabulin Q9NX95 8 109573978-109691791 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 82.7" "Cell line enhanced" "Detected in many" "HaCaT: 13.2;PC-3: 14.9;SK-BR-3: 30.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "memory B-cell: 9.4;naive B-cell: 4.4" "Lineage enriched" "Detected in single" 29 "B-cells: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053057 Uncertain Supported Vesicles Vesicles "HPA053057: " "unprognostic (4.69e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-1)" "prognostic favourable (7.74e-4)" "unprognostic (1.22e-2)" "unprognostic (1.37e-1)" "unprognostic (2.16e-1)" "unprognostic (3.13e-1)" "unprognostic (5.52e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-1)" "unprognostic (6.05e-3)" "unprognostic (6.89e-2)" "unprognostic (4.27e-2)" 17.6 19.7 18.2 2.5 25.5 0.8 13.3 36.8 31.3 7.7 8.7 4.0 11.5 7.1 3.4 7.9 4.1 12.8 6.9 2.6 15.2 23.0 3.3 26.6 5.2 3.1 13.5 17.9 5.5 82.7 1.6 12.4 2.1 14.7 5.1 12.5 3.5 12.6 10.0 2.5 5.3 7.4 5.1 7.2 1.2 8.7 1.7 5.1 0.3 7.6 1.1 5.1 2.9 3.8 9.4 0.1 0.0 0.0 0.0 0.3 0.1 5.1 2.6 2.1 0.0 0.3 0.3 1.4 1.8 0.0 0.0 0.0 4.6 3.1 0.4 0.3 1.4 13.2 0.4 3.5 0.0 0.0 7.1 0.0 7.8 4.6 3.4 0.0 0.0 1.2 4.5 0.0 4.3 1.9 0.2 0.9 2.0 0.1 0.1 0.0 0.4 14.9 0.0 0.0 0.0 5.7 1.2 10.0 1.1 4.7 30.4 1.0 3.8 0.2 2.7 0.1 1.1 0.0 0.8 0.8 0.0 0.3 6.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 9.4 0.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 18.2 25.5 36.8 31.3 15.2 23.0 13.5 17.9 14.7 5.1 SYNE1 "8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B" ENSG00000131018 "Spectrin repeat containing nuclear envelope protein 1" Q8NF91 6 152121684-152637801 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" Actin-binding "Cancer-related genes, Disease mutation, Emery-Dreifuss muscular dystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 33.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 33.8" HPA019113 Approved Supported "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA019113: AB_1857707" "unprognostic (9.99e-2)" "unprognostic (1.91e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-1)" "unprognostic (2.28e-1)" "unprognostic (9.58e-3)" "unprognostic (1.11e-1)" "unprognostic (3.55e-3)" "unprognostic (1.58e-1)" "unprognostic (9.85e-2)" "unprognostic (8.87e-3)" "unprognostic (2.70e-1)" "unprognostic (4.14e-3)" "unprognostic (5.83e-2)" "unprognostic (1.82e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" 12.7 11.5 18.2 9.1 30.2 41.7 9.0 62.0 25.0 16.8 7.3 9.8 12.4 2.7 15.2 18.4 6.2 12.9 7.9 22.7 21.0 17.5 18.4 11.2 16.1 13.7 13.2 15.1 27.7 10.6 37.3 37.0 4.7 19.7 10.1 6.3 10.5 3.6 12.5 22.0 16.9 5.3 19.1 9.7 15.5 9.0 8.3 11.6 9.0 20.6 9.5 12.1 10.0 12.3 3.2 0.8 33.8 1.5 4.7 6.4 1.4 0.1 3.9 2.8 3.2 3.9 8.6 1.0 8.8 4.6 2.3 4.2 0.8 0.1 8.3 0.5 4.8 0.2 1.0 2.3 2.4 10.0 2.7 3.5 2.6 2.7 9.0 0.6 1.6 5.5 0.5 5.0 10.3 4.4 0.0 9.5 6.2 0.4 1.4 0.1 0.6 1.5 1.9 5.5 2.3 8.9 0.1 1.7 2.6 1.4 0.5 6.1 0.5 0.3 5.9 10.7 14.5 3.7 4.8 18.9 8.0 13.3 5.9 1.9 3.1 3.0 1.1 33.8 6.4 0.7 4.1 2.9 4.2 6.1 0.8 3.2 4.0 5.1 1.1 4.7 1.5 0.7 5.1 1.4 18.2 30.2 62.0 25.0 21.0 17.5 13.2 15.1 19.7 11.6 SYNE2 "DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2" ENSG00000054654 "Spectrin repeat containing nuclear envelope protein 2" Q8WXH0 14 63852983-64226433 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 111.4" "Cell line enhanced" "Detected in many" "Daudi: 43.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 15.8;pons and medulla: 16.3" "Cell type enhanced" "Detected in many" "eosinophil: 30.3" "Group enriched" "Detected in many" 10 "granulocytes: 30.3;T-cells: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003435, HPA050204" Enhanced Supported "Nuclear membrane,Intermediate filaments" "Nuclear membrane, Intermediate filaments" "HPA003435: AB_1080162, HPA050204: AB_2681051" "unprognostic (1.93e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-1)" "unprognostic (2.33e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-3)" "unprognostic (9.04e-2)" "unprognostic (2.58e-3)" "unprognostic (1.99e-2)" "unprognostic (2.41e-2)" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "prognostic favourable (3.56e-9)" "unprognostic (5.05e-3)" "unprognostic (3.14e-1)" "unprognostic (1.51e-2)" "unprognostic (4.80e-2)" 30.8 4.5 2.3 18.0 2.8 5.5 29.7 15.8 3.3 16.1 13.4 1.9 7.7 3.6 18.8 13.6 17.2 7.1 8.6 27.3 2.3 2.4 35.6 13.0 15.2 11.0 2.7 2.1 22.8 22.4 60.1 17.6 14.1 16.3 13.7 4.8 13.0 9.8 9.2 111.4 24.1 10.6 10.2 2.3 16.0 6.9 14.3 1.9 16.9 30.9 29.7 15.8 11.1 26.4 2.3 1.1 30.3 0.1 1.5 16.3 1.3 17.3 5.9 8.7 2.8 8.7 2.6 11.5 1.2 1.2 2.0 3.5 1.9 3.6 43.5 1.8 1.1 8.4 5.7 2.2 2.5 6.6 2.2 0.2 4.3 0.5 1.7 0.7 0.2 3.7 8.2 2.5 2.3 4.5 0.2 3.5 1.4 9.7 4.6 0.2 3.9 1.8 5.4 8.2 1.4 13.2 8.3 8.1 6.0 13.8 3.3 3.7 3.8 0.1 3.9 3.2 5.2 1.0 3.6 4.8 2.1 16.5 0.9 0.0 4.6 0.2 0.0 30.3 16.3 0.1 11.0 2.1 10.0 10.8 0.0 2.3 4.9 7.4 13.3 1.5 0.1 1.1 11.1 1.3 2.3 2.8 15.8 2.6 2.3 2.4 2.7 2.1 16.3 1.9 SYNE3 "C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53" ENSG00000176438 "Spectrin repeat containing nuclear envelope family member 3" Q6ZMZ3 14 95407266-95475836 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 12.2;bone marrow: 10.0" "Cell line enhanced" "Detected in many" "ASC diff: 24.8;ASC TERT1: 19.4;Karpas-707: 21.9;REH: 17.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055227, HPA077140" Approved Supported "Nuclear membrane" "Nuclear membrane" "HPA055227: , HPA077140: " "unprognostic (4.63e-2)" "unprognostic (6.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.48e-3)" "unprognostic (7.15e-2)" "unprognostic (2.12e-3)" "unprognostic (2.45e-1)" "unprognostic (2.61e-2)" "unprognostic (4.92e-1)" "unprognostic (2.87e-1)" "unprognostic (8.50e-2)" "unprognostic (3.32e-1)" "unprognostic (7.41e-6)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (6.95e-2)" "unprognostic (7.19e-2)" 12.2 2.4 1.2 2.7 1.3 10.0 6.5 0.3 1.2 2.1 1.0 0.6 1.2 0.6 1.1 2.0 1.2 2.8 1.6 1.1 0.4 1.0 2.7 4.0 1.6 3.0 0.1 0.0 0.5 2.1 0.6 1.6 1.9 0.4 1.1 2.8 1.5 1.2 2.6 2.7 0.9 1.6 1.7 4.3 1.6 2.8 3.4 2.6 5.4 5.1 0.9 3.7 2.2 0.6 0.0 0.3 0.5 24.8 19.4 7.4 2.7 4.8 2.6 2.1 3.9 0.6 3.1 0.4 1.3 0.1 0.6 2.0 1.2 10.4 0.4 2.1 0.5 1.0 3.2 3.3 5.5 5.4 0.7 3.3 1.9 4.6 0.1 21.9 2.0 0.7 1.9 3.6 0.1 1.3 17.3 12.1 6.7 0.3 0.3 0.5 2.7 0.1 0.0 1.3 1.0 4.8 4.2 1.9 1.2 2.6 0.3 2.6 5.3 3.0 3.9 7.4 14.5 5.4 5.1 0.4 2.2 4.0 2.8 3.4 2.9 2.3 2.1 3.3 3.7 3.0 2.4 0.9 4.1 2.6 2.3 2.2 SYNE4 "C19orf46, DFNB76, FLJ36445, Nesp4, Nesprin-4" ENSG00000181392 "Spectrin repeat containing nuclear envelope family member 4" Q8N205 19 36003299-36008793 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "CACO-2: 18.2;Hep G2: 15.8;MCF7: 18.5;SK-BR-3: 22.6;T-47d: 17.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "cerebellum: 7.6" "Not detected" "Not detected" HPA060253 Uncertain "HPA060253: " "unprognostic (8.54e-2)" "unprognostic (6.48e-2)" "unprognostic (1.32e-2)" "unprognostic (1.24e-1)" "unprognostic (5.54e-2)" "unprognostic (2.42e-3)" "unprognostic (3.76e-2)" "unprognostic (2.03e-2)" "unprognostic (1.93e-1)" "unprognostic (3.15e-2)" "unprognostic (3.36e-3)" "unprognostic (6.02e-2)" "prognostic favourable (8.64e-9)" "unprognostic (1.25e-1)" "unprognostic (2.54e-2)" "unprognostic (4.50e-1)" "unprognostic (1.97e-2)" 0.1 0.2 0.2 0.4 2.7 0.1 6.3 15.3 2.0 3.1 1.8 0.3 16.9 3.5 1.0 10.3 1.3 4.6 3.5 0.1 0.2 4.4 6.5 9.0 4.2 0.1 2.1 0.1 1.0 7.5 14.1 18.1 3.3 10.0 9.5 1.7 1.4 10.9 12.6 0.2 0.9 4.4 0.4 1.0 0.3 2.6 0.3 0.6 1.4 14.4 0.7 1.0 1.3 1.1 0.0 0.0 0.8 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.1 2.3 0.0 0.0 0.1 0.1 18.2 2.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.5 0.2 0.0 0.2 15.8 0.2 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.0 18.5 0.3 0.0 0.0 0.1 0.4 0.0 0.2 1.2 0.5 2.8 0.0 0.0 22.6 0.1 17.2 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.7 15.3 2.0 0.2 4.4 2.1 0.1 10.0 0.6 SYNGR1 ENSG00000100321 "Synaptogyrin 1" O43759 22 39349925-39385588 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 21.0;monocytes: 18.9;T-cells: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029673, CAB034277" Enhanced Supported Cytosol Cytosol "CAB034277: AB_2255766, HPA029673: AB_10670430" "unprognostic (2.68e-3)" "unprognostic (1.84e-3)" "unprognostic (5.90e-2)" "unprognostic (8.51e-2)" "unprognostic (3.74e-1)" "unprognostic (5.98e-3)" "unprognostic (7.39e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-2)" "prognostic favourable (2.41e-4)" "unprognostic (1.16e-1)" "prognostic favourable (4.98e-7)" "unprognostic (1.32e-3)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" "unprognostic (1.04e-1)" 4.4 11.4 19.4 2.7 31.4 39.9 8.0 66.9 62.0 15.6 6.3 8.5 1.0 3.3 9.2 6.5 17.3 9.8 6.1 21.6 31.6 22.3 5.5 2.0 3.3 3.8 17.4 35.1 38.8 14.5 10.3 4.1 3.7 23.5 10.9 2.6 19.5 23.5 10.4 13.4 26.2 3.0 7.2 7.0 4.1 4.8 7.2 5.4 0.7 4.6 4.6 5.2 7.8 9.0 2.4 21.0 0.8 18.9 2.6 15.2 7.8 2.6 4.7 8.6 15.4 0.8 2.2 3.8 11.4 20.1 14.5 13.4 1.0 0.3 0.1 2.6 3.0 3.7 5.8 0.2 4.4 0.0 18.0 0.2 0.3 0.5 2.5 0.7 5.3 3.3 0.9 4.0 0.0 0.7 5.1 0.3 2.2 6.0 2.3 2.1 1.7 9.2 6.7 0.0 0.7 0.4 7.3 13.6 2.8 2.9 12.4 11.8 18.3 13.4 0.2 0.0 10.1 0.1 0.0 3.1 0.1 7.2 0.4 14.5 15.5 0.2 18.9 0.3 15.2 5.5 0.9 2.4 0.6 4.4 21.0 2.2 0.7 8.2 0.8 2.6 0.2 15.3 0.1 7.8 19.4 31.4 66.9 62.0 31.6 22.3 17.4 35.1 23.5 5.4 SYNGR3 ENSG00000127561 "Synaptogyrin 3" O43761 16 1989660-1994275 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.3" "Cell line enhanced" "Detected in many" "HDLM-2: 25.1;HMC-1: 16.2;Karpas-707: 13.7;SK-BR-3: 17.1;U-266/70: 21.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.7;NK-cells: 4.6;T-cells: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034278, HPA042842" Enhanced Approved "Plasma membrane" "Plasma membrane" "CAB034278: AB_2200905, HPA042842: " "unprognostic (8.89e-3)" "prognostic favourable (6.92e-4)" "unprognostic (6.07e-3)" "unprognostic (2.94e-3)" "unprognostic (2.92e-2)" "unprognostic (8.06e-3)" "unprognostic (2.52e-1)" "unprognostic (5.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.06e-1)" "unprognostic (3.69e-3)" "unprognostic (1.05e-1)" "prognostic favourable (7.12e-7)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.79e-1)" "unprognostic (8.78e-2)" 1.1 11.1 20.3 3.7 21.8 1.6 1.1 24.2 55.3 1.5 2.3 2.6 0.0 2.2 1.0 1.0 1.3 1.1 1.3 1.4 14.6 40.8 1.7 1.0 1.3 4.0 27.1 20.1 1.5 1.0 9.4 3.1 5.4 28.2 1.3 2.2 0.9 2.1 1.1 0.9 1.1 2.5 1.7 4.4 2.2 2.1 4.2 2.0 0.0 1.0 0.0 4.7 1.4 0.2 3.7 0.7 0.0 0.8 4.6 2.7 0.9 0.4 2.1 1.9 0.2 0.2 0.2 2.4 0.9 1.6 0.8 0.6 3.2 1.5 3.1 0.7 0.7 1.8 2.1 0.3 0.2 25.1 1.5 0.0 2.7 1.5 1.1 0.0 16.2 0.5 0.1 0.0 0.5 0.2 9.0 13.7 0.4 2.4 0.1 0.1 10.1 0.9 0.0 0.2 2.4 1.3 0.0 4.5 5.7 2.3 17.1 0.2 2.3 0.2 0.3 0.5 7.9 0.0 0.3 21.6 2.5 3.6 0.3 2.8 0.3 0.0 0.8 0.0 0.9 0.3 2.1 3.2 1.7 2.7 0.7 3.7 2.0 0.8 0.0 4.6 0.7 0.0 1.6 0.9 20.3 21.8 24.2 39.3 14.6 40.8 27.1 20.1 28.2 2.0 SYNJ2BP Arip2 ENSG00000213463 "Synaptojanin 2 binding protein" P57105 14 70366496-70417061 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000866 Approved Supported Approved Mitochondria Mitochondria "HPA000866: AB_2276678" "unprognostic (2.68e-1)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "unprognostic (1.28e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.60e-2)" "unprognostic (5.70e-2)" "unprognostic (6.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.44e-2)" "prognostic favourable (1.11e-16)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (5.35e-3)" "unprognostic (1.14e-2)" 12.0 13.8 10.8 8.2 13.0 1.7 11.2 15.8 13.7 11.8 20.1 14.1 14.1 21.0 12.5 10.4 16.3 9.5 11.7 15.7 10.5 8.9 32.0 25.9 10.4 6.8 11.0 6.4 10.3 11.0 28.9 22.2 12.0 13.4 15.3 16.7 11.6 13.2 15.0 27.4 6.7 32.2 15.2 12.4 11.3 16.8 16.9 9.9 7.0 16.9 14.4 7.9 15.4 9.1 4.6 5.1 0.6 5.3 3.8 7.4 1.9 9.6 6.2 10.9 7.3 8.4 9.8 7.6 7.4 7.7 5.3 6.0 6.0 9.1 0.0 7.1 8.5 8.3 10.9 8.1 12.6 1.3 5.5 3.5 9.5 7.8 7.4 0.0 1.2 7.6 6.7 6.6 3.7 11.5 2.0 2.0 9.4 6.9 4.9 1.4 7.9 7.6 6.2 15.8 2.6 11.5 14.5 8.0 13.9 10.2 8.6 6.0 16.0 2.5 12.6 12.6 8.8 4.8 6.0 2.7 10.1 0.0 11.2 1.2 10.4 0.6 5.3 0.1 4.3 5.1 4.9 4.6 5.2 5.0 5.1 3.9 7.4 5.9 0.6 3.8 3.3 3.2 3.9 1.9 10.8 13.0 15.8 13.7 10.5 8.9 11.0 6.4 13.4 9.9 SYS1 "C20orf169, dJ453C12.4" ENSG00000204070 "SYS1, golgi trafficking protein" Q8N2H4 20 45361937-45376798 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA046716 Approved "HPA046716: " "unprognostic (8.24e-2)" "unprognostic (1.19e-1)" "unprognostic (5.58e-2)" "unprognostic (1.51e-2)" "unprognostic (1.04e-1)" "unprognostic (1.47e-2)" "prognostic unfavourable (4.62e-4)" "unprognostic (2.10e-2)" "unprognostic (1.63e-2)" "unprognostic (4.77e-1)" "unprognostic (4.66e-3)" "unprognostic (2.33e-1)" "unprognostic (4.28e-2)" "unprognostic (4.90e-2)" "unprognostic (4.38e-2)" "unprognostic (5.38e-3)" "unprognostic (2.01e-2)" 19.2 22.3 17.1 22.7 22.0 24.7 20.8 12.7 29.2 22.3 21.3 22.1 16.1 13.2 25.4 20.5 19.0 38.0 21.6 19.2 17.3 17.5 26.9 34.4 22.0 33.5 21.3 13.3 30.0 30.8 18.6 19.3 17.8 18.6 20.6 16.6 20.2 27.6 23.8 24.1 13.3 20.5 19.2 19.3 17.5 21.5 14.3 20.2 18.1 37.0 10.4 25.7 21.9 20.8 13.8 44.1 17.4 10.0 8.7 16.3 13.0 7.9 14.6 6.1 10.5 19.4 12.0 10.1 8.0 11.6 12.5 10.6 36.4 15.3 4.8 19.2 13.3 17.1 12.0 14.5 8.5 7.0 6.8 5.6 8.1 19.0 16.7 10.3 11.8 14.9 21.3 13.9 8.4 12.3 8.9 7.4 8.8 17.0 8.7 10.4 6.8 20.6 1.4 7.0 7.6 14.6 6.7 4.7 5.9 12.7 8.0 15.6 18.2 6.9 6.9 16.1 10.6 8.5 7.8 9.0 5.8 1.8 10.8 7.2 8.9 17.4 10.0 15.1 15.3 9.6 16.1 10.4 14.8 15.6 11.2 13.8 16.3 14.1 12.6 8.7 9.8 44.1 15.4 13.0 17.1 22.0 12.7 29.2 17.3 17.5 21.3 13.3 18.6 20.2 SYT1 "P65, SVP65, SYT" ENSG00000067715 "Synaptotagmin 1" P21579 12 78863993-79452008 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 141.7" "Cell line enhanced" "Detected in many" "hTERT-HME1: 22.5;LHCN-M2: 18.0;SH-SY5Y: 17.4;WM-115: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.3;memory B-cell: 3.3;naive B-cell: 3.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008394, HPA064788" Enhanced Supported "HPA008394: AB_1857696, HPA064788: AB_2685351" "unprognostic (1.02e-3)" "unprognostic (2.55e-1)" "unprognostic (4.21e-3)" "unprognostic (3.77e-2)" "unprognostic (3.16e-2)" "unprognostic (3.68e-5)" "unprognostic (2.78e-2)" "unprognostic (1.83e-2)" "unprognostic (7.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-1)" "unprognostic (6.14e-3)" "unprognostic (3.05e-8)" "unprognostic (2.89e-2)" "unprognostic (8.26e-2)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" 1.3 11.5 23.9 2.1 31.8 1.3 1.4 44.3 141.7 1.8 2.3 1.8 0.0 1.8 5.6 1.4 1.4 1.4 1.7 1.1 32.4 22.9 2.0 2.0 1.5 1.2 23.1 38.6 3.6 1.2 1.1 1.4 2.3 28.9 4.3 2.5 2.7 1.2 3.8 1.1 1.2 2.6 12.9 2.5 2.2 1.8 1.4 3.6 0.0 1.2 0.0 1.2 1.3 0.7 3.4 0.9 0.0 2.3 0.0 0.0 0.1 0.0 10.5 7.9 0.0 0.8 2.3 0.0 0.7 0.9 0.6 0.6 0.5 0.3 0.0 1.6 0.1 0.3 0.1 1.2 0.9 0.1 0.4 0.6 0.2 0.0 2.0 0.0 0.1 0.6 0.8 2.9 22.5 7.5 0.4 1.2 18.0 1.6 1.0 0.0 5.8 3.0 0.0 8.2 0.0 0.0 3.0 10.5 17.4 0.0 1.3 0.2 3.9 0.0 3.0 1.1 0.4 0.0 3.3 1.9 4.2 0.0 2.6 0.0 16.2 0.0 2.3 0.0 0.0 0.2 0.0 3.3 0.0 0.0 0.9 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.9 31.8 44.3 74.8 32.4 22.9 23.1 38.6 28.9 3.6 SYT10 ENSG00000110975 "Synaptotagmin 10" Q6XYQ8 12 33374238-33439819 "Predicted membrane proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;fallopian tube: 8.1" "Cell line enhanced" "Detected in some" "AF22: 3.7;K-562: 2.2;MCF7: 7.5;NTERA-2: 1.9;RPTEC TERT1: 1.9;RT4: 3.0;SCLC-21H: 3.9" "Cancer enriched" "Detected in single" 5 "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA055426 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA055426: " "unprognostic (3.60e-1)" "unprognostic (4.93e-2)" "unprognostic (9.34e-4)" "unprognostic (5.53e-2)" "unprognostic (3.67e-1)" "unprognostic (4.74e-3)" "unprognostic (3.19e-1)" "unprognostic (1.97e-6)" "unprognostic (4.00e-1)" "unprognostic (2.39e-1)" "unprognostic (2.41e-1)" "unprognostic (1.91e-1)" 0.3 1.5 0.6 0.7 10.1 0.1 0.3 0.2 4.1 2.9 3.6 0.9 3.0 1.0 0.3 0.8 0.3 8.1 0.4 0.5 0.8 3.1 3.3 1.4 0.2 0.1 0.6 3.4 0.4 0.2 0.1 5.8 0.2 14.6 1.6 1.6 0.1 1.8 3.2 0.2 0.2 1.3 0.6 2.7 0.2 1.6 0.6 0.3 0.0 0.2 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 7.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.9 3.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.1 0.2 4.1 0.8 3.1 0.6 3.4 14.6 0.3 SYT14 "FLJ34198, sytXIV" ENSG00000143469 "Synaptotagmin 14" Q8NB59 1 209938174-210171389 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.4;pituitary gland: 31.1;testis: 9.5;thyroid gland: 15.9" "Cell line enhanced" "Detected in some" "BJ hTERT+: 13.1;SCLC-21H: 6.8;TIME: 10.9;U-138 MG: 8.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036963 Supported Vesicles Vesicles "HPA036963: AB_10670378" "unprognostic (1.38e-4)" "unprognostic (8.62e-3)" "unprognostic (1.93e-1)" "unprognostic (3.90e-4)" "unprognostic (1.97e-1)" "unprognostic (4.43e-5)" "unprognostic (1.92e-1)" "unprognostic (1.88e-2)" "unprognostic (6.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.81e-1)" "unprognostic (4.85e-3)" "unprognostic (2.30e-4)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (3.33e-3)" 0.7 3.2 5.9 0.8 7.4 0.8 0.6 17.4 10.2 0.6 0.7 3.8 0.0 0.7 1.4 0.8 0.6 0.6 0.6 0.6 4.5 2.6 0.9 0.6 0.7 0.7 3.3 5.9 0.8 1.2 0.6 31.1 0.6 5.0 0.8 0.8 1.1 0.6 0.6 0.7 0.7 0.7 0.7 2.4 0.7 0.9 9.5 3.0 0.0 15.9 0.0 0.6 0.6 0.4 2.0 0.8 2.1 0.5 1.1 0.8 0.1 3.3 0.1 0.0 0.0 0.3 0.0 0.0 2.7 13.1 2.8 1.5 0.0 0.2 0.0 0.1 0.3 4.2 0.0 0.0 3.3 0.6 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 1.9 5.8 0.5 0.0 0.0 5.0 0.0 0.0 0.0 4.5 1.8 0.0 0.1 0.1 0.2 3.0 6.8 3.1 0.0 0.0 5.6 0.0 0.1 10.9 8.3 4.0 0.7 1.4 0.1 0.1 0.0 0.7 0.0 1.9 2.1 0.4 0.6 0.8 0.2 0.4 0.6 0.5 0.4 0.3 2.0 0.4 0.6 1.8 1.1 0.5 0.8 0.4 0.1 5.9 7.4 17.4 10.2 4.5 2.6 3.3 5.9 5.0 3.0 SYT15 CHR10SYT ENSG00000204176 "Synaptotagmin 15" Q9BQS2 10 46578217-46594173 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 26.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA036971, HPA036972, HPA064559" Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA036971: , HPA036972: , HPA064559: " "unprognostic (1.64e-2)" "unprognostic (9.28e-3)" "unprognostic (1.54e-1)" "unprognostic (6.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.31e-2)" "unprognostic (5.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.02e-2)" "unprognostic (1.49e-2)" "unprognostic (3.19e-4)" "unprognostic (4.03e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-2)" "unprognostic (1.15e-3)" 4.7 2.4 5.7 6.5 4.8 0.2 3.9 3.1 7.0 11.5 1.6 3.3 1.1 1.3 7.1 3.9 5.3 5.3 3.3 4.3 6.1 4.7 2.9 1.1 13.2 5.3 5.1 2.8 2.4 10.4 4.7 2.3 5.6 11.3 2.7 2.0 7.4 9.2 5.6 2.3 11.4 2.4 3.8 2.7 3.1 1.4 2.4 1.1 1.1 2.7 8.3 4.1 3.1 4.3 1.2 1.8 1.2 3.8 1.8 2.2 1.1 2.2 2.7 1.6 0.6 1.5 1.6 1.8 2.8 4.7 1.8 2.2 5.5 4.7 0.6 1.9 2.4 8.3 0.0 0.7 2.7 1.2 3.0 1.3 2.3 3.7 4.9 2.5 2.4 2.9 0.9 1.4 3.8 1.1 0.6 1.6 0.9 3.9 1.3 4.1 1.0 0.9 1.6 0.0 1.5 2.9 1.2 0.9 1.1 1.9 26.2 1.3 3.7 1.3 3.0 0.8 3.0 1.9 1.7 2.2 2.2 1.9 1.8 1.5 0.7 0.0 1.7 1.2 2.2 3.8 2.1 1.0 1.7 1.1 1.8 1.2 1.5 1.9 0.7 1.8 2.3 1.1 0.5 1.1 5.7 4.8 3.1 6.4 6.1 4.7 5.1 2.8 11.3 1.1 SYT16 "CHR14SYT, Strep14, SYT14L, yt14r" ENSG00000139973 "Synaptotagmin 16" Q17RD7 14 61811974-62112550 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.8;testis: 6.8" "Cell line enhanced" "Detected in some" "A-431: 10.4;PC-3: 5.4;RPTEC TERT1: 6.3;RT4: 16.7;U-2 OS: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004199, HPA076871" Enhanced Approved Cytosol Cytosol "HPA004199: AB_1080156, HPA076871: " "unprognostic (2.55e-2)" "unprognostic (1.43e-2)" "unprognostic (4.12e-1)" "unprognostic (8.88e-4)" "unprognostic (1.41e-1)" "unprognostic (9.08e-2)" "unprognostic (9.57e-2)" "unprognostic (9.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.34e-1)" "unprognostic (3.41e-2)" "unprognostic (1.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.53e-3)" "unprognostic (2.15e-1)" 0.4 1.3 7.2 0.4 17.2 0.6 0.6 0.7 20.8 0.4 0.4 0.4 0.0 0.4 1.0 2.1 0.4 0.7 0.5 0.5 3.3 3.4 0.7 0.4 0.5 0.5 1.6 12.3 0.4 4.0 0.4 1.9 1.1 1.8 4.6 0.4 0.0 0.4 0.6 0.4 0.5 0.5 0.4 0.9 0.5 2.6 6.8 0.7 0.0 0.5 0.0 0.4 0.9 0.6 0.2 0.1 0.6 0.1 0.1 0.2 0.0 10.4 0.2 0.3 0.0 0.0 0.0 0.1 0.7 1.0 1.0 0.6 0.0 0.0 0.1 0.2 0.0 0.5 0.0 1.0 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 5.4 0.0 0.0 0.0 6.3 16.7 0.3 2.9 0.5 0.7 0.0 0.0 0.0 0.0 2.8 6.8 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.6 0.1 0.1 0.1 0.0 0.0 7.2 17.2 0.7 18.9 3.3 3.4 1.6 12.3 1.8 0.7 SYT2 ENSG00000143858 "Synaptotagmin 2" Q8N9I0 1 202590596-202710417 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" Differentiation "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 40.1" "Cell line enhanced" "Detected in some" "AF22: 12.4;NTERA-2: 8.6;U-2 OS: 2.6" "Cancer enriched" "Detected in some" 7 "testis cancer: 3.8" "Group enriched" "Detected in many" 5 "cerebellum: 36.2;cerebral cortex: 14.7;pons and medulla: 40.1" "Cell type enriched" "Detected in single" 8 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA063655 Enhanced Supported "HPA063655: " "unprognostic (1.32e-2)" "unprognostic (4.99e-2)" "unprognostic (4.89e-2)" "unprognostic (1.03e-2)" "unprognostic (2.21e-1)" "unprognostic (2.24e-2)" "unprognostic (3.00e-1)" "unprognostic (2.35e-3)" "unprognostic (8.81e-3)" "unprognostic (1.17e-1)" "unprognostic (1.53e-2)" "unprognostic (6.33e-2)" "unprognostic (1.56e-2)" "unprognostic (6.23e-2)" "unprognostic (3.26e-1)" "unprognostic (2.54e-1)" "unprognostic (5.17e-3)" 1.1 6.1 0.4 1.1 5.9 0.5 0.3 36.2 14.7 0.6 0.7 0.3 0.0 1.1 1.7 4.1 0.4 0.8 1.1 1.5 0.6 1.5 0.5 0.4 0.6 0.7 5.5 0.4 3.1 0.4 0.2 0.3 0.5 40.1 0.9 0.7 1.6 1.1 0.5 1.1 0.7 1.3 0.5 7.1 1.2 0.7 2.4 1.1 0.0 0.6 0.0 0.5 1.0 0.3 0.1 0.0 2.4 0.1 0.1 0.2 0.0 0.0 0.2 12.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.2 1.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 8.6 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.4 5.9 36.2 14.7 0.6 1.5 5.5 0.4 40.1 1.1 SYT5 ENSG00000129990 "Synaptotagmin 5" O00445 19 55171199-55180441 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 73.0" "Group enriched" "Detected in some" 4 "EFO-21: 15.4;HMC-1: 34.1;K-562: 12.0;SCLC-21H: 9.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA078390 Enhanced "HPA078390: " "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "unprognostic (9.76e-2)" "unprognostic (4.59e-2)" "prognostic unfavourable (6.54e-4)" "unprognostic (9.85e-2)" "unprognostic (3.24e-3)" "unprognostic (5.94e-2)" "unprognostic (1.36e-3)" "unprognostic (1.82e-1)" "prognostic favourable (5.54e-4)" "unprognostic (1.15e-3)" "unprognostic (3.71e-7)" "unprognostic (7.09e-2)" "unprognostic (5.21e-2)" "unprognostic (4.42e-2)" "unprognostic (3.55e-1)" 1.2 9.8 20.0 2.7 30.9 1.4 1.0 1.3 73.0 1.8 1.7 1.0 0.0 2.2 1.2 1.0 1.2 1.3 1.3 1.1 22.0 18.8 1.1 1.1 1.2 1.2 6.1 19.8 1.1 2.6 1.1 16.3 1.1 8.3 1.1 1.7 0.0 1.1 1.0 1.2 1.4 1.8 1.5 1.9 1.2 2.9 3.5 3.6 0.0 1.2 0.0 1.3 1.1 0.0 1.0 1.8 3.6 0.8 1.1 0.5 0.5 0.1 0.1 0.2 0.2 0.5 0.0 0.2 0.3 0.0 0.0 0.5 0.0 0.6 0.9 15.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.0 34.1 0.4 0.1 0.0 0.0 0.3 12.0 2.1 0.0 0.3 0.3 0.0 0.0 2.1 0.1 0.2 0.2 0.0 0.0 9.0 4.0 0.0 0.5 0.4 0.2 0.0 0.0 0.7 0.7 1.0 0.0 0.1 0.7 0.4 0.3 0.0 0.2 3.6 0.8 1.1 0.4 0.5 0.4 0.7 0.3 0.5 1.8 1.0 0.4 0.5 3.4 1.1 0.4 0.8 0.3 0.5 20.0 30.9 1.3 36.6 22.0 18.8 6.1 19.8 8.3 3.6 SYT6 ENSG00000134207 "Synaptotagmin 6" Q5T7P8 1 114089291-114153919 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.9;kidney: 3.7;pancreas: 11.1" "Group enriched" "Detected in some" 7 "NTERA-2: 20.6;WM-115: 14.6" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basal ganglia: 27.9;olfactory region: 87.2" "Low region specificity" "Detected in many" HPA058362 Approved Vesicles Vesicles "HPA058362: " "unprognostic (7.12e-2)" "unprognostic (2.03e-2)" "unprognostic (3.26e-3)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (2.49e-1)" "unprognostic (4.11e-2)" "unprognostic (3.60e-3)" "unprognostic (1.19e-1)" "unprognostic (4.71e-1)" "unprognostic (5.50e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-1)" "unprognostic (2.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-2)" "unprognostic (1.18e-1)" 0.3 2.2 2.6 0.8 6.5 0.3 2.1 0.2 10.4 0.4 0.3 5.1 0.0 0.9 0.4 0.2 0.2 0.3 0.5 0.3 2.3 14.9 3.7 0.3 0.4 0.3 2.8 1.3 2.3 11.1 0.7 0.3 1.4 3.9 1.5 0.6 0.9 1.1 0.2 0.4 0.4 0.5 0.3 4.2 0.3 0.3 0.9 3.3 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.1 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.6 6.5 0.2 9.3 2.3 14.9 2.8 1.3 3.9 3.3 SYT7 "IPCA-7, MGC150517, PCANAP7, SYT-VII" ENSG00000011347 "Synaptotagmin 7" O43581 11 61515313-61581148 "Predicted intracellular proteins, Predicted membrane proteins" Exocytosis Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.4;prostate: 36.9;salivary gland: 37.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 15.0;hTERT-HME1: 39.3;RT4: 16.0;SCLC-21H: 12.7;SK-BR-3: 17.9;T-47d: 17.5" "Cancer enhanced" "Detected in all" "prostate cancer: 54.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012869 Enhanced "HPA012869: AB_1857698" "unprognostic (7.09e-2)" "unprognostic (8.26e-2)" "unprognostic (2.43e-1)" "unprognostic (2.10e-2)" "unprognostic (5.42e-2)" "prognostic unfavourable (1.20e-4)" "unprognostic (4.37e-2)" "unprognostic (5.08e-2)" "unprognostic (2.74e-3)" "unprognostic (1.79e-2)" "unprognostic (1.02e-2)" "unprognostic (2.54e-2)" "prognostic unfavourable (1.16e-4)" "unprognostic (2.08e-1)" "unprognostic (1.69e-1)" "unprognostic (2.23e-3)" "unprognostic (2.47e-1)" 2.5 3.7 16.2 1.4 22.7 0.6 6.9 22.8 46.4 2.8 4.0 3.2 0.0 2.1 2.0 1.9 1.9 1.7 1.4 11.1 11.8 7.8 4.4 28.2 1.7 0.8 4.9 23.6 1.2 11.9 2.2 22.2 12.7 8.8 36.9 4.2 2.4 37.7 1.3 2.8 1.6 3.3 1.8 1.5 1.8 3.4 2.5 3.0 0.0 3.5 0.6 0.8 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.6 0.8 0.2 0.0 0.4 6.4 4.6 0.1 15.0 0.2 0.2 1.4 3.0 0.0 0.2 0.0 3.0 0.4 0.1 0.1 0.1 0.7 0.0 0.6 0.8 0.4 0.0 0.0 0.2 3.5 1.8 39.3 0.0 0.0 0.1 0.2 9.3 0.0 0.1 1.0 6.3 0.0 0.3 0.7 0.0 16.0 12.7 2.3 0.8 17.9 0.1 17.5 0.0 0.0 3.7 1.4 4.2 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 22.7 22.8 37.5 11.8 7.8 4.9 23.6 8.8 3.0 SYT8 DKFZp434K0322 ENSG00000149043 "Synaptotagmin 8" Q8NBV8 11 1828307-1837521 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 61.8;skin 1: 41.6;urinary bladder: 31.4" "Group enriched" "Detected in some" 5 "CAPAN-2: 27.1;hTCEpi: 43.2;T-47d: 11.6" "Cancer enhanced" "Detected in many" "urothelial cancer: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052700 Uncertain "HPA052700: " "unprognostic (1.66e-3)" "unprognostic (2.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.14e-1)" "unprognostic (6.31e-2)" "unprognostic (2.06e-1)" "unprognostic (3.10e-2)" "unprognostic (1.36e-2)" "unprognostic (1.02e-1)" "unprognostic (8.25e-2)" "unprognostic (7.09e-2)" "unprognostic (2.48e-1)" "unprognostic (2.33e-6)" "unprognostic (2.87e-2)" "unprognostic (1.75e-1)" "unprognostic (5.52e-2)" "unprognostic (2.77e-2)" 0.1 0.1 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.7 0.9 0.0 6.8 0.7 0.1 7.3 19.9 0.6 61.8 0.1 0.1 0.0 0.5 0.3 2.3 0.0 0.0 0.0 0.1 7.8 0.0 0.1 5.7 0.0 5.6 0.1 0.3 11.8 4.2 0.1 41.6 3.6 6.3 0.1 0.1 3.1 0.1 0.0 0.0 0.1 19.4 13.3 31.4 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 27.1 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 43.2 0.0 5.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.8 0.0 0.2 0.0 2.3 0.0 11.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TACSTD2 "EGP-1, GA733-1, M1S1, TROP2" ENSG00000184292 "Tumor associated calcium signal transducer 2" P09758 1 58575423-58577773 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Tumor antigen" "Amyloidosis, Corneal dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.9;salivary gland: 56.4" "Cell line enhanced" "Detected in some" "A-431: 74.1;CAPAN-2: 100.5;HaCaT: 100.7;RT4: 34.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 12.4" "Group enriched" "Detected in many" 65 "dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043104, HPA055067, CAB072852" Enhanced Supported "Nucleoli,Vesicles,Plasma membrane" "Plasma membrane" "Nucleoli, Vesicles" "CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687" "unprognostic (1.80e-2)" "unprognostic (3.08e-1)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (5.70e-2)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (7.91e-2)" "prognostic favourable (3.99e-4)" "unprognostic (7.10e-2)" "unprognostic (2.55e-1)" "unprognostic (6.91e-3)" "unprognostic (2.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 17.1 0.0 0.0 23.1 0.0 0.0 1.7 2.6 103.9 2.7 0.9 0.0 0.0 0.0 10.4 0.0 8.0 0.0 0.0 0.0 9.0 0.0 0.0 1.5 15.7 0.0 56.4 12.6 0.0 42.1 0.0 0.0 0.0 0.0 7.3 0.0 0.1 20.6 17.7 36.1 0.0 3.7 12.4 3.2 0.0 0.0 1.8 74.1 0.0 0.0 0.1 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 100.5 0.0 9.7 6.3 100.7 0.0 18.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 1.1 4.2 0.0 0.1 0.0 15.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 13.5 34.8 0.0 0.0 3.2 26.8 0.1 17.5 0.1 4.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 12.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.8 TAF15 "hTAFII68, Npl3, RBP56, TAF2N" ENSG00000270647 "TATA-box binding protein associated factor 15" Q92804 17 35713791-35864615 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052059, HPA063647" Supported Enhanced Nucleoplasm Nucleoplasm "HPA052059: , HPA063647: " "unprognostic (1.26e-1)" "unprognostic (2.66e-3)" "unprognostic (1.10e-1)" "unprognostic (1.63e-2)" "unprognostic (1.82e-1)" "unprognostic (1.27e-1)" "unprognostic (8.48e-3)" "unprognostic (4.75e-2)" "unprognostic (8.06e-3)" "unprognostic (2.08e-2)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (1.79e-2)" "unprognostic (1.39e-2)" "unprognostic (5.41e-2)" "unprognostic (3.35e-2)" "unprognostic (2.99e-1)" 14.0 12.9 12.7 15.3 16.2 13.9 11.0 13.7 14.1 10.5 11.7 15.0 13.2 12.7 10.2 11.0 12.6 8.0 11.5 13.1 11.8 9.8 15.0 8.9 19.4 14.7 8.3 10.7 11.3 14.6 18.1 11.1 11.1 11.4 10.1 9.2 9.8 15.3 26.9 14.7 13.4 17.5 15.9 12.7 11.0 11.3 15.5 21.1 9.4 12.8 15.8 12.0 9.8 3.7 3.2 3.8 3.6 4.7 7.2 2.2 28.7 47.3 25.3 24.5 20.3 11.5 16.6 32.9 11.2 15.0 14.7 31.6 20.8 57.2 23.7 21.3 30.6 33.6 33.1 21.7 16.1 43.9 32.9 34.4 33.1 20.0 53.1 22.1 18.3 17.4 22.7 35.7 20.2 30.8 23.7 16.9 34.3 57.9 12.9 15.6 13.6 34.6 37.6 21.4 19.0 51.7 19.2 18.9 41.0 12.4 13.0 29.0 18.3 27.3 11.6 25.3 16.7 39.5 22.4 27.3 41.7 22.9 26.2 19.0 3.8 3.5 3.5 4.9 3.4 7.2 3.0 3.5 3.8 2.5 3.7 3.3 3.7 2.0 4.7 3.6 3.2 3.9 2.2 TAF1B "RAF1B, RAFI63, SL1, TAFI63" ENSG00000115750 "TATA-box binding protein associated factor, RNA polymerase I subunit B" Q53T94 2 9843354-9934416 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071254 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA071254: " "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "prognostic favourable (8.58e-5)" "unprognostic (1.44e-3)" "unprognostic (5.43e-2)" "unprognostic (1.24e-1)" "prognostic unfavourable (6.94e-7)" "unprognostic (9.17e-2)" "unprognostic (3.29e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (2.98e-1)" "prognostic favourable (8.55e-4)" "unprognostic (2.59e-1)" "unprognostic (2.49e-1)" "unprognostic (2.79e-2)" "unprognostic (1.49e-2)" 13.4 11.7 10.2 10.7 11.1 7.8 12.1 14.0 12.7 12.3 7.4 8.4 15.9 7.1 19.2 14.5 16.5 13.6 9.7 8.5 9.3 11.7 17.9 9.9 11.5 13.9 9.2 9.5 12.7 8.9 22.6 19.5 20.2 10.7 12.6 8.1 11.6 10.1 20.1 7.2 11.3 7.5 11.1 8.5 13.9 8.4 17.1 9.2 23.3 14.9 10.9 15.8 9.9 14.4 9.8 11.3 4.9 13.1 8.5 12.9 4.6 12.0 12.0 16.7 5.1 8.4 12.9 26.9 13.2 13.2 14.4 12.5 11.1 9.8 14.2 7.0 10.7 6.9 14.5 16.3 16.1 13.8 15.8 15.3 5.1 14.9 10.9 12.0 17.1 10.1 9.6 10.6 15.7 21.6 10.2 15.1 14.5 8.0 9.0 10.2 20.1 8.8 5.4 14.1 4.4 14.7 10.8 7.1 18.2 11.4 15.3 11.6 5.3 9.6 10.0 17.4 20.5 17.0 18.2 7.4 8.8 20.2 10.5 13.9 14.9 2.6 8.4 4.9 11.5 13.1 10.9 9.5 9.5 12.9 11.3 9.8 6.3 9.4 0.4 8.5 10.0 9.4 9.4 4.6 10.2 11.1 14.0 12.7 9.3 11.7 9.2 9.5 10.7 9.2 TAF1D "JOSD3, MGC5306, TAF(I)41" ENSG00000166012 "TATA-box binding protein associated factor, RNA polymerase I subunit D" Q9H5J8 11 93729948-93784391 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030703, HPA055935, HPA060385" Uncertain Supported "Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite" Nucleoplasm "Nucleoli, Mitotic spindle, Centriolar satellite" "HPA030703: , HPA055935: , HPA060385: " "unprognostic (9.91e-3)" "unprognostic (4.38e-2)" "unprognostic (6.80e-2)" "unprognostic (1.71e-1)" "unprognostic (5.40e-3)" "unprognostic (6.46e-2)" "unprognostic (3.68e-3)" "unprognostic (9.70e-2)" "unprognostic (5.24e-3)" "unprognostic (3.55e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-2)" "prognostic unfavourable (3.17e-7)" "unprognostic (1.95e-1)" "unprognostic (2.51e-1)" "unprognostic (2.34e-1)" "unprognostic (6.37e-2)" 13.9 10.6 12.5 19.9 18.4 14.2 12.9 17.3 20.1 15.1 14.7 4.3 17.3 16.8 15.2 9.7 16.0 11.5 18.1 11.1 12.0 7.6 13.6 18.7 15.8 19.0 14.4 13.6 20.9 30.5 9.3 24.3 18.5 13.6 16.4 13.4 3.9 12.3 11.4 31.5 14.5 17.8 18.1 22.1 18.4 13.0 8.0 13.6 13.1 13.2 12.9 12.2 28.1 17.1 24.1 14.3 22.3 9.2 9.0 16.3 2.7 3.8 3.0 4.1 4.1 4.1 16.0 7.5 4.4 3.2 5.6 4.0 10.5 10.6 9.4 8.4 4.2 11.6 4.8 6.9 6.2 2.5 2.0 9.6 17.3 6.2 4.0 8.7 5.2 4.4 7.4 4.5 7.3 7.0 6.5 18.6 7.7 1.2 7.3 16.8 3.2 2.4 3.5 4.7 8.0 6.5 6.2 2.9 6.2 2.6 9.5 3.0 11.8 2.2 6.8 8.4 5.6 12.7 6.4 8.3 9.4 7.9 3.1 9.3 2.8 17.4 9.2 14.8 10.0 6.5 10.0 19.5 13.8 10.9 6.2 24.1 16.3 13.6 22.3 9.0 5.2 14.3 9.4 2.7 12.5 18.4 17.3 20.1 12.0 7.6 14.4 13.6 13.6 13.6 TAPBP TAPA ENSG00000231925 "TAP binding protein" O15533 6 33299694-33314387 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007066 Approved 1100000 "HPA007066: AB_1857769" "prognostic favourable (2.76e-4)" "unprognostic (1.43e-2)" "unprognostic (7.01e-2)" "unprognostic (1.98e-2)" "unprognostic (1.59e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.21e-2)" "prognostic favourable (6.29e-4)" "unprognostic (1.67e-2)" "unprognostic (2.37e-1)" "unprognostic (3.63e-1)" "unprognostic (1.61e-2)" "unprognostic (3.82e-1)" "unprognostic (1.19e-2)" "unprognostic (1.21e-1)" "unprognostic (6.54e-3)" 31.8 24.5 10.5 28.0 12.4 19.3 14.1 13.2 13.6 15.8 41.3 10.1 17.1 44.2 13.2 21.2 23.8 15.0 22.4 22.4 10.5 8.5 26.7 48.7 34.8 20.9 8.9 8.3 17.9 16.5 27.3 13.6 28.8 9.2 21.8 11.0 13.9 20.9 16.6 18.5 16.2 46.6 20.6 7.4 46.8 23.2 10.0 8.6 55.2 40.2 17.8 34.6 19.6 13.8 15.7 15.7 26.9 23.6 25.1 24.0 29.1 0.8 0.5 1.7 3.5 3.8 4.8 17.1 8.1 19.9 10.1 12.0 0.0 30.9 7.0 8.4 11.3 0.8 0.0 6.8 2.0 18.9 2.3 6.1 3.8 4.8 0.0 7.7 9.9 12.2 5.8 0.2 1.5 0.1 0.5 19.0 2.0 3.1 6.9 5.9 0.0 2.2 1.1 0.1 0.5 3.6 0.4 3.0 0.2 0.2 0.7 3.0 0.5 0.1 14.1 17.5 4.1 0.5 0.6 23.4 15.8 8.9 11.9 7.8 11.9 21.4 14.0 26.9 24.0 15.7 22.5 15.7 18.1 22.6 15.7 10.1 12.7 16.1 22.2 25.1 23.6 14.9 12.5 29.1 10.5 12.4 13.2 13.6 10.5 8.5 8.9 8.3 9.2 8.6 TAPBPL "FLJ10143, TAPBP-R, TAPBPR" ENSG00000139192 "TAP binding protein like" Q9BX59 12 6451690-6466517 "Predicted intracellular proteins, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 32.3;HDLM-2: 18.4;Karpas-707: 23.2;RPMI-8226: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039545 Uncertain "HPA039545: AB_10673360" "prognostic favourable (1.98e-4)" "unprognostic (3.56e-1)" "unprognostic (4.58e-2)" "unprognostic (2.30e-1)" "unprognostic (1.32e-1)" "unprognostic (4.61e-2)" "unprognostic (1.91e-1)" "unprognostic (7.64e-2)" "unprognostic (4.07e-2)" "unprognostic (3.18e-1)" "unprognostic (5.66e-2)" "unprognostic (1.40e-1)" "prognostic favourable (6.04e-5)" "unprognostic (3.53e-2)" "unprognostic (7.61e-2)" "unprognostic (6.28e-2)" "prognostic favourable (7.86e-4)" 11.2 11.2 5.4 12.5 7.3 7.2 10.6 2.3 5.7 11.3 23.3 8.6 26.1 22.3 10.9 17.6 8.9 13.4 15.0 14.7 6.6 3.9 15.5 18.1 12.3 10.5 7.8 4.0 9.9 13.1 10.1 10.4 18.2 6.7 10.4 8.6 12.9 24.3 20.9 5.5 7.3 38.5 8.3 7.7 15.5 16.7 4.1 6.0 27.8 20.2 9.1 20.2 11.1 8.9 12.9 26.8 31.7 42.8 36.6 32.6 34.6 3.1 2.3 0.0 1.3 5.4 7.1 6.6 2.0 6.3 2.5 4.3 2.6 32.3 2.7 1.2 2.6 3.9 0.0 0.5 0.4 18.4 0.0 2.7 1.6 2.7 6.7 2.6 7.6 10.5 1.8 5.1 0.8 3.8 0.0 23.2 0.5 6.8 5.3 1.4 0.3 0.4 5.4 1.6 17.7 2.3 8.7 0.2 0.0 7.6 4.7 0.5 0.2 5.9 3.6 3.0 1.1 0.7 3.6 3.7 0.9 1.5 5.5 2.6 3.2 31.7 37.3 24.8 32.6 42.8 21.2 12.8 17.5 21.2 26.8 12.9 11.1 20.6 26.9 36.6 33.6 22.2 11.0 34.6 5.4 7.3 2.3 5.7 6.6 3.9 7.8 4.0 6.7 6.0 TARM1 ENSG00000248385 "T cell-interacting, activating receptor on myeloid cells 1" B6A8C7 19 54069895-54081365 "Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.1;lymphoid tissue: 2.4" "Cell line enhanced" "Detected in some" "Hep G2: 1.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 2.8;neutrophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "HPA051022, HPA054401" Uncertain "HPA051022: , HPA054401: " "unprognostic (1.56e-1)" 0.1 0.7 0.1 0.0 0.1 1.2 0.2 0.1 0.4 0.0 0.1 0.0 0.4 0.0 0.1 0.3 0.8 0.1 0.1 0.1 0.1 0.2 0.6 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.1 2.4 0.2 0.7 0.7 0.1 0.0 0.1 0.5 0.3 3.1 0.5 0.6 0.3 0.2 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.3 0.3 0.0 0.0 0.6 1.1 0.4 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.4 0.8 0.7 1.7 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.7 0.0 1.0 0.2 0.8 0.4 0.4 0.2 0.0 0.0 0.6 0.2 1.4 0.4 1.1 0.2 0.0 0.6 0.0 0.9 0.2 0.1 1.1 0.1 1.1 0.4 0.3 0.0 0.9 0.2 2.8 0.5 0.6 0.3 0.4 0.2 0.1 0.2 0.1 0.2 0.5 0.1 0.3 3.1 0.6 0.3 0.3 0.1 0.2 TAS2R1 "T2R1, TRB7" ENSG00000169777 "Taste 2 receptor member 1" Q9NYW7 5 9628997-9712378 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 13.0" "Group enriched" "Detected in some" 5 "BJ hTERT+: 3.5;U-266/84: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051879 Uncertain "HPA051879: " "unprognostic (2.19e-1)" 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TATDN1 CDA11 ENSG00000147687 "TatD DNase domain containing 1" Q6P1N9 8 124488485-124539458 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023634, HPA053045" Uncertain Supported Nucleoplasm 2000000 Nucleoplasm "HPA023634: AB_1857779, HPA053045: " "unprognostic (2.19e-3)" "unprognostic (3.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.87e-2)" "unprognostic (1.65e-1)" "unprognostic (1.23e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-2)" "prognostic unfavourable (2.53e-4)" "unprognostic (2.50e-1)" "unprognostic (6.33e-3)" "unprognostic (3.44e-2)" "unprognostic (4.30e-2)" "unprognostic (2.24e-1)" "unprognostic (5.12e-2)" 16.6 14.1 16.1 13.0 18.6 9.9 27.4 22.7 18.8 14.9 14.4 11.7 9.9 12.3 16.7 15.3 15.5 16.8 10.1 16.4 14.9 14.4 19.4 17.1 16.3 14.7 22.7 17.0 28.9 34.7 13.2 18.4 10.5 19.4 13.8 16.0 8.1 18.6 11.1 40.4 14.0 11.9 16.9 21.2 8.2 16.3 8.3 18.3 15.1 26.2 14.5 13.3 15.2 13.3 10.5 10.0 13.7 7.2 11.1 18.1 8.9 20.2 14.3 13.8 9.6 12.4 23.5 10.4 11.1 12.3 14.2 13.2 14.0 22.2 15.4 25.2 12.2 16.7 16.6 16.6 23.6 19.7 11.0 14.3 11.9 12.1 23.6 10.8 5.3 17.6 26.4 20.7 43.8 11.3 11.6 10.1 18.9 61.5 16.1 6.7 13.7 18.6 10.8 10.2 17.2 20.0 14.3 11.5 16.2 12.5 25.3 26.1 17.0 11.7 8.8 10.1 26.9 18.4 30.2 13.0 19.8 19.4 18.9 19.3 8.7 13.7 7.2 2.8 8.2 6.0 12.7 10.5 12.5 10.1 10.0 10.4 18.1 16.6 1.5 11.1 4.5 7.5 12.9 8.9 16.1 18.6 22.7 18.8 14.9 14.4 22.7 17.0 19.4 18.3 TAX1BP1 "CALCOCO3, TXBP151" ENSG00000106052 "Tax1 binding protein 1" Q86VP1 7 27739331-27844564 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024432 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA024432: AB_1857783" "unprognostic (1.38e-2)" "unprognostic (5.52e-2)" "unprognostic (3.55e-2)" "unprognostic (2.71e-2)" "unprognostic (2.55e-1)" "unprognostic (9.83e-3)" "unprognostic (1.81e-2)" "unprognostic (2.36e-1)" "unprognostic (4.59e-2)" "unprognostic (6.72e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (3.69e-1)" "prognostic favourable (2.80e-6)" "unprognostic (1.76e-1)" "unprognostic (4.76e-2)" "unprognostic (1.21e-1)" "unprognostic (3.03e-1)" 28.5 63.0 31.1 19.5 49.8 34.9 30.7 33.5 48.4 33.8 33.4 16.1 26.7 23.7 27.4 35.5 46.6 30.7 28.2 47.4 30.8 31.9 51.0 35.3 28.7 23.0 41.0 34.8 32.0 29.7 46.3 69.4 65.8 54.1 36.4 31.1 18.7 32.3 32.6 50.3 23.5 41.0 48.8 41.7 34.5 30.3 30.3 35.2 34.2 44.5 27.0 24.6 51.3 29.0 21.1 17.5 59.7 31.3 17.3 33.0 22.5 40.0 22.2 22.8 21.5 36.1 26.4 15.5 30.0 36.9 22.5 28.3 17.9 32.7 8.5 28.3 43.7 28.6 21.3 19.6 35.3 16.0 11.0 23.1 23.9 35.7 34.1 33.6 27.5 22.3 40.8 26.1 30.1 24.2 25.7 26.3 45.4 14.7 14.7 33.3 25.6 20.9 12.3 24.5 17.4 31.8 45.4 15.1 24.6 42.0 55.0 62.5 25.6 50.8 26.0 21.3 33.3 26.4 19.7 48.4 33.5 16.0 24.9 64.0 48.7 37.4 24.2 59.7 21.8 29.3 26.3 21.1 25.9 25.3 17.5 17.9 24.0 24.0 48.9 17.3 31.3 16.2 33.0 22.5 31.1 49.8 33.5 48.4 30.8 31.9 41.0 34.8 54.1 35.2 TAZ "BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2" ENSG00000102125 Tafazzin Q16635 X 154411518-154421726 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039557 Approved Approved "Plasma membrane" "Plasma membrane" "HPA039557: AB_10672899" "unprognostic (1.14e-1)" "prognostic favourable (5.70e-4)" "unprognostic (4.94e-3)" "unprognostic (1.43e-1)" "unprognostic (8.29e-2)" "unprognostic (7.84e-2)" "unprognostic (1.56e-2)" "unprognostic (8.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "unprognostic (4.68e-2)" "unprognostic (8.39e-2)" "prognostic unfavourable (1.22e-7)" "unprognostic (4.00e-3)" "unprognostic (4.20e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" 11.9 8.7 12.1 15.0 13.6 36.8 11.7 12.4 13.5 10.9 15.4 15.6 12.1 13.9 10.8 13.0 15.1 9.9 14.1 25.9 11.0 8.4 13.3 14.0 14.3 17.3 16.7 9.6 12.6 16.3 10.7 8.9 9.1 13.1 11.1 10.8 12.2 12.7 14.5 27.9 18.6 15.0 11.7 12.8 25.4 12.8 3.4 15.1 17.2 11.8 13.4 14.4 10.8 19.5 16.7 14.7 13.8 10.3 12.3 17.2 7.8 11.0 12.5 4.6 5.1 9.0 5.4 8.8 3.9 7.7 6.0 8.3 4.1 13.8 13.1 21.3 5.7 16.8 6.5 7.2 4.2 11.2 9.6 2.6 8.0 6.4 10.1 5.0 6.2 5.5 13.2 5.2 11.8 9.0 5.2 13.9 5.2 6.7 12.7 15.8 1.3 13.1 10.5 7.0 17.6 8.2 3.2 5.8 8.2 2.5 7.4 10.7 4.5 8.9 6.5 4.9 6.3 12.0 5.9 32.5 12.8 27.3 6.0 17.6 5.6 5.7 10.3 13.8 12.1 9.3 11.0 11.3 17.2 15.5 14.7 16.7 14.4 12.5 9.4 12.3 7.4 7.3 12.2 7.8 12.1 13.6 12.4 13.5 11.0 8.4 16.7 9.6 13.1 15.1 TBC1D10C "Carabin, EPI64C, FLJ00332" ENSG00000175463 "TBC1 domain family member 10C" Q8IV04 11 67403915-67410089 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 55.4;bone marrow: 16.0;intestine: 14.5;lymphoid tissue: 35.0" "Cell line enhanced" "Detected in some" "Daudi: 7.8;HEL: 6.2;MOLT-4: 23.1;NB-4: 27.8;U-937: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA069743 Enhanced Approved "Nuclear bodies" "Nuclear bodies" "HPA069743: " "prognostic favourable (3.83e-4)" "prognostic favourable (4.20e-4)" "unprognostic (9.23e-2)" "unprognostic (3.84e-2)" "unprognostic (1.28e-3)" "prognostic favourable (1.86e-5)" "unprognostic (6.22e-3)" "unprognostic (1.17e-2)" "unprognostic (3.65e-2)" "unprognostic (3.55e-2)" "unprognostic (3.28e-2)" "unprognostic (2.55e-1)" "prognostic unfavourable (4.35e-7)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (7.18e-2)" "unprognostic (3.81e-2)" 1.3 0.4 0.7 20.8 0.8 16.0 0.7 0.4 0.4 0.9 3.0 0.4 0.7 2.4 0.5 0.6 1.6 1.3 1.5 0.8 1.1 0.3 1.9 1.5 5.2 22.4 0.5 0.8 0.6 0.5 0.0 0.4 0.7 0.4 1.1 0.4 1.4 3.6 0.2 0.4 0.4 14.5 0.2 0.8 35.0 3.1 0.7 0.9 27.1 4.6 1.0 27.8 1.8 1.8 39.1 13.1 52.5 30.6 25.9 55.4 49.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.8 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.4 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 23.1 27.8 0.0 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 5.0 0.0 11.5 0.0 33.2 10.0 52.5 51.1 23.7 36.2 37.6 44.5 44.7 13.1 39.1 46.8 42.3 49.1 25.9 30.6 11.0 55.4 49.2 0.7 0.8 0.4 0.4 1.1 0.3 0.5 0.8 0.4 0.9 TBC1D23 FLJ11046 ENSG00000036054 "TBC1 domain family member 23" Q9NUY8 3 100261000-100325251 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038151, HPA038152" Approved Enhanced "Golgi apparatus" "Golgi apparatus" "HPA038151: AB_10672405, HPA038152: AB_10672620" "unprognostic (9.23e-3)" "unprognostic (6.01e-2)" "unprognostic (2.77e-2)" "prognostic unfavourable (5.37e-4)" "unprognostic (1.79e-2)" "unprognostic (6.18e-2)" "unprognostic (7.87e-3)" "unprognostic (6.16e-2)" "unprognostic (7.92e-2)" "unprognostic (2.02e-2)" "unprognostic (2.98e-3)" "unprognostic (3.66e-3)" "unprognostic (1.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.51e-1)" "unprognostic (5.64e-2)" "unprognostic (2.32e-1)" 26.2 28.3 13.4 13.2 14.3 20.4 17.8 28.2 18.9 18.0 17.9 13.6 18.2 18.3 19.1 14.3 20.5 13.3 14.4 16.2 12.8 10.6 20.8 23.2 15.8 11.6 17.6 13.8 19.6 18.5 18.3 25.6 33.5 16.8 16.5 16.0 12.2 20.6 10.6 30.9 20.5 29.6 15.5 19.3 18.2 15.2 17.0 18.1 19.1 16.8 15.7 15.1 21.0 16.9 11.5 17.5 22.5 20.1 20.8 15.5 14.8 33.0 6.8 8.0 4.3 15.5 21.0 7.8 20.1 20.2 21.0 25.2 13.5 5.7 7.9 9.8 20.9 11.2 28.5 12.6 32.8 4.7 7.3 21.7 8.3 8.8 15.7 9.6 17.6 16.9 10.6 11.5 16.9 11.1 17.8 11.8 13.3 6.8 7.7 4.7 9.1 13.1 6.5 17.4 9.3 12.4 7.2 11.4 6.5 10.5 8.0 13.4 8.7 9.5 11.0 14.8 14.6 7.0 12.8 11.5 12.2 14.3 20.0 9.4 12.6 22.5 16.6 20.6 12.0 19.3 12.6 11.5 11.8 11.1 17.5 10.8 10.9 11.6 11.2 20.8 20.1 7.5 15.5 14.8 13.4 14.3 28.2 18.9 12.8 10.6 17.6 13.8 16.8 18.1 TBC1D24 "DFNA65, DFNB86, KIAA1171, TLDC6" ENSG00000162065 "TBC1 domain family member 24" Q9ULP9 16 2475051-2509560 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Deafness, Disease mutation, Epilepsy, Mental retardation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 33.4" "Cell line enhanced" "Detected in all" "SCLC-21H: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA044712, HPA068080" Uncertain Supported "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "HPA044712: AB_10795619, HPA068080: " "prognostic unfavourable (3.22e-4)" "unprognostic (5.23e-2)" "unprognostic (4.02e-2)" "unprognostic (6.41e-2)" "unprognostic (3.52e-1)" "unprognostic (1.52e-2)" "unprognostic (1.40e-1)" "unprognostic (2.03e-2)" "unprognostic (1.68e-1)" "unprognostic (7.37e-2)" "unprognostic (4.37e-2)" "unprognostic (1.28e-1)" "unprognostic (4.66e-3)" "unprognostic (2.02e-2)" "unprognostic (8.19e-2)" "unprognostic (7.78e-3)" "unprognostic (1.61e-1)" 6.0 5.8 11.0 2.9 9.6 3.7 4.9 15.8 17.7 4.2 3.5 2.8 6.7 3.8 3.3 5.0 2.2 4.3 3.5 4.9 9.0 5.4 7.6 6.6 6.4 3.0 3.8 12.2 2.1 16.6 5.2 5.6 3.6 7.5 4.5 1.9 5.4 33.4 6.4 6.1 3.5 2.8 3.1 3.7 3.4 3.8 2.4 4.5 0.8 5.5 1.0 2.3 4.0 2.9 0.2 1.3 0.0 0.9 0.2 2.2 1.0 2.6 5.0 3.3 6.8 4.0 4.0 2.9 4.7 2.4 3.1 2.6 4.7 2.2 6.5 4.3 3.6 4.7 5.2 1.4 2.2 7.1 6.2 5.9 6.5 4.0 2.4 4.2 2.5 1.5 2.1 2.7 1.1 3.8 7.1 3.6 2.8 4.6 2.9 8.5 3.0 3.3 15.1 6.4 4.5 2.2 1.7 26.5 6.4 3.1 11.6 1.9 3.7 3.8 4.0 6.1 6.6 5.9 4.6 2.4 2.1 8.1 2.6 6.2 5.4 0.0 0.7 0.0 2.2 0.8 0.7 0.2 0.5 0.7 1.3 0.1 0.5 0.3 0.0 0.2 0.9 0.6 0.0 1.0 11.0 9.6 15.8 12.4 9.0 5.4 3.8 12.2 7.5 4.5 TBC1D2B KIAA1055 ENSG00000167202 "TBC1 domain family member 2B" Q9UPU7 15 77984036-78077724 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041833, HPA048174, HPA052663" Approved Enhanced Cytosol Cytosol "HPA041833: , HPA048174: , HPA052663: " "unprognostic (3.13e-1)" "unprognostic (2.16e-1)" "unprognostic (8.25e-2)" "unprognostic (1.28e-2)" "unprognostic (3.94e-2)" "unprognostic (1.43e-1)" "unprognostic (5.07e-3)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (8.22e-3)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (1.23e-3)" "unprognostic (6.68e-2)" "unprognostic (3.07e-2)" "unprognostic (3.37e-1)" "unprognostic (3.19e-2)" 26.0 14.1 9.3 12.0 10.0 11.9 21.4 8.4 8.4 22.8 16.7 8.4 7.3 7.6 20.2 13.0 9.3 18.2 20.0 7.8 7.7 4.3 8.2 18.3 22.7 12.5 8.3 5.6 31.2 16.6 17.7 7.1 28.9 7.2 13.6 10.8 20.7 8.6 14.0 5.0 10.5 14.3 15.5 9.7 19.9 12.6 11.0 7.3 20.4 10.4 5.8 14.4 17.1 18.4 0.4 3.2 3.7 2.1 3.8 4.2 1.3 5.0 4.0 4.8 4.5 33.9 27.1 8.4 11.5 17.4 10.8 12.0 5.0 2.0 7.7 4.6 9.7 7.3 10.4 12.7 8.3 14.6 8.1 4.9 3.8 3.4 16.1 12.4 7.5 26.3 8.9 7.2 4.8 12.3 2.5 5.4 14.0 5.5 4.6 8.1 3.8 3.9 7.0 22.1 1.7 5.6 19.1 2.5 7.0 10.7 7.3 13.6 2.4 13.0 15.0 11.9 7.8 3.7 6.1 9.1 9.6 4.2 4.1 16.8 6.2 0.0 2.1 0.9 3.9 1.8 2.2 0.2 2.6 4.2 1.4 0.4 1.9 1.5 3.7 3.8 0.5 3.2 1.5 1.3 9.3 10.0 8.4 8.4 7.7 4.3 8.3 5.6 7.2 7.3 TBC1D3 "DKFZp434P2235, PRC17, TBC1D3A" ENSG00000274611 "TBC1 domain family member 3" Q8IZP1 17 38181659-38192541 "Predicted membrane proteins" "GTPase activation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 3.4;intestine: 5.5;lymphoid tissue: 3.5;testis: 5.5" "Cell line enhanced" "Detected in some" "AF22: 9.0;REH: 5.6;U-138 MG: 7.8;U-266/70: 12.1;U-266/84: 4.7;U-698: 6.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 3.4 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.9 1.9 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 5.5 0.0 3.5 0.0 0.0 0.0 2.2 0.0 0.0 0.9 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.6 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 12.1 4.7 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 TBC1D30 KIAA0984 ENSG00000111490 "TBC1 domain family member 30" Q9Y2I9 12 64781193-64881032 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 19.8" "Cell line enhanced" "Detected in many" "MCF7: 23.0;RPMI-8226: 13.6;RT4: 17.7;SCLC-21H: 16.6;SK-BR-3: 17.0;T-47d: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Group enriched" "Detected in many" 17 "granulocytes: 2.4;monocytes: 1.1;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039772, HPA040043" Approved Supported "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA039772: AB_10795409, HPA040043: AB_10795411" "unprognostic (1.85e-1)" "unprognostic (6.95e-2)" "unprognostic (2.66e-1)" "prognostic favourable (3.61e-5)" "unprognostic (9.35e-2)" "unprognostic (2.09e-1)" "unprognostic (2.65e-5)" "prognostic favourable (5.08e-4)" "unprognostic (1.75e-3)" "unprognostic (2.16e-2)" "unprognostic (2.44e-1)" "unprognostic (9.72e-2)" "unprognostic (7.32e-2)" "unprognostic (7.62e-3)" "unprognostic (8.72e-2)" "unprognostic (2.67e-3)" "unprognostic (7.80e-3)" 1.8 1.6 4.7 2.3 11.4 0.5 5.3 13.4 15.8 7.6 3.3 1.5 12.4 5.0 3.1 2.5 1.2 2.1 4.8 1.1 7.1 5.5 3.9 1.7 3.9 0.9 4.7 7.0 1.5 19.8 8.9 6.5 1.4 16.5 3.7 3.5 2.0 14.4 11.6 0.9 1.3 3.5 2.4 3.0 2.5 6.9 3.2 2.8 0.0 3.3 0.2 0.7 4.9 1.9 0.0 0.0 2.4 1.1 0.0 1.3 0.3 6.9 1.4 0.4 0.4 0.0 0.5 0.6 0.0 0.0 0.0 0.1 6.5 2.2 0.3 1.1 0.0 0.1 6.8 0.1 0.0 0.0 6.7 0.3 1.2 0.3 0.1 2.3 1.4 0.4 0.0 0.0 0.2 5.7 0.0 2.4 0.2 23.0 0.0 0.4 0.9 6.8 0.1 0.1 13.6 0.8 17.7 16.6 1.3 1.4 17.0 0.2 12.4 1.1 5.4 0.0 1.0 0.5 3.4 0.0 0.0 0.2 0.1 0.7 0.3 0.0 1.1 0.0 0.4 1.1 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 2.4 0.0 0.7 0.0 0.0 0.3 4.7 11.4 13.4 15.8 7.1 5.5 4.7 7.0 16.5 2.8 TBC1D3B "PRC17, TBC1D3I" ENSG00000274808 "TBC1 domain family member 3B" A6NDS4 17 36165681-36176636 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 6.6;testis: 3.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.3;HeLa: 9.7;T-47d: 7.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.94e-2)" "unprognostic (1.49e-1)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.11e-1)" "unprognostic (2.83e-1)" "unprognostic (2.51e-1)" "unprognostic (1.17e-1)" "unprognostic (7.15e-2)" "unprognostic (9.96e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (3.56e-1)" "unprognostic (1.34e-1)" 0.0 0.1 1.0 0.4 0.4 0.1 0.0 0.1 1.2 0.0 0.0 1.0 0.4 0.2 0.0 0.0 0.0 0.2 0.6 0.1 1.3 0.0 0.0 0.2 0.0 0.8 0.8 1.2 6.6 0.5 0.0 2.0 1.9 3.5 0.0 0.1 0.4 0.0 0.0 0.7 0.0 1.0 0.4 0.1 1.4 2.4 1.4 1.8 1.5 1.8 4.8 1.2 0.7 1.3 2.1 0.5 11.3 0.2 0.9 0.7 4.9 0.7 1.1 0.5 2.0 3.8 0.8 9.7 0.7 0.9 0.3 1.4 1.5 2.2 1.5 0.2 0.9 0.7 1.1 0.4 0.1 1.0 4.3 0.5 0.5 1.5 0.4 0.1 1.5 1.4 0.9 1.3 1.1 0.7 0.9 7.9 1.0 2.7 0.5 0.4 3.9 0.5 1.6 1.2 0.5 1.4 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.1 TBC1D3C MGC44903 ENSG00000278299 "TBC1 domain family member 3C" Q6IPX1 17 38057693-38068592 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.3;skin 1: 3.5;testis: 3.4" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.5 1.2 0.5 0.1 0.0 1.8 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.3 3.5 0.0 0.1 0.0 1.5 3.4 0.0 0.9 0.0 0.0 0.0 0.8 0.3 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.2 0.1 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.5 0.2 0.0 1.0 0.0 0.0 5.4 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 TBC1D3D ENSG00000274419 "TBC1 domain family member 3D" A0A087WVF3 17 38003976-38014902 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 7.9;skin 1: 4.2" "Cell line enhanced" "Detected in some" "AF22: 3.8;CAPAN-2: 11.3;HaCaT: 8.2;HeLa: 9.2;RPMI-8226: 4.9;RT4: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.8 1.5 0.8 0.0 0.0 0.8 4.2 7.9 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.0 0.7 0.2 0.0 0.3 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 2.1 9.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 4.9 0.0 5.5 0.5 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 2.9 1.0 0.0 3.4 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 TBC1D3E ENSG00000278599 "TBC1 domain family member 3E" A0A087X179 17 38127951-38138862 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.9;gallbladder: 3.0;pancreas: 4.3;testis: 4.1" "Cell line enriched" "Detected in some" 4 "HHSteC: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " "unprognostic (1.18e-1)" "unprognostic (3.35e-1)" "unprognostic (3.51e-1)" "unprognostic (4.22e-2)" "unprognostic (6.28e-2)" "unprognostic (1.87e-2)" "unprognostic (5.07e-3)" "unprognostic (1.32e-3)" 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 9.5 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 TBC1D3F ENSG00000275954 "TBC1 domain family member 3F" 17 36428618-36439566 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 4.8" "Cell line enhanced" "Detected in single" "HL-60: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046969 Uncertain Vesicles Vesicles "HPA046969: " 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TBC1D3G ENSG00000260287 "TBC1 domain family member 3G" Q6DHY5 17 36323884-36334759 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 8.7" "Group enriched" "Detected in some" 35 "SiHa: 5.4;U-2197: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Supported Approved Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (5.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 TBC1D3H ENSG00000274226 "TBC1 domain family member 3H" P0C7X1 17 36377531-36388423 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "cervix, uterine: 1.6;testis: 5.0;urinary bladder: 3.3" "Cell line enriched" "Detected in some" 10 "CAPAN-2: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Approved Approved Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 TBC1D3I ENSG00000274933 "TBC1 domain family member 3I" A0A087WXS9 17 36253456-36264553 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "skin 1: 1.3;testis: 3.0" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.2 0.0 0.9 0.5 0.0 1.3 0.9 0.0 0.3 0.1 3.0 0.0 0.1 0.2 0.1 0.2 0.7 0.2 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.6 0.0 0.1 0.1 0.2 0.1 10.9 0.1 0.6 0.0 1.6 0.0 0.1 0.0 0.1 0.7 0.7 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.2 0.1 0.9 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.7 0.0 TBC1D3K ENSG00000273513 "TBC1 domain family member 3K" A0A087X1G2 17 37924415-37935365 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.3;skeletal muscle: 1.1;testis: 4.2" "Group enriched" "Detected in some" 5 "SiHa: 2.2;T-47d: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3L ENSG00000274512 "TBC1 domain family member 3L" B9A6J9 17 37977972-37989048 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 10.8" "Cell line enhanced" "Detected in many" "BEWO: 23.9;NB-4: 22.1" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in many" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles Vesicles "HPA046969: , HPA047745: , HPA052553: " "unprognostic (5.14e-2)" "unprognostic (8.71e-2)" "unprognostic (8.44e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (6.34e-2)" "unprognostic (3.19e-1)" "unprognostic (9.50e-2)" "unprognostic (1.76e-1)" "unprognostic (1.04e-1)" "unprognostic (1.80e-2)" "unprognostic (6.63e-6)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (1.28e-3)" 0.5 2.4 1.8 0.6 1.8 1.3 0.2 1.2 2.4 0.0 2.9 2.4 1.2 0.8 0.0 0.0 0.6 1.0 1.8 0.5 0.3 0.1 0.3 1.4 1.1 3.3 1.3 4.1 10.8 1.0 0.2 2.7 1.8 0.9 0.0 0.3 1.2 0.6 0.3 3.8 0.8 1.0 1.0 0.4 7.4 9.8 4.0 6.0 7.5 6.9 23.9 3.4 2.3 3.1 3.6 5.4 0.1 2.5 0.1 4.3 12.2 3.6 3.2 2.0 7.3 9.3 0.0 15.9 2.3 5.4 1.0 9.3 5.8 8.0 4.0 2.3 4.1 1.9 8.8 5.0 4.0 4.4 22.1 3.8 2.2 2.9 4.6 0.0 9.7 10.2 5.5 7.6 0.0 4.0 4.4 5.8 1.5 9.4 0.0 5.4 4.1 4.6 6.2 2.7 0.0 6.2 3.1 3.5 0.0 0.8 0.9 0.3 0.6 0.0 0.1 0.3 0.9 0.1 0.6 0.6 1.0 3.8 1.0 0.8 0.3 0.3 0.4 TBC1D5 KIAA0210 ENSG00000131374 "TBC1 domain family member 5" Q92609 3 17157162-18444817 "Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035125, HPA035126" Uncertain Supported "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA035125: AB_2674479, HPA035126: AB_10670696" "unprognostic (1.87e-1)" "unprognostic (3.57e-1)" "unprognostic (2.86e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (4.30e-3)" "unprognostic (3.07e-2)" "unprognostic (3.31e-1)" "unprognostic (3.56e-2)" "unprognostic (6.27e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "prognostic favourable (1.75e-7)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (5.72e-2)" "unprognostic (7.07e-2)" 22.2 20.9 24.8 21.3 24.7 21.1 17.7 25.5 25.1 21.0 13.3 25.7 14.5 10.3 17.4 15.9 16.4 22.4 18.5 16.2 24.4 20.0 19.9 13.9 16.9 20.4 25.9 14.9 28.3 17.2 35.3 27.8 16.5 21.4 14.2 13.7 16.6 13.9 17.0 10.3 15.2 13.8 17.7 31.3 24.3 12.9 17.3 24.7 10.0 29.1 9.7 21.2 17.8 20.7 13.5 9.7 12.3 8.6 4.2 8.7 4.6 11.5 13.0 10.7 10.0 21.2 31.2 11.7 12.5 18.3 8.2 7.1 6.3 10.5 21.5 13.6 25.3 3.6 9.4 15.2 17.1 19.0 3.6 20.6 5.3 7.3 13.6 20.0 18.1 20.1 18.2 17.8 10.8 18.6 12.9 20.0 19.9 7.8 9.8 4.6 8.8 13.7 21.6 13.8 15.3 12.3 9.0 4.0 19.1 23.9 5.6 8.5 15.9 16.8 20.1 22.7 10.2 11.7 13.6 11.6 15.7 21.0 17.5 19.1 21.2 10.2 8.6 12.3 6.7 7.1 8.7 11.7 5.1 4.8 9.7 13.5 3.9 4.4 11.5 4.2 6.4 6.3 5.5 4.6 24.8 24.7 25.5 24.6 24.4 20.0 25.9 14.9 21.4 24.7 TBC1D7 "dJ257A7.3, FLJ32666" ENSG00000145979 "TBC1 domain family member 7" Q9P0N9 6 13266542-13328583 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034748 Approved "HPA034748: AB_10671232" "unprognostic (9.53e-2)" "unprognostic (8.39e-2)" "unprognostic (3.18e-1)" "unprognostic (1.81e-2)" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (3.95e-3)" "unprognostic (5.54e-2)" "unprognostic (9.30e-2)" "prognostic favourable (4.98e-5)" "unprognostic (4.36e-2)" "unprognostic (1.66e-1)" "prognostic unfavourable (2.03e-7)" "unprognostic (1.57e-1)" "unprognostic (3.46e-2)" "unprognostic (3.48e-1)" "unprognostic (2.78e-2)" 8.8 11.8 14.9 13.2 14.3 21.9 13.7 17.5 19.3 10.7 14.7 12.9 10.0 14.2 8.7 20.9 15.8 6.4 10.4 30.4 14.7 13.6 21.2 16.1 13.2 12.3 14.5 13.5 7.6 10.6 7.5 14.1 14.1 14.1 12.9 16.8 17.7 11.6 10.1 13.5 12.4 10.5 10.1 12.8 11.4 9.2 12.4 11.9 19.4 7.8 14.7 14.8 10.7 10.2 8.7 23.0 23.5 12.0 11.1 7.6 5.6 6.4 6.5 9.3 9.5 7.3 4.2 6.5 2.9 3.4 6.2 7.0 13.0 5.9 4.5 19.7 4.8 5.3 6.3 7.4 5.7 7.0 7.5 12.5 4.4 11.4 17.0 8.0 19.2 5.7 10.5 7.7 5.0 10.4 14.0 6.1 7.9 10.6 10.3 19.5 6.3 6.3 15.4 4.0 19.2 13.9 8.9 18.1 8.0 7.2 14.3 79.0 13.8 4.8 7.4 6.5 8.1 3.5 4.0 14.5 42.1 21.5 6.0 8.5 13.1 12.5 12.0 14.0 6.7 10.2 4.3 8.7 5.7 5.9 23.0 7.9 5.3 6.4 23.5 11.1 7.2 22.6 7.6 5.6 14.9 14.3 17.5 19.3 14.7 13.6 14.5 13.5 14.1 11.9 TBCD ENSG00000141556 "Tubulin folding cofactor D" Q9BTW9 17 82752064-82945922 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, GTPase activation" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045200 Approved "HPA045200: AB_10969134" "unprognostic (4.15e-1)" "unprognostic (1.01e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-3)" "unprognostic (2.72e-1)" "unprognostic (4.73e-2)" "prognostic unfavourable (2.39e-5)" "unprognostic (3.41e-3)" "unprognostic (9.03e-3)" "unprognostic (5.35e-2)" "unprognostic (1.75e-3)" "unprognostic (6.40e-2)" "unprognostic (1.16e-1)" "unprognostic (4.96e-1)" "unprognostic (1.10e-1)" "unprognostic (1.02e-1)" "unprognostic (1.53e-2)" 21.3 18.6 26.2 17.8 28.6 17.3 22.6 39.4 38.6 25.3 15.6 20.6 29.0 13.4 24.2 24.7 23.4 19.9 28.4 20.9 20.7 14.9 18.6 19.2 22.5 18.8 15.0 26.4 22.6 24.2 30.1 31.0 23.5 21.6 20.4 13.3 23.7 56.1 18.4 17.6 17.8 16.3 18.8 16.8 25.1 23.9 26.6 18.5 32.3 30.5 15.9 18.3 20.6 20.2 0.7 7.7 9.1 24.0 8.3 15.5 8.0 18.0 18.1 19.2 26.8 11.3 12.5 19.6 10.9 7.2 12.2 8.6 10.1 4.9 10.6 10.3 12.9 19.1 42.9 10.6 10.5 13.4 16.8 24.8 16.0 13.2 7.3 8.7 18.4 10.4 7.9 9.1 4.1 36.4 13.3 4.4 10.4 20.4 57.9 5.5 9.0 13.4 31.1 21.5 6.6 8.6 17.3 18.5 21.4 11.8 21.0 7.2 15.7 5.4 15.5 23.1 17.4 14.4 17.4 6.4 4.7 11.7 14.4 11.0 8.7 9.1 8.8 4.6 13.1 21.0 15.5 0.7 11.4 13.2 7.7 0.6 4.8 5.7 1.9 8.3 24.0 1.6 8.0 8.0 26.2 28.6 39.4 38.6 20.7 14.9 15.0 26.4 21.6 18.5 TBXAS1 "CYP5, CYP5A1, THAS, TS, TXAS, TXS" ENSG00000059377 "Thromboxane A synthase 1" P24557 7 139777051-140020325 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.1;lymphoid tissue: 51.7" "Cell line enhanced" "Detected in some" "NB-4: 34.7;PC-3: 11.1;RPTEC TERT1: 9.9;U-937: 28.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 13 "basophil: 38.1;classical monocyte: 44.5;eosinophil: 45.2;intermediate monocyte: 67.1;myeloid DC: 18.7;neutrophil: 38.8;non-classical monocyte: 56.4" "Group enriched" "Detected in all" 20 "dendritic cells: 18.7;granulocytes: 45.2;monocytes: 67.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA031257, HPA031258, HPA031259" Enhanced 32000000 "HPA031257: , HPA031258: AB_2673813, HPA031259: AB_2673814" "unprognostic (4.46e-2)" "unprognostic (3.07e-1)" "unprognostic (8.80e-2)" "unprognostic (1.12e-1)" "unprognostic (2.72e-1)" "unprognostic (9.41e-2)" "unprognostic (5.10e-2)" "unprognostic (3.12e-1)" "unprognostic (2.38e-1)" "unprognostic (3.07e-2)" "unprognostic (1.11e-1)" "unprognostic (3.03e-2)" "prognostic unfavourable (1.14e-4)" "unprognostic (1.52e-1)" "unprognostic (5.00e-3)" "unprognostic (8.53e-2)" "unprognostic (5.34e-2)" 13.5 7.7 6.6 17.6 8.9 13.8 5.4 1.5 5.6 3.7 6.3 13.9 0.8 6.5 3.2 4.1 3.4 5.0 13.9 3.7 7.6 5.7 6.1 8.1 20.3 43.9 12.6 2.0 2.5 3.1 1.4 3.5 9.0 9.0 5.2 8.6 4.4 8.2 2.6 1.6 1.9 9.3 7.9 19.3 51.7 7.1 2.0 12.7 7.5 2.4 2.2 6.1 9.3 2.5 1.3 18.7 45.2 67.1 1.5 2.2 25.1 0.1 3.0 0.1 0.0 0.6 1.9 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 4.5 0.3 8.2 0.0 0.0 0.8 2.7 7.3 1.0 0.0 0.0 0.4 1.0 0.2 1.0 0.3 0.0 1.0 34.7 0.1 11.1 1.3 0.0 0.5 9.9 0.0 0.1 0.5 0.1 0.0 0.3 0.0 6.6 0.9 0.2 0.1 0.6 0.5 2.3 0.4 0.1 0.2 28.2 0.8 38.1 44.5 45.2 1.1 67.1 1.7 1.3 2.2 0.6 18.7 0.5 0.3 0.2 38.8 1.5 56.4 3.3 2.0 25.1 6.6 8.9 1.5 5.6 7.6 5.7 12.6 2.0 9.0 12.7 TCEANC2 "C1orf83, FLJ32112" ENSG00000116205 "Transcription elongation factor A N-terminal and central domain containing 2" Q96MN5 1 54053587-54112519 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046918 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046918: " "unprognostic (2.80e-1)" "unprognostic (6.19e-2)" "unprognostic (6.56e-3)" "unprognostic (2.34e-1)" "unprognostic (5.12e-3)" "unprognostic (1.35e-3)" "unprognostic (1.73e-5)" "unprognostic (8.64e-2)" "unprognostic (7.93e-3)" "unprognostic (6.59e-2)" "unprognostic (3.55e-1)" "unprognostic (3.52e-2)" "unprognostic (9.63e-2)" "unprognostic (2.26e-3)" "unprognostic (8.57e-2)" "unprognostic (7.51e-3)" "unprognostic (2.08e-1)" 5.9 5.9 7.9 7.6 11.1 6.5 5.9 3.0 7.9 6.1 5.4 13.4 6.6 6.8 5.3 6.2 7.9 5.2 4.4 4.4 8.3 6.4 7.2 4.7 4.8 9.4 10.2 4.5 4.3 6.4 6.6 6.2 6.0 8.8 5.1 8.1 6.5 5.5 4.1 9.4 6.8 6.4 6.3 14.1 8.2 5.2 15.4 8.8 15.7 5.7 3.0 10.8 7.3 5.1 7.8 7.6 10.1 8.9 10.2 6.3 3.8 5.1 2.3 5.9 4.9 4.0 6.3 5.7 5.6 4.3 6.3 5.6 1.4 3.3 4.6 4.9 2.4 5.2 7.8 4.3 8.0 10.2 4.2 6.8 5.5 2.7 2.5 5.0 6.9 4.7 3.7 5.5 3.2 8.0 6.7 4.3 5.2 1.9 10.0 3.7 13.6 3.9 10.0 10.8 6.7 2.3 3.1 5.1 5.4 3.6 5.6 6.7 5.5 9.4 4.2 5.7 3.6 5.5 6.8 9.9 14.3 6.4 4.8 6.9 7.1 5.9 7.3 10.1 4.7 8.9 4.6 7.3 5.4 5.8 7.6 7.8 6.3 6.2 9.4 10.2 6.5 6.9 4.1 3.8 7.9 11.1 3.0 7.9 8.3 6.4 10.2 4.5 8.8 8.8 TCTA ENSG00000145022 "T cell leukemia translocation altered" P57738 3 49412206-49416475 "Disease related genes, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007342 Approved Approved Cytosol Cytosol "HPA007342: AB_2202399" "unprognostic (5.58e-2)" "unprognostic (4.33e-2)" "unprognostic (6.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.17e-2)" "unprognostic (3.35e-2)" "unprognostic (2.18e-1)" "prognostic favourable (6.76e-4)" "unprognostic (3.74e-1)" "unprognostic (3.38e-3)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favourable (5.00e-15)" "unprognostic (1.68e-1)" "unprognostic (1.96e-1)" "unprognostic (3.43e-1)" "unprognostic (6.41e-3)" 15.4 29.3 21.8 9.2 21.9 7.9 16.3 12.5 26.1 18.3 16.9 23.1 19.5 14.0 13.6 46.9 12.8 20.1 19.3 13.1 20.6 20.8 35.6 27.2 17.2 14.3 23.2 18.5 19.4 18.5 17.9 28.4 19.1 22.2 25.2 21.8 23.3 16.0 20.0 10.5 7.8 19.4 16.5 25.6 15.1 16.3 9.3 12.8 12.6 34.1 10.2 11.4 13.0 8.9 9.5 10.1 14.6 28.0 13.4 13.0 13.4 5.8 7.2 4.7 7.0 20.8 9.1 6.1 12.1 9.0 12.3 10.4 4.2 6.4 7.0 8.9 28.5 6.8 9.1 12.2 10.1 10.4 6.3 11.6 9.4 5.4 12.6 5.0 15.3 19.6 12.7 13.7 11.0 12.7 4.2 16.0 30.0 5.4 6.0 4.5 3.8 16.8 3.7 5.0 16.3 21.1 7.8 12.6 4.1 14.4 16.0 13.1 13.6 4.7 11.4 9.3 5.7 19.2 4.5 8.8 11.5 4.7 21.9 8.8 12.8 12.7 11.5 14.6 13.0 21.9 7.6 8.0 8.4 10.0 6.6 9.5 10.4 11.0 13.2 13.4 28.0 10.1 10.7 13.4 21.8 21.9 12.5 26.1 20.6 20.8 23.2 18.5 22.2 12.8 TCTN2 "C12orf38, FLJ12975, JBTS24, MKS8, TECT2" ENSG00000168778 "Tectonic family member 2" Q96GX1 12 123671113-123708403 "Disease related genes, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039900 Enhanced Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA039900: AB_10673366" "unprognostic (3.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.30e-2)" "unprognostic (1.45e-2)" "unprognostic (1.63e-3)" "unprognostic (1.32e-1)" "unprognostic (3.09e-3)" "unprognostic (3.14e-2)" "unprognostic (7.05e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-3)" "unprognostic (2.23e-1)" "unprognostic (1.69e-1)" "unprognostic (2.79e-1)" "unprognostic (2.46e-1)" "unprognostic (7.86e-2)" "unprognostic (2.68e-1)" 5.5 5.5 6.4 5.1 18.1 2.3 8.4 10.5 10.0 11.2 5.6 9.1 12.0 2.9 15.7 14.1 4.1 32.0 7.2 5.4 6.2 10.2 11.8 2.3 9.4 4.0 4.4 8.3 18.0 7.9 16.1 18.8 5.3 18.5 11.0 4.9 17.6 11.9 10.2 1.9 10.2 3.9 7.1 4.2 4.5 6.1 17.2 3.2 3.1 15.6 5.1 4.2 5.9 7.5 4.5 4.7 2.4 1.1 1.4 5.4 0.4 10.7 10.6 8.1 11.2 11.0 12.4 9.4 4.1 7.9 8.5 7.2 6.7 10.8 0.3 6.7 6.4 14.0 4.3 3.7 8.6 2.3 6.5 1.0 7.4 5.0 3.9 2.8 4.1 6.1 7.4 12.0 3.5 11.3 5.7 0.2 6.0 5.6 3.1 5.8 5.0 6.5 3.1 8.0 1.5 10.6 7.8 4.8 6.3 12.7 4.3 5.8 18.3 3.8 7.0 12.0 6.2 10.7 4.9 3.0 6.1 1.0 15.3 0.3 7.1 2.4 0.5 2.2 3.9 1.1 5.4 3.8 4.4 4.0 0.8 4.5 5.0 5.0 0.8 1.4 0.9 4.7 2.5 0.4 6.4 18.1 10.5 10.0 6.2 10.2 4.4 8.3 18.5 3.2 TCTN3 "C10orf61, DKFZP564D116, JBTS18, TECT3" ENSG00000119977 "Tectonic family member 3" Q6NUS6 10 95663396-95694143 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026987 Approved Approved Microtubules "Intracellular and membrane" 2600000 Microtubules "HPA026987: AB_10600911" "unprognostic (1.58e-1)" "unprognostic (1.54e-1)" "unprognostic (9.78e-2)" "prognostic favourable (5.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.50e-2)" "unprognostic (8.88e-3)" "unprognostic (1.08e-1)" "unprognostic (3.03e-2)" "unprognostic (9.25e-3)" "unprognostic (3.78e-3)" "unprognostic (7.29e-2)" "unprognostic (4.60e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (9.30e-3)" "unprognostic (1.59e-1)" 14.6 21.4 9.3 16.3 12.7 3.9 17.4 9.4 12.2 18.4 13.4 12.2 21.8 11.6 21.7 41.1 15.6 21.7 20.8 15.1 8.5 9.8 23.1 22.9 19.6 26.0 9.3 7.6 25.9 35.3 52.6 19.3 21.7 13.6 17.8 16.2 21.9 19.8 30.1 7.2 15.7 16.6 16.7 7.9 16.3 14.9 20.7 7.3 11.0 43.7 13.6 15.6 16.7 14.9 18.2 24.6 4.5 13.0 15.1 19.6 11.4 12.0 18.0 16.8 35.1 36.7 29.4 10.8 16.4 33.6 18.7 21.3 13.3 21.7 12.0 14.7 23.4 18.0 16.8 20.3 21.8 13.1 13.2 4.2 10.3 17.7 19.6 15.2 9.6 24.8 19.0 17.9 29.3 29.9 8.1 16.7 24.0 12.5 8.0 12.9 5.5 13.6 10.2 12.9 13.6 27.3 9.0 5.1 11.1 13.4 7.1 18.5 27.6 13.4 13.4 15.3 9.9 10.7 18.5 7.4 13.2 7.9 22.5 18.0 7.5 4.5 9.0 3.3 15.7 12.8 19.6 18.2 15.3 16.3 24.6 13.4 16.6 13.8 0.7 15.1 13.0 15.0 11.5 11.4 9.3 12.7 9.4 12.2 8.5 9.8 9.3 7.6 13.6 7.3 TDRKH TDRD2 ENSG00000182134 "Tudor and KH domain containing" Q9Y2W6 1 151770107-151791416 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, RNA-mediated gene silencing, Spermatogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 46.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016419, HPA019625" Approved Approved Centrosome,Cytosol Cytosol Centrosome "HPA016419: AB_1857870, HPA019625: AB_1857871" "unprognostic (2.27e-3)" "unprognostic (2.89e-1)" "unprognostic (8.60e-2)" "prognostic unfavourable (1.66e-4)" "unprognostic (1.29e-1)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (2.63e-1)" "unprognostic (2.91e-1)" "unprognostic (2.06e-1)" "unprognostic (3.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.63e-2)" "unprognostic (8.70e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-3)" "unprognostic (1.14e-1)" 2.7 3.5 8.8 4.2 10.9 1.6 4.6 18.0 9.9 2.6 3.3 6.3 7.5 2.5 2.0 6.2 2.1 2.4 2.3 3.6 8.8 8.9 3.1 3.7 4.4 5.4 8.1 7.8 1.4 3.5 46.5 5.5 3.7 15.9 6.2 4.3 2.9 6.4 6.7 4.5 2.5 2.5 3.1 7.6 5.9 3.1 19.3 4.9 8.0 7.3 1.0 5.2 3.7 2.0 3.8 5.3 5.3 7.0 7.3 13.1 4.2 6.3 5.5 4.9 11.4 0.3 0.5 4.8 1.1 0.6 3.4 2.3 3.6 9.2 7.4 10.1 0.4 3.9 7.2 7.5 5.3 19.2 5.1 7.4 1.6 2.5 2.2 1.4 1.2 0.6 3.0 7.3 3.1 3.6 5.7 6.7 1.0 17.2 11.7 2.2 3.8 9.6 1.4 3.1 15.4 6.0 3.1 7.2 11.8 8.0 6.4 7.4 14.0 5.6 1.4 1.6 2.9 5.0 6.1 13.8 16.9 8.3 7.4 6.0 2.2 5.3 0.9 1.9 8.8 4.3 13.1 3.8 8.2 8.8 2.0 3.6 6.0 7.5 0.7 7.3 7.0 5.3 9.4 4.2 8.8 10.9 18.0 9.9 8.8 8.9 8.1 7.8 15.9 4.9 TECTA "DFNA12, DFNA8, DFNB21" ENSG00000109927 "Tectorin alpha" O75443 11 121101173-121191493 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.5" "Cell line enhanced" "Detected in some" "AF22: 3.5;SCLC-21H: 2.4;SH-SY5Y: 5.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA018870 Approved "Secreted in other tissues" "HPA018870: AB_1857879" "unprognostic (1.12e-3)" "unprognostic (2.42e-1)" "unprognostic (1.42e-2)" "unprognostic (1.45e-2)" "unprognostic (4.30e-2)" "unprognostic (3.11e-1)" "unprognostic (3.00e-2)" "unprognostic (3.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.14e-1)" "unprognostic (1.39e-6)" "unprognostic (1.22e-1)" "unprognostic (4.15e-3)" "unprognostic (6.97e-3)" "unprognostic (1.12e-1)" "unprognostic (3.28e-2)" "unprognostic (4.19e-2)" 0.6 1.6 1.1 0.4 3.5 0.4 0.6 2.9 5.5 0.4 0.5 0.2 0.6 1.8 0.1 0.6 0.7 2.1 1.3 2.6 0.7 0.9 1.1 0.2 1.4 1.6 0.7 4.2 2.5 0.6 0.9 0.3 0.5 1.6 1.0 0.2 0.2 0.6 1.0 0.4 0.4 2.0 1.4 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 3.5 1.8 0.1 0.2 0.5 0.5 0.3 0.1 0.2 0.3 0.0 0.2 1.7 0.2 0.0 0.7 0.0 0.2 0.6 0.9 0.5 0.1 0.0 0.3 0.5 0.3 0.4 0.6 0.1 0.0 0.4 0.0 1.2 0.4 0.2 0.2 1.3 0.7 0.1 0.1 0.6 0.1 0.5 0.1 2.4 5.4 0.3 0.2 0.3 0.3 0.5 0.0 0.4 0.5 0.2 0.4 1.3 1.3 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 TEK "CD202b, TIE-2, TIE2, VMCM, VMCM1" ENSG00000120156 "TEK receptor tyrosine kinase" Q02763 9 27109141-27230175 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 35.8;NTERA-2: 17.8;TIME: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010359, HPA073265" Approved Supported "Plasma membrane,Centriolar satellite" "Secreted to blood" 7750000 8300000 "Plasma membrane" "Centriolar satellite" "CAB010359: AB_2203226, HPA073265: " "unprognostic (2.24e-1)" "unprognostic (1.74e-1)" "unprognostic (5.55e-2)" "unprognostic (1.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.26e-3)" "prognostic favourable (2.31e-5)" "unprognostic (7.48e-2)" "unprognostic (1.72e-2)" "unprognostic (1.41e-1)" "unprognostic (5.58e-2)" "unprognostic (2.72e-1)" "prognostic favourable (7.81e-4)" "unprognostic (7.50e-3)" "unprognostic (6.87e-3)" "unprognostic (1.83e-1)" "unprognostic (5.24e-3)" 28.6 7.8 8.1 4.6 5.9 0.4 17.9 3.4 5.4 10.8 4.7 4.6 3.4 3.2 14.5 5.3 6.7 5.9 9.1 13.0 7.1 6.1 25.4 8.7 27.8 2.9 6.9 3.4 6.1 4.5 3.5 4.0 36.3 6.9 5.4 4.7 12.4 3.4 5.5 7.8 3.0 5.3 10.6 5.3 23.4 4.0 3.7 3.5 0.3 9.7 8.4 2.4 6.4 12.4 0.0 0.1 2.2 0.6 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.2 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.0 0.0 0.6 0.0 0.0 0.7 0.0 0.8 0.3 35.8 0.0 0.0 0.3 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 8.1 5.9 3.4 5.4 7.1 6.1 6.9 3.4 6.9 3.5 TELO2 "hCLK2, KIAA0683, TEL2" ENSG00000100726 "Telomere maintenance 2" Q9Y4R8 16 1493344-1510457 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041348, HPA041473" Approved Supported "Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" "HPA041348: AB_10794514, HPA041473: AB_10795593" "unprognostic (1.27e-1)" "unprognostic (2.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.35e-1)" "unprognostic (1.13e-1)" "unprognostic (2.52e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (2.64e-1)" "unprognostic (1.91e-1)" "unprognostic (3.08e-2)" "unprognostic (2.94e-2)" "unprognostic (5.99e-3)" "unprognostic (1.47e-3)" "unprognostic (2.21e-1)" "unprognostic (6.75e-2)" "unprognostic (3.15e-3)" 13.8 11.7 9.2 14.2 9.0 19.3 14.3 21.9 14.9 11.1 11.3 15.7 11.4 17.3 11.7 14.8 12.9 11.8 13.4 9.6 9.9 9.1 9.6 11.1 8.8 14.4 10.2 15.9 12.1 18.5 8.6 10.3 12.1 10.9 12.3 3.6 11.1 18.6 11.0 18.9 23.5 16.2 10.4 8.3 20.7 14.0 9.0 10.4 17.3 10.6 11.2 14.8 10.6 10.5 8.3 8.2 3.2 11.4 3.8 5.1 5.0 8.1 12.2 3.8 7.2 1.5 1.6 14.7 13.0 2.5 6.3 4.6 15.6 7.8 12.0 11.3 2.0 8.6 2.7 4.9 1.2 7.0 23.6 6.9 14.1 9.0 2.5 8.7 10.4 3.1 1.9 5.8 1.2 3.7 17.7 4.3 2.5 27.5 10.2 23.3 12.2 10.3 30.6 5.3 12.2 2.3 7.7 16.0 9.0 11.2 10.7 4.0 9.9 10.5 5.8 13.7 9.6 13.2 10.7 7.9 5.0 21.9 4.3 12.3 11.4 0.0 6.8 3.2 5.1 8.6 5.1 5.4 3.6 4.3 8.2 8.3 4.2 3.2 0.5 3.8 11.4 5.0 3.3 5.0 9.2 9.0 21.9 14.9 9.9 9.1 10.2 15.9 10.9 10.4 TENM1 "ODZ1, ODZ3, TEN-M1, TNM" ENSG00000009694 "Teneurin transmembrane protein 1" Q9UKZ4 X 124375903-124963817 "Predicted membrane proteins" "Stress response, Transcription, Transcription regulation" "Neuropeptide, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0;liver: 10.5" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.7;MOLT-4: 9.9;RPTEC TERT1: 3.5;SCLC-21H: 3.5;U-138 MG: 5.9" "Group enriched" "Detected in many" 5 "glioma: 1.6;prostate cancer: 2.2;renal cancer: 1.6;testis cancer: 1.4;thyroid cancer: 7.0" "Region enriched" "Detected in many" 4 "cerebellum: 17.0" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002848 Uncertain "HPA002848: AB_1079523" "unprognostic (1.71e-3)" "unprognostic (8.25e-2)" "unprognostic (3.14e-1)" "unprognostic (8.68e-4)" "unprognostic (5.76e-3)" "unprognostic (3.51e-2)" "unprognostic (7.07e-2)" "unprognostic (2.68e-4)" "unprognostic (6.58e-2)" "unprognostic (1.71e-1)" "unprognostic (4.49e-3)" "unprognostic (3.58e-1)" "unprognostic (2.71e-2)" "unprognostic (4.41e-2)" "unprognostic (1.99e-1)" "unprognostic (3.25e-3)" "unprognostic (4.44e-2)" 1.9 3.0 1.4 0.4 2.4 3.5 1.0 17.0 4.4 0.4 1.1 0.9 0.4 0.1 1.4 2.3 0.4 1.5 2.0 0.4 2.3 2.7 1.8 10.5 0.9 0.9 1.0 4.2 0.4 0.4 0.0 3.5 0.4 3.3 4.8 0.3 1.5 0.9 3.8 0.5 1.6 0.7 1.1 2.6 0.6 0.5 2.3 0.4 0.4 3.1 0.4 0.7 0.4 0.4 0.0 0.0 2.4 0.1 0.6 1.6 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.7 0.0 0.0 1.2 0.0 0.0 9.9 0.0 0.5 1.5 0.0 0.0 0.1 3.5 0.0 3.5 0.0 0.0 0.7 0.0 0.8 0.0 0.0 5.9 0.2 0.0 0.4 0.3 0.7 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.6 0.0 0.9 0.0 0.9 1.0 0.0 0.0 1.6 1.1 2.4 0.6 0.0 0.0 0.2 0.1 1.4 2.4 17.0 3.9 2.3 2.7 1.0 4.2 3.3 0.4 TENM2 "KIAA1127, ODZ2, Ten-M2" ENSG00000145934 "Teneurin transmembrane protein 2" Q9NT68 5 167284799-168264157 "Predicted membrane proteins" "Cell adhesion, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 15.1;heart muscle: 24.7" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 26.1;HBEC3-KT: 17.1;HDLM-2: 16.7;U-138 MG: 30.6;U-2 OS: 26.6;U-251 MG: 19.6" "Cancer enriched" "Detected in many" 6 "head and neck cancer: 15.4" "Region enhanced" "Detected in many" "cerebral cortex: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA038018, HPA038420, HPA068691" Uncertain Approved Nucleoli Nucleoli "HPA038018: , HPA038420: AB_10674682, HPA068691: " "unprognostic (6.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.94e-2)" "unprognostic (9.16e-3)" "unprognostic (3.88e-3)" "unprognostic (3.81e-3)" "unprognostic (5.81e-2)" "unprognostic (2.41e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (3.68e-3)" "unprognostic (4.34e-2)" "unprognostic (4.69e-5)" "unprognostic (3.47e-2)" "unprognostic (1.03e-1)" "unprognostic (5.16e-4)" "prognostic unfavourable (7.52e-4)" 0.2 0.4 2.5 0.0 3.5 0.0 1.8 0.5 15.1 0.6 0.3 0.0 0.0 0.3 0.2 0.4 1.4 0.2 0.3 24.7 6.5 0.9 2.7 1.2 0.3 0.0 0.5 1.7 0.7 0.2 0.0 0.4 0.0 2.3 2.2 0.0 0.2 0.3 1.0 0.2 2.3 0.2 0.0 0.6 0.2 0.3 1.2 0.4 0.0 0.4 0.0 0.9 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 0.0 26.1 0.0 0.0 17.1 0.3 16.7 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.2 3.0 0.1 2.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 3.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 30.6 26.6 0.0 19.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.5 0.5 15.1 6.5 0.9 0.5 1.7 2.3 0.4 TENM3 "KIAA1455, ODZ3, Ten-M3" ENSG00000218336 "Teneurin transmembrane protein 3" Q9P273 4 182143987-182803024 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" Microphthalmia "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 24.0;BEWO: 23.0;HDLM-2: 31.2;T-47d: 30.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047043 Approved Approved Nucleoplasm Nucleoplasm "HPA047043: " "unprognostic (5.79e-2)" "unprognostic (3.01e-2)" "unprognostic (6.62e-2)" "unprognostic (4.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (8.28e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (2.31e-2)" "unprognostic (4.85e-2)" "unprognostic (2.54e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (8.59e-2)" "unprognostic (1.07e-2)" "unprognostic (5.25e-4)" 9.5 10.8 11.3 3.7 12.5 1.0 9.3 8.5 17.8 3.9 8.5 1.5 5.7 2.4 6.4 2.6 2.4 2.9 5.3 3.5 11.8 9.4 2.7 1.4 2.4 2.3 3.5 15.4 8.4 3.2 17.0 15.0 24.5 5.4 8.3 2.5 6.4 2.0 8.0 4.3 1.4 2.5 5.2 6.1 4.8 2.2 4.7 2.3 0.8 12.3 1.8 3.0 3.7 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 24.0 0.1 4.9 8.8 23.0 2.8 0.9 2.5 2.2 11.9 6.2 0.0 0.3 18.5 1.2 5.7 1.2 2.5 31.2 9.5 0.0 0.0 0.0 0.4 0.0 0.0 11.6 0.4 7.8 5.5 3.4 0.0 0.1 3.8 0.8 0.0 0.0 7.7 1.0 0.0 6.2 0.0 0.0 0.0 9.9 9.2 1.4 0.1 0.0 30.9 1.2 7.5 19.7 14.2 0.0 13.9 0.0 0.0 0.0 10.3 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 12.5 8.5 17.8 11.8 9.4 3.5 15.4 5.4 2.3 TENM4 "KIAA1302, ODZ4, Ten-M4" ENSG00000149256 "Teneurin transmembrane protein 4" Q6N022 11 78652831-79440948 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 23.0;parathyroid gland: 44.4" "Cell line enhanced" "Detected in many" "HSkMC: 8.2;PC-3: 9.4;REH: 8.9;SH-SY5Y: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019521, HPA065961" Approved "HPA019521: , HPA065961: " "unprognostic (2.81e-1)" "unprognostic (9.25e-2)" "unprognostic (1.64e-1)" "unprognostic (2.96e-3)" "unprognostic (1.87e-1)" "unprognostic (2.48e-1)" "unprognostic (1.18e-2)" "unprognostic (1.24e-1)" "unprognostic (3.01e-1)" "unprognostic (3.79e-1)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "unprognostic (6.51e-3)" "unprognostic (5.40e-3)" "unprognostic (5.64e-2)" "unprognostic (7.07e-2)" "unprognostic (9.81e-3)" 3.2 2.8 14.7 2.2 13.0 1.0 1.6 1.4 16.9 4.4 1.4 3.6 0.0 1.1 2.7 1.2 3.1 3.7 1.5 1.3 11.4 6.3 2.9 1.0 1.4 1.5 3.3 5.7 23.0 1.3 44.4 12.0 1.1 8.3 1.4 1.4 4.8 1.5 1.3 1.4 5.1 1.2 2.2 12.5 1.3 1.5 2.9 5.7 0.6 8.2 2.1 2.5 1.6 2.3 0.3 1.4 0.6 0.6 0.3 0.1 0.0 0.0 0.0 3.0 0.0 3.4 5.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.9 5.7 1.8 4.5 4.6 0.0 3.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 8.2 2.1 2.2 4.1 0.0 0.1 0.2 0.2 0.0 0.1 0.0 1.6 9.4 8.9 0.0 0.0 5.9 1.0 6.4 15.7 0.0 0.0 0.0 0.0 0.1 0.4 0.1 1.1 0.1 5.2 0.0 0.0 0.1 6.2 0.0 0.0 0.5 0.6 0.0 0.1 0.3 0.1 0.2 0.1 0.1 1.4 0.3 0.0 0.0 0.6 0.3 0.3 0.3 0.1 0.0 14.7 13.0 1.4 16.9 11.4 6.3 3.3 5.7 8.3 5.7 TEX101 "CT131, MGC4766, SGRG, SPATA44" ENSG00000131126 "Testis expressed 101" Q9BY14 19 43401496-43418597 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "blood: 24.5;testis: 56.6" "Cell line enhanced" "Detected in many" "THP-1: 4.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 246 "basophil: 24.5" "Lineage enriched" "Detected in single" 246 "granulocytes: 24.5" "HPA041915, HPA042513" Enhanced "Secreted in male reproductive system" "HPA041915: AB_10795268, HPA042513: AB_10795507" "unprognostic (2.50e-2)" "unprognostic (5.67e-4)" "unprognostic (2.64e-1)" "unprognostic (6.89e-2)" "unprognostic (1.87e-1)" "unprognostic (5.78e-4)" "unprognostic (1.70e-1)" "unprognostic (2.84e-2)" "unprognostic (6.54e-2)" "unprognostic (4.06e-1)" "unprognostic (2.49e-2)" "unprognostic (1.67e-7)" "unprognostic (8.83e-2)" "unprognostic (2.24e-1)" "unprognostic (7.49e-2)" "unprognostic (7.04e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.0 56.6 0.1 0.1 0.1 0.1 0.4 0.1 0.3 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.9 0.5 1.3 0.7 1.0 2.4 0.7 0.4 0.6 0.9 1.0 0.2 0.4 0.4 1.0 1.6 0.4 0.4 1.0 0.7 1.2 0.0 0.3 1.3 0.4 1.9 0.4 0.9 1.2 1.5 0.1 1.0 1.9 0.3 1.0 1.1 0.2 0.6 0.9 0.7 1.0 2.7 0.2 1.2 2.2 0.2 0.9 0.4 0.3 0.8 2.2 0.3 4.8 0.4 0.8 0.8 0.7 1.4 1.0 1.1 0.6 0.9 0.7 0.6 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TEX264 "FLJ13935, ZSIG11" ENSG00000164081 "Testis expressed 264" Q9Y6I9 3 51662693-51704323 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005002, HPA017739" Enhanced Approved Nucleoli,Cytosol "Secreted - unknown location" "Nucleoli, Cytosol" "CAB005002: AB_425976, HPA017739: AB_1857910" "unprognostic (2.80e-3)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (2.79e-3)" "unprognostic (8.11e-2)" "unprognostic (8.26e-3)" "unprognostic (2.05e-1)" "unprognostic (3.06e-3)" "unprognostic (2.30e-1)" "unprognostic (5.19e-2)" "prognostic favourable (5.67e-4)" "unprognostic (1.83e-1)" "prognostic favourable (7.95e-9)" "unprognostic (4.99e-2)" "unprognostic (3.65e-1)" "unprognostic (3.17e-1)" "unprognostic (4.67e-2)" 15.7 34.6 15.1 15.3 18.7 9.0 20.0 8.6 22.8 17.5 21.3 15.0 36.0 18.7 20.1 25.5 17.7 21.9 24.8 19.0 14.6 15.6 35.9 30.7 17.0 22.6 15.7 17.9 15.8 29.0 29.9 12.3 24.5 12.2 20.3 16.7 22.6 43.6 44.3 16.3 29.5 20.8 16.6 15.8 18.6 19.0 90.8 11.5 16.6 33.9 18.5 15.9 16.7 16.3 33.1 34.5 24.7 36.7 22.8 50.7 41.1 11.7 21.6 3.8 19.9 40.4 19.7 7.9 10.1 24.0 16.9 17.1 11.6 28.0 17.0 7.4 14.5 11.5 11.0 20.5 8.2 13.6 17.5 16.2 13.5 15.3 36.1 10.2 18.2 25.9 32.7 19.1 19.6 12.3 8.5 29.6 17.3 13.6 16.2 23.6 4.2 24.3 7.9 5.1 32.0 26.6 16.4 5.6 9.1 12.4 34.3 15.6 16.7 21.5 9.0 17.0 7.1 17.8 13.4 20.7 22.3 8.3 20.9 21.4 16.9 24.7 36.7 21.7 41.9 36.7 41.9 32.2 43.5 39.7 34.5 33.1 36.5 37.0 7.7 22.8 34.7 30.5 50.7 41.1 15.1 18.7 8.6 22.8 14.6 15.6 15.7 17.9 12.2 11.5 TFR2 "HFE3, TFRC2" ENSG00000106327 "Transferrin receptor 2" Q9UP52 7 100620416-100642779 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 112.6" "Group enriched" "Detected in some" 11 "HEL: 27.8;HMC-1: 38.6;K-562: 25.7" "Cancer enriched" "Detected in many" 70 "liver cancer: 136.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 46 "basophil: 5.5;eosinophil: 3.9" "Lineage enriched" "Detected in single" 54 "granulocytes: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011937, CAB016255" Enhanced "CAB016255: AB_628395, HPA011937: AB_1858243" "unprognostic (4.18e-2)" "unprognostic (1.97e-2)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-2)" "unprognostic (4.13e-2)" "prognostic favourable (2.48e-4)" "unprognostic (2.29e-2)" "unprognostic (4.49e-2)" "unprognostic (9.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.90e-1)" "unprognostic (1.18e-9)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" "unprognostic (3.28e-1)" "unprognostic (8.18e-2)" 0.1 0.0 0.1 0.1 0.1 5.3 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.3 0.1 0.0 0.1 112.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 2.8 0.0 0.6 38.6 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TFRC "CD71, p90, TFR1" ENSG00000072274 "Transferrin receptor" P02786 3 196027183-196082189 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 110.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000153, HPA028598" Enhanced Supported Endosomes,Lysosomes "Secreted to blood" 1310000000 14000000 "Endosomes, Lysosomes" "CAB000153: AB_2533029, HPA028598: AB_10601599" "unprognostic (2.95e-2)" "prognostic unfavourable (3.67e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" "unprognostic (6.75e-2)" "unprognostic (7.88e-3)" "prognostic unfavourable (1.15e-4)" "unprognostic (6.92e-2)" "unprognostic (3.30e-3)" "unprognostic (4.35e-2)" "unprognostic (1.34e-2)" "unprognostic (1.14e-2)" "unprognostic (3.63e-3)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "prognostic unfavourable (2.96e-4)" "unprognostic (2.62e-2)" 24.3 11.9 11.9 20.6 11.3 73.8 7.6 9.6 17.8 11.8 25.0 9.5 3.8 11.9 12.1 7.5 18.5 11.7 11.4 18.7 9.5 8.3 15.3 13.6 28.1 8.1 7.4 9.5 50.0 7.8 18.0 6.9 110.0 26.5 7.2 19.4 8.5 8.3 5.0 25.6 9.9 37.4 10.9 13.2 7.9 10.0 8.3 6.1 14.3 7.0 10.5 12.9 11.2 8.0 5.7 7.5 2.2 12.4 1.8 6.5 2.1 21.9 20.0 9.2 18.6 20.4 11.8 57.5 31.4 23.9 22.1 36.7 48.7 20.2 22.5 59.6 11.6 33.9 31.5 10.4 27.1 107.6 10.7 85.3 17.0 22.6 16.1 69.9 17.3 13.3 10.3 19.0 17.2 7.3 35.5 21.6 17.2 20.3 22.9 14.8 28.0 41.0 12.2 13.7 27.0 19.8 55.6 21.0 8.7 30.3 79.7 7.1 77.4 14.6 9.4 26.3 21.4 23.0 47.0 6.1 47.5 35.2 30.8 19.0 15.9 0.0 1.6 2.2 2.5 7.9 1.7 5.7 2.7 1.7 3.7 3.2 2.5 1.9 0.3 1.8 12.4 7.5 6.5 2.1 11.9 11.3 9.6 17.8 9.5 8.3 7.4 9.5 26.5 6.1 TGFA ENSG00000163235 "Transforming growth factor alpha" P01135 2 70447280-70554193 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 23.9;CAPAN-2: 29.5;EFO-21: 15.2;HBEC3-KT: 25.7;RPTEC TERT1: 25.9;U-87 MG: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 6.3;eosinophil: 14.0;neutrophil: 14.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042297 Approved Approved Vesicles "Secreted to blood" 57867 Vesicles "HPA042297: AB_10793878" "unprognostic (1.23e-1)" "unprognostic (1.06e-3)" "unprognostic (3.57e-3)" "unprognostic (6.39e-2)" "unprognostic (1.41e-1)" "unprognostic (8.49e-3)" "unprognostic (1.52e-1)" "unprognostic (3.00e-3)" "unprognostic (6.69e-2)" "unprognostic (9.21e-2)" "prognostic unfavourable (1.20e-5)" "unprognostic (7.74e-2)" "unprognostic (3.70e-2)" "unprognostic (1.60e-1)" "unprognostic (9.21e-2)" "prognostic favourable (1.52e-4)" "unprognostic (9.19e-2)" 2.0 0.5 8.4 4.3 10.7 1.2 6.2 3.5 7.9 5.7 9.4 21.4 0.3 7.4 1.2 2.8 23.8 5.7 14.6 0.8 10.7 6.9 12.4 4.0 3.5 4.2 10.9 5.2 0.5 12.0 1.0 0.8 1.7 9.4 2.2 7.3 9.7 6.3 1.2 0.4 10.8 13.7 1.3 22.5 5.1 7.6 2.3 12.8 0.2 7.4 17.4 12.1 5.4 10.8 0.0 0.6 14.7 0.4 0.2 2.7 0.4 23.9 3.8 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 29.5 0.0 15.2 0.1 12.8 0.2 25.7 0.0 0.0 0.5 0.0 0.6 2.0 0.0 0.3 0.0 0.0 10.3 0.0 10.1 0.0 0.0 0.1 0.0 0.9 0.0 0.5 0.4 7.3 0.0 0.1 6.3 25.9 9.3 0.2 0.0 1.9 0.0 0.0 3.3 0.2 0.2 0.1 1.7 0.0 5.2 0.1 0.1 0.0 24.5 0.8 8.8 6.3 0.4 14.0 1.0 0.1 2.7 0.0 0.6 0.6 0.6 0.0 0.3 0.2 14.7 0.2 0.0 0.0 0.0 0.4 8.4 10.7 3.5 7.9 10.7 6.9 10.9 5.2 9.4 12.8 TGFBR1 "ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI" ENSG00000106799 "Transforming growth factor beta receptor 1" P36897 9 99104038-99154192 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation, Growth regulation" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002441, CAB031481, HPA056473" Uncertain Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: " "unprognostic (2.58e-3)" "unprognostic (1.20e-2)" "unprognostic (3.64e-3)" "unprognostic (2.80e-1)" "unprognostic (8.63e-2)" "unprognostic (3.36e-2)" "unprognostic (1.97e-2)" "unprognostic (1.32e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (8.21e-3)" "unprognostic (1.82e-1)" "unprognostic (1.18e-1)" "unprognostic (1.01e-3)" "unprognostic (3.40e-2)" "unprognostic (3.19e-2)" "unprognostic (1.14e-2)" 11.1 6.9 10.3 11.5 14.6 20.0 15.4 12.6 11.3 14.4 20.0 11.0 5.5 7.4 18.8 8.0 13.2 10.9 14.9 9.7 7.8 7.5 16.0 9.8 19.2 18.9 15.8 4.3 13.3 8.8 6.5 13.5 50.9 14.1 12.3 9.2 10.4 10.2 12.2 8.4 6.6 11.0 28.6 17.9 13.9 25.5 11.4 12.4 10.8 7.7 8.1 11.5 13.0 10.2 1.6 2.0 13.1 2.4 4.0 8.3 1.9 3.3 5.0 30.8 9.5 7.2 5.3 4.6 11.5 12.6 10.7 12.1 5.1 2.4 7.5 3.6 9.0 8.0 10.4 8.9 14.6 19.5 3.2 11.2 5.6 4.5 11.9 6.9 27.3 11.0 9.6 16.8 7.9 1.9 15.5 3.2 14.7 5.2 1.0 7.8 6.5 3.0 2.8 67.2 3.2 2.6 0.8 8.3 9.7 8.9 39.9 11.9 7.4 9.4 3.5 8.0 6.9 34.3 7.0 3.2 3.2 5.1 16.8 11.9 6.9 13.1 2.4 9.1 8.3 1.6 7.2 1.6 3.6 6.1 2.0 1.3 3.5 6.7 4.9 4.0 1.9 1.4 2.2 1.9 10.3 14.6 12.6 11.3 7.8 7.5 15.8 4.3 14.1 12.4 TGFBR2 "MFS2, TBR-ii, TBRII" ENSG00000163513 "Transforming growth factor beta receptor 2" P37173 3 30606502-30694142 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Apoptosis, Differentiation, Growth regulation" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 53.4;ASC TERT1: 80.5;HSkMC: 69.5;LHCN-M2: 65.8;TIME: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB073537 Supported "Plasma membrane" 560000 "Plasma membrane" "CAB073537: " "unprognostic (1.74e-1)" "unprognostic (1.84e-2)" "unprognostic (3.70e-1)" "unprognostic (3.02e-2)" "unprognostic (1.92e-1)" "unprognostic (2.26e-1)" "unprognostic (1.96e-1)" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (2.24e-2)" "unprognostic (7.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.65e-2)" "unprognostic (4.72e-2)" "unprognostic (1.81e-2)" "unprognostic (8.81e-2)" "unprognostic (8.02e-2)" 91.8 24.6 6.7 24.6 10.3 7.3 88.3 3.6 7.3 36.5 42.6 9.8 18.6 13.2 42.6 23.3 36.2 28.4 42.6 73.5 6.9 5.2 32.6 21.9 52.6 75.7 12.6 3.7 22.2 26.0 17.4 10.3 24.2 9.9 35.2 17.5 27.9 22.5 19.5 34.9 17.0 31.3 37.2 12.0 68.7 26.8 15.4 8.2 19.3 40.9 16.8 26.9 48.0 82.0 5.3 6.8 20.0 6.6 1.4 19.7 3.9 2.4 14.4 0.9 0.0 53.4 80.5 2.4 12.5 17.6 4.3 4.3 3.2 13.3 0.3 45.3 16.8 5.0 0.6 18.3 7.2 1.0 1.3 1.4 1.6 16.2 22.8 2.2 11.8 69.5 16.3 18.6 18.0 46.7 0.2 0.0 65.8 0.2 2.3 1.6 0.4 5.8 2.0 5.8 0.3 23.2 5.8 0.0 0.9 3.7 1.0 3.5 0.0 2.4 60.3 21.2 5.2 9.6 4.7 0.4 0.0 2.0 12.7 2.5 8.5 6.9 2.9 20.0 3.5 3.0 3.2 4.0 5.4 4.2 2.6 5.3 19.7 9.1 12.6 1.4 6.6 6.8 1.2 3.9 6.7 10.3 3.6 7.3 6.9 5.2 12.6 3.7 9.9 8.2 TGFBR3 "betaglycan, BGCAN" ENSG00000069702 "Transforming growth factor beta receptor 3" Q03167 1 91680343-91906335 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 65.7;ASC TERT1: 32.0;U-2197: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 21.3;MAIT T-cell: 11.6;memory CD4 T-cell: 5.4;memory CD8 T-cell: 11.4;naive CD8 T-cell: 8.0;NK-cell: 9.0" "Group enriched" "Detected in many" 22 "NK-cells: 9.0;T-cells: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008257, CAB018971" Supported Approved Cytosol "Secreted to blood" 29000000 Cytosol "CAB018971: , HPA008257: AB_1080258" "unprognostic (7.57e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-2)" "prognostic unfavourable (3.36e-4)" "unprognostic (9.39e-3)" "prognostic favourable (4.84e-4)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (1.79e-1)" "unprognostic (9.32e-2)" "unprognostic (1.07e-1)" "prognostic favourable (4.99e-4)" "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "prognostic unfavourable (3.14e-4)" "unprognostic (1.08e-2)" 40.1 15.9 3.2 6.8 3.1 1.6 63.5 1.8 4.4 30.1 15.2 3.5 30.0 3.4 17.6 21.0 22.2 17.6 23.3 16.3 3.9 1.9 12.5 11.9 18.4 18.1 2.6 2.0 62.4 8.9 4.4 4.4 25.1 4.5 21.7 5.6 8.8 14.7 46.5 19.2 13.4 9.8 34.4 4.1 27.1 11.1 14.0 3.0 1.1 7.5 6.5 3.1 39.2 42.1 0.0 0.6 0.6 0.6 9.0 21.3 3.9 2.7 2.6 4.0 0.6 65.7 32.0 12.7 2.0 10.0 2.3 2.8 1.2 0.4 0.0 0.5 3.6 0.4 1.0 0.2 1.8 9.3 2.1 0.0 3.3 11.1 1.4 0.1 0.0 7.7 1.3 5.1 1.1 1.1 6.4 0.2 0.6 0.0 0.0 0.0 1.6 0.9 0.1 1.3 0.5 0.9 16.0 0.1 0.0 0.9 0.0 5.5 0.3 1.0 3.6 3.9 1.0 22.3 0.4 9.9 0.9 0.0 0.8 0.5 0.4 0.6 0.0 0.0 21.3 0.1 11.6 0.0 5.4 11.4 0.0 0.0 1.7 8.0 0.3 9.0 0.6 0.6 2.4 3.9 3.2 3.1 1.8 4.4 3.9 1.9 2.6 2.0 4.5 3.0 TGFBR3L ENSG00000260001 "Transforming growth factor beta receptor 3 like" H3BV60 19 7916145-7919097 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pituitary gland: 56.6" "Cell line enhanced" "Detected in some" "PC-3: 5.6;REH: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 8 "T-cells: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA074356 Enhanced Approved Vesicles Vesicles "HPA074356: " "unprognostic (1.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (2.63e-1)" "unprognostic (7.65e-2)" "unprognostic (9.51e-3)" "unprognostic (1.09e-1)" "unprognostic (6.96e-2)" "unprognostic (3.41e-2)" "unprognostic (2.81e-1)" "unprognostic (2.04e-1)" "unprognostic (3.50e-3)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (1.06e-1)" "unprognostic (8.62e-3)" 0.3 2.0 1.6 0.2 2.8 0.6 0.3 1.9 6.4 5.0 0.6 0.0 0.3 6.0 2.8 0.5 0.3 0.7 0.2 2.1 0.7 0.8 3.7 4.0 0.3 0.1 0.5 1.7 0.3 0.3 0.9 56.6 0.4 1.9 2.5 0.1 0.6 0.8 0.7 0.3 0.5 5.7 2.0 0.6 0.3 0.4 0.5 0.0 0.0 0.3 0.0 0.1 1.1 0.8 0.1 0.3 0.0 0.1 0.0 2.9 0.1 0.1 0.2 0.1 0.5 0.1 0.0 3.3 2.6 0.0 0.2 0.0 0.5 0.0 0.1 3.0 0.1 1.9 0.0 0.0 0.0 3.4 1.1 0.5 0.2 0.6 0.2 1.7 0.3 0.2 0.1 0.0 0.0 0.0 0.7 0.5 0.0 1.5 1.2 0.2 0.6 5.6 13.6 0.0 3.0 0.2 0.0 1.0 2.5 0.3 0.0 0.6 0.9 0.5 0.2 1.8 2.9 2.0 0.9 0.8 0.9 0.8 0.4 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.6 0.1 0.9 1.9 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.3 0.0 0.1 1.6 2.8 1.9 6.4 0.7 0.8 0.5 1.7 1.9 0.0 TGOLN2 "TGN38, TGN46, TGN48, TGN51, TTGN2" ENSG00000152291 "Trans-golgi network protein 2" O43493 2 85318020-85328425 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB011489, HPA012609, HPA012723" Enhanced Enhanced "Nucleoplasm,Golgi apparatus" 9800000 "Golgi apparatus" Nucleoplasm "CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975" "unprognostic (3.03e-2)" "unprognostic (1.82e-2)" "unprognostic (2.35e-1)" "unprognostic (4.39e-2)" "unprognostic (3.90e-2)" "unprognostic (2.66e-1)" "unprognostic (5.50e-3)" "unprognostic (2.49e-1)" "unprognostic (2.98e-1)" "unprognostic (1.52e-2)" "unprognostic (5.19e-2)" "unprognostic (2.72e-2)" "unprognostic (6.30e-2)" "unprognostic (2.83e-2)" "unprognostic (3.22e-2)" "unprognostic (2.04e-2)" "unprognostic (5.37e-2)" 40.0 40.7 34.3 38.4 38.0 55.6 36.5 51.7 43.1 33.3 50.0 38.7 31.5 53.2 41.2 31.1 23.9 33.3 44.9 43.2 31.9 34.4 59.6 66.2 44.1 37.4 35.4 36.7 36.1 34.4 39.5 21.8 50.4 35.8 34.0 50.1 26.9 38.9 36.5 23.7 23.7 63.1 36.0 40.3 47.1 36.8 22.3 33.2 31.8 44.8 17.0 37.7 39.9 32.9 9.4 14.9 34.2 34.1 8.6 12.3 22.7 11.2 29.1 12.4 16.3 29.9 31.4 28.9 34.2 39.9 23.3 18.7 24.3 34.1 14.1 27.1 47.3 18.4 8.9 16.7 38.7 23.1 8.9 20.2 10.3 26.0 16.3 39.1 46.9 23.2 10.7 30.1 18.2 33.6 11.6 23.2 34.3 10.2 12.6 19.9 10.9 11.8 13.3 45.5 10.4 25.0 17.7 11.7 9.7 29.9 22.5 19.8 12.6 17.6 35.6 50.0 18.6 37.7 40.9 15.2 19.5 13.8 37.0 30.4 32.5 17.6 27.5 23.5 12.3 26.9 9.6 9.4 9.2 8.3 14.9 9.1 9.6 9.1 34.2 8.6 34.1 5.6 7.2 22.7 34.3 38.0 51.7 43.1 31.9 34.4 35.4 36.7 35.8 33.2 THAP12 "DAP4, P52rIPK, PRKRIR, THAP0" ENSG00000137492 "THAP domain containing 12" O43422 11 76349956-76380971 "Plasma proteins, Predicted membrane proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008758 Approved Approved Nucleoplasm Nucleoplasm "HPA008758: AB_1855714" "unprognostic (2.79e-1)" "unprognostic (9.79e-2)" "unprognostic (1.16e-3)" "unprognostic (6.47e-2)" "unprognostic (8.85e-3)" "unprognostic (1.23e-1)" "unprognostic (4.03e-3)" "unprognostic (1.08e-1)" "unprognostic (6.68e-3)" "unprognostic (1.48e-1)" "unprognostic (1.57e-2)" "unprognostic (2.65e-2)" "unprognostic (7.98e-2)" "unprognostic (2.06e-1)" "unprognostic (3.95e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-2)" 17.0 15.4 19.4 15.5 16.9 17.1 26.4 28.8 15.5 14.6 14.5 7.1 7.2 11.9 17.9 13.7 12.5 14.9 10.2 20.6 13.6 11.2 17.0 25.3 13.2 18.5 11.7 8.7 15.2 32.3 10.4 16.2 20.1 14.2 12.8 16.3 8.2 12.4 12.6 20.6 9.3 14.5 13.8 12.7 21.9 13.8 14.4 13.4 43.2 16.3 11.6 17.2 11.9 23.3 5.1 2.9 2.0 2.1 7.5 7.7 2.4 10.6 8.5 16.3 9.2 11.2 16.0 9.9 11.0 11.5 14.0 12.4 17.1 11.5 29.1 17.0 10.5 10.6 20.0 13.1 22.5 21.8 6.3 20.8 6.1 7.9 12.4 26.2 10.3 11.4 17.4 12.4 23.3 12.0 24.0 16.5 12.5 11.5 22.6 14.8 6.7 9.4 17.0 37.4 30.1 8.1 11.3 16.0 10.6 10.7 12.0 5.8 12.0 10.4 10.7 16.8 27.5 34.0 9.6 14.7 15.5 70.6 4.0 14.7 9.0 1.1 2.1 2.0 6.6 2.1 7.7 4.9 6.9 7.2 2.9 5.1 5.1 6.6 0.6 7.5 2.0 1.3 6.3 2.4 19.4 16.9 28.8 15.5 13.6 11.2 11.7 8.7 14.2 13.4 THAP4 CGI-36 ENSG00000176946 "THAP domain containing 4" Q8WY91 2 241584405-241637449 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044982, HPA053448" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA044982: AB_10959786, HPA053448: " "unprognostic (3.17e-2)" "unprognostic (1.70e-2)" "unprognostic (6.56e-2)" "unprognostic (1.36e-2)" "unprognostic (8.35e-2)" "unprognostic (7.23e-2)" "unprognostic (1.16e-3)" "unprognostic (3.61e-2)" "unprognostic (7.56e-2)" "unprognostic (2.18e-1)" "unprognostic (3.24e-1)" "unprognostic (2.21e-1)" "prognostic favourable (1.46e-4)" "unprognostic (2.57e-1)" "unprognostic (1.78e-1)" "unprognostic (5.06e-1)" "unprognostic (1.07e-1)" 11.9 11.5 19.3 13.0 22.5 13.3 26.3 13.8 27.5 12.8 21.3 13.5 10.8 23.7 12.7 19.1 23.6 15.3 16.9 52.4 15.4 18.1 38.2 25.1 13.6 11.9 18.3 11.7 16.7 25.0 30.9 15.0 11.2 15.6 17.1 15.4 12.5 19.7 17.4 55.8 18.5 20.4 13.7 11.3 10.3 18.5 22.7 11.4 16.0 19.0 26.1 15.7 19.4 18.3 14.3 13.9 22.9 12.7 12.5 30.2 9.8 15.1 19.1 11.5 21.3 15.5 16.2 18.1 10.0 15.4 17.2 15.3 17.3 14.2 13.6 5.9 17.8 17.6 23.1 25.5 6.5 10.2 27.1 13.9 13.1 49.2 20.7 16.5 9.8 16.7 20.2 18.4 25.5 15.8 23.8 4.7 13.2 29.7 16.8 40.2 19.8 16.2 19.3 16.1 18.2 35.7 20.2 27.4 18.0 8.4 27.5 22.8 13.7 19.4 13.8 18.4 12.8 17.4 20.3 11.1 6.5 14.0 14.1 14.1 14.0 15.4 9.3 22.9 17.5 10.8 18.5 13.8 19.4 16.2 9.7 14.3 18.7 14.9 6.5 12.5 12.7 13.9 30.2 9.8 19.3 22.5 13.8 27.5 15.4 18.1 18.3 11.7 15.6 11.4 THBD CD141 ENSG00000178726 Thrombomodulin P07204 20 23045633-23049741 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease mutation, Hemolytic uremic syndrome, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 12.9;CAPAN-2: 20.0;EFO-21: 17.5;HaCaT: 16.8;hTCEpi: 22.2;THP-1: 12.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 17.7" "Group enriched" "Detected in many" 7 "dendritic cells: 7.8;granulocytes: 17.7;monocytes: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002425, HPA002982" Supported Approved Nucleoplasm,Cytosol 690000 "Nucleoplasm, Cytosol" "CAB002425: AB_563497, HPA002982: AB_1078444" "unprognostic (1.96e-1)" "unprognostic (2.93e-3)" "unprognostic (8.70e-2)" "unprognostic (3.00e-2)" "unprognostic (3.07e-2)" "unprognostic (1.88e-1)" "unprognostic (7.81e-3)" "unprognostic (4.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.52e-2)" "unprognostic (2.30e-1)" "unprognostic (5.33e-2)" "unprognostic (2.23e-2)" "unprognostic (7.35e-3)" "unprognostic (3.01e-2)" "unprognostic (7.58e-3)" "unprognostic (9.71e-2)" 27.0 6.3 1.4 10.5 6.7 6.9 11.8 1.2 2.7 13.2 14.4 1.4 4.3 2.9 9.7 11.5 21.7 15.8 18.2 24.3 5.0 1.5 7.0 10.0 61.9 26.8 2.5 0.1 10.2 7.2 10.0 10.9 16.4 6.2 6.1 3.3 8.8 6.0 4.2 55.5 32.4 14.1 8.5 7.7 44.4 14.4 15.8 2.4 2.1 18.3 32.2 10.4 14.2 10.4 0.0 7.8 17.7 6.2 1.5 0.0 1.1 5.6 5.0 0.1 0.0 12.9 0.7 0.1 0.1 0.0 0.0 0.0 0.0 20.0 0.0 17.5 1.7 16.8 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.0 0.1 0.6 22.2 0.3 1.4 5.6 2.1 0.0 0.5 0.4 0.0 2.1 0.0 0.8 0.0 0.0 2.4 0.1 8.2 0.3 0.0 4.7 0.6 8.7 0.0 12.5 11.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 1.0 2.9 0.4 0.0 2.8 0.0 0.0 6.2 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 17.7 1.5 5.8 7.8 0.0 1.1 1.4 6.7 1.2 2.7 5.0 1.5 2.5 0.1 6.2 2.4 THOC1 "HPR1, P84" ENSG00000079134 "THO complex 1" Q96FV9 18 214520-268050 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019096, HPA019687" Enhanced Enhanced "Nuclear speckles" "Nuclear speckles" "HPA019096: AB_1857979, HPA019687: AB_1857980" "prognostic favourable (8.43e-4)" "unprognostic (2.06e-3)" "unprognostic (1.84e-1)" "unprognostic (3.69e-2)" "unprognostic (8.75e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (1.83e-5)" "unprognostic (6.74e-3)" "unprognostic (2.49e-3)" "prognostic favourable (2.89e-5)" "unprognostic (3.60e-2)" "unprognostic (1.35e-2)" "prognostic unfavourable (1.80e-6)" "unprognostic (2.03e-1)" "unprognostic (2.24e-1)" "unprognostic (3.42e-1)" "prognostic favourable (9.62e-4)" 11.9 9.1 11.8 12.5 14.5 10.7 7.7 19.0 12.5 10.5 10.7 12.3 10.9 10.4 15.5 8.1 13.4 8.2 7.7 8.5 10.9 9.9 11.6 16.5 7.1 17.6 18.1 7.6 9.9 8.1 11.1 23.3 9.6 11.5 8.4 8.7 8.9 10.4 7.6 12.1 9.1 9.4 10.8 14.2 12.8 9.6 26.3 17.7 16.2 9.2 7.8 17.8 14.6 7.8 11.7 11.0 9.1 9.7 9.7 14.2 6.4 12.8 6.9 16.2 13.5 10.3 7.4 20.0 7.0 7.1 15.3 16.0 14.2 8.3 18.3 6.0 9.8 8.4 20.8 11.7 18.9 5.8 9.0 11.0 9.1 9.6 8.1 25.0 10.2 4.9 7.2 16.3 10.6 16.3 24.9 8.7 13.2 9.6 18.2 14.2 16.0 10.2 25.6 15.5 16.6 8.5 12.6 10.9 8.2 19.7 10.2 11.7 7.0 17.8 8.3 13.7 14.8 10.9 23.2 7.1 12.3 26.7 11.6 17.3 11.7 9.1 6.7 5.7 9.5 9.7 14.2 11.7 11.6 12.0 11.0 9.5 13.6 13.3 0.7 9.7 7.8 6.5 11.4 6.4 11.8 14.5 19.0 12.5 10.9 9.9 18.1 7.6 11.5 17.7 THSD1 TMTSP ENSG00000136114 "Thrombospondin type 1 domain containing 1" Q9NS62 13 52377167-52406494 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 12.0;HBEC3-KT: 12.1;hTCEpi: 12.0;hTERT-HME1: 12.3;HUVEC TERT2: 25.1;LHCN-M2: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012611, CAB020796" Uncertain Supported Cytosol "Intracellular and membrane" 810000 Cytosol "CAB020796: , HPA012611: AB_1857990" "unprognostic (1.21e-1)" "unprognostic (7.54e-3)" "unprognostic (3.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.31e-1)" "unprognostic (1.54e-2)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.87e-2)" "unprognostic (3.35e-1)" "unprognostic (6.10e-3)" "unprognostic (1.55e-1)" "unprognostic (3.05e-3)" "unprognostic (8.44e-2)" "unprognostic (1.31e-1)" "unprognostic (3.35e-2)" "unprognostic (4.90e-2)" 9.7 1.8 8.3 1.8 7.2 0.4 11.1 2.9 6.4 7.6 2.6 1.9 3.6 1.2 6.8 4.9 4.4 5.7 4.9 9.0 8.1 2.2 2.0 2.1 19.8 4.7 2.2 4.6 2.3 1.2 2.5 3.4 16.8 2.1 8.5 2.3 5.5 3.9 3.2 9.7 6.0 2.3 7.4 2.2 6.6 1.9 2.7 1.1 0.7 5.2 5.2 2.5 5.9 4.5 0.3 0.0 0.0 0.0 0.4 0.7 0.0 0.5 2.4 0.2 2.1 2.0 6.5 0.5 5.1 2.5 2.0 3.2 0.0 0.3 0.2 0.6 12.0 2.7 0.0 12.1 3.1 5.6 1.7 0.3 0.0 0.0 1.2 1.2 0.3 2.6 12.0 9.7 12.3 25.1 0.0 0.1 11.5 0.0 0.4 0.2 0.1 0.5 0.3 2.7 0.0 2.7 0.1 0.0 0.4 0.1 0.0 0.4 0.2 0.2 5.8 0.6 1.1 0.0 3.8 0.3 0.0 0.0 1.1 0.3 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.5 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.3 7.2 2.9 6.4 8.1 2.2 2.2 4.6 2.1 1.1 THSD7A KIAA0960 ENSG00000005108 "Thrombospondin type 1 domain containing 7A" Q9UPZ6 7 11370357-11832198 "Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 22.5" "Cell line enhanced" "Detected in some" "A549: 9.5;HUVEC TERT2: 6.3;REH: 6.5;SH-SY5Y: 9.7;THP-1: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 76 "basophil: 7.5" "Lineage enriched" "Detected in single" 76 "granulocytes: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000923 Supported "Secreted to blood" 3000000 "HPA000923: AB_1080271" "unprognostic (3.01e-1)" "unprognostic (7.90e-2)" "unprognostic (3.09e-2)" "unprognostic (1.96e-1)" "unprognostic (5.88e-1)" "unprognostic (3.33e-2)" "unprognostic (1.44e-1)" "unprognostic (9.66e-2)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (2.07e-1)" "unprognostic (8.75e-2)" "prognostic favourable (2.24e-6)" "unprognostic (2.13e-3)" "unprognostic (1.66e-1)" "unprognostic (2.28e-2)" "unprognostic (3.33e-2)" 9.6 2.2 4.7 2.1 5.7 0.6 5.2 2.0 7.2 8.4 2.7 1.0 0.9 1.2 8.3 2.7 1.7 4.8 6.2 2.1 3.8 4.7 17.7 2.0 3.0 1.2 4.6 3.6 6.4 1.4 2.6 9.4 22.5 3.5 8.4 2.1 4.4 1.7 5.5 0.9 1.7 1.5 5.9 4.3 2.3 1.7 2.2 1.9 0.0 4.9 2.5 1.1 4.5 6.8 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 9.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 6.5 0.0 0.0 0.3 0.1 0.7 9.7 0.0 0.3 0.0 0.1 17.5 2.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 5.7 2.0 7.2 3.8 4.7 4.6 3.6 3.5 1.9 THSD7B KIAA1679 ENSG00000144229 "Thrombospondin type 1 domain containing 7B" Q9C0I4 2 136765545-137677717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.2;epididymis: 11.6;retina: 14.9" "Group enriched" "Detected in some" 8 "Daudi: 10.1;SCLC-21H: 21.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051416, HPA056745" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051416: , HPA056745: " "unprognostic (4.65e-3)" "unprognostic (2.25e-1)" "unprognostic (8.98e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (6.50e-2)" "unprognostic (7.80e-3)" "unprognostic (2.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.20e-1)" "unprognostic (6.56e-2)" "unprognostic (4.47e-6)" "unprognostic (2.42e-3)" "unprognostic (1.89e-1)" "unprognostic (4.31e-2)" "unprognostic (4.30e-2)" 4.7 0.3 1.7 0.3 1.6 0.1 2.6 0.7 3.2 0.9 0.5 1.1 0.8 0.3 0.9 11.6 1.6 2.8 0.8 1.4 1.8 3.3 2.7 0.6 0.5 0.2 1.8 1.5 0.4 0.3 1.3 3.0 0.7 24.2 2.1 0.3 14.9 1.2 0.7 0.3 0.2 1.5 2.2 3.2 0.2 0.3 1.1 0.3 0.1 2.1 0.0 0.3 0.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.1 0.0 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 0.7 3.2 1.8 3.3 1.8 1.5 24.2 0.3 THY1 CD90 ENSG00000154096 "Thy-1 cell surface antigen" P04216 11 119417378-119424985 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.7;smooth muscle: 91.5" "Cell line enhanced" "Detected in many" "ASC diff: 52.6;BJ: 82.2;BJ hTERT+: 92.1;fHDF/TERT166: 144.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003733, CAB068243, CAB068244" Enhanced Approved "Nucleoplasm,Plasma membrane" 9800000 Nucleoplasm "Plasma membrane" "CAB068243: , CAB068244: , HPA003733: AB_1846340" "unprognostic (9.98e-2)" "unprognostic (2.71e-1)" "unprognostic (5.13e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (6.87e-4)" "unprognostic (7.43e-2)" "unprognostic (1.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-3)" "unprognostic (3.38e-2)" "unprognostic (3.52e-1)" "prognostic unfavourable (2.40e-6)" "unprognostic (1.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.03e-2)" "unprognostic (1.14e-2)" 28.7 5.9 42.0 23.2 72.4 0.4 7.0 17.6 97.7 26.9 9.0 7.2 2.1 3.5 20.3 13.9 9.8 7.5 31.6 4.3 63.4 41.1 46.6 2.6 6.5 10.9 29.8 34.8 3.2 5.0 7.3 5.5 19.1 53.8 4.6 13.6 8.5 2.9 15.7 1.4 4.2 4.6 91.5 9.3 6.7 5.7 4.0 6.9 3.1 12.0 1.0 10.8 36.9 7.2 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.3 12.3 0.0 52.6 38.1 0.0 82.2 92.1 29.5 32.7 0.0 0.0 0.0 0.0 144.0 0.0 0.4 0.1 22.6 7.0 0.0 4.4 1.5 0.0 16.3 0.0 0.0 28.2 0.0 37.4 1.3 0.0 0.0 0.0 22.7 0.0 0.0 0.0 19.7 0.1 0.0 5.8 0.0 0.0 0.0 2.1 5.6 0.0 0.0 0.0 0.1 0.2 0.0 42.4 14.1 12.2 12.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 42.0 72.4 17.6 97.7 63.4 41.1 29.8 34.8 53.8 6.9 TIMD4 ENSG00000145850 "T cell immunoglobulin and mucin domain containing 4" Q96H15 5 156919282-156963255 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "liver: 32.0;lymphoid tissue: 83.9;testis: 58.9" "Group enriched" "Detected in some" 18 "U-266/70: 45.7;U-266/84: 12.4" "Cancer enriched" "Detected in some" 10 "renal cancer: 6.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 2.3;memory CD8 T-cell: 4.5;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.0;T-reg: 6.4" "Lineage enriched" "Detected in single" 14 "T-cells: 6.4" "HPA015625, CAB026027" Approved 18000000 "CAB026027: , HPA015625: AB_1858018" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (3.01e-2)" "unprognostic (1.10e-1)" "unprognostic (3.11e-1)" "unprognostic (3.42e-1)" "unprognostic (8.42e-2)" "unprognostic (1.10e-1)" "unprognostic (6.90e-2)" "prognostic favourable (3.37e-4)" "unprognostic (1.31e-2)" "unprognostic (4.07e-1)" "unprognostic (3.27e-2)" "unprognostic (2.08e-2)" 6.7 0.4 0.4 3.5 0.4 5.3 0.5 0.4 0.4 0.4 1.3 0.0 0.0 0.0 0.4 1.0 1.5 0.4 0.3 0.8 0.4 0.4 1.7 32.0 0.6 83.9 0.5 0.0 0.4 0.4 0.0 0.4 2.8 0.0 1.1 0.1 0.0 6.5 0.0 0.7 0.4 1.1 0.2 0.5 12.5 0.4 58.9 0.0 21.7 0.8 0.2 8.5 5.3 0.4 0.4 0.0 0.0 0.0 0.0 6.4 1.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 45.7 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 2.3 4.5 0.0 0.0 3.0 3.0 0.0 0.0 0.0 0.0 6.4 1.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.0 TIMM21 "C18orf55, HSPC154, TIM21" ENSG00000075336 "Translocase of inner mitochondrial membrane 21" Q9BVV7 18 74148511-74160530 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010587, HPA051543" Uncertain "HPA010587: AB_1851244, HPA051543: " "unprognostic (4.88e-1)" "unprognostic (2.20e-2)" "unprognostic (1.16e-1)" "unprognostic (8.61e-2)" "unprognostic (3.81e-2)" "unprognostic (3.19e-1)" "prognostic unfavourable (9.22e-5)" "unprognostic (1.42e-1)" "unprognostic (1.59e-2)" "unprognostic (1.93e-2)" "unprognostic (4.79e-3)" "unprognostic (1.55e-3)" "prognostic favourable (1.38e-9)" "unprognostic (2.37e-2)" "unprognostic (5.39e-2)" "unprognostic (1.31e-1)" "unprognostic (6.66e-2)" 13.4 14.0 16.7 10.1 20.3 7.5 11.0 26.2 20.3 8.1 12.7 18.3 8.4 12.9 9.7 13.2 11.1 8.5 6.3 39.2 15.6 14.1 20.3 17.6 7.5 9.5 17.2 13.8 11.6 8.7 14.3 14.1 10.5 18.4 10.3 14.6 10.7 12.1 11.2 45.7 11.5 12.2 10.8 16.2 11.1 10.0 6.9 16.8 8.8 11.2 19.4 10.2 9.3 8.1 13.7 13.4 5.8 14.2 14.3 16.2 7.6 11.7 12.4 11.7 14.4 9.7 8.6 17.3 18.1 6.1 11.0 9.3 9.1 8.6 15.9 5.8 7.0 19.7 16.1 15.4 18.6 10.0 9.3 6.8 21.6 24.8 4.9 25.4 11.4 8.0 9.3 13.9 9.7 8.3 13.7 11.1 13.3 11.8 13.4 21.0 11.2 23.2 12.7 13.6 19.8 14.3 16.7 12.5 6.9 6.8 17.1 10.7 11.9 13.3 5.9 25.9 18.2 8.4 18.7 3.5 26.9 17.2 12.6 27.7 18.0 5.8 8.8 5.1 11.6 13.1 13.7 13.7 11.2 9.7 11.1 11.0 14.4 16.2 1.3 14.3 14.2 13.4 8.2 7.6 16.7 20.3 26.2 20.3 15.6 14.1 17.2 13.8 18.4 16.8 TIMM50 TIM50L ENSG00000105197 "Translocase of inner mitochondrial membrane 50" Q3ZCQ8 19 39480412-39493785 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" RNA-binding "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048843, HPA056448" Enhanced Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA048843: , HPA056448: " "unprognostic (1.49e-1)" "unprognostic (6.97e-2)" "unprognostic (4.90e-2)" "unprognostic (2.80e-3)" "unprognostic (4.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.11e-2)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-2)" "unprognostic (9.43e-2)" "unprognostic (2.01e-2)" "unprognostic (4.14e-3)" "unprognostic (3.04e-2)" "unprognostic (9.87e-2)" "unprognostic (3.82e-2)" "unprognostic (4.04e-2)" 21.3 20.2 17.9 17.0 25.8 23.0 15.7 14.3 38.2 13.4 18.4 18.0 14.4 18.0 19.0 11.7 22.6 15.8 12.5 42.2 17.6 17.4 23.9 28.0 14.2 16.6 17.8 20.2 16.4 19.8 16.4 13.4 20.0 22.0 15.3 12.0 18.1 18.3 14.6 58.1 14.0 16.1 16.5 12.7 15.1 16.9 40.4 14.7 18.5 24.0 25.5 16.9 16.9 18.2 19.3 27.4 10.3 25.3 17.0 19.9 27.8 26.6 64.0 11.9 29.7 10.5 9.6 21.7 21.1 10.8 25.0 20.5 45.9 18.9 30.2 22.4 14.2 15.3 23.8 21.8 13.4 26.3 34.7 28.0 18.7 31.6 16.0 54.5 19.4 12.2 15.5 18.7 17.2 16.2 44.7 18.1 15.7 35.3 33.3 20.9 20.7 24.5 34.0 23.8 23.2 17.2 36.8 31.6 17.7 25.3 37.0 43.3 17.3 29.6 16.3 31.1 29.0 25.6 49.0 17.1 31.5 45.5 23.3 27.4 34.5 10.3 25.3 6.1 16.9 24.0 17.3 19.3 16.2 18.5 27.4 18.1 18.4 17.0 2.1 17.0 22.4 20.6 19.9 27.8 17.9 25.8 14.3 38.2 17.6 17.4 17.8 20.2 22.0 14.7 TLR10 CD290 ENSG00000174123 "Toll like receptor 10" Q9BXR5 4 38772239-38782990 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6" "Group enriched" "Detected in some" 55 "Daudi: 37.3;REH: 12.5;U-698: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory B-cell: 23.5;naive B-cell: 14.9" "Lineage enriched" "Detected in many" 6 "B-cells: 23.5" "Low region specificity" "Detected in all" HPA066755 Approved Centrosome,Cytosol Cytosol Centrosome "HPA066755: " "unprognostic (5.41e-5)" "unprognostic (2.41e-4)" "unprognostic (1.91e-3)" "unprognostic (8.22e-4)" "unprognostic (6.48e-2)" "unprognostic (9.98e-4)" "unprognostic (9.31e-2)" "unprognostic (8.76e-3)" "unprognostic (4.08e-3)" "unprognostic (7.26e-2)" "unprognostic (8.76e-2)" "unprognostic (6.90e-2)" "unprognostic (2.98e-3)" "unprognostic (3.90e-1)" "unprognostic (1.81e-2)" "unprognostic (3.14e-3)" "unprognostic (1.88e-2)" 0.8 0.5 4.2 24.5 9.4 0.9 0.6 0.6 3.5 0.6 1.0 2.5 0.0 0.9 0.5 0.3 1.7 0.9 1.0 0.5 3.2 1.8 0.8 0.7 1.2 27.0 5.5 0.5 0.5 0.6 0.1 0.7 0.2 4.8 0.8 1.4 0.0 2.6 0.3 0.5 0.5 11.2 0.3 11.3 24.4 1.8 0.4 7.4 2.7 0.9 0.0 31.6 3.2 0.6 23.5 4.0 0.7 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.1 0.2 0.4 0.0 1.5 0.0 23.5 0.0 0.0 3.6 14.9 0.0 0.0 0.7 0.0 1.8 4.0 0.0 0.9 4.2 9.4 0.6 3.5 3.2 1.8 5.5 0.5 4.8 7.4 TLR2 "CD282, TIL4" ENSG00000137462 "Toll like receptor 2" O60603 4 153684070-153705702 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.9" "Cell line enhanced" "Detected in some" "HSkMC: 7.4;hTCEpi: 7.4;RPTEC TERT1: 7.6;RT4: 9.3;THP-1: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4" "Group enriched" "Detected in many" 46 "dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060231, HPA071546" Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA060231: , HPA071546: " "unprognostic (4.15e-1)" "unprognostic (3.29e-2)" "unprognostic (5.32e-2)" "unprognostic (1.52e-2)" "unprognostic (3.46e-2)" "unprognostic (4.88e-2)" "unprognostic (1.39e-2)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-2)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (1.11e-4)" "unprognostic (7.87e-2)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (5.93e-3)" 16.3 6.9 6.9 30.0 11.1 34.6 7.3 1.4 5.3 4.7 4.7 3.0 9.3 2.2 3.1 8.0 3.2 7.2 10.0 7.2 6.7 3.3 9.8 7.3 31.1 37.8 12.4 1.4 4.2 5.1 1.1 4.4 6.4 9.9 5.5 1.9 3.3 15.0 9.9 2.5 3.1 4.0 6.6 21.9 29.3 3.9 4.8 9.5 0.9 3.3 1.0 8.5 7.3 3.5 0.2 19.1 72.9 29.5 0.8 0.2 9.3 3.9 0.0 0.1 0.0 0.5 1.6 0.0 0.0 0.3 0.3 0.5 1.9 0.2 0.0 0.4 0.0 3.5 0.4 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.0 6.8 0.5 7.4 7.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.4 1.5 0.1 0.0 0.0 7.6 9.3 0.0 0.2 0.4 0.0 1.8 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.7 0.9 6.2 29.5 0.2 0.0 28.1 0.0 0.0 0.1 0.0 19.1 0.2 0.2 0.0 72.9 0.8 18.4 0.1 0.0 9.3 6.9 11.1 1.4 5.3 6.7 3.3 12.4 1.4 9.9 9.5 TLR3 CD283 ENSG00000164342 "Toll like receptor 3" O15455 4 186069152-186088069 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Receptor, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 48.1" "Cell line enhanced" "Detected in many" "ASC diff: 11.4;ASC TERT1: 12.0;BJ hTERT+ SV40 Large T+ RasG12V: 17.7;CAPAN-2: 27.6;HSkMC: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 7.6;memory CD8 T-cell: 8.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.5;T-cells: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025658 Enhanced "Intracellular and membrane" "CAB025658: " "unprognostic (2.13e-2)" "unprognostic (2.15e-1)" "unprognostic (7.26e-2)" "unprognostic (7.47e-3)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (6.39e-3)" "unprognostic (1.56e-2)" "unprognostic (9.28e-2)" "unprognostic (2.25e-2)" "prognostic unfavourable (3.09e-4)" "unprognostic (1.17e-1)" "unprognostic (4.72e-3)" "unprognostic (1.18e-1)" "unprognostic (4.52e-3)" "unprognostic (3.89e-2)" "unprognostic (1.83e-1)" 11.9 10.7 3.1 6.8 5.0 0.0 11.1 1.7 3.5 9.9 20.1 3.0 6.8 13.4 5.6 7.3 12.9 7.8 8.6 7.7 3.5 2.6 12.4 11.2 12.2 1.0 3.3 1.9 8.9 8.2 4.8 2.7 48.1 3.0 11.3 9.5 5.0 8.5 10.2 2.3 3.8 34.9 6.5 8.0 7.0 8.2 5.8 4.2 1.2 11.8 7.6 3.0 10.3 14.6 0.0 2.5 0.5 0.0 0.7 8.0 1.1 1.9 0.5 0.3 0.0 11.4 12.0 0.9 0.1 8.2 5.1 17.7 0.0 27.6 0.0 1.1 1.2 2.8 0.0 5.8 0.9 10.6 0.1 1.7 0.5 0.0 5.1 1.7 0.7 11.7 2.2 6.8 0.3 2.4 0.0 0.0 2.8 0.0 2.0 0.0 0.8 1.0 2.5 0.0 0.1 4.8 2.7 0.0 0.1 1.4 1.2 2.2 0.3 0.0 1.7 0.9 0.6 0.0 1.2 0.0 0.0 0.0 2.3 1.1 1.9 0.5 0.0 0.0 7.6 0.0 4.3 0.0 1.8 8.0 2.5 0.0 1.2 3.9 0.3 0.7 0.0 0.0 0.2 1.1 3.1 5.0 1.7 3.5 3.5 2.6 3.3 1.9 3.0 4.2 TLR4 "ARMD10, CD284, hToll, TLR-4" ENSG00000136869 "Toll like receptor 4" O00206 9 117704175-117724730 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" Receptor "Age-related macular degeneration, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 29.1;TIME: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 30.1" "Group enriched" "Detected in many" 30 "dendritic cells: 7.5;granulocytes: 30.1;monocytes: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004025, HPA049174" Approved Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" "Plasma membrane" "Golgi apparatus" "CAB004025: , HPA049174: " "unprognostic (1.60e-1)" "unprognostic (8.34e-2)" "unprognostic (7.22e-2)" "prognostic favourable (6.29e-4)" "unprognostic (3.39e-1)" "unprognostic (7.48e-2)" "unprognostic (8.68e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (5.18e-2)" "unprognostic (8.00e-2)" "unprognostic (9.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.63e-2)" "prognostic unfavourable (3.79e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-2)" 29.2 12.1 15.5 23.5 12.5 17.8 21.9 9.4 10.3 6.9 6.8 10.6 3.0 4.4 5.8 7.7 5.0 6.8 10.6 10.9 19.9 7.5 9.0 16.5 16.0 30.9 12.4 11.4 6.7 3.0 2.9 3.8 22.8 10.5 5.7 7.4 7.2 9.0 3.6 7.4 5.2 6.6 10.4 11.1 41.4 4.5 2.4 13.0 1.1 8.3 5.6 7.5 12.1 16.1 0.6 7.5 30.1 21.4 0.0 0.0 6.9 0.0 0.0 12.5 0.0 5.8 11.8 0.1 5.0 8.7 1.2 0.7 0.0 1.2 1.7 0.2 12.8 0.0 0.0 1.1 1.8 0.0 0.0 2.6 2.6 0.1 4.4 9.0 0.0 7.3 0.0 2.7 0.3 15.2 0.0 29.1 15.2 0.0 0.0 1.8 1.5 0.6 0.0 14.1 9.1 0.5 14.6 0.0 0.0 3.1 0.0 0.5 0.0 4.9 21.1 0.6 9.5 0.0 2.3 0.0 0.0 0.0 0.4 9.5 7.4 17.6 21.4 7.2 0.0 19.6 0.0 0.6 0.0 0.0 7.5 0.2 0.0 0.0 30.1 0.0 20.2 0.3 0.0 6.9 15.5 12.5 9.4 10.3 19.9 7.5 12.4 11.4 10.5 13.0 TLR5 "FLJ10052, MGC126430, MGC126431, SLEB1, TIL3" ENSG00000187554 "Toll like receptor 5" O60602 1 223109406-223143282 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 4.4;HaCaT: 6.7;SK-BR-3: 4.3;T-47d: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "classical monocyte: 17.0;intermediate monocyte: 15.7;myeloid DC: 12.8;neutrophil: 13.4;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 10 "dendritic cells: 12.8;granulocytes: 13.4;monocytes: 17.0" "Low region specificity" "Detected in many" CAB009013 Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB009013: AB_2240732" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-2)" "unprognostic (3.81e-2)" "unprognostic (3.09e-2)" "unprognostic (6.83e-2)" "unprognostic (1.49e-2)" "unprognostic (2.71e-1)" "unprognostic (4.23e-3)" "unprognostic (1.46e-1)" "unprognostic (3.69e-2)" "prognostic unfavourable (4.95e-4)" "unprognostic (1.06e-3)" "unprognostic (5.60e-2)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" 3.8 2.4 5.3 4.8 7.3 0.4 9.7 0.8 5.3 7.1 2.7 3.4 1.7 1.7 2.4 6.2 9.0 5.6 4.8 5.8 5.0 2.6 4.6 2.2 6.5 12.5 7.0 0.8 22.5 5.3 6.6 6.3 3.5 6.8 6.2 2.3 3.2 12.6 2.9 1.4 3.7 2.3 3.7 12.8 6.7 4.5 2.3 8.1 1.2 4.3 3.5 5.7 5.9 7.8 0.1 12.8 13.4 17.0 0.2 1.4 5.7 4.4 0.4 0.7 0.4 0.3 0.0 0.6 0.2 0.0 0.1 0.1 0.0 1.3 0.0 0.9 0.4 6.7 0.1 0.5 0.4 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.1 1.9 0.2 0.9 0.0 0.0 0.6 1.0 0.3 2.5 0.0 0.1 0.0 0.2 2.1 0.8 1.8 0.4 1.3 4.3 0.1 4.8 0.0 0.0 0.1 0.1 0.0 1.2 0.2 0.0 0.2 0.0 0.7 0.5 0.0 17.0 0.2 0.1 15.7 0.2 0.1 0.9 0.2 12.8 0.0 1.4 0.4 13.4 0.2 6.3 0.2 0.6 5.7 5.3 7.3 0.8 5.3 5.0 2.6 7.0 0.8 6.8 8.1 TLR6 CD286 ENSG00000174130 "Toll like receptor 6" Q9Y2C9 4 38823715-38856817 "CD markers, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.2;brain: 16.0;lymphoid tissue: 16.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.0;RPMI-8226: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 14.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062733 Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA062733: " "unprognostic (9.82e-2)" "unprognostic (4.76e-2)" "unprognostic (3.30e-2)" "unprognostic (3.05e-2)" "unprognostic (1.91e-1)" "unprognostic (1.87e-2)" "unprognostic (1.83e-1)" "unprognostic (4.45e-2)" "unprognostic (9.26e-2)" "unprognostic (1.30e-1)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (7.62e-7)" "unprognostic (4.89e-2)" "unprognostic (1.02e-2)" "unprognostic (7.78e-2)" "unprognostic (2.12e-2)" 2.9 2.7 6.1 10.7 7.9 6.4 2.1 2.0 3.9 1.8 1.6 2.6 0.2 1.7 1.4 2.0 1.8 1.9 3.9 1.5 4.5 1.7 1.7 2.1 5.0 11.2 10.6 1.9 1.6 1.2 0.7 1.9 2.8 7.2 1.6 2.4 0.9 4.3 0.5 0.9 1.7 7.8 2.1 16.0 16.2 2.1 0.8 6.8 1.8 1.5 1.1 14.8 5.8 1.9 1.8 1.8 14.2 2.6 0.3 0.4 0.6 1.5 6.0 0.2 0.1 0.3 6.9 0.0 1.6 7.1 0.7 2.4 0.0 13.0 7.1 2.8 0.3 0.7 0.1 1.3 1.1 0.0 0.5 3.3 7.2 0.2 0.5 3.6 5.4 2.9 1.3 2.9 1.6 1.4 3.6 2.3 3.3 0.0 0.0 6.3 0.2 1.0 3.5 3.2 10.2 0.4 0.1 0.0 0.1 0.2 0.0 1.0 0.3 1.9 2.0 2.3 7.8 0.9 2.5 0.1 0.0 6.0 5.3 4.3 1.7 0.0 2.6 0.7 0.2 2.4 0.0 1.8 0.1 0.1 1.8 1.2 0.3 0.2 14.2 0.3 1.2 1.3 0.4 0.6 6.1 7.9 2.0 3.9 4.5 1.7 10.6 1.9 7.2 6.8 TLR7 ENSG00000196664 "Toll like receptor 7" Q9NYK1 X 12867083-12890380 "FDA approved drug targets, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5" "Group enriched" "Detected in some" 5 "Daudi: 15.6;U-266/70: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059613 Supported "HPA059613: " "unprognostic (1.22e-1)" "unprognostic (1.09e-2)" "unprognostic (2.36e-3)" "unprognostic (9.29e-2)" "unprognostic (2.06e-1)" "unprognostic (1.06e-2)" "unprognostic (8.27e-2)" "unprognostic (6.20e-3)" "unprognostic (3.75e-1)" "unprognostic (6.91e-2)" "unprognostic (3.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.54e-1)" "unprognostic (4.17e-3)" "unprognostic (1.19e-3)" "unprognostic (1.53e-3)" "unprognostic (1.34e-1)" 2.9 3.1 7.6 7.2 11.3 1.0 7.6 1.7 7.9 2.5 3.3 10.6 0.0 3.2 1.8 2.9 1.8 1.7 5.3 4.1 8.4 5.1 2.2 1.5 7.7 6.9 17.4 2.6 1.6 1.9 1.5 2.2 11.0 12.9 2.2 4.0 1.5 2.7 2.0 1.4 1.4 4.9 3.5 26.5 6.7 3.0 1.5 17.2 7.7 1.7 0.5 9.4 5.2 1.6 6.9 15.7 3.2 8.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 16.1 0.0 3.0 0.0 0.3 0.0 0.2 7.2 3.2 0.0 8.9 0.0 6.9 0.0 0.0 3.7 5.8 0.0 0.0 0.4 0.0 6.8 15.7 0.0 2.2 7.6 11.3 1.7 7.9 8.4 5.1 17.4 2.6 12.9 17.2 TLR8 CD288 ENSG00000101916 "Toll like receptor 8" Q9NR97 X 12906620-12923169 "CD markers, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.8;lymphoid tissue: 45.6" "Cell line enhanced" "Detected in some" "HMC-1: 1.2;PC-3: 2.7;THP-1: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 94 "classical monocyte: 10.0;intermediate monocyte: 9.6;myeloid DC: 5.3;neutrophil: 17.8;non-classical monocyte: 9.2" "Group enriched" "Detected in many" 100 "dendritic cells: 5.3;granulocytes: 17.8;monocytes: 10.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA001608 Enhanced "HPA001608: AB_1080295" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (3.96e-3)" "unprognostic (4.43e-2)" "unprognostic (9.63e-2)" "unprognostic (2.48e-2)" "unprognostic (2.59e-1)" "unprognostic (6.61e-2)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (3.72e-2)" "unprognostic (2.73e-1)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (4.14e-2)" "unprognostic (1.52e-1)" "unprognostic (5.66e-2)" 8.5 1.4 0.9 16.0 1.5 4.7 1.2 0.7 1.1 1.0 1.5 0.4 0.0 0.6 1.0 3.2 1.0 2.0 2.4 3.0 2.0 1.0 2.0 4.0 13.7 33.0 1.7 0.1 1.1 1.0 0.2 1.0 4.0 1.9 1.4 1.7 0.9 1.2 0.0 1.4 0.8 2.0 3.5 3.3 45.6 1.3 1.2 1.6 3.5 1.0 1.1 2.4 4.2 2.4 0.1 5.3 17.8 10.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.0 0.3 0.0 0.0 10.0 0.0 0.0 9.6 0.0 0.1 0.0 0.0 5.3 0.0 0.0 0.0 17.8 0.0 9.2 0.0 0.0 2.0 0.9 1.5 0.7 1.1 2.0 1.0 1.7 0.1 1.9 1.6 TM4SF1 "L6, M3S1" ENSG00000169908 "Transmembrane 4 L six family member 1" P30408 3 149369022-149377865 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 77.5;HUVEC TERT2: 69.9;LHCN-M2: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002760, HPA002823" Uncertain "CAB002760: , HPA002823: AB_1079221" "unprognostic (1.94e-1)" "unprognostic (2.25e-2)" "unprognostic (5.20e-2)" "unprognostic (4.79e-2)" "unprognostic (2.89e-2)" "unprognostic (2.47e-3)" "unprognostic (3.85e-3)" "unprognostic (2.74e-2)" "unprognostic (5.09e-1)" "unprognostic (3.23e-1)" "prognostic unfavourable (4.01e-4)" "unprognostic (4.06e-1)" "prognostic unfavourable (2.24e-4)" "unprognostic (4.67e-2)" "unprognostic (2.10e-1)" "unprognostic (2.67e-1)" "prognostic unfavourable (3.43e-6)" 72.7 16.9 10.2 11.8 15.5 0.3 44.3 6.4 11.6 33.6 16.3 8.2 4.0 8.6 32.0 35.5 89.2 18.2 54.2 37.5 10.2 10.0 26.9 22.8 111.0 10.9 13.2 2.9 26.0 54.3 3.9 5.2 50.8 17.6 26.0 14.0 20.4 45.4 7.8 29.6 14.8 15.9 21.5 13.1 35.8 25.9 14.4 11.8 1.7 17.0 76.0 48.4 32.4 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 39.3 42.1 0.0 0.1 13.0 50.0 0.0 12.5 50.2 2.7 1.0 16.9 77.5 0.0 40.3 2.5 47.6 0.2 8.9 2.6 0.1 0.0 0.6 45.7 55.8 4.7 0.0 0.0 4.8 2.2 19.2 9.5 69.9 0.0 0.0 75.3 0.0 0.0 0.0 0.1 19.1 0.0 0.1 0.1 49.9 5.9 0.0 0.0 5.2 2.9 0.5 0.1 0.1 44.1 26.1 4.6 0.5 26.4 0.0 0.0 0.1 37.9 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.2 15.5 6.4 11.6 10.2 10.0 13.2 2.9 17.6 11.8 TM7SF2 "ANG1, DHCR14A, NET47" ENSG00000149809 "Transmembrane 7 superfamily member 2" O76062 11 65111845-65116384 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.1" "Cell line enhanced" "Detected in many" "MCF7: 21.6;RPTEC TERT1: 24.9;T-47d: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030691, HPA072704" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "HPA030691: AB_10602480, HPA072704: " "unprognostic (1.62e-1)" "unprognostic (5.23e-2)" "unprognostic (1.70e-2)" "unprognostic (1.78e-1)" "unprognostic (5.74e-2)" "unprognostic (1.10e-1)" "unprognostic (5.98e-2)" "unprognostic (6.06e-2)" "unprognostic (5.72e-2)" "unprognostic (1.74e-2)" "unprognostic (7.06e-2)" "unprognostic (1.69e-1)" "prognostic favourable (8.49e-8)" "unprognostic (8.77e-2)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.44e-2)" 27.7 78.1 6.9 2.2 12.5 2.0 10.0 5.6 21.7 4.7 3.1 22.4 5.1 4.8 1.5 11.0 11.5 6.4 8.5 28.2 7.4 6.6 8.3 38.6 5.1 1.7 10.3 9.6 13.5 22.6 11.8 6.2 2.2 13.2 19.8 2.3 5.4 28.5 3.3 3.3 17.9 2.8 1.3 7.3 1.9 8.8 5.3 8.8 1.9 7.4 13.6 10.4 2.6 6.1 7.4 22.6 1.8 1.0 7.3 7.6 3.0 2.6 3.5 8.3 12.0 3.3 0.2 5.3 0.6 1.3 1.0 1.1 8.6 12.2 5.3 9.4 0.4 4.3 3.7 5.8 0.7 5.0 1.8 3.3 1.0 17.3 6.8 1.3 3.6 1.5 1.8 4.8 0.6 0.9 1.9 4.1 0.3 21.6 2.2 5.7 4.5 4.0 7.1 0.4 12.4 24.9 3.8 9.5 10.6 0.4 9.1 2.1 48.4 3.5 0.6 0.1 1.2 1.2 0.8 9.4 5.9 3.0 0.8 2.0 0.3 0.5 1.0 1.8 5.5 0.8 4.3 7.1 3.5 4.5 0.9 7.4 7.6 5.5 0.7 7.3 0.5 22.6 3.1 3.0 6.9 12.5 5.6 21.7 7.4 6.6 10.3 9.6 13.2 8.8 TM9SF1 "HMP70, MP70" ENSG00000100926 "Transmembrane 9 superfamily member 1" O15321 14 24189143-24195687 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA059249 Supported Approved "Golgi apparatus" "Golgi apparatus" "HPA059249: " "unprognostic (3.27e-1)" "prognostic unfavourable (8.94e-4)" "unprognostic (9.31e-2)" "unprognostic (1.48e-1)" "unprognostic (3.84e-2)" "unprognostic (1.19e-2)" "unprognostic (4.84e-3)" "prognostic unfavourable (2.04e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.62e-3)" "unprognostic (2.44e-1)" "unprognostic (4.24e-1)" "unprognostic (2.20e-1)" "unprognostic (4.18e-3)" 13.3 20.4 6.3 10.9 6.6 3.4 14.0 5.4 8.1 18.5 15.6 10.4 33.1 10.7 17.7 21.8 14.1 23.4 18.4 14.6 6.2 6.0 24.5 46.4 17.0 14.6 6.2 7.1 17.6 39.9 27.4 12.3 25.1 6.5 16.9 9.4 15.6 31.8 36.0 10.1 12.0 16.8 13.6 5.9 12.7 14.7 10.3 5.6 9.6 32.3 12.9 12.1 12.8 12.4 10.6 25.8 18.0 13.6 14.5 10.8 8.6 9.4 15.8 7.0 5.4 14.0 10.9 11.0 18.6 21.1 22.2 25.1 7.9 18.4 5.6 12.4 15.7 21.3 4.4 11.2 12.2 9.4 7.4 4.3 8.3 16.3 9.8 8.1 10.2 12.7 15.7 14.0 8.1 12.6 5.2 10.9 13.3 14.9 4.7 5.5 3.2 18.7 7.1 10.4 9.4 7.8 12.8 7.1 8.2 22.4 10.1 9.0 9.6 3.6 12.7 19.5 8.9 10.2 11.6 15.3 11.7 4.1 6.5 4.5 13.2 17.2 13.6 15.2 10.0 10.9 10.8 10.2 9.9 8.7 15.0 10.6 9.2 8.7 18.0 14.5 10.4 25.8 9.9 8.6 6.3 6.6 5.4 8.1 6.2 6.0 6.2 7.1 6.5 5.6 TM9SF3 SMBP ENSG00000077147 "Transmembrane 9 superfamily member 3" Q9HD45 10 96518109-96587452 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039609 Approved Approved "Golgi apparatus,Vesicles" 320000 Vesicles "Golgi apparatus" "HPA039609: AB_10673535" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (1.43e-2)" "unprognostic (5.11e-2)" "unprognostic (4.95e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-2)" "unprognostic (3.09e-2)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (4.14e-3)" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (8.28e-3)" "unprognostic (6.18e-2)" 28.4 23.9 19.6 31.0 19.3 12.8 24.5 16.0 18.9 29.3 54.2 16.5 49.9 42.9 31.5 27.3 28.4 23.7 57.7 37.3 19.5 19.2 28.7 50.8 25.2 17.0 20.8 13.5 31.3 33.6 27.4 20.3 50.7 18.7 35.6 35.7 18.5 43.0 57.9 18.4 22.4 60.0 21.4 26.3 25.6 69.6 15.4 18.3 27.1 33.1 16.1 26.6 34.7 34.4 3.3 11.2 7.7 3.6 5.5 6.5 2.4 37.0 25.3 28.2 39.4 41.3 30.9 33.9 51.3 38.0 22.3 18.4 30.3 73.4 27.4 28.5 45.2 35.1 25.5 28.2 41.9 30.6 21.9 24.3 22.4 23.7 31.1 49.6 28.4 28.4 28.6 31.4 54.6 24.4 24.1 31.6 33.9 16.9 19.2 19.2 17.9 15.6 23.9 35.7 21.4 31.7 27.6 13.1 29.5 27.1 26.1 26.1 44.9 18.9 42.7 27.8 23.6 27.7 46.8 32.8 37.2 25.4 37.7 34.8 19.3 7.7 3.6 5.5 5.8 3.5 6.5 3.3 6.2 6.3 4.3 2.2 4.8 6.0 4.2 5.5 3.5 11.2 6.0 2.4 19.6 19.3 16.0 18.9 19.5 19.2 20.8 13.5 18.7 18.3 TMBIM1 "LFG3, PP1201, RECS1" ENSG00000135926 "Transmembrane BAX inhibitor motif containing 1" Q969X1 2 218274192-218292586 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012093, HPA070824" Approved Supported Vesicles Vesicles "HPA012093: AB_1858056, HPA070824: " "unprognostic (4.36e-2)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (1.73e-3)" "unprognostic (2.34e-3)" "unprognostic (3.81e-3)" "unprognostic (8.91e-3)" "unprognostic (5.58e-3)" "unprognostic (9.85e-2)" "unprognostic (3.76e-3)" "prognostic unfavourable (4.22e-4)" "unprognostic (1.69e-1)" "prognostic favourable (3.38e-4)" "unprognostic (1.22e-1)" "unprognostic (4.63e-2)" "unprognostic (2.75e-2)" "unprognostic (4.50e-1)" 64.3 34.6 26.5 22.1 45.0 23.0 84.3 11.0 38.3 35.7 42.2 43.1 33.7 41.8 35.0 30.0 86.8 25.1 50.3 34.6 21.0 17.2 50.7 69.3 46.7 34.3 37.5 13.7 27.9 87.6 31.3 15.0 92.7 40.9 31.6 40.1 23.9 40.1 43.7 53.2 49.5 70.6 41.2 50.3 22.7 57.8 13.2 32.5 9.4 66.4 42.1 36.3 57.7 54.5 17.0 19.6 60.3 43.5 13.0 24.0 33.6 26.8 9.7 0.5 7.1 62.9 26.6 29.0 26.4 32.6 15.6 18.0 24.8 66.7 6.1 19.3 38.8 46.0 9.0 59.2 15.4 22.1 3.7 38.9 6.7 29.7 28.5 0.5 38.5 25.1 55.7 32.0 40.9 16.6 24.2 11.5 27.3 1.1 0.4 6.7 0.4 8.7 0.9 4.3 4.8 21.0 84.8 0.5 0.5 8.7 32.4 18.3 8.7 5.9 25.1 28.2 7.8 13.0 9.5 5.6 6.5 2.7 27.7 6.1 15.9 60.3 27.7 59.9 24.0 36.2 20.5 17.0 22.0 19.5 19.6 14.0 14.7 15.8 35.5 13.0 43.5 5.3 23.5 33.6 26.5 45.0 11.0 38.3 21.0 17.2 37.5 13.7 40.9 32.5 TMBIM4 "CGI-119, GAAP, LFG4, S1R, ZPRO" ENSG00000155957 "Transmembrane BAX inhibitor motif containing 4" Q9HC24 12 66135846-66170072 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA077642 Supported "Golgi apparatus" "Golgi apparatus" "HPA077642: " "unprognostic (5.41e-2)" "unprognostic (1.27e-1)" "unprognostic (3.19e-1)" "unprognostic (8.14e-2)" "unprognostic (2.69e-2)" "unprognostic (5.62e-2)" "unprognostic (7.18e-3)" "unprognostic (8.51e-2)" "unprognostic (2.49e-1)" "unprognostic (1.33e-2)" "unprognostic (3.36e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.68e-2)" "unprognostic (3.75e-2)" "unprognostic (2.20e-3)" 47.2 57.3 18.4 31.2 23.8 22.2 40.1 9.2 21.0 34.8 36.5 30.8 39.8 24.1 42.5 40.3 32.2 33.7 31.7 37.2 18.9 19.9 56.2 66.7 46.8 48.6 27.3 14.4 41.6 63.5 30.6 48.2 42.5 27.2 34.5 29.5 44.8 56.4 39.7 29.1 24.9 45.8 37.0 34.2 55.7 39.1 66.7 22.5 39.6 54.3 32.0 38.1 36.8 31.6 30.6 38.9 100.3 60.9 18.8 26.1 61.1 12.9 17.0 10.9 20.0 37.2 35.1 11.5 20.2 35.3 15.7 12.8 8.7 21.6 12.2 24.1 28.3 21.6 5.5 17.8 10.3 19.6 7.3 23.5 8.7 10.1 18.9 28.4 30.5 24.6 25.9 7.7 8.7 23.9 17.2 44.2 25.8 21.2 10.7 9.8 13.1 17.3 5.7 7.3 13.5 35.1 21.6 5.5 13.3 22.9 42.8 26.8 40.2 39.3 28.8 19.5 7.2 14.0 11.8 22.9 12.4 8.6 26.7 27.8 23.0 51.4 56.7 53.9 21.9 55.6 21.9 30.6 22.9 22.4 38.9 28.8 26.1 23.0 100.3 18.8 60.9 25.9 23.2 61.1 18.4 23.8 9.2 21.0 18.9 19.9 27.3 14.4 27.2 22.5 TMC6 "EVER1, EVIN1, LAK-4P" ENSG00000141524 "Transmembrane channel like 6" Q7Z403 17 78110458-78132407 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.6;brain: 43.1;lymphoid tissue: 41.4" "Cell line enhanced" "Detected in many" "K-562: 33.7;SK-BR-3: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051430 Uncertain "HPA051430: " "unprognostic (6.34e-2)" "unprognostic (5.14e-2)" "unprognostic (5.55e-2)" "unprognostic (2.81e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" "unprognostic (5.36e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-1)" "unprognostic (9.94e-2)" "unprognostic (1.74e-1)" "unprognostic (6.61e-2)" "unprognostic (1.16e-2)" "prognostic favourable (1.82e-4)" "unprognostic (2.70e-2)" "unprognostic (1.10e-2)" "prognostic favourable (3.20e-4)" 10.5 3.5 7.5 26.1 25.5 39.6 8.3 2.1 12.8 4.1 8.8 33.5 5.6 13.5 3.1 1.7 9.5 5.6 6.5 8.1 12.5 8.1 6.9 3.7 14.4 39.2 43.1 4.6 1.7 6.4 1.8 2.4 6.6 20.3 7.5 4.7 3.6 12.7 7.2 2.3 6.5 17.5 2.7 31.4 41.4 9.1 1.6 31.2 12.1 5.0 2.7 24.8 7.3 6.5 13.5 8.3 9.8 26.7 15.6 27.2 13.2 5.4 4.3 2.4 1.9 0.0 0.0 4.9 0.0 0.0 0.0 0.0 7.8 6.2 6.2 7.7 0.0 9.7 0.3 1.8 0.0 0.6 3.5 12.8 1.1 9.6 0.6 11.7 21.9 0.3 5.2 0.0 0.4 4.7 33.7 23.4 0.0 11.0 5.7 20.0 1.9 1.6 2.6 0.2 18.1 3.6 20.3 0.6 1.5 1.8 38.5 10.4 21.9 17.8 1.6 0.0 3.0 0.0 0.1 18.5 8.1 3.9 0.0 19.0 0.3 6.4 4.9 9.8 27.2 16.9 23.7 13.5 20.1 21.9 8.3 10.2 18.1 18.7 6.9 15.6 26.7 2.5 17.0 13.2 7.5 25.5 2.1 12.8 12.5 8.1 43.1 4.6 20.3 31.2 TMCO1 "HP10122, TMCC4" ENSG00000143183 "Transmembrane and coiled-coil domains 1" Q9UM00 1 165724293-165827755 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, Glaucoma, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054768 Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA054768: " "unprognostic (1.22e-2)" "unprognostic (3.28e-3)" "unprognostic (2.36e-1)" "unprognostic (1.45e-1)" "unprognostic (2.97e-1)" "prognostic unfavourable (5.17e-7)" "prognostic unfavourable (3.21e-4)" "unprognostic (5.92e-2)" "unprognostic (4.16e-2)" "unprognostic (7.95e-3)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" "prognostic unfavourable (1.25e-4)" "unprognostic (2.85e-1)" "unprognostic (1.94e-1)" "unprognostic (2.14e-2)" "unprognostic (9.80e-2)" 28.8 48.5 28.1 18.7 29.8 17.2 34.1 21.5 28.7 30.2 47.4 26.9 37.6 43.0 28.4 43.3 34.3 24.9 30.6 25.9 23.8 26.8 62.6 89.8 24.9 23.6 27.2 21.0 30.6 37.3 32.6 50.1 47.0 31.1 30.7 48.8 29.9 43.5 38.5 20.2 20.9 70.9 23.7 31.4 29.4 29.9 34.4 22.4 36.3 53.7 24.1 31.1 29.4 25.2 46.0 76.6 52.5 57.6 45.1 61.7 78.0 29.6 33.6 25.7 15.5 47.4 22.5 25.1 51.0 36.2 30.1 31.4 47.9 45.0 18.9 53.1 36.9 42.3 33.4 26.8 32.8 48.1 30.9 23.9 39.0 29.5 38.3 40.7 31.5 30.6 31.2 34.9 28.2 21.8 62.0 37.2 42.1 23.0 32.1 30.9 32.8 38.1 23.7 28.8 47.8 36.5 39.2 26.5 46.4 39.1 41.6 31.0 54.5 51.7 23.9 27.7 23.1 24.3 47.2 71.2 96.2 66.6 22.2 26.6 36.7 52.5 55.6 51.2 53.0 50.8 55.6 46.0 56.5 56.5 41.8 39.8 46.0 53.2 43.1 45.1 57.6 76.6 61.7 78.0 28.1 29.8 21.5 28.7 23.8 26.8 27.2 21.0 31.1 22.4 TMCO3 "C13orf11, FLJ20623" ENSG00000150403 "Transmembrane and coiled-coil domains 3" Q6UWJ1 13 113490995-113554590 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 17.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039561, HPA048126" Uncertain Approved Cytosol Cytosol "HPA039561: , HPA048126: " "unprognostic (7.89e-2)" "prognostic unfavourable (5.80e-4)" "unprognostic (6.78e-2)" "unprognostic (7.88e-2)" "unprognostic (2.89e-1)" "unprognostic (6.01e-2)" "prognostic unfavourable (1.14e-5)" "unprognostic (2.93e-2)" "unprognostic (9.44e-2)" "unprognostic (3.08e-3)" "unprognostic (2.76e-2)" "unprognostic (8.47e-3)" "unprognostic (3.70e-3)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (6.27e-3)" "prognostic unfavourable (4.10e-4)" 16.1 20.5 15.1 11.1 14.2 40.3 14.5 38.7 14.6 21.3 15.7 18.6 16.7 13.0 23.1 15.5 13.1 17.2 23.2 17.0 14.4 13.0 18.0 15.5 13.8 9.4 17.4 9.6 16.9 46.1 18.6 18.6 23.2 21.2 16.1 14.1 17.1 25.8 14.5 10.2 7.7 17.6 18.9 20.7 14.8 27.8 11.0 11.3 7.2 7.5 13.4 11.3 13.2 23.9 2.6 5.0 17.4 8.5 4.1 1.8 2.0 27.0 9.1 13.4 9.2 27.6 40.9 7.3 29.7 28.4 13.1 13.3 10.0 12.1 6.5 7.6 32.5 11.0 7.0 10.7 20.4 13.2 7.2 5.8 14.8 10.0 26.1 9.5 12.2 33.1 25.6 9.8 20.4 21.4 8.3 9.2 22.9 4.9 4.9 5.7 6.7 14.6 6.2 8.1 4.6 21.9 3.7 11.8 9.7 9.2 20.3 9.4 12.0 18.0 33.2 14.8 15.9 10.8 12.5 11.5 6.5 4.1 49.0 5.0 7.1 2.4 6.9 6.8 1.1 4.4 1.4 2.6 1.4 1.8 5.0 1.4 1.5 1.5 17.4 4.1 8.5 1.1 1.2 2.0 15.1 14.2 38.7 14.6 14.4 13.0 17.4 9.6 21.2 11.3 TMCO5A "MGC35118, TMCO5" ENSG00000166069 "Transmembrane and coiled-coil domains 5A" Q8N6Q1 15 37921939-37967724 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 130 "testis: 43.9" "Cell line enhanced" "Detected in some" "HeLa: 1.2;hTERT-HME1: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 6.0;basal ganglia: 2.2;cerebral cortex: 5.7;hippocampal formation: 6.7" "Low region specificity" "Detected in many" HPA056530 Enhanced "HPA056530: " "unprognostic (2.60e-1)" "unprognostic (1.69e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMED1 "Il1rl1l, IL1RL1LG, MGC1270, p24g1, p24gamma1, ST2L" ENSG00000099203 "Transmembrane p24 trafficking protein 1" Q13445 19 10832438-10836318 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018507 Uncertain "HPA018507: AB_1858063" "unprognostic (6.98e-2)" "unprognostic (3.42e-1)" "unprognostic (3.03e-3)" "unprognostic (1.28e-1)" "unprognostic (8.65e-2)" "unprognostic (2.27e-1)" "unprognostic (1.98e-2)" "unprognostic (4.20e-2)" "unprognostic (9.86e-2)" "unprognostic (7.27e-2)" "unprognostic (9.52e-2)" "unprognostic (4.93e-2)" "prognostic favourable (8.66e-5)" "unprognostic (9.49e-2)" "unprognostic (2.56e-1)" "unprognostic (5.16e-2)" "unprognostic (2.45e-2)" 12.1 15.8 9.5 8.7 9.4 10.5 17.0 5.2 11.5 13.5 10.5 13.6 16.8 11.8 13.1 19.7 12.8 15.4 14.8 23.6 10.7 10.2 20.9 32.2 9.3 12.5 13.1 6.5 22.4 19.4 10.5 18.3 35.3 9.9 12.8 4.2 13.2 15.6 10.4 33.5 8.7 10.1 6.3 11.5 14.8 11.6 11.4 10.0 12.5 22.7 18.2 9.2 12.8 10.0 17.6 27.0 14.2 32.2 37.6 20.8 20.9 13.2 23.2 9.9 15.1 9.7 10.9 10.4 20.5 19.0 21.9 31.4 21.6 19.6 9.8 48.7 14.5 11.6 6.0 11.0 7.9 14.2 15.2 13.4 17.6 17.0 14.2 9.9 32.0 15.5 12.7 13.0 7.2 12.8 11.2 27.6 8.8 23.3 7.4 14.2 14.7 23.7 9.0 7.5 15.3 12.8 11.3 10.5 10.8 11.8 11.4 11.2 15.2 13.8 12.9 27.4 11.7 27.1 21.4 16.9 17.1 8.9 19.6 21.9 13.4 4.1 32.2 14.2 20.8 30.7 14.5 17.6 14.4 16.9 27.0 14.3 13.5 14.9 11.7 37.6 31.4 19.5 12.2 20.9 9.5 9.4 5.2 11.5 10.7 10.2 13.1 6.5 9.9 10.0 TMED10 "p23, P24(DELTA), p24d1, p24delta1, TMP21" ENSG00000170348 "Transmembrane p24 trafficking protein 10" P49755 14 75131470-75176631 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034442, CAB037251, HPA047139, HPA050539" Enhanced Supported "Golgi apparatus" 6000000 "Golgi apparatus" "CAB034442: AB_2204336, CAB037251: AB_1841216, HPA047139: AB_2679951, HPA050539: AB_2681163" "unprognostic (2.00e-1)" "unprognostic (1.73e-2)" "unprognostic (2.02e-1)" "unprognostic (2.51e-3)" "unprognostic (4.06e-1)" "unprognostic (1.17e-3)" "unprognostic (5.88e-2)" "unprognostic (1.21e-1)" "unprognostic (3.68e-2)" "unprognostic (6.46e-3)" "unprognostic (1.01e-2)" "unprognostic (1.27e-2)" "unprognostic (1.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.82e-1)" "prognostic unfavourable (8.67e-4)" "unprognostic (2.06e-2)" 34.2 31.5 24.5 19.3 24.6 5.6 35.2 14.0 23.0 55.8 28.2 34.7 47.3 22.9 39.1 52.3 31.3 38.8 30.5 39.5 25.1 25.0 37.4 70.3 28.1 42.1 26.9 15.6 42.5 125.6 28.1 33.8 54.9 23.0 35.6 31.4 33.8 119.7 48.9 35.7 26.0 31.0 30.0 31.8 28.3 28.7 29.0 21.3 34.4 55.5 27.8 39.1 29.6 30.5 15.6 27.3 31.9 17.8 37.5 37.9 30.9 21.5 12.4 20.5 33.9 48.4 45.5 26.9 22.8 38.0 24.1 27.1 12.0 38.2 19.1 19.6 39.2 21.6 19.0 33.2 38.9 10.2 8.6 11.6 8.2 18.2 41.2 23.1 12.2 33.2 53.4 18.6 53.4 41.8 10.1 42.6 34.5 24.3 16.1 18.4 12.4 13.3 16.2 13.2 26.7 28.8 22.1 20.0 21.1 21.0 35.2 39.7 33.2 37.8 28.7 23.6 15.6 15.8 11.8 24.1 22.7 21.6 43.1 20.5 22.7 31.9 17.8 10.7 24.7 14.9 37.9 15.6 24.3 23.9 23.9 11.9 21.9 23.2 7.9 37.5 14.7 27.3 14.2 30.9 24.5 24.6 14.0 23.0 25.1 25.0 26.9 15.6 23.0 21.3 TMED2 "P24A, p24b1, p24beta1, RNP24" ENSG00000086598 "Transmembrane p24 trafficking protein 2" Q15363 12 123584531-123598577 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014060 Approved Supported Vesicles Vesicles "HPA014060: AB_1856389" "unprognostic (6.36e-2)" "unprognostic (3.38e-3)" "unprognostic (5.41e-3)" "unprognostic (1.75e-2)" "unprognostic (2.98e-2)" "prognostic unfavourable (3.36e-6)" "unprognostic (3.57e-3)" "unprognostic (2.20e-2)" "unprognostic (4.31e-2)" "unprognostic (9.76e-3)" "unprognostic (1.03e-2)" "unprognostic (3.94e-2)" "prognostic unfavourable (2.35e-7)" "unprognostic (2.97e-1)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (9.87e-2)" 31.3 31.9 15.7 21.8 21.2 23.5 32.0 13.2 21.5 38.5 31.6 20.4 41.1 27.6 33.4 49.0 41.3 27.4 28.9 41.7 15.7 17.1 32.6 120.1 28.1 29.4 18.2 16.7 37.4 135.4 18.1 36.3 40.0 18.9 33.3 32.8 23.8 90.2 38.0 46.3 27.4 34.2 30.5 22.5 25.6 32.4 17.8 15.0 24.0 49.2 23.8 30.0 34.0 27.8 32.4 69.3 58.9 40.9 39.5 61.2 36.2 41.8 37.3 24.8 42.9 56.6 50.2 59.1 72.8 58.8 46.4 36.8 37.2 36.5 35.9 39.1 72.5 41.9 33.5 39.2 48.8 26.9 28.9 38.7 22.7 48.0 107.6 52.7 33.4 42.2 65.5 39.8 54.1 43.3 39.0 24.6 47.3 31.1 27.9 43.3 35.8 33.6 29.1 40.5 41.7 56.6 63.5 30.9 26.8 48.7 49.0 48.2 83.1 42.8 41.0 39.6 25.0 38.2 40.7 54.5 50.5 30.5 46.7 34.9 46.7 58.9 39.8 39.6 46.8 40.9 61.2 32.4 42.4 44.1 44.2 27.2 34.6 40.3 31.5 39.5 37.8 69.3 38.3 36.2 15.7 21.2 13.2 21.5 15.7 17.1 18.2 16.7 18.9 15.0 TMED3 "C15orf22, p24B, p24g4, p24gamma4" ENSG00000166557 "Transmembrane p24 trafficking protein 3" Q9Y3Q3 15 79311062-79427432 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 182.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049314, HPA076949" Approved Supported "Golgi apparatus" "Golgi apparatus" "HPA049314: , HPA076949: " "prognostic unfavourable (7.71e-4)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (8.86e-3)" "unprognostic (1.41e-1)" "unprognostic (2.03e-3)" "unprognostic (2.42e-2)" "unprognostic (2.49e-1)" "unprognostic (4.85e-1)" "unprognostic (9.06e-2)" "unprognostic (8.09e-2)" "unprognostic (9.90e-2)" "prognostic unfavourable (3.73e-4)" "unprognostic (2.16e-1)" "unprognostic (2.88e-1)" "unprognostic (2.50e-1)" "unprognostic (1.52e-1)" 6.1 7.0 5.0 6.1 5.8 7.5 16.8 9.6 8.9 15.0 12.0 6.9 32.2 6.0 10.0 34.9 31.2 9.9 18.0 11.4 6.1 10.0 11.0 4.6 7.7 12.2 5.7 7.5 8.1 68.0 6.5 23.5 24.2 8.2 15.0 13.9 7.1 182.4 34.0 2.0 25.0 6.0 9.4 7.1 9.4 16.0 13.9 4.2 7.0 18.8 20.9 23.4 11.2 17.4 28.3 40.9 34.0 33.0 21.7 29.3 32.2 14.3 37.4 7.2 13.7 50.8 39.1 15.6 34.2 46.5 23.3 28.9 31.1 26.4 6.7 26.1 52.2 27.1 21.4 21.8 12.2 13.3 33.0 22.6 33.7 22.9 29.6 24.0 45.0 28.9 32.2 13.3 19.6 27.1 10.0 0.1 22.7 30.1 6.7 21.9 10.0 21.0 8.3 10.5 33.7 21.2 10.9 22.1 10.9 18.1 34.8 32.3 30.4 17.0 22.1 18.9 17.1 0.4 23.7 14.2 16.3 9.4 24.2 38.4 22.0 21.7 26.5 34.0 23.3 31.3 24.8 28.3 23.1 25.2 40.1 23.4 29.3 28.1 2.3 21.7 33.0 40.9 26.2 32.2 5.0 5.8 9.6 8.9 6.1 10.0 5.7 7.5 8.2 4.2 TMED4 "HNLF, p24a3, p24alpha3" ENSG00000158604 "Transmembrane p24 trafficking protein 4" Q7Z7H5 7 44577894-44582287 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014650 Approved "Intracellular and membrane" "HPA014650: AB_1858066" "unprognostic (7.34e-2)" "unprognostic (1.68e-3)" "unprognostic (1.46e-3)" "prognostic unfavourable (7.37e-4)" "unprognostic (2.09e-3)" "unprognostic (4.50e-3)" "unprognostic (2.54e-2)" "unprognostic (3.38e-2)" "unprognostic (1.77e-1)" "unprognostic (1.61e-1)" "unprognostic (2.42e-3)" "unprognostic (4.65e-2)" "prognostic favourable (1.37e-4)" "unprognostic (1.21e-1)" "unprognostic (6.12e-2)" "unprognostic (4.11e-1)" "unprognostic (6.61e-2)" 19.5 28.1 19.8 15.5 23.4 20.0 20.7 28.1 32.6 23.2 44.2 34.7 58.3 40.8 26.2 39.3 19.6 26.5 27.4 30.4 20.7 22.6 42.0 25.8 21.8 15.9 23.8 19.2 39.2 52.7 59.3 37.8 55.4 23.9 28.3 23.3 38.3 39.3 45.2 29.2 19.8 55.2 25.7 28.3 20.8 25.4 17.6 19.9 21.9 55.1 14.7 24.8 23.0 21.2 30.3 50.7 35.2 27.7 33.2 46.4 21.3 15.0 18.5 26.8 30.3 24.1 14.4 22.9 18.3 22.7 18.9 23.7 20.2 37.7 14.3 30.6 19.5 24.8 14.0 15.3 23.0 18.9 23.0 12.7 33.2 19.1 21.8 20.3 24.6 18.6 23.3 20.0 16.3 16.8 19.8 32.0 22.3 13.5 19.6 27.5 17.1 19.2 16.9 12.9 27.8 27.1 24.9 21.5 30.7 19.6 44.0 20.3 34.5 20.8 15.8 14.0 20.9 16.0 28.5 48.2 43.7 17.5 28.8 22.1 49.1 32.2 26.6 35.2 38.6 26.3 46.4 30.3 38.9 36.9 23.3 25.5 32.5 35.9 24.9 33.2 27.7 50.7 32.3 21.3 19.8 23.4 28.1 32.6 20.7 22.6 23.8 19.2 23.9 19.9 TMED5 "CGI-100, p24g2, p24gamma2" ENSG00000117500 "Transmembrane p24 trafficking protein 5" Q9Y3A6 1 93149742-93180728 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050289 Approved "HPA050289: " "unprognostic (3.35e-1)" "unprognostic (1.44e-2)" "unprognostic (2.02e-3)" "unprognostic (4.38e-1)" "unprognostic (3.16e-1)" "unprognostic (4.86e-2)" "unprognostic (2.83e-3)" "unprognostic (6.37e-2)" "unprognostic (8.60e-2)" "unprognostic (3.72e-2)" "unprognostic (1.64e-2)" "unprognostic (1.28e-1)" "unprognostic (1.40e-1)" "unprognostic (6.01e-2)" "unprognostic (1.86e-1)" "unprognostic (4.46e-2)" "unprognostic (1.38e-1)" 16.5 22.2 9.4 13.9 11.8 21.0 22.7 7.6 11.1 8.8 11.4 8.5 10.9 12.8 8.6 12.2 10.2 8.1 12.1 20.2 9.5 6.3 30.4 57.4 15.8 11.3 16.5 6.4 9.9 13.6 9.4 15.6 17.3 13.8 9.1 10.8 6.0 14.6 9.2 22.7 6.2 12.5 6.6 17.9 15.2 11.4 7.7 12.4 8.4 19.0 8.4 10.2 12.5 19.2 14.8 15.9 30.2 20.2 8.9 16.8 15.3 21.9 9.4 10.4 10.4 30.1 18.2 23.3 17.6 17.5 14.2 21.1 15.9 17.5 10.7 18.1 15.2 12.0 12.0 10.6 16.0 12.3 14.7 9.9 10.2 16.2 18.0 11.6 15.3 21.7 15.4 22.1 20.1 16.6 16.7 30.7 13.6 3.6 12.9 8.7 6.9 12.9 9.8 17.7 17.2 17.8 12.4 6.0 7.0 21.2 19.2 20.2 9.2 9.9 16.6 15.0 15.2 19.0 17.9 21.3 26.6 13.1 9.8 11.0 6.7 30.2 19.5 26.2 14.3 19.3 16.8 14.8 14.7 16.4 15.9 10.6 11.3 13.1 9.7 8.9 20.2 11.0 16.2 15.3 9.4 11.8 7.6 11.1 9.5 6.3 16.5 6.4 13.8 12.4 TMED6 "MGC23911, p24g5, p24gamma5" ENSG00000157315 "Transmembrane p24 trafficking protein 6" Q8WW62 16 69343248-69351809 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "pancreas: 144.2" "Cell line enhanced" "Detected in many" "Hep G2: 17.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA012532 Approved "HPA012532: AB_1858065" "unprognostic (6.85e-2)" "unprognostic (1.42e-1)" "unprognostic (6.31e-3)" "prognostic favourable (7.74e-5)" "unprognostic (9.84e-3)" "unprognostic (7.57e-2)" "unprognostic (2.40e-1)" "unprognostic (1.20e-1)" "unprognostic (7.94e-2)" "unprognostic (3.74e-1)" "unprognostic (2.94e-2)" "unprognostic (4.76e-2)" "unprognostic (4.58e-3)" "unprognostic (9.71e-2)" "unprognostic (1.50e-1)" "unprognostic (1.36e-1)" "unprognostic (4.52e-3)" 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 0.2 0.4 0.9 0.2 2.0 2.7 0.3 4.5 0.2 5.6 0.3 0.2 0.2 0.1 6.1 3.1 0.7 0.2 0.2 0.2 1.0 144.2 0.0 0.2 0.2 0.2 0.2 1.7 0.2 0.2 3.5 0.2 0.1 2.8 0.2 0.2 0.3 16.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.2 0.0 0.6 0.0 2.0 0.2 0.7 1.9 1.6 1.1 0.1 0.1 1.0 2.3 0.1 0.0 0.3 2.4 1.0 4.8 0.8 0.0 1.2 0.2 0.2 0.4 0.7 2.0 2.4 0.8 17.3 0.1 3.0 1.1 0.2 0.9 0.1 0.3 0.1 1.6 0.6 0.3 1.9 1.3 3.3 2.2 1.8 2.6 1.4 1.8 0.7 2.0 3.8 1.5 3.1 1.1 1.2 0.6 2.1 2.1 2.7 1.5 0.9 1.5 1.6 1.5 5.2 1.4 2.5 0.9 0.0 0.4 0.0 0.8 0.6 1.5 0.6 2.0 0.4 0.2 0.3 0.5 2.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 TMED7 "CGI-109, FLJ90481, p24g3, p24gamma3" ENSG00000134970 "Transmembrane p24 trafficking protein 7" Q9Y3B3 5 115613508-115632992 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008960, CAB025883" Supported 100000 "CAB025883: , HPA008960: AB_1080280" "unprognostic (1.40e-1)" "unprognostic (8.42e-2)" "unprognostic (1.45e-2)" "unprognostic (1.22e-1)" "unprognostic (2.04e-1)" "unprognostic (4.35e-2)" "unprognostic (1.27e-1)" "unprognostic (2.26e-3)" "unprognostic (2.02e-1)" "unprognostic (2.11e-2)" "unprognostic (6.15e-3)" "unprognostic (4.10e-2)" "unprognostic (6.82e-2)" "unprognostic (4.95e-2)" "unprognostic (3.06e-1)" "unprognostic (4.79e-2)" "unprognostic (1.22e-1)" 23.0 25.3 21.6 16.7 23.0 16.1 31.0 12.5 30.0 32.8 24.7 28.6 37.8 21.7 29.9 43.8 23.3 23.8 21.6 30.4 23.5 22.1 33.7 81.7 26.3 26.2 24.8 14.9 27.9 38.0 31.5 35.5 37.0 20.6 30.3 25.9 19.8 34.6 41.1 20.1 15.9 29.0 27.0 35.4 21.4 24.2 16.6 22.2 17.3 47.9 17.0 16.9 32.9 21.6 10.3 18.4 17.4 21.7 12.5 14.7 16.2 18.6 12.6 13.3 16.5 34.9 26.5 20.9 33.1 35.2 24.6 40.4 10.7 33.1 9.7 32.8 34.2 14.9 12.4 38.4 39.0 22.4 10.4 8.9 13.2 22.5 37.4 9.2 18.0 24.4 18.4 23.4 29.7 23.5 8.5 13.5 26.3 8.8 6.9 8.2 9.4 10.8 7.6 19.8 18.5 29.8 13.2 10.2 12.1 27.0 15.8 19.3 19.1 12.1 23.8 33.7 14.5 24.2 19.6 9.0 6.9 10.0 27.2 15.4 18.6 16.3 21.7 17.4 13.9 21.4 14.7 10.3 11.1 12.7 18.4 9.0 11.2 11.5 15.0 12.5 16.4 12.2 9.9 16.2 21.6 23.0 12.5 30.0 23.5 22.1 24.8 14.9 20.6 22.2 TMED9 "HSGP25L2G, p24a2, p24alpha2" ENSG00000184840 "Transmembrane p24 trafficking protein 9" Q9BVK6 5 177592158-177596124 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014650 Approved 46000 "HPA014650: AB_1858066" "unprognostic (5.75e-3)" "unprognostic (4.35e-2)" "unprognostic (1.37e-1)" "unprognostic (3.82e-2)" "unprognostic (9.37e-3)" "unprognostic (5.14e-3)" "unprognostic (2.55e-2)" "unprognostic (1.90e-2)" "unprognostic (1.37e-1)" "unprognostic (7.00e-2)" "unprognostic (4.01e-1)" "unprognostic (2.58e-1)" "prognostic unfavourable (5.88e-5)" "unprognostic (2.88e-1)" "unprognostic (4.71e-2)" "unprognostic (9.07e-2)" "unprognostic (3.65e-2)" 23.3 32.6 22.3 24.5 21.3 20.9 36.3 12.4 21.5 27.1 29.5 13.3 56.0 21.0 24.1 46.2 38.1 22.0 28.4 30.9 17.6 17.1 37.4 91.8 29.9 38.4 19.1 20.4 19.7 134.5 21.6 25.5 80.5 21.0 27.3 31.3 17.5 72.2 55.7 20.5 24.0 21.2 26.7 16.0 31.0 31.3 20.0 15.7 13.8 32.3 24.1 28.2 22.0 28.9 32.3 96.6 35.3 47.6 33.6 44.0 51.5 34.6 39.8 18.9 60.0 49.7 35.4 83.3 61.1 51.0 33.8 47.0 58.5 52.2 19.8 79.3 61.7 29.0 18.0 88.8 33.8 96.6 24.4 16.8 33.9 52.9 50.4 45.5 62.9 33.1 46.5 35.4 40.1 50.2 19.2 36.8 36.3 82.2 10.7 32.3 20.7 37.0 18.7 23.6 52.2 40.4 31.0 9.9 13.9 31.5 37.9 33.6 38.4 46.3 42.9 42.2 30.5 34.1 49.4 62.0 36.8 18.8 55.9 57.3 53.3 29.0 47.6 35.3 44.0 44.9 43.6 32.3 35.1 34.1 44.7 30.2 30.1 27.5 19.2 33.6 39.2 96.6 34.0 51.5 22.3 21.3 12.4 21.5 17.6 17.1 19.1 20.4 21.0 15.7 TMEFF1 "C9orf2, CT120.1, H7365" ENSG00000241697 "Transmembrane protein with EGF like and two follistatin like domains 1" Q8IYR6 9 100473113-100577636 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 21.1" "Cell line enhanced" "Detected in some" "AF22: 7.7;BEWO: 9.6;NTERA-2: 19.4;REH: 13.0;SCLC-21H: 16.6;SH-SY5Y: 11.1" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051501 Uncertain "HPA051501: " "unprognostic (1.96e-1)" "unprognostic (2.30e-1)" "unprognostic (9.69e-3)" "unprognostic (2.32e-2)" "unprognostic (9.02e-2)" "unprognostic (3.59e-2)" "unprognostic (2.87e-2)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (1.05e-1)" "unprognostic (5.04e-6)" "unprognostic (1.30e-4)" "unprognostic (1.52e-1)" "unprognostic (3.97e-2)" "unprognostic (3.44e-3)" 1.2 1.2 5.0 1.0 13.9 1.2 1.1 1.4 21.1 1.6 1.3 15.0 0.0 1.0 3.0 1.0 1.0 1.2 1.6 1.0 9.1 8.9 1.2 1.0 1.1 1.4 10.3 7.9 1.0 1.0 1.1 0.4 1.8 11.7 1.5 1.1 0.1 1.1 1.4 1.0 1.0 1.3 1.4 13.8 1.2 1.3 4.1 12.6 0.0 3.1 0.0 1.1 1.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.4 0.1 0.2 9.6 0.6 0.1 0.4 0.5 0.5 0.1 0.0 1.7 0.2 0.0 2.9 0.0 0.4 0.0 4.3 0.0 0.2 0.4 0.4 0.0 0.0 0.2 0.0 0.4 0.1 1.2 0.1 0.0 0.6 0.0 4.8 0.0 19.4 0.2 13.0 6.6 0.0 0.3 0.0 16.6 11.1 0.0 0.0 0.2 0.0 0.0 1.7 1.5 2.6 0.1 0.6 3.0 2.1 2.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 13.9 1.4 15.4 9.1 8.9 10.3 7.9 11.7 12.6 TMEFF2 "CT120.2, HPP1, TENB2, TPEF, TR" ENSG00000144339 "Transmembrane protein with EGF like and two follistatin like domains 2" Q9UIK5 2 191949043-192195709 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.6;prostate: 46.3;seminal vesicle: 17.5" "Group enriched" "Detected in some" 4 "AF22: 16.9;LHCN-M2: 48.4" "Cancer enriched" "Detected in some" 21 "prostate cancer: 57.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015587 Approved "Secreted in male reproductive system" "HPA015587: AB_1858069" "unprognostic (2.12e-3)" "unprognostic (5.37e-1)" "unprognostic (3.10e-1)" "unprognostic (5.89e-7)" "unprognostic (4.96e-2)" "unprognostic (1.27e-1)" "unprognostic (8.82e-2)" "unprognostic (1.64e-1)" "unprognostic (1.86e-1)" "unprognostic (5.55e-2)" "unprognostic (2.09e-2)" "unprognostic (3.79e-2)" "unprognostic (4.17e-3)" "unprognostic (1.55e-2)" "unprognostic (2.91e-1)" "unprognostic (1.81e-1)" "unprognostic (1.20e-1)" 1.1 3.8 20.2 1.1 14.7 1.0 1.1 7.4 29.6 1.1 2.0 18.4 1.7 1.7 1.0 11.1 2.4 1.1 3.0 1.4 17.7 18.5 1.0 1.0 1.1 1.0 15.7 17.7 1.1 1.1 1.1 0.4 1.0 11.1 46.3 2.8 2.8 1.1 17.5 1.3 1.1 1.7 1.1 11.1 1.1 1.4 1.8 15.9 0.0 1.1 0.0 1.2 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 16.9 0.0 2.6 2.7 0.0 0.0 0.3 0.8 1.0 0.0 0.0 0.0 0.0 4.6 0.0 1.0 0.0 3.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 7.3 0.0 0.9 5.0 0.0 0.0 0.0 48.4 0.0 0.0 0.0 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 1.2 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 14.7 7.4 22.7 17.7 18.5 15.7 17.7 11.1 15.9 TMEM101 "FLJ23987, MGC4251" ENSG00000091947 "Transmembrane protein 101" Q96IK0 17 44011188-44023946 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039739 Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA039739: " "unprognostic (1.40e-3)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "prognostic favourable (4.29e-4)" "unprognostic (5.91e-2)" "unprognostic (3.91e-3)" "prognostic unfavourable (7.10e-4)" "unprognostic (1.80e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (1.53e-1)" "unprognostic (1.61e-1)" "prognostic favourable (4.10e-5)" "unprognostic (1.59e-2)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" 11.0 10.9 8.4 7.3 14.2 5.1 58.9 6.3 16.5 22.7 11.4 13.7 7.7 8.4 33.3 14.5 15.1 19.2 15.4 12.4 8.7 8.6 37.2 12.0 11.4 16.1 9.5 9.4 13.0 27.8 10.7 8.5 17.8 11.6 13.9 8.6 11.5 20.9 59.7 15.5 13.8 9.5 11.6 10.1 11.0 13.6 16.9 8.9 10.0 25.4 12.9 13.2 12.5 11.6 23.8 25.9 11.7 25.0 23.8 27.2 17.8 9.6 23.7 8.5 7.0 20.3 19.6 8.5 10.1 15.4 20.1 19.2 17.6 25.3 10.9 2.8 10.4 14.9 9.8 17.6 15.4 11.8 19.8 8.2 19.0 35.6 17.5 13.1 14.3 17.5 20.1 14.2 20.2 17.5 16.8 21.5 12.5 12.9 14.1 15.1 4.0 26.8 12.3 18.4 19.8 16.7 7.9 11.1 8.8 6.5 0.2 24.1 11.7 25.3 10.5 18.5 12.4 8.0 19.8 22.4 15.4 5.0 19.4 12.5 16.4 11.7 24.9 8.6 19.4 25.0 21.8 22.7 24.5 22.3 25.9 23.8 27.2 22.1 9.1 23.8 17.8 25.2 25.1 17.8 8.4 14.2 6.3 16.5 8.7 8.6 9.5 9.4 11.6 8.9 TMEM104 "FLJ00021, FLJ20255" ENSG00000109066 "Transmembrane protein 104" Q8NE00 17 74776483-74839779 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044330 Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA044330: AB_10960543" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (5.95e-2)" "unprognostic (4.99e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (7.46e-2)" "unprognostic (2.86e-2)" "unprognostic (4.75e-1)" "prognostic favourable (1.97e-5)" "unprognostic (8.14e-2)" "unprognostic (6.17e-2)" "unprognostic (8.46e-2)" "unprognostic (7.95e-2)" "unprognostic (2.82e-3)" "unprognostic (1.00e-2)" 11.5 15.5 10.6 11.6 12.1 15.4 7.7 10.5 13.9 8.1 7.9 19.1 9.5 7.6 7.4 8.9 9.3 6.8 9.6 9.0 11.4 8.2 10.9 19.9 14.7 19.0 17.3 9.1 9.4 18.7 21.0 14.7 12.5 13.1 8.0 6.7 10.0 15.1 9.1 7.5 9.7 7.7 9.4 18.5 10.4 8.3 17.4 14.2 7.5 11.7 6.5 10.2 10.6 6.1 4.9 8.8 5.7 7.7 3.9 7.9 5.0 6.2 15.4 8.3 9.3 11.7 7.3 4.9 10.8 11.0 13.9 15.5 12.6 6.8 3.3 3.5 12.3 7.1 8.3 6.0 7.4 2.4 11.7 8.3 6.3 8.7 8.6 13.6 7.7 5.8 6.7 14.1 3.1 9.9 4.8 5.2 9.4 6.0 8.1 5.5 4.5 12.4 5.1 13.1 5.5 6.2 5.5 7.0 9.2 6.0 7.8 8.0 10.0 21.1 7.8 29.4 7.5 11.1 14.0 3.6 3.1 3.8 11.3 14.2 11.1 2.2 7.7 5.7 7.9 6.5 4.0 4.9 7.6 7.2 8.3 1.6 6.3 4.4 3.6 3.9 6.6 8.8 7.5 5.0 10.6 12.1 10.5 13.9 11.4 8.2 17.3 9.1 13.1 14.2 TMEM106B "FLJ11273, MGC33727" ENSG00000106460 "Transmembrane protein 106B" Q9NUM4 7 12211241-12243367 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Amyotrophic lateral sclerosis, Disease mutation, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058342 Approved Supported Endosomes,Lysosomes "Endosomes, Lysosomes" "HPA058342: " "unprognostic (5.29e-2)" "unprognostic (2.34e-2)" "unprognostic (4.20e-2)" "unprognostic (6.20e-2)" "unprognostic (2.73e-1)" "unprognostic (1.87e-2)" "unprognostic (3.50e-2)" "unprognostic (5.89e-2)" "unprognostic (4.44e-2)" "unprognostic (1.30e-1)" "unprognostic (3.01e-3)" "unprognostic (2.09e-2)" "unprognostic (1.75e-3)" "unprognostic (5.52e-2)" "unprognostic (3.06e-2)" "unprognostic (2.16e-2)" "unprognostic (1.70e-1)" 17.1 48.3 16.2 11.4 23.7 6.2 17.0 18.5 29.0 26.0 20.3 19.4 13.5 16.1 24.9 19.7 18.5 19.9 18.0 20.8 15.7 16.2 30.9 33.0 12.9 11.7 20.5 21.2 22.1 18.3 17.5 31.3 35.3 26.8 27.2 22.6 15.2 23.2 24.3 23.9 15.5 18.1 24.8 24.8 13.5 15.5 12.0 21.3 14.7 30.7 14.9 12.4 21.4 17.9 7.6 2.8 8.8 6.3 14.1 19.4 7.3 9.8 23.4 9.5 25.3 22.2 21.6 10.1 14.6 33.4 10.3 13.3 5.7 38.9 3.9 16.5 19.4 11.4 8.2 9.6 14.1 5.7 7.5 4.8 10.9 6.7 17.9 12.7 6.9 17.3 12.4 7.6 18.0 15.8 11.5 11.8 15.4 4.2 2.8 7.2 15.3 9.5 7.1 8.2 7.7 25.5 9.9 12.2 17.3 15.6 14.2 13.4 12.9 9.1 15.6 14.9 18.0 12.8 12.5 10.9 19.7 4.6 18.6 5.2 34.1 8.8 4.2 4.8 9.4 4.9 13.5 6.3 11.6 11.1 2.8 7.6 19.4 13.5 2.5 14.1 6.3 0.9 9.7 7.3 16.2 23.7 18.5 29.0 15.7 16.2 20.5 21.2 26.8 21.3 TMEM106C MGC5576 ENSG00000134291 "Transmembrane protein 106C" Q9BVX2 12 47963569-47968878 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 133.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047204 Enhanced "HPA047204: " "unprognostic (1.63e-2)" "unprognostic (5.84e-2)" "unprognostic (1.56e-2)" "unprognostic (2.40e-1)" "unprognostic (3.13e-1)" "unprognostic (1.04e-1)" "prognostic unfavourable (5.27e-8)" "unprognostic (1.05e-1)" "unprognostic (1.90e-2)" "unprognostic (1.52e-3)" "unprognostic (3.60e-1)" "unprognostic (7.29e-2)" "prognostic favourable (4.62e-4)" "unprognostic (1.12e-2)" "unprognostic (1.16e-1)" "unprognostic (2.57e-2)" "unprognostic (1.83e-1)" 10.6 19.1 12.6 18.5 17.3 12.2 20.4 17.5 16.3 16.6 41.2 6.5 29.0 33.9 19.7 43.6 17.5 15.1 23.1 25.8 17.7 14.4 26.4 13.6 16.5 10.4 8.5 14.6 21.4 39.1 33.7 27.4 23.6 12.8 15.9 45.3 30.4 59.0 16.6 8.0 11.3 58.1 16.9 7.1 31.0 21.9 28.3 5.8 23.1 20.5 16.1 15.2 12.1 16.6 14.9 5.1 10.7 4.1 7.3 26.2 16.5 36.5 25.6 23.7 26.2 11.0 8.0 22.6 20.6 29.8 37.7 32.5 38.3 37.9 32.2 29.1 22.6 25.2 37.2 22.6 36.0 30.7 35.7 25.0 36.8 15.5 8.4 25.5 18.6 5.5 15.5 34.3 18.2 23.9 16.8 36.9 26.3 26.5 36.9 11.4 4.2 35.4 32.7 30.8 27.4 19.9 28.1 16.0 19.1 32.0 21.6 21.5 79.1 20.8 5.9 15.9 27.3 22.9 36.4 20.6 33.5 35.9 20.2 133.6 15.2 10.7 3.7 9.5 19.5 3.3 23.8 14.9 19.1 20.2 5.1 12.1 17.9 19.6 3.2 7.3 4.1 0.8 26.2 16.5 12.6 17.3 17.5 16.3 17.7 14.4 8.5 14.6 12.8 5.8 TMEM108 "CT124, MGC3040" ENSG00000144868 "Transmembrane protein 108" Q6UXF1 3 133038391-133397792 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.6" "Cell line enhanced" "Detected in some" "HMC-1: 11.6;LHCN-M2: 6.5;SCLC-21H: 10.0;SH-SY5Y: 44.3" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063350 Enhanced Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane, Cytosol" "Nucleoli, Vesicles" "HPA063350: " "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.07e-3)" "unprognostic (3.17e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.06e-4)" "unprognostic (2.08e-1)" "unprognostic (7.27e-4)" "unprognostic (1.11e-1)" "unprognostic (3.03e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-2)" "unprognostic (6.12e-2)" "unprognostic (1.36e-2)" 2.2 15.1 12.7 2.2 13.8 0.7 2.4 15.6 21.7 3.2 1.8 7.5 0.2 1.1 3.7 1.3 12.7 2.4 1.6 8.4 10.0 8.1 1.0 0.6 12.1 2.5 5.3 13.7 0.8 1.0 6.1 2.8 9.1 4.9 4.0 2.2 16.1 1.8 3.2 25.6 2.2 2.0 10.4 4.4 2.0 2.2 16.8 4.3 0.0 4.1 1.5 3.3 12.0 1.3 0.8 0.4 1.0 0.4 0.6 0.8 0.6 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.4 0.8 3.9 0.0 0.0 0.0 0.0 11.6 0.1 0.0 0.0 0.0 0.6 0.0 0.0 6.5 0.3 0.0 0.1 1.8 0.0 0.0 2.2 0.0 0.5 0.0 10.0 44.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.3 0.8 0.0 1.7 1.0 0.3 0.2 0.5 0.3 0.3 0.3 0.2 0.5 0.0 0.8 0.3 0.4 0.9 0.6 0.4 0.4 0.8 0.6 12.7 13.8 15.6 21.7 10.0 8.1 5.3 13.7 4.9 4.3 TMEM11 "C17orf35, PM1, PMI" ENSG00000178307 "Transmembrane protein 11" P17152 17 21197280-21214624 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051795, HPA062854" Uncertain Supported Mitochondria Mitochondria "HPA051795: , HPA062854: " "unprognostic (2.29e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "unprognostic (3.55e-1)" "unprognostic (3.36e-3)" "unprognostic (1.45e-2)" "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (1.16e-1)" "unprognostic (1.90e-2)" "unprognostic (1.40e-1)" "unprognostic (1.19e-1)" "unprognostic (1.97e-1)" "unprognostic (2.17e-2)" "unprognostic (4.61e-2)" 9.7 6.5 5.5 6.2 5.8 13.2 9.7 6.2 8.7 6.1 6.1 6.3 4.3 5.4 6.8 7.6 8.5 5.1 5.2 8.3 5.1 5.1 8.0 9.0 5.9 5.0 5.6 4.5 6.2 10.7 4.5 5.1 10.6 6.5 7.4 4.1 6.4 11.0 6.2 30.2 8.2 7.2 6.3 5.3 6.0 6.5 8.4 4.5 7.3 8.8 12.8 7.9 5.9 5.7 8.0 7.0 11.7 12.2 5.5 6.5 7.6 4.4 3.2 4.6 3.2 6.7 3.7 5.7 9.1 2.5 8.0 5.6 10.5 2.0 4.3 5.0 7.0 5.8 6.5 6.6 1.8 4.5 6.5 3.0 3.0 1.8 7.5 3.5 4.3 5.1 5.3 9.1 4.2 3.9 3.8 1.6 3.7 2.7 5.7 5.4 5.0 2.7 4.0 8.7 2.6 3.6 1.3 2.7 4.6 3.6 4.3 4.4 2.7 3.1 3.2 4.5 6.8 6.4 8.5 2.2 2.1 10.2 3.6 4.6 2.6 4.7 12.2 11.7 5.4 8.7 4.9 6.1 5.5 4.9 7.0 8.0 6.5 4.9 9.8 5.5 10.9 6.1 4.9 7.6 5.5 5.8 6.2 8.7 5.1 5.1 5.6 4.5 6.5 4.5 TMEM116 FLJ90167 ENSG00000198270 "Transmembrane protein 116" Q8NCL8 12 111931282-112013185 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in all" 4 "T-cells: 14.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040720 Approved Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA040720: AB_10795623" "unprognostic (8.91e-2)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.71e-1)" "unprognostic (5.48e-2)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (6.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.34e-1)" "unprognostic (3.27e-3)" "unprognostic (9.12e-2)" "prognostic favourable (1.08e-4)" "unprognostic (2.41e-1)" "unprognostic (1.33e-1)" "unprognostic (2.85e-2)" "unprognostic (3.19e-3)" 3.7 10.7 4.4 3.0 8.4 1.0 10.2 6.7 6.6 5.3 4.1 11.2 9.1 9.5 3.9 6.4 4.9 4.2 5.8 20.2 5.3 3.7 26.8 10.0 7.2 3.7 8.7 5.5 4.7 4.1 31.2 9.6 2.7 14.0 4.5 3.4 5.9 12.5 7.0 5.0 11.8 9.0 5.1 8.2 3.9 8.7 20.8 7.3 6.0 6.6 3.6 5.6 8.6 4.5 2.5 3.0 3.0 3.3 1.5 14.9 3.4 4.1 4.4 6.2 6.9 6.2 4.9 4.2 3.4 5.5 4.5 4.9 3.3 3.5 4.8 2.2 2.5 4.3 3.4 3.6 3.9 11.6 2.8 3.1 4.2 4.1 9.9 1.2 0.5 6.0 6.3 5.7 10.0 1.5 5.9 3.9 4.5 6.2 1.8 9.8 7.7 2.9 4.9 2.5 8.3 14.0 23.6 5.9 3.9 3.7 3.2 5.7 11.8 16.3 1.1 4.2 1.3 3.8 1.5 4.7 8.1 4.6 5.9 3.8 5.9 0.8 1.8 3.0 6.5 3.3 5.2 2.1 14.9 12.1 2.1 2.5 7.9 8.6 0.3 1.5 2.4 3.0 13.5 3.4 4.4 8.4 6.7 6.6 5.3 3.7 8.7 5.5 14.0 7.3 TMEM119 ENSG00000183160 "Transmembrane protein 119" Q4V9L6 12 108589846-108598320 "Predicted intracellular proteins, Predicted membrane proteins" "Biomineralization, Differentiation, Osteogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 104.8;ASC TERT1: 29.0;BJ hTERT+: 30.4;HSkMC: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051870, HPA052650" Enhanced "HPA051870: AB_2681645, HPA052650: AB_2681901" "unprognostic (4.90e-2)" "unprognostic (2.66e-1)" "unprognostic (6.84e-2)" "unprognostic (5.97e-2)" "unprognostic (2.35e-1)" "unprognostic (3.29e-2)" "unprognostic (6.67e-2)" "unprognostic (8.40e-2)" "unprognostic (1.51e-1)" "prognostic unfavourable (8.37e-4)" "unprognostic (1.61e-1)" "unprognostic (1.56e-1)" "prognostic unfavourable (2.06e-6)" "unprognostic (1.29e-2)" "unprognostic (8.76e-3)" "unprognostic (1.40e-2)" "unprognostic (1.87e-2)" 20.3 4.4 8.0 18.7 10.3 1.3 28.7 2.1 7.4 36.4 6.7 13.2 2.8 8.0 14.0 8.0 4.7 9.0 19.4 11.1 6.9 4.3 6.7 0.8 25.6 24.2 11.0 4.2 1.8 5.6 3.3 4.9 3.4 8.3 10.7 8.4 13.7 4.2 15.0 1.2 9.7 12.2 9.2 10.2 10.4 5.7 6.1 10.3 0.8 15.8 4.9 14.2 18.7 14.3 1.5 0.8 4.9 1.4 0.8 1.3 0.2 0.0 0.0 0.2 0.1 104.8 29.0 0.1 2.1 30.4 0.0 0.5 0.0 0.1 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 1.3 0.0 0.2 44.7 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 7.1 0.0 0.0 0.0 0.0 0.3 0.2 2.4 0.0 2.0 0.0 0.4 0.5 0.1 1.2 0.1 0.0 3.1 0.9 0.8 0.8 0.3 0.7 0.8 1.3 0.9 0.4 1.5 1.3 1.1 4.9 0.8 1.4 0.8 0.4 0.2 8.0 10.3 2.1 7.4 6.9 4.3 11.0 4.2 8.3 10.3 TMEM123 "KCT3, PORIMIN" ENSG00000152558 "Transmembrane protein 123" Q8N131 11 102396332-102470384 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 140.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026001, HPA062862" Supported "Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus" "Vesicles, Cytosol" "CAB026001: , HPA062862: " "unprognostic (2.64e-1)" "unprognostic (8.39e-2)" "unprognostic (4.18e-3)" "unprognostic (1.40e-1)" "unprognostic (7.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.36e-4)" "unprognostic (3.08e-1)" "prognostic unfavourable (2.66e-4)" "unprognostic (1.67e-1)" "unprognostic (1.38e-2)" "unprognostic (8.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-2)" "unprognostic (3.65e-2)" 21.3 23.1 18.8 30.1 23.3 39.8 38.6 7.4 18.8 35.2 38.2 19.1 15.1 12.4 65.3 20.8 31.9 21.6 20.8 36.8 20.7 14.0 27.0 95.4 39.5 55.5 22.6 13.7 27.8 24.7 14.5 8.5 23.9 21.1 34.9 19.9 13.9 53.3 22.2 13.2 29.7 17.6 29.7 22.4 39.9 23.7 22.9 24.6 71.9 66.0 20.1 27.1 43.7 39.8 23.3 30.3 48.3 29.2 52.4 55.5 51.3 28.8 25.9 26.8 24.9 34.3 28.1 18.2 22.5 48.8 46.1 51.3 32.8 140.1 48.7 58.1 52.1 31.3 29.1 37.1 51.0 29.3 10.6 25.3 10.2 48.7 30.3 53.7 19.0 31.3 42.3 32.9 49.3 51.5 16.9 0.1 38.0 9.3 46.6 16.8 16.0 23.7 28.7 74.1 46.7 43.9 28.6 12.7 15.0 27.3 37.4 14.8 23.1 21.0 60.3 31.0 34.8 26.8 16.9 18.9 10.5 49.5 9.0 59.9 20.4 30.1 26.8 48.3 26.3 29.2 40.0 16.7 41.3 31.8 30.3 23.3 55.5 46.9 17.6 52.4 24.2 8.1 42.9 51.3 18.8 23.3 7.4 18.8 20.7 14.0 22.6 13.7 21.1 24.6 TMEM126B HT007 ENSG00000171204 "Transmembrane protein 126B" Q8IUX1 11 85628573-85636539 "Predicted membrane proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014480, HPA019186" Uncertain Supported Mitochondria Mitochondria "HPA014480: AB_1858083, HPA019186: AB_1858084" "unprognostic (1.11e-1)" "unprognostic (4.97e-2)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (5.67e-1)" "unprognostic (1.44e-1)" "unprognostic (5.55e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (6.70e-3)" "unprognostic (4.42e-2)" "unprognostic (4.30e-2)" "unprognostic (1.94e-2)" "unprognostic (1.78e-1)" "unprognostic (6.50e-2)" "unprognostic (5.86e-2)" "unprognostic (2.66e-2)" 15.5 17.0 28.9 13.5 28.0 6.4 22.1 26.7 33.2 19.7 21.2 12.2 15.5 21.7 21.9 35.4 16.5 15.9 19.1 26.2 27.2 31.7 27.5 19.9 16.5 18.9 28.7 25.7 15.9 15.3 13.9 28.0 14.6 28.8 19.8 20.0 14.2 16.8 16.6 15.7 15.1 20.8 24.2 24.9 19.3 18.9 11.7 27.0 15.1 22.6 17.5 18.8 20.8 14.3 14.0 14.9 12.5 13.2 15.8 19.6 11.5 14.5 12.0 13.6 6.4 25.7 20.6 4.3 12.9 14.1 10.3 15.7 33.3 14.8 15.5 28.6 11.0 17.7 21.7 13.3 9.8 21.4 19.7 11.7 21.2 14.6 14.6 28.6 14.5 15.0 17.0 15.7 19.1 15.7 27.8 12.8 25.5 18.7 11.4 35.5 14.7 19.8 9.9 10.2 13.0 20.2 16.3 12.4 7.7 12.2 10.0 12.6 20.2 17.7 8.2 15.8 11.1 39.7 13.5 6.0 33.5 18.7 8.0 23.4 8.3 12.5 11.7 5.7 15.4 13.2 19.6 14.0 19.1 18.4 14.9 12.9 19.1 18.9 4.5 15.8 9.6 13.4 18.3 11.5 28.9 28.0 26.7 33.2 27.2 31.7 28.7 25.7 28.8 27.0 TMEM130 "DKFZp761L1417, FLJ42643" ENSG00000166448 "Transmembrane protein 130" Q8N3G9 7 98846488-98870771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 28.2;brain: 82.2;pituitary gland: 24.0;testis: 26.4" "Cell line enhanced" "Detected in some" "BJ: 3.9;BJ hTERT+: 8.8;EFO-21: 8.6;NTERA-2: 5.1;SH-SY5Y: 10.5" "Cancer enhanced" "Detected in many" "renal cancer: 9.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012928 Approved Supported "Golgi apparatus" "Golgi apparatus" "HPA012928: AB_1858085" "unprognostic (1.36e-2)" "unprognostic (1.33e-3)" "unprognostic (3.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.61e-3)" "unprognostic (3.23e-2)" "unprognostic (2.97e-1)" "prognostic favourable (7.84e-4)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "unprognostic (4.69e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-3)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.17e-2)" "unprognostic (1.73e-1)" 1.3 28.2 27.3 2.0 53.8 1.4 1.8 14.1 82.2 3.5 1.8 2.8 0.0 1.6 1.8 8.0 2.2 1.7 2.2 1.4 29.3 47.0 2.8 1.1 5.4 2.4 13.4 35.1 1.7 1.6 1.5 24.0 1.3 25.8 2.7 1.9 1.0 1.3 6.2 2.1 1.3 2.1 1.6 9.2 1.4 1.4 26.4 3.9 0.1 1.4 0.0 1.2 1.7 1.2 1.0 0.6 4.8 0.9 1.0 0.7 0.3 0.0 0.7 0.0 0.0 0.3 0.0 0.2 3.9 8.8 0.7 0.6 0.1 0.1 0.1 8.6 2.2 0.1 0.0 0.0 0.1 0.2 0.4 0.1 0.3 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.4 0.2 0.7 0.4 0.7 0.2 0.2 5.1 0.0 0.2 0.0 0.8 0.1 0.0 0.6 10.5 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.4 0.3 0.1 0.4 0.5 0.2 2.2 0.9 0.6 0.5 0.4 0.4 0.7 0.5 0.4 0.2 1.0 0.7 0.6 4.8 1.0 0.6 0.6 0.4 0.3 27.3 53.8 14.1 44.2 29.3 47.0 13.4 35.1 25.8 3.9 TMEM131 "CC28, KIAA0257, PRO1048, RW1, YR-23" ENSG00000075568 "Transmembrane protein 131" Q92545 2 97756333-97995891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017678, HPA017682" Approved Uncertain "Vesicles,Intermediate filaments" "Vesicles, Intermediate filaments" "HPA017678: AB_1858086, HPA017682: AB_1858087" "unprognostic (1.16e-2)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (7.42e-2)" "unprognostic (8.58e-2)" "unprognostic (4.18e-2)" "unprognostic (7.59e-3)" "unprognostic (3.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (5.10e-3)" "unprognostic (5.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "unprognostic (1.77e-1)" 16.6 19.4 13.7 33.6 19.2 15.8 15.6 18.5 19.4 21.0 25.5 19.1 14.5 18.6 21.8 15.7 19.9 17.3 20.1 17.3 11.7 12.1 14.6 15.8 15.7 24.0 14.1 14.0 21.2 22.0 31.4 27.8 30.9 15.0 17.7 24.1 14.6 18.6 12.7 31.4 24.2 23.6 21.1 13.2 22.5 26.3 14.4 15.3 23.2 14.7 16.8 27.6 20.5 16.7 4.5 5.2 7.3 3.5 5.4 5.4 2.2 13.3 8.2 15.5 11.2 16.3 19.8 16.9 19.9 19.5 10.2 12.3 10.6 19.4 21.4 11.0 20.5 9.7 16.2 26.6 15.2 15.1 10.5 15.5 5.8 15.2 18.4 14.4 20.9 18.9 10.9 18.1 18.9 12.5 9.2 22.9 31.0 8.0 10.4 9.2 8.5 17.8 15.3 9.9 9.4 10.5 16.0 17.5 8.5 12.9 8.9 12.2 7.5 13.4 14.8 26.7 12.3 12.8 7.6 9.8 13.4 10.8 20.9 12.7 18.0 7.3 2.8 7.3 4.0 3.5 4.6 4.5 3.4 4.0 3.7 4.2 4.2 5.4 1.9 5.4 3.2 5.2 2.1 2.2 13.7 19.2 18.5 19.4 11.7 12.1 14.1 14.0 15.0 15.3 TMEM131L "DKFZp586H1322, KIAA0922" ENSG00000121210 "Transmembrane 131 like" A2VDJ0 4 153466346-153636711 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 69.4" "Cell line enhanced" "Detected in many" "Daudi: 36.5;MOLT-4: 33.9;U-698: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043472, HPA048443" Uncertain Approved "Nucleoli fibrillar center,Vesicles" Vesicles "Nucleoli fibrillar center" "HPA043472: , HPA048443: " "unprognostic (1.12e-1)" "prognostic favourable (6.69e-6)" "unprognostic (1.71e-1)" "unprognostic (3.75e-2)" "unprognostic (8.37e-2)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "unprognostic (3.30e-2)" "unprognostic (3.23e-2)" "unprognostic (4.11e-2)" "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (4.35e-3)" "unprognostic (2.92e-2)" "unprognostic (3.39e-2)" "unprognostic (3.94e-2)" "unprognostic (3.51e-2)" 7.5 1.9 2.1 37.9 6.0 27.3 6.6 0.5 3.0 6.5 5.6 2.3 3.5 1.5 11.9 7.9 6.6 5.0 4.3 5.6 2.5 1.6 3.4 13.0 6.1 27.6 2.2 1.6 4.9 23.0 0.8 6.4 2.5 2.1 5.3 3.1 5.3 10.3 3.2 17.5 5.2 10.0 8.1 3.0 26.5 6.0 3.2 3.9 69.4 4.1 5.5 36.8 7.1 5.8 18.5 13.3 13.6 23.7 14.9 17.9 10.3 2.0 1.3 5.6 5.9 3.3 2.9 0.1 2.9 1.4 2.0 2.6 9.0 1.3 36.5 0.7 3.8 2.0 4.3 5.0 3.1 3.3 3.1 7.1 2.5 2.3 2.2 7.8 0.4 2.7 3.1 2.6 2.5 5.1 6.7 0.1 2.0 3.7 33.9 5.7 5.0 1.9 11.8 5.4 2.3 1.3 0.8 4.2 3.3 2.3 5.1 3.0 1.9 5.8 4.0 2.7 4.9 3.2 2.4 4.0 4.1 43.3 0.8 4.7 2.2 6.1 12.4 13.1 8.5 23.7 11.2 18.5 10.7 7.9 13.3 17.3 17.9 12.0 13.6 14.9 18.6 1.3 12.9 10.3 2.1 6.0 0.5 3.0 2.5 1.6 2.2 1.6 2.1 3.9 TMEM132A "FLJ20539, GBP, HSPA5BP1" ENSG00000006118 "Transmembrane protein 132A" Q24JP5 11 60924463-60937159 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.1" "Cell line enhanced" "Detected in many" "EFO-21: 45.3;MCF7: 44.8;SK-BR-3: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051979, HPA060492" Enhanced Approved Mitochondria 1900000 Mitochondria "HPA051979: , HPA060492: " "unprognostic (2.52e-2)" "unprognostic (2.01e-1)" "unprognostic (3.75e-2)" "prognostic favourable (1.98e-5)" "unprognostic (7.94e-3)" "unprognostic (3.74e-1)" "unprognostic (4.42e-3)" "unprognostic (2.39e-2)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (5.98e-2)" "prognostic unfavourable (1.55e-9)" "unprognostic (3.31e-1)" "unprognostic (9.74e-2)" "unprognostic (1.50e-1)" "unprognostic (8.41e-3)" 3.6 6.1 28.6 9.2 25.2 1.2 4.4 23.9 58.1 14.0 3.2 11.3 0.8 3.4 14.4 2.2 4.8 3.2 6.2 4.0 17.0 22.9 3.1 1.3 4.5 2.4 20.4 21.4 6.9 3.9 1.5 6.6 19.8 13.8 4.1 2.0 19.3 21.5 2.9 4.3 1.8 2.6 4.6 9.3 2.5 8.5 3.4 9.7 0.0 2.0 1.0 6.0 4.9 2.0 0.4 0.1 1.6 0.1 0.0 0.1 0.1 8.9 12.5 11.2 23.9 0.9 0.5 19.9 6.7 21.9 6.2 5.2 4.4 8.5 0.0 45.3 2.0 17.0 2.5 11.7 2.4 0.1 3.7 0.2 8.0 8.2 8.4 0.1 0.3 2.1 2.2 11.6 1.8 10.7 0.5 0.6 2.0 44.8 0.2 0.0 14.9 7.2 0.1 4.7 1.0 9.4 4.7 11.3 26.6 4.8 46.1 4.1 31.9 0.1 12.5 2.4 11.4 0.7 12.7 0.1 0.0 0.4 20.2 0.0 11.6 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.1 28.6 25.2 23.9 36.8 17.0 22.9 20.4 21.4 13.8 9.7 TMEM132B "KIAA1786, KIAA1906" ENSG00000139364 "Transmembrane protein 132B" Q14DG7 12 125186836-125662377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 19.3" "Cell line enhanced" "Detected in some" "HSkMC: 7.8;NTERA-2: 8.9;RPMI-8226: 3.8;U-138 MG: 13.9;U-937: 3.9" "Cancer enriched" "Detected in single" 7 "glioma: 3.3" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.0" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035661, HPA035662" Uncertain "HPA035661: AB_10669774, HPA035662: " "unprognostic (3.38e-3)" "unprognostic (4.39e-2)" "unprognostic (6.73e-2)" "unprognostic (6.33e-2)" "unprognostic (1.06e-1)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (1.26e-1)" "unprognostic (4.58e-1)" "unprognostic (1.12e-1)" "unprognostic (6.23e-3)" "unprognostic (1.29e-2)" "unprognostic (4.29e-4)" "unprognostic (1.20e-1)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (3.73e-3)" 0.2 0.2 6.1 0.1 7.5 0.0 0.1 0.2 19.3 0.6 0.3 0.2 0.8 1.0 0.5 0.2 0.3 0.7 5.1 2.6 0.1 0.0 0.0 0.1 2.6 0.1 0.2 0.0 1.1 0.2 0.4 0.4 2.8 0.6 0.5 2.4 0.2 0.2 0.5 0.0 0.3 0.8 2.7 0.3 0.1 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 2.6 2.8 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.1 0.0 0.0 2.9 0.3 0.0 0.0 0.0 8.9 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.9 0.0 0.1 0.0 0.0 0.2 0.0 2.2 3.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 TMEM132C "DKFZp761O2018, PPP1R152" ENSG00000181234 "Transmembrane protein 132C" Q8N3T6 12 128267403-128707915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.5" "Group enriched" "Detected in some" 6 "AF22: 5.9;ASC diff: 8.5;Daudi: 9.5" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.6;testis cancer: 4.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "gdT-cell: 5.4" "Lineage enriched" "Detected in single" 55 "T-cells: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015633, HPA015984" Supported Centrosome,Cytosol 110000000 "Centrosome, Cytosol" "HPA015633: AB_1858089, HPA015984: AB_1858088" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (7.34e-2)" "unprognostic (8.60e-2)" "unprognostic (2.37e-1)" "unprognostic (1.99e-3)" "unprognostic (5.48e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.85e-2)" "unprognostic (6.29e-2)" "unprognostic (7.97e-3)" "unprognostic (2.54e-1)" "unprognostic (5.71e-2)" "unprognostic (6.33e-3)" 37.5 4.2 9.6 1.1 7.0 0.8 23.3 5.0 6.6 22.0 2.5 4.2 8.9 1.2 5.9 5.7 4.7 13.4 5.1 3.5 5.0 3.8 1.3 0.8 1.6 2.0 4.9 3.1 7.9 4.1 0.9 0.6 5.1 4.6 3.7 1.3 5.3 2.9 9.1 1.9 2.2 1.4 2.1 3.9 1.1 1.5 2.1 5.4 0.0 1.1 0.9 1.3 3.8 10.5 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 5.9 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.6 7.0 5.0 6.6 5.0 3.8 4.9 3.1 4.6 5.4 TMEM132D "KIAA1944, MOLT, PPP1R153" ENSG00000151952 "Transmembrane protein 132D" Q14C87 12 129071725-129903666 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 18.0" "Cell line enhanced" "Detected in some" "AF22: 5.4;Karpas-707: 1.7;MOLT-4: 9.1;NTERA-2: 3.5;U-266/84: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 19.1;cerebral cortex: 57.9;hippocampal formation: 46.6" HPA010739 Approved 150000 "HPA010739: AB_2204753" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (2.07e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-2)" "unprognostic (2.89e-1)" "unprognostic (3.07e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (4.31e-4)" 0.4 0.9 4.5 0.7 6.6 0.7 0.4 0.4 18.0 0.4 0.8 0.6 0.0 0.8 0.5 0.4 0.4 0.4 0.4 0.4 2.9 4.2 0.6 0.7 0.8 0.4 1.7 6.2 0.5 1.1 0.4 0.7 0.4 0.8 1.1 0.7 1.2 0.4 0.4 0.4 0.5 0.9 0.5 0.6 0.4 1.0 1.6 0.8 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 9.1 0.0 3.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 6.6 0.4 11.7 2.9 4.2 1.7 6.2 0.8 0.8 TMEM132E DFNB99 ENSG00000181291 "Transmembrane protein 132E" Q6IEE7 17 34579487-34639318 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;kidney: 8.8" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 30.9" "Group enriched" "Detected in some" 8 "glioma: 7.6;renal cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.6" "Group enriched" "Detected in many" 20 "NK-cells: 1.4;T-cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070608 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" 140000 "Nucleoplasm, Golgi apparatus" "Nuclear bodies, Cytosol" "HPA070608: " "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.29e-5)" "unprognostic (3.37e-1)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-3)" "unprognostic (1.72e-1)" "unprognostic (1.80e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.55e-4)" "unprognostic (1.67e-2)" "unprognostic (1.51e-2)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 0.4 0.5 4.9 0.4 4.1 0.2 0.3 17.3 8.7 1.2 0.4 1.7 0.3 4.9 0.6 0.5 0.4 0.4 0.8 0.5 2.9 5.1 8.8 1.3 0.4 0.7 4.5 2.8 0.5 0.2 0.3 0.0 0.9 5.3 0.4 0.5 0.0 0.8 0.8 0.3 0.8 2.8 0.6 20.0 0.7 0.6 2.4 2.2 0.0 0.4 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.0 1.4 2.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 3.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.4 0.5 0.0 0.0 2.6 1.8 0.0 1.4 0.0 0.0 0.0 0.4 4.9 4.1 17.3 6.9 2.9 5.1 4.5 2.8 5.3 2.2 TMEM134 FLJ21749 ENSG00000172663 "Transmembrane protein 134" Q9H6X4 11 67461710-67469272 "Predicted membrane proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043744 Approved Supported Cytosol Cytosol "HPA043744: AB_10794773" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (4.67e-2)" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (7.22e-2)" "unprognostic (3.85e-1)" "unprognostic (1.39e-2)" "unprognostic (4.30e-2)" "unprognostic (3.48e-1)" "unprognostic (1.75e-1)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-2)" "unprognostic (4.43e-3)" 7.1 15.3 11.2 11.9 14.9 4.8 7.8 6.5 12.7 10.1 11.2 13.4 16.1 8.8 7.2 16.4 30.2 10.3 14.1 22.7 9.7 7.9 13.1 23.7 8.1 10.9 12.9 7.9 6.9 42.1 6.9 4.7 10.7 10.1 15.6 5.1 7.1 16.9 14.0 46.2 31.8 10.2 6.9 12.5 12.3 14.0 12.0 9.7 11.1 8.3 20.7 21.6 10.4 13.2 51.9 23.9 25.9 44.5 22.7 32.2 19.2 7.0 2.7 3.8 8.3 2.6 4.5 4.3 1.5 2.7 1.7 0.7 3.3 8.4 6.7 16.3 3.6 5.9 1.7 6.2 1.1 6.4 2.9 1.2 2.4 3.4 4.0 1.3 2.0 4.4 8.0 1.3 4.6 1.8 1.6 3.9 3.8 16.7 7.4 4.9 6.5 9.5 3.7 2.3 21.7 6.6 7.2 3.7 8.0 5.3 8.4 15.4 20.4 1.3 3.4 6.3 5.5 7.4 1.9 16.6 10.5 4.4 9.3 1.7 5.0 12.5 15.4 25.9 20.9 34.7 22.9 51.9 25.0 23.3 18.2 50.3 25.5 23.9 7.2 22.7 44.5 23.9 32.2 19.2 11.2 14.9 6.5 12.7 9.7 7.9 12.9 7.9 10.1 9.7 TMEM135 FLJ22104 ENSG00000166575 "Transmembrane protein 135" Q86UB9 11 87037844-87323758 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056685, HPA069473" Uncertain Supported Vesicles Vesicles "HPA056685: , HPA069473: " "unprognostic (1.55e-2)" "unprognostic (1.11e-1)" "unprognostic (2.70e-2)" "unprognostic (6.51e-2)" "unprognostic (3.10e-2)" "unprognostic (4.42e-1)" "unprognostic (1.45e-2)" "unprognostic (2.63e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "prognostic favourable (9.02e-4)" "unprognostic (3.48e-2)" "unprognostic (7.34e-2)" "unprognostic (1.35e-2)" "unprognostic (1.80e-1)" 31.6 28.9 10.5 9.5 12.0 5.9 23.3 11.4 14.8 8.3 14.3 12.8 18.9 21.8 15.1 7.8 7.4 8.4 12.6 12.6 9.9 11.3 16.5 31.2 11.7 9.8 13.8 10.2 14.1 9.2 14.7 24.4 13.5 12.9 15.4 12.1 12.8 16.9 17.8 14.9 7.5 20.1 11.1 11.2 8.3 10.1 15.7 11.4 14.1 15.0 6.4 7.0 10.7 9.9 5.9 7.0 2.2 6.0 8.4 10.4 4.5 4.2 6.9 4.8 6.6 15.7 15.1 6.2 3.2 8.5 3.9 8.4 12.1 19.2 12.0 8.4 4.2 4.1 6.6 7.9 4.2 10.5 4.1 9.6 7.3 42.2 8.8 5.2 4.9 17.3 4.8 5.2 3.6 9.8 8.8 16.4 4.2 3.4 12.7 6.1 5.8 5.9 6.7 3.9 9.5 8.8 13.1 2.5 6.3 5.1 14.6 7.0 20.8 5.8 5.2 4.3 5.3 14.7 2.5 6.9 12.4 13.0 3.0 5.9 7.8 0.9 5.8 1.7 9.7 6.0 8.5 5.9 6.3 10.4 6.6 5.2 7.1 6.8 2.2 8.4 2.7 7.0 6.5 4.5 10.5 12.0 11.4 14.8 9.9 11.3 13.8 10.2 12.9 11.4 TMEM139 FLJ90586 ENSG00000178826 "Transmembrane protein 139" Q8IV31 7 143279957-143288048 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.1;kidney: 22.6;placenta: 28.0" "Cell line enhanced" "Detected in some" "A-431: 9.5;CAPAN-2: 17.9;EFO-21: 12.6;RPTEC TERT1: 31.5;SK-BR-3: 11.1;T-47d: 30.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036982, HPA036983" Approved Approved "Plasma membrane,Focal adhesion sites" "Plasma membrane" "Focal adhesion sites" "HPA036982: AB_2675413, HPA036983: AB_10672275" "unprognostic (2.58e-1)" "unprognostic (4.38e-1)" "unprognostic (6.62e-3)" "unprognostic (1.41e-1)" "unprognostic (2.10e-1)" "unprognostic (2.16e-3)" "unprognostic (2.83e-2)" "unprognostic (4.90e-2)" "unprognostic (1.60e-1)" "unprognostic (2.82e-2)" "prognostic unfavourable (1.66e-4)" "unprognostic (2.89e-1)" "prognostic favourable (3.05e-5)" "unprognostic (1.73e-1)" "unprognostic (1.42e-2)" "unprognostic (2.83e-2)" "unprognostic (9.08e-3)" 1.5 2.2 0.9 2.8 1.9 0.0 2.1 0.6 1.6 6.3 14.7 6.0 1.5 22.7 1.6 3.5 0.4 4.6 4.8 2.3 1.6 1.1 22.6 7.8 5.5 0.1 4.2 0.7 0.9 9.6 6.4 2.0 28.0 4.8 1.6 2.9 1.4 6.1 2.2 0.1 1.1 25.1 0.4 13.4 0.8 2.0 3.0 2.1 0.1 8.8 0.4 0.7 2.1 2.4 0.5 0.3 0.9 3.2 0.0 2.0 0.4 9.5 0.7 0.1 0.0 0.0 0.0 6.4 0.1 0.0 0.0 0.0 2.2 17.9 0.1 12.6 0.0 8.1 0.0 4.1 0.0 0.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.6 0.4 0.0 0.7 0.1 0.1 0.0 31.5 2.4 0.1 0.0 0.4 11.1 0.0 30.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 3.2 0.0 0.5 1.3 0.8 0.0 0.0 1.1 0.6 0.0 0.0 2.4 0.3 2.0 0.4 0.9 1.9 0.6 1.6 1.6 1.1 4.2 0.7 4.8 2.1 TMEM150C "FLJ12993, TTN3" ENSG00000249242 "Transmembrane protein 150C" B9EJG8 4 82483170-82562357 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "epididymis: 74.9" "Cell line enhanced" "Detected in some" "AN3-CA: 8.9;MCF7: 24.6;SCLC-21H: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052921 Enhanced "HPA052921: " "unprognostic (2.99e-1)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.89e-3)" "unprognostic (1.71e-3)" "prognostic favourable (7.87e-4)" "unprognostic (2.94e-2)" "unprognostic (5.55e-2)" "unprognostic (1.06e-1)" "unprognostic (3.94e-2)" "prognostic favourable (5.68e-4)" "unprognostic (4.57e-2)" "prognostic favourable (4.59e-6)" "unprognostic (4.18e-1)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-3)" 7.0 30.0 10.8 3.2 12.8 1.5 12.4 0.6 16.0 8.4 4.4 8.3 12.9 4.4 3.2 74.9 2.5 4.6 3.9 7.4 12.7 7.9 9.7 7.7 3.6 8.1 7.5 10.3 18.0 2.2 1.7 10.5 5.5 7.3 7.1 2.6 12.4 10.3 4.7 3.5 3.1 4.4 4.0 5.4 7.6 3.0 4.2 6.8 2.7 7.0 1.6 6.9 3.2 3.3 5.5 1.4 5.0 0.9 1.3 0.7 0.3 0.3 0.9 6.8 8.9 0.0 0.1 0.7 1.5 3.7 0.9 1.1 0.0 0.4 0.2 0.7 0.2 0.1 4.2 0.0 1.1 0.4 2.1 0.5 0.8 0.0 0.0 0.0 1.0 4.1 0.4 0.0 0.0 2.2 0.0 0.1 0.1 24.6 0.4 0.6 3.1 0.4 0.9 0.1 0.8 0.3 3.4 17.3 2.7 0.5 0.2 2.4 0.4 0.1 0.5 0.4 0.2 0.1 0.8 0.1 0.3 0.3 0.5 0.3 1.9 5.0 0.9 1.0 0.7 0.4 0.4 3.5 0.7 0.6 0.2 5.5 0.5 0.6 3.7 1.3 0.6 1.4 0.2 0.3 10.8 12.8 0.6 16.0 12.7 7.9 7.5 10.3 7.3 6.8 TMEM154 FLJ32028 ENSG00000170006 "Transmembrane protein 154" Q6P9G4 4 152618632-152680165 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.3;HMC-1: 28.0;Karpas-707: 21.8;U-266/70: 27.3;U-937: 21.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4" "Lineage enriched" "Detected in many" 9 "granulocytes: 75.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA019184, HPA055411" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA019184: , HPA055411: " "unprognostic (1.09e-1)" "unprognostic (3.56e-1)" "unprognostic (5.17e-2)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-1)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (2.64e-1)" "unprognostic (1.65e-1)" "unprognostic (5.00e-3)" "unprognostic (7.67e-2)" "unprognostic (2.23e-3)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" 1.4 0.7 0.8 12.5 0.8 8.3 2.0 0.7 0.7 5.0 1.4 1.3 0.9 1.0 1.1 1.2 36.1 1.1 2.4 1.7 0.8 0.8 1.0 4.8 7.9 20.4 1.3 0.1 0.7 0.8 0.1 3.5 3.5 0.8 3.9 1.1 0.5 16.1 2.5 1.3 28.7 3.0 2.2 1.2 16.2 2.7 0.6 0.1 8.2 1.5 26.0 38.0 7.1 6.3 8.3 2.9 75.4 6.0 0.1 3.4 2.2 12.0 0.0 0.1 0.0 0.2 3.5 5.5 3.0 11.3 3.3 6.4 0.1 1.6 12.4 1.3 2.8 8.8 0.0 24.3 6.2 0.0 0.0 0.6 0.1 0.0 3.6 9.5 28.0 3.3 11.7 10.7 9.3 8.3 0.0 21.8 0.2 0.8 3.7 2.9 0.6 2.9 0.4 0.0 0.0 19.2 7.4 0.0 0.5 0.7 2.4 0.4 0.3 6.7 3.3 0.4 2.0 0.3 4.2 27.3 9.2 6.8 4.6 21.7 2.5 49.8 5.8 44.8 0.8 5.9 1.5 8.3 1.8 1.3 2.9 7.2 1.8 1.2 75.4 0.1 6.0 0.3 3.4 2.2 0.8 0.8 0.7 0.7 0.8 0.8 1.3 0.1 0.8 0.1 TMEM158 "p40BBp, RIS1" ENSG00000249992 "Transmembrane protein 158 (gene/pseudogene)" Q8WZ71 3 45224466-45226278 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.8;endometrium 1: 31.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 65.0;U-138 MG: 27.5;U-87 MG: 90.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 46.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 85.5" "Low region specificity" "Detected in all" HPA074974 Approved "HPA074974: " "unprognostic (3.84e-1)" "unprognostic (9.83e-3)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (3.77e-2)" "unprognostic (5.73e-2)" "unprognostic (3.31e-2)" "unprognostic (4.67e-3)" "unprognostic (6.23e-2)" "unprognostic (6.41e-2)" "unprognostic (1.84e-3)" "prognostic favourable (6.43e-5)" "prognostic unfavourable (5.42e-9)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (2.86e-2)" "unprognostic (4.49e-3)" 1.8 6.4 16.4 4.5 46.8 2.2 2.3 2.1 10.9 13.1 3.4 2.3 18.5 1.4 31.1 7.3 21.3 2.0 11.0 0.8 9.0 11.2 1.9 1.2 1.0 1.1 2.5 5.0 1.7 2.4 0.7 5.7 1.4 2.6 15.6 2.7 0.5 1.3 27.0 2.4 2.7 1.2 19.6 1.8 0.8 2.2 3.0 4.3 0.0 0.7 0.8 1.7 6.7 1.6 0.0 0.0 0.9 0.1 0.0 0.0 1.1 2.3 0.4 0.8 0.1 1.5 3.7 0.7 6.0 65.0 3.3 5.4 0.1 0.1 0.0 0.3 2.0 3.3 1.0 0.2 9.9 0.1 0.3 0.0 1.2 0.0 2.1 0.4 1.2 4.9 0.1 6.6 0.5 0.3 14.8 0.1 5.9 0.1 0.0 4.1 7.3 9.0 0.0 0.2 0.9 1.3 2.2 1.2 0.2 2.3 0.0 0.3 0.0 0.8 0.9 27.5 2.0 17.3 20.8 0.0 0.0 0.0 90.2 2.3 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 16.4 46.8 2.1 10.9 9.0 11.2 2.5 5.0 2.6 4.3 TMEM159 promethin ENSG00000011638 "Transmembrane protein 159" Q96B96 16 21158377-21180616 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 28.7" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 14.6;cerebellum: 13.7" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018033, HPA063509" Approved Approved Vesicles Vesicles "HPA018033: AB_2204762, HPA063509: " "unprognostic (7.62e-3)" "unprognostic (2.42e-1)" "unprognostic (1.99e-2)" "unprognostic (1.06e-1)" "unprognostic (8.68e-2)" "unprognostic (6.80e-2)" "unprognostic (3.32e-1)" "unprognostic (2.93e-1)" "unprognostic (3.35e-1)" "unprognostic (2.93e-3)" "prognostic unfavourable (1.59e-4)" "unprognostic (2.03e-1)" "prognostic favourable (8.11e-5)" "unprognostic (8.28e-2)" "unprognostic (1.28e-1)" "unprognostic (1.84e-2)" "unprognostic (1.57e-2)" 35.6 12.7 2.2 6.0 14.6 1.8 27.4 13.7 2.8 25.3 13.5 1.0 10.1 2.7 28.3 9.8 37.1 8.4 23.9 32.4 1.4 1.6 11.3 1.2 10.7 7.6 1.2 1.6 22.0 6.1 5.6 1.2 5.3 1.7 29.7 6.4 10.9 35.2 7.9 57.5 32.5 7.3 45.5 1.5 3.6 7.9 10.9 1.4 6.1 17.4 35.5 21.9 43.7 21.1 11.4 11.3 12.2 8.6 7.5 13.1 7.3 5.8 2.7 3.0 11.1 28.7 18.5 1.5 2.7 11.7 1.2 2.2 2.1 8.0 7.6 3.2 8.7 8.8 4.9 4.5 1.3 3.4 1.8 3.5 1.0 3.9 6.7 2.7 9.4 6.8 23.4 6.5 20.8 6.5 2.5 2.3 2.0 10.3 2.0 2.0 2.7 1.7 11.0 1.6 2.8 14.4 17.5 0.3 0.4 7.4 10.1 3.4 16.8 2.1 4.6 1.7 2.2 9.3 0.7 0.2 0.6 2.5 8.3 2.4 1.8 12.2 8.6 8.0 10.1 5.9 8.7 11.4 13.1 8.6 5.0 9.2 9.6 8.8 3.9 7.5 7.1 11.3 13.0 7.3 2.2 14.6 13.7 2.8 1.4 1.6 1.2 1.6 1.7 1.4 TMEM167A "FLJ30508, MGC23909, TMEM167" ENSG00000174695 "Transmembrane protein 167A" Q8TBQ9 5 83052846-83077863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077278 Approved Vesicles Vesicles "HPA077278: " "unprognostic (5.38e-3)" "unprognostic (2.84e-3)" "unprognostic (3.78e-2)" "unprognostic (4.40e-2)" "unprognostic (1.66e-1)" "unprognostic (3.34e-1)" "unprognostic (4.06e-3)" "unprognostic (7.74e-2)" "unprognostic (9.94e-3)" "unprognostic (3.99e-3)" "unprognostic (2.72e-1)" "unprognostic (4.09e-2)" "unprognostic (2.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.51e-1)" "unprognostic (1.13e-3)" "unprognostic (1.29e-2)" 22.9 38.0 29.3 20.9 31.3 19.8 23.2 24.2 32.8 24.9 18.8 21.8 12.2 20.5 16.9 20.6 16.7 13.1 21.2 21.8 27.8 28.4 26.2 25.3 21.4 16.3 32.9 20.9 12.9 23.6 22.2 32.9 26.1 35.5 18.0 22.8 15.2 21.3 15.9 15.6 16.1 19.7 17.3 26.7 18.2 17.5 9.7 25.3 22.8 22.2 16.1 17.5 18.4 14.3 2.9 8.4 13.2 15.6 3.9 4.3 6.8 13.1 8.0 30.2 26.8 44.5 31.1 27.7 20.8 16.3 13.5 17.8 12.1 17.1 8.4 13.0 24.5 11.1 20.1 27.0 22.5 11.5 12.4 22.7 15.0 18.6 17.4 11.6 14.9 24.3 19.0 17.3 16.4 16.5 12.5 17.1 19.7 11.5 14.1 12.8 31.1 13.7 12.6 19.3 23.1 18.9 10.4 14.3 18.6 13.9 14.6 20.5 26.4 27.5 22.5 8.5 8.4 24.4 18.6 10.0 27.8 8.5 15.6 21.1 20.0 13.2 15.0 6.8 2.6 14.2 3.0 2.9 3.6 3.2 8.4 2.4 3.9 3.0 8.8 3.9 15.6 4.0 4.3 6.8 29.3 31.3 24.2 32.8 27.8 28.4 32.9 20.9 35.5 25.3 TMEM168 "DKFZp564C012, FLJ13576" ENSG00000146802 "Transmembrane protein 168" Q9H0V1 7 112762382-112790592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020389, HPA077143" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA020389: AB_1858101, HPA077143: " "unprognostic (1.54e-1)" "unprognostic (2.23e-1)" "unprognostic (2.55e-1)" "unprognostic (4.92e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-2)" "unprognostic (2.30e-3)" "prognostic favourable (4.07e-6)" "unprognostic (1.60e-3)" "unprognostic (8.73e-2)" "unprognostic (3.07e-3)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.47e-1)" "unprognostic (1.84e-1)" "unprognostic (4.89e-3)" "unprognostic (3.30e-2)" 14.4 14.9 9.0 11.4 14.6 5.6 15.4 6.9 15.7 15.7 21.2 17.9 17.6 13.2 17.4 18.3 19.1 15.0 12.1 18.9 11.8 8.2 18.8 11.8 13.5 21.3 12.6 7.8 17.5 9.9 28.2 12.7 26.3 15.5 16.6 24.3 18.4 19.6 14.5 11.0 25.5 18.4 19.7 15.7 16.4 14.3 13.9 12.4 17.8 17.5 12.6 17.4 14.7 16.9 15.4 17.9 16.5 16.9 13.7 22.4 10.0 9.1 7.8 7.3 6.6 12.6 25.8 10.4 10.2 9.6 3.8 3.4 9.9 9.8 9.8 6.9 10.1 10.0 7.4 8.9 10.0 15.3 7.6 8.2 9.6 5.6 8.5 9.4 10.8 12.5 23.2 4.4 6.6 11.2 11.3 9.0 13.9 14.7 8.0 5.9 5.9 6.0 5.4 3.6 14.2 9.7 17.6 5.5 10.9 13.4 18.4 7.8 10.3 8.3 15.9 18.7 9.4 8.6 13.1 15.4 13.0 11.0 12.1 8.3 23.4 16.5 16.9 12.5 14.2 13.7 16.9 12.4 15.3 13.8 17.9 15.4 22.4 15.5 9.4 13.7 13.5 12.2 13.7 10.0 9.0 14.6 6.9 15.7 11.8 8.2 12.6 7.8 15.5 12.4 TMEM179B ENSG00000185475 "Transmembrane protein 179B" Q7Z7N9 11 62787415-62790405 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016585, HPA062068" Enhanced "Nuclear speckles" "Nuclear speckles" "HPA016585: AB_1844357, HPA062068: " "unprognostic (1.18e-2)" "unprognostic (2.83e-1)" "unprognostic (2.20e-1)" "unprognostic (1.78e-2)" "unprognostic (1.68e-1)" "unprognostic (6.11e-3)" "unprognostic (1.96e-2)" "unprognostic (2.35e-1)" "unprognostic (2.44e-1)" "unprognostic (1.25e-2)" "unprognostic (4.61e-3)" "unprognostic (2.76e-2)" "unprognostic (4.56e-1)" "unprognostic (1.64e-1)" "unprognostic (2.16e-1)" "unprognostic (5.74e-3)" "unprognostic (3.60e-2)" 26.1 34.6 13.2 19.5 15.7 13.4 36.0 6.3 15.4 24.9 31.3 23.7 37.7 24.5 27.8 53.6 24.9 28.9 35.0 21.8 12.9 11.1 43.1 55.4 39.0 43.2 17.1 9.8 27.4 47.1 15.5 17.5 39.8 20.9 28.8 29.3 28.0 55.1 54.2 16.7 29.7 44.2 20.4 19.9 30.4 26.5 29.4 14.8 25.5 44.9 21.2 28.2 24.1 24.0 35.5 80.6 70.4 67.6 28.3 35.4 53.5 12.4 25.4 6.3 12.5 49.6 12.6 7.8 13.6 16.8 10.8 12.4 14.5 28.9 5.7 19.6 27.0 22.8 11.6 12.3 8.3 16.9 16.6 8.3 11.5 13.2 33.5 10.4 11.6 24.2 20.0 20.3 25.1 10.8 11.4 16.3 12.2 28.3 13.4 20.3 9.4 28.1 9.1 10.1 29.7 20.2 15.4 8.6 9.5 17.6 22.8 23.3 26.7 12.9 13.9 14.2 10.7 26.0 11.2 18.7 11.0 7.4 20.4 6.4 16.4 52.6 67.6 70.4 35.4 64.9 34.8 35.5 32.5 33.9 43.2 31.5 28.9 28.5 49.9 28.3 61.8 80.6 31.3 53.5 13.2 15.7 6.3 15.4 12.9 11.1 17.1 9.8 20.9 14.8 TMEM183A C1orf37 ENSG00000163444 "Transmembrane protein 183A" Q8IXX5 1 203007386-203024848 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072607 Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA072607: " "unprognostic (2.94e-3)" "unprognostic (1.60e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-2)" "unprognostic (5.99e-2)" "prognostic unfavourable (2.62e-4)" "unprognostic (6.46e-2)" "unprognostic (3.21e-2)" "unprognostic (4.82e-3)" "unprognostic (5.28e-2)" "unprognostic (7.84e-2)" "unprognostic (4.83e-2)" "unprognostic (6.01e-3)" "unprognostic (9.55e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" 12.2 12.6 22.4 13.5 20.8 50.1 17.2 31.9 30.4 14.4 21.1 12.4 6.7 20.0 13.6 15.2 19.3 12.0 15.0 11.5 19.8 21.0 16.0 21.1 13.4 20.2 19.3 14.8 15.0 29.9 12.0 8.2 10.9 20.8 15.0 23.6 11.1 22.2 13.6 8.8 16.1 18.8 17.6 12.4 14.5 15.8 27.7 12.3 23.3 20.5 14.8 17.7 15.3 20.7 17.4 27.2 35.6 24.4 26.4 23.7 24.3 12.7 12.4 15.9 26.1 21.1 15.9 26.3 12.8 12.7 14.9 13.1 15.0 13.5 31.8 9.3 16.5 16.1 21.3 18.0 12.4 10.3 25.9 15.7 14.5 16.5 15.3 28.1 13.8 15.5 20.0 12.2 24.8 18.7 32.2 11.6 13.8 28.4 22.9 28.9 43.7 19.8 17.7 27.2 25.6 23.0 12.5 20.5 25.7 19.2 32.0 18.4 22.9 22.2 13.8 10.1 14.1 17.2 14.0 11.8 18.9 24.7 11.1 21.9 10.6 21.1 24.4 35.6 18.1 20.4 17.9 16.6 20.5 20.5 27.2 17.4 23.7 19.3 21.3 26.4 18.5 19.5 21.2 24.3 22.4 20.8 31.9 30.4 19.8 21.0 19.3 14.8 20.8 12.3 TMEM185A "CXorf13, FAM11A, FRAXF" ENSG00000269556 "Transmembrane protein 185A" Q8NFB2 X 149596556-149631912 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048295, HPA071744" Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA048295: , HPA071744: " "unprognostic (9.76e-2)" "unprognostic (2.83e-2)" "unprognostic (7.73e-2)" "unprognostic (2.71e-3)" "unprognostic (4.08e-1)" "unprognostic (1.97e-1)" "unprognostic (4.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.78e-2)" "unprognostic (2.69e-1)" "unprognostic (3.17e-1)" "unprognostic (1.37e-2)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (1.40e-1)" 4.3 5.0 6.8 4.8 6.2 1.7 4.1 7.2 8.2 5.1 3.8 3.1 7.3 2.3 6.2 7.4 5.8 5.8 5.3 12.0 4.4 4.4 3.1 3.4 3.3 3.0 3.3 13.8 5.4 7.3 4.8 10.8 6.0 5.5 3.5 6.3 4.8 7.2 4.5 6.2 3.3 6.6 3.7 7.8 2.7 12.3 4.0 3.8 3.8 4.5 4.3 4.6 5.8 5.3 7.7 12.2 5.0 13.5 10.4 6.3 11.0 11.2 12.9 7.6 17.6 11.9 5.1 10.9 13.3 11.0 16.7 6.8 19.1 13.5 24.3 12.0 14.0 14.9 10.3 12.0 8.7 11.1 7.8 13.0 7.3 12.7 11.3 8.0 11.3 17.5 11.4 7.1 9.5 3.2 8.8 7.9 18.0 7.8 7.8 9.6 12.5 7.6 19.6 7.7 12.7 14.5 4.5 6.4 8.3 14.3 14.2 7.6 6.5 11.4 8.4 7.7 15.4 13.3 8.3 7.3 19.8 14.9 13.4 11.5 2.2 5.0 12.2 10.1 3.0 9.0 5.3 7.3 10.4 7.7 5.0 10.3 9.2 7.1 13.5 2.5 5.7 9.0 6.3 TMEM187 "CXorf12, DXS9878E, ITBA1" ENSG00000177854 "Transmembrane protein 187" Q14656 X 153972327-153983195 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA038134 Uncertain Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA038134: AB_10669517" "unprognostic (1.51e-1)" "unprognostic (4.35e-2)" "unprognostic (1.41e-1)" "unprognostic (1.28e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (8.94e-2)" "unprognostic (2.41e-1)" "unprognostic (3.09e-1)" "unprognostic (4.22e-2)" "unprognostic (5.33e-2)" "unprognostic (7.41e-2)" "prognostic favourable (9.14e-8)" "unprognostic (6.73e-2)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (7.04e-2)" 8.8 13.0 9.2 6.8 10.2 3.4 10.5 13.2 9.0 7.6 9.0 10.5 13.9 6.8 8.8 9.3 9.5 12.0 6.8 8.1 9.6 6.0 7.6 10.2 7.7 10.2 10.4 9.0 10.9 24.4 7.5 13.0 7.3 11.0 10.3 4.5 6.7 14.1 10.1 8.5 10.7 10.9 6.8 8.0 10.0 8.0 5.9 8.7 8.4 10.8 2.9 9.9 7.9 7.4 13.4 19.6 17.8 9.8 10.1 22.5 10.9 8.3 9.5 2.1 7.6 8.2 7.4 1.1 3.4 1.7 1.0 3.4 1.9 14.4 1.3 19.7 2.7 7.6 2.9 5.0 0.8 10.7 3.9 2.3 5.0 3.1 7.0 1.1 2.6 8.3 7.6 2.9 4.3 2.6 2.0 10.8 4.3 9.0 4.4 1.5 1.5 10.6 4.1 1.1 13.9 5.3 2.7 2.8 2.8 5.0 4.2 3.6 8.0 2.7 4.8 1.7 1.8 6.9 1.9 7.6 5.1 1.7 5.1 5.0 0.9 17.8 9.8 11.9 14.7 7.3 14.7 9.7 18.1 15.9 7.4 13.4 22.5 13.9 9.5 10.1 6.9 19.6 17.6 10.9 9.2 10.2 13.2 9.0 9.6 6.0 10.4 9.0 11.0 8.7 TMEM189 Kua ENSG00000240849 "Transmembrane protein 189" A5PLL7 20 50118254-50153734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059549 Approved Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA059549: " "unprognostic (3.11e-2)" "unprognostic (7.04e-3)" "unprognostic (1.56e-2)" "prognostic unfavourable (7.51e-4)" "unprognostic (1.71e-1)" "unprognostic (1.04e-1)" "unprognostic (2.03e-3)" "unprognostic (7.00e-2)" "unprognostic (2.19e-2)" "unprognostic (1.35e-1)" "unprognostic (8.63e-2)" "unprognostic (5.79e-2)" "prognostic unfavourable (5.79e-11)" "unprognostic (1.85e-1)" "unprognostic (1.20e-1)" "unprognostic (9.46e-2)" "unprognostic (4.42e-2)" 15.1 13.9 12.0 11.0 23.8 7.7 13.6 7.9 18.1 13.0 14.5 33.7 20.5 13.2 16.3 17.3 27.0 10.0 12.3 15.5 15.0 10.7 9.1 21.0 14.3 8.3 33.1 9.0 6.5 8.9 19.8 6.5 26.1 20.7 13.3 11.5 7.9 14.6 22.0 17.1 24.3 13.2 32.2 32.1 10.4 14.5 11.3 24.9 10.0 8.5 11.7 14.8 16.0 15.4 2.0 6.2 6.3 13.9 4.1 5.8 3.9 8.7 8.0 9.6 7.5 14.7 11.1 16.1 6.1 5.8 13.0 7.3 21.7 14.0 3.2 9.9 5.8 24.3 4.8 12.5 4.7 1.7 3.7 4.1 11.7 18.5 8.3 6.7 11.3 9.3 29.2 7.3 7.7 15.4 4.3 4.8 4.3 7.7 5.3 16.9 4.7 8.4 4.3 7.4 3.5 24.4 12.9 5.0 3.3 7.0 24.2 13.8 3.8 9.5 12.2 11.0 5.7 7.0 6.0 3.5 5.8 1.3 9.4 5.0 8.8 5.3 5.7 6.3 3.7 10.8 2.9 2.0 4.1 3.1 6.2 1.9 3.5 4.1 2.3 4.1 13.9 3.9 5.8 3.9 12.0 23.8 7.9 18.1 15.0 10.7 33.1 9.0 20.7 24.9 TMEM192 FLJ38482 ENSG00000170088 "Transmembrane protein 192" Q8IY95 4 165070608-165208549 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014717, HPA024110" Enhanced Supported Nucleoplasm,Endosomes,Lysosomes "Endosomes, Lysosomes" Nucleoplasm "HPA014717: AB_1844373, HPA024110: AB_2204898" "prognostic unfavourable (9.52e-4)" "unprognostic (5.38e-3)" "unprognostic (9.16e-2)" "unprognostic (4.39e-2)" "unprognostic (2.60e-2)" "unprognostic (1.55e-2)" "unprognostic (2.91e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (3.10e-1)" "unprognostic (3.27e-2)" "unprognostic (5.06e-2)" "prognostic favourable (2.33e-14)" "unprognostic (2.09e-2)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (9.30e-2)" 12.6 14.4 11.3 7.4 13.6 5.3 12.1 12.0 11.9 11.6 9.7 10.5 6.2 8.3 9.7 10.0 7.8 10.1 8.9 10.4 9.9 9.4 40.7 37.7 9.1 8.5 13.0 10.6 21.8 21.3 20.3 14.2 9.3 13.1 19.4 11.7 24.7 11.3 7.8 19.0 7.4 8.2 8.6 13.3 10.8 10.5 8.6 11.3 3.1 22.9 5.2 6.6 12.1 7.3 18.2 12.0 3.4 12.5 13.4 12.8 7.7 6.2 9.5 3.4 8.7 9.0 3.2 8.0 9.5 14.1 10.0 11.2 5.5 10.3 13.8 5.7 6.1 5.6 12.8 9.8 11.6 8.9 6.6 7.6 7.1 6.2 23.0 18.8 10.3 11.6 20.9 8.9 18.3 8.1 13.0 23.2 12.2 13.6 3.2 5.6 7.1 8.1 7.4 3.0 12.5 8.1 9.2 7.3 7.7 14.9 23.7 15.1 11.5 8.7 6.1 4.4 5.4 13.8 10.8 22.8 30.2 19.2 10.6 10.4 17.5 2.0 12.5 3.4 9.7 10.9 12.8 18.2 7.5 9.9 11.6 15.2 8.3 10.0 1.4 13.4 5.8 12.0 6.0 7.7 11.3 13.6 12.0 11.9 9.9 9.4 13.0 10.6 13.1 11.3 TMEM198 "MGC99813, TMEM198A" ENSG00000188760 "Transmembrane protein 198" Q66K66 2 219543663-219550595 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 16.9;SH-SY5Y: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042385, HPA062897" Enhanced Approved Vesicles Vesicles "HPA042385: , HPA062897: " "unprognostic (2.59e-2)" "unprognostic (8.51e-2)" "unprognostic (5.97e-3)" "unprognostic (2.77e-1)" "unprognostic (4.43e-2)" "unprognostic (8.09e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (4.28e-1)" "unprognostic (2.06e-1)" "prognostic favourable (6.89e-4)" "unprognostic (6.39e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" 3.0 9.4 14.4 3.1 10.3 0.9 2.3 14.2 22.0 3.3 2.6 4.1 1.4 16.1 4.0 2.5 2.7 2.5 3.9 3.4 16.5 5.2 3.0 2.6 2.4 1.8 4.1 11.9 10.9 20.0 5.2 13.0 2.6 6.2 4.0 1.8 3.0 7.0 4.3 3.5 2.2 6.4 3.5 7.5 1.8 4.7 5.0 4.9 0.0 4.0 0.5 1.9 3.8 1.2 0.2 2.6 0.1 0.0 0.8 0.4 0.4 0.5 0.1 4.7 8.0 1.0 0.9 4.2 2.4 1.3 2.0 1.7 10.3 1.3 2.1 2.4 1.5 2.8 1.7 1.1 0.4 7.0 2.0 1.7 2.1 8.4 1.4 0.6 4.0 2.1 0.6 0.9 2.3 0.0 6.1 6.8 1.2 1.0 0.1 0.5 6.1 0.7 0.2 2.9 2.4 1.2 1.1 16.9 14.7 0.6 1.7 4.0 0.2 3.3 0.1 2.2 0.9 2.0 1.0 6.6 1.9 2.2 2.0 0.1 2.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 2.6 0.0 0.4 14.4 10.3 14.2 22.0 16.5 5.2 4.1 11.9 6.2 4.9 TMEM2 ENSG00000135048 "Transmembrane protein 2" Q9UHN6 9 71683366-71816690 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 67.6" "Cell line enhanced" "Detected in many" "AF22: 37.7;BEWO: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044889 Approved Supported "Vesicles,Plasma membrane" 130000 "Plasma membrane" Vesicles "HPA044889: AB_10962641" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (6.15e-3)" "unprognostic (1.21e-2)" "unprognostic (2.93e-2)" "unprognostic (3.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (1.31e-4)" "unprognostic (1.13e-2)" "unprognostic (2.33e-1)" "unprognostic (7.59e-2)" "unprognostic (1.16e-1)" 23.3 3.9 6.0 10.5 4.4 12.4 13.6 8.9 6.0 3.0 18.6 1.9 10.1 12.2 4.5 5.2 4.4 4.9 19.2 9.5 8.6 3.6 9.3 24.9 35.7 14.0 4.0 4.1 3.1 9.2 24.0 9.5 67.6 4.3 5.5 13.1 7.9 9.5 10.2 5.5 6.4 20.0 5.5 5.1 15.6 14.5 3.7 2.4 6.4 8.0 4.6 8.8 11.4 6.8 6.3 0.9 5.5 2.1 0.5 4.1 1.4 5.9 28.8 37.7 1.7 3.9 7.1 35.0 20.3 13.0 14.1 10.4 8.1 8.2 0.1 6.1 5.2 9.0 12.2 2.8 19.2 0.7 3.7 10.3 6.1 21.4 6.1 0.0 2.8 7.3 3.1 10.9 2.4 18.5 1.4 3.0 7.6 5.0 1.2 0.1 7.8 2.8 0.9 11.2 0.8 8.9 19.4 1.9 0.2 5.3 3.7 5.4 2.6 0.4 8.1 9.6 10.8 5.3 10.1 0.6 8.7 0.3 1.8 0.9 12.1 0.2 2.1 5.5 2.7 1.9 0.8 0.7 2.9 2.6 0.9 6.3 4.1 2.0 4.5 0.5 1.8 0.2 3.9 1.4 6.0 4.4 8.9 6.0 8.6 3.6 4.0 4.1 4.3 2.4 TMEM205 "MBC3205, UNQ501" ENSG00000105518 "Transmembrane protein 205" Q6UW68 19 11342776-11346518 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041504 Approved Approved "Nucleoplasm,Nuclear membrane,Endoplasmic reticulum" "Endoplasmic reticulum" "Nucleoplasm, Nuclear membrane" "HPA041504: AB_10795595" "unprognostic (2.54e-2)" "unprognostic (2.60e-2)" "unprognostic (7.19e-2)" "unprognostic (1.57e-2)" "unprognostic (6.83e-2)" "unprognostic (1.80e-1)" "unprognostic (5.04e-3)" "unprognostic (3.77e-2)" "unprognostic (1.01e-2)" "unprognostic (5.56e-3)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" "unprognostic (8.10e-2)" "unprognostic (5.78e-2)" "unprognostic (8.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" 15.8 40.5 25.7 10.6 29.4 14.5 19.3 16.2 36.3 30.3 19.2 19.8 34.6 18.7 15.5 29.7 14.6 25.9 27.8 31.7 24.5 23.6 36.1 90.8 19.4 22.9 25.2 21.9 21.7 50.5 52.4 21.7 17.5 20.6 24.3 11.3 31.8 28.6 28.4 30.0 15.0 18.2 16.9 21.4 14.2 17.2 23.1 13.2 11.1 46.6 15.4 13.3 21.3 13.1 21.9 43.1 11.0 71.0 10.4 14.8 32.1 19.0 47.2 5.8 19.8 11.6 14.0 11.0 7.2 16.8 15.9 12.4 14.3 6.1 17.1 44.1 14.6 19.5 8.4 21.8 10.7 20.0 8.0 4.5 16.4 23.5 29.3 7.7 14.6 13.2 22.3 10.2 17.1 19.1 13.7 73.2 9.8 48.1 11.5 21.4 10.4 36.2 10.9 9.0 45.1 38.6 34.5 10.5 16.0 7.6 31.5 17.6 27.4 22.4 11.2 20.0 7.6 21.8 16.1 43.6 43.5 10.1 19.3 34.5 15.3 5.2 71.0 7.1 14.6 29.8 14.8 21.9 12.2 12.8 43.1 18.4 9.8 11.8 11.0 10.4 17.5 31.0 14.6 32.1 25.7 29.4 16.2 36.3 24.5 23.6 25.2 21.9 20.6 13.2 TMEM207 ENSG00000198398 "Transmembrane protein 207" Q6UWW9 3 190428655-190449876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 75 "kidney: 21.1" "Cell line enriched" "Detected in single" 6 "U-266/70: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014332 Uncertain "HPA014332: AB_2204907" "unprognostic (4.81e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM208 HSPC171 ENSG00000168701 "Transmembrane protein 208" Q9BTX3 16 67227103-67229278 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041868, HPA041949" Supported "HPA041868: AB_10962347, HPA041949: AB_10959903" "unprognostic (9.42e-2)" "unprognostic (7.94e-2)" "unprognostic (1.36e-3)" "unprognostic (2.05e-2)" "unprognostic (2.23e-2)" "prognostic unfavourable (9.63e-5)" "unprognostic (2.02e-2)" "unprognostic (1.44e-1)" "unprognostic (1.27e-1)" "unprognostic (2.44e-1)" "unprognostic (6.53e-2)" "unprognostic (6.40e-2)" "unprognostic (1.31e-2)" "unprognostic (2.29e-1)" "unprognostic (5.18e-2)" "unprognostic (7.73e-2)" "unprognostic (9.42e-2)" 14.5 37.0 19.9 15.9 20.5 10.0 22.1 23.3 23.7 19.5 22.0 16.3 26.4 23.7 15.4 32.1 17.3 17.8 19.3 13.2 19.2 21.1 23.0 51.5 25.1 16.7 21.7 20.8 11.8 45.0 31.5 27.9 19.1 21.2 14.8 22.3 17.3 29.6 25.0 10.7 13.6 20.0 14.8 15.8 17.0 19.7 25.4 19.3 9.2 19.4 16.0 16.1 15.6 12.0 23.9 58.6 24.8 39.1 17.2 27.8 31.0 19.0 25.8 12.2 14.6 39.7 18.7 22.5 20.0 25.2 22.3 19.0 31.7 23.9 19.3 24.1 28.4 26.0 19.6 27.5 14.1 8.4 29.9 10.4 19.1 32.1 40.5 16.7 28.6 25.2 34.8 29.5 25.9 16.6 17.8 24.8 25.9 38.5 16.5 24.3 20.7 18.1 18.0 15.2 55.1 29.7 12.9 20.5 21.0 36.2 15.1 16.1 19.8 20.9 10.1 16.9 11.1 24.2 22.0 38.2 36.5 39.4 29.6 16.0 23.9 21.7 39.1 20.2 27.8 34.8 25.3 23.9 26.4 24.2 30.2 19.5 21.8 24.0 24.8 17.2 26.8 58.6 25.4 31.0 19.9 20.5 23.3 23.7 19.2 21.1 21.7 20.8 21.2 19.3 TMEM209 "FLJ14803, NET31" ENSG00000146842 "Transmembrane protein 209" Q96SK2 7 130164715-130207770 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031678 Uncertain Approved "Nuclear membrane,Nuclear speckles,Vesicles" "Nuclear membrane, Nuclear speckles, Vesicles" "HPA031678: AB_10603135" "unprognostic (3.03e-1)" "unprognostic (5.06e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.36e-1)" "unprognostic (4.50e-3)" "unprognostic (5.98e-2)" "unprognostic (1.25e-1)" "unprognostic (1.66e-1)" "unprognostic (3.19e-1)" "unprognostic (6.00e-2)" "unprognostic (2.34e-3)" "unprognostic (1.11e-1)" "unprognostic (3.48e-1)" "unprognostic (1.68e-2)" "unprognostic (3.24e-1)" 12.0 33.5 9.9 9.1 12.1 9.4 12.2 12.7 13.3 9.4 12.2 23.8 9.5 10.4 16.4 11.8 8.8 11.2 8.1 7.9 9.9 10.9 11.6 16.9 10.3 12.2 11.6 12.0 13.7 19.8 19.0 18.7 18.6 16.4 10.3 12.9 19.0 16.5 10.3 10.1 11.1 19.0 10.5 19.1 13.3 8.8 17.8 11.3 24.9 18.6 8.0 13.1 11.1 8.9 14.1 10.8 10.0 13.4 13.8 20.5 10.4 9.4 9.1 12.4 15.3 7.2 7.4 9.2 8.6 8.7 7.9 10.6 10.1 17.2 14.0 6.5 5.5 14.2 14.5 10.0 14.1 17.3 8.3 7.3 15.4 6.7 12.8 15.3 7.4 8.2 10.3 15.7 15.7 6.0 23.5 16.5 9.5 12.3 29.1 9.3 18.5 8.1 15.7 13.9 23.2 7.9 12.1 11.1 17.1 19.7 31.7 12.5 10.2 10.3 4.7 14.4 5.6 15.0 20.7 22.0 32.2 29.2 23.4 17.7 22.1 10.0 8.9 9.5 17.0 13.4 17.7 14.1 17.4 15.4 8.6 14.0 20.5 17.3 1.3 13.8 11.3 10.8 17.3 10.4 9.9 12.1 12.7 13.3 9.9 10.9 11.6 12.0 16.4 11.3 TMEM210 ENSG00000185863 "Transmembrane protein 210" A6NLX4 9 137170858-137172409 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 18.7" "Cell line enriched" "Detected in some" 7 "RPMI-8226: 15.4" "Cancer enhanced" "Detected in single" "prostate cancer: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Group enriched" "Detected in many" 4 "dendritic cells: 4.1;granulocytes: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA066907 Enhanced "HPA066907: " "unprognostic (5.17e-2)" "unprognostic (5.04e-2)" "unprognostic (2.87e-5)" "unprognostic (4.18e-2)" "unprognostic (3.63e-2)" "unprognostic (3.14e-2)" "unprognostic (8.00e-2)" 0.1 0.0 0.1 0.1 0.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.1 4.0 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.0 18.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.6 4.1 1.4 0.3 0.5 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.7 0.1 15.4 0.0 0.0 0.1 0.1 0.0 2.0 0.1 1.4 0.0 0.0 0.1 0.1 0.6 0.0 0.3 0.2 0.0 0.3 0.2 0.0 1.4 0.3 0.1 0.2 0.2 0.3 0.1 0.2 0.2 0.2 0.6 0.3 0.3 1.2 0.5 0.2 4.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TMEM213 ENSG00000214128 "Transmembrane protein 213" A2RRL7 7 138797952-138838101 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "kidney: 48.1;salivary gland: 35.6" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 4.4" "Cancer enriched" "Detected in some" 22 "renal cancer: 21.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA054059 Enhanced "HPA054059: " "unprognostic (2.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-2)" "unprognostic (1.19e-2)" "unprognostic (3.19e-2)" "unprognostic (6.84e-2)" "unprognostic (1.17e-2)" "unprognostic (2.10e-1)" "unprognostic (6.14e-2)" "unprognostic (6.08e-2)" "unprognostic (1.91e-2)" "prognostic favourable (5.54e-7)" "unprognostic (4.33e-1)" "unprognostic (9.99e-2)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" 0.1 0.0 0.1 0.0 0.1 0.4 2.1 0.0 0.1 1.2 0.0 0.0 4.3 0.3 0.1 0.2 0.1 0.0 0.4 0.0 0.1 0.1 48.1 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 35.6 2.9 0.0 3.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.3 0.1 0.0 1.1 0.8 4.1 0.7 4.6 1.2 0.2 0.4 0.4 0.7 1.5 0.3 0.3 1.4 0.6 0.2 0.1 0.3 1.1 1.7 0.9 0.6 0.1 0.8 0.0 0.0 0.3 0.6 1.2 1.3 1.0 0.7 0.1 1.0 0.9 0.5 0.2 0.1 0.4 0.5 1.2 1.9 0.3 0.2 0.4 0.8 0.3 0.3 0.6 0.9 0.7 4.4 1.7 1.3 1.1 0.4 1.0 0.2 1.2 0.3 0.1 1.8 0.9 1.4 0.7 1.6 0.5 1.1 0.8 0.4 0.8 4.1 0.7 0.7 0.9 0.6 1.2 0.7 0.5 0.6 0.3 1.1 0.6 0.6 3.4 4.6 0.6 0.8 0.4 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 TMEM218 ENSG00000150433 "Transmembrane protein 218" A2RU14 11 125096545-125111763 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038489 Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038489: AB_10672748" "unprognostic (3.70e-2)" "unprognostic (1.16e-1)" "unprognostic (7.60e-2)" "unprognostic (2.41e-3)" "unprognostic (8.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavourable (1.93e-5)" "unprognostic (3.63e-2)" "unprognostic (7.09e-3)" "unprognostic (2.18e-1)" "unprognostic (6.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.95e-2)" "prognostic favourable (5.50e-4)" "unprognostic (6.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.72e-2)" 24.2 19.0 14.0 13.2 15.7 7.0 13.5 11.9 12.4 14.7 12.3 16.8 12.3 12.5 17.5 16.3 12.8 20.8 16.5 10.4 14.1 9.3 13.1 13.6 11.9 13.7 13.6 10.0 17.8 19.7 12.8 17.4 8.8 10.5 17.4 9.4 18.0 15.0 11.1 9.7 8.8 12.4 14.7 11.7 17.5 13.3 7.8 11.3 10.0 13.0 12.0 12.4 14.2 13.6 18.0 28.7 18.5 25.2 19.1 14.0 15.4 7.7 15.2 9.7 11.7 9.0 12.5 5.8 7.7 5.9 6.0 7.9 1.5 23.0 9.8 19.5 4.7 9.0 6.0 7.4 8.0 13.6 8.6 21.9 4.2 6.2 8.8 6.8 8.2 9.8 9.8 10.7 12.8 8.8 8.8 12.5 10.4 4.0 1.7 14.4 7.9 14.5 10.1 11.7 7.4 5.4 7.8 8.4 12.6 10.6 4.2 5.4 20.2 9.9 11.1 7.4 6.8 8.7 8.4 7.2 6.0 8.0 6.0 14.3 13.0 18.5 25.2 10.1 14.0 18.8 12.2 18.0 13.3 13.2 28.7 13.7 11.5 13.5 9.6 19.1 17.4 24.9 11.7 15.4 14.0 15.7 11.9 12.4 14.1 9.3 13.6 10.0 10.5 11.3 TMEM219 IGFBP-3R ENSG00000149932 "Transmembrane protein 219" Q86XT9 16 29940885-29973052 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA059185 Approved "HPA059185: " "unprognostic (4.13e-2)" "unprognostic (1.94e-3)" "unprognostic (1.51e-1)" "prognostic favourable (5.79e-4)" "unprognostic (2.62e-1)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (9.83e-2)" "unprognostic (8.53e-2)" "unprognostic (1.71e-1)" "unprognostic (4.18e-1)" "unprognostic (1.19e-1)" "unprognostic (3.10e-2)" "unprognostic (1.31e-1)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-3)" 33.0 35.9 49.0 27.8 47.1 22.0 69.7 17.1 31.3 33.9 43.1 25.4 54.5 39.9 24.4 54.0 32.4 43.5 46.9 48.1 38.4 32.2 35.0 37.1 71.9 50.7 41.3 24.8 28.3 59.2 31.9 23.3 18.7 26.8 31.6 27.9 25.8 61.1 71.3 25.8 26.5 55.9 28.3 41.3 29.2 32.8 46.8 24.8 20.1 33.5 22.1 22.2 24.9 37.4 41.9 58.3 83.8 66.2 23.6 46.1 56.3 14.3 16.9 14.9 19.0 40.4 41.4 17.5 15.0 30.2 22.2 29.3 8.3 42.6 12.4 28.5 36.0 8.5 8.2 20.8 9.8 19.8 16.9 11.1 13.1 26.8 47.0 7.1 28.0 38.0 30.7 15.7 12.9 35.0 7.4 23.8 27.7 15.0 10.3 23.1 8.9 11.5 19.9 9.5 26.0 38.3 9.2 8.6 17.3 5.2 10.3 26.3 17.2 27.0 20.0 18.0 11.0 9.1 6.9 19.1 6.5 9.9 24.1 25.4 15.0 71.8 66.2 83.8 30.5 47.5 31.1 41.9 43.2 31.6 53.6 40.2 41.0 31.8 31.3 23.6 34.2 58.3 46.1 56.3 49.0 47.1 17.1 31.3 38.4 32.2 41.3 24.8 26.8 24.8 TMEM220 ENSG00000187824 "Transmembrane protein 220" Q6QAJ8 17 10699015-10730316 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 58.2" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 10.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047680 Uncertain Nucleoplasm Nucleoplasm "HPA047680: " "unprognostic (1.71e-2)" "unprognostic (4.60e-2)" "unprognostic (6.31e-3)" "unprognostic (4.04e-3)" "unprognostic (1.05e-3)" "unprognostic (1.84e-4)" "prognostic favourable (2.23e-5)" "unprognostic (4.58e-2)" "unprognostic (4.96e-3)" "unprognostic (2.81e-1)" "prognostic favourable (1.72e-4)" "unprognostic (2.97e-1)" "unprognostic (4.34e-3)" "unprognostic (2.25e-1)" "unprognostic (2.63e-2)" "unprognostic (7.80e-3)" "unprognostic (5.97e-2)" 6.5 7.4 4.5 2.4 4.6 3.3 7.8 1.3 2.8 4.7 6.1 3.8 14.3 8.1 4.9 11.1 3.3 3.9 10.1 6.3 3.8 2.4 6.4 58.2 4.6 3.1 2.9 1.2 4.8 6.0 2.4 2.4 1.7 4.9 12.0 2.8 6.6 3.5 18.5 4.1 3.7 15.4 5.4 2.5 4.7 7.1 17.2 3.5 0.6 9.4 2.6 2.4 4.1 3.4 11.6 2.9 2.3 2.5 4.5 9.0 1.9 0.5 3.5 1.3 8.1 5.1 5.1 1.0 6.8 7.2 4.7 6.7 0.0 0.3 1.2 0.5 4.2 0.4 3.3 0.6 3.4 0.4 1.5 0.5 0.2 2.8 7.4 0.9 0.8 3.4 0.4 1.5 0.3 2.1 0.4 0.3 2.9 0.4 1.1 1.4 4.9 0.0 4.7 0.2 0.6 10.9 0.2 0.5 5.8 0.3 0.1 0.7 0.4 1.8 4.7 0.4 1.3 2.6 0.4 0.8 0.3 0.3 4.9 1.4 0.6 1.4 2.5 2.3 0.9 1.8 1.1 4.2 2.2 1.3 2.9 11.6 9.0 6.1 2.1 4.5 0.8 2.3 0.4 1.9 4.5 4.6 1.3 2.8 3.8 2.4 2.9 1.2 4.9 3.5 TMEM222 "C1orf160, DKFZP564D0478" ENSG00000186501 "Transmembrane protein 222" Q9H0R3 1 27322145-27336400 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016579, HPA059374" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA016579: , HPA059374: " "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-3)" "unprognostic (1.52e-1)" "unprognostic (1.33e-1)" "unprognostic (4.11e-2)" "unprognostic (1.16e-1)" "unprognostic (2.51e-2)" "unprognostic (1.96e-2)" "unprognostic (2.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.29e-3)" "unprognostic (5.28e-2)" "unprognostic (1.56e-1)" "unprognostic (3.83e-2)" "unprognostic (7.80e-2)" 18.4 22.0 28.0 12.0 31.4 19.5 17.8 23.2 45.4 18.1 17.1 32.1 13.2 14.4 16.5 25.0 22.8 29.8 21.3 27.5 28.9 30.8 20.6 35.0 18.8 15.0 26.0 20.8 22.3 24.6 19.9 22.4 20.0 26.7 22.9 14.3 26.4 21.7 25.2 19.9 15.6 21.3 18.6 21.5 15.2 16.7 20.7 16.4 19.4 24.0 14.9 19.1 17.8 13.3 22.8 19.9 36.5 21.0 19.2 23.2 15.7 12.2 14.9 12.6 20.6 19.6 14.3 10.1 19.0 21.9 26.1 22.2 6.1 25.8 7.8 14.9 20.2 17.0 13.7 18.5 10.9 10.3 26.4 13.0 12.4 14.1 29.2 12.9 13.1 24.8 10.5 24.9 14.3 17.3 9.8 18.1 16.2 10.9 18.5 13.6 23.5 18.7 15.4 8.7 15.7 25.2 7.2 27.0 23.8 14.7 20.8 18.4 20.6 20.9 15.8 15.4 13.0 24.7 17.9 19.6 17.4 8.1 23.3 25.1 22.1 19.3 13.7 17.0 22.3 20.3 17.0 22.8 20.7 17.0 12.0 18.9 20.9 21.4 36.5 19.2 21.0 19.9 23.2 15.7 28.0 31.4 23.2 45.4 28.9 30.8 26.0 20.8 26.7 16.4 TMEM223 MGC3196 ENSG00000168569 "Transmembrane protein 223" A0PJW6 11 62771629-62792021 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014504 Approved Approved "Nucleoplasm,Nuclear membrane,Mitochondria" "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA014504: AB_1853881" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.87e-1)" "unprognostic (3.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-2)" "unprognostic (3.20e-3)" "unprognostic (1.97e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-3)" "unprognostic (1.29e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (7.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.14e-3)" "unprognostic (9.75e-2)" 10.9 20.6 12.8 13.4 19.5 8.7 11.6 11.1 25.5 11.7 15.2 13.4 12.0 16.6 12.7 15.5 12.3 11.9 11.8 21.7 12.6 12.8 19.5 20.4 10.5 16.2 12.4 15.6 12.5 38.7 10.4 13.0 10.9 13.2 14.8 11.6 13.9 22.4 15.0 21.3 16.2 18.2 8.4 11.1 16.1 16.2 8.2 11.6 19.0 13.4 10.6 14.2 11.1 10.2 32.4 28.0 8.9 16.6 23.1 30.7 15.3 15.1 12.9 7.7 10.6 6.2 7.1 10.6 8.2 7.1 9.2 7.7 11.3 18.6 11.4 20.1 5.8 23.1 9.3 10.1 5.3 18.0 17.5 8.4 14.6 13.4 11.5 10.3 10.0 7.7 10.2 6.0 7.6 7.0 12.8 8.5 6.8 22.0 10.3 23.0 15.3 15.7 12.9 9.4 25.3 14.2 9.7 13.3 17.6 8.5 17.4 21.5 26.0 9.7 7.4 11.1 13.4 10.1 9.7 17.6 14.0 13.0 13.1 9.3 11.5 7.3 16.1 8.9 28.4 16.6 27.2 28.2 28.1 27.6 17.5 32.4 30.7 29.8 7.5 23.1 10.5 28.0 23.9 15.3 12.8 19.5 11.1 25.5 12.6 12.8 12.4 15.6 13.2 11.6 TMEM229B "C14orf83, FLJ33387" ENSG00000198133 "Transmembrane protein 229B" Q8NBD8 14 67447084-67533739 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.8;ductus deferens: 27.5" "Cell line enhanced" "Detected in some" "Daudi: 9.1;MCF7: 9.5;SK-MEL-30: 8.1;U-937: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046562 Approved "HPA046562: AB_10960265" "prognostic favourable (5.38e-4)" "unprognostic (6.55e-2)" "unprognostic (1.23e-1)" "prognostic favourable (1.21e-5)" "unprognostic (7.37e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (2.01e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (2.76e-3)" "unprognostic (1.95e-2)" "unprognostic (5.18e-1)" "unprognostic (8.66e-2)" "unprognostic (1.22e-1)" "unprognostic (8.20e-2)" "prognostic favourable (1.79e-5)" 1.6 14.5 9.4 5.2 7.1 1.6 3.8 27.8 11.5 11.8 5.9 2.7 27.5 15.9 1.5 11.9 1.3 2.2 4.2 1.7 10.6 7.9 2.2 1.5 3.5 8.3 9.0 5.7 1.2 5.7 5.8 8.1 7.7 13.3 2.9 3.4 5.1 4.1 11.8 0.6 1.4 14.1 3.3 6.5 9.4 4.2 5.6 2.0 8.9 9.7 0.0 6.1 5.9 1.7 1.2 2.8 8.7 6.9 5.5 11.0 5.0 2.2 0.3 0.0 0.6 0.2 0.0 0.9 0.4 0.5 0.6 2.4 0.0 7.2 9.1 0.0 0.2 0.0 0.2 0.5 0.1 2.9 0.7 5.5 0.0 0.0 0.8 5.9 1.1 0.1 0.3 0.1 0.0 0.0 0.1 0.3 0.0 9.5 3.5 2.2 0.1 0.4 3.3 0.1 1.3 0.1 4.8 1.4 0.3 0.0 3.5 8.1 7.5 5.7 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.4 24.3 5.1 6.0 5.1 8.7 11.0 6.7 10.6 1.2 6.5 8.7 2.8 1.1 5.7 7.1 0.1 5.5 6.9 1.6 2.6 5.0 9.4 7.1 27.8 11.5 10.6 7.9 9.0 5.7 13.3 2.0 TMEM230 "C20orf30, HSPC274" ENSG00000089063 "Transmembrane protein 230" Q96A57 20 5068232-5113103 "Predicted membrane proteins, Transporters" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009078, HPA061421" Uncertain Enhanced "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA009078: AB_1078345, HPA061421: " "unprognostic (1.39e-1)" "unprognostic (3.61e-1)" "unprognostic (3.73e-1)" "unprognostic (1.28e-1)" "unprognostic (3.71e-2)" "unprognostic (9.67e-3)" "unprognostic (5.85e-3)" "unprognostic (4.34e-3)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "unprognostic (2.74e-1)" "unprognostic (4.07e-2)" "unprognostic (9.70e-2)" "unprognostic (2.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.84e-2)" "unprognostic (1.55e-2)" 40.0 40.4 34.3 17.1 27.9 15.6 80.9 20.2 44.8 35.7 29.9 23.2 33.3 18.7 30.2 39.0 26.0 27.4 31.4 49.7 32.7 36.1 44.6 81.0 32.9 49.2 41.1 23.1 31.5 53.5 22.4 31.5 21.8 25.8 33.8 27.9 27.4 26.8 31.0 32.4 10.6 29.4 28.1 44.3 20.6 25.8 24.0 16.4 18.8 42.5 24.9 22.2 31.5 18.9 45.6 44.7 30.5 49.2 39.1 48.2 78.3 33.4 23.6 31.0 23.3 70.2 62.7 23.6 27.1 41.0 26.9 29.8 18.6 33.5 16.1 22.4 39.2 27.9 23.0 40.5 39.1 17.8 26.4 28.4 7.4 56.9 45.0 32.8 11.8 43.3 45.3 20.6 41.4 35.3 26.5 44.5 44.0 9.5 33.0 30.7 23.6 33.7 21.4 20.8 34.4 40.3 17.2 26.2 31.8 16.3 34.4 56.5 27.5 31.4 29.6 35.0 20.4 33.5 29.0 29.8 59.0 31.3 14.1 28.4 36.6 28.4 48.1 30.5 39.3 49.2 48.2 45.6 43.1 41.9 44.7 37.9 45.0 44.3 15.6 39.1 46.1 43.8 38.6 78.3 34.3 27.9 20.2 44.8 32.7 36.1 41.1 23.1 25.8 16.4 TMEM231 "ALYE870, FLJ22167, JBTS20, MKS11, PRO1886" ENSG00000205084 "Transmembrane protein 231" Q9H6L2 16 75536744-75556286 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 58.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA042081 Enhanced Approved Vesicles Vesicles "HPA042081: AB_10795391" "unprognostic (4.29e-2)" "unprognostic (9.84e-2)" "unprognostic (8.07e-2)" "unprognostic (2.71e-3)" "unprognostic (1.03e-1)" "unprognostic (9.34e-2)" "unprognostic (2.90e-2)" "unprognostic (2.81e-1)" "unprognostic (2.92e-1)" "unprognostic (1.69e-2)" "unprognostic (3.34e-3)" "unprognostic (7.84e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (1.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.28e-1)" 3.7 5.3 7.9 2.8 14.7 2.5 4.1 5.0 12.4 7.1 4.1 16.6 3.6 4.0 6.4 10.1 3.1 58.4 4.8 7.9 9.1 9.9 4.7 2.5 7.3 2.7 6.5 9.9 14.3 4.7 6.6 7.7 3.6 14.3 5.4 3.5 6.6 3.1 5.6 1.9 3.3 4.2 7.7 6.2 2.7 3.2 8.5 6.6 0.2 8.0 1.0 2.2 3.5 3.0 5.0 3.2 6.2 0.9 1.0 3.5 1.3 3.9 2.4 6.3 10.5 6.1 15.0 3.4 4.3 5.5 5.4 6.5 1.5 6.3 4.3 6.0 6.2 9.5 0.7 5.0 3.3 0.8 2.6 0.2 3.2 1.4 5.4 2.4 1.9 3.3 6.2 5.4 13.3 3.7 4.2 0.2 1.6 10.0 1.5 4.6 3.7 2.2 0.8 0.9 9.6 6.9 1.4 5.3 3.5 8.7 2.1 3.9 2.0 2.7 5.5 4.2 3.6 2.7 2.3 8.2 7.1 1.3 10.5 1.2 4.1 3.0 0.9 0.6 1.7 0.9 3.5 5.0 1.8 2.9 2.5 2.4 1.6 2.4 6.2 1.0 0.5 3.2 0.5 1.3 7.9 14.7 5.0 12.4 9.1 9.9 6.5 9.9 14.3 6.6 TMEM232 FLJ43080 ENSG00000186952 "Transmembrane protein 232" C9JQI7 5 110289233-110738956 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.8;pituitary gland: 19.8;testis: 23.7" "Cell line enhanced" "Detected in some" "U-266/70: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049386 Uncertain "HPA049386: " "unprognostic (1.12e-2)" "unprognostic (1.43e-1)" "unprognostic (7.27e-2)" "unprognostic (1.47e-2)" "unprognostic (1.20e-1)" "unprognostic (4.40e-1)" "unprognostic (8.49e-2)" "unprognostic (9.88e-2)" "unprognostic (1.91e-1)" "unprognostic (1.22e-1)" "unprognostic (6.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.32e-5)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (3.14e-4)" "unprognostic (8.96e-2)" 1.2 2.3 4.6 0.7 5.9 0.5 2.0 3.0 6.8 2.1 1.0 3.7 4.9 1.2 1.7 4.8 1.2 21.8 2.8 1.4 4.7 4.5 6.1 1.4 2.9 0.9 2.9 4.8 3.4 1.3 3.6 19.8 1.1 9.2 1.6 0.9 3.1 1.3 1.6 0.7 1.0 0.9 1.0 3.1 0.8 1.7 23.7 4.4 0.5 6.1 0.0 0.8 1.3 0.9 1.1 0.0 0.8 0.1 0.3 0.6 0.1 0.9 0.4 2.7 0.9 2.4 4.0 0.5 0.0 0.0 0.5 0.5 0.4 0.4 1.2 0.8 0.1 0.9 0.5 2.0 0.6 2.5 0.4 0.4 0.0 0.0 2.0 0.7 0.5 1.1 0.3 0.6 1.0 0.4 0.7 0.8 1.6 0.3 1.4 0.8 0.3 0.0 0.5 0.3 0.5 2.8 0.0 2.6 2.7 0.3 0.0 2.3 1.0 0.3 0.0 2.6 0.3 0.2 0.1 6.6 2.2 1.0 2.1 0.7 0.4 0.0 0.1 0.8 0.0 0.0 0.5 1.1 0.0 0.1 0.0 0.0 0.4 0.6 0.0 0.3 0.0 0.0 0.0 0.1 4.6 5.9 3.0 6.8 4.7 4.5 2.9 4.8 9.2 4.4 TMEM240 "C1orf70, SCA21" ENSG00000205090 "Transmembrane protein 240" Q5SV17 1 1535174-1540453 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.3" "Cell line enhanced" "Detected in many" "HEK 293: 9.4;HHSteC: 9.0;SCLC-21H: 10.6;SH-SY5Y: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066721 Supported "HPA066721: " "unprognostic (2.24e-1)" "unprognostic (1.87e-1)" "unprognostic (5.52e-5)" "unprognostic (2.31e-1)" "unprognostic (2.47e-1)" "unprognostic (1.01e-1)" "unprognostic (1.37e-1)" "unprognostic (3.85e-2)" "unprognostic (3.48e-2)" "unprognostic (1.21e-1)" "prognostic favourable (2.52e-4)" "unprognostic (9.13e-2)" "unprognostic (7.96e-3)" "unprognostic (9.50e-4)" "unprognostic (2.64e-1)" "unprognostic (8.38e-2)" "unprognostic (1.93e-1)" 3.8 4.7 10.8 1.7 17.1 0.8 1.7 24.3 21.8 4.6 5.1 1.8 0.9 1.2 9.1 2.2 1.7 4.2 2.5 3.5 12.2 7.9 1.5 0.8 2.4 1.2 5.6 10.3 10.3 2.1 3.3 3.9 3.7 5.0 4.7 1.5 2.5 4.1 7.9 6.9 2.8 2.9 5.1 2.8 2.6 1.7 2.1 4.9 0.3 1.5 0.2 0.9 2.8 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 1.0 6.6 0.7 1.2 4.9 1.5 4.1 2.2 4.2 2.3 0.0 0.4 0.8 0.8 2.0 2.4 0.1 0.2 0.7 4.0 9.4 0.5 3.0 1.2 9.0 0.0 0.9 6.2 1.9 1.5 0.3 4.3 1.3 0.3 0.1 0.2 0.6 0.8 4.2 1.5 3.8 1.2 0.9 0.4 0.0 10.6 13.1 1.4 0.5 4.2 0.6 0.0 2.2 0.6 1.9 0.8 1.8 2.0 0.5 0.4 2.3 2.7 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 17.1 24.3 16.5 12.2 7.9 5.6 10.3 5.0 4.9 TMEM248 "C7orf42, FLJ10099, FLJ13090" ENSG00000106609 "Transmembrane protein 248" Q9NWD8 7 66921225-66958551 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016495 Uncertain Approved Vesicles 1200000 Vesicles "HPA016495: AB_1848643" "unprognostic (6.74e-2)" "unprognostic (1.73e-2)" "unprognostic (4.86e-2)" "unprognostic (4.64e-2)" "unprognostic (6.67e-3)" "unprognostic (9.36e-2)" "unprognostic (1.39e-2)" "unprognostic (4.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.54e-2)" "unprognostic (9.18e-2)" "unprognostic (2.80e-3)" "unprognostic (1.30e-1)" "unprognostic (8.96e-2)" "unprognostic (5.11e-2)" "unprognostic (8.28e-2)" "unprognostic (5.57e-2)" 32.2 33.0 23.8 30.2 30.6 11.9 44.6 28.0 28.4 38.7 32.8 23.8 39.0 32.1 40.6 32.9 26.0 36.1 40.7 28.2 24.6 30.4 30.9 46.3 31.6 38.3 20.9 21.3 40.8 58.4 47.2 28.9 35.6 21.0 34.7 32.4 39.4 36.9 36.8 19.1 23.7 44.8 34.7 23.8 32.6 33.7 33.3 20.6 40.1 37.7 24.0 35.9 33.2 40.7 10.7 10.1 8.6 5.2 9.0 9.3 2.3 18.1 21.4 18.1 25.8 41.3 31.8 15.9 22.4 38.6 21.4 23.2 15.5 23.9 18.5 27.4 30.1 16.5 15.5 18.5 26.7 16.9 11.4 13.5 15.3 17.8 26.8 22.4 18.8 28.6 21.6 17.9 15.0 27.8 25.8 12.5 33.9 11.0 21.0 27.7 26.9 14.7 15.4 21.1 31.2 28.9 14.0 12.6 27.1 19.7 36.4 19.8 18.2 20.7 25.6 30.1 14.8 19.6 24.5 15.3 17.2 20.8 25.2 25.0 28.5 2.3 5.0 8.6 7.9 5.2 9.3 9.6 8.5 8.1 3.9 10.7 8.4 8.8 7.4 9.0 3.1 10.1 5.6 2.3 23.8 30.6 28.0 28.4 24.6 30.4 20.9 21.3 21.0 20.6 TMEM25 FLJ14399 ENSG00000149582 "Transmembrane protein 25" Q86YD3 11 118531041-118547280 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 19.4;T-47d: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012163, HPA051562" Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" 4900000 "Golgi apparatus, Vesicles" "HPA012163: AB_1858112, HPA051562: " "unprognostic (1.53e-2)" "unprognostic (7.18e-2)" "unprognostic (2.43e-1)" "unprognostic (6.69e-2)" "unprognostic (3.61e-1)" "unprognostic (6.50e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (1.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.66e-2)" "unprognostic (8.19e-2)" "prognostic favourable (0.00e+0)" "unprognostic (1.15e-1)" "unprognostic (2.51e-1)" "unprognostic (1.26e-1)" "unprognostic (7.01e-2)" 4.8 15.0 15.0 3.7 23.3 1.7 12.0 28.0 36.5 9.4 19.4 9.5 6.7 35.5 10.1 21.2 9.0 9.2 7.1 6.4 11.9 17.0 14.7 10.6 8.0 3.5 10.7 19.5 19.4 14.1 17.3 15.9 4.9 14.0 12.5 3.2 14.4 16.1 15.5 12.7 6.2 26.2 8.7 9.7 4.0 6.7 3.9 5.1 1.5 12.7 4.3 4.6 8.3 6.1 3.8 3.4 0.5 0.2 6.6 11.1 3.8 1.8 0.4 3.3 5.4 3.5 0.5 3.2 3.0 5.6 2.8 5.7 15.1 10.6 0.2 11.6 2.9 8.4 0.0 10.2 2.5 6.5 6.2 0.3 2.9 3.4 9.2 0.1 0.3 4.3 6.3 3.0 0.5 4.0 1.4 6.7 2.8 2.2 3.2 0.2 2.8 7.3 4.4 2.3 6.6 14.4 0.2 10.0 6.7 2.9 19.4 0.0 25.2 0.3 1.4 1.2 6.3 0.2 0.9 6.7 4.4 1.7 0.2 0.1 0.1 0.5 0.2 0.2 5.6 0.2 7.5 3.8 7.9 3.1 0.5 3.0 11.1 5.8 0.4 6.6 0.2 3.4 6.1 3.8 15.0 23.3 28.0 36.5 11.9 17.0 10.7 19.5 14.0 5.1 TMEM254 "bA369J21.6, C10orf57, FLJ13263" ENSG00000133678 "Transmembrane protein 254" Q8TBM7 10 80078646-80092557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029105, HPA072613" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA029105: , HPA072613: " "unprognostic (9.40e-2)" "unprognostic (1.76e-1)" "unprognostic (9.52e-2)" "unprognostic (5.74e-3)" "unprognostic (5.39e-2)" "unprognostic (6.04e-2)" "unprognostic (3.66e-1)" "unprognostic (3.90e-1)" "unprognostic (1.64e-2)" "unprognostic (1.87e-3)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (7.65e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (3.45e-3)" "unprognostic (5.96e-2)" 8.4 13.4 10.8 6.0 14.1 4.7 15.9 6.9 13.5 14.1 13.1 11.7 14.7 10.1 12.4 40.1 35.8 17.3 10.5 4.8 9.4 6.3 10.0 30.8 6.8 9.0 7.7 9.0 8.7 12.1 8.3 10.1 14.8 9.5 25.8 13.7 10.7 16.3 9.1 3.0 43.9 13.4 6.6 8.2 6.9 9.0 21.5 8.8 8.6 11.8 12.4 15.4 13.0 20.5 12.6 14.7 27.7 18.1 9.8 22.9 11.9 7.1 6.9 11.6 8.9 14.3 18.0 17.7 7.0 5.1 5.1 5.2 5.2 22.3 5.5 11.9 8.9 7.6 4.7 5.7 5.4 9.0 8.3 1.4 2.2 7.2 6.5 6.8 7.3 11.6 26.4 4.5 3.9 4.5 4.0 12.0 5.1 14.6 5.5 5.0 6.3 22.6 6.8 1.4 4.7 7.0 6.0 4.1 6.7 6.5 16.1 6.9 22.9 4.5 6.5 4.0 6.9 6.8 3.9 8.3 11.7 0.4 10.1 6.9 3.3 27.7 16.2 7.4 11.9 18.1 14.9 12.6 13.8 12.3 13.2 9.6 22.9 15.6 1.7 9.8 17.6 14.7 16.0 11.9 10.8 14.1 6.9 13.5 9.4 6.3 7.7 9.0 9.5 8.8 TMEM255A "FAM70A, FLJ20716" ENSG00000125355 "Transmembrane protein 255A" Q5JRV8 X 120258650-120311556 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.4;ovary: 29.6" "Cell line enhanced" "Detected in some" "Karpas-707: 16.9;RPMI-8226: 10.8;SK-MEL-30: 17.7;U-2 OS: 7.6;U-87 MG: 19.3" "Group enriched" "Detected in many" 10 "glioma: 21.3;melanoma: 8.0;renal cancer: 7.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 10 "T-cells: 5.9" "Low region specificity" "Detected in all" HPA048470 Approved Uncertain "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA048470: AB_2680406" "unprognostic (3.41e-2)" "unprognostic (8.96e-2)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" "unprognostic (8.55e-4)" "unprognostic (7.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (2.02e-1)" "unprognostic (1.32e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.17e-2)" "unprognostic (2.55e-4)" 3.9 5.5 6.8 3.4 14.4 1.5 5.4 6.8 7.8 11.2 3.5 12.4 1.7 1.9 3.2 2.9 4.4 6.3 2.1 2.4 5.3 25.4 2.4 1.5 4.8 5.0 30.4 4.4 29.6 1.1 0.6 6.6 0.8 18.4 3.8 3.9 7.1 1.3 3.3 2.4 4.0 2.8 2.0 13.0 2.8 2.1 0.9 7.8 6.4 0.9 1.8 5.7 1.6 8.0 0.5 0.3 0.0 0.6 0.0 5.9 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 1.1 0.4 0.5 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 16.9 0.3 0.0 0.0 0.0 5.9 0.0 0.0 0.0 10.8 0.0 0.0 3.4 0.1 0.3 0.0 17.7 0.0 0.2 0.0 0.0 7.6 0.0 2.8 0.0 3.2 2.4 19.3 0.0 0.0 0.0 0.6 0.0 5.9 0.2 3.3 0.5 0.4 2.2 0.3 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.9 6.8 14.4 6.8 3.9 5.3 25.4 30.4 4.4 18.4 7.8 TMEM260 "C14orf101, FLJ20392" ENSG00000070269 "Transmembrane protein 260" Q9NX78 14 56488354-56650606 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 61.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003502 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA003502: AB_1078314" "unprognostic (4.63e-2)" "unprognostic (2.41e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (2.51e-1)" "unprognostic (3.58e-2)" "unprognostic (2.04e-1)" "prognostic favourable (7.11e-4)" "unprognostic (7.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-3)" "unprognostic (3.22e-1)" "unprognostic (2.23e-3)" "unprognostic (5.81e-2)" "unprognostic (8.11e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-2)" 7.8 7.4 7.3 11.0 10.6 3.8 9.1 13.3 9.9 61.0 8.8 13.7 11.6 8.1 11.8 12.1 6.7 11.4 10.3 6.0 8.9 8.6 10.7 8.7 8.4 8.8 10.8 7.5 14.8 13.6 12.4 17.2 8.7 9.7 8.7 9.1 8.7 7.4 13.0 5.2 8.6 10.7 8.9 12.2 9.2 8.4 10.1 8.3 17.6 12.6 4.6 8.8 10.1 9.7 2.0 4.6 2.9 2.8 6.3 3.5 2.0 7.3 5.2 4.0 8.5 14.3 11.8 7.9 7.9 8.8 5.2 6.2 2.4 5.5 6.0 7.8 5.9 8.6 9.3 5.7 8.2 7.4 4.7 3.9 2.4 3.2 10.1 5.4 9.3 14.5 10.4 2.9 10.1 6.8 4.7 6.5 6.8 4.9 2.8 2.0 3.7 8.3 4.0 6.4 2.0 8.8 11.0 8.5 4.2 8.9 6.4 5.2 8.2 8.4 9.5 10.6 4.0 7.9 3.9 3.9 3.1 3.5 6.6 4.0 5.2 0.0 2.8 2.9 3.5 1.9 2.4 1.8 2.4 1.8 2.2 2.0 3.2 2.3 1.4 6.3 1.7 4.6 2.9 2.0 7.3 10.6 13.3 9.9 8.9 8.6 10.8 7.5 9.7 8.3 TMEM30A "C6orf67, CDC50A, FLJ10856" ENSG00000112697 "Transmembrane protein 30A" Q9NV96 6 75252924-75284968 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014561 Approved Supported Mitochondria Mitochondria "HPA014561: AB_10601823" "unprognostic (2.00e-1)" "unprognostic (2.00e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-2)" "unprognostic (3.48e-1)" "unprognostic (1.02e-2)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (4.80e-2)" "unprognostic (1.88e-1)" "unprognostic (5.06e-2)" "unprognostic (7.12e-2)" "unprognostic (8.96e-2)" "unprognostic (1.00e-1)" 29.9 29.6 42.7 28.3 63.3 23.8 27.2 40.3 55.1 33.4 31.3 36.8 22.3 21.2 31.9 25.7 30.1 24.6 30.6 22.9 45.6 48.2 39.6 48.1 45.0 23.9 43.8 41.0 25.2 41.0 57.0 45.5 29.4 50.5 33.6 36.8 20.5 31.9 31.7 18.6 19.4 22.5 39.8 45.3 28.9 28.0 14.1 40.3 21.1 43.1 17.0 29.3 32.8 22.8 9.1 24.3 42.7 26.8 13.1 16.3 16.7 10.4 10.1 18.7 15.6 47.1 44.3 15.4 42.6 33.5 16.6 25.4 10.8 24.4 12.2 29.5 37.4 12.3 8.3 23.7 44.4 15.6 12.3 11.7 11.0 11.1 26.9 14.1 20.6 41.0 23.5 23.0 12.9 52.7 11.4 21.6 32.3 6.9 4.9 10.2 6.6 8.7 8.2 13.2 15.3 64.3 25.7 13.1 12.8 21.6 10.7 14.3 11.8 44.1 45.7 21.0 23.5 13.1 30.0 17.8 24.2 5.2 16.6 27.2 32.9 12.3 26.8 17.7 12.7 26.6 15.3 9.1 13.0 12.2 24.3 7.5 12.5 12.6 42.7 13.1 25.6 10.6 16.3 16.7 42.7 63.3 40.3 52.7 45.6 48.2 43.8 41.0 50.5 40.3 TMEM38B "bA219P18.1, C9orf87, D4Ertd89e, FLJ10493, TRIC-B" ENSG00000095209 "Transmembrane protein 38B" Q9NVV0 9 105694544-105776612 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018465 Uncertain "HPA018465: AB_1858116" "unprognostic (3.34e-1)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (2.46e-2)" "unprognostic (2.68e-1)" "unprognostic (7.20e-2)" "unprognostic (1.51e-2)" "unprognostic (3.11e-3)" "unprognostic (1.88e-2)" "unprognostic (3.54e-2)" "unprognostic (5.82e-3)" "unprognostic (5.80e-2)" "prognostic favourable (7.96e-4)" "unprognostic (1.09e-1)" "unprognostic (2.09e-1)" "unprognostic (3.89e-3)" "unprognostic (9.98e-2)" 8.8 10.0 6.0 4.0 7.4 10.4 17.4 4.1 5.7 6.8 7.4 10.4 2.8 4.0 5.5 11.0 4.8 4.5 4.2 28.3 6.6 6.1 18.6 11.7 5.7 8.1 12.5 3.4 11.7 4.1 5.3 16.6 2.9 7.9 5.1 7.3 9.2 4.2 4.4 43.9 4.0 6.4 5.2 10.4 3.6 4.3 21.1 9.0 3.3 17.9 15.6 3.0 7.5 8.2 26.3 24.2 24.5 13.3 12.0 20.2 11.3 5.8 9.2 7.1 11.3 41.5 9.2 15.2 8.7 5.5 8.3 8.6 14.2 8.1 13.6 4.3 3.0 4.3 10.2 4.8 9.1 10.2 13.9 5.6 6.4 8.7 5.8 16.8 12.0 8.6 4.3 5.7 8.1 3.3 29.2 12.2 5.1 16.2 11.6 5.1 5.5 10.0 7.8 22.5 6.5 3.8 4.9 12.5 3.0 8.7 14.3 6.2 17.9 11.9 1.7 7.6 7.6 28.8 8.7 14.9 37.0 6.7 14.1 18.5 15.0 5.8 9.7 24.5 6.7 13.3 8.7 26.3 9.2 7.9 10.8 24.7 20.2 12.5 1.4 12.0 11.5 24.2 7.8 11.3 6.0 7.4 4.1 5.7 6.6 6.1 12.5 3.4 7.9 9.0 TMEM39A FLJ10902 ENSG00000176142 "Transmembrane protein 39A" Q9NV64 3 119429500-119468830 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039140 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA039140: AB_10673303" "unprognostic (2.16e-1)" "unprognostic (8.75e-2)" "unprognostic (4.25e-2)" "unprognostic (6.86e-2)" "unprognostic (1.56e-2)" "unprognostic (2.81e-1)" "prognostic unfavourable (3.26e-4)" "unprognostic (9.68e-2)" "unprognostic (6.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (1.66e-2)" "prognostic unfavourable (1.00e-5)" "unprognostic (4.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.88e-1)" "unprognostic (6.41e-2)" 13.7 12.7 5.6 13.0 8.8 9.3 13.2 10.5 6.4 18.3 8.7 10.4 27.0 9.6 20.8 18.3 10.9 13.5 13.4 14.4 5.1 3.8 9.7 16.7 15.2 11.0 8.9 2.4 17.6 37.5 8.3 47.9 19.5 7.6 13.9 9.5 12.1 30.2 30.0 8.7 10.7 10.6 9.6 8.4 11.8 11.5 15.4 8.0 11.3 17.4 9.5 19.2 11.9 13.0 8.6 18.1 11.5 11.2 11.9 13.8 9.2 15.7 7.9 14.1 10.0 28.2 26.4 14.9 15.6 26.8 16.9 23.6 13.9 12.1 6.6 14.8 14.4 16.4 14.6 6.2 18.7 6.5 5.6 8.1 6.0 14.1 19.0 15.0 12.2 16.0 10.3 12.3 30.0 11.2 8.0 19.1 9.4 7.3 7.9 5.5 13.6 15.8 8.6 7.4 14.2 4.9 6.1 6.1 8.6 14.7 8.5 21.1 8.1 14.1 9.6 10.5 10.0 7.3 9.8 22.0 6.2 15.7 15.7 10.9 14.9 11.5 11.2 8.0 13.5 6.2 13.8 8.5 8.4 11.3 13.2 8.6 7.0 7.1 4.7 11.9 4.8 18.1 9.8 9.2 5.6 8.8 10.5 6.4 5.1 3.8 8.9 2.4 7.6 8.0 TMEM51 "C1orf72, FLJ10199" ENSG00000171729 "Transmembrane protein 51" Q9NW97 1 15152532-15220480 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "classical monocyte: 1.8;intermediate monocyte: 2.3;myeloid DC: 1.7;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 23 "dendritic cells: 1.7;monocytes: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014547, HPA019441" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA014547: AB_1858121, HPA019441: AB_2670142" "unprognostic (1.21e-1)" "unprognostic (1.84e-1)" "unprognostic (8.74e-2)" "unprognostic (1.89e-2)" "unprognostic (3.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.47e-2)" "unprognostic (7.81e-3)" "unprognostic (7.84e-2)" "unprognostic (1.39e-1)" "unprognostic (3.00e-2)" "unprognostic (8.91e-2)" "prognostic favourable (8.16e-8)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (5.58e-2)" "unprognostic (1.67e-3)" 4.6 14.1 4.7 7.7 4.4 0.4 7.0 14.2 5.1 9.7 22.4 4.5 14.3 15.9 5.3 7.6 12.0 7.2 25.3 3.7 5.0 2.2 23.5 3.9 10.4 7.4 4.1 3.4 15.4 36.7 14.5 5.2 7.5 4.2 12.3 7.8 16.1 7.5 15.5 1.2 5.3 22.9 8.9 5.7 7.1 18.9 3.4 3.9 2.0 3.8 12.3 8.4 18.5 22.2 0.0 1.7 0.0 2.8 0.0 0.0 0.3 18.9 10.1 5.8 1.4 1.0 2.2 0.0 2.2 9.2 6.8 9.2 13.3 21.4 0.0 7.2 1.4 18.4 2.0 7.1 3.9 0.0 5.1 0.4 0.5 13.2 8.5 0.0 18.6 0.7 6.4 8.8 9.7 6.2 2.9 0.0 3.4 6.5 0.0 0.0 1.0 3.9 2.6 3.7 3.3 17.2 19.7 0.9 17.3 1.8 7.5 18.2 1.0 2.0 4.3 7.1 6.2 3.1 6.8 0.2 0.2 0.0 7.0 0.2 8.2 0.0 1.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 4.7 4.4 14.2 5.1 5.0 2.2 4.1 3.4 4.2 3.9 TMEM53 "FLJ22353, NET4" ENSG00000126106 "Transmembrane protein 53" Q6P2H8 1 44635238-44674555 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.7;liver: 44.7" "Cell line enhanced" "Detected in all" "CAPAN-2: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 38.7" "Lineage enriched" "Detected in all" 4 "dendritic cells: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021134 Approved Approved "Golgi apparatus,Focal adhesion sites" "Golgi apparatus" "Focal adhesion sites" "HPA021134: AB_2205162" "unprognostic (5.28e-2)" "unprognostic (2.60e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-2)" "unprognostic (3.93e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "unprognostic (2.88e-2)" "unprognostic (2.19e-2)" "prognostic favourable (6.96e-4)" "unprognostic (3.00e-1)" "unprognostic (1.34e-1)" "prognostic favourable (1.02e-5)" "unprognostic (1.15e-3)" "unprognostic (1.84e-2)" "unprognostic (4.07e-2)" "unprognostic (2.29e-2)" 8.3 9.0 6.0 4.4 8.7 6.0 7.0 2.4 11.8 4.9 11.0 8.8 4.6 16.6 5.7 7.2 4.5 5.3 7.6 9.3 6.2 6.1 14.8 44.7 7.3 6.4 6.8 6.2 7.7 5.4 3.3 6.4 4.3 8.0 5.2 7.2 13.9 6.0 3.8 4.2 3.9 16.4 4.5 6.1 4.8 7.7 18.8 4.4 3.6 8.2 3.1 4.0 7.3 3.7 5.3 38.7 3.6 8.6 2.8 3.1 2.8 7.6 8.8 8.0 5.8 10.4 7.9 9.6 2.2 6.7 4.4 6.6 2.8 24.1 2.4 7.3 2.1 6.9 2.2 4.7 2.3 3.8 5.6 2.8 3.6 13.4 10.4 2.2 10.2 9.3 7.3 8.8 1.9 2.4 1.2 3.1 2.6 4.5 2.5 6.5 4.6 5.2 4.0 1.1 23.5 13.1 8.0 5.6 5.4 2.4 9.6 12.4 2.9 5.8 1.0 3.2 5.5 4.6 2.8 2.2 2.6 1.3 8.4 5.7 3.7 3.6 5.2 2.3 3.0 8.6 2.6 5.3 3.1 2.5 2.6 5.0 1.5 2.0 0.5 2.8 6.0 38.7 3.0 2.8 6.0 8.7 2.4 11.8 6.2 6.1 6.8 6.2 8.0 4.4 TMEM59L "BSMAP, C19orf4" ENSG00000105696 "Transmembrane protein 59 like" Q9UK28 19 18607430-18621039 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 148.3" "Cell line enhanced" "Detected in some" "AN3-CA: 20.3;ASC diff: 24.7;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;SH-SY5Y: 12.0" "Cancer enriched" "Detected in many" 8 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010661, HPA070701" Approved Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA010661: AB_1078338, HPA070701: " "unprognostic (3.24e-2)" "unprognostic (5.53e-2)" "unprognostic (1.24e-4)" "prognostic unfavourable (1.62e-4)" "unprognostic (1.70e-1)" "unprognostic (5.40e-3)" "unprognostic (3.53e-2)" "unprognostic (6.91e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-3)" "prognostic favourable (8.80e-4)" "unprognostic (4.65e-2)" "unprognostic (9.17e-7)" "unprognostic (1.47e-3)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-5)" 2.6 12.8 36.9 2.5 39.4 1.7 1.9 41.9 148.3 2.2 2.9 7.5 0.0 2.0 2.5 2.0 2.5 2.1 2.9 3.5 39.9 49.6 1.9 1.8 1.9 1.8 17.7 32.8 1.8 2.8 4.9 13.2 2.3 24.1 2.2 2.2 1.9 2.3 2.6 2.5 1.8 3.0 3.1 7.3 1.7 2.0 2.4 5.2 0.0 1.8 0.0 1.7 2.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.4 0.0 0.6 0.2 20.3 24.7 1.2 0.0 2.1 0.4 0.8 0.4 0.0 1.0 0.1 14.6 1.3 0.3 6.0 0.0 0.7 0.1 0.9 0.0 0.3 14.8 3.8 0.0 0.3 9.1 0.0 0.2 0.7 0.0 0.0 0.1 0.5 0.8 0.1 0.0 1.8 0.6 0.1 0.0 0.2 0.0 0.0 0.3 12.0 1.4 0.0 0.0 0.2 0.0 0.2 0.4 4.9 0.1 1.3 3.0 1.1 0.1 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.4 36.9 39.4 41.9 70.3 39.9 49.6 17.7 32.8 24.1 5.2 TMEM61 ENSG00000143001 "Transmembrane protein 61" Q8N0U2 1 54980792-54992293 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 22.1;pituitary gland: 29.1;salivary gland: 34.1" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 22.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 5.2;pons and medulla: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030614 Uncertain "HPA030614: AB_10603216" "unprognostic (7.62e-2)" "unprognostic (1.67e-3)" "prognostic favourable (1.07e-4)" "unprognostic (1.00e-1)" "unprognostic (6.63e-4)" "unprognostic (6.15e-2)" "unprognostic (2.67e-3)" "unprognostic (1.49e-1)" "unprognostic (3.05e-1)" "unprognostic (4.46e-2)" "unprognostic (1.91e-2)" "unprognostic (7.24e-2)" "prognostic favourable (1.78e-7)" "unprognostic (8.47e-2)" "unprognostic (2.20e-2)" "unprognostic (4.01e-2)" "unprognostic (4.62e-3)" 0.2 3.9 0.4 0.7 1.0 0.0 2.7 5.2 0.5 0.9 3.7 0.2 4.9 2.4 0.2 3.8 2.9 2.0 1.7 0.0 0.5 0.6 22.1 0.0 2.4 0.0 1.1 0.7 1.1 4.2 7.8 29.1 0.5 5.2 2.4 2.3 0.5 34.1 6.7 0.4 1.8 3.5 5.3 0.8 0.4 2.2 0.2 0.1 0.1 0.6 0.8 1.8 4.7 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 22.1 2.3 0.0 1.1 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 5.2 0.5 0.5 0.6 1.1 0.7 5.2 0.1 TMEM63A KIAA0792 ENSG00000196187 "Transmembrane protein 63A" O94886 1 225845536-225882369 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.4" "Cell line enhanced" "Detected in many" "RPMI-8226: 37.7;SK-BR-3: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066504, HPA066936, HPA068918" Enhanced "Vesicles,Centriolar satellite" 96000 "Vesicles, Centriolar satellite" "HPA066504: , HPA066936: , HPA068918: " "unprognostic (5.31e-2)" "unprognostic (3.46e-2)" "unprognostic (2.14e-2)" "prognostic favourable (8.79e-4)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-2)" "unprognostic (2.57e-1)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.92e-2)" 10.5 7.4 14.7 11.6 38.8 18.6 12.2 4.1 23.2 14.3 14.0 91.4 17.3 12.2 12.2 11.2 6.6 13.9 12.9 8.5 30.2 15.1 14.3 15.1 12.6 15.4 59.3 16.4 13.1 22.4 11.6 5.3 11.3 34.9 22.3 17.8 5.7 55.8 19.1 6.9 9.9 13.3 8.8 71.0 14.0 22.9 3.0 49.6 11.2 8.0 4.5 12.4 13.3 9.6 5.4 10.0 5.5 4.1 8.7 16.6 5.7 9.3 2.8 2.4 7.1 19.6 6.8 16.9 7.1 7.7 8.0 8.1 10.2 6.9 2.6 13.2 8.7 14.4 2.6 4.3 3.7 8.7 4.7 11.3 6.5 6.1 4.5 4.2 29.9 7.1 2.7 4.7 2.9 5.1 9.4 2.2 6.3 5.9 3.7 4.3 13.3 4.6 3.7 7.5 37.7 12.2 24.7 0.2 1.3 5.2 42.0 5.1 9.7 4.0 6.1 4.6 3.2 4.2 6.4 0.9 3.4 0.6 4.2 2.4 8.4 5.5 3.2 3.0 9.4 2.7 10.6 5.2 12.1 8.9 2.5 5.4 10.9 6.3 5.1 8.7 4.1 10.0 16.6 5.7 14.7 38.8 4.1 23.0 30.2 15.1 59.3 16.4 34.9 49.6 TMEM64 DKFZp762C1112 ENSG00000180694 "Transmembrane protein 64" Q6YI46 8 90621995-90791632 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "epididymis: 84.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034221 Enhanced "CAB034221: AB_1567653" "unprognostic (3.61e-1)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" "unprognostic (1.14e-1)" "unprognostic (2.27e-1)" "unprognostic (2.55e-3)" "unprognostic (4.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (3.30e-1)" "unprognostic (2.35e-1)" "unprognostic (2.59e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.17e-2)" "unprognostic (1.97e-1)" 9.2 12.6 4.3 5.2 5.3 2.1 6.1 2.7 6.1 10.6 10.8 16.2 14.5 5.7 11.9 84.0 7.3 5.7 6.3 5.8 6.2 5.5 11.6 11.7 7.2 6.7 11.2 3.3 10.1 11.3 4.1 5.9 6.1 10.0 10.7 3.7 15.1 12.4 11.0 8.2 6.8 11.3 9.6 12.1 7.2 5.4 9.7 7.5 2.3 20.0 5.2 7.2 11.9 10.9 5.7 0.6 3.2 0.8 5.9 3.7 1.6 12.6 9.9 5.0 2.6 23.3 17.0 2.7 9.4 9.0 7.4 8.2 2.7 8.7 8.2 3.8 5.7 4.4 13.2 6.3 9.8 16.6 4.8 15.4 3.9 6.2 8.2 0.9 2.6 22.1 7.0 3.0 6.9 7.4 6.9 18.3 12.4 16.9 0.0 2.2 0.7 5.2 1.8 11.0 4.2 14.6 24.6 3.5 10.0 6.1 5.4 11.3 5.4 0.7 7.3 7.5 6.6 5.4 7.6 12.1 0.2 9.0 6.8 1.9 9.8 3.2 0.2 0.3 3.0 0.6 3.7 5.7 3.2 3.4 0.6 2.9 1.5 2.1 0.1 5.9 0.8 0.4 1.4 1.6 4.3 5.3 2.7 6.1 6.2 5.5 11.2 3.3 10.0 7.5 TMEM68 FLJ32370 ENSG00000167904 "Transmembrane protein 68" Q96MH6 8 55696424-55773407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018216, HPA019173" Uncertain Approved Vesicles Vesicles "HPA018216: AB_2205185, HPA019173: AB_1858129" "unprognostic (4.43e-2)" "unprognostic (3.10e-2)" "unprognostic (8.04e-2)" "unprognostic (2.40e-1)" "unprognostic (4.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.46e-3)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (3.37e-2)" "unprognostic (3.28e-2)" "unprognostic (1.03e-1)" "unprognostic (3.92e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.41e-2)" "unprognostic (1.63e-1)" 10.4 18.3 14.0 8.4 18.0 10.6 14.6 18.9 20.5 13.0 15.1 16.3 16.0 14.6 15.4 17.9 16.1 25.4 12.5 7.4 13.8 13.2 20.6 14.6 11.3 10.5 12.7 10.2 15.7 13.5 15.9 18.5 15.6 13.2 15.8 16.6 13.1 14.0 12.2 7.8 17.6 18.3 14.4 13.3 12.9 12.0 9.8 11.7 22.7 18.8 13.4 12.3 17.1 13.0 9.2 7.2 21.7 7.7 8.2 10.5 3.9 12.6 7.6 13.0 7.9 11.0 12.7 22.8 11.3 8.7 10.9 10.6 10.8 24.0 13.9 13.4 7.5 16.1 10.1 15.1 12.2 19.1 11.4 16.9 6.9 11.3 12.2 7.1 9.4 8.6 23.2 11.0 26.1 9.9 16.1 14.1 15.9 6.6 17.8 9.8 14.1 4.0 13.1 5.4 8.9 18.1 9.9 10.9 9.6 7.6 12.3 22.2 18.2 9.3 7.7 8.3 10.5 14.3 9.2 12.2 15.2 17.6 11.4 11.9 12.9 21.7 7.1 5.0 7.2 4.4 10.5 9.2 8.6 7.6 7.2 9.2 7.2 10.1 7.9 8.2 7.7 6.4 6.3 3.9 14.0 18.0 18.9 20.5 13.8 13.2 12.7 10.2 13.2 11.7 TMEM71 FLJ33069 ENSG00000165071 "Transmembrane protein 71" Q6P5X7 8 132685007-132760712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 65.7;lymphoid tissue: 31.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.0;HDLM-2: 32.3;Karpas-707: 6.9;U-937: 19.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 65.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 65.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA058401, HPA070655" Uncertain Enhanced Mitochondria Mitochondria "HPA058401: , HPA070655: " "unprognostic (1.39e-3)" "unprognostic (7.27e-2)" "unprognostic (8.82e-2)" "unprognostic (3.10e-3)" "unprognostic (7.94e-2)" "unprognostic (3.91e-3)" "unprognostic (4.18e-2)" "unprognostic (5.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (8.83e-2)" "unprognostic (1.90e-2)" "unprognostic (6.29e-3)" "unprognostic (4.39e-2)" "unprognostic (2.73e-1)" 4.2 1.1 1.4 8.2 1.5 20.8 5.4 0.7 1.2 2.5 9.9 0.8 0.4 1.2 1.0 2.0 4.8 1.9 4.1 25.5 1.8 1.2 1.9 2.3 8.3 20.9 2.2 0.8 1.9 2.9 0.0 1.4 1.0 1.7 2.2 2.2 5.8 5.8 1.3 1.3 1.3 7.2 2.2 4.2 18.2 2.9 0.9 1.4 31.3 2.2 2.5 10.6 7.0 2.8 1.4 8.2 65.7 13.5 2.9 14.8 8.4 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.7 8.0 0.3 0.5 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.2 0.9 32.3 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 1.2 0.6 0.0 6.9 1.4 0.0 1.6 1.2 0.7 0.2 0.1 1.1 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.3 0.5 0.7 3.3 0.0 1.6 0.0 5.7 19.1 2.4 12.5 13.5 23.9 8.0 3.9 14.8 1.4 5.9 5.6 8.2 1.3 9.0 6.5 65.7 2.9 3.2 0.2 0.7 8.4 1.4 1.5 0.7 1.2 1.8 1.2 2.2 0.8 1.7 1.4 TMEM74B "C20orf46, FLJ11190" ENSG00000125895 "Transmembrane protein 74B" Q9NUR3 20 1180561-1185415 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9;intestine: 16.0" "Cell line enhanced" "Detected in some" "CACO-2: 7.7;Hep G2: 9.7;K-562: 16.4;Karpas-707: 7.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045213 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA045213: AB_10961999" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.05e-3)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (6.91e-3)" "unprognostic (1.97e-1)" "unprognostic (1.77e-4)" "unprognostic (9.58e-2)" "prognostic favourable (3.07e-5)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.55e-7)" "unprognostic (1.20e-1)" "unprognostic (9.77e-2)" "unprognostic (8.37e-2)" "unprognostic (5.07e-3)" 2.3 0.3 4.3 0.3 13.9 0.0 1.1 2.3 7.3 0.1 0.7 12.5 0.6 0.3 0.7 3.9 2.5 3.9 2.3 6.9 0.6 1.0 9.4 0.9 2.3 0.0 0.6 0.2 3.5 12.2 0.5 0.9 3.3 11.3 2.9 4.6 16.0 1.1 1.1 0.6 2.7 0.9 1.6 0.4 0.7 0.0 1.6 0.1 0.0 0.1 0.0 0.5 0.3 0.0 4.8 2.7 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 7.7 0.7 0.1 0.9 0.0 0.3 3.6 0.5 0.1 0.0 4.6 1.1 0.0 9.7 0.0 0.0 1.3 0.0 1.0 0.0 0.2 0.1 16.4 7.4 0.0 0.1 0.1 0.1 3.3 0.4 0.0 0.2 0.0 0.8 0.7 0.7 2.1 0.1 0.0 0.1 0.0 0.1 2.0 0.0 3.2 0.1 0.1 3.2 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 TMEM78 FLJ40168 ENSG00000177800 "Transmembrane protein 78" Q5T7P6 1 229249636-229251810 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.3;bone marrow: 2.5" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 5.3" "Low lineage specificity" "Detected in many" HPA042351 Uncertain "HPA042351: AB_10961259" "unprognostic (2.45e-2)" "unprognostic (3.07e-1)" "unprognostic (1.23e-1)" "unprognostic (1.51e-1)" "unprognostic (3.33e-1)" "unprognostic (9.45e-2)" "unprognostic (5.59e-2)" "unprognostic (1.29e-1)" 0.1 0.4 0.5 0.2 0.5 2.5 0.4 0.7 0.7 0.1 0.1 0.1 0.5 0.6 0.1 0.3 0.2 0.1 0.4 0.3 0.1 0.6 0.0 0.7 0.3 0.2 0.7 0.5 0.2 0.0 0.4 0.3 0.7 0.0 1.8 1.2 0.2 0.0 0.3 0.6 0.1 0.7 0.3 0.2 0.1 0.1 1.3 2.6 5.3 0.5 1.3 0.9 0.1 0.4 1.3 0.7 2.1 0.2 0.0 0.6 0.4 0.0 0.1 0.1 0.2 1.9 0.4 0.5 0.4 1.0 0.0 0.0 0.3 0.6 0.6 0.7 1.8 0.3 0.0 0.5 0.5 0.2 0.0 0.1 0.0 0.1 0.3 0.7 0.0 0.3 0.6 1.5 0.6 0.6 0.4 0.4 0.2 0.2 1.0 0.4 0.5 0.5 0.2 0.0 0.5 0.1 0.0 0.6 0.5 0.5 0.3 0.9 0.6 0.8 0.5 0.6 0.8 5.3 0.5 0.7 0.7 0.3 0.5 0.8 0.6 0.5 0.1 1.3 0.9 0.8 2.6 1.3 0.5 2.6 0.4 0.1 TMEM81 "HC3107, KVLA2788, MGC75217, UNQ2788" ENSG00000174529 "Transmembrane protein 81" Q6P7N7 1 205083129-205084460 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052515 Approved "Intermediate filaments" "Intermediate filaments" "HPA052515: " "unprognostic (9.19e-3)" "unprognostic (3.53e-1)" "unprognostic (1.91e-3)" "unprognostic (6.48e-2)" "unprognostic (2.44e-1)" "unprognostic (2.08e-1)" "prognostic unfavourable (3.25e-6)" "unprognostic (3.66e-2)" "unprognostic (2.68e-2)" "unprognostic (6.18e-2)" "unprognostic (5.86e-2)" "unprognostic (2.48e-2)" "prognostic unfavourable (6.65e-9)" "unprognostic (8.91e-2)" "unprognostic (6.24e-2)" "unprognostic (2.42e-1)" "prognostic favourable (2.67e-4)" 1.5 2.7 2.8 1.6 3.8 2.0 2.1 11.2 5.3 2.1 1.3 1.2 1.5 3.5 1.4 1.2 1.1 2.2 3.3 2.7 4.2 3.3 1.5 2.3 2.8 2.3 1.0 3.4 2.2 2.0 1.8 1.7 1.4 2.1 4.6 4.1 1.2 1.7 2.4 3.0 1.0 6.1 1.4 2.7 0.9 1.6 1.5 1.5 4.3 1.4 0.2 4.6 0.9 2.4 3.7 6.2 8.2 9.1 3.6 3.2 4.5 2.7 2.3 1.4 6.6 1.7 4.5 3.2 2.5 2.1 10.0 3.8 4.1 3.9 3.9 3.7 5.2 3.3 6.3 1.9 2.1 3.7 6.9 3.6 1.8 4.6 8.4 1.9 2.9 4.7 4.4 8.2 4.8 5.4 3.0 7.2 4.7 5.4 2.3 3.9 6.1 2.8 3.4 7.2 2.5 8.1 2.1 4.4 2.3 5.6 4.9 4.3 5.3 3.6 6.3 2.9 7.4 4.3 1.2 0.2 4.6 1.4 0.2 1.5 2.3 1.1 1.5 1.4 2.5 4.0 2.5 0.2 1.4 1.5 2.7 0.9 TMEM87A DKFZP564G2022 ENSG00000103978 "Transmembrane protein 87A" Q8NBN3 15 42210452-42273663 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018104, HPA018189" Enhanced Supported "Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" "HPA018104: AB_1858135, HPA018189: AB_2205198" "unprognostic (7.07e-2)" "unprognostic (1.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.05e-2)" "unprognostic (2.49e-1)" "unprognostic (6.39e-3)" "unprognostic (1.19e-2)" "unprognostic (2.44e-1)" "unprognostic (2.95e-1)" "unprognostic (8.13e-3)" "unprognostic (4.31e-3)" "unprognostic (1.38e-1)" "unprognostic (3.41e-2)" "unprognostic (7.90e-2)" "unprognostic (2.19e-1)" "unprognostic (5.49e-3)" "unprognostic (3.63e-1)" 22.0 18.2 15.6 15.6 24.9 38.9 49.1 15.9 19.6 23.2 28.0 35.8 30.6 13.2 26.0 25.8 34.5 23.3 16.4 14.8 17.4 15.2 16.9 16.2 36.3 16.8 38.9 17.9 20.5 25.0 29.3 20.8 35.3 24.9 41.5 31.2 20.8 45.1 27.4 18.9 30.8 19.5 23.7 37.2 14.7 21.1 20.9 32.5 16.0 38.7 24.3 21.2 24.8 25.2 19.2 15.8 29.3 21.0 25.3 26.6 15.8 13.3 6.7 10.3 9.1 20.4 17.4 16.3 18.5 27.4 18.1 18.2 9.8 29.5 5.7 18.4 19.6 34.8 9.2 17.0 14.6 15.0 8.3 11.6 17.7 10.9 22.0 21.1 16.6 18.1 38.3 13.2 22.3 13.9 12.5 22.9 17.2 8.5 6.9 12.5 8.7 9.7 11.1 16.1 11.9 11.7 42.7 11.4 14.3 17.7 23.7 16.3 9.2 20.4 13.7 36.1 8.8 23.5 27.2 16.0 30.0 12.3 14.0 15.8 22.4 29.3 17.6 19.8 20.1 20.7 22.9 19.2 24.8 23.3 15.8 15.4 23.8 23.5 10.3 25.3 21.0 14.3 26.6 15.8 15.6 24.9 15.9 19.6 17.4 15.2 38.9 17.9 24.9 32.5 TMEM87B FLJ14681 ENSG00000153214 "Transmembrane protein 87B" Q96K49 2 112055223-112119318 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035183 Approved Approved "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA035183: AB_10600829" "unprognostic (3.19e-1)" "prognostic unfavourable (3.78e-4)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "unprognostic (1.39e-1)" "prognostic unfavourable (4.28e-4)" "prognostic unfavourable (4.72e-4)" "unprognostic (4.20e-3)" "unprognostic (1.85e-1)" "unprognostic (6.07e-2)" "unprognostic (2.87e-2)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.52e-7)" "unprognostic (1.32e-1)" "unprognostic (5.35e-2)" "unprognostic (1.05e-1)" "unprognostic (3.25e-3)" 10.8 14.5 5.6 19.5 7.1 5.1 17.2 6.5 8.5 11.6 20.8 6.6 36.8 22.1 14.5 14.3 14.5 10.1 17.0 7.3 5.8 6.5 10.0 13.1 14.6 25.8 6.6 5.4 9.6 15.8 11.3 22.8 20.1 7.4 23.5 21.3 7.0 18.3 43.8 3.8 12.0 37.9 10.3 8.2 22.4 17.3 5.5 5.7 11.6 12.3 11.0 17.9 13.9 12.0 8.4 3.7 4.9 8.3 4.6 10.1 4.9 10.4 3.3 2.9 13.1 12.4 16.9 11.2 17.9 23.9 11.5 14.2 8.1 14.6 10.0 9.5 23.2 17.7 1.8 10.5 14.7 6.4 2.0 14.0 2.1 6.9 12.1 9.7 15.1 11.2 12.8 14.1 11.4 11.9 8.2 6.8 16.0 6.4 4.5 4.6 2.3 8.6 3.7 4.6 8.2 9.7 15.0 2.4 3.2 7.9 19.4 16.1 10.6 6.8 13.5 11.6 3.6 9.1 3.9 5.5 8.9 6.4 13.2 4.8 8.3 4.9 4.0 3.3 4.7 7.0 8.1 8.4 10.1 6.4 3.6 6.6 9.3 5.1 2.4 4.6 8.3 3.7 9.7 4.9 5.6 7.1 6.5 8.5 5.8 6.5 6.6 5.4 7.4 5.7 TMEM88 "FLJ20025, MGC71744" ENSG00000167874 "Transmembrane protein 88" Q6PEY1 17 7855065-7856099 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "AN3-CA: 31.6;HHSteC: 21.1;HUVEC TERT2: 24.6;NTERA-2: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "eosinophil: 1.5;neutrophil: 4.5" "Lineage enriched" "Detected in single" 20 "granulocytes: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052991 Approved "HPA052991: AB_2682006" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "prognostic unfavourable (1.16e-4)" "unprognostic (3.44e-2)" "unprognostic (3.03e-1)" "unprognostic (6.49e-2)" "prognostic favourable (4.43e-6)" "unprognostic (1.98e-1)" "unprognostic (2.64e-2)" "unprognostic (2.18e-1)" "unprognostic (5.68e-3)" "unprognostic (9.04e-2)" "unprognostic (1.09e-2)" "unprognostic (2.68e-3)" "unprognostic (1.71e-1)" "unprognostic (7.56e-2)" "unprognostic (2.72e-1)" 22.3 9.2 2.8 6.5 4.3 5.0 20.0 2.4 5.0 13.5 10.8 5.1 3.8 4.8 15.7 6.7 14.9 10.6 10.8 43.3 3.5 3.9 28.0 2.5 14.5 8.8 4.5 2.0 7.0 8.5 2.0 9.3 27.9 4.9 13.0 2.6 30.5 6.6 10.0 26.2 1.3 6.3 10.4 2.9 7.7 7.1 6.0 0.4 0.9 16.9 13.6 2.0 8.2 16.2 0.0 0.1 4.5 0.2 0.0 0.2 0.1 0.1 0.2 3.9 31.6 0.0 0.1 1.9 0.2 0.1 0.0 0.1 0.7 0.1 0.2 0.1 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.3 0.4 21.1 0.2 1.2 0.5 0.9 0.6 0.1 24.6 0.5 0.0 0.4 2.1 0.2 0.5 12.8 0.0 0.1 0.1 0.0 0.3 0.7 0.3 1.7 0.2 0.3 0.8 0.6 0.1 2.5 0.2 0.7 0.9 0.2 0.1 0.0 0.2 0.1 0.2 0.3 0.0 0.2 1.5 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 2.8 4.3 2.4 5.0 3.5 3.9 4.5 2.0 4.9 0.4 TMEM89 ENSG00000183396 "Transmembrane protein 89" A2RUT3 3 48620759-48621855 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 28.3" "Cell line enhanced" "Detected in some" "NB-4: 2.8;U-2197: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053577 Uncertain "HPA053577: " "unprognostic (1.61e-1)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (1.07e-1)" "unprognostic (1.94e-3)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (2.02e-2)" "unprognostic (6.31e-3)" "unprognostic (5.90e-3)" "unprognostic (3.35e-2)" "unprognostic (3.83e-2)" "unprognostic (8.41e-2)" "unprognostic (2.71e-1)" "unprognostic (3.86e-2)" 0.1 0.0 0.1 0.1 0.1 2.8 0.1 0.1 0.5 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.1 0.5 0.5 0.1 0.1 0.1 0.7 28.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.7 0.4 1.1 0.3 1.1 0.7 0.0 0.2 0.0 1.1 0.2 0.4 0.0 0.0 0.3 0.0 0.5 0.8 0.6 0.5 0.0 1.5 0.0 1.4 1.9 0.6 0.0 0.0 0.0 0.0 0.8 0.0 2.8 0.6 0.0 0.7 0.5 0.0 0.7 1.2 0.1 0.9 0.0 0.7 0.4 0.8 0.0 0.0 1.4 1.5 3.1 1.5 0.5 0.8 0.5 1.8 0.7 2.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 TMEM91 "FLJ27310, IFITMD6" ENSG00000142046 "Transmembrane protein 91" Q6ZNR0 19 41350911-41384083 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 15.1;HSkMC: 16.2;TIME: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 51.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 51.9" "Low region specificity" "Detected in all" HPA053240 Uncertain "HPA053240: " "unprognostic (3.02e-3)" "unprognostic (1.92e-2)" "unprognostic (5.13e-3)" "unprognostic (2.97e-2)" "unprognostic (1.29e-1)" "unprognostic (9.90e-2)" "unprognostic (4.70e-2)" "unprognostic (2.83e-1)" "unprognostic (1.03e-1)" "unprognostic (5.69e-3)" "prognostic favourable (3.54e-5)" "unprognostic (1.07e-1)" "prognostic unfavourable (3.52e-7)" "unprognostic (1.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.63e-1)" "unprognostic (3.06e-2)" 10.5 6.2 12.1 9.2 42.0 35.5 22.0 5.2 13.0 12.1 9.8 9.5 12.9 4.3 17.3 12.8 11.2 15.8 9.7 7.2 11.3 22.9 8.3 4.2 13.9 6.8 9.3 13.7 9.7 12.9 4.3 19.2 10.8 11.6 12.3 5.1 12.3 8.6 13.5 4.0 29.7 5.4 10.9 8.1 15.7 6.0 15.2 14.7 6.0 10.7 3.8 8.6 14.4 12.1 0.4 3.4 51.9 12.5 0.3 2.0 11.0 2.2 5.5 4.1 1.9 5.1 11.0 3.7 1.7 2.5 0.9 1.7 0.4 2.0 1.1 1.6 2.2 0.7 1.1 1.9 2.3 1.6 2.5 15.1 3.6 8.1 9.3 2.5 4.1 16.2 9.6 3.1 7.0 6.9 2.8 4.5 1.6 5.0 1.4 4.5 1.7 3.3 3.0 1.1 1.0 2.6 1.3 1.2 2.3 3.9 0.8 2.5 0.7 7.0 15.2 2.6 2.3 2.3 2.1 3.0 0.4 0.9 5.0 3.1 0.9 7.1 12.5 0.9 1.5 2.6 1.8 0.1 0.8 0.7 2.1 0.4 2.0 0.9 51.9 0.3 1.8 3.4 1.0 11.0 12.1 42.0 5.2 13.0 11.3 22.9 9.3 13.7 11.6 14.7 TMEM92 FLJ33318 ENSG00000167105 "Transmembrane protein 92" Q6UXU6 17 50271406-50281485 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 74.7" "Group enriched" "Detected in some" 4 "A549: 9.7;CACO-2: 16.5;CAPAN-2: 15.9;EFO-21: 33.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 21 "granulocytes: 5.5" "Low region specificity" "Detected in all" "HPA063009, HPA069820" Approved Enhanced Nucleoplasm Nucleoplasm "HPA063009: , HPA069820: " "unprognostic (3.54e-3)" "unprognostic (2.39e-2)" "unprognostic (9.85e-2)" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "prognostic unfavourable (8.35e-4)" "unprognostic (4.37e-3)" "unprognostic (2.45e-2)" "unprognostic (1.11e-1)" "unprognostic (4.39e-1)" "unprognostic (3.88e-3)" "unprognostic (2.97e-2)" "prognostic unfavourable (1.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (7.81e-2)" 0.2 0.1 0.3 1.9 0.3 0.4 0.3 0.3 0.3 3.3 27.9 0.3 0.1 23.3 1.2 0.3 1.0 0.7 11.7 0.1 0.8 0.3 0.4 10.2 6.1 0.1 0.3 0.2 2.4 1.2 0.0 0.1 0.3 0.9 1.2 1.8 1.1 4.3 1.2 0.1 0.2 74.7 0.4 0.4 0.3 17.9 0.5 0.3 0.1 0.1 0.4 1.6 2.2 3.7 0.1 0.2 5.5 0.1 0.0 0.0 0.0 1.0 9.7 0.2 0.0 0.0 0.4 2.1 0.2 0.3 0.0 0.0 16.5 15.9 0.0 33.0 0.7 0.1 0.2 1.8 0.1 2.6 0.1 0.0 1.0 1.6 0.1 0.1 0.1 0.1 1.9 0.1 0.5 0.0 1.5 0.0 0.0 0.0 0.0 0.2 3.6 4.3 0.2 0.0 4.1 3.6 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.5 0.0 0.1 2.3 0.0 0.0 0.0 0.2 0.1 0.2 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.3 0.8 0.3 0.3 0.2 0.9 0.3 TMEM94 KIAA0195 ENSG00000177728 "Transmembrane protein 94" Q12767 17 75441159-75500090 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008423, HPA050660" Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA008423: AB_1852283, HPA050660: " "unprognostic (4.05e-2)" "unprognostic (3.43e-1)" "unprognostic (5.78e-2)" "unprognostic (4.32e-2)" "unprognostic (1.01e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.42e-1)" "unprognostic (7.27e-2)" "prognostic favourable (2.26e-4)" "unprognostic (9.71e-2)" "unprognostic (1.14e-1)" "unprognostic (1.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.44e-2)" "unprognostic (4.96e-2)" 14.6 25.6 26.6 11.2 32.0 13.9 9.8 24.4 32.7 11.7 16.7 30.3 8.2 15.4 13.0 8.5 14.5 27.4 13.7 21.1 21.7 13.3 14.0 9.6 17.0 10.6 24.0 23.0 17.1 13.9 17.2 18.6 18.6 21.9 12.5 11.5 25.4 11.8 12.5 40.4 16.2 15.2 9.4 15.9 14.3 14.8 16.5 23.4 10.7 18.4 9.6 9.2 13.7 7.1 4.6 6.2 5.5 4.6 4.3 7.1 4.5 7.5 19.7 16.3 25.6 8.2 9.3 23.4 4.5 10.0 7.7 7.9 6.6 11.8 10.6 15.1 7.9 9.9 7.8 12.5 4.3 9.5 11.1 10.8 8.8 9.9 11.1 12.0 23.5 16.1 7.0 7.7 6.7 14.0 11.2 12.4 10.1 8.8 24.8 7.5 6.8 7.7 17.6 19.3 9.8 7.6 19.9 14.5 15.4 5.4 23.5 13.5 14.5 14.3 8.1 7.7 9.8 8.0 6.4 27.0 7.7 5.8 9.1 11.1 10.5 0.2 4.6 5.5 7.1 2.9 5.4 2.0 3.3 4.7 4.6 4.6 2.8 4.4 1.2 4.3 2.7 6.2 4.1 4.5 26.6 32.0 24.4 32.7 21.7 13.3 24.0 23.0 21.9 23.4 TMEM97 MAC30 ENSG00000109084 "Transmembrane protein 97" Q5BJF2 17 28319095-28328685 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "pancreas: 228.7" "Cell line enhanced" "Detected in all" "CACO-2: 71.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044795, HPA076689" Enhanced Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA044795: AB_10959306, HPA076689: " "unprognostic (1.35e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (4.34e-2)" "unprognostic (3.20e-2)" "unprognostic (9.03e-2)" "unprognostic (1.04e-2)" "unprognostic (1.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.17e-2)" "prognostic unfavourable (1.24e-4)" "unprognostic (1.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.99e-1)" "unprognostic (4.01e-2)" 2.0 11.5 3.1 2.8 3.3 1.7 3.4 2.9 4.9 2.6 4.2 2.2 1.2 4.7 2.9 1.9 3.1 4.0 8.1 1.6 2.4 3.0 2.2 33.7 12.5 3.4 2.4 2.7 8.2 228.7 1.7 0.6 2.0 7.7 6.9 3.8 3.2 1.5 2.8 5.7 3.6 3.2 3.4 4.0 1.7 13.2 31.5 1.3 4.6 1.3 3.9 2.5 12.5 6.0 9.0 13.8 1.7 2.3 8.2 10.0 4.6 9.9 25.1 48.1 23.7 6.4 9.2 15.8 9.6 6.2 15.3 20.5 71.0 7.6 27.3 10.6 3.7 10.7 30.5 16.4 12.1 12.8 21.4 10.2 13.1 30.2 5.8 16.2 8.2 18.7 2.1 15.0 6.2 4.6 21.4 20.6 5.1 16.8 25.3 15.3 21.2 6.5 20.4 52.9 24.6 18.8 45.4 34.7 15.2 15.4 12.3 7.8 21.6 7.5 3.0 16.5 13.1 14.1 17.6 16.6 32.7 24.9 3.3 11.7 9.7 0.4 2.0 1.7 7.3 2.3 8.5 9.0 6.2 8.8 13.8 5.1 10.0 9.3 0.9 8.2 0.8 8.0 5.8 4.6 3.1 3.3 2.9 4.2 2.4 3.0 2.4 2.7 7.7 1.3 TMEM98 DKFZP564K1964 ENSG00000006042 "Transmembrane protein 98" Q9Y2Y6 17 32927910-32945106 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 96.8" "Cell line enhanced" "Detected in many" "CACO-2: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 7.9" "Lineage enriched" "Detected in single" 12 "dendritic cells: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040473, HPA053385" Uncertain Supported Nucleoplasm Nucleoplasm "HPA040473: AB_10794876, HPA053385: " "unprognostic (1.55e-2)" "unprognostic (5.15e-2)" "unprognostic (4.36e-3)" "unprognostic (7.20e-2)" "unprognostic (1.19e-1)" "unprognostic (7.93e-2)" "prognostic unfavourable (8.14e-4)" "prognostic favourable (7.10e-4)" "unprognostic (6.38e-2)" "unprognostic (2.22e-1)" "unprognostic (3.41e-1)" "unprognostic (9.18e-3)" "prognostic favourable (3.85e-4)" "unprognostic (5.16e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-1)" 15.5 15.9 11.8 7.1 36.8 0.9 13.3 6.5 28.3 21.6 26.1 55.5 5.6 29.7 30.5 23.0 8.2 29.6 27.7 13.5 17.0 9.4 10.8 7.7 17.0 3.1 50.4 18.5 60.2 25.7 6.3 7.4 8.0 40.8 24.7 28.7 96.8 14.8 7.4 2.6 7.1 34.0 19.0 37.1 5.7 29.7 9.7 37.7 0.6 14.2 7.4 3.5 15.6 13.3 0.5 7.9 0.6 0.1 0.2 0.6 0.1 1.5 5.7 24.7 0.0 34.0 30.6 0.2 23.9 32.5 12.7 27.5 57.7 1.7 0.3 0.3 30.0 0.2 15.7 6.3 7.5 5.0 19.3 0.9 0.0 25.6 15.7 0.0 0.3 25.5 6.3 16.0 2.6 32.8 15.7 0.0 34.5 0.0 0.0 0.1 16.4 8.9 0.0 23.2 0.1 2.9 10.2 2.1 34.1 0.5 0.0 18.7 7.7 0.0 26.8 18.2 17.1 0.2 0.0 2.0 0.7 0.0 9.2 0.0 9.7 0.5 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.6 0.0 0.5 0.1 0.2 0.6 0.2 0.1 7.9 0.1 0.1 11.8 36.8 6.5 28.3 17.0 9.4 50.4 18.5 40.8 37.7 TMEM9B C11orf15 ENSG00000175348 "TMEM9 domain family member B" Q9NQ34 11 8947294-8965011 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037784 Uncertain "HPA037784: AB_10671886" "unprognostic (3.18e-1)" "unprognostic (4.68e-2)" "unprognostic (2.58e-1)" "unprognostic (1.84e-3)" "unprognostic (1.13e-1)" "unprognostic (8.48e-3)" "unprognostic (2.56e-2)" "unprognostic (6.34e-2)" "unprognostic (1.52e-1)" "unprognostic (3.78e-2)" "unprognostic (1.89e-2)" "unprognostic (5.06e-1)" "prognostic favourable (4.26e-5)" "unprognostic (1.83e-1)" "unprognostic (1.82e-1)" "unprognostic (5.51e-3)" "unprognostic (9.56e-2)" 18.4 22.8 37.6 17.2 39.3 35.5 30.3 24.8 43.8 22.4 34.8 37.3 19.9 29.6 13.0 35.0 36.7 18.0 22.1 28.9 34.9 33.4 34.3 24.7 34.5 27.2 40.1 24.7 15.1 29.2 33.3 25.2 33.9 31.0 19.8 38.3 24.5 27.6 17.6 26.6 26.1 40.8 12.5 42.0 24.5 31.9 14.8 25.9 17.8 42.8 24.9 23.5 23.3 21.1 36.7 40.5 52.2 50.6 31.3 47.2 49.2 20.6 14.1 8.1 15.6 41.7 23.8 13.9 26.4 24.0 15.6 16.3 10.7 33.0 12.8 14.0 27.5 27.9 7.6 19.5 16.8 23.6 14.6 8.6 12.7 10.2 23.6 17.3 27.7 21.6 33.2 9.6 19.5 18.7 6.7 19.8 29.9 14.5 5.4 11.1 2.5 16.2 6.1 10.4 10.3 23.7 24.3 8.9 7.7 15.0 31.7 13.0 19.1 11.8 20.0 19.1 8.6 32.3 16.1 8.2 14.1 9.1 24.2 11.6 16.1 50.2 38.1 52.2 37.9 47.4 39.1 36.7 37.0 41.7 40.5 31.3 31.0 43.0 18.1 31.3 50.6 28.8 47.2 49.2 37.6 39.3 24.8 43.8 34.9 33.4 40.1 24.7 31.0 25.9 TMIE DFNB6 ENSG00000181585 "Transmembrane inner ear" Q8NEW7 3 46694528-46710886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.7;brain: 11.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.3;EFO-21: 5.6;hTCEpi: 3.8;SH-SY5Y: 4.8" "Cancer enriched" "Detected in many" 5 "glioma: 6.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.1" "Lineage enriched" "Detected in single" 17 "T-cells: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038298 Uncertain Uncertain Vesicles,Cytosol "Vesicles, Cytosol" "HPA038298: AB_10675792" "unprognostic (6.59e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-3)" "unprognostic (2.48e-3)" "unprognostic (1.88e-2)" "unprognostic (5.40e-3)" "unprognostic (3.94e-2)" "unprognostic (8.80e-2)" "unprognostic (3.37e-2)" "unprognostic (6.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.35e-2)" "unprognostic (4.58e-2)" "unprognostic (1.23e-1)" "unprognostic (4.41e-2)" "unprognostic (5.29e-2)" "unprognostic (6.78e-2)" 1.2 11.7 6.7 0.7 2.9 0.0 0.5 2.7 7.0 0.8 0.9 2.3 0.4 0.6 0.8 1.2 2.2 1.0 0.4 1.0 5.9 11.4 1.4 0.9 1.8 1.2 5.8 4.8 2.8 0.4 0.0 8.1 0.7 3.8 0.9 0.6 1.1 0.8 1.8 5.8 1.3 0.6 0.7 5.2 1.2 0.3 1.6 1.0 0.4 0.8 1.7 1.3 0.8 0.4 0.0 0.3 0.0 0.1 0.0 6.1 1.2 2.0 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.2 0.0 6.3 0.0 5.6 0.0 0.2 0.4 0.5 0.0 0.0 0.0 1.6 0.1 0.0 1.8 0.0 0.0 0.0 3.8 0.0 2.5 1.0 0.0 0.5 0.0 0.3 0.1 0.0 0.4 0.3 2.4 0.0 0.5 0.2 0.1 0.7 4.8 0.7 0.8 0.1 0.2 1.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.0 1.8 1.0 0.3 0.0 6.1 0.9 0.0 0.0 0.0 0.0 1.0 1.2 6.7 2.9 2.7 7.0 5.9 11.4 5.8 4.8 3.8 1.0 TMIGD1 "TMIGD, UNQ9372" ENSG00000182271 "Transmembrane and immunoglobulin domain containing 1" Q6UXZ0 17 30316333-30334059 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "intestine: 47.3" "Cell line enhanced" "Detected in some" "BEWO: 1.4;NB-4: 1.3;U-2197: 1.8;U-698: 1.9" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021946 Approved Mitochondria Mitochondria "HPA021946: AB_1858140" "unprognostic (1.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" 0.2 0.0 0.2 1.1 0.2 0.0 0.2 0.2 0.2 0.2 26.8 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 1.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 33.9 0.2 0.2 0.2 0.2 0.0 47.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 TMIGD2 "CD28H, IGPR-1, MGC23244" ENSG00000167664 "Transmembrane and immunoglobulin domain containing 2" Q96BF3 19 4292232-4302431 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 34.0;lymphoid tissue: 43.8" "Group enriched" "Detected in some" 4 "BEWO: 9.3;HEL: 21.4;MOLT-4: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 34.0" "Group enriched" "Detected in many" 37 "dendritic cells: 30.8;NK-cells: 23.0;T-cells: 34.0" "Low region specificity" "Detected in many" HPA011081 Approved "HPA011081: AB_1079372" "unprognostic (1.08e-3)" "unprognostic (6.55e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-4)" "unprognostic (4.31e-2)" "unprognostic (8.68e-3)" "unprognostic (7.78e-3)" "unprognostic (2.87e-2)" "unprognostic (1.86e-1)" "unprognostic (2.28e-1)" "unprognostic (2.12e-1)" "unprognostic (3.26e-1)" "unprognostic (7.10e-5)" "unprognostic (2.62e-2)" "unprognostic (4.54e-1)" "unprognostic (5.12e-4)" "unprognostic (8.89e-4)" 0.4 0.2 2.8 6.0 1.6 6.4 0.2 0.4 1.8 0.4 3.4 2.2 0.2 2.1 0.7 0.2 0.7 0.6 1.0 0.2 2.1 1.9 0.4 1.0 1.4 9.2 3.4 0.8 0.4 0.2 0.1 0.2 0.9 1.0 0.5 0.6 0.3 0.7 0.2 0.2 0.2 6.1 0.2 2.4 9.7 1.0 0.7 1.2 43.8 0.6 0.5 5.3 1.0 0.3 0.1 30.8 0.7 0.1 23.0 34.0 7.3 0.0 0.1 0.2 0.2 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 21.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.1 0.2 0.0 3.7 1.0 0.0 0.0 0.1 0.1 2.5 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 2.7 0.0 34.0 0.0 4.4 6.6 0.1 0.1 25.5 12.9 0.7 23.0 0.1 30.8 0.4 7.3 2.8 1.6 0.4 1.5 2.1 1.9 3.4 0.8 1.0 1.2 TMPO "LAP2, LEMD4, TP" ENSG00000120802 Thymopoietin "P42166, P42167" 12 98515512-98550379 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" DNA-binding Cardiomyopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 130.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008150, CAB009847" Enhanced Enhanced "Nuclear membrane" "Nuclear membrane" "CAB009847: AB_2205450, HPA008150: AB_1079235" "unprognostic (2.36e-1)" "unprognostic (4.46e-3)" "unprognostic (5.90e-2)" "unprognostic (2.80e-2)" "unprognostic (1.35e-1)" "unprognostic (2.95e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (1.74e-2)" "unprognostic (3.69e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-3)" "prognostic unfavourable (9.34e-4)" "unprognostic (6.01e-3)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (3.26e-2)" 10.8 9.5 8.1 25.0 9.5 36.8 12.7 19.1 11.0 16.9 22.9 10.7 8.7 15.9 18.4 17.1 23.0 15.4 10.3 9.6 8.5 8.3 15.8 20.5 13.8 34.0 9.0 11.2 34.7 21.6 9.9 9.9 13.6 7.6 15.6 17.6 12.5 14.0 9.7 9.4 11.7 22.6 10.7 9.4 29.1 16.8 11.4 10.3 130.9 13.2 12.2 35.4 13.0 17.9 14.1 10.9 18.1 33.1 9.7 15.6 13.3 30.3 20.0 49.4 25.1 4.1 5.5 29.3 25.0 13.2 33.9 24.6 21.8 15.2 53.0 15.4 14.5 19.5 41.4 18.8 31.1 37.0 25.7 45.4 18.3 14.4 3.7 52.4 30.3 3.1 6.2 20.0 10.8 19.3 38.2 20.6 21.0 19.1 85.4 41.3 29.7 18.8 71.7 32.8 36.7 12.0 28.4 39.1 23.4 42.7 26.9 13.4 30.3 25.2 10.3 19.7 17.2 13.4 25.5 22.4 38.2 59.3 5.6 30.4 26.1 18.1 14.4 6.1 9.5 25.0 10.2 10.9 11.1 10.8 10.9 14.1 15.6 11.7 1.1 9.7 33.1 6.1 13.3 13.3 8.1 9.5 19.1 11.0 8.5 8.3 9.0 11.2 7.6 10.3 TMPRSS11D ENSG00000153802 "Transmembrane serine protease 11D" O60235 4 67820876-67884032 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 18.1;esophagus: 41.2;lymphoid tissue: 20.3;tongue: 67.6;vagina: 23.1" "Cell line enhanced" "Detected in single" "RH-30: 1.2" "Group enriched" "Detected in many" 5 "cervical cancer: 36.0;head and neck cancer: 30.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052834 Uncertain "Intracellular and membrane" "HPA052834: " "unprognostic (1.19e-1)" "unprognostic (6.83e-2)" "unprognostic (8.82e-2)" "unprognostic (2.10e-2)" "unprognostic (1.21e-2)" "unprognostic (1.12e-1)" "unprognostic (3.22e-1)" "unprognostic (2.88e-1)" "unprognostic (1.32e-1)" "unprognostic (4.79e-1)" "unprognostic (4.38e-3)" "unprognostic (1.96e-1)" "unprognostic (6.91e-2)" "unprognostic (4.48e-2)" "unprognostic (2.19e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.6 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 67.6 20.3 0.4 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMPRSS11E "DESC1, TMPRSS11E2" ENSG00000087128 "Transmembrane serine protease 11E" Q9UL52 4 68447449-68497604 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.8;lymphoid tissue: 39.1;tongue: 40.5;vagina: 36.6" "Group enriched" "Detected in some" 6 "HaCaT: 5.8;HBEC3-KT: 2.2" "Group enriched" "Detected in many" 6 "cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.8" "Lineage enhanced" "Detected in single" "B-cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA051062 Enhanced "Intracellular and membrane" "HPA051062: " "unprognostic (2.53e-1)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" "unprognostic (9.14e-2)" "unprognostic (5.03e-2)" "prognostic unfavourable (6.73e-4)" "unprognostic (2.22e-1)" "unprognostic (9.70e-3)" "unprognostic (2.16e-1)" "unprognostic (3.74e-2)" "unprognostic (4.03e-2)" "unprognostic (8.39e-2)" "unprognostic (1.27e-1)" "unprognostic (3.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 28.9 0.0 0.0 1.2 0.0 1.1 10.5 103.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 1.4 0.0 0.0 13.6 0.5 0.0 1.6 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 40.5 39.1 2.6 36.6 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 5.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMPRSS11F FLJ16046 ENSG00000198092 "Transmembrane serine protease 11F" Q6ZWK6 4 68053198-68129880 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 18.3;lymphoid tissue: 11.4;skin 1: 10.9;tongue: 13.1" "Group enriched" "Detected in some" 8 "HEL: 2.4;K-562: 5.4;Karpas-707: 1.6;U-266/70: 1.6" "Group enriched" "Detected in some" 7 "cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026911 Uncertain "HPA026911: AB_2205589" "unprognostic (9.46e-2)" "unprognostic (5.30e-1)" "unprognostic (7.16e-2)" "unprognostic (8.79e-3)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (1.22e-1)" "unprognostic (5.08e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.1 0.0 0.0 1.4 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 13.1 11.4 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMPRSS2 PRSS10 ENSG00000184012 "Transmembrane serine protease 2" O15393 21 41464551-41531116 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 75.6;pancreas: 64.5;prostate: 68.2" "Cell line enhanced" "Detected in some" "CACO-2: 14.6;MCF7: 6.3;RT4: 35.2;SK-BR-3: 7.2;T-47d: 5.4" "Cancer enriched" "Detected in many" 7 "prostate cancer: 250.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034493, HPA035787" Enhanced Supported "Nucleoplasm,Cell Junctions" "Intracellular and membrane" "Cell Junctions" Nucleoplasm "HPA034493: , HPA035787: AB_2674782" "unprognostic (4.80e-3)" "unprognostic (3.49e-1)" "unprognostic (2.16e-1)" "prognostic favourable (2.56e-4)" "unprognostic (1.72e-1)" "unprognostic (1.05e-2)" "unprognostic (4.28e-2)" "unprognostic (1.51e-3)" "unprognostic (9.43e-2)" "unprognostic (9.02e-3)" "unprognostic (6.24e-2)" "unprognostic (6.43e-2)" "prognostic favourable (7.86e-6)" "unprognostic (2.00e-2)" "unprognostic (1.68e-1)" "unprognostic (1.41e-1)" "unprognostic (2.15e-2)" 0.2 0.1 0.2 15.5 0.4 0.0 6.1 0.2 0.5 1.3 38.7 0.4 24.4 17.5 0.5 0.9 10.7 2.2 17.3 0.2 0.3 0.1 19.4 18.4 20.7 0.2 0.2 0.2 0.7 64.5 0.0 1.3 1.0 0.4 68.2 18.5 0.3 52.3 35.7 0.2 2.1 75.6 0.9 0.2 0.3 36.7 0.8 0.3 0.5 19.9 3.9 10.2 5.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 14.6 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.5 1.3 0.0 0.0 0.0 1.4 0.6 35.2 0.0 0.4 0.0 7.2 0.1 5.4 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 0.2 0.5 0.3 0.1 0.2 0.2 0.4 0.3 TMPRSS4 "MT-SP2, TMPRSS3" ENSG00000137648 "Transmembrane serine protease 4" Q9NRS4 11 118077012-118121890 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 44.9;HaCaT: 19.2;RPTEC TERT1: 31.5;RT4: 39.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 4.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006238 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006238: AB_1080316" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (1.19e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-2)" "unprognostic (5.50e-2)" "unprognostic (8.17e-3)" "unprognostic (1.95e-2)" "unprognostic (2.41e-1)" "unprognostic (9.62e-2)" "prognostic unfavourable (3.14e-4)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-2)" "unprognostic (9.96e-3)" 0.3 0.3 0.2 14.2 0.3 0.0 0.3 0.3 0.2 11.4 23.5 0.1 0.0 16.1 3.1 2.8 60.9 0.6 45.4 0.3 0.3 0.3 17.7 0.3 3.2 0.0 0.2 0.0 0.3 0.4 0.0 0.3 0.8 0.1 9.9 26.2 0.2 4.0 0.0 0.3 2.4 27.4 4.2 0.2 0.3 13.7 0.7 0.0 0.6 0.3 13.7 41.0 43.9 22.3 0.5 0.1 4.5 0.7 0.2 0.1 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 44.9 0.0 1.7 0.0 19.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.0 31.5 39.3 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.1 0.9 0.2 0.7 0.1 0.1 0.0 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.0 0.1 0.0 TMPRSS5 "MGC141886, MGC148044" ENSG00000166682 "Transmembrane serine protease 5" Q9H3S3 11 113687546-113706373 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 24.0;salivary gland: 15.0;skeletal muscle: 6.0" "Cell line enhanced" "Detected in some" "AF22: 4.4;CAPAN-2: 7.1;WM-115: 5.8" "Cancer enhanced" "Detected in some" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010992 Approved Nucleoplasm Nucleoplasm "HPA010992: AB_1858152" "unprognostic (1.53e-2)" "unprognostic (3.81e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (2.99e-3)" "unprognostic (3.08e-1)" "unprognostic (5.19e-3)" "unprognostic (8.49e-2)" "unprognostic (8.13e-2)" "unprognostic (3.38e-2)" "unprognostic (1.96e-3)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (4.04e-3)" 2.1 1.7 10.8 1.0 24.0 3.2 2.2 2.1 14.8 1.2 1.0 21.6 0.0 1.0 1.2 0.9 1.8 1.1 2.2 1.2 11.5 5.7 0.9 0.9 0.9 1.1 11.6 12.7 1.4 1.2 0.6 1.5 1.2 16.5 1.2 1.3 0.9 15.0 1.4 6.0 2.7 0.7 1.2 16.9 1.1 2.4 2.3 8.8 0.0 1.1 0.4 1.3 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.8 4.4 2.5 0.5 0.4 0.6 1.2 0.5 0.6 0.9 2.5 7.1 0.3 3.2 0.5 0.8 0.4 0.4 0.3 0.5 1.3 1.0 0.6 0.0 0.3 1.0 0.8 0.6 0.6 0.6 1.2 0.8 0.8 0.5 0.9 0.0 0.8 1.2 0.5 0.2 0.9 0.5 0.0 0.7 0.4 0.6 1.0 0.5 0.1 3.5 0.5 0.6 0.5 0.9 1.7 0.6 0.7 0.5 0.2 0.1 0.4 0.9 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 24.0 2.1 12.3 11.5 5.7 11.6 12.7 16.5 8.8 TMPRSS7 ENSG00000176040 "Transmembrane serine protease 7" Q7RTY8 3 112034843-112081269 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.2;testis: 5.2" "Cell line enhanced" "Detected in some" "HaCaT: 1.4;hTCEpi: 2.7;RT4: 1.3;U-266/70: 1.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA040630 Uncertain "HPA040630: AB_10796124" "unprognostic (4.02e-2)" "unprognostic (9.87e-2)" "unprognostic (9.05e-2)" "unprognostic (2.16e-2)" "unprognostic (2.24e-1)" "unprognostic (4.64e-3)" "unprognostic (6.63e-2)" "unprognostic (2.16e-1)" "unprognostic (2.29e-2)" "unprognostic (4.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.94e-1)" "unprognostic (7.23e-2)" "unprognostic (2.96e-1)" "unprognostic (2.06e-2)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.2 0.1 0.1 0.0 0.5 0.8 0.0 0.0 0.0 1.0 5.2 0.3 0.0 0.2 0.0 0.8 0.5 2.2 0.3 0.5 0.7 0.1 0.3 0.0 0.7 0.2 0.4 0.1 0.9 0.6 0.7 0.2 0.5 0.6 0.2 0.0 0.0 0.0 1.4 0.0 0.9 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.1 0.4 0.0 0.8 0.0 0.5 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 2.2 0.3 0.7 0.2 0.2 0.1 0.6 0.3 0.2 0.0 0.8 0.7 0.2 1.7 0.5 0.2 0.5 0.2 0.1 TMPRSS9 ENSG00000178297 "Transmembrane serine protease 9" Q7Z410 19 2389771-2426239 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 6.3;lymphoid tissue: 4.6;testis: 5.9" "Cell line enhanced" "Detected in some" "Karpas-707: 6.1;SK-BR-3: 3.1;U-266/70: 5.4" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "eosinophil: 2.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.4" "Region enhanced" "Detected in single" "basal ganglia: 0.5" "Low region specificity" "Detected in all" HPA051483 Uncertain "HPA051483: " "unprognostic (1.63e-1)" "unprognostic (1.94e-2)" "unprognostic (5.62e-3)" "unprognostic (1.86e-1)" "unprognostic (1.54e-2)" "unprognostic (1.87e-3)" "unprognostic (3.30e-1)" "unprognostic (6.44e-2)" "unprognostic (7.29e-2)" "unprognostic (2.07e-1)" "unprognostic (6.30e-2)" "unprognostic (9.20e-3)" "unprognostic (2.28e-3)" "unprognostic (8.67e-2)" "unprognostic (1.96e-1)" "unprognostic (3.07e-3)" "unprognostic (6.73e-2)" 0.1 1.1 0.9 0.4 0.2 2.0 1.3 0.0 0.2 0.0 0.4 0.3 0.4 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 6.3 0.0 0.1 0.0 0.2 1.2 0.0 0.2 0.1 0.1 0.0 0.5 0.0 1.5 1.8 0.4 0.0 0.0 4.6 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.9 2.4 0.0 0.0 0.0 0.1 1.7 0.3 0.2 0.6 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.6 0.5 0.4 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.8 0.2 2.1 2.3 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 1.0 6.1 0.0 1.2 0.1 0.4 0.5 0.8 1.1 0.0 0.8 0.0 0.3 0.1 0.2 0.2 3.1 0.1 0.4 1.6 0.4 1.1 0.8 1.1 0.7 5.4 1.3 1.5 0.2 0.9 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 TMTC4 "FLJ14624, FLJ22153" ENSG00000125247 "Transmembrane and tetratricopeptide repeat containing 4" Q5T4D3 13 100603927-100675093 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016489 Uncertain Approved Vesicles Vesicles "HPA016489: AB_1858157" "unprognostic (1.49e-1)" "unprognostic (1.87e-1)" "unprognostic (8.34e-2)" "unprognostic (1.35e-1)" "unprognostic (2.43e-2)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (1.96e-1)" "unprognostic (1.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.99e-1)" "unprognostic (6.04e-2)" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" 4.1 4.4 11.4 4.4 13.7 1.9 5.7 10.6 21.8 6.6 7.0 45.7 8.3 8.5 8.7 7.5 4.8 13.2 4.9 3.2 16.9 8.7 11.5 9.8 3.5 3.6 16.9 10.0 5.3 12.8 7.5 3.3 4.0 29.6 7.9 7.6 4.6 6.9 5.6 9.4 6.5 7.3 6.0 25.2 3.9 7.9 9.7 11.3 4.2 7.2 3.9 4.6 7.7 4.3 2.4 6.4 0.2 3.3 1.3 4.4 1.4 4.9 4.2 22.1 11.7 2.9 5.9 24.7 2.8 2.5 2.7 2.2 4.2 9.3 14.9 9.5 2.4 3.5 6.8 3.0 3.2 8.4 4.9 6.3 7.9 6.7 3.1 8.1 0.1 8.3 5.8 1.0 4.9 12.1 4.7 1.9 3.1 4.4 5.9 4.7 5.9 4.2 6.4 3.9 3.3 11.1 3.9 11.4 11.8 5.5 10.7 2.8 7.9 23.0 18.8 2.4 4.2 2.2 4.9 5.0 4.0 2.8 11.8 5.3 7.0 0.0 2.0 0.2 2.7 2.1 2.4 2.0 2.6 4.4 6.4 2.4 3.0 1.1 0.0 1.3 3.3 4.2 3.8 1.4 11.4 13.7 10.6 21.8 16.9 8.7 16.9 10.0 29.6 11.3 TMX1 "PDIA11, TMX, TXNDC, TXNDC1" ENSG00000139921 "Thioredoxin related transmembrane protein 1" Q9H3N1 14 51240162-51257546 "Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003085 Approved Supported "Nucleoli,Endoplasmic reticulum" 740000 "Endoplasmic reticulum" Nucleoli "HPA003085: AB_1080424" "unprognostic (1.83e-1)" "unprognostic (7.42e-2)" "unprognostic (6.97e-3)" "unprognostic (1.49e-2)" "unprognostic (2.63e-1)" "unprognostic (1.12e-2)" "prognostic unfavourable (1.29e-6)" "unprognostic (3.70e-2)" "unprognostic (1.51e-1)" "unprognostic (6.84e-2)" "unprognostic (2.44e-3)" "unprognostic (5.07e-2)" "unprognostic (9.30e-2)" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (3.21e-3)" 21.8 24.2 13.6 18.5 18.3 15.5 19.7 14.1 12.3 14.4 20.7 17.2 27.0 17.7 17.5 19.2 25.0 13.3 15.0 11.3 13.5 11.9 24.9 29.2 20.0 25.3 22.6 9.2 15.5 23.9 18.4 19.0 21.9 16.3 14.2 21.2 13.3 21.0 27.9 12.5 16.7 23.4 17.0 24.9 29.1 18.1 12.9 17.9 37.5 23.5 17.6 17.4 20.2 19.9 9.4 17.0 9.6 17.5 12.6 12.5 13.3 13.6 12.6 17.5 9.4 14.0 11.0 18.8 17.2 13.9 17.4 22.3 12.7 25.2 19.5 16.2 11.5 13.5 30.9 11.3 31.7 19.6 10.6 14.2 11.0 12.5 12.2 32.6 14.4 13.1 10.4 11.7 8.6 15.4 11.7 13.5 16.5 16.8 14.5 17.6 19.9 15.8 15.4 31.6 11.7 16.8 17.8 11.1 8.2 13.7 9.2 12.3 13.5 14.6 9.9 18.4 17.1 13.0 15.6 11.8 11.9 16.0 8.1 18.6 17.2 9.6 15.4 7.2 10.2 17.5 12.5 9.4 10.9 10.5 16.2 7.4 10.8 12.0 5.7 12.6 12.6 17.0 12.1 13.3 13.6 18.3 14.1 12.3 13.5 11.9 22.6 9.2 16.3 17.9 TMX3 "FLJ20793, KIAA1830, PDIA13, TXNDC10" ENSG00000166479 "Thioredoxin related transmembrane protein 3" Q96JJ7 18 68673688-68715298 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014157 Uncertain "Intracellular and membrane" "HPA014157: AB_1858469" "unprognostic (2.11e-1)" "unprognostic (5.15e-2)" "unprognostic (2.14e-2)" "unprognostic (9.47e-2)" "unprognostic (6.82e-2)" "unprognostic (7.20e-2)" "unprognostic (4.96e-3)" "unprognostic (1.54e-1)" "unprognostic (3.21e-3)" "unprognostic (5.20e-2)" "unprognostic (9.83e-3)" "unprognostic (2.73e-1)" "prognostic unfavourable (2.87e-4)" "unprognostic (2.69e-2)" "unprognostic (1.53e-2)" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" 22.8 16.8 14.7 22.8 31.3 12.2 20.5 28.0 34.2 16.4 15.4 14.0 16.0 17.8 22.1 21.7 16.9 18.3 16.8 20.2 17.1 18.2 19.2 19.9 23.3 25.6 14.2 18.7 16.0 16.3 20.4 19.3 19.6 26.8 18.7 16.9 18.2 14.6 16.3 14.1 16.5 21.1 21.1 16.7 26.3 15.2 11.1 11.1 29.6 19.2 13.4 22.1 19.9 14.8 4.9 9.6 3.4 6.9 7.6 8.7 4.1 3.3 5.4 10.6 8.2 21.9 23.4 7.8 26.9 28.7 19.6 21.9 2.5 10.0 9.7 5.3 39.1 12.9 6.9 13.5 30.2 9.2 6.2 8.9 8.6 4.5 23.2 18.8 14.7 18.6 8.7 21.2 19.2 24.8 5.7 13.5 23.2 2.1 10.1 6.0 4.4 8.9 9.4 20.9 11.8 16.6 7.4 10.2 7.9 13.1 8.5 9.9 5.5 16.1 23.7 35.1 9.6 7.8 19.6 9.1 9.1 9.1 21.2 15.6 25.6 2.6 4.3 3.4 6.1 6.9 8.7 4.9 6.3 5.6 6.9 3.6 7.1 6.9 1.1 7.6 4.7 9.6 6.4 4.1 14.7 31.3 28.0 34.2 17.1 18.2 14.2 18.7 26.8 11.1 TMX4 "DJ971N18.2, KIAA1162, PDIA14, TXNDC13" ENSG00000125827 "Thioredoxin related transmembrane protein 4" Q9H1E5 20 7977348-8019829 "Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000399, HPA015752" Enhanced Supported "Nuclear membrane" "Nuclear membrane" "HPA000399: AB_1858471, HPA015752: AB_1858470" "unprognostic (3.93e-2)" "unprognostic (5.96e-2)" "unprognostic (1.86e-2)" "unprognostic (1.18e-3)" "unprognostic (5.14e-2)" "unprognostic (8.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.22e-1)" "unprognostic (3.66e-1)" "unprognostic (2.96e-1)" "unprognostic (5.80e-3)" "unprognostic (3.16e-1)" "prognostic favourable (2.60e-5)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (1.55e-1)" "unprognostic (7.06e-2)" 11.2 24.6 15.4 10.6 20.8 15.7 12.2 19.9 30.5 27.5 17.6 11.7 34.2 8.0 18.0 21.6 10.0 18.6 13.3 35.0 15.5 30.9 18.5 17.3 11.6 14.7 15.6 16.2 23.0 11.0 23.9 40.9 7.6 21.8 16.7 8.2 14.7 24.2 31.4 21.7 6.5 10.2 19.2 10.7 9.9 13.7 48.2 7.2 8.5 16.3 8.8 8.7 14.8 11.2 10.1 9.9 51.2 8.0 11.5 17.8 13.5 4.2 6.3 6.3 7.1 14.1 15.7 1.9 10.9 15.2 7.0 5.0 4.2 10.6 11.4 8.7 10.9 3.8 4.5 6.7 7.3 5.7 5.0 5.6 2.8 6.9 13.3 20.7 8.4 9.5 8.6 6.0 14.1 8.0 6.9 29.2 7.7 2.8 0.6 13.0 5.0 7.0 6.5 22.6 11.8 9.9 2.4 12.6 15.4 18.2 0.8 10.7 7.7 10.2 10.5 18.9 5.2 7.0 10.6 29.5 8.2 22.7 9.1 10.3 13.1 22.6 8.0 23.3 12.2 4.7 12.0 10.1 12.5 17.8 9.9 8.1 7.6 10.2 51.2 11.5 5.0 3.3 15.9 13.5 15.4 20.8 19.9 30.5 15.5 30.9 15.6 16.2 21.8 7.2 TNFRSF10A "Apo2, CD261, DR4, TRAILR-1, TRAILR1" ENSG00000104689 "TNF receptor superfamily member 10a" O00220 8 23190452-23225126 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA050958, HPA054475" Approved Supported Nucleoplasm Nucleoplasm "HPA050958: , HPA054475: " "unprognostic (3.66e-1)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (4.89e-2)" "unprognostic (9.44e-2)" "unprognostic (8.39e-2)" "unprognostic (5.32e-2)" "unprognostic (2.18e-2)" "unprognostic (2.72e-1)" "unprognostic (4.48e-2)" "prognostic unfavourable (1.00e-4)" "unprognostic (1.49e-1)" "unprognostic (1.99e-3)" "unprognostic (1.91e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-1)" "unprognostic (2.87e-1)" 11.9 4.0 2.1 13.0 3.4 8.4 9.7 2.0 2.8 6.0 10.9 1.4 4.5 5.9 5.3 5.6 13.6 4.1 12.7 6.3 2.2 2.0 10.9 10.6 11.0 12.4 3.0 0.7 2.7 12.9 3.6 1.8 6.9 4.0 5.1 7.2 2.1 8.2 4.3 3.8 7.1 10.2 3.8 2.9 13.2 6.1 2.6 3.0 9.5 5.8 14.9 25.4 6.7 8.7 13.2 4.5 3.8 4.3 3.9 13.9 4.2 7.9 14.4 0.7 0.0 0.5 2.9 0.0 1.6 1.0 0.8 2.3 11.0 14.0 18.4 18.8 1.0 15.2 12.9 20.6 1.4 4.5 0.1 9.7 8.7 6.2 7.4 5.2 9.3 5.0 17.0 18.3 15.8 9.7 15.0 6.6 3.9 6.2 0.2 3.3 10.0 8.8 0.1 0.0 13.2 11.0 17.2 0.4 0.5 4.0 10.2 0.0 5.4 4.0 13.6 0.0 0.1 0.8 0.0 7.8 11.0 14.3 0.1 1.7 0.2 2.0 4.3 3.8 3.8 1.9 10.3 10.4 12.3 7.7 4.5 13.2 12.1 7.0 0.5 3.9 1.7 0.0 13.9 4.2 2.1 3.4 2.0 2.8 2.2 2.0 3.0 0.7 4.0 3.0 TNFRSF10B "CD262, DR5, KILLER, TRAIL-R2, TRAILR2, TRICK2A, TRICKB" ENSG00000120889 "TNF receptor superfamily member 10b" O14763 8 23020133-23069179 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA023625 Approved "HPA023625: AB_1847860" "unprognostic (8.43e-3)" "unprognostic (7.43e-3)" "unprognostic (3.04e-2)" "unprognostic (4.94e-3)" "unprognostic (1.13e-1)" "unprognostic (7.74e-2)" "unprognostic (2.15e-1)" "unprognostic (9.51e-3)" "unprognostic (2.70e-1)" "unprognostic (2.82e-2)" "unprognostic (2.30e-3)" "unprognostic (1.96e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (4.01e-2)" "unprognostic (1.03e-1)" "unprognostic (1.86e-1)" "unprognostic (5.52e-2)" 29.6 18.5 5.2 16.4 7.3 7.6 19.6 2.3 5.8 11.5 23.1 7.5 13.3 14.1 10.4 13.9 12.1 11.4 22.1 13.2 6.4 3.2 14.3 36.1 21.3 11.6 7.9 2.6 16.2 20.0 14.8 6.1 8.5 8.2 15.1 14.3 7.9 11.5 14.5 15.5 6.1 31.2 10.5 8.6 17.4 11.2 7.8 6.4 4.1 17.7 13.0 15.2 17.9 9.9 3.1 12.1 2.8 12.9 0.8 4.0 5.2 8.5 22.7 33.3 10.1 15.6 20.4 32.6 20.6 26.5 11.2 17.5 9.4 8.6 5.1 14.0 11.2 8.3 8.7 39.0 20.0 5.1 7.3 0.0 8.9 17.6 52.3 1.9 8.6 30.3 35.0 24.9 26.6 35.5 3.6 0.0 22.0 2.8 0.2 2.8 8.3 8.2 4.6 12.1 3.2 21.7 13.5 0.0 5.6 10.3 2.9 10.9 5.0 2.4 31.4 16.4 8.5 5.2 14.8 6.6 1.1 2.4 16.7 3.7 23.4 2.8 12.9 0.4 1.6 9.3 2.7 3.1 1.9 1.6 12.1 1.6 4.0 1.6 2.6 0.8 11.9 0.0 1.3 5.2 5.2 7.3 2.3 5.8 6.4 3.2 7.9 2.6 8.2 6.4 TNFRSF10C "CD263, DcR1, LIT, TRAILR3, TRID" ENSG00000173535 "TNF receptor superfamily member 10c" O14798 8 23102590-23117437 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "blood: 173.4" "Group enriched" "Detected in some" 5 "BEWO: 37.1;HUVEC TERT2: 30.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "neutrophil: 173.4" "Lineage enriched" "Detected in many" 113 "granulocytes: 173.4" CAB025635 Enhanced "CAB025635: " "unprognostic (2.63e-1)" "unprognostic (4.49e-3)" "unprognostic (7.21e-3)" "unprognostic (2.07e-2)" "unprognostic (3.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.81e-2)" "unprognostic (2.11e-3)" "unprognostic (5.56e-2)" "unprognostic (4.37e-2)" "unprognostic (8.98e-2)" "unprognostic (1.94e-3)" "unprognostic (2.74e-3)" "unprognostic (4.83e-1)" "unprognostic (1.84e-1)" "unprognostic (1.34e-3)" "unprognostic (6.54e-2)" 5.5 1.5 1.9 14.0 3.6 12.6 2.0 1.4 3.9 2.9 1.5 0.7 0.1 1.2 1.5 1.2 1.4 3.7 13.5 5.6 1.9 1.1 2.8 3.2 13.7 28.4 9.2 0.0 2.4 2.1 2.5 4.5 12.8 3.1 2.7 1.8 1.7 1.7 0.8 2.3 0.8 2.2 1.9 4.4 26.4 1.8 1.4 2.3 0.8 4.4 0.5 0.9 5.2 1.9 0.0 0.3 173.4 1.5 0.0 0.0 0.4 0.4 1.4 0.5 2.4 0.0 0.3 37.1 1.5 0.0 0.1 0.1 0.0 1.4 0.1 0.7 1.4 0.2 0.1 0.1 0.1 2.5 0.5 0.1 0.3 1.1 3.6 0.2 1.0 4.1 0.3 0.7 0.3 30.9 0.0 0.0 0.2 1.0 0.0 0.9 1.6 0.0 0.1 0.1 0.0 5.9 0.1 0.0 0.0 0.1 0.2 0.7 5.1 0.2 6.5 0.6 1.2 1.4 0.1 1.5 0.8 0.0 2.2 0.3 0.9 2.7 1.5 25.4 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 173.4 0.0 1.1 0.0 0.0 0.4 1.9 3.6 1.4 3.9 1.9 1.1 9.2 0.0 3.1 2.3 TNFRSF11A "CD265, FEO, LOH18CR1, PDB2, RANK" ENSG00000141655 "TNF receptor superfamily member 11a" Q9Y6Q6 18 62325287-62391292 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3" "Cell line enriched" "Detected in some" 6 "HDLM-2: 51.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "NK-cell: 8.9" "Lineage enriched" "Detected in many" 8 "NK-cells: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010391, HPA047976" Approved Supported "Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane" Cytosol "CAB010391: AB_2205352, HPA047976: " "unprognostic (4.08e-1)" "unprognostic (2.71e-1)" "unprognostic (3.23e-3)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "unprognostic (1.35e-1)" "unprognostic (9.96e-4)" "unprognostic (4.24e-3)" "unprognostic (7.79e-4)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (2.88e-1)" "unprognostic (4.69e-5)" "unprognostic (1.56e-1)" "unprognostic (1.78e-1)" "unprognostic (4.02e-2)" "unprognostic (7.07e-2)" 6.5 1.7 1.7 4.8 1.2 0.2 4.3 0.4 2.3 1.5 18.4 0.8 7.6 23.1 0.9 1.9 3.8 1.3 28.7 1.1 1.3 0.7 0.9 0.8 2.3 7.4 1.0 1.0 0.7 2.9 0.1 10.1 2.8 0.7 2.1 13.9 1.3 34.3 12.9 0.6 3.3 23.9 1.3 2.9 1.2 4.3 1.2 0.8 0.7 2.0 1.8 2.3 2.3 2.3 0.0 0.6 0.2 0.0 8.9 1.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.0 1.5 0.1 0.9 3.5 0.3 0.1 51.3 2.3 0.0 0.5 0.7 0.0 0.2 0.5 0.1 0.1 0.3 1.3 1.3 0.0 0.0 0.0 0.4 0.0 0.0 2.5 8.1 0.1 0.0 0.2 0.6 0.6 8.7 0.3 0.2 1.3 0.0 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 8.9 0.0 0.6 1.0 0.0 1.7 1.2 0.4 2.3 1.3 0.7 1.0 1.0 0.7 0.8 TNFRSF12A "CD266, FN14, TweakR" ENSG00000006327 "TNF receptor superfamily member 12A" Q9NP84 16 3018445-3022383 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 25.0" "Group enriched" "Detected in many" 8 "eosinophil: 38.1;neutrophil: 29.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA007853 Approved Approved "Plasma membrane,Cytosol" 170000 "Plasma membrane, Cytosol" "HPA007853: AB_1858463" "unprognostic (1.44e-1)" "unprognostic (2.46e-3)" "unprognostic (8.90e-2)" "unprognostic (2.60e-1)" "unprognostic (4.06e-3)" "prognostic unfavourable (5.50e-4)" "unprognostic (7.04e-3)" "unprognostic (1.98e-3)" "unprognostic (4.17e-3)" "unprognostic (2.85e-1)" "unprognostic (5.02e-3)" "unprognostic (3.88e-1)" "prognostic unfavourable (8.78e-4)" "unprognostic (2.98e-2)" "unprognostic (6.00e-2)" "unprognostic (2.80e-3)" "unprognostic (2.17e-2)" 10.8 14.2 2.4 11.3 5.1 2.7 21.2 0.9 3.0 8.0 18.9 3.2 4.1 14.5 11.6 10.2 10.7 6.4 28.1 27.0 5.0 2.6 50.4 36.2 23.0 2.6 4.8 0.5 6.4 47.0 51.1 20.0 81.3 25.0 11.1 1.9 2.8 17.3 6.9 23.3 5.0 31.0 16.8 4.3 3.9 13.2 5.3 3.3 1.2 11.5 11.5 4.7 14.8 5.2 0.0 4.1 38.1 3.5 2.0 2.4 1.1 24.3 19.8 2.2 4.1 4.0 9.2 13.1 51.3 37.2 44.0 28.3 8.5 43.5 0.1 68.0 34.1 27.0 0.5 37.5 16.9 0.9 1.3 0.1 6.6 7.2 27.8 0.4 1.8 8.5 26.0 46.2 55.4 12.7 2.7 0.3 46.3 46.0 0.0 3.2 10.7 43.4 0.2 24.7 1.0 44.5 4.8 2.5 0.8 36.6 17.0 30.3 8.9 0.7 22.3 79.3 36.6 52.4 84.2 0.8 0.3 0.3 24.7 2.2 62.3 3.5 3.5 38.1 1.8 2.0 2.4 0.0 0.8 1.5 4.1 0.0 0.4 0.8 29.9 2.0 1.3 0.1 1.0 1.1 2.4 5.1 0.9 3.0 5.0 2.6 4.8 0.5 25.0 3.3 TNFRSF13B "CD267, IGAD2, TACI" ENSG00000240505 "TNF receptor superfamily member 13B" O14836 17 16929816-16972118 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 45.1;lymphoid tissue: 44.6;skeletal muscle: 30.5" "Group enriched" "Detected in some" 8 "Karpas-707: 54.6;RPMI-8226: 34.3;U-266/70: 24.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 42 "memory B-cell: 45.1;naive B-cell: 13.1" "Lineage enriched" "Detected in single" 65 "B-cells: 45.1" "Low region specificity" "Detected in all" HPA030453 Uncertain "HPA030453: AB_10601700" "unprognostic (3.94e-5)" "unprognostic (1.11e-3)" "unprognostic (4.88e-2)" "unprognostic (4.30e-3)" "unprognostic (1.23e-4)" "unprognostic (2.16e-1)" "unprognostic (1.62e-3)" "unprognostic (1.47e-2)" "unprognostic (1.61e-4)" "unprognostic (2.22e-1)" "unprognostic (9.78e-2)" "unprognostic (1.59e-5)" "unprognostic (1.20e-1)" "unprognostic (4.49e-1)" "unprognostic (1.39e-1)" "unprognostic (2.05e-1)" 0.5 0.3 0.4 17.6 0.3 0.2 0.5 0.2 0.3 0.7 3.0 0.1 0.0 1.9 0.3 0.0 2.7 0.5 0.5 2.5 0.3 0.3 0.6 0.5 1.2 12.5 0.3 0.2 0.3 0.3 0.0 0.3 0.0 0.1 0.9 1.2 0.6 9.0 1.1 30.5 0.3 14.8 0.0 0.4 44.6 2.4 0.3 0.1 0.9 0.6 0.9 37.8 2.3 0.4 45.1 0.0 0.1 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 54.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 4.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.0 13.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.1 0.1 TNFRSF13C "BAFFR, CD268" ENSG00000159958 "TNF receptor superfamily member 13C" Q96RJ3 22 41922023-41926818 "CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.3;intestine: 18.9;lymphoid tissue: 69.1" "Group enriched" "Detected in some" 6 "REH: 19.9;U-698: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 51 "memory B-cell: 14.5;naive B-cell: 20.3" "Lineage enriched" "Detected in single" 59 "B-cells: 20.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA003246, CAB008380" Enhanced "CAB008380: AB_590602, HPA003246: AB_1078264" "unprognostic (3.43e-4)" "prognostic favourable (4.44e-7)" "unprognostic (6.52e-2)" "unprognostic (9.10e-2)" "unprognostic (7.64e-3)" "unprognostic (4.83e-3)" "unprognostic (2.89e-2)" "unprognostic (3.78e-3)" "unprognostic (1.95e-1)" "unprognostic (1.27e-1)" "unprognostic (2.51e-2)" "unprognostic (1.66e-1)" "unprognostic (4.79e-8)" "unprognostic (2.21e-1)" "unprognostic (1.89e-1)" "unprognostic (1.77e-1)" "unprognostic (9.44e-2)" 0.9 0.8 0.8 41.0 1.0 3.3 0.6 1.0 2.0 0.5 1.2 4.4 0.0 0.7 0.4 0.2 5.0 0.5 0.6 0.6 0.8 0.9 0.9 0.5 1.8 48.4 1.0 0.6 0.4 0.4 0.0 0.4 0.1 1.8 0.6 0.7 0.5 5.8 0.0 1.2 2.0 18.9 0.1 1.1 69.1 1.4 0.7 0.6 2.0 0.8 0.3 51.4 9.5 0.7 20.3 0.2 0.3 0.2 0.2 0.2 0.5 0.3 0.2 1.1 2.3 0.0 0.0 0.5 0.1 0.1 0.2 0.8 0.9 0.5 1.8 0.4 0.2 0.3 0.6 0.0 0.3 0.4 2.2 0.2 0.3 0.2 0.1 1.6 0.4 0.1 0.0 0.4 0.1 0.0 0.4 1.8 0.2 0.7 1.5 1.7 0.7 0.1 19.9 2.4 1.5 0.0 0.2 1.2 0.3 0.1 0.4 0.3 0.4 2.2 0.2 0.5 2.6 0.9 0.3 2.1 1.0 10.8 0.1 1.7 0.5 0.3 0.1 0.1 0.1 0.1 0.2 14.5 0.2 0.1 0.0 20.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.5 0.8 1.0 1.0 2.0 0.8 0.9 1.0 0.6 1.8 0.6 TNFRSF14 "ATAR, CD270, HVEA, HVEM, LIGHTR, TR2" ENSG00000157873 "TNF receptor superfamily member 14" Q92956 1 2555639-2565382 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.3;HDLM-2: 14.4;HHSteC: 16.9;Karpas-707: 13.3;SK-MEL-30: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA006404, CAB026150, CAB030007" Approved Approved "Cytosol,Rods & Rings" Cytosol "Rods & Rings" "CAB026150: , CAB030007: AB_2303380, HPA006404: AB_1851348" "prognostic favourable (4.39e-5)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "prognostic favourable (8.01e-6)" "unprognostic (1.11e-2)" "unprognostic (6.83e-3)" "unprognostic (9.62e-3)" "unprognostic (2.32e-1)" "unprognostic (3.25e-1)" "unprognostic (1.62e-1)" "unprognostic (2.31e-1)" "unprognostic (1.64e-1)" "unprognostic (1.86e-2)" "unprognostic (1.16e-2)" "unprognostic (2.72e-2)" "unprognostic (1.58e-1)" "prognostic favourable (7.79e-6)" 15.9 24.9 4.9 38.9 2.8 11.0 21.9 2.0 4.5 16.8 36.3 3.2 18.5 36.3 15.2 20.5 13.7 12.3 36.7 12.7 4.9 2.5 19.3 20.5 30.3 33.2 3.6 5.7 12.8 7.3 3.5 9.3 8.3 3.9 21.5 8.2 44.1 20.9 22.6 5.2 8.4 41.9 14.6 4.1 36.7 16.7 5.9 2.7 23.5 10.8 10.6 25.0 15.4 17.2 18.2 9.7 30.2 25.8 8.1 25.1 14.2 1.3 0.1 0.1 2.3 5.0 2.7 0.7 0.7 2.3 1.3 1.9 0.2 14.3 0.8 0.1 2.1 1.3 0.0 0.8 0.2 14.4 0.0 8.4 0.4 2.6 16.9 1.1 10.4 2.6 1.4 0.7 0.1 3.7 1.1 13.3 1.2 0.0 4.6 1.3 0.0 1.2 3.8 0.0 4.1 0.2 2.0 0.4 0.0 0.5 0.1 27.9 0.4 0.3 9.4 0.2 0.6 0.2 0.1 10.8 2.6 0.4 2.3 1.2 1.0 3.0 15.1 8.2 17.2 25.8 14.9 16.6 18.0 14.8 9.7 18.2 17.3 14.9 30.2 8.1 24.1 8.7 25.1 14.2 4.9 2.8 2.0 4.5 4.9 2.5 3.6 5.7 3.9 2.7 TNFRSF18 "AITR, CD357, GITR" ENSG00000186891 "TNF receptor superfamily member 18" Q9Y5U5 1 1203508-1206691 "CD markers, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 46.6;skin 1: 28.9" "Group enriched" "Detected in some" 11 "RPMI-8226: 61.2;SCLC-21H: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 46.6" "Group enriched" "Detected in many" 11 "NK-cells: 46.6;T-cells: 19.0" HPA008025 Approved "Secreted to blood" "HPA008025: AB_1849696" "unprognostic (1.20e-3)" "unprognostic (4.61e-2)" "unprognostic (4.59e-2)" "prognostic favourable (7.72e-6)" "unprognostic (2.73e-4)" "prognostic favourable (4.12e-4)" "unprognostic (3.43e-2)" "unprognostic (2.31e-1)" "unprognostic (3.33e-2)" "unprognostic (1.01e-1)" "unprognostic (1.00e-1)" "unprognostic (1.20e-1)" "prognostic unfavourable (4.40e-11)" "unprognostic (1.02e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-1)" "unprognostic (2.08e-1)" 1.4 0.5 1.0 8.9 1.0 1.9 4.2 4.9 2.5 14.3 8.3 0.3 0.1 5.7 2.1 1.1 4.7 1.0 3.7 0.2 0.5 0.3 1.1 1.7 3.0 9.1 0.4 2.4 0.3 2.7 9.4 3.8 1.3 1.7 1.9 1.2 0.5 9.0 2.6 1.0 28.9 5.0 0.2 0.3 6.7 3.8 0.8 0.1 4.4 0.9 2.7 8.2 1.5 2.2 2.9 0.0 0.2 0.0 46.6 19.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 4.6 0.0 0.0 61.2 0.0 0.0 43.9 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.6 1.3 8.5 1.2 0.0 2.9 0.3 0.4 0.2 46.6 0.0 0.0 19.0 2.1 1.0 1.0 4.9 2.5 0.5 0.3 0.4 2.4 1.7 0.1 TNFRSF19 "TAJ, TAJ-alpha, TRADE, TROY" ENSG00000127863 "TNF receptor superfamily member 19" Q9NS68 13 23570370-23676104 "Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 60.5;skin 1: 47.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.1;BJ hTERT+: 26.3;fHDF/TERT166: 20.0;Hep G2: 27.3;SK-MEL-30: 45.6;WM-115: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "naive B-cell: 1.9;T-reg: 4.0" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010135 Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA010135: AB_1079797" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" "unprognostic (1.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.86e-3)" "unprognostic (2.01e-2)" "prognostic favourable (3.87e-4)" "unprognostic (3.74e-1)" "unprognostic (5.47e-2)" "unprognostic (4.41e-2)" "unprognostic (6.56e-2)" "prognostic favourable (9.13e-7)" "unprognostic (3.44e-2)" "unprognostic (6.05e-2)" "unprognostic (3.25e-3)" "unprognostic (5.38e-3)" 1.3 1.3 1.0 0.4 1.4 0.6 4.6 0.8 2.0 3.4 1.5 3.0 17.1 0.7 5.3 7.3 5.1 14.3 2.3 14.7 1.5 1.5 7.1 0.5 7.9 0.6 3.0 1.3 3.4 2.2 0.1 8.0 3.8 2.8 12.7 0.8 11.4 60.5 13.0 1.2 47.9 0.9 4.1 1.9 2.5 2.4 2.7 1.1 0.8 5.7 8.0 3.7 2.7 4.0 1.9 0.7 0.7 0.0 0.6 4.0 0.2 0.0 1.0 1.1 0.0 1.6 16.1 1.1 1.2 26.3 0.6 0.9 7.6 0.0 0.0 0.0 20.0 0.0 1.0 0.9 1.2 0.0 0.9 0.2 0.8 27.3 0.7 0.0 0.3 7.7 0.2 7.6 0.1 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.7 1.6 0.0 4.5 0.0 2.7 0.1 10.5 1.8 0.0 0.0 45.6 0.0 0.1 0.0 3.8 0.2 0.0 1.1 0.0 0.0 0.0 1.5 0.0 28.4 0.0 0.0 0.7 0.0 0.0 0.4 0.7 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.7 4.0 0.2 1.0 1.4 0.8 2.0 1.5 1.5 3.0 1.3 2.8 1.1 TNFRSF1A "CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60" ENSG00000067182 "TNF receptor superfamily member 1A" P19438 12 6328757-6342114 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Apoptosis, Host-virus interaction" Receptor "Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 86.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004102, CAB010309" Approved "Secreted to blood" 170000 "CAB010309: AB_2206639, HPA004102: AB_1846232" "unprognostic (2.19e-2)" "unprognostic (3.76e-2)" "unprognostic (8.14e-2)" "prognostic favourable (8.22e-4)" "unprognostic (3.07e-2)" "prognostic unfavourable (3.68e-4)" "unprognostic (1.50e-1)" "unprognostic (1.41e-3)" "unprognostic (1.00e-1)" "unprognostic (8.05e-2)" "unprognostic (4.78e-2)" "unprognostic (1.54e-2)" "prognostic unfavourable (2.70e-7)" "unprognostic (1.43e-2)" "unprognostic (2.92e-2)" "unprognostic (5.14e-3)" "unprognostic (1.74e-1)" 55.1 43.9 16.8 28.9 16.8 13.7 40.6 7.2 15.6 40.3 41.5 14.1 22.6 39.2 38.2 27.5 39.4 34.2 37.1 26.8 14.0 7.5 49.3 61.6 40.9 37.2 19.2 6.4 59.5 21.4 20.3 19.9 45.3 18.3 37.0 23.0 31.1 25.7 22.2 34.2 30.9 81.7 38.8 25.1 43.6 28.2 21.8 15.7 31.6 42.7 25.4 22.3 49.1 58.5 0.0 20.8 86.5 27.1 1.8 11.6 15.9 7.4 57.8 8.1 11.5 56.0 57.3 15.3 15.9 27.5 21.3 18.6 6.9 29.7 0.6 5.5 34.3 20.8 2.5 18.6 14.8 0.1 4.8 4.1 16.0 15.3 49.7 19.3 13.0 59.0 18.7 17.7 26.1 26.0 6.2 5.7 24.5 10.6 6.1 18.2 19.7 16.9 5.3 12.9 5.7 16.5 13.5 0.0 0.4 22.5 11.8 11.8 3.2 21.1 28.3 16.8 14.4 12.6 14.7 0.0 1.8 2.4 20.1 18.0 20.8 2.2 27.1 15.0 11.6 21.8 11.1 0.0 4.9 9.5 20.8 0.0 4.5 6.6 86.5 1.8 17.5 6.0 4.8 15.9 16.8 16.8 7.2 15.6 14.0 7.5 19.2 6.4 18.3 15.7 TNFRSF1B "CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80" ENSG00000028137 "TNF receptor superfamily member 1B" P20333 1 12167003-12209228 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.1;K-562: 20.9;THP-1: 24.5;U-87 MG: 16.8;U-937: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 70.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004796 Approved "Secreted to blood" 3226667 2500000 "HPA004796: AB_1078436" "unprognostic (4.45e-2)" "unprognostic (2.27e-3)" "unprognostic (7.62e-2)" "unprognostic (3.82e-3)" "unprognostic (6.30e-2)" "unprognostic (4.47e-3)" "unprognostic (5.28e-3)" "unprognostic (2.79e-1)" "unprognostic (1.69e-2)" "unprognostic (1.73e-2)" "unprognostic (7.26e-2)" "unprognostic (2.48e-1)" "prognostic unfavourable (8.35e-5)" "unprognostic (2.02e-1)" "prognostic unfavourable (8.68e-4)" "unprognostic (3.26e-2)" "unprognostic (1.10e-1)" 43.4 4.7 4.6 44.3 13.8 29.2 42.3 2.1 6.1 13.3 13.1 6.6 1.9 11.9 9.7 10.2 6.5 11.3 11.6 21.8 8.5 6.2 6.2 22.2 24.5 60.6 9.1 2.2 9.4 4.2 2.3 4.4 24.9 15.0 7.3 8.2 8.3 5.7 3.7 11.5 6.2 17.3 11.5 22.6 48.3 10.5 6.0 6.1 10.9 6.2 5.6 16.2 18.3 8.4 2.7 13.2 25.7 70.1 2.5 12.7 19.9 0.0 0.1 2.0 0.0 5.5 7.5 4.3 0.5 1.0 2.0 2.2 0.8 17.1 0.1 0.3 1.8 0.0 0.4 0.0 1.1 6.8 0.0 0.0 0.1 0.0 12.9 0.1 1.8 7.4 0.0 6.8 0.0 10.4 20.9 3.1 0.9 0.0 0.0 3.9 0.1 0.6 0.5 0.2 12.0 0.0 0.4 0.0 0.0 0.3 0.1 0.6 0.0 24.5 3.6 3.0 0.1 13.0 0.0 0.9 0.0 0.0 16.8 17.7 0.7 0.0 20.7 3.0 9.4 49.3 5.4 2.7 6.6 7.7 13.2 1.7 2.0 3.0 25.7 2.5 70.1 2.8 12.7 19.9 4.6 13.8 2.1 6.1 8.5 6.2 9.1 2.2 15.0 6.1 TNFRSF21 "CD358, DR6" ENSG00000146072 "TNF receptor superfamily member 21" O75509 6 47231532-47309905 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.4" "Cell line enhanced" "Detected in many" "RT4: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 35 "plasmacytoid DC: 31.6" "Lineage enriched" "Detected in single" 309 "dendritic cells: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006746, CAB009805" Approved Supported "Plasma membrane,Cytosol" 1300000 "Plasma membrane, Cytosol" "CAB009805: AB_2206956, HPA006746: AB_1078701" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (3.26e-1)" "unprognostic (7.85e-2)" "unprognostic (1.44e-1)" "unprognostic (3.41e-2)" "unprognostic (9.80e-3)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (7.53e-2)" "unprognostic (1.38e-3)" "unprognostic (1.74e-1)" "prognostic favourable (7.23e-6)" "unprognostic (1.48e-1)" "unprognostic (1.34e-1)" "unprognostic (9.78e-2)" "unprognostic (1.45e-2)" 25.9 3.7 9.7 8.7 13.6 5.9 7.8 7.4 20.8 9.6 19.3 26.9 1.0 6.4 9.1 3.0 21.8 9.9 18.7 4.1 13.8 16.0 26.2 4.6 9.5 11.5 26.8 7.9 5.0 17.9 35.6 4.4 17.0 29.5 10.2 18.5 3.0 15.2 2.4 3.5 2.7 10.2 8.2 63.4 11.6 30.4 5.8 10.1 11.5 2.9 19.2 16.5 41.2 11.6 0.0 31.6 0.1 0.0 0.0 0.0 0.2 29.9 9.7 9.5 3.0 26.1 7.7 10.8 3.5 6.9 1.1 0.4 16.8 21.2 2.2 14.2 2.5 18.1 1.4 12.9 0.6 0.0 2.9 0.0 1.2 16.9 15.3 0.4 0.1 13.7 15.5 0.6 11.8 5.1 0.7 0.0 0.3 5.9 2.6 0.2 7.4 10.1 5.6 2.9 3.2 18.1 102.3 6.8 1.5 3.0 2.8 2.4 2.2 2.1 1.0 2.8 2.6 0.1 3.2 0.0 0.0 3.1 4.7 2.1 7.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.2 9.7 13.6 7.4 20.8 13.8 16.0 26.8 7.9 29.5 10.1 TNFRSF25 "APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR" ENSG00000215788 "TNF receptor superfamily member 25" Q93038 1 6461151-6466195 "Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1" "Cell line enhanced" "Detected in many" "HDLM-2: 19.7;NB-4: 7.8;RPMI-8226: 19.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 11 "cerebellum: 19.2" "Cell type enhanced" "Detected in many" "T-reg: 9.5" "Lineage enriched" "Detected in single" 10 "T-cells: 9.5" "Group enriched" "Detected in some" 6 "amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3" "Not detected" "Not detected" HPA069834 Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" "Secreted - unknown location" "Plasma membrane, Actin filaments, Focal adhesion sites" Nucleoplasm "HPA069834: " "unprognostic (8.09e-3)" "unprognostic (6.91e-3)" "prognostic unfavourable (4.46e-4)" "unprognostic (1.97e-1)" "unprognostic (9.63e-3)" "prognostic favourable (3.09e-4)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (6.01e-2)" "unprognostic (3.98e-2)" "prognostic unfavourable (1.65e-7)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (8.68e-3)" 2.2 1.6 1.2 20.3 1.6 0.4 1.4 19.2 1.8 1.4 13.4 0.7 0.6 2.8 1.2 0.6 4.1 2.4 2.1 2.3 1.8 0.9 1.4 2.3 6.3 13.9 1.1 0.6 1.1 0.6 1.4 14.0 4.1 1.3 1.9 1.3 1.1 10.5 2.3 0.8 24.1 11.2 0.6 0.6 18.9 0.8 1.0 0.8 11.7 1.1 3.2 26.0 3.2 1.5 0.0 0.4 0.0 0.9 0.6 9.5 1.3 1.4 0.3 0.8 1.5 0.0 0.4 0.8 0.6 0.4 0.2 0.0 1.2 2.1 0.0 2.9 0.0 3.1 0.4 3.6 0.0 19.7 1.4 0.8 1.1 0.0 0.6 0.0 0.0 0.0 2.4 1.2 3.1 3.1 0.0 0.0 0.0 1.6 0.0 7.8 1.0 5.3 0.6 0.2 19.3 0.8 0.5 3.8 5.2 0.0 1.9 0.1 1.6 2.1 1.6 1.0 1.5 0.0 1.5 0.0 3.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.7 0.3 8.0 0.0 6.9 3.2 0.4 0.0 6.4 1.1 0.0 0.6 0.9 0.0 9.5 1.3 1.2 1.6 19.2 1.8 1.8 0.9 1.1 0.6 1.3 0.8 TNFRSF4 "ACT35, CD134, OX40, TXGP1L" ENSG00000186827 "TNF receptor superfamily member 4" P43489 1 1211326-1214138 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 12.5;blood: 18.4;lymphoid tissue: 13.6" "Group enriched" "Detected in some" 9 "MOLT-4: 7.8;NB-4: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 15.9;T-reg: 18.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" CAB016128 Enhanced "CAB016128: AB_626897" "unprognostic (2.24e-1)" "unprognostic (8.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.55e-3)" "unprognostic (1.02e-1)" "prognostic favourable (3.50e-6)" "prognostic unfavourable (6.03e-4)" "unprognostic (3.30e-1)" "unprognostic (1.48e-2)" "unprognostic (7.04e-3)" "unprognostic (1.04e-2)" "unprognostic (1.47e-1)" "prognostic unfavourable (4.52e-6)" "unprognostic (1.61e-1)" "unprognostic (5.46e-2)" "unprognostic (2.42e-1)" "unprognostic (5.91e-2)" 12.5 0.2 0.6 8.8 0.4 0.7 7.3 0.3 1.2 1.1 3.1 0.3 0.3 2.6 0.8 0.7 1.7 0.9 0.8 6.7 0.8 0.1 2.2 0.4 5.3 8.4 0.3 0.6 0.5 0.9 0.0 1.3 5.9 0.6 3.2 0.3 0.6 2.2 1.1 4.4 0.8 4.3 0.3 0.3 13.5 3.5 2.0 0.3 13.6 4.1 0.8 10.9 1.4 0.7 0.0 0.6 4.1 0.0 8.1 18.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 15.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.2 0.0 1.8 0.0 15.9 1.7 0.0 0.0 1.5 0.0 0.2 8.1 0.0 0.6 18.4 1.5 0.6 0.4 0.3 1.2 0.8 0.1 0.3 0.6 0.6 0.3 TNFRSF8 "CD30, D1S166E, KI-1" ENSG00000120949 "TNF receptor superfamily member 8" P28908 1 12063377-12144207 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.3" "Cell line enriched" "Detected in some" 21 "HDLM-2: 109.9" "Cancer enriched" "Detected in some" 12 "testis cancer: 9.3" "Region enriched" "Detected in single" 14 "basal ganglia: 13.1" "Cell type enhanced" "Detected in some" "intermediate monocyte: 21.7;non-classical monocyte: 33.3" "Lineage enriched" "Detected in many" 5 "monocytes: 33.3" "Low region specificity" "Detected in many" "CAB000016, HPA014823, HPA032081, HPA032082" Approved Supported "Plasma membrane" "Plasma membrane" "CAB000016: AB_563546, HPA014823: , HPA032081: , HPA032082: " "unprognostic (1.07e-2)" "unprognostic (2.06e-2)" "unprognostic (2.52e-2)" "unprognostic (5.98e-2)" "unprognostic (2.50e-1)" "unprognostic (1.46e-3)" "unprognostic (2.19e-1)" "unprognostic (3.93e-2)" "unprognostic (1.18e-1)" "unprognostic (9.18e-3)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (3.17e-8)" "unprognostic (3.31e-1)" "unprognostic (8.56e-2)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" 10.7 0.2 0.1 7.2 13.1 1.4 5.8 0.2 0.4 1.1 0.8 0.0 1.5 0.2 1.7 1.3 0.9 2.1 1.4 3.8 0.1 0.2 0.9 0.2 3.9 2.9 0.5 0.5 1.2 0.4 0.0 0.1 6.2 0.5 1.0 0.5 0.0 0.7 0.3 3.1 1.6 1.3 1.3 1.4 2.9 6.4 2.5 0.9 3.0 0.7 2.7 5.3 2.6 3.8 0.0 3.2 6.8 33.3 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 109.9 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.3 0.0 0.0 0.2 0.0 4.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.3 0.0 21.7 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 6.8 0.0 33.3 0.8 0.3 2.7 0.1 13.1 0.2 0.4 0.1 0.2 0.5 0.5 0.5 0.9 TNFRSF9 "4-1BB, CD137, ILA" ENSG00000049249 "TNF receptor superfamily member 9" Q07011 1 7915894-7943165 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 13.5;lymphoid tissue: 18.3" "Cell line enriched" "Detected in some" 8 "HDLM-2: 45.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5" "Group enriched" "Detected in many" 5 "granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA071425 Approved "Nucleoli,Plasma membrane" "Plasma membrane" Nucleoli "HPA071425: " "unprognostic (7.23e-2)" "unprognostic (1.72e-2)" "unprognostic (8.26e-3)" "unprognostic (1.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-4)" "unprognostic (9.47e-3)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "prognostic unfavourable (2.69e-8)" "unprognostic (1.64e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (9.55e-2)" 0.8 1.0 0.3 11.0 0.3 1.9 0.5 0.2 0.3 0.4 0.5 0.1 0.1 0.6 0.3 0.1 0.6 0.8 1.6 1.8 0.3 1.0 0.7 0.7 2.1 10.8 0.3 0.1 0.3 0.6 0.0 0.5 0.2 0.5 0.4 0.7 0.3 2.1 0.1 0.3 0.5 2.3 0.1 0.3 7.9 0.7 0.5 0.1 18.3 0.7 0.9 17.5 1.4 0.4 0.5 1.1 6.6 1.5 4.1 13.5 1.1 1.2 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.9 0.3 0.1 0.4 0.0 0.1 0.0 0.2 0.4 45.9 0.1 0.2 0.2 0.0 0.9 0.0 0.5 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.2 0.2 1.5 0.1 0.2 0.1 0.1 0.1 5.7 0.2 0.0 1.1 1.5 0.2 1.5 0.4 0.2 0.2 1.0 8.0 1.1 0.5 0.3 1.6 6.6 4.1 0.1 0.3 13.5 1.1 0.3 0.3 0.2 0.3 0.3 1.0 0.3 0.1 0.5 0.1 TNFSF10 "Apo-2L, CD253, TL2, TRAIL" ENSG00000121858 "TNF superfamily member 10" P50591 3 172505508-172523507 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 115.1" "Cell line enhanced" "Detected in many" "BEWO: 20.5;CAPAN-2: 14.6;HMC-1: 67.6;RPTEC TERT1: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 42.4;classical monocyte: 25.6;intermediate monocyte: 39.5;neutrophil: 50.3;non-classical monocyte: 38.3" "Group enriched" "Detected in all" 5 "granulocytes: 50.3;monocytes: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054938 Uncertain Approved Microtubules "Secreted to blood" 67430 Microtubules "HPA054938: " "unprognostic (9.16e-2)" "unprognostic (2.79e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-3)" "unprognostic (2.52e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-1)" "unprognostic (2.01e-1)" "unprognostic (1.99e-1)" "unprognostic (1.71e-2)" "prognostic unfavourable (9.43e-4)" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (3.68e-2)" "unprognostic (1.32e-1)" "unprognostic (6.27e-2)" 30.9 22.1 3.4 14.6 4.7 2.0 23.3 3.0 5.4 31.4 25.8 4.4 17.1 20.6 13.0 10.3 33.3 9.6 10.7 9.9 3.8 3.2 115.1 44.4 91.5 23.5 5.5 3.4 13.5 11.6 10.9 6.7 100.8 6.7 37.6 19.5 12.0 50.6 12.9 13.9 13.0 54.0 7.9 5.6 35.8 9.5 6.0 4.6 8.3 28.2 17.7 16.1 22.4 24.0 3.4 9.5 50.3 39.5 9.3 7.0 11.9 3.3 0.1 0.0 0.0 2.4 1.8 20.5 0.0 0.1 1.0 1.6 0.0 14.6 2.1 9.8 0.0 14.4 0.0 1.8 0.2 5.2 0.0 0.0 0.4 0.3 0.1 3.8 67.6 2.4 2.3 0.4 0.0 7.4 0.0 2.4 0.0 0.0 0.4 5.1 0.0 0.1 0.7 0.0 0.9 34.1 1.3 0.0 0.1 7.5 0.3 0.1 4.1 2.2 0.3 0.0 0.0 0.0 0.2 2.6 0.3 2.6 0.2 2.2 0.0 42.4 25.6 2.7 2.3 39.5 3.1 3.2 6.4 3.5 9.5 3.4 4.7 1.8 50.3 9.3 38.3 0.6 7.0 11.9 3.4 4.7 3.0 5.4 3.8 3.2 5.5 3.4 6.7 4.6 TNFSF11 "CD254, ODF, OPGL, RANKL, TRANCE" ENSG00000120659 "TNF superfamily member 11" O14788 13 42562736-42608013 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Differentiation "Cytokine, Developmental protein, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 14.3;lymphoid tissue: 19.8" "Cell line enhanced" "Detected in some" "Daudi: 1.7;HSkMC: 5.2;NTERA-2: 7.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "NK-cell: 14.3" "Lineage enriched" "Detected in many" 8 "NK-cells: 14.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB009193, HPA045142" Enhanced "Secreted to blood" 17195 "CAB009193: , HPA045142: " "unprognostic (3.97e-4)" "unprognostic (1.40e-1)" "unprognostic (9.01e-3)" "unprognostic (3.81e-3)" "unprognostic (1.12e-1)" "unprognostic (1.09e-1)" "unprognostic (7.09e-2)" "unprognostic (7.70e-2)" "unprognostic (2.29e-1)" "unprognostic (1.25e-3)" "unprognostic (1.00e-1)" "unprognostic (1.50e-1)" "unprognostic (3.94e-5)" "unprognostic (1.87e-1)" "unprognostic (9.67e-2)" "unprognostic (5.46e-2)" "unprognostic (7.74e-2)" 0.5 0.2 0.2 19.5 0.2 0.0 4.6 0.1 0.2 0.8 0.8 0.1 2.4 0.2 0.2 0.1 3.7 0.2 1.3 0.3 0.1 0.7 0.6 5.3 0.4 19.8 0.1 0.1 0.1 0.6 0.0 0.3 0.3 0.4 0.5 2.2 0.1 1.6 1.0 0.2 0.5 6.0 0.1 0.1 0.8 0.3 3.3 0.1 2.8 0.4 0.1 5.2 2.3 0.7 0.0 0.1 1.8 0.0 14.3 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.6 0.0 0.1 5.2 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 7.4 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.1 0.7 0.1 0.1 0.4 0.1 TNFSF13B "BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20" ENSG00000102524 "TNF superfamily member 13b" Q9Y275 13 108251240-108308484 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 76.5;lymphoid tissue: 39.6" "Cell line enriched" "Detected in some" 7 "U-937: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 76.5" "Group enriched" "Detected in many" 10 "dendritic cells: 31.0;granulocytes: 76.5;monocytes: 53.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB009188 Enhanced "Secreted to blood" 393384 530000 "CAB009188: " "unprognostic (6.48e-2)" "unprognostic (3.05e-3)" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" "unprognostic (2.61e-2)" "unprognostic (7.99e-2)" "unprognostic (8.19e-2)" "unprognostic (1.37e-1)" "unprognostic (1.63e-1)" "unprognostic (1.02e-2)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (2.53e-11)" "unprognostic (1.23e-1)" "unprognostic (4.14e-2)" "unprognostic (1.88e-1)" "unprognostic (1.25e-1)" 7.2 8.2 3.0 18.5 8.2 13.2 3.4 1.4 5.2 1.6 4.2 2.1 1.0 7.8 1.2 6.5 3.5 2.9 9.4 9.4 5.7 2.9 3.1 5.0 13.2 39.6 7.2 2.6 2.9 2.7 0.5 2.1 6.4 5.7 3.7 6.4 2.6 5.4 1.8 1.6 1.6 6.8 3.5 11.6 23.5 3.4 1.0 4.9 7.2 5.1 1.7 12.7 8.5 3.8 1.0 31.0 76.5 53.7 0.6 5.3 20.8 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.3 0.2 0.7 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.3 0.1 0.0 0.1 3.5 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.0 0.1 0.0 7.9 0.0 0.1 0.0 0.0 0.1 3.7 0.1 0.0 3.8 59.5 0.6 1.2 53.7 14.4 0.8 39.8 5.3 0.6 3.5 0.7 31.0 1.0 1.7 0.5 76.5 0.6 31.7 11.5 2.8 20.8 3.0 8.2 1.4 5.2 5.7 2.9 7.2 2.6 5.7 4.9 TNFSF14 "CD258, HVEM-L, LIGHT, LTg" ENSG00000125735 "TNF superfamily member 14" O43557 19 6661253-6670588 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.8;liver: 50.6" "Cell line enhanced" "Detected in some" "HDLM-2: 21.1;NB-4: 4.7;THP-1: 3.3;U-937: 12.0" "Cancer enhanced" "Detected in many" "liver cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 50.8" "Group enriched" "Detected in many" 5 "granulocytes: 50.8;T-cells: 16.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012700 Approved "Secreted to blood" 40957 "HPA012700: AB_1852870" "unprognostic (2.78e-3)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (2.35e-3)" "unprognostic (3.82e-4)" "unprognostic (4.51e-2)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (1.05e-2)" "unprognostic (9.23e-2)" "unprognostic (9.22e-2)" "unprognostic (3.59e-1)" "prognostic unfavourable (6.07e-13)" "unprognostic (1.09e-1)" "unprognostic (9.56e-3)" "unprognostic (1.75e-1)" "unprognostic (3.62e-2)" 11.2 0.9 0.6 4.6 0.6 2.5 1.3 1.2 1.5 0.8 2.4 0.4 0.2 2.8 2.7 2.3 1.8 3.6 2.0 2.1 0.6 0.1 1.0 50.6 4.3 8.3 3.8 0.2 2.9 2.5 0.0 0.9 1.8 1.4 1.2 1.8 1.9 1.4 1.5 0.2 0.7 3.8 1.6 0.3 8.2 1.8 1.6 0.2 1.5 1.4 0.9 5.9 2.1 14.1 0.3 1.7 50.8 4.5 7.2 16.6 2.9 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 0.0 21.1 0.0 0.1 0.2 1.1 0.0 0.6 0.5 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 3.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.7 12.0 0.0 28.3 4.5 27.4 11.4 1.0 16.6 0.1 4.9 9.2 1.7 0.3 0.8 4.2 50.8 7.2 0.1 0.1 3.9 2.9 0.6 0.6 1.2 1.5 0.6 0.1 3.8 0.2 1.4 0.2 TNMD "BRICD4, ChM1L, myodulin, TEM, tendin" ENSG00000000005 Tenomodulin Q9H2S6 X 100584802-100599885 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.4;seminal vesicle: 25.0" "Group enriched" "Detected in some" 13 "HAP1: 7.2;NTERA-2: 17.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA034961, HPA055634" Uncertain "HPA034961: AB_10670285, HPA055634: " "unprognostic (3.60e-2)" "unprognostic (9.84e-3)" "unprognostic (3.19e-2)" "unprognostic (7.77e-3)" "unprognostic (2.42e-1)" "unprognostic (2.15e-1)" "unprognostic (2.36e-2)" "unprognostic (1.37e-1)" "unprognostic (9.40e-2)" "unprognostic (9.60e-4)" "unprognostic (6.82e-2)" "unprognostic (5.67e-2)" "unprognostic (1.48e-1)" 18.4 0.1 0.1 0.4 0.0 0.0 10.9 0.0 0.1 0.4 0.6 0.0 11.1 0.0 0.2 8.9 0.4 0.2 0.3 0.7 0.9 0.1 0.7 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 1.9 0.6 1.1 0.4 4.7 1.3 25.0 5.9 2.9 0.5 0.5 0.0 0.1 0.1 0.2 0.0 0.2 0.1 2.6 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.1 0.6 0.0 0.6 0.0 TOMM20 "KIAA0016, MAS20, MOM19, TOM20" ENSG00000173726 "Translocase of outer mitochondrial membrane 20" Q15388 1 235109336-235128936 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005585, HPA011562" Supported Enhanced Mitochondria Mitochondria "CAB005585: AB_628381, HPA011562: AB_1080326" "unprognostic (1.30e-1)" "unprognostic (3.08e-3)" "unprognostic (1.66e-2)" "unprognostic (4.49e-2)" "unprognostic (8.65e-3)" "unprognostic (1.17e-2)" "unprognostic (7.09e-2)" "unprognostic (3.28e-1)" "unprognostic (3.18e-2)" "unprognostic (1.75e-1)" "unprognostic (1.16e-3)" "unprognostic (5.05e-2)" "unprognostic (7.08e-3)" "unprognostic (2.33e-2)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (3.97e-1)" 27.2 35.0 46.3 15.3 60.2 32.7 52.8 40.0 66.2 36.1 25.5 28.4 29.0 24.4 34.5 39.0 28.0 40.0 27.9 33.9 47.1 48.7 41.2 35.2 24.2 33.6 42.5 40.5 50.9 63.6 38.6 25.4 27.1 48.2 34.0 28.2 23.5 47.8 30.7 33.4 33.0 21.3 33.8 54.5 19.0 27.2 16.3 23.0 18.0 58.7 28.4 21.9 36.2 28.9 15.9 20.9 16.4 13.8 9.8 22.6 14.2 35.9 19.0 25.0 21.0 19.7 39.8 38.8 25.9 22.4 24.4 17.8 24.5 25.4 43.8 34.5 22.4 28.8 27.7 25.1 32.2 10.5 59.2 26.7 25.4 46.3 33.0 59.8 16.1 35.5 34.5 24.4 33.7 26.4 56.0 16.2 26.7 10.5 25.4 27.1 56.2 10.3 31.1 19.1 56.7 27.4 25.9 32.9 77.1 20.1 28.2 55.1 43.6 65.8 23.3 21.5 13.0 27.1 54.9 38.4 36.1 32.1 25.2 28.7 36.2 16.4 12.4 4.1 13.9 12.9 17.1 15.9 18.1 17.3 15.1 12.7 22.6 17.6 3.9 9.8 13.8 20.9 15.5 14.2 46.3 60.2 40.0 66.2 47.1 48.7 42.5 40.5 48.2 23.0 TOMM20L UNQ9438 ENSG00000196860 "Translocase of outer mitochondrial membrane 20 like" Q6UXN7 14 58395916-58408701 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 28.3" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.9" "Group enriched" "Detected in many" 10 "B-cells: 1.0;T-cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA076397 Enhanced "HPA076397: " "unprognostic (1.72e-1)" "unprognostic (2.34e-4)" "unprognostic (8.13e-2)" "unprognostic (7.80e-3)" "unprognostic (5.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (4.93e-1)" "unprognostic (1.37e-3)" "unprognostic (3.06e-2)" "unprognostic (5.66e-3)" "unprognostic (4.57e-6)" "unprognostic (8.75e-2)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" 0.5 0.4 0.2 0.2 0.6 0.1 0.5 0.6 0.8 0.5 0.5 0.8 0.0 0.0 0.9 1.8 0.2 0.4 0.5 0.3 0.2 0.2 0.7 0.3 0.4 2.2 0.3 0.0 0.7 1.2 1.1 0.5 0.3 0.6 0.8 0.5 1.7 0.5 0.5 0.2 0.3 0.4 1.4 0.3 0.3 0.6 28.3 0.0 0.0 0.9 0.0 0.6 0.3 0.2 1.0 0.1 0.0 0.1 0.0 1.9 0.4 1.8 0.0 0.5 1.9 0.0 0.0 2.0 0.3 0.0 0.3 0.0 0.0 0.5 1.6 0.2 1.0 0.3 0.0 0.0 0.0 2.8 0.6 0.5 0.0 0.5 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.9 1.2 0.5 0.8 2.0 2.1 0.7 0.3 0.3 0.5 3.3 2.3 0.5 0.4 0.5 1.4 2.8 0.0 0.2 0.4 0.0 0.5 0.0 0.3 0.2 1.5 1.4 0.5 0.0 0.0 0.0 0.4 0.1 0.0 1.0 0.1 0.5 0.0 0.2 0.1 1.9 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.6 0.6 0.8 0.2 0.2 0.3 0.0 0.6 0.0 TOMM22 TOM22 ENSG00000100216 "Translocase of outer mitochondrial membrane 22" Q9NS69 22 38681948-38685421 "Predicted membrane proteins" "Protein transport, Translocation, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003037 Supported Enhanced Mitochondria Mitochondria "HPA003037: AB_1080329" "unprognostic (5.54e-2)" "unprognostic (5.04e-3)" "unprognostic (2.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.32e-1)" "unprognostic (1.85e-2)" "prognostic unfavourable (2.90e-5)" "unprognostic (1.01e-1)" "unprognostic (4.28e-1)" "unprognostic (7.01e-2)" "unprognostic (1.64e-2)" "unprognostic (7.39e-2)" "unprognostic (5.44e-2)" "unprognostic (5.32e-2)" "unprognostic (1.99e-1)" "unprognostic (7.86e-2)" "unprognostic (1.64e-1)" 27.6 26.2 25.6 30.1 24.3 29.5 29.4 17.6 28.2 22.2 26.8 14.7 22.4 28.0 20.1 25.6 34.1 24.4 23.8 31.6 23.2 21.0 29.4 46.0 18.1 32.1 24.0 19.8 27.8 47.5 10.9 12.6 27.6 18.5 21.0 32.8 15.8 31.4 26.7 38.2 24.6 29.7 22.8 20.0 27.7 23.3 24.7 11.3 44.2 27.4 40.4 33.5 24.1 30.2 22.5 29.7 6.9 22.9 18.0 21.3 28.6 19.6 11.6 17.9 18.9 13.2 12.3 19.3 16.3 11.4 23.9 18.0 21.1 11.8 20.0 13.5 15.9 16.4 27.1 24.7 19.3 17.2 29.8 26.9 9.1 20.2 17.3 71.1 19.1 16.8 17.6 21.5 14.1 17.5 20.3 16.0 15.9 15.3 21.3 33.1 27.3 23.7 23.7 23.2 18.9 15.9 14.5 21.0 13.9 19.1 24.2 18.5 16.8 23.6 17.8 14.7 27.6 13.4 24.6 22.2 26.8 31.0 18.4 24.7 20.0 4.7 22.9 6.9 16.9 22.0 21.3 22.5 18.3 17.8 29.7 18.0 18.7 20.0 2.2 18.0 18.1 25.8 21.1 28.6 25.6 24.3 17.6 28.2 23.2 21.0 24.0 19.8 18.5 11.3 TOMM70 "KIAA0719, Tom70, TOMM70A" ENSG00000154174 "Translocase of outer mitochondrial membrane 70" O94826 3 100363431-100401398 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014589, CAB017156, HPA048020" Enhanced Enhanced Mitochondria 120000 Mitochondria "CAB017156: , HPA014589: AB_1858185, HPA048020: " "unprognostic (2.74e-2)" "unprognostic (2.25e-1)" "unprognostic (2.57e-2)" "unprognostic (2.69e-3)" "unprognostic (2.12e-2)" "unprognostic (5.96e-2)" "unprognostic (2.06e-3)" "unprognostic (5.01e-2)" "unprognostic (9.86e-2)" "unprognostic (1.21e-1)" "unprognostic (9.73e-3)" "unprognostic (5.38e-2)" "unprognostic (2.62e-3)" "unprognostic (1.73e-1)" "unprognostic (3.53e-1)" "unprognostic (3.34e-2)" "unprognostic (6.98e-3)" 21.7 16.1 16.2 12.4 52.4 9.6 21.3 23.6 26.5 16.9 18.2 12.5 13.8 19.4 17.4 15.0 20.8 14.2 12.2 25.2 16.5 19.8 24.9 40.7 10.5 13.5 16.1 20.6 21.7 18.0 20.1 17.1 15.5 29.0 19.0 20.6 13.3 14.5 19.4 42.8 13.3 17.8 22.3 14.0 12.1 14.8 14.7 15.6 18.7 20.5 19.9 16.6 22.3 22.5 4.3 3.0 2.5 2.5 5.6 5.4 1.8 23.6 16.6 14.2 20.3 20.0 21.8 18.4 20.3 17.3 18.5 19.2 23.5 13.6 28.3 17.9 17.1 23.5 25.5 18.5 27.4 10.7 11.8 32.5 11.0 22.8 12.5 39.5 15.0 19.4 17.2 16.5 27.0 13.5 23.1 23.1 22.1 17.5 26.7 16.0 19.5 35.4 24.6 28.7 30.1 15.0 17.9 25.7 21.4 14.7 23.7 26.4 30.7 22.5 12.2 16.4 21.8 9.1 15.1 25.2 35.9 48.1 15.8 23.9 12.4 2.2 2.2 2.5 4.1 2.2 5.1 4.3 5.1 4.5 2.9 3.1 5.3 5.4 0.6 5.6 2.5 3.0 2.0 1.8 16.2 52.4 23.6 26.5 16.5 19.8 16.1 20.6 29.0 15.6 TOR1AIP1 "FLJ13142, LAP1B" ENSG00000143337 "Torsin 1A interacting protein 1" Q5JTV8 1 179882042-179925000 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047151, HPA050546" Enhanced Enhanced "Nuclear membrane" 17000 "Nuclear membrane" "HPA047151: AB_2679956, HPA050546: AB_2681167" "unprognostic (1.41e-1)" "unprognostic (3.95e-3)" "unprognostic (1.24e-1)" "unprognostic (2.37e-1)" "unprognostic (8.53e-2)" "unprognostic (1.15e-1)" "unprognostic (9.00e-2)" "unprognostic (6.33e-2)" "unprognostic (7.04e-2)" "unprognostic (8.62e-2)" "unprognostic (1.93e-1)" "unprognostic (9.10e-2)" "unprognostic (4.40e-2)" "unprognostic (4.41e-2)" "unprognostic (2.87e-1)" "unprognostic (7.75e-2)" "unprognostic (4.02e-2)" 29.3 26.4 27.1 25.1 28.1 52.2 25.4 28.6 30.5 33.2 40.0 24.6 38.2 11.6 33.6 33.0 30.1 27.6 27.2 29.3 28.3 20.8 27.2 27.1 25.5 28.2 31.7 23.6 42.5 24.6 31.1 30.5 20.3 27.3 33.6 17.0 27.0 21.9 42.9 44.7 17.8 21.6 46.9 26.1 27.8 30.9 23.5 32.2 24.9 34.5 28.8 21.8 40.7 30.5 19.0 27.9 61.0 35.9 21.4 29.4 29.9 12.9 13.0 9.0 11.5 40.9 27.5 17.4 17.6 21.0 16.5 17.0 10.2 24.6 3.4 19.5 17.9 22.8 8.4 14.1 19.4 22.0 8.5 9.3 12.4 9.9 18.8 31.4 28.8 22.2 11.0 20.1 19.0 14.7 13.4 17.2 17.2 11.5 12.8 9.8 13.0 5.1 7.9 14.2 8.9 16.0 25.3 7.7 10.7 21.7 20.9 29.3 16.4 32.4 15.1 23.3 9.8 15.2 20.6 19.5 25.6 6.9 8.8 17.4 35.1 45.8 26.4 61.0 24.9 29.1 29.4 17.7 23.0 24.9 27.9 19.0 23.8 24.4 41.0 21.4 35.9 20.2 24.2 29.9 27.1 28.1 28.6 30.5 28.3 20.8 31.7 23.6 27.3 32.2 TOR1AIP2 "IFRG15, LULL1, NET9" ENSG00000169905 "Torsin 1A interacting protein 2" "Q8NFQ8, Q9H496" 1 179839967-179877803 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051849, HPA058348, HPA070542" Uncertain Enhanced "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA051849: AB_2681637, HPA058348: , HPA070542: " "unprognostic (1.22e-1)" "unprognostic (8.49e-3)" "unprognostic (2.61e-1)" "unprognostic (2.25e-2)" "unprognostic (2.15e-1)" "unprognostic (1.92e-2)" "unprognostic (4.35e-2)" "unprognostic (1.82e-1)" "unprognostic (6.17e-2)" "unprognostic (7.64e-3)" "unprognostic (3.06e-1)" "unprognostic (3.45e-1)" "prognostic unfavourable (2.29e-4)" "unprognostic (9.99e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-2)" "unprognostic (1.36e-1)" 13.3 16.4 11.2 7.3 13.1 30.4 17.5 12.1 11.6 9.1 19.8 10.0 26.9 15.2 11.4 18.7 15.9 8.5 10.1 11.2 11.1 10.0 11.7 37.9 13.2 9.5 9.7 10.4 13.5 16.4 17.4 19.3 41.3 11.0 9.3 8.3 10.0 9.9 16.9 23.0 12.0 30.7 11.6 12.0 9.0 12.2 8.8 11.2 6.7 17.4 10.5 9.5 10.4 13.4 6.9 9.2 17.7 8.7 4.9 7.4 2.5 12.7 12.8 10.2 21.0 25.2 14.1 40.2 16.9 20.8 13.8 14.1 18.9 22.3 10.4 21.6 18.4 19.3 17.6 17.5 18.7 11.6 9.5 12.7 20.9 15.7 18.5 13.3 14.6 22.2 13.7 18.6 20.2 19.4 24.3 11.1 16.6 7.4 9.6 9.2 24.2 3.2 10.6 14.3 14.7 10.6 22.2 8.5 21.6 19.1 21.4 16.5 21.3 9.7 24.9 20.1 18.5 11.1 13.3 17.7 25.1 20.7 11.1 9.7 18.9 17.7 6.6 7.7 7.1 8.7 6.8 6.9 6.8 6.1 4.4 6.9 7.4 7.2 13.4 4.9 7.9 9.2 5.7 2.5 11.2 13.1 12.1 11.2 11.1 10.0 9.7 10.4 11.0 11.2 TP53I11 PIG11 ENSG00000175274 "Tumor protein p53 inducible protein 11" O14683 11 44885903-44951306 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 83.1;T-47d: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 23.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059727, HPA061276" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" "Endoplasmic reticulum, Golgi apparatus" "HPA059727: , HPA061276: " "prognostic unfavourable (7.33e-5)" "unprognostic (1.87e-1)" "unprognostic (4.03e-2)" "unprognostic (3.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "prognostic unfavourable (6.12e-4)" "unprognostic (6.55e-2)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (4.65e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" 33.3 8.0 20.0 13.3 10.7 19.0 27.6 36.0 26.2 14.7 21.1 8.6 17.6 13.6 16.8 10.4 15.6 21.5 28.5 33.1 8.4 12.3 12.5 7.8 21.4 12.8 5.8 8.6 18.2 18.5 3.0 9.5 16.6 14.1 20.6 19.4 17.6 18.9 11.9 12.6 14.5 21.1 23.5 7.4 28.2 18.4 9.9 5.5 6.7 18.9 12.7 14.9 15.1 19.1 5.2 14.1 23.7 11.1 4.6 4.4 2.1 0.0 17.3 5.9 8.4 6.3 0.4 0.1 5.6 10.9 1.9 2.5 1.0 0.1 3.0 4.8 1.5 3.3 3.4 0.1 0.7 6.4 3.4 0.2 0.1 0.0 11.7 0.1 23.4 27.1 0.4 2.7 1.2 6.5 0.4 0.0 2.4 14.8 0.3 27.2 10.8 5.8 13.2 3.6 1.4 0.0 1.0 83.1 3.0 9.7 21.1 0.0 46.8 1.6 1.5 13.0 9.2 19.9 0.0 0.1 0.0 0.0 0.0 1.7 3.6 0.0 3.1 0.0 3.1 3.2 4.4 4.9 0.6 3.2 2.6 5.2 0.0 1.1 23.7 4.6 11.1 14.1 0.5 2.1 20.0 10.7 36.0 26.2 8.4 12.3 5.8 8.6 14.1 5.5 TPBG "5T4, 5T4-AG" ENSG00000146242 "Trophoblast glycoprotein" Q13641 6 82363206-82370828 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.5;hTCEpi: 30.0;hTEC/SVTERT24-B: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 3.2" "Lineage enriched" "Detected in single" 16 "T-cells: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010554 Enhanced Approved Nucleoplasm 330000 Nucleoplasm "HPA010554: AB_1858206" "unprognostic (3.03e-1)" "unprognostic (1.46e-2)" "prognostic unfavourable (6.68e-4)" "unprognostic (1.06e-1)" "unprognostic (4.52e-3)" "unprognostic (7.47e-3)" "unprognostic (8.55e-2)" "unprognostic (3.55e-3)" "unprognostic (8.39e-2)" "unprognostic (3.42e-2)" "unprognostic (8.02e-2)" "unprognostic (4.94e-1)" "unprognostic (3.77e-1)" "unprognostic (7.46e-2)" "unprognostic (1.06e-1)" "unprognostic (1.54e-1)" "unprognostic (5.57e-2)" 10.2 2.9 0.4 4.8 15.7 1.2 10.2 0.0 8.8 22.0 4.6 1.9 12.1 4.2 12.6 4.6 35.2 8.4 9.3 5.3 0.7 2.0 6.6 1.7 4.1 3.0 4.3 1.4 5.8 4.8 4.1 11.2 16.9 17.6 14.1 4.6 5.1 11.5 9.4 2.6 12.6 4.9 16.2 4.5 5.7 6.2 3.3 7.9 4.2 13.0 6.8 4.5 22.9 25.5 0.0 0.0 0.0 0.1 0.0 3.2 0.0 4.4 6.7 2.4 5.0 8.9 12.9 4.2 21.0 24.5 4.2 5.8 0.7 6.3 0.0 2.2 11.5 8.7 2.8 11.6 4.5 0.0 3.5 2.5 3.2 0.2 7.3 0.2 2.1 8.2 30.0 27.4 10.2 1.0 0.4 0.0 1.1 9.2 0.0 0.0 2.9 5.3 0.0 4.7 0.0 6.2 6.3 1.2 3.8 4.6 6.7 0.0 11.2 0.8 3.1 3.7 3.6 7.8 4.5 0.0 0.0 0.0 17.9 0.3 3.8 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 15.7 0.0 8.8 0.7 2.0 4.3 1.4 17.6 7.9 TPCN1 "FLJ20612, KIAA1169, TPC1" ENSG00000186815 "Two pore segment channel 1" Q9ULQ1 12 113221050-113298585 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039757 Approved "HPA039757: AB_10795156" "unprognostic (7.87e-2)" "unprognostic (7.98e-2)" "unprognostic (1.10e-2)" "unprognostic (1.22e-1)" "unprognostic (7.34e-2)" "unprognostic (3.07e-2)" "unprognostic (1.32e-3)" "unprognostic (4.53e-1)" "unprognostic (5.34e-2)" "unprognostic (1.48e-2)" "unprognostic (1.74e-3)" "unprognostic (1.52e-1)" "unprognostic (1.11e-1)" "unprognostic (2.23e-1)" "unprognostic (9.08e-2)" "unprognostic (1.39e-1)" "unprognostic (2.47e-3)" 18.1 28.6 16.0 15.8 24.8 9.7 17.7 67.8 28.1 19.1 19.1 30.8 23.6 17.0 23.9 19.7 21.8 19.2 25.3 46.5 18.0 11.4 31.2 15.2 18.6 13.6 34.4 17.9 25.6 30.3 28.5 25.0 16.4 28.4 16.3 17.5 26.7 29.9 28.7 28.4 13.2 19.4 16.9 22.1 18.0 11.3 9.7 27.8 5.4 32.5 16.1 24.8 17.4 15.5 5.5 9.3 5.0 13.7 8.6 3.4 3.8 5.0 15.6 1.8 2.2 14.0 15.8 5.2 7.2 52.0 3.9 4.7 11.5 17.7 11.7 11.0 7.4 6.4 4.1 13.1 5.3 1.4 3.2 4.4 7.9 6.3 18.2 1.5 10.0 15.0 6.6 7.5 13.3 5.9 4.9 4.2 4.7 6.2 0.4 23.2 2.9 7.8 0.8 2.2 22.8 12.5 18.8 2.2 3.5 5.9 15.3 6.1 4.9 14.2 2.4 5.7 2.8 7.8 4.5 7.1 4.2 10.1 17.0 3.7 4.3 5.0 13.7 1.2 1.7 2.3 2.1 3.5 2.4 2.3 9.3 5.5 3.4 2.1 0.5 8.6 0.3 4.9 1.1 3.8 16.0 24.8 67.8 28.1 18.0 11.4 34.4 17.9 28.4 27.8 TPM1 "C15orf13, CMH3" ENSG00000140416 "Tropomyosin 1" P09493 15 63042632-63071915 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 544.2;skeletal muscle: 589.5" "Cell line enhanced" "Detected in many" "BJ: 123.0;fHDF/TERT166: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 23.8" "Group enriched" "Detected in all" 4 "dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000261, HPA009066, CAB017698, HPA047089, HPA053624" Supported Approved "Actin filaments,Cytosol" 280000000 "Actin filaments" Cytosol "CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: , HPA053624: " "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.00e-2)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-2)" "unprognostic (1.20e-1)" "unprognostic (1.66e-3)" "unprognostic (3.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.53e-2)" "prognostic unfavourable (7.30e-4)" 17.9 5.7 5.5 32.4 5.2 1.2 15.2 5.6 5.1 48.1 119.7 2.4 84.2 14.6 72.4 38.3 121.6 36.2 75.3 544.2 4.1 2.6 14.5 4.4 10.5 3.3 3.3 7.0 27.0 29.3 1.9 3.2 17.7 4.1 72.5 28.0 19.1 12.9 81.3 589.5 6.5 39.5 245.2 2.7 6.5 51.7 9.6 2.3 0.4 7.7 121.7 5.9 193.8 38.7 2.7 8.4 23.8 11.6 1.2 3.4 9.9 43.6 28.8 34.8 1.7 12.2 7.7 114.6 123.0 45.3 75.7 56.3 20.2 8.7 0.1 56.5 122.9 24.2 29.5 19.7 50.4 1.1 4.1 6.4 31.0 9.8 34.2 0.2 1.4 10.7 11.4 62.2 16.6 19.8 0.6 1.5 57.8 22.5 1.9 0.5 41.5 5.0 0.7 12.3 1.2 108.1 24.1 8.3 5.7 14.7 23.3 5.2 17.0 1.2 91.2 100.1 49.2 14.9 87.2 0.4 0.3 0.5 28.3 1.7 69.3 23.8 6.1 2.9 2.5 11.6 2.0 2.7 2.4 2.7 8.4 2.6 2.6 2.3 6.7 1.2 7.9 1.7 3.4 9.9 5.5 5.2 5.6 5.1 4.1 2.6 3.3 7.0 4.1 2.3 TPO TPX ENSG00000115705 "Thyroid peroxidase" P07202 2 1374223-1543711 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "thyroid gland: 411.3" "Group enriched" "Detected in some" 5 "Karpas-707: 14.0;RPMI-8226: 5.9" "Cancer enriched" "Detected in some" 364 "thyroid cancer: 188.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "memory CD4 T-cell: 5.1;T-reg: 3.0" "Lineage enriched" "Detected in single" 21 "T-cells: 5.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007987, CAB009587" Enhanced "Intracellular and membrane" "CAB009587: , HPA007987: AB_1080270" "unprognostic (1.55e-1)" "unprognostic (1.04e-1)" "unprognostic (2.88e-1)" "unprognostic (1.77e-2)" "unprognostic (3.56e-2)" "unprognostic (9.11e-2)" "unprognostic (2.24e-2)" "unprognostic (1.85e-1)" "unprognostic (1.32e-1)" "unprognostic (1.19e-4)" "unprognostic (2.61e-2)" "unprognostic (3.29e-1)" "unprognostic (5.44e-4)" "unprognostic (1.21e-1)" "unprognostic (3.73e-2)" "unprognostic (4.98e-3)" "unprognostic (7.10e-3)" 1.1 0.0 0.1 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.4 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.1 0.5 0.0 0.2 0.1 0.1 7.1 0.2 0.1 0.1 0.1 411.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 5.1 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 1.4 0.0 0.0 0.1 0.2 0.0 0.0 5.9 0.0 0.0 0.0 0.1 0.0 2.0 0.0 1.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.3 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 3.0 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TPSG1 "PRSS31, TMT" ENSG00000116176 "Tryptase gamma 1" Q9NRR2 16 1221651-1225257 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 16.0" "Group enriched" "Detected in some" 9 "HMC-1: 22.3;MCF7: 7.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060458 Enhanced "HPA060458: " "unprognostic (1.86e-1)" "unprognostic (3.46e-1)" "unprognostic (5.21e-3)" "unprognostic (1.27e-1)" "unprognostic (5.58e-2)" "unprognostic (1.18e-2)" "unprognostic (3.45e-2)" "unprognostic (4.60e-2)" "unprognostic (9.97e-2)" "unprognostic (1.34e-1)" "unprognostic (8.92e-2)" "unprognostic (6.39e-2)" "prognostic unfavourable (1.76e-8)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (8.65e-4)" "unprognostic (5.70e-2)" 1.3 0.6 0.4 4.5 0.4 0.0 3.1 0.4 0.4 0.6 14.4 0.4 0.4 14.0 1.2 0.4 0.7 0.5 1.0 0.4 0.4 0.0 0.4 0.4 0.6 0.4 0.4 0.4 2.0 0.4 0.0 3.2 0.4 0.4 1.1 8.8 0.4 0.4 0.4 0.4 1.1 16.0 1.2 0.4 0.4 1.0 1.3 0.4 0.4 0.4 1.1 0.4 1.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 TPTE2 TPIP ENSG00000132958 "Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2" Q6XPS3 13 19422877-19536762 "Enzymes, Plasma proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 12.3" "Group enriched" "Detected in some" 4 "HDLM-2: 9.9;Karpas-707: 2.9" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA068342 Approved "Endoplasmic reticulum,Cytosol" Cytosol "Endoplasmic reticulum" "HPA068342: " "unprognostic (2.50e-1)" "unprognostic (2.10e-1)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-2)" "unprognostic (5.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (5.40e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-1)" "unprognostic (1.05e-12)" "unprognostic (1.04e-1)" "unprognostic (1.47e-1)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" 0.0 0.1 0.4 0.2 1.0 0.0 0.1 0.7 0.8 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.2 12.3 0.0 0.6 0.0 0.0 0.5 0.4 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 9.9 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 2.9 0.0 0.3 0.3 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 TRABD PP2447 ENSG00000170638 "TraB domain containing" Q9H4I3 22 50185915-50199598 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000822 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA000822: AB_10959384" "unprognostic (9.37e-2)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "prognostic favourable (1.19e-5)" "unprognostic (2.80e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-3)" "unprognostic (6.12e-2)" "unprognostic (2.40e-1)" "unprognostic (4.68e-3)" "unprognostic (1.65e-1)" "unprognostic (3.27e-2)" "prognostic unfavourable (1.85e-4)" "unprognostic (1.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.87e-2)" "unprognostic (2.98e-3)" 8.9 10.3 8.3 28.8 13.4 45.5 12.0 15.3 11.4 10.6 14.7 7.4 19.9 15.9 9.3 15.6 19.9 9.2 18.1 10.0 9.0 4.9 13.4 20.0 13.1 25.6 12.4 6.1 10.2 42.9 5.9 12.0 9.6 9.5 14.8 6.0 8.4 24.6 19.5 14.0 13.0 18.3 9.3 9.6 19.5 16.5 9.7 11.8 21.0 13.2 13.2 33.1 11.5 13.1 6.9 33.0 23.0 14.2 14.7 13.6 9.2 22.4 14.9 5.4 8.8 2.9 3.4 13.5 7.8 5.1 6.6 5.6 9.4 10.8 13.9 7.7 3.6 14.1 6.9 13.8 1.3 9.7 32.2 8.0 23.0 15.9 11.6 16.2 16.0 5.5 8.5 4.8 6.5 6.4 9.8 22.8 2.8 24.8 11.2 18.4 7.9 14.2 31.4 7.3 29.3 5.0 21.8 6.3 10.6 6.7 24.3 11.1 10.4 16.4 7.1 5.5 13.7 7.1 8.7 27.8 4.9 16.6 6.8 11.3 8.6 7.0 14.2 23.0 10.9 12.5 10.2 6.9 9.8 9.8 15.4 3.6 6.7 7.7 19.5 14.7 7.6 33.0 13.6 9.2 8.3 13.4 15.3 11.4 9.0 4.9 12.4 6.1 9.5 11.8 TRABD2A "C2orf89, TIKI1" ENSG00000186854 "TraB domain containing 2A" Q86V40 2 84821650-84907008 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 29.3;intestine: 26.6;lymphoid tissue: 24.7;ovary: 23.7" "Cell line enhanced" "Detected in many" "BEWO: 24.3;HDLM-2: 18.3;HSkMC: 13.0;hTEC/SVTERT24-B: 10.7;SiHa: 10.4" "Group enriched" "Detected in many" 9 "colorectal cancer: 14.4;stomach cancer: 3.0" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 29.3" "Lineage enriched" "Detected in many" 17 "T-cells: 29.3" HPA045817 Approved "Intracellular and membrane" "HPA045817: " "unprognostic (7.49e-3)" "unprognostic (3.35e-1)" "unprognostic (3.08e-1)" "unprognostic (3.29e-2)" "unprognostic (3.82e-5)" "unprognostic (2.46e-2)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "unprognostic (6.68e-2)" "unprognostic (1.66e-1)" "unprognostic (1.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.47e-4)" "unprognostic (4.29e-2)" "unprognostic (7.60e-2)" "unprognostic (1.41e-3)" "unprognostic (1.37e-1)" 1.8 0.5 0.7 24.7 1.6 2.1 6.3 0.6 3.7 0.5 23.2 0.9 0.0 2.4 0.5 0.4 0.5 1.3 0.2 0.7 0.9 0.8 0.9 0.9 3.0 11.3 0.9 3.1 23.7 0.4 0.4 0.6 2.0 0.2 0.5 26.6 1.2 3.3 0.0 0.3 1.2 9.3 1.8 0.9 3.1 0.6 0.6 0.0 6.4 0.7 0.0 6.3 0.7 0.7 1.7 0.6 0.5 0.1 1.3 29.3 5.3 0.7 0.6 0.2 0.1 7.2 7.8 24.3 1.2 1.9 3.5 6.4 0.3 2.7 0.0 0.3 3.8 0.0 1.7 0.3 5.2 18.3 0.4 0.0 5.1 0.0 0.8 0.0 0.0 13.0 0.0 10.7 4.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.1 0.0 0.1 0.2 3.4 0.4 0.0 1.2 2.2 0.0 0.0 3.0 2.0 0.0 0.0 0.1 0.0 3.3 0.1 4.0 0.3 13.1 5.0 0.6 1.7 29.3 18.2 0.5 1.3 0.0 0.6 8.5 5.3 0.7 1.6 0.6 3.7 0.9 0.8 0.9 3.1 0.2 0.0 TRAF3IP3 T3JAM ENSG00000009790 "TRAF3 interacting protein 3" Q9Y228 1 209756032-209782320 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 86.5;lymphoid tissue: 69.5" "Cell line enhanced" "Detected in some" "HDLM-2: 39.9;Karpas-707: 16.6;MOLT-4: 20.6;NB-4: 23.7;THP-1: 22.4;U-266/70: 24.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040796 Enhanced Approved Vesicles Vesicles "HPA040796: AB_10794861" "prognostic favourable (4.11e-4)" "unprognostic (1.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.36e-4)" "unprognostic (2.67e-1)" "unprognostic (1.91e-5)" "unprognostic (3.83e-3)" "prognostic favourable (8.15e-4)" "unprognostic (5.30e-2)" "unprognostic (3.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.39e-1)" "unprognostic (1.38e-4)" "unprognostic (3.08e-1)" "unprognostic (2.93e-2)" "unprognostic (3.16e-2)" "unprognostic (4.21e-2)" 2.2 0.8 1.7 30.6 2.1 9.8 1.3 0.6 1.5 1.5 3.8 2.2 0.3 2.3 1.5 1.4 2.5 1.7 4.6 1.2 1.7 1.4 3.4 2.4 5.8 32.6 3.8 0.6 1.2 1.3 0.0 1.0 1.0 2.7 2.2 3.6 1.7 8.4 1.3 0.7 1.1 19.8 1.0 3.8 38.3 4.1 1.4 2.6 69.5 2.4 1.5 33.6 5.7 1.9 43.9 25.3 54.9 29.5 50.1 86.5 56.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 39.9 0.0 3.8 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 20.6 23.7 0.0 0.0 2.4 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 24.6 8.6 1.5 0.0 11.1 0.0 54.9 24.1 24.8 48.9 25.7 51.8 43.9 67.8 55.9 25.3 41.4 76.9 60.8 6.5 50.1 29.5 18.6 86.5 56.3 1.7 2.1 0.6 1.5 1.7 1.4 3.8 0.6 2.7 2.6 TRAT1 "HSPC062, TCRIM, TRIM" ENSG00000163519 "T cell receptor associated transmembrane adaptor 1" Q6PIZ9 3 108822698-108855005 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 17 "blood: 57.9;lymphoid tissue: 128.9" "Cell line enriched" "Detected in some" 33 "MOLT-4: 39.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 57.9" "Group enriched" "Detected in many" 160 "granulocytes: 53.1;T-cells: 57.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002356, CAB026130" Enhanced "CAB026130: , HPA002356: AB_1080375" "unprognostic (1.54e-4)" "unprognostic (1.41e-3)" "unprognostic (6.82e-2)" "unprognostic (4.95e-3)" "unprognostic (2.84e-2)" "unprognostic (2.19e-3)" "unprognostic (1.87e-3)" "unprognostic (2.02e-2)" "unprognostic (7.21e-3)" "unprognostic (8.96e-3)" "unprognostic (8.03e-2)" "unprognostic (4.32e-1)" "unprognostic (2.86e-5)" "unprognostic (3.12e-1)" "unprognostic (3.01e-2)" "unprognostic (2.90e-4)" "unprognostic (4.36e-2)" 2.6 0.3 0.2 8.2 0.2 1.8 1.3 0.2 0.3 0.8 1.0 0.1 0.1 0.9 0.7 0.3 0.9 0.8 1.9 0.7 0.2 0.2 1.1 1.0 4.0 17.8 0.2 0.2 0.5 0.5 0.0 0.4 0.3 0.3 1.1 1.0 0.1 1.9 0.3 0.4 1.0 5.5 0.2 0.3 9.0 1.6 0.5 0.1 128.9 1.1 1.0 9.8 2.8 1.1 0.1 0.1 53.1 0.1 0.3 57.9 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 39.2 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.1 0.1 0.0 10.5 0.0 21.2 0.1 42.1 21.6 0.0 0.0 57.9 14.2 0.6 0.3 0.1 0.1 17.9 22.9 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.1 TRDN ENSG00000186439 Triadin Q13061 6 123216339-123637093 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1" "Cell line enhanced" "Detected in some" "HAP1: 1.5;K-562: 1.8;MCF7: 6.0;SCLC-21H: 1.2;SK-BR-3: 1.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "basophil: 2.9" "Lineage enriched" "Detected in single" 30 "granulocytes: 2.9" "Region enriched" "Detected in single" 10 "olfactory region: 13.6" "HPA038226, HPA058226" Enhanced Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA038226: AB_10795574, HPA058226: " "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.20e-2)" "unprognostic (3.06e-3)" "unprognostic (2.40e-1)" "unprognostic (2.38e-1)" "unprognostic (2.42e-1)" "unprognostic (8.42e-2)" "unprognostic (8.71e-2)" "unprognostic (9.93e-3)" "unprognostic (2.12e-1)" "unprognostic (2.55e-2)" "unprognostic (3.97e-2)" 3.8 0.4 0.4 0.0 0.5 0.0 0.3 0.2 0.2 0.3 0.1 0.0 0.7 0.1 0.3 9.2 3.0 1.9 0.1 52.8 1.6 1.3 0.1 0.1 0.1 0.1 1.6 0.1 1.5 0.1 0.0 3.2 0.1 1.3 1.9 0.1 1.3 2.0 0.2 215.5 0.1 0.1 0.2 3.4 0.1 0.1 0.7 0.5 0.0 1.2 80.1 1.6 0.1 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 6.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.2 1.6 1.3 1.6 0.1 1.3 0.5 TREM1 "CD354, TREM-1" ENSG00000124731 "Triggering receptor expressed on myeloid cells 1" Q9NP99 6 41267926-41286719 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 96.9;bone marrow: 38.5;lung: 34.2" "Cell line enriched" "Detected in some" 7 "U-87 MG: 23.6" "Cancer enhanced" "Detected in many" "lung cancer: 9.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 96.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 96.9" HPA005563 Uncertain "Intracellular and membrane" "HPA005563: AB_1858259" "unprognostic (6.41e-2)" "unprognostic (1.47e-3)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (6.07e-3)" "unprognostic (2.97e-2)" "unprognostic (5.73e-5)" "unprognostic (1.29e-1)" "unprognostic (1.24e-2)" "unprognostic (4.13e-3)" "unprognostic (2.24e-3)" "unprognostic (7.65e-2)" "unprognostic (3.18e-7)" "unprognostic (6.32e-3)" "unprognostic (4.95e-2)" "unprognostic (1.08e-1)" "unprognostic (7.26e-2)" 10.2 0.6 0.7 21.1 1.5 38.5 1.0 0.6 2.1 0.7 0.9 0.7 0.5 0.1 1.0 1.5 0.6 4.2 5.1 3.7 1.2 0.9 1.1 3.7 34.2 8.0 2.7 0.1 2.1 1.8 0.2 2.7 31.2 2.3 0.9 0.0 2.5 1.3 0.1 2.4 0.4 1.1 3.8 3.9 12.1 1.0 2.6 0.6 0.3 2.2 1.9 1.0 3.9 0.7 0.2 5.0 96.9 12.8 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.6 0.0 0.0 0.3 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 1.5 0.0 0.0 12.8 0.3 0.0 3.1 0.0 0.0 0.0 0.0 5.0 0.2 0.0 0.0 96.9 0.0 1.4 0.1 0.0 4.1 0.7 1.5 0.6 2.1 1.2 0.9 2.7 0.1 2.3 0.6 TREM2 "TREM-2, Trem2a, Trem2b, Trem2c" ENSG00000095970 "Triggering receptor expressed on myeloid cells 2" Q9NZC2 6 41158506-41163186 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.6;brain: 34.8;lung: 24.6" "Group enriched" "Detected in some" 4 "hTCEpi: 36.5;THP-1: 20.2" "Cancer enhanced" "Detected in all" "glioma: 93.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.9" "Group enriched" "Detected in many" 6 "dendritic cells: 4.9;monocytes: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010917, HPA012571" Approved "Intracellular and membrane" 19000 "HPA010917: AB_1080365, HPA012571: AB_1858260" "unprognostic (3.89e-1)" "unprognostic (4.44e-3)" "unprognostic (2.77e-2)" "unprognostic (1.80e-2)" "unprognostic (1.29e-1)" "unprognostic (1.53e-1)" "prognostic unfavourable (4.24e-4)" "unprognostic (4.83e-2)" "unprognostic (1.07e-1)" "unprognostic (8.57e-3)" "unprognostic (1.33e-1)" "unprognostic (2.09e-1)" "unprognostic (3.58e-3)" "unprognostic (8.04e-2)" "unprognostic (1.04e-2)" "unprognostic (3.16e-3)" "unprognostic (1.85e-2)" 35.6 11.8 10.1 3.0 13.4 0.3 8.6 1.6 21.7 5.9 2.9 24.1 0.0 0.9 1.5 2.1 0.6 6.5 8.4 1.7 10.4 9.5 1.0 2.1 24.6 1.7 21.7 5.2 2.7 2.5 2.7 2.9 8.8 13.4 1.8 3.9 2.1 4.4 3.0 0.8 0.4 1.2 3.8 34.8 0.5 2.2 0.8 12.9 0.0 1.6 0.8 0.5 4.2 0.5 0.5 4.9 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.6 36.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.1 10.1 13.4 1.6 8.3 10.4 9.5 21.7 5.2 13.4 12.9 TREML1 "dJ238O23.3, TLT1" ENSG00000161911 "Triggering receptor expressed on myeloid cells like 1" Q86YW5 6 41149342-41154337 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7" "Cell line enriched" "Detected in single" 166 "HEL: 37.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "basophil: 19.2" "Lineage enriched" "Detected in single" 31 "granulocytes: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016700, HPA017860" Enhanced 94000000 "HPA016700: AB_1858262, HPA017860: AB_1858261" "unprognostic (6.70e-2)" "unprognostic (3.50e-3)" "unprognostic (1.15e-3)" "unprognostic (1.62e-1)" "unprognostic (3.48e-2)" "unprognostic (4.53e-5)" "unprognostic (1.10e-2)" "unprognostic (2.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.12e-3)" "unprognostic (2.34e-2)" "unprognostic (7.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.36e-1)" "unprognostic (8.38e-2)" "unprognostic (7.51e-2)" "unprognostic (3.41e-2)" 1.2 1.2 2.1 3.7 1.2 10.5 0.6 0.5 1.3 0.4 0.3 0.3 0.3 0.0 0.3 0.6 0.3 0.6 1.3 10.0 2.1 1.6 0.3 0.3 2.9 7.7 3.3 0.3 1.9 0.5 0.2 0.6 1.7 1.2 0.3 1.3 0.6 1.3 0.3 0.8 0.3 0.4 0.3 4.3 26.7 0.2 0.8 0.3 1.4 0.6 0.3 7.1 1.1 0.3 0.1 0.3 19.2 0.6 0.0 0.2 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.6 0.8 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 3.9 0.0 0.1 0.3 0.0 37.9 2.1 1.2 0.5 0.7 2.1 1.6 3.3 0.3 1.2 0.3 TREML4 TLT4 ENSG00000188056 "Triggering receptor expressed on myeloid cells like 4" Q6UXN2 6 41228324-41238882 "Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5" "Cell line enriched" "Detected in single" 7 "HEL: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 5.4;neutrophil: 10.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.3" HPA065044 Uncertain "Secreted - unknown location" "HPA065044: " "unprognostic (1.49e-1)" "unprognostic (1.51e-1)" "unprognostic (5.58e-2)" "unprognostic (2.07e-1)" "unprognostic (2.12e-1)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (9.50e-3)" "unprognostic (1.18e-4)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (5.26e-2)" "unprognostic (1.21e-2)" 0.3 0.1 0.1 1.2 0.3 3.1 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.6 0.3 0.2 0.1 0.2 0.1 0.2 3.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.4 9.5 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 1.3 0.9 10.3 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.4 0.0 0.5 0.0 0.1 0.0 0.0 0.5 1.3 0.0 0.0 10.3 0.0 0.4 0.9 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 TREX1 "AGS1, DRN3" ENSG00000213689 "Three prime repair exonuclease 1" Q9NSU2 3 48465811-48467645 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Exonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease mutation, Neurodegeneration, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 31.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035437, HPA046721" Supported Supported Cytosol Cytosol "HPA035437: AB_10672092, HPA046721: " 14.2 14.3 16.7 14.6 10.6 20.7 17.2 13.0 16.9 13.4 11.0 12.8 17.5 10.3 8.1 14.9 16.6 14.5 12.3 9.8 14.4 14.2 11.6 12.7 12.5 26.2 14.6 17.4 7.3 13.0 6.8 31.2 11.6 11.2 15.4 9.3 10.8 32.2 19.3 10.8 22.9 10.9 8.2 12.6 25.5 12.4 4.6 10.1 18.5 7.4 18.3 21.7 13.3 10.6 24.9 35.5 23.3 41.8 8.6 13.1 20.1 8.0 7.4 6.2 4.4 7.7 7.9 0.0 2.6 13.1 22.0 31.0 0.1 9.6 9.5 5.4 11.1 9.4 0.4 11.8 3.1 8.0 0.7 5.5 26.6 0.4 9.7 5.0 3.9 6.9 1.1 11.1 4.4 9.3 0.0 14.6 9.3 0.1 7.0 3.6 0.0 4.6 5.8 1.6 18.6 5.8 1.6 0.0 3.7 9.6 13.0 6.3 0.4 8.4 9.8 4.1 3.9 8.7 6.1 11.8 6.8 4.0 9.1 10.7 3.3 2.1 41.8 3.0 9.8 32.5 5.6 24.6 13.1 9.4 35.5 24.9 12.4 10.3 23.3 8.6 24.3 28.0 11.6 20.1 16.7 10.6 13.0 16.9 14.4 14.2 14.6 17.4 11.2 10.1 TRIB2 "GS3955, TRB2" ENSG00000071575 "Tribbles pseudokinase 2" Q92519 2 12716889-12742734 "Enzymes, Predicted membrane proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 40.2;HEL: 39.4;K-562: 53.6;SK-MEL-30: 39.1;WM-115: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 24.8" "Group enriched" "Detected in many" 9 "B-cells: 7.1;NK-cells: 9.5;T-cells: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001305 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA001305: AB_1080371" "unprognostic (1.84e-1)" "unprognostic (2.49e-2)" "unprognostic (4.31e-3)" "unprognostic (1.86e-3)" "unprognostic (6.68e-3)" "unprognostic (3.93e-2)" "unprognostic (4.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.80e-2)" "unprognostic (3.32e-2)" "unprognostic (2.52e-3)" "unprognostic (1.67e-2)" "unprognostic (1.08e-3)" "unprognostic (1.30e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-2)" "unprognostic (2.13e-2)" 19.6 30.9 13.2 17.7 13.3 7.0 23.2 23.2 23.0 10.8 12.3 10.5 6.7 8.7 23.0 22.6 8.1 11.6 14.5 18.2 15.0 10.8 24.8 10.6 18.9 33.0 13.4 16.2 52.3 14.4 6.6 11.3 23.0 15.5 16.3 6.9 35.7 9.9 13.6 6.9 8.2 11.9 17.6 10.4 38.9 19.5 13.9 10.1 37.3 12.1 6.2 33.4 21.9 23.2 7.1 0.6 1.5 0.1 9.5 24.8 4.5 0.0 0.0 30.6 40.2 11.0 10.2 0.0 1.7 1.6 1.0 1.7 0.1 3.3 3.4 1.2 3.6 0.5 2.2 3.4 0.9 3.8 6.3 39.4 0.1 0.5 13.7 2.2 15.1 9.4 3.5 4.4 1.2 4.8 53.6 0.0 1.7 0.3 5.0 9.4 14.5 3.9 0.0 10.2 1.4 7.0 5.0 26.4 12.6 0.2 1.6 39.1 0.0 0.2 3.0 14.6 7.3 0.1 3.8 0.0 0.0 4.9 7.8 7.7 53.8 0.8 0.1 1.5 7.3 0.0 8.8 5.3 14.4 7.7 0.6 7.1 8.5 5.2 0.3 9.5 0.1 0.0 24.8 4.5 13.2 13.3 23.2 23.0 15.0 10.8 13.4 16.2 15.5 10.1 TRIM13 "DLEU5, Leu5, RFP2, RNF77" ENSG00000204977 "Tripartite motif containing 13" O60858 13 49995888-50020481 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000367 Enhanced "HPA000367: AB_1856196" "unprognostic (1.14e-1)" "unprognostic (8.22e-2)" "unprognostic (6.14e-2)" "unprognostic (2.23e-3)" "unprognostic (4.75e-3)" "unprognostic (5.01e-2)" "unprognostic (4.60e-2)" "unprognostic (2.83e-2)" "unprognostic (2.59e-2)" "unprognostic (2.38e-2)" "unprognostic (2.44e-1)" "unprognostic (5.07e-1)" "unprognostic (7.28e-3)" "unprognostic (4.66e-2)" "unprognostic (9.01e-2)" "unprognostic (2.37e-2)" "unprognostic (1.55e-2)" 13.2 9.8 9.9 11.9 11.4 37.5 19.6 18.5 13.5 13.1 11.7 12.3 15.2 8.6 13.9 10.7 18.8 12.2 8.7 12.4 10.1 9.2 16.6 9.9 14.7 12.4 12.2 8.0 13.8 14.0 10.8 14.4 10.0 11.5 14.5 14.0 9.6 16.2 15.6 16.3 18.2 13.0 10.4 10.8 15.3 10.6 49.0 12.1 25.1 17.3 13.9 15.5 13.0 12.9 28.4 20.6 21.6 13.0 15.4 17.2 8.4 5.1 6.0 20.9 16.1 11.8 18.5 9.5 8.5 12.3 6.9 4.8 8.3 11.8 19.1 2.6 9.2 8.1 9.2 11.2 8.5 7.3 8.1 18.9 4.6 9.2 13.2 18.1 11.1 13.5 16.5 6.3 10.5 15.2 10.0 6.1 13.5 4.6 15.0 28.4 18.9 4.5 18.3 0.9 5.7 14.6 8.5 8.4 13.8 7.7 8.0 11.8 9.0 23.0 14.1 7.1 6.6 5.8 4.7 4.4 3.6 14.0 3.2 8.3 9.6 12.1 10.8 16.1 12.2 9.3 15.3 28.2 16.5 15.9 13.5 28.4 14.6 13.6 21.6 15.4 13.0 20.6 17.2 8.4 9.9 11.4 18.5 13.5 10.1 9.2 12.2 8.0 11.5 12.1 TRIM55 "MURF-2, RNF29" ENSG00000147573 "Tripartite motif containing 55" Q9BYV6 8 66126896-66175487 "Predicted intracellular proteins, Predicted membrane proteins" "Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 34.3;liver: 22.0;skeletal muscle: 37.0;tongue: 24.4" "Cell line enriched" "Detected in some" 15 "LHCN-M2: 96.9" "Group enriched" "Detected in some" 10 "liver cancer: 12.3;renal cancer: 5.8" "Region enriched" "Detected in single" 4 "cerebellum: 3.3" "Cell type enhanced" "Detected in single" "T-reg: 1.3" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in single" 8 "olfactory region: 0.5" "Group enriched" "Detected in some" 9 "hippocampal formation: 0.8;pons and medulla: 1.1" "HPA038793, HPA053691" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus" Cytosol "HPA038793: AB_10673289, HPA053691: " "unprognostic (5.44e-3)" "unprognostic (1.25e-2)" "unprognostic (5.93e-3)" "unprognostic (4.07e-2)" "unprognostic (6.83e-3)" "unprognostic (3.77e-3)" "unprognostic (8.31e-2)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.50e-1)" "unprognostic (5.18e-2)" "unprognostic (2.10e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-2)" "unprognostic (1.77e-3)" 2.1 0.0 0.3 0.2 0.2 0.0 0.1 3.3 0.1 0.4 0.1 0.1 0.3 0.0 0.0 6.6 0.8 3.0 0.1 34.3 0.4 0.1 2.7 22.0 0.1 0.4 0.1 0.1 0.5 0.1 0.0 2.0 1.4 0.8 0.3 0.0 0.1 1.0 0.0 37.0 0.3 0.1 0.0 0.1 0.1 0.1 3.8 0.0 0.0 0.9 24.4 1.2 0.1 0.0 0.6 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 96.9 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.3 6.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.2 3.3 0.1 0.4 0.1 0.1 0.1 0.8 0.0 TRIM59 "Mrf1, RNF104, TRIM57, TSBF1" ENSG00000213186 "Tripartite motif containing 59" Q8IWR1 3 160432445-160485773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6;lymphoid tissue: 24.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017750 Uncertain Approved "Rods & Rings" "Rods & Rings" "HPA017750: AB_1858312" "unprognostic (3.74e-1)" "prognostic favourable (4.36e-4)" "unprognostic (1.76e-1)" "unprognostic (1.03e-1)" "unprognostic (1.10e-1)" "unprognostic (3.02e-1)" "unprognostic (8.00e-4)" "unprognostic (1.88e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "prognostic unfavourable (1.15e-5)" "unprognostic (1.02e-3)" "unprognostic (2.44e-11)" "unprognostic (7.92e-2)" "unprognostic (2.42e-1)" "unprognostic (4.03e-2)" "unprognostic (5.91e-3)" 1.3 1.4 8.0 6.0 19.3 18.6 2.7 2.1 14.5 1.8 3.5 30.6 0.3 3.6 4.1 1.3 6.6 2.8 3.6 1.2 13.4 6.4 2.0 1.6 2.6 13.8 28.3 6.3 2.1 2.4 2.7 2.5 2.6 14.3 2.9 3.5 0.1 2.6 1.6 1.6 6.8 4.0 3.8 14.5 6.3 3.3 10.4 28.4 24.6 2.8 0.3 14.5 6.1 3.1 7.8 4.7 16.1 2.2 8.8 15.2 2.6 8.7 7.0 8.9 0.6 3.6 4.9 11.7 14.0 12.1 17.5 16.8 0.7 15.3 23.5 10.4 10.4 15.1 0.0 5.7 23.0 21.3 8.5 0.8 2.1 0.9 5.0 10.3 1.4 4.1 1.7 8.5 6.0 12.2 11.0 10.0 16.3 9.3 6.2 0.7 23.4 11.7 8.9 7.8 10.5 6.1 2.9 5.8 1.3 3.9 11.7 0.3 13.8 9.6 9.2 1.2 4.1 2.0 1.3 16.7 6.0 5.9 1.5 13.5 1.3 16.1 2.2 3.7 8.3 2.2 9.4 7.8 13.6 11.2 3.2 6.9 9.4 11.1 2.7 8.8 1.0 4.7 15.2 2.6 8.0 19.3 2.1 11.8 13.4 6.4 28.3 6.3 14.3 28.4 TRPV2 "VRL, VRL-1, VRL1" ENSG00000187688 "Transient receptor potential cation channel subfamily V member 2" Q9Y5S1 17 16415542-16437003 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.6;fHDF/TERT166: 34.8;HMC-1: 29.3;SK-MEL-30: 30.2;TIME: 27.2" "Cancer enriched" "Detected in all" 8 "melanoma: 59.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044993 Uncertain Supported "Plasma membrane" "Plasma membrane" "HPA044993: AB_10960889" "unprognostic (1.57e-1)" "unprognostic (4.34e-3)" "unprognostic (2.05e-2)" "unprognostic (1.58e-2)" "unprognostic (2.85e-2)" "unprognostic (6.16e-3)" "unprognostic (5.25e-2)" "unprognostic (1.25e-1)" "unprognostic (8.40e-3)" "unprognostic (2.43e-1)" "unprognostic (3.11e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (1.19e-6)" "unprognostic (7.94e-2)" "prognostic unfavourable (5.53e-4)" "unprognostic (8.07e-2)" "unprognostic (1.23e-1)" 25.4 17.6 5.9 14.3 4.9 15.6 11.3 1.9 7.6 6.7 6.0 4.2 0.5 5.4 8.2 6.1 5.7 6.8 6.7 8.9 5.0 8.1 4.4 4.5 25.8 24.9 6.0 4.2 8.9 8.4 7.7 1.8 15.6 8.1 6.3 5.0 4.9 4.4 2.1 3.8 5.0 8.8 9.2 4.1 23.4 5.3 2.8 2.5 23.4 5.7 4.2 18.0 8.1 6.7 9.0 25.9 20.4 22.3 26.5 29.8 17.4 0.0 0.5 0.0 0.0 8.5 26.6 1.6 2.6 3.0 3.0 2.9 0.1 0.0 3.0 0.7 34.8 0.0 0.0 0.0 1.7 13.5 0.2 3.3 0.0 8.2 10.2 4.6 29.3 11.8 0.0 17.9 0.2 1.2 11.4 8.5 14.1 0.1 5.9 6.4 0.0 0.0 3.5 0.1 1.3 13.2 0.3 0.4 0.0 0.0 0.0 30.2 0.0 4.0 27.2 0.0 0.1 0.1 0.3 0.0 0.1 1.5 2.7 6.8 4.1 20.4 12.2 15.2 29.8 22.3 25.9 9.0 21.9 27.6 25.9 8.7 12.5 21.7 3.0 26.5 19.8 22.7 21.2 17.4 5.9 4.9 1.9 7.6 5.0 8.1 6.0 4.2 8.1 2.5 TRPV5 "CaT2, ECAC1" ENSG00000127412 "Transient receptor potential cation channel subfamily V member 5" Q9NQA5 7 142908101-142933808 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 26.0" "Cell line enhanced" "Detected in single" "RT4: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063175 Uncertain "HPA063175: " "unprognostic (7.44e-2)" "unprognostic (3.93e-2)" "unprognostic (1.22e-2)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.78e-2)" "unprognostic (1.07e-1)" "unprognostic (7.95e-2)" "unprognostic (7.73e-4)" "unprognostic (4.87e-2)" "unprognostic (3.41e-1)" "unprognostic (4.58e-1)" "unprognostic (7.76e-3)" 0.1 0.0 0.8 0.4 0.7 0.5 0.5 0.1 0.8 0.1 0.1 0.1 0.1 0.7 0.1 0.3 0.1 0.1 0.1 0.1 1.1 0.7 26.0 0.1 0.1 0.2 1.6 0.4 0.1 0.3 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.3 0.1 0.2 0.1 0.1 0.1 3.5 0.2 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.5 1.1 0.7 1.6 0.4 0.7 0.1 TSC1 "hamartin, KIAA0243, LAM, TSC" ENSG00000165699 "TSC complex subunit 1" Q92574 9 132891348-132946874 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011568, CAB012481, HPA074132" Supported Enhanced Cytosol Cytosol "CAB011568: AB_732752, CAB012481: , HPA074132: " "unprognostic (1.88e-1)" "unprognostic (1.51e-1)" "unprognostic (1.40e-2)" "unprognostic (2.56e-1)" "unprognostic (6.67e-2)" "unprognostic (4.23e-3)" "prognostic unfavourable (6.03e-6)" "unprognostic (1.96e-2)" "unprognostic (3.48e-2)" "unprognostic (1.24e-1)" "prognostic favourable (8.01e-4)" "unprognostic (1.84e-2)" "prognostic favourable (7.91e-4)" "unprognostic (9.49e-2)" "unprognostic (1.46e-1)" "unprognostic (2.35e-1)" "unprognostic (1.16e-1)" 10.4 13.6 15.8 8.8 26.8 13.6 11.4 32.1 28.3 12.7 10.8 22.6 7.9 9.1 14.6 12.3 10.9 12.4 9.7 17.6 13.0 12.1 13.1 9.4 11.6 10.2 12.5 15.1 21.2 12.1 15.9 19.5 15.8 21.1 11.8 12.6 13.1 11.6 10.4 20.0 13.8 11.2 14.2 12.4 13.7 10.6 36.2 14.9 10.5 16.2 8.6 14.2 10.9 11.1 2.8 3.1 4.8 7.0 4.9 7.1 2.6 6.1 7.3 10.0 8.2 10.3 9.8 18.8 8.3 13.4 8.7 8.6 12.4 7.2 14.4 3.6 15.8 16.0 11.7 8.4 8.9 6.9 6.2 4.6 14.5 10.1 12.3 6.7 6.2 10.5 6.4 11.1 13.6 10.0 8.0 7.9 9.9 11.4 6.0 5.8 13.7 6.1 7.3 18.9 8.1 3.9 8.1 5.0 7.7 9.7 6.1 4.8 11.0 4.0 10.3 14.3 8.6 8.5 5.6 4.4 9.8 14.0 8.1 4.0 6.3 4.1 4.4 4.8 6.5 7.0 7.1 1.9 3.6 5.7 3.1 2.8 5.9 5.3 1.7 4.9 3.2 1.8 5.7 2.6 15.8 26.8 32.1 28.3 13.0 12.1 12.5 15.1 21.1 14.9 TSC2 "LAM, PPP1R160, TSC4, tuberin" ENSG00000103197 "TSC complex subunit 2" P49815 16 2047465-2089487 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "GTPase activation" "Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002225, HPA030409, HPA049679" Approved Enhanced Cytosol Cytosol "CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: " "unprognostic (2.80e-1)" "unprognostic (1.01e-1)" "unprognostic (1.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.02e-1)" "unprognostic (1.03e-3)" "unprognostic (2.04e-2)" "unprognostic (6.05e-3)" "unprognostic (3.43e-1)" "unprognostic (8.94e-2)" "prognostic favourable (5.06e-4)" "unprognostic (4.32e-2)" "unprognostic (3.91e-2)" "unprognostic (2.14e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-2)" "unprognostic (8.96e-2)" 13.9 11.9 16.9 12.4 20.0 10.9 13.2 35.1 26.9 20.5 17.0 19.4 17.9 14.0 20.1 12.2 13.0 18.6 15.0 14.0 13.3 8.8 11.8 9.8 12.7 10.1 13.8 14.7 21.1 16.1 20.0 18.1 10.6 14.6 13.8 10.8 16.7 22.9 19.6 31.7 14.5 13.2 13.5 11.4 12.9 16.6 21.4 12.9 14.1 20.1 11.3 10.9 18.0 14.0 4.7 5.6 7.7 4.9 3.6 7.0 3.7 7.2 11.6 16.1 18.2 19.2 16.2 13.6 17.4 11.9 13.1 11.2 13.9 13.8 10.9 15.5 14.3 12.0 9.6 12.6 9.8 8.3 15.8 10.3 22.5 5.7 13.2 12.8 12.5 19.1 8.0 10.6 7.9 12.3 10.0 9.8 11.6 14.4 15.2 3.8 16.7 11.4 24.2 17.6 13.9 5.3 6.5 12.2 23.1 24.8 16.4 8.8 15.0 9.5 19.4 13.8 9.4 12.3 8.8 21.9 21.8 21.8 5.7 5.2 16.3 6.2 4.9 5.4 7.0 4.7 6.7 4.4 4.4 4.1 5.6 4.7 3.1 4.8 7.7 3.6 3.7 1.5 3.2 3.7 16.9 20.0 35.1 26.9 13.3 8.8 13.8 14.7 14.6 12.9 TSN "BCLF-1, REHF-1, TRSLN" ENSG00000211460 Translin Q15631 2 121737103-121767853 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059561 Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" 320000 "Nucleoplasm, Endoplasmic reticulum" "HPA059561: " "unprognostic (3.15e-2)" "unprognostic (1.83e-1)" "unprognostic (3.53e-1)" "prognostic unfavourable (7.05e-4)" "unprognostic (7.13e-3)" "unprognostic (3.12e-2)" "prognostic unfavourable (3.06e-4)" "unprognostic (2.32e-2)" "unprognostic (7.58e-2)" "unprognostic (2.39e-2)" "unprognostic (1.10e-1)" "unprognostic (2.24e-1)" "unprognostic (1.62e-1)" "unprognostic (6.48e-2)" "unprognostic (1.04e-2)" "unprognostic (3.42e-2)" "unprognostic (3.18e-1)" 14.9 18.7 23.1 13.0 24.6 43.0 25.6 17.8 27.7 18.6 23.1 23.7 11.8 17.2 17.9 19.1 18.2 15.2 16.3 18.7 20.6 23.0 24.7 22.0 15.0 22.6 22.8 20.1 17.5 20.7 19.3 17.9 13.8 23.3 15.0 18.9 16.5 16.3 18.2 29.4 18.9 16.4 14.3 22.0 17.5 15.4 33.9 17.6 28.3 17.2 18.7 17.4 13.9 14.2 22.1 22.7 22.0 24.4 19.6 23.1 20.7 21.4 9.7 14.4 12.1 13.3 10.6 8.0 18.4 16.7 19.3 19.1 27.1 11.8 29.9 21.7 16.5 10.0 21.0 16.9 26.8 16.6 17.2 17.6 14.0 24.2 14.9 24.6 12.6 9.0 18.7 21.9 14.5 15.8 26.6 14.3 17.4 11.0 14.9 27.6 17.5 18.5 25.2 16.1 22.0 23.3 14.2 18.9 11.8 12.0 17.3 20.6 11.5 18.4 11.8 13.9 23.7 9.2 17.3 13.3 37.7 33.5 16.1 16.7 16.8 17.2 24.4 22.0 19.6 22.2 22.7 22.1 20.4 17.0 22.7 18.0 23.1 20.1 7.9 19.6 19.0 16.5 20.2 20.7 23.1 24.6 17.8 27.7 20.6 23.0 22.8 20.1 23.3 17.6 TSNARE1 FLJ31164 ENSG00000171045 "T-SNARE domain containing 1" Q96NA8 8 142212080-142403240 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA015890, HPA074249" Approved Approved Nucleoplasm Nucleoplasm "HPA015890: AB_1858402, HPA074249: " "unprognostic (2.92e-2)" "unprognostic (1.44e-1)" "unprognostic (3.94e-3)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (1.09e-2)" "unprognostic (1.48e-2)" "unprognostic (3.72e-3)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.87e-3)" "unprognostic (1.66e-1)" "unprognostic (6.26e-2)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "prognostic favourable (7.33e-4)" 9.0 8.4 14.3 10.1 14.3 5.3 9.0 14.4 18.4 11.2 8.9 15.6 7.4 15.2 12.6 10.5 7.4 13.2 8.2 7.2 8.6 8.0 8.6 6.6 9.2 8.2 12.7 12.9 17.9 24.3 9.0 9.8 4.8 11.6 10.5 4.3 10.5 17.1 11.5 11.7 31.9 16.5 7.4 8.4 13.2 11.3 8.9 14.3 6.3 12.3 6.5 9.7 9.3 8.8 1.2 1.5 3.9 5.0 1.2 2.3 1.4 5.1 5.0 3.3 4.1 2.7 2.4 10.5 1.5 2.5 1.5 1.6 1.5 5.5 2.7 8.3 1.2 4.5 1.5 5.3 0.6 3.0 4.7 3.0 1.2 5.5 7.0 7.2 7.5 4.7 4.9 0.0 3.5 1.6 6.1 0.3 1.1 6.7 5.9 6.5 3.3 12.0 0.0 1.8 4.6 2.9 6.3 13.8 8.4 6.8 5.7 10.0 3.7 6.5 4.1 2.4 6.7 4.6 3.2 0.4 2.1 4.2 4.5 19.0 2.5 3.9 1.3 0.3 2.3 5.0 1.6 0.8 1.3 0.6 1.5 1.2 0.5 0.9 0.1 1.2 3.5 0.0 1.5 1.4 14.3 14.3 14.4 18.4 8.6 8.0 12.7 12.9 11.6 14.3 TSPAN11 ENSG00000110900 "Tetraspanin 11" A1L157 12 30926428-30996599 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 25.6" "Group enriched" "Detected in some" 6 "AF22: 18.5;HSkMC: 18.3;NTERA-2: 14.7;SCLC-21H: 7.1;SH-SY5Y: 14.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA066789 Approved Vesicles Vesicles "HPA066789: " "unprognostic (4.10e-2)" "unprognostic (4.27e-2)" "unprognostic (4.38e-3)" "unprognostic (1.18e-2)" "unprognostic (4.51e-1)" "prognostic favourable (5.28e-4)" "unprognostic (4.28e-2)" "prognostic favourable (3.43e-4)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (1.51e-2)" "unprognostic (3.03e-2)" "unprognostic (5.77e-3)" "unprognostic (2.04e-2)" "unprognostic (5.81e-2)" "unprognostic (2.90e-3)" "unprognostic (1.79e-1)" 3.1 2.5 6.4 16.0 3.8 0.0 2.5 15.2 12.7 9.0 25.6 9.0 3.0 4.4 6.4 7.8 8.8 2.4 12.2 8.8 5.0 4.7 1.6 1.0 8.5 2.6 4.1 3.8 1.9 1.4 0.3 1.5 0.8 3.8 5.4 11.0 12.2 3.8 6.8 0.8 6.5 10.9 8.3 2.6 2.6 4.5 1.6 3.7 0.0 4.0 12.3 8.9 6.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.5 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.5 0.0 1.1 1.6 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 18.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 14.7 0.1 0.0 0.0 0.3 0.0 0.0 7.1 14.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 3.8 15.2 4.3 5.0 4.7 4.1 3.8 3.8 3.7 TSPAN14 "DC-TM4F2, MGC11352, TM4SF14" ENSG00000108219 "Tetraspanin 14" Q8NG11 10 80454166-80533123 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014773, HPA057174" Uncertain Supported Vesicles 170000 Vesicles "HPA014773: AB_2208670, HPA057174: " "unprognostic (7.52e-2)" "prognostic favourable (3.56e-4)" "unprognostic (6.55e-3)" "unprognostic (1.56e-1)" "unprognostic (4.40e-2)" "unprognostic (1.18e-1)" "unprognostic (2.11e-2)" "unprognostic (8.90e-2)" "unprognostic (5.21e-2)" "unprognostic (3.13e-1)" "unprognostic (5.15e-3)" "unprognostic (4.12e-3)" "prognostic favourable (4.20e-4)" "unprognostic (2.52e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (2.57e-3)" 56.8 10.3 15.4 17.2 14.1 22.0 45.1 5.2 16.8 30.0 14.1 15.1 28.1 13.3 18.9 22.4 44.6 22.2 15.1 15.2 13.4 7.7 22.9 16.0 32.9 47.4 18.8 10.8 21.7 14.4 12.3 7.4 39.0 13.0 20.0 12.3 22.7 24.8 16.5 11.3 33.3 17.3 15.3 16.5 28.2 12.6 12.9 14.5 16.0 26.2 19.1 26.7 30.5 28.4 4.4 10.1 16.2 47.7 26.1 29.0 21.3 21.5 31.9 29.6 10.2 45.7 14.6 13.9 11.1 21.3 12.1 8.9 30.7 12.6 7.0 21.4 6.0 22.5 8.3 20.1 9.9 12.3 3.2 19.7 3.8 26.3 15.3 7.3 4.8 14.0 17.9 12.2 22.3 45.0 10.9 5.1 3.4 18.5 10.6 5.2 6.7 0.0 36.8 3.4 1.1 47.4 31.0 6.4 9.7 4.4 30.9 34.2 12.5 17.7 63.6 3.0 12.7 2.9 7.7 2.5 9.1 2.5 10.1 14.9 13.3 3.8 14.8 16.0 29.0 30.4 13.2 4.4 22.7 25.7 10.1 4.2 27.1 25.2 16.2 26.1 47.7 4.0 17.9 21.3 15.4 14.1 5.2 16.8 13.4 7.7 18.8 10.8 13.0 14.5 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451473-69507669 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.8;EFO-21: 48.5;MCF7: 36.6;PC-3: 60.3;SK-BR-3: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 17.4" "Lineage enriched" "Detected in many" 6 "T-cells: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044657 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044657: AB_10967927" "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavourable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavourable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 34.2 3.1 11.5 9.7 22.7 0.9 24.9 40.4 17.0 8.9 30.4 49.2 12.5 24.0 15.1 8.4 7.1 16.2 17.1 8.3 18.0 9.2 10.2 3.0 20.4 4.9 33.1 11.2 3.0 10.8 1.4 3.3 17.7 16.8 17.6 24.9 5.4 16.8 17.0 9.9 4.6 21.5 23.0 43.0 13.5 46.4 4.0 28.3 0.8 6.7 2.7 4.8 22.6 6.8 0.0 2.7 0.0 0.0 0.1 17.4 0.5 11.1 23.1 0.4 0.0 0.5 0.0 2.7 0.0 0.4 0.6 1.5 9.9 34.8 0.0 48.5 0.5 22.7 1.6 2.5 0.7 9.1 4.6 0.6 0.7 2.2 0.2 0.0 0.4 0.5 0.7 0.3 0.3 8.9 0.2 0.0 0.2 36.6 0.1 0.2 0.6 60.3 0.8 0.4 0.4 6.7 20.6 7.9 3.0 0.1 30.6 3.8 13.4 0.5 7.7 0.0 0.1 0.0 3.8 0.2 1.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 17.4 0.0 2.7 2.5 2.7 0.0 0.9 0.2 0.0 0.1 0.0 0.2 0.9 0.5 11.5 22.7 40.4 17.0 18.0 9.2 33.1 11.2 16.8 28.3 TSPAN3 "TM4-A, TM4SF8, TSPAN-3" ENSG00000140391 "Tetraspanin 3" O60637 15 77041404-77083984 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 69.4;naive B-cell: 69.7;plasmacytoid DC: 46.7" "Group enriched" "Detected in all" 5 "B-cells: 69.7;dendritic cells: 46.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015996 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA015996: AB_1858406" "unprognostic (5.94e-2)" "unprognostic (3.05e-1)" "unprognostic (7.32e-2)" "unprognostic (2.15e-2)" "unprognostic (4.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.92e-2)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (5.41e-3)" "unprognostic (3.51e-3)" "unprognostic (2.90e-2)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-1)" "unprognostic (3.79e-3)" "unprognostic (1.35e-1)" 64.0 31.4 71.6 16.9 66.5 6.0 43.3 36.8 67.5 31.4 75.3 49.4 74.2 70.6 28.4 95.9 16.8 53.8 39.4 24.6 58.1 63.7 44.9 17.8 41.9 22.9 64.4 45.8 33.0 31.6 53.6 44.0 23.1 54.1 21.3 82.7 44.3 30.8 60.9 79.3 16.3 71.2 27.6 49.2 19.1 46.1 21.3 40.4 14.2 43.0 24.7 25.4 23.2 15.2 69.7 46.7 1.5 10.8 8.3 6.9 12.1 21.0 57.5 47.8 30.1 84.0 51.7 15.8 33.8 36.8 41.7 45.6 35.0 44.1 20.7 50.3 34.8 47.9 45.3 23.1 31.4 23.2 68.7 14.8 44.1 33.1 40.8 19.0 10.9 48.7 28.0 23.0 20.5 50.9 15.6 18.3 40.7 8.0 16.8 18.1 33.8 25.6 21.2 59.4 21.8 68.5 12.0 43.4 48.0 23.1 19.6 62.8 21.0 36.1 48.2 38.7 15.1 23.3 47.2 40.3 54.8 11.0 34.3 28.5 22.0 0.8 7.5 1.5 5.1 9.9 5.4 69.4 2.6 3.7 14.8 69.7 6.9 6.3 0.7 8.3 10.8 46.7 0.6 12.1 71.6 66.5 36.8 64.2 58.1 63.7 64.4 45.8 54.1 40.4 TSPAN31 SAS ENSG00000135452 "Tetraspanin 31" Q12999 12 57738013-57750211 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 59.0" "Cancer enhanced" "Detected in all" "glioma: 54.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030758, HPA057489" Approved Approved "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA030758: , HPA057489: " "unprognostic (2.66e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (8.96e-3)" "prognostic unfavourable (1.09e-4)" "unprognostic (4.31e-3)" "unprognostic (1.19e-1)" "unprognostic (6.51e-3)" "unprognostic (5.31e-2)" "unprognostic (2.68e-1)" "unprognostic (2.79e-1)" "prognostic favourable (9.91e-5)" "unprognostic (1.68e-1)" "unprognostic (1.59e-1)" "unprognostic (6.32e-2)" "unprognostic (1.58e-1)" 27.0 26.4 19.4 18.2 22.5 5.4 21.8 14.3 20.5 21.9 20.1 30.5 23.0 16.3 23.1 37.6 21.3 27.7 23.3 23.3 19.1 17.8 32.1 29.2 20.7 14.5 20.3 16.0 32.0 32.1 31.4 22.7 31.5 19.4 23.3 19.0 32.1 24.6 22.0 19.8 15.2 24.0 17.5 24.3 23.1 18.2 11.4 17.1 14.6 42.4 16.5 20.7 20.2 16.8 17.6 35.4 18.6 24.8 23.7 22.0 18.8 3.5 8.7 8.9 2.2 20.7 13.6 5.8 5.6 7.5 3.0 3.0 6.0 19.2 3.2 12.6 13.0 7.4 2.3 12.0 4.3 8.5 6.3 4.4 7.2 2.5 20.4 4.3 7.6 12.0 14.2 5.9 12.5 8.0 3.1 9.4 9.8 7.2 3.3 2.5 1.9 2.8 4.2 59.0 8.4 12.5 7.3 3.1 7.6 6.1 8.9 4.4 16.8 6.8 10.9 4.9 4.1 2.6 3.0 11.7 2.6 1.5 13.3 2.9 7.4 18.6 15.7 11.1 22.0 15.7 21.3 17.6 17.8 18.9 15.6 16.8 17.8 16.7 5.3 23.7 24.8 35.4 12.1 18.8 19.4 22.5 14.3 18.5 19.1 17.8 20.3 16.0 19.4 17.1 TSPAN32 "PHEMX, TSSC6" ENSG00000064201 "Tetraspanin 32" Q96QS1 11 2301997-2318200 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5" "Group enriched" "Detected in some" 8 "HEL: 15.4;HL-60: 6.7;NB-4: 5.6;THP-1: 5.9;U-937: 9.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024135 Uncertain Approved Nucleoplasm 37000 Nucleoplasm "HPA024135: AB_1858409" "unprognostic (7.50e-3)" "unprognostic (4.88e-4)" "unprognostic (1.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.45e-3)" "unprognostic (2.10e-4)" "unprognostic (7.72e-3)" "unprognostic (8.25e-3)" "unprognostic (9.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.02e-1)" "unprognostic (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (4.20e-1)" "unprognostic (4.35e-1)" "unprognostic (8.13e-2)" 1.2 0.4 0.3 6.3 0.5 17.5 0.5 0.4 1.0 1.3 1.3 2.1 0.0 0.2 1.6 1.6 0.9 0.6 1.4 11.9 0.3 0.4 0.9 0.8 3.1 5.1 0.5 0.3 0.8 0.4 0.0 0.4 0.9 0.5 1.2 0.1 1.7 5.6 0.9 0.3 0.5 1.1 1.8 0.8 5.8 1.4 0.4 1.1 7.4 0.5 2.1 11.5 1.0 0.8 1.1 14.9 17.9 19.3 25.3 13.2 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 15.4 0.0 0.1 0.7 6.7 1.1 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 9.4 0.0 17.9 15.2 2.0 13.0 17.9 8.1 1.1 4.7 11.1 14.9 0.6 3.7 13.2 8.4 25.3 19.3 0.7 5.8 9.5 0.3 0.5 0.4 1.0 0.3 0.4 0.5 0.3 0.5 1.1 TSPAN6 "T245, TM4SF6, TSPAN-6" ENSG00000000003 "Tetraspanin 6" O43657 X 100627109-100639991 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 88.4" "Cell line enhanced" "Detected in many" "NTERA-2: 42.7;RT4: 64.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "pons and medulla: 34.2" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.6" "Lineage enriched" "Detected in single" 8 "T-cells: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004109 Approved Approved "Nucleoli fibrillar center,Cell Junctions,Cytosol" "Cell Junctions, Cytosol" "Nucleoli fibrillar center" "HPA004109: AB_1080301" "unprognostic (7.71e-2)" "unprognostic (8.97e-2)" "unprognostic (3.56e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-3)" "unprognostic (5.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-3)" "unprognostic (2.04e-3)" "unprognostic (8.76e-2)" "unprognostic (3.83e-3)" "unprognostic (4.28e-2)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (9.54e-3)" 27.0 9.8 7.0 4.4 6.6 0.1 33.0 2.9 4.9 15.9 17.8 12.6 6.4 9.7 11.1 10.4 27.1 24.2 10.0 5.7 7.4 7.3 26.7 68.2 8.3 3.6 6.9 4.1 27.6 25.1 19.6 17.7 23.6 34.2 15.5 20.3 16.7 88.4 6.7 3.5 4.7 11.6 4.7 10.4 8.6 8.0 17.5 6.6 2.9 24.6 11.0 19.8 17.2 11.5 0.3 0.2 0.8 0.2 0.3 6.6 1.4 7.8 10.5 28.3 14.3 12.4 6.7 11.5 4.5 7.0 8.9 20.8 23.5 13.7 0.0 18.8 4.6 6.4 0.1 8.5 10.5 0.0 15.2 1.4 6.8 26.1 6.9 0.0 1.1 13.2 4.1 7.8 3.0 18.9 0.0 0.0 9.1 8.1 0.0 0.1 42.7 7.9 0.0 13.4 0.0 13.9 64.4 1.8 7.7 4.4 3.9 6.0 5.7 1.0 5.3 5.6 8.5 9.1 2.9 0.0 0.0 0.0 4.9 0.0 3.9 0.5 0.1 0.2 1.0 0.1 3.5 0.3 2.4 0.8 0.0 0.2 6.6 3.8 0.8 0.3 0.2 0.2 0.1 1.4 7.0 6.6 2.9 4.9 7.4 7.3 6.9 4.1 34.2 6.6 TSPO "BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS" ENSG00000100300 "Translocator protein" "B1AH88, P30536" 22 43151514-43163242 "Cancer-related genes, FDA approved drug targets, Predicted membrane proteins" "Lipid transport, Transport" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 139.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011232, HPA046260" Uncertain Approved Vesicles,Mitochondria,Cytosol "Mitochondria, Cytosol" Vesicles "CAB011232: , HPA046260: " "unprognostic (5.29e-3)" "unprognostic (1.41e-1)" "unprognostic (3.31e-1)" "unprognostic (4.02e-3)" "unprognostic (3.95e-1)" "unprognostic (1.46e-2)" "prognostic unfavourable (1.61e-4)" "unprognostic (2.16e-1)" "unprognostic (1.17e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.34e-3)" 33.9 21.2 9.8 17.8 11.0 117.3 48.7 2.7 8.1 24.9 23.9 12.3 10.3 20.5 12.3 13.6 83.2 14.3 36.8 32.1 8.0 5.4 18.0 22.0 39.8 40.0 15.4 5.2 13.3 13.2 4.0 6.7 15.5 9.7 23.1 9.7 16.4 34.6 9.2 13.2 46.6 23.0 12.7 11.4 27.2 39.0 10.5 10.0 9.4 17.9 44.3 50.0 19.1 41.3 22.9 99.9 91.4 139.5 28.5 43.8 104.8 47.1 23.4 1.6 22.2 8.9 29.6 1.7 35.3 17.3 17.8 18.9 4.5 36.1 0.0 24.4 27.3 39.1 4.4 27.3 2.3 7.9 18.4 4.8 25.7 1.6 32.4 10.7 24.2 22.9 45.1 10.5 9.4 42.0 3.9 8.9 18.2 39.4 0.1 29.9 1.9 58.4 10.6 0.0 80.5 22.6 28.5 2.3 10.9 16.7 33.4 41.1 12.5 41.5 43.3 22.0 16.5 22.5 14.8 3.6 0.6 0.4 28.6 34.8 28.2 43.8 139.5 75.3 28.4 86.3 22.2 16.3 39.5 27.8 99.9 22.9 30.4 24.5 91.4 28.5 57.1 17.7 43.8 104.8 9.8 11.0 2.7 8.1 8.0 5.4 15.4 5.2 9.7 10.0 TSSK1B "FKSG81, SPOGA4, STK22D, TSSK1" ENSG00000212122 "Testis specific serine kinase 1B" Q9BXA7 5 113432554-113435031 "Enzymes, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 50 "testis: 59.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.3;EFO-21: 2.1;RT4: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA027827 Enhanced "HPA027827: AB_10603138" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 59.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.6 0.1 0.2 0.0 1.0 0.0 0.0 0.0 0.2 0.0 1.3 0.2 2.1 0.0 0.4 0.2 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.5 0.1 0.0 0.1 0.3 0.0 0.4 0.0 0.5 0.2 0.2 0.3 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSSK4 "C14orf20, STK22E" ENSG00000139908 "Testis specific serine kinase 4" Q6SA08 14 24205697-24208362 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 46.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA060660, HPA077103" Approved Approved "Cell Junctions" "Cell Junctions" "HPA060660: , HPA077103: " "unprognostic (1.95e-1)" "unprognostic (4.30e-2)" "unprognostic (1.52e-1)" "unprognostic (5.69e-2)" "unprognostic (2.36e-1)" "unprognostic (3.38e-5)" "unprognostic (1.06e-1)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (3.39e-1)" "unprognostic (7.03e-3)" "unprognostic (1.27e-3)" "unprognostic (3.42e-1)" "unprognostic (4.30e-2)" "unprognostic (6.28e-2)" "unprognostic (8.98e-2)" "unprognostic (7.26e-2)" 0.6 0.9 0.6 1.7 0.6 3.1 0.6 1.5 1.8 0.6 0.6 0.6 0.6 1.5 0.8 0.9 1.4 0.8 1.7 0.6 0.6 0.4 0.6 0.6 0.8 2.8 0.6 0.6 0.8 0.9 0.0 0.6 0.6 0.6 0.6 0.0 0.6 1.4 0.6 1.0 4.7 1.6 0.6 0.6 1.5 0.6 46.1 0.6 0.6 1.4 0.6 0.6 1.0 0.6 2.1 1.7 2.0 1.0 1.8 2.0 0.7 1.0 4.0 3.9 1.5 0.1 0.0 4.3 1.6 0.1 0.0 0.0 2.1 3.7 3.1 0.9 0.1 3.8 0.0 0.1 0.0 1.6 3.0 3.4 4.8 3.0 0.0 1.5 3.7 0.0 0.0 0.0 0.6 0.1 1.3 2.0 0.0 3.8 3.6 1.6 0.7 3.2 2.9 1.5 2.6 0.0 5.2 2.2 2.0 2.7 2.5 0.8 1.6 1.7 1.4 2.9 1.8 3.7 1.3 4.2 4.8 4.7 1.0 2.8 0.9 0.0 1.0 2.0 2.0 1.0 0.7 2.0 1.6 1.6 0.6 2.1 1.6 1.7 2.0 1.8 0.9 1.7 0.7 0.7 0.6 0.6 1.5 0.6 0.6 0.4 0.6 0.6 0.6 0.6 TTC13 FLJ22584 ENSG00000143643 "Tetratricopeptide repeat domain 13" Q8NBP0 1 230906243-230978875 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018022, HPA051558" Uncertain Approved Nucleoplasm Nucleoplasm "HPA018022: AB_2211524, HPA051558: " "unprognostic (2.68e-1)" "unprognostic (1.64e-1)" "unprognostic (3.42e-1)" "unprognostic (9.59e-3)" "unprognostic (8.10e-2)" "prognostic favourable (7.66e-4)" "unprognostic (2.60e-2)" "unprognostic (5.40e-3)" "unprognostic (1.97e-1)" "unprognostic (1.80e-2)" "prognostic favourable (4.59e-5)" "unprognostic (2.29e-1)" "prognostic unfavourable (1.60e-11)" "unprognostic (4.48e-2)" "unprognostic (3.01e-1)" "unprognostic (5.96e-2)" "unprognostic (7.54e-3)" 10.5 7.1 8.9 16.6 26.7 13.1 9.6 11.2 12.4 7.3 13.6 12.5 8.6 10.5 9.3 9.2 8.5 9.2 8.9 7.0 9.9 7.9 6.9 9.0 12.2 23.4 13.3 9.3 8.2 13.7 13.5 15.5 9.9 12.6 8.1 21.6 7.9 9.6 9.5 15.6 12.8 15.6 8.4 14.7 21.3 15.6 3.9 13.7 18.4 9.8 6.2 18.9 8.0 9.1 4.2 10.8 7.6 7.7 11.9 10.0 5.1 7.9 8.2 8.0 15.7 7.5 4.9 16.6 11.7 9.3 6.6 7.5 11.9 8.8 14.8 10.8 7.0 12.9 5.3 4.3 4.4 16.5 16.2 4.4 8.7 8.1 8.0 9.0 4.1 4.3 7.7 6.2 5.8 11.6 4.7 8.6 6.0 4.1 4.8 8.6 9.1 10.2 7.7 11.6 20.5 6.9 5.5 11.1 9.6 8.9 9.3 15.6 9.8 11.8 5.9 7.8 1.1 10.5 20.7 10.7 17.5 4.5 7.7 5.7 12.7 7.6 7.6 6.8 10.0 5.8 6.8 4.2 7.0 8.2 10.8 3.9 5.7 6.8 2.9 11.9 7.7 7.4 5.4 5.1 8.9 26.7 11.2 12.4 9.9 7.9 13.3 9.3 12.6 13.7 TTC14 "FLJ00166, KIAA1980" ENSG00000163728 "Tetratricopeptide repeat domain 14" Q96N46 3 180602130-180617828 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009295 Uncertain Supported Nucleoplasm Nucleoplasm "HPA009295: AB_1858425" "unprognostic (2.72e-1)" "unprognostic (4.85e-1)" "unprognostic (1.11e-1)" "unprognostic (1.59e-2)" "unprognostic (1.48e-2)" "unprognostic (1.54e-1)" "unprognostic (2.43e-2)" "unprognostic (1.39e-1)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (3.63e-1)" "unprognostic (2.22e-3)" "unprognostic (2.27e-3)" "unprognostic (1.95e-1)" "unprognostic (2.08e-1)" "unprognostic (8.07e-2)" "unprognostic (2.33e-3)" 17.2 20.3 30.0 30.4 32.0 23.1 20.5 18.2 32.4 22.8 20.8 15.8 25.6 19.3 29.0 37.9 12.7 25.2 16.9 16.8 25.6 15.4 22.3 14.1 18.6 30.7 22.8 28.7 41.9 24.3 33.7 49.0 18.0 22.1 26.4 19.0 15.9 15.5 28.7 11.9 17.8 20.7 17.5 23.8 25.7 19.8 16.6 24.3 41.1 35.2 11.1 23.0 20.3 23.4 14.2 18.2 17.1 13.7 14.3 15.0 5.9 8.6 6.9 10.9 6.3 14.9 12.8 10.4 12.6 10.2 9.2 15.2 9.5 11.6 13.1 13.6 9.0 12.6 10.2 6.6 12.4 24.2 10.3 12.3 16.1 22.0 11.0 13.1 11.4 16.4 12.9 9.1 4.6 7.2 5.2 2.6 10.3 2.5 9.9 1.0 7.8 14.1 11.7 6.8 13.9 5.3 6.6 9.3 9.2 12.0 6.1 11.9 22.4 12.8 11.4 18.6 9.6 8.4 23.1 19.6 29.8 29.4 8.9 16.6 8.1 17.1 9.8 10.4 11.6 10.7 14.1 14.2 12.2 11.4 7.4 12.5 15.0 11.9 7.8 14.3 13.7 18.2 10.4 5.9 30.0 32.0 18.2 32.4 25.6 15.4 22.8 28.7 22.1 24.3 TTC3 "DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII" ENSG00000182670 "Tetratricopeptide repeat domain 3" P53804 21 37073226-37203112 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016810, HPA023964, HPA036304" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: " "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.37e-2)" "unprognostic (8.52e-2)" "unprognostic (9.29e-2)" "unprognostic (8.71e-2)" "unprognostic (1.61e-1)" "unprognostic (2.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (6.74e-2)" 22.9 22.1 34.0 18.7 36.5 12.0 23.4 39.2 40.0 34.9 20.6 15.9 26.7 13.0 21.6 33.3 15.3 19.5 19.0 21.5 29.1 16.5 21.4 17.0 15.4 14.3 17.7 27.5 34.5 25.8 27.4 50.4 15.2 34.7 28.9 19.9 16.1 24.5 25.4 21.6 16.1 16.8 21.6 21.7 13.6 21.3 19.5 19.9 19.7 35.4 11.1 15.1 23.3 18.9 10.6 12.8 4.8 5.7 9.1 18.6 3.8 21.4 7.6 35.7 6.7 34.5 50.2 12.4 23.6 29.4 10.7 14.5 10.1 10.8 18.5 8.2 39.5 7.0 10.7 14.5 15.1 19.6 7.7 37.4 11.5 13.1 12.6 20.8 12.1 25.9 9.0 10.8 9.7 15.8 22.5 21.8 20.0 16.6 20.2 5.4 10.1 13.0 27.1 17.1 9.7 12.4 16.6 27.3 20.8 29.3 16.8 15.2 19.0 8.2 20.5 15.3 6.1 18.7 8.8 21.9 15.7 18.5 25.2 20.9 11.5 2.9 4.4 4.8 9.1 4.8 13.6 9.5 10.6 12.3 7.9 10.6 18.6 11.3 0.7 9.1 5.7 12.8 7.2 3.8 34.0 36.5 39.2 40.0 29.1 16.5 17.7 27.5 34.7 19.9 TTC33 OSRF ENSG00000113638 "Tetratricopeptide repeat domain 33" Q6PID6 5 40512333-40755975 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038252, HPA038253" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA038252: AB_10674551, HPA038253: AB_10671739" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.04e-3)" "unprognostic (3.01e-2)" "unprognostic (1.99e-1)" "unprognostic (2.01e-1)" "unprognostic (2.60e-1)" "prognostic favourable (1.83e-4)" "unprognostic (8.50e-2)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (4.28e-3)" 11.0 11.8 13.5 6.9 27.7 1.5 11.0 20.4 20.1 11.7 9.9 6.4 8.1 8.2 12.3 7.8 9.1 10.1 9.0 13.4 11.5 12.1 14.7 15.0 9.0 8.9 8.8 19.4 15.2 8.6 15.6 15.1 9.0 13.1 11.5 9.2 7.3 9.3 10.6 24.2 6.4 9.1 10.5 9.5 8.4 8.7 9.0 9.8 14.3 12.8 5.5 9.2 10.8 9.0 7.2 5.3 15.9 10.8 7.8 10.0 8.2 5.1 4.5 8.8 11.3 6.2 8.9 4.1 7.1 7.5 7.8 8.0 2.3 5.4 16.3 4.3 5.3 2.8 8.5 3.8 12.9 18.4 6.4 3.6 15.4 6.4 6.3 9.2 5.2 5.3 7.2 7.3 7.5 10.8 8.3 12.6 9.4 1.3 16.1 8.9 2.7 4.5 15.7 17.6 9.1 8.3 3.2 6.4 7.3 17.8 8.7 9.5 6.9 10.4 7.4 9.4 8.5 5.9 5.8 10.3 11.1 8.9 6.3 12.3 7.4 15.9 6.1 11.1 8.1 9.0 8.7 7.2 8.5 7.5 5.3 6.9 10.0 8.0 9.0 7.8 10.8 3.9 9.0 8.2 13.5 27.7 20.4 20.1 11.5 12.1 8.8 19.4 13.1 9.8 TTC39A "C1orf34, DEME-6, KIAA0452" ENSG00000085831 "Tetratricopeptide repeat domain 39A" Q5SRH9 1 51287258-51345116 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 21.5;MCF7: 16.9;SK-BR-3: 52.6;T-47d: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 23.4" "Lineage enriched" "Detected in single" 46 "dendritic cells: 23.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028098, HPA043440" Uncertain Approved Centrosome Centrosome "HPA028098: AB_10601705, HPA043440: " "unprognostic (5.05e-2)" "unprognostic (1.95e-1)" "unprognostic (3.35e-2)" "unprognostic (7.60e-2)" "unprognostic (8.53e-3)" "unprognostic (2.86e-2)" "prognostic unfavourable (5.05e-5)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (8.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.89e-2)" "unprognostic (1.73e-3)" "unprognostic (5.40e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 1.2 4.9 3.2 6.0 5.5 0.6 23.4 0.7 4.3 8.5 18.0 0.2 8.1 3.3 1.4 10.4 10.4 4.5 17.9 8.3 3.3 7.4 40.4 3.1 12.4 0.5 4.2 2.4 0.9 22.3 6.1 12.1 0.9 10.1 12.3 20.2 3.1 10.1 10.7 2.2 5.6 4.5 0.8 4.9 0.3 18.7 28.2 2.0 0.2 5.5 8.5 6.2 5.0 5.0 0.1 23.4 0.5 0.0 0.0 0.0 0.2 2.2 1.2 0.2 0.1 0.1 0.2 9.3 0.1 0.0 0.0 0.0 5.7 0.9 0.0 4.1 0.1 0.0 1.2 0.0 0.0 21.5 4.3 0.1 0.5 1.1 0.4 0.0 0.2 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.0 16.9 0.2 0.0 1.6 0.2 0.0 0.0 1.4 9.2 2.9 7.8 0.7 0.1 52.6 0.5 38.1 0.2 0.2 0.1 1.0 0.1 0.1 2.2 2.8 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 23.4 0.0 0.2 3.2 5.5 0.7 4.3 3.3 7.4 4.2 2.4 10.1 2.0 TTI2 "C8orf41, FLJ23263" ENSG00000129696 "TELO2 interacting protein 2" Q6NXR4 8 33473386-33513601 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023523, HPA029823" Approved Enhanced Centrosome Centrosome "HPA023523: AB_1845776, HPA029823: AB_10602337" "unprognostic (6.30e-2)" "unprognostic (3.09e-2)" "unprognostic (9.34e-3)" "unprognostic (5.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.13e-2)" "unprognostic (4.25e-3)" "unprognostic (2.64e-1)" "unprognostic (3.10e-1)" "unprognostic (2.97e-2)" "unprognostic (1.31e-1)" "unprognostic (2.23e-2)" "unprognostic (3.27e-3)" "unprognostic (1.07e-2)" "unprognostic (2.05e-1)" "unprognostic (1.94e-1)" "unprognostic (9.35e-2)" 10.7 13.1 8.0 9.7 12.2 12.0 10.7 11.1 13.5 11.0 9.3 11.2 6.4 8.7 11.8 10.9 11.4 10.5 7.3 12.7 9.4 7.5 10.7 14.0 9.3 14.9 10.1 10.5 10.9 9.9 11.7 16.5 9.2 9.6 9.8 9.5 11.4 12.1 8.7 14.8 11.0 10.5 9.8 10.7 14.3 9.7 25.7 9.0 22.9 13.2 7.6 17.1 10.3 10.2 22.1 36.7 19.3 14.6 17.2 19.3 24.0 5.2 9.8 12.8 12.8 9.4 6.8 5.4 7.9 9.0 13.3 13.3 7.5 4.4 15.0 12.0 5.8 9.3 20.5 9.2 11.9 6.7 6.2 8.9 5.8 8.0 10.6 8.2 9.0 5.5 11.8 9.9 9.0 11.5 13.5 11.9 9.2 10.5 24.6 8.6 17.1 6.5 16.8 10.4 7.1 7.3 5.6 15.7 8.3 7.8 7.2 9.6 7.3 6.7 7.5 8.2 7.3 8.5 7.6 6.5 6.3 22.3 8.2 8.3 8.8 10.4 14.1 19.3 15.7 14.0 16.1 19.2 16.0 15.6 11.9 22.1 19.3 18.1 13.0 17.2 14.6 36.7 15.2 24.0 8.0 12.2 11.1 13.5 9.4 7.5 10.1 10.5 9.6 9.0 TTN "CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD" ENSG00000155657 Titin Q8WZ42 2 178525989-178830802 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 136.5;skeletal muscle: 713.8;tongue: 227.0" "Cell line enhanced" "Detected in many" "RH-30: 4.8" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA007042, CAB022682, HPA030048" Enhanced 25000000 "CAB022682: , HPA007042: AB_1080292, HPA030048: " "unprognostic (1.00e-2)" "unprognostic (3.92e-1)" "unprognostic (1.77e-1)" "unprognostic (7.11e-2)" "unprognostic (3.71e-2)" "unprognostic (1.49e-2)" "unprognostic (6.62e-2)" "unprognostic (1.84e-1)" "unprognostic (2.49e-2)" "unprognostic (1.86e-1)" "unprognostic (2.79e-1)" "unprognostic (2.65e-1)" "unprognostic (3.49e-4)" "unprognostic (1.99e-1)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (1.34e-2)" 23.7 0.3 0.2 0.3 0.3 0.9 0.3 0.2 0.4 0.2 0.2 0.0 0.0 0.2 0.2 21.3 8.3 0.2 0.3 136.5 0.2 0.2 0.2 0.2 0.4 0.4 0.2 0.0 0.3 0.4 0.2 0.3 0.3 0.0 0.7 0.2 0.0 11.6 0.2 713.8 0.3 0.2 0.2 0.3 0.3 0.2 0.4 0.0 0.0 5.6 227.0 15.8 0.3 0.2 7.0 0.3 1.9 0.3 5.0 7.3 0.1 0.7 0.3 1.9 1.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 1.8 0.3 2.4 0.6 0.0 1.7 0.0 0.0 0.0 2.3 2.0 3.7 2.6 1.0 0.0 0.3 0.8 2.4 0.0 0.0 0.0 1.4 2.1 1.2 0.4 0.4 1.6 2.5 0.4 1.8 1.3 4.8 1.3 0.0 0.6 1.0 1.7 0.4 1.3 0.0 0.7 2.4 1.6 0.0 0.0 0.9 0.4 3.5 0.4 3.5 0.1 1.1 0.9 1.9 0.3 0.7 0.5 0.2 0.2 6.9 1.2 0.9 0.2 7.0 2.7 3.5 1.3 5.0 0.2 0.3 7.3 0.1 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 TTYH3 KIAA1691 ENSG00000136295 "Tweety family member 3" Q9C0H2 7 2631951-2664802 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 52.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 10.8;non-classical monocyte: 8.6" "Lineage enriched" "Detected in many" 5 "monocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053520 Uncertain "HPA053520: " "unprognostic (2.53e-2)" "unprognostic (6.65e-3)" "unprognostic (3.86e-3)" "unprognostic (1.35e-1)" "unprognostic (5.25e-2)" "unprognostic (7.42e-2)" "prognostic unfavourable (2.53e-5)" "unprognostic (5.53e-2)" "unprognostic (1.96e-1)" "unprognostic (8.59e-3)" "unprognostic (5.40e-2)" "unprognostic (2.06e-2)" "prognostic unfavourable (2.58e-5)" "unprognostic (7.90e-2)" "unprognostic (5.45e-2)" "unprognostic (1.03e-1)" "unprognostic (8.85e-2)" 23.2 15.2 18.9 27.4 17.3 9.6 13.8 48.2 37.0 8.4 10.2 9.3 6.7 18.6 14.1 10.3 4.8 7.8 17.5 9.8 14.9 11.5 24.4 25.3 11.7 26.7 12.1 12.4 8.3 7.0 5.0 7.1 22.2 9.4 10.0 6.9 8.3 12.2 7.9 3.1 11.2 20.2 10.1 9.3 22.5 12.4 8.4 7.6 10.3 10.4 3.8 7.6 13.1 7.4 0.4 2.4 1.6 10.8 0.3 0.3 2.8 10.4 20.8 22.0 30.7 6.2 5.6 24.7 16.9 15.4 7.5 8.8 8.5 7.6 0.8 20.7 16.1 4.7 3.1 7.7 2.1 1.4 10.5 5.2 4.4 23.5 8.3 1.0 3.3 13.3 3.8 8.0 2.1 24.7 1.5 1.1 4.9 6.1 3.8 11.2 28.1 8.1 15.9 15.9 0.9 11.6 11.4 9.2 46.5 10.4 2.0 9.7 5.5 28.4 28.8 17.6 52.9 10.2 18.9 2.0 1.2 2.9 12.6 3.9 37.7 0.0 5.1 1.6 0.2 10.8 0.3 0.3 0.1 0.2 2.4 0.4 0.3 0.1 0.6 0.3 8.6 1.0 0.2 2.8 18.9 17.3 48.2 29.7 14.9 11.5 12.1 12.4 9.4 7.6 TUBA8 TUBAL2 ENSG00000183785 "Tubulin alpha 8" Q9NY65 22 18110331-18146554 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 50.3;skeletal muscle: 125.4" "Group enriched" "Detected in many" 6 "NB-4: 20.4;SCLC-21H: 10.1;TIME: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.2;NK-cell: 5.8" "Group enriched" "Detected in many" 14 "granulocytes: 4.2;NK-cells: 5.8" "Group enriched" "Detected in many" 4 "cerebellum: 61.3;olfactory region: 66.2" "Low region specificity" "Detected in all" "HPA043684, CAB046031, HPA063394" Approved Supported Microtubules 260000000 Microtubules "CAB046031: AB_11124541, HPA043684: , HPA063394: " "unprognostic (1.07e-1)" "unprognostic (1.34e-2)" "unprognostic (2.79e-3)" "unprognostic (1.52e-2)" "unprognostic (2.74e-1)" "unprognostic (8.92e-2)" "unprognostic (6.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-2)" "unprognostic (3.36e-1)" "unprognostic (2.90e-5)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (4.08e-2)" "unprognostic (5.61e-4)" 3.2 1.2 5.3 1.2 10.5 2.4 2.5 20.5 23.4 1.4 1.2 1.5 0.2 1.5 1.2 4.3 2.6 1.6 1.3 50.3 7.5 5.6 1.2 2.0 1.2 2.2 3.9 9.2 1.3 2.2 1.8 4.3 1.0 2.5 1.7 1.1 0.4 2.1 1.2 125.4 1.4 1.4 1.2 1.1 1.6 1.7 19.2 1.0 0.0 3.5 13.3 1.3 1.1 0.3 0.0 0.2 4.2 0.1 5.8 0.3 15.7 0.4 0.9 0.7 0.8 1.3 0.8 0.3 0.7 0.7 1.2 1.1 0.3 0.9 0.6 3.3 0.6 0.3 2.1 0.1 0.3 1.9 1.9 2.3 0.4 0.3 0.7 1.4 1.2 0.7 0.6 0.8 0.1 1.8 0.9 0.7 0.4 2.6 1.7 20.4 0.9 1.0 1.6 0.0 0.2 0.4 0.3 10.1 1.1 0.4 0.5 1.2 0.5 3.3 25.4 0.1 0.2 0.7 0.5 2.3 1.1 0.7 0.8 0.9 0.2 1.2 0.1 2.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 4.2 5.8 0.1 0.2 0.0 15.7 5.3 10.5 20.5 23.4 7.5 5.6 3.9 9.2 2.5 1.0 TVP23A "FAM18A, YDR084C" ENSG00000166676 "Trans-golgi network vesicle protein 23 homolog A" A6NH52 16 10760919-10818794 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.3" "Cell line enhanced" "Detected in some" "NTERA-2: 3.5;SH-SY5Y: 6.0" "Cancer enhanced" "Detected in some" "glioma: 2.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060582 Uncertain Approved Vesicles Vesicles "HPA060582: " "unprognostic (6.70e-4)" "unprognostic (1.64e-3)" "unprognostic (2.38e-2)" "unprognostic (8.24e-3)" "unprognostic (2.72e-2)" "unprognostic (4.39e-5)" "unprognostic (4.96e-2)" "unprognostic (4.68e-2)" "unprognostic (4.42e-2)" "unprognostic (9.22e-2)" "unprognostic (1.73e-2)" "unprognostic (2.42e-1)" "unprognostic (8.78e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.87e-2)" "unprognostic (2.87e-4)" 1.9 4.3 10.1 3.3 11.0 5.5 1.1 5.6 13.3 1.7 1.4 2.3 1.6 2.4 2.4 2.3 1.2 2.3 3.2 2.5 9.4 8.0 1.3 1.5 2.3 6.1 6.6 11.8 8.7 2.0 0.5 3.6 0.8 5.7 4.6 1.4 3.1 2.1 3.7 1.9 2.5 2.6 2.8 2.9 3.2 2.1 2.8 3.1 1.3 1.5 0.0 2.6 2.4 1.4 1.6 3.8 0.8 0.8 0.5 0.8 0.4 0.3 0.8 0.9 1.0 0.0 0.3 0.7 0.2 0.0 0.0 0.1 0.2 0.7 1.3 0.4 0.2 1.1 0.0 0.0 0.0 2.7 0.6 0.4 1.7 1.2 0.0 0.3 1.5 0.4 0.0 0.4 0.0 0.0 0.4 1.2 0.0 0.8 0.8 1.1 3.5 0.1 1.9 0.3 0.3 0.1 1.3 0.5 6.0 0.2 0.6 0.1 0.6 0.5 0.9 1.0 0.8 1.1 0.5 3.2 0.5 0.8 0.9 1.1 0.5 0.6 0.8 0.2 0.6 0.6 0.4 0.9 0.8 0.2 3.8 1.6 0.4 0.4 0.8 0.5 0.6 0.8 0.2 0.4 10.1 11.0 5.6 13.3 9.4 8.0 6.6 11.8 5.7 3.1 TXNDC11 EFP1 ENSG00000153066 "Thioredoxin domain containing 11" Q6PKC3 16 11679080-11742878 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041174, HPA041390" Supported Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA041174: AB_10794191, HPA041390: AB_10796670" "unprognostic (1.96e-2)" "unprognostic (1.43e-1)" "unprognostic (6.82e-3)" "prognostic favourable (2.12e-5)" "prognostic unfavourable (1.36e-4)" "unprognostic (2.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.68e-3)" "unprognostic (4.90e-2)" "unprognostic (2.17e-1)" "unprognostic (1.08e-1)" "unprognostic (2.01e-1)" "unprognostic (2.35e-2)" "unprognostic (9.96e-2)" "unprognostic (8.30e-2)" "unprognostic (3.23e-2)" "unprognostic (2.34e-2)" 12.5 12.5 6.1 10.9 8.1 24.1 12.3 12.8 9.9 12.7 20.8 8.3 13.2 19.2 12.9 16.0 12.6 12.7 17.5 11.4 7.3 4.4 21.2 47.2 22.4 21.3 7.4 4.4 13.9 22.9 28.6 11.4 15.0 7.1 13.2 15.4 18.6 24.1 14.3 23.2 9.9 27.4 7.8 5.0 23.6 17.6 5.6 6.7 15.9 28.6 11.6 33.2 15.0 10.2 5.7 3.6 9.6 3.3 7.8 9.2 3.5 8.7 6.1 2.8 3.9 7.7 6.5 5.0 8.7 11.9 8.0 10.3 3.0 14.0 22.1 14.7 10.9 7.9 3.5 7.3 6.6 9.8 4.6 4.7 7.0 14.7 11.4 6.8 9.5 4.9 8.3 8.9 14.2 10.0 7.1 28.5 7.0 7.9 5.3 2.6 3.7 3.1 6.9 5.8 47.3 9.1 4.7 4.0 3.8 17.0 13.3 9.2 8.1 9.5 10.3 3.7 4.3 17.4 5.0 38.9 21.2 13.3 7.9 8.7 6.2 4.9 3.3 9.6 2.7 2.5 6.6 5.7 4.9 6.0 3.6 4.9 4.8 3.1 1.0 7.8 2.8 2.8 9.2 3.5 6.1 8.1 12.8 9.9 7.3 4.4 7.4 4.4 7.1 6.7 TXNDC15 "2310047H23Rik, C5orf14, FLJ22625" ENSG00000113621 "Thioredoxin domain containing 15" Q96J42 5 134873803-134901525 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015483 Approved Approved "Golgi apparatus" 48000000 "Golgi apparatus" "HPA015483: AB_1845722" "unprognostic (1.56e-1)" "unprognostic (1.22e-2)" "unprognostic (2.29e-2)" "unprognostic (3.73e-2)" "unprognostic (2.14e-2)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.86e-2)" "unprognostic (7.95e-2)" "unprognostic (6.68e-2)" "unprognostic (9.71e-3)" "unprognostic (3.88e-2)" "prognostic unfavourable (1.44e-4)" "unprognostic (2.36e-1)" "unprognostic (4.37e-1)" "unprognostic (1.41e-3)" "unprognostic (1.50e-1)" 23.5 40.5 16.3 22.8 28.1 5.6 22.6 24.9 30.5 30.3 26.1 23.8 36.1 17.0 32.4 40.8 19.0 24.6 24.8 30.7 14.8 16.3 26.3 26.9 25.7 26.2 18.2 20.4 26.5 38.8 23.6 40.9 28.1 19.9 26.5 18.6 27.7 37.8 33.9 24.3 16.3 18.3 28.6 18.8 31.7 23.0 16.6 18.4 13.1 40.4 16.7 21.1 25.6 22.6 23.2 22.5 20.2 24.5 19.3 24.9 20.7 8.8 24.1 12.1 20.8 18.3 26.5 1.7 35.5 38.9 12.3 27.9 17.5 11.5 11.1 20.1 29.4 6.2 8.4 14.5 11.1 25.0 11.1 5.8 14.8 12.7 16.9 3.7 15.4 17.0 12.1 16.9 10.4 18.5 2.8 32.6 17.1 10.7 5.8 7.4 5.4 10.1 8.6 16.1 34.7 9.4 8.7 8.3 9.8 21.6 5.1 17.1 7.9 5.4 25.2 18.5 11.1 17.0 11.9 22.3 34.9 9.5 28.6 7.9 12.0 20.2 24.5 13.8 24.2 23.7 24.9 23.2 19.6 24.9 22.5 15.9 16.7 19.2 5.8 19.3 22.6 22.2 21.2 20.7 16.3 28.1 24.9 30.5 14.8 16.3 18.2 20.4 19.9 18.4 TXNDC16 KIAA1344 ENSG00000087301 "Thioredoxin domain containing 16" Q9P2K2 14 52430590-52552522 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002543 Approved Approved Mitochondria "Secreted - unknown location" Mitochondria "HPA002543: AB_1079199" "unprognostic (1.37e-1)" "unprognostic (7.79e-3)" "unprognostic (5.95e-3)" "unprognostic (2.36e-1)" "unprognostic (5.95e-3)" "unprognostic (9.73e-2)" "unprognostic (2.50e-1)" "unprognostic (1.43e-2)" "unprognostic (7.01e-2)" "unprognostic (1.49e-1)" "unprognostic (2.07e-2)" "unprognostic (1.21e-1)" "prognostic favourable (6.79e-4)" "unprognostic (1.39e-1)" "unprognostic (1.56e-1)" "unprognostic (3.55e-3)" "unprognostic (2.04e-1)" 7.0 5.2 10.2 5.9 12.5 5.4 8.6 20.5 15.0 12.1 7.0 7.4 16.1 5.1 8.5 18.4 4.8 5.4 6.5 5.6 9.2 9.4 6.4 8.9 6.1 5.0 9.5 11.3 13.4 7.8 8.6 9.4 7.0 8.9 32.8 7.4 8.1 5.6 24.2 4.2 6.5 5.9 5.6 14.0 11.5 7.4 8.2 10.5 9.7 5.1 3.4 4.8 7.8 7.3 1.2 5.3 3.6 6.3 1.1 4.7 2.2 5.9 0.6 6.7 3.7 5.0 3.7 5.3 2.0 2.6 3.4 6.7 2.2 4.9 9.8 6.8 1.6 5.7 7.7 2.7 5.3 4.1 10.1 4.5 5.0 2.0 3.6 5.3 2.2 6.8 2.5 4.4 3.2 3.8 5.7 15.3 2.9 2.9 6.6 3.7 7.4 3.6 13.3 12.8 8.9 4.3 6.2 22.1 7.6 9.8 10.2 2.8 6.5 3.9 2.0 4.6 2.3 5.2 3.3 4.2 5.7 9.9 1.3 5.6 2.6 2.4 6.3 2.5 2.7 4.8 2.9 1.2 2.8 2.0 5.3 0.8 1.4 1.4 3.6 1.1 5.2 2.2 4.7 2.2 10.2 12.5 20.5 15.0 9.2 9.4 9.5 11.3 8.9 10.5 TYR "OCA1, OCA1A, OCAIA" ENSG00000077498 Tyrosinase P14679 11 89177452-89295759 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase, Tumor antigen" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 70 "retina: 82.0;skin 1: 25.2" "Cell line enriched" "Detected in single" 844 "SK-MEL-30: 84.3" "Cancer enriched" "Detected in single" 1755 "melanoma: 351.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000079, HPA043241, HPA050889, HPA064583" Enhanced Enhanced Vesicles Vesicles "CAB000079: AB_564045, HPA043241: , HPA050889: , HPA064583: " "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (1.85e-3)" "unprognostic (9.75e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 82.0 0.7 0.0 0.0 25.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 TYRO3 "Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif" ENSG00000092445 "TYRO3 protein tyrosine kinase" Q06418 15 41557675-41583586 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.2;ovary: 48.2" "Cell line enhanced" "Detected in many" "BEWO: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071245 Approved 6400000 "HPA071245: " "unprognostic (1.26e-1)" "unprognostic (6.34e-2)" "unprognostic (1.47e-1)" "unprognostic (2.68e-1)" "unprognostic (3.29e-1)" "unprognostic (6.77e-2)" "unprognostic (1.56e-3)" "unprognostic (5.41e-2)" "unprognostic (3.72e-1)" "unprognostic (3.21e-1)" "unprognostic (2.69e-1)" "unprognostic (1.37e-1)" "unprognostic (1.92e-10)" "unprognostic (7.59e-2)" "unprognostic (5.22e-1)" "unprognostic (4.04e-3)" "unprognostic (1.84e-2)" 18.3 4.1 18.7 2.1 16.6 1.5 7.7 27.3 39.2 2.3 1.8 25.6 1.2 2.3 5.0 4.2 12.7 11.7 3.1 2.5 15.1 7.8 6.4 1.6 3.2 1.9 19.6 18.2 48.2 9.5 1.3 0.8 5.9 14.0 3.3 1.7 1.7 2.4 6.7 1.4 13.0 2.9 4.8 23.1 5.4 3.6 17.9 16.6 0.0 1.8 2.2 4.1 2.9 2.8 1.2 1.0 5.0 0.9 1.0 0.8 0.2 4.7 3.1 9.9 10.8 9.3 6.4 33.5 6.9 4.4 6.9 6.4 17.6 1.6 0.1 8.9 5.6 11.2 11.1 1.7 3.2 2.7 7.4 1.4 10.0 8.3 6.6 2.4 0.2 2.0 3.5 5.2 1.8 5.1 8.7 2.0 3.7 4.5 1.1 0.4 22.9 3.2 14.7 9.0 1.7 0.6 9.2 11.9 3.4 6.5 10.3 7.7 8.5 2.8 3.9 13.7 6.0 10.1 10.4 0.8 1.6 1.4 8.3 15.8 8.2 2.6 0.9 0.8 0.6 0.5 0.6 0.7 0.6 0.8 0.3 1.2 0.7 0.7 5.0 1.0 0.5 1.0 0.5 0.2 18.7 16.6 27.3 32.7 15.1 7.8 19.6 18.2 14.0 16.6 TYROBP "DAP12, KARAP, PLO-SL, PLOSL" ENSG00000011600 "TYRO protein tyrosine kinase binding protein" O43914 19 35904401-35908295 "Disease related genes, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 267.2;bone marrow: 125.7;lymphoid tissue: 123.6" "Group enriched" "Detected in some" 10 "HMC-1: 116.0;THP-1: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 267.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009493, HPA041899" Enhanced "CAB009493: AB_638987, HPA041899: AB_10795266" "unprognostic (7.09e-2)" "unprognostic (8.38e-3)" "unprognostic (7.87e-2)" "unprognostic (4.76e-2)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (5.27e-2)" "unprognostic (8.04e-2)" "unprognostic (2.07e-2)" "unprognostic (2.47e-1)" "unprognostic (2.91e-1)" "unprognostic (1.50e-1)" "prognostic unfavourable (1.05e-4)" "unprognostic (4.47e-2)" "unprognostic (1.72e-2)" "unprognostic (4.27e-2)" "unprognostic (4.39e-2)" 76.0 21.4 13.3 54.9 20.7 125.7 16.4 2.8 11.3 11.9 14.3 24.0 2.3 17.1 8.1 19.3 7.2 14.0 25.7 17.5 12.9 14.2 17.6 29.8 75.3 80.0 20.8 5.6 11.7 8.7 1.8 9.0 32.0 17.2 14.9 12.3 15.0 12.4 7.2 7.3 6.7 18.9 16.0 36.3 123.6 10.4 7.3 18.6 8.5 6.7 6.6 10.3 22.3 8.4 0.7 79.3 267.2 190.6 62.8 20.3 162.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.1 5.3 116.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 7.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.8 0.0 32.8 190.6 100.9 20.3 134.4 10.6 0.7 0.4 2.8 79.3 0.3 0.5 2.3 267.2 62.8 130.3 68.5 0.3 162.3 13.3 20.7 2.8 11.3 12.9 14.2 20.8 5.6 17.2 18.6 TYRP1 "b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP" ENSG00000107165 "Tyrosinase related protein 1" P17643 9 12685439-12710290 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase" "Albinism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 277.3" "Cell line enriched" "Detected in some" 52 "SK-MEL-30: 173.5" "Cancer enriched" "Detected in some" 262 "melanoma: 313.2" "Region enriched" "Detected in some" 5 "pons and medulla: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "olfactory region: 5.6;thalamus: 2.0" "Low region specificity" "Detected in all" "HPA000937, CAB002520" Enhanced Supported Vesicles 16000 Vesicles "CAB002520: AB_564153, HPA000937: AB_1080437" "unprognostic (7.48e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-1)" "unprognostic (3.16e-3)" "unprognostic (8.10e-2)" "unprognostic (3.82e-3)" "unprognostic (1.53e-1)" "unprognostic (2.25e-3)" "unprognostic (4.46e-1)" "unprognostic (8.71e-2)" "unprognostic (6.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.68e-6)" "unprognostic (1.27e-1)" "unprognostic (5.99e-2)" "unprognostic (1.95e-2)" 0.2 0.0 0.2 0.2 0.3 0.0 1.7 0.2 1.0 0.2 0.5 1.3 0.2 1.6 0.2 0.3 3.6 0.2 1.4 21.5 0.9 0.1 5.7 0.2 2.1 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 5.0 0.2 1.8 277.3 1.1 0.2 1.3 51.1 1.4 0.4 1.1 0.2 0.6 0.5 0.2 0.2 0.2 0.9 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 173.5 2.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 1.0 0.9 0.1 0.2 0.3 5.0 0.2 TYW1 "FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W" ENSG00000198874 "TRNA-yW synthesizing protein 1 homolog" Q9NV66 7 66995173-67239519 "Enzymes, Predicted membrane proteins" "tRNA processing" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA013568: , HPA014118: , HPA015535: AB_1856487, HPA043136: , HPA047029: , HPA047052: , HPA052097: " "unprognostic (1.53e-1)" "unprognostic (5.49e-3)" "unprognostic (1.62e-1)" "unprognostic (3.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.20e-1)" "unprognostic (1.83e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "prognostic unfavourable (1.73e-4)" "unprognostic (4.86e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-2)" "unprognostic (4.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (1.79e-2)" 15.4 19.1 10.2 12.3 15.4 11.9 15.1 14.9 15.3 18.8 12.9 21.2 18.2 14.1 22.7 15.3 12.0 15.5 10.8 12.9 10.8 9.8 15.2 17.7 11.1 15.5 14.1 10.8 19.4 23.9 22.9 28.0 13.2 14.5 14.9 16.5 17.8 15.3 14.7 26.2 14.4 12.8 14.0 13.9 15.1 12.6 13.7 13.4 19.7 19.0 13.6 23.3 15.3 15.2 9.6 8.3 3.6 9.1 11.2 11.8 5.3 10.5 13.5 8.3 17.1 12.4 8.6 9.6 11.3 8.6 9.0 8.4 15.4 13.8 18.4 17.4 10.4 12.5 17.1 13.9 13.0 14.4 13.1 7.9 11.2 10.4 12.3 18.3 10.6 8.8 14.1 12.1 18.7 8.1 20.9 11.1 10.2 10.4 11.5 15.3 14.5 12.1 13.1 11.6 23.1 12.2 10.7 12.7 12.6 13.6 26.4 11.3 18.0 13.0 9.5 10.3 7.4 8.2 15.4 11.2 15.8 22.2 8.4 17.2 14.2 2.0 7.0 3.6 8.6 7.8 11.7 8.5 9.4 9.8 8.3 9.6 11.5 11.8 2.0 11.2 9.1 6.6 6.8 5.3 10.2 15.4 14.9 15.3 10.8 9.8 14.1 10.8 14.5 13.4 TYW1B "LINC00069, MGC87315, NCRNA00069, RSAFD2" ENSG00000277149 "TRNA-yW synthesizing protein 1 homolog B" 7 72558744-72828198 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA013568: , HPA014118: , HPA043136: , HPA047029: , HPA047052: , HPA052097: " "unprognostic (2.61e-1)" "unprognostic (3.54e-1)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (1.91e-2)" "unprognostic (6.22e-3)" "unprognostic (3.88e-2)" "unprognostic (1.64e-2)" "unprognostic (1.19e-2)" "unprognostic (8.96e-3)" "unprognostic (5.78e-2)" "unprognostic (2.90e-2)" "unprognostic (4.33e-4)" "unprognostic (1.02e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" 2.7 1.6 1.8 4.5 3.8 4.4 4.2 6.0 3.3 5.6 2.9 5.8 7.4 1.5 6.0 5.2 3.4 4.1 1.5 2.3 1.9 3.1 7.9 2.9 2.4 3.9 1.7 10.1 5.7 2.0 11.6 3.0 3.4 4.1 4.4 4.7 4.1 5.9 4.4 2.5 2.9 3.6 4.7 3.0 3.1 7.2 3.8 6.0 5.9 1.8 6.0 3.1 1.1 7.5 5.4 5.7 3.5 2.4 3.0 0.9 2.3 2.4 1.0 2.0 1.6 0.5 1.1 1.2 0.5 1.0 1.1 7.9 4.1 7.2 0.7 0.8 1.1 1.9 0.8 1.3 7.7 2.3 0.7 1.2 4.6 0.8 7.3 2.0 3.7 0.6 1.3 0.8 0.7 9.8 7.6 1.0 0.9 2.3 3.7 1.8 4.5 1.4 5.4 2.6 1.1 0.8 1.8 0.9 1.5 8.2 4.3 2.1 2.6 3.1 1.8 4.3 9.5 1.4 6.6 8.0 8.2 0.5 2.0 9.5 4.0 3.5 5.7 3.0 1.8 2.8 7.5 2.0 1.8 1.4 5.2 2.3 2.7 4.3 2.4 1.7 5.4 2.0 0.9 UBA1 "A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X" ENSG00000130985 "Ubiquitin like modifier activating enzyme 1" P22314 X 47190861-47215128 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000289, HPA001506, CAB019435, CAB073410" Approved Enhanced Nucleoplasm 16000000 Nucleoplasm "CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305" "unprognostic (7.18e-3)" "unprognostic (1.52e-1)" "unprognostic (7.54e-2)" "unprognostic (2.40e-1)" "unprognostic (9.29e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (6.10e-5)" "unprognostic (7.22e-2)" "unprognostic (2.42e-3)" "unprognostic (3.43e-2)" "unprognostic (8.50e-3)" "unprognostic (2.17e-3)" "unprognostic (1.85e-3)" "unprognostic (1.13e-1)" "unprognostic (5.38e-2)" "prognostic favourable (1.78e-4)" "unprognostic (1.21e-2)" 45.6 63.0 56.0 47.2 50.6 42.0 38.3 58.1 75.7 48.0 39.3 55.9 44.9 36.3 52.9 34.1 59.4 56.0 39.9 48.7 49.5 39.9 51.1 60.0 42.0 48.2 47.7 62.3 57.6 34.9 78.8 55.5 39.1 47.6 40.2 35.5 41.0 47.5 45.7 77.7 56.1 37.9 59.4 35.5 53.4 38.7 36.0 48.6 52.7 65.0 43.9 54.0 39.2 52.7 28.9 30.6 32.6 36.0 25.6 29.0 24.1 45.8 47.6 54.5 82.8 37.3 34.0 24.1 30.5 32.5 43.9 35.8 37.8 35.0 34.2 20.3 61.0 44.3 68.3 64.9 32.3 28.3 69.4 21.4 52.8 30.3 26.3 36.0 46.2 31.9 34.0 63.8 49.8 57.5 23.2 30.8 43.5 58.1 33.9 31.9 58.0 74.4 39.5 38.0 58.2 35.1 49.4 35.3 26.5 90.9 44.2 20.2 61.5 22.5 42.0 33.0 38.3 47.5 28.4 21.1 21.9 48.8 33.9 25.8 39.4 17.4 27.0 27.4 29.0 36.0 25.4 28.9 24.0 25.9 30.6 22.0 19.1 23.4 32.6 25.6 32.8 20.8 28.2 24.1 56.0 50.6 58.1 75.7 49.5 39.9 47.7 62.3 47.6 48.6 UBA2 "ARX, FLJ13058, HRIHFB2115, SAE2" ENSG00000126261 "Ubiquitin like modifier activating enzyme 2" Q9UBT2 19 34428352-34471251 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041436 Supported Supported Nucleoplasm 9400000 Nucleoplasm "HPA041436: " "unprognostic (2.37e-1)" "unprognostic (3.17e-1)" "unprognostic (2.13e-2)" "unprognostic (1.36e-3)" "unprognostic (6.39e-3)" "unprognostic (8.72e-3)" "prognostic unfavourable (3.76e-4)" "unprognostic (1.96e-2)" "unprognostic (2.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.58e-1)" "unprognostic (2.65e-2)" "prognostic unfavourable (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (2.11e-2)" "unprognostic (2.00e-1)" "unprognostic (1.88e-1)" 49.2 23.5 25.1 29.5 28.4 30.6 70.9 44.3 30.4 26.5 25.4 20.7 24.0 17.8 32.3 24.2 27.4 25.1 23.7 31.0 25.6 27.7 22.8 25.5 24.5 37.8 26.9 23.2 30.3 29.4 28.8 26.8 39.1 25.1 25.1 23.9 20.7 20.9 31.5 56.3 29.2 20.4 28.8 27.4 28.6 20.9 56.7 19.9 55.9 25.9 27.1 34.4 29.2 38.9 8.6 10.8 7.7 6.2 8.5 13.0 3.6 28.6 42.0 43.1 17.8 23.4 19.2 17.6 22.4 19.3 29.0 32.5 35.9 17.5 53.7 34.7 18.2 11.7 45.6 17.5 41.0 38.4 30.8 57.0 21.5 35.9 30.2 45.2 24.8 13.8 22.3 20.5 36.2 22.7 56.4 30.5 25.4 28.7 34.8 25.1 32.3 14.6 27.7 29.7 23.9 20.4 30.1 36.7 36.0 20.4 18.8 30.1 13.5 55.5 14.6 32.7 22.8 20.9 40.1 32.2 45.7 52.0 20.7 34.6 28.7 5.9 4.8 7.7 8.4 5.0 11.2 8.5 10.5 12.1 6.0 8.6 13.0 10.4 0.6 8.5 6.2 10.8 8.0 3.6 25.1 28.4 44.3 30.4 25.6 27.7 26.9 23.2 25.1 19.9 UBA5 "FLJ23251, UBE1DC1" ENSG00000081307 "Ubiquitin like modifier activating enzyme 5" Q9GZZ9 3 132654446-132678097 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017235 Uncertain Enhanced Vesicles,Cytosol Cytosol Vesicles "HPA017235: AB_1858507" "unprognostic (4.34e-3)" "unprognostic (6.44e-2)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.06e-1)" "unprognostic (3.28e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.84e-2)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" 14.8 30.3 17.8 12.3 19.8 13.2 17.4 17.9 26.2 14.5 15.0 10.5 27.8 16.2 13.4 24.2 15.1 13.3 12.7 21.2 15.3 16.3 22.7 29.8 13.7 14.8 16.0 25.0 15.1 41.4 29.3 32.7 18.1 21.2 18.8 16.7 11.7 37.8 33.5 32.5 15.7 17.9 14.6 13.6 18.9 18.5 15.3 12.7 17.9 23.5 17.5 17.4 15.1 12.5 11.1 14.1 5.0 6.6 18.9 15.0 7.9 27.0 10.1 17.8 14.6 12.6 14.4 18.7 23.4 24.2 14.7 17.1 18.3 10.1 21.6 17.2 16.9 16.5 17.6 18.4 21.9 20.5 7.5 26.2 16.3 20.5 12.5 32.1 15.4 12.5 10.9 14.0 21.1 16.5 16.3 32.0 16.4 24.0 17.7 12.1 16.2 9.7 15.5 15.6 40.9 13.5 21.0 17.2 15.5 13.7 13.8 19.8 16.6 16.3 14.8 15.6 15.3 7.5 12.2 30.3 20.3 40.0 17.8 11.7 13.9 4.1 5.1 5.0 9.6 5.8 11.6 11.1 10.8 15.0 11.8 6.9 12.9 12.8 1.1 18.9 6.6 14.1 10.7 7.9 17.8 19.8 17.9 26.2 15.3 16.3 16.0 25.0 21.2 12.7 UBA7 "D8, UBA1B, UBE1L, UBE2" ENSG00000182179 "Ubiquitin like modifier activating enzyme 7" P41226 3 49805207-49813946 "Plasma proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 22.3;HEL: 20.8;HMC-1: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB015444, HPA058182" Approved Approved Nucleoplasm,Vesicles,Cytosol 1400000 "Nucleoplasm, Vesicles" Cytosol "CAB015444: AB_793598, HPA058182: " "prognostic favourable (1.55e-4)" "unprognostic (7.07e-3)" "unprognostic (1.59e-2)" "unprognostic (1.61e-2)" "unprognostic (3.77e-1)" "unprognostic (2.31e-2)" "unprognostic (5.08e-3)" "unprognostic (3.61e-2)" "unprognostic (6.33e-2)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "prognostic unfavourable (1.04e-5)" "unprognostic (9.11e-2)" "unprognostic (3.81e-2)" "unprognostic (1.57e-1)" "prognostic favourable (1.48e-4)" 11.3 12.1 6.8 22.0 7.5 16.0 11.5 2.0 6.7 10.8 12.7 14.4 25.4 19.6 17.2 31.6 17.7 12.9 33.1 9.1 6.7 3.9 15.9 11.9 18.8 28.2 6.0 6.2 19.1 9.5 1.4 8.4 8.9 9.4 18.5 12.1 14.2 24.5 34.2 3.3 9.0 25.5 11.3 7.7 35.9 13.2 3.4 5.9 20.4 17.8 18.4 23.5 12.6 13.1 12.4 14.3 24.8 21.7 11.1 11.8 13.0 4.3 0.0 0.3 0.1 12.0 12.7 1.3 2.3 10.4 16.7 22.3 0.0 9.1 0.1 1.8 8.5 2.4 0.0 4.1 1.4 11.1 0.0 20.8 0.2 1.3 8.9 1.9 40.6 19.5 0.2 6.5 0.4 8.3 0.0 1.3 3.8 0.1 4.2 5.1 0.0 0.4 5.4 0.4 0.7 3.4 8.4 0.0 0.3 2.8 4.1 1.4 0.4 13.8 3.7 3.3 0.4 1.4 0.9 0.0 0.0 0.1 9.1 7.4 0.7 13.9 14.7 24.8 11.8 21.7 10.3 12.3 10.8 10.5 14.3 12.4 9.9 8.9 4.6 11.1 17.2 5.2 10.6 13.0 6.8 7.5 2.0 6.7 6.7 3.9 6.0 6.2 9.4 5.9 UBAC2 "FLJ30548, PHGDHL1, RP11-178C10.1" ENSG00000134882 "UBA domain containing 2" Q8NBM4 13 99200774-99386434 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013448 Approved Approved Cytosol Cytosol "HPA013448: AB_1855301" "unprognostic (7.04e-2)" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "unprognostic (7.30e-3)" "unprognostic (2.23e-1)" "unprognostic (2.79e-3)" "unprognostic (9.48e-3)" "unprognostic (6.50e-3)" "unprognostic (1.58e-1)" "unprognostic (6.95e-2)" "prognostic unfavourable (1.73e-4)" "unprognostic (6.44e-2)" "unprognostic (6.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.16e-1)" "unprognostic (6.08e-2)" "unprognostic (3.26e-2)" 16.7 15.6 9.1 15.6 10.4 11.0 24.2 8.2 13.9 14.6 14.6 10.0 18.3 16.7 17.2 17.1 29.6 18.1 15.4 15.5 11.0 7.6 15.1 20.0 20.6 36.5 8.2 10.1 15.1 25.5 11.8 9.5 22.1 9.8 11.1 14.6 11.9 19.5 13.7 26.9 26.3 17.6 13.8 11.7 13.4 14.9 24.8 8.1 21.6 20.6 17.3 24.5 17.2 15.8 25.3 23.9 24.7 23.1 31.3 37.5 31.8 13.3 8.4 6.3 9.2 16.2 17.6 15.4 6.9 24.9 12.7 9.9 8.1 28.9 5.6 12.4 10.6 12.2 9.2 12.0 7.3 9.4 9.1 9.2 4.5 5.0 13.7 11.6 7.1 13.6 15.0 7.3 23.0 11.1 8.0 2.9 10.3 3.5 8.7 2.9 7.9 6.6 7.0 5.6 4.0 8.7 6.8 6.8 10.2 5.8 17.3 10.1 11.6 37.2 7.9 5.0 4.9 5.1 7.6 3.9 3.3 1.9 10.8 17.8 9.7 20.8 23.1 17.3 27.3 22.1 37.5 19.6 23.4 27.3 18.6 25.3 32.7 32.2 24.7 31.3 21.2 23.9 15.1 31.8 9.1 10.4 8.2 13.9 11.0 7.6 8.2 10.1 9.8 8.1 UBE2J1 "CGI-76, HSPC153, NCUBE1, UBC6" ENSG00000198833 "Ubiquitin conjugating enzyme E2 J1" Q9Y385 6 89326625-89352848 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 62.5;Karpas-707: 54.0;U-266/70: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003509, CAB073419" Enhanced "CAB073419: , HPA003509: AB_1858531" "unprognostic (1.82e-1)" "unprognostic (3.20e-2)" "unprognostic (1.55e-3)" "prognostic favourable (2.87e-4)" "unprognostic (3.41e-1)" "unprognostic (7.93e-3)" "prognostic unfavourable (6.90e-5)" "unprognostic (1.19e-1)" "unprognostic (9.36e-2)" "prognostic favourable (7.43e-4)" "unprognostic (1.74e-1)" "unprognostic (9.33e-2)" "prognostic unfavourable (1.11e-4)" "unprognostic (5.11e-2)" "unprognostic (2.83e-1)" "unprognostic (3.87e-2)" "unprognostic (9.38e-2)" 18.7 17.3 14.6 47.1 15.4 52.7 28.2 19.1 13.6 18.8 25.9 11.3 24.4 28.0 19.5 18.4 19.2 18.0 19.9 17.1 14.4 14.7 18.7 33.5 20.4 52.0 17.0 9.5 17.2 46.1 11.5 13.6 27.5 13.0 22.9 26.3 10.7 42.1 33.2 12.5 11.3 36.3 17.9 18.9 45.8 24.4 17.7 14.4 42.5 17.6 16.4 47.7 21.7 21.4 20.7 23.7 15.9 17.8 6.4 6.4 6.1 8.1 2.8 7.9 10.1 8.3 10.8 0.0 13.0 11.5 8.1 8.9 4.6 5.1 62.5 7.3 13.4 3.3 5.1 7.5 13.2 8.7 8.0 11.3 3.7 7.6 22.1 14.2 7.4 8.2 7.6 6.7 11.6 18.0 9.1 54.0 9.4 5.0 5.9 10.9 2.7 4.1 23.3 10.2 29.9 10.1 5.7 4.0 8.1 5.5 12.2 12.0 4.8 31.6 12.0 4.5 4.3 8.0 9.9 60.7 30.1 17.1 8.9 10.3 7.4 10.3 6.6 12.3 3.4 11.1 4.0 20.7 4.6 4.2 6.5 13.4 4.3 3.9 15.9 6.4 17.8 23.7 6.4 6.1 14.6 15.4 19.1 13.6 14.4 14.7 17.0 9.5 13.0 14.4 UBE3A "ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A" ENSG00000114062 "Ubiquitin protein ligase E3A" Q05086 15 25333728-25439056 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009723, HPA039410, HPA040380" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952" "unprognostic (7.95e-2)" "unprognostic (2.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.99e-1)" "unprognostic (1.13e-1)" "unprognostic (3.55e-2)" "unprognostic (1.44e-1)" "unprognostic (3.05e-1)" "unprognostic (5.07e-2)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (4.83e-2)" "unprognostic (6.31e-2)" "unprognostic (3.08e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-1)" "unprognostic (8.17e-2)" 19.3 19.4 20.3 23.1 25.0 17.8 20.2 30.0 25.1 21.7 19.9 14.3 19.8 14.1 21.0 22.1 19.8 18.5 17.2 24.0 22.2 20.8 20.2 24.6 19.7 23.1 19.1 19.5 23.0 17.2 26.1 24.6 20.1 20.9 20.6 17.9 13.3 19.3 21.5 70.2 18.4 18.8 21.2 19.9 18.8 16.9 26.4 16.4 36.4 25.0 26.6 19.5 19.9 26.6 15.6 11.9 11.6 14.8 21.1 16.0 5.7 19.3 10.9 27.6 16.4 16.1 19.2 13.6 29.8 18.7 21.1 19.2 25.3 9.7 34.7 22.6 22.2 17.9 34.9 21.0 25.8 17.9 11.7 28.8 18.4 14.9 24.2 34.7 21.3 22.6 19.8 19.9 25.5 16.5 29.0 24.8 33.1 10.5 28.7 10.1 17.9 15.9 29.5 41.2 15.3 19.1 30.4 28.3 21.4 24.1 26.2 34.2 21.4 19.6 21.2 37.0 30.6 17.7 21.7 28.4 33.5 46.8 21.2 18.9 19.2 8.6 8.7 11.6 13.3 7.6 15.2 12.0 14.0 15.9 11.9 15.6 16.0 14.2 2.0 21.1 14.8 11.1 10.1 5.7 20.3 25.0 30.0 25.1 22.2 20.8 19.1 19.5 20.9 16.4 UBR1 ENSG00000159459 "Ubiquitin protein ligase E3 component n-recognin 1" Q8IWV7 15 42942897-43106113 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038838 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038838: AB_10673120" "unprognostic (1.07e-2)" "unprognostic (5.02e-2)" "unprognostic (9.77e-2)" "unprognostic (1.55e-2)" "unprognostic (1.89e-2)" "unprognostic (1.29e-1)" "unprognostic (2.67e-1)" "unprognostic (1.49e-1)" "unprognostic (4.79e-1)" "unprognostic (2.97e-2)" "unprognostic (1.93e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (1.89e-1)" 16.7 13.2 13.7 18.3 16.7 28.4 18.8 21.8 18.1 18.2 16.2 14.8 10.5 11.3 21.0 12.9 10.8 15.9 14.2 19.7 10.0 15.4 14.4 10.6 16.6 14.9 11.8 10.5 16.3 16.4 26.3 25.6 16.2 18.9 15.3 12.9 12.5 11.8 16.8 23.6 11.0 14.4 18.2 12.1 14.7 13.8 13.7 14.7 23.2 18.8 9.7 14.3 17.3 19.7 4.6 5.0 5.5 4.2 6.2 7.2 1.8 4.9 7.2 8.3 6.7 13.2 10.2 7.9 12.1 13.4 10.7 13.9 9.1 3.9 5.8 7.2 12.4 8.6 11.9 10.6 12.8 11.9 5.8 22.9 14.4 4.4 9.2 16.1 11.0 11.0 6.0 13.1 10.7 12.0 13.0 8.8 13.3 2.8 8.7 4.8 4.7 7.4 11.4 11.4 5.0 10.8 11.7 8.4 7.5 15.9 8.4 5.6 8.1 8.4 16.5 13.2 8.2 11.7 12.2 10.4 17.6 16.7 9.0 10.2 11.9 4.4 3.0 5.2 5.7 4.2 6.5 4.1 5.9 6.9 2.9 4.6 5.9 7.2 5.5 6.2 3.4 5.0 4.1 1.8 13.7 16.7 21.8 18.1 10.0 15.4 11.8 10.5 18.9 14.7 UBR3 "DKFZp434P117, FLJ37422, KIAA2024, ZNF650" ENSG00000144357 "Ubiquitin protein ligase E3 component n-recognin 3 (putative)" Q6ZT12 2 169827458-170084131 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035390 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA035390: AB_10670699" "unprognostic (1.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.59e-2)" "unprognostic (1.27e-1)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.19e-2)" "unprognostic (5.56e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (2.18e-1)" 11.9 15.5 10.9 6.1 18.3 5.4 9.6 15.5 18.9 9.9 10.0 9.8 9.1 6.7 11.5 7.1 10.7 8.1 7.8 23.1 10.3 7.2 12.9 16.9 9.2 5.6 11.9 14.0 8.9 9.8 20.9 14.9 7.2 14.7 11.2 7.3 8.0 11.1 9.2 76.3 11.5 8.4 9.6 10.2 6.9 9.2 7.9 11.4 6.3 14.9 10.9 6.0 12.8 8.7 2.0 2.8 1.9 2.1 2.4 4.3 1.2 8.8 7.5 8.0 10.6 16.0 12.7 6.8 16.0 9.3 9.3 7.5 11.5 5.6 10.0 13.9 12.4 11.7 9.5 8.1 11.6 10.4 8.2 36.6 8.0 12.2 8.0 12.1 11.9 7.6 7.6 12.1 8.1 9.1 19.0 10.9 15.7 8.3 7.8 5.9 6.3 6.3 7.5 13.2 10.6 6.7 12.5 15.8 8.6 11.2 10.4 6.5 6.8 6.8 11.5 14.0 5.7 10.9 10.0 8.9 6.9 9.2 11.5 7.1 7.7 0.0 2.1 1.7 3.2 1.8 4.2 2.0 1.9 2.7 2.8 1.2 3.3 4.3 1.9 2.4 1.6 2.4 3.1 1.2 10.9 18.3 15.5 18.6 10.3 7.2 11.9 14.0 14.7 11.4 UBXN4 "KIAA0242, UBXD2, UBXDC1" ENSG00000144224 "UBX domain protein 4" Q92575 2 135741619-135785055 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036325 Approved Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA036325: AB_10669788" "unprognostic (1.22e-2)" "unprognostic (1.08e-1)" "unprognostic (5.24e-2)" "unprognostic (1.47e-1)" "unprognostic (1.54e-1)" "unprognostic (1.90e-1)" "unprognostic (1.17e-1)" "unprognostic (2.91e-1)" "unprognostic (5.40e-2)" "unprognostic (2.94e-2)" "unprognostic (2.63e-2)" "unprognostic (1.93e-1)" "unprognostic (1.83e-2)" "unprognostic (4.44e-2)" "unprognostic (1.27e-1)" "unprognostic (3.25e-2)" "unprognostic (5.14e-3)" 32.5 37.8 24.3 27.0 28.4 24.5 29.5 28.6 27.6 35.5 29.2 26.6 35.0 31.7 32.7 33.2 29.4 26.5 27.7 25.5 25.7 21.2 34.3 64.7 27.8 24.1 30.0 28.8 34.7 38.8 42.1 39.7 33.5 33.0 30.5 27.6 23.0 38.0 38.2 52.0 29.7 33.8 26.2 38.3 25.4 29.7 32.1 29.8 47.3 39.9 25.0 25.1 35.5 36.3 24.8 27.3 33.6 23.4 27.2 24.8 16.7 40.5 11.9 24.2 19.7 32.1 35.4 27.1 35.0 35.2 30.2 27.1 19.8 30.3 26.2 45.6 30.8 29.1 14.8 20.8 32.0 32.6 18.1 23.5 17.5 26.3 29.4 26.1 23.0 26.9 17.7 28.4 26.4 35.5 22.3 37.5 27.2 20.2 31.0 13.9 18.8 20.6 26.1 33.0 43.9 29.0 30.3 23.7 14.4 31.4 19.6 18.8 22.2 21.5 33.1 26.3 12.7 26.3 17.5 32.9 19.7 22.4 33.0 17.5 24.5 26.0 18.5 27.1 23.7 20.3 22.8 24.8 22.6 22.9 17.7 22.2 23.2 22.1 33.6 27.2 23.4 27.3 24.8 16.7 24.3 28.4 28.6 27.6 25.7 21.2 30.0 28.8 33.0 29.8 UBXN8 "D8S2298E, REP8, UBXD6" ENSG00000104691 "UBX domain protein 8" O00124 8 30732247-30767006 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 30.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017725, HPA077538" Enhanced Supported "Nucleoplasm,Nucleoli,Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "Nucleoplasm, Nucleoli" "HPA017725: AB_1847462, HPA077538: " "unprognostic (3.00e-2)" "unprognostic (2.30e-1)" "prognostic favourable (6.13e-4)" "unprognostic (7.71e-2)" "unprognostic (2.24e-1)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (1.84e-2)" "unprognostic (1.90e-1)" "unprognostic (5.13e-2)" "unprognostic (1.58e-1)" "unprognostic (1.06e-2)" "prognostic unfavourable (5.25e-5)" "unprognostic (2.49e-1)" "unprognostic (1.96e-1)" "unprognostic (1.51e-1)" "unprognostic (6.88e-2)" 5.0 5.3 3.9 1.4 4.8 1.4 4.3 1.5 9.2 3.0 3.5 4.0 6.7 3.1 3.8 14.3 4.1 3.6 3.8 2.8 5.7 8.2 21.5 2.1 3.9 7.6 4.0 30.6 10.3 6.2 3.5 6.2 6.2 4.8 4.7 1.6 1.8 6.1 1.7 4.1 2.9 2.9 7.1 5.7 3.3 11.5 6.1 0.9 9.1 2.8 2.3 2.9 3.7 6.0 8.2 1.0 6.1 3.3 8.4 3.4 7.6 7.7 5.6 5.8 9.1 12.2 6.2 13.7 8.0 7.5 9.2 12.2 2.7 12.2 11.3 11.1 6.8 1.1 7.6 11.6 6.4 12.5 34.3 6.3 14.9 13.6 7.8 19.4 9.5 7.9 12.0 5.9 6.5 33.4 9.2 16.5 7.2 7.9 6.0 10.8 5.8 9.5 5.4 8.5 12.8 10.0 3.2 8.1 3.8 11.3 24.7 8.4 13.6 8.3 8.5 3.7 3.8 12.7 4.0 12.5 9.2 7.6 12.6 12.1 0.0 6.0 0.7 8.4 6.1 7.3 6.0 4.5 8.0 6.7 2.9 4.4 7.4 1.0 3.3 3.0 8.2 4.3 3.4 UGT1A6 "GNT1, HLUGP, UGT1F" ENSG00000167165 "UDP glucuronosyltransferase family 1 member A6" P19224 2 233691607-233773300 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 111.7;liver: 50.1;urinary bladder: 32.7" "Cell line enhanced" "Detected in some" "CACO-2: 13.4;EFO-21: 20.8;HaCaT: 74.4;RT4: 37.6" "Cancer enhanced" "Detected in many" "renal cancer: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009819, HPA054065" Enhanced "CAB009819: AB_2241481, HPA054065: " "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (5.43e-2)" "unprognostic (6.03e-2)" "prognostic unfavourable (2.89e-6)" "unprognostic (2.79e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-3)" "unprognostic (9.97e-2)" "unprognostic (2.16e-2)" "unprognostic (3.52e-1)" "unprognostic (7.50e-2)" "unprognostic (2.01e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.8 0.5 0.2 0.5 2.0 0.3 0.9 13.0 0.0 1.1 0.1 0.1 0.0 111.7 50.1 1.9 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.3 0.1 3.3 0.4 0.1 1.3 1.2 0.1 3.8 1.2 2.3 0.1 0.1 8.1 0.2 0.1 0.5 0.2 5.6 8.7 32.7 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.4 0.0 20.8 0.0 74.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 37.6 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 UGT2A1 ENSG00000173610 "UDP glucuronosyltransferase family 2 member A1 complex locus" Q9Y4X1 4 69588417-69653249 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 10.6;liver: 14.5;pituitary gland: 21.2" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;HUVEC TERT2: 1.9;U-266/70: 3.5" "Cancer enhanced" "Detected in some" "liver cancer: 0.7" "Region enriched" "Detected in single" 17 "pons and medulla: 1.7" "Cell type enhanced" "Detected in some" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "HPA017261, HPA045108" Uncertain "HPA017261: AB_10963582, HPA045108: " "unprognostic (3.93e-3)" "unprognostic (5.62e-1)" "unprognostic (1.28e-4)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 14.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 1.7 0.0 0.0 1.5 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 2.0 0.5 0.9 0.4 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.2 1.7 0.5 0.4 0.2 0.2 0.1 0.1 0.4 0.2 0.1 0.3 0.2 0.1 2.0 0.9 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 UGT2A2 ENSG00000271271 "UDP glucuronosyltransferase family 2 member A2" Q9Y4X1 4 69589309-69639642 "Enzymes, Predicted membrane proteins" "Olfaction, Sensory transduction" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "cervix, uterine: 1.6;kidney: 2.6;liver: 5.4;pituitary gland: 3.8;skin 1: 1.8" "Cell line enhanced" "Detected in single" "U-266/70: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045108 Uncertain "HPA045108: " 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 5.4 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A3 FLJ21934 ENSG00000135220 "UDP glucuronosyltransferase family 2 member A3" Q6UWM9 4 68928463-68951791 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 150.5;kidney: 43.2" "Cell line enriched" "Detected in some" 9 "Hep G2: 20.5" "Cancer enriched" "Detected in many" 5 "renal cancer: 46.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 53 "granulocytes: 5.3" HPA045108 Supported "HPA045108: " "prognostic favourable (3.31e-4)" "unprognostic (3.97e-3)" "unprognostic (8.87e-3)" "prognostic favourable (6.07e-7)" "unprognostic (2.10e-2)" 0.1 0.1 0.1 4.3 0.1 0.0 0.7 0.1 0.1 0.1 63.8 0.1 0.1 31.9 0.1 1.7 0.1 0.1 14.6 0.3 0.1 0.1 43.2 9.6 0.1 0.1 0.1 0.1 0.1 12.0 0.0 0.1 0.1 0.1 0.1 8.6 0.1 0.1 0.1 0.1 0.1 150.5 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 UGT2B10 ENSG00000109181 "UDP glucuronosyltransferase family 2 member B10" P36537 4 68815993-68831196 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 277 "liver: 120.4" "Cell line enriched" "Detected in single" 39 "Hep G2: 15.8" "Cancer enriched" "Detected in single" 296 "liver cancer: 93.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045108 Uncertain "HPA045108: " "unprognostic (3.50e-3)" "unprognostic (1.92e-3)" "unprognostic (4.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 120.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B11 ENSG00000213759 "UDP glucuronosyltransferase family 2 member B11" O75310 4 69199951-69214731 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "breast: 77.4" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;HL-60: 3.0;NB-4: 2.4;RPTEC TERT1: 3.6;U-2197: 1.4" "Group enriched" "Detected in some" 17 "breast cancer: 17.4;liver cancer: 13.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 62 "basophil: 6.8;eosinophil: 5.6" "Lineage enriched" "Detected in single" 68 "granulocytes: 6.8" HPA045108 Uncertain "HPA045108: " "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.49e-1)" "unprognostic (6.53e-2)" "unprognostic (2.26e-2)" "unprognostic (1.65e-1)" "unprognostic (7.84e-3)" "unprognostic (5.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.51e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 77.4 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 3.3 0.1 0.1 0.0 1.2 7.3 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 7.0 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 3.6 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 6.8 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 UGT2B15 UGT2B8 ENSG00000196620 "UDP glucuronosyltransferase family 2 member B15" P54855 4 68646630-68670628 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 22.4;intestine: 50.7;liver: 65.4" "Cell line enhanced" "Detected in some" "A549: 3.2;HL-60: 2.1;RH-30: 1.2;RPMI-8226: 1.1" "Cancer enriched" "Detected in many" 10 "liver cancer: 120.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 2.7" "Lineage enhanced" "Detected in single" "B-cells: 2.7" HPA045108 Approved "HPA045108: " "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (2.22e-2)" "unprognostic (3.86e-1)" "unprognostic (1.94e-1)" "prognostic favourable (9.82e-4)" "unprognostic (6.73e-2)" "unprognostic (3.49e-2)" "unprognostic (7.84e-2)" "unprognostic (5.81e-3)" "unprognostic (2.39e-2)" "unprognostic (5.38e-2)" "prognostic favourable (4.50e-4)" 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 48.0 0.1 0.1 5.4 0.1 0.1 0.2 0.0 22.4 0.1 0.1 0.0 0.1 65.4 0.1 0.1 0.1 0.1 0.1 5.3 0.0 0.1 0.1 0.1 0.2 1.6 0.1 0.1 0.1 0.1 0.0 50.7 0.1 0.1 0.1 5.7 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 2.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 1.1 0.0 0.2 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.2 0.4 0.1 0.5 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 UGT2B17 ENSG00000197888 "UDP glucuronosyltransferase family 2 member B17" O75795 4 68537184-68568527 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 68.1;liver: 21.6" "Group enriched" "Detected in some" 7 "BEWO: 3.1;NB-4: 3.5;RPMI-8226: 5.1;SH-SY5Y: 2.3;U-2197: 2.1" "Group enriched" "Detected in many" 7 "colorectal cancer: 16.3;liver cancer: 10.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "memory B-cell: 3.3;naive B-cell: 11.9" "Lineage enriched" "Detected in single" 59 "B-cells: 11.9" HPA045108 Supported "HPA045108: " "unprognostic (1.66e-1)" "unprognostic (2.97e-2)" "unprognostic (2.96e-2)" "unprognostic (2.41e-1)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.36e-1)" "unprognostic (8.44e-3)" "unprognostic (9.67e-2)" "unprognostic (4.80e-3)" "unprognostic (8.52e-2)" "unprognostic (2.45e-1)" "unprognostic (6.44e-2)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" 0.4 0.1 0.4 4.7 0.4 0.0 0.4 0.4 0.4 0.4 55.6 0.4 0.4 54.1 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.1 0.4 21.6 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 20.7 0.4 0.4 0.4 0.4 0.1 68.1 1.1 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 11.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 5.1 0.2 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 UGT2B28 ENSG00000135226 "UDP glucuronosyltransferase family 2 member B28" Q9BY64 4 69280499-69295050 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "breast: 71.7;salivary gland: 25.6" "Group enriched" "Detected in some" 10 "Daudi: 6.9;NB-4: 6.3" "Cancer enriched" "Detected in single" 8 "breast cancer: 1.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 2.5;eosinophil: 4.0" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.0" HPA045108 Uncertain "Intracellular and membrane" "HPA045108: " "unprognostic (1.81e-1)" "unprognostic (1.40e-1)" "unprognostic (7.20e-3)" "unprognostic (1.51e-2)" "unprognostic (4.37e-5)" "unprognostic (9.79e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 71.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.2 4.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B4 UGT2B11 ENSG00000156096 "UDP glucuronosyltransferase family 2 member B4" P06133 4 69480165-69526014 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 105 "liver: 175.1" "Cell line enriched" "Detected in some" 9 "RH-30: 10.1" "Cancer enriched" "Detected in some" 96 "liver cancer: 351.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033260, HPA045108" Enhanced "Intracellular and membrane" "CAB033260: AB_2241496, HPA045108: " "unprognostic (7.46e-2)" "unprognostic (1.50e-1)" "unprognostic (9.37e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-2)" "unprognostic (1.47e-1)" "unprognostic (9.43e-3)" "unprognostic (3.52e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.1 175.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B7 UGT2B9 ENSG00000171234 "UDP glucuronosyltransferase family 2 member B7" P16662 4 69051363-69112987 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 125.4;liver: 156.0" "Group enriched" "Detected in some" 5 "EFO-21: 20.5;RPTEC TERT1: 81.6" "Group enriched" "Detected in many" 7 "liver cancer: 116.4;renal cancer: 101.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045108 Uncertain "HPA045108: " "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "prognostic favourable (7.65e-5)" "unprognostic (1.11e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-2)" "unprognostic (5.41e-3)" "unprognostic (1.68e-1)" "unprognostic (1.74e-2)" "unprognostic (1.17e-3)" "unprognostic (1.98e-1)" "prognostic favourable (3.79e-4)" "unprognostic (1.08e-2)" "unprognostic (2.55e-1)" "unprognostic (6.23e-3)" "prognostic favourable (5.38e-4)" 0.1 0.1 0.1 0.2 0.1 0.0 0.4 0.1 0.1 3.1 7.9 0.1 2.5 6.4 0.6 4.7 0.1 4.7 1.5 0.1 0.1 0.1 125.4 156.0 0.2 0.1 0.1 0.1 0.6 14.7 0.0 0.1 0.2 0.1 0.3 0.4 0.2 1.0 2.7 0.3 0.2 27.7 0.1 0.1 0.2 0.1 0.6 0.1 0.2 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 81.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 UGT3A1 FLJ34658 ENSG00000145626 "UDP glycosyltransferase family 3 member A1" Q6NUS8 5 35951010-36001028 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 44.0;liver: 47.7" "Cell line enriched" "Detected in single" 42 "RH-30: 24.7" "Group enriched" "Detected in some" 15 "liver cancer: 6.7;renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047697, HPA056290" Uncertain Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA047697: , HPA056290: " "unprognostic (2.41e-3)" "unprognostic (4.47e-1)" "unprognostic (4.04e-1)" "unprognostic (4.62e-1)" "unprognostic (1.42e-2)" "unprognostic (6.05e-2)" "unprognostic (9.14e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 5.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 44.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 3.2 0.1 6.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.4 0.2 0.2 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035017-36071358 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2" "Cell line enhanced" "Detected in some" "HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;T-47d: 5.7;THP-1: 12.9" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Region enhanced" "Detected in single" "pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: " "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.1 1.1 0.1 0.0 0.2 6.4 1.6 0.1 0.6 0.1 0.1 0.5 0.4 0.0 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.6 5.6 0.8 0.1 0.0 0.5 0.0 0.2 0.0 0.0 1.7 0.2 2.0 0.6 0.0 2.9 0.1 0.0 0.1 14.4 0.1 0.0 0.3 1.4 0.1 13.2 0.0 37.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.4 5.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 4.0 0.0 21.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.6 0.1 0.6 0.5 0.0 2.0 0.0 UGT8 CGT ENSG00000174607 "UDP glycosyltransferase 8" Q16880 4 114598455-114678224 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 96.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.3;RH-30: 12.1;RPTEC TERT1: 25.0;SCLC-21H: 14.2;U-87 MG: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 7.3;naive B-cell: 10.6" "Lineage enriched" "Detected in single" 12 "B-cells: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014405, HPA065785" Enhanced Approved Mitochondria Mitochondria "HPA014405: AB_1858606, HPA065785: " "unprognostic (7.38e-3)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (2.38e-1)" "unprognostic (1.63e-1)" "unprognostic (1.63e-2)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-3)" "unprognostic (4.49e-2)" "unprognostic (2.76e-1)" "prognostic favourable (8.55e-5)" "unprognostic (2.80e-1)" "unprognostic (1.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.49e-1)" 0.9 0.8 13.2 2.8 30.0 1.0 3.1 2.7 44.8 4.9 15.5 66.6 0.0 18.4 2.7 0.6 1.2 3.0 7.1 0.9 24.2 12.4 20.1 0.8 1.0 3.2 53.9 15.9 0.8 4.8 0.3 0.9 0.5 38.3 0.9 17.3 0.0 4.5 0.8 0.8 1.8 16.1 1.5 96.6 1.3 10.0 3.3 42.6 0.0 8.5 0.0 3.4 0.8 1.0 10.6 0.0 0.9 0.0 0.0 0.6 0.3 0.3 0.1 2.0 0.3 0.1 0.0 0.3 0.1 0.0 0.0 1.5 6.8 25.3 7.6 0.6 0.1 10.7 0.0 0.0 0.0 0.1 5.3 0.1 11.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 6.4 1.5 0.0 0.1 0.1 0.8 3.0 3.8 0.7 12.1 0.2 25.0 0.3 14.2 2.1 0.1 2.2 0.3 0.4 2.4 0.5 0.5 8.6 0.3 7.9 2.5 0.4 0.2 12.5 0.4 7.8 0.2 0.0 0.9 0.0 0.0 0.6 7.3 0.1 0.0 0.0 10.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 13.2 30.0 2.7 24.4 24.2 12.4 53.9 15.9 38.3 42.6 ULBP1 RAET1I ENSG00000111981 "UL16 binding protein 1" Q9BZM6 6 149964007-149973710 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.9;lung: 9.7;testis: 10.5" "Cell line enhanced" "Detected in many" "HAP1: 23.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 13.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA007547, HPA071005" Enhanced Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA007547: AB_1079430, HPA071005: " "unprognostic (8.94e-3)" "unprognostic (2.44e-1)" "unprognostic (2.85e-2)" "unprognostic (2.33e-2)" "unprognostic (3.28e-4)" "unprognostic (6.69e-3)" "unprognostic (5.27e-2)" "unprognostic (2.47e-2)" "unprognostic (5.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.57e-12)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 0.7 0.6 2.0 0.4 0.6 0.5 0.5 13.9 1.5 0.4 0.7 0.2 0.0 0.4 0.5 0.5 0.8 0.9 0.5 1.2 1.5 0.3 1.2 0.9 9.7 0.2 0.3 0.0 1.2 0.4 0.6 0.6 1.3 1.0 0.8 0.4 0.5 1.0 0.2 1.6 0.6 0.3 0.3 1.2 0.3 0.9 10.5 0.2 0.2 3.8 0.6 0.5 0.7 4.9 0.7 0.1 0.9 1.8 0.3 3.5 0.3 2.7 1.3 2.7 1.4 2.7 7.9 2.8 3.7 1.1 1.7 2.9 1.8 3.2 2.8 2.9 12.8 2.7 23.7 4.6 4.4 12.4 3.9 0.2 0.9 0.0 14.0 0.1 1.0 8.6 5.8 11.7 3.1 2.4 2.3 0.0 4.1 3.3 2.9 0.0 1.0 4.3 1.2 2.4 0.4 5.0 2.1 0.9 0.3 5.4 3.4 0.8 2.7 5.5 1.9 1.3 2.3 5.2 3.2 0.4 0.4 2.5 8.2 4.1 3.4 0.1 0.2 0.1 2.4 1.3 3.5 0.7 1.2 2.8 0.1 0.2 0.7 1.2 0.9 0.3 1.8 0.0 1.9 0.3 2.0 0.6 13.9 1.5 1.5 0.3 0.3 0.0 1.0 0.2 ULBP2 RAET1H ENSG00000131015 "UL16 binding protein 2" Q9BZM5 6 149942000-149949235 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 10.8" "Cell line enhanced" "Detected in many" "SiHa: 31.7;U-2197: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0" "Lineage enriched" "Detected in single" 7 "T-cells: 5.5" CAB018974 Approved Supported "Vesicles,Plasma membrane" "Secreted in other tissues" "Vesicles, Plasma membrane" "CAB018974: " "unprognostic (2.09e-5)" "prognostic unfavourable (8.07e-4)" "unprognostic (2.38e-3)" "unprognostic (3.90e-1)" "prognostic unfavourable (2.44e-4)" "unprognostic (1.26e-2)" "unprognostic (2.38e-3)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (1.75e-2)" "unprognostic (1.42e-4)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (4.86e-1)" 3.3 1.7 4.5 1.9 2.3 4.3 5.9 5.3 6.5 1.6 0.6 0.0 0.0 0.9 0.6 0.5 10.8 0.5 1.6 4.1 4.4 1.0 1.9 1.7 6.2 1.1 1.0 2.1 0.2 1.6 0.3 1.1 4.4 3.9 0.6 0.7 0.3 1.5 0.4 0.6 1.0 0.4 2.0 0.6 0.5 0.7 3.6 0.1 0.5 3.5 4.6 2.4 4.1 5.2 0.0 0.0 0.0 0.0 0.8 5.5 0.9 9.2 0.8 0.2 2.9 0.5 2.8 1.6 9.5 5.6 10.0 8.2 3.5 5.2 0.0 14.6 10.8 6.6 3.6 8.7 5.8 4.2 1.8 0.5 1.4 0.0 3.5 0.0 0.7 1.3 6.7 8.9 3.9 5.7 1.1 0.0 7.4 6.4 0.8 0.0 0.0 4.9 1.4 2.2 0.0 14.2 2.7 0.3 0.0 31.7 0.6 0.9 0.9 3.9 8.9 6.6 8.2 22.9 11.0 0.0 0.0 0.4 9.4 5.0 4.7 0.0 0.0 0.0 5.5 0.0 0.6 0.0 1.8 3.2 0.0 0.0 0.6 3.9 0.0 0.8 0.0 0.0 3.0 0.9 4.5 2.3 5.3 6.5 4.4 1.0 1.0 2.1 3.9 0.1 UMOD ENSG00000169344 Uromodulin P07911 16 20333052-20356301 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Ciliopathy, Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 417 "kidney: 237.4" "Cell line enriched" "Detected in single" 32 "EFO-21: 3.8" "Cancer enriched" "Detected in single" 39 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009446, HPA043420, HPA054721" Enhanced "Secreted in other tissues" 83000000 "CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (6.45e-2)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 237.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 UMODL1 ENSG00000177398 "Uromodulin like 1" Q5DID0 21 42062959-42143453 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 22.7" "Group enriched" "Detected in some" 5 "SCLC-21H: 3.6;U-266/70: 8.9" "Group enriched" "Detected in some" 7 "lung cancer: 0.6;testis cancer: 2.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA067245 Uncertain "HPA067245: " "unprognostic (4.70e-3)" "unprognostic (3.75e-5)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (4.92e-2)" "unprognostic (1.32e-2)" "unprognostic (2.72e-7)" "unprognostic (2.38e-1)" "unprognostic (9.47e-2)" "unprognostic (2.63e-2)" "unprognostic (3.82e-1)" "unprognostic (9.24e-3)" "unprognostic (4.37e-2)" "unprognostic (1.78e-1)" "unprognostic (4.02e-4)" "unprognostic (2.68e-1)" 0.6 0.1 0.4 3.6 0.1 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 4.9 0.0 0.2 0.2 0.3 0.4 0.4 0.6 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.2 3.8 0.0 22.7 0.1 0.0 2.0 0.1 0.0 0.5 0.1 0.3 0.5 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.5 0.5 0.0 0.1 0.3 0.7 0.6 0.0 0.0 0.5 0.0 1.0 0.2 0.4 0.1 0.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 UNC45A "GC-UNC45, SMAP-1" ENSG00000140553 "Unc-45 myosin chaperone A" Q9H3U1 15 90930180-90954093 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Myogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039228 Approved Supported "Nuclear speckles,Cytosol" 21000000 "Nuclear speckles" Cytosol "HPA039228: " "unprognostic (1.46e-1)" "unprognostic (3.83e-2)" "unprognostic (4.51e-2)" "unprognostic (1.97e-1)" "unprognostic (2.68e-2)" "unprognostic (1.70e-3)" "prognostic unfavourable (7.72e-4)" "unprognostic (2.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (1.98e-1)" "unprognostic (9.85e-2)" "prognostic favourable (7.46e-7)" "unprognostic (9.30e-2)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-2)" 19.1 21.0 10.1 14.4 10.1 11.9 20.6 21.8 14.6 20.3 27.6 10.7 23.2 13.0 29.7 15.5 24.9 20.4 24.8 12.8 9.5 7.3 16.2 15.9 15.2 13.2 11.9 12.3 22.1 19.4 25.8 14.1 22.8 11.5 23.8 10.9 15.3 20.2 29.6 6.9 26.6 16.9 35.8 9.7 15.7 22.4 18.4 10.8 18.0 20.8 12.6 16.9 33.2 30.4 10.1 12.0 12.1 11.9 10.8 14.5 9.8 15.1 30.9 12.8 11.1 35.1 16.3 11.4 17.2 14.9 23.5 18.9 24.6 20.1 17.9 23.2 21.7 33.7 21.7 22.2 11.1 19.8 31.6 34.5 32.3 17.6 19.9 8.5 23.5 20.1 27.2 23.0 16.9 31.8 15.2 14.7 17.6 24.4 10.9 7.3 17.3 15.7 21.8 19.5 19.0 16.0 36.1 18.1 16.4 23.2 23.2 21.5 21.0 17.7 31.3 20.1 14.5 16.9 18.0 14.1 19.5 8.4 19.7 20.0 20.4 12.1 9.0 5.4 14.5 8.3 14.0 10.1 11.9 11.2 12.0 8.3 10.0 9.1 1.8 10.8 11.9 10.7 10.5 9.8 10.1 10.1 21.8 14.6 9.5 7.3 11.9 12.3 11.5 10.8 UNC5A "KIAA1976, UNC5H1" ENSG00000113763 "Unc-5 netrin receptor A" Q6ZN44 5 176810477-176880898 "Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.9;brain: 35.3" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 43.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8;eosinophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.8" "Group enriched" "Detected in all" 4 "amygdala: 42.5;basal ganglia: 24.9;cerebral cortex: 36.4;hippocampal formation: 44.5;hypothalamus: 19.1" "Low region specificity" "Detected in all" HPA071450 Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA071450: " "unprognostic (5.95e-2)" "unprognostic (1.15e-1)" "unprognostic (4.18e-3)" "prognostic unfavourable (2.23e-4)" "unprognostic (5.26e-2)" "unprognostic (2.23e-1)" "unprognostic (6.66e-3)" "unprognostic (5.06e-3)" "unprognostic (3.52e-1)" "unprognostic (1.36e-1)" "unprognostic (5.07e-1)" "unprognostic (9.95e-2)" "unprognostic (3.77e-5)" "unprognostic (6.39e-2)" "unprognostic (2.89e-1)" "unprognostic (2.27e-1)" "unprognostic (5.17e-2)" 0.9 11.9 10.5 1.1 11.1 1.2 1.4 35.3 30.9 1.1 0.7 0.4 0.0 1.3 0.8 0.9 0.7 1.5 1.0 0.7 7.6 4.6 0.7 0.7 0.9 1.7 1.6 12.6 0.9 3.2 0.6 5.1 0.6 2.1 0.8 0.7 0.3 0.9 0.7 0.6 0.7 0.9 0.8 0.8 0.6 1.2 1.3 0.5 0.0 0.8 0.0 0.7 0.9 0.2 0.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 1.2 5.0 0.0 43.3 1.9 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.3 1.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 10.5 11.1 35.3 22.2 7.6 4.6 1.6 12.6 2.1 0.5 UNC5B "p53RDL1, UNC5H2" ENSG00000107731 "Unc-5 netrin receptor B" Q8IZJ1 10 71212570-71302864 "Plasma proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 43.7" "Cell line enhanced" "Detected in many" "HHSteC: 46.0;hTCEpi: 40.6;SH-SY5Y: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.5" "Lineage enriched" "Detected in single" 6 "monocytes: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA076687 Approved "HPA076687: " "unprognostic (3.98e-2)" "unprognostic (3.14e-2)" "unprognostic (9.28e-2)" "unprognostic (2.71e-1)" "unprognostic (5.64e-2)" "unprognostic (1.46e-1)" "prognostic unfavourable (3.01e-5)" "unprognostic (8.82e-3)" "unprognostic (6.79e-3)" "prognostic unfavourable (3.80e-5)" "unprognostic (7.70e-3)" "unprognostic (6.67e-2)" "prognostic unfavourable (1.54e-4)" "unprognostic (4.17e-2)" "unprognostic (4.62e-2)" "unprognostic (9.89e-3)" "unprognostic (2.25e-1)" 3.8 12.4 9.1 4.6 19.8 0.5 2.3 23.1 12.5 5.7 8.3 29.5 33.6 3.2 5.4 7.5 14.2 9.1 10.5 13.8 12.2 6.8 6.6 2.1 9.3 3.9 27.1 9.7 4.5 5.2 1.5 5.3 6.0 15.0 10.1 6.0 7.1 4.5 43.7 3.0 5.9 4.5 5.5 17.5 8.5 9.9 6.0 20.4 2.2 4.6 5.2 3.6 9.6 8.9 0.0 0.2 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.2 1.1 3.6 5.9 0.1 2.0 5.8 0.0 0.1 1.1 5.4 0.0 2.0 12.4 14.0 0.4 0.8 0.0 0.0 1.3 3.1 0.2 0.0 46.0 0.0 0.3 5.1 40.6 0.5 2.6 0.8 0.1 0.0 0.0 0.4 0.0 0.0 3.1 0.1 0.0 1.4 0.0 0.0 6.1 6.2 38.1 0.4 0.4 0.3 0.6 0.1 2.4 0.4 1.8 0.7 0.8 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 9.1 19.8 23.1 12.5 12.2 6.8 27.1 9.7 15.0 20.4 UNC5D "KIAA1777, Unc5h4" ENSG00000156687 "Unc-5 netrin receptor D" Q6UXZ4 8 35235457-35796550 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.4;intestine: 11.7;pituitary gland: 14.2;prostate: 10.6" "Group enriched" "Detected in some" 4 "HEK 293: 4.1;HeLa: 3.9;NTERA-2: 13.5;SH-SY5Y: 4.8;U-251 MG: 4.1" "Cancer enhanced" "Detected in some" "prostate cancer: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042940 Uncertain "HPA042940: AB_10959525" "unprognostic (7.88e-2)" "unprognostic (1.28e-1)" "unprognostic (1.41e-2)" "unprognostic (2.29e-1)" "unprognostic (7.60e-2)" "unprognostic (1.87e-1)" "unprognostic (8.47e-2)" "unprognostic (3.82e-2)" "unprognostic (2.04e-1)" "unprognostic (4.13e-2)" "unprognostic (1.99e-1)" "unprognostic (4.48e-8)" "unprognostic (1.34e-1)" "unprognostic (9.15e-2)" "unprognostic (4.28e-1)" 0.3 3.9 8.4 0.4 13.5 0.3 0.4 2.8 15.4 5.0 0.9 0.5 0.1 11.7 3.8 0.5 0.4 0.6 0.3 0.3 3.6 9.4 5.0 0.3 0.5 0.3 1.3 8.1 0.3 0.6 0.4 14.2 0.3 4.7 10.6 1.5 3.3 0.4 0.8 0.3 0.4 3.9 2.4 0.8 0.4 0.6 1.6 0.8 0.0 2.1 0.0 0.3 0.3 0.4 0.0 0.0 0.8 0.2 0.3 0.1 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.5 1.4 0.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.3 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 8.4 13.5 2.8 15.4 3.6 9.4 1.3 8.1 4.7 0.8 UNC79 KIAA1409 ENSG00000133958 "Unc-79 homolog, NALCN channel complex subunit" Q9P2D8 14 93333219-93707876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.6;pituitary gland: 18.9" "Group enriched" "Detected in some" 5 "REH: 8.3;SCLC-21H: 6.1;SH-SY5Y: 3.9;U-937: 3.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071881 Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA071881: " "unprognostic (8.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.70e-2)" "unprognostic (6.91e-2)" "unprognostic (1.06e-1)" "unprognostic (7.73e-2)" "unprognostic (2.99e-2)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.73e-3)" "unprognostic (8.03e-3)" "unprognostic (2.87e-1)" "unprognostic (3.39e-2)" "unprognostic (2.66e-2)" "unprognostic (5.57e-2)" "unprognostic (3.03e-2)" "unprognostic (7.47e-2)" 1.1 3.9 7.1 1.0 12.1 0.9 1.0 17.6 14.6 1.0 1.1 4.5 0.0 1.1 1.1 1.1 1.2 2.0 1.1 1.2 6.7 5.8 1.4 1.1 1.0 1.0 3.2 9.1 1.1 5.0 1.4 18.9 1.0 6.8 1.0 1.1 1.3 1.0 1.0 1.6 1.0 1.1 1.2 3.0 0.9 1.9 7.0 3.5 0.0 1.3 0.0 1.0 1.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 8.3 0.0 0.0 0.2 0.2 6.1 3.9 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 7.1 12.1 17.6 14.6 6.7 5.8 3.2 9.1 6.8 3.5 UPK1B "TSPAN20, UPK1" ENSG00000114638 "Uroplakin 1B" O75841 3 119173517-119205153 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 56.4;urinary bladder: 41.9" "Group enriched" "Detected in some" 4 "CACO-2: 15.0;RPTEC TERT1: 14.0;RT4: 54.2" "Cancer enhanced" "Detected in many" "urothelial cancer: 147.3" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA031799, HPA031800" Enhanced "HPA031799: AB_10671579, HPA031800: AB_10671580" "unprognostic (1.20e-2)" "unprognostic (7.18e-2)" "prognostic favourable (3.87e-5)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (8.77e-3)" "unprognostic (3.67e-1)" "unprognostic (2.71e-1)" "unprognostic (3.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.92e-2)" "prognostic unfavourable (7.76e-4)" "unprognostic (1.68e-1)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" 6.1 0.2 0.2 0.2 1.2 0.0 0.2 0.2 0.3 3.6 0.7 0.0 0.0 0.0 1.5 0.3 2.4 5.1 12.9 1.8 0.2 0.2 6.6 0.6 1.4 0.0 0.2 0.1 0.8 11.6 0.0 0.4 56.4 1.1 15.4 0.0 0.0 0.4 0.0 0.2 0.6 0.2 4.3 1.8 0.2 22.9 0.7 0.0 1.4 0.2 1.4 12.9 41.9 1.1 0.7 1.1 2.5 0.5 0.6 1.9 0.5 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 15.0 0.0 0.0 2.0 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.0 54.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.5 0.3 0.3 0.2 0.4 0.2 0.3 0.5 0.7 1.9 0.3 1.8 0.6 0.4 1.1 0.2 0.5 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.1 1.1 0.0 UPK2 "MGC138598, UP2, UPII" ENSG00000110375 "Uroplakin 2" O00526 11 118925164-118958559 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "prostate: 39.0;urinary bladder: 52.4;vagina: 25.9" "Group enriched" "Detected in some" 6 "MCF7: 45.9;RT4: 51.8" "Cancer enriched" "Detected in many" 72 "urothelial cancer: 339.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.0;T-reg: 1.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043312, HPA061106" Enhanced "HPA043312: AB_2678420, HPA061106: AB_2684429" "unprognostic (6.04e-3)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (3.97e-2)" "unprognostic (1.21e-1)" "unprognostic (4.12e-4)" "unprognostic (1.65e-1)" "prognostic unfavourable (9.57e-4)" "unprognostic (3.13e-3)" "unprognostic (1.37e-1)" "unprognostic (1.05e-3)" "unprognostic (6.35e-3)" "prognostic unfavourable (7.30e-7)" "unprognostic (6.69e-2)" "unprognostic (7.45e-2)" "unprognostic (2.98e-1)" "unprognostic (1.00e-1)" 1.0 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.0 0.0 0.2 0.2 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 3.8 0.0 39.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 6.8 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.2 1.3 52.4 25.9 0.7 0.6 0.0 0.1 2.0 1.9 0.2 1.2 0.1 0.0 0.1 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.8 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.6 1.9 0.2 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.0 UPK3A UPK3 ENSG00000100373 "Uroplakin 3A" O75631 22 45284982-45295874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;skeletal muscle: 24.5;urinary bladder: 45.5" "Group enriched" "Detected in some" 5 "Hep G2: 18.3;RT4: 30.6" "Group enriched" "Detected in many" 6 "prostate cancer: 35.3;urothelial cancer: 78.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "classical monocyte: 8.5;intermediate monocyte: 9.6;myeloid DC: 33.7;non-classical monocyte: 11.3;plasmacytoid DC: 13.0" "Group enriched" "Detected in many" 16 "dendritic cells: 33.7;monocytes: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018407, HPA018415" Enhanced Uncertain "Nuclear membrane,Nuclear bodies" "Nuclear membrane" "Nuclear bodies" "HPA018407: AB_1858641, HPA018415: AB_1858640" "unprognostic (1.27e-2)" "unprognostic (3.20e-3)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (3.98e-5)" "unprognostic (1.69e-2)" "unprognostic (4.82e-4)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-5)" "unprognostic (2.01e-2)" "unprognostic (5.45e-2)" "unprognostic (1.83e-1)" "unprognostic (6.05e-3)" 0.2 0.1 0.3 1.6 0.4 0.9 0.3 0.2 0.5 0.4 0.7 0.0 0.0 0.0 0.2 2.3 0.2 0.2 0.6 0.2 0.3 0.3 0.2 0.2 0.2 1.0 0.4 0.1 0.2 0.2 6.4 0.5 0.0 0.7 17.9 0.5 0.6 12.9 1.8 24.5 0.2 1.8 13.0 0.3 0.7 0.2 0.2 0.0 1.3 4.6 1.7 0.6 45.5 2.7 0.3 33.7 1.4 11.3 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 30.6 0.1 0.0 0.1 0.5 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 9.6 0.0 0.3 0.0 0.0 33.7 0.2 0.0 0.0 1.4 0.1 11.3 13.0 0.0 2.8 0.3 0.4 0.2 0.5 0.3 0.3 0.4 0.1 0.7 0.0 UPK3B "FLJ32198, MGC10902, p35, UPIIIb" ENSG00000243566 "Uroplakin 3B" Q9BT76 7 76510428-76516521 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0" "Cell line enhanced" "Detected in some" "A549: 7.7;CAPAN-2: 27.8;HaCaT: 5.7;RT4: 19.0;T-47d: 15.9" "Group enriched" "Detected in many" 12 "ovarian cancer: 64.6;urothelial cancer: 78.4" "Region enriched" "Detected in single" 58 "pons and medulla: 5.8" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" HPA010506 Approved "HPA010506: AB_1080479" "unprognostic (8.33e-2)" "unprognostic (1.30e-1)" "unprognostic (3.62e-3)" "unprognostic (2.26e-3)" "unprognostic (7.87e-2)" "unprognostic (8.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.63e-1)" "unprognostic (4.03e-1)" "unprognostic (5.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.06e-2)" "unprognostic (8.37e-9)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-1)" "unprognostic (6.34e-2)" 28.5 0.3 0.0 7.1 0.0 0.4 0.3 0.0 0.3 1.5 6.9 0.1 0.0 0.3 0.8 7.9 40.2 2.8 3.0 9.4 0.0 0.0 0.3 0.4 34.1 0.4 0.0 0.0 13.2 0.3 0.3 0.1 0.3 5.8 1.4 0.3 0.8 1.4 0.3 0.4 1.1 0.5 1.5 0.2 0.4 0.6 6.1 0.0 0.2 0.3 6.1 25.0 20.5 2.1 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.6 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 27.8 0.0 0.2 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.2 2.3 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 UPK3BL1 "UPK3BL, UPLP" ENSG00000267368 "Uroplakin 3B like 1" "B0FP48, E5RIL1" 7 102637025-102642791 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 45.1;lymphoid tissue: 34.6" "Cell line enhanced" "Detected in many" "HaCaT: 47.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA011403 Supported "HPA011403: " "unprognostic (4.63e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-2)" "unprognostic (2.45e-1)" "unprognostic (3.28e-1)" "unprognostic (6.19e-3)" "unprognostic (3.35e-1)" "unprognostic (2.88e-1)" "unprognostic (9.39e-3)" "unprognostic (4.00e-1)" "unprognostic (8.11e-2)" "unprognostic (6.46e-3)" "unprognostic (1.15e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-1)" "unprognostic (1.79e-1)" "unprognostic (3.93e-2)" 3.0 2.2 2.1 3.3 2.7 7.9 3.0 4.5 2.1 6.5 2.9 3.6 3.4 1.7 45.1 3.7 1.0 2.2 3.0 1.9 4.6 4.0 3.4 7.1 2.1 3.7 3.8 3.4 4.3 1.7 5.9 1.5 7.7 23.7 6.5 5.1 4.6 0.9 2.0 8.8 3.0 1.3 13.1 34.6 11.8 15.1 5.3 6.8 13.6 5.9 7.1 9.6 4.7 7.2 5.7 3.7 1.6 1.5 0.2 5.1 0.0 0.8 0.8 2.1 0.9 4.0 1.1 1.4 0.9 47.8 1.1 5.3 0.6 6.5 8.4 1.1 2.4 1.7 0.5 1.9 1.9 3.2 6.9 0.0 1.3 6.7 2.8 4.0 2.4 16.6 2.9 15.9 1.7 1.7 2.9 2.0 6.0 6.8 5.8 2.5 5.8 9.9 2.6 2.4 0.8 2.9 2.3 14.2 6.1 5.0 2.8 4.2 1.9 0.6 3.0 4.4 2.3 13.6 5.9 8.5 9.6 5.2 4.4 5.3 5.0 4.7 6.8 4.9 6.3 4.8 7.1 7.1 1.7 6.8 7.9 4.7 UPK3BL2 ENSG00000284981 "Uroplakin 3B like 2" E5RIL1 7 102538417-102543849 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.2;lymphoid tissue: 12.8" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA011403 Approved "HPA011403: " 0.8 0.0 1.5 6.5 1.0 0.3 0.0 0.6 1.0 0.7 0.4 12.2 0.9 0.6 0.0 0.0 0.1 0.8 3.4 0.4 0.7 0.2 0.3 1.2 0.8 1.5 3.6 2.7 2.8 0.9 0.1 3.2 0.4 0.0 4.5 12.8 2.5 5.0 8.4 6.1 3.7 1.0 7.9 1.3 5.7 8.9 3.8 6.7 1.8 0.6 13.2 10.5 13.2 13.3 16.5 3.0 9.7 6.5 5.3 4.0 18.7 0.4 5.0 3.7 7.2 10.9 2.3 14.6 5.2 7.7 5.6 7.2 6.4 7.3 3.8 3.6 6.0 6.0 15.1 4.8 23.5 6.3 9.5 1.5 1.8 4.9 2.1 9.5 7.5 22.6 4.9 5.4 5.9 2.9 5.3 3.1 5.3 2.7 7.1 3.2 4.5 4.2 15.1 4.8 4.0 2.0 10.2 5.1 0.2 3.7 2.6 7.9 1.9 2.9 4.7 3.1 2.5 1.5 5.0 5.6 2.8 6.1 1.0 2.0 8.4 3.0 1.3 UQCC1 "BFZB, C20orf44, CBP3, FLJ10850, UQCC" ENSG00000101019 "Ubiquinol-cytochrome c reductase complex assembly factor 1" Q9NVA1 20 35302566-35412141 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034875 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments" "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA034875: AB_10603226" "unprognostic (9.66e-2)" "unprognostic (3.93e-1)" "unprognostic (3.45e-1)" "unprognostic (8.72e-3)" "unprognostic (4.01e-1)" "unprognostic (1.31e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (2.82e-2)" "unprognostic (7.66e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "unprognostic (6.72e-3)" "unprognostic (3.23e-1)" "unprognostic (3.60e-1)" "unprognostic (5.27e-2)" "unprognostic (1.34e-2)" 12.6 19.2 13.7 10.6 24.5 2.5 10.1 19.6 23.9 10.9 13.3 15.7 12.1 13.0 14.2 14.2 10.5 11.7 8.4 34.3 13.5 15.9 20.0 17.2 8.7 10.9 16.6 18.2 11.9 10.8 19.8 17.0 10.1 20.1 11.9 17.5 15.8 12.1 12.9 70.2 9.2 11.3 15.5 15.5 11.2 12.2 13.2 13.4 8.9 14.2 17.1 13.8 11.0 9.9 13.5 13.5 16.3 11.9 19.7 15.2 9.6 6.8 9.9 11.2 10.3 11.4 12.5 1.6 13.0 14.1 23.3 16.2 32.1 13.5 21.8 24.6 8.1 18.1 19.7 22.5 17.7 6.5 7.8 29.3 13.2 25.7 7.2 17.5 8.7 12.2 23.0 12.4 15.6 7.9 12.6 7.2 16.2 8.9 20.0 6.3 9.4 20.4 11.0 17.5 12.0 21.4 7.7 15.8 10.6 11.0 53.0 11.4 7.9 11.2 7.4 15.9 10.1 8.3 11.8 11.2 12.1 9.1 28.4 10.2 12.8 16.3 7.7 11.0 12.7 11.9 15.2 10.3 12.1 12.5 13.5 13.5 14.6 13.2 0.3 19.7 7.7 11.5 11.2 9.6 13.7 24.5 19.6 23.9 13.5 15.9 16.6 18.2 20.1 13.4 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673687 "Disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA046851: " "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavourable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 10.0 13.4 8.9 11.4 8.5 10.6 14.7 8.7 9.9 7.3 15.4 4.7 19.7 16.5 7.3 8.5 14.5 6.5 12.4 13.2 8.0 8.7 10.7 13.4 5.6 8.3 8.5 8.7 9.5 15.4 5.3 7.6 6.2 7.7 12.3 4.9 7.1 22.9 14.1 27.8 8.6 14.8 6.0 6.2 9.6 12.2 5.7 5.4 6.4 13.5 12.3 9.1 8.0 18.1 23.7 21.2 15.2 20.8 14.0 19.4 15.5 11.8 24.1 3.5 5.5 2.2 2.2 3.0 4.7 1.6 3.6 3.5 14.1 10.4 7.7 9.8 1.6 11.8 3.4 5.5 1.1 3.9 12.5 4.4 12.7 9.0 3.0 7.0 3.5 2.1 4.7 3.1 3.6 2.7 9.3 5.6 1.9 36.3 6.8 17.3 3.9 13.7 7.9 5.4 13.7 2.7 5.9 7.2 7.3 5.2 19.1 7.0 18.2 6.6 3.5 7.8 9.1 8.1 10.5 8.7 4.7 7.9 6.4 6.1 5.6 9.1 20.8 15.2 18.1 14.4 17.1 23.5 18.0 15.9 15.8 23.7 16.6 13.3 8.9 14.0 12.7 21.2 19.4 15.5 8.9 8.5 8.7 9.9 8.0 8.7 8.5 8.7 7.7 5.4 URGCP "DKFZp666G166, DKFZp686O0457, FLJ20654, KIAA1507, URG4" ENSG00000106608 "Upregulator of cell proliferation" Q8TCY9 7 43875894-43926411 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019879, HPA020134, HPA029468" Approved Supported Cytosol Cytosol "HPA019879: AB_1858651, HPA020134: AB_1858652, HPA029468: AB_10601831" "unprognostic (5.66e-2)" "unprognostic (1.10e-3)" "unprognostic (1.18e-1)" "unprognostic (2.75e-1)" "unprognostic (2.21e-3)" "unprognostic (2.42e-2)" "unprognostic (3.74e-2)" "unprognostic (1.26e-1)" "unprognostic (3.79e-1)" "unprognostic (2.21e-1)" "unprognostic (3.23e-3)" "unprognostic (3.71e-1)" "prognostic favourable (1.90e-4)" "unprognostic (1.56e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (1.69e-3)" 13.7 27.1 18.5 13.4 21.4 8.6 13.4 28.3 29.5 15.8 18.2 18.6 14.8 22.2 18.3 15.1 13.8 15.6 11.6 19.3 18.3 15.9 20.4 21.3 12.1 9.5 13.8 19.5 21.6 18.4 22.5 22.1 14.4 17.9 17.7 19.6 19.8 18.4 17.1 26.8 17.4 21.0 19.1 10.9 13.8 12.8 7.0 17.2 8.3 14.6 7.9 12.5 15.0 12.3 6.1 9.8 5.8 7.5 2.6 11.9 6.1 13.8 13.0 5.2 16.8 14.3 13.2 5.1 15.4 30.6 18.8 19.2 10.8 11.4 8.3 8.8 16.5 22.5 14.8 12.4 18.5 15.6 8.5 5.6 12.9 9.3 15.2 8.7 10.8 10.1 15.3 14.8 14.4 9.3 14.1 6.5 12.5 10.6 9.0 7.4 9.9 12.3 12.7 7.2 11.4 17.9 14.2 13.8 23.3 17.4 26.0 8.1 13.2 10.5 8.6 10.6 4.7 11.8 12.8 17.9 25.9 10.4 12.3 13.7 20.1 2.6 4.5 5.8 9.0 7.3 9.9 6.1 9.6 11.9 9.8 5.6 10.6 9.3 0.5 2.6 7.5 1.5 9.6 6.1 18.5 21.4 28.3 29.5 18.3 15.9 13.8 19.5 17.9 17.2 USE1 "D12, MDS032, p31, SLT1" ENSG00000053501 "Unconventional SNARE in the ER 1" Q9NZ43 19 17215346-17219829 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026851, HPA047562" Approved "HPA026851: AB_10602903, HPA047562: " "unprognostic (3.03e-3)" "unprognostic (2.61e-3)" "unprognostic (2.24e-2)" "unprognostic (3.09e-2)" "unprognostic (1.03e-1)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (3.04e-2)" "unprognostic (4.24e-1)" "unprognostic (2.94e-2)" "unprognostic (1.15e-1)" "unprognostic (2.89e-1)" "prognostic unfavourable (3.59e-4)" "unprognostic (8.14e-2)" "unprognostic (3.23e-1)" "unprognostic (6.61e-2)" "unprognostic (1.31e-2)" 20.8 24.3 31.9 16.2 25.2 21.2 17.6 18.4 35.2 14.6 17.9 22.0 11.4 14.7 15.6 17.3 16.0 16.8 17.4 24.9 28.0 20.4 15.6 29.7 13.0 21.2 25.7 20.9 23.6 29.9 11.7 12.1 14.5 20.7 14.3 9.7 14.9 32.1 13.9 39.3 18.5 13.0 12.9 21.6 20.7 16.8 10.7 16.8 22.8 15.5 16.3 15.1 17.3 12.5 40.0 26.9 11.0 18.4 15.3 38.8 20.6 12.6 7.6 4.2 17.4 14.3 13.7 14.6 9.2 10.8 10.4 13.1 9.9 15.3 8.6 21.6 12.6 7.4 3.7 12.6 3.6 18.2 16.8 15.8 14.4 10.3 29.5 17.6 14.7 18.7 6.8 9.0 18.1 6.9 10.0 29.9 10.9 15.3 16.8 13.0 8.1 26.7 13.4 4.6 33.1 12.0 10.4 11.4 10.1 10.3 15.0 15.4 9.6 27.8 10.0 6.9 6.7 12.5 11.4 33.8 30.8 11.2 18.7 28.2 11.5 11.0 18.4 5.2 17.9 15.2 20.1 39.5 26.6 21.4 21.9 40.0 38.8 28.4 3.3 15.3 11.3 26.9 25.2 20.6 31.9 25.2 18.4 35.2 28.0 20.4 25.7 20.9 20.7 16.8 USP30 "FLJ40511, MGC10702" ENSG00000135093 "Ubiquitin specific peptidase 30" Q70CQ3 12 109023089-109088026 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016952 Approved "HPA016952: AB_1858680" "unprognostic (2.34e-1)" "unprognostic (1.57e-2)" "unprognostic (7.04e-2)" "unprognostic (9.91e-2)" "unprognostic (2.48e-1)" "unprognostic (5.89e-2)" "unprognostic (1.91e-1)" "unprognostic (3.60e-3)" "unprognostic (1.98e-1)" "unprognostic (4.96e-2)" "unprognostic (5.07e-2)" "unprognostic (1.07e-1)" "prognostic favourable (5.23e-6)" "unprognostic (2.49e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-3)" 11.7 18.9 12.7 9.0 17.6 12.2 10.4 11.9 21.0 10.3 13.2 29.2 13.6 14.9 12.4 8.5 9.2 11.1 8.4 9.0 10.3 10.6 12.4 21.7 8.9 10.4 16.6 7.8 17.5 12.4 14.7 13.0 6.7 16.0 9.4 11.3 16.4 10.1 12.4 16.4 13.6 14.1 8.6 14.3 9.8 8.5 21.3 16.3 8.7 11.1 5.3 7.1 10.8 8.1 14.2 12.2 12.7 11.0 18.3 17.4 6.0 4.7 3.6 9.7 8.3 6.8 7.8 5.4 5.3 6.9 6.2 5.5 4.3 3.6 11.9 4.5 5.2 5.3 8.4 5.5 7.1 13.8 10.6 3.8 3.3 6.1 7.3 7.6 4.3 9.4 6.7 5.5 5.4 7.1 5.7 5.8 5.2 5.5 11.9 4.3 3.0 10.2 12.9 6.9 7.2 5.0 5.7 8.8 7.9 7.2 5.4 5.6 13.4 5.9 5.1 5.7 3.1 5.5 3.5 14.6 12.1 17.9 6.1 4.6 6.3 9.5 7.1 12.7 15.4 11.0 17.4 14.2 12.9 14.3 4.6 14.2 13.7 12.6 4.2 18.3 8.8 12.2 11.2 6.0 12.7 17.6 11.9 21.0 10.3 10.6 16.6 7.8 16.0 16.3 UST 2OST ENSG00000111962 "Uronyl 2-sulfotransferase" Q9Y2C2 6 148747328-149076990 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032022 Approved "HPA032022: AB_10603326" "unprognostic (3.43e-1)" "unprognostic (1.90e-1)" "unprognostic (7.87e-3)" "unprognostic (3.22e-5)" "unprognostic (1.83e-3)" "unprognostic (1.50e-1)" "unprognostic (5.71e-2)" "unprognostic (1.96e-2)" "unprognostic (8.31e-3)" "unprognostic (2.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.11e-1)" "unprognostic (9.25e-3)" "unprognostic (9.48e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (3.02e-2)" 8.6 16.0 4.8 7.1 9.3 0.8 8.5 20.9 10.8 12.8 8.6 6.0 6.6 2.6 10.8 8.1 8.2 10.4 12.2 4.5 6.3 12.6 5.2 2.2 8.6 4.9 14.1 4.5 15.6 19.0 0.7 2.3 6.1 13.0 9.8 4.0 10.7 4.3 6.9 3.7 8.6 5.6 11.5 9.1 8.0 5.7 12.1 6.5 3.1 37.5 5.7 4.9 10.6 21.0 1.5 1.3 0.1 0.9 6.2 1.7 0.4 0.0 2.1 12.5 9.5 15.1 12.6 0.1 5.2 13.9 2.6 6.8 0.0 0.8 4.4 1.1 8.2 3.8 8.8 4.4 5.2 5.8 6.6 0.1 7.0 0.1 5.6 0.2 1.9 6.5 10.0 6.7 12.6 0.1 0.0 0.0 2.0 5.4 0.0 0.0 7.2 2.8 2.0 1.7 5.0 0.1 9.9 6.4 0.0 17.6 4.3 3.3 3.2 0.2 0.2 7.5 0.9 1.7 4.7 0.0 0.0 0.0 8.4 3.5 4.2 0.0 0.2 0.0 1.7 0.7 1.4 0.8 1.3 1.5 1.1 1.5 0.1 0.7 0.1 6.2 0.9 1.3 0.4 0.4 4.8 9.3 20.9 7.4 6.3 12.6 14.1 4.5 13.0 6.5 VAMP1 "SYB1, VAMP-1" ENSG00000139190 "Vesicle associated membrane protein 1" P23763 12 6462237-6470987 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.7;brain: 85.2" "Cell line enriched" "Detected in many" 6 "U-698: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002779, CAB016119, CAB079000" Approved Supported "CAB002779: , CAB016119: AB_628309, CAB079000: " "unprognostic (2.33e-1)" "unprognostic (6.72e-3)" "prognostic unfavourable (6.37e-5)" "unprognostic (8.09e-3)" "unprognostic (2.17e-1)" "unprognostic (1.14e-3)" "prognostic unfavourable (6.97e-4)" "unprognostic (1.22e-2)" "unprognostic (6.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.40e-3)" "unprognostic (3.48e-2)" "prognostic unfavourable (1.04e-11)" "unprognostic (1.47e-2)" "unprognostic (5.99e-2)" "unprognostic (1.62e-1)" "unprognostic (3.65e-2)" 3.4 6.8 10.2 13.7 12.8 38.7 4.2 9.8 53.1 5.7 8.0 11.1 1.6 4.7 8.7 5.4 3.9 5.1 5.2 4.0 14.1 25.4 3.2 4.3 5.3 24.3 33.5 10.0 3.8 2.4 1.1 3.1 2.4 85.2 8.6 8.8 4.8 6.3 7.6 4.0 4.2 7.9 7.7 31.3 12.4 5.4 3.7 8.3 3.7 7.9 0.8 23.0 5.0 4.7 5.5 2.5 13.4 1.0 2.1 7.0 2.5 0.9 3.4 1.8 2.6 5.6 6.4 2.2 1.8 3.4 1.9 5.4 1.1 3.1 9.7 0.4 4.4 2.9 2.3 1.0 2.8 7.6 5.4 1.5 10.2 1.2 2.6 3.7 3.7 4.7 0.4 2.4 1.4 1.7 0.5 2.8 4.2 1.0 4.9 4.3 9.2 1.5 5.4 3.0 1.8 1.2 1.3 0.4 0.8 3.7 1.9 1.4 0.6 1.4 2.0 0.8 2.9 1.9 1.2 2.5 1.0 66.4 3.5 7.8 0.7 6.9 1.0 13.4 6.7 0.4 5.3 5.5 5.5 6.2 1.1 1.3 5.8 4.8 5.5 2.1 0.5 2.5 7.0 2.5 10.2 12.8 9.8 53.1 14.1 25.4 33.5 10.0 85.2 8.3 VAMP2 "SYB2, VAMP-2" ENSG00000220205 "Vesicle associated membrane protein 2" P63027 17 8159149-8163546 "FDA approved drug targets, Predicted membrane proteins, Transporters" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 168.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" CAB078785 Supported "CAB078785: " "unprognostic (8.25e-2)" "unprognostic (4.41e-2)" "unprognostic (1.58e-2)" "prognostic favourable (1.08e-4)" "unprognostic (2.81e-2)" "unprognostic (1.15e-1)" "unprognostic (1.43e-2)" "unprognostic (7.28e-2)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "prognostic favourable (3.83e-6)" "unprognostic (8.27e-2)" "prognostic favourable (9.76e-8)" "unprognostic (1.21e-2)" "unprognostic (7.00e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" 22.0 38.3 65.1 16.2 111.7 57.4 20.2 72.2 168.0 20.1 16.3 51.6 11.6 15.7 27.4 24.1 11.6 26.8 14.4 22.1 61.7 56.5 23.5 11.4 21.0 23.1 52.7 71.1 48.4 22.6 52.2 40.6 15.4 88.4 25.1 19.3 37.5 19.5 27.0 33.6 25.0 17.9 25.2 30.7 27.2 17.4 15.1 35.1 9.2 22.0 8.8 22.8 11.7 16.0 25.1 15.4 37.8 8.8 25.1 33.4 9.3 14.1 10.6 26.5 14.1 23.2 18.2 11.9 13.3 16.9 13.6 18.8 4.2 9.7 16.2 9.5 21.3 17.3 17.3 14.3 15.8 18.7 18.9 11.3 27.3 5.8 20.9 7.5 17.5 20.1 21.6 15.6 23.6 13.2 8.7 18.9 23.0 7.5 19.6 10.4 6.1 7.8 24.9 12.0 12.7 17.6 9.6 12.3 19.6 10.4 5.9 13.0 13.3 9.7 20.2 8.3 11.5 15.1 12.3 20.7 11.7 11.7 21.1 13.1 18.8 13.7 7.4 24.5 28.4 6.9 24.4 25.1 28.2 30.0 5.7 22.1 33.4 30.8 37.8 25.1 8.8 15.4 20.1 9.3 65.1 111.7 72.2 168.0 61.7 56.5 52.7 71.1 88.4 35.1 VAMP4 ENSG00000117533 "Vesicle associated membrane protein 4" O75379 1 171700160-171742247 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050418 Enhanced Approved "Golgi apparatus" "Golgi apparatus" "HPA050418: " "unprognostic (9.38e-2)" "unprognostic (7.09e-2)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (9.66e-2)" "unprognostic (6.97e-2)" "unprognostic (1.05e-2)" "unprognostic (3.69e-3)" "unprognostic (5.10e-2)" "unprognostic (3.14e-2)" "unprognostic (2.87e-1)" "unprognostic (4.80e-2)" "prognostic unfavourable (5.43e-6)" "unprognostic (8.92e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-2)" "unprognostic (1.15e-1)" 16.0 20.1 14.3 13.0 25.3 7.3 14.1 24.3 22.9 13.2 12.3 12.7 15.6 12.3 13.9 14.4 13.8 10.9 13.2 12.1 16.1 16.1 13.1 13.0 16.3 16.0 16.0 21.6 11.7 15.7 19.8 30.3 16.0 26.8 12.2 11.6 17.2 15.5 20.6 9.0 15.4 12.1 12.9 20.6 14.9 13.3 18.3 15.3 13.2 18.5 7.5 13.0 14.2 13.7 9.5 7.3 12.8 10.4 10.4 14.6 10.8 6.6 2.2 6.1 4.9 9.1 10.8 3.9 12.3 9.8 3.1 3.8 1.9 9.0 4.2 11.1 9.9 4.5 2.4 4.1 4.4 7.6 3.5 3.6 3.0 1.5 5.6 3.1 2.8 4.9 7.3 3.8 7.2 5.6 8.7 5.3 6.6 2.2 7.3 4.3 2.9 8.6 6.2 4.7 11.0 6.4 2.2 3.7 7.1 6.2 6.6 5.2 8.9 5.9 6.5 9.7 3.2 13.7 11.7 19.2 16.0 5.8 14.9 2.8 7.7 10.0 10.4 12.8 10.5 8.4 14.6 9.5 14.2 12.0 4.9 7.6 10.2 10.9 3.8 10.4 8.3 7.3 12.4 10.8 14.3 25.3 24.3 22.6 16.1 16.1 16.0 21.6 26.8 15.3 VAMP5 ENSG00000168899 "Vesicle associated membrane protein 5" O95183 2 85584408-85593412 "Predicted membrane proteins" "Differentiation, Myogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 33.7;HUVEC TERT2: 63.0;LHCN-M2: 74.0;TIME: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035082 Supported Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA035082: AB_10610564" "unprognostic (1.92e-1)" "unprognostic (3.09e-2)" "unprognostic (6.09e-2)" "unprognostic (1.13e-2)" "unprognostic (4.16e-2)" "unprognostic (1.25e-3)" "unprognostic (1.28e-2)" "unprognostic (5.29e-2)" "unprognostic (1.17e-2)" "unprognostic (3.49e-2)" "unprognostic (2.22e-1)" "unprognostic (7.59e-2)" "prognostic unfavourable (1.28e-5)" "unprognostic (9.61e-3)" "unprognostic (3.46e-2)" "unprognostic (1.71e-2)" "unprognostic (2.60e-1)" 26.2 25.8 12.6 18.9 14.1 11.7 27.5 4.3 9.2 17.9 22.1 8.5 9.2 7.6 18.9 27.2 24.3 18.3 18.8 37.0 11.0 10.9 18.5 31.2 28.8 32.1 16.8 9.6 19.6 6.3 3.2 7.2 24.4 17.7 29.0 6.9 16.0 7.7 13.0 70.9 9.5 17.0 25.5 14.1 33.3 12.3 13.7 8.1 18.0 17.5 19.8 13.0 21.8 25.8 10.2 13.8 27.5 80.4 14.3 39.4 39.3 0.1 0.0 0.4 0.0 16.0 28.1 0.4 17.0 27.0 16.7 18.5 6.7 2.6 0.0 0.4 29.4 0.1 0.0 0.4 7.4 24.0 0.5 0.3 0.4 9.3 33.7 0.7 0.1 19.4 1.6 7.0 0.2 63.0 0.0 0.0 74.0 2.4 10.4 2.3 0.0 0.1 15.6 0.0 0.4 0.4 0.6 0.0 0.6 0.1 4.8 0.1 0.5 0.8 43.0 0.4 1.2 1.3 0.0 0.0 0.5 0.4 19.7 0.9 11.4 8.2 38.1 27.5 31.7 80.4 29.8 9.7 24.1 23.5 12.8 10.2 18.5 22.3 11.8 14.3 64.4 13.8 39.4 39.3 12.6 14.1 4.3 9.2 11.0 10.9 16.8 9.6 17.7 8.1 VAMP7 "SYBL1, TI-VAMP, VAMP-7" ENSG00000124333 "Vesicle associated membrane protein 7" P51809 X 155881293-155943769 "Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036733 Approved Supported Vesicles 14000 Vesicles "HPA036733: AB_10672228" "unprognostic (7.54e-3)" "unprognostic (1.35e-2)" "unprognostic (2.07e-1)" "unprognostic (1.04e-1)" "unprognostic (6.15e-3)" "unprognostic (2.70e-2)" "unprognostic (5.77e-2)" "unprognostic (7.95e-2)" "unprognostic (7.18e-2)" "unprognostic (3.38e-3)" "unprognostic (1.02e-1)" "unprognostic (1.15e-1)" "prognostic favourable (2.83e-4)" "unprognostic (1.29e-1)" "unprognostic (3.42e-1)" "unprognostic (2.47e-1)" "unprognostic (2.97e-1)" 11.9 12.7 43.9 9.5 51.2 13.4 51.9 21.2 41.1 38.4 9.3 2.5 2.5 9.6 36.5 6.6 10.4 8.5 9.3 26.9 46.8 12.5 61.4 20.5 10.3 9.8 50.6 44.8 34.5 7.9 12.8 35.0 68.7 58.5 9.4 10.5 2.5 8.3 9.0 12.0 9.3 11.3 12.0 63.0 8.4 8.4 5.6 47.6 2.5 10.4 2.5 11.6 10.2 26.1 6.6 13.5 34.8 13.8 11.2 11.0 10.6 21.9 9.6 6.6 13.7 18.4 17.7 17.8 17.1 15.3 15.5 31.5 10.3 14.4 30.6 31.9 20.5 7.9 14.8 12.0 20.6 12.7 13.0 12.7 14.3 7.3 20.6 26.0 19.9 16.4 12.0 17.3 15.9 17.2 27.1 17.0 17.5 11.0 10.1 14.8 4.7 14.1 7.7 13.0 22.7 20.6 11.1 5.0 14.6 10.1 10.2 15.0 10.0 21.9 18.1 14.3 14.9 20.5 24.2 39.2 49.5 42.9 12.5 31.9 15.9 34.8 12.9 19.7 8.3 13.8 10.5 6.5 9.9 10.2 13.5 6.6 9.2 9.8 11.2 11.2 12.8 7.7 11.0 10.6 43.9 51.2 21.2 41.1 46.8 12.5 50.6 44.8 58.5 47.6 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 172.5" "Cell line enhanced" "Detected in many" "HL-60: 80.6;NB-4: 125.9;U-937: 83.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Supported "Nucleoplasm,Golgi apparatus" 210000 "Nucleoplasm, Golgi apparatus" "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favourable (8.07e-9)" "prognostic favourable (1.59e-6)" 16.5 8.2 7.1 20.7 11.2 27.6 24.2 1.9 6.2 16.3 49.4 5.7 43.5 24.1 6.0 25.5 65.4 17.1 28.8 13.0 4.7 3.8 67.7 46.5 53.1 48.0 10.5 3.2 7.1 58.0 15.4 8.3 108.1 11.9 22.1 31.9 7.7 90.7 40.4 9.0 43.3 87.1 6.8 10.4 53.5 28.7 5.5 8.4 24.5 47.5 35.4 34.9 20.6 30.4 39.2 172.5 37.7 69.7 41.4 51.3 100.9 23.4 3.0 0.2 0.2 0.2 0.1 23.5 0.0 0.0 0.0 0.0 17.5 21.6 5.2 17.1 0.1 16.7 0.2 42.1 0.0 21.4 16.3 27.1 10.4 19.8 0.3 80.6 28.1 0.2 29.9 0.0 7.0 5.4 19.3 1.1 9.6 33.0 0.0 125.9 0.3 2.5 0.5 0.8 35.4 48.8 35.4 0.8 0.3 11.5 61.0 1.8 22.3 62.6 10.8 0.0 1.5 0.3 0.2 0.3 13.2 30.8 0.3 83.6 0.1 37.7 69.7 25.2 40.4 57.7 38.8 39.2 46.8 39.5 63.5 37.8 37.3 39.1 4.5 41.4 34.3 172.5 51.3 100.9 7.1 11.2 1.9 6.2 4.7 3.8 10.5 3.2 11.9 8.4 VAPA "hVAP-33, VAP-A" ENSG00000101558 "VAMP associated protein A" Q9P0L0 18 9914002-9960021 "Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009174 Approved Enhanced "Endoplasmic reticulum" 5300000 "Endoplasmic reticulum" "HPA009174: AB_1080549" "unprognostic (4.03e-2)" "unprognostic (7.47e-2)" "unprognostic (9.36e-2)" "unprognostic (5.20e-2)" "unprognostic (2.00e-1)" "unprognostic (2.99e-2)" "unprognostic (4.79e-3)" "unprognostic (1.80e-1)" "unprognostic (5.39e-2)" "unprognostic (6.80e-3)" "unprognostic (2.99e-2)" "unprognostic (8.11e-2)" "prognostic favourable (5.72e-7)" "unprognostic (1.03e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-1)" "unprognostic (5.77e-2)" 27.5 64.8 28.8 21.0 35.5 73.5 27.4 32.9 39.4 24.9 34.3 30.7 19.3 27.8 30.8 23.8 42.3 27.9 29.4 39.9 28.0 30.2 32.7 33.2 35.1 24.6 33.4 28.8 40.6 36.5 25.0 19.4 35.2 48.1 25.2 32.7 18.0 27.9 21.8 55.4 27.6 32.3 28.5 39.1 27.7 34.0 25.2 28.8 36.3 36.4 28.3 22.9 36.0 30.2 24.5 30.6 62.5 37.3 22.2 24.6 39.7 18.5 11.3 13.7 8.9 16.1 17.5 19.1 23.1 19.2 21.0 23.1 15.1 18.5 18.3 21.6 20.1 13.0 13.2 22.0 24.1 11.3 16.6 29.9 12.1 23.3 38.3 40.3 57.3 16.4 22.3 19.9 23.7 21.2 30.0 19.2 18.4 10.0 30.9 23.4 8.8 18.0 16.2 18.6 24.8 20.5 18.8 19.3 10.5 26.7 16.3 16.6 15.2 20.9 22.6 34.3 25.5 35.5 28.0 34.4 27.9 21.9 19.4 17.4 23.5 26.1 37.3 62.5 19.3 32.4 22.7 24.5 20.3 20.7 30.6 22.7 22.2 20.4 59.2 22.2 26.4 21.8 24.6 39.7 28.8 35.5 32.9 39.4 28.0 30.2 33.4 28.8 48.1 28.8 VAPB "ALS8, VAP-B, VAP-C" ENSG00000124164 "VAMP associated protein B and C" O95292 20 58389122-58451101 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Unfolded protein response" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013144, CAB013722" Supported Enhanced "Endoplasmic reticulum" 220000 "Endoplasmic reticulum" "CAB013722: , HPA013144: AB_1858717" "unprognostic (3.28e-3)" "unprognostic (3.88e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (9.36e-2)" "unprognostic (3.15e-2)" "unprognostic (4.76e-3)" "unprognostic (2.80e-1)" "unprognostic (4.47e-2)" "unprognostic (8.06e-3)" "unprognostic (3.11e-2)" "unprognostic (2.99e-1)" "prognostic favourable (1.08e-8)" "unprognostic (1.05e-1)" "unprognostic (5.31e-1)" "unprognostic (6.34e-3)" "unprognostic (2.99e-2)" 17.4 31.1 21.8 12.6 24.3 4.8 13.2 16.5 31.8 11.7 16.1 17.0 13.3 22.5 13.0 13.1 14.8 13.7 12.7 24.5 21.4 22.1 21.8 23.5 13.6 10.4 23.2 25.1 17.7 15.5 28.5 16.3 11.1 31.6 15.0 12.1 11.4 17.9 15.7 46.8 15.3 20.6 15.2 24.9 11.4 14.7 9.4 15.8 6.7 26.7 18.8 9.4 11.6 18.5 5.6 4.3 6.8 5.2 6.6 9.5 4.6 10.7 10.8 12.2 6.5 11.3 4.7 10.8 9.7 4.0 15.0 7.4 43.6 10.4 9.5 13.9 6.5 20.6 9.7 13.9 9.0 4.4 7.3 5.7 12.0 13.7 11.3 5.4 7.3 10.7 16.2 8.3 6.9 7.4 13.5 5.4 7.2 33.9 8.4 10.7 6.4 14.4 8.4 11.4 6.2 11.4 14.5 17.2 11.9 16.0 42.6 16.6 17.4 8.1 10.2 24.3 11.8 12.1 12.9 7.3 7.8 11.0 20.5 5.9 12.2 3.9 4.4 5.2 7.8 4.4 9.1 5.6 9.0 6.2 4.3 4.7 6.7 9.5 6.8 6.6 5.2 4.3 5.0 4.6 21.8 24.3 16.5 31.8 21.4 22.1 23.2 25.1 31.6 15.8 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383528 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in many" 12 "U-2197: 123.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" 2400000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: " "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavourable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 22.4 10.2 4.9 7.7 6.7 3.8 28.6 1.6 6.5 19.9 5.1 5.6 6.4 5.1 14.3 13.6 16.2 9.9 10.2 12.9 4.4 1.8 21.6 14.1 17.2 5.2 2.7 2.9 21.0 9.8 1.7 5.9 30.2 4.8 12.9 2.0 33.6 7.9 13.1 7.0 16.0 4.0 9.4 3.6 7.9 6.5 14.7 3.5 0.0 15.2 5.5 8.2 16.6 19.0 0.3 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 2.7 3.1 1.1 5.2 5.1 1.6 2.6 0.3 0.5 0.0 1.9 3.4 0.0 0.0 0.1 0.2 1.1 0.1 0.1 1.4 1.6 9.9 0.0 0.0 3.2 0.0 3.9 0.1 0.0 0.2 0.0 0.2 1.8 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.1 0.9 2.4 4.1 0.0 0.9 0.2 0.0 4.8 1.2 123.8 0.6 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 6.7 1.6 6.5 4.4 1.8 2.7 2.9 4.8 3.5 VCAM1 CD106 ENSG00000162692 "Vascular cell adhesion molecule 1" P19320 1 100719742-100739045 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "kidney: 69.6;lymphoid tissue: 129.2" "Group enriched" "Detected in some" 5 "HHSteC: 56.9;HSkMC: 38.0" "Cancer enriched" "Detected in all" 8 "renal cancer: 89.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "gdT-cell: 1.3;memory CD8 T-cell: 2.9;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 17 "T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000154, HPA034796, HPA069867" Enhanced Approved "Cell Junctions" 960000000 "Cell Junctions" "CAB000154: , HPA034796: , HPA069867: " "unprognostic (2.96e-1)" "prognostic favourable (3.82e-4)" "unprognostic (1.31e-1)" "unprognostic (7.49e-3)" "unprognostic (1.04e-1)" "prognostic favourable (7.19e-5)" "unprognostic (1.60e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (3.95e-2)" "unprognostic (8.23e-2)" "unprognostic (1.80e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.55e-2)" 10.9 18.1 1.5 20.2 3.2 1.3 5.2 0.9 1.1 3.7 5.0 3.3 1.4 3.3 4.9 4.5 5.3 4.9 6.8 7.2 1.7 2.3 69.6 11.8 9.8 26.8 2.8 1.7 11.1 6.6 10.6 3.5 10.9 4.2 8.3 5.5 15.3 4.9 1.1 4.7 1.8 6.3 4.2 3.7 129.2 3.0 2.5 1.6 13.3 3.5 2.8 20.9 8.2 2.8 0.0 0.1 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.2 0.1 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 8.2 0.0 0.0 0.0 0.0 56.9 0.0 0.0 38.0 0.0 10.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 2.9 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 3.2 0.9 1.1 1.7 2.3 2.8 1.7 4.2 1.6 VEZT DKFZP761C241 ENSG00000028203 "Vezatin, adherens junctions transmembrane protein" Q9HBM0 12 95217746-95302790 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004811, HPA017066" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA004811: AB_1080563, HPA017066: AB_1858742" "unprognostic (3.91e-1)" "unprognostic (6.34e-3)" "unprognostic (3.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.47e-1)" "unprognostic (1.31e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (2.28e-1)" "unprognostic (9.93e-2)" "unprognostic (4.18e-1)" "unprognostic (1.10e-3)" "unprognostic (3.37e-3)" "prognostic unfavourable (1.93e-5)" "prognostic unfavourable (3.68e-4)" "unprognostic (1.51e-1)" "unprognostic (4.06e-1)" "unprognostic (5.02e-2)" 12.3 21.4 15.4 14.3 17.2 5.1 14.6 28.3 27.2 12.9 14.4 9.1 19.0 9.5 17.1 15.9 15.6 11.5 12.1 14.7 11.8 9.5 12.1 10.4 13.8 9.6 11.0 14.0 13.3 12.6 15.7 20.4 19.6 11.4 15.8 10.6 10.3 10.9 13.9 42.7 16.1 11.0 16.2 12.5 7.2 10.7 7.2 12.2 13.6 29.8 14.5 10.0 15.7 12.2 5.2 4.4 1.1 3.5 2.4 5.0 1.2 10.4 9.7 13.4 7.2 10.3 7.3 5.2 7.7 9.6 6.1 9.8 3.5 4.9 13.5 5.0 6.6 5.4 9.5 6.7 11.4 9.1 5.3 5.2 2.5 3.7 5.6 10.2 3.0 9.3 11.7 5.8 16.6 12.8 3.0 5.3 5.5 2.8 8.8 4.8 6.8 9.8 8.0 6.3 4.4 17.8 7.6 9.1 7.9 7.4 11.1 3.5 13.8 1.7 10.3 5.6 2.1 2.4 4.2 5.2 7.8 11.5 2.1 3.7 2.8 0.5 3.1 1.1 3.6 3.5 4.7 5.2 5.0 2.1 4.4 3.6 2.4 2.0 0.3 2.4 0.9 1.8 3.5 1.2 15.4 17.2 28.3 18.8 11.8 9.5 11.0 14.0 11.4 12.2 VIPR1 "HVR1, RDC1, VPAC1, VPAC1R" ENSG00000114812 "Vasoactive intestinal peptide receptor 1" P32241 3 42489299-42537573 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 83.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 27.2;RT4: 19.4;SK-BR-3: 11.1;WM-115: 35.3" "Cancer enhanced" "Detected in many" "prostate cancer: 10.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.2;intermediate monocyte: 2.6;MAIT T-cell: 1.9;memory CD4 T-cell: 4.8;memory CD8 T-cell: 1.9;myeloid DC: 3.9;naive CD4 T-cell: 5.5;naive CD8 T-cell: 1.7;non-classical monocyte: 2.3" "Group enriched" "Detected in many" 32 "dendritic cells: 3.9;monocytes: 3.2;T-cells: 5.5" "Group enriched" "Detected in many" 5 "amygdala: 6.5;basal ganglia: 4.1;cerebral cortex: 9.2;hippocampal formation: 8.5" "Low region specificity" "Detected in all" HPA026777 Approved "HPA026777: AB_10604003" "unprognostic (9.02e-2)" "unprognostic (9.34e-3)" "unprognostic (3.70e-1)" "unprognostic (1.57e-1)" "unprognostic (1.28e-1)" "unprognostic (1.47e-2)" "unprognostic (8.89e-4)" "unprognostic (4.00e-3)" "unprognostic (1.03e-1)" "unprognostic (2.95e-2)" "unprognostic (1.28e-2)" "unprognostic (2.72e-1)" "unprognostic (1.82e-3)" "unprognostic (7.70e-2)" "unprognostic (1.69e-1)" "unprognostic (1.03e-2)" "unprognostic (1.05e-2)" 8.1 1.8 5.6 6.4 11.8 1.3 7.4 10.2 13.8 2.0 17.7 0.6 27.8 22.0 0.9 4.6 2.7 1.0 10.6 3.1 2.9 1.2 1.4 15.4 83.1 5.1 1.3 8.4 0.5 1.4 2.9 1.2 1.9 1.9 13.0 18.1 2.2 9.7 29.0 0.8 12.2 25.9 1.3 0.9 2.7 3.7 0.9 1.3 0.0 7.2 3.2 3.1 6.0 2.4 0.1 3.9 0.1 3.2 0.0 5.5 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.9 27.2 0.1 1.3 0.0 1.1 0.0 0.7 0.0 0.0 2.1 1.6 0.8 0.0 0.1 0.0 0.2 0.0 1.7 0.1 0.5 0.3 0.0 0.0 0.0 2.2 0.0 0.1 1.7 0.1 0.2 0.0 1.2 0.0 19.4 0.6 0.0 0.0 11.1 0.0 6.8 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 3.2 0.0 0.4 2.6 1.9 0.1 4.8 1.9 3.9 0.0 5.5 1.7 0.1 0.0 2.3 0.0 0.7 1.3 5.6 11.8 10.2 13.8 2.9 1.2 1.3 8.4 1.9 1.3 VKORC1 VKCFD2 ENSG00000167397 "Vitamin K epoxide reductase complex subunit 1" Q9BQB6 16 31090842-31095980 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 173.3" "Cell line enhanced" "Detected in all" "ASC diff: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042720 Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "HPA042720: AB_10961864" "unprognostic (5.99e-2)" "unprognostic (2.98e-1)" "unprognostic (7.11e-3)" "unprognostic (7.68e-3)" "unprognostic (5.49e-2)" "unprognostic (3.23e-3)" "unprognostic (3.02e-2)" "unprognostic (2.32e-2)" "unprognostic (2.42e-1)" "unprognostic (2.66e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-1)" "prognostic unfavourable (2.09e-10)" "unprognostic (1.11e-2)" "unprognostic (6.65e-2)" "unprognostic (3.12e-2)" "unprognostic (9.66e-2)" 21.3 23.0 9.3 11.5 11.0 12.9 28.1 9.4 14.5 24.3 19.3 17.1 16.5 12.6 24.0 27.4 18.5 17.8 22.6 20.1 9.8 10.2 29.9 173.3 16.4 17.5 13.7 9.1 25.5 55.5 14.0 25.0 22.5 13.3 22.3 12.6 20.8 34.8 21.4 11.4 15.9 26.8 27.7 12.5 15.4 17.5 18.2 10.6 15.8 25.6 13.8 14.6 28.4 18.7 32.3 49.9 59.6 40.6 24.7 43.7 33.6 10.4 26.9 8.9 25.3 98.2 58.5 9.9 38.9 33.8 19.1 32.6 11.2 12.1 8.2 21.0 48.6 9.7 12.2 15.2 21.8 11.6 29.7 7.5 37.3 53.6 15.5 14.5 11.3 33.8 8.2 26.4 22.7 20.7 9.8 19.6 37.4 37.9 10.6 29.8 16.0 25.9 19.3 23.5 40.9 18.9 9.2 18.1 21.9 17.0 12.4 18.8 20.4 17.7 18.0 25.7 9.2 23.6 14.6 11.9 11.0 7.2 66.9 25.1 13.2 21.5 40.6 59.6 40.3 28.1 39.7 29.9 40.5 40.7 39.6 32.3 36.4 35.4 34.2 24.7 28.3 49.9 43.7 33.6 9.3 11.0 9.4 14.5 9.8 10.2 13.7 9.1 13.3 10.6 VLDLR "CARMQ1, CHRMQ1, VLDLRCH" ENSG00000147852 "Very low density lipoprotein receptor" P98155 9 2621834-2660053 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Receptor "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 50.5" "Cell line enhanced" "Detected in many" "BEWO: 27.6;THP-1: 28.3;U-87 MG: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "eosinophil: 14.1" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032462, HPA051312" Uncertain Approved "Vesicles,Cytokinetic bridge,Centriolar satellite" 180000 "Vesicles, Cytokinetic bridge, Centriolar satellite" "CAB032462: AB_2216805, HPA051312: " "unprognostic (5.31e-2)" "unprognostic (2.65e-1)" "unprognostic (6.92e-2)" "prognostic favourable (5.95e-4)" "unprognostic (1.15e-1)" "unprognostic (2.67e-2)" "unprognostic (2.48e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-2)" "unprognostic (3.79e-2)" "unprognostic (2.33e-1)" "unprognostic (6.75e-2)" "unprognostic (1.48e-2)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (4.34e-2)" 11.3 13.7 7.2 3.7 9.6 1.3 11.2 8.7 7.3 6.9 3.9 12.8 6.5 1.2 12.1 4.3 11.6 15.1 5.5 38.0 7.6 4.5 8.8 2.5 6.9 0.9 13.2 5.3 50.5 20.8 43.6 5.9 9.4 7.7 5.7 2.9 12.3 7.5 4.4 21.2 3.4 1.6 15.7 10.1 5.5 5.8 5.6 10.3 0.0 8.8 12.5 3.9 11.9 6.1 0.1 0.8 14.1 0.1 0.1 1.1 0.0 0.0 3.0 19.1 0.9 2.8 0.2 27.6 8.6 2.8 2.3 6.6 4.8 0.3 0.0 9.3 5.3 0.2 5.3 5.8 7.4 10.1 2.0 0.1 2.5 2.2 3.1 12.0 2.1 1.2 4.2 0.8 0.4 1.1 0.0 16.9 1.3 0.8 2.2 1.6 9.6 1.2 0.2 0.6 0.0 11.0 1.2 4.3 3.0 0.6 1.0 11.9 0.5 28.3 0.3 3.1 5.9 0.0 5.7 12.9 5.2 3.0 20.5 10.0 1.2 0.1 0.1 14.1 0.2 0.0 1.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 2.0 0.1 0.0 0.8 0.0 0.0 7.2 9.6 8.7 7.3 7.6 4.5 13.2 5.3 7.7 10.3 VMP1 "EPG3, TANGO5, TMEM49" ENSG00000062716 "Vacuole membrane protein 1" Q96GC9 17 59707192-59842255 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "blood: 193.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 193.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 193.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030773, HPA064780" Approved Approved "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "HPA030773: AB_10602248, HPA064780: " "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (4.09e-2)" "prognostic unfavourable (1.56e-5)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "prognostic unfavourable (8.02e-4)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" "unprognostic (2.98e-1)" "unprognostic (8.43e-2)" "unprognostic (4.21e-2)" "prognostic unfavourable (2.77e-8)" "unprognostic (1.88e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-3)" 22.0 37.8 20.4 21.9 24.9 13.0 18.6 20.0 28.7 18.2 32.0 27.8 16.7 40.5 18.3 15.4 22.9 14.4 25.2 19.6 21.7 22.3 22.9 43.0 22.4 20.1 23.1 15.6 16.5 22.9 19.0 20.1 27.9 29.8 17.3 29.3 20.0 17.8 13.9 19.8 19.2 39.7 14.3 26.4 36.6 19.0 17.6 16.2 14.4 18.1 12.5 16.8 19.5 17.6 3.3 10.9 193.2 39.9 3.8 4.1 24.7 20.4 41.2 13.4 20.7 28.7 17.7 21.6 32.6 23.3 20.4 27.4 27.0 29.5 11.8 48.8 22.0 25.5 15.5 18.7 25.4 30.2 19.5 15.1 23.6 28.4 28.0 17.1 18.6 27.0 16.0 26.2 22.3 21.6 19.8 20.9 21.0 56.4 15.9 9.0 15.1 21.3 8.8 23.5 24.3 25.2 23.9 9.6 21.9 18.6 15.8 21.6 32.8 14.7 30.4 27.4 26.2 21.7 26.9 32.4 37.2 16.4 30.2 10.5 27.6 7.0 35.1 4.4 3.8 24.4 4.0 3.3 3.7 4.0 10.9 2.8 3.5 3.8 193.2 3.8 39.9 3.6 4.1 24.7 20.4 24.9 20.0 28.7 21.7 22.3 23.1 15.6 29.8 16.2 VPS35L "C16orf62, MGC16824" ENSG00000103544 "VPS35 endosomal protein sorting factor like" Q7Z3J2 16 19555240-19706793 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042969, HPA053547" Uncertain Approved Mitochondria Mitochondria "HPA042969: AB_10794920, HPA053547: " "unprognostic (7.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.17e-1)" "unprognostic (7.20e-2)" "unprognostic (1.51e-1)" "unprognostic (2.67e-1)" "unprognostic (1.15e-1)" "unprognostic (2.74e-1)" "unprognostic (2.52e-1)" "unprognostic (1.22e-3)" "unprognostic (3.57e-2)" "unprognostic (2.06e-1)" "prognostic favourable (1.31e-8)" "unprognostic (1.82e-3)" "unprognostic (8.92e-2)" "unprognostic (5.08e-2)" "unprognostic (1.13e-2)" 19.1 22.5 21.3 13.5 28.6 10.6 15.3 20.1 35.0 21.4 16.5 44.4 9.9 12.5 27.9 21.4 16.1 18.6 16.4 16.1 21.8 21.1 20.7 15.9 14.7 13.9 23.5 14.0 22.7 14.3 37.9 24.6 18.7 28.8 15.4 18.4 22.6 15.4 18.6 18.2 12.5 13.5 23.8 23.9 25.5 12.6 26.1 21.6 16.0 21.5 9.3 15.3 17.2 14.5 11.7 25.5 12.6 23.8 21.9 14.7 15.6 9.0 16.1 15.0 12.0 19.3 27.1 2.3 13.4 22.4 14.7 17.0 2.3 15.8 11.0 29.2 22.1 2.5 11.8 7.1 16.2 0.6 6.5 6.4 14.5 0.2 25.7 10.4 13.5 19.4 10.3 13.5 8.7 23.4 8.8 2.6 23.9 6.4 9.1 2.7 9.7 2.0 7.8 4.8 2.7 16.2 2.0 9.3 9.4 16.5 0.5 7.4 5.5 9.1 24.3 7.5 7.1 10.5 1.4 10.1 17.9 4.1 14.7 8.5 11.9 12.6 21.1 9.4 11.9 23.8 14.7 9.2 11.5 11.7 25.5 11.7 13.4 11.9 2.5 21.9 20.8 6.7 12.0 15.6 21.3 28.6 20.1 35.0 21.8 21.1 23.5 14.0 28.8 21.6 VRK1 ENSG00000100749 "Vaccinia related kinase 1" Q99986 14 96797304-96931722 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000660, HPA017929" Enhanced Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA000660: AB_1080579, HPA017929: AB_1858770" "unprognostic (1.03e-1)" "unprognostic (1.17e-2)" "unprognostic (1.84e-2)" "unprognostic (2.24e-3)" "unprognostic (5.42e-2)" "unprognostic (1.19e-2)" "prognostic unfavourable (4.15e-4)" "unprognostic (4.20e-2)" "unprognostic (2.11e-2)" "unprognostic (5.47e-2)" "unprognostic (5.14e-2)" "unprognostic (1.60e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (4.56e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-1)" 6.0 4.4 7.1 9.8 17.1 39.0 8.7 8.6 10.2 6.1 7.8 4.4 4.1 5.2 5.9 5.7 9.4 6.9 3.3 6.0 7.4 6.5 6.2 4.3 4.5 18.3 6.9 6.1 5.9 3.7 3.8 5.1 7.1 6.7 5.3 9.1 4.1 4.8 4.1 4.3 6.4 6.9 5.4 6.1 15.7 6.7 33.3 6.9 33.0 4.9 6.1 18.4 5.9 5.7 20.8 13.5 20.1 9.5 28.5 22.3 12.5 15.7 9.1 22.5 10.0 2.7 5.0 14.0 11.9 9.3 19.1 19.0 10.8 15.6 40.1 8.1 7.0 17.5 21.0 15.5 26.3 22.8 11.3 25.0 6.0 11.1 2.9 48.0 15.7 2.7 2.8 14.4 10.6 13.2 21.2 25.4 16.4 18.0 38.1 20.7 14.4 17.3 35.7 39.4 13.6 8.7 16.2 15.9 9.0 10.5 10.8 8.0 12.3 19.0 7.1 8.7 7.8 15.0 11.9 13.3 15.7 38.8 13.6 21.0 10.3 20.1 7.6 14.5 15.1 9.3 18.4 20.3 17.6 18.5 9.9 20.8 19.1 19.3 4.5 28.5 9.5 13.5 22.3 12.5 7.1 17.1 8.6 10.2 7.4 6.5 6.9 6.1 6.7 6.9 VRK2 ENSG00000028116 "Vaccinia related kinase 2" Q86Y07 2 57907651-58159920 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046459, HPA047503" Approved Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB046459: AB_1858773, HPA047503: " "unprognostic (1.87e-1)" "unprognostic (5.84e-2)" "unprognostic (4.65e-2)" "unprognostic (1.33e-3)" "unprognostic (1.27e-1)" "unprognostic (1.60e-2)" "prognostic unfavourable (6.32e-6)" "unprognostic (3.90e-2)" "unprognostic (4.76e-2)" "unprognostic (2.96e-2)" "prognostic unfavourable (4.65e-4)" "unprognostic (1.36e-1)" "prognostic unfavourable (4.66e-5)" "unprognostic (3.48e-1)" "unprognostic (1.62e-1)" "unprognostic (2.99e-1)" "unprognostic (3.56e-1)" 18.7 17.7 10.9 21.9 28.3 14.9 16.1 2.4 15.1 15.6 13.5 27.3 16.3 9.9 18.4 16.7 26.8 13.2 10.9 21.6 14.4 8.9 12.4 15.2 15.6 19.5 29.2 13.5 14.2 20.0 16.1 18.7 16.1 18.7 15.7 15.6 9.3 20.5 17.6 21.5 12.8 12.9 20.1 19.0 20.1 13.5 12.5 31.2 13.6 17.4 16.7 23.0 18.1 19.4 19.7 17.0 21.6 21.3 11.3 12.2 9.2 14.1 9.5 1.1 6.3 7.1 13.1 19.6 13.1 13.2 9.1 9.3 19.3 15.1 17.3 17.3 11.5 10.8 13.7 14.3 13.7 31.1 9.2 19.5 7.6 13.8 11.3 16.5 11.6 7.2 17.1 14.6 21.0 26.1 19.1 11.1 15.1 8.1 0.1 12.7 12.0 4.8 18.9 4.8 11.8 15.1 11.7 3.8 0.1 20.8 12.4 10.5 8.7 10.2 14.5 0.2 30.2 8.1 0.2 16.4 12.9 9.3 7.3 20.5 15.0 13.7 16.8 21.6 10.1 21.3 12.2 19.7 9.8 11.8 16.6 19.0 7.4 9.5 6.0 11.3 20.6 17.0 11.5 9.2 10.9 28.3 2.4 15.1 14.4 8.9 29.2 13.5 18.7 31.2 VSIG1 MGC44287 ENSG00000101842 "V-set and immunoglobulin domain containing 1" Q86XK7 X 108044970-108079184 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 29.5;stomach 1: 66.6;testis: 87.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.7;HUVEC TERT2: 11.6;PC-3: 3.9;TIME: 2.9" "Group enriched" "Detected in many" 17 "lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.7;T-reg: 11.2" "Lineage enriched" "Detected in many" 4 "T-cells: 11.7" "Not detected" "Not detected" "HPA001445, HPA036310, HPA036311" Enhanced Approved Vesicles,Cytosol "Vesicles, Cytosol" "HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350" "unprognostic (4.33e-3)" "unprognostic (4.60e-2)" "unprognostic (3.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.51e-1)" "unprognostic (4.80e-2)" "unprognostic (3.25e-2)" "unprognostic (9.79e-2)" "unprognostic (4.58e-1)" "unprognostic (2.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.25e-1)" "unprognostic (6.31e-7)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-3)" 0.1 0.0 0.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.3 0.8 0.1 0.3 0.1 0.2 0.2 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.0 1.3 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 66.6 87.4 0.1 0.1 0.1 0.1 0.4 1.5 0.1 2.6 0.1 0.6 0.1 0.2 11.7 2.5 0.2 1.0 0.0 0.2 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.5 0.0 5.7 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.3 0.4 1.0 0.1 1.9 11.6 0.1 0.3 0.0 0.4 0.4 0.3 0.4 3.9 0.3 0.0 0.0 0.7 1.0 0.2 0.1 0.2 0.2 0.6 0.1 0.0 2.9 0.3 0.9 0.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 1.0 0.0 3.7 2.6 7.7 3.3 0.0 1.0 11.7 5.4 0.4 0.2 0.1 0.1 11.2 2.5 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 VSIG10 ENSG00000176834 "V-set and immunoglobulin domain containing 10" Q8N0Z9 12 118063593-118136026 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 60.9" "Cell line enhanced" "Detected in many" "HAP1: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA062022 Enhanced Approved "Centriolar satellite,Cytosol" Cytosol "Centriolar satellite" "HPA062022: " "unprognostic (1.32e-1)" "unprognostic (7.76e-2)" "unprognostic (2.05e-1)" "unprognostic (4.62e-3)" "unprognostic (1.09e-1)" "unprognostic (6.42e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (1.09e-1)" "prognostic unfavourable (7.53e-4)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (1.75e-1)" "unprognostic (2.85e-2)" "unprognostic (1.17e-1)" "unprognostic (1.80e-2)" "unprognostic (1.48e-2)" 8.1 10.2 2.6 9.8 3.1 0.4 18.0 2.9 2.6 8.2 31.6 2.7 5.2 11.7 4.5 4.5 8.9 4.0 7.6 3.6 2.4 2.2 6.2 11.9 11.6 3.8 3.2 1.4 5.9 10.9 8.9 4.0 12.2 3.4 8.4 13.9 4.0 6.3 6.4 12.9 4.6 60.9 3.8 2.5 3.3 5.5 3.9 2.5 1.7 26.3 6.1 4.9 6.1 8.6 0.7 2.4 3.5 2.0 0.4 0.6 0.4 4.9 7.3 3.2 10.6 13.2 6.0 8.0 8.6 5.6 4.3 3.5 2.1 11.9 0.7 3.4 6.3 12.2 22.1 2.2 5.1 2.4 3.3 1.1 6.9 3.2 2.6 0.7 1.8 2.7 6.5 3.3 2.1 9.3 1.4 0.1 4.0 5.3 0.0 0.7 9.8 4.7 1.8 8.7 0.0 6.2 16.2 2.7 3.4 8.4 3.5 2.2 7.8 3.4 10.8 4.9 3.1 6.1 4.3 0.1 0.1 0.0 7.1 3.5 9.8 0.6 2.0 2.3 0.4 0.6 0.6 0.0 0.4 0.2 2.4 0.7 0.4 0.6 3.5 0.4 0.2 0.7 0.6 0.4 2.6 3.1 2.9 2.2 2.4 2.2 3.2 1.4 3.4 2.5 VSIG10L ENSG00000186806 "V-set and immunoglobulin domain containing 10 like" Q86VR7 19 51331536-51342124 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6" "Group enriched" "Detected in some" 5 "Hep G2: 7.0;T-47d: 12.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA060453, HPA066745" Uncertain Approved Nucleoplasm Nucleoplasm "HPA060453: , HPA066745: " "unprognostic (1.70e-2)" "unprognostic (1.95e-2)" "unprognostic (1.30e-2)" "unprognostic (2.98e-3)" "unprognostic (1.08e-2)" "unprognostic (3.96e-2)" "prognostic unfavourable (8.75e-4)" "unprognostic (2.40e-3)" "unprognostic (2.78e-1)" "unprognostic (9.87e-2)" "unprognostic (2.62e-2)" "unprognostic (1.87e-1)" "unprognostic (2.90e-4)" "unprognostic (1.42e-2)" "unprognostic (8.51e-2)" "unprognostic (7.74e-2)" "unprognostic (5.19e-3)" 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.1 9.8 0.1 0.0 2.0 0.1 0.6 0.0 70.9 0.0 0.9 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 1.2 0.1 0.0 72.9 2.6 0.2 4.9 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 37.6 52.2 0.1 10.8 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.1 1.4 0.1 0.6 0.6 0.1 0.3 0.1 0.1 0.0 0.2 0.4 1.1 0.9 0.1 0.1 0.1 0.0 0.0 0.1 0.8 0.8 0.2 0.2 7.0 0.0 0.0 1.2 0.0 0.8 0.2 0.0 0.0 0.6 2.0 0.0 0.6 0.0 0.1 0.9 0.7 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.9 0.0 12.8 0.0 0.1 0.0 0.2 1.1 0.0 1.7 1.1 0.1 0.8 0.2 0.4 0.0 0.6 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 VSIG2 "CTH, CTXL" ENSG00000019102 "V-set and immunoglobulin domain containing 2" Q96IQ7 11 124747472-124752238 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 38.2;stomach 1: 105.5" "Cell line enriched" "Detected in some" 4 "RT4: 38.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035919, HPA050147" Enhanced Approved Nucleoplasm 81000 Nucleoplasm "HPA035919: AB_10669981, HPA050147: AB_2681032" "unprognostic (1.64e-3)" "unprognostic (1.21e-1)" "unprognostic (1.10e-2)" "unprognostic (1.90e-1)" "unprognostic (2.00e-1)" "unprognostic (2.18e-3)" "unprognostic (2.16e-1)" "unprognostic (2.22e-2)" "unprognostic (3.47e-3)" "unprognostic (2.02e-1)" "unprognostic (6.01e-2)" "unprognostic (2.78e-2)" "unprognostic (2.99e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.36e-2)" 1.3 0.1 0.3 11.2 0.4 0.2 3.3 0.3 0.5 5.2 23.5 0.7 0.3 0.7 1.0 0.8 8.6 2.9 38.2 0.6 0.3 0.2 1.6 0.7 25.3 0.3 0.3 0.3 2.2 0.4 0.0 0.3 0.7 0.5 18.5 24.3 0.4 12.4 0.8 0.3 0.3 2.0 3.5 0.3 0.3 105.5 1.2 0.3 0.3 28.9 3.1 5.3 26.0 14.7 0.3 1.4 0.6 3.8 0.8 2.1 2.7 0.2 0.1 2.7 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.8 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 9.0 0.0 4.3 0.4 0.2 1.7 0.0 0.0 0.0 0.0 1.6 0.1 0.3 0.0 0.9 0.0 0.0 0.3 2.1 0.2 2.0 0.0 0.0 38.5 0.1 0.5 0.0 2.6 0.0 0.2 1.3 2.3 1.0 0.6 0.2 0.4 0.1 0.0 0.0 0.3 0.9 0.5 0.0 3.8 0.0 0.0 0.6 1.6 0.0 1.8 0.3 1.4 0.3 2.0 1.6 0.6 0.8 0.5 0.0 2.1 2.7 0.3 0.4 0.3 0.5 0.3 0.2 0.3 0.3 0.5 0.3 VSIG4 Z39IG ENSG00000155659 "V-set and immunoglobulin domain containing 4" Q9Y279 X 66021738-66040125 "Plasma proteins, Predicted membrane proteins" "Complement alternate pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.0;U-937: 2.7" "Cancer enhanced" "Detected in all" "glioma: 88.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 26 "classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1" "Group enriched" "Detected in many" 30 "dendritic cells: 13.1;monocytes: 13.9" "Low region specificity" "Detected in many" "HPA003903, CAB026000" Enhanced Uncertain "Nucleoli,Plasma membrane,Cytosol" 41000000 "Plasma membrane, Cytosol" Nucleoli "CAB026000: , HPA003903: AB_1858776" "unprognostic (6.87e-3)" "unprognostic (4.79e-2)" "prognostic unfavourable (1.34e-4)" "unprognostic (3.19e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (9.37e-3)" "unprognostic (1.24e-1)" "unprognostic (3.10e-1)" "unprognostic (1.37e-3)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "prognostic unfavourable (1.95e-6)" "unprognostic (3.70e-2)" "unprognostic (5.45e-2)" "unprognostic (3.37e-2)" "unprognostic (3.47e-2)" 67.1 28.1 15.9 17.6 16.6 2.6 19.0 1.8 10.4 6.3 18.0 5.6 1.0 9.2 6.1 14.2 9.3 28.7 15.5 15.9 11.5 3.5 18.5 22.9 61.4 37.0 17.9 3.4 8.2 8.2 3.7 7.9 52.4 12.0 10.9 12.6 8.1 11.3 4.0 10.5 4.0 14.6 39.9 16.7 28.5 9.4 13.5 17.8 0.0 10.7 1.7 1.8 14.4 9.0 0.1 13.1 0.4 13.9 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.1 3.1 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.0 0.8 2.7 0.0 0.0 13.9 0.0 0.0 8.1 0.0 0.0 0.0 0.2 13.1 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 3.3 15.9 16.6 1.8 10.1 11.5 3.5 17.9 3.4 12.0 17.8 VSIG8 ENSG00000243284 "V-set and immunoglobulin domain containing 8" P0DPA2 1 159854316-159862657 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 83.5" "Cell line enhanced" "Detected in some" "HeLa: 3.5;Karpas-707: 1.7;U-2 OS: 1.1;U-266/70: 1.3;U-87 MG: 2.1" "Group enriched" "Detected in some" 6 "cervical cancer: 3.0;endometrial cancer: 3.0;head and neck cancer: 4.6;urothelial cancer: 1.0" "Region enriched" "Detected in single" 13 "cerebellum: 4.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA023219 Uncertain "HPA023219: AB_1845635" "unprognostic (8.66e-3)" "unprognostic (2.17e-1)" "unprognostic (2.74e-1)" "unprognostic (9.13e-3)" "unprognostic (4.50e-3)" "unprognostic (1.15e-2)" "unprognostic (9.26e-2)" "unprognostic (6.28e-2)" "unprognostic (1.68e-2)" "unprognostic (2.79e-1)" "unprognostic (2.93e-3)" "unprognostic (9.32e-2)" "unprognostic (7.94e-7)" "unprognostic (1.72e-2)" "unprognostic (4.25e-1)" "unprognostic (1.81e-3)" "unprognostic (1.99e-1)" 0.4 0.1 0.2 0.2 0.3 0.0 0.2 4.2 0.2 2.2 0.2 0.2 0.2 0.2 0.2 0.2 2.5 1.0 0.2 0.2 0.2 0.2 2.7 0.2 0.2 0.2 0.2 0.2 1.2 0.2 0.0 0.2 0.3 0.2 0.2 0.0 0.2 4.3 0.2 0.2 18.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.8 0.4 83.5 9.2 0.2 2.0 0.6 0.0 0.1 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.2 0.2 0.4 1.0 1.1 0.2 0.0 1.3 0.0 0.0 2.1 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.5 0.6 0.3 0.5 0.0 0.0 0.7 0.5 0.1 0.7 0.0 0.0 0.3 0.0 0.2 0.3 4.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 VSIR "B7-H5, B7H5, C10orf54, GI24, PD-1H, SISP1, VISTA" ENSG00000107738 "V-set immunoregulatory receptor" Q9H7M9 10 71747559-71773498 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 111.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.0;HaCaT: 19.7;HMC-1: 33.0;U-937: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 111.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007968 Approved Nucleoplasm 360000 Nucleoplasm "HPA007968: AB_1845518" "unprognostic (1.19e-1)" "unprognostic (1.76e-3)" "unprognostic (1.64e-1)" "unprognostic (6.67e-2)" "unprognostic (9.29e-2)" "unprognostic (2.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (1.02e-2)" "unprognostic (6.82e-2)" "unprognostic (8.70e-2)" "unprognostic (2.57e-3)" "unprognostic (2.72e-1)" "prognostic unfavourable (6.93e-4)" "unprognostic (2.37e-3)" "unprognostic (3.29e-1)" 20.8 5.7 13.3 23.4 14.8 55.3 30.4 3.4 10.2 10.7 12.9 10.5 5.4 16.6 14.7 8.8 13.7 15.0 10.8 13.6 13.0 9.8 5.8 4.1 20.1 60.0 12.4 7.2 17.5 4.4 2.4 3.8 48.2 11.8 11.0 7.1 8.1 8.6 8.7 4.7 9.1 16.3 12.7 11.1 55.1 10.2 6.4 11.8 4.6 7.7 10.1 17.6 14.1 24.8 1.9 24.4 111.3 44.9 5.8 11.7 40.1 3.2 6.4 0.0 0.1 3.5 2.9 3.1 1.2 7.8 1.5 2.6 2.6 26.0 0.2 1.6 11.0 19.7 0.0 0.7 0.4 0.1 0.0 4.3 1.3 0.2 4.8 0.7 33.0 2.4 0.7 0.2 0.1 0.5 0.1 2.4 0.9 0.1 0.7 5.4 0.0 1.2 0.0 0.3 1.5 0.0 1.5 0.0 0.1 1.6 1.2 1.2 0.1 9.3 1.7 0.0 0.0 5.3 0.0 1.8 0.9 0.0 0.1 28.8 0.1 22.0 42.3 81.0 8.9 40.5 11.7 1.8 8.9 8.4 24.4 1.9 8.3 8.3 111.3 5.8 44.9 6.4 8.8 40.1 13.3 14.8 3.4 10.2 13.0 9.8 12.4 7.2 11.8 11.8 VSTM1 UNQ3033 ENSG00000189068 "V-set and transmembrane domain containing 1" Q6UX27 19 54040825-54063953 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 53.5;bone marrow: 39.4" "Group enriched" "Detected in some" 7 "EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 3.9;U-2 OS: 3.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 15 "eosinophil: 53.5" "Lineage enriched" "Detected in many" 15 "granulocytes: 53.5" HPA059365 Approved Vesicles "Secreted to blood" Vesicles "HPA059365: " "unprognostic (5.13e-2)" "unprognostic (5.31e-2)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (3.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-1)" "unprognostic (9.47e-2)" "unprognostic (1.31e-5)" "unprognostic (3.73e-1)" "unprognostic (1.14e-1)" "unprognostic (9.74e-2)" "unprognostic (4.67e-2)" 0.9 0.2 0.7 0.1 0.2 39.4 0.1 0.0 0.5 0.2 0.1 1.3 0.0 0.1 0.3 0.1 0.1 0.6 0.1 4.2 0.7 0.2 0.5 1.2 4.0 7.2 0.6 0.0 0.2 1.1 0.1 8.7 2.0 0.2 0.1 0.1 0.2 0.1 0.1 2.1 0.1 0.8 0.3 0.1 7.9 0.1 0.5 0.3 3.0 0.4 0.0 0.1 0.8 0.0 0.0 0.0 53.5 3.6 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.0 53.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.6 0.0 0.0 2.1 0.7 0.2 0.0 0.5 0.7 0.2 0.6 0.0 0.2 0.3 VSTM4 "C10orf72, FLJ31737" ENSG00000165633 "V-set and transmembrane domain containing 4" Q8IW00 10 49014245-49115509 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 6.8;RH-30: 7.8;SH-SY5Y: 6.7;U-138 MG: 8.9;U-2197: 20.0;U-87 MG: 9.8" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 22.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017279 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" "Nucleoplasm, Vesicles" "HPA017279: AB_10959519" "unprognostic (8.46e-2)" "unprognostic (5.41e-1)" "unprognostic (1.89e-1)" "unprognostic (2.07e-1)" "unprognostic (1.80e-1)" "unprognostic (2.84e-2)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" "unprognostic (3.03e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (4.25e-4)" 13.0 31.6 7.2 3.4 6.7 0.4 10.5 3.3 7.1 18.2 6.2 9.3 3.1 2.0 13.2 5.9 6.1 6.5 11.7 10.3 7.2 4.4 9.3 3.0 8.9 7.0 8.9 5.4 27.2 1.3 22.8 4.6 7.7 10.1 11.2 4.4 15.1 2.8 9.2 3.8 4.2 4.1 12.5 7.9 2.8 5.4 7.8 6.0 2.9 20.8 6.9 3.4 9.4 8.6 1.8 0.9 2.7 0.9 1.7 0.7 0.2 0.0 0.1 2.6 0.1 1.1 0.6 0.1 2.1 3.4 0.8 0.2 0.1 0.1 0.1 0.1 4.9 0.1 0.1 0.0 0.3 2.6 1.1 0.1 0.0 0.1 0.1 0.1 0.0 4.1 0.0 3.5 0.0 0.0 6.8 0.1 0.6 0.1 0.0 0.1 0.5 0.0 0.0 7.8 4.0 0.0 0.1 0.1 6.7 0.1 0.1 0.0 0.1 0.2 0.0 8.9 1.1 20.0 0.1 0.0 5.3 0.0 9.8 0.1 0.1 1.9 0.9 0.4 0.6 0.3 0.5 0.8 0.4 0.3 0.2 1.8 0.7 0.6 2.7 1.7 0.5 0.9 0.3 0.2 7.2 6.7 3.3 7.1 7.2 4.4 8.9 5.4 10.1 6.0 VSTM5 "C11orf90, LOC387804" ENSG00000214376 "V-set and transmembrane domain containing 5" A8MXK1 11 93818232-93850531 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 9.9;placenta: 10.7" "Cell line enhanced" "Detected in some" "A-431: 1.8;HaCaT: 2.5;PC-3: 10.5;SH-SY5Y: 4.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029525, HPA063591" Uncertain Uncertain "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA029525: AB_10600789, HPA063591: " "unprognostic (1.26e-1)" "unprognostic (4.48e-3)" "unprognostic (2.78e-1)" "unprognostic (1.54e-4)" "unprognostic (2.45e-2)" "unprognostic (9.91e-2)" "unprognostic (8.56e-2)" "unprognostic (1.37e-2)" "unprognostic (1.68e-2)" "unprognostic (1.04e-1)" "unprognostic (2.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.31e-1)" "unprognostic (3.53e-2)" "unprognostic (2.37e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" 0.5 0.6 3.1 0.4 2.9 0.1 1.1 2.2 8.2 2.8 3.0 0.4 0.6 0.5 0.9 3.2 0.5 0.5 1.5 0.8 3.2 9.9 2.1 0.1 0.3 0.2 4.7 3.5 0.3 1.3 0.1 1.2 10.7 4.9 1.6 4.4 0.3 1.4 1.3 0.2 0.3 1.3 1.9 1.3 0.1 4.9 0.4 0.0 0.0 0.4 0.0 0.3 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.9 0.2 1.1 0.0 0.0 0.2 2.5 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.3 0.0 0.3 0.3 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.9 2.2 8.2 3.2 9.9 4.7 3.5 4.9 0.0 VTCN1 "B7-H4, B7H4, B7S1, B7X, FLJ22418" ENSG00000134258 "V-set domain containing T cell activation inhibitor 1" Q7Z7D3 1 117143587-117210960 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 72.8" "Group enriched" "Detected in many" 6 "breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054200 Approved Approved "Plasma membrane,Cell Junctions,Focal adhesion sites" "Plasma membrane" "Cell Junctions, Focal adhesion sites" "HPA054200: " "unprognostic (4.13e-1)" "unprognostic (1.71e-3)" "unprognostic (2.95e-1)" "unprognostic (3.44e-2)" "unprognostic (1.71e-3)" "unprognostic (2.56e-1)" "unprognostic (7.94e-2)" "unprognostic (4.86e-2)" "unprognostic (3.53e-1)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (5.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-1)" "unprognostic (3.07e-1)" "unprognostic (1.45e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 46.4 0.1 0.1 6.7 0.1 0.1 7.0 0.0 2.6 29.9 0.4 14.2 1.9 0.2 0.1 0.1 27.0 0.9 0.3 0.1 0.1 0.1 4.5 35.9 0.0 1.4 3.0 0.1 1.5 0.0 0.1 17.5 3.6 0.2 2.2 0.1 0.8 0.1 0.1 1.5 2.5 0.1 0.2 0.1 0.5 1.5 2.1 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.0 72.8 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 VTI1A "MVti1, Vti1-rp2, Vti1a" ENSG00000151532 "Vesicle transport through interaction with t-SNAREs 1A" Q96AJ9 10 112446998-112818744 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054108 Supported Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA054108: " "unprognostic (9.81e-2)" "unprognostic (6.42e-2)" "unprognostic (4.49e-2)" "unprognostic (1.50e-1)" "unprognostic (1.66e-1)" "unprognostic (2.28e-1)" "prognostic unfavourable (6.50e-5)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic favourable (7.27e-5)" "unprognostic (3.74e-2)" "unprognostic (1.98e-1)" "unprognostic (1.67e-3)" "unprognostic (2.61e-1)" 16.8 12.8 14.5 17.9 17.9 25.2 14.6 16.7 18.6 10.0 13.8 14.3 14.4 15.2 11.8 11.6 21.1 9.5 10.3 13.1 13.4 11.1 15.4 11.8 15.7 15.4 12.8 12.2 10.5 12.8 17.4 13.7 11.0 14.6 11.4 17.0 11.2 14.3 13.6 18.4 17.1 16.5 12.8 12.7 16.0 12.3 9.8 13.0 18.8 14.2 9.7 19.6 13.1 15.6 7.3 6.8 14.8 11.7 7.3 8.8 5.5 10.8 9.1 8.7 11.7 13.4 11.9 5.2 11.6 14.8 9.5 10.7 10.2 11.3 11.3 4.5 13.3 13.0 7.4 9.3 13.0 14.1 6.5 9.8 6.6 10.7 9.5 13.5 14.3 9.0 12.1 10.7 22.4 10.1 8.9 14.2 12.5 7.4 10.7 10.4 3.6 5.3 11.3 12.4 5.0 10.0 9.7 3.9 7.6 8.3 7.3 7.6 6.5 7.6 14.0 7.4 6.4 9.0 12.9 6.2 8.7 13.3 12.2 12.5 7.2 8.9 8.9 11.9 7.5 11.7 7.0 7.3 6.3 6.0 6.8 6.7 6.2 6.4 14.8 7.3 10.4 6.4 8.8 5.5 14.5 17.9 16.7 18.6 13.4 11.1 12.8 12.2 14.6 13.0 VTI1B VTI2 ENSG00000100568 "Vesicle transport through interaction with t-SNAREs 1B" Q9UEU0 14 67647075-67674831 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044121, HPA048150, HPA060118" Approved Enhanced "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA044121: , HPA048150: , HPA060118: " "unprognostic (2.26e-1)" "unprognostic (4.83e-2)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (3.00e-2)" "unprognostic (2.36e-3)" "unprognostic (3.25e-3)" "unprognostic (9.12e-2)" "unprognostic (1.90e-2)" "unprognostic (3.86e-1)" "unprognostic (2.60e-1)" "unprognostic (2.11e-2)" "prognostic favourable (3.53e-12)" "unprognostic (8.35e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (8.02e-3)" 37.5 21.4 49.3 14.9 39.3 14.3 32.1 12.6 32.9 11.3 22.8 16.8 16.1 21.3 12.5 42.5 34.1 14.6 22.0 49.6 36.9 30.4 39.0 30.5 14.8 16.3 38.1 20.5 12.7 27.9 20.3 11.3 21.0 24.2 16.2 27.4 15.4 25.7 18.8 31.0 21.8 20.2 22.9 37.1 15.6 20.7 15.4 20.2 8.2 25.9 18.8 19.5 19.4 24.2 18.7 22.4 52.1 29.6 20.1 21.7 18.9 38.3 19.4 11.3 6.5 22.6 13.5 16.4 17.0 10.6 8.2 8.5 9.6 13.8 11.5 14.5 18.9 10.9 12.9 12.9 13.4 11.8 8.2 11.6 11.7 12.3 9.7 7.2 8.4 13.1 14.0 9.1 9.4 9.5 7.6 9.0 12.0 45.5 9.0 26.7 7.3 31.3 10.9 12.8 4.2 12.2 23.1 6.3 13.1 12.0 16.3 24.1 15.2 20.3 13.6 22.9 34.2 18.4 15.7 8.5 9.1 17.7 19.3 13.5 10.5 28.6 23.4 52.1 19.8 29.6 16.9 18.7 17.5 20.2 22.4 16.4 16.7 20.4 10.6 20.1 24.7 14.7 21.7 18.9 49.3 39.3 12.6 32.9 36.9 30.4 38.1 20.5 24.2 20.2 WBP1 WBP-1 ENSG00000239779 "WW domain binding protein 1" Q96G27 2 74458329-74460891 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057067 Approved Approved Cytosol Cytosol "HPA057067: " "unprognostic (5.94e-2)" "unprognostic (2.48e-1)" "prognostic unfavourable (1.04e-4)" "unprognostic (6.05e-2)" "unprognostic (2.98e-1)" "unprognostic (1.11e-1)" "unprognostic (5.80e-2)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "prognostic favourable (6.83e-4)" "unprognostic (1.17e-2)" "unprognostic (1.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.57e-1)" "unprognostic (5.09e-2)" "prognostic favourable (6.36e-4)" 17.6 23.5 37.6 12.6 34.8 15.1 18.1 12.1 27.5 22.4 14.9 34.4 23.6 15.9 19.2 26.1 19.0 31.0 20.6 21.2 30.9 22.7 23.0 26.4 15.4 15.5 28.6 17.2 27.6 35.9 27.7 22.1 15.4 20.8 29.8 10.2 32.1 49.1 25.5 15.3 19.7 15.8 16.4 25.2 14.7 17.9 10.6 17.0 40.5 36.0 17.2 17.6 18.7 19.2 19.2 30.3 15.3 18.5 21.5 24.0 16.5 6.1 29.2 17.8 20.1 22.8 17.5 13.4 6.6 12.3 6.6 5.4 15.2 11.7 6.0 11.8 15.1 9.1 7.2 17.1 6.4 23.6 17.0 8.4 13.8 21.3 14.5 3.0 8.3 24.5 18.2 8.8 13.1 13.1 3.3 21.5 16.7 41.6 10.3 7.7 12.7 15.6 10.4 20.0 9.0 17.5 26.0 10.5 26.3 8.8 14.6 18.1 19.5 8.1 8.1 16.0 13.2 6.2 6.4 32.8 11.4 7.0 17.2 7.9 14.1 15.3 18.5 12.2 18.1 14.2 15.9 19.2 16.0 17.6 19.4 18.8 22.4 19.4 13.0 21.5 12.0 30.3 24.0 16.5 37.6 34.8 12.1 27.5 30.9 22.7 28.6 17.2 20.8 17.0 WBP1L "C10orf26, FLJ20154, OPAL1" ENSG00000166272 "WW domain binding protein 1 like" Q9NX94 10 102743970-102816267 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037635, HPA038371" Uncertain Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA037635: AB_10672462, HPA038371: AB_2675980" "unprognostic (3.28e-2)" "unprognostic (6.46e-2)" "unprognostic (1.14e-2)" "prognostic favourable (4.03e-4)" "unprognostic (5.35e-3)" "unprognostic (2.73e-2)" "unprognostic (3.33e-2)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.43e-3)" "unprognostic (2.55e-1)" "unprognostic (1.34e-1)" "prognostic favourable (1.56e-6)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (4.88e-2)" "unprognostic (1.53e-1)" 23.8 23.0 11.5 12.9 13.7 2.3 14.2 9.5 14.2 19.0 14.5 12.2 13.3 9.0 18.9 14.9 13.1 18.9 15.3 23.6 11.9 8.9 11.6 21.3 13.3 11.5 14.9 8.0 23.6 9.3 12.5 13.5 14.1 17.5 15.2 9.2 20.2 21.8 14.9 77.3 20.1 12.3 16.3 15.0 12.5 15.0 11.0 10.1 23.2 26.1 35.5 11.1 17.6 11.4 6.1 8.2 14.7 16.7 12.4 8.7 8.9 10.1 13.2 7.3 12.2 24.3 19.7 14.9 10.4 28.2 10.4 13.1 8.9 15.9 8.8 14.1 15.9 11.3 5.3 9.0 7.9 8.8 5.6 17.8 6.0 6.4 15.7 8.5 21.2 21.3 16.1 13.3 10.3 20.2 8.6 11.0 17.7 13.3 10.2 9.5 5.5 6.4 20.6 19.1 5.6 9.2 10.0 1.7 7.0 5.7 5.8 11.7 23.6 9.5 15.0 10.0 10.4 11.2 9.2 20.5 10.7 6.5 14.1 16.4 4.4 6.6 11.8 14.7 8.7 13.7 6.9 6.1 7.4 8.4 8.2 6.0 6.8 7.2 14.4 12.4 16.7 5.2 7.5 8.9 11.5 13.7 9.5 14.2 11.9 8.9 14.9 8.0 17.5 10.1 WDFY4 "C10orf64, Em:AC060234.3, FLJ45748, KIAA1607" ENSG00000128815 "WDFY family member 4" Q6ZS81 10 48684876-48982956 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.7;lymphoid tissue: 31.2" "Cell line enhanced" "Detected in some" "Daudi: 29.4;HDLM-2: 26.9;HL-60: 10.2;THP-1: 9.1;U-698: 12.5;U-937: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory B-cell: 8.9;myeloid DC: 6.7;naive B-cell: 12.5;neutrophil: 6.2;plasmacytoid DC: 19.7" "Group enriched" "Detected in many" 7 "B-cells: 12.5;dendritic cells: 19.7;granulocytes: 6.2" "Low region specificity" "Detected in many" HPA040634 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040634: AB_10795491" "unprognostic (6.20e-2)" "unprognostic (6.60e-3)" "unprognostic (1.87e-1)" "unprognostic (3.31e-2)" "unprognostic (1.87e-1)" "unprognostic (9.38e-4)" "unprognostic (9.41e-2)" "unprognostic (3.89e-3)" "unprognostic (2.15e-2)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" "unprognostic (9.64e-2)" "unprognostic (3.21e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-2)" "unprognostic (1.97e-1)" "unprognostic (3.76e-2)" 2.7 1.5 3.6 31.2 5.4 8.6 1.5 0.9 2.7 1.2 1.6 5.2 0.0 1.1 1.2 1.5 1.5 1.5 2.6 1.4 3.1 1.9 1.7 1.2 9.4 20.8 5.3 0.6 1.1 1.1 0.2 1.1 0.8 3.7 1.2 1.5 1.2 5.7 0.4 0.9 2.0 10.2 1.3 7.3 19.1 1.6 1.5 4.4 4.1 1.6 0.9 26.6 3.0 1.2 12.5 19.7 6.2 1.7 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 3.1 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 12.1 0.0 0.0 1.7 0.0 0.0 1.6 0.0 8.9 0.0 0.1 6.7 12.5 0.0 0.0 6.2 0.0 0.8 19.7 0.0 0.6 3.6 5.4 0.9 2.7 3.1 1.9 5.3 0.6 3.7 4.4 WDHD1 "AND-1, CHTF4, CTF4" ENSG00000198554 "WD repeat and HMG-box DNA binding protein 1" O75717 14 54938950-55027105 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.1" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 23.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000632, HPA001122" Enhanced Enhanced Nucleoplasm Nucleoplasm "HPA000632: , HPA001122: AB_1080589" "unprognostic (1.88e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-2)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (6.85e-3)" "unprognostic (2.33e-4)" "unprognostic (5.52e-3)" "unprognostic (7.28e-3)" "unprognostic (8.05e-3)" "prognostic unfavourable (9.24e-4)" "unprognostic (5.11e-2)" "unprognostic (2.67e-4)" "unprognostic (8.31e-3)" "unprognostic (1.50e-1)" "unprognostic (3.49e-2)" "unprognostic (2.36e-2)" 5.0 2.8 6.3 6.6 7.5 10.8 3.8 7.2 4.6 3.7 4.9 2.7 0.6 3.2 4.2 2.9 7.0 4.0 2.3 2.3 3.2 2.3 2.8 2.1 2.9 8.9 3.3 2.5 4.1 2.0 3.0 1.9 6.0 4.4 2.1 7.3 2.6 3.0 2.2 2.0 4.5 3.6 4.6 2.8 4.6 2.8 8.8 3.5 21.1 2.1 6.4 11.2 3.6 4.3 4.8 1.8 4.3 0.9 4.3 4.6 1.6 15.8 10.2 20.2 8.9 2.0 4.8 11.8 15.4 6.6 12.4 15.3 6.7 10.6 18.1 7.9 4.4 13.5 30.1 8.8 26.2 12.1 5.2 11.9 10.0 6.5 0.8 22.5 9.1 2.5 1.6 15.3 6.0 8.0 14.9 9.1 11.9 8.7 21.1 4.4 16.0 10.7 19.8 29.2 6.9 3.5 10.6 11.8 8.3 16.3 4.1 5.3 11.1 4.5 5.2 15.8 18.8 11.5 13.0 2.7 5.6 24.2 7.2 11.1 12.4 4.3 0.8 1.4 2.3 0.6 3.2 3.0 2.7 3.3 1.4 4.8 3.3 4.6 1.2 4.3 0.9 1.8 3.9 1.6 6.3 7.5 7.2 4.6 3.2 2.3 3.3 2.5 4.4 3.5 WDR11 "BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15" ENSG00000120008 "WD repeat domain 11" Q9BZH6 10 120851175-120909524 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038980 Approved Approved Microtubules,Cytosol "Microtubules, Cytosol" "HPA038980: AB_10675955" "unprognostic (8.98e-2)" "unprognostic (8.83e-3)" "unprognostic (1.27e-1)" "unprognostic (5.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.57e-3)" "unprognostic (1.45e-1)" "unprognostic (2.98e-3)" "unprognostic (2.84e-1)" "unprognostic (3.84e-1)" "unprognostic (8.31e-2)" "unprognostic (1.80e-3)" "prognostic favourable (5.04e-4)" "unprognostic (5.09e-2)" "unprognostic (1.87e-1)" "unprognostic (8.99e-2)" "unprognostic (2.38e-2)" 18.6 21.9 10.6 17.4 17.2 6.2 16.4 17.1 18.9 17.3 15.5 21.5 18.0 14.5 22.6 15.9 19.6 21.0 15.7 10.6 11.5 12.7 25.2 19.8 14.9 17.0 13.9 10.6 19.4 16.1 33.9 17.7 18.4 26.0 16.5 17.3 19.0 20.3 21.5 8.5 14.8 19.9 17.5 20.0 19.7 18.9 12.8 12.9 20.6 24.0 11.7 19.8 22.0 17.3 6.4 6.8 15.5 16.3 3.9 3.3 3.4 11.9 11.8 11.6 19.1 16.3 20.8 8.1 11.6 23.2 12.9 16.4 6.6 13.4 8.7 6.0 17.1 11.8 13.4 16.0 16.0 11.8 11.5 9.4 9.5 6.3 15.4 13.0 10.9 17.0 12.8 11.7 19.1 24.3 7.4 10.9 13.7 5.1 8.1 5.1 5.6 7.5 3.3 19.6 7.5 15.0 10.0 5.8 10.3 10.0 11.2 30.6 8.2 8.4 17.9 8.9 5.4 1.3 10.7 5.5 3.4 10.8 12.7 10.8 4.6 15.5 5.9 2.5 3.3 8.0 2.6 6.4 2.3 3.1 6.8 3.8 2.4 2.5 0.5 3.9 16.3 1.6 2.9 3.4 10.6 17.2 17.1 18.9 11.5 12.7 13.9 10.6 26.0 12.9 WDR17 ENSG00000150627 "WD repeat domain 17" Q8IZU2 4 176065834-176182818 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9;parathyroid gland: 19.0;pituitary gland: 22.5" "Cell line enhanced" "Detected in many" "AF22: 8.9;SCLC-21H: 10.3;SH-SY5Y: 7.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042766, HPA054501" Approved Approved "Nuclear speckles" "Nuclear speckles" "HPA042766: AB_10806372, HPA054501: " "unprognostic (3.41e-4)" "unprognostic (1.72e-1)" "unprognostic (1.20e-1)" "unprognostic (6.43e-7)" "unprognostic (3.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.07e-1)" "unprognostic (1.91e-1)" "unprognostic (8.62e-2)" "unprognostic (1.42e-1)" "unprognostic (1.39e-3)" "unprognostic (6.04e-4)" "unprognostic (3.66e-4)" "unprognostic (9.25e-3)" "unprognostic (4.63e-2)" "unprognostic (7.32e-3)" "unprognostic (8.24e-3)" 2.1 5.8 12.4 2.2 22.1 1.5 3.3 12.2 23.9 2.0 2.9 3.4 0.0 1.6 4.5 6.2 1.9 3.5 3.0 1.3 9.7 7.1 6.2 1.0 3.6 1.8 4.4 16.3 4.0 3.0 19.0 22.5 0.7 7.9 2.3 3.1 6.0 1.7 2.2 0.7 1.2 1.8 2.8 4.0 2.9 3.1 4.1 6.9 0.1 10.2 0.0 1.6 1.9 1.5 1.1 0.7 2.6 1.6 1.3 0.8 0.2 0.0 3.7 8.9 0.1 0.2 0.6 0.3 0.2 0.0 0.8 3.1 0.2 0.1 6.1 0.0 0.1 0.1 3.9 2.0 0.8 0.0 3.2 0.0 0.7 0.0 0.3 3.3 4.8 1.4 1.2 0.1 0.5 0.0 0.0 0.3 0.6 1.6 3.4 0.1 2.0 1.9 0.0 3.8 0.0 0.5 0.0 10.3 7.4 0.0 2.4 6.2 0.4 0.0 0.0 1.2 1.7 0.1 5.8 4.4 2.9 3.5 7.0 0.0 2.4 2.6 0.6 0.3 0.6 1.6 0.3 1.1 0.6 0.4 0.2 0.8 0.7 0.8 1.7 1.3 0.3 0.7 0.3 0.2 12.4 22.1 12.2 21.8 9.7 7.1 4.4 16.3 7.9 6.9 WDR33 "FLJ11294, NET14, WDC146" ENSG00000136709 "WD repeat domain 33" Q9C0J8 2 127701022-127811187 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026897, HPA046527" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA026897: AB_1858803, HPA046527: " "unprognostic (1.26e-1)" "unprognostic (7.22e-2)" "unprognostic (1.50e-1)" "unprognostic (1.79e-2)" "unprognostic (6.63e-2)" "unprognostic (8.32e-2)" "prognostic unfavourable (2.13e-4)" "unprognostic (1.01e-1)" "unprognostic (1.66e-2)" "unprognostic (8.13e-2)" "unprognostic (5.72e-3)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" "unprognostic (3.64e-1)" "unprognostic (2.04e-1)" "unprognostic (9.85e-2)" "unprognostic (1.03e-2)" 19.8 19.2 18.1 22.5 22.5 18.8 21.7 51.4 24.3 20.9 19.8 22.0 22.8 18.2 32.2 19.0 20.6 18.6 17.9 16.8 17.7 16.5 22.3 32.3 18.5 25.0 19.4 14.5 29.2 21.8 26.4 41.8 20.9 22.0 21.9 19.5 24.4 25.3 17.4 22.0 27.8 21.3 21.0 22.2 28.1 18.0 24.5 20.8 39.5 25.2 16.6 30.5 21.5 22.4 24.4 21.6 26.7 18.3 25.9 26.3 14.4 18.2 10.3 18.1 14.6 10.8 11.2 18.7 16.8 13.4 17.7 16.8 24.0 14.1 23.2 18.6 11.0 14.9 20.4 14.1 23.3 21.2 12.1 22.3 13.1 25.6 12.1 26.8 16.7 10.9 15.0 16.9 14.5 15.0 18.5 20.8 12.4 11.5 27.8 19.7 21.9 11.8 19.5 18.3 18.3 10.1 23.8 16.9 13.2 15.0 13.9 11.8 10.7 15.7 14.0 14.0 20.5 15.6 14.3 20.4 31.0 44.2 11.4 10.8 12.9 21.2 16.7 26.7 21.5 18.3 21.9 24.4 21.9 20.6 21.6 23.0 23.3 22.1 11.4 25.9 18.2 15.8 26.3 14.4 18.1 22.5 51.4 24.3 17.7 16.5 19.4 14.5 22.0 20.8 WDR83OS "C19orf56, PTD008" ENSG00000105583 "WD repeat domain 83 opposite strand" Q9Y284 19 12668071-12671356 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065685 Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA065685: " "unprognostic (1.73e-1)" "unprognostic (5.37e-3)" "unprognostic (1.03e-1)" "unprognostic (4.86e-2)" "unprognostic (1.27e-1)" "unprognostic (3.29e-2)" "unprognostic (7.47e-2)" "prognostic favourable (2.09e-4)" "unprognostic (1.71e-1)" "prognostic favourable (8.84e-4)" "unprognostic (4.17e-3)" "unprognostic (1.09e-1)" "unprognostic (7.87e-3)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (1.02e-1)" "unprognostic (8.34e-2)" 43.7 59.8 39.3 29.4 39.4 48.7 64.6 25.3 42.7 51.2 52.0 37.1 53.0 29.7 43.3 84.9 60.6 68.2 66.6 53.2 35.1 35.9 54.2 70.2 49.5 47.7 38.6 29.1 69.6 104.0 33.0 45.8 64.6 27.4 60.0 45.4 35.4 69.7 55.7 56.3 46.7 53.3 51.3 42.2 40.9 41.2 43.3 30.1 30.7 84.8 60.3 49.0 45.1 61.8 87.0 94.2 99.3 101.3 84.2 77.9 107.6 29.1 28.1 35.6 40.1 46.4 38.3 15.4 21.7 27.8 25.5 22.1 24.3 25.5 11.6 50.7 49.5 23.4 32.3 33.4 21.8 27.4 47.3 15.1 27.9 39.2 36.0 26.4 24.5 38.9 43.2 27.6 32.8 33.1 26.9 30.3 32.5 93.7 19.8 63.9 29.8 82.3 16.8 17.8 46.3 31.2 33.1 29.0 45.4 23.9 25.7 30.0 31.6 47.0 23.3 46.1 13.0 50.5 31.7 54.6 61.7 18.2 39.7 45.7 29.8 98.0 101.3 96.1 70.3 92.3 65.9 87.0 67.4 71.9 94.2 79.1 62.0 68.8 99.3 84.2 95.4 64.6 77.9 107.6 39.3 39.4 25.3 42.7 35.1 35.9 38.6 29.1 27.4 30.1 WLS "C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls" ENSG00000116729 "Wntless Wnt ligand secretion mediator" Q5T9L3 1 68098473-68233120 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 71.8;ASC TERT1: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 10.0;neutrophil: 29.1" "Group enriched" "Detected in many" 46 "granulocytes: 29.1;monocytes: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA069520 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA069520: " "prognostic favourable (4.03e-4)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (8.13e-3)" "unprognostic (5.93e-2)" "unprognostic (4.51e-3)" "unprognostic (5.41e-3)" "unprognostic (7.46e-3)" "unprognostic (7.70e-2)" "prognostic favourable (9.43e-4)" "unprognostic (1.34e-1)" "unprognostic (4.82e-2)" "prognostic favourable (3.67e-7)" "unprognostic (4.48e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-2)" "prognostic unfavourable (3.51e-4)" 13.7 17.2 33.5 14.3 39.0 1.5 14.5 6.8 26.6 20.0 28.3 25.8 51.6 9.1 19.5 55.1 26.7 19.9 37.1 24.1 23.1 25.4 36.8 8.9 20.3 6.9 27.0 18.6 31.4 34.7 12.1 9.8 29.2 44.5 29.0 22.8 37.8 14.5 47.4 5.3 19.3 14.1 46.2 30.5 10.8 24.4 12.2 22.3 1.9 8.9 13.5 8.2 29.6 17.0 0.0 0.4 29.1 10.0 0.0 0.0 1.9 2.0 3.0 71.8 0.0 39.8 55.6 41.6 9.9 24.5 13.9 19.3 4.3 4.7 0.0 10.0 2.8 20.8 16.1 16.3 11.8 0.1 12.0 0.0 8.6 0.0 34.8 0.0 0.1 39.7 11.0 34.0 11.2 32.5 0.0 0.1 20.4 0.3 0.0 0.2 3.2 4.8 0.0 15.1 0.0 2.4 10.7 4.0 8.4 9.1 0.4 11.9 1.9 0.3 37.7 13.3 10.7 21.3 13.4 4.8 0.1 0.0 30.7 0.3 24.3 0.0 10.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 29.1 0.0 0.3 0.1 0.0 1.9 33.5 39.0 6.8 23.8 23.1 25.4 27.0 18.6 44.5 22.3 WNT10A ENSG00000135925 "Wnt family member 10A" Q9GZT5 2 218880363-218899581 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation, Ectodermal dysplasia, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 24.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 16.0;HaCaT: 46.2;HDLM-2: 19.0;RPTEC TERT1: 8.9;U-266/70: 24.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.9" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 8.4" "Lineage enriched" "Detected in many" 6 "dendritic cells: 8.4" "Low region specificity" "Detected in some" "Region enhanced" "Detected in single" "basal ganglia: 2.2" HPA013898 Uncertain "Secreted to extracellular matrix" "HPA013898: AB_1858847" "unprognostic (2.99e-4)" "unprognostic (4.31e-2)" "unprognostic (8.55e-2)" "unprognostic (1.17e-3)" "unprognostic (2.87e-2)" "unprognostic (2.59e-1)" "unprognostic (1.62e-1)" "unprognostic (2.56e-2)" "unprognostic (1.04e-1)" "unprognostic (6.34e-2)" "unprognostic (2.23e-3)" "unprognostic (9.52e-2)" "unprognostic (6.64e-9)" "unprognostic (1.22e-1)" "unprognostic (1.72e-1)" "unprognostic (4.89e-3)" "unprognostic (1.82e-1)" 0.9 0.4 0.5 10.6 2.5 0.6 0.8 0.1 1.7 2.0 4.2 0.3 2.3 5.5 0.3 1.7 10.5 1.8 0.9 0.6 1.5 0.9 3.6 0.3 1.9 3.3 0.3 0.0 1.0 0.1 0.0 6.0 5.0 0.1 2.2 1.5 3.4 8.0 7.5 0.9 12.4 3.0 1.1 0.1 4.2 3.7 0.6 0.6 2.1 0.3 24.8 10.2 8.0 3.7 1.1 8.4 0.0 0.0 0.0 1.4 0.1 5.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 16.0 0.9 3.6 0.0 46.2 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 8.9 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 24.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 1.1 0.4 0.1 0.0 0.0 0.0 8.4 1.4 0.1 0.5 2.5 0.1 1.7 1.5 0.9 0.3 0.0 0.1 0.6 WNT4 WNT-4 ENSG00000162552 "Wnt family member 4" P56705 1 22117305-22143969 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 34.3;skin 1: 28.6" "Cell line enhanced" "Detected in some" "HaCaT: 10.0;SCLC-21H: 12.2;SK-BR-3: 10.3;T-47d: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.8" "Low region specificity" "Detected in many" HPA011397 Uncertain Approved Vesicles "Secreted to extracellular matrix" Vesicles "HPA011397: AB_1858854" "unprognostic (1.85e-1)" "unprognostic (9.08e-2)" "unprognostic (6.67e-3)" "unprognostic (1.75e-2)" "unprognostic (7.17e-2)" "unprognostic (4.30e-3)" "unprognostic (2.77e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (5.34e-4)" "unprognostic (2.14e-2)" "prognostic favourable (4.90e-4)" "unprognostic (1.01e-1)" "unprognostic (2.95e-2)" "unprognostic (4.21e-1)" "unprognostic (2.32e-1)" "unprognostic (4.74e-2)" "unprognostic (9.49e-2)" 0.5 6.5 1.0 0.3 1.0 0.0 1.4 0.6 1.7 4.3 1.7 1.1 1.0 2.0 3.1 6.6 6.9 6.4 6.4 0.6 1.5 3.1 1.1 1.2 1.4 0.3 1.0 1.7 34.3 1.9 0.0 3.7 11.8 1.7 7.7 1.0 1.7 3.0 1.8 2.7 28.6 4.1 1.2 1.5 0.3 2.8 0.9 0.8 1.4 2.2 5.4 2.8 2.0 3.5 0.0 0.0 2.8 0.0 0.0 0.4 0.0 1.5 0.1 3.0 0.1 0.1 0.0 2.7 0.6 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.1 10.0 0.0 0.8 0.0 0.3 0.3 0.3 0.3 0.0 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 1.8 12.2 0.0 0.1 10.3 0.7 4.1 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.6 1.7 1.5 3.1 1.0 1.7 1.7 0.8 WRB "CHD5, GET1" ENSG00000182093 "Tryptophan rich basic protein" O00258 21 39380244-39428528 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018527 Approved "HPA018527: AB_1858860" "unprognostic (4.34e-3)" "unprognostic (3.28e-1)" "unprognostic (2.88e-2)" "unprognostic (4.37e-2)" "unprognostic (2.56e-1)" "unprognostic (5.08e-2)" "unprognostic (6.86e-2)" "unprognostic (1.57e-3)" "unprognostic (8.74e-2)" "unprognostic (1.15e-2)" "unprognostic (4.02e-3)" "unprognostic (9.48e-2)" "unprognostic (6.50e-3)" "unprognostic (2.21e-2)" "unprognostic (2.67e-2)" "unprognostic (5.78e-3)" "unprognostic (8.13e-2)" 11.8 28.1 41.2 7.0 34.4 4.9 15.9 25.1 35.7 18.2 10.5 32.1 10.3 12.1 18.1 29.4 9.5 42.4 11.5 17.0 35.9 46.2 23.2 20.0 11.4 7.9 35.0 24.3 26.2 9.4 5.6 17.1 13.2 32.1 15.6 9.5 16.6 9.1 13.8 22.4 6.0 11.6 14.0 40.8 8.0 10.6 32.4 23.3 5.8 17.1 6.2 8.7 10.4 8.0 19.2 26.2 31.2 17.6 16.8 19.2 24.6 14.6 13.6 24.3 14.7 31.7 29.9 7.7 21.1 21.0 9.9 9.1 12.5 20.4 24.4 15.1 21.9 5.5 19.4 12.8 14.0 10.6 12.6 17.3 12.8 20.0 19.0 13.1 6.5 19.1 12.6 15.9 14.8 24.0 26.0 15.5 25.8 33.6 14.9 10.0 22.5 9.8 16.9 14.9 17.7 28.0 7.8 12.2 18.6 17.9 9.5 21.3 17.8 15.1 14.6 12.7 4.6 17.2 9.2 19.7 27.5 10.8 30.8 22.6 14.2 18.4 17.6 17.1 13.5 12.7 11.9 19.2 16.5 14.2 19.4 12.1 19.2 17.9 31.2 16.8 12.5 26.2 14.6 24.6 41.2 34.4 25.1 33.6 35.9 46.2 35.0 24.3 32.1 23.3 WWP1 "AIP5, DKFZP434D2111" ENSG00000123124 "WW domain containing E3 ubiquitin protein ligase 1" Q9H0M0 8 86342738-86478420 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023180 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" Cytosol "Golgi apparatus, Plasma membrane" "HPA023180: AB_10602587" "unprognostic (3.89e-1)" "unprognostic (6.63e-2)" "unprognostic (3.81e-2)" "unprognostic (7.91e-2)" "unprognostic (3.70e-1)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.24e-2)" "unprognostic (1.83e-1)" "unprognostic (9.43e-3)" "unprognostic (3.09e-3)" "unprognostic (1.48e-1)" "prognostic favourable (5.45e-5)" "unprognostic (2.35e-1)" "unprognostic (4.63e-1)" "unprognostic (3.19e-3)" "unprognostic (1.01e-1)" 15.4 9.1 9.7 15.6 14.1 5.2 20.9 8.5 9.5 11.5 16.9 7.5 21.1 8.7 11.9 19.3 11.7 7.2 22.0 40.7 8.7 8.5 16.9 37.2 10.2 15.9 10.0 7.8 10.1 11.3 40.7 7.3 15.6 12.7 17.8 11.3 8.9 11.8 9.4 58.0 13.8 13.0 18.4 9.9 19.1 11.4 10.4 9.5 11.1 11.2 18.0 12.5 14.5 12.3 3.7 2.6 6.5 2.8 2.9 10.4 2.3 22.9 10.8 7.5 5.3 9.4 9.3 6.9 8.4 8.9 6.7 8.0 7.6 14.1 9.9 5.7 14.3 19.7 10.5 13.4 11.6 12.2 8.4 11.3 9.6 17.8 6.9 4.5 5.9 8.4 17.2 7.3 13.6 29.4 5.9 11.6 11.3 11.4 10.8 3.4 4.5 12.2 7.1 9.0 8.7 15.0 17.6 2.2 5.2 8.3 42.1 8.9 12.5 4.2 33.8 10.0 11.9 10.6 4.3 13.8 8.4 10.1 12.4 0.8 7.6 6.5 2.8 4.8 7.2 2.4 6.0 3.7 8.7 7.1 1.9 3.6 10.4 6.3 1.7 2.9 2.8 2.6 8.0 2.3 9.7 14.1 8.5 9.5 8.7 8.5 10.0 7.8 12.7 9.5 XPO7 "KIAA0745, RANBP16" ENSG00000130227 "Exportin 7" Q9UIA9 8 21919671-22006585 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043727, HPA048153" Uncertain 24000 "HPA043727: , HPA048153: " "unprognostic (6.30e-2)" "unprognostic (1.95e-2)" "prognostic favourable (2.29e-4)" "unprognostic (6.61e-3)" "unprognostic (1.81e-1)" "unprognostic (1.33e-2)" "unprognostic (1.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.18e-1)" "unprognostic (6.81e-3)" "unprognostic (9.66e-2)" "unprognostic (3.69e-2)" "unprognostic (2.76e-2)" "unprognostic (6.58e-2)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" 18.5 22.3 24.4 15.8 34.6 40.1 20.5 33.2 37.1 22.0 18.5 28.5 19.4 12.1 24.0 23.0 21.9 24.3 15.8 23.3 26.8 22.9 31.3 17.0 18.2 18.9 19.2 23.6 31.9 20.1 39.3 27.2 24.0 26.5 20.1 22.4 26.8 18.6 23.6 22.6 22.7 16.9 22.5 19.7 22.0 18.3 29.6 20.4 23.2 27.6 11.4 22.9 19.9 25.5 8.6 8.9 7.2 8.2 5.7 9.5 6.7 17.0 30.3 22.6 16.2 19.1 16.7 17.9 16.9 20.0 25.1 22.8 23.0 10.7 28.0 19.4 20.9 16.7 32.3 24.3 44.5 8.4 16.5 31.4 25.4 16.8 13.0 15.0 24.0 13.0 17.2 25.0 24.2 24.1 37.2 22.7 18.4 13.2 37.2 14.0 29.1 12.2 21.6 29.2 14.7 16.5 35.6 13.7 21.8 15.9 16.8 16.8 15.3 12.5 15.6 13.2 16.9 18.7 17.0 8.0 8.8 30.3 20.2 18.4 23.2 7.2 6.0 4.4 9.5 8.2 8.2 8.6 8.6 7.3 8.9 5.9 6.6 8.0 3.0 5.7 7.0 3.2 8.3 6.7 24.4 34.6 33.2 37.1 26.8 22.9 19.2 23.6 26.5 20.4 YIPF2 "FinGER2, MGC3262" ENSG00000130733 "Yip1 domain family member 2" Q9BWQ6 19 10922185-10928681 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019902 Approved Approved "Golgi apparatus,Mitochondria" "Golgi apparatus, Mitochondria" "HPA019902: AB_1858925" "unprognostic (1.27e-1)" "unprognostic (8.56e-2)" "unprognostic (2.90e-3)" "unprognostic (8.38e-2)" "unprognostic (3.66e-1)" "unprognostic (3.96e-1)" "unprognostic (1.93e-1)" "unprognostic (7.65e-2)" "unprognostic (4.30e-2)" "unprognostic (5.62e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.92e-2)" "unprognostic (5.99e-2)" "unprognostic (2.00e-2)" 11.8 16.4 9.2 8.3 9.3 13.5 12.9 12.0 16.8 16.0 13.8 11.9 15.3 17.0 14.4 26.7 17.1 17.6 16.7 11.9 9.7 10.6 16.4 34.3 11.8 9.6 10.7 10.3 18.4 56.4 11.1 40.7 35.5 11.9 14.0 8.4 16.6 53.5 20.7 11.1 11.2 14.6 8.8 8.4 10.2 18.4 52.0 10.6 11.0 22.1 12.9 12.5 13.9 13.8 10.8 22.3 16.2 14.7 7.2 9.8 6.7 23.1 8.6 5.7 9.1 14.6 13.7 11.8 18.6 21.6 12.6 18.0 25.6 19.2 4.6 30.4 19.2 18.1 4.4 17.8 3.6 15.0 16.1 9.1 9.6 13.8 23.7 15.1 18.8 13.3 12.7 8.9 13.9 9.8 11.3 24.9 8.6 39.6 9.5 15.5 11.0 20.7 8.3 5.3 23.2 12.1 11.0 17.3 8.7 13.0 20.7 17.6 19.7 21.1 14.3 16.0 5.9 23.1 13.2 37.0 14.4 8.4 25.4 26.6 17.0 16.2 13.2 5.6 9.8 14.7 7.6 10.8 7.9 9.0 14.8 7.2 7.0 9.8 2.1 7.2 12.4 22.3 7.8 6.7 9.2 9.3 12.0 16.8 9.7 10.6 10.7 10.3 11.9 10.6 YIPF5 "FinGER5, SMAP-5" ENSG00000145817 "Yip1 domain family member 5" Q969M3 5 144158159-144170714 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042338, HPA073622" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles" "Endoplasmic reticulum, Golgi apparatus, Vesicles" Nucleoplasm "HPA042338: , HPA073622: " "prognostic unfavourable (7.83e-5)" "unprognostic (1.13e-3)" "unprognostic (1.95e-2)" "unprognostic (8.35e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.12e-5)" "prognostic unfavourable (3.26e-5)" "unprognostic (2.89e-2)" "unprognostic (1.99e-1)" "unprognostic (3.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.69e-1)" "unprognostic (1.24e-2)" "unprognostic (5.11e-2)" "unprognostic (6.49e-2)" 26.6 26.6 18.4 14.7 21.2 15.8 22.5 19.2 22.6 23.9 22.2 17.2 22.5 26.5 25.7 22.0 27.2 18.9 19.0 18.3 15.1 18.5 23.0 27.8 20.4 21.0 16.2 20.5 19.6 41.7 21.5 45.3 37.1 21.8 16.8 23.4 18.9 32.7 18.3 11.9 24.5 30.5 25.2 19.7 18.8 23.8 20.7 16.2 14.0 20.2 21.2 20.1 24.1 19.9 22.3 27.2 28.8 28.1 23.7 36.7 23.4 11.4 7.7 10.0 7.9 24.0 26.0 9.1 39.2 26.6 17.7 28.6 12.2 12.1 6.3 18.9 42.5 10.6 9.5 19.2 23.9 8.8 8.3 4.6 13.4 12.4 19.4 10.3 7.7 19.6 18.0 15.8 13.0 16.7 4.9 10.6 23.8 6.0 5.0 5.9 6.4 8.4 5.4 14.9 10.4 11.0 10.2 6.8 8.4 13.6 7.3 17.4 15.2 6.8 64.4 20.9 10.1 20.1 15.4 9.7 15.9 8.0 19.9 9.9 15.1 25.6 21.0 28.8 30.3 28.1 34.3 22.3 31.0 33.6 25.0 21.5 32.8 30.8 15.6 23.7 25.4 27.2 36.7 23.4 18.4 21.2 19.2 22.6 15.1 18.5 16.2 20.5 21.8 16.2 YME1L1 ENSG00000136758 "YME1 like 1 ATPase" Q96TA2 10 27110112-27155266 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066953 Approved Supported "Nuclear bodies,Mitochondria" Mitochondria "Nuclear bodies" "HPA066953: " "unprognostic (2.28e-3)" "unprognostic (3.00e-2)" "unprognostic (1.34e-1)" "unprognostic (7.19e-2)" "unprognostic (8.12e-2)" "unprognostic (2.47e-1)" "prognostic unfavourable (8.25e-6)" "unprognostic (7.08e-2)" "unprognostic (2.91e-1)" "unprognostic (9.24e-2)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (1.44e-2)" "unprognostic (7.09e-2)" 27.8 37.3 22.7 25.0 26.2 41.4 39.2 27.8 27.5 27.6 24.3 15.7 29.8 22.3 29.9 35.9 34.5 25.3 24.4 34.1 23.4 21.5 26.8 45.4 26.9 38.7 19.3 25.5 32.5 33.8 27.8 28.6 33.4 22.0 25.9 26.3 23.3 28.1 31.3 79.0 26.8 25.3 34.6 20.2 26.5 24.7 24.7 20.9 41.7 30.9 32.0 28.9 36.4 28.9 55.6 79.2 73.9 53.0 45.5 56.0 45.9 40.0 30.1 36.1 17.8 35.4 38.1 29.5 39.6 23.2 40.7 46.7 40.7 49.4 42.8 26.4 43.7 38.8 43.3 35.0 45.0 38.8 26.0 40.6 26.9 28.5 38.9 27.7 33.4 31.2 41.4 35.5 36.0 42.5 47.1 43.6 44.9 27.1 51.2 16.0 28.6 14.1 44.3 57.9 39.5 33.2 19.1 27.8 35.6 39.6 30.8 39.7 29.5 34.8 41.6 24.7 34.5 41.4 35.5 21.9 32.1 54.7 35.1 51.5 18.8 53.0 53.0 55.2 55.3 44.8 56.0 51.4 53.8 51.2 42.6 55.6 49.7 51.9 73.9 45.5 47.3 79.2 52.6 45.9 22.7 26.2 27.8 27.5 23.4 21.5 19.3 25.5 22.0 20.9 ZBTB11 "ZNF-U69274, ZNF913" ENSG00000066422 "Zinc finger and BTB domain containing 11" O95625 3 101648889-101677495 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015328, HPA024138" Approved Enhanced Nucleoplasm Nucleoplasm "HPA015328: AB_1858938, HPA024138: AB_1858939" "unprognostic (3.25e-3)" "unprognostic (9.62e-2)" "unprognostic (4.92e-2)" "prognostic unfavourable (7.49e-4)" "unprognostic (2.86e-2)" "unprognostic (7.04e-2)" "unprognostic (1.17e-3)" "unprognostic (4.77e-1)" "unprognostic (6.65e-3)" "unprognostic (1.75e-1)" "unprognostic (1.41e-1)" "unprognostic (1.45e-2)" "unprognostic (5.64e-2)" "unprognostic (2.91e-1)" "unprognostic (1.89e-1)" "unprognostic (5.90e-2)" "unprognostic (2.09e-1)" 11.6 11.0 14.8 14.8 16.5 44.0 13.7 21.9 16.0 14.1 11.9 8.5 8.4 11.4 13.6 10.4 14.1 10.9 10.5 9.1 12.3 12.4 10.5 12.9 14.2 16.6 11.2 12.9 15.0 16.4 19.1 14.3 14.2 14.3 13.0 10.8 7.1 15.2 13.2 16.2 16.6 12.7 12.3 13.5 16.6 11.7 13.7 13.6 28.7 13.6 10.2 16.4 14.4 22.3 6.8 8.0 9.6 11.6 5.2 9.0 4.6 9.8 10.9 7.3 9.6 11.3 11.2 12.7 9.7 9.3 8.7 9.7 9.9 6.8 11.8 7.9 7.1 12.2 10.7 10.8 15.7 12.3 7.6 26.3 10.1 9.1 8.7 18.5 9.7 8.9 13.9 8.0 18.8 8.5 15.1 14.5 9.3 11.9 16.2 8.3 6.8 16.2 13.3 11.3 14.4 8.2 11.6 21.3 7.9 12.5 10.3 12.8 13.0 10.1 9.7 13.5 10.0 5.5 9.5 16.7 13.9 22.2 8.4 12.2 9.5 9.6 6.3 7.0 6.8 8.2 9.0 5.4 5.8 7.5 8.0 6.8 6.8 5.6 4.3 5.2 11.6 4.8 6.3 4.6 14.8 16.5 21.9 16.0 12.3 12.4 11.2 12.9 14.3 13.6 ZDHHC11 "FLJ13153, ZNF399" ENSG00000188818 "Zinc finger DHHC-type containing 11" Q9H8X9 5 795606-850986 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.2" "Cell line enhanced" "Detected in many" "T-47d: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA057886, HPA069008" Uncertain Approved "Lipid droplets" "Lipid droplets" "HPA057886: , HPA069008: " "unprognostic (2.67e-1)" "unprognostic (9.76e-3)" "unprognostic (4.47e-5)" "unprognostic (5.43e-2)" "unprognostic (7.46e-2)" "unprognostic (4.68e-2)" "unprognostic (3.71e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-2)" "unprognostic (2.32e-1)" "unprognostic (2.28e-2)" "unprognostic (2.65e-1)" "unprognostic (5.23e-5)" "unprognostic (4.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.86e-2)" "unprognostic (3.51e-2)" 1.8 1.4 3.4 1.0 4.2 0.7 2.7 11.0 3.8 1.6 1.5 6.3 1.0 9.5 1.7 2.9 3.2 10.3 1.2 6.4 4.2 3.8 2.0 2.6 7.5 1.0 15.2 1.9 1.5 1.9 1.8 7.8 1.2 10.9 2.7 1.2 1.0 1.4 3.4 2.1 2.7 1.7 1.0 5.0 2.4 5.9 6.3 6.1 1.0 1.1 2.3 1.8 1.0 1.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.3 7.4 4.1 0.8 1.3 0.3 5.5 0.3 0.1 0.2 0.1 1.0 0.3 3.0 0.8 0.1 6.9 2.2 0.0 0.1 9.0 4.8 0.3 2.6 3.7 0.3 4.3 0.3 0.4 0.3 0.9 1.0 0.0 0.7 1.7 0.2 3.3 0.4 2.6 7.3 2.9 4.5 2.8 4.1 0.2 1.5 4.1 0.7 0.2 0.1 3.1 11.5 0.7 0.4 0.2 6.9 3.9 0.1 5.5 7.7 0.9 0.3 8.9 0.2 0.0 0.0 0.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.2 11.0 3.8 4.2 3.8 15.2 1.9 10.9 6.1 ZDHHC11B ENSG00000206077 "Zinc finger DHHC-type containing 11B" P0C7U3 5 710360-766952 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell line enhanced" "Detected in some" "HAP1: 5.0;RPMI-8226: 4.4;SCLC-21H: 6.5;THP-1: 7.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "HPA057886, HPA069008" Uncertain Approved "Lipid droplets" "Lipid droplets" "HPA057886: , HPA069008: " "unprognostic (2.81e-1)" "unprognostic (8.38e-3)" "unprognostic (3.79e-2)" "unprognostic (5.11e-3)" "unprognostic (7.18e-2)" "unprognostic (4.02e-3)" "unprognostic (1.19e-1)" "prognostic favourable (3.98e-4)" "unprognostic (4.39e-3)" "unprognostic (1.29e-1)" "unprognostic (1.45e-4)" "unprognostic (6.94e-2)" "unprognostic (1.43e-2)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (2.31e-1)" 0.3 1.8 2.9 0.0 3.7 0.0 0.6 11.7 5.3 0.0 1.1 3.8 0.5 0.4 2.8 3.4 0.5 3.8 3.9 2.9 0.4 0.6 5.3 0.0 2.8 0.8 2.4 1.5 3.7 0.1 0.6 1.9 1.0 0.4 3.3 4.8 5.9 0.0 2.5 3.3 3.8 0.8 0.7 0.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.9 0.8 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.2 1.0 0.3 0.0 2.4 5.0 0.2 0.0 3.0 2.3 0.0 1.9 0.9 0.0 1.5 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.2 0.0 0.0 4.4 0.1 1.5 6.5 1.9 0.1 0.0 0.6 0.1 7.0 0.1 0.0 2.5 0.0 0.0 2.4 0.8 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 ZDHHC17 "HIP14, HYPH, KIAA0946" ENSG00000186908 "Zinc finger DHHC-type containing 17" Q8IUH5 12 76763588-76853696 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 16.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016807, HPA058674" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA016807: AB_1858999, HPA058674: " "unprognostic (1.06e-1)" "unprognostic (2.26e-2)" "unprognostic (2.63e-2)" "unprognostic (3.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-3)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.56e-3)" "unprognostic (5.42e-2)" "prognostic unfavourable (7.11e-5)" "unprognostic (1.77e-2)" "unprognostic (2.69e-1)" "unprognostic (2.98e-1)" "unprognostic (1.71e-2)" 7.9 7.8 10.0 5.8 14.0 11.3 8.8 18.1 18.1 8.0 5.9 9.2 3.8 3.6 12.0 6.8 6.4 7.0 5.5 6.4 8.7 6.5 9.1 13.1 5.4 7.1 11.3 10.7 11.5 5.2 9.5 10.3 8.7 13.2 7.9 5.4 5.9 5.7 7.3 5.4 5.9 6.4 8.0 10.0 7.1 6.1 6.4 11.6 7.5 6.2 4.1 5.7 5.6 6.3 3.8 16.3 5.8 2.2 1.7 3.6 1.4 5.7 7.1 22.2 11.3 13.4 14.2 10.9 11.7 9.7 7.8 6.9 5.6 4.2 8.0 7.1 11.3 5.5 8.8 7.3 12.2 6.7 9.3 11.6 8.7 8.5 9.0 11.6 10.4 13.3 7.7 7.3 11.0 8.9 12.5 3.7 10.1 5.4 8.3 15.6 16.4 8.1 11.3 7.9 8.7 9.0 8.9 8.7 15.1 12.9 4.7 7.5 10.5 11.7 12.3 10.7 8.1 6.5 6.6 6.0 5.8 8.7 4.0 5.5 11.0 5.7 2.1 5.2 3.6 2.2 2.9 2.6 2.9 2.7 2.6 3.8 3.1 2.6 5.8 1.7 2.1 16.3 1.2 1.4 10.0 14.0 18.1 13.8 8.7 6.5 11.3 10.7 13.2 11.6 ZDHHC2 "DHHC2, ZNF372" ENSG00000104219 "Zinc finger DHHC-type containing 2" Q9UIJ5 8 17156029-17224799 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023331 Uncertain "HPA023331: " "unprognostic (8.92e-2)" "unprognostic (4.23e-1)" "unprognostic (1.80e-2)" "unprognostic (2.53e-1)" "unprognostic (6.89e-2)" "unprognostic (2.25e-1)" "unprognostic (6.12e-2)" "unprognostic (1.78e-2)" "unprognostic (1.04e-1)" "unprognostic (2.37e-2)" "unprognostic (2.16e-1)" "unprognostic (1.58e-1)" "prognostic favourable (3.24e-4)" "unprognostic (5.00e-2)" "unprognostic (3.87e-1)" "unprognostic (2.87e-2)" "unprognostic (5.10e-2)" 10.1 22.5 14.8 9.4 14.5 24.4 14.8 22.8 12.2 12.9 13.4 17.5 17.4 9.3 7.0 10.5 5.3 12.8 6.4 10.1 13.0 14.0 24.2 7.5 12.7 10.3 13.6 10.9 13.0 27.0 19.2 20.2 6.1 14.7 12.0 10.3 21.2 15.9 13.7 15.9 3.4 9.1 8.8 25.9 11.2 14.1 14.2 14.5 13.8 32.3 10.4 10.2 17.3 8.7 5.3 4.6 4.9 2.7 4.4 7.0 1.5 1.0 5.4 10.5 2.2 9.2 16.5 6.1 18.0 21.9 10.2 12.2 1.7 15.0 10.9 7.1 15.6 0.7 14.1 8.9 19.0 7.1 7.1 9.8 7.8 2.1 9.2 10.3 1.2 6.9 1.4 12.8 11.7 16.8 1.1 29.3 12.3 0.2 7.6 6.2 6.6 8.3 7.6 10.5 4.0 18.6 11.5 5.6 3.7 7.7 0.0 1.7 0.4 4.7 13.9 5.2 16.0 11.5 17.9 5.8 21.9 12.8 14.4 9.5 2.3 2.6 2.6 4.9 4.1 2.7 7.0 5.3 5.1 4.9 2.2 4.6 4.7 5.0 1.8 4.4 1.6 4.6 2.6 1.5 14.8 14.5 22.8 12.2 13.0 14.0 13.6 10.9 14.7 14.5 ZDHHC23 MGC42530 ENSG00000184307 "Zinc finger DHHC-type containing 23" Q8IYP9 3 113947901-113965401 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.7;naive B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016808 Uncertain Approved Nucleoplasm Nucleoplasm "HPA016808: AB_1859002" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (4.48e-3)" "prognostic unfavourable (2.85e-4)" "unprognostic (1.49e-1)" "unprognostic (3.98e-3)" "unprognostic (1.37e-2)" "unprognostic (2.48e-1)" "unprognostic (3.19e-1)" "unprognostic (6.63e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-2)" "prognostic favourable (1.48e-7)" "unprognostic (2.58e-2)" "unprognostic (1.83e-1)" "prognostic unfavourable (5.90e-4)" "unprognostic (3.29e-3)" 1.0 0.8 6.3 2.1 5.9 0.4 1.9 2.7 10.4 1.4 7.7 0.9 2.2 6.0 1.5 1.6 1.7 2.1 1.8 1.3 8.9 1.9 4.7 3.2 2.4 2.7 0.9 4.7 1.1 4.4 8.2 3.5 0.4 1.4 1.8 9.9 1.2 4.9 1.4 1.2 2.9 5.4 0.7 0.9 1.9 5.0 25.8 0.6 0.8 5.5 0.9 2.8 1.7 1.5 2.7 1.1 0.5 0.0 0.0 0.5 0.1 13.3 3.4 0.4 7.9 1.2 0.2 11.6 5.3 1.6 1.0 1.6 5.5 9.0 6.1 4.7 3.0 8.8 10.1 1.4 1.7 3.6 4.6 5.7 4.9 3.4 0.4 6.3 5.3 0.2 1.7 0.2 0.7 0.9 0.0 3.6 0.1 7.7 5.2 0.4 2.4 3.8 0.9 4.6 5.1 5.6 6.6 13.9 3.5 4.1 13.7 2.6 8.2 2.1 0.2 3.8 7.7 0.8 2.3 4.1 5.3 9.9 3.3 4.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.1 0.0 1.7 0.1 0.0 0.5 0.0 0.0 1.1 0.1 0.1 6.3 5.9 2.7 10.4 8.9 1.9 0.9 4.7 1.4 0.6 ZDHHC3 "DHHC3, GODZ, ZNF373" ENSG00000163812 "Zinc finger DHHC-type containing 3" Q9NYG2 3 44915257-44976185 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012465, HPA016616" Approved Approved "Golgi apparatus" "Golgi apparatus" "CAB012465: , HPA016616: AB_1859004" "unprognostic (2.80e-1)" "unprognostic (6.07e-2)" "prognostic favourable (3.43e-4)" "unprognostic (3.10e-2)" "unprognostic (2.47e-2)" "unprognostic (3.38e-1)" "prognostic unfavourable (1.37e-4)" "unprognostic (4.20e-2)" "unprognostic (1.04e-1)" "unprognostic (6.37e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "prognostic favourable (1.81e-8)" "unprognostic (2.64e-1)" "unprognostic (1.49e-1)" "unprognostic (5.33e-2)" "unprognostic (4.26e-2)" 23.1 25.8 11.7 17.5 14.0 29.5 39.8 12.5 20.8 17.2 27.9 13.7 17.8 18.4 19.2 17.9 29.1 13.0 22.7 34.6 11.2 9.1 21.7 19.0 20.2 16.1 12.1 7.7 16.5 15.0 16.9 8.8 19.5 19.4 16.1 28.9 14.7 17.4 22.5 20.0 43.0 33.2 15.4 13.6 15.4 20.9 48.0 10.1 14.1 20.4 22.1 20.6 21.4 20.7 5.4 11.4 17.1 10.0 6.0 7.1 5.2 11.9 9.6 8.7 12.1 37.3 18.9 9.7 10.6 13.3 13.6 12.2 11.6 15.8 10.9 5.7 18.7 15.4 13.4 18.7 14.4 10.8 5.7 9.6 13.3 8.5 8.5 25.0 7.9 16.2 23.1 12.9 12.8 14.2 14.1 9.7 12.4 7.7 7.5 18.2 11.6 19.2 5.6 7.3 8.2 13.4 37.6 2.7 10.5 12.7 13.2 5.8 9.9 17.3 15.1 11.8 10.8 13.7 13.8 6.7 12.4 10.8 10.7 38.3 8.7 17.1 10.0 13.8 6.5 5.5 6.1 4.7 4.7 7.1 11.4 5.4 4.9 6.3 11.4 6.0 7.2 6.7 6.9 5.2 11.7 14.0 12.5 20.8 11.2 9.1 12.1 7.7 19.4 10.1 ZFPL1 "D11S750, MCG4" ENSG00000162300 "Zinc finger protein like 1" O95159 11 65084223-65088400 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014909, HPA017347" Enhanced Enhanced "Golgi apparatus" "Golgi apparatus" "HPA014909: AB_1859055, HPA017347: AB_1859056" "unprognostic (2.03e-1)" "unprognostic (5.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (9.12e-6)" "unprognostic (1.19e-2)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" "unprognostic (3.63e-1)" "unprognostic (7.34e-2)" "prognostic favourable (2.73e-5)" "unprognostic (1.88e-1)" "unprognostic (1.44e-1)" "unprognostic (4.34e-2)" "unprognostic (6.94e-2)" 22.2 23.6 20.9 17.3 25.0 34.9 20.4 17.3 31.8 19.1 23.2 30.6 24.9 24.7 23.6 27.6 24.5 26.3 24.1 26.5 21.6 18.4 21.8 28.8 16.2 15.4 29.1 19.2 26.4 40.0 16.9 30.4 33.0 21.2 22.4 14.0 23.1 38.4 25.7 33.0 24.2 26.4 18.5 21.6 18.6 24.7 28.5 23.7 17.7 26.0 22.0 21.6 24.5 18.7 11.1 11.6 33.1 12.2 12.2 13.9 6.5 26.8 18.8 11.9 12.4 10.6 15.1 19.0 12.7 15.7 15.0 11.9 12.6 18.8 9.3 25.4 18.1 14.7 6.8 15.6 5.2 13.4 12.6 9.6 14.6 25.8 22.9 7.3 13.0 14.2 21.1 11.3 19.6 14.2 11.3 14.5 11.1 37.9 11.2 16.1 8.2 16.7 10.4 6.8 24.0 11.7 13.5 13.0 11.1 10.2 19.4 27.7 28.7 11.4 13.8 10.1 16.9 22.0 10.3 10.1 9.8 11.5 15.6 6.9 18.8 33.1 11.5 23.0 9.2 12.2 9.7 10.7 8.6 9.5 11.6 11.1 9.6 8.5 15.9 12.2 11.0 10.9 13.9 6.5 20.9 25.0 17.3 31.8 21.6 18.4 29.1 19.2 21.2 23.7 ZFYVE27 "FLJ32919, SPG33" ENSG00000155256 "Zinc finger FYVE-type containing 27" Q5T4F4 10 97737121-97760907 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037523, HPA069876" Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA037523: AB_10672351, HPA069876: " "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "prognostic unfavourable (6.91e-4)" "unprognostic (3.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.30e-2)" "unprognostic (2.48e-2)" "unprognostic (7.15e-2)" "unprognostic (2.05e-3)" "unprognostic (5.24e-2)" "unprognostic (3.38e-3)" "prognostic favourable (7.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.26e-2)" "prognostic favourable (7.80e-4)" 10.1 22.6 16.1 12.7 20.8 20.7 11.8 28.6 33.0 10.3 17.4 15.7 17.4 25.6 11.6 25.4 9.8 17.9 14.1 12.8 17.6 20.7 15.5 18.2 11.3 15.2 15.1 23.4 17.1 15.4 19.6 24.3 14.3 17.6 13.3 17.5 25.6 14.0 11.8 7.9 17.1 24.0 9.4 14.7 18.1 14.9 14.2 13.3 12.2 13.1 5.5 14.7 8.5 10.4 11.2 8.5 13.4 12.6 9.0 15.2 11.7 10.4 12.9 7.8 17.2 8.9 6.2 10.6 10.7 11.3 12.5 12.3 11.4 21.8 16.2 12.3 7.7 23.5 11.2 10.4 6.6 16.6 11.3 7.6 12.7 10.6 11.4 12.2 15.4 10.1 12.6 12.3 9.5 7.0 11.3 10.9 9.3 8.1 9.8 23.2 6.3 10.0 11.3 7.8 7.6 12.0 6.4 6.3 12.2 7.2 6.1 27.7 13.3 12.2 7.4 6.3 7.5 9.6 20.3 12.7 10.7 8.4 15.8 15.8 7.2 7.1 8.4 13.4 15.2 9.1 13.1 10.9 10.5 12.0 8.0 11.2 12.1 12.9 12.1 9.0 12.6 8.5 13.4 11.7 16.1 20.8 28.6 33.0 17.6 20.7 15.1 23.4 17.6 13.3 ZMYM5 "MYM, ZNF198L1, ZNF237" ENSG00000132950 "Zinc finger MYM-type containing 5" Q9UJ78 13 19823482-19863636 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA015544, HPA020879" Uncertain Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA015544: , HPA020879: " "unprognostic (4.14e-1)" "unprognostic (3.05e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.94e-2)" "unprognostic (9.35e-2)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.31e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (4.37e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 10.2 10.6 7.4 10.5 8.6 11.4 10.7 18.2 11.9 9.7 8.5 6.0 6.2 6.9 9.3 10.6 12.4 8.5 10.9 9.0 8.5 5.6 7.6 7.8 8.9 10.6 13.7 5.5 11.0 8.2 6.4 18.6 8.1 9.2 9.7 7.5 7.6 9.5 9.4 9.5 8.7 10.7 9.7 13.2 9.6 8.1 25.2 10.6 22.1 10.8 7.5 12.3 10.9 10.9 12.8 9.9 15.6 8.7 9.3 13.1 5.4 6.5 3.4 8.0 6.2 5.7 9.0 2.9 6.4 9.9 10.1 8.6 8.2 13.0 9.0 6.7 9.2 6.2 5.8 7.4 11.9 7.2 4.6 16.9 6.1 5.6 17.6 12.4 9.1 11.0 9.0 5.5 10.5 10.4 6.8 7.9 9.6 16.1 9.0 12.4 4.2 5.2 10.1 10.0 3.6 8.6 7.3 7.3 7.0 7.9 6.8 20.6 10.2 10.6 8.3 5.7 4.1 7.5 4.4 12.9 5.7 13.5 5.5 5.3 9.0 15.6 7.0 9.9 11.7 6.3 12.4 12.8 13.1 11.2 7.0 11.1 10.4 11.1 13.7 9.3 8.7 9.9 10.5 5.4 7.4 8.6 18.2 11.9 8.5 5.6 13.7 5.5 9.2 10.6 ZMYM6 "Buster2, MYM, ZBED7, ZNF198L4, ZNF258" ENSG00000163867 "Zinc finger MYM-type containing 6" O95789 1 34986165-35031968 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA011004, HPA071865" Approved Approved Nucleoplasm Nucleoplasm "HPA011004: AB_1859075, HPA071865: " "prognostic favourable (1.30e-5)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" "unprognostic (3.92e-2)" "unprognostic (2.11e-6)" "unprognostic (1.77e-3)" "unprognostic (4.83e-3)" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.70e-2)" "unprognostic (9.29e-2)" "unprognostic (7.15e-2)" "unprognostic (2.28e-1)" "unprognostic (1.72e-1)" "unprognostic (4.84e-3)" 12.8 14.7 9.4 13.3 15.9 21.3 11.6 16.3 16.0 10.7 10.9 14.6 9.8 11.0 13.3 13.6 12.8 11.7 10.7 10.8 8.6 8.3 11.7 9.7 12.2 14.9 13.8 10.2 15.9 11.5 13.7 33.7 7.9 17.0 11.0 12.9 12.5 12.9 11.0 8.0 13.6 15.3 11.9 16.7 20.1 11.6 14.9 10.1 16.2 15.4 8.4 14.7 12.5 11.2 10.1 12.3 9.0 9.3 6.5 9.3 4.3 9.3 5.1 9.3 8.9 10.7 13.5 5.8 7.8 11.7 9.4 10.3 4.0 10.3 12.9 8.4 11.5 9.2 10.3 8.3 11.5 8.9 6.1 11.3 7.3 5.4 9.4 15.7 13.4 11.3 11.9 10.4 8.7 10.5 17.5 14.2 9.4 3.0 7.2 10.7 9.4 8.2 10.3 12.3 7.3 7.7 7.3 9.7 9.1 9.1 8.6 10.6 5.7 8.7 10.7 11.8 8.7 12.3 11.5 8.7 13.3 9.5 11.9 15.2 9.4 4.6 9.3 9.0 9.3 7.5 8.1 8.1 6.4 5.3 8.3 10.1 9.1 6.1 4.9 6.5 9.1 12.3 6.8 4.3 9.4 15.9 16.3 16.0 8.6 8.3 13.8 10.2 17.0 10.1 ZMYND11 BS69 ENSG00000015171 "Zinc finger MYND-type containing 11" Q15326 10 134465-254637 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015816 Supported Nucleoplasm Nucleoplasm "HPA015816: AB_1845427" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (3.00e-1)" "unprognostic (1.12e-1)" "unprognostic (9.12e-2)" "unprognostic (2.33e-2)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (1.80e-2)" "unprognostic (3.73e-2)" "unprognostic (4.47e-3)" "unprognostic (6.35e-2)" "prognostic favourable (4.76e-7)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (9.04e-2)" "unprognostic (1.42e-1)" 19.9 19.6 35.7 12.8 35.0 5.1 23.9 38.0 32.5 26.4 26.9 27.3 18.5 15.4 28.8 24.8 23.0 21.8 18.5 28.7 34.1 27.7 26.9 17.8 19.7 12.0 33.3 26.2 30.0 24.2 63.6 24.0 17.6 27.5 28.0 17.9 17.0 21.6 30.2 29.1 16.2 15.4 49.2 38.0 15.5 19.5 15.9 28.9 7.1 46.0 13.4 12.4 31.3 29.6 4.4 4.0 16.2 2.8 12.3 10.7 4.3 23.7 25.2 20.6 16.4 23.3 22.6 12.4 24.2 14.1 17.2 16.2 15.1 23.9 0.0 7.8 30.3 14.3 11.2 17.4 22.1 9.3 9.1 26.1 13.8 16.2 25.3 7.0 14.7 15.7 22.6 16.7 15.5 21.3 6.9 17.3 28.4 29.0 10.9 9.5 6.5 4.3 10.4 13.3 12.4 21.7 27.9 9.2 16.9 26.9 31.9 12.5 28.7 13.8 27.5 17.3 6.0 33.8 18.2 13.9 17.6 1.7 17.2 13.3 11.5 9.8 2.0 16.2 10.7 2.8 9.5 4.4 7.7 10.7 3.1 3.0 8.3 8.3 0.9 12.3 1.2 4.0 7.2 4.3 35.7 35.0 38.0 31.4 34.1 27.7 33.3 26.2 27.5 28.9 ZNF333 KIAA1806 ENSG00000160961 "Zinc finger protein 333" Q96JL9 19 14689801-14733746 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043973, HPA054680" Uncertain Approved Nucleoplasm Nucleoplasm "HPA043973: AB_10961277, HPA054680: " "unprognostic (8.16e-2)" "unprognostic (2.80e-4)" "unprognostic (5.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-2)" "unprognostic (1.45e-3)" "unprognostic (2.98e-2)" "unprognostic (2.17e-3)" "unprognostic (2.12e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-3)" "unprognostic (3.46e-2)" "unprognostic (1.32e-5)" "unprognostic (4.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.62e-1)" "unprognostic (7.06e-3)" 10.7 8.1 8.8 7.8 11.3 12.2 9.4 16.2 12.1 11.4 9.9 14.3 7.0 4.5 16.5 11.0 5.3 10.8 6.6 6.3 8.6 6.9 5.8 4.9 8.7 7.3 16.8 9.8 15.3 9.1 8.2 7.5 7.4 10.3 8.8 5.9 10.3 5.7 8.5 14.5 7.7 6.5 11.6 9.6 13.0 6.7 8.8 12.8 6.7 6.9 4.3 6.6 9.5 8.8 2.7 4.9 7.9 5.0 13.5 5.4 2.4 1.5 0.9 5.7 7.7 8.3 7.8 2.2 3.5 4.8 3.0 4.4 0.4 1.4 2.4 3.9 4.5 1.4 2.0 1.4 4.6 5.5 1.5 9.8 2.1 2.4 6.8 3.9 5.6 7.1 3.8 2.8 8.0 4.4 2.0 4.7 3.8 0.8 2.5 9.4 2.3 1.7 3.6 3.2 2.3 3.0 2.0 3.1 6.1 3.1 0.4 5.6 1.5 6.6 7.1 5.2 2.4 8.3 3.6 2.2 1.0 2.4 5.4 6.8 6.1 7.9 4.0 6.0 4.0 5.0 5.4 2.6 3.6 3.0 4.9 2.7 4.1 3.6 7.0 13.5 4.3 2.4 3.0 2.4 8.8 11.3 16.2 12.1 8.6 6.9 16.8 9.8 10.3 12.8 ZNF511 MGC30006 ENSG00000198546 "Zinc finger protein 511" Q8NB15 10 133308475-133313162 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA035360 Uncertain "Intracellular and membrane" "HPA035360: AB_10601931" "unprognostic (3.35e-2)" "unprognostic (2.19e-1)" "unprognostic (1.91e-1)" "unprognostic (8.84e-2)" "unprognostic (1.31e-1)" "unprognostic (1.16e-1)" "unprognostic (3.04e-1)" "unprognostic (1.68e-2)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (1.40e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (1.13e-4)" "unprognostic (1.94e-2)" "unprognostic (3.91e-2)" "unprognostic (2.55e-1)" "unprognostic (4.52e-2)" 11.4 11.2 10.1 13.2 10.3 14.8 20.5 16.9 11.0 12.0 18.3 8.7 17.1 8.2 16.8 13.2 13.1 15.4 11.7 20.6 9.4 7.7 13.8 21.2 11.4 16.4 9.6 8.7 21.2 30.1 9.9 13.6 9.7 8.2 17.4 10.9 11.4 17.3 13.6 25.9 9.3 19.1 15.5 8.8 12.7 12.1 21.3 10.8 12.3 16.0 23.2 11.9 12.2 16.8 21.5 19.3 21.6 18.9 12.8 15.6 15.3 11.0 12.7 7.2 8.8 7.4 6.3 6.8 6.3 10.4 15.1 12.8 20.9 11.3 13.8 5.2 7.1 10.1 11.2 9.7 5.9 9.5 32.1 7.1 5.7 10.6 6.0 12.9 10.4 6.2 5.3 11.5 5.4 6.7 11.1 3.8 5.2 18.1 3.7 16.6 7.8 23.8 6.2 9.3 2.8 7.6 4.0 4.2 6.8 5.2 5.8 7.4 4.9 7.3 6.5 6.3 6.2 5.4 15.0 4.9 7.5 16.0 7.4 6.2 2.5 10.6 18.9 21.6 14.3 14.9 11.8 21.5 12.5 15.6 18.9 14.7 14.4 13.5 2.9 12.8 14.7 19.3 10.4 15.3 10.1 10.3 16.9 11.0 9.4 7.7 9.6 8.7 8.2 10.8 ZNF511-PRAP1 ENSG00000283496 "ZNF511-PRAP1 readthrough" 10 133309410-133352529 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 31.6;liver: 23.8" "Cell line enhanced" "Detected in many" "BEWO: 6.9;CACO-2: 7.0;Hep G2: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035360, HPA038713, HPA052451" Supported "HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: " 2.1 1.6 1.1 5.0 1.7 1.2 6.2 3.0 2.7 3.1 11.9 1.9 4.9 31.6 3.9 3.5 3.5 1.3 3.0 4.8 1.8 13.7 23.8 2.1 4.7 2.2 1.9 4.9 9.7 0.9 2.1 1.5 1.7 5.1 7.6 2.9 5.0 3.0 5.8 1.3 28.1 4.4 0.8 3.0 3.4 6.5 2.7 3.2 4.6 7.1 3.0 2.0 4.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.2 3.3 5.2 0.0 0.0 6.9 0.0 1.4 0.0 0.0 7.0 2.2 0.0 3.3 1.7 0.1 0.8 0.0 2.1 0.3 0.0 0.9 0.0 16.6 0.0 1.3 1.8 0.0 0.0 1.5 5.0 0.0 0.3 6.3 0.0 0.0 3.4 5.3 0.3 0.0 0.9 1.2 3.0 0.2 0.3 0.5 5.6 0.3 2.8 2.4 0.0 0.5 0.0 0.0 3.1 2.6 0.1 1.5 0.0 0.8 0.4 1.1 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 ZNF584 FLJ39899 ENSG00000171574 "Zinc finger protein 584" Q8IVC4 19 58401504-58418327 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043408, HPA048075" Uncertain Approved "Nuclear speckles" "Nuclear speckles" "HPA043408: , HPA048075: " "unprognostic (6.06e-2)" "unprognostic (3.27e-3)" "unprognostic (3.76e-3)" "unprognostic (8.15e-3)" "unprognostic (5.50e-2)" "unprognostic (1.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.04e-2)" "unprognostic (6.33e-2)" "unprognostic (2.17e-1)" "unprognostic (1.01e-3)" "unprognostic (1.90e-3)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.80e-1)" "unprognostic (3.27e-1)" "unprognostic (1.36e-2)" 10.4 9.3 7.3 7.4 11.7 3.3 11.7 16.6 12.1 10.6 8.6 9.5 6.4 7.4 10.5 8.2 9.2 13.8 10.5 13.3 7.6 9.6 10.4 13.4 7.9 6.7 7.2 5.0 11.9 13.1 13.6 11.6 5.8 7.9 8.6 5.5 10.8 7.6 13.0 13.3 11.7 4.6 10.9 6.2 6.4 8.1 6.3 7.8 6.6 11.5 10.3 6.7 8.7 16.6 4.4 5.0 1.2 4.5 4.1 8.4 3.9 6.9 10.2 7.0 9.1 6.8 6.9 2.8 5.5 9.7 3.4 4.1 1.6 2.0 3.4 4.4 8.8 3.9 7.5 8.9 3.9 4.5 30.8 9.3 5.8 1.9 11.7 10.2 2.6 7.0 6.4 10.3 14.4 6.7 9.3 3.1 5.5 4.9 8.5 3.1 1.7 14.3 6.2 5.2 5.3 4.8 8.2 5.6 5.9 11.9 3.3 4.6 2.1 5.1 4.1 13.4 4.1 5.5 8.6 3.1 5.5 0.7 9.6 3.5 4.3 0.0 3.2 1.2 5.0 3.1 8.4 3.3 6.8 7.2 5.0 4.4 3.8 5.7 1.0 4.1 4.5 4.4 7.2 3.9 7.3 11.7 16.6 12.1 7.6 9.6 7.2 5.0 7.9 7.8 ZNF816 ZNF816A ENSG00000180257 "Zinc finger protein 816" Q0VGE8 19 52949379-52962911 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA042466 Uncertain Approved Nucleoli Nucleoli "HPA042466: AB_10797497" "unprognostic (1.83e-2)" "unprognostic (1.90e-1)" "unprognostic (1.64e-1)" "unprognostic (4.81e-2)" "unprognostic (3.12e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-4)" "unprognostic (1.69e-1)" "unprognostic (1.33e-3)" "unprognostic (4.82e-2)" "unprognostic (1.01e-1)" "unprognostic (3.72e-2)" "unprognostic (5.36e-3)" "unprognostic (6.21e-2)" "unprognostic (5.45e-1)" "unprognostic (8.59e-2)" "unprognostic (1.39e-2)" 6.2 6.4 4.9 8.0 8.3 2.8 8.0 14.7 6.6 10.2 8.9 4.5 12.5 4.7 6.7 10.1 8.4 12.1 9.8 5.8 5.0 3.3 9.6 3.2 7.0 7.1 10.4 3.4 9.5 8.7 6.7 11.8 9.2 6.1 15.5 10.4 4.5 8.6 9.8 2.4 5.3 7.3 8.0 9.1 11.0 9.4 5.4 8.9 18.9 10.2 5.8 8.5 14.3 9.4 11.6 8.4 14.4 7.7 17.6 17.5 7.4 4.0 0.1 3.7 9.5 6.9 7.6 10.9 3.4 3.5 4.4 6.5 3.2 2.7 10.9 7.2 3.0 2.4 5.3 3.9 4.3 5.4 11.2 5.1 4.2 4.9 2.3 0.0 7.9 3.6 5.0 2.6 5.1 3.7 8.0 0.4 5.5 3.2 8.7 5.8 4.4 5.0 4.9 8.0 5.4 6.9 32.9 2.8 5.2 0.4 5.7 2.2 3.8 5.9 3.5 3.2 3.2 2.1 3.8 3.8 10.9 10.2 0.4 5.4 3.8 10.0 7.3 14.4 13.6 6.2 17.5 9.9 12.7 13.1 8.4 11.6 17.2 13.8 4.1 17.6 7.7 8.3 11.5 7.4 4.9 8.3 14.7 6.6 5.0 3.3 10.4 3.4 6.1 8.9 ZNRF3 "BK747E2.3, FLJ22057, KIAA1133, RNF203" ENSG00000183579 "Zinc and ring finger 3" Q9ULT6 22 28883592-29057487 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 28.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036702, HPA036703" Uncertain Uncertain "Golgi apparatus" "Golgi apparatus" "HPA036702: , HPA036703: AB_10672227" "unprognostic (1.07e-1)" "unprognostic (2.13e-3)" "unprognostic (7.48e-3)" "unprognostic (5.72e-2)" "unprognostic (6.81e-2)" "unprognostic (1.36e-1)" "unprognostic (2.22e-2)" "unprognostic (1.75e-2)" "unprognostic (1.37e-1)" "unprognostic (3.68e-2)" "unprognostic (5.18e-2)" "unprognostic (3.94e-1)" "unprognostic (9.55e-5)" "unprognostic (6.49e-2)" "unprognostic (1.02e-1)" "unprognostic (3.70e-2)" "unprognostic (2.55e-2)" 4.6 11.8 16.8 2.5 14.7 1.0 4.5 12.2 18.1 7.8 5.7 7.7 21.8 5.1 8.3 22.2 5.9 8.1 3.8 4.3 22.0 5.0 13.6 7.5 8.7 1.2 6.1 17.7 10.0 5.4 16.3 4.2 8.0 8.1 12.0 5.9 4.9 12.1 13.4 5.6 7.6 4.7 7.8 8.9 2.2 6.4 6.7 10.5 0.0 6.9 1.9 1.5 5.7 4.9 0.2 0.4 1.5 1.0 2.0 0.5 0.1 3.6 8.7 8.1 2.3 1.5 1.8 15.5 2.2 1.1 1.8 1.7 13.1 2.0 0.0 3.5 1.1 6.2 5.6 3.5 2.2 4.8 5.7 1.4 1.5 28.6 1.3 4.3 1.5 1.8 3.3 2.8 2.8 1.5 3.1 2.1 2.5 3.5 0.1 2.2 3.0 3.5 4.3 5.3 3.3 7.5 5.4 13.5 5.0 4.0 3.9 2.3 2.6 1.9 1.4 6.8 5.8 5.3 3.6 2.8 3.8 5.1 2.9 2.4 3.5 1.0 0.2 1.3 0.2 1.0 0.4 0.1 0.2 0.1 0.4 0.2 0.1 0.5 1.5 2.0 0.2 0.3 0.1 0.1 16.8 14.7 12.2 18.1 22.0 5.0 6.1 17.7 8.1 10.5 ZP2 ZPA ENSG00000103310 "Zona pellucida glycoprotein 2" Q05996 16 21197450-21214510 "Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 35.2" "Cell line enriched" "Detected in single" 35 "HDLM-2: 8.9" "Not detected" "Not detected" "Region enriched" "Detected in some" 22 "cerebellum: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA011296 Approved "Secreted in female reproductive system" "HPA011296: AB_1859485" "unprognostic (2.35e-2)" "unprognostic (3.12e-2)" "unprognostic (6.60e-2)" "unprognostic (9.83e-2)" "unprognostic (3.44e-3)" "unprognostic (3.12e-1)" "unprognostic (1.66e-1)" "unprognostic (4.41e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 1.1 35.2 0.1 0.8 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.9 1.6 0.0 0.1 0.0 3.1 0.0 0.0 0.1 1.5 0.1 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.1 0.0 0.0 0.0 0.0 1.6 0.0 ZP3 "ZP3-372, ZP3-424, ZP3A, ZP3B, ZPC" ENSG00000188372 "Zona pellucida glycoprotein 3" P21754 7 76397518-76442071 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 16.4;hTCEpi: 17.5;Karpas-707: 24.1;MCF7: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA054061 Supported "Secreted in female reproductive system" "HPA054061: " "unprognostic (6.48e-2)" "unprognostic (3.08e-1)" "unprognostic (7.74e-2)" "unprognostic (1.59e-1)" "unprognostic (9.04e-2)" "unprognostic (2.68e-2)" "unprognostic (1.99e-3)" "unprognostic (1.29e-1)" "unprognostic (9.20e-2)" "unprognostic (1.94e-1)" "unprognostic (3.10e-3)" "unprognostic (1.15e-2)" "prognostic unfavourable (1.02e-6)" "unprognostic (1.33e-1)" "unprognostic (1.42e-2)" "unprognostic (6.72e-2)" "unprognostic (2.13e-1)" 2.4 5.6 3.3 1.9 13.9 4.3 6.7 1.7 4.4 3.1 5.1 3.2 1.8 4.2 2.6 5.3 7.4 8.7 1.5 1.4 2.1 2.4 2.0 2.0 1.2 6.9 2.6 2.2 5.8 11.9 1.4 3.1 1.4 4.6 3.3 5.7 5.6 3.7 3.4 2.7 8.7 2.6 2.5 2.8 3.6 2.5 2.3 4.0 0.8 2.0 4.4 4.7 1.7 4.1 2.8 10.3 0.9 9.9 0.3 5.2 3.4 7.8 16.4 0.1 8.5 0.4 0.5 0.4 0.5 1.2 0.1 1.5 0.6 7.0 0.0 0.3 2.0 2.0 1.7 0.5 0.1 4.3 4.0 1.3 4.6 0.1 3.7 0.3 2.4 0.7 17.5 1.7 0.5 0.3 1.8 24.1 0.0 32.2 0.7 4.1 1.7 4.7 0.0 0.7 1.7 0.7 0.1 3.6 0.0 2.1 11.0 0.2 7.2 1.3 1.0 0.1 0.9 0.1 0.1 7.3 5.9 0.1 0.7 9.1 1.4 0.5 9.9 0.1 0.2 3.9 0.5 2.8 1.3 0.6 10.3 1.5 5.2 3.7 0.9 0.3 4.2 2.2 0.2 3.4 3.3 13.9 1.7 4.4 2.1 2.4 2.6 2.2 4.6 4.0 ZP4 ZPB ENSG00000116996 "Zona pellucida glycoprotein 4" Q12836 1 237877864-237890922 "Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.1;ovary: 2.3;placenta: 1.0" "Cell line enriched" "Detected in some" 4 "BJ hTERT+: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA008547 Supported "Secreted in female reproductive system" "HPA008547: AB_1080766" "unprognostic (7.12e-2)" "unprognostic (2.70e-1)" "unprognostic (4.59e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZPLD1 ENSG00000170044 "Zona pellucida like domain containing 1" Q8TCW7 3 102099244-102479841 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.0;gallbladder: 6.7;kidney: 2.6" "Cell line enriched" "Detected in some" 8 "RPTEC TERT1: 12.2" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 8 "non-classical monocyte: 3.0" "Lineage enriched" "Detected in single" 11 "monocytes: 3.0" "Region enriched" "Detected in single" 7 "olfactory region: 3.4" "Low region specificity" "Detected in all" HPA077519 Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA077519: " "unprognostic (2.49e-1)" "unprognostic (2.83e-3)" "unprognostic (6.38e-3)" "unprognostic (1.88e-1)" "unprognostic (5.02e-2)" "unprognostic (1.37e-2)" "unprognostic (2.68e-1)" "unprognostic (2.63e-1)" "unprognostic (4.63e-1)" "unprognostic (2.89e-4)" "unprognostic (4.59e-2)" "unprognostic (1.05e-3)" "unprognostic (1.97e-2)" "unprognostic (9.65e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 2.5 1.0 0.0 0.0 0.2 6.7 0.3 0.0 0.6 2.6 0.3 0.0 0.0 0.3 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 12.2 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 ZZEF1 "FLJ10821, KIAA0399, ZZZ4" ENSG00000074755 "Zinc finger ZZ-type and EF-hand domain containing 1" O43149 17 4004445-4143020 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031778, HPA031790" Uncertain Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA031778: AB_10599831, HPA031790: AB_10600999" "unprognostic (4.48e-2)" "unprognostic (7.59e-2)" "unprognostic (6.75e-2)" "unprognostic (2.39e-2)" "unprognostic (1.43e-1)" "prognostic favourable (1.02e-4)" "unprognostic (2.80e-1)" "unprognostic (1.44e-2)" "unprognostic (1.23e-1)" "unprognostic (2.21e-2)" "prognostic favourable (6.08e-4)" "unprognostic (1.54e-1)" "unprognostic (1.38e-3)" "unprognostic (6.09e-3)" "unprognostic (1.80e-1)" "unprognostic (9.43e-2)" "unprognostic (6.46e-2)" 11.3 11.7 8.0 13.5 10.2 21.1 10.5 14.4 14.3 11.3 23.8 17.5 9.2 17.7 11.6 11.0 12.8 9.9 11.1 10.7 7.7 7.7 8.8 9.6 12.1 15.6 8.3 8.4 12.0 15.3 18.0 12.6 13.1 11.3 11.4 17.3 17.6 10.1 11.8 37.7 13.9 42.4 10.9 7.5 16.1 12.8 8.1 9.7 22.5 12.1 6.5 14.2 12.4 9.8 1.5 1.8 3.8 3.4 1.1 4.2 1.5 10.3 16.2 5.9 8.0 14.8 8.4 7.0 9.0 11.5 10.6 10.3 8.0 3.6 9.9 6.1 12.1 11.9 11.8 6.2 10.8 11.5 12.3 9.4 13.1 5.2 10.1 8.0 18.9 10.8 8.4 10.4 12.3 13.6 6.9 10.1 6.6 7.1 9.9 4.7 3.5 6.3 11.1 7.2 4.2 6.0 10.7 4.6 6.8 10.2 6.4 8.8 6.3 6.1 16.0 9.4 4.7 11.6 11.8 4.5 2.3 5.1 9.3 7.2 8.6 2.8 2.3 2.3 3.2 3.2 4.2 1.5 2.2 2.0 1.8 1.3 1.5 2.5 3.8 1.1 3.4 1.7 1.4 1.5 8.0 10.2 14.4 14.3 7.7 7.7 8.3 8.4 11.3 9.7